Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	17.0	36.3	12.3	13.8	15.0	19.1	17.1	15.2	15.6	20.3	15.1	19.1	12.3	19.1	7.2	19.3	19.9	9.4	22.7	12.9	13.7	21.7	24.6	14.0	17.6	14.3	14.1	19.2	23.9	18.0	24.8	17.4	14.8	18.4	15.1	12.3	18.5	11.7	22.6	17.3	17.7	16.8	13.7	22.2	21.6	27.3	14.0	25.2	19.4	18.5	21.6	17.8	17.9	17.2	26.1	77.3	63.2	38.0	28.6	32.2	38.9	29.8	31.3	72.6	42.1	54.0	56.7	62.2	47.4	37.3	41.9	37.6	106.4	78.8	42.1	41.0	68.1	49.7	29.9	40.7	26.4	45.5	37.9	28.1	39.4	48.9	44.6	40.4	56.6	56.2	67.6	70.6	30.4	72.8	71.2	46.1	40.0	27.7	53.1	72.1	39.3	69.4	38.2	17.5	32.8	41.3	20.2	46.9	21.0	40.2	61.2	38.8	25.5	34.9	51.1	27.4	32.9	32.5	43.5	54.7	25.6	39.6	40.5	1.0	17.7	10.7	18.4	20.2	20.8	20.0	15.9	16.8	18.8	21.8	21.7	21.4	1.1	10.5	22.5	22.6	17.4	15.2	12.3	15.0	15.2	15.6	12.9	13.7	14.3	14.1	14.8	13.7	14.0	17.2	11.7	12.8	7.8	17.9	15.1	7.4	19.0	26.2	10.2	11.8	13.2	13.0	8.2	17.2	15.4	14.7	16.7	58.4	13.7	9.3	13.7	20.4	12.5	11.9	12.9	11.7	8.4	41.2	7.3	18.3	49.5	14.9	13.3	8.9	8.2	13.1	11.0	12.0	28.5	1.7	6.6	13.1	18.3	12.4	9.3	26.2	17.7	10.6	10.6	5.6	11.6	18.0	15.5	6.6	11.4	8.9	11.0	12.8	20.8	8.1	11.2	18.5	12.6	15.5	19.7	11.0	39.7	34.2	40.5	13.1	7.4	36.5	11.4	14.9	17.2	13.0
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 89.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 777.7;Rod photoreceptor cells: 640.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebral cortex: 31.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	9.1	12.6	0.3	8.1	0.6	12.0	8.1	0.9	31.0	7.1	0.0	7.0	4.6	9.9	9.9	7.4	7.5	5.4	20.4	2.9	0.0	10.5	5.1	10.3	9.0	4.7	2.9	5.5	13.1	89.7	13.7	9.9	3.5	8.6	6.3	28.2	6.7	8.2	13.0	6.3	8.5	7.6	0.0	8.6	12.6	6.7	4.8	13.2	23.4	6.7	7.7	7.8	7.1	4.8	25.1	15.3	14.6	12.3	13.7	14.3	41.0	19.4	16.8	12.0	11.3	15.6	10.0	0.9	4.6	27.6	16.5	11.4	11.7	11.4	27.1	20.6	4.4	13.3	9.0	10.0	11.7	9.5	31.3	12.9	9.6	23.7	30.9	10.2	27.4	12.3	3.2	14.1	22.5	3.7	8.8	5.6	6.4	4.9	8.3	5.8	13.8	2.2	10.0	51.0	4.2	6.6	12.0	8.8	10.2	9.9	5.3	12.9	25.6	26.4	17.5	19.7	19.4	12.9	3.9	1.5	23.0	16.0	19.1	1.4	0.5	0.2	1.4	0.2	1.4	0.1	1.3	1.0	0.3	0.3	1.7	1.5	1.5	1.1	2.2	0.2	1.0	0.5	0.3	0.6	0.9	31.0	2.9	0.0	4.7	2.9	3.5	0.0	4.8	4.8	54.6	35.3	34.2	77.7	13.4	15.9	20.8	15.9	32.5	254.4	42.2	40.9	86.7	102.9	19.3	143.5	777.7	81.6	149.1	130.6	43.0	46.0	23.9	36.6	67.4	56.0	72.1	35.3	265.8	67.4	56.3	29.5	44.9	65.7	21.0	24.4	118.2	38.2	62.4	306.2	327.7	31.6	12.2	128.8	23.5	32.7	38.2	67.1	10.6	156.4	72.7	53.2	252.4	147.8	113.9	55.9	76.3	46.6	57.4	42.1	56.0	90.0	10.7	640.8	19.7	26.7	45.5	46.9	59.3	23.3	9.9	213.3	158.1	33.6	21.7	49.0
AAMDC	"C11orf67, CK067, FLJ21035, PTD015"	ENSG00000087884	"Adipogenesis associated Mth938 domain containing"	Q9H7C9	11	77821109-77918432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 656.7"	"Cell type enhanced"	"Detected in all"		"Theca cells: 385.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 143.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 280.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA037918, HPA037919"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA037918: AB_2675737, HPA037919: AB_2675738"	"unprognostic (3.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (6.02e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.84e-2)"	75.8	180.9	30.1	13.0	35.8	21.0	62.5	35.2	42.6	51.0	31.4	66.6	37.4	41.4	27.9	24.6	47.5	23.4	178.9	30.5	31.7	56.0	57.9	46.9	13.8	37.2	34.4	56.7	34.4	27.4	28.6	21.7	35.9	46.0	29.2	20.1	36.6	34.6	656.7	55.4	47.5	40.2	31.9	31.7	62.4	42.2	34.3	23.7	42.2	173.0	13.6	48.1	42.7	42.7	30.3	24.3	37.2	26.5	106.0	73.3	10.0	49.2	33.4	43.8	54.1	280.1	44.6	20.3	46.5	83.0	43.2	16.9	56.4	32.9	51.9	47.1	45.3	19.5	43.5	52.4	52.2	11.2	17.1	98.3	22.2	46.0	24.2	40.2	131.3	27.0	23.1	32.0	93.2	35.6	23.8	44.3	17.3	84.5	41.4	22.3	63.6	19.6	58.2	18.1	13.1	49.2	62.4	26.7	36.0	55.1	41.2	21.1	138.2	45.5	24.7	87.5	16.5	34.2	58.4	37.8	17.7	18.0	26.2	143.1	28.9	33.3	14.6	17.7	18.8	18.3	28.4	24.2	32.6	25.2	24.8	18.4	16.9	35.9	17.5	33.8	47.3	16.3	30.1	35.8	35.2	42.6	30.5	31.7	37.2	34.4	35.9	31.9	34.3	42.7	68.4	83.3	25.4	19.6	10.0	64.2	82.7	51.0	24.5	10.0	58.7	67.2	114.1	62.9	42.5	79.1	4.2	29.1	11.8	70.2	144.8	60.0	100.1	37.7	27.8	55.7	22.7	19.1	6.9	73.1	43.1	64.5	39.3	35.8	41.2	53.4	93.9	122.2	46.9	11.8	8.9	48.7	44.7	29.9	35.9	36.3	68.3	22.5	83.6	8.4	56.2	101.3	16.5	18.1	24.8	70.2	132.2	64.3	10.2	46.6	160.3	200.8	50.1	13.9	46.0	53.5	65.8	154.0	85.4	29.2	100.7	15.7	14.8	385.5	61.0	71.2
AAR2	"bA234K24.2, C20orf4"	ENSG00000131043	"AAR2 splicing factor"	Q9Y312	20	36236131-36270918	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034220, HPA048645"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034220: AB_1564205, HPA048645: AB_2680475"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.54e-3)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (5.09e-2)"	"unprognostic (6.84e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	22.3	26.8	14.5	14.3	15.8	22.3	21.6	15.8	15.5	19.8	19.1	27.5	15.1	25.6	25.0	17.8	23.2	16.5	18.8	14.3	14.7	20.9	23.5	19.2	17.5	15.9	15.2	22.6	18.6	25.5	10.0	17.5	15.9	19.9	17.3	7.5	18.1	21.1	23.4	25.9	18.9	27.9	15.5	18.1	23.0	16.4	15.4	26.2	17.9	20.7	19.9	25.8	16.2	17.2	26.9	30.7	28.8	33.2	48.9	32.4	22.9	25.4	33.7	58.1	45.7	69.2	35.0	18.2	35.6	36.9	44.8	36.6	46.6	48.2	35.8	17.0	28.2	57.9	19.3	43.3	36.9	39.5	27.9	39.6	68.7	41.5	31.5	29.4	36.3	36.0	36.8	34.3	32.4	32.0	56.0	48.9	25.1	39.1	49.5	30.7	48.3	42.4	33.0	19.6	33.2	36.1	37.8	100.7	32.8	26.2	57.1	42.8	26.6	54.9	34.3	33.0	32.2	31.1	42.3	34.6	39.9	26.3	29.7	60.6	46.2	41.6	43.0	49.4	43.2	32.5	40.0	41.4	49.1	35.5	50.0	43.0	8.9	58.4	58.1	39.8	50.2	57.4	14.5	15.8	15.8	15.5	14.3	14.7	15.9	15.2	15.9	15.5	15.4	17.2	11.7	6.4	12.5	4.6	10.8	5.7	10.6	11.8	6.8	4.4	10.3	9.5	6.8	11.5	8.4	9.2	8.4	21.3	10.9	7.1	11.7	19.7	2.8	6.9	8.9	11.9	11.4	14.7	6.3	21.0	14.3	12.7	6.6	6.6	15.9	10.8	11.4	11.8	15.0	15.2	7.1	10.5	12.2	15.0	2.5	3.1	11.1	8.5	10.6	3.7	12.3	6.1	14.4	5.0	9.9	17.3	7.6	15.1	7.5	11.3	8.4	8.0	11.1	3.5	6.6	9.8	13.9	17.0	14.5	9.0	7.5	18.6	7.9	15.3	8.7	8.9
AARSD1	MGC2744	ENSG00000266967	"Alanyl-tRNA synthetase domain containing 1"	Q9BTE6	17	42950526-42964498	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.2;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021408, HPA022869, HPA023714"	Supported		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (2.85e-3)"	"unprognostic (9.78e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.67e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.69e-3)"	18.2	19.6	18.1	13.7	20.2	16.5	20.3	17.9	21.4	19.9	17.2	20.4	12.8	20.7	21.1	18.6	20.3	13.5	34.4	19.5	19.8	20.5	24.4	13.7	17.4	19.3	18.1	26.0	25.5	24.7	20.5	14.6	19.7	18.1	17.4	13.5	20.5	18.4	68.9	15.6	13.7	23.2	17.7	14.2	20.5	72.3	18.8	19.3	21.4	60.5	20.7	19.6	17.6	20.3	38.7	52.4	39.6	39.8	47.0	44.8	30.5	41.2	34.5	46.9	31.1	45.8	32.0	104.3	2.0	43.2	28.7	32.1	55.2	62.2	53.7	35.1	43.7	41.4	57.6	25.3	61.6	81.6	22.2	40.8	33.1	32.6	81.5	32.2	38.3	46.4	76.3	21.3	45.0	22.0	81.8	58.3	27.6	53.5	26.3	53.3	80.8	107.0	46.7	35.8	51.1	32.0	20.0	20.5	54.0	43.0	54.8	68.4	37.3	48.4	43.4	24.9	58.6	33.6	46.3	64.7	31.7	50.1	52.7	4.1	19.0	1.5	20.5	27.3	27.1	27.2	21.4	24.4	29.9	31.2	26.9	26.3	0.6	25.4	24.5	33.3	22.6	17.8	18.1	20.2	17.9	21.4	19.5	19.8	19.3	18.1	19.7	17.7	18.8	20.3	6.3	12.8	8.2	0.0	22.6	8.3	11.7	10.6	26.2	22.1	8.4	8.0	0.7	4.3	13.2	14.7	33.3	8.7	6.9	11.9	3.9	7.2	68.2	7.5	7.0	7.1	12.0	14.7	0.0	6.1	8.7	12.4	12.8	5.3	5.1	11.1	7.5	4.2	5.0	15.2	0.0	6.7	22.4	4.1	6.4	26.9	13.1	6.8	3.6	0.0	6.1	5.5	17.5	0.0	0.0	4.3	4.5	10.9	21.7	9.6	4.5	4.9	9.6	16.2	0.0	7.2	15.0	44.5	21.4	17.4	4.5	2.7	17.7	13.7	10.0	6.7
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138626	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 5.7;skin 1: 20.7"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 12.9;Suprabasal keratinocytes: 38.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"hTCEpi: 38.7;SK-BR-3: 18.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 1.0;hippocampal formation: 1.1"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	5.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.3	0.2	0.2	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	2.8	0.3	3.9	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	38.7	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.5	0.1	2.7	0.0	18.3	0.0	0.2	9.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	12.9	0.9	6.0	0.0	0.2	1.0	0.5	0.5	0.0	5.1	0.0	0.0	1.1	0.0	3.0	0.0	0.1	2.2	2.6	0.3	0.1	0.0	0.0	1.4	0.0	2.7	0.1	1.5	3.7	0.0	0.5	0.0	0.0	0.4	1.7	2.9	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.6	1.9	0.0	0.7	0.0	1.0	0.0	0.1	3.1	0.2	0.0	0.0	0.2	0.7	0.4	2.2	38.6	3.4	0.0	0.1	0.9	2.7
ABCA13	"FLJ33876, FLJ33951"	ENSG00000179869	"ATP binding cassette subfamily A member 13"		7	48171458-48647497	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	15	"bone marrow: 44.6"	"Group enriched"	"Detected in some"	5	"Basal respiratory cells: 33.8;Club cells: 25.8;Respiratory ciliated cells: 101.5"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.8;LHCN-M2: 2.4;U-2 OS: 6.4;U-266/84: 2.9"	"Not detected"	"Not detected"							HPA063601			Approved	Vesicles,Centrosome,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	"Centrosome, Cytosol"	"HPA063601: AB_2685057"	"unprognostic (8.97e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.03e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-2)"	0.0	0.0	0.1	0.1	0.3	44.6	0.6	0.1	0.2	0.3	0.3	0.2	0.2	0.1	1.1	1.2	1.2	0.3	0.0	0.3	0.1	0.9	0.3	1.3	0.1	0.1	0.3	0.0	0.7	0.0	1.2	0.0	0.1	0.0	0.3	0.4	0.9	0.2	0.0	0.9	0.1	0.0	0.0	0.5	0.0	1.6	0.1	0.6	3.0	0.0	1.7	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.0	1.3	0.0	1.2	0.3	0.7	1.4	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.2	0.0	0.1	2.4	0.0	0.0	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	6.4	0.3	1.0	1.9	2.9	0.0	0.8	0.3	0.2	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.1	33.8	0.0	0.0	1.2	0.3	10.5	0.0	25.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	10.2	1.8	0.5	0.2	0.0	0.8	0.6	0.4	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.9	0.2	0.0	0.5	0.2	6.1	0.0	0.0	6.1	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	101.5	0.0	0.0	0.1	1.8	3.6	3.7	1.7	0.0	0.0	0.1	0.1	0.5	0.2
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.2"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 427.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;SCLC-21H: 45.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.8	8.7	19.1	3.0	20.8	0.7	6.7	10.2	25.5	3.0	0.0	7.9	2.0	3.7	3.5	2.9	4.4	2.7	6.1	23.4	17.1	6.5	1.1	91.2	3.7	20.1	15.8	3.4	13.1	11.2	11.1	4.3	22.2	4.9	1.2	7.4	9.1	4.3	6.2	4.3	3.9	4.6	11.1	3.4	4.9	8.9	19.1	11.3	24.6	3.8	6.5	4.5	2.2	19.7	0.7	21.6	4.1	33.1	0.8	0.0	0.3	5.8	1.4	2.3	2.4	3.0	3.4	0.2	8.4	2.7	2.1	0.6	19.2	0.3	0.8	34.6	12.9	2.2	2.5	0.5	2.9	0.4	3.6	0.3	0.5	0.3	1.1	13.4	32.4	0.2	24.0	0.0	0.1	29.3	0.1	2.4	4.4	5.2	10.4	5.4	0.7	3.8	18.7	0.7	45.9	33.0	4.1	23.4	0.6	1.6	76.5	2.0	9.3	0.2	1.1	9.0	9.8	6.1	2.9	0.1	4.7	11.7	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	19.1	20.8	10.2	25.5	23.4	17.1	20.1	15.8	22.2	11.1	19.1	19.7	4.3	70.5	427.4	30.0	1.1	0.6	0.5	0.2	2.2	20.7	8.4	6.7	6.7	4.3	9.5	18.4	12.5	0.0	2.1	0.3	0.0	5.7	7.7	1.3	0.3	6.3	5.4	0.0	60.3	3.8	0.0	2.7	0.0	2.9	29.7	7.7	5.3	0.7	1.0	18.5	58.6	0.8	4.1	1.2	1.8	3.8	1.8	3.1	1.8	13.1	2.2	7.1	2.1	32.2	37.2	1.9	0.4	3.4	3.6	1.5	0.4	2.0	2.4	12.5	6.6	7.2	2.9	5.1	15.0	1.2	1.6	0.0	3.9	1.3	0.4	0.2
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992834-94121148	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"choroid plexus: 144.6;retina: 461.0"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 450.4;Rod photoreceptor cells: 482.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	6	"hippocampal formation: 9.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;EFO-21: 6.8;HeLa: 2.3;SK-BR-3: 3.0;SuSa: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.5	0.0	0.4	0.1	0.3	0.0	0.8	1.1	0.7	0.5	144.6	0.2	2.5	0.1	8.4	0.2	0.4	0.1	0.2	9.3	0.1	8.7	0.9	0.3	0.4	0.4	0.5	0.2	0.0	0.0	0.1	0.6	0.2	0.2	0.1	461.0	0.0	1.4	0.1	2.1	2.9	0.0	0.1	0.1	0.1	1.0	1.4	0.3	0.4	0.0	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	6.8	0.3	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.4	2.3	0.7	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.9	0.5	0.0	1.2	0.0	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.0	0.6	3.0	0.1	3.1	0.3	0.0	0.1	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.7	9.3	0.1	0.4	0.5	0.2	0.1	1.4	0.4	1.2	0.0	1.1	1.3	0.0	0.1	0.2	1.7	0.0	27.9	0.5	1.3	1.1	0.0	1.8	7.3	450.4	0.3	0.0	0.0	0.0	0.0	8.8	0.3	0.1	3.1	0.0	0.0	0.4	0.0	1.5	0.2	0.0	0.9	0.0	0.2	1.4	0.3	0.1	10.1	0.6	16.2	0.0	0.3	0.0	21.9	0.0	0.0	0.0	19.7	0.0	37.3	0.0	0.5	0.0	0.0	0.0	0.4	0.0	2.6	1.3	0.4	2.3	482.9	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.6	0.7
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867289-68955392	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 231.5;Granulosa cells: 117.3;Leydig cells: 502.6;Microglial cells: 162.1;Oligodendrocytes: 406.6;Skeletal myocytes: 216.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 31.9;ASC TERT1: 69.6;HSkMC: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	39.1	30.5	12.6	2.8	28.1	0.0	21.3	21.0	18.3	10.0	9.6	16.4	6.2	11.9	15.6	7.6	23.7	16.9	42.1	13.6	16.1	9.5	33.7	18.2	1.1	28.2	19.8	51.5	5.7	3.8	11.1	9.0	29.0	9.5	16.9	9.2	14.8	8.6	12.3	6.2	11.8	6.6	20.7	12.4	14.3	19.5	18.4	4.5	17.0	26.7	3.0	16.3	14.6	58.1	0.0	0.0	3.9	0.0	31.9	69.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	12.0	0.0	0.0	53.5	0.0	0.8	0.0	0.4	6.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	28.1	21.0	18.3	13.6	16.1	28.2	19.8	29.0	20.7	18.4	58.1	22.6	51.3	1.1	0.7	0.0	6.0	1.8	0.0	2.8	5.0	0.7	1.0	18.8	0.0	4.3	0.0	2.1	0.2	0.3	0.0	0.0	0.0	4.8	0.4	14.0	6.8	0.0	0.0	0.5	0.0	0.1	231.5	3.1	0.3	1.3	117.3	5.7	48.1	1.1	5.0	0.6	0.0	0.0	1.9	9.4	19.4	502.6	2.6	1.8	162.1	0.0	100.3	0.0	0.5	406.6	0.0	0.0	70.3	1.9	0.4	0.0	0.1	0.0	3.3	39.5	216.6	44.5	5.1	1.7	2.5	4.7	0.3	2.1	60.9	0.0	0.4
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209772-219218994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.2	8.7	4.3	3.4	3.9	10.4	7.6	3.2	4.6	7.7	4.4	6.5	6.9	8.4	8.2	11.4	9.6	7.1	8.5	4.0	5.1	5.2	15.9	5.9	1.9	4.4	4.2	12.9	5.7	4.8	6.0	3.1	6.2	8.0	3.3	3.0	6.2	8.6	30.4	6.8	6.3	7.9	4.1	3.9	7.9	18.0	5.7	2.6	10.7	9.8	2.9	14.9	7.9	5.0	0.3	22.9	4.7	28.8	30.8	11.1	27.6	8.5	7.9	9.2	9.2	35.5	5.0	0.3	42.8	8.6	5.0	49.1	0.6	3.6	3.0	15.0	4.7	36.3	24.9	65.8	37.0	0.0	12.0	16.3	4.2	6.2	0.1	13.9	16.3	4.8	31.4	4.4	6.3	12.0	2.3	0.1	7.2	53.6	9.2	12.3	14.3	1.6	5.1	0.4	16.6	17.8	17.6	41.4	18.7	17.4	12.4	0.8	7.5	12.5	0.5	16.9	10.3	11.2	9.6	0.1	14.0	0.4	17.0	0.7	0.4	0.0	0.7	0.4	0.2	1.0	0.5	0.2	0.3	0.8	1.2	0.8	0.0	0.4	0.3	2.3	0.5	1.0	4.3	3.9	3.2	4.6	4.0	5.1	4.4	4.2	6.2	4.1	5.7	5.0	0.2	0.0	0.0	14.7	0.3	0.3	0.0	0.5	1.2	1.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.8	1.2	0.3	0.6	0.4	0.0	1.3	12.9	0.0	0.1	0.7	5.1	0.2	0.0	0.5	0.0	0.4	0.1	0.0	10.9	0.3	0.0	0.3	0.4	1.0	0.3	0.3	0.0	3.7	0.0	0.3	0.0	13.6	5.6	0.3	0.0	0.4	0.5	0.0	0.5	0.2	2.2	0.8	0.0	0.4	0.3	1.0	0.3	2.8	0.3	0.3	0.1	0.4	0.2	0.1
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 20.1;pituitary gland: 34.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	0.4	2.8	2.6	0.0	3.7	0.0	1.8	3.9	5.2	3.5	0.0	0.7	0.5	2.6	1.4	0.1	0.6	0.0	1.6	3.1	1.4	0.5	0.1	5.0	0.0	3.3	2.7	0.4	20.1	0.2	34.4	0.4	3.3	2.1	0.3	2.2	0.0	1.5	1.5	0.2	1.0	0.2	0.6	0.1	6.1	0.4	1.2	0.0	3.4	0.6	0.0	0.4	1.3	3.5	0.0	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	3.9	5.2	3.1	1.4	3.3	2.7	3.3	0.6	1.2	3.5	0.3	0.0	0.0	19.6	0.3	0.0	0.1	0.0	0.0	39.0	5.3	3.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.5	17.9	0.3	22.0	0.0	48.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	39.3	0.7	0.0	0.3	0.5	0.0	0.0	0.1	0.0	3.7	0.0	1.9	0.0	39.2	7.6	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.0	0.7	2.0	0.1	0.8	0.0	0.1	0.0	0.1	2.6	0.1	0.2
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797389-21942529	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 60.3;Astrocytes: 72.1;Hepatocytes: 99.4;Sertoli cells: 131.5;Smooth muscle cells: 140.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.9;BJ hTERT+: 14.0;CACO-2: 20.8;HSkMC: 27.1;U-138 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	27.4	5.9	4.5	3.4	5.4	1.7	9.2	3.1	9.2	8.2	11.6	7.4	4.0	19.1	8.3	6.2	12.3	11.7	28.3	5.4	3.6	6.6	45.2	7.7	3.5	4.8	7.4	10.9	3.5	1.9	2.2	3.6	3.7	7.9	1.8	3.2	4.5	9.9	41.9	4.2	3.1	21.0	3.4	4.4	8.1	1.2	5.1	1.8	6.3	30.3	1.5	5.3	5.1	7.2	0.9	0.2	11.9	0.3	24.9	11.0	0.3	6.1	14.0	7.0	3.5	20.8	1.0	0.5	1.2	0.6	0.8	0.3	0.0	0.0	7.2	0.3	0.2	0.5	0.8	0.3	0.1	0.5	0.6	27.1	0.0	6.7	2.5	0.4	0.0	0.4	0.3	1.2	0.3	1.4	0.2	0.4	1.4	1.2	0.6	0.5	0.3	0.3	0.0	1.2	0.4	1.7	0.4	0.5	0.2	1.7	1.2	0.3	0.3	27.0	1.9	2.2	8.7	1.1	1.3	0.4	6.7	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.5	5.4	3.1	9.2	5.4	3.6	4.8	7.4	3.7	3.4	5.1	7.2	33.8	35.3	60.3	72.1	0.2	3.4	1.5	5.0	0.6	0.8	0.5	0.8	38.2	0.0	25.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.8	20.6	19.7	0.0	0.0	17.2	0.2	0.1	26.2	1.1	0.6	24.0	0.0	7.1	99.4	0.1	1.7	1.0	0.0	0.0	2.4	5.9	0.1	0.3	2.5	10.6	2.8	0.0	15.9	0.0	1.5	1.4	0.1	0.0	0.4	0.0	0.5	0.0	0.1	20.4	1.2	131.5	11.1	140.7	0.4	1.6	1.1	2.3	0.3	2.5	0.2	0.0	2.2
ABCF3	EST201864	ENSG00000161204	"ATP binding cassette subfamily F member 3"	Q9NUQ8	3	184186023-184194012	"Predicted intracellular proteins, Transporters"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036332	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoli	"HPA036332: AB_10603571"	"unprognostic (1.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.53e-2)"	16.1	56.1	10.9	13.3	10.9	16.8	15.8	11.8	13.4	18.2	9.6	15.5	15.7	15.5	12.3	20.0	17.0	12.7	28.5	10.9	12.7	19.2	22.7	14.4	17.0	13.9	12.3	20.0	23.6	43.5	21.0	16.4	12.8	16.2	13.6	14.2	26.9	19.6	46.8	19.6	16.3	12.4	9.2	17.8	17.5	16.5	12.4	14.6	17.9	41.3	16.1	17.1	17.6	11.6	49.9	30.2	16.9	32.8	48.1	26.9	33.3	35.2	39.1	46.7	36.5	52.0	19.3	29.8	69.5	38.1	54.9	46.4	26.5	37.1	24.1	38.4	25.5	25.7	26.6	30.8	40.4	29.2	25.2	39.7	33.5	33.1	32.7	27.4	33.8	25.7	24.1	34.9	33.5	60.0	28.7	18.8	25.7	51.1	41.2	28.5	28.1	50.4	25.4	29.6	29.1	16.9	36.5	69.1	33.8	18.3	93.7	25.3	33.5	24.9	27.1	39.5	53.1	39.2	40.5	38.2	38.8	28.7	31.3	8.1	29.1	22.7	32.9	30.4	34.7	23.6	29.0	27.5	25.6	23.8	36.0	29.5	14.6	24.0	32.4	15.8	27.2	37.2	10.9	10.9	11.8	13.4	10.9	12.7	13.9	12.3	12.8	9.2	12.4	11.6	10.2	9.6	2.0	6.2	17.4	14.5	10.0	29.8	9.6	16.7	10.8	6.7	11.6	17.2	19.7	14.7	14.6	36.9	16.2	19.8	29.4	22.5	9.5	11.2	12.0	11.6	11.4	8.6	7.1	22.4	25.5	12.5	13.3	12.0	9.5	16.0	16.8	20.0	21.6	20.2	9.9	13.4	30.5	9.4	6.9	10.2	12.5	12.9	16.0	3.7	22.8	14.7	17.5	6.6	7.3	20.5	9.8	11.7	19.4	9.0	28.6	37.3	14.4	22.3	6.6	11.9	9.5	12.8	17.1	14.5	10.2	43.8	16.6	18.1	14.7	11.7
ABHD13	"bA153I24.2, BEM46L1, C13orf6, FLJ14906"	ENSG00000139826	"Abhydrolase domain containing 13"	Q7L211	13	108218392-108234243	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032143, HPA032144"	Approved		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"HPA032143: AB_2674178, HPA032144: AB_10602304"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.62e-2)"	7.0	5.3	3.7	7.0	4.0	16.3	7.3	5.9	5.3	6.2	7.0	6.5	7.0	6.3	10.2	5.6	4.3	6.4	4.3	4.1	3.2	6.1	10.4	6.9	8.3	3.3	3.3	5.2	4.7	5.7	3.8	8.4	3.2	6.2	7.3	6.4	4.6	5.6	4.2	4.3	7.4	6.8	3.2	7.8	6.8	3.8	3.4	9.3	7.6	6.4	7.1	7.5	4.3	3.9	9.8	4.0	10.5	5.9	8.0	9.5	5.1	9.5	9.5	8.2	9.7	6.2	9.1	8.2	9.7	7.4	8.1	8.8	7.9	11.0	13.0	11.1	6.9	10.1	5.7	6.1	8.0	21.1	12.0	9.8	10.3	6.4	8.3	7.7	9.8	11.2	5.5	4.5	8.5	4.1	10.3	8.8	5.0	14.5	4.7	8.7	7.5	4.8	11.5	8.7	7.9	9.9	5.0	8.3	10.6	9.3	7.7	19.3	10.2	5.8	6.0	6.8	6.5	8.8	7.4	9.0	13.7	13.0	10.7	7.7	8.2	16.0	5.9	7.6	8.8	6.8	8.0	7.2	7.2	6.0	7.6	6.3	9.0	9.5	7.2	5.3	8.4	8.6	3.7	4.0	5.9	5.3	4.1	3.2	3.3	3.3	3.2	3.2	3.4	3.9	17.6	22.4	16.6	8.1	24.5	44.4	21.4	33.3	15.9	12.8	16.8	10.8	7.2	27.1	22.2	11.0	0.0	20.9	23.7	14.7	9.8	19.1	24.8	12.3	13.4	18.2	30.5	16.2	21.4	21.0	15.4	19.9	19.9	14.4	14.0	9.5	19.6	29.5	19.5	18.5	17.4	11.6	44.7	21.5	40.1	18.2	15.5	24.6	26.6	15.0	25.8	12.6	19.6	16.1	15.2	20.8	14.3	17.3	10.2	20.7	16.4	11.5	18.4	12.2	19.7	15.1	18.2	22.9	12.3	21.1	51.1	21.3	28.4	12.5	12.1	26.3
ABHD15		ENSG00000168792	"Abhydrolase domain containing 15"	Q6UXT9	17	29560547-29567037	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 26.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 79.4;Hepatocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;MAIT T-cell: 6.6;NK-cell: 10.8;plasmacytoid DC: 23.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA014470	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA014470: AB_1852993"	"unprognostic (1.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.45e-2)"	19.2	3.8	3.6	6.2	4.0	8.2	10.6	3.8	3.3	4.6	3.8	7.3	11.2	4.5	3.3	4.7	4.7	5.2	4.9	3.1	4.1	8.9	26.2	6.0	9.1	4.9	4.2	2.9	8.1	7.9	9.1	4.5	4.7	4.7	6.5	1.6	5.1	3.8	2.6	4.6	11.2	4.0	4.2	9.9	8.3	1.8	4.3	4.6	5.8	3.8	8.1	5.6	4.6	4.9	5.8	22.1	2.7	7.7	29.0	12.6	11.3	7.8	8.6	7.6	6.9	5.1	2.9	8.6	5.6	8.4	13.4	15.6	9.7	3.3	4.2	26.5	7.3	3.5	11.0	6.5	8.8	9.0	15.4	9.4	8.9	7.3	1.4	5.6	5.6	5.0	4.6	8.0	4.1	7.8	8.5	10.4	0.6	19.5	6.5	19.7	10.5	20.0	13.7	8.8	1.9	3.1	11.7	5.2	3.1	2.9	13.2	20.5	6.9	4.4	5.5	11.1	7.0	13.3	9.6	4.4	8.8	5.6	9.6	18.3	0.6	2.8	2.6	0.3	6.6	1.4	1.4	2.2	1.5	2.5	0.4	1.3	0.6	10.8	0.2	23.6	1.2	1.1	3.6	4.0	3.8	3.3	3.1	4.1	4.9	4.2	4.7	4.2	4.3	4.9	2.4	3.2	4.1	2.6	11.7	1.3	1.1	2.5	2.2	0.1	3.8	2.4	3.0	2.8	4.3	7.3	0.0	1.5	79.4	12.0	0.0	3.0	0.3	4.7	3.1	2.9	7.2	7.0	0.3	7.6	1.4	4.0	2.0	5.1	2.5	2.9	4.2	30.2	7.2	1.7	0.5	6.1	2.0	6.7	8.4	0.7	4.7	9.5	5.4	2.8	5.6	1.1	15.5	0.5	1.2	5.6	2.5	4.5	5.2	1.5	17.7	5.6	5.2	0.9	0.0	3.5	1.9	0.8	0.6	2.0	2.4	0.3	11.8	4.5	7.4	1.2
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2, acylglycerol lipase"	P08910	15	89087459-89202355	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.8;Hepatocytes: 402.5;Late spermatids: 462.1;Oligodendrocyte precursor cells: 421.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 69.8;neutrophil: 52.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEL: 340.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	18.5	36.3	20.0	20.2	20.9	34.9	22.5	40.2	27.2	19.5	130.3	21.1	47.9	20.7	56.1	17.4	23.4	47.2	36.1	29.0	20.3	22.4	137.6	45.3	14.7	13.3	32.4	24.5	57.9	18.4	14.0	11.1	13.5	44.2	18.9	14.5	12.7	18.6	21.8	13.1	35.9	22.4	11.0	24.6	72.9	52.0	24.2	15.5	17.1	46.3	16.1	31.1	9.6	16.4	33.0	62.3	14.7	16.3	29.2	39.0	8.2	21.4	62.5	19.8	18.6	15.7	55.3	9.4	23.9	27.4	54.1	42.6	32.4	26.4	28.0	48.1	15.8	340.5	14.0	12.8	14.8	24.2	74.4	20.1	18.6	70.1	45.5	33.7	25.3	20.7	30.3	27.4	56.3	13.3	15.0	5.8	6.6	76.9	18.1	20.7	32.2	71.9	27.0	51.5	25.2	39.0	41.4	19.4	34.4	13.5	21.7	18.6	38.6	70.9	23.7	24.2	55.8	23.5	49.3	10.9	58.2	21.5	55.4	8.4	13.4	69.8	3.5	11.3	2.1	2.4	3.2	3.4	7.1	2.2	3.2	3.2	52.2	11.2	17.8	5.7	8.7	6.9	20.0	20.9	40.2	27.2	29.0	20.3	13.3	32.4	13.5	11.0	24.2	16.4	43.4	96.1	118.1	87.5	10.7	18.6	47.3	27.0	7.4	25.5	26.6	17.8	52.0	130.1	82.1	42.3	18.8	4.6	53.7	65.9	1.9	48.9	331.8	28.3	36.8	27.7	48.7	40.8	103.6	85.2	7.7	26.6	103.0	25.9	60.7	18.5	21.0	402.5	40.8	20.2	114.7	58.7	87.5	59.2	26.6	462.1	32.9	67.3	58.7	46.9	46.4	45.5	36.0	421.2	54.4	106.4	38.0	59.8	27.4	171.1	53.1	18.0	158.0	14.7	78.9	36.1	53.4	119.8	13.2	20.8	17.5	2.6	24.5	35.2	38.7	117.5
ABITRAM	"C9orf6, CG-8, FAM206A, FLJ20457, Simiate"	ENSG00000119328	"Actin binding transcription modulator"	Q9NX38	9	108934400-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.7;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 10.6;Fibroblasts: 4.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035917, HPA035918"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	14.2	11.9	17.2	10.0	18.7	15.6	17.2	16.8	21.9	12.5	18.7	14.9	14.4	13.6	25.1	16.4	21.5	10.9	15.8	17.7	17.3	13.6	14.6	12.7	9.0	16.8	17.1	13.5	13.3	23.2	13.9	12.5	17.2	12.1	16.2	24.7	15.3	14.2	13.2	24.5	13.1	12.5	17.5	8.5	14.5	20.2	17.5	11.9	19.0	11.8	12.0	11.9	11.4	18.3	18.5	19.8	19.5	23.4	36.2	44.6	28.1	17.1	20.0	17.0	13.9	29.5	9.7	17.0	9.8	16.6	22.3	41.3	17.2	18.3	16.0	10.4	17.6	10.5	25.8	27.0	30.7	40.4	13.3	25.3	33.6	20.7	47.6	20.9	23.7	26.1	39.7	16.6	20.3	53.0	28.9	16.3	22.6	55.9	28.7	13.9	33.9	18.9	22.5	19.2	26.7	13.7	27.0	23.3	30.1	20.0	31.6	21.4	14.9	9.2	16.9	39.3	21.7	14.7	38.5	12.6	30.1	15.6	13.4	38.8	31.2	31.0	14.8	33.4	22.6	16.5	23.1	19.6	35.5	10.8	22.9	17.6	37.4	21.1	34.6	37.0	21.1	20.1	17.2	18.7	16.8	21.9	17.7	17.3	16.8	17.1	17.2	17.5	17.5	18.3	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0
ABR	MDB	ENSG00000159842	"ABR activator of RhoGEF and GTPase"	Q12979	17	1003518-1229738	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 171.7;Late spermatids: 164.0;Microglial cells: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 31.3;hTERT-RPE1: 38.6;LHCN-M2: 24.6;RPMI-8226: 21.5;TIME: 41.3;U-251 MG: 42.0;U-698: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053618, HPA054824"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA053618: AB_2682208, HPA054824: AB_2682616"	"unprognostic (1.69e-1)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.20e-3)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.74e-2)"	22.7	21.7	4.5	5.5	3.1	1.3	20.0	1.2	6.0	27.0	0.0	58.9	1.9	28.5	0.1	42.0	22.9	0.6	40.5	5.1	1.7	9.7	3.0	28.5	1.0	4.2	5.0	14.7	8.6	1.2	22.4	1.6	7.3	18.2	7.0	1.2	28.1	0.4	9.0	25.0	40.5	8.1	6.9	21.0	19.5	13.9	6.7	4.8	10.5	0.0	5.7	22.0	24.7	12.3	1.0	1.3	0.3	0.1	1.3	0.2	1.7	0.2	0.3	0.1	0.0	0.6	0.0	31.3	0.7	0.3	1.7	0.1	4.0	0.1	0.9	11.8	14.5	0.0	0.4	0.1	0.8	2.7	9.5	0.4	0.0	0.3	12.7	38.6	0.0	0.0	0.1	0.0	24.6	1.2	0.1	3.4	0.2	0.7	0.2	0.2	0.0	21.5	0.2	0.4	0.3	0.6	0.1	0.0	1.8	0.1	11.5	3.0	41.3	0.3	0.4	3.0	42.0	0.1	0.6	29.5	1.9	5.1	0.8	9.0	0.2	0.6	0.1	0.5	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.5	0.0	4.5	3.1	1.2	6.0	5.1	1.7	4.2	5.0	7.3	6.9	6.7	12.3	20.0	32.1	24.6	171.7	9.6	17.1	18.2	19.0	11.4	75.5	11.3	8.3	23.7	22.8	21.0	1.8	2.1	2.4	13.3	61.0	0.0	17.7	37.0	14.3	6.1	22.1	15.0	2.5	80.5	6.3	3.0	13.7	18.8	9.7	19.6	16.3	18.2	0.6	30.4	11.8	67.6	37.2	16.2	31.9	49.4	164.0	13.7	31.0	19.6	146.1	25.5	25.8	34.0	41.7	5.2	48.3	38.4	9.4	4.2	21.8	36.8	7.9	26.7	20.0	39.5	19.9	25.3	2.7	8.3	22.3	16.9	2.2	15.5	0.6	53.2	25.1
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028745-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 440.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 501.5;NB-4: 530.8;U-937: 515.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		9200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	20.1	9.6	16.8	73.7	16.2	87.7	44.9	13.5	20.8	20.7	14.7	95.0	74.1	22.0	136.0	42.0	12.4	36.0	13.3	18.6	15.7	50.0	60.7	31.2	123.1	14.7	14.6	4.1	16.1	49.1	14.4	29.1	16.2	16.3	86.5	5.4	40.8	12.2	3.0	38.8	74.4	23.5	14.9	73.9	34.4	32.3	16.4	139.6	42.4	7.5	87.9	79.6	17.1	16.0	76.8	40.7	100.7	94.8	39.7	62.2	110.6	59.7	42.9	44.5	91.2	91.2	87.4	0.4	105.8	59.8	189.5	112.9	90.4	130.0	51.9	204.4	167.4	297.8	20.7	31.6	57.6	501.5	130.5	55.9	108.2	59.9	49.1	79.4	237.5	204.9	38.4	100.4	129.5	162.7	314.2	530.8	120.9	119.1	78.5	199.8	62.3	23.8	121.7	225.0	225.4	24.8	40.5	112.3	194.5	141.9	45.1	369.8	175.7	28.2	24.0	58.9	107.7	54.1	169.2	20.9	35.7	515.5	84.2	232.3	178.0	114.2	161.1	334.3	252.2	93.8	259.3	208.2	193.9	96.9	250.9	235.9	48.8	152.1	514.5	215.9	260.2	347.8	16.8	16.2	13.5	20.8	18.6	15.7	14.7	14.6	16.2	14.9	16.4	16.0	54.2	19.2	22.2	2.0	87.1	139.6	71.4	195.2	108.1	0.3	86.6	67.8	3.8	27.1	126.2	44.1	0.0	77.1	151.3	304.5	60.7	145.3	4.8	85.8	20.1	55.0	43.1	75.7	12.8	145.0	207.7	23.5	55.5	129.0	79.4	59.9	53.6	254.3	353.1	0.0	9.1	116.8	162.8	286.1	133.9	13.7	4.7	187.6	87.2	5.6	167.9	49.8	189.5	1.0	1.0	167.4	250.6	12.8	121.0	47.9	247.5	440.3	74.1	1.3	32.9	7.2	37.3	3.6	7.7	116.6	90.1	48.6	198.5	17.7	123.6	133.8
AC004922.1		ENSG00000284292	"Novel protein, ARPC1A and ARPC1B readthrough"		7	99325879-99394653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Club cells: 2.5;Exocrine glandular cells: 1.5;granulocytes: 1.3;Pancreatic endocrine cells: 1.1"					"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004334	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"																		1.5	1.2	0.1	0.9	0.1	0.5	1.2	0.1	0.3	1.1	0.0	1.4	0.9	0.9	0.0	1.3	1.0	0.1	1.0	0.2	0.1	1.0	1.2	1.8	0.8	0.5	0.2	0.8	0.9	0.1	0.8	0.2	0.3	0.9	0.0	0.0	1.2	0.0	0.4	0.7	1.9	0.2	0.1	2.9	1.2	0.5	0.2	0.2	1.2	0.0	0.1	1.2	1.0	0.0	1.9	2.1	0.4	0.2	0.3	1.0	2.5	1.6	0.7	0.9	1.0	4.1	3.5	2.5	4.8	1.5	1.7	1.6	0.1	1.1	0.2	1.0	1.7	1.2	1.3	0.9	0.2	1.4	1.4	1.4	0.7	1.3	0.6	0.3	1.0	0.8	1.6	2.2	1.0	5.1	3.8	0.1	0.7	0.7	2.8	1.4	0.3	0.7	0.2	1.0	0.4	0.3	1.3	2.7	6.0	0.3	0.8	0.7	2.0	3.3	1.3	3.6	2.4	0.0	1.0	2.4	1.7	2.5	3.5	11.8	20.7	23.7	8.7	20.4	6.2	9.3	8.5	8.7	16.6	11.1	7.1	6.9	16.9	7.1	18.7	11.2	16.5	31.5	0.1	0.1	0.1	0.3	0.2	0.1	0.5	0.2	0.3	0.1	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.5	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AC005324.2		ENSG00000251537	"Novel tripartite motif-containing 16 (TRIM16) and CMT1A duplicated region transcript 1 (CDRT1) protein"		17	15571491-15651653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;CAPAN-2: 1.1;HaCaT: 2.1;HeLa: 1.1"									"HPA023623, HPA066431"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"		Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (3.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.80e-11)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.09e-1)"	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC006059.2		ENSG00000280571	"Novel protein"		3	42705756-42804518	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	6	"brain: 2.2;retina: 7.6"	"Cell type enriched"	"Detected in single"	4	"Alveolar cells type 1: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047429			Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA047429: AB_2680043"	"unprognostic (1.72e-1)"	"unprognostic (4.20e-1)"			"unprognostic (8.65e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.72e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.09e-3)"		"unprognostic (2.99e-2)"	"unprognostic (3.01e-2)"	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.1	0.0		0.0	0.7	0.0	0.0	7.6	0.1	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0		2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.2	0.6	0.4	0.7	0.7	0.6	0.7	0.7	0.5	2.2	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC008397.2		ENSG00000285188	"Novel protein"		19	18207961-18255419	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"stomach 1: 3.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.0;Alveolar cells type 1: 9.6;Alveolar cells type 2: 10.6;Breast glandular cells: 2.2;Breast myoepithelial cells: 4.6"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.2"									"HPA048975, HPA054218"	Uncertain		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA					"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "																		0.1	0.0	1.8	0.1	2.3	0.0	0.0	1.2	2.3	0.3	1.2	1.2	0.8	0.7	1.9	0.1	0.7	0.3	0.5	2.1	1.5	0.4	0.0	1.2	0.0	1.3	1.5	0.2	0.4	0.0		0.6	1.4	0.2	1.0	0.0	0.0	0.7	2.4	0.0	0.5	0.5	1.3	0.4	3.6	0.3	1.6	0.0	0.0	2.6	0.0	0.1		1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.3	1.2	2.3	2.1	1.5	1.3	1.5	1.4	1.3	1.6	1.6	2.0	9.6	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AC008687.1		ENSG00000267335	"Novel protein"		19	49022953-49036895	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	6	"pituitary gland: 17.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.6;HMC-1: 4.4;U-138 MG: 1.6;U-251 MG: 6.0"									HPA038925	Uncertain		Approved	Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"		Cytosol		"HPA038925: AB_2676272"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	17.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.6	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.2	0.0	0.0	1.6	1.3	0.3	6.0	0.3	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AC008695.1		ENSG00000273217	"Novel protein"		5	131425891-131796983	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 8.2"	"Cell line enhanced"	"Detected in single"		"A549: 2.5"									"HPA037982, HPA037983"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: AB_2675769"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.8	1.9	2.5	0.3	4.4	1.1	2.7	3.0	0.3	1.5	8.2	3.9	0.5	1.9	0.7	0.0	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
AC011005.1		ENSG00000230626	"Novel protein similar to mitogen-activated protein kinase kinase 2 MAP2K2"		7	129126518-129130793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"testis: 3.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051993	Uncertain		Approved	Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"			Cytosol		"HPA051993: AB_2681685"	"unprognostic (2.03e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.36e-5)"	"unprognostic (3.43e-2)"	0.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.4	0.0	0.3	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	1.4	0.4	0.4	0.0	0.0	0.3	0.4	3.1	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012254.6		ENSG00000288607	"Elongin A3 family member B"	Q3SY89	18	47022287-47023927	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	34	"brain: 3.4;choroid plexus: 3.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	2.0	0.0	2.7	0.0	0.0	0.9	1.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	3.4	3.2	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0		2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.7	0.9	1.3	1.1	1.1	3.4	3.2	2.7	1.8	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012488.2		ENSG00000286165	"Novel protein"		2	189661519-189667881	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	5	"brain: 2.7"	"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.7"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;HDLM-2: 1.2"									HPA075042			Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"		"Cluster 26: Non-specific - Cell cycle regulation"		Cytosol		"HPA075042: AB_2686731"																		0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.2	2.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0		0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.2	0.8	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.3	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.7	1.1	0.4	0.4	0.3	1.3	0.4	0.0	0.2	2.1	0.3	0.2	0.5	0.6	0.2	1.0	2.3	0.4	0.2	0.3	0.2	2.7	0.2	0.2	0.3	0.1	0.4	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC090373.2		ENSG00000288616	"Elongin A3 family member D"	A6NLF2	18	46962768-46964408	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	37	"brain: 3.4;choroid plexus: 4.0"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	1.4	0.0	2.2	0.0	0.0	1.2	1.4	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	3.4	1.9	0.0	0.0	0.0		0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0		1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	1.2	1.4	1.0	0.9	3.4	1.9	2.4	0.8	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC093827.5		ENSG00000285458	"Novel protein"		4	86886472-86936178	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 3.1;Distal tubular cells: 5.9;Respiratory ciliated cells: 8.0"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.1"									HPA057434	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Focal adhesion sites"	Cytosol	"HPA057434: AB_2683438"																		1.3	1.2	2.2	0.7	2.5	1.1	1.9	3.6	3.3	1.2	1.3	0.9	1.0	1.1	2.0	1.3	1.0	0.8	2.7	2.6	2.2	1.7	0.7	1.0	0.5	2.0	2.0	1.1	0.9	1.6		0.9	2.1	1.4	1.2	2.0	1.4	0.9	3.4	2.8	1.0	1.0	1.0	0.9	1.3	1.9	2.1	0.6	2.2	3.7	0.4	0.9		3.6	1.6	1.0	0.4	0.7	1.5	1.3	0.6	1.5	1.6	0.5	0.7	0.7	2.6	0.2	1.3	1.0	1.2	1.1	0.7	0.9	0.6	1.2	0.6	1.2	1.3	0.7	0.8	2.1	0.8	0.9	2.3	0.5	1.7	0.8	0.4	0.6	0.9	5.1	0.3	0.5	0.9	0.7	1.0	1.6	0.5	1.6	0.6	1.3	1.5	1.1	0.5	0.8	1.1	1.0	1.3	0.7	2.0	1.3	0.6	1.1	1.5	0.5	0.7	2.3	1.1	2.3	0.9	1.0	0.6	0.3	0.3	0.3	0.3	0.3	0.5	0.3	0.2	0.3	0.3	0.3	0.3	0.6	0.4	0.4	0.2	0.5	0.1	0.1	2.2	2.5	3.6	3.3	2.6	2.2	2.0	2.0	2.1	1.0	2.1	3.6	0.7	12.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	5.9	0.4	0.0	1.1	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.6	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0
AC117378.1		ENSG00000285625	"Novel protein"		12	56714612-56741535	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 3.2;skeletal muscle: 3.6"	"Cell type enhanced"	"Detected in single"		"Alveolar cells type 2: 1.1"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 17.4;REH: 18.1"									HPA073152			Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"		"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA073152: AB_2686575"																		0.4	0.5	1.3	1.7	1.5	2.0	0.5	1.9	3.2	0.3	1.0	0.8	0.3	0.7	0.0	0.5	0.4	0.0	0.1	1.2	1.3	0.2	0.8	0.6	0.2	1.4	1.4	0.3	2.6	0.0		0.2	1.6	0.3	0.4	2.7	0.0	0.3	3.6	0.2	0.5	0.2	1.1	0.6	0.2	0.5	1.5	1.9	0.2	0.0	0.7	0.4		1.9	5.6	1.3	3.7	2.2	1.3	0.0	4.0	3.6	0.6	2.0	1.4	0.0	2.9	2.6	5.8	0.5	1.5	8.9	2.2	1.0	1.0	3.8	1.5	6.2	1.3	0.7	0.9	15.8	10.3	0.9	1.4	2.0	2.2	2.5	0.5	8.5	3.0	5.4	2.8	2.6	17.4	9.9	9.3	4.6	1.4	18.1	4.4	2.0	2.6	1.3	3.7	0.6	1.3	0.0	6.6	1.0	1.7	11.3	1.5	1.0	15.3	4.8	5.4	15.1	8.9	4.6	1.7	5.6	1.5	2.6	1.8	3.8	7.2	4.8	9.4	10.7	11.7	8.8	3.7	12.1	13.3	11.0	0.0	6.1	6.3	5.0	12.4	4.9	1.3	1.5	1.9	3.2	1.2	1.3	1.4	1.4	1.6	1.1	1.5	1.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC127029.3		ENSG00000285947	"Novel protein"		17	63917203-63931385	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 14.0;naive B-cell: 18.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 18.4"	"Cell line enhanced"	"Detected in single"		"U-698: 2.2"									"HPA009178, HPA043715"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"		"Cluster 27: U-698-M & Daudi - Adaptive immune response"		"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA009178: AB_1078483, HPA043715: AB_2678632"																		0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	2.2	0.4	14.0	0.7	0.3	0.5	18.4	0.4	0.2	0.0	0.5	3.8	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC240274.1		ENSG00000271254	"Neuroblastoma breakpoint family member 1"		Unmapped	4612-29626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Spermatocytes: 186.6"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"		"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "																		12.0	29.1	16.1	10.4	19.5	9.4	10.9	19.5	17.7	12.7	14.0	21.1	17.0	18.1	13.3	9.6	18.6	12.4	7.9	14.7	18.3	14.9	8.2	12.8	6.6	22.2	19.7	29.6	5.7	18.0		14.6	21.7	11.6	21.8	13.8	11.2	9.2	10.9	11.8	25.0	16.4	18.3	12.9	8.5	40.6	20.5	6.8	12.0	6.8	7.4	8.5		23.5	25.6	33.3	36.9	26.2	12.1	13.2	8.4	37.6	22.7	34.4	28.8	12.2	9.7	20.0	2.9	34.8	11.9	14.0	14.3	7.0	46.2	13.4	29.2	5.4	19.6	16.7	16.4	17.5	11.4	8.7	10.0	19.6	15.6	22.3	9.8	32.6	24.4	6.7	13.5	35.0	21.5	7.5	5.8	3.6	79.2	38.4	23.5	2.9	8.3	14.0	27.3	44.2	37.2	31.0	16.0	10.8	28.1	5.2	13.3	21.2	21.5	53.0	17.1	7.8	28.3	16.1	5.2	26.3	7.6	1.5	0.8	1.1	0.6	0.8	1.1	0.6	0.4	0.4	0.3	0.9	0.6	0.7	0.7	2.3	0.6	0.5	0.0	0.4	16.1	19.5	19.5	17.7	14.7	18.3	22.2	19.7	21.7	18.3	20.5	23.5	2.5	22.4	11.6	0.0	1.4	0.0	1.6	0.0	6.8	2.0	4.3	4.8	0.0	1.5	4.3	0.0	4.2	9.5	0.7	12.9	1.9	2.5	46.1	2.1	3.6	4.4	0.0	5.2	0.0	2.7	12.8	6.4	3.6	1.6	15.2	14.3	2.5	2.7	6.9	0.0	0.0	4.3	0.0	4.2	0.0	11.0	16.8	5.2	0.0	0.0	4.0	2.4	2.1	0.0	0.0	2.8	3.4	18.4	0.6	0.9	5.7	1.6	10.9	1.4	6.6	6.1	2.3	186.6	46.2	5.9	0.0	2.6	1.6	33.3	3.6	0.9
AC242842.3		ENSG00000286185	"Novel protein, identical to neuroblastoma breakpoint family, member 19 NBPF19"		1	149390623-149556361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA							Cytosol	Microtubules	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC245033.1		ENSG00000260836	"Novel protein"		15	82536788-82573194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 32.1;Alveolar cells type 2: 45.1;Club cells: 8.6;granulocytes: 12.6;Respiratory ciliated cells: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-2197: 12.6"									HPA055060	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA					"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"	"Nucleoli, Cytosol"	"HPA055060: AB_2682686"									"unprognostic (2.91e-2)"									0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.4	0.4	12.6	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.6	0.2	0.1	0.3	0.4	0.5	0.2	0.3	0.3	0.0	32.1	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159762045-159779112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 231.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 262.1;Early spermatids: 187.0;Exocrine glandular cells: 176.6;Hepatocytes: 214.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	10.9	21.6	22.2	18.5	24.4	22.4	23.6	30.2	30.0	12.8	20.1	38.5	31.2	10.9	40.0	32.6	11.4	10.6	9.4	22.7	27.6	27.0	231.3	20.2	25.0	39.4	26.3	17.3	9.4	12.5	3.2	11.8	39.1	35.6	33.8	19.5	15.5	9.3	4.9	18.1	17.9	15.8	24.8	9.7	19.5	28.6	24.4	39.4	9.0	7.1	36.7	13.7	9.1	28.1	70.1	58.8	451.9	160.8	57.2	111.6	14.4	57.4	70.5	141.8	244.5	234.0	87.1	55.9	29.0	48.7	458.2	64.5	174.8	465.8	166.7	35.2	174.4	127.4	97.2	418.8	62.0	81.4	35.8	62.2	40.1	231.1	92.9	21.4	68.8	160.1	139.9	104.3	85.5	113.0	137.0	154.0	142.8	65.5	41.7	83.9	94.4	173.1	377.2	93.7	107.8	63.2	67.5	43.3	26.2	18.5	83.4	157.3	39.2	50.3	45.7	72.1	154.0	47.7	89.0	142.0	15.7	151.2	77.1	30.1	24.9	46.7	47.9	33.9	47.3	46.6	54.1	47.8	34.7	51.4	53.3	43.2	11.0	41.3	23.6	30.4	79.0	46.2	22.2	24.4	30.2	30.0	22.7	27.6	39.4	26.3	39.1	24.8	24.4	28.1	11.8	12.8	45.4	15.3	25.8	26.1	32.4	262.1	22.2	19.4	33.4	24.5	1.2	42.9	115.5	20.2	2.1	53.7	28.6	34.7	70.5	78.8	187.0	14.3	9.9	18.8	17.2	38.5	14.3	176.6	97.0	21.6	9.7	25.9	13.3	47.7	16.1	214.8	58.1	13.5	14.7	23.6	83.4	14.8	29.8	128.8	13.7	25.7	30.2	1.0	58.9	22.5	30.9	13.0	17.5	65.6	28.8	19.2	25.5	38.7	15.4	50.0	30.1	24.7	0.0	25.1	44.9	28.5	45.6	43.0	21.0	35.2	31.0	102.5	33.0	38.9
ACBD7	"bA455B2.2, FLJ38219"	ENSG00000176244	"Acyl-CoA binding domain containing 7"	Q8N6N7	10	15075475-15088776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 37.8;choroid plexus: 17.1"	"Cell type enriched"	"Detected in some"	5	"Astrocytes: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 28.7;MOLT-4: 29.2;U-698: 21.8"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 17.6"	"Low region specificity"	"Detected in all"			"HPA043326, HPA062478"			Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA043326: AB_2678429, HPA062478: AB_2684777"	"unprognostic (2.15e-1)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-3)"	"unprognostic (6.53e-3)"	"unprognostic (7.30e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.18e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.90e-2)"	0.3	0.3	34.9	0.4	36.0	1.4	4.2	28.8	37.8	0.2	17.1	0.4	0.9	0.3	0.8	0.4	1.9	0.4	0.2	31.6	29.7	0.4	0.4	0.4	0.7	33.7	37.1	0.4	0.4	0.3	0.6	0.3	26.3	0.4	0.4	7.7	2.3	0.5	0.9	1.3	0.5	0.2	27.2	0.4	0.5	3.0	35.1	6.7	1.7	0.0	0.5	0.3	0.1	23.2	3.4	0.8	12.7	7.0	1.0	0.6	1.8	0.8	0.7	1.9	3.0	3.8	4.2	2.9	4.3	2.5	2.6	0.6	6.9	1.8	2.9	6.0	10.2	3.4	1.1	2.3	0.1	0.4	1.3	0.3	0.1	1.0	0.1	3.2	2.9	28.7	2.4	3.6	2.5	10.5	29.2	4.5	6.3	1.0	2.0	16.4	4.3	6.9	1.6	1.0	9.7	6.6	2.7	8.6	1.1	4.7	10.9	0.6	1.6	0.7	6.6	1.3	2.8	10.4	19.1	21.8	2.1	0.5	0.7	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0.1	0.0	34.9	36.0	28.8	37.8	31.6	29.7	33.7	37.1	26.3	27.2	35.1	23.2	0.1	0.0	0.6	28.1	0.1	0.1	0.1	0.0	0.6	0.2	0.5	0.6	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.2	0.0	0.0	5.3	2.6	0.1	0.4	1.8	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.3	0.0	0.1	0.0	1.0	0.0	0.6	0.0	1.5	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.1	1.6	0.8	0.0	0.3	0.3	2.9	0.4	0.5	0.0	0.1	0.2	0.1	0.1	0.1
ACCSL		ENSG00000205126	"1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like"	Q4AC99	11	44047981-44059977	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.0;Excitatory neurons: 2.6;Inhibitory neurons: 2.7;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.8"	"Cancer enriched"	"Detected in single"	22	"melanoma: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA065042			Approved	Cytosol		NA	NA						"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA065042: "					"unprognostic (2.37e-2)"				"unprognostic (2.91e-1)"				"unprognostic (9.76e-5)"	"unprognostic (7.42e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACMSD		ENSG00000153086	"Aminocarboxymuconate semialdehyde decarboxylase"	Q8TDX5	2	134838616-134902034	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"kidney: 141.1;liver: 162.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 120.2;Proximal tubular cells: 408.1"	"Group enriched"	"Detected in some"	23	"liver cancer: 21.2;renal cancer: 19.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"RPTEC TERT1: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010533, HPA011179"	Enhanced		Approved	Cytosol		NA	NA		12000	"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA010533: AB_1844517, HPA011179: AB_1844516"	"unprognostic (1.06e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (2.39e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.65e-5)"	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	7.1	0.2	0.0	0.3	141.1	162.5	0.1	0.3	0.8	0.2	0.7	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.6	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.3	0.8	0.3	1.2	0.2	0.5	0.1	0.6	0.3	26.7	0.4	1.0	0.3	0.1	0.3	0.4	0.8	0.2	0.7	1.0	0.0	0.4	0.2	0.8	0.2	0.1	0.5	0.2	0.3	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.3	0.0	0.3	0.8	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.2	50.1	0.0	9.2	0.0	0.0	0.0	0.0	54.8	0.2	0.0	0.0	0.1	0.0	0.0	2.7	8.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	120.2	0.0	0.0	7.3	0.0	0.0	1.9	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.0	0.0	2.5	1.9	0.1	0.0	0.0	0.0	0.0	0.0	408.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0
ACOT9	"ACATE2, CGI-16, MT-ACT48"	ENSG00000123130	"Acyl-CoA thioesterase 9"	Q9Y305	X	23701055-23766475	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035533	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		7600	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035533: AB_10696506"	"unprognostic (5.69e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	24.1	18.8	8.0	19.5	7.5	15.8	19.8	7.5	9.5	17.7	10.3	22.0	15.5	22.5	8.4	12.1	17.3	13.6	49.3	7.2	9.1	15.5	14.5	26.1	12.7	8.0	7.5	15.1	14.0	11.7	8.8	17.8	8.6	16.1	16.4	9.6	18.6	22.1	27.6	12.5	15.8	32.3	6.9	18.4	17.7	6.2	8.5	6.3	17.4	14.2	12.5	21.3	14.7	7.5	81.5	54.0	23.1	51.4	37.2	42.0	11.7	62.7	54.3	60.7	58.4	48.5	71.4	4.1	39.1	70.5	81.8	48.3	29.6	79.9	84.2	18.8	44.6	27.4	55.0	35.6	49.9	10.8	33.3	37.5	53.6	71.5	80.5	39.6	90.3	0.6	17.7	26.7	66.7	28.4	15.2	26.1	33.9	31.8	65.3	15.7	87.6	34.4	72.8	29.8	4.5	22.1	68.4	28.3	41.6	85.5	31.9	14.0	84.7	50.7	33.8	73.3	34.7	6.4	16.1	0.5	37.4	10.5	43.6	24.7	30.2	22.2	10.2	43.5	14.1	11.1	12.6	11.3	32.4	9.9	4.0	9.4	15.8	12.3	56.2	5.4	20.8	18.6	8.0	7.5	7.5	9.5	7.2	9.1	8.0	7.5	8.6	6.9	8.5	7.5	34.6	48.1	27.3	12.1	23.0	20.1	45.9	51.8	7.4	5.3	5.6	6.7	44.3	18.6	36.8	16.5	25.0	4.0	21.5	9.7	5.9	59.6	0.8	20.8	22.9	38.7	2.4	11.2	6.1	52.5	11.4	33.4	16.8	21.6	37.3	14.8	32.9	11.8	42.4	5.0	8.6	10.3	16.2	37.1	95.4	0.4	18.0	57.3	33.8	13.1	192.3	11.9	19.6	4.5	3.1	83.4	15.0	25.6	27.7	52.4	14.6	30.3	38.0	9.9	26.3	35.2	65.1	1.6	10.4	3.5	10.7	3.0	21.2	30.4	11.2	38.2
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537283	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 177.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		29000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	8.8	8.3	4.1	2.1	4.6	0.1	5.8	4.4	4.5	9.3	16.8	12.9	25.4	9.4	5.8	6.3	10.8	8.2	16.7	4.3	4.5	42.1	177.3	6.2	1.7	5.3	4.8	11.2	4.6	9.6	4.6	3.4	4.4	10.8	8.3	1.8	7.2	9.8	8.2	2.9	21.6	11.2	4.5	1.4	4.0	4.9	4.9	4.0	16.1	17.0	1.2	8.7	6.0	4.1	0.0	0.0	0.2	0.0	16.4	25.9	4.7	3.1	0.2	0.0	0.4	0.8	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.6	4.4	4.5	4.3	4.5	5.3	4.8	4.4	4.5	4.9	4.1	1.9	3.2	5.8	11.1	0.6	0.6	7.6	0.5	5.7	0.3	1.3	3.8	14.3	4.3	0.9	3.7	0.0	0.7	0.0	4.2	15.6	0.3	0.1	0.4	1.3	1.6	3.0	2.7	0.6	1.9	0.4	8.6	2.0	0.2	1.3	8.6	6.1	89.0	5.2	1.7	0.6	5.1	0.0	1.9	0.4	1.8	10.8	1.7	0.0	1.0	0.5	10.8	0.0	0.5	0.0	0.4	0.8	8.6	0.1	0.6	27.9	51.0	0.0	0.8	6.6	7.0	5.2	0.4	0.4	3.0	0.3	0.8	0.3	9.6	4.6	3.8
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1061.1;Late spermatids: 2128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	41.2	104.0	43.1	45.5	47.6	91.9	64.7	43.9	54.0	43.4	63.9	61.4	64.0	46.6	69.3	43.3	57.9	45.4	57.3	49.4	47.1	78.1	106.4	46.8	66.2	43.4	44.2	59.2	94.1	73.9	59.2	61.7	44.3	52.1	64.7	72.7	71.1	44.2	76.6	41.3	60.7	41.5	44.9	44.7	67.1	46.1	45.3	66.2	63.7	74.9	61.9	47.5	36.4	50.2	78.3	112.5	177.4	97.4	76.1	77.1	142.2	92.6	97.7	91.9	80.8	151.7	78.5	48.8	70.7	85.1	114.6	76.5	169.4	97.0	82.3	118.7	157.9	142.3	99.0	348.5	105.7	162.5	80.4	78.7	90.5	81.9	102.3	95.5	105.8	176.9	145.1	95.1	110.9	103.1	178.5	161.3	214.1	204.7	111.7	118.2	176.1	114.5	144.2	110.5	191.6	191.3	56.0	137.6	196.3	115.0	82.1	89.8	88.9	101.3	65.2	84.0	142.6	123.8	261.2	150.4	120.0	138.9	123.7	65.4	61.6	57.2	88.8	75.2	118.1	106.6	100.4	103.2	57.3	97.2	118.1	115.2	10.9	121.5	80.2	65.3	117.6	115.0	43.1	47.6	43.9	54.0	49.4	47.1	43.4	44.2	44.3	44.9	45.3	50.2	62.5	44.8	96.7	9.1	102.6	79.2	105.3	173.4	51.8	53.1	118.8	130.0	84.9	131.5	119.6	68.0	8.4	207.1	101.3	81.9	270.1	226.7	1061.1	113.1	56.2	70.6	82.5	291.5	20.4	169.0	279.7	74.2	54.6	85.5	70.3	95.9	56.0	115.8	141.1	28.6	21.0	125.1	126.1	72.0	66.3	2128.2	94.4	74.6	81.8	16.9	117.8	92.2	152.4	19.6	26.0	174.4	109.2	92.2	106.4	187.0	174.2	306.6	128.1	56.9	92.1	42.5	87.0	122.6	137.4	87.4	91.2	187.7	86.0	124.4	143.9	148.3
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562886-179588407	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 243.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	19.7	20.4	8.3	23.5	9.8	17.8	33.0	10.1	12.4	24.6	11.0	31.1	24.7	27.6	25.9	25.3	25.0	15.6	18.6	7.9	9.5	22.3	21.8	19.0	32.0	10.4	9.8	31.9	20.6	24.3	13.1	23.5	10.8	21.3	37.8	16.3	21.3	21.4	12.3	26.8	23.8	26.3	9.4	19.9	22.3	62.5	8.9	46.0	20.5	13.9	41.4	24.8	20.7	11.9	196.4	59.5	142.2	75.7	53.4	58.0	111.7	78.1	60.2	142.3	119.8	126.6	94.8	154.0	136.8	73.5	164.7	88.7	126.3	95.7	174.6	156.7	105.0	125.5	58.2	101.9	61.0	157.4	75.2	40.7	96.1	91.5	76.6	44.5	82.5	90.7	100.1	85.1	103.6	135.6	140.1	96.8	127.6	178.0	129.5	128.7	118.0	284.4	113.4	76.2	116.9	83.2	119.1	118.5	125.2	71.2	231.5	128.8	62.5	101.0	87.1	104.1	237.8	54.6	86.5	231.3	55.6	165.0	113.5	5.7	19.3	14.7	24.5	25.5	32.4	29.2	27.8	28.5	34.1	24.1	30.2	31.3	2.6	26.7	30.1	19.3	39.1	24.3	8.3	9.8	10.1	12.4	7.9	9.5	10.4	9.8	10.8	9.4	8.9	11.9	31.1	22.4	23.1	6.2	27.1	47.2	48.0	60.4	29.0	6.1	24.5	23.9	6.7	30.0	38.1	27.6	8.4	51.2	21.6	13.4	35.2	51.1	53.5	27.1	28.8	26.7	30.5	62.3	2.8	44.7	67.5	28.1	23.4	20.8	14.5	31.0	13.6	16.8	34.9	0.0	3.8	26.7	48.8	17.1	18.7	17.7	32.3	15.4	30.2	3.7	27.1	16.7	18.6	6.6	19.0	38.8	18.8	30.1	25.8	45.4	18.2	25.8	35.6	14.9	26.3	25.0	49.0	243.2	92.1	42.7	45.9	30.6	21.6	35.1	40.4	38.5
ACTL8	CT57	ENSG00000117148	"Actin like 8"	Q9H568	1	17755333-17827063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"testis: 7.1"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 50.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"U-266/84: 245.3"					"Not detected"	"Not detected"			HPA027176			Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA027176: AB_1844553"	"unprognostic (1.79e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.89e-1)"		"unprognostic (1.43e-1)"	"unprognostic (5.49e-2)"		"unprognostic (4.68e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.4	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.2	0.0	11.0	0.3	0.2	0.6	0.0	1.5	0.0	0.0	0.1	1.4	0.0	0.5	1.4	0.0	3.3	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.5	13.3	0.0	2.4	0.0	0.0	9.2	5.9	0.1	0.0	0.0	27.5	0.0	0.0	0.4	0.0	0.0	5.2	0.5	0.0	0.5	0.4	0.0	0.0	0.1	1.9	0.2	0.1	245.3	0.1	4.9	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	50.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0
ACTR2	ARP2	ENSG00000138071	"Actin related protein 2"	P61160	2	65227788-65271253	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005083, HPA015050"	Approved		Approved	Cytosol		NA	NA		35000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB005083: AB_2221848, HPA015050: AB_1844556"	"unprognostic (2.23e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (3.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.03e-2)"	113.0	70.7	39.9	216.2	48.3	160.5	77.0	42.2	54.7	81.4	38.3	142.4	104.8	70.1	64.5	111.0	53.7	90.9	64.9	51.4	47.2	85.6	108.9	115.9	246.4	43.6	41.4	43.9	61.7	61.9	25.0	109.6	42.9	71.7	139.1	70.2	64.9	64.1	60.4	69.4	118.2	104.4	48.0	172.0	107.3	46.2	45.5	182.2	73.1	64.9	256.3	128.6	46.0	61.1	267.3	221.2	205.5	224.5	218.8	296.1	213.2	367.3	284.1	280.0	193.6	249.3	214.2	590.6	181.8	406.9	174.3	196.8	179.8	258.3	459.4	337.2	150.8	652.1	147.6	235.9	248.0	619.8	731.6	256.5	201.6	312.2	297.7	228.6	356.6	202.0	282.1	209.2	480.0	198.2	325.4	330.6	173.2	245.7	157.5	347.9	266.0	248.6	328.7	341.7	105.2	171.6	239.0	273.5	262.0	186.9	167.6	417.4	467.9	306.5	184.8	202.8	408.9	158.0	155.2	824.1	264.4	598.7	353.9	325.4	182.4	220.6	104.3	241.4	111.8	97.1	91.1	98.6	213.1	80.4	70.3	99.2	258.2	104.1	273.3	79.3	113.9	344.5	39.9	48.3	42.2	54.7	51.4	47.2	43.6	41.4	42.9	48.0	45.5	61.1	187.1	86.6	112.7	32.3	202.4	74.7	88.0	93.0	70.0	81.8	75.8	57.1	76.3	51.5	93.2	97.5	66.7	81.8	257.9	280.5	50.9	100.5	37.5	114.5	131.4	131.0	110.8	89.8	152.6	129.0	138.6	96.0	105.0	163.2	191.1	77.8	113.6	102.9	277.7	104.3	106.0	166.5	85.5	450.1	311.8	92.5	65.3	352.0	88.9	97.4	378.9	87.9	207.0	38.7	68.9	164.4	195.3	74.4	119.7	114.9	131.1	89.0	127.7	82.4	124.9	63.3	122.8	31.4	41.8	102.5	90.6	124.4	203.2	74.2	172.8	181.7
ACTR6	"ARP6, FLJ13433"	ENSG00000075089	"Actin related protein 6"	Q9GZN1	12	100199122-100241865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038587, HPA038588"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA038587: AB_10670781, HPA038588: AB_10672719"	"unprognostic (1.24e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (7.70e-9)"	"unprognostic (4.11e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.40e-2)"	15.0	16.7	17.6	12.8	17.7	7.4	28.9	18.2	24.5	13.9	17.9	14.6	15.2	15.2	18.1	13.8	14.2	10.3	17.5	18.2	19.8	22.1	19.6	12.2	20.8	18.0	18.6	17.9	5.0	20.8	4.5	17.0	19.1	16.8	15.3	20.6	15.3	15.9	14.3	13.6	14.4	14.4	18.3	16.1	10.6	21.3	17.7	20.4	16.3	15.8	19.2	17.1	4.5	20.8	60.2	23.5	27.1	35.9	22.4	28.3	63.3	26.0	22.6	25.0	18.2	15.2	17.8	32.9	24.7	19.5	18.8	23.0	36.5	22.5	34.3	48.9	33.8	22.8	22.2	17.7	23.6	33.7	17.7	17.4	27.7	20.2	25.8	38.5	28.9	38.0	36.9	10.5	29.2	15.5	33.7	50.8	31.6	22.5	34.2	27.0	27.3	41.4	27.3	35.8	24.8	47.0	35.3	62.5	36.5	22.4	40.6	39.5	18.8	18.4	12.3	20.5	23.7	23.6	55.6	42.8	12.1	21.2	21.7	5.7	6.4	10.0	15.2	11.5	19.3	12.6	17.9	20.3	8.2	12.1	19.4	19.6	3.0	19.4	13.2	12.0	20.5	12.1	17.6	17.7	18.2	24.5	18.2	19.8	18.0	18.6	19.1	18.3	17.7	20.8	33.5	16.0	17.7	6.5	25.8	22.9	36.2	72.4	29.6	32.7	26.5	23.9	34.8	8.6	38.1	23.9	18.8	55.6	36.9	9.9	46.9	21.4	135.2	56.8	27.7	20.7	12.5	21.7	20.9	12.0	68.4	25.0	12.2	28.9	33.0	19.1	16.1	16.4	23.7	33.7	23.2	11.3	73.2	19.1	13.4	34.3	20.2	17.5	32.0	13.1	19.5	27.0	25.7	17.1	17.4	13.2	10.0	22.6	19.7	24.7	11.7	67.9	67.9	32.8	32.9	27.8	36.8	80.8	19.9	23.8	19.7	96.0	36.6	23.8	13.3	33.8
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951699-51997078	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB026126: , HPA063761: AB_2685115"	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	16.5	10.3	20.7	10.0	20.8	13.5	13.2	13.6	23.4	13.9	9.1	24.6	28.2	8.8	18.0	20.9	15.3	12.2	10.1	21.5	13.3	34.3	29.9	14.7	6.4	12.5	13.9	9.4	40.7	52.7	14.7	11.1	13.1	14.0	24.4	17.4	32.8	15.3	13.1	45.6	26.1	8.1	9.5	8.8	24.9	15.7	16.1	7.6	11.4	8.8	7.4	12.6	18.8	18.3	11.4	24.3	18.6	10.3	20.9	16.2	10.5	12.6	14.2	13.1	9.9	49.5	17.1	5.0	17.2	13.8	14.6	19.6	17.8	15.2	13.5	7.3	21.0	12.3	5.9	15.6	23.8	19.9	43.8	32.0	19.4	14.8	18.6	13.9	18.7	17.7	13.3	14.9	11.8	23.2	19.1	17.2	18.0	24.0	8.5	10.2	14.4	6.4	37.2	17.0	23.5	19.5	13.6	19.2	9.0	13.1	21.1	12.8	12.0	9.0	13.6	10.2	6.1	9.0	6.8	6.7	9.7	9.4	11.8	2.5	1.2	3.9	0.3	1.8	0.5	0.0	0.3	0.3	0.7	0.2	0.8	0.4	1.0	0.0	2.2	0.3	0.5	0.3	20.7	20.8	13.6	23.4	21.5	13.3	12.5	13.9	13.1	9.5	16.1	18.3	8.0	3.2	13.4	8.1	2.9	18.6	10.1	9.2	23.3	45.3	11.3	8.6	5.9	17.2	12.0	25.8	29.2	0.7	2.0	49.7	3.9	17.7	2.9	12.3	8.1	10.9	24.6	0.8	34.8	14.4	0.8	12.6	19.9	9.0	11.4	9.4	17.9	24.4	4.0	37.0	30.2	28.7	2.0	16.7	5.3	8.4	9.9	10.0	7.2	9.4	10.1	8.8	1.0	21.6	11.3	13.3	22.1	9.4	2.3	15.1	31.8	17.0	15.8	24.5	6.6	17.5	12.2	3.8	16.5	17.7	25.3	0.5	4.6	5.6	24.7	15.5
ACVR2A	"ACTRII, ACVR2"	ENSG00000121989	"Activin A receptor type 2A"	P27037	2	147844517-147930826	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.5;Inhibitory neurons: 63.4;Oligodendrocyte precursor cells: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 26.3;RH-30: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046997	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA046997: AB_10970077"	"unprognostic (4.55e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-3)"	"unprognostic (8.73e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.99e-2)"	7.3	4.0	6.2	4.6	7.4	3.3	7.0	10.8	6.4	5.4	1.0	6.3	7.7	5.2	6.6	7.2	4.5	7.7	3.7	7.5	7.5	5.6	7.4	4.6	3.1	2.6	4.5	4.5	4.4	4.3	3.9	7.7	3.9	6.8	6.5	8.3	7.5	5.2	17.5	19.5	9.3	7.0	3.8	4.0	6.8	6.4	8.6	2.3	6.7	6.3	3.9	7.4	7.4	4.6	1.8	2.1	13.2	5.0	7.3	4.7	5.4	4.1	5.0	6.9	12.0	5.8	8.1	0.1	3.6	6.7	2.5	6.2	12.0	6.1	8.8	1.4	7.3	0.9	3.6	10.2	26.3	1.0	0.9	8.1	7.3	4.5	8.9	5.2	5.3	1.6	2.0	3.5	4.7	4.8	0.4	0.8	14.9	5.5	3.6	0.2	23.3	1.3	5.6	11.5	13.0	7.3	3.5	4.2	5.4	5.6	2.5	1.4	4.1	6.4	7.5	6.1	2.9	1.0	0.3	2.4	3.9	0.5	5.2	0.2	1.7	0.2	0.6	2.0	0.2	0.1	2.4	1.1	1.3	0.3	1.5	0.3	0.0	4.8	2.0	1.7	0.2	0.7	6.2	7.4	10.8	6.4	7.5	7.5	2.6	4.5	3.9	3.8	8.6	4.6	13.7	6.4	7.0	26.8	1.5	29.7	6.9	9.5	13.1	15.4	6.8	12.4	7.9	17.2	10.7	7.3	14.6	4.9	6.0	16.5	1.9	6.3	5.3	6.4	12.2	11.9	9.0	0.0	62.5	6.3	2.5	17.4	6.6	5.7	0.0	2.2	11.7	12.1	5.4	11.8	63.4	12.9	8.2	7.3	18.9	2.1	9.9	5.7	10.6	33.7	7.2	3.3	6.2	84.9	34.1	7.6	10.0	11.3	5.2	7.7	23.7	5.8	10.2	9.4	32.9	8.3	10.9	18.2	14.1	14.4	29.8	5.3	5.9	2.9	11.7	11.8
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053237-75069483	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		89000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	13.7	38.4	46.2	15.2	48.6	21.1	22.1	49.9	65.5	17.3	50.8	21.5	15.6	14.4	36.7	20.8	29.6	10.2	17.0	45.0	54.0	29.1	9.6	19.7	27.7	50.7	49.7	13.6	12.4	21.1	36.5	15.3	51.8	17.3	26.9	44.0	15.8	15.0	34.0	35.0	21.1	15.6	46.6	16.5	19.3	26.9	50.4	39.7	30.1	21.1	28.1	16.1	17.6	56.0	78.9	43.1	60.9	37.4	24.5	26.6	32.6	44.7	17.2	45.5	63.5	42.8	86.9	86.5	26.4	18.2	25.7	68.1	39.9	19.1	73.8	127.8	49.3	57.6	123.6	32.1	14.3	36.6	56.8	14.9	27.7	61.5	30.0	28.8	60.0	80.9	45.2	103.0	60.0	52.3	82.7	67.7	18.6	67.6	40.8	64.7	80.8	41.2	62.2	39.0	112.0	44.5	29.5	20.8	74.2	29.1	44.5	35.4	27.3	29.5	55.6	61.3	48.4	23.8	52.4	94.6	46.1	42.5	32.8	5.3	2.8	17.5	10.9	6.2	12.7	13.7	18.3	12.9	5.1	14.1	15.4	14.5	1.2	14.0	10.5	10.3	24.6	6.7	46.2	48.6	49.9	65.5	45.0	54.0	50.7	49.7	51.8	46.6	50.4	56.0	18.5	6.4	9.1	17.0	18.2	28.7	44.4	54.1	30.1	38.6	20.8	24.0	21.2	31.5	28.9	66.2	12.5	27.3	18.7	24.5	39.2	20.6	31.6	89.2	18.4	26.5	30.1	47.5	17.8	18.7	33.7	22.7	13.7	17.8	12.0	19.8	10.4	5.7	22.3	43.7	25.0	25.2	73.2	6.6	11.7	11.0	16.8	12.3	39.2	15.9	10.1	23.2	16.5	16.1	44.4	20.2	20.6	16.6	16.9	20.2	16.7	22.3	137.9	32.4	26.3	11.1	31.5	89.8	14.1	23.8	24.0	13.7	22.3	20.4	33.8	34.4
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 26.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 8.6;Cardiomyocytes: 11.0;Endometrial stromal cells: 15.6;Fibroblasts: 9.6;Gastric mucus-secreting cells: 8.2;Glandular and luminal cells: 7.5;Granulosa cells: 6.8;Skeletal myocytes: 6.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 13.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 72.0;ASC TERT1: 43.0;EFO-21: 36.6;hTERT-RPE1: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.63e-5)"	26.4	1.2	0.4	1.7	0.5	0.0	15.3	0.4	0.8	3.4	1.7	3.2	0.5	4.3	1.3	3.7	9.8	2.3	14.5	0.4	0.9	11.0	0.4	7.2	1.1	4.4	0.6	2.7	1.4	0.4	1.3	16.9	1.5	1.9	1.9	0.2	1.3	1.1	1.8	5.0	3.6	4.6	1.0	2.3	5.5	0.9	1.2	1.1	7.0	1.0	0.3	8.8	2.6	1.0	0.0	2.6	1.6	0.8	72.0	43.0	0.0	2.7	5.2	1.0	0.2	0.5	1.2	0.0	36.6	0.2	2.6	7.0	0.6	0.7	0.2	0.0	1.7	0.0	3.3	0.0	0.7	0.0	0.0	14.1	0.0	0.6	0.1	19.5	0.0	0.3	0.0	0.0	0.0	0.1	0.1	8.1	1.3	0.0	5.7	0.0	4.1	0.0	0.1	0.1	0.6	0.0	12.1	0.0	0.0	5.2	3.9	0.0	0.0	0.6	8.5	7.0	3.5	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.8	0.4	0.9	4.4	0.6	1.5	1.0	1.2	1.0	8.6	0.0	0.0	0.3	0.2	0.5	0.1	3.5	0.0	1.3	5.6	2.7	11.0	0.0	0.5	1.8	0.0	0.6	0.0	1.0	0.0	0.0	0.0	4.4	15.6	1.7	0.0	0.0	0.4	0.8	0.6	9.6	8.2	7.5	0.0	6.8	0.4	0.1	0.9	0.0	1.6	0.5	2.0	0.0	0.3	0.0	5.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.9	0.7	0.0	0.0	0.1	1.0	0.5	0.0	0.0	6.9	3.6	0.2	0.3	0.0	0.3	0.8	0.1	0.0	1.8	0.1
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 146.7;Endometrial stromal cells: 36.9;Extravillous trophoblasts: 46.4;Fibroblasts: 34.5;Hofbauer cells: 34.0;Syncytiotrophoblasts: 99.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 11.1"	"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 92.0;BEWO: 200.3;HSkMC: 43.8;K-562: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	32.0	5.1	1.1	14.9	1.0	4.2	24.7	0.8	11.1	22.9	7.9	19.3	3.6	20.0	1.6	33.3	29.2	7.7	22.3	0.8	1.4	6.4	17.3	26.1	1.8	4.4	2.8	17.1	3.0	0.5	3.0	62.9	2.9	9.0	3.8	0.6	11.8	3.4	37.7	11.8	13.7	11.4	1.2	5.4	17.2	2.4	3.6	0.8	6.1	47.9	1.2	32.8	23.3	1.5	22.0	0.6	0.3	3.9	19.1	92.0	200.3	20.8	18.0	12.1	7.0	1.8	8.5	0.2	4.3	14.4	0.2	11.0	0.8	3.2	4.9	1.7	0.4	6.2	2.6	8.9	15.3	0.3	3.0	43.8	0.9	3.0	6.8	10.3	0.1	0.0	67.7	0.7	2.2	0.5	0.0	1.1	3.5	0.6	0.7	0.0	0.0	0.1	2.1	0.8	0.1	0.6	6.7	15.9	0.1	10.0	4.5	11.5	3.8	0.7	5.5	8.6	0.3	1.9	0.6	4.5	0.8	4.0	0.5	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.3	1.1	1.0	0.8	11.1	0.8	1.4	4.4	2.8	2.9	1.2	3.6	1.5	2.8	0.0	1.5	1.0	0.5	2.4	2.3	0.2	0.6	1.7	1.3	1.8	2.2	10.0	0.6	0.0	0.0	146.7	1.0	0.2	0.0	1.7	0.6	2.6	36.9	5.3	0.0	0.0	0.3	0.6	46.4	34.5	0.0	5.4	2.5	0.9	1.8	10.6	34.0	0.0	0.1	0.2	0.0	24.0	12.5	0.7	30.1	20.0	3.6	0.0	23.1	1.4	1.0	0.0	0.0	12.3	0.1	3.4	3.2	2.2	0.0	0.2	0.9	2.2	0.0	14.3	3.8	0.1	1.6	5.5	2.8	99.5	1.7	0.5	0.3	2.5
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase RNA specific B1"	P78563	21	45073853-45226560	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 62.9;Excitatory neurons: 54.1;Horizontal cells: 69.0;Inhibitory neurons: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 65.8;HHSteC: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	15.4	7.0	14.9	10.3	13.2	5.2	11.4	39.1	26.5	14.7	29.6	35.7	3.0	23.0	6.3	7.4	13.6	8.1	10.1	20.0	17.9	9.5	7.0	35.2	13.4	30.6	17.2	7.8	6.1	9.3	6.1	12.3	30.8	17.9	4.8	28.6	6.8	8.1	13.6	15.9	10.8	11.7	8.7	16.1	19.0	4.5	22.7	5.7	6.6	11.8	8.7	60.4	11.9	12.7	7.0	1.0	5.3	6.2	6.3	4.3	7.2	4.6	7.6	14.4	9.0	10.9	1.1	2.2	12.1	22.6	7.9	0.6	7.8	19.1	15.9	1.7	7.0	15.2	65.8	7.2	65.7	10.5	7.2	23.7	8.1	5.1	14.9	5.4	15.4	20.4	3.5	0.8	42.2	5.1	6.8	10.0	8.6	3.4	10.1	2.0	5.0	7.1	3.2	2.3	30.6	8.2	36.4	1.6	11.6	8.5	3.5	8.2	16.3	4.7	5.7	19.4	17.5	6.6	3.1	1.8	4.3	24.1	25.8	0.7	0.0	2.4	0.4	0.2	0.8	1.0	1.1	0.7	0.0	2.6	0.7	0.6	0.1	0.3	0.2	1.0	0.8	0.2	14.9	13.2	39.1	26.5	20.0	17.9	30.6	17.2	30.8	8.7	22.7	12.7	29.0	0.0	1.1	10.7	12.0	11.1	2.9	3.4	2.8	62.9	6.2	7.1	21.6	1.5	1.9	0.0	12.5	0.5	5.9	0.9	0.0	1.3	2.7	1.6	8.8	21.2	0.0	2.1	54.1	0.5	1.2	9.4	2.6	1.6	8.2	5.5	14.3	6.3	5.9	69.0	85.7	0.9	0.0	3.4	4.9	2.9	3.7	3.2	5.4	37.5	5.0	34.2	2.1	16.1	4.8	1.0	0.1	5.7	4.0	5.5	0.3	2.7	0.7	16.0	0.0	32.9	12.7	11.4	17.7	1.5	7.2	1.0	13.7	1.4	1.2	2.3
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase tRNA specific 2"	Q7Z6V5	6	143422832-143450695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	6.8	8.8	1.4	3.1	1.3	5.4	6.3	1.9	1.5	6.3	1.8	7.8	3.1	4.8	1.4	10.3	6.1	1.2	3.4	1.3	1.2	7.7	12.0	8.5	4.2	1.2	1.2	5.8	10.5	1.5	6.6	1.1	1.3	7.3	4.1	1.4	5.4	1.1	3.1	8.9	8.8	1.7	1.0	10.7	8.9	2.8	1.5	1.9	8.6	0.7	3.5	6.5	7.9	1.4	1.8	1.6	2.2	7.2	1.7	5.3	2.7	2.6	1.1	1.6	2.2	4.0	4.4	7.0	2.7	1.7	1.7	5.8	4.3	4.1	3.4	3.5	9.2	10.4	7.3	8.3	2.1	15.0	4.6	2.4	6.0	3.2	6.3	1.8	3.7	6.5	11.3	5.4	2.7	2.5	6.0	7.6	2.5	2.6	2.8	7.0	5.7	5.6	3.0	1.9	4.7	3.1	2.1	6.0	1.8	1.2	2.4	5.0	3.4	2.6	1.9	5.6	4.8	5.9	4.2	4.9	2.7	13.0	2.8	0.0	0.2	0.0	0.6	0.3	0.8	0.5	0.5	0.5	0.6	0.3	0.7	1.0	0.1	0.4	0.0	0.6	1.3	0.4	1.4	1.3	1.9	1.5	1.3	1.2	1.2	1.2	1.3	1.0	1.5	1.4	4.6	6.4	12.9	8.8	6.9	6.6	4.3	4.1	6.2	3.7	5.6	6.3	4.0	5.7	4.1	1.8	0.0	2.4	11.9	4.3	3.9	5.6	1.2	2.7	11.1	4.8	4.2	14.9	11.2	4.1	2.6	5.3	12.2	5.9	7.6	7.1	3.9	5.2	4.9	1.7	10.4	6.0	4.1	4.3	6.1	1.6	6.8	5.3	5.4	7.5	2.1	1.9	8.2	12.5	4.2	6.6	2.4	3.4	4.2	6.8	1.6	1.4	2.1	4.3	0.0	5.1	5.1	2.4	5.6	9.8	9.2	0.8	8.9	6.2	8.8	4.5
ADCK5	FLJ35454	ENSG00000173137	"AarF domain containing kinase 5"	Q3MIX3	8	144373101-144393242	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 61.7;Theca cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025692, HPA028679"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA025692: AB_10599486, HPA028679: AB_10600226"	"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.31e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.90e-2)"	3.1	9.1	1.3	1.5	1.3	0.9	3.4	1.1	2.6	4.5	0.9	6.7	4.8	3.7	0.2	6.4	3.7	0.5	4.1	1.4	1.1	4.3	6.4	2.8	1.1	1.4	1.1	4.5	5.0	0.8	3.5	0.6	1.3	4.1	0.7	0.5	4.1	0.8	4.0	5.2	8.4	0.4	0.9	5.7	4.4	6.7	1.2	1.1	3.6	0.7	0.5	4.0	4.2	1.2	2.5	3.1	0.7	2.1	0.5	0.5	3.7	2.2	1.2	1.8	0.7	3.6	2.7	1.1	1.5	0.5	0.6	3.2	0.1	2.2	0.1	2.8	1.0	2.9	2.6	3.9	1.6	0.7	2.2	1.0	1.4	0.6	0.7	0.9	1.2	2.1	1.9	1.9	0.9	6.9	2.2	2.9	0.4	2.3	2.3	2.8	1.0	2.0	1.2	2.3	0.4	1.1	3.1	2.4	1.8	0.5	2.1	1.9	0.8	0.8	3.2	2.2	1.5	0.9	0.3	1.0	1.9	2.5	1.3	0.9	2.0	1.2	1.1	2.7	1.3	0.9	1.3	0.8	3.2	2.7	1.3	0.7	0.4	1.0	2.7	2.0	2.1	1.3	1.3	1.3	1.1	2.6	1.4	1.1	1.4	1.1	1.3	0.9	1.2	1.2	5.8	3.2	1.7	4.9	6.5	4.1	3.3	10.2	2.2	10.3	5.0	6.1	2.3	7.2	6.9	5.5	16.7	4.3	6.6	33.5	3.9	9.3	8.2	3.7	4.2	5.0	8.4	3.0	7.6	7.1	11.2	4.5	20.4	4.8	8.9	16.2	2.5	8.2	8.0	3.3	8.3	31.2	12.2	5.5	4.3	11.3	5.9	5.0	3.6	2.8	9.1	6.4	7.2	4.0	2.4	9.5	16.8	7.2	3.7	2.7	61.7	6.9	9.5	16.3	13.1	2.5	4.4	26.5	19.2	4.7	5.1	2.5	4.8	42.3	25.4	3.1
ADCY7	"AC7, KIAA0037"	ENSG00000121281	"Adenylate cyclase 7"	P51828	16	50246137-50318135	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 42.8;granulocytes: 50.6;Kupffer cells: 65.1;Langerhans cells: 48.0;Macrophages: 45.4;Microglial cells: 52.5;monocytes: 42.4;NK-cells: 76.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 81.0;HMC-1: 194.6;RPMI-8226: 100.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041218, HPA048241"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA041218: AB_2677365, HPA048241: AB_2680326"	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.59e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.52e-4)"	8.1	3.9	6.8	23.9	7.3	24.7	5.6	7.8	8.8	3.9	6.9	8.2	4.1	3.7	2.3	14.3	7.6	12.4	5.5	6.2	10.6	1.6	3.8	23.3	27.1	14.4	11.4	19.4	2.0	1.6	2.0	14.5	12.8	2.7	8.8	0.8	4.0	2.1	2.2	13.7	8.6	7.8	10.9	29.7	7.8	1.9	12.9	19.3	2.4	3.5	24.5	7.6	4.7	19.1	16.3	18.5	0.7	2.6	1.9	24.0	1.7	9.7	4.5	8.1	7.0	23.4	28.4	4.2	25.4	41.0	0.5	50.5	22.3	10.0	8.9	50.7	6.9	81.0	18.4	5.8	20.6	10.6	194.6	12.0	8.5	5.7	8.3	4.4	2.3	17.7	30.4	7.9	10.5	9.2	5.8	34.9	3.5	8.4	31.1	5.7	7.1	100.6	5.0	1.1	4.0	9.8	5.4	2.0	4.8	4.4	0.1	38.7	17.6	0.9	25.5	2.9	3.6	0.3	0.6	8.5	9.3	32.6	3.4	9.2	7.6	2.8	6.9	10.7	5.1	2.8	2.9	5.2	12.2	3.3	2.5	3.6	4.1	9.5	18.1	6.8	4.4	5.6	6.8	7.3	7.8	8.8	6.2	10.6	14.4	11.4	12.8	10.9	12.9	19.1	1.4	19.2	35.9	2.0	15.4	3.7	0.4	0.6	1.2	1.2	1.3	2.8	1.0	0.0	7.9	0.0	6.2	11.6	42.8	3.3	0.0	1.9	1.5	6.7	6.5	1.9	0.0	12.4	6.4	0.2	1.8	9.2	3.6	13.6	50.6	4.7	1.4	0.5	35.2	0.0	3.8	0.7	0.0	65.1	48.0	1.3	0.6	45.4	5.4	52.5	42.4	0.5	76.2	3.5	0.7	4.2	10.4	1.2	15.6	0.5	0.1	0.2	1.0	0.8	6.6	28.3	2.2	0.0	1.5	7.2	4.0	4.0	26.6	16.0	2.3	1.3
ADCY9	AC9	ENSG00000162104	"Adenylate cyclase 9"	O60503	16	3953387-4116442	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 45.4;skeletal muscle: 52.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 95.3;Inhibitory neurons: 72.7;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041328, HPA044225"	Approved		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA041328: AB_2677414, HPA044225: AB_2678863"	"unprognostic (1.78e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.24e-8)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-2)"	6.9	5.6	5.1	4.4	7.6	1.5	6.1	3.2	7.5	8.2	45.4	8.2	8.2	8.0	2.4	8.4	9.2	6.9	14.9	10.7	0.0	9.4	11.9	14.0	1.9	3.0	0.6	11.2	15.8	9.1	5.1	9.9	0.9	4.4	6.8	2.9	11.9	5.8	52.9	5.9	9.6	7.9	0.1	4.4	6.4	4.0	1.3	2.1	18.8	28.6	2.6	9.7	6.1	5.2	8.5	12.9	3.8	7.0	13.3	16.0	5.6	14.5	15.1	8.0	6.3	10.6	7.2	0.0	21.8	40.1	4.8	8.0	14.9	9.1	5.4	10.4	14.3	0.3	29.4	20.3	14.2	1.1	6.4	17.1	13.6	9.3	4.9	6.6	5.4	2.7	4.7	0.0	8.3	15.3	0.1	4.4	6.9	3.6	6.9	13.3	18.0	0.4	2.9	2.3	8.7	3.8	11.3	13.2	9.6	4.2	33.5	15.0	4.9	15.8	4.3	15.6	6.4	3.2	2.1	1.7	3.4	4.4	6.3	0.8	0.3	0.2	0.4	0.3	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.3	5.1	7.6	3.2	7.5	10.7	0.0	3.0	0.6	0.9	0.1	1.3	5.2	7.0	12.8	12.8	33.3	1.0	6.4	1.1	3.9	5.2	10.6	4.2	3.7	17.3	22.8	7.1	12.9	12.5	1.8	5.8	19.5	0.0	4.5	0.8	6.1	10.5	6.3	1.2	0.4	95.3	5.3	1.8	8.1	1.5	5.7	0.0	15.3	8.2	19.9	1.5	1.7	72.7	7.6	2.0	4.7	2.0	2.2	8.4	3.3	7.2	31.9	2.6	5.5	4.1	42.3	12.5	3.5	4.3	7.5	2.5	1.1	15.0	5.6	9.5	14.9	0.0	9.4	12.5	1.1	5.0	0.9	3.8	1.0	3.4	4.8	7.2	1.3
ADD2	ADDB	ENSG00000075340	"Adducin 2"	P35612	2	70607618-70768225	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 66.5;brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.7;Erythroid cells: 74.1;Excitatory neurons: 70.1;Horizontal cells: 139.7;Inhibitory neurons: 51.8;Late spermatids: 62.4"	"Group enriched"	"Detected in many"	5	"glioma: 5.2;testis cancer: 11.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.2;non-classical monocyte: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 33.9;JURKAT: 33.1;K-562: 46.5;NTERA-2: 86.7;RPMI-8226: 41.7;SCLC-21H: 42.8;U-251 MG: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009796, HPA034509, HPA034510"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.47e-7)"	"unprognostic (2.81e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-3)"	1.8	1.7	19.5	1.9	21.0	66.5	0.9	14.6	52.8	0.7	0.0	0.9	0.1	0.5	0.3	1.4	0.7	0.3	0.9	18.7	10.8	0.4	0.2	0.9	2.5	14.0	0.2	0.2	1.7	0.2	4.0	0.7	9.5	0.5	0.3	16.0	0.2	0.2	0.8	0.3	0.9	1.0	0.0	1.2	0.3	2.8	0.9	0.7	1.4	1.0	2.2	0.5	0.6	9.6	17.6	20.5	0.8	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	2.7	12.3	0.0	33.9	0.0	0.0	0.1	20.1	1.7	0.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	8.0	0.0	33.1	46.5	0.0	0.0	0.1	0.2	1.6	86.7	0.0	0.4	0.0	0.5	41.7	5.7	0.0	42.8	19.3	21.6	0.1	0.1	9.4	0.1	10.7	0.8	0.2	0.9	0.0	47.1	14.1	17.0	0.0	0.7	7.1	7.9	0.0	0.0	0.0	0.0	1.2	0.0	2.2	0.0	0.0	0.0	1.7	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.3	19.5	21.0	14.6	52.8	18.7	10.8	14.0	0.2	9.5	0.0	0.9	9.6	2.8	0.0	0.5	1.0	4.2	0.1	0.3	0.0	0.0	23.3	0.2	0.0	2.5	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.1	31.7	0.1	0.2	3.9	0.0	74.1	70.1	1.1	0.2	1.0	1.1	0.1	0.0	0.0	2.9	0.0	0.2	139.7	51.8	0.0	0.0	1.0	0.4	62.4	0.9	0.6	1.8	2.8	0.8	0.8	0.0	17.6	1.8	0.3	0.0	0.7	0.1	0.6	0.0	0.0	0.0	8.7	0.0	0.6	0.3	3.5	6.8	0.0	0.1	0.3	0.5	1.5	0.0	1.3
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 211.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 245.4;Kupffer cells: 111.1;Macrophages: 131.6;NK-cells: 160.6;Plasma cells: 141.5;T-cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013707	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	Yes	10000000	2400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA013707: AB_1846345"	"unprognostic (3.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.51e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.41e-2)"	45.6	21.4	4.7	79.5	7.6	211.6	21.5	7.8	6.3	60.9	4.0	52.7	43.6	143.6	7.0	15.1	48.9	33.2	30.4	4.8	6.0	28.0	19.9	80.2	58.2	9.6	7.4	14.6	31.4	6.1	7.5	32.7	8.4	17.0	29.7	0.4	22.1	10.4	29.5	14.9	51.0	75.3	6.6	145.0	40.5	3.4	9.0	32.5	21.3	13.5	32.0	42.2	29.3	12.1	118.1	81.9	0.8	77.2	33.3	54.1	12.2	79.6	127.0	56.0	61.0	23.5	115.9	13.5	78.5	103.1	79.6	27.2	21.0	38.8	25.0	73.4	23.7	26.4	113.0	10.4	41.0	57.4	117.3	23.9	1.0	57.1	19.4	18.2	5.6	22.7	35.0	101.9	61.9	26.6	3.7	76.3	2.3	92.7	100.4	7.8	33.7	61.8	18.7	10.4	1.0	2.8	45.4	64.1	57.9	1.8	16.7	52.3	14.0	19.0	31.1	79.5	133.2	0.2	0.4	1.1	67.6	100.4	72.0	371.6	158.5	772.8	187.5	281.4	123.9	28.5	94.2	129.6	102.6	18.5	65.5	91.9	623.2	179.2	352.9	48.4	70.6	242.4	4.7	7.6	7.8	6.3	4.8	6.0	9.6	7.4	8.4	6.6	9.0	12.1	10.0	35.3	93.1	1.3	88.6	0.0	8.5	0.0	2.2	0.5	7.2	6.7	3.7	12.8	17.3	0.0	0.0	4.1	245.4	25.8	0.0	18.1	0.1	16.1	26.9	13.1	4.9	25.7	1.4	22.5	46.3	20.0	49.5	13.3	77.0	1.4	23.9	2.9	50.8	0.0	1.8	25.9	0.0	111.1	0.0	1.4	6.5	131.6	0.0	6.5	55.3	2.6	160.6	2.0	11.2	21.2	30.6	4.9	141.5	12.8	17.8	0.9	27.7	1.5	26.3	34.6	23.1	0.5	5.3	3.2	0.0	7.9	184.3	3.7	29.1	17.6
ADGRF3	"GPR113, hGPCR37, PGR23"	ENSG00000173567	"Adhesion G protein-coupled receptor F3"	Q8IZF5	2	26308173-26346817	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 11.4;Early spermatids: 12.0;Late spermatids: 28.0;Microglial cells: 5.6;Oligodendrocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;U-937: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA044500	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"	Cytosol	"HPA044500: AB_10794290"	"unprognostic (9.58e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.68e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.66e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.70e-5)"	0.1	0.1	0.5	0.4	0.3	0.4	0.0	1.0	0.6	0.0	0.5	0.1	0.5	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.4	0.8	0.1	0.1	0.5	0.6	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	0.5	0.4	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.5	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.2	0.0	1.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	1.4	0.4	0.9	0.0	0.0	0.8	0.7	0.3	0.0	1.1	0.8	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.7	0.7	1.2	0.0	1.4	0.1	0.0	0.0	0.4	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.3	1.0	0.6	0.4	0.4	0.6	0.3	0.4	0.3	0.4	0.4	0.4	0.0	0.0	11.4	1.3	0.0	0.3	0.0	0.0	0.9	0.3	0.4	0.7	0.0	0.0	0.0	2.1	0.1	0.8	0.0	0.0	0.1	12.0	0.9	1.1	0.2	0.0	0.0	3.4	0.0	0.1	0.2	0.5	0.8	0.0	0.2	0.0	0.2	0.1	1.7	4.1	0.1	0.0	0.0	0.0	28.0	0.0	0.5	0.0	5.6	0.3	0.2	0.0	3.0	6.3	0.1	0.0	0.0	2.7	0.1	0.4	0.1	0.0	1.2	0.0	0.2	0.3	1.5	0.4	0.1	0.0	0.1	0.9	0.2	0.2	0.1
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989307-19122637	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 1227.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Endometrial stromal cells: 5.4;Fibroblasts: 5.3;Gastric mucus-secreting cells: 9.2;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;BEWO: 7.3;HeLa: 5.9;NTERA-2: 6.4;RPMI-8226: 4.5;SH-SY5Y: 6.6;U-2197: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		22000000		"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	3.9	0.3	0.1	0.9	0.1	0.0	2.0	0.0	1.1	1.0	0.0	0.5	0.5	1.0	1227.7	0.5	16.5	1.6	1.3	0.8	0.7	0.4	0.7	1.3	5.0	0.4	1.5	0.2	1.2	163.4	1.1	0.5	0.6	2.1	0.4	0.9	8.5	3.6	0.2	0.4	1.1	0.4	0.1	2.4	9.0	1.9	0.3	6.6	1.6	1.1	3.7	0.8	1.0	0.2	0.2	6.0	0.0	0.0	0.1	0.9	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	5.9	0.2	0.8	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.2	6.4	0.0	2.0	0.0	0.0	4.5	0.0	1.2	2.2	6.6	1.5	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.4	14.6	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.8	0.7	0.4	1.5	0.6	0.1	0.3	0.2	0.6	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.6	1.2	1.1	1.0	7.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	1.1	5.4	0.6	0.0	0.0	4.4	0.2	0.3	5.3	9.2	3.2	0.0	0.2	1.4	0.4	0.0	3.3	5.0	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.0	4.7	0.0	4.8	0.0	10.1	7.0	3.1	0.0	1.5	0.0	3.4	0.0	0.1	2.2	0.7	0.0	1.6	0.6	0.1	1.4	0.1	0.0	0.0	0.3	0.3	0.0	0.3
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	306	"liver: 2739.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	8.9	0.3	0.5	0.1	0.5	6.6	0.3	0.0	0.0	0.7	2739.1	0.8	0.0	0.1	0.1	0.1	1.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1501.5;liver: 5858.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1501.5	140.2	2.2	36.4	3.4	0.1	924.6	1.9	9.0	41.0	13.5	202.2	38.5	161.4	74.8	105.8	385.0	145.1	215.3	2.0	1.9	66.7	5858.7	373.2	25.8	4.7	2.2	117.7	49.1	7.8	24.2	6.8	3.2	26.7	114.7	0.1	67.9	26.7	66.6	159.2	237.1	73.4	4.4	72.7	141.1	2.8	2.2	19.8	94.5	228.2	16.0	287.9	118.7	2.4	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	1.9	9.0	2.0	1.9	4.7	2.2	3.2	4.4	2.2	2.4	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968432-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1238.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 12067.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 847.5;PC-3: 680.7;RT4: 1035.2"					"Low region specificity"	"Detected in all"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA026810: AB_2672003"																		1238.9	58.8	253.4	50.9	238.3	1.0	246.1	221.8	380.1	201.9	226.1	114.2	476.9	114.1	49.1	114.2	235.9	46.7	90.6	251.6	278.5	147.2	82.5	209.5	15.5	259.4	237.0	252.6	73.2	26.9	55.1	28.4	241.8	312.5	48.1	29.0	296.8	233.8	87.5	115.6	491.6	75.8	239.8	73.6	75.2	27.2	242.7	25.8	116.6	131.9	44.7	242.9	171.1	247.4	259.8	4.9	0.1	0.1	123.3	224.9	16.1	97.0	166.9	1.7	0.4	6.5	29.5	0.0	3.4	209.9	8.4	847.5	0.0	39.7	1.0	9.1	0.0	0.0	22.5	1.8	19.9	0.2	3.4	1.9	132.0	0.6	70.1	6.7	50.4	3.6	0.3	36.3	4.0	130.4	0.6	6.5	0.0	6.4	680.7	0.5	0.0	3.4	14.6	1035.2	11.8	3.0	36.0	222.0	1.7	0.0	270.7	2.7	132.6	3.4	17.4	13.2	0.6	4.0	3.3	0.4	6.3	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	2.5	1.9	0.0	0.0	0.0	0.0	0.5	0.3	253.4	238.3	221.8	380.1	251.6	278.5	259.4	237.0	241.8	239.8	242.7	247.4	1215.2	1842.9	476.5	3.9	15.0	528.4	141.9	309.7	39.9	5.4	651.4	253.2	0.0	58.6	614.4	187.6	2.1	299.2	14.3	658.7	1352.0	29.9	9.6	55.7	63.9	944.9	30.0	37.5	0.1	272.1	16.9	508.0	121.3	195.1	48.9	11.7	1691.7	257.4	26.4	0.0	0.3	418.7	128.1	17.3	492.0	48.4	1309.5	25.3	610.1	10.3	99.9	703.9	0.0	1.0	0.2	336.8	1115.3	469.8	3.4	481.9	12067.2	1144.8	88.2	16.5	1472.6	705.4	2422.0	3.2	6.2	35.0	438.6	166.8	40.7	2.4	443.5	1160.7
ADNP2	"KIAA0863, ZNF508"	ENSG00000101544	"ADNP homeobox 2"	Q6IQ32	18	80109262-80147523	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 41.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007126	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Mitochondria, Cytosol"		"HPA007126: AB_1080729"	"unprognostic (4.93e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.64e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (9.90e-4)"	"unprognostic (5.19e-2)"	8.0	6.2	17.3	6.6	13.1	41.3	8.1	7.3	31.2	6.0	9.9	7.2	9.1	7.4	10.8	8.6	6.6	7.5	8.0	10.2	9.1	6.7	7.9	7.5	7.2	15.4	10.1	8.0	8.2	9.6	6.9	6.7	14.0	6.8	6.6	12.4	6.4	6.3	2.7	12.7	6.6	7.8	9.4	6.5	7.8	22.0	18.0	9.4	8.4	4.5	7.1	7.7	6.9	15.6	23.1	17.8	36.2	27.0	8.1	11.4	27.0	16.3	18.6	19.2	23.8	16.9	11.5	0.2	6.2	13.3	23.6	20.8	35.4	21.1	20.2	21.0	17.8	32.3	12.8	18.5	14.8	47.5	34.5	11.9	19.6	19.7	26.1	12.8	19.4	36.1	31.8	33.3	11.4	16.4	43.8	9.9	24.9	10.3	20.6	16.6	40.5	16.4	11.6	30.3	24.7	31.8	18.4	18.1	13.0	17.6	17.8	36.0	13.3	22.6	56.6	9.5	18.4	11.7	23.1	46.8	15.1	19.8	15.7	0.0	0.4	0.2	1.2	0.7	0.8	0.8	1.5	1.0	0.2	0.3	0.8	1.4	0.6	0.6	1.2	0.8	0.8	0.5	17.3	13.1	7.3	31.2	10.2	9.1	15.4	10.1	14.0	9.4	18.0	15.6	17.0	19.2	20.9	21.9	10.2	39.5	24.4	11.7	16.5	20.3	17.0	11.9	16.6	10.0	12.6	3.7	27.1	10.1	15.5	17.4	0.0	7.9	9.9	15.8	14.2	14.5	22.2	22.3	22.7	10.9	8.3	15.9	13.3	31.2	12.0	13.6	15.4	19.5	9.9	25.2	25.2	18.9	14.2	10.6	13.8	8.2	7.5	14.6	14.2	11.2	5.5	9.7	3.1	17.1	36.8	11.5	15.9	11.7	9.7	21.7	10.6	7.2	10.2	30.2	0.0	15.6	14.5	45.4	38.3	23.7	43.2	9.7	15.5	17.8	13.6	32.2
ADRA2B	"ADRA2L1, ADRA2RL1, ADRARL1"	ENSG00000274286	"Adrenoceptor alpha 2B"	P18089	2	96112876-96116571	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 9.0;Langerhans cells: 8.0;Sertoli cells: 32.9;Smooth muscle cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;EFO-21: 1.0"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.5;cerebellum: 1.0;thalamus: 3.2"	"Low region specificity"	"Detected in some"			"HPA066029, HPA074948"	Approved		Supported	Vesicles,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Cytosol	"HPA066029: AB_2685599, HPA074948: "	"unprognostic (6.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.93e-4)"	"unprognostic (1.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (6.80e-5)"	"unprognostic (4.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-2)"	6.4	2.1	1.5	0.3	1.7	0.8	3.0	1.4	2.7	1.5	4.9	2.3	0.3	1.9	3.8	0.7	3.0	0.6	10.1	1.2	1.4	5.1	7.0	0.5	0.2	1.8	1.6	1.7	0.8	0.5	0.5	0.8	1.7	1.4	0.3	0.0	2.2	1.5	6.4	1.9	2.6	0.7	1.3	8.6	2.2	1.6	2.6	0.2	1.3	5.0	0.1	2.5	1.8	2.4	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	2.7	1.2	1.4	1.8	1.6	1.7	1.3	2.6	2.4	2.9	0.0	0.0	0.0	0.9	1.1	0.7	0.7	0.6	0.0	0.9	0.9	2.5	0.0	1.5	1.8	0.0	0.8	2.9	0.1	0.0	0.2	0.0	2.2	1.0	2.4	2.4	0.0	0.0	0.6	0.2	1.0	1.1	9.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.2	0.0	0.3	8.0	0.0	1.8	5.1	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.4	0.7	0.0	0.1	1.4	0.0	32.9	0.7	13.3	0.0	0.3	0.6	1.4	0.4	2.8	0.1	0.1	0.3
ADSS2	ADSS	ENSG00000035687	"Adenylosuccinate synthase 2"	P30520	1	244408494-244451909	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.4;Cytotrophoblasts: 49.3;dendritic cells: 59.6;Extravillous trophoblasts: 97.2;Hofbauer cells: 35.8;Syncytiotrophoblasts: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		690000	"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.8	20.5	17.8	28.1	22.0	43.9	34.6	21.7	26.7	25.9	17.0	28.7	28.7	23.4	29.8	32.6	23.9	21.0	8.9	19.2	21.1	32.9	24.3	25.3	31.9	21.9	19.6	21.7	19.8	27.6	14.5	28.6	23.1	25.3	29.8	11.4	22.8	25.6	10.8	33.2	27.1	25.2	19.6	23.7	35.0	70.3	20.9	33.8	34.9	8.4	34.9	36.2	21.5	28.7	89.9	48.6	41.6	36.9	47.6	67.8	76.2	88.5	74.4	62.3	47.0	64.6	84.5	79.7	57.1	68.9	26.6	66.1	45.9	58.0	69.5	59.6	81.0	53.1	47.8	49.3	57.1	127.1	65.6	46.8	68.5	58.1	58.3	72.1	225.6	43.3	94.0	57.7	62.7	21.6	82.3	85.0	110.5	85.0	53.1	74.9	39.4	86.5	103.8	55.2	56.2	49.2	75.2	69.0	91.4	43.9	48.0	66.7	99.4	57.1	31.3	67.0	93.7	69.1	97.2	60.0	47.2	146.8	86.3	48.3	22.8	20.0	20.4	29.9	22.0	15.3	18.6	17.8	20.1	12.3	15.6	17.9	17.5	23.6	33.6	7.9	22.3	18.8	17.8	22.0	21.7	26.7	19.2	21.1	21.9	19.6	23.1	19.6	20.9	28.7	26.4	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	49.3	59.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	97.2	9.3	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	54.0	11.0	0.0	0.0	0.0
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104345-44114562	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 103.0;Fibroblasts: 263.2;Leydig cells: 151.6;Peritubular cells: 508.9;Smooth muscle cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.1;BJ: 193.0;BJ hTERT+: 126.0;fHDF/TERT166: 208.9;JURKAT: 145.0;WM-115: 117.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 57.6"	"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2700000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	190.5	59.9	45.0	59.8	56.0	10.6	153.0	38.6	44.8	312.1	28.0	95.3	19.2	268.8	59.6	65.7	199.8	155.9	156.7	47.3	92.9	68.7	20.3	166.0	45.5	114.7	81.5	253.7	28.9	10.1	43.3	89.0	79.6	112.1	25.0	1.3	50.7	213.5	21.3	84.8	79.1	119.3	74.3	54.4	71.2	40.4	52.1	73.3	83.7	14.1	16.7	138.7	198.0	66.6	0.6	0.0	44.5	0.1	141.1	49.6	1.0	193.0	126.0	21.6	4.5	0.0	0.1	5.3	20.9	208.9	0.2	0.1	2.4	3.5	9.1	0.6	0.0	13.3	0.1	0.0	39.6	0.1	0.3	75.8	0.0	72.9	0.1	1.1	9.7	145.0	8.3	0.3	0.0	0.2	86.9	16.1	19.1	0.0	0.4	71.3	1.7	1.7	5.0	0.0	4.9	25.3	0.1	0.3	85.9	41.9	0.4	14.4	34.1	0.0	86.2	0.5	0.3	1.0	0.9	102.8	0.4	0.2	117.9	0.0	0.0	0.0	0.3	0.0	0.2	1.5	0.2	0.0	0.0	1.4	0.9	0.5	0.0	0.1	0.0	7.6	0.0	0.3	45.0	56.0	38.6	44.8	47.3	92.9	114.7	81.5	79.6	74.3	52.1	66.6	23.6	0.0	2.5	32.3	11.8	34.5	5.7	1.3	1.8	0.8	2.0	14.6	26.4	1.5	1.4	7.3	0.0	2.0	22.7	0.0	0.0	0.9	3.1	3.3	103.0	18.0	0.0	1.3	0.1	0.0	3.3	263.2	8.6	2.9	2.5	33.3	30.4	0.6	3.6	0.0	0.3	0.0	0.0	1.8	42.0	18.0	151.6	3.2	85.4	17.8	1.0	0.2	1.0	6.0	0.3	0.4	0.0	508.9	9.7	16.9	0.0	2.2	2.2	0.8	39.5	23.6	173.4	4.0	4.6	1.5	27.4	3.4	4.8	28.7	0.0	2.4
AFAP1	"AFAP, AFAP-110"	ENSG00000196526	"Actin filament associated protein 1"	Q8N556	4	7758714-7939926	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 170.5;Extravillous trophoblasts: 116.3;Inhibitory neurons: 117.2;Late spermatids: 373.8;Oligodendrocyte precursor cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.9;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"TIME: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015642, CAB024712"	Enhanced		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Actin filaments, Cytosol"	"Focal adhesion sites"	"CAB024712: , HPA015642: AB_1844632"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.44e-2)"	12.6	3.1	7.0	8.7	5.8	0.7	9.7	4.5	6.9	8.7	2.9	17.6	5.6	15.4	2.0	11.0	8.5	9.4	10.8	5.8	4.5	4.9	1.2	8.5	4.4	3.7	2.7	7.1	3.8	14.7	7.9	12.6	2.8	7.7	9.8	3.4	8.6	10.2	3.5	5.3	7.7	15.4	3.4	4.0	6.7	22.0	3.5	3.1	7.4	2.4	4.8	14.2	8.3	3.5	31.9	23.2	16.2	12.9	15.4	27.8	21.3	46.4	68.1	43.6	40.0	7.4	7.2	0.1	15.2	75.5	72.3	15.1	8.6	18.7	28.6	0.9	5.7	0.0	33.2	4.5	43.0	0.0	0.4	17.2	13.8	54.4	35.5	72.2	53.0	4.8	0.7	6.8	23.0	10.3	0.6	0.0	7.0	13.2	44.3	0.0	12.1	1.5	4.7	4.1	31.8	53.0	15.9	10.9	12.4	21.4	4.1	0.3	126.7	53.0	11.8	69.6	23.0	0.0	0.2	0.0	18.9	0.1	61.9	0.0	0.4	2.9	0.4	0.1	0.5	0.0	0.6	0.6	0.0	0.0	1.2	0.5	1.0	0.0	0.0	0.0	0.5	0.7	7.0	5.8	4.5	6.9	5.8	4.5	3.7	2.7	2.8	3.4	3.5	3.5	22.5	6.4	2.0	4.6	0.2	2.9	9.7	16.2	7.4	1.2	10.2	8.9	5.9	10.0	12.7	11.0	4.2	5.6	2.3	14.8	0.0	19.2	170.5	7.5	17.6	20.1	14.5	0.0	24.7	7.7	116.3	21.1	11.2	8.8	0.0	4.4	14.3	0.0	8.5	0.0	117.2	20.6	0.0	0.3	3.6	373.8	11.1	6.0	1.8	30.9	0.6	10.2	0.0	125.2	5.4	29.9	8.6	12.4	0.6	13.5	6.4	4.2	6.4	0.7	6.6	8.0	13.4	12.5	10.0	6.2	4.3	8.8	7.3	2.6	13.9	9.9
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100192428	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 154.9;Excitatory neurons: 491.3;Inhibitory neurons: 300.7;Oligodendrocyte precursor cells: 211.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 11.4;prostate cancer: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 31.0;naive B-cell: 44.2;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	17	"B-cells: 44.2;dendritic cells: 23.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;U-698: 56.5"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.3	1.6	3.1	6.2	3.9	11.2	11.6	17.4	13.2	3.5	0.0	5.1	1.1	7.7	0.8	3.5	4.5	2.2	4.3	9.7	5.0	1.4	1.7	6.5	14.2	2.2	0.0	6.3	0.4	0.1	4.4	6.2	1.8	16.2	2.2	4.2	1.9	2.5	0.7	0.9	6.0	5.9	0.0	7.3	4.6	5.4	0.0	7.7	1.2	0.7	12.2	6.7	2.2	9.8	0.2	0.0	18.0	6.4	0.0	0.6	0.0	2.8	0.7	5.6	1.9	0.0	0.0	51.1	0.1	3.8	12.4	0.2	0.5	0.0	4.0	14.3	6.3	0.0	0.0	0.0	0.4	0.2	12.4	0.8	0.0	12.8	0.2	13.8	0.0	2.2	0.3	0.1	0.0	0.1	4.3	0.3	1.8	0.0	3.2	7.5	0.0	0.3	0.0	0.0	17.4	6.5	0.0	0.3	11.0	1.5	17.9	16.5	6.7	19.1	3.4	0.5	2.9	0.8	0.1	56.5	15.9	1.5	2.0	0.6	0.5	0.1	0.0	0.5	0.3	31.0	0.2	0.0	5.1	44.2	1.9	0.0	0.0	1.0	0.4	23.9	0.0	0.8	3.1	3.9	17.4	13.2	9.7	5.0	2.2	0.0	1.8	0.0	0.0	9.8	1.2	6.4	40.9	41.8	154.9	1.8	0.4	0.0	1.8	21.8	78.9	37.7	11.1	0.0	3.7	0.0	12.5	0.4	32.8	0.1	0.0	0.0	33.9	0.9	19.8	6.0	22.9	3.4	491.3	0.0	0.2	13.5	1.1	1.1	0.0	31.6	0.7	1.2	1.8	47.1	300.7	0.5	0.0	9.2	18.2	38.5	10.8	16.5	14.2	66.5	5.2	6.8	0.0	211.6	46.7	0.0	0.1	21.1	0.8	14.3	0.1	1.9	0.0	1.7	0.0	1.1	8.5	10.5	9.8	0.0	1.3	0.1	6.1	5.7	0.6	0.3
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294991-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 6.4;Distal tubular cells: 9.8;Hofbauer cells: 5.7;Proximal tubular cells: 6.3;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	1.8	2.1	2.2	1.3	2.7	2.1	2.2	2.0	3.3	1.7	2.7	2.6	4.2	1.5	1.9	1.6	2.2	1.5	4.6	1.7	1.9	5.0	3.7	1.7	1.8	1.8	2.0	1.7	2.1	5.4	1.5	2.2	2.0	1.6	3.1	3.1	1.8	1.7	3.7	1.2	3.0	1.7	1.7	2.0	2.8	10.7	2.7	2.3	3.0	4.0	2.1	1.7	1.1	3.2	2.7	1.4	3.4	6.1	3.5	5.1	3.3	3.0	4.4	4.8	4.7	5.7	3.3	4.8	3.8	4.7	5.8	1.5	4.4	4.5	5.4	2.8	2.6	5.7	1.8	6.6	3.5	5.3	2.7	4.7	3.6	3.6	5.8	3.1	2.6	3.5	5.9	2.2	4.5	2.6	0.9	4.8	2.2	4.6	2.8	3.3	4.6	2.8	6.1	2.9	3.7	3.2	2.4	3.5	6.4	4.5	2.8	9.8	3.2	2.9	0.7	2.6	3.4	1.5	2.6	3.7	3.6	6.0	4.5	0.0	1.6	2.8	1.0	1.2	1.3	2.5	1.5	1.9	1.4	3.4	2.1	1.4	0.4	2.4	4.3	1.6	2.3	0.7	2.2	2.7	2.0	3.3	1.7	1.9	1.8	2.0	2.0	1.7	2.7	3.2	2.4	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	5.0	3.7	0.0	6.4	1.1	0.0	9.8	3.1	0.0	2.6	2.6	2.2	0.0	0.0	0.0	3.8	4.6	1.2	0.0	1.8	2.5	5.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	6.3	5.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	0.9	4.5	0.0	0.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"liver: 3.7"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 107.5;Proximal tubular cells: 101.6"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 208.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	192	"Hep G2: 2165.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	150000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.7	5.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.7	2.8	0.3	0.0	0.1	0.0	0.1	2.5	107.5	2.3	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	101.6	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	1.5	0.2	0.1	0.2	0.0
AGBL3	"CCP3, MGC32955"	ENSG00000146856	"ATP/GTP binding protein like 3"	Q8NEM8	7	134986508-135147963	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.5;Excitatory neurons: 40.7;Inhibitory neurons: 34.2;Oligodendrocytes: 37.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5"	"Low region specificity"	"Detected in all"							"HPA020397, HPA024150"	Uncertain		Approved	Cytosol		NA	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA020397: AB_2242453, HPA024150: AB_1844639"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.32e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.15e-4)"	"unprognostic (5.00e-3)"	"unprognostic (6.10e-4)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.11e-3)"	1.0	0.9	1.0	2.3	1.3	2.2	2.3	2.0	3.0	0.8	1.2	1.2	0.8	2.9	7.9	0.1	1.8	0.7	0.8	1.0	1.9	1.7	0.6	1.8	2.3	1.3	1.2	3.5	2.3	0.4	0.3	0.9	1.1	1.9	1.5	1.3	2.5	2.1	2.4	2.5	2.0	1.6	1.3	3.8	2.5	5.1	1.7	0.9	2.8	0.8	0.9	0.3	0.2	1.8	1.7	0.9	2.2	0.5	0.6	0.8	1.3	0.4	0.0	0.3	0.5	3.0	1.9	2.7	0.8	0.0	0.9	1.8	0.8	0.3	0.0	2.2	5.5	2.3	4.0	3.0	0.0	1.0	0.0	0.1	0.0	1.3	0.0	0.0	0.9	3.0	1.7	1.5	0.3	1.5	0.6	0.9	1.9	0.2	0.2	1.6	0.1	0.8	1.5	0.3	1.3	1.4	0.3	0.0	0.2	0.0	1.2	2.3	0.0	0.2	0.5	0.3	1.0	3.3	1.1	1.3	1.1	2.8	2.7	0.0	0.1	0.1	0.8	0.0	0.7	0.8	0.4	0.9	0.2	0.7	0.7	1.7	0.2	0.9	0.0	0.6	0.6	0.6	1.0	1.3	2.0	3.0	1.0	1.9	1.3	1.2	1.1	1.3	1.7	1.8	6.7	3.2	0.6	18.3	3.5	1.3	0.9	1.2	2.8	5.1	2.2	2.2	2.1	4.3	2.0	9.2	2.1	0.3	0.9	0.6	7.9	4.6	70.5	6.6	1.8	4.8	3.0	3.0	40.7	2.9	0.4	2.8	4.6	2.6	1.3	3.2	5.0	1.9	0.5	3.3	34.2	0.4	0.0	1.3	0.7	11.8	3.4	0.8	5.4	22.5	6.9	2.8	1.0	16.6	37.3	1.7	0.1	2.2	6.1	1.3	0.4	7.6	6.4	3.3	0.0	2.0	4.1	21.4	6.3	1.2	0.3	0.1	2.0	2.4	0.5	1.0
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"parathyroid gland: 49.9;testis: 192.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	8.8	16.7	8.4	8.0	7.4	13.6	12.4	7.8	8.2	14.4	9.5	16.2	8.8	14.0	26.0	18.3	20.8	14.3	12.7	7.3	11.3	22.5	7.2	11.2	10.7	8.3	7.8	14.4	15.0	49.9	12.5	11.2	8.9	15.2	11.5	16.3	21.2	16.5	7.1	20.5	9.9	14.6	6.1	8.5	11.8	192.9	9.1	15.6	28.5	6.5	8.6	14.9	7.3	7.5	55.0	34.7	55.4	37.2	11.6	23.0	62.9	10.9	23.5	30.9	31.9	30.2	40.5	30.3	34.0	18.9	43.4	24.6	44.8	49.4	33.9	25.9	66.8	44.5	42.0	65.7	23.6	21.6	14.4	24.4	36.7	27.1	22.0	46.9	32.8	43.5	38.9	23.8	30.3	21.5	63.2	32.3	39.4	39.4	23.7	64.5	62.9	48.0	31.9	13.6	37.1	53.6	21.5	16.7	35.0	53.9	24.9	16.3	16.4	28.6	39.2	13.8	23.9	47.7	27.2	62.4	31.8	24.4	26.1	8.8	1.8	4.5	3.3	1.1	2.5	4.6	4.1	4.6	4.1	2.3	3.6	2.2	1.1	8.5	0.7	2.3	2.8	3.8	8.4	7.4	7.8	8.2	7.3	11.3	8.3	7.8	8.9	6.1	9.1	7.5	3.6	0.0	10.1	5.2	6.3	3.3	8.3	7.2	13.6	5.7	8.6	6.7	6.7	10.0	6.8	9.2	0.0	14.7	1.8	5.9	19.6	8.3	302.7	13.0	3.9	4.9	2.4	11.6	7.9	6.0	7.9	6.4	5.6	5.8	1.3	14.1	6.4	4.1	5.2	0.0	9.1	8.4	6.1	3.1	3.5	338.0	10.5	8.0	7.2	6.5	4.9	6.8	0.0	10.1	10.1	5.0	7.6	11.3	17.1	6.0	6.3	25.0	10.7	10.0	0.0	4.2	7.0	156.8	41.2	16.3	2.7	8.3	5.0	9.4	8.6	10.5
AGFG2	"HRBL, RABR"	ENSG00000106351	"ArfGAP with FG repeats 2"	O95081	7	100539203-100568220	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"salivary gland: 289.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 34.3;Hepatic stellate cells: 57.5;Hepatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019689, HPA073562"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA019689: AB_1855074, HPA073562: "	"unprognostic (7.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.03e-6)"	"unprognostic (7.83e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.90e-3)"	"unprognostic (9.31e-2)"	12.8	35.6	16.7	5.1	20.1	5.0	11.2	10.8	15.8	11.6	6.8	18.9	10.3	21.9	5.3	30.8	16.4	11.1	9.8	22.0	14.7	14.0	53.9	7.8	9.0	19.4	12.0	30.2	18.8	7.4	17.7	2.2	14.1	13.3	9.9	2.2	289.4	13.4	6.2	26.0	13.4	7.6	11.1	29.1	13.5	12.1	15.5	4.4	10.7	5.6	6.4	11.7	12.5	12.3	10.8	17.2	2.2	5.1	15.1	7.8	3.0	5.1	13.6	7.9	8.2	15.1	9.6	6.8	16.5	6.0	34.8	8.8	2.4	5.2	3.5	24.1	6.7	2.1	8.3	33.1	6.1	2.2	11.7	13.0	3.9	6.4	7.1	4.9	21.6	4.4	6.4	9.2	6.5	9.5	8.8	8.0	1.5	30.0	7.1	4.3	2.5	6.1	4.6	5.7	3.1	3.8	9.9	14.0	4.6	3.4	4.0	3.0	5.5	9.8	6.7	24.5	5.4	5.6	31.4	2.6	7.4	6.5	5.7	2.2	0.0	2.2	1.7	0.2	1.5	0.3	1.7	2.0	0.1	0.6	0.5	0.7	0.4	0.5	0.0	0.4	1.4	0.6	16.7	20.1	10.8	15.8	22.0	14.7	19.4	12.0	14.1	11.1	15.5	12.3	16.9	0.0	3.9	15.0	3.2	2.0	7.4	2.3	8.6	1.6	4.3	3.6	9.1	34.3	3.1	25.8	2.1	1.8	4.9	25.8	11.7	13.4	1.7	2.8	3.2	13.4	26.5	5.9	6.2	11.6	1.6	3.6	10.2	4.2	2.5	7.2	57.5	37.0	1.5	3.3	4.8	12.0	2.0	5.4	3.1	2.3	5.6	1.3	3.6	3.7	7.1	4.0	7.2	3.0	2.5	7.2	9.6	9.1	7.3	3.6	11.1	2.8	1.0	1.7	13.1	1.5	5.6	14.5	14.5	9.2	5.4	0.8	12.6	6.8	15.2	6.9
AGO1	"EIF2C1, hAGO1"	ENSG00000092847	"Argonaute RISC component 1"	Q9UL18	1	35869808-35930532	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067849			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cytoplasmic bodies"	Cytosol	"HPA067849: "	"unprognostic (2.35e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.61e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.77e-3)"	6.2	6.6	10.7	7.6	9.5	6.5	6.5	7.1	8.6	7.0	7.5	6.5	6.7	7.1	5.0	5.8	6.6	4.8	7.2	8.9	9.3	6.2	4.7	6.4	6.7	9.1	9.7	8.0	5.7	10.1	5.1	5.1	9.1	8.1	7.0	6.7	6.5	8.6	8.6	11.0	7.4	7.9	11.3	8.9	6.4	5.2	8.4	9.0	6.0	7.9	8.4	5.1	4.4	9.1	14.2	9.4	21.1	18.7	14.4	8.6	23.2	7.3	11.1	12.6	11.9	19.2	9.9	16.0	9.0	14.6	8.7	7.5	30.4	11.7	15.3	14.9	10.0	32.4	15.4	16.8	6.4	19.4	12.5	7.1	5.5	21.3	10.9	8.0	18.2	13.7	24.0	8.9	10.3	10.9	20.4	10.0	47.6	19.1	8.0	15.3	15.9	6.8	5.5	17.8	26.1	11.6	25.6	10.5	8.4	23.7	8.5	7.7	14.9	9.8	21.6	13.7	13.9	9.1	7.9	7.4	10.3	11.6	12.7	1.9	3.8	1.8	1.9	5.1	1.7	1.6	1.4	1.7	1.6	1.4	1.6	1.5	2.4	1.4	4.1	1.6	1.3	4.5	10.7	9.5	7.1	8.6	8.9	9.3	9.1	9.7	9.1	11.3	8.4	9.1	10.1	3.2	9.3	11.4	11.8	13.9	7.2	6.4	17.6	34.0	13.0	9.9	15.8	12.8	9.1	14.7	39.6	5.2	25.4	12.6	1.9	11.5	5.2	11.6	12.4	13.3	25.9	5.5	15.3	13.2	4.7	10.6	9.7	7.7	16.5	12.5	10.0	13.4	13.3	35.3	15.6	15.5	6.1	30.5	20.0	6.7	14.9	19.2	5.4	4.7	23.9	12.9	20.6	13.6	14.5	11.3	11.1	20.7	7.9	10.6	29.4	10.1	11.4	30.5	13.1	13.1	15.5	12.7	16.8	10.8	14.5	2.3	10.7	14.7	16.2	7.2
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute RISC catalytic component 2"	Q9UKV8	8	140520156-140635633	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		65000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cytoplasmic bodies"	Cytosol	"CAB019309: , HPA067849: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	7.8	4.1	6.9	6.2	11.5	11.3	5.9	12.4	9.2	6.9	2.4	8.6	3.2	7.7	5.9	6.3	8.3	5.1	7.3	5.7	11.4	5.9	3.8	9.1	6.1	14.0	10.1	9.5	5.0	7.0	8.0	5.8	11.3	5.8	4.0	6.8	4.8	4.6	17.5	8.5	6.2	5.2	5.9	5.2	6.6	3.3	10.8	7.6	6.3	9.1	5.4	6.6	6.7	19.2	18.9	15.2	15.3	17.6	9.9	11.5	12.9	11.6	8.4	5.1	6.3	17.0	5.5	21.5	14.1	11.3	5.5	12.4	26.2	12.5	11.3	12.2	13.7	25.2	28.7	11.0	8.9	10.5	8.2	7.9	11.0	14.1	14.6	7.0	12.0	13.4	26.9	13.2	16.8	28.5	18.2	8.3	11.4	12.9	26.3	18.5	12.9	9.7	6.5	19.3	18.0	13.0	18.1	6.1	12.8	15.7	15.7	15.1	16.9	8.8	24.5	14.0	18.9	11.5	4.0	14.7	6.5	18.7	13.2	0.7	0.8	0.2	0.8	0.7	0.9	0.4	0.8	0.7	0.7	0.7	0.8	0.8	2.2	0.8	0.8	0.5	0.7	0.6	6.9	11.5	12.4	9.2	5.7	11.4	14.0	10.1	11.3	5.9	10.8	19.2	30.8	22.4	25.1	50.3	40.7	21.9	74.8	5.7	17.6	26.5	34.5	24.5	22.2	8.6	22.6	14.7	43.8	46.5	63.1	14.8	7.9	25.6	21.2	73.1	54.3	37.8	24.2	122.9	32.6	18.2	21.5	44.3	28.5	129.4	17.1	31.6	27.5	14.6	14.9	42.1	36.4	19.1	2.0	26.0	48.5	14.9	37.3	53.0	5.4	32.8	36.0	26.1	32.0	51.3	83.2	37.9	18.6	46.3	46.6	115.0	12.7	9.4	15.4	29.7	32.9	65.9	44.5	3.1	4.0	31.8	23.9	79.1	49.1	12.0	19.3	100.1
AGO3	"EIF2C3, FLJ12765, hAGO3"	ENSG00000126070	"Argonaute RISC catalytic component 3"	Q9H9G7	1	35930718-36072500	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 155.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048342, HPA067849, HPA075436"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750"	"unprognostic (4.10e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.39e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.81e-1)"	3.6	2.8	4.5	2.6	8.4	7.4	2.9	6.9	6.9	3.3	7.4	3.0	1.4	2.9	3.2	2.7	2.7	1.9	3.4	4.6	6.9	2.5	4.3	3.5	3.0	8.5	7.2	3.7	2.9	3.3	6.2	3.5	7.4	3.2	2.0	5.1	2.5	2.2	3.2	3.8	2.5	2.7	6.8	2.8	2.8	5.6	8.0	3.3	3.2	4.4	3.1	3.0	3.0	14.0	6.6	4.4	5.5	4.4	7.5	4.6	6.7	5.2	5.4	7.9	8.4	4.9	7.2	7.2	6.5	5.4	9.1	5.3	5.9	3.8	10.5	9.9	3.7	8.8	8.3	3.7	4.0	8.5	7.2	2.2	3.4	11.4	7.2	3.1	6.8	7.4	9.8	10.2	7.0	2.5	6.5	4.6	9.6	3.4	7.8	7.5	7.4	7.1	2.5	6.2	6.7	4.2	9.4	2.3	3.3	8.3	3.5	3.5	5.4	5.5	13.9	4.9	6.4	5.6	10.5	9.9	2.8	5.4	5.4	9.8	4.3	13.2	4.9	4.1	3.1	6.5	3.1	3.4	4.8	6.4	4.4	4.3	13.0	5.4	6.1	4.2	3.4	2.3	4.5	8.4	6.9	6.9	4.6	6.9	8.5	7.2	7.4	6.8	8.0	14.0	32.2	86.6	43.2	80.6	32.6	38.7	35.9	17.8	35.3	69.1	26.1	17.8	19.1	17.2	23.0	25.8	112.6	11.8	36.6	13.2	0.0	15.8	56.0	26.6	43.0	33.8	46.7	18.7	103.8	12.2	14.8	42.3	19.9	35.6	55.9	31.6	36.8	24.7	16.4	42.1	101.1	16.0	20.3	31.7	45.1	76.7	37.9	29.7	23.2	70.3	36.9	35.2	27.8	141.8	155.9	17.3	9.1	41.3	24.7	41.1	15.0	8.8	17.5	89.6	19.7	64.4	29.9	37.5	22.1	20.0	33.5	12.9	35.3	31.0	17.5	27.9
AGO4	"EIF2C4, FLJ20033, hAGO4, KIAA1567"	ENSG00000134698	"Argonaute RISC component 4"	Q9HCK5	1	35808016-35857890	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 60.6;Inhibitory neurons: 72.0;Microglial cells: 63.7;Oligodendrocyte precursor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 7.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012179, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Cytoplasmic bodies"	Cytosol	"CAB012179: , HPA067849: "	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.70e-5)"	"unprognostic (3.92e-3)"	"unprognostic (3.99e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-3)"	"unprognostic (4.91e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.58e-2)"	8.8	4.9	7.2	8.8	7.1	20.4	7.7	8.6	7.9	8.4	8.6	9.6	4.7	8.9	6.6	7.3	7.2	6.2	9.9	6.8	6.8	5.0	7.5	11.4	7.0	7.4	7.1	7.0	8.6	6.5	5.8	8.9	7.4	8.1	6.4	18.1	8.4	6.1	13.3	20.1	7.8	9.8	6.8	14.2	9.7	7.3	7.3	7.3	5.5	11.8	6.8	8.2	8.5	7.6	6.0	1.5	11.3	6.5	5.8	6.6	5.7	4.5	4.4	4.6	5.3	0.8	9.0	9.6	6.0	6.6	4.7	2.4	4.9	3.6	4.3	10.7	4.5	4.9	4.2	2.8	5.5	5.6	7.2	4.3	7.6	2.5	3.8	8.8	7.9	11.5	3.7	3.7	6.2	0.9	9.1	6.2	3.7	3.8	2.7	9.0	10.1	1.2	4.5	7.4	5.0	7.3	4.1	3.7	12.7	9.6	3.0	24.6	9.5	3.5	1.7	3.6	3.4	5.4	1.8	1.4	4.3	7.0	3.2	1.3	2.7	3.0	0.8	1.5	1.4	0.6	0.7	1.1	2.0	0.4	0.3	0.4	7.5	0.6	1.4	0.4	0.2	0.8	7.2	7.1	8.6	7.9	6.8	6.8	7.4	7.1	7.4	6.8	7.3	7.6	16.4	19.2	21.7	54.9	6.7	9.8	4.7	5.4	9.6	28.2	8.5	7.1	21.8	12.8	9.2	11.0	22.9	4.2	17.9	5.5	1.9	5.6	2.0	12.7	9.4	11.6	12.6	5.0	60.6	5.6	4.7	7.2	10.7	10.9	2.5	11.4	22.1	11.5	13.5	6.7	72.0	8.4	2.0	42.3	10.0	1.6	5.0	28.9	3.6	63.7	33.6	6.5	6.2	87.4	54.8	14.4	11.7	5.7	4.3	9.0	10.0	1.5	10.3	32.2	19.7	6.8	8.5	11.3	1.6	5.9	12.8	4.1	10.3	3.6	5.7	6.7
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020120-1056118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		20000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	11.4	2.7	8.7	4.3	5.5	2.0	14.7	0.1	13.9	14.4	8.9	10.9	7.9	13.7	1.8	15.6	14.6	7.3	9.9	5.8	0.0	44.0	13.3	19.8	1.6	16.0	1.4	5.5	28.0	3.9	8.3	5.1	6.1	14.4	1.5	0.8	24.8	8.2	4.2	16.5	9.6	2.9	2.2	6.3	13.4	9.7	7.9	2.6	34.7	2.0	1.6	16.2	11.6	9.9	124.3	75.1	11.1	42.7	2.4	3.0	122.1	61.4	19.6	39.7	24.5	60.6	205.3	2.3	236.9	9.6	19.3	210.1	4.1	75.6	4.7	4.4	28.6	0.2	102.1	54.2	17.1	1.8	23.1	10.5	32.2	12.6	27.7	55.9	7.2	1.7	25.7	0.7	3.5	93.0	0.8	17.6	28.4	39.7	54.5	20.1	27.0	18.5	70.0	51.4	2.4	25.9	124.8	129.1	121.9	12.7	114.8	7.4	107.8	47.7	169.0	6.4	50.6	1.2	0.6	3.5	30.4	10.8	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	5.5	0.1	13.9	5.8	0.0	16.0	1.4	6.1	2.2	7.9	9.9	27.4	25.6	8.8	15.0	2.2	15.0	9.2	94.5	19.9	1.4	32.7	39.2	3.1	61.5	42.0	156.3	8.4	1.6	0.9	29.9	1.9	91.2	0.4	37.2	14.0	29.0	6.7	1.7	23.1	16.9	4.8	8.7	17.9	62.7	2.5	7.2	21.8	13.1	4.1	5.0	7.8	11.6	36.7	2.9	10.1	1.0	5.6	4.3	24.9	12.2	15.6	10.5	0.0	15.1	29.6	87.3	17.7	2.6	0.6	22.3	18.1	16.0	33.0	5.3	6.6	3.3	23.3	0.8	11.4	11.7	6.0	1.2	2.9	2.3	18.3	21.2
AHCYL1	"IRBIT, PPP1R78, XPVKONA"	ENSG00000168710	"Adenosylhomocysteinase like 1"	O43865	1	109984765-110023742	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"One-carbon metabolism"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 337.1"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 328.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042589	Approved		Supported	Cytosol		NA	NA		160000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA042589: AB_10793885"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-3)"	68.0	66.1	222.3	33.5	271.0	14.7	51.4	244.2	238.0	66.5	175.2	52.1	126.8	54.3	91.8	47.9	72.9	65.2	38.2	183.8	300.2	102.1	69.2	44.6	31.5	337.1	292.5	53.0	73.3	178.5	51.4	56.3	271.6	44.2	51.6	68.8	50.9	64.1	91.8	38.5	64.1	57.3	310.0	34.6	56.3	28.3	299.6	32.2	75.3	44.6	37.5	49.3	39.9	295.6	100.9	83.4	77.3	80.5	182.8	106.8	127.2	78.1	87.7	72.2	70.7	65.3	56.4	42.5	64.9	115.5	55.0	63.0	69.2	89.1	95.0	355.3	59.8	70.8	106.5	69.5	188.4	61.1	47.7	109.7	55.2	90.0	131.0	175.5	92.2	70.7	51.8	84.1	75.7	80.1	51.3	30.2	91.5	140.6	64.1	54.9	161.1	47.7	157.7	99.8	75.4	49.1	121.1	142.9	165.2	116.8	76.5	60.3	80.3	69.3	67.3	82.8	70.4	68.8	30.5	36.0	142.2	65.7	145.1	3.9	5.0	4.6	2.2	5.4	2.3	3.9	2.3	3.1	3.5	4.4	2.4	2.3	4.7	2.5	3.8	3.2	5.0	2.2	222.3	271.0	244.2	238.0	183.8	300.2	337.1	292.5	271.6	310.0	299.6	295.6	67.3	35.3	74.8	328.1	30.1	89.2	100.1	61.7	47.8	62.3	105.9	71.2	49.8	85.8	68.0	117.7	223.1	80.7	29.4	72.0	125.2	142.2	41.6	226.2	69.1	59.0	85.5	42.0	48.7	110.5	50.4	107.4	69.8	181.1	31.7	81.1	61.8	158.2	42.8	63.9	50.4	71.1	65.1	75.8	67.7	29.6	93.5	62.2	62.2	53.4	57.2	99.9	19.6	60.8	53.2	100.8	38.5	81.6	27.0	108.1	134.3	143.6	83.5	105.7	46.0	87.9	105.7	31.6	13.1	75.6	108.4	100.3	26.8	61.4	78.9	134.2
AHCYL2	"IRBIT2, KIAA0828, long-IRBIT"	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 488.0;intestine: 177.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 567.4;Distal enterocytes: 334.0;Excitatory neurons: 131.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 235.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 40: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	7.1	10.2	25.4	15.6	35.9	3.2	8.4	27.2	34.4	10.6	488.0	157.4	57.8	9.1	7.2	9.6	7.4	55.8	4.6	47.3	32.5	28.5	7.7	65.8	10.8	30.3	28.1	11.4	13.7	19.2	21.3	12.1	22.5	9.3	177.4	57.8	30.6	7.0	37.3	24.3	38.6	11.8	27.8	7.0	41.9	10.5	39.0	9.4	42.6	27.7	9.4	16.1	7.6	25.2	8.7	13.5	25.4	15.3	6.8	9.9	5.4	6.8	9.4	7.5	6.6	7.9	5.7	5.3	6.9	7.4	15.9	6.0	12.8	10.7	8.3	235.7	16.0	12.4	14.5	6.4	4.0	9.3	15.4	9.1	13.5	6.0	9.1	12.7	15.1	10.1	5.8	28.7	9.9	8.2	13.7	12.1	12.7	8.6	9.5	9.0	6.9	14.4	15.0	11.5	11.6	7.3	15.5	6.5	9.3	21.0	6.1	6.6	8.6	6.4	3.6	16.9	7.2	12.0	14.6	7.2	16.4	9.8	9.9	0.1	0.4	0.7	0.3	0.9	0.4	0.3	0.5	0.2	0.4	0.1	0.4	0.1	0.1	1.3	0.4	0.1	1.8	0.2	25.4	35.9	27.2	34.4	47.3	32.5	30.3	28.1	22.5	27.8	39.0	25.2	4.7	60.9	98.6	567.4	9.3	15.6	5.1	7.2	31.3	10.8	4.8	4.3	7.3	18.6	16.4	5.5	6.2	12.5	2.2	334.0	11.7	4.5	61.7	5.9	5.3	5.2	9.1	3.4	131.2	5.3	2.9	3.6	30.1	8.7	5.7	6.0	5.7	6.0	4.7	5.0	115.5	32.9	6.1	10.0	6.1	30.6	4.1	7.3	24.9	99.3	7.7	91.0	2.1	127.2	77.5	6.2	71.8	6.8	7.4	6.2	27.0	17.1	8.7	5.9	6.6	5.1	4.3	5.1	2.3	17.8	9.8	15.2	7.3	8.3	46.1	15.1
AIDA	"C1orf80, FLJ12806"	ENSG00000186063	"Axin interactor, dorsalization associated"	Q96BJ3	1	222668013-222713210	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027935	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA027935: AB_10602226"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	72.3	36.1	53.6	39.1	63.8	21.9	40.2	57.1	66.5	47.8	47.1	50.0	25.3	36.1	56.1	45.2	31.3	40.8	45.8	51.7	62.0	39.3	49.0	46.2	51.2	63.0	58.4	40.6	32.5	32.5	21.4	47.8	62.8	35.1	36.1	19.4	28.0	42.1	28.4	26.6	28.9	54.2	58.9	37.4	28.2	44.3	58.5	33.8	37.5	49.7	52.9	47.2	31.2	69.6	74.3	56.2	65.5	70.4	181.2	169.9	71.4	135.7	145.0	95.1	87.0	64.3	62.0	39.5	67.2	161.7	73.4	44.8	81.4	89.9	115.4	59.6	30.0	50.4	64.2	61.9	95.2	62.5	28.4	104.0	78.9	113.4	108.9	102.4	117.8	49.6	77.1	54.3	180.8	27.6	40.9	38.4	163.6	83.9	118.8	43.8	183.9	57.9	110.9	49.7	43.1	72.1	91.0	53.4	83.8	100.3	43.5	38.5	94.1	127.4	62.9	124.9	162.7	40.3	80.4	35.2	118.1	38.7	128.0	5.7	2.8	2.9	5.7	4.4	4.8	14.2	7.2	6.2	2.5	13.8	7.4	5.8	1.6	3.5	5.0	7.2	10.2	4.1	53.6	63.8	57.1	66.5	51.7	62.0	63.0	58.4	62.8	58.9	58.5	69.6	80.2	22.4	49.9	6.5	57.9	32.5	36.2	19.8	20.5	18.8	20.8	18.0	8.6	27.1	18.7	33.1	33.3	20.6	46.5	19.0	29.4	38.6	20.4	27.1	48.9	52.4	36.1	46.7	8.9	37.9	55.0	52.6	12.8	46.6	3.8	32.4	43.9	36.9	31.5	23.5	11.1	22.4	22.4	37.8	40.2	23.8	60.3	42.5	37.4	30.9	58.9	32.1	38.1	10.6	10.0	51.1	19.8	50.8	32.1	61.2	24.4	54.4	32.8	13.8	32.9	66.1	43.9	35.3	17.9	26.6	30.3	9.0	28.0	32.0	17.8	33.7
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009255-6023834	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.9;tongue: 102.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol		NA	Yes		35000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.09e-4)"	19.2	21.0	13.6	14.3	15.1	12.4	17.3	15.6	17.0	11.0	12.8	25.8	47.7	16.7	16.7	22.0	14.4	8.8	45.3	15.4	14.6	25.7	33.8	12.6	14.3	14.9	14.5	7.4	17.0	28.7	7.8	13.4	14.7	11.9	24.4	11.9	16.4	15.2	154.9	21.6	27.8	19.3	15.2	13.0	14.6	44.1	15.1	15.4	25.8	102.5	19.5	17.0	13.7	16.2	90.3	100.2	33.1	48.3	34.5	37.3	113.7	49.5	33.3	79.9	59.4	110.1	58.5	109.6	46.2	51.4	90.1	98.6	113.6	74.2	49.6	35.6	84.0	61.2	54.8	84.2	106.2	86.7	53.1	57.4	109.1	72.3	117.9	13.3	60.2	43.8	86.7	35.6	59.4	142.6	37.4	157.2	136.0	44.3	70.4	83.5	73.8	93.3	119.1	41.7	66.1	62.6	50.4	101.3	72.9	41.9	94.5	70.1	51.8	46.0	112.9	77.0	111.2	44.5	73.9	95.5	38.5	122.3	75.6	46.7	61.4	19.5	41.5	77.5	34.9	47.3	27.7	32.5	92.4	31.9	27.1	28.9	6.0	48.3	57.9	58.7	32.3	43.4	13.6	15.1	15.6	17.0	15.4	14.6	14.9	14.5	14.7	15.2	15.1	16.2	15.0	9.6	10.3	8.1	13.0	10.8	22.5	58.5	24.5	10.2	11.8	15.1	2.2	28.6	40.2	12.9	6.2	50.8	10.1	17.6	70.5	52.6	134.7	25.3	23.9	20.0	6.7	24.2	5.8	57.3	64.0	15.1	23.4	20.6	12.6	16.7	13.2	38.8	50.0	6.7	6.7	18.2	57.0	19.1	14.3	84.5	19.9	18.1	19.6	1.9	40.3	17.8	17.5	5.0	10.4	40.1	14.5	18.0	23.8	23.0	59.3	67.7	34.9	11.2	13.1	16.0	24.5	91.1	26.8	37.1	11.6	39.5	12.6	38.0	39.8	17.8
AJM1	"ajm-1, C9orf172"	ENSG00000232434	"Apical junction component 1 homolog"	C9J069	9	136844415-136848801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7;pituitary gland: 19.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;dendritic cells: 5.2;Granulosa cells: 4.9;Theca cells: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA021200	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Focal adhesion sites, Cytosol"		"HPA021200: AB_10601695"	"unprognostic (3.30e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.68e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.00e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.07e-3)"	"unprognostic (7.27e-2)"	2.4	3.1	14.7	1.0	15.6	1.2	1.7	26.7	17.0	3.8	0.0	17.4	2.1	4.7	0.2	3.2	4.1	0.4	5.3	18.3	1.8	3.6	4.9	2.2	0.5	6.2	2.9	1.4	7.4	0.8	19.9	0.6	2.8	7.7	0.8	0.8	2.3	1.3	3.1	2.6	5.7	0.5	0.0	5.0	5.9	6.4	3.4	0.3	3.2	0.5	0.3	9.3	3.6	4.7	3.0	2.3	0.3	0.9	0.4	0.3	3.7	2.3	0.4	0.3	0.1	0.8	1.5	1.8	1.9	0.6	0.7	3.2	0.3	0.9	0.0	4.6	1.7	0.4	5.2	0.7	1.2	1.1	3.2	0.7	1.1	0.3	0.2	1.8	0.2	0.8	2.8	1.1	0.5	3.3	0.3	3.6	0.9	2.4	3.0	2.2	0.7	5.9	0.7	0.5	5.6	2.0	1.5	5.8	3.3	0.4	4.6	2.2	2.4	3.8	2.6	1.3	1.4	5.0	3.7	0.6	6.6	3.6	0.9	0.0	0.4	0.0	0.5	0.3	0.1	0.0	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.5	1.1	0.0	0.2	14.7	15.6	26.7	17.0	18.3	1.8	6.2	2.9	2.8	0.0	3.4	4.7	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	0.0	0.0	5.5	0.0	0.6	5.2	0.0	0.0	1.8	0.0	0.8	1.1	0.2	0.0	0.0	0.0	0.5	0.9	0.4	0.0	1.8	1.3	4.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	1.0	2.3	0.0	0.0
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 185.9;Late spermatids: 275.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	46.0	58.0	18.7	12.5	19.6	11.6	40.0	20.6	27.1	26.1	19.8	40.8	15.2	32.4	21.6	29.7	29.6	7.7	48.4	19.8	20.3	54.9	46.6	29.5	13.0	19.7	20.1	32.6	35.8	11.6	28.6	12.1	19.5	32.9	12.6	23.2	30.9	8.3	79.8	20.6	30.1	9.5	18.7	28.0	36.4	43.3	19.5	13.3	33.0	23.3	12.5	35.5	28.0	20.7	40.3	18.8	28.0	42.6	43.6	26.3	51.1	59.3	18.6	23.8	30.7	56.0	35.5	82.1	54.9	23.4	62.2	14.0	37.2	23.3	40.0	33.1	15.7	40.7	47.8	44.9	33.0	49.5	17.1	14.0	33.3	23.0	37.0	25.0	14.8	45.8	36.6	29.3	28.6	42.1	50.2	31.4	25.0	17.9	10.5	55.8	34.5	44.5	40.3	31.3	14.4	13.3	28.2	26.4	44.6	21.3	25.1	54.7	29.5	20.4	34.6	41.4	47.6	33.1	74.4	75.3	29.8	69.3	28.9	25.2	16.8	20.1	19.2	22.1	20.3	29.8	22.8	24.9	24.8	26.1	24.5	26.3	2.7	24.1	21.0	29.9	25.8	13.3	18.7	19.6	20.6	27.1	19.8	20.3	19.7	20.1	19.5	18.7	19.5	20.7	51.5	22.4	30.0	14.0	33.9	0.0	95.7	0.0	33.6	19.8	57.3	86.6	55.6	18.6	16.7	23.9	10.4	86.7	27.2	16.8	185.9	75.6	174.9	36.4	34.6	38.6	9.7	29.2	14.8	78.5	95.1	47.3	16.8	30.2	21.5	31.7	30.7	42.5	71.3	20.2	15.4	21.3	0.0	30.6	0.0	275.9	33.5	32.2	0.0	6.5	42.4	58.7	34.0	13.0	17.0	59.1	25.5	32.0	29.4	116.6	48.6	149.8	18.2	29.3	52.6	40.9	50.0	56.5	37.9	24.3	0.0	66.2	27.6	44.7	32.9	88.1
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108963484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 4.8"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 80.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;hTCEpi: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030270, HPA030271, HPA030272"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.0	0.0	1.6	0.0	1.5	0.1	0.0	1.8	2.5	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	80.6	0.3	5.1	1.4	0.0	0.0	1.0	0.2	0.8	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.7	0.0	0.0	0.3	17.8	2.5	0.1	1.8	0.0	0.0	0.4	0.0	3.5	3.1	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.9	0.6	1.4	0.1	0.1	0.7	0.1	0.7	0.5	0.0
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 341.5;liver: 481.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	341.5	20.8	9.8	10.0	11.6	1.0	205.6	10.7	12.9	17.4	8.1	37.1	29.6	5.6	3.3	202.5	8.6	98.1	83.8	7.2	16.6	43.0	481.9	23.5	2.1	18.7	13.7	10.4	11.8	1.1	8.1	0.8	17.1	11.7	13.3	15.2	116.5	12.9	286.9	42.5	33.7	9.2	11.5	2.1	137.0	11.8	16.8	4.4	38.3	36.5	9.3	253.9	47.0	9.7	0.0	2054.8	2.4	214.1	2439.5	83.4	0.1	0.7	8.6	0.9	2.0	8.1	0.2	0.4	11.5	14.2	10.0	57.8	0.2	10.7	1.2	0.6	0.2	0.7	516.4	3926.2	4.6	0.4	0.9	218.3	126.4	10.5	10.4	0.7	0.9	0.3	81.9	0.3	20.4	3.3	0.2	0.0	0.7	2684.9	0.8	0.3	0.6	34.6	19.0	1178.9	1.2	0.4	21.2	0.3	0.1	0.4	0.5	4.0	8.6	5.1	1.8	74.6	0.8	0.6	0.6	0.3	25.9	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	11.6	10.7	12.9	7.2	16.6	18.7	13.7	17.1	11.5	16.8	9.7	15.2	12.8	2.8	0.0	0.9	11.9	9.5	141.7	20.5	1.9	0.8	1.4	5.5	102.9	128.8	0.0	0.0	0.0	0.0	10.3	0.0	18.3	17.3	0.7	0.5	7.5	1.8	8.0	2.6	103.3	0.1	44.2	133.5	0.8	0.0	0.1	10.8	397.4	0.1	3.3	4.2	5.4	46.8	12.0	7.8	7.8	79.2	1.0	8.8	19.7	0.6	39.6	0.0	5.5	0.3	90.0	6.6	78.6	0.8	23.7	15.9	3.6	40.3	3.0	0.0	5.3	13.9	0.2	0.3	112.9	13.5	0.0	1.3	0.4	8.5	271.9
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 717.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	41.8	0.0	0.0	0.0	0.3	717.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
AL035461.3		ENSG00000286235	"Novel protein"		20	5950949-6039856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.0"									"HPA045141, HPA066433"			Approved	Nucleoplasm,Cytosol		NA	NA					"Cluster 37: Hep G2 - Hepatocyte cell processes"		Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "																		0.9	0.9	0.1	1.0	0.1	0.4	2.6	0.1	0.3	1.8	0.1	1.5	1.4	1.3	1.5	1.4	1.3	0.8	1.5	0.1	0.1	1.5	1.1	1.2	1.4	0.1	0.1	1.6	0.8	1.4		1.8	0.1	1.7	2.6	2.2	0.5	1.5	0.3	0.7	1.6	2.1	0.1	0.9	1.0	2.0	0.1	2.3	1.2	2.9	2.4	1.0		0.1	0.5	5.4	5.0	2.4	5.4	4.7	0.7	1.2	4.5	4.3	4.7	7.3	3.0	1.6	0.1	3.7	3.2	0.4	8.4	6.6	7.1	0.3	0.0	7.2	2.5	18.0	0.8	2.4	1.1	2.8	1.7	4.1	4.0	3.7	2.4	3.0	0.4	2.0	5.2	2.0	3.5	0.7	2.7	6.9	0.1	2.2	3.2	1.8	4.0	4.9	2.6	2.1	0.0	10.8	1.2	6.7	1.4	5.6	0.0	1.6	0.8	0.8	1.2	0.1	0.2	0.9	1.4	4.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL133500.1		ENSG00000285547	"Novel protein"		X	72301691-72572843	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	6	"epididymis: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;SH-SY5Y: 1.4"									"HPA048560, HPA049051"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"		"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA048560: AB_2680442, HPA049051: AB_2680612"																		0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2		0.0	0.1	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.6	0.6	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.2	0.0	0.1	0.1	0.5	1.2	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.1	0.6	0.0	0.1	0.2	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL139300.1		ENSG00000256500	"Novel protein"		14	103562962-103685924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.7;tongue: 16.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;granulocytes: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA044617, HPA052450"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044617: AB_2679024, HPA052450: AB_2681838"					"unprognostic (1.56e-1)"													4.3	2.6	0.9	2.9	1.0	0.8	1.3	0.9	5.2	1.2	0.2	1.4	0.0	0.8	0.2	1.6	0.9	0.1	12.8	1.4	1.6	0.5	0.5	1.0	1.6	1.0	1.7	1.0	2.5	7.5	3.8	0.1	1.6	1.4	0.0	3.5	1.6	1.1	31.7	0.6	0.7	3.1	0.7	0.4	0.7	9.4	1.1	2.9	0.1	16.5	1.7	3.4	0.5	1.2	8.1	15.9	18.5	0.6	8.2	7.8	5.6	25.7	19.7	29.3	17.0	9.5	12.1	22.0	17.2	19.2	19.3	5.5	12.4	13.3	17.4	6.7	0.0	8.7	6.1	8.7	9.7	10.8	3.4	8.6	0.6	13.5	11.0	14.5	15.2	13.7	11.6	3.4	21.4	15.4	18.9	1.2	12.1	19.5	13.9	7.7	12.1	11.4	13.6	9.0	22.1	12.2	14.6	5.7	12.1	6.2	13.0	6.6	8.4	11.3	9.2	16.9	10.4	6.4	8.6	25.6	19.6	3.4	9.8	0.2	0.8	1.1	0.5	1.3	0.7	0.3	0.7	0.9	0.4	1.3	1.0	0.4	0.7	0.6	1.6	1.5	1.4	0.3	0.9	1.0	0.9	5.2	1.4	1.6	1.0	1.7	1.6	0.7	1.1	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL353671.1		ENSG00000288684	"Novel protein"		9	32455323-32552603	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.4"	"Low cell line specificity"	"Detected in some"											"HPA047193, HPA073217"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 36: HEL - Hemostasis"		"Plasma membrane, Cytosol"		"HPA047193: AB_2679978, HPA073217: "																		0.7	0.1	0.5	0.3	0.5	0.2	0.2	0.4	0.5	0.4	0.5	0.3	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.3	0.6	0.3	0.5	0.2	0.0	0.9	0.9	0.1	0.0	0.8		0.1	0.9	0.2	0.2	0.0	0.2	0.4	0.4	0.2	0.3	0.2	0.5	0.2	0.2	0.1	0.8	0.5	0.1	0.5	0.1	0.2		0.9	0.3	0.5	0.6	0.1	0.8	0.7	0.2	1.4	0.7	0.7	1.4	0.7	0.0	0.4	0.2	0.6	0.9	0.1	0.2	0.7	0.0	1.3	0.4	1.8	0.7	0.0	0.4	0.8	0.1	0.7	0.5	0.6	1.0	0.8	1.1	1.3	0.2	0.1	0.7	0.0	0.3	0.7	0.3	0.9	0.1	1.4	0.3	0.1	0.3	0.7	0.6	1.4	0.5	0.2	0.2	0.1	0.1	0.0	0.5	0.6	0.5	0.6	0.4	0.3	0.5	0.4	0.4	0.2	0.0	1.7	0.4	1.6	0.5	0.4	0.3	0.5	0.5	0.6	0.3	0.3	0.6	0.5	5.4	0.4	0.3	0.1	0.8	0.3	0.5	0.5	0.4	0.5	0.3	0.6	0.9	0.9	0.9	0.5	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL441992.2		ENSG00000286112	"Kynurenine aminotransferase 1"		9	128819663-128881931	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 1.9"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"											"HPA021176, HPA021177, HPA027736"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"		"Cluster 16: U-266 - Nucleosome"		Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"																		0.3	0.1	0.6	0.2	0.7	0.5	0.2	1.5	1.9	0.2	0.5	0.2	0.2	0.3	0.5	0.2	0.3	0.2	0.1	0.6	0.3	0.1	0.3	0.1	0.3	0.4	0.3	0.3	0.2	0.1		0.3	0.4	0.3	0.1	1.1	0.2	0.4	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.3	0.5	0.3	0.1	0.4	0.2	0.2		1.3	0.4	1.5	1.0	0.6	1.2	0.4	1.2	1.0	0.1	0.7	0.6	1.1	0.4	1.1	0.5	0.6	0.7	1.2	0.6	1.1	0.1	0.9	1.3	1.0	1.4	0.8	0.2	0.9	0.4	0.4	0.5	0.9	0.4	0.7	0.3	1.0	1.6	0.2	0.2	0.5	0.9	0.7	0.9	1.3	1.1	1.2	1.1	0.3	0.2	0.3	0.6	1.0	0.9	0.0	0.2	0.7	0.2	0.3	1.0	0.7	0.6	0.3	0.7	1.2	2.6	0.9	0.3	0.7	0.3	0.8	0.9	0.2	1.0	0.3	0.9	1.4	0.7	0.7	0.7	1.1	0.8	0.8	0.6	1.3	0.5	1.9	0.8	0.5	0.6	0.7	1.5	1.9	0.6	0.3	0.4	0.3	0.4	0.2	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386312-113401290	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 209.8"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 147.8;Granulosa cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced		Approved	Cytosol		NA	NA		44000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (7.33e-5)"	"prognostic favorable (5.64e-4)"	"unprognostic (4.16e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (8.80e-5)"	"unprognostic (2.87e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.31e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-2)"	54.7	153.9	73.5	16.8	82.7	82.2	23.2	75.2	84.7	18.4	53.6	25.7	29.5	16.3	26.6	35.0	15.6	27.4	51.9	66.0	74.5	73.2	209.8	20.6	15.6	85.4	83.5	28.9	46.5	73.2	15.9	24.9	84.5	34.1	24.5	19.0	98.6	24.2	28.8	38.9	26.6	17.6	80.1	13.6	50.4	13.1	81.1	20.3	25.9	23.9	18.7	18.4	19.3	83.7	8.1	14.8	11.0	15.7	71.2	48.4	67.8	21.9	35.4	13.7	17.2	19.2	16.7	11.7	12.7	30.3	11.0	29.1	8.1	14.6	8.3	29.5	10.2	22.0	18.2	26.2	16.4	21.2	19.0	41.2	10.8	12.7	5.5	53.9	27.1	18.6	8.9	16.5	23.7	61.8	23.8	21.2	5.4	57.9	27.4	19.5	18.7	19.8	21.4	16.6	10.2	9.4	27.2	32.5	20.1	19.2	34.1	23.7	30.7	12.5	9.3	25.1	12.4	23.8	26.0	9.8	34.1	18.9	13.6	10.2	13.7	23.6	11.3	15.5	6.0	6.8	9.3	6.0	14.6	10.2	8.7	9.9	6.2	6.9	17.4	6.0	10.8	9.7	73.5	82.7	75.2	84.7	66.0	74.5	85.4	83.5	84.5	80.1	81.1	83.7	7.2	16.0	15.6	18.6	10.4	7.0	8.9	7.1	8.0	12.9	16.7	11.6	50.3	25.8	12.0	14.7	27.1	48.2	7.4	27.7	13.7	20.3	5.4	17.7	9.2	11.5	9.1	147.8	10.0	26.3	23.2	10.2	15.3	27.7	14.5	86.5	11.0	70.0	17.0	5.0	10.7	12.5	10.2	15.1	6.4	10.8	11.8	12.4	12.4	9.4	12.4	6.4	8.2	7.1	20.0	15.0	35.3	14.7	11.0	7.6	32.6	59.0	10.6	15.7	6.6	8.9	24.6	6.8	9.5	22.6	9.1	11.4	8.8	11.7	16.7	9.2
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 311.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	119.2	105.5	49.6	29.8	51.0	24.8	76.8	49.3	60.3	51.5	62.5	45.7	54.8	38.6	93.4	105.6	50.2	32.0	48.2	47.4	57.5	142.4	206.5	38.5	40.3	50.5	52.1	53.6	44.0	81.9	39.9	38.0	51.4	65.3	50.6	46.4	104.1	45.6	93.6	54.7	48.6	42.0	50.7	37.9	39.5	63.4	49.3	39.0	123.0	56.4	60.1	39.4	43.9	55.6	55.7	53.5	48.7	44.1	152.1	132.8	40.7	71.9	101.5	70.8	61.0	33.4	40.7	0.1	67.1	64.8	34.9	42.8	40.0	70.3	83.0	25.9	50.6	35.3	34.7	36.5	78.2	56.0	36.1	86.0	34.8	75.2	62.5	97.8	62.2	45.9	56.9	48.4	111.7	33.4	37.6	57.6	71.3	145.1	64.7	31.7	62.0	74.3	92.5	52.0	57.7	39.8	51.4	57.1	67.4	65.6	108.8	84.0	61.9	42.5	41.5	52.4	37.1	44.7	62.5	54.8	47.9	52.6	41.7	61.8	35.2	50.9	45.5	37.7	48.8	49.9	43.8	49.6	34.5	46.8	43.8	50.4	51.3	43.0	45.3	21.6	69.8	45.6	49.6	51.0	49.3	60.3	47.4	57.5	50.5	52.1	51.4	50.7	49.3	55.6	56.2	16.0	47.6	12.7	43.3	32.6	43.3	43.8	68.3	25.0	83.0	54.6	46.5	55.8	36.8	51.5	22.9	48.5	39.3	43.9	97.8	42.9	45.4	27.7	39.1	49.4	55.8	28.2	5.6	37.0	76.4	60.6	36.2	20.4	38.0	60.9	59.3	158.8	61.9	13.5	8.3	56.9	32.6	59.1	24.9	39.8	95.4	43.8	56.9	6.5	34.6	311.5	39.1	12.1	12.2	32.2	33.1	115.5	34.8	39.6	80.3	204.4	59.4	28.9	26.3	32.5	40.1	85.6	49.9	123.8	51.9	38.2	43.7	148.4	63.6	28.3
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 26754.8;tongue: 9180.4"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 3267.9;Extravillous trophoblasts: 2322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004177, CAB006252"	Supported		Approved	Cytosol		NA	NA		640000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	569.3	696.4	616.8	443.1	697.4	732.5	512.6	617.3	719.7	566.0	617.0	774.1	517.9	533.7	201.0	1302.0	449.7	420.5	2286.1	731.9	652.0	709.0	217.1	425.6	358.2	762.3	654.0	510.4	390.5	943.1	525.1	351.4	763.9	457.7	400.1	465.2	904.9	597.6	26754.8	643.4	488.3	465.2	545.5	417.5	595.0	138.7	657.8	280.9	454.5	9180.4	478.3	761.8	740.3	558.7	2206.1	1620.4	477.9	1542.8	714.6	808.5	1520.8	1297.9	1336.2	1291.6	1603.0	1158.1	1643.6	1487.6	2072.2	1318.6	708.6	1632.6	966.8	2829.1	939.3	658.5	1272.9	1219.3	1202.7	2591.1	1112.5	1793.8	1251.3	1115.7	979.6	1455.4	968.9	2119.7	965.4	686.9	1070.0	951.1	1393.4	3136.7	1100.2	1477.0	1192.8	848.1	1346.6	1613.9	765.2	3353.2	1629.4	1230.5	950.7	668.5	808.6	3368.5	1213.9	591.2	1433.0	1194.7	1162.5	1892.3	750.3	1046.7	1430.0	1861.5	1387.3	1369.3	3524.5	1715.9	1532.9	2050.6	2694.7	2081.7	1008.7	2466.5	1138.1	908.5	1091.7	1047.0	2182.7	877.9	1027.4	996.9	2531.7	819.9	2780.2	824.0	1476.3	4372.2	616.8	697.4	617.3	719.7	731.9	652.0	762.3	654.0	763.9	545.5	657.8	558.7	17.0	12.8	32.4	83.2	281.2	792.0	716.4	3267.9	784.8	387.4	34.4	21.6	1968.4	273.1	1385.1	42.3	118.9	1194.1	107.9	1834.8	111.6	120.9	258.8	15.8	11.8	261.1	323.9	215.8	66.2	76.2	2322.1	329.7	513.3	16.1	196.5	18.7	289.5	102.0	1181.9	733.6	70.0	755.1	1265.4	632.2	715.4	1152.4	380.8	388.8	924.9	50.6	417.7	662.1	328.5	40.2	60.8	126.2	1497.1	405.1	409.4	676.9	1755.7	75.8	700.9	298.9	486.4	680.9	572.9	25.8	123.6	1174.6	684.5	1361.3	294.3	15.2	937.7	1146.2
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28576948	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1384.6;choroid plexus: 589.6;retina: 1183.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.5;Horizontal cells: 274.2;Muller glia cells: 127.1;Proximal enterocytes: 120.0;Rod photoreceptor cells: 348.5"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 250.9;U-266/70: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		150000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	87.0	24.3	953.6	12.7	909.7	23.6	42.5	1238.3	1162.3	39.3	589.6	18.5	18.7	17.9	10.9	40.8	14.3	10.9	285.5	955.7	958.0	16.8	98.3	13.7	19.3	1297.5	962.6	39.1	4.9	12.1	30.6	4.1	1384.6	18.9	14.7	1183.1	19.9	15.8	4.8	74.5	43.9	12.4	926.9	24.4	23.3	14.2	1090.2	9.6	7.4	8.1	30.5	19.0	47.0	886.1	29.9	2.1	13.7	55.7	29.9	32.9	2.9	16.7	37.7	12.9	76.0	17.9	3.0	14.9	17.3	15.5	3.3	36.9	10.3	102.3	23.4	12.4	8.9	28.3	11.6	30.4	25.8	10.0	29.2	27.8	13.9	1.5	24.0	1.7	5.3	29.7	19.3	71.9	10.7	15.1	11.9	32.0	20.8	6.7	15.3	9.5	1.6	250.9	1.9	4.3	36.2	61.9	9.1	67.3	0.5	20.8	36.6	21.2	3.5	1.2	5.3	2.1	2.4	161.0	51.4	10.9	105.2	28.0	1.9	0.5	7.4	3.0	21.6	8.7	30.6	24.0	29.5	17.8	9.4	25.1	37.7	28.4	18.0	29.4	5.3	4.6	40.9	19.0	953.6	909.7	1238.3	1162.3	955.7	958.0	1297.5	962.6	1384.6	926.9	1090.2	886.1	4.2	0.0	15.8	97.6	9.8	7.5	20.3	80.5	8.6	112.5	9.0	11.0	22.1	11.5	29.3	7.3	106.3	1.1	9.5	31.7	3.9	21.9	0.9	1.0	3.0	11.3	21.6	3.2	19.2	10.2	6.5	5.8	6.6	1.2	13.3	4.9	14.3	93.1	5.4	274.2	41.3	12.9	28.5	4.4	5.3	1.3	9.3	3.1	24.9	21.5	34.1	127.1	12.3	26.7	16.8	12.4	12.4	10.1	2.6	6.1	120.0	2.1	11.8	348.5	13.1	6.4	10.1	0.3	3.2	7.9	10.9	1.5	17.0	11.7	5.1	7.8
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13 UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002853, HPA005498"	Approved		Approved	Vesicles,Cytosol		NA	NA		11000000	"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA002853: AB_1078131, HPA005498: "	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	15.1	17.9	10.5	18.8	11.7	16.6	18.3	11.5	19.0	17.2	12.3	18.2	13.7	16.1	20.5	14.7	15.4	16.4	13.2	10.2	13.8	21.0	23.8	13.8	23.4	12.6	12.1	15.8	14.7	23.4	17.9	14.1	13.3	17.7	19.4	11.8	15.6	13.4	9.2	19.4	17.3	17.5	11.4	18.5	15.5	17.4	11.8	17.3	18.2	9.9	20.1	21.3	14.7	16.6	22.3	24.4	21.8	13.8	13.8	19.6	12.3	17.7	18.3	22.4	27.5	24.9	23.1	19.5	33.0	24.7	46.5	12.6	26.1	12.5	23.5	14.4	17.6	10.7	26.1	28.4	20.3	19.5	40.5	23.6	22.8	18.0	38.6	23.3	24.8	21.8	23.9	53.5	22.5	55.8	16.4	17.6	19.9	66.3	33.6	12.8	13.9	26.7	36.6	34.0	13.1	19.1	25.2	15.2	16.3	21.7	13.6	18.5	16.7	19.2	9.7	24.9	34.4	25.8	47.1	31.5	20.5	25.5	15.2	39.5	15.8	16.6	9.5	16.3	9.3	10.6	10.6	9.2	18.5	12.1	13.0	10.8	3.0	4.6	12.9	9.5	14.6	9.6	10.5	11.7	11.5	19.0	10.2	13.8	12.6	12.1	13.3	11.4	11.8	16.6	50.9	16.0	30.8	33.6	127.9	35.2	65.8	53.5	33.6	15.1	33.9	31.6	18.7	22.8	36.0	18.4	10.4	27.3	73.9	39.2	45.0	37.4	21.1	48.2	31.1	37.4	26.5	27.1	64.7	52.1	39.1	34.6	37.2	47.9	109.8	15.7	28.2	28.4	42.5	11.8	57.4	49.0	46.8	39.2	52.3	9.4	21.5	56.1	28.4	83.4	41.8	16.0	29.9	41.7	77.5	58.0	55.6	16.1	60.4	46.9	38.5	55.5	35.3	16.5	26.3	38.7	46.2	32.6	22.4	26.5	35.4	48.7	71.1	28.8	32.8	64.6
ALG5	bA421P11.2	ENSG00000120697	"ALG5 dolichyl-phosphate beta-glucosyltransferase"	Q9Y673	13	36949738-37000763	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007989	Approved		Approved	Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA007989: AB_1078132"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (7.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.86e-1)"	29.1	32.3	12.1	19.6	13.3	26.9	41.6	13.4	25.7	34.2	14.9	36.0	27.1	23.5	77.9	21.7	23.3	23.2	18.5	12.4	13.7	41.2	61.9	24.5	20.7	13.5	13.1	20.6	90.1	40.2	18.7	25.4	14.0	26.5	46.4	11.2	51.9	30.9	18.5	20.9	27.6	23.4	13.6	23.6	36.6	15.2	12.6	22.7	54.9	10.5	28.9	30.5	21.6	14.8	24.3	35.0	31.5	29.4	95.1	61.8	22.5	63.9	81.1	63.7	53.7	71.0	84.1	35.2	25.9	45.7	55.0	57.5	41.9	55.0	62.6	37.4	77.7	77.2	27.5	40.1	85.1	69.6	43.7	62.7	88.8	49.4	60.6	41.5	47.7	43.9	39.8	49.7	59.9	45.6	47.4	59.8	29.1	188.2	27.5	54.3	30.4	102.5	71.5	49.8	25.2	45.5	29.2	62.8	34.2	25.4	34.4	79.1	36.1	32.7	20.4	37.2	45.8	35.8	28.8	37.4	51.2	41.9	57.1	59.1	55.7	26.2	53.4	62.3	54.4	44.1	49.1	55.6	57.1	40.2	46.4	47.2	5.8	54.7	53.0	109.0	65.7	69.2	12.1	13.3	13.4	25.7	12.4	13.7	13.5	13.1	14.0	13.6	12.6	14.8	52.0	51.3	51.9	11.1	51.5	34.7	45.9	142.9	27.3	19.8	50.2	42.5	14.2	61.5	86.0	53.3	10.4	81.4	49.4	28.9	23.5	93.5	33.7	31.5	44.1	45.5	36.1	25.9	19.5	140.2	74.4	46.0	32.1	40.1	29.2	25.9	37.9	77.3	69.7	11.8	22.4	76.3	111.9	37.1	52.1	25.8	40.0	39.4	80.0	14.0	45.2	36.6	25.7	18.1	30.6	85.9	50.9	38.4	166.6	56.4	51.4	62.7	43.8	25.2	46.0	34.4	70.7	57.6	23.7	33.6	30.3	81.3	43.0	58.5	62.2	50.7
ALMS1	KIAA0328	ENSG00000116127	"ALMS1 centrosome and basal body associated protein"	Q8TCU4	2	73385758-73625166	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Cone-rod dystrophy, Deafness, Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.4;Excitatory neurons: 64.9;Late spermatids: 86.6;Oligodendrocytes: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"RH-30: 32.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035277, HPA043200"	Enhanced		Approved	"Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles, Centrosome"	Cytosol	"HPA035277: , HPA043200: AB_10796689"	"unprognostic (2.86e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.91e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.58e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	2.6	2.4	5.3	2.4	6.8	5.5	4.3	16.0	5.2	4.1	4.5	3.1	2.3	4.5	4.7	1.9	6.4	2.5	1.6	5.3	4.8	3.5	2.4	3.1	3.2	6.8	6.4	9.8	4.5	4.8	1.7	2.7	6.0	3.5	3.0	10.4	2.9	3.6	0.8	2.9	1.9	3.6	5.1	2.4	2.9	22.2	5.7	8.7	4.6	3.1	2.9	2.6	1.5	7.8	14.3	4.6	9.0	8.2	6.2	5.8	6.7	4.8	5.0	6.2	4.8	4.8	1.5	13.8	3.3	6.7	8.0	6.5	12.3	4.2	8.3	6.7	4.1	7.9	4.4	10.2	4.1	10.9	3.8	4.5	3.7	7.6	3.9	3.9	6.3	9.3	7.4	4.9	7.1	7.0	10.2	14.3	10.6	5.7	3.9	10.8	32.5	5.1	4.1	3.7	7.1	10.0	9.1	1.5	5.2	7.5	1.7	2.5	5.4	8.2	8.3	7.1	11.7	6.6	4.0	10.4	3.7	8.2	4.0	0.2	0.0	0.5	0.2	0.1	0.1	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.0	0.2	0.1	0.3	0.2	0.0	5.3	6.8	16.0	5.2	5.3	4.8	6.8	6.4	6.0	5.1	5.7	7.8	7.3	6.4	10.3	48.3	5.6	2.4	3.1	2.6	6.8	23.3	4.7	4.8	7.2	7.2	9.1	11.0	25.0	3.3	12.8	4.4	0.0	4.7	68.4	30.6	13.2	8.0	7.3	15.4	64.9	3.7	2.7	8.9	10.7	9.3	5.1	21.8	4.6	2.2	3.3	21.9	55.8	5.2	0.0	3.1	2.7	86.6	8.1	6.3	3.6	31.9	5.3	9.2	5.2	54.3	92.7	3.4	1.3	9.1	10.2	3.2	4.0	1.7	25.2	39.7	6.6	14.8	9.5	30.6	26.7	6.9	3.3	1.9	7.8	11.5	5.3	2.0
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"skin 1: 56.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.1;Pancreatic endocrine cells: 6.3;Prostatic glandular cells: 1.8;Spermatocytes: 1.8;Spermatogonia: 1.7;Suprabasal keratinocytes: 1.8"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 3.9;melanoma: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.4;HBEC3-KT: 10.1;hTCEpi: 7.3;hTERT-HME1: 13.7;T-47d: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.0	0.0	0.5	0.0	0.3	0.0	1.6	1.9	2.1	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.4	0.2	0.1	0.7	0.1	0.0	0.1	0.3	0.0	0.1	56.2	0.0	0.0	0.1	0.0	0.0	0.8	1.0	0.0	0.0	0.0	1.2	0.0	1.8	0.5	6.4	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.1	0.5	0.2	0.2	0.1	2.9	0.4	0.8	10.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.3	0.1	13.7	0.0	0.0	0.9	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	0.0	4.4	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.9	2.1	0.7	0.4	0.8	0.7	0.7	0.1	1.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	2.1	1.2	0.0	0.0	0.6	0.5	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.4	0.1	0.1	0.2	0.0	0.0	1.2	0.9	1.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	1.7	0.3	1.8	1.1	0.0	0.0	0.0	0.6
ALPK2	HAK	ENSG00000198796	"Alpha kinase 2"	Q86TB3	18	58481247-58629091	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 41.9;skeletal muscle: 38.3;tongue: 33.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 120.4;Cone photoreceptor cells: 47.9;Early spermatids: 15.9;Late spermatids: 24.3;monocytes: 18.1"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 7.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 51.2;BJ hTERT+: 31.0;fHDF/TERT166: 46.6;U-138 MG: 25.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	"unprognostic (7.35e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (5.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-2)"	0.8	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.8	0.3	0.0	0.9	41.9	0.4	0.0	9.2	4.5	0.1	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.2	2.1	0.3	0.0	38.3	0.5	1.0	0.1	0.0	0.5	1.7	1.1	0.0	3.5	0.0	33.2	4.4	1.5	0.0	0.0	0.0	13.7	0.9	0.0	0.4	3.4	0.3	51.2	31.0	21.2	18.1	3.4	0.0	0.0	5.2	46.6	2.9	0.0	0.0	0.0	21.5	11.5	0.0	0.0	4.4	1.8	2.7	0.0	0.0	3.0	0.0	6.4	0.2	0.7	0.0	0.0	0.0	0.4	13.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	8.3	0.0	0.0	0.0	25.3	11.2	3.5	8.7	20.9	19.2	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.2	0.1	4.8	120.4	0.0	0.0	0.0	47.9	0.0	0.1	0.0	1.9	1.5	15.9	0.0	2.3	0.9	0.0	0.0	1.0	0.7	0.0	8.9	0.0	0.1	0.0	4.0	0.4	3.0	0.7	1.7	0.7	0.0	0.0	0.3	3.0	24.3	0.3	2.4	0.0	0.0	18.1	2.6	0.0	0.0	0.8	0.2	2.3	0.0	0.6	0.0	0.3	13.6	0.0	0.9	0.0	3.8	1.7	1.1	0.1	0.0	0.9	0.1	0.3	0.0	0.0	0.0
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	24.7	60.7	19.5	27.9	16.7	4.2	22.9	18.0	25.8	3.4	26.0	5.0	2.6	5.8	1.3	4.1	10.4	3.9	16.4	17.8	18.8	45.7	56.3	54.9	6.4	21.7	17.7	2.8	3.9	3.3	9.3	3.1	22.4	7.1	1.5	18.8	6.4	9.2	1.1	4.2	7.5	3.5	18.2	45.5	4.7	4.2	21.3	1.5	8.6	5.7	5.9	9.7	3.3	17.3	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.5	16.7	18.0	25.8	17.8	18.8	21.7	17.7	22.4	18.2	21.3	17.3	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
ALS2	ALS2CR6	ENSG00000003393	"Alsin Rho guanine nucleotide exchange factor ALS2"	Q96Q42	2	201700267-201782112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 91.8;granulocytes: 46.9;Inhibitory neurons: 66.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 26.4"	"Group enriched"	"Detected in many"	5	"basophil: 23.0;eosinophil: 6.8"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 23.0"	"Cell line enhanced"	"Detected in all"		"HMC-1: 50.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 87.8"	HPA046588	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Intermediate filaments, Cytosol"		"HPA046588: AB_2679709"	"unprognostic (3.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.84e-1)"	7.3	5.5	2.6	2.6	3.1	5.6	6.8	26.4	4.2	6.4	4.5	6.6	3.2	6.6	7.8	4.8	6.4	3.8	13.7	3.4	1.6	8.0	14.5	6.7	2.8	0.9	1.0	6.0	5.7	4.3	10.0	3.5	1.7	6.1	3.4	5.4	5.4	1.6	13.5	7.1	6.6	4.8	0.3	5.3	6.8	5.3	1.4	2.4	6.3	5.9	2.8	6.2	5.7	2.6	6.5	6.7	7.1	5.6	7.0	5.1	7.2	8.6	10.4	14.0	13.2	5.8	8.4	1.2	3.8	11.7	6.1	3.7	4.6	10.6	18.0	3.5	4.8	15.3	6.2	5.2	8.1	16.4	50.4	9.8	4.1	11.5	14.0	5.7	10.0	8.6	9.8	5.7	9.6	7.5	6.7	20.3	9.2	4.6	5.3	5.4	7.7	4.2	9.8	8.8	3.4	7.8	6.4	7.1	9.2	14.3	5.4	7.2	7.9	11.6	7.2	3.5	6.2	7.1	9.2	4.5	8.5	3.4	7.2	23.0	0.9	6.8	1.6	1.7	1.9	1.2	1.3	1.3	1.4	1.0	1.5	1.5	0.9	3.0	1.2	0.8	2.1	0.8	2.6	3.1	26.4	4.2	3.4	1.6	0.9	1.0	1.7	0.3	1.4	2.6	7.6	12.8	16.7	28.7	2.8	5.4	3.8	4.4	3.4	15.1	5.4	4.3	32.3	8.6	4.3	9.2	29.2	5.7	3.7	3.6	0.0	6.9	16.5	14.0	6.8	10.4	4.8	12.0	91.8	3.3	3.2	6.9	9.7	6.8	46.9	10.1	13.2	20.3	5.9	8.4	66.6	6.9	2.0	3.2	3.0	6.5	7.8	4.8	0.0	27.2	3.1	5.9	4.1	36.2	44.0	6.1	3.9	8.2	2.3	4.4	7.8	6.1	17.5	15.4	0.0	9.3	8.4	7.3	5.6	4.6	6.0	6.7	3.9	5.2	4.7	3.7
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7;skeletal muscle: 27.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.7	8.2	6.5	11.2	6.1	0.4	5.5	11.8	0.3	6.9	1.4	5.1	3.0	0.4	2.6	0.7	1.7	1.7	7.6	6.9	5.8	60.7	2.3	4.4	15.5	8.6	1.4	3.3	0.7	0.5	2.0	9.5	2.8	0.2	1.8	2.0	0.2	27.3	5.8	5.0	0.6	2.7	5.9	4.8	13.1	8.0	0.6	0.9	0.9	0.4	0.3	0.2	15.4	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.2	11.2	5.5	11.8	7.6	6.9	15.5	8.6	9.5	2.7	8.0	15.4	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.1;Hofbauer cells: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	14.7	20.2	2.7	5.6	3.4	5.5	13.7	2.4	4.8	12.9	2.8	12.6	9.1	12.2	0.7	10.6	10.8	4.3	7.0	3.3	2.0	18.7	13.8	12.2	7.9	3.4	3.1	9.3	8.2	3.1	8.5	4.5	2.8	10.8	0.8	0.4	13.7	3.2	8.8	15.4	17.3	1.4	2.4	26.1	9.9	37.0	4.2	3.7	12.1	1.3	1.9	10.9	9.8	4.3	9.6	11.7	3.1	6.7	3.5	2.5	15.4	9.0	3.4	7.4	9.0	8.7	16.9	4.4	4.4	1.7	14.0	9.3	1.7	2.5	0.2	6.0	7.8	6.6	13.8	12.7	12.9	4.6	16.8	6.6	2.5	4.9	0.8	1.8	4.0	12.5	14.3	9.3	3.1	19.0	7.8	11.7	6.7	0.8	10.1	29.6	4.4	14.0	2.4	5.4	10.3	9.9	5.7	13.1	21.4	0.5	13.1	1.5	6.9	7.4	11.3	14.3	4.7	15.7	14.1	8.9	8.1	9.5	7.4	9.5	3.3	9.6	4.8	7.5	3.8	6.4	3.5	2.9	1.2	4.1	2.7	2.4	8.4	3.1	9.9	9.9	3.8	2.9	2.7	3.4	2.4	4.8	3.3	2.0	3.4	3.1	2.8	2.4	4.2	4.3	8.0	3.2	11.6	1.3	16.7	8.9	5.2	3.2	4.0	10.3	13.6	11.6	2.5	10.0	5.2	5.5	6.2	16.7	16.4	16.2	5.9	30.3	64.1	6.0	4.1	8.3	12.6	11.0	1.6	17.0	27.1	9.9	7.1	5.2	7.0	13.1	18.2	11.9	127.0	23.5	1.1	12.8	6.1	47.6	12.1	27.4	10.5	28.9	19.6	1.9	26.9	11.0	20.6	0.5	0.8	14.5	26.4	6.4	11.5	4.1	59.4	48.9	9.1	13.0	0.0	7.8	8.4	52.9	16.3	5.1	8.9	27.9	13.2	7.6	10.4	4.2
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755540-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 14.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.2;Enteroendocrine cells: 15.1;Excitatory neurons: 6.6;Horizontal cells: 3.3;Inhibitory neurons: 5.7;Rod photoreceptor cells: 4.9"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: AB_2682423"	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.0	0.6	4.0	0.0	4.5	0.1	0.0	14.6	8.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.2	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.9	0.0	2.8	0.0	1.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	4.5	14.6	8.1	3.7	3.2	1.2	0.2	1.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.5;ovary: 33.1"	"Group enriched"	"Detected in some"	4	"granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HEL: 40.1;K-562: 22.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 9.4"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.6	41.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.5	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.2	33.1	12.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.2	0.1	0.1	0.0	0.0	5.7	0.7	9.1	0.5	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	40.1	0.0	0.8	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	3.5	2.6	0.0	0.1	1.5	0.0	4.2	0.1	2.1	0.1	2.7	0.0	0.1	26.0	36.1	11.4	0.3	0.1	0.0	0.0	0.0	0.0	1.2	0.0	2.5	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.3	0.0	0.0	0.3	0.8	94.9	0.1	0.0
AMIGO2	"ALI1, DEGA"	ENSG00000139211	"Adhesion molecule with Ig like domain 2"	Q86SJ2	12	47075707-47079959	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 62.6;Enteroendocrine cells: 60.4;Glandular and luminal cells: 72.8;Granulosa cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 192.0;fHDF/TERT166: 183.2;hTERT-RPE1: 312.2;LHCN-M2: 179.2;RT4: 251.9;U-2 OS: 149.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054004, HPA059601"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	Yes		390000	"Cluster 32: T-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA054004: AB_2682339, HPA059601: AB_2684078"	"unprognostic (2.63e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.29e-3)"	10.8	19.8	4.5	7.0	4.9	3.5	22.8	3.6	5.4	20.3	2.3	39.4	3.3	30.7	7.9	4.0	36.4	19.3	5.6	3.2	8.8	7.7	4.6	20.0	12.4	9.1	37.9	28.7	3.6	6.4	5.3	13.2	19.6	11.3	9.0	25.7	4.5	11.0	1.1	4.4	12.6	34.3	4.3	17.4	5.5	10.7	13.1	2.8	4.2	2.2	7.6	22.6	14.3	3.9	44.4	105.5	6.3	0.2	2.5	0.2	17.2	14.8	39.3	4.7	3.8	0.3	192.0	0.0	47.6	183.2	117.0	64.8	0.0	117.6	5.5	8.6	0.7	0.0	11.0	0.1	3.8	1.2	1.7	0.9	20.1	122.6	59.5	312.2	15.0	0.9	8.5	0.0	179.2	2.1	3.6	0.1	4.5	21.2	27.1	0.3	46.5	0.1	52.3	251.9	18.8	0.0	76.2	9.0	0.5	3.4	11.2	1.0	4.1	2.6	149.9	1.7	121.3	1.9	0.4	0.2	10.0	3.4	2.8	0.0	0.1	0.0	4.4	0.2	6.0	3.7	6.8	6.9	0.7	1.6	15.3	12.1	0.1	8.6	0.0	8.8	4.4	4.7	4.5	4.9	3.6	5.4	3.2	8.8	9.1	37.9	19.6	4.3	13.1	3.9	7.2	9.6	3.1	1.0	3.6	2.4	13.1	39.4	15.4	62.6	10.8	37.7	1.6	1.5	4.9	1.8	0.0	1.0	12.4	0.4	1.9	5.3	1.4	31.5	6.0	12.7	60.4	5.7	2.6	19.3	28.1	11.1	0.5	72.8	7.0	76.8	32.2	1.2	4.8	0.0	0.2	3.1	2.0	3.5	1.1	2.3	2.5	7.2	1.8	1.9	5.3	15.6	2.1	0.0	0.1	40.4	1.5	0.7	3.8	10.7	0.0	0.1	2.9	4.9	0.0	3.2	27.7	0.7	2.4	2.5	0.4	8.5	7.6	12.8	0.3	33.9
AMMECR1L	MGC4268	ENSG00000144233	"AMMECR1 like"	Q6DCA0	2	127861630-127885967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000590, HPA057234"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Cytosol	"HPA000590: AB_2666037, HPA057234: AB_2683376"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.92e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (8.91e-2)"	12.4	10.1	3.1	3.4	3.3	2.4	10.9	3.2	3.8	12.1	2.6	9.9	4.5	12.1	2.4	10.0	11.5	5.0	9.4	3.2	3.4	9.2	12.7	8.9	3.7	3.4	3.3	10.8	10.5	8.5	7.2	7.4	3.3	9.7	4.6	2.3	8.9	5.7	8.3	11.4	9.4	7.3	2.9	10.1	9.6	12.7	3.8	5.4	9.0	7.9	5.1	9.4	11.4	3.2	8.0	5.6	16.4	12.3	15.7	12.0	11.1	10.0	14.4	13.6	14.6	15.0	7.4	6.5	6.6	18.2	6.0	7.7	17.2	10.5	17.9	13.1	9.8	5.7	5.4	11.2	18.3	9.7	9.6	15.6	21.9	18.8	18.4	12.6	19.1	9.5	8.3	5.4	14.6	4.7	10.3	2.7	11.3	9.7	14.1	11.0	15.7	4.7	10.1	3.7	11.0	11.9	12.9	16.2	27.0	14.1	7.0	8.6	13.4	16.6	9.0	5.4	8.5	5.6	11.1	7.6	7.7	7.7	12.5	0.5	1.2	3.8	1.5	1.3	2.0	1.4	1.6	1.5	1.7	1.6	1.4	1.1	1.8	1.6	1.6	1.8	1.4	1.3	3.1	3.3	3.2	3.8	3.2	3.4	3.4	3.3	3.3	2.9	3.8	3.2	9.8	19.2	8.1	5.9	7.2	18.0	8.6	4.8	9.6	5.3	14.5	9.7	12.0	10.0	9.2	3.7	6.2	5.9	7.1	8.6	0.0	6.2	11.4	11.8	27.0	10.4	5.4	5.0	10.4	5.8	7.7	11.1	10.2	12.6	7.0	10.2	8.2	16.2	4.6	1.7	9.2	9.4	2.0	7.5	6.6	15.1	6.8	5.8	5.4	8.4	4.4	4.2	3.1	7.5	10.8	9.2	6.7	8.2	12.2	14.8	5.5	4.6	14.7	6.0	0.0	15.4	11.8	6.6	9.8	13.2	15.8	7.7	7.0	6.4	9.3	13.9
AMOTL1	JEAP	ENSG00000166025	"Angiomotin like 1"	Q8IY63	11	94706431-94876748	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 111.4;WM-115: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001196	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		59000	"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Cell Junctions"	"HPA001196: AB_1078147"	"unprognostic (2.21e-1)"	"unprognostic (5.25e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.03e-6)"	"unprognostic (7.47e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.29e-2)"	15.4	10.3	15.1	7.6	9.8	1.7	15.0	7.8	7.2	11.7	8.7	36.5	4.5	14.2	5.9	30.4	13.3	13.3	19.1	12.2	12.4	6.4	7.8	15.8	3.5	12.0	28.8	4.8	15.6	13.8	14.1	24.1	13.2	32.4	7.3	6.6	10.9	23.1	112.0	21.7	8.4	20.5	7.3	9.2	12.4	11.7	30.4	27.9	9.7	71.7	9.7	27.5	14.0	6.2	57.1	16.0	41.9	0.0	44.1	38.1	19.9	31.0	53.7	13.9	16.2	29.7	1.5	2.7	14.9	42.2	11.4	72.4	20.1	111.4	14.6	4.6	15.4	30.7	16.2	0.1	10.2	6.8	0.2	22.7	67.3	47.7	78.9	35.9	29.3	11.9	79.0	2.9	33.1	16.6	21.3	4.1	6.3	0.1	10.5	0.0	76.2	4.9	19.4	23.6	31.7	38.3	2.0	42.4	11.2	28.1	2.2	9.6	27.1	38.0	27.6	0.8	21.6	1.5	0.0	16.0	10.6	0.1	105.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	15.1	9.8	7.8	7.2	12.2	12.4	12.0	28.8	13.2	7.3	30.4	6.2	28.4	35.3	35.0	17.0	0.8	35.4	19.7	11.7	29.0	4.7	6.9	14.9	51.0	10.0	10.1	7.3	4.2	30.1	1.0	0.0	0.0	17.3	127.0	22.3	12.7	31.1	0.0	6.3	26.8	17.0	15.6	30.9	0.5	27.4	2.5	4.9	36.4	17.0	4.9	15.2	61.3	0.0	4.1	4.0	10.0	62.9	8.1	3.2	10.6	46.9	1.4	14.4	0.0	20.6	1.4	10.8	0.0	12.4	0.7	19.4	0.0	4.0	4.2	1.1	13.1	32.7	30.2	16.7	11.4	21.7	26.9	27.9	1.4	3.4	0.0	8.4
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68205481-68257712	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 477.3;Early spermatids: 736.8;Late spermatids: 1665.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: AB_2681818"	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	52.3	51.8	54.5	32.6	66.4	36.4	45.0	57.1	87.2	41.2	50.0	57.8	26.2	44.5	53.4	38.4	52.5	37.9	77.0	59.5	56.6	59.2	38.1	32.9	54.0	58.8	56.7	48.7	45.3	64.4	59.1	29.5	58.0	41.6	32.9	78.5	40.0	51.2	95.6	43.1	36.9	41.7	55.3	43.3	39.7	194.4	60.0	53.2	53.3	86.8	51.7	48.5	36.5	61.4	94.6	98.9	87.5	72.9	65.6	113.4	140.0	71.0	88.3	116.1	93.7	42.3	60.4	142.6	74.9	104.8	107.0	46.0	68.6	198.5	154.0	50.2	67.7	52.8	38.6	83.1	124.9	49.8	86.9	96.9	213.9	107.5	206.2	113.0	118.9	121.7	54.6	86.5	150.9	67.3	110.2	45.4	43.5	51.1	98.5	41.3	238.9	106.7	71.2	50.1	85.7	67.2	64.8	125.5	130.9	184.6	100.7	33.5	65.2	143.8	72.0	55.8	74.8	121.9	121.9	255.7	105.1	69.0	79.1	76.6	25.2	35.3	34.8	30.3	46.2	30.7	43.2	46.0	30.3	41.3	37.8	40.4	45.1	63.7	40.9	28.1	58.3	36.9	54.5	66.4	57.1	87.2	59.5	56.6	58.8	56.7	58.0	55.3	60.0	61.4	18.5	12.8	15.6	477.3	38.7	18.6	31.6	58.4	30.1	13.8	29.7	34.3	81.4	21.5	32.8	23.9	8.4	64.0	58.0	9.4	109.5	28.8	736.8	28.4	17.2	24.4	21.1	21.0	36.4	26.0	66.9	28.2	14.8	18.5	34.1	28.9	21.4	15.5	41.8	18.5	30.0	16.7	40.7	26.1	71.0	1665.0	36.1	39.0	56.9	27.2	46.4	65.7	69.0	56.8	47.7	25.4	10.8	32.7	46.2	17.7	15.2	69.0	61.8	12.8	19.7	26.5	26.8	274.4	59.4	26.4	22.6	34.2	49.3	26.1	15.1	24.5
ANAPC13	"APC13, DKFZP566D193, SWM1"	ENSG00000129055	"Anaphase promoting complex subunit 13"	Q9BS18	3	134477706-134486716	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 463.7;Proximal tubular cells: 373.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046114	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA046114: AB_10961429"	"unprognostic (2.84e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (2.98e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (3.57e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.44e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (2.66e-7)"	"unprognostic (3.10e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.16e-1)"	56.7	73.3	54.1	29.0	56.1	30.0	65.9	58.0	68.6	49.1	74.4	44.6	35.2	46.8	114.4	35.1	48.2	48.0	98.5	56.8	63.4	121.2	86.8	45.4	38.8	60.3	58.6	52.2	50.1	77.2	63.7	51.1	62.3	60.0	45.8	62.6	53.7	54.4	87.1	38.1	33.8	48.1	58.0	40.1	54.3	29.3	57.2	35.7	95.6	67.9	36.6	51.3	33.3	58.3	91.9	56.2	87.4	74.9	144.7	191.6	67.5	116.0	106.4	83.4	77.9	70.6	52.9	61.9	244.8	172.2	100.1	53.0	82.6	83.6	119.9	31.7	37.7	63.3	43.2	119.3	104.6	104.2	43.5	127.7	90.3	83.5	155.1	93.4	130.9	59.3	85.9	51.2	266.9	117.3	53.5	103.1	59.8	157.7	54.5	42.6	68.5	113.7	165.3	56.0	35.4	58.0	103.2	37.8	107.4	92.8	94.2	101.6	91.9	115.2	47.0	164.1	52.2	56.2	65.6	127.3	71.4	57.4	100.9	112.9	96.6	86.5	52.7	108.2	69.7	86.1	78.7	69.9	91.8	68.9	94.2	80.7	236.4	67.6	111.4	70.1	72.9	84.8	54.1	56.1	58.0	68.6	56.8	63.4	60.3	58.6	62.3	58.0	57.2	58.3	46.6	35.3	47.0	3.6	41.7	42.1	47.6	72.2	47.8	41.0	60.8	49.9	112.8	67.2	41.7	84.6	12.5	95.8	26.8	22.1	463.7	51.5	42.5	38.1	39.5	51.8	40.8	26.3	7.0	53.8	96.6	57.2	38.2	28.9	18.9	34.5	53.6	64.5	78.7	20.2	8.3	40.6	77.3	71.3	48.8	104.6	50.7	43.8	97.8	6.5	33.4	85.0	42.2	4.0	6.3	39.5	42.6	44.0	46.0	74.7	54.6	373.4	49.3	38.3	19.7	26.6	58.5	46.2	64.2	44.3	50.6	70.3	35.4	59.5	35.4	52.9
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	14.4	19.0	11.8	14.0	14.3	12.6	15.7	12.7	16.1	20.1	11.8	18.8	10.6	21.4	16.7	36.2	18.0	11.4	22.7	13.0	12.9	18.6	13.3	13.7	18.0	12.3	11.7	16.7	14.1	24.9	14.7	8.5	12.4	18.5	16.2	13.2	20.5	17.5	33.8	18.0	14.5	21.1	12.4	16.6	15.7	30.1	12.1	24.0	20.2	24.9	20.7	19.0	24.8	12.8	49.7	66.8	47.8	40.9	48.8	24.6	27.4	33.9	30.6	61.1	42.2	68.5	30.8	78.6	33.5	45.8	35.2	49.1	71.8	46.5	61.8	42.0	57.8	69.3	46.0	57.3	35.5	62.5	31.6	27.0	32.7	53.0	35.0	43.6	60.1	55.2	110.7	16.4	48.7	53.0	95.6	46.7	42.0	48.1	57.6	72.8	47.2	93.1	41.4	62.5	61.8	35.4	53.2	41.2	57.3	41.9	87.1	56.0	38.2	36.3	34.1	32.6	40.6	27.4	59.5	105.6	40.5	52.6	42.9	20.2	12.1	20.5	18.2	17.2	21.7	14.3	19.6	17.7	20.1	18.7	16.1	17.5	9.3	24.3	15.9	10.9	26.1	14.4	11.8	14.3	12.7	16.1	13.0	12.9	12.3	11.7	12.4	12.4	12.1	12.8	13.1	16.0	18.4	17.6	12.9	10.1	19.6	16.5	13.1	18.5	12.8	11.6	17.5	10.0	22.6	12.9	20.9	12.4	10.7	9.2	11.7	16.9	7.6	22.8	18.6	15.7	10.8	33.6	28.1	15.2	10.1	16.9	16.3	15.3	15.8	42.5	11.7	13.4	22.4	21.9	22.6	10.8	32.6	17.9	6.6	12.7	18.3	12.5	17.8	13.1	14.7	16.1	11.3	22.6	29.3	16.2	8.9	21.8	11.4	20.0	7.3	15.0	18.4	22.9	13.1	15.9	16.2	74.1	42.2	38.3	13.4	7.3	14.0	32.4	14.9	17.5
ANKEF1	"ANKRD5, dJ839B4.6, FLJ21669"	ENSG00000132623	"Ankyrin repeat and EF-hand domain containing 1"	Q9NU02	20	9986126-10058303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.0;testis: 14.6"	"Group enriched"	"Detected in many"	21	"Early spermatids: 323.1;Late spermatids: 383.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041151	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center, Plasma membrane, Cytosol"		"HPA041151: AB_10796569"	"unprognostic (4.72e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.38e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.73e-2)"	"prognostic favorable (4.44e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (3.11e-1)"	2.4	1.4	1.1	1.5	1.1	0.6	3.1	2.7	1.4	2.2	2.8	2.5	2.5	1.0	1.0	2.5	4.0	2.2	1.0	0.9	1.7	2.5	4.0	1.7	1.2	1.4	1.3	2.2	14.0	4.3	2.2	0.7	1.4	1.9	2.3	5.3	2.6	2.1	0.6	2.8	2.4	0.7	0.9	1.2	3.7	14.6	1.6	1.7	5.7	0.6	1.8	1.6	1.3	0.9	9.0	8.7	0.9	2.1	2.2	1.5	5.9	1.3	0.1	1.6	0.8	5.1	7.2	0.1	2.4	0.3	9.7	7.1	2.3	9.0	1.9	0.0	1.4	1.1	2.2	5.3	1.0	0.9	0.2	3.9	9.8	1.5	1.4	4.0	1.4	3.2	3.4	6.1	0.4	2.4	1.4	0.0	4.4	11.2	2.4	0.0	0.1	5.6	5.3	5.5	6.5	3.1	3.8	8.7	0.0	3.2	7.2	0.8	0.9	1.1	1.4	0.1	1.4	7.0	14.2	1.3	2.4	0.4	1.2	0.0	0.0	0.0	0.7	0.0	1.1	0.5	0.7	0.5	0.0	0.4	1.0	0.6	0.1	0.5	0.0	0.5	0.7	0.2	1.1	1.1	2.7	1.4	0.9	1.7	1.4	1.3	1.4	0.9	1.6	0.9	0.5	3.2	6.7	1.3	2.0	0.3	2.3	1.6	3.4	1.7	3.4	1.8	1.8	2.8	2.0	7.3	0.0	2.2	1.2	2.7	1.9	4.5	323.1	6.7	1.0	1.8	5.3	0.4	1.1	6.3	2.0	0.9	10.7	2.8	1.3	0.7	0.7	9.1	1.3	3.3	2.8	3.8	2.0	0.3	0.6	383.0	3.4	1.4	0.0	1.0	0.0	0.8	3.1	0.5	0.4	5.3	4.2	4.1	4.8	1.9	3.3	2.8	16.2	4.9	0.0	0.7	0.3	5.1	3.4	8.6	0.3	1.5	2.6	1.1	3.7	1.5
ANKH	"ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1"	ENSG00000154122	"ANKH inorganic pyrophosphate transport regulator"	Q9HCJ1	5	14704800-14871778	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Phosphate transport, Transport"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 160.1;Hofbauer cells: 208.8;Inhibitory neurons: 214.5;Oligodendrocytes: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068104			Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA068104: AB_2685954"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.76e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.46e-2)"	9.9	10.6	22.1	6.6	23.8	8.0	9.9	33.9	29.3	5.5	26.6	12.8	16.8	7.1	4.9	7.4	7.7	9.4	32.2	22.5	25.5	8.1	21.4	7.1	8.5	25.3	28.2	16.0	15.2	19.2	22.8	8.5	25.1	32.7	11.4	25.1	14.3	9.2	40.9	20.3	15.0	8.5	24.9	6.8	7.3	1.9	26.8	11.5	10.7	37.6	14.1	7.3	7.4	28.8	7.2	5.4	6.7	1.1	13.8	32.3	3.2	6.8	13.7	2.6	2.7	4.3	9.0	16.9	15.7	9.4	6.2	4.6	4.6	7.5	3.0	6.7	11.3	0.4	47.8	11.6	4.6	4.1	1.3	10.2	13.0	8.1	9.2	9.2	5.5	12.3	3.5	35.2	8.7	9.6	6.9	13.3	2.6	9.5	6.0	9.8	3.3	15.3	0.0	2.3	16.4	4.5	33.3	5.3	7.5	6.1	0.3	1.5	5.4	6.9	6.9	11.5	12.6	9.2	9.3	13.0	23.8	15.1	29.0	0.6	0.2	0.0	1.4	0.4	2.3	1.5	2.9	2.3	0.3	1.6	3.3	1.5	0.3	0.3	0.9	0.3	4.6	0.4	22.1	23.8	33.9	29.3	22.5	25.5	25.3	28.2	25.1	24.9	26.8	28.8	50.1	25.6	19.1	64.6	15.4	25.2	79.1	33.7	40.9	58.0	29.7	15.5	73.4	7.2	10.8	7.3	127.2	76.4	21.1	58.2	5.9	1.7	1.2	7.1	14.9	25.4	41.8	69.9	160.1	11.8	6.1	25.6	8.2	16.9	17.7	9.8	12.5	32.7	208.8	20.2	214.5	37.7	8.2	89.3	29.9	1.9	5.0	42.6	10.6	106.8	3.4	20.1	21.6	95.5	261.5	6.8	31.4	31.6	14.7	55.4	44.6	10.2	6.4	50.1	0.0	32.8	12.3	2.3	7.2	10.1	10.7	42.0	25.9	8.6	37.3	22.3
ANKMY1	"FLJ20499, ZMYND13"	ENSG00000144504	"Ankyrin repeat and MYND domain containing 1"	Q9P2S6	2	240479422-240569209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 187.5;Late spermatids: 213.1;Respiratory ciliated cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026620, HPA048869"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026620: AB_1844834, HPA048869: "	"unprognostic (2.89e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.46e-1)"	"unprognostic (3.97e-5)"	"unprognostic (8.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.59e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.20e-4)"	4.9	4.4	6.4	5.7	7.6	12.5	6.3	6.0	7.3	7.5	6.1	6.0	6.5	5.4	8.7	5.8	24.6	4.7	3.4	5.4	4.9	5.0	6.2	6.9	9.0	8.1	12.3	7.4	8.6	6.2	4.5	3.9	8.0	6.6	5.5	3.8	5.1	5.2	3.5	8.2	7.2	3.0	8.0	8.2	9.6	67.9	7.1	7.1	6.5	2.1	6.7	5.7	6.4	11.1	7.0	15.2	3.2	6.0	2.9	4.1	13.4	3.3	5.0	2.7	3.6	4.9	14.2	7.0	0.6	3.7	4.1	7.6	6.2	7.8	3.2	12.9	5.2	13.9	8.6	13.0	2.4	7.8	12.8	6.6	18.7	2.5	17.7	8.2	2.8	11.0	13.2	8.8	4.6	6.7	7.2	12.8	2.7	12.1	9.0	20.1	9.8	11.1	4.1	15.0	7.5	5.6	2.7	7.2	10.0	3.9	6.2	11.9	3.6	10.0	3.3	4.0	5.9	20.0	5.5	7.0	5.7	11.8	7.9	0.0	2.1	4.5	4.6	1.8	2.7	2.8	2.8	2.9	2.7	4.1	4.1	3.0	0.9	1.3	2.3	1.8	0.9	2.4	6.4	7.6	6.0	7.3	5.4	4.9	8.1	12.3	8.0	8.0	7.1	11.1	3.0	0.0	8.1	23.8	7.2	0.9	1.8	5.3	13.1	3.5	4.3	3.7	2.2	1.5	10.1	3.7	4.2	3.0	8.1	4.8	1.9	2.7	187.5	40.8	3.6	3.5	4.2	6.5	17.0	4.3	1.7	2.8	16.8	4.5	5.7	4.8	2.9	6.4	2.7	3.3	25.4	4.5	6.1	7.6	2.0	213.1	4.1	6.7	0.0	38.4	5.5	2.6	7.2	21.1	42.9	3.2	2.2	3.0	3.4	2.8	5.7	2.9	62.6	4.0	0.0	2.2	3.5	28.8	8.9	5.0	2.3	2.9	8.6	2.9	4.7	2.0
ANKMY2	"DKFZP564O043, ZMYND20"	ENSG00000106524	"Ankyrin repeat and MYND domain containing 2"	Q8IV38	7	16599779-16645817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067100			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA067100: AB_2685777"	"unprognostic (3.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (5.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.85e-2)"	11.1	10.9	13.1	7.1	16.8	14.4	14.4	13.4	19.0	14.0	14.7	17.0	15.2	13.2	12.1	11.6	15.7	13.6	39.1	17.3	13.0	16.1	11.1	11.8	9.6	11.8	11.4	25.6	11.9	15.4	11.7	9.2	11.2	13.4	17.0	23.4	13.2	18.5	23.5	10.8	17.3	11.7	11.9	10.5	24.8	9.6	12.0	13.2	21.8	23.3	9.1	14.4	11.3	14.0	20.9	17.0	23.2	22.6	21.5	22.2	12.8	24.2	29.7	18.3	28.4	30.0	30.9	4.2	28.5	26.4	38.3	21.0	15.4	9.6	27.7	9.1	12.0	37.8	20.2	13.4	13.8	28.5	13.5	19.8	4.9	19.3	19.0	25.5	16.8	26.2	41.0	6.5	26.5	5.6	12.5	19.4	15.9	62.5	22.2	20.2	21.0	9.7	28.6	17.2	15.0	8.6	16.0	11.9	10.0	21.2	14.1	24.5	10.2	14.4	12.5	31.8	17.2	24.6	19.6	6.6	21.8	23.1	22.9	30.1	4.0	17.5	11.6	5.0	11.0	7.9	9.4	11.8	6.0	7.9	7.7	9.2	3.0	13.6	11.8	5.7	10.6	6.6	13.1	16.8	13.4	19.0	17.3	13.0	11.8	11.4	11.2	11.9	12.0	14.0	6.8	3.2	15.1	17.3	6.5	4.7	8.6	9.1	7.4	17.3	7.3	10.9	37.9	10.0	15.1	11.0	6.2	13.6	10.3	13.6	21.5	8.0	42.5	7.9	5.5	7.3	19.2	15.8	57.3	8.9	11.7	13.6	20.9	4.9	6.3	14.7	4.6	5.6	9.5	8.4	36.5	14.2	10.2	7.4	6.7	31.0	12.8	7.4	14.2	15.9	6.1	19.6	8.2	22.6	19.2	5.2	11.7	13.5	8.1	4.1	19.9	12.9	28.8	19.6	26.3	6.3	12.1	9.8	4.0	6.7	4.1	17.0	8.7	15.7	14.1	6.1
ANKRD12	"FLJ20053, GAC-1, KIAA0874"	ENSG00000101745	"Ankyrin repeat domain 12"	Q6UB98	18	9136228-9285985	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 106.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040705	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA040705: AB_10673301"	"unprognostic (2.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.03e-2)"	15.8	9.3	17.1	20.5	21.4	20.5	13.7	59.9	26.0	11.1	2.2	13.0	12.9	11.8	9.5	14.4	6.2	14.6	11.9	13.9	18.4	13.0	13.8	11.5	22.4	11.2	13.4	14.1	11.9	10.5	5.9	14.1	13.2	12.2	12.0	29.8	12.3	10.6	26.7	20.2	13.4	9.1	10.4	19.9	14.5	27.7	15.8	11.4	16.4	12.3	18.5	13.5	8.0	32.3	10.1	6.7	9.0	6.0	14.2	14.5	7.3	15.3	14.2	5.4	7.4	6.1	7.6	13.9	8.7	10.6	16.4	9.1	6.8	6.0	14.5	14.8	8.1	6.4	4.7	9.0	10.5	15.0	19.7	7.6	13.1	7.7	12.4	12.2	9.2	8.0	14.7	106.4	13.2	5.7	10.1	10.2	3.4	24.7	6.8	9.0	12.6	51.1	7.1	15.8	20.9	7.7	15.0	7.4	11.1	8.0	9.2	12.4	19.9	39.5	18.1	32.1	14.4	30.8	52.0	25.9	19.4	7.9	15.2	102.0	26.4	85.1	42.4	24.1	47.9	63.6	54.9	42.0	19.2	56.2	55.9	43.4	157.3	30.4	37.2	60.6	44.0	18.3	17.1	21.4	59.9	26.0	13.9	18.4	11.2	13.4	13.2	10.4	15.8	32.3	235.1	278.9	261.5	198.5	246.9	108.2	205.9	83.3	116.7	301.0	87.5	108.5	138.6	94.4	137.7	68.0	523.3	46.3	267.2	163.1	19.6	99.7	204.9	144.3	91.9	136.8	92.7	90.7	172.1	83.5	41.1	126.8	64.2	292.9	187.2	76.3	121.7	74.0	67.8	286.0	218.1	90.4	107.8	99.7	126.2	230.9	134.8	149.3	90.7	161.1	178.2	125.5	244.1	184.5	347.4	93.0	147.1	141.4	210.1	196.8	126.1	37.0	88.5	315.4	111.7	173.2	150.0	239.5	152.8	70.9	96.0	78.1	298.3	63.0	71.0	170.7
ANKRD36	UNQ2430	ENSG00000135976	"Ankyrin repeat domain 36"	A6QL64	2	97113153-97264521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.0;retina: 20.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 240.8;Inhibitory neurons: 255.3;Oligodendrocyte precursor cells: 155.3;Oligodendrocytes: 217.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (4.24e-3)"	"unprognostic (7.59e-2)"	"unprognostic (6.15e-3)"	"unprognostic (9.86e-2)"	"unprognostic (9.83e-3)"	"unprognostic (5.25e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.75e-1)"	1.8	1.6	5.8	2.7	8.3	11.8	3.2	25.0	7.8	2.2	0.3	1.8	1.8	3.6	4.2	1.0	2.1	1.9	1.3	5.3	4.0	0.9	0.6	2.4	2.9	7.1	2.0	4.5	1.8	1.8	1.9	1.3	8.2	2.3	2.6	20.3	2.1	1.4	0.7	3.2	1.8	2.3	1.5	3.3	2.8	7.1	6.2	3.1	2.1	0.5	2.2	1.4	1.8	9.5	4.4	1.4	3.9	2.4	0.9	2.1	1.5	2.1	1.3	1.5	1.5	1.3	2.3	5.5	1.0	1.4	1.2	2.9	1.4	1.9	1.3	2.9	2.4	4.7	6.4	2.4	0.4	3.8	1.9	1.4	0.9	1.2	1.9	2.2	2.9	8.9	3.6	10.1	0.8	1.0	4.4	4.4	0.9	0.4	2.8	5.0	1.9	2.2	0.8	2.3	3.3	2.2	2.3	1.3	0.7	1.5	1.4	1.9	3.9	4.2	3.8	4.1	2.3	6.5	2.8	5.1	2.2	4.5	1.0	9.2	2.2	3.1	7.2	1.0	7.4	9.2	7.1	6.1	0.9	8.1	7.2	7.5	3.3	4.9	2.3	10.1	6.6	2.0	5.8	8.3	25.0	7.8	5.3	4.0	7.1	2.0	8.2	1.5	6.2	9.5	16.9	44.8	27.4	85.5	27.8	15.7	8.4	28.2	14.2	51.0	9.0	11.2	26.2	2.8	31.5	7.3	75.0	1.4	38.2	4.9	0.0	7.1	70.7	39.6	22.2	19.3	13.8	14.3	240.8	18.6	5.6	19.5	84.6	19.3	26.6	39.4	11.7	1.1	5.1	21.9	255.3	10.5	12.2	3.8	26.2	14.3	26.1	10.2	39.2	46.9	6.1	9.3	26.8	155.3	217.7	9.5	3.6	18.0	56.3	5.9	2.2	2.7	43.2	65.0	0.0	36.4	20.7	123.4	22.1	9.8	9.2	0.4	39.6	9.1	8.1	14.1
ANKRD36B	"FLJ21281, KIAA1641"	ENSG00000196912	"Ankyrin repeat domain 36B"	Q8N2N9	2	97492663-97589965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 73.4;Oligodendrocytes: 71.1;Plasma cells: 81.7;Spermatocytes: 76.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.03e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.20e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.13e-6)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.71e-3)"	"unprognostic (6.98e-2)"	4.4	1.8	3.0	1.6	4.8	21.5	4.7	13.7	5.8	4.7	0.0	3.2	1.0	4.1	2.3	1.8	5.0	1.7	2.7	3.1	2.5	2.4	1.1	3.0	2.6	4.7	1.2	5.3	6.1	1.0	2.9	0.8	5.3	3.4	2.8	10.1	4.3	1.4	1.3	4.1	3.5	2.8	1.0	3.1	3.2	13.1	4.1	2.9	2.7	0.2	1.9	3.1	3.1	7.2	2.9	1.4	1.4	1.7	1.1	2.8	1.8	1.5	1.2	1.0	1.1	1.8	3.2	4.7	1.1	1.5	1.0	0.4	1.1	1.1	1.1	1.5	2.2	3.6	3.5	1.3	0.8	2.6	1.6	1.5	1.5	1.5	2.4	2.8	1.4	7.1	3.8	5.0	1.2	0.5	3.0	3.3	0.9	0.5	1.4	3.2	0.6	0.7	1.4	2.1	1.8	2.3	1.2	0.7	0.9	3.1	1.6	2.0	2.6	1.5	1.8	2.5	2.8	3.9	5.7	3.3	1.9	3.9	1.3	1.9	0.1	0.2	0.6	0.1	0.6	0.6	0.8	0.5	0.1	1.0	0.9	0.6	0.1	0.8	0.0	0.8	0.4	0.1	3.0	4.8	13.7	5.8	3.1	2.5	4.7	1.2	5.3	1.0	4.1	7.2	14.6	12.8	15.0	27.1	28.3	0.0	6.9	0.0	20.5	36.7	5.4	7.4	15.4	5.7	17.3	9.2	20.9	1.4	15.4	5.9	0.0	9.4	48.9	29.6	10.1	12.5	14.4	16.4	68.5	14.0	3.9	11.4	73.4	14.1	22.8	23.4	4.2	0.7	3.4	16.8	68.7	12.6	0.0	1.2	0.0	7.3	12.8	9.5	0.0	19.7	7.3	6.8	12.3	42.3	71.1	9.7	3.6	7.5	81.7	5.0	2.5	1.3	16.8	34.1	6.6	25.2	9.9	76.4	11.1	24.0	0.0	0.1	35.2	7.1	6.7	12.4
ANKRD36C	DKFZp667P0924	ENSG00000174501	"Ankyrin repeat domain 36C"	Q5JPF3	2	95836919-95991831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 615.1;Gastric mucus-secreting cells: 498.9;Inhibitory neurons: 290.7;Pancreatic endocrine cells: 311.5;Urothelial cells: 411.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 30.9"									"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.35e-6)"	"unprognostic (9.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	2.0	1.5	5.3	2.1	9.3	16.3	6.1	24.0	8.9	2.6	1.5	2.8	1.2	3.8	2.3	2.3	3.1	4.8	1.4	4.2	9.3	1.2	0.6	2.6	3.5	9.4	5.9	6.0	1.8	1.6	1.6	1.5	11.3	1.9	2.6	10.6	14.6	1.5	0.7	3.6	1.6	1.9	2.6	2.9	5.4	12.0	9.7	6.5	1.6	0.9	2.9	3.2	1.9	25.8	8.4	1.6	3.3	2.3	2.1	5.7	1.3	1.9	1.4	2.5	3.3	1.9	1.9	8.3	2.5	1.4	2.5	1.9	3.0	1.5	3.2	4.8	4.1	3.2	4.5	2.4	0.5	9.9	2.4	1.7	1.2	2.0	1.0	2.5	4.3	11.7	3.3	10.2	2.8	1.2	7.7	3.7	0.7	0.4	30.9	4.0	2.5	3.3	1.3	1.6	3.0	2.7	1.3	2.1	1.3	1.2	1.0	2.3	4.8	3.1	3.4	2.4	2.4	3.8	3.4	8.9	0.9	6.7	1.3	48.0	3.3	2.8	20.8	0.5	13.4	17.1	16.7	13.9	2.5	19.5	14.5	14.2	0.2	12.6	1.0	35.0	15.6	1.3	5.3	9.3	24.0	8.9	4.2	9.3	9.4	5.9	11.3	2.6	9.7	25.8	32.3	38.5	19.9	123.1	26.9	10.7	53.4	33.6	11.4	84.4	38.4	20.8	29.1	4.3	91.0	9.2	79.2	0.3	47.2	23.5	0.0	226.3	118.4	42.6	28.7	25.8	21.0	27.1	227.9	615.1	0.8	26.3	498.9	25.8	34.1	41.3	15.4	1.5	8.3	33.7	290.7	70.2	12.2	7.0	14.7	17.7	32.6	15.9	14.2	46.9	27.4	15.8	50.4	147.8	177.7	311.5	8.4	36.5	48.7	145.8	7.7	0.9	82.3	72.9	19.7	56.1	31.0	178.7	22.4	7.7	7.4	0.3	47.5	13.1	22.0	411.9
ANKRD40	MGC15396	ENSG00000154945	"Ankyrin repeat domain 40"	Q6AI12	17	50693198-50707914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 164.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021668, HPA021759, HPA074884"	Uncertain		Approved	"Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Nucleoli fibrillar center, Cytosol"	"HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: "	"unprognostic (2.73e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	42.8	19.7	126.7	15.5	163.3	7.8	25.7	130.4	159.3	20.6	63.4	32.0	11.8	23.8	13.7	18.4	19.4	16.2	27.6	98.5	115.4	17.8	17.8	22.5	16.6	150.3	152.4	20.6	19.4	26.9	10.8	23.1	142.2	18.3	16.3	20.7	15.0	24.7	107.0	14.4	16.3	27.9	141.3	20.5	18.7	10.3	135.2	16.9	16.9	84.0	14.4	25.3	16.9	164.8	41.1	38.6	34.2	34.6	48.2	39.8	29.9	36.2	39.5	41.3	38.7	82.6	20.5	43.3	49.2	46.4	44.3	22.8	49.3	29.4	66.8	40.0	31.7	59.1	25.1	40.7	26.4	41.6	24.0	34.3	29.5	40.3	50.1	30.2	32.9	35.1	34.0	42.3	34.4	32.0	52.2	15.1	38.0	33.0	36.1	35.2	61.9	30.8	32.5	34.8	18.1	50.5	20.2	27.2	39.6	59.1	31.4	27.4	40.4	55.8	44.1	29.2	46.7	44.3	43.4	38.3	30.6	15.9	46.4	7.4	7.0	3.1	10.9	11.2	12.5	9.8	12.0	12.3	7.1	9.2	11.1	13.4	1.8	10.7	12.3	14.2	9.3	4.6	126.7	163.3	130.4	159.3	98.5	115.4	150.3	152.4	142.2	141.3	135.2	164.8	39.0	16.0	11.4	11.4	13.9	45.0	24.2	6.1	11.4	14.3	19.8	11.7	31.7	12.8	4.9	18.4	4.2	14.9	19.9	13.5	27.4	16.6	1.8	10.4	20.3	31.4	6.0	7.4	16.0	17.5	18.9	19.6	5.6	16.1	9.5	14.3	32.9	21.9	19.0	35.3	15.6	12.3	6.1	32.4	25.1	3.1	34.2	16.3	26.6	11.2	13.2	19.6	8.2	12.1	32.2	19.9	8.4	37.6	4.5	30.5	9.6	24.8	5.0	12.0	46.0	39.1	27.3	17.5	21.1	10.4	33.2	10.7	15.7	9.7	12.8	24.1
ANKRD42	"FLJ37874, PPP1R79, SARP"	ENSG00000137494	"Ankyrin repeat domain 42"	Q8N9B4	11	83193712-83260694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 170.5;Late spermatids: 63.2;Respiratory ciliated cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039917	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039917: AB_10672894"	"unprognostic (6.59e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.90e-1)"	5.2	13.3	8.0	5.2	8.9	9.0	6.0	4.3	11.8	7.4	15.8	5.8	5.2	6.0	19.7	4.8	15.8	7.6	5.3	11.6	14.3	11.1	4.7	6.6	3.8	10.0	9.2	8.7	5.9	12.3	13.1	3.9	7.9	7.2	4.2	17.8	6.0	7.4	2.7	5.5	4.9	5.3	7.6	4.5	6.2	37.2	10.7	2.8	11.8	2.2	4.1	7.3	5.5	8.2	5.6	9.7	4.7	9.5	14.3	15.0	4.1	11.4	8.8	6.7	4.1	5.9	6.8	2.2	14.1	10.3	13.4	11.9	5.0	7.8	5.5	3.2	3.7	4.0	14.5	4.0	10.0	11.6	9.0	8.9	8.8	17.0	8.9	12.3	7.0	4.0	12.0	2.0	9.8	7.9	1.7	12.2	3.9	8.8	6.1	2.7	6.5	2.8	21.8	6.6	3.7	4.9	14.9	9.2	2.9	6.1	13.9	6.2	10.2	10.2	7.1	37.1	5.4	2.9	7.1	4.5	7.9	6.7	4.3	5.7	2.6	3.2	2.9	3.0	1.9	5.0	2.5	2.9	3.5	3.8	1.2	2.0	2.0	4.4	8.0	1.4	1.1	1.7	8.0	8.9	4.3	11.8	11.6	14.3	10.0	9.2	7.9	7.6	10.7	8.2	7.6	9.6	16.0	7.5	8.5	11.2	21.5	6.5	4.0	3.9	11.9	9.8	7.8	8.6	8.0	7.3	39.6	3.1	7.1	5.2	9.8	7.7	170.5	53.1	21.9	8.5	3.0	2.1	33.3	6.7	3.3	13.0	7.7	15.4	13.9	7.8	9.3	4.8	5.0	1.7	27.3	3.1	12.2	7.2	9.9	63.2	8.7	8.8	7.2	7.5	7.3	7.4	2.1	4.5	2.9	5.7	4.9	10.5	4.7	10.6	5.8	14.8	61.6	22.4	13.1	16.6	9.0	55.5	17.3	4.7	15.3	5.5	9.1	14.5	3.9	11.5
ANKRD46		ENSG00000186106	"Ankyrin repeat domain 46"	Q86W74	8	100509752-100559784	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013758	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA013758: AB_10962626"	"unprognostic (3.71e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.08e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-3)"	19.2	38.7	29.1	8.4	30.2	2.2	14.6	25.1	33.6	15.1	15.6	9.2	10.2	12.7	16.3	12.7	11.4	7.7	20.1	30.1	25.8	32.7	41.6	10.7	9.9	22.3	22.2	22.6	18.5	16.1	10.3	20.8	24.4	13.5	9.1	35.2	17.1	13.2	62.2	11.2	11.0	12.4	24.9	11.1	11.6	8.3	24.0	15.4	20.0	36.2	10.9	9.5	9.9	28.7	10.0	12.2	17.9	10.1	13.6	8.0	20.0	12.8	5.8	9.6	8.1	17.8	5.9	31.2	23.3	4.4	3.1	7.5	18.5	9.5	10.1	11.2	16.3	39.0	6.4	14.1	7.7	9.3	4.7	5.8	17.1	6.1	10.2	10.3	11.9	21.4	20.8	9.9	9.3	11.4	43.3	16.8	13.1	25.6	9.0	33.1	6.0	21.0	14.1	10.6	19.8	20.1	5.5	9.9	8.5	21.5	14.8	15.7	9.0	4.4	4.9	6.5	5.1	23.0	23.8	25.7	4.8	29.6	7.2	16.4	7.3	7.6	14.4	3.7	17.1	12.7	13.5	12.4	9.6	11.1	17.5	15.2	1.8	16.9	6.8	8.8	13.8	10.9	29.1	30.2	25.1	33.6	30.1	25.8	22.3	22.2	24.4	24.9	24.0	28.7	11.5	6.4	3.9	17.9	14.2	10.8	11.3	9.0	19.4	30.1	10.7	7.4	13.1	12.8	4.8	22.0	18.8	32.1	12.2	5.7	29.4	8.3	1.2	4.6	6.7	12.5	7.3	12.2	41.5	6.0	14.1	11.9	9.7	4.7	4.5	13.8	21.8	34.6	11.4	67.3	36.9	7.6	2.0	6.7	9.3	2.2	21.1	4.0	10.6	24.4	8.1	46.4	10.3	24.1	23.4	3.3	9.1	26.4	13.8	10.5	20.3	61.8	6.5	31.5	26.3	15.1	12.8	14.4	17.2	13.9	14.2	23.4	9.3	11.9	8.5	9.6
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664048-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 56.8;HUVEC TERT2: 58.2;TIME: 147.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	6.0	2.6	3.2	4.2	4.5	4.5	5.7	1.3	3.1	11.4	2.6	4.7	3.1	7.6	2.5	6.4	2.8	8.5	5.0	3.7	6.2	4.4	5.8	9.6	2.3	4.3	4.2	6.5	3.3	5.7	1.0	14.8	3.8	8.9	5.6	1.8	3.9	6.2	1.4	11.0	3.9	8.9	2.1	3.1	7.4	15.1	7.2	4.6	7.4	3.6	1.9	14.2	5.6	2.0	6.3	11.6	32.0	14.9	25.0	15.8	3.2	15.9	13.4	8.1	5.2	5.0	8.1	0.0	4.8	22.8	7.3	5.7	21.3	12.3	14.1	0.0	4.6	5.3	15.3	5.0	17.8	8.8	6.6	16.0	16.4	12.8	56.8	15.2	58.2	5.7	9.6	11.0	15.5	14.3	11.1	3.2	6.7	9.2	16.9	9.0	9.9	1.4	10.2	25.7	9.2	11.5	11.0	6.9	12.9	13.3	7.4	7.4	147.7	17.1	13.3	8.5	13.8	8.0	0.1	2.1	7.8	3.7	20.0	0.0	0.5	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.0	0.1	3.2	4.5	1.3	3.1	3.7	6.2	4.3	4.2	3.8	2.1	7.2	2.0	18.3	32.1	24.6	10.7	0.9	40.4	21.7	17.9	24.5	2.8	12.2	7.1	9.0	12.8	12.5	5.5	0.0	2.9	2.7	7.3	0.0	9.3	41.0	6.6	14.2	21.5	8.4	5.0	15.1	20.1	29.0	16.5	11.7	7.7	5.1	20.4	29.6	8.8	5.3	21.9	42.2	3.7	18.3	13.4	13.0	55.6	6.8	12.6	10.6	30.9	12.8	2.7	0.0	30.7	13.4	15.1	2.8	12.0	0.6	11.7	3.7	4.7	11.0	0.9	0.0	10.9	17.5	17.2	11.2	33.0	30.7	4.1	1.2	33.7	5.3	18.0
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099680-56233330	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.3;liver: 3.1;lymphoid tissue: 3.6;testis: 9.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 161.3;Hepatic stellate cells: 41.7;Inhibitory neurons: 103.5;Late spermatids: 29.1;Spermatocytes: 59.3"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 22.9;eosinophil: 20.7;naive CD4 T-cell: 19.8"	"Group enriched"	"Detected in many"	74	"granulocytes: 22.9;T-cells: 19.8"	"Group enriched"	"Detected in some"	6	"HEL: 34.4;HMC-1: 17.1;NB-4: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA051049: AB_2681326, HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.4	0.1	2.2	0.7	3.0	0.7	0.1	0.0	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.1	0.9	8.3	0.4	3.1	0.3	3.6	4.1	4.6	0.1	0.0	0.0	0.2	0.6	5.2	0.0	0.2	0.4	1.0	0.0	0.0	0.4	1.3	0.1	3.3	1.6	0.3	9.8	7.8	3.2	0.2	0.0	2.0	0.3	0.1	0.9	0.2	0.3	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.2	1.3	0.0	1.6	17.1	0.0	0.1	0.0	0.0	0.1	4.2	0.1	2.9	1.1	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	1.7	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	2.0	0.4	22.9	0.2	20.7	0.1	0.1	0.0	0.0	4.3	0.0	0.1	0.0	19.8	0.8	2.0	0.0	0.1	0.0	1.0	2.8	2.2	3.0	0.0	2.4	0.9	8.3	4.1	4.6	5.2	3.3	7.8	0.9	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	161.3	0.4	0.8	2.2	0.0	0.0	1.3	0.2	0.3	0.6	0.5	7.5	2.5	0.1	41.7	0.6	0.7	0.0	103.5	0.0	0.0	3.2	1.9	29.1	0.6	1.4	1.8	1.0	0.9	0.9	3.1	18.6	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	59.3	0.6	0.0	0.0	1.2	3.9	0.5	0.0	0.2
ANKS1A	"ANKS1, KIAA0229"	ENSG00000064999	"Ankyrin repeat and sterile alpha motif domain containing 1A"	Q92625	6	34889255-35091406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.0;Inhibitory neurons: 160.5;Microglial cells: 168.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036768, HPA036769"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		17000	"Cluster 14: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA036768: AB_10670923, HPA036769: AB_10672473"	"unprognostic (3.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.79e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (1.18e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.80e-2)"	15.0	19.1	15.2	8.0	13.9	5.7	15.0	16.4	15.8	10.9	13.8	29.0	10.5	10.7	7.4	15.4	20.1	10.0	18.6	12.7	13.4	13.1	10.7	18.8	9.3	15.6	17.0	17.4	9.4	16.4	8.4	27.8	17.4	11.7	9.0	22.9	9.2	15.4	20.1	15.6	14.3	14.3	14.0	23.0	14.8	16.5	22.1	7.6	13.8	9.5	5.7	27.2	13.1	11.9	15.4	7.3	14.8	14.2	6.5	6.4	22.3	6.0	6.7	7.2	8.7	18.4	9.7	10.4	10.0	6.4	13.1	15.7	17.4	17.6	8.3	8.0	21.9	7.3	9.2	13.7	4.0	11.8	6.7	7.4	14.9	9.3	12.3	7.7	15.9	10.7	12.6	4.4	6.4	10.0	7.4	12.8	10.7	20.3	8.4	8.9	8.3	10.6	14.5	27.9	58.5	14.8	10.3	14.1	43.7	18.1	11.1	13.0	13.9	7.3	9.2	7.6	8.9	6.7	10.9	5.5	5.6	16.8	20.3	0.0	0.6	0.5	0.2	0.9	0.4	0.4	0.2	0.4	0.5	0.1	0.3	0.2	1.1	0.2	1.5	1.1	0.3	0.4	15.2	13.9	16.4	15.8	12.7	13.4	15.6	17.0	17.4	14.0	22.1	11.9	48.2	80.1	11.4	54.2	4.4	12.1	9.1	4.2	4.0	28.8	11.3	14.4	25.3	11.5	8.3	12.9	64.6	8.9	5.5	17.2	0.0	7.3	12.7	32.1	7.4	31.7	13.2	5.7	94.0	5.9	7.5	10.0	13.3	35.6	2.5	17.2	47.5	6.6	11.9	8.4	160.5	11.0	18.3	29.2	10.9	11.3	12.8	18.9	5.4	168.6	8.1	21.7	10.3	90.5	75.9	10.2	7.6	30.1	6.4	13.3	10.0	7.0	29.0	45.4	19.7	10.3	13.5	6.9	5.9	8.5	20.5	12.4	4.8	5.9	9.2	14.9
ANKS3	"FLJ32345, FLJ32767, KIAA1977"	ENSG00000168096	"Ankyrin repeat and sterile alpha motif domain containing 3"	Q6ZW76	16	4696510-4734378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Rod photoreceptor cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041409, HPA041482"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA041409: AB_10794375, HPA041482: AB_10795594"	"unprognostic (3.02e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-3)"	5.1	4.9	5.5	2.4	5.6	1.9	4.6	6.1	7.9	7.3	5.3	8.7	2.6	6.3	1.5	3.9	6.8	2.9	4.9	5.3	5.7	7.9	5.0	4.6	3.0	5.4	5.4	8.7	5.5	2.8	7.2	2.4	5.7	6.9	1.2	2.5	6.5	4.0	6.5	4.3	4.1	2.8	5.1	4.3	4.9	5.0	5.5	2.0	6.2	3.3	2.0	6.9	5.7	6.0	2.5	29.4	3.7	8.3	7.1	5.8	8.6	11.0	8.9	10.0	8.9	15.3	6.1	5.5	13.4	7.4	3.9	4.9	8.2	6.0	4.4	7.2	15.6	5.2	14.6	3.8	7.7	2.8	4.3	3.7	6.2	9.6	9.2	6.0	1.9	3.6	12.4	1.7	5.9	9.3	5.5	10.3	10.0	3.7	5.4	8.6	9.3	10.0	7.6	3.1	12.1	11.6	5.7	8.3	4.7	2.1	8.2	3.6	3.4	7.3	9.9	13.7	5.7	8.6	16.4	8.6	4.0	2.8	8.5	0.0	0.4	0.0	0.8	0.5	1.2	1.2	1.0	0.7	0.8	1.3	1.5	0.9	0.0	0.6	0.6	2.2	0.7	0.5	5.5	5.6	6.1	7.9	5.3	5.7	5.4	5.4	5.7	5.1	5.5	6.0	9.0	6.4	14.3	18.3	9.9	7.6	13.2	12.9	8.0	42.9	11.6	11.0	4.9	14.3	11.7	22.0	110.5	12.6	9.9	9.8	19.6	16.5	6.1	10.1	15.1	9.4	9.0	5.5	28.8	8.6	8.5	13.1	13.7	6.8	0.0	21.4	14.6	8.1	8.1	50.5	27.7	13.6	14.2	4.4	4.3	6.4	27.1	4.9	10.6	6.5	12.5	12.5	20.6	17.1	21.2	13.3	13.3	28.2	7.5	16.1	8.8	16.1	15.1	92.2	6.6	13.8	12.3	29.1	25.4	6.0	9.7	6.7	10.6	19.1	12.8	6.2
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233699-21253850	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 12.3;kidney: 5.9;liver: 13.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 63.4;Enteroendocrine cells: 25.1;Hepatocytes: 28.0;Intestinal goblet cells: 40.0;Paneth cells: 38.2;Proximal enterocytes: 113.0;Proximal tubular cells: 37.5;Undifferentiated cells: 24.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Region enriched"	"Detected in single"	8	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HDLM-2: 3.4;Hep G2: 8.2;OE19: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.0	0.0	0.1	0.6	0.2	0.1	0.0	2.1	0.2	0.0	0.0	8.9	9.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	5.9	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	7.1	0.2	0.0	0.0	0.7	0.1	12.3	0.2	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.8	2.8	0.6	1.8	0.0	0.0	0.0	63.4	0.0	0.2	0.8	0.3	0.1	0.3	25.1	0.0	1.3	1.7	0.0	0.2	0.0	0.1	1.3	0.0	0.4	28.0	0.0	0.0	0.2	40.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.3	38.2	0.0	0.0	0.5	113.0	37.5	0.0	0.3	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.1	0.6	0.0	24.7	0.4
ANKS6	"ANKRD14, FLJ36928, NPHP16, SAMD6"	ENSG00000165138	"Ankyrin repeat and sterile alpha motif domain containing 6"	Q68DC2	9	98731329-98796965	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.8;Inhibitory neurons: 48.6;Oligodendrocytes: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA008355	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA008355: AB_2058277"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.31e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.94e-2)"	"prognostic favorable (3.44e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.68e-1)"	5.7	4.8	8.0	3.2	8.8	1.5	4.7	14.3	10.0	9.5	7.6	10.5	4.2	8.9	4.9	8.7	10.2	3.3	3.9	8.1	7.7	9.4	2.7	6.6	2.4	12.5	8.9	10.3	12.8	5.5	4.8	2.0	12.4	5.5	4.9	2.2	5.4	2.3	3.7	5.3	7.7	4.9	8.2	3.2	11.5	5.7	10.1	2.6	13.6	1.0	2.9	8.7	5.2	9.7	8.2	12.3	10.9	19.3	9.0	7.3	7.4	5.9	10.0	6.5	7.7	6.7	5.8	15.2	4.4	8.4	9.2	23.9	8.1	9.9	3.4	21.2	8.3	3.6	7.7	2.9	8.8	2.0	2.3	8.9	12.0	8.7	8.9	7.9	7.4	13.8	26.0	3.5	5.0	13.5	0.9	3.9	17.3	36.3	12.2	10.2	26.8	1.2	11.7	5.1	7.1	8.1	2.5	14.2	6.7	8.8	0.0	4.1	7.6	6.5	7.2	18.4	5.8	6.8	12.1	2.4	9.4	6.8	9.8	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	8.0	8.8	14.3	10.0	8.1	7.7	12.5	8.9	12.4	8.2	10.1	9.7	3.5	6.4	10.5	16.0	2.4	1.8	0.9	8.2	5.2	12.0	1.5	2.2	4.4	10.0	7.7	12.9	8.4	3.1	1.5	5.1	3.9	4.2	3.0	3.7	5.3	3.2	4.9	0.8	52.8	8.9	2.7	4.9	7.7	3.9	1.3	6.2	1.8	1.7	1.9	0.0	48.6	7.1	0.0	1.3	0.9	5.8	2.8	0.9	0.0	9.4	0.7	1.9	2.1	14.1	54.2	9.3	3.1	4.5	1.4	3.9	4.8	5.9	11.1	0.8	0.0	2.7	3.2	3.8	5.9	5.6	1.1	1.1	2.4	6.2	10.4	2.9
ANKZF1	"FLJ10415, Vms1, ZNF744"	ENSG00000163516	"Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1"	Q9H8Y5	2	219229783-219236679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035208	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035208: AB_10602229"	"unprognostic (5.23e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.27e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (3.87e-2)"	"unprognostic (9.68e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-3)"	9.1	9.2	7.8	8.8	8.6	7.8	10.8	9.9	9.8	13.8	9.6	13.1	9.6	10.1	3.2	15.2	13.5	6.1	14.1	7.9	8.0	13.9	14.4	10.7	13.7	10.1	8.5	16.0	15.6	6.4	12.5	5.9	9.3	15.1	5.2	8.2	15.3	5.6	16.9	17.3	15.2	4.6	7.9	18.1	14.2	7.9	8.7	11.9	11.9	8.1	8.3	12.4	15.0	10.5	31.6	6.1	8.1	11.8	10.6	8.8	32.5	10.1	10.0	13.6	17.2	14.9	13.2	6.6	18.0	4.3	15.3	22.7	10.5	17.5	10.0	13.9	11.0	14.6	19.1	13.9	10.6	9.6	13.7	8.9	33.1	10.1	15.9	22.6	9.4	17.0	24.8	14.9	6.9	13.6	14.1	24.1	13.5	13.7	10.9	14.3	9.9	21.4	7.6	7.9	10.3	10.5	11.9	23.9	19.8	19.5	6.4	23.7	10.3	11.4	8.7	10.1	13.3	31.6	19.9	12.9	19.4	13.8	5.1	9.9	9.1	11.0	16.1	9.0	17.4	13.0	16.3	16.2	9.4	13.3	19.0	18.0	12.3	24.4	14.0	9.8	17.1	13.6	7.8	8.6	9.9	9.8	7.9	8.0	10.1	8.5	9.3	7.9	8.7	10.5	10.2	16.0	17.2	24.2	28.0	9.3	14.5	28.9	9.6	39.8	14.4	13.6	9.2	11.5	24.8	12.9	31.3	10.5	32.7	17.3	13.7	20.5	4.4	28.2	9.7	11.8	9.6	19.6	19.0	12.6	27.2	8.9	17.9	13.0	21.6	21.4	8.6	13.1	7.7	32.0	21.0	19.1	20.3	8.2	5.3	4.0	23.9	10.9	10.6	6.5	15.6	18.0	43.3	13.6	25.3	14.2	16.0	16.6	17.7	13.6	25.2	16.5	65.1	55.4	6.6	13.2	12.8	10.1	17.0	8.3	9.9	11.6	30.0	21.3	17.6	11.1
ANTKMT	"C16orf24, FAM173A, MGC2494"	ENSG00000103254	"Adenine nucleotide translocase lysine methyltransferase"	Q9BQD7	16	720581-722590	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.1;Cytotrophoblasts: 46.0;dendritic cells: 14.9;Extravillous trophoblasts: 37.4;Hofbauer cells: 88.4;Syncytiotrophoblasts: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 74.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046262	Approved		Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046262: AB_10963070"	"unprognostic (3.94e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.88e-4)"	"unprognostic (2.11e-1)"	"unprognostic (4.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.24e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.28e-2)"	"unprognostic (3.60e-3)"	14.8	22.6	23.2	4.1	23.5	3.7	13.0	22.9	38.1	11.6	21.3	18.9	9.9	14.0	0.3	14.8	11.4	1.0	26.1	22.8	22.4	30.5	37.5	13.0	3.6	26.7	24.9	8.4	23.2	3.0	27.9	2.2	22.5	16.1	1.0	1.8	13.8	3.4	21.5	10.5	18.1	1.3	23.1	23.1	20.9	23.5	23.6	2.7	17.4	3.3	1.5	15.5	11.1	25.3	15.9	10.5	1.7	5.2	0.4	0.8	24.7	14.9	3.3	3.2	3.5	9.4	13.0	21.0	24.2	1.6	5.2	24.7	1.7	5.6	0.8	44.5	27.1	8.4	10.4	10.1	4.1	15.4	10.9	2.0	4.2	1.3	3.3	6.0	1.2	12.8	18.3	8.5	2.5	22.8	1.9	32.6	7.8	7.8	31.8	8.3	5.0	37.3	7.8	4.5	7.8	21.6	7.4	12.2	24.6	1.1	12.5	12.6	12.1	2.6	23.2	8.7	10.3	74.0	36.0	23.1	6.2	9.8	7.1	0.1	11.5	9.6	12.0	7.2	25.0	17.5	8.7	19.6	7.3	21.4	9.0	26.7	1.3	11.6	8.2	10.0	23.3	6.9	23.2	23.5	22.9	38.1	22.8	22.4	26.7	24.9	22.5	23.1	23.6	25.3	7.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	46.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	37.4	8.3	0.0	0.0	0.0	0.0	0.0	0.0	88.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	25.6	1.5	0.0	0.0	0.0
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2185.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5755.6;Pancreatic endocrine cells: 5217.8;Prostatic glandular cells: 4575.5;Urothelial cells: 4326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 4429.7;classical monocyte: 2762.3;intermediate monocyte: 2401.9;myeloid DC: 4018.8;non-classical monocyte: 2686.5;T-reg: 1681.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 174.7"	"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		19000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	975.6	370.5	49.0	461.9	50.5	151.7	708.5	49.6	96.9	806.3	95.6	631.2	502.0	296.2	267.2	2185.3	388.4	453.9	393.0	47.6	79.4	358.3	185.5	878.3	200.7	90.0	83.6	187.0	324.3	344.0	163.9	650.4	84.9	399.3	606.1	30.2	933.4	386.4	304.8	1140.8	487.5	425.4	73.3	301.6	379.0	116.1	120.9	188.7	351.2	205.8	541.1	842.2	1256.7	80.1	4183.3	4421.4	223.6	105.5	2962.4	4744.2	971.0	4703.6	2968.4	2868.4	2534.9	2083.5	1903.6	10.0	3907.2	5983.6	2185.1	4304.9	992.9	8695.5	3113.5	846.8	103.9	78.2	1918.7	882.7	1782.0	4.5	59.9	2324.4	2278.6	2013.2	4335.0	3477.2	5455.0	58.4	320.9	447.9	6271.8	468.4	18.5	239.1	508.2	3444.1	3283.5	48.9	1198.8	226.6	5172.4	2410.7	295.1	171.9	1774.5	424.8	1942.8	2305.1	922.7	173.6	6336.8	2534.1	3406.8	8668.0	4807.4	172.6	616.3	83.8	2449.2	47.9	5206.0	4429.7	2762.3	355.0	603.8	2401.9	668.5	657.9	686.4	701.7	4018.8	412.1	77.0	313.9	73.6	287.1	2686.5	609.4	1681.4	3754.4	49.0	50.5	49.6	96.9	47.6	79.4	90.0	83.6	84.9	73.3	120.9	80.1	673.9	2141.0	414.8	0.3	101.3	2512.2	3396.9	5755.6	246.4	2.5	395.9	337.4	28.2	773.5	3086.6	560.9	0.0	1874.5	135.9	933.6	13.7	3941.4	93.0	855.9	457.1	772.0	103.4	38.7	0.2	2411.4	2714.4	1076.7	328.7	1376.3	105.7	97.5	474.0	64.2	1537.2	0.0	1.3	689.0	1668.2	429.6	1992.1	126.6	771.1	715.1	1417.6	15.9	1284.0	19.4	138.0	1.5	0.1	5217.8	920.9	638.7	144.5	4575.5	845.8	51.8	2446.8	8.1	184.1	437.7	831.1	13.0	29.3	789.7	2325.1	1150.1	224.1	8.6	749.9	4326.1
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039233-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5"	"Group enriched"	"Detected in all"	6	"B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3"	"Cell line enhanced"	"Detected in many"		"HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	4.7	1.3	3.2	12.1	3.2	19.8	3.9	3.0	3.8	3.5	3.5	2.5	3.3	2.4	1.7	1.8	3.3	3.5	2.9	2.8	2.9	2.0	1.3	4.6	26.1	3.4	3.3	1.2	0.8	0.6	1.1	3.2	3.2	2.7	2.7	0.1	1.7	1.2	2.5	2.1	8.2	2.1	3.5	15.8	3.3	1.5	3.3	25.2	2.7	3.0	17.2	3.2	3.8	4.0	2.1	2.1	1.6	1.2	2.6	8.0	0.4	0.5	0.3	0.5	0.6	3.9	1.9	6.8	6.5	1.6	2.2	0.8	5.0	0.5	0.5	13.3	4.0	2.2	5.9	1.8	4.1	2.6	0.8	27.7	0.2	2.4	0.2	0.1	16.2	33.1	1.5	8.9	2.1	3.1	30.0	4.1	0.0	1.7	14.8	30.9	3.6	3.9	0.7	1.1	5.7	0.0	2.7	0.7	0.7	0.2	0.7	4.9	9.9	0.5	0.0	0.8	2.5	4.4	6.7	3.3	3.6	117.7	1.4	5.6	3.5	1.7	53.9	2.5	63.5	34.3	56.1	59.9	3.5	32.9	96.3	72.1	3.2	24.8	8.1	5.2	66.5	26.6	3.2	3.2	3.0	3.8	2.8	2.9	3.4	3.3	3.2	3.5	3.3	4.0	32.2	0.0	9.9	0.0	23.8	3.7	1.4	0.3	2.2	0.1	1.9	2.2	1.3	4.3	1.5	0.0	0.0	0.4	36.4	0.5	0.0	0.1	4.0	1.1	5.0	24.8	1.8	8.2	0.0	0.0	1.1	7.2	1.5	0.8	15.2	4.1	38.2	1.4	8.7	0.0	0.0	0.1	2.0	18.2	5.6	1.5	1.5	7.5	7.2	0.0	7.1	0.2	47.4	0.0	0.0	0.1	0.0	0.4	7.8	1.2	1.0	0.4	2.0	0.0	0.0	3.4	3.7	0.7	1.6	1.2	2.3	0.4	66.0	0.3	0.5	1.4
ANXA4	ANX4	ENSG00000196975	"Annexin A4"	P09525	2	69644425-69827112	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 569.9;pancreas: 356.8"	"Cell type enhanced"	"Detected in all"		"Cholangiocytes: 2344.8;Ductal cells: 1469.8;Proximal enterocytes: 657.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 414.2;Hep G2: 456.9;RPTEC TERT1: 623.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005076, HPA007393, CAB017560"	Enhanced		Approved	Cytosol		NA	NA		550000	"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168"	"prognostic unfavorable (8.55e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (7.23e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.97e-2)"	48.2	21.6	14.5	33.6	15.4	30.8	45.9	14.9	18.9	62.4	52.4	101.7	271.3	50.9	30.3	43.0	68.6	569.9	26.1	14.4	15.2	104.0	120.9	81.6	21.1	15.6	15.1	38.8	356.8	78.0	11.9	52.7	15.8	46.3	92.3	30.0	39.2	52.1	17.2	61.0	232.4	52.0	15.7	24.2	108.2	9.7	15.2	23.0	43.6	20.4	24.0	61.3	50.2	16.6	69.6	249.4	3.4	31.0	185.0	158.3	11.3	66.0	101.5	27.1	38.0	37.9	121.7	22.8	414.2	109.5	78.9	104.7	23.8	108.1	27.6	65.2	20.3	35.0	20.5	456.9	131.2	12.5	43.0	95.9	104.8	36.5	87.3	62.9	71.1	11.0	2.0	20.1	74.7	63.8	18.3	22.8	6.1	280.0	34.3	19.4	6.8	28.3	623.2	99.1	5.1	22.9	72.9	99.5	103.8	35.6	33.3	156.3	100.9	49.2	23.8	65.5	37.7	8.2	9.7	1.3	75.8	59.7	34.1	80.4	34.7	29.6	23.1	42.5	17.5	40.6	11.7	17.5	50.6	46.7	2.0	12.5	4.9	9.5	58.7	15.5	14.5	24.2	14.5	15.4	14.9	18.9	14.4	15.2	15.6	15.1	15.8	15.7	15.2	16.6	66.4	205.1	154.8	47.3	27.3	74.2	98.5	148.2	68.9	8.2	36.8	36.4	10.6	2344.8	139.4	84.6	6.2	86.4	27.2	315.1	221.1	1469.8	14.6	257.9	79.0	49.1	18.6	12.6	29.9	344.4	370.1	103.6	196.7	488.8	111.5	24.3	33.9	68.5	227.6	8.4	17.7	193.8	240.1	46.1	80.4	11.2	64.7	54.5	92.5	63.7	87.2	48.7	45.3	17.6	106.0	245.7	268.6	92.2	6.9	55.6	657.1	400.4	230.2	59.9	6.6	27.6	64.6	15.8	3.7	61.3	79.6	439.6	32.5	19.1	174.1	96.9
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100706-151157785	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 343.8;monocytes: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 861.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		1800000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	292.9	135.4	98.1	164.2	104.1	109.7	188.3	94.0	150.6	148.9	151.8	196.0	44.5	181.5	105.0	94.7	149.9	108.7	188.7	102.5	123.1	82.6	214.4	131.6	161.8	144.2	109.4	181.7	78.3	29.6	161.9	141.1	146.2	124.9	78.2	133.6	70.3	208.6	331.3	62.7	119.9	300.1	92.3	150.9	111.4	52.5	127.4	160.8	86.7	371.5	176.4	206.5	107.4	104.8	3.0	30.4	212.8	317.1	861.2	417.8	55.1	397.4	526.4	323.5	477.6	106.7	15.6	26.9	138.5	578.6	268.1	0.5	165.9	200.2	300.3	110.5	52.1	15.3	62.1	204.7	295.0	97.6	94.7	508.6	1.5	282.3	42.0	476.9	420.6	197.5	22.0	396.1	737.6	100.4	181.8	151.7	56.2	1.2	92.4	120.4	592.9	31.0	42.2	0.3	12.2	49.3	39.9	282.7	175.6	308.4	488.3	201.1	326.8	296.6	84.2	19.4	107.1	205.4	289.5	4.5	154.5	459.7	46.2	89.7	89.4	82.9	290.4	54.7	190.4	175.4	213.4	263.3	118.3	179.0	145.8	181.6	17.6	261.9	25.0	30.2	190.9	331.7	98.1	104.1	94.0	150.6	102.5	123.1	144.2	109.4	146.2	92.3	127.4	104.8	90.3	16.0	17.3	19.2	146.8	11.0	11.5	2.2	1.8	16.5	30.7	24.0	59.5	12.8	1.1	23.9	6.2	64.3	110.3	0.3	25.4	6.5	56.9	1.8	38.5	45.6	21.4	36.4	36.5	17.8	33.7	105.9	9.2	1.7	57.5	343.8	57.1	147.1	85.4	15.2	36.3	2.4	0.0	41.0	77.8	46.8	123.3	41.2	55.2	10.3	445.2	45.6	187.4	18.6	5.6	12.1	1.2	211.4	120.3	7.3	1.0	48.4	4.7	125.8	230.1	55.3	150.6	2.5	1.5	0.6	8.1	177.2	143.4	149.4	2.5	1.5
ANXA9	ANX31	ENSG00000143412	"Annexin A9"	O76027	1	150982249-150995634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 61.5;Collecting duct cells: 12.9;Ductal cells: 21.2;Hepatocytes: 17.4;Proximal tubular cells: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;granulocytes: 1.0;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.6;Hep G2: 42.3;MCF7: 59.2;OE19: 47.8;T-47d: 139.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028404, HPA028698"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Cytosol"		"HPA028404: AB_10599190, HPA028698: AB_10600227"	"unprognostic (4.06e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.93e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.74e-6)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.72e-2)"	3.2	3.7	2.6	2.6	7.1	2.4	6.9	6.1	3.5	2.2	3.3	2.1	4.6	6.4	5.9	26.2	4.7	9.2	6.0	1.7	3.5	22.0	29.9	3.1	2.3	9.0	6.7	4.7	35.8	19.2	1.2	1.0	7.9	2.4	0.3	7.2	7.5	21.2	3.8	32.4	4.2	2.9	4.5	2.8	4.2	3.8	5.3	0.5	25.0	0.2	23.2	6.3	6.0	12.1	11.7	2.8	4.2	4.4	0.0	0.0	11.4	1.0	0.8	0.1	0.0	33.9	40.6	0.4	2.5	0.0	1.3	6.8	0.0	0.8	0.1	3.9	4.4	6.1	4.7	42.3	0.0	2.4	2.6	0.0	0.3	0.1	0.2	9.5	0.0	1.8	3.0	13.2	0.1	59.2	0.5	3.2	1.1	47.8	0.8	2.8	0.6	15.0	0.1	17.0	6.4	3.6	2.6	28.8	1.7	2.3	139.9	3.7	4.7	0.9	1.3	0.7	0.8	4.0	13.0	18.8	6.2	4.2	3.3	0.0	1.2	0.7	0.0	0.7	0.3	0.2	0.1	0.2	1.6	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.4	2.6	7.1	6.1	3.5	1.7	3.5	9.0	6.7	7.9	4.5	5.3	12.1	0.1	0.0	1.1	0.3	0.2	0.1	0.4	0.8	0.0	0.0	4.5	2.5	0.4	61.5	4.5	12.9	0.0	2.0	0.1	0.0	3.9	21.2	1.5	1.3	0.8	0.1	0.0	0.0	0.2	7.5	0.3	0.6	0.0	1.6	1.3	0.0	0.0	17.4	2.2	0.0	0.2	0.0	0.0	0.6	0.4	0.9	1.5	1.4	1.8	0.0	0.2	0.0	0.0	1.0	0.5	2.9	0.1	1.2	0.0	0.3	0.3	44.6	2.5	0.0	0.0	0.1	0.3	4.9	0.2	0.3	0.0	1.5	0.2	0.0	0.3	5.4
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 422.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"ASC diff: 307.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	422.8	48.4	2.6	31.9	3.2	1.4	169.2	2.5	4.2	52.8	2.7	210.8	17.3	95.1	33.5	88.0	84.8	50.7	50.2	2.9	2.5	24.1	19.1	218.6	12.4	2.5	2.5	26.5	12.0	8.4	5.4	28.0	2.6	59.1	41.0	1.7	14.7	103.6	17.8	24.6	57.6	144.8	2.3	21.4	66.6	12.8	2.4	5.9	28.2	22.9	3.9	142.1	50.9	2.5	0.1	1.5	0.2	1.0	307.5	0.3	5.0	0.3	0.1	0.2	0.8	0.9	0.0	0.7	0.7	0.1	0.2	0.5	0.8	0.2	0.8	1.5	5.7	0.4	0.5	18.4	0.8	0.3	1.0	3.3	1.0	0.3	0.8	0.0	0.2	2.2	0.3	1.7	0.6	0.2	0.2	1.4	0.7	0.1	0.4	0.7	0.8	3.0	0.1	2.2	0.3	0.4	0.0	0.2	2.0	2.2	0.1	0.1	0.0	0.3	2.7	1.2	0.4	4.8	5.9	0.6	0.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	3.2	2.5	4.2	2.9	2.5	2.5	2.5	2.6	2.3	2.4	2.5	58.2	3.2	6.0	0.0	0.5	2.9	0.1	0.0	2.2	0.0	1.1	2.2	9.5	0.0	1.9	0.0	0.0	0.1	0.4	0.1	0.0	0.2	4.5	0.8	2.3	12.3	0.0	0.0	0.4	0.2	0.1	11.3	0.0	1.4	1.3	2.1	20.7	0.2	1.4	0.0	0.3	0.1	0.0	1.4	2.7	2.6	3.4	0.9	3.6	3.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	74.9	0.0	0.4	0.1	1.4	1.0	0.4	118.3	2.6	93.0	1.1	1.3	0.7	1.8	0.3	0.6	74.6	0.1	0.3
AP001273.2		ENSG00000284057	"Novel protein, C11orf54-MED17 readthrough"		11	93741664-93812378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"kidney: 9.5"	"Cell type enriched"	"Detected in single"	7	"Respiratory ciliated cells: 4.4"					"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA040511, HPA046619"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	Cytosol	"HPA040511: AB_10795369, HPA046619: "																		1.3	2.1	0.6	2.1	0.5	0.0	1.1	0.5	1.0	1.5	0.3	1.8	4.9	1.2	0.4	0.3	1.4	1.9	1.5	0.4	0.6	9.5	4.6	1.1	0.8	0.6	0.5	2.3	0.3	2.0	0.5	1.7	0.7	2.3	1.6	1.4	1.6	1.0	1.1	1.6	3.3	0.5	0.5	0.7	1.8	1.3	0.5	1.6	1.5	1.8	1.2	0.9	0.2	0.7	0.6	0.0	3.3	0.6	1.9	0.0	1.9	0.0	1.0	0.7	1.3	0.6	1.4	2.2	4.0	2.5	1.0	2.2	4.0	0.9	0.4	3.3	0.3	0.7	1.4	0.0	1.4	0.0	0.7	1.4	0.6	0.0	1.5	2.9	1.0	1.7	1.3	0.5	3.9	0.0	2.6	2.2	1.4	6.0	0.1	0.8	2.3	1.3	3.5	0.0	0.7	0.3	2.1	2.4	4.9	2.8	2.5	0.9	2.8	0.3	0.8	0.4	1.3	0.6	1.3	2.9	0.2	1.8	1.3	1.9	1.2	1.8	1.1	1.2	1.3	1.0	1.1	1.4	1.5	0.4	1.1	1.4	1.8	1.2	1.4	0.8	2.1	1.2	0.6	0.5	0.5	1.0	0.4	0.6	0.6	0.5	0.7	0.5	0.5	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP3B2	NAPTB	ENSG00000103723	"Adaptor related protein complex 3 subunit beta 2"	Q13367	15	82659281-82710112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.7;pituitary gland: 18.8;retina: 33.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 27.1;Excitatory neurons: 61.7;Inhibitory neurons: 56.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 22.8;Rod photoreceptor cells: 58.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.5;NTERA-2: 9.5;RT4: 17.3;SCLC-21H: 29.0;SH-SY5Y: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039467, HPA039818"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039467: AB_10795143, HPA039818: AB_10795299"	"unprognostic (3.17e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.48e-6)"	"unprognostic (8.44e-2)"	"unprognostic (7.62e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.43e-2)"	0.7	4.5	15.3	0.9	18.6	1.1	1.4	15.5	20.7	0.9	0.0	1.1	0.7	1.1	2.3	0.7	0.9	0.4	0.2	19.6	5.5	0.6	0.2	0.3	0.5	15.6	5.4	1.2	2.1	12.7	18.8	0.6	13.2	1.4	0.6	33.0	0.9	1.4	0.3	0.9	0.9	1.3	1.1	0.7	1.1	6.2	4.7	1.0	2.1	0.4	1.3	0.8	0.6	11.3	0.2	0.4	9.5	3.2	1.6	0.2	5.7	0.5	0.0	0.8	0.2	0.4	0.4	0.8	4.9	0.2	1.8	0.9	1.0	0.0	0.2	3.2	0.7	0.3	0.4	0.2	0.3	0.4	1.8	1.0	1.1	0.1	0.7	0.1	0.0	2.8	1.0	0.7	0.1	2.5	0.3	0.5	9.5	0.1	0.1	0.3	0.0	0.2	0.0	17.3	29.0	17.5	3.2	1.4	2.4	1.0	0.2	1.9	0.2	0.3	0.9	0.4	1.3	1.6	8.8	0.7	2.2	0.5	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.3	0.2	0.9	0.1	0.1	0.4	0.0	0.1	15.3	18.6	15.5	20.7	19.6	5.5	15.6	5.4	13.2	1.1	4.7	11.3	0.1	0.0	1.1	20.9	0.1	0.4	2.1	0.6	1.2	18.4	1.5	2.3	0.8	0.0	0.1	0.0	27.1	0.1	0.2	0.1	0.0	0.2	8.0	0.2	0.6	0.1	13.9	0.0	61.7	0.4	0.1	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	13.5	56.9	0.5	6.1	0.0	0.6	5.4	0.9	0.1	0.0	4.7	0.0	4.1	0.0	44.7	22.8	0.0	0.1	0.4	1.2	0.7	0.0	0.4	0.0	58.6	0.0	1.3	0.7	9.8	3.1	0.7	0.1	0.0	0.1	0.2	0.0	0.6
AP3D1	ADTD	ENSG00000065000	"Adaptor related protein complex 3 subunit delta 1"	O14617	19	2100988-2164468	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074408			Approved	Cytosol		No	No		28000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA074408: AB_2686686"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (4.24e-2)"	"unprognostic (8.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.37e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (8.11e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.73e-2)"	30.0	40.7	39.0	36.3	39.0	27.6	28.8	29.4	55.1	29.5	39.4	36.2	35.8	35.1	16.6	38.2	32.5	28.0	43.7	45.0	39.8	35.8	40.9	31.1	37.2	39.4	43.3	29.8	63.9	40.0	56.4	33.4	48.0	31.3	22.5	29.6	48.0	34.0	61.1	30.0	35.4	32.8	26.0	34.8	37.7	44.9	38.9	33.2	43.9	40.3	27.6	34.3	25.5	34.5	114.8	117.5	68.5	105.0	85.7	71.8	83.9	90.3	87.9	94.2	85.2	134.8	61.8	61.7	51.0	134.1	115.7	76.4	99.2	109.7	61.1	89.9	94.6	80.5	74.7	106.3	149.9	88.4	102.5	89.5	72.3	98.1	141.6	79.7	92.6	44.2	84.2	210.9	84.1	84.4	85.6	46.8	102.8	78.2	74.2	90.3	75.0	83.4	70.7	162.7	97.4	81.1	82.3	85.7	154.2	62.5	83.2	101.0	121.7	89.7	37.7	123.4	106.7	176.5	184.6	78.6	122.5	57.4	91.5	0.2	3.3	2.9	3.5	3.6	5.6	2.4	3.4	4.1	3.9	2.9	2.7	3.4	3.4	5.5	3.0	7.5	2.1	2.2	39.0	39.0	29.4	55.1	45.0	39.8	39.4	43.3	48.0	26.0	38.9	34.5	29.5	60.9	61.7	41.4	35.5	20.3	41.3	20.3	36.5	66.6	39.5	26.5	77.7	44.3	34.1	40.5	35.5	55.3	32.5	79.5	21.5	53.3	70.7	34.4	36.9	37.1	47.8	42.9	24.1	74.2	71.9	38.2	69.8	48.9	17.1	38.9	29.6	49.2	66.9	48.8	30.2	68.8	18.3	38.4	30.2	68.6	37.9	43.4	39.2	18.7	31.7	55.5	29.9	21.1	28.3	67.7	54.0	38.0	67.6	65.5	52.6	36.0	30.3	43.9	19.7	37.8	33.6	105.3	129.5	38.0	23.3	78.0	36.9	39.6	56.8	59.4
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916379	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		52000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	30.4	25.4	14.7	20.7	17.1	14.4	20.7	17.3	17.1	18.0	14.2	19.9	13.6	15.0	15.0	13.8	17.2	18.5	20.0	13.9	16.3	27.0	19.4	21.2	20.2	18.7	16.4	12.3	17.2	15.8	9.1	13.3	18.4	16.8	19.5	16.8	31.7	23.6	65.6	10.0	16.3	12.3	17.1	15.5	18.8	10.7	16.0	31.3	24.6	38.3	16.3	19.1	9.6	20.9	25.1	27.3	33.5	8.3	27.7	26.8	14.5	36.8	38.0	38.9	44.4	15.6	21.3	77.1	21.7	15.5	40.3	28.8	56.1	24.9	53.3	49.9	56.3	39.5	27.8	42.6	41.2	111.3	28.9	23.6	20.6	22.1	40.7	19.1	29.8	49.8	94.2	45.2	27.6	24.2	59.7	57.7	25.1	39.6	61.7	36.4	89.1	29.6	46.8	36.3	28.5	13.6	45.0	37.2	50.2	17.4	38.9	34.3	24.1	29.2	26.9	68.1	9.0	43.9	36.1	89.4	32.2	27.3	37.2	11.3	27.3	25.4	17.2	30.0	21.3	24.5	21.1	18.8	42.7	24.3	21.4	18.3	6.7	31.4	36.8	27.2	27.2	18.4	14.7	17.1	17.3	17.1	13.9	16.3	18.7	16.4	18.4	17.1	16.0	20.9	24.7	35.3	30.1	42.4	27.9	25.0	37.5	62.7	19.4	28.8	73.8	36.2	23.1	37.1	63.0	18.4	4.2	37.2	25.5	49.5	187.9	30.2	8.0	33.4	23.9	22.8	35.5	42.5	28.4	32.4	23.4	24.4	29.6	24.8	20.3	22.0	21.0	26.0	76.5	18.5	35.2	41.3	87.5	47.1	31.8	8.3	23.9	47.6	21.4	17.8	59.4	23.1	25.7	51.3	108.8	25.4	28.4	24.8	44.2	33.0	35.0	101.7	56.8	21.6	39.5	37.8	30.1	32.4	22.3	31.4	26.3	26.4	25.8	27.1	50.1	50.4
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837622	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 19248.5"	"Group enriched"	"Detected in many"	21	"Hepatocytes: 27332.1;Proximal enterocytes: 18348.1"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	17	"Hep G2: 3460.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1450000000000	110000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	3.2	1.4	1.2	3.6	1.2	0.0	2.1	1.1	1.4	0.8	0.8	7.4	1709.3	3.5	0.4	1.1	6.1	1.7	67.2	1.0	1.1	3.7	19248.5	2.7	3.2	1.1	1.1	23.1	2.5	0.0	4.2	1.6	1.1	1.1	0.2	0.1	0.7	1.0	0.8	1.0	4053.7	2.1	1.1	9.0	14.6	384.5	1.2	0.9	3.7	0.2	0.1	0.5	1.5	1.2	0.0	0.0	0.6	0.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	203.4	0.3	3.1	6.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	7.3	1.9	3460.4	0.0	16.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	0.3	15.0	1.2	1.2	0.1	0.5	15.0	20.3	0.0	2.6	5.7	20.7	8.9	0.0	0.0	3.9	0.0	0.1	2.6	0.0	0.4	2.1	0.1	1.2	0.2	4.9	0.0	5.5	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.5	0.0	0.2	0.0	1.2	0.6	0.1	1.2	1.2	1.1	1.4	1.0	1.1	1.1	1.1	1.1	1.1	1.2	1.2	2.0	3.2	3.3	0.3	49.7	0.1	0.5	0.2	0.6	0.5	0.9	0.9	37.0	479.0	1.3	0.0	0.0	0.6	5.1	0.4	0.0	0.1	36.9	15.2	4.3	50.3	1.8	541.9	0.5	1.1	4.2	5.8	17.9	1.7	2.5	419.2	458.7	27332.1	3.3	0.0	0.8	458.8	0.0	681.2	2.0	149.7	22.4	2.1	0.0	0.0	0.0	0.3	3.1	0.0	0.3	0.3	458.2	4.9	1.0	0.1	18348.1	9.0	0.4	0.6	6.6	1.6	13.0	39.8	11.2	0.0	0.6	4.2	35.7	1051.7	175.7	0.3
APOL6	"APOL-VI, APOLVI"	ENSG00000221963	"Apolipoprotein L6"	Q9BWW8	22	35648446-35668404	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.9;NK-cells: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB028574, HPA029165, HPA029167"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832"	"unprognostic (7.25e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.76e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (6.61e-4)"	23.4	7.3	4.1	15.8	4.3	16.1	10.0	3.4	4.0	6.8	3.3	13.2	19.2	5.5	5.5	5.9	6.6	9.1	4.2	3.9	5.1	6.4	46.5	15.5	15.5	8.7	5.0	12.2	2.9	2.6	2.4	7.8	5.8	7.9	11.8	2.6	14.0	5.1	3.1	4.5	19.7	7.4	6.7	18.2	14.0	2.3	4.9	10.1	8.5	3.9	10.4	13.2	3.7	5.4	12.8	4.1	0.3	1.5	30.1	15.0	17.3	5.3	14.2	17.3	21.7	2.0	14.2	17.7	2.6	14.0	12.6	16.2	0.1	8.6	4.5	33.6	0.1	7.4	2.6	4.0	23.7	10.4	12.4	19.3	5.7	5.9	3.3	3.9	3.6	8.0	0.8	31.2	3.2	1.3	14.6	3.2	0.5	0.9	5.3	6.1	6.8	8.7	7.6	28.9	0.4	0.2	8.5	7.2	10.0	1.1	1.2	12.1	3.9	4.3	2.6	3.0	2.8	16.4	14.2	1.7	8.1	16.2	6.1	7.5	4.8	2.6	7.3	7.6	6.1	1.0	4.8	5.8	2.4	0.7	4.6	5.3	7.5	5.0	8.5	0.3	5.5	4.2	4.1	4.3	3.4	4.0	3.9	5.1	8.7	5.0	5.8	6.7	4.9	5.4	58.6	70.5	34.3	6.8	15.7	8.0	10.8	14.7	13.6	0.2	16.8	10.8	7.3	34.3	38.6	12.9	0.0	8.3	79.1	101.1	9.8	33.6	10.5	18.4	48.9	33.4	47.3	11.6	0.2	41.9	35.6	33.4	41.8	17.2	36.8	12.2	39.3	135.9	34.9	0.0	1.3	55.3	20.3	58.1	19.9	7.4	26.1	50.5	8.8	17.8	68.5	3.8	126.7	9.5	2.1	45.7	43.7	18.8	51.0	43.2	88.6	31.6	47.4	0.0	0.0	25.3	22.0	0.5	0.2	15.6	5.3	2.5	67.7	6.0	35.9	62.0
APOO	"FAM121B, MGC4825, Mic23, MIC26, MICOS26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907938	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 180.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	9.0	23.7	55.8	9.0	58.0	7.9	13.3	58.1	76.3	13.1	67.8	17.3	14.4	10.6	19.6	12.6	20.8	9.3	65.1	57.9	58.4	46.5	18.2	8.6	11.7	58.8	57.0	9.4	14.2	62.0	29.2	10.9	57.3	13.7	18.8	52.8	19.7	15.0	45.9	7.7	12.0	12.0	57.0	8.4	17.7	16.8	56.8	14.0	20.3	73.2	11.6	11.2	8.1	57.1	36.5	32.7	53.9	37.8	8.8	19.9	8.3	17.9	21.9	37.4	38.8	19.3	17.0	31.5	21.9	16.5	48.5	29.3	68.5	35.7	41.2	33.4	48.7	15.9	28.6	31.1	20.8	40.9	17.1	22.2	20.7	41.2	30.4	20.1	26.6	38.8	22.9	33.2	35.1	34.6	41.2	43.0	49.2	47.5	52.7	31.5	26.6	75.6	74.1	18.4	36.4	26.5	39.0	36.7	39.7	52.4	63.6	17.9	6.5	23.9	14.6	86.6	27.9	26.3	50.5	28.7	38.5	19.8	35.8	14.8	4.8	1.4	12.6	15.9	16.6	10.8	13.7	12.5	14.0	10.2	10.9	10.7	3.0	10.3	16.0	16.6	14.0	7.7	55.8	58.0	58.1	76.3	57.9	58.4	58.8	57.0	57.3	57.0	56.8	57.1	7.4	16.0	11.5	61.7	11.8	14.0	17.0	74.3	11.4	20.4	14.3	17.0	61.8	21.5	28.3	23.9	14.6	17.2	11.3	12.8	180.0	28.4	25.9	56.0	13.0	10.1	7.2	20.8	61.4	16.0	8.9	11.7	13.3	24.4	3.8	14.2	7.9	13.9	22.7	20.2	76.5	17.0	44.7	14.6	12.0	15.7	11.5	9.9	28.4	74.0	34.2	50.0	8.2	43.7	76.5	10.2	20.0	15.8	14.8	14.1	24.0	80.6	106.9	32.4	6.6	10.8	22.3	26.1	53.2	18.9	7.0	12.4	9.5	17.0	22.3	16.8
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		36000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: AB_2686262"	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.41e-4)"	"unprognostic (7.56e-3)"	41.5	63.5	40.0	58.6	48.6	97.5	33.4	37.9	50.4	44.1	62.9	35.5	29.6	38.9	14.0	37.7	48.3	44.2	42.9	42.2	38.5	47.8	40.2	71.8	53.4	50.6	42.3	49.4	37.1	20.4	48.9	35.5	45.9	44.9	18.2	8.6	33.3	25.7	20.1	47.1	43.3	28.7	40.1	117.5	31.3	16.4	50.8	32.2	46.6	20.1	25.2	39.7	37.5	56.8	19.7	41.9	15.2	18.5	63.4	42.9	23.1	26.2	46.5	29.8	29.3	56.0	50.8	42.9	51.3	44.4	40.7	64.5	23.2	64.4	12.5	50.9	28.4	36.6	40.3	81.9	43.7	25.1	98.7	47.5	65.4	48.7	23.4	36.2	33.2	31.3	31.5	17.4	13.9	40.3	38.9	89.3	9.5	35.1	25.9	36.8	23.2	21.3	27.5	61.1	15.7	32.0	19.1	27.9	84.8	19.5	25.1	56.8	37.5	41.0	28.5	42.8	16.4	27.4	14.3	23.0	21.8	37.4	22.3	19.3	24.8	30.7	8.9	39.4	5.2	6.6	5.9	6.8	15.9	4.7	4.5	5.4	50.8	13.4	51.3	5.3	6.7	17.6	40.0	48.6	37.9	50.4	42.2	38.5	50.6	42.3	45.9	40.1	50.8	56.8	8.9	28.9	32.3	33.6	16.1	7.4	7.5	14.3	15.4	4.3	8.7	7.9	2.6	7.2	9.0	16.5	33.3	9.2	18.3	16.5	9.8	13.5	50.1	14.1	11.7	7.8	23.3	9.9	7.7	7.5	8.9	22.4	16.3	9.1	10.8	36.9	9.7	10.8	43.0	0.0	7.0	12.8	12.2	45.6	25.1	6.4	20.8	57.3	8.8	30.0	29.0	7.4	21.6	17.6	31.5	12.1	10.9	15.1	12.3	4.8	20.9	5.3	20.2	2.8	0.0	8.6	8.8	0.4	2.8	10.8	5.4	4.9	12.4	10.5	15.1	7.4
ARCN1	COPD	ENSG00000095139	"Archain 1"	P48444	11	118572390-118603033	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037573, HPA044874"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		140000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Golgi apparatus, Cytosol"	"HPA037573: AB_10696938, HPA044874: AB_2679126"	"unprognostic (1.46e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.56e-3)"	75.4	67.7	47.5	53.8	51.0	30.4	67.5	52.0	60.5	78.0	61.2	65.0	59.2	69.2	111.1	72.5	60.5	51.6	75.6	46.8	50.9	58.3	91.6	62.6	53.2	51.2	51.3	65.5	119.7	61.9	88.7	54.7	51.1	68.8	67.1	39.2	79.6	64.5	51.1	60.9	64.9	71.0	50.0	57.9	71.8	46.2	50.5	58.8	65.2	55.0	62.2	66.4	60.9	57.2	90.9	72.6	135.3	98.9	174.0	172.7	66.6	244.8	208.5	102.4	120.7	239.4	116.6	96.4	199.7	275.7	148.0	123.7	160.5	139.5	151.5	128.0	66.3	211.6	56.7	151.4	197.1	140.4	121.8	157.8	117.6	175.0	168.7	149.3	162.2	95.0	106.8	139.2	201.3	157.0	123.2	130.8	85.3	207.7	92.4	107.9	134.2	147.4	137.3	107.0	88.3	86.6	130.2	129.0	70.1	132.5	155.9	111.4	144.0	129.4	65.1	118.4	109.5	79.9	78.5	147.6	74.3	122.6	161.4	118.1	49.8	50.7	52.7	59.8	69.0	39.5	51.7	51.3	54.0	35.4	48.0	44.7	41.5	64.5	64.5	44.9	53.9	55.8	47.5	51.0	52.0	60.5	46.8	50.9	51.2	51.3	51.1	50.0	50.5	57.2	43.6	35.3	47.9	12.4	32.2	31.6	38.5	31.5	23.9	22.4	39.4	27.9	46.5	24.3	41.9	31.3	4.2	17.2	45.6	68.4	9.8	34.3	11.1	38.4	72.2	43.1	40.2	14.9	15.4	37.8	36.1	44.9	39.3	50.4	39.3	31.9	31.4	55.7	30.3	18.5	17.7	80.2	22.4	36.0	37.6	8.5	48.1	35.3	23.2	11.2	49.0	17.3	26.8	17.1	20.2	46.9	35.8	41.3	68.3	51.5	56.2	30.5	46.2	13.6	19.7	52.7	45.7	44.8	47.6	30.4	34.7	30.2	38.4	43.9	42.6	51.6
ARF1		ENSG00000143761	"ADP ribosylation factor 1"	P84077	1	228082660-228099212	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007742	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB007742: AB_562043"	"unprognostic (9.54e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.73e-1)"	"unprognostic (8.95e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.94e-1)"	268.3	282.5	213.8	176.7	222.5	426.9	241.9	188.1	261.9	249.1	215.1	259.8	242.6	266.6	193.1	304.7	247.5	189.2	340.0	242.7	231.3	257.0	324.7	298.2	185.0	200.6	201.6	237.3	327.6	296.9	299.1	276.9	207.6	244.0	177.3	96.7	355.2	203.9	330.9	237.3	240.8	176.2	196.6	251.4	265.6	193.9	218.9	184.4	240.3	206.4	154.7	229.0	233.1	206.4	476.6	321.6	257.4	257.9	289.9	362.6	425.7	409.5	433.0	444.3	386.8	383.6	442.7	239.9	428.8	438.3	204.6	298.8	316.4	399.4	219.4	355.3	506.8	234.3	209.8	386.6	559.5	342.1	333.8	350.4	476.7	408.6	427.0	374.1	443.3	267.0	456.0	533.3	431.4	341.8	350.0	495.9	331.7	656.7	643.0	279.0	228.1	750.6	315.1	242.1	362.6	320.0	265.9	790.0	466.8	87.8	543.9	681.0	406.0	324.6	256.5	479.4	626.8	498.5	301.0	331.1	445.9	285.0	670.6	1003.7	556.5	625.5	387.3	527.8	472.4	276.7	328.0	359.8	423.6	261.3	253.2	280.8	863.6	345.5	528.2	571.4	417.9	1082.4	213.8	222.5	188.1	261.9	242.7	231.3	200.6	201.6	207.6	196.6	218.9	206.4	276.9	173.1	185.2	25.8	205.1	262.6	281.7	248.0	104.2	114.3	209.1	172.0	139.8	125.8	208.1	115.8	45.9	373.7	267.8	487.8	230.9	422.7	236.3	164.6	218.7	247.2	230.1	173.8	42.3	404.5	565.8	227.3	142.8	240.8	198.3	128.8	152.4	124.8	409.4	158.2	41.1	436.9	213.6	198.8	256.2	429.9	229.2	300.1	300.6	35.6	356.0	162.2	214.2	30.7	40.7	400.2	407.2	227.2	282.8	344.6	370.1	173.3	180.7	80.2	230.1	149.6	416.0	321.1	155.7	158.3	286.0	676.7	224.9	174.6	335.2	370.0
ARFGAP1	"ARF1GAP, bA261N11.3, FLJ10767"	ENSG00000101199	"ADP ribosylation factor GTPase activating protein 1"	Q8N6T3	20	63272785-63289790	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051019, HPA056273"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles"	Cytosol	"HPA051019: AB_2681313, HPA056273: AB_2683084"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.86e-3)"	"unprognostic (8.62e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.86e-1)"	12.9	16.7	13.1	15.5	14.3	12.1	13.0	13.1	20.6	19.1	8.4	19.1	13.1	20.8	8.6	15.8	16.1	16.8	14.1	14.4	11.0	15.9	17.8	16.1	16.1	14.1	12.0	17.7	28.3	11.8	63.9	15.4	14.2	20.1	9.5	11.7	18.4	13.4	14.1	19.1	18.1	12.5	9.1	20.5	18.5	24.2	12.5	14.2	17.9	7.5	11.3	16.5	14.9	15.9	32.6	60.2	25.6	30.6	30.3	32.5	51.2	46.4	36.5	90.7	45.5	145.2	35.2	24.5	41.7	55.4	41.5	43.2	23.5	73.8	28.5	15.8	26.7	19.4	64.7	128.4	46.2	28.8	38.4	28.5	46.9	44.0	24.9	30.5	32.9	25.5	34.9	27.8	25.1	53.2	52.9	28.0	34.5	34.3	51.9	29.7	36.8	23.6	22.3	38.8	27.3	29.9	55.1	58.7	59.2	20.7	42.8	36.4	42.8	56.0	77.3	35.0	37.6	28.4	20.2	26.5	56.9	20.0	35.3	4.8	5.7	6.4	5.6	7.1	6.4	3.0	3.1	5.3	5.7	4.2	3.0	3.0	2.4	4.7	9.5	4.2	4.1	6.0	13.1	14.3	13.1	20.6	14.4	11.0	14.1	12.0	14.2	9.1	12.5	15.9	12.6	22.4	30.7	34.9	11.2	10.1	6.0	8.6	4.0	26.6	17.6	14.4	12.4	11.5	14.4	12.9	33.3	12.5	15.4	37.6	9.8	12.2	15.9	11.0	17.1	14.2	24.5	9.5	14.5	15.4	24.9	16.3	50.4	14.9	15.9	30.6	13.6	23.3	14.9	21.9	14.9	40.4	2.0	14.4	11.5	23.3	12.5	13.5	12.4	5.6	12.3	11.8	15.5	18.6	24.8	28.2	18.3	9.8	17.8	11.6	17.4	11.5	18.8	20.1	6.6	11.1	14.9	21.3	7.4	6.7	8.5	15.2	10.3	16.8	24.0	9.2
ARHGAP10	"FLJ20896, FLJ41791, GRAF2"	ENSG00000071205	"Rho GTPase activating protein 10"	A1A4S6	4	147732063-148072776	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 137.6;Oligodendrocyte precursor cells: 124.7;Peritubular cells: 121.1;Rod photoreceptor cells: 132.9;Sertoli cells: 144.7;Smooth muscle cells: 107.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 80.2"	HPA039589			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039589: "	"unprognostic (8.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (8.15e-5)"	"prognostic unfavorable (6.26e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.09e-2)"	35.0	11.4	4.6	7.0	6.3	3.3	22.6	2.0	7.1	35.1	9.8	47.0	4.9	16.9	9.8	35.7	35.1	13.0	38.7	6.0	2.6	9.7	7.9	15.1	5.8	3.1	4.7	33.4	9.2	16.0	6.2	10.7	3.5	26.0	8.0	14.4	11.1	20.0	38.6	22.2	16.6	13.3	3.6	9.8	26.3	11.8	5.5	11.3	16.9	33.1	6.7	44.2	30.8	4.1	21.0	8.3	4.4	9.2	33.2	45.1	46.0	28.3	23.5	17.9	13.8	21.6	11.8	0.0	4.7	24.4	15.0	10.1	16.4	23.4	21.5	11.4	10.9	7.2	6.2	0.7	51.2	7.1	8.0	23.4	17.9	22.3	19.0	22.7	22.0	6.0	1.0	38.3	32.3	25.5	4.5	0.0	4.1	13.9	4.0	8.1	12.7	24.5	12.3	19.0	10.7	5.1	7.4	29.6	7.9	19.0	3.7	0.6	21.9	16.8	12.9	10.3	13.8	14.2	1.8	0.1	25.5	0.9	15.1	0.0	1.7	16.7	5.3	0.1	10.5	0.0	4.1	6.2	3.0	0.0	1.2	6.0	0.2	5.3	0.1	0.1	5.4	2.4	4.6	6.3	2.0	7.1	6.0	2.6	3.1	4.7	3.5	3.6	5.5	4.1	18.5	3.2	4.1	5.5	1.5	14.4	7.9	7.0	16.5	7.1	13.0	15.4	64.8	5.7	3.5	1.8	43.8	29.0	11.1	0.2	0.0	5.8	13.6	16.3	83.5	11.8	0.0	1.3	63.3	16.0	48.2	45.6	11.2	31.8	1.3	21.7	4.2	13.0	20.9	3.3	26.7	0.4	0.0	6.2	33.7	10.2	137.6	24.2	5.4	46.9	58.4	8.2	8.2	124.7	2.1	14.0	0.1	121.1	3.2	4.5	0.8	15.0	1.3	132.9	144.7	22.7	107.3	4.7	13.3	15.7	10.2	12.7	16.0	9.1	1.1	3.1
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639941	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.2;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 38.7;Extravillous trophoblasts: 23.7;Granulosa cells: 21.1;Plasma cells: 18.6;Spermatocytes: 24.7;Spermatogonia: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040830, HPA066481"	Enhanced		Approved	Nucleoli,Cytosol		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoli	"HPA040830: AB_10805830, HPA066481: "	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.05e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.7	0.9	2.0	7.9	2.5	24.2	1.7	2.1	2.1	1.5	1.2	7.5	6.1	1.5	1.0	5.3	0.8	1.7	0.7	1.7	1.9	0.6	1.3	1.7	13.5	2.6	3.0	0.6	2.6	1.2	0.7	4.3	2.6	0.6	8.8	0.5	1.2	0.5	0.9	4.4	7.6	4.8	2.5	2.8	3.6	8.6	2.2	26.1	1.3	0.4	14.3	2.8	1.9	3.0	80.8	69.4	73.1	46.2	5.0	13.0	39.6	78.5	50.2	80.0	63.3	52.2	41.5	43.5	23.7	49.9	91.3	56.9	55.3	43.8	110.9	83.5	27.4	132.6	68.9	33.5	2.0	103.8	55.5	4.3	5.5	61.6	50.9	15.2	61.5	94.4	101.0	112.7	95.3	31.7	58.6	39.7	44.6	71.6	44.5	67.8	141.7	38.2	28.4	41.6	64.7	44.5	72.9	46.2	17.6	37.6	63.6	115.8	35.3	102.5	74.1	42.0	87.2	38.3	63.7	123.7	44.4	129.1	91.8	0.1	0.3	0.8	0.5	0.5	0.2	0.3	1.0	0.9	0.4	0.2	0.4	0.5	0.0	0.1	0.1	0.2	0.8	0.3	2.0	2.5	2.1	2.1	1.7	1.9	2.6	3.0	2.6	2.5	2.2	3.0	0.7	0.0	2.3	0.3	4.6	4.8	1.1	2.4	2.2	0.2	1.3	1.7	0.9	4.3	1.9	1.8	0.0	9.8	2.9	6.2	0.0	0.8	4.7	3.8	2.6	2.0	0.0	38.7	1.0	0.8	23.7	3.5	8.6	2.8	0.0	21.1	1.8	2.1	9.5	0.0	0.6	7.8	0.0	6.5	4.2	5.0	0.6	3.5	0.0	1.0	3.9	0.1	2.1	0.5	1.4	0.5	2.9	0.4	18.6	1.4	1.1	0.4	1.4	1.0	6.6	1.4	3.3	24.7	22.6	10.5	2.3	3.1	5.4	2.0	14.1	2.1
ARHGAP17	"FLJ10308, FLJ13219, NADRIN, RICH1, WBP15"	ENSG00000140750	"Rho GTPase activating protein 17"	Q68EM7	16	24919389-25015666	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041703, HPA075891"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		21000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA041703: AB_10794304, HPA075891: "	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.42e-2)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (3.02e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.81e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.76e-4)"	46.0	40.5	8.2	15.2	9.8	9.2	37.2	9.2	10.2	29.9	9.6	32.7	11.3	28.9	7.9	33.6	28.6	11.9	48.1	7.9	9.2	25.9	22.9	31.8	24.9	10.6	9.5	24.8	24.1	9.3	30.3	15.3	10.4	23.6	12.2	2.3	21.3	7.9	41.0	34.3	39.2	11.6	8.7	66.8	28.9	25.5	9.7	12.0	28.2	11.1	20.9	25.6	29.8	11.6	28.5	16.7	21.9	23.1	22.0	23.0	23.7	18.1	19.3	20.9	20.4	25.9	11.5	13.0	12.0	36.4	19.9	7.7	21.8	12.8	22.2	20.0	26.1	10.8	37.8	43.3	25.0	15.5	10.7	29.4	7.7	22.6	16.3	15.0	35.7	11.7	14.3	0.0	23.6	20.8	14.3	19.8	25.2	8.1	13.7	68.1	17.9	5.2	25.9	6.4	14.6	14.5	18.6	20.5	8.2	17.5	11.1	40.2	46.7	15.5	11.9	35.6	15.1	13.0	17.3	7.5	19.1	22.6	14.1	5.6	9.7	9.0	6.3	17.5	5.7	25.3	5.5	6.3	14.6	22.8	6.2	6.1	4.8	6.2	15.8	25.9	8.0	8.1	8.2	9.8	9.2	10.2	7.9	9.2	10.6	9.5	10.4	8.7	9.7	11.6	33.8	9.6	11.0	26.8	46.3	14.5	6.8	8.9	14.2	6.4	11.0	9.7	24.9	7.2	9.1	5.5	10.4	11.1	36.3	49.5	3.9	13.3	6.3	30.6	21.8	32.3	21.0	16.2	28.8	16.0	18.9	16.0	15.3	66.4	7.0	16.9	26.7	6.8	27.1	10.1	33.0	21.8	8.2	30.3	21.7	10.8	13.4	25.2	16.0	59.0	22.8	6.4	14.4	40.2	68.9	17.6	27.2	11.7	11.5	11.1	35.4	5.0	8.5	7.5	26.3	15.5	43.8	7.0	11.7	24.7	24.0	15.7	21.1	15.9	19.7	12.2
ARHGAP23	KIAA1501	ENSG00000275832	"Rho GTPase activating protein 23"	Q9P227	17	38419280-38512385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.4;Hepatic stellate cells: 46.1;Oligodendrocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 296.7;RT4: 115.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019818, HPA047291"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA019818: AB_1844993, HPA047291: AB_2680012"	"unprognostic (3.35e-1)"	"unprognostic (5.11e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.50e-3)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.38e-5)"	"unprognostic (8.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.25e-1)"	25.6	13.8	36.2	8.3	66.2	10.7	18.8	47.2	54.6	25.9	5.5	22.8	3.0	28.4	3.7	60.8	18.4	7.8	27.3	34.4	37.5	11.8	2.9	28.0	4.1	63.7	59.6	18.1	3.5	3.1	6.2	19.4	54.1	19.9	2.8	8.5	12.8	12.5	10.6	61.1	10.4	11.6	43.0	30.7	13.4	16.1	66.1	5.4	9.5	5.8	11.0	36.3	29.5	97.8	32.5	17.2	15.2	5.1	9.5	31.1	19.6	44.8	49.5	37.7	21.8	56.8	55.1	0.7	35.2	102.5	18.7	296.7	1.7	62.3	26.6	3.5	3.3	0.0	55.1	0.4	47.2	3.0	0.3	18.8	11.8	27.7	17.3	31.0	39.4	6.0	0.6	8.3	21.6	0.0	10.2	6.3	9.0	1.2	6.3	17.0	33.0	10.4	16.0	115.7	3.7	8.8	26.9	0.1	0.3	21.2	6.7	7.9	57.7	62.6	22.9	12.9	12.1	6.5	7.3	1.9	16.3	8.1	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	66.2	47.2	54.6	34.4	37.5	63.7	59.6	54.1	43.0	66.1	97.8	27.2	12.8	1.5	23.8	0.7	9.9	17.5	10.6	9.1	59.4	1.7	3.9	20.4	1.5	13.2	3.7	0.0	27.0	0.2	0.1	0.0	2.9	7.6	8.5	10.0	34.9	0.0	4.0	9.3	1.4	3.1	11.6	3.1	5.7	0.0	4.9	46.1	0.5	5.1	26.9	16.2	0.4	2.0	2.5	4.2	21.0	9.0	1.2	1.8	9.4	0.2	9.6	0.0	20.1	129.2	7.0	0.1	7.2	1.7	15.4	0.0	0.2	8.3	3.4	0.0	10.9	7.6	13.5	2.7	27.5	25.9	16.6	1.8	1.3	0.3	42.2
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475150-86002668	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 99.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1364.3;Microglial cells: 905.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.9;memory B-cell: 47.3;naive B-cell: 36.8;plasmacytoid DC: 12.7"	"Group enriched"	"Detected in many"	5	"B-cells: 47.3;dendritic cells: 12.7;monocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 109.0;ASC TERT1: 65.5;HHSteC: 63.6;HUVEC TERT2: 121.9;RPTEC TERT1: 67.2;TIME: 87.0;U-138 MG: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	14.6	2.2	6.5	7.5	5.1	18.7	9.2	6.2	5.8	5.5	3.9	7.4	7.3	9.4	4.6	6.1	4.1	10.9	27.3	5.7	6.6	99.8	9.5	15.7	10.5	15.7	11.5	5.5	30.1	8.1	5.4	22.4	17.2	5.4	6.1	8.4	10.6	7.2	10.2	7.0	10.3	14.1	12.1	16.4	26.0	3.4	10.4	7.5	27.8	7.7	15.5	9.1	5.6	19.1	3.0	6.2	4.4	0.1	109.0	65.5	4.8	21.5	28.5	5.2	8.4	0.1	0.0	2.8	7.4	48.8	6.4	0.0	0.2	9.0	11.0	0.0	1.2	3.6	0.6	0.2	63.6	0.4	0.0	48.4	0.9	10.3	4.7	23.9	121.9	0.0	6.6	0.4	46.1	0.0	0.1	0.0	0.3	1.5	11.3	0.6	22.4	11.8	67.2	0.0	2.3	2.3	2.5	3.5	7.8	4.7	0.4	0.2	87.0	59.9	1.2	4.4	0.3	0.3	0.0	3.9	10.1	2.2	19.9	0.0	15.9	0.0	0.0	3.0	0.0	47.3	0.0	0.0	3.8	36.8	0.0	0.0	5.5	0.0	2.3	12.7	0.0	3.1	6.5	5.1	6.2	5.8	5.7	6.6	15.7	11.5	17.2	12.1	10.4	19.1	14.0	57.7	28.8	1364.3	142.1	8.2	3.9	35.6	10.2	6.6	1.2	4.7	26.4	47.1	18.3	46.0	6.2	54.8	9.9	1.0	226.9	9.4	30.5	1.2	12.9	9.5	2.4	0.0	12.2	11.8	26.2	24.7	25.0	1.4	1.3	6.7	4.2	9.5	10.5	111.0	51.3	3.3	6.1	33.7	21.3	8.8	16.8	26.3	19.6	905.0	34.0	27.7	0.0	27.2	21.8	7.4	2.9	12.4	2.0	2.3	0.2	205.9	24.8	6.6	6.6	50.0	21.3	8.1	5.9	4.0	6.3	232.9	4.1	18.4	5.0	1.9
ARHGAP26	"GRAF, KIAA0621, OPHN1L, OPHN1L1"	ENSG00000145819	"Rho GTPase activating protein 26"	Q9UNA1	5	142770377-143229011	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 237.3;Excitatory neurons: 611.6;Inhibitory neurons: 261.5;Late spermatids: 153.3;Microglial cells: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"neutrophil: 24.7;NK-cell: 9.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 24.7;NK-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 85.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035106, HPA035107"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA035106: AB_2674465, HPA035107: AB_10669855"	"prognostic favorable (2.05e-4)"	"prognostic favorable (1.36e-4)"	"prognostic favorable (6.95e-4)"	"prognostic favorable (5.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (9.43e-3)"	"unprognostic (7.19e-3)"	"unprognostic (8.65e-2)"	"unprognostic (3.21e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.88e-6)"	11.0	4.5	10.9	17.7	6.5	36.4	11.3	19.3	17.0	11.9	0.6	12.9	12.0	7.7	9.1	6.4	15.5	14.2	15.0	10.8	3.4	8.9	6.8	19.0	6.4	0.5	2.7	3.0	4.9	3.9	12.2	20.9	0.3	7.4	12.7	17.2	12.8	4.2	12.6	7.4	11.3	9.7	2.3	16.7	15.2	15.4	10.1	13.8	8.3	10.5	12.2	12.2	5.8	9.9	16.4	29.1	8.0	7.6	12.3	12.7	12.4	2.2	2.4	7.6	12.1	44.9	33.0	2.0	16.1	4.9	21.5	7.5	4.1	15.3	8.7	33.8	4.6	0.1	5.3	26.9	7.8	22.6	2.9	4.7	23.0	12.8	31.0	5.6	10.2	9.9	0.6	85.4	2.4	2.3	12.9	9.2	4.3	23.2	7.7	5.2	12.5	36.5	20.4	25.6	3.4	4.7	3.8	4.4	7.1	6.5	2.4	6.2	21.0	4.1	5.8	0.4	8.1	4.0	14.0	0.4	10.7	21.3	5.6	4.0	3.9	2.3	3.8	2.5	1.7	0.5	0.8	2.4	3.0	0.4	0.3	1.1	24.7	9.8	1.6	0.7	0.3	1.8	10.9	6.5	19.3	17.0	10.8	3.4	0.5	2.7	0.3	2.3	10.1	9.9	39.4	16.0	22.5	237.3	5.8	6.9	13.8	13.2	5.7	15.9	20.7	17.0	37.6	21.5	14.1	0.0	8.4	1.3	41.6	38.7	0.0	17.9	77.2	17.9	4.0	32.5	3.6	11.8	611.6	21.1	0.6	13.6	39.8	55.6	26.6	6.4	40.0	6.5	26.4	75.7	261.5	26.4	0.0	48.0	44.9	153.3	6.5	51.6	10.6	326.0	47.3	7.5	40.2	30.7	29.8	21.1	27.8	14.3	14.5	29.3	27.9	5.8	16.1	52.6	46.0	27.6	17.7	2.6	8.7	7.5	5.5	1.9	29.3	50.5	26.8	36.2
ARHGAP27	"CAMGAP1, FLJ43547, SH3D20, SH3P20"	ENSG00000159314	"Rho GTPase activating protein 27"	Q6ZUM4	17	45393902-45434421	"Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 99.1;Paneth cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;OE19: 20.5;RT4: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023919, HPA053053"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA023919: AB_2059402, HPA053053: AB_2682027"	"unprognostic (9.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.21e-4)"	16.2	7.3	4.3	8.6	6.7	11.6	15.8	4.0	4.8	27.1	3.1	39.6	10.5	8.7	1.7	98.0	11.7	3.2	22.7	3.7	4.0	20.4	6.5	28.4	9.1	5.4	4.5	3.6	7.7	3.1	10.4	4.0	4.7	17.0	8.9	0.5	37.7	1.5	4.4	27.3	51.6	2.4	4.4	63.0	12.7	8.9	5.5	6.3	16.7	1.8	6.7	17.6	44.2	4.3	6.1	6.0	0.1	1.7	0.8	0.4	16.7	0.0	0.3	0.4	0.1	5.3	11.9	5.5	11.4	0.4	2.6	3.8	0.8	1.1	0.2	11.3	3.7	0.3	2.7	3.5	0.1	0.0	15.7	0.8	4.7	0.0	1.7	0.5	3.6	5.9	1.5	9.8	0.5	4.2	5.3	1.9	0.3	20.5	4.9	4.4	0.2	1.9	3.9	26.1	0.8	0.5	0.7	5.0	0.3	2.0	3.9	10.2	5.6	0.0	1.4	0.1	0.5	12.0	8.4	1.2	0.3	1.5	0.1	1.0	5.2	4.4	2.4	8.6	1.5	3.6	1.5	2.7	4.3	2.7	1.2	1.3	10.0	1.8	11.4	7.2	2.1	4.0	4.3	6.7	4.0	4.8	3.7	4.0	5.4	4.5	4.7	4.4	5.5	4.3	19.9	6.4	17.8	2.9	23.1	10.3	15.2	9.3	2.8	3.3	11.4	7.4	10.6	15.7	13.0	18.4	4.2	7.7	38.0	99.1	3.9	6.0	1.1	11.0	2.5	20.8	19.2	1.7	3.6	3.4	11.5	3.1	31.6	18.4	4.5	0.5	17.5	2.1	15.0	1.7	8.8	34.2	10.2	47.1	13.4	1.1	0.3	33.1	7.2	19.7	26.0	1.6	23.7	3.0	2.5	19.1	79.6	0.0	15.9	28.3	57.0	6.4	11.7	1.6	0.0	3.0	2.9	6.7	2.0	9.7	8.7	14.1	14.2	1.0	43.4	57.4
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 440.8;Endothelial cells: 298.6;Prostatic glandular cells: 593.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A-431: 118.8;hTERT-HME1: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	32.9	3.7	7.0	2.8	5.5	0.1	30.3	22.5	8.0	8.8	7.3	9.4	2.1	7.4	5.3	4.5	10.2	6.5	19.2	4.6	5.5	23.7	16.8	27.1	4.9	6.8	6.1	10.2	7.4	6.5	6.2	17.4	7.1	11.2	3.2	14.9	12.1	7.0	11.6	14.7	6.4	5.6	6.4	21.7	10.4	5.8	8.6	3.0	22.8	12.7	2.8	8.0	9.3	5.1	118.8	4.8	7.0	0.1	26.7	57.5	24.5	38.6	62.9	31.0	45.1	13.7	5.4	0.0	85.2	76.5	36.3	24.8	0.2	27.4	63.9	0.1	4.1	0.4	6.6	7.6	2.7	0.0	0.0	11.7	5.4	23.7	100.9	36.4	88.0	0.1	0.0	0.0	32.1	4.7	2.2	0.1	9.0	0.6	82.1	1.4	5.6	0.0	82.7	10.8	0.1	1.5	24.1	20.5	2.0	26.5	5.6	0.4	84.2	20.0	26.2	29.7	32.3	0.1	0.1	0.2	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	5.5	22.5	8.0	4.6	5.5	6.8	6.1	7.1	6.4	8.6	5.1	440.8	51.3	18.4	26.4	2.9	23.5	239.2	31.7	4.6	16.0	87.3	46.1	26.0	31.5	39.6	130.6	18.8	29.5	2.0	0.9	54.8	83.5	94.1	36.9	11.4	298.6	0.0	3.2	11.3	17.2	102.6	63.6	20.9	106.2	3.8	13.8	177.1	56.1	3.0	92.5	24.1	1.0	6.1	13.6	17.9	24.4	24.5	6.2	26.6	208.9	2.5	94.2	0.0	2.0	3.5	55.7	0.1	21.8	0.1	593.9	0.1	78.1	12.5	81.2	190.7	58.2	127.8	80.3	116.5	1.7	17.2	14.1	4.1	11.1	1.6	146.9
ARHGAP33	"FLJ39019, SNX26, TCGAP"	ENSG00000004777	"Rho GTPase activating protein 33"	O14559	19	35774532-35788822	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.4;Cone photoreceptor cells: 25.0;Horizontal cells: 20.2;Oligodendrocytes: 22.7;Rod photoreceptor cells: 33.7;Spermatocytes: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030117, HPA030118"	Supported		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA030117: AB_10599306, HPA030118: AB_10601238"	"unprognostic (1.44e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.61e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (3.09e-8)"	"unprognostic (5.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-2)"	7.7	8.7	24.3	4.2	28.8	20.5	10.9	14.3	39.1	20.4	8.2	11.2	4.0	13.9	1.3	8.1	17.1	2.8	6.9	30.0	21.0	10.1	5.6	6.8	5.8	19.9	16.5	26.9	11.9	4.2	33.6	1.6	18.0	12.5	1.3	9.9	7.4	3.3	3.4	9.8	9.2	2.0	15.2	11.1	10.4	39.6	19.5	11.7	18.0	1.3	2.2	9.4	13.7	22.1	9.0	5.6	15.5	11.7	0.6	1.5	1.2	7.2	0.9	2.7	1.9	2.3	6.6	5.2	2.6	2.1	2.3	2.4	1.9	2.0	1.0	16.4	3.6	7.6	8.6	2.1	0.7	2.7	58.1	2.2	0.4	2.1	0.8	2.2	1.6	20.4	3.7	22.1	2.4	6.8	18.8	7.4	3.5	3.4	2.5	25.4	2.5	2.5	1.2	1.4	15.4	9.4	3.2	5.7	1.1	1.9	8.3	7.5	3.1	11.0	10.6	5.8	8.5	19.5	4.0	5.2	4.0	8.9	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	28.8	14.3	39.1	30.0	21.0	19.9	16.5	18.0	15.2	19.5	22.1	2.7	0.0	1.1	7.8	1.0	1.7	1.0	1.0	4.6	27.4	4.8	4.7	2.3	2.8	2.7	1.8	25.0	0.7	5.1	1.4	0.0	0.4	11.4	6.1	4.8	1.6	3.5	6.5	12.1	0.7	1.0	3.5	3.6	2.5	5.1	7.3	1.1	1.5	1.2	20.2	11.3	2.3	2.0	0.8	1.9	8.9	4.1	0.7	0.0	1.9	0.2	7.3	0.0	19.1	22.7	0.7	0.6	3.0	2.2	0.6	0.3	0.2	4.2	33.7	0.0	4.6	3.1	22.2	6.2	4.2	1.7	0.4	3.6	7.2	2.8	0.6
ARHGAP39	"CrGAP, KIAA1688, Vilse"	ENSG00000147799	"Rho GTPase activating protein 39"	Q9C0H5	8	144529179-144605816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.3;Endometrial ciliated cells: 31.4;Excitatory neurons: 41.7;Inhibitory neurons: 33.1;Oligodendrocytes: 30.8;Respiratory ciliated cells: 27.6;Rod photoreceptor cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044491			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Nucleoplasm, Microtubules, Cytokinetic bridge"	"HPA044491: AB_10794775"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-7)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.97e-2)"	1.6	3.9	4.3	0.8	5.2	0.0	3.4	2.3	9.4	4.9	1.2	4.5	1.7	2.8	0.8	5.0	8.2	0.7	1.9	8.5	2.3	4.9	1.6	2.7	0.3	8.4	5.9	2.6	5.2	1.3	9.9	0.7	5.5	4.2	0.6	3.1	3.5	1.4	0.7	5.2	2.7	0.5	4.7	1.3	2.0	21.8	3.5	0.7	7.5	0.1	0.1	1.9	3.1	9.5	8.3	8.1	3.8	5.8	0.7	0.6	7.2	2.1	0.7	2.6	1.6	5.2	4.8	0.8	5.4	0.8	2.7	7.0	1.8	2.0	0.5	0.0	7.2	0.1	5.8	3.4	1.3	0.0	0.8	0.5	3.2	3.3	1.4	1.3	0.8	0.4	7.7	0.0	1.1	13.4	4.6	0.0	4.0	3.4	11.4	4.3	3.0	3.2	2.1	4.1	10.9	7.7	6.2	2.1	3.8	1.4	9.0	1.2	2.0	1.9	0.1	6.6	4.5	0.0	0.1	0.3	3.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.2	2.3	9.4	8.5	2.3	8.4	5.9	5.5	4.7	3.5	9.5	0.8	3.2	2.3	34.3	0.6	3.7	0.6	1.9	2.2	7.2	5.0	3.3	1.6	0.0	2.8	3.7	20.9	0.6	0.1	7.5	0.0	2.4	3.9	31.4	2.8	1.1	0.0	0.0	41.7	2.5	0.9	1.2	1.1	6.0	0.0	6.0	0.7	1.4	0.5	3.3	33.1	4.2	4.1	0.0	0.4	3.1	2.1	0.2	5.4	1.0	0.0	3.6	0.0	15.6	30.8	1.4	7.9	8.2	0.0	1.0	3.3	1.5	27.6	24.5	6.6	2.5	2.1	8.5	11.2	2.1	3.0	0.5	0.3	3.1	5.2	0.7
ARHGAP42	"AD031, FLJ32810, GRAF3, TMEM133"	ENSG00000165895	"Rho GTPase activating protein 42"	A6NI28	11	100687288-100993941	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 102.8;Early spermatids: 74.7;Oligodendrocyte precursor cells: 226.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.2;RH-30: 20.4;RT4: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039924, HPA060528"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"	Cytosol	"HPA039924: AB_10674428, HPA060528: AB_2684308"	"unprognostic (1.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.03e-1)"	6.6	2.9	5.7	3.8	6.7	1.2	3.7	5.9	6.7	6.4	7.9	6.7	7.7	5.8	3.1	3.2	3.4	6.7	4.7	5.3	8.0	9.2	10.1	6.2	4.6	6.9	7.1	3.1	1.2	5.6	1.3	15.1	6.8	2.8	6.1	31.6	3.1	2.8	3.3	3.1	7.9	4.2	6.7	4.6	9.4	2.1	7.3	9.3	8.1	5.1	2.9	5.3	1.7	7.3	0.6	4.6	5.0	0.1	2.7	4.7	4.0	0.7	1.1	1.2	2.7	6.3	30.2	0.9	8.3	2.1	5.5	9.4	2.8	1.6	1.2	0.0	2.7	15.3	13.0	2.1	5.2	0.1	0.1	3.6	2.8	5.3	0.9	2.9	1.9	3.9	0.5	0.0	4.2	0.9	1.8	0.0	6.8	7.5	6.7	5.4	20.4	0.5	6.8	21.1	3.4	1.8	10.9	0.4	8.0	10.6	1.0	1.8	4.0	4.1	5.3	4.6	2.3	4.6	0.0	6.2	4.1	3.3	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	5.7	6.7	5.9	6.7	5.3	8.0	6.9	7.1	6.8	6.7	7.3	7.3	8.7	48.1	5.3	102.8	3.7	2.4	6.5	1.5	2.2	3.1	2.9	4.6	6.8	14.3	13.4	3.7	25.0	0.7	3.4	22.2	1.9	4.5	74.7	16.0	19.6	6.1	1.8	3.6	2.4	3.9	2.1	12.6	16.3	18.1	0.0	21.8	6.8	6.3	1.6	1.7	47.7	3.6	2.0	0.3	1.2	38.9	1.2	1.4	10.6	39.4	0.0	32.2	0.0	226.2	0.5	10.0	12.1	2.6	5.6	14.6	7.9	19.8	11.8	62.0	39.5	4.5	38.6	3.6	2.3	2.3	3.4	6.4	0.6	6.2	4.7	18.3
ARHGEF10L	"FLJ10521, KIAA1626"	ENSG00000074964	"Rho guanine nucleotide exchange factor 10 like"	Q9HCE6	1	17539698-17697874	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	41	"classical monocyte: 18.8;intermediate monocyte: 18.0;myeloid DC: 13.4;non-classical monocyte: 4.8"	"Group enriched"	"Detected in many"	48	"dendritic cells: 13.4;monocytes: 18.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026426, HPA026440, HPA028115"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles, Cytosol"		"HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285"	"unprognostic (4.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.13e-5)"	"unprognostic (3.61e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.21e-3)"	22.2	10.5	11.9	11.4	10.9	1.7	16.5	38.7	11.4	24.2	13.8	29.4	15.9	16.2	4.6	28.1	16.0	11.9	30.2	10.3	12.2	32.5	87.5	13.0	4.5	19.4	18.5	10.4	43.9	17.0	7.9	5.9	19.4	18.4	12.9	4.0	25.9	19.5	66.2	40.9	21.7	8.7	10.9	9.7	20.8	3.7	17.7	1.6	18.0	35.5	4.3	24.6	21.7	9.3	8.0	9.1	11.3	3.9	19.1	6.3	7.6	5.4	10.6	6.3	5.3	9.5	23.6	0.0	9.8	10.2	8.8	6.0	1.6	2.9	1.2	0.2	2.9	0.0	9.5	26.9	4.2	0.0	0.0	8.5	5.5	3.9	1.1	12.7	1.2	0.0	0.0	0.2	17.8	7.7	0.0	0.2	4.9	12.2	0.0	0.0	4.5	3.0	13.4	16.4	16.5	12.2	4.2	2.9	12.3	3.2	11.0	9.5	0.0	5.5	6.5	6.5	2.3	0.0	2.5	0.0	8.5	0.2	3.0	0.0	18.8	0.0	0.0	18.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	7.6	11.9	10.9	38.7	11.4	10.3	12.2	19.4	18.5	19.4	10.9	17.7	9.3	1.3	3.2	7.4	82.6	1.0	5.7	5.3	7.2	5.2	16.1	13.7	12.3	36.4	20.0	13.9	31.3	2.1	0.7	0.1	41.6	9.8	19.8	15.9	3.4	4.2	2.1	37.8	2.7	16.7	20.3	0.6	8.5	17.9	6.5	0.0	3.9	2.5	43.7	26.0	10.1	23.8	45.5	8.2	8.6	26.4	8.9	5.0	18.6	3.6	19.7	9.6	14.6	0.0	24.6	7.1	11.7	24.9	6.8	0.2	5.9	13.6	18.3	9.4	5.4	13.1	10.8	18.3	11.9	1.6	8.0	8.7	1.0	0.6	0.3	46.1	12.1
ARHGEF12	"KIAA0382, LARG"	ENSG00000196914	"Rho guanine nucleotide exchange factor 12"	Q9NZN5	11	120336413-120489937	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018911, CAB025581"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB025581: , HPA018911: AB_1845003"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.91e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (5.43e-6)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	25.6	30.6	27.2	14.3	26.9	11.4	31.9	26.8	32.1	32.9	26.4	27.6	25.0	27.8	25.4	27.6	29.3	28.4	40.3	30.9	23.0	67.4	66.4	36.7	11.9	17.8	25.6	25.2	26.1	68.4	14.6	42.9	17.3	26.5	29.1	47.7	25.0	30.9	32.2	49.5	25.5	30.3	20.1	21.5	32.2	9.7	35.9	13.5	51.5	31.8	18.7	28.7	22.0	19.3	38.1	31.6	41.9	39.8	55.0	54.5	16.7	43.8	49.8	26.1	33.1	37.5	27.2	3.2	51.7	79.8	46.6	27.5	54.1	56.0	51.3	31.1	25.8	61.8	34.0	29.2	49.2	0.1	43.7	52.4	39.7	57.8	63.8	58.0	80.7	32.7	52.4	122.5	67.0	26.6	0.1	0.1	11.4	49.3	26.1	13.4	47.4	11.9	65.1	66.1	30.0	36.4	61.5	51.0	16.2	25.0	43.1	5.1	80.1	57.2	24.2	37.6	32.4	35.1	15.4	20.2	23.6	7.9	44.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	27.2	26.9	26.8	32.1	30.9	23.0	17.8	25.6	17.3	20.1	35.9	19.3	86.2	73.7	88.4	274.9	8.6	90.5	69.1	47.2	42.1	134.6	55.1	26.9	87.6	68.6	57.8	97.5	185.6	16.7	11.5	59.7	35.2	45.6	6.4	61.4	55.7	94.0	37.8	69.7	239.0	50.9	10.4	44.0	34.7	140.3	11.4	44.9	85.6	118.3	7.3	90.9	192.4	39.6	18.3	31.2	25.6	14.8	29.8	18.2	51.6	118.0	8.7	41.0	13.4	143.2	55.0	53.5	52.1	33.4	9.3	85.6	48.1	76.3	48.7	80.9	26.3	58.4	60.3	16.3	13.8	55.3	85.1	28.7	16.1	43.1	41.3	99.1
ARHGEF17	"KIAA0337, p164-RhoGEF, TEM4"	ENSG00000110237	"Rho guanine nucleotide exchange factor 17"	Q96PE2	11	73308276-73369388	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Endometrial stromal cells: 40.5;Sertoli cells: 85.5;Smooth muscle cells: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007991	Uncertain		Approved	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA007991: AB_1845005"	"unprognostic (2.36e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.27e-5)"	"unprognostic (6.96e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-3)"	"unprognostic (7.12e-3)"	"unprognostic (6.85e-3)"	"unprognostic (3.42e-3)"	32.8	12.2	32.7	9.1	39.5	3.3	24.1	24.1	45.7	37.0	15.3	38.2	5.5	39.9	15.2	10.0	30.5	17.6	34.5	29.6	33.7	24.9	5.4	31.2	5.9	38.2	31.6	24.2	8.2	19.1	15.3	23.6	37.6	25.4	5.3	7.2	11.7	27.3	11.5	10.7	16.4	22.6	21.3	12.8	19.8	7.1	36.9	3.1	36.0	12.2	2.7	26.9	20.2	28.8	9.6	11.4	24.1	28.4	18.7	15.7	14.8	26.6	38.2	25.9	16.5	30.2	8.2	0.0	18.2	50.7	11.8	14.5	8.1	10.8	10.8	16.9	2.4	0.0	21.0	11.9	21.6	0.8	0.5	27.1	12.2	15.6	9.3	16.9	19.4	1.2	0.9	0.2	14.6	13.7	0.3	17.4	3.2	6.4	2.4	4.0	27.3	0.6	16.5	6.7	15.8	12.1	22.6	26.4	31.3	22.0	43.8	8.2	12.9	12.5	25.5	5.3	8.6	1.6	0.3	0.1	4.4	1.9	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.7	39.5	24.1	45.7	29.6	33.7	38.2	31.6	37.6	21.3	36.9	28.8	13.9	16.0	16.3	38.5	0.2	3.4	2.4	6.0	5.7	12.6	11.1	12.3	25.5	8.6	7.4	7.3	0.0	7.2	0.1	1.5	0.0	6.4	1.1	10.5	40.5	10.9	1.2	1.3	29.5	0.7	5.3	10.7	2.6	8.9	0.0	13.7	10.8	0.6	2.0	23.5	24.8	0.7	0.0	0.3	4.2	2.0	10.8	1.4	1.8	8.4	1.1	11.1	0.0	10.6	2.0	2.4	0.4	20.3	1.6	4.1	0.0	4.3	5.4	2.3	85.5	5.2	67.5	1.6	8.3	1.1	2.7	6.2	0.6	2.0	1.0	1.5
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 339.7;Astrocytes: 248.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: AB_2680671"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	8.0	2.1	5.8	1.8	5.7	0.3	6.0	4.1	5.3	5.0	7.7	18.3	7.3	4.3	1.2	7.4	6.2	5.5	3.2	4.6	5.0	1.7	15.5	16.3	0.3	5.9	7.3	3.9	6.0	9.9	1.7	3.4	5.8	3.4	2.6	7.1	3.1	4.8	0.4	6.2	6.6	7.1	5.4	0.8	8.7	5.1	6.1	0.8	3.1	1.4	0.9	5.1	6.4	4.8	8.5	3.7	10.6	6.8	5.1	1.4	0.3	0.3	0.0	3.1	4.3	6.5	0.8	5.0	0.5	0.6	4.9	8.9	6.7	4.4	3.9	0.0	8.8	0.1	2.6	1.5	4.7	1.6	0.2	1.3	0.4	4.0	0.5	1.8	0.6	5.4	0.0	0.0	2.0	8.1	2.0	0.1	6.7	2.4	3.0	0.0	12.9	0.0	0.7	4.1	3.2	1.1	1.7	14.4	1.5	4.6	10.1	0.5	0.0	1.1	5.3	0.1	26.6	4.5	0.7	0.0	2.5	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.7	4.1	5.3	4.6	5.0	5.9	7.3	5.8	5.4	6.1	4.8	5.0	339.7	26.8	248.8	1.7	19.5	9.0	2.7	17.6	11.6	54.2	6.6	1.8	20.0	10.8	3.7	4.2	1.8	4.3	1.5	0.0	2.2	11.9	4.7	4.5	4.3	0.0	2.7	4.2	2.5	1.1	12.0	14.3	2.1	5.1	3.6	8.6	60.8	0.6	5.0	10.1	7.9	6.1	2.5	3.4	3.4	10.5	1.3	3.6	7.5	2.7	58.1	12.3	41.7	5.1	2.0	6.9	18.8	0.7	7.5	21.4	0.1	14.9	47.8	0.0	14.1	3.7	4.7	37.0	11.7	23.7	6.2	4.7	2.5	8.1	5.7
ARHGEF28	"p190RhoGEF, RGNEF, RIP2"	ENSG00000214944	"Rho guanine nucleotide exchange factor 28"	Q8N1W1	5	73626158-73941993	"Predicted intracellular proteins"	Differentiation	"Guanine-nucleotide releasing factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.1;Granulosa cells: 83.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 97.8;LHCN-M2: 92.2;TIME: 59.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037602	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytosol"	"Plasma membrane"	"HPA037602: AB_10672282"	"unprognostic (1.97e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.91e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.98e-4)"	4.8	23.9	4.5	1.1	4.7	0.0	7.5	0.4	5.1	3.9	0.0	3.3	3.2	4.1	2.5	6.4	9.8	5.3	1.9	5.0	4.3	31.5	6.4	7.3	0.4	1.6	2.0	19.0	20.7	1.2	6.0	0.5	3.2	5.0	3.7	6.0	19.2	3.6	0.9	14.8	2.5	3.5	1.4	2.8	21.8	1.5	3.2	4.0	13.6	0.9	2.9	3.7	6.6	2.8	30.1	21.0	0.1	2.6	2.6	3.6	0.0	10.8	21.5	13.5	13.3	6.3	12.8	0.1	22.5	3.7	30.4	10.0	1.4	17.4	20.2	0.2	3.1	0.6	3.3	27.2	20.9	0.0	0.0	3.3	7.0	21.0	97.8	25.2	44.4	0.6	0.0	0.0	92.2	2.8	0.0	0.0	0.2	7.9	8.5	0.0	5.5	3.7	36.4	18.0	2.0	3.9	5.3	0.8	0.6	0.0	4.6	0.1	59.8	6.6	9.2	0.5	10.3	1.1	0.0	0.2	10.1	1.4	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	4.7	0.4	5.1	5.0	4.3	1.6	2.0	3.2	1.4	3.2	2.8	9.1	28.9	16.4	3.9	0.2	25.7	14.1	14.1	40.5	4.9	7.5	11.0	2.0	24.3	15.5	31.3	0.0	0.3	2.1	3.7	15.6	13.0	9.6	32.7	1.7	12.8	11.4	2.7	73.1	11.3	0.3	3.1	35.7	12.6	1.3	83.2	2.2	7.3	0.3	13.5	34.5	10.7	40.7	0.3	0.9	2.6	10.2	3.3	1.8	32.8	0.6	26.8	1.0	34.7	15.2	26.3	4.6	5.7	1.2	16.0	3.9	26.7	50.4	1.6	6.6	0.5	7.0	1.0	1.3	20.4	25.6	0.1	1.2	32.3	6.7	17.3
ARHGEF3	"DKFZP434F2429, GEF3, STA3, XPLN"	ENSG00000163947	"Rho guanine nucleotide exchange factor 3"	Q9NR81	3	56727418-57079329	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 157.8;NK-cells: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 88.8;RPMI-8226: 92.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034715, HPA064945"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA034715: AB_10600780, HPA064945: AB_2685389"	"unprognostic (1.84e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (8.25e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (9.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.99e-2)"	"prognostic favorable (1.96e-7)"	"unprognostic (8.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-2)"	16.8	43.2	11.2	20.6	14.8	9.8	13.8	14.4	17.4	16.0	30.9	14.3	6.4	38.0	12.5	19.0	23.2	22.3	12.7	25.9	10.8	25.3	5.2	24.8	29.3	11.2	9.1	20.6	29.1	52.3	21.6	21.3	10.7	14.8	13.5	8.2	21.5	15.3	8.0	12.6	9.6	34.5	7.6	21.5	15.8	14.3	11.6	36.1	14.2	8.5	28.7	17.2	11.6	12.8	24.2	8.4	1.2	7.7	2.7	2.2	16.5	2.6	2.2	2.6	3.4	4.1	22.3	12.6	2.5	4.7	25.3	12.1	7.2	30.8	3.0	18.4	3.5	10.3	5.2	88.8	6.6	0.0	10.9	9.7	19.9	2.3	3.5	23.6	25.5	13.3	2.9	27.2	5.9	3.7	34.8	1.3	2.3	19.5	12.9	0.2	9.2	92.2	19.8	13.2	1.4	3.8	15.3	11.2	6.9	8.5	2.9	10.6	11.8	1.3	6.0	5.4	4.0	35.0	14.2	45.1	21.7	12.2	10.9	20.6	23.0	3.7	96.1	25.5	72.5	26.0	73.6	85.0	13.9	16.9	59.3	73.5	8.3	39.7	32.2	5.9	67.4	76.0	11.2	14.8	14.4	17.4	25.9	10.8	11.2	9.1	10.7	7.6	11.6	12.8	22.7	16.0	22.4	30.0	24.2	11.1	8.6	16.3	32.5	9.5	7.6	9.9	9.8	2.8	12.6	23.9	4.2	11.4	57.5	4.8	11.7	11.0	22.6	10.1	7.0	40.3	9.6	14.1	157.8	10.2	7.9	13.5	36.2	16.5	13.9	4.8	22.9	0.1	7.6	0.0	70.8	1.3	2.0	38.1	8.2	14.1	17.7	18.7	10.6	63.7	19.9	9.0	137.0	68.3	80.0	7.5	1.4	24.0	22.1	11.2	0.2	7.3	9.5	1.2	0.0	8.0	4.4	3.3	2.6	37.9	14.9	11.9	64.3	3.2	3.2	13.4
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889875-38975454	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.8;Excitatory neurons: 15.2;Late spermatids: 26.8;Spermatocytes: 34.7;Spermatogonia: 35.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.6"	"Group enriched"	"Detected in some"	4	"BEWO: 5.6;HeLa: 2.6;SiHa: 7.2"	"Region enriched"	"Detected in many"	32	"cerebellum: 280.4"	"Region enriched"	"Detected in all"	6	"cerebellum: 23.1"	"HPA034661, HPA041051"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Vesicles	"Nucleoplasm, Cytosol"	"HPA034661: AB_10669679, HPA041051: AB_2677274"	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.4	2.1	4.9	0.6	5.2	0.0	0.9	22.6	5.8	1.5	4.4	1.0	0.1	1.5	2.6	0.4	1.4	0.8	0.5	4.9	4.1	0.9	0.2	0.7	0.3	4.1	5.4	3.5	0.4	0.7	3.4	0.5	4.0	0.9	0.3	4.0	0.5	0.7	0.3	0.8	0.4	0.5	3.1	0.3	0.5	5.7	7.2	0.1	1.1	0.0	0.2	0.7	0.7	5.0	0.2	0.0	0.2	0.1	0.1	0.1	5.6	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.1	2.6	0.1	0.4	0.2	0.1	0.5	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.3	0.3	0.2	7.2	0.3	0.0	0.6	0.0	0.2	0.4	0.1	0.9	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.2	3.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.9	5.2	22.6	5.8	4.9	4.1	4.1	5.4	4.0	3.1	7.2	5.0	0.4	0.0	1.5	7.8	0.1	0.0	0.1	0.0	0.6	2.5	0.3	0.6	0.8	1.5	0.6	0.0	0.0	1.1	0.0	0.1	0.0	0.1	34.8	1.8	1.2	0.4	0.0	2.7	15.2	0.0	1.9	1.2	0.0	0.2	0.0	1.4	0.0	0.2	1.0	0.0	11.4	0.4	0.0	0.0	0.0	26.8	1.2	0.2	0.0	1.9	0.1	3.6	0.0	5.5	3.4	0.0	0.0	3.4	0.0	0.1	0.0	0.4	3.9	2.9	0.0	0.3	1.5	34.7	35.6	0.1	0.1	0.5	0.0	2.0	0.1	0.2
ARHGEF37	FLJ41603	ENSG00000183111	"Rho guanine nucleotide exchange factor 37"	A1IGU5	5	149551947-149634968	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 36.8;Oligodendrocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 9.3;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 13.9;HaCaT: 26.1;hTCEpi: 33.8"	"Region enhanced"	"Detected in many"		"cerebellum: 10.4"	"Low region specificity"	"Detected in all"			"HPA043885, HPA053487"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"HPA043885: AB_2678715, HPA053487: AB_2682167"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.16e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.10e-1)"	4.2	3.8	26.9	2.2	38.9	5.2	24.5	33.3	33.8	5.5	34.0	20.8	6.8	7.4	13.6	14.0	10.6	6.3	12.1	23.4	28.6	9.1	2.5	6.4	1.5	41.1	35.9	3.8	10.7	28.1	6.7	3.2	39.5	23.3	7.5	14.4	39.9	35.4	20.4	45.1	7.4	10.2	32.5	1.4	23.3	5.5	35.3	1.6	2.9	10.5	4.8	10.6	8.9	51.3	4.4	1.7	1.2	5.1	0.3	0.6	3.0	0.5	0.9	0.8	0.8	0.0	5.6	0.6	13.9	0.6	1.5	26.1	0.4	2.6	1.6	1.1	1.3	0.4	2.9	0.3	1.0	0.0	0.8	0.7	33.8	2.6	3.3	2.7	4.2	1.8	0.6	1.1	0.0	0.6	0.8	0.8	0.3	10.7	3.1	0.5	0.6	0.0	5.7	2.1	2.1	5.0	3.2	0.3	0.5	0.6	7.7	0.1	3.4	0.3	0.9	0.1	0.7	0.7	1.6	0.5	1.0	0.1	3.6	9.3	0.5	0.3	0.2	0.8	0.3	0.1	0.1	0.2	0.2	0.4	0.5	0.4	3.0	0.2	0.3	0.7	0.1	0.0	26.9	38.9	33.3	33.8	23.4	28.6	41.1	35.9	39.5	32.5	35.3	51.3	9.2	0.0	4.5	5.9	2.8	6.8	9.6	10.4	0.6	4.6	32.7	24.4	15.8	17.2	16.5	9.2	4.2	6.2	4.6	18.2	0.0	3.7	5.3	9.4	2.0	7.4	11.4	14.3	5.1	4.9	1.4	2.7	9.7	9.9	7.0	1.7	6.8	3.2	3.1	5.0	7.5	9.6	8.2	2.5	3.3	1.5	1.8	2.9	3.6	12.2	3.9	36.8	7.2	2.0	62.3	5.1	10.1	10.5	2.0	10.5	15.9	1.4	17.8	7.6	6.6	5.7	4.5	16.0	5.7	4.8	9.7	4.5	3.3	1.5	10.5	5.7
ARHGEF6	"alpha-PIX, alphaPIX, αPix, Cool-2, Cool2, KIAA0006, MRX46"	ENSG00000129675	"Rac/Cdc42 guanine nucleotide exchange factor 6"	Q15052	X	136665547-136780932	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 193.9;Granulosa cells: 128.2;Microglial cells: 77.8"	"Cancer enhanced"	"Detected in all"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 117.6;HL-60: 153.7;HMC-1: 532.0;JURKAT: 152.7;U-937: 158.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003578	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA003578: AB_1078203"	"unprognostic (9.64e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.08e-2)"	"unprognostic (7.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-3)"	44.0	16.2	23.4	30.5	24.4	31.4	23.5	25.0	19.5	10.7	11.6	13.2	7.5	12.9	5.3	7.6	7.0	17.3	32.9	25.2	26.9	6.7	8.5	25.6	41.8	26.8	29.2	16.5	3.9	10.3	6.2	46.9	27.8	7.8	11.1	4.6	8.7	8.8	68.7	6.2	14.4	16.6	29.0	39.4	12.3	3.8	26.5	51.4	5.6	54.7	39.6	14.3	8.7	30.1	1.1	0.0	5.1	0.0	11.2	28.5	0.1	1.6	9.5	1.5	8.2	0.0	0.0	5.5	2.3	8.0	7.8	0.8	6.1	0.0	1.5	28.1	2.0	117.6	0.1	0.0	4.2	153.7	532.0	30.9	0.1	5.4	0.1	10.1	3.0	152.7	0.5	22.1	20.4	0.2	70.6	88.4	4.9	0.0	2.3	26.6	37.2	0.1	1.6	29.5	0.3	6.7	0.2	1.2	4.0	2.6	3.5	61.2	0.5	7.6	1.2	9.3	7.2	3.6	0.1	57.3	35.1	158.2	10.1	57.2	16.4	71.3	13.8	18.9	16.0	6.2	15.4	11.3	19.1	5.4	13.7	12.3	9.1	12.4	16.1	6.0	21.5	15.3	23.4	24.4	25.0	19.5	25.2	26.9	26.8	29.2	27.8	29.0	26.5	30.1	18.1	6.4	8.9	57.1	22.4	1.1	0.9	0.8	1.2	0.8	16.1	10.8	60.0	0.0	2.4	1.8	0.0	0.3	23.6	0.1	1.9	0.6	12.0	0.9	2.4	13.2	0.0	11.3	20.6	1.8	0.4	10.7	5.6	1.6	193.9	128.2	12.5	2.5	15.2	13.5	21.6	0.4	0.0	46.5	25.1	35.8	14.9	40.3	3.6	77.8	36.1	4.7	36.0	48.2	4.3	0.7	0.0	14.7	12.8	0.4	0.0	0.2	2.2	0.3	13.1	33.5	18.5	0.7	0.7	0.6	1.7	0.4	40.5	30.1	0.1	0.7
ARID4A	"RBBP1, RBP-1, RBP1"	ENSG00000032219	"AT-rich interaction domain 4A"	P29374	14	58298504-58373887	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048899			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA048899: "	"unprognostic (1.57e-1)"	"unprognostic (9.39e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.70e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.52e-2)"	9.8	6.9	8.6	11.1	9.2	34.7	9.1	14.8	10.0	8.6	8.9	7.7	8.8	9.5	6.8	7.4	6.8	9.0	8.7	8.0	11.7	9.4	18.7	10.3	14.9	7.9	7.7	12.5	7.4	9.8	5.4	9.8	7.6	8.6	8.8	14.0	6.7	7.6	5.4	8.7	9.1	8.2	6.8	14.0	8.9	6.9	12.3	14.5	10.6	6.3	11.2	8.4	7.5	10.7	8.5	7.0	19.2	9.5	9.3	11.2	9.7	9.9	8.4	6.6	10.4	8.3	13.1	20.4	10.3	8.4	6.3	9.6	8.6	4.8	9.6	14.3	5.5	9.2	8.2	8.0	5.6	19.7	12.8	8.4	5.2	6.4	6.6	10.5	10.6	11.6	10.7	16.3	7.1	11.5	14.3	17.7	3.8	8.2	8.7	14.5	16.6	6.1	7.1	14.9	16.5	14.3	16.9	8.4	12.0	9.4	14.3	17.8	15.3	11.2	8.7	9.1	4.6	5.3	4.2	18.3	6.7	12.3	5.8	65.8	19.5	59.1	20.6	20.1	23.3	31.5	25.3	22.1	14.9	42.3	27.0	26.5	109.4	29.1	40.8	19.8	19.8	10.1	8.6	9.2	14.8	10.0	8.0	11.7	7.9	7.7	7.6	6.8	12.3	10.7	57.7	83.3	100.9	68.9	73.5	38.4	21.2	22.1	64.3	111.0	29.5	35.8	55.0	24.3	32.3	27.6	52.1	19.9	74.0	33.0	19.6	23.3	18.2	40.5	37.6	47.1	22.8	45.8	94.2	21.7	21.3	40.1	26.0	52.6	65.2	39.9	37.5	41.9	34.7	112.7	78.6	35.5	20.3	47.7	49.5	8.8	36.4	59.3	26.6	63.7	75.8	63.9	49.4	86.5	91.4	24.9	38.6	36.1	55.1	20.9	43.4	14.9	11.2	64.2	19.7	40.0	43.0	38.6	33.8	55.4	33.4	20.4	77.0	34.1	32.9	17.7
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901684-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 968.2;Syncytiotrophoblasts: 920.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 115.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	50.0	8.1	2.9	21.2	5.8	6.9	34.3	3.2	11.3	37.2	20.7	17.5	10.2	39.0	4.6	20.2	20.6	39.3	18.3	4.4	1.6	21.4	8.3	18.3	18.8	7.8	6.9	17.5	6.2	13.3	10.0	21.0	11.4	18.3	11.7	4.1	15.8	10.2	87.2	18.1	14.2	42.5	0.9	16.9	11.5	6.9	9.0	13.1	7.8	11.9	16.7	30.9	19.6	9.7	2.2	0.9	6.0	14.7	13.0	34.0	1.2	42.9	115.2	29.9	23.3	52.7	2.3	3.9	10.1	41.4	4.3	14.3	20.6	6.5	36.0	13.7	6.1	2.1	10.4	13.5	23.9	0.6	25.2	43.3	3.4	17.6	20.2	26.2	3.9	7.5	1.9	5.7	9.9	7.7	14.4	1.1	1.1	10.2	13.5	17.7	9.8	1.1	20.1	23.9	3.3	4.4	19.2	10.6	12.8	13.1	8.7	0.7	3.3	16.5	22.0	25.1	10.9	0.4	0.0	11.4	14.3	0.8	5.4	9.6	1.2	0.8	13.3	2.8	1.8	37.5	19.7	11.8	2.2	41.2	12.8	8.4	2.2	12.3	8.2	1.0	30.9	5.4	2.9	5.8	3.2	11.3	4.4	1.6	7.8	6.9	11.4	0.9	9.0	9.7	86.2	131.4	70.7	54.5	199.8	968.2	453.9	111.3	105.9	54.4	112.8	96.6	72.8	27.1	96.3	51.5	0.0	187.8	89.1	7.5	99.7	56.1	31.7	164.7	231.0	134.1	36.4	5.2	167.8	14.6	150.7	343.6	21.4	457.7	24.6	37.6	119.2	7.4	51.0	74.0	181.9	18.7	22.4	44.1	162.4	20.1	151.6	43.6	138.7	34.7	39.0	17.2	58.7	74.4	155.8	41.1	25.2	60.5	234.5	193.7	5.4	304.8	38.4	3.6	131.5	496.3	463.9	8.2	5.8	65.7	477.8	920.4	178.2	24.3	41.7	233.9
ARL11	"ARLTS1, FLJ33930"	ENSG00000152213	"ADP ribosylation factor like GTPase 11"	Q969Q4	13	49628507-49633872	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.2;Hofbauer cells: 31.3;Kupffer cells: 34.8;Macrophages: 18.2;monocytes: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 38.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.9;HMC-1: 10.7;NB-4: 11.1;THP-1: 14.5;U-698: 6.6;U-937: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040855, HPA040887"	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Intermediate filaments, Cytosol"		"HPA040855: AB_10793864, HPA040887: AB_10796229"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.72e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.14e-2)"	0.8	0.8	0.5	3.9	0.5	3.5	0.7	0.6	0.7	0.6	0.8	1.0	1.2	0.2	0.2	1.0	0.3	1.1	0.4	0.4	0.6	0.1	0.6	2.2	6.9	1.0	0.7	0.2	0.1	0.3	0.3	1.9	0.8	0.2	1.5	0.1	0.6	0.2	0.3	0.6	1.9	0.7	0.7	4.8	0.6	0.3	1.0	3.7	0.4	0.4	3.9	1.3	0.8	1.2	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.6	0.0	5.2	10.7	0.1	0.1	0.0	0.0	0.0	0.4	5.1	0.3	0.1	0.0	1.3	4.9	11.1	0.1	0.0	0.0	5.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	3.5	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.6	0.0	6.3	0.0	21.8	15.3	16.3	0.1	17.9	0.2	7.9	0.3	0.3	8.1	10.1	0.8	0.4	38.0	0.8	13.4	8.6	0.3	4.4	0.5	0.5	0.6	0.7	0.4	0.6	1.0	0.7	0.8	0.7	1.0	1.2	0.9	0.0	1.1	0.0	18.2	0.3	0.3	0.2	1.2	0.7	1.0	0.9	0.6	2.8	0.0	0.0	0.0	4.7	3.4	1.7	0.0	0.0	1.7	0.1	0.1	1.2	1.2	6.9	0.0	0.0	5.1	0.3	0.0	0.1	7.6	0.0	1.8	0.6	31.3	0.0	0.0	3.4	0.0	34.8	3.5	1.3	0.3	18.2	0.0	3.7	19.2	0.3	1.0	0.0	0.1	0.1	10.2	0.0	2.9	0.1	4.2	0.1	2.3	0.5	0.0	0.3	0.2	1.5	0.3	4.1	0.0	1.5	1.2	0.5	3.1	0.4
ARL13A	ARL13	ENSG00000174225	"ADP ribosylation factor like GTPase 13A"	Q5H913	X	100969708-100990831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 5.1"	"Group enriched"	"Detected in some"	29	"Early spermatids: 69.8;Late spermatids: 55.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037377, HPA037378"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA037377: AB_2675442, HPA037378: AB_10670932"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.37e-4)"	"unprognostic (2.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.1	5.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	55.5	0.6	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARL2	ARFL2	ENSG00000213465	"ADP ribosylation factor like GTPase 2"	P36404	11	65014160-65022184	"FDA approved drug targets, Predicted intracellular proteins"	"Cell cycle"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 430.8;Late spermatids: 1125.1;Proximal tubular cells: 505.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044610	Supported		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol"	"HPA044610: AB_10964207"	"unprognostic (9.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-3)"	"unprognostic (6.43e-2)"	"unprognostic (6.87e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.24e-2)"	124.8	93.7	161.5	40.6	190.2	51.3	112.0	172.4	200.2	106.3	132.3	123.1	52.7	121.2	28.2	67.2	94.6	48.0	169.1	157.0	168.7	138.5	22.5	90.4	37.7	171.5	167.9	95.7	75.3	65.3	68.5	56.1	167.2	84.7	32.9	43.5	67.9	66.6	214.2	95.8	73.4	60.9	171.4	63.4	85.2	116.1	167.4	33.5	85.7	158.1	29.0	112.2	93.5	184.4	162.0	257.0	76.5	115.8	207.4	156.5	70.5	82.5	181.7	111.2	109.1	72.8	110.0	62.1	144.5	112.7	168.1	101.4	82.9	140.0	53.1	65.5	130.6	61.9	109.2	111.9	157.8	77.9	54.9	123.7	114.6	92.6	204.4	160.5	150.4	74.0	152.8	110.1	76.4	194.1	63.1	174.5	120.3	77.7	208.6	33.4	81.6	152.9	120.9	70.6	143.3	79.3	66.4	67.6	225.8	74.4	72.3	94.3	109.2	205.9	68.6	164.7	82.1	37.9	57.6	38.5	97.2	112.5	171.3	46.5	78.2	72.5	120.4	80.2	130.9	163.1	110.0	116.9	101.7	149.0	123.5	137.2	10.2	83.3	48.2	140.1	79.0	136.9	161.5	190.2	172.4	200.2	157.0	168.7	171.5	167.9	167.2	171.4	167.4	184.4	179.1	22.4	43.6	0.0	42.7	81.4	94.4	118.4	63.7	70.2	66.8	83.9	103.2	51.5	66.4	82.8	29.2	179.7	40.0	110.0	268.0	142.0	430.8	42.2	59.0	148.0	83.3	69.4	0.0	76.0	193.5	107.0	29.6	50.7	95.7	71.5	137.4	19.7	98.3	69.0	0.0	68.4	83.4	49.7	73.5	1125.1	71.7	49.5	177.9	0.0	100.6	208.4	55.6	0.0	0.0	68.3	115.7	71.1	16.5	79.9	162.4	505.5	47.0	48.9	65.7	74.2	109.7	126.5	79.4	56.3	82.8	107.3	40.0	65.7	98.0	75.9
ARL6IP6	MGC33864	ENSG00000177917	"ADP ribosylation factor like GTPase 6 interacting protein 6"	Q8N6S5	2	152717893-152762396	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 214.0;eosinophil: 161.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 214.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014743	Approved		Approved	"Nuclear membrane,Cytosol"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear membrane"	Cytosol	"HPA014743: AB_1845030"	"unprognostic (4.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (5.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.57e-1)"	"unprognostic (7.39e-2)"	5.1	3.9	3.0	1.8	4.0	8.3	4.7	3.2	3.0	4.4	2.2	3.7	2.4	4.2	1.2	6.0	3.8	1.2	2.7	2.6	3.1	2.5	1.9	4.0	3.4	3.9	3.3	5.0	2.7	1.1	3.1	4.4	4.3	3.1	1.9	3.2	3.9	1.8	3.5	7.1	3.5	1.6	3.6	4.4	3.1	5.3	3.3	3.9	3.2	2.0	2.4	4.2	5.5	5.3	9.6	6.2	13.7	3.9	4.1	4.6	19.7	11.6	4.9	9.6	12.2	14.2	13.3	17.2	10.6	5.2	4.3	10.7	8.1	5.7	10.4	26.1	15.1	14.2	5.3	13.0	4.5	12.1	12.4	3.3	6.5	10.6	8.9	3.4	7.5	11.9	14.9	10.6	7.8	7.1	12.1	12.6	13.3	3.2	12.7	13.0	13.4	13.9	4.5	7.2	11.6	12.0	10.4	1.1	9.7	4.7	4.7	7.9	10.0	14.4	9.9	10.2	10.3	9.9	10.3	13.1	6.8	10.4	12.3	214.0	9.1	161.8	13.2	10.2	13.2	20.3	13.3	13.5	10.9	18.4	13.6	11.4	24.8	9.7	12.8	24.8	19.7	13.2	3.0	4.0	3.2	3.0	2.6	3.1	3.9	3.3	4.3	3.6	3.3	5.3	34.3	16.0	10.0	30.7	41.9	106.6	48.5	74.0	50.7	6.3	20.3	14.9	4.3	17.2	29.9	11.0	4.2	155.7	42.4	14.1	17.6	24.9	14.1	17.7	20.0	31.3	13.8	81.0	21.0	18.6	136.2	27.9	30.1	25.0	27.3	19.4	28.5	5.9	39.8	8.4	23.8	22.2	38.7	24.2	57.2	24.2	19.6	33.6	46.2	30.9	46.2	19.8	32.0	38.7	56.8	22.5	18.6	17.0	33.8	40.3	16.3	8.8	29.2	15.8	32.9	22.2	24.9	24.4	30.0	43.4	106.6	108.4	45.2	27.9	24.5	51.3
ARMC5	FLJ13063	ENSG00000140691	"Armadillo repeat containing 5"	Q96C12	16	31458080-31467166	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041524, HPA063706"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA041524: AB_10796676, HPA063706: AB_2685098"	"unprognostic (1.37e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.14e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.97e-6)"	"unprognostic (4.70e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	6.3	7.9	9.0	3.4	9.2	21.4	4.3	8.9	11.7	6.0	7.0	5.8	4.6	6.9	0.9	9.9	5.6	2.0	6.5	9.2	8.1	8.7	24.6	4.6	3.2	12.3	9.4	6.8	6.4	3.0	9.0	2.1	12.4	7.7	0.9	2.4	5.3	2.2	16.0	8.5	7.0	1.7	9.1	8.8	6.8	6.8	9.2	2.9	9.7	3.9	1.3	5.6	6.6	10.5	5.0	7.6	3.3	4.8	2.0	1.5	8.4	6.5	2.8	3.6	3.0	7.2	5.0	4.9	13.3	3.5	3.6	7.5	3.9	5.7	0.7	6.8	9.9	2.2	12.4	16.7	4.0	14.9	14.3	3.7	6.3	3.6	1.0	4.2	5.5	8.0	11.2	11.5	2.5	12.2	5.6	59.5	5.3	2.2	5.0	10.0	4.7	18.2	2.9	5.6	10.7	9.4	5.9	7.8	4.6	2.0	5.1	17.6	10.9	7.8	5.7	3.2	5.4	10.4	9.8	3.0	5.1	12.2	5.7	2.9	2.3	0.7	3.2	1.1	2.7	2.7	2.5	2.6	3.0	2.2	2.2	2.6	1.3	7.1	1.3	7.2	3.2	2.6	9.0	9.2	8.9	11.7	9.2	8.1	12.3	9.4	12.4	9.1	9.2	10.5	8.7	6.4	14.3	4.2	6.2	6.5	9.2	8.7	9.1	6.0	6.3	5.0	5.8	11.5	8.2	0.0	6.2	7.5	7.6	11.1	3.9	5.0	1.2	5.2	8.6	10.8	7.8	8.2	4.3	4.4	5.4	6.1	6.6	7.6	9.5	6.7	8.9	28.7	6.1	13.5	4.0	8.7	6.1	3.7	4.0	0.6	4.4	6.7	1.8	2.8	3.9	7.2	6.2	2.0	4.6	4.4	3.8	5.7	8.0	6.9	9.2	4.6	3.4	5.9	0.0	8.7	6.6	5.5	8.0	9.6	6.3	11.5	7.6	6.1	7.7	6.1
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing X-linked 1"	Q9P291	X	101550547-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 74.9;ASC TERT1: 66.9;BJ hTERT+ SV40 Large T+ RasG12V: 78.2;LHCN-M2: 70.7;RH-30: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000268, HPA005685, CAB020695"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Cytosol"	"CAB020695: , HPA000268: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	24.4	34.0	16.8	8.8	18.4	3.1	21.9	14.9	21.9	32.3	18.2	31.4	7.0	30.4	21.2	11.4	25.2	17.5	32.8	18.0	19.5	13.7	4.0	16.5	5.5	16.2	17.9	48.3	12.8	16.9	25.9	14.9	18.8	24.3	7.6	12.0	14.1	23.0	27.7	10.9	12.0	21.2	15.6	14.1	14.8	5.9	17.7	6.3	16.4	25.5	3.4	23.2	21.7	17.9	2.1	0.6	16.0	0.0	74.9	66.9	0.2	25.5	49.7	31.4	78.2	0.0	0.4	0.0	21.3	39.3	34.2	2.1	0.0	3.7	17.7	0.1	0.0	14.9	5.1	0.0	39.6	0.0	0.2	56.5	4.8	23.8	0.0	25.9	19.2	0.0	0.3	0.3	70.7	1.0	0.0	0.1	23.1	0.0	0.2	0.0	87.8	0.1	21.6	0.0	15.8	13.1	0.0	0.3	45.9	4.4	2.5	11.0	25.6	18.9	10.0	55.5	0.3	0.0	0.3	0.0	18.6	0.0	12.1	0.0	3.3	0.4	0.0	3.1	0.5	0.0	0.4	0.3	7.7	0.2	1.1	2.7	0.1	1.8	0.9	4.0	0.8	1.6	16.8	18.4	14.9	21.9	18.0	19.5	16.2	17.9	18.8	15.6	17.7	17.9	27.6	25.6	7.4	8.5	0.7	33.1	22.9	5.0	18.2	32.2	19.1	17.4	59.7	7.2	4.1	23.9	6.2	1.6	3.7	0.6	13.7	21.1	0.3	10.4	23.2	29.9	5.4	4.2	9.5	7.1	2.6	53.2	9.2	11.2	24.1	20.0	20.7	0.8	27.9	21.9	11.8	2.2	2.0	9.5	33.4	2.0	47.2	17.5	58.7	4.7	5.7	36.0	0.0	11.1	8.4	5.6	0.1	44.4	0.4	20.6	0.6	13.6	3.6	13.9	46.0	60.6	39.9	1.6	0.7	3.8	21.7	2.6	2.3	35.6	2.5	7.5
ARMCX3	"ALEX3, GASP6"	ENSG00000102401	"Armadillo repeat containing X-linked 3"	Q9UH62	X	101622797-101627843	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000325, HPA000967, HPA001530"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349"	"unprognostic (1.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.23e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-2)"	34.9	58.9	30.8	24.4	33.0	14.7	32.2	35.4	35.7	45.0	27.6	31.5	20.2	40.9	105.3	18.1	27.7	34.0	51.0	34.1	38.7	37.2	24.6	29.5	21.8	34.5	33.7	38.3	57.4	103.6	47.7	45.4	34.8	44.5	21.8	19.0	59.6	46.7	30.7	11.9	21.5	36.3	35.4	41.3	29.7	12.9	35.5	20.1	49.9	63.6	21.5	31.9	22.5	37.7	26.4	18.8	48.8	23.9	109.4	118.3	10.0	56.5	54.3	23.2	68.3	20.7	21.5	9.5	31.7	64.7	50.8	5.0	34.9	20.2	28.7	21.6	23.2	18.7	64.9	30.2	85.2	18.2	41.5	67.0	27.4	30.9	30.3	65.1	47.6	11.6	15.2	78.9	67.4	10.9	15.0	0.8	24.4	49.5	4.3	19.1	62.2	8.9	36.0	10.1	22.1	18.9	28.3	1.5	63.9	67.7	19.2	19.0	67.5	29.8	18.9	70.8	11.2	69.7	20.9	0.1	50.4	14.5	25.5	43.6	15.3	13.6	14.6	15.8	18.3	15.0	14.0	12.4	15.8	9.8	15.2	10.6	5.6	13.7	16.8	25.8	9.0	14.4	30.8	33.0	35.4	35.7	34.1	38.7	34.5	33.7	34.8	35.4	35.5	37.7	67.4	44.8	36.1	16.3	61.1	37.9	81.2	40.6	42.7	63.1	70.9	42.3	114.6	50.1	48.4	75.4	58.4	55.3	61.1	20.4	37.2	53.9	0.6	42.2	80.9	69.2	82.4	25.6	35.9	30.6	27.4	85.8	33.1	78.8	79.1	45.5	58.2	48.6	50.7	62.2	41.8	67.6	40.7	52.5	84.9	2.8	64.7	72.3	97.8	18.7	27.2	86.6	34.0	28.6	31.0	30.6	22.1	72.6	122.6	75.2	20.1	43.1	25.1	13.3	32.9	57.1	73.2	2.5	0.4	24.6	21.5	114.9	58.0	70.2	32.1	81.2
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 88.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.2	11.0	10.4	8.8	10.6	10.3	17.8	10.0	11.5	13.7	6.9	12.8	10.8	15.2	15.5	11.0	15.0	10.0	10.7	11.4	9.3	12.6	11.3	11.2	10.4	7.7	7.0	20.3	14.7	19.9	7.2	8.4	7.6	20.6	15.3	10.6	15.7	13.5	9.3	11.2	12.3	13.9	7.3	8.0	13.5	5.4	9.6	16.2	19.5	10.1	13.3	11.2	6.5	11.4	17.8	15.7	36.4	19.4	15.9	17.8	20.4	17.1	13.1	19.5	34.5	18.7	21.5	0.0	20.3	17.2	22.3	15.1	32.8	16.3	22.1	0.0	13.1	17.9	19.2	15.6	20.6	32.7	20.0	22.3	20.7	16.9	20.3	15.5	20.0	0.0	17.6	0.1	26.3	15.8	23.3	3.9	16.4	30.3	29.5	22.7	88.9	0.1	14.5	24.2	17.1	15.4	30.5	15.7	24.7	10.4	10.8	15.4	20.3	14.5	12.8	16.5	12.3	0.0	13.0	0.0	11.4	32.7	37.8	0.1	11.8	3.2	13.9	12.3	13.3	12.5	12.8	10.9	11.3	6.4	17.8	14.0	1.0	9.3	7.8	10.0	9.7	11.1	10.4	10.6	10.0	11.5	11.4	9.3	7.7	7.0	7.6	7.3	9.6	11.4	6.9	6.4	6.9	0.0	9.0	5.6	11.7	8.0	19.4	16.5	8.9	7.7	4.4	7.2	10.3	9.2	20.9	5.7	9.2	6.8	21.5	10.0	0.3	5.9	8.3	9.6	9.6	3.4	0.0	9.7	2.6	9.9	10.7	5.7	1.3	7.8	5.7	9.6	6.0	1.7	0.0	9.8	4.1	7.2	3.5	0.5	8.4	6.6	8.8	0.0	4.6	6.5	10.3	0.0	0.0	9.3	3.8	6.0	12.0	9.3	9.6	10.6	13.7	20.8	0.0	6.7	7.8	3.0	5.3	14.5	5.7	3.7	9.5	7.5	9.7	11.1
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		410000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	17.1	16.0	8.5	15.3	9.5	5.5	25.0	9.6	12.2	16.1	8.3	16.6	18.9	16.0	16.1	12.0	12.6	11.3	16.8	8.6	10.0	41.5	37.6	19.5	21.0	9.0	9.1	11.9	6.8	11.6	5.3	22.2	9.1	12.2	17.6	16.4	7.6	11.1	19.0	8.8	14.5	14.9	9.6	12.8	14.1	14.1	9.8	15.6	27.7	22.6	18.5	17.3	8.1	9.0	24.6	18.4	37.9	34.2	30.3	47.4	60.9	44.8	39.1	36.9	48.4	47.8	19.7	36.2	29.5	31.8	33.7	24.2	112.7	33.5	61.7	40.6	34.9	26.0	21.7	55.9	37.8	50.1	31.7	38.2	23.3	49.3	29.2	30.6	52.8	27.0	38.5	44.3	46.4	101.8	31.7	47.4	64.4	23.7	15.3	41.0	32.7	28.6	112.6	31.2	15.6	10.2	37.5	34.9	23.8	67.4	98.9	38.6	44.6	17.9	25.0	66.8	36.3	21.1	28.5	43.7	31.7	60.7	21.6	53.8	26.9	52.0	13.5	34.5	18.1	17.5	17.4	14.5	22.9	14.7	15.9	14.8	22.1	21.0	33.4	8.5	25.1	21.1	8.5	9.5	9.6	12.2	8.6	10.0	9.0	9.1	9.1	9.6	9.8	9.0	16.3	25.6	40.4	6.5	13.2	0.0	8.4	0.0	11.4	10.0	33.5	16.3	18.6	14.3	6.2	23.9	8.4	31.7	12.6	10.6	45.0	19.5	1.4	19.4	29.3	10.6	4.9	6.5	11.4	17.8	39.0	14.2	12.2	23.3	3.8	7.7	15.4	48.7	35.4	8.4	9.8	8.9	0.0	34.0	0.0	3.1	19.3	23.6	0.0	5.6	36.0	17.3	18.6	6.6	8.9	19.5	7.2	14.7	15.2	5.4	18.6	79.3	10.9	20.9	0.0	6.7	14.3	25.2	14.8	11.1	0.0	36.0	14.0	15.5	10.7	9.6
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325898-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 442.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		760000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	74.4	82.9	61.6	39.7	63.3	40.4	63.2	60.1	71.9	69.8	71.9	80.7	92.8	60.1	80.9	124.6	75.5	53.3	121.7	78.7	73.9	65.9	77.4	62.2	41.9	64.6	67.7	81.5	63.8	65.4	62.1	54.3	71.7	56.9	78.2	33.0	66.6	55.5	48.0	84.5	84.9	57.2	60.8	52.7	99.1	42.4	68.4	39.2	78.8	47.1	44.9	61.6	74.9	62.9	265.3	144.3	155.1	73.6	144.2	242.4	133.5	185.5	216.1	185.5	184.4	164.4	301.7	92.3	270.5	226.7	273.8	110.6	208.0	270.8	221.5	46.7	186.4	49.7	99.9	137.1	156.1	59.2	63.7	227.6	149.1	237.8	252.0	220.0	310.8	75.9	125.9	105.6	289.8	398.6	99.4	78.5	150.5	295.3	326.1	58.1	107.8	113.9	142.0	162.7	161.7	138.3	180.9	260.2	255.9	264.2	130.2	88.4	239.3	239.0	211.0	424.7	302.1	39.6	80.0	130.7	206.6	130.1	320.2	111.7	49.9	88.8	24.2	80.8	19.3	30.8	23.1	31.5	43.0	28.8	30.0	22.6	63.7	30.7	86.1	31.9	33.5	26.9	61.6	63.3	60.1	71.9	78.7	73.9	64.6	67.7	71.7	60.8	68.4	62.9	124.3	51.3	55.5	20.9	45.2	41.4	139.5	249.1	54.7	38.0	107.2	131.6	46.7	95.8	130.1	58.8	18.8	189.6	27.3	196.2	135.0	213.6	32.1	55.0	43.7	96.4	74.2	68.8	31.6	276.9	345.8	70.6	140.2	57.4	13.3	141.4	135.0	75.8	84.6	33.7	28.0	209.4	132.2	77.5	26.1	24.6	66.8	56.0	80.0	26.2	68.6	79.8	42.2	19.1	28.4	442.5	191.6	67.4	52.4	151.5	295.7	155.5	102.2	40.1	184.1	59.1	188.4	171.6	130.0	88.9	47.9	129.7	29.8	87.7	166.3	280.7
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635783	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	86.1	49.2	17.4	148.2	22.5	69.1	48.8	23.7	23.8	46.5	13.0	104.7	99.5	69.5	15.7	77.8	52.0	52.9	35.7	20.0	22.3	39.0	64.3	103.1	158.9	35.2	22.8	30.6	51.7	29.9	19.7	108.2	29.7	46.0	68.9	8.0	45.9	35.9	18.7	42.6	117.4	78.9	24.0	120.8	88.6	38.4	24.1	130.5	46.0	22.5	131.3	75.9	51.8	37.8	313.4	167.7	141.0	98.1	114.0	161.5	338.7	419.7	317.9	176.3	143.0	150.9	215.9	284.9	463.9	241.7	114.6	211.2	101.1	141.6	93.9	413.6	87.1	172.9	212.6	132.6	185.2	254.8	325.0	197.6	148.2	215.7	170.3	201.2	213.7	196.1	133.3	229.1	233.9	125.6	238.5	67.9	133.7	238.5	63.0	219.2	126.3	278.6	97.3	158.7	61.1	164.7	435.8	186.1	167.3	147.1	185.2	222.5	480.9	259.0	134.5	293.8	410.1	270.1	321.8	196.2	204.5	179.6	204.6	1221.0	987.7	1563.7	395.7	1110.1	315.7	338.3	382.3	407.1	838.9	339.7	409.4	415.4	1852.1	392.6	1267.7	394.3	512.4	1913.3	17.4	22.5	23.7	23.8	20.0	22.3	35.2	22.8	29.7	24.0	24.1	37.8	148.7	375.0	188.9	8.1	163.3	249.1	178.3	275.9	91.0	34.2	79.9	118.9	30.2	150.2	197.6	82.8	14.6	475.1	227.4	283.5	166.3	344.3	35.5	78.8	211.4	186.7	202.0	90.0	21.6	280.2	734.2	166.2	87.1	119.8	258.8	147.7	181.7	87.4	608.5	38.7	13.8	146.6	238.0	556.3	740.8	24.2	125.9	558.5	254.3	20.6	635.1	56.7	423.3	7.5	51.5	381.6	234.5	183.6	132.1	182.6	213.6	152.0	95.2	25.4	243.3	83.9	286.8	151.9	137.3	161.5	244.9	199.5	234.4	144.4	155.4	234.6
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 260.8;lymphoid tissue: 170.1;skeletal muscle: 85.6"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 861.9;Oligodendrocyte precursor cells: 624.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 260.8"	"Immune cell enriched"	"Detected in single"	30	"plasmacytoid DC: 10.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 10.1"	"Cell line enhanced"	"Detected in some"		"JURKAT: 111.4;MOLT-4: 68.4;REH: 37.3;RH-30: 20.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 254.3"	HPA017303	Enhanced	Supported	Approved	Nucleoli,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	Cytosol	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		0.2	0.2	34.8	0.4	260.8	4.5	0.1	85.2	69.9	0.0	0.0	0.4	0.2	0.0	0.0	2.6	0.0	0.0	0.2	48.5	15.7	1.1	2.3	0.1	0.1	14.3	7.8	0.0	0.1	0.0	12.6	0.0	15.6	1.1	0.4	2.9	2.1	0.2	85.6	0.2	0.3	0.0	0.0	0.2	0.2	0.0	9.1	170.1	0.5	48.6	0.4	0.0	0.0	44.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.6	0.0	5.2	0.0	0.0	0.0	0.6	0.0	111.4	0.0	0.2	2.6	0.0	68.4	0.0	0.1	0.0	2.7	37.3	20.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	34.8	260.8	85.2	69.9	48.5	15.7	14.3	7.8	15.6	0.0	9.1	44.5	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.0	0.0	861.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	108.2	0.0	0.0	0.0	0.0	3.5	0.3	0.1	0.0	21.5	0.1	0.0	0.0	624.8	85.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.5	0.0	21.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443674	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 345.8;Late spermatids: 460.2;Oligodendrocyte precursor cells: 622.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 11.6;monocytes: 6.7"	"Cell line enhanced"	"Detected in all"		"TIME: 167.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		31000	"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.63e-8)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	35.1	22.2	13.5	12.2	15.1	47.8	24.0	7.6	22.0	17.6	3.9	13.4	5.5	19.0	12.2	10.7	17.2	14.6	24.7	14.7	10.5	11.9	9.3	30.1	18.0	14.2	20.9	18.2	7.8	18.1	10.5	27.8	16.5	12.7	8.9	8.6	8.5	11.4	13.4	17.3	12.2	17.9	9.4	30.0	10.6	28.5	29.1	16.3	16.4	10.4	19.0	15.9	15.6	17.1	48.9	31.5	41.1	27.4	46.7	61.9	37.1	44.2	83.8	57.2	62.3	17.5	18.2	14.4	31.8	67.7	38.6	13.2	24.7	41.4	86.3	20.6	15.9	22.6	20.7	23.6	119.9	10.4	6.7	61.7	15.3	33.6	50.3	66.9	60.2	7.7	13.0	45.7	54.0	15.1	13.3	9.8	13.1	24.1	30.5	13.6	9.6	7.0	18.1	25.2	14.6	44.4	32.4	20.5	26.5	42.5	17.0	22.4	167.5	45.9	28.9	20.6	69.8	42.2	12.0	9.7	34.6	14.6	50.3	0.0	2.2	1.5	0.5	2.1	0.3	1.3	1.0	0.9	3.7	1.0	1.3	0.8	11.6	0.6	6.7	0.4	0.8	1.1	13.5	15.1	7.6	22.0	14.7	10.5	14.2	20.9	16.5	9.4	29.1	17.1	97.2	3.2	6.3	206.6	22.7	47.7	21.9	12.0	29.6	25.0	12.4	14.7	33.7	27.1	11.5	3.7	16.7	42.2	14.6	3.6	3.9	10.5	159.7	14.3	34.2	109.1	13.1	98.9	345.8	8.7	37.6	43.7	4.6	27.7	9.5	30.1	103.9	8.2	64.0	62.2	225.8	4.3	8.2	56.1	168.8	460.2	39.1	73.1	44.4	181.8	71.4	9.5	15.5	622.3	245.9	12.5	4.7	54.9	13.7	37.9	5.8	4.3	4.2	7.8	78.9	28.5	90.1	61.4	95.5	25.2	44.9	46.7	23.1	58.9	4.8	22.0
ASB2	ASB-2	ENSG00000100628	"Ankyrin repeat and SOCS box containing 2"	Q96Q27	14	93934166-93976739	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 522.2;tongue: 157.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 51.1;Early spermatids: 26.4;Late spermatids: 29.9;Skeletal myocytes: 27.6;T-cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 50.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.8;RPMI-8226: 12.4;SK-MEL-30: 5.9;U-266/70: 42.1;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001546			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA001546: AB_1078224"	"unprognostic (5.65e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.62e-6)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.49e-7)"	"unprognostic (2.51e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.27e-1)"	2.9	0.8	0.8	5.6	2.1	0.5	1.5	0.0	1.9	12.0	0.0	66.5	4.0	31.6	0.3	4.0	26.6	0.5	78.5	0.6	0.0	0.5	0.5	3.0	7.4	0.1	0.0	2.9	0.3	0.2	0.2	0.2	0.3	14.4	0.4	0.0	6.6	0.9	522.2	2.3	18.3	1.6	0.0	4.2	17.2	0.4	0.3	0.4	1.2	157.6	3.2	30.4	8.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.4	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.0	12.4	0.0	0.2	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.9	0.0	0.0	0.0	0.2	0.0	42.1	8.6	1.7	0.5	2.6	0.5	0.0	0.2	50.8	1.9	2.7	0.3	1.9	1.7	3.8	4.2	0.4	0.2	0.5	0.1	0.0	7.8	0.4	2.3	1.3	0.8	2.1	0.0	1.9	0.6	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.0	0.3	3.3	0.4	0.1	8.4	0.0	0.2	0.2	0.9	51.1	0.0	2.9	0.0	0.0	0.1	3.0	0.0	0.0	1.4	26.4	1.7	0.3	0.5	0.0	2.7	4.7	0.0	0.5	1.9	1.1	2.5	0.0	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	0.0	0.3	29.9	0.3	5.3	1.8	1.9	5.8	0.8	2.1	0.0	0.7	0.2	0.0	0.4	10.7	0.1	0.0	0.0	0.4	1.1	0.0	27.6	5.0	0.8	8.4	0.1	0.1	2.9	14.5	0.1	0.1	0.3
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3, p50"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	19.0	24.9	18.3	13.9	23.5	7.3	16.4	22.4	24.5	16.1	18.8	14.4	9.0	17.1	16.4	14.3	15.3	13.7	24.8	17.2	20.7	15.2	21.6	13.5	18.5	23.4	20.6	17.9	22.7	14.2	11.9	13.0	23.6	11.9	9.9	15.7	12.8	14.5	29.7	17.1	14.6	12.4	21.7	17.1	14.4	18.4	20.4	22.3	13.4	17.3	16.8	15.7	13.6	30.4	29.3	40.3	25.8	58.1	34.0	37.9	21.1	18.0	33.5	26.5	30.7	31.4	105.3	37.0	35.6	26.3	17.9	38.4	21.1	30.6	26.5	27.2	20.1	24.1	29.1	36.4	32.7	25.2	24.1	33.3	68.9	26.7	45.0	38.1	36.4	40.4	34.8	51.8	35.0	25.7	34.2	36.1	15.7	18.8	8.8	20.1	21.1	27.4	49.8	21.0	27.1	16.9	26.1	65.7	49.4	23.9	21.7	18.5	32.0	15.2	27.1	11.6	19.4	28.4	40.4	45.5	24.6	55.9	10.8	20.4	19.0	35.0	16.5	20.3	17.0	31.4	19.4	17.7	21.0	32.5	27.2	25.8	12.5	26.6	15.4	28.9	29.2	19.0	18.3	23.5	22.4	24.5	17.2	20.7	23.4	20.6	23.6	21.7	20.4	30.4	16.7	9.6	5.8	25.5	20.5	6.2	14.0	22.8	9.6	12.9	9.0	6.3	23.6	10.0	13.4	12.9	14.6	17.7	18.6	4.7	23.5	20.4	27.5	12.1	13.8	13.9	3.6	11.1	33.1	20.0	19.5	16.5	6.6	12.1	12.7	12.6	10.4	22.0	18.2	25.2	42.9	5.2	16.2	24.1	8.7	14.2	20.5	12.7	19.6	27.2	21.4	19.9	16.5	35.7	52.8	14.7	8.4	20.7	14.5	8.0	9.5	11.4	9.8	14.3	13.1	10.8	15.9	27.8	28.2	10.9	7.0	15.2	17.9	18.9	6.5	9.2
ASCC2	"ASC1p100, DKFZp586O0223, FLJ21588"	ENSG00000100325	"Activating signal cointegrator 1 complex subunit 2"	Q9H1I8	22	29788609-29838304	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 155.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001439, HPA052879"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA001439: AB_1078229, HPA052879: AB_2732577"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.01e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.97e-3)"	"unprognostic (5.19e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.05e-3)"	26.6	31.3	11.4	22.7	12.7	53.7	24.9	12.6	13.7	23.7	16.7	24.5	23.7	21.0	16.1	42.0	19.9	17.1	22.8	11.6	11.9	19.8	35.8	22.1	24.5	13.5	12.9	19.9	23.5	21.8	26.7	21.8	13.2	27.1	24.6	8.4	29.8	18.0	43.5	30.1	23.1	19.2	12.9	29.4	37.0	24.5	12.5	29.6	28.3	32.3	34.0	26.8	27.5	13.3	46.9	26.8	28.4	38.7	41.6	36.7	40.7	47.6	36.3	48.4	48.1	31.5	24.7	46.5	33.4	46.2	30.7	55.5	36.8	54.0	40.5	59.8	64.3	39.9	33.0	38.0	52.1	72.3	115.6	39.6	48.2	55.0	50.0	28.4	42.9	30.7	41.8	43.7	44.3	57.8	44.5	37.9	20.7	65.6	36.0	53.0	34.9	48.6	29.6	76.1	43.8	38.5	44.3	48.2	35.4	28.8	34.3	37.4	42.8	67.1	11.3	41.2	47.9	51.9	42.8	54.4	39.2	39.9	49.5	44.7	29.8	53.6	32.1	49.2	28.4	18.8	23.6	26.9	37.7	15.0	24.1	24.6	9.2	33.7	43.9	21.7	30.3	20.0	11.4	12.7	12.6	13.7	11.6	11.9	13.5	12.9	13.2	12.9	12.5	13.3	27.7	19.2	14.7	18.6	35.8	30.0	25.2	38.1	13.1	9.4	23.3	12.3	19.1	31.5	33.3	40.5	4.2	46.3	40.5	38.8	11.7	25.4	110.2	14.0	28.1	20.7	15.5	116.0	13.5	24.9	63.3	22.9	69.8	20.0	34.9	24.3	22.9	25.7	30.6	5.0	13.8	23.2	44.7	29.2	37.3	155.2	31.1	29.1	28.4	11.2	27.9	12.2	56.7	15.6	16.3	27.7	34.0	24.8	32.4	16.2	46.8	18.2	24.4	13.6	19.7	19.6	19.7	48.4	22.5	35.0	39.2	44.3	34.9	27.8	23.9	34.2
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957674-102960513	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;choroid plexus: 13.7;liver: 11.1;pituitary gland: 30.1"	"Group enriched"	"Detected in some"	5	"Astrocytes: 17.0;Enteroendocrine cells: 36.4;Oligodendrocyte precursor cells: 42.7"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"SCLC-21H: 53.7;SH-SY5Y: 29.0"	"Low region specificity"	"Detected in all"							"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA029217: AB_10669595, HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.0	1.1	18.7	0.0	18.3	0.0	0.0	18.9	23.0	0.5	13.7	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.0	18.2	16.8	0.0	11.1	0.5	0.5	20.1	18.1	0.4	0.2	0.0	30.1	0.0	18.5	0.3	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	1.2	0.1	18.7	5.5	0.1	0.0	0.0	0.0	0.3	19.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	29.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.3	18.9	23.0	18.2	16.8	20.1	18.1	18.5	19.9	18.7	19.4	0.1	0.0	0.0	17.0	0.3	0.0	0.3	0.0	0.0	4.3	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	36.4	0.0	1.7	0.0	0.0	0.2	4.6	0.1	0.0	0.0	0.0	1.8	0.1	5.0	4.1	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.4	0.0	42.7	0.3	0.2	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4
ASIC3	"ACCN3, DRASIC, TNaC1"	ENSG00000213199	"Acid sensing ion channel subunit 3"	Q9UHC3	7	151048292-151052756	"Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 12.5;Early spermatids: 15.6;Granulosa cells: 14.8;Late spermatids: 61.0;Spermatocytes: 10.3"	"Group enriched"	"Detected in many"	4	"glioma: 3.1;testis cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 16.7;U-266/84: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049155, HPA054805"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA049155: AB_2680657, HPA054805: AB_2732588"	"unprognostic (8.71e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.45e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-12)"	"unprognostic (1.49e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.31e-3)"	2.8	2.1	8.2	0.3	9.0	0.6	2.7	11.7	10.9	13.3	6.7	7.9	1.1	7.7	1.5	1.9	7.2	0.7	10.9	7.9	8.8	4.8	4.0	3.2	0.8	9.3	7.9	6.4	2.1	0.5	18.1	0.6	10.3	5.3	0.6	8.7	1.6	0.4	6.0	2.9	4.1	0.8	7.0	2.8	3.8	19.9	8.6	0.6	4.1	0.9	0.7	3.1	4.3	11.5	1.5	4.0	1.7	2.7	3.7	0.0	7.4	0.4	0.2	0.3	0.5	0.8	1.9	0.9	0.4	0.2	1.8	2.4	1.0	0.0	0.7	8.9	4.5	1.7	3.4	0.0	0.0	0.1	3.9	0.9	0.7	0.2	0.0	2.9	0.1	1.1	4.2	6.8	0.5	6.3	0.3	0.4	1.8	0.1	3.3	3.1	1.7	0.5	0.3	1.4	2.3	8.2	0.6	0.5	4.3	4.9	1.8	0.4	0.1	1.4	2.1	4.3	1.1	16.7	10.2	0.1	2.3	5.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	9.0	11.7	10.9	7.9	8.8	9.3	7.9	10.3	7.0	8.6	11.5	0.4	0.0	0.5	2.9	0.5	0.6	0.0	0.2	0.0	9.7	0.6	0.6	2.1	0.0	0.2	0.0	12.5	0.2	0.3	0.6	0.0	0.2	15.6	0.9	1.1	0.3	0.0	0.0	3.4	0.4	0.2	0.3	0.5	0.8	8.9	14.8	0.0	0.9	0.6	6.7	4.2	0.1	0.0	0.6	0.9	61.0	1.5	0.4	0.0	0.0	0.6	1.6	0.0	1.5	5.1	0.4	0.0	1.9	0.1	0.3	0.2	0.2	0.6	4.9	0.0	0.7	0.4	10.3	5.6	0.0	0.9	0.7	0.3	0.2	0.2	0.2
ASL	ASAL	ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075800-66094697	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 396.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 294.6;Exocrine glandular cells: 218.6;Hepatocytes: 578.0;Paneth cells: 240.4;Proximal enterocytes: 259.9;Proximal tubular cells: 243.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		12000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	21.7	16.1	5.9	16.7	6.0	23.9	22.0	6.6	8.5	18.2	8.7	53.8	60.7	17.0	6.7	28.7	18.1	27.7	16.9	5.9	8.0	61.2	396.4	27.4	10.3	7.4	7.1	19.7	37.1	15.1	19.8	9.1	9.8	19.5	35.7	2.4	18.3	9.8	8.7	15.1	45.6	10.1	6.2	30.5	43.9	4.5	7.6	5.3	24.9	6.9	8.8	19.3	19.8	6.7	48.4	18.9	11.2	36.7	26.3	18.1	22.1	34.0	31.8	49.5	43.6	43.7	59.0	15.9	53.7	48.5	36.6	13.4	7.1	59.1	11.1	10.5	8.9	18.8	17.9	77.2	48.8	24.0	51.3	38.3	19.5	31.8	51.8	12.5	48.1	11.3	34.4	27.8	25.4	36.6	4.8	28.9	15.8	65.5	26.1	12.1	11.0	51.6	31.9	31.6	18.4	24.3	32.3	109.7	12.3	11.4	46.0	19.7	55.1	53.7	30.8	23.5	45.2	30.2	16.9	19.0	55.0	41.5	49.5	34.2	42.6	50.8	16.9	46.6	15.1	21.8	11.5	13.4	46.2	13.8	8.2	8.5	7.3	73.7	36.1	2.5	23.4	27.3	5.9	6.0	6.6	8.5	5.9	8.0	7.4	7.1	9.8	6.2	7.6	6.7	34.5	19.2	61.4	5.2	20.4	5.5	21.4	24.2	9.1	12.7	24.5	20.4	9.2	124.4	25.8	31.3	22.9	20.7	25.4	294.6	52.8	73.7	4.0	41.2	12.1	30.7	54.0	47.1	9.4	218.6	45.7	14.4	115.7	34.1	44.5	12.0	42.8	578.0	46.0	15.2	9.7	126.5	16.2	41.2	17.6	6.3	9.3	22.3	8.8	1.9	48.3	7.2	34.0	2.5	4.8	118.3	240.4	8.2	23.4	14.9	259.9	243.1	42.8	13.2	13.1	16.9	17.5	3.2	5.7	19.5	4.3	22.3	18.0	13.5	189.4	22.0
ASNSD1	"FLJ20752, NBLA00058, NS3TP1"	ENSG00000138381	"Asparagine synthetase domain containing 1"	Q9NWL6	2	189661385-189670831	"Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036132, HPA036133, HPA075042"	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA036132: AB_2674960, HPA036133: AB_10696650, HPA075042: AB_2686731"	"unprognostic (1.32e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.15e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.98e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	27.1	26.1	23.1	19.2	24.5	36.9	33.5	31.8	33.5	27.9	21.3	21.1	22.5	28.6	19.6	21.3	24.0	19.7	32.2	23.6	25.5	30.5	40.4	21.9	27.1	24.2	24.0	37.6	27.1	33.2	19.1	33.7	24.5	21.6	18.3	40.2	25.2	20.8	59.6	17.5	17.7	28.1	24.6	23.0	20.4	17.5	24.1	27.9	26.3	70.5	25.1	27.4	17.1	25.9	33.1	22.0	53.5	42.5	58.9	50.4	47.2	66.4	57.1	65.7	67.5	72.5	22.6	65.3	39.0	61.9	36.4	26.5	60.2	49.2	76.6	65.4	72.5	57.5	48.5	69.2	61.4	59.9	33.2	59.9	37.2	66.3	58.9	46.5	63.3	46.9	58.6	49.6	69.6	43.2	68.8	68.9	81.0	55.3	102.4	41.3	43.4	62.4	39.0	40.2	59.5	31.2	41.7	35.0	59.1	66.7	52.3	55.9	57.0	56.6	44.5	48.1	73.4	73.7	86.5	93.4	44.1	33.9	52.7	82.8	26.1	107.6	38.8	22.7	48.6	37.2	42.3	43.3	26.7	37.2	49.4	45.3	48.9	49.1	25.2	21.4	57.6	37.3	23.1	24.5	31.8	33.5	23.6	25.5	24.2	24.0	24.5	24.6	24.1	25.9	31.3	54.5	34.9	10.1	41.1	30.0	24.4	31.2	25.0	22.4	29.7	25.9	43.7	28.6	35.6	16.5	12.5	67.2	36.1	24.1	82.2	35.7	7.0	24.8	34.9	31.1	36.0	41.7	17.2	45.3	43.3	41.8	16.8	22.8	19.0	24.6	29.6	51.9	34.1	15.2	18.9	25.2	26.4	28.0	23.7	5.6	40.7	24.5	17.8	7.5	34.7	40.5	50.4	14.6	17.6	36.5	12.0	33.8	37.9	23.0	18.7	56.7	29.4	27.0	46.0	48.7	47.9	30.3	43.8	29.4	28.4	119.9	42.7	30.9	27.7	19.3
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.1;kidney: 39.0;liver: 132.4"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 135.8;Proximal tubular cells: 487.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;MOLT-4: 16.5;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042631, HPA042654"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		200000		"Cluster 15: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	0.5	2.5	18.1	0.9	20.9	0.5	0.0	23.7	40.1	0.0	7.3	0.2	6.6	0.2	0.0	0.3	0.0	1.7	0.3	19.8	17.3	39.0	132.4	0.2	0.9	17.0	17.5	0.0	0.8	0.0	19.6	0.0	16.8	0.3	0.0	5.4	1.6	0.0	0.3	1.1	2.5	0.0	13.4	0.6	0.3	0.2	22.9	2.4	0.9	0.0	0.0	0.1	0.1	21.9	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.6	0.0	0.7	3.8	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	1.7	0.0	1.6	16.5	0.1	0.0	0.6	0.2	0.4	0.3	1.1	0.0	0.2	1.7	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	3.6	0.8	1.8	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	20.9	23.7	40.1	19.8	17.3	17.0	17.5	16.8	13.4	22.9	21.9	0.0	0.0	0.0	3.3	2.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.4	1.5	0.0	9.2	4.2	0.0	0.0	0.1	45.0	0.0	0.7	0.0	0.0	0.1	7.1	10.7	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	135.8	0.0	0.0	4.4	0.1	0.0	1.9	0.0	2.5	0.0	3.4	0.0	2.8	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	8.8	487.2	0.0	4.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Assembly factor for spindle microtubules"	Q8IZT6	1	197084121-197146694	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 10.1;lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.5;Granulosa cells: 121.1;Plasma cells: 44.8;Spermatocytes: 43.8;Spermatogonia: 44.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017816			Approved	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.2	0.1	0.0	3.0	0.0	10.1	0.4	0.0	0.1	0.2	0.0	1.6	2.1	0.3	0.0	1.5	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.3	5.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	1.9	0.0	0.2	0.0	0.0	2.7	1.9	0.7	0.0	0.9	1.1	3.2	0.1	17.0	0.1	0.0	5.1	0.6	0.4	0.2	44.6	22.9	39.1	23.2	1.9	5.5	14.7	35.1	23.2	32.6	25.6	16.7	31.1	45.4	12.5	27.5	13.8	40.2	33.6	12.1	39.1	41.8	25.4	33.1	56.1	12.8	0.4	51.9	20.5	0.6	1.0	26.1	15.2	7.3	31.5	32.9	41.8	50.7	29.0	16.0	40.6	10.3	17.8	24.8	6.4	30.2	55.5	31.7	7.4	11.4	20.4	29.5	50.6	20.6	9.5	20.8	26.9	12.7	28.9	20.9	20.0	34.9	61.2	13.9	21.6	26.8	14.9	11.0	42.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	1.1	1.3	5.8	6.1	1.5	4.0	2.2	0.1	2.4	2.4	1.1	0.0	1.3	1.8	0.0	20.0	7.8	7.7	0.0	0.3	3.9	2.9	6.2	4.3	0.0	99.5	2.0	0.0	14.8	9.8	13.3	8.1	1.3	121.1	6.4	2.2	11.6	0.0	4.8	6.8	4.1	6.4	2.4	4.5	0.6	6.4	0.0	0.0	0.9	0.7	4.1	0.0	1.0	0.5	0.2	1.5	44.8	2.0	0.4	0.4	0.8	0.3	0.0	0.6	7.0	43.8	44.7	27.1	3.4	3.7	9.1	5.7	16.9	2.1
ASPRV1	"FLJ25084, SASPase, Taps"	ENSG00000244617	"Aspartic peptidase retroviral like 1"	Q53RT3	2	69960089-69962265	"Human disease related genes, Plasma proteins, Predicted membrane proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"skin 1: 424.0"	"Cell type enhanced"	"Detected in some"		"NK-cells: 3.1;Oligodendrocytes: 4.2;Spermatogonia: 3.3;Suprabasal keratinocytes: 10.7"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 23.1;melanoma: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 8.7"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.9;REH: 4.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA034809, HPA034810"	Enhanced		Approved	Cytosol		NA	NA		150000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 61: Skin - Cornification"	"Cluster 14: REH - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA034809: AB_2674343, HPA034810: AB_10601456"	"unprognostic (4.75e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.43e-2)"	2.6	2.1	5.8	0.9	7.3	0.9	17.1	6.1	6.6	3.1	3.0	1.7	1.6	2.5	2.6	0.9	2.3	1.1	1.8	5.3	6.0	2.2	1.9	1.7	1.0	7.2	6.7	4.8	0.7	0.2	4.0	0.9	6.5	2.2	0.6	1.5	1.3	1.3	4.4	424.0	1.7	1.2	6.0	3.9	1.2	3.6	6.5	2.1	1.3	2.1	1.0	1.5	4.5	9.3	0.0	0.3	0.9	1.9	1.2	0.4	0.2	0.2	0.4	0.2	0.1	0.6	0.0	0.7	0.1	0.2	0.2	0.2	0.8	0.1	0.2	1.3	2.5	1.5	0.2	0.6	0.4	1.3	1.0	0.5	0.4	0.2	0.4	0.3	0.2	1.6	0.5	1.9	0.2	0.3	1.1	2.9	1.0	0.2	0.2	4.9	0.5	0.3	0.0	0.0	1.0	0.2	0.1	0.7	0.8	0.2	0.0	0.5	0.1	0.0	0.9	0.0	0.2	2.0	1.3	1.4	0.1	0.9	1.0	0.0	0.1	1.5	0.5	0.1	0.5	0.0	0.2	0.4	0.0	0.1	0.1	0.4	8.7	0.3	0.0	0.8	0.7	0.4	5.8	7.3	6.1	6.6	5.3	6.0	7.2	6.7	6.5	6.0	6.5	9.3	1.1	0.0	0.0	1.3	0.0	0.4	0.1	0.2	0.0	1.1	0.5	0.9	2.6	0.0	0.1	1.8	0.0	0.3	0.1	0.5	0.0	0.1	0.1	0.4	0.5	0.8	0.0	0.0	1.0	0.2	0.0	0.7	0.0	0.4	0.0	1.1	1.4	0.1	0.2	0.0	1.5	0.9	0.0	0.3	0.6	0.5	0.9	0.3	0.0	1.0	0.2	1.2	3.1	1.5	4.2	0.3	0.0	0.7	0.1	0.2	1.1	0.9	0.2	1.6	0.0	0.7	1.1	1.4	3.3	0.0	10.7	0.4	0.2	0.5	0.2	0.1
ASTN2	KIAA0634	ENSG00000148219	"Astrotactin 2"	O75129	9	116423112-117415070	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 354.6;Excitatory neurons: 370.0;Inhibitory neurons: 1011.0;Late spermatids: 228.2;Oligodendrocyte precursor cells: 900.3;Oligodendrocytes: 225.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027035	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA027035: AB_1845122"	"unprognostic (3.25e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.93e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	3.3	9.8	26.1	2.7	26.3	3.6	4.3	39.0	36.0	5.3	9.0	5.2	3.4	3.2	3.9	2.2	8.0	2.5	22.5	27.0	25.8	5.5	4.1	2.2	2.4	29.3	36.2	2.8	6.7	3.1	11.6	1.8	28.7	25.2	3.2	13.4	5.8	11.3	7.3	2.4	4.1	2.8	21.4	2.4	5.6	17.6	35.0	6.0	1.8	5.6	1.8	3.2	3.5	39.2	3.7	12.0	4.3	7.1	7.6	7.0	15.4	5.7	2.3	2.5	2.8	8.1	4.4	8.8	6.1	3.8	9.3	1.3	11.5	0.6	3.1	4.8	2.9	3.1	5.8	17.0	3.0	1.8	6.2	9.5	1.1	7.8	0.7	5.4	1.8	10.5	3.9	5.9	7.9	3.8	4.1	1.4	13.2	10.6	6.4	4.9	27.5	2.5	8.0	12.3	6.3	37.9	6.8	2.0	4.8	14.5	15.5	1.3	3.5	5.9	9.1	5.6	4.9	9.0	5.0	8.3	10.5	2.0	25.8	2.5	0.4	0.5	2.8	0.3	3.6	1.5	3.1	2.4	0.2	1.6	3.0	2.5	1.9	5.9	0.6	0.9	8.8	1.0	26.1	26.3	39.0	36.0	27.0	25.8	29.3	36.2	28.7	21.4	35.0	39.2	0.6	6.4	8.9	354.6	1.1	1.3	3.2	0.4	1.2	4.9	4.2	4.8	22.7	2.8	5.0	1.8	10.4	0.4	1.0	0.4	3.9	0.8	122.5	4.7	5.5	1.3	12.6	0.4	370.0	1.1	0.4	4.9	4.1	0.7	6.3	37.0	0.7	2.9	3.2	10.1	1011.0	1.0	0.0	0.0	1.6	228.2	2.8	1.0	0.0	36.5	0.2	3.0	0.0	900.3	225.9	0.5	2.1	5.7	3.6	11.7	5.7	6.9	11.7	5.1	0.0	1.9	2.0	7.7	13.2	0.3	0.6	0.3	3.8	1.9	1.8	2.2
ASZ1	"ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3"	ENSG00000154438	"Ankyrin repeat, SAM and basic leucine zipper domain containing 1"	Q8WWH4	7	117363222-117428123	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 10.7"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 89.0;Spermatogonia: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020558	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA020558: AB_1845123"								"unprognostic (4.30e-1)"				"unprognostic (1.87e-1)"			"unprognostic (1.42e-1)"			0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	6.6	0.2	0.0	89.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family AAA domain containing 5"	Q96QE3	17	30831966-30895869	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 59.3;Spermatocytes: 73.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"	Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	0.7	0.4	0.3	2.1	0.2	12.3	1.2	2.6	0.5	0.8	0.1	1.2	1.4	1.0	0.4	1.3	0.7	0.5	0.4	0.3	0.2	0.4	0.5	0.8	3.6	0.2	0.1	0.9	0.5	0.3	0.5	1.4	0.3	0.6	1.6	2.5	0.7	0.4	0.4	2.5	1.4	0.6	0.1	1.4	1.1	2.0	0.3	5.3	0.6	0.1	2.9	0.6	0.9	0.6	7.2	6.0	14.0	13.3	0.3	1.4	5.5	6.3	3.2	6.9	9.8	6.6	5.1	19.5	5.9	2.9	4.7	13.0	9.1	4.7	12.4	4.4	7.9	11.7	8.0	4.6	0.2	23.1	9.2	0.6	0.6	10.1	3.5	1.4	3.6	18.7	18.7	15.9	4.6	4.2	26.1	11.5	8.2	5.3	2.9	17.6	26.4	9.3	1.8	7.6	8.1	7.2	7.0	4.0	3.7	7.6	7.6	10.2	2.8	8.3	11.3	12.0	11.4	5.2	5.9	24.0	3.6	10.7	8.4	0.4	0.2	0.3	0.3	0.3	0.2	0.3	0.1	0.2	0.1	0.4	0.2	0.2	0.6	0.6	0.1	0.5	0.3	0.1	0.3	0.2	2.6	0.5	0.3	0.2	0.2	0.1	0.3	0.1	0.3	0.6	4.3	3.2	4.1	6.8	9.9	4.7	3.1	2.6	3.4	19.3	4.7	5.1	2.7	0.0	2.6	3.7	0.0	21.7	10.7	6.6	0.0	4.1	13.9	4.4	8.5	5.4	0.0	59.3	20.4	2.9	21.1	5.4	9.7	5.1	3.8	32.6	2.9	0.7	8.7	11.8	17.4	8.6	2.0	2.8	7.4	7.8	3.7	5.7	7.2	11.2	10.0	2.9	12.3	16.6	14.9	4.0	2.4	2.2	24.4	2.4	2.3	0.5	2.7	21.3	0.0	7.4	6.5	73.3	34.5	9.3	4.5	7.9	10.5	8.4	13.0	2.3
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.6;Late spermatids: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 8.0;AN3-CA: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus, Cytosol"		"HPA046816: AB_2679822, HPA050999: AB_2681303"	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.35e-4)"	5.3	6.0	2.3	0.6	2.9	0.6	7.6	1.8	3.3	12.4	0.9	8.6	0.5	9.7	3.6	7.6	9.8	0.7	5.5	2.6	3.3	11.3	7.6	5.8	0.6	2.3	2.7	13.4	6.0	0.2	21.3	0.4	2.5	13.5	0.6	2.5	7.7	0.3	4.9	6.6	7.8	0.7	1.9	5.6	7.4	13.5	2.5	0.7	9.3	0.0	0.7	9.2	8.4	3.1	1.4	0.7	8.0	5.3	0.9	0.7	0.6	0.3	0.0	0.2	0.4	2.3	1.4	0.1	1.1	1.1	2.2	1.5	2.5	0.9	0.0	1.0	4.2	0.1	0.1	2.6	0.4	0.5	1.1	1.4	0.5	0.3	0.0	1.0	0.5	3.8	1.5	0.0	1.3	1.5	1.0	0.3	0.4	2.2	0.0	1.0	0.1	0.4	1.3	2.4	0.3	3.2	0.6	0.6	0.4	0.0	2.9	0.4	1.0	3.0	1.3	0.0	0.5	0.9	2.5	0.8	1.6	3.4	2.1	0.5	0.4	0.3	0.1	0.3	0.1	0.5	0.2	0.1	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.5	0.1	0.1	2.3	2.9	1.8	3.3	2.6	3.3	2.3	2.7	2.5	1.9	2.5	3.1	6.2	0.0	1.5	14.7	6.4	5.6	14.0	16.9	14.2	9.0	9.4	11.4	1.9	5.7	8.6	14.7	10.4	11.9	4.1	7.6	7.9	11.9	87.6	9.0	7.7	7.9	18.0	3.0	7.8	4.5	6.3	6.9	8.2	8.0	1.3	16.0	3.3	2.9	6.1	1.7	11.4	8.9	14.2	1.6	3.1	42.4	4.1	3.1	0.0	5.6	9.1	12.5	6.2	16.6	13.1	9.3	10.8	8.6	4.1	11.6	9.7	5.4	10.8	10.7	6.6	8.0	7.8	12.4	11.8	8.0	5.4	8.9	4.7	6.1	11.1	15.3
ATF7	ATFA	ENSG00000170653	"Activating transcription factor 7"	P17544	12	53507856-53626410	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 141.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003384	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (2.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.59e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.28e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.17e-1)"	26.4	13.2	12.4	18.1	19.6	15.4	23.9	26.1	16.7	21.1	11.5	21.9	12.6	24.4	14.5	22.4	17.8	18.1	20.6	15.1	15.5	17.4	14.6	20.2	13.2	20.8	16.9	24.6	18.4	14.2	11.5	18.3	21.8	19.0	21.1	15.3	24.2	14.6	30.5	24.6	14.0	25.9	14.8	14.3	18.0	12.6	18.2	16.4	16.4	22.2	15.7	19.9	20.9	29.1	16.6	32.1	16.6	18.2	30.8	39.1	10.8	19.6	20.1	21.3	14.2	23.0	25.2	25.8	25.4	24.2	8.7	20.2	13.0	21.7	19.2	25.2	16.7	22.6	37.4	24.8	20.7	29.0	16.1	30.7	28.1	26.5	29.9	35.3	42.6	14.0	26.0	23.2	32.1	30.9	17.6	20.2	16.3	18.7	17.4	22.9	19.7	24.9	32.3	21.2	13.8	14.6	29.9	21.7	30.8	16.0	29.2	17.6	31.4	25.2	17.7	20.2	17.9	11.4	14.6	16.2	20.6	27.1	23.6	15.3	13.8	13.8	7.4	19.1	7.6	10.5	10.1	7.5	10.8	11.5	7.2	8.6	8.6	14.2	14.1	7.5	10.4	8.8	12.4	19.6	26.1	16.7	15.1	15.5	20.8	16.9	21.8	14.8	18.2	29.1	30.5	12.8	17.3	83.2	16.3	22.2	24.0	35.9	25.6	9.4	33.3	31.1	18.2	22.8	23.4	14.7	25.0	22.2	14.0	21.4	37.2	30.3	32.2	16.5	23.1	25.4	18.6	13.2	29.0	31.6	25.0	23.8	17.3	22.5	28.6	25.0	28.9	14.7	25.3	10.1	29.7	20.3	24.4	24.1	23.1	35.8	27.1	24.9	24.9	55.3	24.0	23.9	17.5	40.7	141.9	27.5	13.8	24.5	12.5	25.0	17.9	46.0	17.0	10.9	26.3	25.6	27.5	9.9	17.9	34.1	28.8	27.9	17.3	20.2	18.4	28.9
ATF7-NPFF		ENSG00000267281	"ATF7-NPFF readthrough"		12	53506688-53625979	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A549: 1.4"									HPA003384	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA003384: AB_1078234"	"unprognostic (1.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.37e-4)"	"unprognostic (6.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.91e-2)"	"unprognostic (2.26e-7)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.77e-3)"	0.1	0.0	0.1	0.0	0.5	0.3	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.2	0.0	0.5	0.2	0.2	0.0	1.0	0.2	1.4	0.0	0.1	0.5	0.7	0.0	0.0	0.4	0.5	0.1	0.1	0.2	0.5	0.1	0.0	0.0	0.4	0.1	0.3	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.7	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.8	0.5	0.1	0.6	0.7	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.7	0.0	0.0	0.4	0.1	0.1	0.1	0.5	1.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.8	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ATG13	KIAA0652	ENSG00000175224	"Autophagy related 13"	O75143	11	46617527-46674818	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039350			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039350: AB_10673142"	"unprognostic (3.66e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.47e-1)"	32.3	39.7	55.9	26.1	67.6	60.5	30.1	49.4	63.7	30.6	46.1	26.5	29.3	28.2	32.2	32.0	32.1	29.6	36.8	55.2	51.8	28.7	43.9	25.3	31.5	60.2	59.4	29.7	44.6	37.5	57.7	21.9	61.8	31.1	24.1	48.4	35.9	25.5	34.5	39.6	28.0	24.8	51.8	36.4	36.4	82.0	59.6	40.6	36.8	33.4	33.6	27.4	29.1	87.9	32.8	58.5	44.1	26.1	60.2	70.0	44.5	37.5	65.4	45.0	57.0	40.2	31.7	30.2	25.6	56.5	58.1	38.8	42.7	50.3	45.2	57.9	81.1	32.8	39.7	71.2	67.4	44.1	54.1	84.9	59.0	31.0	67.9	63.9	45.0	69.4	57.8	66.8	40.8	48.8	44.0	65.1	55.0	59.5	49.9	41.4	57.0	53.7	29.9	34.5	41.6	42.1	51.2	40.6	55.4	42.1	58.0	89.5	44.6	54.7	33.3	51.1	41.2	61.1	73.8	38.6	67.8	39.3	40.9	41.7	36.1	48.5	35.1	42.6	27.9	27.1	31.2	27.8	35.0	21.7	26.4	29.2	67.7	31.5	35.1	25.6	44.7	39.9	55.9	67.6	49.4	63.7	55.2	51.8	60.2	59.4	61.8	51.8	59.6	87.9	10.6	16.0	16.2	14.7	16.9	9.3	12.0	9.0	13.1	22.7	16.7	12.3	13.2	8.6	12.0	12.9	39.6	9.9	25.4	24.5	7.9	18.9	42.7	30.0	17.3	12.7	18.0	28.2	23.4	32.3	22.4	14.8	20.9	46.1	8.8	22.5	13.2	22.5	15.1	33.7	25.7	22.6	14.2	19.1	9.8	46.8	11.5	15.7	12.4	15.0	22.8	16.3	19.6	25.1	61.0	30.4	12.9	11.3	36.6	19.9	19.5	13.5	9.4	32.2	13.1	16.9	19.9	46.3	16.3	15.8	11.5	26.4	18.0	9.8	11.9	24.3
ATG16L1	"APG16L, ATG16A, ATG16L, FLJ10035, WDR30"	ENSG00000085978	"Autophagy related 16 like 1"	Q676U5	2	233210051-233295674	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012577, HPA063900"	Supported		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA012577: AB_1845155, HPA063900: AB_2685146"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.93e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.08e-1)"	7.6	7.8	7.0	3.8	7.5	14.3	8.8	7.9	8.4	8.1	12.8	11.1	5.0	9.6	5.5	11.6	7.1	3.3	10.7	7.3	6.6	9.2	15.1	7.6	5.8	6.5	6.3	8.5	8.6	5.3	5.5	4.0	6.9	12.1	5.2	5.6	11.5	4.3	19.9	17.2	11.1	5.2	6.3	11.5	11.1	13.5	6.5	5.9	11.2	6.1	5.2	11.5	8.2	7.7	13.3	12.2	4.9	8.5	12.4	8.0	14.0	11.4	9.3	9.6	8.9	8.9	9.7	3.1	3.7	8.9	14.3	7.7	9.8	6.4	9.8	6.2	7.7	7.1	9.1	14.6	9.1	5.6	9.0	5.3	9.1	11.5	8.7	7.2	9.0	4.7	7.6	2.9	10.2	9.3	6.7	11.2	19.1	14.1	17.6	4.8	10.3	2.6	9.9	8.4	8.8	6.5	7.8	8.5	8.5	7.4	5.3	7.1	10.7	6.2	5.4	9.6	10.3	6.5	3.9	6.1	10.5	5.7	10.2	0.0	1.7	2.9	4.8	1.4	3.7	2.0	3.1	4.4	1.4	2.2	3.5	3.5	1.2	4.1	4.7	0.7	3.8	2.1	7.0	7.5	7.9	8.4	7.3	6.6	6.5	6.3	6.9	6.3	6.5	7.7	6.1	6.4	8.2	5.2	7.4	9.1	4.6	5.2	3.4	8.4	12.0	6.6	5.6	7.2	11.6	5.5	4.2	4.6	20.9	13.9	5.9	8.3	1.2	16.4	10.9	6.4	9.0	3.8	31.0	6.7	6.2	5.2	8.2	31.8	9.5	6.4	6.1	10.2	5.6	1.7	25.6	5.1	6.1	6.3	5.7	1.7	4.1	5.1	10.6	8.4	6.6	7.1	4.1	11.6	21.4	16.8	8.0	3.8	8.1	7.1	9.2	5.6	11.5	19.5	6.6	5.8	6.9	11.0	17.6	7.3	13.2	3.7	19.2	5.1	8.4	6.0
ATG4B	"APG4B, AUTL1, DKFZp586D1822, KIAA0943"	ENSG00000168397	"Autophagy related 4B cysteine peptidase"	Q9Y4P1	2	241637213-241673857	"Enzymes, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037195, HPA069803"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB037195: AB_1078237, HPA069803: AB_2686200"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.60e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.64e-4)"	12.0	17.5	21.4	8.1	21.7	14.7	13.2	20.9	24.7	18.0	20.1	19.7	11.4	16.8	5.3	16.2	16.8	7.6	18.4	21.6	23.0	19.7	18.0	12.4	13.2	23.0	21.4	16.5	16.4	12.1	21.5	7.2	23.6	22.6	5.4	8.5	14.4	9.6	18.7	16.7	18.3	6.7	20.7	19.9	16.1	19.7	22.4	16.1	18.7	7.6	7.8	16.3	14.6	21.5	8.8	15.6	16.9	13.5	15.8	10.5	29.5	23.8	9.8	16.5	12.4	15.0	9.8	7.4	7.2	11.8	10.5	16.5	16.0	20.3	3.8	18.8	31.8	19.6	14.1	40.2	20.1	13.6	12.0	13.8	15.0	9.0	7.1	16.8	11.0	44.3	23.4	5.1	8.6	32.6	33.4	36.9	30.9	23.8	25.9	51.3	25.1	16.2	11.4	14.9	26.2	21.3	17.5	13.9	27.8	14.1	15.5	24.6	15.4	7.1	12.0	14.8	13.3	21.1	17.0	34.6	18.8	21.4	17.6	3.9	17.9	19.2	18.5	15.6	15.9	15.8	14.2	15.6	20.4	16.5	18.0	12.8	12.8	11.8	18.9	17.0	20.4	16.8	21.4	21.7	20.9	24.7	21.6	23.0	23.0	21.4	23.6	20.7	22.4	21.5	23.2	32.1	33.8	41.1	25.6	24.3	27.2	41.3	25.0	22.2	24.4	21.8	16.2	25.8	29.9	27.6	33.3	35.8	33.5	61.8	19.6	37.5	18.1	28.6	21.9	25.3	35.9	31.8	38.5	40.2	28.5	22.6	40.8	43.3	19.0	36.5	20.3	27.9	33.4	42.1	33.8	36.4	42.7	28.5	34.5	25.9	22.1	30.7	28.4	31.9	51.2	24.5	41.2	20.1	41.0	41.5	41.5	24.8	28.6	35.6	70.5	25.1	26.7	26.8	19.7	22.7	22.8	58.3	63.3	19.9	25.4	53.9	29.4	27.6	35.6	32.5
ATG4C	"APG4C, AUTL1, AUTL3, FLJ14867"	ENSG00000125703	"Autophagy related 4C cysteine peptidase"	Q96DT6	1	62784132-62865516	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 60.8"	"Cell type enriched"	"Detected in all"	7	"Oligodendrocytes: 449.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007049	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA007049: AB_1845159"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (9.83e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	7.9	8.0	23.3	10.3	41.1	5.8	7.8	25.0	24.0	8.5	6.3	8.4	6.7	8.0	5.9	7.2	6.5	8.8	6.0	19.7	25.0	11.2	11.1	8.1	13.3	28.5	29.9	8.3	7.5	10.8	3.3	12.8	29.3	6.5	8.7	6.6	9.8	6.2	5.2	5.5	6.6	9.4	23.7	12.1	7.7	8.1	26.5	13.7	9.9	5.2	10.9	8.3	3.9	60.8	11.5	8.9	13.5	11.9	17.4	18.5	13.5	16.6	11.3	15.7	17.5	6.5	8.8	23.9	12.5	8.5	18.3	8.6	16.1	12.7	22.5	18.0	15.0	27.2	9.3	8.7	12.4	22.2	17.4	15.5	8.9	16.7	7.9	15.1	19.1	26.3	23.4	19.1	13.4	5.4	22.5	8.5	19.8	16.2	14.5	26.5	32.2	17.2	11.2	8.1	18.2	9.1	11.0	20.6	22.1	23.2	10.0	10.3	7.6	12.5	12.2	21.3	18.4	16.3	24.0	20.0	14.3	21.5	15.4	32.6	17.4	14.1	7.2	14.1	10.1	34.3	10.2	8.9	31.9	30.8	14.1	12.0	2.5	12.5	8.6	19.0	9.8	11.5	23.3	41.1	25.0	24.0	19.7	25.0	28.5	29.9	29.3	23.7	26.5	60.8	12.6	6.4	10.6	50.3	29.7	5.0	6.2	9.9	6.8	5.2	5.8	5.8	10.0	5.7	9.7	7.3	2.1	37.7	14.1	3.7	19.6	7.2	8.1	5.5	10.2	12.8	6.0	15.8	42.0	8.1	30.7	12.2	8.2	4.9	12.0	7.8	12.8	10.0	36.5	5.0	40.8	4.3	4.1	17.9	7.3	3.0	8.7	25.1	8.8	58.1	29.7	10.5	9.2	57.8	449.9	4.8	4.2	9.8	24.2	3.5	4.8	24.8	4.8	5.2	6.6	8.3	8.3	37.2	14.6	6.6	4.0	29.0	9.2	9.1	6.6	3.6
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311956-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 171.4;Extravillous trophoblasts: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		3900000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	24.8	26.0	19.8	31.7	23.4	26.4	33.9	21.4	23.5	22.2	18.8	36.4	32.0	30.0	20.3	19.4	29.4	20.4	21.3	19.6	21.5	32.7	34.6	18.0	44.9	20.5	21.5	32.0	26.2	29.6	18.6	37.3	23.3	28.7	47.5	19.1	18.8	38.4	43.2	23.8	27.2	37.0	21.0	27.6	24.5	20.1	22.9	41.8	22.5	25.4	51.8	29.1	17.6	27.5	102.2	133.8	85.1	144.0	112.5	113.2	40.6	105.4	91.9	117.4	134.9	278.6	157.3	149.6	122.8	110.0	164.5	106.7	187.8	157.0	169.5	113.4	189.3	179.1	108.7	271.5	145.4	226.1	92.0	98.4	119.8	154.7	188.5	82.0	79.7	144.5	237.0	124.4	166.3	178.7	203.4	112.1	330.3	167.4	84.9	185.8	117.3	133.4	126.4	146.5	129.3	87.8	84.3	103.1	124.3	189.2	169.7	82.9	70.2	96.0	101.2	127.3	65.8	160.3	195.7	300.1	85.6	124.5	146.8	12.6	16.4	0.4	34.6	23.5	59.1	56.6	49.0	53.8	36.3	39.9	50.0	46.9	1.8	55.4	21.1	31.7	50.2	29.0	19.8	23.4	21.4	23.5	19.6	21.5	20.5	21.5	23.3	21.0	22.9	27.5	7.2	12.8	19.3	18.6	34.7	15.0	28.2	55.0	30.7	10.0	18.2	16.1	21.1	28.6	33.3	23.9	4.2	171.4	23.3	17.6	27.4	45.2	1.1	20.7	28.2	6.1	19.2	32.2	15.4	49.3	166.3	25.3	22.4	20.8	25.3	32.9	5.3	22.2	52.4	10.1	15.4	33.8	26.4	14.4	10.8	1.7	23.9	20.2	30.2	2.8	26.1	21.3	26.8	16.6	25.7	32.4	28.5	34.3	36.3	24.0	18.8	52.7	27.3	14.7	26.3	19.2	29.0	3.3	43.8	24.6	8.5	95.4	29.8	40.7	58.4	18.1
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 20.0"	"Cell type enriched"	"Detected in some"	30	"Intestinal goblet cells: 226.1"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA049400: "			"prognostic favorable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.1	20.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	226.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793503-182921629	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	20.6	10.7	4.7	24.9	6.9	70.6	17.4	15.9	7.6	19.1	13.8	26.3	24.3	18.7	14.6	45.4	13.7	21.1	14.1	6.0	6.3	18.0	18.3	16.5	27.9	7.5	6.1	20.5	21.0	29.4	10.3	14.5	7.3	28.3	29.0	30.8	19.4	13.4	11.4	28.2	24.0	19.5	5.6	21.8	51.1	31.6	6.6	44.6	16.8	16.8	28.4	25.7	22.5	15.8	69.7	9.7	20.5	28.7	42.6	46.1	19.3	32.8	41.6	23.2	27.1	23.7	34.0	31.3	53.5	44.0	48.2	40.4	24.6	31.3	40.2	73.9	20.9	76.7	13.1	5.2	24.8	62.3	47.3	31.5	34.7	26.1	37.4	34.1	37.0	48.7	27.7	94.3	37.8	22.9	50.3	19.1	14.5	38.1	19.2	21.2	59.8	37.8	28.1	55.8	12.5	22.0	86.2	10.7	36.9	18.3	11.9	43.7	36.6	35.0	38.7	30.5	56.2	131.0	125.5	58.1	24.1	25.3	20.9	5.5	1.0	4.3	1.7	1.0	1.7	2.1	1.4	1.7	1.1	1.3	1.2	1.8	3.8	1.8	1.0	2.4	1.2	0.8	4.7	6.9	15.9	7.6	6.0	6.3	7.5	6.1	7.3	5.6	6.6	15.8	26.8	16.0	13.2	34.6	27.8	34.3	25.7	15.9	26.2	12.2	13.8	9.7	15.6	18.6	16.5	20.2	14.6	12.8	43.0	44.6	0.0	12.5	34.1	19.0	22.9	15.7	6.7	26.1	81.6	16.5	3.8	19.5	46.4	22.1	11.4	14.0	16.1	16.4	10.4	38.7	64.3	30.5	16.2	19.4	26.4	23.8	19.3	29.3	14.2	45.9	19.9	8.4	27.8	67.8	132.6	25.2	27.0	21.1	55.5	35.8	24.3	7.8	19.8	31.4	19.7	24.1	17.7	18.7	11.4	43.8	44.6	9.6	40.9	7.0	27.3	45.4
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	38.0	22.5	8.5	32.0	9.3	36.9	22.8	12.2	14.8	17.0	18.4	21.2	20.2	18.9	17.0	18.0	17.4	24.2	55.7	10.4	9.3	36.2	87.0	35.5	20.8	9.7	8.4	15.9	16.4	50.3	15.3	54.8	9.1	15.5	22.0	11.6	21.8	15.2	17.0	11.5	16.6	16.9	9.5	16.9	24.4	9.6	12.8	16.3	46.0	14.4	19.4	40.1	16.3	10.1	184.6	19.3	33.0	35.2	49.7	64.9	96.8	62.7	75.4	74.9	132.5	114.1	45.2	74.2	161.1	89.4	197.9	64.2	37.5	66.9	171.4	175.5	31.4	43.1	24.8	31.7	77.1	139.7	91.6	32.6	36.8	127.8	89.0	105.0	38.0	34.9	46.2	139.1	90.7	41.0	53.9	34.8	41.1	64.5	33.5	40.0	77.1	48.8	71.6	53.4	52.4	30.5	64.1	77.9	52.9	31.2	127.7	92.4	37.1	81.2	64.2	162.1	116.5	93.4	141.2	116.6	149.3	80.6	55.7	0.2	0.4	0.4	0.4	0.6	0.5	0.4	0.4	0.7	0.6	0.2	0.5	0.5	0.0	0.6	0.2	0.3	1.0	0.2	8.5	9.3	12.2	14.8	10.4	9.3	9.7	8.4	9.1	9.5	12.8	10.1	56.6	51.3	34.1	51.6	22.3	82.5	49.1	42.1	21.1	25.9	32.1	16.6	50.0	78.6	35.9	49.7	20.9	29.6	26.6	43.7	3.9	66.6	2.0	52.3	65.4	50.5	30.6	23.5	61.8	71.4	19.0	53.2	42.8	181.8	8.8	27.9	68.9	153.2	37.2	15.2	80.6	24.1	26.4	31.1	384.4	2.3	10.2	110.1	62.2	76.8	27.0	8.4	18.6	64.3	49.6	87.8	23.7	13.2	37.8	94.3	11.6	41.4	31.7	13.6	13.1	35.8	42.4	15.2	6.8	36.5	71.2	64.6	24.4	14.1	24.7	69.9
ATP6V0B	"ATP6F, HATPL, VMA16"	ENSG00000117410	"ATPase H+ transporting V0 subunit b"	Q99437	1	43974487-43978295	"Metabolic proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 1694.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2268.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 769.4;granulocytes: 2268.9;monocytes: 1046.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044281			Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA044281: "	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.23e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (6.13e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (5.55e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (8.87e-4)"	78.9	162.2	222.2	68.3	225.4	286.4	79.4	234.5	267.0	63.8	253.8	94.8	61.1	57.5	97.3	101.0	61.5	64.5	107.2	231.3	256.2	233.8	168.3	115.8	71.6	235.4	232.9	49.7	172.0	182.0	157.5	76.6	251.1	101.4	90.8	106.6	112.1	60.7	138.6	98.9	83.8	55.7	232.2	143.7	124.9	56.7	244.0	60.1	101.7	84.0	74.7	92.6	70.9	255.4	150.4	135.9	99.4	129.1	149.3	78.0	142.9	134.1	168.5	217.1	183.6	143.2	144.5	140.3	119.7	119.0	253.2	118.4	233.4	170.1	99.8	135.4	266.4	175.0	209.7	195.1	238.0	262.7	307.9	97.4	219.6	235.3	206.5	136.7	105.1	167.3	189.5	260.9	177.1	147.3	103.2	411.3	182.4	184.8	271.1	150.7	108.1	371.7	225.2	159.1	260.9	137.2	89.0	303.1	319.0	111.4	128.8	419.5	62.8	119.0	105.7	222.6	311.4	241.9	397.5	150.3	161.2	355.5	188.5	528.7	1046.6	892.1	161.2	652.9	161.5	321.1	171.0	156.8	630.7	271.9	129.7	130.1	2268.9	124.4	618.8	769.4	187.2	1450.9	222.2	225.4	234.5	267.0	231.3	256.2	235.4	232.9	251.1	232.2	244.0	255.4	125.1	80.1	126.9	26.4	176.6	335.9	161.9	577.2	173.6	238.7	241.5	219.1	101.7	144.4	367.7	283.3	102.2	197.4	216.0	242.1	201.5	347.8	4.4	186.6	93.6	136.9	224.0	114.6	36.5	328.5	223.3	118.9	114.7	207.9	206.7	77.0	102.1	241.0	815.7	129.5	40.5	306.2	1694.7	347.6	454.5	12.9	78.9	489.8	281.1	24.4	379.2	220.2	103.0	28.6	62.4	379.0	382.7	65.5	301.2	355.1	186.0	223.5	244.1	231.7	78.9	77.4	444.3	116.6	197.9	192.9	358.3	496.5	121.2	135.9	241.8	337.5
ATP6V0C	"ATP6C, ATP6L, ATPL, VATL, Vma3"	ENSG00000185883	"ATPase H+ transporting V0 subunit c"	P27449	16	2513952-2520218	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 115.3;Basal squamous epithelial cells: 363.7;Gastric mucus-secreting cells: 128.0;Macrophages: 152.4;Plasma cells: 235.0;Squamous epithelial cells: 385.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065100			Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA065100: AB_2685421"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"prognostic favorable (1.07e-6)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.04e-2)"	203.2	247.2	150.2	95.4	176.0	182.7	165.2	82.8	252.8	178.7	66.7	172.0	95.0	154.8	32.9	337.0	147.8	23.2	211.8	204.1	196.7	414.4	207.1	230.5	50.8	136.5	139.7	154.3	140.5	103.9	327.2	62.1	141.6	144.2	29.7	110.5	214.2	48.3	301.0	281.2	164.4	30.0	72.4	222.0	175.7	143.9	147.5	44.9	166.8	54.0	31.0	134.4	207.4	135.7	154.4	174.5	84.6	125.9	105.3	54.3	203.5	234.4	72.1	98.2	90.4	163.9	206.4	81.8	209.3	106.0	154.2	193.4	90.7	137.6	45.1	207.1	295.5	95.2	128.1	201.7	152.6	139.9	274.3	98.2	104.4	118.6	59.6	90.8	68.5	88.2	214.5	143.0	80.0	323.5	141.3	363.3	176.3	99.4	211.4	240.8	73.5	251.1	163.8	97.4	277.6	224.4	201.3	215.5	204.4	74.8	222.5	175.9	171.4	154.3	184.6	229.6	160.1	280.9	351.5	146.5	137.1	105.3	161.4	89.4	123.2	203.4	51.4	139.4	53.3	58.5	46.8	56.5	76.6	55.0	52.1	47.0	165.8	52.7	171.7	105.1	50.8	78.8	150.2	176.0	82.8	252.8	204.1	196.7	136.5	139.7	141.6	72.4	147.5	135.7	1.8	25.6	49.2	38.2	115.3	1.0	0.2	0.4	363.7	0.5	1.1	0.6	0.1	0.0	18.3	1.8	0.0	0.5	3.4	3.4	0.0	0.8	0.0	4.3	2.6	12.7	0.0	73.4	72.7	0.2	1.0	48.8	128.0	3.6	17.7	0.6	1.4	0.7	1.0	0.0	107.3	0.7	0.0	1.3	0.8	0.2	0.6	152.4	0.0	39.4	0.3	0.4	0.0	36.7	53.0	0.6	0.2	0.0	235.0	0.2	2.4	1.1	25.1	0.8	0.0	0.7	17.0	0.8	1.1	385.2	1.0	1.2	72.7	0.4	2.3	0.2
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 162.7;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: AB_2683402"	"unprognostic (5.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.29e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.83e-1)"	23.8	32.2	31.6	23.8	36.8	9.7	21.6	18.7	38.2	17.8	20.7	15.4	16.1	19.0	14.2	15.6	16.8	19.8	30.1	39.4	28.9	51.7	27.5	18.6	26.2	25.4	24.5	17.7	18.8	39.0	22.2	30.2	31.5	18.3	18.8	36.7	15.3	16.1	17.2	11.9	17.8	20.6	20.2	19.9	17.4	20.9	25.5	21.9	37.8	24.3	24.5	25.2	14.0	26.3	68.4	38.6	20.2	15.6	54.6	39.3	27.7	49.0	49.7	60.6	68.9	30.4	76.7	41.2	58.2	40.8	97.5	29.6	42.4	41.0	87.8	30.3	26.4	39.2	28.0	35.8	59.5	20.8	52.5	28.8	55.4	77.4	36.2	35.6	43.9	28.7	54.6	37.3	71.4	32.1	46.2	16.7	19.1	67.9	37.6	24.6	36.0	36.4	70.3	48.8	28.5	22.6	26.9	26.9	102.0	40.5	58.9	27.8	44.4	33.2	36.1	74.3	35.0	45.1	17.7	42.1	60.2	47.2	33.2	16.8	30.5	38.1	15.1	44.9	17.2	18.7	12.7	15.1	29.0	18.7	14.4	16.0	50.2	18.7	42.7	15.8	23.1	21.1	31.6	36.8	18.7	38.2	39.4	28.9	25.4	24.5	31.5	20.2	25.5	26.3	31.3	32.1	26.4	38.2	22.9	34.9	33.1	31.2	21.1	32.3	21.9	20.6	43.3	15.7	26.5	31.3	16.7	35.4	15.5	14.7	64.6	36.9	162.7	18.3	19.5	25.5	15.6	33.6	64.9	31.5	35.6	28.4	12.2	16.4	24.1	14.0	17.5	19.0	101.8	37.0	56.6	12.4	46.8	47.6	99.6	166.9	24.2	62.8	19.6	36.5	34.3	34.5	14.4	39.2	44.7	30.4	18.2	18.4	25.1	34.7	19.2	139.1	41.2	25.3	19.7	20.7	45.5	11.1	23.4	19.5	32.8	74.8	18.5	17.4	13.5	27.4
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 90.2;RT4: 168.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	9.1	5.4	1.3	8.5	2.0	1.2	9.5	3.6	3.9	16.3	3.0	76.2	30.3	5.9	3.5	14.8	10.6	18.0	4.4	1.7	1.1	6.6	7.7	8.3	2.2	2.1	1.1	2.1	23.3	9.7	2.7	6.9	2.0	17.6	61.7	0.6	20.6	11.5	1.9	8.4	38.2	8.3	1.0	4.6	46.1	0.6	1.9	1.5	22.0	1.8	3.6	30.0	13.0	3.0	32.0	10.7	0.1	0.6	10.5	19.2	11.9	62.6	63.6	67.4	40.4	8.0	24.3	1.5	19.3	90.2	22.3	44.9	0.2	13.9	64.3	0.2	1.1	0.2	2.6	2.5	2.2	0.4	0.6	2.9	12.6	20.8	34.0	39.5	33.0	0.3	0.3	0.7	34.1	15.6	0.1	0.3	0.3	35.5	3.3	0.3	0.2	0.0	7.9	168.1	0.8	0.7	1.3	32.5	0.1	0.5	10.3	0.6	35.3	48.3	2.0	7.7	14.2	0.4	0.4	0.5	1.1	0.4	2.8	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.0	0.2	0.1	0.0	0.0	1.3	2.0	3.6	3.9	1.7	1.1	2.1	1.1	2.0	1.0	1.9	3.0	25.9	19.2	27.0	11.1	4.1	7.8	66.7	20.6	10.2	0.7	28.4	10.4	5.4	27.1	48.9	40.5	0.0	25.6	0.6	279.7	0.0	27.0	2.8	26.3	4.0	30.8	68.4	0.4	61.2	53.1	2.7	7.1	98.4	40.1	4.5	0.9	33.2	19.1	2.4	6.7	11.7	180.5	22.4	2.8	4.0	0.4	0.3	1.0	7.2	37.5	0.9	0.1	0.0	20.6	10.7	38.5	116.7	0.0	0.9	70.8	58.2	0.2	44.7	1.2	13.1	2.8	20.7	0.3	1.5	28.0	16.3	10.9	1.7	2.3	185.7	119.2
ATRN	"DPPT-L, MGCA"	ENSG00000088812	Attractin	O75882	20	3471018-3651118	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 101.6;Inhibitory neurons: 101.1;Oligodendrocyte precursor cells: 89.5;Oligodendrocytes: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008853	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		27000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA008853: AB_1078248"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.19e-6)"	"unprognostic (3.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.91e-2)"	12.8	19.1	10.5	10.3	12.2	8.6	17.2	9.3	13.2	16.5	8.9	11.8	55.8	11.8	15.6	10.4	11.7	13.9	19.1	13.4	12.2	23.9	62.8	14.4	7.5	8.0	8.7	14.0	20.2	40.1	8.7	22.6	9.0	12.8	12.3	24.2	13.9	13.2	11.6	14.9	33.4	14.9	11.3	13.8	24.0	16.6	10.8	7.8	32.3	14.2	9.6	15.7	9.1	15.8	40.8	37.6	21.9	18.4	37.9	61.5	28.1	26.6	37.5	27.4	23.1	16.3	27.1	0.0	17.5	37.4	33.8	55.6	15.0	58.1	36.4	4.5	12.8	12.7	10.0	35.1	22.8	27.2	8.3	33.1	46.0	29.0	27.8	34.3	36.0	8.7	20.2	19.2	27.0	11.7	11.1	10.4	14.7	13.2	22.3	9.2	50.9	30.8	24.8	28.5	12.9	20.2	26.7	48.9	36.3	21.3	26.2	25.5	44.7	29.0	17.0	30.8	26.6	13.4	20.1	0.1	17.9	17.9	29.6	3.6	3.2	2.0	2.3	2.8	1.0	1.4	1.2	1.4	2.8	1.7	2.0	1.7	0.0	1.5	3.1	2.6	1.8	1.0	10.5	12.2	9.3	13.2	13.4	12.2	8.0	8.7	9.0	11.3	10.8	15.8	11.1	16.0	10.4	70.2	5.8	6.4	4.3	14.1	6.8	22.5	9.9	8.8	12.6	20.0	10.3	11.0	37.5	7.4	8.0	6.5	1.9	8.2	7.1	9.9	15.1	11.1	9.6	7.4	101.6	14.6	8.4	12.7	20.4	11.8	7.0	39.3	17.9	50.9	10.4	37.0	101.1	10.7	4.1	14.2	6.7	5.4	12.5	11.5	7.2	64.6	10.1	11.8	5.2	89.5	85.7	10.0	14.3	7.9	11.4	7.0	34.6	7.3	10.2	20.1	32.9	14.3	10.9	21.3	21.1	8.5	7.2	5.1	5.8	21.0	12.6	5.2
ATXN7	"ADCAII, OPCA3, SCA7, SGF73"	ENSG00000163635	"Ataxin 7"	O15265	3	63863155-64003462	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA034989: AB_10602596"	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	7.5	6.3	4.5	11.4	4.1	24.4	7.1	4.9	4.4	7.4	0.2	6.9	8.0	8.6	4.7	8.7	6.3	9.6	5.8	3.1	3.7	7.1	8.4	9.0	12.7	3.4	3.3	8.0	21.0	10.9	2.3	8.3	2.7	6.7	8.8	16.3	7.8	5.2	7.1	9.3	9.2	7.9	0.7	10.6	8.4	15.0	3.1	16.5	7.5	8.7	11.7	7.4	4.4	3.2	8.4	5.7	8.1	7.2	8.5	11.3	9.5	6.5	9.0	11.1	10.5	8.9	8.7	12.5	3.1	9.0	12.5	6.5	9.6	9.1	11.9	22.8	4.9	16.1	10.7	4.2	6.4	8.5	17.7	7.9	9.0	15.7	17.7	9.0	8.4	13.3	6.3	26.2	7.7	25.8	12.7	6.8	5.5	5.7	3.0	9.1	7.1	10.1	6.1	11.0	3.1	5.6	13.2	9.4	10.8	6.4	5.1	12.2	11.9	11.4	12.0	12.7	12.9	12.9	13.2	10.3	10.3	11.6	9.4	15.8	1.1	2.1	3.7	1.0	3.3	1.0	6.2	4.0	0.8	2.4	6.2	4.1	4.5	3.5	0.7	1.5	6.2	1.3	4.5	4.1	4.9	4.4	3.1	3.7	3.4	3.3	2.7	0.7	3.1	3.2	2.4	9.6	9.1	34.6	17.0	43.6	24.9	17.6	29.6	73.2	3.4	1.7	10.5	35.8	17.9	5.5	102.2	14.1	21.5	38.3	0.0	2.8	17.1	3.3	1.5	16.1	26.4	29.5	81.2	4.2	13.6	16.6	18.8	3.5	14.7	1.2	26.7	22.8	14.2	25.2	67.0	19.7	24.4	34.6	30.3	9.5	12.8	20.1	12.4	64.6	33.5	24.5	54.6	60.3	46.7	2.5	28.5	13.2	14.8	26.1	28.1	0.7	27.4	70.8	0.0	39.2	15.6	14.8	15.6	25.6	46.2	61.2	41.5	1.6	20.1	38.6
ATXN7L1	"ATXN7L4, KIAA1218, MGC33190"	ENSG00000146776	"Ataxin 7 like 1"	Q9ULK2	7	105604772-105876599	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.7;Early spermatids: 93.4;Excitatory neurons: 107.3;Inhibitory neurons: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021448	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA021448: AB_1845213"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.01e-1)"	5.0	4.3	2.8	4.4	3.0	4.3	4.5	5.0	4.3	6.6	0.6	5.3	4.1	4.7	4.5	4.1	5.8	4.3	2.6	2.8	1.3	7.3	6.3	4.0	6.4	1.6	1.7	6.5	3.2	4.9	3.3	5.7	1.5	4.7	5.9	2.0	5.8	3.8	2.3	5.9	5.0	4.1	0.1	5.7	4.8	10.2	1.8	10.1	5.0	3.1	5.9	4.5	5.2	2.7	3.2	4.3	9.0	4.2	5.5	6.5	2.8	5.7	5.6	5.0	4.6	4.2	6.1	1.3	4.3	6.1	4.4	3.0	5.1	5.9	3.7	18.0	3.3	4.3	3.2	4.1	3.3	7.1	13.9	4.5	4.7	3.3	3.3	3.7	4.6	3.0	5.2	2.8	4.2	7.7	3.9	4.3	16.7	9.0	4.3	3.8	3.0	1.0	3.8	3.2	5.6	3.7	4.0	8.0	7.9	8.9	4.1	7.2	11.5	7.8	3.5	6.5	2.2	0.6	0.0	0.1	4.8	10.9	8.0	2.3	3.8	4.2	2.4	4.4	1.8	3.5	6.5	5.6	2.9	3.5	6.9	3.9	1.3	4.4	2.8	1.9	14.3	3.3	2.8	3.0	5.0	4.3	2.8	1.3	1.6	1.7	1.5	0.1	1.8	2.7	8.3	0.0	3.9	60.7	8.0	5.1	5.4	4.9	6.2	7.8	5.2	3.9	2.4	4.3	3.6	5.5	2.1	6.3	16.8	11.3	5.9	3.9	93.4	13.1	6.4	5.2	5.4	9.4	107.3	2.6	3.6	5.9	11.2	7.9	5.1	7.9	6.4	17.0	7.5	8.4	96.3	8.5	2.0	11.6	6.1	56.6	6.5	9.3	8.8	55.3	10.8	2.0	19.6	46.8	51.3	4.2	11.0	4.5	7.4	4.6	43.7	42.6	14.9	1.0	6.6	7.5	6.4	20.9	2.5	7.0	4.0	5.3	13.3	7.7	9.4	3.7
ATXN7L2	"FLJ00381, MGC46534"	ENSG00000162650	"Ataxin 7 like 2"	Q5T6C5	1	109483479-109492804	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 7.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029827, HPA054952"	Uncertain		Approved	"Nucleoli rim,Vesicles,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli rim"	"Vesicles, Cytosol"	"HPA029827: AB_10602390, HPA054952: AB_2682647"	"unprognostic (4.53e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.77e-4)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.94e-3)"	1.2	2.7	1.3	0.7	1.4	3.0	1.1	1.3	2.7	1.9	0.7	1.2	0.5	2.0	0.1	1.2	1.4	0.8	1.3	2.5	1.0	2.0	1.7	1.0	0.9	1.1	1.1	1.9	1.0	0.3	2.1	0.4	1.0	1.2	0.1	0.1	0.9	0.4	7.9	1.7	1.4	0.3	0.9	2.2	1.0	5.2	1.3	1.5	2.2	1.6	0.5	1.3	1.2	1.4	1.8	1.4	0.9	3.6	1.2	2.2	2.5	1.3	1.6	2.6	1.8	3.0	1.2	4.8	2.0	1.6	0.7	2.1	1.9	1.8	0.3	4.4	2.7	2.6	3.0	1.3	0.8	4.0	6.0	2.4	0.9	2.8	0.0	1.1	0.6	5.1	4.5	2.6	0.5	5.8	7.1	5.2	5.6	1.9	2.0	4.9	2.3	3.4	0.9	1.9	8.4	3.4	1.4	4.5	2.2	0.2	0.8	4.1	0.3	1.9	5.5	1.8	5.3	1.7	1.2	4.6	2.2	3.3	4.8	0.0	0.8	1.1	2.3	1.1	2.2	1.0	1.9	2.5	0.6	1.3	1.7	1.6	0.9	1.4	0.8	0.4	1.8	1.0	1.3	1.4	1.3	2.7	2.5	1.0	1.1	1.1	1.0	0.9	1.3	1.4	1.0	0.0	0.5	5.5	2.4	0.6	1.4	1.3	1.8	3.5	1.4	0.9	1.9	1.5	2.1	1.8	2.1	1.4	1.6	1.4	0.0	1.4	3.5	0.8	2.4	1.3	1.8	0.8	4.7	1.8	1.5	1.7	1.1	1.0	4.5	2.3	1.8	1.1	0.6	3.3	3.9	1.1	2.0	1.2	1.0	1.0	1.2	0.6	0.0	1.0	0.4	0.9	1.0	3.0	1.8	1.5	1.4	1.5	2.9	0.7	0.7	0.6	0.3	2.0	0.0	2.5	4.8	4.2	4.9	1.3	0.9	3.1	2.6	3.5	0.9	0.9
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"Activator of transcription and developmental regulator AUTS2"	Q8WXX7	7	69598296-70793506	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 598.7;Excitatory neurons: 871.5;Inhibitory neurons: 1405.7;Microglial cells: 583.7;Oligodendrocytes: 1231.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 8.1;naive B-cell: 9.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 82.8;REH: 84.1;SCLC-21H: 112.5;T-47d: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	8.7	5.2	50.4	9.1	41.1	8.5	17.2	10.6	19.0	7.9	0.0	11.3	6.8	7.4	6.2	11.5	7.0	13.3	5.5	21.8	32.0	13.9	20.2	10.8	4.8	40.6	25.9	14.6	5.7	11.3	9.7	4.1	23.0	11.3	10.0	11.0	48.2	5.7	15.2	20.5	15.6	7.5	14.0	6.5	10.5	7.9	37.3	10.7	5.8	5.2	6.3	10.5	10.5	8.7	0.3	7.5	82.8	4.3	5.4	3.2	0.9	5.2	0.0	0.4	0.5	29.1	0.3	13.0	1.9	5.0	0.5	27.1	10.0	11.5	2.3	60.5	22.4	6.2	7.8	0.3	2.4	0.1	0.4	8.6	15.2	12.5	3.1	3.0	0.0	13.5	0.6	6.5	7.2	4.8	1.2	2.4	59.0	18.9	0.1	84.1	40.0	39.8	0.0	12.5	112.5	61.3	5.3	9.2	0.2	35.4	80.0	0.1	0.0	0.3	27.1	8.8	52.6	0.2	0.2	43.1	0.1	0.2	0.2	1.0	0.2	0.1	1.4	0.1	1.9	8.1	0.9	1.4	0.6	9.4	0.1	0.8	0.4	1.5	0.1	2.8	0.2	0.6	50.4	41.1	10.6	19.0	21.8	32.0	40.6	25.9	23.0	14.0	37.3	8.7	13.7	19.2	38.2	598.7	19.9	28.6	21.1	25.0	34.7	37.2	72.9	41.5	20.8	11.5	22.2	9.2	16.7	1.2	103.2	23.5	5.9	13.1	31.8	11.5	36.0	15.9	28.9	5.2	871.5	1.3	0.1	19.3	4.1	11.0	0.0	44.4	12.1	28.8	0.8	63.9	1405.7	23.4	38.7	2.6	17.1	27.7	15.8	5.5	17.8	583.7	0.8	11.2	25.7	292.0	1231.2	3.9	15.3	14.7	37.7	32.6	15.3	12.4	20.3	20.7	26.3	13.7	17.2	10.1	16.9	20.3	16.1	1.4	35.5	10.4	25.3	26.6
B3GNT7	beta3GnT7	ENSG00000156966	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7"	Q8NFL0	2	231395710-231401164	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 71.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 272.8;Intestinal goblet cells: 145.2;Paneth cells: 126.4;Undifferentiated cells: 354.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.5;HEL: 15.6;THP-1: 14.0;WM-115: 23.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA013881, HPA035625, HPA035626"	Enhanced		Approved	"Golgi apparatus,Mitotic spindle,Cytosol"	"Intracellular and membrane"	Yes	NA		3600000	"Cluster 40: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Mitotic spindle, Cytosol"	"HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (3.57e-1)"	3.1	12.9	5.9	2.8	5.1	14.2	3.8	4.0	5.8	2.5	4.6	56.2	25.2	1.9	6.8	2.9	4.6	14.0	4.7	5.6	6.5	2.2	1.2	15.3	1.6	6.0	7.0	16.7	25.4	14.3	8.8	5.4	5.3	3.2	71.2	2.1	7.5	4.4	0.4	5.0	28.4	2.3	4.3	5.1	35.6	1.3	7.3	2.4	8.4	0.3	1.5	3.7	0.6	5.4	0.7	2.8	0.3	0.6	0.1	0.2	1.0	0.2	1.1	0.1	0.1	1.4	19.5	2.2	5.8	0.3	0.2	5.1	0.2	0.0	0.1	0.3	0.5	15.6	0.5	0.9	0.1	0.1	0.8	0.1	1.4	0.2	0.3	1.1	0.2	0.4	0.5	0.4	0.1	0.9	0.2	0.7	6.3	7.7	3.3	0.3	0.1	0.4	0.6	1.7	0.5	0.8	0.3	1.7	0.7	6.9	0.6	14.0	0.2	0.4	0.4	0.2	0.2	2.3	0.9	0.7	0.3	0.2	23.7	0.7	0.1	0.7	2.9	0.5	0.5	9.9	0.1	0.4	6.5	7.0	0.1	0.7	0.2	32.1	0.6	3.1	0.2	1.0	5.9	5.1	4.0	5.8	5.6	6.5	6.0	7.0	5.3	4.3	7.3	5.4	0.9	41.7	30.2	0.3	8.7	2.3	1.7	8.7	0.0	0.4	5.2	2.5	1.1	95.8	29.7	1.8	2.1	0.6	61.7	272.8	0.0	16.1	0.4	13.3	2.2	4.7	103.0	0.4	0.5	84.3	64.9	2.3	51.5	18.5	9.5	17.3	3.3	0.2	11.2	0.0	0.4	145.2	18.3	10.1	38.6	1.2	1.5	9.7	3.6	0.0	2.9	0.5	10.3	55.3	0.2	69.8	126.4	8.2	5.5	11.6	93.2	0.4	82.2	1.8	0.0	0.5	2.3	0.9	1.4	0.0	2.7	2.1	10.0	0.4	354.6	16.2
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.4;Late spermatids: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 150.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 150.2;monocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	15.8	12.1	12.3	27.8	13.3	89.4	13.3	27.6	16.0	18.1	9.9	13.4	17.4	19.8	9.7	23.0	9.1	26.1	13.2	10.5	19.5	16.0	30.5	21.4	16.9	23.0	28.4	11.6	17.2	8.3	3.3	50.6	31.0	13.3	13.2	12.0	17.4	8.6	26.3	23.3	17.4	15.9	14.2	20.7	13.5	27.3	16.6	14.2	12.6	12.8	14.8	29.8	13.1	12.3	21.5	8.6	26.1	6.8	20.2	57.7	16.3	23.0	55.0	21.8	24.3	18.1	28.9	25.5	18.0	21.1	22.7	11.1	15.7	30.9	38.6	21.3	13.3	78.7	18.9	18.6	26.8	22.8	28.1	30.3	46.4	42.8	63.4	25.7	11.7	13.9	40.6	129.7	30.2	7.6	19.5	13.0	40.3	8.4	8.9	19.8	61.8	33.1	11.5	16.8	10.8	12.2	12.6	23.5	29.0	26.0	17.1	27.1	29.6	21.3	29.4	23.1	11.8	74.9	51.9	26.9	17.3	27.8	64.9	72.4	51.1	38.6	5.0	40.1	4.1	10.3	8.3	4.3	24.9	13.7	11.9	6.0	150.2	7.1	46.0	6.0	14.8	15.3	12.3	13.3	27.6	16.0	10.5	19.5	23.0	28.4	31.0	14.2	16.6	12.3	31.9	28.9	15.3	12.1	90.6	59.0	53.2	17.9	19.4	16.6	18.3	15.1	20.7	15.7	23.1	14.7	18.8	13.7	33.0	30.7	7.9	19.8	164.4	32.2	45.9	26.0	30.9	33.0	5.1	16.6	15.7	31.3	30.5	64.1	48.6	13.6	22.1	20.9	22.0	13.5	36.9	24.7	12.2	57.1	113.8	422.4	13.4	113.8	21.4	68.4	109.1	10.2	24.7	33.7	25.0	28.2	38.2	14.3	87.8	50.7	25.5	12.8	15.7	12.6	32.9	54.7	36.6	31.5	28.4	34.7	58.1	39.7	31.3	17.4	11.7	48.4
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.2;lymphoid tissue: 96.4"	"Cell type enriched"	"Detected in many"	10	"B-cells: 455.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"memory B-cell: 310.4;naive B-cell: 253.0"	"Lineage enriched"	"Detected in many"	16	"B-cells: 310.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.6;HEL: 10.6;HL-60: 9.6;U-266/70: 31.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	8.5	3.6	0.6	35.1	0.6	6.2	2.2	1.5	0.9	2.3	0.2	2.8	2.4	0.8	3.2	0.8	2.3	3.0	0.7	0.5	0.7	3.2	0.3	8.1	82.2	0.8	0.8	0.1	0.5	0.4	1.5	0.8	0.9	5.8	3.3	0.2	2.4	4.7	0.1	0.7	24.2	1.0	0.9	56.1	7.4	3.0	1.0	9.7	12.9	0.2	96.4	7.6	0.7	0.6	0.0	3.0	0.0	0.0	3.4	1.4	0.1	0.1	0.1	0.4	0.6	0.1	4.6	13.6	1.2	0.0	0.0	0.2	0.1	1.5	0.4	0.0	0.0	10.6	2.6	0.0	0.1	9.6	0.0	0.6	0.4	0.0	0.0	1.2	0.1	0.0	0.1	4.0	0.6	0.5	0.0	0.6	0.0	0.4	5.7	0.2	0.6	0.0	0.4	6.1	2.6	0.0	0.3	0.2	0.0	0.1	0.5	2.5	1.3	0.0	0.6	0.0	0.0	31.0	0.0	2.2	0.1	5.3	0.0	10.8	1.7	19.7	0.4	0.5	0.1	310.4	0.1	0.2	10.5	253.0	0.1	0.1	0.9	1.5	0.2	5.2	0.2	11.3	0.6	0.6	1.5	0.9	0.5	0.7	0.8	0.8	0.9	0.9	1.0	0.6	3.5	44.8	27.1	6.8	455.9	0.1	2.2	0.5	0.0	0.2	1.7	0.4	0.5	0.0	10.0	3.7	0.0	2.1	5.8	0.0	0.0	0.2	2.8	13.1	1.0	1.3	0.0	6.1	7.3	0.2	0.6	1.4	6.1	15.2	1.3	0.1	0.0	0.1	1.5	0.0	1.6	0.4	2.0	2.9	25.1	2.0	0.0	13.0	5.4	4.7	2.8	1.8	1.0	1.0	1.3	4.1	1.3	0.4	13.7	4.4	0.2	4.2	2.2	0.1	0.0	0.1	0.8	1.9	5.6	0.8	1.1	0.3	12.9	2.1	1.1	4.3
BAZ2B	WALp4	ENSG00000123636	"Bromodomain adjacent to zinc finger domain 2B"	Q9UIF8	2	159318979-159616569	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 477.3;Oligodendrocytes: 604.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 115.8;neutrophil: 213.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 213.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019819, HPA059292"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA019819: AB_1845282, HPA059292: AB_2683968"	"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.14e-2)"	20.6	23.8	23.0	18.1	43.7	36.7	22.1	57.4	26.8	23.8	3.6	18.2	17.1	33.6	19.7	22.1	24.4	26.1	18.4	21.8	41.4	17.3	16.8	24.7	14.7	45.3	29.1	42.4	19.3	24.6	17.5	20.5	47.7	18.4	16.4	52.0	23.4	19.8	18.4	17.5	18.5	23.5	26.0	20.9	17.0	26.4	43.7	21.5	25.4	22.3	13.6	20.9	14.7	75.3	7.4	14.7	48.4	29.4	14.2	22.8	8.4	15.3	18.7	8.2	9.6	22.1	19.9	12.4	25.8	15.0	8.4	16.6	19.4	20.7	13.0	4.5	11.1	24.7	26.9	3.1	9.3	16.3	17.0	18.0	22.2	20.6	22.2	30.4	42.5	8.3	25.7	2.3	13.1	9.1	5.6	10.5	16.1	1.5	12.4	13.1	15.7	8.8	16.4	26.2	32.1	27.9	30.3	3.7	18.5	25.0	5.8	46.7	42.6	14.9	30.1	6.5	10.3	9.0	1.0	14.0	14.1	17.5	10.0	115.8	27.4	36.4	10.1	12.0	8.3	6.5	6.1	10.5	17.7	9.6	4.1	6.6	213.2	19.7	11.3	24.5	7.1	6.0	23.0	43.7	57.4	26.8	21.8	41.4	45.3	29.1	47.7	26.0	43.7	75.3	105.3	99.3	148.0	477.3	34.3	32.6	70.1	35.8	66.0	91.8	56.4	38.9	60.8	61.5	71.5	68.0	310.6	18.5	40.1	45.4	9.8	55.5	158.0	69.8	63.9	82.5	99.9	42.1	180.4	38.9	7.2	54.9	59.7	118.9	73.9	71.9	71.0	29.4	25.5	94.2	177.3	52.1	36.7	58.0	37.1	35.4	59.4	76.6	14.2	289.5	81.4	87.3	41.2	300.6	604.3	54.3	55.5	35.0	42.2	50.0	51.7	12.4	73.3	332.3	13.1	74.9	54.1	98.2	20.7	49.6	37.5	26.7	38.9	83.2	48.6	91.6
BBC3	"JFY1, PUMA"	ENSG00000105327	"BCL2 binding component 3"	"Q96PG8, Q9BXH1"	19	47220822-47232766	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.4;Basal squamous epithelial cells: 111.5;Prostatic glandular cells: 132.9;Suprabasal keratinocytes: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 4.5;neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 28.4;NB-4: 34.9"									"CAB007752, HPA070403"	Approved		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB007752: AB_562336, HPA070403: "	"unprognostic (4.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (2.62e-5)"	3.1	4.4	3.1	2.1	2.8	4.8	4.0	4.3	4.7	3.2	1.8	6.4	2.4	3.4	0.6	1.9	3.6	2.0	3.9	3.3	2.4	5.1	5.6	7.7	2.7	2.8	3.7	3.2	7.7	2.0	2.1	1.9	2.9	4.1	1.8	0.2	7.5	1.2	10.4	8.2	5.0	0.7	2.3	6.1	5.0	2.6	2.8	4.0	3.1	1.1	0.8	4.9	3.4	2.5	3.8	8.3	9.0	1.9	2.1	4.1	22.1	5.9	7.9	1.4	3.5	2.5	6.3	14.7	2.5	1.5	2.5	1.2	1.3	5.3	0.2	9.3	15.9	4.2	2.8	16.4	28.4	0.7	13.4	9.8	8.4	3.0	2.8	3.7	10.3	4.4	10.9	9.0	1.0	8.6	1.6	34.9	5.6	6.5	1.1	4.1	1.3	17.7	0.4	1.3	1.5	13.5	2.7	5.6	18.7	7.1	1.9	11.7	6.9	1.7	11.1	0.2	1.9	14.4	3.4	9.5	2.6	2.2	6.2	4.5	0.4	0.2	0.4	0.5	0.4	0.1	0.1	0.3	0.2	0.0	0.5	0.3	3.4	0.6	0.4	0.1	0.3	0.2	3.1	2.8	4.3	4.7	3.3	2.4	2.8	3.7	2.9	2.3	2.8	2.5	16.2	9.6	7.4	1.6	21.7	117.4	78.8	40.3	111.5	6.5	46.4	29.1	5.6	10.0	21.8	7.3	0.0	4.7	28.3	51.9	0.0	52.4	14.6	65.2	14.0	15.8	21.4	16.8	3.2	39.8	5.5	12.1	23.4	66.2	12.7	8.4	3.9	3.5	7.1	0.0	3.9	40.6	30.5	10.3	31.9	3.3	6.2	17.1	64.0	2.8	15.7	3.7	32.0	1.0	0.5	55.2	49.3	4.1	19.3	132.9	16.2	4.1	22.9	4.4	6.6	12.4	34.9	0.5	1.7	59.4	143.3	20.5	28.5	10.2	27.4	66.2
BBS4		ENSG00000140463	"Bardet-Biedl syndrome 4"	Q96RK4	15	72686179-72738475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 120.9;Rod photoreceptor cells: 89.9;Spermatocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 62.3"	"Low region specificity"	"Detected in all"							HPA039418	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA039418: AB_10672962"	"unprognostic (3.47e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.76e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.05e-1)"	9.5	14.8	11.0	6.8	11.2	7.7	10.9	10.1	13.1	13.3	18.1	12.0	5.1	12.5	15.4	5.8	17.5	9.3	11.1	10.9	11.9	15.6	12.7	10.4	8.0	10.9	12.4	14.0	11.1	17.4	20.7	7.9	12.6	20.7	7.6	45.4	7.9	9.4	18.7	9.2	7.9	9.3	10.9	7.6	11.0	20.4	11.5	11.5	16.1	10.2	7.0	11.1	9.1	11.0	6.1	15.7	34.0	14.4	16.5	19.7	9.0	11.9	24.4	11.3	14.8	8.1	20.2	9.6	24.7	10.2	8.6	9.4	9.1	9.9	10.3	10.0	11.0	11.4	13.3	9.2	13.5	10.2	8.6	18.8	13.2	16.3	12.8	17.1	8.9	18.3	25.4	8.2	18.1	10.7	9.6	9.6	48.8	12.3	6.8	6.4	17.1	12.3	19.2	15.2	16.4	19.2	20.8	15.0	31.2	13.1	20.4	11.3	12.5	13.2	10.0	62.3	6.7	17.1	17.8	21.0	14.9	15.3	18.1	5.5	1.9	3.3	5.1	2.9	4.9	4.8	4.3	5.5	1.6	6.0	4.3	5.9	1.6	11.0	2.5	3.1	5.7	2.8	11.0	11.2	10.1	13.1	10.9	11.9	10.9	12.4	12.6	10.9	11.5	11.0	6.0	19.2	19.2	35.3	8.3	3.1	6.0	9.4	10.8	39.0	8.4	10.5	19.8	4.3	18.2	12.9	120.9	10.0	10.6	3.5	5.9	14.4	19.9	28.8	11.1	8.1	4.2	5.2	18.6	11.3	5.8	12.4	7.7	8.4	13.9	8.7	7.1	7.4	7.8	21.9	22.8	8.0	6.1	5.8	2.4	12.2	15.8	5.9	5.4	19.7	4.4	39.4	9.2	31.7	30.7	8.9	4.9	20.3	9.0	8.0	5.1	9.4	48.8	89.9	0.0	11.0	11.5	79.0	63.6	4.6	2.8	5.3	9.3	24.3	5.1	2.8
BCAP29	"BAP29, DKFZp686M2086"	ENSG00000075790	"B cell receptor associated protein 29"	Q9UHQ4	7	107580246-107629170	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029215, HPA049694"	Supported		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA029215: AB_10602331, HPA049694: AB_2680854"	"unprognostic (3.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.42e-3)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.43e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.81e-1)"	47.1	25.7	19.4	22.5	23.7	16.7	28.0	18.1	27.0	48.6	12.8	32.6	16.1	42.6	18.6	34.4	21.7	23.0	61.0	24.4	17.9	20.1	33.3	26.0	16.7	17.5	17.6	21.4	18.9	34.5	12.2	26.7	18.0	31.9	31.2	9.6	18.4	25.0	38.7	22.1	18.8	38.2	19.5	18.1	22.4	70.1	19.2	12.8	85.5	31.5	15.7	30.9	32.5	21.1	71.7	22.8	26.4	13.8	65.2	81.6	22.6	80.6	68.2	32.9	39.7	23.2	72.1	13.4	54.5	58.1	75.1	35.8	13.7	38.6	52.5	50.1	17.3	27.1	35.6	26.2	63.3	33.6	41.2	48.9	31.8	46.7	38.0	95.4	116.9	25.3	58.3	33.4	75.4	67.2	23.2	34.3	15.4	29.7	30.0	18.6	34.1	34.6	60.6	49.1	10.2	37.7	68.2	54.9	58.2	39.3	25.6	37.5	113.9	102.5	52.1	94.6	104.7	31.7	67.9	27.5	66.5	30.5	77.2	47.5	10.5	25.5	9.5	13.6	9.3	12.8	7.5	9.5	10.0	8.5	4.3	8.5	3.9	9.9	21.7	10.1	13.6	8.1	19.4	23.7	18.1	27.0	24.4	17.9	17.5	17.6	18.0	19.5	19.2	21.1	169.8	67.3	57.2	35.6	33.9	38.5	80.7	99.0	25.0	35.2	40.4	34.2	117.8	27.1	77.7	23.9	10.4	30.2	31.4	38.1	15.6	46.4	227.1	54.6	93.3	99.0	22.3	73.2	81.1	73.6	50.8	72.9	32.6	102.0	58.3	14.8	73.2	40.7	52.6	8.4	71.3	35.8	69.2	36.6	35.6	95.8	61.2	49.6	37.4	44.0	41.6	28.3	22.6	50.8	49.7	71.2	32.5	89.1	17.7	110.4	15.6	19.5	55.9	26.7	78.9	62.9	91.3	202.2	35.0	46.5	38.8	70.7	33.5	32.0	45.4	83.5
BCAR1	"CAS, CASS1, Crkas, P130Cas"	ENSG00000050820	"BCAR1 scaffold protein, Cas family member"	P56945	16	75228181-75268053	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000443, HPA042282"	Approved	Approved	Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB000443: , HPA042282: AB_2677929"	"unprognostic (5.44e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.43e-3)"	"prognostic unfavorable (9.11e-5)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.20e-1)"	34.7	22.3	3.5	4.2	5.8	0.0	27.9	16.9	6.6	37.7	6.3	34.4	15.8	39.2	2.6	22.5	25.3	9.4	47.1	2.3	7.9	47.3	34.2	38.8	2.1	3.9	1.9	19.7	32.4	5.9	29.5	14.1	2.3	25.6	3.5	1.3	25.5	5.7	93.8	18.2	33.1	3.8	0.0	33.7	44.6	34.3	4.2	0.9	26.8	6.8	1.1	24.9	26.2	15.8	21.8	36.8	17.5	6.0	6.7	6.3	34.1	29.5	17.1	20.9	16.4	46.5	32.1	1.9	38.2	33.3	23.6	18.2	6.1	34.0	6.0	0.1	20.0	0.0	23.7	37.2	16.7	0.1	15.1	19.1	16.3	25.3	12.5	12.3	57.9	0.0	20.0	1.0	12.6	48.9	0.1	1.3	23.4	16.1	24.0	0.8	7.9	8.2	19.1	27.9	21.4	31.5	28.7	6.6	11.2	8.4	15.0	5.4	53.6	34.4	29.5	8.8	44.2	8.0	4.7	0.7	22.2	0.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	16.9	6.6	2.3	7.9	3.9	1.9	2.3	0.0	4.2	15.8	30.1	22.4	6.9	9.4	1.2	28.0	59.7	36.8	12.0	26.5	20.3	14.4	22.9	31.5	21.8	22.0	6.2	46.8	0.7	75.7	27.4	51.9	19.0	13.7	27.9	49.2	34.8	0.0	13.1	61.8	25.7	21.1	71.9	22.5	8.9	15.0	46.8	21.0	6.0	13.5	11.7	42.1	12.2	1.4	6.3	26.8	16.4	2.1	32.0	10.3	0.6	12.9	0.0	19.1	31.2	68.5	59.6	33.4	1.4	58.4	57.4	38.9	13.1	6.8	19.7	8.5	38.5	20.6	17.1	12.5	17.6	36.1	2.2	10.9	33.7	62.7
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3 adaptor protein, NSP family member"	O75815	1	93561741-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.5;Basal prostatic cells: 149.0;Extravillous trophoblasts: 75.0;Urothelial cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0;memory B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 159.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavorable (8.41e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic unfavorable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	31.0	10.6	17.7	6.6	20.9	1.0	18.5	19.3	15.3	10.0	21.1	15.3	13.4	5.7	3.6	8.1	9.5	7.5	13.1	14.8	18.7	15.9	11.9	14.2	13.8	21.1	20.6	11.4	4.2	4.0	4.6	17.0	18.9	8.9	16.6	1.5	21.9	9.5	24.4	15.6	12.9	8.0	19.0	4.8	16.2	6.3	21.7	4.3	10.4	21.1	13.0	13.6	9.8	17.8	56.0	23.4	43.5	3.4	18.4	14.4	37.1	56.9	98.3	45.9	28.1	4.0	40.9	9.0	18.9	88.1	59.4	34.0	1.3	73.5	39.7	4.0	1.3	0.0	16.2	10.3	33.1	0.4	0.2	17.3	79.5	47.5	159.7	44.1	51.1	1.1	1.6	0.3	125.7	8.6	1.0	0.2	13.6	24.5	79.7	3.7	62.7	1.3	120.4	70.1	1.5	3.6	27.4	29.1	36.1	16.8	32.9	2.2	60.8	67.3	17.5	29.2	76.0	4.5	2.1	1.2	10.1	0.2	25.2	2.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.3	1.6	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	17.7	20.9	19.3	15.3	14.8	18.7	21.1	20.6	18.9	19.0	21.7	17.8	26.9	3.2	7.2	72.5	10.2	9.8	149.0	11.3	2.8	0.9	7.9	13.5	7.1	11.5	11.7	14.7	0.0	27.5	2.5	30.8	27.4	11.3	11.3	13.3	2.6	17.9	14.9	0.4	5.2	6.3	75.0	6.3	15.8	16.6	3.8	33.7	5.7	10.3	11.9	21.9	11.2	20.7	8.2	5.3	12.7	12.8	10.2	8.3	19.6	64.6	9.4	4.0	0.0	3.0	2.1	28.0	22.0	1.2	8.9	36.3	25.8	23.7	18.1	0.4	72.3	23.8	19.9	4.2	3.7	4.8	10.2	18.9	3.7	8.3	10.3	106.1
BCAS4	"CNOL, FLJ20495"	ENSG00000124243	"Breast carcinoma amplified sequence 4"	Q8TDM0	20	50794894-50882676	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 71.6;B-cells: 76.0;granulocytes: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 73.9;naive B-cell: 76.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 96.5;U-698: 88.7"					"Low region specificity"	"Detected in all"			HPA038812	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments, Cytosol"		"HPA038812: AB_10795141"	"unprognostic (3.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.30e-2)"	1.6	1.2	7.6	7.7	8.2	2.2	3.0	4.8	14.9	5.0	7.2	3.7	1.0	4.1	4.1	2.7	2.8	2.0	1.8	15.4	6.0	5.8	0.8	2.1	21.3	4.8	5.6	2.0	2.0	4.8	4.0	2.2	5.3	6.0	0.7	2.3	2.8	4.0	1.0	1.2	7.6	1.8	3.3	9.4	3.5	3.6	6.4	11.7	4.3	0.8	23.1	5.3	2.8	6.8	12.3	21.8	1.7	9.3	3.3	8.7	3.7	15.8	14.2	11.1	7.8	10.4	7.3	96.5	5.8	6.7	22.3	18.2	10.8	22.9	6.3	6.2	9.4	0.4	8.3	8.7	4.7	0.1	0.5	2.8	13.0	8.5	4.2	13.7	0.6	7.5	0.3	0.6	4.0	42.9	3.7	0.3	7.6	1.8	17.6	30.5	2.9	0.9	5.1	11.0	9.5	9.9	24.5	23.2	0.5	8.1	45.9	1.1	0.5	11.8	17.3	12.1	3.9	1.4	7.4	88.7	4.9	0.7	1.1	2.2	0.3	0.2	15.3	0.2	8.7	73.9	9.4	19.0	0.2	76.1	32.2	25.4	1.4	20.0	0.2	18.8	8.9	13.3	7.6	8.2	4.8	14.9	15.4	6.0	4.8	5.6	5.3	3.3	6.4	6.8	1.2	22.4	71.6	6.5	76.0	2.0	27.5	28.9	2.2	6.2	12.6	8.3	17.7	4.3	35.3	9.2	2.1	29.1	16.1	0.3	41.1	11.8	4.0	6.0	6.4	23.7	33.6	5.2	11.5	3.1	4.8	26.6	3.1	7.7	113.5	9.4	2.2	0.4	3.2	8.4	14.3	3.7	44.7	1.3	2.8	1.1	1.5	6.2	5.4	0.0	1.9	10.6	21.6	8.5	0.8	8.9	0.1	3.0	6.1	15.0	0.7	5.2	40.0	6.6	6.6	4.9	35.7	3.2	11.0	1.2	2.4	10.9	35.7	1.5	1.1	25.5
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA038011: AB_2675784"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	40.0	35.1	37.7	38.3	39.1	62.4	52.4	41.1	43.4	31.4	42.3	37.6	32.3	31.0	54.6	38.5	33.0	26.6	48.0	37.5	38.7	55.3	67.9	27.2	49.3	38.3	38.3	42.8	47.1	41.6	24.8	32.5	39.2	42.4	41.1	55.7	58.2	28.6	77.5	31.8	31.7	31.4	38.7	29.8	42.8	48.3	39.0	50.0	39.8	63.6	48.7	55.9	30.1	40.8	225.6	114.4	126.9	141.3	70.9	77.2	105.9	117.9	112.1	142.3	131.2	188.2	146.4	156.6	72.1	108.6	107.1	121.4	219.3	167.0	197.6	145.3	148.5	157.9	97.5	210.0	89.4	219.7	96.1	79.9	98.7	170.1	178.3	108.0	137.7	145.1	177.7	78.1	122.5	134.7	142.7	220.4	98.2	188.0	170.2	134.7	133.5	94.3	126.6	106.0	67.2	68.5	88.1	142.4	149.9	102.7	76.9	96.3	93.0	65.9	116.9	98.2	215.9	79.3	94.9	233.0	129.7	112.5	52.0	30.3	68.3	41.1	56.2	86.6	77.8	76.8	63.7	61.9	75.2	71.4	71.1	64.4	11.2	68.2	94.3	65.0	75.6	48.1	37.7	39.1	41.1	43.4	37.5	38.7	38.3	38.3	39.2	38.7	39.0	40.8	21.6	64.1	67.9	16.6	46.9	66.9	59.3	60.6	58.1	24.2	32.2	27.3	80.4	28.6	67.0	23.9	22.9	41.4	28.2	16.7	78.2	52.7	14.7	37.6	36.6	30.4	25.8	47.3	21.3	44.1	38.0	43.2	40.2	33.2	27.1	33.6	23.2	50.4	35.8	16.8	21.0	23.1	42.7	28.9	22.2	9.4	37.0	29.3	23.2	11.2	36.2	30.2	28.8	22.1	25.7	45.1	19.6	31.2	57.7	51.9	22.7	62.4	74.7	25.1	26.3	47.5	37.5	105.3	117.2	57.8	52.1	33.8	38.6	28.3	33.3	55.5
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR activator of RhoGEF and GTPase"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (7.46e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (9.15e-10)"	"unprognostic (1.47e-1)"	"unprognostic (7.10e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.43e-2)"	19.4	11.1	34.3	11.0	65.7	34.6	17.4	15.9	30.7	14.3	10.6	11.7	10.0	12.3	16.1	24.5	12.1	9.3	12.2	45.0	22.2	21.1	13.8	18.6	13.7	27.1	26.5	9.4	14.6	20.6	25.0	10.3	24.1	11.8	7.6	7.4	18.3	10.1	5.8	23.5	10.2	8.8	20.9	11.4	16.1	11.0	35.0	14.7	19.7	5.7	10.8	15.3	14.3	14.1	47.6	20.1	30.3	31.2	17.7	12.1	45.6	16.8	15.7	15.2	12.2	35.6	18.7	32.9	30.5	14.4	14.7	47.6	3.6	46.8	4.3	63.3	32.3	28.8	27.7	28.6	22.9	26.9	14.6	10.2	31.1	22.8	19.8	27.0	53.6	23.3	112.5	15.1	7.0	31.3	25.4	21.4	25.8	37.4	19.5	32.9	12.4	21.7	23.7	29.6	27.7	26.3	30.7	26.1	12.6	19.3	16.6	21.7	61.4	9.1	1.0	14.9	14.0	3.4	14.8	11.7	23.4	20.1	14.3	0.0	0.5	0.0	3.1	0.2	1.1	0.6	1.5	1.6	0.4	0.6	1.3	1.7	0.5	1.5	0.5	0.4	0.8	1.4	34.3	65.7	15.9	30.7	45.0	22.2	27.1	26.5	24.1	20.9	35.0	14.1	19.3	9.6	11.5	51.2	4.5	15.4	11.9	18.2	6.2	22.9	17.1	9.9	7.5	17.2	20.9	18.4	22.9	14.0	23.9	17.7	9.8	14.4	5.6	22.1	8.0	27.8	19.9	5.5	24.6	16.6	6.8	7.1	11.7	31.4	10.8	9.9	70.6	22.1	7.2	23.5	20.7	13.9	12.2	9.3	11.1	13.5	8.7	9.2	5.4	18.7	6.6	13.2	15.5	32.2	7.0	27.7	8.1	5.7	10.7	11.8	10.7	18.2	12.5	9.4	0.0	4.0	6.8	2.7	7.3	9.3	15.8	10.8	10.3	10.0	13.7	13.3
BEGAIN	KIAA1446	ENSG00000183092	"Brain enriched guanylate kinase associated"	Q9BUH8	14	100537147-100587413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;pancreas: 23.8;pituitary gland: 19.6"	"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 143.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Group enriched"	"Detected in some"	7	"HeLa: 56.6;SH-SY5Y: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002899			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA002899: AB_1078277"	"unprognostic (2.98e-4)"	"unprognostic (2.75e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.77e-3)"	"unprognostic (1.93e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-1)"	1.9	3.2	15.3	0.4	14.9	4.0	1.7	16.4	27.2	3.4	0.0	1.2	2.6	2.4	0.8	1.0	6.0	1.2	2.6	22.0	5.1	1.0	0.7	1.4	0.5	6.4	1.5	4.8	23.8	4.6	19.6	1.6	6.6	4.1	0.2	2.1	1.5	1.3	0.7	1.2	2.7	0.8	1.0	5.8	1.2	2.8	3.2	1.0	1.0	0.1	0.5	1.5	1.3	11.9	0.8	3.3	1.8	11.1	0.0	0.0	0.3	0.3	0.0	0.5	0.1	0.0	1.1	0.3	0.5	0.5	2.5	0.4	0.5	0.0	0.0	0.0	1.1	5.1	56.6	0.0	0.1	0.2	0.3	0.3	0.2	0.9	1.2	0.0	0.1	0.7	0.6	0.1	0.0	4.4	0.4	1.6	1.3	0.3	1.9	0.1	0.3	7.0	0.0	0.2	2.9	129.7	3.0	0.1	3.0	0.0	0.9	13.7	0.0	0.4	3.8	0.1	0.0	0.0	0.0	0.2	9.2	2.5	0.3	0.8	0.1	3.4	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.0	0.1	15.3	14.9	16.4	27.2	22.0	5.1	6.4	1.5	6.6	1.0	3.2	11.9	0.8	0.0	0.6	18.6	0.3	2.4	1.8	0.3	0.0	3.7	0.5	1.1	2.3	0.0	0.7	0.0	0.0	0.1	0.2	0.3	0.0	1.4	0.4	0.1	0.1	0.6	0.0	0.0	18.4	8.0	0.2	1.5	0.0	0.1	9.5	0.1	1.4	0.0	0.3	143.0	10.9	0.0	0.0	0.0	0.8	0.8	1.8	0.3	1.8	4.7	1.1	0.8	0.0	15.6	0.8	2.9	1.1	6.8	0.3	1.6	2.7	0.1	0.1	2.3	0.0	1.7	0.7	0.9	1.5	0.3	2.0	0.1	0.3	0.4	0.4	0.4
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110853-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;prostate: 3.3;testis: 9.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 8.1;Inhibitory neurons: 6.2;Muller glia cells: 10.7;Spermatogonia: 38.3"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 33.2;HEK 293: 7.9;HEL: 21.1;MOLT-4: 13.1;SuSa: 15.4;U-698: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.0	0.0	0.7	1.1	0.7	0.8	0.0	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.3	1.1	0.0	0.1	0.2	2.1	1.2	3.6	0.1	0.0	0.0	1.0	0.3	2.8	3.3	0.2	1.1	0.0	0.0	0.0	0.0	1.2	0.1	0.1	1.2	0.2	9.4	0.7	1.1	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	33.2	0.0	0.0	0.0	7.9	21.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	7.0	0.0	0.1	0.0	0.0	13.1	0.0	6.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	4.7	0.8	0.0	0.0	0.0	15.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	1.3	1.3	1.1	1.2	3.6	2.8	0.1	0.7	0.4	0.4	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.0	3.4	4.4	0.0	0.0	0.3	0.0	0.0	0.0	4.8	2.5	0.0	0.0	3.3	6.2	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.1	10.7	0.0	3.5	0.2	0.0	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.6	38.3	0.0	0.0	0.0	1.5	2.2	0.0	0.0
BEND5	"C1orf165, FLJ11588"	ENSG00000162373	"BEN domain containing 5"	Q7L4P6	1	48727519-48776969	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Proximal tubular cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 6.5;naive B-cell: 8.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 8.0"	"Cell line enhanced"	"Detected in some"		"AF22: 3.4;HDLM-2: 11.7;JURKAT: 4.5;MOLT-4: 4.8;REH: 6.5;SH-SY5Y: 2.9"	"Low region specificity"	"Detected in many"							"HPA054347, HPA058007"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear speckles"	Cytosol	"HPA054347: AB_2682456, HPA058007: AB_2683577"	"prognostic favorable (2.50e-5)"	"unprognostic (1.36e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.68e-2)"	"prognostic favorable (8.30e-6)"	1.7	1.9	5.1	0.7	5.1	1.0	1.8	4.1	7.4	2.8	4.1	3.4	0.4	2.0	1.5	0.6	2.5	2.0	1.6	5.1	4.3	3.4	0.1	0.9	2.1	6.3	5.0	4.4	1.7	1.8	3.4	0.3	6.4	1.5	0.4	3.7	1.0	1.2	2.6	0.8	1.6	0.7	4.1	2.7	1.7	1.0	4.8	4.8	1.8	1.7	1.4	2.2	1.7	5.3	0.0	0.0	3.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	4.8	0.2	2.6	0.0	0.0	6.5	1.1	0.0	0.0	1.2	1.1	2.9	0.0	0.0	0.2	1.2	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.2	1.7	8.0	1.6	1.0	0.2	1.2	0.0	1.7	0.0	0.4	5.1	5.1	4.1	7.4	5.1	4.3	6.3	5.0	6.4	4.1	4.8	5.3	8.7	6.4	3.1	0.0	17.2	1.9	4.6	4.6	1.8	13.3	4.0	16.9	8.6	8.6	6.1	5.5	16.7	0.3	0.6	0.5	54.8	6.4	8.9	2.7	1.9	6.9	12.1	0.8	0.0	1.8	0.5	8.4	2.6	1.3	1.3	10.2	4.6	0.2	0.3	8.4	0.0	0.8	2.0	0.6	4.4	7.1	13.1	1.5	3.6	0.0	0.5	22.7	0.0	0.0	0.0	2.6	4.5	21.4	7.6	1.1	0.2	30.2	6.4	17.8	6.6	6.8	5.6	3.7	9.1	0.3	2.3	0.1	2.8	11.4	1.6	1.9
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064171	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 439.4;pituitary gland: 399.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 354.2;Granulosa cells: 260.7;Horizontal cells: 363.4;Muller glia cells: 716.1;Rod photoreceptor cells: 142.2"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 607.0;HBF TERT88: 680.4;HL-60: 1562.2;hTERT-RPE1: 1044.5;SCLC-21H: 465.3;U-937: 484.1"									"HPA045384, HPA078630"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA045384: AB_2679305, HPA078630: "	"prognostic favorable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.34e-2)"	1.5	83.8	253.7	3.8	260.1	42.7	2.5	201.9	317.4	5.5	142.9	10.5	5.0	15.6	55.5	0.8	21.4	1.3	16.7	274.9	439.4	10.7	4.2	2.8	1.2	222.6	248.2	20.2	71.6	112.0	399.2	0.4	261.1	6.7	4.3	173.0	2.3	3.6	0.6	1.0	6.3	4.8	203.1	2.5	8.6	92.9	265.5	3.5	26.0	0.8	0.4	0.8	2.9	223.9	0.7	0.0	37.6	0.1	0.0	0.1	1.1	21.6	0.0	412.1	607.0	0.0	0.1	0.1	0.8	158.1	130.0	0.4	0.0	0.5	680.4	0.2	1.2	129.2	0.0	85.2	6.9	1562.2	2.6	9.2	0.0	89.3	0.1	1044.5	0.1	120.8	0.2	0.2	84.6	0.0	294.7	0.2	337.9	97.8	62.0	0.2	0.7	7.6	0.0	0.3	465.3	266.6	0.5	0.6	1.9	5.9	0.3	432.4	0.0	0.1	140.2	1.1	16.7	71.9	2.9	0.7	54.4	484.1	27.2	0.4	0.2	3.4	0.3	0.0	0.3	0.5	0.9	0.5	0.0	1.0	1.4	0.6	0.5	0.9	0.2	0.1	0.4	0.7	253.7	260.1	201.9	317.4	274.9	439.4	222.6	248.2	261.1	203.1	265.5	223.9	1.1	0.0	0.5	16.3	1.2	8.7	11.1	0.0	1.2	354.2	7.2	32.5	9.6	31.5	0.7	5.5	39.6	0.2	0.2	0.4	72.4	6.1	12.1	1.4	0.6	5.3	79.6	0.8	64.6	13.8	0.2	3.9	8.2	2.8	0.0	260.7	30.4	1.2	1.4	363.4	56.1	6.9	10.2	4.0	1.2	31.8	8.1	2.2	7.2	12.2	1.5	716.1	0.0	32.6	20.9	6.3	3.3	2.6	0.0	7.5	0.8	19.5	0.0	142.2	0.0	15.9	14.4	38.5	13.8	0.0	6.5	0.5	2.0	0.2	3.5	1.7
BICC1		ENSG00000122870	"BicC family RNA binding protein 1"	Q9H694	10	58512872-58831435	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 120.5;Cholangiocytes: 158.7;Collecting duct cells: 86.5;Ductal cells: 98.5;Fibroblasts: 79.6;Microglial cells: 165.8;Proximal tubular cells: 148.2"	"Group enriched"	"Detected in all"	4	"pancreatic cancer: 9.2;renal cancer: 25.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 59.1;BJ hTERT+: 61.4;CACO-2: 93.1;RPTEC TERT1: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070797			Approved	Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Centrosome	"HPA070797: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.79e-2)"	"unprognostic (6.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.40e-3)"	"unprognostic (7.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.94e-2)"	10.6	6.1	0.3	4.0	0.5	0.3	8.7	0.0	1.6	5.8	1.9	4.5	1.2	4.9	4.0	3.5	7.5	11.6	10.5	0.6	1.0	28.6	2.4	5.8	2.4	1.2	0.6	13.9	16.9	0.8	3.6	3.6	0.2	3.8	4.1	1.4	4.3	4.2	7.6	6.1	2.7	4.7	1.2	2.9	2.7	3.1	0.7	1.4	4.6	6.2	2.7	5.5	5.6	0.7	0.0	59.1	0.8	0.0	17.9	23.0	0.0	38.5	61.4	34.4	40.4	93.1	12.3	0.0	39.8	39.3	8.8	0.8	6.1	7.0	47.4	0.1	5.9	0.0	7.4	0.1	11.5	0.0	0.0	36.0	2.2	26.9	28.6	42.3	0.1	0.0	0.0	0.2	13.4	0.1	0.0	0.0	0.5	0.0	3.8	0.0	14.3	0.0	140.8	7.1	0.2	7.3	0.1	0.4	3.4	2.4	0.0	0.6	0.0	8.2	7.7	1.4	5.0	0.0	0.0	0.1	23.8	0.0	7.8	6.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.5	0.1	0.0	0.3	0.5	0.0	1.6	0.6	1.0	1.2	0.6	0.2	1.2	0.7	0.7	4.1	0.0	0.5	120.5	1.5	7.1	1.3	1.3	0.6	0.6	1.1	4.3	3.3	158.7	1.7	86.5	0.0	0.4	0.1	0.3	78.2	98.5	5.2	43.8	14.4	1.4	3.6	0.0	70.4	3.5	0.2	79.6	0.5	7.2	0.0	4.2	3.3	1.4	3.5	0.0	37.2	1.2	0.0	0.6	18.5	3.2	71.1	1.7	21.4	165.8	1.1	10.1	0.0	25.6	2.7	35.3	1.2	50.0	0.3	2.4	0.0	148.2	14.1	0.2	6.6	40.0	9.8	0.1	3.9	0.3	4.7	4.1	1.5	8.7	1.6	0.1
BICD2	KIAA0699	ENSG00000185963	"BICD cargo adaptor 2"	Q8TD16	9	92711363-92764833	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 83.6;Squamous epithelial cells: 103.2;Suprabasal keratinocytes: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023013, HPA024452"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA023013: AB_1845352, HPA024452: AB_1845353"	"unprognostic (9.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.39e-2)"	15.4	10.6	11.4	13.5	10.0	12.0	10.9	10.9	10.5	20.8	7.8	18.5	4.6	15.5	6.0	47.0	12.8	9.4	19.8	11.1	8.6	9.1	8.5	16.0	14.7	11.0	9.8	12.5	8.9	17.7	6.0	10.4	10.3	11.3	5.0	6.5	14.6	13.1	22.3	63.4	10.4	13.7	10.5	17.3	9.5	9.4	10.0	13.8	10.0	15.3	16.8	15.2	30.9	12.3	32.6	26.5	19.2	19.8	36.6	25.1	27.1	30.8	22.2	17.2	13.6	15.6	14.4	36.3	19.5	34.4	22.0	99.4	21.8	49.1	19.4	17.4	23.5	19.2	25.6	21.7	21.8	26.9	30.0	25.8	67.1	28.8	22.0	20.4	26.0	15.4	19.3	27.5	38.1	21.4	25.6	16.7	13.3	23.8	32.0	27.8	41.8	19.3	27.8	27.0	13.4	20.7	21.7	19.9	14.3	19.2	8.2	12.3	34.9	31.8	21.1	53.9	33.9	22.5	17.5	31.9	26.9	16.3	28.4	1.6	3.4	4.4	1.2	3.6	1.2	1.8	1.4	1.6	3.8	2.0	1.3	1.2	7.5	1.1	5.9	3.2	0.9	1.7	11.4	10.0	10.9	10.5	11.1	8.6	11.0	9.8	10.3	10.5	10.0	12.3	21.7	28.9	12.7	14.7	27.6	73.7	17.1	19.2	83.6	12.8	11.4	10.2	54.5	8.6	16.2	7.3	6.2	8.5	26.1	3.4	3.9	10.1	6.5	21.3	26.7	26.4	10.8	16.0	16.2	5.1	6.5	26.0	5.6	21.1	24.1	13.0	19.2	7.5	14.2	15.2	14.0	1.9	12.2	32.4	30.2	7.6	21.1	40.7	16.0	19.7	38.9	22.0	7.2	9.5	18.5	8.5	3.6	33.4	22.1	18.7	0.8	6.7	14.0	6.4	19.7	23.0	33.1	9.7	8.4	103.2	130.8	7.3	17.2	13.8	3.6	20.3
BICDL2	CCDC64B	ENSG00000162069	"BICD family like cargo adaptor 2"	A1A5D9	16	3027682-3036944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 104.8;pancreas: 127.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 52.2;Breast myoepithelial cells: 22.1;Ductal cells: 34.3;Endometrial ciliated cells: 28.9;Exocrine glandular cells: 49.8;Glandular and luminal cells: 28.3;Pancreatic endocrine cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;BEWO: 15.4;CAPAN-2: 14.4;HaCaT: 22.5;MCF7: 22.8;RT4: 10.8;SK-BR-3: 11.0;T-47d: 14.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.7"	HPA043251	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Intermediate filaments, Actin filaments, Cytosol"		"HPA043251: AB_10794925"	"unprognostic (2.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.06e-3)"	"unprognostic (9.65e-5)"	"unprognostic (5.79e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.32e-2)"	"prognostic favorable (9.04e-4)"	0.4	0.0	0.2	1.9	0.2	0.0	8.6	0.4	0.4	20.7	0.1	25.1	10.4	0.7	2.6	104.8	6.0	3.4	0.0	0.2	0.1	5.8	0.9	5.9	0.0	0.6	0.3	0.1	127.2	4.1	1.5	0.3	0.8	16.8	6.4	0.0	44.4	3.2	0.6	43.8	13.5	0.2	0.2	0.2	21.5	0.1	0.3	0.2	6.1	0.0	3.1	11.4	44.3	0.2	9.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	2.6	14.4	0.0	0.0	0.0	0.0	22.5	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	6.4	0.0	0.1	0.0	0.2	0.0	10.8	0.2	0.1	0.0	11.0	0.0	0.3	14.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.2	0.1	0.6	0.3	0.8	0.2	0.3	0.2	0.3	12.8	18.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	52.2	22.1	0.0	0.0	12.4	16.5	0.0	4.5	1.3	0.0	3.9	34.3	0.0	28.9	2.8	0.5	0.0	0.0	0.0	49.8	6.1	0.6	0.0	28.3	2.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.1	0.0	0.0	0.2	12.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.6	0.3	0.0	0.0
BLOC1S4	"BCAS4L, CNO, FLJ11230"	ENSG00000186222	"Biogenesis of lysosomal organelles complex 1 subunit 4"	Q9NUP1	4	6716174-6717664	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043840	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	Cytosol	"HPA043840: AB_10965701"	"unprognostic (3.09e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.24e-3)"	"unprognostic (5.62e-3)"	8.6	11.7	8.0	7.9	8.2	9.8	8.9	8.3	8.7	9.4	9.1	8.9	9.2	9.9	7.1	11.1	9.3	6.5	8.0	8.3	7.7	10.0	11.3	6.3	12.1	8.1	8.2	12.0	7.9	5.6	7.2	7.7	8.3	9.4	5.7	4.3	8.2	6.4	10.8	8.6	11.4	5.1	8.4	13.1	8.8	6.3	8.3	8.9	7.6	5.7	8.6	9.6	8.6	8.6	15.3	10.3	15.2	15.6	11.7	15.0	30.5	12.0	13.2	11.0	9.7	9.2	16.0	14.4	12.6	10.9	15.5	10.1	8.6	14.0	8.4	11.7	14.1	22.0	10.3	23.2	14.3	10.8	19.7	14.2	13.6	8.7	7.5	10.8	10.3	12.3	29.3	12.6	11.6	15.1	17.6	37.5	19.7	11.2	20.0	17.9	16.8	13.0	15.3	13.3	13.1	17.5	9.9	7.1	22.7	11.6	22.4	20.8	11.6	10.0	8.9	11.8	15.4	18.8	19.8	19.4	11.2	19.6	16.3	2.5	2.7	14.0	4.4	4.6	4.5	6.3	5.4	4.8	3.6	5.2	8.4	4.5	1.4	2.5	3.1	3.4	5.1	1.7	8.0	8.2	8.3	8.7	8.3	7.7	8.1	8.2	8.3	8.4	8.3	8.6	18.7	6.4	5.9	3.9	40.8	23.6	35.2	4.9	26.7	29.1	25.2	27.8	5.3	21.5	5.7	23.9	6.2	65.1	49.5	21.7	25.4	9.7	2.5	28.6	28.0	20.2	11.4	26.5	6.8	7.0	93.1	27.8	21.9	25.3	3.8	18.7	32.5	23.6	35.8	30.3	6.6	22.8	4.1	24.0	22.2	1.6	32.3	16.6	30.2	5.6	18.1	38.4	60.8	4.5	8.3	9.9	33.9	22.6	19.7	40.3	33.9	51.3	4.6	24.7	6.6	26.6	20.0	16.0	14.3	23.1	24.9	63.3	47.7	39.1	24.2	34.8
BMERB1	"C16orf45, FLJ32618"	ENSG00000166780	"BMERB domain containing 1"	Q96MC5	16	15434475-15625028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 57.0"	"Cancer enhanced"	"Detected in all"		"glioma: 30.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 101.8;U-2197: 81.3;U-87 MG: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041114, HPA063757"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA041114: AB_10794542, HPA063757: "	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.28e-2)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.79e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	30.9	15.4	90.3	10.5	111.6	1.1	21.6	67.4	112.7	46.0	48.2	46.1	8.3	40.5	19.7	21.4	38.4	23.9	47.3	107.0	87.2	23.1	21.8	13.4	6.4	123.0	74.0	40.9	18.6	3.9	40.8	1.3	118.5	32.4	9.3	40.6	12.6	27.6	86.9	13.0	19.1	35.6	69.6	9.2	21.6	40.3	80.5	4.0	13.5	41.3	4.0	44.4	25.3	96.2	1.4	31.5	12.8	1.5	56.7	50.7	0.3	18.1	62.6	15.5	8.4	0.0	0.9	0.1	4.0	101.8	37.5	0.2	4.1	5.3	7.9	0.4	0.7	6.7	11.9	1.5	19.4	0.1	13.6	24.5	5.2	33.8	0.5	25.8	25.2	14.5	0.4	0.5	24.2	21.6	5.1	0.9	17.2	0.4	10.7	1.0	16.3	0.1	8.8	4.6	26.2	27.6	0.9	8.3	5.5	2.1	0.4	0.4	8.9	34.2	17.6	81.3	9.4	5.7	12.5	0.2	124.3	0.2	7.1	0.1	0.1	0.1	8.7	0.0	1.7	2.1	2.0	5.2	0.5	1.3	1.5	2.8	0.6	0.2	0.1	0.2	2.6	1.1	90.3	111.6	67.4	112.7	107.0	87.2	123.0	74.0	118.5	69.6	80.5	96.2	7.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321099-22331484	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 134.0;Late spermatids: 165.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 508.3;U-937: 583.9"									"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	29.0	31.1	26.6	25.1	35.1	21.9	36.0	29.9	42.4	27.6	28.2	26.2	19.7	30.7	29.7	21.9	22.6	23.9	20.5	25.0	27.8	26.0	35.6	23.4	27.7	29.5	30.1	21.7	25.7	56.9	25.0	28.7	31.6	33.7	21.5	40.4	19.9	26.1	44.4	14.4	20.8	36.2	29.9	36.2	22.5	35.3	28.1	24.9	23.9	35.5	27.0	23.8	14.8	45.4	74.9	36.1	41.2	12.7	68.9	54.6	40.5	49.7	22.2	37.3	43.5	37.6	93.4	38.1	32.8	45.6	42.2	26.1	59.1	35.0	45.4	508.3	72.8	104.7	28.7	42.9	41.1	39.8	55.7	35.5	58.8	41.2	45.3	47.0	26.2	62.1	105.4	63.3	48.6	30.2	106.9	11.4	9.3	36.3	83.4	79.6	57.1	37.3	35.3	25.2	33.8	66.0	32.7	42.5	57.3	17.8	38.5	153.8	56.4	41.4	122.6	99.6	67.6	76.1	110.8	83.1	59.5	583.9	27.4	15.1	1.3	2.5	5.2	3.0	7.0	4.4	5.3	5.0	0.9	2.2	4.4	4.3	0.6	5.2	2.1	1.6	4.1	2.0	26.6	35.1	29.9	42.4	25.0	27.8	29.5	30.1	31.6	29.9	28.1	45.4	18.9	25.6	24.0	0.0	23.1	15.9	20.5	12.4	22.8	20.9	24.4	20.3	19.0	22.8	19.8	12.9	8.4	12.7	14.2	5.6	13.7	16.3	134.0	12.1	25.3	24.0	13.2	19.1	0.0	18.2	22.2	19.8	7.7	9.8	12.0	12.6	28.5	30.7	9.9	30.3	0.0	9.9	14.2	19.7	25.6	165.1	36.1	13.8	37.4	0.0	17.5	13.9	15.5	0.0	0.0	22.9	7.3	36.5	33.9	29.1	4.6	13.0	16.9	15.2	19.7	26.5	28.6	19.8	22.2	11.2	14.6	6.7	22.4	17.0	10.3	20.4
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932825	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.7;Inhibitory neurons: 79.9;Oligodendrocyte precursor cells: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"CAB019398: "	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.05e-3)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (3.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.07e-1)"	9.1	6.4	4.3	4.5	5.2	0.0	10.3	5.4	5.5	8.1	4.9	9.9	5.4	12.9	11.9	7.8	7.4	9.6	7.8	4.7	6.1	7.0	4.3	7.3	2.9	6.8	5.8	11.6	5.8	9.9	2.6	6.5	6.3	12.5	8.2	4.8	12.1	13.0	7.9	9.3	8.6	12.5	6.2	2.9	7.3	5.2	4.6	2.9	19.1	4.8	3.0	7.9	4.1	6.5	14.6	7.8	27.6	26.8	15.0	10.6	5.5	14.5	18.3	9.4	11.3	11.0	13.1	4.7	6.1	19.2	5.9	15.0	15.8	14.3	14.1	5.5	8.2	5.9	6.9	19.0	10.2	7.4	37.7	10.7	8.5	11.2	9.5	13.9	0.0	8.1	7.6	2.7	12.3	7.0	6.7	7.8	17.6	5.2	4.2	0.0	12.3	0.1	18.9	12.1	3.7	12.8	17.8	8.4	12.6	34.1	15.0	4.1	6.2	7.0	9.8	12.7	13.3	0.3	12.3	5.3	6.5	5.6	6.0	0.3	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.0	4.3	5.2	5.4	5.5	4.7	6.1	6.8	5.8	6.3	6.2	4.6	6.5	3.5	35.3	22.4	142.7	3.5	12.1	7.1	9.9	17.6	7.5	10.2	10.2	22.6	18.6	10.5	11.0	20.9	14.1	2.3	10.7	1.9	10.6	0.7	10.7	19.7	4.5	18.0	0.0	63.8	9.5	1.0	20.6	19.4	13.9	15.2	22.9	9.3	7.2	3.4	11.8	79.9	13.9	8.2	4.8	6.1	4.1	33.5	2.3	8.8	34.7	0.8	12.9	2.1	122.2	64.3	8.9	4.9	31.2	3.2	13.7	10.6	5.5	16.5	20.4	6.6	20.3	19.2	2.1	6.6	11.5	9.8	5.1	4.3	11.9	11.1	6.7
BMT2	"C7orf60, DKFZp762M126, FLJ31818, SAMTOR"	ENSG00000164603	"Base methyltransferase of 25S rRNA 2 homolog"	Q1RMZ1	7	112819147-112939875	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 12.9;Extravillous trophoblasts: 25.9;Hofbauer cells: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044405, HPA050733"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA044405: AB_10959783, HPA050733: AB_2681223"	"unprognostic (5.26e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.61e-5)"	"unprognostic (1.50e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.22e-2)"	"unprognostic (9.10e-2)"	3.9	4.0	7.2	4.8	7.4	4.9	5.8	8.9	10.7	5.9	5.7	4.9	2.6	7.3	4.2	7.3	4.4	5.0	12.7	7.3	8.4	5.4	2.3	4.3	5.8	5.3	6.6	5.8	3.1	4.8	2.9	5.1	5.6	5.6	4.3	9.3	5.0	6.4	3.2	3.8	3.3	7.2	6.1	6.0	3.1	8.0	8.7	8.2	5.2	4.2	5.7	6.3	4.3	5.8	5.9	4.9	12.3	11.1	16.3	18.6	3.7	6.1	27.5	10.8	15.6	3.0	4.6	2.0	7.7	11.2	11.9	2.8	6.6	9.1	17.6	6.2	6.7	10.3	3.1	3.7	7.3	4.0	9.6	14.2	7.1	8.5	7.4	13.5	8.8	3.7	3.3	3.8	13.2	4.5	9.5	11.5	2.7	4.2	5.1	4.7	16.1	6.2	8.3	7.8	4.9	12.5	11.5	4.7	6.8	11.8	2.3	3.6	6.2	13.8	3.3	8.9	4.8	4.9	4.9	3.7	14.9	5.9	8.2	6.7	3.8	6.5	3.2	3.9	3.9	2.5	3.1	3.7	3.9	2.4	4.2	3.7	8.7	3.7	4.4	2.3	5.2	1.6	7.2	7.4	8.9	10.7	7.3	8.4	5.3	6.6	5.6	6.1	8.7	5.8	6.8	6.4	5.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	7.9	7.6	0.0	0.0	1.8	12.9	0.0	6.9	4.8	0.0	0.0	3.4	0.0	4.6	8.5	2.6	0.0	0.0	0.0	2.5	25.9	2.7	0.0	5.4	0.0	8.9	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.6	0.0	0.0	6.6	3.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	8.2	2.6	5.8	0.0	0.0
BNIP5	"C6orf222, DKFZp779B1540"	ENSG00000189325	"BCL2 interacting protein 5"	P0C671	6	36315761-36336888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 24.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;OE19: 2.3;REH: 1.0;U-937: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA038407, HPA058189"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"		Cytosol		"HPA038407: AB_10669644, HPA058189: AB_2683634"	"unprognostic (1.97e-5)"	"unprognostic (5.46e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.66e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	24.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.2	23.5	0.1	0.0	0.0	4.2	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BNIPL	"BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753"	ENSG00000163141	"BCL2 interacting protein like"	Q7Z465	1	151036321-151047720	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 128.5;skin 1: 181.4;vagina: 69.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 17.2;Squamous epithelial cells: 42.7;Suprabasal keratinocytes: 57.1;Urothelial cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"T-47d: 46.1"	"Group enriched"	"Detected in some"	9	"basal ganglia: 1.6;cerebellum: 2.4"	"Not detected"	"Not detected"			HPA019946			Uncertain	Cytosol		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA019946: AB_2732424"	"unprognostic (2.62e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.50e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.88e-4)"	"unprognostic (1.91e-1)"	"unprognostic (8.43e-11)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (6.81e-2)"	0.4	0.3	0.9	0.4	1.0	0.6	15.6	3.0	1.3	25.1	0.7	0.4	0.3	0.3	0.2	128.5	2.7	0.3	0.7	0.9	1.0	2.9	1.2	9.4	0.6	1.5	1.0	0.6	0.4	1.1	0.6	0.5	1.1	12.5	0.2	0.8	22.9	4.7	1.6	181.4	0.5	0.1	0.7	1.1	1.4	4.3	1.0	0.7	7.4	0.1	10.1	9.7	69.7	1.1	0.4	0.4	0.6	0.6	0.4	0.4	0.7	0.3	0.0	0.3	0.2	1.5	0.4	0.7	0.7	0.0	0.1	1.5	0.9	0.2	0.6	1.1	1.0	1.2	0.8	0.2	0.1	0.6	0.6	0.0	3.1	0.2	0.3	1.0	0.0	1.1	0.6	0.5	0.3	2.0	0.7	1.2	0.5	1.0	0.4	0.3	0.3	0.4	0.6	0.4	1.3	0.6	0.5	0.9	0.3	2.2	46.1	0.4	1.1	0.7	0.5	0.2	0.1	1.7	1.3	3.9	0.1	0.3	0.8	0.5	0.1	0.1	0.3	0.1	0.2	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.9	1.0	3.0	1.3	0.9	1.0	1.5	1.0	1.1	0.7	1.0	1.1	0.4	16.0	17.2	0.0	0.3	15.3	6.1	3.9	12.5	0.4	14.2	6.1	0.3	0.0	11.0	11.0	0.0	1.6	1.2	0.3	0.0	0.0	7.6	1.1	1.3	0.8	0.0	0.0	1.1	0.0	0.4	0.9	0.0	1.1	0.0	0.4	2.5	0.1	0.3	0.0	1.2	0.3	2.0	0.6	5.5	1.3	0.9	1.9	3.6	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.6	5.5	0.8	0.3	12.8	1.5	0.0	0.9	1.2	0.9	0.3	42.7	57.1	2.6	1.3	0.2	0.4	24.4
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135400-74147912	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 173.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 313.2;Distal tubular cells: 352.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: AB_2682063"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	35.6	39.3	52.1	22.6	54.3	40.8	31.4	58.9	66.1	20.2	55.0	46.5	33.8	24.5	25.1	31.7	20.8	11.9	101.0	52.7	56.5	59.8	33.7	23.5	22.2	57.0	53.8	16.6	44.7	56.2	29.6	14.2	56.0	25.4	37.6	35.7	39.7	23.7	117.8	16.6	28.9	22.6	54.7	21.9	41.1	15.8	53.7	24.8	28.8	173.9	21.6	27.1	24.3	55.3	102.8	134.0	44.8	46.2	81.5	78.3	113.9	92.5	54.5	104.0	72.0	176.6	45.4	67.2	79.7	82.4	99.3	53.2	107.9	135.4	95.8	126.5	172.8	85.4	88.3	269.8	76.1	167.3	39.0	62.2	96.6	100.9	124.2	45.9	79.4	144.3	183.2	73.7	116.0	163.6	136.4	123.1	66.9	196.8	198.6	88.5	120.1	132.0	138.8	106.2	70.4	40.7	68.3	106.8	123.3	62.0	62.6	102.8	42.6	83.9	142.9	93.8	185.4	67.5	135.3	92.7	87.6	131.8	73.8	14.7	14.2	3.9	68.3	29.9	75.7	45.4	92.7	72.6	37.8	44.5	79.3	68.7	3.0	51.7	33.5	65.1	91.2	40.6	52.1	54.3	58.9	66.1	52.7	56.5	57.0	53.8	56.0	54.7	53.7	55.3	54.7	9.6	29.8	8.5	33.2	22.7	44.5	111.8	43.3	29.9	82.0	109.5	313.2	44.3	50.1	84.6	16.7	54.9	42.8	125.4	352.1	93.2	20.0	67.0	46.2	45.5	76.1	138.2	14.3	111.4	167.5	48.6	58.1	61.5	25.4	31.9	36.4	113.3	113.9	26.9	15.0	128.3	83.4	32.1	28.9	10.2	32.9	32.2	99.6	3.7	59.4	61.8	62.8	7.5	7.7	95.0	70.9	46.3	76.1	50.9	85.6	266.4	51.2	52.6	19.7	39.6	64.4	66.8	80.5	101.0	16.9	22.3	45.1	83.0	176.2	52.0
BORA	"C13orf34, FLJ22624"	ENSG00000136122	"BORA aurora kinase A activator"	Q6PGQ7	13	72727749-72756198	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 13.5;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040866	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA040866: AB_10794868"	"unprognostic (9.93e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.32e-12)"	"unprognostic (7.04e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.28e-2)"	1.6	1.3	1.2	4.3	1.2	6.0	2.4	1.4	1.7	1.6	1.9	4.2	4.3	1.3	1.5	3.5	1.4	1.3	1.0	1.2	1.3	1.8	1.7	1.8	7.6	1.6	1.3	1.2	1.7	0.5	1.9	2.3	1.5	1.8	5.0	3.5	1.9	1.0	1.1	4.2	3.5	1.7	1.1	4.2	3.2	4.0	1.4	8.1	1.9	0.9	6.8	2.2	2.2	1.5	32.5	8.5	19.6	14.7	2.4	2.4	11.6	9.8	8.6	17.9	18.1	20.6	17.2	23.8	6.4	6.4	10.3	15.0	17.1	11.5	22.1	20.9	12.3	28.7	11.4	15.8	1.7	54.2	17.1	1.9	2.6	8.9	15.1	5.0	14.6	22.8	12.7	10.7	14.6	9.8	20.8	21.8	10.8	36.8	6.0	16.4	12.3	10.6	6.5	10.0	6.9	7.0	12.0	12.8	10.2	15.0	6.4	24.6	4.8	5.8	9.7	8.3	16.3	6.9	7.0	14.8	16.3	24.8	13.9	1.3	1.1	0.5	1.9	1.9	2.3	1.6	1.8	2.0	1.9	1.9	1.6	2.5	0.1	1.8	1.2	1.4	1.9	1.1	1.2	1.2	1.4	1.7	1.2	1.3	1.6	1.3	1.5	1.1	1.4	1.5	1.6	3.2	2.8	3.6	5.4	0.6	1.3	2.2	3.4	1.7	1.4	1.3	0.3	1.5	2.1	1.8	2.1	7.5	3.9	3.1	0.0	1.9	12.6	2.2	2.3	1.4	0.0	13.5	4.3	2.6	11.5	1.7	3.6	2.4	1.3	5.1	1.8	0.4	4.6	8.4	3.1	2.7	0.0	2.8	1.5	2.7	0.9	2.8	0.0	3.7	3.5	1.1	4.1	2.5	7.3	1.7	2.2	1.2	5.2	1.2	3.2	0.8	2.7	2.3	13.1	1.6	1.5	11.8	4.3	3.4	1.1	2.9	4.1	1.5	5.8	1.4
BORCS7	"C10orf32, FLJ40752"	ENSG00000166275	"BLOC-1 related complex subunit 7"	Q96B45	10	102854259-102864961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 201.5;Proximal tubular cells: 208.5;Theca cells: 209.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA037648	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Cytosol	"HPA037648: AB_10673634"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.46e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.08e-8)"	"unprognostic (9.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-3)"	25.4	58.5	20.5	12.8	20.9	23.4	29.8	20.3	25.1	21.3	22.3	19.7	23.2	21.8	23.7	13.4	29.7	22.4	22.3	21.5	23.1	39.8	67.0	23.8	15.1	21.2	21.7	21.8	17.5	53.3	23.7	21.7	21.3	27.2	15.2	20.2	16.9	17.4	28.6	13.9	19.5	16.7	22.5	24.4	20.9	20.2	22.7	14.6	55.3	25.9	12.3	17.4	16.0	23.0	14.9	19.8	23.4	20.7	25.6	35.1	19.5	21.6	44.1	16.3	15.5	13.3	16.6	9.4	11.1	34.6	17.1	12.2	7.9	11.1	12.0	12.1	16.7	21.7	12.5	27.7	29.5	39.4	35.9	44.1	29.8	11.0	17.4	34.0	28.9	13.2	13.0	9.7	26.4	10.9	11.0	16.2	7.9	20.3	18.4	19.8	31.4	13.8	13.6	16.1	6.6	25.5	8.0	14.2	34.7	10.4	27.0	22.2	21.6	13.7	14.6	14.1	15.3	24.9	40.8	11.1	29.0	22.7	5.0	31.3	30.1	22.9	17.3	35.0	19.4	26.5	17.9	18.0	22.1	23.2	19.8	18.4	9.6	27.7	32.9	47.1	19.7	15.1	20.5	20.9	20.3	25.1	21.5	23.1	21.2	21.7	21.3	22.5	22.7	23.0	85.2	54.5	79.6	0.0	49.1	0.0	61.0	0.0	45.5	50.9	94.5	62.9	0.0	48.6	32.2	42.3	39.6	89.6	57.4	18.0	201.5	35.3	21.1	61.1	38.8	67.3	34.0	18.3	0.0	33.3	39.2	60.4	39.8	31.9	34.1	44.2	68.2	74.9	51.7	63.9	0.0	33.4	0.0	49.8	0.0	22.8	42.3	54.1	0.0	0.0	52.1	109.8	53.5	0.0	0.0	28.5	48.5	62.1	28.6	53.8	70.1	208.5	43.7	50.6	39.5	53.3	44.0	80.1	52.4	44.7	0.0	121.5	39.8	209.5	41.0	54.5
BORCS8-MEF2B	MEF2BNB-MEF2B	ENSG00000064489	"BORCS8-MEF2B readthrough"		19	19145569-19192158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 2.2;dendritic cells: 1.4;Gastric mucus-secreting cells: 1.5;Late spermatids: 1.1;Plasma cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.0;U-266/70: 3.1"									HPA004734	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"		"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (2.74e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.29e-2)"	0.2	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.6	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.6	0.2	0.2	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.6	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.1	0.1	0.7	0.2	0.1	0.1	0.4	0.3	0.4	0.0	1.4	0.3	0.1	0.0	0.5	0.5	0.2	0.1	0.2	0.1	0.5	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.9	0.1	2.0	0.5	0.2	1.3	0.1	0.6	0.0	0.7	0.7	0.1	0.0	0.1	1.6	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.0	1.5	0.0	3.1	0.6	1.7	0.3	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.1	1.4	0.8	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.2	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.5	0.0	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.6	0.0
BPNT2	"FLJ20421, gPAPP, IMPA3, IMPAD1"	ENSG00000104331	"3'(2'), 5'-bisphosphate nucleotidase 2"	Q9NX62	8	56957931-56993867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.6;Cardiomyocytes: 53.8;Cytotrophoblasts: 18.0;dendritic cells: 16.2;Extravillous trophoblasts: 91.8;Hofbauer cells: 26.6;Syncytiotrophoblasts: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		480000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	37.6	37.3	14.8	16.1	19.9	12.4	19.3	19.2	19.8	25.5	8.9	17.4	13.3	21.9	16.2	19.1	13.4	16.5	29.4	16.0	17.9	23.4	36.2	17.2	12.3	17.2	17.6	11.8	19.6	35.6	13.7	24.9	17.7	31.0	17.6	19.7	21.9	23.6	37.4	14.3	12.7	25.7	15.3	15.5	16.9	16.5	18.0	15.4	27.1	30.1	13.3	22.4	12.2	29.3	42.4	34.5	26.0	26.9	78.2	53.3	35.7	62.9	60.9	44.1	38.3	17.4	29.2	26.3	47.0	67.3	31.2	33.7	31.8	42.5	65.0	36.4	22.7	51.4	23.0	31.2	48.5	33.0	35.1	43.2	41.6	39.7	63.9	40.8	59.5	24.3	22.5	46.1	48.9	22.1	40.6	19.8	19.2	48.1	12.7	27.9	23.4	29.7	46.0	24.9	10.1	28.1	35.3	42.9	36.3	27.1	38.4	23.9	50.1	59.3	34.2	59.2	45.8	47.5	42.5	27.8	81.0	27.0	37.3	1.8	0.9	0.5	0.9	0.6	0.7	0.7	0.6	0.5	0.7	0.9	0.6	1.1	2.5	3.2	2.6	1.0	0.4	0.3	14.8	19.9	19.2	19.8	16.0	17.9	17.2	17.6	17.7	15.3	18.0	29.3	22.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	18.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	91.8	14.4	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	33.8	1.8	0.0	0.0	0.0
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2 DNA repair associated"	P51587	13	32315086-32400268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 3.1;testis: 2.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 115.4;Spermatogonia: 85.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.0	1.3	0.0	5.8	0.5	0.0	0.0	0.2	0.2	0.7	0.5	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.3	2.1	0.1	0.1	0.1	0.1	0.0	0.0	1.0	0.1	0.1	0.8	0.0	0.2	0.0	0.0	0.7	0.5	0.3	0.1	0.9	0.6	2.7	0.2	3.1	0.2	0.0	2.0	0.5	0.2	0.1	4.7	4.0	6.0	5.0	0.6	1.4	7.0	4.8	3.1	5.5	5.0	10.6	6.0	15.9	3.2	2.1	7.6	6.1	5.5	2.9	10.5	10.5	3.1	10.3	2.5	3.5	0.1	15.4	4.9	0.2	0.0	10.3	6.9	0.4	4.5	8.1	7.0	5.5	6.4	5.1	11.8	8.3	8.3	4.9	2.3	11.4	17.3	3.0	1.4	5.4	2.4	4.6	5.9	2.4	2.2	2.2	2.9	7.3	1.3	6.3	6.8	7.0	6.7	2.0	3.3	8.0	2.7	5.7	5.8	0.0	0.3	1.5	0.5	0.7	0.1	1.7	0.4	0.4	0.3	2.2	0.5	0.4	0.8	0.5	0.8	3.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	4.4	9.6	2.6	0.0	12.4	2.5	3.3	2.5	2.2	0.0	4.3	3.3	1.9	0.0	1.8	0.0	0.0	14.1	10.5	4.8	0.0	2.5	5.2	4.4	6.3	5.5	1.2	29.5	0.7	1.6	12.7	5.8	10.7	4.6	3.8	26.9	1.4	0.8	9.5	0.0	0.5	4.4	0.0	7.5	11.0	4.4	2.1	14.4	3.6	4.7	20.1	0.3	0.0	0.0	0.6	1.2	1.8	1.2	27.8	1.2	1.0	0.6	2.9	0.0	13.1	8.3	5.3	115.4	85.6	8.0	1.3	5.5	7.9	4.2	7.8	2.3
BROX	"C1orf58, FLJ32421"	ENSG00000162819	"BRO1 domain and CAAX motif containing"	Q5VW32	1	222712553-222735196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		270000	"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA031445: AB_10602697"	"unprognostic (1.27e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.50e-2)"	17.4	14.5	19.3	18.1	21.9	40.8	23.3	21.0	21.6	17.5	14.1	25.9	21.6	17.3	15.3	27.7	18.5	19.2	16.5	16.6	20.7	22.3	16.9	20.1	19.0	23.2	18.2	21.6	14.8	26.2	8.9	20.5	23.3	17.3	24.9	16.3	16.6	17.8	26.7	23.2	27.5	17.7	22.7	20.9	24.9	12.8	20.2	14.4	26.5	20.5	22.1	16.4	13.5	33.6	56.6	34.2	20.1	17.5	28.6	30.2	38.8	38.2	47.6	30.6	34.8	19.0	71.6	18.7	44.1	47.2	16.5	48.2	22.9	36.5	46.1	23.2	20.4	28.2	34.8	19.2	32.2	32.2	25.4	26.8	34.8	38.4	44.8	34.5	28.3	11.9	43.0	24.8	38.0	17.4	13.7	16.7	25.3	46.0	39.8	14.4	61.2	42.3	36.3	55.6	22.5	35.3	41.7	46.3	28.8	18.9	57.1	32.5	40.7	42.1	23.9	43.6	43.5	18.4	33.8	16.7	34.0	26.8	39.0	75.4	28.0	36.6	21.3	42.1	24.1	15.9	27.0	21.8	26.1	14.4	17.8	22.6	52.7	28.4	44.1	14.4	27.2	18.6	19.3	21.9	21.0	21.6	16.6	20.7	23.2	18.2	23.3	22.7	20.2	33.6	35.7	73.7	46.5	15.7	30.4	48.6	32.3	32.2	27.3	16.3	42.1	23.9	35.9	30.0	38.3	51.5	8.4	29.7	49.1	56.2	56.7	40.0	20.8	43.2	30.9	29.0	31.8	73.0	17.1	32.5	32.6	29.7	35.7	54.2	16.4	26.3	31.8	28.4	36.6	35.3	20.1	50.1	32.6	65.5	33.1	23.7	24.2	50.8	49.8	12.2	52.4	31.0	42.2	25.1	27.3	54.5	44.6	32.0	23.2	47.8	48.4	58.8	67.8	20.8	52.6	27.4	26.8	29.9	27.4	40.4	46.7	51.6	40.5	35.1	41.0	56.4
BRWD3	"FLJ38568, MRX93"	ENSG00000165288	"Bromodomain and WD repeat domain containing 3"	Q6RI45	X	80669503-80809877	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 69.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012802	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA012802: AB_2066662"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.17e-3)"	"unprognostic (7.04e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-1)"	3.2	2.2	1.5	4.0	2.2	5.1	3.1	6.0	1.8	3.0	1.2	3.0	3.6	3.0	2.5	4.4	3.2	2.4	1.9	1.6	2.4	2.2	3.1	3.4	4.3	1.6	2.3	4.5	3.1	2.0	3.1	3.6	1.7	2.3	3.2	5.8	3.3	1.9	1.4	6.1	4.1	1.9	1.6	3.9	3.1	3.9	2.4	5.2	3.5	1.7	3.9	2.8	3.5	2.0	4.4	4.6	7.1	4.6	2.8	3.4	5.0	2.5	2.1	3.1	4.2	2.2	5.9	4.7	5.7	2.3	3.8	7.7	10.7	4.2	4.2	4.0	4.5	9.6	7.8	3.3	2.1	5.5	6.2	2.3	2.9	3.5	4.9	4.6	4.8	4.1	7.1	11.5	3.7	0.8	3.3	5.6	10.6	4.8	1.9	2.8	12.2	2.9	3.8	3.7	1.6	4.0	6.1	3.3	2.7	12.9	1.5	5.5	4.4	3.7	4.5	3.4	2.7	5.1	5.7	5.4	3.0	11.0	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	1.5	2.2	6.0	1.8	1.6	2.4	1.6	2.3	1.7	1.6	2.4	2.0	16.1	12.8	13.4	48.3	14.5	17.5	8.0	8.6	13.6	27.7	9.7	6.2	8.2	15.7	15.4	5.5	16.7	5.7	13.1	13.8	0.0	6.5	2.8	11.5	15.6	13.3	7.2	12.0	47.0	6.0	7.7	10.5	21.9	16.6	11.4	22.4	8.2	5.6	5.5	62.2	54.2	10.8	2.0	13.2	17.7	3.7	9.9	19.7	1.8	45.9	17.5	8.1	6.2	69.4	53.5	8.8	22.4	10.1	13.5	13.0	17.1	4.0	12.7	20.8	6.6	14.3	11.9	6.7	9.6	16.8	20.9	7.7	15.1	12.7	12.1	19.2
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318421-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 100.3"	"Cell type enriched"	"Detected in many"	9	"Inhibitory neurons: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.0;Hep G2: 13.6;MOLT-4: 17.9;PC-3: 12.3;RT4: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA055898: AB_2682964, HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.4	0.7	7.2	2.7	4.3	4.4	2.9	5.5	10.9	8.1	5.9	0.6	0.7	0.9	1.2	29.4	0.3	0.9	0.6	2.9	13.2	4.2	1.1	0.6	2.9	24.3	16.0	0.1	0.8	100.3	3.5	2.0	24.4	3.4	0.6	1.9	5.6	1.3	0.5	11.1	1.4	0.5	11.4	1.4	0.6	0.7	21.7	17.2	18.9	0.2	3.3	1.7	11.1	5.3	0.1	25.0	5.0	0.0	1.8	0.5	0.0	0.6	0.0	0.2	0.0	0.3	4.0	0.0	6.1	0.1	2.4	9.2	5.1	9.5	0.3	0.0	1.6	0.0	0.1	13.6	0.0	0.2	0.1	2.0	4.0	0.0	2.9	3.8	0.7	10.5	0.0	0.0	0.2	0.9	17.9	2.0	5.3	0.5	12.3	0.0	8.1	0.0	0.0	11.4	6.8	2.5	0.0	0.2	0.0	0.4	0.5	0.7	1.0	0.1	0.2	0.0	2.0	0.1	0.0	0.1	6.4	2.6	0.0	0.9	0.4	0.5	1.0	0.1	3.5	0.0	1.1	0.6	0.7	0.1	1.4	1.3	1.3	0.1	0.3	0.1	0.6	0.6	7.2	4.3	5.5	10.9	2.9	13.2	24.3	16.0	24.4	11.4	21.7	5.3	0.3	0.0	0.0	17.3	0.3	5.2	3.7	2.5	6.8	3.5	0.7	3.2	2.9	0.0	3.0	0.0	0.0	0.2	1.2	0.0	0.0	0.8	0.0	1.2	1.9	0.3	3.5	1.3	8.7	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.0	0.9	0.3	1.7	266.4	0.4	0.0	0.6	4.3	0.0	0.6	1.7	0.0	1.0	1.8	0.2	3.1	12.5	1.9	0.3	0.0	4.1	0.7	2.8	0.2	0.9	0.3	0.4	0.0	0.0	1.1	0.1	0.2	27.5	7.7	0.4	4.5	3.4	0.4	3.4
BTF3L4	MGC23908	ENSG00000134717	"Basic transcription factor 3 like 4"	Q96K17	1	52056199-52090716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067026	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA067026: AB_2685765"	"unprognostic (6.12e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (6.73e-8)"	"unprognostic (8.85e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.56e-2)"	44.6	51.9	28.4	30.3	29.3	61.0	43.6	28.8	36.1	31.4	28.3	25.1	14.5	36.4	30.7	36.0	36.5	23.9	40.1	28.8	33.0	35.0	40.9	26.3	36.6	31.0	31.2	52.9	38.3	42.1	31.0	37.4	31.6	29.2	23.6	31.4	29.9	24.5	70.1	35.9	18.6	34.8	30.3	28.1	27.6	34.0	31.8	49.2	43.1	59.0	40.8	42.3	29.9	39.7	99.8	23.7	113.5	59.6	60.4	76.4	117.3	96.1	96.3	108.0	115.2	43.8	50.8	92.3	93.9	68.3	127.1	56.6	111.1	75.0	137.0	64.4	77.7	105.8	41.0	65.5	163.8	118.2	70.0	79.2	101.0	100.2	140.1	89.1	86.9	75.1	81.5	57.0	98.0	42.1	82.6	69.9	202.7	76.7	51.2	53.6	132.1	109.8	105.3	78.6	89.1	100.6	112.5	102.8	141.7	124.8	92.8	124.8	64.0	60.5	65.4	78.4	114.8	98.9	176.3	89.4	52.2	90.0	77.9	70.3	74.2	70.9	29.7	78.9	40.2	49.9	42.8	31.0	72.9	49.7	49.1	38.2	31.6	49.7	70.9	34.3	62.6	64.3	28.4	29.3	28.8	36.1	28.8	33.0	31.0	31.2	31.6	30.3	31.8	39.7	60.4	35.3	22.3	17.0	76.0	107.7	91.7	153.6	65.4	43.6	81.2	75.6	44.7	52.9	82.2	69.9	33.3	111.1	45.9	18.7	168.3	106.0	115.3	82.9	83.6	55.1	52.2	114.9	30.8	80.1	137.6	77.2	44.4	73.3	22.8	128.2	56.0	81.0	129.3	38.7	32.9	33.8	120.1	127.8	92.9	25.4	72.4	87.4	78.2	27.2	86.5	62.0	49.4	29.7	39.5	72.7	26.3	55.7	58.7	135.9	23.4	162.9	75.7	33.2	59.2	73.7	106.3	97.1	31.1	108.5	160.3	145.8	56.0	114.9	34.8	106.7
BTG1	APRO2	ENSG00000133639	"BTG anti-proliferation factor 1"	P62324	12	92140278-92145846	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2751.6;Langerhans cells: 2893.3;Suprabasal keratinocytes: 3004.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 33.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA005972			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA005972: AB_1078303"	"prognostic favorable (4.36e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (9.81e-2)"	91.5	36.9	1.9	19.8	2.0	93.9	80.1	33.5	4.1	62.3	1.4	38.9	8.5	45.6	1.5	29.5	55.9	7.1	45.2	2.5	4.6	52.4	69.7	55.5	23.8	3.6	2.6	45.6	63.7	8.3	26.2	6.2	3.7	40.5	4.8	5.2	30.5	4.5	20.5	120.6	58.4	8.2	3.5	92.2	39.3	12.4	3.1	20.1	21.9	3.7	18.2	38.5	60.1	3.0	5.7	5.4	3.5	0.9	13.4	16.9	3.2	8.0	6.3	2.3	2.3	2.4	1.6	5.7	1.5	3.3	3.5	3.9	1.6	3.0	2.2	9.8	8.8	0.8	2.9	1.3	15.0	3.7	1.9	14.1	11.9	4.5	11.7	8.5	5.0	2.4	4.6	7.1	3.4	3.7	5.5	9.4	2.2	3.0	11.0	15.2	2.4	1.5	5.5	6.5	3.4	7.8	6.1	4.4	17.3	2.1	21.5	7.7	2.6	3.9	1.3	3.6	3.7	14.0	6.3	8.9	3.1	2.4	4.6	36.2	21.8	151.8	22.8	16.2	27.8	92.4	47.3	40.7	9.2	105.5	133.1	53.6	75.9	68.8	22.8	8.0	66.8	51.3	1.9	2.0	33.5	4.1	2.5	4.6	3.6	2.6	3.7	3.5	3.1	3.0	1186.6	96.1	185.4	12.1	2512.8	2751.6	1030.9	206.6	912.9	592.7	607.5	573.8	119.5	1009.4	140.4	174.7	196.0	412.8	1907.2	672.9	320.8	388.1	411.8	216.7	258.8	709.0	452.4	230.7	7.9	255.8	416.3	529.1	406.7	264.7	286.6	197.4	339.1	274.9	361.4	424.0	20.6	373.8	193.3	564.3	2893.3	213.7	287.1	1251.4	983.6	31.9	1241.2	877.6	1354.3	22.1	8.4	364.4	668.7	241.9	758.5	791.3	667.9	162.6	53.0	377.2	539.0	870.7	723.5	130.1	101.5	508.7	3004.2	1342.7	2354.0	786.4	410.9	1513.3
BTRC	"beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1"	ENSG00000166167	"Beta-transducin repeat containing E3 ubiquitin protein ligase"	Q9Y297	10	101354033-101557321	"Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 109.7;Excitatory neurons: 154.0;Inhibitory neurons: 144.4;Oligodendrocyte precursor cells: 183.5;Oligodendrocytes: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031156, CAB032986"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB032986: AB_2243598, HPA031156: AB_2673764"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.23e-1)"	5.2	9.2	16.3	3.8	19.3	2.8	8.5	8.9	17.4	6.8	7.8	6.3	3.9	6.1	10.5	8.4	7.7	5.8	14.6	18.9	16.3	8.0	6.4	4.9	4.2	10.7	12.6	11.0	6.5	13.1	9.4	7.9	13.7	8.8	4.7	21.6	6.9	5.9	12.2	6.8	4.7	7.1	10.0	6.5	5.7	13.8	16.3	6.4	8.5	12.1	5.6	6.4	6.7	13.7	8.7	13.0	17.2	20.0	16.1	14.1	6.3	12.0	18.4	11.8	10.0	9.0	6.5	13.8	11.8	9.9	12.3	12.9	14.1	13.0	11.7	9.5	11.5	10.1	8.0	11.5	8.9	14.9	5.7	9.0	14.7	10.4	18.4	22.4	15.3	12.7	11.0	4.5	12.0	7.2	9.8	7.5	7.8	9.0	9.9	12.4	24.6	2.8	10.3	5.4	12.9	11.2	8.1	3.5	11.3	19.2	9.2	5.1	12.7	6.1	10.3	8.6	8.5	7.5	18.2	8.7	6.4	7.3	3.9	1.8	1.7	1.8	2.9	1.5	2.8	2.5	3.0	2.5	2.3	2.1	3.4	2.8	1.1	2.5	1.6	1.1	2.8	1.6	16.3	19.3	8.9	17.4	18.9	16.3	10.7	12.6	13.7	10.0	16.3	13.7	8.6	3.2	9.4	109.7	6.9	5.6	4.1	6.9	12.5	32.5	10.0	7.4	28.0	8.6	10.6	3.7	29.2	11.5	6.1	5.0	7.9	9.7	41.9	11.7	12.4	9.0	3.0	20.6	154.0	7.2	7.2	10.3	3.6	10.6	13.9	10.1	6.4	6.7	5.9	16.8	144.4	4.9	6.1	3.5	2.5	21.6	9.0	5.0	1.8	69.3	4.6	13.6	8.2	183.5	148.0	7.9	3.2	10.5	6.3	6.6	5.5	9.4	13.0	26.0	6.6	8.3	7.6	33.8	18.3	7.4	7.1	12.4	8.2	5.9	4.8	6.2
BX664615.2		ENSG00000283886		Q8NFD4	9	39816599-39874562	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HDLM-2: 4.8;SCLC-21H: 6.2;SH-SY5Y: 4.5;SiHa: 4.1;WM-115: 8.8"									HPA021733			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"		"Cluster 7: SCLC-21H - Neuronal signaling"		Nucleoplasm	Cytosol	"HPA021733: AB_10602499"																		0.4	2.6	1.2	1.6	1.3	0.4	0.7	1.3	2.3	1.4	1.4	0.3	0.4	1.1	1.1	1.2	0.9	1.2	3.5	1.3	1.4	3.8	1.6	0.8	1.4	1.4	1.5	2.2	1.9	1.4		0.1	1.3	1.0	0.2	5.4	2.1	0.7	0.3	2.4	0.9	0.4	1.1	0.8	0.6	0.4	1.4	0.5	5.4	0.1	0.1	1.0		1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.1	0.1	0.1	6.0	0.0	1.3	0.0	0.0	0.0	0.0	1.0	0.0	4.8	1.3	0.0	2.9	0.0	0.1	0.9	0.1	0.3	3.9	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.4	0.7	6.2	4.5	4.1	2.3	0.2	0.0	0.5	0.0	3.0	0.2	0.4	1.6	0.0	0.0	1.6	2.2	0.0	0.0	8.8	0.9	0.0	0.7	1.0	0.6	0.7	0.7	0.7	0.8	0.6	1.6	0.6	0.8	0.0	0.5	0.4	0.7	0.5	0.2	1.2	1.3	1.3	2.3	1.3	1.4	1.4	1.5	1.3	1.1	1.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 265.5;skeletal muscle: 367.7;tongue: 258.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 278.2;Extravillous trophoblasts: 875.6;Syncytiotrophoblasts: 762.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Cytosol"		"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavorable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	26.1	18.1	8.5	26.8	10.1	45.7	49.7	6.9	14.3	19.1	9.7	51.2	28.9	18.4	9.9	42.6	20.2	17.2	265.5	10.2	6.3	37.8	18.4	20.0	30.0	5.2	6.3	16.0	30.0	6.7	10.4	80.4	6.5	19.3	56.8	88.0	23.8	34.3	367.7	55.5	30.0	39.0	5.6	16.5	50.2	11.6	6.9	33.0	36.5	258.9	38.4	59.5	26.2	8.8	91.7	81.3	138.2	201.7	67.5	118.3	125.7	126.0	156.3	117.6	124.9	201.8	129.7	208.0	143.7	96.9	87.6	181.6	164.8	141.5	152.0	27.8	99.8	129.6	84.4	117.0	70.5	180.3	79.1	90.6	74.6	104.0	187.7	92.4	171.6	149.7	251.9	43.5	96.9	105.0	90.0	210.4	143.9	259.5	174.1	111.0	91.2	216.6	113.4	152.6	179.9	106.8	50.8	419.9	67.7	156.7	187.8	149.5	97.6	93.1	119.1	141.5	136.3	89.5	92.8	288.1	45.5	220.6	340.3	2.6	46.0	5.0	27.3	55.2	44.6	44.6	39.8	36.9	98.8	42.9	56.8	47.1	2.1	56.8	41.6	38.5	31.8	44.0	8.5	10.1	6.9	14.3	10.2	6.3	5.2	6.3	6.5	5.6	6.9	8.8	32.8	22.4	60.5	3.9	30.0	57.6	69.9	60.5	82.6	55.9	52.3	57.0	278.2	17.2	53.9	47.8	64.6	214.3	26.8	42.4	58.7	47.5	9.8	31.9	43.2	42.9	30.5	63.5	48.6	65.6	875.6	43.5	110.1	40.6	21.0	33.3	8.9	13.7	65.0	6.7	32.0	49.5	61.1	33.4	46.0	6.4	12.2	30.7	24.9	12.2	47.5	19.7	19.6	19.1	17.9	47.0	42.9	9.8	31.9	52.0	19.2	20.8	32.6	106.4	6.6	30.2	54.2	11.3	4.1	99.6	51.6	762.9	29.3	52.6	90.6	79.0
C10orf62	bA548K23.1	ENSG00000203942	"Chromosome 10 open reading frame 62"	Q5T681	10	97589721-97590934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	155	"testis: 277.9"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 9848.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA072947	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Vesicles"	"HPA072947: AB_2686562"		"unprognostic (3.66e-2)"		"unprognostic (3.97e-2)"	"unprognostic (2.81e-1)"		"unprognostic (5.36e-2)"		"unprognostic (3.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.63e-2)"		"unprognostic (2.53e-2)"	"unprognostic (2.04e-2)"				0.0	0.2	0.3	0.0	0.8	0.0	0.2	1.4	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.5	0.7	0.7	0.0	0.0	0.9	1.0	0.0	0.3	0.1	0.2	0.0	0.9	0.3	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.5	0.0	0.0	277.9	0.8	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.4	0.4	0.3	0.5	0.9	1.0	0.9	0.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1711.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9848.3	39.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.3	0.0	0.0	6.6	0.0	0.0	40.7	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295628-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"bone marrow: 50.4;heart muscle: 20.0;lymphoid tissue: 14.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 68.1;dendritic cells: 29.4;Macrophages: 20.3;monocytes: 28.4;NK-cells: 47.4;T-cells: 16.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 51.7;HL-60: 19.7;NB-4: 18.4;THP-1: 12.7;U-937: 22.2"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.4	0.6	0.3	7.1	0.4	50.4	0.6	0.4	0.4	1.6	0.2	0.9	0.6	0.6	0.3	0.6	0.7	2.1	20.0	0.3	0.3	0.7	1.3	4.7	14.0	1.1	0.5	0.2	0.4	0.1	0.3	0.6	0.8	0.6	1.3	0.0	1.5	0.4	1.0	1.3	3.5	1.0	0.6	14.9	2.6	0.3	0.4	3.6	0.9	0.2	7.3	1.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	51.7	0.1	0.1	0.5	19.7	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	22.2	0.0	80.3	14.9	45.8	23.8	31.4	16.1	4.7	7.8	18.8	17.1	5.8	11.6	16.3	12.6	23.9	58.4	1.7	6.1	16.5	0.3	0.4	0.4	0.4	0.3	0.3	1.1	0.5	0.8	0.6	0.4	1.0	0.2	0.0	4.2	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.1	0.3	68.1	2.8	0.0	0.0	0.0	0.1	29.4	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	13.9	0.0	0.0	0.2	1.7	0.5	0.0	15.8	0.0	2.5	0.0	3.7	0.0	0.0	0.0	0.0	12.5	15.5	0.0	0.0	20.3	1.8	0.0	28.4	0.0	47.4	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.4	0.0	16.0	0.0	0.0	0.0
C11orf45	"FLJ43646, MGC35558"	ENSG00000174370	"Chromosome 11 open reading frame 45"	Q8TAV5	11	128899565-128906035	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.7;Hofbauer cells: 8.7;Kupffer cells: 5.9;Late spermatids: 8.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 11.2;U-937: 8.9"									HPA039716	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA039716: AB_10672892"	"unprognostic (8.32e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.97e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.55e-9)"	"unprognostic (2.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.87e-2)"	"unprognostic (7.22e-2)"	0.6	3.3	1.7	0.7	4.4	0.8	0.9	0.6	2.1	1.0	0.8	0.7	1.4	0.5	0.6	2.9	1.0	2.0	4.5	1.4	1.6	2.0	0.5	2.6	0.8	1.9	1.9	0.9	2.6	3.8	2.3	2.1	1.6	1.1	0.9	0.2	1.6	2.8	0.1	6.6	0.9	0.5	1.1	1.5	1.8	1.1	2.3	2.4	1.8	0.2	0.9	1.2	1.3	2.2	2.4	4.5	0.0	0.0	0.3	0.4	1.6	0.8	4.7	1.7	4.2	6.3	5.8	0.0	3.2	0.5	4.2	2.3	2.4	11.2	0.8	0.0	1.1	0.3	2.7	0.0	0.2	0.0	0.0	0.3	1.5	1.3	0.9	3.8	1.0	3.5	0.0	0.2	2.0	1.2	2.6	2.4	1.8	1.0	3.9	1.1	4.6	0.5	3.9	1.1	0.0	0.2	1.8	5.0	0.3	1.2	0.8	4.4	0.5	0.0	6.2	0.0	0.8	0.1	0.0	0.0	0.8	8.9	0.2	0.0	0.6	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.9	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.7	4.4	0.6	2.1	1.4	1.6	1.9	1.9	1.6	1.1	2.3	2.2	0.1	0.0	0.5	0.0	0.0	2.8	1.3	0.9	5.7	0.0	0.3	0.4	1.7	0.0	0.2	0.0	0.0	2.0	0.0	0.1	1.9	1.0	2.0	0.3	0.1	0.2	0.0	0.0	0.3	0.8	2.1	0.3	0.0	0.5	1.3	0.3	0.4	0.0	8.7	0.0	0.2	0.1	0.0	5.9	0.8	8.2	0.0	2.2	0.0	2.8	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	1.5	1.7	3.0	0.9	1.2	0.2	0.1	0.2	1.1
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"	Q7Z7L8	11	43925342-43943878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 750.2;ovary: 721.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 796.5;Endometrial stromal cells: 906.3;Fibroblasts: 801.3;Granulosa cells: 982.4;Peritubular cells: 474.3;Smooth muscle cells: 1942.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"SH-SY5Y: 197.7"	"Low region specificity"	"Detected in all"							HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"	478.3	199.0	28.7	39.2	24.3	4.9	203.5	26.1	34.2	305.0	18.4	151.0	19.7	283.4	8.7	44.8	750.2	61.1	269.3	24.8	44.4	226.8	179.2	377.9	6.8	93.8	42.4	721.3	60.7	3.2	126.5	15.4	38.5	157.3	8.4	1.3	22.2	14.3	110.8	97.2	130.3	28.4	35.1	54.4	240.2	67.8	44.5	5.0	119.4	10.3	0.7	176.3	148.1	21.0	0.0	0.0	0.0	0.0	4.0	2.0	1.1	0.3	1.3	0.0	0.1	0.1	0.0	0.0	0.5	0.5	2.1	0.1	0.4	0.0	0.0	0.0	2.9	6.2	0.1	0.0	0.8	0.5	0.6	0.3	0.1	1.4	0.0	0.0	1.2	2.1	2.3	0.0	0.0	0.0	2.4	2.7	1.7	0.0	0.9	10.3	0.7	4.7	0.0	0.0	2.2	197.7	0.0	0.0	19.4	5.5	0.0	2.3	2.7	9.2	3.8	2.3	0.2	22.5	0.2	3.2	7.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	24.3	26.1	34.2	24.8	44.4	93.8	42.4	38.5	35.1	44.5	21.0	796.5	6.4	139.9	0.0	1.9	92.9	15.2	1.6	5.2	15.4	8.2	13.7	6.0	0.0	1.9	0.0	2.1	1.5	13.7	0.3	0.0	4.5	4.3	34.1	906.3	260.3	0.0	2.7	0.0	0.6	4.4	801.3	4.1	183.3	13.9	982.4	172.7	6.4	3.8	1.7	0.0	0.2	0.0	8.4	171.8	13.9	215.6	27.1	174.3	0.0	0.1	2.7	0.0	0.0	0.0	1.9	0.0	474.3	9.4	73.6	0.0	0.0	0.9	9.3	302.4	173.2	1942.9	2.1	1.5	6.5	88.5	3.1	14.2	243.9	0.1	50.5
C12orf40	FLJ40126	ENSG00000180116	"Chromosome 12 open reading frame 40"	Q86WS4	12	39626167-39908300	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;Late spermatids: 5.2;Spermatocytes: 33.2;Spermatogonia: 7.6"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039032			Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA039032: AB_2676316"					"unprognostic (1.75e-1)"								"unprognostic (2.76e-6)"	"unprognostic (3.45e-1)"	"unprognostic (1.96e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	7.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0
C12orf60	MGC47869	ENSG00000182993	"Chromosome 12 open reading frame 60"	Q5U649	12	14803666-14906586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.7"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 452.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA043911			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA043911: AB_10963941"	"unprognostic (3.71e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.09e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-2)"	0.8	4.7	0.9	0.5	1.2	0.8	0.7	1.1	1.5	0.6	1.6	0.5	0.1	0.4	1.4	0.4	1.4	0.8	3.3	0.9	1.1	2.6	6.0	0.9	1.8	1.2	1.2	0.5	0.9	1.1	0.6	0.7	1.2	0.9	0.4	6.4	0.8	0.5	1.3	0.5	0.5	0.2	1.2	3.3	0.8	14.7	1.2	0.7	1.3	0.8	1.0	0.5	0.4	1.5	1.8	1.9	1.9	5.5	2.0	1.4	1.7	1.3	0.7	1.3	1.6	0.8	1.9	1.5	1.5	0.4	2.0	2.0	2.1	4.3	1.8	3.6	2.2	1.2	0.5	1.3	1.7	1.8	0.6	0.7	2.6	1.3	2.9	1.8	2.6	2.5	2.0	0.3	1.9	0.6	0.7	1.1	6.6	2.7	1.1	2.2	3.3	2.3	2.5	0.5	1.4	1.7	2.8	0.7	2.6	5.6	2.2	0.8	2.0	1.2	1.3	0.9	1.5	0.9	0.7	5.1	1.5	1.7	1.7	0.1	0.5	1.7	0.9	0.6	1.5	1.6	0.7	1.3	0.5	1.0	1.8	1.5	0.1	1.6	0.3	0.4	1.6	0.4	0.9	1.2	1.1	1.5	0.9	1.1	1.2	1.2	1.2	1.2	1.2	1.5	0.9	0.0	0.0	6.8	3.3	0.3	0.5	3.9	0.0	4.0	1.2	1.7	3.6	0.0	3.0	5.5	20.9	1.8	0.9	0.3	7.9	1.8	452.6	3.6	0.6	1.8	0.0	11.6	3.1	1.1	1.6	2.2	0.0	1.1	0.0	1.0	0.0	1.1	1.3	1.7	3.7	0.4	8.2	0.9	0.8	72.6	3.1	1.0	0.0	1.0	2.8	2.8	5.2	10.6	10.8	0.8	0.2	2.6	1.2	0.5	0.3	3.4	8.0	17.0	19.7	2.0	1.6	31.9	8.9	0.2	1.0	0.3	2.8	0.5	0.5	0.3
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123233385-123258079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 60.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favorable (7.82e-5)"	7.3	12.6	16.2	10.2	16.1	9.0	8.0	23.0	19.6	13.0	13.5	10.9	11.4	12.1	13.8	9.5	11.4	8.2	15.0	16.0	13.2	12.6	14.5	8.9	18.2	12.6	12.3	17.2	8.5	10.2	19.7	7.3	14.9	13.7	8.2	15.7	16.2	9.0	13.0	13.8	11.3	7.0	8.8	12.8	10.6	16.7	14.8	60.0	12.3	12.5	13.4	10.3	11.0	18.3	28.4	20.5	20.8	39.1	12.0	11.1	13.7	22.3	16.5	25.1	18.0	21.8	15.8	36.1	20.3	8.4	23.5	20.4	25.7	12.5	25.0	29.2	22.5	44.0	20.7	18.6	26.1	20.4	19.7	14.2	33.2	18.9	35.1	37.0	17.0	53.6	45.6	13.4	16.7	12.3	46.2	39.3	13.7	25.6	31.7	35.7	25.9	33.5	22.8	13.0	40.7	18.2	24.0	8.8	23.4	16.5	18.3	24.7	14.8	23.1	27.3	23.3	24.4	22.7	28.3	32.6	17.1	26.2	28.1	85.3	12.9	50.6	53.9	14.9	67.6	83.9	72.3	71.9	21.7	73.5	96.6	78.2	11.8	63.3	16.3	36.6	73.1	33.5	16.2	16.1	23.0	19.6	16.0	13.2	12.6	12.3	14.9	8.8	14.8	18.3	46.0	41.7	47.7	9.8	54.3	45.4	36.7	29.4	59.2	34.5	23.3	50.0	52.7	14.3	18.0	25.8	14.6	41.1	56.2	16.4	60.7	20.7	22.9	12.2	24.2	27.9	9.6	37.0	13.7	10.8	22.8	41.3	23.0	11.2	15.2	24.1	18.5	33.5	14.3	45.4	15.9	20.7	28.5	9.2	24.2	6.2	37.9	19.7	24.9	7.5	26.3	35.7	44.3	14.6	10.4	13.6	17.4	42.2	42.2	22.8	19.9	39.3	14.8	36.6	13.1	42.7	33.1	115.2	59.7	40.6	36.1	10.8	63.0	43.3	20.8	8.0
C12orf71	LOC728858	ENSG00000214700	"Chromosome 12 open reading frame 71"	A8MTZ7	12	27081057-27082578	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;testis: 3.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"NK-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 1.0"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.4"	"Not detected"	"Not detected"							"HPA038359, HPA058728"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA038359: , HPA058728: AB_2683800"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-8)"	"unprognostic (4.85e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.1	0.1	0.3	0.1	0.5	1.4	0.1	0.0	0.3	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.1	3.2	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.3	0.3	0.1	0.1	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C14orf119	FLJ20671	ENSG00000179933	"Chromosome 14 open reading frame 119"	Q9NWQ9	14	23095505-23100456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003638	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	Cytosol	"HPA003638: AB_2243669"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.26e-3)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.63e-1)"	41.5	49.2	26.7	34.3	28.6	15.5	46.9	30.3	32.0	41.1	34.7	42.8	33.6	40.1	42.3	45.6	33.2	27.5	36.6	26.8	29.7	49.4	37.2	38.1	34.2	30.3	29.6	33.6	31.6	35.3	38.4	33.7	30.6	30.6	51.3	25.5	36.2	38.5	32.9	30.9	41.2	48.8	29.7	47.1	41.0	25.2	31.5	40.4	33.9	31.1	50.8	47.5	33.9	32.2	53.9	52.5	77.4	47.2	166.8	144.3	62.1	88.5	129.9	114.1	134.6	41.9	81.3	40.9	44.8	144.2	138.0	89.9	74.6	117.4	157.6	65.2	36.5	61.6	41.4	180.8	130.7	93.2	91.9	177.0	104.1	96.3	70.5	104.0	126.6	72.7	41.9	44.4	127.2	77.8	44.3	72.1	48.7	124.5	79.2	38.6	57.5	47.0	130.8	85.9	37.1	33.8	73.7	68.6	81.0	85.5	46.4	53.2	103.0	54.0	47.0	81.6	40.6	41.5	52.6	50.5	49.4	58.3	49.2	317.0	160.8	302.7	122.6	106.0	140.9	143.9	138.9	137.3	150.7	121.0	144.0	142.6	94.5	131.0	74.4	102.2	188.7	203.2	26.7	28.6	30.3	32.0	26.8	29.7	30.3	29.6	30.6	29.7	31.5	32.2	50.9	48.1	47.7	4.2	41.9	26.5	89.0	144.5	23.9	28.6	41.9	50.5	23.7	34.3	75.9	31.3	8.4	89.0	53.5	44.1	129.1	95.9	22.6	39.0	45.2	56.2	28.3	65.4	3.8	84.3	105.5	42.9	30.5	33.2	54.4	39.6	46.4	29.6	107.8	20.2	4.4	57.4	81.4	38.9	32.1	15.1	64.0	53.1	48.0	5.6	93.2	36.1	58.7	2.0	11.5	97.0	42.4	48.5	31.4	59.8	61.5	100.3	48.3	21.5	32.9	18.6	47.1	52.7	25.6	33.5	34.0	143.1	46.5	81.3	51.7	83.2
C14orf28	"DRIP-1, DRIP1"	ENSG00000179476	"Chromosome 14 open reading frame 28"	Q4W4Y0	14	44897275-44907257	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 184.9;Late spermatids: 127.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059635			Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA059635: AB_2684091"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.06e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.33e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.01e-1)"	5.4	2.4	2.4	2.4	2.8	1.0	3.5	2.5	3.5	3.8	2.5	5.3	4.1	6.1	3.7	3.1	4.5	2.6	5.0	2.4	2.5	2.8	4.8	2.8	2.7	2.8	2.6	6.5	3.5	2.5	2.1	2.8	2.8	3.9	3.1	2.3	3.6	4.5	4.6	3.3	4.2	4.5	2.5	3.0	3.8	8.6	2.6	1.4	3.6	4.6	2.9	5.3	2.5	3.1	1.9	1.3	2.5	4.3	4.9	2.6	5.6	3.7	4.1	1.8	2.8	0.1	2.4	2.5	2.2	2.6	4.0	1.0	0.6	1.8	3.1	9.3	0.5	1.2	0.5	2.6	1.4	1.1	2.8	2.0	3.0	0.5	2.9	3.4	1.0	3.0	0.6	3.4	1.4	3.7	1.1	2.2	0.4	3.6	1.4	1.8	3.0	1.0	2.5	2.4	0.5	0.7	1.5	3.0	1.7	2.0	5.4	1.1	1.5	6.8	3.3	1.1	0.7	4.8	4.2	1.6	1.9	0.6	2.2	1.1	1.1	4.6	2.6	1.7	2.9	4.8	2.5	3.3	1.2	3.1	5.4	3.2	2.3	2.5	2.3	2.1	3.1	1.4	2.4	2.8	2.5	3.5	2.4	2.5	2.8	2.6	2.8	2.5	2.6	3.1	5.9	3.2	2.7	1.6	8.8	3.1	9.4	10.3	10.8	3.2	6.5	7.2	12.1	5.7	4.7	5.5	0.0	5.6	6.0	6.7	9.8	8.4	184.9	1.6	4.8	5.3	3.0	2.1	4.0	8.7	4.9	8.9	5.6	2.8	1.3	2.9	5.3	11.5	4.6	3.3	3.8	7.0	8.2	5.4	3.1	127.9	10.5	3.8	5.4	6.5	4.4	3.4	5.2	9.0	9.5	5.9	4.9	16.1	5.5	14.2	15.8	16.0	1.8	2.9	19.7	3.6	11.2	18.5	10.2	5.4	4.4	6.6	6.5	3.3	5.2	7.6
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521131-67530146	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 23.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 222.6;Spermatocytes: 258.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Vesicles"	Cytosol	"HPA062820: AB_2684874"	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favorable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	4.7	3.8	2.3	1.5	6.2	5.3	3.6	7.1	4.2	3.1	0.0	2.3	2.8	2.3	1.9	2.0	2.9	1.5	5.7	3.8	1.6	3.0	2.5	2.3	1.3	1.0	2.4	2.7	4.2	4.4	5.1	2.0	1.0	2.5	2.2	10.8	2.6	2.1	23.7	4.1	1.8	1.4	0.7	1.7	2.4	7.7	2.1	1.4	2.8	8.3	1.0	2.2	2.4	2.3	4.2	4.4	1.1	4.9	5.0	7.2	3.1	1.8	3.2	3.3	2.6	3.4	2.9	3.5	3.8	2.0	3.9	4.9	4.4	1.2	2.7	2.1	10.4	3.7	3.3	4.6	3.2	4.6	3.0	7.5	3.4	1.1	4.0	2.4	1.6	10.6	4.3	7.6	1.0	2.4	3.8	7.6	1.8	3.3	5.6	5.1	2.5	13.0	2.3	2.9	6.4	4.8	3.2	3.0	6.1	2.1	2.7	7.1	1.6	4.4	6.8	5.5	4.7	7.1	11.2	8.5	1.9	9.0	2.2	7.9	4.3	7.8	4.5	3.7	5.2	5.3	5.9	4.5	4.8	3.6	6.2	5.0	0.5	3.8	3.2	4.9	4.0	3.5	2.3	6.2	7.1	4.2	3.8	1.6	1.0	2.4	1.0	0.7	2.1	2.3	28.0	22.4	13.5	4.9	23.1	67.2	32.6	32.3	120.7	75.5	55.7	82.3	74.5	18.6	14.3	16.5	37.5	42.6	23.8	38.6	80.3	25.1	222.6	17.5	24.2	26.8	27.1	11.8	14.8	29.8	31.9	56.8	15.8	17.1	34.8	15.2	22.9	44.7	30.5	13.5	15.7	47.5	48.8	24.8	25.6	42.6	41.0	19.9	37.4	3.7	15.6	97.1	23.7	5.0	8.5	27.6	48.4	25.6	37.4	63.3	49.0	77.1	8.4	93.9	32.9	38.2	38.7	258.9	52.1	62.7	60.9	20.5	34.4	28.9	39.2	20.0
C15orf65	FLJ27352	ENSG00000261652	"Chromosome 15 open reading frame 65"	H3BRN8	15	55408495-55418798	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 168.5;Endometrial ciliated cells: 79.4;Respiratory ciliated cells: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 13.2;SK-MEL-30: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA067189: AB_2685800"	"unprognostic (2.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (3.18e-7)"	"unprognostic (1.59e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	1.3	2.1	2.8	0.5	3.0	0.6	3.2	2.6	3.4	4.3	5.3	4.0	1.8	1.9	6.0	0.8	7.9	3.1	5.6	2.8	3.1	7.2	1.3	2.3	1.1	3.6	3.5	1.2	8.5	4.6	8.9	0.5	3.4	3.3	3.6	7.5	9.0	2.7	6.9	1.4	1.6	2.1	3.1	1.2	6.3	9.0	3.0	1.5	4.0	2.8	1.1	1.6	1.1	2.9	0.9	1.3	2.7	1.7	4.0	5.8	0.4	1.5	2.2	1.2	2.5	0.0	1.5	1.2	4.0	5.1	3.2	1.2	0.0	2.5	0.4	2.5	1.8	1.2	9.3	0.4	7.6	2.8	1.5	1.9	13.2	3.8	1.0	6.9	2.4	0.0	2.3	4.0	5.8	2.1	0.1	7.6	0.7	4.8	3.0	0.5	0.0	10.5	7.0	0.0	7.7	4.3	1.9	3.2	13.0	1.1	6.4	2.7	1.8	2.1	0.9	2.0	0.7	1.8	4.8	1.0	5.9	6.7	1.1	4.7	0.4	1.7	0.2	0.7	0.0	0.9	0.0	0.3	0.3	0.8	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	2.8	3.0	2.6	3.4	2.8	3.1	3.6	3.5	3.4	3.1	3.0	2.9	3.3	3.2	1.1	4.6	3.3	1.3	3.7	13.1	2.2	1.7	8.6	10.8	7.8	5.7	8.0	5.5	0.0	1.1	0.5	6.7	17.6	8.8	168.5	79.4	4.1	3.9	3.6	0.4	4.0	11.0	1.5	3.6	5.1	7.2	4.5	1.9	4.6	1.7	2.9	3.3	2.7	18.8	14.2	1.9	1.9	17.0	4.4	1.0	3.6	1.0	0.8	5.1	0.0	1.0	0.9	6.6	16.8	5.7	2.6	4.8	1.9	22.5	47.5	8.2	6.6	3.2	3.4	23.9	3.6	0.8	1.7	0.0	1.0	4.2	4.8	2.1
C16orf46	FLJ32702	ENSG00000166455	"Chromosome 16 open reading frame 46"	Q6P387	16	81053497-81077267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.7;Late spermatids: 112.4;Respiratory ciliated cells: 31.8;Spermatocytes: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041136, HPA041379"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041136: AB_10795535, HPA041379: AB_10794666"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.53e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.72e-2)"	0.5	0.5	1.9	0.4	1.9	0.6	0.8	1.6	2.8	0.7	4.0	0.3	0.2	0.7	1.2	0.3	2.7	0.4	0.3	2.2	2.1	1.0	1.0	0.4	0.1	2.0	2.2	0.4	0.7	0.5	1.8	0.7	2.1	0.9	0.2	1.3	0.4	0.4	0.7	0.1	0.2	0.4	1.9	0.2	0.3	5.9	2.1	0.2	2.8	0.3	0.2	0.6	0.4	2.4	1.2	0.2	0.4	0.2	2.0	0.4	1.1	0.2	1.5	0.8	0.5	0.2	1.7	0.3	0.7	0.3	1.0	0.4	0.4	0.8	1.5	0.3	0.3	0.3	0.9	1.1	1.2	0.4	0.9	0.8	0.6	2.0	1.2	0.9	0.7	0.6	0.8	0.6	0.6	0.9	0.1	2.4	0.5	0.4	0.2	0.9	0.1	0.2	1.4	0.7	0.6	0.5	1.7	0.5	0.3	0.7	0.5	0.6	0.6	0.4	0.2	0.3	0.3	0.6	1.0	0.7	0.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	1.6	2.8	2.2	2.1	2.0	2.2	2.1	1.9	2.1	2.4	1.0	0.0	2.3	11.4	0.5	1.9	8.9	6.4	2.2	2.3	5.7	3.2	2.3	4.3	4.6	0.0	4.2	8.2	0.3	0.6	5.9	1.2	94.7	17.3	2.0	1.7	1.2	0.4	12.1	0.4	15.8	2.1	0.5	1.7	0.0	0.3	1.1	3.3	3.3	0.0	9.0	1.7	8.2	0.6	1.0	112.4	8.1	1.5	5.4	1.0	0.3	5.6	1.0	7.1	16.3	0.5	0.6	7.5	0.5	7.5	0.1	3.9	31.8	8.1	0.0	3.1	2.0	32.7	6.8	0.8	2.7	6.3	0.7	0.8	0.8	5.0
C16orf70	"C16orf6, FLJ12076, lin-10, LIN10"	ENSG00000125149	"Chromosome 16 open reading frame 70"	Q9BSU1	16	67109941-67148544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 47.9;Oligodendrocytes: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041131, HPA041214"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA041131: AB_10795487, HPA041214: AB_10794267"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.15e-2)"	11.3	10.0	15.6	7.6	16.6	18.1	11.1	15.5	17.4	13.2	10.8	10.2	7.3	11.2	8.9	17.8	10.6	7.5	10.3	18.5	13.6	14.0	57.3	9.8	9.2	15.7	16.1	11.1	8.3	16.1	10.9	11.8	17.0	14.4	10.1	8.1	12.0	8.5	29.7	30.4	10.0	10.8	16.2	14.7	8.6	13.8	15.6	9.2	9.0	15.3	11.7	10.5	14.6	21.4	13.7	19.3	19.0	19.9	23.6	13.9	44.5	15.4	16.6	30.7	33.3	22.1	11.7	13.9	13.3	18.2	16.9	18.0	23.7	14.9	39.7	7.1	19.7	10.6	12.2	47.4	14.5	10.9	58.0	14.1	20.6	30.2	13.9	16.6	17.3	17.5	17.5	5.8	19.4	13.6	21.2	16.6	21.5	18.4	29.4	29.5	32.2	21.9	13.4	8.2	24.5	13.2	46.2	10.7	12.0	18.7	22.0	9.0	13.4	21.5	18.4	15.5	13.5	8.8	17.3	41.3	19.4	10.9	17.5	3.2	17.4	6.1	4.4	12.2	5.9	6.9	6.6	8.1	14.6	4.5	6.8	6.3	6.2	5.9	13.6	4.8	7.2	8.9	15.6	16.6	15.5	17.4	18.5	13.6	15.7	16.1	17.0	16.2	15.6	21.4	5.1	6.4	5.9	11.1	6.6	9.1	2.5	5.1	19.4	7.4	8.7	6.7	1.3	1.5	3.2	0.0	0.0	8.8	5.0	4.9	5.9	4.4	1.6	12.9	8.5	6.2	7.2	11.1	20.4	2.9	9.5	5.1	8.6	30.6	9.5	8.7	5.0	47.9	18.6	10.1	18.5	8.4	4.1	13.5	7.8	1.6	4.7	13.2	10.6	17.8	13.3	2.7	3.1	11.1	41.6	4.8	8.6	6.4	7.5	4.6	5.4	10.3	11.0	5.9	13.1	5.3	6.4	24.7	24.8	20.5	12.1	7.0	6.7	8.2	5.7	1.3
C17orf100	LOC388327	ENSG00000256806	"Chromosome 17 open reading frame 100"	A8MU93	17	6651762-6693202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.9;Late spermatids: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.0;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA046824			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA046824: AB_2679825"	"unprognostic (9.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.65e-2)"	0.9	1.6	4.1	1.7	4.9	0.5	1.5	3.3	4.8	1.9	2.2	1.6	3.0	1.6	2.2	4.3	2.0	1.1	0.6	3.5	4.5	2.4	3.6	1.2	3.2	3.2	3.7	1.3	4.5	3.5	9.5	0.8	3.2	2.5	1.5	5.3	2.8	1.0	0.6	7.3	3.0	0.8	3.4	2.9	2.4	5.5	4.1	1.7	3.3	0.8	1.2	1.9	2.3	3.9	1.1	2.1	4.6	1.5	0.7	1.3	2.2	0.6	3.4	1.4	2.7	3.2	1.5	1.3	2.3	1.1	3.6	4.1	0.9	2.2	2.0	5.6	6.3	1.2	2.4	10.0	1.6	0.2	3.2	1.8	2.1	0.7	1.5	4.1	0.8	6.7	1.6	1.2	1.8	2.4	1.4	2.1	0.6	1.9	1.4	2.6	0.8	2.0	2.9	1.0	4.8	9.4	2.9	0.3	3.4	1.4	2.5	0.3	1.3	1.3	2.6	0.8	1.1	1.7	1.2	0.8	1.1	0.4	3.1	3.9	0.9	4.0	1.2	1.3	1.6	2.3	2.2	1.4	1.6	2.5	2.5	1.4	0.8	1.4	1.3	0.5	1.5	0.9	4.1	4.9	3.3	4.8	3.5	4.5	3.2	3.7	3.2	3.4	4.1	3.9	1.7	0.0	1.7	0.0	3.2	2.8	5.4	4.8	8.0	3.8	4.9	5.0	0.4	0.0	4.9	0.0	2.1	1.7	0.6	3.8	1.9	4.1	32.9	3.0	3.0	1.8	7.7	1.3	1.4	3.2	1.8	1.6	4.1	2.9	8.9	4.7	0.0	0.0	1.2	1.7	1.4	7.1	10.2	0.0	1.3	48.7	0.9	0.7	1.8	1.0	1.2	5.1	1.0	1.5	2.2	3.3	2.6	1.9	0.9	4.5	9.0	2.1	2.4	5.8	6.6	1.9	3.0	16.4	4.6	7.0	3.0	1.5	1.7	3.8	3.9	5.1
C17orf58		ENSG00000186665	"Chromosome 17 open reading frame 58"	Q2M2W7	17	67991099-67996469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 35.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 55.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 37.3"	HPA023036	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA023036: AB_10601144"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (1.31e-10)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.01e-1)"	11.9	5.4	5.2	2.8	5.5	3.9	16.9	5.4	10.0	26.8	4.8	8.4	4.0	15.1	6.9	5.1	7.8	4.7	5.9	5.7	5.3	6.1	9.4	3.4	3.2	5.4	5.3	4.8	4.8	3.2	2.0	35.6	5.1	5.8	7.3	8.9	4.3	3.6	3.5	3.5	4.6	10.9	5.5	2.3	6.8	3.0	5.2	2.1	6.8	7.3	7.1	8.8	7.6	5.5	9.8	9.5	9.3	11.6	6.6	16.6	7.3	4.0	11.4	6.9	11.2	5.6	12.4	13.0	8.9	3.3	12.1	4.9	21.3	8.6	16.6	23.5	21.5	8.4	3.2	17.8	10.4	7.2	14.9	9.2	10.2	6.7	15.4	7.7	32.7	11.2	18.2	19.6	6.7	13.1	1.3	9.5	10.7	23.6	10.0	3.1	10.2	17.4	8.7	6.5	6.9	12.5	6.0	55.5	20.8	11.4	15.8	8.2	6.1	5.8	5.9	4.2	8.5	38.9	30.9	11.6	14.8	12.6	10.5	8.6	2.8	5.0	2.2	2.9	0.7	3.0	0.8	1.7	3.9	0.5	0.3	0.8	1.1	2.7	5.0	0.1	0.4	1.8	5.2	5.5	5.4	10.0	5.7	5.3	5.4	5.3	5.1	5.5	5.2	5.5	21.6	0.0	1.7	6.2	3.5	4.8	5.5	5.6	7.4	8.9	31.0	21.8	4.7	12.8	6.1	11.0	10.4	28.6	4.1	10.5	23.5	10.1	0.9	21.0	40.5	16.3	3.6	8.4	5.0	9.3	21.7	51.6	19.9	19.4	12.7	3.8	14.3	18.5	16.9	5.0	4.6	15.0	10.2	9.7	21.5	2.8	3.7	7.3	8.8	2.8	18.4	31.9	12.3	3.0	4.6	10.7	10.0	5.3	7.0	11.6	10.9	19.7	16.5	15.6	6.6	36.2	14.1	7.3	6.0	20.7	8.4	15.3	4.1	8.3	10.1	7.6
C17orf75	"NJMU-R1, SRI2"	ENSG00000108666	"Chromosome 17 open reading frame 75"	Q9HAS0	17	32324565-32350023	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004061, HPA075333"	Approved	Approved	Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA004061: AB_1078337, HPA075333: "	"unprognostic (4.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.92e-2)"	"unprognostic (7.80e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.60e-2)"	8.1	15.9	10.9	10.4	11.4	7.5	13.2	12.1	13.5	8.9	12.3	11.7	13.3	12.4	18.7	8.7	15.0	7.0	19.4	10.8	11.7	21.3	14.5	8.7	12.9	11.2	10.9	16.1	13.2	27.8	13.4	10.4	11.8	11.6	12.6	26.1	12.2	10.6	17.5	7.2	10.8	10.4	10.5	9.5	12.9	26.3	11.1	16.0	14.1	14.3	13.2	9.6	8.2	11.2	39.2	33.4	51.0	15.5	13.3	14.5	27.9	25.5	22.4	34.3	29.1	18.2	14.9	23.5	28.6	18.2	52.6	42.5	32.8	27.6	46.6	18.0	37.9	18.7	39.8	39.5	26.6	26.3	14.1	13.4	33.0	25.2	17.4	28.6	25.3	43.6	38.9	31.8	22.8	29.2	76.5	26.9	37.7	23.9	14.7	50.1	31.5	44.0	21.4	18.2	50.4	44.3	21.1	19.1	62.7	37.2	50.4	16.8	19.8	18.8	35.4	9.3	42.4	42.5	51.0	82.9	15.3	23.0	5.7	34.6	12.4	16.4	17.6	12.0	20.1	18.2	16.9	18.3	16.1	19.9	18.2	17.0	3.2	19.0	17.1	12.8	19.6	15.4	10.9	11.4	12.1	13.5	10.8	11.7	11.2	10.9	11.8	10.5	11.1	11.2	12.6	12.8	30.7	7.2	13.8	5.9	13.4	27.8	12.5	25.0	11.3	13.5	25.8	8.6	19.3	14.7	8.4	31.8	10.7	3.8	43.0	16.2	10.0	17.2	8.8	10.5	12.6	13.5	11.1	13.8	18.0	9.8	9.7	10.5	11.4	18.3	6.4	11.0	9.7	32.0	15.0	8.0	28.5	7.5	3.7	6.3	7.5	7.8	5.4	2.8	6.7	17.5	11.3	10.1	8.7	11.8	3.2	8.2	14.0	6.4	6.9	29.9	29.9	23.0	39.5	9.7	13.1	88.0	31.8	12.0	6.1	16.3	15.1	10.5	8.4	8.2
C17orf97	"LIAT1, LOC400566"	ENSG00000187624	"Chromosome 17 open reading frame 97"	Q6ZQX7	17	410325-431062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 58.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 546.2;Late spermatids: 1313.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 7.0;U-2197: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023583	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA023583: AB_1853122"	"unprognostic (6.62e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (7.73e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.19e-2)"	2.1	5.2	1.2	1.0	1.6	0.7	2.8	0.6	2.4	4.1	2.9	4.0	0.8	3.9	1.8	3.2	8.9	1.8	3.8	1.2	1.0	8.5	2.7	2.8	1.2	1.6	2.6	3.8	2.9	1.9	7.0	0.3	1.3	3.1	1.1	2.7	3.1	2.4	4.7	3.7	2.5	0.6	1.4	1.5	3.0	58.8	1.1	1.9	6.9	0.7	0.6	2.7	2.5	1.2	2.1	3.0	1.4	1.7	0.7	0.6	0.7	1.5	1.0	1.1	0.7	0.0	3.1	0.5	1.1	3.4	0.9	7.0	3.8	0.8	1.1	0.3	0.4	1.5	2.6	0.2	2.5	0.3	0.6	0.7	1.9	2.6	0.3	1.6	1.2	3.4	0.2	0.0	0.7	1.8	5.2	2.7	2.1	6.2	0.9	0.5	0.3	1.9	4.8	1.7	0.4	1.6	1.9	2.6	0.4	2.3	1.6	2.3	1.1	1.4	0.7	9.1	0.6	0.2	0.2	0.0	1.7	0.7	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.6	0.6	2.4	1.2	1.0	1.6	2.6	1.3	1.4	1.1	1.2	1.4	3.2	5.9	2.6	0.8	3.3	3.5	6.5	0.0	4.3	7.7	6.0	6.1	7.2	9.5	20.2	20.9	1.6	0.9	18.4	62.6	13.3	546.2	87.1	6.3	3.3	16.1	5.7	3.3	3.5	0.3	3.5	4.6	8.4	2.5	8.6	2.5	5.3	1.9	1.7	3.1	8.5	14.2	0.0	1.5	1313.1	8.4	2.0	3.6	1.9	3.1	13.5	0.0	0.5	0.9	4.7	6.4	6.4	0.1	4.5	3.8	28.0	55.8	26.4	6.6	3.4	4.6	156.2	12.4	1.8	1.0	0.8	0.8	15.4	10.4	1.6
C18orf25	"Ark2N, ARKL1, MGC12909, RNF111L1"	ENSG00000152242	"Chromosome 18 open reading frame 25"	Q96B23	18	46173553-46266992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051314, HPA051899"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA051314: AB_2681438, HPA051899: AB_2681657"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.46e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.97e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	8.5	6.9	9.0	8.9	8.9	34.1	10.4	12.3	10.3	11.9	18.1	8.1	7.7	9.2	7.9	37.5	9.6	6.5	15.8	8.0	8.2	8.8	8.1	9.6	12.1	10.2	12.9	9.2	6.0	18.8	6.2	8.2	11.2	8.3	9.2	27.6	13.3	7.5	23.3	13.2	8.9	9.4	7.4	11.1	8.7	12.0	10.2	15.0	11.9	16.0	15.4	9.8	16.4	9.1	18.4	17.9	14.8	16.9	10.4	9.3	19.0	26.0	13.8	27.3	23.1	13.9	20.5	14.0	24.1	17.7	9.8	40.9	27.7	17.7	29.5	23.5	8.9	12.4	16.0	10.6	17.9	23.5	16.0	8.7	20.2	31.9	26.3	15.9	11.0	12.9	14.1	16.3	15.3	13.7	17.9	11.9	13.2	6.3	7.0	16.0	17.6	20.7	26.1	32.5	20.7	10.8	19.1	13.4	13.7	17.9	8.8	14.3	16.0	24.7	17.6	6.0	24.3	21.3	19.7	22.3	12.8	24.4	27.0	4.9	8.9	18.6	6.3	9.9	11.2	6.9	12.3	9.6	8.8	9.0	8.6	6.8	22.7	3.5	14.3	12.6	8.7	6.9	9.0	8.9	12.3	10.3	8.0	8.2	10.2	12.9	11.2	7.4	10.2	9.1	18.4	12.8	9.1	16.0	19.2	25.2	10.4	11.5	11.4	14.5	13.4	9.9	30.4	5.7	9.5	14.7	20.9	8.1	26.1	15.1	1.9	9.1	2.4	42.1	14.4	16.2	12.0	16.8	62.5	6.5	10.5	12.1	13.7	39.2	15.2	9.9	11.7	13.0	9.1	13.5	45.2	10.0	6.1	13.1	18.0	3.5	8.1	12.9	7.2	22.5	11.1	12.4	9.2	25.6	25.9	20.4	10.1	10.5	16.5	13.0	9.2	7.6	16.9	30.6	19.7	14.8	11.8	20.6	14.9	14.2	31.8	24.4	18.6	6.6	10.1	23.3
C19orf67		ENSG00000188032	"Chromosome 19 open reading frame 67"	A6NJJ6	19	14081624-14085875	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	27	"testis: 6.6"	"Group enriched"	"Detected in some"	28	"Early spermatids: 30.0;Late spermatids: 28.2;Spermatocytes: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046351			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA046351: "	"unprognostic (1.21e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.45e-4)"	"unprognostic (1.25e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.76e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.94e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.5	30.0	0.4	0.2	0.1	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	28.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.1	9.9	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.2
C19orf71	LOC100128569	ENSG00000183397	"Chromosome 19 open reading frame 71"	A6NCJ1	19	3539154-3544030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 53.7"	"Group enriched"	"Detected in some"	69	"Early spermatids: 566.4;Late spermatids: 357.0"	"Cancer enriched"	"Detected in all"	5	"melanoma: 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HeLa: 92.7;SK-MEL-30: 48.2;WM-115: 170.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048654	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Endoplasmic reticulum"	"HPA048654: AB_2680480"	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.74e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (2.02e-5)"	"unprognostic (5.52e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-3)"	2.6	4.5	3.7	8.1	3.5	10.5	2.2	15.0	5.6	3.4	0.0	2.7	8.5	4.9	0.8	3.5	4.5	3.8	2.5	4.4	5.6	6.3	3.5	4.4	9.5	4.6	3.1	4.7	7.6	0.7	7.5	3.2	3.8	4.1	0.6	3.3	12.3	2.3	2.5	13.0	7.3	0.9	1.4	9.8	6.0	53.7	4.6	1.9	11.0	0.5	1.2	2.6	2.5	10.9	15.9	12.8	4.1	5.5	0.1	0.1	8.3	9.8	0.0	0.0	0.0	8.1	4.7	2.8	7.2	0.1	20.8	13.8	0.1	0.7	0.0	16.0	7.5	2.1	92.7	2.4	0.0	2.1	9.7	0.1	0.2	0.3	0.1	4.5	0.1	7.3	11.1	13.9	0.0	11.1	3.5	5.2	3.5	0.5	3.9	5.3	6.1	14.9	0.0	6.2	9.7	8.9	17.0	8.5	48.2	1.9	9.6	5.2	13.2	7.6	9.9	23.2	9.3	11.0	3.1	4.1	22.7	9.4	170.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.5	15.0	5.6	4.4	5.6	4.6	3.1	3.8	1.4	4.6	10.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	566.4	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	357.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	2.7	1.6	0.0	0.0	0.1	0.1	0.2	0.0	0.1
C19orf73	FLJ10490	ENSG00000221916	"Chromosome 19 open reading frame 73"	Q9NVV2	19	49118402-49119143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5"									HPA062719	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA062719: AB_2684847"	"unprognostic (3.02e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (3.05e-1)"	"unprognostic (9.00e-5)"	"unprognostic (1.19e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.13e-3)"	0.9	1.3	3.7	0.4	3.9	0.1	1.5	5.8	4.6	0.7	2.3	1.7	2.1	1.0	1.3	2.0	0.5	0.3	1.7	4.2	3.7	1.7	3.4	1.0	0.2	4.1	3.7	0.2	4.8	0.8	3.8	0.2	3.9	1.5	0.7	1.0	2.5	0.4	1.8	2.5	1.5	0.2	3.9	1.8	1.4	1.3	3.9	0.6	1.9	0.9	0.3	0.7	1.2	4.5	1.7	2.1	0.8	4.0	1.3	0.2	0.9	0.5	0.3	0.8	0.6	0.1	0.9	1.2	0.4	0.3	1.2	1.1	1.0	0.1	0.1	2.4	8.5	1.1	1.6	1.4	1.3	0.0	0.4	0.1	2.7	0.6	2.2	0.6	0.1	4.2	2.0	2.0	0.4	1.8	1.4	1.3	0.6	1.8	0.4	1.2	1.6	1.6	1.5	0.7	4.2	1.9	0.8	1.0	1.6	0.5	1.0	0.4	0.8	1.0	1.8	0.3	0.4	1.2	2.5	1.4	0.7	1.5	1.2	0.0	2.0	0.4	1.6	1.3	2.7	1.5	1.2	1.5	3.4	4.4	2.4	1.8	0.0	5.0	2.8	2.7	1.2	1.5	3.7	3.9	5.8	4.6	4.2	3.7	4.1	3.7	3.9	3.9	3.9	4.5	1.6	0.0	0.0	1.3	2.8	2.2	10.3	2.9	4.0	3.9	6.1	6.1	0.7	4.3	2.6	3.7	0.0	1.0	1.0	3.5	3.9	2.6	0.5	1.4	1.1	1.7	3.0	5.7	1.3	2.0	0.9	1.3	3.1	1.0	0.0	0.3	2.2	7.2	1.3	1.7	1.4	4.8	10.2	0.8	0.6	0.7	0.0	1.5	3.6	0.0	0.9	6.9	4.1	1.5	3.0	1.7	1.9	1.5	3.3	8.6	5.0	8.9	2.5	4.8	0.0	1.1	1.6	0.7	4.9	5.4	2.6	0.4	1.7	2.6	5.0	4.1
C1GALT1	"C1GALT, T-synthase"	ENSG00000106392	"Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1"	Q9NS00	7	7156934-7248616	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 204.3;Syncytiotrophoblasts: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"LHCN-M2: 288.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011294, HPA012819"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		43000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies, Cytosol"		"HPA011294: AB_1845623, HPA012819: AB_1845624"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.38e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-1)"	12.9	7.2	12.8	14.2	17.7	37.7	16.6	16.1	15.5	18.5	25.0	15.2	29.4	5.6	6.4	21.6	16.2	16.6	12.6	11.3	13.7	30.8	22.0	15.0	19.1	17.7	15.6	4.6	6.1	45.8	8.6	27.0	17.7	5.1	18.0	23.6	23.3	6.8	7.5	8.8	19.3	7.3	17.9	15.5	22.4	7.3	14.2	14.3	12.5	11.3	14.0	13.0	7.3	24.6	63.5	25.9	9.6	16.0	28.1	57.0	28.0	71.5	60.7	32.4	51.1	20.0	63.9	33.4	17.0	31.7	93.5	18.3	14.0	27.5	58.3	15.1	8.1	31.1	15.9	62.3	28.1	34.3	13.2	44.0	20.0	75.7	70.0	47.4	30.3	29.9	61.0	19.9	288.7	10.5	8.8	22.8	51.7	47.8	20.3	29.6	53.1	19.3	46.6	32.4	9.9	27.2	46.9	57.0	52.8	57.5	15.6	19.6	30.4	55.2	76.7	74.7	31.3	34.4	28.7	32.9	36.9	42.9	55.8	56.0	12.9	38.4	17.7	20.2	19.7	20.4	16.6	20.6	15.1	16.6	17.7	19.4	29.1	22.7	34.0	16.4	16.2	14.1	12.8	17.7	16.1	15.5	11.3	13.7	17.7	15.6	17.7	17.9	14.2	24.6	23.2	41.7	54.2	32.3	57.1	26.3	17.0	48.4	29.0	28.1	24.5	10.8	24.0	25.8	40.6	18.4	33.3	91.9	44.8	29.9	5.9	29.1	17.2	28.4	8.7	12.7	15.6	49.7	44.3	25.3	81.1	26.0	41.3	31.7	12.0	36.2	13.9	23.5	38.2	47.1	42.5	18.8	30.5	21.1	20.5	19.9	6.5	33.0	23.2	65.6	21.9	22.9	49.4	52.3	204.3	46.2	22.6	6.4	43.2	14.5	27.7	40.0	29.7	34.8	6.6	17.2	15.3	16.6	35.6	46.4	19.5	204.8	39.6	8.9	26.7	25.7
C1orf100		ENSG00000173728	"Chromosome 1 open reading frame 100"	Q5SVJ3	1	244352635-244389663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 35.0"	"Group enriched"	"Detected in some"	151	"Early spermatids: 1207.7;Late spermatids: 851.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"K-562: 5.9"	"Not detected"	"Not detected"							"HPA031179, HPA031180"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA031179: AB_10599995, HPA031180: AB_10599026"	"unprognostic (9.84e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.37e-2)"	"unprognostic (9.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-5)"	"unprognostic (1.85e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-4)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1207.7	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	851.9	5.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf127	FLJ37118	ENSG00000175262	"Chromosome 1 open reading frame 127"		1	10946471-10982037	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"pancreas: 4.4;skeletal muscle: 16.5"	"Cell type enriched"	"Detected in some"	9	"Enteroendocrine cells: 20.4"	"Cancer enriched"	"Detected in single"	9	"pancreatic cancer: 2.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.3"	"Cell line enriched"	"Detected in single"	4	"THP-1: 2.6"	"Not detected"	"Not detected"							HPA027654	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear speckles, Cytosol"		"HPA027654: AB_10611814"	"unprognostic (1.82e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.03e-1)"	0.2	0.6	0.3	0.1	0.3	0.1	0.1	1.2	0.7	0.1	0.2	0.3	0.7	0.0	0.1	0.6	0.0	0.3	0.6	0.2	0.3	0.0	0.2	0.4	0.6	0.2	0.5	0.0	4.4	0.1	0.2	0.2	0.3	0.1	0.6	0.0	0.2	0.0	16.5	0.0	0.3	0.0	0.2	0.6	1.9	0.5	0.7	0.1	0.2	3.7	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	1.2	0.7	0.2	0.3	0.2	0.5	0.3	0.2	0.7	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.8	0.0	0.8	0.6	0.1	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf21	PIG13	ENSG00000116667	"Chromosome 1 open reading frame 21"	Q9H246	1	184387029-184629019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 52.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 305.1;Syncytiotrophoblasts: 284.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 3.9;memory CD8 T-cell: 2.0;naive CD8 T-cell: 1.8;NK-cell: 2.6"	"Group enriched"	"Detected in many"	13	"NK-cells: 2.6;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 12.3;HSkMC: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026831	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA026831: AB_1845636"	"unprognostic (8.27e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (3.35e-8)"	"unprognostic (1.81e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.60e-2)"	9.8	13.2	7.4	1.3	11.8	0.5	13.4	8.3	12.4	15.5	0.0	14.6	3.0	13.0	6.8	8.2	12.8	2.8	12.7	10.6	3.8	3.3	5.6	7.9	0.8	7.4	2.7	11.3	3.4	2.5	4.7	1.9	7.7	14.1	5.0	7.4	4.6	6.8	52.6	16.5	11.9	3.8	3.2	5.5	9.7	1.6	6.1	1.5	3.4	20.6	1.0	15.7	15.0	5.5	0.2	0.1	3.8	0.2	5.9	6.0	5.0	1.7	1.7	1.0	0.6	0.0	0.0	0.0	0.0	2.5	0.3	1.1	1.6	1.7	0.9	12.3	3.9	0.0	0.8	0.0	2.3	1.2	0.6	8.7	4.0	1.2	0.9	4.4	1.4	2.8	0.0	3.5	1.4	1.3	1.4	0.3	4.4	2.0	0.3	1.9	2.5	2.1	0.0	0.8	1.6	6.0	1.0	0.7	3.5	2.2	0.1	0.1	1.7	2.2	0.8	4.2	2.3	7.2	4.1	0.0	3.7	1.8	2.4	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.5	2.0	0.2	0.0	0.2	1.8	0.0	2.6	0.0	0.1	0.0	0.9	7.4	11.8	8.3	12.4	10.6	3.8	7.4	2.7	7.7	3.2	6.1	5.5	107.5	38.5	113.0	201.4	1.2	152.6	234.9	29.6	82.6	23.4	87.9	63.6	90.7	25.8	38.1	1.8	0.0	119.3	99.8	149.9	7.9	6.7	47.0	11.0	89.3	98.4	19.2	14.5	144.2	19.6	99.3	91.8	7.1	21.7	10.1	11.2	101.4	83.7	40.9	26.9	165.9	66.3	24.4	8.8	31.5	37.8	76.4	9.5	64.0	16.9	19.7	42.9	141.1	305.1	3.6	14.1	203.3	19.2	20.2	105.7	193.6	12.3	17.5	9.5	19.7	108.8	48.2	3.4	17.3	76.3	145.6	284.6	32.2	32.8	76.4	181.7
C1orf216	FLJ38984	ENSG00000142686	"Chromosome 1 open reading frame 216"	Q8TAB5	1	35713877-35718894	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.8"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028299, HPA031343"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA028299: AB_10601122, HPA031343: AB_2673834"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (7.68e-10)"	"unprognostic (3.31e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.93e-2)"	10.5	10.6	35.8	6.1	39.1	4.5	7.6	25.1	47.8	10.7	15.8	17.3	3.5	13.2	11.3	5.6	9.1	7.6	11.7	42.6	37.0	4.7	5.3	9.9	7.3	31.6	27.5	8.2	4.4	7.0	9.3	4.7	33.3	8.7	5.3	28.8	5.2	9.9	15.6	7.7	7.9	16.0	27.3	8.8	7.1	9.8	33.4	4.8	6.0	14.7	7.0	10.7	7.9	37.9	7.7	17.6	8.6	12.5	43.5	31.7	6.3	21.1	25.9	31.9	30.3	10.7	16.3	8.3	15.2	32.5	26.0	7.1	24.1	14.6	27.5	31.4	10.3	57.8	27.6	2.9	16.5	28.1	36.6	32.9	18.2	22.8	7.4	23.6	21.2	6.3	23.4	25.6	34.9	12.9	10.5	24.8	13.6	8.4	14.9	7.0	11.5	8.2	11.0	9.0	12.7	12.4	20.3	4.1	44.1	5.3	8.2	12.6	24.8	25.6	19.5	19.0	22.2	7.6	20.3	6.0	25.6	27.6	40.9	0.0	2.7	0.1	4.3	2.8	1.3	2.0	3.3	5.3	2.5	1.5	0.8	3.1	0.0	0.6	2.1	0.5	1.2	2.9	35.8	39.1	25.1	47.8	42.6	37.0	31.6	27.5	33.3	27.3	33.4	37.9	4.9	0.0	2.2	5.9	2.3	6.0	3.5	2.9	0.6	19.6	3.6	2.5	7.1	0.0	1.5	1.8	14.6	2.5	7.1	0.1	0.0	6.0	14.8	1.0	3.7	6.1	1.8	7.8	17.6	2.7	1.5	7.3	1.1	1.6	4.5	5.2	6.4	2.3	7.9	23.5	15.0	0.3	2.0	4.8	6.1	8.5	8.4	5.0	16.0	9.4	6.9	21.0	10.3	7.1	8.7	2.0	0.1	20.7	2.7	1.7	0.1	0.8	0.3	31.8	0.0	6.8	7.8	11.2	5.2	0.2	4.5	1.1	6.2	4.7	0.7	1.5
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	11.3	12.5	20.6	6.3	20.4	14.3	11.7	19.5	24.4	15.5	18.2	13.4	7.9	13.4	5.5	18.8	13.0	4.0	9.4	20.5	20.3	11.2	11.6	8.6	9.0	20.8	19.7	16.1	12.9	7.4	9.9	7.1	20.6	14.2	3.9	2.7	12.5	8.5	9.6	19.6	10.5	5.0	19.2	10.8	12.3	7.5	20.3	9.2	12.1	3.5	7.3	14.4	14.7	21.0	22.2	24.3	17.0	10.9	8.2	8.3	40.0	16.8	7.4	14.6	10.9	24.1	22.2	22.7	35.6	6.6	10.3	25.4	16.0	16.6	5.3	24.6	76.7	13.9	20.1	23.1	13.3	32.0	16.7	7.6	19.5	14.3	13.1	9.2	16.1	26.1	35.2	13.3	10.7	27.8	42.0	44.4	34.4	28.5	55.6	32.1	24.2	36.4	13.6	18.2	28.1	27.2	16.0	29.4	23.3	4.5	31.0	29.2	15.1	11.8	18.1	32.7	37.2	23.9	12.7	21.6	14.2	18.3	19.2	14.9	29.0	43.3	28.2	35.9	35.2	37.2	31.1	30.7	37.6	29.9	36.1	30.2	4.7	35.9	34.9	49.3	34.7	17.5	20.6	20.4	19.5	24.4	20.5	20.3	20.8	19.7	20.6	19.2	20.3	21.0	37.7	22.4	22.4	10.4	29.8	66.8	35.5	58.5	47.3	51.4	41.1	50.9	18.1	28.6	31.0	38.6	18.8	76.2	49.8	61.6	45.0	38.0	4.4	28.2	31.7	33.9	26.3	57.4	12.9	39.5	59.3	34.3	25.0	43.7	24.7	36.9	32.2	24.4	40.4	47.1	10.1	58.8	54.9	24.2	72.7	5.5	51.3	29.8	32.0	2.8	32.4	42.5	30.9	9.5	14.3	37.5	43.5	46.6	28.1	37.4	47.8	38.3	25.1	54.5	65.7	31.6	44.7	44.0	50.0	54.1	80.6	28.3	47.2	28.0	56.6	25.8
C1orf68	"LEP7, XP32"	ENSG00000198854	"Chromosome 1 open reading frame 68"	Q5T750	1	152719522-152720470	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"skin 1: 678.3"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 78.3"	"Group enriched"	"Detected in some"	13	"head and neck cancer: 2.4;melanoma: 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HaCaT: 1.8"	"Not detected"	"Not detected"							HPA057942			Approved	"Plasma membrane,Cytosol"		NA	NA		220000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"	Cytosol	"HPA057942: "		"unprognostic (1.73e-1)"				"unprognostic (7.46e-2)"			"unprognostic (9.34e-2)"									0.4	0.0	0.0	0.0	0.0	0.2	42.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	678.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.8	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	78.3	0.0	0.1	0.0	0.0	0.0
C1orf74	"FLJ25078, URLC4"	ENSG00000162757	"Chromosome 1 open reading frame 74"	Q96LT6	1	209779208-209784559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 6.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 14.9;Glandular and luminal cells: 28.4;Squamous epithelial cells: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028496	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA028496: AB_10602698"	"unprognostic (3.25e-1)"	"prognostic unfavorable (8.52e-6)"	"unprognostic (8.41e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.40e-2)"	0.6	0.9	0.7	2.4	0.7	1.1	2.2	1.8	0.7	0.9	0.2	1.6	1.3	0.8	2.0	4.0	1.1	0.9	1.5	0.7	0.9	1.9	1.7	0.9	4.3	0.8	0.8	0.9	0.8	1.2	0.8	1.1	0.8	1.6	2.0	0.9	1.9	0.9	1.0	6.7	2.8	0.6	0.7	4.2	1.7	1.3	1.1	2.1	1.2	0.9	2.4	1.9	1.7	0.8	4.7	2.4	1.5	0.8	2.0	2.3	3.5	2.6	3.4	3.1	3.2	4.9	3.5	4.9	1.5	1.7	1.9	9.3	0.9	7.6	3.6	4.9	3.1	3.2	1.7	0.4	2.8	4.6	1.4	1.4	6.6	3.9	6.3	2.6	1.8	6.6	6.5	3.5	2.7	2.4	3.9	4.7	6.4	3.2	4.1	4.0	7.2	6.9	2.7	4.0	6.0	6.5	3.5	2.7	4.0	3.4	4.2	2.4	1.7	2.6	3.1	2.7	4.2	3.2	3.4	5.4	2.3	3.7	3.8	4.7	0.8	0.7	1.3	0.9	0.9	1.8	0.6	1.0	1.6	3.7	1.1	1.2	0.5	1.5	0.5	2.7	0.6	0.9	0.7	0.7	1.8	0.7	0.7	0.9	0.8	0.8	0.8	0.7	1.1	0.8	0.6	3.2	2.2	0.0	1.1	2.2	6.1	4.6	6.8	1.6	3.7	2.8	2.0	0.0	1.8	0.0	0.0	3.9	1.5	3.5	7.9	1.9	0.1	14.9	1.8	0.8	3.6	2.1	0.5	2.0	5.0	0.9	2.6	28.4	1.3	2.2	1.4	2.3	2.8	1.7	0.6	5.9	0.0	1.3	0.3	0.6	2.5	1.6	0.0	1.0	1.3	2.2	0.0	0.0	0.3	4.1	3.5	0.0	0.6	5.1	2.4	7.4	1.8	1.3	0.0	0.4	1.0	3.6	4.7	25.0	4.8	4.0	1.1	2.8	3.4	12.1
C1orf94	MGC15882	ENSG00000142698	"Chromosome 1 open reading frame 94"	Q6P1W5	1	34166883-34219131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 19.6"	"Group enriched"	"Detected in some"	28	"Early spermatids: 65.2;Late spermatids: 27.9;Spermatocytes: 34.6"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 17.0;U-87 MG: 48.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045805			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA045805: AB_10969626"					"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"				"unprognostic (9.77e-2)"	"unprognostic (4.09e-2)"			"unprognostic (1.65e-2)"	"unprognostic (2.31e-1)"			0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	19.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	1.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.5	0.4	0.8	0.5	0.5	0.5	0.8	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	65.2	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	34.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 214.2;heart muscle: 319.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 120.0;Sertoli cells: 105.2;Smooth muscle cells: 105.8;Syncytiotrophoblasts: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.5;BJ hTERT+: 72.9;HHSteC: 112.3;HSkMC: 61.3;U-87 MG: 66.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	314000000	40000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"CAB025429: , HPA051101: AB_2681343"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.81e-3)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (1.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.95e-2)"	214.2	75.3	9.5	14.8	15.2	0.5	156.0	16.1	13.3	50.2	45.3	38.3	4.6	45.1	6.5	18.9	63.5	24.3	319.1	9.1	18.2	25.3	45.7	44.4	14.0	18.3	25.4	70.5	14.9	13.5	17.5	42.2	18.0	57.1	6.3	0.9	34.9	44.0	27.0	38.6	29.3	13.3	14.1	35.7	25.0	5.4	21.9	5.1	115.0	21.3	6.6	34.7	42.3	13.2	0.1	32.3	0.3	0.1	313.5	27.1	0.2	13.6	72.9	7.0	11.9	2.7	14.0	0.1	1.5	5.1	18.1	0.7	1.0	0.5	5.0	0.1	3.5	0.2	11.7	1.5	112.3	0.1	0.2	61.3	0.2	14.5	0.8	9.3	8.8	1.6	0.1	0.3	1.6	0.1	0.3	0.2	3.0	3.7	27.9	0.1	22.3	0.4	0.0	0.4	1.3	5.3	9.2	1.8	32.7	1.2	0.0	0.0	1.4	32.6	0.8	4.0	4.8	0.3	0.1	0.1	66.2	0.2	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.5	15.2	16.1	13.3	9.1	18.2	18.3	25.4	18.0	14.1	21.9	13.2	36.1	0.0	0.6	4.9	0.4	6.5	0.7	12.3	0.6	0.1	9.2	1.8	10.8	5.7	0.5	1.8	0.0	21.5	0.4	3.2	0.0	19.5	0.1	0.6	17.9	38.3	4.8	2.7	0.2	5.9	1.5	23.6	2.6	0.6	0.0	25.3	120.0	1.9	2.6	0.0	0.9	6.3	2.0	7.5	11.3	0.7	10.5	1.1	3.6	5.6	10.9	0.5	0.0	0.5	0.3	3.7	3.1	3.4	0.1	1.8	0.9	0.2	0.3	0.5	105.2	12.7	105.8	0.0	0.7	0.4	4.5	47.3	0.8	18.1	5.2	0.6
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2915.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 276.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2"	"Not detected"	"Not detected"							"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	416.4	136.1	26.4	207.7	28.5	1.7	252.5	27.1	43.1	309.2	36.7	192.4	84.6	209.0	147.2	152.9	315.4	543.8	191.5	25.4	34.8	60.2	2915.2	224.9	209.2	44.3	31.7	485.9	62.1	21.8	33.1	52.9	31.2	174.4	215.2	9.7	96.9	139.1	57.0	104.1	154.2	251.8	30.9	168.5	150.1	90.0	30.9	88.1	139.0	154.7	192.5	455.7	189.8	31.3	0.2	18.6	1.2	10.2	769.5	1012.7	4.5	143.3	336.1	74.7	135.7	0.9	2.0	0.5	19.7	179.6	20.2	1.1	0.3	2.1	6.7	0.7	0.7	0.5	5.6	48.2	230.3	1.8	0.9	540.2	2.8	60.2	4.4	94.2	0.1	0.2	0.4	0.1	9.9	0.0	0.4	1.6	10.3	0.0	0.6	0.2	1.1	1.5	3.1	2.5	0.8	0.9	86.6	1.8	2.1	17.4	0.1	0.0	0.5	34.2	2.6	133.8	0.2	0.6	0.5	0.8	73.6	1.2	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	26.4	28.5	27.1	43.1	25.4	34.8	44.3	31.7	31.2	30.9	30.9	31.3	37.6	16.0	41.0	9.4	5.7	76.2	18.9	22.2	23.9	0.9	4.5	15.4	21.5	171.6	15.5	3.7	0.0	3.7	0.7	0.1	1.9	285.2	6.6	8.7	272.4	30.6	0.0	112.2	2.9	42.9	2.5	687.0	11.2	7.3	5.1	25.7	93.5	2795.1	8.1	5.0	1.7	0.0	2.0	62.8	103.7	29.9	1193.2	6.4	88.9	19.7	1.0	15.2	0.0	1.5	0.6	31.7	0.1	640.1	1.8	9.7	0.0	7.1	4.6	1.1	138.1	34.9	127.6	6.3	5.3	6.3	53.8	2.6	12.8	30.7	0.2	5.2
C20orf194	DKFZp434N061	ENSG00000088854	"Chromosome 20 open reading frame 194"	Q5TEA3	20	3249306-3407669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 226.9;Cone photoreceptor cells: 202.3;Excitatory neurons: 205.6;Inhibitory neurons: 163.1;Oligodendrocyte precursor cells: 135.7;Oligodendrocytes: 191.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052103, HPA067418"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center, Cytosol"		"HPA052103: AB_2681727, HPA067418: AB_2685835"	"unprognostic (9.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (9.58e-3)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.52e-2)"	11.8	9.5	19.7	5.2	22.4	3.6	8.7	18.5	20.1	10.1	6.8	14.4	4.1	10.4	5.4	8.4	9.8	8.3	15.3	19.5	21.4	11.2	2.6	10.0	4.5	21.5	22.9	12.3	6.3	4.2	8.8	9.1	21.1	8.6	4.3	16.4	5.8	11.6	32.3	5.6	6.6	12.9	19.6	7.3	9.7	10.4	21.8	3.8	9.6	11.6	2.9	12.6	8.9	26.0	4.0	3.6	9.7	4.7	19.7	21.6	1.1	9.2	10.3	6.0	7.5	0.0	4.3	0.0	2.5	12.3	7.7	4.7	3.7	9.1	8.2	0.9	1.8	1.1	1.4	10.0	9.2	1.2	0.5	17.7	6.9	7.9	6.8	8.6	12.2	3.5	2.0	0.0	8.9	1.8	2.5	6.5	2.9	2.2	2.3	2.9	8.8	0.1	7.8	8.1	1.9	5.7	4.1	7.2	12.0	8.3	6.8	11.3	13.7	7.5	3.2	4.7	4.5	0.1	0.0	0.0	2.4	1.2	5.8	0.4	0.8	0.0	0.5	0.4	0.2	0.2	0.3	0.4	0.9	0.4	0.1	0.3	0.0	0.0	0.4	1.0	0.4	0.2	19.7	22.4	18.5	20.1	19.5	21.4	21.5	22.9	21.1	19.6	21.8	26.0	23.6	28.9	9.2	226.9	3.7	6.9	6.7	10.8	8.6	35.1	10.1	10.8	28.5	15.7	10.3	12.9	202.3	1.8	8.9	0.1	1.9	9.1	31.8	10.6	15.9	20.1	0.0	4.0	205.6	4.7	5.4	13.4	19.4	12.1	14.0	53.3	25.7	2.3	19.6	30.3	163.1	0.5	4.1	34.0	25.5	8.9	19.9	22.4	8.8	89.9	14.1	10.0	3.1	135.7	191.2	9.4	14.8	13.5	1.5	5.4	7.4	8.4	21.8	13.9	13.1	18.4	22.2	28.5	25.0	7.2	5.7	1.8	7.8	16.4	1.4	5.2
C20orf27	FLJ20550	ENSG00000101220	"Chromosome 20 open reading frame 27"	Q9GZN8	20	3753508-3767781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 178.7;Hofbauer cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 144.6;intermediate monocyte: 249.1;myeloid DC: 199.4;non-classical monocyte: 235.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 199.4;monocytes: 249.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		140000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA047483: AB_2680064"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (8.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	55.8	24.0	48.8	20.4	125.4	103.6	45.2	44.7	70.9	39.5	33.7	117.3	17.0	42.5	8.7	29.6	51.8	25.5	27.9	45.6	63.3	25.7	24.7	20.8	24.5	52.9	59.3	66.3	23.6	9.4	23.3	8.9	67.5	24.2	7.8	4.9	15.7	10.9	22.4	26.9	33.9	14.1	43.8	45.5	86.8	22.7	59.5	11.0	23.4	11.5	9.8	73.9	26.3	40.7	172.9	177.7	24.4	106.1	49.5	28.1	42.7	45.5	25.1	70.4	50.3	120.5	61.6	111.1	41.4	48.2	94.7	140.9	65.7	101.9	24.9	26.1	138.3	63.2	35.9	212.6	36.2	88.2	24.7	41.0	41.8	93.3	46.1	24.2	48.2	72.9	114.6	59.8	37.3	240.2	107.6	186.3	114.9	107.0	248.4	86.6	67.9	123.7	43.9	62.0	121.8	56.6	41.2	155.3	85.1	10.4	36.9	96.8	35.9	104.8	73.8	171.6	129.6	50.5	93.2	80.7	31.5	161.2	53.9	1.3	144.6	2.3	28.7	249.1	42.1	38.7	33.6	38.6	199.4	36.2	37.6	37.5	5.4	32.5	235.3	38.7	34.2	87.4	48.8	125.4	44.7	70.9	45.6	63.3	52.9	59.3	67.5	43.8	59.5	40.7	54.0	0.0	3.3	3.3	26.5	24.2	23.0	26.8	35.3	9.7	28.2	45.7	3.7	8.6	7.4	11.0	2.1	17.5	15.8	10.2	29.4	32.6	21.8	13.8	178.7	28.7	15.7	99.1	6.0	30.0	49.2	27.1	14.3	7.5	22.9	45.0	19.6	17.9	142.9	1.7	9.5	15.9	16.2	119.0	53.1	15.3	32.6	92.2	37.4	5.6	97.4	24.6	15.5	3.5	2.1	34.7	14.6	24.8	20.2	46.6	19.3	32.4	2.7	13.6	65.7	17.1	98.8	27.3	39.1	34.8	32.8	7.3	24.1	69.7	33.0	22.7
C2orf16	DKFZp434G118	ENSG00000221843	"Chromosome 2 open reading frame 16"	Q68DN1	2	27537386-27582721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 21.4"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 94.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.4;SiHa: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052136, HPA056962"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA052136: AB_2681742, HPA056962: AB_2683290"	"unprognostic (4.32e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.79e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.53e-3)"	0.1	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.2	0.2	0.3	0.1	0.2	0.2	1.2	0.1	0.1	0.3	0.1	0.5	0.3	0.0	0.5	0.0	0.3	0.2	0.0	1.5	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.4	21.4	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.2	0.6	0.6	0.9	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.8	0.3	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.1	1.2	0.5	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.5	0.8	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.5	0.2	0.0	0.6	2.4	0.4	1.8	0.4	0.2	0.1	0.4	0.4	1.1	0.5	0.8	0.3	0.4	0.1	0.0	0.7	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	94.1	0.3	0.2	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	14.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C3orf14	HT021	ENSG00000114405	"Chromosome 3 open reading frame 14"	Q9HBI5	3	62319015-62336213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 159.7;Spermatocytes: 173.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 28.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 408.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048286	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA048286: AB_2680340"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.69e-3)"	"unprognostic (6.91e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.76e-5)"	"unprognostic (1.57e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.33e-5)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	7.6	15.9	35.4	5.9	37.3	1.3	35.6	32.3	44.5	6.7	23.0	8.3	3.5	7.8	8.1	18.8	4.2	6.5	10.2	37.6	36.7	15.0	3.4	6.9	5.8	32.2	31.4	9.1	12.6	3.8	31.0	5.0	33.0	17.9	4.3	27.2	12.4	5.5	1.3	17.3	4.8	7.1	33.5	4.3	6.2	32.8	33.8	3.7	9.1	1.3	9.2	12.7	9.3	33.0	0.1	22.1	27.2	0.0	18.9	24.8	19.3	33.6	21.2	41.7	41.0	0.3	36.8	0.0	0.1	20.4	84.6	6.7	0.0	21.4	32.1	0.0	14.5	20.5	0.0	0.0	12.0	0.3	45.2	11.3	28.9	47.8	39.6	0.9	21.0	0.0	2.4	0.3	43.0	408.7	0.0	0.0	33.4	31.9	41.9	0.1	0.0	11.8	37.0	64.3	45.9	40.8	21.3	90.0	38.7	20.5	34.0	25.1	0.5	22.2	0.2	105.1	34.8	24.1	0.0	0.0	22.1	0.0	78.4	9.2	4.7	0.7	0.2	17.9	0.0	4.1	3.9	3.3	5.4	1.4	1.1	0.8	0.5	0.9	28.1	7.6	7.9	2.4	35.4	37.3	32.3	44.5	37.6	36.7	32.2	31.4	33.0	33.5	33.8	33.0	8.7	22.4	11.8	11.8	3.3	36.8	23.6	41.5	31.3	34.7	90.2	77.0	7.7	11.5	38.1	22.0	4.2	21.4	8.0	2.6	60.7	35.7	159.7	11.3	14.8	12.1	87.4	2.1	34.8	55.1	19.6	20.9	4.1	12.6	1.3	7.9	5.7	3.1	32.0	37.0	33.4	3.8	44.7	10.0	27.2	62.9	14.0	13.4	46.2	3.7	56.6	35.4	0.0	13.0	15.8	35.8	0.8	10.5	0.5	21.8	2.7	41.5	12.3	28.0	0.0	15.8	21.6	173.2	53.5	30.8	28.7	9.9	5.0	20.6	3.9	23.3
C3orf18	G20	ENSG00000088543	"Chromosome 3 open reading frame 18"	Q9UK00	3	50558025-50571027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 29.3;Early spermatids: 54.2;Late spermatids: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.2;NK-cells: 2.0;T-cells: 6.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.8"	"Group enriched"	"Detected in all"	4	"cerebellum: 28.2;olfactory bulb: 27.5"	"Low region specificity"	"Detected in all"			HPA012105	Approved		Approved	Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA012105: AB_1845717"	"unprognostic (9.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (2.80e-9)"	"unprognostic (7.65e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	6.1	8.7	23.0	2.9	23.6	0.9	5.6	30.0	24.0	10.8	25.8	11.9	1.8	10.6	4.4	3.5	9.3	3.6	33.3	22.2	25.6	9.4	4.9	3.7	3.8	23.6	24.9	12.6	6.6	27.3	12.5	2.1	23.2	9.2	2.6	28.4	7.1	9.8	36.2	3.1	5.3	9.5	22.8	5.2	10.1	19.7	25.1	3.1	9.0	26.8	3.6	9.5	6.4	22.1	1.8	2.7	3.1	0.6	10.1	9.0	1.0	11.1	17.2	9.9	7.2	0.2	2.8	2.3	2.6	15.2	9.3	0.2	0.0	4.3	5.2	48.8	0.3	5.0	6.9	0.8	5.0	0.0	6.0	8.9	0.6	9.6	0.5	7.9	1.9	7.2	1.1	2.2	5.9	0.4	0.4	1.5	3.8	1.9	12.3	1.0	0.3	2.7	0.6	0.4	3.4	16.1	2.9	0.6	0.3	3.5	3.4	1.3	0.6	9.9	7.7	18.1	1.4	2.8	2.5	0.3	14.0	5.1	0.2	0.0	0.4	0.7	5.1	0.1	6.3	2.2	4.3	4.8	0.4	1.4	5.0	6.1	0.0	2.0	0.1	0.8	2.2	2.5	23.0	23.6	30.0	24.0	22.2	25.6	23.6	24.9	23.2	22.8	25.1	22.1	1.8	0.0	1.1	8.1	2.2	1.1	1.1	0.9	1.2	10.2	1.8	2.0	29.3	0.0	1.4	1.8	8.4	0.4	1.3	0.3	3.9	2.1	54.2	1.1	2.3	2.6	1.8	0.0	5.6	1.8	0.8	4.9	1.5	0.5	0.0	3.1	2.5	2.2	1.6	1.7	8.3	0.7	0.0	1.3	0.3	62.6	4.7	1.1	0.0	3.7	8.9	12.4	3.1	3.0	3.3	0.7	0.1	4.1	1.6	0.5	0.1	3.5	1.2	17.3	13.1	5.6	5.3	2.7	2.5	0.1	0.4	0.1	3.0	2.7	0.3	0.2
C3orf38	MGC26717	ENSG00000179021	"Chromosome 3 open reading frame 38"	Q5JPI3	3	88149959-88168729	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 341.2;Late spermatids: 312.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 147.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034736, HPA034737"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034736: AB_2674307, HPA034737: AB_10671505"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (9.28e-3)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.67e-2)"	10.2	8.8	7.1	11.1	9.2	42.1	12.4	11.2	11.5	10.7	6.8	11.1	9.7	9.1	10.9	12.1	10.6	9.7	9.9	7.8	8.6	10.4	14.1	10.1	17.7	8.0	7.5	11.6	7.8	10.7	4.8	12.4	8.6	10.1	11.0	7.7	8.8	9.5	8.0	8.2	10.0	10.9	8.7	13.2	10.4	32.8	7.8	20.9	12.0	10.8	18.4	12.5	5.2	12.8	16.6	17.4	32.5	17.7	22.5	19.8	15.0	26.3	31.5	38.6	51.9	19.5	22.5	22.8	23.1	24.5	18.4	11.8	23.7	19.2	33.1	40.1	11.7	27.1	12.3	16.9	30.8	37.9	22.5	27.7	20.1	26.1	21.8	25.2	23.1	23.7	18.0	25.1	43.4	19.4	38.3	16.9	40.0	31.0	18.8	23.9	11.4	21.5	25.7	22.6	10.1	14.6	24.1	14.2	42.2	26.2	25.5	30.0	20.6	24.2	25.7	147.7	29.8	22.6	36.2	33.0	18.8	29.8	23.0	47.8	22.3	24.1	16.8	32.4	21.4	26.0	15.3	17.2	23.5	22.3	15.1	15.6	9.7	23.4	27.4	16.2	20.5	21.6	7.1	9.2	11.2	11.5	7.8	8.6	8.0	7.5	8.6	8.7	7.8	12.8	13.3	19.2	7.5	5.9	30.9	11.7	18.8	19.9	14.2	21.6	11.0	9.5	6.9	8.6	16.7	5.5	22.9	21.6	24.4	13.9	19.6	16.7	341.2	14.4	13.3	10.8	16.2	23.5	9.7	13.7	22.7	17.3	11.7	10.2	14.0	14.2	11.4	7.5	26.7	6.7	9.1	13.3	14.2	23.9	25.1	312.0	16.4	24.0	16.0	6.5	28.0	23.2	23.7	10.1	15.0	15.3	19.3	15.1	17.5	18.6	16.1	14.5	21.2	24.8	13.1	14.9	16.6	75.7	12.2	14.9	14.1	25.6	24.6	18.1	11.1	22.5
C3orf49		ENSG00000163632	"Chromosome 3 open reading frame 49"	Q96BT1	3	63819299-63848636	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 19.5;Late spermatids: 34.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.0;MCF7: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053582	Uncertain		Approved	Vesicles,Centrosome,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Vesicles, Centrosome"	"HPA053582: AB_2682199"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.07e-1)"	0.0	0.2	0.1	0.2	0.4	0.6	0.0	1.2	1.7	0.1	0.0	0.1	0.6	0.3	0.0	0.7	0.1	0.2	0.3	0.2	0.0	0.1	0.3	0.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.1	0.0	1.4	0.3	0.0	1.1	0.9	0.3	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.1	0.2	0.7	0.4	0.4	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.7	0.3	1.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.6	0.8	2.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.4	0.0	1.8	0.4	0.4	0.5	0.4	0.1	0.6	0.4	0.9	0.0	0.4	0.4	0.3	0.1	0.9	0.1	0.1	0.2	0.3	0.5	0.3	0.4	0.6	0.7	0.2	0.9	0.1	0.9	1.4	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.4	1.2	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.2	0.1	0.5	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	19.5	0.2	0.2	0.1	0.0	0.0	3.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	34.4	0.3	0.0	0.0	1.0	0.1	0.2	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.3	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.3
C3orf52	"FLJ23186, TTMP"	ENSG00000114529	"Chromosome 3 open reading frame 52"	Q5BVD1	3	112086335-112131004	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 17.4;skin 1: 26.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 129.6;Pancreatic endocrine cells: 82.8;Prostatic glandular cells: 75.6;Syncytiotrophoblasts: 75.0;Urothelial cells: 132.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.4;U-698: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007678, HPA008119, HPA011968"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826"	"unprognostic (8.86e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.49e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-6)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.59e-2)"	1.2	1.0	0.1	1.2	0.2	0.6	2.7	0.2	0.3	0.7	0.2	7.5	3.3	0.9	0.0	2.6	0.7	5.0	4.0	0.2	0.1	4.8	0.3	3.8	1.2	0.0	0.1	0.2	17.4	0.0	2.0	3.3	0.1	1.7	13.7	0.1	3.8	3.4	0.5	26.3	5.2	0.9	0.1	0.7	13.7	0.9	0.3	6.6	7.6	0.1	2.0	5.8	1.6	0.1	11.0	2.0	4.2	0.0	0.6	0.0	1.8	15.5	6.7	10.1	11.3	26.4	10.1	0.4	1.9	3.1	4.4	8.7	6.1	0.3	19.4	0.0	2.8	7.9	1.8	1.9	4.6	0.0	0.1	0.6	8.7	5.2	15.0	5.4	2.2	0.0	2.8	2.8	7.5	1.7	0.3	0.0	12.3	7.9	0.6	0.3	13.2	0.0	18.1	16.5	0.5	0.9	2.4	5.2	6.3	6.8	9.5	0.0	5.8	3.6	5.5	0.0	0.0	3.9	0.0	30.1	2.7	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.8	16.0	10.0	0.3	1.6	32.5	129.6	10.0	45.5	0.0	14.8	3.3	2.1	4.3	19.3	18.4	0.0	18.1	0.7	30.4	0.0	26.3	24.2	24.8	3.1	3.5	11.9	0.0	3.2	35.9	25.6	4.7	64.2	44.1	0.0	0.4	0.4	0.0	1.9	0.0	0.6	56.6	8.2	0.3	2.7	23.3	0.3	1.0	1.8	1.0	2.6	0.0	0.0	0.5	0.3	82.8	30.7	0.4	4.6	75.6	7.8	2.1	14.8	0.0	0.0	4.6	4.7	3.2	5.3	44.0	33.5	75.0	2.0	3.0	8.9	132.5
C3orf56	FLJ40141	ENSG00000214324	"Chromosome 3 open reading frame 56"	Q8N813	3	127193131-127198185	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA055395			Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA055395: "															"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C3orf70		ENSG00000187068	"Chromosome 3 open reading frame 70"	A6NLC5	3	185076838-185153060	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9;smooth muscle: 14.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Bipolar cells: 76.8;Melanocytes: 39.2;Oligodendrocyte precursor cells: 143.2;Peritubular cells: 49.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 3.9;SCLC-21H: 16.4;SK-BR-3: 7.2;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041861	Uncertain		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA041861: AB_10804119"	"unprognostic (1.45e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.62e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.06e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	2.2	0.8	10.8	2.4	8.5	0.1	1.3	7.2	8.8	3.1	0.0	11.1	2.6	9.8	2.6	5.1	5.2	2.2	2.0	9.9	9.1	0.5	0.3	0.9	0.4	15.9	11.5	2.3	0.2	2.1	0.8	1.3	10.1	5.1	4.1	3.9	3.0	8.4	0.5	1.5	3.6	14.8	13.6	2.1	2.8	4.0	12.0	0.3	1.1	0.6	0.6	4.9	2.0	14.0	0.0	0.1	1.9	0.0	0.0	0.0	0.1	2.6	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.1	0.0	0.6	2.2	0.1	0.5	0.0	0.3	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.8	2.0	0.1	0.0	3.9	0.0	0.0	0.4	16.4	0.1	0.8	7.2	0.4	0.0	0.4	1.8	0.6	0.0	1.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	10.8	8.5	7.2	8.8	9.9	9.1	15.9	11.5	10.1	13.6	12.0	14.0	5.1	0.0	0.0	45.7	1.0	4.1	0.3	0.0	0.6	76.8	1.0	0.5	1.6	0.0	0.0	0.0	0.0	10.8	0.0	9.1	0.0	0.1	1.2	0.1	2.3	4.4	1.2	0.0	13.8	0.2	0.6	3.8	0.0	0.1	0.0	3.9	6.8	0.0	4.0	3.3	19.4	8.8	0.0	0.6	0.7	1.5	3.4	0.3	39.2	6.5	0.6	2.5	0.0	143.2	10.1	0.5	2.2	49.7	0.1	0.3	4.6	0.1	0.0	7.3	6.6	1.3	15.4	6.8	12.5	0.2	1.8	0.8	0.2	1.8	6.3	0.3
C4orf48		ENSG00000243449	"Chromosome 4 open reading frame 48"	Q5BLP8	4	2041993-2043970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.9;choroid plexus: 62.6;pituitary gland: 74.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 412.4;Paneth cells: 484.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 158.3;NB-4: 117.3;PC-3: 343.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052447	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA052447: AB_2681837"	"unprognostic (7.96e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.17e-3)"	13.5	18.3	50.0	4.6	68.4	2.7	9.6	71.0	66.6	5.2	62.6	20.4	2.7	5.5	0.2	4.3	7.8	0.4	8.2	49.4	60.8	20.2	4.0	7.9	1.3	81.5	63.2	6.6	18.9	2.4	74.5	2.1	58.6	7.1	0.9	0.2	9.2	1.4	1.2	3.1	16.3	0.6	67.8	18.5	11.9	56.1	60.3	0.3	9.3	0.0	0.6	6.8	2.9	97.9	33.4	27.1	5.3	24.9	2.4	3.9	35.3	31.2	6.0	5.6	5.3	18.6	19.6	4.4	29.2	1.2	10.4	9.2	0.6	3.5	1.7	20.1	158.3	10.5	15.8	10.7	5.2	21.7	70.3	3.0	5.9	1.2	0.0	1.8	5.9	17.9	35.1	0.1	3.9	20.6	24.6	117.3	15.8	1.8	343.1	56.1	8.3	11.2	5.0	12.3	42.7	60.0	15.3	0.7	47.7	0.5	8.3	10.3	26.5	14.7	31.9	11.0	35.3	23.8	22.4	0.4	14.6	13.2	20.8	88.5	451.6	431.5	123.6	325.6	127.5	187.7	157.2	138.3	270.0	167.9	89.1	92.9	349.2	29.6	290.7	301.1	199.8	192.8	50.0	68.4	71.0	66.6	49.4	60.8	81.5	63.2	58.6	67.8	60.3	97.9	13.3	0.0	1.9	8.8	58.1	21.9	6.6	13.2	7.4	12.0	147.0	139.8	10.6	20.0	14.2	200.5	0.0	8.0	52.8	412.4	70.5	320.8	97.1	326.7	92.6	42.1	235.1	30.7	5.6	222.7	116.5	47.7	35.7	107.3	107.5	209.0	123.1	11.9	235.5	18.5	8.2	154.2	44.7	272.1	113.3	350.5	19.3	158.9	327.3	7.5	205.2	78.8	20.6	6.0	41.1	198.2	484.2	28.2	84.1	10.9	223.7	7.9	28.8	15.0	13.1	1.7	53.2	99.7	193.2	5.7	10.1	13.1	73.9	50.9	117.1	11.1
C4orf54	"FOPV, LOC285556"	ENSG00000248713	"Chromosome 4 open reading frame 54"	D6RIA3	4	99636529-99654648	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 72.7"	"Cell type enriched"	"Detected in single"	17	"Endometrial ciliated cells: 14.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.6;SK-BR-3: 1.1"	"Low region specificity"	"Detected in single"							HPA079091			Approved	"Nuclear bodies,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	Cytosol	"HPA079091: "	"unprognostic (3.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.20e-1)"		"unprognostic (2.42e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	6.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	72.7	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.7	0.0	14.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101119-42142620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 157.0;skin 1: 73.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 163.8;Pancreatic endocrine cells: 219.9;Prostatic glandular cells: 144.6;Urothelial cells: 226.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 57.8;CACO-2: 52.0;CAPAN-2: 44.0;OE19: 181.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	3.7	1.0	0.4	2.2	0.4	1.0	8.7	0.6	0.7	31.7	0.3	14.1	33.4	1.0	0.1	157.0	5.8	6.6	1.8	0.4	0.1	14.9	0.5	5.8	0.3	0.4	0.1	0.2	18.0	2.5	1.7	1.5	0.4	12.1	11.7	0.9	47.1	2.3	0.9	73.6	20.7	0.5	0.0	0.1	36.2	0.7	0.3	0.7	10.7	0.3	13.9	9.9	54.9	0.6	57.8	0.5	0.0	0.1	0.3	6.1	29.0	2.9	4.4	7.6	7.6	52.0	44.0	0.0	5.4	5.4	0.1	37.5	0.1	17.3	5.2	5.1	7.2	2.8	5.0	12.1	2.0	0.0	0.2	4.0	30.4	5.9	8.8	3.1	0.0	0.3	1.7	0.5	1.7	20.4	0.4	0.3	3.6	181.7	1.5	0.1	0.0	0.3	6.2	25.5	3.0	0.1	4.7	35.2	0.1	4.1	25.2	0.3	0.8	0.4	3.5	13.5	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.4	0.4	0.6	0.7	0.4	0.1	0.4	0.1	0.4	0.0	0.3	0.6	0.8	44.8	16.6	0.3	0.2	52.5	88.6	31.8	19.4	0.8	41.7	19.8	5.1	45.8	63.1	51.5	20.9	12.4	1.2	89.9	0.0	57.9	22.2	91.9	9.4	2.8	7.3	0.0	0.5	134.7	1.0	9.2	57.1	135.8	1.3	18.3	1.4	0.0	0.8	5.0	0.5	41.3	38.7	1.2	6.8	163.8	0.6	1.5	12.4	0.0	3.8	0.5	4.1	0.5	0.2	219.9	66.8	1.5	0.3	144.6	102.7	7.7	92.1	7.9	0.0	7.9	4.9	4.9	9.1	81.4	82.0	4.1	1.5	45.4	43.7	226.0
C6orf47	"D6S53E, G4"	ENSG00000204439	"Chromosome 6 open reading frame 47"	O95873	6	31658298-31660778	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.5;HBEC3-KT: 7.6;HDLM-2: 4.7;HEK 293: 6.1;U-2 OS: 5.5;U-266/84: 5.5"	"Low region specificity"	"Detected in all"							HPA045281	Uncertain		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA045281: AB_10961000"	"unprognostic (5.99e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.59e-3)"	11.2	12.9	0.4	0.4	0.5	0.2	10.8	1.1	0.7	11.9	0.2	18.0	0.0	15.1	3.2	21.4	12.1	1.0	17.2	0.4	0.5	15.0	10.9	12.0	1.4	0.7	0.5	11.2	13.1	0.6	11.6	0.8	0.7	12.4	1.0	0.6	13.5	0.0	18.9	17.9	17.6	0.0	0.5	18.1	15.5	4.8	0.6	0.7	11.5	0.0	0.0	16.6	13.1	0.8	0.1	4.5	0.0	0.3	3.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	0.6	3.0	2.4	3.8	0.0	0.0	0.0	7.6	0.0	4.7	6.1	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.3	0.0	0.3	0.0	1.2	3.8	0.9	2.6	0.3	0.0	0.1	0.0	0.0	0.0	1.1	0.4	5.5	0.0	0.2	3.7	5.5	0.9	1.9	0.0	0.2	0.6	1.5	2.8	2.6	1.0	1.3	1.9	0.7	1.6	1.0	1.4	2.0	0.8	1.8	0.7	0.9	0.6	1.4	1.9	0.4	0.5	1.1	0.7	0.4	0.5	0.7	0.5	0.7	0.5	0.6	0.8	8.7	6.4	10.9	0.0	16.6	25.1	29.1	14.6	18.2	16.0	12.2	6.5	1.5	25.8	11.5	12.9	8.4	20.0	17.7	42.2	25.4	24.2	0.0	4.3	7.8	10.9	6.7	6.1	0.0	28.9	15.1	11.2	11.7	6.1	11.4	12.8	15.4	8.5	18.2	6.7	0.0	21.6	4.1	17.4	18.7	0.0	16.1	17.1	8.8	0.0	19.4	12.5	32.0	0.0	0.0	29.9	29.0	21.8	5.1	25.6	40.9	18.1	5.0	13.5	32.9	13.0	14.2	1.0	5.5	20.9	26.9	23.8	16.1	15.8	26.2	47.0
C6orf62	"DKFZP564G182, FLJ12619, XTP12"	ENSG00000112308	"Chromosome 6 open reading frame 62"	Q9GZU0	6	24704861-24719998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 354.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030564, HPA030566"	Supported		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA030564: AB_10600000, HPA030566: AB_10599425"	"unprognostic (2.07e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (4.16e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.01e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.62e-6)"	110.0	82.6	105.0	115.1	108.3	118.0	87.3	101.8	112.5	60.7	92.1	76.5	90.3	70.6	100.7	56.6	76.6	62.7	59.7	94.2	103.9	92.9	107.5	96.5	144.3	121.4	120.6	93.8	121.8	71.2	45.4	87.4	106.2	84.2	76.8	151.0	94.0	75.4	84.1	93.5	93.1	69.2	107.8	156.2	110.3	125.0	126.8	133.1	85.5	58.3	143.0	73.7	36.9	109.6	154.6	73.9	108.2	169.8	106.6	142.2	118.5	178.0	172.6	204.4	211.2	91.8	116.7	177.9	258.3	172.0	230.8	114.5	103.7	137.1	221.0	301.2	61.9	194.0	104.8	112.7	191.0	235.0	201.4	106.0	267.6	138.6	182.8	152.2	162.0	97.8	160.6	121.6	199.3	96.3	160.4	325.9	118.0	79.9	86.0	127.8	126.0	164.7	131.2	165.5	170.9	99.5	219.8	239.4	349.4	105.4	197.1	174.2	192.7	214.7	108.8	83.7	239.4	289.6	494.0	213.6	75.9	294.8	209.8	214.5	246.5	271.9	211.0	253.7	227.1	204.4	215.0	229.7	192.9	170.8	216.6	241.0	177.8	223.4	277.4	198.1	226.3	522.4	105.0	108.3	101.8	112.5	94.2	103.9	121.4	120.6	106.2	107.8	126.8	109.6	136.4	83.3	76.7	67.3	91.1	57.5	53.0	56.7	58.6	56.6	107.7	86.7	36.6	94.4	56.3	93.8	50.1	50.8	147.9	105.8	37.2	63.4	147.2	83.1	92.0	85.9	95.9	128.6	50.9	74.0	62.2	78.0	86.6	112.8	55.2	122.8	86.7	132.8	90.1	42.1	39.4	89.3	48.8	354.8	105.3	53.9	54.0	138.8	49.8	94.6	120.8	43.6	96.8	35.2	53.1	83.2	84.9	47.4	54.3	98.3	90.2	71.5	80.5	63.3	52.6	120.5	64.9	98.9	101.6	103.2	56.0	75.2	95.7	61.6	98.8	63.3
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Cone photoreceptor cells: 4.2;Excitatory neurons: 4.6;Inhibitory neurons: 4.7;Oligodendrocytes: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 36.6"	"Lineage enriched"	"Detected in all"	15	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: AB_2680837"	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	1.5	1.6	2.4	0.6	2.9	0.7	2.0	2.6	4.5	1.6	1.7	1.6	0.5	1.7	3.2	1.6	2.0	1.9	2.1	2.8	3.2	2.7	1.6	1.5	1.6	3.4	3.0	2.2	1.7	3.1	1.4	2.0	3.5	2.6	1.0	1.9	1.6	2.8	1.7	1.4	1.2	1.9	1.9	1.8	1.9	3.7	2.7	1.6	2.7	1.9	1.2	1.2	0.9	4.5	2.7	8.5	2.2	3.7	2.9	2.0	2.5	5.9	2.0	3.4	3.0	4.9	3.9	7.4	3.7	5.2	4.3	4.1	1.7	5.0	4.2	3.3	7.3	4.0	8.2	3.2	6.2	3.2	2.2	2.9	3.4	3.3	3.3	1.4	2.6	4.8	5.0	1.5	3.3	6.1	1.7	2.5	3.0	1.7	9.8	1.7	2.8	3.7	2.1	6.9	2.8	3.9	8.3	2.9	2.7	3.3	3.3	2.1	7.3	3.6	3.8	4.3	3.3	4.0	9.1	2.2	3.7	3.5	8.3	36.6	1.6	15.7	1.5	2.0	2.3	2.2	1.0	1.5	1.0	1.6	1.6	1.7	8.8	2.2	2.3	0.8	0.8	1.1	2.4	2.9	2.6	4.5	2.8	3.2	3.4	3.0	3.5	1.9	2.7	4.5	0.4	0.0	1.1	2.3	0.7	0.3	0.4	0.1	0.6	0.9	0.4	0.5	0.6	0.0	0.1	3.7	4.2	0.7	0.3	0.1	1.9	0.9	0.1	0.4	0.6	0.7	0.0	0.4	4.6	1.1	0.4	0.6	0.0	0.2	0.0	0.6	1.1	0.5	0.2	0.0	4.7	0.2	0.0	0.0	0.4	0.3	0.6	1.2	0.0	2.8	0.3	0.7	2.1	3.0	7.9	0.9	0.3	0.7	0.2	0.3	0.7	1.5	1.0	0.4	0.0	0.3	0.8	1.7	1.3	0.4	0.4	0.8	0.5	1.0	0.2	0.1
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590021-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: AB_2678218, HPA052175: AB_2681750"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	18.1	18.9	16.9	12.2	18.2	21.3	18.9	15.9	18.5	23.0	15.0	21.6	12.6	23.3	6.5	16.5	22.2	9.3	17.6	16.3	16.2	19.6	21.5	17.2	17.3	18.8	17.2	19.9	21.7	10.1	17.0	7.2	16.9	22.9	7.1	3.8	16.6	9.8	21.9	21.4	18.6	11.1	16.0	27.2	20.0	17.3	17.3	18.5	19.0	10.2	10.9	20.9	17.1	20.4	21.5	17.6	12.0	28.5	19.3	10.7	15.8	12.6	10.9	17.8	10.9	16.5	8.7	25.2	16.0	9.4	33.7	23.3	16.2	11.5	8.1	9.9	23.3	9.4	11.5	17.6	22.5	22.7	29.0	12.4	17.0	10.7	11.2	9.4	19.6	26.7	25.1	18.6	10.7	36.1	19.9	46.9	24.0	10.6	23.2	40.1	9.5	21.5	11.6	18.5	15.7	29.2	12.2	39.9	17.3	12.5	18.3	33.8	14.2	14.7	48.2	16.3	27.9	22.5	23.8	23.8	9.9	24.9	44.3	0.5	1.5	2.2	2.0	1.5	2.6	1.7	2.4	2.6	1.1	1.6	2.4	2.0	1.4	1.6	1.6	2.9	2.7	0.9	16.9	18.2	15.9	18.5	16.3	16.2	18.8	17.2	16.9	16.0	17.3	20.4	12.9	9.6	8.6	11.1	13.7	15.2	8.8	4.6	13.1	7.1	14.2	14.5	6.0	12.8	6.1	1.8	6.2	11.6	23.6	11.8	0.0	8.9	8.2	9.9	12.6	12.8	12.6	4.2	9.5	10.2	10.6	11.2	10.7	8.9	1.3	16.0	12.5	7.4	13.4	5.0	8.3	12.5	8.2	11.3	10.2	3.5	8.1	12.9	7.2	7.5	8.4	6.7	18.6	9.5	13.2	10.2	9.8	8.6	10.9	10.9	8.5	8.0	5.3	6.5	6.6	12.0	14.5	11.9	13.5	11.7	12.8	9.7	17.5	14.0	11.6	7.6
C8orf37	"BBS21, CORD16, FAP418, FLJ30600, MOT25, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244913-95269201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease variant, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	1.7	1.8	1.7	1.2	1.9	0.9	2.3	2.3	2.2	2.3	3.2	1.0	0.9	2.4	3.1	1.0	3.9	1.4	2.7	1.7	1.8	2.4	1.8	1.5	2.2	2.3	2.9	4.8	1.2	3.5	2.3	1.8	2.2	2.0	0.9	5.0	1.5	1.7	1.1	1.5	1.0	2.3	2.7	1.7	1.1	1.7	1.8	2.4	2.4	1.8	1.9	1.2	1.4	2.9	2.8	4.5	3.6	1.9	1.2	3.3	1.0	1.2	2.7	1.5	2.0	0.7	6.0	5.6	2.8	2.0	3.8	2.3	1.5	3.1	3.3	1.8	1.4	4.4	2.7	2.0	1.4	0.9	2.3	3.3	1.4	1.8	5.0	3.9	2.3	3.3	2.3	3.2	2.0	2.1	4.8	1.1	1.1	5.6	3.0	2.5	1.9	1.4	3.4	1.2	3.5	3.4	2.5	0.5	2.1	2.7	4.2	0.8	2.0	1.9	2.4	1.6	1.2	2.9	3.0	3.8	3.6	2.1	2.4	0.3	0.3	0.1	0.2	0.2	0.5	0.4	0.3	0.3	0.5	0.8	0.3	0.5	0.4	0.7	0.1	0.2	0.1	0.2	1.7	1.9	2.3	2.2	1.7	1.8	2.3	2.9	2.2	2.7	1.8	2.9	2.4	3.2	2.6	6.8	2.5	0.9	3.7	2.9	4.0	2.7	1.3	2.4	5.3	0.0	3.3	7.3	2.1	2.5	1.8	0.1	7.9	1.8	10.2	3.4	1.3	1.5	0.0	0.4	6.8	2.7	2.9	2.8	1.1	1.0	0.0	1.9	1.1	3.8	1.3	3.3	5.2	0.1	2.0	1.6	1.2	8.7	3.1	0.8	1.8	1.9	1.8	5.3	0.0	8.5	5.7	1.2	0.2	3.0	0.7	1.9	0.1	4.7	7.9	4.1	0.0	2.5	4.2	6.0	3.5	0.9	1.8	0.8	1.1	3.0	0.5	1.8
C8orf48	FLJ25402	ENSG00000164743	"Chromosome 8 open reading frame 48"	Q96LL4	8	13566869-13568288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 33.3;Late spermatids: 51.9;Spermatocytes: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.5;U-87 MG: 11.5;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026107, HPA027440"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA026107: AB_10600765, HPA027440: AB_10601678"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.07e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.84e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-3)"	"unprognostic (7.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.70e-2)"	1.1	0.2	1.1	0.6	2.2	0.0	1.8	1.3	1.6	1.3	0.2	0.5	0.4	1.1	2.9	0.6	1.8	1.2	1.3	1.2	1.2	1.2	0.8	1.2	0.4	2.2	1.5	0.6	0.4	0.3	0.5	0.6	2.6	0.2	0.4	4.8	0.4	0.4	0.1	1.3	0.4	0.9	1.2	0.2	0.9	7.0	1.7	0.2	4.4	0.4	0.2	0.8	0.3	2.9	0.0	0.1	1.8	0.0	6.0	6.0	0.0	5.5	6.1	2.9	4.9	0.0	0.0	0.0	0.0	2.9	13.5	0.6	0.2	1.1	5.7	0.0	0.6	0.6	0.0	0.0	2.1	0.0	0.9	1.9	3.6	3.9	1.0	0.7	3.8	0.0	0.1	0.0	7.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	3.2	0.0	0.2	6.3	2.0	0.0	0.0	1.7	5.1	4.9	6.0	5.0	0.0	0.0	0.0	11.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	1.3	1.6	1.2	1.2	2.2	1.5	2.6	1.2	1.7	2.9	1.0	0.0	0.0	2.0	0.0	1.0	0.0	1.0	0.0	0.2	0.9	0.8	0.3	0.0	0.9	0.0	2.1	0.0	0.0	0.1	0.0	2.7	33.3	1.8	3.0	0.7	0.0	0.0	0.6	1.1	0.0	2.7	0.0	0.2	0.0	0.3	1.1	0.5	0.1	0.0	0.3	0.0	2.0	0.0	0.0	51.9	5.0	0.2	5.4	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	3.0	0.0	0.0	0.0	3.6	1.9	4.3	6.6	1.2	4.5	18.2	2.3	0.8	0.4	0.0	0.1	3.4	0.0	0.1
C8orf76	FLJ14825	ENSG00000189376	"Chromosome 8 open reading frame 76"	Q96K31	8	123219967-123241377	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 164.9"									HPA023708	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"prognostic unfavorable (9.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.71e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.95e-11)"	"unprognostic (1.54e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.71e-2)"	10.5	14.1	12.0	9.5	12.8	12.6	10.8	13.3	15.0	9.3	13.3	10.8	9.4	7.7	11.4	15.4	8.9	8.7	13.0	12.0	12.6	9.2	18.4	9.4	14.1	12.3	12.5	8.3	10.8	7.7	17.3	12.2	12.4	10.5	11.8	11.0	12.5	8.1	15.2	8.4	11.1	7.8	12.7	14.3	10.0	7.3	12.6	13.9	9.8	7.9	13.9	10.5	10.3	13.4	24.7	22.4	20.3	14.3	19.5	17.8	13.9	22.7	22.0	26.0	26.1	20.5	17.5	16.8	24.4	21.9	19.4	18.4	22.9	12.4	29.3	27.0	31.9	19.7	10.1	28.0	35.0	10.5	15.6	13.1	23.3	23.3	19.4	15.2	23.4	25.9	28.6	12.8	21.9	72.3	30.7	23.1	16.6	59.4	37.6	16.1	10.4	19.3	22.4	20.1	26.7	24.8	22.7	164.9	25.0	20.6	20.2	24.7	12.9	14.8	28.3	16.1	19.0	16.8	19.8	18.2	15.9	23.7	16.3	19.9	18.3	28.3	13.6	21.4	14.4	11.7	14.8	17.6	19.2	14.8	14.0	14.1	10.9	15.0	18.1	16.8	21.3	13.2	12.0	12.8	13.3	15.0	12.0	12.6	12.3	12.5	12.4	12.7	12.6	13.4	12.4	12.8	2.0	7.2	17.7	13.5	17.8	29.0	17.1	8.2	13.8	13.8	5.9	7.2	25.4	1.8	10.4	27.4	23.4	21.3	5.9	16.4	5.1	10.7	15.4	11.7	24.7	8.6	6.8	11.8	31.5	15.1	8.2	11.5	22.2	10.8	8.9	11.1	22.6	136.3	8.2	12.5	32.6	14.5	17.7	4.0	12.8	16.3	14.2	3.7	21.7	12.9	20.6	3.5	8.8	14.8	13.8	7.5	19.1	21.6	19.4	11.2	48.3	7.7	19.7	11.5	28.7	14.4	17.1	12.6	11.5	40.2	18.1	8.8	15.7	39.9
C9orf116	"MGC29761, PIERCE1, RbEST47"	ENSG00000160345	"Chromosome 9 open reading frame 116"	Q5BN46	9	135495181-135501734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 97.2;testis: 62.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 520.9;Endometrial ciliated cells: 442.5;Late spermatids: 579.4;Respiratory ciliated cells: 610.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 41.3;T-47d: 41.9;U-2197: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021439, HPA065287"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA021439: AB_1845799, HPA065287: AB_2732732"	"unprognostic (9.02e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (3.53e-5)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	2.6	16.3	11.9	0.8	12.8	0.9	3.1	10.7	13.0	5.5	24.5	2.1	1.0	4.2	25.7	1.9	97.2	2.8	2.0	14.0	13.6	9.5	3.5	9.2	0.7	15.8	19.7	2.8	6.5	6.8	16.9	1.5	15.9	4.2	1.2	10.1	3.4	6.3	1.5	1.8	1.4	1.2	15.4	1.9	3.1	62.5	14.5	0.6	8.1	0.9	1.2	2.7	1.5	13.0	11.0	18.7	8.1	12.7	3.5	7.4	1.6	7.3	5.1	8.7	5.9	7.1	10.9	1.9	9.5	4.9	4.7	7.4	9.1	4.1	7.4	0.5	8.0	0.0	21.0	22.1	9.7	1.5	5.0	5.2	3.2	4.4	1.4	7.1	4.2	8.6	10.3	1.4	4.2	41.3	5.7	1.9	17.1	17.2	21.5	8.7	3.9	6.9	21.0	7.7	7.9	8.3	10.3	4.4	1.2	3.7	41.9	1.8	2.1	5.0	6.5	42.9	2.9	4.7	12.6	1.8	14.7	0.7	1.5	0.0	0.8	0.0	0.5	0.5	1.2	0.2	0.4	0.4	0.3	0.4	0.7	0.5	0.0	0.6	0.1	0.1	0.5	0.3	11.9	12.8	10.7	13.0	14.0	13.6	15.8	19.7	15.9	15.4	14.5	13.0	1.2	9.6	7.8	2.3	1.9	0.9	1.8	39.7	2.2	5.0	11.7	9.8	1.7	15.7	46.3	14.7	14.6	11.5	0.7	0.5	11.7	26.0	520.9	442.5	6.6	2.1	1.2	1.3	2.1	7.8	3.4	5.2	4.6	23.9	1.3	12.0	0.7	1.6	3.6	3.3	2.2	1.0	38.7	1.2	1.4	579.4	8.1	1.3	0.0	0.0	2.0	13.2	0.0	1.0	0.2	6.9	1.7	7.5	3.6	2.4	1.3	58.8	610.3	19.9	0.0	1.4	15.0	133.8	20.0	1.3	0.3	4.5	1.6	41.4	1.7	3.1
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397810	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 39.2;choroid plexus: 105.6;fallopian tube: 108.7;testis: 90.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 744.6;Endometrial ciliated cells: 841.0;Late spermatids: 3115.3;Respiratory ciliated cells: 1312.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.2	0.6	20.6	0.3	26.6	0.0	0.7	19.5	29.8	7.8	105.6	3.2	1.9	0.7	0.0	0.4	108.7	0.3	17.5	20.8	22.8	3.4	0.3	18.4	0.2	35.9	39.2	0.4	0.9	0.1	10.6	0.2	29.8	1.6	0.7	1.2	1.9	0.4	1.4	0.6	5.4	0.5	33.0	0.2	1.4	90.6	22.3	0.3	0.6	1.7	0.3	0.9	0.4	25.5	0.2	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.3	0.4	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.3	0.0	0.4	1.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.2	0.6	0.4	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.8	0.3	0.0	0.2	0.0	0.0	0.4	0.1	20.6	26.6	19.5	29.8	20.8	22.8	35.9	39.2	29.8	33.0	22.3	25.5	0.4	6.4	15.1	11.4	0.3	2.2	3.3	67.3	2.2	1.4	1.6	1.8	37.0	1.5	116.4	7.3	0.0	0.6	0.1	11.3	72.4	1.1	744.6	841.0	6.1	2.1	12.1	0.0	11.3	1.5	0.3	3.5	0.5	9.8	8.8	0.2	1.4	4.1	0.4	0.0	12.6	13.4	81.4	1.0	1.0	3115.3	10.5	2.7	0.0	1.0	0.0	2.2	1.0	4.0	5.4	0.2	7.3	7.2	0.5	4.5	142.5	13.7	1312.6	0.9	32.9	0.5	25.5	21.0	6.9	0.4	1.0	0.5	1.6	0.0	20.5	2.4
C9orf40	FLJ10110	ENSG00000135045	"Chromosome 9 open reading frame 40"	Q8IXQ3	9	74946583-74952912	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.9;Cardiomyocytes: 45.0;Erythroid cells: 39.2;Spermatocytes: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042167	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		230000	"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Cytosol"	Centrosome	"HPA042167: AB_10797382"	"unprognostic (2.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.15e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	4.9	2.1	6.9	4.3	6.8	6.2	4.4	6.8	9.6	4.2	4.5	5.8	8.4	3.7	1.5	3.9	3.1	1.6	2.9	7.1	7.2	2.6	3.1	2.1	4.7	7.4	6.9	2.6	2.3	2.9	3.1	3.7	7.2	2.7	5.1	7.9	2.2	2.4	3.1	2.2	11.3	2.7	7.3	3.9	2.6	11.8	6.8	4.3	2.1	2.5	4.7	4.2	4.2	8.4	29.6	6.3	16.3	6.6	6.5	8.2	30.2	23.0	7.1	15.7	16.8	1.8	9.0	26.5	6.7	5.8	26.2	8.6	12.9	1.3	24.9	36.0	19.9	14.1	11.2	11.3	5.2	17.2	21.5	4.1	8.5	8.7	6.2	6.3	4.9	19.1	20.3	17.5	20.7	8.3	30.3	19.9	19.2	15.4	19.2	28.0	12.8	6.5	6.7	7.1	17.7	7.8	10.1	8.5	7.3	14.3	10.3	13.1	6.4	14.1	15.9	19.5	20.4	33.2	26.7	17.0	10.7	19.0	15.5	0.6	0.1	2.1	0.3	0.1	0.1	0.8	0.3	0.3	0.1	0.5	0.7	0.4	0.1	0.0	0.2	0.3	0.4	0.1	6.9	6.8	6.8	9.6	7.1	7.2	7.4	6.9	7.2	7.3	6.8	8.4	29.9	3.2	0.5	2.3	5.8	2.4	4.4	1.1	3.4	9.7	6.0	6.2	45.0	0.0	0.6	3.7	8.4	20.9	3.2	13.4	1.9	3.3	12.0	2.9	6.2	12.1	1.2	39.2	5.8	3.1	24.9	5.9	2.6	6.4	0.0	3.1	8.2	3.8	11.3	1.7	4.6	7.9	0.0	4.2	3.7	2.9	4.4	3.5	1.8	6.5	2.6	4.8	2.1	1.5	4.0	2.5	7.3	5.3	4.2	5.4	20.3	2.2	1.0	16.4	0.0	3.8	5.8	42.2	10.6	7.1	5.3	12.3	4.8	9.2	17.0	3.9
C9orf43	MGC17358	ENSG00000157653	"Chromosome 9 open reading frame 43"	Q8TAL5	9	113410054-113429690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 45.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 114.2;Late spermatids: 226.0;Spermatocytes: 91.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021310			Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA021310: AB_1845825"	"unprognostic (2.91e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-1)"	0.3	1.5	0.9	0.1	1.0	1.9	0.5	0.9	1.2	0.2	0.8	0.2	0.1	0.2	1.2	0.3	0.7	0.3	0.2	0.9	1.2	1.2	1.5	0.2	0.4	1.3	1.6	0.8	0.8	0.9	1.4	0.2	1.2	0.5	0.2	1.2	0.7	0.4	0.1	0.5	0.2	0.0	1.3	0.4	0.5	45.6	1.1	0.4	0.8	0.3	0.4	0.2	0.2	1.3	0.5	0.4	0.2	0.7	0.6	0.3	0.3	0.2	0.4	0.7	0.5	0.5	0.4	1.3	0.4	0.1	1.4	0.9	0.2	0.6	0.2	1.1	0.2	1.1	0.8	0.2	0.5	0.2	0.1	0.7	1.0	0.8	1.0	0.4	0.6	1.5	0.7	1.2	0.3	1.0	0.5	0.3	0.3	0.6	1.6	0.3	0.2	0.7	0.7	0.2	1.2	0.3	1.2	0.5	0.7	0.5	1.6	0.1	0.0	1.0	0.2	0.6	1.0	0.7	1.5	2.0	0.5	0.4	0.3	0.0	0.1	0.0	0.3	0.3	0.0	0.3	0.1	0.4	0.2	0.1	0.3	0.4	0.4	0.2	0.0	0.3	0.0	0.1	0.9	1.0	0.9	1.2	0.9	1.2	1.3	1.6	1.2	1.3	1.1	1.3	0.4	0.0	0.0	4.9	1.5	0.6	0.6	0.5	1.2	1.7	0.8	0.9	0.1	0.0	1.6	0.0	0.0	0.5	0.3	0.2	1.9	0.3	114.2	3.0	0.7	0.7	0.0	0.8	0.6	0.2	0.4	0.2	0.0	0.6	0.0	0.7	0.0	0.9	0.3	0.0	0.7	0.1	0.0	0.3	0.4	226.0	2.1	0.5	0.0	0.0	0.7	1.8	0.0	0.5	1.8	0.9	0.0	1.5	1.8	0.3	0.1	0.9	6.7	2.8	0.0	0.7	0.3	91.5	17.9	0.7	0.0	0.0	0.4	0.7	0.2	0.6
CAB39	"CGI-66, MO25"	ENSG00000135932	"Calcium binding protein 39"	Q9Y376	2	230712842-230821075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 188.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037112, HPA076632"	Approved		Approved	Nucleoli,Cytosol		NA	NA		100000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli	Cytosol	"CAB037112: AB_1078367, HPA076632: "	"unprognostic (4.36e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (1.04e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.36e-1)"	43.7	31.0	30.1	55.2	32.9	50.9	29.6	31.5	40.6	26.5	29.3	53.7	48.0	30.7	35.0	55.8	30.0	41.3	55.6	34.3	33.9	54.1	38.6	40.0	58.0	36.5	34.5	29.2	33.1	42.5	17.1	35.5	36.4	39.9	56.0	45.6	34.4	31.2	188.5	34.3	51.2	40.4	34.0	38.0	46.2	41.3	33.6	45.1	37.3	127.8	59.1	49.4	30.5	39.5	131.6	30.0	39.8	34.0	48.2	59.8	45.3	73.7	91.8	45.4	47.2	36.6	140.0	33.8	56.5	64.5	76.5	59.1	44.8	138.5	91.9	142.1	35.1	90.5	36.9	39.5	40.9	126.6	100.8	42.5	79.1	58.5	128.4	51.8	57.1	46.1	153.9	30.3	43.8	45.6	59.1	77.9	39.8	53.4	52.0	67.8	59.3	33.5	84.6	104.9	43.2	26.4	55.2	68.2	59.9	44.7	16.9	72.4	73.1	63.9	24.3	68.2	61.0	39.0	31.8	53.8	45.4	72.4	53.4	4.0	3.6	6.0	4.7	4.4	4.8	3.0	5.8	6.1	3.0	2.4	4.7	6.5	10.3	9.3	4.3	2.2	6.2	2.4	30.1	32.9	31.5	40.6	34.3	33.9	36.5	34.5	36.4	34.0	33.6	39.5	41.6	64.1	37.5	42.1	29.6	97.8	44.2	23.0	23.3	14.4	28.3	18.9	69.1	17.2	30.5	51.5	33.3	20.8	32.3	162.5	29.4	26.0	12.0	41.4	25.2	29.6	20.4	32.0	85.1	32.7	18.7	24.1	28.5	39.5	20.3	16.6	28.2	29.3	56.8	28.6	69.3	48.5	24.4	81.2	72.4	13.5	17.4	66.2	30.2	93.7	49.6	39.6	29.9	58.8	64.3	72.3	62.4	32.0	37.0	84.4	54.6	39.8	55.6	40.5	13.1	27.5	27.3	30.8	29.5	31.2	85.1	23.1	52.0	18.9	34.8	88.6
CABCOCO1	"bA63A2.1, C10orf107, Em:AC022398.2, MGC44593"	ENSG00000183346	"Ciliary associated calcium binding coiled-coil 1"	Q8IVU9	10	61662929-61766766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.6;testis: 15.5"	"Group enriched"	"Detected in some"	10	"Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Centrosome	"Nucleoplasm, Cytosol"	"HPA041398: AB_10794374"	"unprognostic (1.89e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.79e-4)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.52e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.33e-2)"	1.0	0.5	4.2	0.2	4.2	0.0	1.2	3.5	3.9	4.2	5.9	1.2	0.3	3.5	0.5	0.3	26.6	0.8	0.2	4.4	4.6	1.8	0.3	4.1	0.0	6.8	8.9	0.2	0.5	2.9	4.2	0.8	7.2	4.1	0.6	0.9	1.0	2.5	0.1	0.3	0.5	0.7	8.3	1.0	0.5	15.5	4.0	0.1	0.7	0.0	0.1	0.4	0.6	7.8	0.0	0.2	0.1	0.0	0.0	2.5	0.0	0.4	1.7	0.3	0.6	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.9	0.5	0.1	0.0	0.1	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	5.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	3.5	3.9	4.4	4.6	6.8	8.9	7.2	8.3	4.0	7.8	1.9	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.0	0.0	7.4	3.7	0.0	0.3	0.0	0.0	0.0	0.8	0.0	60.4	4.1	0.4	0.0	0.0	0.0	0.2	0.2	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	88.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.2	1.2	0.0	0.0
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	27.2	28.7	28.9	15.5	29.1	30.9	24.3	33.3	40.9	33.3	32.6	37.0	13.6	32.4	8.7	23.4	35.9	10.1	30.9	28.8	25.6	36.0	28.2	28.5	19.6	28.0	27.5	27.3	28.1	15.6	46.2	8.2	28.1	34.0	8.4	13.3	22.1	14.1	17.4	24.7	33.1	11.0	23.1	37.2	31.9	34.4	29.2	19.5	50.3	7.0	10.0	29.7	27.1	28.9	24.7	17.7	23.6	20.8	20.9	24.1	33.3	20.4	17.5	16.0	18.1	22.0	11.9	28.6	11.0	20.5	20.8	23.1	28.4	18.5	14.2	48.3	27.8	24.6	21.1	46.8	9.9	57.1	25.6	20.5	11.6	19.6	14.7	19.2	27.1	25.1	52.1	15.2	9.2	32.0	27.1	62.1	14.7	34.5	12.6	26.3	17.3	36.0	14.6	24.8	30.2	25.9	25.2	17.4	26.1	21.3	15.6	25.6	22.3	37.0	28.6	14.3	14.9	26.5	17.1	16.9	17.3	27.3	15.8	7.2	3.9	15.5	5.7	2.7	6.3	2.5	4.3	7.5	2.6	4.1	5.2	4.8	17.4	5.4	1.9	3.0	3.7	2.5	28.9	29.1	33.3	40.9	28.8	25.6	28.0	27.5	28.1	23.1	29.2	28.9	14.5	22.4	37.5	37.5	22.7	8.3	8.9	11.0	13.1	33.3	14.2	10.8	18.5	4.3	9.1	9.2	89.6	17.4	24.6	19.9	7.9	11.6	16.6	43.6	19.6	15.1	14.8	18.3	54.2	9.7	6.9	16.4	29.6	26.8	17.7	21.1	13.2	9.4	21.7	33.7	39.4	13.0	20.3	12.6	16.2	16.0	21.5	16.1	10.6	20.6	19.2	14.5	44.3	21.1	35.9	10.8	6.6	19.9	24.4	7.1	8.8	7.9	24.4	50.1	19.7	14.6	32.6	60.7	41.6	13.6	9.5	22.4	36.5	18.4	13.8	7.3
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 42.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 188.7;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 34.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;NB-4: 1.0;NTERA-2: 1.1;U-266/70: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.0	1.0	33.5	0.6	30.5	1.2	0.0	0.0	34.6	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.7	0.0	0.3	42.8	3.4	1.3	0.0	0.1	0.4	4.6	6.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.2	9.7	0.4	0.1	1.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	33.5	30.5	0.0	34.6	42.8	3.4	4.6	6.2	0.9	9.7	3.8	1.1	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.4	0.0	0.0	188.7	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	116.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.5	0.0	0.2	0.0	73.9	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53991637-54012666	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 90.7;tongue: 29.9"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 8.3;Horizontal cells: 1.7;Respiratory ciliated cells: 9.1;Skeletal myocytes: 2.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	107	"basophil: 13.3;eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	133	"granulocytes: 13.3"	"Cell line enhanced"	"Detected in some"		"A549: 12.7;EFO-21: 23.6;HHSteC: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	Cytosol	"HPA056615: AB_2683192"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"		"unprognostic (7.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.89e-2)"		"unprognostic (2.27e-1)"		"unprognostic (7.69e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.07e-8)"	"unprognostic (9.79e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.1	0.9	0.3	0.2	0.1	0.2	0.2	0.0	0.3	8.8	0.0	0.0	0.6	0.6	0.0	0.0	2.2	0.0	1.0	2.0	0.0	0.0	2.9	1.9	0.0	0.8	0.4	0.0	0.1	1.0	0.0	90.7	0.0	0.2	0.0	1.0	0.1	0.3	2.3	0.4	0.0	0.0	29.9	0.1	0.0	0.0	0.5	0.0	12.7	0.2	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	23.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	5.6	0.0	0.1	0.1	0.0	0.0	0.0	1.9	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.1	1.6	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.2	0.0	2.8	0.0	0.0	0.0	3.5	0.1	0.2	0.0	0.0	13.3	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.9	0.6	0.6	1.0	2.0	0.8	1.0	0.4	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	8.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	9.1	0.0	0.0	2.3	0.1	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 75.1;Fibroblasts: 38.2;Hepatic stellate cells: 48.2;Hofbauer cells: 53.7;Leydig cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 45.1;BJ: 37.7;BJ hTERT+: 37.5;fHDF/TERT166: 43.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	49.7	18.5	7.2	12.5	6.5	2.1	38.9	6.3	9.0	54.4	7.0	18.4	6.5	58.1	5.5	12.2	43.3	21.6	34.2	7.0	7.3	10.7	4.5	23.2	13.7	8.0	6.4	48.1	7.1	3.1	7.3	10.0	7.8	21.1	4.3	0.4	14.9	10.6	9.7	17.9	19.6	15.9	7.7	35.3	13.8	11.5	8.0	5.6	21.6	11.1	6.1	33.9	39.3	7.9	11.0	7.5	1.8	2.4	27.3	45.1	9.1	37.7	37.5	11.2	15.7	3.3	5.3	3.3	4.2	43.2	0.7	5.0	3.8	0.0	2.1	0.4	21.5	7.8	2.5	0.6	12.4	1.3	0.7	15.6	0.0	3.3	0.1	20.8	13.5	8.3	1.8	19.8	7.5	25.0	3.0	3.7	4.8	2.3	6.7	9.2	3.0	7.5	1.0	0.9	5.3	2.3	1.5	6.2	2.1	0.8	1.2	2.5	24.5	3.6	4.4	12.6	2.7	3.0	7.6	3.8	31.0	24.0	0.8	70.0	91.9	1.8	83.7	178.4	69.6	27.7	56.5	69.7	152.1	7.3	10.8	42.3	3.6	62.9	214.6	17.8	82.7	85.6	7.2	6.5	6.3	9.0	7.0	7.3	8.0	6.4	7.8	7.7	8.0	7.9	18.2	3.2	0.6	1.0	4.9	5.4	2.9	0.6	4.0	0.1	3.4	4.4	3.3	1.5	0.0	3.7	0.0	3.1	11.3	0.1	0.0	4.2	1.0	1.4	19.8	25.5	1.2	5.7	2.3	0.2	75.1	38.2	1.5	2.1	8.8	11.4	48.2	0.6	53.7	0.0	0.5	0.1	2.0	28.8	18.8	2.5	45.7	21.5	8.8	2.8	17.3	0.2	33.0	1.0	0.2	0.1	0.1	16.1	3.1	0.8	0.0	0.3	0.0	0.1	19.7	16.8	27.9	0.8	0.9	0.8	3.8	19.2	19.4	6.0	0.0	1.0
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206079	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 91.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 184.3;non-classical monocyte: 216.9"	"Lineage enriched"	"Detected in many"	7	"monocytes: 216.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA051109: AB_2681346"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	5.2	5.1	2.9	14.5	2.9	4.5	3.1	3.9	3.8	9.2	12.6	70.1	91.9	3.3	1.4	2.1	19.3	18.7	1.2	3.1	2.7	29.1	15.0	5.1	3.9	2.8	2.7	1.7	7.0	0.9	3.5	5.4	2.9	6.2	64.7	4.3	2.2	4.4	3.4	4.8	76.0	7.3	2.4	5.9	15.6	3.3	3.0	4.5	1.6	0.7	4.0	3.5	2.3	3.3	3.4	11.6	7.9	4.8	1.6	1.7	5.7	2.2	2.3	4.8	3.0	22.1	29.8	3.7	3.0	1.9	3.7	15.1	18.2	2.8	2.0	3.3	16.9	6.7	21.6	7.9	3.5	5.8	14.7	1.6	4.4	1.8	3.4	3.0	5.9	10.8	6.2	3.9	0.7	10.2	14.5	12.6	8.5	24.1	3.4	30.1	8.1	8.2	1.3	6.0	4.4	4.3	3.5	3.2	9.9	3.1	2.8	12.6	3.5	5.0	4.5	9.2	8.7	14.4	9.4	10.0	3.3	14.9	2.2	0.1	43.7	0.2	0.1	184.3	0.6	0.6	0.6	0.2	29.1	0.1	0.5	0.3	21.3	0.0	216.9	1.4	0.4	18.3	2.9	2.9	3.9	3.8	3.1	2.7	2.8	2.7	2.9	2.4	3.0	3.3	1.3	0.0	1.5	3.3	0.7	1.5	0.8	2.8	1.8	11.1	0.4	0.1	0.3	12.8	15.8	3.7	0.0	0.5	0.3	49.2	0.0	2.5	6.5	9.4	0.6	6.4	7.7	1.3	3.8	4.3	0.5	3.2	31.6	0.4	0.0	0.4	5.0	8.1	3.9	8.4	4.0	17.1	0.0	11.7	1.5	0.5	3.7	8.1	0.0	4.7	3.9	2.0	2.1	3.0	3.4	3.0	39.3	6.8	2.4	1.1	36.2	25.4	107.8	3.1	0.0	1.1	0.7	0.0	0.4	1.3	2.0	0.1	1.2	0.1	21.1	1.1
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499570	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 3060.6"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 172.1;Breast myoepithelial cells: 156.1;Suprabasal keratinocytes: 390.7"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"A-431: 400.3"					"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favorable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	3.9	0.5	0.0	0.0	0.0	0.1	41.2	0.0	0.0	94.0	0.0	0.8	0.0	0.3	0.7	67.5	0.1	0.0	1.3	0.0	0.0	0.3	1.7	0.8	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	554.0	0.0	11.7	3060.6	0.6	0.0	0.0	0.4	0.8	1.0	0.0	9.2	0.6	0.0	13.4	0.1	306.6	0.0	400.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	27.3	0.3	2.2	0.0	0.0	172.1	156.1	0.2	0.0	1.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	11.1	0.0	0.0	0.4	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.2	0.3	6.8	390.7	0.0	1.2	0.0	0.0	3.3
CAMK1	"CaMKI, CaMKI-alpha"	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757347-9769992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 58.3;Hofbauer cells: 76.2;Macrophages: 71.2;Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 280.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 280.5"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 403.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol		NA	NA		110000	"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB031904: AB_630964, HPA051409: AB_2681473"	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	52.4	99.7	50.1	17.2	48.9	5.1	37.2	39.9	61.0	27.0	31.8	33.6	9.2	31.8	13.7	8.0	37.0	11.1	20.5	61.2	46.3	24.9	36.4	23.9	11.1	37.8	41.7	41.2	8.4	14.4	21.6	6.7	38.8	31.1	10.6	5.9	9.8	19.7	7.1	7.9	16.5	26.0	36.8	16.7	21.7	29.8	46.9	4.3	19.5	7.8	15.0	28.4	18.3	46.1	0.5	16.4	12.6	0.0	64.7	24.3	32.6	38.4	21.1	43.1	40.4	24.1	3.0	1.1	9.0	26.0	6.2	2.7	0.0	5.0	27.0	0.4	95.4	53.5	32.1	34.1	35.9	4.5	403.3	25.3	4.1	60.6	6.7	35.4	36.8	0.9	7.2	1.2	16.3	10.3	0.3	38.8	9.0	0.4	25.7	0.3	0.4	1.1	25.9	2.8	4.2	16.7	6.6	0.7	4.0	5.3	4.1	67.2	19.6	19.8	24.4	28.0	48.7	0.4	0.3	1.0	41.5	14.7	3.0	17.8	21.3	280.5	0.3	42.2	0.1	0.1	0.4	0.2	14.1	0.2	0.3	0.1	1.0	3.6	43.0	0.4	2.0	4.7	50.1	48.9	39.9	61.0	61.2	46.3	37.8	41.7	38.8	36.8	46.9	46.1	58.3	0.0	3.1	17.9	2.8	5.0	19.2	3.4	5.7	9.9	5.2	4.6	0.1	12.8	2.1	11.0	2.1	0.4	3.0	2.6	9.8	14.4	1.8	1.8	14.9	22.8	6.0	4.8	25.6	4.0	1.2	23.3	5.6	3.1	30.5	16.7	30.4	23.5	76.2	0.0	14.5	2.3	0.0	46.4	40.2	7.2	36.1	71.2	5.4	8.4	36.7	39.4	3.1	6.6	2.7	5.5	2.9	45.1	0.2	17.5	3.6	47.4	1.3	7.7	59.2	12.2	42.7	1.5	3.7	1.5	3.8	0.8	7.1	6.6	7.6	11.0
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349547-12835545	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 57.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 167.4;Cone photoreceptor cells: 392.0;Excitatory neurons: 416.9;Inhibitory neurons: 233.6;Microglial cells: 168.6;Rod photoreceptor cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 14.9;basal ganglia: 16.7;cerebral cortex: 35.6;hippocampal formation: 29.6;white matter: 14.5"	"Immune cell enhanced"	"Detected in all"		"eosinophil: 75.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 75.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 113.8;U-266/70: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	6.6	4.8	14.9	8.4	16.7	6.8	4.3	4.5	35.6	7.4	1.1	11.4	3.5	3.2	2.8	8.6	3.8	5.9	14.6	29.6	0.6	2.6	8.2	7.5	9.6	3.7	0.1	2.7	16.9	0.9	2.8	2.9	0.0	4.7	12.4	57.9	4.3	7.0	1.5	18.5	6.3	5.2	0.7	10.9	3.1	6.1	1.3	23.5	13.0	2.3	12.6	7.1	9.2	14.5	0.3	6.1	6.8	0.3	4.0	1.4	0.4	0.9	2.2	1.4	2.0	8.6	4.8	3.4	0.7	0.6	3.4	3.2	8.4	1.2	1.1	113.8	4.1	13.6	19.4	0.4	1.1	0.3	11.8	0.2	5.2	2.7	0.2	14.6	0.8	7.2	0.4	0.4	1.7	7.2	26.9	5.6	4.6	0.0	2.7	20.2	3.7	6.4	0.2	6.5	10.4	4.8	13.2	4.9	0.0	0.9	3.4	3.3	0.3	5.6	8.1	18.1	4.0	50.3	16.8	11.3	8.2	8.8	0.1	19.5	4.9	75.1	3.8	7.1	3.9	12.1	3.3	4.8	9.3	14.7	3.8	2.6	29.8	3.1	8.7	2.8	1.1	3.4	14.9	16.7	4.5	35.6	29.6	0.6	3.7	0.1	0.0	0.7	1.3	14.5	12.5	3.2	25.2	130.6	68.0	22.9	8.6	26.3	13.1	167.4	3.4	1.7	17.1	12.8	36.6	1.8	392.0	0.2	22.1	36.7	0.0	9.0	20.4	3.6	4.0	13.7	16.1	7.6	416.9	22.0	0.9	30.4	2.0	2.0	23.4	2.0	15.0	13.7	16.0	45.4	233.6	27.4	10.2	50.1	61.2	9.2	23.6	36.2	3.6	168.6	34.8	24.2	30.9	111.6	7.2	10.5	42.8	60.9	23.9	4.9	2.0	1.2	27.5	214.2	26.3	7.2	10.2	4.8	11.0	24.6	41.2	0.3	21.6	8.7	33.2	20.9
CAMK2A	"CAMKA, CaMKIIα, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 662.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 245.8"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 662.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 1071.1"	"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		66000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	0.2	0.9	161.7	0.2	230.9	0.1	0.1	0.0	662.9	1.2	0.0	1.0	0.1	2.8	0.3	1.3	1.5	0.3	4.8	453.1	0.0	0.7	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.0	3.5	0.3	0.0	0.8	0.2	1.9	0.7	0.4	95.0	0.7	0.4	2.4	0.0	0.3	0.5	0.1	0.0	0.0	0.1	34.7	0.0	2.0	0.7	99.6	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	230.9	0.0	662.9	453.1	0.0	0.0	0.0	0.0	0.0	0.0	99.6	0.0	0.0	0.0	12.1	0.0	3.4	0.0	0.0	0.0	5.1	0.0	0.0	14.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.0	245.8	0.0	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	55.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	3.6	9.4	0.0	0.4	0.0	8.5	8.1	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	3.6	1.8	0.0	0.3	0.0	1.4	0.3	0.2	0.0	0.0	0.0
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 159.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 272.9;Excitatory neurons: 182.9;Inhibitory neurons: 200.0;Microglial cells: 187.4;Oligodendrocyte precursor cells: 203.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 272.6"					"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		240000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	28.6	25.6	52.7	26.6	45.1	5.7	21.0	45.8	52.0	18.9	1.6	36.4	28.8	23.5	9.8	29.7	18.8	30.7	159.3	60.2	23.9	19.3	37.3	22.9	35.2	11.8	33.9	25.4	15.2	56.5	9.1	19.8	12.6	32.2	39.1	79.2	13.4	41.7	105.1	15.8	34.1	24.9	21.0	18.4	37.1	19.8	46.7	16.3	23.7	60.0	31.4	27.4	19.7	22.9	4.8	62.5	67.5	22.8	144.0	272.6	24.0	145.4	96.3	56.0	48.0	42.3	17.6	91.2	20.7	102.3	70.7	2.1	42.6	22.8	56.6	35.1	10.8	0.0	22.0	49.2	73.0	0.1	0.2	176.3	30.5	43.5	107.1	88.5	50.6	11.3	3.6	39.4	106.8	17.1	9.3	3.6	9.8	60.3	22.8	17.9	79.0	0.4	57.3	42.7	18.2	18.3	20.0	29.3	19.5	55.9	0.6	23.7	30.7	146.9	34.8	63.6	29.1	30.4	16.5	76.7	75.7	5.5	70.8	0.0	12.7	0.0	6.7	7.0	12.7	11.2	6.6	7.5	15.7	22.6	7.4	6.5	0.9	9.7	2.5	0.1	13.2	7.7	52.7	45.1	45.8	52.0	60.2	23.9	11.8	33.9	12.6	21.0	46.7	22.9	43.7	41.7	37.6	128.3	55.1	18.4	16.6	8.3	22.8	83.3	14.0	17.1	272.9	62.9	24.7	29.5	87.6	0.5	19.0	70.9	5.9	8.4	3.2	18.2	35.2	27.2	103.8	3.6	182.9	20.1	0.4	50.1	71.9	47.0	10.1	13.0	24.3	57.2	18.6	72.3	200.0	88.1	14.2	17.3	22.3	6.2	20.2	31.5	5.4	187.4	16.0	35.9	28.8	203.1	128.0	11.6	57.3	19.9	20.4	36.2	52.4	23.1	21.7	74.0	6.6	32.8	44.4	3.1	3.4	37.1	31.8	1.1	27.8	12.3	48.6	27.5
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CAND2	"KIAA0667, TIP120B, Tp120b"	ENSG00000144712	"Cullin associated and neddylation dissociated 2 (putative)"	O75155	3	12796472-12871916	"Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 135.0"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 120.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.4;REH: 12.4;U-266/84: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005777	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	Cytosol	"HPA005777: AB_2667431"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.78e-5)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-3)"	3.0	3.2	7.9	0.5	7.9	1.0	1.9	6.4	8.7	4.8	7.6	6.5	0.9	6.4	2.2	2.4	6.2	1.7	25.3	8.0	9.6	2.4	1.6	2.4	0.8	8.0	7.4	5.0	2.4	5.4	8.3	0.8	8.3	3.6	0.7	2.2	3.3	3.0	135.0	1.4	2.3	3.4	6.6	2.2	3.3	15.7	8.8	0.8	3.1	36.2	0.6	4.4	2.7	8.6	0.8	1.6	5.6	0.2	0.2	0.1	0.3	1.4	0.6	3.4	4.1	0.9	0.3	1.0	1.9	0.9	0.9	0.2	6.4	0.1	2.6	1.8	19.4	1.5	2.9	1.4	5.2	0.2	0.1	1.2	0.3	3.1	0.1	3.3	0.7	7.2	5.3	1.0	1.0	3.3	2.6	0.8	3.8	0.4	2.0	12.4	1.2	1.0	0.2	1.5	3.9	4.6	0.1	0.9	1.2	1.1	1.6	6.3	0.4	1.0	0.9	1.0	1.4	1.3	9.9	8.4	0.6	1.2	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	7.9	7.9	6.4	8.7	8.0	9.6	8.0	7.4	8.3	6.6	8.8	8.6	0.9	3.2	1.1	5.9	0.2	0.4	0.8	0.6	1.8	16.0	0.4	0.5	4.8	1.5	0.7	1.8	10.4	0.2	0.2	0.1	0.0	0.9	120.6	0.4	1.4	1.8	0.0	0.4	19.3	0.0	0.2	2.6	0.5	0.3	0.0	5.6	3.3	2.0	4.2	13.5	25.3	0.0	0.0	0.0	0.8	23.2	4.7	0.4	0.0	4.7	0.0	2.9	1.0	12.1	7.2	0.0	0.0	10.1	0.2	0.5	0.0	0.7	0.3	3.1	0.0	4.1	4.0	1.4	5.3	0.4	0.1	0.1	1.0	9.2	0.0	0.4
CAP1	CAP	ENSG00000131236	"Cyclase associated actin cytoskeleton regulatory protein 1"	Q01518	1	40040233-40072649	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 832.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 1954.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030124	Approved		Approved	Cytosol		NA	NA		73000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA030124: AB_10600799"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.44e-6)"	"unprognostic (5.37e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	175.2	96.8	78.6	275.0	92.3	314.9	137.5	87.6	95.3	131.2	77.8	223.7	143.7	207.2	100.4	196.2	134.2	135.3	82.3	82.6	85.3	130.7	124.4	181.7	266.8	98.0	87.6	87.7	67.8	115.1	62.8	184.2	94.4	105.0	210.4	63.4	117.4	140.1	48.1	120.2	165.0	236.6	89.7	206.1	147.8	75.0	91.5	186.8	106.8	56.0	326.4	231.2	130.4	107.9	435.9	185.1	216.4	134.8	310.6	290.5	338.9	749.8	437.7	398.9	399.9	272.5	440.1	339.5	295.7	598.7	275.7	267.1	265.8	535.7	548.1	461.6	164.9	520.2	188.7	216.8	286.4	326.9	1417.9	297.5	280.6	612.5	345.4	456.5	346.4	185.7	201.6	215.0	621.7	129.2	265.4	194.9	367.7	312.1	207.9	197.0	297.6	198.6	451.3	452.0	107.5	222.9	308.7	366.4	523.8	443.1	170.0	1954.7	628.9	347.3	317.9	188.0	641.4	178.9	381.8	301.0	451.5	353.8	466.9	1371.5	776.8	2592.7	665.8	1097.6	526.2	328.0	473.4	643.9	868.3	325.6	397.1	537.9	1560.4	479.8	1402.6	333.8	701.5	1838.4	78.6	92.3	87.6	95.3	82.6	85.3	98.0	87.6	94.4	89.7	91.5	107.9	132.5	121.8	90.9	17.6	179.0	112.3	149.0	236.2	48.9	40.8	81.8	89.9	15.7	80.1	161.8	114.0	27.1	212.9	206.9	372.1	111.6	364.1	411.3	94.5	109.8	163.2	76.1	73.4	22.3	272.3	439.6	107.9	74.5	182.9	229.1	70.9	167.0	77.0	426.0	42.1	16.7	180.2	142.4	411.6	333.3	480.3	88.0	390.8	99.6	25.3	606.5	160.9	315.1	13.0	30.4	832.7	202.0	176.8	117.1	130.7	159.7	142.1	105.6	49.5	164.3	68.9	207.1	118.0	67.9	97.2	132.8	237.8	238.0	74.8	151.5	221.4
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393505-17557790	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 577.1;tongue: 313.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Excitatory neurons: 158.1;Inhibitory neurons: 137.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 26.1;basal ganglia: 40.9;cerebral cortex: 87.2;hippocampal formation: 50.2;white matter: 32.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 101.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	17.8	11.6	26.1	7.6	40.9	0.0	10.7	0.9	87.2	15.4	2.9	32.6	4.1	28.5	17.8	21.7	16.8	11.4	113.6	50.2	11.1	8.7	4.5	4.7	1.7	3.2	3.8	4.5	4.2	7.5	5.1	8.8	2.7	25.1	9.6	9.1	7.7	30.7	577.1	2.6	8.9	42.7	0.0	3.1	9.8	1.5	9.1	3.1	5.5	313.0	2.3	14.5	6.4	32.3	15.5	24.6	44.4	55.1	0.3	0.1	10.4	52.3	42.7	46.6	43.0	8.1	6.9	0.0	48.9	62.1	60.5	8.2	21.3	20.9	66.8	0.1	7.9	0.0	15.4	26.5	4.3	0.0	0.0	3.5	9.9	23.1	10.3	72.3	2.2	0.0	0.0	0.1	101.6	25.2	0.0	0.0	17.0	0.8	15.6	5.2	59.1	1.1	23.6	6.4	6.1	10.9	19.0	59.2	31.3	82.8	65.0	11.2	0.2	36.6	31.6	1.0	47.6	0.0	0.0	0.2	11.7	0.1	48.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	40.9	0.9	87.2	50.2	11.1	3.2	3.8	2.7	0.0	9.1	32.3	2.0	3.2	1.5	9.8	0.0	1.9	4.3	6.2	5.7	16.4	10.2	8.4	126.5	4.3	5.4	1.8	4.2	16.5	0.0	1.9	3.9	2.7	0.1	13.9	13.7	2.7	6.0	0.0	158.1	0.7	12.2	7.9	0.0	5.8	0.0	22.8	3.9	2.4	2.2	8.4	137.2	1.3	2.0	0.0	2.2	0.0	0.6	0.3	0.0	10.3	0.0	6.3	0.0	16.6	7.2	3.7	1.9	4.9	0.0	1.9	0.0	16.7	33.9	2.2	32.9	25.5	43.4	0.1	3.2	2.1	0.9	37.5	0.3	0.3	1.6	0.6
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586734-240617705	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: AB_2683037"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favorable (8.47e-5)"	"prognostic unfavorable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	10.0	18.6	16.8	6.8	16.2	7.9	9.6	21.0	25.0	11.8	16.5	12.7	13.1	10.7	3.7	14.5	13.7	6.1	24.6	17.9	14.0	23.8	14.7	12.2	10.6	15.6	15.8	13.3	12.6	5.3	18.1	4.5	15.4	14.9	7.1	10.6	10.2	5.3	5.8	12.1	14.0	2.8	12.6	29.8	15.8	17.0	16.7	6.4	13.2	2.8	5.4	11.1	10.0	16.8	8.0	11.2	11.2	9.5	4.5	3.6	19.7	9.9	4.1	6.5	5.9	8.7	18.7	5.9	3.5	3.6	8.9	12.7	3.0	6.6	3.3	23.0	19.8	10.9	20.4	16.0	7.1	7.1	15.3	2.6	4.8	6.7	2.7	6.7	5.2	16.8	12.5	7.3	2.8	7.1	16.2	27.5	17.4	9.5	8.1	15.5	8.1	13.1	9.9	9.8	28.1	22.0	6.3	9.3	13.8	3.5	4.8	9.3	8.6	11.0	9.7	9.5	11.8	16.3	4.2	10.7	10.4	12.8	11.0	1.5	0.9	1.8	1.0	0.6	0.3	1.0	0.6	1.1	0.4	1.1	0.7	0.9	4.1	3.0	0.6	1.2	1.3	0.4	16.8	16.2	21.0	25.0	17.9	14.0	15.6	15.8	15.4	12.6	16.7	16.8	8.9	3.2	6.0	19.6	7.5	4.6	7.2	3.8	6.2	14.9	6.2	5.3	9.5	12.8	4.8	9.2	14.6	5.4	14.2	7.2	7.9	13.0	1.9	14.7	5.7	7.0	11.3	1.7	9.5	9.1	5.2	5.3	4.6	13.8	22.9	11.3	7.5	3.0	6.7	48.8	9.0	6.3	8.2	5.3	1.7	2.6	9.0	7.8	1.8	7.5	7.7	13.4	8.2	7.5	7.2	13.8	4.6	9.4	7.4	10.1	9.9	6.2	9.4	18.6	0.0	5.6	7.6	12.6	7.7	3.7	5.3	5.5	11.3	9.0	6.4	6.9
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066961-77126155	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 60.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 170.3;Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 89.8;Paneth cells: 72.6;Proximal enterocytes: 75.6;Undifferentiated cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	6.7	12.2	8.5	10.9	7.9	2.7	4.9	6.4	8.6	13.5	3.5	60.5	60.7	10.0	5.7	31.6	10.8	36.3	7.2	8.5	8.7	15.1	52.1	4.8	1.9	11.7	8.2	13.2	5.6	1.0	5.1	2.8	12.5	16.0	49.9	3.8	7.7	8.9	1.6	3.1	52.4	11.3	9.9	3.5	47.9	21.5	7.9	2.8	4.7	1.7	2.7	15.4	10.5	8.1	0.8	12.5	8.6	7.8	32.0	30.4	0.7	11.8	22.9	13.4	10.0	6.9	3.6	0.4	7.7	24.5	14.4	0.5	3.8	1.0	6.4	0.5	0.8	2.1	0.5	0.9	7.9	0.2	0.4	16.1	1.4	22.6	5.2	18.8	14.4	5.1	0.2	0.0	26.9	19.9	1.8	0.3	6.6	106.6	9.3	2.0	27.0	0.4	4.6	16.4	0.5	13.5	1.0	2.7	5.9	5.7	1.7	0.1	23.9	25.4	12.3	34.8	1.3	0.8	1.7	0.1	13.1	0.3	5.7	0.0	0.2	0.0	1.3	0.3	0.1	0.0	0.1	0.5	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.0	0.7	8.5	7.9	6.4	8.6	8.5	8.7	11.7	8.2	12.5	9.9	7.9	8.1	1.6	0.0	0.5	4.2	1.0	1.7	0.3	2.2	0.0	3.1	0.5	1.8	1.7	24.3	10.3	23.9	0.0	0.1	3.4	170.3	1.9	10.3	1.1	1.9	5.9	2.4	22.3	5.7	4.6	32.7	0.4	7.6	80.0	3.5	0.0	10.2	2.9	40.4	0.9	1.7	6.7	89.8	10.2	1.6	1.8	1.3	12.5	1.2	7.2	1.0	0.3	5.8	5.2	11.6	0.7	22.4	72.6	4.5	0.9	2.0	75.6	9.9	11.1	2.1	0.0	8.3	4.1	0.5	2.3	2.5	0.9	0.0	1.5	5.3	69.2	2.4
CAPN7	PalBH	ENSG00000131375	"Calpain 7"	Q9Y6W3	3	15206152-15252916	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004745, HPA046617"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Centrosome	"HPA004745: , HPA046617: AB_2679721"	"unprognostic (2.70e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.85e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.05e-2)"	13.9	11.9	4.6	11.6	5.9	13.2	16.6	12.5	5.4	16.9	9.3	12.1	12.9	16.1	14.9	11.4	14.4	11.1	11.6	4.1	8.1	15.2	19.1	12.1	14.3	5.9	5.7	19.8	15.3	20.1	9.2	12.9	5.5	14.1	12.2	28.5	13.9	12.7	25.3	11.6	13.6	13.8	6.0	11.4	14.0	12.1	6.8	16.9	23.5	16.5	15.7	10.2	9.8	9.7	14.3	18.5	15.1	9.5	26.0	20.1	51.4	18.1	20.8	22.1	16.7	13.3	10.0	24.6	12.3	20.7	13.6	9.7	22.5	23.3	19.0	23.7	17.5	30.8	24.8	17.7	19.3	25.1	15.0	13.9	33.2	28.7	14.1	20.9	15.9	23.3	30.3	25.1	21.6	20.8	17.9	10.5	14.5	20.7	17.7	10.2	25.1	17.1	16.4	25.8	12.2	15.8	29.5	15.7	20.8	19.2	27.9	25.8	14.4	19.8	14.9	25.9	21.4	17.2	37.1	12.4	18.1	18.0	17.5	4.6	3.0	5.1	3.3	2.5	5.3	3.5	3.6	2.8	2.9	3.1	4.9	4.6	1.8	3.6	4.4	2.4	3.0	3.0	4.6	5.9	12.5	5.4	4.1	8.1	5.9	5.7	5.5	6.0	6.8	9.7	15.8	12.8	23.6	44.1	35.0	21.4	13.5	10.6	47.3	42.7	20.3	16.0	33.2	8.6	20.6	1.8	56.3	21.2	21.7	11.2	9.8	12.6	15.5	32.2	31.5	19.0	20.9	14.9	60.2	16.9	12.6	27.6	30.1	29.9	15.8	28.9	14.6	20.8	12.2	55.5	65.8	11.3	4.1	11.9	23.0	14.8	24.8	20.9	21.4	49.6	18.4	31.2	10.3	73.9	86.0	13.0	6.9	26.4	52.8	20.0	16.7	15.2	34.9	98.1	39.5	31.5	24.8	26.8	17.8	29.7	23.2	26.1	34.2	21.1	11.8	14.3
CAPNS1	"30K, CANP, CANPS, CAPN4, CDPS"	ENSG00000126247	"Calpain small subunit 1"	P04632	19	36139953-36150353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006872	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		9000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006872: AB_1078382"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-2)"	425.4	357.9	363.0	171.4	374.4	235.7	371.7	359.4	507.1	368.1	353.9	371.4	263.2	303.5	193.8	761.7	306.6	197.8	692.5	379.8	411.1	488.5	273.5	396.7	167.4	401.0	392.3	267.6	250.9	330.9	317.9	147.3	401.0	357.0	287.6	136.2	374.9	281.4	491.3	211.9	341.4	290.0	356.5	363.6	311.1	273.6	400.3	200.8	329.9	373.4	275.1	354.8	402.5	384.1	395.2	977.6	240.0	342.7	566.3	683.0	48.2	315.8	673.4	631.3	488.1	223.3	572.2	141.9	463.7	1067.5	225.6	207.0	291.3	780.8	514.7	592.4	142.9	166.0	259.7	373.0	655.0	166.7	393.9	740.8	477.9	411.1	577.5	767.3	699.8	173.5	204.4	554.4	978.6	522.7	295.4	301.4	137.9	754.6	490.6	156.5	194.7	262.3	1208.8	368.7	159.1	199.4	385.1	532.0	155.5	279.4	308.6	261.4	460.6	555.5	424.3	188.1	318.7	198.4	277.6	126.8	630.4	225.9	480.8	24.8	50.1	22.6	44.4	75.6	28.5	29.4	30.9	36.4	46.1	32.3	18.7	25.2	25.2	24.6	83.4	58.7	34.7	21.1	363.0	374.4	359.4	507.1	379.8	411.1	401.0	392.3	401.0	356.5	400.3	384.1	172.7	125.0	98.6	10.4	49.3	30.7	76.2	69.1	29.6	21.1	91.7	75.1	149.5	130.1	85.9	163.7	0.0	74.9	107.1	250.1	62.6	226.3	102.9	168.5	118.3	136.6	107.8	47.3	13.4	251.3	87.8	83.3	66.8	234.4	63.4	84.7	157.1	78.4	155.1	16.8	11.9	220.3	52.9	244.6	86.9	230.2	93.2	130.5	39.2	15.9	208.4	78.2	109.2	6.6	21.9	254.2	187.5	76.0	50.2	98.0	243.5	135.3	74.6	33.1	46.0	64.3	92.9	120.1	6.5	109.1	28.8	70.1	62.8	132.2	165.6	112.4
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566684-55567687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 85.7;skin 1: 102.4"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 87.8;Basal squamous epithelial cells: 117.3;Squamous epithelial cells: 108.6;Suprabasal keratinocytes: 149.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.8;intermediate monocyte: 1.0"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.8;monocytes: 1.0"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 223.0"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA059749: AB_2732639, HPA076768: AB_2732322"	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.4	0.0	0.4	0.1	0.7	0.6	6.6	0.9	0.5	14.3	0.4	0.0	0.0	0.1	0.2	85.7	0.8	0.0	0.1	0.5	0.6	0.0	0.1	0.2	0.0	1.5	0.9	0.1	0.1	0.0	0.1	0.3	1.6	4.2	0.0	0.1	16.8	0.1	0.7	102.4	0.1	0.0	1.1	0.1	0.1	0.0	1.1	0.2	0.3	0.0	18.6	18.1	33.5	1.5	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	23.0	0.0	1.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.7	0.8	0.0	223.0	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	1.1	0.1	7.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	1.2	0.0	0.1	3.8	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.7	0.9	0.5	0.5	0.6	1.5	0.9	1.6	1.1	1.1	1.5	0.6	0.0	0.5	0.0	0.0	87.8	10.0	13.7	117.3	0.0	0.2	0.3	0.0	0.0	11.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.8	7.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.5	0.7	0.0	0.0	108.6	149.3	2.3	0.2	0.1	0.0	15.4
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine	Q13938	19	5912339-5916211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 334.8"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8"					"Low region specificity"	"Detected in all"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favorable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	12.2	25.9	37.5	10.9	35.1	10.0	11.6	55.0	30.1	47.2	55.4	16.1	6.9	21.7	4.6	12.9	334.8	11.2	13.5	40.2	69.6	38.3	21.5	49.5	12.2	72.6	105.3	13.8	24.0	3.3	27.9	9.3	85.7	40.4	2.8	2.2	24.9	30.9	4.3	16.2	18.7	2.3	60.9	25.2	37.5	6.4	50.0	5.7	30.8	1.1	4.2	44.2	13.7	66.1	2.2	2.3	0.9	6.3	2.1	3.2	4.0	0.7	0.7	0.3	0.6	1.5	13.8	0.9	4.0	1.5	0.7	2.3	0.1	0.6	0.0	4.7	1.9	0.8	4.8	4.7	2.5	0.8	3.5	4.1	4.2	0.4	0.8	4.0	1.0	4.7	0.7	5.4	0.7	4.4	2.4	4.0	0.7	19.4	12.6	3.1	0.3	4.7	1.8	6.2	1.0	4.9	1.0	65.1	6.6	2.0	4.3	4.7	1.5	0.6	0.4	4.6	17.1	19.8	6.5	1.1	7.7	1.8	2.8	0.4	0.7	0.3	1.7	0.6	0.9	0.9	1.0	1.3	0.8	1.8	0.8	0.7	0.7	1.8	0.4	1.5	1.0	0.8	37.5	35.1	55.0	30.1	40.2	69.6	72.6	105.3	85.7	60.9	50.0	66.1	5.3	12.8	16.5	11.1	3.3	4.8	32.1	122.8	1.8	2.5	8.9	8.8	2.2	0.0	161.5	121.4	4.2	24.3	7.4	5.3	35.2	34.7	6.5	2622.9	48.3	5.5	19.2	0.4	2.6	5.9	22.8	12.9	33.6	330.8	6.3	8.1	0.0	0.0	5.2	6.7	3.2	25.1	197.4	0.0	5.9	5.7	4.7	6.6	10.6	6.5	3.0	7.7	9.2	3.5	12.9	36.9	3.3	4.9	3.8	20.4	4.2	4.5	1557.4	4.2	6.6	3.5	42.7	0.4	0.6	0.9	4.1	20.5	9.2	3.3	9.3	128.6
CAPZA2	"CAPPA2, CAPZ"	ENSG00000198898	"Capping actin protein of muscle Z-line subunit alpha 2"	P47755	7	116811070-116922049	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007470, HPA007643"	Uncertain		Approved	Cytosol		No	No		4500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA007470: AB_1845985, HPA007643: AB_2667886"	"unprognostic (1.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.58e-2)"	26.3	20.1	17.0	20.0	17.3	43.3	21.8	22.5	25.8	18.0	16.9	24.4	20.4	19.7	19.0	20.8	14.2	20.7	45.7	21.3	17.5	37.3	33.9	23.8	20.1	17.0	17.1	12.6	13.4	19.4	7.5	24.9	20.5	20.3	23.9	13.4	14.6	20.5	64.3	12.3	23.4	28.1	14.5	22.3	20.0	8.7	19.6	16.4	22.8	53.1	17.3	28.1	11.3	18.3	30.0	19.5	19.8	25.2	35.9	37.8	9.8	28.7	41.3	28.8	32.7	14.5	38.1	20.8	46.5	41.3	36.1	18.2	20.4	24.1	45.4	22.7	14.9	31.3	18.0	24.6	22.2	21.2	40.9	30.2	26.9	22.9	21.9	34.8	63.2	12.9	20.8	35.2	57.9	13.0	28.3	35.6	29.5	31.3	16.8	19.7	26.2	42.1	69.3	24.6	20.6	23.5	27.7	104.1	29.7	25.0	14.5	25.0	23.0	47.0	14.6	37.5	28.5	27.7	21.0	39.6	28.0	29.6	34.0	57.3	34.8	45.6	11.1	45.6	13.2	14.4	13.5	11.9	33.2	12.6	12.9	13.1	69.4	15.9	54.9	18.1	18.1	45.3	17.0	17.3	22.5	25.8	21.3	17.5	17.0	17.1	20.5	14.5	19.6	18.3	177.9	73.7	67.4	44.4	109.4	243.1	219.8	224.3	94.4	106.6	85.1	67.3	219.4	71.4	146.5	171.0	27.1	151.7	96.2	147.4	516.5	193.1	9.6	139.4	113.7	189.5	121.2	263.9	59.2	160.3	204.0	124.8	103.5	340.1	126.2	48.8	262.3	110.6	314.1	107.7	48.0	102.6	286.8	238.5	274.9	16.2	74.6	262.9	181.5	64.6	222.4	164.5	72.1	49.8	47.1	193.1	147.5	110.9	83.0	140.9	182.6	519.7	99.7	95.9	92.1	122.8	188.9	43.1	47.0	94.1	218.8	144.1	108.6	78.7	109.9	207.0
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line subunit beta"	P47756	1	19338775-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1188.8;Late spermatids: 3669.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		6600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	210.2	193.0	126.1	196.7	126.9	154.3	189.1	128.8	133.4	233.9	129.0	294.5	149.1	254.5	145.8	265.1	199.9	144.2	207.5	139.9	129.8	161.3	127.7	217.9	223.8	133.7	128.6	205.1	94.2	128.6	121.5	178.7	132.5	200.9	214.2	123.8	152.5	177.9	301.8	195.1	220.6	241.4	126.3	215.9	192.6	216.2	135.8	237.1	155.2	214.2	271.8	230.3	222.2	143.8	263.9	146.4	260.0	179.3	355.6	467.0	187.9	435.9	430.0	364.0	377.5	189.6	338.1	179.7	186.4	533.5	218.7	212.0	224.0	297.9	424.3	280.0	160.5	340.1	170.6	298.3	355.0	236.5	533.6	424.0	243.4	314.9	292.6	300.5	338.6	204.5	132.1	229.7	393.9	185.1	270.5	307.0	200.5	343.8	155.3	223.4	184.6	225.2	507.6	133.0	158.0	123.4	255.2	200.6	299.3	229.5	222.2	199.6	351.5	237.9	207.0	409.4	208.7	156.0	188.8	217.4	314.1	306.8	261.5	456.1	358.2	1077.5	304.0	542.3	265.0	266.1	318.5	329.4	362.3	203.7	263.5	293.7	576.3	196.7	703.0	199.1	404.2	597.6	126.1	126.9	128.8	133.4	139.9	129.8	133.7	128.6	132.5	126.3	135.8	143.8	197.7	99.3	68.9	52.9	160.3	156.3	282.8	263.0	103.6	93.9	106.9	117.7	87.6	112.9	143.5	101.2	41.7	338.0	247.5	301.7	297.4	322.1	1188.8	86.7	122.2	182.4	141.2	89.4	49.8	256.5	396.4	178.9	101.9	96.8	147.5	164.6	156.0	98.7	800.9	77.4	67.5	278.7	215.7	302.6	276.7	3669.8	232.7	311.2	144.1	124.6	561.5	151.1	338.8	42.7	64.9	349.6	295.2	302.4	103.4	206.8	235.6	251.2	122.6	93.2	243.3	97.8	262.6	119.0	81.5	150.3	182.7	342.2	268.2	197.9	193.8	280.5
CARD10	"BIMP1, CARMA3"	ENSG00000100065	"Caspase recruitment domain family member 10"	Q9BWT7	22	37490362-37519542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.5;Ductal cells: 25.4;Endothelial cells: 24.8;Pancreatic endocrine cells: 39.4;Paneth cells: 27.6;Proximal enterocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.5;U-2197: 82.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029359, HPA055612"	Approved		Approved	"Vesicles,Intermediate filaments,Cytosol"		No	No				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Intermediate filaments"	Cytosol	"HPA029359: AB_10601354, HPA055612: AB_2682861"	"unprognostic (9.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (7.73e-6)"	"unprognostic (3.66e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.31e-2)"	"unprognostic (9.69e-2)"	10.0	8.4	3.7	5.0	3.3	0.1	10.5	2.9	4.0	6.5	2.8	13.3	34.1	6.0	1.3	8.4	7.5	7.8	10.7	3.1	3.0	14.9	12.4	6.1	2.1	4.7	3.3	3.1	9.2	2.7	2.1	4.7	5.0	5.4	8.8	0.3	19.0	4.2	8.0	9.7	35.9	4.2	3.3	4.1	9.9	15.0	4.2	0.8	6.8	8.2	1.0	6.1	5.8	2.9	31.3	23.1	4.1	3.0	0.1	8.7	19.6	2.8	6.5	12.8	10.0	14.2	21.8	0.0	10.8	5.4	12.4	43.0	4.9	56.5	3.9	0.1	11.8	0.7	15.6	22.1	5.4	0.5	1.9	2.9	11.5	24.5	31.2	10.2	26.1	0.0	3.3	0.0	9.9	11.0	0.1	2.0	7.2	17.0	13.2	0.0	38.9	3.0	19.1	5.4	1.5	2.4	21.0	9.5	2.1	5.0	10.1	1.7	35.0	9.5	26.9	82.8	16.4	0.1	0.0	0.0	30.2	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.3	2.9	4.0	3.1	3.0	4.7	3.3	5.0	3.3	4.2	2.9	22.6	0.0	2.0	0.0	0.2	8.5	6.8	3.4	2.2	1.2	3.9	4.3	3.7	10.0	1.6	3.7	0.0	0.4	0.2	35.5	1.9	25.4	7.8	3.3	0.4	24.8	7.7	0.0	0.1	19.6	1.6	1.9	15.8	6.2	0.0	0.4	17.9	4.8	0.1	0.0	0.6	19.8	4.1	0.0	1.2	8.6	0.0	0.4	5.4	3.7	0.0	0.0	0.0	0.0	0.1	39.4	27.6	0.7	0.2	8.6	35.5	12.4	1.2	0.2	0.0	6.2	1.1	0.4	3.4	2.5	3.8	0.0	0.6	1.0	11.3	9.7
CARF	"ALS2CR8, FLJ21579, NYD-SP24"	ENSG00000138380	"Calcium responsive transcription factor"	Q8N187	2	202912214-202988263	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 66.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034557, HPA043191"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA034557: AB_10601663, HPA043191: AB_2732503"	"unprognostic (4.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.58e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	4.5	5.3	4.2	5.7	8.6	5.4	7.7	6.4	5.1	5.9	2.5	5.2	4.5	9.4	9.9	5.5	6.8	6.0	4.9	4.4	5.0	6.8	4.5	5.1	8.8	5.9	6.0	7.9	3.9	7.8	5.1	4.7	6.5	6.7	6.0	16.1	4.6	6.4	4.5	7.4	4.9	6.6	4.6	7.5	6.0	21.5	5.5	9.4	10.6	5.4	7.8	5.7	5.0	12.3	2.5	2.4	6.1	5.4	4.5	9.5	4.7	3.7	4.7	3.8	3.4	2.8	6.2	3.8	1.6	4.3	4.6	4.5	3.2	2.7	4.3	3.0	1.7	5.9	3.0	1.7	3.8	3.5	2.9	7.8	5.2	3.3	8.6	9.6	2.3	13.9	2.5	15.5	5.9	4.9	7.2	5.6	2.6	1.6	3.5	5.1	4.2	3.1	6.9	2.6	4.3	4.6	4.0	2.2	1.7	7.7	3.6	6.5	2.7	7.1	1.8	4.6	2.4	13.7	8.4	4.2	6.1	4.1	4.4	1.4	1.0	0.8	2.2	1.9	2.4	2.0	2.2	2.1	1.2	2.4	3.1	2.2	0.4	8.8	1.1	1.9	4.7	0.6	4.2	8.6	6.4	5.1	4.4	5.0	5.9	6.0	6.5	4.6	5.5	12.3	5.6	9.6	15.7	28.7	14.6	3.2	3.9	5.5	5.2	33.5	6.7	5.5	6.6	7.2	14.1	14.7	18.8	4.2	9.2	2.7	11.7	4.4	19.0	7.1	5.0	5.6	1.8	7.6	21.5	2.4	9.3	7.4	5.6	2.9	20.3	19.6	8.2	3.2	3.9	26.9	25.0	4.7	6.1	8.2	3.7	16.7	10.8	4.9	1.8	16.9	5.9	9.6	18.6	39.2	66.1	2.9	3.2	9.4	4.0	2.0	9.5	5.8	17.7	31.1	6.6	7.1	5.6	37.2	8.6	4.4	2.7	1.8	10.2	10.5	6.2	2.7
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 135.8;Oligodendrocyte precursor cells: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 47.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 47.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	10.2	11.1	13.6	11.9	12.9	7.3	15.7	12.3	11.1	11.6	12.4	25.3	32.1	11.1	9.4	13.7	10.5	18.5	6.8	14.2	17.1	16.4	13.4	12.2	12.5	13.2	19.4	13.5	12.8	11.8	6.3	16.3	15.7	10.6	27.3	19.8	13.2	8.3	5.0	9.3	31.9	12.0	15.4	12.4	19.8	3.6	25.2	15.4	10.6	6.1	10.4	15.3	8.8	18.0	27.4	32.5	31.4	19.1	21.6	18.6	10.9	23.2	18.7	13.2	12.3	72.3	42.6	0.4	12.0	29.3	23.8	52.3	35.2	23.2	22.8	25.4	20.9	0.6	27.7	26.2	22.1	4.4	3.6	19.8	63.2	25.1	30.1	27.5	11.6	15.3	2.2	21.3	30.2	30.9	8.4	2.2	29.7	37.6	22.6	12.7	79.8	13.2	31.2	54.8	29.7	15.6	43.7	17.7	13.9	52.7	19.0	0.8	14.2	24.4	25.8	22.1	13.3	7.6	5.2	9.5	24.4	3.1	16.9	47.1	1.5	8.7	0.8	1.1	0.8	0.7	0.9	1.3	0.4	0.9	1.2	1.1	1.7	4.3	0.7	0.5	4.5	0.6	13.6	12.9	12.3	11.1	14.2	17.1	13.2	19.4	15.7	15.4	25.2	18.0	13.0	12.8	20.4	101.9	8.8	32.6	42.7	11.1	8.0	42.2	23.7	16.5	7.8	8.6	14.6	7.3	22.9	2.0	12.1	25.8	50.9	13.7	0.9	9.6	24.1	16.0	13.8	0.8	96.6	14.5	0.7	18.8	18.8	11.9	0.0	17.4	8.9	15.0	21.3	50.5	135.8	28.7	14.2	2.8	21.5	1.0	9.9	10.7	10.6	60.0	2.5	9.3	0.0	447.8	59.7	22.1	24.1	9.4	7.0	16.4	35.2	20.9	15.7	25.7	19.7	38.2	20.6	2.9	2.1	13.9	32.5	1.6	26.5	47.7	41.8	33.2
CASKIN1	"ANKS5A, KIAA1306"	ENSG00000167971	"CASK interacting protein 1"	Q8WXD9	16	2177180-2196605	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 45.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Bipolar cells: 22.9;Excitatory neurons: 20.8;Horizontal cells: 42.1;Inhibitory neurons: 26.4;Muller glia cells: 20.2;Oligodendrocyte precursor cells: 28.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.8;HDLM-2: 14.7;HEK 293: 3.2;SCLC-21H: 6.4;SH-SY5Y: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055990, HPA076882, CAB079050"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"CAB079050: , HPA055990: AB_2682997, HPA076882: "	"unprognostic (4.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.21e-4)"	"unprognostic (2.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.39e-1)"	0.1	0.2	15.1	0.0	16.6	0.0	0.4	0.4	45.8	0.6	0.0	0.4	0.0	0.4	0.0	0.1	0.3	0.0	3.0	22.5	6.4	0.2	0.0	0.0	0.0	23.9	8.0	0.5	0.5	0.9	3.9	0.0	14.9	0.5	0.0	2.1	0.6	0.1	0.1	1.0	0.1	0.0	0.2	0.0	0.1	1.2	19.3	0.0	0.7	0.0	0.0	0.0	0.3	11.0	0.0	0.4	1.6	3.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.3	0.0	14.7	3.2	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.9	0.1	0.0	1.1	0.0	0.8	0.6	0.0	0.0	0.8	0.0	0.3	0.1	0.0	6.4	3.1	0.1	0.2	0.2	0.1	0.8	0.4	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	16.6	0.4	45.8	22.5	6.4	23.9	8.0	14.9	0.2	19.3	11.0	0.0	0.0	0.0	39.5	0.1	0.4	0.2	0.6	1.2	22.9	1.2	1.3	3.5	0.0	0.1	0.0	8.4	0.0	0.2	0.4	0.0	0.1	0.0	0.6	1.1	0.3	0.0	0.0	20.8	0.2	0.2	0.3	0.0	0.9	0.0	0.4	0.0	0.0	0.1	42.1	26.4	0.1	0.0	0.0	0.3	0.1	0.3	0.1	0.0	4.7	0.0	20.2	0.0	28.6	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	6.4	0.0	0.1	0.1	0.4	1.6	0.4	0.4	0.1	0.1	0.1	0.0	0.1
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969366	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	45.7	21.7	7.0	69.4	7.2	48.5	44.4	7.4	12.4	26.4	8.6	27.6	62.4	18.4	33.1	47.7	34.9	50.1	17.8	7.5	8.0	33.3	54.1	61.3	80.2	9.7	8.1	43.2	52.5	4.7	11.0	70.2	8.7	21.7	30.7	2.0	55.2	15.5	7.5	46.7	58.8	32.2	8.3	71.1	42.4	4.9	9.0	57.2	15.6	18.1	82.1	76.5	30.5	8.7	33.8	9.5	0.0	12.9	58.2	140.4	27.8	68.0	103.2	80.5	117.0	22.4	128.5	22.3	123.1	71.5	110.4	52.7	0.0	94.3	78.8	22.4	0.4	53.1	7.4	55.8	158.2	48.5	19.2	122.6	127.0	97.9	144.4	104.7	143.8	0.5	1.3	0.0	64.4	2.8	26.1	46.7	0.0	71.6	28.2	21.4	21.5	14.2	64.9	46.2	0.6	0.4	60.8	31.6	49.3	0.7	11.9	62.5	93.2	84.4	30.4	80.8	40.5	0.0	0.0	0.3	42.2	105.5	63.4	136.4	292.0	50.6	208.9	312.9	224.8	141.9	155.6	193.9	205.5	144.4	93.4	138.5	667.2	226.2	255.4	35.4	257.9	410.9	7.0	7.2	7.4	12.4	7.5	8.0	9.7	8.1	8.7	8.3	9.0	8.7	78.1	60.9	60.8	0.3	87.4	55.8	63.3	130.1	21.1	0.0	40.8	48.4	5.6	47.1	107.0	22.0	0.0	129.1	80.4	12.4	15.6	157.5	0.6	35.9	27.7	73.0	20.9	12.4	0.0	189.9	103.0	53.6	33.1	45.7	34.8	32.6	82.1	34.7	116.7	0.0	0.2	37.8	73.2	168.0	81.2	2.1	29.2	105.2	30.2	23.4	141.5	1.9	177.1	1.5	0.2	148.5	8.6	20.7	50.5	31.1	85.4	41.1	86.1	0.4	6.6	38.1	34.2	0.2	0.5	25.8	45.9	115.9	102.1	36.8	32.9	80.0
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 49.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 608.8;Horizontal cells: 138.0;Rod photoreceptor cells: 477.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 12.4;HDLM-2: 13.4;SCLC-21H: 19.8;SK-BR-3: 18.9"					"Low region specificity"	"Detected in some"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	2.1	2.0	0.6	2.2	0.8	4.6	7.0	0.1	1.1	5.9	2.4	20.6	12.0	7.8	0.8	15.3	5.6	2.7	20.1	0.2	1.2	7.4	2.7	11.3	1.3	1.0	0.7	0.9	6.0	0.2	2.1	1.7	0.8	18.2	3.3	35.1	19.9	5.8	34.4	49.0	11.6	3.3	2.3	2.2	17.3	1.7	0.9	1.3	3.4	5.8	1.9	10.7	11.6	0.1	12.4	1.0	2.2	2.2	0.0	0.0	0.5	0.4	0.1	0.4	0.4	2.6	2.8	0.5	2.5	0.5	1.0	10.5	2.3	2.4	0.2	13.4	4.1	0.8	2.0	2.8	0.3	1.4	3.8	0.1	8.7	0.1	0.8	0.0	0.4	1.9	0.0	0.0	0.1	6.6	0.7	8.9	0.2	6.4	0.6	1.0	1.5	0.1	2.0	5.0	19.8	1.8	3.2	18.9	0.3	0.8	10.1	1.3	0.1	0.0	1.6	1.0	0.2	0.0	0.0	1.3	0.1	3.8	0.2	0.6	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.4	0.6	0.8	0.0	0.1	0.6	0.8	0.1	1.1	0.2	1.2	1.0	0.7	0.8	2.3	0.9	0.1	12.9	28.9	21.7	1.6	6.1	33.0	20.1	21.2	30.7	12.7	57.9	30.4	25.2	17.2	17.8	14.7	608.8	0.7	15.3	60.4	3.9	14.1	0.6	41.8	5.6	14.4	41.3	1.3	1.6	8.9	1.2	2.3	57.6	66.7	4.5	4.5	5.0	5.1	1.1	138.0	0.9	39.1	16.2	0.3	5.1	1.6	0.0	1.8	1.8	1.9	6.7	28.4	9.2	0.5	0.3	18.1	40.8	6.8	6.1	33.4	46.3	1.1	41.2	477.7	0.0	6.8	5.1	2.5	3.5	31.0	61.2	0.7	7.6	1.5	27.1	27.6
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 31.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Gastric mucus-secreting cells: 27.0;Late spermatids: 49.2;Proximal enterocytes: 20.7;Spermatocytes: 28.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;HMC-1: 1.8;MCF7: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.2	0.1	0.5	0.1	0.8	0.3	0.4	0.8	0.9	0.4	0.2	0.2	0.4	0.2	0.7	0.2	0.5	0.1	0.1	0.4	0.5	0.2	0.2	0.3	0.3	0.7	2.8	0.4	0.2	0.2	0.2	0.1	0.7	0.4	0.2	0.2	0.3	0.2	0.2	1.0	0.3	0.1	0.4	0.2	0.2	31.3	0.8	0.2	0.5	0.0	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.6	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.7	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.7	0.1	0.1	0.0	0.5	0.8	0.8	0.9	0.4	0.5	0.7	2.8	0.7	0.4	0.8	1.1	4.9	0.0	2.7	2.6	3.6	2.5	2.4	1.0	4.6	1.3	4.8	8.0	3.0	1.5	0.6	1.8	0.0	1.7	5.1	10.1	0.0	1.0	29.4	4.9	4.4	2.7	1.8	3.2	4.3	0.7	0.3	3.0	27.0	8.8	1.3	2.0	2.5	0.3	3.2	1.7	3.8	3.9	2.0	1.2	3.1	49.2	1.8	3.3	0.0	1.9	3.9	1.9	10.3	3.0	17.0	0.4	5.6	2.2	2.2	1.9	20.7	0.9	1.3	1.4	0.0	5.3	3.7	28.9	3.7	4.9	1.8	1.4	3.4	1.9	3.5	1.8
CBFB	PEBP2B	ENSG00000067955	"Core-binding factor subunit beta"	Q13951	16	67028984-67101058	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 243.7;U-698: 336.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038852	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA038852: AB_10795358"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (2.89e-8)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	18.2	11.7	5.7	17.3	12.0	11.8	16.5	9.3	7.3	19.2	6.0	11.4	5.5	15.4	2.7	23.3	16.6	5.2	18.0	7.1	8.1	16.4	14.2	18.1	16.3	13.9	9.3	17.3	14.7	9.8	15.0	7.3	11.5	14.5	3.5	3.8	21.3	4.8	38.6	17.4	14.5	4.9	8.6	18.0	15.1	6.9	9.5	13.4	15.9	10.5	12.1	15.2	20.3	17.2	54.8	43.7	14.8	40.6	8.7	12.2	54.0	76.1	23.6	43.6	30.0	79.1	51.0	106.3	81.2	39.7	16.3	53.7	30.7	22.6	29.2	63.3	48.3	67.2	27.3	38.0	17.8	77.7	171.3	18.2	11.1	51.3	30.4	10.2	25.4	42.2	104.9	28.9	20.8	44.5	115.8	28.9	25.5	16.4	74.1	243.7	92.7	73.4	15.5	43.2	37.9	31.5	166.2	11.0	37.6	10.4	15.4	28.6	87.1	70.8	70.2	34.6	79.6	76.8	147.8	336.8	50.2	50.7	65.0	29.2	7.6	6.3	6.0	9.5	6.5	6.2	5.5	6.4	10.2	7.2	5.0	3.9	4.1	18.2	5.6	2.3	6.0	5.6	5.7	12.0	9.3	7.3	7.1	8.1	13.9	9.3	11.5	8.6	9.5	17.2	20.1	9.6	20.2	37.2	38.2	56.2	42.2	18.0	27.9	5.8	27.8	14.7	19.8	21.5	18.8	40.5	12.5	15.8	30.0	11.9	27.4	17.6	6.1	23.8	16.0	26.1	19.0	18.5	11.5	28.0	32.1	28.7	16.8	29.8	27.8	34.2	28.5	15.8	37.9	10.1	16.5	12.8	22.4	41.9	66.8	7.6	23.9	39.1	51.6	53.4	25.0	13.2	44.3	97.5	99.8	74.1	6.8	21.1	38.3	50.5	6.9	11.6	20.8	15.3	13.1	21.6	21.0	17.4	19.1	32.2	63.1	17.0	48.6	11.2	11.8	62.0
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206298-119313926	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Approved	Cytosol		NA	NA		67000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	6.8	4.0	5.6	9.5	5.7	8.5	5.6	5.3	6.5	5.0	0.2	6.2	3.9	6.5	3.4	5.6	5.6	3.9	4.1	5.3	8.1	4.4	2.7	7.9	10.7	5.8	6.3	3.7	3.8	6.1	2.9	6.4	6.5	4.0	5.0	8.3	3.6	4.6	2.5	5.2	6.6	7.4	5.2	9.9	5.2	18.2	7.9	22.5	4.1	3.2	11.2	5.8	4.9	6.0	10.7	7.6	26.6	16.7	7.8	9.2	16.0	11.2	11.4	10.8	10.2	16.7	12.6	25.1	10.0	14.0	21.7	15.2	18.4	9.4	22.7	14.8	4.7	26.4	6.2	5.1	9.5	30.3	27.9	8.1	10.1	26.7	28.4	11.1	26.3	23.7	21.7	9.9	19.1	11.3	16.2	17.0	14.0	9.2	8.8	17.5	13.5	4.6	9.3	8.2	3.7	11.3	20.9	8.8	7.3	18.1	9.4	24.8	22.8	16.0	11.5	11.6	14.7	3.3	5.3	19.9	6.7	25.4	11.9	0.8	2.4	2.0	0.9	2.8	0.8	1.5	1.1	0.9	2.6	1.2	1.2	1.3	8.6	0.4	2.5	1.4	1.0	0.9	5.6	5.7	5.3	6.5	5.3	8.1	5.8	6.3	6.5	5.2	7.9	6.0	23.2	9.6	8.3	23.5	23.2	18.0	5.9	7.5	19.4	14.0	13.6	11.7	8.8	5.7	6.0	11.0	45.9	6.3	24.0	7.6	1.9	6.1	28.2	9.9	19.6	23.2	8.4	5.7	38.5	6.7	10.5	9.4	9.2	16.8	3.8	20.8	20.0	3.1	16.0	13.5	39.1	4.9	2.0	59.1	43.2	42.0	7.8	41.2	16.0	45.0	46.8	13.2	22.6	26.2	19.6	10.6	11.6	12.8	19.7	8.0	5.1	5.4	4.8	33.3	26.3	11.6	22.7	38.0	36.2	18.5	21.9	7.0	24.9	10.6	5.1	10.9
CCDC102B	"ACY1L, AN, C18orf14, FLJ23594, HsT1731"	ENSG00000150636	"Coiled-coil domain containing 102B"	Q68D86	18	68715209-69055189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 28.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 72.8;Early spermatids: 138.2;Excitatory neurons: 80.8;Late spermatids: 83.3;Oligodendrocytes: 90.1;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 9.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.2;BJ hTERT+: 29.0;fHDF/TERT166: 26.2;HSkMC: 15.4;Karpas-707: 10.2"									"HPA040623, HPA048194"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Cytosol	"HPA040623: AB_10805715, HPA048194: AB_2680309"	"unprognostic (3.92e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.50e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.50e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (2.90e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.13e-3)"	7.1	2.9	1.5	3.7	1.8	0.7	2.7	0.6	3.5	2.8	0.0	3.8	1.5	1.7	1.1	3.4	1.8	13.6	3.2	1.3	2.0	4.3	1.7	14.3	8.6	2.6	1.6	0.9	1.5	2.6	0.9	28.4	3.1	1.2	4.5	2.2	1.3	1.3	0.6	1.0	2.6	3.7	2.0	2.2	3.6	2.0	2.3	1.5	5.2	1.1	2.0	10.6	1.5	3.6	0.0	0.0	4.0	0.3	3.6	14.2	0.2	0.8	29.0	0.3	0.5	0.1	0.4	0.1	0.6	26.2	0.5	0.4	0.1	0.2	0.4	1.2	0.4	0.8	0.0	1.3	7.0	0.1	0.4	15.4	0.6	0.4	3.5	0.6	0.2	2.0	0.0	10.2	2.4	0.0	0.6	0.3	0.8	0.2	0.5	1.3	0.2	0.5	0.1	0.0	1.7	1.5	0.1	0.0	0.1	1.6	0.3	1.3	4.0	0.6	0.2	0.2	0.3	4.4	0.3	0.8	2.1	1.7	2.5	0.0	0.1	0.3	1.0	0.2	0.9	0.5	0.6	0.8	0.2	0.6	1.8	1.1	0.0	1.0	0.2	9.1	0.3	0.3	1.5	1.8	0.6	3.5	1.3	2.0	2.6	1.6	3.1	2.0	2.3	3.6	11.5	0.0	2.2	72.8	4.4	0.6	0.8	0.8	0.6	6.4	2.7	2.9	10.0	0.0	2.1	3.7	6.2	0.8	12.4	0.4	5.9	0.7	138.2	2.9	6.7	6.8	0.0	3.0	80.8	1.8	0.6	15.3	0.0	1.1	2.5	5.7	8.6	0.8	3.2	6.7	33.6	0.2	0.0	1.9	1.8	83.3	32.3	3.3	0.0	44.0	2.1	11.9	7.2	36.2	90.1	0.2	2.6	9.1	2.2	0.4	0.3	5.3	1.5	13.4	78.9	3.8	37.3	1.9	5.7	0.7	0.6	0.3	3.8	3.7	0.4	0.6
CCDC103	"CILD17, FLJ13094, FLJ34211, PR46b"	ENSG00000167131	"Coiled-coil domain containing 103"	Q8IW40	17	44899142-44905390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 15.1;testis: 27.2"	"Cell type enriched"	"Detected in some"	5	"Respiratory ciliated cells: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 14.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA043131			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA043131: AB_10796686"	"unprognostic (9.40e-3)"	"unprognostic (1.75e-1)"			"unprognostic (5.60e-2)"	"unprognostic (1.99e-2)"		"unprognostic (4.50e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-2)"		"unprognostic (4.69e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.60e-1)"	0.3	1.2	1.3	0.5	1.6	0.4	0.5	1.1	1.4	1.1	2.6	0.6	0.3	1.2	1.5	0.2	15.1	0.8	0.2	1.3	1.6	1.7	0.4	1.5	0.1	2.7	3.9	0.8	0.5	1.4	0.9	0.3	2.0	0.4	0.3	1.9	0.3	1.1	0.3	0.3	0.2	0.9	2.0	0.2	0.5	27.2	1.8	0.4	1.8	0.0	0.2	0.3	0.3	1.3	2.5	14.4	1.4	2.4	2.3	1.6	1.3	1.0	2.5	1.3	0.8	2.9	3.3	0.3	2.0	0.7	5.7	3.5	0.5	1.7	0.6	6.9	4.9	0.8	3.3	0.1	1.2	1.7	0.4	1.1	3.2	1.6	0.6	2.4	1.1	1.1	1.9	0.2	0.3	2.0	0.3	0.6	0.5	1.8	2.3	0.5	0.7	0.7	6.6	1.3	4.1	1.0	0.6	0.3	1.8	1.3	3.7	1.4	1.6	0.8	2.8	0.8	2.0	0.6	0.7	0.7	7.0	0.8	0.7	0.4	1.6	1.3	0.2	0.9	0.1	0.1	0.0	0.3	1.1	0.3	0.1	0.1	0.2	0.4	0.8	0.4	0.0	1.0	1.3	1.6	1.1	1.4	1.3	1.6	2.7	3.9	2.0	2.0	1.8	1.3	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	7.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267190-115296693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045120, HPA050621"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: AB_2679222, HPA050621: AB_2681191"	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	4.3	3.6	5.7	5.3	6.3	7.3	6.0	7.4	7.3	4.5	2.6	9.1	7.2	5.6	6.2	4.5	4.1	3.1	6.0	5.8	6.6	2.8	1.2	5.5	4.6	6.4	5.5	2.1	10.2	4.5	4.6	2.4	6.3	6.7	9.3	7.9	6.5	5.0	4.3	4.9	6.3	5.4	5.7	4.6	6.4	40.7	5.9	3.7	4.0	2.5	4.2	3.8	3.6	7.8	12.0	5.9	11.5	18.5	7.1	14.0	2.9	10.5	5.3	7.7	8.7	2.6	6.7	14.8	8.9	7.2	11.4	7.5	12.1	6.0	16.0	12.0	10.1	9.8	8.8	3.8	9.7	12.9	4.8	6.4	7.2	9.8	13.0	8.8	12.1	13.1	4.1	11.6	10.8	9.3	19.2	11.4	13.1	11.0	11.0	20.6	14.5	113.7	7.7	4.2	17.9	23.5	11.5	7.2	32.8	7.8	12.2	18.9	12.6	10.1	6.9	19.7	14.8	13.2	13.2	3.0	6.7	9.9	6.0	0.3	5.0	11.0	2.9	4.0	3.3	2.8	2.2	2.5	5.4	4.0	2.8	1.9	3.2	3.0	4.9	10.2	0.1	2.1	5.7	6.3	7.4	7.3	5.8	6.6	6.4	5.5	6.3	5.7	5.9	7.8	15.7	16.0	14.0	16.0	19.2	14.1	5.0	6.0	8.0	29.2	19.4	18.4	17.6	8.6	8.4	5.5	10.4	0.7	19.5	23.6	5.9	28.2	8.5	23.0	21.4	12.4	40.6	20.8	26.4	25.9	2.0	11.5	14.3	12.3	9.5	15.0	7.9	3.1	32.7	10.1	15.2	33.4	6.1	28.6	31.5	18.5	4.1	31.5	14.2	15.0	36.6	11.0	11.3	21.1	54.7	27.1	18.7	4.1	27.3	8.0	11.8	4.4	11.7	24.9	13.1	18.5	18.2	201.8	73.3	13.8	22.6	0.5	9.2	5.5	32.8	3.4
CCDC117	FLJ33814	ENSG00000159873	"Coiled-coil domain containing 117"	Q8IWD4	22	28772674-28789301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 104.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000826	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Microtubules, Cytosol"	"HPA000826: AB_1078417"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.61e-3)"	"unprognostic (9.07e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-3)"	"unprognostic (8.25e-2)"	9.5	10.2	11.8	12.7	12.7	21.8	11.9	15.7	22.8	14.2	13.4	11.2	11.8	11.5	8.0	8.2	9.1	9.5	7.9	11.6	12.5	9.8	24.2	9.4	18.2	11.6	11.8	12.5	9.4	12.6	6.7	19.1	11.5	9.8	11.2	10.6	18.3	9.3	16.9	8.2	9.4	9.7	11.8	12.6	10.0	36.6	13.1	17.9	10.9	20.7	20.3	10.6	7.5	17.6	19.9	16.0	32.2	31.7	20.6	18.0	25.5	19.7	23.9	33.4	29.2	24.6	9.4	61.7	8.6	18.0	14.2	20.2	47.8	7.8	31.6	33.6	31.4	25.2	17.3	36.6	14.1	40.6	30.9	12.2	16.8	19.3	11.9	14.9	23.5	20.0	36.0	26.6	15.2	25.6	24.1	32.8	26.4	35.3	7.7	48.1	50.8	27.0	14.9	7.6	12.3	16.4	30.4	28.0	12.7	38.0	34.9	17.4	13.7	41.7	28.3	13.3	15.3	61.7	68.9	51.2	14.6	21.9	18.1	13.5	14.6	15.3	10.0	13.2	10.2	10.0	8.3	9.8	14.6	12.4	14.5	11.8	6.7	25.3	12.9	12.7	11.6	14.9	11.8	12.7	15.7	22.8	11.6	12.5	11.6	11.8	11.5	11.8	13.1	17.6	11.1	22.4	14.3	4.2	18.3	10.6	14.4	4.3	6.2	7.7	21.9	14.2	10.4	15.7	8.5	14.7	14.6	16.5	20.4	13.2	7.9	9.9	104.0	20.7	32.5	15.5	20.4	17.4	6.6	10.0	17.8	14.3	6.6	31.0	17.2	11.9	10.8	42.3	9.3	3.3	7.1	12.3	4.1	18.9	19.0	38.2	12.8	15.4	17.8	7.5	14.7	6.2	21.6	4.5	12.8	9.7	8.9	7.9	26.4	22.6	9.0	12.5	13.8	15.2	0.0	9.6	16.1	49.5	48.5	9.5	10.9	24.6	14.7	9.0	12.4	22.3
CCDC121	"FLJ13646, FLJ43364"	ENSG00000176714	"Coiled-coil domain containing 121"	Q6ZUS5	2	27625638-27629012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 10.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051791	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Actin filaments, Cytosol"		"HPA051791: AB_2681611"	"unprognostic (1.52e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-3)"	"prognostic favorable (4.12e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.65e-4)"	"unprognostic (7.78e-2)"	"prognostic favorable (1.87e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.86e-2)"	"unprognostic (5.42e-2)"	4.0	3.1	5.1	1.8	5.7	1.3	5.2	6.1	6.3	3.9	5.0	3.0	2.4	4.8	4.4	2.8	7.1	2.6	6.0	4.8	5.6	5.3	2.9	4.0	2.3	8.6	7.2	9.9	2.4	7.7	2.5	3.4	6.0	4.3	3.0	7.2	5.3	5.7	3.6	3.0	2.2	3.4	5.4	4.1	3.4	25.3	8.6	2.4	7.1	5.6	2.2	2.3	1.8	7.8	3.3	3.8	5.1	5.7	9.1	4.0	6.4	1.7	0.8	1.7	0.8	2.9	3.0	1.7	2.6	1.1	4.9	3.1	3.8	1.4	1.8	2.4	4.1	1.0	2.1	3.8	1.7	1.5	2.9	1.3	4.5	0.9	2.4	2.8	3.4	0.8	4.6	2.3	2.4	2.8	1.2	1.6	5.3	4.2	1.9	5.7	12.4	3.0	3.5	2.6	6.6	7.6	1.4	6.3	2.2	4.1	5.2	3.6	1.8	1.5	5.5	1.3	4.7	1.4	1.5	2.5	3.6	2.1	1.8	1.8	1.9	10.8	0.4	2.9	1.3	2.3	1.4	0.5	1.4	1.9	2.3	1.6	4.2	2.3	3.4	0.4	0.3	1.0	5.1	5.7	6.1	6.3	4.8	5.6	8.6	7.2	6.0	5.4	8.6	7.8	7.3	6.4	2.6	1.6	2.9	0.6	1.7	0.8	0.6	5.1	2.4	3.2	3.2	4.3	1.9	0.0	20.9	3.1	1.3	1.9	7.9	3.6	186.5	17.1	5.2	5.8	1.2	1.7	0.7	1.1	2.0	4.2	2.6	7.6	0.0	2.8	5.3	2.0	1.9	3.3	1.1	1.3	2.0	1.6	2.1	44.7	8.7	2.2	1.8	0.0	0.8	12.7	0.0	1.5	2.9	2.0	0.8	6.8	0.3	1.2	1.4	3.9	21.2	12.4	13.1	5.6	3.2	31.0	10.0	1.4	1.1	1.8	1.7	4.9	2.1	0.8
CCDC138	FLJ32745	ENSG00000163006	"Coiled-coil domain containing 138"	Q96M89	2	108786757-108885477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 154.1;Excitatory neurons: 56.5;Inhibitory neurons: 58.9;Oligodendrocytes: 48.7;Respiratory ciliated cells: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049899, HPA054223"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA049899: AB_2680941, HPA054223: AB_2682420"	"unprognostic (2.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.24e-5)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.77e-2)"	"unprognostic (7.06e-4)"	"unprognostic (7.88e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.93e-2)"	1.0	0.9	2.0	2.0	1.8	3.5	2.4	4.8	3.1	1.3	2.1	1.9	1.0	2.1	1.3	2.1	4.3	1.8	0.7	2.4	2.3	1.7	2.8	1.3	4.5	2.6	2.4	1.6	1.7	0.7	0.8	1.3	2.4	1.4	2.3	2.3	1.3	0.7	1.0	2.4	1.7	1.5	2.0	1.2	1.8	10.9	2.0	6.4	0.8	0.7	3.8	1.6	1.3	3.0	14.7	6.7	22.4	11.6	1.8	2.0	14.2	6.3	2.0	14.6	10.6	21.8	8.4	35.2	9.2	2.0	7.3	12.2	16.3	8.5	13.0	8.2	21.0	16.3	11.6	18.2	2.2	22.4	2.3	1.4	2.5	17.2	5.1	2.2	7.7	15.0	31.4	15.8	7.5	8.2	32.2	15.3	33.3	8.0	6.9	21.1	21.2	21.3	8.1	11.5	15.7	15.3	13.6	7.3	11.1	13.6	7.8	10.7	4.9	9.2	16.2	6.0	13.5	4.9	12.2	36.4	3.8	17.2	9.3	2.6	0.5	0.8	1.1	1.2	2.2	3.0	1.5	2.3	0.5	3.2	2.2	2.6	0.3	2.0	0.4	4.8	2.4	1.2	2.0	1.8	4.8	3.1	2.4	2.3	2.6	2.4	2.4	2.0	2.0	3.0	2.4	0.0	3.3	14.7	7.9	2.4	3.5	4.5	6.8	7.3	3.6	3.9	1.4	2.8	9.6	1.8	8.4	5.2	13.6	0.9	1.9	3.7	154.1	38.9	7.0	2.7	5.4	5.9	56.5	1.4	5.5	6.3	8.6	7.3	4.5	6.7	1.1	2.4	2.2	6.7	58.9	2.5	2.0	1.6	1.5	34.0	3.7	3.9	1.8	10.3	1.3	1.8	6.2	19.1	48.7	3.3	0.5	1.9	14.4	1.1	0.7	1.7	43.8	7.0	0.0	5.0	3.5	29.5	20.1	7.0	2.8	1.4	5.9	5.5	2.9	2.3
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 42.8;Erythroid cells: 26.3;Late spermatids: 25.8;Spermatocytes: 99.7;Spermatogonia: 34.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	0.7	0.3	0.5	0.9	0.8	2.1	2.8	0.5	0.6	0.6	0.3	0.8	0.7	0.6	1.5	0.8	1.1	0.5	0.2	0.6	0.5	0.6	1.3	0.7	1.2	0.9	0.6	0.8	0.8	0.6	0.5	0.7	0.6	1.6	0.8	1.7	3.9	0.5	0.1	2.1	0.7	0.6	0.7	0.8	0.6	10.5	0.7	2.8	0.7	0.2	1.4	0.5	0.6	1.2	5.4	1.0	6.9	0.0	0.5	1.9	0.0	5.7	6.9	5.3	6.5	0.1	4.4	6.3	4.9	2.0	10.5	4.2	2.9	3.8	9.4	5.3	1.1	7.7	0.8	1.6	0.2	2.3	4.3	0.5	2.7	11.0	5.5	1.0	4.0	7.8	5.2	6.3	11.2	1.2	4.9	2.6	1.6	4.6	6.3	5.9	12.6	2.0	0.8	2.1	3.9	3.4	3.3	0.4	1.5	3.3	7.9	2.0	2.9	10.8	2.4	4.8	7.2	1.5	1.8	5.3	1.5	12.6	7.3	4.0	0.5	0.8	1.0	0.7	1.1	0.3	0.9	1.7	0.1	0.7	1.2	1.4	0.4	1.1	0.8	0.5	1.7	0.5	0.5	0.8	0.5	0.6	0.6	0.5	0.9	0.6	0.6	0.7	0.7	1.2	2.4	3.2	1.1	5.2	2.3	5.0	2.1	2.2	2.2	6.4	4.2	2.8	0.6	0.0	2.9	0.0	0.0	0.9	2.9	1.1	0.0	2.3	42.8	2.6	2.0	3.4	1.2	26.3	1.2	3.5	0.4	2.5	3.6	1.4	8.9	4.4	1.4	1.4	3.2	3.3	2.0	2.1	0.0	2.6	3.3	25.8	4.4	2.6	3.6	1.0	0.7	3.6	8.2	5.0	6.1	1.8	0.5	2.2	1.2	1.1	0.2	1.0	5.3	2.8	6.6	2.2	2.3	99.7	34.5	3.2	3.8	0.1	3.4	0.9	1.7	1.2
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756818-42802439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 178.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 43.4;Spermatocytes: 103.0;Spermatogonia: 37.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 3.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 13.6;JURKAT: 13.3;U-2 OS: 23.5;U-266/84: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 62: Liver - Hemostasis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	7.5	5.7	2.3	2.2	5.4	1.5	6.5	4.6	2.9	6.0	2.9	5.2	3.9	3.0	0.6	2.2	4.1	4.9	7.8	2.1	4.7	8.6	178.0	6.1	7.4	5.8	5.1	8.3	4.0	0.0	7.8	2.3	6.6	4.6	0.3	2.2	2.7	0.3	1.8	3.3	13.3	0.4	4.0	14.9	4.5	5.0	4.6	4.0	3.3	0.6	2.6	2.6	4.9	7.1	0.4	0.1	1.0	0.1	3.2	4.1	0.0	5.7	0.1	0.0	0.4	0.0	0.3	0.0	0.3	2.6	4.3	4.6	0.0	0.0	0.5	0.1	0.4	0.2	13.6	5.5	3.2	0.1	0.0	5.3	0.0	2.3	0.0	8.5	1.8	13.3	0.6	1.2	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.4	6.5	0.0	0.1	0.0	4.7	0.4	0.1	0.1	0.2	23.5	5.2	0.2	0.1	16.8	0.2	6.9	0.2	0.1	0.0	0.1	0.1	3.1	0.6	3.7	2.0	2.3	3.9	0.6	2.7	3.0	4.7	0.2	5.1	0.3	8.3	1.6	1.0	2.3	5.4	4.6	2.9	2.1	4.7	5.8	5.1	6.6	4.0	4.6	7.1	4.9	60.9	43.4	3.9	10.2	3.7	0.3	0.7	2.2	15.8	1.9	1.5	11.7	2.8	7.6	1.8	0.0	1.6	6.0	2.4	0.0	0.8	14.9	2.3	11.1	4.3	1.2	10.3	2.6	1.1	1.0	17.7	0.0	3.1	9.5	5.3	7.1	5.1	2.6	33.7	9.3	2.9	2.0	14.4	5.6	7.4	6.5	8.0	3.6	1.0	0.9	34.2	21.6	7.5	13.0	1.9	3.0	7.5	3.4	0.3	6.4	0.7	3.9	2.7	0.0	13.0	5.0	103.0	37.8	3.5	4.0	1.8	9.1	10.5	1.3	0.3
CCDC159		ENSG00000183401	"Coiled-coil domain containing 159"	P0C7I6	19	11344684-11354944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 275.7;Late spermatids: 277.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047126, HPA054655"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA047126: AB_10961722, HPA054655: AB_2682558"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (1.87e-7)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.40e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (9.46e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (8.62e-4)"	15.7	43.4	29.3	17.3	33.8	32.6	18.2	28.9	41.0	30.0	29.2	25.8	22.9	22.5	24.9	18.2	24.0	20.6	21.8	32.3	31.3	25.9	36.0	22.8	20.9	34.4	31.3	31.3	23.3	39.5	33.5	9.3	33.4	45.1	11.8	12.4	21.6	18.5	6.1	19.0	24.0	13.8	27.4	41.8	26.2	43.2	34.2	12.4	30.4	6.7	14.5	24.2	21.7	38.1	3.7	3.2	2.6	8.0	10.3	14.8	2.7	5.8	6.0	6.7	8.9	1.0	3.8	3.0	14.7	11.0	2.0	3.0	1.5	9.2	4.1	15.0	2.2	7.2	2.5	3.9	17.9	2.8	10.4	17.8	24.0	4.9	6.5	7.1	19.2	5.3	6.5	33.6	3.4	4.5	4.5	6.0	1.4	5.0	11.5	4.8	0.0	19.6	6.1	5.3	1.1	4.3	5.9	6.6	11.0	4.6	9.8	11.9	12.8	5.3	1.6	9.3	5.5	30.8	8.0	6.2	7.2	14.7	7.9	51.5	52.8	38.5	21.5	46.3	21.1	16.0	14.6	20.2	31.6	20.4	13.2	10.4	25.3	30.2	33.8	8.4	31.5	23.5	29.3	33.8	28.9	41.0	32.3	31.3	34.4	31.3	33.4	27.4	34.2	38.1	10.7	16.0	13.6	7.5	14.5	7.5	15.4	14.9	10.8	11.3	12.5	8.9	9.8	12.8	16.7	18.4	41.7	5.1	12.4	13.0	25.4	8.2	275.7	9.0	8.8	10.3	10.8	4.6	4.5	9.5	5.5	8.1	30.5	10.0	34.2	11.5	12.8	10.9	23.3	6.7	3.0	12.5	10.2	26.7	14.8	277.4	11.5	20.3	12.4	2.8	28.9	16.6	39.1	2.0	10.2	8.7	24.0	13.5	15.0	16.6	29.2	38.6	16.9	27.9	0.0	5.2	8.4	4.7	3.9	11.0	8.1	6.0	17.9	20.1	9.5	19.7
CCDC167	"C6orf129, dJ153P14.2"	ENSG00000198937	"Coiled-coil domain containing 167"	Q9P0B6	6	37482938-37499893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 281.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 145.2;granulocytes: 140.2;T-cells: 423.5"	"Cell line enriched"	"Detected in all"	9	"U-698: 1553.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045215	Uncertain		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA045215: AB_10962866"	"unprognostic (1.82e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (6.99e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.71e-7)"	"unprognostic (1.57e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.95e-1)"	13.2	19.2	49.8	22.8	52.1	28.3	18.5	52.7	54.2	22.1	49.0	19.9	11.6	15.8	45.1	26.6	21.3	11.9	34.9	49.0	51.0	22.0	56.4	13.3	49.5	53.4	51.1	8.5	19.1	27.2	15.0	15.4	52.9	22.8	23.5	14.4	22.6	13.5	21.4	13.4	14.4	31.6	53.0	28.3	15.0	37.7	51.9	90.7	15.1	26.2	70.3	16.8	17.1	57.7	27.2	61.9	137.1	95.4	37.4	65.5	50.4	31.6	25.8	48.8	54.5	66.1	39.5	146.9	69.4	54.8	92.1	20.7	90.4	74.1	49.7	122.9	166.9	69.7	25.3	168.7	39.1	68.4	26.4	30.7	153.4	52.1	47.4	34.2	154.0	150.2	44.1	123.1	85.1	90.2	129.1	56.6	8.0	76.7	39.3	79.0	48.4	108.9	66.3	53.6	93.3	109.6	47.1	46.0	74.3	119.3	50.1	70.3	38.5	31.8	61.6	17.8	32.5	89.3	97.1	1553.2	30.8	147.9	90.8	34.9	32.6	140.2	140.0	35.6	169.2	145.2	230.0	177.9	56.3	122.6	105.5	99.7	10.0	55.8	29.5	35.8	423.5	165.8	49.8	52.1	52.7	54.2	49.0	51.0	53.4	51.1	52.9	53.0	51.9	57.7	18.6	6.4	10.3	5.2	50.6	14.1	26.5	62.1	10.8	9.4	22.4	30.4	50.0	24.3	36.0	14.7	8.4	67.1	33.4	31.8	31.3	69.3	108.2	19.1	31.8	23.4	25.2	86.7	2.2	50.4	108.7	26.4	16.3	31.7	15.2	61.9	25.0	141.9	89.8	15.2	3.2	56.2	48.8	18.8	31.4	281.6	13.1	23.8	55.2	1.9	25.2	56.5	29.9	2.0	7.3	57.9	13.6	18.8	100.2	35.9	10.8	89.0	30.3	11.8	6.6	14.0	28.7	96.8	118.9	26.2	15.2	29.7	59.7	38.1	36.6	31.9
CCDC168	"C13orf40, FLJ40176"	ENSG00000175820	"Coiled-coil domain containing 168"	Q8NDH2	13	102729367-102759072	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"testis: 8.8"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 1011.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048184, HPA058793, HPA078547"	Uncertain		Approved	Nucleoli,Centrosome,Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Centrosome"	Cytosol	"HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: "	"unprognostic (2.06e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.94e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.2	0.0	0.3	0.3	0.0	0.7	0.0	0.0	0.0	0.7	1.8	4.5	0.0	1.8	0.0	0.0	0.3	2.3	0.1	0.0	0.3	1011.0	0.2	1.2	0.6	0.0	0.0	1.1	0.4	0.5	0.4	0.0	0.4	0.0	0.4	0.4	0.0	0.3	0.0	0.9	0.0	0.0	0.6	0.0	91.3	2.1	0.6	0.0	1.0	1.6	0.0	0.0	0.5	0.6	0.4	0.0	0.7	1.4	0.5	0.0	0.2	0.0	0.0	0.0	2.9	0.7	3.1	1.5	0.0	0.0	0.4	0.9	0.2	0.2	0.2
CCDC175	C14orf38	ENSG00000151838	"Coiled-coil domain containing 175"	P0C221	14	59504539-59576812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 18.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 8.4;Early spermatids: 11.9;Excitatory neurons: 15.9;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 11.4;Spermatocytes: 17.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 18.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004200	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA004200: AB_1078743"	"unprognostic (3.64e-3)"		"unprognostic (8.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"					"unprognostic (3.83e-1)"			"unprognostic (2.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.27e-1)"			0.0	0.0	0.1	0.0	0.2	0.1	0.0	18.4	0.5	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	18.4	0.5	0.0	0.2	0.7	0.8	0.8	0.4	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.6	0.0	8.4	0.0	0.0	1.1	0.0	0.0	11.9	5.0	0.1	0.0	0.0	1.7	15.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	1.5	4.8	0.0	0.3	0.0	0.0	0.1	1.5	0.0	5.0	3.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	7.4	11.4	0.0	0.4	0.3	17.7	4.4	0.0	0.0	0.0	0.0	0.1	2.4	0.1
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.6;lymphoid tissue: 8.9;testis: 9.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.5;Spermatocytes: 137.2;Spermatogonia: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	1.9	1.0	1.3	4.3	1.4	10.6	1.1	1.6	1.1	1.0	1.0	1.9	1.7	1.2	0.8	1.6	0.7	1.1	1.0	1.1	1.3	0.6	2.0	1.7	8.9	1.4	1.3	1.3	0.4	0.3	0.8	1.3	1.4	0.6	2.7	0.6	0.7	0.3	2.0	2.1	1.6	1.2	1.1	3.5	1.5	9.5	1.3	6.5	0.7	0.9	5.9	1.6	0.9	1.4	24.8	8.1	18.7	5.9	4.5	4.7	9.7	15.1	7.9	15.1	15.3	4.3	8.3	31.9	8.2	8.1	14.7	11.5	8.2	11.8	21.9	15.9	10.7	21.9	18.5	7.6	1.6	23.1	9.8	3.1	1.0	11.5	11.1	4.2	10.0	14.0	23.8	23.9	20.4	3.5	11.1	9.3	17.1	6.7	10.0	14.0	22.3	9.4	7.4	10.9	8.2	5.2	21.4	10.8	6.1	8.3	5.1	13.3	7.7	17.7	12.4	11.5	17.5	10.2	14.5	18.8	3.7	20.1	4.8	5.1	3.6	5.8	2.3	4.1	2.7	10.2	2.1	2.2	1.7	11.6	1.7	1.9	6.0	1.2	3.8	12.5	2.5	0.5	1.3	1.4	1.6	1.1	1.1	1.3	1.4	1.3	1.4	1.1	1.3	1.4	5.0	19.2	9.6	16.6	17.6	4.1	7.9	4.5	8.0	2.4	3.8	4.2	9.5	0.0	3.6	3.7	4.2	5.7	18.4	3.6	0.0	2.3	50.5	6.6	7.6	4.6	0.0	40.2	13.2	2.9	6.7	8.8	8.2	6.1	19.0	13.5	5.0	4.5	8.2	1.7	12.6	3.2	6.1	14.2	10.4	16.3	6.2	17.5	3.6	15.0	12.9	0.7	7.2	7.5	15.7	2.0	4.4	6.4	22.7	4.6	2.1	1.5	5.6	0.7	6.6	9.8	8.1	137.2	47.7	8.2	7.2	2.9	15.7	5.1	6.9	8.9
CCDC184	"C12orf68, LOC387856"	ENSG00000177875	"Coiled-coil domain containing 184"	Q52MB2	12	48183644-48185926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.5;Late spermatids: 15.1;Sertoli cells: 46.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;AF22: 6.3;hTERT-RPE1: 2.4;SH-SY5Y: 4.3;U-2 OS: 2.5;U-87 MG: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039947, HPA041715"	Uncertain		Approved	Mitochondria,Cytosol		No	No				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Mitochondria, Cytosol"		"HPA039947: AB_2676764, HPA041715: AB_2677634"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.36e-2)"	1.1	5.3	12.3	0.9	12.0	0.1	1.0	11.2	21.4	3.5	1.1	1.8	0.2	5.4	0.3	0.9	1.0	1.3	2.3	10.8	25.7	0.7	0.3	0.8	0.2	18.3	12.5	7.5	0.6	5.8	11.6	2.3	24.5	1.4	0.4	5.0	0.4	0.8	0.9	0.4	0.9	1.4	7.5	0.9	1.0	6.2	11.9	0.0	0.9	0.4	0.0	2.0	1.5	10.8	0.0	2.7	6.3	0.2	0.5	0.5	0.0	0.2	1.2	0.3	0.5	0.3	0.1	0.0	0.1	0.2	1.6	0.1	0.6	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.3	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.7	2.5	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	12.0	11.2	21.4	10.8	25.7	18.3	12.5	24.5	7.5	11.9	10.8	1.2	0.0	0.0	2.6	1.1	0.0	0.1	0.0	6.2	2.3	0.3	1.9	0.6	0.0	0.6	0.0	0.0	0.7	2.0	0.1	0.0	0.3	62.5	0.4	9.4	3.1	5.3	0.0	5.6	0.0	0.6	11.2	1.1	0.2	0.0	4.2	6.8	0.0	0.9	5.0	12.7	0.0	0.0	0.3	0.0	15.1	0.3	0.5	0.0	1.0	0.0	3.0	0.0	1.5	1.1	0.1	0.0	2.2	0.2	0.1	0.0	0.0	5.1	7.0	46.0	8.6	7.6	12.7	1.8	2.2	0.0	1.5	3.2	1.8	0.0	0.0
CCDC189	"C16orf93, MGC104706"	ENSG00000196118	"Coiled-coil domain containing 189"	A1A4V9	16	30757423-30762221	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 18.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 208.2;Late spermatids: 318.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 12.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041806, HPA046289, HPA075094"	Approved		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041806: AB_2677684, HPA046289: AB_2679615, HPA075094: "	"unprognostic (5.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.45e-4)"	"unprognostic (3.60e-2)"	"unprognostic (5.41e-3)"	"unprognostic (7.76e-5)"	"unprognostic (1.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.06e-7)"	"unprognostic (1.75e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.41e-2)"	1.1	5.2	6.7	1.6	6.8	7.9	2.7	5.8	8.7	3.0	12.2	1.9	1.1	1.8	4.3	1.7	10.4	1.6	0.7	7.4	6.7	6.5	1.3	3.9	1.1	6.9	8.1	2.1	3.7	2.3	12.6	0.6	8.9	4.1	1.7	3.5	3.3	1.9	0.3	1.2	1.8	0.7	6.8	2.1	2.0	18.4	6.7	1.7	6.5	0.1	2.1	1.4	1.2	5.9	7.1	5.2	1.1	5.3	1.5	1.7	0.3	2.6	1.2	2.8	2.1	0.3	5.0	0.2	4.3	2.1	1.4	8.2	0.8	4.3	1.2	0.7	9.8	1.9	10.1	2.5	0.3	2.4	1.8	0.4	0.4	5.1	4.4	4.0	2.2	1.8	2.6	1.2	2.2	4.3	2.9	4.6	1.9	2.2	2.5	2.8	1.6	5.2	6.2	0.0	4.2	1.5	3.0	7.7	1.6	1.3	7.5	3.6	1.8	1.3	1.0	2.2	2.6	3.6	2.2	2.1	8.3	7.3	0.4	1.9	1.1	6.0	0.1	1.3	0.9	1.0	0.0	0.2	1.8	0.1	0.0	0.2	0.4	1.9	3.3	12.2	0.1	0.8	6.7	6.8	5.8	8.7	7.4	6.7	6.9	8.1	8.9	6.8	6.7	5.9	0.6	0.0	3.1	0.0	4.3	0.0	4.0	0.0	4.6	1.0	6.8	4.2	0.0	0.0	3.7	7.3	4.2	2.9	16.1	1.6	5.9	3.9	208.2	42.9	2.3	1.4	2.4	14.3	0.0	3.0	1.1	3.5	12.8	4.0	1.3	2.3	0.7	1.1	4.5	0.0	0.0	2.0	0.0	2.2	0.0	318.0	7.5	5.4	0.0	0.0	4.8	3.7	1.0	0.0	0.0	1.9	1.6	4.9	11.9	3.6	1.0	8.6	49.6	15.0	0.0	1.0	1.5	52.7	15.7	2.0	0.0	2.5	2.1	7.0	1.8	3.7
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 36.4;Respiratory ciliated cells: 57.6;Spermatocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.0;intermediate monocyte: 2.2;memory B-cell: 3.5;naive B-cell: 2.2;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.5;granulocytes: 1.0;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: AB_2684591"	"prognostic favorable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (3.18e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.6	4.8	11.8	1.3	11.9	0.4	3.3	11.3	15.9	5.9	12.3	3.8	1.9	3.2	1.9	2.1	11.2	3.1	1.3	11.8	12.0	11.8	3.6	2.9	1.4	11.6	11.8	2.4	5.6	6.2	12.9	1.0	11.7	7.2	2.1	6.6	4.4	5.0	0.8	1.1	2.4	1.3	11.8	2.4	3.8	19.1	12.3	0.9	9.1	0.2	1.0	4.1	2.4	11.5	4.7	2.8	1.2	1.4	1.2	0.8	2.7	0.2	1.9	1.4	2.4	1.8	13.4	3.8	5.0	0.5	4.0	4.7	0.7	6.5	1.3	3.9	1.6	1.9	1.7	0.5	1.3	0.6	3.2	0.3	0.6	4.5	0.4	4.3	1.1	1.4	0.8	1.4	2.0	4.0	0.2	1.4	2.7	4.2	2.2	1.3	0.0	0.7	5.5	1.8	2.9	2.6	4.0	2.3	2.6	2.5	6.7	0.1	0.3	2.1	5.9	1.5	0.7	0.5	1.8	0.8	5.3	0.5	1.7	0.0	0.4	1.0	0.3	2.2	0.2	3.5	0.1	0.1	0.4	2.2	0.0	0.0	0.4	0.3	1.8	0.3	0.0	0.2	11.8	11.9	11.3	15.9	11.8	12.0	11.6	11.8	11.7	11.8	12.3	11.5	1.7	3.2	7.2	17.0	2.3	1.1	7.9	26.5	9.1	8.9	13.3	12.1	1.0	12.8	22.0	9.2	6.2	5.6	0.9	11.3	21.5	9.4	20.7	30.9	2.4	2.1	36.4	1.3	17.7	7.2	2.2	2.5	21.9	6.9	2.5	1.6	2.5	2.6	3.3	3.3	10.0	13.6	14.2	2.0	2.2	11.7	2.1	3.6	3.6	1.9	2.7	10.2	0.0	5.0	2.4	6.5	8.3	3.0	1.8	5.7	6.3	11.5	57.6	15.4	0.0	2.9	3.8	50.6	19.9	3.9	0.9	2.5	1.3	3.9	10.2	11.4
CCDC25	FLJ10853	ENSG00000147419	"Coiled-coil domain containing 25"	Q86WR0	8	27733316-27772653	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023256	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA023256: AB_2072067"	"unprognostic (1.43e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-2)"	"prognostic favorable (1.11e-7)"	"unprognostic (3.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-1)"	14.0	20.9	10.1	11.8	11.4	4.9	17.4	10.5	17.1	10.1	7.3	14.3	35.5	10.4	14.3	14.2	12.9	11.9	12.2	9.9	11.3	22.5	32.3	8.8	14.0	11.1	10.5	10.8	16.3	18.3	7.5	10.6	11.5	11.6	15.7	11.1	13.5	12.0	28.4	10.3	30.8	10.3	11.3	10.5	20.0	10.9	11.9	11.4	18.8	15.2	14.2	11.7	9.4	13.0	50.1	27.9	25.8	24.7	22.8	33.0	17.2	41.0	39.5	24.7	24.0	11.2	17.9	53.6	27.7	20.9	21.2	23.1	23.6	40.0	35.5	20.3	16.4	66.9	23.1	19.3	36.9	23.8	20.8	37.1	25.9	27.1	37.6	28.7	54.0	33.7	32.2	24.6	27.8	19.2	55.3	19.9	37.9	49.4	14.8	18.7	44.4	28.8	32.3	26.7	15.1	41.7	27.5	21.0	42.8	19.0	24.0	13.1	44.6	22.5	33.4	38.9	21.7	24.5	33.8	19.5	35.0	30.8	23.8	20.3	8.9	6.6	15.2	12.6	17.8	19.8	19.6	16.1	11.6	15.5	18.3	19.3	3.2	14.3	13.4	18.1	23.2	10.4	10.1	11.4	10.5	17.1	9.9	11.3	11.1	10.5	11.5	11.3	11.9	13.0	47.5	25.6	38.9	12.4	34.8	21.4	39.6	46.5	55.2	42.6	57.3	61.6	62.5	60.1	44.5	53.3	12.5	77.6	31.2	61.6	109.5	76.9	183.1	46.8	51.0	54.2	26.5	46.7	30.5	134.6	56.0	49.3	63.2	33.3	63.9	39.3	55.0	144.5	44.7	55.5	21.9	58.6	46.8	33.5	27.2	162.9	47.2	27.4	37.4	12.2	44.4	60.2	35.0	12.1	17.7	83.7	51.1	47.4	40.7	55.2	182.1	128.6	53.7	38.9	46.0	44.4	49.1	91.1	59.6	56.7	22.3	42.4	38.7	88.1	71.2	36.0
CCDC27	FLJ32825	ENSG00000162592	"Coiled-coil domain containing 27"	Q2M243	1	3746460-3771645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 16.9"	"Group enriched"	"Detected in some"	63	"Early spermatids: 87.6;Late spermatids: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	HPA044395			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA044395: AB_10962987"	"unprognostic (1.36e-1)"	"unprognostic (6.67e-3)"		"unprognostic (3.23e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.28e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	27.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 132.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 50.1;Excitatory neurons: 100.2;Inhibitory neurons: 41.3;Peritubular cells: 60.5;Smooth muscle cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 10.4;HAP1: 19.1;HDLM-2: 32.4;hTERT-RPE1: 14.8;U-2 OS: 20.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 20.8"	HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA062425: AB_2684759"	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	91.8	11.0	32.9	5.9	35.2	0.1	37.2	17.9	40.2	48.1	17.8	10.1	6.6	25.0	41.3	60.4	56.7	70.7	21.9	37.1	20.1	19.0	20.6	21.0	12.4	18.6	19.1	86.2	6.5	4.9	10.2	22.2	19.6	35.2	7.4	1.6	7.1	22.0	30.7	132.2	14.3	24.2	19.8	24.7	13.1	11.6	21.7	42.0	20.0	13.3	4.2	23.2	27.4	30.5	0.0	0.2	1.7	9.4	0.0	0.0	0.1	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.7	0.0	10.4	1.9	19.1	3.6	0.6	32.4	8.1	0.0	0.2	0.0	0.7	0.0	0.0	2.3	2.3	0.4	0.0	14.8	0.9	0.8	0.0	0.2	1.0	0.2	0.0	5.4	1.5	0.0	0.1	0.0	4.1	0.3	0.0	0.0	3.6	1.6	7.0	1.0	0.0	4.4	0.0	0.0	0.0	0.0	20.0	1.2	0.3	0.0	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.9	35.2	17.9	40.2	37.1	20.1	18.6	19.1	19.6	19.8	21.7	30.5	12.4	0.0	0.0	10.1	0.1	50.1	6.4	26.3	13.6	1.2	0.9	4.7	7.9	1.5	2.1	0.0	0.0	0.3	1.3	0.1	1.9	0.0	0.2	0.1	0.7	27.2	0.0	0.0	100.2	0.0	0.2	16.0	0.5	0.4	0.0	16.4	8.2	0.2	0.3	0.0	41.3	0.1	0.0	0.0	6.4	1.5	22.4	0.6	14.2	3.7	0.0	0.3	0.0	22.6	23.2	0.1	2.5	60.5	0.0	3.0	0.3	0.4	1.1	2.1	32.9	7.9	119.4	0.0	5.7	2.1	37.2	0.3	1.0	6.0	0.3	1.3
CCDC57	"FLJ00130, FLJ23754"	ENSG00000176155	"Coiled-coil domain containing 57"	Q2TAC2	17	82101460-82212830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Late spermatids: 729.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 3.7;naive CD8 T-cell: 7.6"	"Lineage enriched"	"Detected in many"	6	"T-cells: 7.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023315, HPA023326, HPA023342, HPA023344"	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Microtubules	"Centriolar satellite, Cytosol"	"HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162"	"unprognostic (2.51e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.55e-5)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.80e-3)"	5.3	8.4	3.3	5.8	5.1	8.3	8.3	6.1	8.2	13.0	6.4	8.7	7.2	9.4	6.4	3.5	11.0	6.6	4.3	3.7	1.5	12.4	7.4	8.1	5.3	2.1	1.4	12.3	10.5	7.9	16.9	3.4	1.3	14.4	3.0	9.0	9.1	5.8	4.0	5.6	6.6	3.6	0.1	6.2	7.7	12.2	1.8	8.1	17.7	1.1	2.8	6.9	6.5	3.1	5.2	10.4	5.4	6.9	3.1	5.8	6.0	3.9	3.9	2.8	2.5	3.0	7.9	2.7	3.7	3.2	2.9	12.0	1.6	7.2	1.6	2.8	10.6	4.5	20.3	6.7	4.0	4.5	5.6	5.9	5.5	5.3	6.9	6.5	3.4	3.9	5.8	1.5	2.0	7.5	8.8	8.5	1.7	3.0	4.1	4.7	2.4	3.8	5.5	6.2	18.5	11.3	3.4	17.3	6.7	3.4	9.9	5.3	3.7	11.0	10.0	4.8	8.2	11.0	1.2	0.9	8.5	5.1	4.5	0.5	0.4	0.5	0.6	0.1	0.2	0.4	0.5	0.8	0.4	0.3	3.7	7.6	1.3	0.3	0.1	1.2	0.2	1.0	3.3	5.1	6.1	8.2	3.7	1.5	2.1	1.4	1.3	0.1	1.8	3.1	5.9	25.6	62.7	19.6	35.8	11.7	22.7	23.7	19.4	22.5	82.3	66.2	5.3	17.2	41.9	29.5	41.7	36.2	45.4	27.6	9.8	15.8	116.1	44.9	15.9	6.9	42.7	14.1	72.8	17.1	34.2	9.8	36.2	19.2	34.9	33.2	7.1	101.0	29.9	25.2	54.4	46.9	30.5	42.1	35.8	729.3	8.1	28.7	33.8	13.1	39.6	10.0	48.4	16.1	10.6	18.1	26.9	10.1	36.5	20.4	31.6	13.2	52.3	66.3	6.6	14.3	9.9	13.6	6.9	21.2	18.3	12.4	40.2	10.5	37.2	23.1
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621837	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	2.7	3.1	3.8	3.6	3.7	3.0	5.2	3.7	4.3	4.8	4.2	4.0	3.0	4.1	5.3	2.5	5.7	3.4	2.9	3.7	4.2	4.1	2.0	3.6	4.9	3.8	3.7	6.0	3.3	5.4	4.5	3.3	3.9	4.0	4.1	7.8	3.3	3.6	4.5	2.5	2.8	4.9	3.8	4.3	3.2	3.7	3.7	5.1	4.9	2.6	4.9	3.7	3.1	3.8	5.6	2.0	5.8	3.7	8.9	5.2	4.6	6.8	6.4	9.1	7.8	4.3	4.3	15.6	1.6	3.8	5.8	2.8	3.4	6.5	10.1	5.6	4.0	9.5	9.0	4.6	6.2	12.8	3.3	4.9	8.8	7.7	5.1	8.0	6.0	7.7	9.3	2.4	7.2	4.7	10.0	7.5	9.7	4.8	7.5	3.4	5.2	8.6	5.3	1.9	2.2	4.2	8.7	5.5	5.2	4.9	1.9	5.2	3.1	6.6	5.2	6.3	9.9	4.7	5.3	8.0	4.9	14.3	5.5	10.0	1.5	3.5	4.1	2.0	5.4	2.7	7.0	5.0	1.1	1.6	8.0	5.8	0.3	5.1	2.4	1.0	14.8	2.6	3.8	3.7	3.7	4.3	3.7	4.2	3.8	3.7	3.9	3.8	3.7	3.8	39.7	22.4	22.6	42.7	41.3	28.2	20.1	30.5	15.9	68.5	18.5	21.0	30.5	30.0	29.0	22.0	108.4	23.0	51.5	7.7	29.4	23.7	202.5	58.1	33.5	28.8	21.0	40.8	93.2	10.5	14.6	29.9	18.8	13.9	34.2	38.3	37.9	8.5	18.4	52.2	95.8	11.4	22.4	35.8	27.9	109.6	54.0	20.7	26.6	51.5	56.1	36.8	105.0	70.9	96.7	14.1	9.8	47.8	28.1	25.5	11.5	20.3	51.5	111.5	32.9	38.6	30.9	55.8	46.8	12.1	29.5	16.4	51.7	33.6	14.5	11.4
CCDC68	SE57-1	ENSG00000166510	"Coiled-coil domain containing 68"	Q9H2F9	18	54901509-54959461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.8;placenta: 32.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 95.2;Early spermatids: 95.4;Pancreatic endocrine cells: 87.9;Paneth cells: 68.7;Proximal enterocytes: 61.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 10.8;HHSteC: 13.6;HSkMC: 14.9;RT4: 10.5;TIME: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA040865, HPA048197"	Supported		Approved	"Golgi apparatus,Cytosol"		No	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA040865: AB_2677176, HPA048197: AB_2680310"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.38e-1)"	5.5	3.8	1.6	4.1	1.5	0.4	3.4	1.4	2.7	4.2	2.3	18.9	20.2	3.3	0.8	1.8	2.4	5.1	5.7	1.5	3.6	2.8	9.5	13.0	0.8	2.0	2.3	15.7	2.8	0.8	3.6	32.4	2.0	4.2	18.2	0.6	1.8	1.3	1.5	0.9	24.8	2.7	1.2	7.2	14.3	8.8	3.3	0.6	2.6	4.4	1.3	2.3	1.8	1.3	10.8	3.3	0.0	0.0	3.0	8.3	0.0	0.3	4.2	0.6	0.7	5.9	6.2	0.0	7.6	0.0	0.1	0.1	0.7	6.8	0.5	0.0	1.6	0.8	3.6	1.2	13.6	0.0	0.0	14.9	0.0	3.2	0.1	0.0	4.9	0.0	0.0	0.1	0.4	0.8	0.0	0.2	0.0	7.6	3.6	0.3	0.0	0.3	1.2	10.5	0.1	2.5	3.3	1.0	0.1	1.2	0.0	0.0	28.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.6	1.5	1.4	2.7	1.5	3.6	2.0	2.3	2.0	1.2	3.3	1.3	38.5	19.2	10.3	0.3	1.0	0.3	7.4	4.8	1.2	0.1	2.0	1.9	5.5	10.0	13.3	1.8	0.0	2.3	0.3	95.2	1.9	7.2	95.4	15.0	2.5	40.8	6.0	3.6	5.7	35.6	2.7	9.6	38.2	27.1	8.8	2.6	37.5	7.0	0.4	0.0	0.5	21.8	8.2	3.2	1.3	36.7	3.4	0.6	0.0	12.2	1.0	3.3	1.0	0.0	0.1	87.9	68.7	0.7	0.0	32.4	61.1	5.3	4.2	0.2	6.6	0.9	3.0	1.2	2.2	1.1	0.0	6.0	0.4	3.8	20.2	6.4
CCDC7	"BIOT2, C10orf68, FLJ13031, FLJ32762"	ENSG00000216937	"Coiled-coil domain containing 7"	Q96M83	10	32446140-32882874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"brain: 28.1;testis: 78.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 489.6;Late spermatids: 914.3;Oligodendrocytes: 161.0;Spermatocytes: 176.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA075536			Approved	"Nucleoli,Mitotic spindle,Cytosol"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	"Mitotic spindle, Cytosol"	"HPA075536: AB_2686755"	"unprognostic (3.43e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.65e-5)"	"unprognostic (6.95e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.95e-5)"	"unprognostic (7.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	1.0	1.2	10.9	0.9	20.3	2.4	1.3	28.1	14.5	1.4	0.0	1.1	1.2	1.3	1.5	1.2	0.8	1.1	1.1	3.1	8.9	1.1	0.7	1.2	1.6	13.7	9.1	1.5	1.5	0.8	1.7	0.9	17.0	1.1	1.5	3.0	0.8	1.3	0.7	0.7	1.0	1.2	10.7	1.1	1.2	78.0	15.6	0.8	1.9	0.6	1.4	0.8	1.0	23.7	1.4	1.5	0.4	1.8	1.2	0.9	0.6	1.2	0.4	0.4	1.2	0.3	2.0	1.0	0.6	0.8	1.1	0.6	0.7	0.7	1.6	3.6	0.2	0.5	1.3	0.4	2.1	0.6	0.9	0.8	0.3	0.8	0.3	0.8	0.5	1.6	0.8	3.4	1.5	0.2	0.4	0.3	0.4	0.7	1.4	0.9	1.9	0.1	1.2	0.3	0.9	1.0	0.2	0.2	0.9	0.5	1.0	0.8	2.0	1.0	1.2	1.3	0.7	1.1	0.8	1.0	1.3	4.0	0.6	0.0	0.3	0.0	1.7	0.2	1.7	1.2	2.7	1.5	0.1	0.6	2.9	2.0	0.0	1.8	0.1	1.0	2.0	0.3	10.9	20.3	28.1	14.5	3.1	8.9	13.7	9.1	17.0	10.7	15.6	23.7	7.4	6.4	8.6	87.8	4.8	1.9	1.1	0.5	2.2	8.9	4.1	3.9	7.2	0.0	3.0	1.8	4.2	0.7	6.2	2.0	1.9	4.6	489.6	5.0	6.1	3.5	3.0	2.1	84.3	3.4	1.1	3.7	4.1	5.4	12.6	7.0	0.0	0.0	1.7	0.0	103.3	2.8	0.0	0.0	1.2	914.3	9.6	3.1	1.8	93.7	2.4	3.5	4.1	96.0	161.0	2.8	0.5	7.2	3.8	0.5	2.4	1.1	1.1	23.1	13.1	6.0	3.6	176.0	9.4	1.3	1.1	0.1	8.6	4.6	2.1	0.6
CCDC71L	"C7orf74, FLJ36031"	ENSG00000253276	"Coiled-coil domain containing 71 like"	Q8N9Z2	7	106654360-106661158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067925	Approved		Approved	"Golgi apparatus,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Actin filaments"	Cytosol	"HPA067925: AB_2685925"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.35e-2)"	51.5	9.8	2.7	19.6	2.7	15.8	18.7	2.0	2.9	13.1	3.3	14.6	6.5	16.9	2.8	6.8	36.2	10.8	8.2	2.9	3.2	18.1	46.7	22.1	9.6	8.2	2.8	10.1	9.3	5.2	6.4	3.7	3.7	11.2	5.4	1.0	12.6	6.6	5.3	6.2	15.8	7.2	3.3	18.7	16.3	6.9	4.6	14.5	10.2	2.5	8.0	40.0	9.3	3.6	24.8	5.1	7.4	8.9	16.3	15.4	0.0	37.0	47.5	14.2	15.4	0.7	15.3	16.5	12.6	63.3	27.1	2.8	3.6	10.7	11.7	38.7	8.5	2.1	0.9	0.0	25.5	8.4	19.4	13.2	6.4	6.5	3.7	24.1	50.0	9.2	56.0	39.9	17.1	7.1	11.5	13.3	16.0	2.0	17.0	15.4	2.1	3.3	7.3	1.4	3.2	22.1	23.9	8.6	55.9	15.4	3.9	10.1	22.0	31.4	2.9	3.7	14.6	38.4	3.8	13.5	24.3	10.8	35.3	4.9	0.6	1.8	1.1	0.4	0.8	1.3	0.8	0.8	0.4	0.9	0.4	0.6	4.1	0.6	0.7	1.4	1.7	0.5	2.7	2.7	2.0	2.9	2.9	3.2	8.2	2.8	3.7	3.3	4.6	3.6	44.0	3.2	11.6	1.0	9.4	8.2	50.5	2.1	6.8	4.3	39.9	33.0	6.2	18.6	1.6	5.5	2.1	3.0	26.2	12.9	11.7	7.4	1.2	18.7	78.7	21.4	6.6	11.6	1.8	10.7	7.4	47.8	3.6	20.2	12.0	3.3	45.7	34.4	8.1	6.7	2.8	7.3	4.1	10.0	13.9	2.1	21.8	22.5	12.4	1.9	6.5	5.0	10.3	2.5	1.8	13.9	10.1	17.7	4.3	11.0	10.1	4.7	6.8	4.8	0.0	24.5	30.1	7.1	4.9	4.0	5.1	3.3	13.7	3.4	9.5	18.3
CCDC8	"3M3, DKFZp564K0322, PPP1R20"	ENSG00000169515	"Coiled-coil domain containing 8"	Q9H0W5	19	46410329-46413564	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 36.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 27.0;Distal tubular cells: 39.2;Granulosa cells: 25.7;Leydig cells: 70.8;Peritubular cells: 57.9;Theca cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.5;AN3-CA: 22.2;HSkMC: 19.6;K-562: 20.3;RH-30: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041993	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041993: AB_10795388"	"unprognostic (3.05e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (5.43e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.18e-3)"	4.1	16.3	4.1	2.7	3.8	0.7	8.8	3.9	2.6	13.9	7.5	3.3	0.9	13.9	10.5	1.3	22.9	4.2	24.7	3.6	3.9	11.2	0.7	4.4	0.9	5.2	7.4	36.8	13.6	9.1	12.9	6.7	5.3	6.4	1.2	1.3	10.8	7.5	2.1	3.1	2.2	6.5	4.8	2.3	2.2	5.9	4.2	5.6	9.0	2.4	0.8	7.5	7.3	4.4	1.9	0.1	18.5	22.2	4.8	6.0	8.9	9.6	0.0	2.1	0.9	0.1	0.1	0.2	12.5	7.6	0.4	0.2	0.1	15.0	1.0	0.0	9.4	0.0	0.2	1.0	16.0	0.1	0.1	19.6	0.0	5.2	15.2	0.3	0.1	0.1	20.3	0.0	6.8	0.0	0.0	1.3	13.3	0.0	0.0	0.7	24.8	0.0	16.1	0.1	2.9	0.1	0.1	0.1	0.1	14.2	0.1	4.7	1.7	1.2	4.9	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.1	3.8	3.9	2.6	3.6	3.9	5.2	7.4	5.3	4.8	4.2	4.4	0.7	0.0	1.1	1.3	0.0	0.9	6.5	1.5	0.0	0.4	1.8	19.3	27.0	7.2	4.0	11.0	0.0	7.5	0.1	0.0	39.2	14.8	0.4	15.0	13.9	1.2	0.0	0.0	0.0	1.1	10.0	17.3	0.0	3.9	1.3	25.7	1.1	0.0	1.7	0.0	0.0	0.0	2.0	0.0	0.9	2.9	70.8	0.6	1.8	1.0	0.0	14.6	0.0	1.5	0.1	3.6	0.0	57.9	0.0	3.7	0.0	1.2	2.4	0.5	13.1	12.3	8.3	0.4	5.5	0.0	0.1	2.1	0.2	32.7	0.0	0.8
CCDC82	FLJ23518	ENSG00000149231	"Coiled-coil domain containing 82"	Q8N4S0	11	96349241-96389956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 493.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038704, HPA070631"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA038704: AB_10674835, HPA070631: "	"unprognostic (3.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.94e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	22.2	15.1	16.5	19.6	19.7	17.1	17.6	32.0	26.6	15.9	8.7	18.1	13.0	18.4	13.9	10.4	15.9	16.8	13.7	17.4	24.6	16.6	22.1	17.9	23.4	18.2	16.5	18.3	13.8	11.8	18.2	17.4	19.5	13.0	13.3	43.2	12.8	15.8	14.3	14.3	16.9	13.8	12.4	20.3	16.7	23.7	17.9	22.3	17.9	14.9	20.1	16.7	14.5	31.1	12.9	17.9	52.4	21.0	35.9	30.0	20.8	47.0	28.0	29.9	42.4	31.1	41.3	26.1	42.8	23.1	50.5	29.1	17.5	14.7	42.5	44.5	11.7	49.1	42.7	26.0	25.6	41.5	33.2	18.3	9.2	58.9	22.8	28.0	35.9	25.3	31.4	28.1	40.5	1.1	34.9	40.2	12.0	21.6	12.7	23.7	44.2	21.0	22.6	32.9	9.6	22.7	26.6	2.7	23.0	35.5	5.0	19.5	42.6	50.1	28.1	43.7	25.3	9.5	29.9	36.0	16.2	30.7	38.6	59.4	12.5	25.1	23.7	15.2	24.5	22.5	24.7	23.6	14.0	19.3	26.9	25.5	17.9	35.7	16.2	18.7	28.5	17.9	16.5	19.7	32.0	26.6	17.4	24.6	18.2	16.5	19.5	12.4	17.9	31.1	57.9	19.2	31.4	30.7	32.9	30.5	27.0	31.5	19.4	58.9	14.0	18.5	37.2	18.6	28.9	31.3	100.1	16.6	55.1	10.7	27.4	34.6	493.8	57.6	37.0	53.6	19.8	16.4	67.0	17.5	20.5	44.9	13.7	26.4	40.4	36.4	38.6	32.1	25.2	32.0	67.0	9.0	24.4	27.4	38.4	76.8	43.8	32.5	26.6	23.4	37.2	41.6	42.2	54.3	119.7	32.3	12.2	42.9	27.2	14.5	8.8	40.1	71.8	50.6	32.9	45.4	48.4	85.4	57.0	13.0	20.5	8.2	40.7	24.9	10.3	18.7
CCDC9	DKFZP586M1019	ENSG00000105321	"Coiled-coil domain containing 9"	Q9Y3X0	19	47255980-47273701	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.6;Late spermatids: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 116.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045624, HPA072007"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA045624: AB_10961402, HPA072007: AB_2686482"	"unprognostic (4.53e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.22e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (4.02e-1)"	22.7	21.1	11.7	16.1	12.2	40.7	22.2	10.5	16.1	27.8	17.3	24.8	13.7	24.7	8.8	18.1	24.8	10.3	21.8	12.7	10.0	25.9	22.7	26.6	10.6	15.9	12.0	30.7	49.0	14.0	16.6	13.6	11.3	25.8	8.5	12.6	20.0	12.3	26.2	34.9	18.9	9.8	9.5	23.1	24.8	35.8	12.6	9.3	23.0	11.7	7.7	23.8	23.9	12.3	27.5	27.7	21.2	23.7	6.6	17.9	24.1	37.2	16.4	22.4	24.5	29.5	21.1	12.5	10.0	24.8	18.6	25.5	19.7	16.0	12.1	33.3	12.3	32.3	27.3	22.7	21.1	13.2	31.9	19.2	23.0	21.4	20.0	19.0	15.1	15.6	45.0	61.8	15.0	32.8	15.4	116.9	23.7	45.3	10.8	26.9	20.2	14.4	10.2	19.7	8.3	21.1	50.5	36.4	20.3	17.3	30.2	26.7	20.9	25.8	23.0	15.6	32.2	20.5	38.5	19.0	24.2	17.8	20.3	0.4	1.1	2.0	1.3	1.4	0.7	0.6	1.0	1.0	0.9	0.9	1.0	0.7	3.6	1.1	0.8	1.4	1.9	0.4	11.7	12.2	10.5	16.1	12.7	10.0	15.9	12.0	11.3	9.5	12.6	12.3	13.6	6.4	1.7	1.3	16.4	14.0	15.7	1.8	12.0	3.1	8.9	5.2	3.0	2.8	1.9	1.8	4.2	5.4	9.3	13.1	5.9	7.5	50.6	13.0	10.3	9.7	3.6	8.2	1.4	11.2	9.1	7.6	14.3	16.8	8.2	4.3	3.3	3.6	5.8	0.0	1.0	12.0	2.0	7.8	14.4	79.3	4.4	9.8	7.2	1.9	10.4	1.8	7.2	0.5	0.9	11.1	11.5	3.8	15.2	8.9	7.8	6.7	2.1	7.6	6.6	8.7	10.5	2.8	7.5	12.7	17.8	15.3	12.2	5.3	8.4	13.5
CCDC97	"FLJ40267, MGC20255"	ENSG00000142039	"Coiled-coil domain containing 97"	Q96F63	19	41310172-41324873	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043320, HPA043572"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043320: AB_10964344, HPA043572: AB_10962488"	"unprognostic (9.25e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"	14.6	12.9	19.0	17.8	21.3	23.0	14.3	17.7	17.7	20.3	14.4	14.0	14.2	17.3	23.4	20.2	21.9	12.3	15.6	16.5	18.2	12.0	11.8	14.3	23.8	23.5	20.2	24.0	17.7	15.8	13.7	10.5	19.9	16.2	11.2	10.7	18.0	14.6	30.6	20.2	16.6	14.2	18.1	20.0	15.7	32.1	20.4	21.9	16.3	20.5	22.2	14.8	17.2	20.5	25.2	54.1	28.2	32.9	36.2	28.7	20.3	16.6	13.4	25.7	21.9	32.4	23.6	23.9	17.4	13.9	17.3	16.7	38.8	33.1	19.5	44.1	37.6	21.9	25.5	21.5	27.5	36.6	45.3	28.1	41.7	30.0	25.0	21.1	18.0	25.8	28.5	44.4	24.9	18.3	33.6	8.9	13.2	30.5	19.3	37.5	22.4	17.5	23.7	47.3	25.1	22.2	37.0	40.3	16.5	18.6	27.5	27.6	21.6	22.1	22.0	11.5	27.8	45.3	42.2	22.7	21.0	26.7	30.0	9.4	7.2	8.5	12.0	7.6	13.4	9.1	8.1	8.7	5.8	10.0	8.7	7.8	11.9	10.4	12.6	6.3	7.2	8.1	19.0	21.3	17.7	17.7	16.5	18.2	23.5	20.2	19.9	18.1	20.4	20.5	7.3	12.8	6.7	5.2	22.3	4.6	11.4	11.3	6.2	11.8	11.2	8.8	6.7	7.2	8.9	9.2	12.5	11.1	23.9	13.5	7.9	13.1	3.7	9.3	8.6	8.4	11.5	7.8	4.1	26.1	4.5	10.0	15.3	9.8	16.5	11.2	9.7	6.5	15.3	10.1	4.7	12.1	18.3	10.0	7.9	8.4	12.8	12.3	1.8	3.7	16.1	7.1	25.7	1.0	6.6	20.5	5.9	11.3	18.6	10.0	16.7	9.3	12.2	8.5	0.0	13.1	8.5	22.5	12.9	10.8	5.8	18.3	20.1	7.2	10.7	13.3
CCDC9B	"C15orf52, FLJ43339"	ENSG00000188549	"Coiled-coil domain containing 9B"	Q6ZUT6	15	40331452-40340967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.0;Collecting duct cells: 20.2;Ductal cells: 30.0;Pancreatic endocrine cells: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 122.5;hTERT-RPE1: 110.8;WM-115: 138.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040484, HPA041834"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		77000	"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA040484: AB_10794742, HPA041834: AB_10795643"	"unprognostic (5.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.68e-2)"	4.9	10.3	9.5	7.7	13.1	2.8	8.1	10.9	10.7	12.0	15.0	73.4	9.9	23.9	7.3	33.2	10.8	12.0	53.0	9.0	12.7	10.2	5.0	12.3	3.3	13.1	12.6	4.0	25.3	11.3	10.2	3.9	12.7	16.2	12.5	4.3	28.3	22.7	67.4	15.4	18.1	24.2	11.6	5.6	22.3	8.3	12.7	1.3	45.2	65.1	5.9	25.9	16.7	12.6	50.0	6.8	0.0	0.4	1.1	4.6	2.5	14.8	14.6	16.1	15.6	0.5	44.7	0.3	20.1	47.8	58.6	122.5	0.2	40.4	15.1	0.0	0.3	14.9	64.4	4.7	8.5	0.2	2.8	5.7	9.0	6.9	20.3	110.8	11.6	0.8	0.1	0.7	27.9	0.0	0.5	0.0	0.2	23.1	12.7	0.0	4.2	0.2	48.0	2.8	0.1	3.6	8.8	19.1	8.4	0.2	1.9	2.3	62.1	29.7	47.2	7.9	39.8	0.0	0.1	0.6	36.2	2.8	138.3	4.3	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.5	0.4	0.1	0.2	0.0	0.2	9.5	13.1	10.9	10.7	9.0	12.7	13.1	12.6	12.7	11.6	12.7	12.6	2.7	12.8	10.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.5	3.0	0.0	0.0	1.3	20.2	0.0	0.0	0.2	0.0	1.9	30.0	0.0	1.8	0.4	0.6	0.0	0.0	0.0	3.7	0.1	0.6	0.0	2.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0
CCN4	"WISP-1, WISP1, WISP1-OT1, WISP1-UT1"	ENSG00000104415	"Cellular communication network factor 4"	O95388	8	133191039-133231690	"Cancer-related genes, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HSkMC: 110.5;hTEC/SVTERT24-B: 64.5;U-2197: 61.9"	"Region enriched"	"Detected in some"	6	"olfactory bulb: 9.8"	"Low region specificity"	"Detected in many"			"HPA007121, CAB012205"	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"CAB012205: , HPA007121: AB_1858844"	"unprognostic (7.77e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (7.52e-3)"	"unprognostic (2.55e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.67e-3)"	4.4	10.3	1.3	7.6	2.6	0.0	0.9	0.5	1.4	10.9	0.9	3.9	1.2	14.0	0.9	0.9	5.9	7.8	3.7	1.3	0.4	15.8	2.0	8.3	3.0	0.7	0.6	6.0	0.8	9.2	2.3	2.8	0.7	3.3	0.8	0.0	1.1	1.4	0.4	1.4	2.3	13.6	0.6	2.2	2.8	1.2	0.9	0.2	1.1	0.2	3.9	6.0	3.6	0.8	0.0	0.5	0.0	0.0	7.6	4.2	0.1	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	110.5	0.0	64.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.6	0.0	0.0	0.0	14.8	0.8	61.9	0.0	0.0	0.0	0.0	12.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.6	0.5	1.4	1.3	0.4	0.7	0.6	0.7	0.6	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542387-99568825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: AB_2686120"	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	31.3	32.5	15.9	27.4	17.0	33.0	47.4	26.1	19.3	29.8	26.8	30.9	42.8	21.9	58.7	41.3	18.9	42.1	23.6	17.3	17.9	54.3	74.6	25.1	39.6	17.0	16.9	16.7	62.6	47.3	22.2	35.7	17.0	34.6	30.3	27.0	70.4	23.2	22.1	32.5	35.0	21.9	17.0	24.1	41.6	17.1	18.1	32.1	60.6	17.7	43.3	34.6	19.7	18.0	86.9	29.8	45.8	99.2	39.3	53.7	126.9	61.4	78.3	75.9	97.9	118.2	53.2	177.2	69.1	51.5	69.8	60.5	72.2	91.1	109.7	45.1	91.2	101.6	44.4	97.7	67.6	118.6	35.3	51.5	55.4	55.9	67.3	52.0	82.2	102.3	151.6	62.9	68.3	53.8	43.7	98.5	64.1	53.5	47.4	75.8	76.7	71.2	105.3	101.2	72.5	43.8	35.6	67.1	69.5	65.5	46.5	117.8	60.6	38.4	51.2	47.0	92.8	42.9	69.7	134.1	69.0	87.9	55.8	40.9	20.7	16.2	21.2	22.1	39.8	29.7	25.5	20.9	23.4	25.3	27.4	21.7	3.3	28.2	16.7	23.0	29.6	30.7	15.9	17.0	26.1	19.3	17.3	17.9	17.0	16.9	17.0	17.0	18.1	18.0	37.1	44.8	32.8	25.5	58.3	75.1	99.3	58.0	50.7	42.8	60.0	31.0	16.1	81.5	57.5	23.9	22.9	110.3	45.0	32.2	84.1	127.2	45.1	36.7	27.3	46.3	43.6	23.3	64.2	186.9	93.3	33.2	38.2	43.1	32.4	31.1	36.4	53.0	41.1	25.2	56.6	38.2	67.1	37.0	52.8	45.5	22.4	32.8	58.7	24.4	41.2	64.6	40.2	52.8	40.5	133.7	27.1	25.2	120.5	158.8	37.8	128.4	37.4	42.2	19.7	26.9	40.2	62.3	21.4	60.0	67.5	176.4	38.7	42.8	46.3	147.0
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157207-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	HPA034684	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	46.4	23.6	15.5	35.6	18.2	88.0	81.5	64.3	20.8	39.6	8.3	33.5	28.0	39.2	26.7	136.0	18.8	32.8	14.9	17.5	11.4	71.0	11.0	26.3	73.5	13.5	14.7	37.4	14.7	46.3	8.8	64.6	13.5	78.1	34.4	81.2	34.3	31.4	12.3	29.2	25.1	33.8	13.1	48.1	25.4	11.2	15.2	67.3	53.2	34.4	73.5	53.5	37.1	19.2	30.9	3.9	66.5	35.5	43.1	54.9	45.0	25.4	72.6	19.4	36.0	4.6	43.8	61.7	40.0	23.7	18.4	21.7	17.6	83.8	37.2	43.2	11.8	5.2	18.1	9.1	22.4	9.3	62.1	46.9	40.8	9.1	19.9	64.6	29.4	35.9	3.0	36.7	36.0	12.0	42.9	19.7	6.8	15.0	4.1	24.3	64.8	4.1	121.9	84.1	17.7	56.1	30.0	46.7	18.0	39.4	34.9	13.8	27.6	26.3	26.0	19.1	4.2	26.9	21.9	43.8	18.4	14.4	13.4	14.8	1.7	21.0	0.9	2.7	2.1	3.2	1.3	1.0	1.9	6.3	1.0	0.6	8.0	2.1	3.1	2.8	6.1	0.8	15.5	18.2	64.3	20.8	17.5	11.4	13.5	14.7	13.5	13.1	15.2	19.2	25.0	12.8	12.3	14.7	55.8	37.1	29.0	27.8	113.8	112.4	101.1	53.6	4.7	8.6	25.4	55.2	22.9	29.7	35.5	57.6	86.1	33.7	0.8	50.4	44.6	35.7	16.7	1.7	13.8	19.6	98.7	61.5	18.3	107.7	39.3	20.3	35.3	3.9	32.3	25.2	26.7	38.0	50.8	45.3	56.7	2.3	27.7	35.8	56.9	10.3	61.8	28.4	17.5	17.1	13.9	49.2	24.6	27.4	20.5	74.3	29.6	70.9	15.3	46.8	65.7	61.3	41.5	9.2	10.1	40.8	26.7	15.7	31.1	17.1	16.1	57.8
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747426-132754403	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;intestine: 3.6"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 3.5;Muller glia cells: 4.9;Plasma cells: 4.8;Undifferentiated cells: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"MOLT-4: 25.7"					"Low region specificity"	"Detected in all"			HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA056288: AB_2683086"	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.2	0.3	1.2	0.9	1.9	0.1	0.2	1.3	1.5	0.5	0.0	2.6	3.6	0.1	0.3	0.1	0.3	0.4	0.3	0.9	0.8	3.1	0.0	0.5	0.8	2.2	1.3	0.2	1.2	0.0	0.6	0.1	1.6	0.9	2.7	1.1	2.6	1.3	0.3	0.3	2.1	0.1	0.9	0.4	2.4	0.7	1.5	1.5	0.4	0.0	0.9	0.9	0.2	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.4	0.0	0.6	25.7	0.1	0.4	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.3	1.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	4.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.8	0.1	1.2	1.9	1.3	1.5	0.9	0.8	2.2	1.3	1.6	0.9	1.5	4.3	0.2	0.0	0.5	0.0	0.9	0.1	0.4	0.8	0.0	0.1	0.4	0.1	0.6	0.0	0.4	0.0	0.0	0.4	0.1	3.4	3.9	0.4	2.2	0.4	0.0	0.1	1.2	0.0	0.6	1.5	0.2	0.3	7.1	0.5	1.3	0.0	0.0	0.0	0.1	1.7	0.5	3.5	0.0	0.0	0.0	2.1	0.3	0.4	0.0	0.0	0.0	4.9	0.0	1.0	2.4	1.5	2.3	0.0	4.8	0.6	1.8	0.3	1.0	0.2	0.0	0.1	0.2	0.2	0.7	0.0	0.1	0.0	1.9	0.1	4.2	0.6
CCNQ	"CycM, FAM58A"	ENSG00000262919	"Cyclin Q"	Q8N1B3	X	153587925-153600045	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 72.4;Extravillous trophoblasts: 98.6;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050137, HPA059843"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA050137: AB_2681029, HPA059843: AB_2684140"	"unprognostic (3.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.25e-2)"	11.8	12.8	19.9	8.2	21.3	7.3	11.7	19.6	24.9	11.9	15.6	16.2	8.9	12.9	12.7	13.1	11.1	4.0	33.9	20.8	20.5	13.5	13.2	10.6	12.5	23.2	21.6	10.5	15.0	10.3	23.6	9.2	23.4	13.6	8.0	6.4	12.9	8.8	34.3	12.1	13.6	6.1	20.0	17.2	13.3	6.2	21.2	9.0	11.1	13.6	12.2	14.0	11.7	24.9	43.7	31.2	12.1	43.5	20.9	11.2	18.7	25.0	21.8	23.5	23.6	33.3	14.3	34.9	44.6	25.1	35.3	26.7	38.4	22.6	22.2	20.3	39.2	7.8	19.4	23.5	19.0	28.2	18.9	14.1	20.1	15.7	16.1	10.0	19.0	16.1	10.6	15.6	19.1	50.5	19.7	38.0	15.1	44.4	52.4	22.6	20.0	17.8	17.0	17.6	16.0	21.1	12.0	19.3	34.4	11.9	7.3	25.0	14.6	20.5	29.3	46.7	38.5	21.8	23.1	43.4	18.5	45.4	15.7	0.0	1.6	4.9	2.7	1.4	1.0	6.1	2.3	1.9	1.3	4.1	2.5	1.7	0.9	0.7	0.8	1.2	3.4	1.1	19.9	21.3	19.6	24.9	20.8	20.5	23.2	21.6	23.4	20.0	21.2	24.9	21.0	3.2	13.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	24.1	31.0	0.0	0.0	3.1	7.3	0.0	40.7	20.4	0.0	72.4	23.3	0.0	11.9	17.3	7.8	0.0	0.0	0.0	37.1	98.6	8.4	0.0	8.7	2.5	16.3	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	22.7	0.0	0.0	0.0	0.0	34.0	0.0	0.0	5.9	0.0	0.0	41.6	2.2	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	120.9	10.0	18.4	0.0	0.0
CCNT2		ENSG00000082258	"Cyclin T2"	O60583	2	134918235-134959342	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005559	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA005559: AB_1078608"	"unprognostic (2.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.44e-4)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (3.28e-4)"	13.4	12.1	10.1	12.2	10.2	29.0	15.6	13.7	12.4	16.4	10.6	13.0	13.4	13.5	14.8	12.8	14.0	9.4	11.7	9.9	10.8	10.9	18.3	14.9	15.5	10.4	10.0	17.4	19.8	15.0	15.1	12.0	10.8	13.5	12.1	19.0	13.0	10.7	10.3	15.4	14.4	8.5	11.1	15.6	14.8	12.3	10.5	14.4	14.5	9.7	14.1	15.0	16.3	14.4	9.0	4.4	28.0	10.5	13.6	13.7	21.3	12.2	9.9	11.2	13.9	11.9	10.1	14.6	8.9	10.0	5.4	11.4	17.0	9.1	16.3	7.9	11.5	15.8	11.9	16.9	13.3	14.3	13.4	12.6	17.6	11.1	13.5	14.4	16.8	10.8	13.4	14.6	13.2	6.1	16.0	21.2	22.8	7.4	9.0	15.2	10.0	11.7	17.4	24.4	19.1	15.8	8.9	10.3	14.2	20.3	10.8	17.3	15.3	14.4	15.9	6.2	9.0	10.2	6.7	15.1	9.0	11.2	12.5	3.8	1.6	2.0	1.7	2.0	2.1	1.6	1.9	2.1	2.1	1.2	3.3	2.6	2.1	2.8	1.0	1.9	2.6	1.3	10.1	10.2	13.7	12.4	9.9	10.8	10.4	10.0	10.8	11.1	10.5	14.4	27.1	25.6	26.0	49.6	38.0	15.0	28.8	17.9	26.7	34.7	21.6	15.4	23.5	14.3	21.8	14.7	33.3	11.9	35.3	22.4	7.9	16.2	5.5	20.2	30.2	21.5	18.5	20.0	73.6	14.9	9.6	23.7	46.9	33.1	11.4	31.1	18.9	20.9	10.1	42.1	70.1	16.4	6.1	15.7	22.1	14.6	14.0	25.2	8.8	52.5	23.6	12.9	19.6	76.9	81.8	14.2	19.0	22.2	26.5	35.4	19.1	7.0	12.4	34.5	19.7	17.7	24.2	17.7	23.6	25.3	18.2	13.7	29.0	25.2	17.1	50.5
CCSER2	"FAM190B, KIAA1128"	ENSG00000107771	"Coiled-coil serine rich protein 2"	Q9H7U1	10	84328586-84518521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 1945.3;Late spermatids: 5466.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037481, HPA037482"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA037481: AB_10672385, HPA037482: AB_10671501"	"unprognostic (4.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.74e-2)"	20.1	10.0	22.4	9.4	22.1	9.6	13.7	28.6	23.1	18.4	15.8	20.7	11.5	18.9	15.3	27.8	10.2	12.2	55.7	22.4	28.3	11.6	12.7	16.5	12.1	31.0	25.1	13.6	11.8	11.4	6.6	10.7	32.2	14.6	12.2	18.5	9.5	15.5	66.2	13.3	11.3	24.7	25.4	10.3	10.8	63.1	31.0	16.3	24.5	62.9	11.3	16.5	11.0	26.8	17.1	13.0	15.2	33.7	21.4	35.1	10.7	20.2	33.1	12.3	23.8	7.4	17.7	11.4	12.9	37.1	19.7	14.2	11.5	12.8	18.4	37.5	7.2	4.1	5.8	9.3	20.1	6.1	8.3	17.4	18.1	19.8	62.2	31.5	33.7	21.0	5.4	33.6	22.2	10.6	10.6	4.3	6.6	5.9	10.3	10.6	7.8	4.2	11.0	17.8	4.6	8.4	11.1	7.3	34.7	20.9	13.4	3.0	30.5	36.7	16.6	18.2	21.5	33.5	12.2	9.0	23.7	7.7	16.2	4.9	4.3	7.7	19.4	3.9	19.8	7.5	14.3	18.2	4.1	6.9	12.8	13.8	5.9	20.3	3.2	6.2	9.6	8.5	22.4	22.1	28.6	23.1	22.4	28.3	31.0	25.1	32.2	25.4	31.0	26.8	50.9	41.7	40.8	120.2	28.8	35.3	57.8	28.1	22.8	87.0	43.7	43.1	218.6	12.8	32.6	16.5	31.3	24.9	101.2	16.1	37.2	31.3	1945.3	21.2	33.9	54.1	16.3	3.0	146.7	45.8	19.3	52.2	21.4	28.8	14.5	28.5	37.1	24.0	20.9	62.2	142.5	28.9	22.4	21.4	66.2	5466.2	51.6	29.2	26.6	124.6	39.5	58.5	81.4	209.6	222.3	34.1	13.8	59.8	42.1	55.4	49.6	26.1	22.0	55.9	13.1	61.8	65.3	103.6	84.0	36.4	47.0	68.4	90.4	30.0	21.4	67.2
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	85.3	122.3	121.4	103.0	125.8	79.5	119.4	132.2	176.7	77.1	139.0	95.3	87.2	93.6	77.1	106.9	119.9	67.4	100.8	125.3	135.5	114.5	108.3	60.1	123.9	129.4	126.1	113.5	82.3	120.4	65.3	93.3	129.5	86.6	112.9	135.7	74.9	89.8	134.8	93.8	83.3	137.3	132.4	67.1	80.7	120.3	130.2	129.1	87.6	120.8	148.5	136.7	70.6	143.8	432.3	562.3	324.3	311.9	352.5	261.2	419.7	388.8	315.9	617.9	378.0	611.1	396.3	689.5	442.3	337.9	392.5	395.5	1045.2	519.9	519.1	384.3	660.6	437.6	438.6	579.2	261.9	547.7	357.2	333.7	312.4	556.6	514.7	303.3	531.6	425.3	795.2	250.1	375.5	603.5	688.2	372.1	656.4	859.5	702.1	587.3	314.5	771.1	496.9	349.9	434.9	448.1	347.0	635.0	388.7	531.0	560.2	707.3	366.1	249.0	373.0	263.3	717.1	457.5	808.2	975.7	288.1	349.1	408.1	75.1	107.1	49.0	129.0	137.0	171.2	142.1	144.3	138.8	171.7	156.8	177.0	156.7	14.9	145.8	146.8	120.8	164.3	222.3	121.4	125.8	132.2	176.7	125.3	135.5	129.4	126.1	129.5	132.4	130.2	143.8	82.8	54.5	62.5	18.3	104.8	144.9	241.1	247.4	119.5	124.5	133.2	118.5	121.1	98.7	132.3	90.1	106.3	226.7	100.5	71.7	113.5	208.6	111.9	118.4	137.4	122.4	125.3	134.0	29.7	183.2	217.8	113.9	70.8	86.6	73.0	180.1	74.6	88.4	162.6	74.0	34.6	93.8	193.3	83.0	96.5	226.7	83.6	78.1	112.1	22.5	153.6	158.1	105.0	37.2	41.9	199.1	78.8	88.0	95.8	169.0	115.9	212.3	137.6	244.3	118.3	110.3	145.4	410.0	232.4	123.1	159.8	184.6	112.1	347.9	149.8	157.9
CCT6A	"CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20"	ENSG00000146731	"Chaperonin containing TCP1 subunit 6A"	P40227	7	56051685-56063989	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 1612.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Supported		Approved	Cytosol		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (9.00e-10)"	"unprognostic (1.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.44e-3)"	58.5	58.8	48.3	66.6	50.5	67.0	59.7	52.6	71.1	43.5	55.9	52.6	53.2	52.0	38.2	68.1	50.9	39.8	56.7	50.2	56.4	72.5	53.3	41.1	69.6	52.5	52.9	42.1	60.8	69.4	39.1	56.4	53.9	44.9	60.1	46.5	45.5	49.4	124.3	58.0	51.8	61.4	53.2	46.1	52.2	49.5	53.5	61.3	49.7	85.5	81.1	72.1	47.6	55.3	1612.6	357.8	211.6	322.5	145.7	181.6	243.2	293.0	165.4	284.4	227.7	407.0	196.7	487.8	222.9	192.1	511.6	333.2	438.2	339.2	390.0	276.8	328.1	306.1	337.0	363.8	157.3	444.1	240.5	157.1	191.1	287.8	284.4	224.8	283.7	221.2	682.0	121.2	325.5	199.2	346.4	392.7	449.3	356.6	466.8	315.1	213.9	284.8	321.6	302.3	280.3	282.0	259.2	440.7	272.6	321.8	324.6	341.6	238.6	194.1	372.4	651.4	617.1	146.7	321.5	596.7	194.4	389.0	658.4	21.0	69.9	34.0	57.8	87.7	77.3	65.9	59.7	63.3	96.5	50.4	59.8	64.8	8.4	77.7	103.0	54.0	68.3	81.2	48.3	50.5	52.6	71.1	50.2	56.4	52.5	52.9	53.9	53.2	53.5	55.3	94.6	89.8	106.4	13.1	83.3	108.8	201.4	175.3	91.6	60.2	77.4	83.2	114.0	65.8	187.7	47.8	27.1	199.6	93.4	56.6	88.0	263.1	22.5	209.6	121.0	129.4	102.1	163.4	19.3	274.2	264.8	97.0	88.2	133.8	131.7	123.4	71.0	66.7	148.2	38.7	23.7	94.2	124.1	83.5	79.2	19.5	70.5	104.0	58.7	19.7	206.9	80.7	80.3	18.1	22.7	245.6	66.7	90.7	106.4	184.8	65.2	146.4	190.3	60.8	59.2	99.1	136.3	115.0	219.8	160.9	109.7	199.9	91.8	189.7	138.6	145.9
CCT6B	"Cctz2, TSA303"	ENSG00000132141	"Chaperonin containing TCP1 subunit 6B"	Q92526	17	34927859-34981078	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"testis: 126.1"	"Group enriched"	"Detected in many"	27	"Early spermatids: 448.5;Late spermatids: 185.2;Spermatocytes: 490.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"unprognostic (1.56e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.99e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.56e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.82e-7)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-1)"	"unprognostic (4.23e-4)"	"unprognostic (1.49e-1)"	2.9	3.3	1.9	0.8	2.3	3.8	5.5	2.0	2.7	2.2	1.6	1.7	1.4	1.9	5.5	1.8	2.7	0.9	1.7	1.7	2.0	4.0	5.0	1.2	1.4	2.2	2.1	2.4	2.6	2.5	2.7	0.6	2.3	2.7	1.1	2.3	3.3	2.6	5.1	2.7	1.4	1.6	2.3	1.6	2.0	126.1	2.0	1.6	2.9	3.8	1.7	1.9	1.5	2.7	0.7	1.0	2.6	1.1	3.3	2.0	0.9	1.3	5.3	2.2	3.1	0.7	2.1	5.0	0.5	2.4	1.6	1.0	0.1	0.7	0.7	0.5	1.9	0.7	0.3	0.6	4.5	2.4	0.7	2.7	1.3	0.2	2.6	0.4	0.6	0.8	0.5	5.0	2.4	1.9	0.5	5.2	1.4	0.4	0.6	2.4	1.2	12.2	1.4	0.8	3.0	1.5	2.4	0.9	4.1	0.6	1.9	2.4	0.5	1.0	0.1	1.2	0.6	4.4	1.0	4.7	1.1	1.5	1.3	0.0	1.1	0.9	0.6	1.1	0.6	0.9	0.7	0.4	2.6	0.8	1.0	1.0	0.0	1.6	1.1	0.6	0.3	0.6	1.9	2.3	2.0	2.7	1.7	2.0	2.2	2.1	2.3	2.3	2.0	2.7	2.4	0.0	3.1	4.6	2.6	2.4	2.8	3.2	6.2	1.5	8.7	7.0	4.2	4.3	3.9	1.8	0.0	1.8	4.0	0.9	3.9	3.4	448.5	8.8	3.7	2.1	0.0	0.8	3.9	8.0	0.5	3.5	1.5	3.6	2.5	4.6	0.7	3.1	1.5	0.0	3.7	2.3	6.1	2.2	4.0	185.2	10.8	2.9	5.4	4.7	1.6	8.7	4.1	7.1	10.7	2.7	1.6	4.1	3.9	2.1	0.7	6.9	8.8	2.5	0.0	3.7	3.0	490.2	13.5	3.1	2.6	0.8	2.7	6.9	1.8	3.6
CCT7	"Ccth, Nip7-1"	ENSG00000135624	"Chaperonin containing TCP1 subunit 7"	Q99832	2	73233420-73253021	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 393.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008425	Approved		Approved	Cytosol		NA	NA		1900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA008425: AB_1078428"	"unprognostic (5.02e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.37e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.12e-2)"	113.3	150.8	104.5	108.6	109.7	93.4	111.4	114.6	110.9	109.6	118.1	113.6	84.8	123.0	117.1	119.7	133.3	69.0	162.9	109.1	114.5	111.9	114.0	83.4	126.5	109.7	109.4	140.4	114.2	134.7	97.0	101.4	114.0	115.2	123.2	83.7	92.1	110.7	252.4	103.9	88.3	147.5	112.7	98.7	106.8	162.9	110.7	153.0	87.4	241.2	158.5	120.0	101.1	120.7	396.3	641.9	361.8	393.0	259.1	211.7	460.7	348.6	311.8	573.6	359.0	1054.5	272.1	760.3	219.0	365.9	529.3	328.2	816.6	533.8	635.9	420.7	722.9	516.2	403.2	755.3	287.5	614.9	367.5	328.9	297.7	565.9	683.3	301.4	521.0	444.7	650.2	265.8	488.7	613.6	686.5	776.1	519.1	540.6	455.8	614.8	927.2	535.0	411.6	374.7	512.4	315.9	302.6	411.0	406.7	333.6	235.2	331.4	339.7	390.9	464.3	245.7	679.7	298.1	341.1	709.2	319.4	686.1	435.6	157.7	131.4	78.1	190.8	178.8	211.3	216.6	193.5	191.4	202.0	208.8	208.9	195.3	39.5	192.1	209.8	203.7	186.0	299.3	104.5	109.7	114.6	110.9	109.1	114.5	109.7	109.4	114.0	112.7	110.7	120.7	77.7	57.7	45.6	12.4	87.5	69.1	149.7	161.5	55.8	81.1	63.8	77.1	99.2	68.6	96.7	58.8	18.8	190.2	74.3	54.8	109.5	148.2	393.0	99.8	96.4	91.6	75.3	77.8	10.8	139.0	213.2	94.8	57.1	58.1	73.6	108.2	61.8	69.3	133.6	82.4	13.3	102.2	118.0	58.8	58.1	246.3	104.7	57.3	74.7	10.3	98.9	125.5	74.2	12.1	15.0	134.1	60.3	107.2	112.3	156.0	67.3	133.2	108.2	88.6	72.3	91.8	126.7	288.9	127.8	71.1	73.6	166.5	77.2	190.6	127.6	112.5
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	72.7	125.0	62.5	99.1	67.0	99.5	100.4	70.3	84.0	78.5	78.0	87.9	77.9	74.8	88.2	83.7	80.9	64.3	116.3	66.9	74.7	102.7	92.7	70.1	140.8	64.5	65.3	88.0	95.3	100.0	40.6	107.0	69.0	77.1	102.1	71.3	70.7	72.5	121.1	75.0	78.6	85.5	66.7	88.9	68.8	79.1	68.7	141.2	78.5	145.2	154.3	122.3	50.3	66.1	437.4	243.1	319.4	233.3	220.4	302.3	350.9	340.5	219.1	386.2	317.5	548.6	269.0	858.8	229.1	237.1	466.8	174.4	632.2	391.7	441.1	364.0	348.1	1185.2	289.8	384.3	227.0	609.0	335.6	229.0	244.9	448.6	372.6	278.6	368.1	379.7	935.8	519.0	404.1	270.9	456.6	359.4	572.6	433.6	310.6	411.7	596.5	547.4	409.1	283.2	316.7	231.6	334.1	356.6	364.7	347.5	319.9	526.7	267.4	221.3	613.7	216.7	439.7	329.2	651.8	695.1	256.3	704.5	339.0	79.9	110.1	54.4	56.9	120.9	79.6	79.8	76.3	73.4	133.3	61.8	85.5	82.1	11.5	87.7	132.2	83.5	92.7	127.4	62.5	67.0	70.3	84.0	66.9	74.7	64.5	65.3	69.0	66.7	68.7	66.1	66.9	64.1	61.7	15.0	120.1	143.1	197.6	278.6	70.0	85.6	88.4	76.5	75.7	90.1	150.0	75.4	18.8	268.9	122.1	67.3	144.8	194.1	17.0	106.6	92.8	94.8	97.0	150.2	26.7	138.0	275.8	93.4	52.0	73.7	112.8	135.6	55.3	53.4	170.5	77.4	31.3	106.2	201.4	115.6	122.4	20.5	84.2	109.9	115.6	26.2	226.6	96.1	97.9	13.6	21.4	131.2	92.1	92.9	130.7	185.9	107.4	189.7	147.7	84.6	105.2	88.7	214.7	170.1	176.8	90.2	131.4	285.3	105.1	254.5	161.1	170.6
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"parathyroid gland: 330.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.3;Basal respiratory cells: 62.8;Hofbauer cells: 45.0;Squamous epithelial cells: 51.4;Suprabasal keratinocytes: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 206.4;BJ hTERT+: 126.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	8.6	1.1	2.3	2.4	2.5	2.8	5.5	2.1	2.1	9.9	0.7	6.9	1.3	12.5	5.6	10.2	3.2	4.1	5.8	2.0	4.0	7.0	1.1	6.6	1.0	3.2	3.6	0.7	0.5	330.4	0.4	6.5	3.5	3.6	2.9	0.2	3.4	2.5	1.2	18.9	2.2	12.6	3.7	2.1	1.1	1.8	2.5	3.1	1.3	3.3	2.2	4.5	7.4	3.1	35.6	29.4	1.5	0.1	48.2	206.4	0.0	30.5	126.0	9.0	18.4	0.1	20.2	0.0	19.7	63.5	19.5	96.5	3.5	60.9	12.1	8.5	5.5	11.5	21.0	5.8	10.1	0.0	0.3	60.7	52.4	18.6	68.7	34.2	71.6	3.9	0.0	0.2	45.0	0.8	0.8	0.0	2.4	0.3	18.9	2.6	8.4	40.6	4.8	3.6	0.0	0.1	68.6	0.7	30.8	1.3	0.8	5.8	68.7	96.8	10.1	17.2	28.5	0.7	17.9	0.1	40.3	0.1	89.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.3	2.5	2.1	2.1	2.0	4.0	3.2	3.6	3.5	3.7	2.5	3.1	65.3	3.2	1.7	39.8	1.1	41.4	8.4	62.8	35.9	0.3	2.2	2.2	13.0	0.0	16.3	0.0	0.0	0.4	1.2	0.1	1.9	0.1	23.4	10.8	10.5	38.0	0.0	7.6	4.0	0.0	0.5	25.0	0.5	15.0	2.5	0.0	21.0	0.6	45.0	0.0	3.3	0.1	4.1	2.7	28.5	21.0	0.6	13.5	23.2	19.7	3.3	0.0	0.0	1.5	1.0	0.4	0.0	0.0	1.7	10.8	0.0	23.5	16.0	0.2	0.0	7.4	13.2	1.0	3.5	51.4	43.8	1.4	4.6	1.4	0.2	7.2
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.9;lymphoid tissue: 31.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 27.5;Breast myoepithelial cells: 20.3;Excitatory neurons: 18.9;Inhibitory neurons: 16.6;Melanocytes: 14.2;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 10.8;HDLM-2: 10.1;HUVEC TERT2: 10.6;TIME: 10.1;U-87 MG: 22.7"									HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA		660000		"Cluster 14: B-cells - Humoral immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 30: Mammary glandular cells - Lactation"	"Centrosome, Cytosol"	Nucleoplasm	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	7.5	2.0	0.6	6.4	0.7	0.1	3.7	0.4	1.4	2.0	1.3	14.6	8.6	0.9	0.6	3.0	0.7	4.2	1.3	0.6	0.5	0.7	2.6	2.7	8.0	1.7	1.3	0.3	0.4	0.3	0.5	10.6	1.8	0.5	21.9	1.8	0.8	1.2	0.4	0.6	18.5	3.2	1.2	31.8	4.5	4.1	3.6	4.6	0.7	0.9	6.3	6.1	0.3	1.0	0.2	0.5	0.3	0.0	1.1	0.4	0.0	1.0	2.1	0.2	0.9	0.0	1.7	0.0	0.4	1.0	10.8	0.0	0.0	1.4	1.6	10.1	0.0	0.0	0.6	1.6	0.0	0.7	0.1	0.3	0.0	0.3	3.9	0.7	10.6	0.0	0.2	5.6	6.3	0.0	0.0	8.1	0.2	0.0	0.0	1.9	1.8	2.2	0.0	0.0	1.4	6.5	5.1	8.0	0.0	0.4	0.0	6.6	10.1	3.5	3.2	0.3	0.0	0.1	0.1	0.0	22.7	0.5	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	1.4	0.6	0.5	1.7	1.3	1.8	1.2	3.6	1.0	4.1	0.0	0.0	2.6	0.3	1.3	0.0	1.1	0.0	2.5	27.5	20.3	0.7	0.0	2.1	0.0	4.2	0.1	0.5	0.4	0.0	0.0	3.1	0.0	0.1	2.5	0.0	0.0	18.9	1.4	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.4	9.1	0.0	16.6	0.1	4.1	4.1	5.2	1.5	0.0	6.4	14.2	7.5	0.2	1.1	0.0	4.5	2.4	3.3	2.6	0.0	1.2	0.0	0.0	0.1	1.2	2.1	19.7	2.1	10.5	3.4	0.8	0.1	1.3	0.3	0.3	0.0	0.1	0.1
CD164L2		ENSG00000174950	"CD164 molecule like 2"	Q6UWJ8	1	27379176-27383333	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 19.9;fallopian tube: 30.0;salivary gland: 13.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 28.5;Endometrial ciliated cells: 53.6;Respiratory ciliated cells: 146.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.2;CAPAN-2: 4.1;HaCaT: 1.9;HBEC3-KT: 2.2;hTCEpi: 2.8;SK-BR-3: 2.6;T-47d: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062915	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA062915: AB_2684903"	"unprognostic (8.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.64e-5)"		"unprognostic (7.81e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.91e-6)"	"unprognostic (1.33e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.71e-2)"	0.1	0.1	0.3	0.0	0.3	0.0	2.5	0.2	0.4	4.9	1.0	0.2	0.0	0.3	0.5	19.9	30.0	0.1	0.0	0.4	0.3	0.9	0.2	5.1	0.0	2.0	1.5	0.0	0.8	0.8	3.4	0.0	0.6	4.1	0.2	0.0	13.5	0.3	0.0	11.1	0.1	0.0	0.8	0.0	0.7	0.5	0.2	0.9	0.4	0.0	1.8	0.0	9.3	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.9	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.1	0.1	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	2.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.4	0.3	2.0	1.5	0.6	0.8	0.2	0.4	0.2	0.0	3.7	0.0	0.2	2.9	9.6	12.9	28.5	0.0	5.7	14.4	0.9	0.0	10.1	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.2	53.6	0.5	1.5	0.0	0.0	0.2	0.2	0.1	0.5	0.0	1.0	0.0	0.0	1.1	0.0	0.1	0.0	0.3	0.5	12.2	0.0	0.4	1.6	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.2	3.4	0.0	0.1	146.1	0.0	0.0	0.1	2.8	0.1	1.0	9.3	2.8	0.0	0.4	0.0	0.5	4.4
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	157	"lymphoid tissue: 528.9"	"Cell type enriched"	"Detected in some"	21	"Langerhans cells: 153.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"myeloid DC: 19.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 19.2"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 587.9"									HPA021824	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"	Cytosol	"HPA021824: AB_1846262"	"unprognostic (7.72e-3)"	"unprognostic (1.55e-4)"	"unprognostic (1.66e-5)"	"unprognostic (1.04e-2)"		"unprognostic (1.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.53e-2)"	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.6	0.0	0.7	0.1	0.0	0.0	0.1	0.2	1.0	2.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	3.3	0.2	0.1	0.0	1.0	0.7	0.0	0.0	528.9	0.3	0.1	1.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	118.6	0.0	0.0	0.0	0.0	587.9	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.9	153.1	0.2	0.0	7.0	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466399-74484794	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 95.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 103.5;granulocytes: 59.5;Hofbauer cells: 114.0;Kupffer cells: 97.6;Macrophages: 90.9;NK-cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 104.4;NB-4: 45.9;RPMI-8226: 88.7"									"HPA010971, HPA011645"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010971: , HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	10.6	7.5	6.7	31.1	7.1	24.4	4.6	7.1	31.1	2.8	7.5	9.2	11.3	3.5	1.8	3.5	3.1	14.2	4.7	6.9	7.8	3.5	14.6	18.1	27.0	11.4	8.6	1.5	3.2	1.4	3.6	13.9	13.2	4.0	8.6	1.0	4.0	2.5	1.6	4.5	13.5	11.7	9.2	95.2	4.9	1.2	12.1	14.1	2.3	2.7	11.7	9.5	2.6	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	5.5	104.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.5	45.9	0.0	0.0	0.0	0.2	0.0	88.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	17.1	0.0	845.6	170.3	481.9	226.4	374.2	48.3	18.9	45.5	67.5	159.2	6.4	16.7	52.5	560.5	456.5	387.6	149.7	3.1	197.0	6.7	7.1	7.1	31.1	6.9	7.8	11.4	8.6	13.2	9.2	12.1	12.5	1.0	0.0	7.4	0.3	7.8	0.9	0.1	0.2	0.0	0.0	0.6	1.8	0.6	1.5	0.7	0.0	0.0	0.7	103.5	0.1	0.0	0.1	0.0	0.6	0.2	2.5	0.0	5.7	0.1	0.0	1.2	0.8	0.5	0.7	59.5	0.0	2.2	1.3	114.0	0.0	0.3	0.2	0.0	97.6	24.0	0.4	0.0	90.9	3.6	5.6	36.6	0.0	225.6	1.0	0.0	0.0	0.1	0.0	14.5	0.1	0.0	0.4	0.6	0.1	6.6	0.6	0.5	0.0	0.4	0.2	0.6	1.5	33.2	0.0	0.2	0.2
CD320	"8D6, 8D6A"	ENSG00000167775	"CD320 molecule"	Q9NPF0	19	8302127-8308358	"CD markers, Disease related genes, Predicted membrane proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 419.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 418.4;RPMI-8226: 381.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014500, HPA073489"	Approved		Approved	Cytosol		NA	NA		61000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA014500: AB_1846295, HPA073489: AB_2686609"	"unprognostic (9.97e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (4.19e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.90e-2)"	61.8	44.7	39.3	15.8	36.7	8.1	57.5	41.1	42.8	26.2	46.7	52.9	18.8	34.2	63.4	15.7	28.4	16.5	48.4	34.1	40.0	31.2	24.1	25.9	15.3	42.8	40.9	27.7	45.3	15.5	25.7	11.4	46.7	35.2	15.5	4.7	21.3	12.8	34.2	15.8	43.8	13.0	40.9	57.1	45.5	38.3	44.1	10.5	44.4	16.7	7.1	32.5	21.3	36.0	71.7	71.5	15.5	201.1	49.2	25.6	36.6	36.6	48.5	71.2	54.3	77.0	41.7	63.7	111.4	26.8	53.3	44.7	0.1	57.7	13.8	90.0	216.7	30.8	58.4	111.5	33.1	58.8	74.6	24.4	13.6	41.7	34.4	31.7	70.3	42.3	95.4	214.4	28.4	67.6	63.1	418.4	109.3	62.1	293.6	76.6	21.5	381.7	53.9	1.7	143.4	62.3	75.5	32.1	94.5	11.5	2.6	26.2	40.5	82.0	60.6	122.9	117.0	200.5	136.3	71.0	58.4	214.3	90.2	0.5	2.7	0.1	219.9	3.0	125.9	48.4	140.0	117.7	5.1	49.4	94.1	107.1	3.3	91.0	2.2	113.8	102.4	69.4	39.3	36.7	41.1	42.8	34.1	40.0	42.8	40.9	46.7	40.9	44.1	36.0	419.5	12.8	18.8	6.2	34.4	18.5	29.8	39.3	25.6	53.7	42.6	47.6	34.6	14.3	13.0	18.4	33.3	42.7	53.4	126.2	13.7	46.5	25.2	14.6	28.2	146.8	50.9	22.5	6.1	18.5	54.0	53.3	23.0	22.5	11.4	65.6	143.5	20.0	29.5	21.9	10.2	69.6	26.4	7.5	20.2	57.9	21.8	6.4	39.2	34.7	6.2	21.6	33.0	9.0	5.5	18.6	54.7	17.0	121.2	60.8	3.3	48.0	8.8	46.2	13.1	32.0	26.3	122.1	30.2	10.4	14.1	35.4	43.3	119.3	128.6	21.1
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 139.6;T-cells: 294.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	21	"gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.7"	"Group enriched"	"Detected in some"	52	"JURKAT: 70.9;MOLT-4: 193.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	0.7	0.8	0.6	10.5	0.8	1.3	1.0	1.1	0.8	0.7	1.1	2.3	3.3	0.5	0.6	1.4	0.9	2.5	0.5	0.5	0.4	0.6	1.6	2.8	27.9	0.9	0.6	0.4	0.5	0.2	0.0	0.3	0.8	0.9	2.7	0.4	1.6	0.3	10.5	0.9	4.6	0.6	0.3	11.5	4.1	0.4	0.8	94.7	0.6	0.3	20.4	3.0	0.4	1.9	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	70.9	2.5	0.3	0.0	0.6	193.8	1.3	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.7	0.3	0.2	0.2	0.1	9.2	1.2	1.2	229.0	0.6	135.6	0.8	187.3	197.3	0.6	0.9	192.6	241.7	6.4	1.4	1.2	1.5	200.0	90.4	0.6	0.8	1.1	0.8	0.5	0.4	0.9	0.6	0.8	0.3	0.8	1.9	3.2	3.2	6.9	0.0	7.8	2.3	0.1	0.0	1.8	0.2	2.0	2.9	0.8	1.5	1.9	0.0	0.0	0.1	139.6	0.4	0.0	0.3	1.0	0.4	0.4	1.4	0.0	3.4	0.1	0.0	0.0	2.3	13.7	0.4	6.3	0.0	4.2	1.7	0.1	0.0	0.1	0.2	0.0	3.8	5.8	1.4	0.0	7.7	5.4	1.0	8.1	0.0	14.4	0.0	0.3	0.0	0.1	0.0	18.5	0.0	0.0	0.6	0.7	0.8	0.0	1.3	1.6	0.2	0.4	0.6	2.4	0.3	294.0	0.1	0.3	0.0
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711831	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 148.4;lymphoid tissue: 283.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 336.1;dendritic cells: 251.2;Kupffer cells: 245.8;Macrophages: 218.3;monocytes: 366.6;NK-cells: 454.2;T-cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 220.9;HMC-1: 236.9;U-266/70: 501.4;U-266/84: 360.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002497, HPA055146"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	11.8	5.9	1.4	115.3	1.5	148.4	18.8	1.5	4.7	10.2	2.3	24.9	20.5	6.7	5.0	8.4	5.7	26.6	4.3	1.3	1.7	4.4	19.9	31.0	283.9	2.6	1.8	3.1	2.0	1.6	1.6	5.8	2.7	8.1	32.5	0.1	14.0	4.4	2.9	3.5	48.3	12.5	2.1	160.0	32.5	2.9	3.2	138.9	5.2	3.4	256.8	41.8	4.5	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	220.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	6.0	0.0	2.1	0.0	0.0	0.0	27.1	236.9	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.4	78.6	0.0	0.0	78.9	38.4	0.1	0.0	0.0	4.7	0.1	34.3	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.1	0.0	0.3	0.2	0.4	501.4	360.3	89.9	0.2	66.7	0.1	218.1	327.1	230.8	242.8	470.2	335.8	206.2	275.2	283.4	329.7	161.2	277.9	301.6	82.1	160.7	487.4	57.0	229.9	603.5	1.4	1.5	1.5	4.7	1.3	1.7	2.6	1.8	2.7	2.1	3.2	4.1	3.7	0.0	9.6	0.7	336.1	5.5	0.8	0.0	1.8	0.0	2.0	1.7	1.1	2.8	1.3	3.7	0.0	0.6	251.2	0.1	1.9	0.2	0.1	0.7	0.5	2.8	1.2	21.5	0.1	0.2	0.8	2.4	6.6	0.6	90.7	0.1	7.1	2.0	86.4	0.0	0.1	0.1	0.0	245.8	106.5	0.5	1.8	218.3	39.2	1.0	366.6	0.0	454.2	0.5	0.0	0.1	0.0	0.4	127.4	0.4	0.0	4.9	2.2	0.0	0.0	1.7	2.1	0.5	0.3	0.7	3.0	0.4	376.2	0.0	1.2	0.5
CDC123	"C10orf7, D123"	ENSG00000151465	"Cell division cycle 123"	O75794	10	12195965-12250589	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037830, HPA057540"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA037830: AB_10671368, HPA057540: AB_2732614"	"unprognostic (5.35e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.16e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (5.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.19e-2)"	44.9	40.0	38.1	53.8	44.3	73.5	45.9	40.6	46.1	43.5	39.1	54.1	37.1	39.0	46.9	50.1	42.3	34.0	61.0	41.7	41.5	42.6	55.6	35.8	69.1	40.3	38.4	31.4	29.4	42.3	33.0	50.8	40.5	35.4	58.3	29.7	31.5	39.3	49.7	44.3	39.1	53.4	41.3	45.3	35.4	35.7	40.1	65.2	41.5	52.5	81.1	63.6	34.7	43.7	155.4	187.4	148.3	157.1	125.4	136.3	117.7	137.0	94.2	194.8	205.5	274.0	186.5	259.7	123.5	153.6	116.1	157.7	237.0	223.3	172.0	176.8	206.6	199.3	142.8	266.6	162.1	151.6	159.0	131.3	118.9	214.0	126.5	98.0	206.3	320.6	224.2	114.5	178.6	135.0	208.3	133.8	221.4	223.1	76.3	195.7	111.9	234.0	173.2	86.3	72.3	140.8	139.6	165.4	152.6	120.4	180.7	179.2	200.9	107.7	127.6	167.9	166.6	112.5	233.5	320.7	135.4	155.3	69.7	133.8	99.2	242.2	103.6	117.0	108.1	158.6	114.8	115.0	139.0	170.5	93.5	99.9	233.4	121.1	129.4	116.0	143.5	167.3	38.1	44.3	40.6	46.1	41.7	41.5	40.3	38.4	40.5	41.3	40.1	43.7	48.6	32.1	35.9	18.3	51.5	54.2	49.2	162.1	39.9	28.5	28.0	32.3	56.4	24.3	75.8	35.0	6.2	120.8	55.3	25.1	86.1	91.1	7.9	26.8	39.5	49.7	20.9	36.8	33.2	82.6	138.2	46.3	26.5	26.1	49.4	36.6	34.2	37.6	101.3	26.9	27.9	31.9	105.8	25.9	34.0	10.1	41.7	37.2	46.2	21.5	79.3	43.3	45.3	19.6	23.5	84.3	34.3	45.9	44.2	46.5	30.7	73.0	62.5	29.9	39.5	32.3	59.8	50.2	41.5	46.5	74.0	77.6	51.3	72.4	47.0	50.7
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDC42EP2	"BORG1, CEP2"	ENSG00000149798	"CDC42 effector protein 2"	O14613	11	65314866-65322417	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 50.5;Langerhans cells: 77.7;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 50.4;intermediate monocyte: 118.8;neutrophil: 171.5;non-classical monocyte: 88.5"	"Group enriched"	"Detected in many"	15	"granulocytes: 171.5;monocytes: 118.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.5;PC-3: 61.0;U-2197: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038562	Approved		Supported	Microtubules,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Microtubules, Cytosol"		"HPA038562: AB_10671745"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.73e-3)"	"prognostic unfavorable (2.89e-5)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-2)"	42.1	5.7	15.4	7.7	25.1	0.4	23.1	20.7	20.0	13.9	5.8	15.4	9.1	16.6	1.7	7.7	15.3	15.2	22.4	15.7	17.0	15.3	4.1	19.1	1.8	24.9	23.6	10.8	5.8	0.6	5.0	11.6	22.3	10.2	1.6	1.9	4.9	4.5	6.6	5.6	13.0	6.8	17.5	18.4	14.5	2.1	21.4	0.4	16.8	5.6	1.2	18.6	9.4	44.3	7.1	6.6	0.9	4.3	14.6	26.4	1.3	7.4	28.8	5.5	6.2	19.8	16.7	0.5	20.9	19.9	2.0	8.9	2.5	26.0	1.2	1.0	3.8	1.3	12.8	14.8	51.5	0.4	0.5	11.5	2.7	20.3	28.8	4.5	22.4	1.0	2.6	4.3	7.1	10.7	0.8	1.6	3.7	18.5	61.0	0.8	0.7	0.5	19.5	4.9	0.5	1.7	18.0	14.7	1.1	0.7	2.5	0.4	30.6	6.7	5.6	55.9	3.1	0.1	1.7	0.6	11.2	0.3	2.7	0.0	50.4	2.1	0.1	118.8	0.1	1.2	0.0	0.1	9.9	0.0	0.1	0.0	171.5	0.0	88.5	0.4	0.0	17.8	15.4	25.1	20.7	20.0	15.7	17.0	24.9	23.6	22.3	17.5	21.4	44.3	25.8	0.0	0.0	0.0	1.5	12.7	11.0	25.8	6.8	15.3	12.1	6.3	6.3	2.8	17.0	12.9	0.0	0.5	1.6	10.0	3.9	50.5	0.5	6.0	11.6	36.4	1.8	2.7	0.6	40.3	3.5	32.3	9.7	11.1	5.7	1.5	26.7	0.9	1.3	3.3	0.4	8.0	8.2	18.7	77.7	1.9	18.6	33.3	12.4	1.0	18.3	1.0	0.0	0.0	10.6	65.1	15.6	13.5	1.8	7.4	21.2	3.7	6.3	5.3	39.5	16.6	16.2	1.7	3.4	4.8	10.1	1.6	1.4	1.8	8.4	36.4
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287879-40304657	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2;lymphoid tissue: 17.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 500.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	2.1	1.9	0.5	13.7	0.8	27.2	3.4	0.2	1.9	3.2	0.0	8.4	7.5	2.2	1.1	5.7	1.0	2.8	0.6	1.1	0.1	0.5	3.0	1.4	16.4	0.1	0.0	0.9	1.9	0.8	0.5	9.3	0.3	1.1	8.7	0.5	1.3	1.2	0.3	2.8	6.7	3.7	0.0	3.7	3.6	10.1	0.2	16.7	1.7	0.5	17.1	4.3	1.8	0.6	155.1	119.0	115.1	86.5	6.7	12.7	118.0	159.9	49.0	149.2	166.5	135.8	64.9	123.9	99.6	35.9	85.9	214.0	112.2	76.2	148.9	64.5	98.4	96.2	122.3	134.6	4.4	133.3	55.1	4.7	8.1	156.4	107.1	14.8	46.9	84.2	183.0	109.0	71.9	95.8	199.3	43.3	101.6	96.9	48.7	145.0	286.8	119.9	30.3	184.8	85.6	76.9	146.9	500.3	55.4	100.3	100.8	120.0	34.7	95.5	146.3	170.8	196.1	46.1	103.6	222.8	84.6	93.9	109.2	0.1	0.1	0.0	0.8	0.0	0.5	0.4	0.6	1.1	0.7	0.3	0.4	1.1	0.1	1.5	0.0	3.6	2.4	0.6	0.5	0.8	0.2	1.9	1.1	0.1	0.1	0.0	0.3	0.0	0.2	0.6	2.2	0.0	2.0	0.7	4.9	4.2	1.1	3.7	3.4	0.2	2.1	2.2	0.9	1.5	1.3	0.0	0.0	23.2	2.3	7.8	0.0	1.3	2.2	1.3	2.9	2.1	0.0	37.2	2.0	0.6	34.6	5.6	3.6	5.1	0.0	8.1	1.1	0.9	8.3	0.0	0.7	6.1	0.0	1.3	2.1	1.0	2.8	1.5	0.0	0.0	0.0	0.4	2.1	0.0	0.2	1.5	3.0	0.7	31.6	1.3	0.8	0.2	0.2	0.3	13.1	0.6	4.6	69.5	57.2	9.1	1.6	16.7	3.3	1.9	9.3	2.4
CDCA3	"GRCC8, TOME-1"	ENSG00000111665	"Cell division cycle associated 3"	Q99618	12	6844793-6851292	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.5;retina: 66.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Erythroid cells: 46.5;Extravillous trophoblasts: 74.1;Proximal enterocytes: 65.5;Spermatocytes: 71.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA026587			Approved	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA026587: AB_1846386"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.51e-5)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (3.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-3)"	"unprognostic (8.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.94e-2)"	1.2	2.6	0.7	7.3	0.5	16.0	1.2	1.0	1.0	4.4	0.3	6.1	20.7	2.9	0.4	9.0	1.9	1.1	2.8	0.6	0.6	1.6	1.6	1.7	17.2	0.7	0.7	4.6	1.1	0.4	8.6	4.7	0.6	3.1	7.8	66.3	2.5	0.3	0.5	6.3	18.5	3.0	0.4	4.6	3.2	21.4	0.6	30.5	1.8	0.2	23.4	2.2	4.0	0.5	106.8	88.8	81.0	45.1	4.3	6.8	95.0	71.7	46.4	119.5	83.3	142.7	86.9	64.9	8.6	54.9	86.9	71.0	53.3	55.0	117.0	97.2	60.9	56.8	58.9	81.7	0.5	41.3	47.2	3.1	3.9	63.0	34.6	27.9	50.9	44.2	47.8	36.4	116.7	94.1	60.0	46.0	86.2	75.8	62.3	57.6	68.5	34.3	40.2	36.4	12.2	23.6	61.8	53.5	18.7	87.0	21.9	38.6	22.3	52.6	67.2	35.0	117.2	19.7	21.5	104.2	25.4	53.6	92.0	0.0	0.2	0.0	0.1	0.1	0.3	0.7	0.7	0.8	0.2	0.2	0.2	0.4	0.2	0.4	0.3	1.1	4.3	0.5	0.7	0.5	1.0	1.0	0.6	0.6	0.7	0.7	0.6	0.4	0.6	0.5	0.7	0.0	0.5	0.7	4.1	2.9	1.7	5.0	2.2	12.3	1.9	2.5	1.2	1.5	1.1	0.0	56.3	29.5	0.9	6.9	0.0	1.1	12.4	1.8	2.3	1.7	1.2	46.5	0.5	0.4	74.1	5.2	4.6	2.3	4.5	15.2	3.9	1.6	19.3	6.7	0.6	11.9	4.1	4.0	3.1	6.8	1.8	3.5	0.0	1.0	1.1	1.1	1.0	0.5	0.5	0.4	4.0	0.4	19.2	1.4	65.5	0.9	0.4	18.0	6.6	0.5	8.3	71.5	14.8	12.6	1.8	8.5	4.6	1.4	17.4	2.6
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 64.2;Cytotrophoblasts: 84.5;Extravillous trophoblasts: 154.5;Spermatogonia: 69.9;Suprabasal keratinocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064971			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA064971: AB_2685395"	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (4.19e-4)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	3.9	2.6	1.9	7.4	2.0	55.8	4.2	3.0	2.1	8.7	2.1	4.6	4.7	5.4	1.8	18.6	4.1	2.6	2.7	1.7	1.8	3.4	2.7	3.6	11.6	2.1	1.9	4.1	3.2	1.8	1.7	9.2	2.1	3.8	2.9	1.3	5.5	2.2	1.4	24.7	4.9	3.5	1.9	6.6	3.8	11.6	2.0	14.6	3.3	1.5	8.5	4.2	10.2	2.0	40.6	41.3	46.7	35.6	7.9	13.2	61.1	59.0	18.0	45.2	39.7	50.9	50.2	52.9	31.5	20.9	34.5	63.5	32.9	68.0	27.1	58.2	26.1	33.4	33.9	43.2	9.7	59.8	27.0	9.4	20.8	35.2	32.7	15.1	31.4	45.0	37.5	53.0	32.1	98.8	56.2	40.1	34.8	35.1	94.0	53.6	68.1	19.7	15.9	46.2	27.2	33.5	56.6	22.3	46.8	20.5	44.0	39.8	48.8	39.9	50.5	55.3	79.5	19.5	25.9	54.4	33.5	30.2	67.5	1.1	4.3	10.6	11.9	4.9	14.8	8.4	12.7	16.7	4.7	5.4	7.4	8.9	1.6	12.9	5.6	5.1	11.1	7.0	1.9	2.0	3.0	2.1	1.7	1.8	2.1	1.9	2.1	1.9	2.0	2.0	5.4	0.0	2.2	0.7	7.4	64.2	26.5	36.6	13.1	3.4	8.7	8.3	0.6	0.0	9.0	1.8	0.0	84.5	11.5	4.3	3.9	12.7	8.1	9.0	9.0	10.9	3.0	53.0	1.8	7.0	154.5	10.2	3.1	12.5	28.6	15.1	7.9	2.2	24.3	13.5	1.3	6.6	6.1	5.9	22.6	6.8	8.4	8.4	17.8	2.8	9.3	4.6	9.2	1.0	1.8	12.3	3.3	6.0	11.8	16.1	1.9	1.8	7.7	2.6	6.6	4.6	12.5	43.0	69.9	21.3	67.1	25.9	17.7	3.6	9.5	43.2
CDH24	CDH11L	ENSG00000139880	"Cadherin 24"	Q86UP0	14	23047062-23057538	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 11.7;Astrocytes: 9.1;Bipolar cells: 8.2;Endothelial cells: 8.8;Enteroendocrine cells: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 52.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074551			Approved	Vesicles,Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	Vesicles	"HPA074551: "	"unprognostic (2.30e-1)"	"unprognostic (3.06e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.71e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.85e-2)"	4.3	2.4	4.9	1.2	3.8	1.2	3.6	3.8	4.7	5.9	1.7	2.7	1.1	8.6	1.1	4.0	4.3	4.2	2.0	9.4	4.3	2.9	0.5	3.3	1.3	4.0	3.9	2.4	2.1	2.2	1.9	1.6	3.9	3.1	1.7	1.7	3.1	1.6	0.7	2.9	2.4	4.0	2.3	2.4	2.0	1.7	3.8	3.7	4.6	0.5	0.9	2.6	4.1	5.3	4.6	4.5	18.3	20.9	4.4	2.2	10.1	8.4	5.4	7.0	9.0	5.7	6.1	0.3	6.7	9.2	1.8	25.8	8.0	7.1	5.6	7.1	6.7	1.0	12.7	1.9	4.9	13.2	0.3	17.3	2.3	7.6	5.0	8.5	11.5	4.2	2.9	11.0	6.1	12.9	1.0	8.8	4.6	4.7	10.2	22.9	6.1	8.4	2.0	3.8	52.9	14.2	19.7	10.4	1.1	5.0	9.3	1.9	10.7	6.9	26.0	2.8	6.3	3.5	1.1	0.3	7.2	3.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.8	3.8	4.7	9.4	4.3	4.0	3.9	3.9	2.3	3.8	5.3	11.7	0.0	0.0	9.1	0.3	1.5	0.8	0.5	3.4	8.2	2.1	1.1	2.0	0.0	0.5	1.8	0.0	2.3	0.9	1.9	1.9	0.5	0.4	0.6	2.1	8.8	10.7	0.0	2.6	0.5	2.5	1.7	1.1	1.0	0.0	4.3	2.5	0.0	0.6	0.0	1.7	1.7	0.0	0.0	0.3	1.0	0.0	0.1	1.8	2.8	0.1	4.4	0.0	5.5	0.2	0.6	0.3	0.0	0.3	0.8	0.2	0.5	0.5	0.8	0.0	0.2	1.5	1.1	2.5	2.0	2.3	1.9	0.7	2.5	2.1	0.9
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 101.5;Oligodendrocytes: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 134.8;TIME: 160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	21.4	11.2	26.3	18.9	45.9	48.1	18.4	23.0	34.7	13.2	8.3	17.0	11.9	26.2	9.1	14.6	13.9	16.2	11.4	36.7	28.6	11.6	16.3	20.6	21.7	23.2	23.0	15.7	10.5	10.6	8.0	31.8	23.0	14.0	12.2	19.3	8.7	11.1	8.8	11.0	11.5	29.5	27.4	21.8	10.5	26.6	28.5	24.8	11.6	12.3	22.2	17.1	12.8	54.0	15.4	12.5	32.5	8.9	15.9	41.2	24.1	34.8	46.9	29.1	27.2	7.7	8.8	22.7	23.0	24.5	15.6	13.8	19.8	20.9	39.5	24.9	15.5	32.7	8.5	10.9	34.4	17.9	18.4	30.0	21.3	43.0	77.1	51.8	134.8	18.9	24.7	18.1	66.8	9.5	17.0	28.1	14.4	7.6	22.8	29.2	18.0	19.8	35.1	12.7	17.1	11.7	19.9	18.4	25.9	24.7	14.0	15.7	160.5	25.6	10.0	13.8	18.7	26.0	21.1	24.1	9.6	7.6	19.2	66.7	6.4	17.1	22.2	9.3	24.0	17.5	17.9	25.1	10.0	16.6	25.0	21.7	23.2	31.4	9.0	7.3	15.8	16.6	26.3	45.9	23.0	34.7	36.7	28.6	23.2	23.0	23.0	27.4	28.5	54.0	58.1	16.0	6.5	54.5	37.3	26.8	10.7	8.6	19.4	11.8	13.8	9.8	11.9	7.2	10.3	9.2	16.7	12.0	64.4	7.2	0.0	4.9	3.3	17.6	10.0	51.7	15.0	17.9	101.5	3.6	27.9	24.0	21.4	17.2	18.3	8.9	34.2	10.8	12.1	5.0	59.2	7.9	4.1	14.5	20.7	4.1	9.9	16.7	17.8	64.6	8.6	22.6	32.0	52.3	259.2	7.4	3.4	9.4	64.7	12.5	6.5	8.6	15.4	9.6	6.6	22.7	22.0	8.8	21.6	24.2	25.9	13.7	63.2	10.7	6.0	15.1
CDK3		ENSG00000250506	"Cyclin dependent kinase 3"	Q00526	17	76000906-76005999	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 5.3;Breast myoepithelial cells: 5.0;Glandular and luminal cells: 5.2;Granulosa cells: 6.3;Ionocytes: 10.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA007420	Uncertain		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA007420: AB_1078490"	"unprognostic (6.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.80e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.75e-7)"	"unprognostic (4.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (4.47e-4)"	12.7	11.0	11.4	7.7	11.8	10.6	12.2	11.5	13.8	15.7	12.0	14.9	10.4	11.5	10.7	11.1	13.7	10.3	8.4	11.3	12.2	18.4	34.8	14.2	10.5	12.0	11.7	15.9	15.1	4.8	19.7	8.9	12.2	25.7	10.1	6.9	13.6	8.4	3.6	24.7	14.7	7.6	11.5	21.9	12.2	15.6	11.8	5.8	19.5	3.3	10.5	10.8	13.3	13.6	5.5	7.5	13.5	6.5	7.3	9.0	26.1	4.6	4.6	8.0	7.4	7.0	11.0	6.5	4.5	5.7	4.6	11.6	10.2	4.1	5.6	3.3	14.1	12.7	17.8	7.3	6.7	5.9	14.9	8.7	10.8	7.3	5.1	13.0	6.9	4.1	5.6	4.5	4.3	12.1	6.3	21.8	6.3	3.8	8.4	10.4	5.2	7.2	6.9	15.8	8.4	22.0	3.8	12.0	3.2	14.2	17.4	10.9	5.5	16.4	9.6	5.4	6.7	9.9	7.2	6.2	5.4	5.5	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	11.4	11.8	11.5	13.8	11.3	12.2	12.0	11.7	12.2	11.5	11.8	13.6	4.3	0.0	0.0	0.0	0.5	2.7	0.0	4.0	0.0	0.0	5.3	5.0	0.3	0.0	2.2	0.0	0.0	0.0	3.1	0.0	1.9	2.0	0.0	2.9	3.9	1.4	0.0	0.0	0.0	2.3	0.0	1.3	0.0	5.2	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	4.4	0.0	0.0	1.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	1.2	2.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.7	0.0	1.0	2.8	0.0	0.0
CDKN1C	"BWCR, BWS, KIP2, P57"	ENSG00000129757	"Cyclin dependent kinase inhibitor 1C"	P49918	11	2883213-2885775	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 206.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 155.1;non-classical monocyte: 376.4"	"Lineage enriched"	"Detected in many"	14	"monocytes: 376.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002924	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA002924: AB_1079548"	"unprognostic (5.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.79e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	127.4	182.9	8.2	3.3	38.0	1.7	92.5	43.3	18.7	73.7	6.5	48.1	1.4	70.6	0.2	29.9	70.7	0.8	82.6	11.7	18.8	149.5	8.3	34.5	0.2	55.1	33.5	206.4	28.5	0.2	27.8	28.1	45.0	33.1	0.2	0.5	21.7	1.5	60.3	26.6	25.0	0.4	31.8	20.6	54.1	8.6	34.3	0.2	17.0	0.9	0.4	75.0	49.4	95.3	0.1	0.1	1.6	0.0	0.4	0.5	1.8	0.3	0.6	0.3	0.0	3.3	0.4	0.0	12.0	0.2	0.1	0.5	0.3	0.3	0.1	5.6	1.2	0.1	12.8	0.0	3.3	0.0	1.4	2.4	1.6	0.0	0.2	0.1	0.3	0.1	2.7	0.8	0.5	0.1	0.0	6.0	10.6	0.5	4.0	2.2	0.0	18.7	0.7	0.0	3.5	33.0	25.2	0.3	15.2	0.9	0.2	2.8	0.4	0.0	2.2	0.0	0.1	7.3	0.0	0.1	0.0	1.8	6.8	9.1	1.2	0.9	0.4	155.1	1.8	0.0	0.4	0.6	26.9	0.3	1.0	0.3	2.2	0.0	376.4	0.2	0.7	14.7	8.2	38.0	43.3	18.7	11.7	18.8	55.1	33.5	45.0	31.8	34.3	95.3	357.3	3.2	5.8	1.0	11.6	10.7	81.7	4.9	30.7	11.9	81.0	150.5	45.3	61.5	10.8	31.3	6.2	575.3	46.9	20.3	15.6	9.8	176.5	38.8	101.5	100.8	106.5	0.8	0.6	0.6	1531.7	141.0	17.9	56.2	0.0	31.2	74.6	4.0	91.0	8.4	1.2	25.0	12.2	23.5	23.2	276.4	74.3	54.9	35.6	4.7	14.1	68.3	0.0	3.5	65.7	4.3	4.2	44.4	12.9	64.6	4.0	78.5	7.5	27.4	32.9	238.3	71.4	2.1	3.5	17.3	11.8	2241.2	25.1	781.8	15.2	71.8
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974634	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 98.4;lymphoid tissue: 96.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 73.5;Sertoli cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 273.1;U-937: 284.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	98.4	23.2	21.6	9.1	23.6	36.0	30.6	22.6	31.4	17.5	20.3	19.3	13.4	20.4	11.8	11.1	15.2	15.5	24.2	21.6	23.0	10.4	7.2	9.9	22.5	23.0	22.4	47.6	17.4	19.9	7.8	7.3	24.0	9.9	12.6	7.8	8.8	24.9	20.5	18.9	14.2	22.2	21.2	11.1	7.4	5.2	22.2	96.2	9.7	8.6	23.4	13.1	16.3	30.3	67.6	32.9	5.9	99.6	108.0	16.4	1.5	61.8	76.2	121.8	107.8	1.8	25.7	140.3	58.5	63.5	41.6	8.2	71.4	9.8	63.4	78.4	90.7	102.5	254.6	21.5	5.5	74.0	42.8	5.6	1.9	32.8	14.6	45.6	32.7	115.0	45.0	0.0	76.2	22.0	91.1	40.4	0.1	31.6	71.3	108.6	86.8	0.4	42.9	34.1	49.6	114.3	88.1	67.5	23.6	0.6	31.3	273.1	21.6	130.8	44.1	76.3	0.9	128.1	131.9	113.2	0.0	284.5	118.3	22.4	3.7	17.9	7.3	2.2	8.4	4.9	10.8	9.7	9.3	4.3	6.0	5.8	0.4	10.5	0.9	11.5	22.0	5.6	21.6	23.6	22.6	31.4	21.6	23.0	23.0	22.4	24.0	21.2	22.2	30.3	9.5	0.0	3.9	2.0	5.6	10.1	2.6	8.1	23.9	8.2	3.8	29.5	14.3	5.7	6.1	3.7	16.7	4.9	11.3	2.8	17.6	6.3	4.9	1.1	18.2	8.1	8.4	73.5	0.6	3.4	12.1	31.0	3.1	1.2	16.5	12.6	20.3	8.8	28.3	5.0	0.6	10.2	14.2	20.5	16.0	7.1	39.4	11.0	7.2	1.9	17.1	26.9	17.5	2.0	3.3	3.1	10.2	47.8	14.0	1.8	24.6	40.8	3.2	9.9	85.5	38.9	26.7	32.0	15.0	22.0	11.2	1.9	18.2	28.6	9.1	1.2
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816659	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 506.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 329.4;Hepatocytes: 149.5;Leydig cells: 91.0;Syncytiotrophoblasts: 481.9;Theca cells: 104.7"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 48.1;ASC diff: 57.9;ASC TERT1: 22.3;GAMG: 17.2;HAP1: 17.1;NTERA-2: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	119.3	18.1	26.1	3.3	28.2	0.2	35.9	24.6	31.2	9.5	109.8	4.8	0.7	8.3	140.3	3.5	13.7	10.5	26.1	28.3	30.7	3.1	506.7	11.7	6.6	23.6	26.2	25.8	14.2	0.7	20.7	35.2	25.6	9.1	1.8	15.9	7.2	72.8	8.5	3.0	4.0	6.2	25.6	3.7	4.1	15.6	26.7	1.3	9.6	19.9	3.1	8.1	5.7	25.6	0.0	0.0	48.1	0.0	57.9	22.3	0.2	1.4	0.4	4.6	4.5	0.0	0.0	0.0	0.0	0.6	17.2	0.1	17.1	0.0	6.6	0.1	8.5	1.7	0.0	1.4	0.2	0.1	0.0	8.5	0.0	0.7	0.0	1.2	6.3	0.0	0.0	0.0	5.5	0.0	1.2	0.2	17.8	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	11.0	0.1	0.0	0.0	4.0	0.0	5.4	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	26.1	28.2	24.6	31.2	28.3	30.7	23.6	26.2	25.6	25.6	26.7	25.6	4.1	0.0	1.3	6.8	0.7	0.8	0.8	0.0	0.6	27.3	1.0	7.1	3.4	0.0	0.0	1.8	6.2	329.4	0.3	0.0	0.0	9.9	6.0	0.3	7.1	3.1	1.8	2.7	12.2	0.2	17.0	27.8	0.0	0.3	0.0	7.5	33.9	149.5	23.4	1.7	16.4	0.0	0.0	5.7	1.6	15.0	91.0	0.6	1.8	1.0	0.6	31.4	0.0	5.5	3.1	0.3	0.0	37.6	0.0	0.9	0.0	2.0	0.0	3.8	13.1	7.3	3.9	1.6	1.4	0.5	1.3	481.9	0.9	104.7	0.0	0.1
CDPF1	"C22orf40, LOC150383"	ENSG00000205643	"Cysteine rich DPF motif domain containing 1"	Q6NVV7	22	46244011-46250311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018823	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Nucleoplasm	"HPA018823: AB_1853018"	"unprognostic (1.98e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (3.13e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.83e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	6.2	9.5	7.1	4.1	7.3	2.6	6.1	6.9	8.6	8.1	6.7	10.3	4.2	7.8	2.9	4.9	7.2	4.0	8.6	6.9	6.8	7.9	7.5	4.6	6.3	7.6	7.1	7.7	6.7	6.2	6.4	3.8	7.0	8.9	2.8	2.6	6.7	5.1	7.9	5.0	6.3	4.8	6.7	9.1	6.7	3.2	7.1	7.4	8.0	5.8	4.0	7.7	5.7	7.4	5.5	7.2	6.5	9.8	4.7	6.9	6.7	3.3	4.5	6.6	6.3	1.8	7.0	5.1	4.0	2.7	5.3	7.7	3.8	2.8	3.9	7.3	10.3	3.1	5.2	6.3	7.0	9.3	4.3	7.4	7.8	5.8	7.4	7.5	5.8	13.0	5.2	6.9	6.2	3.8	12.1	5.8	5.2	8.0	6.7	8.9	4.3	11.7	5.8	2.1	3.1	7.8	4.2	7.8	9.4	3.8	8.9	5.1	3.7	10.7	7.4	5.9	4.7	7.9	4.0	5.9	5.8	6.3	11.1	1.4	6.4	10.5	10.4	9.1	9.9	6.9	10.0	9.0	6.3	8.3	11.3	8.5	1.6	10.0	9.9	10.9	8.7	8.0	7.1	7.3	6.9	8.6	6.9	6.8	7.6	7.1	7.0	6.7	7.1	7.4	6.9	6.4	3.9	1.0	7.1	1.8	2.9	8.1	1.2	4.5	4.7	6.7	6.1	5.7	4.0	7.3	0.0	12.8	4.5	1.3	7.9	10.7	1.0	2.5	3.3	8.9	4.2	3.4	1.1	11.2	10.0	5.8	3.1	1.9	14.5	6.9	6.8	4.8	9.3	0.0	1.8	3.7	6.1	5.0	2.0	1.2	5.0	4.2	5.4	0.0	8.1	5.7	19.6	1.5	2.5	8.3	1.4	7.9	3.8	5.1	3.4	8.1	6.9	5.4	13.1	4.5	6.5	4.3	8.1	3.1	2.0	4.5	6.1	9.1	5.3	2.1
CDR2L	HUMPPA	ENSG00000109089	"Cerebellar degeneration related protein 2 like"	Q86X02	17	74987632-75005800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 23.2;Glandular and luminal cells: 28.9;Late spermatids: 30.9;Pancreatic endocrine cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 61.8;U-138 MG: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022015	Enhanced		Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA022015: AB_1846462"	"unprognostic (4.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.36e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	9.0	5.9	17.7	2.7	34.2	0.1	8.0	40.8	21.7	10.3	19.4	10.5	22.4	12.7	0.9	6.7	6.8	8.8	19.6	14.9	25.2	16.5	1.5	12.9	0.9	42.2	33.9	3.2	4.3	2.6	6.0	7.0	38.6	7.4	1.4	1.7	8.3	5.1	2.1	4.6	11.5	5.4	28.4	1.8	15.1	7.8	35.5	0.5	4.7	3.2	0.7	9.5	6.9	45.1	15.0	42.1	9.2	19.3	15.8	13.8	4.2	21.3	9.4	12.2	15.5	25.1	13.5	0.0	21.9	37.3	11.0	39.2	11.0	5.2	8.0	0.3	18.6	0.1	26.2	16.3	9.1	1.7	0.7	8.1	8.1	29.0	3.0	8.7	26.5	3.2	6.5	2.1	13.0	13.5	2.0	1.6	12.0	35.3	20.6	6.9	14.0	6.5	32.5	9.3	15.8	53.4	26.8	61.8	2.0	5.5	17.1	2.8	19.0	62.4	13.1	39.7	13.6	2.0	1.3	0.0	17.3	5.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.7	34.2	40.8	21.7	14.9	25.2	42.2	33.9	38.6	28.4	35.5	45.1	9.4	16.0	0.0	0.7	0.0	6.0	2.1	2.3	4.6	3.9	7.3	5.8	4.1	11.5	3.4	5.5	0.0	2.9	0.8	0.3	15.6	12.9	7.5	23.2	12.8	12.5	4.9	0.0	2.6	6.9	0.5	6.8	14.8	28.9	0.0	0.7	7.9	0.4	1.6	0.0	5.3	4.2	2.0	0.6	4.6	30.9	2.8	1.6	1.8	5.6	0.6	0.9	0.0	2.5	16.8	26.0	0.0	2.6	0.4	8.1	19.5	2.7	4.0	2.5	0.0	4.2	6.8	3.1	1.7	2.6	2.4	2.3	0.5	1.6	2.3	14.1
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573686-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 559.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 1103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	117.0	68.6	39.1	113.7	42.0	161.3	73.0	40.6	42.9	59.3	48.3	80.0	57.5	60.6	54.9	78.7	51.6	76.4	74.5	37.0	47.1	64.4	112.9	83.6	159.3	46.0	41.8	57.9	84.3	85.8	43.0	108.5	46.0	43.2	70.8	49.2	52.7	47.7	250.9	55.0	65.5	75.7	44.6	121.6	89.0	95.9	45.8	194.5	97.4	155.9	165.6	104.3	49.3	47.8	376.2	85.5	147.6	98.0	166.7	203.6	174.5	201.6	261.1	197.6	194.7	213.4	147.0	473.9	298.0	227.4	229.2	158.2	213.5	202.0	366.4	306.1	80.1	282.3	93.2	130.9	258.2	318.7	173.4	194.7	206.7	178.2	473.4	139.6	254.5	137.9	205.7	309.9	289.5	107.1	260.9	180.9	148.9	161.6	108.2	156.8	197.6	382.2	206.9	150.7	116.5	87.8	192.0	140.4	246.0	210.0	456.3	190.8	316.4	209.4	198.5	168.5	202.7	446.9	363.2	1103.9	117.0	187.8	124.7	14.3	10.5	17.6	13.0	12.3	13.5	11.1	12.2	13.2	9.7	7.0	9.7	15.2	9.7	6.4	13.7	15.9	24.0	5.7	39.1	42.0	40.6	42.9	37.0	47.1	46.0	41.8	46.0	44.6	45.8	47.8	116.3	57.7	69.8	7.2	114.9	145.9	217.3	19.5	63.7	22.6	97.6	77.2	86.2	74.4	34.4	84.6	10.4	51.6	169.7	158.0	37.2	42.1	324.7	174.0	160.5	99.5	47.2	59.5	13.2	87.6	82.0	93.7	88.7	314.4	45.0	63.0	91.1	97.2	118.5	23.5	12.3	102.4	10.2	146.8	117.7	559.5	34.2	145.0	55.2	17.8	100.4	109.5	90.6	8.0	14.5	88.1	101.2	35.7	239.4	320.2	26.9	74.4	27.4	29.9	26.3	120.9	92.5	21.2	30.9	94.0	128.3	35.2	126.5	124.4	90.1	219.5
CDX4		ENSG00000131264	"Caudal type homeobox 4"	O14627	X	73447254-73455245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"skin 1: 1.1"	"Cell type enhanced"	"Detected in some"		"Spermatogonia: 1.2;Suprabasal keratinocytes: 1.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043714, HPA056528"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA043714: , HPA056528: AB_2683166"															"unprognostic (1.97e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase 3A"	P09093	1	22001657-22012542	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2216	"pancreas: 262614.2"	"Cell type enriched"	"Detected in some"	56	"Exocrine glandular cells: 34710.4"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"MOLT-4: 24.9"									"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			20.0	4.5	0.0	3.0	0.0	2.8	11.6	0.0	0.0	12.9	0.0	4.5	21.3	4.1	0.0	7.4	3.0	0.1	44.6	0.0	0.0	4.1	13.5	3.0	6.0	0.0	0.0	118.5	262614.2	0.0	6.9	14.9	0.0	8.8	0.0	0.0	44.0	0.0	3.9	5.2	12.2	0.0	0.0	6.3	47.7	3.2	0.0	0.3	3.1	0.0	0.0	2.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	25.5	40.7	0.1	0.0	0.6	0.0	0.0	0.1	34710.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	197.1	0.3	2.4	0.0	0.0	94.0	0.0	0.0	0.0	0.0	619.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase 3B"	P08861	1	21977022-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2088	"pancreas: 49621.1"	"Cell type enriched"	"Detected in some"	45	"Exocrine glandular cells: 14881.1"	"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				9.0	1.8	0.0	0.6	0.0	0.8	4.5	0.0	0.0	4.4	0.0	1.8	6.2	1.6	0.1	2.6	1.2	0.0	8.4	0.0	0.0	1.6	5.0	1.2	1.1	0.0	0.0	23.7	49621.1	0.0	2.2	3.4	0.0	3.1	0.1	0.0	9.5	0.0	1.6	1.9	2.6	0.0	0.0	2.3	17.2	2.4	0.0	0.0	1.2	0.0	0.0	1.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	10.4	78.6	0.3	0.0	0.6	0.0	0.0	0.2	14881.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	309.9	0.9	0.9	0.0	0.0	60.4	0.0	0.0	0.0	0.2	325.6	16.0	0.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0
CELSR2	"ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3"	ENSG00000143126	"Cadherin EGF LAG seven-pass G-type receptor 2"	Q9HCU4	1	109249539-109275751	"G-protein coupled receptors, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.8"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 97.6;Oligodendrocytes: 48.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 13.3;basal ganglia: 21.6;cerebral cortex: 44.6;hippocampal formation: 50.8;white matter: 26.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 47.9;HaCaT: 48.4;MCF7: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013952	Uncertain		Approved	Cytosol		NA	NA		1300000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA013952: AB_1846518"	"unprognostic (4.46e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.16e-2)"	0.9	1.4	13.3	0.5	21.6	0.3	4.1	0.1	44.6	5.6	0.0	2.9	0.8	2.2	3.1	13.9	16.1	1.1	5.2	50.8	0.0	4.7	0.6	1.1	0.7	4.1	0.6	0.6	3.8	6.0	2.9	0.9	1.0	3.0	0.7	5.7	5.6	7.9	8.9	24.7	1.1	1.6	0.6	0.4	2.0	9.4	1.5	1.2	9.1	4.0	2.4	1.9	9.4	26.6	14.0	12.8	47.9	8.9	0.1	0.0	13.0	1.6	1.1	2.9	0.8	2.0	0.4	2.5	10.9	1.0	2.2	48.4	12.5	7.8	1.5	0.3	5.3	1.1	11.8	2.8	1.0	0.8	6.2	0.2	18.5	1.2	0.8	10.8	0.5	7.7	8.5	0.6	0.0	56.6	1.4	0.7	15.7	1.6	2.5	12.8	4.4	0.7	10.3	4.7	19.5	9.2	7.6	16.2	10.1	11.3	15.3	3.1	0.0	0.0	8.5	0.8	12.4	3.2	1.0	0.7	2.6	1.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	21.6	0.1	44.6	50.8	0.0	4.1	0.6	1.0	0.6	1.5	26.6	0.9	9.6	5.0	15.0	0.2	15.7	5.1	19.7	9.6	13.2	16.4	16.3	13.5	2.8	11.3	18.4	4.2	2.2	1.9	1.3	1.9	2.6	5.1	12.8	1.4	1.5	1.8	0.0	34.0	0.4	1.3	1.2	2.6	17.7	1.3	5.5	0.4	7.1	1.1	97.6	27.7	0.9	2.0	0.8	3.4	9.3	3.4	0.9	10.6	5.6	1.0	29.9	3.1	24.6	48.1	1.5	0.5	19.2	0.4	4.3	0.2	3.1	8.4	5.2	6.6	5.0	4.9	1.6	6.8	31.0	22.9	0.5	1.5	0.0	2.0	6.9
CEMIP2	TMEM2	ENSG00000135048	"Cell migration inducing hyaluronidase 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 92.5;placenta: 79.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 105.8;dendritic cells: 378.1;Glandular and luminal cells: 137.3;Plasma cells: 155.1;Syncytiotrophoblasts: 89.8;T-cells: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 143.4;BEWO: 117.4;OE19: 144.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017080, HPA044889"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA017080: , HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	25.1	5.4	9.7	24.8	6.5	29.7	11.1	9.7	8.3	5.1	15.0	24.2	27.2	7.2	2.7	6.6	5.6	41.5	7.7	19.0	2.8	10.4	60.2	35.0	23.1	4.1	3.6	2.2	19.3	92.5	4.6	79.6	4.9	7.0	28.0	17.3	11.1	8.0	4.8	6.1	23.7	11.7	4.1	15.9	33.2	6.8	8.2	18.6	9.4	8.6	20.7	32.0	3.4	5.5	22.5	85.0	143.4	6.6	13.7	22.9	117.4	81.7	48.7	51.6	40.5	24.3	31.3	0.4	20.0	18.8	11.6	35.2	38.6	9.9	73.2	2.5	11.2	38.9	20.9	68.7	23.9	0.4	9.8	28.0	11.4	38.9	8.1	14.0	68.2	3.3	4.7	10.2	28.8	15.1	4.1	0.6	28.2	144.3	8.6	3.3	39.9	2.4	31.6	60.4	6.3	0.6	19.3	12.5	20.5	45.2	8.8	1.3	30.3	33.7	38.3	17.4	39.3	1.8	37.8	0.9	6.1	3.9	43.7	0.1	1.3	3.1	1.4	1.1	0.3	0.4	1.5	1.3	0.5	3.0	2.1	1.0	2.3	0.3	1.0	0.1	2.3	0.9	9.7	6.5	9.7	8.3	19.0	2.8	4.1	3.6	4.9	4.1	8.2	5.5	105.8	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	0.0	58.7	46.7	0.0	0.0	0.0	14.7	0.0	47.9	378.1	0.0	0.0	20.2	0.0	42.1	24.2	14.7	0.0	0.0	0.0	36.2	14.4	4.3	0.0	137.3	0.0	3.8	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	30.8	0.0	0.0	155.1	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	89.8	86.1	3.1	0.0	0.0
CENPI	"CENP-I, FSHPRH1, LRPR1, Mis6"	ENSG00000102384	"Centromere protein I"	Q92674	X	101098218-101163681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 6.8;lymphoid tissue: 7.1"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 4.8;Excitatory neurons: 2.9;Extravillous trophoblasts: 4.7;Granulosa cells: 3.2;Oligodendrocytes: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061297			Supported	"Nuclear bodies,Cytosol"		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	Cytosol	"HPA061297: AB_2684471"	"unprognostic (3.10e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.78e-6)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.62e-3)"	"unprognostic (1.20e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-13)"	"unprognostic (1.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-1)"	1.1	0.6	0.9	3.1	1.0	6.8	1.2	2.0	1.0	1.0	0.5	2.7	2.8	1.8	1.4	2.6	0.6	1.4	0.5	1.1	1.1	0.4	0.8	1.0	5.4	1.4	0.6	2.3	0.9	0.2	0.0	2.5	1.4	1.2	3.5	1.8	0.5	0.6	0.2	3.2	2.3	2.7	0.1	1.6	1.5	1.2	1.0	7.1	0.8	0.6	6.3	1.4	0.8	2.9	44.9	30.3	36.6	28.1	4.6	8.2	16.4	47.5	25.2	47.1	94.5	40.9	28.0	32.7	16.5	18.8	72.5	25.7	54.2	25.3	65.4	20.6	13.8	20.2	43.5	15.6	0.5	26.8	21.2	3.3	2.2	62.5	7.7	13.5	40.7	23.3	14.5	58.3	46.1	31.5	26.7	9.8	28.3	21.2	36.8	24.7	53.0	21.0	11.8	26.4	23.4	12.3	58.1	16.3	9.6	33.0	16.2	8.6	16.7	44.0	36.6	41.2	38.3	9.1	23.3	36.5	17.3	35.2	34.7	0.7	0.5	0.6	0.4	0.7	0.3	0.6	0.4	0.6	0.2	0.4	0.4	0.4	1.1	0.7	0.7	0.7	0.8	0.3	0.9	1.0	2.0	1.0	1.1	1.1	1.4	0.6	1.4	0.1	1.0	2.9	0.5	0.0	0.0	2.3	0.9	0.3	0.1	0.6	0.0	0.5	0.4	0.3	0.4	0.0	0.7	0.0	0.0	1.9	0.5	0.8	0.0	0.2	0.2	0.4	0.8	0.5	0.0	4.8	2.9	0.0	4.7	0.6	0.0	0.6	0.0	3.2	0.7	0.2	1.4	0.0	2.3	0.7	0.0	0.6	0.8	0.0	0.3	0.3	0.0	1.0	0.6	0.5	0.0	1.5	3.3	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.3	0.0	0.7	1.0	0.3	0.9	1.4	0.1	0.3	0.4	0.8	1.4	0.2
CENPV	"CENP-V, p30, PRR6"	ENSG00000166582	"Centromere protein V"	Q7Z7K6	17	16342534-16353656	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 100.4;Spermatogonia: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.3;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 106.4;JURKAT: 105.1;NTERA-2: 103.4"	"Low region specificity"	"Detected in all"							"HPA042529, HPA042616"	Enhanced		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Midbody, Cytosol"	"HPA042529: AB_10793882, HPA042616: AB_10794050"	"unprognostic (7.64e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.60e-3)"	4.0	4.7	11.7	0.6	11.3	5.1	4.6	9.3	11.7	4.4	7.1	9.1	9.8	5.9	3.5	0.5	6.6	1.3	5.6	11.9	13.2	3.4	10.7	2.6	1.2	11.6	11.0	6.2	4.0	3.9	7.0	1.2	10.0	3.1	8.0	4.0	1.5	4.0	21.1	0.8	10.6	4.0	11.6	1.1	13.2	10.3	11.4	17.1	2.4	9.5	1.2	4.2	1.7	11.9	10.7	20.4	106.4	53.4	3.0	2.7	18.2	8.7	8.6	26.5	20.0	20.5	4.7	42.5	17.0	6.5	4.9	3.2	69.3	0.6	16.8	0.0	85.9	10.1	5.0	41.1	29.2	10.1	0.0	7.6	2.8	31.6	18.7	3.0	15.2	105.1	17.4	0.0	8.0	1.8	80.2	34.2	103.4	69.1	0.0	57.1	4.1	4.9	6.1	15.4	56.8	43.9	22.2	0.3	5.2	48.6	0.3	24.8	1.0	0.0	8.6	1.2	0.0	0.0	0.0	24.9	0.0	14.0	0.6	0.0	0.0	1.3	0.1	0.0	0.0	1.4	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	11.7	11.3	9.3	11.7	11.9	13.2	11.6	11.0	10.0	11.6	11.4	11.9	13.3	0.0	2.7	3.9	13.7	1.0	29.7	0.5	4.6	40.0	22.5	31.6	4.2	30.0	4.4	1.8	4.2	19.6	19.6	43.0	31.3	7.5	16.3	2.6	32.4	5.0	39.4	12.6	18.9	23.3	22.1	9.2	59.1	2.7	5.7	39.7	1.8	50.1	6.0	11.8	21.8	63.0	0.0	1.4	0.7	9.0	8.7	4.6	8.8	3.7	2.0	45.9	13.4	19.6	11.7	17.8	83.9	11.7	10.7	38.0	100.4	43.5	2.5	15.0	26.3	4.2	17.9	81.6	124.2	2.5	2.6	6.4	10.7	8.7	78.9	45.0
CEP112	"CCDC46, MGC33887"	ENSG00000154240	"Centrosomal protein 112"	Q8N8E3	17	65635537-66192133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Group enriched"	"Detected in many"	8	"Early spermatids: 1061.4;Late spermatids: 1606.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 32.0;RH-30: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069724			Approved	"Nucleoplasm,Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Centrosome"	"Midbody ring, Cytosol"	"HPA069724: "	"unprognostic (9.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.48e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	11.3	3.9	5.0	2.7	5.4	1.7	9.5	7.1	5.8	8.3	11.9	7.8	2.0	8.5	8.2	4.3	8.3	7.0	8.0	7.4	5.1	5.6	3.2	7.4	2.5	5.8	5.7	8.2	4.6	8.7	8.3	7.2	4.2	7.2	3.1	25.4	3.0	7.9	8.8	3.3	2.9	8.0	3.4	8.8	4.2	49.0	5.5	2.8	7.1	14.0	1.7	5.4	5.9	3.4	5.0	10.5	13.3	3.8	6.9	14.0	0.4	4.5	7.7	5.5	5.0	1.5	2.0	1.6	4.3	9.8	15.5	0.6	2.9	2.9	7.8	2.6	4.8	0.3	4.7	1.9	2.9	0.6	0.2	8.4	4.8	5.2	1.6	11.0	16.8	2.7	0.3	5.0	32.0	0.7	5.3	0.4	1.3	1.1	4.4	1.5	75.9	0.4	6.0	0.3	3.5	7.4	4.7	0.5	3.6	11.4	3.8	0.4	7.9	14.3	8.2	3.9	6.7	2.3	2.1	0.2	4.4	0.2	5.3	1.3	0.4	0.4	0.3	0.2	0.6	0.3	0.8	0.3	0.2	0.8	0.5	0.3	1.3	0.8	0.2	1.4	0.5	0.1	5.0	5.4	7.1	5.8	7.4	5.1	5.8	5.7	4.2	3.4	5.5	3.4	39.7	9.6	35.8	83.6	1.1	2.5	2.9	2.2	2.2	36.7	2.7	5.5	28.3	4.3	15.3	1.8	20.9	0.7	0.8	1.5	1.9	7.4	1061.4	15.3	15.8	25.4	1.8	0.4	117.4	4.7	1.5	12.4	1.5	3.3	2.5	11.2	19.2	0.2	1.8	1.7	103.8	0.3	0.0	0.8	11.3	1606.0	24.8	2.3	14.2	99.3	0.0	14.7	1.0	29.7	6.6	4.4	0.5	19.9	0.4	1.5	0.0	4.3	23.7	154.3	13.1	43.7	12.5	40.6	16.5	2.4	1.6	0.1	2.5	3.1	1.5	1.3
CEP170B	"Cep170R, FAM68C, KIAA0284"	ENSG00000099814	"Centrosomal protein 170B"	Q9Y4F5	14	104865268-104896770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 229.4;Distal enterocytes: 81.2;Rod photoreceptor cells: 112.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000871, HPA059017"	Enhanced		Approved	Microtubules,Centrosome,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Microtubules, Centrosome"	"HPA000871: AB_2666124, HPA059017: AB_2683883"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.41e-4)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-2)"	13.0	12.8	13.0	4.9	14.1	0.2	13.2	0.0	27.6	11.9	0.0	27.8	17.9	14.8	2.6	31.3	14.7	6.0	9.9	16.6	1.7	29.2	20.2	14.9	0.8	12.3	4.4	6.3	27.7	6.1	21.1	2.7	10.6	19.5	5.7	10.2	18.5	7.7	6.5	36.2	21.1	4.1	0.0	4.5	24.3	15.4	5.1	1.0	20.7	1.4	1.9	16.1	16.4	10.3	23.4	19.1	1.4	17.8	7.4	5.3	41.3	18.0	7.0	8.9	5.9	20.3	14.0	0.0	21.5	13.8	6.1	50.7	4.2	21.1	2.3	8.6	8.8	0.0	22.9	13.4	14.9	0.1	18.2	5.2	26.2	9.3	13.5	7.0	9.0	0.1	6.0	0.2	7.7	49.4	0.1	0.3	5.9	33.2	16.3	7.7	0.1	5.6	8.9	39.1	4.8	5.0	26.7	15.5	24.2	3.0	27.1	3.4	20.0	14.0	15.3	39.0	12.3	0.8	0.1	0.1	11.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	14.1	0.0	27.6	16.6	1.7	12.3	4.4	10.6	0.0	5.1	10.3	1.7	9.6	15.3	5.2	0.8	23.8	12.6	12.8	10.2	18.0	15.2	11.4	3.7	22.8	10.0	18.4	229.4	3.6	0.2	81.2	1.9	12.2	0.8	16.2	6.3	4.4	22.1	0.0	17.7	24.0	7.6	5.4	48.4	18.2	5.7	5.7	8.6	12.8	1.4	40.4	14.9	41.0	8.2	0.8	5.2	1.7	3.7	1.3	8.8	2.8	1.0	11.1	0.0	5.5	5.9	31.8	42.9	8.6	0.7	30.3	27.5	5.0	20.1	112.6	6.6	6.8	7.8	1.7	5.2	13.9	24.6	6.7	1.9	0.0	35.6	24.5
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 67.6;Excitatory neurons: 94.4;Inhibitory neurons: 91.3;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039392, HPA040503"	Uncertain		Supported	Centrosome,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	2.9	2.2	5.0	4.6	7.6	10.8	4.9	9.8	5.2	4.7	0.0	4.5	4.0	6.4	3.9	3.7	4.9	5.7	3.6	4.1	2.4	2.8	2.9	4.4	6.9	4.1	4.7	9.9	4.6	4.7	2.5	4.6	3.6	4.0	5.4	6.8	4.1	3.5	1.8	3.5	4.7	4.6	3.4	5.2	4.7	9.3	5.0	11.6	5.5	3.9	5.6	4.1	2.5	9.7	13.5	7.2	19.1	10.1	8.1	12.6	6.1	9.2	12.1	14.3	15.1	9.9	5.8	15.2	6.1	9.4	10.4	6.4	16.7	8.8	16.8	6.0	6.0	13.8	11.3	5.2	4.3	22.2	10.2	8.8	3.2	12.0	10.9	8.2	11.9	10.7	19.3	9.9	11.3	6.8	19.2	9.6	6.1	24.9	4.4	16.3	14.9	7.9	4.9	13.6	13.9	7.8	14.7	7.2	4.4	9.0	5.8	11.3	12.1	11.2	26.2	12.9	12.8	6.6	10.1	17.0	7.2	9.9	11.0	0.4	0.6	0.5	0.9	0.4	0.7	0.5	0.6	0.6	0.3	1.3	0.6	1.0	0.6	0.2	1.7	0.5	0.5	0.3	5.0	7.6	9.8	5.2	4.1	2.4	4.1	4.7	3.6	3.4	5.0	9.7	13.3	9.6	12.8	67.6	11.4	1.9	3.9	4.3	5.2	13.1	6.4	5.8	28.7	4.3	9.3	7.3	22.9	5.3	13.7	7.6	0.0	4.7	23.3	11.0	11.8	8.5	0.0	18.7	94.4	3.6	3.3	10.5	15.8	12.1	2.5	40.9	8.2	6.5	4.6	11.8	91.3	8.7	4.1	10.1	3.9	14.2	10.2	10.1	1.8	62.8	15.3	6.5	14.4	76.9	90.6	4.8	5.7	13.9	15.0	5.5	4.5	1.2	8.0	17.8	26.3	11.3	8.1	33.5	24.0	8.5	3.1	1.9	12.3	60.6	8.0	7.6
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109174418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 50.3;Spermatocytes: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	10.5	7.6	5.1	7.8	5.9	10.2	10.2	10.8	7.8	8.2	4.6	8.5	8.7	9.3	10.5	6.2	6.0	9.4	7.7	5.8	4.1	8.0	10.0	6.6	8.9	4.9	4.2	6.5	7.5	16.9	5.6	10.1	5.5	6.4	10.9	12.0	5.2	6.3	6.1	6.8	7.8	10.8	3.9	7.7	7.3	26.2	5.5	14.4	8.7	6.6	7.4	6.4	6.5	7.9	17.9	7.9	23.1	22.9	21.2	35.2	18.1	40.3	22.1	35.8	39.8	11.9	15.3	16.0	18.4	20.9	30.8	9.1	16.1	15.4	56.1	20.3	16.1	34.8	18.9	12.3	19.6	28.5	14.5	21.2	11.0	30.3	29.9	19.2	32.4	52.5	63.9	52.5	32.4	11.8	32.0	24.6	7.6	14.7	14.6	25.7	17.4	15.7	17.0	7.4	17.4	14.4	19.8	14.7	12.9	15.0	18.2	43.9	14.7	23.1	13.6	24.4	42.9	15.4	19.1	25.3	21.8	43.1	18.9	15.9	5.2	6.6	4.7	6.1	5.1	3.3	4.8	6.7	5.7	6.3	4.5	6.7	3.6	11.6	9.6	6.0	6.9	4.6	5.1	5.9	10.8	7.8	5.8	4.1	4.9	4.2	5.5	3.9	5.5	7.9	12.9	6.4	5.3	12.4	6.3	3.3	7.6	7.4	7.4	6.6	6.8	7.2	10.3	2.8	6.8	5.5	20.9	9.8	9.7	4.2	7.9	7.0	50.3	12.8	18.5	10.6	5.4	18.1	31.9	5.4	13.2	15.5	8.2	6.9	5.1	20.5	8.2	6.3	10.2	5.0	31.1	3.1	8.2	4.1	6.8	39.3	17.4	7.7	8.8	27.2	7.7	10.4	8.2	26.2	36.1	6.0	4.5	12.4	13.2	4.4	5.7	13.4	9.8	12.3	13.1	21.8	14.1	75.7	13.0	5.8	4.4	8.5	6.7	13.6	6.1	5.0
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 222.5;Late spermatids: 299.3;Spermatocytes: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 2.8;MAIT T-cell: 3.3;memory B-cell: 1.7;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.1;naive CD8 T-cell: 4.0;NK-cell: 2.3;T-reg: 1.3"	"Group enriched"	"Detected in many"	10	"B-cells: 1.7;NK-cells: 2.3;T-cells: 4.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favorable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	7.5	12.0	20.1	6.3	20.9	5.9	13.3	24.1	22.3	30.6	16.2	17.6	56.2	20.9	21.6	12.0	30.6	13.1	15.8	18.1	25.4	21.4	29.4	14.7	5.5	22.1	21.8	18.5	24.1	21.8	15.6	3.9	21.8	21.0	18.1	35.8	8.7	21.7	18.0	6.8	19.0	11.7	20.5	6.1	13.1	69.0	23.9	42.4	39.2	20.8	6.9	12.1	11.7	22.7	53.7	11.1	25.3	30.8	15.2	16.9	23.5	10.4	19.4	14.0	20.5	15.5	27.9	12.5	24.0	19.2	53.1	23.0	23.2	20.6	31.1	22.2	15.3	35.7	26.0	20.1	24.2	1.6	12.5	92.3	11.7	10.6	26.2	37.0	20.5	40.1	26.6	40.5	23.1	20.1	38.4	2.1	15.0	13.9	24.6	41.7	32.9	32.3	26.9	23.8	30.7	19.8	54.5	12.7	60.8	28.4	64.3	17.7	12.1	10.3	19.0	21.3	12.9	37.2	22.1	42.6	22.9	3.3	35.7	0.2	0.0	0.1	2.8	0.1	3.3	1.7	2.1	2.3	0.0	1.4	4.1	4.0	0.2	2.3	0.0	0.1	1.3	1.2	20.1	20.9	24.1	22.3	18.1	25.4	22.1	21.8	21.8	20.5	23.9	22.7	7.0	32.1	69.3	44.1	4.8	9.7	46.3	14.0	22.2	15.8	11.8	9.8	34.3	22.8	27.4	20.2	35.5	8.1	4.6	10.5	72.4	24.9	222.5	114.0	14.9	7.7	15.6	13.7	51.8	17.6	4.4	11.8	16.3	52.6	20.8	21.9	6.1	14.7	2.4	21.9	48.5	11.1	8.2	0.3	3.0	299.3	9.9	2.3	10.6	19.7	0.6	26.4	2.1	60.8	30.5	12.7	8.1	12.8	9.2	29.5	3.3	21.1	34.5	31.1	6.6	17.5	12.4	163.6	9.5	18.6	8.1	9.6	8.9	9.5	23.9	28.6
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536672-181680665	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.1;retina: 16.6"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 43.5;Proximal tubular cells: 13.4;Respiratory ciliated cells: 38.7;Rod photoreceptor cells: 22.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	28	"SCLC-21H: 58.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.5"	"HPA035443, HPA035444, HPA043203"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.5	0.3	0.2	0.6	0.0	1.0	9.7	0.4	3.1	6.0	2.3	0.2	0.8	0.3	0.5	7.8	0.7	0.5	0.8	0.6	8.0	1.3	5.1	0.9	1.8	2.0	0.3	0.7	0.6	0.7	0.1	1.8	1.0	0.3	16.6	1.0	0.2	0.4	0.4	6.8	0.2	1.8	17.1	1.2	0.5	0.4	0.4	0.9	0.3	1.9	1.3	1.2	1.8	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.4	0.0	0.3	0.2	0.0	0.3	2.0	0.0	0.4	0.3	0.4	0.0	0.0	0.6	0.5	0.1	0.3	0.6	0.0	0.5	0.9	0.3	0.7	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.8	0.4	0.0	0.4	1.2	0.0	0.0	0.9	0.0	58.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.1	0.8	0.0	0.0	0.3	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	9.7	0.4	0.8	0.6	1.8	2.0	1.8	1.8	0.4	1.8	0.0	3.2	0.5	0.3	0.0	0.0	0.1	1.0	0.0	0.5	0.0	0.0	0.7	1.5	4.9	0.0	18.8	0.0	1.5	0.0	9.8	0.0	4.6	43.5	0.7	0.3	1.8	0.0	6.8	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	2.0	0.0	0.0	2.8	0.0	0.3	0.0	0.0	0.1	2.5	0.0	0.5	0.2	0.0	0.0	0.0	0.4	0.0	2.7	13.4	38.7	22.8	0.0	0.2	0.5	0.4	0.9	0.0	0.0	0.0	0.6	0.0	1.2	0.0
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 703.3;liver: 345.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 794.4;Hepatocytes: 518.5;Paneth cells: 519.2;Proximal enterocytes: 2529.8;Undifferentiated cells: 499.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 104.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA018897, HPA074629"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558, HPA074629: "	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	18.8	38.1	21.2	18.1	20.6	6.3	13.5	24.1	23.0	22.0	25.6	191.2	703.3	14.6	14.4	132.7	17.9	19.5	51.4	22.1	20.6	96.5	345.7	15.6	11.9	20.8	20.8	17.0	14.4	38.0	15.7	10.1	20.6	16.7	178.8	16.2	32.9	15.0	33.8	32.7	576.5	19.7	20.0	12.4	41.6	9.3	20.9	13.1	27.9	14.3	20.8	13.7	33.5	20.5	11.6	16.6	18.4	25.9	19.5	17.9	14.5	15.9	25.8	17.6	22.1	17.3	23.5	15.7	14.3	20.9	13.3	35.4	14.2	39.8	15.3	10.7	18.9	14.4	9.6	44.2	26.3	21.6	26.3	25.4	82.5	26.0	46.7	24.6	14.1	11.3	22.2	10.9	35.7	9.1	17.7	21.4	10.8	16.3	18.8	20.9	19.1	19.8	60.7	18.6	11.6	16.0	50.9	12.6	14.5	8.1	21.0	26.5	17.5	22.4	12.6	15.3	11.1	23.3	24.0	18.4	36.7	17.3	17.4	4.1	5.4	1.6	5.1	3.8	4.5	3.0	4.1	5.8	4.5	3.1	4.8	4.5	1.6	4.3	4.1	4.3	3.2	3.1	21.2	20.6	24.1	23.0	22.1	20.6	20.8	20.8	20.6	20.0	20.9	20.5	13.2	32.1	24.6	8.8	18.8	19.5	13.5	32.8	39.3	31.2	12.4	18.3	33.6	115.8	19.8	53.3	20.9	16.1	12.9	794.4	37.2	24.6	2.1	26.9	15.0	14.1	24.1	7.8	7.0	33.8	5.7	15.3	60.6	33.7	27.3	80.7	28.5	518.5	19.6	28.6	9.7	196.0	18.3	37.0	9.6	2.3	18.6	15.3	10.6	10.3	19.5	19.0	21.6	8.0	5.9	51.8	519.2	18.0	8.5	19.1	2529.8	176.0	85.4	24.2	32.9	19.5	15.2	47.2	19.7	116.1	20.5	13.5	13.0	22.1	499.5	16.7
CES4A	"CES8, FLJ37464"	ENSG00000172824	"Carboxylesterase 4A"	Q5XG92	16	66988589-67009758	"Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 16.9;skin 1: 13.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 44.4;Excitatory neurons: 53.6;Oligodendrocytes: 37.6;Respiratory ciliated cells: 47.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.3"	"Region enhanced"	"Detected in many"		"white matter: 10.2"	"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.1;HMC-1: 5.2;PC-3: 4.5;SiHa: 7.8;SK-BR-3: 5.7;U-266/70: 5.9"	"Not detected"	"Not detected"							HPA035701	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	Cytosol		"HPA035701: AB_10696357"	"unprognostic (6.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-3)"	3.6	1.5	1.2	0.8	2.6	1.2	2.5	0.1	2.5	1.0	0.0	0.6	0.8	0.5	3.9	1.0	16.9	0.8	2.4	2.3	1.0	2.6	8.4	1.5	0.7	1.7	0.2	1.0	1.1	3.1	3.6	1.0	1.2	0.9	0.7	0.8	4.3	2.1	4.9	13.6	0.8	0.3	0.0	0.5	1.4	0.8	0.8	0.7	2.7	0.2	0.9	1.2	0.7	10.2	0.2	1.5	0.1	0.0	0.9	0.8	0.0	0.4	0.7	0.1	0.0	0.0	2.3	0.0	0.0	1.5	0.0	0.7	0.0	0.2	0.0	19.1	0.0	0.0	1.2	0.0	0.1	0.0	5.2	1.8	3.5	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	4.5	0.2	0.0	1.1	0.0	0.3	1.4	0.9	7.8	5.7	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	5.9	2.2	0.0	1.4	0.0	0.0	0.0	1.4	0.0	0.5	2.5	0.5	0.6	1.0	0.5	0.8	0.0	0.9	0.2	0.0	0.0	3.5	1.2	0.3	0.7	1.2	2.6	0.1	2.5	2.3	1.0	1.7	0.2	1.2	0.0	0.8	10.2	0.4	0.0	11.4	2.0	3.5	5.4	5.7	5.0	3.4	23.1	44.4	7.7	2.8	4.3	7.3	5.5	14.6	4.7	3.9	4.1	1.9	0.9	1.7	9.9	1.4	1.0	9.0	0.0	53.6	1.6	0.9	3.9	3.1	11.1	9.5	4.9	1.1	22.1	5.6	0.0	29.7	1.8	4.1	4.1	2.1	1.2	13.7	3.2	0.0	4.7	5.7	8.3	4.1	6.6	37.6	0.9	9.7	12.8	1.3	3.5	5.8	1.5	47.1	15.3	0.0	1.5	1.8	32.1	11.8	4.1	5.3	4.5	3.3	13.5	3.5	7.5
CETN1	"CEN1, CETN"	ENSG00000177143	"Centrin 1"	Q12798	18	580380-582114	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1084	"testis: 134.3"	"Group enriched"	"Detected in some"	34	"Early spermatids: 930.9;Late spermatids: 435.6;Spermatocytes: 675.9"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001470, HPA028956, CAB037244, HPA069157"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB037244: AB_476871, HPA001470: , HPA028956: AB_10601798, HPA069157: "															"unprognostic (1.51e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	930.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	435.6	12.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	675.9	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CETN2	"CALT, CEN2"	ENSG00000147400	"Centrin 2"	P41208	X	152826994-152830757	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 243.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 639.9;Proximal tubular cells: 345.8;Respiratory ciliated cells: 1116.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001470, HPA028956"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA001470: , HPA028956: AB_10601798"	"unprognostic (3.32e-1)"	"prognostic favorable (7.54e-6)"	"unprognostic (7.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.73e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.20e-1)"	30.2	41.0	61.8	19.8	62.3	26.2	40.3	58.3	80.4	64.6	90.5	54.6	15.2	57.6	116.2	37.2	243.6	31.7	34.6	60.6	65.8	74.7	31.5	39.8	16.0	68.0	75.8	57.2	24.0	55.7	73.9	21.4	70.4	50.3	25.8	40.1	24.4	77.7	19.6	23.8	21.6	54.8	67.4	16.8	29.3	23.3	64.8	21.0	67.2	20.2	21.9	37.3	36.1	67.1	145.2	65.0	78.8	59.6	102.5	110.5	31.4	61.6	73.8	79.9	60.9	29.5	75.8	51.6	157.8	83.1	128.8	55.3	55.3	76.7	94.1	23.2	40.0	11.5	32.1	86.6	38.5	48.7	12.5	67.0	99.2	74.1	39.1	95.4	64.0	40.3	31.0	20.9	78.3	67.9	36.4	53.0	27.5	119.9	82.6	31.9	57.2	53.2	146.9	35.4	38.5	50.0	41.2	42.2	38.2	70.8	45.4	37.2	59.8	56.0	44.9	111.9	69.9	20.9	29.7	81.0	118.3	28.9	28.0	19.9	11.4	35.9	11.7	13.6	14.2	11.9	11.5	13.1	13.5	9.7	12.2	12.5	10.9	12.3	13.7	20.0	10.5	11.8	61.8	62.3	58.3	80.4	60.6	65.8	68.0	75.8	70.4	67.4	64.8	67.1	21.6	51.3	35.7	3.9	19.2	22.6	52.4	201.6	21.6	13.6	46.1	47.6	37.1	64.3	155.8	169.2	6.2	66.6	16.2	13.8	238.7	100.3	60.1	639.9	65.4	29.6	37.1	33.2	4.2	41.1	69.8	42.9	12.2	68.7	24.6	41.0	44.3	96.5	50.0	13.5	3.5	31.7	150.5	23.7	21.3	72.5	67.7	27.3	37.4	1.9	27.8	104.4	20.6	0.5	2.5	39.6	16.0	111.7	16.6	29.3	15.4	345.8	1116.5	29.4	19.7	22.7	64.2	76.5	70.4	33.7	30.5	41.5	19.7	51.8	29.2	42.4
CFAP251	"CaM-IP4, MGC33630, WDR66"	ENSG00000158023	"Cilia and flagella associated protein 251"	Q8TBY9	12	121918592-122003927	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.3;testis: 19.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.7;Fibroblasts: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 31.8;hTCEpi: 30.8;hTERT-HME1: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039902, HPA040005"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA039902: AB_10795236, HPA040005: AB_10795160"	"unprognostic (4.92e-3)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (5.58e-3)"	"unprognostic (6.89e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.8	1.6	0.3	2.4	0.1	1.3	1.3	1.7	3.5	13.2	0.2	0.1	1.9	4.7	0.3	22.3	1.2	1.3	2.4	3.9	2.7	1.4	3.0	0.6	5.5	6.6	2.2	1.7	2.9	6.5	0.9	3.6	0.7	0.1	4.6	1.1	1.6	0.3	1.5	0.2	0.6	2.7	1.7	0.4	19.9	4.1	0.5	4.7	0.4	0.9	0.3	1.3	1.6	4.7	0.4	0.4	0.2	0.5	0.5	0.5	0.3	2.5	1.2	3.0	0.3	1.4	0.2	3.7	0.2	0.7	0.9	0.3	31.8	4.4	0.2	0.5	0.2	0.6	0.3	3.7	0.1	8.6	1.8	30.8	2.4	19.9	0.7	1.3	0.5	7.5	0.1	1.9	0.9	0.3	0.6	0.4	0.4	0.2	0.4	0.8	0.0	5.4	0.5	2.5	0.1	0.2	0.1	0.2	0.8	0.9	0.1	1.0	2.5	3.9	0.5	0.5	0.5	0.2	3.8	2.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	1.6	2.4	1.3	1.7	2.4	3.9	5.5	6.6	3.6	2.7	4.1	1.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
CFAP299	C4orf22	ENSG00000197826	"Cilia and flagella associated protein 299"	Q6V702	4	80335730-80963750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 19.8;testis: 27.4"	"Cell type enriched"	"Detected in some"	54	"Endometrial ciliated cells: 54.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;BJ: 1.6;hTERT-RPE1: 2.5;LHCN-M2: 1.0;SCLC-21H: 1.1;U-251 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043383	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.0	0.9	0.0	1.0	0.0	0.1	1.4	0.5	0.7	2.6	0.1	0.1	0.2	0.0	0.0	19.8	0.1	0.0	1.0	1.0	0.3	0.0	1.4	0.1	5.3	3.7	0.1	0.0	0.0	0.1	0.0	2.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	27.4	1.2	0.1	0.6	0.0	0.0	0.0	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.7	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.0	1.4	0.5	1.0	1.0	5.3	3.7	2.3	3.5	1.2	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	54.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
CFAP36	"BARTL1, CCDC104, MGC15407"	ENSG00000163001	"Cilia and flagella associated protein 36"	Q96G28	2	55519604-55545079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1342.4;Late spermatids: 262.5;Spermatocytes: 346.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008994, HPA017061"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies"	Cytosol	"HPA008994: AB_2275429, HPA017061: AB_1846129"	"unprognostic (8.11e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.66e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.96e-1)"	39.1	42.7	72.7	20.2	74.8	16.5	48.9	61.8	98.8	49.8	82.8	52.3	15.1	47.1	77.0	21.9	62.3	40.9	35.7	75.0	78.5	63.2	17.7	33.9	21.7	71.8	70.4	58.9	33.6	78.0	106.7	20.6	72.1	41.6	23.2	124.3	28.7	45.0	19.2	18.8	25.2	37.4	65.9	18.2	42.1	145.2	73.6	22.8	78.0	27.1	19.7	40.7	33.6	70.1	59.5	47.3	50.2	66.3	64.4	119.4	30.4	36.6	73.4	54.9	46.6	34.6	21.2	21.3	82.3	48.9	81.9	38.4	39.3	51.4	67.7	51.9	76.2	31.0	43.9	38.1	70.0	59.4	38.4	58.1	82.7	74.0	92.1	146.8	58.9	42.5	40.1	18.2	66.1	44.4	35.7	67.5	25.2	38.7	44.8	27.2	59.7	21.7	112.1	33.7	74.1	36.6	49.4	25.6	68.5	26.2	42.1	19.7	32.5	57.6	33.7	58.5	50.8	29.9	14.2	7.3	94.0	26.7	26.8	15.5	4.3	13.6	18.3	5.0	35.4	16.9	50.6	29.6	5.8	11.7	41.1	26.0	5.2	12.3	6.4	13.5	30.5	15.9	72.7	74.8	61.8	98.8	75.0	78.5	71.8	70.4	72.1	65.9	73.6	70.1	51.3	48.1	30.6	15.7	14.5	0.0	52.6	0.0	22.2	39.6	48.7	77.2	37.9	38.6	27.2	35.0	8.4	14.3	14.8	6.4	92.0	61.9	1342.4	184.4	51.8	42.9	17.0	21.0	51.6	60.7	27.0	44.7	21.9	36.3	39.1	27.1	42.1	10.7	23.6	23.5	41.1	12.2	0.0	8.7	0.0	262.5	75.2	12.8	0.0	14.0	16.9	145.0	16.5	21.6	13.3	37.0	11.5	67.7	11.4	41.3	7.6	146.9	99.1	92.4	59.2	43.0	43.4	346.0	29.8	16.1	0.0	7.8	24.7	36.0	9.9	35.6
CFAP54	"C12orf55, C12orf63, FLJ31514, FLJ44112"	ENSG00000188596	"Cilia and flagella associated protein 54"	Q96N23	12	96489571-96875555	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7;choroid plexus: 30.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Alveolar cells type 2: 80.1;Club cells: 42.7;Endometrial ciliated cells: 65.8;granulocytes: 37.8;Oligodendrocytes: 47.7;Respiratory ciliated cells: 106.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 7.7;TIME: 9.4"	"Low region specificity"	"Detected in many"							HPA039897	Enhanced		Approved	Microtubules,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	Cytosol	"HPA039897: AB_10674427"	"unprognostic (1.87e-4)"	"unprognostic (3.63e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.55e-5)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.26e-2)"	"unprognostic (8.00e-2)"	0.8	0.7	5.6	1.3	8.1	2.7	0.9	9.2	10.3	0.6	30.7	0.7	1.8	1.6	1.6	0.7	5.0	0.8	0.5	7.0	4.6	0.9	0.9	1.4	1.2	14.6	14.7	1.0	0.2	0.6	1.0	0.7	7.3	0.9	1.1	6.2	0.8	0.6	1.3	1.6	1.2	0.6	8.5	1.5	1.0	5.4	7.0	0.5	1.3	0.2	1.1	0.4	0.1	12.4	1.4	0.6	0.8	1.1	0.4	0.6	0.9	0.7	0.2	0.2	0.4	0.6	1.9	1.0	1.6	0.4	0.9	1.0	0.3	0.3	0.3	2.0	0.6	0.9	2.3	0.7	0.1	1.5	1.5	0.2	0.3	1.1	0.5	1.8	7.7	0.9	0.6	3.5	0.8	0.7	1.2	1.5	1.7	0.6	1.0	1.2	1.1	1.3	2.2	1.3	1.6	1.2	0.8	0.7	1.0	0.9	2.1	0.7	9.4	1.7	2.2	1.8	1.5	4.2	2.1	0.6	1.3	0.9	1.3	2.4	0.7	0.6	0.7	0.6	0.5	0.7	0.5	0.6	0.3	1.1	0.6	0.6	1.3	0.7	0.7	0.6	0.4	0.1	5.6	8.1	9.2	10.3	7.0	4.6	14.6	14.7	7.3	8.5	7.0	12.4	2.1	70.5	80.1	27.1	2.6	0.0	0.3	0.0	0.0	3.9	0.3	0.6	1.0	1.5	42.7	0.0	22.9	0.3	2.2	0.0	0.0	0.2	33.2	65.8	2.9	6.8	1.2	1.3	21.9	0.0	0.3	6.4	0.5	1.9	37.8	0.6	0.4	0.0	0.2	0.0	3.9	0.0	0.0	0.8	0.0	15.4	0.3	3.2	0.0	1.9	0.1	8.1	0.0	4.0	47.7	0.3	0.1	0.0	5.0	0.5	0.0	0.3	106.4	7.8	0.0	1.7	0.5	16.8	7.0	0.0	0.0	0.0	4.2	1.9	0.1	0.3
CFAP57	"FLJ32000, WDR65"	ENSG00000243710	"Cilia and flagella associated protein 57"	Q96MR6	1	43172330-43254358	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 10.7;fallopian tube: 23.4;testis: 15.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 38.6;Endometrial ciliated cells: 62.4;Late spermatids: 26.7;Respiratory ciliated cells: 85.2;Spermatocytes: 25.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.8;HDLM-2: 1.8;TIME: 1.5"	"Low region specificity"	"Detected in many"							"HPA002736, HPA028623"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA002736: AB_2272982, HPA028623: AB_10603234"	"unprognostic (1.15e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.50e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.78e-2)"	0.4	0.1	0.8	0.0	1.2	0.0	0.3	0.3	0.5	1.0	10.7	0.0	0.0	0.6	2.8	0.1	23.4	0.2	0.2	1.2	1.6	1.0	2.7	2.5	0.0	3.6	4.9	0.2	0.6	0.1	2.0	0.2	2.5	0.4	0.1	1.5	0.1	0.2	0.0	0.6	0.0	0.1	2.7	0.0	0.1	15.8	1.7	0.2	1.0	0.0	0.1	0.2	0.1	1.2	0.9	0.3	0.2	0.1	0.0	0.0	0.2	0.3	0.7	0.5	0.5	0.3	0.3	0.0	0.3	1.0	0.3	2.8	0.2	0.3	1.1	1.8	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.5	0.5	0.1	0.7	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.2	0.2	0.3	0.1	0.3	0.0	0.3	0.3	0.6	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.8	1.2	0.3	0.5	1.2	1.6	3.6	4.9	2.5	2.7	1.7	1.2	0.2	6.4	0.5	1.0	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.5	0.0	5.6	0.0	6.2	0.9	0.0	0.2	0.0	0.2	38.6	62.4	0.6	0.3	0.0	0.0	3.5	0.2	0.1	0.6	0.0	1.2	0.0	0.1	1.1	0.5	0.1	1.7	1.2	0.0	0.0	0.0	0.0	26.7	0.9	0.2	0.0	0.0	2.1	0.6	0.0	0.0	1.1	0.3	0.0	0.7	0.0	0.1	0.7	1.9	85.2	1.2	0.0	0.0	0.1	25.4	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2
CFAP58	"bA554P13.1, C10orf80, CCDC147, FLJ35908"	ENSG00000120051	"Cilia and flagella associated protein 58"	Q5T655	10	104353833-104455102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.4;testis: 13.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 73.3;Endometrial ciliated cells: 25.1;Late spermatids: 58.9;Respiratory ciliated cells: 56.9;Spermatocytes: 34.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;U-2 OS: 6.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.9"	"HPA036555, HPA071938"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	"Plasma membrane, Cytosol"	"HPA036555: AB_10673622, HPA071938: "	"unprognostic (5.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.57e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.62e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.59e-1)"	0.4	0.6	1.0	0.5	1.3	0.4	0.4	0.4	0.7	2.2	2.4	0.5	0.1	1.8	0.2	0.2	8.4	0.2	2.5	0.8	1.2	0.7	0.1	1.3	0.3	2.9	3.7	0.5	0.3	0.7	1.5	0.4	2.2	0.5	0.0	0.6	0.2	0.4	1.3	0.3	0.2	0.6	2.0	0.3	0.3	13.4	1.0	0.1	0.8	0.8	0.4	0.3	0.6	1.1	0.1	0.0	0.7	0.1	0.1	0.3	0.1	1.0	3.1	0.6	1.6	0.0	0.0	2.4	0.2	0.4	1.7	0.2	0.0	0.2	1.8	0.3	0.1	0.5	0.9	0.0	0.3	0.3	0.4	0.3	1.3	0.5	1.6	1.3	1.0	0.1	0.7	0.7	0.8	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.2	0.3	0.3	0.0	0.4	0.2	0.0	0.1	0.5	0.7	0.1	0.4	2.0	0.6	6.5	0.3	1.8	0.2	0.0	0.1	0.7	0.8	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.4	0.7	0.8	1.2	2.9	3.7	2.2	2.0	1.0	1.1	0.4	0.0	0.5	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	10.0	0.0	9.3	0.0	0.0	0.1	0.1	0.0	0.0	0.6	73.3	25.1	0.3	0.4	0.0	0.0	4.0	0.2	0.4	0.7	0.0	0.4	0.0	0.3	1.8	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.0	58.9	0.6	0.2	0.0	1.9	0.1	0.7	1.0	1.0	0.0	0.3	0.0	1.2	0.0	0.2	0.0	0.0	56.9	0.3	0.0	0.8	1.0	34.4	4.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2
CFAP65	"CCDC108, DKFZp434O0527, MGC35338"	ENSG00000181378	"Cilia and flagella associated protein 65"	Q6ZU64	2	219002846-219041527	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.1;choroid plexus: 13.5;fallopian tube: 25.7;testis: 9.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 204.5;Late spermatids: 164.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 10.8"	"HPA055156, HPA063406"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA055156: AB_2682720, HPA063406: "	"unprognostic (3.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (6.08e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.60e-2)"	0.0	0.1	2.3	0.0	2.1	0.0	0.1	1.0	1.0	1.3	13.5	0.1	0.0	0.5	1.8	0.0	25.7	0.4	0.0	2.6	2.8	0.4	0.0	2.7	0.0	8.4	12.1	0.0	0.3	0.1	3.5	0.0	6.2	0.1	0.2	9.2	0.1	0.1	0.0	0.0	0.4	0.0	6.1	0.0	0.3	9.4	2.4	0.0	0.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.1	1.0	1.0	2.6	2.8	8.4	12.1	6.2	6.1	2.4	3.2	0.1	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.8	7.7	8.8	0.0	4.3	6.8	0.0	12.5	0.0	0.1	1.1	0.0	0.6	204.5	45.1	0.5	0.2	29.1	0.0	0.0	1.5	0.0	0.2	2.0	1.8	0.0	0.2	0.0	0.1	0.1	0.0	0.0	25.2	0.0	0.0	0.0	164.3	0.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	1.8	0.7	0.0	1.1	1.9	1.1	29.2	19.5	0.0	0.1	0.0	14.4	5.7	0.0	0.0	0.0	0.2	0.1	5.1	0.1
CFAP77	"C9orf171, FLJ46082"	ENSG00000188523	"Cilia and flagella associated protein 77"	Q6ZQR2	9	132410043-132573319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 11.5;fallopian tube: 29.7;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 127.1;Endometrial ciliated cells: 58.4;Late spermatids: 47.6;Respiratory ciliated cells: 36.5;Spermatocytes: 25.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021329, HPA024647, HPA061069"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657"	"unprognostic (7.28e-4)"	"unprognostic (5.68e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.74e-1)"		"unprognostic (3.01e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	0.0	0.0	1.2	0.0	1.0	0.0	0.0	2.0	0.1	1.2	11.5	0.0	0.0	0.5	0.2	0.0	29.7	0.0	2.4	1.0	1.5	0.1	0.0	2.1	0.0	4.1	6.0	0.0	0.1	0.0	0.6	0.0	3.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	19.3	1.4	0.2	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	2.0	0.1	1.0	1.5	4.1	6.0	3.1	3.3	1.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	58.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.3	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	36.5	3.8	0.0	0.0	0.0	25.5	3.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1
CFAP94	"CASC1, FLJ10921, LAS1, PPP1R54"	ENSG00000118307	"Cilia and flagella associated protein 94"	Q6TDU7	12	25108289-25195162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.4;fallopian tube: 14.0;testis: 22.9"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 1.9;Fibroblasts: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"T-47d: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039662, HPA040141"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Vesicles	"HPA039662: AB_10795468, HPA040141: "	"unprognostic (6.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.62e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.21e-4)"	"unprognostic (2.54e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (2.01e-1)"	"unprognostic (8.74e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.19e-1)"	0.2	0.7	1.6	0.2	2.3	0.6	1.5	0.9	2.0	2.0	12.4	0.3	0.0	1.6	6.0	0.5	14.0	0.7	0.4	2.1	2.3	2.7	0.0	1.9	0.4	5.7	6.0	1.2	0.7	3.3	4.0	0.1	4.2	1.0	0.0	5.1	0.7	1.1	0.1	1.0	0.1	0.3	4.0	0.2	0.6	22.9	3.0	0.4	4.1	0.0	0.1	0.2	0.2	2.5	0.1	0.3	0.4	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.3	0.0	1.0	1.1	0.3	0.0	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.4	0.0	1.1	0.6	0.4	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.4	0.1	0.0	1.0	0.1	0.6	0.2	0.1	0.0	0.1	0.5	1.3	0.0	0.0	0.1	0.8	0.5	0.1	0.4	0.2	0.9	0.3	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.6	0.0	0.2	0.0	0.9	0.1	0.2	1.3	0.3	0.2	0.3	0.0	0.1	1.6	2.3	0.9	2.0	2.1	2.3	5.7	6.0	4.2	4.0	3.0	2.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34709113-34714823	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 372.8;skeletal muscle: 719.9;tongue: 686.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 522.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		47000000	"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	48.7	52.5	71.7	28.6	98.7	18.1	24.6	90.3	116.1	39.8	53.9	92.5	14.3	73.4	19.5	69.0	42.6	24.1	372.8	69.4	85.0	31.4	125.9	24.9	10.7	85.7	83.6	41.2	9.4	24.4	10.9	35.3	88.7	75.4	28.1	41.0	17.1	107.3	719.9	8.2	24.0	115.0	74.7	12.7	36.1	21.7	81.2	10.4	29.4	686.4	9.9	56.8	24.3	130.5	87.1	77.7	49.5	32.0	51.1	185.6	27.9	146.6	170.5	145.6	151.4	61.9	38.5	30.6	58.5	245.2	104.9	17.1	107.4	32.5	268.6	4.2	45.0	6.6	87.4	144.5	81.6	8.2	5.3	139.3	12.4	122.2	67.7	96.8	145.9	4.5	9.9	26.8	186.9	25.5	6.3	4.3	16.3	15.4	118.9	5.4	158.1	4.7	55.1	17.7	10.3	41.7	96.6	21.5	51.2	36.2	47.8	7.5	124.6	140.9	93.0	66.1	72.9	34.3	22.8	11.7	51.7	11.4	34.5	1.8	1.0	1.3	1.9	1.0	3.1	4.9	2.2	2.1	1.6	3.0	1.7	1.8	0.3	1.8	0.4	1.6	2.1	0.9	71.7	98.7	90.3	116.1	69.4	85.0	85.7	83.6	88.7	74.7	81.2	130.5	39.6	105.8	41.6	6.2	17.0	20.0	88.6	31.3	23.9	62.8	19.6	16.6	522.2	22.8	26.3	22.0	20.9	32.2	11.5	0.9	60.7	45.2	2.6	40.3	60.5	45.1	9.5	11.4	9.6	39.7	60.5	69.9	6.1	56.2	5.7	25.8	47.2	112.0	15.6	77.4	14.2	2.4	57.0	15.7	14.4	10.1	57.2	10.6	30.2	11.2	5.7	112.9	15.5	8.0	93.8	24.7	4.0	98.6	60.4	84.0	1.0	101.9	24.7	57.8	32.9	83.9	115.8	49.3	51.9	16.1	19.5	21.3	21.1	47.9	4.6	58.5
CGB1		ENSG00000267631	"Chorionic gonadotropin subunit beta 1"	A6NKQ9	19	49035569-49036895	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"pancreas: 2.7;pituitary gland: 4.3"	"Cell type enriched"	"Detected in single"	77	"Syncytiotrophoblasts: 69.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 17.7"									"HPA038925, HPA038934"	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	3.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	69.9	0.0	0.0	0.0	0.0
CGB2		ENSG00000104818	"Chorionic gonadotropin subunit beta 2"	Q6NT52	19	49031890-49033238	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 40.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 29.9;U-266/70: 12.1;U-266/84: 15.6"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"										"unprognostic (3.05e-2)"								0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.8	0.7	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	4.1	0.0	0.5	0.0	0.1	0.3	0.0	29.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.3	0.8	0.0	3.9	12.1	15.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.2	0.2	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.5	1.8	0.0	0.0	40.0	0.0	0.0	0.0	0.0
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin subunit beta 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 9.8"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 865.9"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 2.9;testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"BEWO: 65.8"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277"									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	2.1	9.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	65.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.2	0.3	0.0	0.3	0.2	0.1	0.4	0.0	0.0	2.1	0.7	0.0	0.0	0.1	0.4	0.0	3.3	1.3	0.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	118.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	865.9	0.0	0.0	0.0	0.0
CGB5	HCG	ENSG00000189052	"Chorionic gonadotropin subunit beta 5"	P0DN86	19	49043848-49045311	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"pituitary gland: 8.7;placenta: 25.6"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 19.7"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 10.0;testis cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"BEWO: 120.1;U-251 MG: 53.2"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (1.38e-1)"				"unprognostic (1.68e-1)"					"unprognostic (1.51e-3)"			"prognostic unfavorable (1.18e-5)"	"unprognostic (1.07e-1)"		"prognostic unfavorable (9.47e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.1	8.7	25.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.4	0.0	0.0	0.0	0.0	120.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.1	2.2	0.0	53.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin subunit beta 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 3.2;skin 1: 3.9"	"Group enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 16.5;Syncytiotrophoblasts: 58.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HaCaT: 3.1;hTCEpi: 3.2;U-251 MG: 7.5"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.3	1.1	0.2	0.0	0.1	0.1	0.1	2.4	0.6	0.0	0.1	0.2	0.1	0.2	0.0	0.6	0.0	0.1	0.3	0.1	0.7	0.0	1.5	0.4	0.1	3.2	0.0	0.0	1.1	0.4	2.2	3.9	0.0	0.0	0.1	0.1	0.0	1.1	0.1	0.2	0.2	0.1	0.0	1.1	1.8	0.1	2.2	0.3	0.1	1.0	0.0	0.0	2.7	0.3	0.0	0.6	0.8	0.5	1.8	0.0	0.1	0.5	1.2	3.1	0.0	2.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	3.2	0.2	0.4	1.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	1.0	0.0	0.0	1.1	0.6	0.1	0.0	1.5	1.5	0.0	7.5	0.2	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.6	0.1	0.6	1.8	0.0	0.1	0.3	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.0	58.7	0.0	0.0	0.0	0.1
CGB8		ENSG00000213030	"Chorionic gonadotropin subunit beta 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 18.8"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 44.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 157.9;U-251 MG: 57.2"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	18.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	1.2	0.0	0.0	0.0	0.0	157.9	0.0	0.0	0.6	0.0	0.0	5.3	0.0	0.1	1.0	4.0	1.3	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	10.1	0.2	0.6	0.0	2.8	7.1	0.7	57.2	0.1	0.2	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0
CHAC2	GCG1	ENSG00000143942	"ChaC glutathione specific gamma-glutamylcyclotransferase 2"	Q8WUX2	2	53767804-53775196	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 44.0;Plasma cells: 27.0;Spermatocytes: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049235	Approved		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA049235: AB_2680686"	"unprognostic (2.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (3.80e-7)"	"unprognostic (5.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.28e-6)"	"unprognostic (1.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	5.0	4.4	1.6	4.8	1.7	6.9	2.1	2.4	2.4	1.2	0.9	4.4	7.3	1.1	2.6	4.5	0.7	1.3	2.5	1.6	2.0	2.9	4.4	1.4	6.6	1.6	1.6	0.6	1.9	1.3	1.6	1.1	1.5	1.7	3.7	3.7	1.7	1.5	4.9	1.2	4.5	2.2	1.3	4.2	4.5	5.4	1.8	4.9	1.0	4.7	6.5	3.2	2.2	1.4	39.9	13.0	13.5	12.1	6.7	3.3	2.9	17.9	3.6	12.5	14.8	9.1	10.0	33.5	25.3	7.8	18.8	14.0	31.1	21.3	21.7	71.3	27.1	26.6	16.3	15.0	10.2	31.8	11.6	4.2	6.2	23.2	17.5	3.3	24.8	23.0	27.8	19.2	16.6	13.0	38.0	26.5	17.5	17.1	23.1	28.6	28.9	34.2	17.3	10.6	16.8	4.7	20.7	15.3	8.7	8.1	9.3	12.5	11.0	7.3	26.1	28.2	29.3	18.9	26.1	28.8	9.9	39.5	10.2	1.3	0.3	0.8	3.5	0.7	3.7	4.3	3.8	3.9	0.8	4.4	4.3	4.1	1.0	1.1	0.5	1.8	3.9	1.9	1.6	1.7	2.4	2.4	1.6	2.0	1.6	1.6	1.5	1.3	1.8	1.4	2.3	0.0	1.1	2.0	11.7	3.4	3.7	7.4	0.6	1.6	2.2	2.0	3.0	7.2	4.1	1.8	0.0	1.9	5.1	3.4	11.7	5.4	13.1	2.2	1.0	3.0	0.0	44.0	4.8	8.0	0.9	1.6	10.2	2.2	1.3	1.5	3.3	7.6	7.8	1.7	4.3	4.6	2.0	1.9	3.0	3.5	2.8	1.7	3.6	1.0	5.8	5.7	8.2	5.0	2.1	7.9	1.4	4.1	27.0	4.1	3.7	9.8	1.9	6.8	0.0	2.4	3.1	47.0	6.6	5.5	3.4	0.4	5.3	5.1	10.6	4.0
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101787-6180321	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 59.0;pituitary gland: 57.3;testis: 31.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 84.3;Early spermatids: 217.8;Excitatory neurons: 80.4;Horizontal cells: 225.4;Inhibitory neurons: 56.2;Late spermatids: 113.2;Rod photoreceptor cells: 49.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 12.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	0.2	4.1	31.8	0.2	40.1	0.0	0.1	0.0	59.0	0.4	0.0	1.1	0.2	0.4	0.0	0.3	0.4	0.1	0.4	34.3	13.6	2.4	0.1	0.3	0.0	3.9	11.1	0.5	0.4	0.9	57.3	0.0	4.4	0.9	0.2	7.9	0.2	2.2	0.2	0.3	0.4	0.1	0.9	0.1	1.0	31.8	10.2	0.3	0.1	0.0	0.0	0.7	0.6	31.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	1.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	12.9	0.2	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	40.1	0.0	59.0	34.3	13.6	3.9	11.1	4.4	0.9	10.2	31.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.0	0.0	84.3	0.1	0.3	2.1	0.0	0.0	3.7	12.5	0.0	0.1	0.2	0.0	0.0	217.8	0.0	0.2	0.6	0.0	0.0	80.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	225.4	56.2	0.0	0.0	0.0	0.3	113.2	0.9	0.1	0.0	2.8	0.0	2.0	0.0	4.5	3.7	0.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	49.9	0.0	0.2	0.5	4.5	17.8	0.0	0.4	0.0	0.1	0.1	0.0	0.0
CHIC1	BRX	ENSG00000204116	"Cysteine rich hydrophobic domain 1"	Q5VXU3	X	73563200-73687102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 47.0;Excitatory neurons: 62.7;Inhibitory neurons: 59.6;Microglial cells: 29.0;Oligodendrocyte precursor cells: 66.9;Oligodendrocytes: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA052062"	Uncertain		Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear speckles, Vesicles"	Cytosol	"HPA026782: AB_1846654, HPA052062: AB_2681714"	"unprognostic (9.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.10e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (1.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.76e-2)"	2.9	7.0	4.4	3.0	4.8	0.6	3.7	4.6	8.5	7.1	2.4	5.2	2.3	5.6	3.8	2.4	4.2	4.6	5.4	5.7	6.1	6.3	1.5	2.7	3.9	5.9	4.6	5.7	2.2	5.9	5.6	2.1	6.0	4.8	4.2	5.4	2.8	5.1	2.6	3.0	3.4	5.4	4.9	4.1	2.5	1.5	5.8	2.8	6.5	5.2	3.5	4.2	3.4	5.1	4.6	4.7	2.3	3.0	6.5	8.7	0.0	5.1	6.8	4.1	4.9	3.1	5.8	2.1	6.9	4.6	8.1	1.4	3.3	2.5	9.0	5.3	4.1	3.2	4.0	0.0	4.2	0.0	6.0	6.1	2.9	7.7	4.1	5.2	5.9	2.1	0.8	20.3	8.1	0.7	1.9	0.0	7.3	0.0	4.6	1.8	5.9	1.3	5.1	2.3	1.3	1.9	5.8	2.7	6.3	3.9	2.3	1.3	6.9	4.7	4.6	9.4	3.1	5.7	15.3	0.0	6.9	3.4	3.7	0.2	0.0	0.0	0.4	0.0	0.7	0.2	0.3	0.4	0.0	0.2	0.3	0.4	0.0	0.3	0.0	0.0	0.3	0.1	4.4	4.8	4.6	8.5	5.7	6.1	5.9	4.6	6.0	4.9	5.8	5.1	8.3	3.2	9.1	47.0	9.4	2.7	4.6	2.7	4.6	10.0	4.2	3.6	12.7	5.7	4.1	3.7	6.2	0.2	7.5	2.1	0.0	3.5	4.1	10.9	5.6	9.4	0.0	4.4	62.7	3.5	0.0	8.2	1.5	7.3	5.1	5.3	5.3	1.6	1.6	13.5	59.6	7.5	2.0	2.2	1.8	1.8	3.1	2.3	5.4	29.0	1.6	5.7	8.2	66.9	76.1	2.4	6.1	9.1	6.7	5.4	1.4	11.4	3.9	7.5	0.0	8.3	5.0	2.0	2.4	2.4	4.5	0.0	8.8	5.9	3.4	4.6
CHKB	"CHETK, CHKL"	ENSG00000100288	"Choline kinase beta"	Q9Y259	22	50578959-50601455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Congenital muscular dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.1;RPMI-8226: 19.8"									HPA018797	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA018797: AB_1846666"	"unprognostic (6.03e-4)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-3)"	14.1	13.0	10.3	0.7	10.3	12.1	13.4	10.5	16.8	10.6	12.2	10.5	3.3	9.5	12.0	11.1	12.0	1.5	11.5	10.1	10.8	13.2	9.4	13.3	4.3	10.5	11.0	8.6	7.7	17.7	14.3	7.2	10.6	12.0	4.8	1.6	11.9	7.2	8.3	11.6	10.7	5.3	10.7	18.1	11.6	14.5	11.0	9.2	12.6	11.7	9.8	11.7	11.1	10.8	4.2	1.3	0.5	1.6	6.7	5.9	10.8	7.3	16.7	4.7	3.1	1.4	2.1	2.1	4.2	3.8	2.4	0.0	1.5	2.0	1.0	0.3	5.4	3.1	2.2	2.3	19.1	2.5	4.8	2.0	6.5	0.6	8.1	4.5	17.1	5.5	1.8	0.3	12.4	5.3	2.0	8.6	0.7	7.0	1.9	3.5	1.8	19.8	11.5	2.0	2.0	3.2	3.0	7.3	5.9	0.2	1.1	2.8	6.9	0.0	1.7	0.0	2.2	7.4	0.0	3.0	2.3	0.4	3.4	12.0	39.5	27.0	26.4	38.4	25.7	24.0	24.2	27.6	35.7	23.6	22.6	20.8	9.6	37.0	26.1	34.1	33.4	32.6	10.3	10.3	10.5	16.8	10.1	10.8	10.5	11.0	10.6	10.7	11.0	10.8	16.7	6.4	28.2	0.0	13.6	4.8	2.3	6.9	8.6	4.8	10.0	7.4	7.7	20.0	12.7	7.3	4.2	8.8	14.0	18.4	3.9	30.6	11.6	3.9	3.4	8.0	15.7	9.0	0.0	23.8	14.1	8.6	19.9	3.3	19.0	2.5	10.4	5.4	14.6	8.4	0.0	19.3	12.2	16.6	9.2	30.5	2.5	10.0	3.6	0.0	48.4	3.3	14.4	0.0	0.0	23.5	24.2	3.0	14.6	2.1	29.3	5.5	11.2	6.0	6.6	2.4	6.8	12.6	10.0	14.5	6.3	8.5	11.2	2.8	17.3	2.2
CHMP2A	"BC-2, CHMP2, VPS2, VPS2A"	ENSG00000130724	"Charged multivesicular body protein 2A"	O43633	19	58551566-58555105	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041153, HPA042031"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		230000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041153: AB_10964358, HPA042031: AB_10961727"	"unprognostic (1.80e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.71e-2)"	131.8	185.9	144.9	86.8	149.6	162.3	125.1	153.7	171.9	108.9	143.5	141.3	113.4	111.7	150.1	154.9	104.6	83.1	182.6	144.4	147.8	163.3	161.3	116.9	81.9	151.1	147.0	101.9	125.0	147.8	118.7	95.8	151.3	112.5	124.1	75.2	137.2	97.1	222.9	158.4	121.9	83.6	149.0	121.2	143.8	73.9	146.8	82.6	123.2	151.7	95.1	114.3	113.7	157.4	110.4	290.9	91.4	85.0	138.9	172.9	112.9	100.0	204.3	52.0	56.0	86.3	160.1	29.3	143.2	168.1	149.2	87.7	76.1	190.4	43.7	98.8	628.2	71.8	214.0	134.7	266.6	121.1	108.0	201.5	266.0	81.5	257.8	175.3	153.1	135.5	86.8	135.6	159.5	187.1	153.7	111.3	38.3	304.2	220.3	65.2	78.6	222.0	230.1	246.8	107.3	181.2	162.0	213.7	123.4	57.3	164.3	121.5	174.4	262.0	37.7	77.2	117.3	339.0	404.9	95.2	185.0	141.0	176.6	278.9	247.4	351.1	134.9	232.7	114.5	127.0	148.0	153.1	216.2	123.0	102.0	116.3	820.6	131.6	243.9	197.1	215.5	208.4	144.9	149.6	153.7	171.9	144.4	147.8	151.1	147.0	151.3	149.0	146.8	157.4	166.1	99.3	119.8	9.4	72.9	165.6	261.4	287.7	69.4	73.9	124.7	120.6	118.7	154.4	207.2	165.5	16.7	288.8	76.5	555.2	442.2	332.6	121.9	194.0	109.2	143.6	155.4	142.5	5.3	522.5	296.8	113.5	115.7	198.8	121.5	102.1	142.5	214.0	269.1	52.2	5.6	296.6	217.7	142.0	145.8	90.9	145.1	134.5	215.3	6.5	203.6	217.6	147.2	3.0	13.4	479.8	615.3	133.2	77.3	258.5	607.0	599.8	242.1	94.3	85.5	103.9	169.7	116.8	89.7	109.5	198.5	460.0	89.2	149.3	226.3	372.7
CHMP2B	"CHMP2.5, DKFZP564O123, VPS2B"	ENSG00000083937	"Charged multivesicular body protein 2B"	Q9UQN3	3	87227271-87255556	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 445.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035069, HPA052754"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA035069: AB_10602798, HPA052754: AB_2681936"	"unprognostic (7.83e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (5.76e-2)"	"prognostic favorable (1.74e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.21e-1)"	26.0	24.2	15.7	22.8	20.2	42.7	26.3	22.3	22.2	28.9	16.2	41.6	38.5	29.5	22.5	35.2	22.6	28.8	27.0	15.1	18.2	29.6	34.5	22.9	21.9	25.1	21.0	24.9	29.2	24.3	30.4	25.0	24.1	34.9	37.5	15.3	24.9	27.7	35.3	26.4	40.8	29.6	23.7	22.1	31.1	16.1	20.3	17.2	43.1	28.0	21.6	42.3	29.7	31.2	68.4	71.6	25.4	17.4	45.0	38.4	29.7	52.8	71.2	45.1	57.1	57.0	115.0	25.3	36.7	60.1	38.6	35.0	31.6	37.6	56.0	41.7	34.7	29.5	24.6	25.4	39.2	44.9	42.5	29.3	63.2	42.9	58.3	42.6	35.8	29.6	17.3	36.7	50.2	53.2	41.1	18.3	32.4	91.1	65.5	21.4	31.0	26.1	36.0	71.3	9.7	10.8	54.2	45.6	91.4	28.8	40.6	13.7	30.6	42.9	36.5	445.0	37.7	37.7	56.3	41.6	47.6	24.8	30.9	124.7	50.7	136.7	27.3	65.2	37.3	49.6	34.6	34.8	55.1	53.4	32.0	32.4	96.8	31.4	67.8	31.3	52.4	37.8	15.7	20.2	22.3	22.2	15.1	18.2	25.1	21.0	24.1	23.7	20.3	31.2	56.2	83.3	68.7	11.4	58.7	132.0	254.5	90.0	53.5	19.9	59.8	52.1	68.8	62.9	85.0	49.7	4.2	75.4	45.7	268.7	138.9	170.6	6.8	86.7	45.2	54.4	46.7	36.2	14.1	261.2	187.0	68.9	48.4	86.9	74.1	27.1	48.5	60.8	86.9	37.0	15.1	80.3	73.2	61.9	87.6	7.5	66.2	72.6	40.9	9.4	62.0	213.9	42.2	10.6	36.0	237.4	241.3	96.3	30.0	226.0	101.7	145.8	90.5	16.3	72.3	58.5	57.5	78.7	76.7	62.8	145.6	180.9	52.9	38.1	81.3	330.3
CHN1	"ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2"	ENSG00000128656	"Chimerin 1"	P15882	2	174798809-175005381	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 772.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 195.2;Excitatory neurons: 596.4;Inhibitory neurons: 111.7;Microglial cells: 97.4;Oligodendrocyte precursor cells: 149.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 6.5;memory CD8 T-cell: 2.1;T-reg: 8.0"	"Lineage enriched"	"Detected in single"	18	"T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 186.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036111			Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA036111: AB_10671241"	"unprognostic (3.18e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (7.31e-3)"	"unprognostic (4.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.46e-2)"	11.8	13.3	368.6	7.3	445.9	0.8	10.5	194.0	772.6	9.2	170.6	10.2	3.3	7.9	38.3	6.9	6.5	11.1	15.1	492.6	241.5	4.7	2.1	19.6	21.5	210.2	225.4	5.8	4.2	43.4	36.3	38.6	210.5	17.0	5.1	39.5	3.2	9.6	2.7	3.8	7.5	13.1	192.4	5.5	7.1	21.3	239.1	3.1	10.2	3.7	18.7	8.7	6.7	422.8	0.4	17.4	57.6	16.3	14.7	67.4	0.4	45.6	186.7	65.1	97.0	0.3	5.4	0.5	1.6	71.8	39.9	2.0	68.0	1.9	30.3	1.3	32.9	11.1	20.1	3.8	34.4	6.4	1.7	53.6	1.9	31.6	11.1	16.1	33.6	30.0	0.7	1.9	57.2	11.8	29.3	2.5	71.7	2.6	23.7	8.2	70.3	0.8	0.9	0.6	71.3	76.3	41.3	0.5	7.3	36.0	3.2	2.2	10.1	26.8	3.9	9.8	20.6	6.4	33.7	0.7	6.7	0.4	6.6	0.4	0.1	0.1	0.3	0.1	0.8	0.2	6.5	2.1	0.0	0.1	1.3	0.4	0.4	0.2	0.2	0.3	8.0	1.0	368.6	445.9	194.0	772.6	492.6	241.5	210.2	225.4	210.5	192.4	239.1	422.8	15.4	3.2	1.9	195.2	1.6	4.5	0.3	0.0	0.0	85.1	7.3	1.4	6.2	1.5	2.6	3.7	27.1	1.2	0.5	0.1	0.0	0.3	24.1	5.3	5.6	17.9	2.4	0.0	596.4	0.6	1.1	28.4	2.0	3.6	0.0	5.1	10.4	0.5	2.7	77.4	111.7	0.0	0.0	0.0	4.0	23.2	3.1	0.9	7.2	97.4	0.0	59.1	0.0	149.8	88.1	0.6	0.0	5.3	1.3	0.6	0.0	0.3	1.0	14.1	13.1	23.8	27.3	17.8	23.6	0.1	3.7	2.1	12.5	5.1	0.2	0.3
CHODL	"C21orf68, FLJ12627, MT75, PRED12"	ENSG00000154645	Chondrolectin	Q9H9P2	21	17901263-18267373	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;lymphoid tissue: 14.1;testis: 31.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 38.6;Oligodendrocytes: 50.1;Skeletal myocytes: 28.3;Theca cells: 26.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.8;U-266/70: 2.8;U-266/84: 7.2;U-87 MG: 7.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.9;hypothalamus: 12.3;pons and medulla: 10.9"	"Group enriched"	"Detected in all"	4	"olfactory bulb: 66.4;spinal cord: 38.6"	"HPA017282, HPA057559"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	Centrosome	"HPA017282: AB_1846687, HPA057559: "	"unprognostic (3.91e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (6.74e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.02e-1)"	3.3	2.0	1.6	1.1	1.4	0.0	1.1	0.7	1.6	0.2	0.8	2.8	1.6	0.6	1.1	0.9	0.5	0.8	3.7	1.7	5.4	3.6	0.0	0.3	0.4	11.5	2.6	0.6	0.1	0.3	2.5	1.9	10.8	5.6	3.5	0.6	0.5	1.8	0.6	2.3	1.0	0.3	1.6	14.1	0.7	31.0	10.2	0.3	1.1	1.7	1.2	0.7	1.1	3.8	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.4	0.1	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.7	0.6	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.8	7.2	0.2	7.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.5	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	1.6	1.4	0.7	1.6	1.7	5.4	11.5	2.6	10.8	1.6	10.2	3.8	1.7	0.0	0.0	5.2	1.0	4.0	0.8	0.8	3.4	1.1	1.0	1.3	0.5	0.0	0.9	0.0	0.0	0.2	0.9	0.0	1.9	0.4	5.0	1.4	38.6	1.5	0.0	0.0	5.5	0.0	0.2	4.6	0.0	0.8	0.0	12.3	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.8	4.0	3.1	0.1	1.8	4.7	0.0	0.4	0.0	12.5	50.1	0.0	0.0	1.9	3.1	0.2	0.0	0.3	0.3	0.1	0.0	28.3	10.5	1.3	1.7	0.5	2.3	0.5	1.3	26.7	0.1	0.3
CHORDC1	"CHP-1, CHP1"	ENSG00000110172	"Cysteine and histidine rich domain containing 1"	Q9UHD1	11	90200429-90223077	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 94.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041040	Approved		Approved	Cytosol		NA	NA		160000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA041040: AB_10794185"	"unprognostic (2.29e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (4.93e-7)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.27e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-1)"	20.2	19.8	17.4	10.5	18.4	10.7	12.0	18.2	94.5	16.2	18.6	14.0	5.4	15.3	8.4	17.5	14.5	7.1	21.7	19.6	20.7	15.9	21.7	18.1	13.4	18.8	18.4	25.4	12.9	5.0	22.3	12.2	18.7	15.4	6.9	7.7	12.3	7.2	18.0	10.3	12.4	6.9	18.4	16.5	14.2	13.7	18.9	10.6	16.9	13.1	13.7	17.0	17.2	26.4	28.1	74.8	26.0	17.0	24.7	14.9	39.6	34.1	11.6	34.9	29.3	113.9	21.9	49.3	54.0	15.1	60.8	35.0	76.7	17.3	38.7	42.4	37.3	46.6	45.1	55.7	19.0	35.0	29.6	5.5	22.9	29.4	33.8	18.7	26.9	28.5	71.8	19.9	41.5	13.9	32.2	45.9	29.9	96.0	63.3	49.2	15.5	29.3	28.5	12.7	24.8	10.2	37.3	28.8	13.8	29.7	49.0	16.6	24.0	25.4	51.1	35.5	40.6	9.4	80.0	38.9	7.3	49.9	22.1	8.6	8.0	8.9	12.0	13.6	13.1	13.1	13.0	12.7	12.7	11.5	13.6	13.2	2.4	16.5	9.2	9.8	17.9	11.2	17.4	18.4	18.2	94.5	19.6	20.7	18.8	18.4	18.7	18.4	18.9	26.4	49.4	19.2	27.4	18.6	55.5	70.7	164.8	20.1	32.5	45.1	33.2	31.8	30.7	12.8	29.3	11.0	135.5	41.3	62.1	30.1	11.7	23.8	93.9	112.7	75.0	48.2	68.8	25.7	65.7	16.1	76.5	50.2	20.4	93.9	87.0	34.0	15.7	14.8	39.2	65.6	60.0	32.7	22.4	19.2	109.2	57.1	32.6	61.7	28.4	30.0	30.5	22.9	39.1	46.8	81.5	20.9	28.5	31.2	42.9	97.5	10.7	25.3	48.0	53.7	13.1	32.6	71.0	98.1	47.0	26.5	81.8	50.9	104.9	51.6	37.0	89.6
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.7	31.7	9.5	17.4	9.3	23.1	13.6	3.8	12.9	14.6	13.5	17.4	13.0	19.5	10.3	14.0	14.6	15.1	19.8	9.6	11.6	14.9	20.4	17.6	16.6	11.1	8.7	14.0	26.2	13.2	43.7	16.1	10.0	19.1	9.0	2.9	22.2	12.9	8.1	14.7	18.9	14.9	5.4	28.9	20.1	9.6	10.5	10.9	17.6	5.0	10.7	16.7	13.6	6.7	27.9	22.3	14.7	43.1	50.0	49.2	22.2	57.3	88.4	30.5	37.1	14.9	46.1	8.4	98.7	91.6	41.5	34.3	6.5	40.8	13.1	32.1	20.3	8.9	25.4	21.0	46.7	18.2	70.9	75.8	22.7	28.9	10.3	63.1	48.6	13.8	8.6	23.7	49.2	45.7	17.0	70.6	19.7	11.6	25.6	15.8	8.7	28.1	29.6	21.7	15.9	28.1	30.7	29.8	15.2	11.0	11.6	29.4	66.9	33.6	5.6	45.2	49.3	43.3	6.8	12.3	122.3	23.9	46.6	0.9	4.4	6.2	4.0	3.6	3.7	1.9	2.1	3.6	4.7	2.0	1.4	1.6	7.2	2.0	3.9	6.9	2.4	3.3	9.5	9.3	3.8	12.9	9.6	11.6	11.1	8.7	10.0	5.4	10.5	6.7	8.3	9.6	11.8	2.3	11.2	4.6	6.6	15.1	6.2	8.8	10.5	5.6	1.9	10.0	11.7	11.0	4.2	11.5	23.4	21.3	1.9	12.4	0.6	6.5	11.0	8.9	8.4	8.6	6.1	16.8	16.3	13.3	18.8	9.0	6.3	14.6	12.5	9.6	12.6	25.2	5.0	12.0	14.2	10.9	6.8	1.0	17.1	11.1	7.2	3.7	11.0	5.3	11.3	5.5	1.8	17.7	17.4	15.1	26.5	11.5	8.5	3.5	8.8	7.4	19.7	7.8	14.6	5.0	3.1	6.6	4.4	10.3	13.0	15.8	9.8	10.5
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 57.6"	"Group enriched"	"Detected in some"	10	"Muller glia cells: 4.0;Skeletal myocytes: 4.4"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RH-30: 99.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	6.3	0.7	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CHST10	HNK-1ST	ENSG00000115526	"Carbohydrate sulfotransferase 10"	O43529	2	100391860-100417668	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 21.5;Muller glia cells: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012884, HPA051545"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		680000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA012884: AB_1846710, HPA051545: AB_2681529"	"unprognostic (5.40e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.27e-1)"	4.3	6.7	26.5	4.2	28.2	3.2	5.1	24.3	33.6	7.1	18.8	6.3	2.3	11.5	13.3	4.2	9.7	5.5	11.0	27.2	23.2	4.3	1.2	8.1	4.4	24.6	26.4	12.7	5.6	9.6	11.5	8.2	23.2	8.0	2.4	9.4	6.1	5.2	6.0	2.2	3.6	12.0	24.8	5.0	4.4	6.1	28.6	5.7	10.0	8.3	5.4	5.5	3.7	25.1	0.2	14.6	28.4	14.6	8.5	11.9	14.2	16.7	11.8	22.4	14.3	0.3	8.5	20.4	14.1	10.1	39.6	0.0	20.2	2.2	14.3	29.1	21.2	10.5	8.3	23.1	10.1	21.5	26.5	8.8	2.7	10.6	2.0	10.7	17.8	19.5	31.0	0.1	9.7	4.8	19.1	16.8	42.0	0.2	17.7	13.6	17.6	0.2	6.2	6.4	30.5	24.9	1.2	0.1	23.3	20.0	7.8	29.0	16.4	15.5	24.5	11.7	15.7	0.0	0.1	21.2	19.0	18.7	18.6	0.0	0.0	0.0	1.3	0.0	0.4	0.8	0.2	1.0	0.2	0.6	0.3	0.7	0.0	0.0	0.0	1.1	0.0	0.5	26.5	28.2	24.3	33.6	27.2	23.2	24.6	26.4	23.2	24.8	28.6	25.1	2.8	16.0	3.1	21.5	4.4	0.9	1.1	0.3	0.6	9.7	2.4	2.0	6.3	1.5	4.4	1.8	0.0	5.4	2.3	0.0	3.9	3.5	1.5	2.7	6.7	4.9	1.8	3.0	10.7	2.9	10.5	5.0	0.0	6.2	0.0	6.5	0.4	0.0	6.2	6.7	7.5	0.0	0.0	0.8	1.1	0.4	2.1	1.3	0.0	6.5	3.2	16.7	1.0	12.5	5.9	2.2	0.0	5.3	2.3	1.5	0.0	1.1	0.7	4.8	0.0	3.7	3.5	1.5	5.1	0.3	0.6	1.4	3.4	8.5	0.1	0.2
CHST15	"BRAG, GALNAC4S-6ST, KIAA0598"	ENSG00000182022	"Carbohydrate sulfotransferase 15"	Q7LFX5	10	124007668-124093598	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 69.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 69.0;monocytes: 38.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 66.0;REH: 90.4;U-266/70: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017584	Approved		Approved	Centrosome,Cytosol		NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Centrosome	"HPA017584: AB_1849437"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.62e-3)"	"unprognostic (7.90e-2)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (6.47e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.63e-3)"	"unprognostic (5.26e-3)"	17.0	10.4	9.3	19.8	25.4	7.0	11.4	5.3	14.6	10.6	23.8	19.8	9.8	7.9	8.3	9.4	15.0	12.8	5.5	17.2	6.0	9.6	13.6	17.2	17.8	8.3	8.2	37.0	14.1	2.8	8.4	6.6	6.7	9.7	8.8	2.8	9.4	13.8	13.7	9.2	15.4	10.6	10.2	36.7	11.5	4.3	9.5	9.3	19.8	5.8	14.2	12.4	9.2	11.6	32.3	21.2	7.8	1.7	7.5	4.0	0.1	6.4	8.6	3.4	4.9	0.6	17.1	0.0	20.1	26.4	2.3	35.9	1.5	20.8	2.9	0.2	5.9	0.1	9.3	16.0	2.4	0.0	39.2	2.5	23.5	9.5	8.0	8.3	6.9	0.1	0.0	66.0	17.0	18.0	0.1	0.1	6.8	4.9	0.1	90.4	10.6	21.6	17.1	3.1	0.8	1.7	17.1	9.6	0.0	19.3	7.0	0.1	8.3	0.9	0.3	24.3	1.0	59.5	15.7	16.9	0.2	0.0	0.1	0.0	21.8	15.3	0.0	33.3	0.0	4.5	0.0	0.0	4.2	4.4	0.3	0.0	69.0	0.0	38.7	4.9	0.3	9.1	9.3	25.4	5.3	14.6	17.2	6.0	8.3	8.2	6.7	10.2	9.5	11.6	14.3	22.4	9.6	4.2	13.5	16.8	16.1	15.3	2.2	5.6	10.5	5.2	2.2	12.8	12.1	20.2	0.0	1.8	7.2	0.1	0.0	9.7	29.5	7.4	5.9	18.2	1.8	0.0	43.8	0.7	2.3	8.4	0.5	14.0	5.7	0.4	42.1	9.0	10.5	0.0	33.2	0.0	16.2	50.2	3.6	34.8	10.2	34.0	1.8	43.1	30.3	0.1	2.1	35.2	1.0	9.8	0.0	1.9	34.3	14.7	0.0	0.7	11.9	0.5	19.7	13.4	11.5	10.4	10.0	2.4	11.6	1.0	1.4	0.8	0.1	15.8
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119771-143124014	"Metabolic proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 114.4;NK-cells: 233.8;Plasma cells: 79.3;Sertoli cells: 92.1;Theca cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.3;NK-cell: 4.9;non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	5	"monocytes: 11.4;NK-cells: 4.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 57.7;ASC TERT1: 58.8;HEL: 48.2;HHSteC: 118.4;HMC-1: 55.4;HSkMC: 62.3;U-266/70: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: AB_2668861"	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	7.7	2.7	17.8	8.1	13.7	16.8	6.3	16.7	14.6	5.7	6.0	3.0	2.1	8.4	1.4	1.1	2.1	1.7	5.6	9.7	13.4	8.4	1.3	7.5	7.7	31.0	18.4	4.9	1.3	0.9	6.9	10.3	28.1	7.4	1.1	11.0	2.7	9.9	1.6	4.4	7.5	3.7	21.4	18.2	3.4	1.7	28.7	14.5	6.7	0.8	5.4	7.1	7.6	48.4	0.0	0.3	3.1	2.6	57.7	58.8	0.2	3.3	9.5	2.3	2.1	0.0	0.0	0.6	2.0	2.3	3.1	0.1	2.3	8.2	1.2	0.8	1.5	48.2	0.1	0.0	118.4	1.2	55.4	62.3	9.7	3.1	10.1	3.6	3.6	7.2	5.5	2.9	15.4	0.0	9.1	12.2	16.5	0.0	8.0	0.5	1.0	0.1	1.7	2.2	3.7	0.0	0.7	0.0	5.6	2.9	0.0	1.9	12.3	7.0	4.1	9.5	13.9	52.4	0.8	3.3	13.8	9.3	37.4	0.7	0.5	0.7	0.3	4.3	0.0	1.1	0.1	0.2	1.6	0.8	0.6	0.5	0.3	4.9	11.4	0.1	0.5	0.9	17.8	13.7	16.7	14.6	9.7	13.4	31.0	18.4	28.1	21.4	28.7	48.4	11.3	0.0	0.0	3.6	17.7	2.4	7.3	2.5	0.0	25.0	2.8	2.7	1.4	0.0	1.8	3.7	2.1	0.6	41.9	0.0	0.0	0.4	0.2	5.7	29.8	9.4	0.0	39.1	6.8	0.2	0.6	14.4	2.0	6.5	11.4	12.5	3.6	0.4	2.8	1.7	8.1	0.0	0.0	10.3	32.2	1.3	12.8	20.2	17.8	1.0	13.6	114.4	233.8	2.5	6.1	5.9	0.0	2.2	79.3	13.1	0.0	0.0	0.1	23.8	92.1	0.8	20.2	0.0	2.2	0.1	0.6	1.0	9.8	58.1	1.3	14.8
CHST3	"C6ST, C6ST1"	ENSG00000122863	"Carbohydrate sulfotransferase 3"	Q7LGC8	10	71964395-72013558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 26.9;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 27.1;Skeletal myocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047523, HPA055704"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		690000		"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA047523: AB_2680075, HPA055704: AB_2682891"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.54e-3)"	18.4	13.4	10.7	5.5	17.9	0.0	11.4	16.8	11.5	10.7	6.2	11.9	0.9	16.0	3.7	6.4	12.9	4.7	14.3	9.9	12.9	7.9	1.2	7.9	1.6	27.9	18.2	20.6	4.6	1.2	4.6	8.0	19.8	11.1	2.1	2.1	6.4	14.8	17.7	8.7	5.4	17.1	14.0	2.5	14.7	18.1	17.3	4.2	5.5	9.0	1.4	9.4	8.4	25.3	15.4	16.4	8.2	20.3	36.6	14.4	0.3	32.0	30.4	19.3	12.8	14.4	30.1	0.0	21.4	37.9	15.5	19.7	7.4	21.9	15.3	0.4	5.5	0.1	27.8	13.8	18.7	0.0	0.1	19.8	24.9	19.0	25.9	37.3	5.7	0.7	4.7	0.0	20.6	0.4	0.0	0.1	3.5	0.5	5.3	0.2	9.9	0.0	26.9	15.7	0.5	8.1	24.2	0.6	24.1	9.9	1.8	3.1	11.9	23.6	27.1	39.6	65.1	0.0	0.1	0.1	17.2	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	17.9	16.8	11.5	9.9	12.9	27.9	18.2	19.8	14.0	17.3	25.3	23.9	0.0	1.9	14.0	0.1	2.8	4.9	6.1	13.6	0.1	4.3	8.0	10.4	5.7	2.5	7.3	0.0	4.6	0.0	0.1	3.9	9.7	0.8	20.1	24.7	5.6	0.0	0.0	0.2	2.7	2.2	9.3	2.6	17.9	1.3	26.9	13.6	0.3	0.8	0.0	0.3	0.0	2.0	0.6	1.9	3.2	20.5	0.7	8.8	4.7	0.7	6.6	0.0	26.7	27.1	12.7	0.0	21.8	0.0	4.2	0.0	3.6	2.0	0.2	6.6	26.8	13.9	1.0	2.1	7.5	2.4	1.1	0.4	5.5	0.1	1.3
CHURC1	"C14orf52, FLJ33064, My015"	ENSG00000258289	"Churchill domain containing 1"	Q8WUH1	14	64914361-64944591	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040072	Approved		Approved	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA040072: AB_10963788"	"unprognostic (2.94e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (6.78e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	47.8	42.0	29.9	39.1	34.8	43.8	37.4	34.5	41.2	41.2	27.2	43.8	30.9	40.0	32.6	34.3	34.2	32.5	58.8	29.8	33.7	34.7	52.4	29.3	43.8	38.8	33.3	43.9	30.2	46.1	25.2	34.5	38.6	32.4	36.4	35.7	26.5	37.7	82.9	30.1	33.9	45.8	34.7	42.2	33.7	25.4	34.3	61.2	32.9	53.0	43.3	38.3	30.5	40.3	119.6	61.8	58.8	43.7	70.1	75.6	68.9	85.3	74.3	47.4	53.9	34.1	75.1	69.9	57.7	73.7	75.2	84.9	51.7	69.2	51.8	79.7	25.3	67.9	47.7	79.3	66.1	37.7	64.9	89.9	50.5	43.0	81.4	79.7	51.6	107.2	30.6	60.5	58.1	97.6	72.7	61.6	31.4	140.9	101.1	63.4	63.2	42.6	64.5	83.8	30.0	36.7	57.6	59.8	81.0	53.7	101.8	78.4	64.8	41.3	87.8	45.0	56.0	49.5	46.8	162.0	43.0	44.6	51.8	201.6	131.9	145.4	111.5	137.6	128.2	161.8	167.5	134.1	107.4	135.9	166.3	139.8	292.8	122.4	138.3	154.7	238.5	143.5	29.9	34.8	34.5	41.2	29.8	33.7	38.8	33.3	38.6	34.7	34.3	40.3	154.6	102.5	89.0	0.0	128.2	58.5	73.8	176.8	130.3	73.8	85.0	98.7	53.4	94.4	98.2	99.3	43.8	90.4	97.9	89.3	131.0	160.7	82.0	130.8	87.3	109.9	89.8	91.5	0.0	222.7	89.7	100.9	75.4	80.8	95.6	69.6	127.5	190.4	89.3	53.8	0.0	100.3	107.8	172.6	69.6	27.1	104.1	130.5	83.6	0.0	214.3	155.2	132.8	0.0	0.0	216.8	118.9	121.5	79.7	70.5	124.6	211.0	145.1	87.2	131.5	100.6	135.7	131.1	81.1	158.3	65.9	89.8	137.0	205.8	121.1	72.2
CIAO1	"CIA1, WDR39"	ENSG00000144021	"Cytosolic iron-sulfur assembly component 1"	O76071	2	96266159-96274173	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017882	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA017882: AB_1846738"	"unprognostic (2.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.15e-2)"	18.4	32.4	26.8	17.0	28.3	12.1	19.4	30.2	29.7	18.9	26.3	16.8	20.1	14.8	18.0	20.1	19.7	15.1	30.4	27.8	27.8	31.0	32.8	17.6	22.3	27.7	27.6	18.6	17.9	36.2	13.4	18.7	28.3	16.9	17.6	17.4	23.6	19.5	27.8	19.3	17.6	16.5	28.9	21.3	16.7	17.1	28.6	22.2	20.5	28.0	21.3	18.6	13.9	30.2	31.8	27.2	28.8	32.3	49.8	40.9	32.0	27.1	31.9	37.5	39.8	44.1	23.0	44.6	46.6	29.8	42.0	28.0	40.8	29.7	33.4	25.0	58.0	28.9	19.4	47.4	28.8	37.8	32.2	35.1	34.5	28.5	43.2	35.9	39.9	33.8	36.9	29.8	35.9	38.1	42.2	40.8	51.3	44.5	58.0	38.3	33.2	47.3	42.6	31.6	36.0	42.2	19.9	48.0	53.1	40.1	24.8	41.4	30.4	26.2	35.4	36.7	29.3	43.5	49.6	30.1	38.4	37.9	31.4	30.9	27.7	34.2	27.8	23.8	31.9	20.9	25.8	29.8	29.1	24.9	24.3	28.5	23.6	30.0	33.8	18.8	23.5	33.0	26.8	28.3	30.2	29.7	27.8	27.8	27.7	27.6	28.3	28.9	28.6	30.2	33.3	28.9	31.4	26.8	32.4	29.1	28.7	39.0	35.9	24.3	23.2	28.4	27.0	15.7	31.6	14.7	14.6	59.3	42.5	21.8	39.2	40.0	25.0	21.2	30.7	30.1	15.7	32.4	44.5	33.6	60.1	32.6	28.1	21.2	37.2	33.3	19.2	27.4	45.2	26.9	36.6	21.1	44.7	23.4	29.6	25.8	20.2	30.6	19.6	20.6	40.6	19.0	42.2	25.1	25.2	35.5	13.0	16.6	44.8	51.7	43.6	72.7	36.2	24.0	32.9	27.3	34.4	42.5	42.3	43.5	34.5	49.8	38.6	54.5	23.6	43.0
CIAO3	"FLJ21988, HPRN, IOP1, NAR1, NARFL, PRN"	ENSG00000103245	"Cytosolic iron-sulfur assembly component 3"	Q9H6Q4	16	729760-741329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 11.6;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 10.9;Hofbauer cells: 16.0;Syncytiotrophoblasts: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 142.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040851	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA040851: AB_10794427"	"unprognostic (6.31e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (7.61e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (9.83e-5)"	"unprognostic (2.49e-2)"	"unprognostic (8.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.33e-3)"	10.4	13.8	16.8	7.5	18.0	10.7	12.3	17.2	27.2	11.6	14.1	16.1	13.3	12.1	11.5	18.5	12.2	6.7	23.1	17.6	16.0	19.5	22.4	9.4	11.7	17.6	17.1	10.1	15.7	12.1	14.9	5.8	17.8	18.9	4.9	4.5	16.8	9.2	20.5	18.1	16.5	4.8	16.3	17.3	16.1	11.3	16.6	12.0	13.0	13.2	7.9	13.1	13.7	17.5	9.1	26.1	10.1	14.9	10.3	7.3	24.6	12.7	9.4	17.2	15.0	18.8	22.0	12.9	19.2	8.0	12.7	20.3	10.0	15.4	6.1	24.1	22.8	10.9	14.7	15.5	13.2	19.3	15.0	9.2	19.1	10.2	8.5	11.4	12.9	50.7	20.3	12.0	8.5	33.9	17.5	9.0	8.6	18.4	16.5	142.5	15.3	23.7	10.6	9.0	11.8	16.1	15.3	36.0	13.4	6.0	33.0	19.7	14.0	14.5	13.6	16.1	11.5	15.8	12.1	35.7	9.9	11.0	19.0	2.7	11.1	8.9	10.9	9.9	8.3	14.8	11.0	8.9	11.9	9.2	8.6	12.4	2.3	15.5	11.6	9.4	11.7	9.9	16.8	18.0	17.2	27.2	17.6	16.0	17.6	17.1	17.8	16.3	16.6	17.5	3.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	20.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	10.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	14.2	0.5	0.0	0.0	0.0
CIB3	KIP3	ENSG00000141977	"Calcium and integrin binding family member 3"	Q96Q77	19	16161368-16173525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"bone marrow: 1.2"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 30.2;Late spermatids: 9.5"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.5;MCF7: 2.2;NB-4: 1.4;THP-1: 1.3;U-937: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043553, HPA043995"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane, Cytosol"		"HPA043553: AB_10964566, HPA043995: "	"unprognostic (8.43e-2)"	"unprognostic (7.26e-5)"		"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.14e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.05e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	1.4	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.7	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	30.2	0.0	0.1	0.0	0.0	0.2	0.1	1.8	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685791-119877320	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 72.8;Excitatory neurons: 147.0;Inhibitory neurons: 139.8;Oligodendrocyte precursor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752"	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	0.7	2.2	13.5	1.6	26.2	6.3	0.6	0.0	19.9	0.9	0.0	2.1	1.2	0.4	0.0	2.5	0.5	0.5	0.6	15.2	5.4	2.5	0.3	1.8	1.5	0.2	5.0	0.3	0.2	0.1	1.6	1.4	0.4	0.5	2.5	3.4	0.8	0.2	0.5	1.6	1.9	0.9	0.9	3.0	2.2	4.8	14.2	6.8	0.6	0.3	2.3	0.5	1.3	6.6	26.2	20.6	21.7	15.3	2.4	6.3	10.4	22.0	19.1	21.8	16.6	14.5	10.3	18.4	10.0	14.2	9.3	14.6	14.4	9.5	32.1	13.6	7.5	25.7	13.2	7.1	0.3	12.7	20.6	0.9	1.2	23.7	14.8	7.3	15.5	19.9	14.5	15.2	19.5	12.2	22.4	14.0	10.4	8.7	12.5	19.3	39.8	6.3	5.0	11.1	15.5	8.4	31.9	6.5	16.0	9.6	23.2	10.6	11.5	21.9	21.4	17.2	22.7	9.9	12.6	14.2	16.8	12.5	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.5	26.2	0.0	19.9	15.2	5.4	0.2	5.0	0.4	0.9	14.2	6.6	4.1	6.4	13.0	8.5	1.2	3.3	0.7	1.0	0.6	8.2	1.8	1.5	1.8	0.0	5.6	9.2	87.6	3.5	0.6	1.1	0.0	0.2	72.8	2.4	2.1	2.7	1.8	12.8	147.0	0.8	4.8	2.2	3.1	3.6	1.3	10.5	1.1	0.7	3.6	0.0	139.8	4.4	6.1	3.7	0.8	44.1	1.2	2.0	3.6	7.5	0.0	15.4	1.0	82.4	18.7	0.2	0.1	1.2	4.1	0.4	0.8	7.5	1.7	15.2	0.0	0.6	3.3	33.2	4.2	7.7	1.3	1.0	2.2	4.3	4.4	1.0
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979251	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 651.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.37e-1)"	59.0	31.9	15.0	33.6	15.8	117.7	67.8	16.4	19.8	44.3	15.0	49.4	40.8	35.0	36.8	61.6	40.9	22.2	35.5	15.4	16.2	37.9	73.3	29.0	71.3	17.5	15.8	31.7	22.4	35.5	18.4	50.6	17.7	26.1	50.5	6.0	28.4	32.9	14.5	51.2	44.3	34.8	17.4	37.0	35.5	48.6	15.7	88.7	30.1	23.5	74.1	30.1	42.6	18.8	459.2	616.5	455.9	245.3	66.9	68.1	361.4	209.1	166.8	463.4	367.8	599.9	653.4	433.8	345.9	143.2	251.2	410.6	468.0	305.2	428.7	392.9	293.9	294.6	249.9	426.5	19.4	359.7	257.9	39.8	132.2	391.4	532.8	91.5	232.5	298.2	486.6	566.8	353.9	452.8	337.3	273.9	575.3	442.1	547.6	334.8	373.6	554.3	165.6	164.2	184.3	463.9	313.6	292.0	347.3	530.2	391.6	492.9	126.0	282.5	292.4	237.0	505.3	348.9	734.7	617.0	179.6	300.1	399.8	2.2	13.0	6.9	19.8	82.0	24.4	74.2	28.0	27.1	22.1	70.4	34.0	32.8	1.7	28.7	105.4	92.6	33.3	28.1	15.0	15.8	16.4	19.8	15.4	16.2	17.5	15.8	17.7	17.4	15.7	18.8	31.7	12.8	33.3	1.3	46.5	217.6	101.3	170.6	74.0	3.4	90.6	140.5	9.2	87.2	63.1	29.5	0.0	224.0	40.7	48.3	80.3	93.0	15.8	43.1	24.6	51.9	20.4	140.1	0.8	112.1	651.8	84.6	20.9	28.3	21.0	66.7	29.6	89.8	132.1	1.7	0.8	57.4	120.1	46.0	121.0	21.7	76.1	37.4	113.8	0.0	41.3	20.7	20.6	0.5	3.5	119.0	41.7	45.9	38.4	130.2	63.1	87.5	52.1	3.0	19.7	50.6	53.0	124.7	151.0	74.9	203.6	131.9	40.7	27.2	80.0	99.5
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311195-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 177.3;testis: 186.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 474.6;Spermatocytes: 692.7;Spermatogonia: 503.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 187.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	13.6	82.9	9.6	38.5	10.0	177.3	20.1	11.9	26.9	10.1	11.8	44.1	43.3	13.0	8.8	53.2	12.1	18.7	10.3	12.7	10.3	35.6	31.2	24.0	102.8	10.5	10.1	9.4	4.2	19.8	4.8	44.3	11.0	15.0	41.0	27.9	10.8	17.8	9.4	19.9	33.1	17.6	10.6	32.6	20.4	186.3	10.8	121.1	12.8	4.8	84.7	26.5	19.9	11.3	685.9	570.1	342.6	230.6	98.7	89.1	249.5	396.1	211.4	428.1	340.0	236.1	328.6	504.9	228.4	149.1	761.4	466.5	415.5	305.1	488.2	398.1	335.5	257.5	378.9	637.5	42.4	531.7	281.2	33.0	69.2	307.2	269.1	162.9	403.2	409.1	313.2	430.6	556.0	509.1	420.7	928.3	501.6	795.5	521.5	358.4	376.4	303.7	342.8	153.5	288.4	171.7	328.7	314.9	324.5	318.4	379.7	304.2	231.4	184.1	350.3	449.6	588.2	345.9	759.2	415.3	271.3	303.1	268.5	40.8	19.5	44.1	22.6	26.5	25.3	61.3	30.4	21.9	22.5	44.7	16.3	21.8	14.5	40.9	14.8	187.9	62.7	23.6	9.6	10.0	11.9	26.9	12.7	10.3	10.5	10.1	11.0	10.6	10.8	11.3	138.6	38.5	103.9	0.3	175.7	280.2	92.1	126.1	259.0	4.1	107.2	169.0	61.3	5.7	49.9	14.7	0.0	231.1	201.1	79.4	23.5	20.1	37.3	149.7	66.4	66.1	122.3	266.9	1.2	11.2	379.4	63.1	74.9	250.2	145.0	144.7	29.3	25.0	184.6	0.0	1.9	164.9	111.9	40.5	474.6	77.0	25.7	164.3	140.5	1.9	31.0	26.1	28.8	1.0	1.1	31.1	67.1	16.6	89.3	72.1	37.6	209.7	32.8	7.3	46.0	75.2	206.5	692.7	503.6	197.5	299.1	199.5	156.0	70.3	162.7	102.1
CLASP2	KIAA0627	ENSG00000163539	"Cytoplasmic linker associated protein 2"	O75122	3	33496245-33718356	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 176.6;retina: 126.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.5;Excitatory neurons: 514.2;Inhibitory neurons: 526.3;Oligodendrocyte precursor cells: 739.9;Oligodendrocytes: 1315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067071			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA067071: AB_2685775"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.48e-6)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.72e-2)"	14.0	25.1	43.4	12.1	84.1	12.3	15.8	100.7	79.1	21.4	0.0	16.9	9.9	20.5	11.3	17.9	16.0	17.7	40.4	44.8	57.5	18.1	10.8	15.3	15.4	69.0	49.9	27.3	11.5	17.7	33.3	15.6	85.9	16.6	13.1	126.4	8.8	20.7	64.9	13.0	11.0	19.4	67.8	14.5	11.2	11.8	60.0	16.1	14.1	63.4	15.9	14.5	11.5	176.6	13.5	29.4	32.9	27.8	20.9	20.4	23.6	24.8	23.2	28.5	30.6	17.2	13.8	44.4	14.1	19.6	18.3	11.5	43.0	19.7	34.4	36.0	30.5	43.7	24.6	15.4	9.9	43.6	35.8	12.7	19.3	30.9	29.2	16.5	28.0	27.0	43.3	24.8	31.1	7.6	32.5	18.6	24.5	13.5	18.4	34.5	30.9	24.1	17.9	15.2	27.4	46.4	28.7	22.1	24.7	26.5	20.9	38.1	27.0	22.3	19.4	16.9	27.7	17.3	34.6	36.5	20.2	29.6	28.8	3.7	4.6	2.6	3.3	4.5	5.1	6.1	2.9	3.2	6.5	3.7	3.9	3.6	0.9	9.1	7.0	6.1	3.5	4.8	43.4	84.1	100.7	79.1	44.8	57.5	69.0	49.9	85.9	67.8	60.0	176.6	19.7	6.4	11.7	294.5	29.9	21.0	8.6	8.8	18.8	103.3	26.0	13.8	37.4	15.7	12.7	14.7	156.4	12.3	36.2	9.9	1.9	6.4	2.8	20.8	15.6	16.1	14.4	12.2	514.2	7.0	8.1	19.2	26.5	27.9	12.0	17.8	16.1	13.9	15.0	92.5	526.3	8.8	8.2	32.3	26.6	2.9	14.3	26.0	16.0	128.4	19.5	32.0	22.6	739.9	1315.9	8.0	5.6	13.5	28.8	12.3	6.1	12.2	13.8	120.6	6.6	34.2	22.9	11.1	14.4	19.3	30.7	12.9	25.6	15.5	11.2	8.8
CLBA1	C14orf79	ENSG00000140104	"Clathrin binding box of aftiphilin containing 1"	Q96F83	14	104985775-105010482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Endometrial ciliated cells: 29.9;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042052, HPA061117"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA042052: AB_2677822, HPA061117: AB_2684434"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	3.6	7.8	5.7	1.3	6.0	1.6	5.8	3.7	6.4	8.0	11.1	5.6	1.7	7.6	11.5	7.8	14.9	3.4	3.0	6.2	7.5	15.9	6.9	5.8	1.5	5.5	6.5	7.1	14.4	9.3	21.7	1.8	4.4	9.6	2.6	3.1	8.1	6.1	1.8	7.6	3.1	3.3	5.0	3.2	5.9	23.9	7.0	1.3	18.2	1.2	1.2	6.0	5.4	4.2	5.1	8.9	2.7	8.3	2.6	3.8	4.1	4.0	3.7	4.7	2.1	0.8	8.7	0.5	8.3	4.0	2.5	10.9	1.0	6.0	3.0	4.2	3.2	0.3	8.9	0.4	9.2	2.3	2.2	2.3	13.6	5.1	10.1	8.0	2.7	4.2	3.1	1.4	2.8	17.5	0.9	6.6	3.4	5.0	8.5	3.2	1.5	2.9	10.4	2.9	17.1	8.9	5.7	2.5	5.0	1.7	18.0	3.1	3.0	5.9	2.7	12.0	3.1	1.6	1.1	0.5	7.6	0.7	4.2	0.4	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.1	5.7	6.0	3.7	6.4	6.2	7.5	5.5	6.5	4.4	5.0	7.0	4.2	1.0	16.0	3.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	7.4	7.4	0.0	0.0	2.5	16.5	0.0	1.8	0.4	0.0	3.9	7.9	0.0	29.9	8.1	0.9	0.0	0.0	0.0	1.3	0.8	1.3	0.0	8.8	2.5	3.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	6.5	19.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.4	6.5	0.0	0.0
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361650	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.7;Proximal enterocytes: 27.4;Theca cells: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.4	5.1	2.2	1.8	3.1	1.0	1.6	3.1	3.0	3.0	1.6	16.2	9.2	3.6	3.8	1.7	2.4	7.5	1.2	2.0	2.4	3.0	1.7	1.2	0.7	3.4	3.0	4.0	4.5	3.4	2.8	1.0	2.7	2.3	10.8	0.6	2.8	2.9	0.9	1.6	8.4	1.6	2.9	1.5	2.2	10.6	3.3	1.3	2.7	0.5	0.9	2.1	2.0	4.3	8.9	3.2	2.5	6.9	2.2	1.8	5.8	2.9	1.7	3.1	2.0	16.8	3.0	3.0	8.2	1.6	8.0	15.1	3.6	3.5	0.9	2.8	4.2	2.7	7.0	7.7	1.3	1.2	2.6	3.6	2.7	2.6	3.0	1.5	2.9	3.3	1.0	1.6	1.1	5.9	0.8	1.6	3.7	7.6	4.4	5.4	2.3	10.7	3.8	6.9	4.0	2.4	3.3	11.4	5.2	1.6	9.4	1.2	1.4	1.5	4.5	7.7	7.7	3.6	5.5	2.1	2.7	5.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.1	3.1	3.0	2.0	2.4	3.4	3.0	2.7	2.9	3.3	4.3	2.2	3.2	4.1	16.6	0.4	1.0	0.9	0.8	1.2	2.1	2.5	2.8	1.2	14.3	1.1	0.0	0.0	1.0	1.9	81.7	0.0	3.7	2.3	2.5	4.5	1.9	3.0	0.8	4.1	2.0	0.6	2.6	2.6	4.4	1.3	11.3	2.5	0.6	0.7	1.7	8.1	3.7	0.0	1.0	0.3	2.7	5.3	1.1	0.0	1.9	0.6	1.7	0.0	6.0	15.1	2.2	16.0	4.9	0.8	0.6	27.4	2.3	2.6	2.5	0.0	0.9	2.1	3.3	1.7	1.1	0.4	1.5	1.2	62.5	9.0	0.5
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11848079	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	13.6	14.8	19.1	7.5	19.1	7.7	11.9	17.3	21.3	14.8	8.2	13.7	6.3	12.6	8.7	7.4	12.6	4.9	13.2	18.0	23.5	11.8	13.7	13.8	7.4	29.6	29.5	18.6	9.2	6.0	20.2	6.4	32.1	12.5	4.8	15.2	7.8	5.5	11.6	9.8	13.0	7.3	15.4	12.0	10.5	17.1	22.5	5.3	14.4	8.1	6.1	11.5	11.1	19.4	5.1	6.4	13.9	11.1	15.2	15.4	3.8	4.1	11.1	7.1	11.7	8.6	15.9	7.9	4.4	5.5	19.3	8.8	9.0	8.8	6.7	3.6	4.5	9.4	13.8	12.1	20.1	3.9	7.6	10.1	6.2	12.7	7.7	9.4	6.9	9.6	10.6	11.7	7.8	3.1	5.7	13.4	5.7	3.3	4.5	7.0	7.4	8.6	9.7	4.4	5.7	9.6	3.9	5.1	13.0	9.5	5.0	10.6	7.4	6.5	7.0	10.1	3.3	7.2	4.0	17.6	8.5	10.2	5.3	0.0	0.8	0.0	0.4	0.6	0.3	0.6	0.2	0.3	0.6	0.9	0.2	0.3	0.0	0.1	1.6	0.6	0.0	0.4	19.1	19.1	17.3	21.3	18.0	23.5	29.6	29.5	32.1	15.4	22.5	19.4	6.4	19.2	23.6	6.8	12.5	3.4	3.7	5.1	6.2	21.7	5.6	4.7	23.5	8.6	7.0	3.7	14.6	3.7	2.5	5.8	0.0	4.5	15.0	7.7	6.6	6.5	6.6	8.2	9.0	4.6	2.9	8.5	12.2	9.8	2.5	12.6	7.1	7.9	7.5	26.9	9.4	2.9	4.1	10.8	7.8	9.0	7.5	10.2	1.8	9.4	7.4	7.7	3.1	9.0	8.8	5.6	4.4	7.2	3.9	4.7	6.3	3.9	8.9	17.0	0.0	8.9	6.4	9.3	9.8	4.8	3.1	4.1	3.8	8.0	3.2	4.5
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"brain: 1093.8;choroid plexus: 316.7"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 575.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	53.6	42.6	477.0	40.7	757.5	49.1	48.8	696.1	804.5	59.0	316.7	58.3	36.5	58.8	43.1	77.8	46.7	50.6	57.6	483.5	577.6	39.2	50.0	46.9	54.7	851.3	670.8	63.9	23.6	32.6	28.2	73.8	837.8	49.5	46.9	46.5	29.8	51.9	43.6	64.8	42.2	63.5	643.7	44.0	37.4	106.6	638.3	44.7	40.5	68.9	54.9	64.0	65.8	1093.8	67.3	26.2	83.2	50.7	96.0	75.0	44.6	52.0	69.8	71.0	97.8	52.7	66.9	33.7	69.1	49.4	134.3	90.4	61.6	39.9	124.3	79.3	27.5	68.3	18.6	48.1	76.2	62.7	67.3	88.4	207.6	54.0	58.7	77.6	79.1	64.7	35.4	100.6	102.9	33.4	47.8	42.8	75.1	28.7	55.9	31.9	110.6	43.4	67.7	30.0	30.1	82.6	74.6	24.4	108.5	110.5	24.5	52.8	75.1	94.6	86.2	65.3	69.3	130.8	59.8	53.9	154.9	61.0	125.2	179.8	91.0	103.9	102.1	55.4	193.5	101.5	190.3	187.1	98.9	99.3	76.6	78.1	70.2	274.0	56.7	63.9	399.7	155.1	477.0	757.5	696.1	804.5	483.5	577.6	851.3	670.8	837.8	643.7	638.3	1093.8	83.3	35.3	36.6	17.9	72.1	144.0	131.7	122.3	87.0	20.1	43.6	45.3	53.8	17.2	71.4	27.6	25.0	52.0	72.8	16.9	29.4	21.2	105.3	21.1	47.7	70.8	28.7	65.4	25.1	16.2	160.6	86.6	30.1	41.7	36.8	25.2	61.4	19.4	35.6	15.2	23.6	19.6	89.5	29.2	168.1	76.7	51.6	46.9	113.8	20.6	42.3	28.1	38.1	30.7	575.2	30.3	16.8	46.6	131.7	98.1	34.6	23.3	27.5	35.0	52.6	53.2	128.4	182.4	55.3	90.1	196.5	95.8	147.1	22.8	17.5	121.9
CLEC4F	"CLECSF13, FLJ39110, KCLR"	ENSG00000152672	"C-type lectin domain family 4 member F"	Q8N1N0	2	70808643-70820599	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 17.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 10.4;Horizontal cells: 5.0;Macrophages: 4.5;monocytes: 4.0;Rod photoreceptor cells: 6.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.0;non-classical monocyte: 4.4"	"Lineage enriched"	"Detected in single"	12	"monocytes: 6.0"	"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056101			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"HPA056101: "	"unprognostic (8.14e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.68e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.44e-1)"	1.5	0.0	0.1	0.6	0.0	0.0	1.1	0.1	0.2	2.7	0.1	0.7	1.6	1.6	0.8	0.7	1.4	1.0	0.7	0.1	0.1	0.6	0.7	0.9	1.2	0.0	0.0	0.6	0.3	0.0	0.6	0.1	0.1	1.5	0.8	17.2	1.7	0.9	1.0	1.3	4.5	1.2	0.0	3.4	0.6	1.0	0.1	0.2	0.3	0.6	0.8	0.7	1.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.6	0.4	0.2	0.3	0.3	0.0	0.0	0.0	10.4	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.1	0.0	0.0	1.0	2.3	1.4	0.0	4.5	0.0	0.0	4.0	0.8	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 41.3"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 18.0;Langerhans cells: 67.5;Macrophages: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"classical monocyte: 9.1"	"Lineage enriched"	"Detected in many"	8	"monocytes: 9.1"	"Group enriched"	"Detected in some"	23	"HL-60: 40.9;U-937: 157.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.1	1.8	1.1	7.3	1.2	41.3	0.6	1.3	2.6	0.7	2.1	0.2	0.1	0.3	0.0	1.2	0.5	1.8	0.5	1.0	3.3	0.5	1.8	4.0	0.1	2.2	3.3	0.3	1.3	1.2	0.5	0.9	2.2	0.4	0.3	1.0	1.2	0.5	0.0	2.6	0.0	1.3	1.6	1.1	0.2	0.5	4.9	0.6	0.7	0.0	0.1	2.3	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.3	0.0	0.0	9.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	1.8	1.1	1.2	1.3	2.6	1.0	3.3	2.2	3.3	2.2	1.6	4.9	2.4	0.1	0.0	4.8	0.7	0.6	1.9	0.0	0.0	0.0	0.2	0.1	0.1	0.3	1.5	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.5	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.0	2.5	0.0	0.0	0.0	18.0	0.0	0.2	0.0	0.0	4.7	67.5	0.7	0.0	58.1	1.8	7.5	6.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.9	0.4	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.3	0.4	0.0	0.0	0.0
CLMN	"FLJ12383, KIAA0500, KIAA1188"	ENSG00000165959	Calmin	Q96JQ2	14	95181940-95319908	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.8;Late spermatids: 313.5;Oligodendrocytes: 418.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.8;SK-BR-3: 16.0;T-47d: 13.5;WM-115: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012634	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Cytosol	"HPA012634: AB_1846973"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.88e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.18e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (2.68e-7)"	"unprognostic (8.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.91e-3)"	11.1	1.1	16.6	4.2	38.9	1.1	10.9	11.4	28.1	7.5	6.9	11.5	3.0	4.9	7.4	2.9	9.2	5.8	5.3	15.5	12.2	13.3	14.1	4.9	1.3	21.5	25.7	2.9	17.3	1.7	2.9	2.3	23.3	6.9	12.8	9.8	9.2	5.0	3.8	3.2	6.7	2.8	7.3	3.0	7.2	32.8	42.9	1.0	5.9	5.5	1.6	4.7	6.9	67.0	6.3	8.4	1.3	0.2	4.9	2.2	0.5	0.1	0.0	0.4	0.3	0.7	10.5	0.0	0.9	0.0	13.8	5.5	0.6	3.7	0.0	4.3	1.5	0.2	0.3	5.0	0.5	0.0	0.1	2.4	3.6	1.6	5.8	1.9	4.2	2.3	0.0	1.2	3.0	5.6	0.3	0.5	0.5	7.7	2.0	4.8	4.4	2.8	3.9	10.3	1.7	1.6	2.1	16.0	8.2	1.2	13.5	0.4	1.2	0.1	3.6	0.0	0.3	1.6	0.1	5.8	2.9	2.5	15.5	7.3	6.9	0.6	0.0	2.4	0.0	3.0	0.0	0.0	1.4	1.5	0.0	0.1	5.7	0.0	1.5	2.4	0.0	2.1	16.6	38.9	11.4	28.1	15.5	12.2	21.5	25.7	23.3	7.3	42.9	67.0	12.9	16.0	3.4	21.9	18.0	6.2	39.2	11.7	37.0	61.8	39.0	22.2	58.6	42.9	17.3	58.8	14.6	2.5	3.5	93.1	27.4	53.1	161.8	76.7	16.9	11.4	23.4	0.4	9.3	47.5	1.8	12.2	33.6	37.3	4.5	0.4	2.2	81.9	7.3	38.7	11.5	72.5	8.2	11.9	7.2	313.5	22.4	15.6	3.6	1.0	17.1	3.5	0.0	5.0	418.6	40.1	44.1	10.9	21.9	62.3	15.9	21.0	115.6	28.2	105.2	4.8	100.6	4.2	15.3	7.1	2.6	2.9	2.8	0.2	50.2	51.5
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit X"	O76031	15	65148219-65185342	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA		65000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA040262: AB_10793961, HPA048199: AB_2680312"	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	7.9	10.8	9.2	6.1	9.7	8.0	9.3	9.5	11.0	7.6	7.4	9.2	8.8	7.8	8.6	13.3	7.9	6.3	14.1	7.8	8.3	12.2	32.9	6.5	9.1	9.8	8.9	9.4	9.4	11.9	4.6	9.8	8.5	8.0	8.0	10.1	7.6	6.0	26.8	14.7	7.4	7.1	8.8	8.4	9.2	9.1	9.4	10.6	9.8	24.0	9.9	7.9	8.9	10.1	8.1	13.7	11.7	14.8	12.2	15.5	12.5	9.2	10.2	9.8	10.3	13.7	11.1	25.0	7.5	12.3	7.3	16.9	43.2	12.1	10.5	9.9	7.9	18.9	12.8	17.4	17.3	24.4	10.5	18.6	16.2	9.0	17.1	11.3	12.6	13.3	17.6	8.6	11.7	10.3	11.6	21.4	13.1	16.0	6.1	22.4	13.9	26.1	18.6	18.5	10.1	8.1	12.4	19.3	13.8	15.3	8.9	20.3	11.2	9.8	8.7	8.0	8.7	9.2	15.0	13.0	9.6	30.4	7.8	2.2	4.1	6.5	4.3	3.5	3.9	4.4	3.7	3.2	3.9	3.9	5.0	4.0	6.4	4.7	3.3	5.9	3.5	2.7	9.2	9.7	9.5	11.0	7.8	8.3	9.8	8.9	8.5	8.8	9.4	10.1	16.4	35.3	35.5	15.3	23.6	19.2	18.8	20.9	18.8	32.3	17.0	15.6	69.9	27.1	29.5	33.1	14.6	41.0	28.5	16.7	21.5	36.8	104.5	24.4	28.7	21.0	10.3	56.8	15.6	31.6	29.2	25.5	33.6	27.5	16.4	37.8	21.0	90.1	22.6	32.0	15.2	20.3	28.5	28.3	16.6	242.3	28.9	20.3	17.8	16.9	34.1	25.9	20.6	12.5	23.9	29.0	18.2	29.7	30.8	24.9	23.1	33.8	27.7	27.2	26.3	23.1	30.1	45.0	30.6	29.1	30.1	89.2	24.4	59.0	24.3	25.5
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392501-176416539	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 1839.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 704.2;MCF7: 641.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	102.9	133.6	125.8	50.1	125.1	40.6	82.9	117.8	176.7	180.4	125.3	133.9	92.3	85.9	23.2	473.7	82.4	34.1	320.8	130.8	129.6	90.4	82.5	96.5	32.9	136.9	122.8	107.2	68.2	70.1	112.8	57.5	138.1	88.1	45.5	37.9	128.6	44.4	322.5	453.1	99.7	41.2	114.5	68.7	123.3	38.9	127.9	43.7	69.5	120.8	58.5	106.2	300.8	133.6	229.1	107.6	29.9	128.2	65.7	49.2	244.4	286.3	110.9	178.6	127.0	140.3	103.9	49.6	165.0	130.2	71.8	213.3	51.4	704.2	69.7	341.7	95.3	33.6	163.3	87.7	102.9	53.2	85.6	52.6	241.5	98.1	114.7	36.0	84.7	39.2	65.2	123.4	100.3	641.9	84.5	81.1	24.4	189.5	158.2	91.3	52.9	165.2	95.6	92.0	127.7	43.7	136.6	148.0	103.6	34.7	61.4	101.9	185.2	64.0	96.3	117.5	165.1	96.5	73.3	68.5	51.4	112.7	74.4	6.6	19.7	61.7	13.6	15.8	7.0	5.9	11.9	13.2	20.0	10.1	10.0	10.0	36.6	15.0	20.8	16.1	24.9	8.1	125.8	125.1	117.8	176.7	130.8	129.6	136.9	122.8	138.1	114.5	127.9	133.6	113.7	57.7	19.8	8.5	54.7	634.0	238.7	155.7	180.4	310.5	105.5	124.6	208.5	72.9	93.4	82.8	64.6	141.1	82.3	794.5	135.0	324.7	9.5	58.4	72.7	102.2	151.8	43.6	25.4	453.1	586.9	136.7	193.2	85.2	48.2	40.8	70.3	96.3	111.9	336.5	24.1	348.5	114.0	80.7	226.1	13.7	122.1	88.4	220.5	6.5	85.7	136.1	107.1	8.0	15.2	1839.9	786.9	129.8	76.4	391.4	545.7	269.7	49.6	64.3	78.9	79.6	161.4	15.9	29.1	415.6	803.0	386.5	81.3	151.2	289.7	436.0
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 18.5"	"Cell type enriched"	"Detected in some"	28	"granulocytes: 53.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"		"Cluster 60: Granulocytes - Receptor signaling"	"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	9.0	0.0	0.2	3.7	0.1	0.2	18.5	0.0	0.2	4.6	0.3	8.7	0.6	3.1	4.3	10.2	0.9	7.3	1.6	0.1	0.2	0.2	0.5	1.5	1.8	0.5	0.3	0.1	1.6	0.6	0.2	0.1	0.3	1.0	8.3	0.0	4.7	1.3	0.9	9.0	5.8	2.2	0.3	0.2	1.5	0.9	0.2	3.0	0.4	3.0	2.4	11.1	0.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.3	0.3	0.3	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0
CMYA5	"C5orf10, DKFZp451G223, SPRYD2, TRIM76"	ENSG00000164309	"Cardiomyopathy associated 5"	Q8N3K9	5	79689836-79800240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 623.5;tongue: 799.5"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 3425.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.3;RT4: 1.5;THP-1: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA074081, HPA077831"	Enhanced		Approved	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles, Cytosol"	"Vesicles, Plasma membrane"	"HPA074081: , HPA077831: "	"unprognostic (5.53e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.01e-4)"	"unprognostic (7.00e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.69e-2)"	"unprognostic (9.74e-2)"	0.9	0.1	1.4	0.2	1.4	0.0	3.9	1.2	2.1	1.7	3.1	1.3	0.1	5.9	4.6	6.6	2.1	0.9	155.8	0.6	0.6	2.5	1.2	0.5	0.0	1.6	2.0	14.6	0.3	3.6	2.0	1.1	1.1	6.1	0.2	1.7	6.1	2.1	623.5	2.2	0.4	4.6	1.1	0.0	0.6	0.5	1.7	0.9	2.3	799.5	0.1	2.1	1.2	0.8	0.0	0.0	0.0	0.1	0.5	0.4	0.6	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	5.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	1.2	2.1	0.6	0.6	1.6	2.0	1.1	1.1	1.7	0.8	2.7	9.6	2.8	69.5	0.4	1.3	17.9	2.9	4.6	2.0	24.4	46.6	3425.2	5.7	12.2	25.8	0.0	21.4	1.3	0.4	17.6	0.7	0.3	29.3	7.2	19.7	1.8	0.0	32.9	0.4	2.9	113.7	3.6	55.2	1.3	2.5	0.4	2.3	2.1	217.0	10.7	0.2	8.2	0.6	1.6	2.3	14.9	1.4	0.0	6.5	0.1	8.8	2.1	156.3	2.9	0.6	0.2	13.5	0.6	4.8	0.0	15.4	6.2	3.0	0.0	165.6	23.1	2.5	2.0	2.2	5.4	32.8	1.2	1.7	0.2	18.1
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129167827-129183922	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA063097: AB_2684939"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	292.7	308.2	175.2	181.1	184.0	254.1	274.6	198.6	211.3	295.9	175.7	314.1	198.5	285.8	197.6	264.6	275.7	195.1	487.2	170.6	184.3	231.6	433.7	258.3	251.0	182.7	175.1	385.8	307.4	277.9	169.5	214.3	187.1	256.6	219.0	231.8	250.8	282.4	1207.6	288.0	199.2	234.9	195.6	200.7	262.1	131.2	181.9	254.2	261.8	797.9	250.7	317.5	269.2	211.7	452.7	266.4	369.9	294.6	355.2	303.9	294.9	344.2	535.7	362.2	412.4	389.2	305.7	589.8	292.2	318.1	269.6	328.3	484.3	396.4	484.6	404.5	357.9	569.2	251.7	420.2	355.7	622.4	314.5	295.5	449.2	254.8	897.8	247.6	324.1	328.1	437.6	391.9	384.0	538.9	578.6	454.1	452.7	399.7	439.1	502.4	343.4	707.7	379.1	425.4	501.2	402.8	271.5	263.0	766.3	214.4	305.6	421.3	347.9	268.4	266.2	374.1	353.7	367.3	365.4	932.3	277.3	419.2	362.4	1077.7	810.5	930.9	551.8	596.8	699.0	691.0	658.8	595.3	552.8	603.8	700.3	610.5	1102.3	601.1	485.5	320.4	704.3	2029.8	175.2	184.0	198.6	211.3	170.6	184.3	182.7	175.1	187.1	195.6	181.9	211.7	253.7	259.6	263.9	27.1	292.8	524.7	417.0	262.9	259.6	153.7	177.5	272.5	608.0	141.5	235.1	79.1	33.3	252.3	188.1	143.9	373.7	226.9	36.0	141.4	195.1	267.5	171.3	246.5	28.2	290.7	396.6	309.4	142.8	172.8	314.5	173.0	167.0	138.5	246.5	92.5	33.7	178.6	140.4	194.4	463.0	42.9	316.0	232.4	318.4	35.6	392.7	350.3	236.9	32.6	42.8	230.1	158.0	319.7	311.7	405.1	196.5	237.4	164.8	153.8	263.0	343.6	571.0	305.2	271.5	286.5	586.7	291.7	304.2	277.7	213.6	376.2
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel subunit beta 1"	Q14028	16	57882340-57971128	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"retina: 600.2"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 331.5;Rod photoreceptor cells: 1111.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.5;RPMI-8226: 1.8;SCLC-21H: 5.0;SiHa: 2.9;SK-BR-3: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.5"					"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.1	2.5	15.5	1.1	13.2	0.2	0.0	0.0	20.4	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.1	0.3	0.0	24.5	24.8	0.0	0.1	0.1	0.2	2.8	3.2	0.0	0.5	0.0	0.2	0.4	4.4	0.0	0.4	600.2	0.0	0.1	0.0	0.2	0.6	0.1	2.4	0.1	0.0	0.4	36.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.5	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.6	5.0	0.0	2.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.5	13.2	0.0	20.4	24.5	24.8	2.8	3.2	4.4	2.4	36.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.0	61.6	0.3	0.0	1.1	0.0	0.1	0.0	331.5	6.9	0.0	0.0	0.0	0.4	1.6	0.9	0.1	4.2	0.0	0.0	3.2	0.4	0.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.4	25.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	89.5	0.0	1.0	0.1	0.2	1.1	0.0	0.0	0.2	0.0	0.3	0.0	1111.1	0.0	0.1	0.2	0.5	0.7	0.0	0.0	1.4	0.1	0.1	0.0	0.2
CNKSR1	"CNK, CNK1, KSR"	ENSG00000142675	"Connector enhancer of kinase suppressor of Ras 1"	Q969H4	1	26177484-26189884	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 57.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 18.6;BEWO: 16.0;CAPAN-2: 29.1;HaCaT: 20.3;hTCEpi: 17.2;OE19: 15.9;SK-BR-3: 20.8;T-47d: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA030847	Uncertain		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA030847: AB_10601100"	"unprognostic (2.73e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.91e-1)"	"prognostic favorable (5.91e-4)"	0.7	0.1	3.6	2.6	4.1	0.3	6.0	5.3	4.7	6.6	2.2	9.4	11.9	2.5	8.2	18.7	8.2	3.6	1.4	3.6	3.7	9.5	1.6	7.3	1.4	4.0	3.6	3.2	13.4	11.7	9.6	4.7	3.8	10.3	7.4	0.9	15.6	6.6	57.2	16.6	11.4	0.7	3.2	2.4	10.5	2.4	3.8	1.1	16.7	14.3	2.9	5.5	9.0	4.9	18.6	0.0	0.3	0.2	0.3	0.0	16.0	0.3	0.0	0.2	0.0	2.9	29.1	2.0	9.1	0.0	0.2	20.3	0.5	13.0	0.4	0.0	0.9	0.4	7.4	9.2	0.1	0.2	0.3	0.0	17.2	0.0	5.0	0.0	0.0	0.6	2.2	0.1	0.0	8.4	0.2	1.5	7.7	15.9	1.7	0.2	0.2	0.0	1.9	10.7	3.5	0.9	0.1	20.8	0.3	6.9	16.7	0.0	0.0	0.0	2.4	1.0	0.2	5.8	1.1	0.7	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.8	0.1	3.6	4.1	5.3	4.7	3.6	3.7	4.0	3.6	3.8	3.2	3.8	4.9	1.6	16.0	7.2	3.6	3.1	14.7	16.9	36.6	17.6	2.8	22.9	20.2	1.1	17.2	21.2	35.0	2.1	34.2	0.5	26.7	1.9	12.3	1.1	15.9	2.8	1.9	18.6	0.0	3.3	12.4	13.7	1.3	34.7	25.9	0.0	1.8	0.7	0.2	2.8	0.0	3.7	20.0	28.5	0.0	1.2	0.8	1.2	0.8	1.8	0.0	1.4	0.7	0.0	0.5	5.1	25.0	29.9	0.7	14.3	15.7	28.4	0.5	33.1	2.9	0.0	3.6	3.3	2.4	4.2	20.2	11.4	32.4	1.1	0.1	20.0	26.6
CNN2		ENSG00000064666	"Calponin 2"	Q99439	19	1026586-1039068	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049095	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		8400000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA049095: AB_2680627"	"unprognostic (2.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.54e-1)"	76.7	22.1	6.3	149.8	7.9	208.8	82.1	9.0	11.2	88.2	30.3	64.1	25.6	118.0	20.0	131.7	88.7	78.8	60.2	6.1	6.7	65.0	42.9	152.2	184.2	9.5	7.7	164.7	69.2	8.6	22.4	37.8	9.6	84.1	33.6	7.5	89.4	68.4	8.1	76.5	64.8	56.0	7.9	154.0	75.1	12.1	9.0	52.2	79.0	7.7	169.9	86.4	79.7	13.3	230.7	75.6	206.9	257.3	104.5	196.9	162.6	204.3	221.8	249.2	192.5	263.0	191.8	151.2	203.9	367.9	58.9	221.3	123.9	324.1	164.7	104.7	10.6	109.6	122.0	205.9	415.0	97.4	230.1	337.2	150.9	158.1	118.5	405.6	142.9	110.1	64.0	225.2	206.0	44.0	8.9	91.5	256.2	184.0	35.0	52.8	72.5	170.9	247.5	265.9	0.5	14.8	252.6	34.3	27.5	149.6	247.6	163.6	349.4	134.8	140.0	210.0	208.9	105.2	86.8	297.8	79.6	117.7	220.9	560.2	142.2	631.5	243.1	180.6	393.5	231.0	301.6	324.2	217.5	201.9	250.1	252.0	845.4	213.8	209.4	96.7	347.3	393.3	6.3	7.9	9.0	11.2	6.1	6.7	9.5	7.7	9.6	7.9	9.0	13.3	10.3	60.9	60.6	0.0	140.4	97.6	274.2	142.9	178.2	1.2	36.5	66.4	6.1	15.7	78.4	36.8	10.4	12.0	66.4	47.0	62.6	63.6	0.5	29.1	52.9	26.3	15.4	44.1	0.1	138.6	99.8	50.4	49.5	40.0	59.5	44.3	37.9	29.8	54.9	0.0	0.1	51.2	42.7	87.9	103.1	1.8	8.1	90.7	14.2	2.8	129.9	0.9	91.6	0.0	0.6	186.9	27.1	76.8	85.8	60.9	3.3	5.9	37.8	7.5	32.9	10.4	70.6	1.7	3.8	135.0	87.8	11.4	160.8	1.7	32.1	170.9
CNNM1	ACDP1	ENSG00000119946	"Cyclin and CBS domain divalent metal cation transport mediator 1"	Q9NRU3	10	99329356-99394330	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;testis: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.1;Excitatory neurons: 69.9;Horizontal cells: 50.5;Inhibitory neurons: 89.5;Late spermatids: 88.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.6;BJ hTERT+: 7.4;BJ hTERT+ SV40 Large T+ RasG12V: 11.3;HAP1: 8.7;OE19: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040408	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA040408: AB_10793963"	"unprognostic (9.04e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.60e-4)"	"unprognostic (4.08e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.03e-1)"	0.2	1.1	9.9	0.2	9.9	0.0	0.5	5.4	16.7	1.8	0.0	0.7	0.4	0.9	1.7	0.8	1.0	0.3	0.1	7.3	7.3	1.7	0.2	0.1	0.0	3.6	2.9	2.6	1.1	0.6	3.6	0.0	3.5	1.7	0.4	5.2	0.8	0.8	0.0	1.2	0.6	0.4	2.0	0.1	0.6	9.8	4.7	0.1	0.1	0.1	0.1	1.7	1.4	10.1	0.0	19.6	0.0	0.0	0.0	0.0	0.0	2.8	7.4	6.7	11.3	0.0	4.4	0.0	0.0	1.4	0.1	1.7	8.7	0.0	4.8	0.0	0.9	1.9	2.8	3.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.4	2.7	0.3	0.0	0.9	7.7	0.8	0.0	0.0	0.0	0.9	0.0	2.2	6.1	2.0	0.4	1.0	0.5	0.0	0.0	0.0	0.6	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	9.9	5.4	16.7	7.3	7.3	3.6	2.9	3.5	2.0	4.7	10.1	0.6	0.0	0.0	4.6	0.0	2.3	3.3	0.1	5.2	25.3	0.7	2.8	1.4	0.0	0.2	1.8	14.6	0.0	0.0	0.0	0.0	0.6	103.1	0.5	1.0	0.4	0.0	0.8	69.9	1.5	0.0	1.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	50.5	89.5	0.1	0.0	0.0	0.8	88.0	2.1	0.3	1.8	4.7	0.1	1.3	0.0	10.6	2.2	2.0	0.3	2.6	0.0	5.9	0.1	0.7	0.6	3.4	0.0	2.0	0.5	1.9	1.6	1.5	1.0	0.0	0.2	1.2	0.1	2.4
CNNM3	ACDP3	ENSG00000168763	"Cyclin and CBS domain divalent metal cation transport mediator 3"	Q8NE01	2	96816245-96835382	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016711	Supported		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA016711: AB_1847394"	"unprognostic (1.50e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.32e-3)"	"unprognostic (3.64e-1)"	"unprognostic (5.31e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.48e-2)"	7.8	8.9	8.0	6.7	10.1	7.0	7.9	15.0	9.5	8.4	8.0	10.5	17.3	8.5	5.2	5.6	10.9	9.4	5.7	7.5	7.1	7.5	20.0	9.1	9.1	9.2	9.0	10.3	26.6	21.4	8.0	10.2	8.5	8.9	8.8	13.1	12.4	9.0	45.1	8.5	14.2	5.8	6.9	9.5	12.4	11.3	8.6	11.4	8.4	6.1	7.2	8.3	7.6	12.5	10.4	9.2	8.7	13.4	10.2	5.4	24.3	6.8	5.5	6.4	6.3	25.3	16.4	11.7	23.3	5.2	7.4	11.8	12.6	8.8	4.8	11.3	29.4	15.3	12.9	28.1	8.9	14.0	11.2	4.5	11.8	8.1	7.3	8.7	7.9	9.6	14.1	19.8	2.7	13.0	12.8	17.4	11.6	15.6	11.5	15.6	11.6	14.4	11.3	12.7	26.5	17.0	8.7	14.2	8.2	13.3	13.5	10.2	3.7	5.6	16.1	9.2	9.8	17.8	18.1	8.6	3.5	13.2	6.0	1.6	0.8	3.5	2.6	0.6	1.6	1.8	1.6	2.1	0.3	2.1	1.5	1.5	3.3	1.5	1.4	1.8	2.2	0.8	8.0	10.1	15.0	9.5	7.5	7.1	9.2	9.0	8.5	6.9	8.6	12.5	4.1	9.6	4.8	9.1	5.4	1.3	2.7	1.1	0.6	17.5	4.9	5.0	15.6	8.6	3.0	0.0	8.4	5.0	8.9	4.7	0.0	5.0	7.3	5.3	4.4	3.7	4.2	5.7	5.7	4.3	2.6	4.3	5.6	12.6	0.0	11.7	6.4	17.4	2.6	33.7	9.5	7.6	4.1	3.4	0.6	1.3	2.5	1.9	3.6	4.7	2.3	6.4	6.2	18.1	19.6	2.7	1.9	4.1	6.4	7.1	8.4	1.9	2.8	13.5	13.1	5.7	4.5	5.9	6.3	2.8	1.6	1.6	6.9	11.5	8.2	3.4
CNOT10	"FLJ12890, FLJ13165"	ENSG00000182973	"CCR4-NOT transcription complex subunit 10"	Q9H9A5	3	32685145-32773875	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 181.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035614, HPA041450"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	Cytosol	"HPA035614: AB_10669975, HPA041450: AB_2677487"	"unprognostic (3.75e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.43e-1)"	8.4	7.8	5.9	11.4	6.5	17.4	12.6	7.8	7.1	10.9	7.2	11.6	9.8	10.7	11.5	9.8	14.1	8.7	7.7	5.7	6.7	10.6	12.5	9.8	14.6	6.1	5.8	12.2	9.4	13.0	10.3	8.5	6.2	9.1	13.8	6.5	8.5	7.5	9.5	13.2	10.6	10.1	6.1	14.5	9.1	39.8	6.3	19.7	12.3	5.8	16.5	9.8	8.7	7.5	24.4	26.7	27.2	25.9	12.9	14.8	181.2	20.1	20.0	28.0	31.3	20.5	20.5	39.6	13.0	14.4	18.1	20.9	32.5	26.5	27.8	34.5	33.3	51.0	23.2	20.0	37.6	42.3	18.9	10.9	23.3	30.9	40.4	18.7	23.2	36.4	54.1	30.1	16.6	20.1	38.0	20.4	41.2	28.0	25.3	37.9	18.5	39.8	18.0	28.1	15.5	29.9	29.5	41.1	24.4	19.3	40.0	47.4	14.3	17.3	24.6	23.0	33.7	30.8	67.8	39.6	17.7	31.7	21.4	18.5	12.0	17.7	11.4	17.1	12.4	15.3	18.6	13.7	15.1	17.4	18.1	16.0	9.6	10.2	25.2	8.4	16.0	12.3	5.9	6.5	7.8	7.1	5.7	6.7	6.1	5.8	6.2	6.1	6.3	7.5	11.6	16.0	22.8	28.4	19.6	10.5	7.2	13.0	9.1	16.8	9.4	9.0	13.2	14.3	15.3	14.7	33.3	14.8	21.0	15.3	5.9	12.9	60.3	23.4	12.9	14.1	15.6	21.2	37.7	13.5	17.1	12.0	15.3	14.1	10.8	17.2	12.8	9.8	11.9	15.2	36.5	10.6	10.2	18.8	14.3	34.3	9.6	14.5	12.4	20.6	37.2	7.4	10.3	29.1	35.3	11.7	16.4	10.5	17.5	6.6	15.2	7.0	29.9	20.9	6.6	14.9	12.5	63.0	33.1	10.2	14.5	8.2	20.1	17.8	14.4	7.3
CNOT2	"CDC36, NOT2, NOT2H"	ENSG00000111596	"CCR4-NOT transcription complex subunit 2"	Q9NZN8	12	70243002-70354993	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067711	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA067711: AB_2685893"	"unprognostic (5.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.23e-2)"	29.8	25.6	24.2	31.2	33.3	78.5	35.0	65.9	28.1	29.2	24.9	31.6	30.2	34.3	34.5	24.4	29.0	27.3	24.0	25.2	28.8	28.7	34.9	29.5	40.4	33.7	32.1	35.1	24.1	32.5	23.4	32.1	30.0	27.8	34.5	46.2	26.0	27.0	33.4	50.3	30.9	30.5	28.6	35.8	25.7	26.2	32.3	50.1	30.7	33.8	42.7	32.8	27.9	43.5	46.2	44.5	70.7	45.3	38.5	42.8	60.1	49.2	59.5	53.8	46.1	55.8	42.1	100.2	45.1	57.4	33.8	43.9	50.2	49.1	59.7	47.1	50.2	66.4	38.8	55.7	40.7	84.3	54.6	50.1	52.4	50.5	59.1	78.7	59.0	61.5	61.9	55.4	47.2	52.4	95.7	61.0	61.0	46.1	46.4	75.1	59.9	61.1	50.7	93.2	50.6	55.7	59.1	46.4	45.6	60.5	59.1	68.4	44.7	50.2	33.6	45.8	40.7	50.3	59.5	77.3	52.5	42.3	41.9	92.8	49.2	57.6	50.1	69.4	56.6	54.0	54.7	58.9	60.3	51.5	62.6	67.6	30.3	62.6	58.5	44.4	55.8	56.3	24.2	33.3	65.9	28.1	25.2	28.8	33.7	32.1	30.0	28.6	32.3	43.5	71.1	41.7	43.2	76.7	79.8	51.1	37.7	45.4	47.3	64.4	40.9	38.0	30.1	58.6	45.6	36.8	56.3	45.3	144.3	50.2	33.2	49.5	44.5	47.8	55.8	55.4	58.0	49.2	110.9	44.7	47.4	57.4	41.3	62.2	76.5	60.1	46.4	34.6	40.3	52.2	115.8	39.0	44.7	55.1	46.7	12.6	45.7	62.7	32.0	86.2	46.3	54.3	56.7	123.6	204.0	45.8	44.4	46.6	77.9	45.4	45.2	30.3	44.7	54.8	39.5	72.3	64.5	53.8	44.7	46.7	64.1	35.4	94.2	50.4	39.2	48.9
CNOT3	"KIAA0691, LENG2, NOT3, NOT3H"	ENSG00000088038	"CCR4-NOT transcription complex subunit 3"	O75175	19	54137749-54155681	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 213.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006408	Approved		Approved	Cytosol		NA	NA		39000	"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA006408: AB_1078543"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.08e-3)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	21.3	29.0	11.3	17.5	11.6	19.6	22.9	13.7	14.1	27.0	7.6	27.1	16.8	27.3	19.6	26.8	27.5	12.5	19.4	10.9	14.2	24.8	25.3	21.2	20.4	12.0	9.5	30.5	28.3	17.5	34.0	19.2	10.4	27.6	13.2	18.0	26.1	18.7	24.1	30.3	25.1	16.8	7.1	29.9	26.6	35.2	10.8	23.6	30.0	11.0	18.1	25.6	25.5	12.0	45.5	69.1	69.7	40.8	25.4	25.2	48.0	39.2	68.4	52.2	45.9	44.2	36.2	53.1	24.8	46.1	41.8	44.1	77.3	39.2	53.1	55.5	213.4	81.7	44.5	39.1	43.3	47.7	54.9	32.1	35.8	46.7	77.3	37.1	41.5	39.0	61.8	47.9	38.3	53.3	63.8	27.9	43.1	87.7	52.4	57.8	52.4	35.7	33.7	85.4	44.9	37.2	75.1	54.6	25.8	50.6	31.3	50.2	37.8	47.3	50.3	23.4	54.4	46.3	54.1	71.2	38.7	37.1	48.0	0.9	1.6	3.1	1.6	1.0	1.2	1.3	1.1	1.5	1.4	1.4	1.2	1.3	4.2	0.8	1.4	3.4	1.2	2.0	11.3	11.6	13.7	14.1	10.9	14.2	12.0	9.5	10.4	7.1	10.8	12.0	14.2	12.8	7.4	10.7	17.4	9.9	17.2	15.7	18.8	17.5	14.0	13.8	2.0	12.8	14.4	7.3	16.7	28.8	20.5	17.8	9.8	14.8	19.9	20.9	19.6	13.2	14.4	13.3	6.1	14.5	28.5	13.6	20.9	21.4	3.8	22.7	12.5	8.5	16.2	16.8	7.0	17.1	18.3	9.7	6.9	6.6	17.1	13.1	5.4	4.7	15.6	12.0	16.5	5.0	8.0	15.1	23.9	9.4	20.8	21.4	14.9	9.0	14.3	18.5	6.6	17.3	17.9	49.2	47.9	16.6	9.9	50.1	15.4	21.6	13.2	17.3
CNOT6	"CCR4, Ccr4a, KIAA1194"	ENSG00000113300	"CCR4-NOT transcription complex subunit 6"	Q9ULM6	5	180494379-180578358	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044568	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA044568: AB_10797257"	"unprognostic (9.41e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.57e-2)"	6.6	6.5	8.7	12.0	9.1	11.9	9.5	16.1	8.8	8.0	10.1	10.0	12.1	9.2	8.6	11.5	9.4	7.3	6.2	7.9	9.3	10.0	5.1	9.7	11.4	8.9	8.7	9.4	6.6	8.7	5.6	11.8	7.9	9.4	11.5	17.5	7.1	7.4	5.2	9.3	11.9	8.1	8.4	10.0	10.1	13.5	9.2	19.7	9.0	7.4	14.0	11.4	8.0	9.4	24.9	29.6	59.2	47.5	9.6	10.9	61.0	17.9	12.0	23.2	27.5	36.1	35.7	26.2	26.5	11.8	32.2	25.5	50.0	59.4	27.1	77.5	25.2	28.6	38.4	23.4	14.3	33.6	20.1	9.3	28.1	17.1	36.1	21.6	28.6	30.2	30.9	24.5	21.8	51.1	43.0	20.2	17.5	25.0	13.9	39.1	29.6	18.6	25.6	48.5	43.0	36.4	30.1	39.7	26.2	28.7	49.9	33.5	31.4	24.5	28.1	18.0	32.0	16.0	30.9	27.4	23.4	45.3	20.6	0.7	0.8	1.2	1.2	1.4	1.3	0.6	1.0	0.7	0.8	0.7	1.4	1.4	0.8	0.7	2.3	0.8	0.8	0.6	8.7	9.1	16.1	8.8	7.9	9.3	8.9	8.7	7.9	8.4	9.2	9.4	12.4	28.9	13.4	16.3	11.9	21.7	6.4	12.9	15.9	18.0	19.5	11.7	11.4	14.3	12.4	11.0	22.9	9.4	21.9	17.1	1.9	11.0	6.4	32.3	22.3	13.2	14.5	27.8	27.2	9.3	12.8	11.8	11.2	21.1	2.5	29.7	13.6	5.7	12.5	18.5	24.9	13.8	6.1	16.2	15.4	9.3	13.1	14.4	10.6	18.7	20.1	13.5	26.8	30.2	33.4	17.6	8.4	18.8	15.5	17.3	12.1	13.1	20.2	17.5	26.3	11.7	13.1	38.6	48.7	23.2	22.3	11.5	16.2	12.8	16.5	19.9
CNPY2	"HP10390, TMEM4, ZSIG9"	ENSG00000257727	"Canopy FGF signaling regulator 2"	Q9Y2B0	12	56309842-56316119	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 475.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038465, HPA038466"	Supported		Supported	Cytosol	"Intracellular and membrane"	NA	NA		220000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA038465: AB_10967609, HPA038466: AB_10672646"	"unprognostic (3.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (8.37e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.06e-2)"	36.7	52.5	28.4	25.8	30.3	24.7	41.8	30.0	30.7	43.3	38.1	36.6	30.9	35.6	74.4	34.1	38.1	25.4	28.4	27.7	31.8	37.8	75.7	30.5	22.0	31.1	29.0	42.7	58.9	47.3	66.8	40.8	28.9	35.3	38.5	18.8	53.1	36.4	21.2	23.5	34.6	24.9	30.5	35.1	42.1	20.0	29.8	27.0	44.7	18.6	26.6	32.9	31.1	32.2	50.6	75.5	76.0	62.8	186.0	64.0	120.7	51.0	117.4	108.7	76.5	116.0	87.9	51.2	95.0	132.4	53.2	72.4	92.3	62.8	68.7	51.3	57.5	49.9	106.1	121.8	83.6	94.9	60.4	76.5	80.5	89.9	106.6	165.5	91.1	59.0	73.8	113.5	81.3	76.2	58.2	105.3	72.6	107.5	109.5	65.1	58.3	84.9	90.1	47.6	67.9	41.7	85.1	86.8	93.6	92.7	78.0	176.8	41.2	42.7	33.6	52.2	74.7	58.4	88.2	41.5	90.2	88.2	70.9	56.8	66.5	36.8	65.8	56.9	77.8	73.2	70.7	71.7	69.5	66.2	70.4	67.0	9.8	70.9	34.6	71.3	68.4	76.4	28.4	30.3	30.0	30.7	27.7	31.8	31.1	29.0	28.9	30.5	29.8	32.2	76.2	48.1	93.7	17.3	79.2	54.8	75.2	129.9	17.1	80.5	178.6	191.6	9.8	140.2	95.2	101.2	64.6	248.3	74.0	80.2	52.8	191.8	40.2	54.7	59.9	72.6	141.9	34.3	31.8	168.7	475.0	77.5	31.1	53.1	91.3	60.7	98.9	185.8	147.4	58.9	32.4	187.2	103.7	59.2	55.8	17.7	103.8	47.8	122.7	13.1	99.7	88.6	125.7	40.2	45.6	162.4	114.1	100.1	68.2	107.4	176.6	145.5	74.1	92.2	26.3	59.1	82.8	72.4	44.0	20.0	53.8	236.4	60.5	78.2	177.8	71.0
CNRIP1	"C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924"	ENSG00000119865	"Cannabinoid receptor interacting protein 1"	Q96F85	2	68284171-68320051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.2;Erythroid cells: 116.2;granulocytes: 122.9"	"Cancer enhanced"	"Detected in all"		"glioma: 14.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	109	"basophil: 12.2"	"Lineage enriched"	"Detected in single"	109	"granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"HEL: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035337			Approved	Cytosol		NA	NA		54000	"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA035337: AB_10601359"	"unprognostic (1.23e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-3)"	27.4	6.4	59.0	5.9	62.3	6.1	20.2	50.9	71.6	30.1	29.6	17.1	3.5	22.4	6.1	5.3	24.2	8.5	16.0	65.1	51.8	10.3	2.9	18.3	5.1	40.4	45.1	31.2	3.0	1.8	15.4	12.1	44.3	15.1	4.6	29.6	5.8	8.9	6.6	8.1	10.9	9.3	44.7	10.2	10.6	2.6	52.7	2.7	8.9	7.0	2.9	20.7	19.2	51.8	0.0	1.1	9.0	0.0	34.1	24.6	0.1	34.5	26.6	30.6	22.3	0.0	0.0	0.0	1.2	33.2	22.6	0.0	0.7	0.2	32.6	0.0	8.1	158.7	2.3	0.0	34.7	0.1	21.7	22.1	0.0	20.0	11.5	18.7	47.8	0.0	0.2	0.1	23.4	0.1	0.0	0.4	16.3	0.0	15.6	0.0	13.2	0.0	0.0	0.0	45.8	47.8	2.2	0.0	28.3	0.1	0.0	1.7	51.4	21.1	12.9	18.5	51.0	0.0	0.0	0.1	16.9	0.0	15.5	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	59.0	62.3	50.9	71.6	65.1	51.8	40.4	45.1	44.3	44.7	52.7	51.8	50.2	0.0	4.3	15.0	0.6	12.9	0.4	0.0	4.6	72.2	0.6	1.7	2.1	0.0	0.6	0.0	22.9	1.2	0.1	0.0	0.0	0.4	0.7	1.9	30.4	60.6	0.0	116.2	48.8	0.2	9.3	44.4	0.5	0.6	122.9	1.3	36.4	0.8	56.3	28.6	39.5	0.0	0.0	25.7	40.9	2.6	45.4	13.9	37.4	16.9	2.5	42.0	0.0	24.1	19.6	0.5	0.0	42.5	0.5	1.2	0.0	0.1	0.0	54.3	46.0	18.7	41.9	0.7	0.5	0.7	10.7	2.1	3.8	27.3	0.0	1.0
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206267	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial stromal cells: 44.3;Excitatory neurons: 52.9;Fibroblasts: 99.7;Leydig cells: 60.3;Sertoli cells: 46.0;Smooth muscle cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"fHDF/TERT166: 1432.1;SiHa: 846.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 29.1"	"HPA009143, HPA010021"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		9100000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Cytosol	"HPA009143: AB_1847095, HPA010021: "	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	105.1	15.7	2.2	16.0	1.9	0.0	65.4	0.8	2.7	112.8	0.4	74.9	8.7	124.5	5.5	36.2	42.2	20.9	25.5	1.0	1.2	25.9	3.5	24.6	7.2	1.8	4.8	123.2	5.9	5.0	4.8	1.8	0.6	20.8	17.2	0.4	16.1	42.4	14.4	48.9	40.6	72.1	0.6	11.4	18.1	4.6	2.0	5.5	19.3	12.5	4.2	26.3	45.8	0.8	0.2	2.2	11.5	0.2	270.2	162.0	28.3	275.4	229.3	186.2	257.3	27.5	0.7	0.0	27.7	1432.1	3.9	59.2	0.5	28.7	174.6	0.2	1.4	0.2	101.1	0.1	97.9	0.3	0.2	234.9	5.0	42.2	50.6	173.6	32.0	0.1	0.0	0.0	29.4	0.2	0.1	0.2	6.4	0.0	15.3	0.1	23.1	0.2	8.9	14.4	0.0	0.0	846.1	21.2	0.3	15.5	131.8	0.5	0.2	78.5	97.0	41.5	91.4	0.1	0.1	0.4	26.4	0.3	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.8	2.7	1.0	1.2	1.8	4.8	0.6	0.6	2.0	0.8	14.2	76.9	5.1	2.3	0.0	20.6	0.6	12.7	5.2	0.4	4.7	7.1	4.1	0.0	4.7	3.7	0.0	0.6	0.0	0.0	0.0	1.4	24.1	6.3	44.3	11.0	0.0	0.0	52.9	4.6	1.3	99.7	2.6	14.1	1.3	0.1	3.3	0.0	0.8	0.0	32.4	0.0	0.0	0.3	18.4	14.7	60.3	1.8	21.4	38.4	0.0	0.0	0.0	19.6	1.2	6.7	0.0	13.2	0.1	1.7	0.0	0.9	1.7	0.0	46.0	20.0	48.6	0.3	0.6	0.6	13.1	0.7	2.5	1.4	0.1	0.3
COL25A1		ENSG00000188517	"Collagen type XXV alpha 1 chain"	Q9BXS0	4	108808725-109302752	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Heparin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;retina: 24.7;testis: 19.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 107.1;Inhibitory neurons: 275.3;Late spermatids: 39.2;Rod photoreceptor cells: 71.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HeLa: 47.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029107			Approved	"Endoplasmic reticulum,Vesicles,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Endoplasmic reticulum"	"HPA029107: AB_10600802"	"unprognostic (1.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.87e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.62e-3)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	6.1	0.5	13.4	0.1	10.3	0.0	2.8	0.0	30.0	1.1	0.3	0.4	2.9	0.6	1.6	0.4	0.9	2.2	0.5	17.8	13.7	1.9	2.2	0.2	0.1	6.5	9.4	1.0	0.2	1.3	7.0	0.3	1.0	0.5	0.3	24.7	4.9	0.5	1.0	0.7	2.5	0.8	6.9	0.8	0.3	19.1	8.9	0.5	2.8	0.3	0.1	0.7	1.0	1.7	0.0	0.0	5.3	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	2.7	0.0	0.1	0.0	3.2	5.9	47.6	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.2	0.0	0.1	1.2	0.2	5.6	0.0	0.8	0.0	1.6	0.0	0.1	0.0	2.6	0.0	0.0	0.0	1.1	0.0	0.0	0.2	1.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	10.3	0.0	30.0	17.8	13.7	6.5	9.4	1.0	6.9	8.9	1.7	8.2	0.0	0.0	12.4	0.1	0.0	0.1	0.0	2.2	2.1	0.4	0.6	1.0	0.0	0.6	1.8	4.2	0.0	0.0	0.0	0.0	0.0	107.1	6.5	2.0	1.6	0.0	0.0	20.5	0.0	0.0	0.7	0.0	18.9	0.0	0.5	0.7	0.0	0.0	1.7	275.3	0.0	0.0	0.0	0.4	39.2	0.6	0.2	0.0	10.3	0.0	2.8	0.0	16.6	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	71.5	0.0	4.7	24.6	7.8	1.6	0.0	0.1	0.0	0.1	0.3	0.0	0.0
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535873	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 21.1;Excitatory neurons: 23.4;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 12.5;Respiratory ciliated cells: 16.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.3;U-266/70: 9.8;U-266/84: 2.8;WM-115: 4.9"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 3.6"	"Region enriched"	"Detected in some"	31	"spinal cord: 33.5"	"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	1.0	3.2	0.8	1.6	1.0	0.3	2.8	1.9	2.7	3.3	1.4	11.7	1.2	2.2	14.1	2.1	4.9	1.5	3.7	1.1	0.9	6.3	0.7	1.2	0.2	0.9	3.6	1.2	5.8	0.2	11.2	0.5	1.4	3.9	4.1	6.7	18.2	5.1	5.9	2.1	3.4	1.7	0.2	0.4	6.5	3.7	1.1	0.2	1.2	3.2	0.1	2.9	4.5	1.5	1.5	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.4	0.0	0.0	1.1	0.4	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.2	1.4	0.1	0.2	0.0	0.7	0.9	0.3	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1	0.5	0.7	0.1	0.5	1.3	0.0	9.8	2.8	0.0	0.2	0.6	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.8	1.0	1.9	2.7	1.1	0.9	0.9	3.6	1.4	0.2	1.1	1.5	0.4	0.0	4.1	39.5	0.0	0.3	0.1	0.2	0.0	5.3	1.6	1.5	0.9	0.0	3.3	3.7	18.8	0.3	0.1	0.8	0.0	0.1	2.0	21.1	0.5	0.1	0.0	0.0	23.4	0.2	0.0	3.1	0.0	3.9	1.3	0.5	1.8	0.0	0.1	5.0	22.6	0.5	0.0	0.3	0.3	1.1	0.9	0.1	0.0	7.5	0.0	2.2	0.0	12.5	9.1	0.4	5.4	0.7	0.0	0.1	0.2	0.5	16.3	5.4	0.0	1.8	0.2	0.9	1.0	0.1	0.1	0.3	0.1	0.2	0.3	0.1
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981769-46005050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 796.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 578.3;Fibroblasts: 816.1;Leydig cells: 353.0;Peritubular cells: 251.3;Smooth muscle cells: 324.4;Theca cells: 246.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1157.2;ASC TERT1: 2331.5;BJ: 927.1;HHSteC: 1025.3;HSkMC: 1711.4;U-138 MG: 1297.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 46.8"	"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		250000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (4.54e-4)"	285.9	50.1	15.7	153.3	9.0	0.7	173.9	33.9	20.4	499.3	32.1	796.8	73.3	556.3	24.6	91.1	411.5	194.4	155.6	10.3	14.9	66.1	48.3	140.3	37.5	23.1	18.4	491.4	57.8	29.1	117.8	287.1	21.5	246.8	40.5	3.4	97.7	142.3	85.4	123.4	217.7	177.9	11.3	70.7	230.5	32.8	14.9	30.7	92.6	39.5	16.6	478.7	284.7	9.7	2.9	20.2	31.2	99.6	1157.2	2331.5	3.9	927.1	586.3	231.7	80.7	16.2	62.8	0.1	75.1	522.2	183.6	4.3	13.5	2.3	19.5	0.5	14.9	0.0	3.7	5.2	1025.3	0.3	2.2	1711.4	1.0	578.6	7.8	20.9	5.6	0.2	0.7	0.6	60.9	1.4	0.3	3.2	22.4	13.4	263.2	0.1	19.5	4.3	1.6	11.1	1.0	39.9	87.6	1.1	17.9	10.4	4.2	4.2	0.5	1297.6	86.7	362.7	358.1	0.6	0.4	0.4	464.1	6.9	116.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	9.0	33.9	20.4	10.3	14.9	23.1	18.4	21.5	11.3	14.9	9.7	74.6	0.0	5.8	26.1	2.5	122.2	11.0	1.5	18.2	18.9	9.2	35.9	42.7	5.7	4.4	9.2	0.0	11.6	2.3	0.6	3.9	23.2	4.6	20.9	578.3	50.6	1.8	0.0	27.1	3.3	18.6	816.1	6.1	16.1	1.3	48.7	101.0	13.4	22.4	15.2	8.2	0.3	0.0	3.3	134.7	18.6	353.0	7.8	147.7	40.3	2.0	18.7	0.0	30.7	2.4	6.1	2.6	251.3	3.5	6.3	2.1	10.3	1.0	4.3	184.1	152.3	324.4	2.6	6.2	5.5	89.9	20.8	13.7	246.5	1.4	3.8
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098112-46132848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 453.2;Fibroblasts: 1455.4;Leydig cells: 605.5;Peritubular cells: 472.1;Smooth muscle cells: 555.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 4.5;MAIT T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1155.7;ASC TERT1: 2116.9;BJ: 1073.7;BJ hTERT+: 982.8;fHDF/TERT166: 775.0;HHSteC: 1129.2;HSkMC: 1524.4;U-138 MG: 1128.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 49.6"	"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		8200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	732.4	96.2	10.1	219.9	10.8	4.5	455.0	8.7	14.4	873.3	21.6	1287.5	97.7	1001.7	36.5	178.8	675.1	283.8	484.3	10.0	14.9	96.5	97.6	394.2	55.7	14.0	19.4	723.6	78.6	24.0	112.2	335.3	11.2	569.9	60.2	0.9	156.2	274.6	123.4	390.6	402.2	275.4	9.8	175.1	441.6	77.0	11.7	35.6	201.3	67.2	25.6	918.6	595.9	12.3	9.4	12.5	34.8	31.2	1155.7	2116.9	10.0	1073.7	982.8	265.5	121.5	2.3	42.4	0.2	79.2	775.0	170.8	0.9	8.1	0.7	21.7	0.8	12.3	0.2	0.2	0.2	1129.2	0.5	4.8	1524.4	0.2	503.6	10.2	0.1	0.6	0.6	0.6	0.8	108.7	5.2	0.4	2.4	19.3	0.0	130.5	0.4	66.9	1.8	0.0	0.1	1.1	54.2	41.6	0.6	0.7	19.4	1.2	6.6	0.2	1128.1	131.5	421.5	270.3	0.7	0.4	0.9	578.1	0.5	164.8	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.4	2.4	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.1	0.5	10.1	10.8	8.7	14.4	10.0	14.9	14.0	19.4	11.2	9.8	11.7	12.3	127.3	3.2	0.6	2.0	3.1	164.4	4.3	0.6	9.1	0.7	12.7	33.5	8.7	4.3	0.6	7.3	0.0	17.6	41.2	0.4	0.0	15.1	4.0	13.2	453.2	101.4	0.0	2.7	0.1	0.4	25.1	1455.4	13.3	10.3	0.0	36.1	123.1	1.4	35.3	0.0	0.8	0.1	0.0	3.1	219.7	23.7	605.5	11.7	181.5	44.0	2.4	3.1	32.0	0.0	0.1	5.9	1.0	472.1	12.1	11.2	0.0	0.4	0.1	0.5	295.9	284.8	555.2	3.7	11.5	4.6	140.4	40.4	32.7	125.3	0.4	3.9
COMMD3-BMI1		ENSG00000269897	"COMMD3-BMI1 readthrough"		10	22316388-22329542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"retina: 10.1;testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.3;MOLT-4: 12.7;U-937: 23.8"									"HPA030471, HPA030472, HPA036584"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"		"Nuclear bodies"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803"	"unprognostic (8.63e-2)"				"unprognostic (2.36e-2)"									"unprognostic (1.83e-2)"				0.9	2.2	0.4	1.0	1.4	0.3	0.8	1.0	1.9	1.5	0.8	0.8	0.6	0.4	0.0	1.8	1.3	0.2	3.0	0.3	1.6	0.4	0.5	0.9	1.0	1.3	0.7	0.6	0.8	0.4	0.1	0.7	0.9	0.5	0.2	10.1	1.8	2.7	6.4	0.7	0.8	0.3	0.4	0.9	1.1	6.7	1.3	2.0	0.4	2.3	1.5	1.0	0.8	2.0	2.1	6.4	3.9	0.2	2.5	2.3	0.4	0.9	1.3	1.4	5.8	7.8	1.2	1.9	0.8	3.0	5.1	1.1	2.8	2.2	1.3	23.3	2.4	5.4	1.5	0.0	1.7	0.6	3.0	2.9	3.2	3.3	0.1	4.3	1.6	8.3	1.4	2.8	0.8	0.0	12.7	0.9	0.4	3.9	2.1	1.7	3.1	1.7	0.5	1.9	0.4	2.7	5.5	1.1	0.2	1.4	0.0	4.7	6.8	2.3	3.9	1.3	0.7	4.9	0.9	3.5	1.2	23.8	0.0	7.4	2.1	3.0	3.4	2.4	3.7	7.5	3.2	4.1	2.2	7.3	2.4	1.8	0.7	4.9	1.3	0.3	6.5	4.9	0.4	1.4	1.0	1.9	0.3	1.6	1.3	0.7	0.9	0.4	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COMMD9	"FLJ31106, HSPC166"	ENSG00000110442	"COMM domain containing 9"	Q9P000	11	36269284-36289449	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009142	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA009142: AB_1847105"	"unprognostic (1.56e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.15e-2)"	"prognostic favorable (8.54e-4)"	"unprognostic (4.94e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.08e-3)"	"unprognostic (7.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.88e-1)"	26.8	32.1	33.8	21.8	34.1	50.8	24.3	35.1	36.7	17.2	29.6	19.6	21.1	14.1	25.1	24.9	20.3	20.5	31.1	33.8	33.8	38.7	36.6	26.8	26.0	34.2	34.4	19.4	26.4	27.4	23.2	24.8	33.9	14.0	24.2	20.3	21.9	13.3	64.2	27.1	20.2	21.9	36.9	26.8	19.7	14.9	36.0	30.6	25.1	61.7	32.0	20.6	16.6	39.1	28.8	33.4	36.1	38.2	54.5	37.8	20.0	33.6	42.6	74.7	69.8	27.3	23.9	33.0	32.5	67.1	57.5	41.4	64.0	45.2	69.6	39.9	75.2	18.2	57.6	48.0	51.0	71.6	52.3	48.0	49.5	40.9	25.0	38.5	62.2	43.3	45.7	34.7	59.4	36.9	47.9	49.6	38.5	55.6	70.3	52.1	81.7	38.9	78.6	26.6	44.1	49.2	47.9	47.1	43.6	29.2	102.7	27.0	41.9	45.0	34.4	107.9	49.8	24.3	53.2	37.2	51.8	66.4	44.0	85.6	376.6	173.7	91.4	359.0	86.8	130.7	87.5	88.4	383.6	138.3	99.8	83.4	42.7	94.8	300.9	145.8	114.5	315.2	33.8	34.1	35.1	36.7	33.8	33.8	34.2	34.4	33.9	36.9	36.0	39.1	26.9	22.4	29.4	2.6	27.0	15.3	12.7	37.4	13.1	16.6	25.6	38.7	29.9	12.8	20.2	18.4	10.4	43.2	28.3	16.9	78.2	70.1	9.5	13.2	20.3	22.8	25.7	23.1	9.4	46.4	52.9	21.2	11.7	17.0	19.0	25.6	15.4	17.1	105.1	5.0	8.7	20.4	34.6	59.5	35.6	28.9	17.7	57.5	24.9	1.9	61.3	36.3	33.0	4.5	8.8	46.5	17.7	11.7	10.4	4.9	30.3	62.5	8.5	22.9	13.1	12.3	22.8	32.8	33.3	19.6	21.6	24.9	19.2	28.4	24.6	12.0
COMTD1	FLJ23841	ENSG00000165644	"Catechol-O-methyltransferase domain containing 1"	Q86VU5	10	75233641-75236030	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 128.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 334.8;Exocrine glandular cells: 249.5;Paneth cells: 272.5;Proximal enterocytes: 435.9;Squamous epithelial cells: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.2;PC-3: 38.3;RPMI-8226: 24.5;U-266/70: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042165	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA042165: AB_10794042"	"unprognostic (2.53e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.08e-3)"	"unprognostic (9.35e-2)"	"unprognostic (6.74e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.35e-1)"	11.0	17.9	1.1	1.0	1.5	1.5	9.8	1.2	1.8	18.3	5.8	23.3	7.4	7.5	0.4	70.6	7.2	0.4	33.5	1.3	1.7	29.1	37.5	11.7	0.6	1.7	2.0	8.0	128.6	3.4	17.1	0.9	1.7	11.8	1.0	1.1	23.9	1.0	28.2	25.3	25.2	0.5	1.1	12.4	27.8	3.4	1.6	0.5	18.5	0.7	0.7	8.3	29.0	0.9	6.9	2.2	0.5	1.3	0.1	0.7	19.0	2.1	1.0	0.3	0.6	1.6	6.0	20.0	3.5	0.4	1.1	9.0	0.9	1.9	0.1	3.2	30.2	0.8	4.8	3.3	1.1	3.5	3.3	0.6	3.2	0.1	2.9	1.3	0.3	3.6	7.8	4.7	0.1	6.2	5.3	11.0	1.2	5.1	38.3	10.6	1.3	24.5	1.8	0.6	8.4	2.3	2.4	16.0	4.8	0.5	8.9	0.5	1.4	0.6	5.9	1.2	2.1	21.5	4.5	9.8	0.7	3.4	0.6	0.0	7.1	3.9	10.6	10.0	11.6	7.1	10.6	11.0	8.5	5.6	3.5	6.1	1.4	7.3	9.4	15.3	8.9	6.8	1.1	1.5	1.2	1.8	1.3	1.7	1.7	2.0	1.7	1.1	1.6	0.9	23.6	19.2	11.5	1.6	18.2	29.4	40.5	54.1	133.1	6.0	29.3	37.1	31.1	57.2	33.8	53.3	10.4	33.4	30.8	334.8	144.8	162.8	1.6	10.5	7.7	13.5	40.2	16.0	3.4	249.5	79.1	13.4	148.8	33.4	12.7	10.3	25.4	84.0	35.1	1.7	3.9	206.0	42.7	24.2	21.3	3.5	9.6	21.8	37.4	6.5	31.8	10.7	24.7	1.5	0.5	109.2	272.5	7.2	50.8	38.7	435.9	140.3	11.3	34.5	32.9	6.2	25.6	2.6	3.4	285.3	38.2	30.4	29.2	10.7	143.8	56.7
COPA	HEP-COP	ENSG00000122218	"COPI coat complex subunit alpha"	P53621	1	160288594-160343273	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		150000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	47.7	43.1	46.6	38.5	48.9	30.0	42.0	57.2	57.1	52.9	67.4	42.3	53.7	46.7	55.1	38.3	41.2	38.6	55.1	48.6	53.7	48.6	55.0	47.0	36.1	57.9	51.0	46.9	49.9	51.8	59.8	48.3	60.0	43.5	47.9	26.2	57.6	39.4	59.1	40.0	49.0	50.0	53.9	42.7	43.5	24.4	51.1	37.6	60.1	38.2	38.9	41.3	37.9	66.4	91.0	68.5	70.1	66.9	164.9	154.7	78.6	116.5	144.3	103.1	138.7	72.0	60.5	64.4	73.3	194.0	57.7	86.0	92.0	81.3	126.5	68.6	64.3	76.8	95.2	79.0	115.1	94.1	74.5	134.8	49.1	140.0	128.9	126.3	126.4	64.4	71.9	69.7	124.4	43.6	49.3	53.3	80.1	97.3	79.0	49.2	89.2	118.9	94.3	94.7	62.1	84.3	157.3	109.2	148.0	115.0	140.4	133.9	162.8	84.3	54.1	108.2	80.2	106.8	76.3	106.6	104.2	51.3	122.8	48.1	39.0	25.4	18.6	36.7	25.5	17.8	16.7	21.3	40.4	14.2	14.3	17.9	10.9	26.7	36.2	17.8	22.9	35.5	46.6	48.9	57.2	57.1	48.6	53.7	57.9	51.0	60.0	53.9	51.1	66.4	53.6	76.9	54.7	44.7	66.4	28.2	35.5	41.6	29.6	52.4	53.0	41.3	51.8	42.9	49.7	40.5	81.3	41.0	83.2	66.8	13.7	49.9	14.7	50.7	68.1	50.4	55.3	37.0	77.6	49.6	63.3	66.2	65.2	64.3	45.6	63.0	52.8	71.1	51.2	45.4	73.8	83.8	30.5	93.7	58.0	6.4	71.1	84.3	26.6	67.5	75.0	41.0	38.1	65.9	178.9	55.5	48.1	56.8	115.9	52.9	98.9	41.4	66.2	53.7	39.5	57.6	52.4	37.6	25.7	35.8	31.8	69.2	58.3	58.1	66.6	61.2
COPG1	COPG	ENSG00000181789	"COPI coat complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		57000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	84.7	111.0	66.6	59.0	68.2	59.4	79.8	69.5	80.7	100.4	93.0	107.6	86.7	75.5	157.4	86.8	70.0	53.8	95.5	70.3	73.7	82.7	149.5	84.4	54.8	74.3	71.5	77.9	162.4	96.3	139.0	81.9	77.4	107.7	109.8	33.4	130.7	72.7	75.7	74.4	86.7	72.2	66.4	81.9	114.0	46.5	73.2	53.5	83.3	43.2	67.1	67.2	72.2	73.2	167.8	83.2	119.1	104.0	272.8	219.0	126.9	266.3	251.8	179.5	225.2	153.9	101.2	91.1	150.8	380.7	145.6	98.4	99.5	157.2	193.6	112.0	41.4	151.9	103.2	252.6	247.9	116.4	156.4	230.9	135.6	143.8	235.0	196.1	164.3	68.9	54.2	213.6	219.2	253.4	68.7	117.7	71.3	243.6	100.9	73.3	111.8	178.3	227.3	136.7	74.1	86.1	204.2	150.3	255.9	129.8	167.1	167.6	223.9	96.9	91.7	207.2	104.2	165.7	86.1	158.9	236.4	86.9	190.0	79.1	49.9	37.2	44.1	59.2	53.6	24.9	39.8	43.9	57.0	26.9	30.0	36.2	37.2	57.0	57.3	52.2	43.8	56.2	66.6	68.2	69.5	80.7	70.3	73.7	74.3	71.5	77.4	66.4	73.2	73.2	16.6	16.0	31.5	7.8	19.2	8.8	16.9	35.4	12.0	9.2	18.9	8.6	23.3	17.2	34.6	27.6	4.2	55.6	19.7	77.0	43.0	44.5	10.4	26.2	27.7	22.8	38.6	22.9	14.1	46.5	63.1	32.5	53.0	36.9	15.2	28.6	28.9	56.5	39.0	5.0	14.8	75.1	22.4	31.2	14.8	4.7	41.0	21.6	23.2	7.5	36.5	12.7	18.6	4.5	11.8	40.8	44.6	31.2	68.4	24.4	64.5	39.5	32.6	7.1	19.7	20.2	33.3	24.3	17.0	16.4	10.2	72.2	19.4	27.7	44.6	20.6
COPRS	"C17orf79, COPR5, HSA272196, TTP1"	ENSG00000172301	"Coordinator of PRMT5 and differentiation stimulator"	Q9NQ92	17	31851871-31859291	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.2;Late spermatids: 288.9;Spermatocytes: 575.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052552	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA052552: AB_2681868"	"unprognostic (1.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.11e-2)"	51.1	46.5	127.4	20.1	130.0	14.2	49.8	124.6	172.8	42.8	129.5	99.0	16.0	43.4	117.6	26.4	51.7	32.0	66.1	128.7	136.2	55.8	68.1	33.9	21.0	123.6	126.7	51.7	41.9	49.0	67.4	19.7	128.8	60.2	27.4	56.0	35.4	46.3	53.5	30.3	31.1	44.4	123.3	25.1	51.6	241.4	131.2	13.2	63.2	53.3	27.8	57.1	33.3	124.1	101.5	132.9	64.4	66.6	104.3	99.5	45.2	109.7	140.3	125.8	127.8	83.4	27.0	53.0	58.8	135.1	245.0	58.5	116.0	67.6	142.3	18.7	153.8	15.4	79.7	99.5	105.5	53.2	43.4	64.2	87.4	169.3	92.4	135.7	68.6	75.2	75.0	46.9	139.6	89.9	79.6	170.7	49.1	65.2	62.8	61.8	120.8	104.4	74.5	62.8	58.4	44.2	65.9	32.6	107.1	56.1	104.4	57.9	37.0	327.8	85.9	116.6	156.3	76.2	77.2	58.3	170.8	50.1	44.9	1.8	2.0	0.0	0.6	2.0	1.6	1.9	0.5	0.1	2.6	3.6	0.3	0.3	0.6	0.0	0.9	1.0	0.8	0.3	127.4	130.0	124.6	172.8	128.7	136.2	123.6	126.7	128.8	123.3	131.2	124.1	54.2	22.4	8.3	13.7	20.9	34.4	69.0	15.3	29.6	43.1	79.2	88.4	78.9	68.6	13.4	86.5	10.4	31.9	10.7	12.1	225.0	99.6	253.2	142.2	38.5	53.5	19.7	18.7	14.6	80.8	54.9	65.7	14.3	40.5	3.8	39.9	62.4	95.4	87.6	26.9	14.8	15.9	40.7	30.3	34.7	288.9	62.4	36.5	58.7	7.5	47.9	136.3	9.2	3.5	9.2	70.7	8.4	65.1	27.4	127.4	6.4	212.0	55.8	43.0	19.7	46.9	63.5	575.6	63.8	21.4	31.7	27.4	11.2	49.6	21.3	39.6
COPS9	"CSNAP, MYEOV2"	ENSG00000172428	"COP9 signalosome subunit 9"	Q8WXC6	2	240126563-240136807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 340.8;Breast myoepithelial cells: 395.6;Distal tubular cells: 498.9;Exocrine glandular cells: 383.2;Pancreatic endocrine cells: 347.0;Proximal tubular cells: 720.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044845	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA044845: AB_10962975"	"unprognostic (6.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-2)"	141.9	129.3	373.7	62.2	373.1	80.5	139.6	386.7	485.1	118.8	367.8	164.4	73.5	97.0	142.5	167.4	93.3	59.3	245.9	386.8	372.6	176.8	93.3	92.1	88.4	373.9	376.2	105.7	183.9	72.3	168.3	50.2	375.8	129.9	52.1	50.3	124.6	69.2	282.2	142.7	99.4	59.3	376.9	113.7	149.6	105.2	384.0	74.9	119.2	131.2	58.0	115.3	125.4	396.2	151.7	200.3	154.5	162.4	209.0	169.6	142.0	213.7	147.0	136.5	173.9	146.2	131.7	41.4	62.5	196.0	218.1	118.9	138.4	197.5	94.0	177.6	510.6	125.0	182.8	458.8	166.1	126.7	112.4	201.1	159.9	102.0	126.3	126.1	203.2	207.8	147.3	87.0	201.8	324.3	204.2	391.0	235.5	188.5	433.3	158.3	207.2	129.3	172.4	256.1	178.7	178.8	112.1	150.7	243.1	118.5	139.0	242.2	165.7	179.5	203.1	231.3	206.9	177.4	166.2	220.1	223.8	148.6	180.9	514.1	298.1	415.1	292.3	315.9	293.1	322.9	298.6	301.0	287.2	237.6	260.5	294.1	106.3	259.4	330.2	364.2	386.0	415.1	373.7	373.1	386.7	485.1	386.8	372.6	373.9	376.2	375.8	376.9	384.0	396.2	187.9	128.2	121.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	340.8	395.6	0.0	0.0	55.7	275.8	0.0	175.1	117.0	0.0	498.9	220.7	0.0	182.6	190.7	75.6	0.0	0.0	0.0	383.2	193.7	82.8	0.0	193.1	61.8	174.9	0.0	0.0	322.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.4	0.0	0.0	145.3	0.0	0.0	0.0	0.0	347.0	0.0	0.0	18.6	0.0	0.0	720.0	67.1	0.0	0.0	0.0	93.1	0.0	0.0	0.0	0.0	132.4	69.8	129.2	0.0	0.0
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266890-56270966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"heart muscle: 166.3;skeletal muscle: 280.7;tongue: 387.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 120.5;Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 24: NB-4 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"HPA068931: AB_2686061"	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	7.0	33.3	16.3	3.5	16.9	4.6	7.2	17.7	19.7	9.1	21.1	9.5	3.2	10.0	16.2	9.0	10.8	6.3	166.3	16.2	17.6	17.1	37.0	6.7	7.8	16.5	18.3	10.2	18.0	15.7	25.4	2.7	17.2	11.9	5.0	26.0	12.6	9.8	280.7	5.0	9.7	7.2	16.4	12.2	8.8	6.8	18.6	7.9	10.3	387.5	8.9	8.5	6.8	15.8	3.7	15.2	14.4	9.4	8.1	8.0	6.0	5.2	12.5	18.3	18.2	11.9	5.6	21.5	11.3	13.3	5.1	3.5	16.8	3.0	10.9	3.2	17.0	10.2	14.1	12.4	11.0	8.1	5.9	8.4	4.9	13.6	5.3	11.4	9.8	14.9	6.8	8.8	17.1	5.1	11.7	29.1	12.0	2.7	8.7	24.2	15.6	14.5	10.1	2.2	20.5	22.0	18.1	3.8	5.8	10.6	5.8	8.9	6.9	3.4	10.0	9.5	5.3	18.1	20.4	10.8	10.2	7.6	2.6	14.1	1.1	1.1	7.4	1.0	7.4	12.7	7.0	7.8	1.7	6.8	8.3	8.1	0.4	5.8	0.9	6.9	5.1	3.9	16.3	16.9	17.7	19.7	16.2	17.6	16.5	18.3	17.2	16.4	18.6	15.8	8.1	3.2	7.2	12.4	20.8	13.4	13.0	2.3	15.4	17.9	8.4	12.7	120.5	7.2	3.2	11.0	16.7	5.8	32.0	2.0	52.8	2.8	0.2	13.7	6.3	9.6	16.2	4.2	3.9	4.6	6.8	10.9	6.6	5.1	4.5	8.2	3.6	15.2	5.2	32.0	6.2	3.4	4.1	2.5	12.1	1.7	8.4	4.5	12.4	3.7	2.5	26.5	13.4	4.5	2.3	2.7	2.5	17.0	18.6	4.4	3.1	18.1	11.0	32.3	39.5	22.1	14.0	4.0	22.2	4.9	10.5	3.0	19.5	10.4	4.4	5.9
COQ10B	FLJ13448	ENSG00000115520	"Coenzyme Q10B"	Q9H8M1	2	197453423-197475308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046057	Approved		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA046057: AB_2679518"	"unprognostic (9.17e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.28e-3)"	"unprognostic (5.76e-3)"	"unprognostic (4.55e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-3)"	25.0	37.7	15.2	17.4	15.4	46.8	19.1	16.2	19.0	15.7	18.6	19.7	16.2	16.5	15.9	18.8	13.0	26.1	34.3	16.2	17.1	28.6	35.1	17.6	19.8	16.3	16.5	10.5	15.9	29.6	14.3	21.6	16.8	17.5	20.3	18.3	12.7	17.6	12.8	12.7	15.4	24.9	16.7	18.8	18.3	10.7	17.3	17.3	21.1	19.1	19.4	31.0	12.2	17.9	15.7	14.7	10.5	18.8	49.6	35.3	24.6	40.2	57.5	42.3	46.8	30.0	18.5	14.7	33.4	32.5	52.5	14.1	15.3	21.3	47.8	29.0	13.2	21.0	19.1	35.4	41.5	17.0	46.6	39.5	32.8	40.3	28.5	22.9	23.3	20.9	17.9	38.1	40.9	20.4	18.6	26.4	16.2	18.4	30.0	13.9	15.7	19.4	45.7	42.0	6.8	13.1	18.4	23.9	52.0	37.2	17.1	23.9	24.6	41.4	14.4	46.8	29.3	36.0	55.0	16.5	51.7	16.3	32.7	70.8	30.0	57.5	43.7	35.5	49.2	32.8	41.4	43.6	26.4	25.2	43.0	44.4	90.7	34.1	42.8	16.7	56.5	38.0	15.2	15.4	16.2	19.0	16.2	17.1	16.3	16.5	16.8	16.7	17.3	17.9	73.2	19.2	19.9	7.2	54.4	105.5	106.5	55.7	44.9	30.2	42.3	24.3	29.0	24.3	42.3	40.5	41.7	32.7	62.5	43.7	129.1	44.9	38.7	35.8	34.5	48.9	26.9	38.3	12.4	46.1	43.7	67.6	33.1	43.5	60.3	12.2	22.9	36.7	32.0	63.9	11.8	44.3	57.0	23.8	74.6	20.7	20.5	44.3	71.2	7.5	29.2	56.7	49.4	7.1	16.0	54.2	36.3	30.5	45.1	65.6	30.0	73.7	41.7	36.6	46.0	60.8	71.0	20.9	39.4	29.0	106.6	173.9	70.9	33.7	19.1	100.0
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 37.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 50.7;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.0	17.0	2.8	8.0	3.2	11.8	5.8	3.5	3.3	7.9	3.6	14.2	9.5	6.3	7.5	10.4	4.4	4.3	15.0	3.0	3.5	5.6	13.6	7.9	6.4	3.6	3.5	6.5	6.5	6.0	4.0	8.4	3.8	6.6	14.2	4.0	7.8	5.0	29.1	10.8	9.1	6.9	4.1	10.1	5.5	3.5	3.9	3.6	5.7	37.5	7.1	7.9	6.5	4.9	26.1	14.7	14.1	27.4	10.5	11.9	9.7	16.1	27.0	29.7	34.4	10.5	38.7	17.2	11.7	28.4	24.6	18.6	23.9	26.0	38.7	17.2	14.8	15.3	22.3	15.4	11.7	31.3	73.5	15.9	16.3	14.2	24.8	8.9	30.7	9.7	10.0	21.4	29.3	27.4	8.6	21.7	10.9	30.6	19.9	14.1	11.4	22.1	45.4	13.8	10.3	6.3	19.0	24.5	9.2	6.7	15.4	18.8	21.0	14.6	14.6	11.1	23.4	5.7	5.2	10.2	29.5	36.8	20.2	2.1	28.8	4.0	2.7	26.8	1.9	6.2	3.0	2.5	21.1	6.9	2.1	3.2	9.8	6.7	33.5	11.2	4.1	13.6	2.8	3.2	3.5	3.3	3.0	3.5	3.6	3.5	3.8	4.1	3.9	4.9	5.4	0.0	4.2	15.7	11.5	6.6	12.4	9.8	4.6	5.9	6.3	5.6	19.5	2.8	10.7	9.2	0.0	25.4	7.1	14.0	31.3	6.7	0.8	7.6	19.5	6.1	4.8	14.1	12.8	10.8	30.0	9.0	6.6	9.2	0.0	17.2	9.3	15.0	50.7	1.7	20.1	15.3	8.2	53.2	7.9	0.8	3.7	25.2	7.2	33.7	21.8	12.6	6.2	25.6	15.6	5.4	15.4	4.9	4.3	12.6	11.0	9.9	6.2	4.8	0.0	7.3	9.7	18.1	19.7	16.7	12.6	12.4	9.6	35.5	26.7	12.9
COQ9	"C16orf49, DKFZP434K046"	ENSG00000088682	"Coenzyme Q9"	O75208	16	57447425-57461270	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 255.4;tongue: 241.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040918	Supported		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Mitochondria, Cytosol"		"HPA040918: AB_10794154"	"unprognostic (9.18e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.03e-11)"	"unprognostic (7.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-2)"	24.3	44.7	21.7	15.1	22.7	10.6	18.0	23.4	26.1	19.6	38.4	48.6	47.3	16.8	16.6	40.0	24.0	19.4	139.7	21.2	22.1	61.3	53.2	14.4	15.6	21.5	21.8	16.6	27.9	79.7	14.9	16.7	20.7	26.2	38.2	11.8	44.1	28.8	255.4	25.2	41.8	28.3	21.3	12.2	35.3	23.8	24.3	18.7	29.2	241.0	17.3	38.2	21.6	21.7	33.6	67.2	18.3	45.8	36.0	27.3	21.3	31.9	25.3	44.8	24.9	41.2	43.0	40.3	59.0	28.8	34.3	70.5	52.8	56.6	28.3	21.4	49.3	27.7	44.2	66.1	39.8	36.1	44.4	45.6	73.7	35.9	68.1	29.8	51.1	35.6	54.7	18.1	27.4	48.6	30.5	26.8	29.6	74.4	90.6	60.8	58.7	104.8	71.3	37.4	56.3	56.7	108.4	103.8	54.9	16.1	59.4	39.5	34.4	32.4	38.9	34.8	40.4	42.9	29.5	48.0	44.4	51.2	37.3	21.0	28.2	23.0	19.5	36.6	20.1	18.8	16.6	17.1	34.4	19.1	17.7	26.0	8.9	24.0	38.2	21.5	25.5	21.9	21.7	22.7	23.4	26.1	21.2	22.1	21.5	21.8	20.7	21.3	24.3	21.7	17.1	12.8	18.9	37.9	15.7	8.4	17.1	55.3	19.9	16.2	21.7	23.1	79.5	45.8	28.7	25.8	16.7	74.7	14.2	68.8	217.2	53.9	37.9	20.4	17.3	17.3	27.6	21.2	21.2	29.3	25.6	20.7	35.7	18.0	7.0	40.7	18.5	53.6	38.8	20.2	24.0	46.6	83.4	16.3	5.4	28.4	21.1	14.1	28.4	7.5	22.7	29.1	14.4	20.6	14.5	27.2	37.0	20.3	15.9	21.5	90.7	114.1	30.0	24.0	13.1	22.6	19.8	66.0	38.8	37.3	11.2	78.7	12.8	91.2	70.2	18.4
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 568.8;lymphoid tissue: 583.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 523.9;dendritic cells: 588.7;Hofbauer cells: 494.4;Kupffer cells: 395.8;Macrophages: 342.7;monocytes: 583.7;NK-cells: 968.1;T-cells: 663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 924.0;HL-60: 645.7;HMC-1: 1086.7;JURKAT: 603.0;MOLT-4: 632.5;NB-4: 771.8;RPMI-8226: 980.9;U-698: 618.2;U-937: 829.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		NA	NA		45000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	29.1	20.8	34.4	306.4	37.1	568.8	11.2	24.9	52.0	10.6	23.6	26.8	44.3	10.0	3.1	22.5	17.9	45.0	11.3	36.9	31.9	11.5	13.1	49.5	583.8	37.6	32.0	6.4	8.4	4.3	9.3	18.4	32.2	11.4	15.3	0.9	32.9	7.3	6.7	17.6	111.0	22.2	35.8	321.4	49.0	4.8	33.9	257.6	12.7	8.8	309.1	57.6	10.4	50.0	3.1	3.6	10.9	21.5	0.1	0.1	6.1	2.6	0.7	5.4	3.0	0.7	6.9	924.0	6.1	0.9	1.5	4.4	5.2	10.8	1.3	302.3	2.5	97.9	0.5	15.0	1.7	645.7	1086.7	2.8	0.0	4.3	0.5	0.4	2.0	603.0	1.5	467.6	3.4	80.7	632.5	771.8	4.0	3.1	6.4	340.0	17.5	980.9	1.3	5.1	17.3	13.0	2.2	110.7	2.0	0.2	1.9	373.0	1.6	4.0	9.0	2.7	3.1	348.5	497.7	618.2	3.0	829.6	6.3	797.2	773.6	2671.1	637.5	859.7	597.8	505.5	567.3	625.6	843.2	512.0	537.1	566.2	1318.9	531.0	898.0	482.1	858.7	1647.2	34.4	37.1	24.9	52.0	36.9	31.9	37.6	32.0	32.2	35.8	33.9	50.0	6.3	22.4	32.5	0.3	523.9	11.3	1.2	3.2	2.2	1.2	4.7	5.5	1.5	17.2	6.0	1.8	0.0	4.6	588.7	2.3	0.0	3.5	0.5	1.1	2.0	12.3	6.0	60.2	3.3	0.9	17.4	9.5	18.8	1.3	83.7	0.6	21.8	4.8	494.4	0.0	1.7	2.2	6.1	395.8	197.9	1.2	0.6	342.7	32.0	4.7	583.7	0.8	968.1	1.5	0.4	11.1	47.5	0.0	201.4	0.8	1.0	4.8	3.5	0.9	6.6	2.9	5.1	0.1	0.9	2.4	9.1	4.9	663.0	2.7	3.3	0.9
CORO2A	"IR10, WDR2"	ENSG00000106789	"Coronin 2A"	Q92828	9	98120975-98192637	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.2;Proximal enterocytes: 93.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 11.4;monocytes: 7.8;T-cells: 11.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 66.6;OE19: 56.4;SK-BR-3: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041161, HPA041302"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA041161: AB_10795537, HPA041302: AB_10794195"	"unprognostic (4.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.40e-3)"	1.9	1.7	1.9	4.9	1.5	14.8	4.7	4.9	3.2	6.1	0.0	17.5	34.3	1.6	0.7	15.2	4.7	18.2	0.3	1.2	2.9	1.1	3.3	7.4	2.9	3.7	3.4	0.3	0.4	2.5	4.0	2.1	4.9	14.3	12.9	1.2	6.1	1.4	0.3	9.3	35.1	2.2	0.8	3.0	11.1	9.2	4.5	5.7	1.2	0.3	5.9	12.8	7.7	1.8	8.4	2.9	0.6	2.0	1.2	1.3	66.6	0.6	0.7	2.1	3.2	19.1	1.4	0.1	9.4	1.2	3.2	23.1	7.7	12.7	1.3	6.9	1.8	0.2	11.6	17.1	2.7	7.9	0.7	0.4	15.4	1.0	18.6	0.7	0.7	10.0	6.8	3.8	0.3	6.3	1.5	7.8	8.6	56.4	2.2	6.1	0.1	0.2	1.3	23.5	1.7	2.4	4.4	45.3	1.6	15.0	5.3	12.8	0.6	0.2	9.7	0.2	2.4	0.7	4.0	0.7	0.5	2.5	2.8	11.2	1.4	11.4	2.4	2.9	5.2	0.6	3.9	3.7	0.5	0.5	2.5	3.3	1.0	1.7	7.8	0.7	11.9	1.5	1.9	1.5	4.9	3.2	1.2	2.9	3.7	3.4	4.9	0.8	4.5	1.8	2.8	12.8	27.8	0.7	3.1	6.6	18.9	47.2	14.8	2.1	8.5	4.3	1.9	28.6	46.4	0.0	4.2	10.5	2.1	76.2	0.0	4.5	2.6	15.6	11.6	6.0	7.2	0.8	11.6	5.1	42.2	2.2	36.2	19.9	0.0	38.1	0.7	3.8	6.0	1.7	10.5	15.7	20.3	12.0	2.6	3.9	0.0	10.6	0.0	1.0	1.8	0.7	2.1	0.5	0.8	22.6	19.7	0.4	1.4	15.7	93.0	1.7	35.8	1.7	0.0	1.5	3.7	0.5	3.3	29.4	9.9	15.9	10.7	0.2	36.3	30.4
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354719	"Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 90.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Late spermatids: 27.4;Respiratory ciliated cells: 12.6;Spermatocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 24.9;SCLC-21H: 10.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.7	0.1	0.3	1.0	0.2	1.1	0.9	1.0	0.5	0.4	0.4	6.7	0.2	0.2	1.2	1.2	0.7	0.2	0.1	0.3	0.3	0.8	0.1	0.3	0.2	0.3	0.5	0.5	0.2	0.0	0.9	0.2	0.4	0.7	4.8	0.4	1.4	0.2	0.3	2.5	0.3	0.2	0.1	0.3	0.2	90.5	0.3	3.3	0.1	0.0	1.9	0.5	0.9	0.6	3.1	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.2	24.9	0.1	0.2	0.3	0.3	1.8	0.7	0.2	0.2	0.9	0.7	0.0	2.0	0.1	0.3	0.2	1.8	0.2	2.7	0.5	0.6	1.7	0.0	0.1	0.4	0.2	0.0	0.6	0.1	0.2	0.6	2.6	0.5	0.1	0.0	0.2	0.1	0.4	10.1	0.3	0.4	0.1	0.0	0.6	0.4	0.0	0.5	0.2	0.5	0.1	0.3	1.6	1.4	0.1	0.1	0.3	0.1	0.8	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.2	0.2	1.5	0.5	0.2	0.4	0.2	0.3	0.3	0.2	1.0	0.5	0.3	0.3	0.3	0.5	0.4	0.1	0.3	0.6	0.2	0.0	0.5	0.0	0.0	0.5	0.7	3.5	1.2	2.4	0.9	1.3	0.6	0.0	2.1	0.0	4.2	0.5	1.8	8.0	0.0	0.5	36.0	1.3	0.5	0.2	1.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.0	0.2	0.0	0.0	0.1	3.3	0.1	1.3	4.1	0.0	0.0	27.4	0.6	0.3	0.0	0.0	0.0	1.4	2.1	0.0	0.1	9.6	4.1	0.0	0.3	0.7	3.4	0.1	12.6	5.4	0.0	0.4	0.5	61.1	1.7	0.3	0.4	0.4	0.6	0.1	6.5	2.3
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.6;skin 1: 57.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 17.7;Basal respiratory cells: 23.7;Exocrine glandular cells: 54.1;Fibroblasts: 11.5;Suprabasal keratinocytes: 31.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 140.1;hTERT-RPE1: 261.0;LHCN-M2: 284.2;U-2 OS: 151.0;U-87 MG: 272.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		390000		"Cluster 31: Skin - Epidermis development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	5.0	4.4	0.4	0.4	0.4	0.1	3.5	0.5	1.7	15.3	0.5	0.0	0.0	0.2	0.3	21.6	0.4	0.1	1.1	0.6	2.1	0.6	0.1	0.4	0.2	1.1	0.7	0.1	12.7	0.0	0.5	2.0	1.1	0.2	0.0	0.2	6.7	0.0	0.3	57.1	0.2	0.8	0.6	3.3	0.4	0.3	1.2	0.8	0.0	0.0	0.9	0.0	12.6	1.1	95.3	5.0	0.3	0.3	0.7	1.5	0.1	74.6	140.1	74.9	18.5	0.7	8.1	0.1	14.3	31.9	75.2	5.5	0.0	41.3	76.7	0.4	0.3	0.0	33.3	2.1	1.8	0.3	0.2	1.0	65.2	6.7	9.4	261.0	0.3	0.1	0.0	0.2	284.2	0.2	0.0	0.0	0.8	0.4	11.1	0.3	75.4	0.1	34.5	4.0	0.2	0.0	49.9	23.3	0.5	28.0	0.5	0.4	57.3	18.1	151.0	6.2	7.4	0.2	0.2	0.1	272.7	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.5	1.7	0.6	2.1	1.1	0.7	1.1	0.6	1.2	1.1	0.0	3.2	0.5	0.0	0.0	17.7	0.5	23.7	0.6	0.0	4.2	2.8	0.3	0.0	8.5	0.0	0.0	5.6	0.1	0.0	0.0	0.5	0.4	0.4	0.2	0.3	0.0	0.0	0.4	54.1	1.2	11.5	0.0	2.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.3	3.6	1.0	0.6	0.0	0.0	0.0	0.5	7.9	0.0	0.0	0.0	0.9	0.0	0.1	2.9	0.0	0.0	1.3	0.4	0.1	0.7	10.0	31.0	9.4	0.1	0.0	0.0	1.6
CPEB2		ENSG00000137449	"Cytoplasmic polyadenylation element binding protein 2"	Q7Z5Q1	4	15002481-15070153	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 127.6;Oligodendrocytes: 406.5;Suprabasal keratinocytes: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072513			Approved	Cytosol		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA072513: AB_2686529"	"unprognostic (6.59e-2)"	"unprognostic (4.21e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	9.6	6.0	13.2	5.1	21.9	26.5	12.3	18.8	21.9	9.8	5.6	11.5	8.4	7.4	8.3	13.3	6.0	9.5	7.3	14.6	15.0	12.0	17.6	8.4	5.6	22.4	16.6	6.3	4.4	16.3	4.2	6.4	20.7	8.4	9.7	16.1	8.1	10.7	5.8	23.5	8.7	8.6	18.7	5.8	10.7	37.9	17.3	4.5	4.8	6.2	6.4	8.0	13.2	45.5	2.9	18.1	1.9	0.7	13.1	26.2	3.6	10.8	6.7	5.8	4.6	0.3	4.2	1.9	2.1	10.1	11.8	3.5	3.9	2.6	3.6	4.8	1.5	0.5	16.3	3.5	6.1	1.0	2.6	12.3	12.5	15.6	14.7	8.7	6.1	0.3	0.4	13.2	26.9	1.5	0.2	4.7	1.7	5.9	2.8	0.3	1.8	0.8	57.3	2.6	1.7	11.1	3.1	2.4	10.6	8.7	1.5	12.2	11.7	24.0	2.1	15.3	6.1	9.0	1.3	1.0	19.3	10.6	9.5	0.0	0.2	0.6	0.1	0.1	0.5	0.0	0.2	0.1	0.2	0.1	0.3	0.1	1.1	0.5	0.1	0.1	0.1	0.1	13.2	21.9	18.8	21.9	14.6	15.0	22.4	16.6	20.7	18.7	17.3	45.5	24.9	32.1	14.2	55.8	8.1	85.8	12.2	6.8	58.1	8.6	31.2	17.8	22.3	12.8	9.3	31.3	27.1	1.4	10.7	26.4	1.9	4.6	64.5	38.4	9.9	14.7	10.2	3.8	58.2	4.9	1.8	13.4	15.3	50.7	10.8	1.8	13.2	23.8	11.2	15.2	127.6	13.1	4.1	14.1	31.0	20.3	6.2	20.3	53.4	39.4	6.6	8.5	3.1	89.5	406.5	7.0	16.9	8.2	17.5	11.8	18.7	14.8	5.1	19.3	0.0	20.7	16.5	16.6	4.6	77.0	129.4	1.4	11.0	3.6	8.1	17.0
CPEB3	KIAA0940	ENSG00000107864	"Cytoplasmic polyadenylation element binding protein 3"	Q8NE35	10	92046692-92291078	"Predicted intracellular proteins"	"Translation regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 32.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 176.0;Early spermatids: 226.2;Excitatory neurons: 233.7;Inhibitory neurons: 286.9;Late spermatids: 408.9;Oligodendrocyte precursor cells: 148.8;Oligodendrocytes: 128.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.1;U-266/70: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070942			Approved	"Nucleoplasm,Plasma membrane,Midbody,Cytosol"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane, Midbody"	"HPA070942: "	"unprognostic (4.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.95e-5)"	"prognostic favorable (5.06e-5)"	"unprognostic (4.09e-4)"	"unprognostic (2.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.84e-9)"	"unprognostic (3.33e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.40e-1)"	1.9	3.9	6.1	1.8	7.2	1.7	3.2	6.2	17.3	2.5	2.1	2.3	3.1	1.9	4.5	4.6	1.8	2.0	5.1	6.4	4.3	4.6	32.2	2.2	1.9	10.4	5.6	3.5	3.5	3.2	4.0	1.6	11.0	4.2	2.6	7.1	7.5	2.4	19.7	4.0	3.0	2.0	1.4	2.6	2.8	12.9	4.4	1.5	6.5	9.5	2.1	1.9	3.1	7.0	0.9	0.2	0.3	1.9	0.5	0.5	0.7	0.8	0.6	1.2	0.9	0.6	1.9	1.1	1.0	0.3	0.5	2.5	0.9	0.6	0.7	1.1	0.9	1.4	1.3	0.8	1.4	0.6	1.4	0.4	1.5	0.6	2.4	1.0	1.1	1.3	0.9	12.1	0.5	0.7	0.9	0.8	0.2	1.3	0.9	1.1	1.6	2.1	1.2	0.4	1.4	0.5	0.8	2.2	1.6	1.0	2.7	1.6	0.8	0.6	0.6	0.4	0.7	6.3	1.7	1.1	0.3	2.2	0.1	2.6	0.4	0.8	0.2	0.5	0.2	0.7	0.1	0.3	0.3	0.1	0.1	0.1	0.5	0.2	0.6	0.2	0.1	0.2	6.1	7.2	6.2	17.3	6.4	4.3	10.4	5.6	11.0	1.4	4.4	7.0	6.1	6.4	7.0	176.0	6.2	8.8	4.0	4.0	7.4	26.0	20.5	10.7	25.3	5.7	4.4	12.9	50.1	2.1	3.0	11.3	5.9	3.2	226.2	9.0	3.0	7.1	19.8	3.6	233.7	2.6	1.6	5.5	4.1	10.8	3.8	4.1	12.5	75.2	4.8	30.3	286.9	9.9	8.2	23.9	3.4	408.9	5.9	10.3	5.4	87.1	8.9	3.2	4.1	148.8	128.6	3.2	4.0	7.9	4.2	10.7	10.1	5.0	8.7	24.7	0.0	4.4	4.1	13.2	7.2	22.0	13.9	1.2	3.3	3.4	5.9	6.5
CPLANE1	"C5orf42, FLJ13231, Hug, JBTS17"	ENSG00000197603	"Ciliogenesis and planar polarity effector 1"	Q9H799	5	37106228-37249376	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.4;Collecting duct cells: 22.0;Endometrial ciliated cells: 50.3;Endometrial stromal cells: 42.9;Glandular and luminal cells: 20.6;Granulosa cells: 40.8;Theca cells: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 21.9;SiHa: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036775, HPA036776"	Approved		Approved	Cytosol		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA036775: AB_10669914, HPA036776: AB_2675308"	"unprognostic (3.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.09e-1)"	2.4	3.1	1.4	1.4	1.9	1.0	3.8	2.6	2.7	3.4	2.5	1.9	1.0	4.2	3.7	2.3	4.2	3.2	1.8	1.4	1.8	3.6	1.5	3.3	1.7	1.3	1.3	5.3	2.4	5.4	2.2	3.3	0.6	4.3	2.0	5.7	2.9	3.6	1.4	2.3	1.1	3.2	0.3	2.3	2.2	4.8	2.5	6.3	6.9	3.3	1.7	2.7	1.4	2.8	5.7	3.5	8.4	6.4	11.4	10.3	3.7	5.8	4.2	6.6	5.2	4.0	7.6	1.4	3.7	5.2	10.4	2.7	2.4	3.5	6.5	3.8	2.6	3.3	21.9	2.4	5.8	0.0	1.8	7.8	4.7	6.7	3.5	7.8	6.5	3.6	0.0	1.2	11.8	0.0	4.2	4.8	2.2	0.0	2.7	4.0	14.9	0.0	6.0	1.7	4.7	3.3	48.7	0.3	3.1	6.8	2.6	3.5	8.0	10.0	6.2	2.7	4.5	1.7	0.0	1.6	2.4	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	1.4	1.9	2.6	2.7	1.4	1.8	1.3	1.3	0.6	0.3	2.5	2.8	19.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	11.3	8.9	0.0	0.0	0.0	22.0	0.0	7.4	8.8	0.0	0.0	8.8	0.0	50.3	42.9	4.8	0.0	0.0	0.0	5.3	5.8	7.6	0.0	20.6	0.0	40.8	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	2.6	0.0	0.0	3.9	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	3.6	3.2	18.9	0.0	0.0
CPNE2	CPN2	ENSG00000140848	"Copine 2"	Q96FN4	16	57092583-57148369	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 87.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.3;Hepatic stellate cells: 82.8;Oligodendrocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041132	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA041132: AB_2677316"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	35.1	7.3	34.5	12.8	50.2	60.6	24.9	41.1	45.3	36.5	36.9	29.2	6.0	20.7	6.6	15.9	28.0	14.3	15.5	36.7	46.6	14.1	9.4	37.2	11.0	52.9	48.1	10.7	7.3	10.9	7.5	27.9	48.6	14.0	28.3	1.7	10.9	17.1	11.7	11.7	21.2	25.1	39.3	18.2	9.2	16.4	61.0	6.3	15.9	13.5	9.2	16.7	18.5	87.4	23.9	45.1	68.0	38.1	12.0	11.6	11.3	25.4	39.8	56.8	39.5	12.7	27.0	14.2	22.7	38.6	31.4	36.7	27.1	15.1	30.6	17.7	15.9	5.9	17.5	10.7	21.6	4.8	0.6	11.1	16.8	22.3	10.8	42.4	84.5	7.6	16.0	0.5	14.5	11.1	7.2	69.9	15.5	11.6	9.5	88.8	21.3	11.9	37.7	9.0	1.4	27.6	32.3	6.9	19.4	30.5	7.5	94.4	60.3	51.6	27.7	13.1	33.5	3.4	3.0	31.8	33.4	20.6	37.0	0.0	1.5	0.8	0.2	0.4	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.2	1.5	0.1	0.1	0.0	0.2	0.4	34.5	50.2	41.1	45.3	36.7	46.6	52.9	48.1	48.6	39.3	61.0	87.4	84.3	19.2	7.4	8.1	1.5	2.3	17.1	6.0	7.4	0.4	8.2	6.9	2.3	4.3	5.1	5.5	0.0	0.6	1.4	43.4	5.9	4.7	19.9	33.4	13.8	41.0	3.6	0.8	1.0	4.2	2.9	12.3	1.5	39.3	0.0	26.7	82.8	2.0	23.6	0.0	7.4	13.7	4.1	25.3	7.4	5.9	6.8	12.0	7.2	8.4	10.7	3.6	0.0	17.1	86.3	6.2	25.1	7.5	0.8	14.2	35.4	2.6	9.2	0.0	32.9	9.3	21.7	0.6	2.6	6.2	4.3	0.8	8.4	2.1	18.2	16.3
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.3;prostate: 25.3"	"Cell type enriched"	"Detected in some"	10	"Excitatory neurons: 351.2"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 34.3;cerebral cortex: 15.2;hippocampal formation: 16.8;thalamus: 12.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.2;AF22: 5.7;Karpas-707: 1.7;RT4: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA032036: AB_10600898, HPA078300: AB_2732377"	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	0.6	0.5	4.8	0.1	34.3	0.0	0.2	0.0	15.2	0.2	0.0	0.3	0.7	0.2	0.6	0.3	0.4	0.0	0.9	16.8	3.7	1.0	0.1	0.4	0.0	0.0	4.2	0.0	0.2	1.9	3.0	0.0	0.1	25.3	0.2	2.0	0.4	3.7	0.0	0.2	0.5	0.3	0.5	0.8	0.5	1.4	12.1	0.0	0.3	0.1	0.0	0.1	0.4	1.2	0.0	6.2	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.8	0.4	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.8	0.4	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.7	1.4	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.8	34.3	0.0	15.2	16.8	3.7	0.0	4.2	0.1	0.5	12.1	1.2	0.9	0.0	0.0	8.8	0.0	0.3	0.4	0.1	0.0	0.8	0.0	0.0	17.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.6	0.1	0.6	4.9	0.0	351.2	0.0	0.0	0.6	3.6	0.6	0.0	0.2	0.0	0.0	0.1	1.7	33.0	0.1	0.0	0.0	0.3	5.6	0.3	1.1	0.0	8.4	0.6	0.3	0.0	8.5	7.1	0.1	0.0	0.0	0.0	17.0	0.0	2.6	0.3	0.6	0.0	0.0	0.4	1.4	1.1	0.3	0.1	0.0	0.0	0.1	0.0	0.9
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36839444	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.4;heart muscle: 92.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 50.6;Cardiomyocytes: 30.0;Excitatory neurons: 35.1;Oligodendrocyte precursor cells: 36.7;Plasma cells: 89.6"	"Cancer enhanced"	"Detected in all"		"glioma: 11.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 62.4"	"Group enriched"	"Detected in some"	80	"memory B-cell: 51.6;naive B-cell: 26.8"	"Lineage enriched"	"Detected in single"	105	"B-cells: 51.6"	"Group enriched"	"Detected in some"	5	"Daudi: 59.4;HUVEC TERT2: 25.7;U-266/70: 19.7;U-266/84: 17.1;U-698: 28.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 135.5"	HPA031369	Enhanced		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	6.4	0.9	16.6	10.7	62.4	1.4	2.3	0.0	29.5	3.9	0.0	6.2	5.6	5.8	1.0	2.4	19.9	2.0	92.7	23.0	2.7	4.5	0.8	2.6	23.6	0.0	4.6	6.6	1.0	0.4	11.0	1.4	0.0	5.8	5.0	2.8	3.5	2.5	0.5	1.8	8.6	4.7	1.1	20.0	5.1	25.3	0.8	2.3	3.3	0.2	28.1	4.9	5.7	13.3	0.9	0.0	0.5	0.1	0.1	0.0	0.3	0.2	0.2	0.3	0.5	0.0	0.2	59.4	0.5	0.8	2.7	0.4	0.1	0.4	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.7	0.0	4.1	25.7	0.2	0.2	1.7	0.5	0.0	0.0	0.4	0.1	0.8	0.0	0.3	0.5	0.0	0.0	0.1	0.5	0.1	0.0	0.0	5.3	0.3	0.0	0.8	5.9	0.4	0.7	0.0	2.1	19.7	17.1	28.1	0.3	6.5	0.1	0.0	0.1	0.0	0.0	0.2	0.2	51.6	0.2	0.0	0.1	26.8	0.0	0.0	0.4	0.0	0.2	0.3	0.0	4.5	16.6	62.4	0.0	29.5	23.0	2.7	0.0	4.6	0.0	1.1	0.8	13.3	2.8	0.0	3.6	1.3	50.6	0.6	0.2	0.2	0.0	13.4	0.3	0.5	30.0	0.0	0.0	0.0	0.0	0.0	1.5	15.1	1.9	0.0	3.3	0.4	0.8	7.4	4.2	0.0	35.1	0.2	0.0	2.8	1.5	1.4	12.6	0.3	5.0	1.0	0.4	0.0	8.6	1.8	0.0	1.9	0.6	4.8	0.0	6.2	3.6	2.8	0.2	1.3	2.1	36.7	0.8	0.5	12.5	0.4	89.6	0.2	2.3	0.1	0.0	1.6	0.0	2.3	1.0	0.8	1.5	1.1	0.1	0.0	2.0	0.2	1.7	0.4
CPNE9	KIAA4217	ENSG00000144550	"Copine family member 9"	Q8IYJ1	3	9703826-9729908	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 69.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 12.9;Excitatory neurons: 28.2;Inhibitory neurons: 8.0;Late spermatids: 61.3"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.0"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.3;U-937: 2.0"	"Low region specificity"	"Detected in all"							HPA060813			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA060813: "	"unprognostic (2.96e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-4)"	"unprognostic (1.47e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.48e-2)"	0.1	2.1	10.9	0.2	7.1	1.2	0.1	12.1	23.6	0.1	0.0	0.4	0.3	0.1	0.0	0.1	0.1	0.1	0.1	5.8	19.6	0.2	0.0	0.3	0.2	69.2	19.8	0.1	0.1	0.1	5.3	0.1	65.0	0.1	0.1	1.1	0.1	0.2	0.0	1.7	0.3	0.2	4.2	0.2	0.3	1.3	39.6	0.1	0.1	0.0	0.1	0.1	0.1	12.9	0.0	0.3	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.2	0.3	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.5	0.0	0.0	0.2	0.4	0.7	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.4	0.3	2.0	0.1	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	10.9	7.1	12.1	23.6	5.8	19.6	69.2	19.8	65.0	4.2	39.6	12.9	0.1	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.6	0.8	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.9	0.1	0.1	0.1	0.0	0.0	28.2	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	1.9	0.0	8.0	0.0	0.0	0.8	0.3	61.3	0.0	0.8	0.0	3.7	0.0	0.7	0.0	2.0	2.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.9	0.7	0.2	0.4	0.0	0.1	0.0	0.1	0.0
CPTP	"GLTPD1, MGC10334"	ENSG00000224051	"Ceramide-1-phosphate transfer protein"	Q5TA50	1	1324756-1328896	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.5;Late spermatids: 167.1;Proximal enterocytes: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056832	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA056832: AB_2683251"	"unprognostic (9.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.27e-2)"	15.7	19.5	14.1	6.0	13.0	2.8	16.9	13.1	22.1	17.6	14.0	28.3	19.8	14.2	8.5	48.9	12.5	3.7	92.8	15.0	10.9	28.4	69.9	12.6	5.4	16.0	13.8	10.8	18.6	14.1	8.0	4.6	17.1	19.1	4.8	2.0	37.2	6.5	55.2	33.0	23.2	2.7	12.3	21.2	31.3	70.7	15.4	4.0	14.2	22.8	4.4	14.7	24.8	11.8	36.0	12.7	6.0	11.0	5.7	4.8	9.7	18.4	9.8	17.1	11.1	17.4	19.6	14.2	20.9	8.5	11.3	26.3	4.8	10.9	6.2	16.8	16.5	10.6	13.6	17.7	14.4	10.3	10.3	9.3	8.3	18.0	5.0	8.3	9.1	9.0	15.8	8.3	5.7	13.3	11.4	12.1	5.5	9.3	55.1	14.0	9.8	41.1	14.0	9.5	14.2	14.9	14.8	46.3	32.8	3.1	16.5	7.1	15.5	18.3	12.8	20.1	15.2	18.1	14.8	14.8	17.6	15.1	5.6	1.8	1.2	6.1	1.6	0.6	0.9	2.9	1.9	1.5	0.8	1.5	1.1	0.9	1.6	1.2	1.2	1.2	5.1	1.4	14.1	13.0	13.1	22.1	15.0	10.9	16.0	13.8	17.1	12.3	15.4	11.8	20.0	0.0	3.2	2.0	7.2	0.0	7.8	0.0	5.2	9.7	15.8	8.6	22.6	12.8	1.3	7.3	0.0	18.6	10.8	35.3	39.2	25.9	72.5	5.9	4.9	13.8	6.1	5.5	3.0	24.3	21.3	7.0	26.5	9.4	0.0	9.1	13.9	31.5	16.4	23.5	3.3	14.0	0.0	7.6	0.0	167.1	12.2	6.3	0.0	5.6	15.8	16.3	18.6	2.0	2.7	49.3	13.3	9.8	18.6	12.0	72.0	18.2	0.0	7.0	13.1	4.7	6.8	52.3	4.8	14.0	0.0	19.6	7.5	9.8	18.4	9.1
CRADD	RAIDD	ENSG00000169372	"CASP2 and RIPK1 domain containing adaptor with death domain"	P78560	12	93677375-93894840	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 161.3;Early spermatids: 164.5;Inhibitory neurons: 122.3;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 287.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005337	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"CAB005337: AB_2085481"	"unprognostic (1.07e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (9.65e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.10e-1)"	"unprognostic (3.79e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.18e-2)"	"prognostic favorable (4.04e-9)"	"unprognostic (2.57e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	10.0	19.3	9.1	5.0	10.5	9.3	11.2	9.9	9.1	12.8	12.8	13.6	16.9	13.0	12.6	13.0	9.9	10.4	41.2	8.7	10.1	17.9	37.3	9.9	7.3	9.7	9.9	10.3	12.7	18.6	15.3	7.2	9.8	11.4	8.2	12.8	11.0	8.9	28.2	11.4	18.0	8.2	8.7	10.4	12.9	13.7	10.0	13.3	9.6	30.0	6.2	12.7	11.3	10.3	7.8	17.4	8.4	9.6	11.8	21.2	10.6	8.8	10.7	7.6	8.9	16.4	3.2	13.9	5.3	10.2	5.8	8.0	9.3	11.5	9.3	14.7	12.3	7.4	7.0	12.2	12.2	6.8	6.8	19.8	17.4	12.2	9.5	8.0	9.3	15.2	21.3	6.4	9.1	12.6	10.1	12.3	10.6	8.9	13.2	16.8	4.3	19.3	7.4	5.7	12.9	12.5	12.0	11.7	21.3	8.1	20.5	13.2	10.0	17.5	8.7	8.4	9.0	15.0	8.7	12.9	8.2	10.0	8.4	62.7	11.6	45.5	23.8	14.7	21.1	15.1	16.5	24.8	9.7	13.5	17.6	13.0	33.9	20.6	23.2	13.1	20.9	12.0	9.1	10.5	9.9	9.1	8.7	10.1	9.7	9.9	9.8	8.7	10.0	10.3	7.8	9.6	6.3	161.3	7.8	7.4	9.3	21.1	6.2	6.4	8.9	7.2	38.7	7.2	18.0	7.3	8.4	14.5	9.0	19.1	23.5	16.8	164.5	11.8	8.7	11.9	7.8	9.1	62.8	22.4	12.7	10.3	10.2	6.7	4.5	3.7	10.0	41.9	11.5	23.5	122.3	14.6	26.4	10.6	6.1	35.2	17.7	16.0	3.6	96.5	9.5	16.9	15.5	174.4	287.2	19.5	19.8	23.7	8.4	10.1	58.5	63.1	20.0	15.5	6.6	15.0	11.4	25.6	11.7	10.1	8.1	10.8	10.2	8.3	13.9	10.1
CRAMP1	"CRAMP1L, KIAA1426"	ENSG00000007545	"Cramped chromatin regulator homolog 1"	Q96RY5	16	1612337-1677908	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041752	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA041752: AB_10796459"	"unprognostic (3.67e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.78e-4)"	"unprognostic (4.17e-2)"	"unprognostic (8.53e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.86e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	8.0	7.5	7.4	5.6	6.2	13.5	9.0	15.0	6.9	11.1	5.9	10.9	8.1	10.3	6.2	9.0	10.7	5.4	8.3	6.6	4.6	9.4	6.3	9.9	7.6	5.4	5.2	12.5	8.8	5.7	12.4	6.9	5.3	12.0	5.4	9.9	8.4	6.4	7.9	11.0	9.5	6.7	3.2	11.0	9.0	22.9	5.5	10.7	12.7	4.8	6.0	9.6	9.5	7.1	8.5	15.5	15.6	14.5	9.8	9.7	20.3	14.4	7.5	11.5	8.2	11.2	14.0	12.0	12.3	9.9	7.1	15.3	18.7	10.0	10.3	12.7	22.6	14.2	16.0	6.9	7.1	19.0	20.6	8.5	12.6	14.5	12.1	11.2	12.4	17.9	19.6	7.1	6.3	12.4	14.8	10.6	14.9	4.9	8.7	51.2	8.4	16.1	8.2	7.5	16.6	14.0	15.8	11.3	8.3	10.9	9.9	24.3	15.2	11.9	12.8	11.4	13.9	15.0	23.3	24.3	3.7	13.0	10.8	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.3	0.0	0.1	7.4	6.2	15.0	6.9	6.6	4.6	5.4	5.2	5.3	3.2	5.5	7.1	10.4	16.0	17.0	0.0	2.7	0.0	5.2	0.0	12.0	8.6	9.3	8.0	0.0	4.3	8.6	9.2	18.8	4.7	12.8	6.1	1.9	5.5	28.0	11.1	14.5	6.8	2.4	4.6	0.0	2.0	3.0	5.4	5.1	15.3	5.1	11.0	6.8	4.3	5.6	3.3	0.0	6.6	0.0	8.2	0.0	9.6	4.4	4.3	0.0	0.0	6.6	6.2	4.1	0.0	0.0	7.1	4.7	6.8	4.7	9.9	6.0	1.6	2.9	17.9	6.6	7.1	5.2	17.3	18.4	9.4	0.0	5.3	5.2	5.6	5.5	5.9
CREBL2		ENSG00000111269	"CAMP responsive element binding protein like 2"	O60519	12	12611827-12645108	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 130.6"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043738	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA043738: AB_10795041"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.53e-1)"	39.8	130.6	24.7	30.4	26.3	5.3	31.9	22.8	29.2	26.4	29.5	23.4	23.1	19.0	28.8	17.1	24.6	28.2	22.5	26.2	28.8	49.7	50.1	32.5	37.5	24.6	24.5	37.2	24.7	56.3	32.2	24.2	24.6	28.2	23.8	35.2	26.4	23.0	10.1	24.6	23.6	18.9	24.8	37.5	25.1	20.9	29.1	24.7	44.3	15.6	29.8	28.0	15.1	27.7	12.5	15.9	13.6	15.5	46.9	47.0	26.3	24.0	40.4	17.3	23.7	11.5	17.9	10.8	9.1	29.3	26.2	10.3	20.7	18.4	29.1	61.0	12.6	8.5	15.1	14.2	30.7	12.2	15.2	30.8	32.2	20.3	33.1	58.7	25.7	8.5	8.7	16.5	29.4	20.1	6.4	9.9	40.8	11.9	14.4	8.7	23.6	6.9	33.1	35.7	16.0	18.2	24.4	11.7	43.3	58.5	6.5	13.6	20.8	23.7	15.1	23.7	23.9	13.9	19.7	2.7	28.1	10.3	24.9	1.1	2.5	2.6	1.7	5.6	3.1	0.9	3.4	2.7	2.8	1.1	3.3	2.7	0.4	1.1	2.6	1.4	5.6	1.5	24.7	26.3	22.8	29.2	26.2	28.8	24.6	24.5	24.6	24.8	29.1	27.7	18.0	25.6	26.5	23.5	14.8	22.2	18.6	11.1	18.8	17.5	23.5	15.9	14.6	30.0	12.2	33.1	2.1	18.1	15.7	17.7	41.1	21.6	40.4	14.2	10.4	19.1	30.0	27.8	15.9	21.8	19.3	25.3	17.9	10.6	10.2	12.1	23.2	48.4	39.3	37.0	17.7	16.4	26.4	120.0	83.0	12.1	36.1	58.2	33.8	33.7	45.6	38.0	10.3	28.6	18.6	21.8	15.0	35.3	17.3	29.5	29.3	58.8	19.9	11.8	39.5	13.7	12.4	45.8	20.8	18.0	29.1	27.5	23.3	11.5	17.6	28.1
CRELD1	"AVSD2, CIRRIN"	ENSG00000163703	"Cysteine rich with EGF like domains 1"	Q96HD1	3	9933816-9945406	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 110.3;hTERT-RPE1: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026964	Uncertain		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA		19000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoli	"HPA026964: AB_10602210"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.78e-2)"	32.7	37.3	63.6	11.4	63.5	9.3	24.8	69.1	94.4	27.7	59.1	57.5	14.0	31.3	17.0	18.0	34.9	16.5	73.2	63.9	65.7	43.0	57.1	27.5	12.4	64.7	63.0	32.5	27.6	22.7	70.9	17.9	66.3	47.6	12.1	16.4	26.3	34.5	48.9	20.1	25.9	22.2	58.6	28.6	35.6	23.6	65.5	10.5	67.6	26.4	9.2	33.6	24.4	68.2	6.4	8.1	19.3	8.8	30.1	17.6	110.3	26.7	8.0	6.1	11.7	11.1	20.7	8.4	57.6	17.7	27.7	4.5	10.4	17.6	4.9	15.2	9.2	7.3	15.2	28.2	68.7	3.3	29.3	21.7	32.3	15.2	13.6	77.2	28.8	11.1	9.5	10.4	6.1	15.5	3.6	19.3	5.7	30.1	6.6	4.8	3.1	21.6	25.9	9.9	6.9	26.7	12.6	10.3	24.3	27.5	27.9	17.0	21.7	12.1	19.5	16.2	6.3	10.7	14.2	15.2	27.3	7.8	13.0	12.3	10.2	9.3	11.9	9.8	12.2	7.9	8.9	11.5	6.9	8.7	11.3	10.4	1.8	13.8	12.9	12.3	7.2	9.5	63.6	63.5	69.1	94.4	63.9	65.7	64.7	63.0	66.3	58.6	65.5	68.2	24.7	19.2	17.5	43.4	14.1	9.7	26.2	48.5	15.9	21.5	17.5	15.0	41.9	31.5	24.0	16.5	16.7	23.7	15.1	10.9	7.9	19.6	6.8	10.3	7.0	20.2	27.0	7.8	38.0	4.4	11.5	20.1	19.4	12.9	21.0	18.8	19.2	14.9	20.6	32.0	37.1	19.1	38.7	8.8	9.0	10.1	32.0	10.0	12.4	15.0	13.9	18.3	27.8	14.6	21.7	8.7	20.4	26.4	15.3	31.4	18.8	11.1	13.2	15.8	26.3	11.0	17.1	68.0	26.5	9.6	12.4	22.2	15.4	11.2	15.4	20.2
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 980.8;Endometrial ciliated cells: 1761.1;Proximal enterocytes: 2548.8;Respiratory ciliated cells: 1702.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 699.8;CAPAN-2: 415.5;HaCaT: 464.1;HDLM-2: 329.5;OE19: 1305.8;T-47d: 586.0"									HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"		NA	NA		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	265.2	21.7	19.2	61.1	19.7	29.4	180.8	20.0	36.4	147.4	20.3	133.9	121.7	108.0	206.6	118.7	118.2	28.1	262.6	18.5	20.3	109.7	17.8	254.6	83.9	26.9	29.1	49.8	18.3	21.2	41.5	28.3	24.6	49.6	55.4	0.2	135.7	87.9	44.7	301.1	312.5	42.4	24.7	94.5	94.2	14.3	21.0	79.6	182.1	50.2	135.7	113.7	98.9	20.3	0.0	699.8	4.8	0.6	12.1	8.3	66.8	1.3	0.4	9.0	0.1	21.0	415.5	228.0	2.4	191.0	2.6	464.1	0.1	0.0	0.0	329.5	0.0	17.7	294.7	116.3	1.8	0.1	0.2	3.8	0.0	23.1	0.0	0.9	0.5	64.6	0.5	0.9	0.0	3.7	8.1	1.6	7.4	1305.8	36.4	181.3	0.0	45.5	0.0	0.0	18.5	1.3	2.6	1.2	0.0	0.5	586.0	106.4	1.5	0.4	0.4	5.5	0.0	0.3	0.2	17.9	0.0	0.0	0.6	121.8	218.6	313.1	209.2	214.4	135.1	697.0	442.0	222.1	442.9	384.2	85.4	100.2	13.9	323.5	283.9	291.3	694.8	465.6	19.2	19.7	20.0	36.4	18.5	20.3	26.9	29.1	24.6	24.7	21.0	20.3	50.2	980.8	256.2	0.3	350.7	186.5	1.2	79.5	67.2	0.0	88.1	18.3	1.0	2.8	501.3	51.5	0.0	2.1	287.8	360.4	1.9	20.5	3.6	1761.1	124.5	86.4	76.5	27.3	0.0	3.1	4.3	313.3	210.0	491.9	521.5	0.1	24.7	1.3	52.2	0.0	0.0	243.1	30.5	168.0	577.3	26.2	25.1	523.7	370.0	1.9	461.4	0.2	83.4	0.0	0.1	34.2	659.2	9.4	584.3	0.7	2548.8	2.5	1702.1	0.0	223.5	8.2	448.0	1.0	11.4	29.4	251.6	1.5	524.7	0.1	190.7	3.0
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917407-20953747	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 344.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Cytosol	"HPA000532: AB_2666019, HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.7	14.8	34.5	18.4	34.9	53.7	16.3	34.6	35.7	17.5	26.0	18.4	22.0	19.4	13.0	26.6	20.4	14.3	25.1	33.7	33.5	17.1	27.3	20.7	25.5	36.8	37.0	27.4	23.5	19.1	16.1	25.9	34.0	16.5	19.6	22.4	14.8	19.0	54.3	24.9	19.7	19.5	38.8	22.4	14.7	13.3	38.9	33.3	14.8	43.0	27.6	18.9	18.4	36.0	43.9	25.8	56.7	44.8	37.5	23.9	61.0	29.0	35.5	43.7	49.1	42.8	19.2	56.1	22.9	30.8	30.0	54.8	67.2	46.3	51.7	47.7	65.5	77.7	28.6	47.3	37.4	83.5	38.0	24.3	60.3	38.1	64.6	35.7	39.1	44.3	344.9	44.8	35.7	41.2	49.0	39.0	44.8	45.5	27.7	62.7	89.9	13.5	29.2	37.8	36.5	46.9	48.6	42.4	36.4	67.7	36.4	45.9	31.9	69.0	77.8	26.2	37.2	42.7	44.4	64.1	51.1	34.8	43.3	16.2	15.0	22.1	18.5	13.9	19.3	12.1	16.2	18.4	16.5	11.4	19.7	18.9	15.9	12.9	26.1	8.3	14.4	21.2	34.5	34.9	34.6	35.7	33.7	33.5	36.8	37.0	34.0	38.8	38.9	36.0	11.8	9.6	17.8	17.3	18.6	54.2	13.5	15.2	29.6	17.8	19.7	14.2	23.1	7.2	12.2	5.5	14.6	19.6	26.4	19.6	1.9	7.7	30.4	19.3	15.3	15.0	20.4	28.6	23.9	8.6	42.4	16.5	10.2	18.4	1.3	15.8	20.7	25.0	17.5	18.5	18.6	19.9	8.2	19.5	20.8	52.5	15.2	15.2	24.9	9.4	19.0	17.5	21.6	16.6	25.0	11.2	11.8	15.4	14.1	19.0	18.5	10.7	14.8	13.2	13.1	15.7	12.1	12.7	11.0	40.2	60.4	27.2	17.8	12.7	18.5	18.6
CRTAP	"CASP, LEPREL3, P3H5"	ENSG00000170275	"Cartilage associated protein"	O75718	3	33114014-33147773	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 377.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 306.9;monocytes: 377.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 795.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043598, HPA044150"	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Intermediate filaments, Actin filaments, Cytosol"		"HPA043598: AB_10960991, HPA044150: AB_10959594"	"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.85e-3)"	"unprognostic (7.36e-2)"	"unprognostic (4.73e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.28e-3)"	157.2	106.5	65.2	38.7	69.2	43.2	123.9	51.9	54.8	211.2	52.9	145.1	35.0	170.1	57.1	58.7	138.3	80.5	83.9	49.6	64.9	67.9	44.6	92.3	37.3	65.2	62.4	131.4	36.0	45.7	22.8	69.9	63.9	90.7	51.6	19.3	54.0	106.5	54.4	84.1	65.6	115.0	67.5	48.2	78.9	25.0	65.3	23.7	77.2	68.9	38.1	142.7	135.8	69.5	64.1	123.3	37.8	119.2	795.0	516.6	219.0	136.1	294.0	160.6	151.9	42.1	35.1	44.4	147.6	259.3	129.9	80.2	68.0	103.9	115.5	110.1	106.0	69.2	87.6	43.7	237.4	45.4	54.8	415.3	208.5	145.0	183.2	311.7	172.0	27.0	60.3	82.1	164.6	54.7	16.5	46.3	45.5	67.5	165.7	59.4	111.0	86.1	127.8	42.0	7.9	61.0	92.0	79.8	201.1	87.3	85.9	109.3	113.0	209.1	89.1	115.4	145.9	59.0	214.3	6.7	164.3	89.7	117.1	13.4	377.6	28.5	35.8	147.7	52.5	39.9	51.4	40.2	306.9	39.2	29.2	27.8	30.5	42.1	46.0	82.5	74.0	200.5	65.2	69.2	51.9	54.8	49.6	64.9	65.2	62.4	63.9	67.5	65.3	69.5	74.0	9.6	42.8	15.3	29.0	60.4	41.1	39.5	150.8	17.9	32.7	43.7	34.7	25.8	22.0	38.6	8.4	49.0	37.1	14.8	11.7	25.0	1.2	17.4	135.7	72.7	6.0	46.0	10.0	32.0	81.6	142.3	29.0	31.2	48.1	58.4	122.4	53.2	107.0	35.3	14.5	26.0	10.2	181.1	91.1	6.3	142.9	108.6	80.0	10.3	134.1	15.9	22.6	17.1	11.6	18.4	16.3	144.8	58.1	24.5	24.4	52.7	6.8	10.1	111.7	78.4	120.9	1.6	15.9	95.1	46.7	28.0	26.5	89.9	36.1	30.0
CRYAA2		ENSG00000276076	"Crystallin alpha A2"	A0A140G945	21	6560714-6564489	"Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	136	"kidney: 125.7;liver: 42.1;retina: 48.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	207	"Hep G2: 37.5"									"HPA037737, HPA038430"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"		Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	125.7	42.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	48.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"		6	106360717-106572017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"esophagus: 61.9;placenta: 72.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 219.4;dendritic cells: 153.6;Plasma cells: 89.9;Syncytiotrophoblasts: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;HBEC3-KT: 124.1;hTERT-HME1: 95.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.2"	"Low region specificity"	"Detected in many"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	17.0	1.2	0.6	21.9	0.5	24.1	17.3	0.7	0.8	6.8	40.3	25.0	25.4	2.4	6.2	61.9	6.7	8.1	1.0	1.9	0.4	15.3	11.8	9.8	20.4	0.8	0.7	2.3	4.9	5.8	0.4	72.0	0.6	25.2	19.2	0.8	9.3	5.4	1.1	42.1	23.7	4.8	0.5	12.6	10.3	5.1	1.5	9.7	2.6	1.2	33.5	19.0	14.0	0.4	34.7	0.2	0.0	0.1	25.5	93.7	9.9	4.9	33.5	10.8	10.0	2.4	11.5	54.0	2.3	21.7	14.6	54.5	0.2	124.1	5.3	74.0	2.3	0.0	1.5	16.9	12.1	33.4	0.2	44.9	66.7	19.7	95.8	0.1	46.5	41.9	1.7	7.3	28.5	3.5	9.7	10.7	0.4	0.2	21.2	16.4	0.4	0.4	14.9	80.0	2.2	0.2	20.3	31.9	0.3	3.0	16.4	24.3	13.5	11.6	1.5	0.2	34.4	5.7	4.7	57.7	56.0	39.3	26.3	0.3	3.4	0.4	7.4	3.6	10.1	6.6	9.8	8.5	8.6	2.9	5.8	5.7	2.4	4.8	4.1	1.0	9.9	4.0	0.6	0.5	0.7	0.8	1.9	0.4	0.8	0.7	0.6	0.5	1.5	0.4	13.4	12.8	11.9	0.0	24.2	0.0	0.0	0.0	0.0	0.0	31.2	14.1	0.0	0.0	13.0	33.1	0.0	219.4	153.6	0.0	3.9	10.9	0.0	20.2	2.7	4.4	0.0	0.0	0.0	12.5	15.3	2.5	0.0	31.6	1.3	0.1	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	26.4	0.0	0.0	89.9	0.0	0.0	15.0	8.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	600.1	76.7	0.1	0.0	0.0
CRYGB	CRYG2	ENSG00000182187	"Crystallin gamma B"	P07316	2	208142573-208146158	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Early spermatids: 1.1"	"Group enriched"	"Detected in some"	6	"ovarian cancer: 1.1;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"hippocampal formation: 3.3;hypothalamus: 2.2;thalamus: 2.0"					HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA						"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (6.73e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYGC	CRYG3	ENSG00000163254	"Crystallin gamma C"	P07315	2	208128137-208129828	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 1.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 1.9;Granulosa cells: 3.7;Late spermatids: 3.2;Spermatocytes: 2.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8;ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"hippocampal formation: 3.2;hypothalamus: 1.5;thalamus: 1.2"	"Group enriched"	"Detected in some"	14	"cerebral cortex: 1.2;hippocampal formation: 1.5"	HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (1.89e-1)"					"unprognostic (2.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYGD	CRYG4	ENSG00000118231	"Crystallin gamma D"	P07320	2	208121607-208124524	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"ovary: 8.0"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 140.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"HEL: 10.0"					"Not detected"	"Not detected"			"HPA041269, HPA043386"	Supported		Approved	Vesicles,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA041269: AB_2732491, HPA043386: "					"unprognostic (4.49e-2)"						"unprognostic (2.64e-1)"				"unprognostic (3.62e-1)"			0.0	0.0	0.5	0.0	0.4	1.3	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.6	0.0	0.0	0.0	0.0	0.5	0.7	8.0	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.5	0.6	0.5	0.7	0.6	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	4.6	0.3	0.0	0.1	0.9	0.0	0.0	0.0	140.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	34.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.9	0.1	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CRYZL1	"4P11, QOH-1"	ENSG00000205758	"Crystallin zeta like 1"	O95825	21	33589341-33643926	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019120, HPA029399, CAB034129"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.28e-3)"	22.4	18.6	23.7	16.4	26.4	22.4	21.1	31.4	33.5	19.2	23.7	28.2	15.0	22.6	19.0	18.8	20.2	16.3	20.0	24.8	25.9	23.5	18.0	16.2	17.7	24.7	26.0	22.0	15.2	22.3	14.2	21.7	25.1	18.3	20.3	29.2	18.0	22.3	19.2	22.9	15.8	21.2	22.5	15.6	17.6	34.0	25.2	18.1	24.5	15.4	14.0	21.0	18.0	34.2	38.0	16.4	45.7	33.8	24.3	35.0	24.0	26.3	37.8	33.0	29.1	24.5	29.0	26.4	23.0	32.5	25.6	20.5	24.6	27.2	30.0	24.6	24.8	49.9	35.5	22.2	38.4	31.0	29.8	32.7	23.4	34.9	27.2	43.1	42.4	42.6	36.8	26.6	31.3	19.3	30.2	31.8	32.3	38.8	21.9	28.5	36.8	36.6	47.1	33.7	19.8	31.2	34.6	17.5	39.7	37.8	34.3	23.1	44.8	26.3	25.3	22.0	20.5	43.4	64.7	29.1	34.4	22.7	30.1	36.1	34.5	36.2	31.7	37.5	34.3	38.2	33.4	29.9	43.3	40.4	43.3	35.3	18.3	47.1	35.6	34.3	29.9	26.8	23.7	26.4	31.4	33.5	24.8	25.9	24.7	26.0	25.1	22.5	25.2	34.2	25.6	32.1	17.3	40.1	25.9	23.6	43.9	58.9	19.9	47.8	22.1	25.1	28.0	31.5	36.0	31.3	31.3	70.4	21.3	20.2	49.0	37.6	90.4	19.6	14.4	29.9	21.0	25.4	42.4	29.1	40.5	28.1	13.3	14.4	65.2	34.5	27.5	15.0	33.5	47.1	47.2	22.5	46.8	26.0	25.7	28.0	44.1	24.6	37.4	26.2	36.1	49.4	41.2	32.2	56.7	28.6	30.3	41.0	11.3	23.3	33.7	44.8	35.0	51.1	19.7	23.7	41.5	139.4	19.4	15.9	21.5	44.6	28.4	27.3	29.4	40.5
CSDC2	PIPPin	ENSG00000172346	"Cold shock domain containing C2"	Q9Y534	22	41561010-41577741	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 143.8;heart muscle: 288.2;ovary: 133.6"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 75.0;Distal tubular cells: 19.6;Granulosa cells: 30.7;Muller glia cells: 51.7;Proximal tubular cells: 42.5;Sertoli cells: 72.3;Smooth muscle cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 12.4;U-2 OS: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003073, HPA076549"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA003073: AB_1078578, HPA076549: AB_2686807"	"unprognostic (9.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (6.42e-4)"	"unprognostic (8.86e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.09e-3)"	6.8	143.8	29.4	1.6	21.8	0.1	3.2	64.5	32.1	69.9	4.1	16.5	0.8	83.5	1.4	3.2	24.1	2.3	288.2	30.5	35.3	40.4	2.6	11.5	0.2	44.4	41.0	133.6	51.1	0.0	20.5	0.4	36.9	26.2	0.5	5.2	1.0	10.4	2.7	2.1	3.2	10.9	26.1	1.1	4.5	31.3	44.9	0.0	2.5	2.7	0.0	27.4	29.0	22.7	0.0	0.2	1.5	0.2	0.0	0.0	0.1	3.4	0.2	0.1	0.1	0.9	0.0	0.0	0.5	4.7	0.5	0.1	0.0	0.0	0.0	0.0	2.9	0.0	12.4	1.5	3.5	0.0	0.0	1.9	0.1	0.0	0.0	3.5	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.1	1.1	0.2	0.0	0.1	0.1	1.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.1	41.8	0.3	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	29.4	21.8	64.5	32.1	30.5	35.3	44.4	41.0	36.9	26.1	44.9	22.7	0.1	0.0	0.0	4.6	0.5	0.3	0.2	0.3	0.6	9.9	0.1	0.6	75.0	0.0	0.0	7.3	2.1	0.1	0.0	0.0	19.6	0.3	1.5	0.2	6.0	0.9	0.0	0.0	6.8	10.4	0.1	5.1	0.0	0.1	0.0	30.7	0.4	0.2	0.2	6.7	11.0	0.0	0.0	0.0	0.0	5.1	5.3	0.3	1.8	0.0	0.0	51.7	0.0	1.0	0.6	2.4	0.0	2.6	0.0	0.2	0.0	42.5	0.7	3.2	72.3	0.4	19.9	2.1	0.3	0.0	0.1	0.3	0.2	0.3	0.0	0.0
CSGALNACT1	"ChGn, CSGalNAcT-1, FLJ11264"	ENSG00000147408	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1"	Q8TDX6	8	19404161-19758029	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 86.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 494.3;Excitatory neurons: 144.4;Granulosa cells: 214.1;Microglial cells: 224.9;Oligodendrocyte precursor cells: 355.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 22.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 62.6"	"Group enriched"	"Detected in all"	5	"B-cells: 44.5;granulocytes: 24.9;T-cells: 62.6"	"Cell line enhanced"	"Detected in many"		"A549: 57.8;BJ hTERT+: 32.3;GAMG: 22.9;RPTEC TERT1: 39.6;U-2197: 36.8;U-87 MG: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068462			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA068462: "	"unprognostic (8.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.17e-3)"	"unprognostic (9.78e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.02e-2)"	19.4	12.5	20.3	8.8	15.7	11.1	7.4	4.8	18.3	18.0	0.7	4.7	3.5	7.0	5.4	31.2	11.8	16.1	35.8	16.3	11.5	6.0	2.8	11.7	7.6	6.3	11.2	57.0	7.9	11.4	3.0	38.8	7.6	31.8	2.5	2.5	6.8	9.8	5.8	4.8	4.7	12.3	6.7	8.7	6.9	2.8	8.9	11.7	86.7	11.0	8.8	23.4	8.1	10.7	2.1	57.8	0.5	0.0	9.3	2.1	7.9	1.4	32.3	0.3	0.3	3.1	1.0	0.0	0.3	0.0	22.9	0.7	0.0	0.0	0.4	7.5	0.4	0.2	16.2	1.9	4.1	0.0	0.1	0.9	1.6	0.7	0.3	0.4	11.6	0.2	0.0	0.1	0.1	2.6	2.9	0.2	0.3	8.3	1.7	0.3	0.1	0.0	39.6	1.6	0.2	0.3	17.2	6.9	2.4	1.5	0.1	0.4	1.0	1.1	1.3	36.8	0.9	0.3	0.0	0.0	26.0	3.4	11.4	0.1	2.9	24.9	5.6	0.1	0.6	44.5	25.7	8.5	2.8	15.9	44.6	11.6	15.6	8.4	0.4	4.2	62.6	11.7	20.3	15.7	4.8	18.3	16.3	11.5	6.3	11.2	7.6	6.7	8.9	10.7	33.3	3.2	1.1	494.3	27.3	4.5	7.4	0.2	0.6	0.3	4.1	0.8	45.8	0.0	0.9	12.9	10.4	1.9	6.2	0.0	1.9	5.7	6.9	7.5	1.2	38.5	3.0	3.2	144.4	1.7	14.6	20.9	2.0	2.0	0.0	214.1	26.7	0.2	15.8	18.5	76.5	0.0	16.2	27.4	6.5	7.4	5.3	14.1	12.4	224.9	3.5	1.0	6.2	355.9	4.6	3.1	0.0	12.0	21.3	21.8	0.0	0.1	1.5	1.0	6.6	2.1	12.0	0.7	0.1	0.5	3.1	8.3	9.6	77.0	0.1	2.8
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 130.9;dendritic cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	21.4	19.9	23.4	89.1	26.2	50.6	19.4	26.5	26.7	26.8	18.2	33.6	36.7	22.4	8.0	98.5	20.0	22.9	29.3	22.5	23.9	21.3	48.8	32.0	169.3	31.0	29.8	19.0	17.2	15.8	21.1	17.6	31.6	24.8	19.5	6.9	31.6	14.1	14.8	36.7	59.9	18.7	29.1	127.9	30.0	19.2	28.2	68.5	19.5	15.8	106.3	33.0	32.8	28.4	62.2	85.6	41.2	68.1	38.5	29.2	35.3	40.7	38.8	75.7	53.6	78.9	56.0	275.7	52.6	37.0	70.2	62.9	87.2	82.1	21.2	134.7	107.8	233.8	29.5	80.2	53.3	123.6	285.1	41.7	39.6	54.0	48.1	37.9	58.1	127.5	68.7	93.1	45.7	104.6	89.7	72.7	51.2	55.7	60.6	98.0	35.4	201.9	34.9	135.6	68.1	47.2	52.8	109.5	72.3	26.2	75.5	179.5	50.7	91.1	47.8	72.5	71.7	49.6	108.7	283.8	47.1	232.5	63.1	88.7	68.0	176.1	74.3	146.8	63.4	95.6	63.6	73.9	76.6	113.6	48.3	57.0	130.8	58.6	169.8	44.3	106.2	79.5	23.4	26.2	26.5	26.7	22.5	23.9	31.0	29.8	31.6	29.1	28.2	28.4	21.3	3.2	9.2	8.5	130.9	9.3	8.2	7.6	13.1	16.6	16.7	17.1	11.5	12.8	9.3	9.2	6.2	7.5	99.1	40.6	1.9	9.3	15.8	10.0	15.1	15.3	9.5	29.2	5.3	14.0	13.7	11.3	27.0	15.3	26.6	19.0	12.5	34.3	50.7	28.6	10.0	23.2	6.1	91.2	44.9	3.3	9.0	85.1	8.8	23.4	86.9	6.4	90.6	3.5	4.7	21.2	18.4	8.2	56.7	13.9	27.5	8.0	9.3	5.1	6.6	6.9	18.1	5.7	12.5	49.4	9.1	5.6	90.3	21.5	27.5	14.9
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492982-149551471	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 847.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB016680: AB_1614518, HPA051334: AB_2681446"	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	77.0	67.6	49.0	67.3	53.9	210.8	97.8	60.0	52.7	67.9	61.5	83.2	56.6	73.7	60.2	142.4	56.6	79.7	87.6	48.6	55.9	50.3	68.2	69.6	60.0	61.3	56.4	53.2	55.0	99.4	48.8	71.7	56.6	88.3	68.2	57.6	71.3	69.2	104.1	121.4	63.1	82.9	57.9	60.7	73.5	45.6	57.8	81.0	76.9	59.5	81.8	94.8	82.3	66.3	154.4	106.4	151.0	144.1	143.6	191.4	185.0	189.7	176.8	146.0	153.5	194.1	187.0	71.6	221.3	183.3	140.7	153.9	101.2	292.5	184.1	124.6	78.0	96.9	96.6	87.8	143.1	163.9	148.4	158.5	313.4	148.1	269.0	163.9	184.7	137.2	102.2	116.0	140.7	104.4	152.2	66.6	71.4	167.6	247.3	129.0	96.1	98.9	112.3	248.3	123.5	110.5	151.1	193.3	200.8	135.6	194.1	134.4	164.6	168.6	83.6	118.2	197.1	117.0	149.2	100.6	169.2	95.6	216.9	106.0	72.6	66.6	47.5	68.9	51.6	50.2	58.1	49.7	80.0	39.9	61.4	55.2	61.1	63.7	67.8	47.4	76.7	94.7	49.0	53.9	60.0	52.7	48.6	55.9	61.3	56.4	56.6	57.9	57.8	66.3	169.7	147.4	176.7	137.1	101.8	684.5	583.1	270.0	187.8	135.8	257.0	158.4	63.5	90.1	298.1	115.8	64.6	171.2	135.6	126.8	92.0	167.1	95.7	195.8	193.5	191.1	129.9	146.7	108.4	184.1	223.7	159.8	124.4	285.2	117.6	114.0	216.4	108.9	136.1	151.4	115.4	141.9	154.6	167.8	311.5	87.5	104.1	183.8	152.9	119.0	156.6	156.9	108.1	168.4	198.1	197.2	113.9	111.7	105.4	368.6	120.4	102.8	276.7	109.6	157.8	190.2	216.1	181.9	88.9	272.4	847.7	350.9	133.5	177.0	115.7	485.2
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 280.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (2.32e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.95e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (2.08e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.16e-3)"	"prognostic unfavorable (4.67e-6)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.25e-3)"	87.1	52.8	81.1	41.2	82.6	51.6	88.3	80.8	95.1	93.6	66.0	73.0	41.4	82.7	52.5	69.0	83.3	48.7	80.9	82.9	73.7	70.2	37.4	92.2	40.3	78.9	78.6	109.5	64.9	74.1	85.1	71.2	79.5	80.3	35.5	47.3	71.6	44.9	60.5	94.8	50.9	45.3	70.2	63.6	58.0	29.5	83.2	33.3	64.4	47.2	37.8	65.7	88.4	93.9	101.5	57.4	121.6	114.7	61.5	88.3	92.1	126.9	168.6	116.7	114.3	63.9	76.7	74.2	53.0	120.7	70.7	77.9	96.1	177.9	79.2	123.0	215.2	23.9	181.2	47.4	123.7	48.3	61.9	90.2	143.8	171.7	220.3	141.0	121.1	60.6	50.9	155.0	110.8	68.4	71.1	60.9	87.2	67.3	69.1	130.8	90.1	123.4	99.0	92.4	181.6	69.3	102.9	109.3	124.7	68.0	59.5	73.0	134.3	94.0	111.3	58.7	102.1	61.2	105.2	104.5	151.0	56.9	176.3	4.8	1.6	3.6	3.0	0.8	3.8	2.1	3.4	3.0	1.8	3.1	1.9	2.5	3.8	5.7	0.5	15.9	1.6	1.2	81.1	82.6	80.8	95.1	82.9	73.7	78.9	78.6	79.5	70.2	83.2	93.9	73.4	38.5	21.7	0.0	32.3	78.6	158.8	89.1	68.9	132.6	53.7	42.4	49.8	34.3	73.9	23.9	60.5	35.2	42.3	28.4	7.9	30.8	46.0	94.3	72.5	76.4	62.8	12.6	0.0	41.8	49.2	60.8	39.8	126.5	3.8	46.6	45.0	21.3	23.1	72.3	0.0	46.0	46.8	17.6	54.1	69.1	85.4	21.8	60.5	0.0	13.3	117.9	28.8	0.0	0.0	57.5	33.1	66.2	83.5	160.5	9.0	6.5	62.8	60.7	72.3	85.7	98.0	8.0	20.0	50.3	104.7	125.5	26.0	34.9	37.6	280.8
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66012008-66013505	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"skin 1: 761.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Club cells: 115.2;Pancreatic endocrine cells: 368.1;Respiratory ciliated cells: 404.0"	"Group enriched"	"Detected in many"	5	"thyroid cancer: 171.0;urothelial cancer: 43.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 130.2;CAPAN-2: 364.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		82000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: AB_2679158"	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	3.2	0.3	0.1	0.3	0.1	0.2	28.5	0.8	0.4	7.4	0.8	0.4	0.0	0.3	0.6	34.6	14.9	0.5	2.8	0.1	0.3	2.6	0.3	18.3	0.0	0.2	0.2	0.7	0.7	2.1	1.6	8.1	0.1	0.9	0.0	0.0	7.4	4.9	2.0	761.4	0.3	0.1	0.1	0.2	0.6	1.8	0.4	2.7	21.4	0.0	2.2	1.2	22.5	0.2	130.2	0.0	0.0	0.6	0.0	0.0	37.6	1.4	0.0	0.3	0.2	1.0	364.6	0.0	1.8	5.1	0.1	4.5	0.0	32.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.6	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.8	0.2	0.7	0.0	0.0	35.8	0.4	0.1	0.8	0.1	0.0	0.2	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.4	0.1	0.3	0.2	0.2	0.1	0.1	0.4	0.2	0.1	93.0	6.1	0.0	0.6	1.1	1.7	41.4	0.6	0.0	5.3	7.1	1.2	0.0	115.2	58.8	0.0	33.3	0.0	0.1	0.0	57.4	0.2	7.7	0.1	0.9	0.0	0.0	0.0	21.6	24.4	2.0	0.0	0.6	21.6	0.1	0.4	0.1	41.1	0.0	0.0	0.0	24.4	1.4	10.0	0.8	0.0	5.3	5.4	0.0	1.1	1.3	0.0	0.0	0.0	368.1	1.1	0.4	9.8	1.9	0.0	0.5	404.0	0.1	0.0	0.3	16.0	5.2	17.6	1.0	27.6	64.2	0.7	0.0	0.4	6.1
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325248-122341969	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5912.9;vagina: 1853.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2493.8;Club cells: 768.0;Kupffer cells: 579.4;monocytes: 1298.6;Squamous epithelial cells: 3020.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 227.7;head and neck cancer: 405.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 514.7;intermediate monocyte: 269.1;myeloid DC: 382.9;neutrophil: 245.6;non-classical monocyte: 161.7"	"Group enriched"	"Detected in all"	193	"dendritic cells: 382.9;granulocytes: 245.6;monocytes: 514.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 282.0;hTCEpi: 1218.6;THP-1: 789.0;U-698: 504.5;U-937: 250.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		28000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favorable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	30.7	4.7	0.8	27.1	0.9	297.8	56.3	1.0	3.7	961.0	1.4	3.8	1.1	2.2	10.3	5912.9	4.6	7.2	5.9	0.8	1.0	2.4	38.9	26.0	25.1	1.5	0.9	21.1	3.7	0.8	5.0	19.0	1.3	19.7	3.6	0.3	996.1	9.6	4.6	369.1	5.8	6.3	1.1	20.4	30.3	1.3	1.4	46.5	2.7	2.8	941.0	39.1	1853.3	1.6	14.6	1.3	0.2	3.2	31.5	58.0	2.9	0.6	0.8	0.0	0.0	0.0	0.0	3.2	7.6	5.9	0.5	86.9	0.0	282.0	0.0	0.3	0.2	0.7	0.0	6.8	6.8	117.6	1.9	30.5	1218.6	2.9	119.1	0.0	0.0	1.5	0.8	29.9	0.5	0.8	0.2	108.3	0.0	0.5	0.0	0.0	0.9	0.0	0.0	141.3	0.0	0.0	14.1	7.5	10.4	0.1	1.6	789.0	0.5	1.7	19.7	0.2	0.9	0.0	1.7	504.5	26.4	250.3	0.3	8.8	514.7	16.4	0.6	269.1	1.5	1.5	0.7	0.6	382.9	0.5	0.5	0.7	245.6	1.9	161.7	6.9	1.0	283.2	0.8	0.9	1.0	3.7	0.8	1.0	1.5	0.9	1.3	1.1	1.4	1.6	1.1	6.4	19.8	0.0	5.0	83.5	136.5	2493.8	117.8	0.0	7.1	119.8	0.2	2.8	768.0	0.0	0.0	230.6	7.4	3.9	0.0	2.1	0.4	0.3	0.4	3.0	0.0	3.8	0.1	22.1	17.8	13.6	12.8	0.3	13.9	0.1	6.1	96.0	134.5	0.0	0.1	0.5	179.0	579.4	90.6	2.4	10.2	243.7	8.8	0.0	1298.6	0.0	20.6	0.5	0.2	46.2	1.5	3.8	2.8	30.2	0.0	0.7	115.7	0.0	32.9	8.8	24.3	0.1	0.5	3020.6	205.0	334.2	4.9	26.1	2.0	134.1
CTCFL	"BORIS, CT27, dJ579F20.2"	ENSG00000124092	"CCCTC-binding factor like"	Q8NI51	20	57495966-57525652	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 11.0"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 61.3;Spermatogonia: 143.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HMC-1: 79.6;K-562: 116.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001472	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001472: AB_1078583"	"unprognostic (2.50e-1)"	"unprognostic (4.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.85e-5)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.00e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.75e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.84e-2)"		0.1	0.2	0.4	0.2	0.5	1.0	0.2	1.2	0.6	0.0	0.1	0.1	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.5	0.2	0.4	0.2	0.4	0.1	0.0	0.2	0.5	0.1	0.2	0.3	0.1	0.2	0.2	0.9	0.1	0.1	0.2	0.5	0.3	0.1	0.0	0.3	0.2	11.0	0.3	0.1	0.4	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.4	0.2	0.1	0.3	0.4	0.2	0.1	0.0	0.4	0.2	0.3	0.7	0.1	0.2	0.2	79.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	116.1	0.6	0.0	0.1	0.3	0.4	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.3	0.3	0.3	0.1	0.2	0.3	0.4	0.2	0.1	0.5	0.3	0.2	0.3	0.1	0.3	0.1	2.9	0.3	0.3	0.4	0.5	0.1	0.3	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.1	0.9	0.2	0.2	0.2	0.1	0.0	0.4	0.5	1.2	0.6	0.4	0.5	0.1	0.0	0.1	0.0	0.3	2.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	3.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.0	0.0	6.6	0.1	0.2	61.3	143.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 177.7;skin 1: 434.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 185.7;Suprabasal keratinocytes: 291.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 13.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067089	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA		35000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"	"Nucleoli, Vesicles"	"HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	34.4	11.1	29.7	11.2	28.2	22.4	35.2	37.3	31.2	59.2	13.1	15.0	18.8	11.8	77.4	177.7	12.5	10.3	43.8	29.5	30.0	17.6	15.7	26.4	8.7	33.8	29.0	14.6	35.9	10.9	19.7	28.2	36.4	24.5	10.2	27.5	53.1	14.1	39.0	434.9	14.9	10.9	27.1	9.3	22.8	27.0	37.5	19.6	21.0	22.3	25.1	13.3	85.1	27.3	74.8	10.9	65.9	50.4	9.8	16.2	21.1	14.4	25.2	20.9	13.3	5.4	92.6	22.9	41.0	18.7	21.6	37.3	7.7	85.9	9.6	58.0	11.9	14.9	3.4	69.3	20.3	11.3	8.4	18.2	83.5	26.7	27.0	17.7	57.2	42.4	26.8	10.5	13.0	45.6	25.3	41.6	35.0	60.0	18.7	28.4	19.3	14.7	10.7	25.2	72.1	45.4	32.9	29.4	44.4	22.3	36.3	27.2	37.7	13.4	16.4	20.4	32.2	22.9	32.5	27.0	5.0	56.6	54.5	2.6	5.2	13.8	2.6	1.8	1.6	1.7	1.3	2.1	6.4	1.5	1.3	1.2	3.7	8.6	1.2	2.0	1.3	2.6	29.7	28.2	37.3	31.2	29.5	30.0	33.8	29.0	36.4	27.1	37.5	27.3	150.6	28.9	13.9	30.0	9.6	103.1	42.3	16.1	40.5	9.0	39.9	33.3	14.0	24.3	17.0	18.4	8.4	71.3	23.5	20.5	33.2	20.9	116.3	20.0	17.9	42.7	49.1	20.0	18.0	18.7	43.2	15.7	30.1	38.5	0.0	27.2	20.0	25.6	58.0	16.8	14.1	37.5	12.2	43.0	97.4	34.8	14.9	38.3	48.0	12.2	33.6	185.7	71.1	17.1	24.1	37.6	28.3	23.0	13.3	53.5	28.6	30.5	5.2	12.8	46.0	15.0	24.5	72.1	43.6	154.0	291.5	48.4	17.2	14.3	28.6	60.5
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 372.9;granulocytes: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 308.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	26.9	16.8	20.9	27.3	22.8	41.8	23.8	21.6	24.8	23.7	23.4	31.8	21.7	27.7	31.1	23.4	25.3	19.8	32.3	22.0	22.4	22.9	46.8	25.3	39.3	22.8	22.3	27.1	17.3	19.7	18.2	22.1	21.7	23.4	23.1	18.8	18.5	30.6	33.3	25.3	25.1	30.6	21.6	54.0	34.8	43.3	22.1	40.1	17.1	20.9	41.2	25.8	20.4	23.6	66.7	60.3	56.7	44.6	40.3	32.8	89.2	41.9	43.7	98.0	86.0	224.8	52.4	73.9	59.6	42.7	94.4	69.8	77.1	98.6	105.3	36.1	38.0	243.0	33.2	110.2	41.8	77.4	308.0	35.1	58.9	55.6	54.8	34.1	59.8	103.8	66.8	29.6	53.5	54.9	127.0	101.4	51.4	74.9	85.8	87.9	109.1	56.3	42.9	55.0	45.1	53.6	72.5	102.3	75.4	52.3	50.6	61.1	44.5	97.4	58.0	64.9	68.8	34.1	46.6	85.5	68.5	48.6	52.7	267.9	77.7	103.3	51.0	103.0	49.1	88.9	49.9	53.8	110.3	83.4	49.8	53.6	16.9	79.9	109.6	86.9	66.2	71.3	20.9	22.8	21.6	24.8	22.0	22.4	22.8	22.3	21.7	21.6	22.1	23.6	28.6	28.9	26.4	21.2	40.0	22.8	32.9	40.7	13.1	26.1	13.0	13.2	39.8	17.2	34.1	18.4	18.8	147.8	40.4	21.1	37.2	34.8	372.9	24.2	24.9	32.5	20.9	43.7	31.6	34.7	69.4	28.7	48.4	21.6	263.6	34.4	44.3	45.2	49.3	18.5	35.6	27.3	42.7	36.0	35.5	131.2	34.2	44.5	26.6	14.0	89.8	32.1	40.2	30.7	39.8	31.9	21.5	33.4	21.6	22.3	34.7	43.1	26.1	25.8	19.7	25.4	48.0	79.4	45.2	10.7	22.4	52.9	38.8	23.7	24.2	20.6
CTNND2	"GT24, NPRAP"	ENSG00000169862	"Catenin delta 2"	Q9UQB3	5	10971836-11904446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 93.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2382.9;Excitatory neurons: 1253.9;Inhibitory neurons: 1124.0;Oligodendrocyte precursor cells: 1418.0;Oligodendrocytes: 433.8"	"Cancer enriched"	"Detected in many"	16	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.1;MCF7: 9.0;SK-BR-3: 5.3;U-266/84: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015077, CAB037339, HPA071124"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"CAB037339: , HPA015077: AB_2669150, HPA071124: "	"unprognostic (7.32e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.23e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.55e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.76e-2)"	0.2	0.7	79.2	0.2	79.3	0.0	0.9	49.7	75.7	0.1	15.2	1.1	0.1	0.1	0.3	0.1	0.2	2.6	3.8	84.6	56.7	0.0	0.5	0.7	0.1	93.8	72.6	0.5	15.8	0.0	9.0	0.3	71.5	0.9	0.3	7.0	0.8	0.2	0.1	0.7	0.5	0.1	77.7	3.9	0.6	2.6	83.7	0.2	0.2	0.1	0.0	0.1	0.2	76.1	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	9.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.0	17.5	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.2	79.3	49.7	75.7	84.6	56.7	93.8	72.6	71.5	77.7	83.7	76.1	0.1	0.0	0.0	2382.9	0.1	0.0	0.1	0.0	0.0	24.0	7.9	4.1	12.7	28.6	0.0	1.8	0.0	0.0	0.0	0.1	3.9	6.5	25.6	0.8	0.1	0.8	4.9	0.0	1253.9	6.1	0.2	0.5	0.0	0.9	0.0	0.0	0.0	0.2	0.1	8.4	1124.0	0.1	0.0	0.0	0.7	31.1	1.5	0.2	0.0	69.3	0.0	33.0	0.0	1418.0	433.8	2.2	0.0	0.0	0.0	2.8	0.0	0.4	0.0	3.6	0.0	3.3	0.3	4.6	5.9	0.0	0.0	0.0	0.1	0.5	0.3	0.1
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979688-41012565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	Yes		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol	"Actin filaments"	"CAB017111: , HPA051322: AB_2681441"	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	9.1	8.1	4.8	11.1	4.7	6.8	6.7	4.0	5.8	9.3	7.9	8.7	4.4	23.6	5.7	14.9	11.1	10.6	5.3	4.9	5.3	12.4	73.4	7.6	12.4	4.6	4.9	3.4	4.7	47.6	0.0	7.8	5.8	13.5	12.0	2.4	50.6	24.8	7.7	4.6	8.4	51.9	4.7	5.0	4.1	14.7	4.9	17.3	4.8	7.6	17.8	17.7	0.3	5.0	77.8	68.5	95.3	60.5	22.9	30.9	138.5	138.8	57.0	141.2	92.0	131.5	66.6	149.8	55.6	61.7	39.4	38.6	91.5	97.0	139.5	66.5	78.0	87.3	72.3	43.3	87.8	128.0	56.8	34.0	49.2	148.5	103.0	23.0	64.1	102.2	84.7	51.5	99.4	42.9	125.0	38.1	126.8	66.4	81.3	100.9	120.0	93.7	71.4	69.4	118.4	61.7	79.2	77.7	33.9	90.8	30.1	152.9	53.5	78.2	119.6	61.7	167.2	36.8	50.8	134.5	59.8	84.5	97.4	0.0	3.5	0.0	3.6	6.5	5.7	5.2	4.1	4.3	11.0	4.0	3.7	6.1	0.0	6.9	5.9	11.9	6.3	3.4	4.8	4.7	4.0	5.8	4.9	5.3	4.6	4.9	5.8	4.7	4.9	5.0	5.4	6.4	18.4	4.9	10.9	8.0	14.3	9.1	9.6	12.5	4.6	4.7	5.7	21.5	7.0	5.5	6.2	15.4	26.4	2.2	1.9	19.2	32.4	4.7	10.8	8.5	3.0	22.5	14.1	17.2	26.4	8.7	7.1	7.3	1.3	15.8	2.2	29.0	11.0	11.8	18.7	3.4	6.1	2.8	6.2	27.9	10.8	6.8	1.8	7.5	8.7	5.4	7.2	7.1	10.3	19.3	1.1	24.8	15.1	19.3	25.2	12.8	2.8	4.3	39.5	9.3	17.5	11.1	40.6	11.8	7.4	5.6	9.9	20.7	5.8	7.3
CTPS2		ENSG00000047230	"CTP synthase 2"	Q9NRF8	X	16587999-16712936	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017437, HPA075930"	Approved		Approved	Mitochondria,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Mitochondria, Cytosol"		"HPA017437: AB_1847326, HPA075930: "	"unprognostic (1.40e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (6.57e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.56e-4)"	5.5	7.0	5.6	4.3	7.2	6.9	10.4	7.6	6.3	9.5	6.0	8.1	12.3	10.3	6.7	5.1	9.0	6.8	4.4	5.1	6.8	6.0	7.5	6.5	6.6	8.0	6.3	13.2	9.2	12.1	4.0	6.6	8.0	9.5	9.5	9.9	7.4	7.0	4.3	7.1	10.3	7.4	6.5	4.4	8.3	2.0	6.3	6.1	6.8	4.6	8.2	6.2	6.2	9.4	13.7	12.6	20.3	16.9	10.1	7.6	0.2	7.3	6.2	12.1	11.0	13.0	14.2	0.4	23.2	7.9	11.0	11.0	28.9	13.9	14.3	0.1	18.9	7.9	17.0	19.2	5.3	5.7	0.2	8.4	4.7	11.3	9.5	13.6	16.5	0.3	11.1	0.5	11.2	18.9	0.2	4.6	34.7	5.2	14.6	0.3	11.6	4.4	13.3	15.5	12.5	22.8	23.5	1.8	14.2	21.9	32.8	16.2	10.3	6.2	3.3	16.5	6.6	0.3	0.2	45.6	5.0	4.9	7.0	0.1	0.6	0.5	0.4	0.3	0.9	0.6	0.8	0.5	1.3	0.5	0.6	0.6	0.0	1.7	2.7	0.9	0.9	0.6	5.6	7.2	7.6	6.3	5.1	6.8	8.0	6.3	8.0	6.5	6.3	9.4	6.7	9.6	6.7	13.4	3.4	3.2	6.0	4.8	4.6	5.4	8.0	6.5	6.0	8.6	8.9	5.5	0.0	3.5	4.4	5.5	3.9	9.8	4.0	7.2	6.4	5.4	11.3	3.8	10.4	9.4	7.9	5.9	6.1	9.0	6.3	9.1	6.8	7.9	5.3	6.7	18.2	7.5	4.1	4.4	2.7	8.6	9.0	3.3	8.8	24.4	6.0	4.4	1.0	26.2	35.5	11.3	9.0	4.1	4.0	3.9	19.2	3.0	6.1	5.1	6.6	4.1	6.6	0.1	0.3	3.7	3.8	1.5	2.7	4.3	8.8	5.8
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 349.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8"	"Group enriched"	"Detected in all"	5	"B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		8700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	34.3	36.4	29.4	100.6	30.2	36.9	48.8	29.9	47.1	112.8	31.4	32.5	77.8	46.7	26.8	37.9	57.6	104.6	51.3	29.6	32.9	238.2	89.5	349.6	191.8	30.8	31.4	30.0	75.5	77.6	10.1	25.7	31.5	59.7	27.3	4.7	63.0	70.7	16.3	48.4	56.7	43.1	30.7	51.8	93.9	10.1	32.7	51.8	27.7	37.7	131.3	202.2	30.6	32.4	122.0	10.0	1.2	30.5	5.4	0.5	20.3	8.6	3.0	13.9	7.0	17.6	306.4	34.6	12.6	0.0	13.5	228.2	5.2	52.6	10.1	183.0	0.4	3.0	1.3	38.4	12.1	0.4	7.1	5.6	10.7	0.2	0.0	59.4	1.0	5.9	76.0	0.0	17.9	2.8	32.6	87.8	8.9	197.4	4.9	0.3	0.4	5.9	49.9	362.1	2.6	5.2	41.5	27.8	75.4	10.1	12.5	48.0	16.4	0.2	6.2	0.0	5.3	0.8	92.4	19.5	0.1	89.2	12.3	0.0	208.5	2.0	7.6	137.7	29.7	83.3	20.5	7.4	183.6	56.0	1.8	3.8	8.7	3.2	94.8	22.9	18.3	147.5	29.4	30.2	29.9	47.1	29.6	32.9	30.8	31.4	31.5	30.7	32.7	32.4	169.8	237.2	1569.9	59.1	127.4	24.2	280.7	363.9	30.1	1.3	45.5	41.7	26.2	358.9	258.7	367.8	4.2	19.8	8.1	9.1	84.1	225.0	25.3	67.0	86.0	124.5	9.1	3.0	2.2	142.0	39.6	53.8	106.0	42.8	32.8	2.7	14.3	115.5	256.7	0.0	2.9	18.6	101.7	177.8	259.6	22.6	73.0	350.4	80.0	15.9	360.9	22.6	5.2	1.5	1.1	84.6	16.0	6.0	155.8	112.0	153.0	523.2	261.6	6.6	19.7	4.5	22.3	12.3	56.4	41.6	18.6	23.4	29.4	17.8	40.1	340.4
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029677-97156556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 643.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 63.7;Cytotrophoblasts: 122.3;Extravillous trophoblasts: 153.0;Granulosa cells: 54.2;Syncytiotrophoblasts: 67.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.1"	"Group enriched"	"Detected in many"	8	"BEWO: 592.6;SuSa: 739.0"					"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.2	0.2	0.6	0.3	0.7	0.3	5.8	0.8	1.6	43.1	0.8	2.9	1.1	2.8	1.7	19.8	1.3	0.5	0.1	0.6	0.5	21.3	0.2	0.9	0.1	0.7	0.6	0.2	2.1	1.4	1.5	16.8	0.6	0.7	3.2	17.2	9.4	0.1	0.7	52.5	0.4	0.8	0.5	0.2	2.8	65.8	0.6	643.6	1.3	0.1	6.0	0.4	20.1	1.0	37.1	5.2	12.1	33.1	0.6	0.0	592.6	0.5	0.0	7.1	4.7	81.0	37.7	0.3	2.8	0.5	50.5	67.2	58.8	43.9	9.7	0.1	4.4	0.8	1.9	3.1	0.2	0.1	3.3	0.0	9.2	1.5	0.8	0.9	2.4	8.5	0.5	0.2	14.4	15.2	0.9	0.3	76.2	78.9	10.7	0.0	27.3	0.1	11.4	3.7	2.4	3.6	39.1	13.1	13.2	739.0	21.1	3.2	0.0	1.0	23.6	0.2	3.5	5.7	20.6	0.8	1.6	0.4	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.2	3.3	0.0	15.1	0.0	0.1	0.6	0.7	0.8	1.6	0.6	0.5	0.7	0.6	0.6	0.5	0.6	1.0	0.9	0.0	1.1	0.3	0.9	30.3	13.0	63.7	19.9	4.6	13.1	9.9	1.3	0.0	17.4	1.8	10.4	122.3	6.9	4.7	1.9	1.8	2.6	15.0	2.9	1.8	1.8	0.0	0.6	0.8	153.0	3.2	0.0	24.0	0.0	54.2	0.4	0.0	13.6	0.0	0.9	1.5	10.2	0.8	3.0	8.2	4.1	2.4	0.0	0.0	0.2	6.5	0.0	0.0	3.5	0.5	10.5	1.2	0.0	8.1	0.1	22.1	4.2	36.6	6.6	1.4	3.6	46.7	33.7	8.2	11.9	67.3	0.5	0.7	4.2	8.4
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.2;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 450.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA		11000000	"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: AB_2683379"	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (2.19e-6)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	91.7	142.5	28.3	15.6	30.0	4.9	82.9	29.7	32.3	112.3	28.5	84.9	28.4	117.8	18.7	131.6	85.0	35.1	106.9	27.7	28.2	109.6	66.9	74.8	9.0	33.2	30.8	112.9	79.5	18.1	94.1	23.9	30.9	101.6	23.8	8.4	92.9	27.0	65.7	104.4	70.9	31.8	29.5	53.3	92.2	62.0	30.3	8.7	89.5	14.5	12.7	88.1	101.2	32.5	450.2	97.2	32.0	37.2	53.2	81.9	52.5	93.8	92.5	80.7	63.4	129.5	110.3	17.5	90.6	121.1	86.3	97.3	38.6	98.7	58.7	35.5	39.1	1.7	73.6	61.1	113.9	0.4	22.6	116.6	68.0	89.4	50.2	84.4	68.8	0.5	51.3	3.3	80.9	122.9	0.9	6.4	35.0	163.4	58.6	0.2	39.3	14.3	90.5	143.7	26.3	44.9	68.3	93.2	158.0	57.2	75.8	1.9	86.8	70.8	45.3	111.2	63.6	7.4	5.2	1.0	141.1	0.4	98.9	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.1	0.4	0.0	6.8	28.3	30.0	29.7	32.3	27.7	28.2	33.2	30.8	30.9	29.5	30.3	32.5	95.3	44.8	51.8	61.7	4.0	151.9	102.8	85.8	46.1	39.4	81.0	57.9	64.1	80.1	95.4	134.3	18.8	83.8	1.6	224.4	64.6	146.5	12.4	86.4	84.8	89.9	74.4	18.9	93.4	221.5	95.6	89.1	76.0	116.1	6.3	117.7	78.9	44.1	10.4	38.7	65.4	123.8	57.0	8.9	34.1	26.1	103.2	38.6	122.7	28.1	5.9	42.5	0.0	40.2	145.8	260.6	177.8	98.9	3.1	153.5	108.4	164.3	89.4	32.5	59.2	61.0	87.5	32.0	47.0	76.7	174.9	106.3	5.4	91.4	111.9	258.1
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 128.8;granulocytes: 139.9;Inhibitory neurons: 194.9;Oligodendrocyte precursor cells: 428.8;Oligodendrocytes: 444.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"non-classical monocyte: 7.7"	"Lineage enriched"	"Detected in single"	26	"monocytes: 7.7"	"Group enriched"	"Detected in some"	6	"HEL: 57.6;HMC-1: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: AB_2679037"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	6.9	1.8	11.4	0.7	16.7	0.0	3.8	13.0	14.7	5.7	6.8	2.4	1.6	10.6	4.8	12.1	6.0	3.5	1.8	12.7	14.8	6.4	1.8	1.8	0.2	15.7	14.7	3.1	7.8	9.3	2.9	1.7	16.3	3.4	2.4	7.9	3.4	1.8	0.5	1.8	2.4	5.2	11.9	2.2	1.3	1.0	15.1	0.7	5.5	0.9	0.9	4.2	4.2	26.1	0.0	0.9	1.6	0.0	0.0	0.0	1.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.1	8.3	0.0	0.0	0.0	2.5	57.6	0.5	0.0	0.2	0.0	74.1	0.3	0.4	0.0	0.0	1.0	1.6	0.0	0.0	0.1	1.1	0.0	0.0	0.0	10.6	0.0	0.3	0.0	0.0	0.2	10.6	0.0	6.1	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	2.6	1.0	0.1	0.0	0.7	0.0	0.2	5.0	0.0	1.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	11.4	16.7	13.0	14.7	12.7	14.8	15.7	14.7	16.3	11.9	15.1	26.1	15.6	3.2	4.8	10.1	0.0	1.9	3.4	3.7	15.9	33.6	1.9	6.7	3.6	10.0	5.6	7.3	56.3	2.8	0.3	1.8	1.9	6.3	1.8	5.1	32.5	10.2	1.8	0.0	128.8	4.2	2.1	9.1	1.1	7.4	139.9	3.8	20.0	1.1	9.2	74.0	194.9	1.1	24.4	10.1	12.3	3.3	0.9	8.0	7.2	75.9	1.3	97.2	0.0	428.8	444.2	0.6	2.1	1.2	0.3	2.1	0.3	24.3	1.4	6.6	0.0	3.3	9.6	0.6	2.1	38.8	0.3	1.1	2.7	0.2	6.8	1.4
CTTNBP2NL	DKFZp547A023	ENSG00000143079	"CTTNBP2 N-terminal like"	Q9P2B4	1	112396214-112463456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007301	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center, Cytosol"		"HPA007301: AB_1847693"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.21e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (8.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (5.12e-2)"	14.5	4.8	5.6	10.3	4.6	0.5	11.3	4.4	6.1	11.8	3.1	15.5	7.5	15.2	4.7	19.5	8.4	16.5	6.3	4.4	7.6	9.1	5.6	13.0	6.2	7.3	6.6	9.4	4.6	7.4	3.5	20.2	7.1	8.9	14.8	8.2	7.0	9.2	3.0	15.4	10.5	13.5	5.7	10.6	8.6	5.8	5.9	4.3	8.3	6.9	8.2	15.6	11.8	7.6	21.8	7.9	25.7	12.2	17.0	22.3	8.6	33.6	31.4	21.4	21.1	6.1	10.7	3.4	13.2	25.4	10.5	17.4	16.9	23.2	24.9	7.1	8.1	4.6	13.1	4.9	19.7	1.6	7.8	26.4	14.0	26.5	23.0	24.5	52.7	5.7	4.2	3.0	29.9	6.4	3.0	0.6	16.6	6.1	12.3	5.3	24.0	0.0	32.6	15.9	12.6	13.2	26.0	5.3	13.3	24.5	4.3	1.8	68.5	21.3	24.9	22.0	15.8	0.4	3.1	0.1	22.1	2.0	57.0	0.0	2.6	0.0	0.0	2.1	0.0	0.1	0.0	0.0	8.6	0.3	0.0	0.0	0.1	0.0	0.4	3.7	2.0	0.4	5.6	4.6	4.4	6.1	4.4	7.6	7.3	6.6	7.1	5.7	5.9	7.6	100.4	57.7	22.4	17.6	4.4	38.7	30.2	32.0	24.5	10.2	12.3	9.5	9.7	7.2	41.4	22.0	6.2	17.6	4.6	64.0	3.9	39.1	3.3	29.1	30.7	71.6	8.3	3.6	44.1	21.6	12.8	24.2	14.8	58.5	19.0	17.8	41.7	1.6	13.5	5.0	31.2	27.4	30.5	29.7	131.7	4.0	10.5	40.8	16.0	81.5	30.5	11.0	0.0	30.2	25.1	47.7	52.7	11.3	0.7	25.4	21.7	22.6	17.5	7.9	19.7	20.1	29.2	16.8	16.7	25.0	60.7	25.4	2.7	9.1	24.4	69.3
CU639417.1		ENSG00000274559	"Histone H2B type F-S-like"		21	5972924-5973383	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;Intestinal goblet cells: 1.4;Paneth cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;T-47d: 2.2;U-2 OS: 1.6;U-266/70: 1.2;U-266/84: 2.2"									"HPA042205, HPA043013, HPA048671"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"										"unprognostic (3.37e-2)"				"unprognostic (2.63e-1)"				0.5	0.3	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.6	0.0	0.4	0.1	0.5	0.5	0.6	0.3	1.3	0.4	0.0	0.1	0.7	0.9	0.5	0.7	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.1	0.4	0.4	0.0	0.0	0.6	0.4	0.5	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.2	0.4	0.0	0.0	0.4	0.4	0.0	0.2	0.6	0.0	0.5	0.3	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	1.1	0.3	0.0	0.4	0.1	0.0	0.4	0.1	0.0	2.2	0.0	0.0	0.0	1.6	0.1	0.2	1.2	2.2	0.2	0.3	0.4	0.4	0.6	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0
CUEDC1		ENSG00000180891	"CUE domain containing 1"	Q9NWM3	17	57861243-57955412	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Oligodendrocytes: 117.9;Rod photoreceptor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 21.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 21.7"	"Cell line enhanced"	"Detected in many"		"T-47d: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023050, HPA024836"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Centrosome	"HPA023050: AB_1847332, HPA024836: AB_1847333"	"unprognostic (4.46e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.77e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.04e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-2)"	20.5	19.2	19.1	13.9	29.5	8.6	17.2	23.2	22.8	31.5	20.6	40.9	7.6	24.7	7.9	32.4	32.4	19.7	38.8	16.6	22.5	25.1	6.1	21.2	7.5	29.5	27.5	9.5	19.0	11.3	21.6	11.9	24.0	24.4	10.6	30.4	30.9	26.3	86.6	11.7	13.2	25.6	21.9	10.6	23.2	3.2	27.8	5.5	18.2	39.7	5.5	31.3	21.2	33.8	27.1	81.7	83.7	15.1	13.5	24.4	2.8	18.8	37.6	38.5	27.7	15.1	100.9	0.4	74.3	36.2	32.6	21.2	9.3	40.1	13.7	52.8	15.8	0.9	58.4	12.6	32.1	0.3	6.3	25.2	23.7	22.5	18.9	33.8	18.8	0.5	1.1	0.4	35.8	15.2	1.4	0.6	2.9	30.7	22.5	2.8	21.6	4.0	25.8	17.5	34.5	18.9	7.9	8.4	32.0	14.2	116.8	2.9	24.2	101.9	63.4	28.2	42.4	0.0	0.4	0.4	44.3	3.7	83.3	0.7	0.5	2.5	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.2	1.9	21.7	0.0	0.2	19.1	29.5	23.2	22.8	16.6	22.5	29.5	27.5	24.0	21.9	27.8	33.8	14.1	19.2	5.9	22.5	0.9	4.1	15.6	6.5	13.1	47.1	11.5	11.6	16.1	17.2	10.4	22.0	64.6	0.7	30.9	6.2	7.9	20.3	0.4	24.6	6.3	10.7	3.5	0.0	4.8	26.3	0.4	15.8	10.2	22.9	0.0	10.0	3.9	3.4	17.3	10.1	13.0	4.5	18.3	11.3	7.3	2.9	6.8	12.9	5.4	30.9	4.3	31.8	0.0	31.2	117.9	27.7	2.1	5.3	0.1	21.8	0.7	8.6	17.6	64.8	6.6	26.6	15.3	0.0	1.3	19.0	2.4	0.7	0.7	1.6	4.2	17.3
CUL5	VACM-1	ENSG00000166266	"Cullin 5"	Q93034	11	108008898-108107761	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002185, CAB017787"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Cytosol"		"CAB017787: , HPA002185: AB_1078587"	"unprognostic (5.66e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (3.83e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	9.8	11.5	6.8	9.5	7.0	28.3	13.0	10.9	9.1	11.8	7.3	9.1	9.0	13.1	9.9	10.6	9.6	8.5	15.2	6.8	8.0	16.3	14.2	8.8	11.2	6.4	6.8	12.4	8.9	13.4	5.7	11.4	6.5	12.1	9.1	12.7	8.5	9.5	46.4	11.4	8.6	10.5	7.4	9.8	9.4	6.5	6.8	12.7	14.4	37.5	10.3	10.0	7.0	10.3	14.4	6.6	19.6	15.1	12.5	20.2	9.7	15.0	16.3	13.4	15.0	21.3	16.5	20.1	27.3	18.8	14.0	18.0	18.4	12.3	19.4	13.2	11.1	18.9	6.2	15.7	21.1	21.8	14.9	15.8	16.1	14.1	18.6	17.5	18.7	16.2	25.0	7.2	21.4	7.9	20.9	18.1	10.3	18.4	11.6	15.0	14.6	21.8	16.4	21.2	13.9	19.6	20.4	21.1	12.3	12.0	31.1	17.0	19.7	24.6	11.4	17.6	16.2	7.2	6.2	26.5	9.6	24.0	16.0	1.2	2.3	1.6	2.1	2.1	2.0	1.7	2.1	1.9	2.3	2.2	2.3	2.3	0.4	1.6	2.2	2.5	1.7	1.3	6.8	7.0	10.9	9.1	6.8	8.0	6.4	6.8	6.5	7.4	6.8	10.3	50.2	57.7	42.5	66.3	49.0	29.8	29.3	26.0	44.3	52.7	35.1	25.7	111.9	37.1	39.2	31.3	66.7	37.6	49.2	21.8	50.9	29.6	6.0	45.4	48.7	41.3	17.6	34.3	84.9	23.5	23.6	42.6	33.1	40.9	43.1	42.8	40.0	54.8	27.1	55.5	83.8	28.7	22.4	41.6	20.3	8.0	30.7	41.2	14.2	61.8	51.7	31.5	30.9	74.4	101.7	29.1	29.0	38.0	48.4	36.6	27.9	76.7	36.6	59.4	19.7	56.0	53.1	35.5	44.0	43.9	30.3	35.8	38.8	48.0	30.3	32.9
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182184-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	53	"Early spermatids: 513.7;Late spermatids: 1508.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	2.9	3.0	3.1	4.9	4.5	6.9	2.9	1.3	3.4	3.2	3.5	3.6	4.0	3.3	1.7	5.5	4.9	3.6	2.6	3.2	2.0	3.1	2.1	3.6	6.3	2.4	2.8	4.3	4.2	5.5	2.9	2.4	2.7	3.4	2.3	3.2	3.9	4.0	2.8	8.0	4.2	2.8	1.5	4.9	4.2	5.2	2.5	7.6	5.2	2.9	4.7	3.8	2.7	2.7	8.2	6.0	3.2	7.7	8.8	5.2	4.4	3.2	5.6	5.0	4.6	1.9	3.4	6.8	6.0	5.1	4.5	5.8	2.7	6.7	2.3	8.3	2.5	7.4	6.8	3.0	5.8	4.7	11.6	7.1	13.8	4.1	3.7	4.4	7.4	11.5	3.9	8.7	4.5	7.2	9.6	6.8	0.6	15.7	3.6	13.9	2.2	6.6	3.8	8.4	5.5	7.8	4.2	5.0	7.2	2.7	8.6	10.4	6.9	12.5	8.6	3.7	6.1	8.3	8.3	5.5	3.2	8.2	5.7	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	3.1	4.5	1.3	3.4	3.2	2.0	2.4	2.8	2.7	1.5	2.5	2.7	6.6	0.0	8.2	16.3	7.5	6.4	2.7	9.3	16.5	10.2	8.0	6.1	6.9	8.6	5.9	3.7	12.5	3.4	6.5	8.8	3.9	4.2	513.7	7.5	5.5	6.8	6.0	3.4	15.8	6.2	1.7	5.3	18.8	6.4	2.5	14.6	9.3	6.4	11.6	11.8	11.9	7.9	6.1	9.6	5.0	1508.3	11.1	8.5	3.6	9.4	6.3	9.6	5.2	11.6	11.2	6.5	2.1	8.2	4.1	2.3	8.5	6.7	8.5	10.0	13.1	6.4	3.6	14.5	10.1	14.2	5.5	2.6	7.1	5.6	7.2	2.9
CWF19L2	FLJ32343	ENSG00000152404	"CWF19 like cell cycle control factor 2"	Q2TBE0	11	107326345-107457844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038166	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA038166: AB_10669518"	"unprognostic (1.38e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.76e-2)"	8.8	5.8	15.4	6.2	16.6	8.2	11.3	20.3	30.9	8.8	16.8	7.3	5.0	10.9	8.2	6.4	7.5	6.0	5.4	14.7	16.7	11.2	8.5	7.1	10.4	16.1	15.9	14.2	5.9	7.8	4.7	8.4	16.2	8.3	6.2	8.6	6.2	8.5	7.0	7.3	5.5	6.9	15.8	9.8	6.7	5.9	16.1	11.8	9.7	8.4	11.0	6.9	6.7	17.7	7.4	5.9	12.5	6.0	10.2	11.5	9.4	9.5	8.8	7.3	9.7	13.9	17.0	12.8	17.7	6.7	9.3	17.6	14.0	7.3	12.7	14.4	7.8	14.2	6.6	9.1	6.6	16.9	11.5	5.9	12.6	8.5	12.7	8.4	10.0	7.6	21.9	7.2	10.7	5.5	13.1	15.3	11.9	12.2	8.3	11.3	11.9	17.3	8.6	9.0	7.2	6.0	13.9	10.3	5.4	10.5	13.8	8.0	9.1	12.1	9.7	6.4	8.6	3.8	7.5	12.3	3.5	16.4	11.3	45.6	10.1	19.3	14.2	9.3	15.7	29.4	16.5	14.4	4.5	27.6	19.9	15.3	19.4	17.4	10.4	19.2	15.7	4.3	15.4	16.6	20.3	30.9	14.7	16.7	16.1	15.9	16.2	15.8	16.1	17.7	56.2	38.5	53.2	38.5	66.1	17.8	16.1	19.1	18.2	97.2	24.2	21.0	28.9	57.2	33.2	82.8	95.9	24.0	57.9	18.3	33.2	22.1	3.1	31.8	39.8	40.8	13.1	23.8	42.3	18.4	22.8	29.3	17.3	34.0	46.2	35.2	51.4	56.1	15.8	69.0	37.4	27.0	14.2	33.7	15.4	9.5	54.3	24.5	14.2	43.1	32.7	47.5	69.0	42.3	68.1	16.3	31.6	63.9	36.1	6.7	25.6	60.5	18.3	131.8	39.5	41.1	30.8	48.0	47.2	9.1	13.4	17.0	55.3	21.4	21.3	7.8
CXorf38	MGC39350	ENSG00000185753	"Chromosome X open reading frame 38"	Q8TB03	X	40626921-40647561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050120	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA050120: AB_2681024"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.73e-2)"	"prognostic favorable (1.44e-8)"	9.0	8.2	5.1	11.5	5.9	10.5	8.2	5.8	5.3	8.0	4.5	7.6	8.3	7.3	4.6	6.1	10.0	6.4	4.8	4.9	5.3	8.1	8.0	10.2	16.1	6.2	5.6	9.5	6.0	9.5	4.8	6.8	6.3	6.3	7.7	5.7	6.5	6.1	5.0	7.9	9.7	5.8	5.8	14.4	6.6	2.1	5.9	13.2	11.1	4.1	13.4	7.2	7.0	7.0	11.3	5.9	6.2	4.9	6.5	10.8	3.3	7.5	10.5	9.1	9.1	7.7	15.8	18.5	6.4	11.2	15.2	7.4	7.6	12.5	8.3	25.7	11.4	12.5	7.1	4.6	10.8	22.0	18.6	9.6	9.0	12.7	12.5	8.7	10.4	15.8	5.3	13.7	17.0	10.5	15.4	16.7	5.6	8.2	12.8	12.7	13.2	14.4	10.7	17.0	7.0	9.6	15.1	7.5	8.9	11.6	11.4	10.1	13.0	11.9	6.8	8.7	6.5	14.7	5.5	7.9	15.4	11.4	8.0	9.3	16.0	22.1	9.2	15.8	9.7	6.9	8.7	7.4	14.2	9.6	7.6	7.8	19.7	7.3	25.1	5.9	10.9	10.3	5.1	5.9	5.8	5.3	4.9	5.3	6.2	5.6	6.3	5.8	5.9	7.0	19.8	9.6	9.1	10.1	26.9	3.6	11.3	6.3	10.8	12.6	10.5	8.0	6.4	18.6	7.6	16.5	18.8	9.2	48.3	15.1	7.9	27.7	1.0	25.2	15.0	14.0	7.3	6.3	11.9	30.1	9.7	8.9	9.7	21.6	17.1	16.5	10.4	10.8	36.6	15.2	13.1	12.7	8.2	30.7	9.8	1.3	9.6	29.5	3.6	8.4	61.9	10.2	41.2	12.1	17.8	40.5	17.2	5.3	16.4	14.7	15.8	14.4	7.8	7.6	6.6	13.5	9.2	6.5	7.4	9.7	5.4	8.2	31.2	20.6	13.3	28.3
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424619-69466264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 318.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"		NA	NA		99000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	60.2	318.0	52.3	51.4	53.9	20.9	50.4	46.0	69.9	45.8	43.6	92.6	69.5	49.3	72.8	59.3	58.2	45.4	58.0	56.9	51.2	71.9	83.8	54.1	68.8	50.7	48.1	44.0	40.1	77.7	28.6	73.8	50.6	47.6	116.0	49.4	36.3	48.3	65.8	45.8	67.8	61.6	44.7	49.6	49.3	38.6	52.3	74.3	54.1	78.2	76.9	80.4	38.2	48.4	186.2	576.4	232.9	144.9	105.1	139.3	99.5	162.3	224.1	266.0	249.2	406.1	221.3	168.0	159.3	157.9	216.0	214.5	224.4	235.0	300.0	90.2	85.5	81.2	97.1	479.1	154.7	169.1	172.4	120.9	116.3	315.9	149.6	111.8	254.7	190.5	133.6	78.4	165.2	241.2	278.9	204.1	173.5	171.4	78.4	260.0	128.7	184.3	359.3	208.7	135.7	69.7	431.6	82.0	142.2	119.0	159.0	133.2	115.9	152.2	124.5	102.2	145.5	94.7	227.0	516.6	157.0	138.0	180.0	121.1	57.6	71.5	103.8	80.0	85.0	68.8	76.9	81.8	69.8	63.1	62.8	75.5	17.1	96.4	59.7	124.2	134.6	105.6	52.3	53.9	46.0	69.9	56.9	51.2	50.7	48.1	50.6	44.7	52.3	48.4	36.2	44.8	46.8	44.7	47.2	49.8	49.2	84.0	66.0	22.8	28.6	26.0	25.0	30.0	51.4	62.5	6.2	159.8	66.7	112.7	78.2	66.2	18.8	56.4	33.3	61.7	23.4	38.7	40.9	70.4	94.1	38.4	27.5	87.7	60.2	36.6	43.9	54.9	64.8	30.3	30.4	76.6	83.4	30.1	57.5	22.7	44.4	33.4	62.2	24.4	55.8	63.0	96.8	23.6	39.4	70.5	78.8	44.4	28.1	34.9	75.9	62.9	49.5	31.6	46.0	22.2	36.5	48.1	46.6	44.9	42.3	59.8	54.1	84.8	61.6	50.4
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961873-202967275	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 605.2"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 187.2;Extravillous trophoblasts: 196.5;Syncytiotrophoblasts: 293.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 187.3;hTCEpi: 188.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	38.6	57.3	37.4	23.0	38.8	19.7	43.7	41.1	40.5	49.7	57.3	35.7	19.3	41.2	131.4	61.6	68.2	27.2	154.8	38.3	48.0	64.5	50.2	44.0	25.2	45.4	49.4	41.7	45.1	82.9	46.1	66.6	55.7	41.1	21.2	34.3	56.9	40.0	605.2	123.8	25.7	37.5	39.9	39.1	92.8	50.7	41.4	40.1	40.5	308.0	38.8	52.7	45.8	43.6	34.8	21.3	18.3	37.7	166.0	37.9	178.5	68.3	63.4	43.2	38.4	17.5	39.9	21.5	56.5	68.1	24.0	187.3	14.9	58.0	28.2	31.2	37.8	12.4	24.0	20.4	59.7	10.5	29.6	61.2	188.3	47.5	25.8	36.4	28.9	25.8	37.0	37.6	157.8	40.4	13.6	9.5	12.1	31.0	40.1	21.9	87.6	45.7	41.1	40.8	15.7	19.1	38.0	124.0	57.4	39.4	57.7	23.4	28.5	49.0	20.8	18.7	38.3	34.9	44.5	10.0	53.6	16.2	37.1	24.4	56.7	46.6	27.4	42.6	36.3	23.4	30.9	28.9	37.6	35.0	41.9	29.6	46.0	32.2	29.4	25.9	34.2	52.6	37.4	38.8	41.1	40.5	38.3	48.0	45.4	49.4	55.7	39.9	41.4	43.6	33.0	22.4	29.8	10.1	15.5	187.2	38.5	89.5	42.1	21.0	46.1	41.9	119.3	37.1	60.5	29.5	29.2	171.1	15.8	10.6	7.9	38.3	5.0	58.7	17.3	30.0	19.2	30.7	8.9	48.3	196.5	28.9	31.6	34.9	28.5	13.6	32.9	44.6	63.5	10.1	11.3	10.8	105.8	45.4	29.7	8.6	29.8	39.5	64.0	8.4	20.9	65.9	11.3	11.6	8.1	72.8	11.3	31.2	12.5	25.8	16.0	38.9	75.9	35.0	13.1	49.1	30.0	23.0	4.3	40.6	157.4	293.5	19.5	27.9	14.7	48.2
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 104.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: AB_2684573"	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favorable (2.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	79.6	20.8	10.1	12.0	10.7	1.7	55.1	20.6	13.6	27.7	14.1	27.1	21.1	19.6	4.6	12.8	20.4	13.2	104.4	9.5	15.8	12.4	19.0	27.8	7.2	17.5	26.0	13.8	12.8	11.7	10.9	8.9	26.8	29.9	9.3	77.6	14.2	11.0	19.3	19.5	26.6	5.9	10.1	12.2	22.9	5.3	14.3	5.3	50.1	9.6	2.6	50.7	25.6	9.8	0.2	1.1	1.8	0.4	79.6	23.1	26.1	0.7	2.0	0.3	0.9	0.0	0.3	0.2	24.1	2.4	0.3	0.7	0.1	33.7	0.1	0.1	0.2	0.4	0.4	61.7	120.7	0.0	0.0	95.4	7.2	2.5	2.5	0.4	0.3	0.8	0.3	0.1	1.2	0.8	0.2	0.4	0.3	0.0	1.4	0.5	0.3	0.2	0.4	0.1	0.6	129.8	0.1	0.0	2.7	5.9	0.2	0.6	0.2	3.1	1.6	0.3	0.0	1.2	0.3	0.3	0.2	0.3	9.9	0.0	0.1	0.1	0.2	0.1	0.1	1.6	0.1	0.0	0.1	2.2	0.2	0.5	0.9	1.0	0.0	0.0	0.2	0.2	10.1	10.7	20.6	13.6	9.5	15.8	17.5	26.0	26.8	10.1	14.3	9.8	94.3	3.2	2.0	2.0	3.5	10.8	1.3	17.3	3.4	38.5	1.4	5.7	6.1	0.0	6.7	0.0	0.0	1.4	1.9	0.1	0.0	0.8	0.7	2.9	4.2	23.1	0.0	0.0	2.4	0.2	0.6	87.6	1.5	0.7	0.0	0.2	2.2	1.2	0.4	8.4	12.3	0.0	0.0	0.0	13.3	2.5	95.7	2.6	78.2	3.7	0.0	22.1	0.0	1.0	1.0	0.1	0.0	23.3	0.6	0.8	0.0	0.2	21.1	12.9	92.1	21.8	95.6	1.6	1.4	0.7	6.7	2.9	2.6	9.2	0.0	1.0
CYP26B1	P450RAI-2	ENSG00000003137	"Cytochrome P450 family 26 subfamily B member 1"	Q9NR63	2	72129238-72147862	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;skin 1: 31.4"	"Group enriched"	"Detected in many"	4	"Leydig cells: 75.8;Peritubular cells: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 9.8;HaCaT: 14.8;RH-30: 18.4;U-2 OS: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012567	Uncertain		Approved	Cytosol	"Intracellular and membrane"	No	No				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA012567: AB_1847429"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.19e-4)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.17e-4)"	"unprognostic (8.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.04e-2)"	26.2	4.3	12.0	1.9	3.3	0.1	15.0	12.3	7.0	5.0	0.4	3.2	3.7	2.5	1.5	3.9	5.5	1.1	8.5	6.7	1.3	8.8	1.0	2.7	4.9	48.0	10.4	4.5	0.6	0.8	9.3	3.3	49.9	2.6	1.2	4.2	9.9	7.3	5.9	31.4	4.7	1.6	0.0	3.5	1.2	13.8	0.7	19.3	14.4	2.3	2.9	3.2	4.2	3.5	0.6	5.9	0.0	0.1	9.8	4.0	5.9	0.9	0.1	0.2	0.2	1.8	0.5	0.0	0.5	0.7	3.0	14.8	8.5	0.0	0.1	0.0	2.7	0.0	7.0	0.9	0.2	0.0	0.3	0.0	0.5	0.0	0.3	3.0	1.1	4.0	0.6	0.1	0.9	2.9	0.0	0.1	0.0	0.1	1.0	0.1	18.4	0.0	0.0	1.3	0.6	0.1	3.0	0.0	3.5	1.2	0.3	0.9	0.0	1.6	19.3	9.0	3.0	0.1	1.2	0.0	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	3.3	12.3	7.0	6.7	1.3	48.0	10.4	49.9	0.0	0.7	3.5	2.4	0.0	0.0	2.0	1.2	14.7	1.1	0.8	0.6	0.2	2.3	0.8	1.4	4.3	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.2	4.1	0.2	0.2	19.0	1.8	5.3	5.3	0.0	0.9	15.6	0.0	0.3	0.0	1.5	34.6	0.8	0.1	0.0	0.7	0.0	0.0	6.1	19.1	9.6	75.8	0.4	7.2	0.0	0.0	7.4	0.0	2.0	0.5	0.4	1.5	229.9	0.0	0.5	0.2	0.1	0.2	0.3	0.0	5.7	20.7	1.5	3.8	1.6	9.7	0.1	0.8	7.5	0.1	0.4
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 594.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 404.3;Hofbauer cells: 148.9;Proximal enterocytes: 206.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 176.9;melanoma: 85.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 151.5;neutrophil: 126.3"	"Group enriched"	"Detected in many"	21	"granulocytes: 126.3;monocytes: 151.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 299.6;HSkMC: 54.7;RPTEC TERT1: 78.5;SK-MEL-30: 103.6;WM-115: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	23.1	50.3	45.2	15.7	59.0	1.3	21.8	57.0	59.3	27.6	75.6	27.6	77.8	19.8	11.6	11.9	34.0	19.1	30.7	42.2	49.3	46.4	594.4	71.7	24.6	63.0	56.1	32.6	8.3	18.5	29.6	6.2	62.7	41.8	20.7	22.5	40.4	29.5	37.9	17.5	81.9	13.2	50.6	13.0	13.8	12.6	58.8	23.6	12.6	49.2	28.0	24.3	23.2	69.2	0.2	0.0	2.7	0.2	4.6	3.3	0.4	1.9	11.7	3.9	7.8	13.7	0.8	0.0	4.3	7.6	0.2	0.1	0.0	0.0	1.7	1.4	1.0	0.0	0.4	299.6	16.2	0.4	0.3	54.7	0.5	0.1	0.0	12.8	5.9	0.0	0.3	0.1	8.3	0.0	0.0	0.2	2.3	0.3	0.5	0.1	2.4	0.5	78.5	0.2	0.2	0.2	0.1	0.0	103.6	2.4	1.6	2.2	5.9	0.0	0.2	0.1	6.0	0.0	0.0	0.1	0.1	0.3	42.9	0.0	151.5	0.4	0.2	17.1	0.3	0.7	0.2	0.5	6.5	0.0	0.1	0.0	126.3	0.0	1.2	0.8	0.0	44.1	45.2	59.0	57.0	59.3	42.2	49.3	63.0	56.1	62.7	50.6	58.8	69.2	10.6	3.2	28.9	33.6	0.9	5.2	52.4	8.5	21.6	15.3	12.7	18.8	5.1	17.2	11.3	3.7	27.1	0.7	0.5	37.0	9.8	12.1	1.0	12.6	4.3	10.3	24.5	8.4	2.2	12.0	0.7	35.4	2.6	14.8	2.5	1.9	19.6	404.3	148.9	10.1	3.9	20.0	4.1	18.2	5.1	1.0	47.5	104.3	49.8	15.0	92.4	28.7	0.0	26.7	108.5	9.7	44.0	26.7	0.0	43.3	206.3	76.9	21.4	14.1	0.0	12.8	7.2	0.7	0.1	3.2	3.1	1.2	2.3	1.2	30.3	20.4
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991282-41018398	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 533.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 420.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;OE19: 1.8"					"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.0	0.0	0.2	0.2	0.2	0.5	0.1	0.6	0.3	0.0	0.3	4.7	5.1	0.1	0.0	0.0	0.0	0.7	0.1	0.3	0.1	15.1	533.7	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	1.7	0.8	0.0	0.1	0.2	0.0	6.7	0.6	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.2	1.8	0.1	0.0	0.1	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.6	0.3	0.3	0.1	0.3	0.1	0.2	0.0	0.2	0.4	0.0	0.0	1.1	0.0	0.8	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.2	7.2	1.4	1.8	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.4	420.9	0.0	0.0	0.1	1.6	0.0	11.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.1	38.3	16.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	4.3	0.7
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784248	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 3796.2"	"Group enriched"	"Detected in some"	40	"Hepatocytes: 2612.9;Proximal enterocytes: 1685.2"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0"					"Low region specificity"	"Detected in all"			"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.3	3.8	0.1	1.1	0.3	0.0	0.3	0.0	0.8	0.1	0.0	4.6	797.6	0.6	0.2	0.4	0.1	0.6	0.1	0.1	0.0	4.9	3796.2	0.1	0.9	0.0	0.0	0.1	43.4	0.0	1.0	0.0	0.0	0.2	2.2	0.4	0.3	0.0	2.4	1.9	853.0	0.0	0.0	0.1	1.1	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.0	0.0	0.8	3.4	0.0	0.1	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.4	32.9	0.0	0.0	0.0	0.3	0.0	5.6	0.0	0.1	0.4	0.0	0.0	1.4	0.0	26.7	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	30.0	2612.9	0.0	0.0	0.6	29.6	2.0	52.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	38.9	0.0	0.0	0.6	1685.2	3.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.9	0.1	2.3	0.5	16.1	1.1
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 44.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Early spermatids: 7.5;Excitatory neurons: 3.9;granulocytes: 2.5;Hepatocytes: 6.4;Late spermatids: 3.3;Spermatocytes: 2.4"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	44.7	0.1	0.1	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.8	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	6.4	0.1	1.7	1.9	0.0	0.0	0.6	1.9	3.3	0.0	0.2	0.0	1.0	0.0	0.2	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	2.4	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.2
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99679998	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 177.7;liver: 276.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 377.4;Distal enterocytes: 382.7;Gastric mucus-secreting cells: 506.6;Hepatocytes: 454.5;Paneth cells: 451.6;Proximal enterocytes: 1074.6;Urothelial cells: 380.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.7;Hep G2: 7.9;OE19: 28.3"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	3.3	14.4	0.1	3.8	0.4	0.6	6.5	0.8	0.9	5.1	0.4	28.4	127.3	3.1	3.0	22.1	3.1	32.7	1.0	0.3	0.0	10.6	276.1	9.2	1.4	0.6	0.0	0.8	47.0	0.0	0.9	0.4	0.4	21.6	21.0	0.7	2.9	5.7	0.9	20.5	177.7	1.1	0.0	0.8	86.5	0.4	0.0	2.1	1.0	0.0	3.2	10.4	13.1	0.5	1.6	3.3	1.6	1.9	0.4	0.6	0.5	1.5	0.0	0.0	0.0	9.7	7.4	1.0	1.5	0.0	1.2	1.2	0.0	0.0	0.0	1.8	1.2	1.2	0.7	7.9	0.1	2.0	0.6	0.0	2.1	0.0	0.0	1.4	0.0	0.9	3.3	2.0	0.0	0.3	2.6	3.8	0.4	28.3	0.8	0.6	1.6	2.2	0.4	1.5	1.2	1.7	0.9	0.8	3.2	1.6	0.5	0.7	1.2	1.8	1.6	1.6	1.2	1.0	2.6	1.7	1.6	2.6	1.5	0.4	0.3	0.4	0.4	0.3	0.9	0.2	0.6	0.6	0.2	0.1	0.4	0.5	0.5	0.4	0.2	0.3	0.5	0.2	0.1	0.4	0.8	0.9	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.5	0.9	12.8	14.8	1.3	4.8	46.1	112.7	31.0	59.7	13.7	1.1	0.4	1.3	377.4	27.3	3.7	12.5	1.7	1.7	382.7	0.0	63.4	2.0	3.1	2.2	6.3	54.6	21.7	8.6	50.7	1.2	8.5	506.6	10.3	10.1	1.8	8.2	454.5	0.6	8.4	11.0	140.5	6.1	9.5	4.5	0.5	2.5	4.1	3.6	2.8	4.9	4.0	10.3	7.1	6.5	80.1	451.6	2.6	6.4	156.3	1074.6	10.8	12.1	21.6	0.0	2.5	3.4	15.1	6.4	107.3	59.0	1.5	7.5	3.1	139.8	380.4
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99705036-99735196	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 304.9"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 85.8;Hepatocytes: 60.5"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.3;Hep G2: 2.5;HHSteC: 1.4"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.2	0.9	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.2	0.5	0.3	0.3	0.1	0.0	6.5	0.0	0.0	0.1	8.5	304.9	2.4	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.1	85.8	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.3	60.5	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.8	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	1.3	0.0	0.2
CYP3A7-CYP3A51P		ENSG00000282301	"CYP3A7-CYP3A51P readthrough"		7	99684957-99735102	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	8	"liver: 12.7"	"Group enriched"	"Detected in some"	10	"Cholangiocytes: 4.3;Hepatocytes: 2.2"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA072245: , HPA075539: "																		0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	1.1	0.1	0.0	0.0	1.5	12.7	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYRIB	"BM-009, CYRI, CYRI-B, FAM49B"	ENSG00000153310	"CYFIP related Rac1 interactor B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 198.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 117.7;dendritic cells: 66.2;Extravillous trophoblasts: 158.5;Hofbauer cells: 239.7;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009076	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1100000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	41.3	26.3	24.8	97.4	37.9	198.6	25.9	29.9	46.1	13.5	23.1	31.1	30.3	15.9	21.1	29.4	15.3	30.7	18.4	28.3	32.2	22.9	26.5	39.0	119.7	35.9	33.1	11.4	15.9	17.8	17.6	42.0	34.9	14.8	35.8	28.5	18.2	13.1	25.8	19.0	42.3	28.8	35.7	83.6	28.6	29.9	33.6	79.2	28.5	24.3	105.1	50.6	14.1	49.9	167.5	87.7	93.6	52.9	8.2	12.1	124.2	49.4	47.8	67.2	71.4	50.9	111.8	165.5	105.9	32.6	53.3	81.2	78.2	130.6	100.3	349.1	54.5	166.4	44.6	57.7	31.9	109.2	137.1	19.3	60.1	45.3	93.9	54.9	60.2	132.0	121.2	186.3	74.5	74.5	372.0	80.3	79.8	130.4	119.7	160.1	63.3	278.3	138.4	67.4	62.1	81.2	99.2	61.9	152.5	84.1	72.4	139.0	37.5	24.7	158.5	52.8	106.8	61.5	195.7	275.1	38.8	233.5	65.3	350.7	212.5	404.4	161.6	256.2	124.7	122.7	91.2	134.0	280.9	98.7	80.1	132.3	553.9	189.6	232.8	179.8	136.7	306.0	24.8	37.9	29.9	46.1	28.3	32.2	35.9	33.1	34.9	35.7	33.6	49.9	8.4	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	117.7	66.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	158.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	60.5	8.4	0.0	0.0	0.0
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 105.6;lymphoid tissue: 114.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.4;dendritic cells: 244.3;Langerhans cells: 552.9;Macrophages: 164.0;monocytes: 490.1;NK-cells: 181.3;Plasma cells: 392.5;T-cells: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 54.6;HDLM-2: 44.3;Karpas-707: 146.4;RPMI-8226: 46.9;U-266/70: 246.5;U-266/84: 99.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA007191	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"	9.2	2.7	1.4	70.0	1.7	105.6	7.7	1.5	3.7	5.7	4.0	12.8	27.3	3.2	2.1	6.9	3.4	11.8	4.1	1.4	1.9	5.2	12.3	26.1	91.5	3.1	1.8	1.5	3.4	0.9	1.4	4.4	2.6	3.3	14.6	0.5	14.3	3.9	1.1	2.8	23.1	7.0	2.5	42.2	41.6	2.5	2.3	53.6	4.0	2.2	114.3	20.8	3.7	3.2	0.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.4	54.6	0.1	0.6	0.0	0.1	0.0	0.0	0.1	44.3	0.0	0.3	0.0	0.0	0.0	7.8	6.4	0.0	0.0	0.2	0.0	4.0	0.0	0.2	0.0	146.4	0.7	0.0	0.0	6.3	0.3	0.8	0.1	0.0	0.1	46.9	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	2.0	0.2	246.5	99.8	24.1	2.4	6.8	0.0	248.9	37.6	109.9	121.8	122.5	122.5	91.5	127.9	115.7	56.1	91.6	205.5	161.0	203.6	90.2	247.9	28.1	136.5	154.8	1.4	1.7	1.5	3.7	1.4	1.9	3.1	1.8	2.6	2.5	2.3	3.2	3.2	3.2	12.2	0.0	240.4	20.9	1.0	0.0	0.6	0.0	24.4	2.5	2.1	5.7	1.3	1.8	0.0	0.7	244.3	0.6	15.6	0.3	1.4	0.3	0.4	4.5	1.8	14.9	0.1	1.9	13.6	6.4	29.0	0.8	7.0	0.0	6.8	1.7	25.2	0.0	0.1	3.7	0.0	86.1	552.9	2.0	0.0	164.0	83.6	12.2	490.1	0.0	181.3	0.0	0.0	0.3	0.3	0.0	392.5	0.7	0.4	1.1	0.0	0.1	0.0	1.5	4.5	0.0	0.6	1.2	17.8	3.0	366.6	0.0	3.8	0.5
CZIB	"C1orf123, FLJ20580"	ENSG00000162384	"CXXC motif containing zinc binding protein"	Q9NWV4	1	53214099-53220634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 29.2;Cardiomyocytes: 45.8;Cytotrophoblasts: 60.7;Extravillous trophoblasts: 76.7;Fibroblasts: 22.2;Hofbauer cells: 66.5;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043835	Uncertain		Approved	"Vesicles,Mitotic spindle,Cytosol"		Yes	No		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Vesicles, Mitotic spindle"	"HPA043835: AB_10796797"	"unprognostic (1.09e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.27e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (6.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-1)"	55.8	35.5	56.1	22.3	58.0	21.9	49.4	57.2	74.6	53.6	56.9	66.5	22.5	57.1	39.8	32.3	52.3	30.2	52.5	57.7	56.6	39.4	43.5	33.1	30.0	57.9	56.6	47.2	25.1	34.6	28.5	30.6	57.0	41.0	34.8	21.6	24.8	45.4	76.5	26.2	31.6	59.2	57.1	32.5	40.3	31.0	57.4	36.3	35.1	65.3	29.7	57.7	37.6	59.0	32.6	34.7	44.7	41.0	101.6	129.1	39.4	47.8	50.4	47.3	50.8	29.6	27.5	50.1	39.0	58.1	45.8	12.6	27.9	46.9	57.0	65.0	47.5	51.0	24.9	45.0	100.0	59.5	32.1	84.6	50.3	50.6	53.3	71.5	78.5	61.0	53.7	13.7	60.1	54.6	73.5	55.6	74.8	39.7	54.3	52.8	56.8	39.7	55.8	32.6	37.6	36.1	45.1	40.9	47.7	72.2	29.2	59.8	49.3	54.5	31.9	38.2	47.2	19.5	30.7	57.3	43.9	58.5	42.8	60.7	56.6	58.6	50.9	72.3	46.9	46.9	49.8	53.6	68.8	45.1	55.0	54.9	22.8	59.0	60.3	46.3	68.2	51.1	56.1	58.0	57.2	74.6	57.7	56.6	57.9	56.6	57.0	57.1	57.4	59.0	29.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	60.7	8.2	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	76.7	22.2	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	46.7	1.3	0.0	0.0	0.0
DAAM1	KIAA0666	ENSG00000100592	"Dishevelled associated activator of morphogenesis 1"	Q9Y4D1	14	59188646-59371405	"Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 467.3;Suprabasal keratinocytes: 332.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026605, HPA064789"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA		9700	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA026605: AB_1847464, HPA064789: AB_2685352"	"unprognostic (2.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	14.5	6.2	13.0	6.8	13.6	5.4	10.4	12.6	12.8	13.6	22.8	13.5	4.8	13.5	5.6	19.0	7.7	5.9	19.3	11.8	14.8	6.9	12.6	10.5	11.1	7.9	8.1	8.0	9.3	20.6	5.3	9.1	8.3	11.9	8.5	24.9	9.4	11.0	5.6	30.9	7.2	10.9	7.8	13.1	7.0	6.9	11.2	4.8	7.4	4.7	15.6	9.5	15.1	10.7	18.2	1.9	13.1	3.5	7.8	5.8	17.1	2.5	2.3	4.7	4.8	9.4	16.6	20.4	4.4	5.6	9.6	39.7	11.8	10.0	4.0	9.0	4.1	6.8	4.8	11.8	4.8	7.9	3.8	3.9	10.6	3.9	4.7	10.8	11.3	10.2	11.9	9.9	2.8	17.0	6.9	4.9	7.5	12.9	5.6	6.3	11.1	2.0	6.8	13.5	20.3	4.8	15.8	23.1	16.1	8.7	30.5	2.1	10.8	3.9	7.4	8.4	2.2	2.2	2.7	22.1	5.0	1.5	8.7	7.7	2.0	2.6	2.3	2.4	3.0	10.8	3.0	2.3	2.2	4.6	2.4	2.6	2.8	6.7	3.5	18.3	4.0	1.9	13.0	13.6	12.6	12.8	11.8	14.8	7.9	8.1	8.3	7.8	11.2	10.7	62.2	35.3	27.0	160.6	37.8	467.3	172.4	128.6	30.7	110.7	56.8	40.6	149.3	38.6	82.3	29.5	308.6	33.0	66.9	47.0	23.5	63.8	40.0	68.4	142.9	71.9	87.7	140.0	143.7	93.1	27.6	67.3	21.9	54.6	26.0	155.2	102.4	47.2	32.8	195.2	202.0	56.7	73.2	16.3	55.8	16.6	60.3	36.1	90.7	66.5	25.2	96.5	16.5	74.9	24.3	191.4	45.1	74.1	30.8	104.2	24.7	12.8	102.4	168.7	32.9	84.6	66.3	51.3	46.3	52.8	332.0	34.2	25.1	25.1	38.1	84.2
DAAM2	KIAA0381	ENSG00000146122	"Dishevelled associated activator of morphogenesis 2"	Q86T65	6	39792298-39904877	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 245.9"	"Group enriched"	"Detected in many"	5	"Astrocytes: 275.6;Oligodendrocytes: 449.8;Sertoli cells: 151.2"	"Group enriched"	"Detected in all"	5	"glioma: 15.0;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 54.9;JURKAT: 30.4;LHCN-M2: 55.8;SK-MEL-30: 68.7;WM-115: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051300, HPA054630"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA051300: AB_2681430, HPA054630: AB_2682549"	"unprognostic (7.53e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.93e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.54e-2)"	"unprognostic (7.94e-2)"	"unprognostic (8.54e-4)"	33.7	22.5	179.4	9.0	229.4	1.8	23.3	175.8	159.3	15.7	65.1	18.9	9.8	14.0	10.4	36.6	18.5	7.4	13.5	144.0	170.5	9.3	4.8	12.4	3.6	234.8	195.8	10.0	7.5	4.1	5.1	12.2	205.0	11.0	8.7	1.6	7.6	21.7	38.3	8.5	20.9	18.3	194.3	40.2	18.9	12.3	187.7	2.5	13.1	38.1	2.3	9.9	11.3	245.9	0.1	0.0	5.8	0.1	12.2	0.3	0.2	9.8	13.1	2.2	1.2	0.9	0.0	0.1	0.5	14.7	4.5	0.1	0.0	0.0	0.8	0.0	2.4	0.0	0.0	0.1	8.8	0.0	0.1	54.9	0.0	0.3	0.0	15.6	0.0	30.4	0.0	0.1	55.8	0.2	1.5	0.1	1.6	3.1	0.1	0.0	10.0	8.1	0.0	0.0	2.0	2.3	0.0	0.7	68.7	11.7	0.0	0.1	0.6	20.8	6.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	179.4	229.4	175.8	159.3	144.0	170.5	234.8	195.8	205.0	194.3	187.7	245.9	11.2	9.6	12.2	275.6	0.1	1.8	0.9	0.0	0.0	1.3	1.5	1.5	2.5	1.5	3.8	0.0	0.0	0.5	0.1	0.0	0.0	0.5	3.8	1.2	10.4	9.0	0.0	2.7	1.4	3.3	0.5	11.8	0.5	2.3	0.0	1.9	2.5	1.2	0.2	0.0	5.8	0.0	0.0	31.5	2.4	6.4	23.6	6.2	8.8	21.5	0.0	5.8	1.0	8.5	449.8	0.3	0.0	22.2	0.0	0.8	0.0	0.1	1.5	1.6	151.2	12.7	48.8	1.0	1.9	0.4	1.1	0.3	0.7	55.9	0.0	1.2
DALRD3	FLJ10496	ENSG00000178149	"DALR anticodon binding domain containing 3"	Q5D0E6	3	49015488-49022293	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 158.9;Late spermatids: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036862	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA036862: AB_10673507"	"unprognostic (2.76e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.56e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.33e-2)"	"unprognostic (9.52e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	11.8	18.5	11.2	6.0	10.9	5.4	14.2	10.6	12.4	14.1	14.5	10.1	7.8	9.8	13.1	18.3	36.9	10.5	10.0	10.8	10.8	21.4	9.0	9.9	9.1	11.5	12.6	15.2	38.7	13.9	14.4	9.6	10.9	10.2	7.9	6.5	11.6	9.5	11.0	18.8	9.6	6.9	12.0	10.8	14.7	51.0	11.2	9.4	19.2	6.9	12.3	10.7	11.5	10.8	12.0	16.6	10.2	20.0	28.5	37.8	12.4	9.9	27.5	16.5	15.8	11.7	14.9	4.9	13.7	27.3	14.3	7.8	13.4	26.1	11.5	7.0	9.1	5.3	13.9	22.0	18.7	15.0	10.5	25.7	26.6	20.9	46.1	42.0	26.0	11.2	4.3	12.0	16.4	20.8	6.6	10.1	16.8	25.3	15.5	3.5	1.5	35.7	44.4	19.0	6.5	21.1	10.9	30.1	23.7	16.8	21.3	16.2	15.9	6.4	9.7	22.6	9.2	37.8	21.9	3.0	24.2	8.3	12.9	12.0	11.1	5.5	13.9	13.7	25.0	23.9	22.4	17.1	11.7	21.1	18.7	12.5	10.9	22.6	12.8	8.1	29.5	12.8	11.2	10.9	10.6	12.4	10.8	10.8	11.5	12.6	10.9	12.0	11.2	10.8	26.8	16.0	12.2	8.5	27.3	25.6	21.6	28.5	22.8	30.2	35.5	40.5	1.2	27.1	20.8	27.6	18.8	28.2	30.0	25.0	37.2	40.7	158.9	61.2	21.5	16.3	19.1	11.1	10.7	39.4	40.0	19.8	28.5	24.6	24.7	32.4	15.0	5.9	19.2	40.4	9.5	22.3	20.3	12.9	24.5	306.6	24.2	16.8	21.4	2.8	23.5	25.8	13.4	6.6	5.5	21.5	21.3	18.4	18.2	10.0	50.4	49.9	75.3	58.4	46.0	19.1	19.0	110.7	33.4	26.5	34.1	18.3	27.1	29.7	30.0	17.3
DBNDD1	"FLJ12582, MGC3101"	ENSG00000003249	"Dysbindin domain containing 1"	Q9H9R9	16	90004871-90019890	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 92.0;skeletal muscle: 48.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 22.8;Ductal cells: 16.0;Exocrine glandular cells: 18.8;Horizontal cells: 30.3;Pancreatic endocrine cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"naive B-cell: 12.9"	"Lineage enriched"	"Detected in many"	4	"B-cells: 12.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043018	Uncertain		Approved	"Nuclear speckles,Cytosol"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear speckles"	Cytosol	"HPA043018: AB_10794921"	"unprognostic (1.07e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (2.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (5.67e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.00e-2)"	1.8	7.4	47.1	2.5	35.3	0.3	4.4	27.5	60.6	4.1	11.6	2.9	1.6	0.9	10.0	28.2	3.6	3.8	4.6	35.2	40.7	13.3	6.5	3.5	4.7	50.6	55.3	3.1	19.5	9.6	7.7	0.1	50.8	3.8	1.4	7.4	15.5	3.1	48.0	6.0	1.7	1.3	30.3	1.2	7.7	1.0	92.0	1.4	5.2	4.8	5.1	1.7	7.3	38.6	22.8	34.7	3.5	44.7	0.9	0.4	24.7	4.9	6.6	10.5	5.3	32.1	19.7	0.0	2.7	1.1	10.2	24.0	41.3	1.2	10.7	0.1	65.4	0.0	4.4	58.6	1.5	0.3	4.7	1.0	3.3	18.8	0.1	25.2	47.3	0.8	6.7	0.4	4.1	139.7	0.1	33.5	59.5	18.6	13.9	14.5	32.3	0.6	64.2	4.5	51.2	53.0	5.6	5.3	44.8	10.2	34.6	4.8	36.2	7.4	15.1	0.4	24.1	0.3	0.3	0.4	3.5	3.9	20.1	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.6	0.5	0.0	12.9	2.9	0.5	0.0	0.0	0.0	0.1	0.0	1.0	47.1	35.3	27.5	60.6	35.2	40.7	50.6	55.3	50.8	30.3	92.0	38.6	0.3	3.2	2.0	2.9	6.0	0.4	0.6	0.6	0.0	1.8	13.5	7.5	2.5	22.8	2.0	9.2	0.0	0.2	0.1	1.4	9.8	16.0	0.0	5.7	0.7	1.1	6.0	0.0	6.1	18.8	0.3	0.2	2.6	7.8	0.0	3.4	1.4	2.5	0.3	30.3	3.6	1.5	2.0	0.0	0.7	0.0	1.2	0.1	3.6	2.8	0.2	10.4	0.0	1.5	0.7	15.0	2.9	0.4	0.5	4.3	0.2	10.8	2.7	1.8	0.0	1.4	1.2	0.1	2.0	8.1	1.0	0.0	1.4	0.3	0.8	1.3
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1300.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 18.8;Gastric mucus-secreting cells: 20.4;Macrophages: 10.7;Smooth muscle cells: 23.6;Squamous epithelial cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"dendritic cells: 18.7;monocytes: 12.5;T-cells: 9.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	71.5	29.7	627.6	33.6	916.1	7.1	59.4	827.6	1054.5	73.6	462.6	160.9	54.5	106.6	41.7	58.7	102.7	33.1	470.5	645.7	709.8	56.3	10.4	63.1	21.3	871.6	808.2	39.1	39.9	65.3	41.3	42.9	853.0	70.2	91.1	34.9	47.7	89.4	316.2	68.6	78.4	100.9	739.9	30.3	82.2	14.4	822.1	23.2	37.2	248.2	27.3	118.7	69.7	1300.9	78.0	13.6	10.8	76.3	6.8	3.0	15.0	44.7	48.4	36.7	24.8	37.2	103.4	1.1	7.7	44.4	13.9	112.1	74.7	4.0	22.4	0.6	43.9	64.5	57.0	34.3	43.1	3.5	94.0	1.2	12.6	13.9	12.8	63.5	25.3	64.8	4.7	1.5	2.9	99.0	5.6	4.9	14.0	50.8	80.0	0.3	1.0	0.7	105.3	1.4	24.8	12.7	15.6	8.4	99.3	7.6	104.0	19.9	41.1	1.5	72.5	48.8	49.5	1.1	1.6	0.3	5.3	0.6	10.9	0.0	10.4	0.0	9.1	12.5	3.3	0.2	8.0	6.8	7.6	0.3	7.4	6.9	0.5	0.8	7.2	18.7	7.4	4.5	627.6	916.1	827.6	1054.5	645.7	709.8	871.6	808.2	853.0	739.9	822.1	1300.9	0.3	3.2	0.5	0.0	3.3	0.0	0.2	0.1	18.8	0.0	0.6	0.3	1.0	0.0	2.5	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.3	0.4	0.2	2.7	0.0	2.1	0.0	0.0	0.0	7.3	20.4	0.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	10.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	3.9	0.4	0.9	0.0	5.3	0.0	0.0	0.6	23.6	0.1	0.0	32.7	0.6	0.0	5.3	0.1	0.4	0.3
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	16.7	19.2	10.3	22.9	11.0	15.2	23.9	11.3	15.6	17.7	12.8	20.7	16.1	16.2	19.1	21.3	18.0	12.7	16.2	10.9	11.1	32.4	20.7	12.9	24.7	10.8	13.7	13.6	18.5	20.0	15.6	18.7	11.4	14.7	21.4	13.8	14.3	12.8	18.8	15.7	14.5	18.2	11.3	14.3	15.6	32.2	10.4	24.7	18.1	16.0	30.5	33.6	14.6	11.9	96.5	84.2	76.9	79.0	54.7	62.7	57.6	70.1	53.2	64.4	65.9	83.1	90.9	132.2	116.1	73.3	64.0	69.9	105.8	89.0	124.1	127.7	74.9	183.0	48.0	95.9	62.2	76.1	75.7	51.8	59.9	95.9	157.5	40.3	91.4	89.6	125.3	56.7	99.9	78.0	144.9	79.3	118.0	268.9	129.6	92.6	93.3	136.4	95.3	78.6	97.6	92.3	43.5	67.3	83.1	67.4	103.9	51.2	60.6	65.3	105.3	85.5	94.7	61.7	116.5	188.0	88.0	162.8	85.7	19.6	37.6	22.1	35.5	46.5	48.8	60.8	37.5	38.2	54.4	50.8	37.0	38.2	4.2	52.8	35.2	28.3	58.0	44.9	10.3	11.0	11.3	15.6	10.9	11.1	10.8	13.7	11.4	11.3	10.4	11.9	40.0	16.0	17.0	9.1	39.7	79.5	76.6	92.4	38.1	19.6	21.6	24.9	20.8	12.8	53.8	33.1	25.0	57.9	34.8	11.0	39.2	55.0	54.6	26.9	35.4	39.9	14.5	22.1	9.5	48.4	75.0	37.4	17.9	24.7	40.6	49.3	17.5	16.9	42.7	16.8	9.0	17.5	69.2	14.8	23.9	16.7	24.2	22.9	26.6	11.2	28.5	28.8	27.8	16.1	20.0	43.6	12.3	17.7	30.3	51.1	24.3	79.1	36.0	23.7	13.1	50.2	48.0	102.0	86.3	37.1	77.0	33.9	33.1	41.7	28.1	56.9
DCAF16	"C4orf30, FLJ20280"	ENSG00000163257	"DDB1 and CUL4 associated factor 16"	Q9NXF7	4	17800655-17810758	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042487	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA042487: AB_10795505"	"unprognostic (2.23e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.40e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-3)"	"prognostic favorable (7.67e-4)"	9.6	8.2	4.5	8.0	7.0	18.1	13.0	6.4	6.7	12.8	2.9	10.4	7.9	13.8	10.2	7.9	11.9	6.6	8.4	4.2	7.4	9.2	4.8	9.1	11.9	6.1	5.8	19.4	11.3	12.3	13.3	9.8	5.7	10.6	9.5	13.3	10.9	7.9	8.2	15.0	10.2	8.9	4.5	8.9	8.8	10.9	7.8	12.0	10.1	4.4	11.4	10.0	10.2	9.4	21.7	4.6	24.3	25.5	6.8	11.9	13.2	13.9	16.3	16.2	19.1	13.1	17.2	24.2	10.8	12.9	13.1	10.7	14.4	14.7	23.9	8.3	13.2	34.2	16.0	21.5	16.3	30.4	13.4	15.5	11.8	20.6	20.3	10.8	11.3	23.6	37.4	39.3	9.4	8.2	33.4	29.0	20.0	6.3	13.1	35.0	27.8	15.7	7.1	16.9	36.0	28.9	14.8	3.9	16.9	12.2	14.3	8.1	14.5	18.7	14.7	20.8	17.8	17.3	7.4	29.4	15.4	20.6	12.8	7.8	1.4	2.1	2.5	1.6	3.3	2.0	2.7	2.8	0.9	2.9	3.4	3.2	1.0	2.1	1.1	1.8	2.1	1.3	4.5	7.0	6.4	6.7	4.2	7.4	6.1	5.8	5.7	4.5	7.8	9.4	11.6	19.2	24.8	13.1	17.6	25.4	24.3	9.4	25.6	12.2	16.3	16.9	21.9	12.8	14.4	9.2	6.2	17.6	27.0	8.6	13.7	9.9	19.6	12.9	18.4	13.0	17.5	21.7	20.2	7.7	10.0	15.9	14.3	13.3	17.1	24.8	11.4	6.4	7.7	15.2	20.2	12.5	14.2	11.9	11.3	11.5	21.1	9.4	10.6	15.0	10.2	27.5	7.2	29.1	36.7	11.8	7.6	22.2	27.6	14.6	9.2	5.1	17.1	14.6	13.1	21.7	16.2	28.8	17.3	19.5	21.2	12.3	20.3	19.0	13.9	19.2
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262549	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	63.3	62.6	35.3	47.0	43.3	54.6	60.6	47.7	52.8	55.8	47.1	72.0	56.6	60.4	76.2	50.2	58.9	53.5	85.1	33.7	41.8	55.8	103.4	50.9	60.5	39.2	37.3	62.2	80.2	85.7	66.3	45.1	37.0	53.6	40.6	106.7	60.6	53.2	219.7	67.2	61.8	44.0	32.6	65.6	67.3	40.7	41.1	67.5	77.9	118.3	51.1	61.1	49.8	53.0	54.2	62.5	72.0	64.8	86.3	65.5	63.7	62.7	81.8	49.5	42.2	69.8	89.6	56.3	112.1	67.2	34.6	64.8	34.6	57.4	31.0	134.9	69.0	63.4	99.7	54.1	69.3	52.9	80.3	74.6	58.9	44.2	60.8	55.3	73.5	73.1	60.6	98.4	46.0	50.0	71.7	54.5	52.7	70.1	62.6	69.2	41.8	115.5	57.7	87.6	49.0	47.3	101.8	113.1	68.2	68.9	104.9	82.0	95.1	60.7	31.5	38.6	58.7	169.8	124.9	94.3	68.7	49.6	51.2	32.9	21.5	22.0	31.5	19.7	29.6	28.5	27.0	29.2	17.5	30.4	29.4	27.0	24.9	30.4	28.4	22.0	30.4	19.2	35.3	43.3	47.7	52.8	33.7	41.8	39.2	37.3	37.0	32.6	41.1	53.0	21.4	57.7	54.9	57.5	35.4	18.4	16.3	17.3	38.7	44.6	27.5	21.8	54.2	30.0	30.5	25.8	64.6	30.9	26.4	20.4	62.6	23.9	3.6	26.6	18.9	26.4	25.1	48.4	53.7	21.6	21.0	28.9	35.2	21.4	34.1	21.2	21.4	77.6	23.8	40.4	49.5	19.2	20.3	29.8	18.9	4.3	28.0	24.2	14.2	39.4	27.6	38.1	18.6	58.8	93.1	19.2	13.6	32.7	45.3	16.3	29.0	38.1	40.5	60.5	13.1	29.5	26.6	28.0	20.4	35.1	24.2	44.3	36.5	25.6	18.8	12.5
DCBLD1	"dJ94G16.1, MGC46341"	ENSG00000164465	"Discoidin, CUB and LCCL domain containing 1"	Q8N8Z6	6	117453817-117569858	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059667	Approved		Approved	Cytosol		NA	NA		22000000	"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA059667: AB_2684099"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.44e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.74e-2)"	"unprognostic (8.99e-2)"	"unprognostic (5.69e-3)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (8.57e-8)"	"unprognostic (6.99e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.36e-1)"	8.3	3.5	3.7	6.0	4.6	0.6	5.7	3.5	4.9	9.1	2.6	6.6	6.5	5.1	3.3	5.4	2.5	9.1	6.0	5.5	2.7	4.8	9.6	9.9	3.4	3.5	3.6	1.9	6.3	6.8	8.3	8.7	3.7	2.6	6.1	1.0	4.8	2.8	5.5	2.9	8.1	3.8	3.4	3.8	7.6	5.6	3.0	1.2	5.9	5.1	2.5	6.3	5.8	4.3	8.0	17.9	6.3	7.0	10.8	13.5	17.9	45.1	58.1	36.9	27.8	37.9	16.7	0.0	21.8	19.1	45.9	17.9	12.1	19.9	38.7	3.5	9.4	6.8	18.5	62.3	46.7	10.0	5.7	15.4	45.5	33.6	31.4	42.5	52.3	6.7	14.8	6.7	48.9	6.4	0.1	6.7	4.7	21.4	7.4	0.0	1.3	4.7	8.2	9.4	19.0	0.3	33.0	3.6	5.3	9.0	4.7	13.1	38.9	0.0	44.1	12.6	19.8	18.9	5.4	5.3	18.7	9.6	16.5	0.0	0.2	0.0	0.6	0.2	0.1	0.0	0.8	1.2	0.2	0.0	1.0	1.3	0.0	0.4	0.1	0.4	0.9	0.5	3.7	4.6	3.5	4.9	5.5	2.7	3.5	3.6	3.7	3.4	3.0	4.3	16.0	16.0	18.8	5.2	3.0	5.2	3.7	12.3	0.6	8.4	4.8	3.6	5.3	12.8	14.4	5.5	6.2	31.5	4.9	9.5	1.9	7.0	33.0	5.3	15.1	11.0	4.2	3.2	20.8	4.8	6.1	6.6	13.7	7.9	1.3	13.9	17.2	9.6	5.8	5.0	3.3	8.5	6.1	7.0	15.0	10.9	0.9	5.8	8.8	13.1	2.5	1.1	6.2	12.1	11.6	10.4	7.7	0.4	1.6	3.0	11.1	2.7	5.7	3.5	13.1	5.1	27.6	2.2	10.6	6.8	6.0	18.2	5.1	2.1	11.1	5.4
DCBLD2	"CLCP1, ESDN"	ENSG00000057019	"Discoidin, CUB and LCCL domain containing 2"	Q96PD2	3	98795941-98901695	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 83.8;Oligodendrocyte precursor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 455.0;hTERT-RPE1: 648.9;LHCN-M2: 776.8;RPTEC TERT1: 479.0;U-87 MG: 581.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016909	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		2200000		"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA016909: AB_1847510"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-3)"	"unprognostic (9.29e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.32e-5)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.59e-3)"	12.2	13.3	4.0	4.5	3.8	1.2	8.2	8.1	5.8	8.3	6.6	11.5	2.8	14.6	8.0	6.4	14.5	12.5	27.6	3.4	5.9	11.0	9.8	11.5	3.6	6.5	6.9	17.8	5.8	13.2	6.6	8.0	26.7	11.5	7.0	22.4	10.1	14.9	5.2	8.3	4.1	16.3	4.8	1.6	6.5	23.8	7.3	6.9	15.7	8.4	3.9	7.8	5.1	5.0	55.3	397.0	52.3	41.2	67.8	160.1	22.7	122.0	57.9	81.4	91.9	33.9	171.6	0.1	373.7	211.5	249.0	50.3	24.1	198.8	186.2	0.8	8.4	19.4	12.1	51.5	41.6	9.3	8.7	63.8	30.3	234.3	455.0	648.9	54.6	7.1	4.0	5.0	776.8	14.6	7.7	5.5	36.5	0.4	135.6	8.1	98.2	4.8	479.0	14.4	14.0	24.3	33.5	6.9	145.9	35.2	26.4	7.3	90.4	208.0	166.6	53.8	433.0	6.3	9.7	7.4	581.3	3.4	92.8	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.0	3.8	8.1	5.8	3.4	5.9	6.5	6.9	26.7	4.8	7.3	5.0	5.9	32.1	52.8	18.3	2.7	22.8	15.5	18.2	17.1	12.9	15.5	16.3	83.8	17.2	19.0	18.4	77.2	12.4	1.6	4.3	0.0	30.5	3.1	32.2	39.5	7.7	3.6	5.9	51.6	8.0	9.7	33.8	6.1	38.3	38.0	52.2	6.8	20.5	4.0	13.5	51.3	8.0	20.3	3.2	6.2	5.8	22.1	4.0	8.8	25.3	1.4	40.9	2.1	88.4	38.9	26.3	4.6	50.4	1.6	11.9	0.7	7.9	22.8	48.9	0.0	12.3	31.3	15.8	24.2	14.1	15.6	4.0	1.8	34.4	8.2	7.1
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131382	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.0"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 970.6;Inhibitory neurons: 664.8"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 29.0;ASC TERT1: 27.3;fHDF/TERT166: 23.5;GAMG: 34.8;HAP1: 17.9;HSkMC: 25.5;NTERA-2: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265"	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	15.5	2.5	22.0	4.0	27.5	0.0	14.2	10.2	45.3	11.8	0.0	4.2	1.1	6.0	4.1	5.4	4.6	7.2	5.5	37.1	37.8	2.8	0.1	2.4	4.2	17.9	13.2	6.1	1.2	1.1	13.7	0.1	53.0	4.1	3.8	17.3	3.4	4.0	2.1	8.4	4.1	19.1	15.7	4.5	3.6	1.3	17.5	1.6	2.8	4.6	2.2	4.3	5.9	18.7	0.0	0.4	6.8	0.0	29.0	27.3	0.0	0.2	0.4	0.2	0.2	0.0	0.1	0.0	0.0	23.5	34.8	0.0	17.9	0.3	0.0	0.0	1.0	0.0	0.8	0.0	1.1	0.0	0.0	25.5	13.0	0.6	0.4	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	37.1	0.0	0.4	0.0	2.0	0.0	1.0	0.0	7.3	4.4	0.0	0.0	2.2	10.4	0.0	0.0	0.0	0.1	6.1	7.6	1.3	0.1	0.0	0.0	2.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	27.5	10.2	45.3	37.1	37.8	17.9	13.2	53.0	15.7	17.5	18.7	8.0	9.6	0.6	132.2	0.1	15.2	1.3	1.8	0.0	9.4	7.8	7.0	5.8	0.0	7.9	3.7	4.2	0.0	0.0	0.0	0.0	0.1	1.5	0.7	1.7	3.8	0.0	0.0	970.6	0.0	0.0	82.6	0.5	0.3	0.0	75.5	0.4	0.0	0.1	10.1	664.8	0.0	4.1	0.3	14.7	1.6	20.8	0.7	14.2	44.0	0.0	73.8	0.0	31.2	19.1	0.2	0.0	4.1	0.3	0.6	0.0	0.6	3.1	4.2	6.6	10.8	22.0	1.3	1.4	1.0	9.7	0.0	0.8	30.1	0.0	1.7
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	"Doublecortin like kinase 3"	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;testis: 2.8"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 53.8"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040685, HPA053234"	Approved		Approved	Vesicles,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Vesicles	"HPA040685: AB_2732487, HPA053234: "	"unprognostic (9.09e-3)"	"unprognostic (1.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.11e-5)"	"unprognostic (7.94e-3)"	"unprognostic (5.80e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.36e-2)"	0.5	0.1	0.9	0.4	3.9	0.1	0.2	0.1	1.8	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.2	1.0	0.3	0.0	0.0	0.1	1.5	0.1	0.0	0.9	0.1	0.1	0.3	1.4	0.0	0.0	2.8	0.7	1.3	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.9	0.1	1.8	0.8	0.7	0.3	0.2	0.0	1.4	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	53.8	0.1	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	0.4	8.9	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.1	3.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	50.8	83.8	39.0	41.6	40.3	29.5	46.7	40.1	44.8	48.9	51.1	41.4	33.1	47.8	29.7	61.2	49.0	54.7	40.6	39.8	43.6	48.9	79.8	41.2	45.2	43.0	42.8	65.8	54.9	61.8	46.9	36.7	40.2	39.9	40.9	25.1	44.6	41.7	41.7	39.3	36.3	46.4	43.8	50.3	54.1	21.8	42.6	42.2	100.8	32.9	49.6	50.1	45.6	46.0	97.8	87.4	88.4	81.3	129.6	176.7	115.0	184.1	163.0	128.7	79.7	89.2	183.0	33.5	44.3	179.9	87.1	47.3	65.5	114.9	117.1	163.8	50.4	155.9	50.4	109.1	139.5	153.3	93.3	149.8	120.8	113.6	117.8	129.6	112.2	73.1	157.4	324.5	175.6	71.5	100.1	94.7	70.0	39.8	79.3	107.3	62.2	65.8	107.9	115.1	86.7	54.3	86.7	73.8	87.4	81.2	56.7	78.8	131.7	105.7	81.7	52.0	142.0	124.5	72.9	42.8	117.4	98.5	127.1	68.6	47.9	45.2	61.0	58.8	76.8	71.0	52.6	62.7	55.0	48.6	51.6	54.6	3.3	73.7	60.2	42.4	50.6	55.6	39.0	40.3	40.1	44.8	39.8	43.6	43.0	42.8	40.2	43.8	42.6	46.0	31.6	12.8	19.5	8.8	31.7	25.4	34.4	35.4	37.5	4.9	39.4	34.2	24.3	38.6	21.5	33.1	4.2	19.0	26.6	16.8	37.2	68.8	7.0	19.7	41.6	30.9	14.5	27.1	10.7	54.5	26.8	42.3	15.8	22.3	22.8	36.2	30.0	45.2	53.8	3.3	11.7	28.5	18.3	38.8	32.1	18.0	44.1	29.4	26.6	9.4	34.8	37.4	25.7	3.0	3.1	75.5	18.5	35.3	27.6	46.1	19.3	45.8	18.7	5.5	32.9	25.8	34.6	10.2	15.4	54.5	23.0	7.3	27.6	42.4	31.3	42.3
DCTN3	DCTN-22	ENSG00000137100	"Dynactin subunit 3"	O75935	9	34613545-34620523	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044905	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoli	"HPA044905: AB_10960996"	"unprognostic (3.38e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.47e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.88e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.26e-3)"	"unprognostic (4.24e-3)"	"prognostic favorable (5.76e-11)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.43e-2)"	72.9	87.9	98.3	33.7	104.6	107.3	72.2	97.0	123.5	80.6	92.9	81.1	42.0	72.9	46.8	98.5	66.4	38.7	127.1	106.0	103.3	88.6	67.0	60.8	48.0	97.1	97.2	78.7	76.5	94.4	108.4	40.7	102.4	68.2	39.0	57.0	69.2	51.4	152.5	111.1	51.1	53.6	94.1	58.7	75.6	36.3	100.3	81.3	71.5	114.4	59.0	69.5	79.2	95.6	147.1	120.7	110.1	115.6	95.1	132.3	45.1	122.7	112.8	166.4	130.2	77.7	53.8	67.0	74.6	161.8	58.4	57.4	101.0	128.3	105.6	211.9	126.5	44.9	202.9	68.5	102.6	118.8	131.3	117.5	109.4	115.6	75.0	81.4	111.1	123.6	54.2	135.3	147.4	120.9	151.4	320.0	33.4	61.0	192.7	75.2	59.7	93.4	81.5	51.2	36.5	93.3	90.9	82.7	48.0	32.2	110.6	134.5	102.7	104.6	84.1	120.1	121.0	90.6	126.0	45.5	164.1	68.6	217.4	235.2	131.1	187.4	99.9	139.4	92.1	88.4	106.0	106.8	133.8	94.7	83.6	98.9	114.4	102.2	150.3	136.1	179.1	152.5	98.3	104.6	97.0	123.5	106.0	103.3	97.1	97.2	102.4	94.1	100.3	95.6	103.7	32.1	38.3	13.1	61.3	101.6	111.8	180.7	82.0	83.2	97.3	146.9	86.1	77.2	91.8	80.9	25.0	128.8	105.6	74.1	207.4	127.5	14.3	78.6	98.8	79.2	74.7	115.7	16.8	154.6	111.9	97.9	56.6	67.1	87.5	82.4	88.5	84.9	133.8	74.0	16.2	64.9	91.6	88.8	99.0	21.1	103.5	76.8	149.4	5.6	94.9	212.9	125.7	7.5	16.8	126.7	84.5	122.6	89.1	54.7	89.0	240.2	95.0	96.7	59.2	82.0	150.5	82.2	72.9	109.9	142.6	99.7	95.7	143.2	61.6	96.6
DCUN1D1	"DCUN1L1, RP42, SCCRO, SCRO, Tes3"	ENSG00000043093	"Defective in cullin neddylation 1 domain containing 1"	Q96GG9	3	182938074-182985953	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 246.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 13031.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA035911: AB_10673489"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.98e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.52e-1)"	14.7	12.3	10.5	12.3	13.9	22.4	13.0	13.2	16.3	11.6	4.0	14.0	13.7	12.9	9.4	18.1	10.4	12.8	15.7	10.0	10.6	19.2	31.5	10.6	15.4	11.0	12.3	12.4	10.2	12.0	8.4	12.6	13.0	13.6	13.1	11.3	11.0	13.9	34.5	14.4	14.4	15.4	11.6	12.5	11.4	246.2	12.0	13.6	17.7	38.1	17.5	14.9	10.2	18.3	54.3	23.5	31.0	13.1	32.4	30.8	26.3	33.9	37.8	37.4	36.2	34.9	39.0	63.6	72.5	32.2	56.4	29.4	27.6	28.5	49.8	52.2	14.3	61.1	17.2	14.8	20.2	36.6	44.3	23.3	32.6	22.3	20.7	28.3	26.7	38.0	20.6	32.6	27.9	28.8	36.2	19.0	25.3	40.4	21.7	27.9	32.4	41.6	27.5	37.6	22.4	22.3	59.7	41.9	33.1	32.6	86.0	29.0	25.6	22.9	22.2	31.7	40.3	26.5	53.3	64.0	29.0	33.8	33.8	10.2	8.5	16.3	6.7	9.2	6.6	6.4	5.6	6.6	10.0	4.1	6.2	6.8	13.7	10.5	6.2	7.5	7.4	5.5	10.5	13.9	13.2	16.3	10.0	10.6	11.0	12.3	13.0	11.6	12.0	18.3	23.5	22.4	29.5	54.2	22.3	43.3	26.0	28.3	23.3	13.2	26.6	15.4	32.5	21.5	30.1	47.8	10.4	18.8	36.3	29.1	37.2	28.3	2437.8	24.0	29.9	23.7	26.9	98.1	52.7	30.5	18.7	29.0	18.3	26.3	29.8	22.1	17.9	52.6	28.6	18.5	40.9	19.6	30.5	45.9	54.2	13031.2	86.6	39.5	12.4	30.0	45.9	18.1	20.6	37.7	91.9	31.9	24.1	64.3	20.2	42.0	27.3	42.3	24.0	22.6	78.9	35.9	37.4	124.6	58.7	25.7	42.5	20.0	27.1	15.3	20.7	43.6
DCUN1D2	"C13orf17, FLJ10704, FLJ20092"	ENSG00000150401	"Defective in cullin neddylation 1 domain containing 2"	Q6PH85	13	113455819-113490951	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.6;skeletal muscle: 108.7;tongue: 69.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 79.6;Excitatory neurons: 43.9;Inhibitory neurons: 37.9;Oligodendrocytes: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 11.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 11.3"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 54.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039349	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA039349: AB_10673240"	"unprognostic (3.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.43e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.21e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.25e-2)"	8.1	8.4	9.7	4.4	8.8	14.0	7.6	23.4	14.6	8.9	30.1	9.2	4.6	9.4	9.4	6.4	7.7	5.4	98.6	8.5	9.7	8.3	8.5	7.7	7.2	12.6	9.9	8.1	7.1	5.9	10.5	7.4	13.4	7.5	6.4	16.8	9.0	4.8	108.7	14.4	8.3	7.4	8.5	9.4	8.3	9.0	10.2	8.1	4.5	69.1	7.3	7.0	7.4	15.3	13.3	7.5	13.0	9.5	9.8	8.3	10.6	10.0	11.4	9.0	10.8	27.4	7.3	9.8	3.4	11.3	13.9	17.2	13.8	7.1	12.5	6.7	23.4	15.6	40.9	7.5	6.0	24.5	11.2	12.0	11.6	9.8	9.0	6.2	8.3	12.9	9.2	8.4	8.6	9.0	16.6	38.1	8.9	9.7	11.8	16.9	20.8	11.2	6.4	8.3	54.7	12.2	6.9	24.6	7.0	8.8	14.1	10.6	12.7	11.3	16.4	9.0	14.3	25.5	11.4	19.2	25.3	10.4	7.7	11.3	1.5	2.2	2.0	1.0	2.5	1.9	1.8	1.4	1.6	0.9	1.8	0.9	0.8	1.9	1.5	0.2	2.0	1.5	9.7	8.8	23.4	14.6	8.5	9.7	12.6	9.9	13.4	8.5	10.2	15.3	7.6	16.0	15.6	27.4	2.4	5.9	2.0	2.3	1.8	9.0	6.7	4.3	79.6	0.0	8.4	3.7	16.7	2.4	2.5	4.8	1.9	1.7	5.9	5.0	6.5	7.1	6.6	3.0	43.9	1.3	1.4	6.6	8.2	6.0	5.1	4.6	5.7	3.9	1.4	18.5	37.9	4.4	0.0	3.5	4.4	8.3	7.2	4.2	5.4	18.7	2.2	4.8	3.1	30.2	42.8	2.1	1.3	5.7	2.0	3.7	3.4	2.5	4.6	9.6	0.0	3.5	3.7	3.8	4.2	4.3	7.4	2.6	3.5	5.2	3.9	3.2
DCUN1D3	"DKFZp686O0290, FLJ41725, MGC48972, SCCRO3"	ENSG00000188215	"Defective in cullin neddylation 1 domain containing 3"	Q8IWE4	16	20854925-20900358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 58.6;Late spermatids: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.2;ASC TERT1: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041983, HPA043511"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA041983: , HPA043511: AB_2678521"	"unprognostic (9.34e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.42e-1)"	20.6	9.5	3.9	6.3	4.3	2.8	9.3	5.5	4.6	8.3	4.1	6.2	3.3	6.2	2.5	8.3	6.9	9.7	7.1	3.4	4.8	5.2	11.9	9.9	2.6	4.0	4.0	5.0	6.8	4.4	4.7	7.9	4.0	5.4	3.9	12.6	3.7	4.1	28.5	7.1	4.0	8.6	3.7	4.4	5.9	8.3	4.8	3.2	4.4	4.0	2.6	8.3	9.4	7.2	4.8	8.6	4.2	8.7	52.2	38.9	5.4	16.1	13.6	7.9	10.5	10.7	8.5	3.0	12.6	15.8	4.7	6.1	4.8	6.7	10.6	4.0	2.9	2.5	7.1	15.8	13.6	3.7	23.9	25.9	9.0	15.2	8.5	8.4	22.2	2.9	2.9	7.4	16.4	6.6	3.4	5.5	9.9	4.1	2.7	6.1	4.5	2.6	7.0	5.0	3.6	4.8	6.2	6.2	3.6	4.7	4.2	1.8	10.9	16.5	5.4	6.9	4.4	6.9	4.3	2.0	17.1	4.1	8.3	1.3	0.3	0.2	0.4	0.6	0.3	0.2	0.2	0.6	0.4	0.3	0.3	0.6	0.3	0.6	0.5	0.2	0.2	0.2	3.9	4.3	5.5	4.6	3.4	4.8	4.0	4.0	4.0	3.7	4.8	7.2	25.6	12.8	19.3	4.6	2.9	31.4	11.7	7.5	19.4	12.4	19.0	10.8	5.2	2.8	7.2	9.2	35.5	3.6	8.2	6.3	0.0	3.8	58.6	14.5	16.2	18.4	20.3	1.3	10.6	5.2	2.0	16.5	5.6	34.3	0.0	4.2	9.7	16.3	2.3	13.5	9.7	4.3	6.1	5.0	20.6	48.5	10.8	15.8	12.4	1.9	1.8	5.2	1.0	10.6	10.8	4.9	1.2	9.8	3.3	6.1	3.0	5.2	4.3	24.8	6.6	20.1	19.6	6.4	3.7	10.7	22.6	5.1	5.9	4.1	4.7	18.3
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;endometrium 1: 1.4;retina: 2.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 39.1;Inhibitory neurons: 90.2;Oligodendrocyte precursor cells: 49.8;Rod photoreceptor cells: 21.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 52.5;SH-SY5Y: 22.1"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 74.0"	"Region enriched"	"Detected in all"	4	"olfactory bulb: 68.6"	HPA036121	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA036121: AB_2674950"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"	0.1	0.2	2.1	0.0	2.4	0.0	1.3	0.0	2.5	0.1	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.0	1.4	2.7	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.3	0.0	0.8	0.0	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	52.5	22.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	2.5	1.4	2.7	0.2	1.3	0.8	0.0	2.4	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.6	2.2	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	39.1	0.0	0.2	6.8	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	90.2	0.2	0.0	0.0	0.4	0.5	0.0	0.0	1.8	1.9	0.0	1.6	0.0	49.8	2.3	0.1	0.0	1.5	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.2	0.0	0.0
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 131.8;kidney: 124.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 364.4;Excitatory neurons: 197.4;Oligodendrocyte precursor cells: 182.4;Proximal tubular cells: 283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 239.4;LHCN-M2: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		350000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	10.3	28.6	95.9	12.8	100.9	0.6	18.8	61.5	131.8	22.4	73.4	45.1	40.1	10.8	76.5	12.6	36.5	25.5	17.4	102.0	77.3	124.8	79.5	26.4	2.6	58.6	84.8	2.9	27.5	21.1	6.3	11.6	62.6	28.5	45.3	34.6	17.7	18.6	30.4	5.6	39.7	16.5	59.5	10.6	29.7	19.1	106.6	1.0	28.9	14.0	2.0	19.2	2.6	80.3	63.1	7.6	36.0	6.9	84.1	78.0	9.2	155.9	120.0	63.6	75.6	89.9	16.5	0.1	39.2	239.4	38.3	17.8	79.7	15.0	93.0	0.3	29.5	0.2	22.3	31.8	40.9	57.6	3.2	60.5	2.0	50.4	24.9	85.5	75.9	0.0	0.1	6.0	179.7	7.5	3.0	0.3	25.5	124.6	22.6	0.0	63.1	0.9	113.4	46.3	59.2	115.0	18.0	56.3	9.1	38.7	29.6	4.9	107.7	31.6	27.0	11.7	57.8	0.0	0.1	0.2	1.6	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	100.9	61.5	131.8	102.0	77.3	58.6	84.8	62.6	59.5	106.6	80.3	14.1	35.3	43.4	364.4	2.6	13.8	4.6	6.8	5.7	4.5	31.2	13.8	11.8	61.5	13.6	69.9	4.2	2.7	0.4	75.3	125.2	15.9	22.5	36.9	9.8	7.5	34.2	2.7	197.4	31.2	0.9	13.9	47.9	24.2	0.0	59.3	8.2	102.8	1.1	0.0	51.0	86.9	8.2	2.2	5.5	25.6	15.8	2.4	12.4	23.4	0.6	68.4	0.0	182.4	9.6	44.5	69.4	74.9	0.0	33.6	68.7	283.3	36.5	9.4	13.1	15.3	18.6	4.6	5.4	32.6	14.3	0.8	2.5	13.5	106.7	8.3
DDIAS	"C11orf82, FLJ25416, FLJ38838, noxin"	ENSG00000165490	"DNA damage induced apoptosis suppressor"	Q8IXT1	11	82899975-82958277	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.9;testis: 10.8"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 8.2;Spermatocytes: 17.2;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038540, HPA038541"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA038540: AB_10672648, HPA038541: AB_2676071"	"unprognostic (2.53e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.86e-6)"	"unprognostic (4.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.04e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.11e-16)"	"unprognostic (7.17e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.13e-2)"	0.9	0.4	0.6	3.3	0.9	7.9	2.1	0.9	1.0	0.7	0.4	1.8	1.6	1.2	1.0	2.9	0.5	0.7	0.5	0.8	0.4	0.4	1.2	3.4	4.4	0.8	0.8	0.5	0.9	0.1	0.1	1.9	0.7	0.5	2.2	0.5	0.8	0.4	1.0	2.2	1.5	1.8	0.5	2.9	0.9	10.8	0.8	5.3	0.4	0.9	6.2	3.5	0.9	1.8	13.6	22.6	21.0	15.2	1.9	3.1	15.3	25.4	10.5	26.8	31.0	22.4	16.2	16.1	36.1	5.7	21.6	24.7	36.0	15.5	36.8	30.7	19.7	23.1	10.6	9.1	0.2	28.6	19.7	0.7	1.4	33.8	15.6	2.3	12.8	20.5	23.9	27.0	23.9	19.6	27.0	23.2	25.1	36.5	24.4	20.0	40.5	20.6	5.7	23.3	15.6	21.5	15.2	15.6	5.7	20.2	16.5	11.7	6.0	26.7	35.9	71.1	30.4	15.4	44.3	56.4	8.4	20.2	26.3	0.7	10.3	4.1	0.5	7.9	0.2	1.1	0.3	0.7	4.5	1.7	0.6	0.4	5.5	2.2	8.5	1.4	0.5	3.2	0.6	0.9	0.9	1.0	0.8	0.4	0.8	0.8	0.7	0.5	0.8	1.8	0.3	0.0	0.0	0.0	4.3	0.0	0.6	0.0	1.8	0.0	1.1	1.1	0.9	1.5	0.0	0.0	0.0	2.7	1.0	0.6	0.0	0.9	4.2	1.0	0.6	0.8	0.0	6.5	0.6	0.6	5.5	0.8	1.1	1.2	0.0	2.5	0.7	0.7	2.5	0.0	0.3	0.7	0.0	6.4	0.0	1.9	0.3	3.5	0.0	1.9	4.5	0.0	4.1	0.5	0.6	0.5	0.1	0.7	8.2	0.7	0.3	0.3	0.0	0.0	0.0	0.8	1.1	17.2	18.2	5.4	0.0	0.3	1.5	0.5	1.6	0.9
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048287-94081212	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (3.06e-9)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	80.7	130.5	23.3	3.9	24.2	23.5	75.2	25.9	29.7	80.0	24.5	85.8	3.7	93.1	37.2	48.9	81.4	6.7	114.3	24.3	23.9	61.2	43.4	69.4	10.4	31.2	25.2	87.3	49.8	7.0	109.0	2.8	25.4	69.9	3.8	8.0	53.9	4.9	123.9	67.4	59.6	4.1	23.9	75.9	66.1	114.3	25.2	8.0	73.5	4.2	9.1	80.2	65.9	26.2	6.5	1.8	11.5	7.5	6.8	8.8	2.7	17.6	14.5	22.4	20.0	2.2	4.0	29.8	6.4	3.9	6.7	4.1	11.9	1.1	24.5	13.0	0.7	15.8	4.3	9.9	5.7	23.0	6.8	1.4	6.6	4.1	3.9	7.5	3.7	5.6	8.5	8.2	9.6	18.2	7.0	19.6	7.6	1.9	0.2	9.3	26.6	3.5	17.0	2.4	9.1	8.4	17.3	4.2	8.5	1.8	6.8	8.1	11.3	6.4	4.4	8.2	5.3	3.4	24.8	31.5	9.2	12.3	5.1	9.5	2.1	1.7	3.0	1.7	0.8	1.7	1.6	1.8	1.2	2.3	3.0	3.0	1.5	3.8	1.8	1.9	2.1	3.0	23.3	24.2	25.9	29.7	24.3	23.9	31.2	25.2	25.4	23.9	25.2	26.2	164.7	169.9	160.6	45.4	245.9	182.8	186.6	147.4	171.4	184.7	86.6	94.7	228.3	64.3	146.4	147.1	131.3	94.0	332.8	74.1	272.0	147.0	98.2	244.0	248.2	142.2	97.5	75.5	62.9	98.9	72.6	189.0	95.8	201.0	154.9	251.5	109.6	103.4	85.1	232.2	73.6	89.0	118.0	92.1	147.4	67.4	231.5	143.5	99.6	45.0	158.0	133.4	122.6	31.7	56.1	91.0	67.4	244.8	225.6	116.4	70.7	242.3	160.4	200.5	164.3	185.0	198.0	506.5	435.9	127.6	145.6	157.1	342.1	305.9	74.9	123.7
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3 X-linked"	O00571	X	41333348-41364472	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 887.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		260000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	164.7	123.2	28.7	113.3	29.9	146.1	99.8	31.9	37.3	102.4	38.8	85.6	80.7	123.4	39.1	107.6	108.8	111.0	96.4	27.0	36.0	110.5	130.6	103.5	118.7	33.6	29.8	108.1	76.9	133.0	52.5	107.3	34.2	68.7	75.8	81.9	72.9	64.8	126.9	91.2	81.6	145.1	32.4	103.2	84.4	43.0	30.9	169.6	104.3	112.5	111.5	153.3	97.7	34.7	230.5	225.6	236.3	122.3	273.6	211.1	136.4	150.6	239.3	167.1	132.3	238.8	141.4	2.5	103.9	185.8	212.4	149.4	292.2	235.0	248.3	130.2	232.9	132.6	237.6	152.1	140.5	253.8	236.4	159.1	150.9	278.4	270.3	204.1	258.3	131.5	258.4	134.5	158.9	157.8	163.0	83.2	212.2	121.3	114.2	187.8	223.3	182.6	143.7	279.1	147.1	220.0	352.3	184.3	194.3	248.9	158.9	172.4	224.5	159.6	166.3	178.7	188.2	153.6	194.0	215.7	161.5	156.1	151.5	50.8	39.0	30.7	23.3	35.3	33.5	21.0	23.3	26.3	34.7	13.0	25.4	25.3	54.0	30.7	39.4	11.7	24.8	37.8	28.7	29.9	31.9	37.3	27.0	36.0	33.6	29.8	34.2	32.4	30.9	34.7	466.5	86.6	150.0	66.9	280.1	264.3	160.5	63.7	191.8	77.1	295.1	237.6	158.0	81.5	96.5	58.8	131.3	94.6	415.2	231.1	43.0	64.3	370.6	261.1	237.7	238.5	183.7	113.0	43.8	85.6	95.1	191.8	178.9	290.1	165.5	180.6	144.2	174.5	123.1	60.6	47.1	161.4	71.2	208.7	269.1	887.5	66.5	319.0	128.1	47.8	112.2	90.0	79.3	44.7	63.1	114.1	156.7	62.8	241.8	145.0	234.9	87.3	102.5	127.1	72.3	351.4	210.1	30.6	57.7	212.6	333.4	172.9	342.4	144.8	129.1	225.8
DDX4	VASA	ENSG00000152670	"DEAD-box helicase 4"	Q9NQI0	5	55738017-55817157	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"testis: 149.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 565.1;Late spermatids: 184.1;Spermatocytes: 320.9"	"Cancer enriched"	"Detected in single"	37	"testis cancer: 3.0"	"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;PC-3: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026170, HPA037763, HPA037764"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.54e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.43e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.55e-1)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	149.7	0.3	0.3	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.2	0.1	0.3	0.1	0.2	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	565.1	0.0	0.0	0.4	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	12.2	0.0	0.0	184.1	5.6	0.5	0.0	1.0	0.0	0.0	0.0	1.5	8.7	0.1	0.0	3.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	320.9	83.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX51		ENSG00000185163	"DEAD-box helicase 51"	Q8N8A6	12	132136594-132144319	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039503	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA039503: AB_10796328"	"unprognostic (2.84e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.65e-3)"	8.5	7.1	4.6	1.9	4.7	4.3	8.6	4.5	5.8	9.7	3.3	8.6	1.6	8.5	2.4	7.2	10.5	1.0	6.8	4.8	4.0	9.3	6.9	6.8	2.5	4.5	4.3	12.9	11.2	1.9	8.7	1.3	4.7	8.7	1.4	2.6	6.9	2.3	9.7	12.0	8.0	1.7	4.2	9.6	8.1	6.7	4.2	2.3	8.5	1.4	1.9	9.3	8.0	5.1	4.1	6.5	2.7	3.4	2.5	2.4	5.0	3.1	1.8	4.5	1.9	4.0	2.0	7.2	2.6	1.9	1.0	4.2	6.7	5.0	2.2	1.7	6.5	8.5	3.8	1.3	3.0	6.0	4.7	2.1	3.6	2.5	2.3	5.0	2.4	7.8	6.4	2.3	1.3	4.1	7.4	12.2	4.7	3.4	11.0	8.6	3.6	7.9	3.1	3.2	6.5	3.4	3.4	4.8	3.5	2.2	4.2	5.5	4.2	1.7	5.1	4.1	7.2	6.4	4.0	8.2	3.5	4.5	4.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	4.6	4.7	4.5	5.8	4.8	4.0	4.5	4.3	4.7	4.2	4.2	5.1	9.5	3.2	17.3	5.2	8.4	12.5	10.1	2.9	7.4	28.5	9.9	10.4	4.5	10.0	9.0	3.7	25.0	6.7	12.9	7.6	1.9	4.1	1.0	6.4	9.2	8.6	8.4	5.0	22.1	5.3	6.4	9.5	9.7	8.8	6.3	18.2	6.8	7.3	5.6	33.7	17.1	11.1	0.0	6.3	8.0	1.1	8.4	6.4	10.6	11.2	4.6	11.7	11.3	8.0	9.0	6.0	8.0	8.2	8.4	11.3	3.3	3.4	4.4	28.0	0.0	17.7	9.1	7.0	11.1	6.3	14.1	4.1	11.1	17.2	12.8	6.8
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999960-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"brain: 2.1;testis: 5.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 62.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.7"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;K-562: 4.6;RPMI-8226: 2.4;U-2197: 1.4;U-266/84: 10.5"									HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.3	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.9	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX6	"HLR2, RCK, Rck/p54"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747763-118791164	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		19000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	31.5	28.4	29.1	34.9	36.0	69.0	34.9	50.7	31.9	33.2	12.7	30.0	23.7	30.5	30.5	33.1	29.1	23.6	37.2	31.5	35.4	30.6	34.2	27.3	49.0	28.4	29.3	48.8	30.7	28.3	17.3	31.6	25.2	32.9	27.9	48.7	32.4	29.2	43.2	27.2	26.2	30.6	29.9	45.4	29.9	28.8	37.1	54.9	37.5	41.9	60.9	30.0	21.9	36.6	33.9	50.4	73.6	71.7	64.0	64.8	47.2	45.6	62.0	43.0	40.4	72.1	50.9	77.6	47.1	78.8	44.3	53.2	88.8	69.1	69.0	62.7	17.4	154.5	30.8	57.1	42.0	110.9	55.8	67.1	49.5	63.5	100.8	54.8	69.1	53.2	72.5	110.4	59.2	96.8	81.0	52.1	53.3	50.1	33.6	89.3	59.2	60.1	50.1	92.7	48.7	63.9	84.7	67.2	28.5	56.2	79.2	44.2	81.2	67.2	38.4	39.8	47.6	34.1	47.8	91.7	26.8	52.2	59.2	13.8	4.8	13.2	10.2	6.2	12.3	12.1	10.0	10.8	5.1	12.0	12.2	11.0	19.0	8.3	12.4	7.1	9.9	6.8	29.1	36.0	50.7	31.9	31.5	35.4	28.4	29.3	25.2	29.9	37.1	36.6	84.6	60.9	57.9	37.9	140.1	30.2	75.2	31.3	69.4	82.2	49.8	43.2	116.9	42.9	41.4	44.1	50.1	38.4	184.0	58.6	31.3	32.2	4.2	77.3	81.5	64.6	85.7	88.2	57.3	35.5	36.5	55.6	42.3	91.7	52.5	54.2	61.8	41.5	38.3	62.2	60.9	59.8	42.7	66.9	44.3	10.5	54.0	70.1	33.8	68.4	75.9	90.0	119.4	50.3	80.9	51.2	57.0	45.1	106.0	49.8	57.2	41.3	35.9	91.3	39.5	92.6	69.7	71.1	76.8	73.4	30.5	76.5	130.2	48.8	53.1	78.2
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 32.8;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 44.0"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	6.9	2.8	2.9	15.8	3.1	51.1	5.8	2.4	4.4	6.6	3.5	9.1	8.7	6.7	2.1	3.2	5.4	9.2	3.5	2.4	5.0	2.2	8.2	10.1	9.6	9.6	3.9	5.3	3.1	3.0	0.4	20.7	5.5	3.8	9.0	6.3	9.0	3.2	1.0	3.0	11.0	7.4	9.3	12.8	13.5	2.2	7.8	15.5	3.5	3.6	7.3	5.9	0.7	5.7	12.3	7.1	2.7	1.1	6.9	19.9	13.3	12.0	25.3	44.0	30.4	0.1	28.0	0.2	0.6	12.2	23.9	4.7	1.2	7.3	12.8	7.0	1.0	27.0	8.1	0.7	8.4	11.1	6.5	5.6	2.1	15.9	1.4	9.2	31.5	6.0	0.5	0.3	28.6	0.3	10.0	7.0	0.6	1.1	5.9	5.4	6.1	0.0	4.2	7.1	0.5	3.6	21.4	2.6	12.2	0.5	1.9	15.3	34.1	2.4	15.6	5.6	4.2	11.2	1.9	0.1	7.8	32.2	3.4	2.4	5.9	5.4	3.7	9.1	5.1	1.2	3.7	3.8	3.6	2.0	2.9	3.3	32.8	2.7	13.1	0.0	5.5	2.5	2.9	3.1	2.4	4.4	2.4	5.0	9.6	3.9	5.5	9.3	7.8	5.7	29.0	9.6	6.7	11.4	14.7	1.0	2.6	3.9	3.4	1.7	11.2	3.3	8.3	2.8	5.1	3.7	22.9	6.1	16.0	24.0	0.0	7.6	15.7	8.5	15.6	18.9	0.0	5.9	1.5	10.1	39.4	13.0	44.4	7.1	8.8	20.3	6.1	6.6	26.1	0.0	5.5	14.1	10.2	23.8	6.0	4.4	3.4	46.2	0.0	33.7	35.6	2.9	24.7	28.6	2.4	26.4	31.5	4.1	6.0	2.1	13.2	3.7	11.5	19.4	6.6	7.1	5.7	0.7	1.4	4.3	2.4	7.1	24.1	12.2	4.5	2.0
DEF8	FLJ20186	ENSG00000140995	"Differentially expressed in FDCP 8 homolog"	Q6ZN54	16	89948697-89968060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041745, HPA049434"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA041745: AB_2677650, HPA049434: "	"unprognostic (4.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (9.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.09e-1)"	37.0	40.3	58.3	38.0	59.4	45.4	36.2	60.0	68.5	41.2	38.1	52.4	20.0	45.9	19.4	45.5	42.1	25.4	49.4	57.5	54.7	45.3	35.2	40.8	72.6	71.6	62.1	47.4	51.2	32.3	50.6	17.1	66.9	42.5	13.5	26.9	37.7	27.5	40.8	48.9	33.7	27.7	50.6	45.6	45.9	14.1	62.6	9.8	41.6	24.8	52.0	44.6	36.4	62.4	54.4	107.7	47.0	65.1	46.9	47.4	56.6	82.9	68.1	117.9	53.8	114.9	64.0	66.8	61.2	54.6	47.1	34.6	55.4	94.1	51.4	16.0	164.6	29.5	62.3	167.4	49.6	21.3	44.9	56.0	77.3	84.1	46.3	48.3	87.1	58.2	97.6	21.8	70.7	198.3	41.4	64.2	60.8	24.6	110.2	86.9	35.8	55.3	62.0	50.0	72.1	74.2	131.5	48.3	44.6	24.3	45.4	67.1	89.9	68.9	73.3	36.0	88.3	40.5	31.3	85.1	72.5	54.2	82.1	8.2	39.3	80.7	26.6	33.1	24.0	49.3	21.8	19.6	26.2	61.1	14.5	14.1	52.6	13.1	18.9	69.1	29.6	27.5	58.3	59.4	60.0	68.5	57.5	54.7	71.6	62.1	66.9	50.6	62.6	62.4	27.7	0.0	14.8	31.0	32.6	44.7	22.1	33.0	15.4	24.1	20.1	22.2	33.9	21.5	20.4	14.7	27.1	29.3	30.7	20.0	29.4	42.6	6.5	12.0	25.5	27.8	21.6	9.1	19.2	92.3	48.2	31.5	11.7	15.6	10.1	20.3	20.7	23.9	63.5	30.3	19.3	17.9	42.7	33.5	62.7	23.3	21.1	30.1	46.2	14.0	56.1	17.8	21.6	15.6	22.6	112.4	20.4	33.4	65.1	46.6	16.9	47.7	16.4	26.3	19.7	20.4	40.7	6.2	11.2	19.9	54.7	32.4	17.5	33.3	15.8	30.1
DENND10	FAM45A	ENSG00000119979	"DENN domain containing 10"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 36.5;Cytotrophoblasts: 53.8;Extravillous trophoblasts: 27.7;Hofbauer cells: 56.0;Syncytiotrophoblasts: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	16.7	14.3	18.7	14.0	20.2	32.4	14.0	18.7	23.6	14.2	17.4	17.9	12.6	13.3	16.7	20.5	11.4	12.7	15.5	18.8	19.2	26.1	31.1	12.6	13.1	19.8	18.9	20.9	9.4	18.0	2.9	15.6	19.8	13.4	14.4	10.6	10.9	10.6	17.6	18.7	15.2	13.2	19.8	14.1	14.2	7.3	19.3	13.1	19.9	11.1	14.6	14.8	9.3	21.7	23.7	24.9	38.6	45.5	75.9	59.1	15.9	32.3	85.9	29.4	30.1	23.7	35.8	16.1	12.8	41.4	33.8	42.2	25.7	28.0	27.0	29.2	24.1	3.8	11.5	32.9	75.4	11.0	10.3	63.7	31.5	20.9	32.6	75.0	36.1	16.8	7.8	22.9	42.0	20.0	17.2	48.5	23.6	22.1	14.6	17.0	40.6	14.3	38.6	25.9	6.9	27.7	21.7	30.2	67.5	36.1	24.9	48.5	36.6	23.3	12.3	28.9	19.4	23.0	10.0	17.7	35.9	54.7	11.2	44.9	26.6	55.6	6.9	31.8	6.6	3.9	10.9	10.0	16.6	3.6	5.7	7.1	40.0	6.1	36.4	5.0	20.4	11.6	18.7	20.2	18.7	23.6	18.8	19.2	19.8	18.9	19.8	19.8	19.3	21.7	9.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	53.8	11.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	27.7	9.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	45.3	1.7	0.0	0.0	0.0
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.5;dendritic cells: 30.1;granulocytes: 15.9;Hofbauer cells: 14.6;NK-cells: 35.0;T-cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 22.5;HEL: 15.1;HMC-1: 44.7;MOLT-4: 14.7;THP-1: 13.8;U-937: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"	2.2	1.0	1.4	21.4	1.3	21.2	1.0	1.5	1.7	0.9	1.5	3.0	4.9	0.9	0.0	1.9	1.3	2.8	1.1	1.4	1.5	1.6	2.1	5.8	32.1	2.4	1.8	0.3	1.3	0.1	0.8	1.8	2.2	1.6	1.2	0.0	3.0	0.5	0.8	1.4	14.4	1.2	1.8	35.1	5.2	0.4	2.8	20.5	1.7	0.3	14.9	3.0	1.3	2.6	0.2	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	22.5	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.0	15.1	0.0	1.6	0.0	7.5	44.7	0.0	0.0	0.1	0.0	0.0	0.0	7.4	0.3	9.4	0.1	0.0	14.7	11.5	0.0	0.5	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	13.8	0.1	0.0	0.0	0.0	0.0	0.4	2.0	10.6	0.1	31.3	0.0	18.3	19.9	32.8	40.1	32.4	35.0	23.8	28.6	35.0	19.5	18.7	35.7	32.1	27.8	23.8	35.0	11.2	35.6	37.1	1.4	1.3	1.5	1.7	1.4	1.5	2.4	1.8	2.2	1.8	2.8	2.6	0.3	3.2	3.0	0.0	27.5	0.4	0.1	0.0	1.2	0.0	0.6	0.6	1.3	2.8	0.0	1.8	0.0	0.2	30.1	0.5	1.9	0.4	0.7	1.5	0.2	0.4	0.0	5.7	0.4	0.0	0.2	0.7	1.5	0.3	15.9	0.5	1.1	0.7	14.6	0.0	0.5	0.9	0.0	11.6	9.2	0.6	0.0	13.8	3.6	2.8	10.9	0.0	35.0	0.0	0.5	0.3	0.4	0.0	13.5	0.2	2.9	6.2	1.6	0.0	0.0	0.0	0.3	0.3	1.2	1.6	0.1	0.3	34.5	0.7	1.0	0.1
DENND3	KIAA0870	ENSG00000105339	"DENN domain containing 3"	A2RUS2	8	141117278-141195808	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 157.0;Microglial cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 34.6;neutrophil: 39.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 39.8;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 64.6;HeLa: 89.5;U-937: 58.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024491, HPA041668"		Approved	Approved	Vesicles,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"		"HPA024491: AB_2671581, HPA041668: "	"unprognostic (2.27e-1)"	"unprognostic (9.62e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.42e-2)"	42.8	8.9	21.7	27.2	18.8	106.4	28.2	12.2	28.4	22.9	14.7	36.2	5.7	17.8	2.1	7.5	19.1	13.6	24.9	19.9	17.7	21.5	6.5	57.9	28.6	33.6	24.7	15.1	7.6	4.1	10.0	15.1	25.7	16.9	7.8	3.7	18.2	8.5	13.8	15.6	23.7	8.3	22.7	43.9	15.8	6.1	21.2	7.1	20.6	11.7	25.1	12.4	17.6	31.4	16.4	14.8	1.0	3.1	4.4	6.4	2.4	8.5	27.4	3.8	3.0	4.6	15.3	4.2	22.8	17.5	7.5	7.8	4.2	10.0	2.7	64.6	3.6	17.3	89.5	1.4	3.9	17.2	2.4	0.5	5.1	4.2	5.3	9.2	21.1	7.8	0.2	40.7	2.9	5.2	2.6	24.1	1.1	3.2	16.6	2.9	0.8	16.6	14.8	5.6	4.7	3.0	1.8	1.3	1.1	7.3	6.8	27.6	16.7	0.7	6.8	10.6	0.3	8.0	37.0	1.3	2.6	58.6	1.0	24.3	5.4	34.6	0.8	8.0	0.8	5.0	0.6	0.3	4.1	4.3	0.1	0.2	39.8	2.7	10.0	0.1	0.2	3.5	21.7	18.8	12.2	28.4	19.9	17.7	33.6	24.7	25.7	22.7	21.2	31.4	49.0	157.0	35.2	2.6	39.7	15.7	7.6	11.7	7.4	4.5	6.3	2.0	10.1	10.0	18.8	22.0	4.2	0.7	29.5	18.3	1.9	3.5	6.1	15.1	8.1	31.7	4.8	5.7	53.9	3.5	0.6	4.8	16.8	14.5	10.8	1.9	16.4	0.3	24.4	1.7	5.2	7.9	4.1	55.6	22.2	2.8	1.5	39.7	8.8	79.6	33.0	0.7	21.6	1.5	1.1	11.0	9.9	0.7	38.8	20.3	1.5	2.7	15.1	0.5	39.5	2.1	21.5	8.7	8.5	2.9	9.1	0.5	12.5	0.6	4.1	6.3
DENR	"DRP, DRP1, SMAP-3"	ENSG00000139726	"Density regulated re-initiation and release factor"	O43583	12	122752824-122771064	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 227.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021783	Approved		Approved	Cytosol		NA	NA		200000	"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA021783: AB_2670820"	"unprognostic (3.65e-2)"	"unprognostic (7.00e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (2.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (8.57e-6)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-1)"	25.4	22.6	19.0	27.0	19.6	27.5	29.6	15.3	23.6	22.2	15.1	25.5	26.7	23.7	22.1	32.5	21.7	22.1	24.4	19.4	20.2	25.5	27.6	18.8	36.2	16.8	21.6	19.2	21.2	59.0	17.1	31.6	19.5	28.0	26.0	16.5	28.4	24.8	60.2	29.6	25.0	24.5	15.2	28.0	23.3	14.6	18.9	38.9	29.8	44.7	35.5	30.0	20.4	16.7	113.1	62.1	77.7	80.1	48.7	71.9	67.6	100.5	56.1	87.6	60.6	86.9	40.6	99.9	103.4	72.5	66.6	84.0	93.8	89.5	117.6	90.9	67.3	122.8	36.2	63.8	63.5	139.6	97.4	62.8	86.9	79.3	107.4	81.6	86.4	109.7	129.8	35.8	94.8	74.9	137.7	134.1	159.2	67.2	128.4	120.6	91.2	63.7	85.3	99.9	89.3	63.4	139.2	40.8	107.3	79.1	129.5	78.1	82.2	81.2	95.9	91.7	102.1	58.8	145.8	160.4	76.4	100.1	90.9	227.9	35.0	58.1	38.8	53.3	45.3	45.5	41.9	39.4	47.3	41.4	48.5	43.4	42.2	47.3	69.9	42.1	49.2	44.5	19.0	19.6	15.3	23.6	19.4	20.2	16.8	21.6	19.5	15.2	18.9	16.7	43.4	70.5	40.1	31.0	59.8	71.9	65.9	55.4	59.7	37.7	66.2	69.8	66.3	45.8	47.7	47.8	41.7	73.0	60.8	40.9	64.6	68.6	17.9	67.7	83.5	51.4	84.8	53.8	39.0	61.8	130.3	48.3	40.8	70.7	43.1	50.4	42.1	54.3	57.4	55.5	36.2	53.6	44.7	50.1	42.4	8.0	50.4	49.3	26.6	25.3	60.2	47.3	75.2	48.2	31.3	88.0	44.6	45.9	47.9	73.2	40.3	67.3	49.5	35.9	19.7	46.2	62.5	120.3	136.8	72.8	64.9	60.6	54.7	47.3	58.8	51.3
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;gallbladder: 21.0;lymphoid tissue: 20.7;testis: 12.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Erythroid cells: 23.8;Extravillous trophoblasts: 21.6;Spermatocytes: 37.2;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA038255: AB_10669521, HPA072558: AB_2686534"	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.42e-4)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (3.08e-4)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.3	0.2	0.4	3.9	0.7	11.1	0.9	0.5	0.5	0.6	0.1	4.1	6.0	0.6	0.0	2.5	0.2	21.0	0.1	0.3	0.6	2.9	0.4	0.4	9.1	1.2	0.5	0.2	0.1	0.0	0.0	7.5	1.4	0.2	5.5	0.1	0.5	0.1	0.0	2.1	6.4	0.9	0.6	1.6	1.4	12.6	0.6	20.7	1.2	0.0	9.7	1.0	1.1	1.5	61.0	20.3	60.5	37.2	1.3	1.9	66.2	16.1	10.9	27.7	35.8	34.0	37.5	34.6	38.5	5.0	36.0	19.8	49.2	36.1	36.9	49.5	35.5	43.3	22.7	42.6	1.0	36.7	40.3	1.2	3.7	9.0	12.9	5.4	26.1	36.3	31.4	45.8	24.7	38.0	59.8	31.9	44.7	13.0	32.6	65.4	49.2	29.4	22.8	29.9	33.6	15.4	37.7	13.4	17.7	27.0	24.9	28.8	12.1	11.7	34.2	9.5	41.6	23.0	43.3	68.0	14.7	53.2	33.3	1.5	0.1	0.9	0.2	0.0	0.2	0.4	1.0	0.7	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	3.2	0.4	0.4	0.7	0.5	0.5	0.3	0.6	1.2	0.5	1.4	0.6	0.6	1.5	0.2	0.0	1.8	0.0	1.9	4.7	1.0	1.5	0.0	0.1	0.5	0.8	0.1	18.6	0.3	0.0	0.0	7.4	1.1	3.1	0.0	0.3	1.9	3.3	1.4	0.9	0.0	23.8	5.5	0.2	21.6	1.1	2.6	11.7	3.8	5.2	0.0	0.3	6.4	0.0	1.7	2.3	0.0	1.6	2.9	2.4	0.3	1.9	0.0	4.7	0.1	0.2	0.0	2.0	7.0	0.9	5.8	0.0	15.9	0.7	3.7	1.0	0.1	0.1	6.6	0.3	1.4	37.2	12.7	5.8	2.0	46.9	4.5	0.6	7.9	0.9
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015876-33033582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 29.0;kidney: 19.6;liver: 74.0;testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 34.8;Early spermatids: 153.3;Extravillous trophoblasts: 47.0;Proximal enterocytes: 33.2;Spermatocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 53.7;RH-30: 40.1;SiHa: 37.3;SK-MEL-30: 34.4;U-2197: 34.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.8	2.5	1.9	3.2	1.8	0.9	2.9	3.7	2.8	2.7	4.6	24.6	1.0	2.2	4.4	0.9	4.4	1.1	2.6	2.7	19.6	74.0	0.9	0.7	3.2	2.7	1.6	3.8	2.3	0.8	1.5	3.0	1.9	5.1	0.1	2.0	1.5	4.9	6.0	29.0	1.7	2.8	0.3	3.0	28.2	2.7	2.9	0.5	0.9	1.5	1.2	3.4	4.9	9.4	5.2	7.3	3.3	3.8	3.6	4.9	16.2	5.4	9.8	13.0	13.5	0.9	0.0	3.7	16.2	4.5	9.4	10.8	3.8	11.5	0.0	14.9	2.5	16.1	19.3	3.2	9.1	10.9	4.6	5.7	5.7	4.2	5.3	0.0	0.0	6.2	0.0	53.7	1.0	0.0	14.6	4.8	7.7	0.0	0.0	40.1	0.1	3.2	1.3	1.6	4.2	37.3	6.6	34.4	5.1	1.7	4.7	0.0	6.3	10.4	34.1	10.6	0.0	0.0	0.1	2.3	0.0	31.5	4.1	0.5	6.7	0.2	0.1	0.0	0.0	0.4	0.2	3.2	0.0	1.9	2.1	0.0	2.4	0.0	1.2	0.0	0.4	2.5	3.2	2.9	3.7	2.6	2.7	3.2	2.7	3.0	2.8	2.7	4.9	0.2	0.0	0.0	1.0	0.0	34.8	12.8	4.5	12.5	0.0	0.2	0.6	0.1	1.5	0.9	0.0	0.0	0.5	0.5	6.0	3.9	0.9	153.3	0.2	0.2	0.3	3.5	3.2	0.1	0.6	47.0	1.6	0.0	0.1	2.5	0.1	1.4	22.6	3.1	0.0	0.4	2.4	0.0	0.6	9.5	16.3	1.5	1.7	1.8	3.7	1.2	0.0	0.0	3.5	10.4	0.8	0.6	1.2	0.1	2.4	33.2	18.4	0.9	0.0	0.0	4.5	1.4	42.3	6.5	6.6	7.4	1.5	0.7	0.2	2.4	1.6
DESI1	"D15Wsu75e, DESI-1, FAM152B, POST, PPPDE2"	ENSG00000100418	"Desumoylating isopeptidase 1"	Q6ICB0	22	41598028-41621043	"Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 761.4;Late spermatids: 415.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053415	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Cytokinetic bridge"	"HPA053415: AB_2682141"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.16e-3)"	"unprognostic (8.75e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	11.9	18.5	34.3	10.4	36.0	7.5	10.9	37.1	36.6	10.7	23.6	13.3	11.6	11.2	11.3	26.4	10.2	8.9	38.1	34.4	37.5	22.3	47.3	14.7	11.6	36.1	37.9	12.4	12.5	13.1	12.2	9.3	35.5	13.0	10.6	12.9	12.0	10.6	16.1	15.5	12.6	11.3	34.9	13.5	16.4	18.7	38.6	8.8	9.2	17.6	13.6	12.7	11.9	35.3	16.7	17.4	17.0	23.4	23.5	28.0	9.6	33.0	21.0	30.0	21.9	23.2	10.4	63.2	22.2	38.2	15.7	23.8	45.7	36.8	31.1	28.6	34.7	14.2	32.5	19.7	28.8	56.4	18.4	24.1	42.2	36.8	34.1	24.3	45.8	21.7	42.0	69.5	24.0	21.2	12.9	17.2	16.8	62.2	26.0	17.3	7.2	65.2	38.0	10.5	12.1	6.3	31.8	34.5	23.0	19.3	11.4	18.3	46.8	22.0	16.0	23.4	16.3	25.4	21.1	29.7	54.4	24.4	29.7	9.1	6.6	7.8	3.3	9.0	4.3	4.1	4.0	3.9	5.2	3.7	3.5	4.3	3.8	2.1	6.2	3.0	5.3	4.2	34.3	36.0	37.1	36.6	34.4	37.5	36.1	37.9	35.5	34.9	38.6	35.3	21.2	9.6	18.9	10.7	27.1	8.7	36.6	42.1	13.1	19.8	29.7	29.8	55.2	18.6	21.7	9.2	6.2	31.1	15.0	29.0	39.2	50.8	761.4	29.5	24.7	24.1	19.7	11.8	13.9	30.2	39.5	17.6	19.4	55.0	10.8	27.6	19.6	72.9	50.4	21.9	18.1	19.9	22.4	28.1	18.6	415.8	19.0	33.8	14.2	6.5	49.4	18.6	30.9	11.6	13.3	50.0	29.5	10.5	46.5	111.0	80.1	53.7	10.8	11.4	26.3	14.3	24.3	149.4	30.7	43.6	13.2	83.6	22.4	28.9	26.3	72.3
DEXI	MYLE	ENSG00000182108	"Dexi homolog"	O95424	16	10928891-10942468	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041511	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	Cytosol	"HPA041511: AB_10796675"	"unprognostic (4.14e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.47e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.83e-2)"	34.7	82.2	52.6	10.8	54.2	5.5	29.3	59.3	60.1	35.3	44.3	46.8	14.6	34.5	23.4	25.0	34.1	11.2	101.6	43.0	54.0	33.1	91.3	27.3	12.5	58.7	55.6	34.6	29.8	20.9	38.0	13.0	62.2	39.1	7.9	6.2	23.5	20.3	128.4	27.6	24.9	15.5	51.8	30.5	34.0	14.8	67.9	11.6	28.4	58.7	10.5	33.5	28.9	45.5	18.1	25.9	13.6	24.1	54.1	29.5	12.5	27.2	28.0	17.4	16.5	12.2	18.5	21.4	39.9	31.0	19.0	22.9	16.2	29.3	14.9	50.4	36.4	10.7	17.1	52.3	30.9	18.3	19.3	30.2	33.1	17.1	19.7	28.2	25.3	29.7	24.5	20.8	19.6	31.9	22.9	19.9	19.1	22.3	26.5	21.2	18.0	32.8	21.9	13.3	28.0	24.7	26.0	28.2	22.6	11.4	22.5	31.6	28.1	17.5	18.7	41.9	18.0	27.2	22.6	6.2	15.4	38.7	20.2	1.3	0.5	7.2	4.6	0.6	4.2	0.5	4.0	5.4	0.3	4.1	4.7	4.6	0.5	3.0	0.2	2.0	3.3	1.0	52.6	54.2	59.3	60.1	43.0	54.0	58.7	55.6	62.2	51.8	67.9	45.5	23.3	6.4	12.1	10.1	12.4	33.3	40.5	9.7	21.6	18.8	19.1	26.0	0.0	41.5	5.9	27.6	12.5	28.1	11.5	8.5	76.3	24.8	8.1	10.5	21.4	27.1	14.9	15.6	8.0	36.2	21.4	33.8	10.7	7.4	1.3	30.4	46.1	106.3	41.2	23.5	13.3	14.5	14.2	15.5	15.8	14.9	75.2	14.6	16.0	8.4	10.7	57.0	18.6	3.5	6.7	31.2	10.1	85.7	14.9	70.7	17.8	70.9	8.8	14.8	19.7	29.9	26.1	3.8	3.7	18.4	32.5	11.6	19.2	38.4	17.5	39.0
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 476.0;breast: 133.6;liver: 331.8;skin 1: 151.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"eosinophil: 137.7;neutrophil: 348.6"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 348.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 22.0"	HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	476.0	5.1	5.8	19.4	11.7	7.2	133.6	2.9	6.1	2.6	5.3	9.0	14.5	1.2	1.8	24.1	2.1	5.8	11.7	5.7	6.4	3.4	331.8	5.6	4.0	3.7	3.9	1.8	4.6	2.1	1.6	1.5	5.5	2.2	4.9	0.6	10.5	1.6	4.1	151.5	16.5	2.8	3.4	15.0	12.8	38.1	6.9	4.3	8.8	5.6	18.2	21.3	12.6	5.1	13.3	6.4	0.4	11.2	80.4	6.4	1.0	1.3	1.7	1.6	1.0	46.6	13.5	21.1	16.8	0.3	11.9	0.5	1.8	6.5	4.4	62.5	1.2	1.5	4.0	64.9	0.9	7.4	7.2	26.8	33.6	7.3	10.6	4.4	1.2	20.9	1.2	27.6	0.7	8.5	5.1	16.7	3.6	124.0	31.5	0.0	0.1	24.8	1.2	35.8	22.6	1.4	12.3	1.9	2.9	2.7	4.4	26.6	1.6	14.1	7.0	0.3	9.1	16.3	40.0	28.8	10.2	23.7	25.3	19.4	22.1	137.7	0.0	4.4	0.4	7.4	0.4	0.0	6.1	7.6	0.1	0.2	348.6	0.0	5.0	1.8	0.0	5.7	5.8	11.7	2.9	6.1	5.7	6.4	3.7	3.9	5.5	3.4	6.9	5.1	3.2	6.4	5.4	0.3	5.0	1.1	0.9	3.0	0.6	0.9	5.2	7.0	3.5	0.0	2.7	0.0	2.1	0.5	0.3	0.6	0.0	1.7	259.3	3.3	0.2	0.5	1.2	2.7	2.9	0.5	0.1	0.7	10.7	0.2	0.0	2.1	2.9	116.4	2.2	1.7	1.3	4.8	0.0	4.1	13.1	64.1	2.1	4.2	1.8	0.0	4.0	0.4	0.0	0.0	1.0	3.7	2.2	0.7	0.9	2.8	1.2	2.2	3.4	0.0	6.6	0.6	1.0	53.9	53.5	0.3	8.0	0.8	0.5	0.2	3.0	15.7
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 105.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	7.4	4.8	3.1	4.2	3.6	3.9	5.8	3.7	3.7	4.0	3.7	5.4	3.9	5.4	2.8	4.2	6.1	2.3	13.8	2.9	2.5	8.0	105.9	3.9	4.2	3.4	3.3	4.9	4.2	6.2	2.5	2.7	3.3	4.0	5.8	3.2	5.4	4.5	10.0	4.5	3.1	5.7	2.1	4.1	4.1	3.6	3.4	3.9	4.1	8.1	5.5	3.9	3.4	5.2	12.5	25.7	6.9	12.1	3.8	5.0	13.9	10.5	4.2	15.6	11.6	20.4	11.1	27.8	13.6	5.7	8.6	12.5	13.7	11.4	18.2	6.0	13.3	15.4	12.6	20.3	10.6	21.4	10.8	4.9	11.3	18.6	19.7	4.7	11.3	18.3	23.9	4.4	9.7	32.7	20.2	17.0	15.9	21.1	10.0	24.9	9.6	29.4	9.4	7.8	8.5	10.2	14.1	14.8	6.8	8.7	13.0	10.3	5.1	14.1	8.3	13.1	15.2	8.8	18.7	46.3	7.1	22.4	12.8	6.1	8.4	1.0	9.4	8.8	12.9	12.0	8.5	9.3	14.5	11.7	11.7	12.6	2.1	10.1	6.3	13.5	8.0	7.2	3.1	3.6	3.7	3.7	2.9	2.5	3.4	3.3	3.3	2.1	3.4	5.2	6.3	3.2	13.1	1.6	7.1	5.6	7.8	11.2	6.8	5.6	6.6	7.1	14.8	15.7	5.5	7.3	4.2	12.3	6.9	1.6	5.9	10.3	2.9	3.8	6.3	9.1	1.2	7.8	2.0	5.1	12.4	7.4	2.6	3.2	8.2	10.2	5.3	124.1	7.9	3.3	2.3	6.6	10.2	6.0	3.1	3.6	2.8	3.3	12.4	1.0	3.8	5.2	8.2	4.0	4.4	5.9	2.4	2.2	4.6	11.2	1.0	20.8	8.1	5.2	0.0	9.7	9.1	6.8	8.1	5.0	3.8	2.9	4.3	13.5	6.7	4.2
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	30.6	43.2	44.6	23.9	48.1	21.7	29.6	51.0	57.5	35.7	50.0	40.9	28.0	33.2	15.6	29.5	38.6	20.1	41.0	46.5	48.6	34.2	41.0	29.6	32.7	46.4	45.1	40.6	49.7	47.0	52.8	19.7	50.0	34.8	29.5	69.1	34.1	27.9	92.6	41.3	32.8	29.1	47.7	31.6	44.2	16.0	45.9	45.2	28.7	70.5	34.7	36.7	33.1	56.2	70.8	50.8	80.8	41.5	34.2	57.7	18.6	44.0	64.9	82.8	82.9	35.4	33.8	71.7	49.4	48.2	75.6	41.0	55.7	63.0	57.4	64.2	37.8	48.8	51.4	47.1	43.8	57.2	72.1	47.2	74.8	49.7	85.2	82.9	59.1	141.5	45.1	49.5	61.5	137.0	105.1	83.3	64.2	90.3	85.1	65.8	29.1	106.6	63.5	34.6	106.7	144.4	44.0	64.2	76.0	48.1	59.0	96.5	29.8	94.4	38.2	93.5	69.2	160.0	184.9	49.9	59.7	66.2	94.5	37.0	58.8	82.7	51.0	54.1	53.0	86.2	59.0	52.8	63.4	82.1	77.7	56.8	18.2	64.2	72.8	64.9	77.6	70.0	44.6	48.1	51.0	57.5	46.5	48.6	46.4	45.1	50.0	47.7	45.9	56.2	40.3	41.7	30.7	10.1	54.8	55.6	79.2	93.0	38.7	75.8	48.3	64.5	8.6	37.1	49.1	33.1	45.9	47.1	52.2	35.2	86.1	53.7	20.9	38.2	24.5	35.0	41.3	26.7	11.9	37.6	55.1	35.0	33.6	27.9	24.1	46.0	30.4	34.6	42.8	42.1	12.5	60.8	79.3	37.6	42.5	27.5	45.1	35.3	49.8	6.5	62.7	115.2	53.5	8.0	14.7	48.7	70.1	34.6	51.1	73.3	87.9	84.1	49.6	129.2	46.0	39.6	53.8	33.3	62.3	39.7	51.0	71.8	51.1	37.4	54.3	71.0
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299780	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 68.9;liver: 61.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000599, HPA076886"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655, HPA076886: "	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.18e-5)"	"prognostic favorable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	12.4	14.8	2.0	2.8	2.1	4.4	13.3	2.3	2.8	17.6	2.7	16.3	21.5	11.5	5.8	68.9	9.4	5.3	5.4	2.0	2.4	15.0	61.2	9.7	4.4	2.4	2.1	7.0	7.7	13.5	8.8	3.5	2.3	10.1	6.6	1.2	26.2	7.4	2.9	40.7	19.8	5.7	2.3	10.5	11.4	5.5	2.1	4.8	11.7	2.8	9.5	8.9	25.4	2.7	16.6	4.0	4.2	1.7	9.4	10.0	1.1	5.9	12.7	13.4	14.6	1.7	15.7	7.7	2.5	9.3	2.2	14.0	3.2	26.5	6.6	5.4	3.6	2.4	9.1	27.2	4.5	4.8	1.9	8.9	15.9	3.4	2.5	11.2	10.2	6.5	4.9	7.4	11.4	7.0	1.8	1.8	0.7	13.4	6.1	6.0	3.0	10.8	10.5	6.4	3.8	2.7	8.2	11.1	3.0	3.0	5.8	1.4	4.0	1.1	2.6	1.7	2.0	4.1	3.5	3.8	4.9	4.1	1.3	15.1	9.0	18.4	6.5	10.2	7.2	9.9	7.2	6.2	11.1	6.3	7.0	4.0	5.9	5.0	6.2	6.8	12.3	5.2	2.0	2.1	2.3	2.8	2.0	2.4	2.4	2.1	2.3	2.3	2.1	2.7	17.8	22.4	17.1	8.5	18.4	32.9	26.9	89.9	28.5	12.3	32.4	27.3	19.0	50.1	36.1	35.0	18.8	48.3	26.2	59.6	39.2	27.1	21.7	14.2	6.7	17.1	19.2	16.2	6.9	30.4	9.5	16.5	19.4	18.0	6.3	14.6	14.6	105.4	28.1	15.2	9.2	39.8	40.7	14.6	18.0	34.8	20.2	17.0	46.2	4.7	15.2	16.5	24.7	7.1	14.2	64.1	50.3	20.7	21.8	17.9	178.8	74.8	22.6	47.7	26.3	10.4	16.3	27.3	14.0	80.5	45.7	26.1	23.4	13.7	41.3	35.9
DHRS11	"MGC4172, SDR24C1"	ENSG00000278535	"Dehydrogenase/reductase 11"	Q6UWP2	17	36591879-36600804	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"intestine: 216.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 129.3;Distal enterocytes: 317.3;Paneth cells: 154.2;Proximal enterocytes: 527.9;Undifferentiated cells: 148.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041226, HPA048236, HPA053623"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted to digestive system"	NA	NA		42000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Golgi apparatus"	"HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209"	"unprognostic (2.00e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	10.0	10.5	6.9	5.4	7.9	4.4	10.9	6.7	9.8	9.5	9.0	74.3	216.0	5.7	1.9	14.6	7.3	2.4	17.2	8.6	9.0	21.9	14.8	4.3	2.4	7.4	7.5	5.1	15.4	9.5	13.3	2.0	7.9	8.0	57.1	22.4	10.3	4.5	16.7	14.4	177.0	6.3	6.6	4.7	11.7	17.0	8.2	2.1	11.9	9.9	3.6	6.8	10.5	7.7	13.9	10.0	3.6	13.8	1.2	2.5	10.6	3.8	2.6	11.9	10.7	22.2	10.1	0.8	1.9	4.0	4.8	13.9	11.5	6.7	10.5	7.1	15.2	3.7	10.1	35.6	5.5	3.0	1.2	2.2	7.3	8.6	6.5	1.9	8.8	11.2	36.1	9.3	5.9	12.5	12.6	5.5	4.5	14.2	0.4	15.2	12.8	22.0	9.9	11.4	10.4	4.9	16.0	12.9	33.3	6.6	19.1	3.6	4.8	1.6	18.2	7.6	10.0	14.1	16.7	4.4	6.5	9.3	5.5	0.1	0.1	0.4	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.7	0.0	6.9	7.9	6.7	9.8	8.6	9.0	7.4	7.5	7.9	6.6	8.2	7.7	9.1	0.0	1.5	4.2	3.3	4.2	8.9	2.8	4.0	20.7	14.6	13.3	9.6	2.8	2.4	7.3	129.3	7.9	1.4	317.3	58.7	10.7	22.9	10.2	5.0	6.7	12.1	31.5	8.2	11.4	4.7	3.4	8.6	6.8	0.0	5.3	5.3	12.7	3.5	16.8	9.6	72.2	2.0	1.9	4.2	30.5	4.1	2.6	19.6	2.8	3.6	15.8	1.0	4.0	2.0	7.5	154.2	5.3	9.1	11.7	527.9	43.1	3.8	71.0	0.0	5.9	5.9	27.7	6.5	12.0	6.0	7.0	3.1	9.3	148.5	15.2
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	19.0	18.8	18.5	8.1	18.6	2.9	19.2	19.6	28.3	17.8	19.9	15.1	15.6	11.4	25.7	12.8	15.9	11.9	22.2	18.6	19.2	22.8	20.2	13.4	7.7	19.3	19.2	8.4	20.2	32.9	7.9	13.2	19.4	15.1	15.8	10.8	18.3	10.2	30.8	18.7	14.5	9.6	19.3	9.2	18.1	24.0	18.3	6.8	16.6	19.5	9.0	12.4	11.1	20.7	17.2	19.9	7.1	15.6	18.5	12.7	12.4	16.0	8.9	11.4	20.7	25.2	17.6	7.2	23.8	13.7	9.0	23.7	10.6	26.2	16.1	13.8	33.9	9.9	13.8	21.8	10.2	5.5	7.0	10.0	17.0	14.6	22.1	5.6	11.3	12.5	6.0	8.6	13.5	35.2	6.0	21.6	9.9	55.4	8.5	10.0	18.8	12.7	39.1	20.5	3.9	8.3	19.8	17.4	17.9	56.8	11.7	11.2	5.6	9.4	6.4	28.7	18.3	4.7	7.9	13.6	14.9	20.3	14.4	19.2	34.3	29.3	6.7	33.9	6.0	7.6	6.5	4.6	21.6	5.9	7.0	6.1	25.0	8.4	40.8	9.4	10.9	14.4	18.5	18.6	19.6	28.3	18.6	19.2	19.3	19.2	19.4	19.3	18.3	20.7	31.1	16.0	18.1	29.4	11.9	16.3	26.7	59.0	11.4	21.3	19.8	17.4	14.1	25.8	38.5	29.5	31.3	52.9	11.3	25.9	17.6	47.2	69.5	38.1	13.6	23.7	7.2	21.9	32.9	39.0	31.8	18.9	14.3	22.2	8.8	13.8	27.5	20.5	29.4	18.5	37.3	28.5	48.8	17.9	15.5	24.4	22.4	14.3	19.6	14.0	20.8	27.6	22.6	36.7	36.2	30.0	24.8	35.0	10.5	29.0	44.4	25.2	50.7	40.1	6.6	15.1	18.2	71.5	22.3	10.7	18.6	51.6	11.2	27.3	22.2	25.1
DHX29	DDX29	ENSG00000067248	"DExH-box helicase 29"	Q7Z478	5	55256055-55307694	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038317, HPA038318"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038317: AB_10673169, HPA038318: AB_10672589"	"unprognostic (3.43e-2)"	"unprognostic (5.09e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.01e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.78e-3)"	"unprognostic (9.40e-2)"	10.6	10.6	5.3	9.7	5.7	6.7	12.0	9.1	7.0	12.5	6.7	12.1	7.2	11.4	6.8	12.7	9.5	8.9	10.7	5.7	5.1	16.9	13.1	9.4	9.5	5.0	5.0	8.9	11.7	18.7	10.4	11.4	5.1	13.4	9.8	8.7	10.3	12.0	24.2	11.6	8.4	12.6	5.5	7.9	10.4	7.4	5.1	10.0	15.4	14.8	9.7	12.0	10.3	7.1	36.7	25.5	20.9	27.2	32.3	28.2	25.6	38.9	30.9	28.2	28.7	21.3	23.0	20.7	34.9	44.5	35.8	26.0	34.0	37.1	40.5	9.1	19.4	18.8	21.6	14.6	18.3	13.3	19.6	23.8	23.0	29.9	17.2	18.5	37.9	16.5	24.4	15.0	33.4	25.9	21.4	11.1	17.5	10.5	27.1	10.9	31.8	35.7	23.0	25.3	19.6	12.5	37.4	21.3	18.6	20.5	28.7	21.7	32.9	25.9	20.2	22.8	27.4	13.2	24.1	29.0	29.9	23.0	29.1	68.6	22.5	24.3	18.0	24.4	20.4	27.3	22.5	20.0	17.5	26.3	25.0	21.6	20.6	24.5	30.1	36.8	21.9	8.9	5.3	5.7	9.1	7.0	5.7	5.1	5.0	5.0	5.1	5.5	5.1	7.1	44.5	70.5	42.6	34.0	35.2	37.6	37.5	71.8	39.3	81.6	44.9	49.8	73.6	41.5	69.4	64.4	41.7	68.3	39.5	34.4	54.8	61.4	54.8	37.4	61.5	40.7	38.4	68.4	47.3	61.7	54.6	52.7	35.7	36.5	31.6	39.0	22.9	45.0	41.2	42.1	46.9	36.4	63.1	26.0	26.6	16.6	46.6	41.5	28.4	28.1	50.7	35.7	35.0	42.7	54.9	61.9	27.3	53.0	57.0	53.2	35.2	105.2	35.9	83.6	52.6	52.8	54.2	117.5	108.1	50.1	47.5	81.3	36.1	106.4	39.9	43.3
DHX57	DDX57	ENSG00000163214	"DExH-box helicase 57"	Q6P158	2	38797729-38875934	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 136.3;Late spermatids: 352.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036160	Uncertain		Approved	"Nucleoli,Intermediate filaments,Microtubules,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Intermediate filaments, Microtubules"	"Nucleoli, Cytosol"	"HPA036160: AB_10670711"	"unprognostic (6.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.77e-1)"	6.1	9.2	6.6	5.2	6.9	4.8	6.5	6.4	8.8	8.1	6.9	7.1	2.2	7.7	10.3	5.4	6.6	4.2	5.3	7.1	7.2	6.8	5.3	4.9	6.2	5.8	6.5	7.8	7.0	9.7	10.0	5.8	6.0	6.2	5.5	8.5	5.6	6.3	9.1	7.1	5.2	7.3	6.0	5.9	5.7	23.4	6.6	6.7	7.2	5.5	6.3	7.4	6.2	6.5	23.4	19.3	21.0	15.8	13.5	16.6	16.2	15.5	15.9	15.2	14.7	15.7	7.2	7.1	15.6	16.9	17.1	11.8	23.6	18.2	24.9	28.0	18.4	13.3	11.5	21.3	12.2	14.5	7.3	16.0	10.8	20.0	12.5	10.8	20.7	5.2	17.8	9.5	16.7	17.7	14.7	12.9	25.1	10.1	11.4	7.0	27.7	13.9	14.2	8.6	16.8	24.8	15.8	16.4	17.4	14.7	11.7	8.0	15.4	15.1	16.5	10.9	17.7	9.3	12.2	2.8	11.4	10.1	10.2	1.6	6.3	1.2	2.8	4.5	3.6	3.8	2.3	2.1	3.2	4.6	2.9	1.7	0.4	2.3	5.6	1.2	2.5	2.9	6.6	6.9	6.4	8.8	7.1	7.2	5.8	6.5	6.0	6.0	6.6	6.5	6.2	3.2	10.9	24.2	8.8	2.7	2.7	5.9	6.2	24.7	5.2	7.6	6.2	10.0	10.9	23.9	56.3	7.2	4.7	2.5	0.0	7.7	136.3	18.0	13.4	6.3	11.9	8.2	36.7	7.6	6.7	9.3	7.1	6.2	10.8	19.4	9.7	6.2	7.0	18.5	38.0	5.7	4.1	11.7	3.8	352.8	15.8	8.5	1.8	25.3	23.9	9.5	8.2	33.2	20.9	8.5	3.1	13.9	8.1	2.0	2.1	6.0	27.3	27.7	0.0	8.8	6.0	19.3	9.8	5.3	2.6	2.9	7.9	14.7	5.0	2.2
DIDO1	"BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333"	ENSG00000101191	"Death inducer-obliterator 1"	Q9BTC0	20	62877738-62937952	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004374, HPA049904"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"CAB004374: AB_2093108, HPA049904: AB_2680944"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (9.92e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.82e-2)"	30.4	20.1	15.7	21.5	17.6	29.1	31.0	22.4	17.8	33.8	23.3	36.3	19.6	38.2	26.8	27.1	36.8	17.5	27.6	15.4	17.2	25.5	24.7	30.9	31.6	16.4	16.4	39.5	24.6	28.5	28.1	24.8	16.6	34.0	19.7	19.9	33.2	24.9	32.5	39.5	36.5	20.9	14.0	35.9	28.8	27.9	17.3	30.8	33.0	22.8	26.9	32.6	31.5	22.2	29.6	22.5	36.7	21.0	18.4	22.6	19.6	21.9	18.5	79.4	22.8	96.4	29.9	29.0	29.4	26.9	46.1	45.2	33.8	42.4	51.1	16.1	22.9	41.9	40.2	69.6	23.5	37.8	41.6	23.3	57.0	27.5	15.4	18.1	22.1	54.6	41.7	25.8	20.5	28.7	76.9	33.1	29.4	35.7	32.2	53.7	47.0	18.5	13.1	26.0	45.2	26.7	43.8	41.9	28.9	21.9	41.8	42.7	27.8	64.3	44.8	21.7	31.5	17.1	11.9	38.2	29.3	18.8	23.7	32.6	7.2	20.2	15.0	9.5	15.9	11.7	13.4	14.8	5.1	9.8	17.6	16.5	10.6	13.8	7.6	10.7	11.8	9.6	15.7	17.6	22.4	17.8	15.4	17.2	16.4	16.4	16.6	14.0	17.3	22.2	24.8	25.6	30.1	37.9	28.4	24.2	35.3	17.8	25.6	25.6	23.1	19.6	27.5	22.8	23.8	25.8	33.3	28.6	49.0	32.3	23.5	18.0	42.8	32.1	26.1	26.2	19.2	21.0	44.9	13.8	15.7	24.2	30.1	34.3	22.8	33.8	20.7	19.6	14.5	38.7	46.0	23.2	14.2	16.8	13.7	13.0	35.1	20.2	21.4	32.8	26.8	16.7	42.2	40.7	47.4	22.2	20.2	33.8	30.0	26.3	25.3	9.6	45.8	23.4	6.6	35.4	23.4	26.1	32.1	26.0	25.6	19.7	32.1	25.6	21.1	34.4
DIP2C	KIAA0934	ENSG00000151240	"Disco interacting protein 2 homolog C"	Q9Y2E4	10	274190-689668	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 125.4;Excitatory neurons: 219.3;Inhibitory neurons: 269.9;Oligodendrocyte precursor cells: 216.2;Oligodendrocytes: 421.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2197: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030264, HPA059325"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"	Vesicles	"HPA030264: AB_10600903, HPA059325: AB_2683979"	"unprognostic (1.72e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.10e-3)"	12.7	7.7	13.8	3.7	18.3	0.2	8.3	18.8	19.9	11.0	0.0	22.1	4.5	12.1	5.4	9.1	8.8	8.6	14.1	13.6	10.7	14.7	8.9	4.9	2.4	16.8	14.6	13.3	8.0	8.1	6.2	4.6	17.4	8.4	4.4	9.4	4.2	9.1	34.5	4.8	7.0	12.4	7.2	3.3	7.3	7.2	18.1	2.1	5.3	20.8	1.5	10.5	7.5	32.6	0.7	6.3	11.5	6.1	19.0	20.5	9.5	13.9	8.6	10.5	8.5	1.8	1.9	0.5	3.6	22.5	2.7	0.1	7.1	1.2	6.4	0.3	6.4	0.1	4.5	2.0	9.2	0.0	8.6	16.9	5.5	6.6	0.0	16.4	2.3	0.1	0.0	1.2	8.0	17.4	0.7	0.0	3.0	5.4	2.6	9.9	4.8	2.0	7.5	7.2	5.8	8.2	2.4	5.0	20.1	6.0	6.6	0.0	0.1	11.1	2.9	33.3	4.6	0.8	14.3	7.2	13.9	0.3	6.4	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.2	0.2	0.0	1.0	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	13.8	18.3	18.8	19.9	13.6	10.7	16.8	14.6	17.4	7.2	18.1	32.6	12.6	9.6	5.8	125.4	4.0	7.9	5.4	2.2	7.4	18.6	11.8	10.0	30.3	17.2	4.7	3.7	22.9	5.2	0.6	2.2	0.0	8.5	19.0	7.9	18.5	7.8	10.8	0.0	219.3	4.0	5.8	15.4	10.2	8.8	20.3	16.3	10.4	24.2	6.2	1.7	269.9	6.2	2.0	3.5	5.2	6.1	11.5	3.6	23.2	44.0	0.6	19.4	1.0	216.2	421.7	7.7	1.3	19.5	0.9	7.7	10.2	17.0	5.3	20.5	6.6	22.7	17.6	21.7	22.5	4.3	3.8	3.8	2.0	5.6	5.7	8.9
DIPK1A	"FAM69A, FLJ23493"	ENSG00000154511	"Divergent protein kinase domain 1A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 30.6;Syncytiotrophoblasts: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favorable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	18.8	4.2	20.2	14.5	23.3	10.0	9.9	22.3	29.5	7.8	14.6	15.2	11.7	15.7	4.7	12.0	9.5	14.6	6.7	20.4	21.2	7.9	32.8	6.0	14.9	21.7	20.6	7.5	4.5	15.1	3.9	16.9	22.3	11.8	15.9	8.3	7.5	13.8	11.3	7.4	11.0	25.5	23.1	10.6	11.9	8.6	20.9	16.1	8.0	7.5	12.2	14.8	6.2	31.0	11.2	12.6	4.6	11.5	17.6	33.5	5.9	33.9	69.0	18.6	37.8	6.7	2.3	38.3	6.0	62.1	38.0	13.6	0.9	25.3	30.5	15.7	12.2	1.2	9.2	17.1	6.3	3.4	2.1	19.6	19.8	40.8	9.7	31.8	0.3	22.7	13.4	37.7	24.1	4.0	12.4	3.1	8.6	18.4	4.6	11.4	36.2	11.5	2.6	11.2	11.8	9.5	9.7	9.2	12.7	10.6	4.3	1.1	1.3	22.1	17.0	43.0	12.0	57.7	60.2	44.0	10.4	2.2	2.0	0.1	1.8	0.1	19.3	0.9	15.5	43.4	22.3	15.5	8.6	26.9	25.6	22.2	0.5	24.2	0.6	14.1	21.9	12.3	20.2	23.3	22.3	29.5	20.4	21.2	21.7	20.6	22.3	23.1	20.9	31.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	30.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	25.3	0.7	0.0	0.0	0.0
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045886-68051631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 143.9;ovary: 60.1;pituitary gland: 52.5"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 64.6;Theca cells: 206.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 4.3;glioma: 16.3;pancreatic cancer: 5.6;thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 8.2;HSkMC: 17.2;TIME: 11.2;U-251 MG: 9.1;U-87 MG: 16.9"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane, Cytosol"		"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favorable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.4	20.1	25.3	0.5	18.7	0.1	5.0	2.2	11.5	5.2	3.0	3.3	7.5	2.5	10.6	1.7	3.3	10.2	11.3	7.0	143.9	6.9	9.5	5.1	0.2	39.6	49.2	60.1	20.0	7.5	52.5	0.6	18.5	2.9	0.8	4.0	2.3	2.6	1.1	2.1	1.4	1.2	7.8	2.5	4.2	5.5	104.7	1.6	3.8	1.9	0.3	3.1	6.4	8.0	0.0	1.5	1.6	0.0	5.2	3.9	0.6	4.6	1.6	0.3	1.2	0.0	0.8	0.0	0.2	4.8	0.1	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.6	0.0	8.2	0.0	0.0	17.2	0.1	0.7	0.0	0.0	1.0	0.2	0.3	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.1	0.5	0.1	0.0	11.2	0.0	0.5	0.2	9.1	2.7	0.0	0.0	16.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	25.3	18.7	2.2	11.5	7.0	143.9	39.6	49.2	18.5	7.8	104.7	8.0	0.3	0.0	1.8	5.2	0.0	3.2	25.0	0.6	0.6	1.1	5.4	6.5	5.9	7.2	2.5	3.7	10.4	1.1	0.0	0.4	64.6	3.7	0.1	0.7	0.7	1.7	16.2	0.0	2.2	18.7	0.1	10.3	4.1	1.8	0.0	0.8	3.3	3.9	0.1	0.0	8.8	2.3	0.0	0.0	4.8	0.8	6.8	0.3	5.4	0.0	0.0	0.7	1.0	5.0	0.2	2.9	0.1	1.5	0.0	5.3	0.1	11.1	0.9	6.1	0.0	16.9	1.7	0.0	1.4	1.7	2.8	0.4	0.7	206.2	0.7	2.4
DLGAP1	"DAP-1, GKAP, SAPAP1"	ENSG00000170579	"DLG associated protein 1"	O14490	18	3496032-4455307	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.4"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 2145.5;Inhibitory neurons: 3599.2;Oligodendrocyte precursor cells: 1264.6"	"Cancer enhanced"	"Detected in many"		"glioma: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 39.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 10.7;HAP1: 3.7;U-2197: 3.3;U-87 MG: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078234			Approved	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"HPA078234: "	"unprognostic (2.50e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (5.87e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.78e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-3)"	"unprognostic (8.93e-2)"	"unprognostic (9.68e-2)"	0.4	4.3	8.3	0.2	18.3	0.0	1.5	4.4	39.4	0.6	0.0	0.3	0.1	0.7	8.2	0.2	6.5	4.1	0.4	24.0	0.0	1.2	0.1	0.7	0.2	0.0	0.0	1.9	0.2	0.0	2.4	0.6	0.0	2.9	0.2	3.2	1.9	10.1	0.1	0.2	0.2	0.3	0.0	0.5	0.1	3.7	0.0	0.1	0.5	0.4	0.1	0.5	0.6	7.4	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.7	0.0	0.2	1.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.4	0.8	1.2	0.0	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	1.0	3.3	0.0	0.2	0.0	0.1	2.3	0.0	0.9	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	18.3	4.4	39.4	24.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	1.5	0.0	4.6	309.8	0.3	0.8	0.3	0.3	5.7	23.6	6.6	2.8	3.1	7.2	0.1	1.8	0.0	0.1	0.1	0.4	0.0	0.2	11.4	31.7	8.3	1.9	3.0	0.0	2145.5	0.2	0.1	1.8	0.5	94.6	0.0	0.0	2.2	0.0	0.2	0.0	3599.2	1.7	0.0	0.0	0.7	13.8	0.6	0.6	12.4	72.1	0.1	0.2	0.0	1264.6	31.0	0.2	0.1	0.4	0.0	3.5	0.0	5.4	4.4	1.4	0.0	0.7	2.2	12.9	4.8	1.6	0.1	0.3	0.8	0.1	0.1	0.1
DLX3		ENSG00000064195	"Distal-less homeobox 3"	O60479	17	49990005-49995224	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 53.8"	"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 35.9;Extravillous trophoblasts: 69.1;Syncytiotrophoblasts: 96.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 135.9;SK-BR-3: 44.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031164			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA031164: AB_10603565"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.44e-5)"	"unprognostic (3.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	0.5	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.5	1.9	0.1	0.1	0.0	0.0	0.3	3.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.4	0.0	0.4	0.9	0.3	0.2	0.6	0.2	7.4	0.4	0.5	0.0	0.0	1.5	0.7	0.0	53.8	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.2	1.8	0.0	3.0	0.4	4.0	0.0	0.5	0.0	0.0	2.6	0.8	0.6	135.9	0.1	0.0	0.0	0.0	1.3	0.2	0.0	1.5	1.6	0.0	17.1	7.1	0.1	0.0	0.0	0.3	0.0	4.2	0.2	0.0	0.0	0.5	0.0	12.7	0.4	0.0	0.0	0.0	0.9	0.1	0.0	1.7	4.1	0.0	0.4	0.5	0.3	0.6	0.0	0.0	0.3	0.0	1.9	15.1	0.1	1.5	44.1	0.0	9.1	17.5	0.9	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.4	0.9	0.4	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	5.0	0.4	1.1	9.1	0.0	3.5	5.3	2.0	0.0	0.2	0.0	0.0	35.9	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.0	69.1	0.7	0.0	0.2	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.0	2.0	3.4	5.1	96.0	0.1	0.0	0.0	0.5
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"skin 1: 4799.0"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 8514.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.7;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"A-431: 150.1;CACO-2: 182.0;CAPAN-2: 153.9;HBEC3-KT: 236.4;RPTEC TERT1: 232.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 51.9"	"Low region specificity"	"Detected in all"			HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		47000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	13.8	9.3	6.5	1.1	11.7	1.7	195.4	7.3	7.0	262.7	16.1	11.0	5.6	16.1	14.4	221.3	73.9	1.8	11.9	5.9	7.0	50.3	4.7	22.3	1.2	18.4	7.2	35.0	59.7	87.1	58.1	2.2	17.8	19.3	4.9	1.9	69.5	14.6	20.1	4799.0	8.4	4.2	6.6	2.9	19.9	4.1	6.6	12.2	60.0	0.2	50.6	14.1	378.5	6.2	150.1	24.0	0.0	0.1	5.7	8.7	40.5	0.5	19.6	1.0	1.4	182.0	153.9	0.0	57.5	1.4	7.3	81.8	44.5	236.4	1.9	0.7	43.0	0.0	0.0	41.3	6.8	0.0	0.5	77.6	62.3	4.2	133.2	13.4	0.0	0.0	0.8	0.2	0.5	130.2	0.1	0.0	129.2	107.9	9.7	0.2	0.0	6.2	232.2	97.4	0.4	0.0	35.6	0.1	14.9	36.7	58.5	0.0	0.3	22.3	67.1	0.8	0.6	0.9	0.3	1.1	18.8	0.3	1.4	0.0	0.0	0.0	6.4	0.0	5.5	1.7	0.5	3.1	0.0	0.1	0.1	2.0	0.0	11.7	0.0	0.2	0.0	1.3	6.5	11.7	7.3	7.0	5.9	7.0	18.4	7.2	17.8	6.6	6.6	6.2	13.9	105.8	115.3	1.0	5.9	1623.7	143.2	169.9	39.3	1.7	71.8	164.3	20.4	100.1	107.6	204.1	0.0	1.0	6.7	6.0	230.9	138.0	15.9	181.5	9.0	27.7	49.3	2.7	6.9	140.2	1.5	47.1	27.0	107.8	7.6	2.4	12.1	4.0	1.0	0.0	5.3	8.0	46.8	0.3	287.0	98.0	13.1	2.8	305.9	0.0	2.6	15.1	28.8	0.0	0.4	146.1	9.3	15.8	3.4	94.0	0.2	7.6	270.2	0.8	0.0	0.9	22.9	7.6	31.4	34.0	8514.1	2.3	15.0	0.2	14.2	77.4
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769709-45782552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Sertoli cells: 59.2;Smooth muscle cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 85.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 8.7"	"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	24.2	68.3	22.1	17.5	24.0	3.0	19.1	22.2	33.1	42.8	25.6	121.5	15.8	92.7	5.3	33.4	61.2	13.9	171.3	21.8	21.6	20.3	8.8	29.8	5.2	24.0	23.8	31.1	34.3	2.9	37.9	8.8	22.3	56.4	4.8	4.1	18.6	37.6	173.6	12.3	34.6	59.9	21.9	17.8	51.7	13.2	23.8	4.2	21.7	143.2	1.3	69.1	34.3	21.3	11.7	16.7	13.5	10.7	13.4	12.9	10.5	26.1	22.2	10.5	8.8	2.2	6.6	2.9	2.8	32.9	9.2	15.1	3.0	1.5	2.2	12.4	16.6	0.8	22.6	1.4	12.6	0.1	5.4	22.8	8.0	6.4	1.7	24.2	3.6	2.1	8.6	8.0	15.4	13.7	1.6	3.8	8.8	4.8	3.3	5.0	85.1	6.4	4.7	11.5	10.2	13.5	13.6	27.6	9.3	4.8	28.6	5.5	8.4	9.2	10.4	8.3	15.0	16.8	11.5	2.9	9.5	1.3	13.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	24.0	22.2	33.1	21.8	21.6	24.0	23.8	22.3	21.9	23.8	21.3	10.5	0.0	2.2	44.1	3.7	8.0	8.1	3.8	5.7	5.7	9.6	9.9	3.7	4.3	3.2	3.7	8.4	2.7	4.2	4.7	1.9	2.7	1.5	8.7	8.6	7.9	10.1	0.4	16.4	17.3	2.0	8.4	8.2	6.3	0.0	9.7	9.3	1.5	0.8	5.0	12.4	8.2	8.2	1.6	9.8	1.8	7.2	0.8	7.2	10.3	0.4	2.6	5.2	26.7	10.0	5.8	4.5	23.3	3.1	4.0	3.8	31.7	7.1	7.4	59.2	27.6	34.9	7.2	6.4	10.1	6.8	1.6	4.5	5.4	5.1	4.6
DMXL1		ENSG00000172869	"Dmx like 1"	Q9Y485	5	119037772-119249138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.3;Inhibitory neurons: 147.3;Oligodendrocytes: 224.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 14.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036431, HPA036432"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Cytosol	"HPA036431: AB_10669791, HPA036432: AB_2675120"	"unprognostic (2.47e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.18e-2)"	7.0	4.8	3.1	7.3	7.0	25.9	9.2	7.8	5.1	7.4	11.9	6.8	6.2	8.7	5.7	8.2	6.6	7.5	6.1	3.5	5.3	13.8	7.1	6.6	10.1	7.4	4.5	10.4	12.0	11.8	2.6	7.2	8.0	27.2	7.1	9.0	8.0	5.8	4.1	8.4	6.1	8.2	6.3	8.2	7.9	5.8	5.6	10.3	13.4	7.3	9.7	6.2	4.5	15.2	10.4	8.0	8.8	9.0	9.3	12.2	9.4	8.4	8.4	8.3	9.6	9.6	6.2	20.2	8.5	10.8	12.9	6.1	9.9	10.0	10.7	15.6	9.9	14.2	14.0	3.4	7.8	9.4	11.8	9.8	5.5	9.6	7.9	8.5	11.0	12.4	12.1	13.3	6.7	6.5	12.6	5.3	4.8	3.6	4.7	9.8	16.3	7.9	6.4	11.9	8.2	8.3	14.5	5.2	12.6	9.4	8.6	10.7	10.7	9.8	8.2	9.9	9.0	12.4	9.4	17.6	12.2	9.1	8.0	4.1	4.9	3.6	2.4	4.4	3.0	8.8	1.9	2.0	3.4	9.1	3.0	1.8	3.8	1.3	8.9	8.3	2.6	2.7	3.1	7.0	7.8	5.1	3.5	5.3	7.4	4.5	8.0	6.3	5.6	15.2	23.7	28.9	20.1	93.4	56.5	13.6	16.5	17.7	22.8	36.8	22.8	15.4	25.7	7.2	17.6	16.5	25.0	12.6	27.5	16.2	17.6	12.0	10.2	19.8	21.1	16.7	6.0	19.1	122.3	20.1	10.3	20.4	27.5	25.0	14.0	15.6	11.0	15.6	16.6	21.9	147.3	12.2	10.2	21.9	19.9	12.1	15.2	31.0	33.8	68.4	29.1	16.9	25.7	111.6	224.0	14.1	11.6	15.4	27.2	36.0	15.8	32.5	13.9	22.6	13.1	28.6	24.7	28.0	23.2	35.0	18.8	16.3	24.3	17.8	11.3	15.0
DNAAF1	"CILD13, DAU1, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 22.7;testis: 45.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 116.2;Endometrial ciliated cells: 311.3;Plasma cells: 225.4;Respiratory ciliated cells: 494.5;Spermatocytes: 116.2"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 3.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.3;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7;Karpas-707: 4.9;PC-3: 1.4;SK-BR-3: 1.4;U-266/70: 4.0;U-266/84: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA041166: AB_10794190, HPA074239: AB_2732250"	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.3	0.7	1.4	0.1	1.2	1.2	0.3	1.1	1.9	2.2	9.7	0.3	0.0	0.5	1.4	0.4	22.7	0.0	0.4	1.6	1.5	1.0	0.8	3.5	0.0	4.1	7.3	0.4	0.3	0.3	2.4	0.2	4.3	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	3.0	0.7	0.2	45.3	1.6	0.0	1.6	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	4.0	2.8	0.4	0.1	0.0	0.0	1.3	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.3	0.3	0.1	0.4	1.0	0.3	1.4	1.2	1.1	1.9	1.6	1.5	4.1	7.3	4.3	3.0	1.6	1.3	1.1	0.0	12.4	1.6	5.7	0.6	1.5	9.6	0.0	1.4	4.5	1.5	0.7	1.5	67.2	3.7	54.2	0.2	0.5	0.1	0.0	1.3	116.2	311.3	4.4	1.9	0.0	0.0	9.6	0.4	0.4	2.4	0.5	14.6	3.8	2.6	2.2	0.6	1.9	0.0	5.2	0.0	18.3	7.0	1.5	26.7	1.2	21.6	87.2	0.0	0.8	2.4	1.0	0.5	0.6	0.9	0.0	0.4	225.4	1.4	0.0	1.7	494.5	51.0	0.0	1.6	7.3	116.2	17.0	0.2	0.3	0.4	4.5	1.2	0.3	0.9
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726699-786475	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavorable (8.42e-4)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	8.4	8.7	7.8	6.7	7.1	7.6	8.5	11.8	8.7	10.3	12.1	11.3	7.4	12.7	4.8	11.6	14.1	5.1	11.9	6.9	7.3	8.3	9.0	6.9	6.5	7.7	10.1	10.6	10.9	7.9	13.0	6.5	6.8	7.9	5.7	4.0	11.5	8.0	24.1	9.1	9.2	6.3	8.3	7.3	9.4	7.8	9.4	6.2	9.1	9.5	5.0	10.5	9.1	8.3	83.1	64.3	18.8	44.0	12.1	13.3	47.2	16.8	16.0	20.5	19.4	64.5	42.8	50.5	23.9	17.7	49.0	49.2	35.0	42.2	15.7	8.6	59.5	12.4	37.4	47.2	16.6	38.1	21.7	16.1	17.8	25.8	19.0	13.7	28.1	25.2	80.0	10.3	15.0	81.5	22.7	34.1	69.3	27.4	50.5	41.4	6.1	34.8	24.3	34.5	39.3	65.1	27.5	66.9	19.9	21.4	59.1	31.5	23.7	11.4	40.1	39.4	38.4	19.9	25.5	29.0	25.1	39.2	60.8	0.0	0.7	0.6	0.8	1.1	1.3	0.6	1.3	1.8	1.1	1.4	1.2	0.9	0.0	1.3	0.8	1.7	0.3	0.8	7.8	7.1	11.8	8.7	6.9	7.3	7.7	10.1	6.8	8.3	9.4	8.3	7.1	19.2	9.1	6.2	3.8	0.0	6.1	0.0	6.8	6.3	8.3	7.1	13.1	4.3	4.3	9.2	27.1	8.0	5.7	4.9	15.6	6.4	0.7	28.2	13.9	7.8	3.6	9.7	12.5	4.2	13.2	7.8	11.7	15.3	0.0	17.6	6.8	8.5	5.8	10.1	10.4	7.4	0.0	7.5	0.0	1.7	7.2	4.8	0.0	7.5	2.4	8.6	2.1	10.6	8.9	9.6	4.1	8.6	6.0	5.1	6.4	11.1	8.0	15.0	0.0	11.4	6.1	7.2	17.4	10.8	0.0	4.5	3.5	12.0	9.1	4.2
DNAH17	"DNAHL1, DNEL2, FLJ40457"	ENSG00000187775	"Dynein axonemal heavy chain 17"	Q9UFH2	17	78423697-78577396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 2.1;retina: 2.5;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 56.4;Cone photoreceptor cells: 87.6;Early spermatids: 43.7;Late spermatids: 36.6;Oligodendrocytes: 52.5"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 2.9;lung cancer: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 5.7;MOLT-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA024354, HPA076261"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA024354: AB_1847911, HPA076261: AB_2732305"	"unprognostic (4.98e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.70e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.35e-3)"	"unprognostic (1.58e-10)"	"unprognostic (5.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.12e-1)"	"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.2	1.6	0.8	1.3	0.9	0.6	2.1	0.4	6.4	0.5	0.7	0.6	0.6	0.3	0.1	0.0	56.4	0.1	0.0	2.5	0.0	0.0	0.0	87.6	0.0	0.1	0.0	0.0	0.0	43.7	1.4	0.5	1.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.8	1.7	36.6	0.6	2.9	0.0	1.0	0.1	1.5	0.0	1.0	52.5	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	7.8	0.0	0.6	0.5	17.4	0.6	0.0	0.1	0.0	0.3	0.4	0.0	0.1
DNAJA2	"CPR3, DNAJ, DNJ3, HIRIP4"	ENSG00000069345	"DnaJ heat shock protein family (Hsp40) member A2"	O60884	16	46955362-46973674	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049789, HPA060538"	Approved		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA		67000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Cytosol"	"Intermediate filaments"	"HPA049789: AB_2680883, HPA060538: AB_2684315"	"unprognostic (7.68e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.67e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.19e-9)"	"unprognostic (9.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.69e-2)"	20.7	25.2	30.5	14.2	32.6	23.9	19.7	33.9	40.5	17.9	32.2	21.3	20.0	22.0	28.6	21.5	17.4	16.4	36.0	32.3	31.9	28.0	36.0	16.6	19.7	29.8	30.2	22.0	17.0	29.2	16.4	19.9	30.5	21.8	19.0	29.5	17.1	20.6	37.1	21.1	20.5	17.0	31.0	22.7	19.2	24.9	31.2	20.3	22.2	38.7	21.4	21.6	18.2	30.5	23.1	26.9	26.6	22.8	35.7	34.1	40.3	29.4	35.4	43.4	20.5	23.7	23.6	37.1	23.2	31.9	18.6	35.0	43.0	30.2	49.8	8.8	36.0	27.2	12.8	50.7	42.7	41.7	36.3	36.5	34.6	25.2	23.7	37.9	30.4	14.7	31.7	12.0	37.0	25.4	30.1	57.5	40.6	21.1	39.6	34.3	48.7	44.1	52.7	24.1	36.1	23.1	34.9	52.1	33.4	26.1	20.3	32.2	31.6	25.4	16.0	18.5	25.1	29.3	21.7	49.0	26.9	35.5	21.8	13.1	10.3	13.5	9.8	12.7	12.9	11.3	13.2	11.2	9.4	8.4	12.9	13.1	10.7	12.8	11.3	6.7	17.2	9.7	30.5	32.6	33.9	40.5	32.3	31.9	29.8	30.2	30.5	31.0	31.2	30.5	64.3	51.3	35.9	11.8	78.4	126.9	75.1	56.4	101.3	38.8	37.5	28.4	100.3	40.0	48.2	40.5	18.8	85.2	76.1	67.6	90.1	73.4	93.3	86.9	76.8	52.2	52.0	49.4	16.6	62.2	72.5	66.2	54.0	72.1	53.9	52.7	31.1	54.9	56.5	37.0	15.3	55.6	52.9	42.5	86.4	56.8	50.1	65.1	72.9	12.2	72.3	60.5	45.3	10.1	11.0	71.2	64.2	59.0	70.7	61.6	83.3	111.4	67.6	43.7	52.6	63.4	99.4	177.7	106.0	111.1	120.5	172.4	89.6	131.4	62.6	87.3
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 138.4;tongue: 144.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 673.9;Late spermatids: 1608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 33.6;CAPAN-2: 43.3;HeLa: 47.3;MCF7: 33.6;RT4: 85.2;SCLC-21H: 53.3;SiHa: 42.7;THP-1: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"CAB004646: AB_426011, HPA041790: AB_2677674"	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	16.5	20.0	60.6	14.0	67.7	63.7	12.6	62.6	138.4	14.1	45.6	18.0	13.8	8.3	20.2	15.8	38.9	11.2	123.3	68.6	93.1	26.7	3.3	19.7	11.3	65.7	73.3	12.1	6.6	7.4	30.9	9.5	89.8	26.7	18.5	33.0	15.6	15.6	123.2	28.6	16.3	19.6	59.8	13.5	24.2	78.3	73.5	9.4	9.6	144.6	12.4	29.6	13.6	71.3	33.6	0.2	0.0	0.0	0.0	0.0	0.1	4.1	0.0	1.1	0.5	0.0	43.3	0.0	0.3	3.2	0.0	31.3	0.0	0.0	0.1	0.1	0.0	19.9	47.3	0.0	9.4	0.0	20.6	3.6	4.1	2.6	0.0	0.0	6.6	0.0	0.0	0.0	0.4	33.6	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.1	85.2	53.3	0.0	42.7	8.6	3.6	2.3	32.4	39.8	0.5	0.0	8.7	4.0	0.4	0.6	2.4	0.0	0.1	4.2	0.0	0.0	0.3	1.1	0.6	0.3	1.0	0.7	0.9	0.9	0.4	0.1	1.7	1.4	0.0	0.1	0.4	0.2	0.5	0.6	60.6	67.7	62.6	138.4	68.6	93.1	65.7	73.3	89.8	59.8	73.5	71.3	41.9	6.4	4.8	12.7	10.0	28.8	209.9	14.0	2.2	19.6	44.6	29.2	43.6	2.8	33.5	7.3	81.3	1.9	6.7	55.5	1.9	1.3	673.9	124.0	11.4	18.9	100.3	92.8	16.6	2.4	3.8	18.3	21.4	41.8	36.9	7.5	6.8	0.2	16.5	6.7	24.0	34.9	10.2	9.5	81.7	1608.0	10.2	51.7	51.6	6.5	3.5	10.3	6.2	15.1	19.0	5.1	55.3	11.3	3.7	115.8	15.8	7.2	138.9	22.6	6.6	17.4	20.2	33.8	27.7	16.9	46.7	6.8	37.1	6.9	42.1	190.1
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.5;tongue: 218.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 5.5;neutrophil: 5.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.5;granulocytes: 5.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA023818: AB_1847793, HPA050794: AB_2681241"	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	14.7	12.5	18.5	11.0	18.7	1.5	8.7	23.0	27.7	14.0	14.8	63.0	7.7	56.0	11.8	32.5	29.6	12.7	64.8	24.0	20.1	8.5	4.4	12.3	4.6	20.3	21.0	8.6	6.1	4.0	25.3	2.4	19.4	27.5	12.2	10.1	6.3	52.1	164.5	5.1	17.9	64.3	18.1	12.2	26.8	16.0	19.3	5.8	10.9	218.5	5.0	33.7	11.5	18.8	4.7	3.8	23.7	12.7	13.6	10.4	2.6	20.1	14.5	30.3	26.8	2.8	1.0	4.5	4.9	22.2	31.7	0.6	9.1	15.8	25.5	6.4	2.9	1.6	5.6	1.3	15.6	0.5	14.2	15.2	1.1	18.0	8.9	13.4	19.6	8.3	0.4	9.3	24.7	3.3	7.8	6.7	11.2	2.1	8.1	6.0	24.4	2.5	4.4	0.4	10.1	16.4	10.8	0.6	2.4	20.2	3.8	1.4	8.8	14.4	31.4	7.6	6.3	3.4	2.5	3.3	16.6	1.8	15.9	0.0	1.0	0.0	0.2	0.3	0.9	0.4	0.2	0.0	5.5	0.2	0.3	0.7	5.2	0.4	0.1	0.1	1.0	0.5	18.5	18.7	23.0	27.7	24.0	20.1	20.3	21.0	19.4	18.1	19.3	18.8	1.9	6.4	1.5	8.5	0.9	2.0	2.3	4.7	1.8	6.0	1.7	1.4	42.9	1.5	1.8	0.0	6.2	0.1	0.5	0.5	0.0	2.8	8.0	1.7	4.8	4.5	0.0	0.0	4.9	3.4	0.7	6.7	2.0	2.2	0.0	1.7	3.6	1.2	4.7	1.7	3.3	0.3	2.0	1.9	11.1	6.7	1.5	3.6	5.4	1.9	1.2	12.0	2.1	6.6	3.2	4.3	0.0	7.9	0.7	1.5	1.6	4.4	1.0	2.7	6.6	14.7	16.8	6.3	1.3	1.8	3.0	0.8	1.4	1.5	0.3	0.7
DNAJB9	MDG1	ENSG00000128590	"DnaJ heat shock protein family (Hsp40) member B9"	Q9UBS3	7	108569867-108574850	"Predicted intracellular proteins"	"Unfolded protein response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 350.9;Plasma cells: 409.3;Syncytiotrophoblasts: 569.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 116.5;Karpas-707: 109.3;U-266/70: 191.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040967, HPA041553"	Supported		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Cytosol"		"HPA040967: AB_10794430, HPA041553: AB_10794300"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.75e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.76e-2)"	21.9	58.4	16.2	21.5	17.1	40.8	29.9	18.0	22.5	34.8	27.0	20.6	23.4	23.9	62.8	13.3	19.4	22.3	45.3	16.8	23.5	63.2	103.8	21.4	21.1	18.8	21.3	27.9	71.6	21.4	43.5	41.6	20.8	28.4	19.4	23.1	41.7	44.6	34.8	10.9	20.7	21.9	19.6	17.6	25.7	33.7	18.5	15.9	77.8	26.3	31.1	28.9	11.5	20.0	9.4	10.6	14.2	16.3	38.6	27.6	31.2	33.6	40.8	18.2	21.8	10.7	17.5	12.4	36.6	10.7	56.6	11.2	16.0	8.3	18.7	13.2	8.7	6.6	7.2	33.0	116.5	9.8	12.3	19.5	63.2	10.8	58.6	41.1	19.3	7.0	9.7	109.3	29.0	14.0	9.3	11.5	14.2	11.0	5.9	6.0	14.3	65.8	15.1	6.1	9.8	20.5	12.4	55.7	65.2	39.4	10.4	13.6	22.4	19.1	9.0	24.0	11.8	191.8	66.0	14.0	16.8	12.7	17.6	75.9	19.3	9.4	34.1	15.0	59.0	24.5	36.2	34.2	14.3	21.2	20.2	23.5	5.3	26.0	17.0	78.1	22.6	30.3	16.2	17.1	18.0	22.5	16.8	23.5	18.8	21.3	20.8	19.6	18.5	20.0	65.7	3.2	28.8	10.1	110.3	185.6	102.4	123.1	71.7	40.3	129.4	58.9	65.6	44.3	75.1	53.3	8.4	106.7	95.0	28.0	49.0	47.5	350.9	46.1	38.1	55.3	66.6	44.9	14.5	45.7	123.0	121.2	51.0	92.5	92.1	16.2	33.5	185.9	40.1	20.2	15.6	76.8	69.2	37.8	190.5	211.4	38.2	60.2	339.7	11.2	16.0	90.4	23.7	8.5	11.2	33.0	32.3	46.3	409.3	144.7	31.3	155.6	35.4	33.3	39.5	49.4	129.0	157.0	89.9	39.4	158.7	569.4	115.1	18.6	28.8	79.5
DNAJC13	"KIAA0678, RME8"	ENSG00000138246	"DnaJ heat shock protein family (Hsp40) member C13"	O75165	3	132417502-132539032	"Human disease related genes, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036923, HPA036924"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Vesicles	Cytosol	"HPA036923: AB_10672480, HPA036924: AB_2675386"	"unprognostic (3.35e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (3.68e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (8.36e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.81e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	11.7	9.4	5.9	12.4	6.5	15.5	11.4	6.0	6.3	12.9	8.2	14.4	10.9	13.8	11.7	10.7	9.9	9.9	12.9	5.9	6.9	16.0	9.8	11.3	11.0	7.7	6.9	11.7	6.8	12.6	5.9	15.4	7.1	10.8	14.3	10.7	9.1	12.1	12.5	9.8	10.4	16.7	6.3	12.2	9.7	7.8	7.5	12.0	15.7	14.2	10.6	12.4	10.3	7.8	31.0	18.0	22.2	10.9	54.3	46.7	13.7	32.3	62.5	31.4	33.8	20.4	18.2	15.7	20.5	46.3	41.1	24.1	22.1	24.3	43.5	18.3	6.4	20.6	17.1	13.6	27.6	21.1	18.3	34.2	16.4	28.5	35.1	22.7	44.6	26.0	11.4	25.6	43.7	24.1	16.8	9.1	12.7	26.7	15.8	15.9	16.5	13.0	27.7	32.4	7.9	11.9	31.6	16.7	36.1	19.0	24.7	17.8	40.9	34.7	17.8	33.3	13.9	14.8	15.7	21.5	36.8	13.6	25.2	2.0	2.6	0.4	0.8	2.2	0.7	1.0	0.9	0.7	2.8	0.4	0.6	0.8	0.5	0.7	4.0	1.4	0.4	0.8	5.9	6.5	6.0	6.3	5.9	6.9	7.7	6.9	7.1	6.3	7.5	7.8	16.8	12.8	21.9	45.7	14.4	6.6	7.3	7.3	6.8	10.8	8.9	7.2	47.2	8.6	11.3	12.9	33.3	7.9	13.2	21.5	1.9	9.0	1.7	10.3	31.3	17.1	14.4	12.8	48.7	9.1	7.7	20.2	16.8	18.7	12.0	18.9	13.2	8.5	20.5	67.3	48.7	12.5	0.0	34.2	9.2	3.6	15.2	26.5	28.4	60.0	25.1	13.3	6.2	46.8	64.7	11.7	12.5	21.4	13.9	10.5	17.0	18.7	13.1	11.5	6.6	22.3	19.7	5.3	13.7	15.4	7.5	5.1	10.8	22.5	13.4	11.0
DNAJC18	MGC29463	ENSG00000170464	"DnaJ heat shock protein family (Hsp40) member C18"	Q9H819	5	139408588-139444491	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 77.9"	"Group enriched"	"Detected in many"	21	"Early spermatids: 529.9;Late spermatids: 1332.4"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036538, HPA060154"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Cell Junctions"	Cytosol	"HPA036538: AB_10670802, HPA060154: AB_2684212"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.73e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.97e-2)"	6.1	3.1	7.7	1.5	7.4	0.9	5.2	7.9	9.5	6.9	4.5	5.8	0.7	6.5	2.3	2.4	6.6	2.1	6.6	7.2	8.3	5.1	1.0	6.8	1.7	8.3	7.2	7.5	1.9	3.6	8.0	2.1	8.6	4.5	1.3	7.6	3.0	2.9	7.5	2.4	3.4	3.5	6.6	2.8	3.5	77.9	7.6	1.6	4.3	4.3	1.2	5.4	4.7	8.1	1.2	1.2	7.9	7.4	4.3	4.5	0.9	2.4	5.3	4.2	7.6	2.9	0.9	5.4	6.4	3.8	9.2	2.1	4.5	7.3	4.4	12.5	5.9	3.7	2.6	1.3	3.4	0.4	1.7	6.1	0.9	7.0	4.3	7.1	5.8	2.0	1.7	5.1	6.3	0.6	1.6	1.7	5.4	0.4	1.8	4.5	8.5	0.9	2.5	1.3	7.3	7.6	2.5	0.9	5.8	10.1	1.1	2.7	7.5	5.5	0.0	1.7	5.2	6.0	8.6	2.8	2.9	2.7	2.4	0.5	0.4	0.5	0.5	0.3	0.7	0.8	0.7	0.9	0.3	0.9	0.7	0.4	0.1	1.4	0.2	0.5	1.7	0.3	7.7	7.4	7.9	9.5	7.2	8.3	8.3	7.2	8.6	6.6	7.6	8.1	14.9	3.2	3.9	12.7	5.0	1.5	8.3	9.4	7.4	29.4	2.2	5.5	11.0	2.8	5.8	1.8	10.4	4.7	7.0	0.7	1.9	4.9	529.9	2.1	11.0	15.2	12.6	1.7	33.1	1.1	3.4	11.3	2.0	2.3	9.5	14.4	13.6	0.2	2.9	16.8	39.0	2.1	0.0	3.5	2.4	1332.4	14.0	3.4	5.4	8.4	3.7	13.7	3.1	17.6	22.1	2.0	1.7	18.8	7.6	3.9	0.8	3.6	3.3	20.1	19.7	21.1	14.2	43.8	12.9	2.6	1.1	4.7	4.2	9.8	1.3	3.4
DNAJC24	"DPH4, JJJ3, ZCSL3"	ENSG00000170946	"DnaJ heat shock protein family (Hsp40) member C24"	Q6P3W2	11	31369840-31432835	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 204.8;Late spermatids: 223.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020025, HPA025237"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA020025: AB_1847801, HPA025237: AB_1847802"	"unprognostic (2.07e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.67e-1)"	7.2	6.3	6.7	5.4	6.7	1.9	6.8	8.5	8.9	4.8	5.8	4.8	4.4	5.9	6.4	5.3	3.1	4.9	11.8	7.0	7.4	6.4	6.0	4.3	6.8	6.7	7.0	4.6	7.3	4.7	4.6	5.0	6.7	5.7	4.4	8.3	5.8	5.9	17.0	8.8	4.5	6.3	6.5	5.8	5.0	4.4	6.9	5.2	6.6	11.3	5.7	5.6	3.4	7.1	4.8	6.4	11.2	8.2	8.7	10.9	4.9	12.7	8.0	7.0	7.3	5.2	4.5	6.3	6.7	8.6	10.4	6.2	6.4	8.2	12.2	14.8	11.9	6.9	10.2	5.3	11.1	14.0	10.9	10.3	10.4	4.3	13.8	10.2	9.5	10.7	13.3	10.9	14.0	5.0	10.8	9.4	5.7	7.0	6.7	6.7	18.8	6.5	10.3	4.5	4.9	6.9	11.0	7.5	11.0	6.3	10.5	9.1	10.0	13.1	8.9	16.3	15.8	13.3	11.3	7.6	19.3	6.6	14.9	4.5	1.0	0.9	2.2	1.8	3.1	1.5	2.2	1.9	0.8	1.6	2.8	2.9	0.7	1.3	1.1	1.6	1.5	1.3	6.7	6.7	8.5	8.9	7.0	7.4	6.7	7.0	6.7	6.5	6.9	7.1	7.5	3.2	7.4	14.0	14.4	12.1	7.0	9.2	6.8	11.9	9.1	7.2	20.3	1.5	9.3	3.7	10.4	8.6	15.5	5.6	3.9	9.1	204.8	6.4	11.0	7.7	7.2	5.2	40.7	9.1	9.4	10.4	7.1	6.3	5.1	5.3	9.3	10.5	8.2	23.5	28.9	5.1	4.1	6.9	10.3	223.9	9.0	8.5	12.4	25.3	7.1	26.2	9.2	41.2	29.9	11.7	6.2	9.4	18.5	7.2	5.2	11.4	4.4	14.6	0.0	9.6	8.3	28.2	18.2	9.5	8.2	6.3	13.5	7.1	5.9	9.1
DNAJC25	bA16L21.2.1	ENSG00000059769	"DnaJ heat shock protein family (Hsp40) member C25"	Q9H1X3	9	111631334-111654351	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 32.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019122	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA019122: AB_1853155"	"unprognostic (3.07e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.94e-3)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (9.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.19e-2)"	3.3	5.2	1.0	2.3	1.1	1.0	2.0	1.0	1.9	1.5	2.5	3.0	2.9	1.7	4.4	1.5	1.8	2.1	2.5	1.1	1.0	5.1	32.1	1.3	0.7	1.4	1.2	1.4	2.9	4.2	1.5	2.7	1.2	3.7	1.6	0.6	4.2	2.2	2.2	1.0	2.4	1.7	0.9	0.7	2.4	1.4	1.0	0.2	2.2	1.7	0.8	3.0	1.3	1.0	2.7	2.0	1.3	2.3	14.1	6.2	5.3	10.4	4.8	3.9	3.7	3.7	1.6	2.4	4.0	7.0	6.1	8.5	1.5	2.9	3.7	1.9	2.0	2.4	0.0	8.0	4.5	4.5	3.3	5.3	8.2	3.0	5.6	3.0	3.3	1.3	4.9	1.8	5.0	2.9	1.3	0.2	2.3	5.1	4.9	2.3	7.3	2.2	8.2	2.8	2.3	1.2	5.7	7.7	3.6	2.3	4.1	0.8	6.5	4.7	2.3	12.9	6.0	3.6	6.0	1.3	8.1	2.1	4.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	1.0	1.1	1.0	1.9	1.1	1.0	1.4	1.2	1.2	0.9	1.0	1.0	9.9	6.4	11.9	0.0	8.3	10.6	16.2	13.8	6.8	7.9	14.1	12.4	13.9	8.6	16.0	11.0	20.9	14.2	16.7	16.2	13.7	17.1	10.8	18.6	18.2	7.9	17.3	3.0	0.0	16.3	24.7	15.3	10.2	19.5	1.3	8.8	6.4	85.3	12.1	13.5	0.0	21.3	6.1	6.4	10.2	2.5	10.2	10.0	12.4	0.0	6.7	4.6	5.2	0.0	0.0	11.7	7.3	10.1	22.6	29.4	21.7	13.5	18.9	19.9	13.1	13.3	15.7	29.5	16.6	7.0	9.2	13.8	8.8	10.6	15.0	22.7
DNAJC27	"RabJS, RBJ"	ENSG00000115137	"DnaJ heat shock protein family (Hsp40) member C27"	Q9NZQ0	2	24943636-24972094	"Predicted intracellular proteins"			Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.8;Spermatocytes: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036815, HPA036816"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA036815: , HPA036816: AB_10673506"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.44e-4)"	"unprognostic (8.84e-2)"	"prognostic favorable (8.48e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.78e-3)"	5.6	3.4	4.3	2.1	5.6	3.8	3.7	7.1	7.0	3.7	4.1	3.7	1.9	4.2	5.0	2.2	4.6	3.0	4.9	4.6	8.7	3.8	2.0	2.7	2.7	7.5	6.5	7.0	2.7	5.1	6.1	2.9	8.2	3.3	2.7	13.3	2.2	3.1	4.6	2.9	2.7	3.0	5.7	2.9	2.9	22.2	6.0	3.5	3.3	7.0	2.4	3.1	2.9	6.5	2.8	1.2	2.6	2.6	3.6	3.0	2.0	2.1	3.2	2.2	1.9	1.3	1.3	2.6	0.5	1.5	1.8	2.2	1.9	1.3	2.3	1.1	1.6	1.6	1.6	1.2	2.3	1.5	2.2	2.3	2.2	1.7	3.5	2.5	0.9	3.1	1.1	2.4	2.4	1.0	2.7	2.6	1.7	1.0	1.1	1.6	5.1	1.4	2.1	1.5	0.9	3.2	2.0	1.5	3.0	2.7	1.3	1.1	0.8	2.9	2.0	1.5	2.0	6.1	2.3	3.1	1.5	2.4	1.3	0.0	0.2	0.9	0.2	0.1	0.5	0.4	0.3	0.2	0.2	0.3	0.4	0.5	0.0	1.3	0.3	0.1	0.3	0.2	4.3	5.6	7.1	7.0	4.6	8.7	7.5	6.5	8.2	5.7	6.0	6.5	7.8	9.6	10.0	19.2	11.2	2.0	5.6	3.6	8.0	24.1	9.8	8.5	25.4	4.3	3.0	7.3	37.5	3.6	10.8	4.5	3.9	2.6	59.8	12.5	9.7	7.7	15.5	11.8	18.2	2.5	2.0	8.8	8.2	5.2	10.8	9.5	6.1	3.4	3.3	37.0	22.1	5.9	6.1	3.2	4.6	32.5	8.7	5.9	1.8	7.5	4.3	12.2	4.1	12.1	24.1	1.7	0.9	6.4	8.8	4.6	4.3	3.1	17.3	25.1	0.0	12.8	23.9	70.7	17.0	8.3	3.3	4.2	11.3	23.2	5.4	3.8
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415871	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.5;retina: 52.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1038.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.1;HEL: 165.8;K-562: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	1.5	11.1	34.7	0.9	43.3	4.7	1.1	33.7	46.9	0.8	0.0	2.1	1.0	0.6	0.4	0.3	1.1	1.0	8.9	42.1	48.0	7.7	0.4	1.5	0.2	60.2	51.3	0.5	2.1	1.0	12.6	7.4	67.6	1.1	1.7	52.8	0.7	0.7	0.4	1.1	1.0	0.9	27.2	2.1	1.7	2.2	42.0	0.8	1.7	0.8	0.3	1.1	0.9	81.5	10.4	2.8	0.1	4.4	2.1	0.5	23.4	20.1	33.1	32.6	31.7	2.7	0.5	9.9	1.7	8.3	8.0	2.5	14.6	3.3	25.8	62.1	6.9	165.8	5.1	0.6	0.2	5.6	3.9	2.7	2.2	3.3	13.8	6.0	0.7	8.0	65.5	1.2	6.6	1.9	2.1	0.0	6.5	0.0	2.2	0.0	4.9	0.4	23.7	0.0	39.4	27.0	11.9	15.5	5.4	37.4	7.5	0.3	6.5	4.8	3.3	0.6	5.9	6.0	4.1	3.0	13.4	4.1	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	43.3	33.7	46.9	42.1	48.0	60.2	51.3	67.6	27.2	42.0	81.5	0.8	0.0	0.5	49.3	0.5	1.3	0.4	0.5	0.0	30.4	0.6	0.3	28.0	2.8	0.2	0.0	14.6	8.9	1.5	0.4	1.9	0.8	2.0	1.8	0.5	3.7	7.2	19.4	237.4	0.7	2.1	5.8	1.5	3.0	0.0	0.6	0.4	0.1	1.2	52.2	237.6	1.9	2.0	0.0	0.8	1.9	0.0	0.7	7.2	18.7	1.1	4.1	0.0	136.7	1038.1	0.4	0.2	0.0	0.9	1.7	0.0	7.2	1.2	21.6	0.0	0.2	8.5	1.7	2.5	0.0	0.3	7.4	0.6	6.9	0.6	0.2
DNAL4	"dJ327J16, PIG27"	ENSG00000100246	"Dynein axonemal light chain 4"	O96015	22	38778508-38794198	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 124.1;Late spermatids: 210.7;Spermatocytes: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 64.0"					"Low region specificity"	"Detected in all"			HPA003647	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	"Nucleoplasm, Nucleoli, Cytosol"	"HPA003647: AB_1078712"	"unprognostic (8.45e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.83e-2)"	11.3	18.0	29.1	6.7	32.3	4.4	14.5	21.0	36.5	18.3	23.2	12.9	7.9	12.2	15.0	18.9	35.4	12.9	13.7	29.2	28.3	24.4	11.1	13.9	8.1	22.1	23.3	17.5	21.3	31.1	30.9	9.9	22.1	18.3	9.6	13.8	18.1	12.1	7.0	17.5	9.8	7.5	22.0	11.4	16.4	65.5	28.0	14.3	25.4	6.2	8.3	14.2	15.5	24.5	17.9	8.9	17.5	15.5	21.8	21.7	0.0	7.5	14.0	11.4	12.2	5.7	20.1	4.5	15.7	10.7	13.1	8.3	11.0	20.5	7.7	11.4	14.8	2.6	2.5	6.6	34.9	14.5	3.7	17.1	64.0	14.9	26.8	29.7	16.6	22.1	5.3	8.5	13.8	21.9	13.6	14.0	6.8	26.3	7.4	12.8	7.5	5.9	23.7	10.8	24.3	13.5	15.4	11.5	30.7	12.1	20.7	13.7	9.8	10.1	10.1	15.5	7.5	5.3	1.8	2.1	29.9	4.9	9.8	15.0	8.5	11.9	11.2	8.9	13.8	7.1	9.3	10.2	8.7	10.6	10.5	9.0	15.0	16.2	11.3	13.2	9.3	7.5	29.1	32.3	21.0	36.5	29.2	28.3	22.1	23.3	22.1	22.0	28.0	24.5	8.2	6.4	10.5	5.5	5.1	5.6	13.4	18.9	10.2	15.0	20.6	17.8	4.3	14.3	15.2	3.7	2.1	27.6	9.7	10.9	31.3	28.4	124.1	56.4	11.8	8.5	12.6	11.2	11.0	15.5	21.2	10.1	6.1	10.5	15.2	20.3	12.8	3.8	13.7	11.8	10.6	14.7	14.2	4.4	2.8	210.7	11.8	6.5	8.8	4.7	5.7	18.9	8.2	6.6	5.1	18.4	9.1	7.5	1.3	9.8	8.5	20.0	41.0	15.4	6.6	6.6	11.6	77.7	20.0	9.1	10.5	19.8	6.0	20.1	13.2	12.0
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 242.8;Paneth cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	55.1	69.9	50.5	63.2	77.8	125.7	46.1	74.1	64.1	49.0	38.8	105.8	65.9	42.2	25.3	67.6	42.5	40.5	87.2	52.3	57.4	72.8	57.2	87.0	62.4	82.7	78.9	36.6	68.2	38.9	41.9	51.3	79.8	47.4	83.9	30.7	55.0	55.7	108.1	92.8	99.6	35.1	60.3	81.0	98.6	55.1	72.9	58.6	47.6	82.8	65.4	64.6	54.5	101.6	116.4	92.8	67.6	54.6	67.6	65.4	86.5	75.1	70.5	108.8	91.7	94.2	74.7	83.2	132.2	81.5	52.5	99.4	92.6	82.1	90.8	103.1	72.4	160.1	81.7	107.1	82.9	87.8	146.5	67.8	62.4	83.5	77.9	66.2	107.3	84.9	131.5	139.1	68.0	140.1	126.3	85.7	76.6	138.3	109.7	125.6	72.6	95.7	71.3	171.1	97.1	63.8	86.6	73.6	54.2	74.9	58.8	106.2	99.6	120.7	40.5	172.0	102.7	112.7	127.3	77.9	89.9	134.0	61.0	3.5	3.5	7.0	4.0	6.2	3.8	2.5	3.0	4.4	4.2	2.1	1.7	3.0	6.5	8.9	8.4	8.4	3.8	4.1	50.5	77.8	74.1	64.1	52.3	57.4	82.7	78.9	79.8	60.3	72.9	101.6	37.8	32.1	22.3	24.8	48.8	23.2	17.1	13.8	22.2	28.8	19.7	16.3	30.3	14.3	25.7	51.5	22.9	25.7	57.2	242.8	50.9	35.2	48.4	32.2	17.9	33.1	21.6	38.1	29.2	32.0	106.9	19.5	168.7	39.7	19.0	36.8	20.3	22.8	49.1	43.7	31.1	106.9	14.2	28.0	39.6	98.0	16.8	55.2	19.6	60.9	43.4	17.2	39.1	23.1	90.9	45.2	177.3	27.8	92.2	20.2	90.7	38.8	18.0	26.3	26.3	18.7	27.6	15.0	12.3	26.6	31.5	31.7	46.4	40.7	82.5	22.8
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009947	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: AB_2683640"	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.15e-4)"	13.6	6.0	3.6	5.5	3.7	10.3	10.2	6.2	5.3	15.8	8.6	17.7	22.5	9.6	12.5	10.2	11.3	11.0	7.5	4.7	4.2	20.6	13.1	8.4	4.6	3.7	3.6	11.5	17.6	31.7	3.9	10.5	3.8	8.9	20.7	15.8	8.4	12.8	13.4	27.4	27.2	8.8	3.0	7.7	23.8	6.9	5.2	20.1	8.1	11.1	5.2	19.8	17.7	3.1	25.7	20.7	18.4	29.2	32.9	27.4	4.4	45.2	43.6	21.5	20.7	14.2	38.0	26.6	18.9	34.9	11.8	19.9	21.6	26.1	29.9	1.4	6.7	3.8	23.7	10.0	17.1	2.6	1.8	13.0	5.7	26.6	23.4	75.5	52.1	8.5	3.6	0.0	44.1	3.2	4.5	5.1	17.7	18.0	12.3	5.5	18.7	1.4	36.6	21.9	3.1	4.2	7.4	1.9	5.7	25.3	1.5	2.4	63.4	16.0	15.3	13.1	29.8	2.1	1.7	36.3	15.2	8.4	12.2	0.0	0.8	0.2	0.7	1.2	0.7	1.2	0.1	0.4	0.3	1.9	0.1	0.3	0.7	2.1	1.2	0.3	0.0	0.6	3.6	3.7	6.2	5.3	4.7	4.2	3.7	3.6	3.8	3.0	5.2	3.1	6.8	9.6	11.0	11.1	14.8	35.1	7.2	5.0	5.2	6.3	9.3	6.3	6.1	12.8	11.2	12.9	35.5	7.7	4.4	36.7	3.9	7.5	1.0	27.0	11.0	12.6	3.6	0.0	15.9	14.3	1.4	17.6	26.0	43.9	2.5	4.1	11.4	12.8	4.7	13.5	24.8	25.0	6.1	10.7	9.6	3.2	13.7	20.5	3.6	23.4	3.3	4.3	0.0	10.6	2.6	19.3	23.6	9.1	6.1	4.0	36.5	3.7	19.9	26.6	0.0	4.3	6.9	4.2	9.3	9.0	45.6	3.7	4.3	15.0	28.4	21.8
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206407	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6"	"Group enriched"	"Detected in many"	4	"Astrocytes: 791.0;Excitatory neurons: 422.8;Microglial cells: 1568.3;Oligodendrocyte precursor cells: 434.3;Oligodendrocytes: 815.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 43.3;HUVEC TERT2: 75.5;TIME: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	7.8	4.4	17.1	6.6	41.6	1.4	4.8	11.4	21.9	5.0	0.0	3.2	1.5	4.6	2.8	2.5	5.2	5.0	4.9	40.6	17.8	4.5	10.0	17.3	2.7	16.5	18.1	8.4	3.2	3.3	3.2	6.9	15.6	4.0	2.8	10.5	3.3	2.5	6.2	2.5	2.4	7.3	14.9	1.8	2.2	2.1	19.2	1.7	3.5	7.3	2.2	3.7	3.5	26.0	0.1	3.5	8.8	7.8	7.2	10.4	5.3	1.0	9.6	1.7	2.8	0.0	0.2	0.8	7.6	2.3	2.0	0.5	1.5	8.8	6.5	2.9	12.9	0.4	5.8	14.3	5.1	1.1	0.4	4.9	1.0	43.3	20.8	3.0	75.5	3.4	0.1	22.6	3.8	1.0	2.0	0.7	5.1	1.5	15.8	0.8	7.0	3.6	6.0	0.5	1.9	7.5	6.2	4.3	5.8	8.2	0.8	0.4	69.0	6.6	3.4	13.7	3.0	1.2	0.5	0.9	0.7	1.8	16.5	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.1	0.1	0.0	0.1	17.1	41.6	11.4	21.9	40.6	17.8	16.5	18.1	15.6	14.9	19.2	26.0	56.4	48.1	6.8	791.0	1.1	5.2	3.3	7.5	8.6	27.4	3.7	6.3	13.1	2.8	16.7	3.7	22.9	0.3	0.1	2.3	0.0	2.1	3.8	1.3	5.5	47.1	10.9	5.3	422.8	0.4	0.2	21.4	0.5	2.2	2.5	5.0	43.9	17.0	14.6	94.2	177.1	0.7	14.2	16.7	21.0	1.5	5.6	27.4	8.8	1568.3	6.1	5.4	0.0	434.3	815.3	1.2	8.0	8.2	0.2	8.2	0.0	1.8	12.2	11.4	13.1	4.2	5.8	0.6	1.9	2.3	2.7	0.0	0.6	26.2	1.5	1.8
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 45.0;lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 506.8;monocytes: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 53.0;granulocytes: 173.6;monocytes: 84.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 52.9;HL-60: 53.3;MOLT-4: 50.1;NB-4: 83.7;REH: 61.9;RT4: 54.3;THP-1: 158.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003218, HPA073349"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695, HPA073349: "	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favorable (6.89e-6)"	11.0	13.3	4.3	35.7	4.4	42.2	7.3	5.2	3.9	4.3	45.0	7.3	7.3	3.0	2.9	7.2	4.3	14.6	2.0	4.0	5.9	16.5	6.1	19.7	51.1	8.8	7.6	2.0	4.2	7.7	2.6	15.3	9.1	5.1	7.3	4.5	4.6	2.8	1.0	3.0	15.4	6.2	9.3	45.6	9.5	7.5	8.8	64.8	4.9	2.5	49.6	14.8	3.3	12.8	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	1.6	1.4	52.9	3.9	0.0	0.0	2.3	0.8	0.3	0.0	18.2	2.3	0.1	0.0	0.2	0.0	53.3	7.1	0.2	9.3	0.0	0.2	0.0	0.0	0.0	11.8	25.9	0.0	3.2	50.1	83.7	0.2	0.2	0.7	61.9	0.1	21.3	0.2	54.3	0.1	0.0	0.0	0.6	3.6	1.0	1.4	158.0	10.2	0.0	0.4	0.7	0.1	10.3	0.1	0.0	0.1	33.3	0.9	65.1	56.9	73.5	12.2	52.0	10.2	25.2	15.7	13.8	53.0	23.2	11.3	11.1	173.6	24.1	84.2	13.8	15.6	22.6	4.3	4.4	5.2	3.9	4.0	5.9	8.8	7.6	9.1	9.3	8.8	12.8	5.0	9.6	33.5	2.3	112.6	6.4	2.5	1.2	45.5	3.6	12.3	10.8	2.3	18.6	4.9	7.3	77.2	70.9	101.9	1.5	1.9	1.0	33.4	1.9	0.7	9.8	8.4	35.1	1.9	6.5	4.3	5.3	12.8	3.2	24.6	12.7	2.9	2.6	58.4	0.0	4.2	12.9	2.0	115.0	49.4	14.8	3.1	107.7	8.8	506.8	134.3	1.1	74.2	4.5	2.2	1.4	24.9	0.4	94.6	1.5	1.2	12.8	8.0	4.2	13.1	30.2	20.6	22.1	13.3	9.4	3.8	42.7	111.6	1.1	1.3	3.4
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490821-3500674	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	7.5	8.8	15.6	4.4	18.9	8.9	6.8	18.9	18.3	6.2	9.9	8.2	17.8	7.6	0.5	11.0	6.7	1.2	12.6	14.7	15.2	11.1	10.9	6.4	3.2	20.6	19.2	6.5	8.5	2.5	8.4	2.2	18.8	7.5	1.0	1.3	6.9	2.1	18.9	10.5	11.5	1.3	16.5	7.9	8.7	8.1	17.6	2.1	5.9	2.2	1.6	8.3	6.9	24.0	18.6	22.4	3.1	7.1	1.6	2.0	15.0	17.4	3.6	8.0	6.5	31.9	7.6	15.3	13.2	2.4	7.5	19.3	4.6	6.1	1.5	21.5	24.5	15.1	13.3	37.7	6.7	20.7	19.9	2.3	5.7	8.2	3.3	2.8	4.3	15.6	34.1	16.4	3.7	22.3	20.3	23.3	19.1	7.1	29.2	25.4	7.6	21.3	5.3	11.1	20.0	15.5	12.7	10.8	18.4	1.3	15.0	11.0	9.9	10.9	14.4	29.0	31.7	21.9	17.4	20.1	12.4	46.6	12.7	1.2	6.7	2.4	7.6	8.1	9.4	11.1	10.1	14.9	11.0	16.5	14.1	12.3	0.4	10.0	8.9	14.1	13.2	5.9	15.6	18.9	18.9	18.3	14.7	15.2	20.6	19.2	18.8	16.5	17.6	24.0	9.5	6.4	2.2	2.0	15.5	23.6	22.6	13.2	12.5	17.2	12.4	10.0	7.7	11.5	7.1	5.5	10.4	30.9	7.6	27.9	21.5	22.2	8.6	10.9	7.9	13.2	13.1	23.2	4.9	21.3	29.9	13.6	16.3	7.8	13.4	10.5	11.7	10.0	21.6	25.2	5.1	17.6	24.4	7.9	9.3	23.8	14.0	9.3	19.6	1.9	16.9	12.7	15.5	4.5	30.0	24.7	17.2	15.1	16.0	28.4	10.8	28.9	4.6	12.4	0.0	16.2	13.6	12.6	12.7	14.5	27.6	34.8	12.1	13.6	27.2	18.7
DOK2	"Dok-2, p56dok-2"	ENSG00000147443	"Docking protein 2"	O60496	8	21908873-21913690	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 25.6;lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.6;Hofbauer cells: 131.8;Kupffer cells: 171.8;Langerhans cells: 288.4;Macrophages: 181.5;NK-cells: 344.0;T-cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1565.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.3;HEL: 54.3;HMC-1: 119.8;JURKAT: 22.3;THP-1: 43.1;U-937: 42.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004379, HPA005507, HPA066571"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		220000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Nuclear bodies, Golgi apparatus"	"CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749"	"unprognostic (5.39e-2)"	"unprognostic (8.84e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.22e-2)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.22e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.80e-1)"	9.5	5.0	1.1	26.5	1.2	19.5	5.0	1.2	2.3	1.9	2.5	5.5	7.0	2.2	0.5	2.3	3.5	6.5	3.5	1.3	1.3	3.0	6.1	25.6	26.3	1.4	1.5	1.4	1.9	0.5	1.1	7.9	1.5	2.3	3.6	0.0	3.4	1.5	2.0	2.3	9.5	6.9	1.2	40.9	6.8	1.6	4.5	16.4	2.4	1.6	7.8	8.4	2.3	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	54.3	0.0	0.1	0.0	0.4	119.8	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.8	5.0	0.0	0.0	0.9	8.7	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.3	0.0	0.1	0.2	0.1	0.2	0.1	0.3	1.4	42.0	0.2	577.6	484.3	1565.6	398.3	624.0	184.5	14.5	274.3	304.8	421.9	6.6	151.0	185.9	37.2	307.6	580.7	7.6	597.2	810.3	1.1	1.2	1.2	2.3	1.3	1.3	1.4	1.5	1.5	1.2	4.5	1.5	2.0	3.2	18.1	0.0	13.2	11.5	0.6	0.0	0.0	0.0	1.2	1.8	2.1	0.0	1.3	3.7	0.0	0.7	130.6	0.3	0.0	0.1	0.2	0.2	0.5	2.8	0.0	10.5	0.1	0.0	1.0	2.6	3.1	0.4	36.3	0.1	5.7	1.1	131.8	0.0	0.0	0.2	0.0	171.8	288.4	0.6	0.3	181.5	19.6	0.0	74.8	0.0	344.0	0.0	0.0	0.0	0.0	0.0	15.4	0.2	0.0	0.7	1.5	0.0	0.0	0.6	2.5	0.2	4.3	0.7	8.5	1.0	147.4	0.0	0.2	0.8
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501904-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.6;lymphoid tissue: 118.4"	"Group enriched"	"Detected in many"	5	"B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 133.6"	"Group enriched"	"Detected in many"	6	"B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0"	"Low region specificity"	"Detected in many"							HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.0	6.1	5.2	30.2	6.2	93.6	4.4	6.5	7.9	3.2	6.3	8.2	6.5	3.4	1.7	5.5	7.8	4.3	4.1	6.0	7.0	5.0	6.5	27.1	31.5	11.3	6.8	2.1	4.5	0.8	3.4	7.0	10.5	5.5	3.5	2.1	6.6	2.0	3.6	2.6	28.9	4.5	6.7	118.4	5.9	8.9	9.9	4.3	4.4	4.1	32.3	7.1	4.0	8.1	5.2	7.8	5.4	6.3	3.2	0.4	13.0	4.4	1.1	14.0	12.9	11.0	2.2	124.0	3.2	4.0	6.8	8.9	12.2	7.6	6.9	26.1	14.6	21.3	21.4	2.5	1.0	46.1	87.5	1.6	4.5	16.2	1.6	1.5	1.9	11.4	14.8	50.2	5.1	12.9	2.7	52.5	12.2	1.5	12.9	148.6	9.3	1.2	4.4	5.2	7.4	4.9	2.0	2.1	6.2	4.8	11.7	63.4	2.7	12.3	11.3	6.5	5.4	11.1	15.0	122.1	2.7	88.0	2.2	16.8	62.4	57.0	0.3	61.3	0.6	37.2	0.1	0.3	14.5	19.6	0.1	0.1	133.6	0.5	77.6	1.2	0.0	28.7	5.2	6.2	6.5	7.9	6.0	7.0	11.3	6.8	10.5	6.7	9.9	8.1	1.4	0.0	5.6	1.6	31.6	0.3	0.1	0.4	1.8	0.8	1.0	0.9	0.4	0.0	0.2	0.0	0.0	0.5	0.3	0.2	0.0	0.2	0.0	0.4	0.4	1.9	0.0	6.3	4.1	0.2	0.7	1.2	0.5	0.8	18.3	0.2	7.1	0.8	55.7	0.0	3.5	0.3	0.0	51.1	2.3	0.4	0.6	38.3	1.8	3.7	45.4	0.3	2.1	0.5	0.5	0.0	0.7	1.2	38.3	0.2	0.2	0.1	0.1	0.6	0.0	1.8	0.4	3.0	1.9	0.7	0.3	1.0	2.2	0.3	0.8	0.1
DOK4	FLJ10488	ENSG00000125170	"Docking protein 4"	Q8TEW6	16	57471922-57487327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 127.9;Paneth cells: 99.9;Proximal enterocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 94.2;CACO-2: 107.8;SH-SY5Y: 239.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008348, HPA055849"	Supported		Approved	Cytosol		NA	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA008348: , HPA055849: AB_2682942"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.18e-3)"	10.5	9.2	12.0	9.6	12.2	1.8	8.8	12.2	12.7	20.7	9.0	43.9	46.1	16.9	12.1	32.8	15.2	17.5	14.8	11.1	11.8	42.0	33.7	23.3	4.3	8.3	11.0	19.8	17.6	12.0	19.8	10.9	13.0	18.3	31.3	4.1	12.6	25.8	3.0	43.2	49.9	12.2	7.5	10.5	37.3	7.0	10.8	3.8	10.7	3.9	7.4	16.7	21.6	9.4	10.3	94.2	15.0	26.8	20.6	22.6	16.7	17.7	23.5	12.4	3.8	107.8	53.1	1.1	75.4	37.2	7.3	21.0	9.2	4.9	5.3	2.7	6.9	22.3	28.2	63.2	29.3	0.3	2.3	15.8	14.2	16.4	1.8	27.6	19.0	3.8	7.3	4.3	14.9	9.9	1.1	4.1	9.6	46.1	4.0	8.9	7.8	1.2	64.8	3.9	73.6	239.9	14.5	6.3	4.5	66.0	5.6	4.2	20.5	2.1	15.1	6.1	0.8	2.9	4.1	0.8	6.7	4.7	9.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	12.0	12.2	12.2	12.7	11.1	11.8	8.3	11.0	13.0	7.5	10.8	9.4	8.3	12.8	14.0	0.7	1.4	7.9	7.2	3.6	5.2	15.5	3.7	5.0	2.4	30.0	3.3	14.7	0.0	0.9	1.8	127.9	5.9	15.0	1.2	2.1	5.3	11.3	3.6	1.3	5.0	23.7	7.6	7.9	36.2	2.9	0.0	19.6	6.8	20.4	0.9	8.4	7.1	30.3	2.0	0.8	1.6	2.0	13.4	1.0	3.6	1.0	0.7	2.2	0.0	2.0	0.4	30.8	99.9	12.0	1.4	7.1	96.6	46.9	2.5	0.8	6.6	1.1	6.9	0.2	4.1	11.6	18.0	0.5	2.5	4.8	34.1	6.1
DOK6	"DOK5L, HsT3226, MGC20785"	ENSG00000206052	"Docking protein 6"	Q6PKX4	18	69400888-69849087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;parathyroid gland: 12.5;retina: 22.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 230.4;Excitatory neurons: 236.8;Inhibitory neurons: 259.1;Oligodendrocyte precursor cells: 178.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.5;Hep G2: 11.1;RPMI-8226: 10.5;SCLC-21H: 4.7;SH-SY5Y: 10.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041099, HPA063534"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	"Focal adhesion sites, Cytosol"		"HPA041099: AB_2677299, HPA063534: AB_2685032"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.62e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.13e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.09e-3)"	1.1	0.7	8.8	0.7	10.3	0.1	0.5	0.9	14.0	1.8	0.0	0.6	0.3	1.5	0.5	0.7	0.7	3.2	6.2	17.8	10.6	4.9	2.4	2.4	0.5	10.9	11.6	2.2	0.2	12.5	0.7	5.9	9.7	1.3	0.5	22.3	0.8	2.1	0.1	0.5	0.5	2.5	4.1	0.9	0.7	1.5	6.5	0.1	2.2	0.6	0.5	3.1	1.1	5.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.0	11.1	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.5	0.0	0.0	4.7	10.5	0.0	0.0	0.0	7.6	0.0	0.0	0.0	4.0	0.6	0.0	1.5	0.3	0.0	0.0	3.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.3	0.9	14.0	17.8	10.6	10.9	11.6	9.7	4.1	6.5	5.8	0.5	0.0	0.0	9.8	0.0	0.3	0.1	0.0	0.0	230.4	0.1	0.0	9.1	0.0	1.3	0.0	14.6	0.0	1.2	0.0	1.9	0.0	45.3	0.4	13.3	1.5	0.0	0.0	236.8	0.0	0.0	6.7	0.0	0.3	0.0	17.2	0.0	0.9	0.0	10.1	259.1	0.0	0.0	0.3	0.8	30.6	1.5	2.1	0.0	8.4	0.1	6.9	2.1	178.4	6.4	0.0	0.0	6.8	0.7	0.1	0.0	9.6	0.0	14.6	0.0	0.4	5.5	0.9	1.1	0.1	0.6	0.0	1.2	4.9	0.0	0.1
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	9.6	14.3	6.6	6.3	6.3	1.5	7.8	6.7	6.7	7.4	8.6	7.5	7.6	9.3	13.5	8.6	8.9	7.9	10.5	6.5	7.1	9.1	10.5	9.1	6.8	6.9	7.6	6.7	14.5	16.8	5.9	9.3	7.3	10.0	6.6	4.4	12.0	10.0	6.7	9.9	7.5	9.4	6.5	8.0	10.6	14.5	7.6	5.1	7.8	7.1	6.6	8.6	5.9	6.8	11.7	42.5	14.8	22.0	42.6	22.2	20.0	23.7	38.1	28.5	21.0	33.7	17.9	6.4	12.3	34.6	40.3	80.3	20.3	29.6	14.7	10.7	17.8	8.0	27.4	24.5	43.0	8.8	13.5	31.1	27.0	30.8	16.8	16.7	28.1	9.1	19.7	10.0	31.3	56.9	7.3	7.3	19.0	33.0	26.0	7.2	19.5	25.1	25.7	17.3	13.5	15.1	31.4	25.6	14.1	13.7	44.8	11.4	23.6	25.6	9.2	32.5	19.8	9.4	25.0	6.4	24.2	8.0	19.9	2.7	15.4	6.9	11.2	15.3	10.1	11.8	9.9	12.3	16.6	12.5	12.8	13.2	2.2	13.0	21.2	9.3	16.8	10.5	6.6	6.3	6.7	6.7	6.5	7.1	6.9	7.6	7.3	6.5	7.6	6.8	8.5	6.4	4.1	2.9	2.6	1.8	3.6	13.9	4.6	9.1	4.4	4.3	3.5	10.0	10.9	7.3	8.4	25.6	3.5	5.2	0.0	15.7	15.1	5.9	7.2	9.2	1.2	3.6	1.2	14.2	16.4	8.1	5.1	3.6	1.3	7.5	16.1	9.2	13.5	5.0	2.2	3.5	12.2	5.2	2.7	3.7	12.2	2.9	3.6	1.9	2.8	10.7	5.2	2.5	1.7	11.1	7.5	6.0	1.5	4.4	7.5	9.0	11.4	7.1	0.0	7.0	15.7	33.8	15.1	3.3	1.3	18.2	2.3	15.8	5.7	2.1
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"DNA replication fork stabilization factor DONSON"	Q9NYP3	21	33559542-33588706	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.3;Erythroid cells: 42.1;Spermatocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: AB_2676570, HPA049033: AB_2680608"	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	5.5	2.9	5.8	5.5	6.5	10.9	4.1	7.9	7.5	8.5	4.2	5.2	5.4	5.7	2.4	5.0	7.0	5.5	4.4	5.4	6.5	3.9	7.9	4.6	10.5	6.7	6.2	10.8	3.4	5.6	5.5	6.6	6.7	4.8	6.3	13.3	3.5	3.4	4.4	8.5	6.1	4.5	5.7	3.6	4.9	21.2	6.5	10.6	3.5	4.8	9.2	4.7	6.2	8.6	67.9	15.5	34.8	30.4	10.7	18.5	23.9	53.7	23.2	41.2	45.1	41.9	19.7	40.5	13.9	28.3	30.6	20.0	43.6	20.2	45.1	36.5	36.5	73.8	34.9	41.5	8.1	39.0	18.2	13.9	5.7	44.4	11.1	13.1	25.1	19.8	67.0	65.2	35.4	14.7	34.0	17.2	35.9	34.8	17.3	33.2	68.4	41.3	21.3	19.0	36.0	14.8	82.1	25.3	23.1	17.1	34.9	19.4	16.4	38.0	25.3	28.6	37.7	56.8	58.1	59.3	22.1	52.1	43.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	6.5	7.9	7.5	5.4	6.5	6.7	6.2	6.7	5.7	6.5	8.6	6.3	3.2	1.9	10.4	4.8	8.2	8.1	3.1	5.2	2.8	5.6	5.7	3.9	7.2	2.3	3.7	10.4	13.2	7.8	3.0	1.9	3.3	57.3	3.0	6.6	8.0	1.2	42.1	9.7	4.7	27.9	6.9	7.1	4.4	8.2	7.5	7.5	6.2	8.9	6.7	11.2	4.2	6.1	3.4	6.3	25.3	10.2	5.5	7.2	4.7	4.0	2.1	4.1	7.5	12.7	3.9	2.5	13.9	19.3	5.7	2.9	4.4	2.8	3.6	0.0	4.4	7.6	62.3	33.5	7.6	9.8	16.6	7.6	3.0	6.8	9.2
DPF1	"BAF45b, NEUD4, neuro-d4"	ENSG00000011332	"Double PHD fingers 1"	Q92782	19	38211006-38229714	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 23.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.9;Early spermatids: 25.4;Excitatory neurons: 24.6;Horizontal cells: 45.4;Inhibitory neurons: 16.3;Late spermatids: 23.4"	"Group enriched"	"Detected in some"	5	"glioma: 5.6;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 19.7;SCLC-21H: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049148	Enhanced	Approved	Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA049148: AB_2680653"	"unprognostic (7.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-16)"	"unprognostic (2.56e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.96e-2)"	"unprognostic (8.20e-4)"	0.1	0.3	12.7	0.4	14.9	0.1	0.1	2.2	23.4	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.4	16.9	9.9	0.1	0.0	0.3	0.1	1.9	4.4	0.3	0.1	0.0	2.5	0.1	2.4	0.1	0.0	2.4	0.2	0.0	0.2	0.3	0.1	0.2	2.0	0.1	0.1	2.4	9.5	0.2	0.0	0.0	0.1	0.1	0.1	14.8	4.6	3.8	15.8	11.7	1.1	0.8	1.6	4.8	2.7	8.0	6.7	2.7	0.4	7.5	3.2	3.7	3.2	2.8	19.7	2.6	3.6	7.2	3.9	2.5	2.0	1.1	0.4	1.9	2.1	0.9	0.1	4.7	1.5	1.0	1.5	5.5	5.6	0.4	7.7	6.4	4.1	0.5	2.9	1.3	4.4	7.5	8.0	1.6	0.8	1.4	22.9	7.8	5.4	0.5	1.0	1.9	2.4	0.4	1.8	11.5	3.7	2.8	4.4	2.9	10.3	9.9	6.1	2.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	14.9	2.2	23.4	16.9	9.9	1.9	4.4	2.4	2.0	9.5	14.8	0.4	0.0	0.0	3.3	0.1	2.3	0.1	1.1	0.0	17.9	0.2	0.6	1.2	0.0	0.1	0.0	8.4	0.1	0.0	0.1	0.0	0.0	25.4	1.5	2.2	0.9	0.0	0.0	24.6	0.0	2.0	1.5	0.0	0.7	0.0	4.3	0.4	0.0	0.2	45.4	16.3	0.0	0.0	0.3	0.4	23.4	0.6	0.1	0.0	1.0	0.0	3.3	0.0	12.5	4.8	0.1	0.0	2.6	0.0	0.1	0.0	0.1	1.4	3.1	0.0	0.7	1.9	6.7	12.6	0.0	1.1	0.1	0.2	1.6	0.0	0.1
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.2;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.3"	"Group enriched"	"Detected in some"	4	"HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	12.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	89.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	327.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.5	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	22.3	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.4	0.1	0.0	17.2	0.5	0.0	0.0	1.3	0.0	0.4	1.6	1.7	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.7	0.0	0.0	0.9	0.3	0.3	11.7	0.0	0.0	6.2	0.5	0.2	0.0	0.3
DPY19L4		ENSG00000156162	"Dpy-19 like 4"	Q7Z388	8	94719703-94793836	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024339, HPA024780"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA024339: , HPA024780: AB_10600869"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.28e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	11.5	12.3	7.3	6.6	10.5	5.1	12.5	9.7	9.4	13.6	8.0	8.6	6.7	12.3	10.5	7.6	11.2	10.0	15.4	6.5	10.1	14.5	15.8	9.1	6.9	9.9	9.0	16.7	9.4	26.4	6.4	12.6	10.3	11.6	9.0	13.0	10.2	9.0	7.2	9.4	7.9	9.5	9.6	11.1	13.1	9.6	8.9	7.0	16.1	9.3	5.8	8.6	8.5	14.4	24.4	15.5	26.1	16.4	25.9	33.3	14.4	21.5	20.3	19.8	19.4	7.3	35.0	5.4	25.8	20.8	13.3	25.0	16.0	16.9	32.7	12.2	12.8	25.3	15.1	12.2	30.1	10.9	5.1	22.2	14.0	16.8	16.2	23.2	24.3	16.0	18.0	9.0	23.3	15.3	20.9	20.5	10.2	27.9	17.2	14.8	17.9	10.9	19.1	18.9	12.8	28.7	17.2	3.6	16.8	15.9	22.8	13.6	24.0	20.5	12.6	23.1	18.1	9.9	13.1	14.8	15.4	18.7	29.6	0.7	0.5	0.0	1.0	0.6	1.4	1.2	1.0	1.6	1.0	0.3	1.1	1.4	0.4	1.4	0.6	1.2	0.4	0.7	7.3	10.5	9.7	9.4	6.5	10.1	9.9	9.0	10.3	9.6	8.9	14.4	21.1	16.0	16.3	20.5	6.3	9.8	14.1	11.6	15.9	19.6	16.2	12.1	26.0	11.5	13.0	40.5	4.2	16.7	3.7	8.5	1.9	8.9	2.1	13.7	20.3	19.0	7.3	9.7	13.2	10.0	11.9	20.4	12.2	13.7	3.8	23.1	65.0	27.5	9.6	13.5	18.3	11.5	10.2	14.8	11.9	5.0	17.4	8.3	10.6	25.3	5.5	11.9	9.2	23.6	39.7	13.0	6.4	18.4	7.9	15.6	10.7	10.7	18.8	17.6	6.6	13.4	14.9	11.9	9.8	16.6	12.1	9.2	7.8	32.6	12.0	14.1
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390808-147510068	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 101.5;Cone photoreceptor cells: 331.5;Granulosa cells: 261.9;Peritubular cells: 205.7;Rod photoreceptor cells: 125.0"	"Cancer enhanced"	"Detected in all"		"glioma: 109.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 685.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Approved	Cytosol		NA	NA		740000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.23e-4)"	58.4	18.6	63.4	54.4	68.6	0.8	37.5	60.3	55.8	66.1	30.4	142.1	18.4	119.9	73.9	69.0	63.4	65.1	59.2	57.0	116.0	7.7	4.4	45.2	18.1	123.7	94.2	88.0	5.5	2.7	12.7	19.8	81.8	104.6	37.6	163.8	24.5	162.0	68.7	23.8	43.3	217.6	115.2	26.4	40.9	19.9	95.2	7.1	22.4	36.0	27.0	118.0	50.6	105.1	0.5	36.1	63.9	0.1	2.3	63.3	1.6	34.1	163.0	71.4	94.4	114.5	3.1	0.0	9.6	100.1	37.4	3.7	13.1	1.4	79.1	16.3	29.2	0.1	30.0	0.2	63.1	0.3	0.2	12.2	0.6	153.8	60.3	178.7	206.9	0.0	0.0	1.3	41.1	0.3	0.2	0.6	135.9	0.2	53.7	0.2	135.1	0.5	63.0	14.2	47.1	685.4	0.3	0.3	10.8	87.9	0.5	1.0	91.1	51.6	38.5	127.0	127.3	113.9	21.7	0.2	47.5	1.4	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	68.6	60.3	55.8	57.0	116.0	123.7	94.2	81.8	115.2	95.2	105.1	59.9	0.0	2.8	101.5	0.0	9.4	3.4	1.5	2.2	14.2	8.1	6.6	7.8	1.5	4.0	0.0	331.5	0.1	0.0	0.2	0.0	9.1	16.8	0.3	4.6	62.6	6.6	0.0	11.3	8.4	0.3	79.8	3.1	1.2	1.3	261.9	57.8	0.4	1.6	5.0	12.9	0.2	24.4	1.2	11.9	19.2	42.9	3.1	19.6	5.6	0.0	28.3	0.0	83.9	0.7	13.7	0.0	205.7	0.3	10.1	0.0	0.1	2.8	125.0	0.0	23.6	40.9	1.8	3.2	3.7	8.2	0.4	1.5	49.6	0.3	4.5
DPYSL5	"CRAM, CRMP-5, CRMP5, CV2, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 111.5"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 85.5;Late spermatids: 134.3;Oligodendrocytes: 331.2"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 141.0;HAP1: 118.7;SCLC-21H: 167.3;SH-SY5Y: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: AB_2686516"	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	0.0	1.9	22.6	0.3	49.4	0.0	0.0	59.4	41.7	0.1	3.8	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	17.6	42.1	0.1	0.0	0.0	0.0	79.6	50.2	0.1	0.0	0.0	7.8	0.0	65.5	0.1	0.2	15.8	0.0	0.0	0.1	0.0	0.3	0.3	54.8	0.0	0.1	7.8	60.2	0.0	0.0	0.0	0.0	0.0	0.1	111.5	0.0	3.0	141.0	0.1	0.6	0.0	3.3	0.0	0.0	0.0	0.0	13.2	0.0	0.0	1.0	0.0	3.9	0.0	118.7	0.0	0.0	0.0	26.2	0.0	0.1	0.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	31.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	167.3	99.0	3.8	0.2	0.0	3.3	0.0	0.0	0.0	0.0	4.1	0.1	3.8	0.0	5.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	49.4	59.4	41.7	17.6	42.1	79.6	50.2	65.5	54.8	60.2	111.5	0.1	0.0	0.0	13.4	0.1	0.0	0.3	0.0	0.0	12.1	0.1	0.0	6.0	0.0	0.0	0.0	85.5	0.1	0.0	0.0	0.0	0.0	45.6	0.1	0.1	0.4	0.0	0.0	18.3	0.0	0.0	0.3	0.0	0.2	2.5	0.2	0.0	0.2	0.1	8.4	40.5	0.0	0.0	0.0	0.7	134.3	1.5	0.2	1.8	2.8	0.1	17.2	0.0	18.1	331.2	0.0	0.0	1.2	0.1	0.2	0.0	0.1	0.0	12.1	0.0	0.7	0.3	2.9	4.6	0.0	0.3	0.0	0.2	0.7	0.0	0.1
DRAP1	NC2-alpha	ENSG00000175550	"DR1 associated protein 1"	Q14919	11	65919274-65921563	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 813.2;Suprabasal keratinocytes: 1015.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 1032.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006790	Uncertain		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"HPA006790: AB_1078702"	"unprognostic (1.69e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.58e-2)"	"unprognostic (8.47e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.96e-5)"	"unprognostic (1.62e-1)"	87.4	86.4	119.0	71.0	120.8	96.8	80.3	121.2	162.8	91.0	103.7	104.4	56.1	89.3	27.9	107.5	74.0	34.9	129.2	120.3	132.4	75.0	76.2	75.1	71.0	119.9	119.6	67.4	73.3	62.6	81.2	43.1	121.5	73.1	21.1	25.1	58.3	48.0	197.1	112.5	62.9	40.2	118.1	85.6	69.9	173.1	120.7	96.6	118.9	78.5	39.2	84.2	83.4	131.6	578.7	226.8	108.3	200.0	99.9	195.3	75.9	634.9	273.2	344.1	223.6	85.6	302.7	142.2	277.3	420.3	395.5	222.7	42.7	292.0	138.2	187.7	70.1	173.4	103.8	85.4	186.0	145.8	228.2	123.7	126.6	365.8	246.7	191.4	142.2	138.9	78.5	223.6	377.4	301.9	255.0	263.6	167.5	73.1	575.9	216.3	107.1	305.4	113.6	82.3	122.2	137.7	149.6	137.8	348.9	46.1	188.2	104.8	413.0	470.1	461.4	1032.4	556.2	201.8	186.6	149.9	490.1	91.4	650.8	146.5	118.9	290.5	131.0	311.9	117.5	139.5	116.3	136.6	183.2	124.2	114.6	123.3	164.6	194.6	538.9	136.8	148.5	112.7	119.0	120.8	121.2	162.8	120.3	132.4	119.9	119.6	121.5	118.1	120.7	131.6	116.7	6.4	30.5	9.1	131.8	813.2	199.3	238.8	139.5	56.9	122.9	189.0	32.9	64.3	89.8	130.6	35.5	136.6	166.9	111.7	283.7	202.8	128.9	78.6	142.8	110.6	151.9	195.7	11.5	170.7	161.9	130.2	58.1	98.9	238.0	78.9	92.1	96.4	298.5	63.9	10.8	120.4	142.4	152.4	462.0	85.7	179.3	208.1	247.3	14.0	241.9	79.9	286.3	11.6	22.9	289.9	126.2	173.0	131.7	423.3	144.8	257.8	54.4	47.9	92.1	90.1	194.1	131.0	171.1	163.8	1015.8	174.4	197.2	107.1	125.0	425.3
DRD1		ENSG00000184845	"Dopamine receptor D1"	P21728	5	175440036-175444182	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 21.3;retina: 8.4"	"Group enriched"	"Detected in some"	12	"Bipolar cells: 40.1;Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 26.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 164.4"	"Region enriched"	"Detected in many"	13	"basal ganglia: 86.7"	"HPA013393, HPA017304"		Supported	Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA013393: AB_1847833, HPA017304: "	"unprognostic (2.74e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.15e-6)"	"unprognostic (6.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.60e-4)"	"unprognostic (5.86e-2)"	"unprognostic (5.43e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	0.4	0.6	4.7	0.0	21.3	0.0	0.2	0.0	8.5	0.4	0.1	0.2	0.1	0.1	0.2	0.3	0.2	0.4	0.0	3.1	0.4	0.7	1.1	0.7	0.0	0.3	0.9	0.1	0.0	0.0	0.1	1.1	0.0	1.1	0.3	8.4	0.0	0.4	0.0	0.0	0.3	0.1	0.7	0.1	0.2	0.0	1.8	0.3	0.1	0.6	0.1	0.7	0.4	2.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	26.4	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	21.3	0.0	8.5	3.1	0.4	0.3	0.9	0.0	0.7	1.8	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	40.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	33.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DRGX	"DRG11, PRRXL1"	ENSG00000165606	"Dorsal root ganglia homeobox"	A6NNA5	10	49364066-49396089	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	19	"adrenal gland: 5.4;brain: 10.4"	"Cell type enhanced"	"Detected in some"		"Langerhans cells: 1.2;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 10.1;pons: 10.4;spinal cord: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"RH-30: 11.6;SH-SY5Y: 46.2;U-2197: 17.7"	"Region enriched"	"Detected in single"	6	"pons and medulla: 3.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 4.0;hippocampal formation: 1.6;medulla oblongata: 2.4;spinal cord: 3.7"	HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA043978: AB_10961154"		"unprognostic (1.42e-2)"	"unprognostic (5.68e-2)"		"unprognostic (3.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.58e-1)"		"unprognostic (4.54e-2)"	"unprognostic (3.74e-2)"			"unprognostic (8.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"		0.1	5.4	0.0	0.2	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	10.1	0.7	0.0	0.0	0.0	0.2	0.0	10.4	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	8.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	17.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.3	10.1	0.7	10.4	8.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.8	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2368.6;Basal prostatic cells: 1651.4;Basal squamous epithelial cells: 3008.4;Cone photoreceptor cells: 1401.1;Oligodendrocytes: 1410.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 488.1;hTERT-HME1: 371.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	60.9	86.2	206.5	16.2	275.8	3.3	117.3	240.6	221.9	158.8	143.3	173.2	25.4	167.1	38.2	66.1	103.9	32.6	166.0	194.6	230.7	52.2	80.8	108.0	11.3	258.1	250.4	78.2	39.8	36.7	78.8	28.7	263.4	84.5	32.4	87.4	100.3	48.7	143.1	166.2	64.2	106.0	209.1	36.7	68.9	28.4	243.3	31.4	29.8	104.1	15.2	90.4	113.2	325.4	62.4	26.6	41.2	20.8	79.5	103.5	24.6	82.2	89.7	37.8	42.1	17.1	15.5	10.4	32.2	220.7	35.6	46.7	34.4	161.2	73.0	52.3	45.2	17.8	49.5	31.4	65.9	15.0	0.4	58.3	488.1	92.5	371.6	69.1	73.3	9.5	12.6	38.2	113.9	20.2	5.1	6.8	27.7	35.6	21.9	0.1	28.8	16.5	118.8	83.0	47.2	37.8	32.7	11.7	64.1	67.7	18.6	27.2	176.5	77.3	55.9	37.0	68.9	39.6	28.6	5.0	55.8	8.8	40.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	0.3	1.3	0.0	0.1	206.5	275.8	240.6	221.9	194.6	230.7	258.1	250.4	263.4	209.1	243.3	325.4	193.2	336.5	11.8	1048.7	5.6	2368.6	1651.4	250.1	3008.4	673.1	81.0	301.5	862.8	77.2	161.7	55.2	1401.1	61.5	7.8	357.8	7.9	204.3	53.6	133.8	218.4	122.7	44.9	12.4	550.4	66.3	11.6	212.5	71.9	166.8	17.1	478.7	60.7	80.3	21.8	307.9	591.7	100.3	118.0	74.2	124.6	15.5	133.3	56.6	215.3	215.5	46.6	200.8	2.1	630.3	1410.3	194.1	283.0	152.4	27.2	229.8	124.2	10.3	52.0	122.6	65.7	381.8	196.6	20.0	13.7	298.2	857.2	26.5	19.7	30.5	48.1	142.8
DUS3L	"DUS3, FLJ13896"	ENSG00000141994	"Dihydrouridine synthase 3 like"	Q96G46	19	5784832-5791225	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041854, HPA041944, HPA062846"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879"	"unprognostic (1.25e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.64e-3)"	"unprognostic (6.08e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (7.35e-3)"	"unprognostic (4.25e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	14.5	15.3	7.1	8.4	7.4	20.7	15.6	6.8	10.2	16.9	7.2	15.4	11.4	16.3	1.6	20.6	17.1	4.1	13.4	7.0	6.6	16.7	25.2	11.7	9.5	8.9	7.3	18.2	24.1	3.9	13.7	5.4	7.3	18.9	2.8	3.0	17.7	5.0	16.7	24.6	18.4	2.8	7.0	19.6	16.9	40.2	7.7	8.1	18.6	3.7	3.7	15.5	16.8	9.4	29.9	28.3	8.1	29.0	2.3	3.7	26.9	9.8	5.7	9.9	7.6	44.4	13.9	30.2	36.1	3.9	11.5	18.9	7.3	9.5	1.5	22.7	63.6	20.3	15.4	16.9	14.2	45.0	56.2	8.6	10.0	11.3	7.8	1.3	6.8	19.8	53.2	0.0	5.4	38.0	38.8	45.9	28.4	10.7	76.9	19.4	17.0	38.1	4.2	20.7	27.9	28.6	10.3	17.0	19.7	1.9	12.1	36.1	9.4	14.3	25.2	43.1	42.6	83.4	66.9	29.3	13.9	46.1	16.4	8.3	20.1	5.8	21.5	30.2	24.7	15.2	16.4	20.3	29.8	19.0	21.2	21.5	2.2	27.9	25.3	30.9	20.1	16.3	7.1	7.4	6.8	10.2	7.0	6.6	8.9	7.3	7.3	7.0	7.7	9.4	7.2	9.6	10.0	2.6	19.9	14.7	19.3	16.7	25.6	6.6	7.7	10.2	3.0	7.2	9.7	1.8	12.5	18.3	9.3	14.4	7.9	12.4	48.8	6.7	8.3	9.2	7.7	25.2	4.2	22.4	17.7	10.9	18.3	8.2	35.5	7.7	4.6	7.5	14.8	11.8	5.0	12.8	4.1	7.2	9.1	10.9	12.8	10.6	5.4	1.9	6.9	4.3	14.4	1.5	4.8	12.0	10.3	6.4	12.3	8.6	12.8	7.2	6.2	11.1	19.7	15.8	9.8	55.0	10.7	16.1	12.8	21.8	13.5	9.8	15.9	12.7
DUS4L	"DUS4, PP35"	ENSG00000105865	"Dihydrouridine synthase 4 like"	O95620	7	107563484-107578523	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044301	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA044301: AB_10967460"	"unprognostic (7.95e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-3)"	"unprognostic (7.74e-3)"	"unprognostic (6.72e-3)"	1.5	1.9	1.1	0.5	1.2	0.4	1.5	1.2	1.5	1.6	0.9	1.4	0.6	1.5	1.7	1.7	1.3	0.6	2.7	1.1	1.2	2.7	2.0	1.0	0.8	1.2	1.2	1.8	1.7	1.2	1.5	0.6	1.3	1.5	0.8	1.0	1.6	0.5	1.7	1.5	1.3	0.5	1.2	1.3	1.6	2.3	1.1	0.7	1.6	1.1	0.8	1.7	1.5	1.4	4.1	1.6	1.6	1.0	0.5	1.0	2.3	0.9	1.4	1.7	1.5	2.1	3.6	4.6	2.1	0.6	4.6	1.2	1.7	2.4	2.3	1.2	1.3	1.2	0.9	2.6	1.6	3.0	0.2	1.2	3.5	1.6	5.7	1.8	2.4	3.9	5.4	1.7	2.7	3.0	4.3	5.8	2.8	3.3	3.4	2.3	1.7	5.3	3.2	2.1	1.6	4.4	1.9	4.2	3.6	2.3	1.9	2.6	1.7	2.5	2.0	1.8	2.6	3.0	3.8	4.9	2.3	4.3	2.9	0.0	0.1	0.0	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	1.1	1.2	1.2	1.5	1.1	1.2	1.2	1.2	1.3	1.2	1.1	1.4	4.5	6.4	3.9	4.6	7.6	5.1	11.0	5.6	10.2	10.0	8.6	10.2	9.2	5.7	6.6	11.0	4.2	9.1	4.5	3.3	7.9	13.3	32.8	11.3	7.2	4.6	9.6	5.0	3.5	16.2	8.8	4.6	5.1	11.0	13.4	10.2	4.2	9.3	6.7	3.3	5.1	5.0	10.2	5.0	3.7	24.9	4.4	5.6	3.6	5.6	5.2	15.4	11.3	4.5	9.7	15.7	6.8	3.8	5.6	8.1	7.7	17.3	15.3	9.8	13.1	3.4	5.7	12.4	11.0	11.2	4.0	3.7	6.7	7.6	6.3	6.9
DUS4L-BCAP29		ENSG00000288558	"DUS4L-BCAP29 readthrough"	Q9UHQ4	7	107563971-107623317	"Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.8;monocytes: 1.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 18.7"									"HPA029215, HPA044301, HPA049694"	Approved		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"		"Cluster 11: RPE1 & U-87MG - Synaptic function"		Cytosol		"HPA029215: AB_10602331, HPA044301: AB_10967460, HPA049694: AB_2680854"																		3.4	2.0	6.7	2.0	7.7	2.9	2.8	7.4	11.4	4.0	4.5	2.6	1.2	4.2	2.0	2.1	1.7	1.3	3.3	7.6	6.3	2.0	2.5	3.9	1.3	6.9	6.5	2.1	0.8	2.4		1.7	7.0	2.0	3.4	3.3	0.8	2.5	5.7	5.8	1.3	3.6	6.7	2.1	1.5	2.4	7.0	1.9	4.3	4.9	1.9	2.0		7.8	7.2	2.8	4.0	1.3	3.0	4.9	1.3	5.7	6.1	4.6	2.9	2.2	3.6	1.9	3.5	5.8	2.1	2.4	3.1	5.1	5.5	2.4	4.3	5.0	2.5	2.0	4.6	6.7	3.2	2.9	3.0	7.4	2.7	5.2	7.2	3.3	7.6	1.8	6.0	3.0	4.9	7.1	2.2	1.7	3.0	3.1	4.4	6.1	5.3	2.0	1.2	6.1	5.3	5.1	4.9	2.1	1.5	6.5	8.8	9.1	2.3	11.0	13.2	2.4	5.0	3.3	18.7	6.3	5.3	5.8	0.4	1.0	0.3	1.1	0.4	0.3	0.4	0.6	0.8	0.5	0.3	0.6	0.0	0.3	1.5	0.5	0.7	0.3	6.7	7.7	7.4	11.4	7.6	6.3	6.9	6.5	7.0	6.7	7.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768096-172771195	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 2357.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 7426.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 7426.8"	"Cell line enhanced"	"Detected in all"		"HHSteC: 201.0;hTCEpi: 359.3;REH: 202.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	922.6	515.4	84.9	364.9	85.8	692.4	586.1	134.8	121.1	501.3	134.7	336.1	66.0	382.3	42.0	526.6	677.4	570.5	395.3	79.4	114.6	281.2	721.3	719.9	178.6	132.0	90.3	541.2	240.1	116.5	319.5	297.3	104.1	438.5	228.5	202.7	350.3	356.9	251.8	1054.1	170.3	452.7	123.7	304.7	396.0	68.1	115.4	131.3	612.9	451.3	56.2	778.1	610.0	121.2	10.7	26.5	8.2	11.5	175.6	102.2	14.0	170.3	49.3	111.9	45.0	29.2	12.4	3.5	48.6	120.4	128.1	4.7	8.1	42.3	52.1	95.8	22.4	2.3	63.1	12.6	201.0	1.2	3.8	98.1	359.3	50.9	82.1	58.2	35.6	7.4	9.0	66.1	73.1	12.6	5.7	5.0	7.4	8.2	7.7	202.2	15.3	32.3	80.2	5.4	35.5	14.9	46.2	76.9	6.3	34.1	6.7	1.9	94.1	79.1	39.8	77.8	13.4	13.6	8.4	3.1	70.3	1.8	3.3	931.4	584.5	1640.7	85.0	589.2	212.6	57.6	75.6	88.6	263.4	54.1	35.9	40.7	7426.8	114.5	791.6	14.3	68.1	409.9	84.9	85.8	134.8	121.1	79.4	114.6	132.0	90.3	104.1	123.7	115.4	121.2	1856.5	410.3	341.0	23.8	918.4	1279.8	1140.5	456.9	1810.4	73.0	464.2	567.7	211.3	739.2	243.1	211.5	27.1	316.2	618.9	633.7	56.7	335.9	71.6	531.6	990.9	870.4	715.5	193.5	11.9	88.7	407.2	1367.4	597.3	1013.7	301.1	175.8	781.4	345.7	1043.0	48.8	13.4	891.8	207.5	1525.5	2357.3	40.3	384.9	1965.5	542.5	66.5	173.3	1159.3	33.0	6.6	4.1	226.3	683.3	311.1	952.2	685.7	736.1	35.5	218.0	190.5	769.2	720.7	671.9	12.9	24.6	1996.9	1956.6	582.0	1015.2	223.4	415.8	676.6
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489891-37513501	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 179.7;Basal prostatic cells: 239.3;Cytotrophoblasts: 162.8;Endometrial ciliated cells: 146.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 36.4;SuSa: 24.9;WM-115: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes		79000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	15.3	14.2	10.9	1.3	11.2	0.3	12.4	11.2	17.0	12.8	10.9	10.3	0.0	9.5	5.5	17.4	7.5	1.2	14.1	11.0	10.9	8.7	15.2	8.6	0.4	11.9	11.1	5.6	6.6	1.0	14.5	0.9	10.6	6.4	1.0	9.9	13.1	0.3	11.0	44.1	5.5	0.8	10.4	2.8	7.6	13.7	10.8	4.4	23.1	4.4	2.7	7.2	17.1	10.7	2.6	0.2	4.9	2.1	0.1	0.6	2.1	10.4	7.8	14.3	15.6	1.2	17.9	0.2	0.9	7.6	0.2	2.8	0.2	6.1	36.4	0.2	0.7	0.0	1.6	6.2	1.5	0.5	3.0	8.5	5.5	4.8	2.5	10.2	0.3	0.2	0.6	3.1	11.4	0.4	9.7	1.7	0.3	3.8	0.0	2.5	0.6	2.5	17.5	2.4	1.9	0.3	0.5	17.6	4.1	24.9	0.8	3.9	1.4	10.8	5.8	0.1	5.8	0.1	0.3	0.1	0.1	0.0	37.5	1.1	0.0	0.7	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.6	0.0	0.2	0.0	0.0	0.2	10.9	11.2	11.2	17.0	11.0	10.9	11.9	11.1	10.6	10.4	10.8	10.7	15.0	6.4	5.4	2.9	8.3	179.7	239.3	74.8	129.1	6.8	42.6	46.0	15.0	4.3	39.6	7.3	8.4	162.8	16.6	0.3	29.4	34.8	36.4	146.9	18.5	21.7	2.4	11.4	12.0	15.1	82.1	30.2	3.1	85.3	87.0	10.6	14.6	15.7	19.7	15.2	5.3	1.2	36.7	2.8	34.8	52.5	13.7	5.9	62.2	4.7	25.3	16.1	15.5	3.0	3.3	74.8	2.9	6.0	9.9	64.9	0.1	16.9	61.3	24.5	0.0	13.2	45.2	26.0	33.4	44.0	92.6	67.9	18.2	26.3	1.1	67.0
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 210.5"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 273.9;Early spermatids: 288.8;Late spermatids: 979.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.8;REH: 16.0;SH-SY5Y: 4.3;SK-MEL-30: 4.0;U-2 OS: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA076649: AB_2686811"	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favorable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.7	5.9	5.3	0.2	7.6	0.1	3.4	10.7	7.5	5.9	4.9	1.8	0.5	3.4	9.0	1.0	1.5	0.7	7.8	4.8	7.7	50.0	0.7	1.6	0.6	17.1	8.7	5.2	2.4	13.0	8.7	0.7	8.1	6.6	0.1	0.6	2.1	3.0	0.9	1.2	1.5	0.3	7.8	2.7	2.3	210.5	7.6	0.3	9.6	0.3	0.2	2.5	2.7	8.8	0.2	0.2	0.1	1.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	4.8	0.1	1.0	1.9	0.2	2.6	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	3.4	0.6	0.0	0.0	16.0	1.8	0.1	0.0	0.0	2.1	4.3	2.6	0.0	4.0	0.1	1.1	0.9	0.0	0.0	3.6	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.6	10.7	7.5	4.8	7.7	17.1	8.7	8.1	7.8	7.6	8.8	2.9	0.0	0.0	1.3	0.8	0.6	1.3	0.0	0.0	0.6	3.6	4.4	2.5	1.5	0.0	18.4	4.2	0.0	0.4	0.1	273.9	2.4	288.8	0.6	4.0	2.2	1.8	0.0	1.7	1.0	0.1	2.9	1.5	0.6	0.0	7.0	1.8	0.1	0.6	6.7	2.6	0.4	0.0	0.6	1.9	979.4	8.7	1.2	7.2	0.0	0.6	2.9	0.0	3.0	4.7	0.6	0.0	10.9	0.0	0.9	0.0	55.3	0.1	0.3	0.0	2.5	3.3	121.5	6.0	0.3	0.1	0.1	0.3	7.5	0.7	0.4
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766125-43778977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 274.3;Late spermatids: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"dendritic cells: 33.5;granulocytes: 11.0;monocytes: 29.3"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	39.8	43.2	63.6	21.6	67.1	9.9	32.7	57.2	91.0	32.4	59.6	96.1	27.8	49.2	31.1	48.4	33.6	33.4	194.8	69.0	65.4	72.0	108.1	50.2	14.3	64.2	64.3	18.2	48.6	47.0	33.1	31.4	64.4	57.7	26.0	30.8	31.8	72.9	261.9	24.6	38.7	62.9	58.5	40.7	57.5	24.5	65.6	6.2	30.5	213.7	13.0	63.1	33.6	64.3	32.3	57.1	21.5	23.1	61.1	32.7	18.3	23.8	56.4	54.4	65.1	55.4	21.1	4.9	36.7	44.7	112.4	27.3	33.7	29.3	56.9	11.1	25.6	16.2	25.9	45.4	74.5	2.0	16.1	30.5	51.5	42.0	36.2	59.0	38.5	15.9	14.7	5.4	64.2	23.1	8.5	8.4	9.9	45.5	41.1	10.5	64.5	12.1	75.8	33.3	12.0	21.6	27.9	18.3	71.8	58.8	82.2	44.7	40.4	61.1	41.5	87.9	40.1	28.5	40.4	1.2	72.4	22.6	20.8	11.0	29.3	6.4	1.5	15.0	2.7	2.6	2.4	1.9	33.5	2.4	1.9	1.7	7.0	1.7	20.6	13.8	1.6	11.4	63.6	67.1	57.2	91.0	69.0	65.4	64.2	64.3	64.4	58.5	65.6	64.3	23.1	25.6	21.2	6.5	9.2	22.4	47.6	17.6	10.8	17.2	20.3	21.3	274.3	54.3	17.9	42.3	25.0	16.3	9.5	36.9	41.1	47.8	88.6	18.8	16.6	33.8	36.4	11.6	18.1	58.9	21.8	25.9	42.8	25.0	38.7	6.1	25.4	108.8	86.6	20.2	15.5	19.9	24.4	49.1	52.0	160.5	14.6	47.2	10.6	15.9	53.9	16.8	4.1	8.5	13.8	56.5	32.3	26.4	8.0	46.2	57.7	87.6	21.1	17.3	32.9	24.1	28.4	3.3	5.0	16.0	28.8	45.0	6.3	15.1	18.0	42.6
DUSP8	"C11orf81, FLJ42958, HB5, HVH-5"	ENSG00000184545	"Dual specificity phosphatase 8"	Q13202	11	1554051-1572271	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 113.6;Distal enterocytes: 57.8;Glandular and luminal cells: 65.6;Horizontal cells: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.5;SCLC-21H: 1.4;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020071	Approved		Approved	Cytosol		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA020071: AB_1847903"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.75e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.30e-2)"	6.6	2.1	3.5	0.2	3.0	1.0	6.0	0.3	8.1	5.1	0.0	11.3	0.0	8.4	0.6	1.4	8.7	0.5	17.0	5.0	0.1	5.4	3.6	9.5	0.3	1.9	0.4	2.4	15.7	0.2	25.5	0.1	0.1	5.1	0.3	1.6	6.1	0.2	13.3	4.3	6.8	1.2	0.3	3.1	8.3	3.1	0.7	0.2	3.7	0.0	0.1	3.6	4.2	2.0	0.6	0.3	0.4	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.6	0.6	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.1	0.3	1.1	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	2.5	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	1.4	1.7	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.8	0.3	0.8	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.0	0.3	8.1	5.0	0.1	1.9	0.4	0.1	0.3	0.7	2.0	14.9	3.2	1.1	0.0	6.3	9.8	8.1	2.7	2.8	113.6	32.1	24.3	6.0	14.3	3.2	12.9	47.9	0.3	11.1	57.8	1.9	7.7	0.3	31.5	24.7	6.5	42.3	0.0	11.1	11.3	0.5	4.3	8.6	65.6	0.0	0.4	1.4	0.6	0.5	90.9	11.3	32.6	6.1	0.0	3.4	0.2	0.6	4.7	5.4	2.8	1.0	22.3	1.0	3.0	5.2	11.0	22.4	0.4	4.7	17.4	19.1	1.6	2.8	35.5	6.6	8.0	15.1	0.8	0.6	2.2	4.8	5.9	10.5	0.7	25.0	14.2
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972290	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 467.9;Late spermatids: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	6.6	17.8	8.2	3.9	8.1	1.4	6.9	8.2	8.5	10.7	9.6	7.1	4.5	8.1	5.8	5.7	8.5	4.2	9.6	8.1	8.4	12.3	13.0	6.4	4.6	9.3	8.6	13.4	10.8	11.8	13.0	4.4	8.7	10.3	3.9	4.8	6.7	6.0	5.3	4.9	5.8	4.8	8.6	9.7	8.6	31.3	8.3	7.0	11.5	7.1	3.0	7.9	7.4	8.5	12.9	6.3	5.8	23.1	9.5	6.4	6.7	7.5	12.0	16.2	15.5	7.6	5.9	5.2	8.5	16.6	5.2	8.7	10.1	16.8	9.4	9.6	12.9	9.3	15.8	16.4	18.7	0.0	4.6	9.7	16.3	10.5	13.5	9.9	21.3	6.6	8.3	11.9	9.8	14.7	1.5	11.1	4.4	8.4	1.3	4.0	4.1	8.2	21.2	4.5	30.1	17.0	6.6	7.3	16.9	4.1	0.0	14.8	7.0	4.7	12.6	4.6	12.3	9.1	9.4	10.2	4.6	14.4	5.2	0.0	1.9	1.0	2.2	1.6	3.9	2.4	2.3	1.4	4.3	2.1	1.6	2.3	0.3	2.1	1.4	1.3	1.6	1.8	8.2	8.1	8.2	8.5	8.1	8.4	9.3	8.6	8.7	8.6	8.3	8.5	11.2	6.4	9.6	11.8	16.8	8.5	15.3	14.3	19.9	13.3	13.6	11.4	7.1	11.5	10.5	3.7	16.7	14.5	14.1	5.0	19.6	8.4	467.9	9.3	10.6	9.8	16.2	4.4	4.4	12.6	9.5	10.9	15.8	8.7	6.3	12.1	8.6	10.9	6.6	5.0	6.2	9.0	12.2	5.9	4.9	242.8	17.7	6.9	12.4	1.9	4.3	16.0	11.3	7.5	6.6	6.9	10.5	12.4	14.7	10.8	10.6	13.3	8.9	15.6	13.1	7.1	14.3	78.4	16.1	11.8	5.5	20.1	15.4	22.6	8.3	11.5
DYNC1LI2	DNCLI2	ENSG00000135720	"Dynein cytoplasmic 1 light intermediate chain 2"	O43237	16	66720893-66751609	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 311.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049538, HPA057201"	Approved		Approved	Centrosome,Cytosol		NA	NA		21000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Centrosome	Cytosol	"HPA049538: , HPA057201: AB_2683366"	"unprognostic (6.03e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.34e-1)"	60.9	44.9	225.7	39.2	240.6	42.4	44.1	207.1	311.6	46.2	131.4	70.5	43.3	50.7	40.6	50.6	37.7	48.7	59.4	184.1	202.3	43.0	29.1	45.9	27.0	228.5	228.0	45.5	44.7	65.7	35.6	46.8	226.2	52.7	61.1	37.3	48.6	49.9	42.3	51.3	44.6	64.9	244.5	36.3	50.2	34.1	221.3	24.6	61.6	49.9	28.8	45.7	40.8	265.1	52.5	54.0	79.1	71.0	100.1	98.3	71.6	84.5	67.1	67.5	87.0	73.4	50.6	21.9	64.6	83.3	49.1	74.1	61.2	60.4	98.2	14.9	43.9	27.0	68.1	70.6	55.5	29.0	38.5	64.8	80.6	77.8	53.4	94.3	96.2	22.4	44.4	28.0	88.8	37.5	18.1	37.5	47.5	58.4	93.0	39.4	166.3	26.5	67.2	73.3	78.8	54.9	152.1	32.6	100.6	56.5	39.7	28.8	123.2	86.9	43.3	43.0	58.2	35.3	27.4	43.0	74.6	27.7	55.8	13.6	16.6	16.6	12.3	9.9	14.2	4.8	10.4	10.2	12.2	9.4	8.7	8.4	15.7	9.3	14.5	7.6	11.4	8.7	225.7	240.6	207.1	311.6	184.1	202.3	228.5	228.0	226.2	244.5	221.3	265.1	117.9	102.5	120.4	44.1	29.5	66.2	63.1	66.1	52.3	82.5	54.8	51.2	48.3	54.3	93.8	27.6	33.3	61.3	47.2	114.0	7.9	85.7	112.6	77.6	68.5	97.6	106.1	28.4	50.9	58.1	62.0	66.7	52.5	87.4	36.7	87.5	62.4	33.3	30.6	107.7	45.4	78.6	65.1	39.9	53.7	66.8	63.3	36.8	69.4	34.7	37.8	116.0	35.0	51.3	106.9	101.7	56.7	80.5	37.3	83.6	60.0	49.4	105.0	61.4	118.3	93.4	87.0	103.0	51.1	53.6	69.9	84.8	32.2	61.2	66.7	95.8
DYNC2H1	"DHC1b, DHC2, DNCH2, DYH1B, hdhc11"	ENSG00000187240	"Dynein cytoplasmic 2 heavy chain 1"	Q8NCM8	11	103109410-103479863	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 173.7;Cone photoreceptor cells: 112.6;Endometrial ciliated cells: 124.0;Excitatory neurons: 164.7;Inhibitory neurons: 101.8;Respiratory ciliated cells: 171.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039015, HPA039016"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA039015: AB_2676309, HPA039016: AB_10673410"	"unprognostic (3.11e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (8.49e-5)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.11e-3)"	4.2	3.0	5.0	1.2	5.2	0.3	3.5	5.6	10.2	5.1	14.6	3.2	1.6	4.6	3.7	1.6	6.5	3.2	2.0	4.1	6.1	3.7	0.8	2.8	0.9	8.3	8.9	5.6	2.9	6.7	6.8	1.4	6.3	2.6	0.7	10.5	2.6	2.5	0.8	2.8	2.1	2.3	5.5	1.9	2.2	7.9	6.7	1.8	4.6	1.5	0.7	3.3	3.0	5.9	1.3	2.7	7.0	3.3	9.5	21.2	0.4	4.0	6.4	6.5	7.0	1.6	1.5	0.0	5.5	8.0	3.1	5.5	5.5	7.7	5.3	0.0	4.6	1.2	4.8	0.2	9.3	2.2	1.3	13.6	2.8	14.9	16.9	10.3	2.7	1.4	0.2	0.0	8.6	5.4	0.7	0.7	1.9	0.0	7.7	0.0	5.9	0.1	7.5	0.9	4.6	3.6	6.5	1.7	3.1	1.7	6.8	1.5	6.4	7.9	3.3	7.7	3.0	0.0	0.0	0.1	2.3	6.7	2.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	5.0	5.2	5.6	10.2	4.1	6.1	8.3	8.9	6.3	5.5	6.7	5.9	12.7	0.0	13.1	173.7	2.3	6.6	13.4	17.3	9.6	25.9	8.2	9.7	10.1	4.3	18.0	27.6	112.6	0.3	2.1	0.2	1.9	7.0	26.1	124.0	43.7	11.1	17.3	1.3	164.7	3.4	0.5	32.0	5.6	7.5	3.8	15.4	9.3	0.8	2.5	32.0	101.8	1.0	4.1	0.8	5.8	11.1	20.8	3.1	8.8	45.0	0.9	16.5	1.0	86.0	72.6	10.5	2.9	18.4	3.3	4.9	0.9	16.9	171.0	85.1	19.7	40.8	18.5	90.6	11.6	5.0	5.5	0.5	5.0	23.5	1.7	5.9
DYNC2I2	"bA216B9.3, CFAP133, DIC5, FAP133, MGC20486, WDR34"	ENSG00000119333	"Dynein 2 intermediate chain 2"	Q96EX3	9	128633653-128656847	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.4;Cytotrophoblasts: 89.8;Extravillous trophoblasts: 95.3;Hofbauer cells: 21.9;Syncytiotrophoblasts: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 35.8;naive B-cell: 52.9"	"Lineage enriched"	"Detected in all"	5	"B-cells: 52.9"	"Cell line enhanced"	"Detected in all"		"MCF7: 432.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040764, HPA041091"	Approved		Approved	Cytosol		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA040764: AB_10795625, HPA041091: AB_10796237"	"unprognostic (1.45e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.01e-5)"	"unprognostic (2.27e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (8.79e-4)"	"unprognostic (6.04e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.65e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-1)"	14.4	49.9	15.7	11.4	15.4	33.2	20.1	14.3	20.1	28.2	30.5	26.7	22.2	22.4	8.9	37.9	30.5	11.1	41.4	15.4	18.9	61.8	39.1	25.1	12.0	17.0	19.4	19.1	36.7	21.2	36.1	11.0	16.4	31.0	10.3	4.5	31.9	14.0	11.1	24.0	27.7	6.3	16.5	23.6	26.3	69.8	16.6	23.8	55.6	4.3	9.5	19.2	23.7	14.7	112.7	202.8	49.8	78.8	11.4	16.1	141.4	46.2	32.9	66.5	42.8	96.6	197.3	40.4	32.4	30.8	62.0	169.4	47.5	50.8	16.6	93.5	40.1	24.0	134.8	52.0	13.9	41.5	39.4	8.0	25.0	66.3	18.9	24.0	46.5	112.6	83.5	34.0	36.4	432.4	151.3	106.1	63.7	97.3	121.0	157.2	66.6	136.8	42.1	36.0	125.1	100.1	143.9	135.9	36.8	13.7	230.5	40.7	28.3	75.9	114.8	95.6	90.7	34.6	100.7	39.6	71.4	41.9	74.0	1.7	1.1	0.4	1.4	1.6	2.3	35.8	2.9	3.9	2.8	52.9	1.1	1.7	0.8	4.5	5.7	11.0	5.7	3.8	15.7	15.4	14.3	20.1	15.4	18.9	17.0	19.4	16.4	16.5	16.6	14.7	2.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	89.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	95.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	37.4	0.2	0.0	0.0	0.0
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 4098.6;Respiratory ciliated cells: 2679.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	Yes		890000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	268.6	261.9	912.5	186.7	967.7	126.8	268.0	895.2	1292.9	354.2	894.7	325.8	162.8	319.4	322.3	719.9	544.2	242.7	257.5	975.4	944.7	352.6	238.4	222.6	241.6	896.1	898.5	247.0	225.1	228.2	309.7	259.2	914.2	225.9	327.4	181.3	245.4	264.6	85.6	626.7	206.3	390.1	935.1	185.2	244.5	360.3	909.7	306.5	176.1	163.9	357.8	389.8	474.4	1001.2	721.6	811.4	779.2	600.8	677.1	713.6	250.8	968.0	451.6	785.6	466.7	770.8	472.3	400.6	510.3	945.1	753.0	629.6	949.3	818.3	781.0	528.3	617.9	390.4	532.9	1062.5	676.2	412.8	620.5	436.2	863.0	584.6	477.5	855.7	831.8	421.5	502.0	446.1	1056.8	960.1	541.4	894.8	642.2	917.7	935.7	543.0	403.0	499.2	1143.1	659.8	535.2	392.0	789.3	677.7	926.6	812.6	673.6	595.3	635.2	592.3	502.1	525.6	852.2	264.0	562.8	404.6	656.8	645.1	776.6	516.6	291.9	384.2	200.6	303.3	155.3	310.4	207.2	211.7	281.8	219.0	132.0	165.7	50.1	282.9	334.8	461.6	373.5	353.0	912.5	967.7	895.2	1292.9	975.4	944.7	896.1	898.5	914.2	935.1	909.7	1001.2	810.1	195.5	101.9	79.3	341.4	922.2	359.1	1275.0	356.8	138.4	800.0	949.4	170.8	303.1	764.6	399.1	83.4	524.6	484.1	689.9	1113.2	691.2	1407.2	1842.5	528.5	541.9	480.8	332.9	111.2	538.9	897.4	538.5	240.5	488.1	316.7	611.9	521.9	499.0	732.1	85.8	62.8	801.6	1121.0	329.4	706.1	4098.6	516.6	466.3	595.9	42.2	701.6	164.0	248.2	47.3	156.4	754.9	798.6	701.8	234.9	304.7	533.4	1125.0	2679.6	193.5	368.1	440.7	1016.3	961.5	721.4	1005.4	1610.1	1006.6	396.6	586.3	498.2	389.6
DYNLT2B	"MGC33212, TCTEX1D2"	ENSG00000213123	"Dynein light chain Tctex-type 2B"	Q8WW35	3	196291219-196318299	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 6.2;Cytotrophoblasts: 29.4;Extravillous trophoblasts: 9.9;Hofbauer cells: 16.8;Syncytiotrophoblasts: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 21.9;dendritic cells: 16.2;T-cells: 25.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 101.7"									HPA049555			Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA049555: AB_2680816"	"unprognostic (1.16e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (5.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.61e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	5.0	7.9	15.2	4.5	15.7	5.1	6.5	14.6	18.6	8.7	15.0	9.1	3.4	7.1	7.9	13.0	36.2	5.1	6.3	15.2	16.0	16.9	2.3	7.0	8.8	15.2	16.8	7.3	5.1	7.9	13.8	3.1	17.0	7.0	4.2	15.0	5.2	3.9	3.0	8.4	4.0	3.7	15.7	4.3	5.0	30.9	16.6	14.7	10.1	1.5	6.0	6.7	9.4	15.0	33.1	23.9	45.3	28.0	11.1	22.3	5.4	13.8	9.3	16.8	18.8	7.9	45.0	21.0	23.0	12.1	7.0	33.7	17.8	14.5	16.3	18.4	13.3	8.6	22.3	3.4	12.7	6.4	0.9	12.1	38.2	14.7	17.1	30.5	10.2	44.0	13.3	10.8	32.6	79.0	28.9	29.4	29.6	36.6	41.5	37.3	7.7	8.7	38.9	13.4	50.9	39.7	29.2	17.2	28.0	18.7	101.7	18.3	19.2	15.0	5.8	6.1	18.0	16.9	38.0	48.8	45.0	11.4	25.8	0.0	3.1	1.4	11.7	1.2	7.1	21.9	13.9	9.0	8.8	13.7	9.1	9.4	1.8	4.6	0.8	16.2	25.1	6.3	15.2	15.7	14.6	18.6	15.2	16.0	15.2	16.8	17.0	15.7	16.6	15.0	5.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	29.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	9.9	3.3	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 156.7;Inhibitory neurons: 158.4;Microglial cells: 176.1;Oligodendrocyte precursor cells: 158.3;Oligodendrocytes: 157.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	23.1	20.4	17.8	22.5	19.9	71.4	22.3	29.9	20.7	23.9	22.2	22.2	18.7	26.6	22.0	18.8	22.6	19.9	28.9	21.3	19.2	19.9	19.8	22.3	30.1	12.1	14.7	29.6	21.5	27.8	20.2	23.0	13.3	18.8	21.6	27.8	21.3	19.2	49.4	24.2	21.7	24.1	12.8	30.4	22.8	29.9	18.6	45.8	25.7	45.2	26.7	24.3	21.1	20.9	23.5	18.2	36.3	25.6	17.1	18.8	32.7	20.8	26.0	20.3	22.0	25.7	19.7	31.7	13.8	37.0	27.1	15.8	27.3	21.2	24.4	49.7	11.6	93.6	30.9	16.1	26.5	36.9	32.3	18.7	24.3	26.5	41.2	23.5	22.3	44.2	36.4	70.4	22.2	23.6	49.3	25.9	38.5	24.1	10.8	62.8	19.7	29.6	22.3	30.4	36.5	20.4	47.1	31.6	33.2	12.2	29.9	34.8	27.8	27.6	8.3	17.2	17.4	47.7	41.6	44.9	22.0	41.8	30.7	3.1	0.5	0.8	1.2	0.8	0.7	1.1	1.3	1.0	0.7	1.0	1.4	1.3	2.3	0.5	1.1	1.3	1.3	0.3	17.8	19.9	29.9	20.7	21.3	19.2	12.1	14.7	13.3	12.8	18.6	20.9	36.8	19.2	25.5	114.3	28.8	37.5	24.1	15.7	18.2	32.7	28.3	18.0	73.0	20.0	23.0	11.0	27.1	10.3	43.0	30.1	0.0	13.5	29.7	44.2	39.3	31.9	21.4	26.1	156.7	14.6	12.4	25.2	21.4	71.4	24.7	35.9	27.1	18.1	15.8	47.1	158.4	18.8	14.2	25.0	27.7	22.2	16.1	32.4	24.9	176.1	18.8	16.4	21.6	158.3	157.2	21.2	22.4	19.5	33.8	29.8	17.1	9.9	27.9	21.8	13.1	38.4	32.5	15.3	24.7	24.6	31.7	15.3	36.8	21.3	19.3	37.2
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401879-20493714	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: AB_2732448, HPA065012: AB_2685403"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	6.5	4.9	4.8	9.8	5.2	19.8	4.1	2.8	5.7	3.3	3.0	5.4	5.2	3.6	3.9	4.9	2.5	6.4	5.1	6.4	4.6	5.8	4.4	4.9	11.0	3.7	4.6	1.4	2.1	3.1	1.8	5.6	4.2	3.3	6.3	6.1	2.7	3.1	10.0	2.6	5.7	6.0	3.7	8.4	3.6	3.4	5.5	8.6	8.5	9.3	9.5	8.5	2.7	3.8	14.3	11.6	32.2	35.1	10.9	11.9	22.0	18.9	16.8	18.2	19.9	14.3	8.8	32.3	35.2	18.2	16.9	14.6	37.8	17.4	30.3	12.2	25.3	58.1	20.4	16.3	11.6	38.6	33.0	9.7	12.6	17.7	21.6	18.8	12.7	29.8	65.3	19.4	20.9	15.0	43.6	43.2	24.2	11.0	11.9	46.5	27.8	36.5	21.8	25.1	22.9	42.2	17.3	24.1	26.3	20.0	12.4	23.4	17.2	28.6	17.4	14.2	30.5	12.1	40.1	38.3	7.1	23.2	41.3	5.6	2.3	1.1	1.6	1.6	2.0	0.4	1.0	2.4	2.6	0.4	0.8	1.8	7.2	3.5	1.1	1.1	1.6	1.1	4.8	5.2	2.8	5.7	6.4	4.6	3.7	4.6	4.2	3.7	5.5	3.8	4.8	0.0	2.6	53.8	10.6	9.2	12.3	7.0	7.4	34.1	11.9	7.2	10.6	4.3	10.6	7.3	22.9	8.3	15.0	12.0	9.8	7.6	12.2	3.9	14.1	8.5	12.0	17.2	67.7	6.9	13.8	9.2	12.8	10.6	20.3	32.3	14.6	4.7	17.1	32.0	31.9	11.7	4.1	47.2	17.7	5.7	2.8	28.7	5.4	27.2	23.8	2.9	15.5	37.7	2.9	14.8	10.3	3.0	19.1	22.1	4.5	25.1	2.2	9.0	0.0	9.0	11.5	3.0	4.7	16.5	8.9	3.1	15.3	5.7	13.8	18.4
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 484.1;esophagus: 1370.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 113.3;Fibroblasts: 118.6;Melanocytes: 74.7;Pancreatic endocrine cells: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 402.1;BJ hTERT+: 293.1;fHDF/TERT166: 279.6;hTEC/SVTERT24-B: 195.6;LHCN-M2: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		8700000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	49.3	15.4	7.6	11.8	8.5	0.8	27.1	7.3	14.7	293.8	6.1	17.7	9.4	51.2	484.1	1370.5	20.1	76.5	81.3	8.1	8.3	15.9	61.2	26.3	1.2	17.4	8.9	8.9	4.1	3.5	12.7	44.6	15.4	15.5	18.1	0.9	223.9	14.0	7.0	70.0	12.4	32.6	8.9	11.5	12.4	2.7	9.4	1.3	11.1	7.8	135.0	24.4	360.1	10.7	35.4	3.5	12.6	0.2	73.9	402.1	11.4	126.9	293.1	76.2	99.5	1.9	19.1	0.6	1.3	279.6	8.8	71.5	0.2	15.0	79.3	0.6	0.7	5.7	4.1	0.7	20.4	0.3	125.5	35.7	0.9	195.6	7.2	112.8	21.3	0.7	27.7	0.8	215.2	0.1	0.4	4.2	1.4	147.8	4.1	2.0	92.7	0.5	2.8	0.1	0.8	0.4	28.8	0.9	106.4	5.8	0.3	34.0	5.8	159.3	23.9	18.3	27.9	0.5	1.1	1.5	84.6	11.7	22.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	8.5	7.3	14.7	8.1	8.3	17.4	8.9	15.4	8.9	9.4	10.7	9.1	0.0	1.1	2.9	0.6	14.7	1.9	6.9	0.0	0.7	0.5	0.6	1.8	7.2	7.9	3.7	0.0	2.2	0.6	1.0	0.0	6.2	0.3	3.1	113.3	15.7	0.0	0.0	12.1	4.3	40.9	118.6	7.7	2.5	10.2	1.0	42.5	1.0	17.0	1.7	10.9	1.4	18.3	2.2	22.8	0.3	9.9	10.8	74.7	2.8	0.1	0.5	0.0	1.0	4.4	70.2	1.1	22.2	0.4	1.5	0.1	0.1	0.4	1.2	13.1	4.1	32.3	0.7	0.6	28.1	19.0	10.9	2.1	5.0	0.5	6.9
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 73.3;Hepatocytes: 49.3;Leydig cells: 122.1;Peritubular cells: 69.6;Skeletal myocytes: 43.6;Smooth muscle cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 19.1;ASC TERT1: 34.5;HSkMC: 36.8;hTCEpi: 42.8;hTERT-HME1: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035347, HPA035348"	Approved		Approved	"Mitotic spindle,Centrosome,Cytosol"	"Secreted to extracellular matrix"	Yes	NA		10000000		"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Centrosome, Cytosol"	"Mitotic spindle"	"HPA035347: AB_10669856, HPA035348: "	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	122.1	14.3	5.0	2.1	5.0	0.6	34.8	6.0	4.9	43.5	8.1	6.8	9.0	40.8	23.2	9.0	30.0	31.7	31.5	4.5	11.6	28.4	81.5	22.5	8.3	5.2	10.3	91.6	6.3	9.1	6.1	3.5	5.8	21.2	7.4	0.3	7.2	22.2	7.4	9.7	14.8	27.8	4.4	0.9	4.3	16.8	8.0	5.0	11.4	24.6	7.8	13.3	11.1	12.0	0.7	0.1	0.4	0.0	19.1	34.5	1.3	0.8	1.1	0.1	0.5	0.6	0.0	0.0	0.1	1.9	0.3	0.5	0.9	0.8	0.1	4.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	36.8	42.8	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.1	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.0	6.0	4.9	4.5	11.6	5.2	10.3	5.8	4.4	8.0	12.0	12.9	0.0	2.3	5.5	0.3	11.5	0.1	0.6	0.6	3.0	0.3	1.3	5.5	1.5	2.0	0.0	2.1	0.1	0.3	0.2	0.0	0.1	5.1	0.6	18.6	5.2	0.0	0.8	3.4	0.0	16.2	73.3	0.5	0.5	0.0	18.2	2.2	49.3	0.4	0.0	2.8	0.4	0.0	1.3	15.4	8.9	122.1	1.1	5.4	17.8	0.1	0.1	0.0	0.5	2.9	0.0	0.2	69.6	1.4	0.1	11.1	9.2	3.3	2.5	26.3	43.6	50.2	0.9	0.6	0.9	9.1	0.8	0.9	13.5	0.6	0.2
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 8.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 26.7;granulocytes: 22.7;Syncytiotrophoblasts: 22.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"basophil: 49.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 49.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.9;HDLM-2: 13.2;HMC-1: 52.7;RT4: 45.3;T-47d: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.4	0.1	0.2	0.4	0.1	0.4	4.8	0.1	0.1	0.7	0.0	0.3	0.4	0.4	5.2	3.3	1.2	0.8	0.9	0.1	0.1	1.1	0.3	0.7	1.2	0.2	0.2	0.4	3.8	0.1	0.1	4.9	0.1	3.6	0.3	0.0	1.4	6.1	0.0	5.8	0.3	0.1	0.1	1.2	6.3	3.4	0.2	2.3	6.4	0.0	2.6	8.7	1.0	0.1	0.0	3.8	0.3	0.0	0.0	0.0	15.9	0.0	0.0	1.3	0.8	1.0	0.0	0.0	0.0	0.2	4.3	8.8	6.5	9.6	1.2	13.2	7.6	0.1	0.1	1.4	0.0	0.4	52.7	0.0	2.7	0.9	0.8	0.0	0.0	1.8	0.4	0.0	0.0	0.4	0.3	0.0	3.9	0.0	0.0	3.4	0.1	0.0	0.0	45.3	0.4	0.3	0.0	1.2	0.2	0.3	12.6	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	49.5	0.3	0.1	3.1	0.4	4.1	0.1	4.7	6.1	0.5	0.2	0.4	3.2	0.3	5.3	0.2	0.1	5.1	2.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.3	0.0	1.3	0.0	0.4	6.9	7.3	16.3	13.1	0.0	7.1	7.4	4.1	5.7	8.4	0.0	0.0	26.7	3.0	0.1	3.9	1.7	10.6	0.2	1.2	1.2	0.0	2.5	0.5	0.9	14.2	1.1	5.1	0.4	22.7	2.8	5.0	0.5	3.4	0.0	0.6	0.1	8.2	1.5	8.9	9.3	0.3	0.6	12.4	1.0	3.7	0.6	0.0	1.0	0.4	0.6	0.0	0.4	1.8	4.2	0.1	0.4	3.2	0.1	0.0	1.4	6.1	13.4	3.7	6.5	5.3	22.6	6.2	0.3	0.0	5.3
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484683	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 26.1;esophagus: 20.8;vagina: 32.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 239.7;Basal respiratory cells: 137.3;Club cells: 146.1;Collecting duct cells: 69.9;Prostatic glandular cells: 62.5;Proximal enterocytes: 91.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.8;EFO-21: 35.9;HeLa: 13.0;SCLC-21H: 16.8;SK-BR-3: 41.2;U-2 OS: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.3	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.0	26.1	1.0	1.9	3.9	3.1	4.7	20.8	1.6	0.2	1.4	0.1	0.0	7.4	1.2	3.7	0.0	0.1	0.1	0.1	2.4	0.0	2.1	0.0	0.1	7.5	0.9	0.2	8.0	0.5	0.2	15.0	17.4	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.5	0.0	0.3	2.4	32.7	0.1	0.2	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	13.8	0.0	35.9	0.0	0.0	1.7	0.0	0.1	0.0	4.2	0.0	0.0	13.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.8	0.4	0.0	0.0	1.3	8.4	9.4	0.9	16.8	0.0	0.3	41.2	0.0	0.9	0.8	0.0	0.0	0.0	15.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	6.4	1.5	0.0	0.0	30.3	239.7	137.3	8.6	0.1	2.5	1.3	0.7	2.8	146.1	69.9	0.0	0.2	0.1	23.3	0.0	8.8	0.0	36.9	0.5	0.6	1.8	0.0	0.0	1.0	0.0	1.8	3.1	6.5	0.0	0.3	0.0	0.2	0.0	0.0	0.0	4.2	38.7	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.9	2.7	0.0	0.1	62.5	91.7	1.6	20.9	0.0	0.0	0.4	3.5	0.0	0.2	2.4	29.1	0.0	0.7	0.8	8.2	45.2
EDRF1	"C10orf137, DKFZp586F1019, FLJ21617"	ENSG00000107938	"Erythroid differentiation regulatory factor 1"	Q3B7T1	10	125719515-125764143	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 145.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031820			Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA031820: AB_10600753"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.84e-4)"	"unprognostic (4.76e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.63e-3)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (3.44e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.68e-3)"	4.1	4.0	2.0	6.1	2.7	21.8	5.6	5.3	2.9	5.6	2.7	4.0	5.0	7.4	4.9	4.7	4.6	4.1	5.1	2.9	2.0	3.6	2.8	4.2	9.7	1.7	1.7	8.0	7.2	4.3	2.9	5.7	2.3	6.8	5.2	4.6	12.3	4.1	5.7	5.1	4.5	5.2	1.5	5.4	4.7	15.1	1.7	9.4	5.2	5.1	8.2	4.4	3.3	4.1	12.6	11.7	15.4	16.5	7.2	10.0	7.8	14.8	13.6	16.3	18.5	15.7	10.4	16.5	6.9	9.6	9.5	15.3	22.6	4.7	18.0	10.3	18.3	12.0	12.5	8.9	9.6	17.0	12.1	6.5	6.0	16.2	8.1	15.6	7.8	8.9	11.1	11.2	10.6	5.3	16.9	11.8	20.6	7.7	10.2	14.0	13.2	9.7	6.5	7.2	7.6	14.9	10.7	5.9	10.1	13.9	10.3	6.8	5.4	8.8	9.6	12.4	17.1	15.0	11.4	26.1	9.3	8.8	5.0	5.9	2.3	1.4	2.7	2.0	3.4	3.1	2.2	2.5	3.0	2.3	2.2	2.8	2.9	2.9	1.3	2.9	3.1	1.4	2.0	2.7	5.3	2.9	2.9	2.0	1.7	1.7	2.3	1.5	1.7	4.1	12.4	12.8	9.7	26.1	19.1	5.9	5.7	5.1	15.4	23.9	9.3	8.4	12.9	8.6	9.0	11.0	33.3	6.7	28.5	5.1	0.0	4.3	145.1	11.2	14.6	9.5	4.2	7.6	40.9	7.2	6.0	12.1	17.3	27.2	20.3	24.7	7.5	7.0	4.1	20.2	31.7	7.5	4.1	7.7	4.2	61.5	21.1	9.2	7.2	22.5	12.2	9.1	13.4	22.1	36.2	8.3	4.9	19.9	27.1	6.6	7.1	2.7	8.6	24.4	6.6	13.0	11.0	26.8	21.4	10.6	8.2	4.5	20.1	18.5	7.3	5.2
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488013-63499239	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 1638.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 130.8;Cardiomyocytes: 125.5;Horizontal cells: 269.2;Rod photoreceptor cells: 50.9;Skeletal myocytes: 49.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 347.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 240.0;MCF7: 405.9;SCLC-21H: 187.0;T-47d: 157.2;U-2 OS: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Approved	Nucleoli,Cytosol		NA	NA		55000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	Nucleoli	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	0.9	32.7	59.3	1.4	81.3	0.0	1.7	17.1	347.2	2.8	0.0	5.1	0.7	0.3	1.1	9.7	0.4	2.4	358.0	73.4	97.3	1.3	3.0	0.8	0.6	95.0	2.9	0.5	6.5	16.2	111.5	0.0	76.3	9.6	0.4	37.2	19.5	0.8	1638.0	6.8	1.9	0.8	0.0	0.3	8.5	1.2	30.7	0.2	0.7	320.7	0.1	2.2	1.8	125.0	0.5	71.0	0.8	16.8	0.0	0.6	7.9	10.0	1.3	51.6	16.3	9.8	41.5	0.0	110.4	0.5	13.4	38.8	240.0	0.7	115.9	0.5	13.1	0.0	24.1	4.1	2.9	0.0	13.4	1.4	2.2	0.1	1.0	0.2	0.0	0.0	3.4	0.2	0.5	405.9	1.4	0.5	11.4	95.6	96.5	8.0	0.2	10.2	2.4	3.9	187.0	89.9	90.0	12.6	1.6	2.2	157.2	3.8	0.0	0.3	202.9	0.7	1.8	0.3	0.9	1.4	0.9	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	59.3	81.3	17.1	347.2	73.4	97.3	95.0	2.9	76.3	0.0	30.7	125.0	0.1	0.0	0.0	9.4	0.7	0.4	0.9	0.0	0.0	130.8	11.8	4.6	125.5	1.5	0.6	0.0	12.5	0.0	1.1	0.4	0.0	1.3	0.2	0.5	0.3	2.2	0.0	0.0	35.5	0.2	0.2	3.6	4.6	1.4	5.7	1.0	1.1	0.1	0.0	269.2	37.2	0.0	0.0	0.3	0.7	0.5	0.0	0.6	0.0	15.0	0.0	11.7	0.0	14.6	12.7	0.3	0.0	0.0	0.3	2.6	0.0	0.5	0.0	50.9	0.0	49.9	3.4	0.0	0.3	0.0	1.8	0.0	1.5	0.0	0.5	1.1
EEF1AKMT1	N6AMT2	ENSG00000150456	"EEF1A lysine methyltransferase 1"	Q8WVE0	13	20728731-20773961	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Breast myoepithelial cells: 19.9;Cytotrophoblasts: 19.8;Distal tubular cells: 27.4;Endometrial ciliated cells: 20.9;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040417, HPA042543"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA040417: AB_2676973, HPA042543: AB_2678045"	"unprognostic (4.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.31e-2)"	9.6	10.3	11.1	5.3	11.6	3.4	9.8	11.8	16.8	11.2	10.5	9.5	4.5	10.8	14.3	5.8	11.1	6.3	9.9	11.2	12.6	9.5	13.5	6.4	6.8	11.1	11.6	10.4	6.3	9.5	9.9	6.5	11.8	10.2	6.0	10.2	7.9	8.9	11.1	5.9	5.6	9.2	12.0	5.8	7.1	4.3	12.0	9.2	9.5	12.2	6.8	8.8	7.5	12.3	11.1	8.5	6.9	11.4	28.3	29.2	16.9	14.4	11.0	12.4	6.4	11.9	12.1	18.0	10.5	15.8	5.8	9.0	9.4	12.2	12.8	11.7	8.4	23.3	3.8	22.8	15.6	46.3	4.6	20.1	10.7	9.2	20.4	13.8	22.4	15.7	13.6	2.4	35.5	30.7	15.6	41.0	12.0	20.2	6.2	19.2	7.6	3.5	17.8	12.7	15.8	9.4	12.5	6.1	16.5	5.9	6.4	42.4	13.3	8.5	0.0	19.1	6.4	3.3	6.7	19.9	7.3	31.4	6.1	0.0	5.2	0.9	8.6	4.1	9.6	13.1	10.3	9.0	8.9	5.4	13.0	11.3	0.7	16.3	4.4	10.8	12.0	6.7	11.1	11.6	11.8	16.8	11.2	12.6	11.1	11.6	11.8	12.0	12.0	12.3	15.0	22.4	9.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.3	19.9	0.0	0.0	8.1	7.3	0.0	19.8	3.1	0.0	27.4	12.6	0.0	20.9	16.2	6.0	0.0	0.0	0.0	10.4	15.2	8.9	0.0	7.0	3.8	13.2	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	36.5	7.3	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	15.7	2.2	9.9	0.0	0.0
EEF1AKNMT	"CGI-01, DFNM1, FEAT, KIAA0859, METTL13"	ENSG00000010165	"EEF1A lysine and N-terminal methyltransferase"	Q8N6R0	1	171781660-171814023	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 8.1;Cytotrophoblasts: 16.9;Extravillous trophoblasts: 22.3;Hofbauer cells: 17.5;Syncytiotrophoblasts: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044498, HPA053705"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA044498: AB_10960884, HPA053705: AB_2682235"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.12e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.12e-1)"	"unprognostic (6.86e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.13e-1)"	10.5	12.6	8.0	11.3	8.6	8.2	11.1	9.4	8.3	10.5	8.2	10.7	12.1	10.2	18.6	9.8	12.1	7.1	9.4	7.8	8.4	10.0	10.4	9.6	13.8	9.1	8.3	11.0	10.0	10.6	5.4	9.0	8.3	9.4	11.4	6.2	10.2	10.4	16.4	11.2	11.2	11.5	8.7	11.3	10.0	13.0	8.9	13.2	9.3	13.1	14.2	10.1	8.5	9.2	27.3	63.3	16.7	17.2	23.1	20.7	44.7	33.5	26.2	39.5	30.7	48.2	27.5	49.5	39.3	22.9	26.0	27.3	51.3	26.8	31.2	32.4	29.1	34.3	33.0	21.3	17.0	46.2	33.4	18.5	24.5	41.1	17.7	18.1	23.9	26.6	69.7	16.6	30.3	20.7	36.9	31.3	63.6	54.0	84.1	33.3	21.9	45.8	22.7	27.7	27.3	37.5	25.3	56.8	31.0	40.3	42.0	39.8	19.8	26.6	24.4	27.6	40.0	42.7	51.2	56.7	20.2	31.5	24.5	1.6	8.0	3.0	8.3	7.7	9.6	8.4	8.3	7.1	7.7	6.1	7.4	10.0	2.3	10.5	7.1	8.9	6.7	7.5	8.0	8.6	9.4	8.3	7.8	8.4	9.1	8.3	8.3	8.7	8.9	9.2	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	16.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	22.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	9.6	0.3	0.0	0.0	0.0
EEF1B2		ENSG00000114942	"Eukaryotic translation elongation factor 1 beta 2"	P24534	2	206159585-206162928	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012477, HPA035029"	Supported		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		840000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli fibrillar center, Cytosol"		"CAB012477: AB_732078, HPA035029: AB_2674422"	"prognostic favorable (2.60e-4)"	"unprognostic (3.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (9.95e-4)"	"unprognostic (2.70e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.62e-6)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-2)"	586.3	402.8	181.5	255.4	188.7	685.9	567.1	177.3	262.6	586.6	236.1	512.2	341.2	453.9	131.2	768.3	515.6	144.0	357.5	171.5	181.9	416.1	445.8	357.3	460.2	185.0	181.1	807.9	1586.9	95.6	219.8	139.5	188.0	357.5	292.3	53.0	468.0	147.5	1038.4	764.6	574.1	192.1	192.7	576.2	491.0	163.3	185.5	346.3	266.6	372.2	444.7	487.7	572.5	190.1	278.2	330.0	377.0	357.3	542.8	914.1	816.4	584.5	556.7	560.1	367.4	733.1	454.2	792.3	358.8	648.9	310.4	352.7	520.1	647.3	509.3	245.8	469.2	562.2	442.9	998.5	719.8	1189.2	483.1	932.9	755.6	418.1	939.0	545.0	605.2	629.9	782.8	644.2	628.0	568.2	946.5	916.2	552.5	628.0	565.3	731.7	796.0	1007.4	606.0	521.8	384.1	395.2	211.1	461.8	588.8	439.8	283.3	1349.0	431.1	290.9	403.6	391.7	529.1	681.5	631.0	918.3	338.7	751.5	224.1	93.9	357.8	44.1	432.5	370.9	794.4	1075.6	761.7	576.5	676.4	848.7	1075.2	897.6	47.9	609.1	298.1	650.3	448.7	1770.3	181.5	188.7	177.3	262.6	171.5	181.9	185.0	181.1	188.0	192.7	185.5	190.1	614.8	198.7	346.8	9.4	2022.8	1142.4	1787.7	737.1	1367.0	114.5	1353.8	2138.0	164.5	619.1	474.5	163.7	27.1	853.8	1097.6	591.9	688.7	756.0	187.8	284.9	1021.6	596.6	445.0	1188.1	13.0	1883.8	1657.1	597.5	575.4	403.4	547.2	1584.1	461.2	682.3	823.0	52.2	12.6	1316.9	270.6	826.2	1008.4	463.5	866.7	868.0	533.6	11.2	1049.6	193.2	924.8	6.0	15.4	890.3	990.9	483.7	1393.5	1529.4	1952.4	1222.5	228.5	117.9	269.5	615.5	748.0	153.7	287.4	2237.4	1259.6	950.5	1228.8	1381.0	1734.8	1525.9
EEF1G	EF1G	ENSG00000254772	"Eukaryotic translation elongation factor 1 gamma"	P26641	11	62559596-62574086	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1021.0;Plasma cells: 770.5;Squamous epithelial cells: 1166.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040688, HPA055316"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		2500000	"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Golgi apparatus"	"HPA040688: AB_10961632, HPA055316: AB_2732593"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.22e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.04e-2)"	1237.6	883.6	646.7	951.1	663.7	1897.3	1890.9	640.9	722.0	1595.1	659.8	1229.0	1094.9	1078.6	1079.3	1634.9	1555.9	749.8	1089.3	616.4	690.9	1162.4	885.3	818.1	1532.7	678.1	661.0	2604.5	2191.5	835.7	708.1	780.5	675.9	1219.1	1272.4	416.0	1588.0	875.6	4810.2	2215.7	1098.5	991.5	690.1	1073.0	1090.2	441.9	677.4	1281.7	1050.2	3030.5	1951.7	1173.7	1440.6	676.7	1773.6	1824.3	1859.1	2656.2	2742.6	3529.1	1866.2	1505.0	2692.9	1830.1	1392.3	2045.9	2161.9	5161.2	2365.4	2392.2	1048.0	2018.3	2229.8	2200.1	1663.3	1693.2	2071.2	1348.7	2061.8	2120.7	2974.2	2810.2	1523.6	4060.8	3913.9	1812.1	4419.8	3014.9	2562.7	1777.2	2755.8	2451.2	2190.6	3611.0	3035.5	4895.3	2304.9	1546.3	1575.0	2545.1	2390.9	4978.7	2454.9	2276.4	1608.2	2002.3	901.7	3010.3	4214.5	1179.1	3496.3	3012.0	1759.8	1057.1	1476.4	2070.0	1338.6	1680.0	1783.1	2609.2	1210.8	2005.2	1517.1	883.9	2365.5	589.6	2182.3	2151.6	4333.1	5399.6	4153.2	2825.0	3623.0	5080.7	6117.7	4188.5	320.6	3285.2	1837.0	2869.7	3307.5	11090.3	646.7	663.7	640.9	722.0	616.4	690.9	678.1	661.0	675.9	690.1	677.4	676.7	2.8	150.6	366.9	14.4	403.6	7.9	2.5	8.8	1021.0	0.5	21.9	10.3	0.0	14.3	300.8	1.8	2.1	17.7	9.6	63.7	3.9	124.8	4.3	2.2	7.2	70.2	148.5	405.0	8.4	188.5	26.8	149.5	252.8	3.5	375.6	1.8	11.0	4.9	12.5	0.0	13.8	152.0	4.1	8.8	4.9	18.8	3.1	134.7	1.8	24.4	126.4	0.8	16.5	6.0	13.0	114.9	121.0	2.2	770.5	3.0	132.1	12.1	152.0	0.5	0.0	1.6	43.9	1.4	0.8	1166.7	6.1	21.1	235.3	1.1	223.8	2.3
EEFSEC	"EFSEC, SELB"	ENSG00000132394	"Eukaryotic elongation factor, selenocysteine-tRNA specific"	P57772	3	128153481-128408646	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 71.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035795	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA035795: AB_10696512"	"unprognostic (1.01e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-3)"	"unprognostic (6.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	13.5	8.2	0.2	0.2	0.2	0.1	12.5	0.2	0.6	14.2	0.1	11.3	0.0	15.6	0.0	12.3	13.9	0.1	25.5	0.2	0.3	14.3	21.8	9.6	2.2	0.4	0.2	12.3	11.7	3.0	8.8	1.6	0.3	12.1	0.6	0.5	9.7	1.9	24.0	16.5	10.7	0.0	0.2	13.4	11.0	19.3	0.4	0.1	9.9	0.0	1.2	12.7	12.3	0.2	0.5	0.1	4.1	1.7	0.1	0.2	0.5	0.0	0.3	0.2	0.2	0.3	6.9	15.2	0.1	3.8	12.3	1.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.1	5.7	0.3	0.3	0.1	0.1	4.0	0.1	0.2	0.3	0.0	0.1	0.2	3.5	0.2	7.9	0.4	0.4	0.1	0.1	0.3	0.2	1.0	0.0	0.0	0.3	10.4	0.0	17.7	15.4	0.3	9.6	0.7	0.0	0.1	0.0	0.2	0.2	0.4	0.7	0.4	0.1	0.4	0.2	0.4	6.3	6.1	5.0	6.0	3.9	5.4	4.4	4.4	8.7	3.9	4.0	5.0	0.0	7.5	4.8	3.7	5.7	4.3	0.2	0.2	0.2	0.6	0.2	0.3	0.4	0.2	0.3	0.2	0.4	0.2	9.4	0.0	6.0	15.0	17.2	6.4	9.3	9.1	7.4	7.8	6.9	8.6	10.1	8.6	4.4	16.5	2.1	22.3	15.7	6.4	15.6	7.9	27.7	3.1	12.5	8.2	11.4	5.9	25.3	7.1	18.3	10.0	10.2	4.5	28.5	10.0	8.9	14.8	14.6	13.5	36.6	11.7	18.3	7.9	8.2	71.6	13.1	11.4	12.4	28.1	9.8	9.3	17.5	45.8	27.1	5.6	2.7	8.6	17.1	9.4	8.6	25.7	2.7	8.2	26.3	9.0	9.1	27.9	16.9	10.8	9.9	29.7	13.7	11.9	10.6	6.0
EFCAB11	C14orf143	ENSG00000140025	"EF-hand calcium binding domain 11"	Q9BUY7	14	89794669-89954777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 557.0;Late spermatids: 363.3;Oligodendrocytes: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA051209			Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions, Cytosol"		"HPA051209: AB_2681389"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.84e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.45e-2)"	5.0	4.1	8.5	3.2	8.1	6.1	9.1	8.2	10.6	5.3	9.9	5.4	5.1	3.8	6.4	4.8	11.0	3.4	2.6	7.3	7.2	7.6	6.0	3.2	3.7	8.1	8.3	4.8	4.8	8.2	3.3	6.4	7.6	5.2	5.4	6.2	4.7	5.0	2.0	3.3	3.8	3.8	7.6	3.5	4.6	36.8	8.3	4.4	7.8	2.4	4.8	4.7	3.0	8.6	8.4	12.7	11.0	13.5	6.5	7.1	30.5	12.1	10.9	16.1	11.2	15.2	29.1	13.1	22.4	8.1	11.4	17.9	9.3	24.2	23.1	14.9	6.1	9.4	11.0	24.6	1.5	12.1	22.0	4.9	5.9	10.5	11.9	9.2	13.6	13.8	10.0	12.5	19.3	43.4	9.0	16.3	4.7	34.3	22.7	10.3	17.1	9.6	15.2	23.0	4.5	7.7	15.3	27.9	14.5	22.4	22.7	8.6	11.5	8.7	11.9	9.3	12.0	7.6	23.2	23.0	12.7	5.7	16.1	14.9	1.1	3.0	0.4	2.5	0.2	2.2	0.7	0.8	1.8	2.4	1.1	1.1	2.7	2.9	5.0	1.6	1.0	0.6	8.5	8.1	8.2	10.6	7.3	7.2	8.1	8.3	7.6	7.6	8.3	8.6	5.8	0.0	1.1	30.3	6.2	5.1	7.0	14.2	2.2	8.6	8.8	7.9	4.2	11.5	9.7	18.4	2.1	15.7	3.0	3.3	9.8	12.1	557.0	37.7	6.3	7.4	0.0	9.5	16.8	16.9	28.9	6.3	1.5	10.5	5.1	8.0	6.4	6.3	11.7	3.3	19.1	6.1	10.2	4.0	6.6	363.3	5.6	5.7	3.6	18.7	8.0	6.8	2.1	40.2	139.9	6.5	9.7	7.5	6.4	2.6	3.6	20.4	47.7	13.2	0.0	5.3	6.0	62.8	14.7	5.4	3.3	7.7	2.5	10.2	12.2	5.9
EFCAB14	KIAA0494	ENSG00000159658	"EF-hand calcium binding domain 14"	O75071	1	46674659-46719146	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 159.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011224, HPA011938"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA		110000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoli, Golgi apparatus"	"HPA011224: AB_1852314, HPA011938: AB_1852317"	"unprognostic (2.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-1)"	49.8	23.8	26.0	25.4	35.5	8.5	30.5	31.9	21.3	42.4	15.5	37.4	30.2	31.7	24.7	39.6	38.4	33.3	36.1	21.3	28.1	44.2	30.6	43.0	26.2	37.5	33.7	35.8	23.1	159.5	18.0	43.6	33.4	30.7	39.3	12.3	30.5	40.1	34.6	28.7	31.5	38.9	29.9	31.7	65.9	27.3	29.9	34.1	43.9	45.9	35.2	40.1	27.1	38.2	34.9	20.3	13.4	23.8	75.2	48.6	37.3	35.4	56.7	40.3	40.6	22.4	23.1	26.5	38.5	51.6	53.7	41.0	28.1	41.3	51.7	62.4	16.9	33.8	15.1	8.7	26.9	44.3	67.1	43.9	61.5	31.4	28.2	37.4	52.6	26.3	23.5	37.9	37.7	12.4	30.6	10.6	22.2	39.8	21.1	22.1	45.9	25.2	37.6	68.4	7.4	9.9	47.7	64.2	29.9	43.3	29.0	38.6	46.0	33.1	16.8	38.1	37.0	38.0	65.2	22.7	43.6	34.5	25.9	23.4	22.6	36.8	25.3	28.0	34.0	18.0	23.0	22.9	19.5	17.0	21.0	21.7	15.4	21.8	26.3	14.1	21.1	24.3	26.0	35.5	31.9	21.3	21.3	28.1	37.5	33.7	33.4	29.9	29.9	38.2	152.3	73.7	84.6	31.3	45.9	31.7	52.3	32.0	44.9	31.6	56.3	34.0	44.9	47.1	46.1	114.0	31.3	40.6	64.4	80.8	31.3	36.2	70.6	36.1	37.4	74.8	37.8	31.1	20.3	38.4	32.0	48.8	79.0	52.2	101.8	27.4	50.7	57.9	42.2	47.1	27.8	64.6	54.9	75.5	44.0	18.9	47.2	52.0	26.6	29.0	65.0	50.6	84.5	29.7	46.2	48.5	61.3	49.7	34.8	73.8	50.5	34.4	49.9	18.6	26.3	50.2	49.9	51.3	27.7	46.5	43.5	59.0	52.0	30.4	46.2	128.4
EFCAB2	"CFAP200, DRC8, MGC12458"	ENSG00000203666	"EF-hand calcium binding domain 2"	Q5VUJ9	1	244969705-245127164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.3;Endometrial ciliated cells: 103.1;Late spermatids: 132.5;Respiratory ciliated cells: 177.2;Spermatocytes: 115.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.1;THP-1: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031206, HPA031207"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA031206: AB_10599710, HPA031207: AB_10599946"	"unprognostic (1.36e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (4.88e-2)"	13.0	10.6	11.5	6.7	13.8	14.4	16.0	14.4	21.9	8.7	26.7	6.8	3.3	21.2	17.5	10.5	36.1	14.7	15.0	11.4	14.4	11.1	5.6	12.6	9.6	18.1	16.9	11.3	9.0	15.4	8.5	16.8	13.9	8.9	12.4	17.7	8.8	13.1	19.7	6.9	7.4	11.4	14.9	7.5	12.4	28.0	12.9	7.4	26.8	7.5	10.7	8.2	4.9	16.3	7.3	9.1	20.3	5.2	7.2	16.7	24.7	9.2	9.7	11.5	10.6	23.5	19.5	25.3	19.2	11.6	12.2	5.7	8.2	5.3	7.1	2.7	5.0	12.4	41.3	10.7	15.2	12.8	77.1	14.6	11.0	15.5	14.4	13.7	18.0	0.7	48.0	20.1	10.0	7.6	2.6	34.6	26.0	10.4	6.9	48.4	3.1	6.8	29.0	12.3	15.9	21.4	16.0	6.1	13.6	22.7	5.9	70.5	2.8	14.1	5.3	7.9	33.7	6.9	12.4	17.2	11.2	35.9	11.7	0.9	1.3	2.3	0.4	1.4	0.5	3.1	0.5	0.3	4.3	3.3	0.4	0.4	3.8	2.3	1.1	8.7	0.6	1.0	11.5	13.8	14.4	21.9	11.4	14.4	18.1	16.9	13.9	14.9	12.9	16.3	13.3	3.2	14.5	76.0	11.5	5.1	11.8	17.2	10.2	12.6	11.6	11.0	58.6	8.6	23.0	23.9	14.6	16.3	9.3	5.4	50.9	8.2	112.3	103.1	18.5	11.7	18.8	17.2	54.6	10.8	46.3	15.5	11.2	11.1	0.0	13.6	12.5	7.3	11.2	5.0	90.3	6.5	22.4	21.3	6.5	132.5	9.0	13.2	7.2	42.2	6.6	19.2	1.0	74.9	75.9	5.6	6.6	6.4	12.0	7.1	2.7	35.6	177.2	19.1	6.6	15.5	15.8	115.9	30.6	5.4	3.0	34.2	7.5	8.3	6.9	10.6
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.3;Excitatory neurons: 58.9;Inhibitory neurons: 47.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	2.7	5.3	7.3	2.2	7.6	2.0	6.0	8.9	10.3	5.8	10.1	3.4	2.0	6.1	6.2	2.9	8.1	4.6	6.5	7.4	9.3	5.6	1.7	4.0	3.6	6.8	7.2	8.0	2.9	10.4	5.9	3.2	7.0	5.4	3.0	8.9	3.1	5.0	6.7	3.1	2.1	4.7	6.5	2.7	3.2	14.6	8.2	7.3	5.9	3.9	3.3	3.7	2.8	8.3	6.5	5.7	7.1	4.5	7.5	11.0	3.6	4.1	4.6	7.2	8.8	1.7	5.0	4.4	9.6	2.5	14.5	6.0	6.1	4.1	8.5	8.6	4.3	3.6	10.4	3.9	4.6	5.1	3.2	6.1	9.9	8.6	5.6	11.4	6.1	8.2	4.8	7.3	4.7	1.5	9.9	3.5	3.1	4.6	5.6	6.2	10.7	4.6	11.1	3.6	15.2	5.8	8.1	4.5	10.5	9.6	4.5	3.8	1.7	4.1	3.5	12.1	4.0	4.7	8.7	5.0	7.4	3.5	6.0	10.1	0.4	0.1	1.2	0.3	1.6	1.8	1.4	1.4	0.8	1.9	1.4	1.3	0.0	1.3	2.6	1.0	1.6	0.6	7.3	7.6	8.9	10.3	7.4	9.3	6.8	7.2	7.0	6.5	8.2	8.3	3.1	12.8	4.1	23.2	6.0	3.1	5.6	7.0	5.7	7.7	2.6	3.9	7.8	2.8	5.6	5.5	4.2	3.7	2.1	0.6	7.9	3.8	55.3	19.9	8.0	3.2	1.8	1.3	58.9	0.7	2.0	5.6	3.6	3.4	2.5	7.9	2.2	1.2	2.6	0.0	47.7	1.3	8.2	2.5	1.6	8.8	10.8	1.8	1.8	14.0	1.9	5.2	2.1	41.7	21.9	1.4	0.3	13.5	6.0	1.4	0.5	5.5	27.5	11.3	26.3	11.8	5.3	73.4	22.7	3.8	2.3	1.2	3.4	5.8	2.1	1.6
EFHB	"CFAP21, FLJ25200"	ENSG00000163576	"EF-hand domain family member B"	Q8N7U6	3	19879472-19947025	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.5;fallopian tube: 17.1;testis: 15.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 77.2;Endometrial ciliated cells: 49.9;Late spermatids: 25.7;Respiratory ciliated cells: 93.6;Spermatocytes: 32.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"RPTEC TERT1: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA034835			Approved	Vesicles,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Vesicles	"HPA034835: "	"unprognostic (9.70e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.51e-5)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	0.5	0.7	1.6	0.1	1.5	0.2	0.9	1.0	1.4	0.9	2.6	0.2	0.0	1.1	0.6	0.4	17.1	0.6	0.2	1.4	1.6	1.0	0.2	2.0	0.2	6.5	5.0	1.5	0.2	0.4	0.4	0.4	3.4	0.4	0.3	0.8	0.2	0.5	0.2	0.4	0.2	0.5	3.7	0.5	0.2	15.5	1.6	0.3	0.5	0.2	0.3	0.3	0.2	2.2	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	19.5	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	1.5	1.0	1.4	1.4	1.6	6.5	5.0	3.4	3.7	1.6	2.2	1.0	0.0	1.1	5.5	0.3	0.1	0.5	1.9	0.6	0.8	1.8	1.4	0.3	5.7	12.4	3.7	2.1	0.9	1.6	0.5	5.9	0.3	77.2	49.9	1.8	0.7	1.2	3.6	1.7	0.2	0.5	1.3	0.0	1.8	3.8	1.8	1.8	0.6	0.5	1.7	2.2	0.2	4.1	1.3	0.3	25.7	2.5	1.0	0.0	1.9	0.2	5.3	0.0	3.0	1.7	0.6	0.1	2.2	0.0	0.3	1.2	8.3	93.6	0.8	0.0	3.6	1.7	32.7	4.3	0.1	0.1	0.8	0.3	1.0	0.4	0.3
EFHD2	MGC4342	ENSG00000142634	"EF-hand domain family member D2"	Q96C19	1	15409888-15430339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 372.4;NK-cells: 416.1;Pancreatic endocrine cells: 481.2;Urothelial cells: 431.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 133.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 370.3"	"Low region specificity"	"Detected in all"							HPA048961	Enhanced		Approved	Cytosol		No	No		220000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA048961: AB_2680572"	"unprognostic (1.37e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (9.11e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (6.31e-9)"	"unprognostic (2.71e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (2.70e-4)"	"prognostic favorable (3.60e-5)"	37.7	78.9	52.5	77.7	56.8	174.3	27.5	31.6	76.9	32.8	20.4	74.3	83.3	33.7	5.9	58.7	29.3	32.9	28.5	75.4	34.9	23.0	33.3	60.0	46.3	100.2	31.4	26.9	75.7	10.7	28.6	21.4	101.7	44.6	29.6	2.7	27.3	19.0	6.4	35.9	96.4	17.3	29.6	140.0	92.0	95.2	36.1	25.2	41.6	4.9	29.5	62.6	40.5	62.9	370.3	91.8	8.8	23.8	14.1	30.0	46.8	46.0	43.4	42.7	40.5	35.5	98.8	79.6	141.6	32.1	54.8	88.1	24.5	80.9	27.0	99.8	47.8	19.1	21.6	57.4	22.5	98.1	160.1	23.9	27.2	87.0	21.9	19.9	55.5	35.5	46.4	37.6	26.6	36.8	50.8	188.6	11.6	50.1	112.9	67.2	82.1	63.4	25.3	76.2	20.1	15.6	40.5	34.3	76.8	6.9	15.1	104.8	105.4	62.5	66.9	196.7	74.8	25.4	63.8	34.9	87.4	193.2	86.8	16.3	33.8	52.5	44.0	34.4	12.7	3.9	9.8	20.9	29.5	4.2	4.6	18.0	133.2	28.5	30.0	10.3	7.6	17.0	52.5	56.8	31.6	76.9	75.4	34.9	100.2	31.4	101.7	29.6	36.1	62.9	54.2	3.2	12.2	5.9	44.1	66.2	123.7	25.2	26.7	1.8	21.3	23.0	7.2	32.9	24.4	22.0	10.4	23.7	372.4	280.0	19.6	69.6	93.6	55.4	28.8	52.6	61.7	28.0	33.9	259.4	222.8	31.1	157.0	69.4	44.5	49.4	23.6	20.9	219.3	0.0	21.9	160.8	24.4	217.1	188.2	221.2	9.9	246.9	23.2	13.1	171.3	4.9	416.1	0.5	3.7	481.2	190.5	6.8	62.9	112.2	305.8	28.1	25.7	5.0	46.0	26.7	28.5	5.4	5.7	48.9	68.5	53.4	120.1	178.3	117.8	431.4
EFL1	"EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1"	ENSG00000140598	"Elongation factor like GTPase 1"	Q7Z2Z2	15	82130233-82262734	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Elongation factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 9.2;Glandular and luminal cells: 9.5;Granulosa cells: 16.0;Pancreatic endocrine cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039654, HPA047110, HPA052345"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.92e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.56e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (8.58e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.05e-2)"	6.2	7.4	5.0	8.2	5.3	8.8	9.9	4.9	5.4	7.3	6.7	13.3	11.6	7.1	7.5	8.3	7.7	7.0	7.3	4.6	5.4	8.6	9.3	6.9	9.6	5.0	5.1	4.9	6.2	14.7	4.6	6.9	5.7	7.2	16.5	7.2	6.7	6.8	11.6	9.0	12.8	8.8	4.8	7.0	8.3	11.2	5.3	16.6	7.8	12.4	10.8	8.1	7.2	6.0	9.8	24.5	18.0	14.9	11.7	16.1	11.6	28.0	33.1	19.9	26.1	12.2	16.7	24.0	11.4	21.4	25.2	24.9	47.5	18.5	31.8	21.8	23.1	26.8	20.2	9.3	18.3	17.0	18.3	7.9	28.9	20.5	46.0	23.7	27.0	30.8	20.5	10.8	23.6	14.1	22.5	13.9	16.0	17.5	12.6	23.8	26.4	13.3	14.1	29.7	15.8	16.8	17.7	20.5	21.6	30.7	15.6	15.1	22.9	28.1	18.5	71.6	28.6	13.4	54.9	20.1	25.1	32.2	10.5	23.1	5.7	14.6	8.6	8.2	6.9	9.4	8.0	7.5	7.0	9.9	6.9	6.0	1.0	6.5	9.9	3.3	7.9	4.8	5.0	5.3	4.9	5.4	4.6	5.4	5.0	5.1	5.7	4.8	5.3	6.0	4.1	3.2	5.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.7	3.9	0.0	0.0	4.3	0.0	0.0	7.1	5.5	0.0	3.9	6.8	0.0	9.2	5.1	1.4	0.0	0.0	0.0	6.0	4.0	2.5	0.0	9.5	5.1	16.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.4	0.0	0.0	5.5	7.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.8	2.9	4.9	0.0	0.0
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1285873-1301431	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.3;liver: 12.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.5;Cardiomyocytes: 4.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 5.0;Paneth cells: 2.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5;stomach cancer: 8.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;CACO-2: 6.2;Hep G2: 13.5;NTERA-2: 6.8;OE19: 6.0;REH: 6.8;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Mitochondria, Cytosol"		"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.0	0.0	1.6	1.5	1.7	0.0	0.0	1.2	1.3	0.1	0.3	9.9	9.9	0.0	0.0	0.4	0.0	3.5	0.0	1.4	2.0	0.4	12.9	0.0	0.0	1.7	3.0	0.0	0.1	0.2	0.3	0.2	1.1	0.0	4.4	0.6	0.0	0.0	0.2	0.1	12.3	0.0	1.9	0.0	0.2	0.6	3.1	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.2	10.3	3.1	0.0	0.0	3.7	0.2	0.0	0.0	0.0	6.2	0.1	0.0	1.8	0.0	0.0	0.0	4.8	0.0	0.0	0.0	1.4	0.0	0.0	13.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.1	6.8	6.0	0.0	6.8	1.0	0.1	0.0	0.4	0.0	13.3	0.7	0.0	0.2	3.5	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.6	1.7	1.2	1.3	1.4	2.0	1.7	3.0	1.1	1.9	3.1	1.4	0.1	0.0	0.0	1.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.0	0.0	2.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.2	0.0
EFNA5	"AF1, EPLG7, LERK7"	ENSG00000184349	"Ephrin A5"	P52803	5	107376894-107670937	"Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Astrocytes: 291.2;Excitatory neurons: 798.5;Inhibitory neurons: 373.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 35.2;RPTEC TERT1: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013282, HPA054047"	Approved		Approved	Vesicles,Cytosol		NA	Yes		10000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"		"CAB013282: AB_2533353, HPA054047: AB_2682355"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.98e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (9.46e-3)"	"unprognostic (4.92e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.92e-7)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.27e-1)"	4.1	1.1	4.5	2.0	6.5	0.1	4.0	1.3	13.6	10.1	0.0	2.3	0.8	1.1	2.0	7.1	2.9	2.7	6.8	3.1	10.2	3.4	0.3	2.4	0.8	0.9	0.3	4.0	0.5	2.5	2.7	2.4	0.6	4.3	2.3	2.5	5.6	4.7	0.5	9.7	0.8	2.2	0.0	5.3	2.5	1.4	2.1	1.4	1.0	1.4	2.5	3.5	4.8	5.4	12.7	22.2	35.2	0.0	16.7	14.2	3.6	0.3	6.3	4.5	11.6	0.2	13.9	0.0	20.5	2.4	7.1	13.1	19.4	18.0	3.6	0.0	12.9	0.1	11.9	0.0	3.1	0.6	0.0	16.0	15.4	0.0	14.4	3.9	13.8	0.0	0.0	0.0	8.3	12.0	0.0	0.0	4.6	0.1	1.9	0.0	16.9	0.4	50.9	15.5	5.8	14.7	6.0	8.9	3.8	11.2	3.9	2.2	0.2	28.3	5.0	17.4	7.1	1.2	0.0	8.3	12.4	0.8	31.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.7	0.0	0.0	0.0	0.1	4.5	6.5	1.3	13.6	3.1	10.2	0.9	0.3	0.6	0.0	2.1	5.4	1.1	9.6	24.4	291.2	0.0	15.9	22.5	18.5	6.2	4.3	11.8	8.5	30.6	11.5	26.0	14.7	0.0	20.3	3.3	4.3	23.5	1.7	1.8	3.2	14.8	8.2	12.0	0.0	798.5	1.3	3.3	16.9	5.6	6.3	0.0	0.1	9.7	0.0	1.7	6.7	373.1	8.5	18.3	0.3	7.0	3.7	18.3	0.4	8.8	37.5	3.6	4.7	2.1	26.2	8.7	13.9	4.9	21.8	1.7	14.1	0.0	0.1	19.6	1.4	0.0	1.3	3.7	0.1	4.0	14.9	24.2	3.8	2.2	2.3	5.9	23.1
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849948-44899445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		94000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	23.6	30.7	26.7	31.3	27.2	37.4	22.4	24.6	28.0	17.6	27.9	26.5	21.6	19.4	18.8	33.1	25.0	16.3	35.3	28.0	26.3	26.1	26.2	22.6	35.5	25.6	26.1	17.6	24.0	27.9	13.2	28.6	26.4	17.8	28.8	15.5	22.5	18.6	65.8	28.5	22.8	23.5	25.1	29.8	22.5	27.5	27.3	41.0	21.2	38.3	46.5	28.8	20.3	26.6	88.7	173.6	82.8	134.9	61.9	60.9	97.1	68.7	91.4	169.6	146.0	134.6	73.9	152.1	79.0	87.1	130.3	98.6	181.5	120.2	196.2	153.9	150.8	150.9	100.9	144.5	68.2	179.9	107.5	66.5	67.4	157.2	85.0	65.2	149.1	134.8	189.6	57.8	98.0	88.2	182.3	118.6	85.7	206.8	143.1	126.1	168.1	132.0	97.0	97.8	135.7	81.1	67.7	49.5	73.9	120.6	131.6	112.2	91.4	126.5	97.4	77.7	176.3	60.2	81.4	150.0	101.6	98.4	132.0	42.7	84.3	85.9	37.2	81.6	41.7	32.3	32.9	36.1	82.8	31.3	28.8	32.2	13.0	44.2	85.0	35.5	35.2	70.7	26.7	27.2	24.6	28.0	28.0	26.3	25.6	26.1	26.4	25.1	27.3	26.6	11.3	0.0	14.0	11.1	18.1	11.7	12.2	15.1	13.6	14.7	14.1	11.8	21.1	22.8	15.3	18.4	33.3	34.5	14.0	15.6	3.9	29.4	12.5	17.8	17.9	21.4	10.8	24.8	17.5	26.7	30.9	14.0	18.3	18.8	19.7	22.6	21.8	22.4	38.5	26.9	17.2	13.4	16.2	30.1	17.5	6.5	12.8	26.2	5.4	12.2	46.7	12.0	21.6	6.0	15.5	27.7	12.0	9.1	20.3	14.5	15.9	13.2	17.4	18.0	19.7	14.8	14.8	28.2	43.3	16.0	14.6	27.2	16.3	21.4	22.2	12.5
EIF1AX	"eIF-1A, eIF-4C, EIF1A, EIF4C"	ENSG00000173674	"Eukaryotic translation initiation factor 1A X-linked"	P47813	X	20124525-20141838	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002561	Uncertain	Supported	Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA002561: AB_1078724"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.26e-3)"	"unprognostic (7.13e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.23e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	61.2	42.9	27.1	47.9	29.2	61.6	58.2	36.8	38.3	45.1	23.0	46.5	43.9	57.9	28.5	49.7	42.2	26.7	47.4	27.9	29.3	58.0	62.0	35.0	44.5	29.3	28.9	66.9	50.6	46.6	19.8	40.1	28.3	36.2	31.6	45.3	49.9	30.8	80.0	42.1	37.3	49.6	32.2	33.7	45.7	30.4	30.4	41.4	48.4	50.4	33.9	42.6	49.2	35.7	233.3	128.4	96.9	129.8	92.5	124.8	78.8	202.6	73.9	108.3	84.9	186.2	108.2	215.5	132.2	134.9	101.4	97.6	172.8	175.9	167.8	88.8	284.5	95.7	148.9	160.1	64.5	257.8	129.5	59.1	105.2	167.4	260.2	71.4	153.3	68.9	252.3	117.6	107.9	113.2	160.3	160.6	252.1	97.5	211.0	129.8	222.3	232.0	85.1	127.7	112.1	124.9	215.0	165.8	139.0	138.8	134.6	108.0	88.3	130.8	81.6	430.8	153.6	79.9	163.3	255.7	89.5	116.1	101.2	36.3	41.0	27.4	47.8	46.5	64.1	69.0	54.4	57.2	41.2	66.4	62.6	52.8	10.7	64.5	47.1	68.1	47.6	52.6	27.1	29.2	36.8	38.3	27.9	29.3	29.3	28.9	28.3	32.2	30.4	35.7	205.4	105.8	116.7	22.2	167.5	474.9	354.9	172.6	178.2	164.0	226.5	212.2	100.2	161.5	154.5	115.8	93.8	191.4	231.5	131.6	187.9	213.6	450.5	210.5	310.1	161.2	167.2	135.2	40.5	230.4	453.8	208.6	107.6	321.9	164.0	140.7	137.4	329.9	196.3	102.6	43.2	213.5	120.1	137.9	230.1	132.2	144.1	157.3	154.7	35.6	118.2	181.3	68.0	23.6	48.0	251.0	140.1	145.2	176.7	469.7	152.2	301.4	93.2	140.4	144.7	288.6	213.9	52.9	101.1	245.4	570.1	227.0	170.5	149.6	288.5	377.0
EIF1AY		ENSG00000198692	"Eukaryotic translation initiation factor 1A Y-linked"	O14602	Y	20575776-20593154	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 121.3;tongue: 131.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 378.0;Erythroid cells: 538.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	7	"cerebral cortex: 34.9"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 180.2;HEL: 220.6;U-266/84: 161.1;U-698: 349.8"					"Low region specificity"	"Detected in all"			HPA002561	Uncertain	Supported	Approved	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA002561: AB_1078724"			"unprognostic (4.31e-2)"		"unprognostic (3.74e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.89e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.89e-1)"		"unprognostic (6.03e-2)"	17.4	22.2	3.3	11.4	3.6	59.8	14.6	3.6	34.9	0.0	3.5	20.8	14.6	0.0	20.6	14.8	0.0	8.9	121.3	3.2	4.4	26.2	25.3	14.9	9.7	4.2	4.4	0.0	13.7	13.3	27.8	16.2	4.3	26.9	25.2	11.6	13.7	20.2	85.2	11.7	28.9	0.0	3.6	31.9	16.5	21.4	3.6	0.0	11.3	131.5	27.7	18.4	0.0	4.6	0.5	26.4	0.0	0.0	0.0	0.0	52.7	57.4	39.1	39.5	39.1	0.0	0.1	180.2	0.2	32.0	0.0	0.0	0.0	0.0	55.0	97.4	0.0	220.6	0.0	65.8	38.4	0.4	0.0	21.1	44.2	0.0	0.0	0.0	0.0	59.4	0.3	0.0	65.1	0.0	144.7	0.2	37.8	0.0	0.0	0.0	70.9	71.9	56.5	67.6	50.1	0.1	0.1	0.3	42.4	71.9	0.0	30.9	56.8	29.9	0.9	0.3	63.1	103.9	161.1	349.8	11.6	0.1	0.0	48.8	20.4	28.3	14.2	21.8	19.7	53.2	25.9	16.8	16.7	55.3	31.2	25.2	125.8	21.6	22.1	66.2	31.7	21.5	3.3	3.6	3.6	34.9	3.2	4.4	4.2	4.4	4.3	3.6	3.6	4.6	0.0	32.1	49.9	2.9	122.1	54.7	68.5	123.8	26.7	19.6	0.0	0.0	378.0	35.8	63.3	53.3	10.4	123.0	51.8	6.8	88.0	47.7	59.6	0.0	0.0	31.3	17.8	538.5	2.0	0.4	45.6	33.1	27.5	0.1	91.7	0.0	57.8	16.5	38.9	6.7	2.4	23.3	61.1	67.9	43.7	16.7	42.9	43.0	67.6	1.0	88.7	92.2	59.8	3.0	2.5	21.5	9.6	43.6	101.2	63.3	28.9	123.6	64.2	26.3	39.5	23.5	31.7	85.0	90.4	29.9	50.6	92.8	48.3	0.0	18.8	73.2
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	"Eukaryotic translation initiation factor 2 alpha kinase 4"	Q9P2K8	15	39934115-40035591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 66.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011811	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA011811: AB_2668543"	"unprognostic (3.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.97e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.11e-3)"	20.1	14.6	21.5	12.2	22.4	18.7	17.6	27.2	23.7	14.6	16.8	15.5	11.3	30.5	15.4	16.0	16.1	17.0	17.7	21.2	22.0	13.4	21.3	16.9	16.9	20.3	20.2	17.1	14.1	17.7	24.1	19.0	20.5	19.8	12.9	13.1	13.9	11.5	18.9	19.0	11.3	15.6	18.9	15.7	15.2	8.9	22.1	13.1	21.8	11.0	11.6	17.2	12.4	28.9	37.1	17.5	30.3	46.3	49.0	81.7	28.9	51.0	58.1	40.8	40.0	25.2	15.6	19.6	25.9	69.3	54.7	38.6	41.1	61.4	56.6	92.8	20.4	41.6	30.8	30.7	42.1	25.6	27.8	65.3	41.2	39.0	69.8	57.3	58.0	40.5	31.3	18.1	81.7	12.3	21.7	34.6	18.8	32.8	38.2	25.4	42.2	33.1	51.4	24.7	16.1	24.4	36.4	22.2	32.3	29.5	30.7	43.4	61.6	54.3	40.9	27.3	33.6	24.6	47.8	6.0	38.1	34.4	77.4	11.6	10.8	8.6	6.8	14.1	5.7	7.1	7.6	7.9	17.6	9.2	8.3	8.2	3.3	8.5	20.5	66.5	5.8	4.9	21.5	22.4	27.2	23.7	21.2	22.0	20.3	20.2	20.5	18.9	22.1	28.9	47.9	16.0	31.1	28.7	29.3	12.0	27.5	17.8	43.3	29.9	45.0	45.2	32.3	32.9	21.4	16.5	12.5	37.5	32.2	21.1	13.7	23.7	1.5	19.3	52.7	35.3	14.4	37.4	42.7	25.4	34.8	36.5	23.4	27.0	24.1	35.0	22.9	27.8	30.7	28.6	53.9	25.9	12.2	33.7	55.4	4.3	42.3	52.1	32.0	29.0	41.1	30.4	16.5	30.2	26.3	47.6	16.2	39.9	115.6	30.7	6.4	18.2	12.9	23.9	46.0	43.6	35.6	8.6	29.8	47.0	14.5	15.2	18.2	64.0	29.6	18.4
EIF2B1	"EIF-2B, EIF-2Balpha, EIF2B, EIF2BA"	ENSG00000111361	"Eukaryotic translation initiation factor 2B subunit alpha"	Q14232	12	123620406-123633766	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034258, HPA049509"	Approved		Approved	Cytosol		NA	NA		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034258: AB_2095995, HPA049509: AB_2680797"	"unprognostic (2.14e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.65e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.78e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.40e-2)"	32.9	32.1	23.5	33.0	25.7	36.4	31.5	27.8	27.9	33.1	23.9	33.2	27.6	34.0	29.5	33.8	31.1	22.0	26.3	24.8	23.7	28.7	29.0	24.4	40.4	25.4	23.8	34.1	32.9	21.7	28.2	31.0	27.4	29.4	30.8	23.5	28.8	26.2	43.1	51.1	29.2	31.5	23.9	33.4	28.7	22.6	25.7	30.0	27.4	27.3	43.1	32.5	31.2	32.2	55.6	47.9	50.0	53.1	45.8	46.2	52.5	66.8	38.2	64.3	46.7	62.8	34.0	104.2	77.3	51.1	28.6	54.3	79.0	52.0	67.3	85.4	87.8	74.9	68.3	55.6	43.3	106.9	90.2	42.0	63.3	55.4	38.9	54.0	59.6	66.8	136.4	34.2	60.2	50.4	86.1	113.3	82.4	59.5	64.1	89.5	61.1	79.2	43.2	46.0	61.9	69.9	49.4	48.7	63.3	46.7	88.5	63.2	56.8	43.8	52.9	63.2	62.4	90.9	102.1	153.6	63.6	71.7	63.9	113.2	87.3	119.3	56.3	104.2	51.3	60.1	57.2	58.9	95.7	53.2	58.0	53.9	9.8	64.8	101.6	59.9	73.2	100.7	23.5	25.7	27.8	27.9	24.8	23.7	25.4	23.8	27.4	23.9	25.7	32.2	29.0	16.0	19.6	10.7	29.3	20.4	17.5	28.3	24.5	19.8	16.0	17.3	20.0	25.8	19.0	18.4	8.4	69.0	33.8	18.3	29.4	33.0	7.6	15.0	28.3	26.0	21.7	21.9	23.4	40.1	58.8	23.6	15.3	14.2	41.2	24.4	22.1	13.1	37.8	16.8	21.2	15.4	18.3	18.6	18.5	5.3	25.1	26.0	19.6	14.0	30.6	34.4	35.0	16.1	21.9	32.8	23.8	16.6	30.7	14.8	26.1	23.9	14.3	21.6	32.9	18.5	29.8	49.2	38.7	27.3	20.5	51.6	26.7	29.3	21.7	14.6
EIF3B	"EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB017562: AB_2246341, HPA048983: AB_2680588"	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	59.3	54.8	29.4	49.5	31.5	88.8	55.1	31.8	31.7	49.6	31.4	74.3	39.5	55.3	28.4	78.2	53.3	34.8	55.1	31.2	32.1	44.7	60.4	42.2	58.9	33.4	32.6	51.0	83.1	39.6	37.9	51.9	33.6	50.3	44.6	17.7	63.4	42.9	155.2	82.9	48.9	52.5	32.6	56.6	59.1	60.8	32.0	53.5	37.0	65.8	64.6	69.4	53.3	35.2	510.8	253.3	102.9	280.4	113.5	102.4	254.4	174.5	130.2	193.8	180.5	334.4	193.2	293.9	139.8	186.2	273.5	269.9	287.1	229.0	212.5	88.6	334.6	224.8	240.8	227.0	159.2	277.0	159.8	127.5	147.9	210.1	219.2	101.8	157.9	133.9	580.9	133.2	179.7	358.4	134.7	306.9	322.6	176.2	224.4	163.3	208.3	304.2	123.4	228.9	233.9	174.9	184.5	403.4	102.8	178.8	270.0	301.3	169.0	149.0	326.9	231.7	319.4	145.7	210.6	295.6	169.3	303.9	372.5	2.1	7.2	4.0	7.5	7.2	9.4	6.5	7.0	8.2	8.0	6.1	8.4	8.5	0.6	16.9	6.6	8.2	9.5	4.8	29.4	31.5	31.8	31.7	31.2	32.1	33.4	32.6	33.6	32.6	32.0	35.2	43.3	25.6	64.1	19.6	35.9	64.2	55.6	25.4	34.1	37.9	74.0	62.4	37.4	30.0	38.8	27.6	64.6	64.9	52.6	49.0	3.9	35.5	11.6	37.1	57.0	50.9	47.8	56.8	20.1	62.6	63.4	47.6	48.9	48.1	17.1	77.0	63.5	67.0	47.4	52.2	19.5	63.0	14.2	39.5	32.3	23.3	43.8	34.3	16.0	8.4	32.6	45.6	38.1	15.6	19.9	70.9	28.9	37.2	42.3	68.8	33.6	31.0	27.4	44.3	26.3	69.2	48.5	34.4	39.4	63.5	78.3	82.6	34.7	119.4	77.0	50.6
EIF3CL		ENSG00000205609	"Eukaryotic translation initiation factor 3 subunit C like"	B5ME19	16	28379579-28403841	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 44.0;Cardiomyocytes: 35.1;Club cells: 37.9;Respiratory ciliated cells: 38.2"	"Group enriched"	"Detected in some"	5	"glioma: 0.8;ovarian cancer: 0.5;stomach cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA047097, HPA049495, HPA050112"	Supported		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 50: Non-specific - Ribosome"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.75e-5)"	"unprognostic (6.56e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.58e-2)"	40.8	35.4	19.9	1.0	20.2	6.2	41.2	20.4	33.5	37.9	16.6	37.1	1.3	29.4	3.5	44.3	33.8	1.9	47.4	20.9	19.7	43.0	39.9	30.7	1.6	21.3	20.2	50.5	72.9	4.0	32.1	2.4	21.9	35.6	2.3	5.4	38.5	3.3	98.6	52.3	30.3	2.0	18.0	32.1	43.1	30.7	19.9	1.8	40.6	6.9	2.9	37.7	35.8	21.2	3.0	6.9	6.6	5.5	9.1	5.2	4.3	3.8	4.6	9.5	8.2	7.7	3.5	4.1	6.8	5.8	7.6	5.5	11.0	10.9	14.1	1.9	6.5	4.7	12.7	15.3	2.7	6.9	8.3	5.7	7.3	5.7	6.0	5.7	3.6	6.8	7.6	7.8	3.6	9.4	8.2	17.3	15.1	5.7	4.0	10.9	8.0	7.4	8.1	5.1	13.1	8.5	3.2	6.4	6.0	1.8	16.4	6.8	5.2	4.2	7.9	5.2	7.6	4.2	3.8	7.2	7.3	7.2	7.7	2.9	1.3	0.7	1.1	1.8	1.3	0.9	1.4	1.2	1.7	0.9	1.2	1.6	0.1	1.1	2.3	0.8	1.2	1.3	19.9	20.2	20.4	33.5	20.9	19.7	21.3	20.2	21.9	18.0	19.9	21.2	0.1	22.4	44.0	0.7	2.2	1.3	2.0	0.3	1.8	0.0	0.5	0.6	35.1	0.0	37.9	0.0	0.0	0.8	0.0	0.4	0.0	0.5	0.1	0.2	0.2	4.9	0.0	8.4	0.5	1.2	0.6	10.5	3.1	0.1	10.1	0.0	1.8	0.2	0.5	0.0	0.6	0.7	0.0	1.3	2.3	0.7	0.3	5.2	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.1	1.7	0.4	5.2	1.1	0.9	1.7	38.2	0.0	0.0	0.5	7.4	0.3	0.6	2.5	1.6	0.8	2.6	0.1	0.7	1.0
EIF3H	"eIF3-gamma, eIF3-p40, EIF3S3"	ENSG00000147677	"Eukaryotic translation initiation factor 3 subunit H"	O15372	8	116642130-116766925	"Cancer-related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1808.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023117, HPA023553"	Approved		Approved	Cytosol		NA	NA		38000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA023117: AB_1848076, HPA023553: AB_1848077"	"prognostic unfavorable (5.26e-4)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.11e-1)"	212.3	164.1	111.0	168.6	119.8	341.1	246.8	114.8	138.5	270.2	104.2	233.1	172.7	212.7	180.0	232.0	211.3	159.2	223.6	106.9	121.0	184.2	181.0	149.2	283.2	118.4	113.7	392.6	249.9	184.0	147.6	161.7	120.6	179.5	201.9	131.0	219.9	158.1	372.6	201.8	167.9	182.5	124.2	171.4	195.2	144.4	111.9	291.0	215.5	278.3	307.1	221.7	237.0	130.2	455.0	256.2	302.2	264.9	390.3	678.0	300.4	292.5	374.4	316.7	306.5	266.1	521.6	719.4	288.6	307.2	230.4	284.4	335.5	445.2	395.5	468.5	271.9	636.0	212.0	400.6	487.8	278.1	325.7	630.0	606.4	287.0	659.5	536.4	348.8	555.5	548.2	370.1	360.4	335.7	778.2	388.1	308.6	995.6	404.5	443.6	201.8	517.6	479.8	327.8	341.6	412.4	153.5	1808.1	504.9	294.8	538.3	550.5	322.5	201.8	374.5	301.5	388.8	591.3	574.4	591.3	280.2	483.4	281.8	165.2	361.6	132.2	217.9	356.8	358.9	438.1	393.5	317.9	468.6	381.4	511.0	432.1	74.4	314.6	366.1	260.9	477.7	585.7	111.0	119.8	114.8	138.5	106.9	121.0	118.4	113.7	120.6	124.2	111.9	130.2	138.9	182.7	210.7	42.4	314.6	337.5	423.7	444.2	266.9	62.7	317.2	273.4	160.8	191.6	253.0	93.8	12.5	488.0	211.4	117.0	448.0	290.5	387.2	81.2	196.0	185.8	201.0	215.8	47.8	380.5	551.0	183.7	125.9	159.2	194.4	166.2	168.8	104.6	332.4	26.9	49.9	301.6	170.9	386.6	402.8	265.0	331.5	261.5	209.9	51.5	509.9	136.0	224.6	58.3	70.3	292.9	240.5	220.1	166.7	338.5	260.2	443.9	92.9	76.8	197.2	251.5	504.1	233.0	176.0	317.4	356.5	577.2	287.5	241.4	345.5	481.2
EIF3I	"eIF3-beta, eIF3-p36, EIF3S2, TRIP-1"	ENSG00000084623	"Eukaryotic translation initiation factor 3 subunit I"	Q13347	1	32221077-32245397	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA029939, HPA029940"	Enhanced		Approved	Cytosol		NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA029939: AB_10611109, HPA029940: AB_10600878"	"unprognostic (4.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.82e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (9.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (4.81e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.47e-2)"	123.4	146.6	69.2	109.3	70.2	103.5	164.5	76.9	87.3	126.4	78.7	137.2	96.4	104.4	162.3	154.7	141.7	93.7	127.0	68.6	71.8	123.8	152.8	99.6	134.0	72.8	71.2	154.1	134.8	141.9	78.3	116.2	73.3	113.2	163.5	52.5	127.2	120.4	247.3	119.8	91.0	144.9	72.7	84.7	118.8	48.9	73.6	164.5	131.8	220.5	187.1	158.0	107.1	79.0	404.3	293.3	207.4	463.5	326.9	427.2	209.3	301.3	514.2	517.2	401.5	317.1	418.3	533.0	320.7	514.0	315.9	265.9	498.6	549.9	667.0	234.4	348.1	288.9	245.8	362.7	352.5	559.1	295.4	413.1	471.2	528.0	569.5	363.4	478.8	363.8	699.1	223.4	502.4	276.3	469.3	370.2	624.2	445.4	339.4	344.1	356.3	509.0	515.9	300.9	325.6	343.4	276.6	351.7	562.1	366.6	282.9	270.7	286.4	333.2	360.3	523.8	653.5	377.7	495.7	487.4	365.2	419.6	440.2	113.8	196.6	93.7	164.4	206.7	180.4	182.1	171.8	160.5	235.8	164.9	148.4	140.5	15.2	183.0	162.0	177.0	219.6	299.8	69.2	70.2	76.9	87.3	68.6	71.8	72.8	71.2	73.3	72.7	73.6	79.0	136.9	51.3	76.7	6.8	114.5	136.6	227.6	275.6	84.8	38.0	123.6	114.7	41.9	87.2	136.4	51.5	10.4	300.8	118.2	90.1	133.1	295.4	60.8	79.2	114.2	163.5	138.6	69.0	6.8	272.8	341.4	125.6	71.9	85.1	115.3	120.3	89.6	77.1	224.1	13.5	8.2	184.0	148.5	108.1	131.5	29.5	172.4	108.8	144.1	5.6	190.8	69.9	112.3	7.1	10.7	284.4	115.6	139.2	107.5	173.9	125.9	216.2	99.2	41.8	92.1	108.0	338.3	76.5	76.6	121.8	141.4	342.3	115.1	192.3	213.5	219.9
EIF3J	"eIF3-alpha, eIF3-p35, EIF3S1"	ENSG00000104131	"Eukaryotic translation initiation factor 3 subunit J"	O75822	15	44537125-44563029	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 209.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050977	Approved		Approved	Cytosol		NA	NA		280000	"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA050977: AB_2681297"	"unprognostic (4.47e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.76e-1)"	"prognostic unfavorable (4.96e-5)"	48.2	34.2	40.0	40.8	42.3	38.7	39.9	41.5	51.7	26.8	34.7	36.2	36.2	26.8	30.8	48.8	22.0	26.1	40.1	39.8	45.0	46.4	58.7	25.8	38.9	44.6	47.9	22.3	65.5	34.9	22.9	44.8	46.1	32.3	37.1	21.2	56.3	29.8	209.6	37.1	31.4	35.5	41.0	30.5	35.3	31.6	44.4	34.0	35.9	104.0	49.8	49.6	31.6	47.0	103.5	55.7	88.4	55.5	60.7	60.0	113.1	161.0	46.9	108.5	72.9	165.6	59.6	96.0	184.6	67.1	102.5	192.3	137.7	99.5	129.5	114.5	79.8	222.5	129.4	108.6	115.1	239.2	98.4	54.6	130.7	72.8	141.6	65.1	117.2	111.1	294.9	119.8	97.8	73.1	124.0	160.8	55.4	190.5	92.9	141.2	145.4	146.1	122.4	118.0	118.4	74.9	150.6	137.1	89.7	69.3	118.0	196.6	140.3	117.6	140.7	127.9	216.4	145.5	302.4	244.8	80.9	249.0	114.0	64.3	40.3	40.7	35.6	41.6	40.8	59.2	45.9	43.7	46.8	53.4	44.1	47.5	18.3	60.4	40.7	76.7	52.9	13.1	40.0	42.3	41.5	51.7	39.8	45.0	44.6	47.9	46.1	41.0	44.4	47.0	92.8	60.9	54.6	16.3	93.1	175.1	112.6	86.5	49.5	56.2	174.6	114.2	95.2	108.7	79.7	145.3	20.9	148.7	122.8	148.0	193.7	145.2	149.7	118.6	141.0	92.2	117.3	139.5	22.0	149.6	170.8	69.2	50.0	175.5	127.4	73.1	99.2	404.3	110.7	43.7	24.1	172.9	61.1	98.7	106.6	103.4	91.0	78.5	60.5	18.7	108.5	50.1	109.2	16.6	27.4	152.3	118.6	71.1	91.9	119.0	94.9	266.4	43.1	66.8	46.0	74.1	94.3	205.4	153.4	70.6	172.0	247.1	88.5	54.7	180.6	102.8
EIF3M	"FLJ29030, GA17, hfl-B5, PCID1, TANGO7"	ENSG00000149100	"Eukaryotic translation initiation factor 3 subunit M"	Q7L2H7	11	32583798-32606264	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031063	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA031063: AB_10602128"	"unprognostic (4.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.28e-9)"	"unprognostic (5.79e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.42e-2)"	96.9	105.0	49.5	72.4	53.0	141.4	135.1	51.9	71.6	89.6	51.1	80.6	77.1	96.5	106.6	95.0	146.4	70.8	86.1	52.0	56.1	112.7	108.4	60.1	122.7	52.3	49.5	162.9	131.6	64.7	49.4	79.8	51.5	71.3	98.4	43.3	78.6	82.3	103.1	102.5	60.2	98.3	52.7	71.1	88.0	74.3	51.7	131.2	107.6	82.4	146.6	113.6	79.5	55.9	173.6	219.0	171.0	218.8	222.7	318.2	251.5	176.1	242.7	264.5	255.6	284.5	124.1	445.6	118.1	201.6	226.7	214.1	301.1	319.4	328.2	151.4	372.3	201.2	164.5	303.4	322.1	473.9	276.4	287.4	355.1	178.8	434.6	221.5	301.3	234.6	403.8	151.2	293.8	204.1	238.3	494.4	188.4	230.8	334.2	192.0	430.7	209.9	291.4	321.4	131.3	203.0	125.2	233.5	279.9	187.0	259.3	279.6	142.1	164.6	188.0	353.0	540.2	183.5	248.8	324.0	148.2	284.3	166.1	71.9	211.7	65.7	99.7	189.3	137.6	144.9	136.9	127.3	258.4	117.9	141.1	129.9	24.8	142.3	142.8	154.8	156.5	186.0	49.5	53.0	51.9	71.6	52.0	56.1	52.3	49.5	51.5	52.7	51.7	55.9	82.7	83.3	66.4	19.2	147.5	212.9	256.2	372.8	189.0	44.7	112.9	132.3	41.1	81.5	168.0	60.7	20.9	261.8	127.8	47.1	131.0	187.3	154.9	76.4	168.8	106.3	72.4	148.5	23.8	250.7	284.0	121.9	103.0	104.3	158.4	123.6	98.6	73.3	197.1	10.1	23.5	132.3	156.6	250.6	209.6	55.2	133.9	153.6	110.3	12.2	283.6	70.0	131.8	20.1	21.6	171.8	87.4	120.4	132.4	212.0	86.3	220.6	87.6	42.5	72.3	140.1	254.9	109.4	72.6	159.5	225.0	243.0	154.1	228.3	169.9	252.9
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572824-7579006	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1342.5;Basal respiratory cells: 1913.6;Langerhans cells: 1330.1;Suprabasal keratinocytes: 1233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		4100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011689: AB_732122, HPA068286: AB_2685968"	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	500.5	373.3	110.2	296.5	113.4	416.2	354.2	118.1	129.6	287.0	116.7	260.6	199.7	290.3	196.6	566.2	307.9	229.5	229.7	112.7	123.9	274.2	328.3	339.0	286.3	128.9	119.1	302.8	360.5	150.4	190.2	301.9	125.9	219.2	289.5	118.5	268.6	168.7	281.2	375.5	228.9	316.6	122.9	291.4	313.2	159.8	131.2	309.3	171.4	122.4	385.2	506.9	321.6	131.5	1048.3	1396.3	914.1	833.9	802.7	931.9	852.4	977.9	1104.0	1770.4	1356.8	1420.1	457.7	1428.7	735.7	1032.2	774.7	907.6	1962.5	1505.4	1890.2	468.1	1454.0	799.3	854.7	1597.9	1226.2	826.4	771.9	1244.8	763.3	1491.8	1510.3	1055.1	1351.6	784.4	831.1	284.9	1294.2	1092.6	865.0	704.8	789.1	1068.6	952.6	802.1	691.1	682.2	1249.8	939.1	481.2	934.2	883.0	585.6	1273.8	679.4	651.5	625.1	976.1	930.2	649.9	603.8	2010.9	276.0	425.7	921.2	1000.8	999.3	1045.7	318.5	1639.1	408.1	463.4	1377.5	755.2	469.1	493.1	497.9	1905.9	412.2	477.7	488.1	157.1	658.5	1076.3	727.7	682.0	2945.6	110.2	113.4	118.1	129.6	112.7	123.9	128.9	119.1	125.9	122.9	131.2	131.5	212.3	115.4	239.6	0.0	139.7	1342.5	678.5	1913.6	173.0	113.5	191.0	183.4	6.8	104.4	799.6	73.5	116.7	345.6	185.8	100.5	152.6	295.4	32.4	120.7	171.6	286.1	116.1	139.6	0.0	231.4	370.5	299.2	129.5	165.0	149.1	237.5	154.2	63.8	212.1	106.0	0.0	117.3	767.0	160.4	1330.1	42.0	160.9	206.7	725.7	0.0	133.3	120.7	119.4	0.0	0.0	313.9	123.3	109.1	134.7	342.8	151.8	174.0	446.1	119.4	151.2	374.4	871.4	71.5	102.8	154.0	1233.4	636.9	224.2	197.1	135.9	474.6
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789897	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011690, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		1600000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB011690: AB_732123, HPA068286: AB_2685968"	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	178.4	288.5	277.5	105.8	302.9	7.3	243.4	328.0	388.2	274.5	251.6	282.5	143.3	325.0	196.3	178.1	322.0	205.3	383.9	309.0	331.3	287.8	202.6	156.2	192.3	275.4	254.5	606.8	272.1	189.2	292.5	218.8	290.2	249.7	179.7	310.3	213.5	262.9	675.3	93.7	165.7	252.8	270.6	159.0	196.0	155.3	316.9	178.0	293.8	553.2	170.0	224.3	186.8	275.6	95.4	44.6	179.1	30.2	624.9	589.3	59.3	158.9	138.5	159.1	202.1	159.9	34.2	200.0	812.8	213.7	283.4	146.8	255.2	66.5	272.0	182.6	134.8	304.8	54.4	214.5	249.6	68.3	209.0	402.5	291.8	47.8	368.3	764.1	275.2	161.6	109.6	311.9	496.8	14.2	112.5	31.2	183.7	337.0	199.4	143.3	124.1	122.2	305.9	110.4	331.8	71.9	241.4	175.4	356.9	427.3	269.6	244.3	205.6	122.8	63.0	123.9	87.7	252.1	374.8	85.9	86.9	71.0	63.9	233.4	78.5	88.5	125.8	87.5	200.8	245.4	183.2	154.5	91.0	203.0	273.4	224.2	50.5	169.6	125.3	85.4	187.3	282.3	277.5	302.9	328.0	388.2	309.0	331.3	275.4	254.5	290.2	270.6	316.9	275.6	265.3	118.6	220.2	68.6	416.9	690.3	770.9	595.8	412.6	267.4	396.7	308.2	271.3	327.5	447.9	261.1	64.6	450.1	370.8	306.7	661.2	254.3	33.0	287.9	297.5	319.2	407.8	221.4	146.8	94.5	251.2	367.8	250.2	344.2	312.1	267.2	258.1	142.4	226.6	390.3	138.0	372.9	455.7	228.6	385.2	56.8	385.8	242.9	345.1	92.8	318.1	383.9	256.4	73.9	118.7	136.0	410.8	472.8	235.7	737.4	567.9	665.2	337.8	192.8	236.7	409.7	489.9	223.8	165.4	314.8	618.0	615.5	449.2	345.6	380.1	879.5
EIF4E2	"4EHP, EIF4EL3, IF4e"	ENSG00000135930	"Eukaryotic translation initiation factor 4E family member 2"	O60573	2	232550674-232583644	"Predicted intracellular proteins"	"Protein biosynthesis, RNA-mediated gene silencing, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019253, HPA077074"			Enhanced	Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Cytosol	"HPA019253: AB_1848092, HPA077074: "	"unprognostic (3.44e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.42e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.38e-2)"	40.8	35.9	27.8	52.4	29.0	58.3	43.0	29.2	34.3	35.4	26.9	67.4	50.6	41.6	36.9	51.9	33.2	42.8	38.3	28.1	29.2	63.9	93.2	45.2	49.2	30.4	28.7	33.6	40.8	36.2	24.5	56.9	31.5	34.8	77.2	34.4	38.8	31.8	153.1	50.2	52.5	56.1	27.1	42.5	51.1	42.2	29.5	41.9	36.2	62.5	61.9	47.3	34.3	31.1	104.9	99.5	108.7	79.3	83.4	110.2	161.9	144.9	88.3	101.9	107.8	109.8	100.3	109.0	39.0	151.6	116.7	88.6	128.2	131.2	128.9	98.6	122.0	146.6	97.4	149.9	98.8	213.0	130.7	103.1	98.1	105.5	78.5	102.8	172.1	53.0	139.0	34.7	118.7	201.4	83.1	171.0	174.3	124.1	83.5	73.2	231.7	72.3	209.6	133.2	98.7	135.5	77.0	86.6	95.3	117.2	81.3	145.3	148.6	88.3	114.9	96.6	106.1	67.3	71.0	139.8	100.0	109.4	78.9	299.2	205.7	194.4	63.6	220.0	51.4	62.2	65.8	67.7	179.3	60.5	55.1	56.1	132.1	70.7	205.9	70.9	114.7	155.5	27.8	29.0	29.2	34.3	28.1	29.2	30.4	28.7	31.5	27.1	29.5	31.1	37.2	41.7	57.3	11.8	40.1	38.0	78.2	127.4	31.3	19.8	41.5	49.3	36.9	65.8	85.4	35.0	18.8	142.0	53.6	109.1	74.3	164.5	129.6	45.6	63.1	46.9	66.0	50.7	20.0	151.5	204.3	60.2	48.9	68.6	43.7	47.2	50.0	119.9	125.4	20.2	19.3	111.3	120.1	90.8	87.5	302.4	38.2	72.6	30.2	10.3	135.8	29.3	51.5	12.1	29.7	159.8	109.3	38.7	51.8	96.8	139.1	170.8	58.8	22.3	26.3	38.8	118.5	68.4	56.0	59.7	51.1	182.5	42.7	92.3	87.9	120.4
EIF4G3	eIF4GII	ENSG00000075151	"Eukaryotic translation initiation factor 4 gamma 3"	O43432	1	20806292-21176888	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 515.2;Inhibitory neurons: 464.4;Microglial cells: 255.8;Oligodendrocyte precursor cells: 425.8;Oligodendrocytes: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025031, HPA025039, HPA025041"	Enhanced		Approved	Cytosol		NA	NA		68000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104"	"unprognostic (1.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.60e-7)"	"unprognostic (1.02e-1)"	"unprognostic (6.95e-3)"	"unprognostic (8.36e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	21.3	20.7	5.2	20.5	6.2	32.3	17.9	1.6	19.7	18.5	57.9	22.7	15.0	21.1	17.1	19.8	18.8	19.9	18.3	4.8	12.7	16.1	14.9	16.4	17.4	5.0	1.5	17.2	12.1	39.5	26.5	15.6	4.9	17.4	24.4	26.4	12.6	20.6	42.2	18.5	17.4	27.5	0.0	17.1	17.3	74.3	3.7	17.1	35.7	23.4	19.9	22.6	16.7	16.6	31.8	25.2	78.3	32.0	80.1	77.9	16.4	66.8	70.4	46.5	46.1	27.2	33.4	60.7	41.1	73.2	42.6	34.5	48.4	53.9	64.3	50.4	48.2	31.6	47.7	18.9	38.5	53.1	56.5	86.4	39.9	47.8	61.2	69.0	59.2	22.3	23.9	42.0	66.3	25.1	16.6	19.2	23.3	36.7	21.3	31.7	29.8	21.4	40.8	16.4	46.1	35.4	70.0	29.6	35.9	46.3	20.7	58.0	60.7	51.4	19.1	73.5	30.2	18.8	22.5	0.3	63.5	78.7	48.4	0.5	0.5	0.9	0.7	0.0	0.3	0.6	0.3	0.3	1.0	0.8	0.2	0.3	1.2	0.4	0.3	0.6	0.5	0.5	5.2	6.2	1.6	19.7	4.8	12.7	5.0	1.5	4.9	0.0	3.7	16.6	50.9	19.2	30.5	181.5	29.5	20.6	19.9	15.0	17.1	52.0	19.2	17.4	44.5	14.3	28.2	16.5	66.7	4.6	51.1	51.3	0.0	20.6	173.9	66.6	81.2	42.7	16.3	26.1	515.2	19.4	8.8	33.8	46.4	46.8	26.6	44.9	46.1	14.7	23.1	50.5	464.4	21.6	4.1	31.5	11.3	121.8	44.7	39.3	14.2	255.8	18.0	18.6	28.8	425.8	483.4	24.8	32.1	44.8	27.3	21.0	15.7	10.3	51.1	40.5	32.9	36.6	31.3	100.6	51.2	33.8	26.3	3.4	23.7	68.4	29.6	28.0
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174231-74197122	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 990.0;Late spermatids: 2765.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		750000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	186.9	174.9	151.0	117.8	159.3	283.3	168.3	163.8	157.3	179.8	129.6	208.4	130.2	186.4	76.6	249.3	163.6	100.0	171.0	149.9	151.9	156.6	197.0	158.4	130.3	161.9	156.9	181.2	226.4	160.7	119.9	162.8	162.2	150.3	100.2	149.8	170.1	125.1	399.8	230.9	148.9	119.2	165.2	137.4	192.9	79.9	164.6	150.2	141.2	173.4	137.2	175.3	179.7	187.1	526.3	341.4	251.3	303.1	220.8	231.8	283.4	359.8	276.3	300.3	289.5	423.3	388.6	444.3	96.6	338.8	424.2	266.6	280.5	481.5	286.3	298.0	329.2	247.5	305.2	345.9	253.1	429.0	236.9	273.2	300.8	326.2	460.7	341.5	326.8	260.1	445.8	186.4	305.2	448.2	342.0	516.8	337.6	430.3	328.9	386.9	342.7	401.5	250.9	324.7	252.7	325.4	340.9	420.3	296.0	331.3	476.8	272.4	340.2	411.6	284.6	345.1	474.4	218.8	299.8	771.4	326.3	435.1	441.4	213.7	229.7	245.6	156.9	255.6	164.5	146.4	161.4	158.3	224.2	132.9	183.9	151.7	150.1	193.5	270.2	95.1	194.7	388.0	151.0	159.3	163.8	157.3	149.9	151.9	161.9	156.9	162.2	165.2	164.6	187.1	105.8	83.3	81.2	15.7	97.1	119.2	153.8	101.5	78.0	93.1	103.0	95.5	43.3	68.6	68.7	44.1	25.0	198.8	91.9	98.7	107.6	148.1	990.0	104.8	98.3	103.0	90.4	79.5	25.3	157.7	381.4	101.6	61.2	112.5	122.4	112.1	79.6	95.7	124.2	97.6	24.6	87.2	91.6	101.2	102.7	2765.8	103.8	86.8	72.9	15.9	157.4	134.7	119.4	16.6	44.2	147.0	82.8	110.6	82.7	140.7	84.6	69.0	57.8	72.3	85.5	107.3	117.7	61.2	64.6	90.1	116.1	395.3	92.4	116.9	109.5	140.4
EIF5AL1	"bA342M3.3, EIF5AP1"	ENSG00000253626	"Eukaryotic translation initiation factor 5A like 1"	Q6IS14	10	79512533-79516440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 10.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 79.2;Intestinal goblet cells: 96.7;Spermatocytes: 76.5;Undifferentiated cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"U-251 MG: 2.2"									HPA074052			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA074052: "	"unprognostic (2.16e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.55e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.81e-1)"	0.8	0.8	0.1	0.2	0.1	0.2	0.6	0.5	0.3	0.4	0.0	0.6	0.2	0.5	0.2	1.4	0.4	0.0	0.9	0.1	0.0	0.5	1.3	0.6	0.3	0.0	0.0	0.3	0.7	0.2	0.4	0.0	0.0	0.5	0.2	0.8	0.5	0.0	1.5	1.0	0.5	0.0	0.0	0.5	0.5	10.6	0.0	0.0	0.5	0.0	0.3	0.5	0.7	0.1	0.4	0.8	0.3	1.7	0.0	0.2	0.3	0.3	0.1	0.3	0.2	0.6	0.3	0.9	0.3	0.0	0.2	0.5	0.1	0.0	0.2	0.2	0.7	0.2	1.0	0.4	0.1	0.3	0.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.6	1.0	0.9	1.2	0.1	0.1	0.3	0.7	0.6	0.5	0.8	0.2	0.5	0.5	0.4	0.6	0.1	0.8	0.7	0.2	0.4	1.0	1.1	2.2	0.4	0.5	0.8	0.7	0.2	0.6	1.1	0.8	0.6	1.2	2.0	1.4	1.3	1.2	1.3	1.6	1.3	0.9	1.3	0.7	1.7	1.3	2.5	1.0	0.8	0.1	0.1	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	16.0	30.0	1.3	10.4	33.8	3.0	7.8	0.0	0.6	5.1	2.4	43.1	2.8	16.1	0.0	0.0	20.8	2.4	79.2	11.7	64.5	14.7	2.9	4.4	12.9	60.0	10.7	0.6	47.8	35.1	15.5	0.0	3.2	48.2	0.9	4.2	5.1	17.5	1.7	0.6	96.7	8.2	8.7	27.9	8.7	5.0	7.2	19.6	0.0	41.9	1.2	13.4	0.0	1.0	65.6	61.2	3.0	0.5	10.3	66.5	11.1	6.1	0.5	0.0	6.9	25.9	76.5	4.3	0.0	34.5	27.6	8.9	3.3	121.3	5.0
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337371-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 769.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		210000	"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: AB_2676843"	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	39.4	31.6	50.3	32.8	53.5	20.8	33.9	50.8	88.8	31.3	51.1	56.3	23.1	35.2	41.7	44.4	29.6	18.5	89.6	48.8	55.3	50.9	38.4	30.9	32.6	54.1	52.5	27.0	48.6	32.1	28.2	29.6	55.0	44.0	30.0	23.8	36.5	33.5	102.9	39.4	29.1	28.7	52.8	30.7	42.1	48.6	53.6	26.2	29.3	56.2	36.6	47.8	33.7	53.0	117.0	57.2	63.8	83.5	75.5	88.7	105.4	100.4	62.9	65.3	64.6	132.5	80.9	132.5	84.6	75.2	77.4	64.9	112.6	97.3	114.6	80.8	67.4	159.6	57.7	175.9	59.7	158.0	94.3	60.2	66.8	91.0	92.1	55.9	96.6	80.0	179.6	64.4	95.2	94.9	100.8	145.7	99.5	76.2	83.0	86.8	94.7	108.2	134.9	96.2	53.8	50.9	54.6	123.8	85.3	120.4	50.5	103.0	106.9	100.7	99.3	53.2	90.7	47.4	72.0	106.0	73.3	172.0	75.9	19.8	11.0	13.7	15.5	12.5	18.2	20.9	16.3	15.5	8.4	19.8	15.9	17.0	2.9	18.3	17.3	26.2	12.5	6.4	50.3	53.5	50.8	88.8	48.8	55.3	54.1	52.5	55.0	52.8	53.6	53.0	121.7	109.0	219.6	23.8	152.4	321.3	200.4	209.0	84.8	103.8	159.1	112.1	579.1	135.8	198.6	343.9	50.1	143.7	142.9	135.0	144.8	210.5	769.9	143.1	175.0	153.2	157.9	154.2	27.4	235.1	205.3	130.4	82.0	157.5	172.7	90.0	146.3	480.9	134.7	77.4	28.3	206.7	144.5	123.5	128.9	144.0	124.5	95.7	142.3	18.7	157.7	91.8	145.2	21.6	36.7	282.6	93.8	175.7	183.2	253.9	102.7	226.2	165.4	111.3	276.1	167.3	157.7	575.3	505.0	99.1	324.8	181.4	133.4	101.7	185.1	244.7
ELAVL2	"HEL-N1, HuB"	ENSG00000107105	"ELAV like RNA binding protein 2"	Q12926	9	23690104-23826337	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 31.8;testis: 43.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.2;Excitatory neurons: 135.5;Inhibitory neurons: 390.6;Spermatogonia: 159.2"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 25.4;AF22: 37.2;SCLC-21H: 119.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022222, HPA063001"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB022222: , HPA063001: AB_2684918"	"unprognostic (3.51e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.74e-4)"	"unprognostic (3.98e-1)"	"unprognostic (9.08e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.65e-1)"	0.1	1.3	12.4	0.1	15.8	0.5	0.2	1.5	31.8	0.1	0.0	0.4	0.1	0.5	0.5	0.2	0.1	0.2	0.1	10.9	23.2	0.5	0.0	0.2	0.2	15.7	13.0	1.1	0.0	0.1	1.0	0.1	15.3	0.3	0.5	5.0	0.1	0.1	0.1	0.5	0.2	0.2	0.1	0.1	0.1	43.1	15.0	0.0	0.3	0.0	0.1	0.4	0.2	9.4	25.4	0.3	37.2	0.2	0.1	0.3	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	7.8	9.9	15.9	0.2	0.0	7.1	0.0	0.1	0.3	0.0	0.2	0.6	0.5	9.6	0.0	11.0	0.0	0.3	0.1	0.9	1.2	5.3	0.0	0.1	0.1	9.8	0.0	11.8	0.1	13.3	0.2	0.0	0.0	119.6	11.5	0.3	0.3	0.3	9.4	0.6	1.9	0.0	0.2	7.9	0.2	0.2	0.1	0.1	0.1	1.3	0.1	1.4	1.1	0.3	0.5	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.5	0.3	0.4	1.5	0.4	0.2	0.3	0.2	0.0	12.4	15.8	1.5	31.8	10.9	23.2	15.7	13.0	15.3	0.1	15.0	9.4	0.9	0.0	0.0	7.8	0.0	1.0	0.4	0.4	0.6	8.8	0.9	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.9	0.1	62.2	0.5	0.2	1.8	4.2	0.0	135.5	0.0	0.0	0.8	0.0	0.2	0.0	10.6	0.0	0.0	0.1	16.8	390.6	1.2	0.0	0.0	0.7	39.5	3.1	0.2	0.0	7.5	0.0	2.8	0.0	5.5	5.5	0.0	0.2	1.5	0.0	0.4	0.0	0.1	0.0	10.6	0.0	1.4	1.0	13.9	159.2	0.5	0.9	0.0	0.1	0.7	1.3	0.6
ELMOD2	MGC10084	ENSG00000179387	"ELMO domain containing 2"	Q8IZ81	4	140524168-140553770	"Predicted intracellular proteins"	"Antiviral defense"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047600	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA047600: AB_2680098"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.17e-8)"	"unprognostic (3.17e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (1.82e-2)"	10.7	13.8	6.8	8.7	7.4	8.6	14.2	9.7	6.9	9.9	12.3	12.2	12.9	10.9	13.2	8.6	10.7	9.1	11.4	6.0	7.8	14.5	15.6	8.5	8.8	8.3	7.6	8.5	8.8	15.5	7.4	9.6	8.0	13.0	13.0	18.0	9.2	9.7	4.3	9.4	15.3	10.2	8.7	7.6	10.3	8.0	7.2	12.5	16.8	5.3	10.2	9.4	6.0	10.6	11.3	12.4	24.9	19.1	25.4	29.2	16.0	26.3	24.7	14.3	17.1	12.2	23.7	18.5	11.3	16.5	17.3	10.1	23.8	16.7	17.6	18.1	14.2	15.3	10.2	16.0	23.1	23.6	13.0	20.1	27.2	12.2	12.5	22.6	15.9	22.2	19.9	29.6	24.8	8.2	25.6	8.1	13.2	16.4	10.1	29.7	19.2	12.0	20.7	17.9	11.8	43.6	17.3	17.5	19.3	27.7	17.1	9.7	16.3	32.7	11.6	15.5	27.6	30.8	47.1	23.1	23.9	18.2	25.3	2.3	6.6	8.0	6.6	7.1	7.4	3.2	5.8	7.2	5.6	6.0	5.9	5.9	15.3	7.5	5.7	9.8	7.3	4.4	6.8	7.4	9.7	6.9	6.0	7.8	8.3	7.6	8.0	8.7	7.2	10.6	14.6	28.9	17.7	22.5	13.1	9.2	11.0	30.3	11.4	20.7	14.7	10.5	14.3	7.2	26.4	18.4	18.8	23.2	19.9	17.6	1.9	22.2	3.9	29.0	24.4	14.5	9.1	7.4	20.2	26.5	8.7	15.5	9.2	15.7	19.7	17.8	11.4	27.1	19.0	15.2	15.6	10.9	22.4	16.4	11.0	1.5	13.1	13.8	17.8	19.7	14.1	16.3	9.2	20.6	35.3	25.6	12.9	10.9	21.7	10.3	27.1	15.9	44.9	24.7	6.6	10.0	18.3	26.9	19.1	12.4	11.6	20.1	13.9	10.9	12.0	8.6
ELOA2	"HsT832, TCEB3B, TCEB3L"	ENSG00000206181	"Elongin A2"	Q8IYF1	18	47032572-47035621	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	33	"brain: 2.3;choroid plexus: 3.4;testis: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041009, HPA043501, HPA048971, HPA049178, HPA050086, HPA053158"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"			Nucleoplasm	Cytosol	"HPA041009: AB_10959881, HPA043501: AB_10960403, HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "	"unprognostic (2.38e-1)"	"unprognostic (4.47e-1)"		"unprognostic (2.54e-4)"	"unprognostic (2.39e-1)"			"unprognostic (8.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.64e-1)"			"unprognostic (5.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.97e-2)"		0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.8	1.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	2.0	2.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.8	1.1	0.7	0.6	2.0	2.3	1.9	0.9	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELOA3CP	ELOA3C	ENSG00000275553	"Elongin A3 family member C, pseudogene"		18	46968695-46969912	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	28	"brain: 2.2;choroid plexus: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049178, HPA050086, HPA053158"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"			Nucleoplasm	Cytosol	"HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	1.2	0.0	1.7	0.0	0.0	0.6	1.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	0.6	1.1	0.8	0.7	2.0	2.2	2.0	0.9	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELOF1	"ELF1, MGC4549"	ENSG00000130165	"Elongation factor 1 homolog"	P60002	19	11551147-11559236	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 497.5;Late spermatids: 1414.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045606	Uncertain		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA045606: AB_10965133"	"unprognostic (4.32e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (4.38e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.12e-2)"	42.7	65.7	78.3	33.3	81.2	62.2	40.8	91.9	95.2	63.1	82.6	57.4	31.3	68.9	43.4	51.4	60.2	29.4	54.4	81.2	89.1	54.9	80.3	40.9	45.3	76.3	77.9	60.3	79.7	48.6	74.4	25.5	83.9	64.1	25.0	22.2	56.4	45.1	57.9	48.1	48.9	34.8	75.5	56.0	66.4	205.2	81.0	47.1	47.4	47.8	38.6	53.2	47.7	101.5	138.7	94.7	63.7	88.0	78.0	78.5	32.8	87.2	73.0	117.1	117.6	94.4	37.1	88.1	83.5	79.3	76.3	63.5	78.2	121.2	81.2	70.2	79.6	110.8	61.8	90.5	87.6	72.5	72.9	76.8	88.7	103.6	74.8	83.7	57.9	82.8	156.1	111.8	71.0	177.8	108.2	84.1	166.1	69.9	172.3	79.2	54.5	93.2	97.6	63.2	80.2	101.4	70.3	83.6	85.2	58.1	70.2	57.5	40.6	120.3	45.5	127.6	133.0	129.0	188.5	75.1	112.1	101.0	61.5	99.6	130.4	144.2	99.5	128.8	92.5	195.5	104.0	93.5	115.0	160.4	92.8	83.4	87.1	106.1	147.3	189.4	153.0	146.4	78.3	81.2	91.9	95.2	81.2	89.1	76.3	77.9	83.9	75.5	81.0	101.5	15.4	16.0	23.9	7.8	50.5	84.9	53.4	74.7	43.9	24.7	47.9	39.2	31.9	50.1	37.7	33.1	8.4	83.6	52.3	59.9	105.7	80.1	497.5	38.9	30.3	32.4	60.3	67.8	10.0	103.0	80.8	42.2	19.4	20.2	22.2	29.5	44.3	37.0	76.7	15.2	10.3	47.1	59.0	53.0	68.9	1414.3	74.0	39.7	69.4	6.5	87.4	45.7	80.3	3.0	9.0	96.1	68.7	71.5	36.5	49.5	80.9	90.7	51.0	17.6	26.3	31.8	38.3	206.3	80.4	32.2	81.3	72.7	47.5	33.7	46.6	43.5
ELOVL3	CIG-30	ENSG00000119915	"ELOVL fatty acid elongase 3"	Q9HB03	10	102226299-102229589	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 30.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.5;Breast myoepithelial cells: 3.2;Skeletal myocytes: 5.0;Spermatogonia: 3.4;Theca cells: 2.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	10	"classical monocyte: 7.1;intermediate monocyte: 2.4;myeloid DC: 2.0;non-classical monocyte: 5.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.0;monocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.5;ASC TERT1: 9.4;HSkMC: 13.9;NB-4: 11.6;SiHa: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036236	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"		"HPA036236: AB_10601550"	"unprognostic (1.52e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (6.25e-5)"	"unprognostic (8.23e-3)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-4)"	"unprognostic (4.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.66e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.79e-1)"	3.2	0.7	1.0	0.3	0.8	1.8	3.5	0.5	1.3	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.2	1.0	0.4	0.8	0.0	1.0	0.1	0.4	0.9	0.1	0.0	0.1	0.0	0.9	0.4	0.2	0.1	0.1	0.3	0.1	0.2	30.5	0.2	0.0	0.4	0.8	0.1	1.2	0.4	0.0	0.0	0.3	0.0	0.2	0.3	0.5	3.2	0.2	0.2	7.8	9.5	9.4	2.8	0.1	0.3	0.4	0.5	0.5	3.0	0.0	0.3	0.0	0.0	0.1	5.9	0.1	0.5	0.0	0.0	0.2	0.4	0.8	0.3	0.0	0.1	13.9	1.6	3.6	0.0	0.0	0.0	0.9	0.1	3.5	0.8	0.0	0.0	11.6	0.1	1.1	1.0	0.0	5.1	0.0	2.0	0.1	0.0	0.4	22.6	0.9	0.7	0.6	8.1	2.7	0.0	1.5	0.0	0.3	0.3	0.5	7.2	0.0	3.4	6.5	0.0	0.0	7.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	1.7	1.0	0.8	0.5	1.3	1.0	0.4	0.4	0.9	0.4	0.4	0.4	0.5	2.5	0.0	1.1	0.0	0.2	0.4	0.5	0.6	0.6	0.0	1.1	3.2	0.3	0.0	0.5	0.0	0.0	0.0	1.1	0.2	0.0	0.1	0.0	0.0	1.3	1.9	0.0	0.0	0.3	0.0	0.7	1.3	0.0	0.2	0.0	0.0	1.4	0.4	0.2	0.0	0.0	0.2	0.0	1.5	0.8	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	5.0	1.2	0.1	3.4	0.6	0.1	0.3	0.3	2.2	0.2	0.1
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513712	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: AB_2685282"	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	13.5	27.0	21.3	14.3	22.8	11.5	15.8	23.6	23.6	14.5	24.3	16.2	15.2	17.2	23.1	15.5	16.9	14.7	19.6	21.0	21.6	17.5	21.3	12.1	21.9	22.8	22.2	21.7	14.8	21.1	15.1	14.4	22.7	19.4	13.9	8.7	16.4	17.7	35.6	16.6	13.4	18.0	22.2	15.7	15.7	21.1	22.9	24.6	19.3	29.0	20.5	16.0	13.3	23.7	37.6	36.4	45.3	46.8	34.9	32.0	26.5	43.4	29.7	54.2	48.6	35.1	38.4	68.7	27.1	37.6	51.3	22.1	43.6	62.5	33.0	39.9	34.4	62.6	55.5	40.4	38.5	49.1	38.5	34.9	33.2	61.4	38.3	31.5	47.3	58.8	67.1	21.7	54.1	44.0	59.8	56.7	55.1	35.4	57.9	29.2	22.3	42.2	38.4	33.9	40.3	40.9	36.9	29.8	25.8	36.0	40.8	41.1	32.8	57.3	41.9	28.9	56.9	44.8	63.5	64.9	28.4	58.8	58.4	19.7	20.4	15.1	31.8	18.9	25.2	33.4	29.4	32.9	25.9	35.2	28.3	28.9	2.8	35.3	13.7	33.9	38.5	25.6	21.3	22.8	23.6	23.6	21.0	21.6	22.8	22.2	22.7	22.2	22.9	23.7	19.3	6.4	12.3	8.8	24.9	8.4	15.2	35.7	19.4	21.7	20.3	22.4	23.0	24.3	20.0	33.1	14.6	44.0	27.8	16.0	60.7	28.1	8.3	15.3	19.4	22.6	17.4	30.3	9.4	23.6	39.6	23.4	17.9	14.0	22.2	56.3	30.0	28.5	28.6	38.7	11.9	15.0	40.7	14.5	8.3	14.5	23.0	17.4	16.0	9.4	21.7	43.7	48.4	5.5	11.7	21.3	12.7	30.5	23.1	10.9	22.9	51.1	15.7	26.0	6.6	14.2	22.6	47.2	22.4	15.6	8.4	26.8	23.9	58.4	21.7	10.4
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580632	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 230.6"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	56.8	9.7	15.5	12.4	15.5	0.7	49.5	14.8	17.1	51.0	18.6	48.0	15.5	25.9	45.5	152.1	35.5	17.7	64.1	13.6	15.6	20.3	83.2	230.6	5.7	16.1	16.8	54.9	13.7	32.8	13.3	23.0	16.0	38.8	34.1	2.0	39.2	17.3	22.5	140.6	28.3	22.3	15.2	16.0	39.1	7.2	18.8	5.3	27.7	25.4	32.8	39.6	72.9	15.7	28.7	39.1	15.9	18.9	35.0	30.0	31.3	40.0	36.8	23.9	35.7	128.5	98.2	0.2	12.6	48.4	17.2	123.9	41.1	49.8	31.3	0.1	26.1	0.1	76.6	72.1	6.1	0.2	0.4	18.4	13.1	31.9	3.2	5.4	10.1	0.1	9.6	2.6	66.9	268.1	0.4	0.6	18.3	46.4	9.5	7.5	18.2	61.7	5.5	182.0	22.0	25.0	49.6	256.2	15.2	45.2	156.6	6.2	5.7	75.5	32.2	25.6	22.7	0.8	1.0	0.2	33.2	0.5	75.7	1.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	1.1	0.3	0.3	0.3	0.2	0.1	15.5	15.5	14.8	17.1	13.6	15.6	16.1	16.8	16.0	15.2	18.8	15.7	239.7	4163.5	368.4	13.1	3.1	356.9	137.9	172.2	111.0	2.3	105.0	94.0	53.1	100.1	255.8	42.3	0.0	74.2	3.1	119.5	0.0	3.8	8.0	78.8	30.9	183.9	104.9	0.0	0.7	67.0	17.8	152.7	46.4	51.9	36.7	68.7	161.0	235.1	10.1	0.0	0.6	207.8	81.4	19.6	136.5	9.3	190.7	17.0	87.2	41.2	33.6	5.7	0.0	22.6	0.6	32.9	158.4	276.1	1.6	86.0	21.0	0.2	142.8	2.2	52.6	256.3	129.3	5.7	12.9	319.5	1174.3	48.0	9.3	73.3	178.5	221.4
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074824-79088599	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Enhanced		Approved	Centrosome,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Centrosome	"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.73e-5)"	9.3	8.4	8.4	8.2	9.4	7.2	9.1	8.6	11.5	11.9	10.2	14.5	14.3	9.6	2.0	5.4	10.7	5.9	9.1	8.3	9.9	7.6	8.8	9.4	9.2	10.0	10.7	13.7	7.9	6.7	7.1	5.6	10.1	10.8	9.2	6.1	9.1	4.3	24.0	9.6	14.9	5.2	8.4	20.0	11.0	3.4	11.0	7.2	11.8	10.4	5.8	11.6	9.5	12.3	6.3	12.8	5.7	10.0	4.4	2.5	9.6	5.6	3.5	4.6	3.9	7.2	6.4	0.0	5.9	5.1	6.2	9.7	7.2	5.4	2.3	4.3	12.5	5.9	14.8	4.2	4.2	6.7	11.2	5.8	7.9	3.4	3.3	7.8	4.9	14.7	9.1	3.6	2.5	5.1	0.6	7.3	2.7	15.4	12.1	12.7	16.8	5.3	2.4	16.4	4.2	9.2	7.3	33.5	4.2	6.8	10.8	7.8	6.4	6.8	6.1	6.4	4.4	10.9	1.9	2.9	4.0	13.6	5.1	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.5	0.1	0.0	0.4	0.1	0.0	0.7	0.1	8.4	9.4	8.6	11.5	8.3	9.9	10.0	10.7	10.1	8.4	11.0	12.3	6.9	0.0	16.0	18.3	6.1	4.5	5.6	3.4	3.4	11.1	7.5	7.4	6.3	5.7	5.7	11.0	35.5	5.3	7.1	23.3	0.0	4.2	1.8	3.9	6.3	7.6	26.2	3.8	5.4	4.3	5.4	6.7	18.8	4.8	5.1	11.5	8.2	11.5	8.6	8.4	10.1	18.6	0.0	13.2	9.8	1.3	3.4	15.5	0.0	14.0	8.8	5.3	6.2	3.5	11.0	2.5	10.7	1.9	5.7	5.3	16.5	2.9	2.9	24.5	13.1	7.9	8.3	1.9	1.6	4.1	5.8	6.7	7.4	7.5	27.5	4.4
ENKD1	"C16orf48, DKFZP434A1319, FBB11"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.2;Endometrial ciliated cells: 38.3;Respiratory ciliated cells: 42.5;Spermatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Centrosome"	Cytosol	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favorable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	12.8	12.8	8.4	4.6	8.3	3.5	14.9	22.0	11.5	23.2	13.6	28.6	3.9	21.2	5.6	8.6	30.7	3.6	13.2	8.2	8.6	26.6	11.6	14.7	2.2	9.9	10.9	21.2	67.2	16.0	25.6	3.3	8.4	20.6	2.7	8.5	13.7	9.2	9.5	12.1	11.1	4.4	10.0	11.9	15.9	41.1	9.1	4.7	22.3	1.6	2.5	21.5	14.2	8.5	11.1	7.5	17.2	8.0	5.6	5.8	8.5	8.5	5.1	6.7	8.1	5.5	16.5	4.1	14.3	5.3	0.0	12.7	4.5	10.2	8.2	6.5	10.2	4.1	25.7	13.1	9.1	7.4	5.4	5.1	7.3	9.1	8.2	15.4	5.5	13.3	6.9	2.5	3.5	5.7	8.2	30.9	8.2	11.5	3.0	28.5	1.8	31.3	7.2	1.1	17.4	18.9	18.2	1.8	9.7	3.9	15.8	10.5	14.3	8.1	11.4	15.2	0.1	19.1	9.2	4.5	12.3	10.8	2.5	0.0	0.4	0.0	0.1	0.1	0.4	0.2	0.3	0.2	0.1	0.0	0.2	0.3	0.9	0.2	0.2	1.3	0.0	0.1	8.4	8.3	22.0	11.5	8.2	8.6	9.9	10.9	8.4	10.0	9.1	8.5	8.8	22.4	14.4	8.8	1.7	6.9	5.9	6.2	4.0	3.6	10.4	11.2	5.5	10.0	4.0	9.2	4.2	3.1	1.5	4.4	1.9	13.1	34.2	38.3	10.5	8.6	13.2	2.1	2.1	10.7	2.4	7.5	1.5	9.5	1.3	7.4	10.4	26.4	4.7	3.3	2.2	6.0	2.0	3.2	4.3	20.6	13.1	2.6	5.4	0.0	3.0	8.8	0.0	2.5	1.7	9.5	1.4	14.3	2.6	6.0	1.8	7.3	42.5	10.5	6.6	9.1	8.0	37.0	7.9	1.2	5.3	3.4	1.9	11.6	4.9	4.4
ENOX2	"APK1, COVA1, tNOX"	ENSG00000165675	"Ecto-NOX disulfide-thiol exchanger 2"	Q16206	X	130622325-130903317	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Growth regulation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000514, HPA003027"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane"	"HPA000514: AB_1078558, HPA003027: "	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.27e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (6.42e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.38e-1)"	6.4	7.6	6.4	5.6	9.2	3.3	6.4	5.5	6.9	6.9	5.0	4.9	4.1	8.8	5.4	7.2	7.6	6.6	10.8	6.1	8.0	4.3	5.4	5.1	8.2	7.5	6.7	7.9	3.8	7.8	1.7	5.9	6.4	6.1	5.3	2.8	4.6	8.0	6.7	4.4	4.7	8.2	6.2	7.3	5.6	5.9	7.6	8.6	6.3	8.3	9.5	6.9	3.0	9.2	15.7	12.9	16.2	7.4	15.3	13.2	7.3	12.6	15.3	8.5	5.3	6.0	12.9	11.3	30.1	11.6	11.4	10.9	11.4	13.0	10.7	15.3	12.1	24.6	7.4	6.6	10.6	20.2	16.6	10.7	19.3	10.1	11.3	4.0	12.8	9.9	17.1	8.6	7.0	21.4	13.2	3.7	9.0	20.8	16.0	8.7	10.4	12.9	10.0	10.5	5.5	9.6	12.2	7.2	17.0	6.1	4.6	10.1	10.5	8.3	4.9	13.2	26.4	9.2	4.9	7.6	23.6	19.2	13.8	7.0	11.1	12.9	9.4	14.1	9.6	11.7	10.5	9.7	10.8	11.9	11.2	9.7	1.8	10.8	7.7	5.8	12.4	9.3	6.4	9.2	5.5	6.9	6.1	8.0	7.5	6.7	6.4	6.2	7.6	9.2	11.8	3.2	7.4	15.0	11.5	4.2	6.9	5.1	19.4	4.4	8.1	5.3	13.0	5.7	7.5	3.7	0.0	6.2	7.9	4.9	7.9	8.0	1.0	8.3	13.3	8.6	4.8	11.6	18.7	9.3	5.5	9.7	10.7	5.4	6.3	7.4	7.5	12.3	6.9	3.3	31.2	6.7	14.2	21.3	7.7	2.2	5.6	12.6	8.8	23.4	18.4	4.3	19.6	51.3	132.2	10.1	2.6	6.4	11.9	6.4	4.5	8.4	13.1	8.3	6.6	11.6	9.5	11.4	10.6	13.8	4.8	7.3	11.1	7.6	5.7	5.7
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 5"	Q9UJA9	6	46159185-46170980	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 243.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 100.1;Respiratory ciliated cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.1;HSkMC: 7.1;SuSa: 6.2;T-47d: 8.7;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		620000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.8	8.6	6.2	1.1	7.6	0.2	13.4	6.9	12.6	12.8	4.0	2.6	1.5	1.8	243.6	1.8	15.4	7.0	4.4	7.0	9.7	24.3	0.5	8.8	1.2	5.8	13.0	9.7	9.7	46.3	19.8	1.7	6.2	29.4	3.2	30.6	14.4	31.0	10.7	1.6	1.9	0.9	4.5	5.7	6.7	35.5	14.0	8.2	51.0	10.3	1.4	5.6	1.8	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.5	0.1	0.3	11.1	1.8	3.6	0.2	3.7	0.0	0.6	1.5	0.1	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.5	2.3	5.4	0.0	0.0	0.2	0.2	4.5	0.6	4.7	0.2	0.0	4.6	0.0	6.2	8.7	0.0	0.0	0.0	1.2	0.0	0.1	5.3	7.9	0.0	2.8	0.0	0.1	0.0	0.0	0.0	14.9	0.1	8.0	0.5	3.0	9.7	0.0	0.8	0.9	8.7	1.1	2.8	0.0	0.0	0.0	3.2	6.2	7.6	6.9	12.6	7.0	9.7	5.8	13.0	6.2	4.5	14.0	6.3	0.4	12.8	12.2	16.3	1.6	0.9	4.8	0.5	1.2	10.6	18.1	10.8	7.5	8.6	6.1	23.9	4.2	4.9	4.2	1.9	1.9	11.6	0.7	15.3	0.8	0.4	8.3	0.0	24.6	7.5	2.9	4.2	2.0	5.4	4.5	4.0	0.4	0.1	0.4	10.1	14.5	2.8	2.0	0.0	0.4	3.8	2.8	0.5	0.0	1.9	0.6	100.1	23.7	9.0	10.5	2.2	2.3	12.0	0.1	12.0	1.7	16.3	47.3	3.4	6.6	25.7	1.8	0.5	2.4	1.1	0.6	0.3	3.2	21.2	2.9	3.3
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	11	"U-698: 8664.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol		NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: AB_2681425"	"unprognostic (6.27e-2)"	"prognostic favorable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	140.5	106.6	151.2	115.1	156.7	219.8	154.9	133.6	188.2	145.2	132.6	135.9	133.6	117.8	183.3	288.0	100.5	94.9	120.2	161.6	144.1	118.8	148.8	124.0	128.4	137.2	135.6	102.4	108.5	173.0	92.0	103.7	134.2	97.7	123.9	121.8	122.9	94.6	301.0	241.3	132.7	105.8	136.9	99.7	124.1	45.2	147.4	157.8	134.4	212.3	146.7	147.0	165.6	157.0	287.1	170.8	236.9	206.9	149.7	126.8	220.7	141.0	148.4	199.9	171.7	207.3	216.6	288.9	196.8	122.1	125.1	238.3	198.5	325.4	160.1	415.1	277.4	434.3	239.6	158.2	108.3	372.1	462.6	100.5	202.0	214.1	293.6	118.8	206.2	224.8	321.7	551.8	140.9	775.5	302.3	272.6	431.2	386.2	211.1	298.6	199.9	328.0	299.2	306.0	303.8	193.3	201.6	385.6	222.1	200.8	533.9	442.9	208.2	143.9	261.9	171.8	340.3	309.4	441.4	8664.2	197.1	357.6	191.8	67.3	54.4	94.3	55.6	62.9	52.2	64.3	46.3	57.5	70.7	55.3	37.7	56.0	53.0	68.8	64.3	58.3	58.2	75.1	151.2	156.7	133.6	188.2	161.6	144.1	137.2	135.6	134.2	136.9	147.4	157.0	103.1	41.7	166.1	20.9	132.9	190.3	225.1	303.9	124.7	59.7	152.7	117.1	102.6	98.7	172.9	82.8	45.9	286.5	148.9	170.7	254.3	160.3	9.7	109.1	68.5	114.2	130.8	178.2	44.7	152.4	184.2	85.9	71.9	93.7	224.3	51.1	80.3	86.9	203.3	67.3	29.3	169.1	211.6	101.1	171.4	17.7	86.0	123.3	103.2	19.7	409.7	83.6	184.4	21.6	19.3	91.5	146.8	104.2	135.6	128.0	187.2	186.0	128.8	50.0	72.3	85.5	94.4	27.6	25.0	269.7	286.8	382.8	140.4	87.9	163.9	253.7
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 27.6;liver: 14.5"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 194.5;Intestinal goblet cells: 181.0;Paneth cells: 174.3;Proximal enterocytes: 167.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.0;OE19: 1.7;RPMI-8226: 5.3;T-47d: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.0	0.0	0.0	1.4	0.0	0.4	0.4	0.2	0.2	0.6	0.0	21.3	27.6	0.1	0.0	0.3	0.7	3.7	0.0	0.0	0.0	3.1	14.5	0.1	0.1	0.2	0.1	0.1	3.1	0.1	5.1	0.1	0.0	0.4	11.2	0.0	6.3	0.2	0.0	0.1	27.2	0.1	0.0	0.2	8.9	0.5	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	5.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.7	0.2	0.0	0.0	5.3	0.7	0.0	0.2	0.5	0.1	0.0	0.1	0.4	2.8	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.7	1.5	0.4	11.5	0.3	20.2	0.0	0.0	0.1	194.5	0.0	1.3	0.0	3.0	0.4	0.1	3.6	0.0	0.0	7.5	0.2	0.1	31.6	4.7	0.0	0.1	0.4	10.1	0.1	0.0	0.0	181.0	8.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	174.3	0.0	0.2	0.6	167.3	5.9	1.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.3	0.1	15.6	1.7
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975217-69013684	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 86.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	19.4	9.1	7.2	12.8	7.2	5.9	19.5	6.7	10.9	14.0	22.4	25.8	7.4	29.9	9.8	17.5	18.5	17.8	28.5	7.1	7.0	10.2	5.7	28.7	8.2	7.7	7.6	11.6	12.6	5.0	9.3	22.3	8.0	27.9	8.6	8.8	16.4	33.7	20.0	9.7	11.4	25.4	7.8	10.0	15.5	8.9	7.8	11.1	7.9	15.2	8.8	24.7	13.7	7.5	19.0	7.1	12.5	14.4	16.6	32.2	8.6	25.4	31.5	16.0	21.0	9.1	10.2	1.1	3.8	28.1	13.6	6.0	8.3	32.3	19.9	62.3	5.6	20.2	15.5	13.5	18.7	11.5	8.2	26.8	29.4	20.6	25.1	19.4	86.2	0.8	5.9	11.1	53.7	5.5	2.0	3.8	13.5	6.2	3.5	0.8	12.4	8.2	13.9	43.4	1.2	6.3	29.1	1.7	23.5	12.8	6.0	15.9	44.6	40.6	13.4	5.1	24.3	6.0	20.5	9.3	16.3	17.1	23.8	5.4	1.5	0.0	2.0	1.4	2.3	1.1	3.0	4.3	2.4	0.7	2.5	2.7	0.2	2.4	0.5	0.4	6.6	1.3	7.2	7.2	6.7	10.9	7.1	7.0	7.7	7.6	8.0	7.8	7.8	7.5	29.6	12.8	10.3	14.0	3.5	7.1	11.4	13.2	16.5	2.2	7.5	11.7	20.7	4.3	14.5	1.8	16.7	0.9	3.1	5.1	0.0	4.6	16.5	15.3	7.5	23.7	6.0	3.8	11.2	8.2	5.3	9.3	9.2	15.4	0.0	9.4	20.3	3.6	6.7	0.0	21.4	4.5	2.0	6.8	9.8	15.1	3.1	8.6	8.8	30.9	6.5	1.4	1.0	9.5	12.2	12.4	3.4	40.6	5.4	8.3	2.1	1.9	13.2	5.6	0.0	26.8	15.2	5.5	2.5	14.8	4.5	0.8	7.0	6.9	3.4	8.6
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.4;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 8.4"	"Group enriched"	"Detected in many"	7	"gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0"	"Group enriched"	"Detected in many"	107	"NK-cells: 33.0;T-cells: 26.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 77.5"	"Group enriched"	"Detected in some"	27	"cerebellum: 30.2;olfactory bulb: 12.7"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.0	0.6	0.2	3.2	0.1	1.8	0.6	8.4	0.4	0.4	0.4	0.7	0.4	0.8	0.8	0.3	0.4	1.6	0.3	0.2	0.3	0.4	2.4	2.2	15.0	0.2	0.3	0.5	0.3	0.1	0.2	0.4	0.6	0.5	0.8	1.6	0.9	0.1	0.1	0.2	1.4	0.4	0.3	12.8	1.3	0.4	0.2	1.5	0.5	0.1	5.4	1.3	0.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	1.3	0.0	7.4	1.1	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.8	0.0	0.9	0.3	0.0	8.3	0.2	0.0	0.0	2.0	2.0	0.0	0.2	0.2	0.9	1.3	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	16.5	0.0	26.2	0.0	3.0	19.5	0.0	0.0	0.2	11.9	0.2	33.0	0.1	0.1	0.0	2.9	0.2	0.1	8.4	0.4	0.2	0.3	0.2	0.3	0.6	0.3	0.2	0.4	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.8	1.5	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	16.8	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.3	1.3	1.8	1.0	1.1	0.1	93.7	0.0	0.0	0.0	0.0	0.4	9.8	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	2.0	0.0	0.1	0.0	31.5	0.0	0.0	0.0
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386697	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 412.0;placenta: 445.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 831.5;Endothelial cells: 425.8;Hepatic stellate cells: 538.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 20.6;eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 267.3;BJ hTERT+: 266.7;HHSteC: 326.3;RT4: 339.8;TIME: 337.8;U-138 MG: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	296.0	52.1	53.4	66.1	48.6	2.3	166.7	44.6	47.7	72.9	139.1	57.1	46.3	87.9	26.0	72.7	80.1	83.2	122.1	39.2	44.7	89.5	110.1	412.0	47.9	60.5	54.2	34.5	59.6	79.4	25.9	445.6	60.2	51.8	42.6	53.6	40.0	66.3	80.5	42.9	50.9	71.7	45.6	84.6	42.8	20.0	75.4	17.9	138.1	153.6	40.3	94.9	47.8	44.6	32.2	33.5	2.1	2.5	153.8	98.6	267.3	98.7	266.7	55.6	60.1	5.8	5.5	0.1	23.8	188.5	55.2	15.2	0.6	79.0	41.3	0.9	1.6	0.0	10.3	71.8	326.3	0.1	19.8	145.0	106.9	108.7	75.8	41.0	193.1	0.7	3.1	0.2	34.2	27.8	0.9	0.8	1.3	22.4	18.5	1.0	3.7	10.5	34.5	339.8	1.4	68.5	77.4	175.5	21.0	68.3	11.7	14.1	337.8	284.0	8.1	38.3	8.4	0.2	0.2	0.1	207.4	5.4	7.4	20.6	0.1	8.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.1	53.4	48.6	44.6	47.7	39.2	44.7	60.5	54.2	60.2	45.6	75.4	44.6	831.5	76.9	151.7	28.4	4.1	48.2	69.8	108.6	43.9	4.5	27.4	29.5	79.2	32.9	124.9	3.7	10.4	126.2	6.6	112.6	1.9	23.0	12.9	36.1	32.7	425.8	4.2	18.7	1.2	52.4	299.9	76.8	32.1	67.6	41.2	2.3	538.7	78.0	55.5	0.0	1.6	13.9	22.4	60.9	30.3	52.7	12.5	21.4	28.4	155.5	0.6	95.5	0.0	31.2	1.3	26.1	53.7	6.4	3.9	57.8	45.9	30.2	31.7	59.3	282.7	23.3	250.5	1.5	4.6	65.0	33.2	349.7	15.9	4.7	23.6	85.7
EPB41L4B	"EHM2, LULU2"	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171974-109321059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.9;pancreas: 149.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 134.8;Excitatory neurons: 79.7;Hepatocytes: 125.2;Proximal enterocytes: 79.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.7;hTCEpi: 49.8;OE19: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavorable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	21.0	9.7	6.0	4.5	8.7	0.0	15.3	2.0	12.2	4.1	11.8	57.6	47.6	1.2	17.9	1.5	10.8	4.2	8.8	10.7	6.4	6.4	88.9	6.3	0.2	2.7	5.3	13.8	149.1	11.1	1.6	2.5	3.7	7.6	56.7	3.0	26.9	9.1	6.1	15.5	51.9	1.9	7.2	0.1	30.6	7.5	10.9	0.6	44.7	0.7	1.6	2.2	3.4	4.3	8.7	10.8	0.7	0.8	0.8	0.0	31.7	1.1	0.4	3.7	1.9	18.5	8.5	0.0	2.3	1.0	8.9	13.9	21.5	11.5	3.9	9.2	5.1	0.0	3.4	26.5	2.2	0.4	0.0	0.3	49.8	1.5	17.0	1.1	0.2	8.0	0.3	0.0	5.2	22.3	0.4	0.2	13.8	62.8	15.7	0.0	0.0	0.6	12.9	13.1	13.1	1.4	3.4	22.2	0.0	6.3	5.2	0.1	0.5	7.5	7.6	2.5	3.1	0.1	0.1	0.0	5.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	8.7	2.0	12.2	10.7	6.4	2.7	5.3	3.7	7.2	10.9	4.3	0.2	6.4	5.1	2.6	0.4	11.5	5.4	6.0	1.2	7.5	22.7	10.4	18.5	20.0	9.6	7.3	0.0	4.1	0.0	134.8	0.0	3.5	11.7	23.8	2.3	0.8	51.6	0.0	79.7	20.8	2.1	2.5	26.0	20.7	0.0	6.2	5.0	125.2	0.6	38.7	58.9	51.4	12.2	1.6	1.5	1.9	13.4	0.4	1.8	3.7	0.0	1.9	0.0	12.1	3.8	10.2	54.4	2.6	0.0	7.2	79.2	0.8	39.2	1.1	0.0	0.8	1.0	1.4	17.2	0.9	24.0	1.9	0.5	6.8	46.5	6.5
EPGN	"ALGV3072, EPG, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308470-74316789	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 49.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.0;Basal prostatic cells: 7.3;Basal squamous epithelial cells: 25.6;Urothelial cells: 5.1"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTCEpi: 157.9;U-2197: 74.8"	"Not detected"	"Not detected"							HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA014420: AB_10601551"	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavorable (2.40e-4)"	1.6	0.1	0.2	1.6	0.1	0.3	1.4	0.4	0.6	5.2	0.1	0.1	0.1	0.0	1.1	49.0	1.5	0.1	0.8	0.2	0.1	0.1	0.2	0.5	0.1	0.2	0.3	0.1	0.1	2.2	0.1	0.5	0.1	0.2	0.0	0.2	3.6	3.1	0.1	3.5	0.1	0.0	0.1	0.3	0.0	1.1	0.1	0.9	0.0	0.0	3.4	1.3	9.6	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.2	0.0	0.0	0.4	0.0	0.8	0.0	0.1	1.8	0.2	3.6	0.0	2.8	0.0	0.0	0.0	0.5	20.2	0.0	0.2	0.0	0.7	0.0	157.9	2.9	11.7	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.0	0.0	0.3	0.0	3.6	0.4	0.0	0.0	0.3	0.3	0.1	0.0	8.3	3.3	0.0	0.0	0.5	0.0	0.2	0.4	0.1	74.8	0.2	0.0	0.0	0.1	0.7	0.1	0.2	0.7	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.3	0.3	0.1	0.7	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.6	0.2	0.1	0.2	0.3	0.1	0.1	0.1	0.4	0.0	0.0	1.5	0.0	0.0	6.0	7.3	0.9	25.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	3.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.0	1.6	0.1	0.2	0.0	0.0	5.1
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107621-89482134	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 31.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 70.6;Inhibitory neurons: 106.6;Microglial cells: 103.0;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	5.4	1.0	2.1	1.8	1.3	0.0	2.3	0.2	3.8	12.3	0.1	3.8	2.3	5.5	0.2	3.2	1.3	18.8	8.2	2.2	0.7	1.3	4.9	2.4	3.6	3.3	0.9	4.1	2.1	1.0	0.9	20.1	4.0	31.5	6.2	8.0	2.2	7.1	0.8	0.7	2.4	7.9	0.8	0.9	2.5	1.0	1.7	1.0	11.0	6.3	3.2	14.3	6.4	2.2	0.0	0.0	197.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	11.2	0.2	0.7	0.0	2.4	0.0	0.0	11.8	0.0	0.0	1.7	2.0	0.0	3.9	0.0	0.0	0.6	0.0	2.5	0.1	0.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.5	0.1	0.1	36.1	0.1	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.2	3.8	2.2	0.7	3.3	0.9	4.0	0.8	1.7	2.2	2.2	0.0	0.0	5.5	0.0	0.5	0.3	0.0	0.6	6.4	0.0	0.1	2.4	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.5	1.8	0.0	0.0	70.6	0.0	0.1	18.1	0.5	0.0	0.0	0.0	1.1	0.0	0.1	20.2	106.6	0.0	0.0	0.0	0.7	1.6	2.1	0.1	0.0	103.0	0.0	4.7	0.0	2.5	48.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	18.7	6.6	0.7	19.2	0.1	0.0	0.3	0.3	0.5	0.2	1.3	0.0	0.1
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 198.8;dendritic cells: 53.7;Early spermatids: 42.2;Excitatory neurons: 47.9;Inhibitory neurons: 44.3;Late spermatids: 41.2;Oligodendrocyte precursor cells: 77.9"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"neutrophil: 24.0;plasmacytoid DC: 23.3"	"Group enriched"	"Detected in many"	33	"dendritic cells: 23.3;granulocytes: 24.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 63.9;HMC-1: 35.5;RPTEC TERT1: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	1.0	0.6	4.7	0.8	18.7	0.7	3.2	40.6	12.8	1.8	0.0	3.2	1.4	2.2	0.9	1.9	1.3	1.7	0.3	7.0	5.1	1.3	1.6	0.3	1.9	5.0	14.4	0.7	0.3	0.2	1.0	0.2	5.5	1.7	0.5	4.2	2.2	2.7	4.9	4.8	0.7	0.7	0.9	1.9	0.6	10.8	12.0	0.7	7.0	10.3	1.7	1.5	1.0	4.2	0.0	0.0	8.4	0.1	0.2	0.0	0.0	6.6	0.1	0.3	0.1	0.1	0.0	1.1	1.6	3.4	0.6	0.1	5.5	0.0	1.2	63.9	0.8	4.8	0.0	0.0	0.0	0.0	35.5	0.1	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.3	4.7	0.2	0.0	0.3	2.4	1.2	0.1	0.0	0.9	0.2	16.5	0.0	1.1	0.2	0.0	0.1	0.0	1.1	0.1	0.7	0.5	1.1	3.4	0.7	7.9	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	23.3	0.0	0.2	4.7	18.7	40.6	12.8	7.0	5.1	5.0	14.4	5.5	0.9	12.0	4.2	1.9	0.0	0.0	198.8	1.0	3.7	0.0	0.0	0.0	1.9	0.8	12.3	1.6	0.0	0.0	0.0	10.4	0.0	53.7	0.0	0.0	0.8	42.2	0.1	0.5	2.8	0.0	0.0	47.9	0.4	0.1	0.4	0.0	0.1	0.0	3.3	0.4	7.0	0.4	0.0	44.3	0.0	0.0	0.0	0.8	41.2	0.6	0.8	1.8	8.4	0.1	16.9	0.0	77.9	5.6	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.3	0.8	0.5	1.6	0.0	5.8	0.0	0.2	3.0	0.3	0.2
EPOP	"C17orf96, LOC100170841, PRR28"	ENSG00000273604	"Elongin BC and polycomb repressive complex 2 associated protein"	A6NHQ4	17	38671703-38674957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4;testis: 10.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 19.3;Breast myoepithelial cells: 13.6;Glandular and luminal cells: 6.4;Syncytiotrophoblasts: 13.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.5;basal ganglia: 8.8;cerebral cortex: 10.4;hippocampal formation: 7.7;white matter: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 47.9;Hep G2: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055190, HPA056555"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA055190: AB_2682731, HPA056555: AB_2683172"	"unprognostic (9.08e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.78e-10)"	"unprognostic (8.97e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	1.6	2.2	4.5	1.7	8.8	0.5	1.1	0.9	10.4	0.9	0.5	0.8	0.3	1.2	0.8	1.9	1.1	0.9	1.2	7.7	0.9	1.6	3.8	1.1	2.7	1.4	1.7	0.8	3.7	4.8	0.8	1.3	1.6	1.4	0.4	2.2	0.8	0.9	0.6	3.3	0.9	0.7	1.3	1.1	1.3	10.0	1.7	1.5	0.6	0.3	3.5	2.9	0.7	5.4	9.2	10.8	6.8	47.9	1.5	0.4	11.7	1.9	0.7	2.1	3.3	10.8	3.3	17.1	11.6	1.2	6.1	7.3	22.6	4.6	3.7	18.2	17.1	3.8	1.5	57.3	3.1	2.1	9.0	1.0	8.0	2.3	4.6	4.4	1.6	18.8	12.0	25.9	1.4	14.4	15.8	5.1	1.5	6.0	9.6	37.3	3.9	37.8	1.3	2.4	10.4	15.8	6.0	7.8	2.1	11.0	11.4	7.2	2.7	2.0	2.0	2.2	1.8	13.5	16.1	21.7	3.9	25.4	7.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	8.8	0.9	10.4	7.7	0.9	1.4	1.7	1.6	1.3	1.7	5.4	4.4	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	19.3	13.6	0.0	0.0	1.3	1.8	0.0	1.7	3.5	0.0	0.0	4.2	0.0	3.4	4.8	1.8	0.0	0.0	0.0	4.0	1.5	1.0	0.0	6.4	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	13.1	0.6	0.8	0.0	0.0
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 72.8;Inhibitory neurons: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		30000000	"Cluster 34: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: AB_2677946"	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	51.5	15.8	3.7	37.0	4.3	27.9	25.5	3.1	5.6	21.8	2.3	37.9	63.4	22.0	14.4	13.2	25.5	23.7	17.1	3.4	5.2	16.4	32.9	31.2	38.2	8.4	5.7	20.7	13.7	19.1	8.2	47.0	7.0	18.6	43.7	12.4	19.3	22.0	20.9	36.5	55.1	21.7	5.0	30.8	33.7	9.1	6.6	63.7	17.5	19.6	36.8	27.3	11.7	6.8	25.9	14.1	21.3	20.0	114.7	111.5	61.4	18.3	59.6	44.0	76.2	17.6	91.1	75.3	37.6	36.0	61.8	25.7	17.8	38.1	27.3	139.8	7.5	24.7	10.0	13.9	130.9	12.0	44.1	46.8	16.2	50.6	15.5	64.3	61.1	48.8	12.9	74.7	26.7	11.6	113.2	12.4	10.6	3.1	10.4	82.4	28.8	38.4	32.8	39.0	7.8	5.5	29.6	19.8	28.6	14.6	17.1	57.0	48.8	37.4	12.6	6.2	31.1	26.9	53.9	57.8	40.2	40.2	22.5	28.8	15.2	18.0	22.6	12.3	20.2	14.8	19.2	19.1	10.5	18.3	22.3	18.1	15.8	23.1	20.6	16.7	13.9	13.7	3.7	4.3	3.1	5.6	3.4	5.2	8.4	5.7	7.0	5.0	6.6	6.8	11.1	9.6	16.3	34.0	15.3	25.0	14.2	19.2	8.6	13.6	6.6	3.9	10.6	10.0	16.9	9.2	2.1	9.6	21.1	24.4	0.0	12.4	27.0	12.7	15.0	16.3	10.3	14.1	72.8	15.5	11.9	18.4	16.3	19.8	15.2	13.9	16.8	28.0	17.6	3.3	79.3	23.9	4.1	29.9	16.1	7.3	9.9	22.9	7.2	24.4	32.5	9.0	20.6	32.6	70.1	12.3	14.1	16.1	32.3	13.5	47.3	6.9	23.1	7.6	0.0	10.3	22.6	1.4	1.8	9.8	11.1	9.2	21.8	5.7	27.3	14.9
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 34.1;Spermatocytes: 30.5;Theca cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	6.8	13.0	10.5	6.9	10.3	4.8	6.5	8.4	11.7	7.5	8.4	7.5	4.9	9.7	3.2	6.3	8.0	4.1	7.0	10.8	9.3	7.6	9.0	5.8	5.8	10.6	9.9	7.8	7.7	7.7	9.7	4.5	9.6	6.7	4.0	3.1	7.3	6.7	11.7	7.2	6.6	6.9	8.1	8.1	7.5	13.9	10.1	5.3	8.4	6.3	5.2	7.5	5.9	8.9	28.0	13.3	27.1	38.4	16.3	19.4	15.2	38.8	27.4	50.2	40.2	32.6	18.6	10.0	21.6	39.9	19.1	14.0	19.1	32.9	18.5	24.4	31.8	16.9	26.8	35.4	33.3	27.1	28.4	22.4	5.6	55.8	31.9	28.2	29.1	28.8	41.8	10.9	34.8	14.7	16.1	17.9	12.7	27.2	24.6	30.3	19.4	8.3	14.0	24.9	15.8	17.1	34.2	23.9	13.6	20.6	22.8	35.4	37.9	46.4	25.3	19.9	88.0	24.9	15.8	14.2	13.8	16.4	21.2	0.0	17.2	6.5	9.1	18.0	11.9	9.1	8.9	8.9	21.8	6.5	8.2	8.7	0.5	15.6	14.9	10.4	9.8	12.1	10.5	10.3	8.4	11.7	10.8	9.3	10.6	9.9	9.6	8.1	10.1	8.9	4.2	6.4	3.4	6.2	5.8	6.2	5.5	8.6	4.6	0.0	6.1	4.3	6.7	8.6	8.7	5.5	0.0	10.5	4.1	5.9	13.7	10.7	4.7	3.3	4.5	5.5	7.2	5.5	2.9	8.2	12.1	6.8	6.1	3.8	0.0	34.1	7.9	12.3	11.5	0.0	3.1	8.5	4.1	8.2	4.2	2.8	6.5	6.3	3.6	1.0	4.2	0.0	5.2	5.0	1.4	8.1	3.1	7.9	7.5	4.2	4.1	13.0	7.5	0.0	0.0	3.5	9.9	30.5	13.1	5.1	5.7	4.8	4.7	29.1	8.8	3.2
ERH	DROER	ENSG00000100632	"ERH mRNA splicing and mitosis factor"	P84090	14	69380128-69398299	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002567	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA002567: AB_1078749"	"unprognostic (2.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (8.61e-3)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.39e-1)"	107.7	113.7	143.3	119.0	146.2	144.4	119.3	145.1	186.7	97.0	146.9	110.5	110.0	111.9	150.3	75.5	112.8	70.1	100.2	145.4	159.1	118.3	142.5	76.3	147.1	142.8	146.8	107.0	66.7	128.2	58.3	98.1	147.6	87.0	122.9	116.7	110.0	84.3	107.0	58.1	99.1	114.8	153.7	96.5	88.7	91.1	149.6	212.2	97.6	85.8	168.4	117.0	51.2	154.5	972.7	574.9	704.6	409.1	271.8	201.1	356.9	450.7	261.3	401.3	372.0	598.5	403.1	879.9	224.3	305.3	340.3	296.1	563.4	376.9	484.2	437.9	428.3	441.4	366.1	731.8	419.6	389.3	334.6	227.1	203.0	355.9	317.2	239.2	337.8	584.5	454.0	301.6	335.7	1043.2	714.1	750.8	537.2	525.6	686.0	558.9	599.9	320.6	415.4	672.8	449.1	439.8	442.1	464.6	355.6	330.8	539.9	564.4	351.4	425.7	699.7	286.7	480.0	351.7	336.2	1096.1	345.1	417.5	442.4	76.6	101.4	80.9	76.6	98.9	77.5	122.2	100.0	88.0	107.4	94.3	92.7	88.2	45.3	121.5	95.1	122.8	116.5	147.0	143.3	146.2	145.1	186.7	145.4	159.1	142.8	146.8	147.6	153.7	149.6	154.5	231.2	60.9	54.3	22.2	189.1	273.1	225.0	702.7	180.4	126.4	244.2	314.2	118.9	181.6	282.2	253.8	37.5	455.3	179.4	117.5	673.1	363.8	100.4	238.1	198.9	211.9	188.5	252.6	23.9	275.3	560.3	237.0	120.3	158.7	127.6	186.7	169.6	239.9	341.5	74.0	23.1	244.0	510.6	147.5	215.2	51.3	270.9	162.5	307.7	16.9	302.3	350.3	174.0	19.6	34.6	289.8	183.9	259.2	237.9	288.9	203.9	508.5	278.4	119.8	190.7	177.7	273.8	321.5	230.9	251.0	318.8	279.9	165.3	281.4	265.9	230.6
ERI3	"FLJ22943, PINT1, PRNPIP"	ENSG00000117419	"ERI1 exoribonuclease family member 3"	O43414	1	44221070-44355260	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 943.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027147, HPA029895"	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA027147: AB_1855725, HPA029895: AB_2673239"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (5.94e-2)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.70e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-3)"	31.1	34.8	105.3	15.5	105.9	24.6	30.5	92.0	140.3	30.1	92.2	34.4	20.6	33.3	34.2	27.9	37.2	20.5	51.7	111.9	98.7	59.8	41.8	25.6	19.3	99.4	108.1	32.4	35.0	45.2	45.1	23.3	122.2	38.8	23.2	22.4	27.8	25.2	77.2	36.1	22.7	28.6	97.2	26.4	28.9	63.3	105.7	24.1	31.2	60.2	20.4	32.2	27.2	103.4	73.6	56.5	69.3	77.7	44.9	55.5	46.0	44.0	61.4	82.1	75.1	37.8	78.3	52.3	76.4	58.7	42.2	41.2	62.6	80.6	55.9	56.9	115.8	60.0	90.2	52.0	67.9	59.3	32.8	57.9	76.9	66.2	91.3	61.0	57.3	59.5	56.4	43.9	55.2	51.2	68.7	57.0	82.2	72.2	83.7	62.6	62.4	75.3	65.2	38.9	120.5	54.9	52.5	71.3	87.7	55.1	46.6	50.1	34.1	54.3	56.5	60.7	72.0	37.7	50.1	56.4	67.7	52.4	70.4	17.6	25.8	15.8	25.5	36.4	27.2	30.8	21.1	24.5	40.3	30.9	24.8	26.0	2.4	26.1	37.3	30.3	29.4	26.2	105.3	105.9	92.0	140.3	111.9	98.7	99.4	108.1	122.2	97.2	105.7	103.4	35.4	25.6	16.5	74.4	26.2	31.6	36.5	64.7	27.3	22.6	36.2	51.3	15.1	15.7	26.2	29.5	2.1	93.2	19.3	31.2	97.8	56.9	202.7	35.3	30.7	27.4	118.3	26.5	36.7	62.5	85.9	39.8	25.0	23.1	15.2	62.8	18.9	22.3	45.0	25.2	34.0	99.1	46.8	19.2	27.2	943.6	36.4	20.1	48.0	38.4	27.9	42.6	15.5	66.4	54.5	37.7	22.2	36.5	28.3	51.0	17.0	167.3	20.4	16.4	6.6	28.5	52.0	68.0	51.4	29.4	34.5	61.6	20.2	54.0	37.1	30.7
ERICH1		ENSG00000104714	"Glutamate rich 1"	Q86X53	8	614746-738106	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003725	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA003725: AB_1853023"	"unprognostic (7.19e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.42e-1)"	15.9	8.7	7.3	17.2	6.5	23.0	13.7	6.4	8.2	10.7	8.3	11.0	8.4	10.1	6.6	10.4	10.5	9.1	10.7	6.9	7.1	22.5	11.6	14.6	21.1	9.0	7.1	11.6	9.0	7.9	11.5	10.1	8.4	9.1	7.2	5.1	9.8	5.8	10.8	13.0	12.4	7.9	6.0	15.3	10.5	8.0	8.4	11.8	13.2	5.5	10.7	12.7	11.6	7.1	15.8	22.2	11.7	14.0	12.4	15.0	24.3	14.9	7.9	13.3	14.6	14.4	9.9	36.0	6.9	12.5	25.3	26.0	21.7	22.9	9.4	15.7	28.1	25.1	15.1	20.8	13.9	15.5	22.6	17.4	14.5	10.1	13.0	13.7	14.7	31.2	26.3	20.2	13.5	13.2	30.0	27.5	18.6	17.6	9.9	27.0	7.6	25.0	14.9	28.7	5.4	15.0	10.9	13.8	20.2	19.2	5.8	18.4	23.7	9.7	4.6	0.6	16.2	13.1	36.7	38.9	19.9	24.6	10.5	24.7	33.0	12.5	8.4	32.3	7.5	17.9	9.7	8.4	17.1	20.1	8.1	7.1	30.0	12.3	29.8	12.7	7.5	10.4	7.3	6.5	6.4	8.2	6.9	7.1	9.0	7.1	8.4	6.0	8.4	7.1	71.0	44.8	36.1	17.9	75.3	36.6	47.0	47.9	32.5	23.3	32.6	32.5	23.0	27.1	31.2	33.1	12.5	62.0	55.4	49.2	109.5	38.4	16.1	35.9	52.2	65.8	19.7	43.9	24.4	36.6	60.4	40.7	66.8	57.4	41.1	48.3	62.4	31.9	41.9	48.8	21.0	50.4	32.6	70.9	68.0	9.2	60.3	69.9	35.6	23.4	126.9	18.2	78.2	11.1	22.5	55.4	54.3	40.6	34.6	51.5	33.3	58.9	26.9	22.1	39.5	33.6	35.6	48.5	58.4	23.2	40.9	54.0	68.3	27.0	39.8	37.0
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443156-41444765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 42.5;kidney: 16.6"	"Group enriched"	"Detected in some"	10	"Proximal enterocytes: 189.7;Proximal tubular cells: 90.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 2.6;Hep G2: 6.2;THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.4	0.1	0.3	42.5	0.6	0.0	0.2	0.5	0.3	2.0	0.0	0.0	16.6	0.0	1.1	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.3	0.0	1.7	0.2	39.2	0.0	0.1	0.6	0.2	0.8	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	13.7	0.2	3.7	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	189.7	90.2	0.0	0.0	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.0	0.3	0.1	3.0	0.0
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064522-98093610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 2.2"	"Cell line enhanced"	"Detected in some"		"A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2"	"Not detected"	"Not detected"							"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (9.38e-4)"	0.5	0.1	1.5	0.3	2.4	0.0	1.0	0.9	1.4	2.5	1.2	1.9	5.3	1.3	0.6	0.7	11.1	12.3	5.3	1.0	2.4	5.6	10.2	0.9	1.0	1.8	2.1	0.9	34.2	2.2	1.3	0.2	1.9	2.7	3.3	2.3	1.3	2.3	0.0	0.7	1.5	0.5	1.1	0.2	12.6	2.4	4.7	0.7	0.6	0.0	0.7	1.9	0.5	1.3	0.0	7.3	0.0	0.0	0.1	0.0	4.7	4.6	1.8	2.3	1.8	0.1	2.4	0.0	6.0	1.2	3.6	0.4	8.0	0.2	2.8	0.0	11.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	0.0	14.7	0.0	0.0	0.1	0.2	0.0	0.8	1.6	0.2	2.8	0.0	0.0	0.2	7.5	18.2	4.1	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	2.4	0.9	1.4	1.0	2.4	1.8	2.1	1.9	1.1	4.7	1.3	0.0	3.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	2.1	1.3	8.0	100.1	3.1	7.3	0.0	0.3	0.0	1.6	0.0	57.6	0.3	27.8	0.6	0.8	18.0	0.0	1.1	18.4	1.8	0.2	7.7	7.7	0.0	4.3	0.4	2.6	0.1	0.0	1.6	2.4	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.1	8.0	0.0	0.5	0.1	14.8	1.6	0.0	0.0	2.5	0.7	24.5	39.4	0.1	0.0	0.2	1.0	0.2	4.7	1.1	0.0	0.1	0.2	0.7	3.6	2.6
ERMARD	"C6orf70, dJ266L20.3, FLJ11152"	ENSG00000130023	"ER membrane associated RNA degradation"	Q5T6L9	6	169751622-169781600	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 49.9;Late spermatids: 48.5;Spermatocytes: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041741	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA041741: AB_10804116"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.31e-2)"	13.8	14.6	5.3	8.4	7.1	10.1	13.1	5.4	6.7	13.7	5.6	11.2	6.3	13.8	20.5	10.5	13.2	7.7	6.8	5.3	5.9	16.1	18.6	9.7	13.8	6.9	6.1	17.4	11.4	6.9	15.4	7.4	7.2	12.7	7.4	14.6	11.0	8.6	14.9	18.7	13.6	6.4	6.5	17.3	10.9	22.1	6.1	9.9	13.2	2.5	13.6	11.2	10.8	9.1	5.1	7.5	9.7	14.8	6.9	11.4	5.1	5.3	7.7	5.0	6.3	2.0	8.3	8.0	4.8	6.5	6.1	13.3	4.0	10.3	4.4	8.6	4.4	11.5	9.9	3.0	13.7	16.1	7.6	13.4	10.4	6.1	15.5	12.8	3.4	14.0	8.0	11.4	6.5	7.7	6.8	14.4	3.2	5.7	5.4	7.5	6.0	13.0	6.2	4.0	3.8	7.0	9.0	9.0	4.9	6.3	7.1	12.8	5.3	5.7	3.4	9.1	6.5	13.1	17.5	6.7	7.2	9.7	6.6	1.6	4.2	1.8	5.2	7.9	5.2	5.1	6.0	5.9	4.4	6.0	4.7	4.4	0.4	5.2	9.7	3.7	7.6	3.9	5.3	7.1	5.4	6.7	5.3	5.9	6.9	6.1	7.2	6.5	6.1	9.1	8.5	3.2	11.1	20.2	6.2	4.1	4.4	7.7	5.2	12.0	5.9	5.1	2.8	5.7	7.7	5.5	10.4	12.2	4.7	3.0	11.7	9.8	49.9	10.8	9.4	5.0	6.0	4.6	9.3	8.5	8.3	7.0	5.6	6.9	2.5	11.7	7.9	10.1	5.9	5.0	11.8	2.9	6.1	5.7	4.4	48.5	4.4	6.1	3.6	8.4	5.6	14.6	5.2	17.1	20.7	5.3	2.4	4.5	4.4	2.5	5.7	9.5	15.5	10.8	6.6	5.5	5.8	37.8	18.0	5.5	3.1	7.1	4.7	10.3	3.4	3.4
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318631-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 498.6;choroid plexus: 136.2"	"Cell type enriched"	"Detected in some"	51	"Oligodendrocytes: 290.9"	"Cancer enriched"	"Detected in some"	4	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HAP1: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	0.7	0.2	212.4	2.3	342.3	18.8	0.5	312.8	386.9	0.5	136.2	0.7	0.5	0.4	0.1	0.4	0.4	0.8	0.3	208.7	266.4	0.5	0.5	2.4	3.3	408.3	313.2	0.2	0.3	0.0	0.4	0.1	391.8	0.3	0.9	0.6	1.7	0.3	0.4	0.7	3.8	0.3	266.5	4.7	1.3	0.5	300.8	1.6	0.4	0.0	3.0	0.7	0.3	498.6	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.3	0.0	1.9	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	3.5	0.4	0.2	0.7	2.3	0.2	0.1	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.5	0.0	0.1	0.0	0.3	0.6	1.2	0.0	0.2	0.1	0.3	0.6	3.4	2.5	0.6	1.7	0.9	0.9	0.5	0.3	0.3	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.3	0.3	0.6	0.5	0.2	0.3	0.2	0.1	212.4	342.3	312.8	386.9	208.7	266.4	408.3	313.2	391.8	266.5	300.8	498.6	0.1	0.0	1.3	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.8	0.2	0.0	1.2	0.9	0.1	0.0	2.2	0.0	1.9	1.1	0.0	3.1	2.0	290.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751586	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.9;placenta: 10.8"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 74.4;Extravillous trophoblasts: 102.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 46.9;hTCEpi: 32.5;RPTEC TERT1: 24.2"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		6000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.1	0.5	1.0	0.2	0.7	0.0	0.9	0.7	1.2	0.8	0.7	0.2	0.2	0.6	0.6	1.2	0.5	0.2	2.6	0.8	0.8	3.5	0.1	0.6	0.2	0.9	0.7	1.3	0.5	12.9	0.0	10.8	1.0	0.4	0.4	0.0	0.4	0.8	0.0	0.3	0.1	0.2	0.9	0.5	0.4	0.7	0.8	0.0	0.4	0.0	0.4	0.5	0.6	1.0	7.6	0.3	1.5	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	46.9	9.9	0.0	1.0	0.1	0.7	0.5	0.0	3.4	0.0	0.0	0.4	0.0	0.1	0.5	0.6	0.0	0.0	2.1	32.5	0.0	4.8	0.0	0.0	0.0	2.7	0.0	0.1	0.5	0.0	0.0	3.1	3.0	1.4	0.0	0.0	0.0	24.2	0.7	2.0	0.4	3.1	1.3	0.0	4.7	4.1	0.7	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.7	1.2	0.8	0.8	0.9	0.7	1.0	0.9	0.8	1.0	0.1	0.0	0.0	0.0	0.5	0.5	1.8	2.3	2.2	0.0	2.2	1.9	2.9	0.0	0.6	7.3	0.0	74.4	0.0	0.1	0.0	2.5	4.2	0.6	0.9	1.3	0.0	0.0	0.4	0.8	102.9	1.5	0.0	1.7	0.0	2.6	0.0	0.0	7.4	0.0	0.2	0.3	2.0	0.0	0.0	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	3.7	0.0	3.0	0.1	0.0	0.0	0.2	0.5	0.2	0.4	2.8	0.1	17.4	0.0	0.2	0.4	1.4
ERVV-1	"ENVV1, FLJ32214, HERV-V1"	ENSG00000269526	"Endogenous retrovirus group V member 1, envelope"	B6SEH8	19	53013921-53016122	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 16.0"	"Cell type enriched"	"Detected in some"	28	"Syncytiotrophoblasts: 260.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.6;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 7.9;SuSa: 6.2"									HPA076115			Approved	Centrosome,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Centrosome	"HPA076115: "	"unprognostic (1.04e-3)"			"unprognostic (7.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"		"unprognostic (1.67e-2)"		"unprognostic (9.92e-2)"		"unprognostic (6.75e-2)"	"unprognostic (4.34e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.35e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	260.9	0.0	0.0	0.0	0.0
ERVV-2	ENVV2	ENSG00000268964	"Endogenous retrovirus group V member 2, envelope"	B6SEH9	19	53044740-53051680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"placenta: 8.4"	"Cell type enriched"	"Detected in single"	4	"Syncytiotrophoblasts: 3.8"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 16.9;SuSa: 10.9;T-47d: 4.6;U-266/84: 2.8"									HPA076115			Approved	Centrosome,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Centrosome	"HPA076115: "				"unprognostic (3.14e-3)"		"unprognostic (2.06e-1)"				"unprognostic (1.31e-1)"			"unprognostic (4.33e-9)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.60e-4)"	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	10.9	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0
ESAM	W117m	ENSG00000149564	"Endothelial cell adhesion molecule"	Q96AP7	11	124752583-124762290	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 405.9;Endothelial cells: 301.0;Hepatic stellate cells: 138.1;Sertoli cells: 151.2;Smooth muscle cells: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.2;naive B-cell: 7.5"	"Group enriched"	"Detected in many"	9	"B-cells: 7.5;granulocytes: 8.2;T-cells: 2.2"	"Group enriched"	"Detected in many"	10	"HEL: 218.8;HUVEC TERT2: 277.9;TIME: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056293, HPA072563"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		82000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Cell Junctions"	Cytosol	"HPA056293: AB_2683089, HPA072563: "	"unprognostic (1.52e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.06e-2)"	97.5	17.7	38.4	9.0	37.7	1.9	79.4	38.8	46.9	33.3	30.1	20.0	7.0	36.2	7.8	21.8	34.2	20.0	83.0	35.2	38.7	63.6	11.5	112.5	8.7	40.9	38.9	14.4	13.6	13.2	14.8	106.9	44.0	19.8	7.8	2.5	15.6	15.6	27.1	18.2	20.9	29.4	37.3	17.3	23.4	4.3	45.4	5.4	95.9	49.8	8.3	30.8	30.2	37.8	1.2	1.6	0.4	1.2	0.0	0.3	5.1	0.1	0.1	0.0	0.1	2.7	14.1	1.2	3.2	0.0	0.2	0.0	3.7	0.0	0.0	1.8	1.3	218.8	0.1	8.0	0.6	0.4	3.6	0.0	0.0	0.0	0.0	0.2	277.9	0.1	0.2	5.9	0.5	1.8	0.0	0.0	0.6	20.8	2.1	0.0	1.0	0.9	0.0	2.4	0.2	0.8	0.1	16.1	0.0	7.5	3.3	0.8	142.0	0.4	0.4	0.5	0.0	0.2	0.2	0.2	0.1	0.5	0.4	8.2	0.6	0.0	0.1	0.3	0.0	2.1	1.5	0.1	0.4	7.5	2.2	0.8	6.5	0.0	0.0	0.4	0.4	24.8	38.4	37.7	38.8	46.9	35.2	38.7	40.9	38.9	44.0	37.3	45.4	37.8	405.9	38.5	56.0	2.0	4.5	15.2	0.5	0.2	2.8	18.5	2.5	3.2	11.2	0.0	3.0	14.7	4.2	1.8	2.5	3.5	5.9	7.6	5.0	1.1	1.5	301.0	0.0	5.3	1.5	2.4	18.7	13.8	3.6	1.4	3.8	0.1	138.1	1.7	1.1	0.0	0.4	0.4	0.0	5.3	22.1	26.3	0.9	25.7	12.4	20.6	1.2	0.7	0.0	0.5	0.4	46.5	2.1	0.4	2.8	1.8	0.1	0.1	1.9	1.3	151.2	4.6	89.4	0.1	0.9	0.8	10.9	37.1	2.0	2.4	1.6	2.3
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 36.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 13.7;Early spermatids: 14.1;Horizontal cells: 55.5;Late spermatids: 37.6;Rod photoreceptor cells: 40.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;K-562: 5.0;U-266/70: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA074772			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA074772: "	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.9	0.3	0.6	6.6	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	36.5	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.1	2.4	1.2	0.9	0.1	0.0	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.2	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.2	2.3	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.3	0.6	1.5	1.2	0.7	0.6	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.4	5.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	13.7	0.0	14.1	0.0	0.0	0.8	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	2.0	0.0	0.0	0.0	0.0	37.6	0.0	0.1	0.0	3.7	0.0	4.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.3	0.0	0.1	0.8	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ETNK1	"EKI, EKI1"	ENSG00000139163	"Ethanolamine kinase 1"	Q9HBU6	12	22625075-22690665	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 299.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010712, HPA029407"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA010712: AB_2668349, HPA029407: AB_2673026"	"unprognostic (2.06e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.98e-3)"	"unprognostic (8.30e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.53e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.75e-4)"	10.1	14.4	13.7	14.5	15.2	12.2	13.7	9.0	15.9	10.8	16.4	27.2	23.3	10.2	19.6	10.8	10.1	14.0	7.3	14.7	28.1	18.4	18.2	12.6	17.4	12.0	14.2	11.7	10.7	10.8	13.7	11.3	15.8	10.9	15.3	18.2	12.4	6.2	6.2	15.3	15.5	7.6	11.1	16.7	45.0	17.8	19.3	23.1	14.5	5.6	14.3	10.8	9.5	17.5	14.8	27.9	30.4	27.5	21.2	21.3	21.7	15.6	12.2	17.4	16.0	20.6	33.3	41.1	14.7	11.6	16.5	10.7	27.1	7.6	28.2	36.8	23.7	34.7	11.5	18.9	20.6	33.9	29.4	13.7	7.2	21.9	17.4	25.8	20.3	15.7	41.8	17.2	22.3	7.7	38.8	67.1	59.3	17.9	20.1	32.7	28.1	32.9	25.6	16.5	9.8	17.8	18.9	13.9	27.1	41.1	24.1	32.1	17.5	12.2	19.9	18.6	25.0	12.9	18.1	46.8	16.2	21.0	23.9	44.0	14.3	15.9	15.4	22.0	15.2	22.2	16.4	14.4	14.1	15.3	17.7	17.7	14.6	17.7	23.4	12.6	20.5	19.2	13.7	15.2	9.0	15.9	14.7	28.1	12.0	14.2	15.8	11.1	19.3	17.5	33.6	48.1	32.2	48.0	55.9	144.3	75.7	34.7	64.9	41.0	56.8	42.2	10.1	45.8	43.8	44.1	50.1	30.1	57.6	116.1	27.4	30.7	299.0	64.2	49.1	34.8	108.3	48.8	104.4	44.5	24.2	38.2	230.4	51.4	34.8	40.9	28.2	41.5	42.9	26.9	104.3	60.7	46.8	88.3	60.0	43.5	24.2	57.0	67.6	84.3	39.1	17.7	43.3	121.2	152.9	39.5	62.9	21.4	63.7	73.8	57.7	33.2	81.6	39.5	39.5	23.3	38.9	49.1	18.5	51.9	170.2	75.4	49.0	41.5	47.8	90.3
ETV6	TEL	ENSG00000139083	"ETS variant transcription factor 6"	P41212	12	11649674-11895377	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 137.2;Microglial cells: 216.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 85.1;NB-4: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000264	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Cytosol	"HPA000264: AB_611466"	"unprognostic (4.03e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (9.38e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.66e-8)"	"unprognostic (1.33e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.54e-5)"	16.9	8.8	4.8	16.3	4.4	40.9	20.0	4.8	5.6	9.4	3.6	15.2	7.5	7.9	11.1	9.5	8.0	9.7	6.6	4.2	4.7	9.2	9.3	16.2	12.8	9.2	6.0	5.0	9.6	5.6	5.3	8.1	6.9	13.5	11.2	2.6	33.3	6.8	5.5	24.3	14.1	9.2	6.8	16.7	8.4	3.5	6.8	17.3	8.9	2.7	14.7	15.0	8.4	6.3	5.6	7.5	6.7	11.6	5.0	4.7	8.1	4.1	6.9	5.2	6.1	0.5	25.9	4.7	4.0	7.0	6.1	7.1	3.0	12.4	6.2	85.1	1.4	29.9	4.0	2.8	6.2	32.0	31.2	9.3	7.5	5.1	10.5	9.9	15.9	21.3	2.3	15.3	4.7	3.6	18.1	45.3	10.9	5.9	2.0	5.1	6.3	12.3	11.9	34.8	1.3	6.8	8.1	7.7	7.7	10.6	2.6	19.9	18.1	11.6	9.8	3.9	8.8	6.7	5.5	2.6	7.6	0.2	13.6	6.2	4.5	5.9	1.1	5.6	1.6	2.3	1.7	1.1	3.5	1.7	1.0	0.6	9.8	2.1	6.8	5.3	1.2	1.2	4.8	4.4	4.8	5.6	4.2	4.7	9.2	6.0	6.9	6.8	6.8	6.3	38.3	6.4	9.6	84.2	37.7	14.9	31.8	27.2	10.8	3.1	66.7	57.8	9.1	21.5	30.7	14.7	6.2	15.0	21.5	45.7	1.9	17.9	17.6	45.3	17.5	37.5	32.4	33.6	63.6	35.9	4.3	12.9	20.9	69.7	10.8	24.0	38.6	10.9	18.3	0.0	117.7	28.9	22.4	53.3	137.2	4.5	7.8	62.6	28.4	216.4	55.7	4.3	8.2	106.6	37.0	38.6	31.6	10.9	71.4	34.2	15.4	11.5	39.3	3.9	19.7	17.6	34.2	0.6	5.4	17.3	22.4	8.6	20.9	21.5	22.5	71.8
EVA1B	"C1orf78, FAM176B, FLJ10647"	ENSG00000142694	"Eva-1 homolog B"	Q9NVM1	1	36322031-36324154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 143.9;Extravillous trophoblasts: 250.3;Syncytiotrophoblasts: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.3;BJ: 29.0;BJ hTERT+: 22.4;HSkMC: 20.4;NB-4: 41.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041928, HPA043537"	Approved		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA041928: AB_2677752, HPA043537: AB_2678538"	"prognostic favorable (4.58e-4)"	"unprognostic (5.66e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.79e-5)"	"unprognostic (1.87e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	26.8	19.4	5.5	3.4	5.4	2.0	35.8	5.5	6.4	41.8	7.5	19.8	2.5	34.0	0.6	12.2	21.9	1.3	19.9	5.0	5.9	39.2	8.5	26.1	1.9	6.8	6.4	30.2	7.8	1.9	9.4	9.0	6.0	29.0	0.4	0.0	28.7	2.9	5.7	24.0	15.8	1.6	7.0	37.6	14.2	7.5	6.6	0.5	33.9	1.0	0.5	22.0	30.1	5.7	0.7	2.7	1.6	3.0	7.9	23.3	6.8	29.0	22.4	5.4	6.3	0.2	2.1	0.0	8.5	9.2	1.0	0.2	0.2	1.1	1.1	3.3	6.0	3.6	0.6	1.3	17.4	0.1	0.6	20.4	0.0	6.9	0.3	0.9	8.7	0.1	1.4	1.0	3.6	0.2	0.1	41.7	1.7	0.0	10.4	1.5	0.3	7.1	4.6	0.0	0.1	3.9	2.8	1.1	13.3	1.1	0.0	2.7	12.7	7.9	0.0	10.5	2.7	0.3	0.0	0.1	2.9	1.8	7.1	4.0	0.9	0.0	0.2	0.3	0.6	0.0	0.3	0.5	0.5	0.0	0.0	0.0	1.7	1.6	0.1	0.0	1.2	0.1	5.5	5.4	5.5	6.4	5.0	5.9	6.8	6.4	6.0	7.0	6.6	5.7	82.8	0.0	0.0	2.3	6.2	16.2	19.3	7.3	0.0	0.0	143.9	90.6	2.2	1.5	5.1	7.3	0.0	54.7	8.4	0.3	1.9	20.2	7.1	9.4	88.4	53.9	0.0	0.8	0.0	15.2	250.3	56.6	0.0	15.2	4.5	15.7	84.9	0.9	48.7	0.0	0.0	0.1	6.1	41.3	28.8	24.8	50.7	30.4	12.4	5.6	10.2	14.1	4.1	0.0	0.1	28.9	1.1	48.5	7.9	56.6	0.4	7.7	5.6	0.9	26.3	7.8	98.4	8.4	3.3	0.7	12.4	161.3	9.7	58.2	0.5	30.3
EVL	RNB6	ENSG00000196405	Enah/Vasp-like	Q9UI08	14	99971449-100144236	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;NK-cells: 591.2;Rod photoreceptor cells: 438.0;T-cells: 373.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 291.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018849, HPA019536, CAB033987"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"		"CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180"	"unprognostic (1.12e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.43e-1)"	38.8	31.3	130.5	91.9	135.1	50.1	58.1	105.0	185.5	44.4	66.3	46.6	29.2	64.8	49.5	30.6	63.7	42.0	53.0	136.9	108.8	42.6	90.3	63.2	159.0	103.1	110.1	51.6	40.8	19.7	98.6	29.1	106.1	52.1	24.2	204.6	41.2	32.0	33.2	41.0	69.9	62.0	92.5	107.7	43.3	31.6	115.5	179.4	37.9	28.8	126.2	43.1	32.8	121.2	15.2	14.2	107.1	30.3	22.4	58.5	59.7	18.9	26.5	14.2	18.7	0.8	11.4	30.9	24.9	19.2	10.5	0.4	49.0	36.3	16.8	30.4	32.6	51.9	11.5	8.4	18.0	16.2	116.7	31.6	18.9	9.1	35.8	29.3	38.3	117.3	25.5	2.3	15.7	22.7	291.7	89.6	19.7	13.1	21.8	65.4	58.7	5.5	17.2	0.6	120.8	73.1	14.3	22.0	7.2	24.6	17.7	47.4	27.7	11.2	16.5	66.9	12.8	55.3	44.1	87.9	14.9	27.1	19.7	2.3	2.6	27.4	20.2	13.9	15.1	9.6	22.6	19.2	4.3	13.2	26.3	24.4	0.6	18.0	16.5	0.8	41.4	10.6	130.5	135.1	105.0	185.5	136.9	108.8	103.1	110.1	106.1	92.5	115.5	121.2	26.4	28.9	42.3	45.1	155.2	20.8	22.2	10.8	12.0	125.4	70.4	50.5	4.7	22.8	14.2	12.9	402.4	22.6	215.3	1.0	31.3	12.9	4.2	40.1	51.9	47.5	8.4	31.1	119.9	14.0	12.0	30.5	20.4	26.2	17.1	45.1	39.3	102.2	144.8	77.4	121.1	3.7	8.2	82.5	76.6	12.0	24.8	92.5	26.6	100.2	42.0	89.1	591.2	86.0	66.1	11.6	2.9	49.7	53.3	17.4	2.6	14.2	41.9	438.0	6.6	29.8	33.9	14.1	28.4	8.7	31.4	14.6	373.3	13.5	3.8	15.9
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853648-55905086	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: AB_2679125"	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (5.50e-5)"	19.7	16.5	18.1	17.3	20.4	12.7	20.0	20.4	20.0	18.9	18.7	18.0	16.8	16.6	20.4	29.3	16.5	15.5	16.5	18.3	20.0	15.9	10.2	17.4	18.3	21.1	19.2	15.1	12.9	20.5	14.5	20.8	20.3	14.3	19.1	18.5	17.4	12.8	13.6	28.1	16.2	15.7	20.4	20.8	15.6	16.9	20.1	13.9	16.3	13.5	20.0	16.2	20.1	25.1	21.8	12.4	21.9	25.3	36.9	45.9	14.6	30.2	30.1	24.1	25.1	8.6	37.1	20.9	20.6	32.6	29.1	25.4	18.0	23.9	34.5	11.1	12.4	19.4	14.8	10.1	34.7	21.3	26.4	37.4	32.1	25.1	27.6	31.2	39.9	16.0	28.3	20.1	53.0	13.8	15.6	21.5	13.9	31.2	23.4	18.0	16.4	17.1	26.9	23.6	16.2	28.7	18.0	29.2	25.5	18.5	18.6	22.6	48.5	29.7	24.2	25.8	26.3	23.9	12.7	18.4	38.6	23.4	28.8	21.3	14.6	13.1	6.5	19.0	8.8	8.4	9.2	9.5	14.3	8.3	8.3	6.0	19.5	12.5	23.6	6.4	11.6	7.9	18.1	20.4	20.4	20.0	18.3	20.0	21.1	19.2	20.3	20.4	20.1	25.1	44.7	41.7	38.0	77.4	24.5	34.8	14.8	34.0	22.2	48.8	26.4	21.2	29.1	17.2	35.6	22.0	31.3	60.8	21.4	38.3	19.6	23.6	45.3	41.0	47.5	39.0	22.2	19.6	72.6	20.0	31.6	28.9	22.4	37.2	36.7	35.5	40.0	12.3	40.9	28.6	86.5	28.8	24.4	37.7	47.4	16.7	21.5	37.8	40.9	56.2	38.7	40.3	22.6	73.4	138.0	36.2	32.4	23.7	19.0	17.4	37.6	21.9	44.7	32.5	32.9	25.9	27.9	47.6	31.6	42.5	39.9	51.2	27.8	44.6	28.7	26.8
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"		19	45212370-45245407	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"kidney: 19.0;thyroid gland: 17.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 15.3;Endothelial cells: 17.7;Hepatic stellate cells: 51.4;Theca cells: 21.2"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 19.1;K-562: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: AB_2684431"																		4.3	8.3	0.3	2.1	0.6	1.6	2.9	0.5	0.4	4.0	1.6	2.7	2.4	4.9	0.4	1.9	2.8	2.3	2.3	0.4	0.3	19.0	2.7	2.7	1.1	0.7	0.5	0.9	2.7	3.3	5.0	0.4	0.5	5.2	0.7	0.1	1.8	2.2	0.9	2.1	3.2	1.9	0.3	8.3	2.9	3.3	0.4	0.4	17.9	0.3	0.5	3.2	2.4	0.7	0.1	0.3	2.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.1	2.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	19.1	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	16.6	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.5	1.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.0	0.1	0.3	0.6	0.8	1.5	0.2	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.4	0.4	0.3	0.7	0.5	0.5	0.3	0.4	0.7	15.3	0.0	1.3	0.7	0.7	0.4	0.3	0.0	0.0	0.7	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	17.7	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.2	0.0	0.4	51.4	0.3	0.0	0.0	1.1	0.6	0.0	1.6	0.0	0.0	1.8	2.8	0.0	0.0	0.1	0.2	2.1	0.5	0.7	0.0	0.0	1.9	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.6	0.4	6.2	0.2	0.9	0.0	0.1	21.2	0.0	0.3
EXOC6B	"KIAA0919, SEC15B, SEC15L2"	ENSG00000144036	"Exocyst complex component 6B"	Q9Y2D4	2	72175984-72826041	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 210.3;Excitatory neurons: 351.1;Inhibitory neurons: 393.6;Microglial cells: 286.7;Oligodendrocyte precursor cells: 288.5;Oligodendrocytes: 863.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034546, HPA063991"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034546: AB_2674218, HPA063991: AB_2685168"	"unprognostic (5.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.29e-2)"	11.3	13.4	22.3	4.2	32.7	1.2	8.6	18.8	23.9	12.6	3.2	8.6	7.3	10.1	6.0	15.1	7.8	6.5	50.7	20.7	25.7	7.2	3.8	7.2	3.1	23.9	25.7	15.0	5.0	13.2	6.1	13.0	23.3	8.0	5.7	14.1	7.7	8.9	11.1	26.5	9.1	10.0	16.4	5.2	6.9	6.9	22.2	4.4	10.2	11.5	6.4	9.7	13.0	40.9	21.7	16.3	14.7	17.8	41.2	16.9	25.3	15.6	21.9	13.2	8.6	22.3	3.3	5.6	9.5	26.2	19.6	35.4	12.4	25.7	18.9	4.2	10.1	16.7	11.0	12.8	22.2	2.4	5.5	14.6	36.6	14.9	23.1	20.6	21.8	8.7	1.8	0.0	17.6	7.5	6.4	2.9	15.3	14.9	9.0	3.4	26.4	2.3	12.7	50.1	7.3	6.3	26.7	8.2	10.9	16.1	5.7	2.3	24.3	15.2	12.8	13.1	9.6	5.5	5.9	0.0	17.7	1.2	12.4	1.3	0.5	0.0	0.7	0.4	0.5	0.7	0.5	0.4	0.4	0.7	0.6	0.9	0.0	0.5	0.6	0.1	0.8	0.4	22.3	32.7	18.8	23.9	20.7	25.7	23.9	25.7	23.3	16.4	22.2	40.9	17.8	0.0	4.1	210.3	4.1	26.1	10.2	9.8	14.8	17.4	5.2	5.2	87.1	12.8	5.1	9.2	25.0	15.1	5.0	10.2	5.9	9.3	62.9	5.6	14.5	14.1	3.0	2.1	351.1	11.5	13.2	12.4	30.5	9.2	8.2	11.6	11.4	5.6	4.6	16.8	393.6	6.0	4.1	12.0	7.1	8.2	8.4	5.0	5.4	286.7	2.0	9.9	1.0	288.5	863.3	11.0	8.6	7.5	3.7	8.1	28.2	5.5	8.4	11.1	0.0	13.5	14.7	12.0	4.9	13.1	37.4	24.6	4.7	5.5	4.5	10.7
EXOC7	"BLOM4, EXO70, Exo70p, KIAA1067, YJL085W"	ENSG00000182473	"Exocyst complex component 7"	Q9UPT5	17	76081016-76121576	"Human disease related genes, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022840, HPA022842"	Supported		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Vesicles, Plasma membrane"	"HPA022840: AB_1848316, HPA022842: AB_1848317"	"unprognostic (5.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-1)"	40.4	31.4	36.0	32.7	37.0	53.2	31.2	31.4	36.7	39.3	34.1	40.1	32.5	40.1	33.1	52.3	52.3	35.4	47.2	36.8	35.5	31.9	30.2	35.9	32.7	35.4	34.3	49.6	41.1	61.2	41.0	35.3	36.5	48.1	27.9	24.7	50.6	43.1	43.0	37.0	34.7	43.5	31.9	32.4	30.3	24.9	36.4	43.5	43.0	41.4	32.3	44.3	30.1	34.8	65.6	79.4	71.9	58.5	66.6	47.0	74.5	58.9	77.6	103.9	74.7	67.5	43.0	33.7	42.0	103.0	65.6	52.7	43.9	57.1	69.0	29.3	59.1	55.8	64.0	72.3	46.4	62.9	55.7	66.1	44.3	80.5	39.2	73.5	116.9	59.8	38.1	33.7	65.6	59.8	102.1	27.8	37.8	49.5	83.4	54.0	123.3	34.6	59.7	133.6	38.9	91.4	66.5	48.6	44.6	68.8	79.7	51.0	77.5	111.3	66.3	74.1	65.8	46.0	18.2	31.2	66.4	28.0	59.0	55.1	41.1	66.1	35.5	57.4	24.4	26.7	26.9	30.4	28.9	26.9	27.7	23.9	46.2	36.4	79.7	12.3	32.0	44.9	36.0	37.0	31.4	36.7	36.8	35.5	35.4	34.3	36.5	31.9	36.4	34.8	31.0	19.2	35.0	36.6	37.7	19.8	40.1	40.8	31.3	87.6	30.2	28.8	7.5	28.6	41.4	40.5	143.9	51.5	37.5	47.6	33.2	38.3	22.4	35.1	25.8	27.1	48.9	48.6	26.2	37.1	29.0	31.6	27.0	34.4	41.1	65.0	30.7	27.0	37.7	67.3	31.1	43.8	54.9	29.6	21.3	52.2	37.3	26.9	24.9	15.0	36.8	52.1	56.7	44.2	35.0	44.6	41.4	38.4	15.7	41.5	62.8	35.3	43.7	108.8	46.0	27.8	49.5	32.1	16.6	20.3	19.9	71.1	35.8	56.6	29.8	44.8
EXOC8	"EXO84, Exo84p, SEC84"	ENSG00000116903	"Exocyst complex component 8"	Q8IYI6	1	231332753-231337852	"Human disease related genes, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027438	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA027438: AB_1848318"	"unprognostic (3.85e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	6.1	5.4	3.0	7.9	3.1	16.9	6.7	4.8	3.9	5.2	2.9	5.0	5.9	4.5	4.8	5.5	4.8	5.0	5.2	3.3	4.2	5.9	6.2	5.9	9.2	3.1	2.7	7.0	6.3	8.7	2.9	6.5	3.4	5.5	4.7	7.5	5.4	3.8	14.1	5.9	6.3	4.4	2.5	8.3	6.8	4.1	3.7	7.4	8.4	9.8	9.1	5.3	3.7	3.7	8.2	9.0	5.4	5.4	13.9	11.2	13.0	10.0	8.4	7.4	7.0	8.6	8.1	9.4	8.6	10.1	6.6	13.2	7.9	10.8	8.1	12.2	19.0	5.7	11.8	5.5	7.8	10.1	15.2	11.3	11.7	11.0	10.4	8.7	9.2	9.6	10.6	21.9	12.0	4.3	9.4	6.2	8.2	10.4	7.6	6.1	8.3	12.0	9.3	9.5	7.1	7.6	10.1	13.1	10.1	4.3	12.5	14.5	12.6	9.9	7.0	13.3	17.7	16.2	9.9	10.1	11.3	8.9	12.7	1.7	0.7	1.3	0.4	0.8	0.5	0.4	0.6	0.5	0.5	0.5	0.7	1.2	2.2	0.8	1.6	0.7	0.6	0.5	3.0	3.1	4.8	3.9	3.3	4.2	3.1	2.7	3.4	2.5	3.7	3.7	10.0	9.6	9.8	2.0	10.9	18.5	5.6	4.0	8.0	4.3	8.1	5.5	8.9	11.5	8.3	9.2	6.2	4.6	10.4	6.7	1.9	3.3	1.6	8.1	9.0	9.3	4.8	7.4	5.3	3.5	2.8	8.2	14.3	10.4	2.5	4.3	6.8	9.6	5.8	3.3	5.9	3.7	2.0	13.3	7.1	1.1	4.1	7.6	3.6	3.7	5.7	5.8	5.2	2.5	6.6	5.0	1.2	5.7	7.9	6.0	6.9	5.2	5.6	12.3	0.0	8.4	5.2	5.1	5.0	11.0	14.8	9.3	10.0	4.6	4.2	8.6
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895179	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 214.1;Theca cells: 328.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		80000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	8.8	24.6	11.4	5.0	15.0	2.2	11.5	12.0	16.4	13.9	19.1	10.8	4.8	18.1	13.7	6.5	10.9	11.4	9.2	10.3	15.4	12.9	12.6	8.4	4.2	12.9	14.9	19.6	9.0	14.6	12.9	24.9	13.7	13.4	7.6	13.9	7.1	11.9	6.9	6.5	5.4	17.0	11.2	6.5	7.3	10.7	17.8	8.2	10.1	7.1	3.7	9.2	6.9	11.3	13.0	6.9	50.2	50.7	53.2	39.3	31.4	23.2	37.5	17.5	39.4	6.1	9.9	15.2	21.8	20.9	13.5	12.7	18.3	19.6	35.4	31.8	13.4	19.0	23.6	18.3	17.5	28.9	9.3	47.3	6.8	35.9	6.6	36.5	65.0	19.2	23.9	2.0	45.1	6.9	15.5	15.5	62.2	12.2	15.5	11.2	51.5	12.1	18.4	9.7	20.6	57.5	17.4	4.6	42.0	35.8	10.9	12.7	27.7	44.0	25.8	27.8	24.4	15.5	15.0	9.8	69.2	29.3	14.4	2.0	0.5	0.0	3.4	0.7	1.5	1.2	1.1	2.3	1.7	1.7	1.2	2.7	0.1	3.9	0.5	4.6	0.0	1.2	11.4	15.0	12.0	16.4	10.3	15.4	12.9	14.9	13.7	11.2	17.8	11.3	12.3	12.8	8.4	39.8	4.9	8.5	10.2	13.8	21.1	20.7	13.2	13.5	12.7	10.0	11.0	14.7	35.5	214.1	5.0	3.3	11.7	5.8	45.3	20.3	28.7	13.1	9.5	16.2	47.1	2.1	36.9	36.0	15.3	11.0	17.7	35.3	13.6	16.4	24.3	3.3	49.9	5.6	12.2	7.3	5.7	34.9	25.1	5.8	23.2	12.2	7.4	18.8	8.2	40.7	32.9	2.4	2.6	34.6	5.9	6.2	2.9	11.9	25.3	19.7	13.1	25.4	22.4	37.1	12.3	8.5	8.1	74.3	6.1	328.5	7.1	4.9
FAAH	FAAH-1	ENSG00000117480	"Fatty acid amide hydrolase"	O00519	1	46394317-46413848	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 128.5;Proximal enterocytes: 87.4;Spermatocytes: 89.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 29.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 37.5;OE19: 18.8;RT4: 42.4;SK-BR-3: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007425	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA007425: AB_1078820"	"unprognostic (6.12e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.39e-3)"	"unprognostic (9.86e-2)"	"prognostic favorable (4.25e-5)"	"prognostic favorable (3.63e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.00e-3)"	7.5	14.2	23.5	2.9	28.4	10.4	9.5	25.6	29.6	7.5	29.3	18.9	22.0	3.9	9.1	8.7	12.0	5.2	5.0	24.6	23.3	20.0	32.8	7.8	2.5	32.1	25.4	3.9	22.4	24.6	19.0	3.4	28.7	44.1	15.2	5.5	17.4	7.1	9.5	12.1	22.0	2.3	27.9	3.3	17.1	46.8	26.4	7.1	38.6	5.6	2.7	6.9	8.2	45.8	5.0	1.2	0.8	1.0	1.2	0.8	37.5	1.0	0.5	0.5	0.8	7.3	11.4	0.3	3.9	0.7	0.4	16.2	0.7	2.3	0.2	2.2	5.4	0.1	0.2	3.5	0.8	1.4	2.8	0.6	10.7	0.4	1.3	0.4	0.0	0.9	0.1	0.8	0.0	10.7	0.8	2.2	3.2	18.8	0.4	0.9	0.4	0.2	9.0	42.4	4.8	3.6	5.6	21.2	0.2	0.9	14.6	14.5	0.0	0.1	0.6	1.1	0.7	2.1	1.0	0.6	0.1	13.4	0.4	0.0	6.9	29.1	0.4	1.9	0.2	0.1	0.4	0.2	8.2	0.1	0.6	0.6	0.4	0.5	1.0	8.8	0.2	1.4	23.5	28.4	25.6	29.6	24.6	23.3	32.1	25.4	28.7	27.9	26.4	45.8	1.2	22.4	13.2	6.5	2.4	5.2	29.0	6.8	10.2	15.5	15.4	9.0	2.9	27.1	11.0	22.0	43.8	16.3	7.3	51.6	0.0	12.4	50.7	9.5	1.9	1.8	15.5	6.6	15.7	6.4	8.7	3.7	37.8	6.0	0.0	6.3	0.4	37.1	2.8	1.7	11.4	38.2	10.2	2.5	4.2	128.5	7.5	3.3	5.4	1.9	2.5	7.3	0.0	7.5	45.1	4.2	41.3	4.5	0.7	20.1	87.4	22.6	5.2	14.5	0.0	2.9	3.2	89.0	23.0	6.4	6.0	12.4	1.2	1.3	55.2	18.9
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322138	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"intestine: 550.0"	"Cell type enriched"	"Detected in some"	10	"Proximal enterocytes: 5965.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 1.6;neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		61000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.2	0.1	0.1	3.1	0.1	0.9	0.0	0.6	0.2	0.0	0.4	28.2	291.0	0.3	0.1	0.1	0.2	0.1	0.6	0.2	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.3	0.0	0.0	0.1	0.4	550.0	1.9	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.3	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.6	0.4	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.2	4.2	0.4	0.1	0.3	0.3	0.0	0.1	0.1	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.8	0.0	0.0	0.0	242.0	0.0	0.0	0.0	1.4	0.1	0.1	1.2	0.0	0.0	0.2	0.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	570.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	383.1	0.0	0.0	0.0	5965.8	17.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	222.5	0.0
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 301.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.8;Proximal tubular cells: 305.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 23.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	99.2	65.4	16.0	7.0	17.1	20.0	59.0	16.6	21.1	19.2	15.1	13.8	14.6	19.3	50.4	15.2	23.0	9.7	20.3	16.3	18.8	65.0	301.5	20.0	5.7	17.9	19.6	26.4	9.9	18.4	16.8	7.8	16.9	16.6	11.9	1.6	14.8	13.6	31.0	10.9	16.8	13.5	17.2	19.1	14.2	20.8	17.4	6.7	14.5	27.7	5.8	16.4	15.8	17.5	20.1	34.4	13.5	17.0	60.2	62.2	32.9	24.3	56.8	26.2	22.3	22.0	35.9	0.4	39.0	52.6	36.8	29.1	46.8	59.6	25.1	12.5	28.5	166.6	18.0	112.1	316.6	79.6	88.8	107.5	37.1	22.9	39.7	84.2	37.4	38.3	71.1	35.7	50.3	31.0	22.3	42.0	9.9	15.5	37.6	12.2	19.3	123.4	77.0	25.2	0.7	8.3	27.4	76.7	77.9	21.6	58.3	55.0	126.1	46.8	30.0	25.5	42.7	32.7	69.5	13.8	99.6	187.5	26.9	34.5	18.8	3.3	9.6	8.1	2.3	0.1	2.4	6.0	25.3	0.1	3.1	2.7	1.3	5.7	8.4	1.9	2.5	9.7	16.0	17.1	16.6	21.1	16.3	18.8	17.9	19.6	16.9	17.2	17.4	17.5	3.0	3.2	13.8	9.8	4.1	6.8	17.5	30.8	15.4	0.4	19.1	13.7	15.5	21.5	12.5	33.1	0.0	37.9	4.9	9.3	52.8	9.3	7.5	3.0	16.2	3.2	4.2	24.4	0.4	3.5	14.1	16.6	3.6	4.0	41.9	6.3	8.9	266.8	72.5	0.0	2.5	13.0	24.4	21.4	6.6	13.5	9.9	30.5	19.6	1.0	5.7	7.3	3.1	2.5	0.6	4.5	12.8	7.9	5.2	9.7	54.1	305.5	5.3	0.4	0.0	9.2	11.2	1.5	2.1	18.2	5.7	22.0	7.7	8.7	22.4	16.4
FAIM	"FAIM1, FLJ10582"	ENSG00000158234	"Fas apoptotic inhibitory molecule"	Q9NVQ4	3	138608606-138633376	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"retina: 235.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 173.3;Rod photoreceptor cells: 228.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 135.7"					"Low region specificity"	"Detected in all"			"HPA042440, HPA052209"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA042440: AB_2677999, HPA052209: AB_2681761"	"unprognostic (6.45e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (3.96e-5)"	"unprognostic (4.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.63e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.98e-2)"	18.3	8.6	16.8	6.9	17.9	4.1	15.6	17.5	21.3	31.7	14.9	9.3	6.4	12.6	19.5	12.2	38.2	12.1	6.4	16.2	18.6	15.3	8.2	10.5	10.8	18.9	17.7	10.8	38.1	8.5	10.4	8.4	19.4	14.9	7.9	235.0	9.6	21.7	5.4	8.5	6.1	9.7	19.2	4.9	9.8	7.3	17.1	19.8	20.3	5.5	13.7	13.5	10.4	19.9	80.8	15.5	1.7	13.9	14.7	27.2	55.4	24.4	14.7	25.2	21.5	26.8	23.2	0.2	21.0	32.0	29.0	20.9	66.8	13.9	28.2	66.2	69.8	15.1	42.9	39.1	16.3	0.0	4.8	38.4	26.5	9.4	14.4	15.4	27.5	5.7	10.0	20.0	15.8	30.7	0.4	68.3	30.1	2.5	15.3	81.4	18.0	2.1	40.4	39.5	26.0	22.1	43.2	23.8	64.6	16.4	40.1	20.0	16.9	5.1	11.9	25.9	12.0	0.0	0.4	135.7	20.8	0.2	21.0	16.8	2.9	2.2	10.5	3.3	9.6	17.0	5.8	8.4	6.3	12.0	3.8	9.8	0.4	18.8	2.2	4.3	6.9	4.3	16.8	17.9	17.5	21.3	16.2	18.6	18.9	17.7	19.4	19.2	17.1	19.9	16.4	19.2	22.9	9.1	12.7	10.8	30.3	35.2	14.2	31.9	14.3	21.5	5.3	68.6	32.4	25.8	66.7	42.0	14.7	5.9	31.3	63.1	12.0	173.3	29.8	14.5	21.1	7.2	7.7	50.0	33.3	16.8	8.2	41.3	41.2	17.2	8.9	9.4	25.2	15.2	6.1	8.8	14.2	3.2	5.7	16.5	17.4	6.5	16.0	1.9	15.6	45.3	21.6	11.1	16.5	31.3	4.4	19.9	14.2	22.1	2.2	28.1	77.5	228.3	0.0	25.0	22.6	14.1	4.2	16.6	13.1	14.6	10.8	14.6	11.7	21.6
FAM102A	"bA203J24.7, C9orf132, Eeig1, SYM-3A"	ENSG00000167106	"Family with sequence similarity 102 member A"	Q5T9C2	9	127940582-127980989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036030			Approved	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA036030: AB_10670675"	"unprognostic (3.27e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.98e-2)"	11.4	40.6	63.9	35.4	86.8	13.9	19.7	64.4	77.2	52.5	20.3	38.9	55.6	33.5	19.4	61.1	47.5	46.7	14.1	59.0	58.0	37.4	39.0	16.1	59.3	76.5	79.4	20.6	35.1	22.4	51.2	9.0	70.7	23.7	17.5	14.5	44.0	20.1	4.0	45.2	65.7	27.2	60.4	27.3	105.5	32.6	91.2	40.1	23.3	3.9	44.7	37.1	47.0	144.1	26.5	56.7	11.9	9.6	25.1	30.0	45.1	10.1	27.4	6.6	4.1	33.1	46.0	29.8	6.6	19.4	14.2	28.4	6.3	5.1	2.5	14.4	6.3	8.9	14.5	30.1	15.6	4.4	66.3	12.2	26.0	18.9	8.0	13.3	9.2	18.0	7.4	36.7	7.7	68.6	17.8	9.5	14.8	52.0	27.4	9.2	8.8	10.7	19.1	44.3	18.7	9.2	16.7	36.9	23.9	12.8	69.3	5.7	9.8	10.3	11.1	55.1	15.5	49.1	72.7	20.7	44.7	5.9	24.9	0.7	0.1	2.5	1.9	0.0	6.1	4.8	9.7	5.7	0.1	1.1	8.9	6.3	0.1	0.4	0.1	0.0	13.4	3.9	63.9	86.8	64.4	77.2	59.0	58.0	76.5	79.4	70.7	60.4	91.2	144.1	3.3	6.4	9.0	37.5	37.2	21.9	29.4	11.5	24.5	15.6	44.9	26.9	11.4	41.5	14.9	64.4	10.4	6.3	10.7	91.2	7.9	61.5	7.0	51.0	35.8	8.6	28.1	8.0	13.8	100.5	5.9	12.4	99.4	46.0	18.4	22.3	54.7	49.1	3.3	26.9	12.2	42.1	40.7	6.9	8.8	7.4	34.2	3.8	23.2	5.6	4.4	69.0	1.0	26.2	103.5	59.3	51.9	43.2	22.6	69.9	131.9	12.9	33.2	14.3	0.0	6.0	7.4	9.8	10.2	38.6	47.9	5.3	40.3	13.1	28.7	122.4
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.9;Langerhans cells: 43.2;Microglial cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	9.1	3.9	8.1	10.5	9.7	21.2	10.7	5.1	9.2	7.4	0.1	13.3	11.0	6.5	4.2	6.0	5.1	14.7	6.6	9.4	8.6	3.2	4.9	7.8	9.0	4.1	6.8	5.3	3.8	7.5	3.8	5.9	8.1	6.3	14.6	3.6	13.7	7.8	1.3	3.7	11.2	8.8	3.0	8.8	7.6	8.6	5.6	8.7	3.5	6.0	8.2	16.4	4.4	5.0	6.9	4.9	9.7	5.2	17.0	10.2	6.4	4.0	5.4	6.1	10.3	1.8	6.8	7.6	3.6	10.4	6.3	13.1	33.2	1.4	7.8	5.1	4.8	10.6	35.8	0.8	4.3	14.0	19.8	5.5	1.4	9.0	0.5	12.3	4.0	12.5	26.3	41.2	14.4	28.4	9.0	10.0	7.6	16.2	24.6	20.8	24.5	1.6	1.7	7.9	31.4	9.3	15.9	27.4	8.3	6.8	5.8	22.5	0.7	9.8	18.4	8.6	15.5	7.6	1.9	7.1	14.4	10.8	5.3	2.9	0.4	0.4	0.3	0.9	0.2	0.3	0.3	0.4	1.0	0.3	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.1	8.1	9.7	5.1	9.2	9.4	8.6	4.1	6.8	8.1	3.0	5.6	5.0	5.9	0.0	2.2	12.1	6.1	6.1	2.3	1.0	4.6	3.9	10.1	7.2	1.9	10.0	2.2	1.8	0.0	2.4	17.2	15.6	1.9	2.7	15.3	2.1	7.8	5.5	7.2	3.8	54.9	6.1	2.7	16.3	6.6	5.2	7.6	3.6	8.2	1.2	9.7	0.0	27.9	8.1	0.0	25.1	43.2	6.9	14.3	27.5	5.4	52.5	15.2	1.2	11.3	25.1	7.2	4.5	10.5	20.7	11.9	1.9	4.5	1.0	1.8	1.1	0.0	3.2	6.5	4.4	6.4	6.5	3.7	3.4	16.4	36.2	13.8	4.6
FAM104A	FLJ14775	ENSG00000133193	"Family with sequence similarity 104 member A"	Q969W3	17	73207353-73236753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 44.8;testis: 153.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1305.1;Late spermatids: 1771.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021459, HPA079514"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA021459: AB_1848361, HPA079514: "	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	16.6	11.7	13.1	14.1	13.0	44.8	15.3	16.9	14.0	14.4	11.1	14.7	12.6	11.7	12.5	17.8	11.1	10.4	12.4	12.9	11.3	10.8	13.9	12.8	17.8	12.0	11.5	12.2	15.0	12.2	16.0	17.8	11.5	14.1	12.4	14.0	12.3	11.1	17.1	21.6	12.8	11.2	11.4	17.0	21.7	153.0	12.6	20.9	11.8	12.0	16.9	13.4	14.8	13.7	41.8	33.5	16.7	31.0	24.7	23.1	54.1	33.4	34.7	35.9	36.9	28.3	26.3	24.3	26.7	32.2	35.0	26.0	21.4	24.3	38.7	28.6	28.7	35.4	29.1	43.5	32.9	31.1	58.1	24.6	31.6	31.9	23.2	23.7	42.6	28.8	28.0	39.6	43.6	28.5	55.7	21.5	22.9	30.7	42.5	30.1	46.3	23.5	27.6	33.7	27.3	36.1	19.6	28.2	36.7	31.0	39.4	31.8	29.8	42.3	49.1	29.1	39.4	38.5	41.5	29.8	37.9	33.7	31.9	72.4	49.4	87.7	57.1	44.6	55.5	53.5	69.6	65.7	48.8	55.8	50.1	60.9	81.9	68.9	49.8	31.7	128.5	82.5	13.1	13.0	16.9	14.0	12.9	11.3	12.0	11.5	11.5	11.4	12.6	13.7	37.1	9.6	10.2	7.5	24.2	57.0	20.7	42.3	17.6	17.7	22.5	21.1	5.6	22.8	26.9	22.0	6.2	122.3	23.0	20.8	31.3	32.7	1305.1	21.9	16.0	23.9	19.8	103.6	14.2	25.3	70.1	19.4	28.5	24.6	29.2	20.4	18.2	18.5	35.6	26.9	14.1	22.9	26.4	21.8	34.2	1771.9	35.1	25.5	24.9	10.3	32.2	20.2	33.0	10.6	11.3	32.1	20.1	24.0	30.4	32.8	26.4	18.9	27.4	19.7	6.6	14.8	43.7	277.3	60.7	29.9	65.8	324.9	32.7	21.3	20.7	51.8
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127412	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 12.8;Erythroid cells: 9.1;Plasma cells: 8.8;Squamous epithelial cells: 7.1;Undifferentiated cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.3;naive B-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	0.9	0.5	0.5	5.9	0.6	4.8	2.7	2.8	1.8	1.0	0.1	5.6	3.4	1.0	0.5	3.4	0.5	0.8	0.3	0.6	1.1	0.4	2.5	1.1	12.3	0.5	1.0	0.2	0.6	0.9	0.0	1.7	0.7	1.0	5.8	1.3	0.8	0.4	0.4	4.4	4.0	2.0	0.1	1.8	3.2	0.8	0.6	18.0	0.9	0.1	13.3	1.7	1.0	2.1	72.6	18.5	26.6	0.4	2.7	4.9	0.3	53.5	26.7	31.2	46.1	38.7	28.0	89.8	35.4	15.7	26.3	54.7	39.5	36.2	55.2	46.8	9.5	9.8	32.3	16.9	0.1	0.3	11.1	1.2	1.2	30.3	2.4	6.0	16.9	24.1	2.8	81.9	37.2	27.3	57.7	0.6	0.3	43.2	21.0	60.1	39.7	34.7	16.8	61.2	5.2	16.9	44.4	50.8	8.7	9.7	56.2	5.0	9.4	24.1	52.4	73.5	49.6	62.6	48.4	0.6	35.0	0.4	35.4	0.2	0.1	0.1	0.1	0.0	0.1	3.3	0.2	0.3	0.1	2.6	0.1	0.1	1.6	0.0	0.1	0.1	0.7	0.1	0.5	0.6	2.8	1.8	0.6	1.1	0.5	1.0	0.7	0.1	0.6	2.1	0.7	0.0	0.0	0.0	12.8	4.2	2.2	4.2	1.8	0.0	2.5	4.2	0.3	0.0	1.4	0.0	0.0	1.1	1.4	4.0	0.0	0.8	0.0	0.9	1.6	1.2	0.0	9.1	0.0	0.0	0.4	1.5	3.6	1.9	0.0	6.3	0.0	0.2	3.9	0.0	0.0	4.4	2.0	0.3	1.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	1.3	0.0	8.8	0.7	0.5	0.1	1.6	0.0	0.0	1.3	1.8	0.1	1.0	7.1	2.7	0.1	3.2	1.1	10.4	1.6
FAM118A	"bK268H5.C22.4, C22orf8, FLJ20635"	ENSG00000100376	"Family with sequence similarity 118 member A"	Q9NWS6	22	45308968-45341955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 104.0;Early spermatids: 125.0;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003902	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Intermediate filaments"	Cytosol	"HPA003902: AB_1848368"	"unprognostic (6.22e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (9.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.16e-3)"	14.1	11.8	14.9	23.7	16.9	21.5	23.3	22.0	17.1	21.9	25.5	23.3	19.9	17.7	66.5	18.6	12.2	24.4	24.5	17.2	15.6	22.9	17.1	19.3	49.1	14.4	15.3	21.7	14.3	38.3	37.6	18.3	14.4	41.7	12.4	9.5	18.4	9.3	30.5	39.7	24.8	10.3	11.4	25.9	21.3	22.7	17.9	13.6	23.7	6.5	27.6	29.7	22.8	15.8	10.9	7.8	11.0	11.9	9.3	8.9	24.0	8.1	13.4	11.5	11.2	25.6	10.1	48.6	6.5	7.5	6.5	40.7	14.3	10.3	11.5	10.6	31.9	26.3	13.2	18.7	12.8	24.8	7.2	9.5	12.3	17.6	10.8	8.0	7.1	14.6	39.5	52.6	5.9	26.1	14.7	51.3	8.2	49.8	10.4	19.0	7.1	17.4	6.6	28.9	21.8	25.6	8.9	19.0	23.9	18.0	8.2	14.4	9.2	8.8	28.8	10.8	10.8	29.0	5.5	24.7	11.9	17.1	16.0	7.1	7.1	2.2	5.8	6.2	4.7	4.3	7.3	7.2	8.8	6.5	11.5	8.6	5.8	5.6	5.0	13.5	10.9	4.4	14.9	16.9	22.0	17.1	17.2	15.6	14.4	15.3	14.4	11.4	17.9	15.8	12.5	9.6	17.0	23.8	21.2	22.6	36.9	18.8	10.8	18.3	10.9	6.6	11.3	8.6	16.6	7.3	18.8	104.0	83.1	21.4	0.0	7.0	125.0	6.7	15.5	20.7	32.9	14.5	23.1	6.2	8.5	19.2	10.2	7.4	1.3	8.8	23.9	14.5	12.9	6.7	18.3	20.5	12.2	13.0	29.9	75.6	35.8	19.8	1.8	62.8	69.5	16.4	39.1	22.6	21.5	4.8	17.7	23.7	25.8	22.6	13.4	3.9	14.6	22.3	0.0	33.6	14.7	72.5	38.8	8.8	9.9	120.9	55.2	7.3	17.5	35.4
FAM120B	"CCPG, KIAA1838, PGCC1, SAN1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407067	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"Early spermatids: 556.1;Late spermatids: 1847.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (1.60e-4)"	"prognostic favorable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	12.3	12.2	9.3	5.7	8.7	4.5	12.5	11.2	11.2	11.6	9.9	11.5	6.2	12.1	8.9	10.0	12.2	6.1	10.7	7.7	9.0	8.3	8.8	9.4	7.1	10.0	9.8	11.0	9.6	7.1	11.4	6.6	10.3	11.0	8.6	9.2	13.8	6.2	17.4	12.3	10.1	7.6	7.7	10.1	10.2	14.4	9.1	7.4	9.8	6.8	6.6	10.9	10.4	10.5	7.0	7.1	8.7	12.7	15.4	14.2	6.2	6.4	13.4	8.5	7.2	6.4	5.2	8.0	5.2	14.2	9.2	8.2	11.0	13.1	13.0	9.0	5.2	10.5	6.5	8.4	10.5	10.5	6.5	14.0	11.2	9.2	12.2	14.6	15.7	6.3	9.5	7.8	17.0	13.7	6.3	11.8	5.3	12.5	4.8	6.5	9.8	10.3	10.3	6.2	6.0	9.6	6.2	8.7	2.9	13.0	7.0	20.6	13.4	4.2	6.3	11.3	6.4	6.6	7.3	9.9	11.6	7.4	15.9	16.5	5.9	7.5	5.4	6.4	6.3	4.4	5.1	6.1	6.4	5.3	6.4	5.3	10.0	11.9	10.1	3.5	6.6	6.7	9.3	8.7	11.2	11.2	7.7	9.0	10.0	9.8	10.3	7.7	9.1	10.5	17.8	22.4	17.6	36.9	13.2	3.6	5.2	11.1	16.5	16.7	13.7	13.6	15.7	11.5	13.0	14.7	33.3	10.5	7.3	11.8	0.0	8.4	556.1	18.8	16.7	15.4	9.6	11.1	48.8	9.1	7.6	13.1	14.3	22.5	10.1	14.1	10.4	10.7	11.0	6.7	53.2	12.5	12.2	9.8	5.6	1847.0	19.3	10.2	19.6	40.3	8.8	7.7	8.2	50.3	62.6	9.2	6.5	14.3	12.0	9.3	10.1	5.4	19.9	14.2	32.9	12.9	10.1	18.4	12.7	10.8	5.8	13.4	13.9	11.2	8.8	6.4
FAM124A	FLJ30707	ENSG00000150510	"Family with sequence similarity 124 member A"	Q86V42	13	51222334-51284239	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 59.1;choroid plexus: 26.7;retina: 25.7"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 232.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HAP1: 18.0;HUVEC TERT2: 10.6;NTERA-2: 35.1;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048182	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA048182: AB_2680301"	"unprognostic (3.94e-3)"	"unprognostic (8.76e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.38e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.05e-2)"	4.6	1.8	13.2	2.7	32.1	0.2	2.9	24.0	22.0	2.2	26.7	8.1	0.6	3.1	4.6	1.2	3.1	2.4	4.9	14.8	20.8	3.7	0.7	1.9	0.8	33.8	27.4	0.8	1.4	0.6	1.3	3.6	31.3	4.6	1.3	25.7	7.3	4.4	1.0	1.0	2.0	5.2	18.4	8.3	3.3	1.2	25.9	3.1	2.4	1.3	0.5	4.5	1.6	59.1	0.0	1.7	1.2	1.1	0.3	0.1	0.1	0.2	0.6	0.2	0.2	0.1	0.6	0.6	0.0	0.0	2.2	0.1	18.0	0.2	0.1	0.1	2.7	0.1	0.5	0.0	1.4	0.9	1.1	0.4	0.2	0.5	0.0	0.0	10.6	4.8	0.1	0.1	0.0	0.3	4.6	0.3	35.1	0.3	2.8	1.0	0.1	2.6	0.0	0.1	2.5	13.3	0.6	2.2	2.0	2.6	0.3	1.1	0.2	0.1	1.2	0.9	1.3	0.3	0.0	0.0	1.6	3.2	1.5	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	13.2	32.1	24.0	22.0	14.8	20.8	33.8	27.4	31.3	18.4	25.9	59.1	8.5	0.0	0.0	17.6	0.4	0.8	2.1	0.0	0.6	10.2	1.1	1.8	10.8	0.0	0.0	1.8	50.1	0.0	0.8	0.2	3.9	2.6	4.7	0.8	3.5	9.3	0.0	0.0	12.0	0.8	0.0	2.2	0.0	1.6	1.3	0.6	8.6	0.1	0.2	6.7	4.8	0.0	0.0	0.6	0.3	5.8	0.6	1.4	3.6	9.4	0.0	3.6	0.0	10.6	232.9	0.7	0.0	0.4	0.0	2.3	0.0	11.7	1.5	43.6	0.0	1.8	2.0	1.7	1.6	0.1	0.1	0.0	0.6	0.7	0.1	0.5
FAM131C	"C1orf117, FLJ36766"	ENSG00000185519	"Family with sequence similarity 131 member C"	Q96AQ9	1	16057769-16073651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.3;kidney: 14.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 9.2;Distal tubular cells: 19.6;Horizontal cells: 38.7;Muller glia cells: 31.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.8;HEK 293: 5.3;PC-3: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031046	Uncertain		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoli, Intermediate filaments, Cytosol"		"HPA031046: AB_2673711"	"unprognostic (4.69e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (9.33e-6)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.44e-1)"	0.3	6.9	10.3	0.0	13.8	0.0	0.2	40.3	12.3	1.1	3.3	0.3	0.0	0.5	0.2	1.5	0.5	0.3	5.6	8.5	15.3	14.9	0.5	0.0	0.0	15.9	14.4	0.4	3.5	3.3	9.4	0.0	18.4	0.2	0.0	3.1	1.9	0.3	0.1	2.7	0.9	0.1	13.5	0.1	1.0	0.7	13.5	0.1	1.2	0.2	0.3	0.2	0.9	20.8	3.3	7.8	0.2	0.4	0.0	0.0	0.0	0.7	0.6	0.8	1.9	0.2	1.7	0.0	0.3	0.4	1.9	0.9	1.0	0.2	0.2	0.0	5.3	0.0	1.6	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.6	2.6	0.5	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.3	1.6	6.0	0.0	0.0	3.5	0.6	0.0	1.1	2.3	0.2	0.9	0.2	0.0	0.2	0.0	1.2	0.1	2.7	0.0	0.0	1.3	0.1	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	13.8	40.3	12.3	8.5	15.3	15.9	14.4	18.4	13.5	13.5	20.8	0.1	0.0	0.0	4.9	0.0	0.3	0.4	0.3	0.0	6.5	0.6	1.0	2.1	1.5	0.3	9.2	4.2	0.1	0.0	0.0	19.6	2.6	1.3	0.3	0.1	0.3	3.5	0.0	0.7	0.4	0.0	0.3	0.0	0.2	0.0	0.3	0.7	0.4	0.0	38.7	8.9	0.0	6.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.6	31.8	0.0	0.0	7.1	0.3	0.0	0.0	0.4	0.5	0.0	0.8	0.2	2.4	0.0	2.3	0.4	0.7	3.5	0.2	1.1	0.0	0.1	0.0	0.1	0.5
FAM135A	"FLJ20176, KIAA1411"	ENSG00000082269	"Family with sequence similarity 135 member A"	Q9P2D6	6	70412941-70561174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.1;Horizontal cells: 238.9;Inhibitory neurons: 172.8;Microglial cells: 132.1;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031743, HPA031744"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA031743: AB_10600767, HPA031744: AB_10601101"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (8.00e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.69e-4)"	"unprognostic (4.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (3.99e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.65e-2)"	2.6	2.8	2.5	4.8	3.6	1.3	2.5	8.1	3.3	4.9	0.6	10.7	13.6	6.3	2.5	29.8	4.1	7.0	4.1	3.2	2.1	4.9	2.4	4.2	3.8	2.4	2.3	6.3	6.0	9.7	1.9	4.0	2.4	16.1	11.1	8.2	4.5	3.5	2.6	9.6	11.5	3.7	1.2	3.5	10.7	10.1	2.2	2.9	3.8	6.5	6.4	4.9	7.1	3.7	7.9	4.8	9.5	6.1	4.5	3.2	8.9	2.5	5.0	2.6	4.3	8.9	6.2	14.3	18.1	1.9	12.6	7.3	9.6	5.6	4.6	6.8	8.2	6.2	4.6	8.0	5.5	12.3	6.4	2.9	13.8	5.0	13.4	3.1	7.2	4.4	10.6	6.8	3.1	0.8	2.2	5.5	6.4	9.2	3.9	6.8	31.3	6.8	9.8	4.0	10.1	3.1	2.9	2.6	3.0	6.3	1.8	5.2	3.6	2.2	5.7	2.2	5.8	8.5	10.3	5.5	1.6	10.4	4.2	1.8	2.3	0.1	0.8	2.0	0.9	1.6	0.7	0.3	3.5	2.0	1.1	0.7	0.6	2.7	3.3	0.5	0.9	0.9	2.5	3.6	8.1	3.3	3.2	2.1	2.4	2.3	2.4	1.2	2.2	3.7	12.0	28.9	12.5	85.8	10.8	15.9	12.9	8.3	31.3	20.8	4.5	4.1	11.5	17.2	8.9	20.2	29.2	2.9	4.7	49.9	5.9	6.7	30.4	13.9	15.6	13.0	23.4	1.7	170.1	12.4	1.5	10.2	45.9	21.4	8.8	13.5	9.7	6.5	5.6	238.9	172.8	29.2	16.2	10.6	15.5	23.8	15.5	11.9	5.4	132.1	11.9	13.8	4.1	219.2	121.3	18.4	31.7	13.2	6.4	35.4	24.0	10.0	9.9	26.4	6.6	11.6	9.3	33.2	10.5	71.4	33.5	8.2	4.6	10.9	25.5	15.8
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.0;Oligodendrocyte precursor cells: 157.8;Syncytiotrophoblasts: 279.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	49.2	12.8	8.5	9.9	9.0	12.7	31.8	14.2	11.8	17.6	13.2	18.3	50.5	12.5	7.5	7.6	23.5	16.3	9.9	9.7	7.3	21.9	39.1	11.8	6.3	8.6	8.4	27.8	38.6	49.2	8.4	35.1	9.5	10.6	14.8	15.9	23.4	10.5	9.7	20.4	29.0	13.3	8.3	5.4	16.3	13.9	9.0	5.6	32.8	21.9	4.8	16.9	10.4	8.8	4.5	6.7	9.8	12.8	55.5	22.7	16.0	10.2	12.4	4.0	3.6	5.6	10.3	0.1	4.0	7.4	6.3	2.7	14.5	7.4	8.9	0.6	10.0	7.5	8.9	0.7	16.3	6.3	1.0	21.9	5.9	10.1	3.6	17.5	6.9	2.5	19.7	0.7	8.7	0.2	0.7	2.8	12.1	0.8	6.9	10.2	16.6	4.0	7.4	21.8	24.6	6.5	2.5	7.9	9.9	9.6	5.5	0.2	2.5	11.2	6.2	5.5	5.9	3.4	2.1	0.1	16.6	0.6	5.9	0.0	4.1	0.0	1.0	2.0	0.7	0.0	2.7	0.3	3.5	0.0	2.9	0.7	0.9	0.4	0.6	1.2	1.5	1.6	8.5	9.0	14.2	11.8	9.7	7.3	8.6	8.4	9.5	8.3	9.0	8.8	42.6	12.8	34.9	95.3	4.3	10.1	22.3	20.4	28.5	16.3	29.7	20.6	25.9	38.6	39.3	11.0	35.5	72.9	12.9	50.4	29.4	10.7	3.4	82.0	33.6	14.1	4.9	31.3	178.0	16.9	35.3	42.1	33.1	98.2	1.3	70.2	12.8	143.0	20.7	0.0	46.5	54.1	26.4	29.6	11.9	5.1	45.1	21.7	19.6	104.9	16.9	22.6	5.2	157.8	17.4	20.7	73.4	33.4	10.3	13.6	37.5	50.4	74.6	11.3	0.0	24.7	31.9	5.3	10.2	14.4	7.7	279.5	9.7	41.2	22.3	19.5
FAM13C	FAM13C1	ENSG00000148541	"Family with sequence similarity 13 member C"	Q8NE31	10	59246130-59363181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.0"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 477.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.1;HSkMC: 5.1;hTERT-RPE1: 3.4;NTERA-2: 4.5;SCLC-21H: 8.6;SH-SY5Y: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037888	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA037888: AB_10962981"	"unprognostic (3.68e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.69e-5)"	"unprognostic (8.54e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-6)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.66e-3)"	13.5	16.2	20.8	3.9	45.8	0.0	9.3	33.2	32.4	8.7	3.7	7.7	4.2	8.7	8.0	13.8	14.5	11.5	8.1	21.3	34.3	3.4	2.1	9.9	4.7	49.3	36.3	21.2	2.2	4.7	4.7	2.6	40.9	17.2	6.2	9.9	5.6	7.9	17.1	7.2	5.9	12.2	35.5	5.1	3.8	5.2	37.6	5.2	6.3	22.9	2.3	4.4	7.9	68.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	1.3	0.2	0.1	0.0	1.2	0.0	4.1	1.9	0.1	0.0	0.0	5.1	0.6	0.2	0.0	3.4	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.8	0.0	0.0	1.3	8.6	5.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	2.5	2.2	0.1	2.1	0.0	0.0	0.1	3.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	45.8	33.2	32.4	21.3	34.3	49.3	36.3	40.9	35.5	37.6	68.0	47.8	0.0	0.0	33.6	0.1	4.8	9.3	0.3	8.0	10.5	0.7	2.7	2.5	0.0	0.7	0.0	6.2	0.0	0.4	0.1	7.9	0.0	49.0	18.6	1.5	35.2	0.0	0.0	66.8	0.0	0.0	19.8	0.5	5.3	0.0	26.9	3.9	0.5	0.0	3.3	73.2	0.2	20.3	0.0	2.5	22.1	23.0	0.7	3.6	7.5	0.0	8.8	0.0	56.8	477.1	0.0	0.0	21.1	0.1	5.4	0.0	0.6	20.7	13.6	39.5	23.4	36.2	1.4	0.7	2.4	6.3	0.0	1.2	17.4	0.2	1.1
FAM151B	UNQ9217	ENSG00000152380	"Family with sequence similarity 151 member B"	Q6UXP7	5	80487969-80542563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.8;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 18.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043805	Uncertain		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA043805: AB_10794287"	"unprognostic (1.29e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.28e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.46e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.44e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.63e-1)"	0.7	1.0	0.7	0.7	0.9	4.7	0.7	0.4	0.9	0.8	0.4	0.4	0.4	0.6	0.9	0.5	1.3	0.9	0.9	1.0	0.5	1.1	0.8	0.7	0.3	0.6	0.4	0.6	0.6	1.1	0.7	1.8	0.2	0.8	0.6	1.0	0.4	0.5	0.3	0.3	0.3	0.9	0.5	0.7	0.5	0.7	0.9	0.2	0.8	0.3	0.4	0.7	0.5	0.7	0.1	1.5	0.7	3.2	2.6	3.7	1.0	1.3	1.9	1.1	2.4	0.1	1.2	0.0	0.2	3.4	3.4	0.8	1.1	0.2	0.9	0.3	0.7	0.3	0.5	0.3	1.1	0.5	1.7	1.8	1.1	1.2	0.1	2.1	1.7	0.4	0.1	0.5	1.8	1.1	0.2	0.2	0.1	0.3	0.6	0.4	2.6	0.4	1.3	0.5	0.3	0.7	0.4	1.2	1.1	0.3	1.7	1.4	0.7	0.2	0.2	0.0	0.5	0.0	0.7	0.0	1.8	1.4	1.1	0.0	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.9	0.4	0.9	1.0	0.5	0.6	0.4	0.2	0.5	0.9	0.7	0.3	0.0	0.0	3.6	0.4	0.3	0.5	2.2	0.6	1.0	1.4	0.8	1.8	2.8	1.7	3.7	0.0	7.9	0.1	0.3	0.0	1.5	4.1	3.9	1.3	0.9	0.0	0.0	17.8	2.1	6.7	2.0	1.5	2.6	1.3	1.1	0.4	0.3	5.1	1.7	21.6	0.5	0.0	4.8	1.2	1.9	1.2	3.6	0.0	6.5	2.2	1.5	0.0	18.6	8.5	0.3	0.3	0.4	1.3	0.7	0.6	4.3	3.7	0.8	0.0	1.2	0.8	4.7	0.9	1.0	1.0	7.9	0.1	1.3	0.2	0.6
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409176-151670503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 32.3;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 11.9;Excitatory neurons: 15.8;Oligodendrocyte precursor cells: 19.1;Suprabasal keratinocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	11	"cerebellum: 13.8"	"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 8.6;HeLa: 10.0;hTERT-HME1: 9.2;SiHa: 8.9;SK-BR-3: 7.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA046348	Enhanced		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	0.6	1.3	0.8	0.3	0.7	1.8	4.4	13.8	1.2	3.2	32.3	3.3	1.9	1.6	4.0	7.8	2.7	0.9	3.4	1.2	0.0	3.4	0.7	1.9	0.2	0.6	0.6	2.4	10.2	8.3	1.3	0.5	0.8	2.2	3.4	6.7	4.7	1.5	34.5	13.4	2.0	1.1	0.3	0.5	2.5	3.4	0.4	1.5	6.8	16.5	2.3	2.2	3.4	0.2	8.6	0.7	0.0	0.2	0.0	0.1	2.9	0.3	1.4	0.8	0.2	3.6	3.0	0.0	0.8	0.3	2.6	7.4	2.1	6.1	0.9	0.0	3.3	0.0	10.0	0.9	0.0	0.0	0.2	0.2	7.0	0.0	9.2	2.4	0.2	0.7	0.0	0.0	0.5	1.2	0.0	0.0	2.8	2.8	0.8	0.0	2.0	0.2	5.1	5.5	1.2	0.4	8.9	7.8	0.2	2.2	3.3	0.0	0.0	0.4	3.7	0.2	1.4	0.0	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.8	0.7	13.8	1.2	1.2	0.0	0.6	0.6	0.8	0.3	0.4	0.2	0.1	3.2	2.0	1.3	0.0	11.9	6.6	2.9	10.8	0.1	2.7	1.9	1.8	0.0	5.2	0.0	0.0	0.3	0.5	5.9	0.0	1.6	3.3	5.9	0.6	0.4	0.0	0.0	15.8	1.8	0.6	0.6	6.1	10.8	1.3	0.3	0.0	0.5	0.3	8.4	2.4	2.3	0.0	0.0	2.1	1.5	0.0	0.6	0.0	1.0	0.0	2.5	0.0	19.1	1.3	1.9	0.3	0.0	1.4	7.9	2.2	0.7	1.3	4.7	0.0	1.0	0.4	6.1	5.8	11.6	14.5	1.6	0.2	0.3	1.8	8.6
FAM160B1	"bA106M7.3, KIAA1600"	ENSG00000151553	"Family with sequence similarity 160 member B1"	Q5W0V3	10	114821744-114899832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043624	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA043624: AB_10797145"	"unprognostic (2.61e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.45e-3)"	"unprognostic (6.43e-2)"	"unprognostic (9.87e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (3.41e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.25e-2)"	15.0	11.7	8.7	10.0	8.4	53.3	11.9	6.1	8.4	12.1	6.1	10.7	12.7	16.0	10.0	7.3	12.3	10.5	14.2	7.8	6.5	7.9	19.0	11.6	12.6	5.6	6.5	14.3	9.8	11.9	7.4	14.9	6.1	10.5	8.1	11.5	8.5	11.3	20.3	8.6	13.2	16.9	5.3	11.4	10.1	18.8	6.9	11.2	11.7	12.3	9.6	11.9	10.0	5.2	16.7	8.9	9.6	14.3	22.9	26.0	11.2	29.7	28.8	16.8	13.4	3.1	6.3	9.9	9.1	27.2	4.3	11.0	4.7	11.9	19.8	36.2	10.2	3.9	16.5	7.2	16.7	10.6	12.8	20.4	11.3	12.5	20.2	36.0	22.9	20.0	5.6	24.4	31.7	7.7	19.0	10.5	6.3	4.8	6.6	16.3	16.3	6.6	11.3	9.9	2.1	8.6	13.2	13.6	15.5	11.3	5.4	6.0	23.1	10.4	6.6	30.7	10.4	10.0	3.0	11.2	13.4	26.0	10.0	19.9	3.2	4.7	5.4	2.4	4.0	3.7	7.4	9.2	3.6	3.6	4.0	5.5	15.2	4.9	2.8	3.7	10.5	2.7	8.7	8.4	6.1	8.4	7.8	6.5	5.6	6.5	6.1	5.3	6.9	5.2	25.9	16.0	8.1	20.5	10.9	7.0	7.9	8.0	14.8	13.9	9.4	6.7	19.5	4.3	8.4	3.7	12.5	12.7	14.1	9.0	1.9	10.2	26.7	12.0	26.2	19.8	7.8	9.9	26.5	9.6	10.2	19.2	23.0	16.8	2.5	29.6	23.9	31.3	6.3	10.1	27.4	9.2	4.1	15.6	6.8	36.0	28.6	11.3	3.6	25.3	11.4	8.3	25.7	28.1	13.8	15.1	3.7	22.2	20.1	19.5	20.8	6.6	8.7	16.9	6.6	13.2	14.4	14.9	6.4	8.9	4.8	12.6	17.5	15.0	5.8	14.8
FAM160B2	"FLJ21801, RAI16"	ENSG00000158863	"Family with sequence similarity 160 member B2"	Q86V87	8	22089150-22104911	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025040	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA025040: AB_1856049"	"unprognostic (3.45e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.67e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.75e-3)"	13.9	11.5	4.5	3.9	4.1	3.6	15.8	3.5	5.5	12.5	3.5	16.2	5.8	12.3	4.9	13.6	12.7	5.6	21.7	3.6	3.5	14.6	10.5	10.6	6.3	4.8	4.2	10.0	22.3	8.2	13.2	5.2	4.1	14.6	2.5	3.0	16.7	10.6	17.7	14.0	13.5	6.9	3.7	11.4	17.4	6.1	4.8	4.2	15.4	7.2	2.2	16.2	12.0	4.6	4.4	8.7	4.3	6.8	9.2	8.1	7.8	8.0	13.6	8.6	5.8	3.9	4.7	4.9	7.7	19.7	7.8	6.3	3.3	9.3	1.9	4.1	4.2	7.3	2.8	2.2	12.4	1.9	5.7	13.6	6.9	6.6	4.4	8.9	9.1	8.8	4.6	3.3	8.3	8.0	5.0	2.9	2.1	8.0	3.8	5.1	3.7	2.5	7.4	8.9	1.8	5.8	4.6	6.6	5.2	4.5	4.3	3.2	10.3	8.4	7.2	8.0	4.6	3.5	0.9	0.9	9.0	3.1	9.7	0.0	0.4	0.1	0.8	0.2	0.5	0.7	0.5	0.6	0.2	0.5	0.4	0.7	0.0	0.4	0.4	0.2	0.0	0.7	4.5	4.1	3.5	5.5	3.6	3.5	4.8	4.2	4.1	3.7	4.8	4.6	16.4	12.8	17.2	17.0	11.6	5.9	10.1	9.9	12.5	22.0	16.4	13.5	26.1	12.8	8.8	12.9	27.1	8.5	10.1	15.5	0.0	9.7	3.7	8.9	14.5	16.8	13.2	1.3	12.3	15.0	15.5	12.5	23.0	11.8	7.0	19.1	16.8	13.6	7.4	23.5	12.0	10.8	0.0	9.4	4.7	2.5	10.8	8.2	1.8	8.4	4.4	8.7	9.2	12.1	11.0	17.1	17.1	5.7	6.3	15.1	14.7	5.0	10.8	23.8	0.0	11.0	14.7	1.5	7.0	16.1	7.5	14.9	11.2	9.6	9.9	12.4
FAM161B	"C14orf44, FLJ31697"	ENSG00000156050	"FAM161 centrosomal protein B"	Q96MY7	14	73931501-73950414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 62.9;Late spermatids: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019125	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA019125: AB_1845570"	"unprognostic (1.50e-1)"	"unprognostic (9.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.76e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (6.78e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.60e-1)"	2.7	8.7	6.6	1.7	6.6	1.2	4.8	5.8	8.2	5.3	3.4	3.9	3.3	5.2	4.3	4.1	5.5	2.7	5.4	6.4	5.9	7.2	5.1	2.8	1.8	6.8	5.7	12.8	2.2	4.3	7.6	2.4	7.1	6.0	2.7	10.1	2.8	5.2	7.9	2.1	3.3	3.4	5.5	3.1	3.3	18.8	6.1	1.9	4.2	4.8	1.8	5.5	3.8	6.6	2.1	1.6	2.2	3.4	4.7	3.5	2.0	3.6	2.8	6.0	5.8	1.5	2.6	3.3	2.3	4.2	2.5	3.9	0.9	1.7	4.1	9.2	1.8	1.6	1.6	1.7	4.0	1.1	2.3	2.6	3.4	6.1	2.2	4.4	2.7	3.4	1.0	1.6	4.3	3.3	3.1	4.2	0.5	1.4	3.5	2.1	2.9	1.3	3.1	3.1	2.7	2.5	5.1	2.3	3.1	1.6	8.1	1.5	2.9	12.4	5.6	3.1	2.2	3.3	2.2	2.1	6.3	1.9	2.2	3.2	1.3	1.9	1.1	0.3	1.3	0.7	1.2	1.7	0.2	0.9	0.6	0.4	0.4	1.3	0.4	0.3	0.7	0.9	6.6	6.6	5.8	8.2	6.4	5.9	6.8	5.7	7.1	5.5	6.1	6.6	3.5	3.2	4.8	4.9	3.0	0.6	2.1	1.0	3.4	8.9	3.7	3.8	3.4	0.0	3.2	1.8	4.2	1.5	1.9	3.5	0.0	1.0	62.9	5.9	3.9	2.2	0.0	1.7	7.3	1.6	1.1	4.6	7.1	4.5	0.0	5.0	2.5	0.7	2.9	3.3	8.6	4.1	2.0	1.2	0.7	142.7	3.4	1.4	1.8	2.8	2.2	8.0	6.2	5.5	2.9	1.2	0.8	9.4	1.4	0.8	4.3	4.2	9.4	16.7	6.6	5.2	4.2	11.0	6.1	0.6	0.9	2.2	3.3	9.6	1.4	0.9
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133577081-133609389	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 60.1"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 24.8;Inhibitory neurons: 17.8;Late spermatids: 17.3"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"	"Group enriched"	"Detected in many"	6	"amygdala: 26.5;basal ganglia: 44.4;cerebral cortex: 60.1;hippocampal formation: 38.2;white matter: 32.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"SH-SY5Y: 50.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067336	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: AB_2685825"	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	10.0	26.5	0.0	44.4	0.0	0.0	0.0	60.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.1	0.4	5.2	38.2	0.0	0.8	8.7	0.3	1.7	0.0	0.0	0.4	0.1	0.0	0.5	0.8	7.3	0.2	0.5	0.2	0.3	0.8	0.0	0.0	0.0	0.0	6.0	0.2	0.4	2.4	0.0	0.2	0.2	0.0	0.0	1.1	0.1	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.7	0.2	0.1	0.0	0.0	2.4	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	44.4	0.0	60.1	38.2	0.0	0.0	0.0	7.3	6.0	0.0	32.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM174A	"NS5ATP6, TMEM157, UNQ1912"	ENSG00000174132	"Family with sequence similarity 174 member A"	Q8TBP5	5	100535374-100586741	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 154.5;Respiratory ciliated cells: 222.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 55.8"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.8"	"Cell line enhanced"	"Detected in all"		"U-266/84: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019539	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	Cytosol	"HPA019539: AB_2293743"	"unprognostic (2.34e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (5.55e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	16.1	23.1	13.0	8.1	14.4	2.8	15.3	13.4	16.5	11.4	23.3	12.6	11.2	12.1	12.1	24.3	34.8	7.5	19.5	13.8	18.6	17.3	15.7	17.2	5.6	13.9	14.0	10.1	22.6	29.3	27.4	15.1	14.9	18.2	8.5	16.8	17.4	11.8	42.8	30.3	10.3	8.0	13.9	10.2	15.5	22.0	14.6	5.3	13.6	24.7	5.4	13.0	16.9	14.6	10.3	10.7	4.3	13.6	10.3	8.4	15.1	23.1	12.9	9.3	12.7	2.2	13.1	1.8	46.2	10.1	16.2	8.6	3.6	15.1	7.0	12.8	10.9	1.3	18.6	6.4	13.9	5.3	12.4	10.7	35.4	7.2	5.5	21.3	14.3	5.3	3.8	13.7	15.9	20.7	1.6	11.1	2.4	1.2	29.1	3.6	16.2	18.2	17.0	12.3	8.6	23.4	16.2	14.5	13.7	5.0	13.9	11.5	16.1	11.7	7.4	19.0	18.5	44.3	61.5	2.4	14.5	7.1	10.4	7.9	4.9	7.1	3.3	5.5	5.1	2.8	3.3	4.0	4.4	3.3	2.9	3.8	55.8	5.5	5.7	4.4	4.4	3.3	13.0	14.4	13.4	16.5	13.8	18.6	13.9	14.0	14.9	13.9	14.6	14.6	40.8	32.1	31.8	13.1	13.8	88.1	31.4	80.3	43.3	29.7	57.3	31.2	17.4	34.3	54.7	29.5	4.2	44.5	10.0	17.8	43.0	30.6	33.2	154.5	13.8	27.1	34.8	20.6	26.0	30.0	40.3	26.9	18.8	25.3	13.3	8.1	35.0	30.6	23.5	30.3	38.3	32.3	85.5	16.8	22.1	10.1	18.0	14.1	49.8	15.9	17.1	75.4	6.2	19.1	25.1	30.2	23.3	24.5	60.7	28.1	23.2	40.0	222.5	42.3	13.1	48.7	24.3	91.5	20.7	59.6	115.1	50.3	13.8	18.4	18.9	43.1
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.3;choroid plexus: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.0;Astrocytes: 261.2;Oligodendrocyte precursor cells: 88.4;Syncytiotrophoblasts: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.8;HEK 293: 11.1;Hep G2: 7.9;JURKAT: 11.6;K-562: 10.4;SCLC-21H: 8.5;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	3.1	1.6	33.3	1.3	36.3	0.2	4.7	37.3	43.3	3.6	30.5	3.5	3.0	2.5	3.0	1.4	3.2	1.8	2.5	34.3	33.0	6.7	6.3	9.9	3.5	31.9	32.4	4.5	3.2	4.8	11.0	23.0	32.4	3.9	0.9	16.3	3.3	2.8	0.9	1.7	1.6	1.6	29.1	0.6	1.7	16.9	32.6	0.6	7.0	2.2	3.5	2.4	2.1	34.5	0.1	0.3	11.8	0.9	0.3	0.3	0.0	0.6	0.4	0.5	0.9	2.0	1.1	0.9	0.0	0.2	5.3	0.0	3.4	0.0	0.2	1.3	11.1	0.1	0.9	7.9	0.2	0.0	0.6	0.4	0.1	0.1	0.0	0.3	0.0	11.6	10.4	0.7	0.3	0.3	0.4	0.1	6.0	0.6	1.3	0.0	0.1	0.0	0.1	0.1	8.5	8.0	0.7	0.6	1.8	2.2	2.1	1.4	0.3	0.8	0.5	0.2	2.9	4.9	3.3	0.3	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	33.3	36.3	37.3	43.3	34.3	33.0	31.9	32.4	32.4	29.1	32.6	34.5	21.0	48.1	103.0	261.2	0.7	2.4	5.9	0.4	11.4	35.2	3.8	8.8	6.4	2.8	17.7	3.7	29.2	61.4	0.6	0.4	17.6	1.0	22.9	2.0	2.0	5.3	6.0	0.4	66.9	1.1	18.9	11.8	1.5	0.8	6.3	8.9	1.8	4.0	5.6	13.5	55.5	0.6	0.0	0.3	1.8	9.2	3.7	1.0	0.0	34.7	0.0	11.1	0.0	88.4	20.6	0.3	1.2	7.2	2.7	1.6	0.4	3.1	37.3	28.4	6.6	45.2	4.1	61.8	16.0	4.2	3.4	266.4	5.8	1.4	0.7	2.0
FAM185A	MGC35361	ENSG00000222011	"Family with sequence similarity 185 member A"	Q8N0U4	7	102748971-102809225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 64.0;Excitatory neurons: 132.4;Inhibitory neurons: 134.5;Microglial cells: 63.7;Oligodendrocyte precursor cells: 70.9;Oligodendrocytes: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020470, HPA029883"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA020470: AB_1853890, HPA029883: AB_10601903"	"unprognostic (8.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.36e-5)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.25e-2)"	0.8	1.1	0.6	0.6	0.6	0.8	0.8	1.0	0.8	1.3	0.6	1.0	0.4	0.8	0.4	1.0	0.7	0.4	1.0	0.4	0.5	1.2	2.8	0.6	0.4	0.5	0.8	1.0	1.3	1.5	0.7	0.5	0.4	1.2	0.7	1.1	0.8	0.8	3.5	1.2	0.8	0.5	0.3	0.6	1.9	0.4	0.7	0.7	0.9	2.0	0.4	1.3	1.0	1.2	0.6	2.0	0.4	2.4	0.4	0.9	1.5	0.6	1.3	0.3	0.0	1.7	2.1	0.6	0.9	0.6	1.5	2.3	1.0	0.9	0.4	1.2	0.1	0.2	0.2	2.8	0.6	0.9	1.1	0.0	1.8	0.0	0.4	1.5	0.6	0.5	1.0	1.1	1.1	3.2	2.1	0.6	0.9	2.7	0.5	0.2	0.0	6.7	0.2	1.4	0.4	1.7	4.0	4.5	0.1	0.0	2.7	0.0	1.6	0.2	1.1	2.1	0.4	3.1	1.4	0.6	0.4	0.6	0.2	0.0	1.4	1.9	1.1	1.2	1.1	2.2	0.7	1.0	1.6	0.8	0.9	0.7	3.7	0.8	0.5	1.2	0.8	0.4	0.6	0.6	1.0	0.8	0.4	0.5	0.5	0.8	0.4	0.3	0.7	1.2	2.9	3.2	1.5	64.0	5.1	4.2	8.1	5.8	9.6	8.8	5.1	3.6	6.3	11.5	6.0	0.0	10.4	13.8	5.6	2.0	19.6	4.6	5.4	5.0	3.8	4.0	1.2	9.4	132.4	2.3	6.5	4.0	9.2	4.1	0.0	7.0	6.4	7.4	4.4	5.0	134.5	3.2	6.1	2.8	1.4	3.3	7.2	3.3	7.2	63.7	3.2	4.9	2.1	70.9	89.2	2.5	1.7	5.3	6.3	3.8	4.6	11.1	3.0	21.4	13.1	4.3	4.1	9.2	5.1	6.7	4.5	8.1	4.1	7.0	3.6	7.0
FAM187A		ENSG00000214447	"Family with sequence similarity 187 member A"	A6NFU0	17	44899712-44905390	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.0;testis: 15.9"	"Cell type enriched"	"Detected in single"	36	"Respiratory ciliated cells: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.7;U-87 MG: 16.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043131			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA043131: AB_10796686"																		0.5	1.9	2.0	0.4	2.5	0.5	1.2	1.4	3.0	1.5	3.6	0.8	0.1	0.8	2.3	0.4	15.0	0.8	0.3	2.3	2.7	2.8	0.3	1.1	0.5	2.6	4.3	1.3	1.3	1.7	2.2	0.1	2.9	0.6	0.7	5.4	0.5	1.0	0.2	0.4	0.3	0.5	2.6	0.2	0.4	15.9	3.1	0.4	3.4	0.1	0.4	0.6	0.3	2.1	1.2	5.6	2.3	1.5	2.5	3.2	1.3	0.5	4.9	2.5	3.3	2.4	4.8	0.2	1.4	1.6	4.6	5.4	0.7	1.9	1.3	5.9	1.4	0.8	2.8	0.7	1.3	1.1	0.7	0.7	2.5	4.5	1.0	4.8	1.2	1.0	1.4	0.2	0.6	1.3	0.1	1.3	0.9	3.0	1.1	0.9	0.1	0.4	13.7	0.7	6.9	1.3	0.5	0.1	1.0	1.1	5.8	1.1	0.5	1.0	1.4	1.3	1.1	0.1	0.2	0.5	16.0	0.8	1.1	0.0	0.8	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	2.0	2.5	1.4	3.0	2.3	2.7	2.6	4.3	2.9	2.6	3.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM193A	"C4orf8, RES4-22"	ENSG00000125386	"Family with sequence similarity 193 member A"	P78312	4	2536647-2732573	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043116	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA043116: AB_10795767"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.84e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.96e-3)"	14.3	11.7	9.7	7.6	9.3	13.0	13.2	15.1	11.5	14.8	9.6	13.4	7.9	13.8	6.8	9.6	12.9	6.0	9.7	9.5	9.7	11.9	11.6	10.1	9.6	9.8	9.0	15.0	11.1	9.2	15.5	7.6	9.3	12.1	6.0	8.9	10.1	7.0	15.1	13.2	12.3	8.0	6.9	12.0	10.5	21.1	10.5	12.4	12.2	8.7	6.7	11.5	11.2	11.8	8.7	10.7	20.0	11.3	12.0	12.2	10.5	13.1	11.3	12.7	10.8	10.9	13.9	17.1	7.7	14.7	15.7	7.4	14.0	9.4	10.8	10.3	8.9	25.7	14.3	11.5	14.4	15.8	17.2	13.3	9.8	12.7	13.0	11.6	12.8	10.0	18.2	18.5	10.8	9.4	25.5	25.6	15.9	8.9	11.8	24.7	10.3	8.4	8.7	11.1	17.1	14.6	11.2	7.8	11.3	10.9	14.3	15.9	17.4	19.2	11.3	10.5	17.5	18.0	14.5	16.1	10.7	12.8	13.8	3.3	0.9	0.8	0.8	0.6	0.6	0.6	0.7	1.2	0.6	0.9	0.7	1.1	1.8	1.3	3.1	1.7	0.6	0.5	9.7	9.3	15.1	11.5	9.5	9.7	9.8	9.0	9.3	6.9	10.5	11.8	21.8	12.8	18.2	62.7	11.2	9.4	6.7	6.5	9.1	25.7	10.5	9.0	14.7	4.3	15.6	1.8	47.9	7.3	20.0	12.9	1.9	9.4	8.9	19.8	21.8	19.4	14.4	17.9	62.4	7.5	7.1	13.2	15.8	27.1	8.8	30.2	11.0	6.3	8.7	15.2	70.8	11.1	8.2	7.6	11.6	13.4	17.1	15.9	14.2	51.5	11.1	15.8	11.3	45.8	58.3	10.1	11.0	14.7	12.4	11.3	11.4	2.8	5.6	26.2	6.6	20.5	17.5	36.2	32.4	9.6	9.9	5.6	14.4	13.6	9.6	9.2
FAM199X	CXorf39	ENSG00000123575	"Family with sequence similarity 199, X-linked"	Q6PEV8	X	104166453-104195902	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003093	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA003093: AB_1078597"	"unprognostic (2.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.08e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-2)"	19.9	11.7	17.0	7.1	16.9	13.8	11.6	18.2	18.7	9.2	10.2	8.4	7.9	10.6	34.8	7.8	9.1	6.8	7.3	15.2	18.8	15.1	7.7	8.1	8.6	15.5	19.1	11.9	11.1	19.9	8.5	9.0	17.5	10.2	8.4	16.1	10.2	13.9	9.4	9.5	7.2	8.7	16.8	8.8	8.3	10.1	20.5	9.0	17.5	9.7	7.8	8.0	7.6	18.8	23.9	14.9	13.2	14.5	9.6	11.5	13.3	12.4	11.6	15.8	14.7	11.6	19.4	13.1	15.0	11.4	12.5	17.6	23.9	18.3	25.7	6.4	13.4	10.4	19.0	13.2	13.7	20.0	14.1	9.0	22.9	15.5	15.6	24.7	16.2	8.3	11.5	28.6	17.8	17.1	10.8	14.2	13.2	20.9	17.3	11.4	8.6	16.5	26.9	15.8	7.1	8.8	30.0	19.7	21.4	12.9	9.8	9.8	20.1	17.6	6.4	13.8	13.5	13.6	12.1	14.4	19.8	21.1	13.1	0.6	0.5	0.3	0.7	0.4	0.7	0.4	0.6	0.8	0.6	1.3	0.9	0.5	0.6	0.3	0.5	0.3	0.8	0.3	17.0	16.9	18.2	18.7	15.2	18.8	15.5	19.1	17.5	16.8	20.5	18.8	18.6	16.0	14.5	33.0	17.8	24.0	11.5	12.6	13.6	23.3	21.3	14.7	13.7	17.2	12.2	62.5	14.6	11.8	23.1	23.9	23.5	11.9	0.6	20.6	27.3	15.7	16.8	9.4	25.9	18.7	13.0	11.7	18.3	31.5	9.5	16.8	14.6	18.8	17.6	33.7	24.5	17.0	16.2	21.4	27.0	3.9	11.8	15.7	10.6	15.9	14.6	20.0	22.6	26.2	21.6	15.4	18.9	14.7	20.2	14.6	14.2	34.8	10.3	16.9	26.3	17.1	13.7	4.1	9.7	21.0	26.3	14.6	15.9	21.6	15.9	15.5
FAM210B	"C20orf108, dJ1167H4.1, DKFZP434A1114"	ENSG00000124098	"Family with sequence similarity 210 member B"	Q96KR6	20	56358974-56368663	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 449.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 299.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042652	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"		"HPA042652: AB_2678098"	"unprognostic (3.29e-1)"	"prognostic favorable (5.44e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.34e-2)"	"unprognostic (9.45e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (1.44e-10)"	"unprognostic (1.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.00e-1)"	38.2	87.6	32.1	13.9	34.1	85.2	62.0	30.0	33.6	43.7	37.7	39.8	24.7	36.5	45.7	31.1	40.1	40.6	43.9	33.9	32.6	34.6	100.3	28.2	13.9	29.6	33.8	108.9	41.5	32.7	28.1	36.7	29.9	66.8	30.6	30.0	54.9	58.7	75.2	36.5	23.3	34.2	29.6	19.6	34.2	14.1	35.9	20.6	28.4	102.2	20.0	32.5	32.7	29.1	19.9	7.5	29.3	71.6	83.2	93.4	57.1	23.8	53.4	42.6	48.7	13.9	9.6	1.6	12.1	40.9	24.6	56.2	15.9	68.7	71.0	2.9	24.9	12.2	16.9	132.0	54.4	1.3	7.4	80.2	75.2	24.1	34.0	49.3	69.4	10.2	93.6	12.7	52.7	20.6	10.4	5.4	24.9	29.0	46.7	0.1	60.4	15.9	21.9	22.9	40.4	72.9	57.9	124.6	299.1	62.3	55.0	11.1	48.4	37.8	25.2	61.0	14.7	9.9	10.9	0.4	30.0	7.7	25.2	2.3	2.3	6.9	1.7	3.3	1.3	1.1	1.9	2.3	1.7	1.3	2.0	1.9	1.0	1.4	1.5	1.5	2.3	1.0	32.1	34.1	30.0	33.6	33.9	32.6	29.6	33.8	29.9	29.6	35.9	29.1	30.3	16.0	29.3	4.2	7.4	24.9	85.4	28.2	70.6	10.3	57.5	98.8	56.8	54.3	19.3	16.5	39.6	77.7	13.5	23.8	64.6	27.9	1.0	41.4	49.0	28.8	50.9	449.3	5.7	19.5	26.3	46.1	44.9	37.4	19.1	47.5	46.1	154.5	28.0	1.7	6.6	28.6	20.3	44.1	21.2	4.7	66.8	26.2	37.4	5.6	36.6	27.8	14.4	4.0	8.4	35.7	15.3	155.7	9.4	48.7	34.1	46.1	15.6	19.2	19.7	28.1	37.1	1.1	9.4	68.6	32.5	41.9	14.6	123.4	33.4	56.3
FAM221A	"C7orf46, DKFZp686F0810, FLJ45875, MGC72075"	ENSG00000188732	"Family with sequence similarity 221 member A"	A4D161	7	23680130-23703249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 69.2;Respiratory ciliated cells: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 19.3;GAMG: 26.5;MOLT-4: 27.4;SCLC-21H: 23.4;SH-SY5Y: 41.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA019719, HPA026748, HPA026752"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912"	"unprognostic (1.28e-1)"	"unprognostic (7.28e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.42e-2)"	"unprognostic (9.30e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.81e-2)"	5.5	3.6	14.9	3.2	17.2	1.7	4.3	18.2	24.4	3.5	15.4	6.5	9.9	2.5	3.4	7.2	9.3	3.4	4.1	14.2	15.7	6.4	9.7	4.7	3.8	17.3	16.1	3.8	20.4	2.7	5.3	1.6	18.1	4.8	8.5	4.8	7.5	2.4	2.6	3.9	7.3	1.9	16.7	2.6	11.9	19.7	16.2	7.7	6.0	4.3	4.9	4.9	4.1	23.8	0.0	1.0	11.1	8.9	0.4	0.0	5.4	0.6	0.8	1.4	1.6	11.6	5.5	1.5	19.3	0.3	26.5	2.4	0.0	0.1	2.2	0.0	15.3	3.3	1.1	0.0	3.0	0.0	17.3	0.7	0.7	0.2	0.1	2.4	3.4	11.7	0.0	0.0	0.4	5.5	27.4	0.0	0.0	0.0	5.8	10.8	1.1	0.0	5.8	5.4	23.4	41.3	1.9	0.0	0.0	2.6	5.6	8.0	0.5	0.1	4.2	2.4	1.1	0.1	0.1	0.0	1.1	0.0	2.0	0.0	3.1	4.2	5.1	2.0	10.7	6.6	8.6	6.4	5.4	6.8	9.8	5.5	0.1	7.8	6.0	4.7	12.2	3.3	14.9	17.2	18.2	24.4	14.2	15.7	17.3	16.1	18.1	16.7	16.2	23.8	7.2	16.0	7.2	13.4	7.2	16.2	9.5	10.0	14.8	6.9	17.8	7.7	5.5	20.0	20.0	7.3	2.1	3.5	5.3	8.2	9.8	15.4	8.5	24.7	2.0	6.9	14.9	3.8	13.7	10.6	0.3	12.3	36.7	11.2	5.1	10.2	6.1	16.0	6.7	6.7	16.3	25.7	18.3	4.1	10.8	10.4	4.7	6.1	8.8	12.2	2.1	8.5	2.1	11.6	69.2	11.5	25.2	3.8	7.1	11.7	15.2	12.3	51.6	8.0	19.7	8.5	5.3	45.2	27.6	14.6	18.9	0.8	7.6	4.4	22.5	11.8
FAM241B	C10orf35	ENSG00000171224	"Family with sequence similarity 241 member B"	Q96D05	10	69630247-69633596	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 19.4;Collecting duct cells: 16.5;Distal tubular cells: 11.7;Ductal cells: 24.3;Exocrine glandular cells: 18.4;Pancreatic endocrine cells: 20.7;Proximal tubular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"gdT-cell: 4.3;MAIT T-cell: 10.9;memory CD4 T-cell: 10.5;memory CD8 T-cell: 7.0;naive CD4 T-cell: 17.2;naive CD8 T-cell: 5.7;T-reg: 7.8"	"Lineage enriched"	"Detected in single"	25	"T-cells: 17.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 57.5"					"Low region specificity"	"Detected in all"			HPA034591	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Centrosome"	Cytosol	"HPA034591: AB_10670572"	"unprognostic (1.12e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.17e-3)"	"prognostic unfavorable (8.64e-4)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (9.72e-4)"	1.6	3.0	26.3	1.9	27.3	1.1	4.7	30.4	40.3	2.2	19.2	6.6	2.7	3.2	11.1	4.8	4.3	2.0	6.6	35.5	31.7	10.7	3.7	4.0	2.9	21.7	24.2	2.1	8.2	8.2	12.7	1.2	28.2	7.8	2.3	11.3	5.5	4.7	4.7	3.4	3.5	3.8	21.5	1.4	5.8	22.2	26.4	2.8	5.8	1.2	2.3	5.8	3.0	22.2	29.4	31.9	3.9	31.8	0.0	0.0	13.6	2.9	0.8	5.1	5.6	23.4	23.6	0.0	42.8	0.6	18.6	11.8	16.6	9.6	7.1	29.4	22.8	0.0	6.7	8.8	8.1	0.0	10.0	0.0	9.4	0.2	4.8	3.8	0.0	43.8	11.1	0.1	0.5	39.9	0.3	0.0	19.1	11.8	57.5	0.0	0.0	0.4	10.9	16.6	16.0	22.2	12.1	29.6	19.0	7.8	20.5	5.1	1.4	0.8	19.4	0.1	8.5	5.1	15.2	0.1	0.4	0.0	0.8	0.0	0.0	0.0	4.3	0.0	10.9	0.1	10.5	7.0	0.1	0.4	17.2	5.7	0.6	0.2	0.0	0.1	7.8	3.1	26.3	27.3	30.4	40.3	35.5	31.7	21.7	24.2	28.2	21.5	26.4	22.2	1.4	0.0	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.3	19.4	0.0	0.0	3.1	16.5	0.0	7.5	0.6	0.0	11.7	24.3	0.0	5.7	0.4	0.7	0.0	0.0	0.0	18.4	5.6	0.6	0.0	5.0	0.0	8.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.3	0.0	0.0	13.5	4.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.9	2.8	3.7	0.0	0.0
FAM43B	FLJ44952	ENSG00000183114	"Family with sequence similarity 43 member B"	Q6ZT52	1	20552573-20555020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 21.0;brain: 21.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Distal tubular cells: 3.9;Excitatory neurons: 2.6;Fibroblasts: 3.8;Inhibitory neurons: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;BJ hTERT+: 2.4;fHDF/TERT166: 4.9;Hep G2: 3.7;SCLC-21H: 4.3;SiHa: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050813	Approved		Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA050813: AB_2681244"	"unprognostic (1.51e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.78e-4)"	"unprognostic (1.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.12e-2)"	1.6	21.0	12.2	0.2	10.7	0.0	0.3	11.0	12.5	0.6	2.4	0.9	0.1	1.0	3.0	0.3	0.9	0.2	3.9	13.5	13.5	5.0	0.4	0.3	0.0	16.6	21.7	0.3	0.5	0.0	0.8	0.6	13.8	0.7	0.1	0.4	0.5	0.1	0.9	0.2	0.3	0.8	9.9	0.8	0.3	0.5	18.8	0.1	1.2	1.4	0.0	0.7	0.4	10.2	0.0	1.7	0.2	3.3	0.1	0.1	0.0	0.3	2.4	0.4	0.0	0.1	0.0	0.0	0.2	4.9	0.8	0.0	0.5	0.0	0.0	0.0	0.7	0.1	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	10.7	11.0	12.5	13.5	13.5	16.6	21.7	13.8	9.9	18.8	10.2	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.1	1.9	1.6	0.0	0.0	2.6	0.0	0.1	3.8	0.0	0.2	0.0	0.0	1.8	0.0	0.1	0.0	7.5	0.0	0.0	0.6	0.0	0.1	0.3	0.1	0.0	1.0	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.3	0.1	0.9	0.7	0.0	0.0	0.1	0.1	0.1	0.0
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283783	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 47.3;Endometrial ciliated cells: 34.0;Respiratory ciliated cells: 91.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"OE19: 28.0"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	6.2	4.9	7.6	0.4	8.3	1.0	6.8	7.5	8.8	2.9	7.9	2.6	3.2	1.7	11.0	1.3	19.6	4.0	1.9	8.0	8.4	7.3	9.1	4.0	0.5	8.1	8.5	0.8	9.1	7.6	8.5	1.5	7.8	4.2	2.9	8.8	4.4	2.7	6.4	1.3	3.5	1.1	7.8	1.2	5.1	8.0	9.5	0.7	9.7	3.2	0.4	1.9	0.7	9.1	0.6	2.1	2.1	0.6	1.6	0.2	0.5	0.2	2.0	0.4	0.4	2.6	2.2	0.1	0.6	0.7	4.5	0.6	0.9	0.5	0.7	2.1	0.1	0.1	1.3	3.6	0.9	0.5	0.3	1.0	0.5	0.6	0.5	0.9	0.2	0.3	0.2	1.5	0.6	3.1	0.2	0.2	0.4	28.0	1.0	0.3	0.5	0.3	3.4	1.8	3.7	2.9	1.0	1.6	0.3	0.5	1.7	0.2	0.5	0.4	0.5	1.2	0.5	5.5	1.2	0.1	1.6	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	7.6	8.3	7.5	8.8	8.0	8.4	8.1	8.5	7.8	7.8	9.5	9.1	1.6	9.6	2.6	4.2	0.4	0.6	2.5	5.1	0.0	12.9	7.7	9.1	7.9	8.6	8.4	0.0	12.5	3.3	0.1	6.2	9.8	7.5	47.3	34.0	0.6	1.8	7.7	0.8	1.0	7.8	1.6	1.5	3.1	2.0	0.0	1.5	1.8	3.6	0.8	1.7	1.1	5.7	14.2	1.0	0.0	6.2	0.6	0.7	1.8	1.0	0.0	4.7	0.0	0.0	2.9	5.8	3.0	0.4	0.4	2.8	13.0	10.3	91.4	7.4	0.0	2.0	2.2	8.8	4.3	0.3	0.3	3.4	0.2	0.8	3.1	1.9
FAM53B	"bA12J10.2, KIAA0140, smp"	ENSG00000189319	"Family with sequence similarity 53 member B"	Q14153	10	124619292-124744378	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037751, HPA037752"	Approved		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA037751: AB_2675645, HPA037752: AB_10672285"	"unprognostic (7.88e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.91e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (7.00e-6)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.81e-7)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.41e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.45e-2)"	12.6	19.2	21.6	14.3	33.3	25.8	8.3	18.1	30.5	12.8	8.4	12.4	15.4	23.6	3.9	13.2	11.2	5.7	18.9	21.1	16.5	10.6	4.2	10.7	31.0	30.3	25.6	19.1	7.2	12.4	12.7	4.9	22.7	8.9	7.1	6.3	15.2	7.0	55.0	14.4	17.1	12.8	17.3	20.1	9.6	15.6	35.9	32.9	16.2	22.3	21.7	8.6	8.0	51.7	10.7	12.5	9.6	27.5	11.3	5.8	26.2	4.8	6.7	5.6	4.9	6.6	6.7	37.2	9.7	6.5	5.5	20.8	12.7	15.4	2.4	44.6	13.2	18.1	6.3	16.7	7.6	16.6	11.8	5.6	16.2	5.2	8.3	7.0	9.1	21.2	13.2	17.0	5.5	20.4	18.7	22.4	5.9	9.5	10.9	32.9	3.6	18.2	4.6	19.3	12.8	12.2	4.7	17.8	60.2	3.8	7.2	21.8	5.0	6.7	5.5	6.6	10.7	2.7	5.3	23.8	5.1	13.6	3.8	0.8	2.2	2.2	6.9	2.1	3.3	3.5	3.0	3.7	1.4	6.0	1.2	2.0	3.2	0.7	2.6	1.9	3.6	3.4	21.6	33.3	18.1	30.5	21.1	16.5	30.3	25.6	22.7	17.3	35.9	51.7	13.4	9.6	12.6	14.0	22.4	3.6	5.9	8.5	12.5	6.1	4.3	2.4	17.9	1.5	6.7	3.7	10.4	4.7	31.5	25.9	1.9	3.1	19.4	12.9	18.6	8.7	15.0	8.6	27.1	4.0	4.9	6.0	6.6	8.3	5.1	9.0	16.8	3.7	13.3	1.7	15.0	17.4	10.2	27.8	5.1	6.2	5.6	16.4	8.8	24.4	14.5	4.5	30.9	16.1	79.4	2.8	12.2	10.5	20.0	3.7	22.4	4.3	14.1	25.6	0.0	9.8	4.6	7.0	8.6	12.1	5.7	0.8	21.4	6.9	15.3	6.7
FAM72A	"LMPIP, MGC57827, p17, RP11-312O7.1, UGENE"	ENSG00000196550	"Family with sequence similarity 72 member A"	Q5TYM5	1	206186179-206204414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.5;Kupffer cells: 18.2;Late spermatids: 30.2;Spermatocytes: 28.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (3.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.20e-5)"	"unprognostic (3.61e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.01e-5)"	"unprognostic (7.70e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-16)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.89e-1)"	4.0	3.1	2.6	5.9	2.9	8.4	3.6	9.1	3.1	1.3	1.0	2.2	3.1	0.9	0.4	2.5	1.8	2.7	1.2	3.1	4.0	1.3	2.0	2.6	10.9	5.4	4.4	1.1	1.4	1.6	0.8	3.5	5.8	1.1	2.3	0.2	1.0	0.7	0.6	5.9	2.9	2.0	4.1	6.3	1.5	7.1	4.8	8.6	0.9	1.0	7.5	1.5	1.5	4.7	21.1	16.4	17.7	7.7	2.6	3.1	21.1	14.6	6.3	17.1	12.7	9.9	31.1	54.2	12.3	3.8	18.8	24.7	20.9	8.1	20.2	29.5	16.3	24.3	16.4	13.9	1.8	42.9	27.0	4.4	1.4	15.1	26.7	5.1	10.7	45.7	50.1	36.7	10.7	12.9	26.9	38.3	32.1	15.1	22.1	29.5	30.6	41.4	9.8	3.2	17.7	10.2	10.6	9.7	9.3	20.1	20.5	23.2	5.5	13.5	15.5	17.7	24.9	29.1	44.8	48.4	11.1	34.9	18.8	0.0	5.9	0.0	0.7	8.0	0.2	1.7	1.4	1.4	4.6	0.5	0.1	0.3	1.0	0.6	4.8	1.9	2.9	2.1	2.6	2.9	9.1	3.1	3.1	4.0	5.4	4.4	5.8	4.1	4.8	4.7	5.9	0.0	1.5	0.0	2.4	1.8	0.4	1.2	1.2	0.3	0.8	0.6	1.5	0.0	0.9	0.0	0.0	0.8	3.7	4.9	0.0	1.0	29.5	1.5	1.5	8.4	0.0	0.4	0.1	0.8	3.8	1.8	0.5	0.7	0.0	0.3	7.1	0.4	9.4	0.0	0.2	3.6	0.0	18.2	5.8	30.2	0.0	6.9	3.6	0.0	9.6	0.6	2.1	0.0	0.1	0.6	0.0	0.0	1.6	0.4	1.3	0.3	2.1	0.2	0.0	0.9	2.2	28.0	4.1	2.0	1.0	0.7	1.4	0.8	1.6	0.8
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.2;lymphoid tissue: 10.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7.3;Early spermatids: 11.3;Erythroid cells: 5.9;Hepatic stellate cells: 6.4;Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	0.8	0.6	1.2	3.7	1.0	6.2	0.8	2.0	1.1	0.5	1.3	1.1	1.3	0.5	0.4	1.6	0.4	1.0	0.3	1.2	1.2	0.4	0.4	0.6	8.1	1.6	1.4	0.4	0.2	0.7	0.2	1.4	1.6	0.2	1.2	0.1	0.4	0.2	0.1	1.9	1.1	0.7	1.3	2.0	1.0	2.3	1.3	10.3	0.3	0.2	6.6	0.8	0.7	1.4	28.6	10.3	16.5	8.2	1.6	2.4	13.3	14.7	6.2	16.8	14.1	0.1	14.5	62.9	19.9	2.7	16.4	17.1	23.1	8.3	25.9	41.1	17.3	27.2	12.0	12.5	1.0	47.7	23.2	1.3	0.9	13.0	26.5	4.2	10.3	51.0	36.1	37.3	12.4	12.1	24.1	39.1	31.6	14.9	20.6	35.8	35.8	28.7	6.7	3.2	18.0	10.4	11.1	8.6	8.6	16.9	11.4	36.5	3.6	13.8	23.5	27.3	26.6	32.6	44.1	61.3	12.4	50.8	32.6	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.4	0.3	1.2	1.0	2.0	1.1	1.2	1.2	1.6	1.4	1.6	1.3	1.3	1.4	1.3	0.0	0.0	0.0	1.6	1.0	0.1	0.2	0.0	0.0	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.8	0.1	7.3	0.0	0.2	11.3	0.2	0.4	2.5	0.0	5.9	0.1	0.2	2.3	0.6	1.1	0.2	0.0	0.5	6.4	0.0	1.1	0.0	0.3	4.9	0.0	1.9	2.8	3.0	0.6	1.6	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.1	2.3	0.0	2.5	0.0	2.1	0.0	0.7	0.0	0.0	0.3	0.9	17.0	3.1	3.5	1.0	0.1	1.2	0.2	3.6	0.0
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.9;lymphoid tissue: 5.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 7.8;Extravillous trophoblasts: 4.5;Sertoli cells: 6.6;Spermatocytes: 9.4;Spermatogonia: 3.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 64.9"									"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.4	0.2	0.1	1.5	0.1	2.9	0.3	0.2	0.2	0.2	0.0	0.4	0.6	0.2	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	4.5	0.1	0.1	0.1	0.2	0.0	0.0	0.5	0.1	0.1	0.6	0.0	0.2	0.0	0.0	1.2	0.4	0.3	0.1	1.2	0.3	1.6	0.1	5.4	0.1	0.1	4.5	0.4	0.4	0.2	18.7	10.6	12.5	5.7	0.6	1.7	12.1	8.9	2.8	12.0	9.0	1.6	21.7	44.4	11.6	1.0	11.0	17.4	17.2	5.5	13.0	15.3	10.0	19.1	9.4	3.3	0.4	39.5	16.6	0.3	0.1	9.1	24.3	2.5	5.1	34.7	34.0	20.5	0.8	1.4	23.2	30.4	10.2	20.8	6.6	29.7	9.0	31.5	2.1	2.3	6.3	11.5	8.7	5.0	4.9	13.0	12.5	33.4	3.7	9.4	15.4	12.5	20.3	41.9	64.9	26.0	5.1	24.1	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.8	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.6	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	2.3	0.3	0.2	1.3	0.0	7.8	0.2	0.2	4.5	0.3	0.0	0.1	0.0	0.5	1.8	0.1	1.7	0.0	0.3	0.6	0.0	2.2	1.4	0.5	0.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	6.6	0.3	0.7	9.4	3.5	1.3	0.3	0.3	0.7	0.3	0.5	0.0
FAM72D		ENSG00000215784	"Family with sequence similarity 72 member D"	Q6L9T8	1	145095974-145112696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.0;lymphoid tissue: 6.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.3;Erythroid cells: 9.7;Extravillous trophoblasts: 5.5;Spermatocytes: 15.4;Spermatogonia: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	"Plasma membrane, Cytosol"	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.70e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-3)"	"unprognostic (5.88e-5)"	"unprognostic (7.65e-4)"	"unprognostic (6.72e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (6.63e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.74e-2)"	"unprognostic (6.50e-2)"	0.7	0.3	0.4	3.0	0.4	4.0	0.5	0.7	0.5	0.3	0.2	0.8	1.0	0.3	0.1	1.1	0.2	0.5	0.2	0.4	0.8	0.2	0.3	0.5	4.8	0.6	0.7	0.2	0.1	0.2	0.1	1.1	0.6	0.1	1.0	0.1	0.2	0.1	0.0	1.9	1.3	0.5	0.4	1.2	0.6	2.1	0.7	6.7	0.2	0.1	4.5	0.6	0.4	0.5	16.6	10.4	11.7	4.5	0.5	1.0	12.4	9.8	3.0	11.1	7.1	7.5	14.7	26.6	9.3	1.5	11.1	17.3	13.6	3.0	12.8	22.6	14.1	13.6	5.8	9.7	0.6	24.0	14.2	0.8	1.1	9.4	16.9	2.0	5.6	33.0	26.8	34.9	7.2	12.4	16.6	22.5	21.1	20.3	14.4	13.9	14.3	30.7	4.0	2.2	10.9	9.1	7.3	6.3	4.4	13.9	17.2	15.7	2.7	8.3	9.6	7.3	16.7	27.0	46.5	39.3	0.2	18.7	10.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.4	0.7	0.5	0.4	0.8	0.6	0.7	0.6	0.4	0.7	0.5	2.0	0.0	0.0	0.0	0.8	1.0	0.0	0.2	1.2	0.0	0.2	0.4	1.1	0.0	0.2	0.0	0.0	1.2	0.1	0.8	0.0	0.1	7.3	0.2	0.3	2.1	0.0	9.7	0.3	0.0	5.5	0.8	0.0	0.2	0.0	0.3	0.4	0.1	1.5	0.0	0.5	0.8	0.0	1.0	1.0	0.6	0.0	1.8	1.8	1.0	0.8	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.8	0.2	0.3	0.1	0.3	0.0	0.0	0.5	0.8	15.4	4.5	1.6	1.0	0.3	0.4	0.1	1.4	0.1
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725961-27763116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.5;Late spermatids: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: AB_2686867"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	21.0	5.8	5.9	8.5	6.5	13.7	11.7	8.3	8.9	9.3	10.1	10.1	8.7	12.9	10.0	11.7	9.7	10.8	10.1	5.5	7.4	11.6	12.0	10.5	10.7	6.9	5.7	9.6	11.3	13.7	7.8	11.1	6.5	10.0	13.4	15.4	7.9	10.4	40.4	12.0	8.8	10.3	4.5	11.0	11.7	18.6	6.9	8.0	15.9	12.8	10.9	7.1	8.0	12.3	10.0	7.8	8.8	9.1	10.9	9.4	15.9	9.1	9.5	13.1	12.9	9.1	13.0	18.1	5.9	10.2	12.5	12.8	11.2	10.1	10.2	9.4	8.2	5.6	11.7	10.7	8.7	8.9	8.4	9.7	10.8	14.6	14.5	6.7	6.7	9.5	10.9	16.5	9.6	9.5	21.4	8.3	13.9	9.6	7.8	12.8	10.4	10.3	10.6	14.1	12.7	5.7	10.5	11.1	11.3	10.7	7.8	3.5	7.3	15.5	6.7	18.1	6.4	14.9	17.7	14.6	9.7	11.5	6.7	9.8	8.8	11.0	10.4	9.4	11.3	9.2	10.8	10.2	8.1	9.7	10.1	11.2	6.1	9.4	10.1	11.3	8.9	5.3	5.9	6.5	8.3	8.9	5.5	7.4	6.9	5.7	6.5	4.5	6.9	12.3	20.0	28.9	17.0	9.4	20.3	19.1	9.4	8.1	23.3	28.5	14.8	12.1	15.9	14.3	8.8	23.9	27.1	31.3	26.7	12.1	21.5	11.7	131.5	19.6	19.6	14.8	4.2	13.5	15.9	9.7	11.5	26.0	17.3	13.9	11.4	8.5	22.1	18.4	11.8	28.6	15.2	10.4	6.1	15.8	25.2	110.7	16.8	15.2	39.2	13.1	11.4	19.1	16.5	5.0	11.6	9.6	9.1	37.2	10.9	5.4	10.3	20.1	25.3	39.6	19.7	25.4	27.6	35.3	55.4	17.3	27.0	45.4	18.9	11.0	9.2	5.3
FAM81A	MGC26690	ENSG00000157470	"Family with sequence similarity 81 member A"	Q8TBF8	15	59372693-59523555	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 31.3;Excitatory neurons: 83.0;Inhibitory neurons: 67.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 5.1;plasmacytoid DC: 11.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.7"	"Cell line enriched"	"Detected in many"	4	"Daudi: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001847, HPA065797"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA001847: AB_2666462, HPA065797: AB_2685560"	"unprognostic (3.43e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.80e-2)"	0.4	0.1	7.0	2.4	10.5	0.2	1.4	0.0	17.0	6.7	0.5	4.3	2.4	2.4	4.4	0.4	6.1	1.6	1.5	11.0	3.2	6.8	0.4	0.7	4.9	0.0	0.1	0.6	1.9	1.1	2.6	0.8	0.1	2.3	5.2	1.3	2.6	1.5	0.5	0.9	1.4	1.2	0.0	1.4	2.4	1.8	6.0	0.4	2.1	2.8	5.5	0.4	0.4	8.3	10.5	15.0	1.1	0.2	0.4	0.2	6.0	0.6	0.0	1.0	2.8	1.8	1.7	66.5	0.3	0.2	14.1	7.8	8.3	2.5	1.9	0.7	4.3	0.0	10.6	0.8	0.0	5.7	1.3	0.0	1.5	0.4	0.8	0.8	0.1	2.7	0.1	0.0	1.0	3.5	0.1	0.1	0.9	2.7	5.4	1.5	14.8	1.7	3.3	3.8	3.0	0.8	6.0	0.3	9.9	0.6	2.5	3.4	0.3	2.4	7.4	2.9	11.4	0.1	0.0	0.8	2.5	2.2	6.7	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.1	2.3	0.0	0.0	0.3	0.1	0.0	11.7	0.0	0.3	7.0	10.5	0.0	17.0	11.0	3.2	0.0	0.1	0.1	0.0	6.0	8.3	0.2	0.0	1.3	11.4	2.5	0.5	1.4	0.2	0.6	0.0	2.4	2.4	6.9	0.0	1.0	31.3	0.0	0.1	0.0	1.7	5.9	0.5	0.5	11.2	0.9	0.7	1.2	1.3	83.0	0.2	1.6	0.6	1.1	1.5	1.3	0.2	0.4	0.2	1.3	10.1	67.0	1.9	2.0	0.6	1.5	1.4	0.3	0.7	8.8	4.7	0.7	1.1	0.0	2.5	8.1	0.4	1.9	0.0	1.2	1.4	0.8	0.3	8.4	0.2	0.0	1.1	3.1	0.2	1.6	1.5	0.4	0.0	0.4	0.2	4.0	1.0
FAM83A	"BJ-TSA-9, MGC14128"	ENSG00000147689	"Family with sequence similarity 83 member A"	Q86UY5	8	123178960-123210079	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 111.3;vagina: 55.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 71.2;Club cells: 58.2;Pancreatic endocrine cells: 28.7;Squamous epithelial cells: 19.3;Suprabasal keratinocytes: 15.2;Urothelial cells: 25.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 52.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 83.5;HBEC3-KT: 126.3;hTCEpi: 66.4;K-562: 206.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA052615			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA052615: AB_2797244"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.98e-9)"	"unprognostic (2.62e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.07e-2)"	0.2	0.6	0.0	0.1	0.0	0.2	0.3	0.2	0.1	18.9	0.1	0.1	1.0	0.0	1.3	111.3	4.3	1.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.7	0.0	0.1	7.5	6.4	0.1	10.2	2.4	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.4	0.0	7.4	3.8	55.8	0.0	83.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.6	0.7	10.6	0.0	0.0	25.9	0.0	126.3	0.0	0.0	0.1	0.8	9.2	0.0	0.0	0.1	0.1	0.0	66.4	0.0	16.8	0.0	0.0	0.1	206.3	0.1	0.0	0.3	0.0	0.1	0.0	4.2	0.1	0.0	0.0	0.1	0.0	18.4	0.1	0.0	14.4	9.7	0.1	0.2	1.5	0.2	0.6	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	4.0	71.2	1.2	0.0	4.4	0.9	1.1	0.0	58.2	1.8	0.0	0.1	0.0	1.0	0.0	0.3	1.0	0.0	0.1	0.1	0.0	0.0	0.6	0.7	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	10.2	0.0	0.4	1.6	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	28.7	0.2	0.0	0.1	0.7	1.1	0.1	9.6	0.0	0.0	0.1	1.4	2.2	0.6	19.3	15.2	0.0	0.1	0.0	0.8	25.0
FAM83E	FLJ20200	ENSG00000105523	"Family with sequence similarity 83 member E"	Q2M2I3	19	48599961-48615076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.7;salivary gland: 28.5;stomach 1: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 22.8;Early spermatids: 26.0;Gastric mucus-secreting cells: 74.9;Intestinal goblet cells: 26.9;Paneth cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.9;OE19: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049305, HPA075968"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Vesicles	"HPA049305: AB_2680705, HPA075968: "	"unprognostic (1.36e-1)"	"unprognostic (9.81e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.00e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.05e-8)"	"unprognostic (5.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.90e-3)"	0.1	0.1	0.2	3.7	0.3	0.4	1.4	0.8	0.5	10.6	0.2	32.7	30.0	1.1	0.1	7.0	3.9	6.4	0.2	0.3	0.2	0.8	0.3	8.0	0.2	0.1	0.1	0.0	1.2	0.0	0.2	0.6	0.2	3.2	16.6	0.2	28.5	0.4	2.7	1.9	30.0	1.0	0.0	0.2	37.4	2.2	0.2	0.1	0.1	0.0	1.3	1.2	4.1	0.5	0.4	0.4	0.0	0.7	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.3	2.9	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.4	0.1	0.1	0.3	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.8	1.1	9.4	0.9	0.2	0.1	0.3	0.0	0.2	0.5	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.2	0.5	0.1	0.1	0.2	0.1	1.0	0.1	0.2	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.8	0.5	0.3	0.2	0.1	0.1	0.2	0.0	0.2	0.5	0.0	9.6	13.4	1.3	0.4	0.0	1.4	0.8	0.6	0.0	1.8	0.8	2.1	8.6	6.5	1.8	0.0	0.1	0.3	22.8	0.0	0.1	26.0	4.8	0.5	0.2	5.4	0.0	0.3	1.1	0.1	0.2	74.9	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	26.9	2.0	0.0	0.0	9.3	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	1.6	16.5	0.0	0.4	3.3	12.7	0.0	5.1	0.0	0.0	0.2	0.2	0.8	0.5	2.3	0.0	0.1	0.3	0.1	12.8	6.9
FAM83H	FLJ46072	ENSG00000180921	"Family with sequence similarity 83 member H"	Q6ZRV2	8	143723933-143738234	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.5;skin 1: 34.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 58.7;hTCEpi: 59.8;MCF7: 118.2;OE19: 62.4;RT4: 70.1;T-47d: 58.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024505, HPA024604"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA024505: AB_1848417, HPA024604: AB_1848418"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (9.69e-3)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	2.1	4.0	1.9	2.1	1.7	0.5	4.4	1.2	2.2	11.5	2.6	9.8	8.4	0.8	3.3	70.5	4.7	3.3	0.8	2.0	1.1	11.8	13.5	6.3	0.9	1.6	2.4	0.3	13.9	7.9	5.9	3.5	1.5	7.2	4.3	1.1	17.1	3.8	0.1	34.9	9.1	0.3	1.3	1.7	11.0	2.8	1.5	1.5	14.1	0.0	4.0	8.3	23.2	2.2	47.0	28.3	0.3	0.1	0.1	0.0	16.6	4.0	0.0	2.0	0.7	25.8	53.4	0.0	6.1	1.0	0.0	56.1	3.5	51.9	0.9	0.0	0.2	1.5	58.7	18.3	4.3	0.6	1.7	2.9	59.8	0.2	15.0	0.8	0.0	4.2	22.2	0.1	0.0	118.2	0.8	0.4	4.8	62.4	15.3	0.1	0.1	6.0	16.5	70.1	7.1	0.2	38.3	53.8	7.8	7.5	58.2	8.2	0.3	0.1	7.2	3.9	0.2	0.0	0.0	0.2	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.7	1.2	2.2	2.0	1.1	1.6	2.4	1.5	1.3	1.5	2.2	0.1	32.1	16.5	0.7	0.6	22.8	17.7	21.9	6.8	2.0	18.2	14.0	4.6	14.3	18.9	29.5	2.1	12.8	0.5	38.5	3.9	22.0	1.2	11.4	2.9	1.0	14.4	0.0	1.3	25.9	17.8	1.6	25.0	25.9	0.0	5.4	0.7	25.5	4.7	10.1	0.5	24.3	16.2	2.8	0.8	0.7	0.0	1.3	1.8	0.0	2.8	6.6	2.1	0.5	0.1	42.7	27.2	0.4	0.4	26.4	23.6	7.0	17.4	2.0	0.0	0.2	1.9	1.7	1.0	38.9	26.9	14.6	0.9	1.2	27.8	33.9
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (5.53e-4)"	10.6	9.6	14.5	5.5	13.9	8.7	12.3	12.3	17.6	14.8	7.2	14.6	13.8	10.7	2.6	17.7	12.3	5.3	11.6	13.8	11.7	12.2	13.3	9.1	6.2	18.9	11.6	12.5	18.6	8.4	11.6	2.3	13.5	13.4	4.7	1.7	13.9	5.8	3.3	25.2	15.4	3.3	12.7	11.8	14.4	9.0	14.4	4.7	11.4	2.5	3.8	12.7	14.6	14.3	15.6	16.3	1.9	9.4	2.0	6.8	8.2	8.8	7.3	8.5	8.9	2.8	11.0	13.9	9.7	5.2	3.0	7.5	3.7	6.3	1.4	22.6	7.6	4.6	2.9	6.5	9.0	3.9	8.1	6.6	13.0	4.3	7.8	4.7	5.0	22.5	12.9	15.0	5.1	17.2	5.9	3.1	1.4	25.5	17.5	11.6	3.9	8.4	10.4	8.0	3.3	9.6	8.8	15.6	5.6	0.9	11.8	12.3	6.7	3.8	10.4	11.9	10.7	16.1	8.8	6.1	9.9	9.2	6.2	0.0	1.9	10.8	2.4	2.7	3.2	2.0	4.2	3.4	2.6	6.5	3.3	2.6	1.7	3.0	2.7	1.0	3.9	1.4	14.5	13.9	12.3	17.6	13.8	11.7	18.9	11.6	13.5	12.7	14.4	14.3	19.8	9.6	8.9	3.6	17.5	21.5	22.3	23.7	14.8	15.1	21.1	26.3	5.4	10.0	21.2	23.9	12.5	11.8	22.1	41.4	21.5	22.2	6.4	18.2	9.1	12.0	25.7	9.7	11.7	32.9	10.9	13.9	17.9	18.0	15.2	8.6	11.4	12.5	11.0	11.8	9.5	32.4	22.4	13.2	18.2	2.4	18.6	14.3	23.2	2.8	14.4	14.6	34.0	5.5	8.5	23.8	42.8	18.4	12.7	12.2	100.4	22.6	22.4	12.5	13.1	13.5	13.8	37.4	37.4	22.3	29.8	6.2	21.8	12.9	34.8	23.4
FARP1	"CDEP, MGC87400, PLEKHC2, PPP1R75"	ENSG00000152767	"FERM, ARH/RhoGEF and pleckstrin domain protein 1"	Q9Y4F1	13	98142562-98455176	"Predicted intracellular proteins"		"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 191.3;Early spermatids: 207.8;Inhibitory neurons: 176.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 125.3;Hep G2: 130.5;SuSa: 110.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000760			Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA000760: AB_1078816"	"unprognostic (4.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.18e-2)"	17.9	35.3	40.7	10.1	43.9	1.5	24.4	24.9	40.8	26.4	18.7	41.8	8.0	19.8	23.7	8.9	18.4	18.5	13.7	42.5	37.9	68.7	67.8	32.8	6.9	35.5	35.3	16.2	45.0	14.2	23.1	28.2	30.2	41.2	12.6	8.9	37.2	25.7	19.7	14.0	13.6	23.4	35.6	13.0	32.9	14.0	38.9	3.3	43.9	15.1	3.7	27.0	16.1	28.6	0.7	10.7	47.1	66.7	13.3	26.0	22.7	72.0	46.9	39.8	34.8	83.9	31.9	0.2	27.0	125.3	9.8	1.5	20.1	19.9	66.4	1.3	20.5	0.4	38.9	130.5	35.3	0.3	0.6	30.6	8.9	11.6	2.6	23.0	26.5	1.0	0.1	0.7	27.8	18.6	2.8	0.4	22.5	40.7	12.5	25.4	18.3	1.4	88.0	46.8	20.0	43.5	8.8	18.9	51.0	110.8	26.9	0.1	25.6	42.8	16.1	29.2	37.0	0.7	0.7	0.5	19.9	1.4	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	43.9	24.9	40.8	42.5	37.9	35.5	35.3	30.2	35.6	38.9	28.6	37.3	44.8	24.8	191.3	2.6	6.9	60.2	8.8	15.4	13.9	73.3	40.8	8.4	123.0	27.5	57.0	45.9	6.7	4.0	10.9	80.3	47.5	207.8	70.3	90.5	23.9	31.1	2.7	75.3	35.1	6.4	29.9	23.4	100.7	13.3	44.5	23.2	58.4	53.5	30.3	176.4	10.1	24.4	22.7	9.3	125.9	19.0	14.0	28.4	44.0	17.5	29.6	2.1	104.5	3.7	47.0	4.4	29.3	3.1	56.8	0.3	139.6	38.6	15.7	19.7	18.7	55.4	9.2	15.9	3.2	2.8	4.5	6.4	60.4	12.6	47.2
FARP2	"FIR, FRG, KIAA0793, PLEKHC3"	ENSG00000006607	"FERM, ARH/RhoGEF and pleckstrin domain protein 2"	O94887	2	241356285-241494841	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 128.2;Oligodendrocytes: 114.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031226, HPA055592"	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA031226: AB_10602808, HPA055592: AB_2682856"	"unprognostic (3.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-1)"	9.6	10.3	13.8	11.4	16.8	5.4	9.0	19.3	16.0	10.0	9.8	22.6	20.2	10.6	7.3	14.1	9.2	10.0	7.6	13.2	12.9	11.0	17.1	10.4	11.9	15.6	15.2	11.0	11.4	13.2	8.4	9.0	15.6	10.1	21.3	10.1	9.2	10.0	10.6	22.6	18.9	11.6	11.7	11.6	20.3	28.1	16.2	8.5	6.8	9.9	13.8	14.2	10.1	21.3	20.0	14.3	25.8	17.7	21.9	29.1	23.1	19.7	16.3	20.0	20.6	15.3	23.4	8.5	5.2	38.8	14.1	22.4	35.0	20.6	30.4	13.3	18.1	18.8	25.4	20.3	16.0	17.0	14.1	29.3	15.2	29.2	23.7	9.3	18.4	16.1	21.7	7.6	16.3	16.7	18.3	12.5	12.8	35.3	11.1	20.3	58.2	25.7	25.9	41.0	30.5	20.3	22.1	15.4	59.5	14.9	8.1	16.8	27.9	18.8	14.3	23.8	16.0	13.0	10.0	18.8	17.2	11.5	39.0	6.1	2.1	7.3	1.3	5.1	1.2	4.4	1.4	1.5	3.1	4.9	0.9	1.0	1.3	1.7	2.8	6.4	2.2	1.6	13.8	16.8	19.3	16.0	13.2	12.9	15.6	15.2	15.6	11.7	16.2	21.3	8.9	28.9	5.9	27.4	23.9	15.4	11.4	8.0	16.5	12.7	11.1	8.3	29.6	14.3	12.3	18.4	18.8	5.8	9.7	36.3	3.9	9.3	42.7	12.0	10.6	10.5	28.1	3.4	43.1	12.3	5.4	12.9	45.3	14.0	6.3	15.9	11.0	11.6	4.2	20.2	36.7	38.7	10.2	8.4	9.4	25.0	14.9	11.9	39.2	38.4	8.5	4.9	2.1	128.2	114.0	12.6	24.1	10.5	14.4	12.8	20.9	7.1	17.3	15.1	19.7	21.4	14.1	45.6	19.7	13.8	15.2	11.1	6.0	11.3	26.2	22.4
FARSA	"CML33, FARSL, FARSLA"	ENSG00000179115	"Phenylalanyl-tRNA synthetase subunit alpha"	Q9Y285	19	12922479-12934037	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001911	Enhanced		Approved	Cytosol		NA	NA		55000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA001911: AB_1848427"	"unprognostic (1.52e-1)"	"prognostic favorable (8.23e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.22e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (8.32e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.84e-2)"	26.4	32.5	30.1	29.4	32.2	31.6	25.0	28.1	40.0	21.8	19.4	29.1	26.2	24.3	12.1	39.2	24.0	16.4	37.4	33.4	32.7	29.1	40.6	20.7	36.0	32.6	31.8	23.1	36.3	30.4	32.1	22.5	33.4	25.5	17.1	14.7	30.4	21.7	57.0	33.3	26.5	17.7	24.3	32.0	30.6	22.6	30.6	33.0	25.5	30.6	25.4	30.6	25.6	31.1	135.7	125.6	49.3	106.9	33.4	31.4	88.9	93.6	60.8	133.0	103.9	154.2	56.1	148.7	147.1	54.1	53.9	101.9	121.0	108.4	48.1	87.9	183.7	117.0	106.8	124.2	108.4	227.7	147.8	43.4	78.7	102.8	82.1	43.8	73.1	148.7	179.6	30.6	56.7	181.5	273.4	283.5	154.2	83.4	210.6	139.5	51.2	191.4	70.5	78.7	153.8	141.4	64.2	109.2	69.0	23.0	85.9	137.5	71.3	108.0	47.8	165.6	180.6	199.6	186.5	156.8	97.7	203.4	114.1	66.6	111.0	86.3	87.1	119.0	108.2	88.2	85.1	81.4	120.4	94.5	85.4	82.3	7.0	118.0	92.8	97.0	87.6	130.2	30.1	32.2	28.1	40.0	33.4	32.7	32.6	31.8	33.4	24.3	30.6	31.1	15.0	9.6	21.4	9.1	24.7	25.4	28.0	63.4	20.5	25.1	18.8	18.5	25.7	14.3	35.4	23.9	10.4	87.5	17.5	26.7	58.7	55.4	5.8	16.0	18.6	20.0	22.8	61.8	12.1	46.4	78.7	18.4	27.5	15.8	23.5	26.3	21.0	25.8	62.9	18.5	12.8	32.6	69.2	23.5	21.2	9.4	19.0	19.7	33.8	1.9	45.5	23.6	25.7	8.5	7.5	47.0	26.3	13.2	40.9	32.6	30.4	55.7	22.3	17.1	6.6	16.5	24.3	20.2	41.9	26.3	29.5	96.7	22.5	28.9	44.7	26.8
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990531-89017059	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 114.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 114.7;T-cells: 96.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.4;Karpas-707: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	11900000	420000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	14.1	26.3	3.6	17.0	3.6	20.8	10.9	2.9	4.7	12.7	2.8	16.4	7.0	12.8	10.3	10.8	14.8	15.7	7.5	3.6	3.7	7.2	23.3	21.7	18.9	4.6	3.1	20.1	3.7	2.7	3.7	10.4	4.0	8.9	23.3	3.3	6.5	9.3	2.3	9.4	9.2	15.0	3.5	11.2	4.4	2.6	3.9	14.4	7.3	2.6	15.6	12.9	10.2	4.3	22.7	8.2	5.4	13.9	37.0	51.3	0.0	51.8	50.2	1.7	9.1	0.1	23.4	4.7	19.0	52.1	9.6	4.0	1.0	44.8	3.2	83.4	8.7	0.4	5.2	14.7	31.6	3.4	1.6	69.2	38.7	31.4	66.0	24.5	4.7	17.8	0.0	109.0	44.0	1.4	6.4	3.4	0.6	0.2	1.8	1.4	0.5	5.0	60.7	7.3	0.4	0.2	7.7	0.0	0.8	7.0	13.9	1.0	9.5	15.8	9.0	15.2	12.3	45.3	5.3	0.4	11.8	10.2	4.5	43.1	9.4	30.9	9.9	12.3	13.8	7.5	27.6	19.6	11.5	4.0	3.1	10.0	114.7	3.1	22.1	0.2	96.2	12.8	3.6	3.6	2.9	4.7	3.6	3.7	4.6	3.1	4.0	3.5	3.9	4.3	10.3	57.7	13.8	40.1	12.8	45.9	109.7	53.1	39.9	0.0	5.5	9.5	3.5	12.8	27.5	9.2	0.0	0.4	16.3	24.9	0.0	6.3	11.3	9.2	22.3	8.9	8.4	9.5	8.8	4.3	0.2	35.4	8.6	15.5	3.8	4.9	2.2	19.3	5.5	1.7	2.8	14.4	8.2	7.0	31.7	4.9	19.0	17.7	12.4	17.8	20.9	14.5	10.3	8.0	0.7	6.5	8.7	13.9	32.2	46.0	15.6	14.4	26.3	0.7	6.6	26.8	29.1	11.3	1.1	28.5	43.9	0.4	48.4	11.8	24.4	30.0
FAT4	"CDHF14, CDHR11, FAT-J"	ENSG00000196159	"FAT atypical cadherin 4"	Q6V0I7	4	125314918-125492932	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Endothelial cells: 18.0;Fibroblasts: 17.9;Hepatic stellate cells: 33.2;Inhibitory neurons: 35.0;Microglial cells: 23.4;Oligodendrocytes: 54.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;ASC TERT1: 11.2;fHDF/TERT166: 11.4;HSkMC: 13.6;HUVEC TERT2: 14.3;TIME: 21.9"	"Low region specificity"	"Detected in many"							HPA052819	Approved		Approved	Cytosol		NA	NA		2300000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA052819: AB_2681963"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.81e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-3)"	3.3	1.0	3.2	1.4	4.1	0.0	2.7	1.2	2.7	4.0	0.7	6.4	0.9	3.0	1.3	2.3	1.9	4.3	4.0	3.8	2.0	2.8	2.5	4.5	0.8	3.1	2.8	4.9	0.9	3.0	0.6	2.9	2.8	3.7	2.3	0.5	1.0	2.6	1.6	1.4	2.2	3.5	3.5	2.7	2.0	0.7	3.3	1.1	4.0	4.8	0.8	2.5	1.8	4.8	0.0	0.9	7.4	0.8	15.5	11.2	0.0	2.6	3.0	1.2	1.2	0.0	0.4	0.0	3.1	11.4	1.5	0.0	2.8	3.2	0.7	0.0	1.3	1.7	3.3	0.1	5.4	1.1	0.0	13.6	1.9	0.7	7.0	9.1	14.3	0.0	0.0	1.9	6.7	0.1	0.5	0.0	0.5	0.0	0.3	0.9	1.5	0.0	0.1	0.0	0.2	1.5	0.4	0.0	0.0	0.4	0.0	0.0	21.9	7.8	2.2	2.7	1.1	0.3	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	4.1	1.2	2.7	3.8	2.0	3.1	2.8	2.8	3.5	3.3	4.8	19.3	6.4	0.0	8.8	0.0	1.7	0.2	1.5	0.0	3.7	0.3	1.3	6.9	0.0	0.3	5.5	0.0	0.1	0.9	0.0	0.0	0.7	0.9	0.6	8.8	18.0	0.0	0.0	9.4	0.2	0.0	17.9	1.1	1.0	0.0	1.2	33.2	7.4	0.2	0.0	35.0	0.0	0.0	2.2	2.2	0.2	5.9	0.3	3.6	23.4	0.0	1.1	1.0	6.0	54.4	0.3	0.0	4.9	1.4	0.4	0.0	0.7	0.1	0.2	0.0	5.3	4.1	0.1	0.6	0.5	0.6	0.0	0.3	5.7	0.0	0.1
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408313-48645721	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.9;placenta: 76.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 132.4;Fibroblasts: 388.5;Leydig cells: 236.1;Oligodendrocytes: 218.7;Peritubular cells: 227.2;Skeletal myocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.1;ASC TERT1: 460.7;fHDF/TERT166: 420.8;HSkMC: 251.3;hTERT-RPE1: 211.1;U-138 MG: 206.9;U-2197: 305.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		520000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	60.9	4.4	1.4	14.5	5.4	3.4	13.7	2.8	2.8	36.0	9.5	8.3	3.8	15.2	6.3	12.6	12.2	27.3	23.5	0.8	2.0	2.7	2.9	10.0	3.7	5.2	6.0	28.4	3.3	3.0	2.5	76.7	3.7	8.0	11.7	1.3	4.6	13.2	4.5	5.7	6.6	35.7	2.3	6.4	6.0	7.1	4.7	2.9	18.6	21.2	3.5	18.8	9.9	5.0	0.1	5.2	19.8	22.4	215.1	460.7	0.2	175.8	62.9	51.1	32.4	0.1	0.3	0.1	7.9	420.8	0.4	0.7	3.9	0.6	45.9	20.7	1.2	2.0	88.5	0.2	120.7	0.8	0.3	251.3	0.1	135.9	15.6	211.1	55.5	1.6	0.0	0.4	55.6	0.0	1.5	0.2	4.0	0.2	7.1	0.1	17.0	0.2	5.9	0.5	0.2	12.9	0.0	2.2	0.1	15.3	0.2	1.4	106.8	206.9	6.2	305.8	37.6	1.2	1.0	0.0	138.9	0.3	13.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	5.4	2.8	2.8	0.8	2.0	5.2	6.0	3.7	2.3	4.7	5.0	50.0	0.0	1.3	34.9	0.4	25.6	0.8	1.5	0.6	6.1	1.3	3.4	14.2	0.0	5.8	12.9	0.0	132.4	0.4	0.0	0.0	0.2	8.7	4.2	105.2	36.1	0.0	5.5	82.3	0.6	40.8	388.5	3.1	2.0	1.3	22.5	34.6	0.6	15.3	0.0	123.5	0.0	0.0	0.8	39.0	22.8	236.1	5.7	42.7	30.0	2.3	0.8	0.0	76.9	218.7	1.7	0.0	227.2	1.7	0.7	0.1	0.6	3.3	0.2	26.3	139.5	55.8	3.3	3.4	0.8	20.6	65.8	4.3	51.3	0.0	0.2
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"placenta: 81.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 298.1;Syncytiotrophoblasts: 163.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 134.1;HSkMC: 94.3;hTERT-HME1: 215.2;HUVEC TERT2: 122.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		11000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (7.41e-5)"	0.1	5.1	0.4	0.8	0.5	3.1	0.2	0.0	0.3	2.2	3.0	0.8	0.3	1.7	0.1	0.1	0.4	0.3	5.5	0.2	0.6	0.1	0.1	0.2	0.5	1.1	1.9	0.5	0.2	0.0	0.8	81.9	0.5	0.8	1.2	0.9	0.3	0.4	0.2	0.2	0.4	1.3	0.5	0.4	0.8	7.4	0.8	0.2	0.5	0.4	0.9	0.5	0.7	0.3	0.0	16.4	58.2	0.0	9.4	16.6	11.8	62.8	0.0	56.0	41.8	0.2	0.0	0.0	0.1	85.5	0.0	9.2	37.6	9.8	52.7	0.1	13.8	0.0	27.3	0.2	134.1	8.4	0.0	94.3	5.3	24.1	215.2	17.9	122.3	0.0	0.0	0.0	35.8	0.1	0.0	3.4	24.5	0.0	18.2	19.2	18.1	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.6	48.0	0.0	18.7	0.0	22.1	41.9	66.8	0.3	0.0	0.0	0.0	6.9	0.0	23.8	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.2	0.4	0.5	0.0	0.3	0.2	0.6	1.1	1.9	0.5	0.5	0.8	0.3	0.1	0.0	0.5	1.6	0.2	0.0	0.1	1.2	0.6	0.0	0.3	0.3	12.7	0.0	1.4	0.0	0.0	298.1	0.0	0.0	0.0	0.3	3.8	10.0	3.9	1.0	0.0	0.0	1.1	0.0	24.3	8.8	0.0	4.7	0.0	0.1	0.0	0.0	34.0	0.0	50.5	0.0	0.0	10.7	0.4	7.2	1.2	2.7	1.8	1.9	6.2	3.8	0.0	17.6	1.5	0.1	0.0	2.2	0.0	2.0	0.0	0.2	1.6	0.1	6.6	0.1	3.5	10.7	3.5	0.1	0.4	163.5	0.1	8.4	0.1	0.1
FBRSL1	KIAA1545	ENSG00000112787	"Fibrosin like 1"	Q9HCM7	12	132489551-132585188	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 90.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049880	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA049880: AB_2680930"	"unprognostic (2.02e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (9.82e-4)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (7.21e-4)"	12.3	19.2	16.3	8.7	13.1	10.1	13.2	20.7	21.2	17.8	7.2	20.5	11.2	18.6	7.7	15.6	18.7	4.1	31.1	16.2	6.7	19.3	26.8	16.2	8.5	10.0	7.7	22.3	39.2	7.3	28.7	5.7	8.0	22.0	3.6	5.9	14.7	7.2	31.9	19.4	23.3	4.1	4.7	28.3	21.4	29.1	9.6	6.2	15.7	9.4	4.7	17.8	15.7	10.2	11.7	18.5	8.7	14.8	3.7	4.5	64.4	10.9	3.1	7.1	4.3	32.7	6.9	19.0	18.4	3.6	6.1	22.6	9.3	6.1	2.3	14.7	47.6	23.2	11.0	25.0	8.0	24.7	23.4	4.1	10.7	6.6	4.8	6.5	7.0	15.9	49.9	3.8	3.1	29.8	33.7	90.0	22.7	8.4	33.4	50.9	9.3	13.2	6.2	11.2	33.4	28.0	10.2	15.8	14.1	3.6	18.6	23.7	11.1	7.6	18.5	13.7	13.9	24.6	13.0	12.0	8.8	23.8	9.4	1.2	0.4	1.2	0.3	0.3	0.3	0.8	0.3	0.3	0.3	0.6	0.3	0.4	0.5	0.2	0.7	1.0	0.6	0.3	16.3	13.1	20.7	21.2	16.2	6.7	10.0	7.7	8.0	4.7	9.6	10.2	14.9	3.2	5.2	24.2	12.8	9.2	7.1	3.3	11.4	28.9	20.7	18.5	13.7	4.3	4.0	11.0	41.7	6.9	19.8	24.0	7.9	6.2	1.4	16.8	17.9	8.8	31.0	12.0	17.0	7.6	5.8	11.8	15.3	22.0	1.3	22.6	7.5	22.2	6.9	11.8	17.1	21.7	0.0	11.6	11.1	2.0	16.1	16.4	5.4	15.0	7.7	9.3	6.2	12.5	16.8	9.0	15.0	15.4	11.9	16.0	13.3	6.4	6.4	22.7	6.6	12.7	11.5	5.7	8.0	10.8	10.4	11.5	10.9	12.7	18.7	10.4
FBXL14	"Fbl14, MGC40195"	ENSG00000171823	"F-box and leucine rich repeat protein 14"	Q8N1E6	12	1565993-1594581	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 47.4;Late spermatids: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053889	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA053889: AB_2682293"	"unprognostic (8.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.90e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (9.04e-6)"	"unprognostic (5.60e-3)"	"unprognostic (1.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.12e-3)"	5.2	4.3	7.9	5.9	10.6	5.8	4.6	8.7	21.4	3.6	2.4	8.4	4.9	4.5	1.6	6.0	5.7	4.8	5.2	10.6	7.8	4.6	3.9	5.7	7.5	7.8	8.1	4.7	11.3	7.1	8.7	4.2	8.3	3.7	3.5	4.2	6.2	4.0	3.3	3.4	6.2	2.1	7.4	6.4	9.7	21.1	9.0	8.3	6.4	2.5	3.3	4.7	4.3	8.6	11.8	16.3	4.8	8.4	4.0	4.1	14.3	2.6	4.7	2.4	2.7	17.1	14.8	15.8	3.1	2.9	4.0	8.1	3.9	6.0	0.4	27.2	19.0	19.6	4.7	5.5	5.3	15.0	14.4	6.5	2.7	4.4	3.7	4.3	4.3	13.4	8.3	43.2	2.9	12.4	15.9	7.4	21.2	6.4	6.7	13.5	7.8	9.9	3.8	10.3	9.2	9.1	6.3	9.5	9.8	4.9	7.5	12.1	6.4	5.3	17.5	6.8	9.5	5.3	6.1	19.7	11.3	8.7	8.2	0.7	0.1	0.0	0.1	0.1	0.1	0.2	0.4	0.4	0.2	1.7	0.4	0.2	0.3	0.6	0.2	0.2	1.6	0.1	7.9	10.6	8.7	21.4	10.6	7.8	7.8	8.1	8.3	7.4	9.0	8.6	1.9	0.0	0.0	11.4	1.1	0.0	0.3	0.5	1.8	4.2	1.1	0.9	0.9	0.0	0.3	0.0	0.0	0.2	0.5	1.6	0.0	0.2	47.4	1.7	0.8	2.3	0.0	0.4	12.3	0.5	0.1	1.3	1.5	0.9	0.0	0.5	2.9	1.1	0.6	10.1	13.4	0.7	2.0	0.8	0.8	103.7	0.3	1.2	0.0	12.2	0.8	2.7	0.0	10.6	17.1	0.1	0.7	1.5	1.8	0.8	1.4	0.8	1.0	3.0	0.0	1.7	1.1	10.4	0.5	2.9	0.0	0.1	1.8	0.9	1.2	0.3
FBXL18	"Fbl18, FLJ11467"	ENSG00000155034	"F-box and leucine rich repeat protein 18"	Q96ME1	7	5431335-5513809	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036049			Approved	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA036049: AB_2674918"	"unprognostic (2.86e-3)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.98e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.28e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.30e-4)"	"unprognostic (1.73e-3)"	2.3	1.9	6.8	2.0	7.0	2.7	1.1	3.2	14.2	1.0	1.8	1.3	1.7	1.5	1.1	2.0	1.1	0.9	1.9	10.2	4.3	1.3	1.2	1.3	1.9	5.3	2.5	1.2	2.6	2.1	1.4	1.3	2.6	1.4	0.9	1.4	2.0	1.2	3.6	3.8	1.5	1.3	0.7	1.5	1.6	1.6	5.8	1.4	1.4	2.0	1.6	1.3	1.0	5.1	11.0	15.2	3.7	9.7	5.7	4.2	6.9	6.5	2.9	4.0	3.9	12.0	7.4	5.2	7.5	4.0	7.4	17.3	4.9	14.7	2.8	3.5	6.3	2.8	10.7	4.7	4.2	4.9	4.3	4.3	7.9	6.4	3.6	3.8	5.0	3.0	8.0	3.5	3.7	16.4	3.0	5.3	13.7	5.1	12.1	6.8	7.8	3.6	4.0	6.1	7.9	12.2	10.2	18.1	3.5	4.5	17.9	4.4	11.4	12.9	16.6	10.1	9.9	5.2	7.5	3.8	7.1	7.1	16.1	6.3	2.1	0.9	1.4	2.1	1.3	1.3	0.9	1.4	1.6	1.8	1.0	1.2	5.0	2.3	2.9	1.4	1.2	1.5	6.8	7.0	3.2	14.2	10.2	4.3	5.3	2.5	2.6	0.7	5.8	5.1	4.8	6.4	4.8	6.2	2.6	2.5	3.0	0.9	1.2	9.7	3.9	9.1	5.3	2.8	5.8	0.0	4.2	3.9	5.5	4.8	0.0	2.4	1.5	7.6	3.5	2.8	4.8	0.4	10.8	2.6	2.7	2.7	4.6	7.3	2.5	3.0	2.5	1.8	1.5	1.7	8.5	1.9	4.1	3.5	2.9	0.5	1.5	2.4	0.0	7.5	3.2	4.7	5.2	4.0	7.8	2.2	2.1	0.7	1.4	2.4	2.4	1.2	3.2	6.6	0.0	4.7	3.0	2.7	4.9	2.4	3.3	2.2	2.9	1.5	4.8	1.8
FBXO10	FBX10	ENSG00000147912	"F-box protein 10"	Q9UK96	9	37510892-37576380	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 29.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.8;Excitatory neurons: 28.6;Inhibitory neurons: 28.2;Late spermatids: 45.7;Oligodendrocyte precursor cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.1;naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"AF22: 24.0;HHSteC: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA002863, HPA072721"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002863: AB_10965996, HPA072721: "	"unprognostic (2.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.93e-5)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-1)"	2.9	8.0	5.9	3.2	6.2	0.8	2.4	2.6	7.4	3.3	3.9	7.4	1.8	4.5	10.7	3.2	2.5	2.7	3.9	9.0	6.4	3.8	3.6	2.3	5.5	3.6	5.1	2.5	6.6	3.8	16.4	2.0	4.4	3.3	1.8	1.6	8.5	2.9	29.8	1.9	4.7	3.2	3.6	10.0	3.2	9.4	6.8	2.0	7.6	13.9	5.3	3.0	2.7	5.6	2.3	5.6	24.0	6.2	11.1	3.9	2.0	4.2	7.6	5.3	7.7	3.2	1.5	14.4	1.4	4.6	2.1	0.2	8.8	2.1	3.8	8.2	5.8	2.9	5.3	2.8	33.8	7.9	1.0	9.0	1.7	4.7	3.1	3.4	7.5	1.4	10.4	3.9	9.4	2.0	3.0	2.6	11.2	3.3	2.1	5.5	10.4	1.8	3.0	1.5	5.1	12.8	2.8	3.4	3.2	7.1	1.4	8.0	6.1	3.7	6.3	3.4	3.1	4.5	3.9	2.3	3.1	3.0	3.5	0.0	0.0	0.0	0.2	0.0	0.2	2.1	0.4	0.2	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.2	5.9	6.2	2.6	7.4	9.0	6.4	3.6	5.1	4.4	3.6	6.8	5.6	0.7	0.0	1.1	12.4	6.7	0.3	0.1	0.4	0.6	3.9	1.2	0.8	1.7	2.8	0.5	1.8	4.2	0.3	0.3	0.1	0.0	1.1	34.8	1.1	4.3	1.4	5.4	0.4	28.6	1.5	0.8	1.8	0.5	1.3	0.0	1.9	3.9	1.2	4.1	3.3	28.2	0.5	2.0	0.3	0.0	45.7	0.9	0.6	1.8	4.7	0.7	1.6	0.0	16.6	7.0	1.2	0.2	1.5	5.7	0.9	0.2	1.3	1.1	1.0	0.0	3.1	1.0	4.2	1.9	0.7	0.6	0.3	1.3	5.0	0.3	0.3
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490278	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 18.4;pituitary gland: 17.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5;Excitatory neurons: 44.4;Inhibitory neurons: 43.6;Rod photoreceptor cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 9.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 9.6"	"Cell line enhanced"	"Detected in many"		"AF22: 20.3;Karpas-707: 22.4"	"Low region specificity"	"Detected in all"							"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: AB_2683795, HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favorable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.5	1.8	3.9	0.9	5.0	2.2	2.6	6.8	7.0	4.1	2.9	1.6	2.0	1.1	18.4	0.7	4.4	1.4	1.4	4.6	3.9	3.2	6.0	1.5	1.4	1.1	1.7	0.7	4.7	7.1	17.3	0.6	2.0	3.5	2.0	14.3	3.4	5.1	1.1	0.4	2.9	0.7	0.3	1.2	2.2	4.2	3.5	0.6	7.0	0.9	2.8	1.2	0.7	4.3	16.5	2.9	20.3	7.5	0.5	0.0	0.3	0.2	0.5	3.0	5.5	3.1	4.6	5.8	7.2	0.1	8.1	5.1	2.3	3.5	3.0	2.6	3.6	2.7	0.3	1.7	0.0	3.5	1.9	0.2	10.8	0.7	3.2	1.5	0.0	5.6	1.1	22.4	1.0	5.7	0.5	5.0	3.9	2.2	4.5	0.2	4.5	8.2	3.9	2.4	13.1	5.4	0.4	3.3	9.5	3.5	13.8	5.9	0.6	1.6	5.8	3.2	3.0	5.2	5.0	5.2	6.8	0.7	3.5	0.3	0.1	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.2	0.1	0.2	0.9	0.0	0.1	9.6	0.2	0.1	3.9	5.0	6.8	7.0	4.6	3.9	1.1	1.7	2.0	0.3	3.5	4.3	0.0	3.2	4.1	7.5	1.7	0.1	3.0	10.9	5.2	8.2	3.9	3.4	2.1	8.6	7.9	3.7	35.5	0.6	0.0	0.5	7.9	5.3	12.1	13.5	1.3	0.2	10.2	0.0	44.4	4.6	0.4	0.9	1.5	6.4	0.0	1.9	0.4	1.9	2.7	5.0	43.6	3.9	4.1	0.8	2.3	12.4	1.2	0.4	0.0	2.8	0.0	9.3	0.0	23.6	3.2	3.1	0.4	0.7	11.1	1.7	0.2	4.7	23.4	48.6	0.0	0.5	1.8	10.5	5.6	1.2	0.0	0.0	0.5	4.2	1.0	1.7
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 238.9;choroid plexus: 125.3;pancreas: 86.9;pituitary gland: 118.3"	"Cell type enriched"	"Detected in many"	4	"Exocrine glandular cells: 685.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 113.4;HBEC3-KT: 96.9;Hep G2: 239.8;SiHa: 440.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA005472: AB_2667332"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	6.8	25.2	217.0	1.8	172.1	0.0	13.5	161.1	216.1	7.2	125.3	4.9	16.4	2.3	6.7	8.9	5.9	2.5	11.6	183.3	238.9	32.8	28.1	5.7	2.0	200.2	196.2	3.6	86.9	29.7	118.3	0.1	201.7	15.1	0.4	7.5	25.1	7.5	4.8	18.1	5.3	0.7	176.0	3.7	9.6	12.0	195.1	10.6	8.4	1.0	3.6	5.1	13.1	192.3	35.7	10.8	0.4	35.1	0.7	0.0	5.3	1.5	3.0	1.1	0.2	113.4	10.0	0.0	40.6	0.3	8.3	0.1	3.6	96.9	0.1	0.8	1.0	0.0	1.7	239.8	4.6	0.1	0.0	3.0	17.0	0.0	0.9	1.1	0.4	0.1	0.3	0.1	0.0	0.5	0.0	0.0	1.3	14.3	1.3	0.1	0.1	0.2	8.2	3.0	3.6	4.7	440.5	0.1	3.9	3.5	21.1	0.0	0.0	0.3	3.1	0.0	0.0	2.4	2.1	1.7	0.7	0.0	1.0	0.0	0.0	0.0	0.9	0.0	1.3	0.7	0.5	1.2	0.0	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.4	0.2	217.0	172.1	161.1	216.1	183.3	238.9	200.2	196.2	201.7	176.0	195.1	192.3	1.2	0.0	1.5	40.8	8.4	19.6	62.3	149.9	90.5	11.3	15.0	75.4	3.7	15.7	33.5	47.8	2.1	0.8	5.9	0.2	86.1	23.2	2.1	1.2	0.7	1.8	1.2	0.0	16.5	685.9	3.9	8.7	6.6	0.7	4.5	0.2	2.5	102.0	0.4	28.6	16.7	0.7	38.7	2.2	2.6	2.4	34.8	1.1	44.4	5.6	3.2	106.6	7.2	6.6	10.4	132.1	2.2	40.6	3.3	39.2	2.0	7.2	44.4	15.8	0.0	1.1	7.7	18.4	12.1	10.0	9.9	1.0	13.0	0.5	0.4	25.0
FBXO3	"FBA, FBX3"	ENSG00000110429	"F-box protein 3"	Q9UK99	11	33740939-33774543	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002467			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA002467: AB_2666602"	"unprognostic (1.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.36e-2)"	"prognostic favorable (2.46e-9)"	"unprognostic (6.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-2)"	21.2	24.2	18.1	14.8	21.6	26.9	27.5	20.7	24.6	21.4	19.0	21.4	18.1	24.8	24.2	33.6	23.3	21.5	46.3	20.3	19.8	47.0	42.0	19.7	18.3	16.5	16.8	28.9	27.1	56.8	17.7	16.5	17.5	25.6	23.7	33.9	23.0	25.5	124.1	28.9	20.5	24.5	17.2	19.1	23.5	25.2	19.0	20.4	34.3	98.8	21.4	20.8	22.5	19.0	22.1	19.2	25.8	27.6	30.4	23.8	15.6	25.7	25.6	20.4	25.3	22.1	21.6	14.6	17.7	28.2	25.1	37.2	34.8	33.9	34.1	14.7	48.2	7.5	28.4	18.3	19.4	17.4	16.9	24.2	33.8	14.1	22.3	29.7	27.3	10.6	25.9	28.4	23.2	14.9	13.0	10.2	13.1	49.4	29.5	9.9	57.5	20.8	29.5	27.5	36.3	20.0	36.4	24.8	19.6	24.6	35.8	13.2	25.2	25.2	22.0	35.9	22.0	15.7	22.1	24.5	22.5	13.4	25.4	25.9	11.9	18.0	21.6	11.8	24.4	16.2	25.5	24.6	12.8	20.0	32.1	22.4	12.8	25.1	15.5	6.6	34.3	15.8	18.1	21.6	20.7	24.6	20.3	19.8	16.5	16.8	17.5	17.2	19.0	19.0	33.3	35.3	17.2	31.3	28.9	48.8	64.2	32.0	35.3	56.8	24.5	14.7	42.4	21.5	31.0	25.8	27.1	22.7	28.9	22.6	56.7	49.6	130.8	17.3	19.2	31.7	23.9	32.8	45.1	25.3	28.7	30.7	17.3	21.8	16.5	25.8	32.5	41.0	12.3	57.2	37.9	18.8	54.9	15.0	20.1	51.3	29.8	11.9	28.4	22.5	15.2	46.7	40.2	30.7	40.1	34.9	25.2	27.1	28.3	33.3	23.2	63.6	34.4	52.4	59.2	26.2	37.1	64.2	27.3	43.6	67.5	36.5	32.9	19.4	16.7	50.4
FBXO31	"FBX14, Fbx31, FBXO14, MGC15419"	ENSG00000103264	"F-box protein 31"	Q5XUX0	16	87326987-87392142	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 65.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030150	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA030150: AB_10670559"	"unprognostic (4.85e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.16e-5)"	"unprognostic (3.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.26e-3)"	33.7	12.8	6.8	6.0	8.5	5.7	24.3	39.0	14.5	14.9	0.0	20.9	8.6	21.7	4.4	10.2	16.8	6.2	18.2	11.9	13.4	5.3	15.9	8.7	6.4	8.3	5.5	15.0	13.1	8.2	19.4	4.9	11.1	10.2	5.8	8.1	11.1	10.7	65.3	17.0	15.9	11.1	2.7	5.2	11.5	18.7	9.5	5.7	8.7	36.8	4.6	21.8	13.0	7.6	7.0	13.1	4.3	11.7	21.6	12.9	12.5	12.0	11.9	11.6	6.1	11.9	5.8	16.3	12.9	12.7	5.9	10.6	8.3	10.0	7.7	7.5	15.5	5.5	8.7	34.1	12.1	5.3	4.4	15.4	8.3	15.2	14.3	7.6	7.2	8.3	15.9	6.3	6.3	10.1	13.0	7.3	8.4	7.3	11.5	16.1	5.1	7.0	5.2	4.9	20.0	9.7	26.7	5.4	8.3	3.1	8.5	4.6	10.1	11.2	8.5	10.8	9.6	14.4	12.0	20.1	9.0	9.8	7.0	0.5	0.1	0.0	0.2	0.1	0.4	0.6	0.4	0.6	0.1	0.3	0.4	0.5	0.2	0.0	0.2	0.2	1.1	0.4	6.8	8.5	39.0	14.5	11.9	13.4	8.3	5.5	11.1	2.7	9.5	7.6	61.3	0.0	4.6	13.1	7.3	14.7	5.1	3.3	17.1	13.8	6.4	6.7	20.6	2.8	2.1	5.5	33.3	10.8	4.6	19.3	0.0	3.6	9.2	18.0	10.6	16.0	9.0	9.5	21.6	5.1	3.1	10.1	6.6	11.1	0.0	5.3	5.3	29.5	4.0	0.0	21.9	11.7	4.1	4.4	7.7	26.3	8.1	2.9	3.6	10.3	4.1	5.3	3.1	8.5	13.6	3.5	17.2	11.3	7.2	5.4	33.6	5.5	11.7	11.9	19.7	8.6	9.8	17.9	6.1	14.6	12.9	7.3	9.0	5.9	16.5	4.5
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: AB_2677484"	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	12.8	11.5	7.3	12.9	8.4	9.8	13.9	8.1	9.9	14.1	8.2	12.5	9.6	12.5	11.1	10.5	10.0	11.5	17.4	7.0	7.7	12.9	18.0	14.5	14.6	8.0	7.6	12.3	9.5	18.5	10.2	13.8	8.0	14.6	13.0	11.0	11.5	12.0	18.7	12.2	11.6	12.3	7.5	14.4	12.5	12.4	7.8	20.2	12.2	16.8	15.6	13.8	11.2	9.9	12.6	13.2	20.1	14.7	22.1	24.6	10.4	16.1	30.7	22.4	30.5	19.6	15.1	18.2	15.5	26.2	23.6	17.2	21.2	20.3	26.8	20.1	13.6	10.8	19.0	13.3	21.9	29.6	17.0	24.0	17.1	21.6	21.1	24.0	30.7	16.6	12.2	19.1	22.3	5.1	18.8	13.8	9.4	13.9	19.8	16.6	29.3	18.4	21.7	14.5	17.9	17.3	21.4	14.2	21.2	17.1	15.0	21.2	20.2	20.4	7.3	10.8	18.2	23.3	25.1	15.3	20.3	16.6	15.8	15.1	6.1	9.1	5.0	8.0	5.5	4.9	4.7	5.0	7.5	3.8	4.8	6.2	11.2	7.7	15.2	3.7	7.4	4.9	7.3	8.4	8.1	9.9	7.0	7.7	8.0	7.6	8.0	7.5	7.8	9.9	10.6	16.0	45.7	25.1	13.8	3.3	5.5	7.4	7.4	10.3	8.5	6.7	18.7	11.5	10.6	11.0	10.4	7.5	13.4	11.3	5.9	8.8	11.2	8.9	9.9	10.8	9.6	7.2	40.2	6.7	6.8	11.8	14.8	10.4	15.8	9.6	11.4	16.9	12.6	13.5	37.4	10.1	6.1	24.9	6.4	2.9	9.0	17.8	3.6	38.4	12.3	5.9	12.3	33.2	44.4	9.9	8.9	18.4	11.0	8.6	9.3	9.3	16.4	9.0	0.0	6.9	7.8	20.6	8.6	9.2	3.8	12.3	12.1	11.2	9.0	8.7
FBXO41	"Fbx41, KIAA1940"	ENSG00000163013	"F-box protein 41"	Q8TF61	2	73254682-73284478	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.9;Enteroendocrine cells: 12.0;Excitatory neurons: 28.8;Inhibitory neurons: 22.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 21.2;basal ganglia: 31.0;cerebral cortex: 42.3;hippocampal formation: 29.6;white matter: 24.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055246, HPA058386"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA055246: AB_2682758, HPA058386: AB_2683701"	"unprognostic (1.15e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.74e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (7.97e-3)"	"unprognostic (7.55e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-2)"	1.3	3.0	21.2	4.6	31.0	3.3	1.5	7.2	42.3	1.7	0.0	1.8	1.4	1.6	2.3	1.3	1.7	1.7	1.0	29.6	4.6	1.1	0.4	1.5	7.7	4.2	3.8	2.5	3.7	5.5	13.9	0.5	4.6	2.6	1.4	3.1	2.6	2.0	0.1	2.3	5.3	1.2	1.1	9.1	1.8	2.3	5.4	5.5	1.2	0.1	6.9	1.5	1.4	24.8	6.4	3.1	1.0	0.0	0.3	0.2	1.4	1.2	1.0	2.0	2.5	7.2	3.6	46.6	0.2	0.2	4.5	5.1	6.5	4.1	2.0	19.4	0.6	14.5	8.0	3.0	1.5	22.2	10.4	2.5	1.6	0.1	1.6	5.6	0.3	12.7	2.9	7.6	2.1	1.7	7.7	20.4	4.7	2.4	2.7	25.4	11.7	23.2	1.3	2.2	15.7	5.8	8.0	3.3	5.0	0.3	4.5	9.2	0.4	7.0	5.9	6.4	1.2	8.5	3.9	22.1	1.8	23.7	3.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	21.2	31.0	7.2	42.3	29.6	4.6	4.2	3.8	4.6	1.1	5.4	24.8	0.3	0.0	0.6	2.6	5.1	0.3	0.3	1.0	1.2	13.9	1.8	1.4	2.1	1.5	0.3	1.8	0.0	0.0	3.4	0.5	0.0	0.5	0.2	0.3	2.5	0.4	12.0	0.0	28.8	2.5	0.1	2.1	0.0	1.1	2.5	2.1	0.7	0.0	1.9	6.7	22.4	0.4	2.0	4.7	1.1	1.5	0.3	3.2	1.8	7.5	2.6	0.9	2.1	5.5	0.9	1.1	0.3	0.7	3.6	0.8	0.1	0.3	1.1	2.3	0.0	0.3	0.7	1.3	2.4	0.5	0.3	0.0	3.1	5.4	0.8	0.2
FBXO45	Fbx45	ENSG00000174013	"F-box protein 45"	P0C2W1	3	196568611-196589059	"Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040730	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA040730: AB_10959311"	"unprognostic (7.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.61e-5)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.16e-5)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (5.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.65e-1)"	5.1	4.2	10.7	6.1	11.5	13.9	7.3	11.8	14.8	4.5	6.8	6.9	5.3	4.7	3.0	8.9	3.6	4.4	3.6	11.0	10.9	3.7	6.9	4.5	6.7	10.7	10.9	5.0	4.6	7.2	3.1	5.4	10.4	5.1	7.0	8.2	4.0	4.3	13.8	12.7	5.1	5.0	11.6	5.1	5.5	12.2	11.5	8.8	3.7	11.5	10.0	6.8	5.0	11.7	45.5	8.5	17.6	22.4	11.6	11.4	20.9	19.7	9.0	15.3	15.6	23.9	15.1	19.1	33.1	12.8	22.8	19.0	33.9	22.5	28.1	27.7	15.3	34.8	15.5	15.1	11.1	46.9	17.1	5.8	24.9	17.3	31.8	8.0	16.9	30.5	42.4	39.2	17.2	45.3	27.5	21.9	27.4	40.3	32.5	23.1	23.0	46.2	12.9	18.3	35.6	24.4	21.4	36.8	23.5	15.4	63.3	31.1	16.8	17.7	19.1	25.7	53.8	38.3	68.5	52.6	15.4	59.6	17.3	1.3	0.9	1.1	0.8	0.9	1.4	0.5	0.8	0.5	1.2	0.8	0.8	0.9	0.4	0.6	1.1	1.4	1.6	0.4	10.7	11.5	11.8	14.8	11.0	10.9	10.7	10.9	10.4	11.6	11.5	11.7	10.2	12.8	4.1	6.5	6.6	9.8	10.2	5.6	4.6	20.1	10.5	7.7	10.8	4.3	4.2	3.7	14.6	2.6	11.5	7.9	0.0	4.4	15.5	8.0	12.9	8.0	17.4	6.1	13.8	7.7	4.6	7.8	10.7	8.8	1.3	6.9	7.9	9.9	5.8	13.5	15.0	8.2	4.1	9.1	11.0	18.9	5.6	7.6	5.4	8.4	8.3	9.3	4.1	6.6	12.4	8.3	4.8	6.4	8.0	14.8	4.0	3.4	6.8	10.7	0.0	10.5	7.5	32.4	24.4	9.4	13.5	1.9	8.2	7.1	9.8	14.5
FBXO46	"20D7-FC4, Fbx46, FBXO34L"	ENSG00000177051	"F-box protein 46"	Q6PJ61	19	45710629-45730896	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 84.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049390	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Vesicles"	Cytosol	"HPA049390: AB_2680742"	"unprognostic (9.02e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (9.33e-2)"	"prognostic favorable (5.44e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.13e-2)"	"prognostic favorable (8.11e-4)"	"unprognostic (9.77e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (5.09e-6)"	7.5	7.2	10.6	11.1	11.0	9.2	8.9	9.5	12.6	13.5	18.4	11.7	7.6	13.6	7.5	21.4	10.3	5.1	8.5	8.8	12.2	7.9	10.5	7.4	14.7	8.7	9.6	14.1	9.6	5.8	9.4	6.6	11.5	9.8	7.5	9.9	10.1	5.3	11.4	13.4	11.1	6.3	6.0	14.4	10.8	12.3	9.9	11.1	10.4	5.4	13.9	9.3	13.0	20.9	14.0	21.5	16.2	18.9	4.1	7.3	18.3	7.1	4.0	5.6	6.5	17.8	17.9	24.1	9.5	4.0	7.9	19.9	12.1	9.1	4.2	30.0	25.5	19.6	84.1	9.8	6.2	8.7	24.2	6.1	8.1	9.5	5.9	14.0	8.4	29.4	15.6	28.4	4.6	13.2	20.3	10.2	10.2	13.0	7.3	27.3	9.0	22.6	6.7	16.3	16.1	14.1	11.4	23.7	9.4	15.3	20.1	10.7	9.6	11.8	10.6	6.5	12.0	27.2	41.0	16.1	13.1	12.3	9.8	4.6	1.1	1.2	1.8	0.9	1.2	2.1	1.3	1.3	0.8	3.8	1.2	1.4	3.3	0.6	1.2	1.3	1.4	0.7	10.6	11.0	9.5	12.6	8.8	12.2	8.7	9.6	11.5	6.0	9.9	20.9	4.8	9.6	4.8	6.2	6.5	26.0	10.0	5.7	9.1	3.3	12.7	8.5	5.4	10.0	6.1	7.3	2.1	7.9	3.4	16.3	1.9	6.5	2.9	8.0	5.1	5.2	7.3	5.9	6.5	4.9	19.0	3.6	6.1	9.2	3.8	11.4	4.2	21.1	3.7	11.8	5.5	12.7	0.0	5.7	8.8	3.1	5.6	3.3	5.4	5.6	5.6	4.0	7.2	4.0	6.1	6.9	12.2	1.9	5.5	8.0	6.3	2.2	7.2	3.4	0.0	3.6	4.7	6.5	4.6	13.3	35.8	12.4	5.1	4.9	9.3	11.1
FBXO8	"FBS, FBX8"	ENSG00000164117	"F-box protein 8"	Q9NRD0	4	174236658-174283667	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002885	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA002885: AB_1078835"	"unprognostic (8.17e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (1.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-1)"	15.7	18.6	13.8	10.5	15.3	10.2	17.8	15.7	17.5	14.3	13.8	18.4	16.3	12.5	19.9	17.0	15.5	15.5	21.2	13.5	16.6	22.9	47.5	14.0	12.9	15.8	14.7	17.0	14.2	21.2	14.2	30.9	16.1	14.7	16.1	17.8	15.2	12.6	6.7	16.1	16.4	16.3	15.1	13.0	15.0	11.2	14.8	15.8	22.2	10.1	12.6	16.0	13.7	17.8	10.0	6.3	12.3	4.3	31.5	33.2	9.8	18.8	19.2	13.3	13.6	5.2	19.9	6.9	19.5	15.7	12.2	6.7	9.2	11.7	13.8	22.5	20.9	7.2	10.4	7.4	23.5	8.5	7.5	19.1	24.5	12.9	13.4	20.5	13.4	8.0	14.9	40.5	18.3	7.9	9.8	8.6	4.4	15.4	7.6	4.9	8.2	12.5	17.8	4.1	13.9	80.8	8.7	16.1	22.4	11.8	11.0	11.0	17.0	9.1	7.3	23.5	11.3	18.5	9.7	6.2	25.2	6.4	13.0	29.4	6.5	14.0	12.1	8.4	15.2	13.2	13.7	12.1	9.0	11.9	12.7	11.6	6.6	10.5	10.0	9.1	16.6	8.4	13.8	15.3	15.7	17.5	13.5	16.6	15.8	14.7	16.1	15.1	14.8	17.8	18.9	3.2	10.0	6.5	15.8	20.6	17.0	26.0	19.4	13.2	16.9	11.4	10.8	15.7	19.5	22.0	6.2	36.6	10.1	20.3	50.9	19.0	20.5	24.9	13.2	15.8	12.1	11.2	10.1	10.9	60.6	32.7	14.8	16.3	2.5	5.3	21.0	58.1	21.2	18.5	13.0	21.5	28.5	19.6	8.2	5.5	17.4	12.2	10.6	11.2	16.3	29.1	9.2	9.0	17.8	12.4	21.4	26.4	9.1	16.8	21.5	44.6	26.2	18.1	13.1	14.9	18.4	34.7	17.6	19.8	31.4	89.6	14.3	10.3	13.7	22.7
FBXW12	"Fbw12, FBXO35"	ENSG00000164049	"F-box and WD repeat domain containing 12"	Q6X9E4	3	48372219-48401259	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"pancreas: 6.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 12.4;Late spermatids: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037491, HPA037492"	Uncertain		Approved	Vesicles,Cytosol		NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA037491: AB_2675504, HPA037492: AB_2675505"	"unprognostic (5.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.36e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.81e-3)"	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	6.1	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.6	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1
FBXW9	"Fbw9, MEC-15, MGC10870"	ENSG00000132004	"F-box and WD repeat domain containing 9"	Q5XUX1	19	12688053-12696631	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 65.6;Respiratory ciliated cells: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042087	Approved		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA042087: AB_10794168"	"unprognostic (4.46e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (4.69e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.42e-3)"	4.2	7.9	4.4	2.1	4.4	4.2	5.6	2.9	5.8	5.2	9.0	5.2	4.4	4.9	2.0	10.3	13.1	2.9	2.9	4.7	4.3	8.6	5.1	4.5	3.0	4.1	6.3	4.0	7.3	4.3	7.4	2.6	4.2	7.2	1.7	2.0	7.6	3.5	2.7	9.4	4.0	1.7	4.0	3.9	5.6	14.9	4.4	2.9	7.5	0.8	1.9	4.6	5.8	3.2	16.6	11.1	7.2	10.6	3.1	5.2	8.7	5.3	5.4	11.1	9.1	6.2	10.0	4.1	13.5	4.8	2.7	14.7	6.9	10.0	1.9	2.9	18.5	4.9	13.2	10.4	7.0	12.3	2.9	7.0	15.8	7.7	3.8	6.6	8.8	9.4	11.9	2.7	2.5	34.5	13.4	16.1	12.2	8.8	10.4	7.0	5.0	23.2	10.0	4.9	16.5	19.6	7.9	16.5	7.6	2.3	16.5	9.3	4.3	6.5	6.0	8.1	8.5	16.4	7.3	4.5	8.1	4.5	4.3	0.0	7.4	0.0	2.7	7.1	4.6	2.8	2.9	2.1	11.1	2.5	2.8	2.0	0.3	4.7	4.9	3.1	5.7	5.0	4.4	4.4	2.9	5.8	4.7	4.3	4.1	6.3	4.2	4.0	4.4	3.2	4.8	3.2	5.4	1.3	1.3	6.0	5.2	18.6	8.0	2.0	12.1	13.0	0.7	8.6	14.3	1.8	6.2	14.4	1.5	5.7	5.9	18.1	6.4	65.6	6.9	4.2	4.8	11.8	3.7	16.0	8.4	4.4	5.6	6.8	0.0	10.7	4.6	3.6	7.0	0.0	3.1	9.2	22.4	4.5	3.7	8.5	2.5	5.9	3.6	0.0	4.2	4.9	1.0	1.0	1.2	11.6	5.6	4.5	1.7	4.2	5.5	17.4	80.3	7.1	6.6	4.4	6.5	30.8	17.3	9.2	8.2	6.4	2.4	20.3	12.5	4.9
FCHO2		ENSG00000157107	"FCH and mu domain containing endocytic adaptor 2"	Q0JRZ9	5	72956041-73090522	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 19.3;neutrophil: 20.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 20.6;monocytes: 6.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037685, HPA037686, HPA077850"	Enhanced		Approved	Vesicles,Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Centrosome	"Vesicles, Cytosol"	"HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: AB_2686860"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.00e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-1)"	16.6	9.8	5.1	11.3	6.5	10.7	15.0	9.8	9.1	14.5	11.4	16.3	17.1	16.1	9.0	29.6	11.3	16.9	10.6	5.2	5.0	19.7	17.9	21.8	11.0	6.7	5.6	14.9	9.1	15.3	4.1	21.2	6.4	13.0	17.1	9.1	11.6	12.6	10.4	12.3	18.6	13.4	5.3	17.1	13.6	7.2	8.8	5.2	24.0	12.2	9.2	14.9	16.5	9.5	15.0	11.8	11.3	9.9	15.6	20.5	33.0	12.9	19.0	9.6	15.1	6.0	25.6	3.5	17.6	18.0	17.8	11.1	9.6	22.6	13.0	3.8	11.3	7.3	9.9	7.6	7.8	1.5	7.3	13.8	11.5	12.8	20.6	21.9	22.3	3.5	8.4	6.2	20.2	7.0	0.0	7.3	3.6	3.0	6.1	3.2	10.8	4.4	23.4	20.8	4.5	7.1	17.7	12.6	8.3	15.7	15.1	10.4	23.1	12.5	5.8	13.9	9.3	2.2	4.4	0.7	8.1	1.1	15.8	19.3	3.2	8.8	1.5	4.6	1.0	0.4	0.5	0.6	1.4	0.9	0.2	0.5	20.6	0.9	6.6	0.5	0.4	0.8	5.1	6.5	9.8	9.1	5.2	5.0	6.7	5.6	6.4	5.3	8.8	9.5	51.8	57.7	44.3	34.9	3.8	10.5	15.6	12.0	12.5	11.1	16.5	12.3	15.1	14.3	23.1	35.0	4.2	14.2	7.0	25.6	13.7	16.0	2.4	24.3	17.0	36.8	14.9	12.6	78.2	17.5	8.9	22.8	17.3	38.3	18.3	9.5	52.1	11.0	19.8	11.8	51.5	14.8	8.2	81.0	13.0	2.8	13.4	45.8	16.0	71.2	12.9	15.4	3.1	62.4	59.1	30.7	29.4	13.9	3.5	22.5	21.0	21.8	21.5	8.9	26.3	25.1	21.3	16.9	14.3	15.0	15.3	13.7	4.4	9.1	14.0	30.2
FCHSD1	FLJ00007	ENSG00000197948	"FCH and double SH3 domains 1"	Q86WN1	5	141639302-141651418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 50.8"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043795	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	Cytosol	"HPA043795: AB_10963435"	"prognostic favorable (8.62e-4)"	"unprognostic (4.08e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.50e-3)"	"unprognostic (8.56e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (6.19e-6)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (4.12e-3)"	"prognostic favorable (1.21e-4)"	8.3	6.7	4.0	19.6	5.2	19.7	8.8	5.7	5.3	16.0	2.8	9.2	11.1	12.5	3.4	9.0	11.0	11.3	5.6	3.1	7.5	7.5	2.8	10.7	23.0	7.2	6.0	17.4	7.7	50.8	13.1	6.7	7.6	10.5	5.2	3.6	11.2	6.3	1.9	21.3	17.2	6.1	3.7	22.2	11.7	3.9	7.1	11.0	11.1	1.9	16.9	11.7	14.3	7.3	13.5	8.3	11.0	23.1	9.2	11.5	19.3	28.5	14.5	25.1	39.3	15.7	28.1	5.6	14.0	22.1	4.0	7.5	3.5	15.8	11.2	23.9	6.0	11.7	12.9	5.8	7.0	3.7	38.1	14.2	12.3	19.8	6.4	21.1	14.6	0.4	7.4	10.3	2.9	11.8	3.0	7.1	3.2	4.7	7.6	0.1	0.1	5.5	8.6	19.8	1.2	12.2	0.5	10.6	16.5	8.3	12.9	11.0	29.8	0.4	6.9	10.3	12.1	12.2	4.4	2.9	21.8	13.1	12.2	5.8	1.2	4.0	4.3	1.3	3.3	3.3	2.4	4.6	1.2	1.7	2.2	3.1	6.5	1.6	2.1	1.2	3.5	2.4	4.0	5.2	5.7	5.3	3.1	7.5	7.2	6.0	7.6	3.7	7.1	7.3	4.0	0.0	2.2	5.5	11.6	2.7	3.7	4.7	9.6	4.9	3.5	4.1	0.6	2.8	3.6	3.7	12.5	1.1	11.4	6.3	0.0	4.7	7.1	1.8	2.9	3.8	4.2	1.3	1.7	6.5	4.3	5.3	9.2	3.4	8.9	4.9	3.9	0.6	5.6	53.8	3.9	4.6	8.2	1.9	1.9	6.6	4.1	5.6	3.6	4.7	3.5	1.9	15.5	0.5	8.6	7.4	3.4	3.8	8.2	2.4	4.3	0.7	3.6	1.7	6.6	2.4	3.8	2.3	4.0	4.4	2.8	1.4	14.4	3.5	2.6	2.3
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206903317-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 65.5;lymphoid tissue: 180.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 262.3;dendritic cells: 43.5;NK-cells: 108.1;T-cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"RPMI-8226: 171.4;U-266/70: 73.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA		5500000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA003910: AB_1078798"	"prognostic favorable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	4.9	1.5	0.3	74.8	0.3	12.6	2.4	0.3	0.8	1.5	0.4	8.0	6.1	2.4	2.6	3.0	1.9	11.3	2.6	0.1	0.4	2.3	5.9	6.0	152.1	0.4	0.1	0.8	1.1	0.5	1.0	1.8	0.2	3.4	9.9	0.2	3.5	1.2	3.6	0.4	65.5	2.3	0.0	115.0	14.2	0.5	0.5	77.2	3.3	1.4	180.6	19.1	1.6	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.3	0.3	0.0	0.0	11.6	0.0	0.4	0.7	0.3	0.0	0.6	0.5	0.0	0.2	0.2	0.9	0.0	1.6	0.1	0.0	0.1	0.7	0.3	1.2	0.0	0.0	7.0	0.2	23.5	0.0	0.2	3.5	0.3	0.1	0.0	0.2	4.9	0.6	171.4	0.1	0.3	0.1	0.0	2.8	0.6	13.0	0.0	0.3	0.0	0.5	0.0	0.5	0.2	0.1	73.8	5.9	23.2	0.8	0.1	0.6	7.9	2.8	3.6	209.3	4.3	276.9	882.3	280.1	266.3	3.2	1057.5	483.2	336.0	56.0	218.8	4.3	13.7	687.7	416.6	0.3	0.3	0.3	0.8	0.1	0.4	0.4	0.1	0.2	0.0	0.5	0.6	1.3	0.0	3.9	0.0	262.3	0.0	4.9	0.0	1.2	0.0	3.5	3.0	3.6	5.7	1.3	0.0	0.0	0.1	43.5	0.9	0.0	1.7	0.2	0.8	0.7	1.7	0.0	8.4	0.0	2.9	0.1	3.4	4.1	0.9	0.0	0.6	4.6	1.4	4.4	0.0	0.0	0.6	0.0	5.7	0.0	0.4	0.3	8.1	0.0	0.0	3.6	0.0	108.1	0.0	0.0	1.2	0.3	0.0	30.5	2.9	0.1	1.0	0.7	0.0	0.0	0.2	2.9	0.1	2.3	1.7	0.0	0.0	74.9	0.0	1.9	6.8
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 355.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 927.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 1187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	73.5	188.2	48.2	66.5	50.4	69.5	68.8	60.1	58.8	63.4	51.1	88.7	167.2	57.5	73.0	142.5	57.4	39.8	72.2	49.9	64.6	78.0	355.7	86.1	76.1	71.1	62.5	45.0	75.7	67.9	40.4	72.5	77.5	56.1	102.9	45.9	82.6	42.7	60.9	107.1	81.1	66.0	53.6	59.3	81.5	42.0	55.0	72.6	46.8	66.7	102.3	47.0	76.8	55.0	293.9	156.2	561.5	204.4	128.7	467.7	199.6	136.8	268.1	213.6	344.2	255.4	677.7	222.3	323.6	120.6	506.9	319.1	338.9	1187.5	198.9	122.4	242.5	129.4	260.1	311.5	210.8	212.1	142.0	335.5	184.6	339.6	168.8	96.4	377.6	322.3	235.1	579.9	225.3	315.1	273.6	205.0	338.9	216.4	225.5	231.6	243.2	620.0	567.7	193.0	217.4	185.6	140.7	253.0	243.0	317.3	182.6	567.6	277.1	118.4	144.3	74.3	254.9	244.3	202.3	401.1	115.3	221.7	191.1	90.6	85.5	124.1	89.2	92.9	79.7	102.8	77.8	91.1	95.6	95.1	69.9	87.1	38.9	115.2	70.0	76.2	113.7	134.7	48.2	50.4	60.1	58.8	49.9	64.6	71.1	62.5	77.5	53.6	55.0	55.0	154.2	73.7	181.6	38.5	68.4	36.8	83.3	927.7	42.1	69.4	84.6	56.9	1.8	97.2	431.5	53.3	62.6	207.8	74.9	343.0	137.0	180.9	216.6	56.7	38.2	161.9	71.4	133.4	30.8	329.9	198.7	59.8	52.0	77.8	62.8	116.6	168.1	361.9	112.0	55.5	28.1	135.7	299.1	54.8	44.4	67.9	60.9	52.8	96.0	15.0	144.7	81.1	87.6	22.6	39.7	256.7	324.3	70.3	91.3	206.1	194.1	145.0	129.6	90.8	72.3	47.0	177.5	42.0	14.2	49.7	59.8	143.5	68.3	230.6	165.4	148.2
FEM1A		ENSG00000141965	"Fem-1 homolog A"	Q9BSK4	19	4791734-4801273	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"skeletal muscle: 273.6;tongue: 121.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016565, HPA063622"			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA016565: AB_1848489, HPA063622: AB_2685063"	"unprognostic (4.62e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (6.18e-5)"	"unprognostic (3.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.70e-2)"	4.3	3.7	8.0	4.0	7.8	7.5	4.4	8.1	8.0	3.2	6.8	3.8	3.7	3.0	3.6	8.4	3.4	2.7	17.8	8.2	6.1	3.8	4.4	4.2	4.7	7.9	7.5	3.5	8.5	9.6	0.9	4.2	7.3	4.9	3.3	3.0	5.9	3.3	273.6	8.5	3.3	3.9	7.1	4.3	3.9	2.4	7.8	4.8	3.5	121.2	4.6	4.1	1.0	8.5	9.2	6.2	5.7	12.4	6.2	3.6	8.3	5.4	4.4	8.5	6.0	9.7	4.1	10.4	5.4	6.7	4.6	9.3	10.1	8.9	5.5	12.4	11.6	10.1	4.9	7.4	9.4	17.0	12.4	5.3	13.6	6.6	9.4	4.0	6.2	13.9	15.1	19.3	5.9	9.3	14.3	6.2	17.7	5.7	15.0	13.1	7.4	11.0	7.7	11.6	18.5	13.1	7.1	13.2	10.4	4.3	10.2	14.5	8.7	7.7	5.6	12.1	14.4	22.3	20.0	8.8	7.9	12.1	11.1	4.7	2.8	2.8	2.5	3.2	2.1	1.9	2.0	2.3	2.6	2.5	1.7	2.0	2.4	2.6	3.0	2.6	1.5	1.8	8.0	7.8	8.1	8.0	8.2	6.1	7.9	7.5	7.3	7.1	7.8	8.5	7.9	25.6	32.8	1.6	16.6	20.1	14.9	7.7	12.5	16.8	20.8	16.4	6.5	18.6	15.5	1.8	16.7	21.2	16.1	16.7	13.7	10.3	5.3	8.7	11.6	12.3	13.1	28.6	2.7	11.8	13.8	9.2	6.1	19.1	22.8	7.5	15.4	18.7	12.3	11.8	3.2	15.5	4.1	15.4	8.7	3.5	9.0	13.1	3.6	2.8	17.2	12.1	32.0	2.5	2.3	12.4	9.4	8.2	9.9	15.5	10.9	10.1	11.3	19.8	6.6	27.1	9.3	12.7	6.2	18.3	29.5	27.1	14.3	16.8	18.0	17.7
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 83.4;lymphoid tissue: 110.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 46.8;Hofbauer cells: 48.7;Kupffer cells: 92.3;Macrophages: 51.9;monocytes: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 315.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 162.6;granulocytes: 315.8;monocytes: 151.7"	"Cell line enhanced"	"Detected in many"		"HEL: 63.5;HL-60: 56.9;HMC-1: 116.6;NB-4: 76.1;THP-1: 110.8;U-937: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	30.8	8.0	9.4	20.2	8.8	83.4	21.3	9.6	10.8	18.1	9.6	12.5	5.8	15.7	2.4	5.9	19.0	14.0	19.6	8.3	8.7	18.9	25.2	30.9	13.8	11.1	9.2	13.5	7.8	2.3	5.6	16.3	10.1	17.9	4.6	1.5	58.3	8.0	6.1	8.0	12.5	10.7	10.4	110.9	9.6	4.5	10.9	4.2	16.0	7.0	5.7	15.1	13.5	9.8	0.4	0.8	0.8	10.3	3.1	8.8	17.9	2.9	0.1	5.1	2.9	2.6	0.1	6.8	0.5	6.0	0.2	1.5	1.7	0.3	1.6	3.3	1.1	63.5	0.0	11.9	6.8	56.9	116.6	8.8	0.1	7.6	0.0	0.0	31.2	9.4	1.8	0.2	0.0	21.3	1.8	76.1	3.2	2.5	0.0	8.6	0.1	0.1	0.0	0.2	0.4	0.1	0.0	2.8	2.3	2.9	0.1	110.8	24.9	0.2	10.4	0.2	0.2	0.1	8.0	2.5	0.3	48.0	2.4	64.4	151.7	315.8	0.5	88.6	0.4	5.2	0.3	0.4	162.6	4.1	0.2	0.3	100.5	51.4	39.8	65.0	0.2	81.5	9.4	8.8	9.6	10.8	8.3	8.7	11.1	9.2	10.1	10.4	10.9	9.8	46.8	3.2	5.8	3.6	5.0	3.8	5.4	0.5	0.6	0.2	4.1	3.8	3.4	8.6	0.5	1.8	0.0	5.3	25.6	0.6	3.9	7.3	1.7	2.0	4.2	29.1	3.0	8.0	2.8	4.3	4.2	9.0	2.0	4.2	29.2	10.7	20.0	15.0	48.7	0.0	0.2	2.0	2.0	92.3	27.9	8.4	9.0	51.9	7.2	5.6	57.8	2.5	26.8	2.0	0.3	2.1	2.0	10.1	4.0	3.1	0.7	1.5	0.2	1.9	13.1	4.6	12.9	4.4	15.9	1.0	2.8	4.5	6.7	3.3	3.7	5.2
FEZ1	UNC-76	ENSG00000149557	"Fasciculation and elongation protein zeta 1"	Q99689	11	125442881-125592568	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 176.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 109.8;Horizontal cells: 166.5;Oligodendrocytes: 246.6"	"Cancer enriched"	"Detected in all"	10	"glioma: 68.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 23.4;MAIT T-cell: 15.5"	"Lineage enriched"	"Detected in many"	23	"T-cells: 23.4"	"Cell line enhanced"	"Detected in many"		"AF22: 48.3;HBEC3-KT: 66.0;NTERA-2: 68.6;SCLC-21H: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038490, HPA076844"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	"Microtubules, Cytosol"		"HPA038490: AB_10672647, HPA076844: "	"unprognostic (5.68e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	16.9	5.4	96.8	2.9	144.0	0.9	11.3	145.5	120.6	21.8	53.1	39.3	1.7	23.5	2.3	6.2	14.7	6.9	37.4	95.5	120.4	6.8	5.5	34.2	1.9	145.6	136.9	12.7	2.5	1.9	17.6	3.8	138.9	15.4	3.3	18.7	6.4	7.6	5.9	7.9	12.6	8.3	134.8	8.8	15.9	12.7	126.7	0.5	10.2	3.0	1.4	26.5	16.9	176.6	0.3	0.0	48.3	0.2	39.2	25.3	0.0	10.3	14.6	3.8	0.6	0.2	0.3	0.1	16.3	21.1	11.4	0.5	31.2	66.0	2.4	2.3	0.5	37.6	0.1	0.0	25.3	0.0	0.6	23.1	17.6	11.5	29.3	0.4	32.0	0.0	4.5	0.6	3.8	1.5	0.2	0.0	68.6	0.5	1.2	0.0	0.1	0.2	0.0	30.3	54.3	5.5	0.3	0.1	1.4	27.3	4.9	26.4	19.3	0.4	2.4	0.2	11.1	0.6	0.5	0.1	7.9	0.0	26.6	0.2	0.8	0.0	23.4	0.1	15.5	0.1	0.9	5.1	0.4	0.0	0.6	5.5	0.2	1.0	0.0	0.1	0.0	4.4	96.8	144.0	145.5	120.6	95.5	120.4	145.6	136.9	138.9	134.8	126.7	176.6	4.9	0.0	5.2	53.2	0.8	8.0	4.9	96.9	6.2	23.1	0.5	10.3	109.8	2.8	9.6	0.0	2.1	8.0	23.3	0.1	27.4	2.8	68.6	0.8	14.2	13.9	5.4	0.0	41.0	0.4	1.2	43.0	0.5	0.5	0.0	11.1	58.9	1.0	91.6	166.5	48.7	0.0	16.2	24.9	15.5	65.9	25.4	2.3	78.2	12.2	1.9	97.1	74.2	32.2	246.6	0.3	0.0	35.3	0.9	12.7	0.0	2.1	3.8	17.8	19.7	25.4	35.6	28.8	7.7	0.2	5.5	4.2	7.8	5.5	0.1	3.5
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	53.0	39.1	48.2	21.0	51.6	16.5	35.9	48.2	68.6	26.9	42.8	34.5	22.1	33.1	18.9	31.7	23.8	23.6	46.7	49.2	48.4	33.6	29.4	27.1	24.3	49.5	46.3	27.6	10.8	20.3	14.2	46.8	48.2	23.5	27.9	26.5	17.1	32.5	108.1	17.0	28.5	41.1	50.1	30.3	21.9	20.8	49.6	18.2	23.9	78.5	19.5	29.1	24.3	56.3	64.9	37.1	49.4	22.3	91.3	122.1	39.5	157.1	76.5	90.7	56.0	24.6	21.5	39.1	94.7	199.2	41.0	25.1	42.4	54.3	98.5	9.3	24.7	31.7	12.2	43.5	44.4	32.9	8.5	119.9	44.2	57.8	69.6	61.2	131.0	9.5	35.4	12.0	170.2	22.7	19.6	27.5	27.1	33.9	57.8	16.9	44.3	14.0	72.9	57.6	1.9	45.7	38.7	31.9	37.8	51.7	11.3	39.1	161.2	59.7	32.9	33.4	92.9	9.8	11.5	26.6	58.9	22.4	84.8	2.5	3.5	5.1	1.7	3.4	1.0	1.6	1.3	1.0	3.5	1.0	1.5	0.7	4.2	3.2	2.3	15.6	1.4	0.8	48.2	51.6	48.2	68.6	49.2	48.4	49.5	46.3	48.2	50.1	49.6	56.3	109.4	54.5	37.5	25.8	23.7	31.4	94.7	45.5	41.5	52.5	31.7	33.1	43.1	17.2	70.2	58.8	45.9	96.4	61.1	57.6	56.7	80.3	5.6	38.4	44.7	100.9	24.0	15.3	45.4	30.6	87.6	50.7	27.0	64.3	24.1	66.0	97.5	37.2	93.7	21.9	22.9	28.8	38.7	88.1	65.4	10.7	54.3	64.6	56.9	45.0	56.0	97.1	35.0	23.1	50.5	74.4	41.4	66.2	17.9	99.1	65.6	45.1	35.9	36.3	59.2	64.0	51.2	12.1	34.9	24.0	32.1	180.1	24.2	47.2	37.7	140.6
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301303-122310691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 126.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 5.1;Spermatocytes: 5.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 126.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 152.1;SCLC-21H: 66.0"	"Region enriched"	"Detected in some"	11	"hypothalamus: 11.7"	"Region enriched"	"Detected in single"	14	"hypothalamus: 7.4"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	24.8	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.5	126.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	152.1	3.8	2.7	0.0	0.0	0.0	0.0	0.2	66.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	7.2	0.3	0.0	0.1	2.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.2	1.8	0.6	24.8	0.3	2.6	0.5	0.2	126.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 16.1;Granulosa cells: 12.6;Inhibitory neurons: 15.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000911, HPA076516"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA000911: AB_1078853, HPA076516: "	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	3.9	5.1	8.2	1.6	6.2	0.0	3.6	5.3	7.6	7.0	2.4	5.6	1.0	7.1	1.6	5.8	5.1	2.2	5.0	8.3	5.2	3.5	1.1	2.8	0.5	3.8	4.1	7.4	3.2	3.6	3.6	3.4	3.7	4.3	1.6	1.6	3.4	3.3	1.3	5.4	2.8	5.4	3.5	2.4	3.5	2.4	4.9	0.4	3.3	1.0	1.0	4.8	5.4	4.6	18.5	6.9	13.2	19.3	7.8	13.8	6.2	10.4	12.8	10.6	8.5	0.6	0.4	0.0	8.2	19.9	9.6	5.3	14.6	9.0	5.8	1.0	8.9	0.0	5.0	2.2	8.3	0.0	0.0	11.3	5.6	16.1	7.6	9.4	9.7	2.3	2.0	0.0	8.4	2.4	0.7	0.0	12.6	0.0	10.2	9.4	6.7	0.0	9.1	0.3	13.1	11.9	10.3	0.2	16.6	21.0	10.3	0.4	6.9	10.5	8.7	23.0	9.4	0.1	0.2	0.1	11.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.2	5.3	7.6	8.3	5.2	3.8	4.1	3.7	3.5	4.9	4.6	3.2	0.0	0.0	4.6	0.0	2.9	1.2	2.0	5.2	2.5	3.2	3.9	3.4	0.0	0.7	0.0	0.0	0.5	0.1	0.2	0.0	1.6	0.4	1.3	7.0	4.2	1.2	0.0	16.1	1.1	1.0	5.1	1.5	2.1	0.0	12.6	2.9	0.3	0.4	1.7	15.2	1.0	0.0	0.0	1.0	0.6	2.8	0.1	7.2	5.6	0.0	2.3	0.0	7.1	1.8	0.5	0.5	4.1	0.1	1.6	0.1	1.4	0.3	3.5	0.0	2.3	4.0	0.3	2.2	5.5	4.1	0.3	0.1	2.9	2.8	1.0
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947523-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 41.8;Early spermatids: 66.1;Late spermatids: 99.0;NK-cells: 69.0;T-cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.9;Karpas-707: 61.4;RT4: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	4.7	1.3	1.8	21.9	1.6	39.4	3.5	1.8	4.9	1.5	2.5	3.0	3.1	1.1	0.4	2.4	2.1	4.6	2.0	1.6	2.7	4.9	2.0	10.2	30.8	3.4	2.6	1.4	7.6	0.4	0.7	3.5	3.5	1.7	2.3	0.0	4.9	1.5	1.1	3.2	11.3	2.7	2.7	29.5	4.3	6.5	3.5	32.4	3.3	2.2	17.6	8.1	3.5	4.0	13.3	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	16.0	9.1	11.3	0.6	0.0	0.1	8.4	0.6	0.0	0.0	19.7	0.1	17.4	0.1	0.6	0.0	4.8	43.9	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.7	61.4	0.0	22.8	20.7	20.4	0.4	4.3	1.1	20.1	0.0	16.3	0.1	33.5	1.2	0.4	0.0	14.4	0.4	0.4	5.8	21.4	0.0	0.0	0.6	0.1	0.1	6.2	6.6	5.4	3.1	10.3	0.0	142.9	50.6	139.6	49.5	63.4	49.9	28.6	51.4	46.6	37.5	36.9	50.1	44.7	178.2	39.1	99.2	16.8	48.4	74.0	1.8	1.6	1.8	4.9	1.6	2.7	3.4	2.6	3.5	2.7	3.5	4.0	1.7	22.4	9.2	0.0	25.3	0.8	0.6	0.4	0.6	0.1	5.8	1.8	2.5	4.3	2.3	9.2	0.0	2.9	41.8	0.4	0.0	7.2	66.1	1.2	0.2	2.1	1.8	11.8	0.6	0.2	3.2	0.9	0.0	0.6	19.6	3.7	1.8	0.8	15.5	0.0	1.6	0.6	0.0	22.3	6.2	99.0	0.3	20.7	1.8	12.2	20.1	0.4	69.0	5.0	0.5	0.4	0.1	0.4	15.8	0.1	0.0	0.7	0.3	3.9	0.0	0.3	0.8	1.6	2.4	0.5	1.0	4.5	47.3	0.1	0.4	0.5
FGF12	"FGF12B, FHF1"	ENSG00000114279	"Fibroblast growth factor 12"	P61328	3	192139390-192767764	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.8;heart muscle: 131.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 413.7;Excitatory neurons: 1213.5;Inhibitory neurons: 1925.1;Oligodendrocyte precursor cells: 1668.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;NTERA-2: 10.3;SCLC-21H: 23.9;U-251 MG: 14.7;WM-115: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071557			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA071557: AB_2686417"	"unprognostic (1.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.75e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.87e-7)"	"unprognostic (2.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.99e-2)"	1.9	35.8	8.5	0.2	14.1	0.0	1.3	0.5	21.3	0.5	0.0	1.1	0.7	1.0	0.2	1.7	1.5	0.5	131.3	17.5	14.2	2.5	0.6	1.1	0.2	11.1	1.0	0.8	7.7	1.6	5.3	0.4	9.9	1.3	0.3	15.4	5.9	6.0	1.1	0.3	0.3	0.7	0.0	11.6	0.6	2.1	3.5	0.1	1.5	0.8	0.2	0.5	0.7	2.8	0.1	1.1	15.1	0.0	0.0	0.0	0.1	0.0	0.1	1.4	1.7	0.0	0.1	0.8	7.2	0.3	0.3	0.2	0.0	0.0	1.6	0.1	0.2	3.2	6.3	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	3.7	0.2	0.0	0.1	0.1	0.0	4.4	0.0	0.0	10.3	7.1	0.3	0.0	0.1	0.0	4.7	1.8	23.9	0.0	0.0	0.6	0.0	1.7	1.1	0.2	0.4	6.2	3.2	0.0	14.7	0.2	2.5	0.0	1.3	0.0	17.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	14.1	0.5	21.3	17.5	14.2	11.1	1.0	9.9	0.0	3.5	2.8	17.8	0.0	0.0	42.7	0.1	0.6	4.2	0.0	0.6	100.2	0.9	1.7	413.7	0.0	1.9	5.5	4.2	0.2	0.0	0.0	7.9	0.7	20.9	1.6	1.6	13.2	0.0	0.0	1213.5	13.1	0.4	18.6	0.5	0.5	0.0	9.0	16.4	0.0	0.1	33.7	1925.1	0.0	0.0	0.3	0.3	38.5	6.8	0.1	1.8	46.9	0.0	3.8	0.0	1668.3	28.2	2.7	1.2	1.2	0.5	1.1	0.0	0.4	0.8	14.2	0.0	0.7	4.8	4.0	8.0	0.4	0.1	0.0	0.1	38.7	0.1	1.7
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.7;gallbladder: 3.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 9.4;Microglial cells: 1.9;Proximal tubular cells: 4.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 11.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.1;BJ hTERT+: 120.0;fHDF/TERT166: 88.0;HBF TERT88: 88.0;LHCN-M2: 81.1;U-138 MG: 109.5;U-251 MG: 55.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: AB_2678001"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.0	0.0	0.2	0.6	0.0	0.1	0.0	11.7	1.2	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	3.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	2.7	0.2	0.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	1.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.1	6.1	21.8	0.0	64.1	120.0	16.5	12.2	0.0	0.1	0.0	0.0	88.0	1.2	0.1	0.1	22.5	88.0	0.0	1.1	0.2	0.1	0.0	1.7	0.6	0.0	6.3	0.0	48.6	23.0	27.9	5.7	0.0	0.0	0.2	81.1	0.0	0.1	0.3	0.1	0.0	2.1	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.8	0.0	0.0	0.2	20.9	109.5	4.6	5.4	55.0	0.0	0.0	0.1	6.3	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.7	1.2	0.6	0.0	2.7	0.2	3.0	0.0	0.5	0.5	0.0	0.0	1.1	0.3	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.6	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 161.3;Inhibitory neurons: 82.9;Oligodendrocyte precursor cells: 309.6;Oligodendrocytes: 129.4;Sertoli cells: 72.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	34	"basophil: 3.3"	"Lineage enriched"	"Detected in single"	34	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"AF22: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	3.1	2.0	3.9	0.4	5.0	0.8	2.0	2.3	4.4	2.4	0.0	2.6	0.4	1.1	1.2	0.6	1.9	1.1	3.3	2.5	5.4	1.9	3.2	1.4	0.6	3.0	4.2	4.6	2.9	0.4	2.6	1.1	3.9	1.6	0.7	1.4	2.6	2.7	1.0	1.0	1.4	0.9	1.8	3.0	1.8	1.1	4.6	0.2	1.1	1.7	0.2	1.7	2.4	5.1	6.4	2.3	18.6	0.0	0.0	0.0	6.8	2.4	1.6	1.7	3.2	0.0	2.2	0.0	6.6	2.6	3.4	0.9	6.2	2.6	1.3	0.0	4.6	0.0	4.7	4.6	1.5	0.0	0.0	0.8	2.2	3.3	9.0	2.6	4.0	0.0	0.0	0.0	5.1	1.6	0.0	0.0	7.9	0.4	2.9	0.0	6.3	0.0	4.2	2.1	2.9	2.5	0.0	1.8	1.7	10.3	2.0	0.0	0.4	7.6	6.8	0.0	5.1	1.1	0.0	0.0	2.3	0.0	4.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.0	2.3	4.4	2.5	5.4	3.0	4.2	3.9	1.8	4.6	5.1	2.9	6.4	7.3	161.3	0.7	1.9	0.1	2.8	1.8	24.4	5.7	2.7	19.4	20.0	3.0	12.9	0.0	21.2	0.2	0.1	1.9	3.7	3.8	0.7	0.7	2.1	0.0	0.0	53.4	1.5	7.4	11.6	4.1	1.6	0.0	23.6	7.9	13.5	1.4	6.7	82.9	0.0	4.1	0.0	1.6	6.4	51.9	0.6	17.8	28.1	0.0	4.3	0.0	309.6	129.4	1.1	0.0	34.3	0.0	1.8	0.0	8.1	4.0	2.1	72.3	16.6	17.8	1.1	1.2	1.0	0.4	16.8	0.2	7.0	0.0	0.0
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FKBP prolyl isomerase 14"	Q9NWM8	7	30010587-30026702	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (4.25e-4)"	6.5	5.1	3.4	7.0	3.5	4.3	6.4	5.4	3.6	9.9	3.1	4.7	3.0	8.5	10.0	4.7	4.3	6.0	6.8	3.2	3.2	3.1	3.2	4.1	3.1	3.3	3.1	5.4	5.8	6.2	7.7	7.9	3.0	6.8	4.8	7.2	4.3	7.5	2.1	4.7	2.9	13.9	3.0	2.7	4.0	2.2	3.5	1.8	3.3	3.2	3.2	8.9	3.8	3.5	7.0	5.2	14.4	33.6	36.8	46.8	6.5	34.9	32.7	12.0	23.3	4.4	4.3	2.4	16.0	31.0	14.7	14.8	8.1	12.8	23.9	1.3	11.6	5.6	9.2	13.1	18.6	4.0	9.3	29.4	13.1	20.9	24.6	28.2	27.0	3.6	9.2	5.0	21.8	2.9	2.1	4.9	7.5	7.7	9.2	0.1	9.6	8.2	11.8	6.1	3.8	12.5	12.2	27.5	8.8	17.0	6.2	5.3	21.7	12.6	14.6	21.8	14.0	7.6	8.3	4.2	18.0	3.8	40.2	0.5	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.4	0.2	0.0	0.6	0.2	0.1	3.4	3.5	5.4	3.6	3.2	3.2	3.3	3.1	3.0	3.0	3.5	3.5	13.5	19.2	16.0	7.2	7.9	27.4	22.0	15.8	35.9	16.3	13.3	13.0	15.7	5.7	11.7	18.4	27.1	11.6	9.4	5.3	1.9	7.4	0.4	30.4	44.3	12.9	1.2	6.5	19.4	3.7	27.3	40.0	15.3	40.0	2.5	9.1	8.6	6.5	6.0	15.2	12.7	9.7	8.2	2.5	11.2	0.4	13.1	5.7	10.6	10.3	3.6	26.5	2.1	11.6	16.6	5.7	19.0	20.7	43.8	17.8	3.3	2.7	6.0	21.4	6.6	13.8	20.4	1.4	3.4	27.5	18.3	15.7	6.0	20.8	6.1	28.0
FKBP15	"FKBP133, KIAA0674, PPP1R76, WAFL"	ENSG00000119321	"FKBP prolyl isomerase 15"	Q5T1M5	9	113161006-113221318	"Predicted intracellular proteins"	"Endocytosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 23.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007979	Approved		Approved	Nucleoli,Cytosol		NA	NA		9800	"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoli	Cytosol	"HPA007979: AB_1848615"	"unprognostic (2.81e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (3.44e-2)"	"unprognostic (5.62e-3)"	17.8	14.8	7.0	17.0	10.5	13.1	15.3	8.7	8.9	17.0	8.1	15.0	9.6	14.8	8.5	16.2	14.7	8.3	14.9	7.8	8.8	12.2	15.2	23.9	15.9	12.5	9.4	14.9	13.4	12.0	15.4	14.2	11.6	14.9	10.2	12.5	17.1	7.3	18.1	20.3	16.7	10.9	8.7	31.0	14.1	5.9	10.9	11.0	15.7	7.6	13.5	16.3	16.4	15.4	13.4	13.2	9.4	8.8	15.6	14.8	12.1	16.6	20.8	15.6	14.2	8.1	13.3	21.7	7.1	18.6	31.2	30.0	10.4	14.0	15.3	16.6	7.1	8.8	16.3	8.0	12.7	18.7	20.9	15.0	13.8	16.1	17.4	18.3	15.1	13.3	10.9	13.4	15.7	19.2	13.8	9.7	8.8	17.4	10.6	12.5	19.1	7.5	11.2	12.2	8.0	8.1	19.5	15.5	8.5	11.6	17.7	6.2	19.9	18.4	6.9	19.2	16.9	12.2	13.0	9.4	19.7	10.3	14.9	2.5	11.3	1.8	3.2	13.9	2.7	1.8	1.9	2.0	7.9	3.1	2.4	1.9	6.4	4.4	23.3	3.3	2.0	4.7	7.0	10.5	8.7	8.9	7.8	8.8	12.5	9.4	11.6	8.7	10.9	15.4	11.1	16.0	26.7	23.5	14.9	5.7	6.2	9.6	11.4	13.7	7.0	5.6	15.4	7.2	14.3	14.7	27.1	13.8	17.3	9.7	1.9	12.7	1.2	13.4	13.9	12.5	4.8	14.7	25.1	13.6	12.4	14.7	11.7	10.0	11.4	13.3	17.2	9.3	61.3	11.8	25.0	8.6	8.2	58.4	13.6	1.7	16.8	57.5	7.2	27.2	31.2	8.0	18.6	21.1	30.1	17.3	8.1	15.8	8.8	6.1	9.2	5.4	15.9	16.1	19.7	10.0	9.2	7.1	10.5	11.1	4.1	12.2	14.9	14.5	8.2	10.5
FKBP6	"FKBP36, PPIase"	ENSG00000077800	"FKBP prolyl isomerase 6"	O75344	7	73328161-73358637	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	222	"testis: 58.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 68.5;Late spermatids: 92.4;Spermatocytes: 142.0;Spermatogonia: 37.2"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA061109, HPA077010"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA061109: AB_2684430, HPA077010: "	"unprognostic (5.07e-2)"	"unprognostic (3.34e-2)"		"unprognostic (1.56e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.20e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	58.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.2	0.6	0.0	0.6	0.0	0.3	0.5	1.5	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	68.5	5.2	0.3	0.2	0.0	0.0	0.3	0.2	0.0	0.2	0.0	1.0	0.0	0.2	0.4	0.2	0.3	0.0	0.3	0.0	2.0	1.3	0.0	92.4	3.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.2	0.0	1.2	0.0	0.0	0.0	0.1	12.6	0.5	0.0	0.3	0.1	142.0	37.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2
FKRP	"FKTR, LGMD2I, MDC1C"	ENSG00000181027	"Fukutin related protein"	Q9H9S5	19	46746046-46776988	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043115, HPA060454"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA043115: AB_2678324, HPA060454: AB_2684281"	"unprognostic (4.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.59e-3)"	"prognostic favorable (8.98e-4)"	"unprognostic (3.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-2)"	10.5	9.1	8.5	8.1	8.2	8.8	9.9	3.7	11.5	11.4	4.5	13.3	4.8	15.2	5.0	8.8	12.6	6.0	15.8	8.5	10.4	12.0	11.9	10.4	7.4	10.1	7.3	12.7	11.1	7.5	16.8	10.1	8.8	13.5	4.3	5.7	11.1	7.4	19.6	7.2	10.5	5.8	6.1	14.7	10.9	9.3	9.4	5.6	13.6	9.8	4.9	13.0	10.5	8.7	12.7	26.5	17.8	12.5	15.4	16.9	15.8	31.7	21.0	12.6	19.9	17.0	21.4	11.7	17.0	18.2	20.9	13.0	6.6	14.8	11.5	21.9	22.2	11.7	14.4	10.7	13.3	9.3	19.8	19.4	12.5	15.6	15.2	14.6	16.7	6.0	12.2	11.0	12.7	5.8	6.8	22.8	17.2	7.8	6.5	18.3	11.1	4.0	8.0	26.4	12.0	23.1	15.8	7.6	10.6	11.7	8.9	7.3	16.8	18.4	19.8	6.7	25.7	11.6	15.4	11.0	15.0	7.5	25.6	1.3	1.8	0.8	1.5	1.0	0.9	1.7	1.1	1.7	1.1	2.4	1.2	1.6	2.2	2.0	1.1	1.9	0.6	1.2	8.5	8.2	3.7	11.5	8.5	10.4	10.1	7.3	8.8	6.1	9.4	8.7	4.7	9.6	7.4	6.8	3.9	0.8	4.8	3.0	1.2	9.8	5.3	5.2	15.5	4.3	5.6	5.5	6.2	9.6	9.1	4.5	5.9	4.2	12.0	7.9	7.3	6.0	7.8	7.8	6.8	2.4	5.9	6.6	3.6	5.1	1.3	6.7	11.4	16.6	7.6	3.3	8.2	4.2	2.0	10.0	1.2	13.2	5.6	4.3	5.4	3.7	6.1	7.8	2.1	8.0	6.2	4.1	4.7	4.1	3.6	4.3	4.2	8.2	9.7	11.0	6.6	7.2	7.0	12.2	4.0	2.4	1.6	18.7	4.3	4.5	4.0	4.3
FLACC1	ALS2CR12	ENSG00000155749	"Flagellum associated containing coiled-coil domains 1"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.8;testis: 17.1"	"Cell type enriched"	"Detected in single"	8	"Cardiomyocytes: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.4;U-2197: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035793			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane, Cytosol"		"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.9	1.1	3.9	1.0	4.3	5.0	0.5	2.8	3.9	0.7	9.8	0.8	0.5	0.7	1.1	1.2	8.3	1.1	4.5	5.0	3.2	1.3	0.7	2.5	1.6	5.8	6.4	0.3	0.9	0.7	1.1	0.8	3.7	0.5	1.0	3.3	1.1	0.8	1.8	1.2	1.0	0.6	4.2	0.8	0.5	17.1	3.0	0.7	1.6	0.4	0.5	0.6	0.4	3.7	0.1	0.2	1.1	0.7	2.7	1.1	0.0	0.8	0.3	0.7	0.4	0.0	0.3	0.2	0.6	1.2	0.4	1.1	0.4	0.1	0.3	0.7	0.1	0.1	1.7	0.4	0.6	1.2	1.0	0.5	0.3	0.7	0.1	0.8	0.1	1.2	0.5	1.6	0.6	0.0	0.6	1.0	0.3	0.4	0.6	0.3	0.5	0.7	0.4	0.2	0.2	0.7	0.7	0.0	3.4	1.0	0.4	1.4	0.9	1.5	0.7	5.9	0.5	0.8	1.8	0.5	1.2	0.6	0.7	3.1	0.4	0.4	0.7	0.3	0.3	0.3	0.4	0.4	0.2	0.7	0.6	0.7	3.6	1.3	0.3	0.2	0.3	0.2	3.9	4.3	2.8	3.9	5.0	3.2	5.8	6.4	3.7	4.2	3.0	3.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322985-14337614	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 156.5;Basal prostatic cells: 168.3;Club cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 27.5;hTCEpi: 51.3;RPTEC TERT1: 17.3;WM-115: 62.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	5.0	3.7	2.3	0.8	3.0	0.0	2.3	6.4	5.3	3.2	0.9	1.6	11.8	2.3	3.1	1.6	2.4	5.0	0.6	5.3	1.3	23.2	7.0	17.7	0.1	0.0	1.3	10.6	1.2	8.2	1.0	1.8	0.8	8.2	0.8	1.6	1.2	14.0	2.0	6.3	2.3	1.4	0.6	0.7	9.7	1.2	2.3	7.3	5.2	0.7	0.3	7.9	2.1	1.8	0.0	12.2	27.5	0.0	0.0	0.0	0.0	2.7	0.8	0.1	0.0	15.3	5.6	0.0	0.9	0.6	0.0	8.0	0.0	8.3	0.1	0.0	1.8	0.0	0.4	0.3	2.4	0.0	0.0	4.6	51.3	0.0	9.7	0.0	0.1	0.2	0.0	0.2	5.3	0.4	3.7	0.0	8.9	6.2	0.1	0.1	0.2	0.0	17.3	3.6	0.5	5.7	0.0	0.0	9.2	15.5	0.5	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.0	0.0	0.2	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	6.4	5.3	5.3	1.3	0.0	1.3	0.8	0.6	2.3	1.8	0.3	218.0	156.5	2.3	0.5	8.7	168.3	26.1	55.8	23.9	4.4	6.5	1.2	24.3	73.1	22.0	6.2	0.5	0.0	2.2	13.7	23.6	0.2	0.7	1.7	1.9	11.3	0.0	27.2	14.9	0.0	8.7	37.8	0.7	5.1	5.0	2.9	8.5	0.2	6.7	39.3	2.5	2.0	0.3	0.7	0.5	3.7	1.3	5.4	1.9	1.6	0.6	0.0	26.2	3.9	10.0	3.0	0.4	0.1	24.9	3.5	49.2	13.4	3.3	0.0	25.0	1.8	0.0	0.1	5.9	16.6	0.0	0.8	1.4	1.5	18.3
FLYWCH1	DKFZp761A132	ENSG00000059122	"FLYWCH-type zinc finger 1"	Q4VC44	16	2911931-2951208	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040753, HPA041001"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA040753: AB_10794880, HPA041001: AB_10794259"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-2)"	16.0	14.6	22.6	11.7	22.4	12.5	14.2	22.6	28.7	18.6	15.9	19.3	12.9	17.7	4.8	12.8	17.0	13.0	19.0	18.9	20.8	12.8	8.3	14.0	11.3	33.2	23.3	20.6	10.7	14.7	16.4	8.2	30.0	17.2	3.7	13.3	13.7	12.5	32.8	20.4	14.4	7.6	19.2	18.7	13.4	4.0	27.3	9.1	15.5	10.7	6.2	21.8	16.2	23.7	10.0	34.8	7.8	23.2	12.4	12.5	23.6	18.2	14.1	9.0	9.2	5.8	31.8	24.4	47.3	14.0	14.7	20.5	6.5	12.2	1.8	40.8	19.6	8.2	30.9	19.5	27.7	10.9	27.3	11.2	37.9	19.1	13.8	16.7	12.9	16.0	18.6	25.0	7.0	23.8	25.1	13.3	12.7	7.5	23.6	43.5	11.6	44.0	10.6	6.7	16.7	15.5	19.1	20.6	24.1	4.3	16.1	19.6	24.4	15.0	13.6	29.4	12.4	37.1	34.5	22.7	16.4	17.8	17.9	1.2	0.8	0.3	1.3	0.4	2.3	0.9	2.1	2.7	0.8	2.6	1.7	1.5	0.1	0.5	0.4	0.5	1.1	1.1	22.6	22.4	22.6	28.7	18.9	20.8	33.2	23.3	30.0	19.2	27.3	23.7	16.7	0.0	4.2	34.3	10.4	12.4	9.3	9.2	23.3	42.1	8.6	11.3	12.3	8.6	5.1	22.0	35.5	21.2	14.3	6.5	1.9	6.1	0.4	6.0	7.7	13.4	2.4	6.5	26.9	6.5	8.5	13.9	12.2	8.9	0.0	48.3	11.0	6.8	8.5	33.7	29.0	4.9	4.1	9.9	5.1	1.2	11.1	8.9	8.8	13.1	7.9	18.8	9.2	18.6	25.6	7.1	2.9	14.3	10.4	5.3	8.9	6.3	8.3	39.3	0.0	16.6	20.9	0.9	3.2	13.1	13.9	8.8	11.9	5.3	7.4	5.6
FMNL1	"C17orf1, C17orf1B, FMNL"	ENSG00000184922	"Formin like 1"	O95466	17	45221444-45247319	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 277.6;lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.1;dendritic cells: 160.0;Kupffer cells: 77.4;Langerhans cells: 141.6;Macrophages: 115.5;monocytes: 132.8;NK-cells: 152.4;Plasma cells: 109.8;T-cells: 134.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 190.8;MOLT-4: 138.4;U-266/70: 158.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008129, HPA028288"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA008129: AB_1848963, HPA028288: AB_10612110"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"prognostic unfavorable (4.23e-8)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.16e-1)"	22.9	7.4	14.2	68.5	11.3	277.6	13.4	10.1	21.5	10.4	9.0	12.5	11.5	5.6	2.3	8.9	14.1	18.5	12.7	20.8	9.0	8.4	8.5	54.6	69.4	16.2	11.2	3.4	6.5	6.8	16.3	12.2	15.5	10.4	7.3	1.3	16.2	3.3	4.7	9.5	36.7	8.2	11.1	104.9	13.7	4.2	17.2	49.7	9.0	6.2	38.7	21.4	10.5	16.3	16.9	32.2	0.3	1.7	0.3	7.0	1.7	2.0	4.3	11.8	8.8	1.5	7.2	51.4	16.2	0.6	12.4	2.7	0.0	0.4	3.9	91.1	4.4	29.8	51.0	2.7	32.6	78.6	100.6	5.4	1.4	15.6	6.7	16.4	0.3	55.8	2.7	190.8	8.8	10.9	138.4	80.7	1.6	2.1	1.0	86.2	11.3	92.7	3.3	2.1	10.0	4.8	9.9	1.7	4.0	2.6	9.2	62.7	4.0	0.7	11.1	1.9	73.3	158.9	75.7	52.2	1.4	62.8	2.5	11.1	6.5	11.3	8.6	7.4	5.7	4.5	6.6	9.4	5.6	5.1	4.4	5.8	28.4	7.2	5.9	3.3	8.1	5.3	14.2	11.3	10.1	21.5	20.8	9.0	16.2	11.2	15.5	11.1	17.2	16.3	7.2	3.2	3.0	0.0	108.1	6.1	2.9	0.9	2.2	4.9	3.3	4.7	2.5	1.5	1.1	1.8	0.0	0.6	160.0	0.7	0.0	1.5	2.5	0.7	4.3	5.7	1.2	34.9	12.8	0.9	1.2	12.9	4.6	1.2	22.9	0.2	6.1	1.5	45.3	3.3	10.3	0.4	0.0	77.4	141.6	0.7	5.3	115.5	44.4	9.4	132.8	0.9	152.4	0.5	1.0	0.5	0.1	0.0	109.8	1.9	0.2	0.8	1.0	1.6	6.6	9.3	2.4	0.8	3.5	0.6	6.1	2.5	134.6	0.2	0.5	1.4
FMNL2	"FHOD2, KIAA1902"	ENSG00000157827	"Formin like 2"	Q96PY5	2	152335174-152649826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 223.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 668.0;Excitatory neurons: 574.9;Inhibitory neurons: 321.9;Oligodendrocyte precursor cells: 371.0;Oligodendrocytes: 2442.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 191.4;hTERT-HME1: 123.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005464	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA005464: AB_1848965"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.58e-1)"	26.4	25.2	88.9	11.1	152.3	0.7	20.8	135.2	119.3	18.1	73.6	15.2	8.9	20.7	14.9	8.5	15.3	16.8	12.0	92.9	102.6	22.2	8.1	32.2	14.2	172.3	136.3	54.0	18.1	23.1	28.4	58.2	165.5	15.2	12.3	10.6	32.1	11.7	24.1	11.3	11.6	16.3	121.6	19.8	17.3	9.0	128.5	14.8	33.1	19.3	8.4	19.3	18.3	223.5	14.5	15.1	45.9	25.5	54.5	58.3	191.4	14.4	29.4	24.9	34.8	16.3	0.9	0.3	29.8	12.6	53.7	16.2	22.4	45.8	39.6	0.1	23.4	0.2	10.0	70.2	15.7	4.0	0.8	38.4	27.8	48.2	123.5	48.3	44.7	6.6	0.6	0.3	13.9	4.0	0.8	4.5	29.5	12.4	30.0	25.9	9.9	20.9	72.9	9.9	46.6	38.0	12.2	4.5	51.4	38.7	1.1	1.5	49.9	37.4	1.0	12.7	25.0	1.3	0.5	0.1	34.7	3.3	77.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	88.9	152.3	135.2	119.3	92.9	102.6	172.3	136.3	165.5	121.6	128.5	223.5	21.5	25.6	25.9	668.0	2.7	26.4	23.0	14.0	19.4	23.8	11.4	10.0	3.8	1.5	16.4	11.0	0.0	36.1	4.5	2.6	13.7	20.4	24.5	14.1	10.8	29.1	8.3	0.4	574.9	6.9	17.8	36.2	8.2	27.0	1.3	36.0	20.0	1.3	40.6	0.0	321.9	3.3	10.2	64.8	53.0	10.5	35.1	31.5	7.2	245.4	4.4	3.9	1.0	371.0	2442.0	10.0	2.1	41.3	5.6	33.5	0.7	8.9	8.5	2.0	6.6	18.7	13.2	6.7	8.0	6.3	16.9	27.0	2.1	13.0	6.1	13.2
FMO4	FMO2	ENSG00000076258	"Flavin containing dimethylaniline monoxygenase 4"	P31512	1	171314183-171342084	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 48.6;liver: 61.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Hepatocytes: 22.1;Oligodendrocytes: 18.5;Proximal enterocytes: 16.5;Proximal tubular cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 5.7;HSkMC: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favorable (1.09e-4)"	"prognostic favorable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	3.7	2.6	2.2	1.9	3.1	0.9	4.1	2.8	3.0	3.3	3.1	5.0	5.4	2.7	6.3	2.3	3.5	4.9	5.2	2.1	2.6	48.6	61.3	3.2	2.9	3.1	2.8	3.8	2.4	4.7	1.9	2.3	3.3	3.1	4.8	0.7	2.0	2.2	1.0	3.4	9.2	2.0	2.6	3.1	5.0	1.7	3.1	3.6	3.2	2.1	3.3	2.4	2.9	3.5	0.1	0.1	0.3	0.4	4.1	3.4	0.2	0.8	3.7	1.1	1.2	0.6	5.3	3.7	5.7	0.1	2.0	0.2	0.7	1.0	1.6	1.6	0.8	0.0	0.0	0.0	0.6	0.7	0.8	6.6	2.4	0.4	1.0	0.4	0.2	1.7	0.2	2.3	0.5	0.7	1.6	1.3	0.4	0.9	1.2	0.4	0.4	2.1	2.6	0.0	0.1	0.0	1.2	1.0	2.4	4.1	2.2	1.0	0.1	0.9	0.3	1.0	0.7	2.9	1.0	2.2	1.8	1.1	0.8	0.2	1.0	0.3	0.9	1.6	0.7	1.2	0.8	1.3	0.9	1.8	1.2	0.9	0.1	1.7	1.1	1.2	2.1	0.8	2.2	3.1	2.8	3.0	2.1	2.6	3.1	2.8	3.3	2.6	3.1	3.5	2.2	0.0	2.6	7.2	3.2	2.8	4.6	5.0	2.8	0.0	2.3	2.0	3.7	2.8	3.7	9.2	0.0	2.8	0.6	7.1	29.4	2.3	5.7	3.8	1.7	1.4	1.2	0.0	0.1	1.4	1.2	6.6	8.2	1.7	1.3	1.5	2.9	22.1	3.7	0.0	0.1	3.2	2.0	5.9	1.3	1.3	1.5	2.7	5.4	2.8	1.6	1.8	1.0	0.0	18.5	1.1	0.7	0.4	1.1	0.9	16.5	49.5	7.3	0.0	0.0	1.8	2.1	0.3	0.5	1.9	1.6	1.9	1.7	2.0	2.8	1.8
FMO5		ENSG00000131781	"Flavin containing dimethylaniline monoxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 683.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 64.2;Cholangiocytes: 133.0;Hepatocytes: 265.4;Proximal enterocytes: 108.8;Proximal tubular cells: 69.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	3.1	5.7	2.0	5.1	2.9	2.0	46.1	3.9	2.8	7.8	0.5	41.3	71.3	2.8	6.9	1.2	3.6	15.8	3.1	2.1	2.4	51.5	683.3	27.1	4.0	4.2	2.9	4.1	48.1	68.3	6.7	2.4	4.8	9.7	46.6	0.9	32.7	4.0	0.8	11.6	73.9	3.5	3.2	4.0	120.1	5.2	3.1	1.1	2.0	1.4	2.5	3.9	1.5	5.6	0.1	1.1	0.6	0.1	2.8	0.8	0.9	0.7	0.5	0.3	0.8	0.7	2.4	0.4	0.8	0.8	0.2	0.4	0.0	0.0	0.0	1.4	0.2	1.6	0.1	41.7	0.9	1.4	9.0	1.3	0.2	0.4	0.0	0.4	0.6	0.2	0.1	0.1	1.5	1.4	0.2	0.7	2.8	5.3	0.8	0.4	0.5	0.4	3.4	0.6	0.5	0.3	0.9	2.8	1.3	1.3	2.1	10.4	1.1	0.0	0.3	0.9	0.0	0.3	0.0	0.3	1.1	0.5	0.3	7.0	12.9	4.1	2.0	5.9	0.3	4.7	0.5	0.6	5.4	8.5	0.3	1.3	1.3	1.2	1.8	2.5	1.6	3.9	2.0	2.9	3.9	2.8	2.1	2.4	4.2	2.9	4.8	3.2	3.1	5.6	2.8	9.6	64.2	11.1	6.4	1.7	3.9	0.9	1.8	2.0	17.5	6.7	1.9	133.0	10.4	14.7	0.0	1.5	1.7	60.8	7.9	7.5	7.7	2.5	1.8	2.7	6.7	4.8	8.2	5.9	1.1	2.9	24.5	6.1	5.7	9.8	5.0	265.4	4.0	3.3	6.4	34.4	4.1	10.0	2.3	4.5	2.8	4.6	28.4	10.3	5.3	0.2	4.1	10.1	17.5	7.0	29.0	1.5	0.4	5.6	108.8	69.2	18.1	1.3	0.0	2.2	1.0	5.9	0.9	1.3	1.6	1.4	2.6	6.6	20.7	6.4
FNDC3A	"bA203I16.5, FNDC3, KIAA0970"	ENSG00000102531	"Fibronectin type III domain containing 3A"	Q9Y2H6	13	48975912-49209779	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008927, HPA012555, HPA012825"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Golgi apparatus, Centrosome"	Cytosol	"HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.14e-2)"	17.8	39.9	15.2	18.7	18.6	17.0	26.3	12.7	16.4	35.2	13.6	23.3	27.5	32.1	38.8	13.1	26.5	26.8	14.0	15.3	39.4	29.7	66.9	21.6	16.7	16.7	19.6	35.4	43.1	27.7	30.8	44.1	17.4	22.1	24.0	21.9	36.8	33.9	10.1	11.4	23.8	26.0	15.5	22.6	28.8	30.4	31.9	21.3	51.2	13.1	18.9	25.6	14.1	17.9	11.6	13.1	47.1	12.4	58.3	73.0	9.2	53.3	70.8	50.2	36.3	17.9	27.7	8.8	9.7	40.5	21.8	12.4	28.4	18.1	72.6	22.1	21.9	14.3	36.9	33.2	35.3	13.4	2.3	37.7	24.8	44.7	51.4	47.1	52.6	11.9	18.0	21.0	55.4	4.7	13.3	26.7	23.2	25.0	11.0	12.6	18.8	16.4	42.4	21.2	17.8	29.4	20.1	17.8	38.8	29.8	9.6	26.0	41.7	26.1	17.9	24.3	38.3	25.4	14.4	8.1	19.6	16.9	27.4	1.9	3.0	1.9	2.5	2.0	3.6	3.3	2.9	2.2	1.9	2.2	3.7	3.3	4.5	2.1	4.0	4.0	2.6	1.7	15.2	18.6	12.7	16.4	15.3	39.4	16.7	19.6	17.4	15.5	31.9	17.9	46.7	54.5	49.0	88.2	36.2	18.4	37.4	17.5	44.3	52.0	33.4	25.5	27.1	27.1	28.9	36.8	37.5	13.2	36.4	21.6	13.7	30.6	45.9	42.1	74.3	42.4	43.5	17.9	159.5	36.2	38.2	58.0	57.6	56.4	31.6	38.8	32.9	74.2	25.4	35.3	170.8	37.4	18.3	31.8	24.4	13.1	33.8	45.5	37.4	112.4	27.0	52.7	24.7	177.9	178.2	25.5	29.0	39.5	165.9	44.2	37.8	48.0	35.6	42.5	6.6	48.0	50.8	89.8	33.7	20.3	11.9	32.3	30.9	46.4	24.7	26.4
FNDC4	"FLJ22362, FRCP1"	ENSG00000115226	"Fibronectin type III domain containing 4"	Q9H6D8	2	27491883-27495200	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 124.2;liver: 126.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 255.2;Hepatocytes: 130.9;Late spermatids: 557.6;Pancreatic endocrine cells: 89.2"	"Cancer enhanced"	"Detected in all"		"glioma: 39.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 35.3;ASC diff: 34.7;HUVEC TERT2: 43.3;SH-SY5Y: 33.2;TIME: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051804, HPA063581"	Uncertain		Approved	Nucleoplasm,Aggresome,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Aggresome, Cytosol"	"HPA051804: AB_2681617, HPA063581: AB_2685048"	"unprognostic (2.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (6.11e-4)"	34.5	124.2	55.4	2.9	54.6	0.0	26.2	59.8	69.0	7.5	40.3	5.9	1.1	4.2	2.7	24.9	3.8	12.2	11.7	58.9	56.0	11.4	126.9	4.6	1.1	64.6	57.5	38.3	11.9	36.5	11.2	2.5	63.6	11.8	1.8	10.4	9.0	3.2	4.1	4.9	3.4	5.4	56.2	5.4	5.6	27.3	59.2	0.4	5.9	4.0	2.8	6.0	8.0	56.1	0.0	0.3	19.9	35.3	34.7	21.2	0.3	8.1	16.3	5.8	5.0	1.6	0.6	0.0	0.9	25.9	7.5	0.0	13.3	4.9	5.0	0.0	2.2	1.7	0.1	18.7	12.9	0.0	0.2	18.2	2.3	10.0	2.0	26.0	43.3	0.0	1.9	0.0	21.3	0.0	0.0	0.1	12.4	0.0	0.7	0.0	0.0	0.0	3.4	0.0	0.3	33.2	0.2	0.0	0.3	2.6	0.1	0.0	39.7	5.4	2.4	2.1	6.3	0.0	0.0	0.0	29.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	54.6	59.8	69.0	58.9	56.0	64.6	57.5	63.6	56.2	59.2	56.1	14.8	0.0	0.5	5.2	0.8	3.4	3.2	0.4	5.7	9.1	8.3	12.8	2.4	14.3	0.2	0.0	4.2	0.2	0.4	0.0	3.9	72.9	255.2	1.6	18.8	10.9	0.0	2.7	20.1	48.3	0.2	17.3	6.1	2.0	5.7	5.9	10.0	130.9	0.5	0.0	18.7	0.5	0.0	3.2	5.3	557.6	15.5	1.0	3.6	5.6	1.0	23.7	0.0	10.6	2.1	89.2	0.0	11.7	0.7	11.9	0.0	0.4	0.2	12.9	0.0	34.4	15.6	5.0	8.4	1.4	2.4	0.0	1.5	1.0	0.1	1.7
FNDC8	DKFZp434H2215	ENSG00000073598	"Fibronectin type III domain containing 8"	Q8TC99	17	35121615-35130732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	474	"testis: 89.0"	"Group enriched"	"Detected in some"	73	"Early spermatids: 592.7;Late spermatids: 2294.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;JURKAT: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026521, HPA059803"	Supported		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA026521: AB_2106163, HPA059803: "	"unprognostic (1.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.10e-1)"		"unprognostic (5.88e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.48e-3)"	"unprognostic (9.02e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	89.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	0.0	0.1	0.5	0.3	0.1	0.0	0.1	0.7	0.3	0.7	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.7	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	592.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2294.8	7.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	19.7	0.0	0.0	7.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FNTA	"FPTA, PGGT1A, PTAR2"	ENSG00000168522	"Farnesyltransferase, CAAX box, alpha"	P49354	8	43034194-43085788	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010149, HPA018830"	Approved		Approved	Cytosol		NA	NA		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB010149: AB_2106299, HPA018830: AB_1848992"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (2.94e-12)"	"unprognostic (3.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-3)"	53.6	33.4	57.7	26.3	69.3	26.8	46.1	74.0	74.0	41.3	52.7	46.3	35.9	34.0	43.2	45.4	33.4	27.1	48.1	54.2	63.7	37.4	47.2	34.7	45.5	75.1	64.8	33.0	43.9	34.3	36.6	50.0	73.6	38.3	32.5	33.8	36.5	34.1	74.3	51.0	32.9	31.4	73.2	36.7	35.4	26.9	61.9	39.9	31.6	64.7	44.2	40.9	43.1	87.6	78.8	37.5	50.9	16.7	88.6	112.5	43.4	44.9	52.4	50.1	46.3	62.1	56.9	88.5	35.5	54.1	67.6	41.9	63.1	71.5	59.4	26.2	42.2	70.9	25.5	54.2	112.7	30.4	35.8	87.6	119.0	36.3	104.2	74.4	89.4	47.9	86.1	50.4	58.5	9.9	72.3	47.1	91.3	66.4	27.1	63.1	83.0	47.8	70.5	58.4	29.7	47.4	56.6	47.3	78.9	59.1	59.1	55.3	69.9	17.9	22.1	68.6	48.0	47.7	46.2	89.2	43.0	56.4	41.3	3.1	7.7	14.3	9.5	10.7	11.3	14.1	9.7	12.6	13.3	15.2	12.9	12.9	4.3	16.1	7.8	12.6	14.3	6.4	57.7	69.3	74.0	74.0	54.2	63.7	75.1	64.8	73.6	73.2	61.9	87.6	68.7	57.7	20.3	33.0	57.4	87.7	82.3	55.3	58.1	22.5	35.5	34.8	44.9	34.3	41.2	33.1	37.5	135.6	69.1	29.6	70.5	73.0	41.2	40.7	55.1	55.8	32.2	38.9	27.9	70.1	124.4	58.7	28.5	46.2	32.4	58.6	56.0	25.9	80.5	20.2	31.9	39.6	34.6	47.5	60.7	52.8	48.1	49.2	94.3	33.7	75.7	42.8	69.0	25.6	79.8	69.4	41.2	60.2	40.8	109.3	67.0	54.8	46.7	57.5	52.6	56.2	47.2	65.9	37.1	73.9	95.6	207.6	60.4	69.6	49.1	76.6
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Cell type enriched"	"Detected in some"	11	"monocytes: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.5"									"HPA012836, HPA069839"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA012836: AB_2105429, HPA069839: "	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.5	0.1	0.3	0.4	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1
FOXN4		ENSG00000139445	"Forkhead box N4"	Q96NZ1	12	109277978-109309284	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 11.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.9;Endometrial ciliated cells: 2.6;Ionocytes: 2.0;Respiratory ciliated cells: 1.2;Spermatocytes: 2.8;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;SCLC-21H: 3.5;SH-SY5Y: 3.6;U-266/70: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050018	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA050018: AB_2680992"	"unprognostic (1.09e-3)"	"unprognostic (9.63e-2)"		"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"		"unprognostic (1.08e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"		"unprognostic (6.00e-2)"	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.2	1.8	0.5	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.8	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	11.4	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	2.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXP4	FLJ40908	ENSG00000137166	"Forkhead box P4"	Q8IVH2	6	41546381-41602384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 40.2;Gastric mucus-secreting cells: 56.6;Intestinal goblet cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"CACO-2: 113.9;OE19: 118.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007176	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cytosol"		"HPA007176: AB_1078911"	"unprognostic (8.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.17e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.13e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-2)"	15.9	10.6	7.7	11.0	6.6	4.9	18.6	3.6	10.4	33.0	1.9	22.7	19.9	32.5	2.0	15.3	16.3	9.1	21.3	10.1	12.0	19.9	28.5	17.3	9.5	13.1	8.6	16.7	34.8	6.3	19.9	5.1	11.8	33.5	6.0	2.9	31.6	10.3	14.3	12.5	18.7	9.1	3.4	8.0	50.1	27.9	12.8	6.8	32.0	4.3	5.9	16.8	15.6	11.4	25.8	36.2	41.2	45.7	7.1	2.5	44.0	14.5	6.8	11.2	7.8	113.9	8.0	29.9	25.7	7.8	33.3	19.3	11.4	13.2	4.1	25.1	20.7	24.2	20.1	74.9	14.1	15.1	19.3	6.6	14.1	10.4	5.6	15.8	10.9	17.6	30.2	11.6	5.0	70.5	17.5	22.4	10.8	118.6	11.7	19.3	13.8	20.9	8.6	22.2	11.9	17.0	15.2	35.4	23.3	10.5	20.0	35.3	17.0	15.1	37.3	24.0	24.0	9.1	6.2	40.9	12.3	25.8	14.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	7.7	6.6	3.6	10.4	10.1	12.0	13.1	8.6	11.8	3.4	12.8	11.4	1.1	0.0	11.7	4.6	6.2	9.2	5.8	5.1	2.8	5.2	19.2	15.2	21.0	7.2	4.8	5.5	2.1	2.6	4.3	22.0	0.0	8.7	26.9	6.3	1.9	3.4	40.2	0.8	2.5	16.1	3.4	4.6	56.6	9.5	3.8	15.0	13.6	21.0	4.1	0.0	1.9	41.7	8.2	4.2	7.0	21.0	4.1	4.4	1.8	1.0	5.4	1.2	7.2	6.6	3.5	20.9	20.3	8.6	3.6	14.7	15.8	8.8	3.4	2.7	13.1	4.8	8.4	2.2	13.1	7.6	7.7	4.4	4.0	0.6	17.4	10.2
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844303-31845604	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Peritubular cells: 56.8;Sertoli cells: 131.5;Smooth muscle cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;hTERT-RPE1: 13.1;RH-30: 10.9;U-2 OS: 14.1;U-251 MG: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	4.5	1.6	2.4	1.4	2.4	0.0	2.8	2.6	3.8	3.7	1.7	1.4	0.3	3.9	2.4	1.0	1.9	2.0	9.7	2.2	2.3	5.4	0.8	5.3	2.5	2.6	2.5	2.0	0.9	0.6	2.3	4.8	2.7	2.4	0.6	0.0	1.1	3.1	1.7	1.5	1.4	1.2	2.2	3.0	1.2	5.5	2.6	1.0	3.5	1.7	0.9	2.6	2.4	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.9	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	14.1	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.4	2.6	3.8	2.2	2.3	2.6	2.5	2.7	2.2	2.6	2.3	4.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	1.1	2.6	0.0	0.0	0.0	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.9	4.9	5.0	0.2	1.8	8.4	0.0	0.0	0.0	0.0	0.0	5.7	0.0	56.8	0.0	0.1	0.0	0.0	0.0	0.1	131.5	0.4	31.5	0.6	0.5	0.1	0.3	0.3	0.1	6.6	0.0	0.1
FP565260.1		ENSG00000275464	"Periodic tryptophan protein 2 homolog"		21	5130871-5154658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 102.4"									HPA024573	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	9.2	9.2	6.4	9.9	8.8	12.1	7.4	7.2	8.0	5.9	4.9	8.5	9.1	6.8	1.7	8.3	7.8	7.3	7.5	7.1	6.8	9.0	6.8	7.1	13.4	7.6	7.2	6.7	7.7	6.5	6.0	7.9	9.1	6.5	8.4	3.5	6.7	4.7	10.1	8.6	8.2	7.3	6.8	11.5	7.6	7.1	7.2	6.7	6.6	3.2	5.3	11.4	7.1	13.7	32.0	24.0	15.4	24.2	6.6	5.0	9.1	0.2	0.0	0.1	0.1	0.4	20.1	0.3	14.1	10.5	20.8	21.0	42.9	19.0	0.0	7.4	15.1	102.4	12.4	11.9	10.4	47.6	29.1	17.8	22.5	25.5	20.1	5.0	20.1	16.5	56.8	11.6	6.6	28.4	34.4	33.1	60.4	36.5	29.3	54.0	14.2	28.8	13.5	25.3	16.6	27.3	25.5	38.4	14.9	4.2	31.5	24.9	10.2	12.0	29.7	0.3	32.9	13.9	16.0	63.5	20.4	62.3	16.7	3.3	7.3	6.9	18.5	12.6	21.2	11.0	11.3	13.5	8.7	11.2	11.1	15.2	4.1	9.9	18.2	5.5	8.5	11.6	6.4	8.8	7.2	8.0	7.1	6.8	7.6	7.2	9.1	6.8	7.2	13.7	0.9	0.0	9.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	1.9	0.0	0.0	2.5	0.0	0.0	2.7	1.1	0.8	0.0	9.3	0.0	0.8	1.1	0.9	0.0	0.0	0.0	8.0	1.4	0.9	0.0	0.9	5.1	0.6	0.0	0.0	6.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.3	1.2	0.4	0.9	0.0
FRAT1		ENSG00000165879	"FRAT regulator of WNT signaling pathway 1"	Q92837	10	97319271-97321915	"Predicted intracellular proteins"	"Wnt signaling pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.2;Early spermatids: 31.3;Kupffer cells: 26.1;Late spermatids: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 8.7;neutrophil: 10.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB046472, HPA055258"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 6: T47d - Mammary gland"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"CAB046472: AB_1849131, HPA055258: AB_2682763"	"unprognostic (1.48e-2)"	"prognostic favorable (5.92e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (6.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (5.27e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.43e-2)"	3.2	2.9	2.6	5.0	2.6	10.6	2.4	3.8	3.5	2.5	1.8	3.2	4.4	2.6	1.0	2.4	3.0	1.2	3.1	2.8	3.1	2.1	11.8	3.3	3.8	3.6	3.4	2.4	3.9	2.0	2.1	1.2	3.1	4.0	1.9	1.9	3.7	1.6	3.8	4.2	4.5	1.5	2.9	12.6	4.8	10.9	3.9	4.1	2.0	2.6	2.4	2.3	2.1	2.6	0.7	1.3	1.4	6.7	1.8	0.9	1.5	0.8	2.9	0.5	0.6	0.2	0.8	4.5	1.5	0.5	1.0	2.0	1.1	1.4	0.1	4.0	2.0	3.8	0.8	1.8	0.6	1.4	4.0	0.8	2.0	0.2	0.9	2.7	1.2	6.1	1.6	3.1	0.4	4.2	4.0	7.9	1.9	4.8	5.5	3.3	0.3	2.9	0.5	1.0	0.7	2.2	1.0	2.1	1.5	1.4	7.7	5.4	1.1	0.3	0.4	1.0	0.3	2.9	1.7	1.5	0.5	7.0	0.0	0.9	2.0	8.7	0.5	1.3	0.4	0.5	0.4	0.7	1.0	0.5	0.7	0.5	10.1	0.2	1.5	0.6	0.3	0.5	2.6	2.6	3.8	3.5	2.8	3.1	3.6	3.4	3.1	2.9	3.9	2.6	4.1	3.2	5.8	1.0	5.8	1.1	1.1	0.9	1.2	25.2	2.9	1.9	3.3	5.7	0.9	1.8	0.0	0.6	16.8	6.0	0.0	1.4	31.3	5.8	1.6	4.0	4.2	4.2	0.7	2.0	1.7	1.5	2.0	4.1	0.0	5.0	3.3	15.6	3.9	3.3	1.6	4.9	4.1	26.1	1.8	85.2	1.2	15.5	3.6	0.0	12.5	4.9	13.4	0.5	0.7	1.1	2.3	1.9	1.1	2.5	3.8	1.0	3.3	8.4	0.0	3.4	1.7	1.2	0.6	1.6	1.6	2.3	9.0	4.7	2.8	2.2
FREM2	DKFZp686J0811	ENSG00000150893	"FRAS1 related extracellular matrix 2"	Q5SZK8	13	38687077-38887131	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 7.7;thyroid gland: 4.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 27.2;Astrocytes: 46.0;Cholangiocytes: 15.7;Endometrial ciliated cells: 18.6;Glandular and luminal cells: 48.6;Oligodendrocyte precursor cells: 15.6;Proximal tubular cells: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 10.6;MCF7: 7.8;RT4: 7.2;SK-BR-3: 6.3;SuSa: 29.7;WM-115: 5.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA028831	Uncertain		Approved	Cytosol		NA	NA		1500000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA028831: AB_10603668"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (7.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.14e-1)"	0.2	0.1	0.3	0.0	1.1	0.0	0.2	0.2	0.9	0.3	0.1	0.5	0.1	0.5	0.2	0.0	0.4	0.8	0.0	0.6	0.0	7.7	2.0	2.2	0.0	0.0	0.4	0.7	2.7	0.0	0.3	1.4	0.0	1.8	0.1	0.3	0.0	0.7	2.8	0.1	0.2	0.3	0.0	0.1	0.9	0.3	0.0	0.2	4.9	3.6	0.0	0.2	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	10.6	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	2.3	0.0	0.2	0.0	1.4	0.1	2.3	7.2	0.2	0.1	0.0	6.3	0.3	29.7	1.1	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.2	0.9	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	27.2	46.0	0.0	0.6	0.1	0.7	0.0	0.2	0.4	0.5	2.7	15.7	1.4	1.8	0.0	5.9	0.0	0.3	5.9	3.2	0.5	18.6	4.5	0.6	0.0	0.0	0.5	0.2	0.4	0.4	0.0	48.6	0.0	0.5	0.0	1.3	0.8	0.0	9.1	0.1	2.0	0.3	0.0	0.1	0.0	0.2	0.0	3.7	0.0	3.3	0.0	15.6	9.7	1.0	0.1	0.0	0.0	0.0	0.0	24.8	2.9	0.3	0.0	3.1	0.7	0.2	0.9	0.0	0.1	1.9	0.5	2.9	0.1	0.1
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060891	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.4;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 18.3;RT4: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	0.8	1.1	1.3	1.2	2.1	1.5	2.4	5.8	5.0	1.8	13.7	4.6	6.2	1.0	2.5	2.9	2.6	2.6	1.8	1.8	0.0	9.0	6.8	1.8	0.7	0.3	0.1	0.9	2.8	1.0	0.4	0.8	1.0	2.2	4.8	2.9	4.0	2.4	2.2	1.9	6.3	0.8	0.2	0.9	4.9	1.9	1.1	1.2	1.0	0.8	1.6	2.1	1.0	5.7	2.5	4.0	0.5	0.9	0.2	0.2	0.6	0.5	0.1	0.0	0.1	3.1	3.8	0.9	3.5	0.5	0.5	5.8	0.2	1.1	0.1	3.3	0.3	1.3	3.3	2.7	0.2	0.9	0.7	0.2	1.5	0.3	0.4	0.4	0.2	0.6	0.6	2.3	1.0	1.3	0.7	0.5	1.0	18.3	0.7	1.1	3.3	1.2	4.8	7.6	0.7	0.8	0.7	5.1	0.5	0.9	1.5	0.7	0.8	1.0	1.0	0.7	0.5	3.6	2.7	1.6	1.1	0.6	0.6	0.9	0.2	0.2	0.4	0.1	0.5	0.2	0.3	0.4	0.1	0.4	0.2	0.3	0.8	0.3	0.2	0.3	0.2	0.0	1.3	2.1	5.8	5.0	1.8	0.0	0.3	0.1	1.0	0.2	1.1	5.7	0.4	0.0	10.3	10.4	0.5	2.7	20.8	23.3	6.8	0.6	7.3	2.9	9.2	11.5	22.6	23.9	0.0	4.4	0.1	34.9	11.7	20.3	89.4	28.1	1.7	0.7	19.8	0.0	12.2	16.4	4.3	3.5	29.0	30.4	3.8	0.2	1.4	21.9	0.9	6.7	7.7	14.5	34.6	0.6	0.4	38.1	0.6	0.6	0.0	1.0	1.0	0.2	0.0	2.5	97.8	21.9	23.3	1.2	0.5	23.4	49.3	28.4	36.6	0.3	13.1	9.9	16.2	4.6	1.0	16.4	3.1	0.8	1.0	2.3	19.1	46.2
FRYL	"AF4p12, DKFZp686E205, KIAA0826, MOR2"	ENSG00000075539	"FRY like transcription coactivator"	O94915	4	48497357-48780322	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.5"	"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 1148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031106, HPA031107"	Supported		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA031106: AB_10600660, HPA031107: AB_10600536"	"unprognostic (7.50e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.22e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	8.8	5.4	12.2	13.2	43.5	15.0	7.9	26.6	22.6	8.4	0.8	37.9	10.4	8.4	3.7	6.6	6.1	8.3	8.6	12.1	19.9	8.4	5.7	9.7	13.4	34.8	23.4	7.9	5.6	20.3	2.7	10.5	31.2	6.5	36.7	29.2	6.8	6.6	4.5	10.2	12.8	9.2	22.2	10.8	10.7	6.3	25.7	16.7	7.9	12.0	13.1	10.2	3.4	81.5	19.7	11.6	26.8	16.4	11.3	16.1	14.5	18.1	17.4	17.6	21.2	9.4	14.7	25.0	14.3	19.3	32.9	11.8	17.8	28.1	37.9	14.3	6.1	45.6	11.3	4.3	7.0	31.6	16.8	11.6	10.5	24.0	24.9	16.4	26.4	21.3	14.8	9.2	22.9	9.6	34.5	10.9	4.6	8.9	9.8	25.4	35.0	4.7	15.7	20.8	23.1	9.9	17.7	5.2	9.9	12.8	6.8	19.6	40.3	19.8	25.5	10.1	35.3	12.4	17.5	22.1	16.6	20.6	19.8	13.5	0.9	1.8	2.0	1.4	1.6	1.5	1.8	1.7	1.0	1.2	2.0	1.9	2.8	2.7	1.0	1.7	1.3	0.7	12.2	43.5	26.6	22.6	12.1	19.9	34.8	23.4	31.2	22.2	25.7	81.5	87.1	38.5	33.1	92.1	50.1	47.3	24.3	32.0	38.7	45.3	23.7	17.0	33.5	18.6	28.9	16.5	135.5	23.6	59.9	122.8	3.9	13.8	11.6	48.2	29.0	74.8	79.5	80.6	110.1	11.6	21.5	23.7	128.4	56.8	46.9	25.6	48.9	15.2	19.4	47.1	172.5	195.1	38.7	30.1	34.0	3.9	17.1	40.1	26.6	214.5	35.1	32.8	63.8	146.8	1148.7	28.8	87.3	18.4	38.6	43.4	50.4	8.4	21.0	105.6	19.7	31.2	37.3	12.8	10.9	37.3	49.3	10.8	54.4	15.6	93.9	53.3
FSD2	"RP11-127F21, SPRYD1"	ENSG00000186628	"Fibronectin type III and SPRY domain containing 2"	A1L4K1	15	82755362-82806070	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"heart muscle: 52.3;skeletal muscle: 154.3;tongue: 44.3"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 81.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 3.6;U-266/70: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046263			Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA046263: AB_2679604"	"unprognostic (2.80e-1)"	"unprognostic (3.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.59e-2)"	0.2	0.7	0.2	0.9	0.2	0.8	0.1	0.7	0.4	0.0	0.0	0.1	0.9	0.4	0.6	1.9	0.3	0.3	52.3	0.3	0.5	0.3	0.1	0.2	1.1	0.1	0.1	0.6	0.6	0.7	0.1	0.3	0.2	1.2	0.0	2.4	0.8	0.0	154.3	1.5	0.8	0.1	0.0	0.6	0.6	0.7	0.3	0.0	0.9	44.3	0.1	0.1	0.0	0.6	0.7	0.7	1.1	1.3	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.6	1.2	2.3	0.5	0.0	0.6	2.8	0.0	0.0	0.2	0.4	3.1	1.3	3.6	1.0	0.0	0.7	0.5	0.0	0.0	0.0	0.1	0.7	0.0	1.0	1.2	2.0	0.0	0.7	0.4	1.4	1.0	0.5	0.6	0.8	0.8	0.6	0.1	1.3	1.1	0.9	0.5	0.5	0.9	0.5	0.9	1.0	0.5	1.6	0.8	0.6	1.0	4.7	2.1	0.8	1.0	2.8	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.7	0.4	0.3	0.5	0.1	0.1	0.2	0.0	0.3	0.6	0.4	0.0	2.2	1.3	0.2	0.4	1.0	0.2	0.0	2.1	0.5	0.3	81.6	1.5	0.8	0.0	6.2	0.1	0.3	0.1	0.0	0.0	4.8	1.7	0.3	1.2	1.2	0.0	3.9	0.4	0.1	3.0	0.0	1.6	1.3	0.6	0.0	0.0	0.3	11.8	3.6	0.0	2.0	0.3	2.1	6.1	0.3	0.2	0.0	1.0	0.1	0.7	0.0	4.0	3.3	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.5	4.5	0.0	4.5	0.6	0.6	0.3	0.0	0.6	0.3	0.4	0.2	0.1	0.3
FSTL1	"FRP, FSL1, OCC-1, OCC1, tsc36"	ENSG00000163430	"Follistatin like 1"	Q12841	3	120392293-120450993	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 352.1;Fibroblasts: 521.9;Leydig cells: 327.4;Peritubular cells: 270.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"basophil: 12.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 12.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1782.4;BJ: 2156.3;fHDF/TERT166: 2692.9;HBF TERT88: 1741.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035251, HPA040815"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		34000000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Cytosol"		"HPA035251: AB_10601906, HPA040815: AB_2732489"	"unprognostic (2.60e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.84e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.47e-3)"	432.4	134.3	20.5	116.3	18.1	2.2	166.1	22.8	22.7	279.9	83.0	156.4	37.1	157.5	50.8	126.1	150.6	257.0	242.7	20.6	22.8	45.4	35.7	120.7	50.3	28.5	44.6	90.3	37.3	35.5	25.7	442.0	23.1	188.3	90.4	29.8	59.3	184.4	31.8	64.2	69.1	409.6	22.7	63.1	68.6	33.5	22.7	24.2	78.8	89.8	38.8	260.4	104.3	20.6	81.0	21.2	222.9	91.8	1304.4	1782.4	1.3	2156.3	1208.9	1374.5	1211.0	0.1	178.5	0.8	178.8	2692.9	112.8	20.5	68.6	270.0	1741.5	1.1	32.5	0.4	159.8	0.3	286.0	1.2	0.9	1362.7	8.5	884.5	192.7	612.1	811.6	11.2	0.5	0.3	227.6	0.5	22.6	2.0	181.3	0.4	181.9	0.7	92.7	1.0	150.4	1.7	39.2	93.5	764.6	13.6	76.5	462.6	23.5	6.2	986.8	507.4	479.8	268.0	323.8	1.0	1.1	2.3	177.4	0.9	67.0	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	2.6	20.5	18.1	22.8	22.7	20.6	22.8	28.5	44.6	23.1	22.7	22.7	20.6	76.9	64.1	9.4	56.5	1.1	64.1	31.9	36.4	10.2	2.3	25.6	24.6	127.5	8.6	42.5	23.9	0.0	114.4	2.5	0.9	0.0	62.6	2.3	44.4	176.7	111.4	3.0	3.6	9.6	5.8	352.1	521.9	3.1	23.0	1.3	66.5	142.5	17.4	20.6	1.7	16.2	0.2	8.2	10.8	91.6	9.8	327.4	11.5	110.3	30.0	9.9	116.1	0.0	9.5	0.9	117.8	0.7	270.8	0.9	108.4	0.0	5.5	74.9	4.3	59.2	62.5	129.3	1.5	4.4	2.2	48.2	54.7	7.1	47.5	0.9	65.3
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 939.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 131.5;Early spermatids: 104.7;Hepatocytes: 444.9;Late spermatids: 124.3;Proximal tubular cells: 395.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 92.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		1600000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.4	1.7	5.4	0.2	6.8	0.0	0.4	3.6	8.4	1.3	3.0	1.3	1.3	1.2	0.4	0.3	0.9	0.1	1.6	4.9	4.7	155.7	939.8	0.2	0.2	4.6	3.9	3.0	4.0	0.0	3.4	0.0	5.6	4.2	0.0	0.0	0.2	0.6	0.4	0.3	1.7	0.0	3.5	0.5	0.5	13.9	4.4	0.0	0.9	0.0	0.0	1.3	1.0	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.0	92.9	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.5	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.4	6.8	3.6	8.4	4.9	4.7	4.6	3.9	5.6	3.5	4.4	5.5	0.0	0.0	0.0	1.0	8.1	0.1	0.0	0.0	0.0	1.3	0.2	0.5	1.5	131.5	0.0	9.2	0.0	0.0	0.1	0.0	46.9	0.0	104.7	0.1	0.4	1.8	0.0	61.5	10.5	0.0	0.0	0.6	0.0	0.2	0.0	0.6	30.4	444.9	0.1	3.3	5.9	0.1	0.0	28.9	0.0	124.3	3.1	1.6	0.0	1.0	0.0	0.2	0.0	1.0	18.5	0.0	0.1	2.6	0.0	0.5	0.3	395.1	0.0	0.4	0.0	0.2	0.5	39.2	17.9	0.2	0.4	0.0	3.6	0.1	0.2	0.1
FTL	"MGC71996, NBIA3"	ENSG00000087086	"Ferritin light chain"	P02792	19	48965309-48966879	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Iron storage"		"Cancer-related genes, Cataract, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 14422.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 74983.4;Kupffer cells: 70127.1;Macrophages: 34584.5;Proximal tubular cells: 58047.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 125209.0;monocytes: 102128.9"	"Cell line enhanced"	"Detected in all"		"HHSteC: 24796.9;HSkMC: 20811.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020769, HPA041602"	Enhanced		Approved	Cytosol		NA	NA		170000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB020769: , HPA041602: AB_2677575"	"unprognostic (2.95e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	6778.7	3262.2	6806.2	2353.2	7172.4	4213.8	4226.0	6782.1	10053.2	2094.3	6429.7	2451.1	2427.0	1523.4	1010.8	1306.2	2169.9	4298.0	2537.3	6497.7	6998.4	8845.6	14422.9	7261.1	3353.2	7250.8	6998.4	2455.3	2166.2	931.7	1730.4	3423.2	7218.5	1946.5	1800.0	684.9	1663.5	1390.4	1345.9	1449.7	2806.6	1842.3	7149.5	6751.4	3204.5	455.9	7581.8	1168.9	3000.4	1072.0	1334.6	4239.9	1804.7	7334.0	869.7	12906.5	949.6	1457.0	16013.9	16478.6	1693.1	2194.1	12820.0	3090.7	6903.8	2852.3	3413.2	656.4	4104.3	13203.9	6755.6	505.8	788.2	1301.8	2765.6	8895.0	507.6	1740.0	3222.8	18949.7	24796.9	4133.3	5591.2	20811.1	1735.9	5272.5	2301.6	4590.4	4549.8	774.6	3284.9	1328.2	6198.4	213.0	1152.1	2402.8	1729.8	15140.6	1306.9	947.6	643.0	6763.9	1989.7	545.0	1209.9	701.5	5761.7	313.4	1239.5	5104.1	183.2	8493.4	3438.3	3353.4	1740.1	4364.3	3083.1	5690.2	13742.1	625.1	3563.9	4334.7	6017.7	64938.4	71067.8	77353.0	6560.6	102128.9	7527.7	17097.3	7247.4	7054.3	25176.6	15607.2	8656.4	7466.9	125209.0	4978.3	91398.0	10579.6	9634.4	94147.5	6806.2	7172.4	6782.1	10053.2	6497.7	6998.4	7250.8	6998.4	7218.5	7149.5	7581.8	7334.0	2757.2	1125.0	3379.9	88.5	3311.5	2793.9	6799.5	2785.4	2159.8	474.7	2597.9	3977.3	777.8	4398.0	2550.4	2021.2	177.2	941.5	2199.4	2314.2	10704.0	4251.2	290.2	504.9	1413.1	4867.0	1613.4	4331.2	60.6	6134.8	1447.8	5703.3	1715.1	617.4	2365.7	942.2	4598.0	23702.0	74983.4	533.3	113.8	2368.8	3039.4	70127.1	16939.0	1601.8	4175.9	34584.5	5085.3	129.3	22965.8	3161.9	2020.6	55.8	309.7	6905.5	5604.7	2010.8	4884.7	9790.5	21474.5	58047.8	1908.0	682.6	1341.1	1643.8	3455.6	82.1	311.2	1985.5	2226.7	1502.7	2590.4	1492.0	2816.8	13083.6
FTSJ1	"CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7"	ENSG00000068438	"FtsJ RNA 2'-O-methyltransferase 1"	Q9UET6	X	48476021-48486364	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 75.7;Pancreatic endocrine cells: 60.1;Plasma cells: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002718	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA002718: AB_1078914"	"unprognostic (2.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.96e-3)"	"unprognostic (2.06e-3)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.24e-10)"	"unprognostic (2.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	14.6	15.2	5.7	14.5	6.8	16.0	13.8	6.5	9.0	16.0	5.2	10.2	8.2	13.8	4.6	14.9	12.1	8.6	11.4	6.6	6.7	10.1	9.8	13.3	16.2	6.0	6.2	12.7	16.8	12.4	12.2	8.4	6.2	10.3	7.7	5.7	15.4	12.8	14.8	14.2	10.2	12.3	6.2	13.7	13.7	9.8	5.8	14.8	14.3	10.9	13.4	14.3	14.1	6.6	75.9	51.1	19.1	76.4	27.1	27.9	31.3	36.0	34.3	51.4	40.5	30.8	102.6	43.6	26.3	55.4	32.4	49.8	38.3	127.3	23.1	33.4	36.3	27.8	62.5	35.5	75.8	38.5	67.4	26.0	63.0	64.8	63.2	28.5	36.4	49.2	24.1	35.2	67.4	42.6	50.4	27.3	43.2	32.1	86.6	40.4	62.7	91.2	48.3	25.4	26.0	25.5	57.4	31.1	27.5	22.1	35.7	21.7	35.8	40.6	54.9	85.3	44.9	47.6	39.8	31.4	89.6	71.3	43.6	19.5	23.7	19.1	34.6	27.1	43.0	27.2	29.5	35.4	28.3	31.5	26.8	34.5	3.4	30.3	27.8	19.1	30.2	27.8	5.7	6.8	6.5	9.0	6.6	6.7	6.0	6.2	6.2	6.2	5.8	6.6	15.1	6.4	11.0	3.9	20.6	12.7	11.4	30.7	14.2	4.5	8.5	8.8	6.7	4.3	23.8	7.3	2.1	5.3	19.7	6.6	17.6	21.2	49.5	11.1	11.8	13.4	5.4	14.7	4.4	18.2	28.7	12.4	16.3	15.2	8.8	9.2	6.4	5.9	17.0	3.3	4.3	11.3	10.2	8.4	10.6	75.7	10.8	11.0	5.4	5.6	8.9	5.7	19.6	3.0	5.8	60.1	2.7	8.6	59.5	17.0	4.8	11.3	14.0	6.5	13.1	9.6	16.7	7.5	10.1	15.0	10.9	5.7	17.0	10.7	9.4	26.5
FUBP3	FBP3	ENSG00000107164	"Far upstream element binding protein 3"	Q96I24	9	130578965-130638352	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047658, HPA058392"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		63000	"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA047658: AB_2680114, HPA058392: AB_2683703"	"unprognostic (1.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (3.12e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.23e-2)"	29.9	23.6	20.4	20.9	23.7	12.4	21.5	22.2	25.3	23.3	16.4	26.1	21.4	30.4	20.5	24.8	21.8	20.4	26.7	19.4	21.0	22.9	40.4	21.3	21.9	24.2	22.5	24.9	22.9	33.7	17.5	28.5	23.8	26.6	20.9	20.2	23.7	24.7	16.0	22.1	22.4	27.0	21.5	22.9	22.5	17.0	22.1	25.8	41.5	13.6	20.9	22.8	22.6	24.5	47.3	42.4	61.1	50.8	43.2	48.7	76.8	67.1	59.0	51.9	40.3	62.0	42.3	45.8	34.5	63.4	45.7	80.3	51.5	56.1	61.1	51.2	45.7	50.3	66.8	46.1	59.2	76.4	54.5	47.6	44.1	54.5	51.1	43.8	43.7	37.2	82.1	27.5	54.7	63.3	59.3	38.8	78.2	74.4	54.5	52.6	75.4	61.7	45.6	49.2	39.5	66.4	70.5	51.8	44.4	45.7	71.0	57.9	55.4	93.9	44.4	63.5	78.4	25.1	44.8	57.9	52.8	33.0	68.2	0.0	2.1	1.2	2.4	2.5	3.6	2.3	2.6	2.9	3.1	1.6	3.1	2.7	0.5	4.0	2.0	2.7	2.3	1.5	20.4	23.7	22.2	25.3	19.4	21.0	24.2	22.5	23.8	21.5	22.1	24.5	26.1	19.2	20.6	45.4	19.5	33.4	20.6	17.6	24.5	26.2	23.0	13.6	20.4	20.0	15.2	16.5	14.6	28.3	18.1	21.1	29.4	19.0	5.1	18.0	24.3	23.9	21.7	20.2	49.4	18.9	31.8	25.0	20.9	26.2	7.6	26.6	26.4	52.0	26.7	32.0	54.1	17.2	20.3	25.4	20.4	9.6	20.5	17.6	37.4	30.0	18.1	59.1	12.3	41.2	56.9	25.7	17.0	27.8	22.8	28.3	15.5	35.9	22.8	28.0	13.1	29.3	29.9	16.8	12.4	31.4	40.9	45.8	19.4	20.7	17.7	26.0
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1019.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 15.6;NK-cells: 14.8;T-cells: 10.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA043410"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA043410: AB_2678467"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	7.9	8.2	21.0	11.9	38.2	3.6	10.5	44.1	28.2	6.9	0.0	11.4	17.5	9.0	5.3	6.8	15.6	11.1	4.7	20.4	27.7	6.9	3.4	8.1	11.7	32.8	29.9	7.3	9.9	9.6	4.6	17.3	29.3	5.8	11.6	8.3	42.6	10.5	2.5	5.3	17.4	11.0	29.4	10.2	31.8	16.4	29.7	11.3	8.4	6.3	18.6	13.3	4.5	64.3	115.9	22.5	12.6	110.6	49.5	38.4	61.6	35.9	64.8	30.3	32.6	16.9	44.8	30.7	29.2	40.1	79.4	9.0	29.9	11.4	45.6	124.2	11.0	33.5	7.2	23.0	26.8	7.6	23.9	96.0	6.8	39.3	19.4	124.4	69.6	17.1	14.1	28.8	20.8	60.8	36.6	16.7	14.7	59.6	66.6	26.9	10.3	17.2	46.5	33.1	23.4	16.6	20.8	9.8	8.0	70.6	10.2	12.9	141.8	34.5	36.0	15.3	30.5	47.3	18.5	74.3	68.6	13.6	11.1	0.7	2.0	0.7	3.6	0.9	3.8	15.6	6.2	5.6	2.6	8.3	6.6	6.6	0.3	14.8	1.4	2.6	10.0	2.9	21.0	38.2	44.1	28.2	20.4	27.7	32.8	29.9	29.3	29.4	29.7	64.3	19.0	12.8	32.5	227.5	43.1	12.1	7.4	11.5	17.1	10.1	18.3	11.7	5.9	8.6	18.9	12.9	4.2	45.5	8.3	5.9	0.0	9.1	37.9	9.9	14.6	16.0	5.4	15.8	169.0	31.7	28.1	22.7	78.0	10.2	7.6	3.3	14.6	3.5	13.0	8.4	166.4	26.5	2.0	12.2	8.6	15.3	12.8	10.2	1.8	70.3	3.6	27.8	9.2	138.7	1019.1	54.7	10.3	13.5	124.3	8.8	24.5	8.4	15.3	9.1	0.0	14.3	13.2	34.6	26.8	7.4	9.8	14.1	18.9	10.6	21.7	7.2
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015974-96215612	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 18.9;stomach 1: 23.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	0.0	0.4	10.5	0.0	12.6	0.0	0.6	14.5	11.7	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	11.8	13.6	0.2	0.0	0.0	0.0	3.4	18.9	0.0	4.8	0.0	0.4	0.4	3.2	0.2	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	5.5	0.0	23.2	0.0	15.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	6.5	6.3	0.1	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	12.6	14.5	11.7	11.8	13.6	3.4	18.9	3.2	5.5	15.3	6.4	0.0	0.0	0.0	776.4	0.2	0.0	0.6	0.0	0.0	4.2	1.4	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.1	1.3	0.0	0.0	333.5	2.0	0.0	0.1	56.1	1.4	0.0	0.4	0.0	0.0	0.1	0.0	238.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.2	0.0	168.9	224.7	0.5	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2
FUZ	"CPLANE3, FLJ22688, Fy"	ENSG00000010361	"Fuzzy planar cell polarity protein"	Q9BT04	19	49806866-49817376	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 78.7"	"Group enriched"	"Detected in many"	18	"Early spermatids: 1243.5;Late spermatids: 2329.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041779, HPA042196"	Approved		Approved	Cytosol		No	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041779: AB_10793974, HPA042196: AB_10797383"	"unprognostic (2.40e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.70e-1)"	9.3	17.6	17.3	2.8	21.0	6.2	9.3	18.8	20.8	11.2	19.7	12.1	4.2	11.1	7.3	6.8	19.5	5.2	13.6	16.4	16.8	16.8	7.1	7.7	4.6	19.9	19.1	15.4	12.3	7.1	12.5	4.0	18.2	11.2	1.9	4.9	7.5	7.3	20.4	6.6	6.9	4.1	19.5	8.8	10.2	78.7	18.7	6.0	11.5	12.4	2.2	9.0	8.2	20.4	0.1	10.6	9.5	12.2	8.9	9.5	2.7	5.2	5.4	7.9	11.0	0.9	17.2	3.1	10.6	4.9	2.5	4.3	2.7	9.2	3.5	11.7	20.5	13.0	7.6	0.0	10.1	7.6	7.0	10.1	6.3	16.1	4.0	6.2	7.5	18.6	3.0	8.7	4.1	0.5	14.1	15.4	15.7	8.4	6.3	24.4	7.7	7.4	9.7	2.7	26.5	31.0	1.0	10.8	17.9	3.7	6.2	4.7	3.7	6.6	5.9	1.9	1.9	24.9	26.5	8.4	7.6	0.2	8.4	7.0	4.6	17.7	4.9	2.2	4.1	5.3	3.1	4.2	3.8	6.0	3.8	4.3	10.6	3.8	1.6	15.0	3.8	2.6	17.3	21.0	18.8	20.8	16.4	16.8	19.9	19.1	18.2	19.5	18.7	20.4	9.2	0.0	2.8	6.2	8.4	3.8	19.3	10.1	8.6	7.2	14.5	14.6	3.9	17.2	7.3	7.3	4.2	17.5	12.2	1.9	66.5	15.3	1243.5	61.6	8.0	6.5	2.4	19.3	2.7	5.1	12.1	11.1	6.1	8.1	10.2	11.5	13.6	5.8	13.2	10.1	3.0	3.5	12.2	7.1	7.6	2329.6	27.7	6.7	0.0	2.8	7.9	26.1	5.2	2.0	9.9	4.5	6.1	17.7	10.9	8.0	7.3	86.1	35.4	11.3	0.0	17.1	9.9	95.3	13.5	5.0	4.1	12.0	6.4	13.7	5.5	14.1
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 163.9;Leydig cells: 237.9;Muller glia cells: 128.7;Peritubular cells: 363.8;Sertoli cells: 355.0;Theca cells: 141.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"classical monocyte: 37.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 37.7"	"Cell line enhanced"	"Detected in some"		"AF22: 136.0;HAP1: 92.9;RH-30: 57.1;SCLC-21H: 204.5;SH-SY5Y: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	58.4	116.3	230.8	30.1	258.5	9.8	39.5	82.5	293.2	112.3	28.1	371.1	22.2	321.5	61.0	29.8	181.6	93.1	117.1	244.3	187.3	70.6	32.8	86.6	30.0	91.8	173.6	281.1	30.1	9.8	175.0	16.7	149.5	107.8	35.9	47.1	29.5	73.2	37.3	22.2	104.6	197.6	71.4	151.9	98.9	86.6	136.4	31.2	66.5	78.3	18.9	202.9	80.4	179.3	0.3	0.9	136.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.6	0.1	4.8	0.7	92.9	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.2	2.6	0.0	1.7	6.3	0.5	27.2	0.0	0.0	0.1	57.1	1.0	3.5	0.1	204.5	114.0	0.0	0.5	5.1	36.9	2.4	2.4	0.0	0.0	30.0	0.5	0.0	0.4	0.3	0.1	1.0	0.4	0.4	0.0	37.7	0.0	0.0	9.4	0.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.9	0.0	0.1	0.6	0.0	9.9	230.8	258.5	82.5	293.2	244.3	187.3	91.8	173.6	149.5	71.4	136.4	179.3	72.2	6.4	2.2	0.0	1.1	6.6	2.4	1.1	0.6	3.5	2.1	21.5	9.3	1.5	0.7	0.0	2.1	0.8	1.0	0.0	1.9	6.4	3.6	0.6	23.9	71.8	12.5	10.7	0.0	0.4	1.1	78.6	0.5	1.0	0.0	29.7	163.9	1.6	72.7	1.7	0.0	0.2	6.1	32.4	9.6	14.3	237.9	18.7	16.0	0.0	9.8	128.7	1.0	0.0	0.0	0.4	0.0	363.8	1.2	4.9	0.0	0.1	1.7	4.4	355.0	49.6	79.6	4.6	3.5	1.4	3.8	1.4	1.4	141.8	0.0	1.7
GAB1	DFNB26	ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 162.7;Microglial cells: 192.0;Oligodendrocyte precursor cells: 288.0;Oligodendrocytes: 1013.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center, Plasma membrane"	Cytosol	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	7.9	8.6	23.3	6.7	69.9	11.5	9.9	35.5	30.0	10.6	2.5	19.7	12.1	18.1	14.2	20.4	9.2	12.5	30.5	20.4	34.6	13.9	9.1	17.9	6.1	57.3	45.4	19.5	8.1	11.3	4.3	21.0	47.9	8.5	22.8	6.9	8.9	14.7	13.4	10.7	12.3	17.7	26.4	7.5	11.3	9.2	45.7	5.4	7.5	16.5	8.7	7.1	9.7	114.8	6.7	1.4	16.7	12.1	8.3	7.9	22.0	4.6	15.2	5.4	9.4	12.8	11.2	0.2	1.4	6.5	3.7	3.8	16.2	5.3	6.2	1.0	3.9	12.2	3.7	6.1	5.7	1.6	2.3	9.7	9.5	6.6	4.3	11.5	7.2	0.2	4.1	21.7	3.8	9.7	0.9	0.0	4.8	3.5	5.3	74.6	8.2	8.8	8.4	8.0	3.9	11.8	3.1	13.3	5.6	11.2	8.5	1.6	5.5	6.9	5.4	3.4	3.5	34.6	18.2	26.3	4.7	4.8	5.7	4.1	0.4	0.5	0.0	0.5	0.2	0.9	0.0	0.0	0.5	1.8	0.0	0.0	2.6	5.0	1.7	2.2	0.0	0.3	23.3	69.9	35.5	30.0	20.4	34.6	57.3	45.4	47.9	26.4	45.7	114.8	13.4	28.9	19.0	89.5	13.1	20.3	8.8	3.3	12.0	2.1	11.6	8.9	34.0	8.6	5.3	12.9	0.0	23.5	10.9	26.2	0.0	6.6	0.9	8.8	9.3	16.3	22.2	40.8	162.7	2.6	10.6	14.4	11.2	21.6	2.5	9.6	13.9	7.0	6.1	3.3	62.2	27.8	4.1	11.6	10.2	3.8	20.8	8.8	16.0	192.0	5.6	15.4	1.0	288.0	1013.6	4.9	10.7	18.8	94.4	7.2	9.3	5.4	3.4	0.8	13.1	7.0	14.3	2.0	5.3	19.9	24.9	10.4	2.7	4.4	13.6	13.5
GAB3		ENSG00000160219	"GRB2 associated binding protein 3"	Q8WWW8	X	154675249-154751583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 20.4;dendritic cells: 32.0;Erythroid cells: 20.4;granulocytes: 20.8;Kupffer cells: 24.7;Microglial cells: 30.9;NK-cells: 39.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HMC-1: 23.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA010090	Approved		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA010090: AB_1849362"	"unprognostic (2.67e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-1)"	3.7	2.1	1.8	7.0	3.5	12.5	2.3	2.6	3.4	1.8	2.2	2.6	3.4	2.0	3.8	1.7	1.9	3.7	7.4	2.0	2.6	1.0	1.9	6.0	7.6	4.7	2.2	1.3	1.0	2.7	0.4	3.7	5.0	1.3	3.4	1.2	2.1	1.9	1.3	3.6	4.2	3.5	2.1	13.9	2.6	4.9	3.6	5.2	3.6	1.6	6.6	3.1	1.1	8.6	0.8	0.0	0.7	1.0	0.9	2.3	0.5	0.3	0.6	0.2	0.3	0.0	0.5	2.5	0.7	0.0	1.5	0.4	0.6	0.4	0.0	2.9	1.0	21.3	2.9	2.4	1.6	6.5	23.3	0.9	0.2	2.0	0.8	0.8	5.2	2.0	4.8	7.3	1.0	0.3	2.4	6.6	0.2	0.0	0.1	3.5	0.0	0.3	1.3	0.0	3.0	0.4	0.3	0.3	0.4	0.5	0.9	3.7	4.8	1.2	1.9	0.8	0.6	8.0	7.0	2.5	2.0	8.4	0.6	26.4	5.9	8.7	13.3	5.7	10.2	1.0	3.5	9.7	5.8	1.3	1.2	6.8	9.0	2.5	3.6	3.3	0.8	5.0	1.8	3.5	2.6	3.4	2.0	2.6	4.7	2.2	5.0	2.1	3.6	8.6	9.9	0.0	6.7	0.7	6.0	0.6	0.0	0.3	0.0	0.1	0.2	0.6	20.4	0.0	1.3	0.0	0.0	0.1	32.0	0.0	0.0	0.8	0.3	0.5	1.2	8.3	0.0	20.4	0.3	0.5	0.6	2.3	0.0	0.1	20.8	2.2	6.1	0.3	13.8	0.0	0.3	0.0	0.0	24.7	5.8	1.7	1.8	18.8	0.0	30.9	16.1	2.6	39.1	8.5	0.3	0.4	0.0	4.5	7.5	0.1	0.0	0.2	1.7	0.4	6.6	0.7	6.6	0.1	1.0	0.2	1.0	0.1	18.6	0.5	0.0	0.1
GABPB2	MGC29891	ENSG00000143458	"GA binding protein transcription factor subunit beta 2"	Q8TAK5	1	151070578-151125542	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028471, HPA058483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA028471: AB_10602319, HPA058483: AB_2683730"	"unprognostic (1.21e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.76e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.65e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.98e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-3)"	5.5	4.9	4.4	4.2	6.4	7.0	4.5	6.9	5.3	5.8	3.8	5.5	3.5	5.1	3.8	4.9	5.8	3.6	6.4	4.2	4.9	4.8	3.8	4.4	5.5	5.5	5.2	9.3	4.1	5.1	5.8	3.2	5.2	5.3	4.8	5.3	4.3	3.7	5.1	7.2	4.7	3.9	3.9	5.4	4.9	11.7	5.7	9.8	5.4	3.7	5.1	5.7	5.5	7.9	9.2	3.2	2.2	2.7	7.6	11.2	2.9	8.4	5.2	4.7	3.3	0.9	6.7	9.6	3.0	8.0	2.5	7.8	4.8	4.3	6.9	3.6	1.8	2.6	5.3	0.1	5.1	10.6	5.2	6.1	4.9	6.5	9.7	3.7	1.7	10.0	6.6	6.5	5.7	13.1	14.6	1.9	1.0	5.3	3.4	4.3	3.6	4.5	4.0	2.5	3.8	1.6	10.7	3.7	3.1	2.1	9.3	11.2	5.3	1.2	4.0	8.5	6.8	3.5	1.8	33.9	3.8	7.9	5.7	1.5	0.9	0.5	1.4	1.1	0.8	1.0	1.5	1.2	0.8	1.3	1.3	1.4	1.4	0.8	1.8	1.6	0.6	1.0	4.4	6.4	6.9	5.3	4.2	4.9	5.5	5.2	5.2	3.9	5.7	7.9	9.4	9.6	16.8	21.2	10.0	11.5	9.3	9.6	10.2	26.3	8.9	10.3	22.4	17.2	14.8	12.9	25.0	5.8	18.0	12.3	9.8	5.7	36.3	13.5	15.4	11.0	9.6	14.9	18.4	5.8	4.6	16.2	9.7	9.7	7.0	11.7	15.7	7.1	8.2	33.7	25.3	15.6	4.1	13.4	9.7	17.1	22.4	11.3	8.8	15.9	14.3	10.9	33.0	11.6	39.3	5.3	8.5	21.4	8.1	6.9	10.7	4.6	20.8	36.5	6.6	38.5	15.4	75.6	55.7	9.6	10.1	4.5	16.3	15.6	16.8	7.0
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 98.5;parathyroid gland: 46.3;retina: 29.7"	"Group enriched"	"Detected in many"	8	"Inhibitory neurons: 392.8;Oligodendrocyte precursor cells: 146.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 20.1;HEL: 64.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 547.6"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	0.2	3.0	22.1	0.0	29.9	3.3	0.1	15.5	33.0	1.0	0.0	0.0	0.0	1.6	4.3	0.4	0.2	0.1	0.0	17.1	98.5	4.8	0.1	0.2	0.1	12.4	41.6	0.2	0.2	46.3	5.0	0.4	17.6	0.8	0.1	29.7	0.1	0.3	0.0	0.2	0.1	0.0	12.7	0.1	0.0	3.2	31.1	0.8	0.1	0.0	0.2	0.6	0.4	14.2	18.2	0.7	0.0	7.3	0.0	0.0	0.1	0.4	0.0	2.6	1.7	4.6	6.7	0.0	0.9	0.5	2.9	20.1	2.3	0.6	1.6	2.8	13.4	64.5	6.0	0.2	0.0	0.3	1.1	0.0	5.5	0.0	2.3	0.6	0.1	0.5	17.0	0.3	0.8	1.5	0.0	0.0	8.1	9.7	6.7	1.0	4.6	0.4	8.5	9.4	6.7	2.1	12.6	0.0	3.5	0.6	0.2	0.0	0.0	12.0	1.7	2.4	7.0	0.0	0.0	0.1	11.5	3.2	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	29.9	15.5	33.0	17.1	98.5	12.4	41.6	17.6	12.7	31.1	14.2	0.0	0.0	0.0	14.7	0.0	0.3	2.1	7.7	2.2	32.5	0.1	0.1	1.3	0.0	3.6	0.0	10.4	0.0	0.0	0.2	7.9	4.5	5.6	4.4	0.4	0.4	3.0	5.5	2.6	5.6	0.1	0.2	0.0	2.9	0.0	5.5	0.0	0.0	4.0	5.0	392.8	0.3	2.0	0.8	0.4	6.2	0.6	0.5	0.0	7.5	0.0	4.9	0.0	146.8	7.6	2.9	0.0	0.0	0.1	0.9	0.0	0.0	4.7	6.0	0.0	0.0	1.2	4.4	7.7	0.6	0.1	0.5	0.0	0.1	0.1	0.4
GADD45B	"DKFZP566B133, GADD45BETA, MYD118"	ENSG00000099860	"Growth arrest and DNA damage inducible beta"	O75293	19	2476122-2478259	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1997.9;Breast myoepithelial cells: 1851.8;Smooth muscle cells: 1753.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 16.3"	HPA029816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA029816: AB_10601325"	"unprognostic (1.32e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.90e-2)"	"unprognostic (8.27e-3)"	"unprognostic (6.00e-2)"	343.5	75.9	45.3	41.4	52.8	321.4	217.4	51.4	63.8	104.8	55.0	205.1	17.2	83.4	3.3	53.9	190.0	91.4	372.7	45.1	57.8	245.6	408.9	343.2	33.1	56.3	55.5	159.2	92.6	49.2	174.1	45.1	54.9	90.8	9.9	57.1	72.6	28.5	84.1	144.8	67.9	27.3	55.0	75.9	187.3	17.1	59.7	65.9	209.2	30.8	12.7	103.9	100.0	49.5	62.1	12.2	1.4	8.1	44.1	33.6	3.8	61.7	17.7	47.6	24.4	17.1	23.3	29.1	40.7	30.7	17.1	33.8	3.2	20.5	11.5	22.5	11.0	3.2	13.9	6.6	74.3	6.7	19.7	54.8	13.1	14.3	70.2	51.3	19.0	3.1	1.6	76.9	49.5	19.9	7.7	33.0	7.3	6.2	25.7	28.5	22.0	46.6	21.7	11.0	0.6	0.6	68.7	50.6	20.9	26.2	26.9	49.5	78.8	47.2	43.2	34.0	77.9	34.3	27.9	12.5	11.5	20.0	15.7	32.1	33.5	131.2	58.1	40.8	52.3	21.0	40.7	45.2	32.9	30.2	35.5	47.9	92.5	43.3	33.5	36.9	54.6	35.3	45.3	52.8	51.4	63.8	45.1	57.8	56.3	55.5	54.9	55.0	59.7	49.5	1997.9	423.1	571.3	24.5	450.9	341.7	805.4	147.3	376.2	11.9	666.3	1851.8	952.6	173.0	226.3	51.5	6.2	93.0	988.3	213.7	191.7	374.3	1.6	614.2	539.7	800.0	85.3	8.6	3.0	209.8	54.0	1143.0	400.1	1122.9	786.6	53.9	138.8	126.1	430.9	13.5	1.5	164.4	282.8	174.8	1169.6	4.7	74.0	863.0	517.6	1.9	157.1	269.8	33.0	0.5	0.9	292.5	309.0	29.3	416.8	823.3	294.3	142.1	211.4	34.2	177.5	818.8	1753.4	1.4	7.8	399.0	308.9	144.2	514.7	128.4	98.8	301.3
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 25.8;tongue: 11.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.4;Club cells: 1.3;Collecting duct cells: 1.8;Fibroblasts: 5.9;Late spermatids: 1.8;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;TIME: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.3	0.4	2.2	0.4	2.1	1.2	0.4	2.6	2.5	0.1	0.1	0.2	0.2	0.3	0.6	0.6	0.2	0.3	0.6	1.8	0.8	0.7	0.3	0.3	0.4	0.9	0.5	0.6	0.4	0.2	0.2	0.3	0.9	0.6	0.2	1.7	0.4	0.1	25.8	0.9	0.2	0.2	0.1	0.6	0.3	0.5	1.0	0.1	0.9	11.3	0.3	0.2	0.0	2.3	0.4	0.0	0.2	0.4	0.3	0.1	0.5	0.2	0.1	0.0	0.0	0.5	0.5	0.4	0.2	0.0	0.2	0.3	4.7	0.1	0.1	0.6	0.1	0.5	0.8	0.2	0.0	0.3	1.3	0.1	0.1	0.2	0.1	0.4	0.1	0.3	0.5	1.7	0.2	0.3	0.2	0.5	0.5	0.1	0.1	0.7	0.9	0.4	0.2	0.6	0.5	0.3	0.2	0.3	1.3	0.3	0.4	0.3	2.4	0.6	0.5	0.8	0.2	0.6	0.3	0.3	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	2.2	2.1	2.6	2.5	1.8	0.8	0.9	0.5	0.9	0.1	1.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	1.8	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0
GAGE1	CT4.1	ENSG00000205777	"G antigen 1"	P0DTW1	X	49599025-49608536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 9.1"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 113.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 739.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	739.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	24.4	113.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12C		ENSG00000237671	"G antigen 12C"	A1L429	X	49532211-49539538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	271	"testis: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/84: 37.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	9.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12D		ENSG00000227488	"G antigen 12D"	A1L429	X	49541767-49549094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	271	"testis: 27.0"	"Cell type enriched"	"Detected in single"	10	"Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/84: 37.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	9.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12F		ENSG00000236362	"G antigen 12F"	"P0CL80, O76087, P0CL82"	X	49551278-49568218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 178.7"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"AN3-CA: 1630.3;K-562: 1415.3"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.7	178.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.9	0.0	0.0	1630.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.1	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1415.3	30.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	360.9	0.0	5.1	56.9	7.5	0.3	1.0	0.6	72.0	0.0	0.2	0.0	171.2	1.3	11.5	4.6	4.8	12.1	3.4	8.4	12.6	8.7	0.0	7.8	9.7	8.6	1.4	14.7	10.5	12.4	20.2	11.5	0.4	0.6	0.2	0.3	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12G		ENSG00000215269	"G antigen 12G"	"P0CL81, O76087, P0CL82"	X	49570434-49577754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"retina: 1.6;stomach 1: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"AN3-CA: 439.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 23: AN3-CA - Transcription regulation"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	439.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	54.7	0.0	0.0	8.4	0.5	0.1	0.2	0.0	0.0	0.0	0.2	0.0	20.8	0.2	1.5	0.9	0.5	1.6	0.8	0.8	2.0	0.2	0.0	1.5	0.3	1.7	0.0	0.3	1.4	0.9	4.7	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12H		ENSG00000224902	"G antigen 12H"	A6NDE8	X	49579983-49587301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	230	"testis: 22.9"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 1.4;Spermatogonia: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"A-431: 53.9;U-266/84: 164.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.3	1.4	0.0	0.0	0.0	164.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE12J	GAGE11	ENSG00000224659	"G antigen 12J"	A6NER3	X	49322057-49329384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 35.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"AN3-CA: 1145.9;K-562: 290.3"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	35.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1145.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	2.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	290.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	32.4	0.0	0.0	0.0	0.2	0.5	0.0	2.5	32.2	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE13	GAGE12A	ENSG00000274274	"G antigen 13"	Q4V321	X	49331616-49338952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 36.1"	"Group enriched"	"Detected in some"	22	"Spermatocytes: 4.2;Spermatogonia: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 303.6;T-47d: 165.3;WM-115: 83.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	303.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	3.6	0.0	2.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	165.3	0.0	0.7	3.4	1.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE2A	"CT4.2, GAGE2"	ENSG00000189064	"G antigen 2A"	Q6NT46	X	49589529-49596827	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	108	"testis: 92.5"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 108.0;Spermatogonia: 358.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 86.8;T-47d: 289.7;WM-115: 325.3"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"															"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	86.8	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	289.7	0.0	0.0	47.3	10.6	0.1	0.0	1.2	13.8	0.0	2.9	0.0	325.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	108.0	358.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE2E	GAGE8	ENSG00000275113	"G antigen 2E"	Q4V326	X	49341192-49345922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"stomach 1: 12.8;testis: 26.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AN3-CA: 2587.1;K-562: 674.0"									HPA043232	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 23: AN3-CA - Transcription regulation"		"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.2	12.8	26.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2587.1	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	4.3	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	674.0	12.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.0	5.0	0.3	0.3	364.7	0.1	3.3	61.8	2.4	0.2	0.2	0.8	20.9	0.0	0.7	0.2	138.5	0.4	0.6	0.1	0.5	0.0	0.0	0.6	0.1	1.0	0.0	1.2	2.1	0.0	0.4	0.4	0.0	1.5	2.9	0.1	0.1	0.3	0.0	0.3	0.2	0.0	0.1	0.5	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168617	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 27.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 37.2;Microglial cells: 23.4;Oligodendrocyte precursor cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 4.5;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.6;plasmacytoid DC: 4.7"	"Group enriched"	"Detected in many"	29	"dendritic cells: 4.7;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	4.3	4.9	9.2	3.9	9.3	0.7	3.7	8.4	12.6	11.0	7.6	6.1	3.8	9.1	3.1	7.8	6.0	5.6	5.0	9.1	9.5	1.4	0.9	5.2	2.9	13.4	9.5	6.3	1.4	3.0	4.2	5.1	10.1	4.8	6.3	0.5	25.6	3.6	1.9	27.7	5.0	9.9	10.7	2.7	2.4	4.8	15.9	22.3	1.9	1.9	3.2	6.7	10.6	13.1	0.1	0.9	5.4	2.3	4.7	9.6	10.9	3.2	3.2	1.8	2.6	0.6	0.2	1.1	0.7	10.4	3.3	12.2	0.3	1.8	0.6	0.1	0.6	0.4	0.2	0.4	3.4	0.3	2.7	11.7	4.6	5.5	0.6	4.0	3.7	4.3	1.6	0.2	3.4	0.4	4.2	0.2	1.9	11.5	1.3	2.7	2.4	0.2	0.0	0.4	0.3	2.2	1.0	0.0	6.7	1.0	0.0	0.3	3.4	0.3	1.6	0.5	0.1	0.2	0.2	2.5	1.9	0.4	43.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	4.5	0.3	0.0	0.1	15.0	4.6	0.3	0.2	0.1	4.7	1.3	2.2	9.2	9.3	8.4	12.6	9.1	9.5	13.4	9.5	10.1	10.7	15.9	13.1	0.7	0.0	0.5	2.9	0.1	4.2	2.0	3.3	7.4	0.0	2.2	2.4	1.0	1.5	0.9	0.0	0.0	0.3	0.3	1.5	0.0	0.6	0.2	0.2	2.1	1.2	0.0	2.7	0.5	0.0	0.4	7.5	0.0	0.3	0.0	1.2	1.4	0.0	37.2	0.0	0.3	1.3	4.1	1.3	0.8	0.0	4.7	9.6	5.4	23.4	0.7	0.4	0.0	24.6	0.5	0.3	2.5	5.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	3.7	3.3	0.6	0.3	4.2	8.1	0.8	0.7	0.1	4.1	1.4
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800781	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 122.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070023			Approved	"Golgi apparatus,Cytosol"		NA	NA		16000	"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"		"HPA070023: "	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (1.41e-2)"	8.9	12.8	12.3	16.0	12.5	6.0	12.8	12.2	17.7	22.3	11.5	58.6	54.6	6.7	12.7	63.1	16.6	31.5	7.1	12.5	12.5	34.0	61.2	20.6	7.5	12.5	12.3	4.6	15.2	15.5	6.7	17.8	12.4	11.0	60.0	6.3	59.7	16.4	4.3	9.7	38.3	10.8	12.6	17.6	122.4	8.7	13.2	8.0	4.7	5.4	15.8	20.9	22.2	12.6	60.3	71.5	27.8	44.5	9.8	13.9	26.9	40.7	53.4	68.6	50.9	65.3	195.4	14.3	54.7	23.5	91.9	65.8	24.5	101.8	51.5	29.4	16.2	40.6	34.4	71.6	102.0	18.4	11.6	30.1	53.4	63.4	156.8	69.2	59.5	30.1	45.9	3.8	49.5	64.5	29.0	19.5	7.8	83.1	67.7	33.6	27.1	18.5	112.7	41.4	10.7	24.1	73.9	66.7	70.6	31.1	47.9	14.5	33.7	52.0	74.9	52.0	50.3	18.5	46.4	18.9	53.0	74.5	27.8	1.7	13.5	3.0	8.5	29.3	8.5	5.4	5.0	6.9	19.0	1.7	5.8	4.1	3.4	37.3	37.1	5.2	9.5	8.8	12.3	12.5	12.2	17.7	12.5	12.5	12.5	12.3	12.4	12.6	13.2	12.6	9.6	12.8	49.3	6.8	7.5	7.6	18.8	110.4	6.2	17.2	26.7	10.9	3.5	37.1	90.6	40.5	16.7	54.1	7.4	131.8	35.2	67.6	21.5	19.9	9.1	14.3	12.1	8.2	9.4	114.8	106.3	14.0	276.8	36.2	10.8	17.4	10.8	38.3	99.3	8.4	10.8	149.5	73.2	5.7	6.8	5.0	4.7	12.5	24.9	5.6	19.4	21.2	7.2	4.5	2.1	92.0	109.0	3.4	9.4	24.9	78.6	89.5	37.0	14.8	0.0	3.7	13.1	14.5	9.7	19.6	4.8	96.3	7.6	99.6	73.8	46.0
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765236	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 126.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 100.1;Hepatocytes: 116.7;Proximal enterocytes: 139.4;Proximal tubular cells: 122.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 42.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		57000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.62e-5)"	18.6	12.5	5.9	7.8	6.7	5.6	17.1	6.4	8.4	17.5	5.9	12.5	20.6	16.5	1.0	24.4	14.9	4.3	19.7	6.0	6.6	32.0	126.4	18.7	7.4	7.9	6.3	13.7	31.2	10.6	5.7	5.8	7.5	13.3	2.0	0.7	20.0	5.7	8.6	20.6	18.3	3.9	7.0	24.5	17.6	16.0	6.8	6.1	11.6	3.6	3.4	13.0	17.8	8.2	20.4	65.2	4.9	20.7	6.8	16.6	16.7	16.9	14.3	16.8	15.8	35.4	4.2	31.2	19.5	9.3	12.6	11.9	5.0	4.4	1.9	14.2	39.3	20.1	25.1	62.4	22.1	13.0	41.9	15.3	6.9	8.5	3.5	8.5	39.1	16.9	15.9	21.2	11.7	77.3	38.6	44.7	4.7	9.8	32.3	43.6	50.1	50.9	9.8	7.3	9.9	26.1	14.6	35.8	35.0	3.8	29.8	20.9	33.4	24.3	22.3	21.7	14.6	44.4	12.4	8.2	26.7	30.3	18.3	7.2	77.2	23.0	23.0	67.8	20.8	27.7	18.5	21.2	70.1	18.9	10.0	14.5	53.1	16.2	55.6	93.3	23.6	40.8	5.9	6.7	6.4	8.4	6.0	6.6	7.9	6.3	7.5	7.0	6.8	8.2	42.1	16.0	12.9	3.3	17.7	8.7	10.0	4.4	7.4	7.3	22.4	20.6	22.6	22.8	10.6	12.9	0.0	48.4	16.3	8.4	68.4	28.5	1.3	4.9	24.5	23.5	8.4	9.0	1.5	55.2	100.1	25.3	10.2	8.6	27.9	16.6	29.3	116.7	56.1	3.3	1.7	20.9	22.4	49.0	25.2	5.6	31.1	33.3	39.2	0.0	42.3	19.2	20.6	2.5	1.6	19.3	49.6	24.0	29.1	5.7	139.4	122.0	4.0	6.1	6.6	19.2	20.8	1.7	22.1	16.6	12.5	42.3	14.9	6.1	28.2	9.2
GALK2	GK2	ENSG00000156958	"Galactokinase 2"	Q01415	15	49155656-49367869	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 92.2;Inhibitory neurons: 90.1;Oligodendrocytes: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043564, HPA048267"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		24000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA043564: AB_2678557, HPA048267: AB_2680335"	"unprognostic (2.27e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.88e-5)"	"unprognostic (2.33e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.93e-1)"	10.3	16.8	8.5	8.5	9.3	6.6	11.2	10.1	9.3	12.5	14.8	15.2	20.2	8.5	8.7	8.1	12.2	8.9	12.8	8.7	8.5	30.4	21.1	10.5	8.3	8.6	9.0	9.3	12.2	17.5	9.6	9.9	9.0	9.7	16.2	7.7	9.9	10.9	10.5	9.0	16.6	10.7	8.5	8.9	13.2	7.0	8.3	12.6	14.8	16.9	10.0	9.3	8.5	11.4	14.7	17.1	7.5	10.1	19.1	29.7	21.9	14.7	20.2	14.7	17.2	21.6	15.0	4.8	11.6	15.9	18.0	20.5	30.2	21.6	20.6	26.2	9.1	26.8	15.7	18.4	20.9	19.2	8.2	15.4	38.4	15.7	37.4	16.8	30.2	11.0	27.4	25.5	16.1	15.9	13.9	15.3	3.3	44.0	15.9	16.7	9.5	71.0	27.3	13.8	9.1	6.0	16.6	33.3	29.6	15.0	16.9	18.3	16.6	14.1	9.6	58.4	14.3	20.9	76.2	8.9	22.2	70.1	19.8	45.4	15.3	28.4	18.1	16.7	18.9	14.0	18.0	17.3	15.2	11.1	14.2	14.3	7.6	19.6	17.2	13.3	35.3	13.1	8.5	9.3	10.1	9.3	8.7	8.5	8.6	9.0	9.0	8.5	8.3	11.4	13.6	3.2	14.9	48.6	12.7	5.6	13.6	16.8	9.1	13.3	12.1	10.3	3.1	27.1	14.5	5.5	37.5	14.8	10.6	14.5	29.4	20.0	12.0	19.2	15.7	12.0	9.0	12.0	92.2	13.1	29.0	12.7	18.3	12.0	2.5	9.8	22.9	25.7	20.4	15.2	90.1	25.1	20.3	16.8	5.7	4.8	11.5	12.6	14.2	63.7	16.5	11.6	20.6	41.7	109.5	10.7	16.2	11.3	27.9	8.3	30.5	56.5	34.1	25.8	0.0	13.4	11.6	22.3	5.9	9.0	6.3	25.7	13.9	13.8	19.0	9.7
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 11.3;granulocytes: 31.3;monocytes: 17.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433, HPA074225"	Supported		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB026404: , HPA042433: AB_2732499, HPA074225: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	9.2	12.8	9.4	9.3	10.0	22.2	6.3	10.0	11.5	9.1	22.1	10.0	10.6	7.4	14.5	8.8	11.4	9.7	11.0	10.6	12.0	8.6	8.1	10.4	7.4	12.6	16.4	6.7	5.0	8.6	11.9	8.6	12.0	7.7	6.1	3.3	8.3	4.7	6.4	8.4	10.6	7.1	10.8	9.1	8.1	26.3	11.3	4.8	9.1	3.6	5.6	9.0	9.1	12.0	5.7	42.7	6.2	43.4	47.1	22.4	41.9	17.9	27.3	19.1	14.7	22.7	36.8	7.1	37.1	29.2	28.8	33.0	9.0	14.2	11.4	4.7	13.8	4.5	17.0	13.2	31.5	3.6	28.5	31.4	26.9	21.4	6.0	27.0	16.4	7.8	9.9	4.1	11.3	33.3	9.2	15.0	14.2	14.3	19.6	19.6	5.4	12.1	11.9	13.2	15.8	12.2	42.4	4.0	21.9	14.4	27.3	32.5	31.3	41.8	31.5	43.2	10.0	4.3	4.5	12.6	45.2	29.7	25.4	1.4	17.4	31.3	4.5	12.5	3.9	3.0	2.5	4.0	11.3	1.3	2.5	3.1	21.7	4.0	9.6	4.7	4.6	8.5	9.4	10.0	10.0	11.5	10.6	12.0	12.6	16.4	12.0	10.8	11.3	12.0	4.8	16.0	4.8	9.4	5.9	6.5	7.3	27.7	9.1	5.0	6.8	5.0	8.4	4.3	11.0	3.7	6.2	9.9	8.5	16.8	3.9	5.7	21.0	27.2	9.6	7.2	12.0	1.3	7.6	3.7	14.0	13.8	6.1	8.9	1.3	11.9	7.5	6.4	18.7	25.2	10.4	6.8	8.2	13.2	6.3	37.3	7.2	11.3	7.2	2.8	18.2	8.8	14.4	4.0	9.8	5.6	13.6	6.8	9.9	6.7	17.3	5.9	35.1	10.0	6.6	9.4	9.0	51.3	42.8	6.3	5.7	15.9	7.9	16.5	10.1	6.8
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174680-16231992	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 157.4;brain: 141.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 103.9;Astrocytes: 34.6;Early spermatids: 26.6;Endothelial cells: 26.9;Hepatic stellate cells: 41.7;Muller glia cells: 47.4;Oligodendrocytes: 69.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"ASC diff: 133.0;ASC TERT1: 128.8;HSkMC: 102.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		40000	"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	157.4	4.9	45.1	1.7	55.8	2.7	87.2	62.5	49.3	12.3	14.4	21.7	3.0	11.4	11.9	12.4	24.9	5.6	18.1	47.9	90.8	11.8	4.0	9.4	4.1	137.6	60.4	22.3	3.6	2.4	3.5	32.3	130.8	6.0	3.9	13.4	25.5	4.7	36.3	41.7	21.2	7.0	102.4	12.3	15.3	9.1	62.8	4.0	18.3	35.3	1.3	33.0	22.8	141.7	0.4	1.3	0.9	1.0	133.0	128.8	0.3	3.4	2.5	0.4	1.3	0.0	0.5	0.5	1.9	7.8	2.3	0.8	0.5	1.4	2.0	0.6	1.4	1.1	1.9	0.0	7.4	1.5	0.4	102.8	0.0	1.2	1.8	2.4	2.8	0.7	0.2	3.0	1.1	1.9	0.0	2.1	0.5	0.8	1.1	0.3	1.1	24.1	0.5	0.5	0.4	0.3	0.4	1.0	0.6	0.6	0.7	1.8	3.9	0.6	4.3	26.8	0.6	1.4	5.1	1.4	2.5	0.4	0.4	0.5	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	45.1	55.8	62.5	49.3	47.9	90.8	137.6	60.4	130.8	102.4	62.8	141.7	103.9	0.0	1.7	34.6	0.1	0.5	0.4	0.0	0.0	3.8	1.1	0.9	2.8	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	26.6	0.5	3.3	26.9	0.0	0.0	4.9	0.0	0.1	24.7	0.0	1.0	1.3	0.1	41.7	1.8	0.1	0.0	3.9	0.0	0.0	0.8	2.1	16.7	1.8	0.5	0.0	22.5	0.1	47.4	0.0	5.0	69.3	0.2	0.0	0.7	1.8	2.1	0.0	0.1	0.0	3.2	0.0	7.3	2.1	25.5	0.5	0.1	0.9	0.0	0.2	0.3	0.0	0.3
GALNT16	"GalNAc-T16, GALNTL1, KIAA1130"	ENSG00000100626	"Polypeptide N-acetylgalactosaminyltransferase 16"	Q8N428	14	69259277-69357033	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.8;heart muscle: 45.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.6;Cardiomyocytes: 46.7;Excitatory neurons: 27.6;Fibroblasts: 24.0;Inhibitory neurons: 23.8;Smooth muscle cells: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.5;ASC diff: 11.7;hTEC/SVTERT24-B: 17.0;hTERT-RPE1: 17.2;SCLC-21H: 8.7;U-2 OS: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059136, HPA075325"	Approved		Approved	Vesicles,Cytosol		NA	NA		370000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Cytosol"		"HPA059136: AB_2683919, HPA075325: "	"unprognostic (9.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.62e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (5.23e-6)"	"unprognostic (5.38e-3)"	"unprognostic (3.34e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.96e-5)"	14.4	11.6	25.7	2.0	24.4	0.1	12.0	14.7	28.4	7.6	6.5	6.5	2.2	7.3	2.8	3.6	5.6	3.4	45.0	27.0	35.5	7.7	2.0	3.4	3.2	19.6	22.5	2.1	4.3	2.5	4.7	0.4	19.9	4.0	2.2	1.3	23.5	4.6	4.4	7.5	3.7	8.6	16.4	12.1	3.2	3.5	40.8	2.2	4.9	5.8	1.3	3.1	5.0	21.3	0.0	0.8	8.5	0.3	11.7	5.3	0.0	1.3	0.1	1.5	2.3	0.4	0.0	0.0	0.2	1.4	0.8	0.0	3.0	0.0	0.3	0.1	6.0	0.0	0.2	0.5	0.1	0.0	0.5	0.5	0.0	17.0	0.0	17.2	0.9	0.0	0.0	0.0	2.8	0.5	0.0	0.0	1.7	0.0	0.1	0.0	4.8	0.0	0.5	0.0	8.7	3.0	1.8	0.4	0.0	0.3	0.3	0.0	0.1	1.7	19.9	2.2	2.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	24.4	14.7	28.4	27.0	35.5	19.6	22.5	19.9	16.4	40.8	21.3	4.0	0.0	0.0	16.6	0.0	4.1	0.4	0.0	0.0	2.8	3.1	3.0	46.7	0.0	0.0	0.0	2.1	0.1	0.2	0.0	3.9	0.1	9.7	0.2	0.4	1.7	0.0	0.0	27.6	0.0	0.0	24.0	0.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	23.8	0.1	0.0	0.0	6.1	11.2	0.9	0.3	3.6	5.6	0.0	0.1	0.0	8.0	1.6	0.0	0.0	3.8	0.0	0.5	0.1	0.1	0.0	0.8	6.6	10.1	14.8	0.6	2.1	0.3	3.3	0.0	0.3	11.2	0.6	0.4
GALNT18	"GalNAc-T18, GALNT15, GALNTL4, MGC71806"	ENSG00000110328	"Polypeptide N-acetylgalactosaminyltransferase 18"	Q6P9A2	11	11270877-11622005	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 149.5;Excitatory neurons: 104.4;Inhibitory neurons: 156.3;Microglial cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 42.1;HaCaT: 52.4;HBEC3-KT: 36.5;PC-3: 36.4;RPMI-8226: 39.3;SK-BR-3: 47.2;U-87 MG: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012955, HPA070681"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		300000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA012955: AB_1849460, HPA070681: "	"unprognostic (1.26e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.81e-2)"	18.0	4.7	19.1	4.1	17.7	0.0	15.6	17.1	20.8	13.0	10.7	24.8	3.0	24.0	2.4	7.7	12.0	11.2	26.9	29.5	12.9	26.5	10.5	51.2	5.4	12.2	17.2	4.9	8.2	9.8	6.4	24.4	13.9	13.0	3.2	3.6	17.0	9.3	10.7	13.0	8.8	13.3	12.3	3.6	6.8	14.7	19.7	6.3	42.8	6.2	3.3	11.7	11.5	12.9	42.1	15.0	2.0	9.1	0.0	0.0	0.3	4.5	11.2	0.6	0.0	1.7	5.4	0.1	3.1	0.1	5.6	52.4	9.9	36.5	0.1	0.0	14.6	0.0	0.1	0.1	0.5	0.0	0.0	0.2	14.9	0.0	13.5	0.0	0.0	18.5	0.0	0.1	1.9	10.2	0.5	0.1	1.5	0.1	36.4	0.0	0.0	39.3	27.5	5.1	0.6	4.1	7.6	47.2	0.3	1.4	9.9	0.1	0.0	0.7	8.1	0.4	0.2	0.0	0.0	0.0	33.6	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	17.7	17.1	20.8	29.5	12.9	12.2	17.2	13.9	12.3	19.7	12.9	40.5	44.8	6.9	149.5	0.1	5.6	6.6	18.3	12.0	1.6	1.6	2.5	8.5	30.0	13.7	20.2	2.1	49.2	0.4	0.8	15.6	19.9	2.2	1.9	0.4	40.6	0.0	0.0	104.4	4.0	3.5	5.4	0.0	1.3	1.3	16.7	18.5	2.6	2.6	0.0	156.3	0.4	8.2	0.8	1.1	1.4	1.5	0.4	1.8	79.6	0.0	43.1	0.0	8.5	10.5	7.3	0.2	3.0	0.2	13.4	0.0	40.8	14.3	2.1	13.1	15.1	7.4	0.6	1.1	1.8	5.4	15.5	0.3	46.7	1.1	1.9
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257705-157318491	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.5;lung: 10.2;stomach 1: 12.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 157.0;Distal enterocytes: 48.3;Intestinal goblet cells: 75.5;Pancreatic endocrine cells: 53.5;Prostatic glandular cells: 40.1;Urothelial cells: 115.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 4.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 45.3;BJ: 29.8;BJ hTERT+: 53.5;fHDF/TERT166: 64.5;HaCaT: 51.8;K-562: 30.7;LHCN-M2: 52.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA		1300000		"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Cytosol"	"Nucleoli, Vesicles"	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.1	0.0	0.0	0.7	0.0	0.6	1.1	4.0	0.3	1.1	5.2	10.6	2.2	0.1	0.1	4.5	0.0	2.7	0.4	0.4	0.0	0.0	0.0	10.2	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.2	0.7	13.5	0.1	8.2	0.1	0.0	0.3	4.1	0.4	0.0	0.1	12.8	0.1	0.1	0.1	0.1	0.1	1.7	4.5	4.6	0.2	45.3	4.8	0.0	0.0	2.0	17.0	0.0	29.8	53.5	0.5	1.1	1.9	24.4	0.0	0.1	64.5	0.0	51.8	0.9	10.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	0.2	0.0	0.9	0.0	0.0	0.0	30.7	0.0	52.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	25.4	0.3	0.6	0.1	0.0	0.1	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.3	0.4	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.1	157.0	36.1	0.0	0.1	0.8	13.3	20.2	6.2	0.0	0.5	2.8	0.5	2.8	32.9	0.0	0.0	0.0	0.2	48.3	0.0	1.2	6.9	1.2	0.0	0.6	2.4	5.2	0.8	3.2	0.0	2.1	35.7	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	75.5	6.1	0.0	0.7	0.5	0.0	0.3	3.6	0.0	1.6	0.0	0.0	0.0	0.1	53.5	26.4	0.0	1.4	40.1	3.1	0.2	10.0	0.0	0.0	0.5	1.2	2.6	0.5	4.5	0.1	0.0	0.3	0.0	22.7	115.1
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		NA	NA		260000	"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favorable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.7	14.0	5.3	6.7	5.9	8.1	6.3	5.5	6.5	6.9	4.6	8.5	18.3	6.9	5.3	5.3	7.8	6.8	10.4	5.2	6.3	10.0	50.0	6.6	12.0	5.5	5.7	8.2	7.5	13.0	6.1	9.2	5.3	6.4	6.7	6.3	12.3	7.5	10.2	15.2	16.5	4.0	4.5	9.7	8.1	2.4	6.1	7.8	8.2	7.6	7.7	5.3	6.1	4.7	5.5	7.5	6.8	2.4	9.0	9.2	7.8	4.2	12.1	4.3	5.1	9.5	4.8	6.1	4.2	5.2	1.6	2.9	1.3	11.8	0.8	9.7	4.8	2.5	14.7	9.8	8.7	1.4	2.9	12.6	7.4	2.7	3.6	9.3	10.6	8.3	2.3	6.4	7.3	5.1	5.4	10.3	2.3	6.7	1.3	8.4	5.9	3.3	12.5	7.8	1.6	5.7	5.0	9.8	5.4	5.0	9.2	8.2	1.6	1.7	3.4	3.4	0.0	3.9	2.4	1.3	4.1	4.4	10.8	16.5	23.7	11.7	15.4	21.5	21.3	24.8	25.2	21.1	21.5	13.2	15.3	14.8	4.6	29.0	20.4	18.2	30.0	17.6	5.3	5.9	5.5	6.5	5.2	6.3	5.5	5.7	5.3	4.5	6.1	4.7	12.6	6.4	21.2	10.7	19.0	21.7	13.4	19.3	19.4	44.0	10.5	12.1	25.7	14.3	15.4	16.5	47.9	72.5	13.9	17.3	29.4	18.3	7.6	7.8	11.8	14.6	16.3	13.7	9.1	7.3	36.3	18.3	9.2	8.0	20.3	24.7	23.6	69.9	24.1	47.1	12.5	17.0	26.4	15.5	8.7	36.8	18.3	12.4	21.4	5.6	15.9	18.7	34.0	6.0	3.7	6.9	37.5	13.9	10.7	4.7	67.1	46.3	11.1	38.5	6.6	11.2	12.2	4.8	6.6	8.6	20.2	59.1	25.5	27.4	20.4	9.2
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 47.9;Oligodendrocytes: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	8.9	7.6	8.2	10.3	13.0	14.3	8.8	9.8	10.4	9.6	10.4	10.6	8.9	11.0	17.8	12.1	8.6	9.4	8.5	7.8	9.2	9.4	13.3	20.4	10.0	12.4	11.1	13.0	8.4	11.3	7.9	8.0	13.2	8.5	12.4	9.7	14.5	8.7	12.9	10.1	9.8	9.8	10.0	11.9	8.5	12.3	10.8	10.3	12.1	10.6	10.2	8.3	9.3	19.2	9.0	4.9	10.7	11.6	12.3	17.2	7.1	19.2	19.7	19.7	16.4	6.4	6.2	4.9	10.2	18.6	14.3	18.3	12.6	19.5	13.6	12.3	6.0	11.9	12.1	12.8	10.4	11.6	10.1	11.8	11.4	8.1	13.6	11.7	13.5	12.0	12.6	13.0	15.8	1.7	7.9	12.7	6.7	4.3	5.5	14.7	12.4	17.0	14.7	8.4	8.2	11.7	10.8	9.4	7.0	5.6	3.3	27.0	13.6	21.6	5.7	17.8	12.1	13.9	20.7	9.7	10.4	20.9	12.1	16.8	11.8	10.2	4.5	13.1	6.2	19.6	7.2	8.6	15.5	23.1	8.9	5.4	6.7	5.7	10.9	12.3	7.3	6.5	8.2	13.0	9.8	10.4	7.8	9.2	12.4	11.1	13.2	10.0	10.8	19.2	6.2	19.2	47.9	35.6	14.5	10.5	17.1	7.9	12.0	5.6	5.6	6.2	8.2	4.3	8.9	1.8	10.4	5.3	4.0	9.5	5.9	5.9	18.6	7.7	11.1	5.0	4.2	5.0	18.9	3.8	5.1	8.1	9.7	11.9	10.8	8.1	5.7	12.4	6.5	3.3	28.5	5.7	10.2	11.7	5.4	4.7	7.2	10.9	14.2	36.5	14.0	9.5	7.2	31.7	86.7	5.4	15.7	6.4	7.1	9.1	7.9	7.7	9.8	8.5	13.1	9.2	7.0	20.5	15.7	18.9	5.3	2.9	6.9	6.4	8.5	20.7
GAREM1	"C18orf11, FAM59A, FLJ21610, GAREM"	ENSG00000141441	"GRB2 associated regulator of MAPK1 subtype 1"	Q9H706	18	32124877-32470882	"Predicted intracellular proteins"		Mitogen		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 29.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 54.7;Urothelial cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.5;hTERT-HME1: 20.7;RT4: 19.6;SH-SY5Y: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040709, HPA042046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA040709: AB_2677090, HPA042046: AB_2677818"	"unprognostic (9.52e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.49e-6)"	"unprognostic (2.36e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	5.0	6.0	5.1	1.8	7.0	7.2	4.5	7.5	7.2	4.2	0.3	4.8	4.4	2.3	2.1	8.2	2.7	2.9	5.1	9.5	7.1	11.2	6.7	3.2	0.6	9.8	6.5	2.7	29.9	0.6	3.3	2.8	8.5	3.0	3.7	6.2	7.9	2.9	5.9	11.0	4.2	2.2	7.6	2.0	8.5	3.4	6.7	0.4	2.0	2.8	1.7	7.2	7.4	11.7	1.2	1.8	1.8	0.4	4.9	4.0	4.5	0.5	0.0	0.0	0.0	0.4	2.7	3.4	2.6	0.1	2.0	4.0	2.7	5.0	0.0	1.0	1.9	0.0	3.8	1.3	3.0	0.3	0.3	4.4	15.5	0.2	20.7	0.2	0.2	2.0	0.2	0.9	2.2	2.8	1.0	0.2	2.0	9.9	1.0	1.2	7.4	5.6	8.0	19.6	6.3	18.0	4.1	6.5	0.1	2.3	0.9	3.4	0.2	1.3	1.3	0.0	0.6	2.3	0.4	0.9	2.3	0.0	1.5	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.6	0.3	0.5	1.0	1.1	0.0	1.9	0.0	0.0	5.1	7.0	7.5	7.2	9.5	7.1	9.8	6.5	8.5	7.6	6.7	11.7	11.9	9.6	42.6	0.0	0.2	0.0	37.6	0.0	3.4	34.2	6.9	5.1	0.0	11.5	8.6	25.8	4.2	20.4	0.0	10.7	1.9	11.8	14.8	19.8	8.7	2.0	3.6	0.0	0.0	13.3	2.6	14.3	27.0	41.7	3.8	0.9	0.4	8.8	1.7	42.1	0.0	8.4	0.0	4.0	0.0	3.4	1.8	1.9	0.0	0.0	0.6	34.9	0.0	0.0	0.0	9.3	5.7	5.3	0.5	54.7	19.8	23.4	4.4	7.4	0.0	29.8	6.5	3.9	7.5	13.7	0.0	33.5	0.9	1.7	7.6	114.2
GAREM2	"FAM59B, FLJ00375, GAREML, KIAA2038"	ENSG00000157833	"GRB2 associated regulator of MAPK1 subtype 2"	Q75VX8	2	26173088-26189663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.2;choroid plexus: 10.4;parathyroid gland: 22.9"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 46.9;Muller glia cells: 19.5;Proximal tubular cells: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 16.8;SH-SY5Y: 10.2;U-2 OS: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071575			Approved	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA071575: AB_2686420"	"unprognostic (1.70e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.04e-1)"	2.2	0.8	27.1	1.1	30.8	0.4	1.9	30.1	22.5	2.3	10.4	3.3	0.6	3.2	0.9	1.5	2.5	1.7	3.0	21.3	26.2	2.0	0.2	1.0	1.5	32.9	32.0	3.6	2.9	22.9	2.3	0.8	27.7	1.8	1.8	3.3	1.4	2.1	2.7	1.4	1.6	2.3	27.0	1.4	2.0	2.6	37.2	0.6	1.7	2.5	1.2	2.7	2.1	23.5	3.0	4.4	5.2	0.4	0.9	1.8	0.4	1.6	0.0	0.5	0.4	8.5	1.0	0.0	2.1	3.4	5.3	0.1	16.8	0.0	0.7	1.9	6.2	1.5	1.5	0.5	6.2	0.1	0.3	2.5	0.8	2.5	0.2	0.3	2.0	4.1	8.1	0.1	3.1	0.0	0.4	0.6	5.6	0.5	1.2	1.7	0.0	0.1	2.7	0.9	1.1	10.2	3.7	0.4	3.2	1.5	0.2	9.0	0.9	2.3	13.8	4.1	0.1	0.3	0.0	1.9	0.1	0.0	3.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.5	0.0	0.0	27.1	30.8	30.1	22.5	21.3	26.2	32.9	32.0	27.7	27.0	37.2	23.5	1.2	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	1.0	0.5	0.9	0.0	1.5	0.0	3.7	2.1	0.4	1.2	1.3	46.9	2.2	4.4	0.5	2.2	1.7	0.0	0.4	0.0	1.6	2.6	3.8	3.6	0.5	0.0	0.8	0.4	0.0	0.6	0.0	0.0	0.7	0.0	0.3	0.0	7.6	2.1	1.1	0.0	0.0	0.6	19.5	2.1	0.0	0.0	1.6	1.2	3.4	0.1	1.1	0.1	42.1	0.0	1.2	6.6	1.6	1.7	1.9	6.2	0.1	0.0	0.3	2.3	0.4	1.5	0.3
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol		NA	NA		300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (5.05e-5)"	"prognostic unfavorable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.1	20.3	9.2	24.2	12.2	18.8	24.3	11.3	11.9	16.4	10.1	23.2	22.1	18.3	17.1	24.8	21.8	15.9	20.7	8.6	10.5	21.0	29.7	16.0	30.3	11.0	10.3	19.0	22.3	19.9	12.8	26.1	11.7	17.0	29.1	20.9	16.8	16.7	29.1	17.4	19.4	26.3	11.3	20.0	19.7	29.3	10.9	34.4	20.8	21.9	38.6	32.2	16.5	14.0	132.2	61.5	90.3	98.8	61.1	64.2	100.3	82.6	70.8	96.8	101.5	117.7	108.9	174.8	48.5	55.6	124.9	67.9	189.0	130.4	138.3	91.3	111.7	265.2	68.5	78.6	85.2	148.6	66.3	57.3	86.5	113.3	162.5	48.1	91.5	138.4	312.4	108.5	84.9	63.6	158.2	100.0	194.4	186.3	71.8	131.1	166.6	246.7	74.7	69.4	93.1	84.1	116.9	89.1	107.1	81.0	113.0	93.9	68.7	64.9	76.9	56.1	90.9	106.8	159.6	193.0	67.1	171.3	96.2	9.0	24.0	16.3	25.9	33.9	31.4	29.7	25.2	27.1	31.6	24.5	26.4	26.2	10.6	43.9	30.6	23.2	34.1	22.8	9.2	12.2	11.3	11.9	8.6	10.5	11.0	10.3	11.7	11.3	10.9	14.0	21.1	19.2	19.8	17.3	30.1	46.0	50.3	34.1	38.1	18.5	18.6	17.3	19.3	11.5	28.0	14.7	35.5	41.2	21.8	12.4	23.5	28.4	21.7	23.3	36.9	21.9	13.1	40.3	19.1	24.2	37.4	27.2	21.4	23.4	7.6	31.8	16.1	18.0	23.6	5.0	21.1	17.1	22.4	17.0	12.0	6.6	17.4	17.0	12.4	10.3	19.8	13.3	22.6	17.6	19.3	31.5	12.7	18.0	22.7	54.3	16.4	14.3	17.8	28.5	13.1	23.0	23.9	57.2	27.6	34.4	45.9	25.6	21.2	55.0	24.1	46.6
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625509-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 39.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 39.8;Excitatory neurons: 114.9;Inhibitory neurons: 141.9;Oligodendrocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Hep G2: 43.2;JURKAT: 24.0;Karpas-707: 85.2;SCLC-21H: 24.8;U-266/84: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favorable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.4	0.8	2.1	0.3	1.9	0.1	0.8	4.5	5.4	0.9	0.0	0.7	1.8	0.8	0.0	0.7	1.2	1.6	3.5	0.7	2.2	5.4	39.7	1.0	1.0	6.2	7.5	2.0	9.6	0.1	2.5	0.4	6.3	1.0	0.4	2.2	1.5	0.6	4.6	0.8	1.6	0.3	3.3	1.3	2.6	0.8	6.1	8.2	0.8	1.8	0.7	1.0	0.7	6.1	0.0	0.1	1.7	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.7	0.4	0.2	0.0	43.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.3	0.0	24.0	1.6	85.2	0.0	0.4	0.3	0.1	0.3	2.4	0.0	0.9	0.5	4.4	0.0	1.1	24.8	1.3	0.0	0.0	0.5	0.2	0.1	0.0	1.8	0.0	0.4	1.1	0.0	1.1	30.7	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	1.9	4.5	5.4	0.7	2.2	6.2	7.5	6.3	3.3	6.1	6.1	0.1	0.0	0.0	39.8	0.4	0.1	0.4	0.1	0.6	1.9	0.4	0.1	12.7	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.3	1.3	0.1	0.4	0.0	0.0	114.9	3.3	0.0	1.0	3.1	0.7	0.0	0.2	0.7	22.9	0.0	0.0	141.9	0.6	0.0	0.0	0.0	5.4	0.6	0.0	0.0	9.4	0.2	0.2	0.0	18.6	83.9	1.6	1.4	0.0	0.5	0.1	0.1	3.2	4.0	1.2	0.0	0.3	0.8	0.4	1.1	0.6	0.0	0.0	0.4	0.1	0.9	0.3
GAS6	"AXLLG, AXSF, DKFZp666G247, FLJ34709"	ENSG00000183087	"Growth arrest specific 6"	Q14393	13	113820549-113864076	"Predicted secreted proteins"	"Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 348.3;Sertoli cells: 322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 70.7"	"Lineage enriched"	"Detected in many"	50	"dendritic cells: 70.7"	"Cell line enhanced"	"Detected in many"		"BJ: 347.0;BJ hTERT+: 494.0;HSkMC: 281.3;RPMI-8226: 493.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008275, HPA056080"	Approved		Approved	"Centriolar satellite,Cytosol"	"Secreted to blood"	NA	NA	8900000	3600000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Centriolar satellite"	"HPA008275: AB_1849497, HPA056080: AB_2683032"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"prognostic unfavorable (8.93e-6)"	124.2	32.5	26.7	18.8	28.7	3.6	77.4	33.9	32.0	244.4	59.3	67.8	48.7	171.7	13.8	63.2	161.3	58.9	169.1	24.1	34.6	72.7	37.1	97.3	22.5	37.4	36.1	118.0	49.9	58.5	58.4	51.6	38.5	100.9	25.2	6.3	84.4	63.8	99.2	101.4	47.8	57.9	30.8	29.4	70.0	60.1	34.1	39.6	101.2	67.5	10.6	127.0	172.0	25.2	151.3	6.6	4.4	3.8	169.5	94.0	18.4	347.0	494.0	141.3	168.4	9.6	71.0	1.4	11.4	157.2	24.9	139.1	2.4	77.7	35.6	0.2	20.1	1.1	11.1	1.0	120.8	1.0	2.1	281.3	44.9	39.1	39.0	243.2	5.3	2.3	2.6	79.9	231.9	7.4	0.8	1.5	9.5	24.0	9.9	4.5	0.1	493.5	51.9	1.9	23.5	21.3	38.3	1.3	0.4	23.8	45.9	119.4	81.7	36.9	45.0	4.4	100.5	0.1	8.0	1.5	41.9	3.6	5.8	0.0	1.4	0.0	0.0	1.1	0.0	0.1	0.2	0.0	11.3	0.1	0.0	0.0	0.0	0.1	0.3	70.7	0.0	1.4	26.7	28.7	33.9	32.0	24.1	34.6	37.4	36.1	38.5	30.8	34.1	25.2	133.2	198.7	25.9	23.2	20.8	84.4	94.7	18.5	70.0	38.0	17.9	114.3	86.8	50.1	23.4	31.3	0.0	1.8	59.1	92.4	27.4	45.7	5.1	35.2	33.1	71.9	10.3	5.3	26.2	6.7	1.9	152.7	19.9	32.3	8.2	154.7	159.9	21.6	101.6	348.3	31.9	69.5	8.2	22.3	100.4	8.9	92.2	48.6	122.7	41.2	9.8	32.7	0.0	3.0	7.5	24.1	58.6	59.5	147.4	30.5	84.1	0.6	15.5	12.5	322.1	22.9	121.1	5.3	17.6	27.6	71.9	2.9	4.7	214.8	151.4	31.1
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 198.3;Late spermatids: 277.8;Respiratory ciliated cells: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Plasma membrane"	"HPA041311: AB_2677402, HPA048238: AB_2680324"	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favorable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favorable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	5.2	10.3	9.5	2.8	9.7	1.4	6.3	10.0	14.3	7.8	12.3	7.7	2.6	6.5	10.1	8.4	18.9	6.1	15.4	9.5	9.9	13.8	5.5	7.1	2.8	10.3	10.0	8.9	10.5	16.3	14.1	2.1	10.1	7.3	3.0	5.0	11.4	8.6	15.1	4.5	3.9	4.4	10.3	3.4	8.2	16.8	10.9	2.5	12.5	10.0	2.0	6.3	5.8	10.2	17.9	14.5	1.8	8.5	7.8	6.2	14.3	3.6	8.8	13.9	4.1	14.1	13.0	1.0	9.1	7.1	8.4	17.8	5.9	9.9	3.3	0.0	10.7	3.7	9.0	16.2	8.7	2.2	2.8	7.9	6.0	10.4	4.7	6.3	8.3	5.8	14.3	2.1	6.1	41.9	2.5	9.9	11.6	11.3	7.4	0.7	15.7	1.0	17.4	8.5	14.6	10.7	18.4	9.7	21.0	1.6	19.6	8.4	6.2	8.6	10.3	4.7	8.3	3.4	5.4	0.0	21.3	2.7	15.1	1.7	1.2	1.4	0.7	2.0	0.7	0.4	1.0	1.4	1.7	0.8	0.8	0.7	1.5	0.0	1.3	1.9	1.6	0.8	9.5	9.7	10.0	14.3	9.5	9.9	10.3	10.0	10.1	10.3	10.9	10.2	5.9	22.4	11.3	20.5	3.1	1.1	4.7	7.0	5.7	11.9	14.1	10.8	7.9	25.8	13.4	22.0	20.9	3.0	0.7	5.9	13.7	17.1	198.3	45.5	7.1	5.8	6.0	3.0	27.5	10.9	3.6	5.5	12.2	10.0	2.5	16.1	7.1	4.8	4.1	26.9	24.6	6.3	8.2	0.8	1.4	277.8	14.0	2.3	5.4	1.9	1.3	12.4	0.0	13.0	6.0	10.0	4.6	7.5	1.1	5.8	5.3	30.9	82.3	28.0	6.6	6.7	9.5	28.7	11.9	7.2	2.6	1.6	1.6	25.2	5.3	5.8
GATA5	"bB379O24.1, GATAS"	ENSG00000130700	"GATA binding protein 5"	Q9BWX5	20	62463497-62475995	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.2;testis: 11.5;urinary bladder: 15.4"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 22.4;Hepatic stellate cells: 7.9;Intestinal goblet cells: 8.7;Proximal enterocytes: 38.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HEL: 2.9;K-562: 4.6;SiHa: 2.0;T-47d: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067583			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA067583: AB_2685867"	"unprognostic (2.21e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.34e-2)"		"unprognostic (1.69e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	2.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.2	11.2	3.5	0.3	0.1	9.5	1.4	2.8	0.0	0.0	4.0	0.7	1.9	0.0	0.0	0.0	0.7	0.1	3.4	0.4	0.4	0.0	5.4	0.0	0.0	0.3	0.3	0.0	0.2	10.0	0.7	0.0	0.0	10.9	11.5	0.0	0.0	0.6	0.2	0.0	15.4	1.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	2.0	0.0	0.0	0.8	4.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.2	1.7	22.4	0.2	0.0	0.0	7.9	0.0	0.3	0.0	0.0	8.7	0.0	0.0	0.3	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.1	0.0	0.1	0.0	0.0	0.0	3.4	0.0
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	39.3	45.7	48.5	23.2	47.5	16.3	39.9	52.8	53.7	46.4	63.3	83.5	54.2	44.6	26.9	36.3	44.2	26.3	83.3	47.2	54.2	84.4	65.9	54.1	24.6	54.1	56.2	39.8	54.1	37.2	65.5	24.7	56.1	60.2	41.0	71.1	50.0	27.7	75.8	39.3	89.7	22.9	45.1	58.5	63.9	30.8	58.9	18.3	61.7	43.7	21.6	53.0	40.9	48.7	18.1	29.3	39.6	38.4	18.8	11.4	40.0	24.1	18.8	23.9	25.0	32.8	14.1	19.3	17.1	14.7	51.5	18.4	38.2	16.2	12.0	27.5	26.2	20.8	87.8	35.6	20.8	31.2	49.4	19.8	29.8	20.3	21.1	57.9	63.4	18.9	20.7	36.0	22.6	18.0	8.5	32.0	41.2	36.6	45.7	15.5	16.0	16.3	33.3	41.9	32.2	43.0	13.5	33.3	24.5	48.1	22.8	27.8	44.6	25.8	30.9	22.4	29.9	24.2	16.5	16.0	32.3	11.3	20.5	11.1	2.9	2.0	3.8	3.9	2.5	3.7	3.7	4.7	2.8	4.7	2.2	1.9	3.2	2.4	2.5	4.4	2.8	2.2	48.5	47.5	52.8	53.7	47.2	54.2	54.1	56.2	56.1	45.1	58.9	48.7	12.7	12.8	8.0	45.1	11.2	7.4	18.2	9.4	6.2	77.5	15.0	10.8	13.7	17.2	14.5	27.6	114.7	11.1	16.6	71.7	21.5	10.5	14.1	10.0	8.1	16.0	35.8	17.2	23.5	12.0	10.2	8.0	46.4	13.8	14.0	18.7	30.7	20.1	9.2	52.2	26.4	35.8	16.2	12.8	10.7	24.3	12.5	10.7	12.4	8.4	13.3	16.2	12.3	18.1	20.2	15.1	57.6	9.8	11.7	15.8	87.4	17.8	17.9	102.9	13.1	12.2	12.2	9.2	5.7	8.8	9.9	22.2	9.4	11.3	41.4	26.3
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489703-81761645	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 149.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 287.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Cytosol		NA	NA		6500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	73.9	53.8	4.5	14.9	5.7	19.7	38.6	7.1	8.2	14.2	14.2	11.8	13.2	17.3	14.2	18.1	13.8	13.0	55.6	6.2	8.2	41.4	108.6	17.2	8.6	10.7	18.7	14.2	14.2	19.1	10.4	25.6	10.3	13.2	13.8	22.0	15.5	14.9	149.1	14.4	11.5	21.8	7.0	12.0	11.1	7.9	7.4	11.4	19.6	56.6	13.2	19.2	13.9	7.4	61.3	36.2	11.9	168.7	287.6	216.8	21.5	99.1	140.1	58.1	97.6	7.1	15.6	67.9	42.7	122.5	34.5	7.1	9.9	45.7	135.4	32.3	6.4	21.2	70.0	22.8	197.5	72.2	17.8	161.2	33.2	93.5	95.5	144.9	130.5	8.0	17.0	38.0	191.1	17.8	12.5	92.7	12.0	16.8	58.0	22.9	53.6	81.1	41.4	20.5	6.0	7.9	64.6	18.7	20.9	17.2	13.3	58.9	183.4	118.9	28.1	84.7	92.8	174.8	21.4	24.6	194.1	47.8	49.8	7.5	11.8	15.6	5.2	10.8	5.1	11.6	5.6	5.7	13.8	12.5	6.4	6.6	11.4	13.5	11.8	4.8	5.1	6.5	4.5	5.7	7.1	8.2	6.2	8.2	10.7	18.7	10.3	7.0	7.4	7.4	49.7	16.0	12.4	31.3	14.9	30.7	22.2	36.8	27.3	18.6	7.5	5.5	60.2	15.7	21.9	31.3	0.0	30.3	8.4	9.5	41.1	32.1	36.2	16.3	15.2	32.0	22.1	4.6	52.4	25.4	74.0	34.9	6.6	14.7	43.1	16.0	15.4	75.2	26.3	30.3	47.4	8.7	12.2	12.9	21.3	16.9	17.4	17.3	24.9	87.1	16.3	10.4	7.2	49.3	63.0	37.8	5.8	13.2	12.8	17.7	11.3	50.8	25.0	17.8	32.9	45.8	26.7	6.9	7.3	20.6	21.3	54.9	8.7	34.2	8.3	14.5
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44143213-44198170	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 12.6;choroid plexus: 7.4;heart muscle: 8.8;liver: 21.5;pituitary gland: 23.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.3;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	0.8	0.3	8.9	0.3	8.3	0.2	0.7	8.1	9.5	2.8	7.4	0.5	0.1	1.2	0.8	0.4	1.2	0.5	8.8	8.2	11.0	1.2	21.5	0.4	0.2	9.0	9.9	1.4	1.8	0.1	23.9	1.6	9.1	1.2	0.2	1.0	0.3	0.7	0.2	0.7	0.5	0.3	8.3	0.6	0.6	0.4	12.6	0.1	0.5	0.1	0.2	1.1	2.0	7.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.2	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.3	2.3	0.7	0.1	0.1	0.3	2.0	0.4	0.8	0.1	0.0	0.1	0.0	0.3	8.9	8.3	8.1	9.5	8.2	11.0	9.0	9.9	9.1	8.3	12.6	7.9	0.3	0.0	0.0	0.7	0.3	1.1	0.7	0.0	1.2	5.0	0.1	0.8	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.5	2.4	0.0	1.8	0.0	0.2	5.2	0.0	0.0	0.0	2.4	0.0	0.4	0.7	5.0	2.4	0.0	0.0	0.0	0.7	0.3	0.9	0.1	0.0	1.0	0.0	2.8	0.0	0.5	1.0	0.1	0.1	2.2	0.2	1.7	0.0	0.1	0.0	0.8	0.0	0.6	3.7	0.5	1.1	0.0	0.1	0.8	0.3	0.5	0.0	0.7
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496839-27523684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	19	"liver: 136.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 96.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.4;Hep G2: 20.7;HUVEC TERT2: 6.4;TIME: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA045855, HPA052227"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB034098: AB_2247323, HPA045855: , HPA052227: "	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.8	7.1	0.8	0.2	1.3	0.9	0.6	4.7	1.6	0.5	1.4	0.1	0.7	0.5	0.6	1.5	0.2	2.3	0.4	1.0	1.3	0.5	136.4	0.2	0.6	1.7	1.2	5.8	1.8	0.2	0.4	0.2	1.6	0.5	0.3	0.9	0.4	0.2	0.3	0.8	0.2	0.3	0.3	1.6	6.5	2.7	1.1	0.2	0.1	0.1	0.3	0.3	0.4	1.4	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	13.4	0.7	20.7	0.8	0.0	0.4	0.3	1.0	0.5	0.1	2.2	6.4	0.1	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.5	0.2	4.2	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	0.8	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.4	0.3	0.0	0.1	0.0	0.2	0.8	1.3	4.7	1.6	1.0	1.3	1.7	1.2	1.6	0.3	1.1	1.4	0.3	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	7.9	0.1	0.6	0.6	0.0	0.0	2.0	10.4	0.0	0.2	18.3	0.1	0.0	0.1	0.7	96.5	0.1	0.0	1.6	0.0	0.0	2.1	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	13.7	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.7	0.2	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 220.7;Urothelial cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 205.4;Hep G2: 178.2;OE19: 287.5;RT4: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	26.7	18.3	18.5	16.6	24.9	37.8	27.2	18.1	23.3	9.5	14.1	22.8	41.9	19.2	10.8	37.0	62.9	32.1	16.4	16.8	18.9	34.1	152.1	10.9	26.2	18.4	19.7	8.5	15.9	18.3	4.8	9.1	20.4	26.9	26.0	14.4	13.1	15.8	11.4	18.8	32.2	16.0	18.2	39.1	32.9	11.3	22.5	13.7	30.0	14.5	24.0	63.7	14.5	36.0	31.3	205.4	16.5	39.1	19.4	8.6	22.1	15.5	24.9	11.4	13.3	30.5	70.7	59.1	28.7	14.1	86.9	43.3	50.7	112.5	15.3	46.9	31.4	39.6	38.3	178.2	22.1	52.8	23.5	13.5	46.6	12.8	56.8	15.0	17.7	50.9	22.4	18.2	5.6	32.9	45.5	20.9	30.6	287.5	19.2	14.9	10.2	52.1	37.0	189.8	47.5	23.3	25.9	40.9	27.8	23.8	28.2	24.6	24.6	10.2	35.5	26.0	23.4	24.1	39.9	34.0	25.6	37.0	17.5	1.2	0.5	0.3	0.5	0.9	0.4	0.8	0.5	1.1	2.3	0.5	0.3	0.6	0.2	4.2	1.0	1.6	0.9	0.3	18.5	24.9	18.1	23.3	16.8	18.9	18.4	19.7	20.4	18.2	22.5	36.0	17.1	0.0	2.4	36.9	12.7	34.8	61.6	56.6	47.3	14.4	23.7	13.6	20.9	38.6	47.4	0.0	25.0	6.4	22.9	22.1	11.7	14.6	2.2	34.8	14.9	14.1	220.7	113.2	22.4	12.8	8.6	13.6	43.8	69.8	2.5	50.9	10.4	118.5	22.7	8.4	30.4	19.4	40.7	87.2	10.9	1.5	6.5	32.1	8.8	24.4	10.6	12.5	17.5	30.2	84.1	15.9	13.2	9.4	10.4	88.3	18.2	27.1	66.5	5.0	13.1	14.0	13.5	3.1	9.2	72.6	24.9	7.8	14.9	26.6	14.8	144.8
GCLM	GLCLR	ENSG00000023909	"Glutamate-cysteine ligase modifier subunit"	P48507	1	93885199-93909456	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 48.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 207.9;Erythroid cells: 301.9;Prostatic glandular cells: 762.3;Urothelial cells: 374.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009568, HPA023696, CAB040554"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-3)"	12.2	13.1	5.4	6.6	4.7	15.0	6.6	5.1	5.4	4.5	5.6	6.2	19.2	3.6	4.0	6.6	14.3	14.1	4.7	4.7	7.5	11.3	48.5	5.9	4.6	6.4	6.9	2.8	7.7	6.7	3.4	10.3	7.1	5.6	5.5	3.6	4.5	5.9	16.0	3.0	12.7	3.6	5.1	6.8	5.7	3.2	5.7	5.0	16.8	11.8	10.1	6.9	3.7	6.1	37.7	58.6	6.4	12.6	20.9	13.0	24.4	43.7	27.3	32.8	24.3	9.9	21.7	14.2	84.8	28.8	106.7	37.3	9.6	18.0	26.2	38.6	12.7	98.9	37.4	42.8	39.1	36.8	15.2	16.1	6.7	67.0	10.7	13.2	36.4	16.0	40.0	20.5	24.0	7.3	26.8	8.5	21.5	36.0	27.4	12.3	19.0	20.9	23.6	43.4	14.8	6.1	41.3	32.2	15.4	71.8	7.2	22.7	38.4	34.1	20.1	64.5	66.7	18.1	25.0	14.7	28.2	20.4	12.2	2.1	0.3	0.7	2.6	0.2	1.5	1.3	2.5	3.4	0.3	2.0	1.5	1.6	1.5	2.3	0.3	1.0	0.7	0.7	5.4	4.7	5.1	5.4	4.7	7.5	6.4	6.9	7.1	5.1	5.7	6.1	28.7	41.7	19.1	16.0	14.6	11.5	207.9	33.2	24.5	24.8	24.2	34.2	16.4	61.5	29.0	29.5	6.2	63.5	39.3	21.7	25.4	25.1	3.9	66.3	27.6	55.5	52.5	301.9	32.0	12.3	19.6	44.5	15.8	50.1	19.7	17.3	31.4	102.4	19.9	33.7	30.7	19.9	22.4	20.7	51.4	4.0	21.5	32.0	8.8	15.0	9.3	21.2	34.0	11.1	11.6	24.2	8.0	12.4	21.6	762.3	47.2	65.1	64.3	13.1	0.0	48.4	37.1	32.0	36.7	33.5	9.2	45.0	34.1	26.5	17.8	374.9
GCNT7	"C20orf105, dJ1153D9.2"	ENSG00000124091	"Glucosaminyl (N-acetyl) transferase family member 7"	Q6ZNI0	20	56491492-56525925	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 4.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.2;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.0;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA052617, HPA059403"	Uncertain		Approved	"Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies, Vesicles"	Cytosol	"HPA052617: AB_2681886, HPA059403: "	"unprognostic (3.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.96e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.69e-2)"	0.0	0.1	0.1	0.3	0.2	4.4	0.0	0.6	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.9	0.0	0.1	0.2	0.2	0.0	0.1	0.2	0.6	0.2	0.1	0.2	0.3	0.2	0.3	0.1	0.4	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4;prostate: 5.5"	"Cell type enriched"	"Detected in some"	24	"granulocytes: 223.3"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.4"	"Immune cell enriched"	"Detected in single"	661	"basophil: 227.7"	"Lineage enriched"	"Detected in single"	661	"granulocytes: 227.7"	"Group enriched"	"Detected in some"	71	"HEL: 151.8;HMC-1: 564.8"					"Low region specificity"	"Detected in all"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA027507: AB_10600756, HPA027510: AB_2672309"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	0.5	0.2	0.4	0.8	0.4	1.8	1.0	6.4	0.7	0.7	0.4	1.2	1.5	0.8	0.5	1.1	0.3	1.4	0.2	0.3	0.4	0.1	0.2	2.1	0.3	0.4	0.3	0.1	0.4	0.1	0.0	0.3	1.2	5.5	1.5	1.2	0.3	0.4	0.2	0.7	1.4	0.6	0.1	0.4	0.9	3.4	0.4	0.7	0.3	0.7	0.2	0.7	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.8	0.2	0.1	0.0	0.1	151.8	0.2	0.0	0.0	0.3	564.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.3	0.3	5.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.4	0.0	0.0	0.3	0.2	0.0	2.3	0.1	0.4	227.7	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.4	6.4	0.7	0.3	0.4	0.4	0.3	1.2	0.1	0.4	1.2	0.0	0.0	4.4	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.9	0.0	9.1	0.0	0.1	0.6	0.0	5.0	0.4	0.0	0.0	0.3	0.0	0.0	223.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.3	1.7	0.0	0.6	0.0	1.4	0.1	0.0	0.2
GDAP1	"CMT2K, CMT4, CMT4A"	ENSG00000104381	"Ganglioside induced differentiation associated protein 1"	Q8TB36	8	74320613-74518007	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.9;Cone photoreceptor cells: 47.9;Excitatory neurons: 75.7;Horizontal cells: 47.1;Inhibitory neurons: 67.3;Oligodendrocyte precursor cells: 67.8;Rod photoreceptor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014266, HPA024334"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Cytosol	"HPA014266: AB_1849581, HPA024334: AB_1849583"	"unprognostic (3.19e-2)"	"unprognostic (1.52e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (2.68e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.17e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.73e-1)"	2.7	9.6	19.0	3.3	22.5	1.2	4.0	15.2	26.0	2.9	4.9	2.5	2.4	3.9	1.9	4.0	2.8	2.5	2.1	25.3	19.7	4.2	1.5	2.4	3.3	14.5	17.0	6.0	7.4	12.4	20.6	1.2	18.1	4.1	2.4	19.0	2.4	4.1	2.7	1.7	2.3	2.8	12.2	1.9	2.0	4.7	16.7	4.5	6.6	3.1	2.8	3.9	2.6	20.5	3.5	16.8	17.7	4.8	1.2	1.6	1.5	1.8	8.2	8.3	9.5	7.8	5.0	14.8	2.5	1.2	10.6	6.6	12.4	7.0	16.2	19.7	3.6	7.4	8.9	14.0	0.7	7.6	15.8	4.7	2.3	5.3	8.2	0.9	1.1	7.3	3.4	0.3	4.8	5.7	12.6	0.4	20.1	24.5	17.9	8.7	9.2	3.2	2.9	15.3	18.2	38.9	13.1	3.4	9.7	4.9	14.9	2.6	0.0	11.7	6.2	2.9	5.5	9.3	15.7	6.8	7.3	0.3	13.8	0.5	0.9	1.0	0.8	3.1	1.0	1.4	0.8	1.3	0.8	1.3	0.6	0.6	1.8	0.7	5.5	0.2	4.0	0.8	19.0	22.5	15.2	26.0	25.3	19.7	14.5	17.0	18.1	12.2	16.7	20.5	6.4	6.4	5.1	27.1	5.9	1.8	7.4	4.2	6.2	46.9	6.2	6.1	5.9	5.7	3.6	3.7	47.9	0.4	3.9	2.1	9.8	5.2	5.4	15.4	7.0	6.7	20.4	2.1	75.7	5.8	0.3	4.8	3.1	2.8	17.2	2.1	6.4	1.8	4.7	47.1	67.3	1.7	12.2	6.3	2.5	1.3	4.1	4.6	1.8	15.0	2.9	23.5	4.1	67.8	41.9	3.7	1.4	5.7	2.6	2.6	3.6	6.6	4.9	47.7	0.0	8.0	5.5	14.7	13.1	3.7	1.3	0.0	3.1	6.5	1.7	3.8
GDF9		ENSG00000164404	"Growth differentiation factor 9"	O60383	5	132861181-132866884	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 5.2;Spermatocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069146	Supported		Approved	"Golgi apparatus,Cytosol"	"Secreted in female reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA069146: AB_2686094"	"unprognostic (4.64e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.10e-2)"	0.3	0.6	1.3	0.2	1.5	0.3	0.8	1.3	2.0	0.4	0.9	0.3	0.4	0.3	4.1	0.3	0.8	0.2	0.3	1.3	1.4	1.4	0.6	0.3	0.5	1.2	1.4	0.5	1.0	0.7	1.7	0.2	1.4	0.6	0.3	1.3	0.8	0.5	0.7	1.0	0.4	0.2	1.4	0.4	1.0	8.9	1.3	0.7	1.0	0.7	0.4	0.6	0.3	1.4	0.2	0.1	0.5	1.1	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.3	0.8	0.2	0.6	0.1	0.9	0.2	0.4	0.4	0.1	0.4	0.7	0.5	0.5	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	3.9	0.0	1.2	0.2	0.2	0.7	0.8	0.2	0.1	0.0	0.6	0.0	0.2	0.3	0.2	1.0	0.9	0.2	0.1	0.5	0.7	0.5	0.1	0.1	0.9	0.4	0.2	0.1	1.3	1.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.3	2.0	1.3	1.4	1.2	1.4	1.4	1.4	1.3	1.4	0.9	0.0	0.0	1.6	0.1	0.1	0.4	0.1	0.0	0.4	1.9	2.2	0.6	0.0	0.1	0.0	4.2	0.4	0.3	0.7	3.9	0.1	19.9	1.4	0.9	0.5	0.0	0.0	0.5	0.2	0.3	0.4	0.0	1.9	0.0	0.5	0.4	0.2	0.1	0.0	0.8	0.9	0.0	0.3	0.0	5.2	0.6	0.5	0.0	0.0	0.0	1.0	0.0	2.0	0.9	0.1	0.1	0.4	0.1	0.6	0.3	0.4	0.6	1.0	0.0	1.6	0.8	15.2	2.5	1.1	0.1	0.7	0.2	0.2	0.5	0.2
GDI1	"FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4"	ENSG00000203879	"GDP dissociation inhibitor 1"	P31150	X	154436913-154443467	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 438.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012979, HPA049290, HPA057668"	Enhanced		Approved	Cytosol		NA	NA		31000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB012979: AB_2533970, HPA049290: AB_2680700, HPA057668: AB_2683498"	"prognostic unfavorable (6.84e-4)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.72e-1)"	77.3	85.9	351.5	54.9	381.7	41.2	67.4	309.6	438.5	99.7	214.0	91.8	36.7	92.2	46.2	57.5	94.6	47.3	99.1	391.8	349.9	74.4	53.9	90.1	53.9	344.5	312.7	120.0	54.7	63.4	176.0	60.4	349.5	74.9	41.7	130.9	49.7	69.5	62.9	61.6	67.5	78.9	311.4	89.4	68.5	54.1	330.6	58.7	63.0	70.8	51.1	89.2	81.2	366.2	100.2	88.9	195.9	164.6	77.7	91.4	64.5	149.6	91.1	140.4	146.0	52.6	51.1	79.5	149.3	139.4	213.2	79.7	172.7	83.9	96.5	147.5	93.8	25.0	142.6	35.5	113.5	24.6	90.5	94.7	101.3	163.4	99.6	154.6	92.4	95.7	31.1	120.5	169.4	99.2	77.9	62.1	53.0	106.1	168.8	77.6	51.6	45.0	98.8	46.5	272.5	210.3	67.6	86.1	109.0	150.3	50.9	42.5	110.4	131.9	116.8	138.4	212.0	182.1	202.0	128.3	140.7	54.5	162.5	23.7	8.4	26.9	12.1	12.6	18.0	9.9	13.0	12.0	7.0	10.1	10.0	10.1	30.0	8.7	21.3	12.1	16.2	7.3	351.5	381.7	309.6	438.5	391.8	349.9	344.5	312.7	349.5	311.4	330.6	366.2	39.3	16.0	27.4	30.3	35.9	27.1	24.8	48.3	33.6	71.3	24.1	25.7	62.6	24.3	29.0	27.6	25.0	22.7	27.0	31.4	31.3	39.4	2.9	33.1	41.1	35.3	90.8	9.2	48.8	31.3	39.3	37.5	37.8	34.3	33.7	29.7	30.4	17.7	36.3	60.6	43.2	24.8	65.1	35.9	40.9	6.0	37.6	35.5	17.8	22.5	59.0	37.7	19.6	33.2	46.4	50.2	25.9	39.9	35.7	27.4	24.3	25.5	46.8	37.1	52.6	29.5	49.8	33.9	66.6	20.7	30.3	49.5	43.2	22.0	15.0	26.2
GDI2	RABGDIB	ENSG00000057608	"GDP dissociation inhibitor 2"	P50395	10	5765223-5842132	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049290, HPA057668"	Supported		Approved	Cytosol		NA	NA		53000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA049290: AB_2680700, HPA057668: AB_2683498"	"unprognostic (1.08e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.26e-4)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.56e-7)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	125.1	111.5	62.4	151.6	70.0	126.6	138.1	76.0	90.3	120.6	66.8	152.9	175.4	96.3	115.3	131.1	96.8	112.6	86.8	59.3	70.7	146.0	241.1	98.3	217.5	85.8	72.7	116.9	165.1	91.3	59.6	135.5	82.6	88.8	160.7	69.1	97.7	92.2	107.0	107.6	160.2	124.1	80.9	138.7	108.6	74.3	65.1	149.1	114.1	99.7	239.2	145.5	81.7	95.4	343.4	245.8	341.1	241.2	298.2	347.5	191.4	325.0	170.8	287.3	312.0	351.8	287.3	553.2	198.2	340.5	88.1	320.8	368.3	289.3	288.0	212.2	174.7	380.0	152.0	428.4	276.9	252.1	230.7	292.6	235.8	249.6	148.9	324.0	400.6	340.1	398.5	203.4	331.6	291.1	390.9	208.0	242.5	355.1	159.3	466.7	181.9	389.8	330.7	250.1	138.0	210.0	257.5	468.5	358.3	289.9	382.3	299.0	342.0	142.3	243.4	420.3	282.2	180.0	314.8	526.5	212.0	275.5	130.0	154.9	280.8	169.0	109.9	347.8	136.4	210.7	136.9	121.6	329.1	204.2	124.8	119.3	138.4	177.5	445.1	146.1	181.5	416.8	62.4	70.0	76.0	90.3	59.3	70.7	85.8	72.7	82.6	80.9	65.1	95.4	101.5	25.6	83.8	31.0	208.1	161.7	131.3	144.8	145.7	37.1	124.5	81.8	76.6	107.2	109.0	57.0	18.8	252.1	148.5	156.6	133.1	185.7	29.5	69.1	138.0	125.4	118.4	177.1	27.7	212.2	312.0	151.5	109.6	84.3	132.5	121.7	121.3	145.9	284.5	92.5	32.1	184.7	91.6	354.2	302.8	40.4	152.2	255.7	149.4	36.5	485.8	75.0	97.9	34.7	49.2	158.1	141.9	141.8	151.3	129.2	271.0	194.1	63.0	36.8	111.7	96.1	125.8	126.2	119.3	177.6	165.1	247.4	120.1	136.9	213.5	131.9
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113537	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 447.4"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 32.1;MCF7: 50.6;OE19: 53.3;SK-BR-3: 165.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	7.1	2.4	6.1	6.0	6.1	1.8	5.4	6.8	11.4	18.7	5.9	25.9	8.4	5.3	9.3	45.6	5.7	2.5	5.2	6.0	6.1	17.9	2.1	6.4	4.2	7.5	6.1	6.8	2.2	0.4	4.8	11.4	8.0	5.7	17.2	6.5	9.0	2.2	2.1	11.0	10.2	5.2	6.3	9.0	18.8	1.8	6.1	4.1	4.7	0.9	20.9	5.4	19.1	6.8	21.8	0.3	5.2	1.5	1.6	5.5	5.5	0.6	1.3	1.8	1.7	1.0	15.2	0.6	2.9	1.5	0.6	1.8	1.6	0.5	1.8	2.5	4.0	0.2	1.0	32.1	1.0	0.7	1.3	0.2	1.6	4.5	0.3	4.1	5.1	4.2	1.0	2.3	2.2	50.6	1.5	2.0	2.6	53.3	0.6	6.3	1.4	7.1	2.6	7.4	1.1	2.2	0.2	165.0	0.5	1.6	3.0	2.7	2.7	0.9	1.1	1.9	1.8	2.7	0.9	1.5	4.2	2.7	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.1	0.0	6.1	6.1	6.8	11.4	6.0	6.1	7.5	6.1	8.0	6.3	6.1	6.8	5.9	6.4	1.1	1.6	1.0	1.3	0.9	4.4	1.2	1.6	4.1	3.0	1.5	0.0	22.2	5.5	0.0	24.2	1.2	98.2	5.9	0.9	67.8	2.6	3.8	4.3	3.5	0.0	0.6	1.3	71.9	2.1	30.1	4.1	0.0	2.0	3.9	0.3	3.1	1.7	0.8	34.2	6.1	1.9	1.0	447.4	3.4	1.4	1.8	1.9	1.2	0.6	0.0	1.5	1.2	19.2	36.7	3.0	0.1	1.1	46.0	100.6	9.0	1.7	6.6	0.6	2.7	1.4	1.3	5.1	2.0	9.3	1.9	1.3	13.9	4.8
GDPGP1	C15orf58	ENSG00000183208	"GDP-D-glucose phosphorylase 1"	Q6ZNW5	15	90233808-90245811	"Enzymes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA048189, HPA059841"	Approved		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA048189: AB_2680307, HPA059841: AB_2684138"	"prognostic favorable (6.32e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-3)"	1.8	3.2	3.9	3.0	3.0	2.0	2.3	4.3	4.2	2.0	3.1	5.7	5.3	2.2	3.0	2.4	4.6	3.0	5.8	3.2	2.9	4.3	4.9	2.9	3.5	3.7	2.9	2.9	3.5	4.9	3.7	1.0	4.6	3.7	7.7	2.7	3.8	3.1	7.9	2.1	3.9	2.8	1.8	3.2	3.5	4.6	2.9	3.1	3.8	1.5	4.1	3.4	1.5	5.0	3.0	11.8	1.4	4.3	4.3	0.9	3.9	2.7	1.7	3.5	3.3	3.5	11.5	7.5	5.2	2.1	2.6	5.0	4.5	3.2	1.4	6.7	7.8	6.7	7.0	5.1	4.6	3.6	4.2	1.1	2.1	2.4	1.3	3.9	4.2	4.4	2.5	2.6	2.1	6.5	2.7	1.6	1.8	9.2	4.8	4.7	1.0	3.8	4.1	5.9	4.5	2.0	4.3	6.6	4.5	2.6	7.6	3.7	4.2	1.8	1.9	2.7	2.7	5.8	7.3	3.4	4.1	3.0	3.3	3.8	2.2	1.0	3.1	2.6	2.7	2.3	2.9	3.7	2.0	4.2	3.0	2.8	3.1	3.4	2.2	2.1	3.9	1.4	3.9	3.0	4.3	4.2	3.2	2.9	3.7	2.9	4.6	1.8	2.9	5.0	1.4	0.0	3.2	0.3	2.1	0.0	2.8	0.9	1.8	3.8	3.4	2.2	6.4	8.6	1.5	7.3	6.2	2.4	2.5	6.5	3.9	3.8	3.0	3.8	1.6	1.7	5.4	1.7	2.6	6.0	1.2	1.5	4.1	2.3	3.8	2.3	1.4	4.5	4.1	1.7	2.8	3.6	0.0	2.2	0.0	2.4	2.8	3.5	0.0	1.0	2.3	3.5	2.1	1.0	2.1	4.9	5.5	2.2	2.4	2.2	3.8	5.8	3.4	4.4	0.0	3.8	1.0	2.9	2.8	1.8	0.3	0.4	3.2	1.5	4.2	3.1
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.9;Cardiomyocytes: 108.2;Excitatory neurons: 133.2;Inhibitory neurons: 106.2;NK-cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.5;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.5;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEL: 30.5;HMC-1: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	10.5	2.0	14.3	2.8	21.6	12.7	9.6	11.2	26.1	5.0	0.0	6.2	1.8	3.6	0.8	8.6	4.4	4.3	16.7	24.5	3.7	2.3	7.2	9.7	4.3	3.0	1.5	1.5	1.5	1.7	3.5	3.9	2.3	4.0	2.8	2.1	3.6	1.4	12.0	5.5	6.5	4.9	0.6	8.8	7.9	0.6	2.5	3.0	2.7	9.7	4.2	6.2	5.8	16.9	12.5	1.3	1.0	2.1	1.7	1.8	1.3	1.0	0.5	0.7	0.4	0.4	0.9	16.8	16.6	1.2	1.0	10.9	3.4	5.4	0.7	1.2	6.0	30.5	7.2	6.6	2.4	9.0	46.3	0.9	4.1	1.6	4.5	2.6	9.5	4.5	0.9	1.5	1.3	4.1	2.0	5.2	1.8	4.3	3.3	6.9	2.1	8.8	0.6	2.4	5.5	1.0	4.0	0.7	4.0	2.1	0.9	0.9	12.2	1.6	3.2	3.5	5.6	13.4	8.3	19.8	1.4	5.3	0.4	0.2	0.4	15.5	1.5	0.9	0.2	2.7	0.2	0.7	0.2	1.9	0.1	0.5	0.3	13.1	0.9	0.1	0.1	1.0	14.3	21.6	11.2	26.1	24.5	3.7	3.0	1.5	2.3	0.6	2.5	16.9	100.9	0.0	1.8	33.0	14.3	20.3	4.9	14.5	19.9	43.8	7.4	3.7	108.2	10.0	14.4	0.0	0.0	1.5	46.1	18.2	0.0	5.3	0.1	3.8	1.0	49.0	8.4	31.2	133.2	3.1	34.7	9.1	2.0	8.0	4.5	0.2	51.4	19.5	2.5	1.7	106.2	11.2	8.2	15.7	31.3	0.3	2.5	21.4	12.4	42.2	4.7	2.1	142.2	58.8	56.6	30.5	31.7	1.2	14.5	3.1	10.6	0.3	13.6	2.7	13.1	19.9	17.5	0.0	3.3	34.6	22.4	0.7	23.4	1.0	4.4	4.7
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719339	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	12.5	12.2	13.4	6.9	13.8	16.6	12.6	27.4	14.8	17.6	13.4	11.8	11.7	10.8	5.5	33.5	13.0	7.9	7.2	13.0	13.9	12.4	40.8	9.3	8.7	11.3	12.9	6.4	8.9	12.0	13.2	14.7	13.6	10.9	9.3	8.1	12.7	7.3	9.2	16.7	9.2	9.2	8.8	18.5	8.0	11.1	12.6	8.1	10.3	7.1	12.9	10.9	26.3	11.5	15.8	25.1	15.1	31.0	14.9	11.3	18.1	12.7	16.5	23.3	23.9	21.5	13.9	26.6	11.8	14.8	12.6	19.4	15.6	14.9	19.3	16.2	20.1	6.7	14.5	30.4	11.4	11.0	12.5	9.1	16.9	31.0	9.2	11.7	34.5	26.9	14.1	4.9	13.2	33.0	18.2	13.4	20.7	9.4	13.8	28.7	8.9	20.8	14.5	21.5	30.4	18.4	31.6	10.5	9.6	8.7	15.9	7.3	26.4	17.8	18.1	16.3	13.0	13.2	19.8	29.0	11.1	15.8	13.3	0.5	4.8	5.2	4.4	2.9	7.2	6.3	7.7	7.9	4.8	7.0	6.6	5.3	9.0	5.9	3.1	5.4	9.2	3.7	13.4	13.8	27.4	14.8	13.0	13.9	11.3	12.9	13.6	8.8	12.6	11.5	36.1	0.0	8.4	8.5	7.7	22.9	15.8	8.1	15.9	13.7	21.7	12.4	5.3	15.7	10.9	11.0	14.6	10.3	10.6	23.8	5.9	21.1	89.6	22.5	10.9	33.8	43.2	56.6	18.3	11.6	24.1	10.4	3.6	8.7	4.5	12.2	31.1	46.7	6.6	21.9	16.8	17.0	16.2	7.5	10.0	29.9	8.7	4.6	8.8	6.5	5.2	12.0	11.3	8.5	7.3	15.8	14.2	11.3	9.1	12.4	20.6	13.0	24.5	11.0	6.6	11.9	11.4	19.9	14.8	10.1	27.3	22.2	10.3	9.3	18.3	21.3
GFUS	"FX, P35B, SDR4E1, TSTA3"	ENSG00000104522	"GDP-L-fucose synthase"	Q13630	8	143612618-143618048	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 32.1;Cytotrophoblasts: 82.1;Extravillous trophoblasts: 156.4;Hofbauer cells: 69.9;Syncytiotrophoblasts: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		850000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	36.3	37.2	21.6	27.7	21.1	52.3	34.0	21.4	25.9	28.6	21.7	45.9	69.2	24.8	19.2	88.7	24.0	29.3	32.1	20.7	21.3	37.5	86.6	28.4	29.1	23.5	21.9	19.0	99.5	22.8	44.0	24.4	22.8	45.0	37.6	6.5	70.9	24.2	30.2	81.5	52.4	19.4	20.2	35.7	111.4	49.4	21.0	26.6	32.1	18.4	27.1	31.0	36.0	22.5	85.6	67.1	29.2	99.7	28.6	26.1	54.1	70.3	73.0	50.2	38.1	78.5	94.3	37.5	64.6	52.5	21.2	60.6	47.8	100.8	23.2	101.7	53.8	58.7	103.0	93.4	57.2	42.2	67.1	30.3	47.4	31.7	127.3	42.2	84.3	61.9	66.4	57.0	41.2	267.5	39.8	53.2	45.8	267.7	87.1	47.1	26.3	122.3	106.1	94.8	67.3	45.9	53.3	100.2	73.0	23.0	133.5	58.8	75.5	34.8	132.0	35.1	67.6	34.1	30.2	29.0	52.8	91.6	54.7	34.9	27.4	42.9	40.3	38.5	43.0	35.2	43.1	46.8	30.1	40.1	31.5	38.5	31.0	63.6	33.8	54.5	57.5	45.7	21.6	21.1	21.4	25.9	20.7	21.3	23.5	21.9	22.8	20.2	21.0	22.5	32.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	82.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	156.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	87.7	1.7	0.0	0.0	0.0
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423439-42721878	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.7;liver: 213.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 53.3;Hepatocytes: 141.3;Inhibitory neurons: 115.7;Oligodendrocyte precursor cells: 181.0"	"Group enriched"	"Detected in many"	4	"breast cancer: 2.8;liver cancer: 7.6;prostate cancer: 8.1;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 21.2;T-47d: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	2200000	24000000		"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	84.7	5.6	1.8	1.7	2.1	0.2	30.1	1.7	1.7	5.2	2.3	5.8	1.1	4.5	4.6	3.9	5.4	5.2	8.9	1.8	5.6	11.8	213.3	4.0	1.3	1.0	2.0	7.5	2.1	5.5	1.2	4.8	1.4	11.1	5.7	0.4	3.7	4.7	45.7	5.6	4.3	4.0	1.1	4.0	6.1	1.7	3.4	2.3	4.6	11.6	0.9	5.0	5.8	1.4	0.0	0.0	0.6	5.0	3.3	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.3	4.3	0.0	0.0	2.6	0.0	0.1	0.0	0.6	0.0	0.0	21.2	7.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.3	0.1	3.5	0.6	56.0	0.1	3.0	4.8	2.1	2.6	0.5	0.5	0.0	0.0	0.5	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	2.1	1.7	1.7	1.8	5.6	1.0	2.0	1.4	1.1	3.4	1.4	17.2	0.0	0.5	14.7	0.4	4.7	4.5	17.8	10.2	0.6	9.7	16.0	18.6	1.5	1.9	1.8	0.0	17.4	0.5	2.8	1.9	0.0	5.1	0.5	9.4	4.8	3.0	5.3	53.3	0.2	2.2	23.8	0.5	0.3	0.0	1.1	6.1	141.3	1.9	0.0	115.7	1.9	0.0	3.0	1.8	2.8	18.6	0.7	1.8	36.5	0.0	0.7	0.0	181.0	3.6	0.2	1.7	12.0	0.0	5.2	0.0	9.6	0.6	0.4	13.1	18.7	15.1	0.7	0.3	2.9	3.7	40.2	0.5	49.4	2.2	0.9
GID4	"C17orf39, VID24"	ENSG00000141034	"GID complex subunit 4 homolog"	Q8IVV7	17	18039408-18068405	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.1"	"Group enriched"	"Detected in many"	12	"Early spermatids: 665.5;Late spermatids: 1287.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044348	Uncertain		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA044348: AB_10959602"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.65e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	7.6	5.1	8.3	4.7	7.7	5.8	6.0	9.6	8.6	6.7	5.0	10.0	4.2	7.3	6.5	11.6	6.1	5.1	10.1	7.5	6.6	5.9	5.5	5.3	5.5	7.7	7.6	7.8	7.6	10.5	3.0	6.5	7.7	6.7	4.6	5.7	7.9	7.9	27.7	12.4	4.6	8.5	7.0	5.7	5.8	69.1	7.8	7.2	6.7	14.4	6.0	8.8	7.3	7.7	11.8	12.1	6.7	10.9	17.2	16.8	11.4	9.6	15.6	10.5	11.8	10.2	4.5	14.9	8.1	11.3	9.6	13.1	9.8	10.6	13.7	8.1	19.6	6.6	9.5	7.5	14.9	3.9	11.1	12.5	18.6	10.5	16.3	13.9	11.8	20.9	6.0	4.1	8.6	3.0	12.8	8.4	5.9	14.4	8.8	10.8	23.9	14.8	7.2	4.6	5.0	7.6	6.5	5.7	7.2	64.9	3.6	5.0	10.0	6.7	3.8	15.7	4.9	7.3	6.7	3.2	9.6	6.7	8.8	4.3	1.1	3.6	1.2	0.6	1.3	2.6	1.1	1.2	0.9	2.0	1.3	1.4	2.9	2.0	0.8	1.6	1.9	0.6	8.3	7.7	9.6	8.6	7.5	6.6	7.7	7.6	7.7	7.0	7.8	7.7	8.7	0.0	1.1	5.2	6.0	11.1	7.5	4.5	4.6	5.8	6.4	7.0	12.4	5.7	3.1	1.8	4.2	8.3	6.1	4.1	9.8	5.3	665.5	5.4	9.5	8.4	1.2	17.2	8.2	5.7	15.2	8.0	1.1	5.5	5.7	10.7	8.2	6.8	7.3	16.8	8.1	4.9	0.0	9.5	7.7	1287.8	12.8	7.4	7.2	11.2	9.7	5.4	10.3	9.5	9.8	9.1	1.6	15.8	5.0	16.3	6.9	11.4	3.5	3.9	13.1	8.6	9.0	78.1	26.3	7.2	18.2	15.5	5.9	7.0	4.4	8.0
GJB7	"bA136M9.1, CX25"	ENSG00000164411	"Gap junction protein beta 7"	Q6PEY0	6	87282980-87329278	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 7.0;pituitary gland: 5.5;placenta: 2.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 10.4;Endometrial ciliated cells: 12.8;Ionocytes: 22.4;Respiratory ciliated cells: 18.4;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;HDLM-2: 7.6;MCF7: 4.1;OE19: 4.8;RT4: 3.6;SuSa: 2.4"					"Not detected"	"Not detected"			HPA014392			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA014392: "	"unprognostic (8.30e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-3)"		"unprognostic (2.61e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.10e-2)"	0.0	0.0	0.2	0.0	0.1	0.3	0.0	1.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.1	5.5	2.6	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.2	1.5	0.0	0.1	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	4.1	0.0	0.1	1.2	4.8	0.0	0.1	0.0	0.0	0.0	3.6	0.1	0.0	0.8	0.0	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.6	0.1	0.1	0.4	0.1	0.5	0.0	0.1	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	1.3	0.0	2.5	0.6	0.3	0.2	0.0	0.5	0.0	0.0	10.4	0.5	0.1	0.0	0.2	1.1	12.8	0.8	0.3	0.0	0.0	0.7	0.2	4.4	0.6	0.0	3.0	0.0	0.1	0.4	0.0	0.5	0.0	1.1	0.0	22.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.0	0.0	0.0	0.0	18.4	0.6	0.0	1.7	0.3	0.3	0.3	0.0	0.0	7.3	0.5	0.2	0.3	0.2
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149930-228159826	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 51.3"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 12.5;Oligodendrocytes: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.4;SCLC-21H: 2.9;TIME: 2.7"	"Region enhanced"	"Detected in all"		"white matter: 105.5"	"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.9	0.9	13.6	0.6	31.2	0.2	1.7	39.0	20.2	4.2	5.2	5.8	0.2	4.7	0.9	1.4	5.4	0.7	1.7	13.9	19.5	1.3	0.5	2.9	0.6	43.9	31.6	3.8	0.5	0.7	1.4	0.5	38.1	3.0	0.3	0.5	0.8	1.7	0.8	1.7	1.7	1.8	28.1	1.4	2.4	1.2	27.6	0.4	2.0	0.8	0.3	4.2	3.5	51.3	0.2	0.2	0.1	0.3	0.8	0.4	1.0	0.8	0.2	0.3	0.4	0.5	0.7	0.1	5.4	1.5	0.4	0.5	0.2	0.2	0.1	0.2	0.9	0.2	1.4	1.2	1.4	0.0	0.0	0.2	0.1	0.5	0.3	0.7	0.1	1.0	0.6	0.1	0.2	0.3	1.1	0.3	0.3	0.0	1.1	0.2	0.1	0.0	0.4	0.0	2.9	1.7	0.2	0.0	0.2	0.1	0.1	0.2	2.7	0.7	2.1	2.5	0.9	0.1	0.4	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.6	31.2	39.0	20.2	13.9	19.5	43.9	31.6	38.1	28.1	27.6	51.3	2.8	0.0	0.6	0.7	0.2	3.4	1.3	0.6	1.8	2.6	1.3	0.6	1.8	0.0	0.0	0.0	12.5	0.0	0.4	0.2	0.0	0.1	0.2	1.0	1.1	4.3	0.0	0.0	0.8	0.5	0.0	2.2	0.0	1.6	0.0	0.3	3.6	0.0	0.1	3.3	1.1	0.3	0.0	0.6	3.8	0.0	2.5	1.3	1.8	0.0	0.0	0.3	0.0	0.0	26.9	1.1	0.0	4.1	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.6	1.8	0.0	0.0	0.5	1.7	0.0	0.8	0.6	0.3	1.0
GK5	MGC40579	ENSG00000175066	"Glycerol kinase 5"	Q6ZS86	3	142157527-142225592	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042606, HPA057998"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA042606: AB_10795509, HPA057998: AB_2683573"	"unprognostic (7.79e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.59e-3)"	4.6	7.0	2.3	3.8	2.4	7.8	6.8	4.8	2.7	5.0	7.0	6.8	9.4	5.4	9.0	4.3	6.0	3.2	2.4	2.3	2.4	3.6	2.1	3.8	2.2	4.4	3.1	8.6	4.0	3.1	5.8	1.7	4.0	8.4	7.3	4.7	11.0	4.0	2.5	5.9	8.0	3.3	2.9	2.2	5.2	3.2	3.0	2.1	4.6	1.5	2.4	4.2	4.4	4.6	11.2	2.7	3.9	2.6	8.0	15.2	6.7	3.6	2.5	3.9	2.5	4.2	6.0	7.9	3.2	3.5	4.3	4.6	4.5	3.5	5.2	2.9	4.3	5.2	7.1	3.1	4.3	6.1	6.7	6.2	3.0	2.6	3.4	2.5	2.3	9.1	4.6	4.7	7.2	7.2	5.3	5.0	2.5	7.5	3.1	4.9	4.2	2.9	4.1	6.8	3.8	2.8	10.1	10.5	3.3	2.3	14.8	4.0	2.5	3.1	2.6	6.9	4.1	4.9	5.1	8.1	5.6	3.8	5.3	2.0	0.4	0.3	1.5	0.3	0.7	0.2	0.5	0.5	0.3	0.4	0.3	0.6	1.1	1.5	2.6	0.4	0.2	0.2	2.3	2.4	4.8	2.7	2.3	2.4	4.4	3.1	4.0	2.9	3.0	4.6	13.7	38.5	30.7	31.6	6.8	4.0	12.3	3.7	15.9	30.6	26.6	13.6	10.5	17.2	17.3	27.6	29.2	13.1	80.5	37.4	7.9	14.9	2.8	32.7	22.5	9.7	27.9	8.8	37.6	20.4	7.3	15.2	25.0	39.2	8.8	23.2	5.0	11.8	5.6	15.2	44.1	42.0	0.0	10.0	3.9	5.2	33.8	20.2	3.6	15.9	9.3	10.2	127.7	27.6	75.6	19.3	31.6	46.6	34.6	21.5	69.5	6.1	14.1	33.0	26.3	16.0	9.0	4.0	5.9	19.4	4.0	6.8	21.0	21.1	34.5	17.3
GKAP1	"FKSG21, GKAP42"	ENSG00000165113	"G kinase anchoring protein 1"	Q5VSY0	9	83739425-83829516	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 50.1;testis: 199.5"	"Group enriched"	"Detected in all"	6	"Early spermatids: 1339.6;Late spermatids: 481.5;Spermatocytes: 642.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035117, HPA035118, HPA066173"	Enhanced	Supported	Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite, Cytosol"		"HPA035117: AB_2674473, HPA035118: AB_10671100, HPA066173: AB_2732740"	"unprognostic (1.91e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.66e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.18e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (9.73e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.24e-3)"	7.9	6.4	18.5	2.7	20.3	3.9	6.2	26.9	23.5	8.2	25.7	12.1	4.3	8.8	6.7	3.7	8.2	5.0	14.9	17.0	19.9	7.4	9.4	4.2	3.9	19.2	19.3	12.9	8.4	10.3	12.5	2.4	19.6	8.8	3.5	22.5	5.2	9.0	50.1	2.0	5.3	6.1	19.4	4.1	7.6	199.5	20.7	9.1	9.9	26.4	3.8	7.8	4.6	23.2	7.2	8.4	6.0	8.0	0.8	0.0	9.0	2.6	2.1	4.1	4.2	1.1	3.7	10.8	2.7	1.2	13.7	1.4	6.0	0.7	7.0	13.2	5.6	6.4	4.1	6.2	8.7	2.9	0.6	0.2	4.8	2.1	2.2	11.9	3.8	10.2	5.3	8.6	1.2	6.6	16.1	9.8	5.1	3.3	4.9	10.9	13.7	3.7	4.3	1.1	20.3	11.9	6.0	2.7	4.8	9.2	1.2	5.8	1.3	1.4	10.0	0.9	4.7	14.6	34.5	4.3	3.0	2.0	1.6	1.2	0.2	0.2	0.5	0.0	0.5	0.7	0.5	0.5	0.2	0.6	0.3	0.7	1.1	2.0	0.1	0.1	0.6	0.0	18.5	20.3	26.9	23.5	17.0	19.9	19.2	19.3	19.6	19.4	20.7	23.2	14.2	6.4	11.2	32.0	17.9	7.0	14.7	2.7	2.8	54.1	21.1	17.3	51.7	20.0	2.6	14.7	45.9	8.8	13.1	5.4	13.7	13.4	1339.6	18.4	5.4	12.6	13.1	14.3	19.7	6.6	2.9	8.6	5.1	13.6	2.5	28.9	10.0	21.3	4.1	121.1	32.6	10.8	4.1	4.4	6.2	481.5	26.4	7.7	10.6	27.2	2.3	51.1	8.2	36.2	42.0	4.9	7.4	21.4	15.0	17.5	9.0	14.3	5.4	85.2	26.3	32.0	11.0	642.9	79.4	4.2	4.5	2.9	13.7	15.4	12.2	8.9
GLIS1	FLJ36155	ENSG00000174332	"GLIS family zinc finger 1"	Q8NBF1	1	53506237-53738106	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.1;seminal vesicle: 7.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.6;Excitatory neurons: 28.0;Inhibitory neurons: 13.3;Proximal tubular cells: 4.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Region enhanced"	"Detected in some"		"cerebral cortex: 2.2;hippocampal formation: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.5;GAMG: 5.9;hTERT-RPE1: 4.7;PC-3: 7.3;U-138 MG: 5.1"	"Not detected"	"Not detected"							HPA001409	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA001409: AB_1078974"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.37e-4)"	"unprognostic (1.98e-4)"	1.0	0.1	0.5	0.4	0.5	0.0	1.2	0.2	2.2	5.1	0.0	0.3	0.3	0.9	0.5	0.8	0.8	0.6	1.0	2.2	0.0	4.3	0.0	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	8.1	0.0	0.0	0.8	7.6	0.1	2.0	0.6	0.2	0.1	0.2	0.8	2.3	0.0	0.2	0.4	0.0	0.0	2.6	4.6	0.3	0.0	0.0	0.0	0.4	2.8	3.7	0.0	2.0	4.5	1.7	1.3	0.0	0.0	0.0	0.1	2.1	5.9	0.0	0.0	0.0	0.5	0.0	1.3	0.0	1.4	0.1	1.0	0.0	0.0	2.5	0.2	2.1	2.0	4.7	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.9	0.1	1.3	0.0	0.0	3.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	2.2	2.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	1.3	0.1	6.6	0.0	0.0	4.0	1.3	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.2	0.1	0.0	0.0	28.0	0.0	0.0	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	1.0	2.9	0.3	0.0	3.6	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	1.2	0.1	0.1	0.0	4.8	0.0	0.0	0.0	0.4	0.8	1.8	2.8	0.3	1.7	0.1	0.1	0.1	0.0	0.1
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 39.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 102.2;Excitatory neurons: 97.8;Inhibitory neurons: 91.5;Oligodendrocyte precursor cells: 72.9;Rod photoreceptor cells: 148.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA031446: AB_2797222, HPA031448: AB_2673888"	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	3.4	4.6	3.6	6.1	4.7	7.5	7.0	6.8	5.8	4.8	4.1	4.7	3.6	6.0	5.7	6.5	3.8	4.0	5.3	4.6	3.3	4.5	3.9	3.8	8.3	2.5	2.9	5.0	3.0	5.3	3.7	5.6	2.7	5.1	4.9	39.1	2.7	3.8	5.2	9.4	4.5	4.7	2.9	4.4	3.8	8.2	2.8	8.6	6.2	4.4	8.8	5.4	4.2	4.1	21.5	8.8	26.7	14.6	9.1	14.2	25.0	15.0	12.5	18.6	16.2	16.2	8.3	22.1	23.4	8.9	27.1	16.2	14.3	13.5	25.4	16.8	20.7	29.1	16.5	16.5	9.0	38.7	14.7	11.2	7.5	21.1	9.3	7.3	19.7	19.6	24.9	12.9	23.7	4.8	23.7	27.8	40.2	10.9	17.4	19.1	36.7	14.9	20.6	20.9	24.3	12.7	25.3	24.1	15.6	15.4	11.5	34.9	13.9	12.8	12.5	22.3	22.4	11.7	18.1	28.6	4.8	36.8	7.7	0.0	0.6	1.2	3.0	1.4	5.5	2.6	3.0	3.6	2.1	1.8	2.8	3.2	0.1	7.4	0.7	1.6	2.6	1.5	3.6	4.7	6.8	5.8	4.6	3.3	2.5	2.9	2.7	2.9	2.8	4.1	6.8	9.6	8.3	29.7	16.7	8.9	13.7	16.2	12.0	28.3	7.6	6.7	10.0	7.2	8.5	12.9	102.2	15.1	31.6	2.9	1.9	5.9	1.7	4.9	13.6	7.9	10.7	12.8	97.8	5.2	12.1	10.5	9.2	5.4	8.2	10.7	5.7	2.1	8.3	26.9	91.5	4.4	10.2	3.9	7.7	1.1	12.5	7.1	8.8	28.1	6.8	14.2	37.0	72.9	46.0	5.3	3.3	7.9	12.2	9.6	2.3	9.7	4.0	148.1	6.6	10.5	18.9	19.8	30.1	9.4	8.9	15.7	28.3	15.0	5.5	7.7
GLOD4	"C17orf25, CGI-150, HC71"	ENSG00000167699	"Glyoxalase domain containing 4"	Q9HC38	17	757097-783390	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021623, HPA023246, HPA023248"	Enhanced		Approved	Cytosol		NA	NA		3500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"	42.5	46.8	27.4	33.5	31.0	22.5	34.5	25.4	33.3	28.4	33.4	71.3	80.5	31.6	33.6	42.9	44.9	32.6	37.3	30.6	36.4	75.7	67.7	31.5	46.9	27.8	27.9	39.9	40.5	37.6	23.2	36.7	28.8	37.8	48.3	25.6	39.5	27.3	39.8	44.3	72.7	31.9	28.3	36.8	85.3	19.4	35.3	35.2	47.4	23.0	40.0	41.5	22.4	27.5	121.1	106.8	120.9	67.1	52.0	51.5	73.8	94.4	57.6	75.0	56.7	87.4	84.0	142.9	100.2	42.8	69.7	85.5	106.6	60.1	78.0	105.4	91.2	69.0	55.7	115.5	51.6	72.1	87.5	36.2	81.9	75.5	66.0	47.7	70.4	116.9	115.1	90.4	80.2	73.9	124.1	55.3	88.7	118.8	36.3	122.7	49.0	65.9	74.5	81.2	54.8	91.8	74.8	53.6	124.6	75.3	66.6	75.2	92.2	71.0	56.8	99.9	120.4	50.3	100.0	89.1	83.6	79.5	75.9	26.1	51.8	48.7	68.1	64.1	73.2	70.0	81.0	82.2	45.9	75.4	68.9	75.7	7.1	64.0	70.4	47.2	99.1	75.9	27.4	31.0	25.4	33.3	30.6	36.4	27.8	27.9	28.8	28.3	35.3	27.5	52.2	57.7	35.2	11.4	48.5	47.9	40.4	91.1	40.5	39.6	39.2	36.3	30.9	54.3	70.4	101.2	29.2	104.5	43.2	39.3	178.1	77.3	34.0	44.0	34.3	43.8	28.9	54.7	12.7	57.4	85.9	41.5	71.4	40.8	40.4	42.1	31.1	58.8	82.3	13.5	13.6	52.0	97.6	30.1	26.5	63.3	38.8	40.8	67.6	7.5	61.7	39.8	44.3	10.1	13.2	58.7	52.0	46.6	27.5	39.4	110.5	186.1	66.8	38.7	46.0	30.3	45.8	23.5	32.9	53.6	54.8	69.1	53.3	57.2	63.7	39.3
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847288	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favorable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	34.4	35.0	26.9	43.4	27.9	43.4	27.7	21.2	27.7	31.7	35.9	46.0	43.3	30.1	24.6	37.7	45.4	30.4	41.7	29.3	26.5	46.9	38.3	32.8	41.7	24.2	26.1	24.9	35.8	60.4	31.5	33.7	22.8	40.2	43.9	41.9	43.5	37.5	44.1	33.6	40.4	37.2	22.5	39.2	44.7	20.3	26.6	45.7	40.2	37.8	43.2	36.5	26.9	22.4	43.2	47.5	76.4	47.9	66.1	52.5	73.4	80.0	59.0	59.6	50.7	66.7	75.5	69.8	74.0	74.2	49.0	47.3	96.4	67.0	53.4	114.0	59.4	72.4	57.7	47.7	37.3	117.6	129.6	50.2	52.3	56.3	41.5	57.6	77.2	65.0	122.8	58.8	65.6	69.8	96.6	64.8	91.0	65.0	35.2	123.5	59.9	86.5	73.4	64.0	93.1	47.1	86.4	80.7	37.1	83.1	90.3	123.9	86.1	41.1	46.0	186.2	50.3	49.0	73.1	145.5	29.3	57.9	85.5	10.3	14.1	7.8	9.0	12.7	8.0	6.2	6.0	8.9	9.7	9.6	6.2	5.6	28.1	7.0	20.8	10.8	6.5	8.2	26.9	27.9	21.2	27.7	29.3	26.5	24.2	26.1	22.8	22.5	26.6	22.4	28.6	38.5	47.3	35.6	29.9	19.1	18.7	17.1	19.4	36.8	30.3	23.6	42.3	28.6	37.3	31.3	29.2	28.0	31.1	54.9	66.5	24.4	11.3	58.2	36.7	28.1	46.3	45.6	43.6	19.4	31.6	23.0	26.0	43.0	31.6	27.4	26.7	53.0	32.0	45.4	37.0	41.2	18.3	39.3	23.9	10.3	24.2	35.9	21.4	32.8	54.5	25.0	28.8	28.6	35.8	29.2	38.8	16.1	26.5	29.0	38.9	54.7	73.3	42.6	19.7	24.6	36.1	21.9	24.5	23.4	24.2	35.7	26.1	28.1	38.8	21.3
GMFB	GMF	ENSG00000197045	"Glia maturation factor beta"	P60983	14	54474484-54489026	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Approved	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (7.93e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.09e-2)"	25.2	21.8	62.8	23.5	68.8	28.8	26.0	61.6	90.4	18.6	39.8	35.0	33.5	19.3	14.0	15.8	14.2	16.5	17.2	61.4	75.6	33.6	25.8	24.2	25.3	73.0	64.5	16.1	12.8	20.1	12.3	26.5	71.4	14.8	35.2	18.4	10.7	12.9	7.0	13.7	29.5	18.2	84.0	18.4	19.0	11.1	71.9	16.2	21.9	10.2	24.4	22.3	11.4	85.3	92.7	36.9	71.8	53.2	75.8	94.5	53.9	93.2	67.9	66.2	82.1	42.6	79.4	85.2	42.4	92.0	39.5	33.4	73.7	64.0	104.4	30.9	25.4	42.5	37.4	39.9	64.7	59.9	35.5	72.0	58.8	57.1	56.0	67.9	60.8	38.4	31.4	28.8	106.1	45.7	36.8	22.9	46.4	52.1	38.9	36.9	84.7	24.4	84.4	86.3	42.4	65.5	64.6	54.4	71.4	59.0	59.8	46.4	48.1	94.9	71.9	48.7	58.4	10.4	19.4	52.0	80.0	36.3	61.5	6.8	10.2	9.1	5.0	13.3	7.0	6.6	5.9	5.1	12.6	7.8	6.2	6.6	16.1	8.0	14.0	4.4	8.5	6.2	62.8	68.8	61.6	90.4	61.4	75.6	73.0	64.5	71.4	84.0	71.9	85.3	23.3	25.6	16.2	8.1	39.3	59.9	50.2	33.6	48.9	18.4	28.0	18.0	17.3	20.0	22.6	25.8	4.2	39.3	33.7	61.8	21.5	38.7	27.3	21.5	29.5	22.2	29.9	14.5	16.8	23.3	84.5	35.1	23.9	36.1	21.6	25.4	16.8	24.5	45.4	21.9	13.6	33.6	26.4	34.6	36.4	7.5	20.2	43.0	46.2	8.4	37.8	25.7	25.7	14.1	16.5	37.3	32.1	15.8	16.9	56.0	26.0	60.5	16.4	15.4	13.1	77.0	54.5	16.0	11.4	33.5	43.8	58.3	26.2	18.8	36.2	56.2
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 577.4;lymphoid tissue: 460.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	111.6	26.3	27.1	188.6	27.4	577.4	71.3	26.9	41.6	26.0	29.3	45.6	33.8	20.7	19.6	19.7	29.0	60.8	25.1	27.9	29.1	36.8	65.9	117.7	299.5	30.7	30.1	9.2	14.4	15.6	10.8	102.4	30.5	18.5	53.2	2.0	18.9	15.0	11.4	16.2	75.0	47.8	29.1	325.3	41.5	7.4	28.6	460.7	37.6	23.6	262.7	93.5	18.3	32.6	1.4	0.0	2.0	0.4	0.0	0.0	0.7	1.1	0.3	0.3	0.2	0.3	33.1	309.6	2.4	0.3	0.1	1.5	0.0	0.7	1.2	99.7	0.5	329.7	0.4	3.5	5.1	356.7	602.6	0.7	0.6	0.5	0.8	0.8	19.2	464.5	12.3	494.4	2.4	0.0	316.6	361.6	0.6	0.1	0.2	409.8	3.2	196.8	0.5	40.9	0.8	0.5	1.3	1.9	2.1	0.6	0.8	641.5	175.7	0.2	3.2	0.8	1.1	26.9	107.3	340.0	1.7	482.4	2.7	4389.0	1574.5	3622.3	720.9	1447.6	773.8	812.5	1058.2	894.4	1139.9	742.7	1044.5	858.2	5262.9	908.0	1686.2	459.6	1840.4	2617.7	27.1	27.4	26.9	41.6	27.9	29.1	30.7	30.1	30.5	29.1	28.6	32.6	304.3	28.9	97.6	0.0	211.7	18.6	4.4	0.3	2.8	0.0	4.2	9.4	3.2	11.5	17.3	0.0	0.0	3.6	273.5	0.9	0.0	1.1	11.8	0.6	2.2	176.4	0.0	119.4	0.5	0.7	4.0	18.2	9.7	0.8	238.0	0.3	272.4	11.8	467.5	0.0	0.4	0.3	2.0	523.4	343.2	30.4	1.8	409.6	74.7	1.9	409.4	0.7	423.3	0.5	0.3	0.3	0.0	0.4	216.8	1.1	0.3	4.6	8.9	0.3	46.0	4.2	26.4	8.6	3.3	1.4	14.8	5.5	370.6	2.3	1.1	4.1
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870650-155944020	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 100.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 272.7;Late spermatids: 193.6;Spermatocytes: 171.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol		No	No		50000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046630: AB_2679727"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	18.8	20.7	7.2	20.0	7.7	44.6	24.1	22.7	11.0	21.2	7.9	19.7	15.8	20.6	16.0	22.1	17.1	14.0	17.9	6.8	8.5	15.9	22.6	18.2	27.0	7.8	6.8	17.0	26.4	23.1	11.5	20.8	8.3	17.4	22.5	10.1	20.9	17.5	20.0	25.0	16.7	23.4	6.3	19.2	18.0	100.3	8.0	32.3	20.3	16.7	29.4	23.3	19.9	8.8	241.0	93.1	123.0	101.1	49.0	77.0	118.9	99.8	91.6	128.2	128.8	170.5	156.2	171.7	116.1	77.1	98.1	114.6	105.7	104.2	175.0	101.1	81.8	183.2	63.7	92.8	55.9	188.5	68.7	57.3	62.9	99.4	150.5	68.2	79.9	91.3	131.7	63.8	96.8	160.1	153.9	99.4	118.5	130.4	68.3	149.2	145.8	207.5	66.3	103.5	73.3	68.0	111.0	156.0	101.8	83.9	163.6	122.3	56.9	84.4	68.5	121.0	204.3	88.8	58.5	288.5	84.8	137.4	77.0	23.7	16.1	11.5	24.7	20.2	29.1	16.0	23.6	22.3	26.1	11.6	23.3	22.3	2.2	29.3	29.5	14.2	27.1	17.5	7.2	7.7	22.7	11.0	6.8	8.5	7.8	6.8	8.3	6.3	8.0	8.8	23.8	19.2	20.2	19.6	21.5	39.9	47.4	43.9	22.8	22.0	19.5	18.5	16.4	15.7	28.4	7.3	2.1	44.1	21.6	8.3	25.4	33.8	272.7	14.3	37.5	29.9	7.2	68.5	40.9	29.5	56.2	32.4	19.9	18.4	28.6	34.0	22.1	11.6	29.9	21.9	41.6	19.7	26.4	18.5	27.1	193.6	23.0	25.2	23.2	22.5	31.7	17.8	30.9	30.2	31.6	21.3	11.9	24.8	21.9	50.6	17.8	22.8	17.3	8.7	19.7	28.6	65.2	171.2	65.5	29.0	38.2	30.8	30.4	63.2	26.8	42.4
GNAL		ENSG00000141404	"G protein subunit alpha L"	P38405	18	11689264-11885685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 99.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 76.9;Inhibitory neurons: 119.5;Oligodendrocyte precursor cells: 58.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 99.0"	"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.4;HeLa: 27.4;U-2 OS: 13.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"basal ganglia: 164.1"	"CAB015464, HPA051160"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"CAB015464: AB_831819, HPA051160: AB_2732564"	"unprognostic (2.29e-3)"	"unprognostic (7.43e-2)"	"unprognostic (8.14e-3)"	"unprognostic (3.41e-5)"	"unprognostic (4.71e-2)"	"unprognostic (9.58e-3)"	"unprognostic (9.93e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.03e-2)"	7.7	1.5	29.2	2.9	99.0	0.8	4.1	3.5	36.7	7.3	0.0	7.1	1.5	6.6	2.2	8.0	3.9	4.6	3.5	39.6	16.7	4.0	2.0	2.7	4.9	8.3	8.9	2.9	1.8	4.8	16.3	2.8	6.8	9.3	3.6	4.1	4.7	17.0	21.7	7.2	3.2	7.5	1.9	2.9	3.1	6.5	14.4	4.3	7.8	13.1	5.5	13.2	7.0	4.8	0.7	8.7	10.3	0.7	0.8	0.2	1.2	0.1	0.4	0.7	0.0	9.2	1.6	26.4	1.6	0.1	5.7	0.4	9.7	8.1	0.0	5.6	9.0	0.2	27.4	5.2	0.1	0.3	0.6	1.2	11.9	0.0	0.2	0.4	0.0	0.3	2.4	0.3	0.3	0.3	0.3	0.8	8.4	7.2	0.2	0.2	1.4	0.2	0.6	0.3	9.4	0.2	12.3	0.6	3.0	2.3	0.2	0.3	1.5	1.1	13.2	0.5	2.6	0.5	0.3	0.1	0.5	0.3	0.3	0.6	0.0	0.1	1.3	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.5	29.2	99.0	3.5	36.7	39.6	16.7	8.3	8.9	6.8	1.9	14.4	4.8	4.3	3.2	5.9	17.0	1.1	10.6	11.6	6.6	10.2	7.2	2.4	8.9	3.6	0.0	8.0	3.7	16.7	0.5	13.8	3.2	1.9	0.4	4.2	1.7	3.6	5.7	0.0	0.0	76.9	3.0	3.5	7.2	1.5	3.8	5.7	3.2	1.8	1.9	0.9	3.3	119.5	0.6	30.5	0.8	5.2	2.7	0.9	2.3	14.2	8.4	0.0	1.1	21.6	58.8	3.7	1.2	1.9	3.0	1.7	6.8	1.5	5.0	10.4	3.9	6.6	14.5	10.9	4.3	10.5	11.5	7.5	0.5	2.9	0.3	1.4	15.0
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716097-78031811	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 556.6;Excitatory neurons: 405.6;Microglial cells: 394.4;Oligodendrocyte precursor cells: 338.3;Oligodendrocytes: 495.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 27.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 27.0"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		800000	"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: AB_2680544"	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	23.5	21.3	37.2	18.8	42.2	43.8	20.1	35.8	51.3	21.1	19.3	30.3	14.5	23.7	18.7	23.2	16.9	20.1	8.6	51.0	38.5	20.9	22.0	31.1	9.9	40.5	42.7	22.4	14.6	16.3	12.5	21.7	39.9	21.2	27.2	10.4	16.8	25.7	10.5	8.9	16.8	27.4	42.4	11.3	27.9	11.5	45.5	19.7	23.1	11.8	9.1	23.5	13.8	48.5	30.6	34.1	29.8	32.0	34.9	35.5	42.8	40.7	29.7	16.6	20.6	10.5	24.1	0.1	32.0	35.5	24.5	48.5	22.5	23.4	20.6	1.1	12.5	83.0	29.0	21.4	31.4	51.8	30.0	24.3	28.0	33.9	32.5	34.3	42.7	70.3	14.8	0.2	29.5	38.5	58.8	31.0	24.0	46.5	4.7	22.0	36.5	0.3	37.8	64.5	33.1	49.6	29.3	23.3	30.5	27.5	22.2	18.3	55.0	29.2	1.9	41.9	24.0	0.2	0.1	0.3	20.3	28.9	32.0	27.0	2.5	5.7	0.8	2.2	1.7	0.9	2.0	1.1	2.8	0.9	2.1	1.7	8.9	3.6	4.5	3.2	2.2	1.5	37.2	42.2	35.8	51.3	51.0	38.5	40.5	42.7	39.9	42.4	45.5	48.5	117.7	176.3	97.5	556.6	4.8	47.3	38.4	42.7	39.3	34.0	75.6	54.5	6.0	58.6	48.3	77.3	16.7	47.4	33.4	137.0	7.9	36.2	18.9	57.5	64.2	107.3	92.3	58.0	405.6	39.7	53.2	51.7	70.8	76.0	50.7	40.2	98.6	64.0	53.7	82.4	242.0	92.5	30.5	139.5	173.9	11.1	39.4	128.8	48.0	394.4	114.6	40.5	8.2	338.3	495.2	54.2	60.7	52.3	6.2	70.5	52.9	45.4	67.0	5.0	26.3	62.3	40.8	5.6	13.2	46.3	21.6	29.0	25.0	45.2	75.4	70.1
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	784.8	1215.3	1564.4	512.6	1524.7	887.4	578.9	1413.1	1768.3	828.5	1373.3	657.1	492.4	611.4	1253.8	883.1	742.9	672.7	1990.6	1557.3	2716.9	625.0	651.1	640.3	769.2	1710.5	1949.4	766.5	1917.7	1799.4	1153.6	884.6	1963.4	577.3	607.3	731.2	2943.9	594.4	2400.4	526.8	527.3	782.4	1598.4	606.6	587.1	357.9	1882.0	854.4	3432.2	2813.1	800.0	687.1	239.3	1483.9	215.6	897.3	1501.9	663.3	2691.8	1822.3	1200.1	1219.1	1635.0	1937.3	1201.8	2480.5	1446.7	911.9	1670.3	2314.3	1305.6	976.1	1499.0	2195.3	1540.9	401.4	784.6	984.9	1651.7	2232.7	1420.7	641.6	483.0	1566.4	1113.6	875.1	1399.1	1561.0	1669.7	1100.6	692.0	1294.6	1319.1	4131.0	1759.5	1452.8	487.9	214.0	894.4	1436.7	1287.3	1589.4	2165.5	1315.8	1818.3	3853.2	2157.6	2117.1	1354.2	1921.8	1570.0	1581.7	1343.3	2210.2	1477.0	688.5	1452.3	1314.0	993.3	1583.2	900.0	473.7	1107.1	217.9	96.7	114.2	68.9	127.3	80.0	103.2	73.4	74.8	129.2	93.6	65.8	82.6	103.4	95.6	150.3	174.9	92.7	100.9	1564.4	1524.7	1413.1	1768.3	1557.3	2716.9	1710.5	1949.4	1963.4	1598.4	1882.0	1483.9	982.6	221.2	258.8	192.0	310.8	130.4	182.0	130.0	205.5	397.8	465.6	684.4	1025.3	237.4	212.2	261.1	56.3	832.6	390.8	357.3	444.1	233.9	734.9	487.7	515.7	518.3	463.1	252.1	232.5	228.9	342.0	380.9	196.3	685.0	138.6	542.3	380.1	256.4	379.1	1886.1	439.7	327.2	181.0	380.4	405.7	1756.9	265.3	437.1	222.3	236.1	204.0	1367.2	137.0	194.5	166.6	339.9	300.0	197.1	309.7	268.1	273.7	153.6	218.0	222.0	210.4	1998.0	560.4	226.0	73.6	240.5	117.8	1211.7	301.8	860.9	304.4	316.5
GNB1L	"GY2, WDR14"	ENSG00000185838	"G protein subunit beta 1 like"	Q9BYB4	22	19783223-19854939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034627, HPA034628"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA034627: AB_10600662, HPA034628: AB_10600440"	"unprognostic (2.14e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.68e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.26e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.64e-5)"	"unprognostic (9.80e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.86e-2)"	3.5	2.2	1.4	2.8	1.8	1.7	3.5	1.0	3.7	3.8	0.6	4.0	4.1	4.1	0.4	4.9	3.9	1.0	2.7	1.8	0.8	2.6	2.8	3.1	2.3	1.3	0.7	3.5	3.9	0.4	2.2	1.4	0.9	3.4	0.3	0.3	3.3	1.3	3.7	5.9	3.7	0.6	0.6	5.3	2.7	2.4	0.9	4.0	3.0	0.6	1.3	4.2	4.2	1.3	13.5	10.2	2.9	8.9	0.9	1.7	8.0	9.1	2.5	4.4	4.1	18.3	5.2	18.1	5.8	2.1	2.1	25.5	2.0	4.3	0.6	11.7	34.0	10.9	13.6	9.1	2.7	12.6	2.9	1.4	2.0	3.9	1.5	1.0	1.7	8.1	66.6	6.8	0.8	19.3	28.1	18.1	5.0	3.9	17.1	14.6	8.1	4.1	0.4	5.4	5.9	6.4	3.5	8.8	15.5	0.5	2.3	3.2	4.2	9.8	11.8	16.1	9.3	8.8	7.8	9.6	10.6	11.1	3.4	7.3	6.0	15.9	13.2	7.9	12.7	9.4	12.6	10.0	9.8	11.9	12.1	11.0	6.1	12.0	5.9	13.3	17.0	7.5	1.4	1.8	1.0	3.7	1.8	0.8	1.3	0.7	0.9	0.6	0.9	1.3	2.4	3.2	4.4	3.6	6.9	22.0	6.3	11.8	5.2	8.5	4.7	5.5	1.6	2.8	5.7	0.0	12.5	15.2	5.2	4.6	3.9	5.6	28.3	2.9	3.3	4.6	0.0	4.0	6.7	3.3	13.8	4.3	2.0	4.1	12.7	7.8	2.2	2.8	10.3	0.0	4.1	4.6	8.2	7.3	15.5	6.5	3.4	4.6	14.2	1.9	4.9	3.0	6.2	4.5	4.3	5.9	2.6	4.9	5.4	8.8	6.3	4.9	1.9	4.7	6.6	2.8	4.4	13.8	10.2	5.1	16.2	4.7	7.9	2.7	5.2	5.3
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530183-54621521	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	4.6	3.6	2.0	7.0	3.6	8.9	4.8	2.6	2.7	4.8	3.1	4.7	3.9	4.7	3.7	5.7	4.7	4.7	7.2	2.7	2.6	4.4	3.9	5.0	7.6	3.1	3.6	3.8	5.0	5.7	2.3	5.6	3.2	3.7	6.1	3.8	4.0	4.4	7.1	5.7	4.7	7.3	2.7	6.9	5.3	2.3	3.4	8.3	8.5	7.8	8.5	6.7	3.5	5.4	20.7	49.1	9.5	20.9	10.2	8.3	15.2	9.8	8.7	13.4	9.9	43.4	16.6	26.9	21.3	18.2	15.1	18.7	34.6	14.9	19.0	15.9	16.4	30.0	34.0	17.2	7.9	42.6	26.0	10.0	7.1	31.0	17.4	5.7	13.4	16.4	19.2	27.0	14.0	36.5	25.5	11.8	29.6	13.0	26.7	27.7	23.9	27.8	10.3	28.8	17.1	8.4	39.7	24.3	11.7	20.9	30.9	11.4	20.0	22.6	22.1	21.8	18.4	19.9	25.7	35.9	12.8	34.6	27.8	23.6	14.4	15.0	16.5	12.8	15.0	15.1	14.8	13.8	11.1	16.0	10.6	11.7	19.2	21.5	15.0	10.2	9.3	12.5	2.0	3.6	2.6	2.7	2.7	2.6	3.1	3.6	3.2	2.7	3.4	5.4	9.2	12.8	18.5	14.4	15.3	1.3	3.6	3.9	9.6	10.2	6.1	3.9	8.5	8.6	11.8	3.7	12.5	7.1	14.1	7.4	3.9	9.4	0.4	8.2	17.2	9.4	3.5	12.0	14.8	8.7	6.4	7.4	10.7	9.6	10.8	10.9	7.1	4.6	4.9	8.4	14.8	4.7	8.2	9.4	4.2	0.0	5.6	9.4	0.0	14.0	12.0	3.4	25.7	16.1	23.2	9.8	3.9	3.0	10.0	4.2	6.8	5.3	7.8	9.3	6.6	8.5	7.1	1.1	7.7	6.6	2.0	5.5	11.9	9.5	7.6	3.6
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960754-42963880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 296.5;pancreas: 600.1"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 842.9"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;SCLC-21H: 9.5;T-47d: 6.1"	"Region enriched"	"Detected in some"	4	"cerebellum: 15.7"	"Low region specificity"	"Detected in many"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		390000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.9	0.9	2.3	1.3	2.5	3.8	7.1	2.8	2.4	0.8	2.0	0.7	0.2	0.8	2.2	0.6	1.3	0.5	4.7	2.2	2.2	0.9	296.5	2.0	1.0	1.1	1.0	1.9	600.1	0.2	8.4	0.4	1.1	20.3	0.3	2.2	9.8	1.2	1.8	0.9	1.6	0.5	0.9	2.9	50.8	0.7	1.9	1.8	1.9	0.4	1.2	0.8	0.7	2.1	0.4	0.3	1.4	3.9	0.4	0.1	0.2	0.3	1.6	0.6	0.9	0.0	0.1	1.3	0.1	0.3	0.7	0.4	0.2	0.2	0.2	1.6	1.2	1.0	0.9	8.5	0.0	0.9	1.8	0.3	0.0	0.3	0.1	0.9	0.0	3.0	1.2	1.5	0.2	1.8	1.6	3.0	0.1	0.4	0.4	1.4	1.3	0.8	0.6	0.2	9.5	1.3	0.1	1.3	0.6	0.4	6.1	2.8	0.3	0.7	0.7	0.4	0.8	1.0	1.0	1.1	0.1	1.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.7	0.0	0.1	2.3	2.5	2.8	2.4	2.2	2.2	1.1	1.0	1.1	0.9	1.9	2.1	0.3	0.0	2.2	5.5	2.8	0.3	5.2	0.7	0.0	1.7	10.2	14.7	5.4	24.3	0.2	1.8	0.0	0.1	1.7	0.0	3.9	0.5	0.2	1.6	0.2	2.2	0.0	77.9	18.4	0.9	0.1	0.3	0.5	0.8	0.0	2.6	24.3	842.9	0.7	1.7	18.2	0.0	6.1	28.9	0.7	0.1	0.9	1.1	0.0	11.2	0.3	0.2	0.0	7.1	4.7	0.6	0.0	2.6	0.5	17.9	0.3	3.4	4.6	0.3	0.0	0.2	0.6	0.6	0.7	0.0	0.1	0.1	3.0	0.0	0.2	1.9
GNPTG	"C16orf27, c316G12.3, CAB56184, GNPTAG"	ENSG00000090581	"N-acetylglucosamine-1-phosphate transferase subunit gamma"	Q9UJJ9	16	1351931-1364113	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 135.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004055	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		560000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"	Cytosol	"HPA004055: AB_1079006"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.07e-2)"	34.8	94.0	33.5	19.3	41.3	25.0	34.5	37.8	43.3	31.4	43.2	27.9	17.7	29.7	28.9	23.6	28.5	23.7	28.7	32.6	34.8	37.1	40.9	28.4	27.9	38.8	35.5	35.7	39.6	40.2	32.9	20.9	39.3	29.9	16.2	15.6	42.9	20.7	34.6	37.2	30.9	14.9	35.1	38.3	34.8	21.4	35.7	13.3	33.9	16.9	14.4	28.8	26.5	44.5	13.3	21.2	15.3	26.9	135.2	50.3	20.1	38.3	49.6	14.9	28.4	19.1	37.0	8.4	43.0	51.8	22.5	24.0	9.2	22.4	7.6	27.0	20.2	11.3	73.9	33.0	57.6	18.2	43.2	67.3	38.4	14.2	20.3	41.6	27.5	15.2	13.7	48.4	24.6	30.7	8.7	18.7	14.4	33.9	11.8	30.5	12.9	38.6	37.3	17.1	12.0	15.5	38.5	39.2	28.7	8.5	36.9	27.3	27.0	29.8	25.5	24.6	19.1	50.6	40.4	17.7	24.4	15.6	20.3	70.5	77.0	49.5	43.3	74.4	39.6	32.1	36.7	40.8	61.5	31.1	33.4	30.8	32.0	32.6	73.9	52.2	46.9	49.7	33.5	41.3	37.8	43.3	32.6	34.8	38.8	35.5	39.3	35.1	35.7	44.5	39.7	41.7	41.7	17.3	31.9	20.9	26.5	25.4	46.7	15.1	34.0	42.9	9.4	37.1	43.2	20.2	25.0	25.0	34.9	25.8	9.8	27.4	2.6	17.7	29.8	25.6	9.1	9.9	22.7	14.5	20.3	49.7	47.4	23.7	24.6	21.1	30.7	35.2	50.2	8.4	20.5	18.0	14.2	43.4	41.7	4.6	30.1	47.8	33.8	9.4	25.7	31.0	30.9	15.1	32.4	14.8	32.9	17.7	76.1	22.1	32.1	41.7	28.5	24.5	19.7	24.4	22.9	25.4	24.2	48.1	20.3	31.1	30.6	20.5	21.7	24.5
GOLGA8A	"CFAP286, FAP286, GM88, GOLGIN-67"	ENSG00000175265	"Golgin A8 family member A"	A7E2F4	15	34379068-34437466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 211.5;Oligodendrocyte precursor cells: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.0;HeLa: 80.1"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (4.80e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.58e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.68e-6)"	24.5	18.6	16.1	10.4	11.7	7.9	32.4	18.5	21.4	56.3	11.0	32.7	10.5	31.6	31.8	31.2	37.6	7.3	23.6	13.1	10.0	33.2	6.8	22.4	14.0	17.8	8.8	62.5	22.9	6.3	22.8	2.2	11.9	37.8	2.2	26.4	26.8	10.2	7.6	36.8	38.2	3.2	7.0	48.1	30.3	40.0	12.8	1.2	56.8	1.0	2.1	33.0	40.2	12.2	2.4	13.4	3.7	12.5	0.1	0.0	2.8	20.3	0.1	3.4	1.5	23.3	0.0	0.1	3.6	2.4	6.9	21.7	9.5	6.8	5.3	20.1	7.6	48.0	80.1	15.0	1.3	18.4	12.6	0.0	19.5	2.3	0.5	2.3	0.3	7.0	46.0	40.0	9.2	4.3	4.7	34.6	6.9	6.4	7.2	19.6	11.2	16.2	7.7	13.8	17.1	8.2	13.6	9.2	2.2	0.1	3.6	11.4	10.5	15.7	3.5	0.0	3.6	37.5	13.4	5.5	4.7	38.9	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.1	11.7	18.5	21.4	13.1	10.0	17.8	8.8	11.9	7.0	12.8	12.2	37.3	211.5	71.6	82.9	16.1	26.1	10.9	13.4	7.4	95.3	36.1	41.9	35.0	5.7	127.6	1.8	100.1	2.9	21.1	6.5	0.0	4.2	37.5	17.6	83.9	18.4	16.1	2.5	114.4	2.6	5.0	17.4	13.7	52.3	13.9	39.3	14.6	1.5	2.4	84.1	91.8	11.9	14.2	6.8	20.1	8.4	31.4	8.5	23.2	38.4	1.7	14.8	6.2	146.8	62.5	4.7	6.9	21.1	19.3	8.5	6.6	0.9	52.0	117.6	0.0	26.7	22.4	33.0	23.5	7.8	21.6	3.3	32.9	39.9	11.7	9.4
GOLGA8B		ENSG00000215252	"Golgin A8 family member B"	A8MQT2	15	34525207-34588503	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 228.4"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 14.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (2.12e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.90e-3)"	"unprognostic (9.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (2.14e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.79e-4)"	16.5	28.8	10.9	7.2	11.0	18.4	20.8	13.8	15.0	28.7	10.8	18.6	0.9	16.8	11.9	10.0	27.9	6.9	15.5	11.0	11.1	41.1	41.8	23.8	19.6	11.2	10.9	55.6	228.4	0.7	60.6	3.0	10.9	37.8	1.4	8.0	18.1	10.6	10.1	13.4	25.2	2.0	10.9	38.5	28.7	43.2	11.1	2.8	113.8	1.3	7.4	19.7	13.4	11.2	2.6	2.8	0.3	5.3	2.8	5.4	7.3	2.3	0.7	2.5	4.0	2.8	3.5	0.0	4.7	2.5	0.3	2.1	0.9	2.4	1.9	3.6	8.4	0.4	20.4	16.2	3.9	2.3	2.5	7.8	3.3	1.5	4.5	2.7	2.6	4.0	0.9	0.2	2.3	1.2	1.2	24.5	3.2	5.0	4.6	0.1	0.0	0.4	2.2	4.9	3.8	5.8	1.3	0.4	3.2	3.9	2.2	4.8	0.0	3.7	8.8	1.1	4.0	1.8	1.7	3.9	1.2	1.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	11.0	13.8	15.0	11.0	11.1	11.2	10.9	10.9	10.9	11.1	11.2	19.0	192.3	66.5	95.0	34.8	21.9	8.8	10.9	33.0	53.6	30.9	34.3	37.4	20.0	74.7	31.3	73.0	7.6	30.6	2.8	1.9	9.2	53.8	17.3	27.1	11.0	7.2	13.0	133.4	13.0	5.4	12.7	20.4	24.5	9.5	36.4	11.0	28.7	1.5	45.4	126.1	10.1	12.2	6.6	9.9	10.8	39.4	5.0	21.4	12.2	6.4	9.3	32.0	112.1	24.2	16.8	4.9	37.6	45.1	7.6	7.1	5.8	39.9	67.8	13.1	13.5	13.8	48.9	28.4	10.0	14.8	2.9	49.8	22.0	9.4	6.6
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.1"	"Cell type enhanced"	"Detected in single"		"Paneth cells: 1.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HEL: 16.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA072646			Approved	Cytosol		NA	NA		270000000	"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060779-129062406	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.1;lung: 3.2;lymphoid tissue: 8.9"	"Cell type enriched"	"Detected in some"	8	"Macrophages: 151.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 29.5;neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	14	"HEL: 85.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2600000	"Cluster 34: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.1	1.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	1.2	0.2	0.2	0.7	0.3	0.0	0.0	0.3	0.6	0.1	0.1	0.0	13.9	0.0	0.2	3.0	0.0	51.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	14.4	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	2.9	0.1	1.7	0.0	0.0	0.6	0.0	1.3	0.0	18.3	0.0	151.9	0.0	0.0	4.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.3	0.0
GPAA1	"GAA1, hGAA1"	ENSG00000197858	"Glycosylphosphatidylinositol anchor attachment 1"	O43292	8	144082590-144086216	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 275.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077224	Approved		Approved	"Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"	"Centrosome, Mitochondria"	"HPA077224: "	"unprognostic (2.53e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	47.0	75.5	35.7	21.2	37.5	48.2	46.7	39.9	43.6	52.2	62.3	46.1	35.8	56.9	18.8	51.7	45.9	25.0	72.1	35.9	35.6	61.9	69.9	42.6	23.4	41.9	37.4	49.9	66.2	47.5	37.2	20.0	40.7	50.9	13.1	11.4	60.5	40.5	71.7	47.1	46.8	18.8	40.1	48.4	55.8	40.9	38.1	18.6	60.1	28.4	12.9	43.0	42.8	47.6	67.3	117.2	26.9	84.7	60.8	51.5	92.8	68.5	66.5	55.8	57.4	49.0	108.9	36.6	94.1	73.9	26.4	82.5	17.9	67.2	8.1	60.4	59.0	58.0	53.1	36.3	58.6	28.5	83.2	56.8	61.6	56.9	39.4	45.0	46.4	61.5	42.1	125.7	54.1	237.6	55.9	26.5	27.2	79.3	275.8	38.1	34.2	176.9	48.4	46.8	45.7	63.2	88.8	112.4	51.1	14.7	73.2	79.3	31.6	51.8	88.6	29.5	77.2	70.0	57.5	24.9	91.2	34.8	72.0	35.7	64.4	59.0	84.2	78.1	57.2	37.4	41.7	66.7	59.6	40.1	40.6	57.7	14.8	69.1	91.9	107.1	40.1	76.7	35.7	37.5	39.9	43.6	35.9	35.6	41.9	37.4	40.7	40.1	38.1	47.6	41.0	38.5	40.0	13.7	46.7	28.8	54.9	84.6	37.0	60.8	74.9	59.9	42.7	55.8	58.0	44.1	64.6	123.4	72.5	100.2	25.4	125.8	5.7	30.8	30.7	37.3	56.9	48.0	12.8	89.9	152.9	57.1	56.6	37.3	64.8	45.1	42.5	74.9	86.6	55.5	14.6	52.6	79.3	53.6	25.6	10.9	40.4	41.2	72.9	6.5	57.4	98.0	98.9	15.6	20.4	76.0	91.0	37.6	85.5	58.0	155.1	90.3	46.8	73.2	59.2	50.8	50.5	194.8	109.9	55.9	22.3	109.3	38.9	66.5	85.3	48.1
GPATCH2L	"C14orf118, FLJ10033, FLJ20689"	ENSG00000089916	"G-patch domain containing 2 like"	Q9NWQ4	14	76151916-76254342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018856	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA018856: AB_1845553"	"unprognostic (5.98e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.81e-1)"	9.9	8.9	7.5	12.1	10.1	37.5	9.7	10.7	9.7	8.9	11.4	9.9	8.5	10.5	9.5	11.3	8.0	12.2	13.3	7.8	10.2	8.9	6.8	10.7	12.1	9.9	8.9	10.4	8.7	9.2	6.9	11.3	9.4	9.8	10.8	15.5	8.2	9.8	12.1	9.0	9.2	11.9	9.9	10.8	9.3	13.8	8.8	11.6	9.7	14.0	12.1	10.5	9.3	12.8	18.7	24.0	19.2	15.3	11.0	17.0	15.7	21.7	15.0	20.7	20.1	16.0	30.8	22.2	12.6	16.8	16.8	22.0	23.4	14.2	36.6	24.7	12.9	19.5	26.1	10.1	14.2	13.7	27.6	17.6	12.6	17.8	23.0	16.2	21.9	18.1	20.6	30.6	18.6	30.6	18.3	17.7	24.2	11.1	17.5	20.3	23.2	11.5	14.7	37.0	15.5	19.2	24.5	21.6	12.0	19.7	25.2	21.2	24.0	26.7	15.3	14.9	16.5	30.7	31.3	29.2	21.4	18.4	28.0	5.3	7.3	7.9	3.5	6.6	3.0	6.3	1.9	5.2	7.2	5.3	4.2	3.0	5.6	5.6	4.8	5.6	4.5	3.7	7.5	10.1	10.7	9.7	7.8	10.2	9.9	8.9	9.4	9.9	8.8	12.8	35.3	16.0	18.2	48.0	30.2	23.3	37.4	26.0	22.2	100.0	19.9	21.2	46.3	18.6	25.2	18.4	104.3	16.2	36.8	18.8	3.9	20.0	151.4	28.9	46.2	38.2	47.8	17.1	76.0	13.3	12.7	36.6	21.9	54.5	43.7	48.2	29.3	11.6	25.2	158.2	67.0	19.3	24.4	43.0	48.9	138.9	24.8	43.5	23.2	59.0	47.7	42.3	43.3	82.0	75.0	30.4	29.4	37.6	24.6	56.9	40.2	13.5	24.4	122.7	26.3	55.0	41.7	56.6	27.2	18.7	27.3	17.4	31.2	34.9	20.6	42.6
GPBP1L1	SP192	ENSG00000159592	"GC-rich promoter binding protein 1 like 1"	Q9HC44	1	45627304-45688113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028593	Approved		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites, Cytosol"	"HPA028593: AB_10602906"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.42e-3)"	"unprognostic (9.79e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.51e-1)"	"unprognostic (7.56e-3)"	"unprognostic (6.13e-2)"	28.7	26.7	25.2	31.0	29.4	49.3	40.9	27.3	28.0	35.0	26.1	57.3	54.0	35.6	37.6	45.0	36.2	30.3	41.7	23.6	27.1	47.0	66.3	39.2	39.9	27.7	28.3	30.6	39.3	41.7	25.5	34.1	28.2	35.8	61.2	27.4	42.4	36.1	46.2	47.2	56.7	36.3	26.8	36.9	42.6	57.9	27.4	54.7	48.7	54.9	49.5	35.6	36.7	32.8	41.1	24.7	42.1	44.9	48.4	47.1	57.5	31.9	52.2	44.8	56.1	25.2	44.8	56.3	40.5	43.7	46.9	42.0	46.6	47.8	56.3	64.4	33.4	73.7	28.9	39.2	66.7	74.2	65.1	34.6	102.0	35.3	99.4	60.2	57.7	71.0	63.7	48.7	51.6	22.0	66.2	65.8	60.4	54.8	27.7	43.0	55.1	41.9	51.5	40.2	51.9	34.7	52.6	76.6	83.5	81.6	35.1	86.2	49.8	32.0	33.6	35.2	48.9	47.2	46.9	41.3	34.0	60.6	34.5	24.0	21.6	40.3	21.6	27.3	22.9	16.5	20.9	21.1	23.0	14.1	22.6	22.4	22.6	26.6	30.6	13.1	26.4	21.1	25.2	29.4	27.3	28.0	23.6	27.1	27.7	28.3	28.2	26.8	27.4	32.8	43.3	60.9	24.4	54.5	45.1	64.9	41.2	28.3	59.2	23.5	51.3	33.5	46.9	41.5	34.3	60.7	35.5	26.2	47.5	96.8	50.9	33.0	23.4	38.1	32.2	38.6	38.3	62.1	48.5	38.9	33.7	25.4	44.9	47.5	59.6	24.3	37.5	81.3	25.0	37.0	49.0	67.2	32.6	49.9	51.6	17.6	20.5	46.1	23.2	70.3	41.3	18.2	45.3	50.8	93.8	51.2	57.0	21.4	36.6	62.8	75.5	58.7	33.0	32.9	19.7	22.4	42.0	78.9	75.3	71.7	67.8	45.4	47.1	27.7	68.6	78.2
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435663-240468076	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 226.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 199.8;Syncytiotrophoblasts: 102.7;Urothelial cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030571, HPA070449"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		9500000		"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322, HPA070449: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.78e-5)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	36.8	78.5	42.8	9.0	37.0	0.4	30.7	25.3	64.4	44.5	3.1	36.7	5.8	37.1	9.3	88.4	30.8	8.5	145.2	41.7	28.5	47.6	35.7	21.9	1.4	29.2	30.4	45.1	25.8	9.8	55.7	29.0	26.3	67.8	3.5	5.0	35.2	22.5	134.2	226.0	17.4	16.4	11.3	15.6	23.0	48.7	46.0	9.1	15.7	35.3	6.6	35.1	62.3	24.8	69.0	92.9	21.6	56.7	64.3	61.5	87.3	161.5	78.8	18.3	21.2	33.3	74.9	1.8	21.8	172.0	100.1	186.0	11.7	114.7	3.8	33.3	9.8	0.1	80.7	41.7	92.2	1.6	6.2	54.3	73.4	41.2	21.3	38.1	9.7	3.4	0.4	3.3	47.5	36.0	1.3	0.6	33.7	7.7	20.5	12.3	98.2	16.1	15.0	109.6	21.5	14.4	105.7	91.9	10.1	19.3	29.1	7.0	45.6	97.3	162.3	46.9	67.8	0.7	0.4	0.8	69.4	1.7	111.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	37.0	25.3	64.4	41.7	28.5	29.2	30.4	26.3	11.3	46.0	24.8	1.2	16.0	6.1	45.7	0.7	45.9	69.6	62.2	56.3	22.4	8.3	18.2	53.2	21.5	34.0	25.8	2.1	73.7	0.3	3.7	7.9	27.8	0.9	6.2	24.7	2.8	0.0	0.0	53.0	10.8	199.8	21.0	1.5	8.9	4.5	49.4	11.0	26.3	9.1	25.2	45.0	7.0	16.2	0.6	7.7	3.8	19.0	1.2	35.6	5.6	1.6	24.9	1.0	18.6	8.9	17.6	0.9	7.5	0.9	67.0	0.5	2.3	30.2	6.4	26.3	33.9	38.2	2.2	9.9	44.8	46.2	102.7	1.9	14.5	3.6	110.5
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398621-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.1;kidney: 7.3;testis: 6.1"	"Cell type enriched"	"Detected in some"	20	"Astrocytes: 3868.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 49.9;HeLa: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA040152: AB_2676863, HPA044081: AB_2678801"	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.1	1.6	10.3	0.3	18.1	0.1	0.0	6.7	9.6	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.5	1.1	8.4	12.1	7.3	1.3	3.2	0.2	18.2	13.4	0.4	0.1	0.0	1.7	0.4	20.5	0.1	0.5	0.5	0.1	0.4	0.0	0.1	0.1	0.1	5.7	0.0	0.1	6.1	23.1	0.1	1.1	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	27.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.6	0.0	1.7	0.0	0.8	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.4	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	10.3	18.1	6.7	9.6	8.4	12.1	18.2	13.4	20.5	5.7	23.1	4.9	0.0	0.0	2.7	3868.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	64.6	0.0	1.6	0.0	0.0	0.1	0.0	0.0	116.6	0.0	0.0	0.4	0.0	0.1	0.0	7.9	0.0	0.0	0.1	0.0	190.6	0.1	0.0	0.0	0.4	1.0	0.3	0.1	0.0	118.0	0.6	0.0	0.0	127.2	20.9	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.1	0.1	0.5	0.0	0.1
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 45.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 9.6;Distal enterocytes: 15.4;Endothelial cells: 11.3;Hepatocytes: 23.5;Kupffer cells: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.9;intermediate monocyte: 2.8;myeloid DC: 5.8"	"Group enriched"	"Detected in many"	19	"dendritic cells: 5.8;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;Daudi: 12.1;fHDF/TERT166: 8.6;Hep G2: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	10.6	12.6	12.7	1.5	11.7	0.2	8.4	9.0	15.9	5.4	8.1	10.8	0.6	5.8	0.3	2.2	4.3	1.2	7.1	10.0	9.6	9.7	27.9	12.1	1.9	9.9	10.2	2.4	2.1	0.4	6.1	6.3	10.5	7.2	1.4	0.9	2.9	5.0	4.3	2.8	3.6	1.8	8.4	8.5	45.3	1.5	11.6	0.9	9.7	1.3	1.0	6.1	4.7	9.2	1.1	0.4	0.3	11.5	2.7	2.6	1.1	6.7	4.4	2.1	3.7	0.2	0.3	12.1	1.1	8.6	0.1	0.6	0.1	0.0	0.2	2.6	2.1	0.0	1.4	22.8	0.4	0.1	0.7	1.5	0.0	1.3	0.0	1.6	0.6	0.2	0.1	0.1	0.5	0.8	0.0	0.4	2.2	2.4	7.9	1.1	0.0	0.0	0.2	0.0	0.1	4.5	0.0	0.5	2.5	0.8	0.2	0.1	1.6	0.4	2.8	6.9	2.1	0.0	0.0	4.4	3.8	0.2	0.2	0.0	2.9	0.0	0.0	2.8	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.4	12.7	11.7	9.0	15.9	10.0	9.6	9.9	10.2	10.5	8.4	11.6	9.2	9.6	0.0	0.0	1.0	1.2	0.5	0.0	0.5	1.8	0.0	0.5	0.5	2.8	0.0	0.0	5.5	0.0	0.0	0.0	15.4	0.0	0.1	0.0	4.4	0.1	11.3	1.2	0.0	0.8	3.1	0.6	1.5	0.5	1.0	0.0	0.4	1.1	23.5	0.6	0.0	0.5	2.8	0.0	16.9	2.7	0.7	2.8	2.9	0.0	1.9	0.6	4.4	0.0	0.5	0.1	0.8	7.4	1.2	0.1	0.8	0.2	5.6	0.0	0.4	0.0	0.7	7.2	0.5	2.7	0.1	0.3	0.0	0.0	0.1	2.0	0.1
GPN3	"ATPBD1C, MGC14560"	ENSG00000111231	"GPN-loop GTPase 3"	Q9UHW5	12	110452486-110469268	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039764, HPA047793"	Uncertain		Approved	"Nuclear speckles,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA039764: AB_2676669, HPA047793: AB_2680157"	"unprognostic (1.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.82e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (3.98e-5)"	"unprognostic (5.50e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (5.81e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.27e-1)"	25.6	18.9	10.4	16.3	11.7	15.4	24.4	12.9	12.9	15.7	11.6	15.6	8.1	17.8	15.2	16.3	18.5	13.8	34.2	10.0	11.0	31.4	32.1	16.9	22.9	12.2	11.2	23.3	19.9	29.2	11.1	21.3	12.8	22.2	13.1	23.4	24.2	18.0	47.9	11.1	10.6	19.5	13.0	16.2	15.6	41.3	10.9	18.1	21.2	51.1	18.1	17.6	13.8	14.9	42.3	65.8	43.2	42.8	47.5	30.1	57.6	57.1	34.1	62.2	50.3	59.7	24.6	81.5	38.5	31.0	46.0	37.9	54.2	50.5	83.9	46.9	50.6	47.7	33.8	50.5	33.2	75.2	42.2	32.2	31.4	61.1	39.5	34.9	45.6	67.0	82.1	17.9	44.3	28.2	69.8	142.8	53.4	58.6	64.8	23.5	59.9	62.2	39.3	37.8	34.7	34.8	57.7	39.0	49.9	55.0	66.7	87.7	25.4	51.6	38.0	51.3	66.6	24.7	68.0	85.1	38.2	68.5	60.3	41.0	54.4	79.4	30.0	71.9	32.8	46.5	32.0	34.2	51.1	47.9	40.5	26.9	27.4	28.4	75.3	62.5	30.1	41.6	10.4	11.7	12.9	12.9	10.0	11.0	12.2	11.2	12.8	13.0	10.9	14.9	23.8	25.6	34.5	3.3	24.5	29.8	49.3	57.9	15.9	18.8	28.8	32.5	43.8	20.0	36.0	33.1	14.6	62.4	26.6	3.8	107.6	30.4	111.1	24.9	24.6	20.8	8.3	26.9	4.3	21.3	74.0	25.4	8.2	21.5	31.0	18.6	18.2	38.1	94.7	21.9	5.6	9.1	40.7	19.1	17.7	22.6	19.9	33.2	16.0	14.0	39.6	25.7	19.6	3.5	6.4	22.4	11.0	23.7	20.9	55.5	5.3	72.1	34.2	33.0	26.3	31.0	35.3	187.2	77.6	20.8	25.4	46.7	19.2	22.1	13.7	40.2
GPR155	"DEP.7, DEPDC3, FLJ31819, PGR22"	ENSG00000163328	"G protein-coupled receptor 155"	Q7Z3F1	2	174431571-174487094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 83.4;stomach 1: 52.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 125.1;Excitatory neurons: 99.4;Inhibitory neurons: 131.1;Melanocytes: 152.9;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 14.6;WM-115: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036159, HPA057384"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies, Cytosol"		"HPA036159: AB_10671835, HPA057384: AB_2683424"	"unprognostic (3.91e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.11e-4)"	"unprognostic (5.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.54e-2)"	4.3	9.7	8.7	5.9	16.3	2.3	2.4	6.5	12.1	2.4	83.4	10.2	3.8	1.9	12.3	5.9	1.6	5.7	7.0	12.2	5.3	20.1	7.3	3.0	6.3	5.5	5.3	2.5	18.2	8.9	2.3	4.4	5.2	7.5	3.7	10.0	3.6	8.4	4.7	13.2	4.0	6.1	3.5	5.4	52.6	2.2	7.1	3.0	8.3	4.4	3.6	4.1	2.7	6.1	0.7	0.3	0.8	2.0	4.9	2.7	0.5	3.8	1.3	0.6	2.1	0.3	0.2	2.2	1.2	2.8	1.3	0.2	1.3	1.1	2.1	0.8	1.5	2.3	1.1	0.2	0.9	0.7	1.1	3.9	3.1	1.9	0.6	4.0	1.0	3.0	0.3	5.5	4.2	0.6	1.6	0.8	0.4	2.3	1.5	1.9	5.6	1.0	2.0	1.3	5.9	5.0	1.2	0.8	2.0	2.5	0.3	0.3	2.6	2.7	1.0	3.9	0.5	14.6	2.2	0.3	3.0	0.6	9.9	1.3	2.2	0.1	1.8	4.0	1.6	1.1	3.1	2.9	0.6	1.0	2.5	3.9	7.3	3.6	5.7	0.3	5.5	1.4	8.7	16.3	6.5	12.1	12.2	5.3	5.5	5.3	5.2	3.5	7.1	6.1	18.5	12.8	3.6	31.3	9.8	42.7	4.0	4.0	29.0	34.9	5.8	6.1	26.0	2.8	6.8	11.0	125.1	1.5	12.2	0.6	1.9	1.9	0.7	1.4	24.1	9.8	12.7	15.2	99.4	6.0	1.2	9.7	9.7	0.6	1.3	4.0	16.1	16.1	6.1	50.5	131.1	0.8	2.0	50.4	23.0	1.8	14.9	27.0	152.9	8.4	34.3	16.7	11.3	130.2	21.2	3.5	0.1	32.0	14.3	3.1	0.4	41.7	0.5	25.8	0.0	16.9	9.5	3.3	3.2	7.5	28.6	0.8	25.7	52.4	1.0	1.8
GPR173	SREB3	ENSG00000184194	"G protein-coupled receptor 173"	Q9NS66	X	53048789-53080615	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 43.4;Excitatory neurons: 19.7;Inhibitory neurons: 14.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003905			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Plasma membrane"	"HPA003905: AB_1078922"	"unprognostic (2.68e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.95e-3)"	"prognostic unfavorable (2.88e-6)"	"unprognostic (3.87e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.08e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.95e-2)"	2.2	2.7	12.6	1.4	11.7	1.0	2.0	14.5	12.5	6.6	4.6	4.2	0.6	5.5	2.1	1.0	6.4	1.4	4.0	12.3	14.2	2.9	0.4	2.6	1.0	10.9	13.6	12.0	0.8	1.1	18.4	2.1	13.3	4.0	1.1	7.0	1.3	2.3	2.4	1.7	2.1	1.9	9.3	3.3	1.9	1.5	14.5	1.5	1.8	1.0	0.4	3.2	3.6	12.0	0.0	0.0	7.8	0.8	4.1	2.4	0.3	1.4	2.7	2.0	2.3	0.8	0.1	0.2	1.9	2.6	5.9	0.8	9.5	0.0	1.7	0.9	1.3	0.6	9.3	0.3	6.0	0.5	0.2	5.8	0.0	3.0	4.1	6.6	3.2	0.2	0.0	5.4	2.9	4.6	0.2	0.1	6.2	0.4	3.5	0.2	2.6	0.7	0.4	0.4	5.8	7.9	0.0	0.8	0.0	4.7	1.2	0.2	5.7	3.4	5.0	2.6	1.1	0.2	0.7	0.8	2.5	0.0	1.8	3.3	0.1	0.2	0.4	0.1	0.2	0.2	0.2	0.1	0.0	0.4	0.2	0.2	0.6	0.8	0.2	0.3	0.1	0.0	12.6	11.7	14.5	12.5	12.3	14.2	10.9	13.6	13.3	9.3	14.5	12.0	0.5	0.0	0.0	43.4	0.2	0.3	0.4	0.6	0.0	6.6	0.1	0.3	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	5.2	1.1	3.5	0.0	19.7	0.0	0.0	1.5	0.0	0.3	0.0	7.1	1.8	0.1	0.2	6.7	14.1	0.4	0.0	0.3	0.7	0.0	3.1	0.2	1.8	11.2	0.0	3.2	0.0	49.3	42.3	0.1	0.0	4.5	0.0	0.3	0.0	0.1	0.1	3.1	0.0	2.0	2.5	0.1	0.2	0.0	0.0	0.1	0.1	2.8	0.1	0.2
GPR20		ENSG00000204882	"G protein-coupled receptor 20"	Q99678	8	141356470-141367286	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 72.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"intermediate monocyte: 2.6;non-classical monocyte: 4.3"	"Lineage enriched"	"Detected in single"	22	"monocytes: 4.3"	"Cell line enriched"	"Detected in single"	6	"EFO-21: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071337			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Cytosol	"HPA071337: "	"unprognostic (4.47e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.23e-2)"	"unprognostic (4.07e-1)"	0.8	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.4	2.0	0.0	1.4	0.4	1.9	0.7	0.6	1.5	0.7	1.1	0.0	0.0	0.6	0.2	1.5	0.0	0.0	0.0	1.2	0.2	0.1	0.2	1.2	0.1	0.9	0.3	0.0	0.2	0.8	0.3	0.4	2.1	1.8	0.0	0.2	1.7	0.1	0.0	0.0	0.5	0.4	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.2	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	72.3	0.3	16.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71753855-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 10.3;Breast myoepithelial cells: 7.5;Collecting duct cells: 12.9;Glandular and luminal cells: 8.1;monocytes: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.8;neutrophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 17.9;HL-60: 17.5;MCF7: 14.6;NTERA-2: 28.9;RPTEC TERT1: 13.6;SH-SY5Y: 10.9;T-47d: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favorable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.4	4.0	21.3	1.5	22.9	15.7	3.9	13.0	19.7	3.5	7.4	1.6	0.3	5.0	2.8	3.7	6.8	1.0	3.4	19.9	20.6	3.2	0.1	1.4	0.2	18.0	18.3	4.4	3.1	17.3	9.2	1.2	16.2	5.1	0.5	1.8	1.4	4.3	0.7	2.1	0.7	2.9	19.7	3.3	2.0	4.7	22.9	0.5	6.2	1.9	0.2	2.0	2.3	18.9	0.0	1.1	1.9	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	17.9	0.0	0.8	0.1	4.3	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	17.5	0.9	0.0	2.9	0.0	1.2	0.0	0.0	3.7	0.0	0.0	0.0	14.6	1.2	0.2	28.9	0.0	0.0	0.0	0.0	0.0	13.6	7.8	3.0	10.9	3.8	0.0	0.0	3.6	9.9	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	7.2	0.0	0.1	0.0	0.0	0.1	21.3	22.9	13.0	19.7	19.9	20.6	18.0	18.3	16.2	19.7	22.9	18.9	0.2	0.0	1.1	0.0	0.1	1.9	4.2	0.0	4.0	10.3	6.5	7.5	3.5	2.8	1.3	12.9	4.2	1.4	0.4	0.2	1.9	0.7	0.2	2.1	4.9	0.4	1.2	1.7	0.0	0.0	1.3	1.2	1.1	8.1	0.0	2.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.9	3.2	0.0	0.0	8.6	0.5	1.0	0.0	0.0	0.3	0.1	1.2	0.0	5.6	0.0	0.1	1.5	0.4	0.0	2.3	1.7	0.2	4.8	4.7	1.7	0.3	0.7	0.5	0.3	2.0
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697275	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 251.4;Kupffer cells: 173.3;Macrophages: 100.6;Microglial cells: 54.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 339.6;eosinophil: 117.9"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 339.6"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	28.2	17.1	5.2	15.1	5.2	0.9	21.5	6.1	5.8	14.0	5.6	12.0	6.5	6.7	2.7	8.2	7.8	17.0	8.3	5.0	7.6	5.0	8.5	10.9	20.0	10.6	7.9	7.3	5.4	5.3	1.4	42.7	11.4	3.2	13.1	0.6	3.6	8.8	0.8	1.0	14.6	16.3	9.9	15.6	7.8	2.7	9.7	6.9	3.7	4.6	16.7	13.3	1.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	339.6	9.7	117.9	0.0	12.9	0.4	1.5	0.4	0.1	2.0	1.2	0.1	0.3	1.1	14.3	7.0	0.3	0.6	2.8	5.2	5.2	6.1	5.8	5.0	7.6	10.6	7.9	11.4	9.9	9.7	18.8	0.9	0.0	2.8	1.0	2.0	0.6	0.2	0.0	0.0	0.0	0.5	2.3	1.2	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.1	0.1	5.0	1.2	0.4	0.7	0.0	1.6	1.0	0.5	0.0	37.3	0.0	2.9	0.8	251.4	0.0	0.9	0.0	0.0	173.3	13.6	1.9	0.9	100.6	1.8	54.4	7.1	0.1	1.0	3.5	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.1	0.0	0.8	19.7	0.6	0.3	0.0	0.2	0.4	1.0	2.5	7.2	0.1	0.1	0.0
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124743885-124765792	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 109.5;retina: 39.0"	"Group enriched"	"Detected in many"	8	"Muller glia cells: 616.6;Oligodendrocytes: 324.9"	"Group enriched"	"Detected in many"	4	"glioma: 19.2;liver cancer: 5.7;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 7.5;fHDF/TERT166: 17.7;hTCEpi: 7.7;SK-BR-3: 6.8;SuSa: 8.0;TIME: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		900000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	0.5	0.1	28.3	0.1	65.3	0.0	0.5	53.8	43.4	0.3	5.2	0.6	0.0	1.6	0.2	3.7	0.6	0.2	0.1	31.2	40.4	0.3	10.0	0.2	0.1	62.8	56.3	0.0	1.5	0.1	0.2	5.1	62.5	0.5	0.3	39.0	0.9	0.5	0.6	2.3	0.6	1.2	45.2	2.1	1.3	10.6	47.8	0.0	0.0	0.1	0.0	1.4	0.6	109.5	0.1	1.4	7.5	0.0	0.0	0.0	2.1	0.5	1.9	1.9	0.4	0.3	0.7	0.0	0.0	17.7	0.2	0.1	2.2	0.0	0.4	0.3	1.0	0.1	4.4	0.0	2.2	0.0	0.3	0.0	7.7	0.0	0.1	0.0	3.6	0.0	0.0	3.4	0.0	0.4	0.0	0.0	1.1	0.0	3.5	0.0	0.0	0.0	0.0	0.1	1.7	2.7	0.0	6.8	2.6	8.0	1.7	0.0	12.7	1.5	0.6	0.0	0.0	1.1	0.0	0.0	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	65.3	53.8	43.4	31.2	40.4	62.8	56.3	62.5	45.2	47.8	109.5	0.1	0.0	0.0	5.9	0.0	4.6	0.5	4.4	6.8	55.8	4.6	3.0	0.6	7.2	1.8	1.8	6.2	10.1	0.0	0.1	0.0	5.1	0.4	2.0	0.4	0.7	0.0	0.0	6.0	0.6	19.7	1.9	0.0	3.4	0.0	0.3	0.4	22.4	1.2	18.5	1.1	1.1	2.0	0.3	0.7	1.7	2.8	0.2	3.6	1.0	0.6	616.6	0.0	1.5	324.9	0.4	0.2	0.7	0.0	3.2	0.0	0.0	1.4	22.5	0.0	4.8	0.7	0.6	2.2	4.6	10.2	3.0	0.5	0.1	0.0	0.4
GPR65	"hTDAG8, TDAG8"	ENSG00000140030	"G protein-coupled receptor 65"	Q8IYL9	14	88005135-88014811	"G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.6;lymphoid tissue: 9.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 256.1;granulocytes: 317.8;Kupffer cells: 112.5;monocytes: 90.9;NK-cells: 319.3;T-cells: 192.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;HEL: 6.2;HL-60: 7.5;HMC-1: 9.0;RH-30: 11.5"	"Not detected"	"Not detected"							"HPA072624, HPA077397"	Enhanced		Approved	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Nucleoli, Cytosol"	"HPA072624: , HPA077397: "	"unprognostic (8.56e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.80e-1)"	2.0	1.1	0.5	9.1	0.6	12.6	0.9	0.5	0.8	1.1	0.6	1.2	1.6	0.7	0.4	0.9	0.7	2.8	0.6	0.4	1.0	0.8	2.7	4.3	8.8	1.9	1.0	0.3	0.4	0.4	0.4	1.7	1.6	0.8	1.5	0.1	0.7	0.5	0.2	0.3	2.4	2.3	1.0	9.6	1.6	0.6	1.2	4.2	0.4	0.5	6.6	3.4	0.5	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.2	7.5	9.0	0.3	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	39.0	19.8	43.6	33.8	28.4	62.4	9.3	16.9	26.2	13.0	8.1	8.6	19.4	15.2	49.1	32.1	5.9	9.0	24.5	0.5	0.6	0.5	0.8	0.4	1.0	1.9	1.0	1.6	1.0	1.2	2.3	2.9	3.2	21.6	0.3	77.8	4.2	0.5	0.0	0.0	0.2	1.9	3.2	0.4	7.2	1.3	0.0	0.0	0.2	256.1	0.5	0.0	0.0	9.1	0.2	0.4	2.1	0.0	6.6	0.0	0.0	0.3	2.3	6.6	0.5	317.8	0.0	3.9	1.4	62.8	0.0	0.0	0.6	0.0	112.5	73.1	1.4	0.6	88.6	3.6	4.7	90.9	0.0	319.3	0.0	0.1	0.0	0.0	0.0	25.6	0.2	0.1	0.3	0.7	0.2	0.0	0.9	2.0	0.1	0.1	0.7	5.3	0.4	192.8	0.9	0.4	0.2
GPRASP2	"FLJ37327, GASP2"	ENSG00000158301	"G protein-coupled receptor associated sorting protein 2"	Q96D09	X	102712176-102717733	"Disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.6;Cardiomyocytes: 16.4;Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017438	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA017438: AB_1849504"	"unprognostic (8.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.14e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.71e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (4.60e-6)"	"unprognostic (1.19e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (6.63e-5)"	5.1	15.0	19.1	2.1	18.9	0.4	7.8	10.6	22.3	13.6	6.7	7.5	1.7	17.7	9.0	4.2	10.7	5.1	14.5	18.6	31.4	10.2	6.8	5.0	1.8	13.8	15.0	30.1	9.3	14.9	20.0	3.7	15.8	12.5	3.1	12.7	9.2	11.8	7.5	5.8	3.2	10.3	12.8	4.2	4.0	4.7	24.8	4.5	15.2	6.5	1.7	6.4	6.5	13.4	0.6	6.8	17.8	13.8	5.5	6.5	1.3	10.3	9.3	8.7	16.9	2.3	3.1	0.0	3.5	10.8	4.3	2.4	21.5	5.6	11.0	0.0	8.3	0.9	2.0	0.5	4.0	1.7	1.2	6.9	5.8	9.7	0.4	10.1	6.2	1.7	2.7	0.7	10.6	3.2	4.9	0.7	8.9	2.2	9.3	6.4	2.9	0.0	5.4	2.5	3.9	12.2	10.4	2.0	1.5	5.4	5.7	3.6	5.6	6.1	12.9	12.5	9.9	0.3	0.4	0.0	8.2	1.1	3.5	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.4	0.2	0.1	1.4	0.6	0.0	0.8	0.0	0.5	0.5	0.4	19.1	18.9	10.6	22.3	18.6	31.4	13.8	15.0	15.8	12.8	24.8	13.4	4.3	0.0	1.5	0.0	0.5	2.3	5.1	2.1	4.0	19.6	3.5	4.1	16.4	7.2	3.6	5.5	2.1	6.2	0.3	0.6	9.8	1.6	0.5	0.7	4.1	4.3	3.0	0.0	0.0	0.9	0.5	6.6	0.0	0.6	0.0	13.2	8.2	7.3	0.9	16.8	0.0	1.4	2.0	0.6	0.8	1.1	12.2	0.6	0.0	0.0	0.5	12.2	0.0	0.0	0.0	1.1	1.8	12.4	0.0	3.2	0.3	10.8	0.8	6.8	6.6	8.9	4.9	13.4	9.1	2.4	3.0	2.2	0.7	8.0	1.1	1.5
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 497.7;intestine: 453.8;liver: 634.0;stomach 1: 374.6;urinary bladder: 350.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 386.1;Distal enterocytes: 436.6;Gastric mucus-secreting cells: 912.3;Hepatocytes: 753.4;Intestinal goblet cells: 438.6;Paneth cells: 463.0;Undifferentiated cells: 776.8;Urothelial cells: 1062.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 493.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 4748.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.2"	"Low region specificity"	"Detected in some"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	1.9	0.2	0.1	53.8	0.3	0.3	5.3	0.5	0.3	23.5	0.1	333.5	96.7	0.7	1.7	187.7	4.9	497.7	0.3	0.2	0.5	30.6	634.0	2.6	0.1	0.4	0.2	0.2	24.5	0.0	1.2	0.2	0.4	43.3	453.8	0.0	71.8	24.9	0.3	25.4	175.7	9.7	0.1	0.6	374.6	2.5	0.3	3.3	0.5	0.0	1.2	350.5	108.2	0.7	0.0	1152.6	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	36.9	9.6	0.0	6.0	0.0	1.9	303.7	0.6	4.8	0.0	0.2	0.1	0.1	1.1	1048.6	0.0	0.1	0.4	0.0	9.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	5.6	0.6	0.3	1.3	4748.8	0.2	0.5	0.2	0.2	0.1	727.5	324.2	0.2	0.1	13.4	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.2	0.5	0.4	0.2	0.4	0.1	0.3	0.7	0.1	0.0	0.0	0.3	6.9	9.9	169.4	104.5	42.1	0.2	0.6	4.1	0.4	386.1	17.1	23.9	0.0	0.1	0.0	436.6	11.7	272.8	13.8	3.8	0.5	3.5	115.2	50.8	0.2	260.6	0.1	2.1	912.3	2.8	13.4	0.1	17.5	753.4	0.0	0.0	0.2	438.6	36.7	26.1	0.8	66.6	0.9	3.5	0.0	1.9	3.2	0.0	0.0	0.0	0.4	163.7	463.0	0.0	2.4	100.7	68.1	31.4	9.0	0.7	0.0	0.0	3.6	0.4	0.0	315.5	9.7	0.0	5.9	0.1	776.8	1062.0
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160167-55167297	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 62.7;Extravillous trophoblasts: 218.9;Fibroblasts: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 254.4;fHDF/TERT166: 246.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036720	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA036720: AB_2675269"	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (5.13e-9)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	13.3	6.1	1.2	12.5	1.2	0.1	12.6	1.2	1.6	37.1	6.9	7.3	2.9	21.1	21.9	6.2	14.3	17.0	11.2	1.0	1.7	6.5	2.2	6.9	3.8	1.5	1.1	27.3	4.6	9.3	2.4	39.7	1.4	10.2	8.4	1.3	7.2	15.8	1.5	5.0	4.1	27.2	1.5	4.0	5.6	5.6	1.2	1.3	22.3	6.3	3.0	17.8	9.8	3.6	37.2	39.0	75.3	77.0	180.7	223.9	36.6	179.8	254.4	97.0	192.7	3.2	82.1	0.0	199.0	246.4	86.5	28.2	46.0	51.5	131.5	0.5	17.3	2.1	49.1	6.9	64.4	0.0	0.0	157.5	60.8	68.3	35.5	126.5	122.7	0.0	1.1	0.1	137.4	14.4	0.0	0.0	32.6	1.0	42.8	0.1	40.2	0.0	65.9	1.3	0.1	1.4	56.6	4.6	68.0	80.8	56.6	3.4	102.7	63.6	65.6	84.5	102.3	0.1	0.5	0.5	103.0	0.1	118.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.2	1.6	1.0	1.7	1.5	1.1	1.4	1.5	1.2	3.6	10.9	0.0	1.1	0.3	0.3	7.1	6.0	38.3	9.1	0.2	8.9	6.1	4.3	0.0	33.3	25.8	0.0	49.5	0.2	0.5	5.9	13.7	0.4	6.5	62.7	18.6	0.0	0.0	0.1	38.8	218.9	76.6	2.6	4.9	4.5	30.9	19.2	0.2	10.2	0.0	0.1	4.7	4.1	0.0	6.9	0.6	51.3	1.1	24.9	5.6	1.1	7.9	0.0	0.0	0.1	15.8	0.3	39.9	1.4	2.6	0.1	0.5	36.5	0.3	13.1	20.1	38.2	0.1	0.4	3.1	6.1	13.3	1.8	29.9	0.9	2.4
GRAMD1A	"FLJ90346, KIAA1533"	ENSG00000089351	"GRAM domain containing 1A"	Q96CP6	19	34994784-35026471	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008852, HPA012570"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Cytosol	"HPA008852: AB_1079203, HPA012570: AB_2112577"	"unprognostic (3.09e-2)"	"unprognostic (4.62e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.95e-12)"	"unprognostic (2.04e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.36e-2)"	37.9	36.9	17.8	28.0	15.9	23.9	31.1	16.4	24.5	33.2	17.5	30.1	15.1	32.5	5.3	11.6	36.2	16.5	30.3	17.4	18.5	27.4	21.2	58.1	28.8	21.8	20.7	38.4	80.8	17.8	29.2	16.8	21.5	32.6	8.4	5.1	55.6	17.0	47.8	14.5	23.3	18.9	18.2	42.1	35.8	16.6	21.5	18.7	25.4	18.9	12.8	35.7	20.1	17.1	17.3	106.0	21.3	41.5	23.9	27.5	19.6	21.6	27.5	21.8	21.6	39.8	11.9	10.8	41.2	25.2	19.3	9.5	22.2	31.9	8.2	48.9	47.3	24.6	25.5	36.8	48.3	21.7	41.1	46.5	19.9	16.1	26.7	36.6	71.5	54.1	31.8	5.7	16.0	13.2	46.5	23.6	38.6	28.4	12.7	47.1	6.9	10.7	24.8	2.5	30.8	64.4	20.0	12.7	33.7	18.4	19.4	20.6	38.9	34.9	22.3	8.0	29.6	8.8	26.3	22.4	23.5	19.6	27.0	23.1	5.7	5.4	3.5	9.6	7.3	0.6	4.6	2.7	5.1	1.2	3.5	5.4	12.7	5.7	19.9	1.7	4.1	3.8	17.8	15.9	16.4	24.5	17.4	18.5	21.8	20.7	21.5	18.2	21.5	17.1	51.0	22.4	37.3	28.1	23.6	20.8	64.4	15.1	18.2	15.8	22.0	18.7	12.3	0.0	16.1	16.5	16.7	13.1	32.3	3.5	3.9	36.8	1.4	15.3	19.9	63.2	39.4	20.4	8.9	57.8	35.8	25.6	10.7	16.5	9.5	39.5	66.4	5.6	53.8	8.4	12.1	15.0	14.2	39.4	81.6	3.0	25.7	37.7	33.8	15.0	146.0	23.1	19.6	12.5	15.1	41.2	9.6	25.2	40.4	68.6	1.4	15.1	11.5	14.9	13.1	15.4	26.0	1.2	5.7	3.4	15.3	33.1	48.1	50.6	19.7	51.9
GRAMD2A	GRAMD2	ENSG00000175318	"GRAM domain containing 2A"	Q8IUY3	15	72159806-72197787	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 35.9;placenta: 48.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 70.5;Cytotrophoblasts: 106.2;Extravillous trophoblasts: 29.5;Syncytiotrophoblasts: 147.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 165.5;SK-BR-3: 75.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029435	Uncertain		Approved	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nuclear speckles"	Cytosol	"HPA029435: AB_10601811"	"unprognostic (5.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (7.29e-2)"	0.0	0.0	2.1	0.5	1.7	0.0	10.2	2.0	1.3	1.9	2.1	1.2	1.0	0.4	35.9	1.1	5.8	0.3	0.1	2.2	3.9	3.2	0.0	15.0	0.4	6.5	13.1	0.1	0.5	0.1	0.7	48.7	10.1	1.3	0.8	0.9	2.1	5.2	0.0	2.5	3.3	0.2	2.6	0.2	0.8	0.4	3.0	0.2	8.9	0.0	0.4	0.3	0.7	2.0	2.1	0.0	0.1	0.0	0.0	0.0	165.5	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.6	0.0	0.0	1.2	0.0	10.0	0.2	0.0	0.2	0.3	0.1	0.0	1.2	0.0	0.0	0.1	2.1	0.0	7.5	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.5	0.6	0.0	0.1	0.0	0.1	0.2	0.1	1.7	0.1	0.3	75.8	0.1	5.5	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.7	2.0	1.3	2.2	3.9	6.5	13.1	10.1	2.6	3.0	2.0	0.1	70.5	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.3	0.0	0.0	7.4	3.7	0.0	106.2	0.1	0.0	0.0	0.1	0.0	14.0	0.2	0.2	0.0	0.0	0.0	0.0	29.5	0.8	0.0	0.7	1.3	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	10.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	147.1	0.3	0.1	0.0	0.0
GRAMD2B	"FLJ21313, GRAMD3, NS3TP2"	ENSG00000155324	"GRAM domain containing 2B"	Q96HH9	5	126360132-126496494	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 73.2;Club cells: 45.8;Endometrial ciliated cells: 51.8;Endometrial stromal cells: 49.0;Extravillous trophoblasts: 46.5;Glandular and luminal cells: 153.2;Respiratory ciliated cells: 48.8;Syncytiotrophoblasts: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.9;MAIT T-cell: 2.8;memory CD4 T-cell: 1.6;memory CD8 T-cell: 2.3;myeloid DC: 1.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 1.8;NK-cell: 1.1;plasmacytoid DC: 4.3;T-reg: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.3;NK-cells: 1.1;T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 114.1;CAPAN-2: 73.6;fHDF/TERT166: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009678, HPA010095"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA009678: AB_2112580, HPA010095: AB_1849952"	"unprognostic (2.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.90e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.12e-2)"	12.8	16.0	56.5	6.9	57.1	1.6	38.7	54.1	55.1	32.2	47.7	28.6	29.6	29.4	15.5	8.9	34.3	10.9	11.7	49.4	54.6	32.9	24.4	11.3	7.4	61.3	64.7	30.3	8.9	8.7	10.0	24.7	55.2	16.9	29.8	6.6	23.1	23.7	3.8	27.3	36.0	22.1	64.9	6.1	16.4	4.1	54.0	13.2	40.4	5.6	11.2	13.8	16.3	60.5	66.1	3.7	3.0	14.6	62.4	21.5	19.4	71.2	114.1	28.7	37.2	2.6	73.6	0.0	26.4	75.4	0.7	17.5	0.9	27.6	30.9	6.1	4.8	3.1	8.2	3.9	14.2	0.0	2.3	34.6	10.4	29.2	9.4	36.4	0.2	0.0	0.0	0.0	50.7	6.7	0.0	0.9	3.1	13.7	4.6	1.3	17.6	14.3	38.8	69.1	1.1	0.1	11.9	6.0	21.2	12.8	22.9	4.2	6.6	6.6	2.1	11.6	12.7	3.9	3.5	0.1	1.4	0.0	19.2	0.2	0.4	0.0	2.9	0.4	2.8	0.5	1.6	2.3	1.7	0.2	3.0	1.8	0.3	1.1	0.3	4.3	2.4	1.2	56.5	57.1	54.1	55.1	49.4	54.6	61.3	64.7	55.2	64.9	54.0	60.5	10.2	16.0	17.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	25.5	73.2	0.0	0.0	45.8	40.5	0.0	32.3	10.0	0.0	23.5	14.1	0.0	51.8	49.0	3.2	0.0	0.0	0.0	8.7	46.5	8.7	0.0	153.2	3.8	4.9	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	2.8	0.0	0.0	18.3	48.8	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	58.6	4.7	2.8	0.0	0.0
GRB14		ENSG00000115290	"Growth factor receptor bound protein 14"	Q14449	2	164492417-164621482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.6;tongue: 20.3"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 92.0;Granulosa cells: 272.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.5"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.5;HUVEC TERT2: 9.6;RPTEC TERT1: 9.1;TIME: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022294, HPA035052, HPA035053"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022294: , HPA035052: , HPA035053: AB_2674432"	"unprognostic (2.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.47e-2)"	"unprognostic (8.33e-5)"	"unprognostic (5.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (9.27e-2)"	0.7	3.0	0.0	0.3	0.4	0.0	0.3	0.0	0.6	0.1	0.1	0.9	0.9	0.2	5.4	1.2	0.1	0.1	2.7	1.3	0.1	6.6	12.6	0.4	0.0	0.3	0.2	2.0	4.7	0.0	0.3	1.7	0.0	0.3	0.3	0.4	0.3	0.3	2.4	0.2	0.2	0.4	0.0	0.2	0.2	2.6	0.3	0.0	0.9	20.3	0.0	0.0	0.1	0.0	0.8	5.5	0.3	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.5	0.0	2.9	0.0	0.9	0.3	0.8	1.2	0.3	0.0	4.1	0.0	0.3	1.3	0.1	0.0	0.0	0.3	0.8	1.8	0.0	1.6	9.6	0.0	0.0	0.0	1.5	2.1	0.0	0.0	1.9	0.2	1.2	0.0	0.0	0.1	9.1	0.4	3.1	0.3	0.0	0.3	0.0	1.1	0.7	0.0	11.8	0.1	1.2	0.0	0.1	0.4	0.1	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.6	1.3	0.1	0.3	0.2	0.0	0.0	0.3	0.0	4.5	0.0	5.4	0.7	0.1	0.1	0.3	0.0	0.0	1.3	1.6	1.4	17.7	22.8	0.0	16.5	0.0	0.2	1.3	0.3	92.0	13.5	1.5	0.6	0.2	3.0	0.0	0.0	24.5	3.3	0.2	2.4	0.0	1.9	0.0	272.4	1.1	40.4	0.0	0.0	6.2	2.6	0.0	1.0	0.3	4.4	9.3	3.2	19.6	1.9	1.0	0.3	0.0	3.5	2.3	4.0	0.0	17.3	0.0	0.8	0.3	14.7	0.0	0.8	13.1	0.8	10.9	0.7	6.4	0.1	0.0	0.1	0.2	30.4	1.6	0.2
GREB1	KIAA0575	ENSG00000196208	"Growth regulating estrogen receptor binding 1"	Q4ZG55	2	11482341-11642788	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"ovary: 278.3"	"Cell type enriched"	"Detected in many"	9	"Granulosa cells: 545.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.3;Hep G2: 39.6;MCF7: 61.8;SH-SY5Y: 40.5;SK-MEL-30: 30.4;T-47d: 138.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024616, HPA027843, HPA028416"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Mitochondria, Cytosol"		"HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344"	"unprognostic (1.52e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.80e-2)"	1.8	3.4	8.5	0.7	9.6	0.4	13.7	2.1	9.9	60.2	0.8	1.0	0.7	61.3	7.0	0.6	53.4	2.8	4.6	7.8	20.4	1.8	3.1	1.4	0.6	8.7	8.5	278.3	7.6	0.7	8.9	3.0	4.4	63.4	0.2	1.5	1.1	3.8	4.0	2.7	0.9	12.8	3.2	0.2	3.0	14.9	10.7	0.3	0.6	4.8	0.3	1.7	21.5	6.5	0.1	1.0	40.3	0.5	0.2	0.2	1.8	0.0	0.1	0.1	0.3	0.3	0.2	2.5	0.3	0.0	6.9	0.2	3.1	0.2	0.1	5.1	3.6	0.4	0.3	39.6	0.5	0.3	2.1	0.5	2.2	0.6	0.4	0.4	0.0	3.9	0.5	1.0	0.3	61.8	1.2	2.0	13.0	0.1	0.1	29.1	0.0	1.9	0.1	0.0	11.8	40.5	0.9	1.1	30.4	5.2	138.0	0.7	0.0	4.1	2.0	0.4	0.1	6.0	4.4	24.7	6.8	11.9	1.2	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.1	0.1	0.0	8.5	9.6	2.1	9.9	7.8	20.4	8.7	8.5	4.4	3.2	10.7	6.5	0.4	0.0	0.5	20.2	0.7	0.8	1.9	0.0	0.6	4.8	24.7	13.7	8.3	5.7	0.6	0.0	2.1	0.2	0.1	0.1	0.0	0.3	0.8	35.7	36.0	1.3	0.0	0.0	15.0	0.2	3.6	16.9	0.0	23.4	3.8	545.2	0.7	8.9	3.2	3.3	46.9	0.0	0.0	0.0	1.2	2.5	20.2	1.4	5.4	1.0	0.0	0.2	0.0	11.6	20.9	0.4	0.0	55.3	5.0	14.3	0.0	2.5	2.9	0.5	0.0	7.2	14.8	1.1	2.9	0.3	0.3	0.3	1.1	33.1	0.0	2.5
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 652.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 864.6;Proximal tubular cells: 817.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	58.9	143.1	72.6	35.5	83.9	40.5	55.7	84.1	74.3	53.0	76.1	60.5	63.5	58.5	62.6	62.5	51.0	36.6	107.6	69.7	76.4	156.5	652.5	42.9	55.8	76.3	76.2	63.4	64.2	49.1	35.7	35.2	77.6	50.7	35.4	20.8	74.8	46.4	168.5	64.2	51.4	42.8	75.9	41.7	60.7	37.9	78.4	34.7	43.4	146.4	51.5	52.9	51.8	89.4	111.7	157.7	87.5	81.0	80.1	86.4	87.7	86.2	114.3	115.8	125.2	60.3	47.2	106.5	50.0	105.3	85.8	49.3	51.7	113.5	69.3	140.3	62.8	61.6	144.1	107.5	124.3	58.7	61.6	104.2	97.2	67.6	87.4	98.0	102.2	67.5	116.1	42.9	104.2	85.3	58.9	60.8	53.5	101.1	67.5	55.4	62.1	59.1	155.9	63.0	36.3	64.3	74.4	143.8	84.1	79.1	80.1	75.7	109.7	63.5	100.4	44.0	76.9	33.1	27.4	70.8	90.8	33.5	95.7	45.0	64.7	33.9	39.3	66.9	32.7	61.6	40.8	44.6	70.3	65.6	39.6	33.9	14.5	64.5	56.7	63.4	57.8	52.0	72.6	83.9	84.1	74.3	69.7	76.4	76.3	76.2	77.6	75.9	78.4	89.4	50.7	57.7	30.2	24.2	37.5	43.3	52.5	87.3	41.5	39.0	53.7	65.7	103.7	177.3	53.8	51.5	20.9	152.6	33.9	65.3	248.4	78.0	14.9	38.4	65.4	47.9	62.2	54.7	10.3	89.0	93.0	67.7	52.0	44.8	50.1	93.3	67.5	864.6	110.8	23.5	11.0	79.7	71.2	82.9	45.8	16.0	74.6	49.2	80.0	14.0	71.1	102.8	33.0	16.1	44.9	73.8	56.9	98.6	30.1	46.4	135.6	817.7	36.0	29.1	78.9	54.3	71.8	22.3	19.0	74.6	56.3	88.9	32.5	233.3	80.9	48.1
GRINA	"HNRGW, LFG1, NMDARA1, TMBIM3"	ENSG00000178719	"Glutamate ionotropic receptor NMDA type subunit associated protein 1"	Q7Z429	8	143990056-143993415	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 432.6;monocytes: 355.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036980, HPA036981"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoli fibrillar center"	Cytosol	"HPA036980: AB_10696791, HPA036981: AB_10962980"	"unprognostic (2.73e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.01e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.70e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.72e-2)"	273.1	218.3	154.1	109.0	147.4	215.1	236.4	143.9	226.4	178.9	99.4	144.9	72.1	137.8	79.7	134.2	149.0	74.5	154.8	158.9	149.8	200.8	447.1	233.9	77.7	151.6	155.6	152.7	97.2	144.4	127.7	86.2	160.5	176.0	33.2	180.7	116.7	181.7	145.4	167.1	138.1	75.1	152.1	311.3	104.6	269.4	163.1	58.5	187.4	57.4	55.2	162.1	139.3	140.2	79.3	155.9	76.4	129.5	392.6	196.9	114.5	112.5	258.9	184.4	168.7	95.5	64.3	57.9	120.2	249.7	128.6	69.8	136.8	162.3	75.5	83.1	95.9	60.2	85.9	114.5	412.0	12.7	90.7	254.2	441.0	132.7	193.3	194.5	90.1	23.9	56.1	76.8	160.7	489.5	34.7	32.6	53.4	75.8	231.2	45.4	39.9	111.4	93.2	229.1	52.3	84.8	163.5	177.9	225.8	104.1	342.2	77.6	91.8	115.4	127.1	158.0	82.1	124.3	78.3	44.6	147.4	79.0	67.6	1.8	32.0	9.7	2.5	36.4	3.5	8.3	2.5	2.9	13.3	7.1	4.5	4.1	18.6	3.3	36.1	22.9	2.3	16.0	154.1	147.4	143.9	226.4	158.9	149.8	151.6	155.6	160.5	152.1	163.1	140.2	54.5	19.2	52.7	35.3	45.4	37.2	32.5	58.7	121.3	91.1	62.7	79.4	23.2	45.8	27.9	53.3	79.2	137.2	22.6	29.1	23.5	75.0	273.8	36.8	56.1	47.7	42.1	60.0	21.3	69.1	55.8	67.7	16.8	36.1	16.4	76.2	51.4	194.5	178.4	33.7	26.6	24.3	42.7	225.1	86.7	432.6	61.5	184.3	37.4	22.5	355.1	89.9	6.2	12.5	9.3	66.0	54.5	67.7	44.4	46.7	72.9	73.6	29.4	95.8	46.0	32.4	45.6	96.0	16.9	83.2	36.9	264.2	20.8	38.7	31.4	25.5
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"	Q9C0E4	3	14489107-14556075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13.3;skeletal muscle: 35.8;tongue: 12.5"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 89.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;NTERA-2: 2.1;PC-3: 6.1;SCLC-21H: 3.4;U-2 OS: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA035673: AB_10669776"	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	1.1	1.1	3.0	0.7	2.7	0.0	1.0	0.0	6.2	1.1	0.0	0.8	0.4	1.1	0.4	2.2	0.8	1.2	13.3	0.2	3.5	2.3	0.3	0.4	0.4	2.9	5.8	3.4	0.5	0.3	1.0	3.9	2.1	0.9	1.0	0.3	0.9	0.4	35.8	2.0	1.0	1.0	1.7	1.6	4.5	0.7	9.6	0.3	0.8	12.5	0.7	1.0	1.2	1.8	0.1	0.9	0.0	0.0	0.3	0.2	0.0	0.3	3.1	0.3	1.9	1.2	0.0	0.0	0.7	0.2	0.5	0.2	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	1.5	6.1	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.3	0.0	1.0	1.1	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	6.2	0.2	3.5	2.9	5.8	2.1	1.7	9.6	1.8	2.3	0.0	0.5	2.3	0.1	0.0	0.1	0.0	1.2	14.9	0.1	1.3	8.5	0.0	0.6	0.0	14.6	0.0	0.7	0.1	0.0	0.0	3.0	2.1	1.4	0.8	4.2	0.0	3.0	0.2	0.0	2.0	2.0	4.9	0.0	0.0	1.1	0.0	0.1	0.0	89.0	0.1	0.0	0.0	0.0	5.2	4.1	0.7	0.0	2.8	0.0	0.5	0.0	0.5	0.9	0.0	0.0	2.2	0.3	0.1	0.0	0.2	0.0	21.9	19.7	4.3	14.7	0.1	0.8	0.2	0.0	0.1	0.3	1.1	0.0	0.0
GRIPAP1	"DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3"	ENSG00000068400	"GRIP1 associated protein 1"	Q4V328	X	48973720-49002264	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 212.7;Rod photoreceptor cells: 169.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000282, HPA000615"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Cytosol"		"HPA000282: AB_1079022, HPA000615: AB_1079023"	"unprognostic (3.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.93e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (3.92e-7)"	"unprognostic (4.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.63e-7)"	17.2	23.8	30.6	23.6	31.7	35.3	16.6	28.0	35.5	19.6	19.6	19.3	19.0	17.5	24.7	19.3	19.3	13.3	15.3	31.4	30.4	20.6	22.0	21.3	25.4	29.2	29.6	19.9	15.4	22.9	33.6	15.6	29.9	19.0	15.4	48.1	16.7	15.5	18.4	24.4	21.9	14.7	23.1	28.1	19.4	19.7	30.1	26.1	20.9	12.9	24.1	18.0	17.5	32.2	27.9	43.6	30.7	64.3	18.1	13.8	27.7	22.4	27.6	28.3	26.7	23.7	24.0	42.1	12.6	22.3	30.4	39.0	38.5	24.5	22.6	49.3	19.7	34.0	59.8	25.2	31.1	36.7	58.3	14.4	34.5	37.7	27.8	26.2	26.1	35.6	25.2	54.3	26.3	51.5	32.2	49.3	36.3	19.8	23.5	35.3	46.1	33.8	28.0	34.1	27.0	30.0	47.6	18.8	28.4	44.4	42.6	72.5	31.3	14.9	23.2	30.7	18.5	33.0	27.6	29.6	25.9	54.9	25.9	32.5	14.6	21.3	10.1	13.3	8.6	11.3	10.4	9.7	12.0	13.6	8.9	9.5	25.9	15.7	13.0	12.4	9.0	9.5	30.6	31.7	28.0	35.5	31.4	30.4	29.2	29.6	29.9	23.1	30.1	32.2	22.6	9.6	25.1	13.7	28.6	8.2	15.5	25.2	10.8	67.6	11.6	9.1	13.9	22.8	26.7	18.4	212.7	21.2	30.1	25.8	29.4	15.5	9.3	23.8	19.3	21.2	21.7	17.2	32.1	18.4	9.9	14.4	26.0	26.3	43.1	31.2	18.5	18.5	17.2	69.0	32.9	22.4	34.6	27.0	18.7	14.4	17.1	28.5	7.2	10.3	32.7	25.3	33.0	18.1	17.7	18.4	30.6	19.2	22.2	16.9	23.9	19.1	25.5	169.4	19.7	16.9	17.8	11.5	10.1	16.6	14.2	26.1	25.1	35.8	16.5	19.5
GRK2	"ADRBK1, BARK1"	ENSG00000173020	"G protein-coupled receptor kinase 2"	P25098	11	67266473-67286556	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 197.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.4;dendritic cells: 80.2;Hofbauer cells: 35.8;Macrophages: 37.6;Pancreatic endocrine cells: 32.4;T-cells: 31.0;Theca cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 318.0;REH: 417.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005021, CAB037248, HPA060707"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB005021: AB_562360, CAB037248: AB_1078280, HPA060707: "	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.31e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.19e-3)"	41.2	35.6	42.4	73.0	42.7	197.1	38.0	31.6	63.8	41.3	16.9	54.3	38.2	34.7	10.4	68.1	41.6	28.8	49.1	44.4	32.5	38.6	47.4	64.1	102.4	36.4	31.6	30.1	33.1	16.2	37.5	25.5	36.5	59.1	33.3	7.9	47.1	22.8	55.6	68.3	88.7	25.1	29.1	186.8	45.4	24.1	36.9	74.7	32.2	40.9	77.8	41.3	47.4	41.8	43.1	29.8	28.1	48.0	22.2	19.9	28.7	24.7	23.4	33.0	27.4	67.1	69.0	215.3	39.5	23.0	44.0	56.7	41.3	33.5	17.2	264.4	26.3	122.5	35.4	30.8	27.9	259.5	238.3	18.0	38.2	26.5	34.8	24.4	42.8	87.7	45.3	107.7	29.0	80.7	147.5	318.0	35.3	125.8	44.4	417.0	55.3	65.2	34.0	54.6	57.0	30.8	36.9	52.9	90.5	16.9	49.7	283.0	24.5	26.7	34.8	33.6	28.4	69.2	67.5	195.3	34.0	153.6	24.6	12.6	17.8	19.2	8.4	27.6	6.3	6.1	6.3	7.0	10.2	6.4	5.0	4.9	35.7	6.9	33.7	9.0	4.4	15.9	42.4	42.7	31.6	63.8	44.4	32.5	36.4	31.6	36.5	29.1	36.9	41.8	33.4	3.2	17.9	0.0	16.7	0.0	0.0	0.0	0.0	0.0	24.5	19.7	0.0	0.0	4.3	5.5	0.0	8.9	80.2	0.0	1.9	10.3	0.0	16.6	14.7	9.0	0.0	0.0	0.0	12.6	5.9	6.1	0.0	18.9	21.5	22.3	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	32.4	0.0	0.0	17.7	0.0	0.0	5.6	0.7	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	9.6	31.0	36.3	0.0	0.0
GSK3A		ENSG00000105723	"Glycogen synthase kinase 3 alpha"	P49840	19	42226225-42242625	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004422, HPA028423"	Approved		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB004422: AB_627680, HPA028423: AB_10612116"	"unprognostic (5.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.22e-3)"	30.6	43.3	37.5	22.1	44.0	30.7	29.4	33.6	90.2	34.5	13.7	39.4	40.9	38.1	21.7	40.2	31.8	18.7	45.8	47.0	30.9	39.2	30.4	30.4	23.7	39.1	30.9	34.5	29.6	34.4	32.1	19.9	37.6	33.3	21.1	32.6	31.7	25.9	79.2	42.9	37.1	23.0	20.5	31.2	35.4	30.6	38.2	32.9	29.6	42.0	22.7	37.7	33.0	49.5	57.0	102.1	54.3	53.2	30.3	29.5	25.9	42.7	36.1	49.6	46.0	39.0	39.6	41.0	39.6	33.9	44.8	25.6	49.5	51.3	38.5	33.8	74.5	41.5	41.3	42.7	42.7	51.7	54.0	27.2	45.8	41.9	47.7	44.8	46.5	34.7	73.9	63.0	41.1	80.0	87.7	39.0	42.8	84.5	40.0	58.4	33.8	30.4	43.4	76.1	63.7	67.5	52.8	71.6	36.6	42.8	39.5	69.5	40.6	52.0	40.9	31.0	71.9	65.8	82.8	38.7	66.4	49.8	58.2	0.9	0.5	1.4	0.5	0.8	0.9	0.3	0.3	0.7	0.2	0.2	0.2	0.8	1.7	0.3	0.4	0.6	0.5	0.7	37.5	44.0	33.6	90.2	47.0	30.9	39.1	30.9	37.6	20.5	38.2	49.5	45.6	6.4	16.2	5.2	16.4	24.6	17.7	7.3	14.8	40.8	35.0	39.2	12.9	17.2	7.9	16.5	62.6	23.4	31.4	42.3	3.9	15.2	8.6	19.6	21.5	26.6	23.4	28.6	15.1	17.2	25.3	21.3	16.8	25.0	2.5	27.2	18.2	13.9	20.3	60.6	14.9	29.7	6.1	21.3	15.4	14.6	17.7	25.2	16.0	8.4	14.4	41.8	21.6	11.1	12.2	24.2	24.3	16.6	12.6	29.0	45.0	16.0	5.9	47.0	6.6	50.4	27.4	16.4	19.4	20.2	28.1	44.1	20.6	42.6	28.8	30.1
GSPT1	"eRF3a, ETF3A, GST1"	ENSG00000103342	"G1 to S phase transition 1"	P15170	16	11868128-11916082	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052488, HPA074588"	Approved		Approved	Vesicles,Cytosol		NA	NA		210000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Vesicles	"HPA052488: AB_2681849, HPA074588: "	"unprognostic (4.13e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-3)"	"unprognostic (3.13e-2)"	60.8	57.5	22.3	49.5	24.7	76.3	46.0	24.4	33.3	42.0	27.4	56.0	33.8	34.5	46.6	67.9	30.1	35.2	53.4	23.9	24.5	53.6	76.3	47.7	55.4	25.0	23.1	33.3	62.2	62.7	27.5	50.0	26.2	47.8	59.6	35.3	41.0	41.8	127.0	43.5	34.3	46.9	25.0	40.2	49.8	68.7	23.1	56.3	57.7	97.8	82.0	85.7	39.6	29.3	220.1	212.9	116.1	161.0	164.2	169.3	167.5	238.0	245.9	187.1	185.4	153.1	197.8	295.7	303.9	207.5	130.1	164.3	297.8	220.3	312.9	142.4	153.6	202.0	163.1	325.5	137.9	258.7	103.5	133.5	170.0	212.0	288.3	122.4	210.4	146.2	331.7	148.7	220.0	211.2	219.8	134.0	232.9	163.0	120.1	256.4	200.5	345.6	184.7	189.3	186.4	99.6	342.0	256.3	144.2	164.3	222.4	122.6	163.3	206.8	129.5	151.5	190.3	146.6	233.2	253.8	145.4	258.1	128.5	1.4	5.8	7.7	6.3	11.1	8.8	7.9	8.1	7.7	7.0	6.5	8.2	8.1	1.9	7.2	9.9	3.8	10.5	4.3	22.3	24.7	24.4	33.3	23.9	24.5	25.0	23.1	26.2	25.0	23.1	29.3	69.4	76.9	160.2	39.5	92.3	242.2	232.0	47.1	170.8	47.7	95.0	61.6	123.4	57.2	69.1	86.5	50.1	76.1	94.5	88.1	103.7	58.9	94.9	109.0	95.6	74.4	66.6	328.5	61.6	63.4	118.3	77.2	81.1	153.9	24.7	93.2	43.5	77.9	75.2	52.2	47.0	107.2	32.6	60.8	116.3	51.6	47.8	80.9	64.0	35.6	50.1	43.6	25.7	38.7	42.9	73.0	66.9	47.4	166.2	271.0	38.3	120.3	52.7	41.5	59.2	94.6	123.0	138.3	83.5	198.5	257.7	102.1	132.1	128.1	114.1	270.4
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52840843	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"Smooth muscle cells: 23.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA						"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.2	0.4	0.0	0.0	0.0	23.6	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 479.1;liver: 609.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.8;Cardiomyocytes: 6.0;Club cells: 6.7;Hepatocytes: 5.5;Kupffer cells: 7.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Region enriched"	"Detected in all"	18	"cerebral cortex: 479.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 87.0;HeLa: 96.1;HHSteC: 78.6;hTEC/SVTERT24-B: 73.0;HUVEC TERT2: 62.4;MOLT-4: 115.4;U-266/84: 64.4"	"Low region specificity"	"Detected in all"							"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	55.5	155.7	26.1	17.4	26.4	9.7	56.9	24.9	479.1	61.5	26.9	39.1	27.9	38.1	69.6	152.3	45.8	29.4	30.5	25.9	25.8	37.3	609.6	28.2	1.8	25.5	26.3	178.4	66.8	48.7	33.5	8.7	26.1	47.0	22.4	10.2	43.8	128.6	69.3	73.5	47.3	64.3	25.0	63.6	59.5	57.0	26.6	33.5	27.7	0.0	17.9	127.0	135.2	25.3	0.3	0.6	0.3	1.3	0.0	0.0	0.5	0.0	0.3	0.2	0.4	1.0	7.0	26.9	0.1	41.6	0.0	1.3	0.1	0.6	0.7	0.1	0.4	87.0	96.1	1.7	78.6	0.0	0.7	0.1	0.1	73.0	0.3	48.1	62.4	50.1	0.0	56.8	2.5	0.0	115.4	0.7	54.6	0.1	0.0	0.4	0.6	11.1	9.0	0.1	5.3	0.7	0.0	0.3	0.5	2.6	1.1	44.5	0.2	35.5	2.0	0.9	0.1	45.1	64.4	3.7	30.7	1.1	2.0	2.2	26.1	32.2	28.8	39.1	31.0	30.8	31.4	28.5	77.8	32.5	33.1	32.6	2.0	30.1	17.4	41.1	38.9	28.5	26.1	26.4	24.9	479.1	25.9	25.8	25.5	26.3	26.1	25.0	26.6	25.3	0.3	9.6	6.8	0.0	0.2	1.8	0.6	2.0	0.0	0.1	2.7	1.9	6.0	2.8	6.7	0.0	0.0	0.0	0.8	0.4	0.0	1.2	0.0	0.9	1.9	0.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	2.5	0.0	5.0	5.5	0.1	0.0	0.0	0.3	0.0	7.1	2.2	0.4	3.7	0.5	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.6	0.1	2.2	0.0	0.1	1.9	0.0	5.1	0.0	0.0	0.3	1.4	0.5	0.4	0.0	1.6	0.0	0.8	0.0	0.2	1.8
GSTM3	GST5	ENSG00000134202	"Glutathione S-transferase mu 3"	P21266	1	109733932-109741038	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 377.9"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 802.2;Early spermatids: 2092.4;Late spermatids: 3843.4;Spermatocytes: 1177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 3.4;gdT-cell: 3.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive CD4 T-cell: 7.8;naive CD8 T-cell: 4.3;T-reg: 1.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.4;T-cells: 7.8"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 228.4;T-47d: 479.6;WM-115: 186.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017130, HPA035190, CAB040583, HPA055972"	Enhanced		Approved	Cytosol		NA	NA		790000	"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992"	"unprognostic (2.13e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.48e-2)"	38.7	39.0	56.9	11.0	61.1	3.3	83.5	50.3	69.1	52.7	109.7	45.0	46.8	32.1	243.2	53.6	35.1	47.0	74.8	56.9	63.6	188.1	20.0	23.6	6.2	54.4	54.8	120.4	101.0	41.1	33.7	21.6	55.5	47.5	19.9	21.1	22.6	165.9	65.8	57.2	27.8	58.3	57.5	14.1	76.2	377.9	61.6	13.2	57.9	51.2	7.9	57.1	53.2	58.3	0.2	6.9	49.3	0.1	64.5	39.9	8.5	54.3	9.4	58.2	56.2	21.8	1.9	0.1	30.8	27.8	40.1	2.6	10.0	22.3	80.5	0.3	14.9	50.8	152.1	33.9	69.5	0.0	115.2	40.3	27.0	87.8	0.1	63.5	73.1	61.9	4.7	0.6	26.6	30.0	14.5	1.2	5.3	0.2	93.1	0.4	31.9	2.3	16.3	117.1	86.1	46.0	112.5	228.4	10.5	14.1	479.6	75.3	57.9	0.8	20.9	59.6	36.3	7.7	13.1	0.2	0.6	0.1	186.9	0.3	0.1	3.4	3.1	0.1	0.8	0.3	3.9	2.2	0.1	0.2	7.8	4.3	0.9	0.7	0.1	0.5	1.9	1.5	56.9	61.1	50.3	69.1	56.9	63.6	54.4	54.8	55.5	57.5	61.6	58.3	22.2	6.4	11.5	18.3	7.0	143.5	97.2	104.4	50.1	17.5	196.1	176.8	88.0	50.1	35.9	222.5	6.2	16.3	8.7	17.3	802.2	88.0	2092.4	51.4	40.6	32.9	50.4	33.0	7.5	149.5	9.0	131.6	43.8	93.6	9.5	22.7	58.2	14.2	10.6	15.2	8.0	24.9	28.5	13.9	54.1	3843.4	385.5	15.1	60.5	2.8	3.5	247.5	2.1	14.6	1.7	126.4	32.5	276.1	3.4	53.7	116.9	38.9	5.4	19.2	190.7	23.8	94.4	1177.6	54.4	71.9	107.4	10.3	24.4	121.4	44.1	80.8
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656099-109674836	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 149.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 382.8;Proximal tubular cells: 109.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"eosinophil: 351.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 351.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"prognostic favorable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	22.3	31.1	19.7	15.3	23.7	5.9	22.5	19.1	23.8	24.5	40.0	45.4	149.5	22.6	24.3	31.3	22.2	17.8	33.5	19.2	19.9	45.9	41.2	14.6	11.8	20.7	20.9	42.9	21.2	57.8	18.6	7.6	20.2	25.8	38.5	12.5	21.2	41.0	92.4	20.6	99.4	25.7	21.1	30.2	28.8	15.1	20.1	9.9	27.7	45.5	15.6	36.8	28.8	20.2	13.5	6.0	10.5	78.9	23.0	35.1	13.4	4.3	34.1	9.8	12.8	43.3	1.5	12.5	16.1	19.1	19.3	13.6	27.1	14.4	6.2	18.9	0.0	27.4	23.5	38.8	37.1	9.5	31.8	22.3	14.0	12.6	0.0	27.5	8.1	31.7	12.8	18.4	6.9	12.7	8.1	41.9	8.2	56.3	31.9	16.9	5.8	18.5	38.8	9.6	7.4	17.6	0.2	68.2	54.9	7.8	18.6	20.1	3.6	11.4	44.0	12.5	6.3	27.0	51.4	1.1	37.1	13.9	32.5	11.9	14.5	351.7	12.2	14.5	7.4	17.0	9.3	14.1	37.8	14.9	8.9	10.7	1.8	12.8	3.6	12.6	14.1	12.6	19.7	23.7	19.1	23.8	19.2	19.9	20.7	20.9	20.2	21.1	20.1	20.2	6.9	9.6	2.7	11.4	9.9	18.1	27.3	17.9	18.8	6.2	14.7	19.0	30.2	21.5	9.5	31.3	0.0	21.0	13.9	53.0	101.8	45.9	3.0	4.5	10.8	8.6	7.2	4.2	3.3	57.7	18.6	22.9	13.3	5.4	21.0	13.3	14.3	35.7	35.6	5.0	3.3	45.9	6.1	17.2	26.0	6.4	30.1	14.9	40.9	2.8	14.8	23.9	17.5	5.0	3.4	35.4	38.6	24.8	13.3	6.7	382.8	109.8	7.5	5.4	32.9	15.3	23.2	7.0	7.3	23.0	15.3	8.8	11.2	12.6	96.7	26.9
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320996-77331597	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 263.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 373.2;Late spermatids: 398.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 182.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		340000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 62: Liver - Hemostasis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	13.9	34.7	11.1	9.7	12.5	9.3	23.2	13.2	16.3	12.7	10.5	21.9	22.5	10.8	22.1	26.9	14.9	11.9	14.3	10.5	12.3	24.5	263.1	7.8	13.5	12.6	11.7	6.5	20.1	26.4	13.3	11.2	12.8	21.1	21.7	5.1	24.1	9.6	47.4	22.1	15.6	7.9	12.3	12.1	18.9	57.8	11.9	14.0	19.5	37.3	17.4	11.9	13.8	14.0	18.8	39.0	27.6	19.9	17.1	23.9	45.8	11.4	11.9	21.6	30.9	13.0	45.2	43.5	14.9	13.6	13.4	24.1	18.9	22.5	20.7	23.2	21.0	20.8	13.3	26.9	26.3	7.8	15.8	22.1	24.0	12.4	20.8	12.0	18.6	24.7	17.5	37.0	14.5	182.1	12.2	16.4	8.2	64.1	30.3	20.2	29.5	34.2	32.5	24.0	30.2	26.2	26.0	49.1	35.6	15.5	81.2	11.1	13.8	17.0	52.5	18.9	8.6	28.2	32.7	35.2	41.9	11.3	20.8	13.4	15.5	9.9	2.6	22.2	2.4	8.2	4.6	3.7	20.7	10.4	3.9	3.1	1.6	5.1	20.1	15.0	7.9	7.4	11.1	12.5	13.2	16.3	10.5	12.3	12.6	11.7	12.8	12.3	11.9	14.0	6.1	6.4	9.6	6.5	13.5	13.4	19.8	26.2	15.9	7.3	36.1	34.2	13.0	47.1	19.0	9.2	4.2	91.4	7.5	34.9	46.9	45.0	125.8	19.4	15.6	11.1	28.8	30.3	2.9	68.0	62.5	15.0	33.1	27.0	3.8	25.7	15.4	373.2	44.6	16.8	3.3	45.7	20.3	38.1	10.9	398.1	11.8	19.0	17.8	3.7	30.4	26.4	4.1	2.0	9.2	41.8	37.4	6.0	13.2	19.8	72.9	77.8	15.0	11.9	0.0	12.3	13.2	51.3	29.4	38.0	14.1	76.2	6.7	55.8	50.3	30.3
GSX1	"Gsh-1, GSH1"	ENSG00000169840	"GS homeobox 1"	Q9H4S2	13	27792483-27794768	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	41	"brain: 7.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	29	"glioma: 3.9"	"Region enriched"	"Detected in some"	4	"hypothalamus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA047096			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA047096: AB_2679929"					"unprognostic (1.62e-1)"													0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.3	0.3	7.5	0.4	0.2	0.2	0.2	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GTDC1	"FLJ11753, Hmat-Xa"	ENSG00000121964	"Glycosyltransferase like domain containing 1"	Q4AE62	2	143938068-144332568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 330.7;Inhibitory neurons: 188.0;Microglial cells: 130.2;Oligodendrocyte precursor cells: 196.6;Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036694			Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA036694: AB_10671709"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-7)"	"unprognostic (8.01e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-3)"	"unprognostic (6.96e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.44e-1)"	"unprognostic (8.23e-2)"	"unprognostic (6.31e-3)"	"unprognostic (1.89e-1)"	15.2	12.6	15.9	7.5	18.0	14.2	9.4	11.7	21.1	11.8	4.2	7.1	4.2	6.7	9.4	7.4	5.8	10.1	15.7	17.3	14.3	9.6	6.7	7.8	11.0	15.4	14.7	12.0	7.2	7.4	4.2	9.5	15.4	6.1	6.7	7.7	6.1	5.8	10.0	5.1	4.8	5.9	17.2	13.5	5.2	12.2	14.3	8.7	10.5	11.3	11.6	9.5	5.5	24.1	6.9	2.8	20.0	3.7	20.1	18.4	6.0	4.7	11.9	10.3	14.2	3.1	6.3	14.8	3.3	8.5	6.6	1.9	4.0	7.1	21.9	19.2	4.7	23.0	2.6	3.3	8.3	9.4	12.0	12.8	17.1	11.1	16.2	7.0	14.9	6.1	4.2	16.8	23.7	3.2	2.5	10.3	5.7	5.3	4.5	7.0	10.4	4.0	11.4	14.0	10.2	7.9	9.1	7.7	9.3	12.4	5.1	10.5	9.2	11.4	8.3	5.1	6.0	10.6	0.0	8.5	6.6	6.2	15.6	2.3	2.6	7.9	5.5	2.4	11.8	4.3	3.6	9.3	2.1	3.5	0.8	5.9	11.3	8.5	2.7	0.7	5.1	3.6	15.9	18.0	11.7	21.1	17.3	14.3	15.4	14.7	15.4	17.2	14.3	24.1	7.7	9.6	23.2	82.3	11.2	7.1	4.4	6.4	4.0	20.4	5.2	5.0	18.5	4.3	14.9	5.5	4.2	4.1	13.6	6.1	5.9	4.5	9.9	3.3	11.4	9.6	4.2	9.4	330.7	10.5	5.2	16.0	4.6	5.6	17.7	15.5	20.3	3.8	10.2	18.5	188.0	3.2	4.1	18.3	11.8	7.7	12.8	16.4	5.4	130.2	11.6	10.8	18.6	196.6	399.6	9.4	4.0	13.9	8.6	4.2	2.6	7.7	13.4	3.9	13.1	25.2	17.0	5.4	23.5	4.9	4.7	4.2	19.7	14.8	3.7	8.7
GTPBP1	"GP-1, HSPC018"	ENSG00000100226	"GTP binding protein 1"	O00178	22	38705742-38738299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003166, HPA064702"	Approved		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		64000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA003166: AB_10601476, HPA064702: AB_2685329"	"unprognostic (1.42e-3)"	"unprognostic (5.82e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (3.17e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.98e-3)"	18.4	19.0	16.5	23.4	19.1	105.4	18.4	20.0	44.3	20.3	20.8	20.5	20.5	20.0	12.1	22.4	22.1	17.7	20.0	18.4	19.3	18.4	17.1	28.9	23.0	19.3	17.0	27.4	22.0	19.2	25.5	16.0	17.0	23.8	17.6	34.7	21.2	15.5	31.7	27.5	22.9	16.6	15.5	28.0	20.4	20.3	16.7	20.0	24.9	19.9	23.0	18.7	19.4	23.9	29.2	10.5	37.4	30.2	12.6	19.7	18.3	27.4	28.7	39.0	33.9	22.0	16.3	27.9	9.8	26.9	17.5	26.6	45.5	28.8	21.6	49.2	32.8	48.7	36.9	16.3	23.9	57.7	24.3	20.3	22.0	31.2	48.7	21.3	24.3	20.2	29.4	56.5	21.8	12.1	32.1	26.1	27.0	16.7	20.8	61.8	38.2	36.7	13.8	23.3	51.0	17.7	33.3	21.0	19.6	16.2	19.0	24.2	26.1	22.3	22.0	16.4	21.2	51.8	18.7	38.5	20.1	29.0	16.9	3.5	3.1	3.9	4.7	4.6	4.2	4.6	3.5	4.9	3.4	3.8	2.5	3.7	7.8	2.3	5.1	1.7	3.3	3.4	16.5	19.1	20.0	44.3	18.4	19.3	19.3	17.0	17.0	15.5	16.7	23.9	17.8	9.6	8.4	7.8	31.8	27.8	36.0	12.7	15.4	32.6	17.5	15.5	11.2	5.7	12.4	12.9	22.9	7.2	35.9	40.3	5.9	13.2	4.5	22.2	14.3	13.1	16.2	35.3	5.5	19.3	7.9	14.5	23.4	26.4	14.0	17.5	13.6	12.4	8.6	20.2	7.9	24.3	16.2	18.4	43.9	5.4	16.1	19.3	10.6	4.7	26.6	13.2	20.6	5.5	15.2	19.9	21.1	19.2	52.8	47.4	29.8	6.1	16.6	41.0	26.3	19.9	14.5	17.2	7.7	19.2	34.2	19.0	31.9	15.5	13.0	51.0
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807811	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.2;Ductal cells: 22.9;Glandular and luminal cells: 15.5;Proximal tubular cells: 22.2;Smooth muscle cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 7.2;non-classical monocyte: 23.9"	"Lineage enriched"	"Detected in many"	13	"monocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 46.0;Karpas-707: 23.7;MOLT-4: 29.9;RPTEC TERT1: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	13.8	7.1	23.6	15.6	30.0	2.2	10.0	5.3	36.6	12.6	0.0	28.9	5.8	16.4	6.0	8.1	13.7	13.3	18.7	30.1	28.2	13.2	7.7	16.5	10.4	9.8	13.9	5.8	10.9	50.3	6.0	43.6	22.8	13.6	8.7	34.7	5.5	12.2	5.9	3.5	11.1	25.0	6.4	11.0	13.8	2.4	14.8	7.2	7.3	14.9	7.3	10.0	11.1	17.0	0.0	0.5	6.5	0.0	2.2	11.4	0.0	2.0	3.6	0.2	0.1	0.0	0.0	0.0	3.0	1.1	5.0	0.1	13.6	0.3	0.8	0.0	4.6	46.0	0.0	0.0	1.2	0.0	0.0	5.1	0.4	0.0	0.2	4.2	0.1	10.2	0.0	23.7	3.0	2.1	29.9	0.1	0.4	0.0	3.2	3.5	0.9	0.7	42.9	4.4	0.7	7.8	0.0	0.2	0.0	6.4	0.0	0.0	0.0	7.3	1.6	12.4	9.5	0.3	0.0	0.0	15.6	0.0	0.0	1.4	0.5	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.5	1.3	23.9	1.6	0.0	5.8	23.6	30.0	5.3	36.6	30.1	28.2	9.8	13.9	22.8	6.4	14.8	17.0	20.2	6.4	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.2	0.0	0.0	0.0	9.2	0.0	1.1	1.1	0.0	5.9	22.9	0.0	3.7	4.3	3.4	0.0	0.0	0.0	4.2	0.2	5.4	0.0	15.5	1.3	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.7	0.4	0.7	0.0	0.0
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828822-2882820	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adipose tissue: 156.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7;Enteroendocrine cells: 20.4;Granulosa cells: 10.2;Hepatocytes: 20.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 39.1;CACO-2: 30.4;Hep G2: 32.6;NTERA-2: 38.4;SK-MEL-30: 87.6;SuSa: 59.0"					"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favorable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	156.3	2.2	10.3	1.9	10.8	0.2	38.9	18.4	8.8	3.0	8.5	3.9	1.5	6.6	1.0	0.9	5.1	2.2	1.4	11.2	18.9	2.0	18.5	0.5	0.6	29.4	24.5	2.5	5.4	1.0	0.8	2.1	27.3	4.0	2.8	1.4	4.7	6.6	0.3	1.9	2.1	3.7	36.0	0.3	4.5	0.9	13.7	0.4	1.7	0.5	0.3	3.7	2.0	35.4	0.1	11.5	39.1	0.2	20.5	0.0	28.5	2.0	6.3	6.1	8.2	30.4	0.6	0.0	3.1	5.2	6.6	0.0	22.5	0.5	6.8	0.2	6.3	0.1	0.7	32.6	6.7	0.0	8.9	8.1	0.4	1.0	0.0	0.2	0.0	0.0	0.3	0.1	6.6	1.9	0.0	1.0	38.4	0.4	0.2	6.1	13.0	0.0	0.0	0.1	0.0	0.7	0.1	0.3	87.6	59.0	4.1	25.4	0.0	0.0	6.7	3.8	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.3	10.8	18.4	8.8	11.2	18.9	29.4	24.5	27.3	36.0	13.7	35.4	0.3	0.0	0.0	10.7	0.2	0.4	1.1	0.5	0.0	1.2	2.1	0.8	1.2	4.3	0.2	0.0	4.2	6.0	0.0	1.2	5.9	1.0	0.4	3.8	1.0	0.3	20.4	0.0	5.9	4.0	7.9	1.6	4.6	0.7	0.0	10.2	0.0	20.2	1.1	0.0	4.9	1.7	0.0	1.0	0.0	0.5	0.6	0.1	3.6	0.0	0.0	1.6	0.0	0.5	0.1	2.1	0.6	3.0	0.0	1.0	0.4	2.4	1.1	0.1	0.0	0.3	1.2	0.3	1.5	0.0	0.3	2.3	0.0	3.2	3.5	0.7
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140751	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"bone marrow: 156.3"	"Cell type enriched"	"Detected in some"	350	"Erythroid cells: 1995.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	203	"HEL: 149.1;K-562: 37.7"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		15000000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.1	0.1	0.0	0.1	156.3	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	1995.6	2.4	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.9	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968130-48993310	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 118.5;skeletal muscle: 319.4;tongue: 201.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: AB_2677571"	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	32.4	26.3	17.9	16.2	18.8	46.0	23.7	26.4	23.3	17.1	22.2	21.7	15.3	18.8	8.9	38.2	18.7	10.1	118.5	19.7	17.6	21.8	14.9	16.0	15.5	22.2	20.9	19.7	13.6	15.7	15.5	11.3	19.6	27.4	14.7	19.2	22.2	15.5	319.4	20.7	19.9	16.7	16.4	18.5	23.2	6.1	20.2	14.7	15.9	201.6	14.4	24.3	23.2	18.3	67.3	26.3	19.0	26.3	43.2	16.9	37.6	45.5	31.7	46.8	54.3	25.8	21.3	28.0	27.0	44.7	12.4	46.6	32.0	57.7	40.6	17.4	46.5	23.1	33.3	23.1	24.3	25.4	15.9	41.8	27.2	30.2	25.4	40.5	39.8	28.8	16.4	36.1	59.4	25.4	31.8	21.9	10.2	29.0	29.8	26.6	33.2	27.5	46.7	70.6	11.8	16.4	40.5	52.1	10.4	25.2	27.7	26.1	31.0	57.1	22.0	26.1	50.5	29.8	33.1	13.5	58.3	22.2	13.1	7.7	9.4	6.6	7.0	5.3	8.6	5.2	6.0	6.5	13.4	3.9	4.7	4.4	3.7	10.6	8.0	7.2	8.6	7.1	17.9	18.8	26.4	23.3	19.7	17.6	22.2	20.9	19.6	16.4	20.2	18.3	3.5	0.0	14.2	21.9	5.9	5.1	3.7	11.7	11.4	4.2	7.3	5.5	67.9	2.8	5.8	0.0	16.7	7.6	6.8	13.2	0.0	8.1	0.3	6.9	8.9	7.1	7.2	4.8	14.7	6.9	31.7	5.0	12.8	11.9	4.5	6.7	9.7	5.2	8.3	0.0	16.6	9.2	4.1	7.0	5.7	0.7	5.3	7.2	7.2	4.7	9.8	3.3	10.3	8.5	6.9	11.8	8.2	5.7	9.7	5.4	9.2	6.0	6.2	11.7	0.0	5.0	7.3	1.3	2.9	15.3	4.1	4.0	5.2	3.8	11.7	3.3
H2BC10	"H2B/k, H2BFK, HIST1H2BI"	ENSG00000278588	"H2B clustered histone 10"	P62807	6	26272931-26273412	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 2.1;brain: 3.4;choroid plexus: 1.7;lymphoid tissue: 2.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.7;THP-1: 3.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.3	0.0	0.1	0.2	0.3	2.1	0.1	3.4	0.9	0.3	1.7	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.4	0.1	0.1	0.4	0.9	1.4	1.2	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.9	0.4	0.1	0.3	1.5	2.1	0.2	0.0	0.2	0.1	0.4	1.9	1.1	0.4	0.6	0.0	0.0	0.0	0.1	0.5	0.3	0.9	2.5	0.4	0.1	0.5	0.3	0.2	0.4	0.6	0.9	0.2	0.4	1.6	0.0	0.2	0.5	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	1.3	0.0	2.2	0.0	0.3	8.7	1.5	1.6	0.3	0.0	2.3	0.0	2.7	0.0	0.2	0.2	0.5	0.6	0.5	0.0	0.0	0.0	3.7	0.5	0.4	0.0	0.3	1.8	1.9	0.3	0.0	0.5	0.3	1.2	0.0	0.2	0.0	1.2	0.5	0.7	0.7	1.2	1.6	0.2	1.4	0.4	0.3	0.3	0.1	0.0	0.1	0.5	0.1	0.1	0.3	3.4	0.9	0.3	0.4	1.4	1.2	1.4	0.9	1.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H2BC11	"H2B/r, H2BFR, HIST1H2BJ"	ENSG00000124635	"H2B clustered histone 11"	P06899	6	27125897-27132795	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.7;Cardiomyocytes: 3.0;Cytotrophoblasts: 1.5;Extravillous trophoblasts: 6.0;Hofbauer cells: 4.1;Syncytiotrophoblasts: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.2"	"Cell line enhanced"	"Detected in many"		"K-562: 150.1;Karpas-707: 86.7;SiHa: 134.1;U-2 OS: 137.1;U-266/70: 129.2;U-266/84: 151.8"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (4.02e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.3	1.4	3.4	2.3	3.9	9.1	1.9	3.8	5.9	15.0	3.8	5.0	1.4	1.5	3.0	9.5	3.7	1.9	4.1	3.0	4.3	2.4	4.2	9.1	3.1	5.3	4.4	1.3	0.6	0.3	1.0	1.7	6.1	6.9	2.4	0.3	3.2	2.3	6.2	2.9	2.5	2.0	5.3	12.7	4.0	31.9	5.9	7.2	2.7	3.7	2.6	2.5	10.8	8.4	13.4	17.1	5.3	4.6	26.3	1.4	7.0	7.1	3.9	29.7	12.6	14.1	7.7	2.4	22.7	7.8	12.9	9.3	6.5	6.3	15.5	16.2	14.3	4.3	18.2	0.8	2.5	1.7	10.2	11.0	0.7	6.6	2.2	4.2	1.3	6.8	150.1	86.7	8.5	6.9	5.9	8.1	5.8	15.1	15.5	3.1	3.5	16.5	2.8	4.7	35.3	3.5	134.1	8.7	4.2	6.9	0.3	6.4	4.1	7.2	137.1	5.6	3.3	129.2	151.8	35.6	1.9	42.3	3.7	2.3	0.7	1.1	0.5	0.8	0.9	1.9	0.9	0.4	0.5	2.4	0.5	0.6	16.2	1.3	0.3	1.2	3.0	15.9	3.4	3.9	3.8	5.9	3.0	4.3	5.3	4.4	6.1	5.3	5.9	8.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.3	0.0	0.0	0.0
H2BC12	"H2BFAiii, H2BFT, HIST1H2BK"	ENSG00000197903	"H2B clustered histone 12"	O60814	6	27146361-27146855	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.4;Hofbauer cells: 1.1;Syncytiotrophoblasts: 3.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 1269.7;SiHa: 771.0;U-2 OS: 949.9;U-266/84: 1355.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	45.2	28.9	10.3	35.9	13.4	46.4	31.2	8.1	13.1	46.1	15.1	45.7	41.6	35.2	27.7	64.2	59.9	37.7	32.1	12.2	11.1	31.3	94.0	47.1	59.6	13.3	12.3	28.9	60.0	14.8	16.2	44.7	12.9	75.1	26.4	0.4	43.1	21.7	8.5	30.3	44.8	22.1	15.7	66.9	56.0	44.6	13.6	65.7	49.2	6.7	24.2	35.0	42.8	21.6	64.6	153.7	25.7	41.2	116.0	37.0	84.7	118.1	70.5	157.9	99.1	133.1	68.9	28.1	338.6	64.2	94.1	78.3	29.8	35.8	19.7	95.1	201.2	42.0	91.0	4.4	46.2	29.9	183.4	205.0	26.8	29.5	28.1	38.8	27.6	14.1	1269.7	194.4	66.5	166.3	49.1	52.6	20.2	204.6	98.8	27.9	24.2	265.9	55.2	23.4	124.1	74.2	771.0	178.6	56.9	18.9	473.7	29.8	41.6	57.6	949.9	54.0	18.8	293.6	1355.8	207.7	34.7	314.1	34.5	244.6	49.0	329.3	21.6	45.3	19.6	112.1	21.3	21.9	53.1	141.9	25.7	20.4	308.2	28.5	96.3	120.8	65.7	68.3	10.3	13.4	8.1	13.1	12.2	11.1	13.3	12.3	12.9	15.7	13.6	21.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0
H2BC13	"dJ97D16.4, H2B/c, H2BFC, HIST1H2BL"	ENSG00000185130	"H2B clustered histone 13"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;brain: 2.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.7;cerebral cortex: 1.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.3;U-266/84: 12.5"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	0.1	0.2	0.3	0.0	0.3	6.1	0.1	2.7	1.6	0.3	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.5	0.0	0.1	0.3	0.3	0.3	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.4	0.2	0.2	0.3	1.2	0.3	0.0	0.4	0.1	0.2	0.3	2.2	2.0	0.6	2.1	0.0	0.0	0.1	1.3	0.3	1.1	2.8	0.9	1.5	0.8	0.5	0.2	0.6	1.4	0.0	0.2	0.4	1.0	2.9	1.6	2.7	3.5	0.0	2.6	2.1	0.9	0.0	0.0	0.0	0.2	0.6	1.8	2.1	5.2	0.0	5.6	12.3	4.5	1.9	1.5	3.0	2.8	0.0	1.3	0.0	2.0	2.7	1.0	3.5	1.4	0.2	0.2	1.2	0.9	0.5	0.1	1.4	1.1	0.9	2.9	12.5	3.9	0.3	4.7	0.5	0.5	0.3	2.3	0.5	0.1	0.7	1.0	0.3	0.6	0.7	0.6	0.2	0.3	4.1	0.2	0.3	0.4	1.1	0.5	0.3	0.3	2.7	1.6	0.5	0.1	0.0	0.1	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC14	"dJ160A22.3, H2B/e, H2BFE, HIST1H2BM"	ENSG00000273703	"H2B clustered histone 14"	Q99879	6	27815022-27815489	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.5;lymphoid tissue: 3.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 14.8;NB-4: 9.9;REH: 6.2;U-266/70: 12.3;U-698: 5.9"	"Not detected"	"Not detected"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.5	0.0	0.1	0.3	0.5	3.5	0.0	1.2	0.6	1.1	0.2	0.3	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.4	0.4	0.3	0.2	0.5	1.5	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.7	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.6	1.0	0.2	0.4	0.8	3.1	0.2	0.0	1.1	0.0	1.0	1.1	1.5	0.0	0.2	0.0	0.0	0.0	1.0	0.3	0.2	0.3	1.5	0.3	0.2	1.9	0.0	0.0	0.4	0.9	0.0	0.0	0.0	1.1	0.0	0.7	0.2	0.6	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.1	14.8	0.0	0.4	4.0	9.9	2.8	0.9	0.6	6.2	0.0	0.3	0.0	0.0	0.2	1.7	0.6	0.9	0.0	0.1	0.8	3.0	0.0	0.0	1.6	1.0	0.1	12.3	0.5	5.9	0.9	1.0	0.7	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	1.2	0.6	0.4	0.4	0.4	0.7	0.7	0.6	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC15	"H2B/d, H2BFD, HIST1H2BN"	ENSG00000233822	"H2B clustered histone 15"	Q99877	6	27837760-27855709	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.9;Cytotrophoblasts: 11.7;dendritic cells: 4.8;Extravillous trophoblasts: 5.3;Hofbauer cells: 11.3;Plasma cells: 4.4;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 5.5;SCLC-21H: 6.4;U-266/84: 7.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	0.2	1.5	0.3	0.5	0.5	1.0	0.6	2.1	0.5	0.7	0.6	0.4	0.4	0.6	0.8	0.3	0.7	0.3	1.5	0.4	0.3	0.6	0.9	0.5	0.6	0.3	0.2	1.0	1.4	0.6	1.0	0.3	0.4	0.8	0.3	1.7	0.5	0.1	0.9	0.3	0.5	0.2	0.5	0.6	0.4	1.5	0.2	0.6	1.2	0.1	0.2	0.3	0.4	1.7	0.7	0.1	1.1	0.8	0.9	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.6	0.5	1.8	0.2	0.5	1.1	1.0	0.3	0.2	0.9	2.1	0.6	2.4	0.6	1.0	0.7	1.8	0.9	0.2	0.1	0.4	0.8	0.1	1.0	5.5	3.8	0.6	0.5	1.6	1.9	0.6	0.5	0.5	0.9	0.7	4.1	0.3	0.2	6.4	1.0	2.2	1.0	0.8	0.5	1.7	0.6	1.2	1.3	1.4	0.7	0.3	3.4	7.1	1.5	0.5	0.4	0.5	0.5	1.4	1.0	1.9	1.2	1.1	4.8	1.3	1.3	2.9	3.3	0.9	0.8	8.8	0.8	0.8	4.0	1.8	0.7	0.3	0.5	2.1	0.5	0.4	0.3	0.3	0.2	0.4	0.5	0.2	1.7	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	11.7	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.1	1.2	0.0	0.0	0.0
H2BC17	"H2B.2, H2B/n, H2BFN, HIST1H2BO"	ENSG00000274641	"H2B clustered histone 17"	P23527	6	27893425-27893891	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;brain: 2.3;lymphoid tissue: 2.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 36.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.89e-4)"	0.3	0.1	0.7	0.2	0.3	2.4	0.1	1.1	0.8	0.6	1.3	0.3	0.2	0.1	0.0	0.5	0.0	0.1	0.2	0.2	0.7	0.2	0.4	1.0	0.7	1.2	2.3	0.0	0.0	0.0	0.0	0.6	1.9	0.5	0.3	0.0	0.2	0.0	0.1	0.4	0.2	0.0	0.8	1.3	0.2	0.2	1.8	2.6	0.2	0.0	0.6	0.3	0.8	2.0	2.8	3.0	1.6	5.1	0.7	0.0	3.0	0.9	0.1	5.3	5.1	1.1	1.5	3.2	2.3	0.2	1.3	2.6	2.9	0.5	1.4	2.4	2.0	1.9	4.7	2.1	0.0	0.3	1.4	0.3	0.0	0.4	0.5	0.1	1.4	2.3	7.6	9.1	0.2	1.3	12.9	10.9	1.8	1.8	2.2	7.4	1.7	5.5	1.1	0.4	7.3	1.4	5.8	1.3	0.8	0.6	2.3	0.2	0.0	1.7	0.3	1.8	2.4	9.1	36.0	8.8	1.0	10.2	0.8	0.6	0.1	1.7	0.3	0.2	0.4	0.5	0.3	0.6	1.0	0.9	0.1	0.2	2.6	0.5	0.3	0.7	0.6	2.0	0.7	0.3	1.1	0.8	0.2	0.7	1.2	2.3	1.9	0.8	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H2BC18	HIST2H2BF	ENSG00000203814	"H2B clustered histone 18"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 1.4;Fibroblasts: 1.3;Hofbauer cells: 8.5;Syncytiotrophoblasts: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"neutrophil: 30.8"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 30.8"	"Cell line enriched"	"Detected in many"	7	"U-266/70: 49.7"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	10.2	6.7	4.2	1.3	5.0	3.0	5.3	10.0	3.7	36.5	13.1	6.5	0.6	1.1	2.5	9.6	9.7	1.0	7.4	3.4	7.0	8.9	7.2	28.0	0.9	6.0	7.4	35.3	4.7	0.3	5.6	2.2	6.7	30.2	0.9	2.9	6.9	0.9	0.7	17.8	3.3	0.6	5.4	15.8	12.9	3.7	5.5	2.8	6.1	0.5	0.7	6.1	34.7	7.9	0.7	1.0	0.5	1.0	0.6	0.1	0.5	1.0	0.2	0.8	1.0	0.5	1.3	0.7	0.4	0.2	0.8	2.1	0.2	0.0	0.1	2.1	0.7	0.7	3.0	0.1	0.4	0.4	2.7	1.2	0.0	0.4	0.5	0.4	0.1	0.5	1.8	3.8	0.0	1.5	5.2	3.1	0.7	3.6	1.5	0.5	1.7	1.2	0.2	0.2	2.7	0.9	6.6	0.3	0.5	1.0	2.0	0.4	0.0	0.7	0.0	1.1	0.6	49.7	1.7	2.0	1.0	0.5	0.2	0.0	1.4	0.3	0.8	0.5	0.8	0.7	1.1	0.4	0.9	2.1	0.5	0.4	30.8	0.7	0.6	0.8	0.2	0.2	4.2	5.0	10.0	3.7	3.4	7.0	6.0	7.4	6.7	5.4	5.5	7.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0
H2BC21	"H2B, H2B.1, H2B/q, H2BE, H2BFQ, HIST2H2BE"	ENSG00000184678	"H2B clustered histone 21"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 86.5;Syncytiotrophoblasts: 160.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 87.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 58.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 58.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.8;U-266/70: 93.7;U-266/84: 53.8"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	17.8	15.3	35.1	7.2	40.2	21.2	17.7	38.7	38.7	60.8	38.7	22.0	5.2	7.4	22.8	41.7	27.5	5.5	77.3	33.5	37.2	46.3	18.0	37.2	6.2	41.6	38.0	61.7	13.4	9.5	32.5	14.8	39.0	95.2	6.1	69.1	23.5	6.6	62.8	84.0	14.8	6.2	41.0	27.3	32.0	13.7	38.9	20.1	15.2	29.2	3.4	25.1	79.5	55.8	2.8	2.8	4.5	0.9	23.5	6.3	2.2	9.7	6.5	4.0	1.3	1.1	4.4	0.5	2.6	8.6	5.7	10.9	3.6	1.7	2.2	3.4	2.8	0.8	11.5	2.1	7.4	0.8	12.6	21.4	7.9	1.7	6.6	4.8	1.3	4.0	12.0	56.8	5.0	16.8	3.1	5.1	2.8	22.6	5.8	3.6	1.7	13.7	3.8	2.3	30.3	4.9	33.4	4.5	2.7	10.7	23.4	2.4	1.7	3.0	33.6	2.2	0.9	93.7	53.8	2.6	4.0	3.6	1.9	21.3	4.8	8.2	1.3	6.2	2.3	1.5	1.8	2.1	3.3	3.8	2.2	2.2	58.6	1.3	12.3	8.9	2.2	10.1	35.1	40.2	38.7	38.7	33.5	37.2	41.6	38.0	39.0	41.0	38.9	55.8	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	25.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	20.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	160.2	0.3	0.0	0.0	0.0
H2BC3	"H2B/f, H2BFF, HIST1H2BB"	ENSG00000276410	"H2B clustered histone 3"	P33778	6	26043227-26043713	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.1;brain: 2.6;lymphoid tissue: 1.1;testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 1.3;Karpas-707: 1.3;MOLT-4: 1.6;NB-4: 1.7;THP-1: 2.0;U-266/84: 2.2"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.0	0.0	0.5	0.0	0.5	1.1	0.0	2.1	0.6	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.2	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	1.3	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.4	0.2	1.3	1.3	0.0	0.0	1.6	1.7	0.7	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.1	0.1	0.1	0.3	0.3	2.2	0.0	0.2	0.5	0.4	2.6	0.5	0.5	0.8	0.1	2.2	1.4	2.4	0.9	1.9	0.9	1.2	0.5	2.0	0.1	0.2	6.4	1.9	0.3	0.5	0.5	2.1	0.6	0.2	1.3	0.9	1.2	0.9	0.6	2.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H2BC4	"H2B.1, H2B/l, H2BFL, HIST1H2BC"	ENSG00000180596	"H2B clustered histone 4"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	18	"neutrophil: 923.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 923.6"	"Cell line enhanced"	"Detected in all"		"K-562: 39.8;SiHa: 75.8;U-2 OS: 51.9;U-266/70: 42.8;U-266/84: 57.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	4.3	3.4	9.5	6.0	17.4	25.0	6.7	11.4	8.8	9.1	9.9	3.1	3.2	1.2	3.6	14.7	7.1	4.6	3.6	10.5	15.0	5.3	13.1	8.0	2.9	20.3	10.9	2.6	2.6	0.9	5.8	7.2	16.3	21.8	2.3	1.5	7.5	0.9	14.5	6.7	3.0	1.2	21.5	5.1	7.0	6.4	9.4	14.9	3.6	8.0	2.3	3.5	10.2	27.6	7.0	4.0	2.1	2.0	1.9	1.1	2.6	6.8	2.5	4.5	3.7	5.6	4.1	2.7	12.5	2.3	3.3	5.2	2.8	2.8	2.2	6.3	2.3	2.2	6.1	9.6	2.6	3.4	8.4	27.3	1.7	1.9	1.1	2.2	1.8	2.1	39.8	21.1	8.6	8.0	7.5	7.2	2.2	7.4	12.4	3.3	3.0	16.3	7.8	1.7	9.4	3.0	75.8	5.8	2.6	5.5	31.8	3.1	5.6	5.5	51.9	3.4	2.8	42.8	57.1	13.2	2.3	8.6	3.8	52.5	9.3	49.9	9.2	10.5	12.4	19.1	13.3	13.0	6.6	35.1	10.3	7.7	923.6	10.5	10.4	22.0	9.3	19.2	9.5	17.4	11.4	8.8	10.5	15.0	20.3	10.9	16.3	21.5	9.4	27.6	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	42.8	0.4	0.0	0.0	0.0
H2BC5	"H2B/b, H2BFB, HIST1H2BD"	ENSG00000158373	"H2B clustered histone 5"	P58876	6	26158146-26171349	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 151.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 22.4;Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 117.9;U-266/84: 134.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	25.4	13.4	17.8	7.6	21.9	53.8	18.5	48.7	19.2	151.7	41.8	34.6	11.0	6.3	27.7	37.6	53.5	15.3	31.4	17.9	29.7	67.2	62.9	36.8	9.2	22.2	23.7	101.8	15.7	2.1	30.5	9.3	28.0	144.0	17.1	9.7	28.9	3.6	18.5	44.1	23.3	4.3	27.5	35.4	26.1	11.3	23.8	35.2	25.2	7.3	4.1	17.9	95.5	33.9	17.9	39.7	12.0	6.8	91.2	8.3	3.6	15.5	8.9	19.6	12.3	13.3	14.5	8.1	95.2	18.5	21.8	27.9	6.8	6.6	9.2	36.6	16.9	5.4	33.7	14.5	9.8	7.2	14.7	59.7	10.3	5.5	7.7	7.6	4.9	7.5	57.1	43.3	3.6	64.2	16.4	18.1	12.6	76.1	18.2	6.5	7.6	54.4	18.7	12.8	38.1	16.1	96.8	25.1	15.9	23.1	63.4	2.6	3.0	24.4	63.4	9.9	3.3	117.9	134.9	20.5	3.1	33.2	5.0	35.3	2.3	16.9	8.1	5.1	10.4	13.4	12.3	13.5	5.6	20.0	11.4	8.7	24.8	10.5	6.9	19.3	8.9	2.4	17.8	21.9	48.7	19.2	17.9	29.7	22.2	23.7	28.0	27.5	23.8	33.9	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	7.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	39.4	0.3	0.0	0.0	0.0
H2BC6	"H2B.h, H2B/h, H2BFH, HIST1H2BE"	ENSG00000274290	"H2B clustered histone 6"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.8;Cytotrophoblasts: 1.0;dendritic cells: 1.8;Extravillous trophoblasts: 1.1;Hofbauer cells: 1.0;Plasma cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 5.3;REH: 5.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.8	0.4	1.6	0.5	2.0	2.7	0.6	3.0	1.5	3.6	3.6	0.7	0.4	0.4	0.4	0.7	0.6	0.4	0.6	1.6	0.3	1.0	0.6	1.3	0.9	1.9	0.8	0.9	0.2	0.1	0.7	0.3	0.4	2.6	0.5	1.1	1.3	0.2	0.8	1.7	0.3	0.2	1.8	0.9	0.8	0.5	0.6	2.9	0.5	0.6	0.6	0.4	2.1	1.5	0.3	2.1	1.9	0.5	1.6	0.2	0.2	1.9	0.6	0.3	0.1	0.5	1.3	0.4	0.8	0.3	0.9	2.7	0.3	0.7	0.3	0.9	0.5	0.2	1.0	0.1	0.1	0.1	1.6	0.4	0.1	0.4	0.1	0.6	0.2	0.5	1.4	1.0	0.0	1.0	3.0	5.3	1.5	1.0	0.5	5.1	0.1	1.5	0.8	1.1	1.5	2.2	2.3	0.8	0.5	0.8	1.6	1.0	0.5	0.8	1.5	0.6	1.2	1.3	2.7	0.3	0.4	0.8	0.3	2.9	0.6	1.0	0.7	0.5	0.5	1.0	0.7	0.9	0.2	1.2	0.6	0.6	2.1	0.6	0.6	1.2	1.1	0.3	1.6	2.0	3.0	1.5	1.6	0.3	1.9	0.8	0.4	1.8	0.6	1.5	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
H2BC7	"H2B/g, H2BFG, HIST1H2BF"	ENSG00000277224	"H2B clustered histone 7"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 7.4"	"Cell type enhanced"	"Detected in single"		"Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"U-266/70: 24.8;U-266/84: 18.8"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.9	0.2	0.6	0.2	1.1	1.2	1.6	4.0	0.9	3.3	1.5	1.4	0.0	0.1	0.0	3.2	1.8	0.2	0.4	0.8	0.6	1.4	0.6	1.7	0.3	1.9	1.7	0.8	0.2	0.0	0.6	0.2	2.4	7.4	0.2	0.6	1.1	0.0	0.0	0.9	0.7	0.0	2.1	2.3	0.7	0.6	1.2	1.7	0.6	0.1	0.4	0.4	4.5	2.4	0.5	0.3	0.2	0.5	0.3	0.0	0.2	0.2	0.1	0.7	0.1	0.7	0.1	0.6	1.0	0.0	0.3	1.0	0.5	0.1	0.3	0.8	0.2	0.4	1.8	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.0	0.1	0.5	2.0	4.5	0.0	0.1	4.0	1.6	0.6	0.8	0.6	1.5	0.7	3.0	0.1	0.1	2.4	0.4	4.9	0.9	0.1	0.3	4.4	0.2	0.1	0.3	2.2	0.0	0.6	24.8	18.8	1.3	0.1	1.2	0.5	0.0	0.0	0.6	0.2	0.1	0.6	0.2	0.2	0.3	0.1	1.0	0.2	0.5	2.4	0.2	0.3	0.3	0.2	0.5	0.6	1.1	4.0	0.9	0.8	0.6	1.9	1.7	2.4	2.1	1.2	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0
H2BC8	"H2B.1A, H2B/a, H2BFA, HIST1H2BG"	ENSG00000273802	"H2B clustered histone 8"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 7.3;Extravillous trophoblasts: 7.4;Hofbauer cells: 22.5;Syncytiotrophoblasts: 24.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 9.6;SiHa: 10.5;T-47d: 21.2;U-266/70: 19.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	3.1	0.9	1.5	1.2	1.4	6.7	13.2	8.0	1.8	23.9	4.8	5.9	1.1	0.9	2.0	9.1	4.3	0.9	3.3	1.5	1.9	4.3	3.1	7.5	1.6	1.4	2.2	5.7	1.1	0.1	2.9	1.1	3.6	19.7	2.0	1.6	6.9	0.5	0.1	13.2	3.2	0.4	2.8	7.1	3.7	1.8	1.9	4.1	2.6	0.0	1.4	1.6	18.4	4.6	3.0	0.1	1.4	0.0	4.4	0.2	0.4	3.7	0.3	2.3	0.9	0.4	2.6	0.0	3.7	0.3	1.0	3.2	1.3	1.2	1.3	2.6	1.6	0.8	1.5	1.4	0.7	0.3	2.4	1.7	0.6	0.7	0.1	0.1	0.5	0.1	9.6	0.2	0.0	2.2	2.8	2.1	1.5	7.1	1.9	1.8	0.8	5.4	1.3	0.7	8.5	1.3	10.5	3.8	1.2	3.7	21.2	0.9	0.3	0.0	1.2	0.3	0.5	19.6	0.1	0.0	0.3	1.3	0.7	18.1	1.3	3.2	2.0	0.9	6.4	4.4	3.2	4.0	5.1	5.3	1.5	1.3	5.8	1.4	1.8	16.0	3.0	2.2	1.5	1.4	8.0	1.8	1.5	1.9	1.4	2.2	3.6	2.8	1.9	4.6	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.1	0.2	0.0	0.0	0.0
H2BC9	"H2B/j, H2BFJ, HIST1H2BH"	ENSG00000275713	"H2B clustered histone 9"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;vagina: 4.3"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.7;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 16.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.5	0.2	0.4	0.6	0.4	1.4	0.6	0.3	0.5	1.9	0.8	2.0	3.0	0.4	0.8	4.2	0.8	0.3	0.2	0.3	0.4	0.9	0.2	1.6	0.8	0.8	0.7	0.1	0.0	0.1	0.1	0.2	0.7	3.5	0.8	0.0	1.3	0.0	0.0	0.6	1.7	0.1	0.6	3.7	0.7	0.6	0.7	2.9	1.0	0.1	0.5	0.4	4.3	1.1	1.8	0.1	7.0	0.0	0.0	0.1	1.1	0.9	0.3	1.2	0.6	2.4	1.1	0.0	1.7	0.1	1.8	3.4	0.0	0.6	1.7	0.9	0.1	1.3	6.1	0.4	0.0	0.0	4.0	0.3	0.3	0.4	0.5	0.0	0.3	1.0	2.7	6.2	0.1	2.0	3.8	2.7	1.6	0.0	1.8	4.0	0.0	0.9	0.0	2.7	3.2	2.9	4.2	1.4	0.6	0.3	2.0	3.3	0.0	0.6	0.0	0.7	3.1	16.9	4.5	0.0	0.5	1.5	3.8	3.7	0.2	0.6	0.3	0.0	0.1	0.6	0.2	0.4	0.6	0.3	0.0	0.1	3.0	0.8	0.1	0.2	0.4	5.2	0.4	0.4	0.3	0.5	0.3	0.4	0.8	0.7	0.7	0.6	0.7	1.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	29.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0
H2BS1	H2BFS	ENSG00000234289	"H2B.S histone 1"	P57053	21	43565182-43565648	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;K-562: 1.0;U-2 OS: 1.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"					"unprognostic (1.29e-1)"					"unprognostic (4.33e-3)"				"unprognostic (2.06e-2)"				0.9	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.8	0.1	0.7	0.0	0.9	0.0	1.3	0.7	0.0	0.6	0.1	0.0	0.2	2.0	1.0	0.1	0.1	0.1	0.5	1.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.7	0.0	0.1	0.6	0.8	0.0	0.0	1.6	0.6	1.1	0.1	0.0	0.7	0.0	0.0	0.4	0.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0
H2BU1	HIST3H2BB	ENSG00000196890	"H2B.U histone 1"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5;cervix: 4.7;vagina: 3.5"	"Cell type enhanced"	"Detected in single"		"Syncytiotrophoblasts: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"T-47d: 3.0;U-266/70: 15.1;U-266/84: 3.8"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	0.7	0.7	0.8	0.0	0.5	0.2	0.2	3.5	0.7	4.7	0.1	0.2	0.1	0.1	0.1	1.4	1.0	0.0	0.8	0.4	1.6	0.6	0.1	0.9	0.1	0.9	0.8	0.6	0.1	0.0	0.9	0.0	1.1	0.8	0.0	0.5	0.3	0.0	0.1	1.2	0.3	0.0	0.4	0.8	0.3	0.2	1.9	0.0	0.4	0.0	0.1	0.4	3.5	0.5	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.8	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.6	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.7	0.0	0.1	1.2	0.4	0.8	0.3	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	15.1	3.8	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.1	0.3	0.2	0.1	0.1	0.8	0.5	3.5	0.7	0.4	1.6	0.9	0.8	1.1	0.4	1.9	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 198.2;skin 1: 61.1"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 129.6"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;neutrophil: 73.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;NB-4: 2.8;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		280000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	1.4	0.3	0.1	2.9	0.1	11.5	2.2	0.1	0.4	0.8	0.1	0.5	0.6	0.4	0.0	1.0	0.7	0.6	0.3	0.1	0.1	0.3	198.2	2.3	0.5	0.1	0.1	0.2	0.9	0.1	3.0	0.4	0.1	0.2	0.4	0.0	0.6	0.1	0.2	61.1	0.8	0.5	0.0	7.6	0.4	0.1	0.1	0.5	0.2	0.6	1.4	0.5	1.4	0.2	0.4	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.4	0.4	0.0	0.6	0.3	0.2	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.1	2.8	0.9	0.1	0.4	0.2	0.1	0.0	0.1	0.6	0.1	0.3	0.3	0.0	0.0	0.0	0.0	11.4	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.0	1.7	0.0	56.9	15.1	2.4	0.0	5.7	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	73.3	0.7	13.6	0.3	0.2	4.4	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	1.1	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.7	2.8	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	3.2	2.0	0.4	0.0	9.7	0.2	0.2	0.7	0.1	0.5	15.0	0.0	0.1	2.5	129.6	0.3	0.0	0.1	0.1	0.0	7.7	0.8	0.0	0.0	3.5	0.0	0.0	6.3	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.4	0.2	1.2	0.7	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	2.8	0.0	0.6	0.0	0.3	0.1
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877294-88895597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 966.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 50.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 50.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.7;U-2 OS: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	10.3	1.9	2.1	11.5	2.0	3.1	8.6	1.9	2.7	5.1	2.1	3.2	0.6	4.3	0.1	6.1	6.2	2.7	4.6	2.1	2.0	6.1	0.9	9.7	11.7	2.4	2.1	2.7	1.4	0.5	2.2	1.4	2.5	5.7	0.4	4.2	6.0	0.7	3.6	6.2	4.6	2.7	2.3	5.7	3.5	1.0	2.4	2.9	4.6	0.6	3.2	6.9	5.6	2.1	2.0	7.0	1.3	15.4	4.4	4.2	4.7	4.4	1.0	1.6	2.0	4.4	6.4	0.0	11.9	5.4	2.5	1.7	14.7	1.9	0.0	34.7	12.9	4.9	0.3	0.0	0.6	0.0	0.1	1.6	0.8	3.0	0.2	0.2	7.1	0.6	0.1	9.3	0.8	0.2	0.1	0.0	11.2	0.0	0.2	0.0	0.6	11.5	2.9	0.1	0.1	4.2	0.9	0.7	6.1	1.9	0.0	0.6	1.3	10.8	31.2	8.1	0.7	1.1	0.1	0.1	3.8	0.0	9.3	1.4	1.1	0.0	1.2	0.8	5.4	0.2	18.3	7.4	2.2	1.5	18.3	8.6	0.3	10.1	0.2	0.8	50.9	5.9	2.1	2.0	1.9	2.7	2.1	2.0	2.4	2.1	2.5	2.3	2.4	2.1	16.0	0.0	3.4	1.3	4.0	32.0	10.8	13.5	4.6	2.5	47.1	42.4	9.3	1.5	10.4	1.8	10.4	5.8	3.2	0.5	0.0	5.3	0.0	6.3	3.7	29.4	0.0	0.0	1.3	2.0	966.2	8.5	1.5	12.1	1.3	2.5	3.3	0.1	19.3	0.0	0.1	0.9	6.1	0.3	22.0	0.2	0.9	3.0	17.8	2.8	9.7	3.8	3.1	0.5	0.1	9.9	0.1	0.7	0.5	10.4	0.0	0.2	2.7	103.8	13.1	7.2	24.5	0.3	2.1	6.3	24.2	20.4	9.4	0.2	0.5	7.8
HAUS2	"C15orf25, CEP27, FLJ10460, HsT17025"	ENSG00000137814	"HAUS augmin like complex subunit 2"	Q9NVX0	15	42548828-42569994	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039965	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA039965: AB_10673025"	"unprognostic (5.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.81e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-3)"	7.9	5.7	5.5	5.8	5.8	36.5	7.5	5.8	9.5	4.7	4.2	5.8	4.8	6.0	5.5	6.4	4.7	4.6	5.8	6.2	5.8	5.3	5.4	7.0	8.1	6.1	5.6	5.4	6.6	4.5	4.2	6.4	6.2	4.2	5.9	5.4	5.0	3.8	7.2	6.2	5.4	6.7	5.8	5.4	4.9	5.0	5.8	8.9	5.1	5.8	7.9	7.0	4.7	7.6	23.6	12.0	21.5	13.7	10.9	12.3	20.3	22.9	13.9	21.8	17.1	24.5	11.8	13.8	11.1	13.4	18.6	34.6	23.7	15.2	21.5	19.4	13.3	20.0	19.7	19.0	15.6	34.2	14.5	10.6	11.1	16.2	17.7	9.2	22.0	19.2	36.2	17.5	21.3	14.1	21.4	28.5	16.8	31.9	15.3	27.9	26.4	15.0	12.6	16.4	17.8	14.8	23.2	20.6	13.2	15.6	18.7	22.4	17.1	28.7	21.4	39.0	43.8	18.7	61.1	40.0	18.5	38.0	21.6	4.0	4.3	3.9	4.4	5.3	4.5	6.0	4.4	3.7	3.9	5.1	3.3	4.5	1.9	2.9	7.5	4.5	5.2	2.8	5.5	5.8	5.8	9.5	6.2	5.8	6.1	5.6	6.2	5.8	5.8	7.6	17.5	12.8	14.4	5.5	19.4	13.6	20.9	10.9	18.2	7.8	8.6	8.0	4.2	14.3	11.6	3.7	16.7	14.5	17.7	7.1	3.9	14.2	35.2	10.9	12.3	14.6	17.3	31.1	11.6	16.5	27.6	12.9	12.2	10.4	24.6	9.0	7.9	9.7	21.7	16.8	9.3	10.6	8.2	18.5	23.6	7.3	11.1	19.0	1.8	9.4	19.6	9.7	10.3	11.6	10.4	18.8	11.2	11.3	20.1	20.2	8.7	13.3	15.8	16.3	19.7	16.5	12.4	34.0	9.6	23.2	15.3	13.4	21.1	14.0	10.8	17.1
HBS1L	"DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038"	ENSG00000112339	"HBS1 like translational GTPase"	Q9Y450	6	134960378-135103056	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis, Translation regulation"	"Elongation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029728, HPA029729"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA		9200	"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Cytosol"		"HPA029728: AB_10611112, HPA029729: AB_10601228"	"unprognostic (3.68e-3)"	"unprognostic (6.39e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-2)"	35.3	32.5	29.7	31.2	51.8	82.5	39.7	37.9	48.1	31.8	23.6	29.9	23.0	31.8	23.0	43.9	29.9	26.6	50.9	28.3	44.6	36.9	63.1	24.5	40.3	41.2	34.7	32.6	39.5	47.1	17.1	35.4	43.0	28.7	29.5	44.8	42.3	29.4	167.2	26.9	26.9	38.5	33.2	23.5	29.6	32.8	39.4	65.5	38.6	123.4	43.4	34.0	20.0	87.1	63.9	41.9	85.7	124.8	76.7	67.9	65.4	125.5	107.7	116.7	143.6	70.7	46.8	109.5	55.3	111.9	84.3	46.6	121.1	92.4	181.2	111.8	82.9	335.3	113.6	95.5	91.9	209.5	87.9	67.8	68.7	111.0	135.0	87.2	98.5	128.2	182.7	89.4	125.1	60.0	129.6	53.0	55.4	75.6	45.3	120.0	95.3	74.9	72.3	59.7	84.2	57.4	85.6	88.7	88.4	67.4	74.1	124.6	93.6	82.4	85.5	103.3	134.8	202.5	158.3	184.8	125.5	106.8	104.9	108.7	47.8	52.0	44.0	44.9	48.9	49.3	51.2	44.2	55.9	42.7	68.9	57.0	22.0	66.4	44.9	44.6	67.5	57.7	29.7	51.8	37.9	48.1	28.3	44.6	41.2	34.7	43.0	33.2	39.4	87.1	25.9	25.6	25.7	27.1	32.0	27.3	26.9	23.2	31.3	42.7	22.1	17.8	56.0	17.2	30.4	11.0	14.6	32.2	36.8	11.1	25.4	25.2	36.3	27.1	28.9	24.4	16.3	58.0	61.4	20.4	33.7	26.2	20.4	27.1	60.0	23.9	18.2	39.3	13.5	21.9	56.2	11.1	16.2	18.0	18.9	12.6	18.6	17.6	30.2	29.0	28.0	26.5	19.6	47.3	198.7	18.7	12.3	22.2	53.7	21.6	13.9	23.5	24.0	26.6	39.5	36.6	25.9	28.3	25.8	24.9	18.6	40.5	34.5	27.5	14.6	25.7
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	142728-154503	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.9;testis: 7.3"	"Group enriched"	"Detected in some"	4	"Erythroid cells: 82.9;Hofbauer cells: 192.0;Late spermatids: 275.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	80	"K-562: 2189.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		80000000		"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA063268: , HPA064073: , HPA071726: AB_2732184"					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.6	0.0	0.5	0.0	0.4	3.9	0.6	0.2	0.8	0.5	0.8	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.5	0.3	0.1	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.6	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.1	7.3	0.2	0.0	0.1	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	27.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2189.0	0.2	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.4	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.5	0.7	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	40.0	0.0	0.1	3.7	0.0	82.9	0.5	0.0	42.4	1.8	0.0	0.0	0.0	0.1	0.4	0.0	192.0	0.0	0.3	0.0	0.0	0.3	0.3	275.5	0.6	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	6.6	1.9	4.8	1.3	1.8	0.0	0.1	10.4	0.1	0.0	0.1	0.0
HDDC3	"MESH1, MGC45386"	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929968-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	13.0	13.1	15.5	7.9	15.1	10.4	9.2	15.0	20.0	6.5	13.9	11.2	10.3	4.3	8.2	5.9	10.4	4.6	13.3	15.1	14.8	12.1	11.4	6.4	8.2	15.1	14.8	6.5	20.0	15.7	8.0	7.0	14.7	7.0	9.1	7.1	20.7	5.8	13.3	7.7	11.9	3.9	15.3	9.3	9.7	4.5	16.1	7.4	9.8	14.6	9.2	5.5	5.5	15.7	12.7	15.7	5.3	6.4	11.8	11.8	9.0	8.5	11.4	7.7	11.5	7.7	25.5	24.2	8.5	7.0	6.1	19.3	11.1	19.3	6.3	30.4	24.4	30.5	6.0	17.7	23.9	11.6	14.1	10.5	30.1	13.9	24.8	12.2	17.0	19.5	24.6	20.7	6.9	19.1	16.1	10.0	4.3	47.2	15.6	13.2	2.1	38.2	15.8	13.2	13.3	8.5	7.1	19.2	21.4	11.0	29.2	30.5	9.8	4.7	10.5	8.1	10.9	33.5	41.4	16.7	17.5	22.4	14.3	10.1	20.1	8.5	23.3	27.4	30.1	35.1	30.0	26.3	27.4	31.4	34.6	25.5	4.7	31.5	26.7	44.0	31.9	25.6	15.5	15.1	15.0	20.0	15.1	14.8	15.1	14.8	14.7	15.3	16.1	15.7	42.8	28.9	7.4	5.9	23.5	5.6	14.1	22.5	6.8	13.8	27.8	30.1	1.1	44.3	21.6	16.5	4.2	48.2	19.1	18.1	76.3	42.3	4.6	18.8	12.4	19.0	19.9	34.3	4.8	56.5	33.0	12.7	13.7	18.6	7.0	14.3	15.7	41.4	45.9	15.2	5.2	32.9	12.2	15.1	10.9	4.3	14.3	19.6	14.2	1.9	36.3	39.9	34.0	1.0	3.9	28.4	30.2	11.7	31.7	14.7	59.7	71.5	20.6	38.8	6.6	13.2	11.5	29.6	38.4	17.2	8.4	24.2	21.4	21.7	33.0	13.5
HDX	"CXorf43, FLJ30678"	ENSG00000165259	"Highly divergent homeobox"	Q7Z353	X	84317874-84502479	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.1;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 45.8;Oligodendrocytes: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 7.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047189	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA047189: AB_10965463"	"unprognostic (7.26e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-5)"	"unprognostic (3.23e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.40e-6)"	"unprognostic (1.14e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.66e-2)"	1.3	1.6	0.6	0.7	0.9	0.0	1.6	2.9	1.6	1.8	0.0	1.3	0.3	1.8	1.5	1.1	1.6	1.3	1.1	0.8	1.3	1.1	1.0	1.0	0.5	1.1	0.6	2.1	0.5	1.2	1.2	0.3	1.0	1.4	1.1	1.8	1.3	1.5	0.4	0.4	0.7	1.7	0.8	1.0	0.7	1.0	0.6	0.4	1.4	0.4	0.6	1.3	1.0	1.3	0.0	1.5	7.5	0.0	4.4	3.9	0.0	2.3	3.2	5.0	4.9	0.3	0.8	0.0	0.4	1.8	6.2	0.3	0.1	0.5	4.3	0.0	0.3	0.0	1.4	0.0	3.6	0.0	0.0	2.2	0.0	3.1	2.2	3.2	5.4	0.0	0.0	0.0	4.9	0.1	0.0	0.0	4.7	0.0	2.2	0.0	5.7	0.0	2.4	1.0	0.2	3.9	0.0	0.1	0.0	2.7	0.4	0.0	6.4	2.5	1.9	0.8	2.2	0.1	0.0	0.0	1.5	0.0	0.9	0.0	2.3	0.0	0.7	3.5	0.1	1.8	0.2	0.2	3.2	0.5	0.6	0.4	0.0	0.9	3.5	0.3	0.1	0.6	0.6	0.9	2.9	1.6	0.8	1.3	1.1	0.6	1.0	0.8	0.6	1.3	7.8	0.0	2.7	19.2	2.8	2.5	23.1	2.8	5.7	9.4	4.8	5.2	1.9	1.5	3.5	5.5	12.5	0.0	2.7	1.7	0.0	7.0	8.7	2.9	7.1	6.7	7.1	0.4	51.1	1.8	0.0	7.7	2.0	6.6	1.3	4.1	1.8	0.7	1.0	6.7	56.7	1.5	0.0	1.9	3.6	2.1	4.1	4.1	0.0	20.6	3.8	4.1	1.0	45.8	26.5	2.9	1.9	3.4	1.2	12.4	0.5	2.9	1.3	5.3	0.0	8.8	7.5	2.4	0.3	3.0	1.7	0.1	1.5	4.7	1.3	19.6
HEATR4	MGC48595	ENSG00000187105	"HEAT repeat containing 4"	Q86WZ0	14	73478484-73558947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4;testis: 11.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 27.4;Early spermatids: 85.5;Excitatory neurons: 19.8;Inhibitory neurons: 16.9;Late spermatids: 29.3;Oligodendrocyte precursor cells: 13.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"cerebellum: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.2;SCLC-21H: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003642, HPA079348"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	Cytosol	"HPA003642: AB_1079376, HPA079348: "	"unprognostic (5.25e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.50e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.82e-3)"	0.5	0.5	0.2	0.8	0.2	0.9	0.4	6.4	1.0	0.7	0.0	0.4	1.9	1.0	0.3	0.6	0.6	0.8	0.6	0.8	0.0	0.4	0.8	0.5	1.6	0.0	0.0	1.0	0.9	0.2	0.5	0.3	0.1	0.4	0.1	2.9	0.8	0.1	1.9	3.6	0.8	0.1	0.0	1.0	0.7	11.5	0.1	0.0	1.0	0.0	0.0	0.3	0.5	0.8	0.7	0.8	0.3	0.5	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.5	0.0	0.8	0.2	0.2	0.0	2.2	0.2	0.9	0.3	0.2	0.7	0.4	0.4	0.3	0.0	1.1	2.4	0.3	0.8	1.1	1.2	0.5	1.3	0.1	0.4	0.1	0.9	0.7	0.1	0.6	0.2	0.1	0.5	0.2	0.1	0.2	0.1	0.1	0.4	0.1	0.2	0.5	0.5	0.3	0.0	0.6	0.5	0.5	0.3	0.3	0.0	0.2	0.2	0.1	0.2	0.2	6.4	1.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.2	0.0	1.5	27.4	0.2	0.3	0.5	0.1	0.0	0.8	0.3	0.3	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	85.5	0.3	0.3	0.4	0.0	0.0	19.8	0.0	0.2	0.5	0.0	0.9	0.0	0.4	0.0	0.6	0.1	0.0	16.9	0.2	0.0	0.0	1.0	29.3	0.6	0.3	0.0	3.7	0.0	0.6	0.0	13.0	6.8	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.0	0.9	0.7	11.1	1.6	0.0	0.9	0.1	0.4	0.1	0.0	0.1
HECA	"dJ225E12.1, HDC, HDCL, hHDC"	ENSG00000112406	"Hdc homolog, cell cycle regulator"	Q9UBI9	6	139135080-139180802	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 125.8;Langerhans cells: 153.3;Suprabasal keratinocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012581, HPA042313"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA012581: , HPA042313: AB_10796903"	"unprognostic (2.98e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-3)"	"unprognostic (5.77e-2)"	17.2	8.7	10.5	21.5	10.4	39.2	14.2	10.1	13.8	13.8	7.8	12.7	16.5	13.4	6.4	19.3	12.6	13.1	17.4	12.1	11.3	6.4	10.8	19.2	28.8	10.7	11.1	16.7	9.9	9.7	7.0	10.9	12.6	9.5	12.4	3.9	17.9	8.1	20.3	26.1	17.6	13.8	11.9	27.5	12.0	9.5	12.4	31.6	9.6	15.8	25.8	14.2	15.9	14.1	4.8	1.0	9.2	10.5	20.8	19.0	6.8	8.6	14.4	3.8	8.8	1.9	5.3	20.9	12.2	17.9	9.1	7.9	5.6	7.8	7.0	32.9	11.9	10.5	4.6	0.3	6.5	18.6	9.2	21.7	18.8	8.3	10.1	10.4	12.9	13.8	4.5	27.5	7.1	4.9	9.0	15.1	1.7	4.2	1.7	14.0	9.3	10.6	3.3	15.2	8.8	2.6	7.1	19.1	5.5	10.2	4.4	24.4	16.4	6.7	6.3	15.2	7.5	16.4	13.1	18.8	2.4	10.7	3.8	7.0	1.3	2.0	2.8	1.8	3.5	1.5	4.3	3.8	1.0	1.9	4.1	4.1	5.0	1.5	5.5	1.1	3.9	1.4	10.5	10.4	10.1	13.8	12.1	11.3	10.7	11.1	12.6	11.9	12.4	14.1	35.6	6.4	13.9	10.1	38.2	125.8	22.4	15.9	38.7	1.8	29.1	14.4	41.9	8.6	11.6	11.0	2.1	7.3	70.2	53.4	0.0	7.0	12.0	37.8	18.5	34.9	13.1	22.5	20.4	9.8	6.2	22.3	11.7	53.4	13.3	11.7	36.8	13.0	19.1	1.7	23.2	25.5	16.2	84.3	153.3	12.4	15.5	65.7	44.4	38.4	25.7	6.6	29.9	13.0	10.9	14.7	28.4	19.5	48.8	42.4	34.8	4.7	12.3	2.7	52.6	26.4	23.7	12.6	6.7	33.7	142.2	17.4	76.7	10.8	17.2	59.1
HERC3	KIAA0032	ENSG00000287542	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"		4	88523810-88708450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"retina: 8.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Excitatory neurons: 73.2;Inhibitory neurons: 101.6;Oligodendrocytes: 113.9"					"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA039170	Uncertain		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA039170: AB_10673414"																		1.0	0.9	1.4	1.4	1.2	2.1	1.3	1.9	1.6	2.1	2.1	1.2	0.8	0.9	0.9	1.5	0.8	0.8	2.4	0.9	1.5	1.5	1.3	1.2	1.4	1.8	1.3	1.1	0.6	5.0		1.1	1.8	2.5	1.6	8.5	1.7	1.8	0.9	1.5	0.7	0.9	1.0	1.7	1.2	0.4	1.3	2.1	1.5	1.9	2.1	1.2		1.4	1.9	0.0	0.3	0.5	0.6	4.5	0.5	1.4	4.1	1.8	1.5	0.4	1.4	2.3	0.3	4.6	1.0	0.3	0.0	1.3	1.9	0.4	0.5	1.6	0.1	0.5	0.6	3.4	2.2	1.8	1.9	1.7	5.1	0.9	3.0	0.6	0.7	0.9	3.6	0.0	1.7	0.3	0.0	0.4	0.3	1.8	1.6	0.9	2.3	0.0	0.4	0.7	0.5	0.6	0.8	0.6	0.3	0.5	3.3	1.8	0.7	0.3	2.1	1.4	0.0	0.7	1.5	1.4	0.9	0.0	0.5	0.3	0.3	0.4	0.4	0.3	0.5	0.3	0.6	0.1	0.7	0.8	0.9	0.4	0.7	0.0	0.8	0.4	1.4	1.2	1.9	1.6	0.9	1.5	1.8	1.3	1.8	1.0	1.3	1.4	8.6	6.4	6.9	35.9	15.5	35.9	10.6	7.6	9.6	23.9	11.3	3.8	0.0	5.7	5.5	9.2	110.5	0.0	11.0	14.6	1.9	4.1	3.6	5.2	7.0	7.3	27.6	8.2	73.2	9.1	0.0	8.1	9.2	9.5	15.8	3.4	7.9	13.5	0.0	32.0	101.6	8.9	8.2	22.3	22.0	3.0	8.4	17.9	14.2	68.4	14.1	14.0	8.2	57.3	113.9	10.9	8.2	13.2	12.3	11.6	10.5	9.2	7.2	70.0	6.6	11.1	8.5	3.5	6.7	16.3	50.7	0.0	16.7	4.9	6.1	11.2
HES4	bHLHb42	ENSG00000188290	"Hes family bHLH transcription factor 4"	Q9HCC6	1	998962-1000172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 345.1;Paneth cells: 397.4;Prostatic glandular cells: 286.6;Smooth muscle cells: 385.7;Urothelial cells: 494.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"eosinophil: 12.4"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 12.4"	"Cell line enriched"	"Detected in many"	7	"HEK 293: 198.1"					"Low region specificity"	"Detected in all"			HPA062465			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA062465: AB_2684771"	"unprognostic (6.23e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.08e-3)"	10.5	1.9	12.9	0.7	15.3	0.5	9.1	8.1	34.3	9.2	0.9	11.0	1.2	10.5	0.4	7.5	10.3	0.1	22.6	6.8	17.9	13.6	3.0	10.8	0.2	22.3	15.8	3.9	5.6	0.9	8.4	1.5	17.0	11.4	0.3	0.8	7.7	2.2	4.0	8.4	3.9	1.2	6.0	4.4	5.6	2.6	24.0	1.4	6.0	0.9	0.3	10.0	8.4	4.0	14.3	1.6	1.5	0.2	0.2	0.1	17.6	8.6	1.0	5.2	5.4	2.3	4.5	0.0	20.0	0.7	2.3	25.3	2.1	0.3	0.2	0.1	198.1	0.1	2.4	2.9	1.7	0.0	1.7	0.1	2.0	0.3	0.4	0.7	0.6	2.5	4.1	0.3	0.0	7.6	11.7	0.6	0.2	3.1	19.2	0.2	1.9	4.4	2.0	0.0	1.1	4.6	5.8	14.3	29.1	0.7	10.5	0.0	1.1	1.6	0.6	0.0	4.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	12.4	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	12.9	15.3	8.1	34.3	6.8	17.9	22.3	15.8	17.0	6.0	24.0	4.0	90.1	0.0	0.0	18.6	15.3	52.1	345.1	1.7	6.8	8.9	158.9	149.4	13.3	20.0	4.0	58.8	0.0	1.5	22.3	88.3	31.3	44.1	1.0	74.7	30.0	63.4	10.7	2.7	12.9	2.9	43.9	65.5	11.2	153.3	53.5	3.1	37.5	0.8	4.8	0.0	25.9	25.4	4.1	10.0	120.5	1.5	7.5	70.8	115.6	11.2	5.2	129.7	12.3	8.5	1.7	10.7	397.4	15.4	2.3	286.6	1.5	0.8	1.1	11.3	164.3	157.8	385.7	3.2	29.6	43.0	82.7	3.4	27.4	2.0	56.9	494.9
HES5	bHLHb38	ENSG00000197921	"Hes family bHLH transcription factor 5"	Q5TA89	1	2528745-2530263	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 18.7;skin 1: 4.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 24.8;Astrocytes: 53.5;Muller glia cells: 113.4;Oligodendrocyte precursor cells: 15.6"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.8"	"Group enriched"	"Detected in many"	4	"amygdala: 10.3;basal ganglia: 14.2;cerebral cortex: 5.1;hypothalamus: 12.4;thalamus: 18.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA065458, HPA076164"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		No	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA065458: AB_2685492, HPA076164: AB_2732303"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.60e-4)"	"unprognostic (1.76e-4)"	"unprognostic (1.60e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (9.95e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-1)"	0.5	0.0	10.3	0.0	14.2	0.0	0.3	0.7	5.1	0.4	0.0	0.5	0.0	0.2	0.0	0.8	0.2	0.0	2.5	2.8	12.4	0.1	0.3	0.3	0.0	1.1	0.9	0.1	0.0	0.0	2.5	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.1	4.8	0.2	0.0	0.4	0.2	0.1	0.9	18.7	0.0	0.5	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	14.2	0.7	5.1	2.8	12.4	1.1	0.9	1.0	0.4	18.7	0.0	24.8	0.0	0.0	53.5	0.2	0.1	0.3	0.2	1.8	2.9	1.1	2.8	1.4	0.0	0.3	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	5.4	0.8	5.1	0.0	0.0	0.7	0.0	0.0	0.3	0.0	8.9	0.0	0.1	0.0	0.0	0.0	3.3	0.8	4.9	0.0	0.0	0.8	0.0	0.0	0.3	0.0	1.9	0.0	113.4	0.0	15.6	0.3	0.0	2.9	0.0	0.0	0.5	0.1	0.0	0.0	7.7	0.0	1.0	6.2	0.0	0.4	6.2	1.4	0.0	0.5	0.0	3.0	0.2
HES6	bHLHb41	ENSG00000144485	"Hes family bHLH transcription factor 6"	Q96HZ4	2	238238267-238240662	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.2;pituitary gland: 62.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 86.0;Enteroendocrine cells: 109.9;Erythroid cells: 120.0;Intestinal goblet cells: 176.0;Ionocytes: 93.6"	"Cancer enhanced"	"Detected in all"		"glioma: 62.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"eosinophil: 5.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in many"		"NB-4: 196.8;SCLC-21H: 123.5;SK-MEL-30: 192.4;THP-1: 85.1;U-937: 100.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073997			Approved	"Nuclear bodies,Cytosol"		NA	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	Cytosol	"HPA073997: "	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.79e-4)"	"prognostic favorable (9.18e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.35e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.49e-2)"	3.4	10.2	44.8	2.8	53.1	12.5	2.6	55.1	57.6	13.8	32.4	22.3	18.4	16.9	0.5	3.0	14.0	1.6	4.7	43.8	37.8	10.0	8.3	5.5	3.1	49.6	43.3	2.6	23.5	4.1	62.6	1.1	44.8	3.9	9.0	1.0	5.1	1.0	25.8	2.6	19.8	2.7	56.2	9.1	11.1	25.5	43.9	3.6	5.1	1.6	2.2	4.6	2.8	58.2	4.9	5.6	23.5	26.9	1.6	0.8	15.1	1.7	1.8	2.3	3.5	4.8	3.0	0.3	3.9	0.4	9.8	3.1	24.1	1.8	0.7	11.5	30.4	5.9	4.5	50.7	3.8	42.7	33.0	2.3	14.6	3.4	4.7	1.3	1.5	25.1	53.4	0.5	1.5	12.3	6.3	196.8	38.5	4.8	4.3	28.1	62.5	11.7	3.1	2.3	123.5	54.6	7.7	10.7	192.4	2.8	9.4	85.1	1.9	2.3	4.9	13.2	14.7	11.6	2.1	8.9	8.2	100.2	4.2	0.1	0.1	5.1	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.4	0.1	44.8	53.1	55.1	57.6	43.8	37.8	49.6	43.3	44.8	56.2	43.9	58.2	3.3	0.0	1.1	63.0	5.7	3.3	6.4	3.0	1.8	9.2	8.8	5.2	6.5	1.5	4.7	3.7	22.9	2.2	30.5	37.1	7.9	9.2	32.2	86.0	7.8	3.8	109.9	120.0	9.6	31.8	3.9	3.5	13.7	6.7	0.0	39.0	2.2	5.2	5.5	3.3	10.3	176.0	93.6	4.8	5.8	9.3	1.5	7.4	35.6	8.4	8.3	6.2	23.7	17.6	19.6	14.9	22.2	1.5	7.1	5.2	13.1	4.9	9.5	4.9	0.0	26.9	12.5	35.3	36.5	2.9	2.0	0.3	9.4	30.0	41.8	2.2
HEY1	"bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1"	ENSG00000164683	"Hes related family bHLH transcription factor with YRPW motif 1"	Q9Y5J3	8	79762371-79767857	"Cancer-related genes, Predicted intracellular proteins, Transcription factors, Transporters"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.2;Endothelial cells: 47.6;Extravillous trophoblasts: 112.6;Skeletal myocytes: 74.5"	"Cancer enhanced"	"Detected in all"		"glioma: 43.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 125.7;PC-3: 28.8;SK-MEL-30: 93.3;WM-115: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055599, HPA063472"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA055599: AB_2682858, HPA063472: AB_2685018"	"unprognostic (1.15e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.71e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.77e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.00e-1)"	21.1	2.2	17.4	2.1	23.0	0.6	19.0	19.4	19.1	7.2	9.6	6.7	1.7	3.5	0.9	2.8	3.9	4.2	23.9	18.4	20.3	2.8	2.8	15.2	2.2	18.1	21.0	2.0	3.4	3.3	18.4	17.8	19.3	6.0	2.6	5.3	10.1	1.7	19.5	4.2	5.8	3.2	19.1	2.4	4.8	3.1	22.8	3.4	6.5	16.2	2.5	9.3	5.2	15.4	1.7	0.1	1.1	9.1	0.8	0.7	22.0	2.1	2.1	0.3	0.3	0.1	0.1	3.3	2.3	1.0	1.0	4.6	4.9	0.1	0.2	0.5	125.7	0.0	4.1	2.1	1.4	0.0	0.7	1.3	3.7	0.1	16.2	0.4	3.4	0.0	9.0	3.6	1.3	0.1	0.0	0.5	0.1	0.3	28.8	0.0	4.6	3.3	0.4	3.9	5.2	14.6	0.1	2.4	93.3	19.6	0.1	0.1	2.0	0.7	2.4	0.0	1.8	3.3	0.7	0.2	3.4	0.0	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	0.0	1.3	0.0	0.0	0.0	17.4	23.0	19.4	19.1	18.4	20.3	18.1	21.0	19.3	19.1	22.8	15.4	105.2	0.0	1.8	15.0	0.8	3.2	3.4	27.6	2.8	6.8	8.6	12.2	4.3	0.0	19.5	0.0	0.0	6.8	1.8	5.3	15.6	2.6	4.6	12.6	4.1	47.6	36.8	0.0	7.7	1.2	112.6	5.3	1.5	33.5	10.8	1.9	41.0	0.9	1.8	21.9	8.0	2.0	26.4	0.6	5.7	3.2	0.0	2.3	33.8	20.6	0.0	10.9	0.0	18.6	1.0	0.7	7.5	0.4	0.8	1.7	0.2	0.4	7.7	12.2	0.0	74.5	12.1	0.6	15.4	3.4	3.0	23.4	1.1	1.5	2.5	2.6
HEYL	"bHLHb33, HESR3, HEY3"	ENSG00000163909	"Hes related family bHLH transcription factor with YRPW motif like"	Q9NQ87	1	39623435-39639643	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 69.5"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 17.5;Leydig cells: 26.1;Peritubular cells: 56.8;Sertoli cells: 52.6;Skeletal myocytes: 33.4;Smooth muscle cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 8.0;LHCN-M2: 20.8;RH-30: 26.5;THP-1: 6.2;U-266/84: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001438, HPA076960"	Approved		Approved	Mitochondria,Cytosol		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Cytosol	"HPA001438: AB_1079052, HPA076960: AB_2732326"	"unprognostic (1.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.26e-6)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.63e-5)"	17.9	12.4	9.5	5.6	12.0	0.1	9.3	10.5	6.9	18.5	4.1	7.2	1.9	27.9	5.7	4.8	17.4	8.0	57.0	5.4	15.0	9.5	4.2	23.5	1.7	11.3	15.6	13.4	69.5	2.4	15.3	29.5	12.9	17.0	3.4	6.7	2.7	14.4	6.0	2.9	4.9	25.0	7.3	6.3	6.0	16.0	17.1	1.3	20.4	5.4	2.0	8.7	11.3	8.3	0.0	2.8	4.8	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	2.0	0.3	0.0	1.6	0.5	0.0	0.0	2.8	0.0	0.3	0.0	3.2	5.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	8.0	0.5	0.7	20.8	1.9	0.0	0.1	0.0	0.2	0.1	1.4	26.5	0.2	0.0	0.5	0.6	0.0	0.0	0.1	0.0	1.1	0.0	6.2	0.0	0.0	0.2	0.0	0.0	0.7	7.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	12.0	10.5	6.9	5.4	15.0	11.3	15.6	12.9	7.3	17.1	8.3	1.3	0.0	0.0	0.7	0.0	0.9	0.1	0.0	0.0	0.9	0.1	0.0	3.6	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	1.0	5.4	1.3	4.0	1.9	0.0	0.0	0.1	3.5	0.3	13.3	2.0	2.4	0.0	0.7	1.4	0.0	0.3	1.7	0.2	0.2	0.0	0.0	2.3	17.5	26.1	0.4	5.4	4.7	0.1	0.4	0.0	0.0	2.4	2.8	0.3	56.8	0.0	0.2	0.0	0.1	0.0	3.9	52.6	33.4	29.5	0.4	2.0	0.1	0.1	0.3	0.3	1.9	0.4	0.2
HGH1	"Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236"	ENSG00000235173	"HGH1 homolog"	Q9BTY7	8	144137774-144140851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 26.4;PC-3: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042470	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA042470: AB_2678013"	"unprognostic (2.13e-2)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (4.62e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.48e-1)"	2.3	3.2	1.8	1.0	1.3	0.6	1.5	1.4	1.8	2.0	1.2	1.9	0.6	2.3	0.1	3.1	1.7	0.5	2.1	1.7	1.1	1.9	3.2	1.3	0.6	2.1	1.2	1.7	3.1	0.8	1.4	0.4	1.4	1.9	0.5	0.1	1.8	0.8	2.7	2.2	1.6	0.7	1.3	2.2	2.9	2.4	1.5	0.6	2.0	1.2	0.6	2.6	1.9	1.6	8.3	2.7	1.9	3.5	2.7	1.7	4.9	13.8	1.1	2.9	1.9	3.6	2.1	23.9	18.7	2.6	1.1	8.6	3.8	1.9	0.9	11.7	14.5	9.1	2.4	1.8	2.6	5.1	5.9	1.2	5.9	3.2	2.0	1.0	1.3	4.9	26.4	0.9	1.8	6.9	17.5	4.7	5.4	3.1	46.6	21.8	1.6	3.7	1.7	1.9	4.1	4.4	6.4	3.4	5.1	0.6	2.9	1.8	4.9	1.7	14.2	5.1	16.5	13.9	9.7	6.1	1.7	8.5	2.8	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.4	0.7	0.2	0.8	0.4	0.3	0.0	0.6	0.2	0.1	0.1	0.1	1.8	1.3	1.4	1.8	1.7	1.1	2.1	1.2	1.4	1.3	1.5	1.6	5.2	0.0	2.4	2.6	5.8	0.0	2.6	0.0	5.2	4.2	6.7	5.7	2.2	2.8	0.6	5.5	0.0	11.1	7.2	1.3	11.7	3.5	11.2	2.8	7.0	3.1	4.9	5.9	1.2	1.8	13.4	4.3	7.1	4.0	0.0	7.9	1.4	9.9	12.2	6.7	1.2	4.0	0.0	4.8	0.0	22.1	7.5	5.6	0.0	1.0	3.5	8.3	14.4	0.0	1.0	2.9	5.6	3.4	4.9	3.2	5.4	10.2	1.5	3.7	6.6	2.6	3.8	15.1	14.8	6.9	0.0	3.1	5.9	11.0	6.5	1.6
HIGD2A	"MGC2198, RCF1B"	ENSG00000146066	"HIG1 hypoxia inducible domain family member 2A"	Q9BW72	5	176388751-176389761	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042715	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria	Cytosol	"HPA042715: AB_2678127"	"unprognostic (9.24e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-2)"	146.1	175.6	143.3	87.0	146.2	133.1	113.5	147.2	175.0	104.7	168.0	199.4	118.9	111.7	51.3	130.0	105.0	80.5	318.7	139.8	146.0	182.7	163.3	95.7	132.9	143.9	142.2	118.7	108.7	204.9	125.1	54.6	141.6	127.9	96.3	45.5	163.2	92.7	422.5	140.8	136.6	68.1	145.3	129.3	148.6	66.0	149.0	110.7	114.0	297.9	92.7	152.3	105.2	145.7	104.9	166.6	99.0	172.6	98.5	186.4	262.2	66.6	109.7	164.7	206.4	176.0	202.2	183.3	149.9	107.1	214.2	127.3	146.2	260.6	65.9	424.0	234.0	92.6	161.7	244.7	137.4	149.7	230.1	238.2	213.2	93.7	113.3	126.3	141.7	146.5	104.0	341.5	124.0	315.9	165.3	178.1	124.8	195.5	181.7	157.1	75.6	324.7	265.5	158.7	107.9	141.5	71.4	295.2	310.5	100.7	173.3	233.7	96.8	118.5	124.7	110.2	142.5	165.2	216.6	158.4	150.5	254.1	77.5	284.2	743.6	219.8	391.2	975.8	389.5	618.1	540.1	452.6	930.0	496.0	488.1	464.2	124.6	308.0	1024.9	616.8	621.8	971.3	143.3	146.2	147.2	175.0	139.8	146.0	143.9	142.2	141.6	145.3	149.0	145.7	100.4	73.7	78.6	0.0	212.5	232.2	332.8	358.0	272.0	60.5	225.5	288.5	145.3	174.5	191.0	182.1	12.5	223.0	184.2	415.6	534.1	204.5	83.9	140.0	120.6	110.9	266.6	90.8	0.0	237.3	185.4	129.1	142.2	124.2	130.0	157.0	120.3	217.0	378.7	65.6	0.0	450.7	219.7	458.8	345.2	56.8	140.1	292.1	257.9	0.0	449.7	138.1	230.7	0.0	0.0	110.0	493.0	85.0	184.2	292.6	313.8	542.8	142.3	47.7	118.3	145.9	138.8	96.7	79.4	301.8	225.0	280.2	223.7	182.1	385.3	532.4
HIGD2B	HIGD2BP	ENSG00000175202	"HIG1 hypoxia inducible domain family member 2B"	Q4VC39	15	72675798-72686182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	10	"testis: 3.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 18.3;Late spermatids: 8.6;Spermatocytes: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019016, HPA042715"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA019016: AB_1850711, HPA042715: AB_2678127"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"		"unprognostic (2.24e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.80e-2)"	"unprognostic (6.11e-4)"	"unprognostic (6.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.3	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	8.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.1	0.0	20.1	1.5	0.0	0.1	0.1	0.1	0.0	0.1	0.2
HINT3	"FLJ33126, HINT4"	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956770-125980244	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 352.2;Spermatocytes: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Mitochondria"	Cytosol	"HPA027914: AB_10602424"	"prognostic unfavorable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	18.1	23.4	31.2	12.6	33.9	12.3	23.0	31.0	43.3	18.3	22.8	19.6	15.7	16.6	17.8	22.3	16.4	16.2	28.4	29.4	31.4	22.2	28.3	21.0	11.3	33.9	32.1	14.7	19.3	30.6	14.4	14.5	33.8	29.7	17.6	15.3	25.5	22.4	112.8	17.5	16.0	17.3	36.6	10.5	24.8	12.3	32.5	13.6	23.5	84.6	11.4	18.4	10.8	38.0	13.2	10.3	14.1	29.5	5.5	14.8	17.5	14.1	20.2	10.6	11.0	25.6	7.2	28.4	25.5	9.4	23.7	19.5	18.2	11.9	12.3	27.4	23.5	12.0	15.1	21.6	25.4	19.2	19.6	11.8	25.9	10.7	27.0	27.3	16.1	21.0	38.3	18.7	10.6	20.1	15.5	13.7	4.8	27.1	9.9	12.8	9.7	9.7	21.8	24.0	28.2	17.4	12.9	18.0	67.8	10.2	18.4	28.9	11.4	7.2	10.1	34.8	20.3	27.1	33.3	18.2	20.4	18.1	9.5	12.5	9.3	8.9	4.4	5.9	4.6	7.0	5.9	4.8	7.7	6.3	6.0	5.3	11.2	5.9	8.6	4.3	6.3	5.3	31.2	33.9	31.0	43.3	29.4	31.4	33.9	32.1	33.8	36.6	32.5	38.0	11.7	80.1	61.2	11.8	16.7	18.1	10.2	22.1	24.5	21.8	26.5	18.4	38.7	10.0	29.8	16.5	8.4	19.2	13.4	17.2	33.2	29.3	352.2	23.6	11.5	12.3	16.3	6.9	27.0	20.2	6.4	13.7	19.4	25.8	9.5	15.2	10.4	17.5	27.2	6.7	29.8	25.1	20.3	15.3	14.6	78.3	9.9	19.3	21.4	5.6	17.3	43.4	11.3	21.6	40.0	21.4	28.7	17.3	8.1	20.9	15.3	28.0	25.7	25.4	6.6	18.3	15.1	110.7	40.2	21.5	17.3	26.4	11.3	14.6	18.5	19.9
HLCS	HCS	ENSG00000159267	"Holocarboxylase synthetase"	P50747	21	36748626-36990236	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 86.2;Inhibitory neurons: 99.7;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017379	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA017379: AB_1850768"	"prognostic unfavorable (7.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.02e-1)"	5.0	5.1	4.9	4.2	5.5	3.3	7.4	9.1	5.8	5.1	9.4	4.7	4.2	4.0	7.0	6.1	5.3	4.2	3.7	6.3	5.4	6.4	10.6	4.9	3.7	5.9	4.6	3.8	7.6	10.6	8.8	4.1	6.3	8.9	4.4	6.1	8.5	6.6	13.3	2.8	4.9	4.5	4.1	3.1	5.7	5.7	5.4	3.3	10.7	6.2	4.3	5.4	2.8	5.5	23.8	10.4	13.0	9.6	14.8	13.7	13.3	13.0	12.7	7.1	7.0	10.8	11.0	10.6	6.4	21.4	13.0	8.2	5.9	11.6	5.5	21.0	9.2	16.4	9.6	6.7	14.9	8.6	11.0	10.2	17.0	10.6	23.6	15.5	9.0	12.0	19.7	31.9	17.4	14.2	4.6	5.4	21.8	16.7	11.3	7.1	7.5	11.2	10.8	24.8	8.3	9.9	16.7	8.8	14.8	10.0	16.2	9.1	10.5	9.1	2.7	8.9	7.8	25.6	19.8	7.1	14.6	11.1	10.7	1.9	0.8	0.8	3.6	2.0	2.9	1.2	1.9	2.3	0.8	1.3	2.4	2.2	1.2	4.8	5.1	1.9	1.6	1.8	4.9	5.5	9.1	5.8	6.3	5.4	5.9	4.6	6.3	4.1	5.4	5.5	3.0	9.6	12.5	46.4	4.1	3.3	9.2	5.3	6.8	12.8	9.4	7.4	4.5	8.6	8.4	12.9	22.9	8.9	5.1	3.5	7.9	7.8	5.6	8.0	8.0	3.8	6.0	7.4	86.2	8.1	5.4	5.1	9.7	8.0	5.7	7.9	4.2	18.5	4.6	18.5	99.7	5.2	4.1	5.1	2.1	4.3	4.4	4.0	0.0	45.9	3.2	5.6	8.2	79.9	80.1	9.0	2.9	7.2	4.2	7.8	8.0	6.1	9.2	14.2	0.0	9.0	6.8	5.2	11.5	8.7	4.0	5.1	5.5	11.1	5.4	6.9
HLX	"HB24, HLX1"	ENSG00000136630	"H2.0 like homeobox"	Q14774	1	220879431-220885059	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 86.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.7;Endothelial cells: 32.5;Hepatic stellate cells: 47.5;Hofbauer cells: 34.1;Kupffer cells: 24.8;Langerhans cells: 23.5;monocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 65.1;neutrophil: 55.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 65.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 32.4;THP-1: 100.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005968	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA005968: AB_1079066"	"unprognostic (6.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.28e-6)"	"unprognostic (8.44e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	35.2	4.7	1.4	10.3	1.3	86.5	18.6	1.4	2.0	7.5	1.5	44.4	4.8	5.5	0.5	3.9	9.3	9.6	18.9	2.0	1.6	6.8	21.8	23.1	8.5	1.9	1.7	4.2	4.3	1.3	3.0	13.8	2.0	6.3	2.0	0.0	3.5	0.4	9.2	8.7	18.9	5.6	1.9	15.7	5.2	1.8	2.6	2.1	9.5	4.2	2.3	11.0	8.8	1.9	0.0	2.1	0.0	3.2	9.2	14.7	3.0	11.4	18.9	12.8	10.6	0.2	0.3	0.0	0.1	6.8	2.5	0.0	0.5	0.0	5.3	3.0	5.9	0.0	1.1	0.3	15.1	3.9	0.8	15.4	0.2	14.7	0.8	1.1	5.7	0.0	4.0	0.0	1.6	0.0	0.0	10.3	0.3	0.0	5.2	0.3	9.0	0.1	0.8	0.1	0.0	2.4	0.7	0.0	32.4	0.1	0.0	100.4	1.8	8.7	0.0	1.3	9.3	0.0	0.0	0.0	14.1	12.3	3.6	65.1	10.4	22.3	0.0	3.4	0.0	5.7	0.0	0.0	13.0	2.7	0.0	0.0	55.9	0.7	0.7	8.7	0.4	3.3	1.4	1.3	1.4	2.0	2.0	1.6	1.9	1.7	2.0	1.9	2.6	1.9	35.7	9.6	5.3	1.0	4.3	2.8	0.1	0.0	0.6	0.1	0.5	1.3	5.7	0.0	0.0	0.0	0.0	0.6	3.0	0.4	0.0	0.5	0.5	0.2	2.6	32.5	0.0	8.4	0.3	0.4	0.7	8.4	0.5	0.3	3.8	0.1	47.5	10.8	34.1	0.0	0.2	0.3	0.0	24.8	23.5	0.4	2.5	17.8	0.0	4.7	44.2	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.2	0.0	0.1	0.0	0.0	6.6	7.5	10.6	0.1	2.2	0.3	3.1	0.4	1.1	0.4	0.3	0.4
HMCN1	"ARMD1, FBLN6, FIBL-6, FIBL6"	ENSG00000143341	"Hemicentin 1"	Q96RW7	1	185734391-186190949	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Cell division, Sensory transduction, Vision"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.8;Endothelial cells: 21.4;Fibroblasts: 22.2;Horizontal cells: 26.9;Microglial cells: 45.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 22.3;hTERT-RPE1: 20.1;MCF7: 76.5;SK-MEL-30: 50.2;WM-115: 43.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 9.9"	"HPA008220, HPA051677"	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		9200000	"Cluster 35: T-regs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Cytosol"		"HPA008220: , HPA051677: AB_2681572"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.00e-3)"	9.7	1.4	1.3	0.6	1.2	0.0	8.4	0.9	1.1	3.7	1.3	9.0	0.9	1.9	2.5	5.4	1.8	6.5	8.4	0.8	1.1	2.5	7.8	20.3	0.4	1.5	1.9	3.9	0.9	0.9	3.2	4.8	1.5	7.5	2.8	0.6	7.7	1.4	4.8	4.1	3.1	4.3	1.4	8.4	1.7	2.6	1.7	0.8	3.2	7.0	2.4	1.8	3.8	0.9	0.2	0.1	1.6	0.0	4.7	4.7	0.0	0.5	0.9	0.3	0.5	0.0	0.1	1.9	0.2	22.3	1.6	5.0	0.1	0.2	0.1	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.7	0.0	5.6	0.4	20.1	2.8	0.0	0.2	0.0	0.0	76.5	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	50.2	4.5	0.1	0.0	0.0	13.7	1.3	0.0	5.1	0.2	0.0	0.3	2.7	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	1.2	0.9	1.1	0.8	1.1	1.5	1.9	1.5	1.4	1.7	0.9	33.8	3.2	7.0	0.3	0.0	3.2	0.2	4.9	2.2	1.7	1.2	1.8	2.8	0.0	0.8	0.0	0.0	0.1	0.2	0.3	0.0	0.0	8.3	0.6	1.5	21.4	0.0	0.0	1.1	0.0	0.8	22.2	0.0	0.9	0.0	5.2	7.9	1.9	0.1	26.9	3.8	0.0	0.0	0.3	2.8	2.7	3.7	0.4	5.4	45.0	0.0	0.1	0.0	3.0	1.5	0.0	0.0	2.2	1.2	0.1	0.0	0.2	1.0	0.0	0.0	2.5	7.7	0.5	0.1	0.4	1.7	0.0	0.4	0.1	0.0	0.2
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	92.4	174.4	132.9	69.5	136.2	72.8	116.1	141.8	190.4	82.2	153.6	100.6	90.4	93.6	168.6	95.1	209.3	82.8	227.2	132.9	135.8	168.4	147.5	111.5	127.1	139.5	135.2	105.5	90.3	116.7	152.0	114.6	140.8	84.7	73.4	164.6	154.3	68.0	151.4	81.1	74.1	76.1	136.6	91.5	106.9	83.2	133.7	112.7	113.2	130.1	109.9	77.1	81.9	145.6	101.7	90.3	309.7	135.0	121.9	99.6	70.1	69.0	73.7	75.6	110.3	508.3	83.9	1.2	124.2	56.5	101.0	63.4	203.6	78.3	74.2	298.7	170.9	355.9	292.3	268.9	78.0	294.9	52.3	121.5	85.4	50.3	27.7	72.9	170.9	74.3	212.3	275.0	123.8	92.9	136.3	564.7	227.8	87.7	224.5	229.7	472.6	103.8	525.3	145.3	126.0	168.5	131.3	149.4	102.4	271.1	85.1	488.6	75.0	20.9	91.7	73.5	155.3	235.3	375.2	1.9	11.8	1.1	103.0	38.3	147.3	13.6	107.8	148.0	95.9	112.9	75.7	92.8	179.2	99.8	88.7	106.8	7.2	142.3	143.9	208.6	90.4	169.3	132.9	136.2	141.8	190.4	132.9	135.8	139.5	135.2	140.8	136.6	133.7	145.6	140.6	96.1	167.9	129.9	110.1	171.1	193.7	516.8	234.5	261.8	301.4	376.3	424.5	231.6	373.7	242.8	75.0	940.6	169.9	35.3	602.6	229.3	72.5	775.8	108.1	166.0	272.9	95.4	115.8	198.6	823.7	165.3	116.2	199.2	109.6	80.9	261.3	256.3	309.7	195.2	105.3	131.1	435.4	186.0	206.5	60.9	187.0	148.4	257.9	58.1	403.3	320.2	198.8	66.9	159.7	107.2	52.4	167.0	211.3	85.3	36.5	852.5	900.3	134.3	144.7	102.4	233.9	26.8	52.0	260.0	149.9	555.3	109.9	232.4	121.5	173.2
HMOX2	HO-2	ENSG00000103415	"Heme oxygenase 2"	P30519	16	4474690-4510347	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 515.3;Late spermatids: 2001.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025464, HPA040611"	Supported		Approved	Vesicles,Cytosol		NA	NA		12000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 43: Testis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"CAB025464: , HPA040611: AB_10961034"	"unprognostic (3.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (2.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (9.87e-2)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.51e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.64e-1)"	63.0	51.3	43.7	23.2	51.9	18.3	55.7	56.9	55.2	47.1	36.2	41.0	34.8	35.8	22.5	84.5	35.9	26.9	149.9	47.7	50.0	71.2	109.5	46.6	33.2	55.8	49.2	25.6	39.7	38.6	43.8	17.9	57.1	34.5	25.1	22.5	44.1	14.1	37.9	44.4	42.6	22.7	44.7	67.8	100.2	152.2	54.3	24.3	41.9	32.3	36.3	33.2	49.0	53.5	82.9	38.2	20.5	45.6	65.8	31.5	33.8	53.9	26.5	48.3	43.7	48.3	55.5	36.9	64.0	55.7	34.6	51.5	75.4	126.9	48.4	51.5	48.4	27.5	35.2	63.3	43.7	56.8	44.4	48.7	41.7	55.7	37.6	37.9	83.7	46.9	44.7	18.1	44.5	114.3	48.7	58.4	34.2	81.1	35.7	54.3	33.7	84.4	72.3	51.8	34.4	19.4	43.1	95.1	66.4	33.9	58.2	36.3	91.7	25.7	39.9	120.3	30.1	24.3	30.0	78.0	16.5	52.5	35.2	87.6	37.1	252.6	166.3	46.5	142.1	69.8	153.8	168.5	73.6	66.8	145.5	151.6	125.1	99.0	35.7	39.2	155.4	142.3	43.7	51.9	56.9	55.2	47.7	50.0	55.8	49.2	57.1	44.7	54.3	53.5	33.8	35.3	41.5	7.8	37.2	54.8	35.7	73.5	19.4	29.3	26.4	29.1	70.6	32.9	54.5	36.8	20.9	75.3	59.8	70.7	129.1	79.7	515.3	38.6	30.9	53.4	31.8	14.3	23.0	90.7	69.6	39.4	89.7	53.3	19.7	38.8	75.0	93.0	67.2	28.6	21.6	37.6	85.5	23.9	52.9	2001.6	45.4	30.6	62.2	5.6	29.3	53.9	141.1	9.5	32.9	114.9	70.7	56.1	47.1	37.7	110.8	239.3	39.9	27.8	72.3	14.6	58.0	199.7	149.8	28.2	51.6	38.4	88.3	47.4	48.9	28.7
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 299.3;Kupffer cells: 263.7;Proximal tubular cells: 268.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"classical monocyte: 110.9;intermediate monocyte: 89.8;myeloid DC: 68.3;non-classical monocyte: 52.2"	"Group enriched"	"Detected in many"	23	"dendritic cells: 68.3;monocytes: 110.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 227.2;HSkMC: 87.9;RT4: 117.1;SuSa: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		130000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	70.4	18.2	13.0	41.7	13.3	12.6	62.3	13.1	18.8	57.3	19.2	53.9	29.3	62.8	27.1	17.5	34.5	68.7	21.7	15.6	19.1	109.7	245.9	49.0	35.1	16.0	15.3	91.0	29.0	40.2	9.5	46.8	18.1	37.0	56.4	6.1	30.5	44.3	5.9	17.4	29.1	33.1	16.1	37.5	29.1	10.3	14.5	8.2	14.6	11.9	16.4	49.7	24.5	22.2	0.7	0.9	5.6	14.6	61.9	64.6	0.4	3.9	6.2	0.4	2.3	29.7	15.7	0.9	50.2	17.0	0.8	1.1	11.9	0.0	0.1	0.7	4.9	0.2	44.5	227.2	28.0	0.3	0.6	87.9	0.1	21.5	0.0	4.7	15.9	0.1	0.5	0.7	47.4	3.7	0.0	0.5	28.1	39.3	5.6	0.5	1.5	0.2	67.9	117.1	0.1	0.8	22.1	28.4	0.1	107.9	1.0	53.2	4.8	4.8	11.8	6.2	16.3	0.4	0.3	0.7	20.9	27.8	3.3	1.3	110.9	0.7	0.5	89.8	0.3	1.8	0.2	0.2	68.3	0.5	0.3	0.4	3.9	0.5	52.2	1.5	0.7	32.6	13.0	13.3	13.1	18.8	15.6	19.1	16.0	15.3	18.1	16.1	14.5	22.2	15.5	28.9	44.1	9.4	5.0	35.6	81.5	64.6	30.7	0.7	78.1	65.4	2.2	133.0	88.9	60.7	0.0	54.9	2.6	59.4	123.3	122.1	1.5	28.3	50.6	9.4	16.4	16.8	16.8	48.0	81.6	54.2	20.9	115.3	0.0	17.4	19.2	165.7	299.3	0.0	13.8	67.8	24.4	263.7	97.2	4.2	131.4	127.4	56.9	31.9	122.0	25.5	4.1	45.8	14.3	71.0	108.6	105.3	0.2	39.8	31.9	268.3	38.4	0.8	78.9	55.2	55.7	0.5	0.9	33.2	25.9	37.6	4.0	43.9	83.5	126.1
HNRNPLL	HNRPLL	ENSG00000143889	"Heterogeneous nuclear ribonucleoprotein L like"	Q8WVV9	2	38561969-38603586	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 155.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046084	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA046084: AB_10960895"	"unprognostic (2.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-2)"	16.0	16.4	16.3	12.5	20.7	51.7	14.7	19.3	21.3	16.2	12.9	16.1	15.5	18.2	13.9	10.2	16.7	14.1	12.8	28.6	8.3	11.1	10.8	16.4	12.5	5.9	8.1	16.9	15.9	16.8	9.2	13.1	7.2	13.9	11.8	26.6	12.8	15.0	13.8	11.4	12.7	12.8	7.8	12.0	15.7	22.6	9.3	31.0	17.7	11.9	9.6	15.2	12.8	15.8	36.7	16.9	48.2	28.4	22.9	21.6	30.1	33.8	27.5	28.8	24.1	19.0	20.7	0.5	29.5	30.4	30.9	23.0	30.7	25.4	29.6	54.6	26.8	26.7	32.3	48.6	21.6	49.9	26.4	16.9	19.6	24.0	26.5	28.5	30.6	23.9	45.9	79.7	34.3	17.2	54.9	27.2	48.4	35.2	30.6	10.6	33.9	18.1	25.0	47.2	32.9	36.9	29.8	25.8	26.0	26.7	21.8	21.6	32.0	21.5	32.1	23.8	28.1	43.4	46.9	0.3	18.5	12.2	26.8	10.6	6.3	9.7	10.3	3.2	17.9	0.4	24.2	18.9	12.0	1.9	7.2	4.6	4.2	6.8	1.2	0.2	38.5	5.8	16.3	20.7	19.3	21.3	28.6	8.3	5.9	8.1	7.2	7.8	9.3	15.8	17.0	19.2	23.4	26.8	5.5	28.7	35.2	16.5	33.0	13.3	18.0	15.2	18.8	8.6	18.8	27.6	8.4	26.2	6.4	13.9	19.6	22.4	155.6	18.1	18.8	20.1	14.4	22.5	68.6	24.3	28.9	26.0	32.1	11.6	9.5	26.3	22.5	7.4	24.4	6.7	40.1	15.4	6.1	15.0	90.2	48.7	27.7	23.1	39.2	37.5	24.5	22.3	2.1	48.7	28.4	21.2	14.2	52.3	23.0	23.6	16.6	18.6	14.5	11.7	39.5	22.6	28.4	91.1	28.8	19.4	21.3	22.2	48.0	22.3	18.8	21.4
HOMER1	"HOMER-1B, SYN47, Ves-1"	ENSG00000152413	"Homer scaffold protein 1"	Q86YM7	5	79372636-79514134	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;skeletal muscle: 34.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 440.0;Inhibitory neurons: 112.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004437, HPA036521, HPA036522"	Enhanced	Supported	Approved	Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171"	"unprognostic (2.80e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.83e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.86e-3)"	2.8	1.3	2.1	2.3	14.0	0.3	2.5	10.6	27.6	3.9	0.0	1.2	0.7	6.7	4.1	4.6	1.7	6.8	20.5	17.9	5.6	5.8	1.7	5.1	1.1	0.0	3.3	3.8	2.2	4.1	2.3	5.4	2.2	1.7	1.0	5.8	1.2	1.7	34.0	2.4	0.8	4.7	0.6	0.8	2.0	5.3	7.4	1.3	15.0	12.9	1.4	8.0	1.7	15.1	14.6	9.8	14.5	23.1	5.4	3.6	33.5	9.0	7.2	9.0	9.6	15.5	9.9	0.2	26.9	7.8	16.2	7.7	18.2	24.5	15.4	2.2	14.3	17.3	3.9	15.7	8.8	8.3	5.4	5.8	15.4	8.1	22.4	3.6	4.3	26.4	21.7	9.3	11.7	20.4	34.8	5.7	24.5	5.2	8.4	22.4	23.8	22.2	9.6	22.3	14.7	8.8	17.2	12.0	9.3	16.0	16.5	7.2	0.7	6.6	16.7	8.0	16.1	4.5	10.8	8.5	18.8	3.3	13.0	0.0	0.0	0.0	0.4	0.0	0.2	0.4	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	2.1	14.0	10.6	27.6	17.9	5.6	0.0	3.3	2.2	0.6	7.4	15.1	4.3	51.3	9.6	21.9	12.1	64.2	28.0	8.5	20.5	24.4	25.6	18.2	95.2	7.2	12.1	16.5	27.1	58.4	20.3	4.3	11.7	4.8	4.7	30.6	24.9	9.5	11.4	0.4	440.0	4.3	44.8	19.3	5.6	39.9	5.7	16.9	4.6	6.9	11.9	52.2	112.1	7.5	10.2	9.6	29.7	5.5	5.6	13.9	21.4	31.9	3.0	4.4	8.2	86.0	19.3	5.5	2.7	8.6	8.9	23.3	3.1	7.0	10.8	8.1	13.1	29.7	19.3	6.9	10.3	23.9	54.8	84.4	9.8	10.2	3.0	25.2
HOOK3	HK3	ENSG00000168172	"Hook microtubule tethering protein 3"	Q86VS8	8	42896946-43030535	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024756	Approved		Supported	"Golgi apparatus,Centriolar satellite,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA024756: AB_1850913"	"unprognostic (1.84e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.73e-1)"	"unprognostic (8.61e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.13e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.12e-2)"	9.8	6.2	3.1	7.4	8.7	11.1	8.9	11.9	8.9	8.2	1.5	7.5	7.5	8.3	8.2	10.6	7.0	14.4	4.6	4.0	11.1	6.6	7.3	8.0	6.6	7.6	4.9	6.1	7.6	7.2	4.1	8.6	7.3	12.4	7.7	8.8	9.6	7.1	10.6	8.1	8.9	6.7	4.4	6.6	9.5	11.4	4.9	6.4	21.7	8.2	7.4	9.3	6.0	15.5	11.2	10.9	26.2	14.2	19.0	16.7	10.1	14.0	11.6	11.5	10.7	14.5	12.8	13.9	13.9	18.8	10.9	6.4	22.1	9.5	18.5	9.5	6.4	26.3	9.2	10.2	10.6	2.8	14.9	13.7	6.6	15.4	13.2	15.9	16.7	9.7	14.7	15.9	14.0	2.7	21.7	5.2	9.5	8.8	3.3	12.6	27.3	3.5	8.6	16.5	6.7	10.6	15.9	6.7	7.4	11.4	12.2	9.4	30.2	17.1	13.2	20.9	9.0	15.6	18.6	18.1	14.5	9.9	25.8	9.4	2.0	2.0	1.2	2.0	0.4	0.9	1.1	0.9	2.4	0.9	0.6	0.8	2.2	1.2	1.9	1.4	0.8	1.1	3.1	8.7	11.9	8.9	4.0	11.1	7.6	4.9	7.3	4.4	4.9	15.5	75.3	93.0	60.6	90.1	43.2	68.3	36.2	28.7	43.3	40.1	29.4	22.4	48.2	44.3	43.6	25.8	33.3	43.6	40.6	26.1	27.4	47.1	120.3	60.0	84.0	65.2	65.4	34.5	102.1	32.8	25.9	65.8	33.1	93.8	53.8	37.9	60.3	36.4	38.0	75.7	107.6	26.9	20.3	79.4	96.4	36.3	44.7	82.8	55.2	78.7	118.6	36.3	37.0	119.1	157.8	59.7	27.6	53.8	43.6	43.5	37.3	21.4	35.2	32.2	65.7	63.4	74.6	28.0	21.5	39.8	74.7	113.7	40.9	42.6	16.2	71.1
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 716.7;skin 1: 1439.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 750.0;Alveolar cells type 2: 569.2;Basal keratinocytes: 414.6;dendritic cells: 345.3;NK-cells: 1150.4;Suprabasal keratinocytes: 377.2;Syncytiotrophoblasts: 321.8"	"Cancer enhanced"	"Detected in many"		"glioma: 43.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 518.2;NK-cell: 781.6"	"Group enriched"	"Detected in all"	15	"NK-cells: 781.6;T-cells: 518.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.2;HUVEC TERT2: 66.9;RT4: 50.5;TIME: 76.2;U-266/70: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	9.5	33.7	212.8	27.7	235.6	12.1	112.2	215.4	322.0	250.1	239.2	30.5	17.2	19.1	541.4	716.7	10.5	35.1	48.8	237.4	212.0	24.0	2.9	372.8	18.4	237.6	211.6	9.4	5.3	13.3	11.7	59.6	218.5	26.9	7.0	22.1	172.0	64.7	19.2	1439.9	11.3	115.6	238.8	11.9	33.9	45.3	215.0	15.8	224.5	31.8	190.4	34.1	368.6	234.2	0.0	0.0	0.0	0.0	5.0	15.7	5.9	0.0	0.0	1.4	1.0	0.0	0.0	12.6	0.7	0.3	2.3	2.2	1.4	0.0	1.9	31.2	0.2	0.1	0.0	0.0	2.0	0.0	0.1	2.6	11.9	3.6	0.0	3.4	66.9	0.0	0.0	0.5	3.2	0.5	0.1	1.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	50.5	1.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	76.2	0.0	0.2	0.5	0.1	26.0	0.1	0.1	3.2	0.0	0.0	5.7	1.1	2.0	518.2	3.5	282.0	43.4	123.6	227.6	2.6	36.5	20.9	150.8	11.2	781.6	4.5	3.6	9.1	365.6	212.8	235.6	215.4	322.0	237.4	212.0	237.6	211.6	218.5	238.8	215.0	234.2	14.5	750.0	569.2	38.2	23.3	414.6	42.2	8.7	59.7	3.5	3.4	3.0	14.8	2.8	125.6	1.8	0.0	2.3	345.3	0.8	1.9	0.4	33.3	2.8	4.0	28.7	8.4	30.5	62.2	0.2	5.5	16.7	5.6	5.2	10.1	99.5	5.3	1.2	4.0	0.0	7.9	11.1	4.1	11.4	30.9	45.9	3.1	7.9	35.6	14.0	41.4	166.4	1150.4	7.1	6.7	1.7	0.0	3.0	9.6	31.3	1.2	0.6	12.5	5.6	32.9	3.7	104.8	3.3	15.3	31.6	377.2	321.8	219.9	0.1	1.4	28.8
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.8;skin 1: 5.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Distal tubular cells: 1.9;Melanocytes: 3.6;Proximal enterocytes: 3.7;Spermatocytes: 3.5;Suprabasal keratinocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 34.7;BJ hTERT+: 17.5;HaCaT: 15.4;HeLa: 12.4;T-47d: 27.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 1.3"	HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	1.8	5.0	1.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	9.3	1.1	0.0	34.7	3.2	4.9	0.0	5.1	17.5	7.4	5.3	0.3	1.3	0.0	0.3	4.8	0.0	15.4	6.6	0.0	3.3	1.0	0.1	0.2	12.4	0.0	0.0	0.1	0.1	0.9	1.4	0.0	0.4	0.0	0.0	0.3	1.5	0.0	4.8	2.2	0.0	0.1	0.0	10.1	0.1	0.0	0.6	0.0	0.7	1.2	0.0	0.2	3.2	7.8	3.1	0.3	27.4	0.0	0.0	0.0	5.8	0.4	0.3	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.0	0.0	0.0	1.0	1.0	3.5	0.9	0.0	3.8	0.0	0.1	0.0	0.2	0.0
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119937	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.6;endometrium 1: 35.9;vagina: 25.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.0;Collecting duct cells: 14.7;Distal enterocytes: 10.6;Distal tubular cells: 15.6;Endometrial stromal cells: 25.3;Endothelial cells: 13.5;Enteroendocrine cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HEK 293: 40.3;RPTEC TERT1: 32.3;SCLC-21H: 11.8;SiHa: 18.4;U-251 MG: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	66	"spinal cord: 6.6"	HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		No	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA065871: AB_2685573"	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	2.0	0.1	0.0	0.5	0.0	0.0	2.6	0.0	0.0	20.6	0.0	18.7	0.0	35.9	0.5	0.5	4.1	0.1	0.0	0.0	0.0	19.9	0.0	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	16.8	5.8	0.0	0.1	6.7	0.1	1.5	0.1	18.1	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.2	2.2	25.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.2	6.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.1	12.0	0.0	0.0	0.5	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.9	0.0	32.3	0.0	11.8	3.1	18.4	0.0	0.1	2.2	0.0	0.0	2.7	0.0	2.1	1.0	14.4	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.0	0.0	0.0	0.0	0.0	0.9	6.2	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	14.7	0.0	0.0	0.1	10.6	15.6	0.0	0.0	1.2	25.3	13.5	24.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.8	0.2	1.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	1.1	0.0	0.2	0.0	4.4	2.9
HPCAL4	"DKFZp761G122, HLP4"	ENSG00000116983	"Hippocalcin like 4"	Q9UM19	1	39678648-39691485	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.2"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 39.2;Distal tubular cells: 11.7;Excitatory neurons: 16.4;Inhibitory neurons: 20.0"	"Group enriched"	"Detected in some"	11	"glioma: 5.4;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 3.0;naive CD4 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	30	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.7;SH-SY5Y: 9.1;SK-MEL-30: 2.9;U-2 OS: 1.9;U-266/70: 2.4;U-266/84: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053808			Approved	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA053808: AB_2682270"	"unprognostic (2.62e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.56e-4)"	"unprognostic (4.73e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.63e-1)"	0.0	10.1	75.1	0.8	89.6	0.4	0.0	38.1	89.3	0.0	0.0	0.3	0.2	0.0	0.3	5.2	0.0	0.2	1.1	91.2	38.0	4.7	0.0	0.6	1.0	16.8	29.8	2.9	4.9	0.2	2.1	0.0	30.1	0.3	0.1	10.9	0.1	0.1	3.2	0.1	0.4	0.0	28.1	0.3	0.6	4.6	58.1	0.2	0.1	1.2	0.8	0.1	0.1	43.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	1.4	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.8	9.1	0.2	0.0	2.9	0.1	0.0	0.1	0.0	0.0	1.9	0.0	0.0	2.4	3.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	3.0	0.5	0.1	0.0	2.6	0.9	0.0	0.0	0.0	0.0	2.2	0.9	75.1	89.6	38.1	89.3	91.2	38.0	16.8	29.8	30.1	28.1	58.1	43.8	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	39.2	0.1	0.1	1.5	0.0	0.6	1.8	0.0	0.0	0.0	0.0	11.7	0.0	3.4	0.1	0.0	0.1	0.0	0.0	16.4	0.8	0.0	0.6	0.0	0.7	0.0	0.2	0.0	0.0	0.0	1.7	20.0	0.0	0.0	0.0	0.0	1.2	1.2	0.1	0.0	1.0	0.0	4.9	0.0	1.5	1.3	0.2	0.0	1.5	0.3	0.0	0.0	0.1	0.0	1.4	0.0	0.3	0.1	2.8	0.7	0.0	0.0	0.0	0.9	0.1	0.0	0.0
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729470-169757944	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 71.0;Distal tubular cells: 92.0;Extravillous trophoblasts: 61.2;Granulosa cells: 56.4;Hofbauer cells: 56.3;Proximal tubular cells: 63.9;Theca cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (5.63e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	19.3	18.6	18.6	16.4	19.9	16.8	21.2	19.6	26.0	19.6	22.0	22.0	12.2	23.3	24.8	15.7	17.1	13.1	22.5	19.2	19.7	18.1	22.1	14.3	21.1	20.2	19.3	22.7	14.4	16.0	19.5	16.8	20.9	17.3	17.7	21.3	13.2	15.7	21.3	19.6	12.8	24.8	19.6	17.5	15.8	14.1	19.6	26.9	18.8	20.9	21.1	16.8	16.8	22.2	33.7	21.0	71.2	37.7	42.6	52.4	30.3	59.9	58.8	72.8	76.7	14.3	35.5	17.5	15.7	39.2	53.3	14.7	49.5	43.6	76.7	55.1	33.7	57.0	30.0	20.5	29.9	48.7	20.1	34.1	43.2	47.1	14.5	44.1	64.1	59.1	43.7	66.2	64.4	27.3	102.7	42.4	29.2	32.2	27.0	44.7	33.8	21.2	41.9	21.9	17.2	63.1	39.7	17.2	56.3	49.1	34.0	43.1	31.3	24.8	39.2	58.4	54.3	31.3	49.8	52.4	68.3	47.0	40.3	19.3	20.0	22.4	28.7	24.0	34.6	22.0	33.0	35.1	26.1	18.1	32.1	33.3	5.3	25.4	23.7	17.9	38.1	21.9	18.6	19.9	19.6	26.0	19.2	19.7	20.2	19.3	20.9	19.6	19.6	22.2	41.6	44.8	26.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	19.9	29.6	0.0	0.0	17.3	27.6	0.0	71.0	14.3	0.0	92.0	45.7	0.0	31.9	36.9	20.1	0.0	0.0	0.0	46.3	61.2	26.1	0.0	21.9	17.7	56.4	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	31.1	0.0	0.0	1.6	0.0	0.0	63.9	15.3	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.3	10.5	56.0	0.0	0.0
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: AB_2680903, HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	28.1	24.6	64.6	3.5	67.2	2.9	27.0	62.1	86.8	30.4	58.3	34.3	2.8	23.6	12.5	80.1	18.9	3.6	56.8	64.4	64.6	33.8	21.8	27.1	4.3	65.6	65.3	20.0	20.5	13.1	38.2	9.0	66.9	38.3	6.9	10.2	27.3	12.3	59.0	69.9	19.5	8.9	64.2	20.6	24.2	16.5	64.8	9.2	20.5	25.2	10.2	34.5	44.2	65.4	59.0	105.6	44.2	25.6	22.2	17.5	39.6	49.9	25.1	64.5	29.5	62.4	29.7	20.4	10.9	63.2	60.7	43.7	46.0	114.1	19.3	19.5	108.4	6.6	43.7	56.1	38.5	13.9	12.0	28.3	118.0	42.0	51.5	19.6	31.5	34.3	29.7	32.3	40.9	110.6	34.0	50.5	26.5	39.9	94.5	31.6	40.7	18.2	47.0	33.2	87.6	43.7	25.5	55.4	17.9	31.5	43.3	14.8	35.4	47.3	44.7	16.4	39.7	20.3	17.7	15.4	39.1	17.0	38.3	0.0	0.5	0.6	0.8	0.7	0.4	0.3	0.9	0.8	0.7	2.0	0.9	0.3	0.0	0.1	4.0	0.9	1.5	0.2	64.6	67.2	62.1	86.8	64.4	64.6	65.6	65.3	66.9	64.2	64.8	65.4	51.3	12.8	10.7	9.1	18.0	131.2	101.7	25.4	82.0	46.0	38.8	75.7	25.2	22.8	11.2	35.0	18.8	78.8	21.5	72.2	74.3	35.2	1.6	36.1	28.6	32.0	29.3	11.2	9.8	37.4	63.4	25.9	33.6	34.1	2.5	26.8	22.9	17.4	39.9	48.8	10.6	26.5	4.1	11.7	38.4	7.9	17.1	21.3	64.0	10.3	12.8	50.8	11.3	4.0	12.3	48.2	30.9	23.0	26.5	61.2	30.8	54.6	20.0	37.6	32.9	20.3	40.3	5.4	21.4	118.1	145.9	78.1	22.0	18.8	26.2	106.4
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.1;Distal enterocytes: 44.9;Glandular and luminal cells: 41.6;Suprabasal keratinocytes: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	5.7	3.0	5.5	3.1	6.2	0.1	3.4	1.7	6.5	5.0	2.1	8.8	2.7	4.3	4.8	3.3	7.4	7.1	1.5	6.1	5.3	4.2	0.7	4.1	1.2	4.6	2.9	5.9	0.6	0.9	0.5	3.9	3.6	2.4	5.1	0.2	1.8	3.5	0.9	5.1	4.3	5.4	3.2	1.0	1.7	0.8	5.8	1.2	1.2	2.2	1.4	14.3	5.0	4.1	2.6	6.1	0.0	0.0	2.7	28.5	4.2	4.6	15.3	13.3	8.8	1.1	21.8	0.0	13.4	10.6	13.5	17.3	0.0	6.3	17.7	10.1	0.0	1.4	9.7	0.0	8.4	4.5	2.4	10.0	3.7	30.4	10.5	18.4	19.1	0.2	0.0	0.1	5.8	0.0	0.0	1.9	0.0	2.6	5.4	0.4	1.6	0.6	23.2	3.6	0.2	0.0	6.6	4.6	0.0	0.2	0.0	3.5	28.8	14.8	9.4	15.3	23.4	0.0	1.7	0.1	22.5	3.9	13.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	5.5	6.2	1.7	6.5	6.1	5.3	4.6	2.9	3.6	3.2	5.8	4.1	11.5	6.4	1.1	33.3	0.1	46.1	8.9	7.4	6.8	0.0	0.5	0.5	0.5	0.0	19.3	1.8	0.0	0.2	0.0	44.9	0.0	0.6	0.3	20.5	6.9	20.2	3.5	0.0	34.6	0.7	1.0	16.7	8.6	41.6	2.5	28.8	2.5	0.0	27.2	0.0	19.1	15.1	4.1	12.5	12.3	0.2	3.7	9.8	0.0	2.8	0.1	0.0	0.0	2.0	1.1	14.0	21.0	0.0	0.0	6.2	29.1	0.7	5.0	0.2	0.0	6.8	2.8	1.8	3.3	2.2	41.5	0.5	1.0	0.2	15.8	19.3
HROB	"C17orf53, MCM8IP, MGC3130"	ENSG00000125319	"Homologous recombination factor with OB-fold"	Q8N3J3	17	44141906-44162476	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA synthesis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.3;testis: 11.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.3;Cytotrophoblasts: 3.4;Extravillous trophoblasts: 8.6;Hofbauer cells: 2.9;Syncytiotrophoblasts: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023004, HPA023393, HPA024430"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879"	"unprognostic (1.72e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (9.39e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.86e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.40e-2)"	1.5	0.4	0.1	1.1	0.1	9.3	1.4	0.4	0.3	0.9	0.0	0.9	0.9	0.8	0.1	2.7	0.5	0.2	0.7	0.1	0.2	0.4	0.6	0.6	1.6	0.3	0.2	0.8	0.3	0.4	0.4	0.9	0.3	0.7	1.0	0.3	0.7	0.3	0.9	1.7	0.9	0.7	0.1	1.3	0.6	11.4	0.2	2.3	0.3	0.2	1.9	0.6	1.2	0.3	8.9	11.1	8.3	7.6	0.6	2.3	9.8	6.7	5.9	12.8	13.9	11.3	5.4	9.4	5.8	5.8	13.3	7.5	10.9	10.5	11.1	10.6	14.0	6.0	10.1	7.7	0.3	6.6	7.3	1.9	1.6	15.7	7.7	1.5	5.3	10.2	13.8	11.6	6.2	6.7	15.7	10.2	5.6	4.0	10.8	10.0	13.2	11.6	3.0	7.0	5.1	2.9	4.1	4.0	3.4	9.4	8.1	7.7	2.4	12.1	9.5	8.3	9.9	6.7	12.2	8.0	5.7	5.1	7.1	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.9	0.4	0.1	0.1	0.1	0.4	0.3	0.1	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0
HS1BP3	HS1-BP3,FLJ14249	ENSG00000118960	"HCLS1 binding protein 3"	Q53T59	2	20560448-20651130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035050	Approved		Approved	Nucleoli,Cytosol		No	No		54000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA035050: AB_10601816"	"unprognostic (4.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (2.06e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-1)"	18.5	31.0	16.4	10.0	20.6	13.7	15.9	17.9	19.6	21.5	19.4	33.6	13.1	22.2	13.3	18.6	19.4	16.4	23.3	16.9	17.5	24.8	57.4	18.5	9.2	20.4	19.3	17.5	14.5	13.1	16.3	15.5	19.4	26.7	12.6	3.7	16.7	17.5	13.0	23.3	17.7	21.1	15.8	18.4	22.0	13.8	21.3	7.4	17.8	10.1	7.6	29.2	17.8	23.3	20.3	23.1	11.5	14.1	58.8	39.2	22.7	7.6	34.9	17.7	23.0	18.2	24.0	13.5	5.9	11.1	80.1	12.5	23.1	24.0	8.6	17.4	19.1	7.2	11.3	61.2	54.8	5.5	30.5	42.1	53.8	20.0	36.5	20.7	34.1	11.9	4.7	28.3	20.5	17.4	2.5	9.3	9.6	29.9	16.4	13.3	23.3	13.4	39.0	24.4	10.9	16.7	5.4	23.4	45.0	23.2	14.6	11.2	21.7	17.3	18.5	27.0	11.7	19.9	24.5	12.9	37.3	25.8	18.7	17.9	14.7	14.5	6.0	13.9	4.2	6.8	3.6	4.7	9.9	4.3	3.0	3.3	17.7	3.8	18.3	3.6	3.4	8.6	16.4	20.6	17.9	19.6	16.9	17.5	20.4	19.3	19.4	15.8	21.3	23.3	17.6	6.4	17.9	3.3	8.2	4.5	7.4	5.6	2.2	4.0	6.2	8.0	6.2	8.6	10.9	7.3	0.0	9.8	6.5	12.5	17.6	21.4	20.8	9.3	9.4	8.4	6.7	7.0	2.6	14.9	17.8	9.7	8.2	12.5	2.5	8.5	11.0	9.2	30.7	15.2	2.5	7.3	12.2	20.1	5.5	42.7	8.4	13.9	14.2	4.7	13.1	8.9	15.5	3.0	5.4	9.7	11.9	10.5	4.9	5.2	21.6	28.2	10.4	5.3	0.0	7.1	17.1	16.7	10.5	5.8	5.3	17.5	6.3	7.8	7.7	4.5
HSF2BP	MEILB2	ENSG00000160207	"Heat shock transcription factor 2 binding protein"	O75031	21	43529186-43659488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 24.1"	"Group enriched"	"Detected in many"	7	"Early spermatids: 125.5;Late spermatids: 49.0;Spermatocytes: 132.4;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031724, HPA075775"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA031724: AB_10601022, HPA075775: "	"unprognostic (1.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.36e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.77e-4)"	"unprognostic (6.00e-2)"	0.3	0.3	0.4	0.1	0.5	0.1	0.5	0.3	0.9	0.5	0.3	0.3	0.2	0.6	0.5	0.3	0.6	0.2	0.4	1.3	0.7	0.5	0.2	0.2	0.3	0.5	0.5	0.7	0.2	0.8	0.8	0.9	0.6	0.4	0.2	0.9	0.4	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.2	24.1	0.7	0.1	0.5	0.1	0.2	0.3	0.4	0.7	4.6	0.9	1.2	0.5	0.2	1.1	1.1	1.6	0.9	1.6	1.4	6.1	4.5	3.5	2.4	0.9	5.7	1.8	0.6	12.8	0.5	0.9	1.1	0.6	1.9	0.3	1.4	1.5	0.4	0.7	8.2	0.7	3.8	7.5	0.4	2.0	1.3	1.1	3.9	0.8	2.0	1.4	3.9	1.1	1.9	2.9	1.2	0.5	2.0	0.8	1.3	1.0	3.3	1.6	1.7	0.5	1.7	1.7	2.6	0.9	3.0	0.2	2.4	1.2	0.9	2.8	0.8	3.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.3	0.0	0.3	0.7	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.9	1.3	0.7	0.5	0.5	0.6	0.3	0.7	0.7	0.2	0.0	0.0	2.6	0.1	0.9	1.5	4.7	2.8	1.0	1.3	1.7	0.7	0.0	2.0	0.0	0.0	1.8	0.2	0.2	0.0	1.1	125.5	0.5	1.4	0.5	0.0	0.0	3.0	0.2	2.8	2.1	0.0	0.4	0.0	2.4	0.4	0.3	0.7	0.0	1.7	0.1	0.0	0.0	0.7	49.0	1.8	0.5	0.0	0.0	0.0	2.1	0.0	3.0	4.4	2.7	0.3	1.5	0.0	0.8	0.0	1.1	2.8	2.5	13.1	0.5	0.9	132.4	63.1	0.6	0.4	0.8	0.2	3.8	0.3	1.0
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.0;lymphoid tissue: 37.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 78.5;dendritic cells: 101.3;Gastric mucus-secreting cells: 40.2;NK-cells: 82.4;Plasma cells: 134.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 232.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.0;HL-60: 43.5;HMC-1: 56.4;NB-4: 140.1;RPMI-8226: 63.2;U-266/84: 41.9;U-937: 137.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (3.47e-5)"	1.6	0.7	0.5	16.8	1.1	47.0	3.3	1.1	1.1	3.0	1.2	9.8	12.7	1.3	1.8	1.7	3.2	5.4	0.4	0.5	0.4	1.5	2.2	5.6	27.2	1.5	0.7	0.5	4.3	2.3	4.0	1.5	1.1	5.1	9.3	0.3	9.5	2.9	0.4	0.4	20.5	1.0	0.7	37.7	12.7	0.4	1.0	8.7	2.6	1.2	35.7	7.5	0.7	2.8	15.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	2.2	21.3	41.0	0.6	0.0	0.8	0.7	0.0	0.6	0.0	2.3	0.1	0.6	0.5	2.6	0.0	43.5	56.4	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	37.4	0.0	9.0	0.1	140.1	0.0	5.5	0.0	3.0	0.0	63.2	0.4	5.6	0.1	0.1	0.0	1.3	0.3	0.0	0.3	15.9	0.2	0.1	0.1	0.2	0.2	5.7	41.9	23.6	0.2	137.3	0.0	232.1	15.5	100.9	17.1	22.0	15.8	56.4	7.6	11.2	25.5	35.8	6.9	9.2	182.6	85.2	38.8	7.6	13.0	16.7	0.5	1.1	1.1	1.1	0.5	0.4	1.5	0.7	1.1	0.7	1.0	2.8	1.0	3.2	8.9	0.0	78.5	0.3	1.2	3.0	0.6	0.0	3.6	1.9	0.6	5.7	11.3	5.5	0.0	2.6	101.3	18.9	0.0	6.7	0.0	4.5	1.5	0.8	8.4	32.2	0.5	5.1	4.1	0.7	40.2	7.9	6.3	0.1	1.4	0.6	1.1	0.0	0.4	19.1	2.0	3.4	2.4	0.1	0.0	7.3	10.6	1.0	10.7	0.0	82.4	1.0	0.3	9.7	18.0	0.0	134.0	2.6	17.9	0.3	7.9	0.0	0.0	1.1	0.7	0.1	0.5	0.1	0.1	3.4	31.0	0.2	9.3	4.1
HSPA12A	"FLJ13874, KIAA0417"	ENSG00000165868	"Heat shock protein family A (Hsp70) member 12A"	O43301	10	116671192-116850251	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 205.0;Inhibitory neurons: 186.4;Leydig cells: 63.3;Peritubular cells: 68.4;Theca cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.3;naive B-cell: 1.7;T-reg: 1.0"	"Group enriched"	"Detected in many"	14	"B-cells: 1.7;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011273, HPA073244"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"		"HPA011273: AB_1851190, HPA073244: AB_2686586"	"unprognostic (7.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.31e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (2.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.55e-4)"	15.8	21.9	10.9	1.5	13.5	0.0	8.8	11.2	28.2	13.7	7.9	12.4	0.7	9.2	12.5	3.9	10.3	2.3	9.6	16.6	11.1	17.4	1.6	3.0	2.7	17.3	12.2	20.5	2.7	20.0	7.9	0.8	16.4	5.6	1.9	11.0	2.6	5.5	4.9	5.7	4.1	4.6	2.7	3.8	4.7	6.2	27.3	2.1	9.4	3.4	2.8	7.9	10.0	14.7	8.0	10.0	0.1	7.1	6.6	4.4	0.1	5.5	10.1	1.9	1.0	10.0	2.8	0.0	4.1	7.6	5.2	6.1	8.4	0.7	4.9	0.0	3.2	0.0	0.8	5.5	1.9	0.0	1.0	1.7	6.6	7.3	0.9	13.9	0.0	3.3	0.0	0.0	2.1	4.0	0.0	0.0	1.2	0.0	0.1	0.0	1.0	1.2	22.1	1.8	5.3	12.7	4.0	2.9	3.0	2.4	3.2	0.0	0.0	1.4	5.5	12.3	10.2	0.1	3.2	0.0	3.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.9	13.5	11.2	28.2	16.6	11.1	17.3	12.2	16.4	2.7	27.3	14.7	2.1	6.4	3.6	27.7	1.0	11.1	1.6	0.5	2.8	35.8	5.2	6.9	7.8	2.8	2.0	12.9	22.9	0.1	0.1	1.6	15.6	4.2	4.4	12.5	16.1	3.1	0.0	0.0	205.0	3.5	0.1	17.8	0.0	4.4	0.0	2.4	2.9	0.4	0.1	30.3	186.4	0.3	0.0	0.0	5.2	9.7	63.3	0.5	26.6	9.4	0.0	35.8	0.0	27.6	54.8	2.4	0.0	68.4	0.1	2.1	0.0	25.4	11.3	10.2	13.1	14.7	14.9	1.0	5.2	0.5	5.1	0.3	0.8	82.0	0.3	0.7
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815543-31817946	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 7514.5;Langerhans cells: 2690.4;Urothelial cells: 3444.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	64	"cerebral cortex: 403.6"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;monocytes: 3.6;T-cells: 3.0"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 4450.4"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	Yes		47000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"	Cytosol	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	640.5	350.5	3.5	12.7	3.8	0.0	167.2	6.3	403.6	414.1	3.4	497.7	0.0	209.7	15.9	452.9	194.6	5.9	927.7	4.3	3.7	745.9	1116.2	1055.0	9.1	5.4	5.1	369.7	308.2	1.1	474.3	12.0	4.0	427.7	4.2	6.5	111.5	0.5	294.4	257.3	174.4	2.2	3.8	451.9	483.2	98.0	3.7	2.5	340.2	0.3	2.3	569.2	553.7	6.1	0.2	524.1	0.0	0.1	20.1	14.4	0.0	0.3	0.0	0.0	0.0	1.6	0.7	0.0	122.9	28.7	0.0	0.4	0.0	34.1	0.0	6.9	4450.4	0.0	1.7	3.1	0.0	1.1	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.4	0.0	0.5	0.7	0.0	0.0	16.6	5.3	0.0	0.1	4.1	0.0	49.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	2.3	3.2	1.1	3.6	0.7	0.6	1.6	1.4	0.3	0.2	0.7	0.6	6.8	0.8	2.0	0.3	3.0	0.4	3.5	3.8	6.3	403.6	4.3	3.7	5.4	5.1	4.0	3.8	3.7	6.1	1537.0	147.4	97.0	427.4	312.4	362.4	7514.5	125.5	968.7	305.3	782.0	844.3	1010.7	81.5	109.3	126.9	379.5	43.2	148.1	634.6	41.1	86.8	81.0	534.7	488.1	1049.0	469.2	64.0	9.7	21.6	154.1	1208.6	592.8	753.4	445.4	18.1	123.5	95.2	270.4	205.3	11.4	560.1	114.0	319.0	2690.4	49.5	603.0	1715.2	839.6	398.2	126.6	768.2	15.5	17.1	207.0	39.5	668.8	160.6	1173.3	1404.1	68.4	72.9	177.2	690.2	151.2	443.4	1802.0	65.4	148.8	1105.8	336.3	104.3	1382.2	285.6	454.9	3444.4
HSPA1B	HSP70-2	ENSG00000204388	"Heat shock protein family A (Hsp70) member 1B"	P0DMV9	6	31827738-31830254	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 3007.4;Urothelial cells: 1619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 204.3"									"CAB008640, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes				"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"	Nucleoplasm	"CAB008640: AB_1617331, HPA052504: AB_2681854"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.69e-2)"	"unprognostic (5.99e-2)"	526.3	340.1	0.7	0.4	1.3	0.0	126.0	1.6	5.6	475.3	0.6	361.2	0.0	154.0	9.1	375.2	231.5	2.3	718.3	1.1	1.9	555.5	685.4	845.3	0.0	0.8	1.0	682.2	336.5	3.3	438.2	0.0	1.2	303.6	0.5	2.6	94.8	0.3	159.9	299.0	139.1	0.0	0.4	274.7	372.0	93.8	1.5	0.0	289.9	0.0	0.0	415.3	503.3	1.2	0.4	24.1	0.4	0.2	1.1	0.0	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.0	8.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	15.4	0.0	0.5	2.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	204.3	0.0	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	1.6	0.0	0.0	0.3	3.2	0.0	0.4	41.5	0.4	0.4	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.3	1.6	5.6	1.1	1.9	0.8	1.0	1.2	0.4	1.5	1.2	563.2	112.2	75.0	140.7	242.7	239.2	3007.4	63.2	630.0	44.6	509.4	403.9	512.3	40.0	73.7	69.9	131.3	82.7	82.8	542.8	19.6	45.5	1.9	434.9	380.2	446.2	318.6	57.9	2.7	15.6	140.8	585.8	595.8	710.4	346.8	14.1	25.7	17.7	142.0	47.1	2.8	426.3	61.1	84.4	1140.4	9.8	220.6	627.1	642.1	126.5	17.7	192.4	1.0	5.5	61.8	21.4	524.1	54.9	967.0	584.2	159.1	38.3	75.0	144.2	105.2	226.4	846.5	15.2	46.4	904.0	221.9	259.7	604.6	116.7	400.5	1619.4
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133052013-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	31.3	36.9	33.8	41.0	37.2	35.6	26.9	38.1	63.7	26.6	52.0	31.8	26.6	27.5	29.3	62.0	26.8	27.8	50.8	39.8	43.8	44.3	47.2	26.3	47.4	37.6	41.0	21.3	29.7	43.5	24.0	37.7	45.0	26.3	34.7	104.0	27.9	26.9	57.7	26.1	26.0	35.3	38.4	28.7	26.6	62.8	40.3	40.2	39.7	41.7	60.9	48.4	23.7	48.2	160.8	215.8	147.6	241.7	137.5	114.6	267.3	171.0	127.8	162.1	199.2	408.0	163.2	264.4	175.2	165.8	382.6	138.9	259.4	282.9	232.7	122.9	148.3	195.4	136.5	225.7	109.6	122.6	163.8	115.1	117.3	209.7	136.3	92.9	157.2	126.5	207.9	79.6	179.8	141.4	173.5	91.0	202.4	123.8	98.7	156.6	180.4	140.2	146.7	207.4	117.0	96.0	163.4	84.4	234.6	273.5	124.3	118.5	139.0	146.8	210.8	127.1	206.1	90.7	215.2	199.9	125.5	198.7	149.2	29.5	22.6	24.9	18.1	35.8	21.5	34.2	16.6	19.0	27.7	42.0	17.1	16.2	14.7	22.9	27.1	10.5	18.0	18.5	33.8	37.2	38.1	63.7	39.8	43.8	37.6	41.0	45.0	38.4	40.3	48.2	30.5	64.1	47.0	12.4	74.8	41.8	116.8	25.5	52.9	58.9	30.3	26.8	113.1	28.6	47.3	22.0	54.2	67.3	38.5	42.9	27.4	48.4	68.7	54.7	48.5	40.8	47.2	46.9	24.2	49.9	66.1	45.3	38.2	46.1	54.6	66.9	19.6	32.9	64.3	35.3	24.8	34.4	36.7	28.2	40.9	31.9	23.3	50.7	30.2	21.5	55.0	60.1	22.6	18.6	24.2	50.1	24.9	25.9	66.5	61.5	27.7	49.7	60.7	152.4	26.3	41.8	85.1	107.4	101.0	71.7	41.8	87.2	58.2	68.0	39.4	69.7
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 436.6;Late spermatids: 901.8;Spermatocytes: 203.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 82.3"	"Low region specificity"	"Detected in all"							"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA		1000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.3	11.3	12.0	1.0	10.5	3.0	3.5	21.7	30.6	3.5	13.5	2.6	2.3	1.0	1.2	13.7	7.0	3.7	6.4	10.6	32.7	13.3	7.4	1.5	0.3	15.2	17.7	3.8	4.0	11.1	8.0	2.9	21.5	4.1	3.5	26.9	5.7	4.9	1.5	8.4	1.2	3.0	12.9	0.9	2.1	108.7	17.7	4.0	3.9	3.6	4.7	2.8	7.7	15.9	20.6	26.5	14.0	22.1	9.5	9.5	16.2	9.1	3.7	8.6	9.5	19.7	9.2	0.1	16.4	2.6	7.0	4.7	82.3	32.9	11.7	38.7	24.7	11.0	33.5	23.7	3.5	42.3	17.9	8.7	29.7	5.7	20.3	8.9	11.3	9.4	19.8	12.2	10.9	14.9	13.6	3.7	3.3	21.5	21.6	0.1	1.5	2.0	29.1	9.2	25.7	9.4	16.4	28.2	1.5	8.3	21.7	7.1	3.2	3.0	0.1	3.7	22.1	23.6	29.3	6.4	11.7	28.3	9.4	0.6	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.0	10.5	21.7	30.6	10.6	32.7	15.2	17.7	21.5	12.9	17.7	15.9	2.7	3.2	9.3	17.6	1.1	28.4	91.9	31.3	40.9	57.7	7.7	9.4	18.1	12.8	27.6	9.2	104.3	10.0	0.8	3.4	19.6	6.8	436.6	17.8	1.6	6.8	18.4	0.0	47.1	2.9	2.1	8.1	2.6	5.2	15.8	2.5	1.8	9.7	1.2	40.4	70.4	3.5	24.4	2.5	9.7	901.8	10.2	4.7	8.8	7.5	3.0	16.6	2.1	19.6	9.3	2.8	0.3	9.8	0.4	26.2	0.3	24.6	52.0	66.8	0.0	18.7	12.5	203.1	13.5	47.5	42.5	16.7	4.2	2.8	5.3	65.2
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241382	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction"	"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1327.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		790000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	211.2	170.2	83.7	276.1	91.7	856.2	147.2	101.8	107.3	202.9	112.0	181.6	166.5	183.6	379.1	150.7	177.9	130.6	284.0	90.2	126.8	168.7	327.8	182.8	145.4	105.8	107.0	142.1	260.7	223.3	182.7	311.3	120.2	192.8	183.7	105.1	211.0	167.5	87.6	143.2	175.8	205.2	111.4	129.8	177.9	173.5	101.7	116.2	692.8	85.2	180.0	197.7	105.1	163.9	593.4	380.3	480.2	631.3	505.6	592.0	1152.8	1047.6	728.2	675.9	778.5	558.4	1093.4	649.5	644.7	682.4	1564.0	732.5	403.3	839.4	684.7	403.7	213.8	396.7	392.9	945.1	2692.4	547.4	730.2	363.6	1515.2	551.3	2309.4	728.1	1065.6	129.0	291.9	870.3	482.2	382.6	249.7	297.8	559.1	1327.5	362.2	233.2	492.4	1061.2	608.4	352.7	248.5	448.0	648.1	653.4	1079.3	715.5	694.3	378.0	791.8	439.5	433.0	462.7	484.2	939.0	994.7	551.2	1070.4	435.9	689.0	455.5	366.3	305.3	384.7	361.8	390.0	209.0	276.7	360.1	322.0	173.9	224.6	277.2	280.9	362.9	252.5	349.5	213.6	758.2	83.7	91.7	101.8	107.3	90.2	126.8	105.8	107.0	120.2	111.4	101.7	163.9	227.1	185.9	273.5	38.5	254.0	292.9	1225.2	573.2	192.9	97.3	193.7	166.2	803.4	97.2	416.9	112.2	352.3	505.9	408.7	426.5	45.0	415.0	86.2	372.1	402.2	247.9	508.8	82.3	19.7	258.4	955.2	455.5	258.4	467.4	334.2	304.6	147.4	379.4	449.4	63.9	34.6	508.2	195.3	133.4	271.0	50.3	175.2	261.6	181.5	30.0	135.0	134.6	80.3	29.7	41.1	313.7	408.3	174.5	1041.5	360.8	196.9	121.2	267.6	176.6	118.3	245.9	673.8	435.7	204.3	167.4	236.4	1327.5	323.8	243.0	376.4	795.4
HSPB11	"C1orf41, FAP232, HSPCO34, IFT25, PP25"	ENSG00000081870	"Heat shock protein family B (small) member 11"	Q9Y547	1	53916574-53945699	"Human disease related genes, Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Stress response, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 412.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030140	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		38000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA030140: AB_10600713"	"unprognostic (5.73e-2)"	"unprognostic (6.37e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (9.58e-7)"	"unprognostic (5.12e-1)"	"unprognostic (6.70e-3)"	"unprognostic (8.31e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.84e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-2)"	25.9	36.4	36.2	34.1	37.1	61.2	46.5	35.5	49.9	33.9	46.4	31.9	25.0	42.6	70.5	30.1	79.6	26.8	26.6	38.4	36.9	35.3	55.1	29.7	62.5	35.5	35.5	41.8	26.4	30.8	23.1	41.6	35.6	34.9	34.5	29.8	24.0	36.6	11.4	37.3	26.0	36.8	36.3	34.8	36.8	30.7	35.3	55.8	96.8	19.6	62.3	39.5	19.2	38.6	115.4	50.3	141.8	31.2	51.1	67.7	59.4	95.8	91.4	142.5	163.8	122.2	60.5	134.7	77.1	69.6	251.8	88.9	62.2	99.5	168.7	114.6	91.6	166.6	108.1	163.7	58.2	83.7	108.0	70.0	76.7	135.5	37.0	88.4	77.4	82.5	102.3	30.6	184.4	24.9	184.8	132.4	59.5	96.1	111.5	125.5	184.3	72.5	118.3	128.7	74.2	59.8	140.7	64.8	95.4	142.7	396.4	118.5	52.7	92.4	115.1	104.9	107.8	54.6	97.3	141.7	148.5	78.1	81.5	171.2	47.4	130.6	87.0	65.9	78.8	95.6	85.6	104.7	56.8	76.9	67.1	84.9	33.5	109.4	71.8	121.8	122.0	58.3	36.2	37.1	35.5	49.9	38.4	36.9	35.5	35.5	35.6	36.3	35.3	38.6	37.8	32.1	31.4	14.7	54.3	106.4	79.6	244.6	68.9	22.4	67.5	73.2	42.7	42.9	134.6	51.5	8.4	181.9	72.0	42.4	117.4	60.4	55.7	249.2	60.0	40.7	77.3	48.6	18.2	65.7	101.3	59.0	27.5	60.3	61.5	59.3	31.8	64.9	115.0	13.5	16.9	42.2	217.7	46.5	74.8	15.7	61.5	57.2	78.2	11.2	80.5	87.8	70.0	13.0	22.9	79.6	52.0	63.6	80.8	70.5	54.7	119.2	412.1	19.8	39.5	32.6	93.0	130.0	97.9	66.4	82.8	116.8	73.7	120.3	39.7	118.0
HSPBP1	FES1	ENSG00000133265	"HSPA (Hsp70) binding protein 1"	Q9NZL4	19	55262223-55280381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 270.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005865, HPA070398, HPA071444"	Supported		Approved	Vesicles,Centrosome,Cytosol		NA	NA		19000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Vesicles, Centrosome"	"CAB005865: AB_304116, HPA070398: , HPA071444: AB_2686396"	"unprognostic (3.07e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.20e-3)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.14e-2)"	24.6	29.0	41.4	14.5	50.8	16.6	25.4	41.4	60.5	29.8	34.1	34.9	15.7	39.3	5.2	42.1	38.4	6.2	46.9	41.9	40.3	38.8	37.9	23.9	12.3	40.3	41.8	34.3	27.4	18.9	26.8	8.3	38.6	29.3	6.7	7.3	25.2	10.4	46.9	33.7	24.0	8.0	39.2	21.0	28.9	32.5	39.6	9.6	27.1	16.9	8.1	33.3	29.7	39.5	86.9	150.0	27.1	38.6	15.3	14.3	78.8	44.3	17.8	45.0	38.3	85.5	57.7	56.1	42.1	24.3	27.0	59.0	33.1	43.9	11.6	48.4	270.8	74.9	48.2	79.7	34.1	72.3	38.1	18.5	39.4	44.6	20.9	19.4	22.5	46.5	61.6	31.1	15.8	80.3	65.4	64.2	95.6	75.2	125.8	63.7	41.7	121.0	30.4	54.8	71.0	108.0	54.2	54.2	46.9	14.4	41.7	56.4	29.8	50.3	55.0	29.4	83.1	48.4	126.9	60.0	57.6	62.6	56.6	2.0	25.7	7.2	39.1	45.4	40.9	53.9	42.2	44.7	52.9	64.3	42.1	41.1	1.7	44.2	39.6	29.3	43.3	25.1	41.4	50.8	41.4	60.5	41.9	40.3	40.3	41.8	38.6	39.2	39.6	39.5	11.8	9.6	11.5	5.5	15.6	26.8	39.7	55.5	29.6	15.9	20.1	20.8	13.2	34.3	35.1	35.0	6.2	48.0	11.6	46.4	72.4	62.5	13.4	69.4	15.2	18.5	22.6	18.1	8.6	46.1	57.0	22.0	25.5	13.4	10.8	20.0	10.4	23.9	39.1	13.5	11.6	31.7	44.7	11.3	13.7	16.0	19.6	11.9	17.8	3.7	28.2	14.9	21.6	6.0	7.3	42.6	44.4	17.7	27.3	29.5	25.5	62.5	119.8	14.8	26.3	24.2	31.9	39.0	28.8	27.9	29.5	37.5	17.1	16.6	58.9	35.2
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822244-21937310	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.8;Endothelial cells: 322.9;Granulosa cells: 776.0;Hepatic stellate cells: 600.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 293.0;HUVEC TERT2: 620.8;TIME: 504.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1400000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	140.7	54.7	3.8	36.1	5.2	1.7	96.2	3.7	4.8	65.9	18.8	153.1	18.3	151.9	6.6	44.1	85.0	53.4	156.6	3.6	2.9	37.6	10.6	49.0	14.2	5.6	4.6	31.3	31.7	13.1	11.8	30.3	5.7	60.3	8.6	0.3	45.0	56.5	65.1	41.0	54.9	96.2	4.0	37.4	76.1	9.0	7.6	6.7	69.1	40.8	3.5	110.2	59.7	4.7	44.0	40.7	13.8	45.9	131.0	99.4	51.5	70.2	17.8	21.1	18.7	50.5	86.7	3.3	293.0	112.9	0.8	26.9	3.1	31.9	5.4	0.6	4.3	15.7	46.0	35.7	27.0	0.0	4.1	61.6	9.4	19.9	6.0	28.1	620.8	0.3	21.4	5.7	32.4	11.8	0.0	20.0	11.7	19.6	17.9	6.3	87.8	6.1	35.1	6.5	1.3	4.1	51.4	20.0	28.7	14.0	8.1	7.2	504.3	41.1	51.8	29.7	2.3	0.5	7.3	2.6	9.7	0.1	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	5.2	3.7	4.8	3.6	2.9	5.6	4.6	5.7	4.0	7.6	4.7	366.8	70.5	28.6	3.6	3.9	26.4	13.5	81.1	21.1	0.6	6.2	21.5	5.8	38.6	30.3	92.0	0.0	11.0	3.4	52.9	0.0	76.1	1.4	24.2	47.7	322.9	2.4	22.9	0.8	25.0	89.0	141.3	62.2	39.8	23.4	776.0	600.4	6.6	6.8	3.3	0.8	12.6	16.2	22.1	19.2	5.8	75.2	4.6	60.5	15.9	1.8	1.6	0.0	2.5	4.3	87.5	29.9	69.2	4.6	19.3	19.2	0.9	28.7	0.6	32.9	82.5	69.8	0.3	4.8	10.0	17.8	9.3	5.0	83.3	20.1	11.8
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90858039	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.6;parathyroid gland: 13.1;testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.0;Excitatory neurons: 5.9;Inhibitory neurons: 24.2;Spermatocytes: 13.1"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"myeloid DC: 1.4"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 11.3;hTCEpi: 10.1;hTERT-HME1: 33.4;LHCN-M2: 13.5;U-251 MG: 9.6;U-87 MG: 10.2;WM-115: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved	Supported	Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: AB_2732228"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	0.5	0.2	2.4	0.9	1.4	0.3	0.3	0.0	2.5	0.4	0.4	0.6	0.5	0.2	0.1	0.7	0.2	0.9	0.1	2.7	7.1	0.1	0.4	0.2	0.6	1.5	3.2	0.1	0.2	13.1	0.1	0.3	1.9	0.2	0.9	0.1	0.3	0.1	0.9	0.5	1.4	0.3	0.5	1.1	0.7	8.7	7.6	0.2	0.1	0.5	0.3	2.3	0.6	0.8	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.7	0.3	0.7	1.0	0.0	1.2	0.0	0.0	0.1	2.0	4.7	1.3	11.3	2.8	0.0	0.2	0.0	0.0	0.0	5.1	0.0	0.6	7.8	10.1	3.3	33.4	6.3	0.0	0.0	0.1	0.0	13.5	0.0	0.0	0.2	1.2	0.0	1.6	1.0	0.1	0.0	0.0	1.2	0.4	0.0	0.5	0.0	5.4	0.6	0.0	0.2	0.3	6.1	0.0	0.1	9.6	0.0	0.0	0.0	10.2	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.4	0.0	2.5	2.7	7.1	1.5	3.2	1.9	0.5	7.6	0.8	0.1	0.0	0.0	0.7	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.4	5.9	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.0	1.7	0.0	24.2	0.0	2.0	2.2	0.0	2.7	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.1	13.1	1.3	0.0	0.1	0.1	0.2	0.0	0.0	0.3
HUS1B		ENSG00000188996	"HUS1 checkpoint clamp component B"	Q8NHY5	6	655939-656963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Sertoli cells: 6.6;Spermatocytes: 19.3;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;U-266/84: 2.2;WM-115: 2.2"	"Not detected"	"Not detected"							"HPA034511, HPA063449"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA034511: AB_2674203, HPA063449: AB_2685014"	"unprognostic (3.56e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-10)"	"unprognostic (7.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	0.4	0.3	0.4	0.1	0.4	0.7	0.3	0.3	0.5	0.8	0.5	0.3	0.2	0.4	0.1	0.6	0.3	0.1	0.4	0.3	0.3	0.5	0.6	0.6	0.0	0.4	0.2	0.5	0.1	0.0	0.5	0.1	0.4	0.8	0.0	0.2	0.4	0.0	0.2	0.6	0.3	0.1	0.0	0.6	0.2	2.1	0.3	0.1	0.4	0.1	0.0	0.4	0.7	0.6	0.3	0.0	0.0	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.5	1.8	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.7	0.4	0.2	0.0	0.2	1.0	1.1	0.0	0.6	0.3	0.3	1.0	0.1	0.2	0.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.3	0.6	0.1	0.9	2.2	0.4	0.0	0.2	2.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.4	0.3	0.5	0.3	0.3	0.4	0.2	0.4	0.0	0.3	0.6	1.1	0.0	0.0	0.0	0.8	0.6	0.8	1.0	0.6	0.7	1.3	1.3	0.2	1.5	0.2	0.0	0.0	1.5	1.7	0.3	0.0	1.3	0.6	0.5	0.4	1.2	0.0	0.0	0.0	0.6	1.1	0.5	0.0	0.9	0.0	0.5	2.2	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.6	0.9	0.5	0.0	0.0	2.6	0.4	2.1	0.0	0.0	1.3	0.1	1.2	0.1	0.7	0.3	0.1	0.1	1.4	6.6	0.7	1.3	19.3	8.0	0.2	1.7	1.5	1.5	0.8	0.3	0.5
HYDIN	"CILD5, DKFZp434D0513, KIAA1864, PPP1R31"	ENSG00000157423	"HYDIN axonemal central pair apparatus protein"	Q4G0P3	16	70802084-71230722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.9;choroid plexus: 23.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;Endometrial ciliated cells: 150.6;Excitatory neurons: 49.2;Respiratory ciliated cells: 153.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;RPTEC TERT1: 2.8;SiHa: 5.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA067155, HPA074129"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA067155: AB_2685792, HPA074129: AB_2686665"	"unprognostic (8.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.88e-4)"	"unprognostic (4.25e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.52e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.97e-2)"	0.3	0.3	2.2	0.3	3.2	0.5	0.5	1.2	1.4	1.2	23.9	0.6	0.2	0.9	2.0	0.1	5.3	0.5	0.5	3.4	3.5	1.3	0.5	1.4	0.3	8.9	9.9	1.1	0.7	2.5	4.4	0.1	5.8	0.8	0.1	6.4	0.3	0.3	0.1	0.5	0.2	0.1	8.0	0.4	0.2	4.7	4.3	0.0	1.9	0.0	0.0	0.5	0.4	4.4	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.1	1.8	0.3	0.1	0.1	0.6	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.0	1.1	0.2	0.0	0.0	0.0	0.4	0.4	0.7	0.0	0.4	0.1	0.1	0.4	2.8	0.4	1.1	0.2	5.3	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.4	0.0	0.1	0.9	0.0	0.5	0.4	0.1	0.3	0.5	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.7	0.1	0.3	0.2	0.1	0.0	2.2	3.2	1.2	1.4	3.4	3.5	8.9	9.9	5.8	8.0	4.3	4.4	0.1	3.2	2.6	35.3	0.0	0.0	0.2	2.6	0.0	17.0	1.5	1.1	2.5	0.0	18.3	9.2	52.1	0.0	0.4	0.0	1.9	2.5	35.4	150.6	6.5	0.7	3.5	0.0	49.2	0.6	0.0	1.4	0.0	4.0	0.0	5.0	0.0	0.0	0.1	0.0	25.9	0.1	4.1	0.0	0.0	31.5	2.5	0.3	3.6	3.7	0.0	9.3	0.0	26.2	21.8	0.3	0.1	4.5	0.1	0.6	0.0	1.8	153.2	30.5	0.0	2.0	1.7	17.7	7.5	0.0	0.0	0.0	0.5	1.6	0.1	0.2
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43450989-43453989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 232.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 97.7;HUVEC TERT2: 106.7;U-251 MG: 99.2;WM-115: 105.5"					"Low region specificity"	"Detected in all"			HPA040092	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favorable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.72e-5)"	31.7	22.8	28.1	9.3	29.2	12.1	19.3	29.6	36.3	23.4	27.9	21.3	44.1	23.3	15.4	15.0	24.2	18.7	20.8	27.0	31.2	29.5	44.6	23.0	11.3	30.9	28.9	42.1	53.7	25.2	14.6	10.5	30.9	19.8	12.3	4.1	35.3	47.0	20.8	16.2	34.4	13.2	30.0	12.2	23.9	3.9	28.4	8.8	19.1	10.2	9.2	17.4	15.3	32.4	58.7	7.3	2.2	3.5	9.8	15.1	0.2	48.4	35.7	52.6	34.3	24.2	97.7	0.0	4.1	29.7	25.1	10.9	0.0	45.8	21.6	15.2	20.5	10.2	25.0	0.0	58.8	0.0	0.0	9.4	12.4	64.0	0.0	56.3	106.7	0.5	1.2	0.0	34.5	1.2	9.6	8.8	11.1	5.6	15.5	46.0	0.0	0.3	37.5	2.2	27.2	20.3	56.0	30.4	13.2	8.7	9.2	72.0	59.5	3.7	0.0	12.4	99.2	0.0	0.0	0.0	4.1	13.4	105.5	10.6	1.7	3.7	4.2	1.3	5.5	4.3	7.1	3.3	5.8	5.3	6.6	2.0	0.1	7.5	1.8	29.9	0.7	4.0	28.1	29.2	29.6	36.3	27.0	31.2	30.9	28.9	30.9	30.0	28.4	32.4	29.8	19.2	64.4	5.9	16.1	28.0	45.2	22.8	51.8	16.9	41.0	65.3	0.4	65.8	23.0	57.0	10.4	18.6	19.2	56.6	45.0	106.7	1.2	9.9	23.6	23.2	69.5	21.5	1.4	86.1	115.9	45.7	25.5	18.7	43.2	33.5	25.0	59.0	29.8	8.4	1.9	89.1	16.2	8.5	31.0	4.5	31.7	23.5	40.9	1.9	15.8	45.0	8.2	4.5	4.8	109.6	97.0	30.5	41.7	33.7	232.5	146.9	12.4	16.7	26.3	31.3	58.2	1.4	3.0	27.3	22.0	12.0	12.3	49.8	47.6	38.4
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 219.3;urinary bladder: 215.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 612.2;Alveolar cells type 2: 561.6;Endothelial cells: 240.8;Langerhans cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 158.3;Karpas-707: 459.7;RPMI-8226: 148.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA	87900000	2200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favorable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	87.9	23.6	9.1	44.6	9.6	117.1	32.4	7.9	12.0	11.2	9.9	17.7	16.8	23.9	3.5	11.0	26.2	56.4	39.1	8.8	9.9	43.9	67.1	219.3	38.3	12.3	8.7	13.0	11.1	8.3	9.3	27.8	10.2	22.2	18.1	10.5	18.0	6.3	15.1	17.9	22.6	23.4	10.0	55.9	21.5	5.6	15.4	28.4	30.8	12.8	32.9	215.3	12.5	10.2	46.3	0.5	7.9	0.2	2.0	4.4	9.7	8.6	91.6	21.8	62.0	14.0	49.8	39.6	130.3	3.8	99.3	8.9	1.7	0.4	45.6	123.8	0.1	3.8	1.4	62.0	158.3	1.3	23.9	55.7	4.0	13.7	20.3	2.0	10.7	4.9	15.0	459.7	1.5	3.3	0.5	34.9	3.1	0.5	24.7	1.0	0.2	148.5	36.8	0.3	0.3	1.1	61.2	3.3	94.5	3.7	6.9	2.8	34.3	22.3	1.9	12.3	0.8	137.4	142.7	25.5	35.1	26.3	32.6	5.0	28.3	5.2	5.3	25.8	9.8	3.8	4.0	6.3	24.7	1.5	1.9	3.8	40.8	15.2	17.0	14.1	6.1	20.8	9.1	9.6	7.9	12.0	8.8	9.9	12.3	8.7	10.2	10.0	15.4	10.2	150.3	612.2	561.6	0.3	31.7	85.3	22.2	62.6	28.5	0.0	50.2	24.9	1.1	21.5	133.5	3.7	0.0	1.1	28.9	2.9	0.0	176.8	2.0	14.1	15.5	240.8	2.4	1.3	0.5	98.7	3.3	136.6	13.7	29.8	139.8	0.1	48.2	12.1	86.7	0.0	0.4	0.7	32.6	53.6	232.6	1.3	4.7	168.3	76.5	7.5	101.9	4.6	5.2	0.5	0.2	113.7	0.3	1.5	57.6	27.1	0.3	15.0	83.2	0.4	6.6	38.2	57.6	0.8	1.6	4.3	69.3	1.2	28.8	0.5	1.6	14.1
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Proximal enterocytes: 84.2;Proximal tubular cells: 224.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA020378: AB_1845794, HPA058429: AB_2683716"	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	8.9	12.0	18.8	6.1	24.5	5.8	8.7	20.6	26.8	4.3	22.7	9.5	26.3	5.3	13.3	8.3	12.9	6.4	5.8	19.1	22.6	50.9	70.5	7.3	11.0	20.3	20.8	5.5	13.8	14.8	9.0	3.0	20.6	8.4	9.2	10.9	8.8	9.5	2.3	7.1	26.9	4.4	20.5	7.9	8.9	3.7	20.8	38.9	13.2	2.6	9.5	5.2	3.9	21.1	4.3	10.4	1.7	1.8	4.6	6.9	7.8	3.4	8.6	3.5	2.8	2.9	5.3	5.8	5.2	5.8	3.5	8.4	1.3	2.0	3.6	11.9	1.6	2.1	4.6	12.7	19.4	1.5	2.8	4.3	3.3	7.2	7.2	6.2	7.9	16.0	1.9	7.1	4.8	26.8	3.7	1.4	1.6	18.1	6.0	4.6	4.2	3.3	9.6	5.5	6.9	8.6	7.5	6.5	7.6	2.5	6.0	8.1	7.4	1.6	1.3	14.3	6.1	9.0	10.4	1.0	7.3	2.4	2.8	100.7	13.0	19.1	30.5	24.1	25.4	39.3	26.0	24.7	18.1	26.7	20.2	27.2	2.8	33.1	47.6	20.9	52.2	24.8	18.8	24.5	20.6	26.8	19.1	22.6	20.3	20.8	20.6	20.5	20.8	21.1	6.2	12.8	8.7	14.7	9.3	6.8	3.2	7.3	4.0	8.9	10.0	8.4	9.9	10.0	8.8	5.5	0.0	8.0	11.3	8.4	80.3	11.3	0.4	34.6	2.0	5.6	7.3	2.5	4.7	16.1	4.6	8.0	4.6	7.0	20.8	10.2	3.3	44.3	11.1	10.1	5.6	12.8	12.2	11.6	7.5	2.0	4.4	8.2	12.4	11.2	19.8	38.0	24.7	8.0	11.4	5.4	21.7	4.1	12.1	4.6	84.2	224.4	28.3	3.5	0.0	8.8	5.9	1.4	1.5	5.4	5.8	3.0	13.7	9.9	11.2	4.2
IDO2	INDOL1	ENSG00000188676	"Indoleamine 2,3-dioxygenase 2"	Q6ZQW0	8	39934614-40016391	"Metabolic proteins, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"liver: 5.4;placenta: 4.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 21.0;Endometrial ciliated cells: 18.4;Glandular and luminal cells: 51.3;Late spermatids: 6.9;monocytes: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054911			Approved	Cytosol		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"		"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA054911: "	"unprognostic (2.00e-3)"	"unprognostic (2.34e-5)"	"unprognostic (2.22e-3)"	"unprognostic (4.41e-3)"	"unprognostic (5.37e-2)"	"unprognostic (3.69e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.47e-7)"	"unprognostic (3.25e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.1	21.0	18.4	4.4	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	51.3	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.0	0.0	0.0	1.9	6.9	0.3	0.8	0.0	0.0	14.6	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.1
IFI27L2	"FAM14A, TLH29"	ENSG00000119632	"Interferon alpha inducible protein 27 like 2"	Q9H2X8	14	94127779-94130253	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 446.8"									HPA049588			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Nucleoli	"HPA049588: "	"unprognostic (9.70e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.76e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.52e-2)"	47.8	114.5	148.9	42.4	157.0	46.6	43.1	159.2	207.3	76.4	142.8	57.3	22.5	51.5	14.5	73.9	54.1	46.4	108.2	149.3	169.0	68.2	10.2	60.0	57.9	162.6	152.7	78.8	27.8	55.0	83.3	10.7	162.3	35.8	20.4	51.6	26.7	21.6	8.8	52.5	52.8	25.6	160.9	72.2	35.5	31.1	160.1	46.9	35.1	9.9	50.5	41.6	72.1	171.9	61.5	39.3	10.8	90.8	70.1	166.5	7.6	118.1	129.9	92.3	99.6	12.1	28.0	29.0	128.3	134.2	59.1	81.6	8.8	150.5	36.8	185.4	3.0	44.0	41.0	4.6	98.5	53.2	116.7	163.1	55.8	50.5	39.0	162.6	49.1	108.5	3.8	446.8	107.5	128.3	32.3	33.9	16.4	41.9	49.2	1.9	40.2	42.2	137.8	25.2	24.1	28.7	3.8	0.0	78.4	22.9	146.4	87.6	65.9	61.5	35.0	79.5	30.1	171.8	164.4	10.4	201.7	124.1	39.2	167.4	238.3	48.0	153.4	167.9	99.4	214.2	140.6	168.4	184.2	201.3	104.2	134.9	37.6	44.3	121.5	153.5	203.5	217.4	148.9	157.0	159.2	207.3	149.3	169.0	162.6	152.7	162.3	160.9	160.1	171.9	86.5	38.5	50.9	10.1	71.8	92.8	73.1	218.3	111.0	27.2	47.9	103.6	162.8	50.1	55.8	178.4	20.9	2.3	79.3	58.2	178.1	159.2	8.2	78.1	113.7	70.1	99.6	20.6	1.6	29.1	2.7	133.0	43.8	11.6	90.7	64.8	121.1	4.2	190.8	23.5	3.6	193.8	57.0	163.7	107.6	31.1	183.0	119.1	236.5	0.0	134.7	181.0	137.0	5.5	13.9	68.1	150.2	115.5	104.4	23.7	125.6	113.3	61.8	113.3	124.9	70.4	87.7	8.3	22.1	105.2	66.9	2.9	92.2	92.7	82.8	55.9
IFNLR1	"CRF2/12, IFNLR, IL-28R1, IL28RA"	ENSG00000185436	"Interferon lambda receptor 1"	Q8IU57	1	24154168-24187959	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 17.4;Proximal enterocytes: 18.2;Urothelial cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 4.9;naive B-cell: 5.9;plasmacytoid DC: 11.3"	"Group enriched"	"Detected in many"	5	"B-cells: 5.9;dendritic cells: 11.3"	"Cell line enhanced"	"Detected in many"		"U-266/70: 51.4;U-266/84: 19.4;U-698: 40.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA017319	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA017319: AB_1851708"	"prognostic favorable (5.12e-4)"	"unprognostic (7.16e-2)"	"unprognostic (8.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.66e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-1)"	0.4	2.2	1.1	2.8	1.2	0.6	2.6	6.2	1.1	1.7	2.2	3.8	5.8	0.9	1.9	3.6	1.8	2.1	3.1	0.8	2.6	3.0	8.4	2.9	7.8	2.5	2.2	1.3	5.0	5.2	5.9	0.3	2.5	3.4	4.0	1.8	4.5	2.1	3.6	7.3	9.2	0.4	1.9	2.8	2.9	1.0	2.7	1.4	4.4	1.3	9.7	2.1	2.3	2.7	6.7	1.3	0.0	0.0	0.0	0.0	1.6	0.0	0.6	1.2	1.0	11.3	1.9	14.3	15.1	0.0	5.4	5.0	6.6	11.6	0.9	3.0	3.5	0.0	2.3	3.4	0.0	0.0	0.0	0.0	3.8	0.3	3.5	2.5	0.0	2.9	0.3	0.0	0.0	1.6	0.2	0.4	14.0	0.5	4.1	0.1	0.0	1.2	2.6	2.8	2.0	1.3	3.5	2.0	1.4	2.4	2.7	0.1	0.0	0.0	2.7	0.0	0.1	51.4	19.4	40.8	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	4.9	0.3	1.4	0.0	5.9	0.5	1.4	0.0	0.0	0.0	11.3	0.3	0.5	1.1	1.2	6.2	1.1	0.8	2.6	2.5	2.2	2.5	1.9	2.7	2.7	0.5	0.0	4.8	2.3	5.9	11.1	10.0	4.1	12.5	3.4	1.4	3.2	3.5	2.8	2.3	1.8	0.0	0.6	5.3	17.4	3.9	2.9	2.2	3.4	0.2	0.5	0.0	0.0	2.2	2.3	1.0	0.8	3.1	2.7	0.0	1.5	0.0	8.4	2.3	0.0	2.8	4.1	0.0	0.8	1.9	4.3	0.3	3.0	0.0	2.8	5.5	2.9	0.0	0.5	0.1	2.4	6.1	0.0	12.5	4.3	18.2	2.3	5.1	2.3	0.0	0.0	0.6	0.0	0.7	8.3	12.6	0.3	2.2	0.1	3.3	17.2
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422887-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 64.2;neutrophil: 112.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 112.3"	"Low cell line specificity"	"Detected in all"											"HPA024122, HPA072413"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA024122: AB_1851452, HPA072413: "	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	35.2	24.6	11.2	6.5	14.4	57.7	32.3	13.2	16.2	23.0	31.7	30.3	8.1	20.8	4.8	24.0	25.4	4.6	30.9	13.9	19.0	21.3	27.3	40.1	3.9	11.0	13.2	31.3	102.9	9.8	31.2	7.9	13.0	28.1	5.5	13.4	25.7	6.4	58.9	21.9	22.2	10.2	11.7	19.9	38.3	24.5	13.1	4.5	25.6	3.1	3.9	24.1	25.8	19.6	22.1	26.8	25.9	21.7	44.4	28.2	25.0	23.8	26.6	36.0	29.6	42.7	21.1	12.2	52.9	18.8	64.6	15.0	21.5	29.2	46.9	17.1	31.7	13.8	46.1	37.9	61.5	19.9	9.5	24.7	43.4	39.7	47.1	18.9	18.3	22.2	46.5	17.4	14.2	35.7	24.1	20.1	51.8	26.9	30.1	24.6	9.2	22.9	6.0	6.1	37.9	18.9	28.0	15.5	61.2	57.7	9.8	15.2	12.6	45.8	10.4	35.0	68.5	27.2	34.8	37.1	12.9	43.6	63.8	19.8	7.6	64.2	7.2	6.5	6.2	8.7	7.7	7.9	6.6	7.2	6.8	7.0	112.3	8.0	6.4	4.6	8.6	5.2	11.2	14.4	13.2	16.2	13.9	19.0	11.0	13.2	13.0	11.7	13.1	19.6	179.3	32.1	31.4	39.2	110.6	197.3	159.3	55.6	259.6	50.3	141.7	142.6	60.6	37.1	55.0	18.4	89.6	66.5	130.9	276.0	17.6	49.6	43.9	123.2	159.7	96.8	138.2	24.6	36.1	56.5	84.2	135.5	162.6	190.1	74.4	51.3	52.8	21.7	126.1	21.9	24.4	183.5	54.9	96.9	153.4	10.1	36.7	141.8	103.2	44.0	55.8	32.4	20.6	24.1	42.6	55.1	287.8	41.0	104.6	143.9	226.9	13.3	34.1	86.8	39.5	138.9	172.7	25.5	14.5	135.1	126.0	151.7	129.8	53.4	180.0	154.4
IFT22	"DKFZp761N0823, FAP9, FLJ13225, FLJ14117, RABL5"	ENSG00000128581	"Intraflagellar transport 22"	Q9H7X7	7	101310914-101321823	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 577.5;Late spermatids: 1478.7;Spermatocytes: 357.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 92.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042930	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Microtubules, Cytosol"		"HPA042930: AB_10794537"	"unprognostic (1.55e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-1)"	12.4	22.1	20.2	3.7	21.4	2.8	14.3	19.1	25.7	18.6	27.2	22.1	2.8	21.1	22.9	8.5	27.8	12.1	24.0	21.4	21.7	35.5	7.8	13.1	4.0	20.0	21.1	19.5	18.4	29.9	31.1	2.8	20.2	18.0	3.4	41.4	14.7	6.4	26.3	10.1	7.5	5.8	20.7	4.7	14.9	76.4	21.2	10.1	24.4	19.6	3.6	17.2	11.5	19.9	26.1	38.6	20.7	47.9	17.1	14.5	4.6	8.6	4.8	10.6	7.9	15.4	19.3	3.1	22.1	17.8	41.1	16.6	12.2	12.7	8.2	6.2	16.4	0.6	16.4	15.8	12.6	8.7	4.9	14.9	10.9	25.2	5.9	36.5	10.4	18.2	11.2	3.4	12.6	92.5	15.6	16.3	21.6	19.5	17.4	14.4	13.1	5.3	20.1	15.8	22.3	37.0	25.3	21.0	13.7	33.5	16.3	6.6	10.6	33.1	24.6	64.0	18.0	3.1	10.3	7.5	21.7	2.5	17.3	1.4	0.8	0.9	4.0	1.7	3.8	7.5	4.8	3.6	1.6	5.9	4.3	4.4	1.1	5.8	3.3	4.7	2.0	2.3	20.2	21.4	19.1	25.7	21.4	21.7	20.0	21.1	20.2	20.7	21.2	19.9	12.0	25.6	14.3	6.5	11.9	0.0	25.1	0.0	22.2	26.6	35.5	54.4	42.9	55.8	19.2	49.7	54.2	19.7	2.3	4.0	138.9	73.9	577.5	176.0	32.1	17.0	18.5	17.4	7.2	36.9	17.3	28.3	12.8	28.0	9.5	37.9	21.8	10.7	17.7	32.0	5.3	13.1	0.0	2.7	0.0	1478.7	37.9	6.9	0.0	2.8	2.9	76.2	3.1	3.0	2.4	29.9	13.5	41.3	4.8	17.1	2.9	170.2	102.7	103.9	13.1	21.8	22.6	357.7	71.5	15.0	0.0	6.6	7.3	36.0	8.0	20.4
IFT57	"ESRRBL1, FLJ10147, HIPPI, MHS4R2"	ENSG00000114446	"Intraflagellar transport 57"	Q9NWB7	3	108160812-108222435	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding	Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 1675.3;Late spermatids: 2795.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 41.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035514, HPA035515"	Supported		Approved	"Nuclear speckles,Mitochondria,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 34: Spermatids - Unknown function"	"Nuclear speckles"	"Mitochondria, Cytosol"	"HPA035514: AB_10601757, HPA035515: AB_10696505"	"unprognostic (1.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (2.98e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.59e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (5.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.12e-2)"	8.9	15.3	11.6	8.6	11.7	13.2	13.1	10.2	15.5	11.7	14.8	13.3	6.0	13.3	45.1	8.5	32.0	13.4	10.4	11.4	11.5	21.3	4.5	40.7	17.3	12.0	12.2	14.0	13.8	23.0	16.3	7.8	11.6	27.5	14.6	24.0	9.1	17.5	4.2	8.6	9.0	10.6	11.9	12.1	9.8	42.8	12.0	8.2	26.1	4.4	16.4	13.9	8.3	11.8	35.5	17.2	12.8	23.1	26.1	26.9	7.1	10.6	25.8	15.3	13.6	12.4	6.1	39.5	13.3	17.8	22.0	13.9	11.5	17.8	25.8	6.2	12.2	13.6	8.0	3.3	19.4	28.5	30.2	16.3	16.1	19.9	34.2	24.4	17.5	6.6	6.4	6.9	17.8	18.9	9.5	25.8	13.6	2.7	21.0	6.1	11.5	6.3	31.6	12.3	21.1	14.7	15.9	5.2	9.9	7.1	11.0	8.3	7.5	19.6	10.2	10.5	12.6	8.1	6.2	20.7	28.4	2.7	7.3	0.2	3.5	3.1	3.6	6.5	5.8	41.9	7.4	4.5	10.2	34.9	6.2	3.7	1.8	6.8	12.8	2.0	5.1	4.9	11.6	11.7	10.2	15.5	11.4	11.5	12.0	12.2	11.6	11.9	12.0	11.8	36.6	471.1	291.2	18.6	98.4	41.0	114.1	72.9	34.7	25.6	42.2	50.9	33.8	58.6	201.9	51.5	68.8	22.3	16.9	51.1	117.4	158.8	1675.3	266.3	57.8	38.2	57.2	13.7	52.6	134.1	19.3	78.9	25.5	37.0	44.3	57.1	25.7	5.9	14.5	28.6	20.3	35.7	42.7	8.1	27.7	2795.4	65.3	19.3	46.2	4.7	13.1	56.8	8.2	13.0	13.5	79.4	36.6	64.3	40.2	151.4	24.3	124.5	528.7	72.7	52.6	61.7	61.3	242.2	43.6	25.4	37.2	14.9	30.2	104.9	52.3	93.0
IFT81	"CDV-1R, CDV1, MGC4027"	ENSG00000122970	"Intraflagellar transport 81"	Q8WYA0	12	110124335-110218793	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 79.1;Respiratory ciliated cells: 148.2;Spermatocytes: 179.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019087, HPA020051"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Centrosome	"HPA019087: AB_1851462, HPA020051: AB_1851465"	"unprognostic (2.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.45e-1)"	5.9	9.0	5.0	4.6	5.0	1.5	8.8	7.5	6.0	15.6	10.8	13.6	2.7	14.5	18.5	5.9	18.3	8.5	7.6	5.2	6.0	9.4	4.1	8.3	3.0	7.2	7.0	14.5	5.2	16.5	15.2	5.0	4.4	12.3	5.7	23.0	9.3	14.3	6.8	5.7	5.2	8.5	5.1	4.0	7.4	31.8	5.3	5.8	13.8	6.7	2.9	11.5	9.7	4.1	14.1	26.2	53.0	22.7	9.6	19.6	4.0	8.8	13.5	18.7	16.0	5.1	7.8	4.6	4.8	17.0	13.2	12.2	19.7	10.4	24.1	5.9	10.8	9.7	15.4	8.4	8.3	6.0	4.5	14.1	11.6	17.7	4.5	45.2	11.8	9.0	12.0	2.5	17.3	3.0	12.3	10.1	26.2	8.1	8.6	14.4	13.9	6.2	23.2	9.4	32.8	36.2	24.1	5.0	36.8	14.7	26.9	9.1	8.0	10.5	5.4	8.8	8.4	7.9	8.0	6.3	25.3	7.6	12.2	0.0	0.3	0.1	0.2	0.2	0.5	0.4	0.5	0.2	1.0	0.4	0.4	0.1	0.8	0.7	0.3	1.0	0.2	0.3	5.0	5.0	7.5	6.0	5.2	6.0	7.2	7.0	4.4	5.1	5.3	4.1	5.2	12.8	20.1	26.4	2.4	6.1	12.9	20.3	11.4	16.4	8.6	11.6	22.1	8.6	26.0	14.7	41.7	2.5	0.6	2.3	15.6	10.9	51.8	79.1	36.1	6.0	21.6	2.5	30.1	4.0	1.6	14.9	8.2	11.9	3.8	16.8	4.6	4.8	2.6	25.2	31.8	4.3	18.3	1.3	1.4	18.1	14.0	2.5	35.6	11.2	2.1	19.1	1.0	41.2	14.5	5.7	1.9	27.8	1.9	3.6	0.9	10.5	148.2	37.7	6.6	14.4	25.6	179.0	46.0	7.4	6.5	1.0	1.5	36.3	3.5	4.8
IFTAP	"C11orf74, FLJ38678, HEPIS, NWC"	ENSG00000166352	"Intraflagellar transport associated protein"	Q86VG3	11	36594369-36675695	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.0;Cardiomyocytes: 60.7;Cytotrophoblasts: 19.3;Extravillous trophoblasts: 19.0;Fibroblasts: 8.5;Hofbauer cells: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044880	Uncertain		Approved	Aggresome,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Aggresome, Cytosol"		"HPA044880: AB_10796908"	"unprognostic (9.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.65e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.24e-1)"	17.1	20.0	19.5	5.3	20.0	13.3	15.3	19.7	31.0	17.0	33.0	30.7	7.5	16.2	23.7	9.5	31.7	12.7	45.3	19.7	19.1	25.3	18.7	11.8	5.4	19.3	20.0	21.8	18.0	16.5	25.9	10.3	19.4	12.8	10.4	19.5	12.2	10.3	41.0	7.2	10.1	16.5	18.9	8.3	17.5	52.4	19.8	10.5	82.2	42.3	5.0	17.5	12.9	20.1	11.4	19.7	41.4	31.3	39.0	56.2	16.4	24.5	26.8	23.6	43.3	0.7	18.8	0.2	18.1	25.0	32.4	4.5	28.3	33.9	48.8	0.2	47.8	19.9	9.2	20.0	30.0	27.4	4.5	36.4	24.4	15.7	22.4	40.5	40.4	15.2	25.4	0.3	25.6	18.8	4.9	22.7	24.8	7.0	31.0	19.5	51.4	11.3	34.1	3.6	0.6	46.6	28.0	5.4	42.6	37.4	38.3	14.7	24.7	32.3	22.3	43.4	21.8	6.2	12.3	0.0	29.4	33.2	17.0	10.5	18.3	1.2	1.6	15.4	5.1	0.0	4.8	3.9	20.9	0.3	11.6	2.9	1.0	14.1	15.3	28.5	0.7	8.3	19.5	20.0	19.7	31.0	19.7	19.1	19.3	20.0	19.4	18.9	19.8	20.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	0.0	0.0	0.0	19.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	19.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0
IGBP1	"α4, IBP1"	ENSG00000089289	"Immunoglobulin binding protein 1"	P78318	X	70133447-70166324	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"	Chaperone	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 342.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000634, HPA001004, CAB034139"	Approved		Approved	Cytosol		NA	NA		48000	"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB034139: AB_2295670, HPA000634: AB_1079102, HPA001004: AB_1079104"	"unprognostic (3.59e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.10e-3)"	56.3	43.2	38.5	29.7	40.3	57.5	55.1	40.3	45.8	68.6	36.9	60.2	57.8	53.3	62.0	46.6	73.5	48.3	53.4	38.6	40.4	57.9	29.4	36.6	59.4	40.4	39.9	119.1	118.6	38.7	35.6	37.6	40.6	42.2	56.2	30.1	64.4	32.1	118.0	63.4	58.3	42.4	41.7	40.7	70.1	18.7	39.7	68.2	57.3	99.9	69.5	52.4	54.5	42.7	42.7	48.9	30.9	35.9	122.2	163.3	44.5	35.6	99.6	47.9	57.1	45.5	55.7	79.1	58.7	62.0	62.6	57.1	73.8	59.1	60.8	31.4	53.2	25.1	52.7	82.9	83.6	59.4	43.9	158.1	143.1	44.3	63.2	166.6	81.8	57.9	51.4	69.5	52.6	42.7	48.7	100.4	37.5	98.0	73.6	42.3	65.0	79.5	77.8	67.2	35.4	43.4	46.3	40.0	87.0	56.4	21.3	61.1	65.8	25.8	40.2	46.0	27.2	65.0	53.7	40.1	36.4	50.5	31.1	51.4	46.1	41.8	34.1	46.0	40.9	50.9	47.4	45.2	51.1	41.8	53.7	48.9	31.4	39.8	39.0	25.6	75.2	48.0	38.5	40.3	40.3	45.8	38.6	40.4	40.4	39.9	40.6	41.7	39.7	42.7	50.1	32.1	54.7	12.1	79.3	100.1	114.2	163.9	82.0	21.5	81.4	82.2	75.8	70.1	85.6	27.6	8.4	123.8	45.3	91.3	103.7	80.3	126.3	58.0	61.1	64.1	69.9	38.9	19.3	143.2	129.0	62.2	46.9	57.9	34.8	90.8	85.3	20.9	82.7	6.7	19.5	128.0	69.2	123.1	89.6	121.5	81.4	75.6	49.8	15.0	119.8	48.9	90.6	13.6	27.6	86.4	153.1	61.7	52.9	70.8	342.0	182.0	57.8	23.6	26.3	62.3	63.0	12.2	25.0	76.2	120.3	124.9	81.9	96.1	128.4	130.4
IGBP1P2		ENSG00000266826	"Immunoglobulin (CD79A) binding protein 1 pseudogene 2"		17	58660424-58692018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	31	"testis: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000634, HPA001004"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"			Cytosol		"HPA000634: AB_1079102, HPA001004: AB_1079104"					"unprognostic (3.14e-2)"					"unprognostic (1.59e-1)"		"unprognostic (2.37e-1)"		"unprognostic (8.67e-2)"	"unprognostic (1.13e-1)"		"unprognostic (2.94e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381484-65422947	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;skeletal muscle: 10.6;tongue: 14.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 18.6;Cone photoreceptor cells: 31.3;Fibroblasts: 14.7;Leydig cells: 34.8;Microglial cells: 14.0;Oligodendrocyte precursor cells: 17.6;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.4;AF22: 9.4;CAPAN-2: 8.1;EFO-21: 4.5;HSkMC: 5.2;NTERA-2: 7.2;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA		64000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	0.9	2.5	5.6	2.4	6.9	0.0	0.5	5.8	2.5	3.4	0.0	0.8	0.5	1.4	4.2	1.6	1.7	4.2	0.9	2.9	7.2	0.1	0.0	0.2	0.6	11.2	9.4	8.5	0.1	0.3	0.9	5.6	6.8	0.4	0.6	0.8	0.5	0.4	10.6	0.8	0.8	1.0	6.9	0.2	1.1	0.6	11.3	0.7	1.9	14.0	0.6	2.1	2.0	4.5	0.0	4.4	9.4	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.5	8.1	0.0	4.5	0.3	0.0	0.0	2.3	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	5.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.8	7.2	0.0	0.0	0.0	2.3	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.9	5.8	2.5	2.9	7.2	11.2	9.4	6.8	6.9	11.3	4.5	0.2	0.0	0.0	18.6	0.0	2.3	0.0	0.0	0.0	7.7	0.2	0.5	2.2	0.0	0.0	3.7	31.3	0.4	0.1	0.0	0.0	0.4	0.4	0.0	2.1	0.3	0.0	0.0	0.9	0.0	0.6	14.7	1.1	0.0	0.0	8.8	0.0	0.0	0.7	0.0	6.3	0.0	0.0	0.0	2.5	1.4	34.8	0.3	5.4	14.0	0.0	1.0	1.0	17.6	1.0	0.3	0.0	4.1	0.1	0.1	0.0	0.7	0.0	12.2	6.6	29.8	1.0	0.8	2.6	0.1	1.1	0.8	0.3	7.0	0.0	0.0
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2141238	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 2749.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1104.3;Extravillous trophoblasts: 3196.3;Leydig cells: 3007.5;Peritubular cells: 643.9;Syncytiotrophoblasts: 1612.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 86.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 862.0;Hep G2: 600.5;LHCN-M2: 333.7;RH-30: 408.5;SH-SY5Y: 495.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	609000000	1200000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: AB_2667860, HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	99.7	58.4	5.5	9.2	32.6	0.9	41.8	12.6	86.0	75.5	236.8	22.3	4.7	75.2	52.7	18.8	128.4	34.8	91.7	6.5	7.1	31.8	305.9	9.8	3.4	20.2	6.6	117.8	37.5	5.2	25.4	2749.2	10.1	14.5	4.8	0.5	11.6	15.2	82.1	8.4	10.9	14.7	13.0	14.4	11.9	23.7	10.9	3.4	12.4	114.0	4.7	24.2	23.6	9.0	0.0	2.8	0.3	0.6	0.2	0.3	1.8	112.8	1.3	3.6	0.4	862.0	0.4	0.1	8.4	0.0	2.1	0.1	0.9	7.0	7.9	0.1	0.5	0.2	0.2	600.5	143.4	0.7	0.0	174.7	0.5	0.7	0.2	0.1	1.4	0.0	0.3	0.0	333.7	2.2	0.1	0.8	1.2	0.2	1.5	0.1	408.5	0.9	0.0	0.9	32.7	495.6	0.7	0.1	0.0	83.0	4.2	0.0	0.4	0.2	20.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	32.6	12.6	86.0	6.5	7.1	20.2	6.6	10.1	13.0	10.9	9.0	40.6	3.2	3.1	0.0	2.6	5.4	0.5	0.5	0.6	0.4	0.0	0.0	6.5	8.6	0.9	3.7	0.0	1104.3	0.0	0.0	0.0	0.0	13.1	0.0	0.0	498.4	0.0	16.0	0.0	0.0	3196.3	334.2	0.0	0.0	0.0	0.0	171.4	494.9	218.2	0.0	0.0	0.0	0.0	11.6	5.5	91.1	3007.5	3.4	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	643.9	0.0	1.1	0.0	0.0	0.9	0.5	65.7	33.5	37.5	3.8	6.3	1.5	4.1	1612.9	1.8	0.0	0.0	0.4
IGFBP3	"BP-53, IBP3"	ENSG00000146674	"Insulin like growth factor binding protein 3"	P17936	7	45912245-45921874	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 1864.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 457.7;Basal respiratory cells: 777.7;Extravillous trophoblasts: 2064.1;Fibroblasts: 463.4;Urothelial cells: 809.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 377.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 54.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 54.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8578.6;U-2197: 3469.4;U-87 MG: 1774.2"	"Low region specificity"	"Detected in all"							CAB010360			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	3250000000	3600000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB010360: AB_2233528"	"unprognostic (4.46e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (8.14e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (5.07e-7)"	"unprognostic (2.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.63e-1)"	350.6	16.2	15.6	28.5	20.2	1.2	278.2	12.2	24.1	291.8	18.9	96.7	67.8	547.3	43.1	28.2	130.9	44.6	284.6	16.5	22.5	65.9	721.3	37.5	68.3	20.7	13.7	233.1	14.4	28.0	98.1	1864.4	21.0	87.4	58.4	11.9	46.2	81.1	57.9	176.5	77.9	198.1	12.8	191.0	81.7	10.8	16.5	18.2	40.8	73.3	67.4	369.7	165.3	15.9	199.6	59.5	113.1	1.0	83.9	34.7	0.9	850.6	153.8	71.9	38.8	0.2	157.4	0.2	263.2	8578.6	35.6	466.5	1.5	3.4	29.2	0.6	0.1	0.3	20.8	0.2	21.9	0.4	1.6	285.7	12.8	15.1	53.8	112.3	0.7	0.0	0.1	3.2	26.8	1.2	1.3	1.4	7.8	1.8	10.9	0.8	0.4	81.4	53.2	423.6	13.6	32.7	293.9	11.4	15.3	250.6	1.5	0.7	0.5	815.4	1.7	3469.4	49.3	11.6	0.7	1.1	1774.2	0.3	282.1	0.0	0.0	0.0	10.1	0.0	8.0	0.0	10.9	10.7	0.0	0.0	4.9	8.1	0.1	0.0	0.0	54.5	0.8	4.5	15.6	20.2	12.2	24.1	16.5	22.5	20.7	13.7	21.0	12.8	16.5	15.9	260.4	3.2	3.9	0.7	1.9	457.7	148.9	777.7	8.0	2.8	12.6	30.4	12.6	8.6	409.7	228.1	0.0	94.1	10.0	0.7	11.7	145.6	1.3	32.3	220.1	168.0	273.7	5.3	2.5	2.0	2064.1	463.4	1.5	31.3	1.3	12.2	182.0	2.6	80.9	0.0	5.6	8.4	57.0	7.2	21.9	3.5	288.3	3.5	16.0	1.9	7.2	0.6	0.0	0.5	0.2	19.0	2.5	6.8	1.0	212.1	0.8	1.0	136.0	0.5	0.0	12.6	124.6	0.8	1.4	9.3	244.6	154.2	9.3	3.6	2.0	809.9
IGFL4		ENSG00000204869	"IGF like family member 4"	Q6B9Z1	19	46039748-46077118	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"retina: 19.5;skin 1: 6.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.2;Cone photoreceptor cells: 14.6;Excitatory neurons: 9.5;Inhibitory neurons: 10.1;Rod photoreceptor cells: 42.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.9;HaCaT: 3.5;OE19: 6.1"									HPA047655	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA047655: AB_2680113"	"unprognostic (1.22e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.96e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.59e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	0.0	0.3	1.3	0.1	1.1	0.1	0.1	1.0	2.2	0.0	0.0	0.1	0.4	0.3	1.3	1.0	0.2	0.5	1.0	1.2	0.4	0.1	0.1	0.3	0.4	0.0	0.1	0.9	0.0	0.5	1.6	0.1	0.4	0.4	0.2	19.5	0.5	0.0	0.2	6.9	0.3	0.0	0.0	0.2	0.2	0.3	0.3	0.0	0.8	0.0	0.0	0.3	0.0	1.8	0.0	3.9	0.1	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.0	0.1	0.5	3.5	0.0	0.0	0.0	0.4	0.6	0.0	0.6	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.4	0.0	0.4	0.0	0.3	0.2	6.1	0.2	0.0	1.7	0.9	0.0	0.2	0.2	0.3	0.0	0.1	0.9	0.4	0.2	0.7	0.4	0.3	0.7	0.2	0.2	0.4	0.3	0.1	0.1	0.6	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	1.1	1.0	2.2	1.2	0.4	0.0	0.1	0.4	0.0	0.3	1.8	0.0	0.0	0.0	2.6	0.0	1.0	0.0	0.8	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	10.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	3.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.0	0.0	0.1	0.8	2.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0
IGSF1	"IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2"	ENSG00000147255	"Immunoglobulin superfamily member 1"	Q8N6C5	X	131273506-131578899	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 73.4;pituitary gland: 167.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Astrocytes: 3.9;Bipolar cells: 14.0;Breast glandular cells: 5.0;Horizontal cells: 3.3;Melanocytes: 3.6;Skeletal myocytes: 7.2"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 65.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 47.6;SH-SY5Y: 31.2"	"Region enhanced"	"Detected in all"		"hypothalamus: 144.0"	"Low region specificity"	"Detected in all"			"HPA012732, HPA035582"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		100000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA012732: AB_2732404, HPA035582: AB_2674687"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (4.25e-8)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.52e-3)"	"unprognostic (8.03e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.13e-2)"	1.9	12.5	9.7	0.8	10.0	0.1	2.8	9.7	9.7	3.3	4.8	0.9	0.4	1.2	2.4	1.6	2.5	1.2	12.1	7.5	73.4	0.7	1.5	0.3	0.4	10.0	21.6	1.1	2.6	0.8	167.8	0.7	24.0	4.0	0.4	6.4	2.4	5.7	2.0	1.4	0.6	3.1	7.4	0.3	1.0	12.2	32.4	0.6	4.5	5.1	0.9	0.4	0.9	8.4	0.4	0.6	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.0	0.0	0.0	0.1	1.8	0.0	0.0	6.0	0.4	0.0	3.0	47.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	4.1	2.8	0.0	0.0	0.0	0.1	0.1	0.2	3.4	31.2	0.0	0.2	0.0	4.1	0.6	0.0	0.0	0.5	0.8	0.0	4.1	1.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.0	9.7	9.7	7.5	73.4	10.0	21.6	24.0	7.4	32.4	8.4	0.2	3.2	0.6	3.9	0.2	0.0	0.5	0.0	1.2	14.0	5.0	1.7	2.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.3	1.5	0.0	0.1	0.0	0.7	0.7	0.3	0.0	3.3	0.4	0.0	0.0	0.0	0.8	1.1	0.0	0.2	3.6	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.3	0.0	0.8	0.0	0.7	0.0	7.2	0.3	0.1	0.4	0.0	0.4	0.3	0.1	0.0	0.0	0.3
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.3;ovary: 16.2;retina: 50.6;testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.9;Early spermatids: 257.9;Inhibitory neurons: 139.1;Late spermatids: 334.0;Oligodendrocytes: 283.2"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.0;HEL: 5.9;SK-MEL-30: 35.1;U-266/70: 11.9;U-266/84: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	0.3	7.8	19.5	0.4	34.0	0.0	0.2	26.9	22.2	0.8	1.5	4.1	0.2	0.5	1.1	1.2	0.6	0.8	2.2	19.3	18.6	8.2	0.1	0.1	0.1	30.5	28.0	16.2	3.7	1.3	1.7	0.1	29.9	0.7	0.8	50.6	0.6	0.8	3.9	1.5	0.9	0.5	23.3	0.1	1.6	35.7	25.6	0.3	3.4	5.0	0.2	0.6	0.8	46.3	0.0	8.0	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	2.7	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.7	0.6	0.0	0.1	35.1	2.1	0.7	0.1	0.0	0.0	1.4	0.0	0.1	11.9	15.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	34.0	26.9	22.2	19.3	18.6	30.5	28.0	29.9	23.3	25.6	46.3	0.1	0.0	0.0	133.9	0.6	0.4	0.1	0.3	2.8	9.1	0.3	0.1	1.3	0.0	0.5	0.0	75.0	0.2	0.1	0.0	0.0	0.9	257.9	4.2	0.8	0.3	0.0	0.0	77.8	0.7	0.0	2.0	0.0	7.2	0.0	26.8	0.0	0.0	0.0	16.8	139.1	0.0	6.1	0.0	0.4	334.0	3.7	0.4	3.6	4.7	0.0	22.3	0.0	43.2	283.2	0.2	0.0	1.9	0.2	0.1	0.0	5.9	0.4	25.7	0.0	0.8	0.9	22.4	6.0	0.7	0.0	0.1	0.2	6.8	0.0	0.4
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 256.5;WM-115: 239.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA036305: AB_2675050, HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.5	1.8	0.9	1.3	1.8	0.3	8.5	1.8	3.9	6.1	1.4	6.5	7.7	2.9	5.7	23.2	2.0	3.2	9.1	1.1	3.0	11.4	0.5	8.4	0.5	2.0	3.5	0.4	2.6	2.1	2.4	11.1	2.3	5.6	5.8	7.5	9.1	5.7	1.6	18.2	8.8	2.9	4.7	0.4	8.7	4.1	4.9	10.9	8.3	1.5	5.3	5.0	10.9	2.9	22.3	36.9	28.2	7.2	6.4	13.4	75.5	0.1	1.0	2.9	1.0	21.5	12.4	0.0	11.4	0.3	15.8	60.7	12.6	30.4	1.3	256.5	9.3	12.1	13.7	0.6	0.0	1.2	22.2	1.7	23.1	0.2	5.2	5.3	0.2	4.1	3.7	0.2	0.6	78.0	0.9	0.8	17.8	13.4	0.9	9.1	34.6	0.1	21.6	27.5	16.4	50.0	8.9	84.7	55.1	53.9	28.7	1.5	0.1	4.9	16.4	0.2	23.0	0.3	1.3	0.1	2.2	0.7	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	1.8	3.9	1.1	3.0	2.0	3.5	2.3	4.7	4.9	2.9	3.5	16.0	36.0	1.0	0.0	19.6	8.6	23.2	23.9	29.3	17.1	10.8	16.1	7.2	9.1	14.7	0.0	13.7	0.1	29.3	3.9	14.0	2.1	8.3	2.1	3.3	3.0	0.0	11.8	1.9	27.3	7.8	16.8	14.4	1.3	7.3	1.8	0.6	2.1	6.7	18.8	5.0	2.0	1.3	11.1	2.2	1.2	0.5	8.8	0.0	3.1	11.3	0.0	1.5	0.4	16.4	7.3	0.0	0.0	10.2	15.4	11.4	11.3	0.8	0.0	26.4	2.8	0.5	3.8	30.6	27.7	13.3	0.4	3.5	9.3	11.4
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 173.0;lymphoid tissue: 112.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	5.0	3.2	3.5	53.0	3.4	173.0	4.4	4.0	3.9	3.6	3.3	7.6	7.0	2.5	2.3	4.8	2.2	7.7	1.5	3.0	4.0	1.4	4.9	11.6	87.1	7.7	5.2	1.6	0.8	0.8	0.6	3.6	7.5	2.3	6.8	0.2	4.6	1.9	1.0	2.0	15.6	4.0	7.3	48.6	12.0	1.7	8.7	112.5	2.1	1.2	73.8	9.6	1.8	10.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	258.6	0.2	52.1	0.0	0.0	0.0	84.5	220.4	0.0	0.0	0.0	0.0	0.0	0.0	128.9	72.4	15.4	0.0	0.0	184.3	80.9	2.4	0.0	0.0	192.3	0.3	39.6	0.0	0.0	1.6	2.0	0.8	1.0	0.8	0.4	0.2	112.1	0.2	0.0	1.9	0.2	0.4	80.8	49.4	342.7	0.5	89.5	0.5	21.2	14.2	25.0	35.4	43.9	29.1	46.7	36.3	35.0	15.1	40.7	48.2	35.7	20.2	24.3	43.3	23.4	32.6	26.4	3.5	3.4	4.0	3.9	3.0	4.0	7.7	5.2	7.5	7.3	8.7	10.3	2.8	3.2	12.2	0.7	120.5	2.8	0.1	0.0	0.0	0.0	2.8	1.9	1.5	2.8	1.8	1.8	0.0	0.4	221.4	0.3	0.0	0.4	3.8	0.5	0.4	2.6	0.0	89.8	0.2	0.0	0.4	2.5	4.6	0.6	23.4	0.2	3.9	2.0	30.6	0.0	0.3	0.0	0.0	64.3	61.0	5.3	0.0	72.1	19.6	91.8	106.6	0.0	150.4	1.0	0.3	0.1	0.4	0.0	128.9	0.1	0.0	1.0	1.5	0.1	0.0	1.5	1.6	0.1	2.1	0.5	2.7	0.7	182.8	0.1	0.1	0.1
IKZF2	"Helios, ZNFN1A2"	ENSG00000030419	"IKAROS family zinc finger 2"	Q9UKS7	2	212999691-213152427	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.4;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 78.3;Squamous epithelial cells: 47.8;Urothelial cells: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;NK-cells: 5.5;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"JURKAT: 70.5;MOLT-4: 31.1;RT4: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059142	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA059142: AB_2683923"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.93e-3)"	"unprognostic (7.09e-2)"	2.1	2.0	2.6	3.8	5.5	5.5	2.3	3.2	3.2	3.4	0.7	1.8	0.8	1.9	3.2	19.4	2.8	3.1	1.9	2.9	3.8	1.5	1.4	2.9	7.0	5.2	3.5	2.0	2.0	5.2	1.9	2.0	5.3	3.3	1.7	5.5	8.4	4.3	4.1	9.1	1.2	0.8	3.2	5.5	4.4	2.5	3.9	40.3	7.8	1.6	6.8	9.6	8.3	7.4	2.8	1.0	5.3	0.3	17.1	17.2	3.3	3.4	3.9	0.8	1.7	1.4	4.6	3.7	4.4	2.0	0.4	6.5	0.1	1.8	2.7	0.0	0.9	1.9	3.6	0.5	0.1	8.9	0.6	16.9	1.6	0.1	0.5	4.3	0.0	70.5	1.2	3.1	1.6	5.2	31.1	8.9	1.1	2.2	0.8	18.1	3.5	0.0	1.5	28.6	1.6	1.0	0.0	3.6	0.0	4.4	4.8	0.9	9.2	4.9	3.8	2.3	0.7	6.0	2.0	20.6	2.4	0.0	1.1	3.9	0.0	4.8	1.8	0.0	4.9	0.2	0.6	1.4	0.0	1.0	0.3	1.5	0.0	5.5	0.0	0.5	5.8	0.3	2.6	5.5	3.2	3.2	2.9	3.8	5.2	3.5	5.3	3.2	3.9	7.4	2.1	9.6	12.6	77.4	5.2	5.9	23.2	7.9	11.4	4.8	5.1	2.2	7.6	1.5	19.5	7.3	4.2	4.3	27.4	2.8	0.0	2.3	1.3	16.1	1.8	2.4	3.0	9.0	17.7	3.1	1.2	2.7	8.6	18.1	3.8	2.5	2.5	2.2	2.1	0.0	19.9	2.3	4.1	2.4	2.1	0.7	1.8	2.8	1.8	31.9	1.3	3.0	39.1	100.5	78.3	3.6	1.0	2.2	13.9	15.9	1.1	1.0	31.7	7.3	0.0	10.2	4.5	0.8	0.7	47.8	8.7	4.0	22.1	2.0	1.4	51.8
IL10RB	"CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2"	ENSG00000243646	"Interleukin 10 receptor subunit beta"	Q08334	21	33266367-33310187	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 198.4;Extravillous trophoblasts: 164.9;Syncytiotrophoblasts: 315.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB020670, HPA047550"	Approved		Approved	Cytosol		NA	NA		1600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"CAB020670: , HPA047550: AB_2680086"	"unprognostic (8.43e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (5.62e-9)"	"unprognostic (3.09e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	24.6	14.5	8.2	30.3	8.2	19.8	18.1	8.1	11.3	20.2	8.6	40.6	36.5	14.7	9.9	27.6	23.9	23.9	13.8	8.1	7.8	16.8	27.5	25.8	27.6	9.0	8.1	20.4	25.4	10.7	11.3	62.5	8.9	18.6	38.0	4.8	23.6	12.3	12.4	20.2	45.7	19.8	8.6	43.1	33.8	5.0	9.5	30.5	14.0	9.8	26.0	29.3	19.3	9.8	28.8	21.6	4.9	19.1	82.7	61.3	30.0	22.9	62.3	23.5	33.6	20.6	36.1	10.9	25.0	37.8	48.3	34.5	13.2	14.8	17.3	28.5	15.5	30.8	15.1	15.2	58.3	29.5	54.6	62.5	26.8	41.2	23.5	36.8	34.6	25.6	20.6	79.7	32.5	29.1	22.6	27.4	4.2	59.1	11.4	18.5	14.4	33.9	22.6	16.6	7.5	8.0	45.4	35.3	37.5	9.7	21.3	104.5	31.0	24.1	22.7	40.0	12.4	49.9	48.3	6.8	40.5	44.5	19.4	103.8	115.0	98.9	32.0	134.9	35.2	51.6	39.3	38.1	67.9	54.1	36.8	36.3	219.4	56.9	141.6	73.6	77.6	87.5	8.2	8.2	8.1	11.3	8.1	7.8	9.0	8.1	8.9	8.6	9.5	9.8	3.1	35.3	20.5	11.8	26.5	14.5	38.0	54.0	19.4	5.8	3.3	2.8	12.3	32.9	32.3	3.7	14.6	198.4	33.6	102.1	0.0	20.1	1.1	2.3	3.5	23.5	10.2	17.7	14.5	30.1	164.9	24.2	29.6	2.4	35.5	2.1	31.8	23.2	116.6	8.4	12.7	64.4	30.5	111.3	25.3	1.6	31.7	54.3	14.2	23.4	80.6	6.7	49.4	14.6	18.5	23.4	86.8	23.7	39.9	44.3	103.1	1.1	15.8	6.4	19.7	16.9	9.1	2.9	5.0	21.7	14.6	315.6	21.0	0.2	41.4	67.6
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 24.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 96.7;Late spermatids: 200.7;Spermatocytes: 44.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	187	"HDLM-2: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042421			Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	40000			"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA042421: AB_10795504"	"unprognostic (2.17e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-1)"	0.3	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.2	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	96.7	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	200.7	2.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.5	44.4	1.2	0.0	0.6	0.0	14.7	0.0	0.0	0.0
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 135.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 57.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1"	"Group enriched"	"Detected in all"	11	"cerebellum: 54.5;hippocampal formation: 27.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 48.8"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	208000	7300	"Cluster 5: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	18.9	6.3	3.5	63.3	3.0	62.1	15.5	57.3	4.1	9.6	13.8	14.4	11.3	9.9	7.7	7.4	17.8	16.2	5.9	2.9	5.7	3.2	9.7	23.7	132.6	5.9	5.7	6.1	2.6	2.3	2.1	9.0	10.5	5.8	16.8	0.5	11.2	4.5	3.3	12.0	39.9	9.8	5.8	86.2	15.6	4.2	5.2	130.4	6.9	8.5	135.3	18.9	10.4	7.6	0.0	0.0	0.0	0.1	17.5	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	29.4	0.0	0.0	0.9	21.0	50.6	0.9	0.0	0.1	0.6	0.0	0.4	3.5	3.2	10.7	0.1	0.0	1.7	22.2	0.0	0.1	0.0	0.1	0.1	51.0	0.0	0.2	0.1	0.1	0.1	0.0	9.9	0.0	0.0	4.6	0.2	0.3	0.2	1.0	0.0	60.3	5.5	25.8	1.8	35.1	1.5	252.8	116.2	321.3	164.5	142.7	185.9	166.0	170.6	180.6	150.9	157.2	224.9	185.6	282.5	213.2	149.1	113.7	197.0	338.0	3.5	3.0	57.3	4.1	2.9	5.7	5.9	5.7	10.5	5.8	5.2	7.6	9.4	3.2	6.6	0.0	135.3	8.2	0.2	0.8	1.2	0.2	0.8	1.4	2.7	8.6	1.9	1.8	0.0	0.3	78.1	0.3	0.0	0.1	1.4	3.1	6.6	7.5	0.0	20.2	3.4	0.2	0.3	15.9	1.1	0.7	27.1	0.0	26.7	9.2	19.0	0.0	4.9	0.3	0.0	59.2	94.4	1.4	10.8	33.1	28.4	18.7	30.2	0.3	121.5	0.0	0.3	0.0	1.2	18.0	55.6	0.1	0.1	0.4	7.7	0.7	6.6	1.1	3.2	2.1	7.5	1.2	3.7	0.4	76.3	0.2	0.7	0.2
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.9;Kupffer cells: 81.4;Macrophages: 61.4;monocytes: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 59.9;NB-4: 52.5;THP-1: 74.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		62000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	9.1	5.6	5.5	9.6	11.3	31.8	6.9	5.7	7.5	5.4	6.8	4.7	3.8	5.4	5.0	5.2	6.0	3.6	4.6	6.3	5.5	3.7	5.7	10.0	6.9	9.8	7.3	4.5	5.2	3.9	3.8	3.5	8.9	5.0	3.4	1.5	5.2	2.8	1.8	6.9	6.2	5.3	7.7	16.6	5.6	2.0	7.7	15.4	4.2	2.6	5.6	4.6	4.7	9.6	7.9	4.5	4.1	5.1	8.0	4.6	5.1	11.5	7.4	5.3	6.8	4.4	5.1	7.1	4.6	11.6	6.9	12.4	5.6	5.4	3.7	11.6	6.6	0.0	2.6	2.8	9.2	59.9	17.8	6.8	7.9	4.7	3.7	5.2	5.7	5.6	3.0	7.3	5.5	6.7	7.2	52.5	2.2	10.1	4.3	1.6	0.8	1.3	5.1	5.8	2.8	0.1	8.0	6.7	5.7	4.6	5.3	74.7	15.9	4.1	5.8	6.1	4.3	5.8	3.4	3.3	6.0	28.3	4.5	8.5	7.4	7.2	1.1	3.4	0.9	0.5	1.5	1.2	3.9	0.4	2.4	1.8	16.5	1.5	3.5	1.8	1.0	2.6	5.5	11.3	5.7	7.5	6.3	5.5	9.8	7.3	8.9	7.7	7.7	9.6	14.0	12.8	14.1	2.9	13.8	8.8	6.6	10.2	10.8	3.9	7.2	5.8	6.1	10.0	8.6	5.5	8.4	6.1	18.7	23.6	0.0	8.7	4.0	7.2	8.1	13.7	13.2	9.2	8.3	12.6	11.9	13.6	29.0	9.7	7.6	58.9	17.5	11.1	34.0	3.3	6.4	13.9	6.1	81.4	16.2	2.1	9.0	61.4	8.8	41.2	114.2	4.3	28.8	12.5	11.4	12.2	12.4	4.5	10.3	9.1	14.7	3.4	8.0	2.9	13.1	10.4	10.0	3.0	13.4	9.0	6.8	6.4	25.4	8.1	12.4	9.6
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143253-112164096	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.5;skin 1: 149.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Basal respiratory cells: 186.4;Basal squamous epithelial cells: 215.1;Kupffer cells: 241.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 117.9;CAPAN-2: 182.3;HaCaT: 167.0;HBEC3-KT: 125.8;hTCEpi: 188.5;PC-3: 110.2;U-2 OS: 208.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	Yes	196000	16000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	19.9	6.1	5.3	18.2	5.4	31.6	12.6	5.9	8.6	38.0	7.0	34.1	22.0	2.4	3.3	124.5	8.0	23.0	3.0	5.3	6.0	23.8	9.1	23.0	67.8	7.5	6.2	1.9	17.9	1.3	2.9	6.7	7.4	6.1	29.1	6.9	15.0	3.0	6.0	149.6	22.0	3.6	6.7	29.3	13.4	1.9	5.7	8.0	3.7	2.1	25.7	25.3	77.0	11.3	117.9	40.0	0.0	0.4	0.0	0.0	0.7	2.0	0.0	0.0	0.1	22.4	182.3	0.1	25.7	0.3	3.2	167.0	0.0	125.8	0.0	0.3	1.2	17.5	35.6	9.9	3.9	9.3	32.6	0.2	188.5	0.3	43.5	0.2	0.1	0.1	0.5	0.3	1.6	0.2	0.2	0.9	0.2	31.9	110.2	0.1	0.1	0.4	79.9	24.8	0.1	0.0	78.4	52.1	0.5	1.0	31.0	25.4	0.3	0.4	208.9	1.2	35.9	0.4	0.3	0.6	0.2	67.1	0.2	6.8	8.7	16.0	0.1	10.9	0.0	0.7	0.1	0.0	25.8	0.7	0.0	0.5	9.5	19.6	6.3	5.6	0.0	2.5	5.3	5.4	5.9	8.6	5.3	6.0	7.5	6.2	7.4	6.7	5.7	11.3	1.0	173.1	38.4	0.7	6.0	122.9	33.5	186.4	215.1	2.6	4.6	7.7	1.0	41.5	66.1	9.2	0.0	2.3	10.8	109.9	80.3	24.7	2.4	94.9	1.4	4.6	14.5	26.3	3.8	143.0	3.7	18.8	20.9	32.5	101.2	2.8	8.2	1.9	68.4	0.0	4.6	30.1	57.0	241.0	37.3	1.9	0.0	123.8	3.6	61.8	38.8	2.7	6.2	2.0	1.1	161.4	104.6	4.5	4.6	23.6	67.5	22.3	69.6	39.1	6.6	0.6	3.9	1.5	1.3	152.6	111.2	1.8	9.6	0.3	47.8	90.5
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 127.1;Endometrial stromal cells: 280.2;Glandular and luminal cells: 315.4;Hepatic stellate cells: 146.7;Langerhans cells: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 624.9;ASC TERT1: 276.8;HHSteC: 196.3;HSkMC: 770.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1400000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	137.3	68.0	7.1	69.5	8.3	18.0	77.5	7.5	11.0	161.1	16.2	39.3	20.7	33.5	105.2	32.1	52.0	92.0	58.3	7.6	9.0	45.7	75.5	115.5	17.1	16.2	8.4	31.1	43.3	126.7	13.1	120.8	8.9	66.7	30.5	8.5	34.2	47.4	18.6	40.1	40.3	49.9	10.0	41.0	43.9	20.6	14.9	21.7	52.5	16.0	19.7	87.4	40.2	7.7	2.0	12.8	0.3	10.8	624.9	276.8	4.4	27.4	123.8	19.2	28.7	5.7	3.4	0.0	19.8	55.0	33.9	5.5	0.2	2.2	16.1	55.5	0.1	0.7	2.9	31.3	196.3	0.1	0.3	770.6	2.3	21.7	5.2	8.4	8.7	0.0	3.5	1.1	28.1	5.6	0.0	1.2	0.7	5.6	0.9	0.3	2.0	0.4	18.3	13.4	0.1	0.3	12.5	7.7	0.0	3.6	11.1	0.8	0.3	54.7	3.6	92.1	2.2	0.1	0.0	0.1	21.3	0.6	3.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	7.1	8.3	7.5	11.0	7.6	9.0	16.2	8.4	8.9	10.0	14.9	7.7	99.3	25.6	73.2	1.3	1.8	31.1	46.8	8.2	5.2	0.1	19.4	13.7	5.2	28.6	68.6	5.5	0.0	6.1	2.5	0.7	3.9	31.7	7.0	127.1	280.2	103.6	1.2	14.3	0.5	21.8	82.8	79.1	2.0	315.4	1.3	0.3	146.7	47.1	5.4	0.0	3.0	0.5	10.2	12.0	188.2	12.6	28.0	26.0	19.6	23.4	7.0	9.0	0.0	0.5	0.5	12.0	0.3	1.5	1.8	65.9	0.0	8.3	28.6	1.0	6.6	37.7	34.3	1.3	1.2	4.5	38.6	23.9	8.5	4.0	0.8	23.6
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 225.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 109.2;Hepatocytes: 295.8;Oligodendrocyte precursor cells: 298.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"eosinophil: 23.8;neutrophil: 95.0"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 95.0"	"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		350000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	6.2	2.9	4.0	11.4	1.1	20.3	4.3	0.0	8.7	4.4	0.5	2.2	1.8	4.0	2.6	13.1	5.4	12.1	3.9	4.6	3.1	3.3	225.8	8.2	2.7	2.4	3.7	3.0	3.9	1.5	1.2	37.0	3.3	3.9	2.2	2.4	5.2	3.4	1.3	11.9	2.2	6.4	1.5	5.4	4.5	1.3	5.5	4.6	4.0	2.1	4.8	9.4	5.5	3.3	13.3	3.0	5.5	0.8	9.5	7.7	10.0	5.8	11.9	13.4	13.2	5.8	29.3	2.2	59.2	16.4	31.1	34.1	3.0	57.6	18.7	2.5	3.6	2.9	5.3	14.5	19.6	20.2	9.5	10.3	23.1	19.7	59.2	27.8	6.0	5.9	0.4	0.2	6.4	6.5	1.7	9.4	8.5	6.0	6.0	9.5	8.2	4.8	5.3	14.8	1.0	0.0	26.3	15.0	247.1	5.2	9.6	14.6	7.9	10.3	10.4	32.1	26.6	5.0	0.2	0.5	17.2	18.0	60.9	11.7	3.8	23.8	1.8	4.3	3.3	2.1	2.1	2.3	3.8	2.1	2.0	1.3	95.0	0.3	6.3	0.6	2.1	1.4	4.0	1.1	0.0	8.7	4.6	3.1	2.4	3.7	3.3	1.5	5.5	3.3	3.5	0.0	14.7	6.5	6.8	44.7	16.5	45.8	68.9	6.5	2.5	4.7	5.5	40.0	22.8	3.7	8.4	8.5	3.6	1.8	0.0	7.7	4.4	8.6	3.8	8.0	5.4	4.4	44.3	7.5	109.2	7.3	7.1	12.3	7.6	0.7	7.5	295.8	7.8	0.0	63.3	1.4	4.1	33.7	17.7	0.6	4.4	28.8	8.8	53.4	5.0	1.0	6.2	298.6	1.5	19.7	0.8	2.6	5.3	11.5	0.7	1.1	8.7	0.6	0.0	18.0	5.1	0.1	0.6	30.9	37.2	24.2	5.2	1.4	1.1	14.3
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 126.4;lung: 162.0;placenta: 199.8"	"Cell type enriched"	"Detected in many"	9	"granulocytes: 501.5"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.3;eosinophil: 29.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 38.3"	"Group enriched"	"Detected in some"	6	"HHSteC: 245.1;HMC-1: 373.7;HUVEC TERT2: 185.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	3100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	22.3	30.3	7.5	3.1	9.8	0.7	14.7	7.8	11.0	3.6	12.2	5.2	1.7	2.5	0.6	4.4	2.6	14.7	24.7	7.2	8.2	126.4	16.0	162.0	0.7	7.6	7.7	1.1	4.8	0.8	5.7	199.8	7.7	4.9	3.4	2.8	1.8	4.6	2.5	4.3	8.0	3.7	8.0	1.4	25.1	0.5	9.6	1.3	4.1	0.7	0.8	6.5	3.9	8.9	0.9	0.2	0.7	0.1	15.1	0.6	0.3	0.5	0.7	0.4	0.6	0.3	0.5	0.5	0.7	0.2	0.2	1.4	0.2	6.3	0.4	0.2	0.1	45.7	0.8	0.8	245.1	1.9	373.7	5.1	1.5	6.2	40.0	0.6	185.5	0.2	0.9	0.8	0.7	0.4	0.6	8.7	0.3	0.4	0.7	0.3	0.2	0.2	1.0	0.3	0.6	0.4	0.5	0.3	0.2	0.4	0.3	0.1	15.4	0.5	0.5	3.5	0.5	0.1	0.3	0.4	0.7	0.6	0.5	38.3	0.0	29.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	7.5	9.8	7.8	11.0	7.2	8.2	7.6	7.7	7.7	8.0	9.6	8.9	22.6	9.6	13.1	0.0	0.1	8.5	20.3	0.4	0.0	0.0	0.3	0.1	2.7	0.0	7.7	1.8	0.0	0.0	3.3	0.1	0.0	3.2	0.4	1.1	14.8	49.7	0.0	1.3	0.2	0.5	0.1	54.5	0.0	2.5	501.5	0.0	26.4	0.7	0.0	0.0	0.2	0.0	0.0	0.3	19.1	1.3	0.9	3.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	37.2	0.0	0.0	3.2	15.7	0.0	0.0	6.6	0.3	39.5	1.5	37.7	0.0	0.0	0.0	5.1	0.0	31.5	0.0	0.0	16.4
IL20RA	"IL-20R1, ZCYTOR7"	ENSG00000016402	"Interleukin 20 receptor subunit alpha"	Q9UHF4	6	136999971-137045180	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 26.4;skin 1: 37.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 58.6;Endometrial ciliated cells: 110.4;Glandular and luminal cells: 69.8;Muller glia cells: 54.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.5;HaCaT: 6.9;OE19: 10.1;RT4: 11.5;SH-SY5Y: 10.8;T-47d: 10.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB024990, HPA042281"	Approved		Approved	Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB024990: , HPA042281: AB_10806235"	"unprognostic (3.75e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (1.43e-6)"	"unprognostic (1.57e-2)"	"prognostic favorable (2.29e-5)"	"unprognostic (9.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (8.03e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.85e-6)"	"unprognostic (9.38e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.64e-3)"	0.9	8.8	3.0	0.7	3.5	0.1	26.4	3.9	2.7	17.1	4.9	4.6	3.1	5.9	4.4	7.0	17.3	4.9	2.4	2.4	3.9	0.4	0.4	5.9	0.0	3.7	4.7	4.9	7.9	2.8	1.6	0.2	4.0	8.6	4.6	4.9	9.7	5.5	0.7	37.7	1.3	3.0	4.3	0.0	6.2	2.0	4.2	1.6	1.1	2.4	2.6	6.0	11.9	3.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	9.5	0.0	0.1	1.5	0.1	6.9	1.2	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	10.1	1.4	0.0	0.4	0.0	0.0	11.5	0.7	10.8	0.5	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.5	3.9	2.7	2.4	3.9	3.7	4.7	4.0	4.3	4.2	3.5	1.4	3.2	26.1	6.2	0.0	21.9	12.0	12.7	6.2	3.5	58.6	39.5	4.6	37.1	22.3	3.7	0.0	2.7	0.5	12.1	0.0	15.3	0.8	110.4	8.0	1.1	7.3	0.0	0.1	0.7	10.6	5.0	19.9	69.8	2.5	0.1	0.4	0.0	0.5	0.0	1.3	23.1	28.5	0.0	1.6	0.9	8.7	0.8	14.2	0.0	0.0	54.6	0.0	3.0	0.3	13.1	11.7	15.1	0.0	18.7	1.7	1.2	36.0	1.3	0.0	2.3	1.7	0.3	3.8	25.3	18.0	8.2	1.3	6.4	12.3	21.1
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 110.7;skin 1: 163.3;vagina: 66.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 36.8;Basal respiratory cells: 115.8;Basal squamous epithelial cells: 60.9;Club cells: 43.0;Early spermatids: 57.0;Late spermatids: 28.8;Squamous epithelial cells: 56.5;Suprabasal keratinocytes: 38.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 86.0;HBEC3-KT: 140.0;HHSteC: 91.8;hTCEpi: 555.6;hTERT-HME1: 102.6"	"Not detected"	"Not detected"							HPA063914			Approved	Vesicles,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Cytosol	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	2.3	0.2	0.1	0.0	0.2	0.0	10.3	0.1	0.6	24.3	0.1	0.6	0.0	0.2	0.0	110.7	0.4	0.0	0.6	0.1	0.1	0.2	5.4	0.5	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.4	0.2	2.2	0.5	0.0	13.6	0.2	1.0	163.3	0.4	0.0	0.1	0.3	0.5	3.7	0.2	2.0	0.5	0.9	9.5	1.3	66.2	0.2	27.2	0.0	0.1	0.4	15.4	64.9	2.6	0.6	1.8	0.3	1.2	2.7	3.4	0.2	14.9	9.7	1.0	86.0	0.0	140.0	0.7	0.4	0.0	0.3	19.5	0.0	91.8	0.2	0.2	11.5	555.6	4.5	102.6	0.7	0.1	0.1	0.3	0.1	0.0	0.0	0.6	0.0	0.4	2.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	54.6	0.0	2.8	4.7	0.5	0.9	0.0	0.2	1.8	0.5	0.5	0.1	0.2	0.2	8.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.7	0.0	0.0	0.7	0.0	36.8	1.7	115.8	60.9	0.0	0.3	0.5	0.4	0.0	43.0	0.0	0.0	1.7	0.8	0.8	0.0	0.9	57.0	0.7	0.4	0.9	0.0	0.0	1.0	0.2	1.4	3.9	0.0	0.8	0.0	0.2	0.0	2.2	0.4	0.0	1.2	0.7	10.2	0.3	6.6	28.8	0.3	0.6	3.6	1.0	1.7	0.0	1.0	1.0	0.2	1.0	0.1	0.7	0.4	1.3	0.2	0.3	5.5	0.0	0.0	0.6	3.6	1.7	1.9	56.5	38.1	1.6	0.6	0.2	0.5	5.3
IL23A	"IL-23, IL-23A, IL23P19, P19, SGRF"	ENSG00000110944	"Interleukin 23 subunit alpha"	Q9NPF7	12	56334174-56340410	"FDA approved drug targets, Predicted secreted proteins"	"Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling"	Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"urinary bladder: 44.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 43.4;Ionocytes: 73.2;Langerhans cells: 151.8;Pancreatic endocrine cells: 70.5;Spermatocytes: 41.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 14.1;memory B-cell: 18.9;memory CD4 T-cell: 25.7;memory CD8 T-cell: 12.5;naive B-cell: 21.5;naive CD4 T-cell: 28.1;naive CD8 T-cell: 17.6;T-reg: 15.6"	"Group enriched"	"Detected in many"	12	"B-cells: 21.5;T-cells: 28.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.3;CAPAN-2: 25.6;U-266/70: 42.1;U-266/84: 20.5"	"Region enhanced"	"Detected in some"		"white matter: 3.9"	"Not detected"	"Not detected"			HPA001554	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA	11000		"Cluster 30: Non-specific - Translation"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA001554: AB_1079135"	"unprognostic (2.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.50e-3)"	0.6	0.3	0.3	2.1	0.2	3.2	0.3	0.1	0.2	0.4	0.1	0.4	0.2	1.0	0.5	4.5	0.4	0.9	0.3	0.4	0.2	0.6	1.1	1.2	4.2	0.3	0.2	0.3	0.7	0.0	0.6	0.6	0.2	0.5	0.3	0.1	1.3	0.2	0.2	0.7	1.9	0.0	0.2	2.2	0.7	4.4	0.3	7.2	0.4	0.0	8.8	44.5	0.5	0.3	15.3	0.3	0.5	0.5	0.0	0.0	1.3	0.3	0.1	0.0	0.0	0.5	25.6	0.9	7.5	0.0	0.8	1.3	0.0	2.5	0.1	1.1	0.5	0.4	0.3	1.2	0.0	0.3	0.9	0.1	0.0	0.0	0.7	3.1	0.0	3.5	0.6	6.2	0.1	0.6	0.6	0.8	2.2	0.3	0.4	0.4	0.2	0.6	8.9	7.4	0.5	0.6	0.3	0.4	1.4	2.1	0.2	7.0	0.5	0.5	0.5	0.4	1.8	42.1	20.5	2.1	0.5	3.7	0.4	0.0	0.4	0.0	2.8	0.0	14.1	18.9	25.7	12.5	0.9	21.5	28.1	17.6	0.2	2.0	0.1	0.1	15.6	10.0	0.3	0.2	0.1	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.5	3.2	2.2	0.0	13.6	3.6	12.1	16.2	0.6	0.0	1.2	1.4	0.4	0.0	23.7	1.8	0.0	0.4	1.5	1.1	1.9	43.4	6.9	11.1	1.0	1.4	0.0	0.0	0.3	7.4	0.5	2.3	1.5	16.6	0.0	0.3	0.0	0.5	2.5	0.0	0.2	1.0	73.2	0.8	151.8	4.2	0.3	14.7	8.8	0.0	34.7	0.5	0.0	0.0	0.3	70.5	0.1	0.7	7.4	6.1	0.4	0.6	15.3	0.5	0.0	0.4	1.4	41.9	6.9	0.6	4.0	0.0	14.4	0.2	2.0	16.3
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 18.3;testis: 26.8"	"Group enriched"	"Detected in many"	5	"Langerhans cells: 295.1;monocytes: 682.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 35.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 103.4"	"Group enriched"	"Detected in many"	6	"monocytes: 36.8;T-cells: 103.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 34.3;HDLM-2: 62.4;Karpas-707: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	1.6	0.6	0.4	18.3	0.6	4.2	0.9	0.8	0.6	1.1	0.7	1.7	4.1	1.6	0.2	0.6	3.9	2.0	0.5	0.6	0.5	4.8	1.2	2.4	9.3	1.7	0.9	0.4	0.7	0.2	0.6	1.9	1.8	0.8	1.4	0.1	0.9	0.5	0.3	1.3	2.7	1.5	1.0	4.1	3.1	26.8	1.2	3.4	0.5	0.2	6.7	4.5	0.5	2.3	1.0	1.2	0.8	0.7	0.0	0.8	0.3	0.5	2.0	1.4	2.1	0.7	1.9	3.5	34.3	0.4	2.9	0.5	0.4	0.0	0.2	62.4	0.2	1.6	0.1	0.5	0.1	1.2	12.3	1.0	0.4	0.6	0.1	0.4	2.6	0.4	0.4	47.3	0.1	0.4	0.7	2.1	0.4	0.9	0.1	1.0	0.9	3.6	2.5	3.2	0.7	0.8	0.5	0.9	0.5	0.2	0.4	2.8	2.9	7.1	1.0	0.1	1.0	4.1	9.7	2.0	1.0	0.5	0.7	0.3	22.0	0.3	6.4	36.8	103.4	0.4	13.2	11.5	11.6	0.2	0.3	0.1	0.5	1.3	5.3	1.3	0.7	8.8	0.4	0.6	0.8	0.6	0.6	0.5	1.7	0.9	1.8	1.0	1.2	2.3	0.8	0.0	0.0	0.0	3.6	9.7	0.6	9.8	0.0	0.1	1.2	1.3	0.5	0.0	5.5	3.7	0.0	0.4	1.0	0.2	0.0	3.5	75.4	2.9	0.6	6.7	0.0	0.0	0.4	4.0	0.7	1.3	0.5	2.1	1.3	0.1	1.1	0.2	97.4	0.0	0.4	0.3	6.1	3.0	295.1	18.4	0.3	38.8	3.6	1.9	682.5	0.1	1.0	0.0	0.4	0.5	0.1	0.4	0.7	1.4	0.3	2.7	1.6	0.2	0.0	0.2	2.5	45.2	3.6	0.4	8.2	0.8	6.3	0.0	0.2	2.1
INA	"NEF5, NF-66"	ENSG00000148798	"Internexin neuronal intermediate filament protein alpha"	Q16352	10	103277138-103290346	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 160.7;pituitary gland: 41.4;retina: 97.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 62.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.4;Excitatory neurons: 28.7;Horizontal cells: 45.4;Inhibitory neurons: 39.8;Late spermatids: 26.5;Rod photoreceptor cells: 48.2;Spermatocytes: 20.3"	"Group enriched"	"Detected in many"	4	"glioma: 4.7;testis cancer: 18.2;urothelial cancer: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 53.0;SCLC-21H: 103.3;SH-SY5Y: 58.7;SiHa: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002059, HPA007572, HPA008057"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Intermediate filaments"	Cytosol	"CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833"	"unprognostic (1.77e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	0.2	12.1	34.2	1.2	35.5	0.0	0.0	63.3	160.7	0.0	0.0	3.3	0.6	0.0	0.0	0.6	0.0	0.1	0.0	31.8	109.5	0.0	0.0	0.2	0.1	107.9	37.5	0.0	2.0	0.4	41.4	0.1	98.1	0.2	1.2	97.3	0.1	0.0	0.0	0.8	1.1	0.8	25.3	0.0	1.1	2.7	72.8	1.7	0.1	0.0	0.2	1.1	0.5	51.9	0.0	25.4	11.8	0.0	0.1	0.0	19.3	13.3	3.3	3.1	0.3	0.0	0.0	0.0	5.4	0.9	1.5	1.9	11.0	0.0	0.7	24.6	4.9	0.0	6.8	0.1	0.2	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	13.6	0.0	53.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	103.3	58.7	71.6	0.1	0.0	2.7	0.0	0.7	0.1	0.0	0.1	0.0	0.0	3.4	3.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	35.5	63.3	160.7	31.8	109.5	107.9	37.5	98.1	25.3	72.8	51.9	0.1	0.0	0.0	6.2	0.0	0.3	0.1	0.0	0.0	62.4	0.0	0.4	0.5	0.0	0.0	0.0	22.9	0.2	0.0	0.1	0.0	0.1	41.4	0.4	0.2	0.9	7.8	0.0	28.7	0.0	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.5	45.4	39.8	0.0	0.0	0.0	0.0	26.5	0.3	0.1	0.0	2.8	0.0	8.7	0.0	1.0	5.4	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	48.2	0.0	0.0	0.6	20.3	4.1	1.0	0.4	0.1	0.1	0.1	0.0	0.6
ING1	"p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a"	ENSG00000153487	"Inhibitor of growth family member 1"	Q9UK53	13	110712736-110723339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 212.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016136, CAB017773, HPA052591"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB016136: AB_628077, CAB017773: , HPA052591: AB_2681876"	"unprognostic (1.14e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (5.81e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.40e-3)"	13.7	7.3	5.9	8.6	6.2	20.2	10.2	6.5	10.2	10.6	5.9	13.4	9.7	12.6	5.3	8.3	14.4	6.7	9.1	6.6	6.7	9.5	18.6	12.8	9.7	7.2	6.2	22.4	8.2	3.1	9.4	7.7	6.4	11.2	4.3	6.7	9.9	4.9	11.7	9.4	12.2	4.8	6.0	14.4	10.0	31.5	6.4	13.0	7.6	9.5	6.3	10.1	9.4	8.0	28.8	11.1	19.8	19.0	9.1	6.1	19.7	14.5	12.1	9.2	11.1	21.5	19.9	18.4	22.9	5.7	14.3	17.8	8.0	7.2	7.7	34.8	15.3	16.3	16.2	16.2	5.2	21.7	15.2	5.6	7.4	8.0	4.8	7.2	6.5	19.6	15.3	15.0	6.0	16.5	37.7	24.9	19.4	17.9	9.3	27.0	10.0	10.4	8.1	14.5	19.4	20.9	14.2	28.3	20.7	6.8	9.5	25.3	9.8	11.3	13.9	11.9	16.5	18.0	19.5	24.0	18.9	17.6	18.8	38.5	4.5	18.0	15.9	5.6	16.7	23.4	13.2	14.2	4.3	27.5	13.5	11.2	6.2	20.4	6.5	4.7	18.8	9.4	5.9	6.2	6.5	10.2	6.6	6.7	7.2	6.2	6.4	6.0	6.4	8.0	87.2	9.6	18.8	5.9	34.5	36.3	15.4	17.0	54.7	16.7	49.8	88.9	27.0	12.8	11.1	7.3	14.6	14.3	32.0	31.5	7.9	11.7	212.5	51.6	58.5	28.6	12.5	12.6	4.4	6.9	78.8	36.1	27.5	55.7	2.5	20.1	11.0	27.4	17.3	3.3	3.8	31.6	12.2	18.2	23.8	45.8	9.3	29.3	17.8	1.9	14.2	17.8	21.6	2.0	4.3	8.0	18.6	14.7	19.7	22.9	34.2	11.5	21.4	21.1	13.1	70.5	57.7	25.5	17.9	48.8	43.8	15.3	29.6	18.0	24.2	22.4
INHBC		ENSG00000175189	"Inhibin subunit beta C"	P55103	12	57434784-57452062	"Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	172	"liver: 165.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Hepatocytes: 5.7;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.4;Karpas-707: 6.3;RH-30: 2.8;U-266/70: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050755			Approved	Cytosol	"Secreted to blood"	NA	NA		21000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA050755: "	"unprognostic (5.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-4)"	"unprognostic (2.90e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	165.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.0	0.2	0.0	6.4	0.0	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.0	1.6	0.0	6.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	2.8	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.7	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INPP1		ENSG00000151689	"Inositol polyphosphate-1-phosphatase"	P49441	2	190343570-190371665	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 727.4;Late spermatids: 836.0;Urothelial cells: 229.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 96.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 96.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036698, HPA036699"	Supported		Approved	"Centriolar satellite,Cytosol"		NA	NA		31000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Centriolar satellite"	Cytosol	"HPA036698: AB_10672226, HPA036699: AB_2675260"	"unprognostic (1.08e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.12e-5)"	"prognostic favorable (5.70e-4)"	24.0	35.0	35.6	11.4	41.2	14.8	20.7	36.5	47.5	27.4	24.5	22.3	36.7	18.1	12.5	71.9	18.9	23.5	30.9	36.2	42.0	19.6	33.1	27.9	9.3	37.5	37.0	11.8	26.6	41.6	29.6	13.4	37.6	18.2	21.0	17.0	17.0	13.4	21.2	37.4	25.3	19.6	34.7	25.8	18.2	52.9	38.1	23.7	19.0	35.7	20.9	42.1	35.8	54.0	26.7	7.4	13.9	0.0	15.0	31.8	0.3	30.9	41.5	28.8	37.5	28.8	16.5	0.2	36.3	30.5	9.3	35.8	5.4	19.9	35.0	32.8	11.7	19.5	22.1	17.5	31.5	15.2	6.0	21.6	30.6	32.9	18.6	20.7	54.7	0.3	48.6	16.3	51.3	0.1	1.1	14.3	4.2	42.3	40.4	0.7	11.2	0.3	22.6	62.2	20.6	7.8	21.7	1.4	31.7	14.4	0.1	21.0	51.0	18.4	13.2	33.3	18.5	3.1	3.5	0.3	5.7	6.0	14.9	26.2	8.3	96.0	6.9	8.1	6.3	3.3	4.3	4.7	8.7	4.4	2.4	3.6	3.9	16.2	4.7	0.2	20.3	5.1	35.6	41.2	36.5	47.5	36.2	42.0	37.5	37.0	37.6	34.7	38.1	54.0	63.0	3.2	5.5	44.1	8.0	86.4	155.4	33.2	50.7	15.0	9.9	14.6	20.9	38.6	27.5	11.0	6.2	6.9	9.7	50.4	7.9	33.4	727.4	18.8	16.0	59.6	31.1	1.7	30.3	85.4	2.6	30.7	29.6	26.9	8.8	3.8	88.5	21.9	8.8	16.8	36.7	23.7	20.3	10.7	27.3	836.0	26.8	14.0	26.6	17.8	12.2	73.2	14.4	29.7	125.6	53.1	40.8	23.7	12.9	90.7	50.6	20.8	13.0	11.9	26.3	26.0	19.4	18.1	11.4	170.2	97.3	4.0	10.4	37.8	35.4	229.0
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537787-132783480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 6.7"	"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 250.8"	"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	22.5	16.9	26.8	12.0	85.5	9.5	17.3	56.9	30.4	29.6	10.9	54.2	19.2	49.5	19.5	29.6	30.7	15.2	75.0	20.4	21.3	14.1	14.6	25.1	8.4	20.5	37.7	19.5	12.8	12.2	14.7	28.8	20.4	24.5	16.7	16.9	13.5	23.6	75.4	22.9	23.4	42.1	17.5	13.9	27.6	22.9	50.5	6.8	14.1	50.3	7.3	35.5	22.7	27.0	35.4	13.7	22.6	21.9	33.8	23.7	18.4	36.4	27.9	23.3	15.4	32.6	14.0	3.1	13.7	38.8	15.1	19.5	24.8	15.2	27.9	10.8	14.4	5.1	17.3	44.7	24.3	12.9	11.9	16.0	14.9	15.0	28.2	18.6	16.3	6.6	7.6	18.2	12.6	28.3	3.6	40.9	10.5	21.0	24.3	7.6	14.9	5.6	19.4	19.9	5.4	18.5	18.3	26.5	22.6	20.5	17.2	30.4	13.7	14.9	17.2	20.1	21.6	3.6	18.4	11.0	14.4	8.6	6.5	6.7	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.3	26.8	85.5	56.9	30.4	20.4	21.3	20.5	37.7	20.4	17.5	50.5	27.0	14.7	9.6	19.7	14.7	4.5	5.4	4.4	1.9	0.0	10.5	7.1	5.3	10.1	4.3	6.4	7.3	0.0	3.9	5.0	24.8	0.0	6.5	12.3	2.8	22.8	10.0	6.1	3.2	33.5	9.2	3.7	5.6	6.6	5.9	8.8	8.6	15.0	17.9	2.9	8.4	25.2	9.9	2.0	7.2	12.0	17.0	7.2	6.9	1.8	19.7	4.1	9.6	0.0	18.1	29.2	12.1	11.5	11.7	2.5	6.5	13.8	4.3	2.5	5.2	6.6	6.5	24.3	6.3	7.3	2.8	5.8	2.5	2.7	10.7	13.9	8.6
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134697	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 123.2;thyroid gland: 204.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 35.0;Distal enterocytes: 24.0;Inhibitory neurons: 19.5;Muller glia cells: 25.2;Proximal enterocytes: 62.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 19.6;SK-BR-3: 41.1;T-47d: 25.7;U-698: 18.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 131.0"	"Low region specificity"	"Detected in all"			HPA034539			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoli fibrillar center"	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favorable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	2.1	3.2	0.8	4.8	0.1	8.9	17.3	13.2	4.0	2.4	10.4	16.3	3.0	0.6	2.4	2.3	1.2	27.8	11.5	15.2	32.1	0.4	2.3	0.5	6.0	4.0	1.2	15.7	123.2	10.1	0.1	5.2	9.2	3.7	5.3	33.1	12.1	2.8	4.4	26.2	1.5	1.4	0.3	13.6	4.4	8.3	0.2	204.2	2.6	0.4	2.7	2.4	5.7	2.1	2.0	1.2	2.3	0.3	0.2	1.1	0.8	0.8	4.1	4.0	1.2	1.3	0.1	1.0	0.4	0.4	2.4	2.5	1.2	1.7	0.0	6.5	0.0	9.7	0.4	0.8	19.6	0.2	0.2	1.3	3.4	0.4	2.7	0.3	0.1	1.8	2.8	0.1	6.4	0.1	0.1	2.3	2.8	0.4	0.0	0.4	4.5	1.7	2.5	9.9	7.5	1.6	41.1	0.5	1.1	25.7	1.6	0.0	0.2	7.3	0.8	0.5	0.1	3.5	18.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	4.8	17.3	13.2	11.5	15.2	6.0	4.0	5.2	1.4	8.3	5.7	0.7	0.0	4.1	3.3	0.0	0.9	2.3	0.3	1.2	9.5	15.8	7.5	6.1	0.0	1.1	35.0	0.0	0.0	0.2	24.0	11.7	1.4	0.4	1.9	0.4	0.5	0.0	0.0	5.5	2.2	0.2	0.6	4.6	2.7	0.0	0.8	0.0	0.0	0.1	5.0	19.5	6.4	0.0	0.0	1.9	0.6	0.0	0.3	0.0	1.0	0.6	25.2	0.0	2.0	1.0	0.8	12.3	0.0	0.1	2.5	62.3	0.5	0.5	3.1	0.0	0.5	1.3	2.4	1.2	1.1	1.3	0.1	0.4	0.4	8.8	1.6
INSYN1	"C15orf59, LOC388135, MGC131524"	ENSG00000205363	"Inhibitory synaptic factor 1"	Q2T9L4	15	73735458-73753351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.6;heart muscle: 48.5"	"Cell type enriched"	"Detected in single"	24	"Cardiomyocytes: 14.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;fHDF/TERT166: 5.8;HEK 293: 3.9;NTERA-2: 3.4;SK-BR-3: 4.7;U-2 OS: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol		No	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	3.5	2.6	32.6	0.9	30.1	0.1	1.9	27.2	42.8	7.9	1.6	6.6	0.8	4.2	3.4	12.0	7.8	1.9	48.5	38.9	28.8	15.5	0.4	2.7	0.2	26.9	56.6	13.5	1.4	2.9	5.2	0.5	27.7	10.6	0.6	3.9	3.3	11.0	4.6	13.3	2.4	3.2	22.8	0.7	3.7	4.5	46.3	0.2	2.1	2.6	0.9	6.4	16.9	34.7	0.0	0.0	1.8	1.2	8.7	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.8	1.0	2.1	1.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.4	4.7	0.4	1.3	2.0	0.1	0.0	1.3	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.6	30.1	27.2	42.8	38.9	28.8	26.9	56.6	27.7	22.8	46.3	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INTS10	"C8orf35, FLJ10569, INT10"	ENSG00000104613	"Integrator complex subunit 10"	Q9NVR2	8	19817391-19852083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039129, HPA050570"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA039129: AB_10794424, HPA050570: AB_2681180"	"unprognostic (9.11e-2)"	"unprognostic (8.41e-3)"	"prognostic favorable (4.00e-4)"	"prognostic favorable (1.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.33e-1)"	27.7	24.0	42.2	24.6	44.1	34.3	29.1	44.2	57.6	27.5	40.3	28.5	26.6	22.5	20.3	26.6	38.7	21.5	21.7	44.4	43.2	29.9	47.6	24.2	30.5	43.0	42.3	25.3	42.6	28.3	18.7	23.0	42.9	29.2	27.3	37.2	30.4	20.0	25.6	31.8	24.1	26.1	42.1	22.7	25.0	15.2	43.7	29.2	43.7	18.6	33.2	24.6	18.0	45.1	40.0	57.3	32.5	42.1	48.7	53.3	41.5	29.5	50.6	40.3	38.4	33.6	19.7	113.9	47.9	33.1	43.9	42.3	39.5	38.5	44.8	22.4	40.0	51.7	62.6	63.2	35.0	45.2	34.2	42.3	58.9	29.8	46.5	24.8	40.2	65.4	66.3	88.2	28.4	33.9	86.7	53.4	42.6	92.9	32.2	43.7	35.9	73.1	52.8	60.7	32.2	26.1	41.1	51.0	37.1	29.1	26.2	43.6	29.2	25.5	35.0	59.1	39.5	24.7	30.5	81.5	51.4	64.4	41.1	10.0	23.7	14.5	19.6	21.4	30.8	26.5	25.6	25.2	30.9	21.7	28.1	25.1	7.7	27.7	18.6	27.1	31.8	20.2	42.2	44.1	44.2	57.6	44.4	43.2	43.0	42.3	42.9	42.1	43.7	45.1	25.5	16.0	51.1	74.4	40.3	37.6	40.9	29.3	43.3	60.2	28.3	20.3	22.5	37.1	39.1	20.2	52.1	33.7	41.5	22.9	35.2	43.6	53.9	78.8	23.1	33.0	20.4	27.3	88.8	40.0	49.2	34.1	25.5	33.4	35.5	63.6	35.3	61.0	42.4	70.7	61.0	34.3	22.4	34.0	25.5	31.9	34.8	35.6	17.8	37.5	37.8	33.9	45.3	80.9	74.9	33.1	27.4	35.0	48.6	53.4	33.9	37.5	70.0	99.0	13.1	29.1	32.5	8.3	32.3	50.8	45.0	22.3	40.6	41.2	42.0	32.7
INVS	NPHP2	ENSG00000119509	Inversin	Q9Y283	9	100099243-100302175	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Calmodulin-binding, Developmental protein"	"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 132.9;Excitatory neurons: 144.8;Inhibitory neurons: 142.8;Microglial cells: 112.4;Oligodendrocyte precursor cells: 144.3;Oligodendrocytes: 233.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049994			Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA049994: "	"unprognostic (3.84e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.53e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.83e-1)"	6.2	6.1	4.2	4.3	7.5	4.6	5.0	7.1	5.4	7.3	7.0	5.6	4.0	7.0	6.3	4.3	5.7	5.4	4.8	4.1	5.6	8.7	9.4	5.2	5.8	6.5	5.5	9.7	4.7	9.7	6.7	5.9	7.1	6.1	4.6	11.8	4.3	5.1	3.6	3.5	4.7	6.1	4.4	5.2	4.4	6.6	6.2	7.8	6.6	4.2	5.7	5.3	5.9	11.6	7.4	13.2	11.0	11.7	13.3	10.7	9.2	8.6	9.0	7.5	6.1	6.7	4.5	17.3	4.9	10.0	13.7	11.1	8.8	11.3	6.1	13.3	6.0	13.0	12.4	7.3	10.0	13.1	10.4	11.2	13.1	7.8	15.8	10.1	13.7	11.7	11.4	10.4	7.8	6.4	10.4	5.1	6.4	13.5	7.6	9.3	19.3	3.9	7.0	6.9	10.0	7.9	9.7	5.8	9.9	8.9	4.1	7.2	10.2	8.7	6.3	9.0	6.5	10.5	13.2	3.5	9.2	5.4	4.8	0.0	1.2	1.9	2.2	0.8	1.9	2.6	1.9	1.2	1.7	2.5	2.4	2.4	0.1	2.5	2.1	1.7	1.2	1.3	4.2	7.5	7.1	5.4	4.1	5.6	6.5	5.5	7.1	4.4	6.2	11.6	5.8	3.2	4.1	132.9	7.1	1.8	7.0	1.5	12.0	4.8	1.7	2.4	2.9	7.2	2.7	0.0	8.4	4.4	5.4	1.4	3.9	2.7	21.5	3.2	7.8	4.8	1.2	6.5	144.8	1.1	3.9	6.0	8.6	3.3	1.3	7.8	1.1	4.0	3.6	6.7	142.8	1.5	2.0	2.2	1.0	35.6	4.7	4.0	0.0	112.4	2.6	2.5	9.2	144.3	233.9	1.5	2.0	3.4	7.4	2.9	2.7	5.8	0.7	5.8	0.0	6.4	4.4	11.0	4.7	5.0	1.6	3.4	6.3	5.3	1.3	4.1
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721662-33746905	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 308.1;tongue: 83.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cardiomyocytes: 11.2;Hepatocytes: 8.9;Horizontal cells: 10.1;Oligodendrocytes: 15.3;Proximal tubular cells: 8.2;Skeletal myocytes: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 21.9;HSkMC: 7.9;LHCN-M2: 36.2;RH-30: 15.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	1.4	0.7	4.8	0.4	15.5	0.0	1.3	12.2	9.5	1.9	5.7	6.8	0.4	3.8	0.1	6.5	1.2	0.1	29.6	5.9	8.8	6.0	18.8	5.2	0.1	14.7	13.1	0.5	0.6	0.0	0.5	4.7	15.0	5.3	0.6	0.9	2.7	1.6	308.1	0.7	2.3	1.8	7.0	3.3	1.6	0.2	12.4	0.5	12.9	83.3	0.0	2.4	1.9	27.1	0.1	0.0	0.5	0.0	0.0	0.1	3.6	0.1	0.4	0.3	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	21.9	0.0	0.1	7.9	1.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.5	5.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	15.5	12.2	9.5	5.9	8.8	14.7	13.1	15.0	7.0	12.4	27.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	8.5	0.4	0.4	11.2	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.2	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.0	8.9	0.3	10.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.0	0.4	6.6	51.7	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2
IPO4	"FLJ23338, Imp4"	ENSG00000196497	"Importin 4"	Q8TEX9	14	24180219-24188869	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 40.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 80.5;Late spermatids: 118.0;Spermatocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039043, HPA064572"	Uncertain		Approved	Cytosol		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA039043: AB_10673233, HPA064572: AB_2685291"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (9.45e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (8.59e-4)"	"unprognostic (5.45e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.15e-2)"	8.9	13.2	1.6	4.7	1.4	4.2	8.0	1.5	1.6	6.9	4.4	7.2	3.2	7.7	2.0	14.0	8.0	1.1	7.8	1.3	2.1	14.1	14.7	6.7	2.8	1.6	1.4	6.9	27.7	2.6	9.4	2.5	1.8	6.8	1.4	0.3	8.7	3.6	21.0	10.7	5.9	1.9	1.4	7.3	8.6	40.4	1.6	2.1	7.0	1.0	1.8	8.7	7.0	2.0	21.9	49.2	6.0	36.0	4.1	8.6	28.4	14.8	6.3	23.5	12.5	39.2	22.4	31.3	16.1	10.6	12.2	25.6	20.4	28.8	2.6	12.1	29.8	20.4	18.6	77.0	8.7	45.4	18.1	7.5	12.3	24.3	6.0	5.3	11.8	15.8	37.5	8.5	15.0	76.6	21.8	21.2	29.1	28.5	41.7	24.4	17.3	23.2	12.6	25.7	29.3	21.1	19.7	31.8	13.9	2.9	27.1	14.7	12.4	22.9	30.8	21.0	32.4	19.8	27.1	34.2	10.8	19.3	31.8	0.0	1.1	0.4	3.3	1.9	3.8	1.8	2.8	2.7	2.4	2.6	2.3	2.9	0.0	2.7	2.4	3.2	1.7	1.9	1.6	1.4	1.5	1.6	1.3	2.1	1.6	1.4	1.8	1.4	1.6	2.0	3.5	0.0	7.9	0.7	4.9	5.9	3.8	5.0	4.6	0.8	11.1	9.7	1.6	8.6	8.7	5.5	4.2	12.1	5.5	3.1	0.0	13.3	80.5	8.3	3.9	5.6	4.2	3.4	1.3	11.0	11.1	4.5	1.1	5.0	0.0	3.1	2.9	5.8	7.9	1.7	1.1	5.9	2.0	2.2	2.6	118.0	5.0	1.3	0.0	0.0	1.7	1.6	2.1	1.0	0.8	6.8	2.5	5.7	2.9	6.1	0.7	11.7	15.1	2.7	6.6	7.0	4.7	52.1	18.8	3.9	6.3	5.9	3.1	6.1	10.4	2.7
IPO9	"FLJ10402, Imp9"	ENSG00000198700	"Importin 9"	Q96P70	1	201829149-201884291	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059540			Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Cytosol	Vesicles	"HPA059540: "	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (8.92e-3)"	"unprognostic (2.23e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.78e-4)"	17.0	18.2	17.8	12.0	17.8	10.1	16.5	18.0	22.5	18.9	16.4	15.9	9.2	19.2	18.2	15.7	15.2	9.2	15.9	18.8	17.6	17.4	26.9	17.9	13.7	17.3	16.7	17.2	17.9	14.8	20.7	14.5	16.8	17.5	13.9	23.7	12.3	10.8	14.0	17.7	15.1	16.7	15.0	19.6	14.3	14.4	17.8	16.2	19.3	10.7	16.7	16.6	15.0	17.1	45.4	46.9	63.0	51.4	35.7	24.1	47.1	34.2	34.3	55.6	53.8	75.6	38.4	26.8	18.9	32.9	48.8	41.0	43.0	47.2	47.9	24.5	38.1	20.0	75.2	57.2	27.2	26.2	31.4	26.7	21.3	60.2	48.5	37.1	56.7	36.0	40.5	24.6	40.4	45.1	30.5	34.2	63.4	40.6	15.2	32.2	65.8	26.6	30.7	71.0	53.3	60.5	37.5	58.7	30.8	96.6	43.1	32.8	31.1	52.1	46.6	29.5	63.5	18.1	12.0	31.5	25.9	30.5	39.8	10.1	10.1	8.7	9.9	13.2	8.6	9.5	9.5	10.9	12.6	8.5	7.6	8.3	2.3	10.2	13.8	6.6	9.5	7.8	17.8	17.8	18.0	22.5	18.8	17.6	17.3	16.7	16.8	15.0	17.8	17.1	25.7	22.4	45.6	48.0	22.1	15.8	14.9	14.3	13.6	57.9	14.5	14.7	23.6	10.0	20.4	7.3	60.5	27.8	17.6	7.5	1.9	16.9	8.0	9.2	28.9	27.3	11.3	28.6	60.1	18.7	20.8	25.4	16.3	11.2	11.4	32.6	23.2	18.1	19.5	75.7	60.7	16.3	10.2	17.6	21.5	8.8	20.2	13.3	14.2	36.5	21.6	38.1	26.8	46.8	50.6	17.6	10.6	28.2	18.2	16.4	8.9	9.0	10.5	56.5	39.5	35.4	26.1	42.0	37.3	16.4	14.2	22.6	17.0	26.0	17.0	12.5
IPPK	"C9orf12, FLJ13163, INSP5K2, IP5K, IPK1"	ENSG00000127080	"Inositol-pentakisphosphate 2-kinase"	Q9H8X2	9	92613183-92670131	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 31.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020603	Uncertain		Approved	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA020603: AB_1851853"	"unprognostic (3.51e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.26e-9)"	"unprognostic (1.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.28e-4)"	5.4	6.9	5.2	4.5	5.7	8.5	6.4	7.5	6.4	9.1	3.9	4.1	3.2	5.2	4.8	31.6	5.4	4.6	7.8	6.9	4.7	4.4	5.3	4.7	5.7	5.5	5.1	5.4	3.6	8.5	8.1	5.5	5.7	4.2	4.4	5.7	8.8	2.8	7.6	29.8	4.2	5.4	5.0	5.4	4.6	11.6	5.6	5.9	4.6	6.1	8.7	5.7	15.5	5.6	19.3	10.1	9.2	8.0	11.1	8.2	30.4	13.5	8.5	13.6	7.8	6.3	7.4	11.9	6.6	18.9	12.0	27.1	16.4	18.9	11.3	14.9	10.4	9.8	21.9	9.9	7.8	16.7	11.2	8.1	18.4	16.3	12.7	12.4	10.3	9.8	13.5	14.1	13.6	26.3	9.6	7.7	15.8	21.2	14.9	8.5	9.8	4.9	8.0	11.5	19.1	11.2	10.9	44.9	7.8	8.9	10.6	4.2	19.7	10.0	11.3	28.2	14.4	13.0	16.2	6.5	13.0	7.5	9.9	0.0	1.4	3.4	3.6	1.8	4.1	2.4	3.0	3.1	2.1	2.2	2.3	2.6	2.1	0.8	1.9	2.3	4.6	1.9	5.2	5.7	7.5	6.4	6.9	4.7	5.5	5.1	5.7	5.0	5.6	5.6	6.8	3.2	3.4	10.1	4.8	25.4	6.4	7.6	16.5	7.5	6.0	4.7	0.4	1.5	5.1	1.8	6.2	10.8	4.6	5.0	5.9	6.2	11.0	8.3	5.3	6.8	6.7	6.1	23.8	8.0	13.8	4.1	7.1	10.2	0.0	3.6	10.0	3.1	5.1	15.2	23.7	3.5	6.1	7.5	4.6	33.7	3.1	5.3	3.6	7.5	2.8	4.9	8.2	20.6	23.3	9.1	1.4	3.0	6.0	6.4	2.6	3.6	2.6	4.6	6.6	3.9	3.5	20.0	19.4	25.5	29.5	22.8	6.0	4.4	3.7	10.5
IQCE	KIAA1023	ENSG00000106012	"IQ motif containing E"	Q6IPM2	7	2558972-2614733	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 410.0;Late spermatids: 419.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.6;granulocytes: 4.6;monocytes: 1.2"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019515	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA019515: AB_1851855"	"unprognostic (2.29e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.91e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.56e-3)"	"unprognostic (3.13e-2)"	4.5	6.6	19.3	6.5	16.7	5.6	6.2	9.6	19.3	7.5	22.5	9.4	12.0	8.3	10.3	5.3	14.6	7.2	6.6	17.3	16.3	6.6	3.3	7.5	4.3	16.5	18.6	7.7	7.6	11.0	14.4	3.5	11.3	7.8	8.7	9.8	9.1	9.3	4.9	7.3	10.1	6.6	13.3	4.6	9.6	31.7	18.6	4.3	10.5	5.5	3.5	5.7	4.3	15.1	35.5	18.2	7.0	23.0	9.2	13.4	13.2	7.2	11.7	8.8	9.4	9.5	19.6	2.5	8.0	16.7	19.7	17.9	5.1	7.4	8.9	6.3	10.9	4.9	21.9	2.6	6.8	12.8	6.4	5.8	13.5	8.3	9.9	10.4	10.3	8.9	15.4	4.5	11.8	35.8	5.2	8.6	6.6	15.7	12.4	4.9	8.4	8.8	10.1	15.9	15.7	18.7	8.2	33.9	7.1	4.9	41.5	17.1	10.3	7.6	15.7	30.2	12.2	4.9	8.0	0.5	15.3	8.5	22.1	0.8	0.8	2.3	0.6	1.2	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.6	4.6	0.2	0.4	2.6	0.2	0.2	19.3	16.7	9.6	19.3	17.3	16.3	16.5	18.6	11.3	13.3	18.6	15.1	4.8	12.8	14.3	14.4	2.1	5.5	5.7	5.3	6.2	8.9	12.3	7.9	9.1	14.3	11.4	12.9	60.5	4.1	13.8	27.4	17.6	20.6	410.0	44.8	15.3	5.7	8.4	1.7	16.6	19.7	10.0	7.0	24.5	9.4	1.3	7.6	6.4	2.8	10.1	20.2	17.4	12.3	12.2	8.1	5.3	419.3	14.0	9.3	0.0	3.7	12.0	14.9	12.3	4.5	4.2	24.1	18.9	15.4	8.0	5.4	12.1	9.5	58.7	36.7	19.7	7.8	6.6	40.9	43.8	3.5	4.3	1.9	4.9	11.2	12.4	4.0
IQCG	"CFAP122, DKFZp434B227, DRC9"	ENSG00000114473	"IQ motif containing G"	Q9H095	3	197889077-197960142	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 52.8;testis: 43.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 255.0;Endometrial ciliated cells: 176.3;Late spermatids: 489.4;Respiratory ciliated cells: 322.2;Spermatocytes: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042787, HPA051981"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Actin filaments"	Cytosol	"HPA042787: AB_10797021, HPA051981: AB_2732572"	"unprognostic (1.50e-2)"	"unprognostic (6.20e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.75e-2)"	6.0	5.2	8.9	3.3	9.7	3.2	5.8	8.4	9.5	5.9	25.2	3.2	2.6	4.6	10.0	4.0	52.8	4.6	4.4	8.7	10.6	6.4	3.7	9.1	3.8	15.0	19.8	3.6	2.0	4.4	6.1	3.5	14.1	3.9	3.7	18.1	2.5	4.5	2.0	2.7	2.7	4.3	14.3	3.4	3.7	43.9	10.9	2.9	8.1	2.1	4.2	3.6	2.2	14.6	5.3	5.8	7.3	7.1	15.6	15.7	2.9	6.4	7.1	7.5	7.6	1.2	5.0	1.9	7.0	5.2	9.6	4.9	5.4	5.0	12.0	4.4	3.8	3.2	3.3	2.9	3.6	4.4	5.0	8.1	6.1	8.1	2.6	6.1	3.6	8.8	3.5	7.2	5.8	12.2	2.4	2.1	4.6	7.8	7.6	6.8	4.8	2.6	7.2	2.2	6.4	7.7	10.6	4.3	4.4	6.4	32.2	3.0	3.7	4.8	3.3	14.5	6.7	6.2	18.4	3.1	18.1	6.1	7.8	2.0	3.8	4.3	3.4	2.7	2.2	4.3	2.9	2.3	3.3	1.6	2.7	3.7	2.3	3.3	2.6	2.9	3.1	2.3	8.9	9.7	8.4	9.5	8.7	10.6	15.0	19.8	14.1	14.3	10.9	14.6	7.4	6.4	7.7	16.6	8.5	9.3	3.3	14.8	2.2	13.1	27.9	15.2	11.0	5.7	31.8	5.5	75.0	6.4	10.1	3.1	15.6	7.1	255.0	176.3	15.0	8.2	4.2	4.8	10.1	4.2	5.8	13.1	5.6	16.3	8.8	30.9	5.3	4.2	6.6	10.1	8.8	2.9	26.4	6.0	24.9	489.4	22.7	10.3	14.2	14.0	2.9	13.5	11.3	10.6	13.2	11.9	1.9	23.7	5.7	2.2	1.4	10.4	322.2	43.8	6.6	6.8	18.7	122.7	31.6	5.9	8.9	5.2	10.8	46.5	2.9	2.5
IQCH	FLJ12476	ENSG00000103599	"IQ motif containing H"	Q86VS3	15	67254786-67502260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.4;Early spermatids: 59.4;Excitatory neurons: 26.5;Late spermatids: 37.3;Respiratory ciliated cells: 30.3;Spermatocytes: 48.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040845	Uncertain		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA040845: AB_10672898"	"unprognostic (2.69e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.89e-5)"	"unprognostic (2.48e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.16e-3)"	"unprognostic (6.42e-2)"	0.3	1.1	0.7	0.3	0.8	0.1	1.6	0.7	1.4	0.9	4.2	0.5	0.2	0.8	2.6	0.5	6.8	0.6	0.9	0.7	1.8	2.2	1.0	0.9	0.4	2.5	2.2	0.3	0.7	3.7	2.0	0.4	1.6	0.6	0.7	5.0	0.6	0.8	0.5	0.6	0.1	0.3	2.0	0.4	1.1	11.5	1.9	1.0	4.1	0.0	0.2	0.7	0.3	1.4	1.7	1.6	0.8	1.3	1.1	2.6	0.6	0.9	0.7	1.3	0.9	0.1	1.9	1.2	0.8	1.5	1.5	2.8	2.6	1.0	2.3	0.2	1.2	0.3	1.6	0.2	1.7	0.5	0.3	1.7	1.1	2.9	2.8	1.3	0.5	3.1	2.6	1.1	1.0	1.8	0.4	0.4	0.9	1.0	1.1	0.3	1.2	1.3	1.6	0.7	2.6	0.7	1.2	1.6	4.8	1.6	4.3	0.3	1.2	1.5	0.7	2.4	1.0	2.5	3.2	0.3	3.1	1.3	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.8	0.7	1.4	0.7	1.8	2.5	2.2	1.6	2.0	1.9	1.4	0.7	3.2	1.1	27.4	0.3	1.3	1.0	1.6	1.8	1.5	2.7	2.2	1.1	0.0	2.8	1.8	8.4	0.2	0.3	0.4	0.0	1.0	59.4	15.9	1.1	0.9	0.0	0.4	26.5	0.8	0.5	0.7	8.2	2.0	0.0	0.7	0.0	0.0	0.3	1.7	18.2	0.5	4.1	0.0	0.7	37.3	0.9	0.3	0.0	8.4	1.0	1.1	0.0	9.0	9.5	0.7	0.0	0.7	0.5	0.3	0.2	2.2	30.3	5.4	0.0	1.5	0.6	48.8	18.2	1.2	0.4	0.3	0.4	4.2	0.4	1.0
IQCJ-SCHIP1		ENSG00000283154	"IQCJ-SCHIP1 readthrough"	B3KU38	3	158962235-159897366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 165.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 7.3;Basal squamous epithelial cells: 12.5;Bipolar cells: 11.5;Excitatory neurons: 11.3"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA003243, HPA003445"	Approved		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA003243: AB_1079877, HPA003445: AB_1079875"																		22.0	5.1	82.3	9.7	90.6	2.2	15.4	84.9	165.9	9.2	56.6	49.8	4.5	19.6	6.3	15.4	18.2	12.5	57.2	83.9	73.9	17.8	14.3	19.6	2.2	93.5	88.0	4.4	2.7	1.1	7.3	23.6	92.0	17.7	6.8	14.2	6.5	20.4	27.6	5.7	12.8	25.9	81.5	4.3	18.3	4.7	87.2	2.5	5.7	3.2	1.8	35.8	10.8	110.5	87.9	14.8	28.9	34.4	6.6	6.3	25.1	73.6	17.3	59.4	40.5	55.6	20.9	4.4	46.4	24.6	22.6	34.8	11.3	24.9	48.5	72.7	27.6	0.1	31.2	2.8	7.7	4.2	0.5	6.5	20.8	26.5	31.1	49.3	44.5	4.9	0.0	0.3	27.7	3.9	0.3	0.0	24.2	7.0	31.9	10.2	58.4	0.0	57.6	4.7	5.8	26.8	39.8	16.7	21.8	32.9	9.8	0.8	37.6	34.0	47.5	22.9	101.5	0.3	0.5	0.4	19.1	12.4	92.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	82.3	90.6	84.9	165.9	83.9	73.9	93.5	88.0	92.0	81.5	87.2	110.5	4.7	6.4	0.0	1.0	0.1	1.5	7.3	0.8	12.5	11.5	0.3	0.9	0.6	0.0	1.4	1.8	6.2	0.0	0.1	0.3	0.0	0.9	2.0	2.1	0.8	5.7	0.0	0.0	11.3	0.6	0.0	3.1	0.0	2.3	2.5	0.0	1.8	0.6	0.0	0.0	4.7	0.2	0.0	0.3	1.2	0.6	0.3	1.2	0.0	0.0	0.6	0.5	0.0	0.0	0.6	1.2	0.0	1.2	0.0	1.3	0.0	4.2	2.4	0.6	0.0	2.5	5.4	0.1	0.4	3.5	0.9	0.0	0.5	0.0	0.2	1.6
IQCK	"FLJ36575, MGC35048"	ENSG00000174628	"IQ motif containing K"	Q8N0W5	16	19716456-19858467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 128.3;Cone photoreceptor cells: 114.7;Respiratory ciliated cells: 98.7;Rod photoreceptor cells: 107.4;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026792, HPA048786"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear speckles"	Cytosol	"HPA026792: AB_1853889, HPA048786: AB_2680520"	"unprognostic (4.21e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	3.8	2.7	5.3	1.3	5.7	0.5	5.9	5.2	6.8	7.5	8.7	2.6	3.8	4.6	15.4	1.6	20.2	5.7	3.5	5.1	8.7	8.7	2.1	4.0	1.5	6.2	7.2	6.5	3.6	19.4	6.3	3.2	5.7	3.4	2.9	11.0	6.4	7.6	3.0	2.1	1.6	3.8	6.8	1.8	3.9	18.2	5.6	1.6	16.8	2.9	1.1	4.1	2.0	8.0	2.6	6.8	8.7	5.7	2.6	8.1	0.5	0.0	4.4	4.0	3.1	0.4	4.8	0.3	4.7	2.4	2.5	3.0	1.9	3.3	2.8	1.1	1.8	0.1	1.9	3.4	8.2	1.6	0.0	4.7	2.7	5.4	1.2	4.5	4.4	4.2	2.8	0.8	2.5	8.5	1.6	0.9	2.6	2.8	6.4	5.3	0.8	0.4	10.0	1.8	8.1	3.4	3.9	1.2	5.3	1.6	3.6	0.9	3.1	1.1	0.9	4.6	0.9	0.1	0.6	0.0	5.4	0.2	1.9	0.0	0.3	0.0	0.5	1.3	0.9	0.5	0.5	0.8	0.1	0.2	1.0	0.5	0.0	0.0	1.3	0.3	0.5	0.3	5.3	5.7	5.2	6.8	5.1	8.7	6.2	7.2	5.7	6.8	5.6	8.0	42.4	16.0	5.1	128.3	1.7	6.1	9.7	16.4	9.6	54.1	18.3	16.5	0.7	24.3	17.8	46.0	114.7	4.9	1.3	8.6	46.9	47.2	57.2	76.9	19.0	22.1	5.4	0.8	31.9	29.6	2.8	11.8	12.8	14.9	0.0	6.2	11.7	2.1	6.0	3.3	45.9	4.3	32.6	2.4	3.9	34.8	18.0	3.7	17.8	15.0	1.5	26.3	0.0	37.2	53.4	29.8	2.2	18.0	2.3	7.3	2.0	32.5	98.7	107.4	6.6	7.5	15.6	101.7	35.8	3.9	5.1	4.1	3.0	18.1	6.7	5.1
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452193-123535077	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 33.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 283.9;Endometrial ciliated cells: 82.6;Late spermatids: 157.5;Respiratory ciliated cells: 88.2;Spermatocytes: 116.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nucleoplasm,Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	"Nucleoplasm, Intermediate filaments, Cytosol"	"HPA049626: AB_2732554"	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.1	0.6	0.2	0.0	0.4	0.0	0.5	1.7	0.9	0.8	3.9	0.1	0.0	0.7	1.1	0.0	5.0	0.8	0.1	0.2	0.5	3.0	0.0	0.8	0.0	1.8	2.0	0.2	0.3	1.7	1.0	0.1	1.3	0.5	0.0	1.1	0.2	0.6	0.1	0.1	0.0	0.2	1.0	0.0	0.1	33.4	0.6	0.0	3.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.7	0.9	0.2	0.5	1.8	2.0	1.3	1.0	0.6	0.4	1.1	6.4	0.5	19.6	0.0	0.5	0.7	3.8	0.0	2.5	1.9	1.8	1.8	0.0	11.4	18.4	4.2	0.4	0.1	0.1	1.9	1.1	283.9	82.6	3.2	0.9	1.8	0.0	12.0	0.4	0.3	1.1	0.0	1.7	1.3	0.3	0.7	0.0	0.1	3.3	8.6	0.2	8.2	0.0	0.3	157.5	2.5	0.4	0.0	4.7	0.3	1.8	0.0	5.0	2.6	0.2	0.0	3.0	0.0	0.5	0.0	5.7	88.2	9.0	6.6	0.7	2.7	116.2	6.0	0.2	0.1	0.7	0.3	2.9	0.0	0.3
IRAG1	"IRAG, JAW1L, MRVI1"	ENSG00000072952	"Inositol 1,4,5-triphosphate receptor associated 1"	Q9Y6F6	11	10573091-10693988	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 7.4;Hofbauer cells: 11.1;Smooth muscle cells: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 24.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 20.8;BJ: 15.3;BJ hTERT+: 17.6;fHDF/TERT166: 6.9;REH: 6.8"	"Region enriched"	"Detected in many"	5	"thalamus: 7.6"	"Low region specificity"	"Detected in all"			HPA008704	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA		220000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nuclear bodies"	"HPA008704: AB_1079413"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.30e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-3)"	29.7	8.0	64.6	18.2	85.8	1.5	16.1	50.4	53.4	55.4	17.7	67.6	8.5	60.8	16.1	37.5	45.6	33.2	10.1	54.5	54.3	9.3	2.1	13.3	3.7	65.8	71.4	20.2	2.9	2.7	3.8	11.8	54.4	37.9	17.3	1.7	4.1	39.5	6.7	9.3	22.0	69.1	55.2	7.1	33.7	8.2	89.8	2.3	10.2	8.1	1.8	43.8	21.9	48.8	0.1	0.0	4.2	0.0	20.8	4.1	0.2	15.3	17.6	0.0	0.0	0.4	1.7	0.0	0.1	6.9	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.7	0.0	0.1	0.2	0.0	0.2	4.8	0.4	0.0	0.1	0.0	1.2	0.0	0.6	0.1	0.3	0.0	0.1	0.3	0.5	0.0	0.1	6.8	0.0	0.3	0.0	0.0	0.0	3.1	0.0	2.6	0.0	4.4	0.0	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	6.0	0.0	0.7	2.2	1.7	0.0	3.9	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	24.0	0.0	5.7	0.1	0.0	0.7	64.6	85.8	50.4	53.4	54.5	54.3	65.8	71.4	54.4	55.2	89.8	48.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501453	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064"	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	17.1	25.2	7.5	18.2	7.7	27.7	18.8	16.3	9.3	15.2	8.4	17.4	17.9	17.9	11.8	15.2	14.6	14.9	12.5	7.4	10.5	18.3	23.1	14.9	22.8	7.0	7.2	22.0	11.4	17.8	8.2	21.8	7.1	16.5	20.3	19.4	10.6	15.4	18.8	14.4	18.4	16.1	7.0	24.8	16.4	15.1	9.5	29.7	28.7	23.5	20.9	13.4	11.7	8.8	19.9	34.9	52.8	33.2	45.5	29.7	35.5	33.3	26.0	29.7	26.9	34.6	33.8	73.1	22.1	28.0	20.3	37.8	124.7	33.2	26.1	23.4	43.0	63.6	35.0	24.4	23.8	69.4	65.7	31.5	22.4	22.9	27.7	30.2	35.4	42.6	67.9	25.4	25.5	29.7	42.8	35.2	69.1	24.1	12.4	49.6	53.0	20.8	32.4	54.2	31.7	47.3	45.1	31.4	35.7	59.2	29.5	59.7	28.9	30.3	20.8	16.8	29.2	31.5	74.8	41.7	21.8	63.1	22.2	3.8	2.5	2.0	2.4	3.3	3.1	2.7	2.6	2.4	3.5	2.6	2.5	3.5	2.8	3.0	2.6	4.0	2.3	1.4	7.5	7.7	16.3	9.3	7.4	10.5	7.0	7.2	7.1	7.0	9.5	8.8	24.3	22.4	40.7	33.0	37.5	14.1	16.6	19.3	14.8	55.6	23.1	18.4	24.9	25.8	26.1	23.9	66.7	35.0	56.2	45.3	0.0	19.9	18.1	19.3	38.2	26.6	31.9	42.3	52.3	19.6	23.7	27.7	32.1	21.2	17.7	66.2	38.9	41.8	26.1	79.1	55.6	31.0	18.3	61.3	18.4	10.8	32.9	37.7	14.2	28.1	52.9	22.4	54.6	50.3	49.0	26.3	49.8	30.5	28.5	33.7	49.1	19.6	25.7	51.1	6.6	29.5	23.2	33.9	29.6	24.5	18.6	30.6	33.9	56.3	36.0	29.6
IRF1	MAR	ENSG00000125347	"Interferon regulatory factor 1"	P10914	5	132440440-132508719	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.1"	"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 516.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 138.1;REH: 114.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011662, HPA063131"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB011662: AB_775784, HPA063131: AB_2684945"	"unprognostic (1.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.09e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.53e-3)"	53.7	19.1	8.2	88.0	7.6	142.1	29.5	8.1	9.4	21.3	7.7	46.3	84.8	21.3	11.7	24.3	24.4	32.6	25.8	7.3	7.5	32.9	54.4	119.0	86.3	17.2	8.1	18.4	15.6	7.4	17.3	22.2	15.8	36.4	38.1	2.8	28.7	16.2	16.7	19.7	68.8	33.1	8.8	117.4	47.4	13.5	10.5	66.4	25.8	13.3	45.3	63.9	24.1	8.0	26.7	22.8	2.3	8.1	22.1	18.9	42.5	14.7	58.8	41.6	52.2	11.3	79.4	26.7	15.8	18.4	64.8	35.7	7.4	33.7	14.3	54.2	7.1	33.2	8.1	6.9	138.1	14.6	34.3	36.9	9.4	31.7	32.2	26.5	22.4	19.1	6.9	97.5	13.1	15.9	87.6	32.7	3.4	9.3	14.6	114.5	23.2	31.7	22.5	27.8	6.4	3.6	14.6	30.8	13.4	10.1	4.7	24.2	13.0	20.5	8.1	12.8	19.8	74.8	27.0	19.3	24.9	27.2	15.5	175.3	167.1	257.0	157.2	244.1	106.9	68.4	104.2	129.9	95.7	62.5	63.5	91.7	621.0	136.9	272.4	52.4	122.1	160.0	8.2	7.6	8.1	9.4	7.3	7.5	17.2	8.1	15.8	8.8	10.5	8.0	369.9	102.5	114.3	1.0	216.5	88.1	129.4	66.3	306.7	14.7	216.5	186.6	17.0	47.1	58.0	22.0	33.3	24.0	396.3	183.6	19.6	112.1	92.5	242.3	170.8	223.1	87.1	36.6	1.1	114.3	42.6	224.4	212.0	288.1	105.2	32.0	58.2	14.6	49.7	1.7	1.2	137.4	57.0	73.9	228.7	9.1	27.4	134.1	72.9	7.5	257.2	16.7	399.6	2.5	1.1	88.6	140.6	7.9	248.6	270.9	155.5	22.4	110.9	46.5	13.1	516.2	225.0	1.3	6.8	118.8	82.7	11.2	301.4	20.5	94.6	95.0
IRX3	IRX-1	ENSG00000177508	"Iroquois homeobox 3"	P78415	16	54283304-54286787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 89.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 66.7;Breast glandular cells: 133.8;Breast myoepithelial cells: 84.6;Endometrial ciliated cells: 73.0;Glandular and luminal cells: 88.2;Respiratory ciliated cells: 67.3;Squamous epithelial cells: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 119.4;NB-4: 204.4;RPTEC TERT1: 236.4;T-47d: 122.9;THP-1: 201.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA066576			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA066576: "	"unprognostic (4.21e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.25e-1)"	8.2	6.8	3.4	0.4	3.0	0.1	75.6	6.3	1.2	29.7	2.7	0.3	0.4	2.2	36.5	33.0	10.9	0.3	63.1	1.2	5.1	42.6	2.2	36.5	2.0	7.5	8.1	0.9	4.0	27.2	7.2	1.9	6.2	23.2	0.0	1.2	43.2	31.3	22.7	89.3	0.6	1.2	6.2	0.1	22.5	0.5	7.5	1.0	9.3	8.8	4.5	4.8	17.5	5.0	1.1	1.1	15.6	15.1	8.4	3.3	1.7	6.6	14.5	13.9	3.4	4.2	6.8	0.0	2.2	10.0	5.5	29.0	12.6	3.6	18.5	14.3	9.8	0.0	22.2	14.6	0.6	16.7	4.1	2.5	59.7	26.5	12.0	9.8	0.0	19.1	0.0	0.0	119.4	7.7	30.9	204.4	1.1	0.0	0.0	23.2	19.2	0.0	236.4	6.2	10.6	1.9	20.4	51.3	2.6	1.7	122.9	201.8	3.4	57.9	6.4	10.6	5.3	0.0	0.0	0.1	38.0	53.7	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.0	6.3	1.2	1.2	5.1	7.5	8.1	6.2	6.2	7.5	5.0	2.6	19.2	66.7	0.0	0.4	25.0	47.4	25.3	45.5	1.3	133.8	84.6	14.1	0.0	43.2	5.5	0.0	0.1	1.3	0.1	1.9	5.2	0.0	73.0	8.1	5.8	0.0	0.0	0.0	0.2	0.1	18.3	2.0	88.2	0.0	5.5	8.2	7.1	0.3	0.0	0.0	0.0	36.7	1.2	2.7	0.0	0.0	9.0	10.6	0.0	0.2	10.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	25.8	0.0	6.5	67.3	1.2	0.0	32.1	6.4	0.4	1.0	72.8	41.3	0.0	1.1	0.1	0.0	34.0
IRX5	IRX-2a	ENSG00000176842	"Iroquois homeobox 5"	P78411	16	54930865-54934485	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Vision"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.0;skin 1: 16.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 40.3;Breast myoepithelial cells: 55.5;Granulosa cells: 43.8;Muller glia cells: 43.1;Squamous epithelial cells: 33.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.1;T-47d: 36.6;THP-1: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047130			Approved	"Nuclear speckles,Microtubules,Cytosol"		No	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"	"Microtubules, Cytosol"	"HPA047130: AB_10962983"	"unprognostic (2.63e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.38e-3)"	"prognostic favorable (4.59e-4)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.28e-2)"	1.7	0.6	1.3	0.0	1.5	0.0	14.0	4.1	0.4	1.8	0.3	0.2	0.0	0.1	0.0	7.2	0.2	0.1	9.8	0.3	1.9	6.9	0.0	6.4	0.0	3.6	4.1	0.3	0.1	0.3	0.4	0.0	3.1	3.4	0.0	1.3	10.2	0.2	1.4	16.9	0.0	0.0	3.6	0.0	2.6	0.7	4.6	0.3	0.1	1.1	0.0	0.6	5.9	3.5	0.8	0.5	8.6	3.2	3.1	0.6	0.4	3.3	8.2	1.1	0.8	1.9	0.8	0.0	0.7	4.5	0.3	8.4	3.0	3.6	0.6	6.0	4.1	0.9	3.4	0.0	0.1	2.0	3.3	0.8	15.1	5.4	2.3	1.5	0.0	4.8	0.5	0.0	6.2	3.3	9.6	12.3	0.1	1.3	2.4	5.0	4.4	0.5	27.1	0.2	2.9	3.0	1.4	7.3	3.9	0.0	36.6	20.2	0.5	5.9	0.2	4.2	1.3	3.6	2.3	2.9	9.6	3.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	4.1	0.4	0.3	1.9	3.6	4.1	3.1	3.6	4.6	3.5	2.4	9.6	21.9	0.0	0.1	8.3	9.7	6.7	15.9	8.6	40.3	55.5	11.1	0.0	15.4	0.0	0.0	0.2	1.0	0.2	0.0	0.3	1.0	9.6	1.2	1.6	0.0	0.0	0.0	0.6	0.0	5.3	7.7	12.2	0.0	43.8	0.0	0.0	0.2	1.7	0.0	0.8	4.1	0.0	2.7	2.4	0.0	0.6	5.4	0.0	0.0	43.1	0.0	0.0	0.0	2.9	0.3	0.0	0.3	4.8	0.0	1.5	13.0	1.9	0.0	8.3	5.2	0.7	2.8	33.9	8.0	0.0	0.4	0.0	0.5	8.5
ISOC2	FLJ23469	ENSG00000063241	"Isochorismatase domain containing 2"	Q96AB3	19	55452985-55462343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 284.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 272.2;Proximal tubular cells: 479.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 270.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043142	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Cytosol	"HPA043142: AB_10794653"	"unprognostic (2.74e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.90e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.09e-2)"	50.4	55.6	39.7	20.0	41.2	21.4	38.3	42.7	52.4	25.4	48.1	62.1	36.2	28.4	8.1	52.2	25.8	17.2	69.5	39.5	43.9	101.4	284.3	26.4	19.2	46.6	44.4	23.3	44.4	39.9	46.3	9.3	43.7	40.9	16.3	3.3	41.8	28.7	95.7	37.6	37.2	16.8	42.6	50.8	41.4	65.6	42.1	9.9	39.1	49.0	14.0	41.6	30.3	44.4	52.8	78.1	20.1	55.6	13.6	28.4	67.7	37.9	36.7	45.7	46.4	40.0	88.2	98.6	66.2	42.2	44.0	51.1	39.7	46.6	14.6	38.9	270.2	57.6	17.8	128.0	55.6	63.2	163.5	42.5	44.2	29.4	22.0	20.4	42.4	39.3	93.6	61.1	28.9	101.9	0.3	73.6	32.4	113.2	217.9	72.1	44.4	126.0	75.0	47.7	24.7	70.5	35.5	75.3	41.4	11.9	63.8	109.4	32.4	34.0	48.5	38.8	44.7	78.7	73.0	78.7	52.2	79.4	58.3	0.7	16.0	0.9	12.7	33.8	12.6	18.7	11.6	16.2	29.5	12.6	11.5	11.8	0.7	24.3	27.8	24.1	15.2	15.0	39.7	41.2	42.7	52.4	39.5	43.9	46.6	44.4	43.7	42.6	42.1	44.4	25.4	6.4	6.3	5.5	38.0	59.5	65.3	148.8	32.5	12.5	51.7	56.5	20.8	48.6	50.3	62.5	2.1	32.5	19.1	200.1	162.4	65.1	44.5	37.8	39.0	36.9	71.3	46.9	3.5	68.1	105.5	44.2	63.7	25.1	45.2	43.2	28.5	272.2	96.0	13.5	5.4	225.4	87.5	44.5	50.6	43.6	38.8	39.0	62.2	2.8	28.0	53.1	21.6	6.6	12.8	56.4	125.8	30.9	80.5	128.7	253.7	479.9	26.1	10.0	26.3	32.0	39.0	183.8	16.4	69.6	68.6	21.6	19.4	123.4	190.7	74.8
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438167	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 223.6;testis: 223.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1141.3;Sertoli cells: 315.5;Syncytiotrophoblasts: 1034.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;NK-cells: 14.4;T-cells: 8.9"	"Cell line enriched"	"Detected in many"	4	"BEWO: 492.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	36.0	32.6	15.2	2.8	13.8	5.8	30.5	12.5	19.5	47.3	223.6	14.2	3.6	44.2	4.4	15.2	78.9	3.7	36.1	19.4	24.5	114.4	13.1	22.2	4.4	16.8	18.8	96.0	40.1	12.8	50.7	46.3	14.2	41.4	0.7	0.9	17.7	26.7	13.2	16.2	16.1	2.8	12.7	35.1	11.3	223.8	25.4	3.0	23.7	3.1	1.8	23.5	31.9	11.3	13.9	42.4	98.6	31.0	0.8	0.2	492.7	6.6	1.0	0.6	0.3	24.5	26.1	0.2	33.5	3.2	0.2	36.6	3.0	0.1	0.0	39.8	116.4	52.0	3.1	80.3	10.2	0.6	1.1	9.4	0.4	2.8	0.4	0.4	6.3	1.1	106.0	2.1	0.0	84.1	4.0	3.4	51.7	14.2	33.7	71.2	0.2	24.6	9.5	0.3	30.4	74.3	1.7	9.9	53.1	20.2	68.2	7.1	18.7	0.5	1.1	0.7	1.6	13.9	7.3	3.2	3.0	1.9	17.7	1.0	0.1	0.0	8.1	0.2	6.2	4.5	8.1	6.9	0.8	2.4	6.2	8.9	0.8	14.4	0.1	2.2	6.2	5.0	15.2	13.8	12.5	19.5	19.4	24.5	16.8	18.8	14.2	12.7	25.4	11.3	38.8	3.2	1.1	2.6	9.0	12.0	82.1	74.9	72.8	0.8	26.1	47.0	4.7	20.0	24.0	47.8	2.1	1141.3	8.4	4.1	52.8	39.4	101.3	33.4	10.9	30.5	64.8	21.5	1.0	8.2	114.0	30.2	7.1	14.8	14.0	36.9	25.7	1.1	84.9	0.0	4.3	4.0	28.5	9.0	7.8	230.1	37.3	4.1	23.2	11.2	5.4	8.6	13.4	0.0	0.3	3.4	1.8	50.4	1.8	21.6	0.7	6.1	23.6	0.7	315.5	5.6	163.6	53.7	21.0	10.6	5.7	1034.6	14.9	14.5	6.2	36.8
ITGA2	CD49B	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989340-53094779	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 406.2;Oligodendrocytes: 370.9;Pancreatic endocrine cells: 558.7;Prostatic glandular cells: 299.3;Urothelial cells: 363.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 91.4;HaCaT: 92.5;hTERT-RPE1: 83.2;HUVEC TERT2: 83.5;TIME: 71.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		43000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.4	12.8	2.4	4.9	6.7	0.4	7.8	4.4	3.7	5.0	0.9	6.1	7.7	4.9	7.4	11.0	2.6	9.0	1.1	2.4	4.2	9.8	0.5	12.5	0.9	4.8	4.9	1.0	1.6	9.3	1.2	4.8	5.4	6.6	5.9	2.4	10.4	11.1	0.5	17.1	7.7	2.4	3.3	6.8	7.5	0.4	4.8	4.3	2.3	0.7	4.6	15.6	8.0	12.9	60.4	15.4	1.3	0.8	3.9	7.1	4.5	60.2	91.4	2.2	3.6	29.0	41.8	0.1	9.8	25.4	33.5	92.5	4.9	67.1	8.5	0.0	4.4	4.3	3.7	17.5	13.3	0.7	1.3	2.9	11.4	59.2	10.5	83.2	83.5	3.1	0.1	0.2	1.6	11.4	0.6	0.1	3.7	15.7	29.6	0.0	0.4	0.1	18.9	32.0	0.6	3.2	3.2	4.1	6.1	2.3	9.6	0.2	71.2	10.8	6.3	1.7	12.1	0.0	0.1	0.1	64.0	0.0	48.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	6.7	4.4	3.7	2.4	4.2	4.8	4.9	5.4	3.3	4.8	12.9	7.4	57.7	13.7	9.1	0.6	151.0	406.2	141.3	56.9	2.7	24.4	39.0	1.3	15.7	133.2	53.3	4.2	1.9	0.9	23.2	9.8	144.0	0.1	20.3	5.0	39.0	13.8	0.0	0.5	169.3	2.2	11.6	13.3	90.6	1.3	45.4	5.3	0.2	0.3	0.0	0.9	37.8	20.3	0.0	6.1	0.2	1.2	2.5	12.4	14.0	1.1	14.7	0.0	0.0	370.9	558.7	20.3	0.0	2.6	299.3	20.6	3.8	103.6	4.3	0.0	4.4	12.1	0.0	1.3	57.0	37.2	0.4	5.8	23.7	30.9	363.9
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301750-71305371	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 89.4;skeletal muscle: 46.1;tongue: 52.9"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 80.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040721			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA040721: AB_10805827"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.6	0.5	1.5	0.6	1.5	0.5	1.0	0.9	2.4	0.5	6.5	1.0	16.6	3.0	4.1	3.3	2.5	89.4	0.6	0.6	0.8	1.4	1.0	0.9	0.6	0.6	1.6	0.5	0.0	0.5	0.3	0.6	6.0	1.8	1.8	1.3	10.3	46.1	0.6	2.1	16.3	0.5	1.1	2.0	1.3	0.6	1.0	0.7	52.9	0.6	5.5	1.5	0.7	0.5	1.4	2.1	1.8	0.1	0.1	0.4	0.7	1.0	0.5	0.5	0.9	1.1	2.1	0.2	1.1	0.5	0.9	1.9	0.6	1.1	0.7	0.9	1.3	1.5	0.4	0.2	0.4	9.3	1.1	0.7	0.2	0.3	0.4	0.8	2.2	1.0	0.5	1.1	0.4	0.8	2.3	3.1	1.4	0.9	1.4	1.6	0.8	1.0	1.3	1.0	0.3	0.5	0.1	0.6	1.4	0.5	0.3	0.0	0.9	1.8	0.1	0.4	1.8	2.8	3.1	0.2	1.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.0	0.9	0.6	0.6	0.6	0.6	0.6	0.5	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	1.7	0.3	0.3	80.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.6	0.1	0.2	0.2	0.8	0.0	0.4	0.2	0.0	0.1	2.3	0.0	0.2	0.0	0.4	1.1	0.8	0.2	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.3	0.1	1.0	0.0	0.5	0.2	0.1	8.6	0.0	0.3	0.1	0.5	0.3	1.1	0.0	0.6	2.5	0.5	0.4	0.0	0.3	0.0	0.1	0.6	0.3	0.1
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191323-53207282	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 45.1;dendritic cells: 62.3;NK-cells: 134.9;Plasma cells: 115.9;T-cells: 62.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	99	"Karpas-707: 4821.4;RPMI-8226: 3980.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042277			Approved	"Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"	1.6	1.4	1.7	20.0	1.8	15.5	1.9	1.7	2.2	2.7	2.0	9.7	11.7	1.6	2.8	6.4	2.9	3.9	0.8	1.5	2.0	4.7	5.3	6.6	29.2	2.3	1.8	0.7	1.2	0.7	1.3	0.5	2.0	1.7	9.5	1.0	4.1	2.3	0.7	11.9	17.3	2.4	1.9	30.0	8.2	0.6	2.8	8.6	3.1	0.6	26.5	6.2	2.9	2.1	0.1	0.0	0.0	0.3	0.1	0.7	1.4	0.5	0.0	0.0	0.5	0.0	2.1	44.5	0.8	0.0	0.0	9.4	0.0	0.3	0.0	16.5	0.0	1.5	0.0	0.0	0.0	1.0	18.5	1.0	1.8	0.2	0.1	0.6	0.0	2.2	0.4	4821.4	0.0	1.6	0.9	7.0	0.3	41.7	0.1	1.8	0.0	3980.8	0.0	1.2	1.9	0.6	0.1	1.8	0.5	0.0	0.8	10.4	0.0	0.3	0.6	0.9	0.0	8.9	17.9	3.8	3.8	2.6	1.6	80.7	5.6	97.7	52.0	1.4	38.2	28.1	51.8	63.0	44.5	29.8	44.5	44.4	1.5	23.7	0.4	11.9	71.8	17.3	1.7	1.8	1.7	2.2	1.5	2.0	2.3	1.8	2.0	1.9	2.8	2.1	1.0	3.2	5.5	1.3	45.1	2.2	0.3	1.7	3.4	0.1	1.3	1.0	0.5	2.8	1.3	7.3	4.2	0.1	62.3	0.6	7.9	0.3	0.0	1.2	0.4	0.9	0.0	2.1	0.0	0.5	0.1	1.3	2.6	2.4	29.2	0.1	0.4	2.2	13.3	0.0	0.1	0.5	0.0	3.7	10.3	0.3	0.0	17.3	7.2	1.9	13.3	7.0	134.9	0.0	0.5	0.9	1.7	0.0	115.9	0.2	0.0	7.6	0.2	0.8	0.0	1.0	8.2	0.2	1.4	3.3	3.7	0.1	62.5	0.1	1.2	1.4
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.9;choroid plexus: 39.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 376.2;Glandular and luminal cells: 551.9;Oligodendrocyte precursor cells: 192.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	133	"basophil: 16.5"	"Lineage enriched"	"Detected in single"	133	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"AF22: 44.3;EFO-21: 54.6;RPTEC TERT1: 88.1;WM-115: 127.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	3.8	2.6	25.7	4.2	41.8	0.3	9.6	53.9	19.2	15.4	39.4	3.7	3.2	7.7	14.0	6.4	7.5	8.7	2.9	19.5	37.5	21.6	0.8	2.4	0.5	38.9	48.4	4.7	13.3	5.1	5.4	5.2	42.7	6.7	2.8	4.6	13.6	9.0	0.2	6.3	4.2	3.0	39.7	0.0	4.2	6.5	35.6	0.8	2.1	0.9	6.9	7.2	9.0	48.6	28.2	1.1	44.3	5.6	3.7	15.2	0.0	0.1	0.5	0.2	1.5	0.3	6.9	0.0	54.6	2.0	1.7	30.1	1.9	4.5	0.5	0.0	0.7	0.0	23.1	0.0	1.8	0.0	0.1	1.8	12.6	0.5	2.4	27.1	2.4	0.0	0.0	8.3	0.8	0.1	0.0	0.0	3.3	0.4	4.8	0.0	3.7	0.0	88.1	2.5	0.7	1.9	8.6	0.2	23.5	0.8	0.7	0.1	3.0	11.2	7.1	3.2	5.8	10.2	0.1	0.0	2.7	0.0	127.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	25.7	41.8	53.9	19.2	19.5	37.5	38.9	48.4	42.7	39.7	35.6	48.6	0.7	12.8	4.8	106.4	2.5	33.1	117.2	39.4	34.7	13.3	26.3	18.7	3.0	38.6	57.9	38.6	0.0	20.0	0.4	5.0	7.9	26.3	3.0	376.2	150.6	5.2	34.0	0.0	28.1	17.4	1.2	15.5	7.7	551.9	1.3	0.9	1.4	0.2	3.3	1.7	8.2	7.4	34.6	1.0	4.7	6.5	44.1	9.8	3.6	4.7	31.6	24.3	0.0	192.0	119.2	35.8	6.1	44.8	2.0	149.7	14.5	76.7	100.1	1.4	0.0	4.8	7.0	1.4	1.1	34.6	12.4	4.9	5.5	1.9	9.6	150.7
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.8;dendritic cells: 20.1;Macrophages: 17.9;NK-cells: 18.6;Plasma cells: 18.4;T-cells: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 35.7;HEL: 15.9;HMC-1: 15.5;Karpas-707: 40.2;U-266/70: 15.4;U-266/84: 24.7;U-937: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane, Cytosol"		"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favorable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.7	2.5	4.0	36.3	4.4	18.6	4.0	3.9	5.6	3.3	3.7	4.0	3.0	2.2	2.4	2.8	5.3	4.8	3.2	4.1	6.7	6.2	2.9	13.1	40.5	7.3	6.1	15.5	1.8	1.9	3.1	5.7	6.4	4.4	3.1	0.6	3.5	1.9	0.7	1.7	15.4	3.5	5.5	55.1	4.6	2.6	6.6	11.3	4.9	0.9	29.7	7.4	3.1	6.1	0.2	0.6	0.5	1.8	0.6	2.4	0.4	0.8	0.0	0.1	0.1	0.0	1.6	0.7	3.3	0.7	0.4	0.2	0.0	0.4	0.0	35.7	0.0	15.9	0.1	1.5	1.2	0.0	15.5	8.4	0.5	0.1	0.0	0.1	0.3	3.6	0.1	40.2	0.0	0.7	6.5	0.0	0.3	0.9	1.3	8.2	0.0	0.7	0.8	0.0	0.0	0.6	0.2	0.4	0.1	0.2	3.5	2.4	0.7	0.0	0.7	0.0	0.0	15.4	24.7	4.3	0.1	24.2	0.3	2.0	7.5	0.3	17.8	14.6	20.2	9.4	21.1	18.6	6.8	10.3	20.2	18.5	25.1	13.4	14.2	5.5	18.0	12.4	4.0	4.4	3.9	5.6	4.1	6.7	7.3	6.1	6.4	5.5	6.6	6.1	5.5	0.0	4.6	2.3	27.8	0.8	0.6	0.5	0.6	0.6	0.5	0.8	1.9	0.0	1.0	1.8	0.0	1.1	20.1	0.0	0.0	0.5	1.0	0.3	2.1	8.0	0.0	6.1	4.3	0.4	0.8	4.6	2.0	0.4	5.1	0.8	9.7	0.4	14.5	0.0	2.6	0.0	0.0	9.2	1.9	2.0	12.5	17.9	3.6	4.7	16.6	0.9	18.6	0.0	0.4	0.5	0.0	14.7	18.4	0.5	0.0	0.3	0.9	0.7	6.6	0.3	2.9	0.3	0.7	0.3	1.0	1.4	37.7	14.8	0.1	0.6
JMJD1C	"DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8"	ENSG00000171988	"Jumonji domain containing 1C"	Q15652	10	63167221-63521850	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 590.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 49.7"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 14.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056175, HPA066195"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA056175: AB_2683057, HPA066195: AB_2685634"	"unprognostic (7.72e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.13e-1)"	16.3	12.5	3.7	18.9	5.4	40.2	22.3	49.7	6.6	19.9	6.4	11.3	16.9	24.0	11.3	12.8	12.5	24.6	12.1	4.0	4.5	15.6	22.3	16.0	22.1	5.0	5.0	24.7	13.1	21.9	6.8	14.4	6.2	14.1	12.3	41.4	13.1	11.5	11.0	11.1	18.9	15.6	3.1	20.9	14.5	15.7	4.8	20.4	20.8	13.8	21.3	16.0	9.4	7.7	23.2	11.5	26.5	20.4	13.8	25.2	9.3	15.8	32.5	13.9	19.0	19.8	24.2	31.3	9.4	14.9	12.6	18.6	7.6	15.2	24.7	8.5	9.6	11.9	11.9	14.4	16.8	25.8	4.3	25.3	15.3	24.7	71.3	31.5	25.4	22.0	21.4	23.0	33.1	6.2	19.8	13.8	28.3	5.2	40.0	34.0	57.5	15.0	14.1	16.5	14.4	23.5	23.8	14.7	22.8	19.3	14.6	46.0	30.6	12.9	18.1	11.3	20.0	20.4	17.4	29.1	15.7	15.1	11.7	0.6	2.7	3.2	1.8	1.8	2.7	4.4	1.9	1.9	2.3	4.2	2.7	2.3	14.1	1.7	1.6	4.0	1.8	1.1	3.7	5.4	49.7	6.6	4.0	4.5	5.0	5.0	6.2	3.1	4.8	7.7	256.1	112.2	93.3	214.5	184.4	151.9	369.2	46.6	93.9	88.7	106.7	92.7	69.4	55.8	96.9	55.2	152.2	34.7	117.4	80.7	13.7	63.3	38.3	155.8	179.7	176.7	86.0	75.3	590.1	47.0	27.7	141.1	119.8	210.1	93.1	79.1	118.2	37.2	57.9	117.8	416.5	66.8	38.7	89.8	185.0	42.3	103.8	206.8	76.5	355.1	96.6	61.2	58.7	419.2	378.8	76.7	88.4	89.5	124.8	161.0	90.6	32.4	104.1	170.9	72.3	214.4	112.6	158.6	146.5	56.4	134.0	33.2	145.6	76.0	52.3	286.7
JMJD7		ENSG00000243789	"Jumonji domain containing 7"	P0C870	15	41828092-41837581	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 5.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 2.0;Squamous epithelial cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 31.2;RT4: 43.5"	"Low region specificity"	"Detected in all"							HPA005726	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA005726: AB_1852017"	"unprognostic (2.92e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	6.7	8.4	6.3	4.2	6.2	8.2	9.0	19.9	9.5	13.6	8.0	7.3	4.8	6.5	3.1	35.4	8.6	6.5	11.2	5.8	6.3	10.1	10.3	10.8	7.3	5.8	5.2	11.6	15.9	9.0	9.8	3.0	7.0	14.5	3.0	1.9	21.9	6.8	7.7	33.3	8.0	2.9	5.1	7.9	11.5	6.7	5.9	5.6	15.6	6.6	6.6	11.4	21.0	7.0	7.9	7.5	9.3	2.6	2.5	1.7	5.8	3.1	6.6	5.1	4.1	10.5	5.9	1.0	6.4	2.0	5.3	19.6	4.3	15.6	1.6	7.7	4.6	10.5	10.4	6.5	4.1	5.1	11.0	1.1	13.6	3.4	7.2	4.7	5.8	9.9	7.0	6.2	3.7	10.8	6.6	4.9	4.0	31.2	4.8	2.9	6.3	7.6	11.5	43.5	9.9	3.5	2.6	13.5	4.3	2.7	26.2	5.4	5.4	3.7	8.3	8.0	6.1	10.2	3.7	3.2	4.9	12.4	5.7	6.1	14.8	10.8	14.1	15.8	14.8	7.2	15.7	18.6	10.6	11.1	19.7	15.6	3.9	13.0	15.8	6.7	16.7	12.6	6.3	6.2	19.9	9.5	5.8	6.3	5.8	5.2	7.0	5.1	5.9	7.0	0.1	3.2	5.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.8	0.0	0.2	0.0	0.2	2.0	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	3.4	0.1	0.0	0.6	0.0	0.0	0.0
JMJD7-PLA2G4B		ENSG00000168970	"JMJD7-PLA2G4B readthrough"		15	41828095-41848155	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Club cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RT4: 2.6"									HPA005726	Approved		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA005726: AB_1852017"	"unprognostic (9.87e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.75e-3)"	1.1	0.3	0.1	0.8	0.0	1.0	0.9	0.3	0.4	1.4	0.5	0.9	0.2	1.1	0.4	1.9	1.1	0.4	0.6	0.1	0.1	0.4	0.3	0.9	0.2	0.1	0.1	1.2	0.5	0.9	0.4	0.1	0.3	0.7	0.2	0.2	1.5	0.4	0.8	2.8	0.8	0.6	0.1	0.6	0.8	0.3	0.3	0.4	0.8	0.5	0.3	1.0	1.4	0.2	0.2	0.0	0.6	2.0	0.5	1.3	0.7	0.4	1.1	0.5	0.8	0.8	0.0	0.2	0.8	0.5	0.0	1.8	0.2	1.2	0.1	0.0	0.2	0.3	0.4	0.2	1.9	0.0	0.9	0.7	0.9	0.2	0.4	0.0	0.2	0.7	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.4	0.1	0.3	0.0	0.8	0.5	2.6	0.6	0.8	1.8	0.0	0.2	0.0	0.4	2.1	0.3	0.3	0.2	2.0	0.7	0.5	0.2	0.0	1.0	0.2	0.2	0.0	0.3	0.0	1.1	0.4	0.5	0.2	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.3	0.1	0.3	0.2	0.2	9.6	4.8	0.0	0.9	0.1	0.2	0.1	2.2	0.6	0.4	0.1	0.6	1.5	2.7	0.0	0.0	0.2	0.1	1.1	0.0	0.6	0.0	0.1	0.3	0.4	2.4	0.0	0.0	0.5	0.1	0.2	1.5	0.4	1.3	0.1	0.0	0.2	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	1.0	0.0	0.1	1.1	0.5	0.0	2.3	0.1	1.2	0.0	0.9	0.6	0.0	0.1	0.2	0.0	0.1	2.0	1.0	0.1	1.0	0.1	1.2	0.1
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 59.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.1;Excitatory neurons: 33.2;Horizontal cells: 50.5;Inhibitory neurons: 28.7;Late spermatids: 14.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Group enriched"	"Detected in all"	5	"amygdala: 17.1;basal ganglia: 24.6;cerebral cortex: 59.1;hippocampal formation: 42.7;white matter: 20.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.7;SH-SY5Y: 7.2;SiHa: 5.0;U-2 OS: 22.5"	"Low region specificity"	"Detected in all"							HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	0.2	1.3	17.1	0.2	24.6	0.0	0.1	1.1	59.1	0.7	0.0	1.1	0.1	0.2	0.0	0.6	0.4	0.0	0.1	42.7	5.6	0.0	0.1	0.1	0.0	6.4	5.8	0.1	0.3	0.0	14.1	0.0	1.1	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.5	0.0	1.1	0.1	0.5	1.4	1.1	0.0	0.1	0.0	0.0	0.1	0.3	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.9	0.0	1.2	0.0	0.0	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.2	5.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	24.6	1.1	59.1	42.7	5.6	6.4	5.8	1.1	1.1	1.1	20.6	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	24.4	0.0	0.0	3.7	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	0.0	41.1	0.0	0.0	0.8	0.0	0.0	33.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.1	50.5	28.7	0.0	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.0	1.3	0.0	10.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.2	0.1	1.1	3.7	0.0	0.0	0.1	0.1	0.5	0.0	0.1
JPH4	"JPHL1, KIAA1831"	ENSG00000092051	"Junctophilin 4"	Q96JJ6	14	23568035-23578790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.2;pituitary gland: 66.5"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 191.4;Horizontal cells: 410.5"	"Cancer enhanced"	"Detected in some"		"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.8;myeloid DC: 3.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.2;monocytes: 2.8"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 14.2;SH-SY5Y: 35.4;U-2 OS: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045022			Approved	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA045022: "	"unprognostic (3.30e-2)"	"unprognostic (1.91e-3)"	"unprognostic (5.05e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-3)"	"unprognostic (5.98e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.96e-3)"	1.5	11.7	83.7	1.0	88.5	0.2	1.0	25.2	126.2	8.4	0.0	1.7	0.8	24.3	5.2	0.4	13.7	0.5	0.3	115.4	29.3	3.0	0.3	2.5	1.0	14.5	11.0	13.6	0.5	1.8	66.5	0.5	11.2	12.3	0.6	12.5	0.3	36.8	0.2	0.9	1.3	12.9	7.2	2.6	0.9	1.4	31.7	0.3	0.4	0.5	0.6	1.6	6.6	57.2	0.0	0.0	0.7	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.7	14.2	35.4	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.3	2.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	83.7	88.5	25.2	126.2	115.4	29.3	14.5	11.0	11.2	7.2	31.7	57.2	0.3	0.0	0.6	0.7	0.0	0.0	0.2	0.0	0.0	191.4	0.2	0.1	1.3	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.3	0.3	5.7	1.7	1.8	0.0	22.1	0.0	0.0	1.4	0.0	0.1	5.1	1.2	1.8	0.0	2.0	410.5	18.3	0.2	0.0	1.3	9.3	0.2	10.8	0.9	0.0	0.0	0.1	1.6	0.0	15.6	0.4	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	7.7	13.1	0.1	2.3	0.5	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.8
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.3"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 1434.2;Inhibitory neurons: 480.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 57.4;HEL: 35.3;OE19: 20.1;SH-SY5Y: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		83000	"Cluster 35: T-regs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	9.4	6.3	15.0	2.2	23.4	0.3	6.7	0.0	31.3	9.1	4.9	2.0	2.5	7.7	1.9	9.5	4.6	2.9	12.8	21.3	3.4	3.8	5.8	4.4	0.9	0.0	6.6	3.1	8.8	3.5	4.1	4.2	0.0	2.8	1.8	4.5	2.8	4.9	27.2	2.0	2.0	6.2	0.0	8.5	12.1	2.6	10.7	0.5	5.1	19.3	1.6	2.6	6.0	20.9	0.7	1.1	6.2	1.3	0.9	0.2	8.1	2.5	1.5	2.4	1.1	57.4	4.5	0.2	0.8	6.4	3.9	0.4	1.4	0.0	2.0	0.0	0.7	35.3	0.4	8.9	0.1	0.0	0.0	0.4	0.0	0.5	0.1	2.6	2.9	0.1	8.3	0.2	0.7	4.2	0.0	0.0	3.5	20.1	5.4	1.8	2.8	0.0	0.2	0.5	2.1	15.9	0.7	0.5	0.5	6.0	1.2	0.1	14.4	7.0	2.8	1.0	1.1	0.0	0.6	0.0	0.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	1.6	0.4	15.0	23.4	0.0	31.3	21.3	3.4	0.0	6.6	0.0	0.0	10.7	20.9	56.2	3.2	3.9	191.3	0.6	1.7	1.5	0.3	0.6	61.2	6.1	7.1	32.1	18.6	0.5	16.5	6.2	8.0	2.5	40.5	1.9	5.0	57.0	15.0	18.8	23.2	9.6	5.3	1434.2	8.4	1.7	5.9	29.0	7.4	3.8	4.4	45.3	21.7	1.0	0.0	480.8	16.4	0.0	1.6	1.1	64.0	3.7	5.3	3.6	48.7	0.0	4.7	8.2	162.3	63.1	4.4	21.0	33.1	0.3	2.6	34.8	3.6	8.4	2.7	19.7	8.8	21.8	5.2	2.6	4.9	1.1	14.2	1.0	17.5	12.3	1.6
KANSL1L	"C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2"	ENSG00000144445	"KAT8 regulatory NSL complex subunit 1 like"	A0AUZ9	2	210021421-210171409	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 198.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.6;Inhibitory neurons: 117.9;Microglial cells: 103.0;Oligodendrocyte precursor cells: 190.5;Oligodendrocytes: 158.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043102, HPA046790"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA043102: AB_2678316, HPA046790: AB_2679808"	"unprognostic (3.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.55e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.99e-3)"	"unprognostic (4.65e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.95e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-3)"	11.6	8.3	10.7	6.2	13.5	5.5	10.3	14.3	9.2	14.4	8.9	9.9	6.5	18.7	17.4	6.9	13.2	15.7	9.7	9.7	11.7	22.7	9.4	11.9	6.7	11.3	12.6	28.5	15.2	198.9	10.0	8.3	12.0	16.9	6.8	12.5	10.0	17.0	12.1	13.3	6.7	13.3	10.6	6.3	12.4	25.3	10.8	26.7	19.7	18.4	5.2	13.6	11.3	17.7	2.7	1.4	14.5	6.1	11.7	8.7	4.0	4.1	5.4	2.7	7.4	2.7	10.9	7.9	5.5	2.8	6.5	3.8	3.4	1.5	4.3	3.4	2.7	6.3	6.1	4.6	7.3	7.4	4.3	5.5	6.5	2.7	1.9	11.5	6.1	7.2	4.5	7.1	4.1	2.7	8.5	19.7	8.4	4.8	1.9	6.1	3.9	6.1	16.0	4.0	9.0	8.5	3.7	2.3	2.9	14.4	2.5	16.1	4.9	5.3	4.3	1.9	3.1	4.9	2.2	7.7	7.0	3.5	7.1	0.2	0.3	0.5	0.2	0.4	0.2	0.1	0.2	0.2	0.4	0.3	0.3	0.3	0.4	0.6	0.1	0.3	0.1	0.1	10.7	13.5	14.3	9.2	9.7	11.7	11.3	12.6	12.0	10.6	10.8	17.7	12.8	28.9	20.1	113.6	4.6	7.4	6.7	3.9	11.4	8.6	5.4	6.7	9.2	20.0	6.6	31.3	14.6	1.7	1.5	2.3	3.9	13.2	30.3	22.3	17.0	8.8	6.0	4.6	79.0	5.5	0.9	14.2	9.2	14.7	10.8	23.6	6.4	7.4	2.7	5.0	117.9	3.2	8.2	2.8	6.7	22.2	14.6	8.5	7.2	103.0	5.5	9.6	4.1	190.5	158.9	6.7	4.7	30.1	3.0	7.0	2.0	15.8	36.0	8.7	13.1	31.1	15.6	44.9	7.8	5.5	11.1	1.9	2.7	6.6	2.8	4.1
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788648-49835026	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	17.6	14.2	16.1	8.1	16.9	40.9	16.6	24.2	21.5	20.1	15.1	20.9	7.2	22.6	12.2	20.4	20.3	6.6	22.8	16.5	14.8	17.7	11.7	14.5	10.4	13.6	12.3	20.9	12.4	23.5	17.1	10.0	15.5	17.5	10.0	19.2	17.8	14.0	37.7	25.5	16.0	12.4	10.3	15.9	16.0	38.6	14.9	17.4	21.1	20.1	13.5	22.5	19.0	18.7	17.1	22.6	22.5	17.3	10.1	14.3	27.2	11.2	16.5	24.7	18.7	35.9	11.5	17.8	21.8	13.7	24.7	16.7	23.0	12.8	32.5	18.6	20.3	20.7	14.8	17.8	15.0	21.6	17.2	13.3	16.6	21.1	25.3	14.4	22.7	16.0	23.6	18.9	27.4	28.8	26.4	23.2	79.0	38.4	20.2	20.6	34.7	18.2	12.8	17.6	25.7	15.7	7.6	9.2	14.9	40.5	38.6	22.9	8.8	24.5	13.3	16.0	19.4	21.4	32.7	23.3	17.3	13.6	23.3	17.1	6.8	9.5	8.3	5.4	10.6	5.8	7.8	8.5	7.0	6.1	9.3	8.5	10.1	11.7	7.1	4.3	8.5	7.9	16.1	16.9	24.2	21.5	16.5	14.8	13.6	12.3	15.5	10.3	14.9	18.7	16.0	25.6	21.3	9.4	23.6	16.8	11.7	10.1	25.0	32.6	18.5	16.6	28.5	20.0	15.6	27.6	31.3	22.7	27.6	11.7	9.8	11.9	23.1	22.4	21.0	18.7	25.1	25.4	14.8	7.5	14.5	15.3	15.3	29.9	24.1	18.2	15.4	10.4	13.3	45.4	16.7	13.4	12.2	22.6	13.2	16.5	16.8	15.9	14.2	10.3	19.1	16.5	25.7	13.0	18.3	10.0	8.9	18.4	18.6	15.4	12.8	10.2	18.6	25.1	39.5	21.2	24.2	73.7	31.6	17.9	20.0	33.8	28.4	15.2	12.1	10.2
KBTBD4	"BKLHD4, FLJ10450, HSPC252"	ENSG00000123444	"Kelch repeat and BTB domain containing 4"	Q9NVX7	11	47572197-47578976	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037792, HPA037793"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037792: AB_10671633, HPA037793: AB_2675671"	"unprognostic (5.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (2.70e-7)"	"unprognostic (4.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.25e-2)"	10.2	13.9	5.8	4.6	6.2	8.7	10.0	7.2	6.2	10.0	6.4	12.8	4.2	13.2	8.8	9.2	10.6	4.6	10.6	5.9	5.8	9.9	8.3	8.3	6.4	5.5	5.7	10.9	8.4	12.4	13.0	4.3	5.6	8.5	6.2	7.4	10.3	6.7	24.3	13.1	10.5	6.7	5.7	10.9	10.4	14.5	5.7	7.9	9.3	11.0	8.4	11.3	8.3	6.0	5.0	11.8	13.0	10.2	7.8	10.6	3.7	9.0	11.8	12.8	11.2	4.0	9.8	9.6	4.8	11.6	9.2	8.5	7.5	13.3	10.9	12.6	10.7	7.2	15.9	5.7	5.8	15.3	14.5	9.6	9.1	5.4	6.9	8.8	13.4	6.7	5.4	7.6	10.2	13.1	11.2	4.6	6.4	14.0	7.6	10.2	17.0	5.4	13.8	11.9	17.2	11.0	7.7	10.4	6.5	4.3	17.4	4.8	10.7	7.9	8.4	12.1	9.0	10.3	20.3	14.2	11.5	4.2	8.8	11.6	4.6	11.7	12.5	3.8	13.8	11.6	9.8	11.4	5.9	10.9	10.6	11.4	8.3	13.5	4.1	2.5	12.8	10.4	5.8	6.2	7.2	6.2	5.9	5.8	5.5	5.7	5.6	5.7	5.7	6.0	6.2	6.4	3.6	3.3	9.6	4.8	6.2	16.4	7.4	14.0	6.9	4.4	0.1	8.6	11.3	11.0	8.4	12.3	9.7	6.9	23.5	13.9	14.5	10.2	5.2	9.0	7.2	9.5	5.7	13.7	7.3	5.8	1.5	4.6	10.8	6.8	7.5	8.8	8.1	13.5	6.6	4.0	20.3	4.1	2.9	18.3	5.0	4.3	1.8	3.7	11.4	24.9	10.3	2.5	4.6	9.0	2.9	9.4	5.8	4.1	6.3	10.9	18.8	12.1	13.1	6.9	6.0	23.7	20.1	4.0	4.5	14.1	10.2	7.6	5.4	4.6
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 47.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 79.6;Excitatory neurons: 48.2;Inhibitory neurons: 120.2"	"Group enriched"	"Detected in some"	5	"glioma: 1.1;testis cancer: 0.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;RH-30: 3.7;SCLC-21H: 3.5;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.1	0.8	1.1	0.1	3.3	0.9	0.2	41.0	47.3	0.9	0.0	0.3	0.3	0.3	0.0	0.2	0.1	0.2	0.1	4.5	8.0	0.1	0.2	0.1	0.2	8.8	3.0	0.2	0.4	0.0	2.2	0.0	9.3	0.2	0.0	7.0	0.3	0.0	0.5	0.5	0.3	0.0	1.0	0.2	0.3	1.4	12.3	0.1	0.3	1.2	0.0	0.3	0.5	18.8	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.1	0.2	1.1	0.3	1.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.4	3.7	0.4	0.0	0.2	3.5	2.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	1.0	0.1	0.0	0.2	0.3	0.4	0.2	0.2	0.4	3.2	0.3	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.0	0.5	0.2	0.2	1.4	0.2	0.3	0.3	0.1	0.1	1.1	3.3	41.0	47.3	4.5	8.0	8.8	3.0	9.3	1.0	12.3	18.8	0.2	0.0	0.0	5.5	1.1	0.0	0.2	0.0	0.0	79.6	0.3	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	9.5	0.2	0.5	0.4	7.7	0.0	48.2	0.2	0.0	0.3	0.0	0.3	0.0	2.8	0.0	0.0	0.0	1.7	120.2	0.0	0.0	0.0	0.0	10.2	0.3	0.2	0.0	7.5	0.6	1.5	0.0	16.1	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.7	0.0	0.2	0.5	6.1	5.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0
KCNC4	"C1orf30, HKSHIIIC, Kv3.4"	ENSG00000116396	"Potassium voltage-gated channel subfamily C member 4"	Q03721	1	110210314-110283100	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 41.7;Hepatic stellate cells: 50.3;Rod photoreceptor cells: 41.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.5;U-87 MG: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014740			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoli, Cytosol"		"HPA014740: AB_1855580"	"unprognostic (9.16e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.25e-2)"	3.1	4.0	24.9	2.2	9.7	1.1	3.6	2.3	11.3	3.8	0.0	2.1	1.2	2.7	1.2	2.4	3.6	4.2	4.2	20.4	9.0	7.9	0.8	2.8	2.2	21.6	12.3	3.6	5.6	6.8	6.1	2.8	23.7	3.3	1.2	7.5	7.1	3.1	4.9	3.7	2.3	1.6	4.7	4.2	3.4	2.5	11.1	1.9	2.7	5.8	1.6	3.0	3.4	2.2	4.1	2.7	0.4	3.3	1.2	0.3	6.3	13.5	1.4	0.9	0.8	7.2	1.4	5.8	6.1	4.0	3.4	5.5	1.7	1.0	0.5	38.5	4.1	0.5	5.4	0.8	0.4	3.6	1.5	0.2	0.3	2.2	0.2	0.7	5.5	2.8	1.2	1.9	0.1	0.6	3.6	1.1	2.7	1.1	6.8	4.5	0.1	1.0	4.2	0.1	1.0	1.0	0.6	11.9	1.3	3.0	1.5	2.1	2.5	1.5	7.0	1.1	0.5	5.0	3.2	1.0	19.5	3.5	13.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.9	9.7	2.3	11.3	20.4	9.0	21.6	12.3	23.7	4.7	11.1	2.2	11.0	0.0	1.1	8.5	2.6	3.2	15.7	2.5	12.0	4.7	10.6	9.3	8.9	8.6	2.0	3.7	41.7	0.4	1.7	10.0	0.0	6.8	0.5	7.9	2.8	14.0	13.2	0.8	13.4	17.0	0.4	4.3	5.1	19.8	1.3	3.4	50.3	0.4	1.3	3.3	10.0	4.8	0.0	2.2	1.1	0.9	1.5	1.5	1.8	7.5	1.4	3.8	0.0	6.0	1.7	11.8	7.1	4.1	1.2	11.0	2.3	0.6	2.5	41.1	26.3	4.2	8.4	0.7	7.4	4.1	3.0	1.1	2.6	0.4	8.3	9.7
KCNH5	"eag2, H-EAG2, hEAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699464-63102037	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 8.5;retina: 4.5"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 62.2;Excitatory neurons: 185.0;Inhibitory neurons: 74.4;Oligodendrocyte precursor cells: 65.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;RT4: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.2	1.0	2.4	0.0	2.1	0.0	0.0	0.0	5.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	2.9	3.3	0.0	0.0	0.0	0.3	0.2	3.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	5.9	4.5	1.8	2.9	3.3	3.0	0.8	8.5	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	62.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.8	0.1	0.2	0.2	0.0	0.0	185.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	74.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	0.0	0.5	0.0	65.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.6	0.0	0.0	0.1	1.6	1.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium inwardly rectifying channel subfamily J member 15"	Q99712	21	38155549-38307357	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 241.6;thyroid gland: 129.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 197.9;Cholangiocytes: 88.6;Proximal tubular cells: 236.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	20	"neutrophil: 395.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 395.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 68.7;GAMG: 103.6;HBEC3-KT: 69.6;RPTEC TERT1: 67.5;RT4: 80.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (1.95e-4)"	8.7	0.5	0.8	20.7	0.7	14.1	2.8	0.9	6.7	12.7	0.5	0.9	1.5	0.5	11.0	8.5	1.2	30.4	0.8	0.8	0.6	241.6	2.8	42.2	1.2	0.9	0.6	0.3	57.8	0.7	0.4	4.6	1.8	2.6	0.4	0.5	25.5	14.6	0.5	3.0	0.7	2.4	0.3	11.7	40.5	1.8	5.4	1.9	129.5	3.0	1.9	25.1	8.1	1.1	1.6	0.0	0.3	0.6	13.7	68.7	0.6	1.0	4.8	0.0	0.0	0.0	0.6	0.2	0.0	7.5	103.6	23.5	0.0	69.6	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.1	21.0	7.2	17.8	3.8	1.5	3.2	0.1	0.2	0.7	31.6	0.0	0.1	0.2	0.0	0.1	0.7	1.5	0.3	0.7	67.5	80.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.4	3.5	0.2	1.7	0.4	0.1	5.6	4.3	0.4	0.3	19.3	0.1	0.0	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.3	395.3	0.0	0.0	0.4	0.0	4.6	0.8	0.7	0.9	6.7	0.8	0.6	0.9	0.6	1.8	0.3	5.4	1.1	2.9	60.9	197.9	0.0	1.1	2.8	10.4	20.7	13.6	0.0	0.5	0.0	1.6	88.6	33.1	31.3	0.0	0.1	0.0	0.0	17.6	27.8	1.9	0.0	0.0	4.6	0.0	0.0	0.3	8.6	0.8	1.5	15.8	0.1	6.3	0.0	0.7	0.4	0.4	0.0	0.1	0.0	2.0	2.9	3.0	2.2	0.6	5.9	1.8	0.0	2.1	0.0	0.0	0.0	0.1	44.7	0.0	0.0	0.1	0.7	0.0	236.9	7.0	0.0	0.0	1.5	0.8	1.1	1.1	16.8	1.6	0.1	1.7	0.1	0.0	9.0
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.7;thyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.8"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 83.8"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.5	0.3	0.3	0.4	0.4	1.2	0.8	0.3	0.6	0.7	0.2	0.6	1.9	1.2	0.0	0.3	0.8	2.5	5.8	0.2	0.3	0.1	4.0	7.7	0.7	0.4	0.5	0.2	3.9	0.1	1.8	4.0	0.3	0.6	0.5	0.0	0.7	0.2	0.1	0.1	1.1	1.0	0.2	0.7	2.9	0.2	0.5	1.3	6.5	0.5	1.1	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	63.8	0.0	0.3	0.3	0.4	0.3	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.5	0.3	0.0	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	7.9	0.0	1.8	1.1	0.1	6.3	0.0	0.7	0.2	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.9	0.0	17.8	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319845-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 151.3;Urothelial cells: 131.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 26.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.4;granulocytes: 26.2;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HEL: 37.6;HMC-1: 40.3;T-47d: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.9	2.4	2.9	7.5	2.4	3.9	5.6	3.0	3.3	29.9	2.7	15.4	4.6	24.0	1.5	30.5	15.7	4.5	6.7	2.7	2.2	3.1	3.0	9.4	5.6	2.9	2.3	9.5	12.5	0.6	1.9	7.0	2.9	6.2	9.4	0.8	14.5	2.4	1.5	19.1	6.8	14.3	2.1	15.6	9.5	2.1	2.8	2.5	1.4	0.7	7.9	13.3	18.2	3.7	9.2	3.3	0.5	0.5	5.1	3.3	0.7	7.8	3.8	2.0	2.7	2.6	9.8	0.6	3.5	11.2	2.1	11.7	4.2	17.7	1.3	0.4	0.3	37.6	1.9	0.4	4.7	2.7	40.3	0.8	15.6	2.5	4.8	10.5	5.3	5.8	0.5	2.8	5.7	20.2	2.4	2.3	0.4	19.4	2.1	3.9	0.5	2.7	7.1	0.8	0.5	0.8	0.8	0.8	0.3	1.8	22.8	10.5	5.8	0.5	4.4	4.1	0.4	1.0	0.2	1.0	0.6	13.4	0.3	26.2	6.9	15.8	1.4	6.2	1.2	1.4	2.0	1.9	11.4	1.1	1.7	1.2	5.0	0.6	7.2	3.1	2.6	2.3	2.9	2.4	3.0	3.3	2.7	2.2	2.9	2.3	2.9	2.1	2.8	3.7	8.7	0.0	10.5	0.0	16.0	43.1	50.6	20.6	20.5	3.3	61.2	32.9	12.1	17.2	15.1	7.3	6.2	2.0	18.5	62.4	0.0	19.1	2.8	32.5	58.8	28.3	12.6	17.9	1.1	47.7	4.0	19.2	28.1	84.8	22.2	72.7	151.3	4.3	39.2	0.0	1.7	64.5	2.0	75.7	61.5	1.2	25.7	47.0	5.4	2.8	62.1	1.2	11.3	0.0	0.9	67.2	39.2	20.3	45.6	41.1	37.6	0.4	7.7	5.9	26.3	3.1	9.3	14.8	3.3	48.0	67.2	2.5	14.8	1.5	26.7	131.5
KCNMB4		ENSG00000135643	"Potassium calcium-activated channel subfamily M regulatory beta subunit 4"	Q86W47	12	70366290-70434292	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.2;choroid plexus: 18.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 95.7;Hepatic stellate cells: 37.1;Inhibitory neurons: 45.0;Oligodendrocytes: 86.9"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 7.7;RH-30: 8.2;RT4: 9.3;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072287	Enhanced	Approved	Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA072287: AB_2686507"	"unprognostic (3.90e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.05e-2)"	2.3	14.9	35.3	1.1	39.5	0.2	2.0	29.7	43.5	3.1	18.9	8.6	1.0	1.8	1.1	1.0	1.7	1.4	4.7	36.4	29.7	3.7	0.5	6.1	1.3	38.5	32.2	2.6	0.5	0.2	1.9	2.5	32.1	3.2	1.2	1.9	1.7	2.1	2.4	2.6	3.0	1.2	28.9	1.2	2.1	2.1	38.4	1.3	2.1	1.5	1.0	2.5	2.6	54.2	0.0	0.3	4.9	2.7	0.3	0.2	0.5	0.6	0.9	0.2	0.7	0.2	1.8	2.4	0.3	0.0	1.0	0.0	5.3	0.8	0.2	1.1	3.1	1.3	1.1	2.9	0.0	0.1	0.1	1.4	0.1	0.0	0.0	0.5	0.2	3.5	0.0	0.0	0.9	0.7	1.8	0.4	7.7	0.1	5.6	2.6	8.2	0.2	0.2	9.3	2.4	2.9	0.7	0.9	0.0	7.3	2.7	0.1	0.1	0.3	1.3	0.1	0.3	1.7	0.0	2.5	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.1	35.3	39.5	29.7	43.5	36.4	29.7	38.5	32.2	32.1	28.9	38.4	54.2	8.5	0.0	0.6	2.6	1.1	3.2	0.2	0.4	0.6	23.1	2.8	1.9	4.3	0.0	0.2	23.9	0.0	0.2	2.1	0.1	0.0	0.1	0.9	4.7	1.1	8.7	0.0	3.2	95.7	0.0	0.4	9.6	0.0	3.4	0.0	7.2	37.1	0.7	1.2	0.0	45.0	0.4	0.0	10.8	2.6	2.2	6.5	2.9	1.8	20.6	0.7	1.5	0.0	13.6	86.9	0.0	0.0	18.0	0.2	0.8	0.0	9.7	0.0	3.0	0.0	12.8	5.1	2.2	7.8	0.2	5.5	0.3	1.4	14.0	0.5	0.0
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"brain: 92.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 12.8;Langerhans cells: 19.8;Skeletal myocytes: 6.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Group enriched"	"Detected in many"	7	"amygdala: 34.8;basal ganglia: 30.6;cerebral cortex: 67.2;hippocampal formation: 92.2;white matter: 30.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"REH: 155.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments, Cytosol"		"HPA065938: AB_2685582"	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.3	0.2	34.8	0.4	30.6	0.1	0.2	0.0	67.2	0.9	0.0	0.3	0.1	0.6	0.1	0.2	0.1	0.1	1.1	92.2	0.0	0.2	0.0	0.1	0.1	4.4	0.0	1.8	0.1	1.6	1.0	0.0	6.8	0.6	0.0	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	2.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	30.6	0.1	0.6	0.2	6.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.5	0.2	5.3	0.0	0.2	0.2	2.5	5.0	0.3	0.1	0.0	0.0	12.8	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.4	0.0	0.0	1.8	0.0	0.1	155.3	0.0	0.2	0.0	0.0	0.2	8.6	0.0	0.0	0.1	0.4	0.3	0.2	0.1	0.0	4.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	30.6	0.0	67.2	92.2	0.0	4.4	0.0	6.8	0.0	0.0	30.6	0.4	0.0	0.0	3.6	1.1	2.5	3.7	0.0	0.0	2.3	0.2	0.3	0.8	0.0	0.7	0.0	2.1	0.1	1.5	0.2	0.0	0.0	0.2	1.3	1.5	1.9	0.0	0.0	12.8	0.0	0.2	2.6	0.0	1.9	0.0	3.6	0.4	0.2	0.1	0.0	4.4	0.0	0.0	0.3	19.8	0.4	0.9	2.1	5.4	1.9	2.2	1.4	1.0	3.0	0.7	0.2	0.0	1.9	0.7	2.8	0.0	0.2	0.0	1.0	0.0	6.8	1.8	0.6	4.0	0.0	3.8	0.1	1.5	2.2	0.0	1.8
KCTD10	"BTBD28, MSTP028"	ENSG00000110906	"Potassium channel tetramerization domain containing 10"	Q9H3F6	12	109448655-109477359	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014273	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA014273: AB_1852159"	"unprognostic (7.21e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	40.3	23.4	20.5	26.2	19.7	15.4	32.9	17.2	20.3	34.2	32.1	42.5	14.7	43.8	14.0	36.6	27.4	33.0	24.1	19.7	31.0	23.0	11.4	31.9	21.9	21.1	23.1	18.1	12.4	22.2	17.0	25.4	26.6	29.2	33.2	14.3	20.7	44.3	11.5	30.3	22.3	57.0	19.2	23.2	25.8	16.3	30.1	14.9	47.1	11.7	22.8	39.0	29.4	18.9	28.4	27.9	84.6	27.5	67.8	91.2	18.5	59.0	80.2	38.8	38.2	28.1	23.1	27.5	34.0	136.4	19.2	22.0	30.7	51.6	35.9	26.0	22.0	32.3	19.2	19.3	44.5	24.9	26.7	92.2	30.7	50.0	29.3	54.7	89.5	26.4	21.5	11.5	68.0	15.1	29.8	32.9	48.1	12.7	36.0	29.2	37.7	22.6	38.5	48.9	29.5	44.3	35.6	38.8	41.8	47.5	45.2	18.8	70.0	42.3	15.5	24.0	32.8	26.0	52.8	37.1	48.8	20.2	60.5	10.9	9.5	6.4	13.5	14.4	10.1	6.6	8.0	10.0	11.9	6.2	8.8	11.1	6.5	25.1	17.2	9.0	10.0	14.9	20.5	19.7	17.2	20.3	19.7	31.0	21.1	23.1	26.6	19.2	30.1	18.9	21.1	16.0	29.9	6.2	9.0	14.7	20.1	17.4	11.4	5.4	12.1	13.5	11.5	10.0	13.7	5.5	16.7	9.1	19.4	31.5	5.9	15.3	12.2	9.9	17.8	26.8	11.5	6.5	9.8	13.1	12.8	15.5	10.7	12.8	14.0	11.3	24.7	5.3	11.5	8.4	8.1	13.4	10.2	13.6	13.3	11.3	11.5	14.6	16.0	8.4	15.7	2.8	81.4	8.0	9.4	25.9	11.8	18.8	7.5	12.2	6.4	10.5	12.2	4.4	26.3	13.4	32.6	13.5	6.3	10.2	16.6	13.5	10.6	10.4	15.0	18.1
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 13.7;Breast myoepithelial cells: 12.8;Exocrine glandular cells: 17.1;Gastric mucus-secreting cells: 14.3;Intestinal goblet cells: 20.8;Prostatic glandular cells: 14.3;Proximal tubular cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 26.1;Hep G2: 29.0;RPTEC TERT1: 45.9;U-2 OS: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.96e-5)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.63e-1)"	3.4	23.1	2.0	1.6	2.0	0.1	20.4	5.1	2.9	10.4	3.2	8.1	4.9	3.4	14.3	1.5	11.7	6.7	0.6	2.1	2.1	11.5	10.3	8.2	0.3	1.9	2.3	0.8	27.2	8.3	2.5	1.3	2.2	7.0	11.9	1.6	28.7	19.1	0.2	1.9	5.2	2.1	1.6	0.6	20.8	0.6	2.5	1.3	15.9	0.6	0.5	2.3	1.4	1.7	0.0	3.5	0.6	0.5	1.3	0.8	3.5	1.8	1.6	3.4	8.4	13.5	8.8	0.1	9.3	1.1	0.4	1.0	0.6	26.1	8.9	0.5	13.2	0.0	3.0	29.0	4.9	0.2	0.1	4.0	0.7	13.9	11.0	2.5	1.0	0.2	0.3	0.1	1.4	0.2	0.3	0.8	6.5	0.5	0.5	0.4	0.0	0.0	45.9	3.5	2.3	0.2	0.0	0.2	4.5	0.8	1.4	1.1	0.8	0.2	20.2	0.7	0.4	0.3	0.2	0.2	0.2	0.2	3.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.0	2.0	2.0	5.1	2.9	2.1	2.1	1.9	2.3	2.2	1.6	2.5	1.7	0.6	3.2	10.8	0.0	0.2	0.4	12.2	2.0	2.8	0.4	13.7	12.8	0.0	1.5	4.1	5.5	0.0	0.6	0.3	5.2	3.9	2.6	0.3	2.7	2.0	0.9	4.8	0.0	0.0	17.1	1.3	1.1	14.3	3.7	1.3	0.5	0.0	4.8	0.2	0.0	0.0	20.8	0.0	0.0	0.0	0.0	3.4	0.4	1.8	0.0	0.1	2.1	0.0	0.0	0.0	10.5	6.6	5.3	0.0	14.3	2.2	15.1	0.1	0.0	0.0	0.0	1.8	0.2	0.3	0.7	0.1	0.7	0.3	0.7	8.5	7.4
KCTD21	KCASH2	ENSG00000188997	"Potassium channel tetramerization domain containing 21"	Q4G0X4	11	78171249-78188626	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041964	Uncertain		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA041964: AB_10795647"	"unprognostic (1.17e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.40e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.70e-1)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	7.3	13.4	14.4	6.2	13.6	3.5	4.4	13.1	14.3	5.8	8.7	6.5	5.0	5.0	9.2	9.6	6.2	7.9	6.3	13.7	14.3	5.5	15.9	6.7	5.4	14.7	16.3	13.7	3.5	5.7	5.9	7.7	15.0	4.2	4.8	4.3	5.8	5.2	8.5	4.9	4.5	7.1	12.4	4.6	4.5	4.0	14.6	5.9	11.2	7.0	6.2	7.1	5.9	14.7	5.2	11.8	6.7	5.0	23.8	16.9	4.1	10.1	9.6	7.1	7.1	11.1	7.8	5.0	9.9	11.4	9.5	10.1	6.5	8.4	7.3	6.9	3.9	3.8	15.4	9.8	13.2	2.4	4.7	16.4	15.4	15.5	8.8	14.8	11.0	6.1	8.1	4.5	9.7	7.3	3.8	7.3	3.0	19.0	8.9	5.0	5.1	3.1	8.3	9.3	4.6	7.1	6.4	4.6	4.9	12.1	10.6	2.6	12.9	11.3	11.0	30.0	3.9	8.6	9.2	4.8	5.9	3.9	6.4	2.0	5.4	7.5	0.9	6.0	1.4	0.6	1.4	1.7	3.7	1.4	1.3	1.0	8.3	1.4	5.1	0.8	1.1	2.2	14.4	13.6	13.1	14.3	13.7	14.3	14.7	16.3	15.0	12.4	14.6	14.7	1.9	0.0	2.7	4.6	0.7	1.8	1.2	1.5	0.6	1.7	2.4	2.2	3.5	5.7	2.0	0.0	0.0	1.2	0.6	2.8	1.9	1.5	0.3	1.4	2.5	2.3	0.0	0.0	4.1	2.2	1.1	2.8	1.1	1.9	5.7	7.0	3.6	7.4	2.3	6.7	3.4	1.3	0.0	3.1	1.1	0.5	4.4	1.3	1.8	4.7	2.8	1.0	0.0	4.0	4.2	2.5	1.7	9.1	1.0	1.9	2.3	2.7	1.1	0.9	0.0	1.2	2.9	1.5	2.7	3.6	1.4	1.9	1.8	3.8	1.7	2.1
KCTD3	NY-REN-45	ENSG00000136636	"Potassium channel tetramerization domain containing 3"	Q9Y597	1	215567304-215621807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 106.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"T-47d: 227.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015142	Approved		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 30: Mammary glandular cells - Lactation"	Cytosol		"HPA015142: AB_1852174"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.60e-3)"	"unprognostic (9.27e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (2.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.27e-1)"	"unprognostic (3.31e-3)"	35.1	77.2	19.6	11.8	26.9	15.9	67.2	34.8	21.8	23.8	19.3	35.1	45.5	23.6	27.4	38.7	19.3	27.7	13.0	19.4	23.2	27.7	71.8	17.0	8.6	29.1	25.4	23.4	32.8	36.7	12.0	29.7	29.9	38.5	28.4	39.8	27.7	29.6	15.2	18.8	49.5	28.9	25.1	11.6	26.7	20.1	25.5	11.3	27.6	23.8	10.9	23.9	30.7	33.8	52.8	37.2	41.6	24.1	34.3	57.5	57.1	42.8	40.0	37.1	38.5	33.0	85.6	14.6	23.4	45.0	11.1	50.3	44.1	43.4	42.5	8.2	45.8	26.3	71.0	46.3	28.3	26.9	5.1	53.5	30.0	47.0	35.5	46.7	34.6	19.8	51.8	13.9	41.1	45.6	11.7	13.8	69.9	76.2	47.0	17.7	58.8	56.9	42.8	35.2	48.7	54.0	65.9	95.0	36.6	52.1	227.5	34.3	31.1	36.8	36.4	46.1	49.4	12.5	18.2	5.3	29.0	14.1	28.5	0.5	0.4	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.4	0.5	0.2	0.2	0.7	0.5	0.2	0.6	0.1	0.2	19.6	26.9	34.8	21.8	19.4	23.2	29.1	25.4	29.9	25.1	25.5	33.8	26.5	9.6	11.6	41.4	2.4	18.0	25.2	9.4	19.4	31.7	60.0	31.9	13.3	40.0	17.6	11.0	18.8	27.2	4.6	15.5	23.5	26.6	1.3	14.0	29.8	20.6	39.6	19.3	53.5	20.7	15.7	30.3	21.4	19.6	5.1	30.7	16.1	60.5	8.0	18.5	62.9	40.6	14.2	9.3	8.4	3.2	27.7	7.9	16.0	33.7	5.5	24.0	0.0	53.3	106.7	16.5	19.1	22.6	4.6	21.9	50.1	28.3	14.4	24.2	26.3	41.8	20.4	6.3	14.6	45.2	17.6	17.5	2.5	32.0	33.0	38.3
KCTD9	"BTBD27, FLJ20038"	ENSG00000104756	"Potassium channel tetramerization domain containing 9"	Q7L273	8	25427847-25458476	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042468, HPA047902"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA042468: , HPA047902: AB_2680205"	"unprognostic (4.18e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (7.88e-4)"	"unprognostic (7.04e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.97e-3)"	18.4	8.2	4.9	11.5	5.8	21.5	22.3	7.9	6.5	15.4	8.6	21.1	19.6	11.3	13.0	23.8	14.6	13.3	38.3	5.5	5.9	12.8	10.8	13.4	12.2	9.1	7.7	14.2	11.2	11.0	9.8	12.0	10.0	17.4	22.6	12.9	17.5	15.6	29.5	19.0	17.7	14.5	7.8	9.4	12.8	12.9	6.9	14.7	13.7	36.7	14.4	15.6	18.7	6.9	46.4	32.4	34.5	11.9	44.0	58.0	28.2	68.6	61.4	44.1	44.5	23.4	33.2	30.1	28.6	69.0	62.3	30.3	30.6	32.3	52.9	15.4	18.2	35.3	30.2	21.7	53.2	12.3	25.1	44.8	38.5	40.2	33.2	26.9	37.8	29.6	37.8	23.0	50.7	12.4	48.2	21.6	16.8	35.8	17.0	18.6	39.8	11.2	45.0	26.1	8.8	11.4	52.7	23.1	35.8	30.8	17.8	14.2	42.2	48.5	28.2	94.1	37.6	6.6	12.9	39.1	33.9	21.8	35.8	0.7	0.5	1.2	1.0	0.7	1.0	0.6	1.0	1.0	0.3	0.3	0.6	0.9	0.5	0.2	0.9	1.0	1.1	0.4	4.9	5.8	7.9	6.5	5.5	5.9	9.1	7.7	10.0	7.8	6.9	6.9	19.5	32.1	18.5	18.6	8.9	74.4	36.4	26.0	31.9	13.7	20.4	12.7	61.1	5.7	24.2	27.6	25.0	9.4	23.3	53.8	13.7	17.6	6.5	12.8	12.7	16.8	10.2	20.2	14.3	27.2	17.6	32.5	8.2	17.9	20.3	10.9	12.5	9.0	9.3	3.3	12.9	16.0	18.3	9.3	18.5	5.2	30.7	12.9	30.2	36.5	8.5	8.1	18.6	17.1	13.6	36.6	21.6	55.7	17.1	52.6	25.8	10.4	17.4	19.6	6.6	21.6	26.2	35.6	26.4	41.6	54.7	11.2	19.8	14.4	17.7	46.0
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382575-48391551	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 605.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 856.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.49e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	109.3	124.4	58.0	61.7	56.5	45.8	106.6	54.5	59.7	132.5	78.1	120.3	132.5	110.0	117.3	107.3	112.2	100.9	96.6	56.1	62.5	119.5	127.2	101.4	53.3	61.1	59.1	165.8	138.9	191.7	116.2	128.7	59.0	102.5	128.5	39.0	137.7	105.0	76.8	103.8	114.5	100.6	56.2	79.5	120.1	93.7	62.9	51.6	121.8	58.4	73.2	102.5	102.4	58.0	216.2	305.3	173.1	184.7	379.7	440.6	126.5	207.4	363.9	247.0	281.0	202.3	238.7	89.1	132.6	456.4	154.4	187.6	211.1	222.2	234.0	72.7	224.5	74.4	99.4	382.2	329.6	84.1	133.4	419.6	268.0	168.5	178.5	387.4	233.0	75.3	131.7	160.9	333.1	173.6	79.4	856.7	126.3	426.8	122.5	112.1	103.4	141.0	316.2	176.3	172.9	134.5	182.1	160.6	113.1	196.7	126.6	102.1	182.6	173.4	142.6	145.3	179.3	451.1	382.0	60.2	110.1	112.4	181.1	10.8	41.0	12.6	18.1	34.7	20.8	17.0	17.6	19.7	30.6	14.3	14.3	16.1	9.9	20.2	30.2	45.4	20.4	18.2	58.0	56.5	54.5	59.7	56.1	62.5	61.1	59.1	59.0	56.2	62.9	58.0	150.8	35.3	54.2	8.5	82.2	75.3	130.6	147.1	124.7	39.4	141.0	154.4	28.8	98.7	110.9	93.8	6.2	231.7	59.5	153.0	56.7	224.1	6.2	72.0	188.8	111.4	145.0	56.8	8.7	169.0	605.5	161.0	120.3	166.3	62.7	149.2	102.8	79.6	180.0	40.4	12.7	379.6	93.6	107.6	73.5	14.2	163.5	103.1	92.5	8.4	102.3	89.8	35.0	10.6	10.6	190.3	199.8	132.0	365.9	161.2	213.8	149.6	49.2	28.1	85.5	87.9	131.6	41.8	69.1	127.7	70.2	387.7	55.4	191.3	202.9	157.6
KDF1	"C1orf172, FLJ34633, RP11-344H11.3"	ENSG00000175707	"Keratinocyte differentiation factor 1"	Q8NAX2	1	26949562-26960468	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 32.6;Ductal cells: 29.4;Syncytiotrophoblasts: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	36	"B-cells: 3.4;T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"A-431: 24.9;BEWO: 20.8;CAPAN-2: 22.7;HaCaT: 21.4;HBEC3-KT: 30.3;hTCEpi: 38.5;OE19: 39.3;SK-BR-3: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA028634, HPA028639"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Cytosol	"HPA028634: , HPA028639: AB_10599191"	"unprognostic (2.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (3.04e-13)"	"unprognostic (1.38e-3)"	"unprognostic (7.83e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.40e-4)"	0.1	1.1	0.4	1.3	0.3	0.1	10.3	1.6	1.3	4.0	0.3	8.9	12.4	0.9	19.7	20.2	7.4	2.9	0.4	0.4	0.2	11.0	4.7	4.4	0.8	0.3	0.3	0.1	16.2	12.5	10.4	3.9	0.4	7.2	7.1	1.3	12.8	4.6	0.0	17.7	10.5	0.3	0.2	0.6	10.6	2.6	0.3	2.3	10.0	0.0	3.4	4.8	8.3	0.7	24.9	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	12.1	22.7	0.0	0.9	0.0	0.0	21.4	0.0	30.3	0.0	0.1	0.4	0.0	0.0	4.4	0.3	0.0	0.0	0.1	38.5	0.0	3.1	0.0	0.0	0.0	1.4	0.0	0.0	14.7	0.0	0.1	1.7	39.3	0.1	0.0	0.0	3.7	5.5	11.7	14.9	0.0	0.2	25.2	0.1	2.7	16.1	0.4	0.2	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.2	2.5	4.3	3.0	0.1	3.4	6.2	3.8	0.0	0.0	0.0	0.0	0.2	1.7	0.4	0.3	1.6	1.3	0.4	0.2	0.3	0.3	0.4	0.2	0.3	0.7	0.2	12.8	8.8	0.0	0.8	0.0	14.3	0.0	10.8	0.6	15.1	16.3	0.3	12.8	2.5	14.7	0.0	32.6	1.5	17.2	25.4	29.4	0.4	7.3	0.8	0.7	7.8	0.0	0.2	23.2	26.5	0.6	13.7	8.0	0.0	0.1	0.0	4.4	2.7	0.0	0.1	13.1	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.2	1.1	0.0	0.0	0.1	21.8	25.2	0.0	0.4	16.8	26.2	10.1	5.1	2.5	0.0	0.0	0.3	6.3	7.5	14.4	0.0	29.7	1.2	0.0	16.9	19.0
KDM5A	"JARID1A, RBBP2"	ENSG00000073614	"Lysine demethylase 5A"	P29375	12	280057-389320	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 45.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006201			Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear bodies"	Cytosol	"HPA006201: AB_1079160"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.81e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.69e-2)"	8.1	8.7	5.8	11.4	8.3	45.5	11.1	11.6	8.5	8.6	10.0	8.2	7.2	9.7	7.1	8.9	7.6	8.0	5.2	6.2	6.5	7.8	9.9	8.8	15.3	6.8	5.7	11.0	9.4	10.1	4.2	11.8	6.5	8.6	9.9	9.6	6.7	7.3	5.5	12.5	7.3	9.4	6.0	13.5	8.8	21.1	6.7	21.6	9.1	7.6	14.4	8.7	7.2	15.0	14.4	25.3	18.3	14.2	16.1	15.2	20.3	12.5	16.5	18.4	19.8	15.2	17.0	24.0	3.9	21.0	16.0	13.3	19.2	14.2	21.9	37.9	15.9	29.3	26.5	9.0	13.0	38.6	22.1	16.6	13.1	22.6	29.9	18.8	18.8	21.0	17.9	32.7	15.7	9.7	27.9	11.0	28.4	12.3	7.9	25.7	47.5	11.4	8.8	32.6	7.0	20.5	24.5	11.0	13.0	25.0	11.9	24.0	26.0	12.0	17.0	13.6	21.1	11.5	13.6	53.7	15.5	16.5	18.0	64.5	21.8	44.4	31.4	25.0	32.3	27.1	24.6	25.9	22.8	32.0	26.3	22.8	63.0	35.8	28.9	32.0	20.9	22.5	5.8	8.3	11.6	8.5	6.2	6.5	6.8	5.7	6.5	6.0	6.7	15.0	53.1	64.1	61.6	61.7	80.6	33.0	22.2	30.1	48.9	69.0	35.3	27.9	38.2	31.5	39.0	35.0	116.7	48.8	103.3	51.3	3.9	37.4	96.8	60.2	72.8	51.6	69.7	51.3	71.7	31.6	34.7	47.2	39.8	99.8	54.4	106.9	42.8	30.9	30.2	87.5	59.1	40.0	40.7	52.5	37.5	32.5	48.4	63.9	26.6	57.1	82.9	48.3	105.0	68.3	85.9	38.7	37.0	55.7	73.1	32.4	33.6	11.8	40.2	71.9	59.2	64.0	59.9	137.1	104.8	50.1	47.6	71.1	80.1	67.5	40.1	42.0
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203508-27221768	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 80.3"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 56.4;Proximal enterocytes: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA026545: AB_1852015"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	2.1	3.5	4.0	3.1	4.0	1.3	2.2	5.3	4.2	2.6	3.2	2.7	13.3	3.0	1.8	2.0	2.5	2.2	2.4	4.1	4.0	3.0	80.3	2.2	3.4	3.7	3.5	3.0	5.1	2.4	4.0	1.5	3.9	3.6	1.7	2.3	2.3	2.1	4.6	1.7	12.5	1.6	3.6	4.6	2.6	2.7	3.8	3.5	3.1	3.0	2.6	2.7	2.3	4.1	1.4	3.0	5.0	2.7	1.1	1.5	2.7	1.7	1.9	3.8	3.3	2.6	2.4	7.6	2.9	2.5	1.9	1.6	3.0	2.7	2.2	9.2	4.4	4.9	3.3	6.2	2.7	3.6	5.5	1.9	2.1	2.4	1.7	2.2	3.1	3.5	6.1	4.8	2.4	2.3	3.4	6.4	8.5	1.1	1.8	5.2	3.1	6.9	1.4	1.6	4.8	2.9	0.7	2.5	1.9	1.7	2.7	4.8	3.4	4.5	2.2	1.7	1.8	2.9	3.1	6.3	1.9	3.3	0.4	0.2	2.1	0.8	2.5	1.9	2.1	1.9	3.6	3.5	1.9	4.3	3.4	4.9	0.1	1.3	1.9	4.0	2.3	2.3	4.0	4.0	5.3	4.2	4.1	4.0	3.7	3.5	3.9	3.6	3.8	4.1	0.7	0.0	1.7	3.3	2.4	0.3	0.2	0.7	3.4	1.9	0.7	0.6	1.5	1.5	1.6	0.0	2.1	2.0	2.4	1.0	3.9	1.3	0.6	0.5	1.2	1.6	5.4	0.8	2.4	0.7	0.7	1.0	3.1	0.4	0.0	1.5	1.1	56.4	2.0	0.0	2.5	1.6	2.0	1.9	1.2	0.9	0.3	1.3	0.0	1.9	1.4	1.4	1.0	1.5	3.2	0.7	0.5	1.2	3.0	0.5	25.4	1.4	5.9	2.5	0.0	0.9	1.4	1.1	2.5	0.6	0.0	1.4	2.0	1.6	1.2	0.2
KHDC1	"bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1"	ENSG00000135314	"KH domain containing 1"	Q4VXA5	6	73241314-73310365	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 32.9;Inhibitory neurons: 30.7;Oligodendrocyte precursor cells: 29.1;Spermatocytes: 38.8;Spermatogonia: 20.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA029032			Approved	Mitochondria,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA029032: AB_10602914"	"unprognostic (3.46e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.83e-4)"	"unprognostic (8.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.17e-3)"	1.2	1.0	11.0	0.6	11.6	0.2	0.9	11.4	13.6	2.1	8.8	1.6	0.1	1.7	1.2	1.0	2.5	1.0	3.9	11.2	11.2	1.0	0.1	0.8	1.3	10.8	11.2	3.0	2.7	2.2	7.5	0.5	11.3	2.0	0.4	3.8	0.6	1.3	1.1	0.4	0.8	0.9	11.3	0.7	1.6	8.3	11.6	2.1	2.4	1.4	1.4	1.4	1.6	11.4	3.2	4.6	0.9	2.4	4.2	4.8	2.2	6.1	6.0	9.3	13.7	4.4	2.5	6.9	2.3	2.7	4.8	3.1	6.4	1.3	7.1	6.5	4.6	4.6	4.2	0.0	5.4	2.3	0.1	6.2	2.7	9.3	2.6	3.9	2.1	7.1	3.4	8.0	3.8	7.7	0.5	2.1	4.2	0.6	9.1	1.0	0.0	5.5	1.5	0.1	11.1	2.4	3.6	0.2	0.3	3.0	0.1	6.8	0.1	2.0	4.2	1.2	6.6	13.5	8.8	4.9	0.1	1.9	0.7	1.9	0.1	0.0	2.1	0.0	1.3	1.2	1.3	2.4	0.4	0.8	1.0	1.6	0.0	1.4	0.0	1.3	2.8	1.1	11.0	11.6	11.4	13.6	11.2	11.2	10.8	11.2	11.3	11.3	11.6	11.4	0.3	0.0	1.5	8.5	2.8	0.8	3.4	5.4	2.8	9.6	2.0	6.5	2.8	0.0	2.1	3.7	2.1	1.7	4.7	0.3	1.9	0.9	12.0	4.6	2.8	0.4	0.0	1.3	32.9	3.7	0.4	3.6	8.2	0.8	0.0	5.8	0.0	0.0	0.5	13.5	30.7	0.7	2.0	0.0	0.4	15.2	2.1	0.3	3.6	2.8	0.7	16.1	3.1	29.1	11.2	3.2	0.2	3.4	6.8	2.0	0.1	0.2	1.4	7.2	19.7	1.9	2.0	38.8	20.9	1.0	0.6	0.1	2.5	2.7	1.1	0.8
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 121.2;kidney: 104.4;liver: 180.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	4.2	3.0	4.3	1.7	2.0	7.1	5.9	2.6	1.2	4.2	112.4	3.8	0.6	2.4	4.3	1.3	1.4	4.8	3.9	104.4	180.5	1.6	1.9	5.4	4.0	3.6	9.4	2.6	1.4	0.5	5.5	1.6	1.2	1.5	4.4	1.4	3.8	2.4	121.2	1.9	3.6	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.3	4.7	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	4.2	4.3	7.1	5.9	4.8	3.9	5.4	4.0	5.5	3.6	3.8	4.7	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
KHNYN	KIAA0323	ENSG00000100441	"KH and NYN domain containing"	O15037	14	24429286-24441843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003402	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA003402: AB_1079190"	"unprognostic (2.95e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.03e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.73e-1)"	24.5	24.1	13.9	28.8	17.1	39.1	23.6	20.7	15.0	27.2	15.0	28.9	27.7	25.1	17.3	27.8	28.1	18.2	18.0	12.3	13.9	16.6	19.0	25.2	27.9	19.7	15.5	41.4	28.3	19.9	18.1	33.0	17.5	25.0	25.6	8.4	24.4	21.2	22.5	26.6	33.4	20.0	14.5	32.4	38.8	9.5	15.4	24.2	22.5	17.7	31.2	27.1	25.2	19.6	28.2	35.1	29.2	23.4	31.2	30.5	29.7	27.3	33.2	30.9	24.2	22.1	48.6	39.3	15.6	25.9	25.3	26.9	25.8	44.4	22.9	63.4	12.0	17.8	33.1	41.1	32.0	26.3	37.1	31.3	100.2	32.0	42.4	42.3	36.4	29.1	24.0	35.7	17.6	36.6	9.6	16.5	7.6	53.7	28.6	15.0	0.3	20.2	19.9	42.1	20.9	21.8	22.4	14.6	36.9	29.0	17.5	30.4	36.2	28.1	24.4	33.9	16.0	66.5	39.9	27.4	15.3	14.4	26.0	0.9	1.3	1.9	1.7	1.6	1.0	1.3	1.4	1.4	0.9	2.3	1.0	1.0	1.7	1.6	1.3	1.5	1.4	1.2	13.9	17.1	20.7	15.0	12.3	13.9	19.7	15.5	17.5	14.5	15.4	19.6	15.3	12.8	16.3	10.7	15.6	8.9	25.3	15.1	11.4	2.9	13.8	11.9	3.4	17.2	13.0	7.3	2.1	24.7	14.3	32.2	1.9	18.1	0.4	8.6	10.3	15.0	10.8	22.1	2.9	41.8	13.6	11.6	36.7	13.4	14.0	13.5	9.7	9.5	13.6	0.0	1.5	26.1	18.3	12.6	9.3	3.1	14.0	13.3	12.4	6.5	16.6	8.3	16.5	3.5	6.7	41.1	17.3	11.3	8.6	33.7	35.0	3.9	12.9	9.2	13.1	13.6	14.3	1.1	1.6	9.4	12.8	26.8	12.7	14.6	17.6	34.3
KIAA0100	"BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488"	ENSG00000007202	KIAA0100	Q14667	17	28614446-28645454	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042781	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted to blood"	No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cytosol"		"HPA042781: AB_10797020"	"unprognostic (1.91e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.24e-3)"	"unprognostic (7.58e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	36.1	30.7	22.4	28.5	20.7	31.5	30.6	18.2	23.5	22.7	31.7	30.8	19.7	23.1	25.7	31.3	29.2	20.5	24.2	24.4	21.3	43.0	18.6	30.7	28.4	29.9	24.4	23.9	24.4	51.8	25.2	29.6	29.3	27.1	34.8	27.5	28.9	27.1	51.9	31.8	26.7	35.3	20.2	28.8	23.3	24.9	26.5	32.3	35.4	42.5	34.9	30.3	16.0	20.6	66.5	123.8	61.4	58.8	109.3	64.8	44.8	60.9	80.1	72.3	67.6	85.9	29.4	92.0	71.2	111.2	75.3	86.2	91.4	89.6	87.1	102.8	88.7	73.2	95.9	47.2	47.0	129.1	121.3	66.5	68.2	98.0	74.1	56.1	104.9	64.1	70.6	29.0	66.8	94.4	94.5	61.1	26.9	119.0	46.6	71.7	69.0	60.0	43.4	116.9	60.2	46.5	76.8	205.5	50.7	76.0	123.2	88.6	98.1	55.0	60.4	74.5	116.2	27.2	33.8	58.0	62.8	81.7	65.4	0.3	1.1	1.5	1.2	1.0	1.2	1.1	0.5	1.0	1.3	0.6	0.6	0.7	0.7	0.8	1.2	2.9	0.7	0.7	22.4	20.7	18.2	23.5	24.4	21.3	29.9	24.4	29.3	20.2	26.5	20.6	21.5	16.0	17.8	15.0	16.5	10.3	8.9	8.7	15.4	31.7	19.3	14.7	30.2	14.3	13.0	12.9	29.2	15.3	34.4	30.5	5.9	9.9	19.4	20.4	16.1	16.4	12.1	14.1	19.1	11.0	9.4	14.1	21.4	16.4	8.2	20.4	18.5	30.5	10.6	28.6	18.3	16.4	8.2	31.5	18.6	23.2	9.3	19.9	10.6	14.0	25.3	14.3	21.6	11.6	12.7	9.8	12.1	6.4	17.1	15.8	17.9	15.1	15.1	22.5	0.0	20.3	20.1	30.5	28.1	22.9	11.1	45.6	17.0	24.2	22.6	11.7
KIAA0232		ENSG00000170871	KIAA0232	Q92628	4	6781375-6884170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 10.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036891, HPA036892, HPA061498"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541"	"unprognostic (6.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.91e-10)"	"unprognostic (1.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.18e-2)"	13.0	12.0	18.6	8.5	19.9	16.2	13.3	20.2	20.9	12.0	17.8	14.0	8.5	15.4	12.6	20.6	15.3	12.4	33.2	18.0	22.3	18.8	15.0	12.0	7.5	18.2	22.5	13.1	10.6	23.9	10.3	10.4	19.8	14.7	12.3	24.7	8.9	14.6	32.5	7.6	11.5	13.1	20.1	12.9	10.9	12.0	23.4	11.7	15.1	51.1	8.6	10.4	9.8	21.0	13.7	13.0	26.7	16.7	18.8	20.2	14.0	17.4	18.1	12.0	10.1	8.2	11.3	9.0	5.8	19.7	18.5	7.0	13.7	7.7	15.5	5.1	5.6	26.7	11.1	11.0	9.9	11.6	33.6	13.6	17.7	13.4	7.4	15.4	12.6	8.9	20.3	7.6	15.4	6.7	22.3	11.7	14.1	10.2	14.3	15.7	27.3	4.2	20.3	12.8	20.2	13.1	12.9	11.4	12.1	18.3	14.5	21.1	16.0	11.0	12.8	9.8	15.2	13.1	14.1	7.0	13.5	12.2	30.3	2.0	2.0	5.7	2.1	1.4	2.9	1.3	1.6	2.5	1.3	1.3	1.5	1.6	10.6	1.8	2.1	2.0	1.6	0.9	18.6	19.9	20.2	20.9	18.0	22.3	18.2	22.5	19.8	20.1	23.4	21.0	27.6	32.1	39.2	62.3	19.1	12.7	27.4	12.9	24.5	77.2	29.0	20.6	132.1	10.0	29.0	12.9	37.5	14.7	23.6	47.9	41.1	23.4	45.0	74.4	28.0	20.6	25.1	49.9	123.8	11.7	7.7	27.7	44.9	38.7	12.6	16.3	15.0	42.9	11.2	99.3	120.7	20.9	30.5	23.9	11.8	64.2	24.8	28.4	7.2	73.1	34.8	49.7	27.8	90.0	138.0	21.8	24.8	33.1	24.2	28.0	29.6	24.6	58.0	44.6	26.3	39.4	31.6	31.6	22.4	19.2	11.1	22.4	27.4	27.0	17.5	35.7
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127438406-127459389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.6;skeletal muscle: 28.3"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 93.0;Alveolar cells type 2: 27.1;Skeletal myocytes: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.4;SCLC-21H: 33.3;SH-SY5Y: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	16.8	2.3	16.9	0.9	18.4	0.0	3.7	20.1	32.6	4.3	8.0	9.7	0.9	2.9	1.8	6.2	2.0	1.6	2.1	18.2	17.4	1.2	0.7	13.2	0.3	16.7	16.9	2.5	0.8	0.0	13.9	0.3	17.2	4.3	3.6	8.7	1.8	1.1	28.3	1.0	4.3	1.8	18.0	2.0	5.4	4.0	17.7	0.3	0.9	10.4	0.2	6.0	3.6	19.6	0.0	2.1	10.4	0.0	0.8	1.7	0.0	0.2	1.3	1.1	2.7	0.0	0.0	0.0	0.0	0.2	7.0	0.0	1.0	0.0	1.6	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	4.3	0.0	0.9	0.0	1.2	0.0	0.0	1.2	0.0	4.7	0.0	4.8	0.0	0.0	0.0	2.6	0.0	0.2	0.0	33.3	17.8	0.0	0.0	0.2	0.0	0.0	1.1	0.0	5.3	0.8	0.0	1.9	0.0	0.0	0.0	4.7	0.3	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	18.4	20.1	32.6	18.2	17.4	16.7	16.9	17.2	18.0	17.7	19.6	0.4	93.0	27.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.7	0.0	0.3	8.4	0.0	0.0	0.0	0.3	0.3	0.6	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	3.6	1.1	0.0	34.3	0.5	1.0	0.1	0.0	0.0	0.1	0.1	3.4	0.0	0.0
KIAA0586	"JBTS23, Talpid3"	ENSG00000100578	KIAA0586	Q9BVV6	14	58427385-58551297	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Early spermatids: 142.0;Late spermatids: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000846, HPA050249"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA000846: AB_2234167, HPA050249: "	"unprognostic (1.90e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.20e-4)"	"unprognostic (8.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-1)"	5.0	5.1	4.6	4.8	4.9	5.4	5.7	6.0	7.1	5.1	4.5	4.9	3.3	4.3	6.2	5.0	4.3	4.9	4.7	4.3	4.9	4.0	6.5	4.2	7.4	4.9	5.1	6.0	4.0	6.1	7.1	3.7	5.0	5.1	6.0	7.9	4.2	4.6	5.8	5.2	4.4	6.3	4.7	5.4	3.9	16.4	4.7	12.4	4.9	6.1	7.1	5.6	4.8	6.5	21.1	14.0	20.2	9.7	16.4	15.6	8.7	17.3	16.3	15.1	15.7	6.0	11.3	23.4	11.4	14.8	6.2	12.3	19.1	10.9	24.8	16.8	6.9	17.9	11.1	18.2	11.2	27.6	15.3	10.5	4.6	11.2	17.7	7.2	19.9	22.3	18.0	12.4	28.4	13.5	16.9	11.4	8.7	10.7	22.8	20.5	23.5	14.6	10.9	8.8	11.1	8.4	18.4	12.3	8.9	10.8	14.7	14.4	18.8	23.4	18.4	12.9	14.5	7.4	9.5	19.0	16.2	21.8	13.7	13.2	2.0	5.0	7.0	2.1	5.6	6.3	6.6	5.3	2.6	6.8	8.5	6.1	2.0	9.7	3.2	3.3	7.1	2.6	4.6	4.9	6.0	7.1	4.3	4.9	4.9	5.1	5.0	4.7	4.7	6.5	17.9	12.8	14.5	29.4	20.9	3.2	6.1	6.2	12.5	30.5	10.1	9.8	14.1	7.2	9.3	9.2	81.3	7.5	20.1	5.9	5.9	6.5	142.0	18.5	19.6	13.9	10.7	22.1	52.0	5.2	8.4	14.5	16.8	11.0	21.5	15.2	9.3	4.7	9.5	32.0	56.7	8.5	10.2	7.9	2.8	108.1	10.2	10.8	8.8	27.2	10.6	17.0	14.4	47.3	73.9	5.9	3.0	12.0	20.6	4.3	4.3	7.7	20.0	51.0	0.0	19.7	12.3	61.6	23.9	12.4	4.5	4.8	24.4	15.7	7.3	3.3
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324152-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.9;Endometrial ciliated cells: 41.8;Late spermatids: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: AB_2670571, HPA061066: AB_2684423"	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.1	8.1	5.3	0.7	5.8	2.4	3.7	14.2	5.2	2.3	10.5	2.5	1.8	3.0	6.2	2.3	5.8	3.1	1.7	5.3	8.7	9.2	5.5	3.0	0.2	4.1	5.0	8.6	9.1	11.6	6.3	1.2	3.9	2.9	1.3	15.0	2.8	2.6	1.5	5.8	1.1	2.9	3.7	0.6	11.1	22.3	6.0	3.2	3.6	1.4	0.4	1.3	1.1	5.0	10.7	6.3	13.2	12.4	0.4	0.3	2.9	2.8	3.3	6.5	7.5	2.8	5.5	0.1	3.0	0.7	11.0	6.1	18.1	5.6	5.4	0.9	10.1	0.2	9.7	2.5	2.3	1.9	0.4	1.5	9.5	6.0	7.0	7.7	0.2	5.8	4.4	0.2	0.6	3.8	6.0	4.0	0.6	2.6	1.5	2.2	0.5	0.0	13.8	1.3	38.1	13.6	4.8	12.5	4.0	9.0	11.8	1.5	0.0	0.8	3.2	1.8	4.2	6.2	14.6	0.1	2.4	0.5	2.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	5.8	14.2	5.2	5.3	8.7	4.1	5.0	3.9	3.7	6.0	5.0	1.5	6.4	2.7	7.5	1.4	9.7	5.1	3.5	17.6	17.8	13.3	8.1	3.7	5.7	3.7	3.7	27.1	2.3	0.9	0.9	5.9	5.0	87.9	41.8	2.2	1.6	8.4	0.8	22.4	2.9	1.2	2.1	11.2	13.3	1.3	8.3	0.4	5.6	0.5	11.8	25.9	1.5	0.0	0.0	0.4	65.4	2.8	0.4	3.6	1.0	0.1	5.7	0.0	12.1	13.1	3.9	1.7	0.4	3.2	3.0	0.2	10.0	25.9	16.3	6.6	5.7	2.1	28.8	11.9	4.7	8.7	0.7	1.2	7.6	1.6	2.0
KIAA1217	"DKFZP761L0424, ETL4, SKT"	ENSG00000120549	KIAA1217	Q5T5P2	10	23694746-24547848	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 108.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 609.1;Inhibitory neurons: 1251.8;Oligodendrocyte precursor cells: 255.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 82.6;Karpas-707: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004941	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA004941: AB_2130659"	"unprognostic (3.60e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-1)"	28.4	16.5	9.8	3.5	12.1	0.2	30.5	2.2	9.6	15.7	42.2	13.1	12.9	6.0	13.3	30.9	16.9	14.7	17.8	27.5	2.0	18.0	17.5	14.4	2.6	6.0	11.2	13.1	13.6	42.8	6.5	20.9	5.7	20.5	14.7	23.7	39.2	22.5	108.4	17.6	11.3	3.3	0.5	7.5	17.4	15.7	4.2	12.6	33.6	52.7	9.3	12.1	19.1	17.2	19.5	9.7	3.8	0.1	2.4	6.8	82.6	3.7	6.0	8.6	18.2	16.6	30.3	1.0	18.6	7.6	17.6	31.5	4.7	36.2	9.5	7.2	3.4	0.4	23.1	19.4	4.2	0.0	0.3	25.3	22.8	19.0	5.2	3.9	0.0	1.7	0.0	75.7	4.4	6.8	10.8	0.6	8.5	18.9	8.7	0.8	22.0	16.2	20.1	25.3	2.4	1.3	9.4	31.4	0.0	38.3	15.2	0.0	20.3	13.1	14.1	52.9	4.9	33.4	30.4	0.1	43.4	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.8	12.1	2.2	9.6	27.5	2.0	6.0	11.2	5.7	0.5	4.2	17.2	149.7	38.5	34.4	27.4	1.0	121.3	74.1	58.0	145.1	13.6	38.8	39.0	39.1	24.3	73.7	33.1	8.4	50.2	0.4	52.5	3.9	32.3	33.7	64.5	19.6	34.4	23.9	0.0	609.1	26.2	21.2	23.3	50.0	85.9	1.3	6.6	25.0	24.8	5.3	0.0	1251.8	22.8	26.4	14.6	7.8	11.3	17.7	1.3	1.8	30.0	0.0	93.6	0.0	255.9	10.3	24.1	22.7	33.1	3.1	36.8	15.4	6.3	36.9	3.1	13.1	19.6	20.4	0.8	1.1	96.4	51.0	65.1	2.2	14.2	19.4	43.7
KIAA1958	FLJ39294	ENSG00000165185	KIAA1958	Q8N8K9	9	112486827-112669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 169.8;Excitatory neurons: 64.2;Inhibitory neurons: 55.1;Oligodendrocyte precursor cells: 127.6;Oligodendrocytes: 166.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020625	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA020625: AB_1852451"	"unprognostic (3.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.58e-1)"	1.1	6.6	5.5	1.1	10.5	4.9	2.2	9.3	6.9	5.1	4.4	1.4	1.7	3.4	0.9	1.5	3.0	1.3	1.3	3.9	6.6	5.8	3.4	2.1	1.3	8.2	8.9	9.9	2.6	1.4	1.8	0.7	7.0	1.5	1.5	10.0	3.0	2.4	0.9	1.6	1.9	3.1	7.5	1.5	4.8	5.8	10.7	3.9	2.4	0.8	1.3	1.4	1.9	14.5	3.7	5.2	20.7	6.0	1.4	0.3	9.9	2.7	0.9	3.2	3.6	9.5	2.4	11.8	3.1	8.9	2.2	3.2	15.3	1.5	4.5	3.6	6.2	4.6	7.3	6.7	0.8	7.0	5.6	0.6	1.2	4.2	2.0	2.9	2.6	11.0	11.0	2.9	1.0	4.2	11.0	4.0	11.4	8.6	2.4	8.8	11.8	3.3	4.3	5.1	10.6	11.2	4.5	4.7	2.7	11.4	4.3	7.1	0.5	1.1	6.1	0.7	3.3	5.3	10.4	6.9	1.4	4.8	0.8	0.4	0.7	0.0	0.5	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.4	0.6	0.6	0.6	0.2	0.6	0.1	0.4	5.5	10.5	9.3	6.9	3.9	6.6	8.2	8.9	7.0	7.5	10.7	14.5	0.5	3.2	19.3	169.8	3.7	4.7	3.4	1.5	6.8	20.6	7.9	4.2	4.3	4.3	6.2	1.8	14.6	1.2	3.0	4.6	7.9	3.2	4.1	12.1	8.1	1.4	4.8	3.8	64.2	6.7	1.0	3.3	8.2	8.0	0.0	20.3	0.4	8.0	1.0	6.7	55.1	4.4	12.2	7.5	4.6	2.5	6.5	4.2	1.8	15.9	2.5	8.3	3.1	127.6	166.4	3.3	6.2	5.3	5.0	6.5	5.0	11.0	5.9	12.1	6.6	2.5	4.1	1.5	8.0	5.3	4.7	0.8	1.6	29.9	5.2	5.7
KIAA2013	"MGC33867, RP5-1077B9.1"	ENSG00000116685	KIAA2013	Q8IYS2	1	11919591-11926428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 116.7;Proximal enterocytes: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052677, HPA060536"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Cytosol	"HPA052677: AB_2681911, HPA060536: AB_2684313"	"unprognostic (3.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.51e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.74e-3)"	27.9	25.6	23.6	17.3	28.7	19.3	25.5	28.0	24.1	25.4	24.9	43.7	65.5	35.5	35.7	30.1	27.1	20.6	39.1	23.9	24.3	30.2	59.4	23.8	21.8	32.3	28.8	19.7	42.4	20.0	31.8	20.9	27.7	27.8	20.1	6.1	40.4	25.7	51.9	37.8	61.8	17.2	27.6	35.1	31.4	37.2	27.3	16.8	26.8	23.2	13.1	32.2	25.5	31.6	61.2	44.5	20.5	40.6	34.0	23.2	33.8	38.1	39.8	45.0	46.4	55.1	61.7	39.8	56.9	36.2	35.2	69.3	27.8	37.6	23.8	46.3	71.4	27.4	39.7	95.7	38.4	57.2	54.3	29.7	41.0	44.1	19.4	48.7	43.6	31.2	42.6	51.5	27.2	46.2	36.6	80.1	27.0	27.0	60.6	46.3	37.4	97.6	29.0	16.5	76.1	43.0	30.9	34.1	74.8	20.4	28.6	52.6	42.1	37.9	49.2	56.3	52.6	61.8	47.1	46.0	45.1	91.8	41.1	3.3	4.9	5.1	4.7	4.2	3.7	5.2	2.5	3.6	3.5	6.8	2.5	3.3	11.1	4.1	3.5	8.5	5.5	2.6	23.6	28.7	28.0	24.1	23.9	24.3	32.3	28.8	27.7	27.6	27.3	31.6	26.1	22.4	13.4	12.4	18.7	22.2	9.2	13.6	6.8	20.7	30.5	27.1	18.7	18.6	13.0	25.8	12.5	18.1	32.6	116.7	3.9	15.5	24.4	23.7	18.4	22.9	40.9	11.8	9.9	19.3	30.8	18.7	17.3	27.7	13.3	23.1	27.1	75.2	26.5	32.0	8.8	50.1	22.4	40.3	23.0	41.5	22.7	27.1	19.6	6.5	26.5	18.7	28.8	8.5	22.1	24.7	72.2	23.0	18.4	17.3	139.9	22.3	17.8	22.1	19.7	27.5	15.7	17.6	8.6	15.0	28.1	13.3	16.0	31.1	59.4	17.3
KIAA2026	FLJ20375	ENSG00000183354	KIAA2026	Q5HYC2	9	5881596-6008482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002109	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytosol"	Nucleoplasm	"HPA002109: AB_1078071"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.41e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (8.34e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	6.8	5.1	13.5	5.6	17.2	6.4	6.2	24.1	11.7	7.8	25.1	6.4	4.8	7.9	5.8	6.1	6.4	5.7	5.7	9.9	12.1	6.1	4.9	5.9	6.7	11.6	13.3	10.2	5.2	8.6	6.2	6.9	11.9	6.2	5.0	10.4	6.1	5.4	9.5	8.2	5.6	6.3	10.3	8.1	6.5	11.5	12.6	8.3	8.4	9.5	5.9	6.2	7.1	17.0	7.1	3.5	7.2	4.6	5.4	8.5	3.2	4.6	6.8	4.4	4.0	2.3	4.0	8.8	1.7	5.8	5.5	3.5	4.2	3.9	6.5	19.2	3.0	26.5	8.4	3.7	4.2	9.4	11.6	5.3	5.0	3.9	6.4	8.3	6.9	5.7	2.8	16.2	5.5	2.2	5.1	17.2	4.0	4.1	2.8	5.3	4.6	4.5	4.8	4.9	9.3	5.3	4.3	4.0	3.7	4.9	4.1	12.6	7.8	8.4	4.7	4.2	5.3	11.1	9.5	8.8	4.3	4.3	2.3	5.0	2.3	7.0	4.2	1.9	4.8	5.9	4.1	3.8	0.9	3.8	4.5	4.8	6.0	4.8	4.5	2.9	2.6	0.8	13.5	17.2	24.1	11.7	9.9	12.1	11.6	13.3	11.9	10.3	12.6	17.0	47.8	44.8	34.0	99.9	40.3	44.6	29.9	21.4	37.5	89.0	33.5	25.5	53.7	42.9	22.1	38.6	79.2	17.1	51.9	31.0	7.9	18.2	33.0	28.3	40.9	39.7	38.5	18.7	97.8	13.4	10.6	33.2	31.1	46.7	20.2	43.5	29.3	18.7	16.9	45.4	119.1	34.7	16.2	25.5	28.8	17.2	70.5	31.9	23.2	113.4	55.1	47.7	95.8	116.1	170.1	18.4	29.1	76.3	35.4	34.4	30.1	11.9	18.2	81.5	46.0	45.8	40.1	127.7	121.2	38.3	52.4	30.0	45.1	38.7	28.5	42.0
KIF1A	"ATSV, C2orf20, SPG30, UNC104"	ENSG00000130294	"Kinesin family member 1A"	Q12756	2	240713761-240824293	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 115.0;pancreas: 34.1;pituitary gland: 42.1;retina: 58.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 393.8;Cone photoreceptor cells: 419.1;Horizontal cells: 536.7;Muller glia cells: 116.4;Rod photoreceptor cells: 176.8"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 62.5;HAP1: 146.0;SCLC-21H: 276.0;SH-SY5Y: 52.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005442			Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Centriolar satellite, Cytosol"		"HPA005442: AB_1079210"	"unprognostic (1.19e-1)"	"unprognostic (2.17e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.90e-2)"	0.2	12.4	54.0	1.1	55.6	0.0	0.1	22.4	113.6	0.1	0.0	2.2	0.7	0.3	0.8	0.0	0.2	0.0	13.7	71.8	25.0	0.2	0.4	0.3	0.0	115.0	47.4	0.7	34.1	0.4	42.1	0.0	107.7	5.4	0.5	58.4	0.2	0.2	0.2	1.0	0.8	0.3	10.2	0.4	2.6	11.2	53.9	0.4	0.9	0.1	0.0	0.1	0.6	99.6	0.0	0.2	1.8	62.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	3.5	0.4	1.4	0.6	146.0	0.0	0.0	8.4	10.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.3	0.0	2.5	0.3	0.0	8.8	0.0	0.0	0.0	0.6	1.2	0.0	0.0	276.0	52.0	0.0	0.8	0.0	0.4	0.4	0.0	2.0	0.0	1.3	0.4	0.0	0.2	0.1	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	55.6	22.4	113.6	71.8	25.0	115.0	47.4	107.7	10.2	53.9	99.6	0.0	0.0	0.0	50.9	0.0	0.9	0.1	0.0	0.0	393.8	0.1	0.3	16.8	0.0	0.0	0.0	419.1	0.0	0.0	0.1	0.0	0.5	2.2	1.1	0.2	1.2	34.2	0.0	57.6	25.1	0.0	2.9	4.1	5.0	0.0	1.5	0.0	0.4	0.1	536.7	72.4	0.8	8.2	0.0	0.4	4.1	0.9	0.1	17.8	9.4	0.0	116.4	0.0	18.1	50.3	14.6	0.0	0.4	0.0	10.4	0.0	0.3	0.0	176.8	0.0	0.0	1.0	46.2	20.5	0.0	0.0	0.0	0.0	3.8	0.1	0.5
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	1.6	0.8	16.1	9.4	16.4	34.1	1.3	0.0	16.5	0.9	0.0	2.4	2.0	0.7	0.4	0.8	1.2	2.1	0.7	21.6	8.3	0.9	1.5	4.8	12.9	5.9	5.7	0.7	0.8	6.0	0.6	0.9	6.5	0.8	1.8	21.4	1.4	0.7	0.3	0.7	6.7	0.8	1.5	12.3	2.5	13.7	9.5	11.8	1.0	0.4	8.0	2.3	0.8	7.9	1.3	1.5	11.8	0.5	0.0	0.0	3.0	0.1	0.0	0.3	0.1	0.7	0.4	39.1	0.5	0.0	3.4	0.3	1.2	0.3	0.4	1.9	0.4	9.7	0.2	0.2	1.0	29.4	41.0	1.0	4.1	0.4	0.7	0.0	1.5	78.8	4.6	49.6	0.0	0.2	24.5	11.2	5.2	3.9	0.0	8.4	0.1	43.8	0.2	0.0	7.2	1.0	0.6	0.5	0.6	2.1	0.2	8.9	2.8	0.0	3.3	0.0	0.2	90.2	44.7	19.3	3.9	12.8	0.3	6.0	0.0	0.6	0.8	0.2	0.9	0.4	0.6	0.8	0.1	0.3	0.5	0.6	1.0	1.3	0.3	0.1	0.6	0.4	16.1	16.4	0.0	16.5	21.6	8.3	5.9	5.7	6.5	1.5	9.5	7.9	1.5	0.0	3.8	22.5	11.0	1.0	0.5	0.2	0.0	25.7	0.4	0.8	1.5	0.0	0.1	1.8	58.4	0.0	17.4	1.2	0.0	0.5	20.4	0.1	0.2	1.8	0.0	4.8	15.6	1.6	0.1	0.6	1.1	0.4	6.3	0.5	1.4	0.3	1.7	1.7	11.8	1.4	0.0	4.4	3.1	82.1	0.9	5.3	0.0	8.4	2.7	20.0	13.4	14.6	4.0	2.4	0.3	0.0	12.0	0.4	0.2	0.0	0.1	26.1	6.6	0.6	1.1	1.9	3.7	0.1	1.0	0.0	18.0	0.1	1.1	2.0
KIF26A	"DKFZP434N178, KIAA1236"	ENSG00000066735	"Kinesin family member 26A"	Q9ULI4	14	104138723-104180894	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1"	"Group enriched"	"Detected in many"	5	"stomach cancer: 3.8;testis cancer: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046882, HPA060346"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046882: AB_2679856, HPA060346: AB_2684259"	"unprognostic (3.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.24e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.68e-3)"	5.0	2.3	2.1	0.7	1.3	2.0	4.6	0.5	1.5	5.0	3.0	2.6	0.4	2.4	0.2	1.4	2.6	0.4	5.7	0.8	1.4	3.8	0.6	2.2	0.3	1.3	1.3	4.1	5.7	0.3	2.9	1.8	1.4	0.8	0.4	0.1	1.0	0.8	2.9	2.8	1.9	0.4	0.9	4.2	1.8	2.8	1.8	0.2	1.5	1.0	0.1	2.0	2.1	0.5	0.0	1.7	1.0	3.9	0.0	0.0	6.7	0.3	0.0	0.0	0.0	3.1	0.0	0.0	5.3	0.0	0.7	2.5	3.1	0.0	0.0	0.0	4.9	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	6.7	0.0	0.0	0.0	24.9	0.0	0.0	20.8	0.2	2.0	18.8	7.9	2.0	0.0	0.0	19.2	39.3	4.4	0.6	0.0	2.5	0.4	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.5	1.5	0.8	1.4	1.3	1.3	1.4	0.9	1.8	0.5	22.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.3	0.1	3.2	0.0	0.0	1.8	0.0	1.0	0.0	1.3	1.9	0.7	0.4	0.2	4.4	11.9	7.7	4.8	0.5	0.2	0.8	2.1	0.0	0.2	0.0	0.4	13.9	0.2	2.6	18.5	0.7	2.6	0.0	0.3	1.1	0.1	0.0	0.1	1.8	3.7	0.0	0.2	0.0	0.0	0.1	0.2	1.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.2	8.1	1.2	1.7	0.4	0.1	0.3	2.8	0.0
KIF3A	"FLA10, KLP-20"	ENSG00000131437	"Kinesin family member 3A"	Q9Y496	5	132692628-132737638	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.3;retina: 33.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.7;Horizontal cells: 185.1;Inhibitory neurons: 157.0;Spermatocytes: 147.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 68.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 68.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037085	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Intermediate filaments, Cytosol"		"CAB037085: AB_477147"	"unprognostic (8.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.21e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.23e-1)"	2.6	8.0	14.3	3.8	15.2	1.6	5.0	9.7	26.3	4.4	0.0	3.4	2.5	4.7	5.0	3.3	7.0	4.0	4.6	16.5	16.7	5.8	1.4	4.5	3.9	12.6	13.1	5.1	2.7	11.8	11.3	3.2	17.6	5.1	2.6	33.9	2.8	4.8	2.5	4.0	2.0	4.5	1.3	2.8	3.7	21.5	8.2	6.0	5.4	3.1	3.7	3.8	3.0	13.8	10.6	12.6	11.4	20.8	7.7	7.8	9.4	8.9	7.0	8.2	10.9	13.0	8.0	29.7	11.6	10.4	24.8	7.2	9.6	17.6	17.2	8.6	10.2	4.3	6.9	4.7	7.9	5.3	11.4	5.8	8.6	12.1	14.0	11.4	10.4	18.8	4.8	15.3	10.1	7.9	34.5	4.2	5.5	3.8	4.8	8.8	9.2	3.2	8.4	9.4	36.2	11.9	12.0	4.3	14.4	18.6	12.8	1.6	10.9	10.1	15.9	7.3	10.6	11.5	19.6	16.4	12.9	4.4	11.1	68.2	0.6	1.9	6.3	1.5	6.9	6.7	6.5	6.1	1.3	4.0	6.4	7.0	0.6	4.8	2.0	1.2	5.4	2.0	14.3	15.2	9.7	26.3	16.5	16.7	12.6	13.1	17.6	1.3	8.2	13.8	10.9	54.5	38.0	65.3	12.0	13.6	15.6	25.5	12.5	76.5	13.7	18.7	29.9	11.5	31.7	38.6	125.1	14.6	18.4	0.8	29.4	20.5	86.2	69.7	20.4	11.3	19.8	3.4	178.7	12.9	11.5	16.8	5.6	23.7	13.9	24.6	13.2	2.4	6.2	185.1	157.0	3.8	54.9	3.5	7.7	25.0	16.4	4.8	42.7	21.5	5.4	47.0	5.2	122.6	100.7	12.4	4.6	24.5	14.4	7.6	1.1	10.8	121.0	99.6	13.1	23.8	40.5	147.1	102.6	9.0	15.9	9.9	23.6	27.7	2.1	6.0
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57546026-57586633	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease variant, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"brain: 1628.2;choroid plexus: 951.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.7;Early spermatids: 12.2;Endometrial stromal cells: 12.9;Excitatory neurons: 28.4;Horizontal cells: 26.9;Inhibitory neurons: 21.7;Late spermatids: 15.2;Rod photoreceptor cells: 11.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.2;K-562: 15.3;NTERA-2: 17.7;SCLC-21H: 34.4;U-87 MG: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: AB_2686601"	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	0.4	10.6	1198.6	4.6	1243.7	4.2	0.5	1056.4	1628.2	2.5	951.3	4.5	3.6	3.8	1.4	1.4	0.6	0.7	0.6	1242.7	1056.4	0.8	0.2	0.8	0.7	1103.5	1046.7	0.6	2.6	9.0	21.3	0.1	1113.3	0.9	1.9	48.0	1.1	0.6	0.3	1.1	2.5	2.0	1002.7	0.8	1.3	4.8	1052.3	0.1	2.3	0.1	0.4	0.5	1.5	1313.2	0.5	0.1	7.2	5.7	0.0	0.0	0.6	1.4	1.3	2.2	3.5	1.2	0.2	3.2	0.4	1.9	1.3	0.8	3.8	0.1	2.5	33.2	4.1	0.5	1.8	7.0	1.9	1.5	1.3	1.0	0.4	1.6	0.1	0.5	0.5	2.8	15.3	9.4	0.0	0.6	0.8	0.0	17.7	0.0	0.0	0.5	0.2	0.3	1.1	0.5	34.4	9.1	0.0	1.6	0.0	2.0	0.9	0.2	0.9	0.6	5.3	1.1	2.1	5.3	7.7	1.9	14.5	0.1	0.6	0.2	0.4	0.1	1.0	0.5	1.6	0.7	0.7	1.2	0.3	0.5	0.9	2.2	1.1	0.3	1.1	0.3	1.0	0.4	1198.6	1243.7	1056.4	1628.2	1242.7	1056.4	1103.5	1046.7	1113.3	1002.7	1052.3	1313.2	0.1	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	40.7	0.1	0.9	2.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	12.2	0.5	12.9	0.7	0.0	0.4	28.4	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	26.9	21.7	0.2	0.0	0.0	0.2	15.2	0.0	0.1	0.0	0.0	0.0	6.4	0.0	8.5	3.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.7	3.3	7.9	0.0	0.1	0.0	0.3	0.0	0.1	0.1
KIFC2		ENSG00000167702	"Kinesin family member C2"	Q96AC6	8	144466043-144474202	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 113.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 59.8;Gastric mucus-secreting cells: 38.7;Inhibitory neurons: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029264	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA029264: AB_10609999"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-3)"	"unprognostic (4.12e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.71e-2)"	12.3	17.2	68.7	6.2	78.3	7.2	14.0	58.3	113.7	24.5	33.2	26.5	11.9	11.4	6.7	45.0	15.3	6.1	10.1	74.7	42.9	32.9	20.6	17.2	7.3	54.9	41.1	13.0	24.9	9.6	45.0	3.2	54.6	31.5	6.3	3.8	19.1	8.0	4.2	75.0	24.4	2.5	35.7	27.6	19.7	25.8	46.4	5.4	24.2	1.7	4.8	22.2	31.8	63.9	13.5	12.7	6.1	13.2	8.7	5.2	13.2	5.3	6.4	4.7	4.6	4.9	18.1	11.6	3.6	5.0	7.9	24.2	6.1	8.1	2.0	10.2	3.7	8.6	34.5	6.6	11.1	2.6	23.4	6.7	28.3	4.7	6.1	21.8	3.0	14.7	7.0	15.9	3.6	25.4	10.3	7.1	0.9	16.5	15.2	24.1	0.3	8.8	19.9	23.1	18.4	16.4	6.2	19.3	6.9	4.3	50.4	5.0	7.6	9.0	22.9	9.4	7.7	6.3	2.9	3.9	17.6	12.3	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.7	78.3	58.3	113.7	74.7	42.9	54.9	41.1	54.6	35.7	46.4	63.9	3.7	9.6	11.3	35.3	4.9	6.0	3.0	2.1	6.2	16.2	7.9	5.8	0.8	7.2	5.2	14.7	6.2	2.0	12.1	29.1	1.9	3.5	13.2	6.8	4.4	2.0	23.4	3.2	59.8	1.4	2.0	2.0	38.7	13.8	8.2	3.3	2.5	8.7	2.7	15.2	39.7	12.2	0.0	5.3	9.1	8.0	7.8	6.4	3.6	12.2	3.5	7.5	3.1	8.5	6.9	2.2	18.5	3.0	7.0	3.4	11.3	5.1	4.5	4.6	0.0	1.8	2.9	7.3	7.5	10.6	11.4	3.0	8.0	6.6	18.0	3.3
KLC1	"hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A"	ENSG00000126214	"Kinesin light chain 1"	Q07866	14	103561896-103714249	"Predicted intracellular proteins"	"Host-virus interaction"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 397.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009798, HPA044617, HPA052450"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		14000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838"	"unprognostic (6.93e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.17e-4)"	"unprognostic (6.58e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.49e-1)"	70.8	49.4	282.9	42.2	302.0	50.3	63.0	273.5	358.7	74.8	220.4	89.9	26.2	71.5	43.9	66.0	65.0	38.4	100.0	310.6	299.8	35.6	29.9	66.0	44.2	378.9	305.0	62.8	43.0	48.5	86.7	45.9	397.0	47.1	34.3	158.6	54.2	47.1	123.4	68.2	48.7	58.0	300.0	49.0	53.9	45.6	301.7	40.2	48.6	71.5	47.4	66.5	69.8	304.0	57.0	74.2	138.6	76.3	92.6	102.8	65.5	129.5	105.4	118.6	81.7	64.0	60.8	75.8	65.2	139.3	53.2	93.0	85.8	69.6	112.0	89.9	43.9	41.6	92.8	66.1	106.8	83.4	79.5	73.4	109.3	89.6	112.1	126.5	104.2	52.8	63.5	83.7	104.4	94.6	56.9	74.0	45.6	90.1	140.4	53.0	60.6	38.2	74.7	122.5	165.1	93.5	105.7	52.7	90.2	85.9	47.9	40.1	152.7	88.4	43.5	123.1	74.1	65.9	50.0	83.3	101.7	47.7	97.0	5.5	4.6	9.8	7.3	4.6	6.6	5.0	6.5	7.8	5.1	6.8	5.7	5.0	5.0	3.1	6.5	7.6	7.0	2.9	282.9	302.0	273.5	358.7	310.6	299.8	378.9	305.0	397.0	300.0	301.7	304.0	45.2	44.8	32.6	92.4	24.3	26.0	45.1	30.1	13.6	140.8	18.7	19.7	39.3	15.7	21.5	20.2	52.1	22.6	29.5	17.9	9.8	42.9	8.0	30.8	41.8	45.5	44.9	13.2	84.1	30.7	30.6	37.4	27.0	43.2	33.6	31.5	39.3	18.9	30.5	138.0	80.8	24.3	28.5	19.9	23.8	17.0	38.5	24.4	39.2	73.1	36.3	45.4	20.6	57.3	89.8	71.2	17.3	48.2	26.2	46.6	15.8	5.1	23.8	106.1	26.3	46.4	46.8	64.8	83.3	20.1	17.6	42.1	30.8	17.1	17.5	38.4
KLC3	"KLC2L, KLCt, KNS2B"	ENSG00000104892	"Kinesin light chain 3"	Q6P597	19	45333434-45351520	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.1;skin 1: 104.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 142.0;Basal prostatic cells: 50.8;Ductal cells: 39.1;Prostatic glandular cells: 66.9;Suprabasal keratinocytes: 183.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 36.1;HaCaT: 16.2;HBEC3-KT: 10.5;hTCEpi: 12.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052797, HPA056508"	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Actin filaments"	"Nucleoplasm, Cytosol"	"HPA052797: AB_2681954, HPA056508: AB_2683159"	"unprognostic (4.11e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.07e-4)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (3.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.14e-1)"	"unprognostic (2.37e-1)"	0.3	0.2	0.5	0.3	1.1	3.0	3.3	1.3	0.8	10.0	0.0	0.1	0.1	0.2	2.1	26.1	0.3	0.2	0.2	0.4	0.2	5.9	0.2	0.9	0.3	0.5	0.0	0.2	4.0	4.0	2.7	0.2	0.2	2.6	0.2	1.0	11.6	1.0	0.9	104.1	0.3	0.0	0.0	0.3	0.5	3.7	0.2	1.0	0.7	0.0	1.8	0.2	20.5	0.7	36.1	0.2	0.2	0.4	0.1	0.1	2.8	0.2	0.0	0.0	0.1	3.5	6.5	0.3	2.8	0.0	3.7	16.2	2.2	10.5	0.2	0.8	5.3	0.1	1.1	0.7	0.0	0.3	2.2	0.0	12.9	0.1	2.5	0.4	0.0	0.5	0.6	0.4	0.1	4.7	0.1	0.4	0.8	0.6	1.1	5.6	0.0	0.3	0.3	1.3	4.5	0.7	0.3	7.3	1.0	0.4	6.5	0.1	0.0	0.4	3.6	0.3	0.4	0.7	0.8	0.3	0.2	0.2	0.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.1	0.0	0.5	1.1	1.3	0.8	0.4	0.2	0.5	0.0	0.2	0.0	0.2	0.7	0.2	0.0	2.4	0.3	0.0	142.0	50.8	17.5	14.8	0.8	10.3	25.3	0.4	2.8	7.3	1.8	0.0	0.2	0.2	0.2	9.8	39.1	3.0	0.9	0.3	1.7	0.0	2.7	0.3	3.1	0.7	1.4	0.0	2.4	0.0	6.7	0.4	0.0	0.3	1.7	0.4	0.5	6.1	0.0	10.9	12.0	1.8	0.4	14.2	0.0	0.8	0.7	0.0	0.0	0.0	11.8	0.0	0.4	0.0	66.9	0.0	1.4	3.8	2.0	0.0	1.1	2.5	0.6	11.3	25.6	183.3	0.7	1.0	0.0	0.1	22.0
KLC4	"bA387M24.3, KNSL8"	ENSG00000137171	"Kinesin light chain 4"	Q9NSK0	6	43040777-43075095	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 81.9;Hepatocytes: 67.8;Paneth cells: 70.4;Proximal enterocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030168, HPA030169"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA030168: AB_10599285, HPA030169: AB_10601105"	"unprognostic (2.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.36e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (6.99e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	12.3	17.2	18.8	11.2	19.6	12.4	13.4	21.8	22.8	16.6	18.6	41.1	72.5	15.1	23.0	10.9	17.7	17.9	25.1	18.7	19.0	24.2	89.9	16.5	13.5	21.2	19.2	19.7	17.8	28.7	24.1	12.2	21.2	17.0	34.2	23.8	19.9	15.8	22.9	17.5	63.7	14.0	17.5	12.5	31.8	24.8	19.6	17.1	19.7	22.8	11.1	17.3	12.9	20.9	7.5	6.0	15.9	18.9	15.0	14.7	13.7	5.5	8.5	9.5	15.6	9.8	11.5	9.9	19.7	13.4	12.6	12.3	15.8	14.9	7.2	10.0	19.1	11.4	18.2	44.0	14.5	5.4	9.1	19.3	18.2	11.8	10.8	29.8	12.1	20.5	7.9	12.8	8.0	13.0	16.2	12.2	6.1	65.4	7.9	12.6	9.0	19.3	14.3	6.5	26.7	12.8	10.3	9.6	20.3	14.9	16.4	15.0	10.2	10.6	12.8	5.4	5.9	25.8	9.9	24.1	5.8	8.5	3.9	2.6	2.6	3.2	2.6	2.6	3.4	3.7	3.7	2.5	3.0	3.2	4.5	3.3	6.5	4.9	2.6	8.7	4.5	2.3	18.8	19.6	21.8	22.8	18.7	19.0	21.2	19.2	21.2	17.5	19.6	20.9	4.1	16.0	14.4	23.5	4.3	3.7	9.2	12.5	15.9	21.8	8.0	8.8	10.6	20.0	10.8	14.7	29.2	11.8	11.4	81.9	19.6	8.7	13.4	8.9	3.8	5.8	22.3	9.3	17.2	9.8	4.9	5.9	33.6	7.9	7.0	12.2	7.5	67.8	6.5	11.8	24.2	35.3	10.2	5.7	2.9	6.5	10.2	3.6	3.6	6.5	5.3	16.3	4.1	10.6	9.7	7.6	70.4	6.8	7.4	5.0	143.4	23.5	19.0	28.0	13.1	6.0	5.5	27.3	15.6	9.4	4.5	13.5	5.3	6.2	44.0	6.6
KLF11	"MODY7, TIEG2, Tieg3"	ENSG00000172059	"Kruppel like factor 11"	O14901	2	10042849-10054836	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.0;Suprabasal keratinocytes: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058276			Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Focal adhesion sites, Cytosol"	"HPA058276: AB_2683664"	"unprognostic (9.66e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.63e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.24e-2)"	27.7	15.6	4.0	7.6	3.2	27.8	22.3	8.3	3.9	13.5	4.1	17.9	7.5	20.0	9.7	13.2	13.7	18.1	19.1	2.9	3.9	15.7	35.2	22.4	9.3	3.7	3.3	23.9	54.2	18.3	2.5	19.5	3.4	10.1	9.3	3.0	15.9	14.8	12.1	26.9	8.7	16.8	3.2	18.8	12.4	30.0	3.5	4.0	16.5	27.3	5.5	12.6	13.1	5.1	6.9	3.3	7.8	0.7	5.3	9.4	18.8	7.9	7.9	4.4	4.6	7.8	15.8	0.0	13.9	9.6	17.9	1.6	6.8	6.1	2.9	47.6	5.2	3.5	9.7	1.6	5.2	14.6	22.1	14.7	22.3	8.4	2.3	11.4	3.9	1.3	9.7	30.8	4.6	8.2	0.0	2.7	12.5	5.6	6.7	7.8	0.2	13.6	10.8	8.5	10.0	6.2	12.0	24.5	23.4	12.2	5.7	19.6	11.2	19.3	15.9	14.7	2.6	27.9	36.0	18.7	5.0	3.8	10.4	0.0	8.2	2.0	2.6	12.3	0.8	3.2	1.8	1.9	7.3	2.9	0.5	1.1	0.2	6.6	14.8	0.3	3.0	5.4	4.0	3.2	8.3	3.9	2.9	3.9	3.7	3.3	3.4	3.2	3.5	5.1	58.8	6.4	4.6	0.3	12.5	60.5	17.7	5.5	25.6	6.2	14.3	13.2	3.5	10.0	6.1	7.3	6.2	3.2	10.1	2.5	29.4	8.2	135.0	9.1	21.5	33.3	7.1	4.6	1.7	8.5	4.2	17.5	9.7	26.6	8.2	15.5	37.5	38.1	12.5	3.3	1.4	7.0	16.2	32.4	42.4	25.9	14.6	22.0	30.2	1.0	16.6	2.2	3.1	0.5	0.3	8.9	1.5	16.6	5.3	15.0	6.1	8.4	4.3	5.8	32.9	10.4	35.7	13.8	39.0	13.1	86.2	8.2	10.8	11.2	7.8	11.7
KLF12	"AP-2rep, AP2REP, HSPC122"	ENSG00000118922	"Kruppel like factor 12"	Q9Y4X4	13	73686089-73995056	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Astrocytes: 319.3;Excitatory neurons: 211.9;Inhibitory neurons: 562.2;Microglial cells: 208.9;Oligodendrocyte precursor cells: 760.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064146, HPA075652"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA064146: AB_2685198, HPA075652: "	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.67e-3)"	2.9	1.9	4.1	6.1	2.9	3.0	2.9	5.5	5.3	2.3	2.7	3.7	1.5	3.6	11.2	2.0	2.8	3.0	5.3	5.6	4.5	5.5	9.9	2.6	11.3	3.3	4.9	5.2	0.9	0.8	3.4	0.8	3.6	2.5	2.9	8.9	1.4	3.2	3.6	1.6	3.6	3.4	3.1	7.6	2.7	1.6	5.1	10.3	1.6	8.5	9.8	2.6	2.0	3.5	0.0	1.4	13.6	0.0	7.5	16.3	0.1	5.4	2.7	5.9	6.2	1.1	3.4	10.5	2.5	8.1	2.3	3.7	3.6	4.2	15.7	6.9	4.9	0.4	6.3	0.0	2.4	7.0	2.5	14.3	1.1	8.4	6.7	11.4	11.9	8.0	0.0	2.6	18.0	1.1	13.6	0.0	1.9	0.5	2.7	7.4	4.9	0.1	3.3	0.2	3.2	13.8	3.8	1.7	6.3	5.0	0.4	1.1	0.1	11.4	3.5	5.2	2.6	7.0	9.6	3.3	20.2	0.0	5.9	0.6	0.0	0.0	2.0	0.2	2.4	0.8	1.7	2.3	0.2	0.7	1.2	1.9	0.0	1.4	0.3	0.4	0.9	0.8	4.1	2.9	5.5	5.3	5.6	4.5	3.3	4.9	3.6	3.1	5.1	3.5	6.6	6.4	1.8	319.3	30.5	4.2	1.3	4.3	0.6	20.8	5.4	6.2	18.7	5.7	3.7	3.7	37.5	0.1	35.4	3.0	3.9	2.1	0.8	4.6	18.8	8.4	0.0	7.8	211.9	0.0	0.1	12.3	2.0	6.3	0.0	29.2	5.0	20.3	0.1	8.4	562.2	1.5	10.2	8.0	12.1	1.6	20.8	5.0	3.6	208.9	6.4	11.2	43.3	760.0	25.4	0.4	3.2	28.6	21.9	3.3	0.2	7.0	6.0	13.1	0.0	12.2	18.1	0.5	3.5	0.7	6.7	0.1	40.3	4.9	3.9	1.8
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Inhibitory neurons: 29.3;Microglial cells: 30.9;Oligodendrocyte precursor cells: 102.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.3;plasmacytoid DC: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.8;HeLa: 57.3;RH-30: 37.2;RPTEC TERT1: 106.0;SH-SY5Y: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.7	7.3	4.6	2.6	11.1	0.4	24.6	2.7	4.8	20.5	5.5	5.4	3.1	31.4	7.3	5.9	10.7	5.6	7.8	3.2	5.9	16.0	4.7	1.4	0.6	5.9	10.3	7.4	4.6	3.4	2.2	0.8	6.4	6.2	3.9	4.2	2.2	12.3	3.6	1.1	4.8	29.3	4.0	1.6	3.2	3.6	5.9	5.0	0.8	5.6	1.2	7.5	5.0	3.8	1.1	0.4	6.9	14.5	0.1	0.0	0.2	0.5	0.0	0.4	0.0	9.1	0.1	0.0	16.5	0.0	0.7	16.9	33.8	5.6	0.0	0.0	12.9	0.4	57.3	0.1	0.8	1.1	2.2	1.8	2.3	0.2	0.7	6.9	25.8	0.0	0.0	0.0	0.0	1.4	5.9	1.6	13.4	0.0	9.6	0.0	37.2	0.1	106.0	4.0	0.0	94.3	0.5	1.2	0.9	2.7	20.9	0.2	0.7	2.4	2.9	2.0	8.6	0.4	0.0	0.2	10.2	0.0	4.1	2.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.6	0.6	0.0	1.1	0.0	4.1	0.2	0.3	4.6	11.1	2.7	4.8	3.2	5.9	5.9	10.3	6.4	4.0	5.9	3.8	0.7	0.0	0.0	13.7	0.0	0.8	6.8	5.4	12.0	6.2	2.4	19.9	10.5	0.0	4.8	1.8	0.0	0.2	0.1	1.2	29.4	1.1	0.3	8.0	22.7	1.9	1.2	1.3	8.0	3.4	0.1	8.7	0.0	1.3	0.0	10.0	8.6	1.3	0.6	0.0	29.3	2.1	0.0	0.0	1.2	0.9	6.2	1.0	1.8	30.9	0.2	7.2	0.0	102.5	12.3	0.7	3.4	1.9	0.1	2.7	2.9	12.7	22.3	1.2	6.6	18.1	5.3	1.8	10.6	4.8	0.4	0.0	0.6	6.4	4.1	3.6
KLHL15	KIAA1677	ENSG00000174010	"Kelch like family member 15"	Q96M94	X	23983720-24027186	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065730	Uncertain		Approved	Aggresome,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Aggresome	"HPA065730: AB_2685547"	"unprognostic (5.89e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-3)"	"unprognostic (7.42e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.40e-2)"	4.8	9.6	2.9	3.7	3.7	53.1	3.3	4.0	3.6	4.1	3.9	3.1	2.9	5.1	8.0	8.7	4.2	4.5	3.3	3.3	3.8	5.0	12.8	3.4	4.0	2.8	3.2	5.9	6.4	7.3	3.3	3.4	2.5	5.8	3.1	5.5	2.5	3.9	3.6	2.1	2.9	5.1	2.8	4.0	4.0	18.3	3.2	6.2	5.1	3.2	3.4	3.5	1.8	2.9	5.0	4.8	5.2	7.7	7.6	5.4	5.4	7.9	6.9	3.6	4.3	4.4	4.4	13.2	2.7	5.2	5.6	3.7	8.4	4.3	8.7	5.2	17.2	8.4	13.4	2.3	4.8	11.0	5.6	5.7	2.2	6.2	6.0	3.2	2.6	7.7	5.4	18.0	6.7	1.7	9.9	10.7	9.9	2.5	5.8	7.8	9.5	8.2	3.3	4.4	13.7	6.5	11.0	2.6	9.2	6.5	3.6	9.7	3.3	5.4	3.3	10.9	5.2	9.9	10.6	14.8	4.3	7.0	4.4	0.2	0.2	0.5	0.3	0.4	0.4	0.1	0.3	0.3	0.3	0.2	0.4	0.4	0.2	0.2	0.4	0.3	0.3	0.2	2.9	3.7	4.0	3.6	3.3	3.8	2.8	3.2	2.5	2.8	3.2	2.9	20.1	6.4	7.9	4.2	10.4	18.0	4.5	4.0	18.8	8.1	18.7	16.9	11.5	5.7	5.4	3.7	12.5	0.5	12.2	3.9	0.0	1.4	3.1	15.5	20.7	10.5	8.4	6.9	7.0	1.4	1.3	12.7	6.6	31.4	8.2	6.3	8.9	11.9	3.6	20.2	9.1	5.0	2.0	9.1	14.1	2.8	3.4	19.8	12.4	3.7	3.9	7.9	3.1	6.0	5.4	1.6	0.7	4.1	8.8	5.6	3.8	2.4	2.8	7.6	0.0	22.6	16.4	2.8	17.7	15.3	9.9	1.4	11.7	13.3	4.8	3.3
KLHL25	"ENC-2, ENC2, FLJ12587"	ENSG00000183655	"Kelch like family member 25"	Q9H0H3	15	85759326-85794925	"Predicted intracellular proteins"	"Translation regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	4	"monocytes: 3.8;NK-cells: 2.5;T-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 29.1;hippocampal formation: 16.3"	HPA023450	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA023450: AB_1852583"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.66e-2)"	6.5	2.4	5.6	2.6	7.6	0.5	5.4	5.8	7.5	4.3	4.3	3.8	4.7	6.6	3.1	5.7	4.0	2.2	3.9	6.0	7.6	3.7	15.1	4.3	1.9	5.4	8.2	3.3	1.6	2.2	3.6	1.1	6.9	4.6	1.1	0.8	3.6	3.1	6.5	9.3	3.4	2.8	4.7	1.6	5.0	10.5	7.6	2.0	2.4	3.0	1.3	3.7	5.0	6.7	2.7	8.1	11.6	5.7	2.3	1.2	6.0	3.4	1.6	4.6	3.5	10.9	4.4	1.7	1.7	2.8	2.9	6.6	12.5	6.4	1.0	1.7	5.8	0.5	3.5	8.4	2.7	0.5	2.0	2.4	2.1	4.5	1.5	2.0	2.5	5.8	0.7	1.5	2.0	5.0	4.3	2.6	10.5	4.6	4.2	8.7	6.9	2.8	1.7	5.6	16.1	11.1	4.9	5.6	2.2	4.7	10.2	0.6	2.1	4.9	8.9	3.2	6.2	1.6	3.7	1.7	2.2	3.0	2.8	0.0	0.1	0.2	1.0	1.2	0.5	0.0	1.0	0.7	0.2	0.2	1.7	1.1	0.0	2.5	3.8	0.6	0.9	0.5	5.6	7.6	5.8	7.5	6.0	7.6	5.4	8.2	6.9	4.7	7.6	6.7	0.8	0.0	1.9	3.6	1.2	2.7	4.0	2.1	0.0	3.3	4.0	2.8	4.3	1.5	1.5	0.0	0.0	1.0	3.6	6.3	1.9	2.3	13.0	3.0	3.6	1.8	10.7	0.0	7.7	2.7	1.5	2.4	8.6	3.2	0.0	2.0	2.2	12.4	0.8	13.5	4.1	7.6	4.1	1.3	2.7	4.6	0.9	1.4	7.2	1.0	0.6	2.7	2.1	6.0	0.9	5.3	3.1	1.5	1.3	2.7	2.7	2.1	2.1	1.1	6.6	2.9	2.9	3.3	4.1	4.4	4.7	1.8	4.0	1.4	5.2	4.3
KLHL28	"BTBD5, FLJ20081"	ENSG00000179454	"Kelch like family member 28"	Q9NXS3	14	44924324-45042322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 27.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000988			Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA000988: AB_1845480"	"unprognostic (8.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.84e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.36e-3)"	"unprognostic (4.92e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.53e-2)"	4.6	4.8	2.6	6.5	3.4	27.0	5.7	9.0	3.6	5.2	3.3	5.0	5.1	5.3	5.0	6.5	5.4	5.5	4.1	2.9	3.9	4.6	6.4	5.6	8.7	3.2	2.9	7.8	3.8	4.2	3.0	5.6	3.5	5.5	6.0	8.1	4.3	3.9	4.7	5.1	5.0	5.8	3.3	5.8	5.0	7.3	3.3	9.2	7.6	8.0	7.4	5.6	3.5	6.4	4.5	6.7	8.6	5.6	7.7	6.8	6.5	5.8	6.4	8.4	7.1	3.0	6.8	6.6	6.2	10.1	2.2	7.6	7.7	6.1	9.2	12.3	4.2	5.7	6.9	3.4	6.9	9.2	12.0	5.3	8.6	5.4	8.6	4.8	6.8	10.2	5.1	16.0	4.9	6.5	7.4	4.7	5.3	5.0	6.3	6.3	9.6	3.7	4.8	8.0	9.8	6.0	7.5	5.0	8.1	5.5	9.4	3.9	8.7	7.5	8.6	5.3	3.3	9.4	11.0	9.2	2.6	4.1	4.6	31.5	7.3	18.3	17.0	10.2	31.5	14.9	17.0	18.0	6.4	13.0	20.0	17.2	16.8	20.3	11.2	8.7	14.2	6.9	2.6	3.4	9.0	3.6	2.9	3.9	3.2	2.9	3.5	3.3	3.3	6.4	15.7	16.0	9.4	17.0	30.1	24.5	16.4	20.1	27.9	24.8	12.9	10.4	12.1	11.5	17.6	18.4	35.5	7.7	27.5	14.9	7.9	10.0	40.2	20.0	13.6	15.4	13.9	27.8	32.6	5.6	8.3	18.0	17.3	9.7	19.0	10.2	16.8	13.1	9.2	15.2	30.0	12.1	6.1	15.8	23.6	62.8	21.8	19.1	23.2	16.9	15.7	23.2	23.7	36.7	40.4	10.3	12.7	17.7	27.0	12.6	13.1	8.5	32.3	23.4	13.1	14.6	19.8	10.8	5.1	19.4	30.1	14.1	38.6	7.7	9.5	15.8
KLHL29	"KBTBD9, KIAA1921"	ENSG00000119771	"Kelch like family member 29"	Q96CT2	2	23385179-23708611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Excitatory neurons: 146.4;Inhibitory neurons: 132.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.9;RH-30: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049057, HPA057379"	Approved		Approved	Mitochondria,Cytosol		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Cytosol	"HPA049057: AB_2680615, HPA057379: AB_2683422"	"unprognostic (8.08e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.12e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.25e-4)"	6.6	9.2	3.9	2.2	4.0	0.1	5.8	0.7	8.9	5.3	3.4	8.8	0.9	6.1	1.2	2.9	4.4	3.1	2.5	5.2	3.3	4.2	2.6	3.9	2.6	2.0	2.6	2.5	1.9	2.3	10.2	3.3	2.5	7.7	1.2	7.0	3.0	4.8	10.7	5.7	3.8	3.0	3.0	5.0	3.9	0.9	3.4	1.6	1.6	2.9	1.6	4.4	5.1	4.5	1.4	1.1	7.5	3.8	7.0	4.6	12.9	7.8	6.0	3.1	2.2	0.0	0.4	5.1	2.6	3.0	16.9	0.2	1.7	6.7	2.1	0.0	8.0	0.0	6.7	0.0	2.4	0.0	9.9	3.4	8.9	4.1	11.6	1.0	5.3	0.2	0.0	0.0	1.7	0.7	1.8	0.0	3.7	0.0	2.3	0.5	19.3	0.1	5.8	2.3	11.3	2.3	1.0	0.8	4.5	3.0	0.0	0.1	5.4	3.1	14.4	6.7	2.7	0.2	0.0	0.0	11.8	0.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	4.0	0.7	8.9	5.2	3.3	2.0	2.6	2.5	3.0	3.4	4.5	1.2	6.4	5.3	6.8	0.3	4.7	10.4	2.9	7.4	8.4	0.4	6.0	2.3	4.3	1.3	1.8	27.1	1.2	0.1	0.1	0.0	1.2	1.8	3.5	5.4	2.3	4.2	0.0	146.4	0.2	0.9	3.9	0.0	3.9	0.0	0.2	0.7	0.5	0.3	1.7	132.7	0.7	0.0	0.0	0.0	0.7	5.0	0.4	1.8	7.5	0.0	1.7	0.0	5.5	4.7	0.4	0.4	4.1	0.0	1.9	0.0	1.3	1.7	26.1	6.6	6.5	6.5	0.1	1.1	2.0	5.8	0.8	0.4	0.4	0.8	1.5
KLHL36	"C16orf44, FLJ12543"	ENSG00000135686	"Kelch like family member 36"	Q8N4N3	16	84648511-84667686	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023423	Approved		Approved	Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA023423: AB_10962985"	"unprognostic (6.50e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.59e-2)"	"prognostic favorable (9.81e-5)"	"unprognostic (3.79e-3)"	"prognostic favorable (5.52e-10)"	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.67e-3)"	9.3	6.4	7.2	6.1	5.8	13.4	7.7	4.2	7.0	5.7	10.0	7.0	6.8	6.6	2.1	8.9	6.8	3.9	9.8	9.0	4.9	6.9	11.3	8.6	7.7	6.4	4.4	8.7	11.4	8.9	6.1	4.6	3.6	6.6	3.2	1.9	7.6	5.3	5.1	8.1	9.0	4.0	3.9	9.3	8.4	13.8	5.9	4.3	8.8	4.5	4.9	8.2	7.1	4.0	18.9	19.9	5.0	11.9	5.4	8.8	18.9	13.9	9.7	5.8	2.8	17.3	12.7	13.2	18.2	11.3	5.9	20.6	5.5	13.4	4.0	8.1	8.0	4.4	6.7	10.9	7.2	5.4	12.2	8.4	11.2	6.7	8.3	8.6	8.7	4.3	14.3	2.1	6.0	28.7	0.8	8.3	7.6	8.1	8.2	18.1	5.8	6.3	11.1	17.2	5.9	4.4	16.6	4.7	8.8	6.0	17.7	16.6	16.9	7.6	12.9	8.2	8.7	7.1	10.2	22.7	10.3	7.3	22.2	3.5	2.7	6.3	3.2	1.7	2.8	4.5	5.9	4.7	3.7	3.7	6.9	5.0	3.2	2.3	2.0	3.4	3.4	2.8	7.2	5.8	4.2	7.0	9.0	4.9	6.4	4.4	3.6	3.9	5.9	4.0	18.5	19.2	16.2	8.5	24.6	15.9	45.3	23.9	15.9	25.8	23.3	15.7	26.5	32.9	16.8	22.0	35.5	23.7	19.3	28.3	5.9	24.5	41.4	13.8	12.3	19.6	18.6	6.5	11.8	14.5	11.7	20.9	16.3	21.4	7.0	22.7	19.2	21.9	19.3	26.9	10.6	23.3	26.4	21.2	17.6	14.7	23.3	18.0	21.4	15.9	22.4	10.5	18.6	7.5	8.5	22.8	20.0	25.2	10.8	56.0	37.0	28.1	16.3	23.0	32.9	21.7	24.9	21.7	6.1	19.3	17.6	19.3	26.8	12.8	21.3	39.8
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 56.7;skeletal muscle: 268.3;tongue: 76.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;SK-BR-3: 2.8;U-2197: 4.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.2	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.2	0.1	0.9	0.1	1.3	0.0	2.5	0.7	0.7	56.7	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.1	1.3	0.0	1.5	0.0	0.8	0.1	0.0	0.7	0.1	268.3	0.2	0.2	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	76.9	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.9	0.0	0.5	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL9	"FLJ13568, KIAA1354"	ENSG00000198642	"Kelch like family member 9"	Q9P2J3	9	21329665-21335404	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (7.82e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (9.43e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.33e-3)"	11.2	10.2	7.8	10.9	8.4	8.9	16.8	10.2	9.2	14.9	8.4	12.0	7.1	15.5	14.6	10.4	13.3	10.2	7.9	7.3	9.1	14.3	10.9	11.2	12.1	8.0	7.9	19.6	10.8	12.8	5.2	16.8	8.1	15.7	12.1	17.7	12.2	11.3	4.6	8.4	10.4	14.2	8.7	15.2	13.4	7.2	8.0	14.4	16.0	8.4	11.5	10.9	7.1	12.3	12.3	14.7	32.6	17.7	41.3	40.7	7.1	22.5	22.9	16.7	18.8	5.6	9.5	5.5	14.2	33.1	16.8	6.6	19.2	22.0	20.6	30.7	14.0	0.0	27.4	14.5	28.7	9.8	6.5	40.2	23.3	13.1	21.1	27.3	25.8	0.0	0.0	7.0	38.6	7.8	20.4	33.9	13.4	12.7	12.4	0.0	14.3	6.6	20.8	15.1	10.3	19.6	13.0	11.6	14.3	30.0	21.0	0.0	31.2	0.1	11.7	9.4	13.2	7.6	11.2	5.7	0.0	10.1	11.5	8.4	6.0	16.5	4.8	6.8	5.5	3.1	5.9	4.4	4.7	2.3	7.1	4.9	1.9	6.2	7.2	3.5	4.5	4.6	7.8	8.4	10.2	9.2	7.3	9.1	8.0	7.9	8.1	8.7	8.0	12.3	20.3	25.6	20.5	9.1	12.2	10.3	34.3	15.4	22.8	27.3	14.8	12.4	17.9	17.2	25.9	16.5	18.8	16.4	12.7	19.5	11.7	14.8	0.8	12.1	26.2	20.2	27.6	10.5	14.2	15.3	7.8	22.6	25.5	12.7	12.0	24.6	37.9	23.1	15.4	18.5	17.0	22.0	22.4	22.8	8.4	1.9	21.5	14.7	17.8	20.6	14.7	20.1	9.2	15.1	23.8	12.2	13.9	24.0	16.3	25.2	13.7	19.3	20.8	21.4	13.1	20.1	22.0	13.4	9.7	19.5	10.4	10.0	17.2	18.7	16.9	21.0
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35717973-35738878	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.5;Rod photoreceptor cells: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006487			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	11.6	10.1	15.4	9.8	15.7	14.3	11.8	17.2	22.9	12.9	12.2	13.6	9.8	14.1	4.4	12.8	13.1	6.8	8.4	14.7	14.8	10.3	10.0	12.1	14.5	15.4	14.4	16.1	16.0	5.1	14.5	5.8	14.7	13.4	3.9	5.8	13.3	5.8	16.1	18.8	14.5	4.5	12.4	15.6	12.7	22.5	15.9	9.3	16.6	5.0	6.8	12.6	12.0	16.0	16.7	36.7	11.1	17.3	6.0	4.3	11.0	6.7	4.7	7.3	5.0	25.3	7.4	15.5	11.8	5.1	8.5	10.8	11.3	5.2	4.2	21.2	13.6	29.7	20.2	24.4	8.6	17.4	26.1	6.9	9.4	8.9	10.7	6.9	5.7	13.5	22.5	15.8	6.4	34.1	15.9	24.4	12.0	18.8	9.2	19.8	8.9	7.6	7.8	21.3	14.0	10.0	13.5	20.6	11.3	7.9	11.8	21.3	12.5	16.3	17.0	10.5	17.4	22.2	15.7	12.4	8.5	18.8	12.2	0.3	0.4	0.4	1.0	0.1	0.5	0.4	0.6	0.7	0.3	0.7	0.6	0.9	1.8	0.5	0.2	2.1	0.8	0.4	15.4	15.7	17.2	22.9	14.7	14.8	15.4	14.4	14.7	12.4	15.9	16.0	24.6	9.6	15.4	13.7	18.6	12.7	10.0	6.2	9.6	64.5	16.1	14.6	9.2	8.6	6.3	9.2	52.1	6.5	27.4	25.2	0.0	6.4	2.8	17.9	31.6	15.6	20.3	7.4	11.7	7.7	6.1	12.4	27.5	26.0	5.1	30.5	11.0	11.2	8.4	35.3	11.8	14.1	6.1	11.8	7.1	4.7	8.1	13.4	5.4	7.5	9.5	25.7	19.6	7.5	10.0	8.4	16.7	12.4	17.9	19.6	13.9	5.0	6.7	71.2	0.0	25.0	17.3	26.5	38.5	11.9	12.9	9.4	20.6	30.7	16.3	14.8
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018978-49060794	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	19.9	21.9	14.0	17.0	14.4	62.1	20.3	14.7	18.1	20.2	3.8	21.3	13.2	26.9	14.4	25.5	24.1	11.7	23.7	12.1	9.1	18.2	20.5	25.1	17.5	9.3	8.2	25.3	33.2	22.9	25.4	16.2	8.6	19.2	14.7	48.0	22.1	16.2	44.9	30.4	27.9	15.5	3.1	36.6	25.5	23.6	12.7	29.0	26.5	21.9	17.2	19.4	19.4	13.4	32.3	31.9	31.0	24.7	29.3	20.4	32.6	17.3	17.1	20.3	10.9	54.8	14.1	33.4	21.2	23.9	14.0	21.5	38.1	19.9	17.7	22.4	26.7	47.2	37.7	29.9	20.5	59.1	43.2	18.4	25.8	30.7	32.0	27.3	31.8	33.2	55.1	19.2	23.7	37.4	26.8	48.0	29.9	45.4	25.0	37.4	22.4	12.0	18.1	37.2	24.6	21.2	28.1	25.5	19.5	26.1	24.0	44.1	49.8	15.5	30.7	14.5	30.5	24.8	20.9	31.7	17.1	28.0	12.5	0.5	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.5	0.5	0.0	0.2	0.0	0.1	14.0	14.4	14.7	18.1	12.1	9.1	9.3	8.2	8.6	3.1	12.7	13.4	12.9	9.6	19.1	17.6	13.3	14.0	7.8	8.1	14.2	26.8	12.1	7.1	7.8	12.8	10.9	18.4	52.1	8.2	15.3	12.3	1.9	6.3	2.8	10.7	12.7	13.2	13.1	16.0	17.4	6.0	6.0	8.8	24.5	13.1	8.2	23.3	17.9	13.0	9.8	21.9	16.5	10.0	6.1	15.7	18.4	2.4	9.6	15.4	10.6	15.0	14.9	6.4	17.5	12.5	19.8	8.8	9.5	10.9	10.1	11.0	13.3	4.5	9.0	38.4	6.6	14.4	12.5	6.5	3.8	18.9	17.6	11.4	15.3	10.8	10.3	9.6
KNDC1	"bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND"	ENSG00000171798	"Kinase non-catalytic C-lobe domain containing 1"	Q76NI1	10	133160219-133226412	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;pituitary gland: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Excitatory neurons: 41.9;Inhibitory neurons: 36.3;Respiratory ciliated cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;EFO-21: 1.2;MCF7: 1.1;NTERA-2: 1.4;RPMI-8226: 2.1;SuSa: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039624, HPA056143"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"	Vesicles	"HPA039624: AB_10671045, HPA056143: "	"unprognostic (2.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (1.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.41e-2)"	1.5	13.7	31.1	0.1	17.9	0.0	0.2	8.4	44.0	2.3	0.0	0.3	0.0	2.8	0.7	0.2	9.0	0.2	0.3	19.8	9.1	0.8	6.5	2.8	0.0	17.3	13.3	8.5	0.5	0.4	27.5	0.4	10.3	1.1	0.0	0.9	0.6	0.9	0.0	0.2	0.2	0.4	3.0	0.5	0.3	1.8	22.7	0.0	2.5	0.0	0.0	0.2	0.9	13.1	0.2	0.3	0.2	1.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.2	0.0	1.2	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	31.1	17.9	8.4	44.0	19.8	9.1	17.3	13.3	10.3	3.0	22.7	13.1	0.0	0.0	9.0	93.4	0.2	0.0	0.1	0.4	0.0	1.6	0.2	0.0	2.4	1.5	4.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	1.5	0.2	3.0	0.0	41.9	0.0	0.1	1.4	0.0	0.3	0.0	1.5	0.4	4.6	0.2	1.7	36.3	0.0	0.0	1.0	0.4	1.0	3.7	1.2	0.0	5.6	0.3	4.5	0.0	6.6	2.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	25.9	1.0	0.0	0.1	0.5	0.0	1.7	0.0	0.3	0.1	0.4	1.2	0.0	0.0
KNOP1	"101F10.1, C16orf88, FAM191A, TSG118"	ENSG00000103550	"Lysine rich nucleolar protein 1"	Q1ED39	16	19701937-19718235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 166.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041079, HPA066169"	Uncertain		Enhanced	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA041079: AB_10962350, HPA066169: AB_2685628"	"unprognostic (6.55e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.75e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	7.5	6.8	14.3	6.9	16.9	4.0	11.5	14.6	22.5	9.1	9.7	8.3	7.1	7.0	8.8	10.4	7.4	6.3	7.3	15.5	15.1	9.9	7.9	5.7	9.0	15.9	15.8	11.4	8.6	13.5	6.4	8.8	17.3	7.3	9.1	8.8	12.5	6.8	14.4	13.0	7.3	4.8	13.2	6.4	8.1	8.9	15.6	5.9	6.2	5.4	6.7	7.2	8.8	22.9	30.2	45.4	49.7	37.9	12.1	11.3	25.5	18.3	9.9	17.1	17.2	32.2	25.5	35.7	72.6	11.1	15.0	27.4	38.9	25.1	16.6	24.2	27.2	21.1	25.3	42.7	21.9	33.5	15.9	7.2	35.1	22.4	18.4	15.0	18.3	25.0	66.1	15.6	16.2	39.3	29.7	27.6	96.8	29.7	17.9	63.0	26.7	41.4	18.0	28.4	44.4	37.4	22.7	29.0	31.2	28.1	33.8	22.4	21.3	26.7	27.4	16.5	24.5	23.0	51.3	44.7	14.4	25.2	26.6	0.4	3.0	1.5	4.0	7.1	5.9	5.8	5.6	3.9	3.6	7.1	10.1	5.7	0.8	4.4	6.7	4.6	3.8	3.5	14.3	16.9	14.6	22.5	15.5	15.1	15.9	15.8	17.3	13.2	15.6	22.9	40.3	6.4	17.8	108.7	19.8	12.2	29.9	47.9	17.6	39.2	37.9	31.9	8.9	38.6	29.5	38.6	87.6	57.1	13.6	43.0	46.9	98.2	2.8	33.8	79.8	47.2	15.0	21.7	9.7	66.3	45.4	26.0	26.5	42.1	6.3	66.9	26.0	53.4	36.5	35.3	12.7	41.7	61.1	24.9	12.6	8.5	60.6	17.9	12.4	16.9	27.2	25.8	33.0	15.1	166.6	77.8	19.0	53.8	14.8	46.4	32.3	34.5	21.3	64.1	46.0	18.7	38.9	67.8	125.3	31.5	16.1	24.6	16.8	53.6	64.4	23.3
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699320-49792682	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.4;tongue: 94.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046852, HPA077643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046852: AB_2679840, HPA077643: "	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	20.8	10.6	13.6	16.9	15.3	29.7	11.7	14.3	19.6	13.7	9.3	17.0	12.3	13.8	11.3	25.4	12.4	14.6	31.9	16.0	15.0	13.8	23.4	17.2	18.4	14.4	13.5	8.3	10.4	12.6	7.1	14.9	14.3	15.8	16.6	33.4	10.4	19.1	145.4	16.2	12.2	25.6	16.1	13.6	13.4	28.5	15.9	19.9	19.2	94.2	20.2	20.1	11.0	17.8	41.3	28.3	53.0	44.6	53.2	58.1	26.6	73.3	60.8	63.5	46.0	86.2	37.6	89.2	14.4	86.6	42.7	47.1	64.1	59.5	105.2	53.8	44.7	65.3	25.4	101.1	51.8	98.7	40.6	42.9	42.3	53.3	69.8	41.7	79.7	36.9	36.7	23.4	88.8	19.1	53.2	53.7	61.4	57.8	19.7	68.6	52.1	27.3	39.1	33.8	22.2	34.8	27.1	33.3	29.5	43.8	19.8	39.3	73.0	46.7	37.5	43.0	49.8	18.8	27.9	76.7	28.4	44.9	47.2	10.3	3.8	3.6	6.7	4.5	9.3	4.9	6.7	6.6	4.2	2.8	6.4	5.9	2.2	6.7	6.0	2.3	8.5	3.4	13.6	15.3	14.3	19.6	16.0	15.0	14.4	13.5	14.3	16.1	15.9	17.8	44.3	67.3	33.8	64.9	35.2	43.1	30.5	21.4	43.9	29.9	23.4	15.0	76.5	21.5	25.7	12.9	33.3	15.5	31.8	26.0	17.6	49.0	316.7	57.4	35.7	44.2	30.5	39.1	90.6	53.7	17.7	30.0	27.0	40.7	33.0	25.4	30.4	36.2	33.1	52.2	83.9	18.4	20.3	37.3	38.7	168.8	22.1	41.9	19.6	55.3	47.1	49.0	35.0	73.4	85.6	51.7	15.0	50.0	36.9	41.7	14.3	28.1	45.8	65.7	26.3	29.1	32.1	66.1	31.8	52.9	49.9	10.5	38.6	61.9	24.9	33.1
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108056-32176563	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	14.2	15.4	12.8	11.0	13.9	20.5	13.1	12.4	15.1	15.4	12.7	17.7	8.8	17.1	12.8	18.8	14.2	8.8	22.0	13.8	17.2	13.8	15.8	15.1	11.1	15.7	16.3	13.4	13.4	24.6	14.3	16.6	18.2	13.9	13.0	17.1	13.4	14.3	39.3	18.5	12.5	17.8	12.0	12.0	14.8	20.2	14.6	12.8	13.5	23.7	14.8	15.6	15.6	14.5	32.0	24.8	21.6	28.0	32.5	28.4	25.3	25.2	29.5	36.0	34.5	27.8	33.9	26.5	29.1	45.6	21.6	26.7	33.5	38.5	45.6	27.0	18.4	27.4	36.4	22.6	28.7	30.4	21.5	28.9	35.8	44.6	42.3	30.3	38.1	20.5	27.0	23.7	34.4	17.5	24.6	17.3	50.5	20.6	18.3	24.5	31.0	21.7	31.4	28.9	20.7	17.4	45.8	27.1	25.0	52.6	19.2	15.9	44.5	33.1	22.7	43.8	36.6	16.9	20.7	20.3	36.3	27.8	32.4	3.2	7.4	7.2	7.7	9.1	7.5	5.3	6.5	6.0	6.0	6.1	7.4	7.2	4.2	3.8	9.9	6.7	7.3	5.3	12.8	13.9	12.4	15.1	13.8	17.2	15.7	16.3	18.2	12.0	14.6	14.5	27.9	41.7	41.5	33.0	36.1	63.6	36.9	37.6	22.2	48.6	44.7	26.7	32.7	37.1	32.4	29.5	58.4	45.4	42.4	29.5	17.6	36.2	294.2	41.0	44.6	40.4	46.1	52.8	62.5	31.6	41.6	35.7	25.5	49.3	13.9	31.3	36.0	77.3	30.4	52.2	58.4	36.0	24.4	36.8	44.8	65.2	34.2	29.3	24.9	30.0	41.4	29.0	47.4	40.7	54.3	46.1	26.4	40.6	24.1	56.7	25.3	33.2	48.2	44.7	32.9	53.1	36.7	78.7	56.2	31.2	85.1	135.7	31.7	31.8	35.6	59.0
KRBA1	KIAA1862	ENSG00000133619	"KRAB-A domain containing 1"	A5PL33	7	149714781-149734575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 40.2"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021237, HPA050448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA021237: AB_2134145, HPA050448: AB_2681129"	"unprognostic (2.19e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (7.48e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.01e-5)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (2.55e-1)"	"unprognostic (6.33e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.31e-2)"	4.1	6.0	6.0	5.0	6.7	3.9	5.4	4.3	10.1	9.2	1.8	9.0	1.5	9.6	2.3	5.7	7.0	4.3	40.2	6.5	4.2	7.6	2.6	4.7	4.6	7.6	4.7	8.9	7.6	6.0	25.2	2.3	4.8	8.9	1.3	4.9	12.9	5.6	6.3	6.9	5.3	6.4	2.6	6.8	7.4	6.8	5.6	3.9	6.1	4.1	3.7	8.1	7.5	7.1	8.0	4.9	9.5	20.0	4.2	4.1	8.3	4.2	5.1	6.6	7.5	0.5	2.1	2.4	8.6	5.3	13.3	7.8	7.2	14.0	3.3	11.1	13.7	4.4	7.5	4.7	5.2	0.0	12.0	9.2	6.5	4.6	2.5	7.8	6.1	13.0	18.4	2.5	3.4	3.2	11.7	6.8	11.4	3.7	4.7	12.2	3.8	1.3	5.1	6.3	7.5	12.7	6.4	18.3	4.5	4.3	3.2	6.8	6.2	8.0	3.4	0.0	5.8	11.7	4.1	10.7	4.7	7.6	8.5	0.0	0.7	0.1	1.4	0.7	0.9	0.6	0.7	0.8	1.0	1.3	1.2	1.0	0.5	0.1	1.6	1.4	1.6	0.7	6.0	6.7	4.3	10.1	6.5	4.2	7.6	4.7	4.8	2.6	5.6	7.1	2.0	0.0	3.2	9.4	1.9	1.8	2.6	2.7	4.6	7.9	4.4	3.9	10.3	5.7	1.6	3.7	4.2	1.2	4.8	0.0	0.0	4.9	0.6	0.8	2.0	1.6	0.0	0.4	6.9	2.7	2.3	3.0	2.6	0.9	0.0	6.3	1.4	1.2	5.2	8.4	6.5	0.1	0.0	2.8	0.9	1.2	4.1	1.8	0.0	1.9	1.6	11.7	2.1	5.5	3.3	1.3	0.0	3.4	1.1	3.0	0.0	1.8	1.6	4.2	6.6	2.8	2.2	1.8	3.5	1.2	1.8	1.2	2.8	3.0	0.1	1.9
KRCC1	FLJ22333	ENSG00000172086	"Lysine rich coiled-coil 1"	Q9NPI7	2	88027205-88064252	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045618, HPA052666"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoli	"HPA045618: AB_10960406, HPA052666: AB_2681907"	"unprognostic (7.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-3)"	28.2	21.0	20.1	28.7	22.8	10.1	38.4	21.7	28.0	33.0	20.7	45.9	32.0	23.9	41.7	32.2	27.1	22.2	31.7	19.9	21.6	31.9	43.6	21.9	38.0	23.2	22.0	24.6	28.6	34.1	15.7	21.9	23.7	25.2	43.8	14.5	24.8	26.0	29.1	25.8	35.7	22.9	21.8	30.7	27.2	15.2	21.7	31.5	33.2	34.6	32.4	24.4	24.9	24.9	29.4	17.8	27.4	20.1	64.1	75.3	20.2	45.5	50.3	23.7	23.1	1.6	38.5	41.4	16.0	28.9	36.1	14.8	6.3	9.4	26.7	43.7	8.7	8.0	4.4	2.8	46.7	12.2	5.5	38.0	46.3	15.9	33.7	61.9	27.1	32.9	11.5	20.2	51.7	25.0	14.1	16.9	20.9	42.3	11.8	28.3	5.0	4.5	36.0	15.8	21.1	21.3	17.3	23.7	54.8	20.1	16.7	49.2	38.2	28.0	2.1	46.5	14.5	45.3	33.6	32.5	30.1	32.0	67.5	59.4	21.6	77.7	18.8	23.8	21.7	36.6	23.0	23.2	25.7	32.5	25.8	21.0	35.8	31.6	21.5	22.5	34.3	16.8	20.1	22.8	21.7	28.0	19.9	21.6	23.2	22.0	23.7	21.8	21.7	24.9	24.2	35.3	41.7	29.4	61.8	33.0	32.6	49.9	53.5	11.9	50.9	50.9	41.3	40.0	49.0	35.0	2.1	46.1	24.8	109.1	60.7	50.5	16.7	34.4	37.8	31.6	41.6	28.2	14.5	70.9	16.3	42.5	17.3	30.9	43.1	28.4	37.9	59.5	48.6	10.1	13.9	56.8	26.4	40.3	39.8	5.3	47.8	38.8	28.4	44.0	53.6	35.9	58.7	34.7	53.5	51.4	79.6	43.2	29.6	62.6	60.4	76.0	62.6	5.4	19.7	40.3	29.7	41.0	20.7	45.4	42.6	41.9	37.2	32.2	72.4	26.4
KREMEN1	"KREMEN, KRM1"	ENSG00000183762	"Kringle containing transmembrane protein 1"	Q96MU8	22	29073035-29168333	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 59.1;Skeletal myocytes: 82.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.3;neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 34.7;U-2197: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058513			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		1100000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA058513: AB_2683739"																		7.3	13.5	10.3	9.5	22.3	4.1	7.6	7.4	10.8	9.1	5.6	13.1	6.6	6.7	8.7	37.2	10.9	4.0	22.7	12.7	7.6	9.0	2.4	11.9	2.9	8.2	9.8	22.2	4.6	48.2	6.5	6.1	8.0	9.1	11.3	4.0	28.3	9.8	28.7	36.3	11.1	6.2	5.6	9.1	9.4	12.5	12.9	22.4	9.5	42.6	16.4	9.2	13.7	8.3	5.2	3.6	11.8	6.2	3.9	11.9	9.9	1.4	12.0	3.8	5.7	16.5	2.4	0.1	4.5	5.6	9.6	24.7	24.6	9.9	4.1	6.2	15.5	1.4	1.7	15.6	4.1	0.1	1.3	11.4	19.7	4.3	2.4	1.6	0.6	10.1	5.4	0.3	4.8	4.4	0.1	1.7	0.5	34.0	2.5	0.8	34.7	0.3	4.1	9.7	23.6	13.1	14.2	5.0	18.3	3.9	18.5	0.9	0.4	15.7	4.8	59.3	1.7	1.2	0.4	0.2	10.0	2.2	18.5	1.3	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	4.6	0.3	0.2	0.6	0.1	0.1	10.3	22.3	7.4	10.8	12.7	7.6	8.2	9.8	8.0	5.6	12.9	8.3	2.0	16.0	18.4	59.1	0.3	15.3	14.0	14.1	7.4	4.4	5.7	6.1	23.9	14.3	18.3	7.3	0.0	15.5	0.3	3.9	1.9	5.4	3.2	6.2	19.7	3.9	0.0	17.2	10.3	4.2	1.8	24.4	8.6	8.0	19.0	5.9	5.3	2.6	2.6	0.0	2.7	19.4	4.1	24.1	6.8	10.8	17.7	2.5	0.0	15.9	2.7	22.2	2.1	10.6	6.3	3.0	9.5	10.5	0.1	10.9	2.2	4.7	18.4	3.4	13.1	82.2	7.9	8.1	6.0	26.3	19.5	5.3	2.3	33.5	10.2	10.5
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652211	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"skin 1: 4660.3"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 265.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 23.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in single"		"HEL: 2.0"	"Group enriched"	"Detected in some"	6	"amygdala: 1.7;hippocampal formation: 2.7"	"Not detected"	"Not detected"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"		NA	NA		9700000000	"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	3.0	0.5	0.0	0.1	0.0	1.0	81.9	0.0	0.0	0.8	0.0	0.9	1.6	0.4	0.3	1.1	0.1	0.0	1.7	0.0	0.0	0.5	1.2	1.0	0.5	0.0	0.0	0.5	1.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	1.6	0.0	47.8	4660.3	0.8	0.0	0.0	0.5	0.7	1.0	0.0	6.8	0.8	0.0	6.1	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	9.5	0.0	0.0	0.1	8.8	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	265.4	0.1	1.0	0.0	0.6	0.1
KRT23	"CK23, DKFZP434G032, HAIK1, K23, MGC26158"	ENSG00000108244	"Keratin 23"	Q9C075	17	40922700-40937646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"salivary gland: 147.7;skin 1: 172.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1328.6;Cytotrophoblasts: 679.8;Prostatic glandular cells: 2203.0;Syncytiotrophoblasts: 3890.8;Urothelial cells: 1590.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 61.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"HBEC3-KT: 9.6;Hep G2: 11.0;SuSa: 7.1;T-47d: 16.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012050, HPA016959, CAB017091"	Approved		Approved	"Intermediate filaments,Cytosol"		NA	NA		590000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 22: Epithelial cell types - Mixed function"	"Intermediate filaments"	Cytosol	"CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228"	"unprognostic (1.62e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.18e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (8.26e-4)"	0.4	0.0	0.0	0.3	0.0	1.1	15.7	0.0	0.0	6.8	0.0	0.1	0.2	1.1	2.1	6.5	3.0	1.5	0.2	0.0	0.0	0.6	1.0	1.4	0.0	0.0	0.0	0.1	3.6	0.1	2.8	15.6	0.0	20.7	0.0	0.6	147.7	0.4	0.3	172.3	0.2	0.0	0.0	3.0	0.2	21.7	0.0	0.4	0.1	0.4	2.5	4.4	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.0	9.6	0.0	0.0	0.0	0.0	0.1	11.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	7.1	16.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.3	0.3	4.6	1328.6	242.1	0.6	0.0	78.0	27.9	0.4	12.8	390.5	3.7	0.0	679.8	1.1	0.1	1.9	462.9	66.2	49.8	7.8	15.1	7.1	0.0	0.5	0.8	109.3	15.0	0.0	66.4	0.0	0.0	0.0	0.0	63.8	0.0	0.3	0.7	57.0	0.0	0.7	10.6	0.6	3.0	5.4	0.0	5.4	15.8	0.0	0.5	0.3	17.7	1.1	0.7	0.0	2203.0	0.0	0.4	275.0	0.2	0.0	0.0	48.4	62.1	0.7	7.9	8.1	3890.8	7.6	0.1	0.9	1590.3
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703752	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 178.0;lymphoid tissue: 76.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.0;Fibroblasts: 4.6;Leydig cells: 3.1;Syncytiotrophoblasts: 4.0"	"Group enriched"	"Detected in some"	4	"cervical cancer: 9.6;head and neck cancer: 15.0;urothelial cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 7.0"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Low region specificity"	"Detected in some"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"		No	NA		300000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.3	0.0	8.0	0.0	0.1	16.7	178.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	5.8	0.2	2.2	1.6	0.0	0.0	0.3	0.5	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	76.3	2.6	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0
KRT74	"K6IRS4, KRT5C, KRT6IRS4"	ENSG00000170484	"Keratin 74"	Q7RTS7	12	52565782-52573843	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 5.6;skin 1: 16.3"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA040655, HPA048596"	Enhanced		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA		130000000		"Cluster 61: Skin - Cornification"		"Cluster 31: Spermatids - Spermatogenesis"	"Intermediate filaments"	"Nucleoli, Cytosol"	"HPA040655: , HPA048596: AB_2680457"		"unprognostic (6.75e-3)"		"unprognostic (3.93e-1)"		"unprognostic (1.60e-1)"		"unprognostic (2.49e-2)"		"unprognostic (9.46e-2)"		"unprognostic (2.29e-1)"			"unprognostic (8.54e-2)"		"unprognostic (1.02e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434371	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 27.5"	"Cell type enriched"	"Detected in some"	7	"Ductal cells: 20.4"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"PC-3: 38.5;U-2 OS: 50.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		1500000000		"Cluster 61: Skin - Cornification"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	"Plasma membrane"	"HPA019367: AB_1852239, HPA076201: AB_2686786"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	50.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.6	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821408-52834311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"skin 1: 68.3"	"Cell type enhanced"	"Detected in some"		"granulocytes: 4.5;Late spermatids: 1.1;Melanocytes: 3.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HMC-1: 425.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA		1900000000		"Cluster 61: Skin - Cornification"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA059347: AB_2683986"	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	425.5	0.0	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0
KRT86	"Hb6, KRTHB6, MNX"	ENSG00000170442	"Keratin 86"	O43790	12	52249300-52309163	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"skin 1: 150.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 33.1;Early spermatids: 35.5;Late spermatids: 24.3;NK-cells: 11.3;T-cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	9	"basophil: 87.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 87.5"	"Cell line enhanced"	"Detected in many"		"A-431: 24.9;A549: 25.7;MCF7: 51.6;RPMI-8226: 32.5;U-251 MG: 14.5"									"HPA039798, HPA049778"	Supported		Approved	Cytosol		NA	NA		160000000	"Cluster 38: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA039798: AB_10674986, HPA049778: AB_2680877"	"unprognostic (4.52e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.22e-2)"	1.2	0.5	0.5	0.2	0.7	2.6	0.5	0.0	0.5	0.2	0.0	0.5	0.4	0.4	0.5	0.1	0.7	0.4	0.1	0.8	0.2	0.2	0.1	0.7	0.0	0.3	0.4	0.1	2.1	0.1	0.1	0.4	0.4	0.3	0.0	0.1	3.8	0.3	0.3	150.5	0.3	0.1	0.2	0.1	0.2	4.0	0.5	0.2	4.1	0.0	0.1	0.8	0.2	1.2	24.9	25.7	0.0	0.0	0.0	0.0	0.3	0.9	0.7	0.3	0.1	0.3	1.3	0.0	1.1	0.0	0.5	1.5	0.0	4.5	0.1	10.9	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.5	12.7	0.0	0.0	0.0	1.8	0.0	51.6	0.0	3.0	0.1	0.2	6.1	0.0	0.0	32.5	0.4	3.2	2.9	0.0	4.5	2.0	2.0	0.0	1.4	0.0	0.8	0.0	1.3	0.1	14.5	0.0	0.0	0.0	0.0	5.3	0.0	87.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.5	0.5	0.7	0.0	0.5	0.8	0.2	0.3	0.4	0.4	0.2	0.5	1.2	0.1	0.0	0.6	0.0	0.3	0.6	2.9	2.0	0.0	0.4	2.8	3.4	0.4	2.8	3.1	0.0	0.0	0.1	33.1	0.2	0.0	2.1	35.5	3.6	0.8	0.2	0.0	0.0	0.5	5.1	1.6	0.3	1.1	4.9	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.0	0.0	1.1	24.3	0.3	0.3	1.8	0.0	0.0	0.2	11.3	0.0	0.5	2.9	0.0	0.0	2.1	2.7	0.0	0.6	1.9	0.3	0.0	1.0	0.4	0.8	0.4	0.0	0.1	1.2	14.2	0.0	0.0	3.5
KRTAP25-1	KAP25.1	ENSG00000232263	"Keratin associated protein 25-1"	Q3LHN0	21	30289145-30289514	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031438	Uncertain		Approved	"Nuclear membrane,Plasma membrane,Cytosol"		NA	NA							"Nuclear membrane"	"Plasma membrane, Cytosol"	"HPA031438: AB_10610000"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTCAP3	KCP3	ENSG00000157992	"Keratinocyte associated protein 3"	Q53RY4	2	27442366-27446481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 182.0;Proximal enterocytes: 168.7;Undifferentiated cells: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"MAIT T-cell: 6.8;memory B-cell: 4.5;memory CD4 T-cell: 5.6;memory CD8 T-cell: 2.6;naive B-cell: 6.4;naive CD4 T-cell: 6.6;naive CD8 T-cell: 2.7;T-reg: 4.4"	"Group enriched"	"Detected in many"	13	"B-cells: 6.4;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"A-431: 84.6;CAPAN-2: 122.5;OE19: 46.6;SCLC-21H: 60.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047136, HPA060203"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA047136: AB_2679949, HPA060203: AB_2684221"	"prognostic favorable (2.67e-5)"	"unprognostic (5.93e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.42e-3)"	2.2	2.7	3.0	6.3	3.5	3.0	16.0	5.3	5.6	11.8	3.7	39.6	44.3	5.8	1.8	18.3	24.9	9.5	0.7	2.9	3.5	7.9	9.8	11.3	3.3	3.9	3.5	2.4	44.6	18.6	14.1	2.9	3.7	20.9	27.8	7.3	38.5	12.7	3.2	14.1	45.5	1.7	3.0	3.1	42.4	2.2	3.3	3.7	11.5	0.0	5.2	10.0	11.2	4.6	84.6	1.2	6.1	2.7	0.3	0.6	17.4	0.9	0.3	1.0	0.9	32.7	122.5	1.0	1.1	0.2	0.5	28.4	0.9	25.0	0.3	1.0	0.6	2.2	1.9	2.7	0.0	0.3	3.9	1.1	2.7	0.6	1.5	1.2	1.0	2.8	1.8	1.5	0.9	27.2	0.9	7.8	27.7	46.6	1.1	0.8	1.8	2.5	1.7	2.4	60.2	2.2	2.3	25.4	3.6	2.0	2.5	1.4	2.4	3.4	5.4	1.2	1.1	7.0	5.9	1.1	2.3	1.1	0.8	0.0	0.0	0.0	0.6	0.0	6.8	4.5	5.6	2.6	0.0	6.4	6.6	2.7	0.0	0.5	0.0	0.0	4.4	1.5	3.0	3.5	5.3	5.6	2.9	3.5	3.9	3.5	3.7	3.0	3.3	4.6	1.1	22.4	27.9	2.6	2.9	23.3	125.1	135.4	71.7	4.9	100.9	105.2	0.5	88.6	92.5	42.3	8.4	17.0	1.9	74.2	5.9	105.4	6.4	50.9	3.8	2.7	62.0	3.6	1.2	182.0	27.6	3.4	68.3	47.9	4.5	0.9	1.4	15.2	2.1	1.7	1.1	123.6	105.8	1.0	2.5	4.7	0.3	2.0	7.2	1.9	2.9	1.9	2.1	1.5	1.3	108.7	112.9	0.0	0.7	123.7	168.7	7.7	85.2	5.9	0.0	0.9	6.9	3.8	29.4	48.0	15.5	7.9	3.0	0.7	190.2	144.2
KXD1	"BORCS4, C19orf50, FLJ25480, KXDL, MGC2749"	ENSG00000105700	"KxDL motif containing 1"	Q9BQD3	19	18557762-18569387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041507, HPA041599"	Approved		Approved	"Nucleoli fibrillar center,Centrosome,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli fibrillar center, Centrosome, Cytosol"		"HPA041507: AB_10795698, HPA041599: AB_10795502"	"unprognostic (8.48e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (7.36e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (7.71e-10)"	"unprognostic (7.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-1)"	87.5	79.2	89.8	67.9	92.8	75.2	81.3	87.9	94.9	78.8	78.6	90.6	58.4	75.0	54.9	79.3	69.5	52.5	81.5	87.0	89.1	76.1	100.4	79.8	81.2	100.8	95.5	84.9	91.9	46.3	86.2	62.9	95.6	87.7	55.2	48.1	66.2	51.2	97.9	70.8	72.7	63.8	90.8	89.4	78.4	78.8	93.4	58.2	71.3	57.3	72.4	89.9	74.7	104.8	125.1	122.2	98.7	114.0	102.0	117.4	157.3	133.6	108.0	99.2	114.2	102.1	145.3	84.6	153.5	118.7	82.1	92.3	153.0	164.5	89.7	103.3	206.5	91.7	98.5	92.6	116.7	147.2	98.4	123.7	117.6	147.8	175.1	107.7	143.4	114.4	146.7	130.2	105.3	144.5	135.2	109.5	124.2	158.3	187.9	127.0	76.9	126.7	103.5	110.0	91.0	115.7	87.6	79.1	113.8	103.3	66.5	102.4	115.2	88.1	76.8	285.9	177.8	153.9	124.1	128.0	151.9	172.2	131.4	45.3	109.5	97.7	73.7	125.0	68.2	69.8	68.4	74.1	99.5	71.5	54.1	59.0	107.6	83.2	125.1	58.9	103.4	95.9	89.8	92.8	87.9	94.9	87.0	89.1	100.8	95.5	95.6	90.8	93.4	104.8	48.3	19.2	29.3	0.3	41.8	34.5	71.8	68.9	34.1	20.5	46.7	54.7	5.7	35.8	37.8	16.5	12.5	97.8	38.1	45.6	80.3	80.3	179.6	26.3	30.2	57.2	43.1	48.0	2.2	113.3	121.9	50.3	43.8	25.1	43.7	37.4	51.0	33.6	123.5	16.8	2.0	52.0	30.5	56.2	49.5	38.5	33.5	49.7	58.7	0.0	110.5	30.2	61.8	0.5	4.4	94.8	46.9	29.3	47.9	125.7	66.4	51.7	27.6	19.2	39.5	36.2	48.3	45.8	23.2	51.7	41.5	111.5	43.8	37.5	49.5	73.6
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.7;Exocrine glandular cells: 38.2;Extravillous trophoblasts: 39.9;Proximal tubular cells: 35.6;Syncytiotrophoblasts: 83.5;Theca cells: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	19.3	22.5	8.3	16.0	9.3	13.4	29.8	10.0	12.2	18.0	12.3	19.9	22.6	21.3	21.7	26.5	18.3	20.0	11.3	9.4	9.5	30.5	27.4	15.4	22.1	8.5	9.5	25.7	30.0	33.4	15.2	22.7	9.2	21.1	21.7	11.0	20.5	22.1	10.6	18.8	17.4	15.7	8.7	17.6	22.7	9.9	8.7	21.6	26.2	10.0	23.7	24.6	14.9	8.9	55.1	11.1	52.2	18.0	19.1	51.2	46.4	31.7	57.2	39.8	49.4	15.6	18.9	35.6	23.8	23.8	27.3	15.7	15.6	25.6	57.7	22.7	21.3	32.4	9.8	26.8	61.8	45.6	8.5	44.9	25.2	29.0	50.1	26.8	37.0	41.0	41.5	19.0	37.9	17.8	48.0	21.6	31.0	42.5	10.3	49.3	36.2	19.2	87.0	49.2	38.9	45.6	44.4	60.0	29.1	31.8	33.3	13.9	27.7	17.5	11.4	55.5	23.1	23.7	13.6	23.6	8.4	19.5	14.7	8.3	12.1	7.5	8.0	7.7	11.1	8.6	10.6	9.5	16.3	8.9	10.6	9.3	8.8	11.3	10.2	5.9	16.3	8.3	8.3	9.3	10.0	12.2	9.4	9.5	8.5	9.5	9.2	8.7	8.7	8.9	10.6	12.8	11.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	16.0	13.7	0.0	0.0	8.1	12.9	0.0	70.7	13.1	0.0	25.4	34.4	0.0	12.7	14.1	4.6	0.0	0.0	0.0	38.2	39.9	10.1	0.0	14.3	5.1	17.5	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	1.8	0.0	0.0	35.6	3.6	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	83.5	7.6	43.3	0.0	0.0
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112107931-112254939	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Early spermatids: 114.7;Extravillous trophoblasts: 119.1;Fibroblasts: 149.2;Leydig cells: 166.5;Microglial cells: 124.6;Oligodendrocyte precursor cells: 160.4;Theca cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 330.5;ASC TERT1: 512.5;HSkMC: 405.5;hTERT-RPE1: 256.0;HUVEC TERT2: 441.3;TIME: 404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		320000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	116.2	9.4	17.6	34.0	17.1	0.5	59.9	11.7	12.9	77.0	12.6	82.6	17.2	77.5	18.5	35.6	115.2	37.3	51.2	12.3	17.9	9.9	4.4	80.8	11.5	12.7	16.3	23.2	4.9	8.6	13.6	68.0	14.7	35.4	34.0	1.3	38.4	40.7	10.6	17.7	34.5	107.8	11.4	1.5	36.7	18.7	22.6	5.0	23.2	18.6	8.9	65.1	40.3	11.4	0.3	0.1	18.8	0.6	330.5	512.5	0.3	91.4	55.8	8.9	1.4	0.0	36.1	0.0	58.0	154.9	19.8	0.3	4.0	0.6	1.5	0.3	46.4	0.0	44.4	0.0	69.6	0.1	0.3	405.5	0.1	64.9	0.2	256.0	441.3	0.0	0.4	0.4	1.7	0.0	0.1	0.3	1.1	0.0	15.1	0.2	0.2	0.3	134.0	2.8	0.4	2.1	14.2	0.4	68.5	1.5	0.4	0.2	404.9	145.1	7.6	160.6	29.1	0.0	0.3	0.3	33.5	0.2	191.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	17.1	11.7	12.9	12.3	17.9	12.7	16.3	14.7	11.4	22.6	11.4	115.7	3.2	4.5	45.4	0.1	22.7	1.4	2.9	8.6	1.6	5.4	9.4	53.3	2.8	10.4	3.7	0.0	1.0	0.6	0.0	3.9	0.7	114.7	6.2	24.8	103.5	0.0	2.7	27.4	0.7	119.1	149.2	3.6	10.5	1.3	3.5	36.0	35.3	3.0	0.0	6.3	0.8	20.3	1.6	20.8	47.0	166.5	2.0	56.9	124.6	0.6	0.0	0.0	160.4	2.0	0.7	0.0	81.3	1.5	1.5	0.0	0.1	1.7	0.5	65.7	5.4	98.2	1.3	1.2	5.0	18.6	3.0	2.7	117.4	0.0	12.9
LAMB2	"LAMS, NPHS5"	ENSG00000172037	"Laminin subunit beta 2"	P55268	3	49121114-49133118	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 151.8;Leydig cells: 146.3;Peritubular cells: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 299.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000053, HPA001895, HPA050033, CAB078160"	Supported		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		25000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Cytosol	"CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: "	"unprognostic (1.12e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.24e-2)"	75.2	73.2	12.8	18.2	14.2	2.6	58.2	15.1	14.9	68.0	47.7	63.1	24.6	72.7	25.5	31.9	63.8	62.2	169.1	13.1	14.5	41.3	31.7	55.1	16.9	20.0	14.8	94.4	32.7	104.7	15.4	99.0	15.4	50.4	18.0	11.7	40.3	81.0	67.5	40.9	32.5	80.2	14.1	29.8	48.4	21.4	17.3	6.7	60.2	70.0	12.8	52.2	55.9	13.5	15.7	38.7	34.4	122.0	196.3	201.5	31.1	131.9	161.8	73.8	75.7	18.3	52.0	0.2	44.4	299.0	38.3	49.3	30.0	47.6	52.3	0.1	9.5	6.9	63.4	32.1	132.5	0.3	0.3	176.9	69.4	61.6	62.1	184.3	75.9	0.0	4.1	0.1	61.4	30.3	0.1	0.3	15.1	20.7	32.0	0.2	16.6	0.5	53.5	19.1	0.2	20.4	74.9	42.9	68.3	57.5	93.4	0.9	126.9	82.2	34.9	28.5	35.4	0.1	0.4	0.4	39.1	0.3	57.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	14.2	15.1	14.9	13.1	14.5	20.0	14.8	15.4	14.1	17.3	13.5	83.7	118.6	53.5	26.1	2.4	31.2	13.9	33.6	33.0	1.7	39.4	40.5	151.8	37.1	43.6	55.2	6.2	11.3	0.9	3.6	5.9	26.4	3.5	15.4	24.4	77.8	0.0	0.4	0.2	9.4	6.4	120.1	50.4	27.2	1.3	88.9	94.9	49.9	10.4	8.4	0.4	3.1	32.6	10.1	31.1	12.3	146.3	7.5	42.7	15.9	3.5	46.7	2.1	1.0	0.6	14.1	14.9	140.7	0.5	10.2	16.4	28.6	11.2	2.6	118.3	80.8	92.3	4.3	8.6	14.2	24.4	9.4	3.8	27.6	5.6	9.3
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757774	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1285.7;lymphoid tissue: 672.2"	"Group enriched"	"Detected in many"	4	"B-cells: 872.9;dendritic cells: 340.2;granulocytes: 639.8;Hofbauer cells: 1150.4;Kupffer cells: 942.2;Langerhans cells: 489.6;Macrophages: 925.0;monocytes: 446.1;NK-cells: 562.3;T-cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 554.0;HEL: 1053.2;HL-60: 676.4;HMC-1: 2382.4;REH: 785.2;U-698: 898.1;U-937: 542.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	144.7	82.1	47.6	443.0	49.7	1285.7	60.4	49.7	90.4	53.1	55.7	82.2	68.1	27.3	16.7	49.5	46.8	137.9	31.6	45.2	62.7	30.5	98.6	284.9	672.2	82.4	67.3	16.4	30.2	21.8	22.6	145.2	75.8	31.5	90.6	5.9	38.5	30.9	9.2	24.0	155.9	93.5	69.2	491.1	72.9	10.9	81.1	298.3	38.5	20.9	636.5	161.1	22.8	114.9	1.2	0.0	1.7	0.0	0.1	0.1	0.6	0.9	0.3	0.5	0.1	0.7	1.2	554.0	56.0	1.7	1.9	2.2	0.0	0.8	0.5	62.3	0.0	1053.2	0.0	1.6	0.9	676.4	2382.4	0.6	1.2	0.6	4.1	0.3	124.2	70.7	13.8	34.0	8.8	0.0	117.5	142.2	0.7	0.0	0.0	785.2	99.6	391.6	0.8	0.1	0.6	0.4	1.3	1.3	1.1	1.0	0.5	422.2	145.3	0.6	3.0	0.6	3.4	2.7	0.7	898.1	3.1	542.8	1.8	1094.2	1522.8	1446.7	538.5	1046.1	616.3	823.6	485.5	502.8	825.7	1089.4	481.2	481.2	1709.5	327.0	1075.7	392.7	656.9	2740.4	47.6	49.7	49.7	90.4	45.2	62.7	82.4	67.3	75.8	69.2	81.1	114.9	62.9	25.6	100.4	0.0	872.9	23.8	1.1	1.3	4.0	0.0	6.2	10.4	5.5	14.3	13.9	3.7	0.0	5.8	340.2	0.8	0.0	1.2	2.0	1.4	0.9	60.2	1.2	78.2	0.2	0.7	8.4	12.3	10.2	1.1	639.8	0.2	47.2	9.4	1150.4	0.0	0.8	0.9	0.0	942.2	489.6	4.9	1.5	925.0	49.8	43.1	446.1	0.3	562.3	0.5	0.5	1.4	0.2	0.4	144.8	0.9	0.5	3.0	11.4	1.3	0.0	4.1	5.6	0.3	1.1	1.8	20.0	8.9	432.7	18.2	2.4	1.9
LARP1B	"DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2"	ENSG00000138709	"La ribonucleoprotein 1B"	Q659C4	4	128061286-128222931	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 393.1;Late spermatids: 449.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036280	Approved		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA036280: AB_10673126"	"unprognostic (1.84e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.39e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.13e-5)"	"unprognostic (8.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.50e-2)"	10.5	8.2	5.1	8.0	6.1	14.4	11.5	8.5	9.7	11.5	2.1	14.8	14.6	8.9	24.1	11.1	9.6	9.1	11.6	5.9	5.4	14.2	50.7	9.9	6.3	3.5	4.2	10.3	35.6	16.3	12.9	10.5	4.4	11.0	16.3	11.0	13.8	11.7	18.2	11.1	15.5	8.3	2.1	6.2	15.4	55.8	6.0	6.5	13.6	13.3	9.3	13.2	9.9	8.6	21.5	7.4	13.2	16.7	13.7	15.5	26.8	18.0	19.9	16.7	10.7	16.9	16.5	26.1	24.6	17.8	12.7	8.3	32.7	19.9	19.9	24.7	20.9	20.9	13.0	41.5	29.7	40.3	8.2	8.1	28.7	13.4	49.0	16.0	19.8	19.4	37.1	42.4	9.6	25.1	35.2	23.1	15.2	33.0	11.9	19.4	20.3	29.8	19.1	16.4	39.1	15.5	15.6	35.7	16.8	17.5	10.5	17.4	16.1	10.7	11.8	17.5	18.1	55.9	22.7	30.1	13.8	30.7	11.5	0.2	2.1	1.3	1.7	1.6	3.1	1.6	1.9	2.2	2.5	1.4	1.5	1.7	0.5	2.6	1.7	4.6	1.7	0.8	5.1	6.1	8.5	9.7	5.9	5.4	3.5	4.2	4.4	2.1	6.0	8.6	18.4	35.3	35.6	46.0	19.9	27.8	25.7	11.7	10.8	37.0	34.9	18.7	30.2	40.0	32.5	20.2	52.1	31.4	15.2	52.2	13.7	22.1	393.1	41.9	32.3	17.3	34.0	25.0	139.1	29.9	23.2	23.4	29.6	62.6	20.8	12.5	15.0	154.6	11.9	23.5	115.6	115.2	18.3	15.7	16.3	449.5	36.4	15.5	17.8	19.7	16.7	17.5	20.6	55.8	51.8	31.3	36.2	19.9	54.5	46.4	37.4	63.2	29.0	71.5	19.7	20.7	23.1	138.3	21.9	25.3	34.7	51.4	14.3	8.4	55.1	30.6
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein 7, transcriptional regulator"	Q4G0J3	4	112637107-112657592	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	RNA-binding	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	37.2	31.6	26.3	32.8	28.3	44.6	35.7	28.6	34.6	28.0	28.0	36.2	33.8	33.3	29.8	31.7	25.8	30.5	59.6	24.9	33.5	40.2	44.1	28.1	44.9	30.2	30.2	34.2	18.3	29.9	20.1	34.1	31.0	32.1	36.7	31.5	23.2	27.2	46.6	30.6	33.2	29.5	28.3	36.9	31.5	24.6	29.1	42.2	38.7	45.3	40.3	33.0	21.8	30.8	42.9	34.9	77.7	44.3	50.7	61.6	44.0	55.3	40.6	45.3	42.0	27.9	62.0	95.4	43.7	46.9	42.2	29.6	75.1	45.2	60.2	86.8	52.1	56.4	35.2	41.9	41.0	131.6	84.6	49.3	50.7	40.4	25.1	62.6	40.4	47.6	71.4	51.1	55.3	35.2	107.4	56.7	182.2	67.5	28.2	62.9	66.2	44.3	68.8	44.8	46.5	64.4	32.0	83.4	55.4	131.4	35.1	61.0	43.7	42.4	49.5	47.7	57.6	34.7	62.5	97.6	57.7	52.4	49.2	70.1	28.1	49.9	32.8	43.1	30.3	48.1	33.9	34.2	25.3	47.4	32.3	31.3	33.2	38.7	60.7	64.0	37.9	20.8	26.3	28.3	28.6	34.6	24.9	33.5	30.2	30.2	31.0	28.3	29.1	30.8	66.1	96.1	79.2	45.1	68.8	24.9	66.5	102.6	34.1	61.3	48.3	50.4	113.2	95.8	91.6	47.8	29.2	79.0	88.7	83.2	111.6	69.3	17.6	78.7	70.5	63.2	38.9	43.6	18.0	64.4	70.2	60.6	32.1	58.8	104.4	51.5	81.4	160.9	70.4	58.9	19.9	79.7	61.1	93.7	27.1	14.9	94.4	67.2	24.9	32.8	96.0	107.1	107.1	20.6	43.1	62.0	85.6	100.1	39.1	38.8	73.1	117.0	109.8	54.1	118.3	74.5	68.3	83.5	87.8	33.3	20.9	100.4	65.9	74.2	75.6	47.9
LARS1	"FLJ10595, FLJ21788, HSPC192, LARS, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase 1"	Q9P2J5	5	146110566-146182696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.8;Cardiomyocytes: 135.7;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 40.3;Hofbauer cells: 36.7;Smooth muscle cells: 22.7;Syncytiotrophoblasts: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: AB_2677185"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.96e-2)"	35.4	37.0	40.0	26.6	42.0	20.2	46.3	42.8	48.9	33.9	44.0	34.4	18.4	33.9	35.4	35.0	34.8	18.7	38.5	40.4	44.3	34.6	25.6	26.4	29.7	42.3	42.9	37.2	49.7	34.7	37.0	22.2	41.8	35.6	34.8	34.7	40.0	28.3	70.6	31.7	28.1	33.4	43.1	35.7	29.8	23.9	43.2	32.7	34.7	58.8	34.8	35.6	30.9	46.2	56.1	59.5	65.9	125.9	88.0	95.7	102.5	45.5	57.8	71.4	92.4	66.1	59.8	67.8	32.7	91.2	72.6	52.9	107.2	116.5	106.4	45.2	88.2	65.5	76.0	58.5	122.7	101.4	51.9	83.7	153.6	92.0	173.3	73.2	87.7	108.0	67.4	121.3	83.4	56.9	102.8	116.1	126.8	63.8	86.8	75.0	62.0	101.9	73.6	44.1	77.7	97.3	50.2	111.6	221.2	76.6	103.1	159.3	63.4	61.2	44.3	56.7	89.4	79.3	82.3	86.3	89.8	164.1	79.1	1.1	11.8	5.4	14.5	19.2	19.6	18.9	16.6	14.9	21.2	15.5	21.2	21.9	0.7	19.2	16.7	16.6	19.6	14.9	40.0	42.0	42.8	48.9	40.4	44.3	42.3	42.9	41.8	43.1	43.2	46.2	26.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.7	0.0	0.0	0.0	0.0	39.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	40.3	16.6	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	33.0	2.8	0.0	0.0	0.0
LAS1L	"FLJ12525, Las1"	ENSG00000001497	"LAS1 like ribosome biogenesis factor"	Q9Y4W2	X	65438549-65534810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044431, HPA061463"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA044431: AB_10965695, HPA061463: AB_2684530"	"unprognostic (9.71e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.53e-1)"	21.5	19.1	36.9	11.4	37.8	16.0	21.2	35.6	53.7	27.1	34.0	26.4	5.8	23.1	6.8	20.0	25.5	6.3	18.6	34.8	34.8	19.1	19.6	17.4	13.1	36.3	37.1	29.9	21.2	12.2	17.5	8.9	36.8	22.7	8.1	9.4	18.8	11.9	19.3	25.4	18.5	10.3	38.1	22.5	20.0	33.6	37.1	12.8	20.5	6.3	14.0	24.2	21.4	37.8	44.1	63.6	36.3	28.5	12.4	16.1	29.1	28.5	14.9	42.8	36.4	30.4	31.3	95.0	31.3	17.8	28.7	31.3	63.9	39.6	50.6	25.6	52.3	32.2	53.2	32.4	16.6	95.9	26.8	17.8	28.7	40.5	25.6	15.1	26.0	46.1	80.3	71.3	25.5	51.8	62.4	53.6	52.6	49.8	63.1	56.2	67.4	79.9	24.7	17.9	24.6	32.9	51.3	26.0	20.1	25.8	19.5	44.6	22.2	26.4	50.9	73.2	44.4	23.7	37.7	94.6	28.1	92.5	13.6	17.7	17.7	11.2	20.1	24.0	21.3	23.9	18.6	23.5	24.2	26.4	23.2	19.8	2.0	22.9	19.3	19.1	21.7	21.0	36.9	37.8	35.6	53.7	34.8	34.8	36.3	37.1	36.8	38.1	37.1	37.8	15.5	12.8	22.3	23.2	21.6	18.2	21.4	24.8	9.1	34.9	12.7	13.6	9.2	21.5	27.0	3.7	29.2	32.8	13.3	6.9	15.6	27.9	58.0	17.5	20.0	17.2	16.7	18.1	19.6	26.6	31.4	16.8	11.7	12.9	18.3	26.0	8.9	14.8	16.3	45.4	17.7	9.4	18.3	8.5	13.4	148.2	17.4	11.7	10.6	8.4	18.1	16.1	12.3	13.0	12.5	21.4	7.7	15.4	26.3	23.5	10.2	14.3	26.7	34.2	13.1	21.8	22.8	24.1	19.1	17.8	18.6	17.8	17.5	22.3	14.1	14.8
LATS2		ENSG00000150457	"Large tumor suppressor kinase 2"	Q9NRM7	13	20973036-21061586	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA039191: AB_2676385, HPA049037: AB_2680609"	"unprognostic (2.77e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.22e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-1)"	"unprognostic (6.57e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-2)"	19.8	12.2	3.9	7.3	4.3	15.1	12.4	4.8	3.7	10.1	7.7	13.1	2.9	12.2	3.0	11.5	9.7	15.1	11.5	5.3	3.3	9.9	9.8	12.4	5.3	5.4	4.6	11.0	10.2	4.3	2.3	13.9	4.5	9.8	4.3	1.3	6.1	8.8	16.7	7.7	6.2	13.1	4.1	11.2	7.8	14.6	5.1	2.4	13.5	13.3	3.3	14.2	8.9	4.7	6.8	7.4	16.0	9.7	18.4	24.1	14.6	22.1	22.8	22.5	19.2	21.1	10.0	0.0	10.5	33.8	8.8	9.6	9.5	10.1	33.1	3.8	2.5	12.4	9.4	16.0	28.6	3.4	4.2	36.0	18.1	14.9	9.9	11.3	32.0	2.8	2.3	0.5	28.9	11.7	0.4	11.6	3.8	7.0	3.5	2.9	28.5	0.0	16.3	3.1	0.3	0.0	17.4	11.3	23.9	13.9	9.8	6.4	40.6	23.8	15.9	17.7	14.1	2.9	1.7	0.0	5.7	3.8	18.6	0.1	0.5	0.5	0.4	0.4	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.9	0.4	0.2	0.0	0.0	0.1	3.9	4.3	4.8	3.7	5.3	3.3	5.4	4.6	4.5	4.1	5.1	4.7	36.6	41.7	9.9	12.1	2.8	32.9	14.7	8.5	21.6	0.4	12.5	11.0	24.3	15.7	10.5	5.5	0.0	24.8	21.0	6.5	3.9	10.1	139.4	40.3	30.4	35.1	0.0	8.2	0.6	7.3	8.9	37.2	8.6	62.1	5.1	9.8	44.6	19.6	9.9	0.0	0.6	1.9	6.1	17.9	49.3	13.7	25.4	26.0	17.8	21.5	11.0	4.9	13.4	2.0	8.8	18.6	2.8	34.6	8.9	21.7	0.6	9.5	11.6	1.0	6.6	32.3	30.0	8.8	14.5	9.9	25.3	48.0	8.1	7.9	1.5	15.2
LAYN	"FLJ30977, FLJ31092"	ENSG00000204381	Layilin	Q6UX15	11	111540280-111561745	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Prostatic glandular cells: 233.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"myeloid DC: 11.2;T-reg: 13.4"	"Group enriched"	"Detected in many"	123	"dendritic cells: 11.2;T-cells: 13.4"	"Cell line enhanced"	"Detected in many"		"BJ: 150.7;BJ hTERT+: 153.7;BJ hTERT+ SV40 Large T+ RasG12V: 96.7;fHDF/TERT166: 95.1;HSkMC: 88.8;hTERT-RPE1: 94.0;U-138 MG: 108.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040087	Approved		Approved	Cytosol		NA	NA		340000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA040087: AB_10793927"	"unprognostic (2.27e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-2)"	10.7	2.0	15.6	5.7	21.4	1.0	8.5	15.7	19.6	15.6	13.7	29.2	3.8	15.8	10.1	4.7	17.7	17.0	7.0	16.6	17.1	5.7	0.9	11.3	7.1	17.4	19.7	39.1	2.0	6.4	6.2	14.1	16.3	14.6	3.3	0.8	5.5	17.0	6.1	2.6	10.6	22.5	14.2	8.2	13.1	4.4	18.0	10.3	27.4	6.1	5.0	8.8	12.2	23.7	0.4	3.9	0.8	0.0	25.4	48.0	7.6	150.7	153.7	71.0	96.7	0.2	0.1	0.0	1.4	95.1	18.7	3.2	9.9	0.7	74.2	0.2	0.5	0.8	0.0	0.2	41.7	0.0	0.2	88.8	0.0	30.8	0.2	94.0	0.9	0.0	0.0	0.1	29.4	0.0	0.1	0.1	4.8	0.0	0.0	0.0	11.4	0.2	0.6	0.0	4.9	18.9	0.5	0.2	0.4	34.9	0.1	0.7	0.6	108.8	81.2	1.0	74.3	0.0	0.0	0.2	14.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.4	0.4	15.6	21.4	15.7	19.6	16.6	17.1	17.4	19.7	16.3	14.2	18.0	23.7	22.2	19.2	2.8	0.3	0.3	2.2	48.8	44.8	0.6	0.4	0.7	15.0	2.7	2.8	23.3	0.0	0.0	1.6	2.6	0.0	0.0	6.5	2.5	3.9	7.7	50.9	0.0	2.7	0.3	0.2	2.1	13.1	0.0	0.9	1.3	9.6	6.8	0.1	0.7	0.0	1.4	0.0	6.1	0.6	13.6	1.8	22.7	1.2	0.0	2.8	0.6	0.2	0.0	4.0	30.1	0.8	0.0	55.3	2.8	233.0	0.0	0.2	32.0	0.2	32.9	2.6	17.3	0.1	2.3	0.1	2.3	0.5	14.5	11.2	0.0	50.3
LBHD1	"C11orf48, MGC2477"	ENSG00000162194	"LBH domain containing 1"	Q9BQE6	11	62662817-62672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 65.9"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Respiratory ciliated cells: 8.7;Rod photoreceptor cells: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.8;JURKAT: 53.8"	"Low region specificity"	"Detected in all"							"HPA012127, HPA023592"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA012127: AB_1845527, HPA023592: AB_1845528"	"unprognostic (4.34e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.18e-8)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.78e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.72e-3)"	4.6	13.1	1.8	5.5	1.8	6.3	3.7	2.9	2.8	3.4	2.9	4.7	3.5	2.0	4.2	3.4	3.4	2.6	3.2	1.8	2.0	3.8	8.6	3.5	7.5	2.1	2.2	1.9	3.8	4.1	3.9	1.9	2.2	4.3	3.4	65.9	3.6	3.5	1.8	2.5	6.0	2.3	1.6	9.5	4.5	7.3	2.1	6.0	4.1	0.9	4.7	3.6	2.6	2.4	2.7	4.7	2.8	2.1	4.2	7.9	6.2	3.6	5.3	5.8	4.6	3.7	30.8	9.4	7.7	4.5	6.0	11.8	3.0	8.4	4.5	12.8	9.5	7.9	14.6	2.7	6.2	7.4	9.9	10.9	0.9	10.4	3.2	6.5	3.2	53.8	8.3	8.3	3.7	4.8	4.6	11.0	3.6	6.4	4.0	11.2	6.9	17.4	7.7	5.4	3.2	4.7	4.0	5.4	12.1	3.8	10.1	11.1	2.5	3.6	2.3	3.7	4.0	13.7	12.8	9.1	3.3	7.4	3.8	1.5	3.5	3.4	3.2	2.4	2.9	2.4	1.9	3.5	3.1	2.5	2.6	2.1	0.8	4.8	2.1	3.9	1.2	2.6	1.8	1.8	2.9	2.8	1.8	2.0	2.1	2.2	2.2	1.6	2.1	2.4	0.8	3.2	2.7	0.0	2.0	0.0	0.2	0.0	1.2	2.3	0.6	0.5	0.8	0.0	2.5	0.0	4.2	0.2	2.0	0.2	0.0	0.2	0.0	2.7	1.1	0.5	0.0	0.4	0.3	0.0	0.3	1.0	2.0	0.7	2.5	1.2	0.0	0.6	0.2	1.7	0.3	0.1	0.0	0.3	0.0	0.3	0.3	1.6	0.0	1.0	0.1	1.5	2.1	0.0	0.1	0.2	0.0	0.4	3.9	0.4	0.4	0.3	8.7	7.6	0.0	1.1	0.3	0.7	0.6	0.9	0.0	0.3	1.8	3.6	0.1	0.3
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 26.5"	"Cell type enriched"	"Detected in single"	5	"Skeletal myocytes: 3.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 1.9;medulla oblongata: 3.5;pons: 2.5;spinal cord: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 3.4;RH-30: 4.3;SCLC-21H: 9.1"	"Group enriched"	"Detected in some"	24	"cerebellum: 1.6;pons and medulla: 3.0"	"Group enriched"	"Detected in some"	18	"cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0"	"HPA002016, HPA002086, CAB079927"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.5	0.4	2.5	4.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.3;Inhibitory neurons: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	4.2	4.9	6.1	5.0	6.7	9.9	5.3	10.8	9.3	6.7	3.4	7.8	12.3	7.2	9.8	5.1	6.1	6.2	11.3	5.3	7.8	9.5	8.6	5.1	5.4	2.9	3.3	4.9	5.9	6.3	3.2	4.3	3.1	7.8	7.9	10.6	4.6	7.0	9.6	6.6	9.5	8.7	0.8	5.3	5.3	8.3	7.0	6.4	10.9	4.1	5.4	4.9	3.7	10.2	16.9	21.6	11.3	19.3	2.6	5.7	16.3	11.8	11.7	12.3	10.3	21.8	19.0	10.5	10.7	18.4	15.2	18.3	38.8	16.0	12.1	13.6	13.0	19.4	12.8	21.6	12.0	28.1	14.3	4.6	12.4	13.0	18.0	8.0	8.7	6.0	18.3	9.5	9.6	12.8	16.1	16.5	12.5	13.6	12.4	15.6	22.9	21.8	9.7	24.7	13.1	20.5	26.4	17.4	15.7	7.7	12.6	9.5	10.0	22.1	18.2	12.4	18.9	7.0	16.2	23.2	22.7	20.1	17.3	15.9	2.3	5.0	5.2	3.8	6.2	7.5	8.3	6.7	2.8	9.7	11.7	11.5	7.2	4.6	3.6	2.0	4.2	3.0	6.1	6.7	10.8	9.3	5.3	7.8	2.9	3.3	3.1	0.8	7.0	10.2	6.5	9.6	6.9	27.1	11.4	7.1	5.0	8.4	6.8	15.5	6.9	5.3	20.1	18.6	8.7	14.7	27.1	5.2	6.7	10.4	0.0	7.7	3.9	12.0	7.0	7.7	13.1	10.3	67.3	16.4	5.3	6.7	3.1	9.4	3.8	11.6	8.6	21.5	6.1	15.2	86.8	14.3	0.0	5.7	3.9	1.4	5.6	3.4	5.4	45.0	2.4	7.9	5.2	50.8	37.3	12.9	8.6	9.1	5.2	5.4	21.4	12.1	16.6	18.2	6.6	10.9	16.3	13.9	21.0	7.9	6.7	1.9	9.1	10.9	17.0	4.7
LCMT1	"CGI-68, PPMT1"	ENSG00000205629	"Leucine carboxyl methyltransferase 1"	Q9UIC8	16	25111731-25178231	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041559, HPA043530"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA041559: AB_2677548, HPA043530: AB_2678532"	"unprognostic (9.08e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.41e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.84e-3)"	"unprognostic (6.71e-2)"	17.5	27.3	41.5	13.3	43.2	19.9	22.5	41.1	44.5	23.9	36.5	22.0	16.8	21.2	31.1	22.8	20.5	13.6	36.1	45.1	42.8	26.9	10.9	14.9	16.7	39.9	39.0	28.1	47.2	32.0	32.9	24.1	42.4	20.8	21.3	21.8	21.2	21.3	52.3	28.2	17.1	18.5	40.2	16.2	22.5	35.4	43.4	21.3	18.6	36.2	20.2	18.1	20.6	43.0	40.3	36.3	33.9	47.2	30.2	42.9	34.9	24.7	40.5	35.7	45.9	46.4	35.7	24.4	34.1	37.6	44.2	20.1	35.9	34.3	47.9	24.9	53.3	13.5	35.4	77.3	67.9	32.0	20.9	48.7	37.7	39.9	41.4	51.3	32.3	54.0	21.5	31.2	39.5	102.3	37.9	60.6	52.1	25.3	37.0	44.3	30.9	47.7	40.7	27.9	55.5	34.1	29.0	45.8	58.2	39.9	46.0	14.9	19.1	34.6	24.3	23.4	25.0	39.8	43.9	25.8	42.3	27.5	26.6	33.4	36.5	46.2	39.4	33.5	43.3	42.0	47.8	42.1	35.0	31.6	42.8	39.2	14.6	33.6	37.6	18.1	82.9	42.2	41.5	43.2	41.1	44.5	45.1	42.8	39.9	39.0	42.4	40.2	43.4	43.0	21.0	16.0	19.8	15.3	23.5	24.1	31.1	55.6	33.6	25.7	39.3	42.0	34.8	15.7	29.6	33.1	2.1	164.5	20.9	60.5	49.0	51.7	76.5	22.7	31.4	22.7	51.4	29.5	29.0	66.7	69.4	29.1	20.9	20.2	9.5	197.7	23.2	9.5	46.8	23.5	30.1	46.9	38.7	33.9	20.0	137.5	26.1	27.0	33.8	17.8	31.3	32.0	32.0	28.1	31.7	46.7	45.1	24.0	28.9	34.6	79.4	90.0	30.0	26.1	26.3	22.9	67.7	67.3	52.9	35.6	31.8	163.8	29.6	78.7	43.7	34.7
LCMT2	"KIAA0547, MGC9534, PPM2, TYW4"	ENSG00000168806	"Leucine carboxyl methyltransferase 2"	O60294	15	43323649-43330582	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA039401	Approved		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA039401: AB_10805478"	"unprognostic (4.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.33e-3)"	"unprognostic (9.57e-2)"	"prognostic favorable (5.69e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	5.1	4.7	5.3	4.8	5.2	1.9	6.3	6.8	10.2	6.3	6.4	4.8	3.4	6.0	7.6	5.0	6.3	3.1	5.5	5.0	6.2	7.3	6.0	4.0	6.5	5.1	5.2	5.7	3.8	8.0	4.2	3.6	5.5	6.2	4.6	7.3	3.9	6.4	4.0	3.8	4.3	5.3	5.2	4.4	4.1	3.9	5.2	7.8	5.7	4.7	9.2	5.2	3.2	5.3	8.8	6.7	15.7	13.7	16.3	5.1	7.7	10.7	12.3	13.2	14.6	10.2	4.0	7.5	20.8	12.0	14.2	20.0	0.0	13.8	10.1	11.6	7.3	13.3	18.3	5.9	9.9	0.0	9.8	7.8	13.0	9.8	9.0	8.9	4.3	16.9	17.1	9.6	16.1	13.4	15.4	6.3	6.8	19.0	5.8	17.8	13.7	7.2	23.4	9.8	21.1	17.6	13.8	11.6	6.0	12.1	14.1	20.2	3.7	15.6	7.1	18.1	17.4	6.5	16.6	3.0	9.7	10.9	16.5	1.7	2.6	3.8	2.3	2.4	3.3	3.2	3.9	2.9	4.4	3.5	6.0	4.1	0.8	2.0	2.2	2.6	3.3	3.2	5.3	5.2	6.8	10.2	5.0	6.2	5.1	5.2	5.5	5.2	5.2	5.3	1.5	0.0	3.1	1.3	3.5	3.1	3.7	1.9	1.8	7.6	2.9	2.8	3.6	5.7	5.7	3.7	8.4	4.3	2.7	2.8	3.9	6.5	2.1	3.6	3.9	3.1	5.4	4.8	1.1	4.0	2.3	3.7	2.0	4.1	1.3	2.2	5.0	4.1	2.7	3.3	1.6	2.2	4.1	1.3	0.8	1.5	5.0	2.7	0.0	1.9	2.4	7.3	4.1	0.5	1.7	3.4	2.1	1.5	2.5	3.3	1.8	4.7	6.2	6.6	6.6	5.1	3.7	23.4	10.5	2.7	2.8	2.5	2.6	2.4	3.3	2.8
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 709.0;epididymis: 402.7;lymphoid tissue: 605.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.4;granulocytes: 309.1;Hofbauer cells: 264.4;Kupffer cells: 401.2;Langerhans cells: 337.6;Late spermatids: 290.9;Macrophages: 466.1;monocytes: 535.7;NK-cells: 471.7;T-cells: 375.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 875.8;HDLM-2: 799.3;HL-60: 850.7;HMC-1: 861.7;JURKAT: 792.7;NB-4: 789.2;THP-1: 840.5;U-698: 1105.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		1800000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	85.9	31.1	11.3	396.9	13.1	709.0	43.9	13.9	30.9	28.5	16.8	54.7	42.4	27.4	402.7	29.5	21.5	76.4	14.5	11.3	14.2	13.1	89.0	173.8	563.5	19.7	18.9	10.0	12.2	12.6	4.3	67.2	21.3	184.5	71.2	4.9	44.4	24.3	7.1	40.6	62.3	60.4	18.6	375.2	53.2	33.2	24.8	499.8	23.6	17.8	605.1	133.0	7.7	29.9	36.1	0.2	1.9	0.0	0.0	0.0	409.8	0.1	1.2	3.9	2.9	237.4	1.4	875.8	179.5	0.0	249.1	1.7	0.1	0.6	3.9	799.3	202.9	187.6	0.4	1.1	0.9	850.7	861.7	2.3	0.1	1.4	1.2	0.3	0.0	792.7	100.4	569.7	0.0	2.8	624.8	789.2	1.0	0.4	8.2	451.6	1.6	638.2	0.0	233.8	2.8	7.5	1.9	91.8	6.4	25.0	6.4	840.5	3.1	22.0	13.6	1.5	25.5	135.3	292.5	1105.7	17.0	530.9	3.6	1007.3	1559.5	810.8	915.7	1806.2	822.0	342.3	539.6	761.2	1134.5	251.6	330.2	560.5	1908.6	650.6	1826.1	297.5	598.1	3644.2	11.3	13.1	13.9	30.9	11.3	14.2	19.7	18.9	21.3	18.6	24.8	29.9	7.4	32.1	73.2	0.3	185.2	12.0	1.2	0.0	1.8	0.4	10.3	11.7	4.2	5.7	18.0	3.7	0.0	9.8	438.4	0.2	0.0	16.9	113.1	4.7	42.8	9.6	1.2	63.9	0.5	16.3	68.3	10.9	19.9	7.0	309.1	0.7	12.5	24.0	264.4	0.0	0.5	0.5	0.0	401.2	337.6	290.9	1.2	466.1	23.2	17.8	535.7	23.7	471.7	0.5	1.5	6.8	2.4	1.9	102.4	42.0	0.1	1.5	13.8	1.2	0.0	3.1	6.2	2.7	1.6	2.2	11.8	13.5	375.3	0.5	0.4	4.0
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116780	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.6;liver: 135.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 37.3;Distal enterocytes: 80.2;Distal tubular cells: 37.2;Hepatocytes: 88.6;Proximal tubular cells: 118.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 11.1"	"Group enriched"	"Detected in many"	45	"granulocytes: 11.1;monocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 11.4;HMC-1: 14.4;T-47d: 29.1;U-266/70: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol		No	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	24.9	14.4	17.7	2.1	19.7	0.7	11.7	20.5	22.6	5.4	34.1	27.2	8.8	3.5	1.1	10.8	5.5	3.0	85.6	16.1	18.9	36.1	135.5	4.9	0.8	20.8	20.2	16.4	18.7	17.0	11.8	0.7	22.4	8.1	9.7	1.3	21.3	3.2	68.7	5.8	5.7	1.2	17.0	1.1	23.1	1.7	19.3	0.5	10.6	52.7	0.6	2.6	3.7	17.5	0.7	2.1	0.0	0.2	1.6	1.4	6.1	0.2	0.1	0.2	0.2	2.8	2.6	0.1	2.1	0.9	1.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.8	11.4	2.6	0.0	14.4	2.0	0.3	0.0	0.0	0.6	0.1	0.4	0.7	2.5	0.0	5.3	0.1	0.8	1.4	2.7	1.3	0.0	0.0	7.8	1.4	0.1	0.0	0.0	0.2	5.2	0.3	0.7	29.1	3.3	0.0	0.0	0.2	0.0	0.0	11.5	0.6	0.0	1.9	0.1	0.0	11.1	2.2	0.6	0.0	3.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	17.7	19.7	20.5	22.6	16.1	18.9	20.8	20.2	22.4	17.0	19.3	17.5	1.6	0.0	6.7	7.8	1.0	0.6	1.8	2.2	0.6	0.5	6.5	2.4	37.3	11.5	2.3	11.0	0.0	2.1	0.1	80.2	37.2	2.3	0.4	2.2	0.3	1.7	3.0	2.7	1.0	6.2	1.2	2.3	32.6	3.8	10.2	2.1	4.2	88.6	7.2	1.7	1.4	11.0	0.0	6.0	1.0	0.6	0.0	3.0	5.4	1.9	2.0	12.0	0.0	1.0	3.2	3.0	28.3	0.0	0.8	2.1	2.4	118.1	2.0	1.4	0.0	4.1	1.3	0.0	0.7	3.6	0.3	3.1	1.0	1.8	15.7	1.5
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205455954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"epididymis: 14.8;testis: 55.1"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4203.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 2.6;medulla oblongata: 2.4;midbrain: 1.2;pons: 2.8;thalamus: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 39.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.9"	HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.1	0.3	0.2	0.0	0.2	0.0	0.3	2.6	0.4	0.3	0.0	0.0	0.6	0.3	14.8	0.8	1.6	0.1	0.0	0.1	0.4	1.0	0.0	0.4	0.0	2.4	1.2	0.6	0.0	0.0	0.5	0.1	2.8	0.2	0.0	1.4	1.9	0.4	0.0	0.4	0.2	0.1	0.4	0.0	0.9	55.1	2.2	0.0	0.6	0.0	0.7	0.1	0.5	0.3	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	39.6	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.4	1.3	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	2.6	0.4	0.1	0.4	2.4	1.2	2.8	0.4	2.2	0.3	0.0	0.0	2.6	1.0	0.0	0.0	1.2	8.4	4.6	12.1	1.6	0.9	0.0	0.0	6.4	0.0	4.2	0.1	0.0	0.0	0.0	1.9	968.7	0.8	0.1	0.7	0.0	0.0	1.4	0.7	0.1	0.2	0.0	1.1	0.0	0.6	1.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	4203.7	12.8	1.1	0.0	0.0	0.0	1.3	0.0	1.0	0.5	6.8	0.1	13.9	0.0	8.5	0.3	4.3	1.6	0.7	6.6	0.0	0.4	15.6	9.7	0.7	0.0	0.4	0.1	0.1	0.3	4.4
LENG8	"KIAA1932, MGC40108, pp13842"	ENSG00000167615	"Leukocyte receptor cluster member 8"	Q96PV6	19	54448887-54462016	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Rod photoreceptor cells: 598.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 479.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042004, HPA061571"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042004: AB_10794642, HPA061571: AB_2684562"	"unprognostic (2.09e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.45e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.85e-3)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (3.64e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.73e-6)"	238.9	243.5	53.8	84.3	62.0	79.5	264.9	62.5	94.5	327.4	75.3	317.4	112.6	318.2	40.6	199.0	384.3	25.5	237.5	53.1	75.5	299.0	193.2	293.0	70.8	60.3	53.1	425.1	545.6	15.7	380.6	30.9	59.0	353.6	28.9	223.7	267.0	28.0	134.2	249.1	336.3	41.1	38.1	386.8	300.0	238.5	69.7	38.3	374.8	10.3	34.5	283.9	279.8	90.7	70.5	57.6	68.0	37.1	20.7	33.6	37.8	58.1	8.9	11.2	21.7	45.3	100.8	55.9	24.6	46.5	2.7	91.0	21.7	27.0	8.2	93.9	479.3	84.0	179.4	32.0	24.4	12.9	68.5	74.9	39.5	6.7	26.4	91.4	17.2	42.6	66.7	84.1	14.0	24.6	53.1	66.8	17.6	17.5	11.9	84.3	20.5	78.6	27.1	19.4	54.4	29.9	6.3	42.7	15.1	34.1	42.7	18.1	81.7	47.2	48.3	7.6	63.0	77.7	38.4	25.7	40.7	89.9	32.4	3.2	1.0	1.4	0.8	0.7	0.9	0.7	0.5	0.9	0.6	2.5	0.8	0.7	4.5	0.9	0.5	3.1	0.9	0.4	53.8	62.0	62.5	94.5	53.1	75.5	60.3	53.1	59.0	38.1	69.7	90.7	46.7	19.2	30.7	77.1	50.2	28.8	21.3	26.4	35.9	122.7	57.2	47.1	2.2	44.3	35.7	40.5	112.6	20.2	57.5	73.5	1.9	18.5	35.4	52.4	33.8	32.5	105.0	43.3	62.8	31.6	11.9	35.3	128.4	64.8	11.4	67.4	35.3	39.2	25.3	95.9	53.4	84.9	42.7	48.2	28.0	12.4	43.5	59.6	24.9	52.5	45.9	36.1	25.7	64.3	86.5	30.8	52.2	36.9	48.2	39.9	74.2	9.8	68.9	598.6	19.7	25.6	44.3	23.7	13.9	40.5	38.5	21.1	37.6	45.7	59.5	43.1
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.2;hTERT-HME1: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 24.0"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	1.2	1.0	3.4	1.1	3.6	5.3	0.7	5.7	4.9	1.6	2.9	0.7	0.8	1.4	1.1	1.1	1.4	1.2	0.8	3.2	2.8	2.3	0.7	2.0	1.3	2.3	2.9	2.1	0.7	1.6	1.3	1.8	3.1	1.1	0.8	4.2	0.4	0.8	0.2	1.1	0.5	0.6	2.0	1.6	2.7	23.8	2.6	2.4	1.0	0.3	1.4	1.9	0.6	4.2	21.2	4.5	3.0	2.9	2.3	7.0	2.5	7.5	9.2	10.6	6.2	1.5	8.3	2.8	16.5	1.5	3.1	2.2	5.9	25.2	11.7	1.2	2.9	3.2	2.3	4.2	2.7	0.7	2.8	1.7	7.2	11.7	26.9	5.9	10.7	3.4	2.6	3.9	9.3	4.2	7.5	1.8	0.8	1.6	18.2	2.9	4.8	1.6	16.8	1.1	2.4	2.3	2.5	0.4	0.9	1.8	2.4	1.2	20.0	3.3	22.5	7.4	1.7	2.6	1.6	2.0	5.6	3.3	2.5	1.3	4.1	0.7	0.9	1.6	2.0	1.5	0.9	1.5	1.7	1.8	1.7	1.7	21.5	1.4	5.0	0.7	5.2	1.3	3.4	3.6	5.7	4.9	3.2	2.8	2.3	2.9	3.1	2.0	2.6	4.2	3.0	3.2	6.4	2.3	10.3	0.5	13.9	7.6	6.8	6.6	2.1	3.3	1.8	4.3	3.2	5.5	6.2	2.6	10.1	1.4	1.9	4.0	76.9	21.8	7.1	4.2	0.0	0.8	3.6	20.5	7.9	5.0	16.8	20.5	9.5	1.1	1.4	0.0	1.4	6.7	7.3	1.9	2.0	2.2	2.3	57.6	2.1	3.6	1.8	1.0	2.0	3.6	1.0	1.5	1.6	48.6	0.1	1.5	4.5	2.9	0.3	3.0	4.9	8.4	0.0	4.5	3.3	54.8	3.3	2.5	0.9	8.1	9.1	1.5	1.3	4.5
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675636-37679802	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3949.7;Langerhans cells: 4906.5;monocytes: 7118.4;Smooth muscle cells: 4703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 1649.6"	"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	No	Yes	10000000	20000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (5.10e-4)"	1921.2	778.5	482.4	523.8	520.7	324.7	1490.9	613.5	695.3	1805.7	465.2	1634.7	197.7	2270.1	196.8	387.4	1147.0	556.0	1397.4	457.7	549.0	362.4	277.4	920.2	176.7	694.5	576.1	1440.2	155.5	188.1	254.8	426.1	661.5	903.0	207.2	39.5	397.5	756.3	1172.9	472.8	475.3	1353.4	593.8	460.7	582.7	244.9	624.9	153.9	290.9	691.9	116.9	1059.7	1156.4	782.4	2850.9	1664.3	36.5	1440.9	3314.6	6505.1	32.7	6450.7	7619.4	4761.9	4716.9	189.6	368.3	3.3	649.1	6661.4	1609.2	296.3	58.8	4309.2	1663.3	2917.2	30.9	251.3	1606.3	791.1	2155.3	145.1	3167.7	4031.7	294.2	3785.7	1609.9	4271.1	5325.7	1.7	186.6	1163.4	3771.1	1287.6	5.2	2038.4	14.3	629.6	3914.9	5.4	2388.6	799.7	2000.0	6.4	5.5	843.4	1287.4	224.3	1644.5	66.7	1187.2	1689.0	7122.0	6224.0	3070.2	2788.9	3349.3	701.8	530.6	13.6	7291.9	762.0	2535.9	1086.5	3047.4	110.2	766.5	2320.4	113.6	567.7	694.9	754.2	3653.1	287.5	114.3	478.1	122.2	415.4	2556.7	899.2	1514.7	4667.0	482.4	520.7	613.5	695.3	457.7	549.0	694.5	576.1	661.5	593.8	624.9	782.4	1505.8	166.7	90.4	12.7	294.3	730.3	144.0	2796.6	49.5	10.0	144.2	477.9	986.3	74.4	213.4	163.7	6.2	88.0	466.5	49.9	17.6	690.2	30.9	183.0	3011.6	1063.6	3.0	74.9	7.5	90.4	1573.3	2540.4	28.1	230.3	540.0	172.2	653.2	614.1	3949.7	8.4	5.4	8.4	339.7	2159.0	4906.5	106.4	975.5	1700.0	2856.6	15.9	7118.4	278.0	588.1	4.0	17.1	233.5	6.1	1300.7	590.9	118.8	0.5	28.7	109.8	45.4	1650.1	1873.6	4703.8	33.8	13.1	18.2	588.0	151.5	767.5	197.2	11.6	57.0
LGALS12	GRIP1	ENSG00000133317	"Galectin 12"	Q96DT0	11	63506052-63516774	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 78.3;breast: 41.3"	"Cell type enhanced"	"Detected in some"		"granulocytes: 17.8;Macrophages: 13.3;monocytes: 2.5;Muller glia cells: 3.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	20	"eosinophil: 554.9"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 554.9"	"Group enriched"	"Detected in some"	14	"ASC diff: 28.9;HL-60: 53.0;NB-4: 109.4;U-937: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021124			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA021124: "	"unprognostic (3.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (4.60e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.22e-2)"	"unprognostic (8.60e-2)"	78.3	0.8	0.1	2.7	0.2	18.4	41.3	0.1	0.2	0.1	0.4	0.9	0.5	0.2	0.0	0.2	1.0	1.7	2.1	0.1	0.2	0.3	0.3	1.0	0.1	0.2	0.2	0.2	0.6	0.0	0.0	0.1	0.2	0.4	0.6	1.9	4.5	0.7	0.5	1.0	2.0	1.0	0.2	1.1	0.9	0.0	0.1	0.3	0.7	1.4	0.0	1.0	0.3	0.2	0.0	0.0	0.0	0.0	28.9	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.8	53.0	3.3	3.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	109.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	5.3	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	112.2	0.0	15.5	28.1	554.9	0.2	3.3	0.2	0.0	0.0	0.0	7.5	0.1	0.1	0.1	5.7	0.2	0.5	0.7	0.3	17.3	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	17.8	0.0	1.1	0.1	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	13.3	0.0	0.0	2.5	3.9	0.0	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0
LGALS9	LGALS9A	ENSG00000168961	"Galectin 9"	O00182	17	27629798-27649560	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 99.1;stomach 1: 87.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 181.1;Gastric mucus-secreting cells: 174.8;Hofbauer cells: 298.2;Intestinal goblet cells: 183.5;Kupffer cells: 254.2;Paneth cells: 181.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 40.2;HMC-1: 124.9;MOLT-4: 44.8;REH: 48.4;THP-1: 83.2;U-937: 92.1"									"HPA046876, HPA047218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA	448000		"Cluster 7: Monocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (2.62e-2)"	"prognostic favorable (2.35e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (4.76e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	20.7	6.4	12.6	46.0	13.0	68.5	9.5	13.8	20.8	25.6	14.3	99.1	46.3	12.8	3.0	14.5	28.4	38.2	8.7	12.8	13.4	2.4	11.6	34.2	60.9	21.7	15.2	5.3	5.2	2.8	1.2	16.8	16.5	3.7	89.2	1.0	21.2	7.9	3.8	4.2	41.8	19.4	17.3	50.7	87.5	3.8	17.0	29.1	4.1	4.1	38.9	39.6	1.9	20.1	2.0	0.7	0.6	0.3	0.1	0.2	1.6	0.4	1.3	8.9	29.6	0.1	12.6	1.5	14.2	1.1	1.5	4.1	0.3	0.1	0.5	9.4	0.9	14.9	0.9	0.0	1.0	40.2	124.9	0.3	0.0	0.4	0.0	0.5	16.5	13.6	0.6	0.5	0.0	0.1	44.8	15.0	0.4	28.4	0.0	48.4	0.0	3.6	5.9	1.0	0.3	0.8	0.0	4.4	0.2	0.9	0.2	83.2	3.1	0.0	0.3	0.1	0.2	0.1	0.1	0.3	0.2	92.1	0.2	32.6	116.2	78.2	5.6	214.9	2.6	32.3	15.6	5.9	165.5	41.7	9.6	4.0	41.7	22.0	217.4	28.5	40.3	75.1	12.6	13.0	13.8	20.8	12.8	13.4	21.7	15.2	16.5	17.3	17.0	20.1	32.2	9.6	6.3	2.0	42.2	3.2	7.7	32.9	18.8	0.2	10.5	13.2	1.7	20.0	40.5	7.3	0.0	2.3	19.0	181.1	3.9	124.1	1.5	11.4	11.6	43.5	40.5	64.3	0.4	126.9	3.1	7.4	174.8	12.9	31.1	11.2	26.0	2.2	298.2	0.0	0.6	183.5	26.4	254.2	85.4	2.2	4.4	154.1	1.8	25.3	150.7	0.2	41.2	3.5	0.9	146.0	181.6	3.0	3.5	4.4	20.6	1.4	15.4	0.6	19.7	1.6	6.2	0.1	0.7	8.8	1.7	3.7	19.6	86.2	126.7	31.1
LGALS9C		ENSG00000171916	"Galectin 9C"	Q6DKI2	17	18476737-18494945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.3;intestine: 9.3;stomach 1: 11.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.1;Gastric mucus-secreting cells: 194.2;Intestinal goblet cells: 37.9;Paneth cells: 58.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"neutrophil: 1.9;NK-cell: 5.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;NK-cells: 5.5"	"Not detected"	"Not detected"											"HPA046876, HPA047218"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.47e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.17e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.84e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	9.3	1.1	0.0	0.0	10.3	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.7	0.0	1.6	0.0	0.0	0.2	4.3	0.0	0.0	1.4	11.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	1.9	5.5	0.6	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.6	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.1	3.4	48.1	0.0	0.2	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0	0.0	0.0	194.2	0.1	0.0	0.0	0.4	0.1	0.7	0.0	0.0	37.9	4.1	2.2	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.0	9.2	0.0	0.0	0.4	58.4	0.0	0.2	0.0	13.5	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.1	4.5	0.1	0.0	1.8	0.0	10.8	0.2
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146830-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 112.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 22.2;Excitatory neurons: 17.7;Inhibitory neurons: 23.7;Melanocytes: 40.9;Oligodendrocytes: 58.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;melanoma: 14.3;thyroid cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;SCLC-21H: 1.6;SK-MEL-30: 1.6;WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	0.3	3.4	44.2	0.1	79.7	0.1	0.2	81.1	84.6	2.9	5.2	0.8	0.3	1.2	0.3	6.5	1.6	0.1	2.2	43.4	70.4	0.4	0.1	15.9	0.0	85.8	72.4	0.2	0.8	0.3	2.8	0.0	90.7	1.3	0.1	3.9	1.7	2.8	0.2	15.0	0.5	0.6	57.1	0.1	0.9	0.8	86.3	0.3	13.0	0.1	0.3	0.2	2.5	112.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	79.7	81.1	84.6	43.4	70.4	85.8	72.4	90.7	57.1	86.3	112.6	0.0	0.0	22.2	2.0	0.0	2.3	0.0	0.0	0.0	2.7	0.1	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.8	0.0	17.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.4	0.0	0.3	0.1	40.9	2.8	0.0	1.2	0.0	6.6	58.4	0.1	0.0	7.2	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.6	0.1	0.1	1.4	0.6	0.0	0.0	0.9	0.0	0.0
LHB	"CGB4, hLHB, LSH-B"	ENSG00000104826	"Luteinizing hormone subunit beta"	P01229	19	49015980-49017091	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	248	"pituitary gland: 4493.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.7;Late spermatids: 4.1;Pancreatic endocrine cells: 8.2;Syncytiotrophoblasts: 10.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;HEK 293: 1.5;Hep G2: 1.4;K-562: 1.3;U-266/84: 2.0"									"CAB022241, CAB022707, HPA038925"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"CAB022241: , CAB022707: , HPA038925: AB_2676272"	"unprognostic (8.12e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.69e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (9.52e-2)"	"unprognostic (4.86e-2)"	1.0	5.1	0.2	0.0	0.1	0.0	0.6	0.4	0.3	0.5	0.0	0.5	1.3	0.5	0.0	1.3	0.6	0.0	0.9	0.1	0.2	1.4	1.9	0.9	0.2	0.2	0.1	0.6	18.0	0.6	4493.5	0.0	0.2	0.9	0.0	0.0	1.1	0.0	0.5	3.1	1.5	0.0	0.0	1.2	4.5	5.0	0.1	0.0	0.8	0.0	0.0	0.3	0.6	0.3	0.1	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.9	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.5	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.3	0.3	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.7	0.4	0.4	0.0	0.6	1.2	0.6	0.5	0.0	0.6	0.0	0.5	0.0	0.0	0.9	0.6	0.0	0.1	0.1	2.0	0.3	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.3	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.5	0.0	0.0	0.1	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	3.7	0.3	0.0	0.2	0.0	0.0	0.0	0.9	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	4.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	1.4	0.1	0.2	0.0	0.0	0.0	0.2	1.1	1.6	0.0	0.0	10.3	0.1	0.1	0.1	0.1
LHX5		ENSG00000089116	"LIM homeobox 5"	Q9H2C1	12	113462033-113472280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 5.0"	"Cell type enhanced"	"Detected in single"		"Basal respiratory cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053908			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA053908: AB_2682304"		"unprognostic (5.20e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-2)"		"unprognostic (1.06e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.56e-1)"			"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.54e-3)"	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.0	1.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.7	0.1	0.0	1.9	5.0	1.5	1.7	1.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.2;salivary gland: 2.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 1.2;Late spermatids: 1.4;Spermatocytes: 3.3;Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 6.2;hypothalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 25.6;U-266/70: 8.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 9.7"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	1.3	1.7	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.3	0.0	0.0	8.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	6.2	0.0	6.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LILRA6	"CD85b, ILT8, LILRB6"	ENSG00000244482	"Leukocyte immunoglobulin like receptor A6"	Q6PI73	19	54236592-54242791	"Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 9.0;lymphoid tissue: 16.9"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 13.8;Kupffer cells: 31.7;Macrophages: 30.6;monocytes: 19.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.4;intermediate monocyte: 3.9;neutrophil: 8.2"	"Group enriched"	"Detected in many"	26	"granulocytes: 8.2;monocytes: 3.9"	"Not detected"	"Not detected"											HPA026985			Approved	"Plasma membrane,Cytosol"		NA	NA		21000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"HPA026985: "	"unprognostic (1.00e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.47e-5)"	"unprognostic (7.76e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-2)"	3.3	1.1	0.0	1.3	0.0	1.6	1.1	0.0	0.1	0.4	0.0	1.0	0.1	0.5	0.0	0.3	2.2	0.2	1.1	0.0	0.0	0.7	1.3	9.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.9	0.0	0.4	0.3	0.8	1.4	0.0	16.9	0.8	0.2	0.1	0.0	0.5	0.0	0.0	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.2	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	5.3	0.0	0.0	0.2	0.4	0.0	0.1	3.8	0.0	0.7	0.9	13.8	0.0	0.0	0.0	0.0	31.7	5.2	0.0	0.0	30.6	0.0	1.0	19.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1
LIMS1	"PINCH, PINCH1"	ENSG00000169756	"LIM zinc finger domain containing 1"	P48059	2	108534355-108687246	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 379.6;Macrophages: 405.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.5"									"HPA058455, HPA061230"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723, HPA061230: AB_2684456"	"unprognostic (1.79e-1)"	"unprognostic (8.82e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (7.51e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.11e-1)"	41.0	45.0	7.0	33.8	10.4	32.9	28.9	9.4	8.4	22.7	10.8	22.1	16.7	35.8	11.6	26.9	31.5	31.2	38.0	6.9	11.4	16.7	20.1	37.0	37.9	12.9	11.0	20.5	15.0	12.0	8.0	32.2	12.8	19.5	18.0	11.5	17.6	26.7	99.1	14.2	20.0	35.8	11.3	21.0	22.2	16.8	15.0	21.4	24.8	35.8	32.8	30.0	17.6	15.9	44.7	49.0	19.0	22.8	30.8	44.5	91.6	49.0	56.0	37.1	37.6	85.3	93.7	43.1	145.4	63.0	55.0	28.3	29.0	50.2	49.3	106.7	52.0	225.6	32.1	45.8	70.4	42.7	402.5	43.5	45.5	98.3	80.3	44.2	135.9	37.3	81.0	58.2	115.4	36.5	41.4	31.4	37.5	29.0	49.6	52.2	65.9	35.0	70.2	79.5	34.3	46.3	76.6	32.5	34.5	25.0	16.8	39.6	184.2	166.6	75.6	37.5	101.2	56.4	81.6	60.6	139.3	47.6	43.6	211.9	69.6	196.2	16.6	119.3	30.5	18.7	72.3	22.4	59.4	18.0	19.2	7.3	31.6	35.9	156.2	7.7	89.0	140.3	7.0	10.4	9.4	8.4	6.9	11.4	12.9	11.0	12.8	11.3	15.0	15.9	143.5	99.3	55.6	80.6	43.2	74.1	63.0	65.1	63.7	26.2	34.9	37.0	61.6	38.6	53.4	29.5	54.2	45.1	40.6	19.2	39.2	80.9	22.5	266.8	122.9	187.6	118.1	84.5	32.6	233.5	130.3	109.4	32.6	379.6	101.4	107.0	76.1	34.6	189.0	15.2	34.6	24.0	48.8	181.1	265.4	12.0	81.4	405.4	44.4	115.2	118.5	69.2	41.2	54.3	66.8	122.3	17.2	88.0	76.3	82.1	33.5	44.0	84.8	18.8	65.7	116.2	161.2	45.4	51.1	75.2	77.0	27.9	82.4	51.3	32.4	66.4
LIMS3		ENSG00000256977	"LIM zinc finger domain containing 3"	P0CW19	2	109898428-109924868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 6.5;fallopian tube: 6.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.6;Distal tubular cells: 1.9;Exocrine glandular cells: 1.2;NK-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 12.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 14.1;HMC-1: 41.3"									HPA058455	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723"										"unprognostic (2.23e-2)"								1.2	1.7	0.2	2.6	0.2	0.4	0.7	0.2	0.4	1.3	0.2	0.5	0.7	6.5	1.7	1.6	6.4	1.3	1.9	0.2	0.3	2.8	0.2	0.5	0.6	0.4	0.3	2.3	0.9	0.5	0.6	1.5	0.4	0.5	1.2	0.4	1.0	1.0	5.7	0.2	0.8	1.5	0.2	0.5	0.7	1.2	0.3	1.0	0.6	2.0	0.4	1.7	0.3	0.5	0.1	0.1	1.8	2.1	0.7	0.6	0.0	2.2	0.0	0.4	0.9	2.2	0.0	0.0	6.5	0.4	4.2	1.2	0.0	2.6	1.8	3.5	0.0	14.1	0.6	1.3	1.9	2.5	41.3	3.0	1.5	1.6	1.9	0.0	3.5	0.0	3.0	2.3	4.6	0.1	0.0	0.3	2.2	1.4	0.8	2.6	4.4	1.5	1.2	2.2	0.6	5.0	5.7	0.0	1.2	0.1	0.0	0.7	10.4	8.8	8.1	4.6	0.4	0.0	0.0	2.8	1.2	0.0	2.6	5.6	3.2	12.3	0.7	5.4	1.4	0.6	4.7	1.5	2.4	0.2	0.8	0.3	0.6	1.2	5.7	0.2	6.1	8.5	0.2	0.2	0.2	0.4	0.2	0.3	0.4	0.3	0.4	0.2	0.3	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1
LINC00634		ENSG00000205704	"Long intergenic non-protein coding RNA 634"		22	41952174-41958933	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	9	"brain: 33.2;choroid plexus: 10.7"	"Group enriched"	"Detected in some"	35	"Astrocytes: 5.2;Excitatory neurons: 4.0;Inhibitory neurons: 3.6;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 1.6"	"Cancer enriched"	"Detected in single"	13	"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 2.9;SCLC-21H: 2.7"									HPA029815			Approved	"Nuclear speckles,Cytosol"		NA	NA					"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear speckles"	Cytosol	"HPA029815: AB_10601803"	"unprognostic (1.42e-1)"	"unprognostic (8.80e-4)"	"unprognostic (3.93e-4)"	"unprognostic (9.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.11e-6)"	"unprognostic (5.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.17e-1)"	0.0	2.1	27.4	0.0	25.9	0.1	0.0	16.3	33.2	0.0	10.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.2	22.6	0.0	0.0	0.0	0.0	19.0	23.6	0.0	0.0	0.0		0.0	17.9	0.1	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	15.6	0.0	0.2	1.0	30.1	0.0	0.0	0.0	0.1	0.0		21.9	0.3	0.0	1.3	1.3	0.0	0.7	0.8	0.0	0.0	0.2	0.3	0.4	1.0	2.4	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	2.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.0	2.5	0.1	1.5	0.0	0.6	1.0	1.4	0.3	0.3	2.0	2.9	0.5	0.1	0.0	0.1	2.7	1.8	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.3	0.8	1.7	2.4	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	25.9	16.3	33.2	30.2	22.6	19.0	23.6	17.9	15.6	30.1	21.9	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 398.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 123.6;monocytes: 355.1"	"Cell line enhanced"	"Detected in many"		"A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		280000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	76.0	46.3	43.5	66.7	65.2	39.8	47.8	64.1	74.4	54.0	39.0	67.7	167.6	38.8	21.7	28.6	37.8	83.5	24.2	43.5	53.1	44.9	218.9	169.5	159.3	74.7	55.5	32.7	21.4	68.9	12.7	79.1	82.2	30.7	72.0	12.6	22.5	33.8	11.8	18.7	227.5	47.7	65.4	398.4	34.3	13.4	57.0	44.5	31.6	22.5	45.5	58.4	19.3	115.5	354.4	49.4	30.7	367.8	343.5	450.8	10.0	171.4	194.8	65.5	121.5	18.6	176.6	63.9	34.0	264.4	73.7	338.7	13.8	92.8	53.6	86.1	34.7	25.1	19.1	81.5	87.6	48.8	48.9	190.4	69.2	72.9	40.6	88.2	14.9	45.4	0.3	108.5	58.3	28.2	45.7	34.6	22.7	62.4	60.0	26.4	39.0	60.5	69.2	50.9	10.5	21.8	41.4	49.9	133.9	20.4	64.4	65.8	26.2	58.8	15.5	132.1	44.6	60.0	65.7	25.8	71.4	112.9	82.1	4.2	167.3	16.9	40.0	355.1	40.6	31.9	35.8	38.8	123.6	33.4	36.7	40.4	7.1	29.8	198.5	25.0	38.2	159.6	43.5	65.2	64.1	74.4	43.5	53.1	74.7	55.5	82.2	65.4	57.0	115.5	75.5	41.7	33.8	11.1	35.9	17.7	30.3	58.1	25.6	5.4	16.1	14.1	9.6	45.8	31.9	33.1	0.0	34.8	31.4	2.8	21.5	35.1	6.8	11.4	20.4	56.7	21.8	27.4	34.4	36.2	32.9	34.6	21.4	15.5	28.5	10.8	54.7	66.7	515.0	16.8	15.1	8.9	40.7	714.8	69.0	2.7	11.5	303.1	48.0	30.0	71.7	33.1	29.9	15.1	143.0	19.3	12.0	21.8	15.4	11.3	161.0	14.0	28.8	2.2	6.6	19.7	21.0	5.1	13.8	31.9	12.5	20.0	33.1	17.6	9.1	24.0
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 32.4;retina: 42.6"	"Cell type enriched"	"Detected in some"	13	"Muller glia cells: 289.4"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Group enriched"	"Detected in some"	13	"RPTEC TERT1: 53.5;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: AB_2683715"	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	0.0	0.3	24.0	0.2	22.3	0.3	0.0	24.7	16.2	0.0	7.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	26.6	30.7	3.1	0.0	0.0	0.5	31.1	32.4	0.0	0.0	0.0	1.5	0.4	24.7	1.5	0.3	42.6	0.0	5.8	0.0	0.1	0.2	0.2	32.2	0.1	0.4	0.1	26.1	0.0	4.6	0.0	0.0	0.0	0.0	29.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.1	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.0	22.3	24.7	16.2	26.6	30.7	31.1	32.4	24.7	32.2	26.1	29.1	0.0	0.0	0.0	21.2	1.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.7	0.0	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.3	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	289.4	0.0	0.5	1.4	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIX1L	MGC46719	ENSG00000271601	"Limb and CNS expressed 1 like"	Q8IVB5	1	145933423-145958017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063598			Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA063598: AB_2685055"	"unprognostic (5.21e-2)"	"unprognostic (4.09e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.95e-1)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (5.27e-4)"	21.0	19.0	14.6	15.2	15.1	6.4	16.0	13.8	13.1	27.1	15.6	23.0	6.7	27.6	11.1	9.8	21.1	15.6	16.3	12.9	13.5	9.8	10.2	15.6	20.4	15.0	15.2	36.9	5.8	7.5	16.3	16.2	14.0	16.2	9.2	19.0	9.4	20.8	34.8	8.1	13.3	25.7	13.9	20.8	11.3	6.6	15.8	16.6	10.8	31.5	20.8	21.1	16.9	15.0	7.3	10.3	31.0	34.5	63.4	53.5	0.4	16.3	29.4	24.8	18.1	0.8	6.7	19.6	17.5	33.1	9.3	0.4	14.6	13.6	23.3	18.2	4.5	10.9	11.0	10.4	20.8	26.2	24.8	32.9	6.2	20.3	29.3	39.9	48.7	25.8	16.4	30.6	39.9	0.2	34.6	21.8	9.0	0.1	13.2	23.2	15.6	32.4	25.7	0.2	11.1	31.6	33.5	0.1	24.9	12.8	1.2	20.3	38.0	41.9	11.5	27.6	27.8	24.5	18.7	19.9	29.5	21.4	20.7	4.0	2.2	3.9	5.7	2.2	7.0	3.0	6.6	5.8	2.1	3.1	6.1	8.0	3.7	3.8	3.8	3.3	5.4	2.6	14.6	15.1	13.8	13.1	12.9	13.5	15.0	15.2	14.0	13.9	15.8	15.0	29.7	0.0	5.8	11.1	23.1	11.3	10.6	10.8	11.4	17.1	3.8	7.5	17.5	14.3	4.9	11.0	8.4	1.4	18.6	2.8	3.9	9.6	10.4	2.3	21.6	36.7	12.6	23.5	5.1	10.0	4.3	28.4	2.6	3.5	5.1	10.8	45.7	19.6	21.1	13.5	6.1	1.4	8.2	24.3	43.8	3.6	35.8	18.8	28.4	15.9	27.4	28.1	35.0	8.5	7.0	11.0	1.2	56.4	17.8	7.5	0.1	7.7	3.0	13.6	26.3	16.8	37.9	24.1	4.7	3.1	7.7	0.8	37.4	21.4	2.1	4.2
LMBR1	"ACHP, C7orf2, FLJ11665, ZRS"	ENSG00000105983	"Limb development membrane protein 1"	Q8WVP7	7	156668946-156893216	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.7;Inhibitory neurons: 128.7;Microglial cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016592	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA016592: AB_1852943"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (3.35e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.10e-2)"	10.0	26.0	8.8	8.4	10.4	7.8	10.7	11.3	13.2	13.6	7.8	8.9	8.0	13.2	18.1	9.9	14.1	10.2	11.2	9.7	13.2	15.7	13.8	9.1	9.4	11.0	10.0	16.5	8.8	38.0	7.5	10.1	11.2	12.2	10.3	14.3	8.4	10.7	6.7	8.4	9.3	13.2	8.9	7.6	11.9	17.7	10.6	11.8	17.6	11.4	8.7	11.9	6.0	8.5	26.9	20.6	27.5	33.4	21.1	24.0	16.6	14.5	20.5	14.2	16.8	15.4	42.4	25.3	27.6	19.7	27.3	20.4	28.4	28.9	29.1	19.5	25.5	19.1	11.6	19.7	13.6	23.8	13.6	19.3	27.0	20.4	27.3	22.8	29.6	23.4	35.7	23.8	26.9	24.3	25.1	20.5	29.4	30.4	18.7	13.1	18.1	31.6	22.8	25.1	26.1	51.9	20.4	27.8	15.6	17.8	19.1	14.3	38.4	25.1	9.3	82.7	19.6	25.6	22.6	24.0	40.0	30.2	16.4	1.8	0.7	1.0	0.7	0.4	1.4	0.6	1.2	1.2	1.3	0.8	1.5	1.0	0.6	0.2	0.7	0.9	0.9	0.6	8.8	10.4	11.3	13.2	9.7	13.2	11.0	10.0	11.2	8.9	10.6	8.5	25.6	3.2	8.1	54.5	23.7	10.5	13.7	9.9	43.3	11.5	12.8	8.5	17.1	11.5	7.2	12.9	2.1	14.3	8.4	8.6	5.9	11.0	7.4	17.0	8.6	24.8	8.3	17.4	110.7	10.1	5.6	15.2	23.0	15.7	5.7	43.2	9.3	19.2	10.2	8.4	128.7	9.9	10.2	10.1	8.0	9.7	10.5	9.3	7.2	99.3	8.2	6.7	3.1	72.4	70.4	12.6	6.1	8.6	23.4	20.0	9.7	12.2	9.7	10.9	0.0	11.9	11.0	18.0	28.7	30.9	12.8	23.1	18.0	26.2	11.1	16.6
LMBRD2	DKFZp434H2226	ENSG00000164187	"LMBR1 domain containing 2"	Q68DH5	5	36098407-36151887	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 71.4;Inhibitory neurons: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012165	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012165: AB_2136131"	"unprognostic (9.43e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.45e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.35e-2)"	4.6	6.6	4.8	5.0	7.2	1.7	6.1	3.6	9.5	4.7	2.2	6.3	7.0	3.4	4.9	4.7	3.2	4.1	6.0	9.0	4.1	7.2	10.3	4.1	5.9	2.1	3.8	3.2	5.0	10.7	4.7	6.1	2.6	6.6	6.3	6.9	6.0	4.4	5.5	5.5	7.1	3.8	3.7	5.1	7.3	3.8	4.7	5.9	9.0	8.6	5.4	4.2	2.9	5.2	5.5	4.0	4.8	7.9	9.7	8.5	16.8	11.1	5.8	8.0	8.0	5.0	11.7	9.8	5.5	5.9	8.2	7.3	6.4	3.9	13.1	14.1	3.9	7.6	13.6	0.9	6.2	9.3	9.7	5.1	6.7	6.9	6.8	6.0	4.4	7.4	9.1	10.0	9.8	3.6	8.0	6.1	2.6	8.5	5.0	6.0	11.1	6.0	6.8	4.7	8.9	6.9	16.1	9.4	3.9	4.7	10.7	11.1	5.9	9.5	2.5	12.3	6.0	8.2	12.8	8.5	9.0	10.4	6.7	10.6	0.8	1.4	1.0	0.8	0.7	1.0	0.9	0.9	0.7	0.8	1.2	1.2	0.6	0.7	0.8	0.8	1.6	0.5	4.8	7.2	3.6	9.5	9.0	4.1	2.1	3.8	2.6	3.7	4.7	5.2	8.8	9.6	9.8	33.3	10.2	6.9	4.8	6.3	7.4	11.9	10.8	6.1	24.1	12.8	7.3	12.9	8.4	9.0	7.5	19.4	3.9	5.0	2.1	6.8	6.4	7.3	6.7	9.0	71.4	7.6	6.6	10.3	15.8	6.5	7.0	7.3	9.3	30.2	11.8	15.2	51.1	12.6	8.2	11.0	6.0	1.4	4.7	8.7	7.2	14.0	9.7	14.3	6.2	36.2	37.8	6.0	6.5	7.2	11.9	6.3	13.0	12.3	12.0	11.2	13.1	10.5	9.7	27.5	10.0	9.7	10.1	19.4	10.0	7.2	12.0	4.0
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 248.8"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 1682.7;Urothelial cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	177	"amygdala: 12.6;basal ganglia: 19.9;cerebral cortex: 25.6;hippocampal formation: 14.9;white matter: 15.4"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 13.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 343.4;fHDF/TERT166: 568.2;LHCN-M2: 525.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 20.8;basal ganglia: 32.8;cerebral cortex: 26.6;hippocampal formation: 33.8"	"HPA020923, HPA050184"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA		8200	"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	Cytosol	"HPA020923: AB_1852963, HPA050184: AB_2681045"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	4.4	5.3	12.6	10.6	19.9	4.1	9.3	0.0	25.6	12.8	4.8	47.4	66.3	5.7	12.1	153.7	14.5	43.3	248.8	14.9	0.0	44.1	61.9	178.7	11.0	0.0	0.0	18.6	25.5	11.8	6.4	41.3	0.0	27.3	32.5	4.8	32.4	15.1	143.5	21.1	79.7	7.9	0.0	5.0	62.7	18.2	0.0	56.8	53.5	99.5	37.1	24.5	38.4	15.4	77.8	43.6	1.7	1.3	86.5	61.4	14.9	343.4	168.3	85.4	91.6	107.4	97.8	6.6	25.7	568.2	21.2	73.5	18.9	16.6	97.8	105.4	4.5	47.8	229.2	102.2	25.0	15.3	24.0	42.0	31.1	37.0	42.3	207.9	36.2	14.7	1.7	0.5	525.9	30.4	11.6	6.4	2.2	119.6	65.0	7.2	159.5	1.6	36.0	18.1	5.4	11.6	62.2	10.8	13.8	8.6	14.0	11.3	55.6	208.7	38.7	25.4	84.9	22.6	18.4	27.8	61.6	17.0	97.0	4.5	0.2	2.7	0.6	0.5	0.9	1.1	3.2	1.0	0.4	2.3	13.6	8.6	0.1	0.6	0.4	1.1	1.4	2.6	12.6	19.9	0.0	25.6	14.9	0.0	0.0	0.0	0.0	0.0	0.0	15.4	1.5	1682.7	279.7	22.2	4.3	24.0	74.7	59.9	72.8	6.8	10.5	13.2	362.6	51.5	317.2	62.5	2.1	45.5	3.6	378.5	15.6	81.5	6.2	92.0	19.0	9.0	71.2	3.6	162.3	37.8	8.7	38.0	276.3	244.4	20.3	9.5	6.1	72.7	6.0	6.7	82.5	96.6	67.1	3.5	4.4	8.0	42.0	6.4	16.0	39.4	2.8	1.9	3.1	30.7	48.4	228.8	351.2	42.5	2.1	344.9	213.8	15.5	199.5	10.5	13.1	27.2	18.1	11.2	6.3	100.9	45.3	17.0	12.9	2.5	75.2	435.7
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896456-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 513.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Leydig cells: 125.6;Peritubular cells: 275.3;Rod photoreceptor cells: 70.2;Sertoli cells: 197.2;Smooth muscle cells: 224.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.8;BJ: 21.3;BJ hTERT+: 34.4;fHDF/TERT166: 17.4;HSkMC: 14.5;hTERT-RPE1: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	157.7	52.5	7.8	28.5	9.7	0.0	75.4	5.7	9.1	161.9	5.5	513.9	25.1	309.5	49.7	135.8	194.7	85.5	31.7	6.2	8.0	11.8	5.1	44.3	7.3	13.6	6.5	72.2	8.4	18.2	5.8	35.3	6.8	165.2	46.9	48.0	21.2	242.5	137.5	43.2	115.5	206.6	5.4	18.5	218.6	17.9	9.1	2.5	39.8	45.7	1.6	368.7	111.9	7.2	0.0	0.1	0.4	1.2	15.8	2.0	1.3	21.3	34.4	1.3	1.5	0.1	0.2	0.0	0.7	17.4	0.2	0.3	0.5	0.0	0.4	0.0	1.4	0.0	0.1	0.0	1.5	0.1	0.1	14.5	0.0	1.0	0.0	54.4	0.1	0.0	0.2	0.2	0.7	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.4	0.1	0.3	0.0	0.5	0.4	9.5	0.7	0.0	0.0	0.1	0.8	0.3	0.0	0.7	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	9.7	5.7	9.1	6.2	8.0	13.6	6.5	6.8	5.4	9.1	7.2	16.1	0.0	1.1	8.5	0.3	1.3	1.0	0.3	0.0	4.8	1.6	40.8	25.1	0.0	0.0	0.0	135.5	1.7	0.0	0.1	0.0	0.0	2.1	2.6	64.5	5.8	0.0	0.0	0.5	0.6	0.3	20.4	0.5	1.2	0.0	0.7	9.3	0.4	1.0	3.3	1.0	0.0	0.0	0.0	2.3	8.2	125.6	0.9	3.6	3.7	0.0	7.3	0.0	4.0	1.0	0.0	0.0	275.3	0.0	0.9	0.0	0.1	0.9	70.2	197.2	5.2	224.3	1.2	0.5	0.8	2.3	1.2	1.3	2.1	0.0	0.4
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106862-98209638	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 50.7;Excitatory neurons: 114.9;Inhibitory neurons: 69.0;Oligodendrocyte precursor cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.2"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: AB_2677698"	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	3.5	7.0	4.2	3.9	6.2	13.8	3.6	0.0	25.2	4.9	0.0	9.7	8.8	3.9	3.9	9.5	4.1	4.2	12.4	6.0	0.0	6.6	6.2	6.6	3.6	2.1	0.5	5.0	14.8	10.7	7.0	3.1	1.8	5.1	8.0	8.2	7.9	4.0	11.1	9.0	9.8	3.7	0.0	4.6	6.5	5.2	1.2	4.9	5.8	7.0	4.8	5.8	6.2	8.7	12.5	14.5	11.0	11.4	5.8	4.6	10.2	5.1	5.5	4.9	5.9	11.5	11.1	6.5	14.3	6.5	18.6	13.4	12.8	7.8	7.6	9.4	9.0	4.4	13.0	11.6	7.0	8.0	7.6	3.2	10.5	10.1	13.6	4.9	7.4	7.4	11.8	13.4	4.5	16.9	8.5	4.8	13.4	17.1	7.0	9.2	7.5	13.0	8.2	21.7	7.8	15.7	10.2	18.4	7.4	11.0	5.1	3.2	9.2	10.2	16.6	20.5	11.7	5.9	11.2	12.8	6.8	6.2	12.3	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.4	1.4	0.1	0.3	0.2	0.2	0.1	4.2	6.2	0.0	25.2	6.0	0.0	2.1	0.5	1.8	0.0	1.2	8.7	6.0	28.9	17.0	28.7	7.8	9.7	4.3	6.2	14.8	14.2	5.5	3.9	22.4	15.7	11.8	1.8	14.6	2.8	7.5	50.7	1.9	6.1	1.1	13.2	7.6	5.7	12.0	8.4	114.9	9.1	1.9	5.4	21.4	26.4	2.5	5.3	2.5	8.4	2.2	6.7	69.0	14.7	4.1	1.6	2.3	2.0	1.8	3.2	1.8	16.9	2.8	6.1	7.2	52.3	29.6	10.3	23.8	4.5	12.9	8.8	14.0	3.0	15.8	10.6	0.0	8.6	5.7	6.9	6.3	15.5	10.9	3.0	8.6	2.7	14.7	20.5
LNP1	NP3	ENSG00000206535	"Leukemia NUP98 fusion partner 1"	A1A4G5	3	100401532-100456319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 46.1;testis: 29.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 50.1;Early spermatids: 147.6;Horizontal cells: 257.4;Spermatocytes: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"PC-3: 18.7;U-266/84: 17.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 6.8;cerebral cortex: 8.7;hippocampal formation: 7.3;olfactory bulb: 5.0"	HPA047926			Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles	"Nuclear speckles, Cytosol"	"HPA047926: "	"unprognostic (1.78e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.40e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.08e-2)"	2.2	1.9	5.1	0.8	5.9	0.1	1.9	5.3	6.1	2.6	3.0	2.5	0.6	3.1	6.7	1.3	3.0	2.0	8.5	5.2	6.0	4.3	7.7	3.1	0.9	5.2	5.1	3.9	3.3	1.7	6.1	2.7	6.4	1.9	1.5	46.1	2.0	2.3	2.9	0.7	1.2	2.7	4.6	1.2	1.5	29.0	4.7	1.3	3.6	2.1	1.1	3.1	1.7	5.3	3.2	1.7	9.9	0.9	4.1	2.9	0.7	2.0	6.3	2.7	2.8	0.9	0.9	2.4	0.9	1.9	2.8	2.1	1.8	3.2	2.9	2.6	2.1	7.1	0.5	4.0	1.8	5.4	0.8	3.5	0.8	1.2	5.0	2.5	0.3	1.0	2.7	11.6	2.1	2.7	6.2	4.3	7.6	2.1	18.7	4.6	5.4	6.1	1.9	0.4	9.5	4.9	1.6	2.7	4.5	2.3	0.6	0.6	0.7	1.0	10.4	1.0	2.2	14.9	17.3	9.5	3.3	3.3	2.1	0.0	0.0	0.0	0.4	0.0	0.9	0.3	0.3	0.2	0.2	0.1	0.4	0.4	0.0	0.1	0.0	0.0	1.4	0.1	5.1	5.9	5.3	6.1	5.2	6.0	5.2	5.1	6.4	4.6	4.7	5.3	0.9	0.0	0.5	4.2	1.8	1.0	1.3	0.7	2.2	42.2	2.2	1.9	10.5	0.0	1.5	1.8	50.1	1.5	0.3	0.6	7.9	0.8	147.6	0.9	2.3	1.2	2.4	6.1	6.9	1.0	1.9	3.2	3.1	0.7	0.0	1.2	0.0	1.7	0.6	257.4	11.3	1.6	0.0	0.3	0.3	34.2	3.4	0.3	21.4	0.0	0.7	17.1	1.0	7.5	3.7	0.6	0.5	1.2	7.5	0.8	1.1	6.0	3.3	44.3	0.0	1.9	4.6	91.8	3.3	0.6	0.6	0.4	0.7	0.7	0.8	0.5
LNX2	"MGC46315, PDZRN1"	ENSG00000139517	"Ligand of numb-protein X 2"	Q8N448	13	27545913-27620529	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040698	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	"Plasma membrane, Cytosol"	"HPA040698: AB_10673138"	"unprognostic (4.97e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.79e-2)"	"prognostic favorable (7.09e-13)"	"unprognostic (4.18e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-2)"	3.2	6.7	2.0	3.7	2.3	3.8	6.9	5.1	3.0	4.0	6.5	10.7	14.2	3.0	4.8	10.6	4.6	7.9	8.7	2.4	2.8	7.9	20.5	11.5	4.0	1.7	1.8	4.3	19.6	7.1	3.2	3.7	1.7	6.4	10.5	8.0	9.4	4.8	5.9	6.6	13.4	3.8	1.9	3.1	9.9	12.3	2.4	7.8	9.9	5.9	5.1	6.2	6.7	1.9	6.4	3.5	6.5	7.2	6.7	3.1	6.8	5.6	4.9	5.4	4.9	12.7	12.5	9.6	4.7	4.9	9.8	12.0	11.8	15.0	7.0	6.0	4.9	12.3	7.2	9.3	10.5	6.6	7.6	2.6	22.8	3.8	14.7	15.4	9.9	9.9	3.8	3.6	7.9	7.9	10.0	4.4	7.2	29.0	3.9	9.2	12.7	5.0	11.9	11.1	16.7	3.5	7.6	15.4	10.1	8.0	10.7	5.2	12.6	3.1	4.3	3.1	4.6	3.5	6.3	9.9	2.0	6.3	4.4	2.0	0.3	0.9	0.5	0.1	0.7	0.5	0.6	0.7	0.3	0.5	0.6	0.6	0.3	1.1	0.2	0.1	1.0	0.2	2.0	2.3	5.1	3.0	2.4	2.8	1.7	1.8	1.7	1.9	2.4	1.9	4.5	32.1	27.6	9.8	5.6	25.4	27.7	15.8	23.9	8.9	13.3	7.6	11.4	25.8	11.4	20.2	2.1	1.5	5.5	27.8	3.9	10.2	16.4	11.0	2.7	7.2	10.2	18.9	23.2	14.2	8.1	3.2	11.7	14.7	1.3	10.8	9.3	59.2	2.3	5.0	8.0	17.0	8.2	5.0	7.7	7.3	2.8	2.8	10.6	21.5	2.3	4.4	5.2	3.0	6.7	11.0	23.5	3.4	5.4	16.8	17.8	7.8	15.9	16.3	0.0	3.1	3.5	15.6	17.5	14.8	22.0	3.0	5.5	11.1	11.9	20.9
LONRF1	"FLJ23749, RNF191"	ENSG00000154359	"LON peptidase N-terminal domain and ring finger 1"	Q17RB8	8	12721906-12756073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023584, HPA024814"	Uncertain		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	Centrosome	"HPA023584: AB_1853233, HPA024814: AB_1853235"	"unprognostic (2.59e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.15e-1)"	16.2	5.8	2.8	4.5	2.7	5.9	10.5	3.4	3.7	11.4	1.3	7.7	2.3	11.3	9.6	13.0	10.5	9.5	4.9	3.0	2.3	6.3	9.9	7.3	7.1	2.2	2.1	15.2	7.5	8.0	3.8	10.1	1.9	10.7	4.3	7.9	8.0	10.6	17.2	28.7	4.5	9.2	2.3	8.4	5.4	15.8	2.6	6.8	8.7	11.3	8.1	7.9	8.3	3.0	1.2	3.0	15.0	4.6	15.6	7.4	10.0	3.8	6.3	4.1	5.7	0.9	3.9	24.0	0.9	6.7	12.9	1.8	12.0	4.7	4.6	3.7	6.8	7.9	0.5	6.2	14.4	2.1	3.0	7.0	8.2	2.6	8.9	3.8	6.4	9.7	1.1	56.6	2.7	4.2	10.4	7.0	15.5	4.8	0.9	5.8	10.2	4.3	3.5	10.2	31.2	3.6	2.2	5.1	29.8	10.7	1.0	10.4	2.9	2.2	3.7	8.9	3.0	4.3	20.7	12.4	12.0	7.2	7.0	0.0	0.1	0.6	0.1	0.5	0.3	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	2.8	2.7	3.4	3.7	3.0	2.3	2.2	2.1	1.9	2.3	2.6	3.0	18.9	9.6	16.3	23.2	25.2	60.8	32.8	7.8	52.3	25.1	15.1	10.3	9.7	10.0	13.1	11.0	16.7	3.6	6.3	4.3	7.9	5.3	57.4	12.1	27.9	15.1	2.4	4.6	67.0	4.0	8.2	24.2	5.6	28.3	6.3	27.8	6.1	14.7	5.6	8.4	43.6	6.4	4.1	9.5	27.6	53.5	29.2	17.2	44.4	21.5	3.6	8.3	0.0	42.7	14.9	4.3	6.4	19.9	16.3	26.4	3.8	6.0	8.7	13.0	19.7	36.7	32.7	8.2	19.7	26.4	73.6	7.3	9.7	3.4	5.8	30.1
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.5;tongue: 137.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.2	15.0	29.0	14.9	30.6	8.6	36.7	24.2	24.9	25.1	21.9	16.7	11.9	16.6	19.0	40.5	15.6	13.0	20.1	21.0	32.1	14.9	27.0	16.1	22.3	31.8	38.2	31.5	9.9	23.1	34.2	11.7	35.3	13.7	8.5	14.8	27.3	14.1	193.5	13.4	19.7	13.0	14.1	14.8	14.9	57.4	35.0	16.1	14.6	137.2	26.3	19.9	23.1	18.8	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.0	30.6	24.2	24.9	21.0	32.1	31.8	38.2	35.3	14.1	35.0	18.8	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013144	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 154.4;Granulosa cells: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	9.7	9.3	17.9	21.2	19.9	19.8	9.8	14.6	17.4	9.7	16.6	13.9	62.8	9.8	6.7	10.0	9.5	25.7	7.2	16.1	24.2	26.4	165.8	21.2	24.3	22.7	22.0	13.2	16.4	13.5	10.9	15.7	24.2	9.0	12.5	10.7	7.4	8.0	2.7	3.6	39.9	9.6	15.6	20.3	28.1	22.0	28.8	18.9	12.1	3.0	19.2	9.9	6.0	14.3	8.7	12.0	17.1	6.6	31.7	27.4	10.5	17.4	22.8	18.9	16.9	16.7	7.1	5.4	10.8	30.2	30.2	0.2	13.8	6.3	13.2	11.2	2.7	13.3	10.0	19.4	27.2	11.2	17.0	27.4	4.6	18.5	17.2	28.2	23.4	14.8	12.8	3.5	28.2	7.2	15.0	12.0	5.7	13.7	13.1	26.7	14.0	23.2	17.6	20.0	14.4	10.2	18.4	9.1	6.8	10.7	0.0	18.0	31.2	25.3	28.7	31.7	14.6	5.0	7.9	12.3	22.1	12.2	8.1	8.7	2.4	7.8	11.8	1.5	12.1	1.0	9.2	7.2	1.0	1.7	9.1	6.3	23.4	12.5	0.8	1.5	9.2	3.2	17.9	19.9	14.6	17.4	16.1	24.2	22.7	22.0	24.2	15.6	28.8	14.3	17.7	67.3	44.0	55.2	20.4	5.6	9.8	8.5	5.7	35.7	12.1	11.2	11.2	154.4	23.9	38.6	14.6	25.2	41.9	45.3	17.6	11.8	3.3	48.2	33.3	18.9	14.9	138.1	26.3	19.0	11.3	25.4	103.0	64.4	12.6	323.0	19.2	131.1	23.1	116.1	65.6	36.8	16.2	26.8	8.9	11.0	22.7	31.1	8.8	79.6	31.2	16.7	59.8	37.7	21.0	22.2	21.6	31.2	16.1	21.2	92.4	54.9	17.1	16.7	6.6	16.6	20.1	26.5	73.0	0.6	2.0	49.5	58.9	20.3	14.0	14.1
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264435-151015727	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		340000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.3	10.7	3.4	9.3	6.9	11.1	22.7	11.1	3.8	13.1	18.6	16.7	13.3	6.9	14.2	13.9	15.2	9.9	8.3	2.9	2.2	23.5	13.4	11.0	15.8	5.1	4.5	8.9	13.5	34.2	6.5	7.0	6.1	20.0	17.4	14.9	13.8	8.9	7.2	19.3	11.5	6.6	3.4	9.6	17.0	9.4	3.7	18.7	19.1	8.9	17.7	12.3	7.0	6.3	27.6	14.3	11.9	11.1	12.2	18.5	17.0	6.0	15.8	10.9	10.2	30.9	35.6	33.7	7.2	8.6	7.5	13.7	22.1	36.6	15.3	25.9	15.8	20.8	19.8	19.0	7.5	29.0	16.2	14.6	21.1	16.0	24.6	23.9	32.9	14.8	22.4	24.3	12.9	21.9	21.9	7.7	10.7	23.7	10.3	18.4	12.0	12.6	42.0	33.7	39.3	13.0	15.1	32.1	7.4	18.1	32.4	6.1	17.2	16.8	12.2	8.7	11.4	20.9	20.5	20.5	26.2	16.0	6.6	5.7	0.6	1.2	5.0	0.2	3.3	4.9	3.3	4.7	1.0	2.1	2.3	4.0	0.1	3.2	2.1	2.1	4.6	1.8	3.4	6.9	11.1	3.8	2.9	2.2	5.1	4.5	6.1	3.4	3.7	6.3	10.4	16.0	14.9	148.5	42.5	17.5	16.4	21.0	28.5	33.5	30.8	18.2	55.9	21.5	21.5	51.5	148.0	23.7	37.7	19.7	9.8	15.2	25.5	51.2	11.0	13.3	42.0	40.2	213.7	13.5	10.6	12.8	56.6	61.8	6.3	22.4	10.0	20.5	6.1	30.3	192.6	23.8	24.4	11.1	12.8	5.5	9.6	17.7	16.0	161.1	8.2	17.7	46.4	239.8	217.4	17.2	20.2	10.1	38.3	22.4	22.0	15.8	36.7	72.6	6.6	13.7	9.8	16.6	22.3	37.3	23.7	24.2	45.6	25.9	27.2	24.0
LRCH1	"CHDC1, KIAA1016"	ENSG00000136141	"Leucine rich repeats and calponin homology domain containing 1"	Q9Y2L9	13	46553168-46753040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 89.2;Inhibitory neurons: 117.6;Microglial cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 37.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021536	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Actin filaments, Cytosol"	Nucleoli	"HPA021536: AB_1853258"	"unprognostic (7.13e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (3.59e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.98e-2)"	15.1	5.0	4.7	10.7	4.7	8.9	14.6	37.1	6.2	15.9	4.2	15.2	7.9	16.3	7.7	10.0	11.8	12.6	8.4	5.7	6.1	14.9	12.2	13.8	16.3	6.5	7.0	10.1	5.6	5.4	5.8	18.2	7.8	10.8	10.0	10.3	10.0	12.0	3.9	17.9	11.6	17.6	7.9	14.6	13.0	4.6	6.8	18.5	6.5	7.5	15.7	13.5	9.7	7.5	7.4	10.4	9.2	9.6	6.6	12.5	23.6	12.4	16.1	15.0	14.2	23.5	12.3	23.4	3.4	11.7	9.8	10.4	7.1	12.5	21.6	24.2	6.6	21.0	4.3	11.1	8.2	13.8	34.5	7.9	9.7	13.9	16.8	12.3	13.1	15.6	4.2	6.9	11.2	14.2	14.8	17.3	5.2	46.3	5.5	8.0	10.0	6.3	28.1	7.5	14.5	14.6	7.0	6.8	18.8	16.2	5.3	18.3	12.5	8.8	6.0	11.0	11.9	1.3	3.7	10.6	10.3	11.9	10.8	0.6	0.9	0.9	1.5	0.7	0.8	2.2	1.1	1.0	0.8	2.7	0.8	0.9	0.3	2.5	0.5	1.0	0.8	0.9	4.7	4.7	37.1	6.2	5.7	6.1	6.5	7.0	7.8	7.9	6.8	7.5	61.5	6.4	6.1	24.8	26.7	37.5	10.5	6.2	27.3	8.3	12.0	11.8	7.2	17.2	6.5	22.0	22.9	13.4	8.4	6.8	9.8	8.3	1.6	5.4	6.5	32.5	1.8	9.9	89.2	4.2	12.7	14.3	18.8	13.7	27.9	2.8	17.5	9.3	13.4	3.3	117.6	10.6	8.2	16.9	30.7	2.1	13.1	12.3	30.2	183.6	8.4	5.5	8.2	64.8	9.7	13.5	5.5	17.0	12.4	12.9	8.0	8.4	2.6	8.5	13.1	15.6	18.6	1.7	4.1	15.9	33.2	9.7	14.7	15.3	7.8	9.2
LRCH4	"LRN, LRRN1"	ENSG00000077454	"Leucine rich repeats and calponin homology domain containing 4"	O75427	7	100574011-100586129	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 205.8;Syncytiotrophoblasts: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 79.6;NB-4: 174.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037667, HPA037668"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA037667: AB_10671882, HPA037668: AB_10672910"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.32e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.98e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.63e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.26e-2)"	29.0	37.5	15.8	25.3	18.3	49.2	26.8	16.8	26.1	32.5	17.0	32.7	19.1	28.3	5.1	35.8	33.7	8.5	28.0	15.5	17.7	35.5	30.9	52.0	33.6	21.4	17.1	55.3	33.5	12.7	51.2	10.9	20.5	36.1	5.5	21.4	36.3	8.8	41.4	30.3	71.6	5.3	16.0	130.1	31.2	112.3	20.3	27.1	47.8	7.2	14.7	24.3	29.9	23.1	15.2	9.8	8.5	9.2	6.5	4.3	17.3	14.5	7.3	9.0	7.1	16.6	24.7	9.9	17.0	3.6	10.7	15.9	5.5	7.0	3.0	10.5	12.2	9.8	12.0	8.1	18.4	18.0	79.6	8.0	7.5	7.6	5.5	7.6	10.3	27.6	18.5	18.7	6.6	32.2	21.2	174.5	11.5	20.5	11.2	25.6	7.1	13.9	10.3	4.2	12.5	18.6	7.8	25.6	20.2	16.2	13.6	40.5	14.4	12.2	23.6	15.2	9.1	23.3	9.9	9.9	9.1	51.6	22.3	22.5	10.6	14.6	5.8	8.4	5.5	6.1	5.9	6.8	7.0	6.6	7.9	6.9	30.6	1.6	5.9	7.7	6.3	3.7	15.8	18.3	16.8	26.1	15.5	17.7	21.4	17.1	20.5	16.0	20.3	23.1	7.5	9.6	12.7	7.5	29.4	12.0	15.4	13.0	5.7	15.9	14.8	8.4	0.8	27.1	15.1	22.0	41.7	39.4	42.9	27.2	15.6	32.7	205.8	11.9	7.7	9.9	6.1	12.2	7.3	24.7	13.9	9.1	14.8	13.5	19.6	12.7	15.4	13.8	32.8	13.5	7.9	11.8	20.3	65.9	33.6	32.3	24.8	40.5	14.2	3.7	66.1	13.6	46.4	4.5	5.2	28.9	13.1	10.1	15.7	12.8	41.9	6.9	12.1	33.5	19.7	9.8	13.3	58.3	33.9	9.0	11.5	103.3	33.7	12.0	10.0	16.4
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 144.4"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		78000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	31.0	1.8	33.1	17.0	29.2	4.0	27.2	15.1	21.0	29.9	0.0	38.6	16.8	21.9	3.0	13.5	26.7	20.9	37.0	21.4	26.7	3.6	11.2	17.6	7.9	29.4	39.2	17.1	144.4	5.2	6.5	4.7	17.2	24.8	14.7	5.0	19.2	7.2	37.2	11.7	13.4	30.5	14.3	3.9	36.5	12.5	51.0	3.5	16.2	32.9	9.6	5.9	5.2	17.7	1.4	1.3	27.6	0.5	7.6	4.8	2.8	4.9	26.6	4.6	14.0	23.6	0.3	79.7	13.1	2.2	6.1	0.0	5.5	10.0	10.1	0.0	16.8	0.0	4.1	2.0	1.8	0.7	16.7	6.0	5.4	55.2	9.0	18.8	24.3	0.3	0.3	0.0	1.0	3.6	0.0	0.1	22.8	2.3	0.0	14.1	8.7	3.7	5.1	0.0	3.9	1.0	4.6	4.1	0.2	4.6	25.6	6.7	8.2	13.9	6.3	27.9	12.9	6.2	3.2	59.5	24.3	0.0	5.0	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.4	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.1	33.1	29.2	15.1	21.0	21.4	26.7	29.4	39.2	17.2	14.3	51.0	17.7	12.5	38.5	50.2	331.1	4.3	11.3	7.8	8.0	14.2	2.1	51.9	35.8	32.0	11.5	25.0	0.0	8.4	0.2	5.8	9.6	1.9	5.6	1.6	29.1	9.7	9.2	26.5	0.0	10.6	17.1	0.1	17.1	19.9	58.8	1.3	14.9	6.4	20.7	2.0	8.4	15.6	26.2	12.2	1.9	7.7	2.1	11.5	2.4	10.6	57.1	1.7	39.8	0.0	37.7	58.3	6.0	10.2	17.3	8.7	15.6	5.7	1.2	33.7	6.8	0.0	65.5	19.9	1.6	20.0	8.9	11.5	0.1	15.2	2.1	22.8	5.0
LRIG3	"FLJ90440, KIAA3016"	ENSG00000139263	"Leucine rich repeats and immunoglobulin like domains 3"	Q6UXM1	12	58872149-58920504	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 42.8;Basal squamous epithelial cells: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 49.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010773	Approved		Approved	Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA010773: AB_1853275"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.46e-2)"	20.8	2.6	3.5	6.7	4.3	0.1	18.8	2.6	3.3	21.0	11.2	18.6	14.2	12.5	10.6	22.3	14.3	17.7	5.3	3.7	3.0	10.3	10.3	10.4	4.3	4.2	5.4	22.4	18.9	9.1	7.1	11.5	3.4	10.5	25.6	1.8	32.9	10.4	4.0	35.9	13.4	15.4	4.5	8.7	17.9	3.3	4.1	12.2	58.2	7.8	9.6	18.6	18.5	7.6	3.9	3.6	13.6	1.0	24.2	28.0	3.1	9.2	26.4	8.7	9.3	10.9	5.0	3.7	18.3	10.3	10.5	17.9	5.1	23.3	6.3	28.1	17.8	0.9	6.3	5.4	4.7	1.6	0.4	27.9	49.8	9.3	19.8	16.9	24.1	4.2	0.2	4.5	5.8	1.8	4.5	0.1	14.4	4.6	5.5	0.0	11.5	9.2	6.7	19.8	13.8	0.0	8.1	5.0	8.6	19.0	9.3	0.2	10.4	11.8	8.1	7.1	12.2	1.9	0.0	0.0	2.5	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	2.6	3.3	3.7	3.0	4.2	5.4	3.4	4.5	4.1	7.6	17.1	16.0	24.6	17.9	0.1	22.4	8.2	42.8	44.9	3.8	6.3	10.3	3.7	34.3	23.0	1.8	0.0	0.8	0.5	24.5	0.0	11.8	0.3	8.2	37.0	16.2	11.5	0.0	1.8	18.1	0.5	19.6	23.4	4.6	0.0	0.1	12.1	7.3	2.6	3.3	6.0	11.4	16.2	0.3	8.2	1.8	27.1	0.4	3.6	9.4	0.0	3.4	0.0	3.5	22.4	7.4	15.6	29.0	1.8	4.4	8.7	4.9	14.1	0.2	6.6	10.6	11.3	0.5	2.0	25.3	22.4	0.3	1.0	15.0	31.5	4.7
LRIT3	"CSNB1F, FIGLER4, FLJ44691"	ENSG00000183423	"Leucine rich repeat, Ig-like and transmembrane domains 3"	Q3SXY7	4	109848107-109872315	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"retina: 17.6"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 33.3;Muller glia cells: 10.2;Rod photoreceptor cells: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013454	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA013454: AB_1853277"	"unprognostic (5.41e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.14e-2)"	0.2	0.2	0.4	0.0	0.5	0.1	0.3	0.3	0.6	0.4	0.2	0.2	0.0	0.2	0.3	0.2	0.3	0.0	0.1	0.4	0.2	0.7	0.3	0.2	0.1	0.3	0.3	0.2	0.3	0.0	0.2	0.0	0.4	0.3	0.0	17.6	0.2	0.1	0.3	0.6	0.2	0.0	0.2	0.3	0.2	0.5	0.3	0.1	0.3	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.6	0.4	0.2	0.3	0.3	0.4	0.2	0.3	0.5	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	33.3	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	10.2	0.0	0.5	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
LRMDA	"C10orf11, CDA017, OCA7"	ENSG00000148655	"Leucine rich melanocyte differentiation associated"	Q9H2I8	10	75431624-76560168	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		Albinism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 61.5;epididymis: 59.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 42.4;Distal tubular cells: 33.2;Endometrial ciliated cells: 27.8;Hofbauer cells: 56.9;Proximal tubular cells: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 57.6;eosinophil: 22.1;intermediate monocyte: 28.8;myeloid DC: 67.5;non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 67.5;granulocytes: 22.1;monocytes: 57.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 46.3;HMC-1: 34.0;NB-4: 65.6;SK-MEL-30: 93.0;THP-1: 48.7;U-937: 43.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047446, HPA050419"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA047446: AB_2680050, HPA050419: AB_2756316"	"unprognostic (1.04e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (6.80e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.26e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.64e-2)"	16.1	61.5	8.0	5.4	8.6	27.5	10.3	7.7	7.7	12.0	4.7	8.1	5.8	6.4	59.5	7.5	9.7	10.2	13.3	7.8	8.4	20.6	35.8	12.8	5.2	11.5	9.6	13.0	24.9	20.6	10.1	12.7	11.8	10.7	7.2	2.4	9.2	10.0	2.7	3.1	4.5	9.0	10.2	10.5	16.8	3.7	10.9	4.1	18.6	4.8	5.1	11.4	4.5	11.5	0.3	5.7	0.2	0.1	2.9	3.5	0.1	0.7	0.0	0.3	0.5	7.6	13.4	0.0	25.8	0.0	0.1	0.3	0.0	0.0	0.1	0.5	1.6	1.6	2.9	46.3	1.1	9.4	34.0	1.4	1.0	0.6	0.1	5.5	0.8	0.1	0.0	1.4	0.1	1.0	0.1	65.6	0.3	3.9	2.2	0.1	0.2	0.1	0.6	8.3	0.3	0.4	8.1	0.0	93.0	0.2	0.5	48.7	0.9	0.3	3.1	2.4	5.3	0.4	0.2	0.2	22.6	43.6	11.3	6.4	57.6	22.1	0.1	28.8	0.3	0.1	0.0	0.0	67.5	0.1	0.1	0.1	3.2	7.1	17.1	0.5	0.2	18.9	8.0	8.6	7.7	7.7	7.8	8.4	11.5	9.6	11.8	10.2	10.9	11.5	42.4	22.4	19.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	5.7	0.0	0.0	3.7	12.9	0.0	1.1	0.8	0.0	33.2	16.6	0.0	27.8	2.5	13.2	0.0	0.0	0.0	15.8	0.8	4.5	0.0	10.0	7.6	16.1	0.0	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	113.4	6.6	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	1.2	0.6	25.7	0.0	0.0
LRRC14	"KIAA0014, LRRC14A"	ENSG00000160959	"Leucine rich repeat containing 14"	Q15048	8	144517992-144525172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021047	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA021047: AB_1853298"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.04e-3)"	8.6	13.1	10.4	6.4	9.9	7.5	9.7	14.9	11.8	15.6	3.1	15.0	7.5	16.2	5.8	14.1	13.1	5.7	10.9	11.8	7.1	11.8	11.9	9.8	9.3	9.9	9.0	12.9	16.2	8.3	16.0	4.9	9.4	19.4	5.3	3.3	12.0	8.1	11.4	13.1	13.3	5.6	9.1	14.5	14.2	11.7	9.1	7.1	16.8	5.0	6.6	14.6	12.2	10.8	18.2	36.2	9.7	15.8	10.2	8.3	13.8	15.9	6.8	12.6	10.8	15.9	21.6	14.5	16.5	11.9	7.7	19.4	15.3	15.8	5.7	19.7	34.8	21.9	42.7	6.9	9.5	9.3	17.3	10.1	13.3	12.7	6.2	10.4	10.9	16.6	29.2	17.1	12.4	22.3	34.9	12.2	7.9	15.8	51.8	29.6	8.0	20.9	7.6	15.6	26.4	14.7	24.2	19.3	11.2	5.7	29.8	10.3	11.8	21.4	37.6	19.0	23.7	9.5	6.0	18.2	20.1	21.4	13.4	1.6	7.2	1.6	8.3	6.8	8.0	7.8	6.2	7.8	7.2	7.9	6.7	5.6	3.8	11.4	6.0	8.4	6.7	8.0	10.4	9.9	14.9	11.8	11.8	7.1	9.9	9.0	9.4	9.1	9.1	10.8	6.3	6.4	3.1	6.5	10.9	6.4	5.0	3.4	9.1	11.5	9.8	9.5	4.6	14.3	6.0	9.2	2.1	6.9	6.9	10.3	5.9	5.4	2.8	6.3	6.8	7.3	5.4	8.4	3.8	8.2	6.6	5.8	10.2	6.4	7.0	11.2	8.9	9.8	7.7	11.8	2.8	8.1	2.0	6.0	4.0	3.9	7.5	4.4	1.8	8.4	7.4	9.5	9.2	6.6	3.3	7.3	4.9	7.9	11.1	8.3	6.0	7.4	7.5	7.4	6.6	5.0	6.7	29.3	22.0	6.6	5.8	5.5	9.4	16.8	11.9	3.9
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191495-196334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 34.0;skeletal muscle: 113.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.6"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 43.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Cytosol"		"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.0	0.0	0.2	0.0	0.5	0.3	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	34.0	0.0	0.8	0.1	0.0	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.9	0.4	0.0	113.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.4	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	4.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	10.1	43.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.5	0.9	0.3	0.0	0.8	0.6	0.5	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC18	"MGC34773, UNQ933, UNQ9338, VKGE9338"	ENSG00000165383	"Leucine rich repeat containing 18"	Q8N456	10	48909483-48914232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 12.1;fallopian tube: 7.6;testis: 14.0"	"Group enriched"	"Detected in some"	8	"Early spermatids: 222.0;Late spermatids: 64.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039256, HPA076699"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA039256: AB_10671873, HPA076699: "	"unprognostic (1.31e-2)"		"unprognostic (3.66e-2)"	"unprognostic (9.83e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.98e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.16e-2)"		"unprognostic (8.57e-3)"	"unprognostic (4.08e-1)"		"unprognostic (1.13e-1)"	0.0	0.0	0.3	0.4	0.2	0.4	0.3	0.5	0.3	0.6	12.1	0.4	0.2	0.2	0.0	0.1	7.6	0.3	0.3	0.8	0.3	0.0	0.0	1.5	0.2	1.0	0.9	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.7	0.0	0.1	0.0	0.0	0.8	0.4	0.2	0.6	0.1	0.2	14.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.3	0.8	0.3	1.0	0.9	0.8	0.6	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.0	6.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	64.1	1.8	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.2	2.8	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515385-46580099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 45.3;skeletal muscle: 165.0;tongue: 94.1"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 198.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.2;HEL: 4.2;LHCN-M2: 4.1;TIME: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039138, HPA064844"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA039138: AB_10795461, HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	2.4	0.7	1.5	0.7	3.6	0.8	1.9	1.1	2.8	3.5	0.2	1.9	0.7	4.8	2.4	1.4	2.4	3.0	45.3	2.7	0.1	4.5	5.6	1.2	0.5	0.4	0.4	5.2	1.1	0.9	1.2	0.9	0.3	2.1	1.6	0.3	2.2	0.3	165.0	1.9	0.8	4.0	0.2	2.8	1.8	0.8	0.1	3.2	22.1	94.1	0.7	2.3	2.0	1.4	0.1	0.0	0.1	0.1	0.6	1.4	0.1	0.5	1.0	0.3	0.5	0.0	0.1	0.2	0.1	7.2	0.0	0.1	2.5	0.0	0.9	0.3	0.0	4.2	0.3	0.0	0.1	0.1	0.0	0.1	0.0	2.8	0.0	2.3	0.1	0.5	0.0	0.2	4.1	0.0	0.5	0.1	1.0	0.3	0.1	0.1	0.0	0.2	0.0	0.2	0.3	0.8	0.5	0.1	1.0	0.7	0.1	0.5	3.2	0.1	0.3	1.6	1.1	0.2	0.2	1.9	0.1	0.1	0.9	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.5	0.1	1.5	3.6	1.1	2.8	2.7	0.1	0.4	0.4	0.3	0.2	0.1	1.4	1.6	9.6	1.1	2.0	0.2	1.9	1.1	0.6	0.6	0.1	0.8	1.3	198.4	7.2	0.0	1.8	0.0	0.1	0.0	0.2	9.8	0.6	2.3	0.3	1.6	4.0	3.0	0.0	12.5	1.0	0.0	11.9	3.1	0.4	10.2	2.5	5.0	10.2	2.0	0.0	11.2	1.8	0.0	0.8	5.7	2.9	0.6	0.6	10.6	3.7	0.0	0.4	0.0	3.5	0.7	1.0	0.4	0.0	3.0	0.6	0.0	0.8	0.7	0.2	0.0	32.7	2.6	0.6	0.7	0.0	2.4	0.1	2.1	7.9	1.9	0.4
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 305.6;tongue: 125.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 31.0;Early spermatids: 25.4;Hepatocytes: 17.5;Late spermatids: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA039630: AB_10795467"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	2.8	5.9	17.1	2.6	17.7	3.3	2.3	13.6	21.5	15.1	10.0	14.1	2.7	6.5	3.1	14.7	4.3	3.1	40.7	18.3	14.8	3.7	32.0	4.5	3.1	17.3	15.5	4.3	3.4	3.2	13.2	1.4	18.1	4.6	4.0	4.4	6.3	4.2	305.6	3.5	4.1	6.9	14.4	3.3	5.0	12.5	18.0	7.3	4.4	125.0	5.3	6.2	19.9	17.5	26.1	18.1	16.2	29.7	9.3	6.5	0.1	4.0	14.5	9.2	8.6	17.2	27.7	5.9	13.2	2.4	31.1	9.8	14.3	18.1	8.1	14.7	3.6	3.2	4.6	53.3	8.6	8.2	2.7	2.6	7.0	11.3	5.4	11.2	18.7	34.6	4.0	7.6	8.4	3.6	31.0	8.4	5.3	26.0	46.3	23.8	8.2	14.8	15.1	2.7	32.4	16.2	2.0	2.5	10.9	4.1	3.4	9.2	10.6	6.3	64.7	10.7	8.9	13.6	22.3	9.3	12.6	32.7	1.7	0.0	0.2	0.0	0.4	0.3	0.4	0.1	0.3	0.4	0.6	0.0	1.0	0.4	0.0	0.4	0.1	0.1	0.0	0.3	17.1	17.7	13.6	21.5	18.3	14.8	17.3	15.5	18.1	14.4	18.0	17.5	1.9	0.0	4.6	9.4	1.1	1.5	0.5	0.6	0.0	8.5	1.5	0.6	31.0	2.8	1.3	0.0	4.2	0.1	0.8	0.8	0.0	3.9	25.4	1.1	1.3	2.4	5.4	1.7	10.0	4.7	0.2	2.8	1.5	0.7	0.0	2.5	2.2	17.5	0.5	1.7	10.1	2.0	0.0	0.6	0.7	50.1	3.1	0.8	1.8	1.9	1.2	7.5	1.0	6.6	3.9	5.8	3.1	1.5	1.7	0.8	0.3	1.6	0.6	2.0	0.0	5.2	1.9	8.5	4.8	0.1	0.6	0.0	1.3	1.8	2.1	0.6
LRRC31	FLJ23259	ENSG00000114248	"Leucine rich repeat containing 31"	Q6UY01	3	169839172-169869935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 21.7;salivary gland: 6.5;stomach 1: 10.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 8.9;Enteroendocrine cells: 10.3;Intestinal goblet cells: 23.5;Paneth cells: 6.0;Undifferentiated cells: 5.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;HAP1: 1.4;OE19: 8.8;RPTEC TERT1: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA058013			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA058013: "	"unprognostic (5.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"		"unprognostic (9.90e-2)"	"unprognostic (4.40e-2)"		"unprognostic (7.90e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.20e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.96e-3)"	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	1.4	0.0	17.5	8.4	0.1	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	5.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	21.7	0.1	6.5	0.0	0.0	0.0	9.6	0.4	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.8	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	1.0	0.3	0.0	10.3	0.0	0.3	0.0	0.0	0.0	3.1	3.0	0.0	0.0	0.0	2.4	0.1	0.0	0.2	23.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.1	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.4
LRRC37B		ENSG00000185158	"Leucine rich repeat containing 37B"	Q96QE4	17	32007872-32053504	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 101.9;Excitatory neurons: 45.4;Spermatocytes: 66.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.5;NK-cells: 3.8;T-cells: 2.6"	"Low cell line specificity"	"Detected in all"											HPA015135	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA015135: AB_1853309"	"unprognostic (5.46e-3)"	"unprognostic (2.56e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.60e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.72e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.72e-3)"	"unprognostic (6.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-3)"	4.7	3.7	7.5	3.7	6.6	25.1	5.2	13.7	10.3	6.9	0.9	4.9	3.4	6.2	4.7	4.2	6.8	3.6	2.6	8.0	4.2	3.6	2.1	5.6	4.6	4.8	3.4	9.1	3.2	5.7	8.3	3.5	5.2	4.7	4.6	6.9	4.7	2.8	3.5	10.5	5.0	5.2	2.2	6.2	5.0	17.9	5.1	10.9	4.1	1.4	4.5	4.6	5.9	7.1	2.7	5.0	15.6	8.9	3.9	4.7	4.8	2.4	9.0	6.9	8.7	6.8	2.6	7.1	5.0	5.5	8.5	3.6	9.3	1.9	5.4	2.2	7.6	3.4	8.1	2.6	5.8	13.3	5.8	5.1	5.9	6.3	15.9	6.6	5.9	12.1	8.2	6.8	2.6	2.5	23.4	20.5	4.8	2.5	3.3	16.2	3.7	5.9	3.9	6.6	2.9	5.0	6.1	3.8	8.8	5.2	10.4	20.9	5.0	4.8	3.2	10.8	6.1	6.8	10.4	7.5	3.4	13.2	3.4	0.0	0.2	1.5	0.5	0.2	1.0	0.1	1.0	1.4	0.4	0.4	1.4	0.4	0.5	3.8	0.1	0.6	2.6	0.3	7.5	6.6	13.7	10.3	8.0	4.2	4.8	3.4	5.2	2.2	5.1	7.1	7.4	6.4	9.1	39.2	5.1	4.1	6.9	3.8	2.8	10.0	7.3	5.6	4.7	7.2	7.1	1.8	0.0	2.3	10.0	2.9	9.8	8.9	101.9	7.9	6.3	6.0	1.8	7.4	45.4	10.5	2.3	6.0	1.5	4.7	3.8	7.0	8.2	2.9	9.7	3.3	33.4	5.7	4.1	8.7	6.9	22.9	6.8	7.9	8.8	14.0	9.3	14.5	20.6	39.7	28.3	9.2	1.8	7.2	3.8	9.1	6.8	8.3	7.8	9.7	0.0	8.9	7.8	66.7	13.0	1.6	5.1	2.2	9.0	4.6	4.8	7.7
LRRC46	MGC16309	ENSG00000141294	"Leucine rich repeat containing 46"	Q96FV0	17	47831634-47837719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"fallopian tube: 78.4;testis: 54.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 143.1;Endometrial ciliated cells: 166.7;Late spermatids: 61.5;Respiratory ciliated cells: 225.8;Spermatocytes: 125.7"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 11.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"T-47d: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021882, HPA074893"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA021882: AB_1853320, HPA074893: AB_2732271"	"unprognostic (1.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-1)"	0.2	0.3	1.4	0.1	1.0	0.5	0.3	1.3	0.8	2.6	4.2	0.1	0.1	1.1	0.9	0.2	78.4	0.2	0.3	1.0	1.8	0.7	0.5	4.8	0.3	2.4	6.7	0.3	0.5	0.2	1.7	0.1	3.2	0.5	0.0	2.3	0.3	0.3	0.1	0.1	0.2	0.0	3.1	0.5	0.2	54.3	1.3	0.4	0.9	0.0	0.1	0.2	0.2	2.1	0.7	2.8	0.3	1.4	0.2	0.4	0.8	0.1	0.8	0.7	1.3	1.1	0.7	0.2	1.7	0.3	0.8	0.7	0.3	0.6	1.1	1.1	1.2	0.6	0.9	0.5	0.1	0.0	0.7	0.0	0.5	1.7	0.5	0.2	0.1	0.4	0.6	0.4	1.1	1.2	1.1	0.0	0.1	0.2	0.4	0.9	0.0	0.6	1.4	0.5	1.2	0.9	0.3	0.0	0.5	0.1	3.6	0.1	0.2	1.6	0.5	0.2	0.2	0.6	0.5	0.5	1.1	0.2	0.1	1.3	0.4	0.5	0.0	0.5	0.0	0.1	0.0	0.3	0.7	0.1	0.2	0.0	0.5	0.8	0.4	0.3	0.0	0.1	1.4	1.0	1.3	0.8	1.0	1.8	2.4	6.7	3.2	3.1	1.3	2.1	0.3	0.0	2.3	0.0	0.5	0.0	0.3	9.7	0.0	0.6	0.7	0.9	0.5	1.5	21.9	5.5	2.1	0.1	0.4	0.2	0.0	0.9	143.1	166.7	1.9	0.4	0.0	0.4	0.2	0.0	0.5	1.2	0.0	3.3	0.0	0.3	0.0	0.1	0.5	0.0	0.3	0.6	12.2	0.0	0.3	61.5	2.8	1.0	0.0	1.0	0.8	1.0	0.0	0.0	0.4	0.6	1.1	1.9	0.2	0.3	0.1	1.4	225.8	7.0	0.0	0.4	3.7	125.7	4.2	0.0	0.0	0.1	0.7	0.3	0.0	0.2
LRRC4C	"KIAA1580, NGL-1"	ENSG00000148948	"Leucine rich repeat containing 4C"	Q9HCJ2	11	40114203-41459773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.4;retina: 17.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 5497.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 19.1;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054800, HPA075816"	Supported		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA054800: AB_2682603, HPA075816: "	"unprognostic (4.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (7.62e-3)"	"unprognostic (4.87e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-13)"	"unprognostic (5.05e-4)"	"unprognostic (5.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-3)"	0.7	3.4	11.4	0.8	14.1	0.0	1.4	0.5	15.4	3.0	0.0	2.5	0.4	1.2	0.3	0.4	0.5	0.8	2.1	14.4	9.6	0.3	1.1	0.8	0.7	7.8	10.7	0.6	0.3	1.7	4.0	0.0	5.7	0.6	0.7	17.1	0.6	1.6	0.3	0.2	0.8	1.3	4.6	0.6	0.5	0.2	8.1	0.6	2.3	0.7	0.7	0.7	2.0	9.2	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	20.9	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	14.1	0.5	15.4	14.4	9.6	7.8	10.7	5.7	4.6	8.1	9.2	0.2	0.0	1.3	498.2	0.2	0.1	0.0	1.4	0.0	35.5	4.2	3.0	1.2	0.0	1.4	0.0	6.2	0.0	0.0	0.0	1.9	0.0	0.9	0.3	10.5	1.4	0.0	0.0	1171.8	0.0	0.0	5.6	0.0	0.9	0.0	0.1	0.0	0.0	0.1	8.4	1274.6	0.0	0.0	0.0	1.9	0.2	2.1	0.4	1.8	49.6	0.0	93.6	0.0	5497.5	221.3	0.3	0.0	1.5	0.1	0.1	0.0	0.7	0.0	99.7	0.0	2.0	0.7	0.3	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0
LRRC57	FLJ36812	ENSG00000180979	"Leucine rich repeat containing 57"	Q8N9N7	15	42537820-42548802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 60.5;Rod photoreceptor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040894	Approved		Approved	Mitochondria,Cytosol		NA	NA		26000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Mitochondria, Cytosol"		"HPA040894: AB_10794996"	"unprognostic (8.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (7.45e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	7.7	7.3	4.8	5.5	4.6	22.0	7.5	4.8	8.5	7.3	3.3	9.3	6.5	7.7	5.5	9.6	8.3	5.3	6.9	6.1	3.1	8.0	6.1	8.6	6.6	3.6	3.4	8.6	7.3	14.0	6.0	7.9	4.1	6.6	10.7	14.9	8.0	5.8	6.0	9.6	8.1	7.3	3.2	6.7	7.8	5.7	3.7	9.6	7.0	6.9	7.4	6.8	8.6	5.4	14.7	11.0	19.5	13.8	16.5	12.7	9.7	20.5	11.2	14.7	15.4	23.3	11.0	6.8	13.8	16.9	16.5	22.7	13.2	16.7	14.7	12.8	12.2	27.7	23.6	10.7	14.7	17.8	15.0	14.0	22.8	13.2	17.1	10.1	23.7	17.3	21.9	14.5	13.6	6.6	9.8	7.5	4.6	26.6	8.5	15.1	19.6	10.5	9.8	24.4	9.8	11.9	24.8	16.3	11.8	12.7	16.1	19.6	24.3	16.5	11.4	17.5	15.5	11.9	36.4	29.0	8.9	16.4	21.0	36.9	9.7	32.0	7.4	14.6	9.3	5.8	7.2	7.2	10.2	7.1	5.8	7.3	12.2	16.9	19.3	5.9	8.5	6.9	4.8	4.6	4.8	8.5	6.1	3.1	3.6	3.4	4.1	3.2	3.7	5.4	16.3	9.6	10.8	6.8	10.4	5.7	13.6	6.5	6.8	13.6	9.6	8.1	11.1	15.7	7.3	9.2	60.5	11.6	18.8	16.4	13.7	10.9	18.7	13.5	13.8	17.3	12.5	15.8	17.1	9.8	19.3	12.7	9.2	13.2	14.5	10.2	19.2	7.5	14.1	20.2	8.8	13.1	6.1	14.2	4.8	20.0	9.6	13.1	7.2	7.5	21.9	21.1	20.6	11.6	8.3	15.2	15.9	16.1	8.4	12.4	15.2	8.4	14.8	87.4	6.6	16.9	10.1	7.8	6.4	11.4	5.5	15.9	11.3	18.4	12.2	12.8
LRRC58		ENSG00000163428	"Leucine rich repeat containing 58"	Q96CX6	3	120324509-120349354	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057574	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA057574: AB_2683474"	"unprognostic (7.87e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.06e-1)"	10.6	22.8	8.4	8.8	11.9	9.0	12.0	11.0	9.3	9.0	9.5	7.7	7.5	10.2	8.3	9.2	6.6	7.4	5.5	7.1	8.6	14.9	11.2	7.4	10.2	11.8	11.3	14.6	10.3	13.7	4.1	9.6	12.6	9.7	7.5	7.2	8.5	8.6	5.0	10.9	7.4	9.7	10.8	9.1	7.3	4.5	9.7	12.2	14.2	5.8	8.8	7.4	6.5	14.8	52.6	18.1	12.2	15.6	27.5	26.1	19.3	18.5	16.0	19.2	23.8	17.0	15.8	34.1	22.4	19.9	27.3	22.4	22.7	18.1	36.5	13.3	14.0	36.5	23.5	19.9	18.5	59.8	18.0	19.3	22.7	23.4	29.9	12.4	11.5	21.5	21.0	42.6	20.9	23.9	47.2	19.1	12.3	23.1	32.8	10.4	32.6	22.1	14.6	19.1	15.6	20.6	32.4	21.9	46.2	8.5	24.1	26.7	17.2	32.0	35.7	21.7	23.5	36.3	44.9	70.6	32.2	44.2	27.4	1.4	2.7	1.1	1.9	2.4	2.7	2.5	2.3	2.4	2.6	2.3	3.5	2.7	1.5	1.6	1.9	2.9	2.6	1.9	8.4	11.9	11.0	9.3	7.1	8.6	11.8	11.3	12.6	10.8	9.7	14.8	26.0	73.7	59.9	18.3	30.8	50.9	20.7	15.9	32.5	32.3	34.0	25.8	17.3	24.3	29.0	18.4	56.3	17.3	33.3	17.9	11.7	22.0	7.8	24.4	48.8	24.1	16.8	34.3	23.8	31.0	28.2	50.0	18.3	27.0	35.4	33.9	27.1	43.0	28.7	25.2	27.1	24.3	12.2	49.0	33.9	7.3	55.9	34.4	33.8	14.0	42.3	46.5	30.9	25.1	34.8	28.8	18.6	73.0	33.0	37.0	24.8	39.6	32.3	26.5	26.3	52.7	33.9	19.5	22.8	31.2	57.0	13.5	28.7	94.6	32.3	17.5
LRRC73	"C6orf154, dJ337H4.2"	ENSG00000204052	"Leucine rich repeat containing 73"	Q5JTD7	6	43506969-43510686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 44.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 411.0;Spermatocytes: 121.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;MCF7: 3.2;OE19: 4.5;T-47d: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046698	Enhanced		Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA046698: AB_10959526"	"unprognostic (3.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.89e-2)"	0.2	6.4	4.6	0.0	4.8	0.0	0.3	0.0	8.9	0.9	0.6	0.4	0.6	0.6	0.3	0.2	5.1	0.5	1.5	5.6	2.4	2.6	0.5	0.9	0.0	1.3	1.4	0.9	1.2	2.9	4.7	0.2	1.5	1.0	0.1	1.3	0.6	0.6	0.0	0.3	0.2	0.3	0.2	0.5	1.0	44.2	3.5	0.0	1.1	0.0	0.0	0.4	0.3	3.7	0.3	0.7	0.4	3.1	0.5	1.5	0.1	0.1	0.9	0.2	0.1	0.0	0.1	0.1	0.0	0.5	0.4	1.2	0.3	0.4	0.0	0.0	0.5	0.0	0.2	0.1	0.4	0.0	0.0	0.2	0.6	1.0	0.1	1.5	0.1	0.1	0.2	0.3	0.6	3.2	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.8	0.0	1.1	1.3	0.3	0.2	0.1	0.0	3.2	0.0	0.1	0.2	0.3	1.1	0.1	0.3	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.8	0.0	8.9	5.6	2.4	1.3	1.4	1.5	0.2	3.5	3.7	0.3	0.0	0.0	1.0	0.0	0.4	3.1	0.7	0.0	5.6	0.8	1.3	1.0	1.5	1.6	3.7	0.0	0.1	0.0	1.0	7.9	0.6	411.0	27.1	4.0	0.6	5.4	0.0	3.3	0.9	0.1	0.8	1.5	1.3	0.0	0.6	0.0	0.8	0.1	28.6	3.3	2.2	0.0	0.0	0.0	58.3	4.4	0.4	1.8	0.0	0.0	8.7	0.0	0.0	0.3	0.2	0.1	4.1	0.0	2.8	2.2	9.4	12.6	8.4	6.6	0.3	0.9	121.6	12.4	0.0	0.0	0.3	0.1	7.1	0.8	0.6
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 62.1;SK-MEL-30: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	5.5	21.5	6.8	6.4	5.0	16.1	0.5	1.8	7.7	1.3	0.1	20.2	47.4	4.0	0.2	2.1	1.3	3.1	2.4	6.8	6.5	2.0	0.6	4.6	5.6	4.1	6.7	4.4	7.0	4.7	3.1	3.4	5.1	1.9	9.0	2.3	1.3	1.1	2.9	2.2	44.0	2.3	3.4	21.5	7.4	10.6	5.1	0.5	4.9	0.6	1.6	1.5	0.5	5.3	8.9	6.3	7.6	6.0	0.2	0.2	1.3	2.4	0.4	1.8	1.5	7.9	2.6	0.6	6.6	0.2	3.7	3.7	0.2	0.0	0.0	3.4	6.5	62.1	3.9	0.0	0.3	1.5	7.3	0.0	0.0	0.4	0.0	3.2	2.3	9.4	3.9	1.7	0.1	12.8	15.3	6.7	1.7	20.3	0.7	5.8	5.5	0.8	0.4	1.8	16.6	4.6	0.6	1.8	21.7	3.3	1.4	1.4	0.0	2.2	10.5	6.7	11.9	12.2	2.6	2.0	0.8	5.1	7.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.7	0.3	0.4	1.0	0.0	0.0	0.4	6.8	5.0	1.8	7.7	6.8	6.5	4.1	6.7	5.1	3.4	5.1	5.3	40.5	41.7	69.7	10.7	21.6	0.0	9.6	0.0	2.2	9.1	24.9	13.3	0.7	14.3	19.8	1.8	6.2	16.1	24.8	52.5	19.6	3.9	7.1	30.0	61.0	14.7	24.7	9.7	5.3	7.1	20.4	30.5	2.0	58.7	29.7	25.0	11.0	10.0	12.0	3.3	3.6	52.2	0.0	13.9	0.0	8.0	16.4	22.9	0.0	1.0	7.7	21.3	2.1	4.0	4.2	6.2	36.0	11.3	12.0	8.7	65.4	19.4	8.7	18.2	13.1	22.9	19.4	8.0	6.5	1.1	0.0	16.7	18.6	66.3	66.0	7.5
LRRC75B	"C22orf36, FAM211B, MGC131773"	ENSG00000178026	"Leucine rich repeat containing 75B"	Q2VPJ9	22	24585620-24593208	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 34.3;Hepatocytes: 25.6;Muller glia cells: 39.9;Proximal enterocytes: 46.7;Proximal tubular cells: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 5.3;MCF7: 5.0;SH-SY5Y: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002540	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA002540: AB_1079263"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.69e-2)"	1.8	0.7	5.8	0.0	5.5	0.3	1.8	5.7	7.4	1.9	3.6	3.2	0.0	1.0	0.5	2.1	1.5	0.0	2.9	5.2	6.0	5.6	3.6	0.8	0.0	6.0	6.1	3.2	3.5	0.0	1.3	0.1	5.7	2.8	0.1	0.6	2.0	0.4	2.5	1.8	1.6	0.0	5.9	0.5	2.5	7.5	5.9	0.1	1.6	0.0	0.1	3.5	1.9	5.8	0.1	2.8	0.0	1.5	0.3	1.1	0.2	0.4	0.4	0.9	1.0	2.0	0.0	0.0	0.7	0.8	0.8	3.0	0.2	1.5	0.0	0.9	1.8	0.2	0.3	5.3	2.6	0.0	0.0	0.0	1.1	1.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	5.0	0.0	1.0	1.3	3.4	1.1	0.0	0.1	0.0	1.2	0.3	1.4	4.2	1.4	0.4	0.5	0.3	0.0	0.5	1.5	1.6	0.9	0.6	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.8	5.5	5.7	7.4	5.2	6.0	6.0	6.1	5.7	5.9	5.9	5.8	1.6	12.8	5.9	9.4	0.3	0.0	2.5	0.0	2.2	2.8	16.2	18.7	4.4	34.3	0.0	7.3	0.0	2.5	0.9	10.7	11.7	9.8	1.6	2.3	3.6	1.8	1.2	1.3	3.8	8.9	0.4	7.1	14.3	6.1	0.0	7.2	2.9	25.6	1.1	1.7	4.1	8.0	0.0	1.6	0.0	7.9	12.8	1.4	0.0	1.0	0.3	39.9	0.0	7.1	2.2	4.0	6.2	9.8	0.6	8.0	46.7	44.5	0.0	1.8	0.0	4.5	4.2	0.5	1.3	2.5	0.0	1.1	0.8	2.0	6.4	1.3
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.2;thyroid gland: 19.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Bipolar cells: 29.2;Cardiomyocytes: 24.8;Excitatory neurons: 81.2;Inhibitory neurons: 46.5;Leydig cells: 56.2;Oligodendrocyte precursor cells: 61.3"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.5;naive CD8 T-cell: 30.9"	"Lineage enriched"	"Detected in single"	70	"T-cells: 32.5"	"Cell line enhanced"	"Detected in some"		"AF22: 24.7;BJ: 14.7;BJ hTERT+: 31.0;GAMG: 15.6;SH-SY5Y: 43.9;SuSa: 13.6;T-47d: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA043820: AB_2678687, HPA046792: AB_2679810"	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.2	23.2	11.9	1.2	12.8	0.6	1.7	10.4	14.7	2.5	4.3	0.9	0.4	0.5	2.3	1.3	0.7	1.0	8.0	11.9	10.4	0.4	2.2	7.5	3.0	6.8	8.5	6.3	0.9	0.2	3.0	5.8	8.6	2.6	1.0	6.3	1.2	4.9	4.1	0.3	1.4	0.4	7.7	1.4	0.4	14.9	13.2	10.5	19.6	0.5	3.6	0.8	0.9	8.9	0.0	0.1	24.7	3.1	11.2	4.8	0.1	14.7	31.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	15.6	0.1	1.5	0.0	3.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	0.1	0.0	0.1	0.1	6.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.0	43.9	0.0	0.0	0.0	13.6	24.3	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	2.7	2.0	0.0	0.1	32.5	30.9	0.2	0.0	0.1	0.0	0.4	6.1	11.9	12.8	10.4	14.7	11.9	10.4	6.8	8.5	8.6	7.7	13.2	8.9	0.8	0.0	4.3	47.0	0.8	0.0	0.0	0.0	0.0	29.2	0.6	0.8	24.8	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.1	0.3	0.5	1.2	1.8	0.0	81.2	0.0	0.5	13.3	1.5	0.5	1.3	0.0	1.1	0.0	0.8	3.3	46.5	0.0	0.0	0.0	0.4	4.4	56.2	0.2	1.8	7.5	0.8	11.0	1.0	61.3	7.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	3.8	0.0	1.6	1.7	1.1	0.4	0.0	0.1	0.4	10.3	0.5	0.0	0.2
LRSAM1	"CMT2P, FLJ31641, RIFLE, TAL"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451489-127503499	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Excitatory neurons: 28.6;Inhibitory neurons: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	7.2	9.8	8.6	3.4	8.6	2.0	7.3	7.3	12.5	10.7	5.2	16.5	3.4	9.0	5.9	8.7	7.8	3.9	17.3	8.8	8.8	9.0	8.8	7.4	4.5	11.1	7.6	10.7	5.7	6.9	9.0	3.4	11.4	9.1	2.6	2.3	7.5	5.6	13.5	21.2	9.1	5.0	7.0	9.5	9.5	4.3	7.9	3.4	8.8	7.2	3.2	12.3	10.2	9.0	5.7	10.8	4.8	10.7	9.8	9.1	8.3	5.3	8.1	10.0	7.6	8.9	5.9	9.8	5.9	9.9	3.6	18.7	7.8	13.3	3.8	11.5	5.3	5.2	9.0	10.2	9.4	6.2	7.3	6.1	7.9	6.1	12.2	10.7	11.2	7.6	4.8	7.6	4.5	17.6	3.9	4.5	4.7	17.4	9.3	7.1	5.6	18.4	11.5	5.1	9.8	9.2	4.1	12.6	8.8	4.3	26.5	3.2	10.2	4.6	5.6	4.2	2.5	6.2	7.9	1.1	9.1	4.5	2.6	18.5	4.8	21.3	3.7	6.5	4.7	3.7	2.8	3.5	6.1	2.7	1.1	1.4	4.0	1.3	6.8	3.6	2.3	3.8	8.6	8.6	7.3	12.5	8.8	8.8	11.1	7.6	11.4	7.0	7.9	9.0	5.3	9.6	3.9	32.0	5.1	1.1	3.1	2.9	4.6	6.7	5.2	5.0	20.4	4.3	7.3	0.0	6.2	5.0	5.3	6.0	5.9	7.1	0.6	3.6	4.7	4.8	1.2	2.5	28.6	1.4	2.1	4.9	12.2	4.6	9.5	6.6	3.3	7.1	6.3	11.8	26.9	5.8	14.2	5.6	3.7	1.2	2.8	7.4	3.6	10.3	7.4	4.7	3.1	18.1	21.0	4.7	5.0	5.3	3.9	5.0	6.6	5.8	6.0	5.2	0.0	5.1	6.0	5.7	3.6	5.8	2.7	7.0	5.6	3.9	4.8	3.3
LRTM2		ENSG00000166159	"Leucine rich repeats and transmembrane domains 2"	Q8N967	12	1820267-1836753	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 11.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.9;Excitatory neurons: 10.2;Horizontal cells: 11.8;Inhibitory neurons: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 4.3;SCLC-21H: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055094, HPA062745"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA055094: AB_2682693, HPA062745: "	"unprognostic (1.84e-3)"			"unprognostic (4.83e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.24e-1)"		"unprognostic (6.20e-4)"	"unprognostic (2.21e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	2.9	0.0	11.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.6	0.0	0.0	0.0	0.0	0.6	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.4	0.0	3.8	3.9	3.6	0.6	4.8	0.5	0.2	11.8	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
LSM1	"CASM, YJL124C"	ENSG00000175324	"LSM1 homolog, mRNA degradation associated"	O15116	8	38163335-38176730	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024601			Approved	"Cytosol,Cytoplasmic bodies"		NA	NA		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Cytoplasmic bodies"	Cytosol	"HPA024601: AB_1853379"	"unprognostic (1.19e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.97e-1)"	30.0	31.9	42.1	27.6	43.0	34.4	28.0	44.1	49.2	25.1	43.4	31.0	25.3	27.5	39.6	27.5	22.9	26.7	61.1	41.5	44.0	36.1	36.7	20.4	33.9	42.8	43.2	20.0	28.3	29.5	22.1	34.6	43.0	27.3	29.4	21.4	32.4	34.1	34.8	24.7	25.4	31.7	43.0	22.4	27.0	20.9	44.1	34.8	28.7	35.0	31.8	37.8	22.5	43.2	66.8	72.1	47.6	54.2	78.1	71.8	41.2	78.6	81.9	74.9	78.3	51.3	45.7	32.2	69.4	96.9	75.3	33.1	61.2	67.0	83.7	49.0	71.8	102.9	52.2	65.4	68.1	36.4	65.3	70.1	60.9	62.0	51.2	57.1	66.1	65.0	83.2	78.7	94.7	66.7	110.7	70.4	68.7	100.9	73.9	53.2	49.2	38.1	102.9	78.8	80.3	67.1	34.3	51.0	98.7	48.3	43.3	76.2	65.1	63.9	77.1	96.0	65.0	82.2	123.2	66.2	74.8	73.7	67.3	161.5	65.7	105.0	58.6	75.0	61.1	59.8	64.6	64.9	66.0	52.4	58.4	67.2	50.5	62.9	78.8	111.1	82.1	78.8	42.1	43.0	44.1	49.2	41.5	44.0	42.8	43.2	43.0	43.0	44.1	43.2	40.8	12.8	24.6	5.2	49.5	66.3	45.6	101.7	26.2	26.6	58.5	42.4	5.9	48.6	61.7	68.0	10.4	109.3	78.4	40.7	180.0	90.6	9.0	65.0	47.1	42.9	46.7	36.2	9.3	119.2	138.9	40.7	25.5	53.0	24.1	29.5	42.5	58.5	84.9	13.5	11.6	48.8	75.3	51.5	46.9	8.4	61.5	58.6	48.0	12.2	104.8	55.0	125.7	7.5	12.4	120.0	54.5	56.8	57.1	92.1	59.8	121.4	51.1	24.1	52.6	39.0	58.0	64.7	129.3	40.8	70.3	102.2	57.8	67.3	49.9	87.3
LSM12	FLJ30656	ENSG00000161654	"LSM12 homolog"	Q3MHD2	17	44034328-44067619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 267.0;Late spermatids: 568.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051934	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA051934: AB_2681666"	"unprognostic (3.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.98e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (8.91e-3)"	"unprognostic (2.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.18e-2)"	20.0	21.9	20.0	16.9	20.5	29.6	18.6	19.9	24.7	16.1	18.4	19.7	17.2	17.5	25.0	28.1	15.1	15.5	22.6	20.8	23.5	20.8	29.3	16.8	20.8	20.9	22.5	15.4	23.9	21.5	14.2	23.0	20.6	16.8	23.6	31.3	18.1	15.4	37.1	16.7	16.9	20.4	19.6	17.2	19.9	24.0	21.6	19.9	18.2	23.7	24.8	22.8	17.4	21.0	47.4	51.3	35.7	56.3	45.9	49.4	65.2	52.3	51.6	65.5	65.3	59.2	50.5	78.6	36.8	59.8	51.9	37.9	75.7	67.7	97.7	59.5	78.5	54.5	38.7	72.6	42.4	95.6	55.9	44.4	53.8	61.3	88.0	42.7	57.1	50.2	81.0	56.6	44.8	46.5	91.4	53.1	52.8	46.7	72.5	57.3	69.8	76.2	61.4	68.5	49.6	32.9	42.4	45.3	55.9	74.0	94.5	62.5	51.8	82.7	49.0	45.1	86.5	44.4	48.3	83.6	70.2	66.9	64.0	43.8	61.7	28.3	48.3	80.3	54.0	46.7	53.5	51.8	70.7	41.0	46.9	46.6	32.6	47.1	78.4	71.9	58.2	61.2	20.0	20.5	19.9	24.7	20.8	23.5	20.9	22.5	20.6	19.6	21.6	21.0	37.9	16.0	17.5	4.6	32.0	50.3	44.0	36.7	42.1	41.4	58.4	44.6	19.3	27.1	27.4	16.5	87.6	48.0	50.4	43.9	43.0	62.7	267.0	57.2	51.2	35.5	39.9	45.8	13.3	101.6	94.0	37.2	28.5	52.3	7.6	39.6	28.9	48.6	43.8	35.3	14.3	46.5	26.4	38.0	64.4	568.8	35.1	44.6	33.8	14.0	50.1	35.4	39.1	8.0	14.8	85.2	38.5	31.6	48.0	76.7	30.3	58.4	22.7	63.1	26.3	35.5	57.9	59.7	70.0	50.5	48.9	83.7	37.8	63.7	48.5	78.6
LST1	"B144, D6S49E, LST-1"	ENSG00000204482	"Leukocyte specific transcript 1"	O00453	6	31586124-31588909	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell shape, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 100.3;lung: 48.8;lymphoid tissue: 181.9"	"Group enriched"	"Detected in many"	11	"Hofbauer cells: 407.1;Kupffer cells: 1326.9;Langerhans cells: 1240.5;Macrophages: 871.6;monocytes: 1096.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 1746.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 39.3;HMC-1: 73.6;MOLT-4: 39.6;NB-4: 76.2;THP-1: 179.9;U-937: 92.9"	"Low region specificity"	"Detected in all"							HPA079451			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA079451: "	"unprognostic (1.08e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.65e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.97e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.95e-1)"	15.2	10.2	4.3	22.0	4.3	100.3	7.9	4.6	7.2	5.6	5.0	7.9	7.1	3.7	1.4	5.5	6.6	3.1	7.6	4.6	5.5	10.8	14.4	48.8	13.8	6.1	4.9	3.0	4.7	0.9	6.1	4.7	6.6	8.9	3.0	0.5	6.9	2.3	2.1	7.8	15.0	5.1	5.4	181.9	5.7	1.8	5.2	15.1	4.6	1.9	7.1	9.1	5.1	6.0	0.3	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	2.5	0.6	0.0	0.0	0.5	0.3	0.4	0.3	12.9	0.0	39.3	0.0	0.0	0.7	29.3	73.6	0.0	0.3	0.1	1.2	0.3	0.9	0.8	0.1	0.2	0.0	0.0	39.6	76.2	0.1	0.0	0.0	18.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	179.9	0.3	0.0	0.4	0.0	0.2	0.1	0.0	5.9	0.0	92.9	0.0	112.2	419.7	681.6	9.4	1273.9	80.7	32.8	15.9	20.2	392.9	21.9	10.9	9.0	1133.0	21.6	1746.7	69.9	12.0	541.6	4.3	4.3	4.6	7.2	4.6	5.5	6.1	4.9	6.6	5.4	5.2	6.0	5.4	35.3	86.7	0.7	43.7	35.2	0.3	0.2	0.0	0.3	3.2	12.2	1.9	7.2	13.0	11.0	0.0	2.9	42.8	1.0	0.0	0.6	1.5	0.4	1.9	12.9	0.0	15.1	0.2	0.2	3.8	9.2	1.5	0.4	70.3	0.1	22.9	5.8	407.1	0.0	0.3	0.0	2.0	1326.9	1240.5	5.4	3.7	871.6	44.4	24.4	1096.6	0.7	60.8	0.5	0.1	0.1	1.1	1.2	4.7	1.0	0.0	3.8	11.0	0.2	26.3	2.2	2.8	2.4	4.6	0.4	28.3	5.3	43.6	0.0	0.4	0.3
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"granulocytes: 327.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 20.2;eosinophil: 63.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 63.1"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 102.0"					"Low region specificity"	"Detected in many"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	8.9	6.9	1.1	0.5	0.8	2.3	5.5	1.5	1.3	4.2	0.7	3.3	0.7	5.7	0.0	3.1	11.8	0.3	12.4	1.0	1.4	7.1	1.9	7.7	0.2	2.1	1.5	5.7	2.0	0.2	3.5	0.4	1.4	4.8	0.2	0.0	4.3	0.8	1.0	3.1	3.2	0.4	2.9	6.1	3.0	1.5	2.6	0.0	5.9	0.0	0.1	4.8	4.0	4.7	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.9	8.9	0.2	0.4	0.3	0.6	102.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.2	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.0	0.1	20.2	0.5	63.1	0.8	0.6	3.0	0.3	2.1	1.5	8.6	0.2	0.4	1.0	0.3	4.7	0.0	0.4	0.2	0.6	1.1	0.8	1.5	1.3	1.0	1.4	2.1	1.5	1.4	2.9	2.6	4.7	32.3	0.0	3.2	2.9	2.3	9.9	9.6	11.2	14.8	0.4	26.4	38.6	0.0	14.3	6.2	14.7	0.0	10.4	5.0	0.6	1.9	5.9	0.3	4.0	1.5	49.5	3.0	2.1	0.8	2.4	1.9	8.3	3.1	5.6	327.4	0.5	72.1	0.9	41.5	0.0	0.7	1.7	0.0	20.8	46.3	0.9	16.4	53.9	1.8	28.1	2.0	0.1	2.1	1.0	1.5	1.9	0.5	47.4	10.0	3.7	2.2	54.8	5.8	0.5	0.0	0.8	1.6	0.1	0.7	5.2	7.0	3.0	10.0	1.5	3.1	10.0
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082638	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 30.6"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 1890.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.9;HAP1: 4.4;HeLa: 1.9;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: AB_2676307, HPA046161: AB_2679564"	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	0.3	6.5	8.6	0.1	8.5	0.1	0.5	11.8	8.0	0.1	1.1	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	6.3	15.1	0.2	0.9	0.2	0.0	10.8	30.6	0.0	0.0	0.0	0.6	0.0	17.2	2.4	0.6	1.1	0.1	0.1	0.0	0.1	0.2	0.3	17.6	0.1	0.1	0.5	15.3	0.0	0.0	0.6	0.0	0.3	0.1	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.9	4.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	11.8	8.0	6.3	15.1	10.8	30.6	17.2	17.6	15.3	16.5	0.3	0.0	0.0	11.4	0.0	0.6	0.1	0.0	1.8	6.9	0.3	1.7	0.6	0.0	0.0	3.7	0.0	0.0	0.1	1.2	0.0	0.0	33.7	0.6	0.7	0.1	0.0	0.0	149.4	0.0	0.1	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	371.4	1.7	0.0	0.0	0.0	6.4	0.9	0.1	0.0	4.7	0.0	0.3	0.0	1890.0	9.1	0.2	23.9	0.0	0.0	4.5	0.0	0.7	0.0	0.8	0.0	0.4	0.3	0.3	0.6	0.9	0.3	0.1	0.0	2.4	1.5	1.6
LXN		ENSG00000079257	Latexin	Q9BS40	3	158645822-158672648	"Predicted intracellular proteins"	"Inflammatory response"	"Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 97.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 123.0;Respiratory ciliated cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"hTERT-RPE1: 1196.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014179, CAB025128"	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		4700000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB025128: , HPA014179: AB_1853404"	"unprognostic (4.46e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (8.45e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.84e-2)"	59.0	47.0	3.7	21.5	6.4	27.1	22.4	7.3	4.4	20.3	14.1	42.0	30.3	13.7	23.7	9.9	34.3	40.5	23.1	4.5	5.4	21.6	5.6	26.3	18.6	3.9	4.3	49.7	14.1	14.0	16.0	22.0	4.1	36.9	44.0	3.6	42.4	17.9	5.4	12.4	26.1	22.9	3.6	10.2	15.0	4.5	6.2	13.8	18.3	7.8	14.3	97.7	14.4	4.2	0.1	40.7	3.1	0.5	17.0	58.2	3.4	31.3	80.4	7.6	15.2	0.1	91.3	0.3	28.2	8.7	0.2	14.1	8.1	12.7	11.2	0.1	40.2	19.6	33.0	0.4	19.5	5.0	0.5	131.5	2.3	14.5	2.4	1196.4	296.5	0.1	0.3	0.9	0.0	167.0	2.1	0.0	3.6	7.3	10.5	5.5	0.0	40.0	27.6	113.4	5.1	0.1	0.0	42.5	10.4	9.4	0.3	0.1	42.8	0.3	0.3	42.3	0.1	0.6	0.0	0.2	14.8	1.6	0.5	28.8	5.8	8.6	5.6	5.8	5.8	10.3	11.7	9.3	7.3	6.9	12.9	7.2	36.7	9.8	3.6	7.6	29.8	6.5	3.7	6.4	7.3	4.4	4.5	5.4	3.9	4.3	4.1	3.6	6.2	4.2	71.0	16.0	9.2	0.3	4.4	5.6	84.1	27.0	4.6	0.3	17.3	21.2	3.8	11.5	38.7	16.5	4.2	13.4	5.5	34.1	15.6	18.5	3.9	20.7	16.5	88.5	35.2	86.3	0.5	26.4	16.2	28.8	6.1	7.6	123.0	3.6	77.8	0.8	22.9	0.0	0.3	73.1	22.4	6.3	18.1	7.9	8.4	8.0	19.6	4.7	17.7	8.9	6.2	0.0	0.3	15.1	58.4	2.6	2.8	49.8	48.6	15.5	120.3	1.2	13.1	1.3	29.4	0.9	10.8	8.6	8.2	4.0	6.5	5.9	30.8	77.0
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 1.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.4;Respiratory ciliated cells: 16.1;Spermatocytes: 15.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 71: Testis - DNA repair"		"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.3	0.2	0.0	0.6	0.4	0.3	0.2	0.2	1.0	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.5	0.5	0.3	0.0	0.0	0.5	0.3	0.5	0.3	0.0	0.0	0.2	0.6	0.0	0.9	0.1	0.3	0.4	0.0	0.6	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.6	0.3	1.7	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	0.4	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	7.8	3.2	1.5	0.3	1.4	1.7	1.8	2.0	0.0	2.8	7.7	8.0	1.2	1.5	2.1	1.8	2.1	0.5	4.2	3.8	3.9	2.1	21.4	6.9	1.4	5.6	3.5	3.0	0.8	4.9	0.2	1.6	3.1	1.8	5.1	1.4	10.4	2.2	6.2	0.0	1.2	2.0	8.2	5.5	3.1	7.5	1.2	11.6	1.8	0.0	3.7	6.0	2.1	1.0	0.6	3.4	3.1	1.5	3.2	2.1	3.0	4.6	16.1	1.1	0.0	2.6	1.7	15.9	13.9	2.0	0.9	0.3	5.2	1.3	3.1	1.9
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43785874-43827206	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.0;Late spermatids: 81.8;Melanocytes: 17.8;Syncytiotrophoblasts: 21.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.0;HaCaT: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA042511: AB_10794279, HPA054670: AB_2682567"	"unprognostic (4.27e-3)"	"prognostic favorable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.1	0.6	2.6	1.4	2.5	0.1	2.9	1.8	6.0	9.3	0.0	2.3	0.1	0.9	1.4	11.4	0.8	1.1	1.5	3.0	2.9	3.0	0.4	4.0	0.7	6.8	3.2	0.4	0.3	0.6	1.6	1.0	6.6	1.3	0.8	2.0	3.1	0.8	0.2	50.6	1.2	1.1	1.7	4.8	1.0	3.8	4.1	0.9	1.4	0.4	1.7	1.9	9.0	4.1	3.5	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.5	0.6	0.4	1.2	0.2	0.7	0.4	1.4	5.2	0.0	0.7	0.3	0.6	0.0	0.1	0.4	0.0	1.5	0.1	0.0	1.7	1.5	0.2	0.7	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.3	1.9	1.2	0.0	0.0	0.0	0.3	0.6	0.2	0.1	0.7	0.7	0.0	1.1	0.4	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.1	2.6	2.5	1.8	6.0	3.0	2.9	6.8	3.2	6.6	1.7	4.1	4.1	0.5	0.0	0.0	4.6	0.0	3.6	2.6	1.6	4.0	1.4	1.8	1.5	0.7	0.0	0.4	0.0	0.0	1.6	0.1	3.7	3.9	0.6	33.0	0.2	0.1	3.1	0.0	0.0	7.7	0.9	8.4	1.2	0.0	0.2	0.0	0.5	0.7	0.0	2.4	0.0	8.8	1.9	0.0	0.6	0.8	81.8	0.3	0.5	17.8	1.0	0.0	0.9	0.0	9.5	7.8	0.3	2.3	1.2	0.0	1.4	0.2	0.0	1.4	0.9	0.0	1.0	0.2	9.9	2.6	3.7	2.8	21.6	0.1	0.1	0.8	6.2
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;placenta: 15.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.8;Early spermatids: 59.7;Inhibitory neurons: 65.9;Late spermatids: 230.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.6;fHDF/TERT166: 48.2;HBF TERT88: 25.0;LHCN-M2: 46.2;RT4: 39.9"	"Low region specificity"	"Detected in all"							HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.72e-4)"	1.4	0.3	8.0	0.6	4.6	0.0	9.3	4.5	5.5	0.9	1.2	1.5	1.7	2.1	0.1	0.5	1.6	11.1	0.6	4.7	9.8	2.0	0.3	0.2	0.2	6.8	24.0	0.6	1.9	1.4	0.3	15.7	6.7	1.4	2.5	7.0	0.2	1.3	0.1	0.6	1.4	2.9	5.6	0.6	3.9	6.8	16.1	0.3	0.2	0.1	1.3	2.6	0.4	4.2	0.2	0.0	6.8	37.6	0.0	0.1	0.5	15.0	6.6	18.9	11.7	0.2	3.0	0.0	0.8	48.2	9.1	3.8	5.3	0.1	25.0	0.0	1.7	0.1	9.6	0.0	0.2	0.0	0.0	0.0	0.4	0.0	11.0	0.4	0.3	0.0	0.0	0.0	46.2	6.7	0.0	3.6	5.4	3.2	4.3	0.0	20.1	0.0	2.3	39.9	1.5	6.7	10.1	11.2	1.2	12.2	1.5	0.8	0.0	0.4	5.7	0.5	8.2	0.0	0.0	0.0	3.5	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	4.6	4.5	5.5	4.7	9.8	6.8	24.0	6.7	5.6	16.1	4.2	0.1	0.0	0.0	40.8	0.0	0.1	0.6	1.0	1.2	2.7	11.7	6.6	0.4	10.0	2.0	0.0	0.0	0.0	0.0	0.4	3.9	2.6	59.7	1.7	0.4	0.9	0.0	0.0	0.3	0.9	0.2	1.4	10.7	2.5	0.0	0.7	0.4	0.0	0.3	0.0	65.9	2.8	0.0	0.0	0.0	230.4	3.1	0.0	0.0	1.0	0.0	4.1	0.0	13.6	1.0	4.5	0.4	0.4	0.1	2.1	1.7	0.0	0.8	3.4	0.0	0.1	0.2	1.0	5.2	0.7	0.0	0.3	0.1	0.0	2.0	1.7
LYPLA1	"APT-1, LPL1"	ENSG00000120992	"Lysophospholipase 1"	O75608	8	54046367-54102017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 787.7;Late spermatids: 796.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		330000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA050941: AB_2681284, HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	25.8	30.3	8.8	31.8	7.6	43.6	45.0	10.5	12.7	23.3	14.7	42.6	44.4	19.7	16.1	55.0	22.9	25.9	40.9	7.9	10.8	63.4	83.5	25.9	49.0	9.9	9.5	11.7	23.8	40.8	8.8	50.4	9.1	35.0	42.1	45.9	35.5	15.0	54.5	41.4	42.8	24.3	9.7	30.2	35.4	65.1	10.3	28.8	28.4	70.7	52.0	63.1	27.5	10.0	124.0	69.3	85.9	78.7	31.0	49.4	109.8	71.7	41.6	65.0	61.1	53.2	116.7	214.8	83.6	47.2	70.5	80.7	122.8	119.9	89.8	78.9	70.0	148.8	37.9	80.0	50.8	91.4	196.1	44.6	103.8	50.8	114.0	55.6	171.6	91.6	154.5	63.4	91.3	32.7	141.1	69.9	129.3	206.3	31.5	85.3	45.2	99.3	100.2	163.6	45.2	77.6	50.1	93.6	113.4	81.0	137.0	81.7	83.4	39.0	56.9	68.7	67.8	89.3	143.8	194.0	52.9	97.1	78.7	93.7	80.7	111.1	44.8	79.6	44.6	73.0	42.2	43.5	92.3	64.4	42.1	41.1	49.3	69.6	108.2	59.7	75.5	98.3	8.8	7.6	10.5	12.7	7.9	10.8	9.9	9.5	9.1	9.7	10.3	10.0	60.4	28.9	53.3	19.9	83.8	61.7	94.8	96.6	82.6	34.9	103.8	64.0	70.8	57.2	71.8	62.5	52.1	199.7	74.5	70.4	303.3	82.8	787.7	86.6	34.7	69.3	57.5	50.0	30.0	89.0	318.3	36.4	74.9	96.3	49.5	31.5	81.4	120.1	121.0	18.5	43.7	77.3	99.7	108.4	83.3	796.2	28.3	82.6	74.7	25.3	102.1	36.9	69.0	20.6	9.8	127.4	63.7	23.0	104.5	171.0	91.6	194.3	62.9	70.3	46.0	24.5	43.1	92.1	239.1	118.2	81.1	334.2	57.0	94.0	90.2	229.7
LYRM2	DJ122O8.2	ENSG00000083099	"LYR motif containing 2"	Q9NU23	6	89568144-89638749	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063932	Uncertain		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA063932: AB_2685155"	"unprognostic (3.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.52e-3)"	"unprognostic (8.49e-2)"	"unprognostic (4.27e-2)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (8.07e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.64e-2)"	10.7	15.9	11.6	10.3	12.3	14.8	14.1	11.2	12.3	9.4	9.1	13.7	8.6	11.1	14.3	12.3	13.4	10.2	17.4	12.5	12.4	17.4	12.4	10.1	12.8	11.2	11.9	9.9	10.5	22.5	10.7	13.9	11.1	13.2	16.1	9.0	9.8	8.6	21.3	6.2	9.5	11.9	12.5	9.0	13.0	8.7	12.5	9.2	25.2	16.9	10.9	10.7	6.6	12.7	18.4	9.6	32.1	19.7	16.0	24.0	12.8	31.3	22.2	24.0	23.8	8.6	9.6	25.1	29.5	29.6	35.7	16.5	20.6	29.7	30.8	32.0	36.5	39.8	9.9	7.3	24.0	42.6	29.7	29.7	28.2	27.2	36.5	19.4	18.8	27.0	41.8	32.0	27.9	16.5	10.0	15.3	7.6	14.9	12.5	20.7	40.1	18.9	27.2	18.1	35.7	24.2	18.3	11.1	31.1	14.6	15.8	43.0	30.2	15.0	13.2	27.4	44.0	22.9	35.1	13.0	31.6	30.3	28.9	16.4	21.0	14.3	21.5	24.8	23.1	32.6	24.0	28.4	19.7	30.9	26.8	25.1	6.0	27.3	33.9	26.1	24.2	14.8	11.6	12.3	11.2	12.3	12.5	12.4	11.2	11.9	11.1	12.5	12.5	12.7	37.1	41.7	50.3	11.8	47.6	11.9	29.0	43.1	29.0	27.0	37.6	45.7	87.5	27.1	48.3	27.6	16.7	87.6	33.9	31.3	93.9	40.1	66.0	86.2	56.6	30.7	40.7	35.3	17.6	49.4	32.9	35.6	37.2	55.8	32.9	33.9	24.7	27.1	57.8	25.2	19.7	43.4	44.7	35.1	12.9	18.7	30.7	39.9	30.2	15.9	44.8	100.6	44.3	13.0	26.4	40.1	32.8	27.1	30.9	25.9	29.3	68.8	70.6	45.3	52.6	39.2	41.1	57.0	31.6	43.3	16.2	72.4	37.5	81.8	39.8	26.2
LYSMD3	FLJ13542	ENSG00000176018	"LysM domain containing 3"	Q7Z3D4	5	90515611-90529584	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018024	Approved		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA018024: AB_2138525"	"unprognostic (4.50e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (5.59e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (1.81e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.97e-3)"	"unprognostic (9.46e-2)"	10.4	14.3	4.2	12.6	4.5	11.7	11.6	7.9	6.3	14.2	10.8	12.3	12.8	12.1	5.2	10.2	7.4	13.4	12.0	4.4	5.4	13.6	24.1	13.3	12.6	4.3	5.7	15.0	9.0	18.2	7.5	17.1	4.5	13.1	11.3	11.4	11.5	10.2	9.7	6.3	11.9	11.0	4.4	11.4	9.7	6.0	5.2	12.5	18.0	16.3	12.6	10.6	5.5	6.3	17.5	11.6	14.5	15.4	22.2	22.4	14.3	27.3	29.5	18.6	30.2	9.9	17.6	21.6	11.5	24.1	29.1	8.7	22.5	26.6	36.3	16.0	14.2	16.4	14.2	16.2	23.0	13.9	26.5	16.6	18.4	17.1	28.5	19.9	27.1	13.6	15.9	32.1	21.1	15.5	16.1	8.1	7.1	4.4	19.4	14.8	24.5	31.0	20.5	11.9	4.4	8.8	16.2	12.1	22.6	11.4	14.0	12.9	34.1	11.2	15.8	24.8	20.1	36.2	24.7	18.2	18.9	23.3	17.9	53.7	11.5	18.1	9.2	14.4	14.7	9.6	10.5	11.4	11.2	8.4	14.1	12.3	17.2	18.5	15.3	5.3	12.7	11.4	4.2	4.5	7.9	6.3	4.4	5.4	4.3	5.7	4.5	4.4	5.2	6.3	18.6	35.3	27.1	8.8	22.0	14.3	10.1	9.7	11.4	10.3	20.3	14.6	25.0	7.2	18.0	12.9	4.2	10.2	27.3	16.6	1.9	7.1	1.2	17.1	21.7	15.7	21.6	12.6	13.4	8.1	10.8	20.0	15.8	24.6	26.0	10.6	21.4	32.9	8.7	20.2	13.5	17.3	10.2	16.7	23.5	1.9	16.8	19.2	7.2	10.3	13.5	21.5	11.3	14.6	18.8	7.7	9.2	13.2	41.5	16.4	14.5	12.9	14.5	13.7	19.7	15.9	16.7	7.5	5.5	13.4	16.6	14.0	21.5	10.9	12.0	13.0
LYSMD4	FLJ33008	ENSG00000183060	"LysM domain containing 4"	Q5XG99	15	99715697-99733561	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029152, HPA059824"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Actin filaments"	"HPA029152: AB_10602033, HPA059824: AB_2684135"	"unprognostic (2.43e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.30e-1)"	7.1	5.5	6.3	1.7	6.8	3.1	6.7	6.3	7.1	8.4	6.2	9.7	4.8	9.4	3.4	11.1	8.1	1.5	20.2	6.4	6.0	11.8	11.8	7.6	2.3	5.9	6.4	8.9	8.0	5.7	7.1	2.8	6.2	9.5	3.2	5.2	9.5	4.2	10.3	16.7	7.9	3.8	5.9	8.0	7.8	7.7	7.0	3.9	5.0	5.9	3.8	7.9	9.4	6.8	3.5	3.3	6.5	3.8	7.1	6.4	3.9	3.9	2.7	3.3	4.8	8.2	3.0	3.8	2.3	3.6	5.8	10.1	5.1	6.3	3.8	0.8	9.2	2.5	7.2	5.7	4.1	1.8	4.6	3.7	9.2	3.0	3.6	2.0	4.5	10.9	6.2	4.8	2.2	4.1	4.8	5.1	4.3	9.7	3.7	3.4	4.6	1.9	5.9	9.0	3.7	3.3	7.2	2.2	3.9	8.3	1.5	3.5	5.8	2.7	7.3	3.7	1.7	6.3	9.1	3.1	3.5	4.5	2.9	0.0	1.3	5.3	2.1	1.9	1.7	1.0	3.0	2.6	0.6	1.7	3.5	1.6	0.4	0.7	2.7	3.0	3.2	2.4	6.3	6.8	6.3	7.1	6.4	6.0	5.9	6.4	6.2	5.9	7.0	6.8	7.0	6.4	3.3	4.6	2.5	8.7	8.1	4.6	8.0	8.0	3.5	6.3	12.8	7.2	3.9	3.7	10.4	2.6	4.9	4.4	1.9	4.1	7.3	1.3	3.0	4.8	3.0	6.1	9.8	9.7	2.0	6.8	3.6	1.7	0.0	2.9	3.9	3.4	4.3	10.1	11.4	6.2	6.1	2.2	3.7	8.1	5.3	3.9	1.8	8.4	8.1	11.6	3.1	6.0	7.4	7.2	3.0	6.8	3.9	2.1	3.9	5.3	2.5	10.0	13.1	3.9	5.7	12.7	11.3	8.1	9.1	1.4	2.9	2.2	2.6	3.5
LZIC	MGC15436	ENSG00000162441	"Leucine zipper and CTNNBIP1 domain containing"	Q8WZA0	1	9922113-9943407	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 304.7;Spermatocytes: 191.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028184, HPA058614"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA028184: AB_10602706, HPA058614: AB_2683779"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.79e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	20.6	18.1	20.2	18.8	24.4	19.4	25.5	24.8	23.4	24.3	16.2	28.5	29.0	25.9	16.2	22.9	23.7	18.1	29.6	19.8	21.2	28.9	30.4	17.0	21.9	24.0	24.1	35.0	13.4	29.2	12.3	22.3	24.2	21.9	27.6	25.9	20.9	19.8	27.3	20.1	27.1	24.8	24.2	15.8	16.7	66.9	21.6	30.0	24.6	27.5	23.8	18.1	15.3	28.4	43.0	27.8	52.5	37.2	32.0	51.9	23.3	38.1	32.1	52.8	50.9	34.6	73.4	51.6	42.3	48.1	33.3	31.9	49.7	55.1	78.7	48.5	33.5	75.7	34.9	57.9	30.7	69.7	37.5	34.3	77.0	74.1	69.2	37.6	41.8	67.4	95.6	28.7	49.1	30.5	57.3	33.8	26.6	53.7	44.5	60.7	69.4	41.9	28.5	19.2	26.1	41.2	46.6	20.2	91.2	49.9	33.5	35.1	38.6	36.5	49.6	52.4	40.8	23.2	57.5	87.4	37.3	101.7	49.6	34.9	25.1	40.3	20.5	29.5	17.8	18.4	20.6	20.1	24.8	20.4	20.1	21.2	25.6	23.2	33.2	38.0	29.3	17.5	20.2	24.4	24.8	23.4	19.8	21.2	24.0	24.1	24.2	24.2	21.6	28.4	34.3	6.4	17.3	6.8	20.7	12.7	21.9	24.1	17.6	12.0	22.6	27.3	57.4	10.0	15.9	7.3	6.2	26.9	26.9	25.9	49.0	27.0	304.7	34.7	36.4	19.9	9.1	24.0	11.1	21.2	45.7	27.8	13.3	27.0	30.4	27.2	14.3	23.9	42.7	42.1	14.8	18.1	10.2	22.6	15.7	91.6	26.4	34.9	14.2	14.0	36.8	45.6	20.6	13.6	23.8	22.6	27.8	27.4	22.4	27.6	41.7	53.0	27.4	18.0	19.7	26.6	31.1	191.3	86.2	29.2	16.8	34.5	26.8	21.4	22.5	21.6
LZTR1	"BTBD29, LZTR-1"	ENSG00000099949	"Leucine zipper like transcription regulator 1"	Q8N653	22	20982269-20999032	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067852, HPA068772, HPA071248"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.25e-2)"	18.4	15.2	9.0	8.9	9.7	6.0	17.3	8.9	10.1	20.1	7.2	20.1	9.9	23.3	4.4	12.6	18.5	9.4	13.4	9.1	9.1	15.8	12.0	16.0	7.3	10.3	9.5	19.5	12.4	11.5	24.7	9.8	10.8	16.2	6.4	3.4	13.0	8.6	14.7	13.6	15.9	11.3	8.1	18.3	13.9	8.2	8.9	6.5	18.8	8.0	5.7	18.1	15.8	9.3	10.3	8.4	12.2	15.0	27.6	18.9	9.6	20.8	14.6	11.6	15.8	4.9	4.2	11.0	7.6	23.4	10.7	13.7	9.3	17.1	4.7	20.5	21.0	11.8	11.8	7.4	14.6	6.4	14.9	17.5	8.5	14.7	10.6	18.4	22.9	10.0	49.8	18.5	13.4	6.3	11.5	6.0	3.8	12.6	9.1	13.4	17.8	4.4	9.2	13.9	11.9	17.9	11.3	19.5	12.4	7.4	9.1	11.7	20.6	27.0	13.3	12.3	11.5	8.0	7.4	3.2	12.2	6.2	13.5	0.0	0.5	0.0	0.7	0.7	0.4	0.4	0.3	0.8	0.4	0.1	0.4	0.3	0.0	0.3	1.0	0.3	0.1	0.5	9.0	9.7	8.9	10.1	9.1	9.1	10.3	9.5	10.8	8.1	8.9	9.3	12.4	12.8	8.6	20.5	7.9	2.2	1.8	3.7	4.0	9.5	7.5	7.6	11.7	5.7	5.2	9.2	6.2	4.1	11.9	10.7	1.9	7.0	0.9	5.5	12.7	10.1	9.1	2.5	14.2	4.9	4.0	10.9	11.2	8.4	5.7	14.7	12.1	8.5	7.7	3.3	13.2	10.0	6.1	8.8	3.5	1.6	8.7	7.1	7.2	14.0	5.0	5.6	5.2	8.0	17.6	6.1	8.9	9.8	9.2	2.3	7.0	7.6	7.3	9.8	0.0	7.0	11.6	4.5	1.5	5.9	3.7	3.6	7.7	10.1	6.7	1.4
MACO1	"FLJ10747, TMEM57"	ENSG00000204178	"Macoilin 1"	Q8N5G2	1	25430858-25500209	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 38.8;Exocrine glandular cells: 62.3;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019680			Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA019680: AB_1858125"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (7.13e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.35e-3)"	8.5	15.0	11.2	5.3	10.8	28.4	8.7	19.9	14.9	8.6	12.8	8.5	6.2	7.9	12.5	16.1	6.9	7.4	8.4	10.9	11.2	11.8	26.3	8.3	7.8	10.6	9.9	16.2	24.9	9.2	8.9	6.8	11.1	12.3	7.8	11.0	16.3	7.9	30.3	9.6	9.0	7.4	10.5	8.7	11.7	14.1	10.0	11.4	12.4	15.2	9.0	7.3	9.6	12.7	8.6	3.6	9.3	18.0	16.4	10.1	4.3	9.0	11.1	9.2	8.6	2.6	11.0	20.1	10.1	11.9	5.2	8.0	8.8	9.2	10.4	9.4	7.9	26.8	5.7	7.7	9.3	10.1	15.3	10.3	13.3	12.5	8.9	9.7	11.6	12.4	15.8	7.5	9.3	5.0	19.0	13.8	13.2	10.1	7.1	12.1	11.0	15.0	15.0	3.7	15.2	15.5	7.5	19.3	10.9	7.3	7.7	14.3	13.8	9.3	6.2	12.9	6.2	12.1	7.2	10.6	10.5	13.1	7.9	0.5	0.3	1.6	0.3	0.2	0.5	0.4	0.5	0.5	0.2	0.5	0.4	0.7	0.1	0.3	0.3	1.1	0.3	0.2	11.2	10.8	19.9	14.9	10.9	11.2	10.6	9.9	11.1	10.5	10.0	12.7	31.3	19.2	23.6	0.0	9.9	0.0	0.0	0.0	0.0	0.0	27.8	17.8	0.0	0.0	11.2	7.3	0.0	13.7	27.0	0.0	5.9	38.8	0.0	19.4	23.8	12.9	0.0	0.0	0.0	62.3	22.7	9.2	0.0	32.5	10.1	26.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	48.6	0.0	0.0	9.8	0.0	0.0	19.6	13.8	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	10.4	11.0	22.7	0.0	0.0
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689236	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 273.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 264.0;Hofbauer cells: 377.6;Kupffer cells: 672.8;Macrophages: 456.7;Squamous epithelial cells: 361.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 88.3;non-classical monocyte: 121.4"	"Lineage enriched"	"Detected in many"	15	"monocytes: 121.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 28.6;hTCEpi: 61.2;SCLC-21H: 16.7;SiHa: 15.6;U-138 MG: 16.4;U-2197: 24.4;U-87 MG: 16.0"	"Low region specificity"	"Detected in many"							HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	35.3	13.8	4.8	37.3	4.9	59.2	27.3	4.4	10.5	16.5	6.9	9.5	7.8	9.3	5.4	33.0	11.3	24.4	10.7	3.7	5.7	17.5	29.3	20.9	27.8	14.3	6.3	6.8	15.8	273.1	3.1	13.2	7.2	8.3	7.2	0.6	18.3	4.7	15.8	85.3	13.2	14.2	9.0	96.3	11.0	3.9	13.1	6.7	50.1	16.7	12.7	13.9	21.9	15.8	0.0	0.0	0.0	2.6	1.5	0.2	0.4	0.3	0.1	0.3	0.1	0.4	0.2	0.0	1.9	0.4	0.0	3.8	0.0	0.0	0.0	0.0	1.4	0.0	1.2	0.2	0.9	0.0	0.1	28.6	61.2	0.2	2.1	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.3	7.4	2.6	6.2	0.0	0.0	0.0	0.0	0.5	0.4	16.7	1.4	15.6	1.5	3.9	5.4	1.5	0.3	0.5	16.4	0.3	24.4	0.0	0.0	0.0	0.0	16.0	0.6	0.0	0.4	24.3	0.0	0.0	88.3	0.0	0.0	0.0	0.1	7.9	0.1	0.0	0.0	2.1	0.0	121.4	0.1	0.0	10.6	4.8	4.9	4.4	10.5	3.7	5.7	14.3	6.3	7.2	9.0	13.1	15.8	70.0	22.4	37.9	1.6	7.8	68.6	50.5	17.1	264.0	12.0	112.2	217.8	208.9	7.2	16.8	51.5	25.0	9.8	7.6	117.1	1.9	2.3	0.8	15.7	64.4	39.1	57.7	4.0	0.8	3.4	2.8	172.7	49.5	27.6	10.8	0.9	34.6	36.1	377.6	3.3	25.4	50.7	6.1	672.8	91.7	2.8	29.5	456.7	21.4	6.5	65.3	21.9	3.1	2.0	1.3	4.9	30.9	24.5	5.6	29.7	89.5	1.3	2.4	8.3	13.1	160.6	102.4	0.8	1.7	361.5	88.2	12.4	9.5	114.6	39.0	19.2
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"placenta: 9.5;testis: 2.6"	"Cell type enhanced"	"Detected in some"		"Sertoli cells: 6.6;Spermatocytes: 57.3;Spermatogonia: 26.2;Syncytiotrophoblasts: 11.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"GAMG: 78.6"					"Not detected"	"Not detected"			"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: AB_2686310"		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	9.5	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.2	4.9	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.0	6.0	0.0	0.4	0.0	12.7	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	57.3	26.2	0.0	0.0	11.2	0.0	0.0	0.0	0.1
MAGEA4	"CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336"	ENSG00000147381	"MAGE family member A4"	P43358	X	151912509-151925170	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 20.2;Spermatocytes: 48.7;Spermatogonia: 179.8;Syncytiotrophoblasts: 33.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 19.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 440.0;AN3-CA: 263.1;HMC-1: 496.1;U-266/84: 836.2"									"HPA021942, CAB040535"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"CAB040535: , HPA021942: AB_1853490"						"unprognostic (7.90e-3)"		"unprognostic (6.66e-3)"	"unprognostic (5.39e-1)"	"unprognostic (1.36e-1)"				"unprognostic (5.81e-2)"	"unprognostic (2.94e-2)"		"unprognostic (4.10e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	440.0	0.0	0.0	263.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.1	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	496.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.1	0.2	4.1	0.0	0.5	132.0	0.0	2.4	105.9	836.2	0.7	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	48.7	179.8	0.0	0.0	33.0	0.0	0.0	0.0	0.0
MAGEB2	"CT3.2, DAM6, MAGE-XP-2, MGC26438"	ENSG00000099399	"MAGE family member B2"	O15479	X	30215563-30220089	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	60	"testis: 29.1"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 24.7;Spermatogonia: 95.8"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 33.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 92.4;K-562: 66.9;Karpas-707: 77.0;U-2 OS: 89.9;U-266/70: 149.7;U-266/84: 168.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA065224, HPA074544, HPA075519"	Enhanced		Approved	Cytosol		NA	Yes				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294"					"unprognostic (4.52e-1)"	"unprognostic (2.55e-2)"		"unprognostic (6.39e-2)"	"unprognostic (5.02e-1)"					"unprognostic (6.57e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	92.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	77.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.5	0.0	14.8	0.2	0.0	89.9	0.3	0.3	149.7	168.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	24.7	95.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909374	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 7.3"	"Group enriched"	"Detected in some"	9	"Sertoli cells: 6.6;Spermatocytes: 17.1;Spermatogonia: 13.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 54.3;Karpas-707: 51.6;U-2 OS: 33.8;U-2197: 65.4;U-266/70: 46.5;U-266/84: 44.4"									"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.6	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.1	33.8	65.4	0.1	46.5	44.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	17.1	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED1	"DLXIN-1, NRAGE"	ENSG00000179222	"MAGE family member D1"	Q9Y5V3	X	51803007-51902354	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 335.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 534.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043645			Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA043645: AB_2678597"	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.14e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.71e-3)"	32.4	125.4	69.8	37.7	73.1	16.7	38.0	34.7	71.1	99.7	99.2	40.0	32.4	57.3	102.4	26.6	64.7	58.8	70.2	70.7	108.8	43.0	71.5	40.4	29.2	57.4	66.2	62.5	80.2	76.8	157.0	116.2	76.3	71.7	39.6	37.1	85.3	89.0	46.8	29.9	32.3	77.6	62.0	35.4	54.6	56.5	84.7	49.0	73.7	39.1	31.6	45.4	35.5	49.7	21.3	76.2	238.5	205.8	184.3	330.4	128.1	281.2	357.7	152.5	240.0	157.3	71.0	29.9	53.6	534.9	54.4	15.6	215.5	99.6	113.2	31.8	83.1	20.3	0.4	205.7	140.9	75.8	35.8	312.2	35.0	128.6	29.1	267.7	184.8	77.1	31.5	57.6	310.5	194.8	87.7	25.4	187.6	69.4	154.3	88.4	154.2	4.1	156.7	37.4	60.9	340.1	0.0	80.6	41.9	232.0	145.6	18.8	185.6	66.1	166.5	234.7	31.8	37.5	59.5	60.3	257.9	6.9	175.1	1.5	4.4	3.1	21.1	6.0	18.7	17.2	13.7	18.5	13.2	19.4	17.1	20.5	1.3	16.3	6.1	55.8	21.1	14.3	69.8	73.1	34.7	71.1	70.7	108.8	57.4	66.2	76.3	62.0	84.7	49.7	12.2	76.9	34.5	85.8	17.1	11.5	20.4	48.1	12.5	33.2	41.9	27.9	53.4	32.9	63.8	35.0	8.4	335.2	17.1	18.6	29.4	47.9	2.5	35.6	73.4	24.5	57.1	13.9	97.5	49.9	171.5	69.5	34.7	54.3	17.7	60.7	39.7	62.5	114.6	45.4	138.5	74.4	54.9	9.2	6.8	10.0	43.2	6.3	24.9	42.2	4.9	39.7	13.4	101.6	55.0	33.5	13.5	57.6	72.6	20.2	15.9	33.2	48.3	12.5	13.1	28.2	50.0	5.7	5.9	12.4	8.2	185.7	11.9	169.9	25.2	18.8
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427710-76431342	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.2;Excitatory neurons: 12.2;Horizontal cells: 28.6;Inhibitory neurons: 12.2;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.8"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favorable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	1.6	3.2	10.0	1.6	10.2	0.3	1.6	3.0	20.6	2.8	0.0	2.2	0.5	3.3	1.7	1.0	2.5	1.1	2.2	12.1	17.0	2.1	0.3	1.3	2.5	7.7	5.1	4.7	2.6	6.1	6.0	0.0	7.9	3.2	0.9	6.4	1.7	4.0	1.1	1.8	1.8	2.6	1.0	2.7	1.6	0.4	9.8	2.9	2.1	0.9	1.9	2.1	1.7	6.7	0.2	3.8	3.9	7.5	2.7	1.5	3.4	2.9	2.9	2.4	1.3	0.8	0.6	0.8	1.4	2.5	7.8	2.9	5.8	5.4	1.9	1.9	0.1	0.0	0.0	2.5	0.5	1.5	0.5	1.1	2.4	0.6	0.6	0.1	0.9	4.2	0.3	0.0	3.6	0.5	4.3	0.2	4.7	0.0	5.8	3.4	2.9	0.0	3.1	0.0	0.0	2.0	0.0	0.4	0.6	3.9	1.7	0.1	0.5	3.6	4.5	3.8	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.2	0.5	0.0	0.2	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.1	10.0	10.2	3.0	20.6	12.1	17.0	7.7	5.1	7.9	1.0	9.8	6.7	0.8	3.2	2.6	3.3	1.7	0.5	0.7	1.2	1.2	11.2	0.9	1.9	1.9	1.5	1.1	1.8	4.2	0.2	1.4	0.3	1.9	1.4	0.0	0.4	1.3	2.4	0.0	0.4	12.2	1.5	0.4	1.3	1.1	0.4	1.3	1.5	1.8	0.2	0.1	28.6	12.2	0.4	0.0	0.3	0.0	0.1	1.5	0.1	0.0	3.7	0.1	5.5	2.1	5.5	5.0	0.7	0.0	4.5	0.3	0.3	0.0	1.3	0.3	5.0	19.7	2.7	3.6	0.3	0.2	0.6	0.1	0.1	2.5	0.8	0.1	0.2
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671465-58754477	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: AB_2680389"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	7.1	2.5	2.9	11.2	2.8	10.5	6.3	4.8	3.6	7.7	4.2	5.1	3.6	5.4	4.2	12.5	5.1	5.8	5.4	3.1	4.1	6.7	6.9	7.3	21.1	3.2	2.6	5.3	4.0	5.3	4.7	4.0	3.0	11.5	5.5	8.7	5.8	3.8	8.3	9.4	7.7	4.2	3.0	11.5	4.6	8.2	4.1	15.6	5.3	2.8	23.1	7.1	9.6	3.6	11.4	16.0	16.8	5.2	3.1	6.7	9.2	19.7	12.1	15.7	12.6	13.8	13.5	27.0	10.3	24.0	11.1	12.0	10.8	7.6	20.8	17.0	6.8	9.7	9.0	21.8	4.0	20.1	11.4	4.0	12.2	11.8	10.4	6.6	3.4	7.7	15.3	42.3	9.6	3.3	4.7	9.7	6.3	4.1	7.1	14.8	11.5	19.7	88.9	2.8	2.5	4.5	11.7	6.0	9.3	12.0	5.1	12.2	5.7	22.6	9.1	7.1	20.8	38.5	54.4	16.3	10.6	15.6	9.9	0.3	0.5	0.2	0.7	0.7	0.6	1.1	1.4	0.8	0.7	2.1	1.0	0.8	0.3	0.5	0.5	1.3	0.8	0.4	2.9	2.8	4.8	3.6	3.1	4.1	3.2	2.6	3.0	3.0	4.1	3.6	35.0	22.4	19.2	24.2	67.8	33.0	32.3	4.8	26.2	14.7	13.6	11.0	14.4	10.0	7.0	11.0	85.5	6.2	53.2	11.1	3.9	16.6	12.7	10.4	17.5	31.1	6.7	0.8	61.3	8.5	6.0	15.7	13.7	24.7	31.7	28.1	10.4	11.1	11.8	55.5	42.9	8.6	8.2	21.0	96.5	8.0	10.2	55.9	12.4	34.7	79.5	26.2	20.6	52.3	11.9	16.2	21.9	7.2	42.2	46.6	8.0	30.7	5.8	18.1	19.7	16.1	12.9	40.1	35.6	25.4	24.7	9.0	55.2	5.7	10.7	38.1
MAMDC4	"AEGP, DKFZp434M1411, EDTB"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 30.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 22.9;Hepatocytes: 26.6;Horizontal cells: 16.8;Intestinal goblet cells: 21.8;Proximal enterocytes: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.9"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol		NA	Yes				"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB026377: , HPA059977: AB_2684186"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favorable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.7	3.2	1.6	1.6	2.0	1.4	2.4	7.2	3.1	3.9	1.5	7.3	3.9	2.5	0.3	2.8	4.5	0.7	6.1	1.4	1.3	8.3	30.7	3.6	0.9	2.1	1.9	3.1	7.4	0.6	15.0	1.0	2.2	7.7	0.8	0.7	3.3	1.0	2.5	2.0	5.8	0.5	1.1	9.7	3.9	4.3	1.7	0.6	11.4	0.9	0.2	2.6	3.1	3.3	1.5	2.5	1.3	2.6	0.5	0.1	16.9	2.5	0.3	0.3	0.5	1.9	1.4	1.3	0.6	0.6	0.7	2.1	0.3	1.2	0.0	1.9	0.9	0.8	6.1	2.2	1.0	0.1	4.6	0.8	1.5	1.2	0.5	1.3	0.7	2.3	2.6	1.1	0.2	4.0	0.9	3.5	1.3	1.0	0.7	1.5	0.4	2.3	0.8	1.3	1.5	1.9	0.5	1.2	1.1	0.8	4.0	0.8	0.7	6.8	4.2	1.4	0.4	2.8	1.6	0.4	1.5	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.0	7.2	3.1	1.4	1.3	2.1	1.9	2.2	1.1	1.7	3.3	1.0	0.0	3.4	6.8	2.0	0.8	1.0	3.9	1.2	5.9	2.4	3.6	7.9	11.5	1.8	1.8	0.0	2.5	2.6	22.9	1.9	0.8	2.2	0.6	1.1	1.5	0.0	3.2	1.1	4.8	3.9	2.4	4.1	1.4	0.0	6.7	2.5	26.6	2.6	16.8	2.1	21.8	6.1	1.9	1.2	2.7	1.8	1.6	0.0	0.0	1.7	2.9	1.0	2.5	1.9	0.9	11.3	1.5	3.0	1.4	23.4	2.5	2.9	7.6	0.0	1.0	2.4	1.6	2.1	0.9	0.4	2.3	1.8	1.8	12.4	0.6
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343195	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 690.5;Microglial cells: 579.9;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 311.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	10.9	2.7	5.8	6.3	5.5	3.1	14.2	17.2	3.9	10.6	6.9	6.1	3.0	5.4	1.8	5.5	8.0	7.7	4.4	7.1	10.6	9.9	2.4	9.8	8.7	9.0	9.0	7.9	5.9	5.9	4.0	12.2	7.4	7.4	6.2	6.8	11.0	5.7	2.0	7.9	4.8	6.5	7.0	10.3	4.8	2.3	7.5	13.7	6.5	4.8	7.0	8.8	6.5	6.6	10.7	2.0	17.8	4.7	18.1	20.7	3.8	12.1	17.9	7.8	8.1	1.3	22.1	2.3	27.7	28.1	4.1	9.6	3.6	11.7	10.7	52.8	1.3	1.4	3.7	4.1	10.5	0.1	0.0	30.4	1.1	13.9	8.2	14.3	4.5	0.3	6.1	3.2	14.0	0.9	0.2	2.9	1.9	5.5	3.3	3.7	3.4	12.3	11.6	14.8	0.1	1.6	4.5	1.9	5.0	5.7	1.7	0.5	19.7	13.6	3.2	4.7	7.7	2.2	0.4	3.3	6.5	2.0	25.6	0.1	0.6	0.0	0.8	0.3	1.3	0.9	1.6	2.1	0.6	1.2	3.2	2.2	2.6	2.4	0.4	0.5	0.6	1.2	5.8	5.5	17.2	3.9	7.1	10.6	9.0	9.0	7.4	7.0	7.5	6.6	43.5	16.0	8.6	690.5	35.4	19.5	21.5	12.6	19.9	44.1	28.6	43.1	5.3	18.6	16.6	12.9	91.8	15.4	21.8	31.0	11.7	19.3	1.4	61.6	49.4	24.0	6.7	2.7	81.6	0.4	26.0	41.6	20.9	52.3	1.3	44.0	9.3	0.4	18.6	0.0	36.8	7.6	4.1	19.2	21.2	3.0	8.7	29.3	12.4	579.9	26.0	21.9	16.5	1300.8	311.4	15.0	16.8	8.6	18.1	19.1	9.4	17.1	24.2	25.9	32.9	3.6	51.5	0.6	0.8	19.4	13.5	13.0	38.1	9.0	14.3	19.2
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 325.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 90.9;Horizontal cells: 299.5;Peritubular cells: 76.3"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	61	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	61	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.7;BJ hTERT+: 61.8;fHDF/TERT166: 94.0;hTEC/SVTERT24-B: 58.1;U-87 MG: 121.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol		No	No		55000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (1.09e-5)"	"prognostic unfavorable (1.66e-5)"	7.2	6.0	65.3	3.8	78.6	0.9	4.4	39.5	325.5	8.0	0.0	16.5	1.2	8.2	2.4	3.0	7.2	4.2	15.5	92.8	37.5	1.2	0.2	2.2	1.0	201.4	41.4	5.0	1.0	2.0	11.7	2.7	186.0	4.8	3.5	21.7	2.5	7.5	4.5	3.2	4.0	13.1	22.5	0.9	4.3	3.8	85.8	24.0	4.1	5.1	0.9	11.9	4.5	156.7	0.3	2.5	11.1	6.4	60.7	41.5	0.1	36.3	61.8	10.5	10.1	4.4	0.1	0.2	15.3	94.0	3.3	0.5	15.0	0.1	6.1	5.5	1.4	14.2	3.5	0.3	5.8	0.4	5.8	31.3	0.1	58.1	0.3	15.8	8.0	41.3	24.0	0.3	42.8	0.5	26.6	0.8	8.1	0.0	1.0	7.2	32.1	0.1	0.2	0.1	34.8	10.6	1.2	0.1	0.3	14.6	2.3	0.6	1.5	33.7	11.3	11.3	0.5	0.0	1.6	5.0	121.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.1	0.1	65.3	78.6	39.5	325.5	92.8	37.5	201.4	41.4	186.0	22.5	85.8	156.7	6.7	3.2	1.1	11.8	2.2	5.5	1.4	1.4	2.8	43.4	1.7	3.6	55.1	0.0	7.9	3.7	25.0	0.3	90.9	1.0	0.0	0.4	13.1	33.2	19.5	5.7	11.4	3.0	34.4	0.0	0.6	46.9	2.6	1.0	7.0	16.7	4.2	0.0	2.4	299.5	45.1	1.7	10.2	0.3	7.4	5.6	51.0	9.4	8.8	12.2	0.7	16.7	0.0	9.5	51.4	0.7	0.0	76.3	1.1	0.5	0.0	0.5	63.6	27.2	32.9	45.7	48.2	10.6	25.6	1.1	4.1	1.1	5.6	3.1	1.4	0.5
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424058-209734118	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 253.3;retina: 411.0"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 875.7;Excitatory neurons: 883.3;Inhibitory neurons: 823.6;Oligodendrocyte precursor cells: 688.6;Rod photoreceptor cells: 514.5"	"Group enriched"	"Detected in many"	4	"glioma: 30.4;thyroid cancer: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 296.9;NTERA-2: 106.7;SCLC-21H: 148.6;SH-SY5Y: 82.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012558, HPA012828"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946"	"unprognostic (2.47e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (1.98e-6)"	"unprognostic (2.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.10e-5)"	5.5	11.6	89.2	1.2	115.9	0.3	5.5	2.7	253.3	4.3	0.0	2.9	0.9	2.3	3.9	6.5	2.5	7.6	8.4	135.2	215.6	5.4	3.8	13.5	1.8	37.7	52.2	7.4	10.7	15.5	33.8	0.8	75.3	7.6	1.7	411.0	7.8	4.9	1.7	16.9	1.6	2.8	14.5	1.7	3.3	6.5	123.9	3.5	16.7	4.6	2.4	1.6	5.3	88.2	2.6	0.6	296.9	0.0	3.9	2.2	0.1	1.9	2.1	0.7	2.2	0.0	16.1	0.0	1.7	3.8	14.0	4.1	23.4	1.8	1.0	0.1	1.4	1.2	8.9	0.1	36.7	0.3	0.2	3.1	9.6	0.1	5.8	17.3	7.8	0.1	0.0	3.1	0.3	1.1	0.1	0.0	106.7	0.5	0.5	0.0	0.6	0.3	3.8	0.1	148.6	82.7	6.3	0.9	3.7	34.8	8.2	0.0	0.2	0.3	1.7	0.1	4.1	1.9	0.0	0.0	15.5	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	89.2	115.9	2.7	253.3	135.2	215.6	37.7	52.2	75.3	14.5	123.9	88.2	16.8	96.1	3.2	127.3	1.8	5.9	3.3	12.0	4.6	144.7	6.2	8.0	4.9	27.1	3.7	5.5	875.7	0.4	0.1	0.0	3.9	26.8	22.1	2.2	1.1	15.7	32.4	2.7	883.3	11.0	0.1	5.3	3.6	4.4	1.3	1.6	18.5	0.4	0.5	33.7	823.6	0.2	6.1	1.4	1.5	10.7	28.6	1.4	19.6	74.0	0.0	129.7	0.0	688.6	53.8	10.0	0.0	15.4	0.1	12.3	0.0	0.4	3.4	514.5	32.9	5.1	26.1	6.6	22.7	2.3	6.5	0.3	0.3	6.6	0.0	0.7
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331"	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (1.56e-4)"	19.1	17.0	17.9	11.7	17.8	19.4	19.5	16.8	19.0	25.1	10.4	24.4	13.1	26.1	3.7	20.2	20.5	5.9	20.8	14.8	15.2	18.7	24.7	17.1	11.7	17.3	17.3	23.2	21.6	9.6	23.4	9.2	17.1	21.0	4.6	5.6	19.2	7.9	52.4	27.9	20.1	6.2	15.1	24.5	18.8	17.5	17.3	10.9	19.0	16.4	6.1	22.0	22.4	19.9	25.8	14.4	12.2	20.2	9.7	9.3	22.8	16.5	8.0	11.0	11.3	20.9	15.2	30.5	25.9	8.8	10.7	22.9	10.7	12.8	4.3	24.7	53.3	21.4	20.9	15.6	12.4	20.1	26.0	10.8	16.1	8.7	9.8	14.5	10.0	21.9	31.9	38.5	6.5	13.4	28.8	48.6	21.7	13.6	32.0	28.5	13.4	31.0	9.8	21.0	22.4	22.5	11.3	19.4	23.9	7.3	21.0	22.7	15.3	33.2	19.0	23.7	22.7	55.5	27.7	28.8	16.6	29.2	13.6	0.0	0.8	0.6	0.6	0.8	0.4	0.7	0.5	0.6	0.4	1.0	0.5	0.7	1.5	1.0	0.5	0.8	0.2	0.4	17.9	17.8	16.8	19.0	14.8	15.2	17.3	17.3	17.1	15.1	17.3	19.9	15.4	25.6	18.1	11.1	27.0	38.6	37.2	22.7	22.2	52.9	23.5	16.5	14.4	24.3	14.5	20.2	77.2	28.3	27.8	31.1	13.7	22.8	4.8	16.2	20.3	19.5	36.5	23.6	9.9	19.0	31.1	18.5	16.3	24.8	10.8	33.3	21.4	22.2	18.6	57.2	11.0	24.0	32.6	22.2	17.1	11.7	28.9	20.5	32.0	6.5	25.3	23.9	46.4	9.0	15.0	25.7	20.8	12.4	30.4	39.8	38.7	18.4	15.3	65.7	32.9	30.2	22.1	17.7	36.4	22.7	42.6	49.3	30.3	30.3	27.6	33.2
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815549-56896152	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 210.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 52.5;THP-1: 51.0"	"Region enriched"	"Detected in all"	6	"olfactory bulb: 18.2"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 57: B-cells - Immune response"	Cytosol		"CAB004500: AB_627926, HPA046509: AB_2679678"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	5.5	3.8	3.0	13.3	2.6	24.0	20.1	4.0	2.1	7.0	6.2	5.4	6.3	7.5	6.6	10.0	9.7	5.7	3.7	2.1	2.7	9.9	6.0	7.5	18.1	3.9	3.2	7.2	9.8	7.1	1.3	11.4	3.7	5.4	6.3	26.9	18.5	8.3	1.7	19.7	6.5	5.7	3.8	20.5	8.1	8.3	3.5	9.9	16.2	4.4	24.0	6.7	6.4	3.9	13.3	7.9	12.1	8.1	1.9	1.5	20.3	2.5	3.3	7.6	10.6	37.1	9.7	11.9	0.9	3.0	6.5	6.7	10.1	4.6	10.5	4.0	4.4	6.6	3.4	17.5	4.7	10.6	17.6	1.9	4.8	2.4	3.8	2.1	3.3	4.0	5.8	20.7	2.0	5.8	7.4	14.2	5.6	6.8	1.0	11.5	8.6	41.1	13.2	13.6	5.1	52.5	7.6	9.5	21.5	10.7	26.0	51.0	9.8	0.7	6.4	2.9	4.7	15.0	8.2	22.1	1.2	6.1	13.2	6.3	3.1	0.7	0.8	4.5	0.7	4.0	2.4	1.1	1.8	3.3	1.5	0.5	1.7	1.7	4.9	1.0	3.8	1.7	3.0	2.6	4.0	2.1	2.1	2.7	3.9	3.2	3.7	3.8	3.5	3.9	20.8	6.4	9.8	17.9	102.5	52.4	15.1	17.1	43.9	14.9	73.2	30.6	3.5	48.6	15.9	36.8	47.9	15.1	31.9	7.3	7.9	18.9	2.0	25.0	20.6	24.0	10.2	14.5	11.7	14.8	8.6	10.7	14.3	43.7	7.6	20.0	21.8	15.0	32.3	28.6	31.8	11.4	6.1	76.0	48.4	3.6	5.3	66.5	37.4	69.3	99.1	11.6	9.2	210.1	12.5	12.9	7.7	1.9	41.5	14.8	10.6	20.7	11.0	38.5	6.6	9.3	11.9	8.6	17.9	69.1	54.7	6.7	31.6	15.4	9.7	12.0
MAP3K10	"MEKK10, MLK2, MST"	ENSG00000130758	"Mitogen-activated protein kinase kinase kinase 10"	Q02779	19	40191426-40215575	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.9;Horizontal cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 22.8;basal ganglia: 17.5;cerebral cortex: 46.2;hippocampal formation: 37.7;white matter: 11.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007039	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Actin filaments, Cytosol"		"HPA007039: AB_1079357"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.69e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.62e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.77e-3)"	"prognostic favorable (2.13e-4)"	6.9	8.3	22.8	2.3	17.5	1.9	6.5	0.0	46.2	7.7	0.0	8.6	2.0	7.9	0.3	5.3	6.6	1.8	10.7	37.7	0.1	7.4	5.2	6.7	2.3	3.2	0.6	7.3	6.9	3.3	14.3	1.6	0.0	8.1	0.6	1.4	5.9	2.0	16.8	7.1	6.3	1.8	0.0	8.1	7.1	11.1	2.4	1.8	6.9	4.3	0.9	7.2	6.6	11.6	6.3	7.2	2.2	5.2	2.0	1.2	6.2	4.3	2.0	1.9	1.9	1.7	1.7	5.7	4.4	1.4	4.6	1.9	0.8	2.2	0.2	10.9	6.8	1.4	3.3	1.7	3.8	1.2	3.4	1.1	5.0	2.0	1.4	2.0	1.7	7.6	5.5	9.1	0.5	3.7	4.5	2.2	2.6	2.0	4.7	5.8	2.3	3.4	1.7	3.8	7.4	10.7	4.9	1.7	10.0	1.3	2.4	2.2	2.9	4.9	4.8	7.3	8.3	12.7	7.7	2.6	5.7	2.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	17.5	0.0	46.2	37.7	0.1	3.2	0.6	0.0	0.0	2.4	11.6	5.6	0.0	0.0	6.5	4.2	1.5	1.8	1.1	1.2	14.9	2.9	2.4	2.8	5.7	0.5	7.3	8.4	0.9	3.3	2.4	0.0	2.5	2.8	2.4	3.6	3.6	4.2	5.3	18.9	4.3	0.8	2.6	5.6	3.8	0.0	10.3	3.9	3.2	2.5	23.5	15.9	1.7	0.0	1.6	2.9	7.6	3.1	2.7	1.8	9.4	2.5	5.7	4.1	9.0	12.4	3.7	2.9	4.9	1.5	2.5	1.7	3.1	0.6	7.7	6.6	4.5	4.0	4.1	1.8	1.8	2.7	1.4	4.4	3.2	2.4	2.0
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489094	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 22: Epithelial cell types - Mixed function"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (1.11e-4)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	14.7	34.0	18.5	13.0	19.8	15.8	21.0	23.2	25.8	17.0	18.5	24.6	24.3	17.9	56.8	19.7	20.2	18.1	10.4	19.7	20.4	30.9	29.6	17.5	11.7	20.7	21.7	22.2	25.9	34.6	20.7	13.1	21.1	19.7	26.2	36.2	26.2	14.9	4.7	14.0	25.0	17.0	21.2	13.1	23.9	18.8	21.5	11.1	25.7	6.8	15.0	23.2	15.8	23.5	73.9	14.5	27.4	0.7	24.4	29.9	16.1	16.5	11.2	26.2	31.5	27.9	27.0	0.6	55.1	30.4	43.7	41.1	0.8	38.4	46.5	82.1	36.8	0.3	18.9	23.3	26.5	39.2	20.1	27.2	32.8	22.6	28.1	27.1	29.6	0.7	0.9	57.5	23.8	23.0	4.6	18.2	31.5	56.5	33.4	0.6	32.8	40.5	46.9	18.8	44.7	29.8	28.0	41.5	59.9	29.8	62.8	21.5	19.7	21.5	27.8	39.4	36.5	29.3	40.8	24.4	31.4	19.5	36.1	14.0	21.6	9.4	16.6	22.1	25.7	42.8	19.6	21.0	37.4	34.9	27.2	26.6	35.9	20.8	15.9	16.4	8.6	12.4	18.5	19.8	23.2	25.8	19.7	20.4	20.7	21.7	21.1	21.2	21.5	23.5	69.5	54.5	82.7	80.0	41.8	141.6	219.1	196.7	100.7	117.9	144.0	115.1	25.2	144.4	131.6	79.1	91.8	139.5	22.9	96.1	287.6	106.6	134.8	76.5	50.7	65.9	106.4	43.8	170.7	127.5	38.9	49.0	72.4	73.1	29.8	96.6	93.5	99.4	64.9	45.4	184.5	130.9	138.4	53.2	193.0	213.0	43.2	52.7	85.4	28.1	283.9	137.5	22.6	102.1	89.8	137.5	95.1	54.2	40.6	322.2	111.6	283.9	125.7	88.8	46.0	38.5	62.7	119.5	39.1	94.6	145.6	203.4	32.2	50.0	109.3	279.4
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327724-233385148	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 20.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 10.0;Collecting duct cells: 14.7;Ductal cells: 11.9;Exocrine glandular cells: 9.8;Glandular and luminal cells: 11.7;Proximal tubular cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 27.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.7	3.8	1.8	1.3	1.6	2.1	2.5	5.2	2.4	1.0	0.7	6.3	11.7	1.2	3.3	2.5	4.6	1.7	0.4	1.4	1.4	13.5	5.4	4.5	0.9	1.5	0.3	0.7	20.3	4.3	2.1	0.3	1.7	1.3	6.9	1.0	3.8	2.7	0.0	3.3	10.1	0.6	0.2	0.5	12.4	9.4	1.8	0.4	2.3	0.0	1.3	1.2	1.8	1.3	11.6	19.4	0.4	0.0	0.0	0.0	9.6	0.3	0.0	0.4	0.8	10.8	9.8	1.1	7.7	0.2	3.6	6.0	14.4	5.9	1.2	21.6	27.4	0.1	11.4	0.0	0.7	19.0	4.3	0.2	7.8	0.3	10.9	2.2	0.7	8.7	0.2	3.7	0.0	2.6	6.1	6.8	13.6	13.4	8.4	0.0	0.0	20.7	13.1	4.8	13.9	3.7	6.6	0.3	0.0	1.5	5.6	6.0	0.0	0.0	1.8	0.1	11.5	3.4	4.6	0.0	1.8	5.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.8	1.6	5.2	2.4	1.4	1.4	1.5	0.3	1.7	0.2	1.8	1.3	0.9	35.3	10.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.0	6.5	0.0	0.0	0.6	14.7	0.0	0.0	0.4	0.0	3.9	11.9	0.0	5.7	1.0	0.3	0.0	0.0	0.0	9.8	0.0	0.5	0.0	11.7	0.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	"Mitogen-activated protein kinase kinase kinase 4"	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 31.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007625	Uncertain		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA007625: AB_1853770"	"unprognostic (3.05e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.84e-2)"	4.9	3.9	5.1	6.4	4.4	5.8	6.0	9.4	7.7	7.8	0.0	6.0	5.3	9.3	3.6	8.5	7.2	4.5	5.5	6.4	4.8	5.0	4.5	6.2	7.3	2.7	2.0	8.6	6.4	8.0	3.9	7.1	3.6	7.3	5.3	4.1	7.3	6.3	11.1	8.5	5.5	7.6	2.7	6.3	5.8	7.5	3.1	9.6	5.5	10.2	9.8	7.1	6.7	5.6	8.1	9.0	16.8	14.7	9.9	11.9	11.1	9.0	7.9	10.2	10.7	12.6	5.8	16.7	6.4	23.2	14.6	19.7	17.4	18.0	12.4	12.4	14.3	21.8	8.5	12.9	7.9	22.9	10.1	7.6	20.5	10.7	9.6	15.8	13.5	12.4	56.1	18.8	11.0	8.3	15.6	11.9	10.3	5.8	13.8	16.9	15.6	13.3	9.0	5.8	9.7	8.5	17.0	17.8	1.5	14.7	7.4	27.6	13.0	12.4	15.9	11.7	43.3	10.8	9.3	15.3	14.6	23.2	13.2	31.5	4.0	2.7	5.2	3.2	9.3	6.7	7.5	4.8	4.9	9.1	5.2	5.2	0.2	4.1	1.9	6.1	5.7	3.0	5.1	4.4	9.4	7.7	6.4	4.8	2.7	2.0	3.6	2.7	3.1	5.6	19.9	19.2	12.2	32.7	20.8	9.8	10.5	9.7	30.7	18.5	13.3	16.8	20.9	10.0	14.9	14.7	22.9	20.6	17.0	7.1	3.9	9.7	5.5	35.3	55.4	14.5	15.4	12.8	66.1	7.5	11.5	16.1	15.8	39.4	3.8	35.3	6.1	8.3	7.3	23.5	64.5	9.3	6.1	8.2	6.4	4.4	11.5	15.3	0.0	45.9	18.8	14.9	10.3	87.4	57.1	12.5	8.1	12.4	18.2	13.6	9.3	6.9	10.6	29.8	6.6	21.8	19.4	14.7	25.7	28.1	11.8	33.1	25.2	8.1	11.7	16.7
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27354067-27366961	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	42.9	17.8	17.2	5.5	17.0	0.6	42.6	17.4	20.7	50.2	16.8	25.4	1.8	30.9	4.1	70.0	38.8	4.7	61.8	16.6	17.4	37.3	10.4	54.2	4.7	18.4	17.5	15.6	15.2	5.2	18.0	5.1	17.6	41.3	4.5	1.4	30.3	7.3	15.2	65.7	17.7	12.1	17.3	22.3	23.6	8.3	18.4	2.8	30.3	11.3	7.9	39.8	53.4	16.6	7.2	7.2	6.9	4.4	9.9	12.5	1.4	9.0	5.3	7.2	4.4	2.0	9.4	0.1	8.4	16.4	3.2	10.1	2.0	6.4	3.6	6.5	7.1	0.3	16.0	4.7	2.7	0.5	0.4	10.2	17.6	7.8	2.3	8.8	4.0	0.7	2.0	2.7	10.2	25.1	0.2	9.0	2.2	8.7	8.1	2.3	3.2	1.7	12.9	9.1	2.0	3.0	8.5	7.1	6.3	3.1	4.4	5.0	11.6	13.2	7.2	16.6	5.2	3.5	4.1	0.0	12.1	5.8	4.3	0.9	0.6	3.3	2.8	2.0	3.7	1.5	2.5	3.1	1.3	2.0	1.8	1.6	1.2	0.7	4.5	0.0	3.0	1.2	17.2	17.0	17.4	20.7	16.6	17.4	18.4	17.5	17.6	17.3	18.4	16.6	45.8	19.2	17.8	6.2	3.9	12.5	11.9	8.8	17.1	1.1	8.1	8.9	12.2	5.7	10.3	3.7	0.0	1.2	4.3	8.4	3.9	2.8	0.4	2.3	6.0	27.7	0.0	0.8	1.5	4.4	2.5	10.3	8.6	5.2	2.5	1.2	28.9	0.9	2.8	5.0	1.7	6.1	4.1	8.5	7.1	1.2	16.1	6.4	5.4	5.6	9.3	5.4	8.2	0.0	0.2	12.8	1.9	15.1	3.1	9.5	1.1	1.7	6.2	0.8	6.6	10.8	11.1	13.5	7.7	14.7	14.8	0.1	8.2	0.3	8.8	14.9
MAP4K5	"GCKR, KHS, KHS1"	ENSG00000012983	"Mitogen-activated protein kinase kinase kinase kinase 5"	Q9Y4K4	14	50418501-50561126	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 332.7;Oligodendrocytes: 707.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 66.7;eosinophil: 26.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 66.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036696, HPA078030"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane"	"HPA036696: AB_10672362, HPA078030: "	"unprognostic (1.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.58e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.53e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.02e-2)"	20.5	12.8	16.2	13.2	31.1	22.1	22.2	20.7	21.5	30.6	3.9	20.8	13.1	33.4	12.9	20.5	19.0	21.5	10.9	18.3	23.9	11.9	10.0	17.1	12.4	28.4	22.0	32.4	14.2	14.8	11.8	19.8	24.8	17.9	16.6	18.6	18.0	21.1	12.3	28.5	14.7	24.7	17.6	15.7	16.8	7.9	23.8	11.6	17.0	14.2	13.2	20.2	23.8	58.1	51.7	15.2	36.5	31.5	33.0	34.5	35.6	59.2	53.0	39.4	34.9	19.3	35.2	35.3	34.3	54.6	20.9	36.1	34.3	31.9	59.7	29.4	24.8	21.7	27.1	17.5	27.9	19.6	33.0	25.2	25.7	34.8	36.1	63.0	52.6	31.7	20.8	22.5	58.6	19.4	26.6	18.7	17.7	16.6	29.5	31.8	55.4	13.5	39.2	39.5	11.7	26.5	33.5	23.0	23.4	29.3	25.8	14.7	53.8	50.9	35.7	35.2	28.2	16.3	18.0	23.6	19.2	13.5	37.2	66.7	2.8	26.3	6.7	3.3	3.8	6.1	4.2	5.9	3.0	9.7	4.4	4.6	1.0	10.1	2.2	4.9	1.0	1.9	16.2	31.1	20.7	21.5	18.3	23.9	28.4	22.0	24.8	17.6	23.8	58.1	40.5	41.7	20.8	135.2	29.9	70.0	42.9	21.4	56.3	56.7	32.6	26.5	10.5	30.0	27.4	27.6	47.9	11.4	30.6	27.5	19.6	29.5	3.7	25.7	52.2	40.4	23.4	46.7	144.2	20.9	19.5	50.1	43.8	49.1	29.8	37.8	38.6	9.0	8.1	33.7	144.1	16.4	8.2	12.3	24.8	3.7	42.6	25.1	23.2	101.2	18.3	19.5	18.6	332.7	707.2	25.9	20.2	51.1	27.0	57.4	10.9	12.0	25.6	33.1	13.1	49.7	41.7	10.6	14.1	54.9	86.1	6.6	31.5	22.4	18.6	61.7
MAP6D1	"FLJ12748, SL21"	ENSG00000180834	"MAP6 domain containing 1"	Q9H9H5	3	183815922-183825594	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 102.6;choroid plexus: 24.9;skeletal muscle: 26.9"	"Cell type enriched"	"Detected in some"	13	"Oligodendrocytes: 101.3"	"Cancer enhanced"	"Detected in many"		"glioma: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"T-47d: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037991	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA037991: AB_10672503"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (8.81e-12)"	"unprognostic (1.08e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.72e-2)"	0.8	0.9	40.9	0.3	66.1	0.2	0.9	60.3	73.2	1.1	24.9	1.3	0.7	1.0	0.9	1.4	1.1	0.4	1.8	40.9	44.5	1.2	1.2	0.7	0.7	67.1	59.1	1.1	4.7	0.4	2.2	0.3	60.4	3.4	0.3	1.0	1.2	0.7	26.9	3.6	1.0	0.4	53.0	1.3	0.7	1.3	56.3	3.6	1.0	14.3	0.4	1.0	1.2	102.6	3.5	2.1	3.6	0.7	0.9	1.2	2.8	4.2	0.8	7.3	5.3	2.5	0.1	0.3	5.4	6.1	3.6	2.7	6.9	1.6	4.5	2.3	11.8	0.5	0.0	0.0	2.3	4.5	1.5	0.5	0.6	1.7	0.8	0.4	1.7	5.5	0.5	0.0	0.7	14.8	10.0	5.8	2.2	2.0	6.7	5.0	5.7	0.0	0.4	0.0	11.7	2.1	2.9	2.2	4.4	2.5	63.9	4.2	0.8	1.8	2.5	2.7	6.1	2.4	1.6	1.4	0.6	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	40.9	66.1	60.3	73.2	40.9	44.5	67.1	59.1	60.4	53.0	56.3	102.6	0.0	0.0	0.0	4.9	0.1	1.1	0.7	0.9	0.6	2.5	0.0	0.0	2.4	0.0	0.4	0.0	2.1	0.3	0.0	0.9	0.0	0.0	3.4	0.0	0.0	0.3	2.4	0.4	7.4	0.0	0.5	0.4	1.1	0.0	0.0	0.0	0.7	0.4	0.9	1.7	3.5	0.4	4.1	0.0	0.7	2.2	0.9	0.3	0.0	0.0	0.5	0.8	1.0	7.1	101.3	0.0	0.1	0.0	0.2	2.4	0.2	0.0	0.3	1.9	0.0	1.6	0.4	2.9	2.1	1.0	1.4	0.7	0.3	0.0	0.3	0.7
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.6;epididymis: 36.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.2	2.8	11.6	0.3	15.3	0.7	0.4	12.5	66.6	0.3	0.0	0.7	0.7	0.6	36.4	0.2	2.3	0.5	0.4	13.9	16.3	3.5	0.1	0.2	0.2	35.8	7.0	0.3	1.1	0.0	3.9	7.6	28.9	0.8	0.8	14.6	0.2	2.0	0.5	0.9	1.2	0.4	3.0	0.1	8.7	9.6	17.1	2.3	0.1	0.1	0.3	0.1	0.3	20.0	0.0	13.3	1.1	0.1	0.1	0.3	0.0	1.4	0.0	0.2	0.1	19.3	0.5	2.3	2.0	0.0	0.2	0.0	0.0	0.0	0.1	1.0	25.0	0.0	21.4	11.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	5.0	1.0	0.0	0.3	0.0	0.0	1.5	0.0	29.1	5.0	12.8	4.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.5	1.4	0.1	1.4	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	11.6	15.3	12.5	66.6	13.9	16.3	35.8	7.0	28.9	3.0	17.1	20.0	0.2	3.2	0.0	4.6	0.6	1.8	0.3	7.2	0.6	29.1	0.9	1.1	1.2	0.0	2.5	0.0	2.1	93.0	0.8	2.2	3.9	1.3	16.4	0.6	0.2	0.7	9.6	0.0	45.5	0.9	9.2	1.1	28.1	0.7	0.0	12.3	0.0	0.2	6.1	18.5	55.2	0.6	2.0	0.0	0.7	17.8	0.6	0.7	0.0	6.5	0.0	2.8	0.0	11.1	3.6	0.8	4.8	1.9	0.9	1.0	3.5	18.8	6.9	8.1	0.0	0.6	0.8	57.8	134.9	0.9	1.6	30.6	0.4	0.9	1.3	0.5
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261716	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 279.7;tongue: 120.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 23.1;Astrocytes: 22.9;Endothelial cells: 15.8;Hepatic stellate cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 31.6"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	11.0	2.3	15.6	3.8	16.5	1.3	7.9	15.5	21.2	11.4	9.2	4.7	3.5	19.0	9.8	6.3	11.2	4.4	15.7	15.1	16.5	10.7	1.4	6.8	4.1	17.1	14.9	10.6	1.8	4.3	25.1	4.1	14.6	10.0	1.1	1.4	4.3	6.9	279.7	1.5	4.4	8.6	14.6	4.3	5.0	4.6	15.2	0.9	3.2	120.9	1.4	6.0	5.9	13.9	23.2	13.9	5.3	16.3	12.4	13.5	7.5	17.5	15.1	28.2	18.3	19.6	7.2	45.1	23.4	19.6	16.8	15.4	24.3	3.4	5.5	12.8	34.0	29.2	46.7	24.9	37.7	28.4	54.5	29.8	6.0	7.2	0.0	16.8	33.2	4.0	26.3	38.5	13.4	12.8	0.0	35.4	15.9	7.6	22.5	41.4	14.2	43.9	17.5	3.0	18.0	6.5	13.3	0.5	22.1	4.2	7.1	29.6	18.7	28.5	26.1	6.6	11.2	9.3	7.3	24.5	7.2	24.7	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.6	16.5	15.5	21.2	15.1	16.5	17.1	14.9	14.6	14.6	15.2	13.9	23.1	0.0	3.2	22.9	1.6	0.8	0.7	3.3	1.2	5.5	1.2	1.3	8.8	4.3	0.8	0.0	0.0	0.3	0.9	0.3	1.9	0.5	0.3	0.6	10.0	15.8	1.8	1.7	9.8	0.0	2.8	5.3	2.6	0.7	10.8	0.6	20.7	0.9	6.3	1.7	6.5	0.2	8.2	2.2	0.8	1.9	6.5	2.2	0.0	6.5	0.6	8.1	0.0	5.0	0.9	0.5	0.0	3.8	2.8	3.6	0.4	8.0	0.9	2.2	6.6	3.3	3.0	0.7	12.1	0.8	0.6	0.4	2.2	3.2	0.3	0.2
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 146.2;Late spermatids: 282.5;Proximal enterocytes: 178.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.8;RPMI-8226: 40.2;RT4: 47.0"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in all"	14	"cerebellum: 37.5"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	8.7	55.9	3.1	8.8	3.0	9.4	14.2	0.5	4.4	18.6	0.0	44.6	30.9	3.4	11.5	102.4	7.6	7.5	2.5	2.9	2.2	17.3	6.7	23.8	7.9	0.6	0.0	5.4	47.7	38.9	33.3	5.6	0.2	16.7	24.4	2.7	49.5	15.5	1.2	74.1	40.1	1.9	0.1	16.1	24.1	40.0	4.2	6.9	18.9	1.0	12.4	12.2	39.3	2.7	31.4	0.3	0.7	0.5	2.4	11.2	4.3	3.3	0.4	0.3	0.8	22.3	28.4	7.0	2.0	2.5	4.6	24.4	0.3	63.8	0.7	20.0	7.9	0.2	1.2	22.8	4.0	0.4	2.2	9.2	25.9	4.3	1.0	4.5	4.1	1.2	0.6	9.4	0.9	12.7	0.4	2.6	0.4	30.9	0.4	21.0	0.5	40.2	11.6	47.0	30.5	0.7	2.5	0.5	0.2	1.3	33.0	4.1	6.3	2.4	0.4	1.0	0.7	0.8	12.7	2.3	0.1	1.3	0.2	7.6	0.4	6.5	18.3	0.1	12.3	13.9	14.5	15.4	0.1	22.0	12.8	14.4	4.6	3.8	0.1	0.2	38.0	8.6	3.1	3.0	0.5	4.4	2.9	2.2	0.6	0.0	0.2	0.1	4.2	2.7	1.5	28.9	33.0	1.0	16.4	27.3	43.5	24.9	15.4	0.7	58.8	17.7	1.7	25.8	27.3	29.5	6.2	55.3	14.9	146.2	15.6	56.9	110.3	9.1	2.8	2.1	65.5	0.0	10.0	115.9	11.8	5.0	32.1	26.2	2.5	21.1	1.1	1.7	40.3	0.0	6.7	83.2	34.6	6.8	3.3	282.5	7.2	8.8	17.8	3.7	14.2	2.1	21.6	1.5	1.2	103.6	102.2	9.8	11.4	37.1	178.4	11.5	3.7	2.4	0.0	2.2	3.4	56.6	2.9	62.6	53.3	32.3	18.5	2.5	93.0	59.9
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716340-143722458	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 54.9;fallopian tube: 46.7"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 62.5;Respiratory ciliated cells: 107.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.6;HeLa: 20.7;MCF7: 14.3;T-47d: 14.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	1.6	0.1	3.3	0.2	4.0	0.0	1.9	1.7	8.1	6.9	54.9	1.0	0.3	2.5	2.4	1.1	46.7	0.2	0.6	5.0	3.6	10.5	0.3	12.1	0.4	10.2	14.5	0.9	4.4	9.4	6.9	0.3	7.0	2.2	0.2	0.0	2.2	1.7	0.1	4.0	0.8	0.4	6.6	0.7	0.8	11.4	6.4	1.1	16.1	0.0	0.2	0.5	2.1	3.0	0.4	0.6	1.9	0.0	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.5	9.6	0.0	1.6	0.0	0.0	5.5	0.1	0.2	0.0	1.0	2.0	0.0	20.7	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.2	3.4	0.0	0.0	14.3	0.0	0.0	2.5	1.2	1.2	0.0	3.7	0.5	1.0	1.6	3.6	5.1	0.0	3.3	0.0	0.2	14.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.0	1.7	8.1	5.0	3.6	10.2	14.5	7.0	6.6	6.4	3.0	0.1	0.0	6.4	0.0	0.1	0.4	0.3	5.7	0.0	0.0	1.0	1.3	0.7	0.0	11.8	0.0	0.0	0.0	0.0	0.1	0.0	1.1	13.8	62.5	0.5	0.3	0.0	0.0	0.2	0.0	0.7	0.8	0.0	1.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.6	16.2	0.0	0.0	11.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	1.4	107.9	0.0	0.0	0.4	2.2	2.3	0.9	0.0	0.3	0.1	0.2	0.1	0.3	0.1
MAPK1IP1L	C14orf32	ENSG00000168175	"Mitogen-activated protein kinase 1 interacting protein 1 like"	Q8NDC0	14	55051647-55070194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034506	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA034506: AB_10669784"	"unprognostic (3.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.17e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (4.82e-5)"	"unprognostic (7.96e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.40e-2)"	31.2	26.3	15.6	27.5	16.5	83.2	26.5	16.7	22.3	26.0	15.4	24.4	18.9	30.2	29.4	27.6	28.9	26.4	33.3	16.0	19.6	42.0	27.3	25.7	29.5	18.0	17.8	34.6	21.9	23.4	22.3	30.2	17.5	24.6	24.8	19.1	30.2	24.6	25.7	27.0	21.2	35.6	17.0	24.2	23.1	21.6	18.0	23.9	25.8	19.9	36.5	34.2	21.8	18.1	49.0	42.3	73.1	46.8	57.8	56.6	56.5	53.7	56.8	65.2	75.2	34.1	42.2	56.3	44.4	72.0	39.2	52.5	79.3	81.3	90.7	51.4	50.6	54.3	39.4	51.7	63.0	67.3	57.4	73.6	60.0	54.5	85.9	47.5	87.9	35.4	51.2	48.7	95.6	59.0	56.9	51.7	53.1	46.2	70.4	48.1	80.4	34.0	89.9	54.1	47.5	55.0	51.9	36.7	51.6	65.1	65.5	38.4	66.8	66.6	87.0	41.7	48.6	29.9	46.3	73.3	53.3	34.7	49.0	44.1	26.7	32.1	24.2	37.4	32.0	31.8	28.3	26.3	29.0	27.4	26.0	26.1	19.7	26.0	36.4	37.2	37.9	25.1	15.6	16.5	16.7	22.3	16.0	19.6	18.0	17.8	17.5	17.0	18.0	18.1	73.5	70.5	66.9	25.5	106.3	71.9	164.0	77.3	53.5	22.9	44.1	36.2	71.2	40.0	66.3	47.8	37.5	121.2	78.0	60.3	70.5	65.0	28.5	73.7	57.1	69.5	57.9	57.7	34.3	69.4	112.3	60.7	70.3	86.2	83.1	41.5	43.2	51.5	75.1	38.7	32.2	54.8	50.8	64.4	88.4	14.1	51.3	72.9	49.8	28.1	65.0	60.0	49.4	27.2	38.1	94.4	44.2	54.2	109.5	104.8	44.1	103.4	39.6	24.9	32.9	59.1	66.5	81.1	60.6	53.6	71.6	151.3	86.4	40.5	46.9	145.3
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"MAPK associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	42.9	47.1	43.4	36.7	48.6	34.7	32.8	39.2	45.6	36.4	44.9	47.3	30.4	29.1	35.9	44.0	29.2	28.0	69.7	44.3	41.6	48.0	46.0	30.1	34.8	47.8	46.2	26.1	36.9	53.3	19.2	30.2	41.9	30.3	38.5	42.9	42.1	36.1	103.7	26.2	32.6	46.2	43.2	28.8	36.2	42.0	51.6	36.6	47.4	76.4	37.9	39.4	31.6	40.9	87.4	97.1	64.3	68.3	86.7	82.2	107.9	108.6	110.0	82.0	57.2	97.9	94.9	89.1	65.9	151.6	89.7	119.1	99.5	126.9	110.8	101.8	41.1	64.3	111.9	95.1	97.3	116.0	72.1	80.9	114.6	117.0	121.7	91.2	123.0	85.8	103.6	67.7	176.4	180.3	87.5	46.8	102.4	204.3	122.0	72.4	152.0	119.3	90.2	62.3	77.9	76.7	109.7	100.9	70.0	86.6	115.8	67.1	79.7	115.3	76.1	140.5	182.5	86.1	225.2	89.9	165.5	52.5	127.6	4.4	6.1	5.7	4.3	6.0	5.9	8.2	4.7	4.8	4.9	7.4	4.1	7.1	19.1	5.8	5.6	7.2	5.8	2.5	43.4	48.6	39.2	45.6	44.3	41.6	47.8	46.2	41.9	43.2	51.6	40.9	22.3	12.8	17.0	64.6	33.5	15.8	30.2	15.3	25.6	25.6	30.6	24.1	68.3	22.8	27.5	14.7	41.7	35.4	31.7	28.9	54.8	48.3	80.2	26.2	42.6	27.1	9.6	22.3	82.6	65.6	50.9	27.0	32.1	29.3	17.7	31.2	19.6	34.5	50.7	32.0	80.1	20.8	22.4	29.5	23.4	116.9	19.0	37.3	23.2	59.0	55.1	30.1	35.0	97.0	96.4	59.2	20.1	17.7	32.3	45.2	27.2	84.6	14.6	26.2	6.6	29.1	33.0	75.4	71.4	29.1	19.5	50.9	29.5	38.4	27.6	37.8
MARCHF10	"FLJ35757, MARCH-X, MARCH10, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 137.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;EFO-21: 4.7;HSkMC: 2.1;SCLC-21H: 8.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.1	0.2	1.3	0.2	1.6	0.0	0.1	1.2	0.9	1.4	10.5	1.1	0.0	0.4	7.5	0.1	12.8	0.1	0.1	1.1	1.3	1.5	0.0	2.7	0.0	3.6	5.0	0.1	0.2	0.3	12.7	0.0	2.6	0.6	0.0	0.1	0.3	0.1	0.0	0.2	0.4	0.0	3.6	0.1	0.4	137.6	1.3	0.2	0.1	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.1	0.0	0.0	0.1	2.5	1.1	0.1	0.8	0.2	0.0	0.0	0.0	4.7	0.3	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.8	0.6	0.0	1.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.0	8.3	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.1	1.3	1.6	1.2	0.9	1.1	1.3	3.6	5.0	2.6	3.6	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MARCHF2	"HSPC240, MARCH-II, MARCH2, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.1;Cardiomyocytes: 42.3;Extravillous trophoblasts: 11.6;Hofbauer cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	65.7	33.0	102.2	20.3	101.5	29.4	49.8	99.5	106.6	24.2	66.4	96.2	15.7	34.4	53.9	32.4	27.1	15.3	101.1	90.9	94.3	35.6	59.1	41.9	19.5	113.7	102.5	15.8	19.2	15.3	30.5	19.8	106.0	40.8	14.0	9.1	25.5	28.8	89.5	34.5	31.4	30.1	109.2	51.2	32.9	18.9	105.1	14.2	47.9	48.6	14.5	49.8	26.1	96.7	11.4	14.2	6.3	29.5	37.9	12.6	10.7	12.3	14.7	9.5	9.8	7.0	5.5	4.4	34.8	26.7	12.6	8.1	8.2	17.5	7.3	22.7	20.3	34.2	6.6	15.9	20.5	5.0	49.6	14.7	20.1	9.2	8.1	13.9	38.2	17.8	4.9	24.5	7.5	21.5	7.0	16.7	13.3	14.0	34.2	11.0	2.0	11.4	22.4	13.9	3.1	17.7	0.8	12.9	24.2	21.5	10.2	10.8	38.9	13.3	8.4	44.5	10.4	21.7	28.2	5.0	21.6	10.2	10.7	52.6	18.5	31.3	10.6	28.6	10.8	7.2	10.6	8.6	13.1	7.3	7.2	9.6	23.4	7.9	25.7	51.8	14.9	17.4	102.2	101.5	99.5	106.6	90.9	94.3	113.7	102.5	106.0	109.2	105.1	96.7	23.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	8.1	9.9	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	11.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	5.7	1.5	0.0	0.0	0.0
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857345-113863475	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 12.7;neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 405.8;TIME: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	42.8	16.8	65.1	58.2	64.1	104.6	50.2	73.2	78.5	31.9	21.6	75.7	38.9	31.2	13.5	45.1	27.3	35.8	18.2	56.8	89.2	24.6	26.1	35.0	45.4	81.0	87.6	39.0	42.4	7.0	20.6	63.0	73.1	37.8	68.2	22.0	28.0	18.0	15.7	32.1	43.3	30.1	106.8	57.0	62.8	10.3	85.5	44.8	16.2	12.9	45.3	86.2	34.5	102.8	39.2	22.6	405.8	22.3	134.0	86.6	2.2	123.0	171.4	84.9	140.6	40.7	54.1	0.1	25.3	228.0	67.3	118.0	67.9	35.7	109.7	0.3	40.2	0.0	22.2	53.3	89.2	10.3	0.7	90.2	68.8	81.8	77.4	231.9	243.1	0.4	4.6	107.6	122.1	0.4	1.3	0.3	52.7	43.5	29.4	0.2	40.7	4.1	26.9	73.6	56.4	163.4	78.7	39.6	89.6	95.0	2.1	11.3	326.0	78.3	0.5	129.9	212.7	288.3	22.4	11.4	60.2	55.8	153.4	0.0	3.9	0.0	0.0	12.7	0.0	4.6	0.0	0.0	1.1	1.9	0.0	0.0	18.7	0.0	7.5	0.0	0.0	0.5	65.1	64.1	73.2	78.5	56.8	89.2	81.0	87.6	73.1	106.8	85.5	102.8	211.2	9.6	15.5	44.7	139.0	504.1	540.7	232.3	275.4	157.0	213.2	176.7	16.6	57.2	115.0	38.6	29.2	7.2	5.5	629.5	37.2	144.3	55.7	111.2	444.0	271.6	336.3	2.5	33.0	229.9	11.2	372.6	135.1	130.4	2.5	526.1	236.0	8.8	371.6	84.1	21.0	369.4	126.1	286.3	605.5	35.7	120.5	381.3	273.9	60.0	447.2	315.5	2.1	194.5	9.7	208.1	223.1	67.0	105.2	380.1	89.9	6.9	145.0	37.7	39.5	89.8	222.8	22.7	16.2	326.3	638.5	29.4	22.3	62.3	352.3	620.2
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.1;epididymis: 1.9"	"Cell type enriched"	"Detected in single"	62	"granulocytes: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				0.4	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.7	0.3	0.7	1.9	1.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.2	0.0	0.3	0.7	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874952	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 37.7;pituitary gland: 23.3;retina: 15.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.7"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	0.0	2.2	6.5	0.3	12.1	0.3	0.1	7.3	37.7	0.2	0.0	1.2	0.3	0.0	0.0	0.2	0.1	0.2	0.2	8.3	2.4	0.1	0.6	0.1	0.1	11.2	1.1	0.3	0.6	0.5	23.3	0.0	9.5	0.2	0.1	15.4	0.2	0.0	0.0	3.7	0.4	0.0	0.0	0.1	0.6	5.0	1.2	0.8	0.1	0.0	0.0	0.2	0.3	3.0	3.6	1.6	1.5	23.3	0.0	0.0	1.9	0.2	0.1	0.3	0.9	0.8	1.5	5.8	2.6	0.0	3.9	0.1	6.8	0.1	0.1	4.1	4.5	0.5	5.8	2.6	0.0	1.3	1.2	0.5	0.1	0.8	0.7	1.3	0.0	15.2	5.2	3.0	0.0	0.8	2.4	0.6	6.9	0.6	7.2	15.9	4.6	8.3	0.3	0.2	40.5	20.2	0.8	1.4	4.3	1.2	3.8	2.1	0.0	2.8	4.2	3.1	0.8	16.7	14.5	3.7	5.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	6.5	12.1	7.3	37.7	8.3	2.4	11.2	1.1	9.5	0.0	1.2	3.0	0.5	0.0	2.4	7.8	0.2	0.9	1.6	0.6	0.6	24.7	0.8	2.5	1.0	0.0	0.3	0.0	43.8	0.6	0.4	0.6	0.0	0.4	14.0	0.2	0.2	1.3	0.0	0.0	64.7	0.5	0.6	1.3	0.0	0.3	1.3	0.5	1.1	0.5	0.2	15.2	70.3	0.1	0.0	1.0	1.2	8.2	0.6	0.7	5.4	6.5	0.1	3.7	0.0	22.1	3.0	0.3	2.5	1.2	0.0	1.0	0.9	0.2	1.0	20.4	0.0	2.0	0.5	8.0	5.2	0.7	1.4	0.3	1.0	0.4	0.7	1.2
MAST2	"KIAA0807, MAST205"	ENSG00000086015	"Microtubule associated serine/threonine kinase 2"	Q6P0Q8	1	45786987-46036122	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 170.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 66.9;Inhibitory neurons: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039722, HPA040155"	Approved		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA039722: AB_10795294, HPA040155: AB_10793957"	"unprognostic (7.80e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (4.31e-8)"	"unprognostic (8.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (6.85e-13)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.90e-1)"	18.3	11.8	16.2	11.0	15.5	8.0	18.7	15.4	17.5	57.4	7.3	39.1	21.9	43.5	12.8	14.7	31.2	19.0	65.3	15.2	19.4	12.2	18.9	17.8	8.9	19.7	27.7	51.9	9.2	13.9	27.0	8.6	26.4	40.0	25.3	24.0	18.4	15.4	170.6	14.6	30.7	26.3	14.6	7.2	24.0	56.3	18.3	5.8	13.2	73.1	11.1	46.9	28.8	15.7	31.7	25.1	24.7	19.2	30.7	41.4	27.6	32.2	22.8	29.4	32.6	29.4	10.1	48.8	15.2	38.6	59.9	15.7	30.1	18.8	30.4	23.7	16.4	22.2	29.2	27.4	28.4	12.0	27.3	34.1	23.7	49.8	37.0	35.2	27.5	12.5	17.3	14.6	34.2	21.9	17.7	12.5	20.4	21.2	28.2	25.6	40.7	9.4	16.1	16.8	34.0	20.6	38.0	50.4	16.3	26.9	22.8	11.9	27.9	55.7	36.8	30.1	33.0	19.5	18.9	17.5	38.0	16.0	24.2	0.0	0.3	0.4	0.3	0.2	0.4	0.0	0.2	0.4	0.6	0.1	0.1	0.2	0.0	0.5	1.5	0.0	0.0	0.2	16.2	15.5	15.4	17.5	15.2	19.4	19.7	27.7	26.4	14.6	18.3	15.7	5.5	0.0	2.0	32.0	2.3	4.2	4.1	3.0	8.0	15.8	8.2	6.7	46.5	4.3	5.5	3.7	54.2	6.1	2.4	66.9	1.9	4.6	38.0	4.4	17.0	7.3	12.1	6.5	45.4	6.3	4.8	12.0	12.8	7.8	0.0	13.0	3.6	6.6	6.2	5.0	86.6	24.6	0.0	2.8	7.8	57.7	9.0	5.3	7.2	30.9	2.5	3.7	7.2	52.3	52.5	8.3	33.9	10.1	5.5	10.7	50.2	5.7	3.1	12.8	6.6	11.7	9.0	28.0	13.2	6.3	2.7	5.5	3.5	12.4	22.4	7.4
MAST4	KIAA0303	ENSG00000069020	"Microtubule associated serine/threonine kinase family member 4"	O15021	5	66596361-67169595	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 519.7;Basal prostatic cells: 507.3;Excitatory neurons: 636.6;Inhibitory neurons: 489.6;Suprabasal keratinocytes: 399.2;Urothelial cells: 676.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 27.7"	"Immune cell enhanced"	"Detected in many"		"basophil: 15.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 33.2;HDLM-2: 43.2;HEL: 35.5;RT4: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000544	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA000544: AB_1079315"	"unprognostic (1.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (9.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.08e-2)"	14.9	11.0	4.6	4.5	5.2	1.9	11.1	0.9	27.7	12.1	0.0	6.0	5.1	10.0	5.0	27.0	9.4	8.0	29.5	4.2	5.4	12.0	8.4	11.0	4.4	5.0	5.5	16.4	4.6	15.3	4.6	8.8	1.2	7.6	4.1	4.7	11.5	6.6	11.2	14.8	4.5	9.3	1.1	5.0	7.0	10.0	3.3	16.8	6.5	7.2	10.1	16.0	21.2	11.4	14.6	7.8	3.8	0.2	12.4	10.9	9.0	3.2	4.9	1.1	1.0	7.3	3.9	1.0	6.5	2.7	2.9	12.8	11.8	33.2	1.3	43.2	3.8	35.5	4.7	3.1	0.9	0.1	11.9	18.4	17.8	7.1	14.2	13.3	26.2	3.2	3.5	3.9	8.9	12.6	5.1	0.2	2.5	1.2	6.3	1.1	3.3	0.7	3.1	42.9	5.5	4.4	4.3	1.7	0.2	2.7	2.8	0.2	25.2	3.0	4.1	4.6	5.4	9.9	4.8	0.2	7.7	0.1	2.4	15.2	0.3	0.8	0.9	0.4	2.5	2.9	4.0	1.0	0.4	2.5	4.2	1.8	3.5	2.3	0.9	1.0	6.9	1.3	4.6	5.2	0.9	27.7	4.2	5.4	5.0	5.5	1.2	1.1	3.3	11.4	130.2	32.1	53.3	519.7	11.4	368.6	507.3	127.9	114.9	15.9	79.3	38.1	139.1	27.1	78.7	18.4	2.1	40.7	4.9	24.4	37.2	59.0	129.2	35.8	5.3	111.8	32.2	5.5	636.6	115.8	50.0	33.2	28.5	55.3	93.8	19.4	70.6	42.2	5.1	8.4	489.6	18.1	40.7	6.9	33.7	127.4	41.3	9.8	48.0	78.7	2.1	55.2	4.1	165.9	108.4	70.8	27.2	32.7	13.5	355.5	14.8	93.9	57.2	4.5	39.5	15.9	31.1	14.8	9.2	211.7	399.2	137.2	21.0	14.7	16.1	676.4
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539168-85545281	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 874.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	270.4	277.5	184.1	153.2	226.7	98.3	136.1	199.3	235.9	173.0	152.6	193.2	141.4	165.5	236.0	166.2	200.1	209.5	189.6	191.5	207.3	203.6	115.7	168.5	121.8	226.8	219.3	211.0	874.7	165.8	284.1	122.3	208.0	196.2	146.5	248.7	137.7	120.0	278.9	141.1	155.6	127.2	194.4	116.7	225.5	132.3	219.2	102.1	388.8	112.0	127.7	262.9	168.2	289.7	175.3	253.0	290.4	181.6	195.3	236.7	171.1	213.5	195.6	219.3	232.4	208.4	569.9	404.5	137.0	261.0	178.9	264.3	369.6	318.6	279.8	207.0	271.0	242.5	408.7	181.9	355.6	364.3	259.7	215.9	315.8	237.4	164.1	278.1	211.5	230.7	277.9	309.0	505.1	149.5	334.4	398.2	193.5	148.7	320.8	350.3	275.0	264.2	328.9	271.2	227.9	209.6	193.2	183.4	354.6	145.9	156.0	192.3	207.7	267.4	160.9	149.3	260.5	189.0	161.4	290.6	175.0	447.3	143.8	9.1	24.7	8.2	22.3	26.9	32.7	19.8	25.2	23.7	23.6	18.9	23.1	20.5	2.5	27.3	22.3	16.6	24.2	24.9	184.1	226.7	199.3	235.9	191.5	207.3	226.8	219.3	208.0	194.4	219.2	289.7	150.5	48.1	83.6	122.4	104.2	143.5	217.1	47.1	206.1	73.5	116.3	134.6	6.5	82.9	57.6	71.7	68.8	36.2	126.3	60.6	19.6	59.2	75.2	28.8	49.2	83.6	83.3	87.1	56.1	58.5	40.6	121.9	106.0	47.4	84.4	83.3	45.0	44.6	67.4	26.9	60.4	65.1	26.4	118.8	141.9	25.8	72.1	165.7	67.6	26.2	64.6	58.8	27.8	28.6	95.5	53.6	48.0	83.8	78.4	66.7	73.8	138.7	35.2	89.0	111.7	298.5	231.0	54.1	56.2	168.2	118.3	38.2	102.0	51.1	70.6	88.4
MB21D2	C3orf59	ENSG00000180611	"Mab-21 domain containing 2"	Q8IYB1	3	192796815-192917856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.8;Inhibitory neurons: 53.0;Langerhans cells: 85.0;Oligodendrocyte precursor cells: 68.9;Syncytiotrophoblasts: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 4.2;T-reg: 3.9"	"Lineage enriched"	"Detected in single"	9	"T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 114.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044026	Approved		Approved	Cytosol		NA	Yes			"Cluster 13: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA044026: AB_10962840"	"unprognostic (3.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (2.76e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.28e-2)"	3.7	4.2	2.5	3.2	2.8	1.3	3.4	3.3	3.1	2.8	1.6	3.0	8.8	5.1	1.9	2.0	3.6	4.7	4.0	2.8	2.3	4.2	1.5	3.6	1.2	2.1	2.0	4.1	1.9	2.3	3.5	13.3	1.8	1.9	2.9	2.0	1.5	1.9	2.7	4.7	9.3	5.6	1.5	2.2	3.5	7.1	1.9	1.4	1.7	1.6	1.7	8.8	2.4	2.3	26.6	3.7	6.3	19.0	3.9	5.8	11.2	18.8	17.5	33.4	19.9	17.0	4.2	0.0	11.0	46.6	13.8	11.5	14.6	4.8	36.2	114.8	8.1	3.3	1.8	2.0	7.4	0.4	1.6	7.6	7.4	9.4	5.8	2.7	6.6	3.3	0.2	1.5	5.8	19.8	0.3	0.0	13.1	14.4	45.9	0.6	10.5	5.6	7.8	15.1	9.8	5.0	4.1	12.8	1.9	12.9	19.9	0.4	2.1	6.3	18.4	11.1	36.3	48.1	41.0	0.0	4.4	4.0	8.6	0.0	0.2	0.0	0.2	0.3	1.9	0.1	4.2	1.0	0.4	0.0	2.6	0.7	0.0	0.0	0.0	0.0	3.9	0.9	2.5	2.8	3.3	3.1	2.8	2.3	2.1	2.0	1.8	1.5	1.9	2.3	2.9	6.4	0.5	16.6	1.2	9.2	0.9	2.0	1.2	10.9	4.6	3.2	1.8	1.5	3.2	0.0	2.1	63.8	0.3	2.4	0.0	6.5	0.2	12.4	2.0	7.7	10.2	0.0	28.6	0.2	9.5	5.9	1.5	15.9	0.0	5.8	9.7	0.2	5.6	8.4	53.0	2.8	4.1	3.8	85.0	1.4	3.1	10.4	14.2	17.8	13.4	1.1	0.0	68.9	30.6	2.2	6.1	6.0	4.2	0.8	15.4	9.6	2.8	1.3	13.1	3.3	4.5	1.8	16.5	1.8	8.7	110.4	3.3	5.4	3.7	2.6
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151606-54224669	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872"	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favorable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	26.9	10.5	6.5	19.2	8.9	20.3	19.9	9.5	9.4	16.0	6.5	17.3	12.0	11.3	15.8	29.5	11.3	11.5	14.9	6.8	8.9	16.7	16.9	16.4	32.1	7.6	8.3	11.4	17.4	16.5	9.2	18.8	7.7	13.4	16.4	14.3	19.4	15.1	15.4	25.4	15.5	11.9	7.0	21.2	13.9	31.5	7.9	20.1	31.0	16.8	35.2	21.0	20.1	8.2	29.1	13.2	23.2	11.7	27.3	23.0	22.5	26.5	33.9	30.6	26.6	8.5	15.8	68.7	13.1	42.1	13.5	45.1	20.1	36.6	33.4	50.2	11.1	10.2	20.4	18.3	28.2	32.7	17.7	20.2	40.3	23.5	34.1	20.3	35.9	20.7	8.0	62.0	28.0	14.0	33.1	18.1	24.2	11.3	17.2	21.8	13.9	27.9	44.5	29.9	25.6	10.8	21.0	21.1	14.7	30.3	10.9	16.3	31.2	31.1	14.1	10.9	24.4	65.1	38.3	52.5	27.4	27.4	19.0	0.0	1.4	0.7	0.6	2.6	0.9	0.7	0.7	1.0	0.8	1.3	0.3	0.6	1.2	0.2	5.0	0.7	1.5	0.4	6.5	8.9	9.5	9.4	6.8	8.9	7.6	8.3	7.7	7.0	7.9	8.2	71.1	28.9	21.0	30.3	44.9	49.3	37.3	21.2	13.1	19.3	46.0	35.3	35.8	24.3	23.0	33.1	16.7	14.3	57.6	51.2	7.9	26.3	1.9	62.1	48.9	38.0	16.3	22.7	42.5	58.4	49.4	32.7	21.9	103.3	8.2	32.0	32.2	25.2	30.3	21.9	38.3	35.9	10.2	142.6	38.7	4.8	25.1	82.2	26.6	43.1	69.3	45.9	8.2	32.2	49.5	54.3	28.0	26.4	53.7	51.5	35.7	23.5	30.0	27.0	26.3	39.0	35.2	6.5	6.1	54.6	62.5	18.3	47.7	43.0	38.7	79.5
MBOAT7	"BB1, hMBOA-7, LENG4, LPLAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 108.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"basophil: 157.3;eosinophil: 265.9;neutrophil: 239.1"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 265.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 216.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA055967: AB_2682990"	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (5.55e-6)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favorable (4.31e-4)"	14.9	108.4	17.6	13.4	14.8	13.1	13.7	0.0	21.4	19.0	0.0	27.8	27.0	19.0	6.6	20.6	20.1	9.2	12.8	17.6	34.4	19.2	16.0	23.6	4.8	24.9	27.8	23.0	21.0	18.9	22.8	6.9	29.2	17.3	5.3	1.0	18.6	20.2	7.9	21.1	25.3	4.4	2.7	26.6	19.9	36.3	28.7	3.2	15.9	1.1	2.3	32.5	18.1	4.8	66.8	43.2	3.8	50.8	21.0	15.4	57.1	90.5	42.6	32.9	49.2	22.1	64.3	11.3	46.5	34.4	10.9	111.9	0.3	26.1	9.0	16.1	54.6	12.8	30.0	12.6	18.9	29.0	216.2	31.0	17.9	17.3	9.8	44.1	46.0	11.0	51.6	42.2	9.2	32.2	10.9	22.7	22.0	21.1	60.1	28.4	7.3	24.9	47.0	71.1	2.3	14.3	57.3	37.0	16.3	4.2	34.5	2.8	73.1	49.4	16.0	12.1	40.8	17.4	31.0	6.4	66.1	25.8	27.9	157.3	22.5	265.9	2.2	11.8	3.3	1.8	3.2	1.7	24.8	1.5	1.1	1.7	239.1	7.8	7.0	7.0	1.9	8.6	17.6	14.8	0.0	21.4	17.6	34.4	24.9	27.8	29.2	2.7	28.7	4.8	11.8	12.8	26.4	11.4	11.3	13.9	66.4	29.2	14.8	15.4	31.1	19.8	8.4	31.5	23.2	44.1	6.2	43.5	15.2	88.8	5.9	52.2	1.1	28.7	22.1	18.5	42.5	13.9	18.7	33.1	52.2	16.3	10.7	26.4	76.8	25.3	15.0	22.7	32.2	30.3	13.6	49.6	16.2	36.8	38.1	4.3	19.3	52.5	8.8	8.4	48.9	24.6	3.1	5.5	9.3	28.6	43.0	15.4	9.3	44.5	101.1	14.5	28.5	8.5	39.5	7.7	19.6	5.1	15.0	17.9	21.6	51.6	23.0	46.3	46.6	47.2
MBTD1	"FLJ20055, SA49P01"	ENSG00000011258	"Mbt domain containing 1"	Q05BQ5	17	51177425-51260163	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021876	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA021876: AB_2140367"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-3)"	7.2	5.3	4.9	5.4	6.0	10.8	11.4	8.2	6.9	8.6	4.6	7.1	7.9	8.5	7.7	7.2	7.0	5.0	4.5	4.9	5.3	6.1	9.8	6.1	8.7	5.3	5.2	11.8	8.6	5.7	5.5	8.6	5.4	6.8	7.8	10.0	6.9	4.8	6.3	14.4	8.1	5.6	5.1	8.7	8.3	25.4	5.1	14.4	8.3	6.8	7.9	6.9	8.3	7.1	6.6	6.1	32.0	12.9	7.5	8.8	16.7	5.0	6.2	5.3	6.4	7.2	8.3	25.7	11.5	3.8	3.9	6.3	14.8	3.7	9.8	7.4	13.4	26.7	7.5	11.1	5.0	18.0	7.7	7.5	7.0	4.0	7.2	10.5	9.4	22.3	21.0	6.3	4.3	6.7	24.8	18.8	18.1	14.0	5.5	28.4	19.3	12.9	8.0	12.4	20.1	30.7	4.5	8.6	10.7	26.6	12.2	35.0	5.7	5.7	5.8	4.2	5.4	15.4	10.5	22.8	3.4	11.8	3.3	2.6	0.1	0.7	0.2	0.1	0.0	0.4	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.1	0.1	0.3	0.3	0.0	4.9	6.0	8.2	6.9	4.9	5.3	5.3	5.2	5.4	5.1	5.1	7.1	11.2	16.0	15.0	47.7	10.3	17.2	6.5	5.4	17.1	9.0	14.7	11.7	7.3	17.2	7.1	7.3	16.7	7.9	9.6	7.8	1.9	5.4	51.6	11.8	15.0	11.3	13.8	17.7	61.5	5.1	5.1	10.8	17.9	16.0	5.1	18.8	10.4	12.8	5.8	10.1	59.9	13.5	6.1	12.3	8.5	12.4	14.6	11.5	10.6	56.2	16.4	4.1	11.3	78.4	94.9	6.4	9.0	10.5	5.1	10.8	10.1	4.6	6.2	12.0	0.0	10.2	13.0	47.8	19.2	10.5	22.0	8.6	8.6	15.6	12.1	9.7
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839617-21885423	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease variant, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	8.6	10.6	3.5	5.2	4.0	1.7	8.8	7.8	4.9	7.5	4.5	5.1	5.2	9.7	6.0	5.8	7.3	6.7	7.7	3.7	4.1	9.4	18.7	5.5	5.0	4.4	4.1	12.5	7.3	11.0	3.8	11.6	4.9	10.5	6.0	8.8	6.6	8.5	7.1	3.7	4.2	10.1	4.1	4.8	5.8	4.1	4.2	4.9	9.0	9.1	4.7	6.8	4.0	6.1	16.9	34.5	16.1	16.5	19.8	24.4	7.7	24.4	24.7	22.7	19.7	13.8	22.5	14.6	12.4	26.2	44.4	15.4	22.4	14.0	27.9	10.9	17.8	7.2	19.7	11.4	27.1	15.6	6.8	23.2	14.8	34.3	25.1	23.0	17.8	8.4	20.3	15.8	26.1	10.5	6.4	8.1	15.0	8.8	25.1	7.9	29.8	16.4	15.7	8.4	3.9	32.8	34.3	21.5	30.5	21.3	28.9	13.2	21.2	28.4	6.6	41.9	18.5	19.1	26.0	6.9	31.6	6.4	28.0	0.0	2.2	0.8	2.2	2.5	2.0	1.9	1.6	2.0	3.6	1.7	2.2	2.6	0.2	2.6	2.6	2.4	3.2	1.7	3.5	4.0	7.8	4.9	3.7	4.1	4.4	4.1	4.9	4.1	4.2	6.1	5.5	9.6	11.5	16.6	5.8	5.5	4.8	7.0	8.0	11.8	7.5	5.1	13.3	8.6	7.1	7.3	18.8	7.0	2.2	3.8	0.0	5.9	0.3	4.0	11.5	5.6	2.4	2.1	16.8	8.9	7.1	10.8	6.1	3.7	10.8	14.5	7.5	18.7	9.4	30.3	25.0	3.4	12.2	9.2	4.0	1.9	10.5	4.8	10.6	11.2	5.0	7.3	3.1	21.6	22.2	6.1	2.4	13.2	9.1	7.4	4.9	7.2	10.7	14.5	0.0	8.6	8.3	2.7	1.5	6.5	2.7	4.8	5.1	12.3	4.3	4.9
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.5;retina: 28.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 79.0;Cone photoreceptor cells: 221.0;Early spermatids: 92.9;Excitatory neurons: 177.2;Inhibitory neurons: 149.9;Oligodendrocyte precursor cells: 185.5;Oligodendrocytes: 69.1;Rod photoreceptor cells: 124.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.0;Karpas-707: 5.0;REH: 3.4"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947, HPA061485"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Centriolar satellite, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655, HPA061485: "	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.1	7.7	9.4	0.3	16.5	0.2	0.1	0.3	33.5	0.3	0.0	0.5	0.0	0.2	0.2	0.2	0.2	0.3	0.2	13.5	6.5	0.4	0.0	0.2	0.5	6.9	6.1	0.2	0.2	3.8	5.4	0.0	7.2	0.6	0.3	28.2	0.1	0.4	0.3	0.2	0.3	0.3	0.0	2.5	0.2	2.6	5.6	0.3	0.1	0.2	0.7	0.4	0.3	19.8	0.0	0.4	0.1	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.0	1.2	0.0	0.2	0.1	0.0	6.0	0.9	2.5	0.2	0.0	0.1	0.8	0.5	0.1	0.0	0.0	0.4	0.0	0.4	1.5	0.8	5.0	0.3	0.7	0.8	0.5	0.8	0.0	1.0	3.4	0.0	0.9	0.2	0.1	1.5	0.5	0.6	0.0	1.3	0.3	0.3	0.5	0.3	0.0	0.5	0.0	0.0	2.0	2.3	1.1	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	9.4	16.5	0.3	33.5	13.5	6.5	6.9	6.1	7.2	0.0	5.6	19.8	12.3	0.0	2.2	17.0	0.2	0.4	0.5	0.2	8.6	79.0	0.3	0.6	1.8	0.0	0.1	5.5	221.0	0.2	0.8	2.1	0.0	0.1	92.9	4.6	2.1	2.0	0.0	0.4	177.2	0.2	0.1	2.0	5.1	4.3	1.3	7.7	1.8	0.4	0.5	8.4	149.9	0.3	2.0	0.8	1.2	16.4	0.9	4.3	1.8	43.1	1.6	3.8	1.0	185.5	69.1	0.1	2.2	0.4	0.6	0.3	0.4	0.1	2.8	124.0	0.0	4.1	0.9	1.4	4.2	11.2	0.4	1.4	2.9	2.9	0.2	1.1
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048500	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 43.5;epididymis: 13.9;parathyroid gland: 35.3"	"Group enriched"	"Detected in many"	7	"Enteroendocrine cells: 113.6;Melanocytes: 151.2"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.0;hippocampal formation: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.9;HAP1: 12.7;RH-30: 15.7;SK-MEL-30: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	3.0	43.5	0.7	0.2	0.2	0.0	2.2	0.0	4.0	5.1	3.3	1.0	5.4	5.7	13.9	0.3	1.7	0.3	4.4	3.5	0.1	5.0	0.1	4.5	0.1	0.0	0.1	2.1	7.4	35.3	7.0	2.5	0.1	0.3	1.0	0.1	3.7	0.6	0.2	4.3	2.2	1.9	0.2	0.9	2.6	0.6	0.5	4.3	1.9	1.1	0.2	0.4	2.4	0.0	9.0	2.0	0.0	0.0	6.6	5.9	2.4	0.1	12.9	3.2	8.8	0.6	1.5	0.0	0.9	0.1	3.0	0.0	12.7	4.2	2.0	3.6	8.6	0.0	0.7	0.0	0.0	0.0	0.0	0.6	1.5	2.6	1.5	3.2	0.0	0.0	0.0	0.0	6.3	0.7	0.0	0.0	1.0	0.0	1.1	0.0	15.7	0.0	0.4	0.0	0.5	0.0	0.4	0.0	29.3	0.9	5.2	6.5	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	4.0	3.5	0.1	0.0	0.1	0.1	0.2	0.5	0.0	16.6	16.0	1.7	0.0	0.0	8.7	3.5	7.0	0.6	0.0	4.2	1.9	6.8	11.5	2.5	3.7	0.0	9.0	0.1	0.3	0.0	1.7	0.4	0.8	8.1	2.0	113.6	0.0	1.2	9.6	0.2	18.4	1.5	1.9	0.0	0.3	0.0	0.1	3.5	0.0	0.4	2.5	6.1	0.0	7.1	0.1	1.8	3.2	151.2	2.8	1.6	0.0	0.0	0.0	0.1	3.6	12.9	0.0	0.3	1.4	4.1	3.4	0.7	0.0	6.6	6.3	1.2	1.8	4.1	0.4	3.4	2.6	1.4	1.0	3.8	0.6
MCRIP1	"FAM195B, GRAN2, MCRIP"	ENSG00000225663	"MAPK regulated corepressor interacting protein 1"	C9JLW8	17	81822361-81833302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 116.5;Exocrine glandular cells: 243.8;Extravillous trophoblasts: 154.1;Hofbauer cells: 161.7;Pancreatic endocrine cells: 137.0;Proximal tubular cells: 140.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045542	Approved		Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA045542: AB_2679363"	"unprognostic (3.11e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (2.26e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.86e-1)"	93.2	76.0	70.1	18.7	68.1	27.4	87.6	65.7	98.5	98.8	46.6	139.6	9.1	100.8	10.4	35.6	87.3	18.3	150.1	68.0	66.0	97.7	82.6	77.6	24.1	72.8	70.8	94.5	97.6	16.8	94.1	18.1	69.7	108.6	3.7	7.3	54.6	15.6	52.2	46.3	57.3	15.9	65.5	85.1	71.5	168.4	71.6	19.9	85.5	16.5	8.0	106.0	65.2	67.0	25.8	38.0	42.8	44.8	26.7	30.1	32.8	29.7	21.1	34.8	37.8	9.9	24.8	15.6	17.3	24.6	12.7	5.8	5.1	17.0	8.6	17.1	52.5	28.0	7.1	38.4	26.2	18.7	25.4	32.7	16.4	19.7	8.5	18.9	61.3	35.5	22.7	13.0	23.1	16.8	60.2	42.4	27.0	10.2	21.5	24.0	27.4	7.1	11.9	22.7	36.0	111.7	14.9	19.5	93.2	16.3	17.9	25.0	39.8	50.1	55.0	56.0	55.3	6.8	2.3	10.8	46.6	16.6	40.5	65.7	31.8	45.4	37.8	43.2	29.2	23.7	29.6	34.0	29.4	33.8	23.7	27.3	24.9	28.3	46.3	39.9	39.5	40.3	70.1	68.1	65.7	98.5	68.0	66.0	72.8	70.8	69.7	65.5	71.6	67.0	84.9	19.2	35.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	69.4	76.6	0.0	0.0	11.2	38.6	0.0	116.5	57.9	0.0	74.3	113.5	0.0	27.5	48.5	38.9	0.0	0.0	0.0	243.8	154.1	38.3	0.0	37.7	20.2	70.7	0.0	0.0	161.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.6	0.0	0.0	49.1	0.0	0.0	0.0	0.0	137.0	0.0	0.0	6.1	0.0	0.0	140.0	13.8	0.0	0.0	0.0	54.3	0.0	0.0	0.0	0.0	98.6	23.3	50.9	0.0	0.0
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 45.3;brain: 37.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 113.3;Excitatory neurons: 510.6;Inhibitory neurons: 412.2;Oligodendrocyte precursor cells: 263.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 37.0;classical monocyte: 28.6;eosinophil: 13.2;intermediate monocyte: 41.4;myeloid DC: 22.3;neutrophil: 40.5;non-classical monocyte: 40.6;plasmacytoid DC: 11.4"	"Group enriched"	"Detected in many"	54	"dendritic cells: 22.3;granulocytes: 40.5;monocytes: 41.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 71.4;RPMI-8226: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	21.3	2.3	12.8	12.5	37.1	45.3	15.9	27.7	19.4	6.0	0.0	7.7	5.1	5.9	2.0	6.4	4.9	17.4	3.8	20.9	10.0	4.4	3.7	12.9	6.1	3.8	0.5	1.7	3.2	1.9	4.0	7.3	5.7	3.5	7.2	1.7	3.7	2.2	3.2	4.3	4.9	11.2	0.5	8.8	5.5	2.1	1.4	7.9	4.6	7.9	4.4	21.3	6.1	13.4	0.3	5.2	3.3	0.1	49.0	19.6	0.2	0.3	25.1	2.3	8.1	0.1	13.3	18.7	19.2	0.0	51.1	0.2	0.4	0.2	2.8	0.0	3.6	11.4	13.3	0.2	6.4	23.6	14.6	7.3	0.0	9.0	32.5	21.2	52.7	7.6	0.3	71.4	18.7	0.6	1.4	17.9	4.1	0.3	20.7	0.9	0.2	73.7	52.7	29.0	10.0	0.5	1.7	0.1	37.1	1.4	0.0	21.8	0.3	9.0	13.9	0.4	4.2	5.0	0.1	0.2	41.8	38.5	9.1	37.0	28.6	13.2	0.1	41.4	0.0	0.6	0.1	0.2	22.3	0.3	0.4	0.0	40.5	0.3	40.6	11.4	0.0	8.5	12.8	37.1	27.7	19.4	20.9	10.0	3.8	0.5	5.7	0.5	1.4	13.4	113.3	3.2	10.8	15.3	3.2	18.1	0.2	6.9	3.4	2.2	1.7	1.1	3.1	0.0	6.6	3.7	0.0	0.3	9.8	0.1	0.0	0.0	27.8	5.5	1.2	97.9	0.0	5.0	510.6	0.2	0.2	18.5	5.6	11.6	63.3	0.1	2.2	0.3	12.2	3.3	412.2	0.0	4.1	42.4	76.5	16.2	0.6	63.5	12.4	67.5	32.9	3.2	2.1	263.4	9.0	1.3	0.0	0.0	2.4	0.8	0.0	0.5	3.5	3.5	0.0	1.8	2.0	1.8	1.4	0.7	13.4	0.3	3.7	0.3	0.0	0.6
MCTS2P	"MCTS2, psiMCT-1"	ENSG00000101898	"MCTS family member 2, pseudogene"		20	31547412-31548081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA001045			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"		Cytosol	"Plasma membrane"	"HPA001045: "	"unprognostic (1.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.17e-3)"	"unprognostic (6.04e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.90e-4)"	"unprognostic (6.59e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	0.9	0.6	0.2	1.6	0.3	1.5	2.2	0.7	1.3	1.0	0.3	1.6	1.0	1.0	0.5	1.3	1.4	0.6	0.6	0.3	0.4	1.0	0.7	0.8	1.8	0.2	0.5	2.5	0.7	1.7		1.5	0.4	1.2	1.1	1.4	0.8	0.9	0.6	0.6	0.5	1.4	0.1	0.8	1.3	1.3	0.4	2.3	1.6	0.7	2.7	2.1		0.4	8.8	0.0	7.6	7.2	2.2	5.4	0.0	3.2	5.1	10.3	4.3	0.2	4.1	13.3	0.1	4.4	3.8	11.1	0.1	15.0	12.4	0.2	10.1	20.2	2.4	2.3	3.1	17.4	10.7	3.8	7.2	4.1	7.4	3.3	4.2	8.0	9.7	4.6	3.8	3.2	16.0	2.8	0.2	23.1	7.9	8.4	25.4	4.7	3.4	1.0	10.9	10.4	3.4	9.1	3.0	5.6	4.9	7.2	5.5	5.2	11.4	4.0	8.2	3.4	4.7	10.0	6.2	11.9	6.5	0.0	0.3	0.1	0.3	0.2	0.7	0.4	0.4	0.5	0.8	0.5	0.7	0.6	0.0	0.8	0.1	0.4	0.1	0.3	0.2	0.3	0.7	1.3	0.3	0.4	0.2	0.5	0.4	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 804.1;Late spermatids: 2062.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	48.6	56.1	96.7	41.3	99.3	39.6	48.4	96.0	114.3	58.3	91.5	54.4	36.5	49.9	65.9	51.0	55.1	33.1	42.6	100.3	110.1	62.4	52.7	38.4	45.1	98.9	98.6	59.4	46.1	69.3	59.0	43.6	101.2	53.0	46.3	55.6	45.8	52.4	30.4	55.4	39.7	53.4	95.5	43.8	46.0	222.9	102.1	70.9	45.6	33.8	61.5	58.9	49.4	96.8	200.9	113.7	166.9	133.0	147.6	97.7	66.3	130.6	137.9	156.8	172.3	169.9	51.6	103.6	133.9	159.9	232.8	99.7	128.8	177.7	147.0	119.8	176.3	192.7	121.8	188.1	76.4	142.7	97.8	79.0	87.5	211.3	137.3	162.0	96.8	166.7	132.9	113.4	176.0	384.7	193.0	165.5	78.3	569.8	99.1	93.3	98.6	104.2	112.4	186.9	160.3	112.0	100.5	86.2	155.3	134.2	130.8	154.9	73.1	175.8	141.2	115.3	229.4	128.0	113.4	174.1	88.3	105.4	146.3	229.1	112.3	214.8	128.9	136.0	118.7	190.3	116.3	126.8	119.8	180.7	115.6	122.7	104.7	145.5	161.6	117.3	158.3	201.2	96.7	99.3	96.0	114.3	100.3	110.1	98.9	98.6	101.2	95.5	102.1	96.8	45.1	25.6	16.7	10.1	46.9	66.3	73.6	129.3	85.4	19.6	56.9	69.8	28.2	42.9	78.1	55.2	4.2	111.8	32.8	56.7	168.3	89.4	804.1	36.2	27.1	51.1	29.9	42.7	11.5	92.4	101.5	52.0	36.7	29.3	46.9	38.9	45.3	54.0	108.1	16.8	11.6	48.7	89.5	39.2	55.3	2062.6	63.3	51.6	67.6	5.6	70.1	98.5	68.0	7.5	11.9	80.5	61.4	59.8	55.0	84.7	82.8	142.2	73.0	23.4	118.3	26.8	102.8	285.9	98.1	73.6	69.6	85.0	51.1	35.0	49.9	86.3
MED17	"CRSP6, CRSP77, DRIP80, SRB4, TRAP80"	ENSG00000042429	"Mediator complex subunit 17"	Q9NVC6	11	93784227-93814963	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.3;cerebral cortex: 1.3;white matter: 1.7"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA046619			Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA046619: "	"prognostic unfavorable (4.94e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.48e-1)"	1.3	0.9	0.2	1.5	0.4	1.5	1.0	2.3	1.3	1.4	1.2	1.5	0.4	1.8	1.0	1.0	1.5	0.6	1.7	0.3	0.2	0.9	0.5	1.1	1.1	0.4	0.2	1.6	1.4	0.5	0.8	1.3	0.3	1.0	0.5	1.1	1.0	0.7	1.6	1.1	2.1	1.0	0.1	2.3	1.7	0.9	0.4	1.3	0.9	1.1	1.0	1.0	1.0	1.7	3.3	1.1	2.7	5.9	3.3	0.4	5.3	7.3	2.5	4.7	2.8	5.9	6.6	5.3	11.6	0.6	1.3	9.8	2.5	1.4	1.3	6.5	2.9	6.0	3.7	1.7	1.7	10.5	10.1	1.3	3.4	3.5	2.1	1.1	1.9	1.4	5.5	3.4	2.7	1.0	12.3	3.1	5.1	0.7	0.8	9.5	7.8	4.4	2.8	2.3	9.7	12.3	5.8	4.7	2.8	0.6	7.2	2.5	6.5	7.2	5.7	9.9	6.3	4.9	10.1	3.9	1.9	7.2	8.5	3.3	3.0	7.6	4.0	3.7	4.5	8.2	5.1	5.0	3.8	5.8	5.2	2.9	3.3	6.7	2.2	4.5	5.3	3.5	0.2	0.4	2.3	1.3	0.3	0.2	0.4	0.2	0.3	0.1	0.4	1.7	7.7	6.4	9.3	16.3	32.1	30.1	39.6	19.4	25.6	24.6	10.1	4.6	15.5	14.3	19.5	7.3	16.7	39.3	25.5	12.4	1.9	15.8	1.0	9.3	14.9	14.2	26.8	9.7	25.8	9.7	27.4	17.2	17.3	13.6	10.8	22.9	16.8	8.6	14.5	15.2	27.7	13.4	16.2	15.5	27.0	3.0	15.8	12.8	14.2	19.7	18.4	13.4	23.7	22.1	25.1	10.4	14.8	21.4	25.6	26.9	13.8	2.7	19.4	43.9	65.7	19.3	16.4	23.1	16.3	18.1	25.7	34.1	28.1	10.4	17.6	36.3
MED21	"SRB7, SURB7"	ENSG00000152944	"Mediator complex subunit 21"	Q13503	12	27022546-27066343	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 228.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017177	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA017177: AB_1857665"	"unprognostic (3.02e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.74e-8)"	"unprognostic (3.18e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-2)"	16.7	24.9	10.5	9.9	11.4	29.0	18.2	14.6	15.2	25.2	11.2	20.4	12.2	20.3	15.0	23.9	19.2	15.0	25.4	11.2	11.6	26.2	16.1	16.6	13.0	9.4	9.5	24.9	13.3	25.7	17.8	16.4	9.6	18.3	16.9	12.4	20.9	17.0	27.9	15.8	12.0	21.8	10.1	12.0	16.3	29.7	10.5	21.1	18.9	35.5	17.1	22.6	23.8	11.3	36.6	40.5	18.6	27.5	41.3	36.1	29.7	46.2	24.5	30.2	32.5	42.5	37.3	21.4	25.9	26.5	54.2	30.7	41.1	36.3	53.8	21.6	36.8	36.5	37.9	22.4	22.0	41.3	21.2	31.1	46.4	45.3	50.0	54.0	46.6	30.8	25.8	28.2	34.7	27.1	38.1	63.8	54.3	50.1	49.8	29.3	133.5	23.7	28.1	37.4	13.4	17.7	57.3	18.2	26.1	79.9	34.6	26.4	39.0	34.8	28.7	43.3	40.3	9.6	21.4	37.8	34.7	39.4	23.3	54.9	23.8	33.6	26.2	26.0	25.4	28.8	30.0	30.8	22.5	26.9	35.2	30.4	18.7	19.0	24.6	18.3	34.5	26.9	10.5	11.4	14.6	15.2	11.2	11.6	9.4	9.5	9.6	10.1	10.5	11.3	30.9	16.0	23.0	7.8	35.4	98.9	121.4	95.1	72.8	9.9	39.4	33.5	32.1	22.8	45.0	53.3	0.0	62.0	33.1	18.5	93.9	41.7	228.6	32.7	26.3	33.0	17.9	68.8	23.8	38.0	56.8	50.8	18.8	35.1	18.4	31.3	25.7	21.8	31.7	13.5	17.6	20.8	65.1	21.7	50.2	87.8	48.4	22.4	71.2	7.5	29.1	27.1	11.3	10.6	14.4	33.4	19.9	47.4	24.5	85.3	22.4	109.3	20.8	13.6	19.7	37.4	54.8	157.7	61.8	70.5	101.3	61.0	46.7	30.6	20.4	145.8
MED26	"CRSP7, CRSP70"	ENSG00000105085	"Mediator complex subunit 26"	O95402	19	16574907-16629062	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.4;Late spermatids: 67.4;Spermatocytes: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057997, HPA071835"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA057997: AB_2732618, HPA071835: AB_2686455"	"unprognostic (2.02e-2)"	"prognostic favorable (2.46e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.98e-3)"	4.5	3.8	4.4	3.8	4.0	11.0	4.1	5.1	4.7	4.0	4.0	4.1	2.4	4.3	1.8	5.2	3.2	2.3	3.2	5.0	5.1	2.8	3.7	4.0	4.9	5.2	4.7	4.7	3.9	3.5	3.6	3.2	4.7	4.2	1.9	2.0	4.5	2.4	6.9	6.4	3.6	2.5	3.6	4.7	3.6	35.9	4.5	4.4	3.1	3.2	4.6	3.9	4.6	4.2	11.1	4.2	3.8	8.3	4.8	3.8	11.1	6.3	4.4	6.7	6.0	6.3	6.5	17.6	6.5	4.0	2.1	8.2	5.9	6.3	4.6	13.0	12.2	6.9	4.2	5.1	4.7	7.9	6.3	4.6	6.1	5.7	5.9	4.0	3.6	9.1	11.5	20.7	4.2	11.1	8.4	7.4	9.0	5.2	13.4	8.7	5.8	19.3	4.0	4.3	10.0	5.4	5.5	5.3	6.4	2.7	3.9	10.3	4.5	8.5	6.8	10.4	8.5	14.3	12.6	14.4	6.0	10.4	5.0	0.7	0.1	0.1	0.5	0.3	0.1	0.4	0.0	0.2	0.2	0.7	0.3	0.0	0.3	0.4	0.1	1.4	0.7	0.1	4.4	4.0	5.1	4.7	5.0	5.1	5.2	4.7	4.7	3.6	4.5	4.2	13.7	3.2	12.7	11.4	11.8	14.1	5.0	3.8	11.4	4.2	14.3	12.2	1.1	2.8	3.0	5.5	10.4	6.2	15.8	5.9	3.9	4.4	65.4	12.9	7.7	6.1	2.4	5.0	8.6	4.0	11.1	7.0	5.6	16.6	1.3	5.8	4.2	5.6	5.0	5.0	7.6	4.7	2.0	8.5	10.7	67.4	6.5	9.9	1.8	1.9	4.9	6.0	4.1	7.1	8.5	6.0	3.0	3.8	15.9	6.7	3.6	2.0	3.5	6.4	0.0	17.7	8.0	54.1	19.4	11.5	10.7	16.8	11.0	6.1	5.1	8.7
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131852928-132079867	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 87.7;Oligodendrocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	14.6	14.7	20.4	10.1	22.7	18.4	14.8	19.6	22.1	14.0	17.6	16.6	8.3	19.0	23.5	17.0	15.2	9.6	18.5	22.8	19.7	14.6	9.9	14.0	15.4	20.3	19.2	12.8	9.0	15.8	17.1	13.1	19.6	15.5	11.1	13.7	11.3	13.7	20.9	20.5	11.7	16.7	19.3	14.2	12.9	18.2	19.3	28.2	13.3	14.4	14.1	17.3	13.7	21.7	33.1	29.8	40.9	32.0	28.4	24.7	33.3	34.7	48.8	73.9	58.8	53.0	29.4	31.7	21.5	39.3	48.1	60.9	54.5	51.8	46.8	34.6	36.1	24.5	31.1	31.3	42.7	43.2	33.4	28.9	37.9	57.9	61.4	22.9	41.4	52.1	36.7	29.0	57.2	57.8	52.4	30.8	40.6	36.5	62.6	44.7	51.0	43.6	31.0	17.8	72.5	28.9	44.4	22.7	26.5	25.7	37.6	22.1	29.5	71.8	31.4	52.6	51.5	10.8	32.0	57.2	40.3	33.9	50.6	5.7	18.1	21.2	26.5	28.6	21.5	16.7	20.2	26.3	28.3	19.3	16.5	21.8	7.0	27.8	24.9	29.2	30.0	18.7	20.4	22.7	19.6	22.1	22.8	19.7	20.3	19.2	19.6	19.3	19.3	21.7	10.4	16.0	7.8	55.8	12.0	6.0	14.4	28.2	18.8	24.6	3.8	6.7	6.2	2.8	17.2	12.9	18.8	33.1	14.5	4.7	13.7	15.0	14.3	8.6	10.3	12.4	5.3	6.3	87.7	16.7	20.4	12.0	10.2	8.3	10.8	12.6	6.8	5.2	17.5	21.9	63.3	5.5	18.3	3.1	5.0	8.4	14.3	9.1	7.2	33.7	10.1	25.0	3.1	69.4	130.0	16.1	2.0	17.0	13.9	7.0	2.3	7.8	9.2	20.0	6.6	16.7	17.0	24.2	28.7	10.9	5.1	54.7	15.5	18.8	4.8	10.1
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145567-19192131	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 39.3"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 29.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"Daudi: 223.4;U-266/70: 217.6;U-698: 299.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	3.0	1.8	4.4	13.9	5.4	2.3	2.6	4.4	6.1	4.0	4.4	3.1	1.8	2.3	0.7	2.2	3.5	1.4	2.2	4.5	4.7	2.7	3.8	2.6	39.3	5.2	4.9	3.9	1.5	0.4	2.6	1.0	4.8	4.5	1.1	0.9	2.6	1.3	1.0	2.8	4.9	1.3	4.3	8.8	2.6	3.2	5.2	1.8	3.4	0.7	31.5	2.3	3.3	6.1	2.3	0.5	1.5	2.1	1.3	2.5	2.2	1.3	0.9	1.8	2.2	0.0	3.2	223.4	1.0	0.9	0.5	2.0	0.3	0.8	0.3	1.0	5.1	1.4	0.6	1.1	2.8	1.2	2.0	1.0	1.8	1.1	1.6	1.0	0.1	4.2	0.9	3.9	0.8	3.9	1.6	1.8	0.2	0.2	12.8	4.6	0.9	5.2	0.5	0.3	0.3	1.8	2.5	0.3	1.7	0.0	0.0	2.5	0.7	1.1	4.0	6.9	1.8	217.6	24.0	299.5	2.6	3.9	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	4.4	5.4	4.4	6.1	4.5	4.7	5.2	4.9	4.8	4.3	5.2	6.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	29.3	0.0	0.0	0.0	0.0	0.0	6.6	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600811-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 68.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.0;Cone photoreceptor cells: 212.7;Oligodendrocytes: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 25.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 25.2;monocytes: 7.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		96000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: AB_2681060"	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favorable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	18.1	10.1	24.1	11.5	28.7	18.8	13.6	28.7	26.1	12.0	4.8	7.2	7.0	6.3	5.6	14.0	14.0	8.5	6.4	26.0	34.4	13.5	38.7	20.3	6.5	37.2	33.6	9.7	5.6	11.5	5.3	5.1	27.3	8.7	6.0	68.2	7.7	6.6	7.3	21.5	7.2	8.9	28.2	15.2	8.0	3.3	34.0	5.6	28.4	8.5	6.2	9.7	7.4	37.3	5.0	19.4	16.7	5.2	22.6	13.9	5.3	5.0	4.4	1.3	1.8	1.1	2.9	18.6	7.4	4.8	6.0	21.2	24.1	8.7	3.6	15.2	6.9	2.5	34.1	8.1	9.6	7.5	15.3	6.5	26.1	8.2	6.6	46.0	11.8	9.9	6.0	8.6	13.9	14.4	14.8	2.7	0.7	11.1	5.2	11.2	18.6	7.9	34.0	16.1	16.4	13.9	6.0	4.8	14.7	2.7	14.5	7.5	13.9	5.0	2.8	18.4	7.7	15.5	19.5	6.0	7.0	8.7	28.8	0.6	7.4	5.1	0.8	2.5	0.3	0.4	0.7	0.6	3.0	0.4	0.6	0.5	25.2	0.5	4.5	0.2	0.7	1.9	24.1	28.7	28.7	26.1	26.0	34.4	37.2	33.6	27.3	28.2	34.0	37.3	6.5	86.6	65.0	143.0	8.4	27.4	5.6	8.4	25.0	31.5	30.3	12.8	28.2	14.3	15.6	23.9	212.7	0.5	10.8	7.5	0.0	4.0	0.9	11.8	5.8	7.6	6.6	18.9	85.9	5.4	1.9	10.3	14.3	19.3	7.0	8.4	10.0	48.0	5.8	13.5	63.8	4.7	16.2	45.2	13.9	2.7	11.5	41.3	26.6	22.5	107.2	30.9	13.4	93.0	240.7	13.8	8.6	11.7	11.5	8.3	7.4	6.6	6.1	75.4	13.1	26.5	9.3	14.8	7.3	41.3	43.9	1.2	11.4	4.8	5.5	6.2
MEIS2	"HsT18361, MRG1"	ENSG00000134138	"Meis homeobox 2"	O14770	15	36889204-37101299	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 522.3;Cone photoreceptor cells: 254.4;Excitatory neurons: 164.7;Hepatic stellate cells: 207.4;Oligodendrocyte precursor cells: 262.4;Oligodendrocytes: 219.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"basophil: 2.9;eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 114.0;SH-SY5Y: 104.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 68.4;olfactory bulb: 177.4"	"HPA003256, CAB004999"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB004999: AB_425545, HPA003256: AB_1079356"	"unprognostic (4.33e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.71e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (6.47e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.15e-1)"	11.1	21.9	14.4	5.3	50.4	0.0	7.4	11.7	24.9	20.9	0.6	33.2	20.6	37.0	4.1	14.2	23.3	17.8	15.7	16.0	14.7	11.1	6.9	8.4	3.4	19.2	25.7	21.1	13.4	3.5	16.4	8.6	20.0	37.7	6.4	18.8	56.8	21.6	0.7	4.4	8.3	36.3	18.0	7.6	14.1	1.6	11.8	11.1	5.4	9.5	3.4	25.6	13.5	20.3	13.3	12.0	15.3	43.6	16.7	20.6	3.6	28.3	15.6	32.9	18.4	17.2	10.8	7.6	0.7	114.0	20.8	22.4	26.9	7.2	18.1	10.9	17.3	58.8	15.8	13.9	28.6	17.5	57.2	27.3	6.3	22.3	6.6	43.2	19.1	2.8	20.1	0.1	6.4	14.3	0.1	6.7	0.2	15.8	3.9	0.0	11.1	4.1	0.0	25.7	11.9	104.0	10.8	7.1	8.0	16.5	3.4	13.3	27.3	37.6	4.6	10.1	12.1	7.5	8.1	14.6	44.3	9.7	9.6	2.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	50.4	11.7	24.9	16.0	14.7	19.2	25.7	20.0	18.0	11.8	20.3	6.5	0.0	7.3	522.3	3.4	17.5	97.3	14.1	79.1	43.8	21.0	16.3	23.9	77.2	11.4	1.8	254.4	23.3	1.0	1.0	0.0	58.4	15.2	10.5	17.1	67.2	1.8	5.3	164.7	27.1	10.0	61.7	25.5	0.8	63.3	14.9	207.4	9.6	3.4	3.3	5.0	0.4	30.5	6.5	6.1	7.4	47.8	1.1	8.8	21.5	0.6	10.7	0.0	262.4	219.7	25.7	0.3	41.3	1.8	38.3	1.4	0.1	26.5	135.9	32.9	14.7	46.4	3.6	3.1	23.8	6.1	4.5	2.3	31.2	1.0	54.1
MEN1		ENSG00000133895	"Menin 1"	O00255	11	64803510-64811294	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030342	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA030342: AB_10610138"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-2)"	"prognostic favorable (6.31e-5)"	"unprognostic (1.40e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.76e-1)"	15.1	24.2	13.1	8.4	13.7	6.5	15.7	12.7	15.0	19.3	13.0	16.8	7.8	17.4	8.1	23.9	16.3	5.5	12.4	14.3	12.7	19.4	30.3	16.1	10.9	12.5	12.5	20.8	26.2	6.3	21.7	7.8	12.6	20.2	4.7	4.7	21.3	7.7	11.0	24.0	20.9	5.3	11.9	25.5	20.6	16.3	13.5	17.1	24.5	5.8	10.2	16.4	18.7	12.9	30.8	33.7	22.4	37.7	30.4	17.4	24.8	19.2	23.3	35.6	21.2	19.0	25.5	43.6	33.8	16.7	29.8	39.0	36.4	28.3	19.3	30.5	48.1	35.6	17.3	30.9	27.2	23.6	22.8	19.2	18.2	26.8	21.9	16.5	33.7	49.3	51.5	15.7	18.9	54.2	60.3	29.3	36.7	30.3	54.7	45.1	29.8	44.1	23.2	22.8	33.6	28.9	26.0	36.9	27.9	16.5	56.6	27.1	17.4	23.5	28.8	36.5	16.7	21.8	30.4	22.1	25.5	16.2	21.0	0.5	0.5	1.4	1.5	0.6	1.8	1.8	1.1	1.9	0.6	1.8	1.9	0.9	0.1	0.9	0.2	1.3	0.9	0.5	13.1	13.7	12.7	15.0	14.3	12.7	12.5	12.5	12.6	11.9	13.5	12.9	6.9	3.2	5.4	5.9	10.6	5.7	4.6	5.3	7.4	8.5	10.2	11.0	4.5	4.3	2.8	3.7	6.2	19.4	8.0	9.2	3.9	8.9	0.9	7.9	11.0	7.0	4.2	10.8	7.4	7.1	21.7	6.9	13.7	12.1	1.3	14.1	7.9	10.9	9.0	3.3	6.2	9.0	6.1	3.1	2.3	0.9	12.2	4.8	8.8	8.4	6.3	7.7	6.2	4.5	5.0	7.5	10.7	3.8	8.4	6.1	9.3	8.0	4.0	6.5	13.1	5.4	5.6	14.2	13.0	9.4	7.0	16.3	8.9	14.3	10.2	3.3
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640389-43661922	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.0;breast: 26.1;heart muscle: 24.9"	"Group enriched"	"Detected in some"	9	"Adipocytes: 63.5;Endothelial cells: 41.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 17.5"	"Lineage enriched"	"Detected in single"	48	"T-cells: 17.5"	"Cell line enriched"	"Detected in some"	14	"HeLa: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	36.0	0.5	0.0	4.7	0.0	0.0	26.1	0.0	0.1	8.0	0.0	4.7	1.6	5.5	1.1	3.7	9.0	5.7	24.9	0.0	0.0	0.2	0.1	1.4	6.6	0.0	0.0	1.0	1.5	1.2	0.5	0.1	0.0	2.6	2.4	0.0	4.9	1.9	8.3	6.6	5.1	10.6	0.0	10.8	3.0	1.1	0.0	3.0	1.9	17.1	5.3	7.7	7.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	1.8	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.3	2.7	0.0	0.0	1.7	0.5	0.0	0.3	0.0	0.0	17.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	1.0	0.3	4.1	0.0	0.0	1.2	0.0	0.4	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	41.3	0.0	0.0	0.7	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	1.8	0.1	1.5	0.3	0.0	0.0
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898607-112029561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.6;Kupffer cells: 119.8;Macrophages: 46.5;Microglial cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 8.6;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	50	"monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.1;Hep G2: 39.9;HUVEC TERT2: 38.4;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		Yes	NA		65000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	59.8	22.8	13.5	28.0	1.5	15.3	18.0	29.3	12.6	44.7	10.9	12.3	11.5	26.3	8.4	15.5	12.0	7.0	22.0	22.5	11.4	21.0	13.6	13.1	23.5	22.3	12.6	9.9	21.2	15.5	20.1	22.4	14.1	7.9	16.6	6.4	16.3	3.2	6.4	14.3	14.4	18.4	30.6	13.9	17.2	30.1	6.8	10.1	4.6	8.9	13.6	9.4	22.0	1.0	1.7	7.6	17.3	0.4	0.2	12.3	0.0	0.2	1.0	1.7	35.1	2.2	0.1	8.1	0.1	7.9	0.2	10.2	0.0	1.4	1.5	5.5	7.0	0.0	39.9	0.3	0.2	1.5	0.5	0.0	8.9	0.6	4.0	38.4	1.5	2.2	3.5	2.9	1.8	0.0	9.1	4.8	1.1	6.0	2.9	2.1	3.0	19.4	23.4	0.3	7.2	0.2	0.5	3.2	2.7	0.0	0.4	5.8	1.0	3.4	0.1	0.0	3.1	4.8	0.1	0.0	1.4	0.0	0.0	0.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.0	0.2	22.8	28.0	18.0	29.3	22.0	22.5	23.5	22.3	22.4	18.4	30.1	22.0	8.8	3.2	27.7	162.6	1.7	1.7	2.9	0.3	1.8	0.6	2.1	4.3	2.7	2.8	6.4	0.0	2.1	3.3	0.4	1.2	1.9	1.1	2.3	8.0	4.7	10.2	0.0	0.4	5.0	1.0	1.1	3.2	0.5	12.1	0.0	3.8	28.5	9.2	25.5	0.0	7.0	2.0	0.0	119.8	1.8	2.7	5.0	46.5	0.0	124.6	1.5	7.7	0.0	10.6	0.6	1.2	1.9	6.8	10.8	2.9	4.4	1.9	1.5	11.3	6.6	1.5	9.2	0.6	1.5	0.6	1.3	18.9	1.3	3.5	1.9	1.6
MEST	PEG1	ENSG00000106484	"Mesoderm specific transcript"	Q5EB52	7	130486171-130506465	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 771.8"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 833.5;Syncytiotrophoblasts: 999.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 24.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 9.1;granulocytes: 19.4;T-cells: 24.2"	"Cell line enriched"	"Detected in many"	6	"AN3-CA: 12338.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005623			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"		"HPA005623: AB_1079364"	"unprognostic (6.14e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.36e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.81e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (6.20e-5)"	"unprognostic (7.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.67e-2)"	117.5	56.2	30.7	16.1	31.3	12.6	63.1	0.0	27.5	6.1	24.1	27.4	28.7	24.4	6.6	6.8	12.0	23.4	7.5	30.2	73.5	17.8	51.8	43.4	5.5	10.2	19.3	18.8	30.0	8.0	33.2	771.8	14.0	12.7	20.9	39.2	21.4	5.5	6.9	4.6	21.6	17.8	2.5	90.2	8.8	26.3	68.4	10.3	11.8	5.2	4.8	11.0	3.9	9.8	77.9	41.7	197.1	12338.6	3.9	1.2	1.1	84.7	38.5	85.1	40.3	237.2	114.4	37.7	27.1	2.6	74.7	11.0	2.9	1.1	33.3	0.4	0.5	66.8	57.0	39.9	322.2	3.2	0.5	5.9	3.1	64.3	0.1	427.5	32.3	0.1	76.5	0.3	164.9	107.6	7.8	85.0	124.1	113.3	20.0	0.8	2168.8	24.5	92.0	72.0	693.2	2.0	71.9	234.0	1.0	195.6	9.2	57.3	33.6	29.2	0.7	276.1	5.6	3.4	8.6	0.7	103.3	1.2	9.7	19.4	2.6	9.1	0.9	2.9	2.2	3.9	2.5	1.8	9.1	3.4	9.4	24.2	1.5	4.3	1.7	0.4	0.1	6.7	30.7	31.3	0.0	27.5	30.2	73.5	10.2	19.3	14.0	2.5	68.4	9.8	7.4	6.4	6.2	12.7	3.3	4.5	47.3	8.6	9.1	13.5	33.3	36.1	0.9	20.0	5.7	16.5	4.2	833.5	2.1	9.3	11.7	20.3	62.7	8.2	12.7	6.0	29.5	35.9	40.8	40.0	187.8	200.3	3.1	9.5	0.0	6.3	44.6	20.4	92.7	1.7	28.1	19.4	6.1	8.8	3.2	37.5	84.8	6.6	1.8	11.2	1.3	45.3	0.0	18.1	1.8	22.8	27.5	13.5	2.3	27.1	24.6	12.3	2.9	22.0	19.7	205.6	12.0	35.7	36.7	10.0	0.6	999.6	2.1	124.8	31.5	23.4
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672196-116798377	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.6;Club cells: 99.8;Glandular and luminal cells: 161.4;Pancreatic endocrine cells: 93.9;Prostatic glandular cells: 149.3;Urothelial cells: 128.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 7.5;hippocampal formation: 6.6;midbrain: 2.5;pons: 4.9;white matter: 7.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 203.8;CAPAN-2: 219.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	100000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	10.3	0.8	0.1	3.4	0.6	7.4	8.9	0.1	7.5	13.1	9.6	9.7	6.5	6.4	2.5	6.1	4.7	11.9	6.2	6.6	0.8	20.1	42.9	20.3	2.3	1.1	2.5	0.8	6.6	0.8	3.8	26.4	4.9	6.7	9.3	3.9	8.7	11.2	14.3	7.7	8.2	5.7	0.3	6.0	15.4	0.5	0.5	3.7	17.6	11.0	3.2	18.4	4.4	7.8	203.8	115.3	0.1	0.6	8.6	8.7	7.9	113.7	48.2	60.3	51.1	25.0	219.0	8.4	179.0	72.1	163.3	51.8	19.7	110.0	123.7	0.3	23.4	0.1	112.5	21.4	1.5	0.3	0.2	11.4	42.4	40.6	129.1	109.4	42.4	0.2	4.5	0.8	114.1	5.0	0.1	0.1	17.3	32.9	113.0	0.2	95.3	0.2	105.8	24.0	16.5	0.0	45.4	15.4	44.9	19.8	0.4	0.9	72.3	89.7	30.6	46.7	88.9	2.5	19.1	1.5	99.3	0.3	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	7.5	6.6	0.8	1.1	2.5	4.9	0.3	0.5	7.8	32.6	28.9	103.6	0.3	1.0	39.0	70.5	58.1	38.1	6.7	6.5	6.9	12.3	11.5	99.8	31.3	0.0	76.0	0.4	20.5	0.0	38.5	0.0	52.5	11.6	20.1	7.2	0.0	2.6	46.9	7.5	7.4	32.6	161.4	0.0	0.0	3.9	30.5	7.0	0.0	1.0	20.5	18.3	1.3	2.2	0.1	0.6	4.4	3.6	1.9	1.0	7.6	0.0	0.5	7.7	93.9	5.5	0.0	0.4	149.3	11.2	15.6	34.5	0.3	0.0	37.8	5.2	0.0	0.6	7.9	17.8	21.8	1.2	0.0	16.4	128.6
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.8	9.5	10.2	20.5	11.6	25.1	28.7	10.5	13.8	24.0	8.8	31.8	24.1	25.7	43.7	52.3	24.3	15.1	41.1	11.2	10.0	24.7	24.0	15.6	24.9	9.5	10.1	14.0	19.5	14.0	11.6	16.9	9.4	29.2	33.5	11.3	23.1	29.7	33.8	28.7	23.4	25.7	9.2	17.6	19.6	51.6	10.6	41.9	18.8	28.7	31.2	34.5	30.8	10.4	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	10.2	11.6	10.5	13.8	11.2	10.0	9.5	10.1	9.4	9.2	10.6	10.4	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715118-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 299.3;choroid plexus: 238.6"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 1153.9"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MCF7: 178.2;PC-3: 133.1;SK-MEL-30: 93.5"	"Region enhanced"	"Detected in all"		"cerebellum: 612.9"					HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: AB_2681369"	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	16.1	36.3	238.0	4.0	233.8	1.5	14.1	203.7	299.3	15.5	238.6	30.7	4.1	17.3	3.0	10.4	37.0	2.5	56.8	209.7	210.3	29.2	49.9	16.8	2.1	258.1	239.0	5.2	46.1	5.5	88.0	3.7	208.5	25.4	1.2	3.0	25.2	13.1	23.3	11.9	12.0	2.9	244.4	12.3	22.2	15.3	258.3	2.4	30.6	5.1	1.8	20.5	11.3	237.4	8.9	73.4	14.2	72.4	24.6	13.8	22.9	17.5	8.7	6.9	4.4	11.0	21.5	1.5	39.6	12.4	26.3	32.6	2.1	17.0	1.1	4.7	32.0	2.9	13.3	57.1	15.1	6.5	9.2	33.3	18.3	2.1	4.2	21.3	2.3	20.3	5.3	1.7	5.2	178.2	2.4	22.0	5.2	9.8	133.1	24.3	16.4	24.4	18.4	2.6	22.5	28.5	6.9	18.9	93.5	1.6	28.6	12.6	8.0	19.4	36.8	22.7	15.4	11.0	3.3	1.7	30.3	4.8	46.6	0.0	0.1	0.2	0.8	0.3	0.5	1.2	0.4	0.8	0.0	0.1	0.2	0.5	0.0	0.5	0.3	0.2	1.0	0.1	238.0	233.8	203.7	299.3	209.7	210.3	258.1	239.0	208.5	244.4	258.3	237.4	46.7	0.0	2.2	91.4	8.5	3.8	17.1	3.3	0.0	45.5	79.5	75.8	16.3	48.6	1.8	16.5	14.6	0.6	26.7	29.0	50.9	8.4	8.0	230.7	54.8	21.5	27.4	2.7	6.6	5.1	2.1	15.1	5.6	14.4	0.0	2.7	20.0	39.5	6.4	70.7	5.7	10.7	2.0	7.8	6.5	25.8	11.1	6.6	10.6	8.4	1.1	1153.9	23.7	44.2	57.6	5.3	26.7	9.4	7.9	27.7	6.2	55.6	9.5	37.9	26.3	11.8	26.7	4.6	11.7	1.4	3.0	0.4	12.7	5.2	9.2	16.2
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	6.8	6.2	4.4	6.6	6.2	8.8	7.8	5.1	5.2	7.2	4.3	6.0	5.3	9.5	5.7	5.9	9.1	4.9	7.2	4.0	4.4	6.3	3.8	7.0	8.3	4.7	5.2	12.3	7.5	10.1	4.5	4.2	4.9	7.4	5.8	7.7	6.6	7.0	6.6	6.4	5.2	8.5	5.0	6.9	4.7	5.4	4.8	10.4	9.3	7.4	8.3	6.4	5.3	7.9	9.0	25.3	12.7	12.9	9.7	12.1	12.3	11.8	9.6	12.4	10.3	34.5	6.1	28.1	11.9	10.1	13.3	12.5	30.2	15.3	16.8	11.0	20.7	14.2	21.2	16.0	10.8	13.3	11.0	10.2	14.0	17.3	24.9	8.5	13.0	16.1	19.1	14.8	8.4	11.0	19.1	7.8	14.9	10.9	10.1	31.8	13.8	12.7	9.2	8.3	6.8	11.4	16.7	9.3	9.0	13.5	11.9	8.6	10.2	11.6	7.3	16.3	16.3	8.3	11.3	19.4	15.5	11.1	15.8	1.6	2.1	0.8	3.5	1.4	4.4	3.5	3.3	3.4	1.5	2.9	4.9	3.7	0.0	1.3	1.0	2.0	2.3	1.4	4.4	6.2	5.1	5.2	4.0	4.4	4.7	5.2	4.9	5.0	4.8	7.9	17.5	12.8	33.5	19.2	25.7	11.5	21.4	12.6	9.6	28.7	14.9	14.1	15.8	15.7	25.8	7.3	45.9	8.9	19.3	11.8	13.7	9.9	20.8	18.8	21.7	13.9	20.4	6.3	20.9	10.8	9.1	18.9	15.3	15.0	24.7	25.5	17.5	9.2	10.4	26.9	21.6	13.7	10.2	10.0	5.9	7.6	14.9	11.6	8.8	17.8	13.7	20.2	30.9	23.6	42.2	9.7	6.3	12.8	14.5	20.1	23.2	9.0	26.3	37.4	6.6	28.0	21.3	11.8	16.7	14.7	12.8	6.0	25.5	28.7	16.8	17.0
METTL18	"AsTP2, C1orf156, HPM1, MGC9084"	ENSG00000171806	"Methyltransferase like 18"	O95568	1	169792529-169794963	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035314	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA035314: AB_10601146"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.28e-4)"	5.6	5.3	5.4	6.2	5.7	4.0	10.5	6.5	6.8	5.8	5.7	6.5	5.2	6.0	8.7	5.2	7.5	4.8	6.1	5.0	5.5	7.4	6.2	5.5	14.1	5.4	5.5	9.2	4.9	22.4	3.4	6.0	5.7	6.8	6.2	7.3	6.3	5.9	4.3	6.2	6.0	5.0	5.8	8.8	7.3	6.5	5.5	10.3	9.0	6.9	11.6	5.6	3.8	6.7	13.0	7.5	11.6	8.3	6.6	12.2	8.6	5.9	6.9	7.8	6.6	9.6	20.7	22.2	16.2	7.7	10.8	14.5	11.5	13.6	9.9	14.0	9.9	15.9	6.6	8.0	13.7	16.9	7.2	5.6	14.2	7.5	8.1	7.6	14.2	16.8	17.1	10.8	10.1	6.3	18.0	11.1	14.9	27.7	18.7	13.0	12.0	16.8	11.7	12.9	8.6	13.4	13.2	14.4	18.2	17.1	19.3	18.1	6.7	9.3	9.0	9.9	13.8	19.8	27.6	29.9	7.1	13.4	9.9	18.2	9.5	23.1	24.8	10.6	31.7	21.6	27.1	28.8	10.0	24.2	31.8	30.9	5.5	24.0	6.6	7.7	34.5	18.3	5.4	5.7	6.5	6.8	5.0	5.5	5.4	5.5	5.7	5.8	5.5	6.7	5.8	3.2	4.6	1.0	9.5	1.5	6.1	10.8	1.8	7.4	4.6	5.2	5.0	2.8	8.5	5.5	0.0	13.7	4.5	3.7	25.4	12.1	16.9	3.7	5.1	8.3	3.0	8.6	1.4	8.0	5.5	5.5	2.0	2.8	7.0	13.4	7.5	2.9	7.7	6.7	1.9	3.6	10.2	5.9	3.2	5.4	6.2	3.7	5.4	2.8	2.6	12.0	14.4	1.5	4.0	5.3	5.7	5.3	2.5	3.1	5.7	11.6	10.9	8.5	0.0	6.1	6.5	16.7	10.2	2.4	0.9	11.5	10.1	10.0	5.5	4.2
METTL21A	"FAM119A, HCA557b, HSPA-KMT, LOC151194"	ENSG00000144401	"Methyltransferase like 21A"	Q8WXB1	2	207580631-207625928	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Paneth cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034712	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA034712: AB_10670160"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (4.80e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	11.1	9.0	18.9	10.8	20.3	22.7	7.9	24.8	24.6	8.9	14.7	9.4	8.2	9.7	7.9	6.7	7.9	7.0	13.7	17.7	19.9	11.2	23.7	9.0	16.5	20.1	19.2	11.1	8.8	9.9	9.9	12.5	20.1	8.4	8.9	16.0	8.6	6.5	21.9	9.2	8.8	7.6	15.1	16.2	12.1	7.6	21.6	17.6	12.4	8.8	15.0	8.5	6.8	27.6	18.4	16.8	27.4	20.8	11.9	12.4	53.0	10.1	12.3	15.9	16.0	32.3	28.6	26.2	21.5	7.7	27.8	10.4	39.6	13.2	13.1	15.3	27.1	30.9	26.7	53.6	21.0	40.7	30.0	11.1	17.2	7.9	13.2	19.5	18.1	43.3	45.0	15.1	10.6	29.7	41.2	69.4	45.5	24.9	11.8	30.1	11.4	38.2	23.0	15.3	32.3	26.5	21.8	7.4	21.6	37.8	10.3	59.4	9.3	13.8	30.6	12.9	17.8	22.3	29.8	54.1	22.6	31.5	20.9	32.8	28.6	54.8	9.5	29.0	16.0	54.2	14.4	13.7	24.1	44.8	26.8	17.4	10.4	16.9	45.6	30.0	12.7	16.6	18.9	20.3	24.8	24.6	17.7	19.9	20.1	19.2	20.1	15.1	21.6	27.6	30.8	16.0	25.3	16.0	55.0	15.9	38.1	25.7	5.7	22.0	16.6	16.4	23.8	21.5	23.1	11.0	8.4	35.5	24.3	17.1	29.4	27.9	31.4	12.5	10.1	24.6	5.4	42.5	20.6	25.1	31.3	16.9	18.3	8.5	46.3	17.7	20.7	12.3	29.9	18.5	17.6	16.3	69.2	22.2	93.7	45.6	9.9	32.8	44.4	44.0	29.7	17.4	16.5	20.6	25.9	23.8	114.4	7.5	16.6	48.1	8.9	23.4	23.3	20.3	13.1	9.6	16.0	24.8	19.1	9.3	12.6	10.5	23.0	15.6	18.6	19.6
METTL27	WBSCR27	ENSG00000165171	"Methyltransferase like 27"	Q8N6F8	7	73834590-73842516	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Distal tubular cells: 29.4;Ductal cells: 16.5;Endometrial ciliated cells: 66.7;Proximal tubular cells: 68.8;Respiratory ciliated cells: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.7;RPMI-8226: 82.2;T-47d: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA074662	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA074662: "	"unprognostic (6.70e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.24e-2)"	2.6	1.5	1.8	0.4	1.4	0.2	2.9	3.4	2.2	6.4	7.9	2.9	1.9	4.1	1.1	1.6	7.2	2.0	0.7	1.6	1.5	10.7	2.0	2.6	1.2	2.3	3.0	2.7	8.9	6.7	3.1	2.0	2.0	5.2	0.7	0.4	5.1	3.3	0.6	1.8	2.6	0.7	1.7	3.1	1.5	5.2	1.5	1.0	3.9	0.1	0.3	2.5	2.8	1.5	12.8	15.5	0.1	1.2	2.3	6.6	2.5	0.1	0.2	0.5	0.4	0.8	18.7	3.1	2.8	2.6	10.7	1.2	0.0	5.0	0.2	2.1	0.1	0.1	4.7	4.8	2.6	0.0	0.1	2.6	1.1	7.8	3.8	0.8	2.9	1.0	0.3	2.6	1.8	3.6	0.1	0.0	0.3	10.2	4.0	0.9	3.4	82.2	4.1	2.4	1.3	0.5	1.7	1.3	1.4	3.5	23.0	0.7	3.4	4.9	1.2	9.4	5.1	3.5	1.3	0.0	1.0	0.1	1.5	0.0	0.6	1.3	0.0	2.2	0.0	2.1	0.3	0.0	0.9	0.6	0.7	0.5	0.6	0.0	0.5	0.7	6.3	0.2	1.8	1.4	3.4	2.2	1.6	1.5	2.3	3.0	2.0	1.7	1.5	1.5	3.8	6.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.3	0.0	0.0	2.5	20.2	0.0	5.4	0.5	0.0	29.4	16.5	0.0	66.7	5.2	1.2	0.0	0.0	0.0	2.3	2.2	2.2	0.0	6.1	2.5	0.7	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	68.8	30.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.9	0.2	0.0	0.0
METTL5	HSPC133	ENSG00000138382	"Methyltransferase like 5"	Q9NRN9	2	169810081-169824931	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038223	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Cytosol	"HPA038223: AB_10672509"	"unprognostic (2.55e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.73e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (3.06e-8)"	"unprognostic (8.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.87e-3)"	51.1	39.5	41.3	27.7	42.5	34.0	50.2	41.0	57.0	30.4	36.1	53.7	29.4	29.4	63.0	36.6	29.2	25.1	65.5	41.9	45.2	38.5	46.9	24.1	35.4	41.0	42.5	25.7	54.1	36.7	30.2	30.7	42.4	32.5	42.2	30.5	47.1	32.1	92.9	32.7	33.0	36.6	43.7	26.4	43.0	24.3	45.1	30.8	37.7	73.5	38.4	42.3	31.5	45.0	97.1	52.5	74.6	83.1	66.9	99.6	122.6	80.1	74.8	95.4	76.1	164.2	111.2	122.8	95.0	66.0	126.8	98.5	103.0	167.9	133.3	95.3	73.8	185.8	40.6	181.8	90.9	235.9	87.6	73.6	220.2	121.2	147.7	99.4	90.0	165.8	176.0	99.9	123.1	93.8	113.7	190.5	101.4	125.5	98.5	113.7	70.0	190.6	167.0	87.5	90.5	67.6	51.5	80.2	146.0	84.2	75.7	104.6	62.2	103.4	84.5	65.4	104.3	97.0	158.8	206.3	86.3	113.7	95.3	45.5	26.0	21.1	39.9	32.5	61.5	65.0	54.8	53.9	32.0	56.3	56.5	52.3	7.7	45.3	31.8	49.5	57.8	34.8	41.3	42.5	41.0	57.0	41.9	45.2	41.0	42.5	42.4	43.7	45.1	45.0	67.1	12.8	28.8	6.8	49.1	38.6	88.9	105.2	47.8	24.8	64.0	111.4	83.1	50.1	65.4	44.1	16.7	96.1	43.2	36.1	111.6	115.6	3.9	61.0	34.8	48.6	60.6	70.9	10.8	146.2	117.4	43.8	24.5	43.1	46.3	35.1	46.4	49.5	77.2	23.5	11.0	66.7	59.0	36.9	33.3	8.7	50.4	35.9	55.2	9.4	53.7	51.6	53.5	7.1	13.2	149.7	48.8	60.2	48.1	92.5	72.2	115.8	61.3	23.0	52.6	47.2	66.5	49.2	97.4	56.2	40.9	39.1	47.6	48.4	69.3	89.2
METTL8	"FLJ13984, TIP"	ENSG00000123600	"Methyltransferase like 8"		2	171317405-171434802	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035421	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA035421: AB_10670116"	"unprognostic (3.13e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.94e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.83e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.59e-3)"	3.6	2.8	2.8	3.2	4.7	3.6	3.7	2.5	3.9	3.4	1.8	5.3	2.2	3.0	2.1	8.6	2.4	2.8	2.5	2.6	1.9	3.1	3.6	2.0	3.5	2.7	2.4	2.2	1.7	2.1	1.2	2.6	2.9	3.9	5.2	1.6	2.1	4.0	3.6	6.8	3.6	6.4	2.0	3.3	2.1	4.2	2.8	2.1	1.8	2.3	3.9	5.2	3.8	4.0	10.3	7.4	5.0	13.0	11.7	14.1	19.1	12.8	9.8	11.1	10.0	13.8	13.5	25.1	9.5	8.1	8.2	10.0	17.7	19.4	13.9	10.8	9.9	15.0	6.5	25.0	11.1	17.0	9.1	12.5	24.7	16.0	28.1	2.6	18.6	10.9	26.7	4.1	9.7	13.5	14.3	4.8	16.9	8.3	8.8	7.0	15.4	21.9	9.1	6.8	12.2	5.1	14.5	11.4	9.2	6.6	9.4	7.0	13.8	11.4	6.1	7.6	7.5	3.6	13.0	15.0	7.2	15.9	11.2	0.5	2.1	0.5	3.4	2.7	4.4	3.4	4.4	3.3	2.1	5.1	1.9	2.1	0.7	3.7	1.6	6.7	4.8	2.5	2.8	4.7	2.5	3.9	2.6	1.9	2.7	2.4	2.9	2.0	2.8	4.0	8.1	6.4	6.1	25.1	72.3	25.5	10.7	18.3	27.9	8.4	10.6	9.1	8.2	14.3	14.1	3.7	2.1	15.5	13.1	8.4	11.7	7.6	13.3	4.0	19.2	8.2	6.7	16.2	28.7	6.2	21.2	14.9	6.1	6.1	6.3	18.5	7.5	10.6	11.8	11.8	33.0	5.7	12.2	9.8	10.2	4.1	14.0	11.9	10.6	17.8	11.4	6.3	7.2	29.1	48.2	8.8	5.3	16.1	24.2	20.4	9.8	18.3	6.4	9.2	6.6	10.8	10.8	11.8	21.3	32.8	26.7	12.9	18.3	23.0	13.7	10.0
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 414.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: AB_2682203, HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	63.6	100.6	41.9	31.1	52.7	118.7	54.5	39.5	53.2	62.9	53.1	45.2	28.3	46.3	70.5	67.8	42.4	32.9	42.0	44.9	41.7	140.8	16.5	49.2	36.1	44.7	43.4	48.6	39.7	68.1	44.7	36.8	40.3	45.6	31.1	38.6	49.8	28.0	77.4	51.5	39.2	33.1	47.1	54.7	44.3	11.0	46.5	56.9	52.7	52.9	44.1	49.5	57.5	48.2	50.8	41.8	95.3	77.0	99.5	156.2	36.1	85.7	103.8	58.8	68.5	30.4	79.9	92.4	64.8	132.6	53.3	33.0	61.1	71.4	71.2	70.5	72.0	41.1	34.1	120.6	75.1	35.8	81.0	111.6	76.6	54.3	81.1	119.4	111.4	97.8	61.8	57.6	112.3	60.2	93.7	71.2	87.6	60.8	64.0	124.8	80.8	82.7	116.3	44.5	61.8	116.0	66.1	53.1	195.0	65.6	44.5	16.7	75.0	96.9	43.9	62.2	49.5	72.8	102.8	71.4	107.6	80.8	66.3	111.0	75.7	33.4	11.4	14.3	13.5	18.3	19.0	21.1	42.5	20.6	20.4	16.2	36.1	17.0	12.0	14.3	20.4	28.8	41.9	52.7	39.5	53.2	44.9	41.7	44.7	43.4	40.3	47.1	46.5	48.2	82.4	19.2	26.1	32.3	66.9	71.8	89.5	143.8	51.2	52.6	77.7	61.7	53.6	34.3	81.3	86.5	45.9	79.4	94.3	49.6	281.8	119.5	7.8	56.4	68.9	89.2	84.9	146.9	48.2	122.9	124.2	67.6	42.8	64.7	47.7	70.0	98.6	11.2	95.8	45.4	37.8	80.4	101.7	181.7	103.3	6.3	63.3	124.2	104.9	40.3	270.1	92.9	109.2	34.2	28.3	114.9	51.5	65.1	58.0	149.4	81.1	414.2	50.4	43.7	65.7	48.9	108.8	17.1	25.1	74.7	77.0	139.1	111.4	57.4	80.5	142.9
MEX3B	"DKFZp434J0617, RKHD3, RNF195"	ENSG00000183496	"Mex-3 RNA binding family member B"	Q6ZN04	15	82041778-82046119	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 14.0;testis: 46.8"	"Group enriched"	"Detected in many"	8	"Early spermatids: 204.7;Granulosa cells: 99.5;Late spermatids: 201.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 65.9;HEL: 49.2;SH-SY5Y: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041093	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA041093: AB_10793868"	"unprognostic (2.42e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.93e-8)"	"unprognostic (1.24e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.51e-2)"	2.2	0.4	1.7	1.5	1.6	2.0	1.5	2.8	2.8	14.0	0.0	3.4	0.6	6.2	0.5	0.9	1.3	2.5	2.7	1.8	0.7	0.7	0.9	1.5	2.7	0.7	0.9	5.6	0.6	0.2	0.8	2.3	0.7	2.5	0.7	0.8	2.6	3.2	1.6	1.1	1.1	1.4	0.3	1.1	1.0	46.8	1.9	6.4	0.8	2.0	1.0	1.4	4.1	1.0	0.2	2.5	17.2	65.9	1.4	2.0	4.9	2.1	1.0	3.6	3.2	0.5	0.4	3.2	1.2	3.9	1.1	0.5	8.2	0.3	2.5	0.7	5.3	49.2	2.8	2.2	2.8	0.6	15.1	1.0	1.3	2.0	4.0	8.4	7.6	6.1	2.4	0.0	6.2	1.6	8.3	4.2	22.4	0.1	0.6	11.4	10.4	1.7	0.1	0.0	13.7	26.2	3.5	0.6	2.4	4.8	0.2	0.8	6.9	9.0	10.3	5.0	3.1	6.1	3.4	3.7	2.9	5.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	2.8	2.8	1.8	0.7	0.7	0.9	0.7	0.3	1.9	1.0	3.6	0.0	0.6	0.0	1.3	2.8	0.4	1.4	5.2	3.1	6.0	8.0	4.5	1.5	0.4	0.0	2.1	11.3	1.6	0.7	0.0	0.8	204.7	1.8	13.5	5.3	1.2	7.2	2.1	0.2	8.7	8.3	0.5	1.3	1.3	99.5	2.5	0.2	1.5	0.0	3.4	1.0	0.0	1.0	9.8	201.1	6.5	5.0	7.2	1.0	0.5	5.2	0.0	4.0	1.3	0.5	0.2	4.5	0.8	0.8	0.0	0.0	0.3	2.9	6.6	1.9	16.8	2.7	18.8	5.8	2.0	2.5	2.0	1.0	1.4	0.2
MFGE8	"BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10"	ENSG00000140545	"Milk fat globule EGF and factor V/VIII domain containing"	Q08431	15	88898683-88913381	"Cancer-related genes, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 407.0;Cone photoreceptor cells: 385.7;Rod photoreceptor cells: 978.7;Sertoli cells: 1084.7;Smooth muscle cells: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.3;NK-cells: 7.7;T-cells: 14.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1784.6;ASC TERT1: 918.2;fHDF/TERT166: 660.4;HSkMC: 935.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002753, HPA002807"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	2830000		"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	Cytosol		"CAB002753: , HPA002807: AB_1078072"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (6.06e-9)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (4.85e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.41e-3)"	237.2	95.2	44.2	45.2	49.6	3.7	226.7	56.4	61.8	272.8	52.4	113.7	21.2	444.7	77.0	67.6	361.8	120.2	485.8	41.6	47.2	69.0	15.6	137.2	47.4	55.9	47.4	228.5	36.5	18.9	49.3	79.6	55.6	129.3	29.3	68.7	97.1	195.8	264.3	118.9	106.9	162.7	47.0	40.7	124.9	38.3	46.5	18.8	90.6	124.1	36.9	163.6	223.4	55.6	19.7	85.4	78.7	98.7	1784.6	918.2	6.9	482.7	142.4	95.4	110.3	90.5	23.5	0.0	147.5	660.4	144.6	10.2	27.6	95.8	31.1	82.3	64.7	138.1	4.6	10.2	469.8	0.2	50.1	935.7	251.8	73.5	122.5	205.3	37.0	35.3	23.4	41.1	185.1	6.2	22.6	3.2	405.4	8.3	38.4	22.7	74.4	26.4	32.6	7.3	8.2	42.9	28.0	2.5	226.1	165.6	2.4	11.1	42.0	233.2	127.8	62.3	36.3	145.3	30.5	15.9	31.6	12.2	91.5	5.3	0.2	0.4	1.3	0.0	4.2	1.2	4.2	2.9	0.0	0.9	4.3	3.3	0.0	7.7	0.1	0.1	14.9	2.1	44.2	49.6	56.4	61.8	41.6	47.2	55.9	47.4	55.6	47.0	46.5	55.6	72.1	12.8	5.4	39.2	4.0	48.7	32.2	116.3	24.5	22.1	407.0	190.4	92.8	8.6	25.5	3.7	385.7	4.5	13.1	1.6	0.0	15.7	11.0	33.3	202.2	66.9	44.8	3.8	5.1	4.3	18.6	220.0	12.8	29.7	5.1	30.1	22.1	15.5	8.1	16.8	0.4	6.4	36.7	32.9	39.7	27.9	187.0	12.9	119.2	15.0	1.8	75.9	9.2	5.5	9.6	28.3	0.2	109.1	8.8	15.8	0.1	0.2	8.3	978.7	1084.7	51.8	476.0	3.3	9.0	21.7	35.9	5.3	12.5	25.8	2.0	10.2
MFHAS1	"LRRC65, MASL1, ROCO4"	ENSG00000147324	"Malignant fibrous histiocytoma amplified sequence 1"	Q9Y4C4	8	8783354-8893630	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Signal transduction inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.4;Glandular and luminal cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 128.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051213, HPA054471"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA051213: AB_2681391, HPA054471: AB_2682498"	"unprognostic (1.33e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.23e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.01e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-1)"	5.8	2.0	7.3	7.9	6.9	11.9	3.6	7.5	8.7	6.3	4.1	12.8	6.1	5.1	3.3	5.3	6.6	5.5	6.6	8.3	6.4	13.5	6.0	9.9	10.4	6.1	7.4	3.4	4.6	5.7	2.0	8.8	6.5	5.3	11.4	5.4	3.4	4.4	2.4	6.1	7.0	8.2	6.5	11.1	6.3	6.0	9.0	9.0	5.4	2.7	8.6	9.2	3.5	6.2	19.5	14.4	8.6	6.6	8.0	10.1	28.3	7.9	17.0	5.6	7.6	23.3	3.7	28.5	9.5	7.6	16.2	6.5	9.1	7.3	4.9	37.0	8.1	2.1	5.3	15.1	9.5	8.2	2.9	5.5	15.0	7.6	7.5	6.0	12.5	34.8	13.4	0.0	4.7	7.0	128.0	7.2	16.8	25.8	6.1	17.4	13.1	4.4	39.3	20.0	13.6	11.0	4.6	7.2	12.7	14.6	4.9	11.1	5.3	6.8	10.1	27.3	15.4	1.5	6.9	21.7	12.6	10.8	4.2	0.0	0.1	0.0	0.9	0.0	0.7	0.4	1.3	0.8	0.2	0.3	0.6	0.5	0.0	0.1	0.0	0.0	1.2	0.3	7.3	6.9	7.5	8.7	8.3	6.4	6.1	7.4	6.5	6.5	9.0	6.2	10.7	54.5	43.9	105.4	6.5	37.5	24.5	6.0	2.8	19.0	6.2	3.2	17.2	20.0	16.5	31.3	4.2	3.7	6.5	30.9	13.7	12.0	2.5	50.8	20.3	19.2	18.8	71.4	46.9	15.4	3.2	17.8	8.2	119.2	22.2	5.4	25.4	17.8	31.8	3.3	56.8	29.3	10.2	27.5	21.0	3.4	11.5	13.0	10.6	61.8	8.0	24.3	14.4	38.2	6.2	28.5	20.7	8.2	2.1	47.5	6.7	16.5	5.4	8.1	0.0	4.5	24.1	1.9	21.7	2.4	50.0	2.3	24.0	1.7	36.3	16.9
MFSD1	"FLJ14153, Minerva, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 214.4;Kupffer cells: 289.7;Macrophages: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 254.5;granulocytes: 246.0;monocytes: 288.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065858	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Cytosol	"HPA065858: AB_2685569"	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	39.7	27.4	11.0	38.1	12.9	35.9	26.9	20.2	15.8	22.5	23.8	31.1	25.7	16.1	19.4	35.0	21.4	32.3	17.2	15.7	14.5	30.3	39.5	40.5	34.5	15.8	12.2	17.9	31.5	36.0	7.5	30.7	16.4	26.8	22.2	8.4	48.4	23.4	11.1	23.4	23.2	26.2	11.5	42.0	36.1	18.0	16.1	16.1	27.9	16.9	21.5	40.0	19.6	17.3	83.3	28.9	9.1	26.3	51.0	45.0	35.9	109.7	61.8	46.5	45.9	10.3	82.8	19.7	73.5	81.9	24.1	37.0	22.0	26.7	40.9	68.2	33.7	57.2	24.0	6.7	52.1	206.0	135.7	59.3	38.5	39.7	9.5	15.9	38.0	14.0	39.9	32.9	85.1	19.2	11.3	83.2	8.5	29.9	50.9	19.8	11.3	170.9	18.1	16.3	18.2	29.8	76.7	70.0	25.0	8.3	56.9	100.1	102.8	58.6	23.2	87.3	60.5	98.3	94.4	9.6	74.1	162.0	39.7	102.4	288.8	246.0	36.6	223.4	35.3	54.2	30.3	33.9	254.5	44.5	32.2	35.5	97.1	32.9	187.8	81.8	38.9	252.1	11.0	12.9	20.2	15.8	15.7	14.5	15.8	12.2	16.4	11.5	16.1	17.3	28.5	19.2	34.0	12.1	39.6	21.4	46.2	38.4	33.0	11.8	33.3	19.7	22.2	20.0	51.6	22.0	6.2	27.5	24.1	33.3	19.6	34.0	5.3	13.6	22.7	28.2	22.8	56.0	14.6	28.5	33.6	33.7	23.9	17.2	48.8	8.9	37.1	34.4	214.4	18.5	15.2	28.6	34.6	289.7	90.7	6.7	12.2	212.3	32.0	16.9	88.7	26.0	25.7	15.1	29.4	29.0	29.9	11.3	32.9	30.0	27.1	31.8	59.3	10.5	13.1	11.8	23.8	11.6	8.7	61.2	26.0	56.0	22.3	19.4	28.3	58.4
MFSD13A	"bA18I14.8, C10orf77, FLJ22529, TMEM180"	ENSG00000138111	"Major facilitator superfamily domain containing 13A"	Q14CX5	10	102461395-102477045	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.4;Hofbauer cells: 15.7;Horizontal cells: 21.9;Syncytiotrophoblasts: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018031	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA018031: AB_2204891"	"unprognostic (2.24e-2)"	"prognostic favorable (8.29e-4)"	"unprognostic (7.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.16e-3)"	"unprognostic (4.70e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.02e-2)"	2.3	2.5	10.0	3.2	13.0	5.2	2.1	14.1	12.8	2.4	2.3	5.0	5.5	3.1	0.7	3.0	2.3	2.3	3.2	10.8	7.2	2.5	6.3	9.0	3.2	7.7	7.7	1.4	3.8	1.7	4.1	2.3	7.8	3.1	3.2	4.9	1.8	0.9	2.3	11.7	4.4	2.5	6.5	6.9	4.0	3.7	9.2	1.8	5.4	1.4	3.6	2.2	2.6	9.4	12.0	5.4	4.0	9.6	0.4	0.4	6.2	2.3	6.0	4.6	10.5	10.7	16.0	10.6	11.8	0.9	4.4	14.6	7.4	6.3	1.7	13.5	6.8	13.1	8.2	5.6	10.1	6.7	12.3	5.2	2.6	2.6	4.6	3.7	5.3	14.2	3.0	5.7	0.4	2.4	11.3	4.3	6.8	10.5	5.2	13.6	0.6	1.8	2.0	3.1	10.0	9.5	2.2	1.2	5.2	1.4	6.0	4.0	1.6	2.1	2.5	2.6	3.3	1.9	5.5	14.0	11.6	10.9	2.9	0.4	4.3	3.5	2.9	3.2	2.8	3.4	2.7	2.3	4.5	1.4	2.8	3.2	2.5	1.2	1.8	0.4	0.8	2.6	10.0	13.0	14.1	12.8	10.8	7.2	7.7	7.7	7.8	6.5	9.2	9.4	4.1	19.2	15.4	0.0	1.1	0.0	1.5	0.0	0.6	8.2	1.5	1.9	0.0	1.5	0.6	1.8	4.2	1.8	5.7	2.6	0.0	2.8	1.8	1.0	1.0	3.8	2.4	3.6	0.0	3.6	2.6	1.6	5.6	1.6	1.3	2.8	6.4	4.0	15.7	21.9	0.0	3.8	0.0	4.8	0.0	1.0	0.9	8.7	0.0	0.0	5.6	3.2	2.1	0.0	0.0	3.2	4.6	2.2	0.8	1.4	5.6	1.5	0.7	13.8	0.0	2.8	1.1	4.5	3.0	2.4	0.0	28.5	3.2	4.0	4.5	1.4
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374569-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	24.4	32.3	25.5	26.1	28.0	18.4	24.6	26.6	33.1	24.0	34.6	24.4	18.8	24.1	29.0	40.2	26.7	20.7	20.8	24.0	26.3	21.9	15.2	32.0	29.4	29.1	28.5	19.0	18.1	95.1	12.7	33.3	28.5	21.3	28.5	17.9	20.8	21.3	12.4	42.4	21.3	23.8	28.5	25.2	24.9	14.1	27.3	30.7	25.7	14.1	34.6	34.7	27.6	29.8	76.4	48.3	36.9	28.8	79.3	56.4	58.4	72.5	62.7	63.3	61.6	24.4	88.9	91.2	42.2	63.1	73.0	163.9	44.6	46.3	61.0	65.7	23.9	31.6	43.0	36.8	56.2	100.0	55.8	52.2	68.5	67.1	51.2	35.4	54.9	49.3	60.6	52.5	85.2	57.8	73.7	56.6	54.2	111.0	38.4	36.6	84.6	29.6	68.2	57.8	35.4	46.4	61.6	71.6	79.6	44.0	32.9	58.3	59.4	65.6	46.1	102.1	68.2	57.6	77.2	24.8	58.6	48.1	60.1	0.5	6.1	4.9	4.1	9.2	3.7	3.3	3.6	4.2	6.2	2.1	3.6	5.1	8.0	3.1	6.3	6.0	4.0	3.0	25.5	28.0	26.6	33.1	24.0	26.3	29.1	28.5	28.5	28.5	27.3	29.8	21.6	6.4	20.0	0.0	17.3	0.0	23.2	0.0	22.2	12.2	29.4	15.6	0.0	14.3	6.8	44.1	4.2	14.2	20.6	16.2	7.9	16.8	3.6	32.2	20.7	18.9	7.3	30.7	0.0	19.0	26.4	17.3	16.3	32.7	3.8	14.1	26.4	13.5	28.9	5.0	0.0	22.9	0.0	66.1	0.0	3.1	16.8	31.0	0.0	0.0	39.1	19.5	15.5	0.0	0.0	26.7	12.1	16.1	12.7	38.5	11.7	7.6	7.3	9.9	13.1	18.1	14.9	14.1	18.2	37.6	0.0	19.2	15.7	17.7	14.4	42.6
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 96.9;liver: 162.0;skin 1: 87.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 136.2;Hepatocytes: 299.6;Proximal enterocytes: 235.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 13.2;intermediate monocyte: 6.6;myeloid DC: 14.7;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 24.3;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 52.0;THP-1: 169.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	6.3	1.4	34.0	3.4	31.7	8.4	13.4	34.8	36.0	4.8	22.2	7.2	14.6	8.5	96.9	12.5	3.5	2.3	1.4	30.9	33.4	5.8	162.0	36.1	2.3	38.5	33.8	2.2	0.6	0.7	8.0	17.1	38.6	2.4	5.0	2.6	4.0	79.2	0.5	87.8	32.0	3.5	32.8	1.5	1.9	33.9	37.2	1.6	7.5	0.1	3.6	20.2	14.1	33.1	6.2	2.7	12.5	18.9	8.7	1.6	0.0	5.9	11.2	12.8	15.1	0.8	3.4	38.0	3.4	3.0	8.8	15.0	12.4	21.8	9.8	4.9	6.0	4.6	0.1	0.1	28.8	6.8	21.8	9.7	13.3	52.0	21.5	2.3	3.1	11.5	0.0	9.5	5.7	0.8	10.6	10.4	10.1	21.4	4.7	7.4	18.5	8.7	2.1	17.9	4.4	6.7	4.5	31.7	3.0	1.1	1.5	169.8	2.0	2.7	5.3	9.5	24.9	1.8	3.5	8.5	28.9	26.0	9.2	0.0	13.2	1.4	0.1	6.6	0.2	1.5	0.1	0.2	14.7	0.2	0.0	0.1	0.7	0.2	1.2	24.3	0.0	3.6	34.0	31.7	34.8	36.0	30.9	33.4	38.5	33.8	38.6	32.8	37.2	33.1	0.5	19.2	136.2	3.3	6.3	52.8	21.2	40.0	51.2	2.0	6.3	2.3	0.6	12.8	30.8	16.5	0.0	0.5	5.7	62.2	0.0	3.4	1.0	25.8	5.5	22.9	1.2	5.7	1.5	24.8	7.6	9.7	24.5	61.8	17.2	0.1	7.1	299.6	6.7	0.0	1.3	34.5	12.2	9.8	43.3	2.7	0.6	16.1	0.0	38.4	5.5	38.8	0.0	0.0	1.6	27.2	39.3	0.4	5.0	13.9	235.1	6.1	33.9	2.7	0.0	5.0	3.3	1.0	1.3	49.3	54.8	52.5	3.3	0.1	20.7	26.6
MFSD6	FLJ20160	ENSG00000151690	"Major facilitator superfamily domain containing 6"	Q6ZSS7	2	190408355-190509205	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 110.6;Respiratory ciliated cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022274	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA022274: AB_2142776"	"unprognostic (9.47e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.14e-2)"	"unprognostic (9.18e-2)"	20.8	40.3	29.1	12.7	31.7	7.6	21.3	37.0	40.3	21.8	0.0	31.8	19.8	10.5	32.8	40.6	19.5	15.8	17.9	35.5	27.6	10.8	2.3	26.4	14.8	45.8	48.3	4.1	16.8	64.5	35.4	8.6	52.4	23.0	28.9	14.9	30.8	32.3	6.4	29.8	24.6	14.4	28.6	20.9	32.1	7.9	38.3	19.9	38.9	14.2	20.6	22.9	21.5	51.2	25.1	15.2	0.5	5.2	10.6	13.6	20.4	12.7	25.3	8.4	10.5	5.6	31.1	39.1	5.8	26.4	15.6	41.5	7.4	22.1	9.5	79.7	11.6	20.9	14.2	2.9	4.2	8.3	6.4	2.1	39.3	12.5	8.1	27.1	3.0	30.5	5.4	42.2	2.2	9.7	38.8	1.8	3.4	27.1	16.1	8.6	1.2	34.1	15.9	45.1	47.5	12.2	17.9	41.7	24.9	1.7	13.6	9.5	12.6	1.4	2.9	16.6	19.7	19.3	8.6	13.8	13.5	16.9	6.9	4.6	1.1	0.4	1.4	0.3	1.5	1.6	1.8	2.0	1.5	0.7	0.9	1.9	0.1	2.1	0.5	0.7	3.5	0.8	29.1	31.7	37.0	40.3	35.5	27.6	45.8	48.3	52.4	28.6	38.3	51.2	48.6	32.1	20.0	7.2	7.6	6.4	11.5	11.7	10.8	9.7	16.8	9.8	21.4	5.7	30.3	23.9	8.4	0.2	14.9	25.1	0.0	13.2	46.8	27.9	5.9	26.7	35.4	7.8	55.7	20.5	0.2	8.9	31.1	22.5	24.0	8.7	16.1	0.8	4.0	28.6	47.9	42.7	12.2	4.0	8.0	13.7	5.6	12.3	8.8	11.2	9.7	6.8	3.1	41.7	110.6	24.9	20.8	5.3	14.9	13.5	13.6	1.0	88.5	7.9	0.0	16.7	7.2	1.0	1.4	28.8	18.3	0.0	17.0	18.6	21.1	22.7
MGA	"FLJ12634, KIAA0518, MAD5, MXD5"	ENSG00000174197	"MAX dimerization protein MGA"	Q8IWI9	15	41621224-41773081	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.6"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042278, HPA058183"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA042278: AB_10794647, HPA058183: AB_2683632"	"unprognostic (5.78e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.97e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.82e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.89e-1)"	3.9	5.2	7.0	5.4	12.1	8.7	7.2	33.6	8.5	7.3	0.0	4.5	3.7	7.4	6.0	4.5	5.8	4.2	4.5	4.9	11.6	5.2	4.6	4.3	7.6	6.4	6.9	12.0	5.0	6.0	3.9	6.9	8.8	5.7	5.1	7.0	5.1	5.5	5.1	6.2	3.9	5.7	3.8	6.8	4.6	8.7	8.6	11.6	7.5	7.8	7.6	5.4	3.9	17.3	2.4	13.5	16.6	10.9	12.8	10.1	13.3	6.7	6.8	7.8	7.7	14.5	7.8	16.2	11.8	7.8	14.2	9.3	25.9	5.9	10.7	7.7	8.5	34.3	22.1	12.8	11.3	31.9	16.4	7.7	7.2	10.9	10.7	3.2	10.3	15.5	40.7	7.2	7.1	6.7	19.4	12.3	10.3	7.0	6.9	21.7	16.9	8.5	4.1	9.8	15.7	15.3	24.0	8.2	4.3	12.1	6.6	20.1	11.0	9.5	13.3	9.8	8.0	9.8	15.7	15.3	6.0	11.9	4.8	3.6	1.4	1.6	2.5	1.0	2.5	2.8	2.1	2.9	1.4	3.0	2.1	2.4	0.6	5.8	3.3	2.4	1.1	1.0	7.0	12.1	33.6	8.5	4.9	11.6	6.4	6.9	8.8	3.8	8.6	17.3	18.5	22.4	19.8	56.5	28.1	7.9	10.9	7.2	13.6	25.5	11.1	8.9	29.5	5.7	16.2	12.9	33.3	18.1	23.6	9.7	7.9	11.8	16.7	16.8	35.4	18.6	7.8	28.6	62.4	5.3	12.0	20.5	18.8	24.9	14.5	32.9	15.0	9.3	11.8	13.5	60.1	10.0	8.2	11.9	8.8	7.0	20.8	17.1	8.8	44.0	13.2	16.0	25.7	64.8	122.6	8.1	13.5	20.7	16.4	16.2	7.6	5.2	14.9	23.6	39.5	35.6	19.2	45.4	40.4	11.7	11.2	26.0	27.5	23.5	11.3	10.7
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 11.8;pancreas: 4.0;salivary gland: 5.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 27.4;Late spermatids: 18.2"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 1.6;RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055697	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.1	0.0	0.0	0.4	0.0	0.2	1.1	0.0	0.4	0.0	0.2	1.5	11.8	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	9.6	0.0	0.0	0.9	0.5	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
MGAT4B	GnT-Ivb	ENSG00000161013	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B"	Q9UQ53	5	179797597-179806952	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 277.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 224.7;Proximal enterocytes: 224.5;Undifferentiated cells: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012804, HPA052134"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		19000	"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus, Vesicles, Cytosol"	"HPA012804: , HPA052134: AB_2681741"	"unprognostic (2.01e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (3.61e-3)"	"unprognostic (7.57e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.42e-1)"	48.4	105.0	17.2	19.0	16.9	24.6	39.9	16.8	19.3	37.0	18.1	147.0	134.1	36.9	13.4	75.1	37.2	23.5	103.3	18.9	14.2	124.8	277.1	61.2	15.5	16.3	15.0	41.1	63.3	22.9	37.7	17.9	15.1	42.3	65.0	4.4	57.9	11.9	43.8	53.4	168.3	14.9	14.6	52.8	96.3	30.6	18.0	10.5	60.1	14.9	16.0	38.7	42.1	16.2	84.2	85.3	40.8	93.7	117.4	65.1	71.1	48.3	98.3	44.4	34.8	91.7	226.4	14.4	122.3	108.2	193.1	61.6	57.9	110.1	32.2	121.0	33.0	43.5	75.1	78.4	85.9	53.7	13.4	70.5	76.6	44.1	53.0	165.2	89.1	16.9	28.7	38.5	73.6	92.6	8.4	47.4	24.7	123.7	35.1	21.6	31.4	40.4	132.3	158.5	67.5	39.7	73.7	75.2	139.1	33.8	51.3	56.3	109.2	106.6	48.6	61.2	80.2	32.5	39.5	35.4	125.0	68.2	78.7	0.0	0.4	5.5	0.1	0.1	0.0	0.0	0.3	0.1	0.3	0.9	0.2	0.3	0.1	0.0	0.3	0.3	0.0	0.2	17.2	16.9	16.8	19.3	18.9	14.2	16.3	15.0	15.1	14.6	18.0	16.2	35.7	12.8	9.2	9.4	7.7	12.5	17.8	12.5	5.2	15.5	29.6	30.7	24.1	37.1	11.1	27.6	4.2	8.1	22.1	224.7	3.9	66.7	0.7	27.2	17.8	24.3	22.9	5.5	11.4	54.0	11.1	15.3	78.5	50.5	5.1	39.5	26.7	89.9	17.7	30.3	10.0	72.2	14.2	20.7	11.7	2.6	15.2	24.5	10.6	9.4	16.8	25.7	6.2	4.5	6.3	89.9	114.6	17.0	7.0	49.0	224.5	22.4	7.7	11.1	13.1	16.2	24.7	1.5	6.5	21.1	11.9	14.0	12.5	24.9	131.8	64.8
MIER2	KIAA1193	ENSG00000105556	"MIER family member 2"	Q8N344	19	301444-344815	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041439	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA041439: AB_2677481"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (2.89e-4)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.71e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (7.22e-6)"	"unprognostic (8.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.68e-2)"	25.0	13.1	14.0	4.5	12.7	2.1	21.2	10.9	18.8	21.6	7.9	17.3	4.5	22.9	2.9	19.7	16.6	3.2	34.3	12.1	11.6	17.7	8.4	28.1	3.8	13.7	13.0	15.3	11.5	2.3	15.7	6.3	12.6	23.1	1.2	2.0	12.9	4.6	18.1	25.5	14.2	2.8	11.1	33.4	13.4	29.4	12.6	3.4	17.1	7.8	1.8	19.7	19.8	11.6	12.8	7.9	7.0	8.1	2.5	3.7	15.1	10.3	4.8	7.6	7.9	12.3	4.0	6.6	5.4	5.4	3.0	10.7	4.5	6.0	2.3	16.0	21.8	3.9	6.9	9.5	7.5	0.0	30.1	4.8	4.6	6.2	2.2	5.1	8.6	8.8	11.3	0.1	4.3	13.5	10.5	14.3	18.1	3.8	0.0	9.1	2.3	1.8	3.7	7.2	11.2	10.1	6.0	4.5	10.7	4.2	5.1	7.1	9.3	10.3	7.2	15.8	11.6	18.5	9.9	5.5	9.7	5.7	10.4	3.7	3.6	2.5	1.1	3.1	0.9	0.5	1.4	1.6	3.9	1.0	1.8	1.2	0.2	0.9	3.5	2.1	0.7	2.3	14.0	12.7	10.9	18.8	12.1	11.6	13.7	13.0	12.6	11.1	12.6	11.6	28.7	0.0	5.4	4.2	5.0	11.2	11.2	8.8	7.4	7.6	7.7	6.9	1.3	7.2	6.0	3.7	16.7	22.3	3.7	4.4	1.9	9.2	6.4	3.4	6.3	24.1	10.7	6.1	4.9	5.4	19.2	6.9	10.2	4.8	0.0	6.9	7.9	2.3	10.2	3.3	4.4	4.6	4.1	8.5	6.3	19.0	6.2	8.7	5.4	13.1	6.7	7.4	5.2	3.0	6.7	8.5	5.9	5.7	4.5	11.9	3.8	0.9	5.7	12.8	6.6	4.1	5.7	18.4	25.1	6.3	10.7	29.4	5.5	6.5	4.9	12.7
MIIP	"FLJ12438, IIp45"	ENSG00000116691	"Migration and invasion inhibitory protein"	Q5JXC2	1	12019466-12032045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"HDLM-2: 362.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044948	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA044948: AB_10795887"	"unprognostic (1.36e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.65e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (8.02e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	15.6	9.6	12.3	12.3	12.8	43.5	15.0	12.0	16.3	15.8	8.7	16.8	7.2	20.8	2.3	10.5	18.0	5.6	16.0	11.7	11.1	12.3	16.3	17.5	14.2	13.1	12.2	23.8	17.4	5.5	9.1	7.2	12.3	14.5	2.3	2.8	12.5	8.5	28.0	14.8	15.8	6.6	12.1	26.1	13.3	26.8	13.4	7.5	15.7	7.8	5.4	17.2	12.4	13.2	20.4	13.4	10.4	20.8	5.7	6.3	36.3	10.9	5.6	20.9	15.1	26.8	32.2	25.8	25.3	5.8	14.7	21.0	7.9	12.3	2.7	362.4	29.4	16.3	22.8	28.5	11.7	24.6	47.4	8.3	15.7	18.6	7.9	3.6	11.7	33.7	49.1	23.4	6.5	20.8	24.6	37.5	19.0	15.2	19.7	34.6	13.3	39.8	9.1	6.2	19.2	20.2	15.9	20.3	39.1	5.8	13.5	42.2	12.3	19.2	20.2	38.8	17.0	19.3	26.4	35.7	12.5	43.0	20.1	18.0	68.7	22.8	25.1	82.2	23.3	44.1	25.9	22.1	43.5	41.5	16.1	12.6	55.7	33.8	90.8	139.5	60.1	41.3	12.3	12.8	12.0	16.3	11.7	11.1	13.1	12.2	12.3	12.1	13.4	13.2	16.4	12.8	7.7	12.4	28.7	13.0	7.4	11.6	9.1	14.0	29.5	17.4	5.4	5.7	7.2	9.2	8.4	37.8	35.5	17.0	25.4	13.8	40.6	7.9	17.2	12.7	16.7	26.7	4.1	18.5	95.9	14.4	14.3	7.3	17.7	17.9	8.9	13.5	39.7	8.4	4.6	10.7	10.2	23.2	20.7	55.6	8.4	30.8	16.0	4.7	56.6	15.4	26.8	5.0	5.0	16.7	16.8	6.8	16.6	11.4	26.0	15.1	8.1	15.3	13.1	12.4	16.2	24.7	48.2	9.9	17.2	33.1	23.6	16.6	16.9	6.2
MIPOL1	CCDC193	ENSG00000151338	"Mirror-image polydactyly 1"	Q8TD10	14	37197913-37552361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.2;Excitatory neurons: 159.4;Inhibitory neurons: 141.1;Late spermatids: 129.2;Oligodendrocyte precursor cells: 91.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002893, HPA050179"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA002893: AB_1079386, HPA050179: AB_2681043"	"unprognostic (3.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.61e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.85e-2)"	2.5	2.7	1.8	1.2	1.6	0.4	4.0	1.0	1.6	4.7	1.8	2.7	1.3	4.4	2.2	3.4	3.4	3.3	2.8	1.4	1.7	4.0	1.9	2.4	0.3	1.9	1.7	6.2	4.5	6.5	2.8	1.4	1.8	5.5	2.1	2.9	3.4	3.3	2.0	1.8	1.2	3.5	1.8	1.2	3.5	7.9	1.8	0.9	5.3	2.8	0.6	3.4	3.5	1.9	5.3	2.2	0.8	7.4	5.3	8.7	0.0	4.8	3.2	4.0	5.9	2.9	3.2	0.0	4.6	4.0	1.6	6.1	0.0	6.6	5.4	0.0	7.8	0.0	3.6	12.8	3.4	0.0	0.1	5.5	6.6	1.1	12.8	4.9	25.2	0.0	10.5	0.1	6.0	5.3	0.0	0.0	3.1	3.5	16.3	0.0	0.7	0.0	5.8	5.9	6.2	0.0	6.2	5.3	5.5	5.4	6.6	0.0	13.4	0.0	3.9	0.0	5.5	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.8	1.6	1.0	1.6	1.4	1.7	1.9	1.7	1.8	1.8	1.8	1.9	7.9	76.9	59.2	41.4	1.2	4.2	15.7	5.8	18.2	13.8	8.0	6.6	14.3	11.5	55.8	9.2	52.1	0.1	0.7	1.6	9.8	4.9	138.2	5.6	13.8	10.4	9.1	1.3	159.4	7.4	0.1	16.2	14.3	6.0	46.7	10.8	3.9	3.0	0.1	11.8	141.1	1.9	6.1	1.6	5.7	129.2	8.4	5.2	7.2	45.0	0.2	6.0	1.0	91.0	24.9	11.3	0.8	9.1	0.1	16.2	0.9	4.0	70.0	23.0	0.0	19.9	16.7	36.2	15.1	6.3	6.3	0.0	4.7	16.2	3.5	8.6
MIS18A	"B28, C21orf45, C21orf46, FASP1, hMis18alpha"	ENSG00000159055	"MIS18 kinetochore protein A"	Q9NYP9	21	32268228-32279049	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 109.9;Spermatogonia: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA018286, HPA020585"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"HPA018286: AB_1845693, HPA020585: AB_1845694"	"unprognostic (1.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.28e-1)"	4.3	5.4	4.3	7.5	4.3	16.9	7.6	5.0	5.6	4.1	3.9	9.5	8.3	6.6	6.3	8.5	5.7	3.2	3.6	4.6	4.2	6.3	6.1	3.7	11.1	4.1	4.0	9.6	4.2	4.0	3.0	7.5	4.0	5.4	10.6	4.2	5.2	3.9	3.2	8.3	9.1	4.9	4.0	6.0	6.7	21.4	4.0	16.4	3.7	2.4	12.1	4.9	5.1	4.7	63.6	15.5	43.8	42.2	6.5	11.2	67.0	32.6	16.8	31.5	27.1	31.0	34.2	69.0	23.6	12.5	37.8	21.1	43.3	24.8	37.6	39.7	48.3	79.3	16.8	40.4	4.3	68.7	25.8	4.9	10.6	26.5	18.9	10.3	22.4	68.9	93.9	56.3	31.1	43.5	79.0	61.9	90.7	43.7	45.0	68.1	65.4	64.4	22.1	21.4	52.4	25.8	49.9	41.7	30.9	31.3	50.8	41.4	13.2	39.2	72.6	30.9	34.1	30.3	51.8	86.8	25.0	108.9	36.4	4.6	7.7	13.0	14.3	10.6	14.4	30.0	15.7	16.6	7.4	29.6	21.4	15.7	2.5	16.9	19.8	20.0	23.5	9.3	4.3	4.3	5.0	5.6	4.6	4.2	4.1	4.0	4.0	4.0	4.0	4.7	8.4	19.2	8.9	1.6	9.5	15.6	7.7	16.9	9.1	9.2	15.0	17.5	5.3	11.5	10.9	11.0	4.2	36.8	11.2	5.6	13.7	13.2	7.5	16.6	12.8	8.4	6.1	22.9	6.8	12.3	53.1	12.4	5.1	15.0	3.8	29.7	12.5	7.4	16.6	8.4	5.2	21.1	14.2	6.3	6.2	7.4	10.5	6.5	5.4	2.8	7.8	10.1	18.6	5.5	6.5	10.8	6.2	10.1	13.9	5.6	3.0	17.2	10.6	7.3	19.7	16.1	12.0	109.9	86.0	20.1	14.8	14.6	7.8	16.5	20.0	5.9
MKLN1	TWA2	ENSG00000128585	"Muskelin 1"	Q9UL63	7	131110096-131496632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 455.1;Excitatory neurons: 336.5;Inhibitory neurons: 256.4;Oligodendrocyte precursor cells: 369.5;Oligodendrocytes: 332.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022817, HPA041810"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Vesicles	"HPA022817: AB_1853974, HPA041810: AB_2677686"	"unprognostic (1.97e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.32e-1)"	12.6	12.1	20.0	6.9	22.3	9.1	13.6	23.1	17.8	10.8	19.1	7.5	9.0	10.1	11.8	7.5	11.9	7.1	8.9	17.1	22.3	13.8	14.7	7.6	8.8	19.4	24.7	13.8	7.7	10.0	4.6	11.6	22.8	16.0	7.3	22.0	11.3	13.4	10.5	9.6	8.4	9.0	18.8	8.7	8.4	9.5	21.4	8.6	11.3	13.5	7.7	7.2	5.4	21.5	14.1	16.0	13.6	13.8	32.8	29.6	8.5	13.3	30.7	14.8	18.8	7.3	11.9	14.6	9.0	16.7	29.3	9.5	14.4	13.1	24.2	14.5	7.0	6.2	13.1	8.5	15.7	10.4	8.7	17.7	8.8	20.6	10.0	15.9	13.7	8.8	23.3	10.2	18.6	5.2	12.3	11.1	15.5	11.4	8.3	7.7	16.0	10.1	16.4	8.1	7.0	15.2	25.7	25.7	12.9	14.1	5.0	12.9	14.1	11.5	6.5	21.1	11.0	24.7	10.0	24.6	39.6	12.3	17.2	1.2	0.7	1.4	1.1	0.9	0.8	0.9	1.1	0.9	0.8	1.6	1.7	1.4	9.5	0.7	1.3	1.2	0.7	0.5	20.0	22.3	23.1	17.8	17.1	22.3	19.4	24.7	22.8	18.8	21.4	21.5	54.4	51.3	43.7	455.1	42.6	44.1	29.3	22.9	31.9	49.7	34.6	21.5	24.9	38.6	27.4	46.0	70.9	17.3	37.6	33.2	7.9	23.0	5.7	30.5	60.4	50.5	37.1	38.9	336.5	23.7	17.4	46.3	36.7	46.9	34.2	42.9	64.2	78.3	21.7	53.8	256.4	29.4	28.5	41.9	52.1	7.8	68.0	35.1	35.6	210.8	44.9	44.1	26.8	369.5	332.5	27.1	36.5	84.2	40.2	49.3	38.7	31.4	25.9	64.9	85.5	64.3	56.9	41.1	28.0	28.9	45.9	14.8	37.9	35.9	28.4	39.1
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453033-140479536	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 328.0;Erythroid cells: 424.2;Late spermatids: 340.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 129.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	39.5	36.8	50.9	47.9	50.7	202.6	47.8	52.6	57.1	43.0	46.6	97.9	69.2	46.7	43.3	49.0	51.3	37.5	64.6	51.0	53.7	47.9	42.7	46.9	49.7	57.6	50.7	56.5	58.1	66.8	42.3	43.0	58.9	48.6	80.1	58.6	56.5	44.4	84.0	51.7	65.8	43.5	50.2	52.7	53.9	123.2	55.6	47.1	46.9	58.5	56.4	45.7	38.9	50.9	96.5	72.3	55.6	83.1	86.5	75.5	78.2	64.6	83.3	49.8	57.2	30.0	98.8	69.4	98.4	63.4	99.2	45.7	63.2	71.2	62.8	138.0	55.6	72.1	43.5	55.9	69.4	62.5	107.1	75.4	105.1	56.2	52.8	81.9	50.8	46.9	58.0	84.8	49.1	82.6	73.4	114.2	143.3	80.7	53.6	52.4	47.4	107.6	80.8	109.2	76.6	79.1	80.8	108.5	120.6	81.6	53.3	53.5	71.9	34.9	27.4	85.8	59.8	200.2	159.2	60.9	99.3	96.1	73.3	58.6	22.5	100.4	15.4	21.3	18.0	33.6	29.5	23.0	18.0	32.9	39.9	25.5	42.5	31.1	26.5	6.0	35.3	15.3	50.9	50.7	52.6	57.1	51.0	53.7	57.6	50.7	58.9	50.2	55.6	50.9	28.4	51.3	37.2	13.4	76.8	82.1	66.6	57.1	57.5	61.5	60.9	36.2	57.7	67.2	71.1	42.3	35.5	75.8	54.0	172.1	103.7	69.8	328.0	58.4	30.6	34.2	97.3	424.2	28.9	67.8	96.6	43.3	38.7	65.7	37.4	79.5	45.7	45.0	59.5	119.5	28.0	107.7	89.5	95.9	93.3	340.6	66.5	86.3	69.4	22.5	119.0	61.4	92.7	15.1	22.1	57.6	140.3	62.4	41.8	101.2	112.4	54.4	70.0	46.4	46.0	34.7	53.3	303.0	60.1	62.4	95.5	138.0	62.9	39.6	103.5	145.9
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557057-12586208	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"Early spermatids: 572.9;Late spermatids: 774.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favorable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	16.3	11.5	15.1	10.9	15.1	3.5	13.8	16.9	17.6	15.7	13.5	16.3	13.0	16.6	12.0	17.9	14.7	11.6	32.5	15.1	17.0	16.0	15.1	13.4	14.5	15.5	15.9	21.7	24.1	23.9	12.8	16.7	16.1	12.5	13.5	11.4	14.0	14.0	32.0	14.5	12.2	18.9	16.7	10.7	13.7	56.3	16.7	21.4	21.1	24.5	17.3	15.3	14.3	17.6	20.6	18.8	24.5	17.4	45.2	44.3	40.6	30.0	35.5	41.7	34.1	19.2	18.8	26.7	16.9	37.7	18.8	10.9	38.4	33.1	37.1	30.9	29.2	40.3	19.1	31.1	51.9	38.8	14.4	46.8	30.6	47.6	30.2	34.8	34.9	39.1	39.7	30.8	37.7	25.9	51.4	17.8	16.5	21.7	40.4	45.9	26.0	32.2	30.4	24.8	14.8	26.4	28.4	12.8	30.4	17.3	29.7	38.0	31.1	23.0	23.0	28.5	43.0	26.6	62.8	60.8	28.8	49.5	41.1	20.9	17.9	32.9	20.7	16.4	26.4	21.3	21.4	22.0	19.8	16.5	22.8	20.8	13.2	27.8	23.3	15.9	24.5	20.2	15.1	15.1	16.9	17.6	15.1	17.0	15.5	15.9	16.1	16.7	16.7	17.6	15.4	19.2	9.6	9.8	13.8	9.6	9.9	13.5	10.2	13.8	8.5	8.9	14.7	1.5	14.2	5.5	4.2	19.7	20.8	7.6	19.6	16.1	572.9	9.7	13.8	14.1	2.4	5.0	15.9	16.8	19.6	11.4	5.1	10.1	19.0	17.3	7.9	5.8	15.5	11.8	15.5	10.0	6.1	7.2	9.1	774.2	20.5	9.6	16.0	6.5	20.1	19.1	20.6	14.1	11.1	16.0	10.8	20.7	14.7	9.5	12.0	11.6	14.2	13.2	13.1	11.3	17.4	66.5	38.4	8.1	9.2	16.1	15.7	23.6	10.1	9.8
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565674-23630075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;retina: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.8;Cone photoreceptor cells: 25.0;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 9.0;Rod photoreceptor cells: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"JURKAT: 26.3;K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	0.3	0.1	4.5	0.4	7.7	1.8	0.5	4.8	6.7	0.1	2.4	0.5	0.2	0.4	1.6	3.4	3.1	0.1	0.1	5.2	5.1	0.3	0.1	0.2	0.7	7.0	6.1	0.2	0.4	0.0	1.1	3.3	7.0	0.3	0.1	8.9	3.1	0.2	0.8	0.4	0.3	0.1	4.0	0.6	0.2	2.4	6.6	2.4	0.2	0.8	0.8	0.2	0.2	14.1	8.5	2.9	6.1	5.6	0.0	0.0	13.0	0.9	0.0	4.3	4.5	14.7	0.0	0.1	0.1	0.0	11.8	12.5	2.4	0.0	2.7	0.1	0.5	15.3	17.0	0.9	0.4	18.6	10.2	0.6	0.0	5.8	0.0	2.8	0.0	26.3	30.6	12.9	3.5	0.0	20.3	7.3	0.0	9.6	12.1	10.7	2.5	7.5	0.0	0.1	1.6	4.4	0.0	7.7	0.1	0.2	4.2	5.2	0.1	13.5	9.9	0.9	9.6	16.8	24.5	8.6	7.9	0.1	0.1	0.6	0.2	0.1	0.6	0.0	0.3	0.2	0.2	0.4	0.0	0.2	0.6	2.3	0.4	0.1	0.1	0.3	0.1	0.3	4.5	7.7	4.8	6.7	5.2	5.1	7.0	6.1	7.0	4.0	6.6	14.1	0.0	0.0	0.0	0.7	0.1	0.5	1.2	0.0	0.0	13.8	0.3	0.0	0.7	0.0	0.1	0.0	25.0	0.8	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.6	0.5	0.0	0.1	1.8	1.0	0.1	3.4	0.0	6.0	9.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	7.4	0.0	0.7	1.6	2.6	0.9	1.8	0.0	0.5	0.2	0.1	0.0	0.4
MLF1		ENSG00000178053	"Myeloid leukemia factor 1"	P58340	3	158571163-158607252	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 182.3;testis: 393.7"	"Group enriched"	"Detected in many"	10	"Early spermatids: 4964.0;Late spermatids: 12837.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"A-431: 84.0"	"Low region specificity"	"Detected in all"							"HPA069479, HPA079339"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA069479: AB_2686140, HPA079339: "	"unprognostic (6.49e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.72e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (9.34e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.36e-2)"	10.9	6.8	16.8	3.0	19.8	3.2	17.4	17.3	22.0	9.8	34.5	10.0	1.8	15.9	14.8	10.2	67.9	15.1	138.9	19.1	19.3	21.2	3.6	17.9	2.9	25.1	25.2	12.8	9.6	20.2	18.1	2.7	24.0	6.2	4.7	46.9	5.1	4.6	182.3	6.2	4.0	14.2	22.0	3.5	6.2	393.7	19.4	2.3	16.5	107.2	4.8	14.1	4.2	24.2	84.0	7.7	28.4	0.1	13.8	18.1	7.8	6.8	8.4	31.9	30.5	0.0	44.8	0.0	29.3	13.1	42.8	16.3	0.3	14.2	44.5	0.0	15.3	3.9	6.3	0.9	10.2	0.0	6.4	10.5	22.3	13.8	8.8	28.2	7.3	0.0	6.3	0.1	22.2	12.5	0.0	0.2	7.6	46.4	21.3	0.0	15.4	0.7	25.0	6.4	34.8	21.7	38.1	13.7	43.9	27.7	41.1	8.9	3.8	27.2	27.2	35.4	31.0	15.6	8.2	0.1	20.0	0.1	20.6	0.0	0.0	0.0	2.8	0.0	1.4	0.5	6.9	6.9	0.2	0.3	1.5	3.2	0.3	0.9	0.3	0.1	8.7	2.0	16.8	19.8	17.3	22.0	19.1	19.3	25.1	25.2	24.0	22.0	19.4	24.2	42.0	25.6	28.2	11.8	6.0	44.7	143.4	35.3	27.3	14.9	52.8	68.7	231.2	17.2	55.2	20.2	33.3	0.7	12.0	12.8	72.4	26.9	4964.0	203.9	29.3	28.4	33.9	3.6	20.2	7.6	5.0	56.3	18.8	24.0	43.8	10.0	18.5	0.2	8.0	10.1	14.1	29.3	28.5	4.1	19.7	12837.2	69.9	11.5	23.2	3.7	1.0	28.5	3.1	9.0	12.7	10.2	14.3	50.4	3.4	37.4	1.3	36.6	329.7	71.1	19.7	131.0	40.5	854.2	192.2	10.4	34.2	1.6	25.3	55.9	14.7	83.1
MLF2	NTN4	ENSG00000089693	"Myeloid leukemia factor 2"	Q15773	12	6747996-6767475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010811, HPA010859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA010811: AB_1079389, HPA010859: AB_1079388"	"unprognostic (1.65e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.42e-1)"	"unprognostic (9.88e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.63e-1)"	121.0	199.0	214.6	67.9	225.7	123.8	109.8	206.5	243.7	119.8	215.4	161.8	106.3	148.5	85.2	168.6	120.6	68.1	181.8	234.6	219.0	163.3	298.7	107.0	66.2	208.0	205.8	116.3	111.0	158.2	145.1	79.4	205.8	142.7	74.1	78.2	131.6	96.3	192.8	144.6	117.8	93.0	205.4	101.5	135.9	97.6	211.1	78.3	114.1	129.2	71.2	135.2	117.5	223.6	222.0	354.3	179.1	294.4	159.3	157.9	283.1	216.6	230.6	318.8	286.9	353.8	195.5	163.1	55.0	265.5	228.1	173.5	220.1	295.3	220.0	274.9	239.3	115.3	174.0	200.7	176.0	128.9	143.0	151.7	240.8	255.2	209.8	257.4	140.7	152.0	152.5	61.8	247.8	320.7	165.7	197.9	554.2	236.1	141.2	102.5	160.2	134.0	310.8	247.7	111.2	224.8	188.8	303.6	203.4	385.8	89.8	186.4	133.7	191.4	279.3	213.5	299.9	80.9	98.2	208.9	259.0	102.2	231.2	259.6	120.3	461.0	82.0	109.9	80.9	85.6	63.7	78.3	134.0	97.6	66.2	75.3	528.0	76.6	129.2	231.6	69.7	115.3	214.6	225.7	206.5	243.7	234.6	219.0	208.0	205.8	205.8	205.4	211.1	223.6	106.3	38.5	30.9	19.2	77.9	136.5	149.3	230.2	261.2	110.2	157.7	156.3	71.9	92.9	108.7	110.3	41.7	264.3	92.4	120.6	279.7	169.9	12.1	64.6	70.7	86.4	100.7	74.9	36.2	125.9	213.7	100.6	91.7	74.9	84.9	84.1	71.0	168.6	147.7	80.8	32.7	138.6	197.4	57.8	70.6	13.3	114.0	78.9	103.2	13.1	138.9	142.7	39.1	19.1	23.5	153.8	124.7	107.2	108.2	202.6	219.6	324.7	58.6	63.5	52.6	77.1	131.8	96.6	80.8	193.1	125.6	427.6	70.2	138.3	145.0	174.6
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Metabolism of cobalamin associated C"	Q9Y4U1	1	45500300-45513382	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 17.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	2.0	3.1	3.3	1.7	5.3	1.2	3.5	5.1	4.2	2.9	2.3	3.7	3.3	1.7	3.0	2.8	3.5	1.3	6.9	3.4	5.1	3.5	17.4	1.2	1.8	4.1	5.6	3.5	2.9	5.5	1.3	1.5	3.9	2.0	4.4	2.1	5.0	2.4	10.8	2.0	2.4	2.3	3.5	1.6	2.3	4.3	5.6	2.2	2.3	6.6	2.0	1.7	1.5	6.0	7.7	3.9	6.6	10.0	6.1	3.7	8.1	5.9	3.9	10.5	9.4	8.3	4.7	12.0	7.4	4.9	2.0	6.2	12.3	14.0	9.6	3.3	11.4	9.4	6.5	9.2	5.8	13.5	3.3	5.3	7.8	11.6	12.6	3.7	5.1	12.5	10.8	6.7	8.1	8.2	9.1	4.3	10.9	8.8	8.9	11.1	2.7	13.2	6.2	6.0	10.5	5.4	8.8	14.5	19.3	4.9	8.3	4.6	2.3	7.3	9.9	8.3	3.3	9.9	8.5	6.9	5.3	6.4	6.9	2.3	0.5	0.5	0.5	0.8	0.8	0.7	0.7	0.4	0.6	0.6	1.3	0.6	0.9	0.8	2.7	1.3	0.4	0.4	3.3	5.3	5.1	4.2	3.4	5.1	4.1	5.6	3.9	3.5	5.6	6.0	1.1	3.2	5.5	1.6	2.1	0.1	1.8	0.8	5.7	1.3	2.7	1.5	9.8	4.3	2.2	1.8	0.0	3.7	0.6	2.8	5.9	1.3	1.0	3.6	4.8	1.5	4.2	4.8	2.6	1.4	4.3	3.6	7.1	3.2	2.5	2.9	2.5	22.9	3.3	3.3	2.7	3.2	2.0	3.2	0.9	1.2	1.8	2.7	0.0	0.0	0.6	1.4	3.1	1.5	5.3	1.8	2.3	1.5	10.4	1.7	2.0	4.6	1.2	5.2	0.0	5.0	2.4	7.4	2.1	11.5	0.1	2.7	2.4	3.9	5.8	1.8
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770502-102780628	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"endometrium 1: 265.4"	"Cell type enriched"	"Detected in some"	38	"Basal respiratory cells: 3913.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 47.8;head and neck cancer: 102.2;lung cancer: 42.3"	"Region enhanced"	"Detected in single"		"thalamus: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 11.8;HUVEC TERT2: 15.1;SCLC-21H: 4.7"									CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.0	0.1	7.7	0.0	0.1	0.1	0.0	0.8	1.2	0.0	0.4	1.1	265.4	0.0	0.2	0.0	1.3	0.0	0.2	0.3	0.1	1.0	2.0	0.1	0.1	0.3	0.2	0.2	0.0	0.0	1.3	0.3	1.4	0.2	0.0	1.6	0.0	0.0	0.1	0.8	0.2	0.0	0.0	2.9	0.5	1.9	0.6	0.0	0.2	0.7	4.4	3.2	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	11.8	0.6	0.1	0.1	0.3	0.0	0.0	3.3	1.8	0.2	2.7	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.5	0.0	15.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	2.8	0.5	1.6	0.0	0.0	0.0	0.0	0.6	4.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.9	3.5	1.2	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.3	0.1	0.3	0.3	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	51.3	3913.2	0.0	0.0	0.7	0.0	0.1	0.0	85.4	29.5	0.0	0.0	0.0	0.4	0.0	34.0	6.1	6.4	2.5	9.0	0.0	0.0	0.0	14.6	0.0	6.3	0.0	12.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	9.5	1.3	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	102.5	0.1	0.0	0.0	42.5	0.0	0.1	29.3	0.0	0.0	0.0	11.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.2
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836560-22849041	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		1400000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	151.5	31.7	5.6	59.9	5.0	1.6	101.5	5.7	7.5	181.3	61.8	77.2	39.5	167.3	19.0	92.1	82.1	148.2	41.3	6.6	7.2	35.9	13.2	91.8	24.8	11.9	8.4	90.2	36.0	65.3	14.2	118.9	9.2	59.9	36.6	9.6	78.1	45.5	18.8	127.5	69.4	106.0	7.3	30.8	57.7	11.7	13.2	13.0	50.0	16.1	30.8	103.9	111.1	10.6	90.6	1.2	26.3	2.0	923.8	651.6	455.9	270.1	606.4	93.3	158.5	21.3	337.4	0.9	146.4	301.9	24.6	216.3	0.3	262.2	99.7	1.1	0.6	37.2	1.7	5.0	794.2	0.4	1.3	887.0	148.7	334.7	288.3	925.5	492.9	0.6	0.8	2.1	185.1	0.7	0.4	79.4	14.7	17.7	52.4	2.1	96.0	0.2	61.4	148.1	0.3	0.6	187.3	0.3	574.2	104.4	1.0	79.5	436.8	724.9	53.7	198.2	329.6	0.8	1.6	1.1	410.9	0.6	396.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	5.0	5.7	7.5	6.6	7.2	11.9	8.4	9.2	7.3	13.2	10.6	13.9	12.8	3.0	2.0	3.4	34.0	23.4	105.4	39.3	0.0	14.1	17.5	4.7	50.1	42.2	7.3	0.0	105.6	0.3	19.9	11.7	63.0	0.4	16.1	81.6	35.2	7.8	0.0	0.0	28.7	244.0	84.0	25.5	14.8	3.8	9.3	32.9	2.7	89.5	0.0	0.0	24.5	34.6	20.2	32.7	2.4	72.1	38.0	37.4	4.7	21.5	14.3	0.0	0.5	0.1	144.7	33.0	54.9	0.3	21.8	19.9	11.7	46.8	0.8	39.5	11.1	73.9	0.8	0.8	33.7	34.2	122.7	2.5	15.6	18.6	37.9
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025754-58046901	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 55.8;Distal enterocytes: 109.3;Proximal enterocytes: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 93.6;Hep G2: 51.1;OE19: 44.6;SK-BR-3: 47.3;WM-115: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: AB_2676956"	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.08e-4)"	11.9	3.8	8.9	4.4	6.0	0.4	7.6	7.3	11.2	5.7	5.8	28.0	40.2	3.5	1.1	4.6	6.1	14.3	41.2	6.9	8.7	14.9	50.1	9.9	2.1	15.8	10.6	1.1	18.5	12.7	8.8	28.4	16.8	4.4	14.3	1.5	8.4	9.5	7.0	4.3	33.0	3.7	5.8	9.3	29.6	34.9	18.7	1.0	46.7	5.6	1.3	5.1	2.8	8.6	15.3	11.4	5.8	30.4	6.0	0.3	93.6	1.4	0.8	5.4	1.2	9.1	38.3	0.2	17.7	1.6	4.2	21.0	5.1	4.4	1.6	0.1	10.0	0.1	4.9	51.1	7.7	0.3	19.5	3.1	7.8	0.9	2.3	8.4	3.7	8.5	12.9	0.1	1.8	7.6	0.7	2.6	17.2	44.6	3.2	7.6	0.7	8.3	16.6	5.4	1.6	10.4	20.0	47.3	9.5	13.2	5.2	8.2	3.4	0.4	9.1	3.5	1.3	0.2	0.1	0.3	1.9	2.3	78.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.9	6.0	7.3	11.2	6.9	8.7	15.8	10.6	16.8	5.8	18.7	8.6	14.3	19.2	14.4	9.1	0.7	2.5	1.0	4.9	2.8	3.4	5.0	3.0	24.7	55.8	12.6	18.4	16.7	48.2	1.6	109.3	1.9	35.7	5.0	3.6	1.1	17.2	11.4	2.7	1.4	12.0	49.2	4.5	35.2	6.4	0.0	18.6	13.6	39.2	12.9	1.7	1.2	33.3	10.2	3.0	0.3	6.9	0.9	0.9	1.8	1.0	0.0	2.1	0.0	4.5	1.4	13.3	38.5	3.4	0.3	1.3	67.3	7.3	6.0	1.9	0.0	0.7	2.4	0.9	4.6	3.3	2.3	48.4	0.7	23.2	45.0	1.7
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032011-88328025	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 2402.1"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.4;HUVEC TERT2: 12.8;SH-SY5Y: 16.2;U-138 MG: 13.7;WM-115: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	0.7	0.3	4.6	0.3	5.8	0.0	1.8	2.2	5.4	1.7	0.0	0.8	0.1	1.6	0.6	0.4	0.6	2.6	0.8	5.1	3.9	0.1	0.1	0.2	0.2	1.0	1.5	1.0	0.6	0.2	0.5	1.0	1.3	0.9	0.4	0.4	0.3	0.7	0.1	0.2	0.3	1.3	1.4	0.4	0.3	0.4	3.0	0.4	1.0	0.5	0.2	0.9	0.5	3.3	0.0	0.2	7.9	29.4	1.0	2.0	0.0	10.9	1.6	3.0	1.8	0.0	0.1	0.0	0.0	4.9	1.8	0.0	5.8	0.0	3.7	0.0	3.4	0.0	0.0	0.0	2.4	0.0	0.5	1.4	0.0	4.4	1.3	5.4	12.8	0.1	0.0	1.1	1.7	0.0	0.0	0.0	1.7	0.0	3.0	0.3	0.6	0.0	0.6	0.1	0.2	16.2	0.0	0.0	0.2	2.2	1.1	0.0	7.1	13.7	7.7	0.2	4.2	0.0	0.0	0.0	5.7	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.8	2.2	5.4	5.1	3.9	1.0	1.5	1.3	1.4	3.0	3.3	2.2	0.0	0.0	20.5	0.1	1.1	0.0	0.0	0.6	4.4	0.8	1.4	1.0	0.0	0.0	0.0	2.1	0.1	0.1	0.0	1.9	0.0	6.5	0.5	15.9	5.2	0.0	0.0	443.4	0.0	0.1	16.0	0.0	0.4	0.0	1.9	1.4	0.0	0.4	1.7	300.3	0.0	0.0	0.0	1.6	6.5	0.9	0.4	1.8	10.3	0.0	3.0	0.0	2402.1	13.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.7	2.9	0.0	1.1	0.2	0.1	0.0	0.2	3.4	0.0	0.1
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 376.0;lymphoid tissue: 105.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 260.1;Langerhans cells: 606.0;Macrophages: 230.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.1;thalamus: 4.8"	"Immune cell enriched"	"Detected in some"	127	"neutrophil: 272.2"	"Lineage enriched"	"Detected in single"	341	"granulocytes: 272.2"	"Cell line enriched"	"Detected in some"	13	"NB-4: 360.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	61000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	19.5	0.6	0.5	61.9	0.8	376.0	8.2	0.4	3.1	2.9	0.8	5.7	11.6	1.0	0.0	2.2	2.2	3.0	3.2	0.3	0.9	2.6	3.8	21.1	103.2	0.8	0.5	0.8	1.6	0.1	1.1	2.0	0.7	1.9	3.4	0.6	3.6	0.4	0.7	3.2	12.4	1.9	0.4	105.3	11.3	1.3	4.8	17.0	2.1	0.9	36.5	12.0	1.1	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.3	28.8	0.0	0.3	0.4	0.0	1.4	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	4.0	0.0	360.6	0.8	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.6	0.6	0.0	0.6	0.0	3.7	0.3	1.2	0.3	10.3	10.9	0.1	0.3	0.3	0.2	0.2	0.1	0.8	0.2	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	272.2	0.0	0.3	0.0	0.0	0.5	0.5	0.8	0.4	3.1	0.3	0.9	0.8	0.5	0.7	0.4	4.8	0.2	0.7	0.0	5.5	0.0	3.9	34.3	0.1	61.5	0.0	3.8	0.5	2.0	0.4	1.5	0.9	0.0	8.4	1.5	2.0	0.0	0.0	0.8	0.9	0.0	0.1	7.2	0.0	0.0	0.1	1.8	2.4	2.5	0.0	0.1	1.3	0.2	0.0	0.0	260.1	3.3	0.2	0.5	0.0	1.3	606.0	0.3	0.0	230.6	56.9	0.0	2.3	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.1	0.0	0.3	6.9	5.3	0.0	0.2	45.5	6.7	11.2	0.2	28.1	1.9	3.4	0.3	0.0	0.1
MMUT	"MCM, MUT"	ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463253	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 199.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 62.5;Cytotrophoblasts: 26.5;Extravillous trophoblasts: 13.3;Hofbauer cells: 12.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	19.8	23.3	12.1	11.5	13.2	8.6	18.4	14.2	16.2	14.0	19.3	22.6	27.1	15.2	15.6	17.9	13.9	14.2	31.0	12.1	13.5	50.6	199.0	12.5	11.8	13.0	12.7	24.2	24.6	31.1	11.7	13.2	13.2	20.8	21.5	17.2	18.7	15.8	23.6	15.0	20.1	14.9	14.1	9.4	20.1	14.6	13.3	12.2	19.2	36.1	11.2	13.0	11.9	16.3	23.9	8.3	24.6	28.8	47.8	45.1	13.6	20.9	27.3	21.6	31.7	9.7	12.1	21.9	16.3	22.4	32.6	13.3	27.6	14.8	30.2	18.9	20.0	11.7	17.5	25.4	34.8	15.1	10.8	27.4	21.6	22.0	25.4	19.3	21.1	23.4	21.6	25.6	25.7	15.0	17.9	14.9	10.5	25.0	6.0	15.8	30.8	30.7	24.9	22.6	22.7	15.8	23.0	16.3	35.7	25.6	14.2	23.9	15.4	20.0	14.6	27.4	28.7	10.0	12.2	18.8	28.1	17.6	17.9	16.0	6.5	11.4	6.4	8.8	8.2	7.6	7.7	8.1	7.8	6.9	9.6	7.2	3.8	12.5	14.7	5.5	10.9	5.8	12.1	13.2	14.2	16.2	12.1	13.5	13.0	12.7	13.2	14.1	13.3	16.3	6.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	26.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	13.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	33.4	0.6	0.0	0.0	0.0
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010663	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 7.2;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 6.6;Enteroendocrine cells: 25.1;Intestinal goblet cells: 19.7;Paneth cells: 7.0;Proximal enterocytes: 7.3;Undifferentiated cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;BEWO: 12.7;EFO-21: 16.2;HEK 293: 13.2;RPMI-8226: 37.6;SCLC-21H: 19.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	39	"spinal cord: 3.9"	HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: AB_2686437"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.3	0.6	0.0	0.0	3.7	7.2	0.0	0.0	0.2	0.0	0.8	0.0	0.5	0.2	0.1	0.0	0.0	0.0	1.3	0.3	0.0	16.3	0.0	2.6	0.0	0.9	0.3	3.0	0.0	1.1	0.0	0.0	0.1	6.1	0.0	0.8	0.0	2.2	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.4	5.8	0.0	17.2	0.0	0.0	12.7	0.0	0.0	0.1	0.0	7.6	2.5	1.4	16.2	0.0	0.5	0.3	3.0	2.3	1.3	2.2	13.2	0.0	1.5	3.6	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	6.1	5.7	2.9	0.0	10.1	0.9	0.2	0.0	1.7	1.1	0.0	2.5	37.6	6.5	0.6	19.3	0.0	2.5	2.2	0.4	0.1	5.4	4.4	0.0	0.0	0.0	0.0	0.0	5.3	2.9	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.6	0.5	0.2	1.3	0.3	0.9	0.8	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	4.4	1.3	0.1	0.0	0.1	25.1	0.0	0.0	3.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	19.7	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	3.1	7.0	0.0	0.4	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.8	0.0	0.0	0.0	0.2	0.0	13.6	0.0
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	36.6	24.7	12.6	64.2	11.8	90.5	31.4	12.9	13.5	36.4	18.6	41.0	42.3	35.0	25.5	40.2	33.2	35.5	25.3	11.4	15.6	48.1	30.7	38.9	91.9	15.8	13.6	31.9	16.0	28.6	9.1	35.8	16.7	30.3	42.7	10.2	19.5	29.4	13.2	38.9	41.7	40.5	15.8	61.1	34.2	19.8	12.8	56.1	33.6	19.4	93.1	46.6	26.0	17.9	78.2	43.9	53.9	58.5	86.9	94.0	63.5	61.3	82.0	78.1	76.6	60.2	55.4	159.0	51.3	77.4	58.2	63.7	69.6	70.2	117.7	113.0	41.5	143.7	28.0	64.3	69.1	126.1	222.1	80.2	67.1	62.6	52.5	58.6	83.3	60.4	62.5	57.2	76.8	42.1	159.4	106.9	50.3	66.4	35.6	108.2	185.2	85.2	67.3	96.1	27.3	35.6	87.1	63.6	56.4	40.4	51.0	59.1	79.6	100.9	53.0	71.4	98.7	42.2	40.5	119.5	68.0	105.3	55.3	103.7	65.3	91.5	37.3	106.1	40.3	57.8	33.3	40.3	60.5	46.1	30.2	36.4	65.6	56.4	126.0	42.1	37.2	79.7	12.6	11.8	12.9	13.5	11.4	15.6	15.8	13.6	16.7	15.8	12.8	17.9	82.6	51.3	58.0	3.9	173.0	136.9	96.5	107.4	60.9	13.3	66.8	45.1	40.0	35.8	79.5	82.8	6.2	63.8	170.1	114.1	92.0	60.9	11.1	88.3	91.3	73.1	37.7	48.8	7.4	52.6	101.9	67.2	55.0	102.2	110.4	58.5	61.1	43.0	169.5	26.9	7.9	67.4	65.1	196.6	246.9	11.8	62.4	226.1	67.6	14.0	350.8	25.2	117.4	6.0	10.1	83.4	85.7	68.4	106.4	127.8	80.4	170.2	116.6	14.5	72.3	60.6	75.3	99.5	44.6	86.6	132.0	66.4	124.4	79.3	74.0	155.3
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187497-36272157	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 10.3;liver: 16.0"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 18.8;Hepatocytes: 39.4;Proximal enterocytes: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 40.7;hTERT-HME1: 49.7;SiHa: 54.9;SK-MEL-30: 38.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	2.0	10.3	0.3	0.9	0.3	0.3	2.5	0.5	0.5	0.9	0.5	1.6	6.1	0.8	1.9	3.8	1.7	1.4	0.3	0.4	0.4	1.2	16.0	1.6	0.2	1.2	0.3	6.4	0.8	2.3	2.0	1.0	1.3	1.3	1.6	0.7	1.8	3.3	0.6	2.0	6.4	0.6	0.2	0.3	1.6	0.9	0.6	0.1	1.2	0.4	1.2	2.7	0.7	0.3	14.3	4.8	0.2	0.1	4.3	5.5	2.9	8.2	4.6	3.9	10.0	3.1	4.4	0.1	2.5	13.4	1.0	8.6	2.9	12.9	5.4	2.4	2.3	0.2	13.5	11.8	14.6	0.1	3.8	8.7	40.7	15.2	49.7	0.5	0.6	0.1	4.9	0.1	6.2	3.6	0.0	0.1	0.8	3.4	4.1	0.0	0.1	0.0	5.5	18.5	0.1	1.2	54.9	3.3	38.8	0.9	2.5	0.2	2.7	3.0	3.7	6.7	1.4	0.1	0.1	0.1	7.8	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.5	0.4	0.4	1.2	0.3	1.3	0.2	0.6	0.3	0.9	12.8	5.0	0.3	0.9	0.6	1.4	3.7	1.8	0.3	4.5	1.9	1.0	4.3	6.4	0.0	2.1	0.5	0.2	2.2	0.0	3.1	7.2	5.9	3.4	0.8	3.0	0.0	0.9	12.4	4.3	2.4	1.5	18.8	0.0	2.0	0.4	39.4	0.6	0.0	1.1	3.1	6.1	0.6	2.6	3.2	1.8	1.0	3.6	4.7	11.9	6.6	0.0	1.0	0.3	4.6	2.3	9.1	0.9	2.3	22.4	0.2	4.5	0.5	0.0	6.5	1.2	0.1	0.3	5.1	1.3	2.3	0.5	2.7	4.5	2.2
MOGAT1	"DGAT2L, DGAT2L1, MGAT1"	ENSG00000124003	"Monoacylglycerol O-acyltransferase 1"	Q96PD6	2	222671658-222709930	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"gallbladder: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.1;Breast glandular cells: 7.2;Cholangiocytes: 7.2;Endometrial ciliated cells: 3.9;Exocrine glandular cells: 5.1;Glandular and luminal cells: 4.9;Hepatocytes: 3.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049944, HPA076308"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"		"Cluster 30: Mammary glandular cells - Lactation"	Cytosol	"Endoplasmic reticulum"	"HPA049944: AB_2680964, HPA076308: "	"unprognostic (6.32e-2)"		"unprognostic (2.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.41e-1)"		"unprognostic (4.28e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-1)"	"unprognostic (9.03e-3)"		0.9	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	16.8	0.4	0.1	0.1	0.8	3.1	0.4	0.0	0.1	0.6	0.0	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.1	0.4	0.6	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.5	8.1	0.0	0.0	0.0	0.0	0.0	0.4	7.2	0.3	0.7	7.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.9	3.9	0.6	0.1	0.0	0.0	2.5	5.1	0.0	0.1	0.0	4.9	0.0	0.2	0.0	3.2	0.9	0.0	1.9	0.0	0.0	0.3	0.3	0.1	0.0	1.3	0.0	0.0	0.6	1.5	0.0	1.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.9	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
MON1A	"MGC13272, SAND1"	ENSG00000164077	"MON1 homolog A, secretory trafficking associated"	Q86VX9	3	49907160-49930173	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053752, HPA058032"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA053752: AB_2682250, HPA058032: AB_2683584"	"unprognostic (1.81e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-1)"	6.2	8.2	15.1	3.1	15.4	2.1	5.5	12.9	18.1	6.1	9.7	10.0	15.2	7.1	1.3	7.7	4.4	1.9	8.8	14.8	13.7	7.6	11.8	5.3	2.7	13.7	14.1	4.7	7.1	3.1	9.5	2.3	14.2	6.8	1.7	1.6	4.8	3.0	14.6	6.7	9.8	2.8	13.3	5.4	7.0	13.7	14.0	3.8	7.7	5.3	2.1	7.9	6.2	14.3	5.7	4.7	2.8	8.9	8.9	5.2	4.0	8.0	3.9	7.6	8.5	7.0	3.7	17.4	7.2	7.5	6.6	7.1	6.2	10.1	3.2	14.5	15.6	7.6	5.5	9.2	11.0	8.9	10.5	7.3	10.8	14.8	5.1	3.9	11.1	7.3	11.9	5.9	5.8	9.4	10.2	13.1	6.4	12.4	23.9	6.3	3.2	13.4	5.4	4.1	8.1	5.0	3.4	6.6	8.4	1.9	5.1	6.0	8.9	5.0	6.0	14.0	13.0	12.3	13.2	10.7	7.7	13.7	7.6	0.2	8.0	4.3	13.8	6.2	15.9	12.2	11.6	14.3	9.8	5.2	14.1	11.6	2.5	17.7	5.2	4.9	13.1	10.4	15.1	15.4	12.9	18.1	14.8	13.7	13.7	14.1	14.2	13.3	14.0	14.3	8.8	3.2	5.4	5.2	3.5	14.9	2.5	6.1	9.1	3.3	4.5	3.6	7.3	1.5	4.2	1.8	4.2	4.6	5.0	5.9	1.9	4.8	14.9	2.5	3.8	6.1	6.7	7.8	5.1	6.7	3.3	3.9	8.2	2.1	4.5	2.8	4.6	14.3	5.4	0.0	5.1	5.6	6.1	3.5	4.2	33.4	3.4	2.4	5.4	1.9	3.0	4.5	7.2	4.5	4.2	12.9	5.9	5.7	8.1	6.0	15.9	13.1	3.6	2.9	0.0	4.5	7.3	16.2	7.2	11.1	9.1	4.0	6.1	6.5	7.1	2.6
MON1B	"HSRG1, KIAA0872, SAND2"	ENSG00000103111	"MON1 homolog B, secretory trafficking associated"	Q7L1V2	16	77190835-77202398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046285	Approved		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA046285: AB_10959467"	"unprognostic (1.73e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (1.94e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.42e-5)"	"unprognostic (2.21e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.75e-1)"	12.9	9.6	19.3	17.2	25.5	15.7	9.0	20.8	18.9	11.1	9.4	15.6	16.3	10.6	12.0	13.2	10.8	13.2	10.5	18.1	19.1	10.6	12.4	12.6	18.3	24.9	24.0	8.8	13.7	17.5	8.3	8.1	21.2	19.7	13.1	21.0	13.9	10.2	11.4	13.6	16.0	9.7	20.6	15.2	13.7	5.6	22.6	15.3	19.7	7.7	15.5	11.8	7.1	23.0	14.8	35.7	15.0	15.5	16.0	15.9	20.5	14.6	17.4	13.0	13.9	20.9	22.4	26.9	24.1	11.9	23.3	29.8	15.7	14.5	11.5	19.6	17.9	19.0	12.7	20.5	22.4	20.9	52.5	15.7	28.5	19.3	17.2	14.0	24.5	24.7	25.6	9.0	11.3	29.9	26.3	24.6	15.5	19.9	9.6	34.0	10.3	30.4	14.9	11.9	22.4	18.8	25.5	10.2	17.6	10.7	23.3	30.6	26.2	16.2	18.5	18.4	13.0	30.0	21.4	72.9	28.7	21.4	20.3	17.8	9.7	16.6	9.5	16.3	9.8	6.0	7.6	8.8	8.3	7.0	5.6	7.2	21.7	10.3	11.1	4.7	9.9	9.0	19.3	25.5	20.8	18.9	18.1	19.1	24.9	24.0	21.2	20.6	22.6	23.0	19.4	38.5	34.8	1.6	17.3	7.5	10.0	12.7	8.0	15.0	16.6	14.4	12.6	12.8	19.8	14.7	18.8	10.5	16.9	42.3	3.9	14.0	17.8	13.1	15.6	20.7	24.0	16.2	1.9	19.5	12.4	12.6	21.9	20.0	12.7	17.4	19.6	28.4	13.2	8.4	3.0	27.9	10.2	32.0	7.8	14.1	9.0	18.7	8.8	4.7	26.1	21.5	26.8	3.0	5.0	20.0	18.7	10.1	13.8	21.0	23.8	11.7	14.6	23.5	19.7	21.6	11.0	10.4	5.3	14.6	9.5	16.8	17.2	10.9	23.5	18.8
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1472.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: AB_2680325"	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	16.7	36.6	14.9	5.6	14.1	13.8	16.8	12.6	19.0	22.1	11.2	17.2	6.8	18.7	3.1	33.5	16.2	8.3	15.1	13.4	14.0	21.0	38.9	13.6	8.0	15.5	13.6	19.2	18.4	7.8	15.6	4.1	13.7	18.1	3.0	2.1	19.6	7.0	10.7	41.8	12.8	5.1	13.3	16.3	19.6	57.9	14.4	7.1	14.9	5.4	5.3	17.4	23.4	13.3	12.6	16.2	13.0	22.9	6.6	4.9	9.3	9.3	10.7	9.3	9.3	15.4	16.1	7.7	20.2	8.3	13.3	9.5	7.5	12.9	1.7	20.4	9.9	8.0	12.1	23.2	8.5	6.1	30.0	13.8	10.8	7.9	4.6	8.2	15.8	12.7	19.2	15.4	9.4	35.9	17.4	47.4	11.9	16.0	24.9	16.4	13.6	18.9	14.8	17.9	7.1	42.8	17.5	26.3	9.8	5.3	16.2	18.3	19.0	18.5	28.3	38.2	9.2	12.2	12.4	5.5	18.3	69.5	22.7	38.7	29.1	40.3	31.3	22.7	36.9	21.7	36.0	36.7	31.7	22.4	21.3	22.2	21.3	37.5	15.9	21.1	57.2	14.8	14.9	14.1	12.6	19.0	13.4	14.0	15.5	13.6	13.7	13.3	14.4	13.3	18.5	9.6	7.0	4.6	10.9	12.1	20.0	31.0	21.1	5.7	28.0	25.8	3.6	21.5	16.9	20.2	6.2	6.6	19.8	9.3	43.0	43.2	324.0	15.7	12.8	16.4	21.6	21.7	4.7	42.8	26.3	16.4	12.8	11.2	3.8	11.5	23.6	31.3	29.8	6.7	7.6	14.2	22.4	25.1	14.8	1472.9	27.7	15.6	26.6	1.9	17.4	19.0	25.7	8.5	4.9	43.9	17.3	21.8	7.8	16.2	15.1	48.7	15.9	4.0	13.1	10.7	17.5	20.3	31.1	26.7	19.6	6.2	24.4	16.7	17.0	25.3
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031627			Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA031627: AB_2673966"	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	7.6	13.2	3.4	9.7	3.7	4.7	7.6	2.9	3.4	10.2	4.7	10.9	22.1	10.2	9.5	13.2	13.5	9.4	5.2	3.1	6.2	10.3	19.4	9.1	8.5	4.7	4.1	9.7	8.2	12.8	11.2	23.6	4.0	11.5	10.7	3.0	14.3	11.2	3.1	27.2	20.2	10.8	4.1	12.1	10.7	16.6	5.4	16.2	9.8	4.2	7.0	9.3	10.8	3.4	29.5	17.9	10.4	40.2	8.3	23.5	39.1	19.8	46.5	56.9	80.7	33.2	31.7	0.0	13.2	27.4	21.1	30.5	39.7	47.4	19.6	32.4	24.2	20.2	26.7	37.8	35.3	8.5	19.3	39.9	14.2	34.6	10.9	37.4	49.2	40.7	27.2	9.8	17.8	54.7	32.7	6.6	23.4	12.2	18.1	57.9	26.2	1.3	26.4	31.9	4.4	15.0	40.9	27.5	31.5	20.2	21.4	19.4	29.7	17.6	31.0	12.4	17.8	11.3	3.3	0.1	34.9	17.4	51.4	0.9	3.5	0.7	12.5	10.3	12.4	2.1	10.8	11.1	6.8	1.5	10.3	8.0	1.1	12.7	12.2	1.0	10.2	7.6	3.4	3.7	2.9	3.4	3.1	6.2	4.7	4.1	4.0	4.1	5.4	3.4	13.0	9.6	10.5	26.4	6.3	8.8	10.4	15.5	8.0	2.4	7.8	7.0	4.1	8.6	17.4	16.5	0.0	54.7	5.6	29.2	3.9	15.5	5.9	5.8	7.3	16.9	15.0	3.8	4.1	15.5	18.4	9.4	23.9	7.0	1.3	36.5	16.8	18.3	15.8	5.0	2.3	18.0	12.2	7.5	6.0	6.2	9.3	10.3	3.6	12.2	14.4	15.1	10.3	18.1	3.3	12.4	26.9	7.5	3.6	11.1	46.2	13.9	18.4	1.1	13.1	4.0	7.4	2.7	3.4	11.7	7.0	38.2	9.2	22.4	15.5	12.1
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401475	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 64.2;smooth muscle: 78.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Basal squamous epithelial cells: 153.1;Early spermatids: 70.2;Endometrial stromal cells: 57.8;Excitatory neurons: 36.0;Oligodendrocyte precursor cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 3.1;naive B-cell: 1.7;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in many"	41	"B-cells: 3.1;dendritic cells: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.8;ASC TERT1: 131.7;BJ: 106.1;fHDF/TERT166: 196.5;HBF TERT88: 120.6;U-2197: 310.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035740	Approved		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	2.8	36.5	18.0	5.7	10.6	0.1	2.5	3.1	11.7	25.7	3.5	13.4	5.2	64.2	11.0	23.5	3.4	28.7	5.4	10.9	4.0	37.0	1.8	25.3	6.2	3.5	3.8	0.8	2.2	0.5	4.5	1.4	3.9	32.0	8.8	5.0	12.2	39.6	0.3	14.4	7.5	78.6	3.6	4.7	5.2	1.8	6.7	2.1	1.8	0.5	15.6	19.1	12.8	10.8	0.1	0.9	4.1	0.0	164.8	131.7	0.2	106.1	71.0	37.7	65.8	0.2	1.2	0.4	0.1	196.5	30.9	0.1	1.4	0.5	120.6	0.0	19.3	0.0	0.1	0.0	1.5	0.1	0.1	31.8	0.0	76.6	2.5	46.6	0.0	0.0	0.0	7.8	22.4	0.0	0.1	0.2	3.5	0.0	0.7	1.1	0.4	0.2	46.3	0.4	2.8	0.2	0.0	0.4	2.4	9.6	0.1	5.9	0.5	17.4	15.9	310.0	56.1	4.1	0.0	0.0	43.9	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	18.0	10.6	3.1	11.7	10.9	4.0	3.5	3.8	3.9	3.6	6.7	10.8	0.4	0.0	1.3	92.7	5.4	28.0	0.4	0.1	153.1	0.3	0.4	0.6	0.7	0.0	2.5	1.8	0.0	0.9	2.7	0.0	0.0	0.6	70.2	1.0	57.8	0.6	0.0	0.0	36.0	0.0	1.5	23.9	0.5	1.2	3.8	0.0	0.0	0.0	0.4	0.0	8.6	0.0	0.0	0.3	4.7	11.8	0.3	0.3	7.2	4.7	0.0	16.4	0.0	33.7	1.1	0.4	0.0	0.4	9.5	1.5	0.0	0.3	0.0	0.8	0.0	6.2	3.3	0.5	0.8	14.6	6.8	0.0	0.5	0.1	0.1	0.0
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		350000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	18.9	50.5	45.4	16.7	47.3	11.7	20.1	52.2	49.2	23.9	41.1	31.8	45.6	23.6	35.3	27.7	27.8	16.0	44.8	46.6	47.9	31.2	39.1	14.9	20.9	55.5	50.1	30.6	31.8	31.1	22.9	16.2	56.2	27.5	31.4	33.6	23.7	22.9	52.2	16.5	33.0	22.5	45.7	23.0	20.9	26.2	50.0	23.2	23.2	70.9	24.2	24.2	19.5	47.1	27.2	36.9	29.8	34.0	66.7	32.2	26.0	22.8	37.2	38.4	53.4	36.7	35.0	38.3	48.6	33.6	30.6	65.9	60.0	66.7	36.2	29.4	74.9	68.8	35.3	39.9	47.5	32.0	19.4	43.1	16.9	36.2	64.4	58.1	52.9	45.2	23.4	30.7	50.1	23.2	34.6	14.2	16.4	40.9	31.0	35.0	28.0	94.9	45.5	30.4	55.7	24.4	26.7	47.5	28.7	43.5	65.3	21.9	24.1	22.9	19.4	17.3	22.6	75.0	48.4	25.1	47.9	45.8	17.1	2.3	16.2	5.7	28.2	17.0	37.0	27.4	38.3	32.6	23.0	31.9	56.0	40.8	2.7	43.1	15.5	19.1	53.1	29.0	45.4	47.3	52.2	49.2	46.6	47.9	55.5	50.1	56.2	45.7	50.0	47.1	5.6	6.4	15.0	7.8	10.8	1.9	7.6	16.4	5.2	23.4	9.2	10.7	54.1	7.2	10.9	14.7	4.2	31.8	9.1	28.3	15.6	19.6	18.9	5.6	9.2	9.6	10.8	4.2	4.9	8.8	11.4	10.9	6.1	8.5	15.2	13.3	6.1	18.8	23.9	35.3	6.1	19.0	8.2	7.2	2.2	31.3	11.1	6.6	3.6	3.7	9.7	20.7	12.3	2.0	6.9	12.2	33.2	8.6	11.8	7.2	70.1	31.4	7.8	16.7	6.6	8.2	10.1	34.5	9.0	9.1	2.7	16.3	11.1	21.0	16.4	6.2
MPP2	"DKFZp761D0712, DLG2"	ENSG00000108852	"Membrane palmitoylated protein 2"	Q14168	17	43875357-43909711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 91.0;Early spermatids: 69.6;Horizontal cells: 35.3;Oligodendrocytes: 59.6;Spermatogonia: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026486, HPA073483"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 56: Bipolar cells - Visual perception"	"Mitochondria, Cytosol"		"HPA026486: AB_1854085, HPA073483: "	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (4.37e-2)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.89e-4)"	2.5	3.8	22.2	1.3	25.7	0.5	3.3	25.0	27.0	5.3	7.3	9.4	1.1	5.6	26.0	3.0	5.0	2.2	8.9	23.3	24.2	1.6	0.2	1.4	0.5	30.0	27.1	3.2	3.4	15.8	13.7	2.5	26.5	7.5	1.2	15.7	1.4	8.7	1.0	1.8	2.5	5.0	24.7	0.7	3.7	16.9	28.0	0.7	3.5	1.5	0.6	6.7	4.4	41.6	7.2	10.5	11.0	15.7	1.4	1.0	6.0	2.5	0.3	9.9	9.0	3.7	4.7	10.4	5.7	2.5	12.2	2.9	15.1	6.0	7.0	0.0	11.5	0.9	9.2	0.2	0.3	0.0	2.9	1.5	0.5	6.8	0.1	5.4	0.7	16.6	3.9	0.0	2.5	2.8	1.5	0.8	19.7	0.8	6.4	7.4	15.5	0.7	0.2	0.2	11.6	10.7	3.0	1.0	4.1	9.8	24.5	4.9	0.1	10.5	13.2	4.0	4.5	3.4	7.4	0.0	15.8	6.9	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	22.2	25.7	25.0	27.0	23.3	24.2	30.0	27.1	26.5	24.7	28.0	41.6	2.1	0.0	0.0	11.1	0.0	0.4	1.4	1.0	0.0	91.0	0.5	2.9	10.5	0.0	0.0	0.0	2.1	5.8	0.1	0.1	0.0	0.7	69.6	0.1	0.4	1.4	0.0	0.0	20.4	0.4	0.4	2.7	0.0	0.1	0.0	1.2	0.0	0.0	0.7	35.3	19.0	0.0	0.0	0.0	0.4	21.1	3.7	0.2	0.0	1.9	0.0	16.1	0.0	13.6	59.6	0.5	0.0	5.7	0.1	0.0	0.0	0.1	0.0	7.1	0.0	1.5	1.9	23.2	31.4	0.2	0.1	2.7	0.3	0.1	0.0	0.0
MPP3	DLG3	ENSG00000161647	"Membrane palmitoylated protein 3"	Q13368	17	43800799-43833170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;heart muscle: 11.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 29.2;Early spermatids: 38.4;Late spermatids: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021818, HPA024742"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA021818: AB_1854086, HPA024742: AB_1854087"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.23e-5)"	"unprognostic (4.59e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.02e-11)"	"unprognostic (9.98e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.75e-2)"	1.4	0.6	2.4	0.3	1.5	0.0	1.4	10.2	2.0	1.5	2.8	0.9	0.4	0.7	1.8	1.0	1.1	0.7	11.8	1.9	2.4	1.1	0.3	2.2	0.2	4.9	2.2	0.6	2.2	0.3	1.8	0.4	4.4	1.6	0.3	0.9	0.5	0.9	0.2	1.0	0.5	0.6	1.5	1.2	1.0	0.8	3.4	0.0	0.7	0.1	0.2	0.8	1.1	2.0	0.5	1.4	0.5	0.6	0.9	1.2	0.0	1.1	0.4	1.1	0.4	0.9	0.8	0.0	0.3	0.8	0.7	0.5	1.1	1.1	1.6	0.0	1.3	0.2	3.3	0.7	0.1	0.0	0.0	0.7	2.3	1.5	2.1	1.4	0.3	0.0	0.5	0.0	0.6	1.1	0.0	0.0	0.6	0.5	1.1	0.0	0.9	0.0	1.8	0.0	4.8	1.1	0.7	1.5	0.3	0.8	2.6	1.1	1.0	1.2	1.9	0.5	1.4	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.5	10.2	2.0	1.9	2.4	4.9	2.2	4.4	1.5	3.4	2.0	12.1	12.8	4.1	3.9	0.0	4.0	8.3	2.7	5.7	2.7	3.2	4.8	29.2	7.2	5.4	1.8	0.0	0.1	0.0	1.2	0.0	3.9	38.4	0.8	1.9	5.3	1.2	0.8	3.6	1.4	0.6	3.3	12.8	1.9	1.3	1.1	3.6	0.7	1.1	10.1	5.4	1.2	0.0	0.0	3.9	76.0	3.7	1.1	1.8	1.0	1.9	0.8	0.0	3.5	10.0	2.9	3.4	2.6	0.0	8.1	0.4	0.3	0.8	1.7	6.6	0.8	2.9	0.8	2.6	4.7	2.7	0.1	0.5	0.3	2.3	3.2
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67240713-67336061	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.4	8.7	13.9	6.3	20.9	5.6	10.6	17.6	16.5	8.8	26.6	12.7	20.4	6.3	21.1	13.6	7.3	7.9	7.4	11.9	17.4	31.4	19.6	12.3	4.8	18.2	18.2	6.1	8.7	19.6	7.2	9.8	18.3	16.2	12.0	17.2	18.4	12.7	18.0	8.4	20.7	7.2	18.1	6.6	9.4	8.8	17.5	10.3	25.1	13.6	6.1	9.0	8.4	27.5	156.4	24.4	24.1	18.5	13.3	12.3	20.6	46.4	23.6	33.2	21.6	23.8	45.9	12.7	21.5	37.8	11.0	31.0	13.9	26.1	50.2	5.5	9.5	11.8	23.6	16.8	15.5	4.5	8.5	13.1	10.0	17.9	23.7	24.2	19.0	13.5	12.6	4.7	53.9	20.4	14.4	5.0	7.7	22.2	16.2	12.2	37.1	15.2	30.1	36.8	13.2	9.4	28.2	27.0	15.5	21.1	28.6	9.2	29.2	41.4	87.2	13.8	19.9	7.8	7.6	19.3	27.2	10.1	14.7	0.1	0.5	0.8	0.4	1.0	0.3	1.1	0.5	0.6	0.8	0.4	1.1	0.6	0.0	2.2	0.7	0.6	0.3	0.4	13.9	20.9	17.6	16.5	11.9	17.4	18.2	18.2	18.3	18.1	17.5	27.5	13.2	64.1	28.9	37.2	8.8	21.0	26.0	14.6	22.2	8.5	22.4	12.8	24.7	11.5	21.1	22.0	43.8	23.1	5.2	47.2	13.7	21.7	5.9	29.5	15.0	17.7	5.4	6.7	24.8	26.9	11.3	17.3	18.3	46.2	5.1	15.8	17.2	20.7	17.6	3.3	34.7	21.2	12.2	11.9	13.4	4.5	8.1	9.2	3.6	22.5	6.6	23.4	3.1	41.2	129.8	26.7	32.5	11.3	13.1	30.1	54.3	33.5	14.9	34.3	6.6	17.7	22.2	22.4	36.1	29.2	17.3	17.5	7.7	7.5	22.4	38.7
MPRIP	"M-RIP, p116Rip, RHOIP3"	ENSG00000133030	"Myosin phosphatase Rho interacting protein"	Q6WCQ1	17	17042457-17217679	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 60.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 60.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022034, HPA022901"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA		29000	"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	Cytosol	"HPA022034: AB_1854093, HPA022901: AB_2297761"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.81e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	126.1	110.0	166.8	74.9	213.0	68.1	102.7	165.7	184.3	128.6	113.4	128.4	78.6	172.7	83.7	151.7	120.5	73.8	245.6	184.5	142.9	156.8	129.1	144.5	80.4	165.5	157.1	90.3	137.5	96.7	116.0	70.5	170.7	113.0	59.9	59.0	83.2	91.8	168.3	96.2	103.3	133.6	145.0	102.2	141.2	99.2	173.6	89.7	139.4	84.6	76.9	133.0	135.3	168.2	328.5	241.7	103.6	85.1	107.2	79.3	146.0	155.2	117.6	131.9	96.9	189.2	242.3	129.3	151.0	251.4	108.9	292.1	133.4	227.3	139.3	127.7	69.8	70.3	216.9	68.6	72.3	38.6	49.4	76.8	133.4	149.9	114.0	189.8	138.9	97.9	43.5	73.1	213.3	113.0	158.1	131.9	46.6	324.2	275.9	127.6	162.4	48.9	101.6	155.3	57.3	94.4	174.7	144.2	81.4	414.0	68.8	60.3	130.8	118.4	128.0	321.3	280.2	51.6	45.0	61.1	221.3	69.1	297.7	2.4	2.5	3.5	8.5	1.9	18.3	9.3	34.8	14.4	2.4	6.9	24.8	12.1	1.1	4.5	1.8	10.0	60.9	9.9	166.8	213.0	165.7	184.3	184.5	142.9	165.5	157.1	170.7	145.0	173.6	168.2	75.9	32.1	48.0	87.1	22.2	27.0	27.9	22.7	12.5	104.6	26.2	29.2	59.9	31.5	30.6	25.8	81.3	25.9	32.9	46.9	3.9	31.8	28.5	43.7	47.4	62.1	22.7	25.0	94.0	28.7	36.2	39.7	72.4	79.4	16.5	51.3	37.9	21.7	12.3	97.6	75.6	17.3	26.4	14.3	18.6	32.4	29.2	17.7	32.0	43.1	13.5	31.3	17.5	73.4	84.4	92.4	26.4	43.2	19.0	40.2	27.9	9.2	30.6	49.3	78.9	71.0	110.4	24.3	31.4	22.4	27.4	31.7	35.0	49.4	27.1	103.0
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029821	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 390.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 553.6;Hepatocytes: 578.6;Paneth cells: 621.4;Proximal enterocytes: 1322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	58.0	57.3	25.3	10.0	32.3	36.5	51.0	29.0	31.0	40.9	29.8	102.4	106.5	34.7	0.6	91.5	42.9	16.6	64.2	22.9	23.4	71.4	390.7	43.5	8.8	34.0	27.5	81.7	106.4	4.8	14.7	9.1	29.7	45.3	17.0	0.5	43.5	9.6	89.7	82.3	93.0	7.0	26.0	22.1	70.3	51.7	31.4	4.5	24.8	23.1	6.0	48.3	62.3	35.1	44.0	50.4	24.2	50.0	27.8	17.2	38.1	23.4	20.6	24.8	33.2	48.6	18.9	68.7	33.0	16.7	16.7	29.9	20.9	33.8	3.6	41.4	119.2	26.5	21.3	115.6	87.5	29.0	35.6	30.0	64.2	16.1	15.1	22.8	50.6	33.1	48.0	19.3	7.0	33.8	2.6	97.5	45.7	56.7	52.2	73.6	28.8	51.9	25.5	14.0	12.4	92.9	15.6	23.9	46.6	12.2	26.0	45.6	39.8	21.3	60.1	23.9	16.0	33.3	16.8	21.0	7.7	34.7	11.1	48.5	71.9	54.7	31.0	27.5	42.4	24.9	20.1	26.4	104.0	25.0	2.7	10.4	21.9	87.8	12.7	16.3	44.3	35.4	25.3	32.3	29.0	31.0	22.9	23.4	34.0	27.5	29.7	26.0	31.4	35.1	21.3	35.3	61.9	14.7	25.1	81.6	80.4	120.3	70.6	4.5	81.4	83.4	29.4	243.1	70.0	60.7	0.0	61.9	20.3	553.6	133.1	146.4	191.1	38.5	46.8	42.6	108.6	122.6	1.1	148.3	119.1	52.8	87.1	72.5	17.2	140.3	108.5	578.6	77.5	3.3	1.9	363.1	85.5	84.6	77.6	115.1	91.0	62.7	58.7	3.7	60.7	24.8	56.7	4.5	14.9	117.9	621.4	84.7	65.7	77.7	1322.1	469.8	13.4	2.8	46.0	34.4	36.0	101.3	11.5	133.7	152.9	50.1	26.6	57.7	397.5	110.6
MRAS	"M-RAs, R-RAS3, RRAS3"	ENSG00000158186	"Muscle RAS oncogene homolog"	O14807	3	138347648-138405534	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 202.3;heart muscle: 132.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"non-classical monocyte: 25.0"	"Lineage enriched"	"Detected in many"	9	"monocytes: 25.0"	"Cell line enhanced"	"Detected in many"		"BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042728	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"HPA042728: AB_10796582"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.69e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.23e-2)"	91.9	67.7	112.7	10.8	130.6	1.7	46.7	118.2	105.5	17.3	48.9	24.2	3.3	28.7	7.1	7.9	26.4	12.0	132.9	105.6	132.8	22.9	5.5	18.4	5.2	126.1	135.9	48.6	5.7	8.2	17.7	10.6	112.9	15.3	4.1	15.9	13.4	15.0	80.4	12.2	8.7	23.2	110.3	12.2	12.0	9.6	202.3	4.9	26.4	48.0	3.3	29.1	12.1	97.8	0.8	7.9	15.8	24.5	59.6	29.2	40.0	92.9	16.0	7.3	8.2	3.3	3.1	0.3	113.7	70.4	18.6	0.1	9.0	1.8	6.1	7.7	3.1	0.5	4.8	20.1	15.9	0.0	1.9	41.5	5.9	0.7	1.4	13.6	1.3	0.0	10.7	0.8	31.4	3.7	0.0	20.4	19.1	0.0	2.7	1.1	33.8	0.2	30.4	2.0	18.6	42.0	62.8	0.7	45.9	10.9	16.1	37.7	0.6	23.7	25.3	24.3	2.4	0.1	1.0	1.2	21.4	0.1	11.4	0.2	2.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.8	25.0	0.1	0.0	0.8	112.7	130.6	118.2	105.5	105.6	132.8	126.1	135.9	112.9	110.3	202.3	97.8	8.9	9.6	1.5	54.2	0.8	2.2	3.0	3.4	1.2	5.6	28.8	34.8	121.7	2.8	3.5	9.2	10.4	20.1	0.2	0.0	58.7	8.6	11.6	1.0	21.4	14.5	1.8	0.0	25.5	3.2	3.2	23.0	2.0	1.5	6.3	35.2	12.8	1.6	26.3	28.6	20.6	0.0	2.0	15.1	18.4	40.0	23.3	18.2	28.4	20.6	12.2	24.3	0.0	28.6	11.0	3.8	0.0	34.3	0.1	3.3	0.0	27.5	1.3	9.6	6.6	20.8	18.9	7.3	18.6	0.4	1.0	14.4	0.8	59.1	0.0	0.6
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764522-13774282	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No		880000	"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: AB_2678141"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	15.8	19.2	7.9	9.0	8.2	9.5	18.5	9.3	8.5	24.8	7.0	17.3	9.6	21.6	4.1	20.5	21.8	5.3	12.9	7.6	7.5	22.3	23.8	15.8	10.5	8.9	7.7	24.4	19.6	7.8	18.0	11.9	8.7	19.3	6.4	5.3	20.5	8.8	11.6	26.0	21.1	5.2	7.1	23.1	18.3	3.6	8.4	7.8	23.0	4.4	8.7	17.6	22.4	10.9	14.7	9.3	5.5	13.1	6.1	9.5	13.0	17.9	9.3	13.8	12.4	9.9	11.5	7.9	6.5	6.6	7.3	25.4	24.5	15.5	10.8	12.6	39.3	6.6	18.5	12.0	4.7	20.3	14.8	9.9	9.4	7.1	6.0	14.3	13.7	7.9	11.6	0.6	7.4	18.7	21.9	14.3	9.1	6.0	27.2	20.5	7.6	17.4	8.1	11.4	10.4	9.9	6.6	13.9	14.5	7.7	11.1	8.2	8.2	8.2	7.6	29.3	8.8	11.0	11.3	2.4	6.8	22.5	9.7	3.4	1.8	0.7	1.7	1.7	1.8	1.5	1.7	2.2	1.4	1.6	1.3	1.1	1.6	1.8	1.1	2.7	1.5	1.3	7.9	8.2	9.3	8.5	7.6	7.5	8.9	7.7	8.7	7.1	8.4	10.9	9.2	9.6	19.8	15.0	10.8	11.1	8.9	10.8	6.8	4.3	9.0	8.4	0.9	8.6	13.4	16.5	8.4	13.2	17.2	8.1	5.9	9.2	0.7	11.5	14.4	13.8	9.1	13.3	22.3	12.7	8.7	12.3	14.3	14.2	13.3	9.9	12.8	10.0	7.2	1.7	19.6	9.3	6.1	7.2	8.4	1.7	17.4	7.4	1.8	9.4	10.5	5.0	17.5	18.1	15.2	6.8	11.0	15.1	13.3	4.7	16.5	10.5	19.2	9.3	26.3	10.8	13.3	0.3	4.5	13.3	11.4	5.3	16.0	22.2	9.8	6.8
MRNIP	"C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537"	ENSG00000161010	"MRN complex interacting protein"	Q6NTE8	5	179835133-179862173	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Endometrial ciliated cells: 49.7;Glandular and luminal cells: 31.3;Respiratory ciliated cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043975	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA043975: AB_2678754"	"unprognostic (4.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-3)"	7.8	7.2	10.5	3.5	10.6	1.4	9.5	13.1	12.9	21.8	11.5	12.3	2.5	11.4	5.9	6.4	16.7	2.2	7.1	10.6	10.3	13.1	10.0	8.9	5.5	10.8	10.6	21.0	10.3	5.2	19.2	1.5	10.8	15.4	2.8	3.0	9.9	7.1	5.4	7.9	17.1	3.8	10.0	19.0	8.8	10.1	10.6	2.7	15.5	2.7	5.3	12.7	13.7	11.8	1.0	1.9	3.5	8.4	7.4	6.6	4.0	2.5	2.3	3.2	4.8	2.5	3.2	4.1	2.9	1.3	1.4	2.6	4.4	8.3	2.6	3.7	3.5	1.3	4.3	2.1	4.6	1.7	1.6	4.9	7.0	3.7	3.0	2.4	3.6	4.1	2.0	1.8	3.5	3.9	2.8	1.7	1.7	1.3	1.9	3.3	1.4	3.2	5.7	0.8	6.6	2.1	1.2	3.3	3.1	2.6	4.1	1.4	0.7	1.8	1.4	1.4	1.5	2.2	1.4	2.9	1.7	2.7	1.3	1.5	0.6	2.9	2.7	0.7	3.8	8.0	4.0	3.2	0.8	10.2	6.4	4.5	0.9	3.5	0.9	4.9	2.6	1.9	10.5	10.6	13.1	12.9	10.6	10.3	10.8	10.6	10.8	10.0	10.6	11.8	22.4	16.0	15.6	0.0	6.2	0.0	0.0	0.0	0.0	0.0	13.7	21.1	0.0	0.0	11.8	18.4	0.0	10.5	11.6	0.0	46.9	5.1	0.0	49.7	19.0	5.8	0.0	0.0	0.0	2.2	6.8	9.7	0.0	31.3	11.4	20.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.0	0.0	0.0	14.5	29.9	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	9.3	7.6	18.4	0.0	0.0
MROH1	"HEATR7A, KIAA1833"	ENSG00000179832	"Maestro heat like repeat family member 1"	Q8NDA8	8	144148016-144261940	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.8"	"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024287, HPA044465"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA024287: , HPA044465: AB_10960985"	"unprognostic (1.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.74e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-2)"	9.2	17.0	7.3	6.3	6.9	18.0	11.0	5.4	15.5	10.5	6.4	16.2	13.3	9.1	5.3	17.0	11.0	3.6	14.0	7.5	2.7	17.2	11.7	17.0	7.0	11.8	4.2	7.7	26.7	5.6	22.3	5.5	10.9	17.2	3.4	0.9	17.3	5.7	5.2	17.8	17.6	2.1	1.1	21.7	18.9	13.0	4.9	4.2	58.8	2.1	3.7	12.9	12.6	3.8	17.0	6.9	0.9	6.5	3.1	3.3	29.3	7.3	5.1	4.0	5.5	11.6	29.7	8.9	10.5	4.2	9.8	15.9	1.0	11.2	1.8	5.1	9.5	10.8	22.1	10.7	7.8	4.8	11.0	6.1	11.4	6.4	9.2	4.7	5.8	7.2	4.5	3.9	4.5	36.3	8.4	10.2	2.5	11.6	32.0	10.8	2.2	9.3	5.9	33.0	7.4	6.4	18.3	17.5	5.4	2.5	12.8	6.7	14.6	8.1	15.2	16.6	6.1	6.8	3.6	9.5	16.0	14.3	4.9	4.8	5.7	1.5	1.8	7.5	1.3	0.9	1.5	1.8	4.3	1.5	1.4	1.0	1.1	0.8	6.8	1.3	4.6	2.2	7.3	6.9	5.4	15.5	7.5	2.7	11.8	4.2	10.9	1.1	4.9	3.8	5.2	9.6	26.3	33.0	6.5	6.2	8.5	9.2	6.8	36.4	12.6	9.5	12.4	5.7	16.6	5.5	12.5	31.3	7.0	39.8	3.9	12.2	5.1	17.8	6.7	7.8	23.4	1.7	56.7	16.6	19.2	6.4	63.7	25.2	14.5	14.3	3.9	7.0	19.7	37.0	61.2	24.8	18.3	11.9	11.4	12.2	3.1	14.5	1.8	13.1	11.4	5.7	7.2	14.6	7.9	18.6	17.5	2.6	9.7	17.6	30.7	5.8	18.8	3.5	6.6	7.2	6.7	19.1	26.2	9.7	5.8	50.1	9.1	7.8	22.3	14.8
MRPS16	CGI-132	ENSG00000182180	"Mitochondrial ribosomal protein S16"	Q9Y3D3	10	73248843-73252693	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050081, HPA054538"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Mitochondria, Cytosol"		"HPA050081: AB_2681007, HPA054538: AB_2682519"	"unprognostic (9.19e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.84e-2)"	24.0	37.8	12.0	18.3	12.7	20.2	22.6	13.3	13.8	18.7	15.8	27.5	24.8	21.6	14.5	32.1	19.1	12.6	47.2	12.3	12.3	32.0	39.5	17.5	22.3	13.0	12.3	18.5	27.4	21.8	20.5	12.9	12.4	19.6	22.0	8.3	23.7	15.3	76.1	25.3	22.4	16.7	12.6	23.3	27.3	21.0	12.8	21.4	17.7	46.3	22.5	20.8	20.2	14.8	84.5	120.5	40.7	55.6	29.1	27.2	65.7	36.7	62.7	49.6	50.5	147.1	78.4	97.8	40.3	36.9	45.2	74.5	43.1	73.2	30.6	54.6	50.4	59.6	61.0	108.5	58.4	79.3	51.4	40.5	54.5	51.4	120.4	37.9	54.2	83.3	92.4	52.2	49.7	92.3	83.4	70.1	52.7	53.7	211.1	75.1	56.1	69.4	48.4	51.3	26.9	49.8	43.5	164.2	83.7	22.5	121.1	38.1	44.8	46.9	83.3	50.3	74.6	79.0	91.4	75.0	50.5	89.5	32.1	31.3	33.0	26.3	26.1	37.3	28.2	42.9	28.4	24.8	27.3	47.5	29.9	26.9	15.0	28.1	30.1	41.8	31.4	39.5	12.0	12.7	13.3	13.8	12.3	12.3	13.0	12.3	12.4	12.6	12.8	14.8	38.0	6.4	32.4	13.7	59.9	35.1	73.9	103.1	42.7	28.0	76.5	87.6	101.1	58.6	71.4	47.8	31.3	118.0	34.0	77.4	248.4	103.7	68.1	54.6	57.8	56.3	54.5	79.8	18.2	119.7	160.7	45.0	52.0	48.4	30.4	52.5	46.8	157.2	154.5	20.2	19.3	102.8	75.3	64.5	36.0	37.8	62.1	57.2	65.8	13.1	78.3	47.9	52.5	9.0	10.7	127.5	55.9	41.8	88.8	126.6	88.6	239.2	51.1	36.2	0.0	38.7	69.0	124.5	70.8	92.8	44.2	106.9	42.6	87.5	114.9	99.0
MRPS35	"MDS023, MRPS28"	ENSG00000061794	"Mitochondrial ribosomal protein S35"	P82673	12	27710822-27756295	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 242.6;Proximal tubular cells: 231.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038513	Supported		Approved	Mitochondria,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA038513: AB_10794084"	"prognostic unfavorable (9.41e-4)"	"unprognostic (8.35e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.51e-5)"	"unprognostic (4.63e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	27.3	42.1	25.0	26.8	26.1	31.2	42.7	26.7	33.4	23.8	28.0	59.2	52.6	25.8	29.4	35.8	29.4	24.1	62.2	26.0	27.2	78.6	77.7	21.6	31.9	25.7	26.0	26.2	27.8	46.9	14.0	29.1	26.5	31.5	61.1	18.4	29.6	24.1	83.3	23.5	46.4	29.8	26.7	21.0	43.9	18.0	26.4	28.3	44.2	72.5	32.1	35.3	20.4	27.9	95.0	102.1	42.4	65.1	58.9	71.8	156.0	61.4	52.6	84.4	76.2	125.0	132.4	88.2	87.5	63.3	65.5	70.0	88.0	77.9	99.1	74.2	82.8	100.2	39.2	103.7	58.5	138.1	51.1	61.4	95.1	71.1	143.2	77.3	69.6	73.0	110.1	58.6	77.9	57.9	96.7	227.0	158.9	231.8	147.7	101.1	109.8	145.3	130.8	77.3	24.0	48.5	84.4	131.0	106.1	93.9	133.6	108.2	54.5	51.4	54.9	117.8	111.4	22.8	36.9	186.8	68.6	104.5	68.5	11.0	21.5	7.8	15.1	38.3	24.1	20.7	18.9	18.7	30.5	19.7	22.3	20.4	1.2	25.9	46.4	14.4	26.4	23.8	25.0	26.1	26.7	33.4	26.0	27.2	25.7	26.0	26.5	26.7	26.4	27.9	25.0	73.7	40.3	13.4	38.2	47.3	42.3	65.0	46.1	20.8	49.8	43.8	94.8	50.1	55.4	51.5	4.2	104.0	21.2	51.8	242.6	92.0	12.6	42.0	42.4	30.1	60.3	26.3	28.0	59.2	113.4	35.9	72.4	40.0	54.5	34.5	18.9	67.1	73.1	18.5	28.0	81.2	40.7	38.4	28.8	9.1	25.4	42.9	42.7	8.4	64.7	27.1	34.0	19.6	25.4	62.2	52.3	24.5	32.1	55.4	63.6	231.4	70.2	18.0	26.3	35.8	39.8	23.9	27.2	68.7	52.1	61.7	34.8	83.8	116.5	46.1
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"intestine: 254.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 1139.3"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.2	0.0	0.0	10.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	234.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	254.3	0.0	0.0	0.5	0.0	0.0	0.3	4.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1139.3	0.0	0.0	0.4	0.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.6	0.1	27.8	0.0
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756867-60776733	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lung: 43.9"	"Cell type enriched"	"Detected in some"	15	"Alveolar cells type 1: 96.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.2;HEL: 3.6;JURKAT: 1.6;MOLT-4: 1.6;U-266/70: 4.0;U-266/84: 2.1"	"Region enriched"	"Detected in some"	28	"olfactory bulb: 166.8"	"Region enriched"	"Detected in single"	26	"olfactory bulb: 20.2"	HPA054563			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 19: Lung - Lung function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.2	0.4	0.2	0.1	2.2	0.3	0.4	0.3	0.2	0.3	1.0	1.2	0.3	0.4	1.0	0.2	0.3	0.7	0.2	0.1	0.0	43.9	0.5	0.4	0.2	1.8	0.1	0.0	0.0	0.7	0.4	0.3	0.6	0.4	0.1	1.2	0.0	0.0	2.2	1.6	0.1	0.3	0.4	0.6	0.2	3.8	0.3	0.0	1.8	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.5	1.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	4.0	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	3.2	0.2	0.2	0.2	0.3	0.4	0.7	0.2	0.4	0.2	0.4	0.1	0.2	0.3	0.2	96.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	2.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0
MSI1		ENSG00000135097	"Musashi RNA binding protein 1"	O43347	12	120341330-120369164	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 104.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Early spermatids: 55.4;Late spermatids: 58.2;Muller glia cells: 82.4;Rod photoreceptor cells: 109.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 119.7;HAP1: 55.3;NTERA-2: 62.6;SCLC-21H: 88.4;SH-SY5Y: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074923, HPA075573"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA074923: , HPA075573: "	"unprognostic (1.21e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	0.5	5.1	11.3	0.3	10.6	0.1	0.8	8.8	11.6	3.2	18.2	1.5	6.1	3.5	1.1	0.9	2.6	0.9	3.3	11.6	10.7	1.0	0.6	0.5	0.3	13.0	13.3	1.8	5.0	1.5	13.7	0.9	9.9	4.0	1.0	104.3	0.7	1.7	22.5	0.7	4.1	1.4	11.0	0.3	4.3	16.2	11.9	0.0	0.8	0.1	0.0	0.5	1.1	8.4	0.1	1.4	119.7	30.5	0.0	0.0	15.2	0.1	0.0	0.8	1.3	21.7	0.6	0.1	1.7	0.0	0.7	0.4	55.3	0.0	0.4	0.6	12.6	0.1	0.5	2.6	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	16.2	0.2	0.3	62.6	0.6	0.7	0.3	0.0	0.5	0.0	0.1	88.4	42.9	0.1	1.0	1.0	11.4	18.5	0.1	0.1	0.5	15.9	0.2	0.1	1.6	0.5	0.2	0.3	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	10.6	8.8	11.6	11.6	10.7	13.0	13.3	9.9	11.0	11.9	8.4	0.1	0.0	0.0	23.8	0.0	1.0	1.4	0.0	1.8	18.4	4.8	2.8	3.3	0.0	0.0	0.0	54.2	0.2	0.0	1.1	1.9	1.2	55.4	3.8	2.1	1.3	10.1	0.0	1.1	5.2	0.6	2.0	0.0	3.5	0.0	1.2	0.0	0.0	0.1	3.3	2.5	3.5	0.0	0.0	0.4	58.2	0.3	0.1	0.0	1.9	0.6	82.4	0.0	9.5	0.5	1.2	12.0	0.4	0.0	8.3	1.2	0.0	0.0	109.9	13.1	4.6	3.2	7.6	3.1	0.1	0.0	0.4	0.1	0.1	8.6	0.6
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148917-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003413	Uncertain		Approved	Nucleoplasm,Cytosol		NA	No			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	11.9	9.4	6.0	21.3	8.7	57.9	13.8	18.8	8.6	14.7	5.0	12.9	13.3	15.2	9.2	12.7	15.5	12.8	9.5	6.3	7.3	11.3	14.1	14.5	33.1	6.5	7.2	20.9	11.5	15.3	8.0	13.1	9.2	12.0	12.7	14.8	13.0	11.5	12.6	11.4	14.8	12.1	6.0	25.8	14.7	17.4	7.2	60.3	17.0	17.2	31.7	13.3	10.1	12.1	26.5	7.5	20.8	23.2	14.4	15.6	33.1	16.1	16.0	14.9	14.9	19.4	15.0	52.1	21.2	14.3	17.0	20.4	24.6	16.2	23.5	25.3	11.9	59.6	19.8	11.0	14.8	51.7	26.1	12.6	17.7	11.7	34.0	14.2	15.1	48.1	22.0	47.7	12.5	15.8	93.8	26.7	25.3	14.7	13.1	40.5	33.5	35.3	7.1	21.2	25.2	16.8	37.7	16.1	26.5	16.2	14.7	28.5	20.6	19.0	15.0	17.4	15.1	47.5	28.0	78.7	15.9	20.2	13.2	5.1	2.5	4.1	5.1	2.9	6.2	3.1	4.7	6.0	2.7	5.4	9.6	6.4	5.9	5.1	2.2	1.5	3.9	4.2	6.0	8.7	18.8	8.6	6.3	7.3	6.5	7.2	9.2	6.0	7.2	12.1	15.0	19.2	11.2	18.9	30.4	28.0	15.6	5.6	23.3	12.9	15.8	9.5	15.2	8.6	7.0	12.9	4.2	8.9	47.1	9.3	3.9	5.1	4.1	9.6	15.3	13.9	18.0	23.1	28.0	5.6	6.3	14.7	9.2	12.9	7.0	12.6	16.8	23.4	8.5	16.8	31.6	14.1	2.0	24.2	25.4	3.7	9.3	18.9	21.4	37.5	21.4	8.0	30.9	39.2	55.1	6.4	5.6	8.6	27.8	14.5	7.7	7.4	5.7	9.7	6.6	18.6	12.3	16.0	12.5	22.8	26.7	4.8	36.2	8.5	12.2	14.0
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5;choroid plexus: 1.1;pituitary gland: 1.5;placenta: 1.2"	"Group enriched"	"Detected in some"	50	"Early spermatids: 96.3;Late spermatids: 216.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 85.7;PC-3: 108.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in other tissues"	No	No		30000	"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	Vesicles	Cytosol	"HPA055174: AB_2682726"																		0.2	0.0	0.6	0.2	0.3	0.0	0.1	0.4	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.2	1.5	0.4	0.0	0.0	0.0	1.5	1.2	0.9	0.0	0.1	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.6	0.3	0.4	0.8	0.3	0.3	1.5	0.4	0.9	0.6	0.3	0.4	1.3	0.0	1.1	0.0	1.1	0.4	1.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	1.4	96.3	0.6	0.1	3.1	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.2	0.0	0.5	2.5	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.8	216.6	0.3	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.1	0.7	0.1	1.5	0.0	0.4	0.2	0.5	0.0	0.0	0.1	0.8	0.5	0.0	0.1	0.3	0.2	0.1	0.3	1.3
MST1R	"CD136, CDw136, PTK8, RON, SEA"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 62.3;stomach 1: 42.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Distal enterocytes: 53.9;Gastric mucus-secreting cells: 108.6;Intestinal goblet cells: 25.7;Pancreatic endocrine cells: 31.2;Paneth cells: 30.3;Proximal enterocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 39.3;CAPAN-2: 98.8;HaCaT: 56.3;HBEC3-KT: 59.4;hTCEpi: 83.4;RT4: 67.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favorable (2.33e-5)"	5.1	0.3	1.1	5.1	1.1	0.2	3.8	1.1	1.7	5.7	1.3	26.5	25.2	1.3	1.2	17.5	1.7	11.4	3.2	1.1	0.9	3.4	1.1	9.5	2.5	0.9	0.8	1.0	5.8	0.1	2.7	0.8	0.9	4.7	20.1	0.2	5.4	1.0	1.3	62.3	23.9	2.0	0.8	1.6	42.6	8.4	0.9	8.8	3.4	0.7	5.6	9.2	11.5	1.0	39.3	14.4	0.1	0.6	0.0	0.0	2.2	0.5	0.1	0.0	0.0	4.1	98.8	1.7	8.8	0.5	0.1	56.3	0.0	59.4	0.0	0.9	1.0	0.1	25.9	0.9	0.9	0.0	1.2	0.3	83.4	0.2	11.7	0.2	0.1	0.2	0.8	0.3	0.0	5.1	0.1	0.1	0.3	33.1	34.6	2.9	0.0	1.1	35.8	67.9	1.0	0.1	11.5	22.6	0.2	0.1	17.7	0.9	0.3	0.0	0.3	0.3	0.1	0.5	0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	1.1	1.1	1.7	1.1	0.9	0.9	0.8	0.9	0.8	0.9	1.0	1.6	25.6	10.3	0.7	1.0	8.8	2.2	14.2	6.8	0.0	2.8	2.5	1.0	0.0	10.6	0.0	0.0	0.1	0.2	53.9	0.0	6.4	15.4	2.9	0.8	0.6	4.2	0.0	1.1	10.0	0.4	0.8	108.6	5.3	0.0	0.1	0.0	0.0	0.1	0.0	1.1	25.7	2.0	0.0	1.4	10.5	0.3	0.5	0.0	1.0	0.6	0.0	1.0	2.0	0.1	31.2	30.3	0.0	0.5	2.2	27.6	0.1	7.6	0.0	0.0	0.5	0.9	1.3	1.5	3.2	4.7	0.0	0.5	0.0	20.1	6.2
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	15.4	15.7	8.7	22.7	10.6	23.8	21.8	17.5	14.5	21.8	6.7	18.2	16.1	25.3	16.1	19.4	19.0	14.2	17.3	9.1	10.3	15.7	20.4	17.0	38.8	9.1	8.3	27.9	17.5	16.2	15.3	14.2	9.6	33.8	19.9	29.4	19.8	18.1	54.4	17.6	22.0	20.1	6.4	22.0	18.3	10.2	9.1	25.1	34.7	41.8	30.8	14.8	16.0	12.7	17.2	14.9	29.7	16.4	38.2	17.5	22.1	27.4	31.5	25.8	36.0	10.5	23.2	24.7	10.0	31.0	30.8	17.6	41.0	38.5	33.8	35.4	28.9	32.2	30.5	46.5	25.5	40.2	23.3	29.0	37.8	30.2	35.6	32.8	30.2	32.4	29.4	10.5	31.9	24.0	28.2	26.4	33.7	35.5	25.8	27.7	33.1	14.1	24.8	31.5	26.2	22.9	20.3	26.8	20.7	19.5	19.6	19.4	39.3	23.4	23.0	27.3	25.7	28.0	7.9	61.2	19.8	24.1	21.4	8.3	10.8	24.9	18.6	10.5	22.7	32.3	29.1	26.8	12.3	31.8	46.0	36.7	3.4	18.1	8.7	9.1	32.5	22.1	8.7	10.6	17.5	14.5	9.1	10.3	9.1	8.3	9.6	6.4	9.1	12.7	20.7	12.8	27.7	40.8	45.6	0.0	20.3	0.0	15.9	0.0	19.8	23.9	19.8	27.1	13.0	20.2	0.0	30.2	34.1	12.1	41.1	24.1	49.2	11.7	19.1	22.4	10.9	22.9	31.2	24.6	28.2	18.6	14.3	12.0	11.4	37.9	20.0	30.6	24.8	0.0	28.8	20.7	0.0	24.5	0.0	61.0	23.3	17.0	0.0	25.3	31.6	0.0	42.2	33.2	39.8	23.7	20.7	26.4	44.8	22.0	43.4	51.4	17.5	0.0	39.5	22.7	18.4	59.0	34.3	23.4	0.0	23.7	37.0	42.9	17.2	17.1
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	1.6	2.2	2.6	0.7	2.9	1.9	1.6	3.8	3.1	2.4	4.0	2.5	1.5	2.5	1.5	2.2	2.6	0.9	4.3	2.5	3.4	2.4	3.5	1.5	1.3	2.5	2.2	2.7	1.4	1.7	2.2	0.8	2.5	2.8	1.5	1.6	1.8	1.3	3.0	1.7	2.2	1.7	1.9	2.3	2.0	1.5	2.9	1.0	1.7	1.5	1.2	2.5	2.1	2.6	1.4	1.9	1.8	3.2	2.5	1.7	1.7	1.3	2.2	1.6	1.5	1.2	1.5	4.7	1.7	2.3	2.7	4.0	3.3	2.2	1.5	1.9	2.8	1.9	1.9	1.3	2.9	2.7	0.6	2.3	2.8	0.9	1.9	2.2	1.5	4.2	2.3	2.2	2.4	1.9	2.3	3.1	2.4	4.0	3.6	2.0	2.5	2.2	2.7	1.6	1.8	1.8	3.1	2.7	2.5	2.2	1.6	2.0	2.8	1.9	1.9	2.4	2.6	1.9	3.1	1.8	1.7	4.6	1.9	3.7	3.3	2.6	4.8	3.1	4.8	4.8	4.7	5.0	6.0	4.7	5.1	5.4	16.5	4.5	2.2	10.1	5.4	2.3	2.6	2.9	3.8	3.1	2.5	3.4	2.5	2.2	2.5	1.9	2.9	2.6	8.5	3.2	9.7	17.0	11.8	3.3	15.2	19.1	14.8	0.0	7.0	7.7	15.8	10.0	10.5	3.7	0.0	11.4	18.1	10.5	25.4	11.8	1.7	7.8	11.6	8.2	7.8	9.4	49.8	10.0	11.7	11.8	8.6	7.0	8.8	8.0	12.8	12.2	16.5	0.0	44.2	8.9	2.0	12.2	12.2	1.7	15.5	9.7	8.8	27.2	7.1	0.0	11.3	19.1	12.9	10.3	15.9	15.4	10.3	16.7	17.5	25.1	5.1	0.0	0.0	12.5	14.5	13.3	20.7	10.7	4.5	8.9	10.1	11.4	15.7	14.5
MTMR10	FLJ20313	ENSG00000166912	"Myotubularin related protein 10"	Q9NXD2	15	30938941-30991628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.2;Oligodendrocytes: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006081	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA006081: AB_2667508"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (7.77e-12)"	"unprognostic (9.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-1)"	18.6	9.5	29.3	10.7	46.9	18.7	10.3	49.4	33.3	11.2	24.8	9.9	12.8	9.4	9.4	20.9	7.5	9.6	12.7	28.0	36.3	30.6	24.2	13.6	12.0	57.6	48.5	11.5	12.4	21.3	1.9	25.9	56.5	11.0	10.3	12.1	14.9	11.4	29.4	11.2	11.6	10.0	45.3	15.1	13.0	8.5	40.8	16.7	14.2	24.0	10.6	10.1	5.4	63.3	8.1	9.0	8.2	5.2	17.7	9.6	7.2	11.9	23.9	9.4	9.4	5.9	3.5	3.9	15.5	15.5	9.1	11.5	6.5	7.0	8.9	12.5	2.1	5.5	6.2	10.4	10.3	8.9	12.2	13.2	5.4	6.1	6.7	10.8	23.7	10.9	4.9	9.2	8.9	2.3	9.3	5.6	4.7	9.7	4.3	6.7	6.7	19.5	35.6	12.7	3.0	7.8	5.4	6.3	2.4	10.4	4.2	16.4	10.9	10.6	8.0	5.6	6.8	9.4	7.8	9.0	6.7	4.7	13.4	3.7	3.2	3.1	0.7	4.0	0.8	1.9	0.8	0.6	3.1	2.8	1.2	1.2	13.5	1.4	7.4	3.7	1.2	1.7	29.3	46.9	49.4	33.3	28.0	36.3	57.6	48.5	56.5	45.3	40.8	63.3	15.8	25.6	15.2	86.2	11.3	8.9	4.3	3.3	8.0	0.0	6.7	4.6	24.1	10.0	7.0	33.1	0.0	19.3	12.9	12.7	1.9	3.4	13.6	10.1	9.6	16.8	6.0	5.2	15.4	3.8	3.1	8.6	13.3	19.7	17.1	9.4	11.4	33.9	11.8	0.0	13.6	7.7	2.0	24.9	16.2	24.9	10.5	19.0	8.8	55.3	13.8	0.0	3.1	25.6	149.3	5.6	9.2	7.5	8.0	6.7	14.4	18.6	4.7	0.0	0.0	10.6	8.9	11.1	8.9	33.6	11.1	38.4	6.8	6.7	8.2	8.7
MTO1		ENSG00000135297	"Mitochondrial tRNA translation optimization 1"	Q9Y2Z2	6	73461578-73509236	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030230, HPA030232"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030230: AB_10598910, HPA030232: AB_10600891"	"unprognostic (2.17e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.64e-1)"	5.8	5.6	3.3	5.5	3.4	4.1	6.0	5.6	4.9	6.6	3.1	6.7	6.1	5.6	4.4	6.3	6.4	3.5	8.3	3.3	3.2	11.6	17.6	5.0	7.8	3.3	2.9	7.3	6.2	9.3	5.7	4.1	3.4	6.2	6.6	6.7	5.6	4.6	9.3	5.3	7.5	5.2	2.7	9.8	6.5	9.9	3.4	7.2	6.3	9.8	9.3	6.8	6.7	4.6	6.5	6.0	8.0	5.9	12.4	13.7	4.3	13.5	14.7	15.7	15.7	13.2	4.1	13.7	9.4	13.9	9.5	10.1	18.6	12.5	24.9	7.6	9.6	15.7	12.0	13.5	16.3	27.0	7.1	9.2	17.4	16.0	16.7	7.8	11.3	14.6	22.5	16.8	14.4	10.9	6.4	9.0	6.5	9.4	5.8	11.3	27.8	25.8	9.2	12.0	5.5	3.9	5.5	14.2	12.2	7.1	7.6	24.1	6.9	7.9	6.6	5.1	13.0	8.5	15.1	6.6	4.7	17.8	11.6	1.3	4.5	3.8	5.9	6.1	9.2	6.2	7.1	5.7	4.7	5.4	7.9	5.9	1.6	8.2	6.0	4.5	12.0	7.0	3.3	3.4	5.6	4.9	3.3	3.2	3.3	2.9	3.4	2.7	3.4	4.6	9.4	16.0	17.9	11.1	22.7	7.8	14.5	13.2	4.6	0.0	5.7	5.0	15.7	11.5	12.1	11.0	0.0	12.1	19.9	6.7	21.5	7.3	127.7	12.0	13.7	11.7	8.4	5.0	14.3	7.5	8.6	10.9	10.2	22.7	6.3	8.4	10.0	22.6	8.7	0.0	15.8	9.0	6.1	8.2	7.2	20.1	11.1	10.6	0.0	11.2	15.1	0.0	18.6	11.1	21.9	7.0	6.9	9.8	20.1	14.4	16.0	17.4	7.5	0.0	6.6	19.7	10.4	42.9	11.6	7.2	10.1	10.3	21.2	11.5	11.7	10.8
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	"Mechanistic target of rapamycin kinase"	P42345	1	11106535-11262551	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069425, HPA071227"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"CAB069425: , HPA071227: AB_2686367"	"unprognostic (3.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.55e-2)"	16.3	19.4	18.2	13.5	19.0	14.0	16.8	18.4	20.1	15.2	18.6	22.8	11.0	17.5	21.8	18.3	14.6	9.0	23.6	19.7	17.7	24.1	27.6	15.2	15.3	16.5	21.2	14.2	18.3	20.6	21.8	11.8	18.4	19.8	16.0	26.9	16.5	13.8	36.4	17.1	19.6	13.8	14.6	21.2	18.7	33.8	22.7	19.2	17.8	17.8	15.9	17.1	14.9	18.7	28.5	25.2	33.3	25.4	39.4	18.6	16.6	23.4	22.3	30.6	29.9	26.0	25.5	31.4	19.6	27.8	18.8	33.1	45.3	35.8	39.3	25.2	33.2	41.7	53.8	33.4	24.7	41.1	29.7	24.0	26.8	43.7	44.0	14.5	39.3	29.6	47.4	26.1	21.6	32.4	28.5	31.2	25.3	29.6	23.5	28.2	39.2	21.0	27.2	25.3	33.4	24.5	50.1	26.8	31.2	36.5	21.8	24.0	42.3	26.5	23.9	20.5	31.8	25.5	25.5	60.5	19.1	43.6	28.6	0.3	1.1	1.3	1.9	2.4	1.6	1.4	1.1	1.0	1.6	1.1	1.3	1.1	0.8	1.1	1.3	1.2	2.4	1.0	18.2	19.0	18.4	20.1	19.7	17.7	16.5	21.2	18.4	14.6	22.7	18.7	9.2	16.0	11.8	40.8	10.0	3.4	5.2	7.6	8.6	0.0	7.7	7.5	25.1	2.8	10.3	9.2	0.0	7.9	9.8	9.4	1.9	8.5	42.0	13.8	16.1	11.0	10.3	14.3	43.8	6.2	7.2	9.2	16.8	18.6	13.3	12.9	5.3	13.4	6.9	0.0	49.2	7.8	6.1	8.2	4.1	36.1	7.8	9.1	8.8	36.5	9.2	0.0	10.3	38.2	37.4	10.4	5.4	8.2	17.2	8.9	7.0	4.5	6.3	0.0	39.5	11.4	12.1	49.3	37.4	15.6	5.7	9.9	9.8	15.3	10.0	5.7
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926760-135977359	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	68.9	49.5	66.7	65.1	75.5	151.1	50.7	41.6	79.4	67.1	45.6	50.5	40.2	65.1	50.9	125.5	62.2	50.5	77.1	79.5	65.0	58.5	49.7	57.8	89.4	77.7	60.0	49.2	23.8	75.9	34.0	61.7	54.0	52.9	55.4	39.9	36.8	51.3	47.6	46.8	46.6	66.1	56.3	79.7	41.2	56.6	65.2	72.5	88.2	48.0	107.8	67.2	58.5	53.3	126.0	90.6	111.5	170.4	160.3	187.2	55.8	189.5	208.0	129.3	137.7	104.5	139.4	229.7	132.7	255.6	188.6	78.9	107.1	161.1	246.1	153.1	84.2	152.9	94.6	77.2	127.3	211.5	213.5	136.5	158.5	152.9	147.7	180.1	205.5	163.6	182.3	138.1	253.2	94.3	208.4	163.0	155.9	121.9	118.9	120.0	83.8	187.7	144.5	103.1	140.6	248.3	157.1	105.8	158.4	102.8	75.4	130.7	215.2	193.5	85.0	192.3	189.7	103.8	160.2	325.9	307.5	185.0	420.2	117.4	75.4	85.2	54.7	105.7	46.0	107.9	33.5	41.7	89.3	125.0	21.5	31.7	180.3	46.0	169.4	82.8	32.6	70.5	66.7	75.5	41.6	79.4	79.5	65.0	77.7	60.0	54.0	56.3	65.2	53.3	110.6	48.1	40.6	0.0	149.8	119.2	58.9	86.8	72.8	0.0	68.6	72.8	82.0	70.1	61.9	69.9	0.0	63.4	131.6	67.1	90.1	69.6	77.8	83.8	153.3	108.5	33.0	91.9	0.0	51.3	73.1	92.4	45.9	131.9	98.6	64.8	87.4	59.2	100.5	0.0	0.0	46.9	46.8	247.5	232.7	28.6	86.3	214.0	101.4	0.0	234.2	0.0	125.7	0.0	0.0	99.9	67.0	123.8	59.2	96.2	52.6	88.3	50.0	0.0	92.1	99.8	79.8	65.8	123.8	143.3	149.0	68.8	86.1	106.5	52.4	106.9
MTSS1	"KIAA0429, MIM, MIMA, MIMB"	ENSG00000170873	"MTSS I-BAR domain containing 1"	O43312	8	124550784-124728473	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 208.2;Oligodendrocyte precursor cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 168.3"	"Group enriched"	"Detected in all"	5	"B-cells: 50.3;monocytes: 168.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 81.4;HDLM-2: 98.7;HEL: 337.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019613, HPA064003, HPA075540"	Approved	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA019613: , HPA064003: , HPA075540: AB_2686756"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.11e-7)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-3)"	24.5	36.2	16.8	13.2	23.2	12.5	14.0	46.1	23.4	12.5	22.3	11.0	6.4	8.4	9.9	45.2	12.5	9.2	17.1	16.3	27.7	24.2	72.9	16.5	16.0	27.5	20.6	10.4	28.5	3.7	11.0	35.7	25.3	10.1	9.1	15.0	13.9	6.3	32.3	30.8	7.9	9.6	20.5	34.5	12.0	22.3	26.4	18.4	6.0	24.4	17.2	15.5	24.3	39.5	3.6	1.1	51.6	1.0	81.4	41.7	0.1	2.1	14.2	1.1	0.5	4.8	0.4	1.6	4.9	0.2	0.4	0.8	0.4	29.2	1.1	98.7	1.2	337.8	0.9	27.0	18.4	0.0	34.5	66.4	65.4	15.9	41.0	2.1	31.5	0.3	0.5	0.3	5.6	2.7	0.8	4.0	1.8	54.8	0.4	0.4	0.1	0.5	11.6	11.3	36.3	2.8	7.9	6.3	26.6	2.5	1.3	1.1	16.7	2.7	1.0	0.2	0.7	0.5	0.3	5.4	29.1	0.4	10.7	3.1	13.1	0.1	22.7	88.1	2.6	44.9	4.8	8.7	11.8	50.3	2.2	6.8	2.2	2.2	168.3	0.2	0.5	29.2	16.8	23.2	46.1	23.4	16.3	27.7	27.5	20.6	25.3	20.5	26.4	39.5	33.0	0.0	26.9	15.7	92.0	35.8	81.4	41.2	9.6	0.0	8.0	19.9	34.9	22.8	30.9	66.2	0.0	36.0	51.4	10.7	21.5	17.6	54.2	25.5	0.9	32.2	44.2	17.2	40.4	5.2	2.3	30.5	26.5	9.7	46.3	0.9	70.3	78.1	74.2	0.0	208.2	17.1	61.1	167.1	116.2	62.1	3.7	96.7	26.6	114.3	90.2	0.0	78.2	360.4	178.4	32.6	15.9	4.5	12.6	71.9	1.2	19.9	42.0	0.0	39.5	25.2	17.3	2.5	10.7	86.1	63.4	94.4	22.7	1.8	15.8	59.2
MTURN	"C7orf41, Ells1, FLJ25903"	ENSG00000180354	"Maturin, neural progenitor differentiation regulator homolog"	Q8N3F0	7	30134986-30162762	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	14	"brain: 1933.2;choroid plexus: 740.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 156.5"	"Cancer enhanced"	"Detected in all"		"glioma: 29.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 8.2;NK-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.9;HEL: 96.2;SCLC-21H: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029507	Enhanced		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA029507: AB_10601149"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.64e-13)"	"unprognostic (9.50e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (3.26e-1)"	88.4	10.8	1190.3	9.7	1373.7	23.3	41.6	1103.3	1933.2	25.7	740.3	35.8	5.4	19.4	95.3	19.5	21.1	10.4	25.0	946.3	1044.1	50.3	4.1	20.9	5.4	1359.2	1275.8	33.4	12.9	15.7	17.4	7.5	1312.7	19.2	10.0	41.0	35.2	23.8	36.6	23.2	13.8	17.0	1311.0	8.3	26.4	10.9	1260.6	7.5	14.7	59.8	5.4	32.1	20.0	1483.6	12.5	2.1	7.1	7.6	52.9	35.9	6.4	6.0	7.0	2.0	2.8	1.0	5.0	0.7	4.8	13.3	11.0	2.4	16.4	23.6	6.4	5.4	13.2	96.2	16.1	6.7	4.1	4.8	30.8	17.9	10.8	6.2	10.9	8.6	3.2	13.1	6.4	5.0	13.8	4.8	5.6	2.3	4.9	11.6	7.5	0.5	16.3	21.4	24.1	5.1	68.7	18.2	3.8	19.1	19.4	6.6	13.5	7.1	15.5	7.8	8.5	16.6	8.5	8.3	12.7	1.1	10.4	10.3	4.0	8.2	0.3	3.6	0.3	0.2	0.1	0.5	0.2	0.1	0.4	0.3	0.1	0.3	2.2	2.1	0.0	1.0	0.7	1.4	1190.3	1373.7	1103.3	1933.2	946.3	1044.1	1359.2	1275.8	1312.7	1311.0	1260.6	1483.6	38.9	16.0	20.0	18.6	5.6	37.5	17.8	6.6	13.1	0.0	48.3	40.8	27.6	17.2	10.2	44.1	0.0	2.6	32.1	3.2	156.5	8.3	14.1	46.6	16.9	18.9	54.1	35.1	55.9	8.6	7.3	24.6	7.7	52.6	6.3	16.6	26.0	5.0	5.3	0.0	34.7	9.1	0.0	23.4	16.8	32.5	17.1	29.3	55.2	37.5	12.1	0.0	6.2	16.6	77.1	10.4	5.9	12.4	4.9	26.6	0.4	11.2	26.6	0.0	6.6	17.8	30.2	2.0	7.3	11.4	36.8	2.2	7.4	5.9	6.0	23.0
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720884-195741123	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 58.5;kidney: 69.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.2;Ductal cells: 55.5;Ionocytes: 152.5;Respiratory ciliated cells: 66.5;Urothelial cells: 84.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		170000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	6.7	5.1	4.3	1.3	5.0	0.9	7.9	7.0	6.7	23.0	3.0	30.0	3.0	5.0	4.5	58.5	20.0	6.4	6.3	3.6	3.4	69.7	21.1	7.9	0.8	4.1	2.7	11.8	16.1	2.0	16.5	0.5	4.0	20.9	7.2	8.1	40.3	1.1	7.0	8.0	14.7	0.8	1.4	6.1	9.8	8.5	4.2	0.8	16.2	1.0	1.4	21.0	26.0	5.0	0.9	0.0	0.2	0.7	0.4	0.0	0.7	0.0	0.2	0.0	0.1	0.0	3.7	0.1	0.7	0.0	0.2	1.5	0.1	0.0	0.1	1.3	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.1	0.7	3.9	0.1	1.0	0.1	1.1	0.1	3.6	1.3	0.4	0.0	28.1	0.2	0.5	0.2	0.0	0.0	0.2	0.8	1.0	0.1	1.3	1.7	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.0	7.0	6.7	3.6	3.4	4.1	2.7	4.0	1.4	4.2	5.0	0.9	35.3	16.7	16.6	0.5	1.8	10.0	6.4	0.6	19.9	3.2	1.5	0.7	14.3	43.7	22.0	35.5	0.1	0.2	53.2	1.9	55.5	0.1	3.5	1.3	1.7	13.8	5.3	7.5	9.9	0.1	1.8	13.3	6.2	1.3	5.3	3.3	7.3	0.5	11.8	7.7	7.3	152.5	1.0	0.8	0.4	5.3	1.1	3.6	1.0	0.0	4.7	0.0	5.0	3.0	12.2	16.9	6.4	1.7	14.2	16.9	3.3	66.5	20.5	0.0	8.8	3.3	1.3	1.3	4.3	1.8	0.0	1.7	1.0	15.2	84.4
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508151	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	16.7	18.1	18.1	12.0	18.7	28.8	16.2	19.9	19.4	15.9	23.3	21.2	14.2	20.4	11.1	21.2	19.6	14.9	33.7	17.8	19.4	19.5	24.6	15.8	13.6	20.3	19.1	19.1	19.8	36.3	14.6	16.3	20.1	16.0	15.7	7.4	19.3	20.0	35.5	21.8	15.8	20.0	18.7	15.2	18.7	12.2	19.5	12.0	16.2	50.4	15.0	19.2	15.5	19.9	34.1	32.1	18.1	37.9	38.5	21.6	19.6	32.9	39.1	40.1	38.2	19.9	54.8	25.4	35.9	46.8	30.4	50.3	32.9	47.5	28.9	25.4	26.1	19.4	20.4	29.2	45.2	27.0	32.0	35.3	61.6	41.1	42.3	23.4	26.5	22.5	25.8	30.1	44.1	17.3	16.4	18.1	18.7	28.1	30.3	15.8	22.8	32.9	47.1	18.7	18.4	27.3	29.6	31.2	40.5	14.6	22.0	25.6	30.2	38.8	22.3	34.1	29.9	34.9	32.9	27.3	30.4	36.1	36.7	36.2	30.0	38.2	33.1	34.7	34.4	25.3	24.8	33.8	29.6	22.8	28.1	27.6	26.7	32.3	30.7	22.8	37.9	34.0	18.1	18.7	19.9	19.4	17.8	19.4	20.3	19.1	20.1	18.7	19.5	19.9	14.5	22.4	10.3	10.4	9.8	5.2	9.2	13.9	5.2	13.5	12.3	11.9	16.6	10.0	9.5	18.4	6.2	37.1	13.2	21.6	11.7	26.3	2.2	7.7	9.5	13.1	8.5	8.6	4.9	23.4	22.5	13.9	7.7	9.4	3.8	14.7	13.6	17.6	23.0	13.5	6.8	12.9	16.2	10.0	6.5	4.0	13.1	9.3	19.6	2.8	15.5	16.0	16.5	5.5	6.0	25.6	14.6	15.4	13.1	9.2	13.2	10.6	9.6	11.9	19.7	11.9	14.7	14.6	15.4	7.4	7.1	37.6	9.2	18.0	12.2	10.7
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 147.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		170000	"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	20.3	51.1	24.2	15.7	27.5	7.0	16.4	26.2	37.5	30.5	19.3	32.3	35.1	20.3	2.2	77.8	13.5	4.9	22.8	24.7	27.8	28.8	78.8	31.0	12.3	32.4	27.8	19.6	25.3	8.3	18.9	6.3	39.3	23.5	4.2	3.4	25.1	6.5	27.2	52.3	26.6	5.7	24.0	24.6	31.5	42.3	24.7	7.0	21.1	8.3	6.8	17.6	36.9	25.6	50.6	34.2	52.4	33.1	18.1	38.7	29.5	25.1	26.0	17.7	14.6	86.1	119.7	24.4	39.8	15.7	63.7	72.8	25.0	133.1	4.9	15.7	38.3	17.8	18.2	127.0	35.9	11.6	11.8	30.9	24.6	46.6	13.5	8.7	18.0	58.0	51.7	13.1	10.2	115.9	39.3	56.6	61.5	17.7	31.3	40.2	15.0	62.3	49.8	33.0	52.2	17.9	62.0	13.3	18.5	11.4	67.8	51.3	39.0	14.7	29.8	27.2	14.2	34.9	17.6	83.2	17.9	55.7	25.7	5.6	12.6	2.4	26.8	13.7	20.4	16.1	18.0	17.9	15.0	22.6	13.2	16.6	1.8	28.3	15.4	28.0	20.4	15.4	24.2	27.5	26.2	37.5	24.7	27.8	32.4	27.8	39.3	24.0	24.7	25.6	17.2	25.6	48.2	22.2	21.5	15.2	12.9	106.3	4.0	27.2	26.5	14.1	16.7	21.5	56.9	20.2	6.2	20.2	79.6	117.5	25.4	30.8	61.6	17.7	10.0	15.8	32.9	26.5	23.4	62.3	29.2	15.5	41.8	26.5	16.5	27.4	20.7	147.2	38.6	23.5	17.0	75.3	32.6	25.5	21.6	96.2	8.1	20.3	21.4	6.5	32.2	16.5	55.6	11.1	14.5	30.0	79.4	9.1	46.3	20.1	47.1	22.6	21.5	18.1	6.6	7.0	20.7	50.8	13.0	13.8	21.6	48.8	36.3	35.5	65.2	20.6
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 264.7;Oligodendrocytes: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 108.2;SK-MEL-30: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229"	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavorable (9.17e-4)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	34.0	32.7	86.8	13.2	98.0	68.0	45.1	92.9	106.1	38.8	67.0	55.9	24.4	45.6	36.2	52.3	42.4	32.8	63.2	84.9	91.1	39.2	51.1	26.4	13.8	93.9	91.8	81.4	44.7	50.6	22.1	28.5	94.7	41.0	35.0	80.2	80.1	52.1	47.3	47.6	29.6	29.8	89.3	14.8	28.0	23.3	94.9	31.2	54.5	53.2	12.3	34.6	41.2	110.8	18.2	8.3	18.0	39.6	30.7	21.4	7.4	11.1	39.2	7.1	23.1	3.2	33.5	24.6	17.6	20.0	11.3	24.3	23.5	27.8	20.0	13.5	30.9	7.3	15.7	14.5	19.5	14.3	14.4	21.7	96.0	12.4	55.2	108.2	7.1	17.5	26.9	54.9	11.3	12.3	10.1	26.1	7.7	31.0	21.2	6.1	26.0	39.9	22.8	1.6	34.3	52.4	11.1	7.3	167.1	23.3	9.9	42.2	7.7	13.5	21.0	13.6	5.6	44.6	26.1	10.0	34.3	46.1	12.7	1.8	2.7	9.7	2.7	2.3	5.1	3.9	5.1	2.8	1.6	3.6	7.7	1.9	5.6	1.4	5.0	1.7	4.8	2.0	86.8	98.0	92.9	106.1	84.9	91.1	93.9	91.8	94.7	89.3	94.9	110.8	28.9	16.0	16.8	139.1	27.9	58.0	57.9	22.8	51.2	49.9	67.2	66.8	80.2	41.5	27.6	33.1	47.9	5.4	23.0	160.7	46.9	19.3	5.1	29.1	36.4	34.1	16.9	264.7	60.8	14.8	20.1	36.0	15.8	37.3	3.8	19.1	27.8	56.6	11.1	52.2	102.5	20.1	18.3	24.1	20.5	8.8	45.1	22.6	104.9	30.9	29.9	144.2	9.2	131.7	214.9	10.4	52.5	55.7	22.5	73.4	57.0	67.1	25.3	46.0	46.0	69.6	63.0	23.8	28.2	37.4	67.3	9.7	36.9	27.4	16.6	36.9
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.3	0.5	1.6	5.3	1.7	35.2	20.1	0.0	0.7	1.6	0.4	25.3	10.9	1.0	0.1	3.0	8.4	0.9	0.1	0.3	0.2	0.1	0.4	2.0	6.3	0.9	1.0	0.0	0.3	3.6	0.0	0.4	0.6	1.4	26.5	0.3	0.6	0.9	0.1	3.0	9.4	1.4	0.2	1.2	2.0	0.7	0.3	66.1	0.1	0.0	7.0	1.1	1.3	0.1	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.6	1.7	0.0	0.7	0.3	0.2	0.9	1.0	0.6	0.2	0.3	0.1	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;lymphoid tissue: 55.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.2	0.1	91.8	1.6	0.1	0.2	1.1	0.2	8.6	7.0	1.4	0.1	10.1	0.4	1.0	0.4	0.1	0.1	0.6	1.1	1.8	55.5	0.1	0.1	0.3	11.2	0.1	0.2	5.7	0.1	0.5	6.9	0.0	1.6	0.2	0.1	4.2	7.8	2.1	0.1	27.8	6.1	15.6	0.4	33.3	0.5	0.0	53.5	3.5	2.5	0.1	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474207-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 171.9;Excitatory neurons: 221.3;Inhibitory neurons: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		28000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	27.3	16.9	12.6	6.1	18.9	13.4	14.7	7.0	29.0	19.6	12.6	12.2	2.3	27.8	16.8	6.6	25.2	26.1	38.9	17.9	8.0	32.5	18.9	66.9	6.5	9.6	7.3	25.9	9.8	13.8	17.7	53.4	9.6	17.7	3.8	22.5	6.6	26.6	4.9	7.9	5.8	22.1	0.5	4.6	9.5	7.4	11.0	5.8	13.6	8.2	4.0	10.5	10.3	13.2	54.1	35.1	216.3	72.7	27.7	33.1	97.1	44.2	39.7	52.2	55.8	94.5	8.0	0.5	28.6	43.9	28.4	5.2	108.7	53.0	58.1	1.2	88.3	62.3	21.7	83.0	64.7	5.4	4.2	47.3	18.9	67.7	26.1	32.1	85.3	70.9	88.1	0.2	32.9	21.6	67.2	1.7	102.1	3.6	7.7	105.9	64.2	0.2	59.1	22.3	17.7	96.8	69.2	3.4	68.1	165.0	18.3	3.6	2.8	48.7	35.6	0.3	38.5	8.3	10.8	13.4	0.3	5.0	111.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	12.6	18.9	7.0	29.0	17.9	8.0	9.6	7.3	9.6	0.5	11.0	13.2	43.0	22.4	14.1	43.1	1.1	4.7	9.5	11.2	9.6	37.1	18.7	16.4	33.5	12.8	11.5	101.2	50.1	171.9	1.0	0.8	17.6	13.7	49.1	28.1	37.6	30.6	2.4	43.5	221.3	1.7	88.6	58.0	3.1	28.5	1.3	41.6	55.6	15.3	15.8	35.3	151.1	1.9	6.1	2.7	3.7	28.6	3.7	1.3	1.8	15.9	0.7	25.9	2.1	96.5	15.5	1.9	0.7	39.9	0.6	7.6	0.0	14.0	21.7	39.4	0.0	12.4	23.6	15.6	27.8	9.5	4.0	76.5	2.0	28.0	2.2	4.4
MYH15	KIAA1000	ENSG00000144821	"Myosin heavy chain 15"	Q9Y2K3	3	108380368-108529322	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9;retina: 2.8;tongue: 1.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Excitatory neurons: 8.8;Inhibitory neurons: 6.3;Muller glia cells: 8.0;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 10.6;Rod photoreceptor cells: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.4;Karpas-707: 2.3;PC-3: 5.1;SH-SY5Y: 1.8;U-87 MG: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034871, HPA057915"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Vesicles	"HPA034871: AB_10669996, HPA057915: "	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.57e-2)"	0.1	0.2	1.5	0.1	1.9	0.1	0.0	1.4	1.4	0.1	0.6	0.4	0.4	0.0	0.3	0.0	0.1	0.2	0.4	1.5	1.7	0.0	0.0	0.3	0.1	1.7	1.5	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.3	2.8	0.1	0.0	0.2	0.5	0.6	0.0	1.5	0.2	0.1	0.6	1.6	0.1	0.1	1.8	0.0	0.0	0.0	1.6	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.9	0.1	0.2	0.0	0.4	0.0	0.1	0.0	4.4	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.0	2.3	1.2	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.5	1.2	0.2	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	1.9	1.4	1.4	1.5	1.7	1.7	1.5	1.5	1.5	1.6	1.6	0.0	0.0	0.5	14.0	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.0	2.3	0.0	0.0	0.0	2.1	0.0	0.1	0.4	0.0	0.2	3.0	1.0	0.1	0.1	0.0	0.0	8.8	0.2	0.0	0.6	0.0	0.1	0.0	0.5	0.0	0.0	0.1	1.7	6.3	1.1	0.0	0.0	0.3	0.9	0.0	0.1	1.8	1.0	0.0	8.0	0.0	5.0	10.6	0.5	0.0	0.0	1.6	0.4	0.1	0.1	0.0	5.1	0.0	0.1	0.6	1.1	0.6	0.0	0.1	0.0	0.1	0.5	1.2	0.1
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281280-36387967	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 1343.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Nuclear bodies,Plasma membrane,Actin filaments,Cytosol"		No	No		410000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments"	"Nuclear bodies, Cytosol"	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	295.9	95.5	42.3	181.1	42.1	245.9	231.5	40.6	54.7	181.2	65.5	192.6	107.0	356.4	39.3	153.8	182.2	134.5	161.1	50.8	39.4	140.7	101.6	286.2	161.7	52.7	51.7	121.1	160.3	55.0	52.6	166.5	48.1	131.8	89.8	9.7	177.2	98.4	84.0	160.6	163.5	174.1	48.8	232.5	135.8	38.2	52.1	125.1	141.2	46.3	104.1	168.8	166.8	48.2	612.2	277.0	86.2	74.2	156.8	195.1	437.3	398.4	507.5	554.6	413.2	302.1	170.3	156.9	230.1	666.1	265.0	412.7	125.2	779.4	559.6	356.1	120.9	302.6	294.3	259.9	481.1	346.9	463.8	233.0	234.7	751.9	626.4	540.3	461.8	113.2	67.3	205.8	448.9	161.9	124.4	204.0	51.7	171.1	169.2	233.3	267.3	146.7	314.5	581.5	129.6	53.0	559.7	217.0	251.6	218.5	162.4	177.1	1343.7	1222.6	370.3	237.5	731.5	135.2	114.7	129.0	463.2	172.3	363.1	72.6	25.2	64.7	32.4	19.8	28.4	13.4	23.5	26.4	17.2	11.9	18.3	20.4	41.2	9.0	26.5	8.0	26.3	54.5	42.3	42.1	40.6	54.7	50.8	39.4	52.7	51.7	48.1	48.8	52.1	48.2	303.9	118.6	87.1	12.7	108.4	144.0	182.4	123.1	72.8	2.6	90.5	89.4	62.6	80.1	89.7	92.0	2.1	87.0	151.7	359.8	7.9	309.4	35.8	89.7	121.6	258.7	73.8	51.9	42.5	245.8	193.1	82.9	123.8	194.7	93.1	117.1	132.8	102.8	100.4	82.4	6.7	131.0	59.0	119.6	124.2	37.4	68.0	168.8	85.4	61.8	196.6	11.9	137.0	7.5	33.3	344.6	186.8	211.4	125.9	184.4	159.8	27.5	51.5	5.3	203.8	39.9	275.2	6.9	10.4	133.6	135.1	46.4	213.2	141.3	139.5	134.3
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216926-44218234	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 7.7;breast: 6.9;pancreas: 5.6;stomach 1: 2.3"	"Group enriched"	"Detected in some"	4	"Adipocytes: 5.5;Distal tubular cells: 3.9;Exocrine glandular cells: 2.2;Extravillous trophoblasts: 1.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	106	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	106	"dendritic cells: 10.6"	"Cell line enriched"	"Detected in some"	31	"RH-30: 134.6"	"Not detected"	"Not detected"							HPA051451	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Mitochondria, Cytosol"	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	7.7	0.1	0.0	0.2	0.0	0.0	6.9	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.5	1.0	0.0	0.0	0.7	0.1	0.4	0.6	0.1	0.0	0.1	5.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.1	0.0	0.4	0.9	0.5	0.1	0.0	0.8	2.3	0.4	0.0	0.8	0.4	0.2	0.3	0.5	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	134.6	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.2	1.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MYO15B	MYO15BP	ENSG00000266714	"Myosin XVB"	Q96JP2	17	75588058-75626849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 179.2"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 275.4;Paneth cells: 294.2;Proximal enterocytes: 127.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 46.4;HEL: 17.7;HMC-1: 24.9;THP-1: 37.7"	"Not detected"	"Not detected"							"HPA022857, HPA023105"			Approved	Cytosol		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA022857: AB_1848813, HPA023105: AB_1859526"	"prognostic favorable (9.34e-4)"	"unprognostic (7.55e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.59e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.90e-5)"	40.0	17.3	34.7	17.3	39.2	57.0	38.1	33.7	45.1	74.7	29.6	53.6	179.2	46.1	7.5	18.6	65.6	25.8	44.4	32.0	34.0	76.0	29.8	55.1	19.2	39.9	36.8	87.1	20.5	4.7	28.9	15.0	40.1	56.5	21.5	9.9	23.6	14.0	13.2	15.9	149.0	9.8	35.5	108.2	25.7	20.9	36.7	17.7	65.8	8.0	7.2	29.0	44.0	46.1	0.6	46.4	0.3	1.2	0.3	0.1	0.7	0.0	0.0	0.0	0.0	5.8	13.6	0.1	1.5	0.0	0.6	0.5	0.0	0.0	0.0	0.6	2.8	17.7	9.5	11.6	1.3	0.0	24.9	0.8	0.8	0.0	0.1	0.8	0.3	7.3	1.2	5.1	0.0	5.0	0.4	7.8	0.7	12.3	11.2	12.7	0.3	2.1	0.3	1.0	1.3	3.2	0.3	0.5	1.5	1.4	3.5	37.7	0.1	0.3	1.2	0.2	0.0	1.7	0.2	0.2	0.7	8.9	0.6	1.3	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.0	0.4	0.2	0.0	0.1	34.7	39.2	33.7	45.1	32.0	34.0	39.9	36.8	40.1	35.5	36.7	46.1	13.7	0.0	3.3	44.7	8.4	2.4	2.4	2.0	8.0	4.5	4.0	2.7	7.5	11.5	2.4	9.2	16.7	0.1	11.9	275.4	1.9	1.6	0.7	11.6	8.9	14.6	31.7	9.2	1.1	1.5	0.1	7.1	52.0	8.1	14.0	13.6	21.0	2.1	5.5	1.7	1.4	40.3	12.2	10.0	12.6	2.7	5.6	17.5	3.6	42.2	6.9	4.9	12.3	32.6	46.6	8.8	294.2	4.9	1.4	1.9	127.5	14.4	8.0	13.5	6.6	7.1	8.4	3.3	6.8	2.2	3.0	0.1	6.2	4.7	20.1	1.8
MYO1D	"KIAA0727, myr4, PPP1R108"	ENSG00000176658	"Myosin ID"	O94832	17	32492522-32877177	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 111.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 193.1;Excitatory neurons: 201.4;Oligodendrocytes: 578.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.7;CACO-2: 148.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054744	Uncertain		Approved	Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA054744: AB_2682589"	"unprognostic (3.83e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.70e-3)"	"unprognostic (3.95e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.01e-6)"	"unprognostic (1.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.53e-6)"	37.7	27.5	10.4	15.6	27.3	3.7	21.0	24.1	15.5	25.5	12.7	111.2	84.4	21.0	22.3	36.0	16.6	31.3	13.2	10.7	13.0	27.1	14.3	31.9	6.3	26.5	22.3	24.6	26.2	27.2	12.3	13.9	25.0	17.8	91.6	1.7	33.1	13.0	5.5	40.6	83.7	18.2	18.5	9.5	26.7	9.8	22.4	7.0	41.0	3.6	14.3	24.6	25.8	52.9	32.3	1.5	0.9	0.3	105.7	60.0	1.2	18.9	36.5	3.4	20.9	148.0	50.0	18.2	3.9	83.7	0.8	29.6	3.8	47.0	5.3	2.3	38.6	16.5	0.1	10.5	6.8	0.0	8.6	17.3	29.3	26.7	24.0	0.4	45.8	9.5	28.2	28.9	16.3	38.6	0.1	0.5	5.8	36.2	28.0	0.0	21.1	21.0	14.6	61.8	36.3	6.2	6.4	11.4	93.2	9.1	50.1	0.2	57.2	16.3	8.2	0.6	0.4	35.2	43.4	0.2	21.6	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	10.4	27.3	24.1	15.5	10.7	13.0	26.5	22.3	25.0	18.5	22.4	52.9	14.3	22.4	13.1	5.5	8.4	8.0	10.1	11.7	26.2	0.9	8.8	8.4	5.0	20.0	12.9	23.9	18.8	19.4	2.7	193.1	5.9	20.8	126.0	7.2	2.8	12.3	26.5	8.2	201.4	23.8	3.1	11.4	30.1	21.3	1.3	24.5	3.9	11.0	8.8	0.0	28.9	93.4	10.2	1.6	8.2	37.6	5.9	4.4	16.0	18.7	0.3	1.2	4.1	9.0	578.3	46.4	94.4	18.4	42.8	18.7	126.5	2.5	25.2	0.9	6.6	5.3	22.8	20.5	7.2	25.4	11.2	12.4	5.7	9.8	81.7	23.3
MYO1E	"HuncM-IC, MGC104638, MYO1C"	ENSG00000157483	"Myosin IE"	Q12965	15	59132434-59372871	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 319.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 23.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 224.1;HaCaT: 208.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003003, HPA023886"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		13000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA003003: , HPA023886: AB_1854253"	"unprognostic (7.90e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (5.38e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	30.6	7.1	19.4	32.9	34.9	1.8	19.5	32.2	30.7	27.7	43.6	54.3	25.3	31.0	29.6	37.6	17.4	38.7	13.3	19.6	24.9	47.7	52.2	19.9	36.9	38.6	35.0	10.3	12.0	22.4	9.3	34.7	39.4	22.9	34.4	9.9	18.7	21.6	11.9	45.6	44.2	22.2	28.4	17.1	32.5	8.3	33.1	7.6	15.2	10.9	41.2	38.1	28.1	57.1	133.3	224.1	12.1	8.2	92.4	74.8	62.2	52.9	25.7	28.8	33.6	55.7	50.5	52.7	37.0	41.3	117.5	208.6	18.9	81.5	38.2	24.1	10.5	0.5	178.4	50.3	85.5	0.3	7.2	103.4	48.8	37.0	107.4	90.7	47.8	0.9	0.3	0.8	49.2	12.4	0.6	1.2	29.3	21.5	49.8	0.2	53.8	32.4	156.9	61.8	6.5	21.9	117.1	24.2	45.8	36.5	16.3	5.8	58.4	57.5	16.6	177.1	52.0	0.3	3.3	1.3	105.4	0.6	53.2	0.0	4.5	0.0	0.2	4.6	0.0	9.2	0.0	0.0	15.4	8.6	0.0	0.0	0.6	3.6	1.6	23.7	0.5	2.5	19.4	34.9	32.2	30.7	19.6	24.9	38.6	35.0	39.4	28.4	33.1	57.1	31.0	6.4	7.7	27.1	19.6	24.9	40.0	24.7	24.5	0.2	9.3	10.2	3.9	17.2	15.4	25.8	0.0	4.3	19.9	73.6	3.9	39.8	4.2	49.4	30.2	30.4	19.7	2.5	9.3	18.1	23.8	14.9	86.6	47.3	4.5	6.7	5.0	13.0	33.5	0.0	8.7	31.2	8.2	5.0	50.1	8.5	9.3	17.6	19.6	56.2	9.0	11.3	3.1	6.6	319.1	64.0	60.0	12.0	9.2	28.3	37.4	3.1	40.9	0.9	13.1	33.7	25.0	1.3	5.1	30.1	24.0	12.9	4.7	6.7	29.3	56.9
MYOZ2	"C4orf5, CS-1, FATZ-2"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135832-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 771.4;skeletal muscle: 225.5;tongue: 173.4"	"Cell type enriched"	"Detected in some"	51	"Cardiomyocytes: 2275.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;HSkMC: 2.3;SK-MEL-30: 6.2;U-87 MG: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	0.6	0.3	0.2	0.0	0.3	0.0	2.1	0.1	0.5	0.7	0.0	1.0	0.0	2.0	0.3	1.0	1.0	0.3	771.4	0.2	0.3	0.7	0.1	0.9	0.3	0.2	0.2	0.6	0.1	0.0	0.2	0.2	0.1	4.8	0.1	0.0	1.8	0.3	225.5	0.5	0.4	0.8	0.2	0.6	0.6	1.0	0.3	0.3	0.3	173.4	0.1	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.2	1.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2275.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	20.8	0.0	0.0	3.4	2.2	0.0	44.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.7	0.0	0.2	0.0	2.9	0.0	0.0	6.6	6.9	22.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 64.1;skeletal muscle: 283.6;tongue: 172.8"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 114.2"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 39.8;fHDF/TERT166: 112.3;HBF TERT88: 25.6;LHCN-M2: 47.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	0.1	0.3	0.2	0.2	0.1	0.6	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.2	0.0	0.1	64.1	0.8	0.8	0.0	0.0	0.0	0.2	0.6	0.2	0.1	0.6	0.0	0.0	0.1	0.1	1.7	0.1	1.7	2.7	0.0	283.6	0.1	0.1	0.2	0.0	0.1	0.8	0.9	0.0	0.1	0.0	172.8	0.0	0.1	0.0	0.3	2.9	1.3	0.0	0.0	0.7	4.1	0.1	39.8	19.7	14.4	5.4	0.0	0.1	0.1	0.0	112.3	20.5	0.7	0.0	0.2	25.6	0.4	0.0	0.0	14.6	0.0	0.3	0.0	0.1	1.6	0.0	7.9	0.9	3.6	0.4	0.0	0.0	0.2	47.6	8.6	0.0	0.1	0.0	0.0	1.3	0.0	2.2	0.0	0.1	0.1	0.1	0.0	5.7	0.9	0.2	0.1	0.0	0.0	1.1	0.7	0.2	4.1	0.1	0.1	0.0	0.0	4.6	0.1	4.2	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.8	0.8	0.6	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.2	0.0	114.2	0.0	0.0	0.0	25.0	0.0	0.0	1.8	0.0	0.0	1.0	1.5	0.1	0.7	0.0	0.0	0.5	0.2	0.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.1
MYRF	"C11orf9, MRF, Ndt80, pqn-47"	ENSG00000124920	"Myelin regulatory factor"	Q9Y2G1	11	61752636-61788518	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 168.0;stomach 1: 88.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1;Cholangiocytes: 60.1;Gastric mucus-secreting cells: 130.0;Oligodendrocytes: 255.8;Pancreatic endocrine cells: 70.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 38.8;CACO-2: 63.6;CAPAN-2: 34.0;EFO-21: 48.6;Hep G2: 21.8;OE19: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018310			Approved	Nucleoplasm,Cytosol		NA	NA		1400000		"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA018310: AB_1845534"	"unprognostic (3.51e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	15.4	0.6	31.3	1.1	99.0	0.3	0.4	67.9	67.5	2.2	0.0	3.8	11.4	13.1	0.1	2.4	15.4	17.3	2.4	36.9	48.8	12.0	16.9	22.3	0.1	101.7	89.4	17.6	31.6	0.0	0.4	1.1	84.9	0.7	1.1	0.4	0.6	0.3	0.1	0.5	10.8	1.9	43.5	0.5	88.3	3.1	85.7	0.0	0.3	0.0	0.1	0.5	0.6	168.0	3.1	38.8	4.7	1.5	0.0	0.0	0.2	0.2	0.1	0.9	0.8	63.6	34.0	0.9	48.6	0.0	1.2	0.3	1.3	0.0	0.9	0.1	0.6	0.2	0.7	21.8	18.9	0.0	0.4	0.3	0.0	0.6	0.0	10.9	0.1	1.6	11.7	0.3	0.2	0.5	0.0	0.9	1.6	37.2	4.8	0.0	0.1	1.9	6.5	0.0	0.1	0.9	0.0	0.4	0.3	10.6	0.6	0.4	1.4	0.4	19.5	0.0	0.6	0.2	0.1	0.3	0.1	2.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	99.0	67.9	67.5	36.9	48.8	101.7	89.4	84.9	43.5	85.7	168.0	0.1	48.1	5.1	2.3	0.6	0.1	0.1	0.2	0.0	0.5	0.8	0.8	1.3	60.1	3.4	3.7	0.0	0.4	1.6	6.4	0.0	31.7	0.2	1.4	3.2	0.6	1.2	0.0	0.9	36.7	0.3	5.6	130.0	4.1	0.0	4.4	0.7	6.0	0.9	0.0	1.1	4.5	6.1	0.0	0.6	1.2	5.9	0.8	3.6	0.0	1.0	3.5	0.0	5.5	255.8	70.5	13.0	3.8	0.4	0.2	12.8	2.2	1.3	0.3	0.0	0.2	1.2	1.4	3.7	0.8	0.0	0.8	0.7	0.3	7.7	3.1
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.6;retina: 8.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 31.9;Cone photoreceptor cells: 60.5;Horizontal cells: 26.9;Oligodendrocyte precursor cells: 112.1;Rod photoreceptor cells: 29.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.6;SCLC-21H: 23.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.5"	HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.2	3.5	5.8	0.2	3.8	1.1	0.1	24.6	4.3	0.0	0.0	0.2	0.8	0.1	0.2	0.0	0.2	0.1	0.1	3.8	6.6	0.1	0.1	0.1	0.1	5.0	5.6	0.1	0.6	0.3	5.5	0.1	5.2	0.1	0.2	8.3	0.0	0.1	0.0	0.1	0.2	0.1	2.7	0.2	0.6	0.7	5.9	0.1	0.6	0.0	0.1	0.1	0.0	3.6	0.0	0.1	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.7	0.3	0.1	0.3	0.0	2.4	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.2	1.7	0.0	0.1	1.8	0.1	0.9	0.0	0.5	7.6	0.2	0.2	0.0	0.1	23.1	6.0	0.0	0.2	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	2.2	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.8	24.6	4.3	3.8	6.6	5.0	5.6	5.2	2.7	5.9	3.6	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	31.9	0.1	0.0	1.2	4.3	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.4	2.4	2.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.5	26.9	5.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	5.0	0.0	112.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	29.0	0.0	0.4	0.1	1.6	8.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0
MZT2A	"FAM128A, MOZART2A"	ENSG00000173272	"Mitotic spindle organizing protein 2A"	Q6P582	2	131464900-131492743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 252.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 79.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 421.1"									"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"prognostic favorable (3.04e-4)"	"unprognostic (3.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.04e-11)"	"unprognostic (1.51e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-1)"	41.7	68.6	31.8	11.6	28.4	40.5	44.4	16.1	74.7	82.9	23.9	59.7	31.8	60.7	2.5	102.7	85.8	6.6	252.2	32.6	24.5	50.8	81.1	28.3	19.2	22.5	23.1	87.9	94.7	14.4	38.2	4.7	24.8	74.4	2.6	0.7	52.6	9.1	48.0	54.5	45.8	2.1	15.3	37.8	64.8	36.8	27.7	7.2	55.0	5.6	4.2	55.1	69.8	23.9	212.0	115.2	3.0	40.9	3.3	7.7	44.1	70.6	17.3	27.8	28.2	286.2	71.3	136.7	88.3	3.4	2.8	94.6	7.2	49.8	1.0	54.5	346.6	56.8	135.3	353.8	17.3	100.7	20.4	22.3	27.8	18.7	8.8	6.4	23.8	122.7	114.1	138.7	6.9	196.1	137.1	421.1	73.0	28.1	259.8	114.5	37.3	317.5	18.7	102.2	160.1	20.4	71.6	46.5	135.2	2.1	74.7	177.8	61.6	70.2	168.9	28.3	68.6	128.9	105.6	116.9	97.2	64.3	41.3	22.1	2.0	79.5	8.5	1.4	9.4	32.4	18.9	10.9	7.7	18.8	20.7	10.2	1.1	7.1	0.8	12.0	21.7	4.9	31.8	28.4	16.1	74.7	32.6	24.5	22.5	23.1	24.8	15.3	27.7	23.9	60.4	16.0	13.8	11.8	126.6	148.1	138.9	81.9	124.1	55.6	196.7	284.6	305.6	111.5	47.3	71.7	20.9	88.7	101.1	159.7	170.2	210.3	25.5	42.2	89.7	68.7	108.8	75.7	15.8	167.8	223.9	100.4	115.2	70.4	23.6	189.2	99.2	128.0	123.1	26.9	16.4	240.7	54.9	79.4	138.1	89.8	152.8	71.4	103.2	4.7	105.2	112.9	114.4	10.1	13.0	269.2	167.0	205.4	140.8	163.1	240.1	255.6	28.9	41.9	92.1	83.2	85.9	44.4	166.3	269.5	142.9	42.4	155.8	156.7	270.4	133.6
MZT2B	"FAM128B, FLJ14346, MOZART2B"	ENSG00000152082	"Mitotic spindle organizing protein 2B"	Q6NZ67	2	130181737-130190729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 962.4"					"Low region specificity"	"Detected in all"			"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"unprognostic (8.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (9.37e-8)"	"unprognostic (1.67e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-1)"	125.3	170.2	161.7	59.9	150.5	159.3	130.6	131.7	284.6	169.3	145.5	174.2	79.5	140.6	18.2	164.8	162.4	16.4	401.3	150.5	141.8	143.8	199.5	86.3	60.3	150.0	142.2	190.3	250.9	49.3	117.1	32.9	133.9	144.2	19.6	11.4	172.6	41.2	202.4	147.1	102.8	20.4	133.4	103.6	160.7	195.1	157.4	48.1	159.0	29.9	25.5	131.8	143.1	151.4	462.9	239.6	38.6	173.1	20.7	49.8	190.5	203.1	56.7	72.2	59.6	384.0	168.3	251.5	288.1	39.5	47.2	223.4	19.7	68.9	11.2	376.3	667.0	132.8	313.5	485.9	71.5	155.1	97.1	65.7	77.6	45.4	26.9	58.4	80.6	251.8	189.6	268.9	35.8	572.5	336.0	962.4	137.8	85.7	435.8	447.0	105.4	626.6	55.3	140.2	304.7	377.8	121.3	201.1	369.8	15.1	218.5	374.8	164.7	199.8	354.7	155.3	203.4	378.1	257.5	257.9	244.6	203.3	133.3	0.4	19.9	83.0	18.6	21.5	16.5	37.6	25.5	24.7	25.4	38.5	29.1	24.2	10.7	27.3	20.4	48.1	21.3	12.2	161.7	150.5	131.7	284.6	150.5	141.8	150.0	142.2	133.9	133.4	157.4	151.4	240.2	41.7	29.4	20.5	253.6	297.2	321.4	193.4	248.2	175.2	543.9	739.1	326.5	243.1	104.6	242.8	43.8	282.8	238.0	378.4	467.6	358.4	327.3	115.5	326.7	210.0	173.0	308.2	21.7	591.7	466.6	250.1	166.7	171.7	50.8	484.6	250.2	363.5	342.0	131.2	22.8	453.0	99.7	232.7	365.6	1258.6	249.8	202.4	268.6	14.0	179.7	358.3	150.4	16.6	24.5	584.9	281.6	143.7	278.7	375.9	181.7	801.3	61.7	110.6	164.3	169.1	277.3	165.4	183.3	418.2	377.2	165.1	282.3	338.4	360.7	358.0
N4BP1		ENSG00000102921	"NEDD4 binding protein 1"	O75113	16	48538726-48620148	"Predicted intracellular proteins"	"Immunity, Innate immunity"	"Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 134.6;Glandular and luminal cells: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040849, HPA041080"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040849: AB_10794866, HPA041080: AB_10794186"	"unprognostic (1.07e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.03e-8)"	"unprognostic (9.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.36e-2)"	9.3	6.7	8.0	7.3	7.8	10.3	9.0	9.7	8.0	10.2	7.9	8.8	5.9	8.6	8.3	18.9	8.4	6.3	7.9	7.6	11.0	7.4	7.0	14.7	7.5	8.5	7.8	9.7	7.6	11.4	9.1	7.5	8.2	8.8	6.3	6.9	10.7	6.4	10.5	19.9	9.3	6.3	7.1	10.9	9.2	4.7	10.7	10.3	8.3	7.9	9.0	8.1	11.3	8.4	7.1	11.8	8.3	8.5	11.4	9.0	6.9	6.5	9.9	12.4	6.3	9.3	5.8	7.9	5.9	10.0	5.5	14.4	7.5	10.3	6.8	4.9	6.2	4.1	4.7	8.3	11.1	6.2	10.8	13.0	15.5	4.4	6.4	9.1	6.3	8.1	6.4	8.2	7.5	4.0	7.4	11.2	6.6	7.3	6.7	11.1	13.5	12.4	6.2	11.9	9.3	6.6	5.5	10.0	9.2	8.6	4.2	8.5	9.3	6.3	5.6	3.5	3.9	12.2	7.8	12.0	7.3	4.9	5.6	0.9	1.3	1.8	1.0	1.2	1.3	0.9	1.3	1.6	0.8	0.6	1.1	1.1	8.4	0.4	0.9	1.0	1.0	0.6	8.0	7.8	9.7	8.0	7.6	11.0	8.5	7.8	8.2	7.1	10.7	8.4	41.2	134.6	32.7	28.4	15.3	20.0	21.6	32.4	19.4	24.1	21.3	21.2	15.1	22.8	25.8	7.3	16.7	13.4	53.8	35.4	5.9	8.4	6.4	36.8	35.8	25.7	9.6	6.5	47.5	13.2	10.5	20.1	30.5	113.8	12.6	23.1	24.3	13.4	19.5	26.9	50.1	21.2	6.1	25.9	40.3	3.7	16.1	36.5	5.4	58.1	31.9	15.3	21.6	38.7	54.8	26.7	21.6	20.7	30.2	30.6	16.1	9.4	18.4	23.0	0.0	26.3	17.6	12.6	24.4	26.8	22.7	28.5	36.5	23.8	13.4	47.5
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056850-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	1.0	0.7	1.4	2.5	1.2	4.1	2.9	1.8	1.6	2.5	1.7	2.2	2.4	3.4	1.9	1.8	1.8	1.6	1.1	0.7	4.2	1.5	5.8	1.6	3.6	2.1	1.7	3.0	4.2	1.4	1.2	3.6	0.7	2.4	2.2	2.2	3.5	0.9	0.7	1.9	2.2	0.8	1.4	1.9	1.9	1.8	4.0	11.3	3.5	1.0	4.1	2.1	1.4	0.5	2.0	2.0	12.0	1.9	0.8	3.8	9.5	2.2	2.5	1.3	2.7	3.9	4.0	10.7	4.3	2.1	2.2	1.5	7.7	2.4	3.0	3.4	2.3	4.8	1.5	1.8	1.9	13.0	11.2	4.3	3.3	2.1	4.6	0.4	3.3	10.0	10.8	4.5	2.5	1.9	26.8	6.4	6.0	1.6	1.7	15.4	14.1	2.5	1.0	4.7	4.7	8.3	2.2	1.6	2.1	7.8	1.5	3.8	4.5	1.5	7.3	0.9	1.7	7.4	8.0	7.3	1.4	4.8	3.0	5.1	0.8	0.4	1.7	0.9	1.8	1.2	2.3	1.3	1.4	1.7	3.4	1.9	0.2	8.2	0.9	6.5	1.1	0.9	1.4	1.2	1.8	1.6	0.7	4.2	2.1	1.7	0.7	1.4	4.0	0.5	9.6	22.4	24.4	19.2	18.2	12.0	14.3	5.1	18.8	33.0	12.3	11.2	12.3	11.5	13.2	22.0	27.1	44.2	36.7	9.0	0.0	6.0	4.7	17.6	15.1	11.4	19.3	22.5	16.5	12.6	12.9	15.5	12.2	20.7	5.1	36.1	6.8	20.7	12.4	72.3	47.2	17.1	10.2	16.3	24.6	4.3	9.9	24.0	7.2	36.5	17.9	12.4	27.8	44.2	3.1	11.4	10.8	3.8	36.0	12.4	7.3	3.6	8.7	22.6	13.1	17.9	6.3	22.0	24.3	13.0	13.1	27.0	28.4	30.4	8.5	9.2
N4BP2L1	CG018	ENSG00000139597	"NEDD4 binding protein 2 like 1"	Q5TBK1	13	32400723-32428311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 23.8;JURKAT: 22.2;NB-4: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038971, HPA057219"	Approved		Approved	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA038971: AB_10673408, HPA057219: "	"unprognostic (2.66e-3)"	"unprognostic (2.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (6.91e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.57e-3)"	24.8	11.9	34.0	14.9	33.8	49.5	26.9	32.9	41.1	23.7	32.3	20.3	15.6	19.5	16.1	11.2	26.3	12.6	12.4	34.2	36.2	15.4	85.6	30.2	26.6	29.0	31.1	45.2	20.3	8.6	37.1	13.5	28.4	21.7	14.6	7.9	12.4	11.6	13.8	27.5	21.1	13.0	28.9	30.1	13.8	4.4	37.2	32.0	17.0	9.7	17.9	16.6	20.5	32.7	0.9	0.3	1.3	0.5	5.0	4.0	0.4	0.6	2.2	1.2	2.0	3.8	5.1	10.3	1.4	1.1	3.7	0.1	3.7	0.3	1.6	15.5	2.3	23.8	1.4	11.4	7.8	9.0	1.4	2.8	0.8	1.0	1.0	9.0	0.8	22.2	0.0	18.3	1.0	0.8	18.6	61.4	1.9	0.0	0.5	17.5	0.6	8.8	4.9	1.8	3.4	4.2	3.7	0.1	1.7	2.4	0.5	16.8	0.4	0.5	0.3	0.3	0.1	10.4	6.6	0.5	0.6	3.4	0.7	59.0	49.3	13.9	18.0	47.2	15.9	28.6	17.5	22.4	43.7	33.0	23.9	20.8	12.5	32.1	34.4	56.0	27.9	36.7	34.0	33.8	32.9	41.1	34.2	36.2	29.0	31.1	28.4	28.9	37.2	32.7	46.1	44.8	27.6	53.2	51.4	30.1	29.6	8.7	23.9	10.6	26.6	22.6	4.3	17.2	16.5	5.5	0.0	22.3	74.8	5.5	9.8	15.0	22.5	23.0	5.7	36.1	37.9	25.5	71.7	8.5	1.1	26.2	6.1	4.8	8.8	16.0	21.0	67.2	22.5	0.0	60.4	9.2	24.4	46.6	102.7	22.7	27.4	54.6	30.2	40.3	110.2	7.2	47.4	72.9	43.4	4.4	12.5	22.2	38.4	24.5	25.8	9.8	8.1	2.2	78.9	48.9	40.4	1.4	2.8	15.2	35.4	10.4	44.0	2.5	12.9	16.5
NAB2	MADER	ENSG00000166886	"NGFI-A binding protein 2"	Q15742	12	57089043-57095476	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 98.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004510, HPA027464"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"CAB004510: AB_627982, HPA027464: AB_10601138"	"prognostic favorable (7.41e-4)"	"unprognostic (4.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (5.67e-3)"	"unprognostic (6.19e-3)"	21.8	16.1	25.2	9.9	26.8	6.8	14.2	30.3	31.0	33.7	24.0	29.8	10.1	32.3	21.0	24.5	31.0	17.4	20.5	28.3	25.0	20.1	22.3	24.0	12.0	23.2	23.1	51.1	10.2	19.5	35.4	11.1	22.1	25.4	5.0	10.7	11.6	16.6	7.6	33.4	15.7	13.4	21.6	16.9	15.9	16.8	25.4	17.4	20.7	9.9	10.4	27.7	33.8	24.8	15.2	9.8	49.2	45.2	43.3	56.7	5.5	44.1	40.8	28.0	23.1	15.6	8.7	9.6	17.6	44.4	8.1	27.0	16.9	34.0	14.3	4.0	4.5	11.4	8.1	16.6	33.2	9.1	26.5	64.4	36.1	32.6	10.9	43.7	7.5	7.2	26.5	9.6	32.4	73.4	14.0	44.5	9.9	12.9	16.6	10.4	64.1	5.1	11.8	6.0	5.5	13.1	21.9	12.5	98.3	12.3	28.0	20.0	8.4	40.7	34.1	28.8	13.2	22.7	6.0	5.1	39.5	5.9	25.1	0.0	1.1	0.2	0.5	2.7	0.6	0.9	0.9	0.7	0.6	2.3	1.1	1.1	0.4	0.4	2.9	0.0	1.0	0.6	25.2	26.8	30.3	31.0	28.3	25.0	23.2	23.1	22.1	21.6	25.4	24.8	7.6	12.8	13.0	5.9	11.6	29.6	19.5	23.4	39.3	20.3	17.3	13.8	2.9	2.8	13.6	9.2	2.1	3.7	4.9	1.1	7.9	7.4	0.6	22.9	21.2	13.7	6.6	4.8	11.4	1.4	10.5	19.7	8.6	25.4	17.1	7.8	18.2	17.1	11.2	10.1	5.4	1.1	10.2	16.3	43.7	2.9	19.6	14.3	21.4	8.4	1.6	7.9	1.0	1.0	1.9	4.1	0.0	18.8	8.7	12.9	8.7	5.6	5.9	4.4	19.7	9.8	16.3	2.6	18.7	23.4	32.5	56.2	10.7	2.5	1.5	8.6
NACA	NACA1	ENSG00000196531	"Nascent polypeptide associated complex subunit alpha"	"E9PAV3, Q13765"	12	56712305-56731628	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	"Activator, Chaperone, DNA-binding"	Allergen	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073152, HPA073648"			Approved	Cytosol		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA073152: AB_2686575, HPA073648: AB_2686621"	"unprognostic (3.35e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (4.58e-11)"	"unprognostic (9.47e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.79e-2)"	1348.3	1065.0	446.1	607.2	455.9	1524.0	1460.8	456.4	614.8	1642.2	421.9	1252.3	618.6	1067.1	1084.0	1511.9	1216.9	545.1	946.9	431.4	473.1	1038.4	893.7	839.1	1026.5	465.7	442.5	2391.0	1384.8	764.5	811.6	607.7	469.4	1139.7	845.2	453.0	1016.0	699.0	1192.4	1706.1	890.4	689.9	492.3	901.9	1035.1	364.0	450.6	1043.6	918.0	376.8	1432.0	1183.1	1447.1	485.1	1128.5	1333.7	1555.7	1198.7	1795.5	3053.1	1489.5	1117.9	1619.4	1509.9	1051.6	1602.0	1220.7	2014.8	1191.0	1019.4	599.8	963.6	1324.0	1814.9	1600.2	1002.6	2111.7	1463.4	890.3	1640.8	1607.2	2139.1	899.1	2430.3	2204.4	1226.9	2477.6	2669.6	1628.2	1184.8	1896.0	2594.7	1445.5	1118.9	1341.7	2670.1	1528.3	1072.6	1440.8	1543.1	1268.7	2180.1	2124.9	1157.6	1130.2	1197.4	835.8	1977.1	1774.5	1027.8	2109.8	2398.2	1085.4	770.4	933.2	834.0	1127.0	1217.9	1475.1	1768.0	1134.0	1422.3	997.9	462.6	987.0	503.8	581.4	1371.7	851.7	969.7	823.0	726.5	1006.8	812.1	941.6	834.7	350.2	748.7	1842.6	1082.7	944.3	1951.8	446.1	455.9	456.4	614.8	431.4	473.1	465.7	442.5	469.4	492.3	450.6	485.1	1444.2	445.5	645.8	38.8	1822.8	2027.4	2219.5	2022.2	2405.1	325.2	2494.6	5365.8	722.7	1159.6	1095.8	395.4	66.7	1867.2	2037.7	656.8	1778.5	1368.9	701.0	899.4	1625.1	1206.0	647.6	1213.0	31.4	2023.3	2894.2	1085.3	649.4	1079.9	735.9	1600.7	993.4	881.6	1594.4	183.4	35.5	1461.3	801.5	1436.7	1664.7	589.5	2409.8	1430.9	1239.8	40.3	2261.1	1195.0	1528.3	26.7	35.1	1574.8	1306.2	1431.2	1160.8	2248.0	1444.7	2734.4	523.2	455.2	802.0	1977.5	1718.3	542.4	479.1	2363.5	2231.6	2323.4	1549.8	2175.1	1762.0	2618.2
NACA2	"MGC71999, NACAL"	ENSG00000253506	"Nascent polypeptide associated complex subunit alpha 2"	Q9H009	17	61590421-61591219	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	33	"testis: 64.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 143.4;Early spermatids: 418.0;Late spermatids: 155.3;Spermatocytes: 233.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 3.2;SK-MEL-30: 2.0"									"HPA073152, HPA073648"			Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA073152: AB_2686575, HPA073648: AB_2686621"	"unprognostic (2.37e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.14e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.53e-3)"	"unprognostic (5.45e-3)"	"unprognostic (3.09e-3)"	1.0	0.9	0.0	0.5	0.0	0.2	1.0	0.0	0.0	1.1	0.0	0.9	0.1	0.7	0.0	1.1	0.7	0.0	0.9	0.0	0.0	1.1	0.8	0.7	0.4	0.0	0.0	1.9	1.1	0.0	0.7	0.1	0.0	1.0	0.1	0.0	0.8	0.0	1.0	1.4	0.7	0.1	0.0	0.7	0.8	64.1	0.0	0.0	0.8	0.0	0.2	0.7	1.0	0.0	0.3	0.0	0.3	0.3	0.1	0.2	0.9	0.0	0.3	0.1	0.2	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.3	0.3	0.1	0.1	0.3	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	1.0	0.0	0.1	0.4	3.2	0.7	0.0	0.1	0.4	0.2	1.1	0.1	0.0	0.3	0.7	0.2	0.4	2.0	0.0	0.8	1.1	0.0	0.1	0.4	0.6	0.3	0.3	0.3	0.3	0.4	0.2	0.2	0.1	0.3	0.1	0.2	0.7	0.3	0.4	0.3	0.3	0.4	0.4	0.4	0.4	0.0	0.3	0.7	0.4	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.0	11.2	69.3	60.6	15.0	0.0	0.7	2.2	3.2	143.4	35.8	5.2	1.8	0.0	17.5	11.7	2.9	86.1	0.3	418.0	0.5	1.1	17.6	3.6	2.7	3.4	0.8	24.1	18.5	0.0	0.6	0.0	0.7	26.4	15.1	14.5	0.0	4.0	9.1	10.2	50.7	66.3	155.3	33.8	8.2	46.2	1.0	23.7	1.5	23.7	1.5	3.5	0.6	11.1	11.3	0.0	48.1	8.1	62.1	2.9	0.9	13.1	63.8	107.3	233.8	11.4	0.0	79.3	24.1	16.3	1.1	11.8	42.9
NACAD	KIAA0363	ENSG00000136274	"NAC alpha domain containing"	O15069	7	45080437-45088969	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 84.2;pituitary gland: 24.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 32.0;Oligodendrocytes: 23.1;Peritubular cells: 12.0"	"Group enriched"	"Detected in many"	7	"glioma: 12.1;testis cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 33.4;SCLC-21H: 25.6;SH-SY5Y: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020981, HPA079208"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	Nucleoplasm	"HPA020981: AB_2670549, HPA079208: "	"unprognostic (5.54e-6)"	"unprognostic (1.89e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.72e-3)"	"unprognostic (2.72e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	3.3	5.2	23.4	1.2	50.2	0.1	3.2	54.2	42.1	6.2	0.0	8.3	0.7	7.9	0.8	2.0	5.5	1.8	4.5	26.3	34.6	2.1	0.2	2.5	0.7	58.9	48.3	8.9	1.0	0.8	24.3	1.9	58.6	4.3	0.8	3.7	1.7	3.0	1.2	1.7	3.0	4.3	32.7	1.6	3.9	3.7	57.4	0.3	1.3	1.0	0.3	5.0	4.6	84.2	0.0	0.0	2.5	0.1	1.6	0.7	0.1	2.9	3.5	7.7	4.8	0.2	0.1	0.0	2.2	5.1	33.4	0.2	2.2	1.9	2.7	0.0	0.8	0.0	1.7	0.0	1.8	0.0	0.0	1.6	0.0	3.3	0.3	4.1	2.4	0.0	0.0	3.5	2.0	0.0	0.0	0.0	2.3	0.0	2.2	0.0	0.9	0.0	0.3	0.0	25.6	17.7	0.0	0.1	0.1	6.7	0.0	0.1	0.9	0.0	0.0	0.2	0.5	1.8	1.0	0.0	1.5	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.4	50.2	54.2	42.1	26.3	34.6	58.9	48.3	58.6	32.7	57.4	84.2	0.3	0.0	0.0	6.8	0.0	0.6	3.5	0.9	1.2	5.5	0.4	1.8	6.0	0.0	0.2	1.8	0.0	0.1	0.4	0.1	0.0	0.6	2.9	0.5	3.1	0.9	1.2	0.0	4.4	0.2	0.1	3.9	1.1	1.2	1.3	3.9	0.7	0.0	0.1	32.0	5.2	0.0	0.0	0.0	0.0	4.9	6.8	0.7	1.8	1.9	1.0	2.7	0.0	3.0	23.1	0.1	0.0	12.0	0.1	2.3	0.0	0.4	0.8	2.8	6.6	5.3	4.2	1.5	1.4	0.2	0.1	0.1	0.3	9.6	0.1	0.9
NADSYN1	FLJ10631	ENSG00000172890	"NAD synthetase 1"	Q6IA69	11	71453109-71524107	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017798, HPA038523, HPA038524"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Golgi apparatus, Cytosol"	"CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (1.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.10e-4)"	29.5	34.1	18.8	24.1	20.4	67.6	26.2	18.5	21.2	30.4	20.3	48.6	39.5	26.0	24.2	56.3	31.2	25.8	20.3	17.8	18.3	33.2	49.8	35.3	33.3	22.4	19.6	27.6	29.5	13.4	36.0	16.5	21.0	45.3	36.0	6.9	32.9	22.8	11.0	31.1	51.1	19.3	18.8	58.4	34.3	25.6	21.7	27.9	31.8	5.1	28.2	43.4	33.4	24.4	15.9	37.8	12.0	21.6	35.0	50.6	32.4	29.7	27.2	15.4	17.0	32.4	25.7	13.4	33.1	35.3	20.7	55.2	15.9	42.6	8.2	27.9	12.8	22.2	27.6	36.3	43.3	45.1	40.9	72.0	65.8	19.9	17.8	34.9	54.6	24.2	11.9	18.5	21.9	49.7	22.4	29.9	7.0	69.6	21.3	27.5	37.2	13.5	37.8	72.1	8.9	12.7	21.2	27.9	56.0	17.9	24.9	24.4	66.2	16.7	14.2	30.9	11.8	24.3	11.0	11.7	29.9	25.6	12.0	6.1	28.0	17.3	15.3	25.0	12.7	12.2	13.5	13.8	31.1	9.2	8.8	11.4	17.7	16.3	22.6	23.0	17.7	21.4	18.8	20.4	18.5	21.2	17.8	18.3	22.4	19.6	21.0	18.8	21.7	24.4	12.6	22.4	32.3	4.2	24.0	6.2	17.8	18.4	26.2	7.8	13.5	10.9	8.3	12.8	19.8	11.0	4.2	17.4	27.3	65.3	3.9	16.5	22.6	21.1	11.1	15.6	23.4	20.2	5.1	17.3	14.5	12.8	51.0	19.7	22.1	23.1	13.9	16.7	20.1	13.5	5.8	30.3	16.2	23.2	18.5	60.9	9.3	25.4	8.8	8.4	25.8	5.9	29.9	7.5	18.5	20.0	55.8	10.1	18.0	17.9	73.3	16.2	16.5	7.3	13.1	9.6	9.8	15.9	5.0	38.3	12.8	17.2	22.3	17.1	43.7	24.2
NAGK	GNK	ENSG00000124357	"N-acetylglucosamine kinase"	Q9UJ70	2	71064344-71079808	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 216.9;Syncytiotrophoblasts: 318.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 391.8;granulocytes: 288.7;monocytes: 594.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035206, HPA035207"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	Nucleoplasm	"HPA035206: AB_2674517, HPA035207: AB_10602031"	"unprognostic (6.15e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.44e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (8.60e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.13e-2)"	41.2	36.0	47.0	61.2	48.0	21.9	35.1	49.5	52.1	57.5	47.0	37.7	21.0	33.6	40.6	156.2	29.0	44.1	31.4	46.9	52.9	35.1	42.8	39.6	79.6	50.9	50.4	31.0	42.2	80.7	42.3	44.3	53.7	30.0	34.2	16.5	75.0	37.9	26.6	63.0	33.6	50.1	48.3	88.9	33.9	50.2	49.0	60.8	27.4	32.3	98.4	71.7	59.7	52.1	55.9	39.2	22.6	25.8	114.2	67.5	98.3	119.0	65.5	95.6	86.8	54.3	29.5	30.3	29.3	107.4	113.5	25.7	22.4	43.9	62.7	44.9	16.4	17.0	12.6	37.5	91.6	10.5	37.7	60.7	49.6	101.8	16.4	68.3	107.7	31.7	8.1	34.8	143.4	52.2	28.6	40.2	28.7	53.5	38.4	22.1	64.2	15.8	65.5	91.4	25.1	13.0	35.2	62.1	45.1	50.7	30.4	13.9	66.0	99.0	37.8	36.9	44.8	23.0	24.8	18.0	69.6	31.5	54.5	86.6	594.1	245.1	36.9	526.5	39.2	102.5	44.2	37.0	391.8	103.7	36.7	30.0	288.7	65.3	378.2	318.5	54.7	466.2	47.0	48.0	49.5	52.1	46.9	52.9	50.9	50.4	53.7	48.3	49.0	52.1	22.9	38.5	34.2	15.0	48.6	26.9	28.4	60.8	19.4	46.1	27.4	27.6	18.0	17.2	56.9	38.6	22.9	146.0	67.4	13.9	41.1	66.1	151.3	22.5	26.1	31.7	23.4	12.8	11.5	45.7	144.0	35.6	15.8	24.9	51.9	31.1	30.0	12.9	216.9	47.1	15.2	20.4	28.5	121.8	67.5	33.0	30.1	106.0	39.2	26.2	118.6	45.4	17.5	17.1	24.0	59.1	32.3	37.6	51.2	15.5	23.3	64.7	35.2	55.6	19.7	31.8	37.4	68.0	25.6	39.9	41.6	318.8	29.1	32.2	16.2	34.7
NAIF1	"bA379C10.2, C9orf90, DKFZp762G199"	ENSG00000171169	"Nuclear apoptosis inducing factor 1"	Q69YI7	9	128061233-128068206	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054898, HPA064931"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054898: AB_2682633, HPA064931: AB_2732725"	"unprognostic (7.09e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.60e-1)"	"unprognostic (6.15e-2)"	"unprognostic (9.41e-2)"	"prognostic favorable (1.02e-5)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.30e-5)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.92e-2)"	2.0	2.4	1.2	1.8	1.4	4.3	1.8	1.2	1.6	2.1	1.3	2.0	2.0	2.2	0.7	2.6	1.8	1.0	2.0	1.2	1.2	1.7	2.6	1.6	2.6	1.4	1.2	1.7	2.4	1.8	1.5	1.6	1.3	1.5	1.2	0.7	2.2	1.4	2.7	2.3	2.3	1.4	1.1	3.2	2.1	3.4	1.6	2.4	1.7	1.9	2.2	1.6	1.8	1.2	5.1	4.4	2.7	7.0	2.5	2.2	6.1	3.8	2.3	3.2	2.6	3.5	4.0	6.2	3.3	2.4	4.5	3.8	2.8	2.9	2.6	19.1	3.8	4.6	5.4	2.0	4.1	6.4	12.5	2.0	3.4	2.5	4.0	2.6	2.9	6.9	11.0	3.9	3.0	5.9	6.2	7.7	3.0	6.9	7.4	5.9	4.3	5.7	2.5	3.1	3.9	4.5	3.8	5.2	4.0	2.0	4.0	6.3	2.0	3.8	11.8	3.2	4.5	6.3	14.0	4.1	3.6	4.1	5.1	0.0	0.7	1.2	0.5	0.6	0.4	0.3	1.1	0.7	0.7	0.9	0.7	0.6	1.5	0.5	1.0	0.5	0.3	0.5	1.2	1.4	1.2	1.6	1.2	1.2	1.4	1.2	1.3	1.1	1.6	1.2	5.6	0.0	3.0	2.0	5.4	4.8	4.6	3.9	4.6	4.0	3.9	2.8	4.2	4.3	3.4	5.5	0.0	5.8	6.6	6.3	3.9	3.5	8.7	2.6	3.5	6.4	5.4	0.8	1.0	6.6	5.7	3.1	1.5	3.2	8.2	3.7	7.1	2.4	5.7	10.1	0.9	4.0	0.0	7.0	3.6	10.9	6.2	3.1	0.0	0.0	5.1	4.6	7.2	2.0	0.7	3.7	5.1	3.0	3.4	3.3	7.3	4.2	1.8	5.0	0.0	4.2	3.5	15.1	7.8	5.0	3.8	4.7	4.0	4.4	3.6	2.9
NAP1L5	DRLM	ENSG00000177432	"Nucleosome assembly protein 1 like 5"	Q96NT1	4	88695913-88697829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 49.6"	"Low region specificity"	"Detected in all"							HPA058227	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA058227: AB_2683644"	"unprognostic (1.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.39e-1)"	9.3	27.7	41.3	4.5	35.7	7.2	5.9	24.1	53.9	7.0	11.6	5.7	2.1	7.9	12.9	4.8	5.8	6.7	7.3	34.1	72.9	7.5	6.2	3.6	3.8	38.0	49.1	9.9	3.3	9.0	23.0	6.0	55.3	8.1	3.5	21.0	2.8	10.4	2.8	2.1	2.8	8.0	25.5	4.4	3.9	6.2	37.6	3.8	11.6	4.0	2.7	7.6	3.5	26.7	0.0	1.9	12.4	7.6	17.7	11.3	0.0	13.5	8.2	6.8	10.5	0.0	1.6	0.0	5.4	7.9	3.0	2.6	22.2	5.4	12.2	4.3	0.0	23.8	7.9	1.9	15.4	12.4	15.0	18.0	1.7	8.0	1.2	8.7	12.2	13.1	6.8	0.1	20.1	0.2	15.3	0.9	5.1	6.6	0.0	8.2	3.6	1.4	4.5	5.7	16.4	49.6	0.0	2.4	10.4	13.2	0.0	3.5	8.8	7.7	1.9	4.9	6.8	3.4	0.0	0.0	16.4	0.0	6.1	0.0	0.1	0.1	1.4	0.1	0.9	0.0	0.6	1.0	0.3	0.2	1.2	1.1	0.2	0.5	0.3	0.3	0.7	0.3	41.3	35.7	24.1	53.9	34.1	72.9	38.0	49.1	55.3	25.5	37.6	26.7	6.4	3.2	6.7	8.5	4.2	1.8	3.8	2.2	5.2	32.4	3.0	5.2	5.3	1.5	4.7	5.5	14.6	16.0	12.2	0.6	15.6	1.8	1.0	2.8	13.0	7.2	17.3	10.5	21.2	2.6	2.2	12.8	4.6	3.3	31.1	5.6	16.8	3.0	5.6	15.2	30.8	2.2	2.0	0.9	3.1	0.7	10.8	2.9	5.4	3.7	1.8	36.8	8.2	5.5	7.6	1.0	1.3	18.0	4.3	2.0	0.1	5.9	1.4	16.1	19.7	9.2	14.5	8.6	3.0	2.2	1.4	22.2	9.0	16.3	0.9	2.2
NAPEPLD	"C7orf18, FMP30, NAPE-PLD"	ENSG00000161048	"N-acyl phosphatidylethanolamine phospholipase D"	Q6IQ20	7	103099776-103149560	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 128.0;Excitatory neurons: 99.2;Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 193.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019832, HPA024338"	Approved		Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA019832: AB_1844422, HPA024338: AB_2671533"	"unprognostic (3.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.32e-6)"	"unprognostic (8.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.41e-2)"	2.0	4.6	1.6	3.6	3.7	2.0	1.7	1.5	4.2	3.6	0.0	7.7	14.5	3.6	2.2	1.9	5.3	5.9	4.0	1.7	0.0	14.9	7.4	3.0	3.3	0.4	1.1	8.6	3.5	6.0	1.5	2.2	0.8	4.5	7.5	4.8	1.7	3.4	2.4	3.1	9.7	3.0	0.5	6.4	9.9	6.7	2.5	3.0	8.2	2.4	2.7	3.5	1.8	9.2	6.9	7.4	5.1	4.3	4.9	4.9	0.9	5.4	3.1	1.6	3.3	2.7	6.3	5.2	7.7	1.7	6.3	5.6	3.3	0.5	3.8	6.9	6.0	1.9	4.1	1.5	1.1	3.3	2.2	2.8	0.9	1.6	0.0	12.5	3.5	3.5	2.0	4.8	5.0	2.2	5.1	2.4	4.7	9.4	9.7	3.6	2.8	1.9	10.5	2.9	3.8	4.6	10.7	3.7	2.7	3.1	2.4	4.4	4.6	7.7	4.0	17.8	4.9	6.8	8.6	3.7	7.6	2.9	14.8	0.1	1.9	3.7	2.7	2.9	2.3	4.6	3.1	3.4	2.1	4.5	4.4	3.2	0.2	1.5	1.9	1.7	2.9	1.4	1.6	3.7	1.5	4.2	1.7	0.0	0.4	1.1	0.8	0.5	2.5	9.2	4.6	19.2	10.0	38.8	13.2	6.6	5.5	5.3	9.6	78.1	5.7	5.0	12.3	17.2	6.8	53.3	52.1	8.1	5.6	37.5	9.8	5.3	128.0	27.5	10.7	5.2	13.8	36.6	99.2	2.6	4.0	7.3	41.3	42.9	4.5	12.0	4.6	19.1	3.9	50.5	56.7	27.0	4.1	5.5	1.8	43.8	31.7	4.4	14.2	21.5	7.2	16.1	18.6	126.7	193.3	5.0	28.7	33.4	10.6	6.5	46.5	32.6	3.0	35.4	6.6	7.8	6.3	21.1	12.2	3.1	2.8	2.9	8.1	18.9	26.8	7.8
NAV3	"KIAA0938, POMFIL1"	ENSG00000067798	"Neuron navigator 3"	Q8IVL0	12	77324641-78213010	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.3;ovary: 18.3"	"Group enriched"	"Detected in many"	6	"Astrocytes: 882.1;Excitatory neurons: 1473.6;Inhibitory neurons: 753.8;Microglial cells: 534.0;Oligodendrocyte precursor cells: 786.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"amygdala: 9.7;basal ganglia: 15.0;cerebral cortex: 17.3;hippocampal formation: 13.6;white matter: 10.3"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 47.0;THP-1: 41.8;U-138 MG: 30.8;WM-115: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032111, HPA061392"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane"	Cytosol	"HPA032111: AB_10603881, HPA061392: "	"unprognostic (3.51e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.68e-7)"	"unprognostic (6.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.29e-3)"	3.8	4.8	9.7	1.0	15.0	0.5	4.0	0.9	17.3	1.2	0.0	1.7	0.3	2.0	2.9	1.9	2.2	5.1	1.9	13.6	0.0	0.4	1.0	3.3	0.6	0.7	0.4	18.3	0.5	0.4	3.1	2.2	0.0	2.1	0.8	5.2	0.9	2.5	1.3	2.6	0.6	2.5	1.4	8.0	0.8	2.8	1.6	1.9	1.2	3.4	0.4	3.3	1.7	10.3	3.5	8.7	0.6	0.2	8.5	18.1	0.3	26.5	20.9	10.7	5.3	1.7	0.6	0.2	1.9	22.0	7.2	2.5	7.8	4.0	19.3	0.1	0.2	0.2	3.9	0.2	6.7	0.1	0.2	6.2	0.2	47.0	11.1	9.3	16.4	0.1	0.0	0.1	26.2	0.5	0.2	12.0	2.7	0.3	2.1	1.0	2.1	0.0	1.7	0.1	0.6	0.0	1.6	0.3	3.5	0.8	0.1	41.8	14.1	30.8	8.1	12.0	18.2	1.2	0.0	0.7	8.8	0.5	38.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.7	15.0	0.9	17.3	13.6	0.0	0.7	0.4	0.0	1.4	1.6	10.3	11.1	19.2	10.0	882.1	0.0	3.6	8.4	0.2	0.0	5.0	3.8	3.8	3.4	0.0	7.5	0.0	0.0	0.1	0.0	0.2	0.0	4.2	10.4	4.2	8.2	5.6	16.4	0.0	1473.6	1.6	0.1	18.7	0.5	10.3	11.4	0.8	3.9	0.0	7.3	50.5	753.8	0.0	0.0	0.0	3.7	4.7	23.9	1.4	12.4	534.0	0.1	18.3	0.0	786.1	144.1	19.2	0.0	7.5	1.2	18.0	0.0	0.3	8.7	2.0	0.0	28.8	5.3	0.3	0.8	0.2	1.4	0.3	1.3	73.7	0.0	2.9
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591756-156609507	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"	"Lipid transport, Transport"	Isomerase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 136.7;Distal tubular cells: 201.5;Ductal cells: 112.8;Exocrine glandular cells: 100.1;Proximal tubular cells: 219.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		3300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	47.1	74.8	61.0	20.9	63.7	22.2	47.9	66.1	69.6	56.8	71.1	62.9	45.5	68.8	88.7	58.0	59.5	26.5	111.1	60.9	64.3	83.8	86.5	43.6	27.0	62.7	64.8	46.5	69.7	104.7	70.0	23.7	61.8	62.5	41.6	17.4	53.9	48.3	71.8	55.8	48.3	39.7	64.7	43.2	67.5	40.8	63.5	30.6	59.8	68.2	34.3	55.0	47.8	70.5	114.2	155.4	43.9	84.4	64.0	43.8	55.5	29.5	62.3	69.5	72.6	130.6	76.8	62.4	113.4	52.5	55.9	111.1	49.4	99.0	47.5	81.2	98.5	58.1	76.2	86.1	75.1	60.0	60.9	44.2	123.7	87.9	81.9	53.4	95.4	104.7	54.7	70.1	71.6	209.6	83.3	98.0	43.1	158.1	118.2	87.7	40.2	212.6	93.0	93.6	114.7	102.9	90.4	172.4	141.6	66.4	178.3	117.5	51.1	45.1	64.8	64.6	70.6	180.1	110.3	53.0	63.1	37.0	70.4	25.4	96.3	52.9	121.2	111.3	121.3	236.2	109.4	124.3	89.1	186.5	122.8	114.9	11.4	141.3	89.1	225.7	110.1	186.6	61.0	63.7	66.1	69.6	60.9	64.3	62.7	64.8	61.8	64.7	63.5	70.5	29.5	41.7	32.9	0.0	14.8	0.0	0.0	0.0	0.0	0.0	87.5	96.0	0.0	0.0	23.5	68.0	0.0	136.7	28.7	0.0	201.5	112.8	0.0	27.3	29.9	18.4	0.0	0.0	0.0	100.1	43.1	27.2	0.0	32.0	5.1	53.5	0.0	0.0	92.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	40.8	0.0	0.0	0.0	0.0	91.0	0.0	0.0	6.2	0.0	0.0	219.6	11.7	0.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	81.3	13.4	48.1	0.0	0.0
NBEAL1	"ALS2CR16, ALS2CR17, MGC164581"	ENSG00000144426	"Neurobeachin like 1"	Q6ZS30	2	203014879-203226378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 1030.4;Langerhans cells: 1016.1;Suprabasal keratinocytes: 1304.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049189, HPA049447"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049189: AB_2680669, HPA049447: AB_2680771"	"unprognostic (3.66e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.59e-2)"	3.0	2.1	1.5	1.7	3.3	1.1	3.3	4.1	1.9	2.7	8.5	6.9	4.6	2.6	2.1	2.1	3.4	3.1	2.6	1.2	2.2	6.5	5.7	4.4	1.1	2.7	2.2	3.7	2.9	2.9	0.9	2.8	2.7	2.2	6.7	3.9	1.7	1.8	1.5	2.2	5.5	2.7	1.6	1.7	7.1	3.6	2.6	1.3	4.6	3.9	1.3	2.9	1.7	3.6	4.2	3.9	1.6	1.4	9.7	7.5	2.3	4.0	2.9	2.1	3.2	4.4	2.1	0.9	3.2	6.8	4.1	3.4	3.2	4.7	4.8	1.9	1.4	1.6	6.0	2.5	2.3	1.5	1.8	2.9	3.0	3.4	4.2	5.0	3.3	1.7	2.9	1.4	4.8	2.9	0.6	0.8	0.8	1.8	3.6	0.7	2.6	1.0	5.8	7.8	1.0	0.8	3.4	2.5	2.5	3.9	2.9	1.5	5.7	5.5	4.6	2.6	1.8	2.4	1.9	1.2	3.3	0.6	1.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	1.5	3.3	4.1	1.9	1.2	2.2	2.7	2.2	2.7	1.6	2.6	3.6	53.0	38.5	72.2	103.5	145.5	1030.4	399.8	231.1	117.8	18.4	81.2	89.2	21.4	223.1	94.4	38.6	27.1	205.9	58.8	173.8	84.1	57.4	30.9	57.8	73.5	155.1	293.5	49.0	88.0	99.2	276.5	154.4	103.9	69.3	107.2	43.3	287.0	203.7	154.5	82.4	79.7	515.3	91.6	531.4	1016.1	49.5	274.3	78.0	629.7	81.5	186.0	19.5	171.9	105.1	130.9	78.5	335.8	129.4	52.4	304.8	343.9	103.1	59.2	26.9	118.3	388.6	265.6	45.1	41.2	118.4	1304.2	229.3	182.3	31.4	528.3	305.2
NBPF1	"FLJ20719, KIAA1693"	ENSG00000219481	"NBPF member 1"	Q3BBV0	1	16562319-16613562	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 73.8;Distal enterocytes: 66.4;Oligodendrocyte precursor cells: 68.3;Oligodendrocytes: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (8.16e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.15e-5)"	"unprognostic (2.16e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-1)"	8.8	32.6	4.0	2.5	5.1	2.0	9.5	5.0	4.3	16.4	2.7	14.9	3.5	10.6	2.5	6.4	10.7	3.3	6.1	3.2	4.5	9.0	8.2	6.2	1.3	5.3	4.8	18.1	7.4	6.0	9.0	4.6	5.1	9.9	5.3	2.9	9.3	4.2	5.5	7.2	13.6	5.7	4.6	8.2	8.8	23.0	5.0	1.7	7.2	2.6	1.8	13.6	11.0	6.0	6.1	8.6	8.4	5.1	2.3	2.7	1.5	4.1	5.4	7.7	6.8	3.1	2.4	4.8	1.2	11.7	3.0	5.5	3.9	2.5	8.9	3.0	4.5	1.5	3.0	3.0	3.7	2.4	3.6	2.9	3.1	11.1	3.2	4.0	3.5	10.9	5.2	2.6	3.0	4.7	10.5	1.8	1.6	1.1	16.3	8.9	4.6	0.5	2.2	1.2	10.4	10.3	10.6	4.3	5.8	2.4	6.6	1.7	4.1	6.7	3.6	9.2	3.6	1.3	6.7	2.7	1.5	3.5	2.8	0.1	0.1	1.3	0.3	0.2	0.4	0.3	0.3	0.4	0.1	0.5	0.3	0.4	0.0	0.1	0.3	0.2	0.0	0.1	4.0	5.1	5.0	4.3	3.2	4.5	5.3	4.8	5.1	4.6	5.0	6.0	5.2	16.0	14.8	73.8	5.7	8.2	3.0	10.9	29.0	7.5	8.4	8.6	14.5	8.6	11.6	11.0	8.4	6.3	3.5	66.4	3.9	5.5	10.4	4.4	8.2	10.2	3.0	5.9	33.6	3.5	7.9	19.7	12.2	3.1	6.3	17.1	3.6	6.1	12.8	10.1	52.1	25.4	12.2	6.6	15.9	6.9	6.8	7.1	8.8	47.8	4.4	5.0	9.2	68.3	87.9	6.1	19.3	7.2	5.3	3.8	24.0	10.8	15.5	6.5	6.6	7.9	10.0	52.5	24.3	14.7	7.7	3.1	4.0	43.2	15.2	3.1
NBPF10	AG1	ENSG00000271425	"NBPF member 10"		1	146064711-146229000	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 46.1;Basal keratinocytes: 57.0;Langerhans cells: 100.9;Suprabasal keratinocytes: 105.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.05e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.64e-5)"	"unprognostic (1.60e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.68e-2)"	3.7	1.1	3.4	2.8	2.8	7.6	4.3	2.2	6.4	4.9	7.4	2.8	1.1	3.5	3.8	2.8	3.0	2.2	1.3	3.6	2.2	1.9	3.2	3.3	2.5	3.8	3.1	5.4	3.3	3.2	0.3	2.5	2.9	2.7	2.8	4.6	2.0	3.0	1.0	7.4	1.2	3.4	1.7	4.4	1.8	3.3	4.5	2.7	2.3	2.2	2.4	2.2	1.4	4.1	6.4	1.7	3.6	2.4	11.3	13.6	3.0	3.3	4.5	3.3	3.3	1.5	3.0	2.7	0.7	6.4	3.2	3.0	4.0	4.5	6.7	3.4	3.0	6.3	5.0	0.8	4.5	2.7	1.9	12.4	4.1	9.2	8.8	10.6	3.9	1.7	2.0	8.7	7.1	7.3	1.1	2.4	1.5	1.6	4.7	1.4	2.6	3.6	2.3	4.5	0.4	0.4	5.1	4.9	1.8	5.8	4.2	3.6	12.3	3.2	2.9	2.9	4.4	5.8	2.3	3.4	2.9	2.9	2.7	2.2	2.0	2.7	0.3	1.0	0.4	1.5	0.3	0.3	0.8	1.5	0.3	0.2	5.6	0.3	2.3	2.2	0.3	0.1	3.4	2.8	2.2	6.4	3.6	2.2	3.8	3.1	2.9	1.7	4.5	4.1	0.5	76.9	46.1	13.7	12.8	57.0	4.9	15.4	5.2	0.5	3.7	2.0	8.4	2.8	22.0	0.0	0.0	0.7	9.2	1.5	0.0	5.3	15.1	2.8	2.8	3.4	0.0	10.5	0.8	2.7	5.0	18.2	3.1	6.1	20.2	6.4	0.7	1.8	1.4	0.0	1.1	2.7	14.2	5.0	100.9	3.3	6.5	17.7	30.2	4.7	14.2	2.0	9.2	5.0	0.1	5.5	25.3	8.2	5.7	2.1	2.2	0.2	19.6	2.0	0.0	7.6	9.9	9.9	5.4	23.8	105.8	0.5	6.6	1.4	3.4	4.5
NBPF11	NBPF24	ENSG00000263956	"NBPF member 11"	Q86T75	1	148102046-148152322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (8.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.78e-2)"	"unprognostic (6.67e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (3.20e-5)"	9.5	7.6	4.0	5.7	5.0	7.6	9.5	4.1	5.4	11.7	4.6	8.5	4.2	9.5	17.0	6.5	10.3	3.8	5.6	3.9	4.0	7.3	18.1	7.0	7.5	6.1	4.6	11.6	12.1	7.7	7.8	4.6	6.0	9.8	5.7	7.2	8.8	7.0	3.3	12.3	10.6	6.5	4.8	12.6	12.0	6.6	5.1	6.1	9.8	1.5	7.7	9.0	8.5	7.1	5.4	4.4	8.6	8.3	5.8	4.7	5.8	4.7	4.5	3.9	4.2	3.4	5.4	9.3	3.7	5.8	3.7	7.1	5.4	1.8	4.8	5.1	5.8	4.2	15.6	3.8	4.1	5.9	14.4	4.1	5.0	5.1	9.8	6.0	3.0	7.9	6.8	0.4	4.0	11.0	6.9	11.0	7.5	12.6	5.6	9.1	4.8	3.6	4.0	10.8	3.4	8.9	7.8	5.3	8.0	11.2	7.7	10.1	7.3	5.0	4.3	7.8	6.1	5.3	4.7	6.3	4.9	3.7	2.9	3.7	0.9	3.0	1.8	0.6	1.3	1.6	1.6	1.1	0.9	2.2	1.6	1.3	0.1	0.5	1.9	1.9	0.6	0.6	4.0	5.0	4.1	5.4	3.9	4.0	6.1	4.6	6.0	4.8	5.1	7.1	6.0	12.8	12.0	19.9	11.9	1.1	2.3	0.3	9.6	4.5	7.8	6.2	6.9	5.7	5.2	3.7	10.4	4.9	9.1	5.5	0.0	3.4	9.7	4.3	4.5	6.9	3.5	8.8	28.1	3.3	4.2	7.0	11.2	7.5	13.9	6.6	7.5	19.1	3.3	5.0	16.8	8.0	0.0	9.6	3.4	1.4	5.3	6.6	7.2	24.4	15.9	3.8	6.2	30.7	29.9	4.1	16.0	2.6	6.9	1.5	4.9	2.7	3.8	6.8	6.6	4.4	5.5	6.9	3.9	8.6	1.4	2.9	8.1	3.3	8.4	1.1
NBPF12	"COAS1, KIAA1245"	ENSG00000268043	"NBPF member 12"	Q5TAG4	1	146938744-146996202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"pancreas: 80.1;stomach 1: 57.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.48e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-2)"	"unprognostic (5.76e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (9.01e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.47e-5)"	10.7	7.8	8.4	9.4	11.1	17.5	10.2	7.5	10.6	11.0	5.9	9.7	8.3	10.8	10.7	7.4	9.9	5.9	5.9	6.8	7.5	7.5	22.3	10.1	11.6	13.2	8.8	12.3	80.1	9.8	10.9	4.8	13.0	9.5	6.5	13.9	9.7	6.7	5.0	10.6	12.3	9.0	7.6	11.7	57.3	9.6	11.7	10.5	11.2	5.4	9.9	9.5	8.6	17.5	8.1	6.2	13.0	11.1	5.7	5.4	8.5	8.3	6.0	5.7	5.6	5.7	7.4	17.9	5.0	6.9	6.2	5.9	9.4	4.5	5.3	6.7	6.5	7.8	16.1	5.0	4.9	5.9	11.0	5.8	8.1	5.4	12.7	7.2	5.1	12.7	12.6	2.8	4.4	11.9	12.8	7.5	7.5	9.7	8.1	12.3	4.8	4.2	4.1	17.3	6.5	13.5	10.7	9.4	5.5	19.2	7.9	17.5	6.2	4.7	8.1	11.6	11.4	10.5	8.2	7.2	5.1	4.0	5.8	2.9	1.0	0.8	1.2	0.4	0.7	1.5	0.8	0.7	0.4	1.3	0.9	0.7	0.2	0.3	0.6	1.0	0.9	0.3	8.4	11.1	7.5	10.6	6.8	7.5	13.2	8.8	13.0	7.6	11.7	17.5	6.3	32.1	24.0	18.6	15.2	3.8	3.0	3.3	11.4	17.0	7.0	4.4	10.9	2.8	7.8	5.5	45.9	4.4	12.9	6.2	0.0	11.8	14.0	2.7	4.0	6.1	10.7	12.8	21.4	8.7	4.7	9.2	6.1	5.2	24.6	4.7	7.9	12.9	3.8	10.1	15.1	9.6	0.0	14.0	6.4	3.8	5.6	11.0	1.8	6.5	16.4	9.4	8.2	24.6	29.3	12.7	15.7	10.5	6.4	1.9	15.9	2.0	6.5	16.7	6.6	6.0	8.6	12.2	6.8	11.4	4.3	1.9	12.1	2.6	10.5	1.5
NBPF14	DJ328E19.C1.1	ENSG00000270629	"NBPF member 14"		1	148531385-148679742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 89.8;Astrocytes: 95.0;Paneth cells: 174.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 128.6"									"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.28e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.92e-3)"	"unprognostic (7.13e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.69e-4)"	"unprognostic (7.23e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.15e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.52e-2)"	31.3	10.3	18.1	26.1	16.8	44.2	26.1	11.0	31.9	21.4	40.8	19.6	9.1	29.4	22.4	24.2	22.5	19.9	9.3	23.5	12.1	13.9	21.2	22.1	22.2	21.2	17.3	45.2	26.9	18.4	3.9	15.7	14.4	19.3	20.1	26.1	16.3	14.7	13.6	51.8	11.3	27.5	10.4	31.9	11.4	23.6	25.1	16.3	16.5	12.2	18.6	16.6	15.7	20.7	80.9	12.9	30.7	21.1	64.1	90.4	14.4	26.5	25.4	16.9	20.2	11.5	21.3	16.0	6.6	32.0	25.1	23.7	20.0	26.4	29.4	29.4	21.3	36.5	47.1	2.3	22.8	30.9	14.9	83.2	23.9	55.7	58.5	97.3	29.2	11.5	13.9	50.8	43.8	44.2	7.8	20.8	13.1	14.8	31.4	11.7	25.4	39.8	17.9	34.0	0.4	0.5	54.4	28.6	15.6	30.2	36.7	26.7	128.6	23.4	23.2	22.9	50.1	41.7	16.2	35.5	39.1	27.0	31.1	11.9	16.2	15.2	2.0	8.3	1.0	11.8	1.5	1.3	4.5	11.3	2.0	1.8	34.9	2.4	15.6	17.7	1.8	1.7	18.1	16.8	11.0	31.9	23.5	12.1	21.2	17.3	14.4	10.4	25.1	20.7	2.9	89.8	83.7	95.0	34.8	2.2	47.3	0.6	10.8	2.0	16.9	9.3	20.2	11.5	15.2	12.9	4.2	1.3	28.1	10.7	0.0	37.4	47.3	11.4	8.5	3.7	3.6	15.5	3.7	16.2	14.0	31.8	6.1	20.0	53.7	21.2	3.3	9.9	13.7	0.0	4.4	7.4	0.0	45.3	3.4	43.8	28.3	49.6	1.8	17.8	61.8	13.3	6.2	28.1	0.7	26.4	174.5	17.0	13.3	22.2	6.9	8.6	9.1	9.8	13.1	14.0	18.1	47.5	13.0	38.2	6.3	1.5	12.4	8.4	21.0	41.3
NBPF15	"MGC8902, NBPF16"	ENSG00000266338	"NBPF member 15"	Q8N660	1	144421386-144461674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 1.3;NK-cells: 1.3;T-cells: 2.5"	"Low cell line specificity"	"Detected in many"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	Microtubules	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.84e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.26e-2)"	17.2	13.9	7.8	10.1	8.0	2.3	18.7	11.3	8.5	21.9	7.2	20.4	3.9	17.4	20.2	13.7	20.0	7.6	13.4	7.6	8.3	17.2	36.5	24.1	16.8	7.4	7.3	21.2	21.3	8.9	17.0	9.8	7.2	18.0	7.8	18.6	14.4	7.4	5.6	15.2	19.3	12.0	6.4	28.9	14.2	6.9	8.4	2.4	25.8	2.9	12.3	15.3	17.2	6.2	13.7	9.3	15.8	29.8	18.2	28.6	19.5	24.6	24.2	15.0	15.2	7.9	14.8	7.0	6.6	18.5	16.9	10.5	17.5	8.0	23.0	23.4	9.6	0.4	23.6	9.6	14.0	0.4	6.5	23.8	13.5	17.7	36.4	20.7	21.1	2.7	3.1	20.5	36.0	29.7	0.3	6.0	6.5	5.0	19.8	6.4	9.2	11.1	16.2	12.4	1.4	35.7	10.5	15.7	17.5	20.1	16.2	5.9	22.6	23.7	15.3	21.0	23.5	18.2	21.0	11.8	0.3	0.7	11.4	0.0	0.2	0.0	0.5	0.0	0.8	1.3	1.5	1.1	0.1	0.9	1.8	0.7	0.1	1.3	0.2	0.0	2.5	0.8	7.8	8.0	11.3	8.5	7.6	8.3	7.4	7.3	7.2	6.4	8.4	6.2	5.9	44.8	20.8	5.9	14.8	2.0	1.5	0.7	22.8	2.7	5.1	3.2	10.3	4.3	12.8	1.8	6.2	1.7	4.9	1.6	0.0	6.4	5.3	2.6	9.6	9.7	6.1	1.7	16.9	4.4	3.2	12.2	11.2	3.8	15.2	5.3	6.1	8.9	1.6	3.3	10.4	3.0	0.0	7.5	1.4	1.4	8.7	8.1	1.8	14.0	6.2	3.1	1.0	7.1	3.4	6.6	23.6	10.5	10.3	1.5	1.4	1.0	5.0	7.1	0.0	3.5	8.7	3.7	1.9	17.6	1.3	0.3	8.4	3.8	5.2	0.4
NBPF19		ENSG00000271383	"NBPF member 19"	A0A087WUL8	1	149475338-149556361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 73.1;Paneth cells: 123.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Microtubules	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (7.92e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.59e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (3.54e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.92e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.61e-2)"	38.1	9.0	11.7	31.4	5.4	55.7	28.7	3.7	35.0	25.8	37.6	19.1	10.6	28.8	24.4	24.6	29.5	16.7	10.2	9.7	3.4	14.3	18.9	27.3	30.2	5.9	10.2	48.8	33.7	17.4	3.8	14.9	8.2	24.8	21.7	57.6	20.6	15.5	15.0	63.4	13.4	30.4	0.4	36.8	13.2	28.6	19.9	33.5	20.7	18.2	26.6	19.1	9.2	7.8	62.9	16.4	33.8	18.0	65.9	55.4	16.0	29.8	22.4	20.2	19.4	14.7	21.9	18.1	7.0	45.4	26.7	27.8	47.8	27.6	30.9	32.6	26.8	51.6	49.1	5.2	13.1	51.9	18.0	38.5	12.1	58.7	73.5	27.6	13.3	25.1	12.7	27.6	43.3	45.9	28.3	31.1	30.7	17.6	25.4	25.5	35.7	29.1	12.5	30.0	2.8	7.1	71.5	23.9	13.0	47.7	44.7	70.4	80.2	40.7	30.5	23.9	46.9	23.1	14.5	54.9	45.6	35.4	12.4	15.1	22.2	7.8	8.9	8.6	6.1	3.3	5.0	3.3	4.4	7.1	6.5	8.6	24.0	9.3	7.1	16.1	2.1	2.4	11.7	5.4	3.7	35.0	9.7	3.4	5.9	10.2	8.2	0.4	19.9	7.8	2.3	51.3	59.2	61.0	12.9	0.0	18.5	0.0	19.4	8.1	13.9	7.6	22.4	2.8	9.9	3.7	27.1	1.5	24.4	2.6	1.9	21.2	57.8	13.9	13.0	2.6	1.2	12.8	7.6	6.2	7.1	14.0	4.6	23.2	20.2	9.2	2.2	7.3	6.6	3.3	6.7	3.1	0.0	40.9	0.0	8.0	32.3	43.8	0.0	12.2	73.1	16.6	36.0	22.1	0.6	10.0	123.8	30.1	17.1	6.8	6.3	0.5	11.7	48.7	19.7	15.9	12.4	30.4	6.2	33.9	0.0	1.4	26.3	2.8	6.0	11.5
NBPF20		ENSG00000162825	"NBPF member 20"	P0DPF2	1	145289900-145405778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in all"	5	"brain: 48.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 30.6;Early spermatids: 25.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Microtubules	"HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (6.25e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.54e-1)"	"unprognostic (4.26e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.45e-4)"	"unprognostic (9.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.70e-1)"	3.7	3.6	10.3	4.3	6.0	4.0	4.2	48.5	8.6	3.7	2.2	3.2	1.8	4.0	4.6	2.3	2.7	3.0	2.1	5.2	4.7	2.7	6.0	3.3	4.3	12.7	41.5	5.1	3.5	6.9	1.9	2.0	15.6	4.1	3.6	9.0	4.6	4.8	3.1	5.8	3.2	4.5	5.2	4.0	2.8	7.9	15.4	5.4	2.7	3.5	4.4	3.2	1.2	9.9	25.7	12.0	3.4	9.8	20.4	35.6	8.5	12.3	2.9	4.1	4.4	13.4	3.0	5.8	4.7	12.0	7.0	7.5	11.9	14.0	11.7	11.9	14.4	3.9	17.6	9.7	4.2	7.1	6.4	10.6	10.4	22.8	18.9	7.7	10.9	3.2	15.5	9.0	17.0	16.0	1.0	3.2	3.2	5.4	19.3	5.8	9.7	3.7	5.9	4.5	6.0	10.6	23.8	12.6	6.6	8.6	9.3	9.2	20.5	20.0	25.5	11.3	27.3	5.2	4.5	13.0	11.3	2.9	3.0	0.5	1.5	0.5	0.9	0.7	0.7	1.3	0.6	0.8	0.4	3.3	0.9	0.7	0.8	2.4	2.0	11.5	0.9	0.4	10.3	6.0	48.5	8.6	5.2	4.7	12.7	41.5	15.6	5.2	15.4	9.9	2.1	22.4	30.6	3.6	3.1	2.9	1.9	2.1	1.2	4.7	3.4	1.8	3.9	1.5	3.0	0.0	18.8	1.3	10.9	1.2	0.0	8.0	25.9	2.4	3.4	4.7	6.1	2.1	6.6	11.2	5.1	7.1	0.5	3.5	7.6	1.6	2.9	16.5	1.8	1.7	3.3	2.4	0.0	4.6	5.8	2.9	5.6	3.3	3.6	1.9	7.5	1.8	2.1	2.0	2.5	11.3	9.8	3.8	3.3	1.5	2.1	0.4	5.4	8.6	0.0	2.6	3.4	11.8	8.1	2.2	3.1	0.7	3.7	1.8	3.3	0.8
NBPF26		ENSG00000273136	"NBPF member 26"		1	120723949-120842110	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 54.5;B-cells: 36.4;Basal squamous epithelial cells: 37.0;Erythroid cells: 55.5;Macrophages: 54.4;Squamous epithelial cells: 106.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.3;monocytes: 7.3"	"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.31e-5)"	"unprognostic (9.78e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.65e-1)"	14.7	7.2	5.4	21.9	5.1	13.2	11.0	7.6	6.3	14.9	13.7	10.2	2.5	15.1	20.1	20.7	11.2	13.3	6.5	3.8	5.8	4.9	10.4	13.3	12.5	5.4	4.4	17.0	8.9	4.3	4.7	8.5	3.6	12.6	9.3	23.1	10.2	8.9	6.4	39.0	8.6	17.3	2.0	13.9	7.5	10.3	8.0	11.9	12.2	5.4	8.5	7.9	11.5	5.8	56.7	0.3	16.4	17.8	18.3	16.9	1.3	19.9	10.1	12.5	12.9	12.2	2.3	4.4	17.2	17.5	21.6	14.4	27.8	28.7	17.4	25.1	1.3	40.1	7.5	4.8	9.1	16.0	11.4	10.2	11.8	31.1	32.6	40.5	0.8	10.5	3.0	30.1	29.5	28.7	4.2	24.6	6.3	2.0	21.5	5.5	15.3	8.2	7.3	19.9	1.5	1.3	22.1	30.5	16.6	19.5	1.0	6.7	17.3	14.0	36.3	43.7	15.7	13.5	4.1	16.2	11.6	23.5	2.2	2.4	5.1	4.6	1.4	2.3	0.7	0.8	1.0	1.2	1.4	2.0	1.0	1.5	13.3	1.3	7.3	1.3	0.5	0.7	5.4	5.1	7.6	6.3	3.8	5.8	5.4	4.4	3.6	2.0	8.0	5.8	0.8	54.5	28.7	3.9	36.4	0.0	2.2	0.0	37.0	0.6	3.9	2.4	2.7	0.0	3.7	0.0	0.0	0.5	4.7	0.6	3.9	4.8	7.6	7.2	4.8	1.4	0.0	55.5	0.4	3.1	2.4	14.9	16.3	7.8	16.4	2.5	1.1	1.4	0.2	0.0	0.3	1.0	0.0	4.4	0.0	0.9	6.5	54.4	0.0	1.0	6.5	0.6	2.1	0.5	0.1	4.0	27.3	4.5	28.0	1.0	1.7	0.7	3.6	2.1	0.0	3.1	6.7	4.9	2.5	106.5	0.0	0.4	21.1	0.9	2.2	0.8
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.1;intestine: 1.2;testis: 3.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;K-562: 10.2;Karpas-707: 3.1;MCF7: 12.6;THP-1: 3.8"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.2	3.1	0.0	12.6	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.0	0.1	3.8	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 2.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.5;HeLa: 1.9;K-562: 11.6;SK-BR-3: 2.4;SK-MEL-30: 1.9"									"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.9	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NBPF9	AE01	ENSG00000269713	"NBPF member 9"	P0DPF3	1	149054027-149103561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Hepatocytes: 28.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 49.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 49.5;monocytes: 14.2"	"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.25e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.42e-6)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.63e-3)"	"unprognostic (8.80e-2)"	15.8	10.5	8.8	11.5	8.6	8.9	13.7	17.3	9.1	16.6	11.4	14.4	6.4	14.2	17.0	9.6	14.6	9.5	10.0	9.0	8.9	11.5	33.8	17.2	13.6	9.6	10.2	14.9	18.6	9.6	13.8	7.5	8.7	12.8	9.0	21.4	10.2	7.2	6.8	12.8	15.2	11.5	7.5	15.5	13.2	10.7	10.6	4.0	25.9	2.6	10.7	12.4	12.5	8.1	50.1	21.4	26.2	35.5	23.0	28.1	20.7	44.7	32.5	23.1	25.0	16.2	21.0	11.9	12.1	23.1	27.8	14.7	18.2	20.9	39.4	30.2	19.1	3.8	41.2	9.7	26.7	5.0	13.8	27.8	15.4	25.4	44.1	42.7	20.5	9.0	14.1	30.1	28.4	38.8	1.4	7.4	9.8	8.8	28.8	13.5	16.3	18.0	18.8	22.9	16.9	34.9	14.8	35.7	19.5	16.0	26.5	9.3	48.6	52.0	15.2	38.2	69.8	36.7	20.8	23.0	18.9	3.2	18.6	49.5	14.2	0.6	0.6	5.1	1.0	2.7	1.8	0.6	1.9	5.5	2.5	1.4	8.2	7.8	2.0	7.7	2.5	1.4	8.8	8.6	17.3	9.1	9.0	8.9	9.6	10.2	8.7	7.5	10.6	8.1	2.5	38.5	16.0	8.5	9.0	5.5	8.7	2.6	2.8	4.8	4.7	2.8	4.2	4.3	12.5	5.5	6.2	2.9	7.2	0.8	0.0	3.4	11.1	8.6	8.7	5.3	1.8	2.1	8.5	2.0	4.0	12.4	4.1	8.8	18.9	7.3	2.2	28.2	3.6	0.0	6.2	1.0	4.1	12.1	17.0	3.8	7.2	12.7	3.6	6.5	14.3	3.7	3.1	7.5	3.2	2.9	7.7	4.1	9.8	3.6	1.6	1.0	6.8	12.0	6.6	7.0	5.2	9.9	4.2	5.9	14.2	1.4	6.3	3.8	1.1	5.9
NCKAP1	"HEM2, Nap1, NAP125"	ENSG00000061676	"NCK associated protein 1"	Q9Y2A7	2	182909115-183038858	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020449	Enhanced		Approved	Cytosol		NA	NA		60000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA020449: AB_1854327"	"unprognostic (7.92e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (5.06e-2)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.61e-2)"	51.5	44.3	48.3	25.6	57.6	1.0	48.7	45.9	58.7	55.0	43.5	59.4	55.9	52.8	52.9	81.3	42.1	42.3	71.8	72.8	47.2	70.6	41.2	40.3	10.3	36.9	46.2	45.0	43.0	88.4	34.0	50.1	41.9	55.4	48.5	58.4	43.2	65.4	89.5	51.1	51.3	74.1	37.9	20.5	57.7	32.1	45.4	15.2	85.4	87.3	24.6	60.8	49.1	44.4	107.1	66.0	99.1	63.6	136.8	132.3	110.2	136.5	123.4	90.6	113.3	102.9	89.2	0.6	89.2	163.1	136.1	99.0	84.6	128.6	150.2	25.7	66.1	23.7	69.4	85.4	140.5	0.2	19.9	99.5	155.4	131.4	213.8	123.7	146.3	6.4	58.7	0.4	173.3	68.5	2.3	0.4	102.1	85.8	112.7	6.9	108.2	0.4	127.9	141.9	72.7	69.3	123.6	97.0	130.0	156.2	52.0	0.7	160.0	153.2	86.1	87.1	84.7	13.4	26.5	0.5	118.6	0.1	79.5	0.4	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	48.3	57.6	45.9	58.7	72.8	47.2	36.9	46.2	41.9	37.9	45.4	44.4	75.3	48.1	47.1	129.9	2.1	87.2	64.7	50.1	38.1	83.9	54.2	39.9	103.9	48.6	57.0	80.9	70.9	33.1	3.7	52.4	27.4	54.3	4.5	56.4	57.9	82.8	50.4	0.8	174.2	62.0	50.2	62.3	49.5	106.6	14.0	43.8	72.8	42.4	5.3	122.8	143.9	58.8	50.8	5.5	23.1	9.0	78.6	4.6	55.2	72.1	0.7	90.7	6.2	136.7	98.8	95.7	69.8	105.3	1.4	116.8	64.3	66.4	40.2	59.9	59.2	86.1	84.1	42.4	28.7	83.6	112.5	52.1	5.5	55.6	55.5	117.3
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671788-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 34.8;lung: 11.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 262.8;Astrocytes: 478.6;Oligodendrocyte precursor cells: 774.6;Oligodendrocytes: 2156.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: AB_2679114"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	1.9	1.0	9.6	0.5	31.3	0.0	3.0	18.6	12.3	1.2	2.5	1.2	2.2	0.4	0.6	4.0	0.4	0.7	2.6	9.5	14.5	4.1	3.9	11.4	1.3	23.4	28.6	2.4	0.9	0.6	0.6	2.6	22.9	0.8	1.0	4.7	2.1	0.3	0.5	2.1	3.2	0.4	10.1	1.7	1.7	1.1	28.6	0.8	1.1	0.6	1.0	0.5	2.0	34.8	0.0	2.2	46.2	0.0	0.1	0.4	0.2	0.7	8.3	0.7	0.8	0.0	0.1	3.6	0.0	0.5	0.5	0.2	0.3	0.7	2.5	0.0	0.3	0.0	7.1	0.0	0.0	0.0	0.0	0.5	3.8	4.4	0.6	7.2	0.8	0.0	0.0	0.0	1.3	0.5	0.0	0.0	1.1	0.3	1.4	0.4	0.0	1.9	1.1	1.1	0.2	1.4	0.0	1.7	2.4	0.4	0.7	0.0	2.4	0.3	0.4	6.7	0.1	0.2	0.0	1.3	0.4	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	31.3	18.6	12.3	9.5	14.5	23.4	28.6	22.9	10.1	28.6	34.8	6.0	262.8	13.3	478.6	0.6	8.9	0.7	1.4	15.4	179.6	14.5	10.8	16.8	0.0	28.6	1.8	41.7	0.1	0.1	5.3	3.9	0.3	6.8	1.1	1.1	2.9	3.6	0.0	16.4	0.2	0.2	6.8	7.7	1.4	1.3	0.0	0.7	6.3	0.6	33.7	41.3	5.4	10.2	7.9	32.2	3.3	26.4	6.2	1.8	147.1	4.1	56.9	0.0	774.6	2156.8	1.0	5.2	7.5	0.0	0.5	20.7	14.0	1.2	7.8	6.6	8.7	24.7	0.1	1.3	15.5	2.8	0.0	0.7	0.0	1.6	1.5
NCOA4	"ARA70, DKFZp762E1112, ELE1, PTC3, RFG"	ENSG00000266412	"Nuclear receptor coactivator 4"	Q13772	10	46005088-46030623	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 476.2;Macrophages: 316.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 251.9;granulocytes: 839.6;monocytes: 363.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051260, HPA065208"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoli	"Golgi apparatus, Cytosol"	"HPA051260: AB_2681412, HPA065208: AB_2685432"	"unprognostic (4.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (8.04e-6)"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	117.1	67.8	45.6	91.5	52.5	189.5	96.9	56.1	50.9	85.1	50.7	110.3	249.7	70.2	74.6	110.3	62.6	87.8	156.8	40.6	55.8	159.7	372.9	108.3	102.6	52.4	53.5	65.5	64.6	97.9	25.2	131.3	53.6	132.2	115.7	33.7	79.2	78.7	163.5	71.1	155.9	98.3	52.6	148.1	90.3	43.6	51.6	124.4	87.0	193.6	150.3	104.6	46.8	60.0	142.7	58.5	68.0	70.4	176.9	159.4	170.3	128.3	204.8	122.1	119.6	91.0	102.3	161.2	149.2	211.2	69.1	141.8	72.6	142.3	137.1	114.4	74.1	108.4	74.3	263.5	124.0	279.9	229.7	156.1	139.2	104.2	175.7	131.6	185.5	79.5	119.7	93.5	171.9	64.0	136.1	104.3	41.4	110.2	34.8	79.5	99.3	96.7	148.9	119.4	68.2	46.1	128.9	146.2	131.5	133.5	105.7	135.3	171.6	75.8	89.9	81.3	87.5	69.3	79.1	156.9	94.6	231.2	41.2	692.1	363.6	611.8	78.9	223.6	86.2	57.6	73.3	74.9	251.9	53.8	78.2	66.4	839.6	119.0	275.3	77.4	92.8	559.4	45.6	52.5	56.1	50.9	40.6	55.8	52.4	53.5	53.6	52.6	51.6	60.0	44.5	51.3	95.2	13.4	44.6	49.5	39.3	126.2	50.7	14.3	49.6	38.5	161.3	45.8	96.2	44.1	29.2	104.7	58.2	108.8	80.3	45.3	105.4	45.1	37.7	52.9	26.9	476.2	17.4	51.8	107.2	45.3	42.3	56.9	195.2	28.2	55.3	166.7	181.4	20.2	20.5	45.4	59.0	254.5	74.2	72.4	37.3	316.1	51.6	16.9	158.4	38.2	44.3	18.6	22.9	47.8	63.9	47.4	37.6	62.0	162.5	128.8	59.7	13.0	13.1	36.7	46.7	24.5	16.5	71.9	56.7	158.2	41.3	60.7	71.3	52.0
NCSTN	"APH2, KIAA0253"	ENSG00000162736	Nicastrin	Q92542	1	160343316-160358952	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021982, HPA054846, HPA070642"	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.75e-9)"	"unprognostic (1.36e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.89e-2)"	51.0	36.6	30.6	42.1	36.1	38.1	43.9	38.5	32.5	52.4	42.0	58.4	80.4	40.3	56.4	35.1	49.7	42.9	50.6	29.9	35.8	59.7	59.3	56.0	38.3	40.0	34.0	51.7	63.8	86.0	30.1	98.7	41.6	45.2	60.9	48.1	60.5	47.3	37.6	38.9	63.5	52.1	37.3	46.2	45.7	41.8	36.4	40.0	63.8	38.4	43.0	45.6	31.5	48.9	52.1	57.4	100.4	82.8	301.0	153.4	108.3	104.0	177.0	95.4	109.9	47.9	140.0	36.6	208.6	209.3	67.1	81.5	47.3	95.9	82.4	56.5	42.3	36.6	70.9	70.0	118.6	82.8	152.0	155.7	92.3	94.3	93.6	207.2	139.9	54.3	66.9	100.2	142.2	34.3	26.8	39.8	82.2	130.6	33.8	35.1	59.9	103.6	130.5	69.9	34.2	75.6	109.1	118.5	70.9	158.0	108.2	186.3	125.5	70.3	46.4	48.8	79.9	130.8	194.4	38.6	106.6	49.8	129.4	71.4	79.0	67.8	27.4	79.0	26.2	31.1	23.5	24.0	75.1	27.8	23.9	23.3	69.2	36.6	79.6	45.1	26.5	52.2	30.6	36.1	38.5	32.5	29.9	35.8	40.0	34.0	41.6	37.3	36.4	48.9	28.0	6.4	9.3	0.0	23.0	10.5	23.8	59.5	15.9	20.0	27.9	23.1	14.6	45.8	42.6	53.3	52.1	107.7	27.8	53.3	7.9	38.9	2.6	19.2	19.7	23.9	20.3	17.2	0.0	27.0	95.7	33.7	17.9	30.2	13.3	25.8	29.6	31.4	58.0	18.5	0.0	31.8	46.8	47.1	18.8	4.7	27.1	33.4	17.8	0.0	31.7	35.0	20.6	0.0	0.0	34.8	33.4	21.1	33.2	15.6	66.1	24.7	28.7	26.3	26.3	23.8	19.6	44.6	35.9	15.5	11.4	147.4	16.5	32.5	29.6	20.5
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687305	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 236.4;Peritubular cells: 207.6;Theca cells: 121.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 55.0;ASC diff: 52.9;HSkMC: 71.3;NTERA-2: 44.0;SuSa: 57.4;U-2 OS: 80.4;U-266/70: 51.7;U-266/84: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA074457: AB_2686691"	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	46.8	49.4	43.3	11.1	40.5	1.2	35.1	26.0	39.7	70.5	30.4	35.9	11.1	63.7	24.0	16.8	47.2	23.8	34.6	36.7	89.6	13.0	4.5	19.6	10.9	36.0	41.3	69.8	11.8	8.7	56.3	32.6	46.2	27.3	10.7	20.8	12.7	39.3	14.7	11.9	20.8	33.5	36.7	19.1	20.3	18.5	69.6	6.8	17.4	22.4	6.6	31.4	40.4	32.3	0.1	0.0	55.0	0.0	52.9	20.1	0.1	35.4	0.0	0.8	9.6	0.0	0.0	0.0	0.1	10.6	8.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	31.8	71.3	0.0	10.2	0.0	0.0	0.0	21.7	1.2	0.0	18.0	0.0	27.6	0.1	44.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.1	0.4	0.0	0.4	0.0	57.4	9.4	0.0	0.0	2.6	80.4	0.0	0.1	51.7	51.7	0.0	5.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	1.5	0.0	0.0	43.3	40.5	26.0	39.7	36.7	89.6	36.0	41.3	46.2	36.7	69.6	32.3	24.1	25.6	11.0	6.8	0.3	13.0	13.8	0.3	27.9	66.0	2.3	19.8	36.8	15.7	1.4	12.9	20.9	1.9	2.9	18.5	23.5	17.9	2.5	1.4	60.8	18.7	6.7	4.2	7.8	10.7	1.4	103.1	4.1	1.1	0.0	83.9	38.9	0.2	7.3	50.5	21.8	4.3	0.0	7.6	13.3	8.6	236.4	2.8	39.2	9.4	0.7	88.7	0.0	9.5	16.4	4.5	2.6	207.6	0.0	6.9	8.1	1.1	4.1	51.0	98.6	91.4	94.0	28.5	21.8	13.4	8.2	2.5	1.4	121.8	7.1	4.1
NDOR1	"bA350O14.9, CIAE1, NR1"	ENSG00000188566	"NADPH dependent diflavin oxidoreductase 1"	Q9UHB4	9	137205685-137217009	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.4;Oligodendrocytes: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024504	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA024504: AB_1854338"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.74e-3)"	6.5	8.2	8.7	9.8	9.6	17.2	6.9	7.9	12.5	8.1	5.4	8.4	9.6	7.8	2.0	8.3	7.9	4.6	6.6	8.3	7.1	9.0	7.1	8.6	11.5	10.7	9.0	7.0	8.9	4.0	8.2	4.0	10.2	9.6	2.9	3.9	8.6	5.2	4.0	9.5	10.6	3.7	7.9	14.2	8.7	10.5	9.9	8.9	10.1	1.5	5.4	7.8	7.2	12.9	14.2	21.2	13.8	21.8	5.7	5.6	42.7	20.4	9.1	19.1	13.0	21.6	16.3	19.9	15.6	7.7	15.3	52.1	10.0	14.3	3.8	25.9	16.3	17.6	59.7	11.6	9.6	19.9	36.2	7.8	9.7	21.6	7.9	5.3	8.9	25.9	29.2	20.6	7.0	25.8	21.0	35.8	22.5	12.9	26.0	38.0	16.5	28.2	6.0	12.4	17.6	17.5	16.8	17.0	10.6	6.1	27.2	22.8	12.0	35.3	22.9	41.7	23.2	12.5	26.8	20.7	15.4	18.1	20.7	1.1	2.1	3.1	1.3	2.2	1.1	0.5	1.2	1.2	1.7	1.0	0.6	0.6	2.9	0.7	1.7	1.1	1.8	1.5	8.7	9.6	7.9	12.5	8.3	7.1	10.7	9.0	10.2	7.9	9.9	12.9	1.4	0.0	2.6	13.4	3.9	0.5	0.7	1.0	5.2	0.4	1.5	1.3	1.6	1.5	1.6	3.7	0.0	4.5	1.4	3.3	1.9	1.1	0.8	1.3	1.9	1.8	2.4	1.3	8.6	1.1	3.5	1.6	5.1	2.1	1.3	2.0	1.1	0.8	2.5	0.0	7.5	1.9	2.0	3.2	1.3	1.1	0.6	2.7	1.8	6.5	5.4	0.1	5.2	3.5	10.5	1.6	1.5	0.4	6.9	0.7	2.6	1.2	0.3	0.9	0.0	0.9	1.4	1.9	1.2	3.2	0.3	3.7	3.8	1.6	2.2	0.8
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.7;granulocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 110.2"									HPA051515	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA051515: AB_2681517"	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	14.9	16.7	11.6	19.6	11.6	53.6	13.3	15.7	14.2	15.7	10.6	13.6	10.7	15.7	11.6	16.8	15.0	15.1	11.4	11.6	11.7	14.4	10.9	17.0	24.6	12.6	11.4	15.8	14.1	18.4	15.8	12.5	11.2	15.6	12.1	14.9	17.7	14.2	8.9	18.8	17.4	15.8	10.4	35.3	13.6	13.6	12.5	31.9	13.3	8.5	23.9	15.3	15.4	11.5	10.0	7.9	16.7	26.2	20.9	23.0	9.1	12.3	24.5	13.4	13.3	4.6	12.4	9.5	7.1	21.8	13.6	11.6	8.1	11.8	9.6	23.4	8.5	9.3	7.0	7.3	36.7	11.8	110.2	22.9	14.5	21.4	22.4	41.1	17.5	17.9	9.2	33.8	16.6	8.1	12.7	13.4	4.5	6.4	36.4	8.5	8.2	5.9	11.5	7.2	5.5	9.0	9.9	23.5	7.5	11.3	18.6	18.6	29.5	6.3	7.8	9.1	8.4	17.4	8.0	11.8	7.2	17.0	5.5	0.7	2.7	1.1	2.7	1.9	3.1	1.2	2.3	2.3	2.0	1.3	2.6	3.4	2.8	1.1	1.7	3.4	1.6	1.8	11.6	11.6	15.7	14.2	11.6	11.7	12.6	11.4	11.2	10.4	12.5	11.5	1.5	0.0	3.0	13.7	5.4	1.3	0.8	0.6	1.2	0.7	4.1	2.3	1.8	0.0	1.8	0.0	0.0	1.4	3.6	4.7	0.0	5.4	7.5	0.8	1.2	1.1	2.4	7.8	7.5	9.6	1.5	1.9	4.6	0.7	14.5	0.3	1.4	4.2	5.2	1.7	7.6	2.6	2.0	8.5	3.1	10.4	0.0	10.8	1.8	2.8	5.4	0.8	0.0	5.0	5.0	7.0	3.2	0.0	10.6	1.3	2.4	7.4	2.7	0.8	0.0	1.4	1.5	2.3	1.7	4.7	1.6	6.2	5.3	0.3	2.2	1.9
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871832-119876662	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3202.9;Distal tubular cells: 2191.3;Proximal tubular cells: 1764.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029768, HPA054359"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Mitochondria	"HPA029768: AB_2673192, HPA054359: AB_2682461"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	260.4	276.7	541.8	179.3	547.2	316.3	275.0	560.4	746.6	226.5	637.9	467.4	387.4	132.4	323.9	145.0	193.2	133.0	983.7	539.2	555.3	495.1	449.6	153.8	186.7	549.0	541.6	149.3	228.5	773.9	121.4	171.4	551.2	185.8	371.3	398.6	280.0	240.2	1381.0	90.8	334.6	180.7	545.6	169.4	297.4	65.8	551.2	273.2	173.3	1367.9	219.4	228.5	90.5	549.6	436.8	561.9	342.0	365.6	466.3	317.8	423.6	346.6	395.9	297.8	368.1	326.5	377.8	385.1	509.4	431.0	514.7	416.5	555.7	392.8	354.6	492.2	751.7	380.6	1110.1	750.5	357.0	575.9	387.2	485.4	577.0	296.5	232.5	413.2	389.1	372.4	230.9	553.4	435.6	965.3	412.5	563.2	489.1	1214.3	988.4	405.3	315.2	1169.8	887.0	765.2	255.9	319.8	714.9	871.1	479.6	476.5	224.2	653.8	395.1	209.4	198.2	422.7	672.5	469.4	798.3	524.9	377.5	719.5	262.1	1064.7	680.6	822.0	486.1	726.1	468.4	560.6	540.8	516.7	745.6	447.7	435.9	523.1	851.5	468.5	815.5	809.1	675.4	780.5	541.8	547.2	560.4	746.6	539.2	555.3	549.0	541.6	551.2	545.6	551.2	549.6	251.9	160.3	188.6	10.7	261.6	213.7	251.4	991.0	194.1	156.2	268.0	322.7	3202.9	511.9	445.8	562.8	79.2	396.5	273.9	1264.2	2191.3	503.6	34.2	332.0	237.9	228.9	459.0	272.3	12.3	512.5	416.1	266.9	322.1	348.9	210.3	177.5	260.3	1022.5	661.7	82.4	14.8	907.2	581.8	413.5	350.6	43.8	294.5	329.3	570.9	14.0	492.3	364.2	277.1	8.0	16.5	506.4	1024.5	285.1	389.2	228.8	1546.3	1764.0	443.2	231.2	216.9	208.4	289.9	50.8	105.2	394.3	249.3	380.6	255.7	126.7	887.7	339.3
NECAP1	DKFZP566B183	ENSG00000089818	"NECAP endocytosis associated 1"	Q8NC96	12	8076939-8097881	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053980, HPA063300"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Vesicles	Cytosol	"HPA053980: AB_2682331, HPA063300: AB_2684981"	"unprognostic (1.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.56e-1)"	"unprognostic (5.79e-3)"	"unprognostic (5.72e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.94e-2)"	11.7	23.7	25.4	11.8	23.2	8.0	13.6	19.3	39.6	14.9	1.0	17.8	15.6	10.2	8.7	12.1	15.5	9.9	12.7	25.5	44.0	15.8	14.4	11.2	8.0	13.0	11.1	16.1	22.3	27.5	24.7	15.9	17.8	15.7	16.9	42.5	15.9	12.4	7.9	9.4	15.6	11.4	13.8	10.1	16.1	13.6	15.2	14.2	12.6	12.2	10.4	16.9	10.1	15.9	20.4	18.8	12.6	17.6	29.6	22.0	28.2	41.8	26.6	36.1	36.2	40.9	23.1	9.2	7.3	20.9	26.2	14.0	35.2	23.1	31.2	28.2	27.4	11.6	21.2	21.4	26.9	10.7	29.2	28.7	26.3	40.4	48.0	27.7	26.2	15.0	27.3	14.8	38.8	25.8	17.3	2.8	35.1	57.2	15.4	6.8	32.0	9.7	24.6	32.0	20.7	14.3	21.3	29.7	15.9	40.7	10.1	8.9	26.6	16.9	33.3	20.3	30.1	9.4	18.4	19.9	30.6	11.7	26.0	28.8	16.6	36.4	10.9	15.7	12.7	9.8	10.3	11.2	11.9	10.2	12.1	11.0	28.7	10.6	22.7	7.2	16.8	13.0	25.4	23.2	19.3	39.6	25.5	44.0	13.0	11.1	17.8	13.8	15.2	15.9	18.9	38.5	24.0	11.4	36.1	25.5	22.0	16.0	25.6	49.0	17.5	10.5	10.4	7.2	18.7	23.9	27.1	14.6	32.9	19.8	25.4	15.3	25.4	11.3	20.9	18.1	16.2	17.0	29.4	16.7	14.5	17.9	17.3	16.1	29.2	33.5	15.4	15.2	13.8	28.6	28.4	16.1	12.2	19.8	39.0	13.7	23.3	22.4	28.4	11.2	14.8	30.7	20.6	14.6	21.3	19.0	16.0	14.7	33.7	21.8	23.9	17.8	13.1	46.3	6.6	17.7	21.3	17.4	22.3	21.0	21.3	22.4	35.6	25.2	14.1	22.0
NECTIN3	"CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3"	ENSG00000177707	"Nectin cell adhesion molecule 3"	Q9NQS3	3	111070071-111275563	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 54.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Syncytiotrophoblasts: 117.3;Theca cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 117.4;TIME: 170.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009869, HPA011038"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		41000000		"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Cell Junctions"	"CAB009869: AB_2284699, HPA011038: AB_1079719"	"unprognostic (3.76e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.77e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.04e-2)"	"prognostic favorable (9.82e-7)"	"unprognostic (2.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.05e-1)"	8.9	4.8	3.9	4.7	6.0	0.2	4.3	6.2	7.5	7.3	0.0	23.0	32.9	7.6	1.5	4.6	9.7	8.2	5.3	6.6	5.0	12.0	29.4	10.4	3.0	10.8	5.6	16.1	7.1	4.6	1.1	22.7	6.7	11.7	23.1	7.3	5.6	8.4	1.7	1.4	21.2	13.6	7.3	3.9	24.6	54.7	12.4	1.5	42.5	7.1	3.1	6.0	3.0	8.8	0.2	36.2	117.4	7.7	45.7	85.3	7.2	78.6	82.7	47.8	39.7	33.4	16.7	0.0	25.4	112.4	26.6	0.6	33.2	11.4	87.4	0.9	8.8	0.1	12.1	2.4	77.2	5.9	1.1	43.6	4.6	31.7	30.3	42.5	40.8	1.5	0.0	30.2	104.2	0.2	7.8	0.0	33.0	11.0	12.9	0.0	58.2	0.2	26.9	19.2	2.9	20.8	1.6	0.0	15.7	38.9	1.3	0.5	170.4	58.8	24.9	11.1	47.2	17.2	0.0	0.2	37.9	0.1	56.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	6.0	6.2	7.5	6.6	5.0	10.8	5.6	6.7	7.3	12.4	8.8	8.3	25.6	11.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	3.1	12.9	0.0	3.9	4.5	0.0	0.0	6.5	0.0	9.0	11.4	4.4	0.0	0.0	0.0	18.9	9.4	9.5	0.0	13.7	1.3	6.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	2.8	0.0	0.0	7.1	0.7	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	117.3	5.3	31.5	0.0	0.0
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"NEDD4 E3 ubiquitin protein ligase"	P46934	15	55826922-55993660	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.6;tongue: 58.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Alveolar cells type 2: 116.7;granulocytes: 73.2;Oligodendrocyte precursor cells: 69.9;Respiratory ciliated cells: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA		6500	"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	6.2	3.6	1.7	4.0	2.0	6.2	6.9	1.9	2.0	5.4	1.9	5.7	4.1	7.1	2.9	4.3	3.5	5.6	4.5	1.5	2.7	6.7	27.4	5.3	3.1	2.5	1.9	4.0	1.8	5.4	2.1	15.6	2.6	5.5	4.4	4.5	3.1	7.6	67.6	9.2	8.1	8.0	2.0	4.9	3.4	1.8	2.2	5.6	7.1	58.1	3.0	5.6	4.4	2.6	21.5	32.8	9.0	8.8	11.5	18.5	14.1	40.0	62.9	29.1	28.5	14.5	6.3	4.8	10.4	15.4	70.2	34.6	9.7	26.3	48.2	11.1	5.6	26.1	7.2	7.9	59.0	10.6	2.3	30.8	64.7	35.2	58.9	14.2	24.3	14.9	11.5	0.0	86.4	10.7	15.2	0.1	2.2	10.9	5.1	10.5	67.5	3.1	11.9	42.3	0.7	5.1	17.4	12.5	15.7	15.8	15.2	8.8	84.5	63.9	20.6	13.5	66.0	3.4	8.1	12.3	42.0	24.6	15.7	0.0	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	1.7	2.0	1.9	2.0	1.5	2.7	2.5	1.9	2.6	2.0	2.2	2.6	35.9	93.0	116.7	28.4	1.6	12.1	3.4	5.5	8.6	0.7	4.6	8.0	5.7	7.2	44.8	0.0	22.9	23.2	2.0	5.2	1.9	3.3	1.7	1.7	13.3	31.1	0.0	17.5	4.2	5.8	7.5	18.5	5.1	1.6	73.2	4.2	17.5	20.5	4.7	0.0	11.9	4.0	2.0	2.2	2.3	1.6	5.6	8.8	1.8	30.0	1.1	8.6	6.2	69.9	28.7	2.9	0.8	7.2	1.9	4.5	25.8	13.4	75.5	6.7	0.0	11.5	17.7	5.3	7.2	7.1	10.4	13.8	9.4	4.8	5.6	1.9
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395943-72282539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 29.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 1968.8;Inhibitory neurons: 1254.4;Oligodendrocyte precursor cells: 726.3;Oligodendrocytes: 442.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.7;TIME: 28.5;U-2 OS: 22.9;U-251 MG: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"		NA	NA		380000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	16.5	5.8	12.8	3.6	15.9	1.2	5.9	4.4	15.7	7.1	0.0	17.5	2.7	5.2	4.1	10.5	7.2	10.7	11.2	15.1	9.1	6.8	0.3	5.5	1.6	1.9	5.6	6.0	4.5	0.7	3.9	2.9	2.7	7.3	7.8	29.8	2.4	5.4	3.3	5.8	5.1	6.4	3.7	0.6	7.4	3.2	12.4	5.6	3.5	5.1	0.8	13.3	6.6	6.5	0.4	0.1	0.8	0.2	26.7	21.0	0.2	19.4	7.2	10.4	12.7	0.1	0.2	0.3	0.1	21.5	0.2	0.6	0.0	0.0	22.4	0.2	0.1	0.1	3.4	0.1	2.2	0.2	0.4	10.2	0.1	8.9	1.5	15.4	12.5	0.3	0.1	0.8	19.5	0.1	0.2	0.2	3.2	0.3	11.0	13.7	20.4	0.3	1.7	0.3	1.5	1.7	6.8	0.1	0.0	0.4	0.1	0.3	28.5	2.3	22.9	0.9	24.5	0.4	0.2	0.1	5.2	13.0	8.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	12.8	15.9	4.4	15.7	15.1	9.1	1.9	5.6	2.7	3.7	12.4	6.5	6.0	0.0	0.5	170.7	0.0	5.0	0.6	0.1	0.0	51.4	0.2	0.5	4.2	1.5	2.5	0.0	27.1	0.0	4.4	0.1	0.0	2.4	6.2	0.1	1.3	2.6	0.0	0.8	1968.8	0.0	0.0	88.7	0.5	0.1	0.0	0.2	0.0	0.0	0.2	1.7	1254.4	0.6	0.0	0.0	16.7	12.5	210.3	2.4	8.8	58.1	3.1	12.2	0.0	726.3	442.7	0.5	0.0	44.8	0.5	1.3	0.0	1.5	7.1	58.7	32.9	8.3	8.5	0.7	2.5	0.3	3.4	0.0	1.1	0.2	0.1	0.7
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"	Q8IXH7	20	58981208-58995133	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262, HPA074936"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	18.9	29.5	20.5	17.7	22.8	23.8	24.5	21.7	23.4	20.7	21.2	18.2	19.3	18.2	16.3	32.9	24.4	16.2	16.9	19.6	21.0	31.7	31.2	14.7	26.4	21.2	20.9	25.2	21.2	30.7	31.8	25.6	21.8	20.4	17.9	31.9	30.0	17.1	29.4	25.9	19.6	14.1	20.8	20.7	19.3	27.9	21.5	31.5	28.5	20.5	27.9	22.6	22.7	24.3	54.7	57.6	68.5	71.9	22.5	38.9	49.6	42.4	38.8	117.1	66.8	189.6	70.7	68.3	64.0	39.8	60.8	89.1	90.1	98.0	94.8	22.4	64.1	90.5	72.4	150.5	26.7	64.2	60.1	40.9	34.3	44.2	32.8	32.8	68.3	54.0	118.1	51.8	53.3	198.2	135.6	95.4	40.3	151.5	122.9	78.4	56.6	121.1	49.0	76.5	75.9	112.6	126.0	148.3	85.9	38.2	157.5	75.0	30.2	91.6	88.8	36.3	67.7	44.4	80.0	71.1	53.7	57.3	80.6	20.0	44.6	22.9	42.0	51.5	50.0	48.6	39.7	51.2	64.9	44.5	37.7	40.1	5.6	47.1	68.8	33.0	39.7	49.0	20.5	22.8	21.7	23.4	19.6	21.0	21.2	20.9	21.8	20.8	21.5	24.3	23.0	9.6	27.6	18.3	50.5	30.2	62.6	43.8	40.9	67.3	32.7	34.2	10.9	47.1	24.3	22.0	41.7	133.1	35.5	14.5	50.9	57.0	18.8	26.2	33.3	26.7	23.4	60.0	23.0	31.4	69.2	26.2	26.5	27.4	16.5	50.9	23.2	24.1	36.9	55.5	22.8	21.9	26.4	15.3	24.0	32.1	37.0	24.0	26.6	10.3	48.1	52.9	49.4	21.1	23.6	34.9	14.4	26.4	37.4	37.8	27.8	49.9	15.0	61.5	39.5	31.6	34.2	63.1	94.9	40.5	31.4	103.0	48.5	43.9	36.2	52.8
NEMF	"FLJ10051, NY-CO-1, SDCCAG1"	ENSG00000165525	"Nuclear export mediator factor"	O60524	14	49782083-49852821	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004160	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		830000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA004160: AB_1079884"	"unprognostic (9.92e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.15e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.81e-2)"	16.5	13.8	9.5	18.0	13.0	42.1	14.7	18.1	14.7	16.2	5.9	13.6	10.0	16.2	13.5	22.5	12.2	13.2	17.7	7.9	10.6	14.9	11.9	13.8	17.9	11.8	11.6	15.2	15.2	24.8	10.3	18.2	11.9	16.0	14.5	14.7	14.6	15.8	23.0	14.3	13.6	15.7	10.9	15.5	14.1	10.7	10.7	16.3	18.5	21.5	17.9	18.0	11.6	18.4	34.3	39.2	35.9	24.1	37.3	31.0	32.1	42.0	28.3	27.6	27.3	23.2	35.3	13.3	32.0	35.7	21.2	47.5	34.1	26.7	42.2	38.9	22.7	38.7	40.3	29.1	23.8	50.7	33.4	26.8	19.6	29.9	27.2	36.3	39.8	23.8	47.3	36.2	37.7	30.6	31.2	17.9	21.9	28.6	36.8	32.6	35.5	20.8	33.7	44.8	23.6	22.2	41.6	40.4	39.2	37.2	37.6	31.1	47.2	39.2	34.4	26.6	28.9	24.5	47.6	40.9	14.7	23.9	35.5	76.4	38.9	45.8	45.7	36.9	44.8	83.7	47.1	44.4	33.9	86.7	55.6	59.1	61.3	47.8	54.4	79.7	46.1	20.3	9.5	13.0	18.1	14.7	7.9	10.6	11.8	11.6	11.9	10.9	10.7	18.4	66.2	41.7	76.7	65.3	81.1	34.4	67.4	81.6	29.6	92.1	31.7	43.1	97.2	34.3	74.4	44.1	100.1	85.8	78.4	51.8	37.2	57.0	13.9	52.2	60.1	65.2	54.0	57.0	75.7	39.1	58.1	53.0	41.8	60.7	89.3	68.0	49.6	28.1	58.9	131.2	80.7	48.9	71.2	48.7	57.0	13.1	65.9	57.9	24.9	62.8	79.4	54.8	82.4	56.8	99.5	46.4	68.5	67.4	50.0	66.1	59.4	29.9	82.4	90.0	72.3	65.7	70.7	83.0	58.3	32.5	34.1	108.4	66.9	64.1	54.6	88.6
NFAM1	CNAIP	ENSG00000235568	"NFAT activating protein with ITAM motif 1"	Q8NET5	22	42380407-42432403	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.9;lymphoid tissue: 19.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 11.4;Hofbauer cells: 17.0;Kupffer cells: 53.9;Macrophages: 27.2;monocytes: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 90.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 90.4;monocytes: 48.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 37.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031812	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA031812: AB_10603121"	"unprognostic (9.77e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	6.3	1.9	1.5	12.4	1.9	30.9	1.1	1.5	2.2	1.8	2.0	1.5	1.3	0.6	0.6	1.3	2.0	2.3	1.3	1.8	2.4	1.2	2.3	7.5	5.5	3.1	2.2	0.3	0.8	0.3	0.6	2.9	2.9	0.9	1.2	0.1	0.8	1.4	0.4	1.4	2.3	2.9	2.3	19.9	1.1	0.7	2.9	2.1	0.7	1.5	2.1	3.1	0.7	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	5.8	0.0	0.0	0.1	0.0	0.4	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.3	48.2	2.8	0.1	32.5	0.2	0.0	0.1	0.0	16.5	0.1	0.0	0.0	90.4	0.0	31.1	0.3	0.0	25.4	1.5	1.9	1.5	2.2	1.8	2.4	3.1	2.2	2.9	2.3	2.9	3.0	0.4	0.0	3.7	0.0	0.5	0.9	0.7	0.9	0.6	0.2	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.8	0.4	0.2	0.5	1.2	0.0	0.7	0.2	0.1	0.5	0.0	0.3	11.4	0.0	0.7	0.6	17.0	0.0	0.6	0.0	0.0	53.9	8.2	5.6	0.3	27.2	0.0	8.4	44.6	0.0	0.0	2.0	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.5	0.5	0.8	0.7	0.0	1.0	0.3	1.3	0.4	0.0	0.5
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061545	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1357.5;tongue: 858.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063384: AB_2684998, HPA065424: AB_2685488"	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	154.3	130.5	109.3	75.0	99.3	31.1	91.1	101.6	98.3	103.5	225.0	107.6	106.0	149.4	88.2	126.0	130.6	97.3	430.8	112.4	146.3	159.6	104.0	83.3	63.8	135.0	131.1	148.8	65.2	115.2	82.5	100.6	131.0	95.7	80.1	67.1	92.1	123.5	1357.5	121.1	113.3	141.0	116.3	113.0	79.0	69.3	126.8	62.3	132.6	858.4	59.2	89.7	86.3	138.2	122.2	265.4	172.0	147.4	349.8	168.2	128.6	193.7	269.2	135.1	149.8	327.6	137.6	139.8	379.2	244.6	175.2	245.5	122.5	154.5	144.7	239.9	104.1	78.8	181.0	111.1	418.6	178.0	122.1	232.6	380.7	246.7	267.2	228.7	214.6	93.5	142.5	377.4	169.4	103.3	115.5	56.0	113.0	110.0	101.4	80.1	241.8	136.4	150.0	181.0	105.8	160.2	132.4	89.0	272.4	222.5	175.7	120.5	291.2	324.2	141.4	112.3	197.4	626.6	460.1	134.1	310.4	73.6	191.3	14.2	11.8	4.0	3.4	6.5	2.0	5.2	3.1	3.5	2.6	4.9	2.4	2.7	26.1	3.0	8.7	12.9	1.2	1.3	109.3	99.3	101.6	98.3	112.4	146.3	135.0	131.1	131.0	116.3	126.8	138.2	60.1	57.7	49.4	25.1	15.8	55.7	19.3	45.0	34.1	68.8	39.2	33.8	303.1	50.1	34.4	77.3	35.5	22.7	14.7	150.7	25.4	41.3	8.1	57.9	92.0	66.3	30.1	11.6	24.5	36.2	21.5	47.9	27.5	58.8	28.4	89.3	80.3	126.7	36.0	72.3	28.0	51.5	38.7	32.8	18.9	10.6	102.2	23.8	21.4	20.6	31.5	25.4	15.5	9.0	14.4	51.8	64.8	83.8	17.4	33.8	100.3	39.1	49.5	34.8	59.2	39.3	53.8	30.0	35.5	25.9	48.4	22.3	14.2	44.6	49.4	24.4
NFKB2	"LYT-10, NF-kB2, p105, p49/p100, p52"	ENSG00000077150	"Nuclear factor kappa B subunit 2"	Q00653	10	102394110-102402524	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 168.0;Karpas-707: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008422, CAB022098, HPA023900"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435"	"unprognostic (1.10e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.98e-2)"	"prognostic favorable (8.45e-5)"	"unprognostic (4.04e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.69e-12)"	"unprognostic (2.37e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.56e-1)"	26.5	21.0	7.6	44.4	7.4	69.3	19.6	7.1	9.2	22.9	8.5	39.1	15.5	21.6	2.3	17.7	20.4	18.5	20.6	7.2	7.2	34.6	28.2	41.0	40.7	8.5	7.5	21.4	24.1	6.1	10.8	14.7	8.0	29.0	6.8	1.1	21.3	9.1	18.4	20.0	26.5	12.2	7.5	50.6	22.7	10.0	8.4	16.9	20.1	7.6	25.7	37.0	19.1	8.0	67.9	48.6	7.7	31.7	11.1	16.6	19.3	18.5	61.0	19.6	25.9	28.6	55.2	32.9	43.5	11.9	48.8	40.9	20.5	28.2	6.8	168.0	11.2	7.0	11.7	15.9	30.1	5.1	45.5	22.0	14.6	34.1	32.3	26.5	7.8	16.1	7.6	157.8	7.4	26.4	7.1	22.7	10.3	15.7	16.6	16.8	24.5	27.0	34.3	22.1	1.7	8.2	16.2	36.7	26.3	7.2	29.3	16.4	21.2	19.0	28.9	25.4	47.0	113.1	105.0	32.6	31.1	14.8	10.9	0.0	1.3	0.0	0.7	0.9	0.7	2.6	0.8	0.7	0.7	2.1	0.8	0.8	5.6	0.8	2.1	0.6	1.1	0.5	7.6	7.4	7.1	9.2	7.2	7.2	8.5	7.5	8.0	7.5	8.4	8.0	20.8	9.6	8.8	3.3	88.3	43.5	59.3	41.2	34.7	2.2	17.1	14.5	3.1	25.8	29.9	18.4	16.7	6.3	39.0	33.3	5.9	33.2	1.1	33.7	14.4	26.1	16.3	0.4	0.1	21.0	15.8	26.0	80.0	52.0	71.8	5.5	11.7	3.7	20.9	0.0	0.1	30.4	22.4	19.4	122.9	1.7	7.5	52.5	30.2	1.9	75.1	3.9	12.3	1.5	0.7	44.9	37.4	4.9	49.1	49.3	33.2	8.6	19.9	5.3	0.0	36.4	43.6	4.7	11.1	17.5	44.6	23.1	54.6	8.8	17.9	45.6
NFKBIB	"IKBB, TRIP9"	ENSG00000104825	"NFKB inhibitor beta"	Q15653	19	38899700-38908893	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 76.4"	"Group enriched"	"Detected in all"	15	"Early spermatids: 892.6;Late spermatids: 1179.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063734			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA063734: AB_2685107"	"unprognostic (2.73e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.50e-3)"	12.6	12.7	3.8	5.2	5.1	10.8	11.7	4.3	3.9	9.3	2.4	12.5	4.2	10.6	0.5	16.0	9.9	1.1	16.7	2.9	3.7	10.6	22.5	13.1	3.6	4.6	4.5	8.0	11.1	1.8	7.7	1.8	4.2	9.8	1.1	1.0	11.8	1.9	30.5	15.6	12.8	0.9	4.0	13.5	13.9	76.4	4.7	2.0	9.7	1.5	1.7	13.5	10.5	5.3	13.7	16.9	2.4	6.2	2.4	1.4	7.8	9.0	3.5	4.7	5.4	11.7	7.2	15.0	9.8	2.0	4.5	7.6	6.2	4.4	1.6	46.2	7.8	10.1	3.0	6.7	8.2	11.7	20.6	1.9	4.9	5.2	6.6	1.3	2.7	10.9	12.0	13.4	1.8	8.7	14.3	11.1	8.2	11.6	7.0	20.0	10.1	14.1	2.3	5.4	14.1	8.6	5.7	8.1	6.7	1.4	5.0	9.8	6.5	8.1	10.5	14.0	14.0	27.5	26.4	32.8	5.2	12.1	10.1	1.2	3.3	10.4	4.0	4.9	3.1	2.9	2.3	3.4	3.0	2.6	1.7	2.5	7.4	7.1	4.2	4.3	5.9	2.5	3.8	5.1	4.3	3.9	2.9	3.7	4.6	4.5	4.2	4.0	4.7	5.3	17.5	9.6	24.3	3.3	34.6	31.6	40.2	25.8	37.0	11.9	17.8	12.6	6.7	11.5	16.6	12.9	4.2	27.0	48.1	56.9	7.9	33.2	892.6	23.7	19.9	23.4	22.1	14.5	4.4	31.0	25.7	19.8	59.1	43.8	66.7	7.6	10.4	21.3	24.6	25.2	5.0	31.1	16.2	17.9	29.9	1179.8	13.7	30.0	17.8	3.7	29.1	16.6	33.0	4.0	8.9	52.4	36.6	15.1	50.2	43.3	49.1	26.3	10.5	12.1	19.7	27.8	28.8	21.3	16.5	33.4	24.2	59.1	38.4	9.5	28.4	38.7
NGEF	ARHGEF27	ENSG00000066248	"Neuronal guanine nucleotide exchange factor"	Q8N5V2	2	232878701-233013256	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 56.2;brain: 129.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.0;Excitatory neurons: 105.9;Proximal enterocytes: 66.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 129.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 53.9;HDLM-2: 45.3;HeLa: 21.6;PC-3: 57.0;T-47d: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 167.6;cerebral cortex: 133.8;hippocampal formation: 73.0"	HPA008160	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA008160: AB_1854450"	"unprognostic (3.92e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.39e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.74e-1)"	1.1	56.2	16.3	2.2	129.6	0.1	1.9	0.0	59.4	4.1	0.0	14.2	42.7	5.0	4.1	10.3	4.8	3.1	2.2	19.8	0.0	7.0	35.5	0.7	0.2	0.0	0.0	2.0	6.0	11.9	2.7	0.3	0.0	1.8	10.5	1.4	2.0	0.7	0.9	30.3	31.3	6.7	0.0	0.4	10.7	3.7	0.2	0.0	0.9	0.7	0.3	1.8	5.2	29.4	53.9	15.4	0.6	0.2	0.2	8.2	0.9	0.9	0.1	0.4	0.0	0.7	5.2	0.0	15.2	10.9	5.5	6.9	11.6	3.0	0.4	45.3	3.8	0.1	21.6	16.7	0.2	0.0	0.3	0.0	0.2	3.5	0.6	0.2	1.9	0.2	0.2	0.2	0.5	4.0	0.0	0.1	1.3	0.2	57.0	0.0	0.0	0.1	1.0	1.4	1.9	0.4	6.6	3.3	0.1	2.0	32.2	0.4	0.0	0.5	4.5	0.3	1.0	0.5	0.2	0.0	3.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	129.6	0.0	59.4	19.8	0.0	0.0	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	10.4	0.0	9.9	1.2	1.2	2.8	0.3	2.1	1.4	2.4	4.3	0.5	0.0	0.0	0.1	0.0	38.0	0.0	3.9	0.7	9.1	0.9	0.4	4.9	0.0	105.9	10.5	0.3	0.7	17.3	2.0	0.0	0.3	0.4	20.4	0.1	1.7	12.8	14.6	0.0	0.3	0.6	2.0	0.0	0.3	1.8	6.5	0.0	5.5	0.0	4.5	6.0	12.1	23.5	1.2	0.1	0.5	66.7	9.8	2.5	0.2	0.0	0.2	0.3	1.1	0.8	3.8	7.5	0.0	0.2	0.5	20.2	1.1
NIBAN3	"BCNP1, FAM129C, FLJ39802"	ENSG00000167483	"Niban apoptosis regulator 3"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"bone marrow: 15.4;intestine: 16.6;lymphoid tissue: 34.7"	"Cell type enriched"	"Detected in some"	8	"B-cells: 11.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7"	"Group enriched"	"Detected in many"	476	"B-cells: 52.1;dendritic cells: 110.7"	"Group enriched"	"Detected in some"	19	"Daudi: 50.1;REH: 23.8;U-698: 33.2"	"Not detected"	"Not detected"							HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.4	0.0	0.0	10.7	0.1	15.4	0.1	0.0	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.4	0.1	1.0	0.1	0.0	0.0	0.5	0.3	0.4	26.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	16.6	0.0	0.0	34.7	0.7	0.5	0.0	1.8	0.6	0.0	12.2	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	52.1	0.0	0.1	0.0	0.0	0.0	110.7	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NIM1K	"MGC42105, NIM1"	ENSG00000177453	"NIM1 serine/threonine protein kinase"	Q8IY84	5	43192071-43280850	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 13.7;choroid plexus: 7.9;pituitary gland: 6.5;retina: 10.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 29.7;Excitatory neurons: 56.0;Horizontal cells: 18.5;Inhibitory neurons: 44.2;Oligodendrocyte precursor cells: 43.7;Oligodendrocytes: 20.3"	"Cancer enriched"	"Detected in some"	11	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HDLM-2: 2.3;PC-3: 2.5;U-87 MG: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007695			Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA007695: AB_2667897"	"unprognostic (7.97e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.84e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-5)"	"unprognostic (2.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.46e-3)"	"unprognostic (4.98e-3)"	0.4	1.2	11.9	0.4	12.5	0.0	0.4	8.9	13.7	0.9	7.9	1.6	0.1	0.2	0.3	0.4	0.5	0.3	0.8	12.5	11.6	0.3	0.3	1.3	0.2	9.9	10.8	0.2	0.3	1.2	6.5	0.4	9.5	0.8	0.4	10.3	0.8	0.6	0.8	0.6	0.5	0.2	10.4	0.2	1.2	0.4	11.3	0.2	0.9	0.6	0.1	0.6	0.8	11.7	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.4	1.5	0.5	2.0	0.0	0.0	0.2	0.2	0.4	0.7	0.1	0.3	0.0	1.2	2.3	0.1	0.0	0.3	0.0	0.7	0.1	0.3	0.8	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	2.5	0.1	0.1	0.2	0.0	0.3	0.4	0.0	0.8	0.2	0.1	0.1	0.2	0.7	0.0	0.4	0.3	0.3	0.3	0.7	0.2	0.1	2.7	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	11.9	12.5	8.9	13.7	12.5	11.6	9.9	10.8	9.5	10.4	11.3	11.7	0.4	0.0	4.4	29.7	0.0	0.5	0.1	0.4	1.8	7.6	0.1	0.0	0.3	0.0	0.1	0.0	6.2	0.1	0.1	0.0	0.0	0.0	1.3	0.0	1.0	0.2	0.0	0.0	56.0	0.0	1.4	1.0	0.5	0.3	0.0	0.1	0.0	0.1	0.1	18.5	44.2	0.0	0.0	0.3	0.0	1.8	0.0	0.2	0.0	1.0	0.6	9.9	0.0	43.7	20.3	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	6.6	0.0	1.2	0.6	0.4	0.4	0.2	0.4	0.0	0.4	0.4	0.0	0.1
NINJ2		ENSG00000171840	"Ninjurin 2"	Q9NZG7	12	564296-663779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.8;Alveolar cells type 2: 39.9;Erythroid cells: 35.4;Hofbauer cells: 30.7;Kupffer cells: 38.3;Oligodendrocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 153.5;MOLT-4: 263.8;THP-1: 54.4;U-698: 49.3"	"Low region specificity"	"Detected in all"							"HPA058980, HPA067226"			Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol"	"HPA058980: AB_2683869, HPA067226: "	"unprognostic (1.16e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.60e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.23e-1)"	20.6	1.8	21.0	11.3	30.8	38.3	16.5	25.9	29.6	7.8	14.5	5.7	5.2	4.3	2.5	9.6	4.1	5.3	12.2	21.8	23.7	2.1	18.7	36.8	14.8	30.5	26.7	1.0	1.9	0.8	1.5	4.4	28.5	4.3	4.9	0.5	7.4	2.9	38.2	11.3	6.4	5.5	23.9	13.3	4.2	5.5	26.0	8.8	4.0	12.8	11.2	8.5	6.5	45.1	1.7	0.4	0.1	1.8	0.3	0.6	2.9	0.2	0.0	0.0	0.1	3.1	11.8	0.0	0.6	6.1	1.7	0.2	0.2	0.0	0.0	8.6	0.1	153.5	34.2	1.9	0.0	4.3	6.1	2.2	0.2	0.0	0.0	0.0	3.1	3.2	9.0	25.5	0.1	0.1	263.8	8.5	2.6	0.1	0.0	6.8	0.2	0.8	2.7	0.0	0.1	0.0	28.3	0.2	0.0	0.3	0.3	54.4	0.7	0.0	1.5	9.8	0.2	0.1	4.2	49.3	0.4	28.5	0.1	6.7	58.1	48.3	32.8	47.2	9.8	18.8	36.2	34.9	49.9	17.7	7.7	16.7	112.9	21.4	39.4	26.2	157.3	33.4	21.0	30.8	25.9	29.6	21.8	23.7	30.5	26.7	28.5	23.9	26.0	45.1	29.8	22.4	39.9	0.3	5.3	5.7	0.3	2.5	6.2	0.0	1.3	1.3	1.5	1.5	8.7	0.0	0.0	2.6	8.9	2.1	1.9	0.2	3.1	5.5	1.6	9.4	4.2	35.4	1.7	0.0	3.9	13.5	1.1	1.2	2.5	0.4	4.2	11.2	30.7	0.0	1.0	3.5	0.0	38.3	7.8	3.1	8.1	18.0	7.2	11.2	12.4	0.2	7.2	3.5	109.7	0.8	2.6	4.1	8.1	0.1	2.1	0.2	5.0	0.1	0.0	1.3	1.6	3.3	3.1	7.6	5.5	0.8	12.5	0.1	3.1	0.2
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL cohesin loading factor"	Q6KC79	5	36876769-37066413	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: AB_2683650"	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	11.5	9.4	5.6	14.7	8.6	25.1	13.5	12.0	7.3	12.9	7.8	12.2	10.0	13.4	6.6	11.4	10.5	11.1	7.7	5.3	5.9	11.6	12.7	11.9	16.5	7.3	6.6	17.6	13.1	19.6	5.0	13.9	8.2	11.1	12.2	22.4	11.2	10.7	9.5	14.2	13.2	12.4	6.3	15.3	13.4	14.2	6.9	29.8	17.2	14.3	16.7	12.6	7.5	11.1	22.5	13.1	33.3	15.6	20.7	22.3	24.4	17.6	19.3	18.9	15.7	18.2	22.6	33.5	11.3	21.6	22.2	19.2	28.9	15.9	27.0	27.9	14.7	40.9	57.4	13.3	14.0	48.4	26.4	16.5	19.3	21.3	28.1	18.1	24.0	20.8	39.3	24.5	17.9	10.8	33.8	18.1	16.0	12.9	11.3	28.2	51.9	13.0	13.1	31.4	24.5	17.2	84.6	22.5	18.0	26.2	23.0	27.3	26.3	24.9	27.1	21.0	13.3	17.7	25.5	39.1	13.6	32.4	19.1	10.9	2.9	4.3	3.2	2.2	3.0	2.8	2.7	2.9	2.3	3.1	2.9	3.3	7.7	2.8	3.3	3.4	2.1	1.6	5.6	8.6	12.0	7.3	5.3	5.9	7.3	6.6	8.2	6.3	6.9	11.1	80.6	131.4	108.6	169.8	84.8	48.4	66.2	34.2	58.1	62.6	43.6	49.4	87.0	38.6	63.3	33.1	77.2	44.1	107.1	45.9	5.9	55.5	13.4	72.9	75.7	74.1	41.5	85.4	179.2	46.7	34.1	64.3	61.2	91.7	84.0	77.7	44.6	28.2	37.1	40.4	165.5	46.3	38.7	51.8	46.6	15.1	66.5	86.7	24.9	236.1	103.3	49.2	97.9	229.2	303.7	55.0	48.6	56.4	84.5	66.4	45.2	12.2	65.2	72.8	52.6	102.9	80.1	185.8	133.6	58.2	47.0	75.9	92.0	73.8	42.9	88.0
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123803865-124825640	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 56.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1721.6;Inhibitory neurons: 636.4;Oligodendrocytes: 2869.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Daudi: 3.0;HEL: 6.4;Karpas-707: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	0.9	0.4	24.2	0.1	33.6	0.7	0.3	30.1	39.3	0.3	9.8	1.0	0.0	0.1	0.3	0.2	0.3	0.2	1.1	29.2	25.3	0.1	0.2	0.2	0.2	40.7	28.0	0.1	0.1	0.0	1.8	0.1	37.4	0.2	0.1	6.6	0.3	0.2	2.9	0.1	0.3	0.3	34.8	0.1	0.2	0.4	28.8	0.5	0.1	3.4	0.2	0.5	0.3	56.8	0.0	0.0	1.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.4	0.0	0.0	0.4	0.0	0.0	1.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	33.6	30.1	39.3	29.2	25.3	40.7	28.0	37.4	34.8	28.8	56.8	0.5	0.0	0.0	97.3	0.0	0.1	0.0	0.2	0.0	3.0	0.0	0.1	1.3	0.0	0.1	0.0	2.1	0.2	0.0	0.0	0.0	0.1	1.7	0.2	0.1	0.3	1.8	2.1	1721.6	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	47.1	636.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.0	47.8	0.0	15.8	0.0	19.1	2869.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
NKAP	FLJ22626	ENSG00000101882	"NFKB activating protein"	Q8N5F7	X	119920672-119943751	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Repressor	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000916	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000916: AB_1079486"	"prognostic unfavorable (4.20e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	9.5	13.1	10.6	9.8	11.5	13.6	10.6	11.8	16.2	9.2	11.1	9.8	10.3	10.6	10.7	7.3	11.0	8.9	11.0	10.5	11.6	11.3	14.5	10.5	14.4	11.9	11.5	14.1	10.1	14.2	2.7	13.5	11.4	10.4	10.1	9.6	9.9	13.5	18.2	7.4	12.7	10.3	11.2	12.5	9.3	8.5	11.0	12.7	10.1	14.4	13.0	9.7	2.4	13.0	25.0	24.3	17.6	22.3	15.3	24.7	28.9	17.7	20.4	23.4	17.2	15.9	20.9	17.6	29.9	14.6	45.8	18.3	33.7	20.6	27.9	29.6	31.2	11.1	20.6	23.3	25.1	25.2	20.4	17.9	26.4	25.1	24.7	25.3	23.2	23.8	30.6	25.5	18.4	33.8	21.4	47.0	23.6	32.4	32.8	22.8	24.3	32.7	17.5	9.6	19.2	27.2	36.8	19.7	52.3	20.9	16.8	21.1	17.4	14.8	9.0	38.4	27.4	25.4	26.7	30.2	20.4	18.9	26.1	39.7	23.5	55.6	20.8	20.0	21.6	32.2	25.4	21.2	20.6	36.6	25.6	24.3	44.5	22.2	23.1	32.5	26.6	14.3	10.6	11.5	11.8	16.2	10.5	11.6	11.9	11.5	11.4	11.2	11.0	13.0	39.9	22.4	40.4	5.2	36.1	25.9	36.1	45.5	26.7	34.0	26.2	33.3	30.3	15.7	42.3	20.2	25.0	62.5	36.0	17.5	37.2	36.7	8.8	33.6	37.4	40.3	22.8	20.6	7.2	44.3	132.0	39.1	17.9	26.7	47.4	41.6	41.4	46.3	53.0	55.5	9.0	27.9	22.4	28.0	23.2	8.9	45.1	33.9	35.6	4.7	35.3	56.3	36.0	7.5	11.0	37.5	23.3	55.3	30.6	40.3	25.8	51.3	49.4	38.5	13.1	33.4	45.0	82.7	69.6	19.6	28.7	72.9	41.5	48.3	23.1	33.7
NKAPD1	"C11orf57, FLJ10726"	ENSG00000150776	"NKAP domain containing 1"	Q6ZUT1	11	112074086-112085150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Endometrial stromal cells: 35.4;Proximal tubular cells: 32.9;Theca cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039493, HPA039892"	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA039493: AB_10795036, HPA039892: AB_10795372"	"unprognostic (5.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.41e-1)"	14.2	11.4	9.5	11.6	10.2	13.0	16.7	12.9	11.8	12.1	8.4	12.2	11.3	15.3	11.8	13.9	13.7	11.8	13.0	9.4	10.4	14.6	11.8	11.0	14.2	9.6	9.7	20.1	12.3	14.1	7.7	15.8	10.5	10.7	11.6	33.4	13.7	11.2	18.6	12.1	11.0	12.5	9.6	12.6	11.5	13.6	9.7	16.9	16.0	10.1	14.0	11.5	9.6	11.4	19.5	12.8	26.6	42.9	26.8	31.0	19.5	28.0	23.8	23.1	26.4	39.8	34.2	54.1	41.8	25.3	26.1	27.4	32.1	30.1	30.0	39.0	22.3	41.6	12.7	19.2	24.8	63.3	26.3	31.8	40.5	27.8	63.7	35.1	20.9	44.0	62.4	32.5	23.4	11.8	57.0	39.2	26.5	32.7	28.3	43.5	32.7	44.6	26.6	17.3	22.1	40.4	29.0	35.3	26.1	23.3	44.2	25.9	21.4	30.7	34.4	19.1	24.5	24.5	58.4	111.4	13.0	58.6	31.7	9.1	7.3	4.8	9.8	7.8	10.2	8.4	10.4	6.8	8.1	9.1	10.9	9.5	4.2	13.4	8.9	20.6	9.0	4.8	9.5	10.2	12.9	11.8	9.4	10.4	9.6	9.7	10.5	9.6	9.7	11.4	19.9	32.1	20.7	0.0	9.4	0.0	0.0	0.0	0.0	0.0	24.5	21.0	0.0	0.0	17.3	16.5	0.0	19.6	15.1	0.0	13.7	20.2	0.0	26.0	35.4	8.7	0.0	0.0	0.0	21.4	17.8	11.3	0.0	20.9	8.8	21.8	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	13.9	0.0	0.0	0.0	0.0	20.0	0.0	0.0	5.0	0.0	0.0	32.9	17.5	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	20.0	6.0	35.6	0.0	0.0
NKX1-2	"bB238F13.2, C10orf121"	ENSG00000229544	"NK1 homeobox 2"	Q9UD57	10	124445243-124450035	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Basal squamous epithelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 5.7;hTCEpi: 5.4;NTERA-2: 10.8;SCLC-21H: 4.7;SuSa: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029367	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA					"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Nucleoli fibrillar center"	"HPA029367: AB_2673011"	"unprognostic (2.43e-1)"	"unprognostic (7.85e-3)"		"unprognostic (6.81e-5)"	"unprognostic (1.55e-2)"	"unprognostic (3.61e-2)"		"unprognostic (5.40e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.20e-1)"		"unprognostic (3.73e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	5.7	0.5	0.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.1	0.0	0.1	12.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
NKX2-5	"CSX, CSX1, NKX2.5, NKX2E, NKX4-1"	ENSG00000183072	"NK2 homeobox 5"	P52952	5	173232109-173235311	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Atrial septal defect, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 229.0"	"Cell type enriched"	"Detected in some"	26	"Cardiomyocytes: 68.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 32.9;NTERA-2: 11.4;SK-MEL-30: 15.2;U-2 OS: 25.4;U-251 MG: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065034			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA065034: AB_2685409"	"unprognostic (3.81e-1)"	"unprognostic (8.53e-2)"		"unprognostic (2.62e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.22e-3)"		"unprognostic (6.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.31e-1)"			"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"		"unprognostic (1.77e-2)"	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	229.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	34.9	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	5.0	1.7	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	7.6	32.9	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	0.5	6.3	0.0	15.2	4.2	0.0	0.1	0.0	5.9	25.4	7.8	20.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.1	0.1	0.0	0.7	0.0	0.0
NKX3-1	"BAPX2, NKX3.1, NKX3A"	ENSG00000167034	"NK3 homeobox 1"	Q99801	8	23678697-23682938	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 303.3"	"Group enriched"	"Detected in many"	6	"Basal prostatic cells: 51.0;Prostatic glandular cells: 124.8"	"Cancer enriched"	"Detected in many"	65	"prostate cancer: 392.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 54.0;neutrophil: 51.6"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 54.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 25.7;SiHa: 26.1;U-138 MG: 25.8;U-251 MG: 23.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA025693, HPA078571"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA025693: AB_1854522, HPA078571: AB_2732384"	"unprognostic (1.47e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.56e-6)"	"unprognostic (6.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.69e-1)"	1.7	3.9	1.0	1.5	1.2	2.2	2.1	1.4	1.4	1.1	0.9	1.4	1.4	1.5	1.3	3.7	1.8	1.1	2.6	1.2	1.6	1.4	4.1	1.4	1.2	1.8	1.5	2.8	1.8	1.0	0.9	0.8	1.6	303.3	0.5	1.7	62.0	1.8	3.2	0.4	1.0	1.9	1.7	0.8	1.4	24.0	1.5	0.5	0.7	3.9	1.6	2.9	1.9	1.4	4.9	3.7	0.0	8.7	3.1	0.7	7.1	6.7	4.2	13.8	16.2	2.1	5.5	0.0	1.0	5.0	25.7	1.2	3.5	7.6	10.9	0.0	1.8	3.4	2.6	5.5	6.0	0.0	1.2	1.2	2.0	14.0	0.8	8.5	0.7	20.1	0.2	0.0	5.5	1.6	11.8	1.0	2.0	0.0	2.6	0.0	5.5	0.5	0.8	5.7	1.6	0.4	26.1	4.8	0.4	9.9	3.5	0.5	0.9	25.8	9.1	2.0	23.0	0.0	0.0	0.0	12.5	2.6	3.2	10.2	0.0	54.0	1.0	0.1	0.2	2.2	0.4	1.0	0.1	1.8	1.4	2.5	51.6	0.6	0.1	0.0	0.0	0.3	1.0	1.2	1.4	1.4	1.2	1.6	1.8	1.5	1.6	1.7	1.5	1.4	6.0	3.2	5.3	0.0	4.1	5.6	51.0	4.1	4.6	3.7	13.5	6.5	9.8	1.5	4.7	0.0	8.4	0.3	0.3	1.0	0.0	2.7	2.7	1.3	2.0	6.8	6.6	0.0	0.4	7.0	1.4	9.1	5.1	2.2	0.0	0.8	4.6	4.9	0.3	3.3	0.4	1.2	2.0	0.3	9.4	6.1	2.1	2.5	1.8	0.0	0.6	4.9	0.0	0.5	0.1	5.2	0.1	6.4	1.0	124.8	0.4	0.7	1.4	4.5	0.0	11.4	5.1	1.8	2.1	2.5	2.0	0.3	2.5	0.8	1.1	12.2
NME1-NME2	"NM23-LV, NMELV"	ENSG00000011052	"NME1-NME2 readthrough"		17	51153590-51171744	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"retina: 51.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 43.5;Basal keratinocytes: 38.4;Basal respiratory cells: 23.3;Club cells: 31.1;granulocytes: 22.7;Langerhans cells: 35.0;Melanocytes: 23.2;Suprabasal keratinocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB002169, HPA008467, HPA041113, CAB076057"	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (6.66e-4)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-6)"	"unprognostic (1.84e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	12.3	21.0	7.2	15.1	7.4	10.9	8.7	6.5	10.3	8.7	6.3	6.7	3.6	9.3	0.8	14.7	9.4	2.2	9.9	8.7	6.8	12.4	16.4	9.2	8.7	7.8	6.7	5.6	16.6	6.4	11.9	7.1	7.8	6.8	2.9	51.2	13.8	2.2	12.9	12.2	4.9	6.8	6.5	7.9	9.0	3.0	7.7	6.2	7.4	3.6	3.7	13.1	9.9	7.3	22.4	5.5	21.2	48.3	27.9	13.1	7.7	32.3	20.8	15.9	9.5	11.1	8.6	30.1	34.3	41.3	33.2	21.9	25.1	44.7	8.8	51.0	46.6	15.2	9.1	22.7	30.5	25.5	42.2	25.4	36.2	21.2	31.4	49.6	28.0	38.8	21.2	36.7	12.3	14.6	141.2	37.4	19.6	66.5	9.5	49.5	21.0	85.0	23.0	9.4	70.1	56.4	13.9	112.7	38.3	37.8	87.8	86.3	34.1	57.0	14.6	76.8	26.2	60.8	52.2	41.4	26.7	24.6	46.4	0.4	16.0	0.7	18.2	24.1	26.9	14.1	15.7	17.1	45.9	23.4	13.9	16.9	1.7	14.4	11.9	28.4	16.9	20.8	7.2	7.4	6.5	10.3	8.7	6.8	7.8	6.7	7.8	6.5	7.7	7.3	0.0	16.0	43.5	0.0	1.5	38.4	0.0	23.3	2.2	0.0	0.0	0.0	2.2	0.0	31.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.2	0.2	5.1	1.8	0.4	3.9	0.0	0.1	12.1	1.5	0.2	22.7	0.1	0.4	0.6	0.0	0.0	3.5	7.2	10.2	0.0	35.0	0.0	0.3	6.8	23.2	0.0	0.0	0.0	0.0	2.0	0.9	0.0	1.1	0.0	2.0	0.0	0.0	0.1	16.3	0.0	0.0	0.0	16.4	0.1	0.0	3.8	51.9	0.0	3.0	0.0	7.8	0.1
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		12000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	34.0	84.4	21.3	8.0	22.7	3.9	34.2	21.0	36.3	41.9	16.8	47.7	15.9	36.7	3.4	27.2	44.3	2.1	36.0	20.2	23.1	44.6	36.3	29.1	5.4	23.7	22.2	43.7	37.2	4.5	71.9	5.2	19.6	59.4	3.1	1.8	35.9	13.0	17.1	31.1	33.8	3.2	22.5	39.4	38.6	16.0	22.0	1.0	40.3	3.1	1.9	38.5	33.5	24.9	1.6	26.9	0.6	21.8	6.1	3.2	2.5	15.7	4.5	2.7	2.1	0.0	31.8	0.4	42.6	2.2	2.8	23.0	1.3	8.8	0.3	32.1	70.9	0.0	12.0	13.0	11.3	5.5	9.8	14.0	7.9	2.7	1.5	5.1	5.6	0.2	11.2	4.4	2.7	40.4	0.4	10.8	28.0	5.4	21.5	15.3	0.3	43.5	4.5	1.2	30.6	23.6	47.1	35.2	4.2	1.2	33.7	13.1	19.9	5.8	21.4	18.5	10.8	11.1	3.7	2.5	8.1	0.9	13.3	10.0	50.7	34.6	33.3	49.6	32.9	36.8	46.3	31.4	45.1	31.9	39.6	31.3	10.8	44.8	55.4	70.3	45.4	41.3	21.3	22.7	21.0	36.3	20.2	23.1	23.7	22.2	19.6	22.5	22.0	24.9	128.8	35.3	62.7	69.9	64.6	72.5	141.3	97.7	179.8	116.3	147.3	165.6	28.0	90.1	76.6	126.9	60.5	86.6	77.9	76.2	60.7	62.9	22.1	66.5	102.9	84.1	135.5	25.7	34.6	37.6	46.3	100.9	76.0	77.6	50.8	71.6	99.9	63.0	74.8	65.6	30.2	109.4	50.8	60.3	91.0	20.3	149.5	71.1	81.8	29.0	136.5	126.9	77.2	40.7	63.7	37.0	104.7	127.5	93.1	98.4	157.2	150.2	70.9	126.7	118.3	75.9	100.8	2.0	40.4	100.9	65.6	46.1	87.3	183.8	107.6	100.6
NME9	"NM23-H9, TXL-2, TXNDC6"	ENSG00000181322	"NME/NM23 family member 9"	Q86XW9	3	138261437-138329886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 14.6;fallopian tube: 17.6"	"Group enriched"	"Detected in some"	6	"Astrocytes: 27.4;Endometrial ciliated cells: 20.0;Excitatory neurons: 26.6;Inhibitory neurons: 17.9;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 36.6;Respiratory ciliated cells: 48.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020943, HPA040000, HPA043881"	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Centriolar satellite"	"CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712"	"unprognostic (2.71e-5)"	"unprognostic (1.68e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.17e-3)"	0.7	0.7	4.1	0.4	4.0	2.9	0.7	8.8	5.5	1.1	14.6	0.6	0.2	0.6	0.7	0.4	17.6	0.4	0.5	3.4	4.1	1.0	0.4	2.2	0.3	6.9	7.0	0.7	1.3	0.9	3.7	0.2	4.2	0.8	0.0	7.4	1.6	0.7	2.7	0.8	0.8	0.2	5.2	0.5	0.6	4.3	5.0	0.5	1.1	0.0	0.2	0.5	0.5	4.4	0.3	0.2	0.4	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.7	0.8	0.1	0.0	1.0	1.7	0.3	0.0	0.0	0.0	0.7	0.0	0.7	0.2	0.4	0.0	0.1	0.1	1.0	0.2	0.1	0.3	0.3	0.0	0.3	0.5	0.9	0.9	0.2	0.6	0.1	0.1	0.3	0.3	0.0	1.1	0.3	0.2	0.3	0.1	0.3	0.4	0.4	0.2	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.4	0.1	0.1	0.1	0.0	0.2	0.2	0.0	4.1	4.0	8.8	5.5	3.4	4.1	6.9	7.0	4.2	5.2	5.0	4.4	0.2	0.0	0.5	27.4	0.0	0.0	0.2	1.1	0.0	1.5	0.1	0.0	1.5	2.8	2.3	1.8	0.0	0.1	0.0	0.0	0.0	0.2	3.1	20.0	0.2	0.3	0.0	0.0	26.6	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.4	0.0	0.0	3.3	17.9	0.0	0.0	0.3	0.0	1.4	0.3	0.0	0.0	1.0	0.0	2.7	0.0	67.8	36.6	0.0	0.0	0.0	0.3	0.2	0.0	0.5	48.4	2.3	0.0	0.5	0.7	5.0	0.7	0.0	0.0	0.3	0.2	0.4	0.0	0.1
NMNAT2	"C1orf15, KIAA0479, PNAT2"	ENSG00000157064	"Nicotinamide nucleotide adenylyltransferase 2"	Q9BZQ4	1	183248237-183418380	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.5;heart muscle: 18.3;pituitary gland: 18.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.3;Excitatory neurons: 195.5;Inhibitory neurons: 265.4;Oligodendrocyte precursor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 26.2;SCLC-21H: 80.6;SuSa: 25.1;U-2197: 45.8;U-87 MG: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015708, HPA061714"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015708: , HPA061714: AB_2732669"	"unprognostic (3.70e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.02e-1)"	8.5	5.9	13.1	0.8	14.8	0.0	5.1	17.2	45.5	2.1	0.0	2.3	0.4	1.2	1.4	0.8	2.3	2.8	18.3	15.6	21.4	0.4	0.0	0.7	0.6	0.7	0.8	0.4	1.7	0.2	18.4	0.9	6.7	0.2	0.9	6.5	0.5	2.5	0.5	0.9	0.9	1.5	0.0	0.1	1.1	8.9	0.8	0.5	6.0	1.4	0.6	0.7	0.8	10.0	1.4	0.5	5.5	0.0	3.1	12.5	4.6	3.4	8.9	1.8	0.6	2.7	5.4	0.0	14.2	0.8	1.5	2.2	0.2	0.1	3.3	0.0	0.1	0.0	2.2	0.0	0.5	0.0	0.1	26.2	1.1	2.1	0.5	11.1	0.5	0.0	0.0	0.1	2.1	0.1	0.0	0.5	9.7	0.1	5.4	0.0	0.2	0.0	5.9	4.5	80.6	6.2	0.7	0.3	0.0	25.1	0.7	1.5	3.0	2.5	0.9	45.8	3.3	0.6	0.0	0.0	35.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	14.8	17.2	45.5	15.6	21.4	0.7	0.8	6.7	0.0	0.8	10.0	21.4	0.0	1.5	3.9	0.0	0.8	0.2	0.6	0.6	12.1	0.2	0.1	35.2	0.0	2.0	0.0	0.0	0.7	0.1	0.1	0.0	0.2	54.3	2.7	0.3	5.2	0.0	0.0	195.5	0.0	12.9	5.7	0.0	7.4	0.0	0.2	0.0	0.0	0.7	20.2	265.4	0.0	4.1	1.0	0.0	42.3	0.0	0.5	1.8	11.2	0.0	0.3	0.0	98.5	6.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	3.4	2.9	19.7	0.3	12.0	0.4	0.2	0.1	0.3	1.4	0.2	0.0	0.0	0.0
NMRK1	"bA235O14.2, C9orf95, FLJ20559, NRK1"	ENSG00000106733	"Nicotinamide riboside kinase 1"	Q9NWW6	9	75060573-75088217	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 68.6;Karpas-707: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049795	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA049795: AB_2680886"	"unprognostic (1.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (3.70e-6)"	"unprognostic (3.56e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.64e-2)"	22.1	11.5	14.6	14.3	15.0	12.6	20.2	17.0	18.9	21.8	15.4	15.3	17.8	11.2	18.5	39.5	16.4	14.1	15.5	15.2	15.4	32.5	53.7	21.7	17.5	14.9	14.8	22.7	45.1	64.1	19.8	14.8	15.2	23.7	13.0	8.8	31.2	13.6	27.2	23.2	22.4	8.8	14.8	31.1	26.0	9.7	14.4	17.3	25.6	13.4	20.0	18.8	25.6	15.2	11.7	2.7	3.2	7.9	21.4	28.0	18.1	17.0	22.4	3.5	5.8	0.1	29.8	6.8	10.0	13.8	7.2	18.5	3.8	9.4	10.0	68.6	3.5	5.1	5.6	5.7	20.3	4.8	0.8	22.5	23.5	6.3	11.8	20.8	25.1	10.8	0.5	79.0	24.6	8.4	4.3	4.3	3.9	40.2	10.0	1.6	29.7	42.1	28.9	19.5	2.2	0.5	7.3	6.4	9.0	19.2	18.4	4.5	20.6	13.5	2.9	12.9	4.6	37.5	31.4	4.1	23.1	4.9	13.8	16.4	5.4	9.3	25.1	5.1	30.5	13.4	43.7	29.2	6.1	9.1	39.4	30.2	9.8	17.2	14.5	17.2	31.6	18.1	14.6	15.0	17.0	18.9	15.2	15.4	14.9	14.8	15.2	14.8	14.4	15.2	42.2	38.5	21.7	11.8	22.6	21.0	36.4	38.2	38.7	8.4	33.4	37.5	15.5	21.5	27.9	23.9	8.4	53.3	43.7	32.8	52.8	30.5	17.8	42.4	16.8	33.4	4.2	10.3	26.2	35.5	75.7	22.7	49.5	37.4	1.3	8.3	55.3	45.2	62.4	11.8	20.6	34.8	22.4	32.5	9.6	30.8	23.6	22.9	26.6	14.0	67.6	15.2	43.3	13.6	23.9	21.5	26.1	12.4	68.8	23.4	83.8	92.1	30.5	8.3	13.1	24.5	15.0	10.7	8.3	50.9	27.0	45.6	48.8	22.2	25.0	32.6
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 239.1;tongue: 384.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 344.3;Hepatocytes: 314.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004829, CAB004975"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Cytosol	"CAB004975: AB_425908, HPA004829: AB_1079495"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	26.0	16.5	12.8	11.8	16.0	15.0	13.7	11.2	21.7	16.4	34.9	25.9	17.2	11.0	16.7	16.8	10.7	15.0	137.7	16.1	11.5	57.0	116.4	13.2	16.5	10.3	12.0	10.1	17.8	55.6	9.6	12.7	9.5	18.3	27.8	12.9	26.6	18.2	239.1	10.4	16.1	20.6	9.3	11.5	31.2	6.2	15.8	26.8	31.1	384.0	17.2	17.3	9.3	15.1	15.4	12.6	30.5	59.6	44.0	50.3	9.9	17.5	39.8	24.8	20.8	19.0	30.4	18.5	21.5	43.9	22.3	16.6	120.5	5.4	27.4	31.1	33.6	24.0	70.7	23.8	27.5	50.2	43.1	37.9	17.5	16.3	18.6	42.6	56.3	22.7	21.4	81.3	60.0	15.1	55.8	35.8	6.4	0.1	15.2	54.7	73.8	70.8	58.0	15.5	44.2	37.7	62.9	1.4	46.7	6.9	47.7	58.3	23.2	29.5	28.3	12.0	8.3	36.1	45.1	26.5	7.1	68.8	22.1	12.5	18.2	16.0	16.7	23.0	17.1	12.0	17.1	15.5	32.0	12.0	15.5	14.7	2.9	23.2	24.7	9.1	22.2	19.3	12.8	16.0	11.2	21.7	16.1	11.5	10.3	12.0	9.5	9.3	15.8	15.1	12.0	54.5	37.8	60.7	19.6	11.5	9.5	19.0	13.1	17.9	9.6	6.3	344.3	38.6	27.0	27.6	35.5	8.7	20.4	34.4	27.4	14.4	16.7	18.5	16.6	19.2	19.9	34.9	124.8	10.7	2.3	27.2	23.9	25.1	25.2	26.8	21.0	314.3	25.0	6.7	110.6	22.6	20.3	40.6	11.9	4.6	14.9	19.8	14.2	45.9	25.9	12.5	35.0	77.9	63.4	9.5	16.7	19.2	20.0	11.7	23.6	21.7	18.1	12.8	0.0	14.0	20.1	4.0	1.4	17.6	8.1	2.1	20.9	18.8	28.9	9.9
NOB1	"ART-4, MST158, NOB1P, PSMD8BP1"	ENSG00000141101	"NIN1 (RPN12) binding protein 1 homolog"	Q9ULX3	16	69741871-69754926	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041522, HPA049430, HPA067411"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Focal adhesion sites"	"HPA041522: , HPA049430: AB_2680764, HPA067411: "	"unprognostic (5.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.61e-3)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.21e-5)"	"prognostic unfavorable (8.16e-4)"	"unprognostic (3.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.16e-1)"	33.3	51.8	13.5	23.2	18.6	31.1	32.2	14.7	17.3	29.2	18.1	25.1	31.5	28.4	14.0	41.8	43.4	24.3	18.5	13.9	13.4	23.7	24.5	20.6	37.0	15.2	13.9	54.5	90.1	17.7	15.3	20.5	15.2	24.9	19.1	7.0	31.1	19.2	36.6	42.5	23.2	20.1	13.9	27.3	37.1	12.8	15.3	26.5	30.8	20.2	30.1	31.5	31.7	14.9	58.7	125.9	29.0	82.7	63.2	98.6	57.5	46.1	63.6	84.0	75.9	143.5	93.5	129.9	69.9	51.2	44.2	84.9	80.3	102.6	49.4	33.0	93.6	50.8	57.5	186.6	111.3	95.0	40.9	125.5	85.8	96.9	122.6	78.0	71.7	77.0	117.2	39.2	42.5	152.8	119.6	187.9	89.2	64.9	73.8	130.5	30.1	164.6	62.5	56.5	75.0	37.1	144.8	50.1	73.8	25.5	54.4	84.0	55.3	56.8	51.8	52.6	76.0	63.9	52.7	230.1	57.0	85.3	64.2	0.3	37.9	5.7	41.5	32.5	58.1	47.0	50.3	38.5	51.3	53.9	53.3	49.0	1.9	65.7	26.5	26.8	68.2	46.7	13.5	18.6	14.7	17.3	13.9	13.4	15.2	13.9	15.2	13.9	15.3	14.9	31.3	3.2	18.8	4.6	36.2	60.0	75.1	84.7	87.6	10.2	52.3	69.7	5.7	24.3	47.2	20.2	0.0	71.9	22.5	14.2	41.1	47.9	10.7	22.0	42.5	39.9	10.2	37.6	6.9	85.9	82.6	35.8	23.4	26.5	16.5	68.5	32.5	14.8	36.2	5.0	6.7	36.9	36.7	30.7	24.1	7.1	36.7	19.6	21.4	2.8	35.7	11.6	35.0	6.0	5.7	46.9	25.1	42.5	24.8	72.0	35.3	37.4	17.1	5.4	26.3	47.2	30.5	18.1	33.4	64.0	59.7	47.5	30.7	77.4	63.2	67.8
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	1.5	0.5	0.5	5.9	0.2	13.6	1.5	0.2	1.0	5.6	0.7	0.9	1.5	0.6	0.3	11.7	0.9	1.3	0.7	0.2	0.4	0.6	1.7	4.3	2.7	1.0	0.9	0.4	0.3	0.2	0.4	1.2	0.7	0.9	0.9	0.0	4.3	0.4	0.6	14.4	1.3	1.8	0.7	4.4	1.4	0.5	1.4	0.8	0.4	0.3	2.3	1.6	12.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.0	5.8	7.3	0.0	0.0	0.0	0.0	0.0	15.9	7.2	0.0	0.3	0.1	0.0	3.0	23.0	6.0	0.4	13.1	0.7	0.1	1.3	1.4	21.3	0.0	0.1	0.5	10.5	3.4	9.0	1.0	0.9	11.1	0.5	0.2	0.2	1.0	0.2	0.4	1.0	0.9	0.7	0.7	1.4	0.8	0.2	0.0	3.7	0.0	1.9	5.9	0.3	1.2	0.0	0.0	1.4	1.1	0.4	1.5	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	5.6	0.8	0.6	1.2	0.8	0.1	0.0	0.0	0.4	0.0	8.3	1.3	0.5	0.0	0.5	2.5	0.0	0.1	0.0	2.0	9.0	22.5	0.0	0.0	15.2	1.8	1.9	15.6	0.0	1.0	0.0	0.2	0.0	0.0	0.4	4.3	0.4	0.0	0.1	1.0	0.0	0.0	0.1	0.4	0.1	0.4	6.1	15.5	0.3	2.3	0.1	0.1	0.3
NOP9	C14orf21	ENSG00000196943	"NOP9 nucleolar protein"	Q86U38	14	24299850-24309124	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000850			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA000850: AB_1078287"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (9.39e-6)"	"unprognostic (7.03e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	9.9	13.0	6.3	5.5	6.7	7.0	9.3	6.2	6.1	8.6	4.6	11.1	7.8	9.9	3.5	16.1	9.5	3.3	13.2	5.8	6.3	8.6	13.8	8.7	6.2	6.7	6.5	11.7	12.6	6.7	7.9	4.1	6.4	9.0	5.5	7.4	10.6	4.4	27.2	12.6	11.4	4.9	6.9	17.3	10.6	7.7	6.8	5.9	8.6	11.2	6.7	9.8	9.3	6.3	6.5	12.8	10.2	12.8	8.7	7.3	9.8	11.4	8.5	13.2	10.2	9.7	11.3	16.7	6.3	10.5	10.7	16.6	20.4	14.2	13.7	10.6	7.8	12.3	18.3	22.4	7.0	28.4	13.5	7.4	10.9	9.7	8.9	7.0	12.4	9.3	10.6	8.0	9.3	11.3	13.2	10.7	4.6	22.9	16.2	16.0	6.1	10.6	8.1	14.8	10.2	7.8	16.1	18.4	3.5	7.3	6.9	7.4	12.8	8.7	7.2	6.9	10.9	11.1	10.6	12.2	4.8	12.7	7.1	0.3	0.6	0.5	0.4	0.7	0.4	0.3	0.3	0.2	0.5	0.4	0.2	0.2	0.1	0.1	1.2	0.3	0.3	0.4	6.3	6.7	6.2	6.1	5.8	6.3	6.7	6.5	6.4	6.9	6.8	6.3	4.0	3.2	3.3	2.6	6.2	12.5	3.2	4.9	6.2	8.1	5.3	3.9	1.2	7.2	8.5	9.2	8.4	6.3	6.7	15.2	0.0	7.3	3.1	5.2	4.8	5.6	10.7	9.9	3.6	10.3	5.8	4.5	6.1	5.0	1.3	9.6	6.1	18.1	7.3	6.7	4.3	7.6	0.0	10.7	6.3	1.3	6.5	5.8	0.0	1.0	7.6	5.5	2.1	3.0	5.0	11.6	8.5	4.5	5.5	5.2	12.5	6.6	7.7	8.0	6.6	5.4	5.4	4.6	5.7	8.1	13.5	6.4	4.9	5.5	14.3	4.6
NOSTRIN	MGC20702	ENSG00000163072	"Nitric oxide synthase trafficking"	Q8IVI9	2	168786539-168865514	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 167.0;Endothelial cells: 129.6;Hepatic stellate cells: 172.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.1;HEL: 41.9;K-562: 31.8;OE19: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044384, HPA076885"	Approved		Approved	Vesicles,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	Vesicles	"HPA044384: AB_2678922, HPA076885: "	"unprognostic (4.74e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.02e-6)"	"unprognostic (4.89e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.98e-2)"	32.6	20.4	6.1	4.6	5.8	0.3	31.4	5.0	7.6	17.5	4.2	15.3	14.0	14.9	4.3	5.1	16.4	14.0	16.1	4.9	5.6	32.6	7.3	30.8	4.6	6.6	6.0	10.6	22.6	3.8	3.8	25.4	6.5	13.3	16.4	0.8	48.9	6.8	5.1	7.3	14.3	12.8	5.5	5.5	23.0	14.4	6.6	1.9	13.5	3.6	3.0	8.1	11.3	5.0	0.0	3.6	1.1	0.0	0.0	0.0	10.1	0.4	0.0	0.0	0.0	6.3	6.5	0.1	4.3	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	41.9	1.8	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	31.8	0.0	0.0	0.1	0.1	0.1	0.1	20.5	0.3	0.4	1.9	0.0	3.4	1.6	0.0	0.1	0.2	1.9	0.0	0.2	0.5	0.0	0.0	0.0	0.7	0.2	0.6	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	5.0	7.6	4.9	5.6	6.6	6.0	6.5	5.5	6.6	5.0	167.0	9.6	10.3	2.0	1.6	1.0	0.6	0.3	0.6	0.1	20.0	11.0	7.1	15.7	3.3	3.7	0.0	18.9	0.4	57.3	13.7	8.0	26.6	16.3	3.3	129.6	11.4	2.7	0.4	21.8	7.0	6.1	41.3	23.2	0.0	72.4	172.5	1.0	1.6	0.0	0.5	35.9	0.0	6.3	0.9	60.9	8.7	1.2	24.9	55.3	0.7	1.6	0.0	2.0	0.0	17.7	53.4	5.7	0.2	3.3	43.1	59.0	1.5	0.3	72.3	1.3	11.3	13.7	1.8	0.4	0.4	26.3	0.9	71.9	20.7	1.2
NOTO		ENSG00000214513	"Notochord homeobox"	A8MTQ0	2	73202574-73212513	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA034660, HPA063906"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"			"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA034660: AB_10601974, HPA063906: "						"unprognostic (6.09e-2)"		"unprognostic (9.77e-2)"		"unprognostic (4.84e-2)"				"unprognostic (1.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-2)"		0.0	0.1	0.3	0.1	0.2	0.5	0.0	0.6	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.6	0.3	0.2	0.2	0.5	0.3	0.4	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPDC1	"CAB-, CAB1, DKFZp586J0523"	ENSG00000107281	"Neural proliferation, differentiation and control 1"	Q9NQX5	9	137039463-137046179	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 397.0;Endothelial cells: 307.2;Enteroendocrine cells: 281.6;Hepatic stellate cells: 406.2;Intestinal goblet cells: 589.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 146.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 12.3;MAIT T-cell: 14.7;memory CD4 T-cell: 19.0;memory CD8 T-cell: 18.9;T-reg: 15.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 19.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 138.4;RPMI-8226: 132.8;T-47d: 140.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		240000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA008189: AB_1854584"	"unprognostic (6.94e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.84e-2)"	129.5	45.7	140.8	12.2	128.1	3.4	133.0	110.6	181.3	130.5	55.0	93.1	23.4	121.6	4.3	53.7	148.6	24.9	149.1	143.3	143.1	75.9	23.7	115.4	13.0	138.9	142.3	68.2	81.2	23.0	266.0	21.1	131.3	260.5	13.4	9.2	137.4	35.1	34.0	56.4	72.1	16.9	120.7	145.2	126.2	35.3	142.9	2.9	68.4	12.4	3.9	97.9	90.5	114.7	33.6	41.9	10.1	67.1	23.7	23.8	2.8	68.7	23.0	16.9	6.7	17.1	18.5	30.3	50.7	28.6	4.6	122.4	8.6	20.5	1.6	25.0	40.4	13.6	123.7	12.9	33.3	11.9	0.3	16.5	31.9	8.7	17.9	43.1	43.6	13.2	0.7	0.8	3.5	138.4	1.0	1.1	21.1	111.0	68.1	19.9	0.0	132.8	28.6	22.7	77.2	50.0	18.4	65.3	46.5	3.6	140.1	17.9	73.9	12.4	21.6	84.1	21.0	0.1	0.4	1.4	17.7	1.2	10.5	0.0	0.6	0.9	12.3	0.1	14.7	0.1	19.0	18.9	1.1	0.0	0.5	3.1	0.0	0.2	0.1	3.4	15.9	3.3	140.8	128.1	110.6	181.3	143.3	143.1	138.9	142.3	131.3	120.7	142.9	114.7	397.0	0.0	7.7	64.3	3.4	23.6	77.6	15.0	31.3	97.5	174.0	139.7	18.3	71.4	19.8	29.5	16.7	1.1	5.5	122.2	0.0	52.5	1.8	39.0	27.7	307.2	281.6	19.3	71.7	66.0	1.3	61.2	153.9	101.3	0.0	9.2	406.2	1.9	22.2	62.2	64.7	589.1	18.3	21.0	20.0	6.9	161.2	6.6	30.2	37.5	3.0	38.5	1.0	38.2	39.0	33.0	106.0	145.6	1.4	234.9	37.5	0.7	7.5	62.0	39.5	23.9	38.9	2.8	19.0	15.9	23.7	1.8	12.3	9.1	98.1	103.1
NPEPL1	"bA261P9.2, FLJ11583"	ENSG00000215440	"Aminopeptidase like 1"	Q8NDH3	20	58689131-58719238	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 23.9;classical monocyte: 18.5;eosinophil: 7.2;intermediate monocyte: 13.0;myeloid DC: 11.4;neutrophil: 13.7;non-classical monocyte: 18.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.4;granulocytes: 23.9;monocytes: 18.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004986, CAB017025, HPA036356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		14000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.87e-9)"	"unprognostic (7.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.73e-4)"	31.9	24.8	20.6	9.4	21.5	19.9	28.1	20.2	28.9	20.4	22.5	40.8	15.9	24.8	3.9	26.9	23.2	15.8	30.7	20.7	19.0	40.6	20.6	26.6	13.6	22.6	20.3	23.6	24.1	16.7	27.0	10.0	20.9	29.3	4.4	2.5	29.7	15.2	66.3	23.7	25.4	8.6	19.7	40.1	27.1	23.1	22.1	7.7	39.2	28.8	6.1	39.2	22.1	21.0	22.5	31.2	5.5	4.5	11.8	21.7	1.7	8.5	0.7	26.6	14.9	18.0	16.6	1.0	44.6	15.7	0.3	24.0	7.5	10.4	2.6	20.0	7.5	8.0	26.0	8.3	29.6	8.1	13.0	21.3	31.7	9.3	0.0	9.8	22.6	6.1	1.1	3.5	10.6	106.6	3.3	21.2	8.3	13.1	33.8	6.6	2.6	12.6	11.1	14.8	10.1	3.2	22.4	6.1	41.8	3.0	23.4	15.3	25.3	6.7	5.4	14.0	4.4	11.7	4.3	0.7	9.8	15.2	2.7	23.9	18.5	7.2	2.5	13.0	3.1	1.4	1.5	1.7	11.4	0.9	0.9	1.8	13.7	3.2	18.8	0.5	3.7	6.3	20.6	21.5	20.2	28.9	20.7	19.0	22.6	20.3	20.9	19.7	22.1	21.0	23.6	9.6	15.6	0.0	3.5	9.2	8.2	17.1	10.8	19.0	17.2	16.0	16.7	10.0	16.4	27.6	25.0	15.0	11.8	7.6	13.7	14.8	2.3	11.9	8.1	13.6	12.0	3.0	0.0	9.2	7.8	16.1	18.8	6.4	2.5	32.3	15.0	9.1	11.2	8.4	0.0	10.2	20.3	16.7	12.0	8.5	22.1	15.1	7.2	0.0	16.3	20.1	6.2	0.0	0.0	10.8	14.3	14.7	8.4	4.4	17.6	19.9	19.0	8.5	19.7	14.9	15.2	6.7	3.0	16.9	11.2	8.9	9.0	9.7	13.1	7.7
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 20.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		30000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	37.3	46.6	27.2	32.4	27.6	41.7	32.0	22.2	28.3	30.4	27.1	35.2	24.5	35.3	23.5	51.5	28.8	23.3	58.4	26.6	31.2	42.2	54.8	37.9	33.2	31.8	27.2	25.9	36.7	29.7	33.2	27.1	28.5	33.3	21.3	20.1	32.4	22.7	164.3	42.1	34.4	29.3	24.1	42.8	36.8	42.8	28.7	33.4	28.4	55.5	28.8	33.2	31.7	32.8	91.9	118.6	46.2	72.1	56.0	46.0	57.2	74.2	82.3	120.4	110.6	90.7	80.2	67.2	57.9	87.7	87.8	72.5	46.0	62.6	104.5	43.0	60.8	77.5	95.5	81.5	53.4	83.4	95.4	45.8	59.1	113.2	40.1	57.7	124.8	62.0	84.1	99.1	73.6	59.5	113.0	45.2	54.3	45.5	74.0	73.6	73.8	54.4	43.6	86.8	61.6	70.6	92.6	127.4	85.7	87.1	100.1	60.9	89.6	156.1	108.1	86.1	121.4	74.8	57.9	84.0	124.6	55.2	102.9	4.1	20.0	4.4	4.6	4.9	2.8	4.7	3.1	3.7	6.3	3.3	2.8	3.7	5.6	2.8	3.1	4.8	3.2	10.0	27.2	27.6	22.2	28.3	26.6	31.2	31.8	27.2	28.5	24.1	28.7	32.8	19.2	12.8	18.1	24.8	15.3	17.6	16.2	12.7	7.4	24.3	19.5	16.1	44.5	11.5	18.5	20.2	29.2	19.5	22.2	38.9	1.9	19.0	96.2	32.8	19.6	22.2	30.5	20.6	38.0	37.4	21.3	15.9	26.0	38.8	3.8	29.2	27.1	54.3	19.1	20.2	36.4	17.2	8.2	27.3	18.7	79.6	17.7	22.8	12.4	19.7	28.7	19.6	14.4	23.1	38.6	47.2	22.8	12.8	16.5	28.4	22.2	27.9	21.5	33.5	19.7	22.3	18.5	29.7	23.9	15.7	24.2	37.1	16.9	19.3	18.9	28.7
NPM3		ENSG00000107833	"Nucleophosmin/nucleoplasmin 3"	O75607	10	101781325-101783413	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036295, HPA036296"	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Actin filaments, Cytosol"		"HPA036295: AB_10671244, HPA036296: AB_10672083"	"unprognostic (3.41e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.58e-2)"	12.7	19.5	9.9	18.5	10.2	27.2	19.0	7.8	10.4	19.6	9.6	15.5	8.3	17.2	10.1	26.6	15.3	9.8	8.4	9.6	11.6	16.4	12.3	10.2	23.3	8.4	8.5	20.6	30.3	16.4	12.4	16.3	8.6	13.4	19.3	1.1	15.1	8.2	13.3	16.7	10.7	19.9	8.5	14.8	13.1	17.1	11.6	20.3	11.1	10.1	25.9	20.9	16.7	9.3	94.8	117.2	34.2	226.2	76.5	80.0	36.1	50.0	75.7	75.8	64.4	126.5	117.1	154.8	91.0	56.0	41.6	99.2	192.6	211.8	59.3	66.1	199.8	124.5	50.5	206.0	86.1	286.6	87.4	69.6	100.8	105.2	417.0	39.0	100.6	187.1	156.9	83.7	63.3	173.8	121.0	371.8	60.7	131.1	89.1	93.3	179.2	158.0	75.0	45.8	70.0	45.1	31.2	72.5	144.7	41.8	94.4	59.0	40.1	30.0	95.8	44.8	94.1	36.0	39.9	179.7	41.9	263.4	31.8	0.0	2.8	0.0	3.6	4.0	6.5	4.0	5.9	6.9	6.4	4.8	9.5	9.8	0.1	8.1	0.8	8.3	2.6	5.1	9.9	10.2	7.8	10.4	9.6	11.6	8.4	8.5	8.6	8.5	11.6	9.3	5.1	3.2	5.0	1.0	15.3	62.7	79.6	121.4	28.5	1.4	55.5	54.4	2.9	28.6	32.0	36.8	0.0	91.4	15.6	16.3	78.2	54.0	8.9	7.3	22.1	21.6	24.2	17.9	2.7	41.2	90.6	29.7	13.7	10.5	16.5	19.6	15.0	19.0	68.6	0.0	2.0	33.1	46.8	21.1	69.9	10.9	28.0	18.0	30.2	1.9	14.7	2.5	18.6	1.5	1.0	34.2	12.7	23.7	19.1	118.5	3.1	61.6	16.4	2.0	6.6	47.9	21.6	46.5	91.3	21.3	49.9	60.7	18.5	29.0	46.9	62.8
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 137.0;thyroid gland: 234.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	22.8	6.3	9.7	5.6	7.9	0.2	27.0	4.7	8.0	32.4	5.7	24.5	56.1	20.9	22.2	10.9	22.4	30.5	5.2	7.5	14.6	105.0	4.0	137.0	4.5	6.1	31.8	10.9	40.1	1.0	47.4	3.4	9.2	82.9	25.2	2.4	8.9	18.7	4.9	8.2	74.1	14.1	4.4	14.8	14.9	3.1	10.5	14.2	234.5	11.5	5.4	9.7	22.1	6.6	0.0	0.2	0.3	0.6	0.0	0.0	30.9	0.2	0.1	0.0	0.0	14.9	19.1	0.2	0.8	0.2	0.0	1.7	7.4	0.0	0.0	0.0	8.4	0.8	32.3	27.1	0.1	0.0	0.2	3.2	2.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.0	24.3	0.4	1.5	0.3	0.1	12.0	0.0	0.1	0.3	37.7	1.6	1.7	0.6	1.8	14.1	0.0	4.1	51.2	1.3	0.0	0.6	0.4	0.5	1.1	0.3	1.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	7.9	4.7	8.0	7.5	14.6	6.1	31.8	9.2	4.4	10.5	6.6	5.2	185.9	103.7	15.3	0.0	1.9	5.2	13.1	1.8	1.1	22.2	7.0	2.5	27.1	56.4	33.1	0.0	2.4	0.7	5.9	1.9	24.7	11.0	1.0	1.5	18.4	15.6	0.0	1.0	2.5	0.2	8.3	1.1	1.9	0.0	3.3	2.9	0.3	0.3	0.0	10.0	10.6	4.1	0.0	1.5	15.4	2.5	0.6	5.4	14.0	0.0	0.0	0.0	2.0	0.3	7.5	3.4	0.0	0.0	28.4	19.6	4.3	6.4	0.2	0.0	1.9	26.4	2.4	2.0	3.6	1.1	1.5	0.3	1.5	11.0	5.7
NPR3	"ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC"	ENSG00000113389	"Natriuretic peptide receptor 3"	P17342	5	32689070-32791724	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 107.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 52.8;Granulosa cells: 97.9;Proximal tubular cells: 143.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 19.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 35.3;fHDF/TERT166: 22.8;HeLa: 81.4;HSkMC: 50.0;U-138 MG: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052702	Supported		Approved	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA052702: AB_2681922"	"unprognostic (8.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.46e-3)"	"prognostic favorable (5.43e-6)"	"unprognostic (6.00e-4)"	"unprognostic (5.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.38e-2)"	21.3	3.4	1.4	0.8	1.2	4.5	3.8	0.9	1.7	8.0	5.6	5.3	0.7	4.1	2.0	5.3	4.7	4.3	27.3	1.3	2.0	107.8	4.8	11.1	0.9	1.5	1.4	1.7	1.3	1.3	0.6	9.5	1.3	6.3	1.1	2.6	1.1	8.9	5.8	5.0	1.4	3.0	1.1	9.6	1.0	1.7	1.3	4.9	13.0	9.5	2.0	1.8	4.5	2.0	0.3	4.3	0.2	0.4	2.4	35.3	0.1	10.0	1.9	0.6	0.6	0.0	0.2	0.0	0.2	22.8	0.7	0.0	4.9	0.1	1.2	0.1	0.0	0.4	81.4	0.0	7.1	0.1	0.2	50.0	0.6	2.6	6.9	2.3	0.3	0.1	0.1	0.6	3.3	0.6	0.0	0.5	0.1	0.0	11.9	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.5	13.3	0.1	0.3	0.2	0.0	0.3	21.5	0.3	1.8	0.3	0.2	0.1	0.0	3.5	0.1	0.3	0.1	0.3	0.2	0.3	0.1	0.2	0.4	0.3	0.2	0.0	0.5	0.4	0.5	3.3	0.4	0.0	0.4	0.1	0.1	1.4	1.2	0.9	1.7	1.3	2.0	1.5	1.4	1.3	1.1	1.3	2.0	3.9	16.0	4.9	1.0	0.8	5.4	0.1	1.6	24.5	11.6	0.2	1.1	27.3	0.0	1.7	9.2	0.0	0.0	0.2	0.1	52.8	0.1	1.4	4.5	8.5	11.9	0.0	13.9	0.4	0.0	0.1	2.6	0.0	16.5	3.8	97.9	15.7	1.6	0.1	3.3	11.4	0.0	0.0	0.3	0.0	3.2	11.1	1.3	0.0	0.0	0.2	1.7	0.0	1.0	0.3	0.0	0.1	12.8	1.4	1.9	0.0	143.4	3.7	1.5	6.6	0.3	6.6	0.1	1.2	23.0	1.3	0.1	1.3	16.5	0.0	0.3
NPRL3	"C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11"	ENSG00000103148	"NPR3 like, GATOR1 complex subunit"	Q12980	16	84271-138677	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011741	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA011741: AB_1845577"	"unprognostic (1.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.50e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	9.6	10.4	17.5	7.2	18.2	19.1	8.5	16.7	22.2	10.1	15.7	6.5	7.3	10.5	5.2	9.3	12.1	6.3	8.9	17.7	18.0	8.0	10.0	7.8	9.4	17.1	18.1	12.9	10.9	12.7	11.7	6.6	16.9	8.8	4.8	7.1	11.0	7.1	15.5	9.9	5.6	7.2	15.5	8.3	6.8	9.4	18.2	7.0	11.0	10.3	6.6	6.5	8.2	18.2	14.5	29.0	12.6	32.2	33.7	16.9	19.8	17.2	16.8	21.3	16.6	46.6	25.6	26.5	22.5	25.5	13.8	17.0	20.5	29.7	12.3	29.2	16.0	38.8	17.3	34.2	31.1	15.9	25.6	20.7	22.2	28.4	24.9	16.0	20.3	21.1	38.6	24.6	19.1	51.2	17.6	12.3	11.9	10.0	20.8	30.1	10.8	37.9	21.6	12.2	26.9	17.1	22.8	30.1	14.3	6.5	22.2	11.1	19.2	32.9	18.2	20.0	13.3	25.9	14.7	37.7	1.1	19.2	18.3	0.0	2.4	0.3	3.0	2.2	3.2	2.0	2.6	2.5	3.5	2.0	2.5	2.9	0.2	2.0	3.1	2.6	2.9	2.2	17.5	18.2	16.7	22.2	17.7	18.0	17.1	18.1	16.9	15.5	18.2	18.2	10.4	12.8	11.7	30.0	22.2	9.4	17.6	15.7	14.8	58.1	16.6	16.8	9.0	12.8	9.2	11.0	66.7	24.6	20.4	6.8	23.5	16.4	31.0	11.8	18.1	13.0	9.6	134.5	29.7	8.9	35.2	17.3	15.8	9.4	3.8	49.2	15.7	10.2	19.7	55.5	30.8	11.7	10.2	14.2	6.4	73.8	22.7	12.8	12.4	15.9	16.4	29.5	79.3	21.1	40.4	11.4	6.6	19.5	14.0	23.3	8.0	23.9	11.0	57.2	6.6	15.6	14.9	62.2	43.0	16.0	5.5	15.3	18.8	28.2	14.4	10.4
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38844028	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 280.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Excitatory neurons: 41.7;Inhibitory neurons: 50.4;Oligodendrocyte precursor cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 280.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 23.3;SCLC-21H: 30.8;SiHa: 23.6;U-87 MG: 87.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		420000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.7	5.0	91.6	1.9	75.4	0.3	2.8	0.3	145.7	8.7	0.0	9.5	1.3	10.9	3.8	3.0	7.9	2.0	15.7	280.2	17.0	1.6	1.9	1.9	1.6	4.1	15.2	8.1	5.2	7.0	6.8	0.4	0.7	8.1	1.5	5.3	4.8	7.0	0.6	1.1	3.3	7.6	3.1	2.5	5.0	1.8	58.0	0.7	2.7	2.5	1.5	7.3	4.8	46.0	1.0	6.2	0.2	1.8	12.2	1.2	0.0	4.1	0.9	7.9	2.7	6.2	1.3	0.0	7.2	1.1	23.3	0.8	1.7	0.2	2.6	0.6	2.0	0.0	0.2	9.6	1.2	0.1	0.3	3.9	0.4	7.2	0.1	11.4	0.3	0.1	7.7	0.3	0.3	9.7	0.0	0.5	7.3	3.0	2.2	1.6	0.0	15.3	2.0	17.1	30.8	2.0	23.6	0.1	0.7	1.7	9.9	2.5	0.4	14.1	8.4	0.0	0.7	2.1	0.0	0.0	87.9	18.5	7.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	91.6	75.4	0.3	145.7	280.2	17.0	4.1	15.2	0.7	3.1	58.0	46.0	4.7	0.0	0.0	9.4	0.3	1.1	2.7	0.9	0.0	6.6	3.3	1.5	18.0	4.3	3.0	3.7	2.1	0.0	2.3	0.0	0.0	7.3	1.7	1.7	3.2	4.2	1.8	0.0	41.7	3.8	0.0	1.5	0.5	3.0	0.0	1.5	5.0	0.4	0.2	0.0	50.4	0.2	6.1	0.3	0.9	0.8	1.8	0.3	1.8	1.9	0.0	4.8	6.2	19.1	10.5	2.0	0.0	2.2	0.9	3.8	0.1	0.5	2.2	3.3	0.0	2.4	2.8	0.2	1.3	0.1	1.0	0.0	1.7	0.3	0.0	3.4
NR1H3	"LXR-a, LXRa, RLD-1"	ENSG00000025434	"Nuclear receptor subfamily 1 group H member 3"	Q13133	11	47248300-47269033	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 66.6;Hofbauer cells: 54.4;Kupffer cells: 100.9;Proximal enterocytes: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 13.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 45.3;HSkMC: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036443, CAB037109"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB037109: AB_1840991, HPA036443: AB_10966142"	"unprognostic (2.95e-3)"	"unprognostic (5.31e-3)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (3.56e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.40e-4)"	60.7	19.9	11.3	19.4	11.8	3.3	51.1	11.2	14.3	25.3	10.2	24.6	48.4	13.6	17.6	7.6	20.3	19.6	18.5	10.3	11.1	23.4	83.8	24.1	46.7	11.0	12.1	15.2	16.7	6.8	7.2	25.4	11.7	19.4	12.0	2.2	14.8	11.5	9.1	11.7	41.0	7.9	10.5	53.2	16.3	21.8	13.8	11.0	20.3	6.3	13.6	22.4	17.5	11.5	3.5	13.8	6.4	6.1	41.0	45.3	31.1	3.5	17.9	5.7	8.8	17.0	43.2	6.1	6.5	2.8	2.1	9.2	7.6	6.1	3.8	5.8	6.1	8.3	18.7	26.1	17.5	2.9	1.0	61.2	3.7	8.7	5.5	9.7	5.0	9.4	10.2	2.5	4.5	14.8	5.8	17.0	7.1	18.7	4.5	8.4	8.3	4.1	5.0	31.9	6.1	2.3	12.2	7.9	10.4	6.1	19.5	8.8	1.3	4.5	6.1	9.1	2.0	11.9	18.3	7.6	8.2	3.9	2.2	7.8	2.7	2.5	1.4	13.3	1.9	1.0	1.5	1.3	4.3	0.7	1.7	1.4	1.6	5.8	4.2	0.7	3.8	1.9	11.3	11.8	11.2	14.3	10.3	11.1	11.0	12.1	11.7	10.5	13.8	11.5	27.2	0.0	11.3	8.1	3.0	3.3	8.6	4.6	2.2	2.4	12.7	12.1	6.6	15.7	4.9	5.5	2.1	11.0	1.5	24.4	11.7	5.8	31.0	2.4	15.3	12.5	1.8	7.0	9.2	8.7	13.3	14.1	17.9	2.8	13.3	7.1	24.7	66.6	54.4	1.7	10.9	14.6	2.0	100.9	3.3	49.0	9.0	24.7	3.6	1.0	5.4	4.4	2.1	3.0	5.6	4.2	10.7	6.0	2.4	4.1	69.5	26.1	2.5	0.8	19.7	7.4	16.3	32.4	16.8	3.0	2.4	6.6	2.1	5.4	19.0	6.3
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073628	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898"	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.62e-5)"	8.3	10.4	4.9	5.0	5.6	9.3	7.7	14.0	9.3	9.3	8.2	8.6	5.6	10.3	9.9	5.4	10.2	4.4	10.0	5.1	5.1	6.6	10.0	8.6	5.5	4.7	4.9	9.9	8.2	6.1	7.2	5.8	5.6	6.7	6.2	15.6	5.2	7.5	14.3	6.1	7.6	7.8	4.6	9.2	6.1	11.9	5.6	5.7	11.9	5.5	5.3	8.1	7.4	6.9	11.4	13.9	23.0	10.2	5.8	10.0	30.5	10.9	7.9	10.6	9.9	12.2	6.2	13.8	3.8	7.3	6.8	11.8	10.7	8.6	8.1	6.0	23.1	16.7	11.5	15.4	11.1	11.3	7.0	10.2	7.0	7.9	9.5	13.3	11.6	16.8	12.9	5.2	12.9	8.3	12.4	26.0	14.5	9.1	24.0	11.7	15.0	8.1	12.3	13.9	11.1	8.8	17.6	7.4	8.4	11.8	12.9	7.5	10.9	8.6	8.4	10.7	6.2	7.7	13.1	13.0	2.1	13.0	4.2	0.3	2.4	2.1	3.9	2.6	5.0	2.0	3.1	3.3	3.7	2.3	4.0	2.8	1.5	2.1	2.3	3.6	2.3	2.3	4.9	5.6	14.0	9.3	5.1	5.1	4.7	4.9	5.6	4.6	5.6	6.9	18.7	35.3	15.4	28.4	14.4	8.3	14.4	7.8	15.4	44.8	7.6	7.5	18.5	8.6	5.6	11.0	18.8	15.3	19.9	10.3	3.9	11.6	25.2	14.8	23.3	15.5	7.2	15.6	55.4	9.4	12.7	17.4	16.3	18.8	10.1	28.0	13.2	12.7	9.5	25.2	73.4	11.4	12.2	11.1	9.5	6.4	43.8	10.9	14.2	34.7	10.7	14.9	12.3	26.2	51.1	18.7	9.9	30.1	13.7	9.4	5.8	8.1	19.6	49.6	6.6	17.3	14.6	67.0	25.9	12.1	7.4	7.8	15.0	18.0	13.3	20.2
NR2F1	"COUP-TFI, COUPTF1, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1"	ENSG00000175745	"Nuclear receptor subfamily 2 group F member 1"	P10589	5	93583222-93594611	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 294.1;Hepatic stellate cells: 171.4;Leydig cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 232.4;AN3-CA: 92.9;HHSteC: 174.1;hTERT-RPE1: 155.1;PC-3: 194.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019281, HPA058974"			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Cytosol	"CAB019281: , HPA058974: AB_2732629"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.75e-1)"	"unprognostic (7.68e-3)"	"unprognostic (3.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.24e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (1.47e-4)"	42.2	40.3	41.8	5.0	39.0	0.2	20.4	32.9	50.7	65.1	12.8	11.3	2.6	29.4	25.2	10.4	77.9	34.3	16.1	44.7	25.6	32.8	13.0	44.4	8.3	31.6	41.1	62.7	7.6	1.6	21.6	52.6	23.8	44.9	3.0	8.7	6.9	40.3	0.3	2.0	7.4	11.8	31.5	7.2	28.8	3.8	42.4	2.1	16.9	3.6	3.8	49.1	40.6	30.8	20.1	9.5	232.4	92.9	48.3	14.8	11.0	11.6	4.7	6.9	7.1	1.3	3.6	0.1	0.7	4.7	2.8	5.0	5.7	0.4	3.0	24.7	45.2	9.2	61.9	15.1	174.1	1.9	0.9	69.7	0.1	3.3	1.3	155.1	26.3	0.1	0.1	0.1	21.4	0.1	0.0	2.7	0.1	1.4	194.2	2.8	1.9	0.1	1.4	0.8	23.9	48.4	5.2	0.0	0.6	4.0	1.9	3.7	26.7	39.3	1.8	20.6	29.4	0.0	0.0	0.1	64.2	0.8	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	39.0	32.9	50.7	44.7	25.6	31.6	41.1	23.8	31.5	42.4	30.8	16.1	0.0	1.7	68.2	1.5	1.3	0.2	0.4	1.8	32.8	3.8	2.4	37.3	1.5	3.5	14.7	54.2	0.6	0.0	0.2	7.9	4.0	3.8	10.1	294.1	70.1	0.0	0.0	23.3	1.6	0.6	69.1	0.5	5.7	0.0	29.7	171.4	5.0	1.3	0.0	47.1	0.0	0.0	15.8	0.4	5.9	93.5	1.9	0.0	59.0	0.0	69.0	0.0	13.0	1.7	3.6	0.0	10.5	0.0	0.5	0.1	37.3	10.8	3.7	13.1	2.9	51.6	4.8	4.4	2.8	0.6	1.1	2.2	11.8	0.0	0.6
NR2F2	"ARP1, COUP-TFII, COUPTF2, COUPTFB, NF-E3, SVP40, TFCOUP2"	ENSG00000185551	"Nuclear receptor subfamily 2 group F member 2"	P24468	15	96325938-96340263	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 292.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 542.2;Hepatic stellate cells: 395.5;Leydig cells: 510.4;Peritubular cells: 610.5;Sertoli cells: 486.4;Smooth muscle cells: 385.7;Theca cells: 572.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058974			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA058974: AB_2732629"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.28e-2)"	95.5	43.1	32.7	18.8	19.2	0.1	59.7	15.0	19.6	128.6	23.5	52.6	21.5	120.9	61.8	22.1	101.5	65.7	44.4	20.0	24.8	79.8	32.1	56.8	42.4	16.2	21.9	292.4	20.0	30.7	20.3	74.7	18.2	60.6	26.7	2.5	22.9	126.4	33.1	24.1	32.1	81.8	12.5	106.2	82.3	26.7	49.3	7.8	46.2	31.5	15.1	46.3	74.5	10.7	154.7	39.1	125.6	78.5	249.1	85.5	41.9	109.1	83.2	111.1	94.3	134.8	153.4	0.1	86.8	55.2	44.1	90.4	22.3	78.3	138.8	0.5	86.5	49.9	48.7	24.6	69.5	38.7	18.0	61.3	26.5	92.5	19.8	130.5	207.3	0.1	135.3	0.4	71.2	105.5	0.1	27.6	1.2	59.6	52.7	0.1	30.9	0.2	244.7	165.7	15.8	0.2	12.3	3.7	17.5	55.0	61.1	2.8	215.3	119.9	39.7	28.3	38.8	0.1	0.4	0.4	67.0	18.9	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	19.2	15.0	19.6	20.0	24.8	16.2	21.9	18.2	12.5	49.3	10.7	133.4	28.9	18.1	0.7	1.1	14.4	24.9	71.7	39.3	7.5	51.9	50.8	46.4	203.0	34.6	62.5	25.0	126.2	2.0	35.7	46.9	22.0	3.2	70.9	542.2	166.1	26.4	5.3	0.1	10.9	50.3	125.8	80.0	68.9	0.0	41.5	395.5	51.6	10.3	3.3	24.8	35.5	32.6	12.2	20.1	22.9	510.4	5.0	26.6	36.5	0.6	30.2	0.0	0.0	0.5	15.6	23.9	610.5	2.8	22.3	14.3	65.5	37.3	13.8	486.4	27.8	385.7	6.4	7.9	20.5	10.4	35.3	5.8	572.5	27.1	21.3
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771311	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 22.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.5;Extravillous trophoblasts: 160.0;Inhibitory neurons: 114.7;Oligodendrocyte precursor cells: 112.6;Spermatogonia: 111.1"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 110.7;CACO-2: 26.5;Hep G2: 25.8;K-562: 34.1;NTERA-2: 39.2;U-266/84: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: AB_2673894, HPA045145: AB_2679233"	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.3	0.8	1.8	0.9	1.9	4.4	0.9	2.2	1.9	0.8	4.5	2.2	1.7	0.5	0.5	1.9	0.5	0.4	1.0	1.8	1.5	1.7	2.7	1.5	0.3	2.0	1.5	0.3	2.9	0.8	1.4	2.3	1.5	1.4	1.5	3.1	1.2	0.5	1.4	2.2	2.5	0.4	1.4	0.8	0.4	22.9	3.4	0.1	5.4	0.8	0.7	0.7	1.3	1.6	1.2	3.0	14.7	2.0	0.3	0.2	110.7	0.2	1.1	0.8	1.3	26.5	2.9	5.0	1.0	0.1	3.8	2.8	1.6	1.3	1.7	1.1	4.6	4.1	4.8	25.8	0.1	2.3	7.2	0.1	1.3	1.2	1.6	0.3	0.2	1.2	34.1	0.7	0.6	0.6	0.1	3.2	39.2	1.3	1.1	1.2	1.5	2.2	0.5	2.0	2.2	0.8	0.2	0.7	0.9	21.7	2.6	1.3	0.0	1.4	3.1	0.9	0.7	3.3	25.0	4.3	0.9	2.3	0.8	0.0	0.6	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	4.9	0.0	0.3	0.1	0.0	0.1	1.8	1.9	2.2	1.9	1.8	1.5	2.0	1.5	1.5	1.4	3.4	1.6	0.8	0.0	7.7	47.0	0.6	37.3	17.4	4.2	13.6	3.8	6.8	3.7	2.0	7.2	5.9	5.5	29.2	36.7	1.6	8.9	1.9	10.1	53.5	4.1	0.9	3.2	4.8	6.1	105.5	3.5	160.0	2.0	2.0	3.7	1.3	16.1	1.4	6.0	8.2	1.7	114.7	6.9	8.2	2.2	30.6	30.3	1.2	3.2	8.8	54.4	5.2	7.0	0.0	112.6	73.0	1.9	6.0	1.9	0.5	19.4	24.5	3.3	8.6	10.7	0.0	1.5	3.5	72.7	111.1	8.6	39.8	30.6	0.3	8.1	11.9	15.5
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588714-113664070	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 2363.9;tongue: 1144.8"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 534.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037953, HPA037954, HPA075074"	Enhanced		Approved	"Vesicles,Intermediate filaments,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"	"Vesicles, Cytosol"	"HPA037953: AB_2675755, HPA037954: AB_10672394, HPA075074: "	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		0.3	0.1	0.1	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	24.8	0.0	0.2	428.6	0.2	0.0	0.1	0.5	0.4	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.0	20.4	1.0	0.0	22.1	0.0	2363.9	0.8	0.1	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.4	1144.8	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	534.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.1	0.0	3.7	0.0	0.0	0.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	4.8	0.0	0.0	0.3	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	57.3	3.3	1.0	2.3	0.0	0.1	0.0	0.2	0.0	0.5	0.0
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137299631-137302271	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 47.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.3;Basal keratinocytes: 97.0;Langerhans cells: 97.9;Squamous epithelial cells: 101.8;Suprabasal keratinocytes: 381.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 45.1;MCF7: 23.3;NTERA-2: 31.9;OE19: 30.8;T-47d: 23.1;TIME: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	8.9	1.7	7.8	7.6	7.9	1.5	6.9	8.8	7.8	6.5	4.2	47.9	22.0	4.4	1.2	22.6	3.6	12.0	12.5	7.3	10.8	6.1	2.7	7.1	1.6	11.5	12.6	2.0	16.8	2.7	7.6	10.3	10.5	9.5	30.5	1.5	3.0	2.1	2.9	26.3	17.8	3.4	9.8	4.2	8.7	10.2	14.8	2.7	4.9	6.5	4.1	10.4	13.5	6.6	4.8	1.0	8.0	8.8	0.0	0.0	2.6	0.1	0.2	0.0	0.1	6.8	3.0	0.0	10.2	0.0	0.4	45.1	13.9	0.4	0.1	0.3	20.6	1.4	2.1	7.6	0.8	2.8	4.3	0.0	2.3	0.0	0.6	0.2	11.8	0.1	11.8	0.3	0.0	23.3	0.2	6.4	31.9	30.8	6.7	8.4	1.5	17.7	1.2	0.6	4.9	8.1	1.4	2.4	0.1	1.7	23.1	5.8	31.9	0.0	0.1	0.1	1.9	0.3	0.2	3.0	0.1	5.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.9	8.8	7.8	7.3	10.8	11.5	12.6	10.5	9.8	14.8	6.6	75.3	0.0	0.0	33.3	17.6	97.0	5.9	20.1	15.9	0.6	24.4	39.2	4.4	5.7	14.3	0.0	0.0	0.1	9.7	22.4	0.0	0.5	17.3	35.2	4.4	21.9	10.2	0.0	2.5	1.1	0.0	2.1	19.4	43.0	0.0	0.3	8.9	0.1	0.4	0.0	0.4	20.5	8.2	0.6	97.9	5.2	0.0	18.6	17.8	9.4	0.0	6.8	0.0	2.0	0.6	0.6	28.3	0.4	3.9	6.2	5.0	0.1	3.2	2.8	6.6	4.0	32.1	0.1	0.6	101.8	381.0	0.0	6.7	3.7	23.4	6.0
NRBF2	"COPR1, COPR2, DKFZp564C1664, FLJ30395"	ENSG00000148572	"Nuclear receptor binding factor 2"	Q96F24	10	63133247-63155031	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 687.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 687.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021670, HPA059477"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"HPA021670: AB_2670803, HPA059477: AB_2684032"	"unprognostic (7.71e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.59e-2)"	18.8	12.6	8.7	20.9	9.2	33.8	17.8	10.5	12.1	15.0	8.6	16.6	16.8	13.1	11.1	14.9	9.5	17.2	12.6	9.5	10.2	14.1	45.1	16.4	21.2	11.0	13.0	11.4	10.4	10.8	9.7	22.0	13.1	10.3	16.7	7.2	14.5	8.6	24.7	15.3	15.7	14.2	10.3	22.6	13.4	11.9	10.5	22.5	18.5	26.3	20.2	19.8	10.7	10.7	23.9	20.8	20.7	19.3	48.5	74.5	20.7	33.2	56.4	26.0	36.7	44.5	24.9	30.8	15.8	37.6	26.1	18.3	20.3	28.0	35.7	27.7	19.6	22.9	10.3	36.0	61.4	30.6	25.5	69.1	59.0	42.5	103.4	48.8	27.1	19.7	23.4	34.8	33.6	17.4	25.9	54.1	24.3	19.4	84.8	25.0	18.8	18.2	30.2	13.4	11.9	20.3	19.9	38.4	61.7	33.8	23.8	30.0	28.2	18.1	26.7	28.3	36.2	43.5	35.6	37.2	50.6	48.2	14.8	124.6	79.5	162.1	28.8	92.3	30.4	47.9	29.4	32.2	68.7	42.5	35.9	33.1	687.6	32.6	93.4	34.1	36.6	55.2	8.7	9.2	10.5	12.1	9.5	10.2	11.0	13.0	13.1	10.3	10.5	10.7	29.7	3.2	30.6	3.9	45.7	28.8	41.8	42.8	20.5	12.2	30.1	40.0	8.9	14.3	30.6	12.9	4.2	53.1	44.0	31.5	23.5	31.6	10.3	30.6	49.9	26.0	15.6	13.2	9.4	35.0	76.8	34.8	16.8	37.7	14.0	15.2	17.9	53.2	48.9	20.2	8.4	41.1	32.6	49.7	34.9	6.3	23.3	56.0	46.2	10.3	56.6	15.4	35.0	5.5	9.3	40.0	32.0	21.4	43.1	40.0	31.9	31.4	24.7	9.0	19.7	26.0	30.6	55.4	71.1	29.4	31.8	285.3	43.3	25.2	29.6	68.6
NRBP2	DKFZp434P086	ENSG00000185189	"Nuclear receptor binding protein 2"	Q9NSY0	8	143833583-143840973	"Enzymes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.2;Oligodendrocytes: 120.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020944, HPA029051, HPA029052"	Approved		Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"CAB020944: , HPA029051: AB_2672886, HPA029052: AB_10602714"	"unprognostic (1.84e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (3.86e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.04e-1)"	18.8	9.6	21.4	6.4	35.9	1.6	18.4	35.6	28.7	15.1	12.6	28.2	7.6	17.3	7.4	9.5	17.6	10.3	15.1	24.9	25.8	18.1	32.3	16.6	4.5	49.6	35.7	13.4	10.7	8.9	14.5	5.7	47.1	19.6	5.6	7.4	19.7	12.6	6.9	17.7	11.1	11.7	30.6	7.1	14.0	6.9	36.4	3.9	15.8	7.1	3.4	14.2	14.0	48.5	10.2	12.9	11.4	14.0	16.5	25.6	2.6	18.7	9.0	7.2	10.3	3.1	8.8	1.1	5.3	24.1	5.2	15.5	7.0	6.6	3.2	12.4	4.7	2.0	36.0	5.3	18.1	0.0	4.1	30.3	15.5	3.1	3.5	22.4	10.5	3.4	6.7	12.7	15.2	3.5	0.8	0.4	3.7	10.1	5.5	3.4	10.0	4.5	8.9	3.1	3.9	7.2	25.3	13.3	10.1	5.9	18.7	0.8	22.5	4.6	12.5	20.4	6.8	6.3	0.5	0.3	22.8	4.1	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.9	35.6	28.7	24.9	25.8	49.6	35.7	47.1	30.6	36.4	48.5	15.1	44.8	13.7	134.2	2.0	9.2	6.2	5.2	5.7	15.4	16.3	23.2	9.9	41.5	10.4	11.0	14.6	0.9	3.2	9.2	0.0	4.3	0.5	8.1	15.2	10.4	9.0	0.0	41.8	4.0	1.0	11.2	15.3	14.1	0.0	8.5	7.5	41.7	2.8	16.8	32.7	8.4	16.2	5.7	4.6	1.2	28.9	4.5	10.6	22.5	3.9	17.7	3.1	30.2	120.7	5.4	3.6	21.4	2.3	7.1	3.9	4.4	7.0	11.4	13.1	14.2	18.3	1.2	3.3	4.7	9.1	0.8	4.4	7.2	6.2	5.0
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 219.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193"	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	30.4	10.2	5.8	10.2	5.2	26.4	14.2	14.9	6.9	24.7	6.5	18.2	16.8	18.2	13.4	9.4	21.4	10.3	5.4	6.4	8.1	15.9	26.9	8.9	8.7	4.8	4.5	13.3	14.4	7.4	3.2	14.6	5.3	10.3	18.1	31.8	6.1	8.4	22.3	4.1	18.3	20.1	6.4	13.1	8.9	8.1	6.7	17.0	5.6	23.8	7.2	14.1	8.4	8.3	22.1	43.5	34.6	0.0	17.4	11.3	12.6	26.1	11.7	16.0	12.5	8.7	17.3	0.1	14.5	23.3	7.9	11.0	2.2	15.6	33.9	0.0	10.0	33.4	15.3	27.2	10.5	16.7	6.7	14.1	21.3	17.6	20.5	17.8	12.6	4.8	24.1	17.4	11.4	11.8	7.8	0.1	14.5	8.8	13.9	92.4	28.0	0.8	9.8	35.8	3.2	0.1	21.7	11.3	8.8	27.7	27.2	12.9	22.0	13.7	9.1	21.4	10.8	8.5	0.2	0.1	29.0	0.0	6.8	0.0	0.4	0.2	0.3	0.2	1.8	0.3	0.3	0.4	0.6	1.0	0.5	0.2	0.1	0.5	0.5	0.6	0.2	0.2	5.8	5.2	14.9	6.9	6.4	8.1	4.8	4.5	5.3	6.4	6.7	8.3	33.2	48.1	37.6	60.7	27.4	18.6	122.6	16.2	22.8	33.9	52.9	26.8	18.3	21.5	40.9	29.5	50.1	16.4	20.7	50.1	9.8	23.0	15.8	60.9	99.1	43.0	37.7	24.2	123.7	27.6	120.8	42.3	26.5	130.9	31.5	94.0	27.1	44.7	45.7	21.9	95.0	41.6	18.3	50.4	21.9	19.3	37.6	57.9	8.8	219.2	40.4	56.2	27.8	102.1	78.2	31.4	42.6	27.1	10.1	49.5	43.0	36.5	15.9	63.1	32.9	112.1	38.6	12.1	6.3	23.1	18.8	14.1	19.9	71.0	47.7	99.8
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Rod photoreceptor cells: 8.8;Sertoli cells: 26.3;Smooth muscle cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	3.9	7.7	3.6	12.4	4.0	5.1	23.4	10.2	7.0	4.8	5.3	2.4	7.4	7.2	2.4	4.8	5.9	5.2	5.8	10.6	12.0	1.6	1.8	4.1	12.4	10.0	8.4	3.0	0.6	2.8	2.6	12.9	4.1	3.0	3.9	3.6	4.9	4.9	2.6	4.7	4.9	8.1	9.1	3.6	2.1	12.0	3.0	5.5	7.5	2.6	4.3	4.7	13.3	0.4	0.9	1.5	0.8	0.0	0.0	1.8	1.1	0.0	0.0	0.0	2.3	1.1	1.2	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.9	1.3	2.0	2.9	0.2	0.0	2.4	1.4	0.0	0.0	0.0	0.0	2.2	0.0	1.3	1.1	2.7	0.0	1.0	1.5	1.2	1.5	0.9	0.4	0.9	1.6	0.7	0.0	1.5	1.1	1.7	0.8	1.2	0.3	2.7	0.8	0.4	1.2	0.6	0.7	0.9	1.6	0.4	0.1	1.8	1.5	1.1	0.8	3.7	0.3	0.1	0.5	0.2	0.3	0.7	0.4	0.5	0.2	0.6	0.8	0.3	0.1	0.4	0.1	0.3	0.1	0.1	7.7	12.4	23.4	10.2	5.8	10.6	12.4	10.0	12.9	8.1	12.0	13.3	0.6	0.0	1.1	0.0	0.2	0.1	0.5	0.0	0.0	5.0	0.1	0.9	1.3	0.0	0.0	1.8	6.2	0.3	0.3	0.0	0.0	0.0	1.6	0.2	0.9	0.6	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.4	0.0	0.1	3.3	3.3	0.0	0.0	0.6	0.3	1.8	0.3	0.5	0.0	2.8	0.0	0.6	3.1	0.5	4.9	0.0	0.0	5.3	0.0	0.3	0.0	0.2	0.0	8.8	26.3	0.5	23.1	0.1	0.3	0.1	0.1	0.0	1.1	0.4	0.0	0.1
NRIP3	C11orf14	ENSG00000175352	"Nuclear receptor interacting protein 3"	Q9NQ35	11	8980576-9004049	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.9;retina: 24.5;testis: 43.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 545.3;Horizontal cells: 242.3;Late spermatids: 478.6;Spermatocytes: 189.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 13.1"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 51.4;SiHa: 34.3;U-87 MG: 47.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058827, HPA072961"	Approved		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA058827: AB_2683829, HPA072961: "	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.03e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.88e-3)"	"unprognostic (1.30e-1)"	1.1	10.2	16.7	1.6	13.4	13.8	3.9	23.2	42.1	3.4	0.0	1.5	0.5	3.2	3.1	0.8	2.2	1.6	1.2	72.9	20.8	1.4	0.2	0.8	0.8	20.5	18.4	0.5	0.4	5.4	1.5	0.8	23.6	0.7	0.6	24.5	0.6	0.9	0.3	0.6	0.6	2.3	25.1	0.5	2.5	43.5	31.6	0.9	0.9	0.2	0.6	1.3	0.7	17.2	0.0	0.9	1.9	0.3	0.7	2.7	0.1	20.3	8.0	16.2	16.9	3.1	1.8	0.1	3.0	5.9	9.6	0.2	5.5	0.5	28.0	1.7	8.5	2.2	1.2	0.2	1.4	26.5	51.4	3.7	0.3	16.7	0.1	17.1	13.3	4.4	4.2	0.2	15.0	0.0	1.3	8.6	6.6	0.1	0.0	0.0	2.8	0.0	0.3	1.2	5.4	1.7	34.3	0.9	5.3	1.4	3.5	2.5	16.6	24.7	11.8	1.4	0.1	0.1	0.0	0.0	47.9	3.1	12.3	13.1	0.1	2.0	0.1	0.3	0.2	0.1	0.5	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.3	16.7	13.4	23.2	42.1	72.9	20.8	20.5	18.4	23.6	25.1	31.6	17.2	4.0	0.0	1.3	1.0	1.7	2.2	5.7	0.5	0.0	19.6	12.1	8.9	1.6	0.0	0.4	0.0	10.4	0.4	7.4	0.6	5.9	0.4	545.3	3.7	4.1	2.5	5.3	2.7	11.5	1.1	0.5	2.5	7.1	6.6	15.8	2.4	0.0	0.0	12.1	242.3	96.3	0.5	8.2	3.1	17.2	478.6	6.8	12.8	3.6	0.0	0.6	4.4	0.0	4.5	1.6	8.2	0.1	5.7	1.2	3.5	0.1	0.0	0.1	10.6	0.0	6.0	3.6	189.8	44.0	0.9	1.0	1.0	5.5	5.6	0.2	4.2
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822539-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.1;ovary: 32.5;placenta: 24.2"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 79.4;Leydig cells: 113.4;Syncytiotrophoblasts: 67.9;Theca cells: 70.2"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	11	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 58.1;HSkMC: 10.6;RH-30: 12.8;RPTEC TERT1: 34.8;SuSa: 40.5"	"Region enriched"	"Detected in single"	28	"cerebellum: 14.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.6"	HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	0.8	16.1	0.0	0.9	0.0	0.0	0.7	7.0	0.3	1.8	0.0	1.4	0.1	1.7	4.6	0.6	0.9	10.1	3.5	0.0	0.1	6.2	0.1	0.2	0.0	0.1	0.6	32.5	0.4	0.1	0.3	24.2	0.5	4.9	0.3	0.1	1.1	0.9	0.2	0.1	0.3	1.7	0.1	0.0	0.5	3.3	0.0	0.1	0.2	3.3	0.0	1.0	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	10.6	0.0	0.1	0.0	3.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.8	0.0	34.8	0.7	0.0	0.2	0.0	1.8	0.0	40.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.1	0.1	0.6	0.5	0.1	0.0	0.4	3.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	1.2	1.0	4.8	0.0	0.0	0.0	0.0	79.4	0.0	0.2	19.6	0.2	1.3	0.0	3.2	0.7	0.0	0.0	0.9	0.0	10.1	8.9	0.0	0.0	0.0	2.1	0.0	0.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	2.6	113.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.5	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.7	1.6	1.7	0.1	0.0	67.9	0.0	70.2	0.2	0.1
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126186-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 542.9;choroid plexus: 474.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 139.1;Horizontal cells: 121.1;Inhibitory neurons: 111.9;Oligodendrocyte precursor cells: 69.9"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 11.2;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		0.0	4.9	276.8	0.4	315.2	0.2	0.0	108.9	281.1	0.1	474.7	1.2	0.4	0.2	0.0	0.1	0.0	0.2	0.0	138.2	466.8	0.1	0.0	0.0	0.1	263.2	332.8	0.0	1.2	0.0	23.5	0.0	468.0	0.0	0.4	22.6	0.1	0.0	0.7	0.1	0.3	0.3	194.7	0.1	0.4	0.3	459.9	0.0	0.1	0.0	0.1	0.0	0.1	542.9	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	11.2	9.2	0.0	0.0	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.2	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.8	315.2	108.9	281.1	138.2	466.8	263.2	332.8	468.0	194.7	459.9	542.9	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.1	0.0	0.0	139.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	121.1	111.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	23.7	0.0	69.9	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 154.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	19.9	57.0	105.7	10.5	114.4	1.7	17.4	87.8	154.7	30.1	71.3	28.3	6.0	32.5	25.9	9.7	27.9	15.4	30.9	114.3	100.6	33.0	4.8	22.4	7.5	94.4	92.0	36.0	20.3	42.6	60.4	16.9	93.9	28.3	9.7	56.9	21.1	25.5	3.4	11.4	13.1	27.5	80.5	16.8	20.2	30.6	96.6	5.5	28.1	5.7	7.2	23.5	18.2	102.9	56.5	68.3	40.2	37.7	53.0	58.4	15.2	37.4	72.3	66.3	66.8	38.2	1.2	0.0	12.6	70.7	48.9	24.1	33.5	5.8	42.4	0.3	33.0	20.8	32.5	70.7	53.5	0.6	3.3	67.4	4.5	48.2	8.1	54.1	46.4	0.3	40.3	35.1	59.2	10.0	0.9	17.9	31.3	0.7	34.9	32.4	22.1	2.7	67.4	0.3	80.8	58.0	44.9	13.0	64.9	26.5	53.2	19.7	31.0	70.6	36.4	2.6	45.6	6.5	1.4	14.7	9.5	0.6	36.7	0.0	0.7	1.2	2.4	0.3	0.7	5.6	0.8	2.6	1.5	6.9	1.0	1.8	0.0	2.8	0.3	3.5	0.6	1.1	105.7	114.4	87.8	154.7	114.3	100.6	94.4	92.0	93.9	80.5	96.6	102.9	3.8	0.0	3.1	16.0	2.2	3.2	3.6	8.5	7.4	26.5	5.8	5.0	5.5	1.5	6.1	12.9	2.1	7.3	0.5	2.6	1.9	14.7	9.6	4.7	12.0	6.9	29.4	1.3	21.0	1.6	6.8	10.4	3.1	3.9	5.1	7.6	5.7	0.3	3.2	16.8	27.1	2.6	4.1	0.9	2.2	14.4	13.1	0.7	3.6	2.8	2.1	17.3	2.1	12.1	5.9	2.9	1.8	10.5	2.6	3.3	0.2	7.8	3.6	15.4	19.7	4.9	9.2	21.3	12.8	1.4	2.3	4.4	1.4	12.9	2.2	2.9
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1900000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	22.8	37.7	38.3	13.5	39.5	27.8	21.5	37.0	45.9	23.2	41.6	23.0	14.9	22.5	26.8	28.5	26.1	13.5	29.1	39.7	38.6	21.4	26.3	18.0	15.2	39.0	39.0	25.7	15.5	23.9	14.1	21.1	39.8	20.9	18.4	22.6	19.3	26.4	69.0	36.6	17.6	22.9	36.4	19.8	18.0	14.8	38.6	21.0	20.0	43.3	18.6	22.4	21.6	39.7	55.6	64.4	35.9	32.0	30.5	31.4	28.7	21.0	41.8	57.7	41.3	53.9	43.1	31.6	16.6	47.8	47.2	50.4	25.9	70.3	40.8	12.3	25.1	29.8	10.3	61.4	33.8	30.7	16.4	23.5	33.3	55.3	20.3	30.8	46.8	23.4	42.5	26.5	36.2	29.1	31.4	54.7	40.7	42.5	65.4	14.7	41.1	29.8	68.6	37.1	20.5	23.4	29.6	59.8	26.7	18.8	36.5	22.0	37.8	38.7	29.4	23.9	40.2	21.9	41.8	24.7	28.9	43.0	29.3	31.4	21.3	80.3	20.0	26.6	19.7	35.0	21.2	19.5	29.7	36.0	23.4	20.7	69.1	16.7	28.1	23.1	28.2	25.5	38.3	39.5	37.0	45.9	39.7	38.6	39.0	39.0	39.8	36.4	38.6	39.7	34.6	22.4	23.2	17.3	36.1	89.2	63.5	106.3	44.3	60.2	28.6	26.0	35.4	24.3	57.8	31.3	22.9	150.7	29.7	68.2	56.7	104.7	23.0	51.0	29.6	44.3	43.6	41.0	24.0	94.5	146.0	41.1	30.5	54.9	40.5	49.1	31.1	42.2	81.1	70.7	24.8	42.5	61.1	43.7	43.6	38.8	39.1	43.8	42.7	14.0	52.9	61.7	32.0	17.6	31.2	123.4	65.7	46.3	41.8	76.0	66.4	73.8	43.2	44.5	78.9	44.2	64.7	106.1	103.2	55.1	75.7	151.6	31.6	48.9	44.0	88.5
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014114-33062797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 191.0;Paneth cells: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010520, HPA010630, HPA029058"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.4	14.3	11.4	26.1	11.4	32.6	21.3	15.2	15.6	12.6	10.8	51.9	40.0	16.9	14.3	18.6	15.9	23.4	16.6	11.5	11.5	22.4	11.8	17.6	30.8	11.1	11.8	13.4	21.4	9.7	7.5	16.3	11.5	12.3	51.0	20.4	9.7	10.0	87.4	28.7	37.3	13.2	12.7	22.9	27.0	9.5	12.0	22.5	17.1	51.0	45.8	23.8	14.4	13.1	42.2	27.6	25.2	29.6	21.2	16.1	20.3	44.8	30.5	29.2	38.9	19.9	115.1	100.4	27.7	29.6	48.3	63.8	28.3	30.8	40.4	16.2	36.2	54.7	36.5	28.7	23.3	55.6	36.9	21.7	23.8	35.9	63.0	16.4	22.2	33.2	43.3	24.8	37.3	29.9	25.0	87.8	27.8	47.1	31.2	25.9	22.9	60.0	87.8	39.8	28.1	37.0	31.1	52.4	66.6	24.5	35.2	33.5	19.8	25.1	20.9	42.6	55.7	50.6	69.0	54.8	20.6	34.9	42.5	112.5	25.9	82.5	26.6	32.7	30.6	64.0	34.2	30.8	22.1	63.6	34.5	29.1	103.8	28.2	39.2	20.6	56.2	37.9	11.4	11.4	15.2	15.6	11.5	11.5	11.1	11.8	11.5	12.7	12.0	13.1	39.1	22.4	13.7	30.7	85.1	46.8	40.9	85.3	47.8	23.9	22.6	18.9	16.9	32.9	40.4	16.5	41.7	36.9	42.5	191.0	29.4	34.4	5.7	40.9	21.0	40.8	119.6	127.1	45.3	79.0	31.6	35.2	42.8	21.4	17.7	38.3	30.0	18.9	25.0	1.7	49.4	98.9	40.7	31.2	23.5	5.0	33.8	111.4	26.6	29.0	37.0	23.4	55.6	48.2	52.4	48.3	186.6	22.2	43.8	45.7	91.8	84.8	53.7	27.1	13.1	30.7	24.9	46.4	24.0	35.5	38.9	28.3	53.7	23.3	71.0	65.9
NT5DC1	"dJ486I3.1, MGC24302, NT5C2L1"	ENSG00000178425	"5'-nucleotidase domain containing 1"	Q5TFE4	6	116100851-116249497	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 117.6"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 429.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030352, HPA079264"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		140000	"Cluster 37: B-cells - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA030352: AB_2154066, HPA079264: "	"unprognostic (1.30e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.61e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.49e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.63e-2)"	19.5	24.0	11.4	12.7	24.6	10.0	19.2	22.7	15.0	10.4	117.6	19.8	29.5	9.1	22.4	16.5	20.6	15.7	25.9	11.0	16.3	28.2	42.6	16.7	21.4	24.1	20.9	13.2	22.2	23.8	9.6	8.3	24.1	28.3	19.9	11.2	22.7	16.6	21.5	10.7	26.8	11.3	21.0	13.5	21.6	10.6	19.3	14.5	28.3	23.2	22.4	15.8	9.4	40.9	24.7	20.3	17.7	23.7	19.2	11.6	31.0	17.7	40.3	27.4	32.2	29.4	24.8	50.3	37.4	15.9	29.7	38.7	12.1	28.1	23.8	78.4	26.7	21.0	16.7	31.0	20.9	46.8	1.9	21.7	22.2	17.6	15.0	59.2	24.7	30.0	26.6	27.5	34.8	25.3	9.0	16.3	16.2	54.1	27.0	52.3	48.3	27.2	25.5	29.2	11.8	17.6	37.9	28.7	26.5	19.4	26.6	9.3	21.6	12.3	20.8	23.7	35.6	40.2	59.2	39.8	29.3	31.0	22.4	14.5	18.2	33.2	20.2	10.5	31.4	41.3	29.8	25.4	24.6	30.1	28.2	24.3	12.9	23.1	12.7	12.4	32.4	19.7	11.4	24.6	22.7	15.0	11.0	16.3	24.1	20.9	24.1	21.0	19.3	40.9	15.4	64.1	45.7	62.3	37.9	26.1	37.9	66.5	29.6	14.0	30.3	23.6	44.2	25.8	44.5	18.4	27.1	41.6	24.9	19.1	64.6	39.6	19.8	32.9	10.7	21.7	26.5	16.2	96.1	40.8	30.4	14.0	26.5	19.0	23.5	16.2	33.5	49.3	31.8	45.4	70.1	30.6	30.5	29.2	14.2	8.3	19.0	18.5	19.6	54.4	49.6	19.8	10.3	29.7	429.4	28.8	19.6	20.7	25.3	28.0	54.6	57.4	76.7	20.2	32.9	29.2	23.9	17.2	28.5	27.4	21.5	25.6	23.8	18.3	35.9	31.5
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841234	"Metabolic proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 80.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 41.2;Excitatory neurons: 36.6;Oligodendrocyte precursor cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Mitochondria	Cytosol	"HPA041634: AB_10795597"	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.11e-4)"	2.9	4.0	14.2	1.9	12.0	17.5	3.3	0.0	13.3	9.3	0.0	80.5	1.0	23.1	5.0	5.2	3.7	1.4	1.9	23.3	7.8	2.0	5.0	2.8	1.3	1.5	1.8	2.9	3.5	0.8	4.5	1.5	1.4	7.5	7.7	2.3	4.1	5.4	7.8	2.5	4.7	6.8	1.2	1.6	6.6	3.1	8.9	0.6	1.9	3.3	1.2	21.7	5.7	4.8	3.6	6.5	3.6	4.2	5.1	4.0	6.8	5.9	3.5	4.1	2.6	4.4	0.9	6.1	1.1	7.0	4.5	4.1	5.2	11.7	5.9	4.5	4.2	7.6	2.5	5.2	2.8	4.1	1.9	3.5	2.5	5.3	22.7	8.3	2.4	3.0	12.2	3.0	9.2	3.3	3.6	6.6	4.5	5.2	6.9	4.9	6.3	2.3	6.5	2.4	4.9	2.0	4.9	5.4	7.1	3.3	3.1	3.8	3.2	4.0	4.8	5.5	11.9	2.7	3.5	4.4	3.8	6.2	6.0	0.4	0.5	0.0	0.6	0.6	1.2	1.3	0.9	0.5	1.5	1.4	0.7	0.6	0.9	0.6	0.4	1.9	0.2	0.3	14.2	12.0	0.0	13.3	23.3	7.8	1.5	1.8	1.4	1.2	8.9	4.8	1.4	0.0	2.3	3.9	2.7	4.5	21.9	3.0	21.6	2.0	5.6	7.4	3.8	2.8	2.1	1.8	0.0	5.2	2.7	5.8	0.0	2.1	12.1	14.0	11.9	1.7	41.2	1.3	36.6	2.0	4.7	3.8	7.7	19.4	0.0	3.7	0.7	5.3	1.8	10.1	24.4	11.4	10.2	4.1	6.5	10.5	5.0	2.8	0.0	6.5	2.9	0.8	1.0	29.1	2.7	2.7	2.2	8.2	2.7	13.0	1.1	2.1	6.9	5.0	0.0	5.6	5.7	0.4	3.1	9.0	4.4	4.1	2.5	4.1	9.2	9.8
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
NTPCR	"C1orf57, HCR-NTPase, MGC13186, THEP1"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA028125: AB_10601091, HPA054304: AB_2682443"	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	3.0	4.0	8.9	2.0	9.3	0.8	3.6	8.3	9.6	5.0	10.9	4.5	2.0	4.2	3.8	3.2	4.7	3.2	4.5	9.0	10.3	3.6	2.8	3.4	2.9	11.4	9.3	5.3	5.9	5.3	4.2	2.5	12.0	4.1	4.3	8.0	3.3	4.0	13.5	4.3	3.9	4.1	9.8	3.4	3.0	2.2	10.0	3.6	4.4	11.8	2.7	3.8	4.2	9.1	2.0	4.9	5.4	2.7	4.0	5.2	0.1	1.3	4.3	4.0	5.5	3.5	2.3	3.1	2.9	2.7	2.2	2.6	3.7	5.0	4.4	2.3	6.9	0.9	3.4	4.5	4.1	1.7	1.8	6.9	9.4	3.9	3.9	4.0	3.3	5.8	2.8	4.6	4.8	1.5	4.4	4.4	5.4	4.0	5.7	2.9	3.5	4.6	5.9	2.4	4.7	7.8	1.9	1.6	1.9	4.0	4.0	3.8	2.5	3.3	2.7	3.6	3.7	5.2	4.6	3.5	3.9	4.1	4.9	0.3	0.5	0.2	0.6	0.6	0.7	0.5	0.9	0.3	0.4	0.6	1.2	1.0	0.9	0.5	0.5	0.1	1.1	0.4	8.9	9.3	8.3	9.6	9.0	10.3	11.4	9.3	12.0	9.8	10.0	9.1	45.5	19.2	21.1	24.8	16.9	19.4	37.3	85.3	24.5	15.8	31.5	34.8	63.9	38.6	36.3	25.8	27.1	68.9	16.1	37.3	93.9	62.2	47.7	27.3	29.4	29.1	25.8	15.8	16.1	64.5	59.1	33.1	16.3	27.7	16.5	44.9	23.9	34.3	42.3	10.1	16.1	50.0	75.3	22.8	17.3	27.3	20.2	21.2	23.2	15.0	30.1	41.0	47.4	16.1	20.8	46.5	31.2	30.5	12.2	40.1	66.0	82.0	27.2	21.8	13.1	21.3	27.7	86.5	40.4	40.1	23.9	28.0	16.5	67.9	66.5	41.6
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 7.0;brain: 21.7"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 22.8;granulocytes: 55.9;Horizontal cells: 57.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 7.6;medulla oblongata: 19.8;pons: 21.7"	"Immune cell enriched"	"Detected in single"	116	"basophil: 94.5"	"Lineage enriched"	"Detected in single"	768	"granulocytes: 94.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 82.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.4"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.1"	"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		79000	"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	0.8	7.0	0.7	0.4	1.8	0.7	0.2	1.8	7.6	0.7	0.7	0.8	0.5	1.0	0.0	0.1	0.5	0.4	1.0	0.3	2.8	3.0	0.0	0.5	0.1	19.8	1.5	0.1	0.2	0.0	0.7	0.2	21.7	1.4	0.0	1.9	0.5	0.3	0.4	0.1	0.3	0.6	0.2	0.1	0.5	1.6	0.4	0.3	0.2	0.2	0.0	0.3	0.5	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	11.9	0.0	14.0	0.0	0.0	0.0	0.0	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	1.6	0.0	0.2	0.0	2.4	0.2	0.0	1.5	2.5	0.0	0.2	0.0	0.5	1.5	18.2	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	1.1	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.1	94.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.7	1.8	1.8	7.6	0.3	2.8	19.8	1.5	21.7	0.2	0.4	0.6	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	4.2	0.7	0.0	0.0	4.3	0.0	0.1	55.9	0.0	0.0	0.0	0.1	57.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.9	3.2	2.7	0.0	0.1	0.0	1.0	0.1	0.0	0.0
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302063-205321745	"Enzymes, Metabolic proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 56.7;vagina: 45.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 46.9;Endometrial ciliated cells: 45.3;Glandular and luminal cells: 52.4;Intestinal goblet cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 120.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.1;RPMI-8226: 36.1;RPTEC TERT1: 40.9;SuSa: 45.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	2.1	3.7	1.3	7.7	1.9	11.4	0.9	4.6	1.7	31.0	3.2	8.0	16.5	1.6	1.3	56.7	4.0	1.7	1.2	1.2	1.3	28.2	5.1	10.3	11.5	2.1	1.8	1.3	16.0	0.8	3.0	4.4	2.0	1.9	8.8	0.5	15.1	1.6	0.7	22.4	12.5	1.2	1.4	13.1	2.5	3.7	2.2	3.9	16.1	1.1	8.0	3.1	45.3	4.1	4.3	23.1	13.7	0.6	0.3	0.6	44.1	5.5	5.7	14.7	5.9	24.4	0.8	7.0	3.2	1.5	24.1	8.3	3.2	8.3	6.3	0.0	0.4	0.0	1.4	4.2	9.3	0.0	0.1	2.6	6.1	8.6	5.0	3.3	0.7	0.0	0.9	1.7	2.8	1.0	0.0	0.1	8.9	3.1	0.7	0.0	1.0	36.1	40.9	0.1	2.1	0.2	1.6	6.5	0.7	45.6	6.6	0.1	1.7	5.3	2.5	0.6	8.7	12.1	2.0	4.4	0.8	0.0	2.1	11.2	16.5	40.1	10.3	11.8	7.6	37.9	12.7	12.3	10.4	39.3	27.9	21.9	120.4	17.5	13.1	4.1	8.1	17.4	1.3	1.9	4.6	1.7	1.2	1.3	2.1	1.8	2.0	1.4	2.2	4.1	2.0	6.4	6.8	0.3	28.0	1.1	3.2	3.7	13.1	1.1	1.9	2.2	2.7	20.0	2.9	33.1	0.0	9.2	7.1	34.9	5.9	46.9	2.0	45.3	7.5	5.9	10.8	2.7	0.1	1.8	29.1	3.7	7.7	52.4	0.0	2.4	0.7	2.6	4.7	0.0	0.4	43.0	18.3	12.3	11.1	2.1	0.0	8.9	7.2	3.7	38.5	1.3	18.6	0.5	3.5	6.9	7.8	0.0	18.5	2.5	18.3	17.2	7.7	0.5	6.6	2.4	5.5	0.9	1.1	21.5	5.4	4.1	5.7	0.5	22.0	0.5
NUBP2	"CFD1, CIAO6"	ENSG00000095906	"Nucleotide binding protein 2"	Q9Y5Y2	16	1782932-1789186	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041704	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA041704: AB_10804006"	"unprognostic (1.94e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.83e-2)"	19.4	34.3	18.2	10.6	19.7	16.6	17.6	19.5	25.5	21.6	26.5	21.9	14.5	18.7	3.8	30.8	17.1	5.9	20.8	17.6	17.1	26.4	53.2	18.0	16.0	21.3	18.4	17.7	34.2	8.3	18.7	10.9	18.9	25.6	4.2	3.4	22.4	10.4	27.9	25.8	20.5	6.7	18.9	26.8	27.2	10.1	19.7	14.0	18.9	8.2	6.4	20.8	20.1	19.8	28.6	91.4	16.2	49.6	12.1	9.2	50.9	32.2	14.8	20.7	23.3	56.1	41.5	45.0	38.1	7.4	15.2	32.6	10.8	31.6	3.8	39.6	85.7	19.6	67.2	83.0	23.6	30.2	38.2	13.1	26.6	16.9	12.1	13.0	26.2	54.9	49.4	29.6	8.7	109.1	58.8	53.7	44.2	26.4	52.6	80.0	33.4	106.1	16.7	21.1	58.4	70.4	31.9	50.4	38.1	4.2	75.5	35.9	29.8	33.8	42.6	31.9	34.1	65.1	44.9	54.4	20.4	36.0	44.2	72.3	58.1	59.8	64.9	61.6	59.2	48.5	56.5	57.7	62.3	47.6	47.1	45.0	29.7	57.9	60.7	87.5	84.2	67.9	18.2	19.7	19.5	25.5	17.6	17.1	21.3	18.4	18.9	18.9	19.7	19.8	41.0	16.0	30.9	9.4	38.4	35.8	39.4	75.8	24.5	36.0	52.2	65.9	24.9	42.9	43.7	31.3	20.9	103.9	55.5	40.2	66.5	64.7	33.1	23.1	32.7	35.1	38.2	36.4	6.2	74.3	83.0	38.0	32.6	24.5	20.3	48.6	31.8	65.0	62.2	23.5	7.4	51.7	54.9	39.3	28.8	90.9	36.7	27.9	58.7	7.5	55.1	54.4	68.0	6.0	11.0	63.7	30.4	30.9	38.0	45.0	65.4	67.1	22.2	42.5	46.0	28.2	43.3	34.0	30.6	44.7	41.5	41.3	42.0	49.6	58.2	32.2
NUDCD3	"KIAA1068, NudCL"	ENSG00000015676	"NudC domain containing 3"	Q8IVD9	7	44379119-44490658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019136, HPA019528, HPA019529"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374"	"unprognostic (3.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.18e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (9.16e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.50e-2)"	2.9	2.8	6.8	1.3	9.0	2.8	2.8	3.2	7.2	2.5	0.0	2.4	1.2	2.2	2.4	2.7	3.5	2.2	7.5	6.6	5.1	2.2	1.8	2.4	2.2	4.4	5.5	3.1	3.3	3.7	1.8	1.7	5.6	2.8	1.8	4.8	2.4	3.3	8.2	3.1	2.0	3.0	3.9	1.9	2.7	3.9	5.6	2.1	2.7	5.7	2.2	2.3	1.8	6.3	2.6	4.9	3.4	6.3	4.2	3.4	1.3	4.1	4.0	4.8	4.9	3.3	1.8	8.1	3.0	5.5	6.6	3.0	4.8	5.6	2.8	4.8	4.9	2.2	2.9	2.3	3.8	3.9	1.3	3.1	3.7	3.6	4.1	2.8	5.9	2.4	6.1	2.6	3.6	2.3	1.6	3.7	4.3	2.5	6.3	2.3	3.7	3.0	2.7	4.0	3.6	10.6	2.4	4.5	1.8	3.4	3.4	5.7	5.7	3.3	3.4	2.2	3.3	7.3	8.1	4.0	3.6	4.5	5.9	0.6	0.8	0.9	1.0	0.8	1.1	1.0	0.9	0.9	0.7	1.0	0.9	0.9	0.5	0.8	1.0	0.6	1.0	0.9	6.8	9.0	3.2	7.2	6.6	5.1	4.4	5.5	5.6	3.9	5.6	6.3	30.5	12.8	19.2	35.9	26.4	11.3	13.0	16.5	20.5	40.9	29.3	25.3	44.5	17.2	16.0	38.6	54.2	19.6	21.9	22.7	23.5	29.6	87.7	27.4	34.4	25.3	17.4	22.3	59.6	21.6	18.1	23.9	23.9	30.9	9.5	35.8	22.5	32.8	18.3	48.8	58.8	25.1	26.4	17.9	9.5	98.3	30.4	13.9	16.0	46.9	21.2	24.8	34.0	36.2	61.2	27.4	18.8	28.2	14.3	15.9	27.2	26.8	21.9	40.2	32.9	17.8	25.2	106.6	21.1	25.5	16.2	14.4	26.2	18.9	27.8	13.3
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.3"	"Group enriched"	"Detected in many"	5	"Hepatic stellate cells: 60.3;Peritubular cells: 29.0"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;HAP1: 14.2;HEK 293: 10.5;NTERA-2: 25.8;SH-SY5Y: 5.6;U-2 OS: 12.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	0.6	1.6	11.2	0.8	9.8	1.5	0.8	3.8	9.8	6.2	2.3	3.1	0.5	5.3	16.1	1.0	3.6	1.4	1.0	9.2	10.0	3.9	1.3	0.3	0.3	5.0	7.1	16.9	0.3	0.0	2.1	0.0	7.1	14.9	0.7	1.5	0.5	14.6	0.1	0.4	1.0	4.1	4.1	3.4	1.2	26.3	11.9	0.4	0.6	0.2	0.3	3.9	3.6	9.3	0.0	0.0	7.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.0	14.2	0.6	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	11.2	9.8	3.8	9.8	9.2	10.0	5.0	7.1	7.1	4.1	11.9	9.3	0.2	0.0	1.3	0.7	0.2	1.0	4.9	0.6	1.8	0.5	0.1	1.5	0.2	0.0	0.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.7	3.5	2.5	0.0	0.8	5.0	0.0	1.0	3.1	0.0	0.1	0.0	5.0	60.3	0.3	0.2	0.0	1.9	0.0	0.0	1.9	0.4	6.2	5.9	0.1	1.8	1.0	0.0	1.7	0.0	3.5	0.6	0.0	0.0	29.0	1.4	2.8	0.0	0.1	0.0	0.5	0.0	1.5	1.9	3.8	7.8	0.4	0.1	0.4	0.2	0.9	0.0	0.2
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496592	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3;testis: 36.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 15.3;Late spermatids: 17.1;Peritubular cells: 20.7;Spermatocytes: 14.6;Spermatogonia: 20.3"	"Group enriched"	"Detected in many"	4	"glioma: 12.1;prostate cancer: 10.6;testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 69.3;NTERA-2: 42.9"					"Low region specificity"	"Detected in many"			"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.0	4.6	11.9	0.9	13.7	1.4	2.1	4.5	14.7	4.0	2.1	2.9	1.1	5.1	3.5	1.3	2.0	1.6	0.5	13.4	20.0	0.5	0.1	0.5	0.6	5.6	7.2	8.9	4.9	0.2	4.3	0.0	8.4	9.1	0.8	2.2	0.7	10.4	0.1	1.2	1.0	4.4	5.6	0.3	1.1	36.2	23.3	2.6	0.6	0.5	0.6	1.9	2.4	7.7	0.0	1.0	20.6	0.0	17.5	22.0	0.1	9.8	2.7	0.5	0.5	0.0	0.0	0.0	0.5	11.9	11.4	1.5	69.3	23.9	0.3	0.0	4.7	0.0	0.0	0.0	8.2	0.0	4.6	13.5	9.3	6.2	22.4	3.9	16.4	21.6	0.1	0.0	19.6	0.5	27.6	0.1	42.9	0.0	17.5	0.0	14.4	0.0	4.3	0.0	0.0	13.4	4.2	0.0	4.0	10.2	0.0	0.1	9.6	4.8	22.4	1.4	0.0	9.0	4.5	15.2	3.1	0.0	1.9	0.0	0.0	0.0	1.2	0.0	0.5	0.1	0.3	0.6	0.1	0.1	0.0	0.9	0.0	0.7	0.1	0.0	0.0	0.3	11.9	13.7	4.5	14.7	13.4	20.0	5.6	7.2	8.4	5.6	23.3	7.7	0.4	0.0	0.0	0.3	0.3	15.3	6.4	12.8	12.0	1.6	0.5	3.9	0.6	0.0	1.6	0.0	0.0	0.3	3.5	0.0	0.0	0.2	11.3	0.5	9.0	0.9	0.0	1.3	6.3	1.5	1.0	7.7	0.0	0.3	0.0	3.4	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.3	3.8	17.1	8.7	0.6	5.4	2.8	0.0	1.4	3.1	4.0	0.6	1.4	0.0	20.7	0.3	10.4	0.0	0.2	0.2	0.2	0.0	3.0	5.3	14.6	20.3	1.6	9.1	0.3	0.8	7.5	0.0	1.3
NUDT16L1	"SDOS, TIRR"	ENSG00000168101	"Nudix hydrolase 16 like 1"	Q9BRJ7	16	4693694-4695859	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044186, HPA063605"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA044186: AB_10968571, HPA063605: AB_2685058"	"unprognostic (1.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (6.81e-2)"	"prognostic favorable (1.02e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.81e-3)"	19.7	46.4	43.1	12.0	44.8	22.2	21.5	43.6	52.5	23.1	45.6	28.5	21.7	21.4	15.3	28.9	23.4	8.4	58.2	44.1	42.0	43.4	64.1	17.2	17.9	45.3	43.2	22.7	24.6	20.4	39.9	8.0	41.9	34.8	11.9	14.5	26.6	14.7	25.0	25.2	29.2	8.5	43.3	33.7	30.1	22.8	44.3	18.2	30.8	16.9	13.1	22.7	21.8	45.7	14.7	23.8	21.2	28.7	15.7	12.1	19.4	17.2	12.9	20.4	12.8	26.9	11.6	15.2	24.4	20.7	10.3	16.8	23.1	23.4	9.5	22.6	38.9	16.8	21.1	32.8	17.0	24.4	19.2	18.7	21.3	17.2	10.7	13.9	15.1	22.6	31.2	18.5	20.1	57.3	36.8	36.0	33.6	24.4	27.0	50.9	22.4	24.2	24.8	18.0	41.8	31.5	25.1	25.9	11.7	16.5	38.4	56.4	20.0	16.7	25.3	39.8	15.9	32.1	20.5	26.1	10.4	32.3	34.8	56.6	54.3	96.2	52.6	48.2	63.1	60.7	63.4	62.8	50.2	65.3	74.0	63.5	68.2	63.9	53.5	83.6	78.3	98.1	43.1	44.8	43.6	52.5	44.1	42.0	45.3	43.2	41.9	43.3	44.3	45.7	23.3	16.0	22.4	14.4	32.6	14.0	19.7	37.4	27.9	52.1	36.0	36.2	52.6	24.3	28.0	42.3	10.4	53.8	43.6	47.7	109.5	28.7	5.2	28.7	33.6	21.4	43.1	23.1	10.2	30.9	31.8	24.0	30.5	29.0	27.9	31.7	17.9	41.8	40.9	47.1	11.8	51.7	89.5	18.3	18.7	8.7	31.4	20.8	30.2	3.7	43.3	83.5	34.0	9.5	15.0	30.0	48.5	50.0	33.0	17.9	77.8	98.2	20.1	58.3	46.0	14.2	22.8	14.8	34.7	24.9	16.6	49.1	43.6	58.0	51.4	17.6
NUDT17	FLJ34433	ENSG00000186364	"Nudix hydrolase 17"	P0C025	1	145845630-145848954	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 15.1;Muller glia cells: 9.1;Spermatogonia: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 8.3;eosinophil: 17.5;plasmacytoid DC: 26.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 26.6;granulocytes: 17.5"	"Cell line enhanced"	"Detected in many"		"T-47d: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030145	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Centrosome, Cytosol"		"HPA030145: AB_10603883"	"unprognostic (8.93e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.63e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.07e-3)"	"unprognostic (6.55e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (5.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.96e-1)"	1.7	2.3	5.8	1.7	6.0	3.3	2.0	6.3	7.1	2.8	5.1	2.6	0.5	2.0	1.2	2.1	2.8	1.8	3.4	5.8	6.2	4.0	2.0	1.8	4.2	5.9	5.7	2.6	2.8	2.3	3.1	0.8	5.5	2.7	1.1	2.6	1.9	2.2	3.1	2.1	2.4	1.2	5.6	4.1	2.1	4.0	6.6	2.0	2.5	2.2	3.3	2.8	2.3	5.6	3.7	2.6	2.4	1.3	1.2	2.0	2.4	1.7	2.8	1.8	2.4	1.6	2.6	5.3	1.8	2.9	0.4	0.7	1.8	1.0	1.2	0.6	3.0	2.1	2.5	2.5	3.8	1.6	6.7	2.0	1.6	1.2	2.0	2.2	3.6	8.6	4.6	4.8	3.3	5.8	1.8	3.1	2.0	2.2	0.3	4.8	0.9	1.7	3.0	0.9	1.1	2.7	1.1	2.2	3.0	2.5	12.2	7.5	2.1	2.1	1.3	1.0	0.7	4.2	2.1	1.4	1.9	2.3	1.6	8.3	0.9	17.5	0.8	2.5	0.5	1.4	0.7	0.5	0.9	0.8	1.5	1.1	0.1	0.3	1.7	26.6	0.8	1.1	5.8	6.0	6.3	7.1	5.8	6.2	5.9	5.7	5.5	5.6	6.6	5.6	3.1	3.2	5.5	0.7	1.8	1.8	0.8	1.4	2.2	1.9	2.6	4.6	0.8	2.8	3.4	0.0	0.0	0.6	15.1	0.8	1.9	1.0	3.3	3.5	1.7	1.8	1.2	0.4	0.6	0.7	0.7	2.3	2.6	4.1	2.5	1.7	1.8	0.5	3.0	0.0	0.7	0.5	2.0	0.6	1.6	2.1	1.5	2.3	1.8	1.9	0.5	9.1	3.1	2.0	0.9	1.4	1.4	0.4	3.8	1.0	0.7	0.6	1.7	3.8	0.0	3.7	1.2	6.8	14.8	1.6	1.3	0.5	2.2	1.8	1.2	0.8
NUDT19	RP2	ENSG00000213965	"Nudix hydrolase 19"	A8MXV4	19	32691961-32713796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042761			Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA042761: "	"unprognostic (1.20e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.61e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.35e-4)"	5.1	11.7	4.0	4.1	4.1	8.4	4.6	3.9	4.5	3.9	9.4	6.9	7.1	3.6	5.4	11.1	3.6	2.9	10.6	4.1	5.1	6.3	6.9	6.4	5.8	4.6	4.3	3.7	8.4	7.1	4.0	4.5	4.8	7.5	7.3	8.3	6.9	3.5	23.9	8.9	6.2	4.3	4.3	5.2	8.1	2.8	4.6	3.1	3.6	13.0	5.1	6.3	5.6	4.6	21.5	24.7	2.7	24.0	8.1	10.5	0.2	11.9	4.4	8.7	8.2	14.0	11.6	0.1	14.0	13.8	6.7	13.7	16.7	13.9	11.4	24.8	10.0	27.7	9.3	5.0	11.2	20.9	8.2	8.5	18.1	7.4	17.8	10.1	13.0	4.2	21.6	15.3	15.9	14.3	0.1	19.3	2.9	5.9	11.5	0.1	5.2	12.1	14.4	15.7	10.7	15.4	21.2	17.7	15.9	4.7	9.8	25.4	10.4	11.9	7.7	12.0	21.5	17.8	16.3	6.9	14.4	20.0	11.2	11.1	26.5	15.4	18.2	36.7	20.0	13.0	18.9	22.6	19.5	9.4	14.9	20.4	5.1	32.2	42.4	15.9	23.6	11.9	4.0	4.1	3.9	4.5	4.1	5.1	4.6	4.3	4.8	4.3	4.6	4.6	5.9	12.8	14.5	7.5	6.4	21.9	9.4	4.6	8.0	14.5	12.0	6.6	22.8	2.8	6.2	7.3	12.5	11.0	9.1	10.6	27.4	2.9	7.7	8.5	9.3	7.3	12.1	10.3	5.9	11.5	11.5	6.6	3.1	10.7	1.3	11.3	13.2	12.5	14.3	3.3	6.7	12.7	8.2	17.6	11.6	3.7	4.1	10.2	12.4	4.7	10.7	4.6	4.1	6.6	7.4	12.0	13.1	9.4	4.1	12.0	15.7	18.8	6.5	30.4	0.0	6.9	7.4	1.6	2.2	9.9	31.5	7.8	9.1	22.3	18.4	10.6
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392669	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		87000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	12.8	12.9	72.7	11.4	65.3	12.0	14.7	41.2	73.1	17.2	33.8	10.4	9.0	13.2	30.1	12.3	17.3	9.2	20.7	64.9	55.9	18.0	12.1	13.3	13.7	60.8	59.6	19.7	10.5	29.9	5.7	10.4	59.0	12.8	10.9	43.1	11.4	17.5	70.8	13.4	9.4	13.0	64.5	16.5	9.8	7.6	73.7	11.4	25.3	51.8	14.9	9.4	7.4	59.5	11.0	8.0	20.9	41.2	13.7	22.9	8.7	7.9	13.2	8.0	5.7	9.7	7.2	37.3	10.5	14.3	5.1	9.2	11.0	21.3	14.7	14.5	15.2	42.9	10.4	20.7	13.0	41.5	21.7	20.8	18.8	9.0	16.8	9.9	23.2	20.1	42.5	14.0	12.6	11.4	28.7	48.1	13.4	32.5	7.3	24.7	17.4	39.2	18.2	22.7	29.3	32.4	17.5	24.4	32.1	6.0	23.6	28.2	25.7	15.6	5.7	14.1	17.4	11.7	28.7	27.9	9.7	40.1	25.4	1.4	3.9	9.2	2.1	4.1	2.4	2.2	2.1	1.9	4.4	3.0	1.9	2.2	2.8	1.4	4.2	2.1	1.6	1.8	72.7	65.3	41.2	73.1	64.9	55.9	60.8	59.6	59.0	64.5	73.7	59.5	36.6	16.0	26.7	0.0	41.4	59.9	72.2	32.4	51.8	117.0	30.5	27.9	47.5	62.9	25.0	42.3	118.9	34.7	28.2	16.1	13.7	19.2	4.1	25.0	38.6	67.0	49.1	40.8	0.0	28.5	32.0	36.4	19.4	37.2	13.9	30.3	109.6	56.1	76.0	169.9	0.0	29.0	22.4	107.1	79.2	8.1	37.6	65.2	53.4	0.0	90.1	137.4	42.2	0.0	0.0	27.9	16.0	63.2	22.8	90.1	25.3	24.4	46.4	126.6	59.2	68.1	35.0	45.6	83.9	58.4	60.2	19.6	26.5	32.8	31.8	64.7
NUDT4	"DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487"	ENSG00000173598	"Nudix hydrolase 4"	Q9NZJ9	12	93377883-93408146	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 361.9;Erythroid cells: 520.6;Muller glia cells: 485.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (1.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.25e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.01e-1)"	"unprognostic (8.32e-3)"	61.2	71.8	52.1	31.9	60.4	169.2	48.7	37.3	75.5	52.1	48.5	57.4	26.6	30.9	62.5	34.8	44.5	89.8	161.6	61.4	53.1	130.5	45.1	29.0	34.3	48.2	54.5	150.2	62.9	41.7	26.5	60.1	47.5	78.7	62.9	102.0	129.8	38.2	87.2	19.8	35.4	37.9	42.5	25.7	34.6	32.3	48.8	34.8	57.5	115.6	36.3	78.6	26.0	52.7	24.1	20.4	36.4	41.1	132.5	54.3	45.5	66.0	52.4	37.0	27.2	188.4	58.6	33.7	14.0	53.1	24.3	29.5	102.4	33.2	56.5	51.9	21.6	126.9	17.1	99.3	126.8	66.8	29.3	118.5	109.2	38.3	85.0	186.1	212.9	59.7	130.7	46.0	42.9	24.6	61.9	63.7	57.2	59.4	47.7	50.7	32.5	36.5	45.0	171.7	29.1	37.5	53.6	103.3	153.2	58.2	75.2	85.6	81.6	31.6	18.0	47.9	42.5	25.6	34.2	49.4	16.6	51.8	98.3	9.5	2.2	11.3	2.8	2.8	5.1	4.5	4.2	2.9	2.0	3.8	4.4	4.4	1.9	6.0	2.5	3.2	4.2	1.9	52.1	60.4	37.3	75.5	61.4	53.1	48.2	54.5	47.5	42.5	48.8	52.7	44.0	19.2	42.8	8.1	74.8	116.8	123.1	22.5	178.7	66.9	58.3	39.1	243.9	114.4	31.8	62.5	62.6	188.7	49.8	226.9	361.9	21.8	125.6	45.7	38.2	66.4	152.2	520.6	16.6	16.5	32.9	99.2	36.2	60.6	25.4	54.2	41.7	53.4	43.7	42.1	7.5	89.3	12.2	35.1	81.0	26.2	39.1	47.2	106.7	5.6	34.3	485.7	34.0	10.6	1.3	55.1	92.8	46.6	113.9	137.8	68.2	52.8	86.1	44.5	72.3	184.4	204.4	115.7	17.3	119.2	96.7	163.8	80.2	37.3	90.4	178.4
NUDT4B	NUDT4P1	ENSG00000177144	"Nudix hydrolase 4B"	A0A024RBG1	1	148748894-148750099	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in all"		"CACO-2: 42.1;RT4: 34.5"									"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"					"unprognostic (1.24e-1)"									"unprognostic (4.01e-2)"				4.9	6.8	0.2	3.6	0.4	23.6	1.8	0.0	0.9	4.4	0.3	5.7	5.3	3.7	2.6	8.1	7.0	17.7	20.8	0.5	0.6	9.8	3.9	2.6	6.8	1.3	0.5	16.1	11.9	4.6	0.3	7.7	0.4	7.5	6.1	0.6	23.6	3.1	5.3	1.3	5.2	3.6	0.3	3.0	4.1	7.7	0.3	3.2	7.9	8.1	3.7	11.1	0.6	0.6	3.5	3.8	1.5	4.7	6.3	5.1	9.3	4.1	6.2	4.4	4.2	42.1	14.8	3.5	1.7	3.7	4.2	5.7	6.8	3.0	2.2	11.0	3.3	8.5	2.3	5.4	8.4	5.8	2.6	10.6	9.7	5.5	5.1	5.3	16.5	4.3	17.6	13.8	4.2	3.0	7.9	1.1	8.3	3.4	6.2	9.7	2.2	10.0	3.2	34.5	3.0	4.4	3.5	8.6	23.7	1.0	11.7	11.0	9.1	5.8	4.5	9.6	6.3	3.2	5.2	4.5	2.7	8.7	17.4	0.0	0.1	2.8	0.0	0.3	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.2	0.2	0.2	0.4	0.0	0.9	0.5	0.6	1.3	0.5	0.4	0.3	0.3	0.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
NUDT8	FLJ41567	ENSG00000167799	"Nudix hydrolase 8"	Q8WV74	11	67627938-67629937	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 78.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 222.8;Intestinal goblet cells: 102.5;Proximal enterocytes: 139.4;Proximal tubular cells: 237.1;Squamous epithelial cells: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 218.9"									"HPA041252, HPA041466"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	Cytosol	"HPA041252: AB_10794551, HPA041466: AB_10793967"	"unprognostic (8.31e-2)"	"unprognostic (7.26e-3)"	"unprognostic (7.31e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.69e-1)"	"unprognostic (4.12e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.19e-1)"	10.3	5.3	6.9	1.9	8.7	3.2	9.9	10.3	10.4	10.1	6.9	12.4	14.2	4.3	2.2	57.6	5.0	1.6	78.9	6.2	8.6	25.5	58.7	6.1	1.8	9.2	8.7	4.6	13.1	12.0	3.0	1.7	8.6	9.3	5.4	0.8	24.1	4.3	58.8	31.7	11.6	1.5	8.4	4.5	9.1	4.4	9.2	2.5	20.4	41.8	3.7	3.7	12.6	9.1	33.5	13.3	5.1	8.4	4.7	5.9	8.1	6.9	3.2	2.7	2.8	11.0	8.5	35.1	10.6	5.4	3.9	16.1	5.9	4.1	0.3	34.3	14.7	2.0	6.1	34.2	1.4	11.2	16.0	3.6	8.1	3.4	1.1	0.7	6.0	42.6	9.9	30.1	2.2	55.9	18.6	16.0	3.1	58.7	28.0	11.4	2.7	218.9	8.4	5.8	2.6	3.7	1.8	18.7	7.1	1.8	10.2	4.6	1.6	7.1	10.1	45.7	1.3	21.6	15.3	7.1	5.0	14.8	4.1	0.0	1.1	1.1	2.9	4.7	2.5	3.2	1.7	3.5	4.6	6.4	1.5	1.8	0.0	9.5	13.7	12.4	1.3	2.1	6.9	8.7	10.3	10.4	6.2	8.6	9.2	8.7	8.6	8.4	9.2	9.1	8.7	0.0	6.5	6.2	12.0	12.1	12.7	9.4	17.6	4.5	42.3	39.9	79.5	15.7	12.1	29.5	0.0	29.7	7.2	76.5	84.1	14.3	3.3	8.2	11.0	9.2	2.4	34.5	0.6	23.9	21.4	12.5	23.4	13.8	8.9	3.7	8.6	222.8	9.4	5.0	0.7	102.5	12.2	5.3	10.8	8.0	5.0	5.0	28.4	0.0	2.5	7.9	4.1	1.0	2.9	9.9	26.4	5.3	15.7	18.5	139.4	237.1	4.5	7.8	6.6	7.8	17.7	13.9	8.8	129.6	25.6	17.4	7.6	6.6	69.8	25.0
NXN	"FLJ12614, NRX"	ENSG00000167693	Nucleoredoxin	Q6DKJ4	17	799310-979776	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Oxidoreductase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.2"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 91.5;Microglial cells: 87.1;Urothelial cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 100.7;HHSteC: 106.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023566	Approved		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA023566: AB_1854737"	"unprognostic (1.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.05e-3)"	16.9	7.5	14.5	8.7	13.1	1.1	19.0	12.1	15.0	41.3	21.9	70.0	5.4	47.2	11.6	27.2	29.1	13.7	16.0	13.5	13.2	14.4	9.5	24.6	5.0	13.6	14.9	14.8	33.6	2.6	6.8	14.5	14.0	39.7	4.6	8.9	20.7	25.0	99.2	24.9	19.8	23.1	12.8	6.4	28.3	9.6	17.1	13.1	12.9	35.7	13.8	43.4	42.5	12.3	14.3	21.2	81.5	52.8	5.3	1.1	4.5	44.6	29.3	46.1	73.3	50.4	14.8	0.6	83.6	57.5	10.8	100.7	52.9	83.2	36.3	0.6	30.9	0.2	12.7	44.8	106.1	0.3	2.3	32.2	75.6	6.0	36.0	9.3	41.9	11.3	7.4	0.0	12.3	5.8	2.9	1.0	39.2	42.3	1.4	6.2	2.1	0.3	32.9	20.6	20.9	13.6	21.1	0.1	1.1	50.3	14.9	13.0	0.0	1.0	19.1	0.4	12.5	7.5	5.2	0.4	0.4	1.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.0	14.5	13.1	12.1	15.0	13.5	13.2	13.6	14.9	14.0	12.8	17.1	12.3	36.5	32.1	11.7	13.4	0.9	17.5	53.6	18.8	12.0	2.6	7.6	12.4	8.6	2.8	13.2	3.7	33.3	0.4	0.4	0.1	0.0	3.5	25.1	20.2	52.1	34.7	1.8	2.7	6.9	24.6	0.7	23.0	1.1	12.6	1.3	1.0	14.6	8.2	6.3	5.0	10.7	0.0	0.0	0.3	8.8	91.5	15.5	1.9	7.2	87.1	0.6	11.4	0.0	23.1	3.3	5.9	0.0	7.2	0.4	36.0	0.0	0.5	15.5	18.0	13.1	14.5	19.2	13.1	10.1	13.1	12.4	0.4	1.5	27.2	0.0	59.0
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88534033-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.4;Endometrial ciliated cells: 39.1;Glandular and luminal cells: 13.9;Granulosa cells: 13.2;Proximal tubular cells: 18.6;Theca cells: 12.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 7.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045526	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA045526: AB_10961044"	"prognostic favorable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	6.5	0.7	4.3	1.2	3.4	4.2	2.8	6.0	5.5	4.0	1.8	0.5	0.9	2.0	1.3	0.4	4.3	1.0	0.7	3.4	3.4	2.3	4.5	0.7	0.9	0.7	1.2	1.1	0.4	0.3	0.1	0.6	1.4	0.9	0.4	4.8	1.6	0.7	1.3	1.5	0.9	0.4	0.4	1.1	0.8	1.3	3.6	0.5	1.3	0.1	0.5	0.4	0.3	5.1	1.5	2.6	1.0	1.0	0.1	0.7	0.7	2.6	0.7	0.3	0.5	0.6	1.0	0.6	1.1	0.3	0.7	1.3	0.4	0.1	0.9	0.4	0.8	1.3	4.0	1.0	0.4	0.7	1.1	0.5	0.2	0.3	0.2	0.4	0.0	0.9	0.9	2.7	0.7	0.7	0.7	1.2	1.4	0.5	0.7	0.5	0.5	0.9	10.4	0.8	0.6	0.4	1.6	0.8	0.5	0.7	1.2	0.6	0.9	0.9	1.9	1.5	0.6	0.9	0.8	0.7	0.7	0.9	0.7	2.1	0.3	0.8	0.6	0.1	0.6	0.2	0.3	0.7	0.0	0.3	0.6	0.7	0.8	0.5	0.1	0.3	0.6	0.3	4.3	3.4	6.0	5.5	3.4	3.4	0.7	1.2	1.4	0.4	3.6	5.1	0.2	0.0	0.0	1.3	0.1	0.0	1.9	0.7	1.2	0.2	7.5	3.2	0.3	4.3	0.1	1.8	0.0	0.2	0.0	0.0	1.9	0.8	11.4	39.1	4.3	0.8	0.0	0.0	1.2	0.2	1.3	0.8	0.0	13.9	0.0	13.2	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	4.4	0.9	0.2	0.0	0.0	0.0	0.5	0.0	1.0	0.7	0.2	0.0	2.2	0.1	0.4	0.0	18.6	0.2	0.8	0.0	0.3	1.3	0.4	1.6	0.0	0.1	1.1	0.3	12.7	0.0	2.2
NYAP2	KIAA1486	ENSG00000144460	"Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2"	Q9P242	2	225399710-225654018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"brain: 8.7"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 136.8;Inhibitory neurons: 238.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 8.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SiHa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045531, HPA056945"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Cytosol	"HPA045531: AB_10960749, HPA056945: "	"unprognostic (2.49e-1)"	"unprognostic (3.34e-1)"		"unprognostic (1.24e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"		"unprognostic (6.13e-3)"		"unprognostic (3.33e-1)"	"unprognostic (2.08e-1)"		"unprognostic (1.32e-8)"	"unprognostic (9.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.27e-1)"	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	1.9	0.0	0.0	0.2	0.0	0.1	8.7	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.7	2.7	1.7	1.9	0.1	8.7	2.0	2.9	2.4	0.0	0.1	0.0	2.3	4.9	0.1	1.3	1.7	0.0	0.0	21.8	0.2	0.0	0.5	0.0	0.6	0.0	2.1	0.2	0.2	0.1	0.0	0.3	0.6	0.2	0.1	0.4	0.0	0.0	136.8	1.2	0.3	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	238.3	0.0	0.0	0.8	1.8	0.8	0.0	0.6	0.0	1.0	0.2	0.5	0.0	1.5	2.5	1.2	0.0	0.0	0.1	1.1	0.0	0.1	0.0	1.5	0.0	3.6	0.5	0.2	0.1	0.0	1.0	0.1	0.5	0.0	0.0	0.8
OBI1	"C13orf7, FLJ13449, RNF219"	ENSG00000152193	"ORC ubiquitin ligase 1"	Q5W0B1	13	78614289-78659155	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.5;Cardiomyocytes: 19.5;Cytotrophoblasts: 15.8;dendritic cells: 8.0;Extravillous trophoblasts: 12.2;Hofbauer cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034785, HPA034786"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034785: AB_10601496, HPA034786: AB_2674331"	"unprognostic (2.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (6.87e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-2)"	5.8	4.8	5.4	6.1	5.8	2.4	6.7	6.6	6.7	5.9	3.0	4.8	4.8	7.1	4.5	5.0	5.6	4.5	7.1	5.6	6.1	4.6	4.4	5.2	9.9	5.5	5.9	7.6	4.1	4.1	2.9	7.4	5.0	5.5	5.3	9.6	4.2	6.1	4.8	5.5	4.7	6.5	6.1	7.3	4.5	14.8	7.2	13.3	5.9	6.4	11.3	6.0	4.5	5.9	23.7	9.1	39.1	23.1	13.5	12.9	17.8	19.3	14.5	18.7	23.3	18.3	17.3	39.8	9.2	12.4	12.2	23.0	31.2	15.3	32.6	24.9	22.8	61.0	11.4	16.1	11.3	59.6	18.2	12.4	16.7	15.7	16.8	10.6	15.6	19.9	16.1	5.3	24.6	6.6	36.5	20.2	0.0	25.1	10.0	42.0	32.2	15.4	12.7	12.5	28.4	15.9	13.4	16.9	14.8	22.2	8.6	47.3	12.9	16.2	14.7	10.7	16.3	5.5	6.6	37.9	25.9	35.6	17.8	4.9	5.4	7.5	7.9	8.8	9.5	8.8	8.8	9.8	6.3	8.9	10.8	9.8	1.8	11.1	10.3	5.3	9.6	6.6	5.4	5.8	6.6	6.7	5.6	6.1	5.5	5.9	5.0	6.1	7.2	5.9	14.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	15.8	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	12.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.1	1.1	0.0	0.0	0.0
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208044-228378876	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 481.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 155.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		4500000	"Cluster 7: Monocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	3.5	2.5	2.4	1.4	18.4	1.6	3.7	10.4	4.4	8.1	18.1	5.2	0.7	3.7	1.8	4.6	5.1	1.1	78.5	0.9	2.7	6.6	1.3	8.9	2.1	4.3	2.7	8.6	5.4	1.1	13.6	0.9	2.4	9.9	0.5	0.8	9.4	1.7	481.3	4.7	5.4	0.5	1.0	9.3	5.2	1.9	6.3	4.9	7.5	112.8	1.3	3.2	7.4	0.1	1.7	2.8	3.6	3.7	0.2	0.2	4.6	1.6	0.7	1.7	1.4	2.1	1.3	3.2	5.4	0.7	0.7	2.1	1.3	2.2	0.3	2.0	3.4	1.7	10.5	0.1	1.2	2.4	2.2	1.4	0.6	0.4	0.5	5.1	0.5	7.0	3.2	0.0	0.3	1.8	3.3	3.5	4.9	0.6	2.1	4.4	0.0	1.9	1.8	1.4	1.7	6.3	0.6	3.9	1.0	0.8	3.4	4.0	1.0	0.0	5.1	0.3	0.5	2.5	0.5	4.7	0.0	0.8	2.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	2.4	18.4	10.4	4.4	0.9	2.7	4.3	2.7	2.4	1.0	6.3	0.1	1.5	0.0	5.5	1.6	2.4	2.2	6.6	7.7	23.9	4.2	7.3	11.9	155.8	4.3	4.5	5.5	10.4	0.1	1.9	0.7	11.7	3.6	4.9	3.9	3.7	3.1	0.0	3.0	3.9	0.5	0.5	5.7	3.1	11.3	7.0	1.8	1.4	0.5	0.1	0.0	5.3	2.7	4.1	0.3	1.0	4.5	3.1	1.1	1.8	5.6	0.5	7.9	4.1	1.5	1.7	0.8	1.1	4.5	1.5	3.8	0.6	4.1	1.3	3.2	0.0	22.9	6.1	1.0	4.1	9.4	1.7	1.2	5.4	6.2	1.2	3.6
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099315	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"choroid plexus: 28.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 30.9;Inhibitory neurons: 40.8;Melanocytes: 42.7;Peritubular cells: 14.7"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 24.6"	"Low region specificity"	"Detected in some"							HPA036402			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.3	0.0	1.8	0.1	1.8	0.0	0.3	0.1	1.8	1.2	28.1	0.1	0.0	0.2	0.3	2.2	1.1	0.0	0.3	1.4	1.8	0.3	0.1	0.6	1.8	0.5	0.9	0.3	0.0	0.0	0.8	1.5	0.6	0.6	0.0	0.0	0.8	1.0	0.2	6.4	0.2	0.0	0.0	1.1	0.1	1.9	2.4	0.4	4.2	0.0	0.7	0.2	2.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	5.6	0.0	0.0	24.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	0.1	1.8	1.4	1.8	0.5	0.9	0.6	0.0	2.4	1.0	0.0	0.0	0.0	0.7	0.0	2.0	0.1	0.1	0.6	0.0	0.0	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.4	5.6	0.2	0.1	0.0	0.0	30.9	0.0	0.1	1.4	0.0	2.8	0.0	2.3	0.0	0.0	0.1	0.0	40.8	0.1	0.0	0.0	0.9	3.0	9.3	0.1	42.7	0.0	0.0	0.0	0.0	2.5	0.8	0.0	1.2	14.7	0.0	0.0	0.0	0.1	2.0	0.0	0.0	1.0	0.8	4.2	4.9	6.1	0.9	0.1	0.1	0.4	0.1	0.2
OCM	OCM1	ENSG00000122543	Oncomodulin	P0CE72	7	5879827-5886363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 2.3;Excitatory neurons: 8.6;Inhibitory neurons: 7.0;Late spermatids: 2.4;Microglial cells: 4.7;Oligodendrocytes: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "	"unprognostic (1.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.90e-4)"	0.2	0.2	2.9	0.3	2.1	0.7	0.5	2.3	3.2	0.4	1.6	0.2	0.0	0.1	0.9	0.2	0.3	0.2	0.1	2.1	2.4	0.3	0.3	0.2	2.1	1.9	2.0	0.3	0.2	0.0	0.3	0.0	2.0	0.3	0.2	0.6	0.3	0.3	0.1	0.7	0.7	0.1	1.8	1.2	0.2	2.1	2.4	0.8	0.3	0.0	0.8	0.1	0.3	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.8	0.4	0.2	0.1	0.4	1.1	0.3	0.0	1.4	1.5	0.4	0.6	0.0	0.2	0.0	2.7	0.4	2.9	2.1	2.3	3.2	2.1	2.4	1.9	2.0	2.0	1.8	2.4	2.2	0.1	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	8.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	7.0	0.0	0.0	0.6	0.0	2.4	0.0	0.1	0.0	4.7	0.3	0.5	1.0	1.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
OCM2		ENSG00000135175	"Oncomodulin 2"	P0CE71	7	97984684-97991169	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046422, HPA052483"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA							"Plasma membrane"	Cytosol	"HPA046422: AB_2679659, HPA052483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OCRL	"Dent-2, OCRL1"	ENSG00000122126	"OCRL inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.2;monocytes: 3.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavorable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	13.9	23.8	12.4	4.7	13.2	5.0	12.7	5.3	13.6	14.9	27.2	16.4	8.0	19.4	16.1	11.6	16.7	8.3	10.7	13.1	20.3	9.5	15.7	10.0	2.8	9.6	14.0	28.4	13.0	34.6	25.6	11.2	17.4	18.5	12.4	9.9	11.0	21.3	14.8	12.4	12.2	15.0	7.6	7.9	14.5	24.6	18.6	4.4	16.8	6.7	3.0	22.8	12.3	8.6	19.3	20.5	17.0	18.7	29.3	24.1	17.1	28.5	22.3	28.2	26.3	14.2	13.3	1.5	46.7	24.1	33.0	11.6	30.5	20.9	29.2	0.1	21.5	5.8	18.5	14.1	21.1	5.7	0.6	20.7	27.3	28.3	27.3	27.7	21.2	8.4	7.9	13.6	28.7	24.2	4.3	8.2	6.2	24.4	30.9	4.2	17.6	11.5	16.1	19.1	20.5	26.1	13.5	18.0	14.6	21.5	13.2	10.0	19.3	23.0	10.6	24.6	29.1	3.8	3.3	3.7	16.2	21.4	18.8	0.0	1.0	0.0	0.1	1.1	0.3	0.1	0.0	0.0	1.2	0.1	0.2	0.1	0.1	0.0	3.6	0.4	0.0	0.4	12.4	13.2	5.3	13.6	13.1	20.3	9.6	14.0	17.4	7.6	18.6	8.6	6.7	3.2	7.8	14.4	2.6	4.7	3.4	5.4	3.4	9.9	9.3	5.6	10.3	4.3	8.8	18.4	6.2	6.4	0.3	14.4	3.9	5.3	31.2	4.9	6.9	6.4	17.5	3.8	20.0	3.6	5.4	7.8	11.7	6.1	0.0	17.0	8.2	11.5	5.0	13.5	23.1	11.8	6.1	11.8	4.0	8.9	23.0	5.8	8.8	21.5	4.3	9.6	0.0	17.6	21.0	8.5	8.3	34.3	1.4	5.9	15.7	5.2	5.4	7.2	0.0	4.5	6.0	6.8	14.6	8.3	7.4	5.7	1.0	7.6	12.2	8.4
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448327	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 560.8;Late spermatids: 834.9;Prostatic glandular cells: 412.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	47.2	23.2	31.0	69.3	31.5	172.9	33.0	30.5	32.2	33.5	48.5	64.8	32.4	66.0	49.2	29.4	56.3	43.7	55.9	29.9	33.0	132.2	92.1	52.4	111.0	32.4	33.0	54.8	61.8	99.6	92.5	20.0	30.6	91.1	72.0	46.2	27.0	55.1	163.3	29.2	41.6	71.2	34.1	42.9	51.5	133.3	34.0	77.1	58.5	73.5	149.1	113.6	26.9	35.7	166.8	130.6	177.1	211.4	31.1	92.4	410.1	234.6	114.9	216.3	99.9	697.3	75.4	870.2	114.6	143.6	208.6	30.2	549.1	265.5	261.2	334.0	231.5	398.1	212.2	429.9	250.8	680.1	91.8	62.5	70.5	490.1	608.3	111.4	176.3	237.6	674.2	274.3	121.7	109.0	680.1	267.3	324.9	228.3	418.8	478.5	556.0	586.3	130.9	119.5	246.6	209.9	293.6	88.8	121.8	135.7	60.0	300.5	124.7	174.4	362.6	227.9	511.7	128.0	416.1	780.8	156.7	443.6	109.9	0.0	1.5	3.0	2.9	2.9	3.3	14.8	4.1	4.8	3.4	15.0	2.8	4.5	0.5	1.4	1.8	12.2	4.4	3.2	31.0	31.5	30.5	32.2	29.9	33.0	32.4	33.0	30.6	34.1	34.0	35.7	78.2	44.8	161.4	7.5	228.9	58.0	123.7	48.8	19.4	36.8	53.2	68.3	55.1	81.5	33.9	40.5	31.3	1.5	188.1	77.7	72.4	50.6	560.8	90.9	66.2	52.2	271.0	111.3	7.5	27.6	70.0	63.2	204.4	127.6	58.9	103.8	14.6	50.3	46.8	6.7	4.1	234.1	22.4	32.1	22.4	834.9	15.5	191.8	23.2	8.4	22.1	126.3	37.0	4.5	2.4	28.6	64.5	11.3	287.4	412.4	31.6	154.1	21.9	77.4	0.0	223.0	79.9	186.5	75.8	52.2	87.5	3.4	133.0	30.2	180.5	142.2
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121180	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 555.7;choroid plexus: 246.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 193.1;Hepatic stellate cells: 78.1;Inhibitory neurons: 70.0"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.8;myeloid DC: 2.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 2.6;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 96.0;MCF7: 84.1;NTERA-2: 104.9;OE19: 78.9;SCLC-21H: 155.6;SiHa: 131.8;T-47d: 200.2;U-2197: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"	NA	NA		200000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: AB_2683443"	"unprognostic (6.77e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	36.7	25.4	410.4	13.0	427.0	0.2	36.8	309.6	555.7	29.9	246.9	24.0	5.0	29.0	70.4	12.1	30.3	8.6	20.7	474.7	309.0	20.3	4.8	15.0	14.5	296.6	301.7	19.4	12.3	4.9	82.8	1.0	293.9	19.3	13.8	47.3	14.0	18.1	17.5	15.3	16.5	17.9	279.9	35.1	15.4	6.8	317.0	11.5	17.5	23.0	19.1	25.0	26.7	372.3	0.0	6.1	12.1	0.2	1.7	1.4	0.5	3.6	0.0	0.0	0.0	0.1	2.7	0.1	0.8	5.2	49.2	2.3	2.6	0.0	0.0	14.4	0.9	0.2	96.0	0.0	0.5	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.3	84.1	0.5	0.3	104.9	78.9	0.0	0.1	0.3	48.3	0.0	0.1	155.6	20.5	131.8	0.4	8.6	7.9	200.2	0.0	0.1	7.7	16.6	87.1	0.2	0.2	0.1	0.3	0.7	0.1	4.3	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	410.4	427.0	309.6	555.7	474.7	309.0	296.6	301.7	293.9	279.9	317.0	372.3	44.2	0.0	7.9	43.8	0.1	9.7	3.3	0.0	3.4	21.6	3.1	3.0	5.9	11.5	1.8	0.0	43.8	0.0	0.1	2.4	0.0	9.7	5.8	0.5	20.4	50.0	2.4	0.0	193.1	2.7	0.0	17.3	0.0	0.7	2.5	14.4	78.1	1.1	0.4	38.7	70.0	2.5	0.0	3.2	7.3	11.9	44.4	2.8	21.4	32.8	2.7	38.6	0.0	48.7	17.3	2.5	2.5	29.3	0.4	5.1	0.0	0.1	0.0	15.7	0.0	13.3	8.8	0.6	3.7	1.3	6.3	0.0	0.7	12.9	4.2	1.4
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777133-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.1;Endothelial cells: 21.2;Fibroblasts: 29.0;Skeletal myocytes: 63.0;Smooth muscle cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 160.0;GAMG: 34.0;HeLa: 39.8;hTERT-RPE1: 38.0;WM-115: 64.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		240000		"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	15.4	2.9	2.6	2.7	3.1	0.3	11.1	2.2	4.6	25.0	3.3	29.9	3.3	25.3	2.8	8.2	6.4	4.8	16.4	2.2	2.4	4.3	0.7	10.5	2.4	2.8	2.1	12.0	4.8	4.6	2.8	7.0	2.8	7.4	6.2	2.2	7.0	12.2	10.8	16.0	6.9	16.0	2.1	32.8	5.5	1.1	2.6	3.1	19.1	10.0	3.7	17.6	14.6	2.1	0.8	14.6	1.2	0.4	16.8	160.0	0.1	1.8	8.2	3.5	3.5	0.2	2.2	0.0	3.4	0.1	34.0	25.5	0.4	0.8	4.0	0.0	0.1	0.0	39.8	0.1	0.9	0.0	0.1	11.3	2.7	10.2	1.4	38.0	0.0	0.0	0.0	0.2	1.8	0.4	0.0	0.3	3.4	0.0	0.9	0.0	9.5	0.0	0.0	1.2	0.0	0.1	2.9	0.2	4.3	28.6	3.9	0.5	0.1	5.2	4.6	5.5	0.7	1.9	0.0	0.1	15.2	0.8	64.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	2.6	3.1	2.2	4.6	2.2	2.4	2.8	2.1	2.8	2.1	2.6	2.1	40.1	0.0	1.3	0.7	0.4	12.0	5.9	17.5	6.2	0.6	2.9	8.3	13.8	1.5	5.5	0.0	2.1	0.3	0.5	0.0	0.0	0.1	0.7	0.2	1.5	21.2	0.0	0.0	0.4	0.6	0.3	29.0	0.5	0.2	0.0	0.9	3.6	0.1	0.1	0.0	0.6	0.0	4.1	1.5	7.9	1.4	2.8	0.9	10.6	8.4	0.1	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.1	4.0	0.0	0.1	11.5	4.0	13.1	63.0	36.4	0.4	0.7	4.5	8.4	0.0	0.6	4.2	0.0	3.5
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023869	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.5;Hofbauer cells: 38.4;Skeletal myocytes: 175.5;Smooth muscle cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 6.7;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	11	"monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.7;HSkMC: 113.3;RH-30: 88.5"	"Group enriched"	"Detected in all"	4	"hippocampal formation: 41.0;white matter: 11.9"	"Low region specificity"	"Detected in all"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA		12000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA054136: AB_2682397, HPA062739: AB_2684858"	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	23.4	6.9	4.2	19.2	7.5	0.4	14.7	2.4	5.6	16.8	6.0	18.3	2.1	16.2	5.0	3.9	11.4	48.3	6.6	5.7	3.4	3.1	0.8	15.3	14.0	3.7	4.0	4.2	1.4	3.5	2.8	40.6	4.7	5.3	2.9	0.2	10.4	6.9	10.2	10.1	5.5	22.0	3.0	10.2	3.3	15.9	9.8	3.7	20.8	6.5	11.2	16.8	7.3	4.2	0.1	0.4	6.6	2.2	21.0	39.7	0.0	2.3	10.6	4.3	11.8	0.0	0.2	0.0	0.3	25.7	4.3	0.0	0.6	0.1	2.5	0.0	0.8	0.5	0.2	0.0	0.3	0.1	0.8	113.3	0.0	5.3	0.0	2.1	0.7	0.0	0.0	1.0	19.3	0.1	0.1	0.2	2.1	0.0	1.0	0.2	88.5	8.9	1.6	0.1	0.8	0.3	9.1	0.0	0.6	19.6	0.0	0.1	0.1	2.7	0.7	4.0	3.6	0.0	0.1	0.0	25.1	2.7	1.3	0.0	0.4	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.2	4.2	7.5	2.4	5.6	5.7	3.4	3.7	4.0	4.7	3.0	9.8	4.2	4.1	0.0	0.6	0.0	0.2	3.3	0.1	0.1	0.0	0.1	0.4	1.0	3.0	1.5	0.7	1.8	0.0	0.3	0.1	0.0	0.0	0.0	122.5	1.2	24.9	1.7	0.0	0.4	2.8	0.0	0.3	21.9	0.0	0.7	1.3	1.1	1.1	0.2	38.4	0.0	0.9	0.1	0.0	31.1	9.0	12.9	20.8	16.6	1.8	8.4	0.9	0.8	0.0	0.0	2.9	0.0	0.0	29.3	0.1	0.1	0.0	0.1	0.1	0.1	6.6	175.5	57.2	8.8	1.7	0.1	2.3	0.3	0.6	16.4	0.0	0.0
OPA3	"FLJ22187, MGA3"	ENSG00000125741	"Outer mitochondrial membrane lipid metabolism regulator OPA3"	Q9H6K4	19	45527427-45602212	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044881	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA044881: AB_10964052"	"unprognostic (3.37e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (3.14e-3)"	"unprognostic (4.53e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.72e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.30e-12)"	"unprognostic (5.85e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-1)"	4.8	7.2	3.3	4.7	3.4	4.0	3.5	4.4	5.2	3.0	3.7	4.6	4.0	4.9	3.0	5.8	3.4	3.3	10.5	3.2	3.1	7.4	7.8	4.4	4.7	4.9	4.0	3.4	4.4	12.0	6.0	4.4	5.0	3.8	3.9	6.4	4.0	4.1	11.1	5.8	5.0	4.7	2.5	5.8	4.9	8.9	5.5	4.6	4.6	12.9	4.7	4.1	3.5	3.2	15.2	18.9	7.4	7.3	4.8	5.9	11.3	9.7	8.9	10.1	10.7	8.8	10.5	13.0	6.9	9.8	11.5	12.0	12.5	13.3	8.9	24.0	12.6	20.1	10.8	9.1	8.8	14.1	25.0	8.9	10.1	11.2	12.2	5.8	7.3	7.6	17.5	14.2	6.9	9.3	11.3	5.8	6.5	12.6	12.9	10.9	6.7	7.1	8.0	26.9	5.5	6.6	12.4	11.3	5.2	6.6	6.3	8.0	15.9	8.5	9.7	7.1	16.7	9.5	19.1	10.6	8.2	10.1	13.1	5.6	5.3	2.9	3.6	7.8	3.6	4.4	3.2	3.1	5.6	3.9	3.9	4.0	4.7	7.8	10.5	5.1	4.8	3.6	3.3	3.4	4.4	5.2	3.2	3.1	4.9	4.0	5.0	2.5	5.5	3.2	11.0	12.8	11.7	8.5	23.0	18.7	22.4	14.6	13.1	22.8	9.2	7.9	25.4	17.2	11.6	11.0	52.1	25.6	15.7	18.8	25.4	18.4	18.5	12.8	13.8	15.2	13.8	5.7	9.5	21.1	29.8	10.6	14.3	20.1	15.9	8.9	11.4	21.9	16.3	20.2	10.2	14.5	16.2	11.4	28.3	20.2	6.2	17.4	14.2	4.7	19.0	15.1	11.3	3.0	8.1	18.2	19.2	6.4	11.9	15.8	21.2	16.8	10.7	36.0	0.0	23.3	23.6	23.9	13.1	11.2	19.6	36.3	14.4	19.5	16.6	16.7
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772485-128775794	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"retina: 41.0"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"LHCN-M2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	41.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORAI3	"MGC13024, TMEM142C"	ENSG00000175938	"ORAI calcium release-activated calcium modulator 3"	Q9BRQ5	16	30949068-30956461	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.3;Hofbauer cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 94.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA015022: AB_1854807"	"unprognostic (1.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.60e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (2.30e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.43e-3)"	"unprognostic (9.17e-3)"	17.3	34.1	18.0	8.2	16.5	17.6	15.2	16.9	17.1	24.4	26.0	22.7	9.2	18.3	16.3	15.4	19.2	9.9	16.7	15.3	16.3	19.3	70.2	14.2	11.9	18.6	18.5	18.9	17.7	18.9	18.0	14.9	17.1	26.3	8.6	4.0	14.6	17.0	7.9	14.3	16.1	9.8	17.4	22.5	17.1	15.6	20.5	11.2	16.4	8.1	10.6	27.2	20.2	17.7	2.8	15.8	8.1	10.7	68.1	60.7	0.6	9.3	62.3	6.8	17.2	1.5	26.1	3.9	20.7	17.9	27.5	12.7	1.4	17.6	4.6	12.3	5.2	10.2	4.9	16.1	94.9	11.2	30.5	65.5	45.9	13.1	25.5	63.8	11.7	2.2	11.7	20.6	22.1	10.8	0.7	42.6	6.6	9.1	4.3	8.6	6.3	30.8	26.2	6.8	2.0	13.5	8.4	2.6	14.9	19.5	19.7	45.5	8.5	5.1	3.5	11.4	2.2	50.4	4.0	3.1	25.3	26.4	7.9	23.2	8.7	26.6	3.4	9.2	3.6	7.1	1.8	2.7	8.5	6.7	2.2	2.9	15.3	11.7	12.6	9.5	2.7	3.3	18.0	16.5	16.9	17.1	15.3	16.3	18.6	18.5	17.1	17.4	20.5	17.7	12.1	6.4	10.8	0.0	23.9	7.9	24.5	25.6	32.5	1.5	11.1	19.6	6.9	5.7	11.6	16.5	2.1	28.1	25.9	11.1	13.7	21.4	61.1	16.5	21.8	16.5	15.0	16.2	0.0	11.4	2.7	25.9	4.1	10.5	7.0	17.9	23.6	77.3	93.8	35.3	0.0	11.3	10.2	43.7	11.5	36.7	53.1	31.4	21.4	0.0	39.1	24.4	17.5	0.0	0.0	9.5	18.4	43.2	18.1	14.0	9.5	48.2	14.7	3.6	26.3	11.0	14.0	26.5	2.5	17.0	4.5	4.4	9.7	61.0	5.8	20.4
ORC2	ORC2L	ENSG00000115942	"Origin recognition complex subunit 2"	Q13416	2	200908977-200963680	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003693, HPA073881"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB003693: AB_425574, HPA073881: AB_2686640"	"unprognostic (3.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (9.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-3)"	5.9	4.9	2.8	6.7	3.1	5.7	8.0	7.6	4.6	5.8	4.6	7.2	9.1	6.0	6.0	5.8	5.1	4.3	8.8	2.7	3.3	5.6	5.2	4.9	8.5	2.4	2.6	6.8	6.9	7.2	5.1	5.6	2.6	6.4	6.8	7.8	7.1	5.8	6.7	8.4	7.7	4.8	1.4	6.5	7.0	20.8	2.6	9.4	8.3	6.0	8.4	5.4	5.8	5.0	17.8	12.3	13.9	13.9	5.6	9.5	23.4	18.1	11.4	16.3	16.1	26.3	14.2	11.2	12.6	10.7	18.3	14.3	30.6	20.6	24.7	24.9	28.2	26.1	22.1	32.4	11.0	20.7	17.7	8.9	12.0	16.7	20.4	12.8	19.1	18.3	42.5	13.3	14.6	16.9	29.1	19.5	33.6	17.2	29.6	20.6	14.1	16.3	17.2	14.1	22.0	16.5	15.9	14.0	10.4	27.2	10.0	10.2	14.7	14.2	14.6	12.3	18.3	9.4	24.1	17.9	11.3	19.9	13.6	0.3	2.5	3.9	3.2	1.0	4.3	5.5	4.5	3.2	2.1	4.6	5.7	4.1	1.2	3.2	1.9	4.9	3.3	1.6	2.8	3.1	7.6	4.6	2.7	3.3	2.4	2.6	2.6	1.4	2.6	5.0	12.9	9.6	18.5	30.7	16.5	19.1	9.0	7.7	23.9	14.6	12.3	7.6	18.0	14.3	14.8	9.2	25.0	20.6	17.5	12.8	7.9	10.0	56.0	11.5	14.1	12.7	4.2	26.7	54.6	12.3	18.5	10.0	14.8	13.3	10.8	27.5	13.2	10.9	8.9	6.7	61.4	13.1	4.1	7.0	7.1	11.6	12.2	7.0	10.6	24.4	11.4	7.0	20.6	41.7	55.9	10.5	9.0	8.2	16.3	9.7	15.2	9.1	12.1	14.9	19.7	13.1	9.1	107.2	22.1	16.1	15.5	10.8	14.7	6.9	14.7	8.4
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.4;Inhibitory neurons: 48.8;Oligodendrocytes: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	9.7	9.8	10.5	7.8	11.5	5.8	13.2	14.3	12.5	10.2	7.8	12.0	8.4	10.8	13.7	10.6	8.9	6.6	6.3	11.2	10.5	10.4	17.4	6.4	12.2	10.3	10.0	10.7	14.5	10.1	7.5	9.5	9.7	16.9	12.8	14.1	8.9	10.6	9.0	11.6	7.5	10.9	9.3	9.0	10.3	19.3	11.6	13.3	10.2	7.9	13.4	11.0	10.0	11.2	37.1	39.2	21.2	38.1	21.8	21.5	18.8	31.0	30.8	34.2	28.5	25.9	23.7	55.4	26.9	19.5	37.9	33.1	42.4	29.9	40.8	32.3	30.5	20.2	19.1	24.8	30.8	37.9	16.5	22.3	27.9	39.4	36.2	14.4	32.8	30.1	65.0	29.3	30.8	52.6	52.4	38.7	23.2	48.6	37.9	21.6	38.0	53.4	26.4	26.4	28.9	23.5	30.2	58.7	41.3	16.5	19.7	28.4	19.2	32.8	36.0	51.8	41.6	33.7	75.8	69.3	22.2	49.7	39.8	14.2	10.6	8.4	20.2	12.7	26.5	24.0	21.6	23.9	12.3	18.7	25.7	28.9	1.4	20.6	10.9	11.4	18.4	13.7	10.5	11.5	14.3	12.5	11.2	10.5	10.3	10.0	9.7	9.3	11.6	11.2	6.7	3.2	7.2	22.2	11.2	4.5	3.6	11.4	10.8	6.6	6.6	5.7	6.2	8.6	9.8	3.7	0.0	22.1	2.6	4.4	1.9	10.3	5.7	3.8	9.8	9.1	5.4	12.8	54.4	9.0	14.3	8.6	9.7	4.5	5.1	11.6	4.6	9.7	8.8	3.3	48.8	8.9	6.1	4.8	4.2	5.7	6.2	6.0	1.8	35.6	7.8	3.4	7.2	31.2	55.9	7.4	5.4	7.9	13.9	4.9	5.9	7.2	12.9	12.5	0.0	4.1	10.9	40.1	24.6	12.6	8.5	10.5	9.5	10.3	8.1	2.0
OSBP2	"KIAA1664, ORP-4, ORP4, OSBPL1"	ENSG00000184792	"Oxysterol binding protein 2"	Q969R2	22	30693782-30907824	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.7;retina: 160.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.4;Excitatory neurons: 132.8;Inhibitory neurons: 156.3;Late spermatids: 304.4;Oligodendrocytes: 182.8;Rod photoreceptor cells: 619.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 41.9;HeLa: 146.4;hTERT-HME1: 38.2;SiHa: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021514	Uncertain		Approved	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA021514: AB_1854813"	"unprognostic (2.89e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.79e-6)"	"unprognostic (9.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	1.4	11.8	6.2	2.8	14.4	52.7	1.5	17.0	20.5	1.6	2.1	1.7	7.5	2.0	14.6	3.7	2.0	3.0	12.2	8.5	4.4	2.6	1.0	1.6	2.3	9.6	9.8	1.6	5.0	9.3	20.9	4.6	10.0	2.3	1.7	160.8	2.9	2.4	2.8	5.4	5.6	1.2	1.8	4.8	3.5	28.7	21.3	0.6	3.2	3.2	1.3	4.4	2.1	15.1	7.1	15.4	1.5	6.7	1.0	5.8	1.6	1.3	3.1	4.8	4.8	14.0	3.9	12.5	5.7	1.9	1.5	4.1	6.2	0.6	3.5	6.7	1.8	41.9	146.4	2.7	0.9	0.2	2.5	0.3	16.8	11.8	38.2	1.6	12.1	4.8	26.7	0.5	11.0	7.8	1.3	4.5	3.8	3.3	13.8	3.5	0.5	0.7	0.6	2.7	16.7	6.8	39.2	4.1	0.4	2.9	4.9	2.2	8.8	3.4	18.1	3.2	6.8	3.2	4.8	2.3	13.3	0.0	2.7	0.0	0.7	0.4	0.5	1.1	1.0	0.5	1.0	0.4	0.6	0.6	1.0	1.1	0.7	1.0	0.9	0.2	0.7	2.0	6.2	14.4	17.0	20.5	8.5	4.4	9.6	9.8	10.0	1.8	21.3	15.1	1.2	0.0	3.1	37.9	0.2	5.2	0.9	0.4	0.6	93.2	1.3	0.8	11.2	2.8	1.0	1.8	81.3	0.2	0.3	1.3	1.9	1.8	135.4	1.6	0.5	2.8	7.2	91.3	132.8	1.5	0.2	1.6	2.0	1.6	0.0	3.2	0.4	0.1	0.2	18.5	156.3	2.8	0.0	0.3	1.8	304.4	2.5	1.7	1.8	8.4	0.4	31.4	0.0	35.7	182.8	0.8	5.2	1.9	1.4	1.2	0.7	0.8	1.3	619.5	0.0	1.1	2.3	48.6	4.4	1.4	9.5	0.3	0.5	1.2	1.2	1.3
OSBPL10		ENSG00000144645	"Oxysterol binding protein like 10"	Q9BXB5	3	31657912-32077580	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 440.2;Late spermatids: 1206.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory B-cell: 11.5;naive B-cell: 6.7"	"Lineage enriched"	"Detected in single"	22	"B-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 93.3;RPTEC TERT1: 118.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003636			Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA003636: AB_1079529"	"unprognostic (5.28e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (5.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.85e-4)"	8.3	2.6	3.1	7.8	3.0	1.2	6.0	0.1	3.6	10.2	6.5	6.5	3.7	8.4	6.6	13.0	5.9	11.4	2.9	4.8	2.7	13.3	2.2	5.8	12.9	1.2	4.9	3.1	1.6	1.6	6.7	22.3	3.0	11.8	7.8	5.5	6.8	20.9	1.6	4.9	6.7	11.1	0.3	9.5	6.1	25.0	1.3	2.8	3.5	2.2	17.8	20.3	5.9	2.6	19.3	10.6	2.0	39.3	4.2	7.4	63.1	5.2	6.1	4.9	6.8	27.0	14.3	45.6	48.8	1.1	17.0	11.5	8.9	45.1	6.0	0.3	8.2	0.1	26.4	18.3	2.7	0.1	0.2	7.7	39.7	7.8	93.3	18.2	23.4	0.2	0.1	0.2	22.7	16.0	0.2	0.1	24.9	64.9	26.5	0.5	0.8	0.9	118.3	7.8	3.0	0.5	8.9	17.0	5.4	36.9	11.1	0.2	15.2	6.1	61.7	0.5	26.2	4.1	3.0	42.6	8.6	0.1	39.3	0.2	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	6.7	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3.1	3.0	0.1	3.6	4.8	2.7	1.2	4.9	3.0	0.3	1.3	2.6	20.5	9.6	3.9	2.9	50.6	10.8	7.5	10.1	4.6	7.3	13.8	6.6	2.3	4.3	7.3	7.3	0.0	15.3	2.4	7.9	9.8	1.8	440.2	11.0	26.5	21.1	15.0	5.7	70.5	4.9	25.9	10.4	6.1	26.4	0.0	1.3	18.2	0.6	2.5	0.0	129.9	4.6	6.1	0.9	6.3	1206.2	11.1	2.2	8.8	17.8	1.7	45.7	1.0	12.1	2.3	16.2	9.0	4.1	21.0	18.3	6.1	24.8	6.9	2.3	19.7	4.8	15.6	7.0	4.1	14.4	12.4	30.2	3.5	1.0	8.8	16.3
OSBPL1A	"ORP-1, ORP1, OSBPL1B"	ENSG00000141447	"Oxysterol binding protein like 1A"	Q9BXW6	18	24162045-24397880	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 214.3;Oligodendrocytes: 433.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	22	"basophil: 93.4"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040959, HPA043401"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA040959: AB_10964295, HPA043401: AB_10960208"	"unprognostic (1.75e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.53e-2)"	"prognostic favorable (4.98e-13)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.56e-1)"	72.0	27.8	77.1	9.4	105.6	15.4	47.9	99.6	136.0	52.4	114.0	34.9	20.7	48.0	17.2	30.8	29.6	21.1	52.0	77.3	90.6	43.5	13.3	24.2	10.4	89.7	95.0	27.3	16.5	62.8	18.7	8.3	94.5	23.0	22.7	82.2	51.5	26.2	170.9	17.5	20.2	41.1	79.2	9.9	21.3	14.3	91.3	9.6	29.0	123.1	7.9	25.4	20.0	136.8	38.2	11.4	26.3	49.1	60.0	48.7	24.5	14.0	40.4	12.4	10.2	7.1	38.9	0.1	16.0	25.1	19.7	37.9	10.4	24.4	11.4	0.2	19.6	12.1	7.8	0.2	29.9	30.4	6.0	63.4	34.4	9.5	38.4	54.0	15.9	10.4	0.0	0.3	15.5	16.1	7.0	9.1	21.7	19.5	36.8	0.0	21.0	3.2	3.3	27.7	16.9	16.6	32.6	37.5	46.1	24.5	13.7	21.7	3.4	45.9	9.4	14.9	13.6	0.4	5.3	1.0	22.3	8.7	26.8	93.4	4.2	1.1	0.2	2.2	0.1	0.0	0.8	0.6	4.1	0.4	0.6	0.5	1.6	0.2	0.7	4.1	0.8	1.5	77.1	105.6	99.6	136.0	77.3	90.6	89.7	95.0	94.5	79.2	91.3	136.8	214.3	16.0	21.6	142.0	5.4	20.1	43.4	16.6	29.6	66.6	73.6	64.3	78.0	41.5	20.0	20.2	22.9	12.1	11.1	23.6	64.6	13.3	67.7	27.6	55.3	89.9	4.8	18.7	180.3	7.4	8.1	59.9	16.3	17.0	17.2	137.9	37.5	12.4	26.6	25.2	166.4	40.0	40.7	27.4	17.9	76.4	42.9	34.3	58.7	67.5	11.0	124.8	0.0	75.9	433.0	10.7	19.1	54.9	2.5	27.1	29.8	71.7	21.7	112.3	32.9	44.7	65.8	6.7	9.9	27.2	10.2	6.4	3.8	103.7	16.2	26.4
OSBPL2	"DFNA67, KIAA0772, ORP-2"	ENSG00000130703	"Oxysterol binding protein like 2"	Q9H1P3	20	62231922-62296213	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 94.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 94.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041127, HPA042659"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA041127: AB_10962008, HPA042659: AB_10960683"	"unprognostic (1.00e-3)"	"unprognostic (7.20e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.20e-5)"	"unprognostic (3.86e-2)"	"unprognostic (8.13e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.32e-2)"	14.6	15.2	21.1	13.4	21.2	32.9	18.9	38.9	21.4	21.9	20.0	24.3	22.8	14.0	15.8	40.7	15.6	20.0	25.4	16.6	20.3	20.8	18.0	16.2	14.3	23.7	24.0	15.8	39.7	26.4	26.4	13.7	22.3	19.8	22.7	14.5	24.9	18.8	18.0	43.5	21.6	17.4	19.4	24.9	27.9	14.9	29.8	17.2	21.9	11.9	20.4	23.1	29.8	19.4	23.9	17.0	19.6	18.3	19.4	19.1	18.5	14.2	27.9	46.6	32.1	61.0	24.1	11.5	37.1	28.4	41.8	40.7	18.9	42.4	25.7	13.7	17.7	30.6	21.5	31.2	19.0	11.8	26.6	17.7	61.0	20.8	23.3	22.1	19.1	29.4	20.3	21.2	13.5	19.4	17.2	19.8	6.4	43.5	15.0	15.9	23.5	15.3	23.6	48.2	25.6	16.7	25.7	48.2	24.3	25.9	32.1	21.0	13.2	23.2	17.0	24.7	17.3	24.5	37.4	17.5	25.7	8.4	14.9	16.1	9.2	34.5	13.0	11.7	11.4	13.7	10.5	13.7	9.9	10.9	9.5	11.4	94.6	16.8	9.9	7.1	17.5	10.9	21.1	21.2	38.9	21.4	16.6	20.3	23.7	24.0	22.3	19.4	29.8	19.4	27.1	16.0	18.3	17.3	16.5	20.1	24.8	24.4	14.2	18.9	24.7	16.6	61.2	15.7	28.2	11.0	6.2	13.4	21.6	44.5	31.3	22.7	33.0	22.6	12.0	18.1	16.3	24.2	13.9	20.1	14.8	17.8	42.8	34.2	10.8	19.2	12.8	14.1	12.3	18.5	21.7	29.6	22.4	11.1	8.0	17.4	17.4	14.3	8.8	10.3	16.8	18.2	27.8	9.0	15.5	39.8	37.0	13.2	21.9	38.8	30.2	14.1	34.3	15.9	13.1	14.8	13.1	22.8	11.1	25.2	27.8	37.1	18.5	12.0	25.7	58.7
OSBPL8	"MST120, MSTP120, ORP8, OSBP10"	ENSG00000091039	"Oxysterol binding protein like 8"	Q9BZF1	12	76351797-76559809	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001309	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA001309: AB_1079530"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-3)"	24.2	13.5	18.1	24.3	43.3	32.5	21.1	9.7	22.5	22.6	12.3	11.2	9.3	22.3	7.7	24.4	10.5	18.4	14.0	15.3	13.7	36.4	19.2	19.6	30.9	11.7	13.4	17.4	14.0	13.0	5.6	18.2	14.0	14.9	11.7	14.2	13.5	12.7	10.7	28.7	13.0	18.9	9.1	26.7	16.0	16.6	13.1	33.7	14.3	11.5	32.0	19.1	10.2	16.6	36.5	22.8	49.7	35.5	67.5	94.8	31.6	54.7	76.3	34.2	31.1	33.2	14.6	50.8	30.4	65.3	21.5	14.9	37.2	31.6	51.3	43.6	33.3	136.0	21.0	19.8	41.7	87.2	53.1	50.4	58.7	51.2	63.3	61.8	30.0	29.1	95.0	22.7	57.3	25.0	58.8	41.4	24.3	13.2	22.6	30.4	67.7	29.3	26.4	30.3	27.2	28.4	46.7	16.6	34.0	38.9	13.0	52.4	70.6	55.0	27.5	57.5	29.7	22.7	38.4	54.6	21.0	47.9	32.8	134.8	50.8	74.1	29.2	37.4	27.9	45.3	31.2	24.6	46.9	40.8	27.9	23.2	195.7	36.0	44.5	54.9	41.1	31.8	18.1	43.3	9.7	22.5	15.3	13.7	11.7	13.4	14.0	9.1	13.1	16.6	63.5	57.7	58.3	54.5	87.8	116.2	65.7	39.6	114.9	49.7	68.4	55.5	42.5	25.8	36.1	51.5	89.6	34.8	111.3	13.6	60.7	53.9	47.4	29.0	102.6	68.7	9.5	63.5	246.3	55.2	28.7	98.0	28.5	44.1	254.8	36.3	52.1	45.9	77.1	42.1	248.6	25.8	40.7	98.0	127.0	22.1	65.9	142.0	35.6	79.6	149.3	50.2	125.7	113.6	92.9	104.0	28.3	82.8	56.8	54.6	23.9	180.2	37.4	37.3	46.0	79.3	83.1	66.2	129.9	89.9	124.5	48.2	105.3	58.4	20.0	62.4
OSCAR		ENSG00000170909	"Osteoclast associated Ig-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 13.6;lung: 28.4;lymphoid tissue: 29.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 35.6;Kupffer cells: 27.8;Macrophages: 42.9;monocytes: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	36	"classical monocyte: 43.0;eosinophil: 26.6;intermediate monocyte: 28.8;myeloid DC: 20.3;neutrophil: 40.0;non-classical monocyte: 27.0"	"Group enriched"	"Detected in many"	79	"dendritic cells: 20.3;granulocytes: 40.0;monocytes: 43.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.9;HHSteC: 9.4;hTERT-HME1: 5.0;NB-4: 5.9;U-937: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	3.7	1.8	0.9	2.3	0.7	13.6	1.8	0.1	1.6	2.2	0.0	1.5	0.0	1.3	0.0	1.5	3.2	1.3	1.9	0.1	0.7	1.5	2.4	28.4	0.3	1.3	0.7	1.1	1.3	0.1	1.0	0.6	0.9	1.7	0.3	0.0	2.2	0.3	0.5	2.1	1.6	1.7	0.7	29.8	1.2	0.9	0.8	0.2	1.1	0.6	0.6	2.2	2.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	13.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.4	0.6	0.0	0.0	0.2	0.6	5.0	0.8	0.0	0.0	0.0	0.4	0.1	0.1	0.0	5.9	0.3	0.1	1.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.5	17.9	0.0	0.0	43.0	26.6	0.3	28.8	0.1	0.0	0.2	0.4	20.3	0.0	0.1	0.0	40.0	0.0	27.0	0.8	0.2	16.8	0.9	0.7	0.1	1.6	0.1	0.7	1.3	0.7	0.9	0.7	0.8	1.7	0.2	3.2	5.9	0.3	0.3	0.8	0.6	0.7	0.6	0.0	0.7	0.4	0.3	1.5	2.1	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.1	0.3	0.9	0.0	1.7	1.9	0.0	0.4	0.6	0.0	0.1	1.3	0.3	0.0	0.0	35.6	0.0	1.0	0.3	0.0	27.8	11.6	0.2	0.0	42.9	0.0	1.0	66.4	0.0	1.0	0.0	0.3	0.4	0.0	0.0	0.4	0.3	0.1	0.2	3.7	0.4	0.0	0.2	0.1	0.6	0.5	0.4	0.1	0.3	0.7	0.4	0.1	0.3
OSGIN1	"BDGI, OKL38"	ENSG00000140961	"Oxidative stress induced growth inhibitor 1"	Q9UJX0	16	83931311-83966332	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 147.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.2;Hepatocytes: 78.4;Late spermatids: 261.1;Proximal enterocytes: 99.0"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 65.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.2;monocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"A549: 66.8;Hep G2: 103.7;T-47d: 73.3;WM-115: 62.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA019239			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA019239: AB_1854779"	"unprognostic (8.36e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (3.31e-3)"	"unprognostic (9.14e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.89e-1)"	8.5	26.5	7.0	4.8	8.3	0.8	7.1	7.6	7.0	4.0	4.3	7.4	31.3	3.3	1.2	12.3	4.5	8.4	10.1	5.2	7.3	14.1	147.4	9.3	1.3	10.1	9.0	4.3	8.5	3.0	3.7	1.6	10.2	5.6	2.5	2.0	5.2	2.2	22.4	3.3	18.7	1.6	5.5	10.5	13.9	15.2	9.3	0.8	13.2	9.6	1.2	12.8	5.7	9.3	4.7	66.8	0.8	2.9	4.1	5.9	5.0	7.7	7.5	7.0	2.5	16.9	24.0	0.1	18.0	6.7	31.5	12.6	3.2	4.9	2.6	1.1	0.8	1.2	15.5	103.7	15.0	2.3	25.7	3.6	3.9	18.1	4.1	3.9	7.2	4.8	6.5	6.5	9.1	31.9	0.9	0.9	0.6	16.5	15.8	2.3	6.7	3.3	4.8	5.9	0.4	1.5	16.0	5.1	32.6	1.7	73.3	2.7	23.1	10.6	16.0	15.7	5.3	2.7	1.2	0.2	35.6	3.6	62.8	0.1	2.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.2	0.0	12.6	0.0	0.0	1.0	7.0	8.3	7.6	7.0	5.2	7.3	10.1	9.0	10.2	5.5	9.3	9.3	2.2	16.0	3.9	0.0	0.6	1.5	8.1	15.7	5.2	0.8	7.9	4.3	9.0	8.6	18.5	1.8	0.0	1.4	0.5	41.8	5.9	11.3	56.2	6.1	1.0	5.4	4.2	0.0	0.1	6.6	0.4	5.4	26.0	5.3	1.3	2.7	6.1	78.4	10.5	0.0	0.1	12.9	12.2	9.4	3.0	261.1	4.1	7.3	7.2	0.0	3.0	8.6	0.0	0.0	0.2	13.2	23.5	12.0	1.3	11.8	99.0	11.7	5.0	0.6	13.1	4.7	5.1	2.3	1.3	6.0	1.7	1.4	0.6	4.6	10.5	5.9
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteoclastogenesis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Melanocytes: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		210000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.1	19.1	4.7	17.9	5.2	5.7	9.8	5.1	5.8	10.4	33.1	12.2	7.9	13.7	9.0	12.7	9.5	12.5	19.2	5.3	9.2	15.6	13.1	16.2	14.7	6.0	7.6	7.5	5.8	15.3	8.3	14.1	7.9	13.8	11.1	17.6	8.9	16.7	11.8	9.8	9.0	23.3	5.3	18.3	8.5	10.1	7.4	13.7	10.7	11.5	13.5	16.9	7.0	8.3	6.0	17.2	20.1	29.4	59.0	19.0	28.6	42.8	42.7	30.7	50.4	10.0	9.8	13.7	34.4	30.0	82.5	11.1	20.2	14.6	47.0	31.6	15.7	28.9	10.9	12.8	45.6	32.1	64.6	28.1	35.7	37.7	30.0	28.2	15.8	15.2	23.3	48.7	50.3	8.4	7.1	7.3	8.0	7.1	13.0	11.4	29.1	7.5	22.0	15.7	2.2	11.8	34.7	8.7	79.9	26.6	10.0	45.8	19.3	26.7	9.8	59.7	61.4	18.6	34.4	11.9	78.9	21.3	60.3	31.4	20.2	22.8	20.3	29.4	21.5	14.7	16.9	22.3	17.8	8.6	15.6	19.8	29.8	22.0	43.5	12.9	22.6	27.0	4.7	5.2	5.1	5.8	5.3	9.2	6.0	7.6	7.9	5.3	7.4	8.3	28.5	9.6	19.0	26.4	26.0	46.7	19.8	11.7	21.6	28.3	10.0	7.0	24.8	12.8	9.4	12.9	10.4	21.7	32.3	21.9	1.9	12.4	12.0	7.5	15.7	20.7	4.2	4.6	36.6	22.9	33.9	24.4	15.8	9.6	24.1	6.9	26.7	13.2	52.8	28.6	40.1	5.8	6.1	46.5	29.5	5.4	14.3	43.1	151.2	20.6	25.6	23.7	40.2	21.1	36.6	16.8	17.0	28.6	25.0	17.9	7.6	25.5	9.8	17.5	26.3	18.5	29.6	28.0	18.7	12.4	31.1	61.2	29.5	23.7	3.3	16.0
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380880	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 1.9;kidney: 5.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 51.2;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-87 MG: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.1	0.0	0.5	0.0	0.7	0.0	0.1	0.0	1.0	0.1	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.1	1.9	0.3	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.1	0.1	0.2	0.0	0.0	51.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	42.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	44.8	57.0	69.9	43.0	78.0	63.5	47.3	53.0	93.4	54.1	39.7	51.9	42.0	49.0	37.4	85.4	55.8	35.9	62.4	79.3	62.5	61.3	47.0	47.1	59.8	65.0	58.0	44.5	43.9	47.1	48.6	49.3	66.1	53.5	39.3	25.6	54.3	42.6	70.2	78.1	51.9	38.0	51.2	58.6	54.0	57.1	65.0	56.0	51.9	48.4	57.1	52.5	56.7	67.7	113.4	198.9	107.2	95.7	70.7	77.8	83.0	66.0	97.1	143.6	105.1	138.1	104.5	59.3	122.0	106.6	124.4	138.1	140.4	165.4	88.1	69.9	111.7	99.3	114.1	172.9	98.8	99.2	104.3	83.4	106.4	110.2	69.8	74.4	137.2	54.6	71.2	65.3	97.9	237.2	109.2	133.0	126.5	95.4	94.1	88.3	41.8	102.5	151.1	162.1	81.5	117.5	74.6	114.1	123.3	72.9	178.2	86.3	100.1	75.8	74.2	103.3	88.4	76.2	51.7	86.4	98.4	64.0	74.5	228.8	186.8	189.9	165.5	244.2	131.2	149.6	152.1	153.6	203.1	139.3	117.1	130.4	184.6	161.8	218.9	140.7	224.7	313.4	69.9	78.0	53.0	93.4	79.3	62.5	65.0	58.0	66.1	51.2	65.0	67.7	37.0	19.2	56.5	15.0	67.2	48.3	70.9	137.8	83.6	44.4	42.5	48.8	31.9	37.1	82.5	46.0	39.6	146.2	56.5	104.7	74.3	80.7	72.6	55.4	36.2	43.4	87.8	35.5	17.8	85.5	109.2	50.0	71.9	44.3	48.7	54.6	35.7	33.2	90.4	30.3	16.9	70.8	101.7	57.4	65.9	87.1	34.2	61.0	51.6	8.4	98.0	43.2	78.2	12.5	18.8	90.1	92.0	25.6	80.8	51.8	90.8	85.2	89.2	55.7	26.3	28.1	62.0	48.0	71.4	77.7	52.6	194.8	73.7	51.7	62.7	71.6
OTUD3	"DUBA4, KIAA0459"	ENSG00000169914	"OTU deubiquitinase 3"	Q5T2D3	1	19882395-19912945	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028543, HPA028544"	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA028543: AB_10599302, HPA028544: AB_10602277"	"unprognostic (6.45e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.15e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-2)"	3.3	5.7	4.8	3.3	5.0	6.4	4.7	5.2	5.9	6.2	2.2	6.4	5.0	7.7	6.0	3.8	5.6	3.3	3.4	4.9	3.2	4.6	3.1	4.9	3.6	2.8	3.1	6.7	4.6	4.1	5.5	2.4	2.8	5.9	3.8	9.3	3.9	4.1	4.9	6.4	5.8	5.6	2.2	4.8	4.8	10.7	3.6	3.7	3.9	4.3	3.0	4.5	4.9	5.2	5.8	2.2	9.5	11.4	4.0	3.5	9.3	6.1	3.5	3.0	3.0	10.2	5.4	9.2	4.8	13.5	2.2	5.6	8.9	3.5	5.9	6.0	11.9	8.8	13.4	7.2	2.2	6.5	7.8	2.9	3.4	4.8	6.2	6.4	4.1	9.2	6.3	3.8	5.3	3.2	5.0	6.5	4.5	4.6	5.6	11.5	24.2	3.4	5.1	6.3	8.4	5.9	4.4	3.5	4.6	9.2	5.2	4.8	5.0	7.3	9.3	8.2	5.3	4.4	4.0	5.6	5.1	8.6	3.4	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.3	0.3	0.1	0.1	0.0	0.1	0.2	0.0	4.8	5.0	5.2	5.9	4.9	3.2	2.8	3.1	2.8	2.2	3.6	5.2	5.0	16.0	7.5	11.4	5.6	14.1	5.9	2.4	4.6	14.9	10.2	9.1	4.7	4.3	2.0	9.2	16.7	2.7	6.5	4.7	0.0	5.1	16.0	11.7	7.8	5.1	12.0	6.1	32.6	4.5	5.4	7.0	5.1	8.3	1.3	16.4	7.9	2.2	1.9	26.9	28.5	7.0	4.1	2.6	8.9	16.4	5.6	5.2	5.4	6.5	4.1	8.9	5.2	21.1	16.6	5.0	6.7	6.0	8.6	9.8	4.7	4.2	9.7	15.5	6.6	7.8	6.1	23.5	21.4	5.7	8.8	2.5	7.0	4.7	7.0	4.8
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922024-48958386	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"U-266/70: 1503.3;U-266/84: 407.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	37.7	44.8	42.9	36.9	44.9	56.7	36.6	39.2	45.5	40.6	33.6	45.8	39.6	43.0	29.9	37.5	41.4	24.7	29.9	44.8	46.1	41.1	39.5	39.6	43.4	44.2	42.8	46.8	37.7	35.6	46.1	26.4	46.0	43.1	21.7	30.2	36.3	32.0	39.7	44.6	47.3	27.0	38.3	60.7	37.5	24.2	44.9	47.0	42.3	25.2	35.8	39.9	36.7	43.9	53.0	77.8	36.0	88.9	59.2	52.3	41.4	45.7	52.9	55.9	59.8	39.7	57.3	58.9	29.2	56.8	49.1	63.3	54.2	45.7	51.7	69.1	65.0	44.5	79.4	45.0	49.3	43.4	48.7	58.1	41.2	58.2	39.5	61.4	44.7	47.8	56.9	90.7	40.0	52.3	67.7	89.2	64.9	19.5	60.4	53.0	52.5	77.4	38.9	46.4	34.7	60.7	60.2	38.7	61.7	82.7	51.6	39.2	64.2	36.5	46.2	97.2	38.1	1503.3	407.1	56.5	56.3	58.9	25.7	5.5	3.3	7.6	6.6	5.2	5.6	8.6	5.1	5.7	4.8	5.3	4.8	7.1	8.5	20.3	5.1	6.2	7.3	3.6	42.9	44.9	39.2	45.5	44.8	46.1	44.2	42.8	46.0	38.3	44.9	43.9	21.3	9.6	22.3	17.3	33.3	22.2	21.2	13.7	13.1	35.5	23.7	19.7	11.5	15.7	16.3	27.6	27.1	13.3	38.2	28.4	9.8	13.6	1.9	24.5	23.2	19.6	48.2	32.6	15.5	18.3	16.3	18.4	21.4	33.1	7.0	28.5	22.1	24.3	16.7	28.6	15.7	28.5	10.2	22.9	33.9	2.9	20.8	25.7	26.6	15.9	22.6	18.0	30.9	14.1	14.1	21.5	19.0	23.7	38.1	27.5	28.1	21.7	21.6	27.9	13.1	19.9	20.1	10.4	12.6	15.9	25.6	30.8	33.3	28.6	20.1	27.4
OTUD6A	"DUBA2, FLJ25831, HSHIN6"	ENSG00000189401	"OTU deubiquitinase 6A"	Q7L8S5	X	70062457-70064179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 4.8"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 64.1;Spermatogonia: 25.1"	"Cancer enriched"	"Detected in single"	57	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053304	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Vesicles	"HPA053304: AB_2682107"															"unprognostic (1.58e-1)"			0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	4.8	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.4	0.1	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.6	0.4	0.3	0.6	0.0	0.0	0.1	0.0	0.1	2.6	0.0	0.3	1.3	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.9	0.7	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.3	0.0	0.3	0.0	1.8	0.0	0.4	0.4	64.1	25.1	0.0	0.6	0.3	1.0	0.2	0.0	0.2
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU deubiquitinase 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	6.6	6.2	5.7	6.3	6.1	5.9	7.2	5.9	8.6	5.2	5.0	5.3	4.2	6.0	4.6	6.4	4.2	3.9	6.5	5.4	6.1	5.4	5.4	4.7	7.4	6.2	6.2	5.3	4.6	4.0	3.5	8.0	6.3	5.8	5.4	3.1	4.3	4.7	10.2	6.4	4.4	5.5	6.3	5.0	4.3	6.4	5.9	5.7	6.0	9.2	6.1	6.3	5.4	7.5	27.6	11.1	12.8	10.4	6.4	5.6	14.5	19.1	7.4	19.1	12.6	8.6	16.6	25.6	9.0	10.2	7.6	9.1	26.4	16.1	31.6	21.6	16.9	34.5	11.7	8.3	13.3	18.7	21.0	7.2	9.8	14.0	35.5	11.6	17.5	19.4	36.5	19.1	18.9	9.6	31.7	17.5	8.1	20.3	27.3	19.4	11.2	28.9	18.9	15.1	3.5	14.6	2.6	55.9	22.7	16.3	25.5	11.8	15.8	12.3	17.2	20.6	20.5	17.1	29.5	37.2	16.8	26.2	23.1	1.7	1.9	1.1	1.5	2.7	2.0	2.0	1.4	1.7	2.6	1.8	2.1	1.9	0.2	3.4	2.1	4.0	0.8	1.0	5.7	6.1	5.9	8.6	5.4	6.1	6.2	6.2	6.3	6.3	5.9	7.5	11.9	9.6	11.3	9.8	13.7	23.2	6.5	4.0	10.8	13.0	6.5	5.2	14.3	8.6	9.2	1.8	33.3	10.8	16.5	5.1	9.8	4.8	0.9	10.6	9.9	10.9	10.8	8.2	18.0	4.9	10.0	9.0	7.7	8.6	18.4	10.7	8.9	11.7	8.1	11.8	15.5	4.9	4.1	8.7	12.5	2.2	9.6	8.3	3.6	12.2	10.2	12.2	11.3	18.6	21.6	6.6	3.7	4.1	12.0	8.9	2.8	8.2	8.8	15.3	0.0	8.2	9.6	3.2	7.0	12.5	18.2	6.7	10.7	9.9	6.4	5.9
OTUD7A	"C15orf16, CEZANNE2, OTUD7"	ENSG00000169918	"OTU deubiquitinase 7A"	Q8TE49	15	31475398-31870789	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 20.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.2;Excitatory neurons: 303.6;Inhibitory neurons: 219.7;Oligodendrocyte precursor cells: 100.0;Oligodendrocytes: 506.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;HAP1: 1.0;SCLC-21H: 3.6;SH-SY5Y: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044554			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli, Cytosol"		"HPA044554: AB_10794895"	"unprognostic (3.61e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-11)"	"unprognostic (6.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.79e-1)"	1.2	0.5	6.6	0.4	9.5	0.0	1.0	7.6	8.6	1.3	0.0	1.4	0.3	1.3	0.5	0.7	1.1	0.3	1.3	6.9	5.9	0.9	0.4	0.8	0.4	8.5	6.9	0.9	1.4	1.2	1.5	0.0	8.2	0.6	0.4	1.6	0.7	0.4	1.1	2.6	0.9	0.6	5.6	0.6	0.8	4.1	8.3	0.3	1.0	0.2	0.4	0.8	0.8	20.5	0.0	0.0	0.1	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	0.8	0.0	0.2	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.5	0.0	0.0	0.1	3.6	1.8	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	9.5	7.6	8.6	6.9	5.9	8.5	6.9	8.2	5.6	8.3	20.5	3.5	3.2	0.0	135.2	0.1	0.4	0.7	0.0	1.8	25.7	1.1	1.3	3.2	0.0	0.6	1.8	2.1	0.0	4.3	1.3	0.0	0.5	1.4	0.4	1.2	1.3	3.6	0.0	303.6	1.0	0.1	1.8	0.5	0.4	0.0	1.0	1.4	0.8	0.2	25.2	219.7	1.7	0.0	0.0	0.3	2.0	0.9	0.3	1.8	28.1	0.2	3.9	13.4	100.0	506.1	0.3	0.7	2.6	2.6	1.9	0.4	1.7	0.0	3.1	0.0	4.1	1.5	4.6	8.3	1.8	0.4	0.1	3.1	0.9	1.5	1.0
OTULINL	"FAM105A, FLJ11127, NET20"	ENSG00000145569	"OTU deubiquitinase with linear linkage specificity like"	Q9NUU6	5	14581792-14616180	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 29.5;dendritic cells: 36.7;Endometrial stromal cells: 16.6;Hofbauer cells: 100.7;Macrophages: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 17.7;HMC-1: 55.6;OE19: 16.1;THP-1: 16.9;U-937: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli, Cytosol"		"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	3.1	2.7	1.2	6.8	1.1	30.3	4.1	1.3	1.6	3.8	4.8	12.3	6.6	1.5	1.4	1.7	1.4	2.7	0.9	1.1	1.8	3.6	1.4	13.1	5.4	2.3	1.5	2.0	7.6	1.2	2.5	4.2	2.1	8.3	13.3	0.5	1.4	10.0	0.4	1.7	9.4	2.5	2.4	7.9	3.3	2.5	1.9	3.4	2.8	0.8	3.6	5.2	3.1	3.6	0.0	0.8	1.6	0.0	0.3	0.0	6.9	2.0	1.8	0.5	1.0	2.8	1.7	0.1	1.1	0.9	2.8	0.1	3.7	1.6	0.7	1.1	4.9	4.6	17.7	0.4	1.7	0.1	55.6	0.1	0.3	0.2	0.0	0.0	0.1	2.9	0.0	7.1	0.2	1.4	0.0	1.7	2.5	16.1	11.9	0.5	0.7	2.0	0.0	13.9	6.0	7.0	0.9	0.6	0.0	1.7	0.6	16.9	0.0	0.9	4.4	0.4	1.6	0.0	0.0	0.1	1.0	27.2	0.4	0.2	33.4	0.3	5.5	16.2	7.3	0.1	6.7	7.2	33.8	0.1	9.0	9.1	8.6	19.2	12.7	25.0	12.8	24.6	1.2	1.1	1.3	1.6	1.1	1.8	2.3	1.5	2.1	2.4	1.9	3.6	10.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	7.4	7.9	0.0	0.0	0.0	29.5	0.0	0.9	36.7	0.0	1.9	0.4	0.0	0.9	16.6	1.1	0.0	0.0	0.0	6.2	2.2	1.4	0.0	1.2	0.0	0.5	0.0	0.0	100.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	12.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	8.8	0.2	0.0	0.0
OVOL2	"bA504H3.3, CHED, CHED1, HOVO2, ZNF339"	ENSG00000125850	"Ovo like zinc finger 2"	Q9BRP0	20	17956979-18059188	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 7.1;stomach 1: 7.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 24.4;Spermatocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.6;CACO-2: 4.1;CAPAN-2: 7.3;HaCaT: 5.4;OE19: 10.0;SCLC-21H: 8.3;SK-BR-3: 5.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 10.3"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.9;hippocampal formation: 3.3"	HPA038531	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA038531: AB_10673012"	"unprognostic (2.85e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-4)"	"unprognostic (4.77e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.76e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	2.8	0.0	0.1	1.5	0.0	3.5	2.9	0.3	0.5	5.3	1.0	0.3	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	4.5	0.4	1.2	0.1	0.0	4.1	1.3	0.0	7.1	0.7	0.0	6.7	2.3	0.0	0.0	0.0	7.9	1.4	0.0	0.1	3.3	0.0	0.2	1.2	3.7	0.0	5.6	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.1	7.3	0.0	1.0	0.0	0.3	5.4	1.0	1.3	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.0	0.1	0.0	0.0	2.1	0.1	2.6	8.3	0.0	0.0	5.4	0.0	0.1	2.8	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.4	8.4	0.3	0.1	8.3	11.4	4.8	4.0	0.0	14.6	11.7	1.4	8.6	8.8	1.8	0.0	1.7	0.2	17.1	0.0	8.4	18.6	24.4	1.3	0.3	3.6	0.0	3.3	10.9	3.2	0.2	17.9	18.4	0.0	0.0	0.0	0.0	0.1	1.7	1.7	15.5	10.2	0.0	0.7	7.4	0.3	0.5	0.0	0.0	0.0	0.7	0.0	1.0	0.3	16.9	10.5	0.4	0.0	12.9	12.0	1.6	6.4	0.0	0.0	0.0	0.7	37.9	0.7	4.9	9.8	0.1	0.4	0.0	12.3	15.1
OXLD1	"C17orf90, MGC104712"	ENSG00000204237	"Oxidoreductase like domain containing 1"	Q5BKU9	17	81665036-81666635	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056878, HPA057019"	Uncertain		Approved	Vesicles,Cytosol		NA	NA		12000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Cytosol"		"HPA056878: AB_2683265, HPA057019: AB_2683310"	"unprognostic (1.08e-1)"	"prognostic favorable (2.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-2)"	11.4	16.7	8.4	3.2	8.3	6.3	12.6	8.5	15.2	7.7	7.9	10.0	4.5	7.9	0.0	11.0	8.4	1.2	15.4	8.1	8.9	14.2	18.0	7.4	3.9	8.9	8.7	5.5	14.8	1.5	6.6	1.7	8.6	11.1	0.2	0.1	10.6	1.9	16.4	14.3	9.8	1.3	9.0	11.7	15.4	29.7	8.9	0.6	8.9	0.0	0.7	10.0	7.5	9.3	15.2	56.0	0.5	12.6	3.2	0.3	9.5	7.3	0.2	0.1	1.4	14.9	14.1	4.7	12.6	0.0	7.8	13.1	0.0	10.0	0.0	7.7	29.4	4.2	26.1	37.2	22.9	3.0	11.1	4.8	6.8	2.9	3.1	0.7	5.3	22.3	7.3	7.2	1.1	38.3	10.7	12.4	6.9	7.9	24.9	9.7	0.4	20.5	2.9	8.2	2.4	11.2	3.1	19.0	27.6	0.2	27.4	17.1	4.5	10.8	7.2	12.2	8.4	19.8	7.9	6.5	14.6	11.3	11.0	18.6	23.6	18.4	23.5	20.8	25.1	26.4	31.9	27.0	22.9	28.6	33.5	26.0	17.1	35.5	22.6	31.2	30.6	23.8	8.4	8.3	8.5	15.2	8.1	8.9	8.9	8.7	8.6	9.0	8.9	9.3	17.9	32.1	17.1	7.5	26.1	8.5	21.5	48.6	21.6	19.9	40.3	40.0	16.2	30.0	26.1	23.9	6.2	37.1	24.8	43.4	72.4	38.1	85.7	29.9	25.6	19.2	21.7	38.1	8.3	47.9	28.8	20.6	28.1	26.9	14.0	26.1	23.6	55.0	44.2	23.5	7.7	35.5	50.8	34.2	11.1	34.6	33.2	21.0	16.0	5.6	41.2	41.3	47.4	7.5	12.6	43.9	41.5	23.7	19.7	40.4	63.4	89.3	36.0	30.9	26.3	11.9	18.5	95.7	20.4	35.8	8.5	27.9	29.5	56.5	31.6	26.6
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.4;skeletal muscle: 12.4;tongue: 7.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.6;Excitatory neurons: 8.9;Inhibitory neurons: 7.9;Ionocytes: 8.2;Skeletal myocytes: 20.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.7;LHCN-M2: 6.7;RH-30: 4.2;U-87 MG: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Cytosol"		"HPA028776: AB_2672771, HPA028777: AB_2672772"	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.3	1.1	0.0	0.3	0.2	0.0	0.1	1.0	2.6	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.3	0.8	1.3	1.0	1.5	0.2	0.1	0.3	0.2	3.4	0.4	0.3	0.1	0.0	1.3	0.8	3.4	0.3	0.0	0.3	0.2	0.7	12.4	0.1	0.1	0.1	0.1	1.6	0.2	1.1	0.6	0.0	0.0	7.7	0.0	0.2	0.1	1.2	0.0	0.4	0.7	0.2	0.1	0.0	0.8	0.1	1.7	0.7	1.2	0.0	0.0	0.0	1.1	0.4	2.9	1.3	0.0	0.1	0.1	0.2	0.0	1.9	0.9	0.0	2.8	0.0	2.4	0.3	0.0	1.2	0.0	9.7	0.0	0.0	2.1	0.6	6.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.2	3.1	1.2	0.1	0.5	0.1	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.2	0.0	0.0	11.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	2.6	1.0	1.5	3.4	0.4	3.4	0.1	0.6	1.2	0.2	0.0	0.6	0.3	0.1	0.1	0.8	0.8	0.6	7.6	0.0	0.4	2.4	0.0	0.2	1.8	0.0	0.5	0.0	0.1	0.0	0.0	2.2	1.8	0.5	0.2	3.5	2.7	8.9	0.0	0.4	1.4	0.0	0.7	2.5	0.1	1.8	0.1	0.1	1.7	7.9	0.7	8.2	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	5.0	3.3	0.0	0.0	0.4	0.1	0.2	0.0	0.3	3.2	1.1	0.0	20.8	0.4	1.6	0.4	0.3	0.1	0.4	0.5	0.1	0.1	0.2
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	22	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 28.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Vesicles, Cytosol"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	4.9	41.6	2.8	4.9	3.1	1.0	6.5	3.0	3.1	17.0	1.8	24.0	2.7	17.6	18.5	11.0	8.0	4.8	8.8	3.3	4.8	51.3	7.0	28.7	2.4	7.6	4.7	16.1	3.6	2.3	8.2	9.2	6.7	37.6	10.4	19.3	4.9	26.5	1.2	17.8	6.7	32.4	5.2	54.8	23.9	4.2	4.9	5.2	3.0	1.7	2.0	11.9	19.9	8.3	46.9	18.2	35.1	0.2	0.6	1.4	42.1	48.7	19.3	7.8	12.6	15.0	18.0	0.1	27.1	8.6	120.2	109.9	0.1	65.3	16.3	0.4	6.2	0.1	12.1	0.3	35.4	0.2	0.3	16.9	21.4	15.2	5.4	73.5	1.4	0.1	0.1	0.4	12.3	1.1	0.1	0.4	11.0	31.3	3.7	0.1	7.1	2.8	109.8	77.5	2.5	0.3	66.1	3.7	29.3	51.1	0.1	0.7	24.4	45.9	16.8	0.4	8.9	3.4	0.2	0.5	10.6	0.2	60.2	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.1	0.0	28.9	0.0	0.2	2.8	3.1	3.0	3.1	3.3	4.8	7.6	4.7	6.7	5.2	4.9	8.3	5.7	48.1	80.3	19.2	1.0	0.0	7.7	0.0	13.6	2.3	1.6	9.9	1.0	2.8	3.1	44.1	4.2	42.0	9.5	19.8	5.9	4.7	19.6	2.0	27.3	10.5	0.0	2.7	55.6	0.8	14.7	10.3	8.6	1.5	1.3	124.1	32.5	0.8	11.4	10.1	60.4	0.5	0.0	3.2	0.0	14.9	4.7	5.6	0.0	91.8	0.8	44.5	0.0	43.7	4.4	30.6	1.9	0.0	0.2	15.1	0.0	26.2	0.0	1.2	0.0	10.9	45.2	0.5	0.9	13.5	0.0	38.6	0.7	74.3	2.1	3.9
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828407-6839847	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.2;Cone photoreceptor cells: 100.1;Horizontal cells: 43.7;Leydig cells: 49.7;Peritubular cells: 38.4;Rod photoreceptor cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 39.6;hTERT-RPE1: 27.3;NTERA-2: 27.5;U-251 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		740000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.5	2.6	1.2	1.5	0.7	0.3	3.9	3.7	2.7	11.9	5.6	5.4	0.8	19.2	0.5	1.6	9.9	1.7	4.5	1.1	1.2	2.0	0.6	3.7	0.3	1.3	0.2	12.4	2.9	4.5	15.4	1.3	0.3	6.0	0.3	4.1	6.5	3.7	0.8	3.0	2.8	3.8	0.2	1.3	3.8	1.2	0.9	0.1	4.3	0.3	0.3	7.8	6.4	0.5	0.0	1.6	7.1	14.0	8.4	10.2	0.3	39.6	22.4	12.2	13.5	0.6	0.0	0.0	0.5	14.9	0.5	0.0	4.4	0.4	2.7	0.1	18.8	1.0	4.2	1.9	5.9	1.0	0.0	11.1	0.4	6.0	3.3	27.3	13.1	1.2	3.7	0.0	5.7	0.0	0.1	0.4	27.5	0.0	1.1	0.0	6.9	0.2	0.6	0.0	2.8	10.5	0.1	0.0	4.8	3.4	0.2	0.2	23.2	12.0	17.5	18.6	27.7	0.1	0.3	0.3	10.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	3.7	2.7	1.1	1.2	1.3	0.2	0.3	0.2	0.9	0.5	2.3	0.0	0.0	3.3	0.5	0.0	4.9	0.0	2.2	47.2	5.3	5.5	11.1	1.5	1.8	5.5	100.1	0.5	0.1	0.1	1.9	1.4	0.9	0.9	19.6	3.9	1.2	0.0	13.1	2.7	0.5	24.1	2.0	0.4	0.0	0.8	7.9	0.0	1.4	43.7	13.7	2.7	0.0	0.0	0.0	2.2	49.7	0.5	0.0	2.8	1.1	5.3	0.0	5.5	1.3	1.3	0.1	38.4	3.1	5.1	0.4	0.4	1.5	28.8	6.6	7.8	11.9	0.7	0.8	0.8	0.0	1.0	0.9	3.2	0.6	1.5
PA2G4		ENSG00000170515	"Proliferation-associated 2G4"	Q9UQ80	12	56104537-56113910	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011711, CAB012428, HPA016484"	Supported		Approved	Cytosol		NA	NA		2300000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912"	"unprognostic (5.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.87e-1)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (6.31e-7)"	"unprognostic (4.25e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (4.59e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.67e-2)"	78.4	59.6	46.7	89.3	50.4	132.9	76.2	50.7	58.0	64.8	43.0	78.7	74.1	64.7	48.2	132.5	64.7	43.7	76.9	48.6	51.8	62.1	72.8	62.5	96.6	49.4	48.3	71.2	75.1	83.7	36.3	69.2	51.0	53.2	90.5	38.3	63.9	55.4	144.0	106.1	69.7	68.4	49.8	61.2	65.5	63.1	48.9	123.4	61.4	92.5	120.7	105.3	76.9	57.2	429.6	374.8	248.9	275.5	112.5	169.8	499.6	441.3	209.7	530.9	293.8	464.7	307.5	850.8	291.2	209.6	155.9	343.5	574.2	493.1	510.9	243.9	517.6	659.1	242.5	400.4	219.7	898.8	232.4	172.5	247.2	460.2	410.8	218.1	327.3	292.0	812.8	380.7	294.7	383.5	700.8	496.2	410.9	264.5	460.9	569.3	449.8	577.2	272.0	315.7	372.8	225.6	290.5	451.6	275.0	183.1	488.7	343.5	264.8	256.3	364.7	300.3	495.5	234.4	345.1	822.1	232.3	532.6	340.9	34.3	87.0	54.6	129.9	96.0	174.7	98.0	136.8	141.3	102.1	81.3	129.7	131.2	13.8	151.5	82.0	98.6	170.9	155.9	46.7	50.4	50.7	58.0	48.6	51.8	49.4	48.3	51.0	49.8	48.9	57.2	135.7	54.5	91.2	9.8	136.3	368.5	244.7	187.4	224.8	56.2	151.9	165.7	37.3	118.7	161.3	130.6	18.8	232.0	163.1	123.4	193.7	235.8	530.6	127.1	218.4	154.2	93.3	552.1	12.8	249.1	321.7	139.5	112.7	142.2	170.9	103.7	107.8	197.5	208.6	33.7	13.0	159.0	99.7	124.2	127.8	238.9	132.0	126.2	129.9	6.5	155.4	117.1	178.2	10.6	14.8	269.3	100.8	126.7	163.5	360.7	118.6	264.7	103.6	48.8	144.7	188.1	191.7	344.6	110.9	295.2	362.7	193.5	176.2	132.2	254.1	242.7
PAAF1	"FLJ11848, Rpn14, WDR71"	ENSG00000175575	"Proteasomal ATPase associated factor 1"	Q9BRP4	11	73876699-73931114	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 130.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 112.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039952, HPA040020"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA039952: AB_10793925, HPA040020: AB_2676802"	"unprognostic (3.13e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.42e-1)"	17.3	29.0	85.2	11.3	92.6	9.0	17.6	82.3	130.1	19.4	68.8	25.0	11.8	16.6	23.8	14.4	19.6	12.0	25.2	80.3	85.9	23.9	21.9	12.6	12.6	88.0	88.6	24.6	22.2	19.1	25.8	11.7	87.3	22.0	16.3	46.4	15.4	19.8	19.8	19.2	14.3	15.5	85.4	16.3	18.5	30.3	85.7	15.9	18.8	7.5	17.2	21.7	16.3	101.2	13.5	30.6	27.2	21.3	28.9	29.6	15.5	22.6	25.9	35.3	25.0	60.2	10.4	40.4	34.4	23.2	32.8	30.2	33.5	27.2	52.2	30.4	20.8	41.4	28.0	50.3	34.6	39.1	15.3	30.5	41.7	38.8	47.2	28.4	27.0	32.1	50.7	33.7	33.2	26.3	34.5	40.5	12.7	71.0	23.7	31.6	72.6	66.5	26.5	22.9	28.8	33.8	26.8	17.7	70.6	25.4	53.1	21.8	19.7	24.8	15.7	35.3	22.3	41.3	50.3	82.2	17.4	25.0	26.5	53.4	26.2	32.3	26.8	17.2	29.5	40.8	28.7	27.3	34.4	36.1	37.0	31.7	2.2	32.4	6.3	24.8	36.8	27.9	85.2	92.6	82.3	130.1	80.3	85.9	88.0	88.6	87.3	85.4	85.7	101.2	9.0	3.2	12.5	40.1	11.5	4.7	11.6	27.3	6.8	50.4	6.8	9.1	19.6	8.6	15.6	16.5	112.6	33.5	9.5	5.5	13.7	15.9	38.4	10.7	12.2	9.8	3.6	20.2	17.4	13.8	4.8	11.5	6.6	9.4	19.6	30.1	11.7	13.6	18.8	47.1	23.7	7.7	20.3	9.5	6.6	22.6	16.8	9.5	14.2	14.0	16.3	37.6	18.6	24.6	55.5	7.3	5.7	18.0	15.3	9.6	12.0	53.5	14.1	51.7	6.6	18.2	12.5	48.9	28.6	9.6	8.1	18.3	9.8	29.9	10.3	8.0
PABPC1L	"C20orf119, dJ1069P2.3, ePAB, PABPC1L1"	ENSG00000101104	"Poly(A) binding protein cytoplasmic 1 like"	Q4VXU2	20	44910060-44959035	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 24.6;Collecting duct cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066650			Approved	"Nuclear bodies,Cytosol"		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Nuclear bodies"	"HPA066650: AB_2685698"	"unprognostic (4.98e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.92e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (4.00e-15)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (8.84e-4)"	2.1	2.3	1.7	2.0	1.8	4.1	2.9	1.1	2.1	4.0	2.5	1.7	0.8	1.5	3.4	2.1	3.4	1.4	1.3	1.7	1.8	6.1	5.9	2.9	3.3	1.4	1.8	6.6	6.1	0.5	6.1	0.6	1.4	5.2	0.6	0.4	2.5	0.9	0.5	2.1	2.9	0.6	1.3	4.4	2.8	1.9	2.5	3.0	7.9	0.1	1.9	1.9	1.9	1.7	2.0	3.4	1.9	4.1	0.4	2.6	8.9	3.7	0.3	1.4	0.4	8.4	3.4	2.2	7.3	0.2	1.2	4.7	0.5	1.3	0.9	1.9	4.0	1.9	8.1	7.2	2.1	1.6	0.5	0.5	6.4	1.2	1.5	1.1	0.0	3.1	3.0	2.2	0.3	8.0	2.8	4.9	1.2	3.0	7.6	3.7	0.6	2.2	0.7	2.6	2.0	3.0	1.6	5.7	6.7	1.8	9.7	1.8	0.2	5.2	5.7	3.4	1.6	5.4	8.8	1.8	1.7	0.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	1.8	1.1	2.1	1.7	1.8	1.4	1.8	1.4	1.3	2.5	1.7	1.3	6.4	24.6	11.8	7.0	1.9	3.3	3.3	6.2	0.5	7.6	9.9	1.5	7.2	15.6	20.2	0.0	6.7	4.7	2.8	0.0	3.3	0.6	9.5	6.8	1.5	4.2	1.7	5.3	0.5	4.4	4.2	12.8	11.1	3.8	10.3	0.4	5.7	3.0	0.0	2.3	3.0	2.0	0.8	1.6	0.6	1.8	3.3	0.0	1.9	2.3	1.4	3.1	11.1	3.2	1.8	2.4	1.9	5.1	3.5	1.5	1.5	10.1	1.3	0.0	2.1	2.6	0.9	2.1	4.9	1.7	3.8	7.0	2.1	4.4	2.9
PABPC3	"PABP3, PABPL3, tPABP"	ENSG00000151846	"Poly(A) binding protein cytoplasmic 3"	Q9H361	13	25096136-25099254	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	42	"testis: 36.8"	"Group enriched"	"Detected in many"	14	"Early spermatids: 217.6;Late spermatids: 135.4;Spermatocytes: 190.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"U-266/84: 6.8"									"HPA045423, HPA067156"	Approved		Approved	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (2.17e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (5.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.61e-3)"	0.4	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.2	0.4	0.0	0.3	0.0	0.3	0.0	0.8	0.2	0.0	0.1	0.2	0.2	0.1	0.2	0.4	0.0	0.2	0.2	0.5	0.4	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.6	0.0	0.1	0.5	0.3	0.0	0.2	0.2	0.3	36.8	0.3	0.0	0.2	0.0	0.0	0.3	0.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	6.8	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.4	0.3	0.3	0.3	0.2	0.4	0.2	0.4	0.4	0.1	0.3	0.4	0.2	0.3	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.1	0.0	0.0	0.0	1.3	11.7	9.9	2.8	0.0	0.1	0.4	0.0	5.3	0.0	1.3	0.0	0.0	2.0	4.0	0.9	0.0	0.3	217.6	0.2	0.4	2.5	4.2	2.7	0.0	0.4	1.8	2.0	0.0	0.1	4.5	0.1	2.5	1.0	1.6	1.7	0.0	1.6	2.0	5.7	12.7	135.4	3.1	1.9	5.4	0.0	2.1	1.3	0.0	0.0	0.0	0.1	3.0	4.9	0.0	4.5	0.5	2.0	1.0	0.0	6.6	4.8	10.5	190.8	5.1	0.0	12.9	2.9	2.5	0.2	2.7	5.0
PACS1	"FLJ10209, KIAA1175"	ENSG00000175115	"Phosphofurin acidic cluster sorting protein 1"	Q6VY07	11	66070272-66244744	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038914	Approved		Approved	Microtubules,Cytosol		NA	NA		17000	"Cluster 46: Basophils - DNA binding"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytosol"		"HPA038914: AB_10672831"	"unprognostic (7.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.46e-1)"	30.6	24.0	26.4	33.7	28.4	26.0	26.4	28.4	29.0	30.4	11.0	29.7	13.3	26.7	17.7	32.1	22.2	23.6	45.4	27.2	18.5	28.0	11.4	30.2	49.8	18.2	20.4	32.4	26.8	18.7	21.6	18.9	17.1	34.6	10.2	35.1	92.8	22.2	22.4	27.6	25.6	30.3	13.0	34.9	24.9	42.2	20.7	35.1	34.0	17.2	46.2	33.9	29.6	18.8	44.1	45.6	21.1	13.3	38.5	46.1	23.7	59.3	41.9	40.6	25.2	28.4	34.3	27.6	38.2	102.5	37.7	27.9	15.6	42.7	54.4	43.7	18.3	45.0	41.7	41.2	45.8	6.5	34.6	46.8	19.8	37.0	47.2	78.1	39.8	18.2	16.7	52.2	44.7	83.3	48.1	16.8	9.8	12.0	21.2	31.6	21.5	47.9	28.9	43.4	29.8	33.6	61.5	34.5	29.1	33.9	39.7	8.3	54.4	52.2	23.1	71.9	25.6	26.2	19.1	7.4	45.0	10.4	26.0	3.7	1.3	2.8	3.4	1.0	2.2	2.9	3.1	2.9	1.3	4.8	3.5	3.1	7.4	2.0	2.9	0.8	4.0	3.0	26.4	28.4	28.4	29.0	27.2	18.5	18.2	20.4	17.1	13.0	20.7	18.8	19.9	3.2	3.0	93.7	41.3	10.1	17.6	8.8	16.5	31.4	16.5	16.3	16.9	8.6	12.1	12.9	50.1	8.1	31.9	2.8	5.9	20.5	17.0	11.1	17.3	18.2	6.1	14.1	113.5	62.7	10.9	15.8	13.7	16.3	23.5	80.3	26.0	4.6	13.1	92.5	90.0	2.2	6.1	14.5	14.7	27.6	18.6	22.7	10.6	96.5	33.4	13.9	38.1	87.4	49.2	54.7	1.2	18.0	13.5	23.3	1.0	13.1	11.8	41.2	13.1	12.3	16.5	20.6	21.8	16.5	9.9	5.7	36.3	16.5	3.6	17.0
PACSIN2	SDPII	ENSG00000100266	"Protein kinase C and casein kinase substrate in neurons 2"	Q9UNF0	22	42835412-43015149	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 95.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049854, HPA056520"	Enhanced		Supported	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA		2400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles, Vesicles, Cytosol"	"Plasma membrane"	"HPA049854: AB_2680915, HPA056520: AB_2683163"	"unprognostic (5.62e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (4.48e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.09e-13)"	"unprognostic (2.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.95e-1)"	40.8	74.3	25.7	37.1	29.1	29.3	40.7	34.2	27.3	37.5	32.3	61.7	40.8	39.1	21.2	34.1	35.3	45.3	55.7	27.7	39.2	47.1	41.1	50.9	34.2	40.5	36.8	31.4	162.4	29.4	39.9	34.2	40.8	47.0	41.6	28.2	43.5	27.4	49.8	39.5	38.1	30.4	30.7	35.9	51.5	19.5	32.5	28.7	43.9	42.4	26.4	36.5	34.5	31.1	76.3	78.3	64.6	41.5	32.6	34.6	52.9	67.8	40.7	59.9	49.7	82.1	43.8	35.2	56.1	50.6	40.8	52.8	42.5	72.1	39.3	36.1	42.4	56.8	39.4	117.8	46.1	40.5	118.1	33.4	69.8	79.1	34.3	48.7	49.9	32.1	49.9	24.9	52.2	49.7	43.1	63.3	35.6	110.4	32.7	52.3	96.5	23.8	68.9	44.4	41.9	18.7	81.1	55.2	155.8	41.5	40.1	53.1	74.3	44.5	56.4	50.0	40.5	18.4	27.2	38.4	42.7	35.4	99.1	26.1	18.5	47.4	6.8	32.2	7.3	11.3	7.8	5.8	21.5	11.6	7.6	5.8	95.7	16.8	33.9	7.9	12.1	14.1	25.7	29.1	34.2	27.3	27.7	39.2	40.5	36.8	40.8	30.7	32.5	31.1	31.7	70.5	60.6	20.2	20.6	23.2	43.4	23.9	21.1	15.7	37.4	31.1	26.3	24.3	37.2	46.0	39.6	34.4	19.9	142.6	45.0	80.2	3.6	51.6	31.3	28.6	24.7	12.6	22.7	65.4	29.6	20.9	36.7	57.4	71.0	14.7	16.1	22.3	42.7	6.7	41.0	49.5	30.5	38.5	50.0	6.2	21.8	44.9	83.6	54.4	51.3	8.4	7.2	29.1	19.5	70.9	62.3	23.3	13.1	50.6	32.0	55.0	30.7	24.9	92.1	23.5	82.9	22.6	27.6	22.5	16.9	48.2	19.1	13.8	42.2	30.3
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 157.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		490000	"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	24.5	40.2	22.7	40.1	26.7	46.8	54.6	28.3	25.0	29.3	21.6	42.8	32.1	29.7	22.1	36.3	35.4	17.8	19.7	20.3	27.8	42.7	109.7	14.1	51.3	26.0	30.1	30.7	21.7	39.5	17.7	45.9	26.1	31.0	54.7	30.4	26.4	25.8	32.4	37.6	30.8	35.7	25.6	18.3	20.7	29.5	26.8	56.4	32.4	24.1	64.5	37.4	25.4	27.2	239.3	175.3	354.3	220.6	74.3	166.1	304.0	201.7	145.1	282.5	276.0	280.5	275.7	548.0	228.3	136.0	154.1	143.6	565.5	293.0	480.8	110.4	198.8	298.7	259.5	313.4	141.8	537.1	127.6	141.9	207.9	301.0	225.0	155.7	235.4	308.6	524.7	198.5	246.8	159.3	621.5	267.2	407.5	454.8	216.5	496.2	151.7	361.5	268.4	164.5	378.8	226.4	198.6	273.7	124.3	287.2	181.2	169.8	127.7	222.6	290.1	221.8	419.0	139.1	128.2	571.1	234.8	385.2	251.0	6.0	5.2	0.4	5.2	8.7	15.0	17.8	14.4	9.2	15.3	11.0	17.4	15.5	1.1	15.9	6.9	17.0	11.2	8.7	22.7	26.7	28.3	25.0	20.3	27.8	26.0	30.1	26.1	25.6	26.8	27.2	16.4	22.4	22.9	17.0	35.7	56.6	71.9	66.0	54.1	27.4	35.8	37.5	23.3	50.1	32.3	33.1	6.2	134.4	15.3	20.5	37.2	45.0	69.4	15.2	49.1	25.1	24.7	80.8	9.1	26.3	157.5	34.2	15.3	23.3	21.0	69.1	13.2	78.7	51.5	28.6	14.6	41.0	34.6	16.1	17.2	10.6	29.8	16.1	17.8	6.5	20.2	14.0	6.2	13.0	12.2	27.4	18.6	23.3	48.1	81.7	15.9	47.7	17.9	24.6	0.0	31.3	29.2	40.0	50.3	53.1	50.4	54.6	16.8	66.4	69.7	48.9
PAIP2B	KIAA1155	ENSG00000124374	"Poly(A) binding protein interacting protein 2B"	Q9ULR5	2	71182738-71227103	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 181.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 86.0;Early spermatids: 95.1;Hepatocytes: 67.1;Proximal tubular cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 15.8;SCLC-21H: 23.1"	"Low region specificity"	"Detected in all"							"HPA046784, HPA072371"	Approved		Approved	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA046784: AB_2679804, HPA072371: AB_2686514"	"unprognostic (8.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (8.17e-5)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.96e-12)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.61e-2)"	2.4	1.6	131.5	1.8	159.1	1.3	4.5	108.3	176.8	3.1	66.3	3.8	3.7	2.9	1.8	6.1	7.2	1.1	23.0	94.7	116.5	10.3	18.1	2.7	2.1	134.9	136.6	11.5	54.2	6.0	2.2	0.6	143.0	4.8	3.7	27.7	37.9	3.5	48.5	16.4	2.7	1.7	132.8	2.2	10.5	2.2	130.3	2.4	11.6	26.7	4.6	2.8	4.0	181.5	2.5	0.6	1.0	3.6	0.4	0.5	4.4	0.3	0.1	0.3	0.2	0.9	1.0	3.2	0.6	0.0	2.4	2.0	6.1	3.7	1.2	1.7	5.0	3.1	0.4	0.1	1.6	0.8	0.2	0.6	3.3	0.2	3.6	0.9	0.6	7.2	5.5	3.0	0.2	3.2	1.0	1.7	2.6	5.8	2.3	0.0	10.5	15.8	1.9	1.7	23.1	1.3	2.6	1.7	1.1	5.5	7.5	0.2	0.1	0.3	1.9	1.9	1.0	6.1	5.5	3.9	0.2	1.1	0.5	0.5	0.3	0.5	1.0	0.4	1.2	2.5	1.3	1.0	0.4	2.6	2.1	1.9	0.2	0.8	0.4	2.3	0.6	0.6	131.5	159.1	108.3	176.8	94.7	116.5	134.9	136.6	143.0	132.8	130.3	181.5	3.3	3.2	4.5	5.2	9.9	7.8	7.0	4.0	5.7	11.3	14.8	8.8	86.0	12.8	2.7	7.3	6.2	3.2	13.2	2.7	21.5	4.9	95.1	18.4	3.9	3.9	41.5	15.6	4.2	41.3	9.2	4.7	11.2	17.5	1.3	7.5	7.1	67.1	1.9	6.7	4.6	6.3	14.2	3.2	1.6	30.0	5.3	2.6	14.2	2.8	2.4	12.3	4.1	2.5	31.9	10.4	4.0	5.3	29.9	9.4	1.3	56.9	15.5	43.3	0.0	9.3	4.0	32.9	7.7	17.3	20.0	6.3	4.7	4.3	8.1	6.0
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1560.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1406.5;Enteroendocrine cells: 321.4;Inhibitory neurons: 487.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 529.9;fHDF/TERT166: 714.5;hTERT-RPE1: 562.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA		98000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	119.3	202.5	71.6	34.6	81.4	10.1	99.0	50.7	82.5	595.0	96.2	125.1	52.6	140.9	678.2	69.4	87.6	97.3	1560.4	75.2	179.9	116.0	20.1	88.3	27.7	86.5	99.8	136.4	104.4	257.8	137.0	60.0	170.9	91.6	80.4	37.6	205.4	236.5	155.3	66.9	52.1	157.9	55.7	52.5	131.6	22.4	106.0	17.9	95.1	159.4	30.5	103.3	116.1	50.0	111.3	16.3	195.9	87.2	529.9	314.8	78.0	307.6	457.0	89.1	268.9	53.5	143.2	0.1	65.0	714.5	125.7	36.8	11.0	135.3	244.0	13.5	44.7	22.9	60.0	17.7	80.3	7.4	23.9	173.4	57.3	65.6	49.2	562.6	186.8	8.9	0.9	15.0	255.6	22.9	0.1	3.2	35.3	19.7	59.3	8.5	108.9	62.4	346.1	13.0	92.3	63.9	131.2	8.3	83.3	114.0	34.0	7.3	144.9	280.8	72.4	133.3	93.4	33.1	8.6	0.4	322.3	30.8	247.6	4.2	8.0	0.2	20.7	1.5	14.9	0.8	12.3	15.6	3.1	0.4	4.1	6.8	16.6	26.3	3.4	1.6	19.9	10.8	71.6	81.4	50.7	82.5	75.2	179.9	86.5	99.8	170.9	55.7	106.0	50.0	45.7	54.5	39.3	47.0	3.9	28.2	12.0	26.1	12.0	19.1	27.5	12.1	1406.5	0.0	30.4	60.7	2.1	1.6	12.6	13.7	7.9	12.6	8.8	47.6	48.6	63.5	321.4	3.4	229.2	21.5	40.6	220.4	26.0	83.0	9.5	68.3	74.6	3.5	5.9	8.4	487.7	13.8	18.3	10.3	48.3	8.1	60.3	9.3	37.4	192.0	9.5	11.6	22.6	154.8	9.3	30.6	6.3	58.6	12.1	26.4	4.8	43.8	19.2	3.8	19.7	36.4	44.9	2.6	5.6	8.0	23.7	6.7	16.6	19.3	6.3	18.2
PANK4	FLJ10782	ENSG00000157881	"Pantothenate kinase 4 (inactive)"	Q9NVE7	1	2508537-2526597	"Metabolic proteins, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011723, HPA012036, HPA027961"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042"	"unprognostic (1.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.57e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-2)"	10.1	11.0	1.0	2.7	1.7	4.7	9.7	1.0	5.1	10.9	2.1	13.9	4.1	11.4	0.0	9.1	10.0	0.0	21.8	1.3	1.0	11.0	12.7	11.9	2.7	1.1	1.4	9.4	8.7	1.2	13.6	2.5	1.2	10.3	2.7	5.6	10.0	1.7	32.8	12.6	11.6	1.8	1.2	13.7	11.5	8.9	1.3	2.8	11.5	20.5	2.6	12.5	10.4	1.2	2.2	6.3	4.9	13.8	9.4	5.2	4.5	0.0	1.7	0.1	2.2	12.6	18.5	2.2	0.7	4.3	8.1	4.6	0.2	7.8	5.5	0.0	12.3	7.4	1.6	5.7	0.7	5.7	0.1	8.0	7.0	11.6	2.3	0.6	5.6	2.7	0.1	14.9	0.7	5.5	11.8	7.7	0.0	3.1	12.5	13.4	0.7	5.3	0.0	3.8	10.8	6.1	0.5	10.7	11.9	3.2	5.4	0.0	1.1	15.1	2.3	5.0	5.7	4.6	0.3	4.7	6.9	7.3	3.6	0.5	0.0	1.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	1.0	1.7	1.0	5.1	1.3	1.0	1.1	1.4	1.2	1.2	1.3	1.2	4.7	6.4	5.1	7.5	6.1	4.1	5.6	7.4	6.2	7.2	3.7	2.4	23.3	2.8	6.4	3.7	10.4	7.8	5.9	7.9	7.9	5.7	1.4	3.8	4.2	5.4	3.0	11.6	6.1	6.9	5.0	6.4	4.6	5.0	1.3	5.3	3.6	7.9	5.3	3.3	6.4	4.5	6.1	5.0	3.0	0.6	5.9	5.0	5.4	1.9	7.4	4.6	11.3	5.5	3.5	5.3	8.8	9.1	7.1	4.0	4.7	4.8	3.1	13.9	19.7	2.6	6.3	6.3	6.1	3.9	4.4	9.7	8.9	3.2	5.9	4.2
PAQR7	"MPRA, mSR"	ENSG00000182749	"Progestin and adipoQ receptor family member 7"	Q86WK9	1	25861484-25875708	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 1939.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 75.5;HaCaT: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046936	Approved		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA046936: AB_2679869"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.47e-1)"	"unprognostic (4.59e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.54e-2)"	5.5	23.9	8.5	4.4	8.4	5.1	5.2	7.5	8.6	11.9	10.0	6.4	20.9	11.1	28.2	17.7	20.0	7.8	3.3	7.9	10.1	35.3	7.4	5.6	4.3	9.6	10.2	35.3	6.6	13.7	6.7	21.4	9.4	7.9	2.9	1.5	5.3	24.3	3.0	31.4	18.9	9.5	9.2	10.2	8.1	46.2	10.6	3.5	5.1	1.9	4.9	13.6	13.5	9.4	30.7	6.0	5.8	18.9	7.1	14.8	20.4	19.9	17.5	19.2	17.0	9.8	75.5	0.3	13.6	19.2	6.3	62.6	3.2	33.0	11.4	12.1	3.4	25.6	8.4	12.1	12.0	0.4	3.1	14.9	43.3	13.7	10.2	16.9	7.5	2.8	2.8	2.1	14.4	7.0	0.2	1.9	9.3	3.1	10.3	2.1	0.6	3.8	39.3	22.9	3.1	11.5	32.1	40.7	14.8	7.9	11.6	4.6	8.1	3.1	9.7	10.2	5.4	0.4	0.4	1.3	14.5	0.7	6.6	5.4	7.3	15.7	1.4	13.9	1.4	4.0	0.8	1.0	7.6	1.7	1.3	1.9	3.7	3.4	17.5	0.8	0.2	1.4	8.5	8.4	7.5	8.6	7.9	10.1	9.6	10.2	9.4	9.2	10.6	9.4	4.9	0.0	3.1	11.4	2.2	18.1	4.3	4.6	4.6	2.1	9.4	9.5	1.9	17.2	5.1	77.3	0.0	52.8	1.3	0.7	21.5	5.6	350.9	23.4	11.5	5.9	4.8	0.0	11.9	13.9	12.3	7.8	0.5	9.0	7.0	4.6	10.4	5.5	11.0	3.3	11.2	2.2	0.0	10.3	14.9	1939.3	19.9	7.8	21.4	7.5	7.6	1.6	0.0	8.5	4.0	6.4	3.0	15.1	0.7	3.1	27.9	70.2	8.6	0.6	13.1	4.3	4.7	11.6	10.0	4.7	13.1	35.7	1.6	5.8	3.7	3.1
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: AB_2682014"	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	5.3	6.5	3.7	6.2	3.8	3.2	7.1	7.5	4.8	6.1	1.4	7.3	8.8	6.1	4.7	7.0	5.8	5.4	8.5	4.0	4.3	12.7	6.9	5.2	9.1	3.6	3.2	5.4	4.0	8.9	4.3	7.7	4.0	6.7	7.8	5.8	5.3	6.3	12.0	7.3	7.0	6.3	3.0	6.9	6.4	7.8	3.7	9.1	6.7	9.0	9.0	6.2	5.2	4.3	15.3	9.5	20.0	17.8	11.2	13.6	14.9	13.6	17.2	17.0	16.1	9.8	15.2	10.5	10.7	13.3	7.8	17.7	17.3	10.2	19.8	15.5	16.6	11.6	7.7	13.2	13.8	16.5	8.9	8.4	21.0	12.3	22.4	13.4	10.6	14.0	18.8	11.1	14.9	9.2	18.0	20.0	22.4	10.5	26.8	21.1	20.7	13.9	16.1	8.4	16.0	19.7	10.6	21.6	17.1	21.2	23.8	10.9	10.0	11.5	12.4	11.8	15.9	10.4	16.2	21.9	18.9	18.8	8.8	6.1	2.5	1.4	2.3	2.2	3.2	3.0	3.0	2.8	2.7	2.9	3.7	3.5	1.3	3.9	3.5	2.9	2.8	2.3	3.7	3.8	7.5	4.8	4.0	4.3	3.6	3.2	4.0	3.0	3.7	4.3	8.2	9.6	15.3	22.2	12.2	6.1	5.2	4.3	12.0	13.9	9.5	7.4	28.6	14.3	9.2	12.9	27.1	7.7	8.9	10.4	9.8	7.3	6.1	17.7	14.8	11.1	6.6	12.8	42.5	6.5	6.2	12.0	11.2	11.8	14.5	17.0	6.8	13.6	9.7	5.0	37.9	10.0	2.0	12.0	4.3	4.6	7.5	11.6	3.6	35.6	12.4	7.3	24.7	26.7	41.4	8.1	3.7	8.2	9.9	5.3	8.7	40.3	21.5	20.7	0.0	11.3	12.0	17.1	13.3	13.8	6.0	4.7	12.0	20.0	11.2	4.4
PARP11	"ARTD11, C12orf6"	ENSG00000111224	"Poly(ADP-ribose) polymerase family member 11"	Q9NR21	12	3791047-3873448	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026895	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026895: AB_1854980"	"unprognostic (9.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.87e-2)"	3.4	5.0	2.7	5.0	2.9	3.2	5.3	2.0	2.9	4.2	2.0	3.6	3.7	6.5	5.4	3.1	4.1	4.0	2.3	2.5	3.4	3.9	4.5	3.8	10.2	3.4	3.2	8.2	2.5	7.8	1.8	3.2	3.3	8.6	4.1	3.3	4.0	4.2	1.8	2.2	3.7	5.2	2.8	6.2	3.3	9.4	3.5	10.4	9.1	2.9	9.4	5.0	1.9	3.5	2.7	2.3	14.0	2.3	4.4	7.2	4.1	3.3	5.5	5.6	5.7	8.7	2.2	8.0	2.0	6.4	6.6	2.2	4.8	4.8	9.0	16.1	4.9	12.0	0.0	6.5	5.1	8.1	4.4	5.9	3.8	4.4	12.4	0.0	4.4	15.3	3.1	6.5	8.1	4.0	4.2	3.1	5.2	2.9	0.3	8.3	9.8	1.8	2.6	6.3	0.9	2.9	3.1	2.8	4.2	15.1	0.5	7.1	8.5	4.9	4.8	7.3	4.4	3.1	7.3	11.7	4.6	4.4	1.2	20.3	8.9	9.2	7.4	7.4	10.0	10.0	8.3	5.5	8.9	8.8	9.2	7.5	8.5	7.7	6.1	7.8	3.7	6.2	2.7	2.9	2.0	2.9	2.5	3.4	3.4	3.2	3.3	2.8	3.5	3.5	8.6	9.6	9.5	16.0	18.3	1.9	4.4	6.7	7.4	10.6	5.7	4.1	3.8	2.8	4.5	1.8	2.1	4.2	17.7	2.6	0.0	3.4	61.5	2.1	9.6	5.3	3.6	12.0	30.8	3.1	1.6	8.4	1.1	1.9	14.7	72.0	6.8	4.1	7.1	3.3	30.8	4.7	2.0	9.8	5.8	45.1	10.5	9.7	1.8	18.7	10.3	5.4	17.5	32.6	18.8	3.3	7.6	8.6	3.7	6.6	2.6	4.1	6.0	6.4	6.6	7.0	9.8	9.9	10.9	3.6	1.8	2.6	15.0	8.9	5.0	3.4
PARP8	"ARTD16, FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846519	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 124.9;Excitatory neurons: 197.9;Inhibitory neurons: 139.3;Microglial cells: 112.4;Oligodendrocyte precursor cells: 158.3;T-cells: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: AB_2680667"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (1.12e-4)"	11.7	13.1	4.6	26.8	8.8	78.2	9.2	0.0	7.9	8.3	0.3	8.8	14.5	6.6	4.2	7.7	9.9	25.7	6.9	14.7	12.6	7.0	8.0	19.8	42.0	3.4	4.5	11.6	12.2	13.8	4.9	12.4	0.1	11.3	9.3	4.6	10.3	7.4	4.8	7.6	15.0	8.4	2.7	43.6	20.2	9.1	7.7	19.2	43.1	2.1	22.5	14.5	5.4	2.0	24.8	0.1	12.2	18.8	3.2	5.7	18.0	4.3	15.7	4.1	12.0	0.9	33.5	14.8	16.9	0.5	43.3	12.4	2.1	13.1	10.0	20.2	15.9	10.6	9.2	1.1	6.3	28.1	0.2	6.8	10.9	8.5	6.0	24.6	0.2	23.1	1.6	9.1	5.9	8.8	31.8	32.5	12.3	0.4	6.0	15.4	24.0	17.1	7.6	12.8	13.0	19.0	13.8	21.6	3.7	17.6	1.0	91.2	0.0	1.0	15.4	1.2	12.6	6.9	0.2	29.5	13.8	7.6	17.7	27.4	13.7	31.9	43.6	4.0	70.6	13.4	34.3	50.5	9.2	16.7	20.9	34.9	28.6	39.5	2.9	4.2	22.5	22.7	4.6	8.8	0.0	7.9	14.7	12.6	3.4	4.5	0.1	2.7	7.7	2.0	6.2	32.1	21.1	29.4	51.7	8.0	5.2	12.7	26.2	13.6	10.4	6.5	5.6	14.3	19.1	22.0	0.0	22.5	124.9	17.2	7.9	14.2	28.7	11.8	8.4	3.9	15.0	7.4	197.9	10.2	6.4	13.4	46.9	10.6	14.5	12.6	6.8	5.0	14.3	6.7	139.3	4.2	8.2	26.1	16.9	15.3	1.2	27.1	8.8	112.4	43.4	0.7	93.7	158.3	7.3	18.7	8.4	3.0	65.0	7.7	8.2	4.3	25.6	2.1	6.6	12.3	13.0	12.8	6.0	14.3	4.0	24.8	157.3	6.5	9.6	13.7
PARVB	CGI-56	ENSG00000188677	"Parvin beta"	Q9HBI1	22	43999211-44172939	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.9;tongue: 170.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 113.2;Hofbauer cells: 90.6;Macrophages: 78.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 158.0;RPMI-8226: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062601, HPA072217"	Enhanced		Approved	Cytosol		NA	NA		24000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA062601: AB_2684803, HPA072217: "	"unprognostic (2.41e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.65e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.05e-3)"	42.6	30.7	26.7	21.3	19.4	43.4	33.0	18.7	24.3	21.8	22.6	21.8	7.4	22.2	13.5	11.9	19.2	10.7	86.9	34.1	24.7	23.0	14.4	29.7	19.2	23.3	25.7	27.1	11.9	18.5	24.3	21.4	26.9	17.0	8.6	10.5	11.4	13.7	195.9	14.2	18.6	22.9	20.8	35.3	15.0	6.6	28.3	9.4	12.8	170.6	16.1	23.9	16.7	19.7	23.5	27.7	0.4	19.1	28.1	35.5	0.1	32.4	20.1	20.9	15.6	28.9	13.8	0.2	17.5	87.2	16.4	0.9	45.9	2.1	11.5	33.1	28.5	100.4	45.8	0.2	46.5	76.5	86.7	55.4	24.0	15.2	0.2	15.0	158.0	0.4	36.6	67.0	22.9	15.9	0.4	50.4	9.8	20.4	18.7	0.2	0.8	159.5	0.5	0.6	24.6	17.1	8.6	1.6	84.9	3.3	15.9	30.7	99.2	19.0	20.0	29.4	3.4	16.2	15.3	0.7	82.8	22.1	106.0	6.9	6.8	1.6	1.0	7.1	1.6	6.2	1.7	1.5	7.2	6.4	0.4	0.9	4.7	0.8	2.9	14.9	2.4	9.5	26.7	19.4	18.7	24.3	34.1	24.7	23.3	25.7	26.9	20.8	28.3	19.7	70.3	0.0	10.6	5.2	48.2	5.2	3.4	1.3	4.0	11.2	8.3	9.4	55.0	4.3	0.9	1.8	16.7	1.0	29.0	0.3	27.4	1.5	6.6	8.0	12.6	63.7	1.2	113.2	15.1	3.1	10.8	18.4	4.1	11.7	64.7	20.2	53.2	12.5	90.6	6.7	12.5	0.7	6.1	49.7	39.5	21.6	19.9	78.7	19.6	28.1	44.7	8.9	9.2	2.5	5.9	4.7	0.0	10.9	58.1	5.1	0.0	30.0	3.8	15.2	6.6	18.2	14.2	1.9	5.8	0.7	4.4	1.8	16.7	2.3	0.6	1.5
PAXBP1	"C21orf66, fSAP105, GCFC, GCFC1"	ENSG00000159086	"PAX3 and PAX7 binding protein 1"	Q9Y5B6	21	32733899-32771792	"Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 155.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003757	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA003757: AB_10600796"	"unprognostic (8.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.38e-3)"	"unprognostic (2.54e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.43e-4)"	"prognostic unfavorable (1.50e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	5.8	6.2	7.3	6.4	8.4	28.6	7.2	10.1	9.8	7.4	8.5	6.8	10.2	8.3	7.2	5.8	7.4	4.9	4.6	7.0	9.2	6.7	6.6	6.3	9.4	8.5	8.1	10.9	6.9	4.7	5.8	6.3	8.5	5.8	7.6	13.0	5.7	5.2	9.3	8.0	7.9	5.3	7.7	7.4	5.5	8.3	8.0	10.1	6.2	6.7	8.0	6.3	6.0	10.5	14.5	11.5	24.4	19.7	9.2	7.4	32.0	10.4	7.0	13.7	10.0	24.3	12.8	16.9	7.9	6.2	10.9	14.1	23.7	9.8	14.5	14.0	18.2	29.6	19.7	17.9	4.5	33.6	17.1	3.9	14.5	16.0	7.5	9.7	9.5	18.4	34.3	15.9	10.3	12.6	23.1	19.8	64.5	16.4	11.0	21.1	22.0	25.0	11.0	13.1	19.3	11.2	15.2	17.3	12.1	15.1	11.3	18.7	8.2	10.5	13.7	11.8	16.5	15.5	19.8	31.0	7.8	30.0	10.7	0.0	0.3	0.1	0.6	0.1	0.8	0.5	0.7	0.5	0.4	0.6	0.7	0.7	0.0	0.2	0.2	0.3	0.4	0.1	7.3	8.4	10.1	9.8	7.0	9.2	8.5	8.1	8.5	7.7	8.0	10.5	28.9	12.8	21.6	62.3	22.0	25.5	21.5	5.6	31.3	50.6	26.0	20.2	12.3	21.5	15.3	20.2	62.6	16.7	39.2	19.4	5.9	7.4	36.8	47.8	51.6	22.3	22.1	17.9	61.6	8.0	12.1	27.1	30.1	45.6	12.0	42.4	15.4	12.7	10.2	21.9	66.1	23.7	6.1	13.9	19.3	32.8	14.6	24.3	21.4	55.3	14.1	28.6	24.7	117.6	155.4	6.8	12.8	17.0	29.1	25.1	17.4	7.9	24.5	81.6	32.9	51.5	23.5	32.2	18.2	26.5	25.4	17.8	29.4	26.3	21.7	32.4
PBDC1	"CXorf26, MGC874"	ENSG00000102390	"Polysaccharide biosynthesis domain containing 1"	Q9BVG4	X	76173040-76178314	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003155	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003155: AB_1078592"	"unprognostic (6.95e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-3)"	"unprognostic (8.82e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.98e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (1.62e-1)"	24.2	31.0	12.4	22.6	11.8	46.6	23.1	12.7	19.9	22.6	12.9	27.2	40.3	24.0	23.6	33.3	19.3	19.2	21.1	12.1	13.5	29.4	31.8	22.4	26.3	13.3	14.0	20.2	19.5	20.8	19.8	22.8	13.1	25.2	28.2	20.1	21.4	18.9	24.3	26.4	33.2	26.1	12.6	25.6	23.8	6.5	13.7	20.6	19.0	19.3	26.7	33.1	21.9	12.5	35.3	50.9	41.5	28.2	53.5	52.3	36.0	62.5	51.2	53.9	46.3	48.9	46.8	47.1	40.3	62.3	68.6	49.7	70.3	68.1	69.5	36.1	45.2	36.0	30.1	72.4	82.0	104.6	49.2	42.2	55.4	74.9	63.2	33.3	69.6	17.0	50.7	22.9	67.8	41.6	49.1	75.3	116.1	87.0	78.9	41.3	43.7	6.0	79.8	64.9	24.3	30.9	27.6	44.0	0.2	53.0	26.8	39.1	60.8	39.9	40.8	48.6	56.7	40.6	77.3	27.8	44.7	35.7	32.3	17.6	41.1	42.6	68.3	62.8	50.6	70.7	61.0	67.8	53.5	57.3	61.9	59.4	7.7	69.6	71.8	56.0	57.0	44.0	12.4	11.8	12.7	19.9	12.1	13.5	13.3	14.0	13.1	12.6	13.7	12.5	32.8	35.3	29.1	2.6	32.9	52.9	84.4	119.6	50.7	21.0	29.3	35.3	38.5	31.5	64.3	40.5	14.6	55.5	57.5	46.9	49.0	71.0	0.9	51.9	49.1	34.4	27.6	17.5	2.3	62.5	60.4	42.9	28.1	45.7	51.4	33.5	25.7	47.9	69.8	8.4	2.4	50.3	77.3	30.5	31.5	3.8	47.8	38.1	46.2	1.9	68.0	26.4	45.3	2.5	2.8	58.7	44.7	38.7	25.7	58.3	105.5	84.1	49.1	25.0	52.6	35.9	47.0	4.4	18.9	59.4	70.5	55.0	49.2	82.0	51.9	82.1
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809624-27838082	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 22.8;testis: 70.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 364.9;Spermatocytes: 436.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 282.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.7;white matter: 13.9"	"Not detected"	"Not detected"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	1.1	0.6	0.1	6.6	0.1	9.1	2.3	0.0	0.1	1.1	0.0	8.9	8.4	1.2	0.0	6.6	0.6	0.7	0.2	0.1	0.1	0.4	1.1	0.7	12.8	0.1	0.3	0.2	0.4	0.2	0.0	5.1	0.2	0.4	10.1	0.0	0.9	0.0	0.2	4.8	8.1	2.7	0.1	1.5	3.6	70.3	0.3	22.8	0.5	0.1	12.4	1.6	2.1	0.1	282.8	94.2	94.4	57.9	8.3	15.7	36.9	129.5	63.0	133.2	112.3	33.7	51.2	156.4	43.3	51.7	150.2	76.4	87.6	44.7	145.7	35.8	48.0	35.0	64.6	49.2	0.6	25.7	54.1	4.4	36.0	62.6	32.8	24.3	68.5	75.9	54.3	100.6	160.4	34.5	87.7	29.1	15.6	80.1	80.0	54.4	126.9	41.2	51.2	44.9	36.1	53.2	48.2	56.0	75.0	26.2	58.0	37.3	40.6	85.6	207.3	111.5	141.5	15.4	39.4	70.1	54.0	43.4	188.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	4.2	8.9	2.8	10.8	0.0	0.0	2.9	2.4	0.5	2.8	2.6	0.0	0.0	29.8	1.3	5.5	0.0	0.6	364.9	2.5	2.2	2.4	0.0	61.7	0.1	0.0	49.3	6.7	6.6	3.5	0.0	13.5	5.7	1.7	5.0	0.0	0.1	9.4	6.1	1.9	1.6	76.8	8.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	3.0	14.0	2.0	1.5	0.3	0.1	0.0	6.6	0.1	5.8	436.4	38.1	9.4	2.4	6.7	1.9	2.4	18.7	3.8
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	24.3	32.1	16.5	11.8	22.3	3.1	36.1	10.7	18.0	88.3	1.9	52.3	22.4	136.8	21.6	30.1	74.6	37.6	24.0	15.3	14.1	29.4	7.7	20.7	4.5	8.8	32.7	52.1	48.1	29.5	14.3	19.5	6.7	38.0	19.8	17.1	43.8	53.8	36.3	10.2	19.9	125.2	13.7	10.2	21.9	6.8	12.6	10.9	35.1	26.5	8.1	40.2	41.5	12.1	2.9	74.4	82.4	19.1	50.8	23.3	3.4	25.2	20.9	8.4	6.1	14.2	11.8	0.0	5.5	47.8	4.3	22.8	31.7	8.1	3.6	3.1	31.3	93.0	56.5	0.3	34.7	0.0	22.2	24.4	0.0	5.4	2.1	19.2	0.3	0.0	0.2	0.0	2.2	47.1	0.2	0.6	111.5	3.8	4.5	0.0	21.6	27.0	6.3	44.1	2.5	39.6	27.8	186.1	0.1	71.4	73.2	0.0	0.5	3.7	8.6	24.2	8.1	8.5	61.2	0.1	0.4	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	16.5	22.3	10.7	18.0	15.3	14.1	8.8	32.7	6.7	13.7	12.6	12.1	28.6	22.4	18.6	382.3	2.8	22.8	115.0	39.8	70.6	39.9	129.9	87.8	50.0	98.7	25.3	33.1	110.5	101.3	1.5	29.2	33.2	47.9	91.3	47.7	144.3	47.0	90.9	30.3	475.9	68.7	7.3	126.7	32.1	38.5	71.7	57.6	68.9	18.7	9.7	5.0	405.0	38.2	50.8	1.9	17.5	124.4	63.6	12.1	16.0	125.5	1.6	33.5	1.0	327.2	227.4	31.7	72.5	103.8	2.8	41.5	40.4	57.9	37.3	30.6	39.5	142.0	70.9	2.3	17.5	83.6	28.1	104.7	7.6	168.0	43.7	75.9
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 153.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 13.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 90.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 167.4"	"Group enriched"	"Detected in all"	5	"basal ganglia: 46.3;olfactory bulb: 161.9"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	10.9	56.0	10.4	12.9	14.6	6.9	10.0	17.4	13.2	27.2	7.0	47.9	6.8	9.8	20.0	11.8	14.2	22.5	38.0	7.2	15.0	7.1	18.1	13.0	8.0	19.7	21.0	58.2	18.8	153.1	12.6	6.7	19.4	30.9	13.7	28.0	11.8	28.0	8.5	19.4	14.3	22.6	18.8	12.8	21.5	8.2	15.3	16.7	35.1	5.7	6.9	20.7	21.9	21.7	11.6	11.0	50.0	43.1	13.1	19.1	8.5	29.9	16.8	19.2	14.5	14.3	21.1	11.3	3.6	22.1	20.8	8.5	28.3	12.3	38.3	12.4	20.5	9.7	7.9	5.8	17.2	9.6	15.5	9.5	13.7	14.5	10.0	45.3	23.1	7.2	0.4	10.3	43.5	5.9	10.0	4.9	35.8	14.2	7.4	18.9	73.3	1.5	15.6	6.4	25.9	45.1	20.2	3.8	9.4	18.8	15.7	90.1	26.6	40.0	10.2	23.8	57.1	7.2	12.8	11.5	19.7	15.2	20.6	2.3	1.7	2.2	0.8	1.4	0.9	1.0	0.9	0.7	1.9	1.5	1.7	0.7	1.4	3.2	1.3	13.9	0.8	1.0	10.4	14.6	17.4	13.2	7.2	15.0	19.7	21.0	19.4	18.8	15.3	21.7	7.3	9.6	16.7	17.9	10.0	22.7	10.3	3.0	6.8	7.5	11.5	8.3	60.3	2.8	8.6	12.9	37.5	0.6	20.7	1.3	7.9	13.5	15.2	1.1	14.0	11.9	11.5	6.3	44.3	2.5	0.9	23.4	5.6	1.5	16.5	9.4	9.7	12.6	15.3	42.1	19.3	5.7	6.1	29.0	23.7	11.4	19.9	22.9	7.2	91.8	13.6	11.5	6.2	136.2	192.2	3.1	12.1	11.3	3.8	13.0	0.9	2.8	8.5	43.1	0.0	5.3	13.0	33.7	16.0	10.4	26.3	0.4	10.5	8.7	3.4	8.7
PBXIP1	HPIP	ENSG00000163346	"PBX homeobox interacting protein 1"	Q96AQ6	1	154944076-154956123	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 176.0;Muller glia cells: 221.4;Theca cells: 153.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"granulocytes: 183.9;NK-cells: 56.9;T-cells: 197.4"	"Cell line enriched"	"Detected in all"	7	"Karpas-707: 1100.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006949	Approved		Approved	Vesicles,Cytosol		NA	NA		26000	"Cluster 13: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA006949: AB_1079572"	"unprognostic (6.17e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (8.94e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (7.19e-4)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.64e-4)"	"unprognostic (1.20e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (3.89e-1)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.26e-3)"	57.7	122.5	169.3	58.4	180.3	35.1	45.9	159.8	158.8	74.5	296.1	124.5	55.4	81.7	39.0	46.0	68.8	52.8	67.7	144.4	173.6	56.9	29.7	49.0	69.4	208.2	189.7	115.3	34.0	102.4	168.9	33.3	168.5	63.6	29.7	38.9	53.0	95.3	139.7	37.2	90.7	52.4	171.7	82.2	82.7	58.1	210.4	80.8	85.9	100.5	59.1	79.2	50.5	161.2	7.3	19.1	29.9	20.0	101.3	31.5	22.0	25.1	55.3	11.9	23.5	5.6	24.9	31.3	79.1	30.5	17.0	26.8	7.3	16.1	8.3	16.9	11.7	7.1	26.2	20.1	46.9	8.6	83.6	48.0	26.2	15.1	3.0	137.7	45.4	23.6	4.2	1100.7	29.8	11.1	17.6	27.5	11.4	19.3	14.4	20.2	43.1	69.7	32.9	14.1	4.9	37.6	32.5	10.2	26.7	56.1	31.0	36.6	42.9	11.8	8.6	7.6	7.8	149.4	133.9	7.7	42.2	12.4	9.6	129.4	10.3	183.9	41.9	14.8	116.3	36.0	112.4	66.9	9.1	23.6	72.9	46.2	95.2	56.9	29.7	16.2	197.4	61.5	169.3	180.3	159.8	158.8	144.4	173.6	208.2	189.7	168.5	171.7	210.4	161.2	24.5	67.3	77.9	56.8	43.0	10.1	24.0	22.4	13.1	23.8	17.6	19.7	38.5	38.6	31.1	42.3	16.7	19.5	48.2	21.0	0.0	46.0	142.1	12.9	25.9	23.8	83.7	22.3	1.5	18.5	24.0	35.9	19.9	10.5	51.9	30.3	28.9	19.4	14.7	1.7	1.2	20.9	69.2	20.2	13.8	176.0	64.3	16.8	26.6	7.5	25.5	221.4	39.1	3.5	1.6	22.4	29.3	129.1	49.0	10.5	56.0	9.9	23.9	8.8	52.6	83.9	50.6	8.8	13.9	6.3	11.5	27.1	116.2	153.3	15.9	13.9
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631744-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;lymphoid tissue: 25.1"	"Group enriched"	"Detected in many"	4	"Adipocytes: 57.6;Astrocytes: 77.1;Early spermatids: 60.7;Endothelial cells: 126.7;Excitatory neurons: 125.2;Hepatic stellate cells: 79.6;Inhibitory neurons: 67.9;Oligodendrocyte precursor cells: 193.0;Oligodendrocytes: 101.1;Spermatocytes: 68.3"	"Cancer enhanced"	"Detected in many"		"glioma: 9.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.7;HEK 293: 9.3;U-87 MG: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA		690000		"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	1.6	1.8	15.8	1.8	20.6	0.0	0.8	7.9	13.9	2.2	0.1	1.2	0.8	2.1	0.8	0.6	2.0	3.2	2.2	11.7	25.5	1.9	1.0	14.0	0.6	9.3	15.8	0.5	6.0	1.6	0.9	4.4	11.4	1.0	0.8	1.0	0.7	0.7	1.7	0.3	0.8	2.1	7.6	25.1	1.5	8.8	27.9	0.2	2.9	1.3	0.5	2.7	0.8	10.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	9.3	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.3	0.0	2.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	1.2	0.0	1.0	0.0	0.0	0.0	5.3	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	20.6	7.9	13.9	11.7	25.5	9.3	15.8	11.4	7.6	27.9	10.5	57.6	0.0	4.3	77.1	0.1	2.7	0.1	0.0	1.2	7.1	0.4	0.6	6.0	1.5	8.6	1.8	0.0	0.2	0.5	0.1	0.0	11.1	60.7	2.6	2.0	126.7	0.0	0.0	125.2	8.3	0.1	11.7	0.0	19.8	0.0	20.5	79.6	0.3	0.6	0.0	67.9	0.0	0.0	1.9	2.5	19.0	1.8	0.5	10.6	12.2	1.6	2.3	0.0	193.0	101.1	1.3	0.0	1.2	1.2	0.3	0.0	0.0	5.1	0.0	6.6	1.9	10.7	68.3	10.6	0.4	1.0	0.0	1.1	1.6	0.0	0.4
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.2"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		5900000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	22.2	5.2	2.6	7.9	3.0	0.1	13.5	2.8	3.2	25.3	2.6	12.2	9.3	30.4	11.2	6.4	11.7	22.5	6.5	2.5	4.8	7.1	2.1	7.2	1.7	4.1	5.8	21.0	1.5	2.0	2.4	44.2	3.8	17.5	13.8	2.1	6.5	13.5	2.6	4.1	8.7	18.4	3.2	6.4	6.7	4.5	3.9	3.6	5.1	23.2	1.4	10.8	8.4	3.0	0.0	0.3	148.2	0.0	175.0	190.8	0.1	27.4	86.8	5.0	7.7	0.3	0.0	0.0	0.1	143.3	0.4	0.4	34.2	0.7	2.6	0.2	1.0	0.0	0.0	0.0	129.4	0.0	0.1	195.9	0.3	9.4	3.8	4.7	1.0	0.7	0.0	0.6	2.8	0.0	3.9	0.1	0.3	0.0	2.7	11.7	4.1	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.2	38.3	0.9	0.0	0.0	69.3	4.2	13.9	0.5	0.2	0.0	0.0	3.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	2.8	3.2	2.5	4.8	4.1	5.8	3.8	3.2	3.9	3.0	3.4	0.0	0.5	1.3	0.0	4.1	0.4	0.1	2.2	2.5	1.1	1.7	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	1.9	72.3	3.0	0.0	0.0	0.2	0.0	0.3	56.3	0.0	1.7	0.0	6.4	2.5	0.0	3.1	0.0	9.0	0.0	0.0	0.0	7.8	1.3	37.9	0.9	1.8	10.3	0.0	6.8	0.0	0.0	0.6	0.0	0.0	58.6	0.1	0.0	0.0	0.1	0.0	0.2	19.7	6.6	25.5	0.6	0.1	1.2	2.6	0.8	0.7	18.5	0.0	0.1
PCDH19	"EFMR, EIEE9, KIAA1313"	ENSG00000165194	"Protocadherin 19"	Q8TAB3	X	100291644-100410273	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 21.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.9;Excitatory neurons: 24.5;Inhibitory neurons: 51.8;Oligodendrocyte precursor cells: 40.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.6;ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027533	Approved		Approved	Cytosol		NA	NA		83000		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA027533: AB_10602043"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.37e-1)"	1.8	0.1	6.8	0.2	7.6	0.0	1.7	0.0	10.7	1.6	0.0	1.3	0.2	1.1	0.2	0.8	0.6	0.4	0.3	10.7	12.0	0.2	0.0	0.1	0.2	0.6	1.3	1.0	0.1	0.1	0.7	0.1	4.1	0.2	1.7	1.8	0.6	0.3	0.4	0.9	0.4	0.9	0.0	0.0	0.5	0.6	21.5	0.8	0.2	0.9	0.0	0.8	0.6	0.0	0.0	0.0	18.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	3.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.6	0.0	10.7	10.7	12.0	0.6	1.3	4.1	0.0	21.5	0.0	29.9	0.0	0.5	13.4	0.0	3.1	0.1	0.9	4.6	12.9	0.5	0.8	1.8	7.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.4	6.2	11.3	1.8	0.0	24.5	0.0	0.1	2.9	0.0	1.4	0.0	2.5	1.1	0.0	0.1	0.0	51.8	0.1	0.0	0.3	3.4	2.2	3.4	0.1	0.0	7.5	0.0	1.9	0.0	40.7	2.2	0.1	0.1	0.4	0.0	0.4	0.0	0.2	1.3	1.9	0.0	5.9	7.8	0.1	1.5	1.0	1.6	0.0	0.2	0.7	0.0	0.1
PCDHA12	PCDH-ALPHA12	ENSG00000251664	"Protocadherin alpha 12"	Q9UN75	5	140875302-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 28.9;Alveolar cells type 2: 5.1;Bipolar cells: 11.4;Cone photoreceptor cells: 6.2;Horizontal cells: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 3.9;cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.1;hTCEpi: 3.4;PC-3: 5.1;RT4: 5.2;SH-SY5Y: 2.1"									HPA035812	Approved		Approved	"Plasma membrane,Cytosol"		No	No				"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA035812: AB_2674796"	"unprognostic (3.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.74e-2)"			"unprognostic (2.24e-2)"		"unprognostic (2.08e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.18e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.97e-2)"	0.3	0.3	0.4	0.0	0.5	0.0	0.2	3.9	1.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.7	0.0	0.3	0.1	0.6	0.1	1.5	0.0	0.3	0.1	0.0	0.7	0.0	0.8	0.0	0.4	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	7.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.6	1.7	5.1	0.0	0.0	0.0	0.1	5.2	0.2	2.1	0.0	0.6	0.0	0.3	1.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	3.9	1.1	0.3	0.1	0.3	0.1	0.4	0.1	0.0	0.5	0.2	28.9	5.1	0.0	0.0	0.0	0.0	0.8	0.0	11.4	0.8	1.3	0.4	4.3	1.9	1.8	6.2	0.0	0.0	0.1	0.0	0.7	1.3	0.8	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.8	0.0	0.1	1.4	0.1	0.0	5.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.1	0.0	0.2	1.3	3.6	0.0	0.2	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PCDHA4	"CNR1, CNRN1, CRNR1, PCDH-ALPHA4"	ENSG00000204967	"Protocadherin alpha 4"	Q9UN74	5	140806929-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;granulocytes: 3.8;Respiratory ciliated cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.6;AF22: 5.6;EFO-21: 5.1;T-47d: 5.4"	"Not detected"	"Not detected"							"HPA043180, HPA073478"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA043180: AB_10806381, HPA073478: AB_2686608"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.90e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.00e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.94e-5)"	"unprognostic (5.01e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.29e-3)"	"unprognostic (4.79e-2)"	0.2	0.2	0.9	0.2	1.2	0.9	0.4	2.9	1.1	0.5	0.0	0.3	0.3	0.6	0.4	0.1	0.3	1.3	0.1	0.9	0.5	0.4	0.1	0.4	0.3	0.6	0.5	0.2	1.2	0.1	0.4	0.1	0.6	0.4	0.2	0.9	0.2	0.3	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.4	0.4	0.1	0.3	0.1	0.2	0.2	0.1	1.5	0.1	6.6	5.6	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	1.1	0.1	5.1	0.1	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.2	0.1	0.2	0.3	0.3	1.1	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.1	0.1	0.1	0.2	1.7	1.2	0.9	0.1	0.1	0.2	0.1	0.2	0.2	2.3	0.0	1.4	0.5	0.8	5.4	0.1	0.6	1.2	0.8	0.5	0.1	0.3	0.1	0.1	0.2	0.2	0.5	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.9	1.2	2.9	1.1	0.9	0.5	0.6	0.5	0.6	0.3	0.4	1.5	0.1	3.2	2.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.2	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.3	0.6	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.3	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.2	2.9	1.1	0.0	0.4	0.5	1.0	0.5	0.0	0.0	0.0	0.2	0.1	0.1	0.4
PCED1A	"bA12M19.1, C20orf81, FAM113A, FLJ22376"	ENSG00000132635	"PC-esterase domain containing 1A"	Q9H1Q7	20	2835314-2841190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Cytosol"		"HPA050816: AB_2681246"	"unprognostic (3.20e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.97e-3)"	45.4	44.2	64.8	30.8	66.1	22.2	35.5	60.6	74.1	62.1	72.0	34.7	24.6	40.0	27.2	31.8	53.4	26.0	27.5	61.7	63.0	70.9	57.8	42.6	36.8	67.4	63.7	63.4	41.2	40.2	63.3	23.3	62.9	65.9	12.6	18.2	35.0	19.8	13.5	21.4	47.7	21.0	61.4	81.9	41.2	25.9	66.6	23.5	86.3	9.0	24.2	40.5	42.5	72.8	31.2	39.1	39.4	21.6	39.8	54.5	29.1	29.2	32.5	29.7	32.2	27.3	54.5	9.1	20.0	19.5	49.5	50.3	9.3	27.1	13.7	45.4	31.0	36.0	49.9	38.7	32.2	6.8	11.6	73.0	56.0	36.3	48.4	42.7	21.7	45.3	28.9	40.1	22.2	20.9	4.9	45.5	44.3	23.3	25.4	24.7	13.3	18.9	33.7	24.7	37.2	57.4	29.8	37.1	51.7	24.9	48.0	23.2	21.6	29.1	20.4	30.4	14.0	69.0	36.5	2.6	7.1	24.8	35.1	3.6	8.2	3.5	11.0	7.3	10.9	9.8	6.7	9.8	9.2	9.8	12.1	11.0	0.6	16.1	7.7	8.0	4.8	8.3	64.8	66.1	60.6	74.1	61.7	63.0	67.4	63.7	62.9	61.4	66.6	72.8	9.9	16.0	19.8	16.0	13.8	4.0	10.6	8.6	30.1	11.9	12.7	13.2	4.9	8.6	10.5	9.2	10.4	5.1	12.8	6.0	13.7	5.0	0.7	12.4	32.3	11.7	8.4	7.2	4.8	2.1	2.5	15.4	22.4	10.1	0.0	18.1	11.0	14.0	6.9	11.8	6.9	9.1	6.1	9.5	6.8	3.0	9.0	12.8	1.8	8.4	5.1	9.6	5.2	8.0	11.6	4.0	8.5	2.2	11.4	6.6	8.6	12.4	8.5	12.4	6.6	7.1	12.3	13.2	7.4	15.1	3.7	3.4	12.2	17.6	7.5	8.3
PCNX3	"FLJ22427, PCNXL3"	ENSG00000197136	"Pecanex 3"	Q9H6A9	11	65615773-65637439	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 12.9;Endometrial ciliated cells: 13.5;Glandular and luminal cells: 20.4;Granulosa cells: 17.7;Pancreatic endocrine cells: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018084	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA018084: AB_1855083"	"unprognostic (9.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.69e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.82e-1)"	5.2	6.5	3.9	8.0	3.3	10.4	5.5	2.5	4.7	5.9	2.0	7.3	8.2	7.8	1.6	7.7	6.4	4.5	4.5	3.2	1.1	5.4	5.1	6.7	7.3	4.4	3.2	6.0	8.1	4.6	6.6	5.0	2.9	6.2	3.2	2.6	7.9	4.9	4.2	7.7	9.0	4.0	1.8	8.6	7.1	8.9	4.2	7.2	7.4	2.1	4.3	6.3	5.6	4.7	19.5	28.6	10.3	25.6	7.9	6.1	23.3	13.5	11.5	12.9	9.4	13.8	21.5	14.2	25.4	12.0	17.5	31.2	11.0	15.6	3.8	12.1	19.4	18.6	28.6	11.4	8.8	18.3	21.9	11.6	7.7	12.7	10.0	5.8	12.7	14.7	21.7	11.7	7.6	28.8	15.6	14.1	20.9	8.4	18.2	21.6	9.2	18.6	5.6	30.9	12.7	19.0	14.3	18.6	15.7	4.5	32.8	12.4	18.3	22.3	20.7	18.6	13.6	19.1	12.2	12.7	17.8	8.8	19.9	3.5	0.9	0.6	1.2	0.4	1.0	0.5	0.7	0.7	0.5	0.8	0.5	0.7	1.3	0.6	0.7	1.2	0.2	0.6	3.9	3.3	2.5	4.7	3.2	1.1	4.4	3.2	2.9	1.8	4.2	4.7	10.8	6.4	6.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	11.3	8.4	0.0	0.0	0.6	12.9	0.0	6.8	10.7	0.0	0.0	9.1	0.0	13.5	9.1	5.1	0.0	0.0	0.0	8.9	5.6	3.2	0.0	20.4	5.1	17.7	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	5.9	0.0	0.0	4.3	0.7	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	8.3	3.0	10.2	0.0	0.0
PCNX4	"C14orf135, PCNXL4"	ENSG00000126773	"Pecanex 4"	Q63HM2	14	60091911-60169133	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 42.8;Endometrial ciliated cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002076, HPA003390"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA002076: AB_1078322, HPA003390: AB_2066703"	"unprognostic (2.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (6.84e-5)"	"unprognostic (2.13e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.59e-2)"	7.8	9.2	4.1	6.3	4.8	7.4	8.1	7.0	4.4	10.1	12.1	6.3	5.0	12.5	7.1	5.6	13.1	8.3	11.1	3.9	6.1	12.3	6.7	7.2	7.1	5.0	6.0	16.3	6.5	11.4	11.9	8.5	4.7	11.7	6.7	18.2	7.1	8.5	12.3	7.4	6.1	10.2	4.9	7.4	6.2	11.0	5.7	11.6	9.7	5.7	7.0	6.6	7.8	6.2	85.2	14.3	25.2	17.3	19.2	22.2	11.1	28.5	44.1	31.2	38.3	15.0	26.1	14.8	11.6	23.7	26.0	11.1	16.6	16.2	51.7	20.8	7.9	25.0	10.1	9.7	39.7	25.0	17.7	18.5	10.2	23.0	38.3	24.3	14.9	34.8	12.5	21.2	48.2	11.5	35.9	8.0	12.7	9.7	17.4	20.9	31.8	6.4	15.8	11.7	17.9	21.8	25.5	9.2	18.2	13.4	22.7	11.1	30.7	66.4	52.8	16.7	20.5	7.1	7.4	19.6	26.1	8.5	33.2	3.4	4.1	3.3	4.8	4.3	6.5	4.1	3.4	4.2	4.4	2.8	3.7	4.4	2.1	8.4	5.2	4.4	3.8	3.4	4.1	4.8	7.0	4.4	3.9	6.1	5.0	6.0	4.7	4.9	5.7	6.2	22.3	16.0	29.9	0.0	18.2	0.0	0.0	0.0	0.0	0.0	19.9	17.5	0.0	0.0	19.2	25.8	0.0	18.3	42.8	0.0	17.6	18.4	0.0	82.0	37.4	14.0	0.0	0.0	0.0	13.1	8.3	13.6	0.0	27.0	15.2	33.9	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	10.3	0.0	0.0	0.0	0.0	20.4	0.0	0.0	18.5	0.0	0.0	14.4	34.2	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	19.4	14.5	33.8	0.0	0.0
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889206	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 87.6;heart muscle: 123.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 138.0;Extravillous trophoblasts: 63.1;Fibroblasts: 225.8;Syncytiotrophoblasts: 241.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.5;RPMI-8226: 36.8;U-2197: 77.9;U-266/70: 68.6;U-266/84: 34.3"	"Low region specificity"	"Detected in many"							HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		580000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	87.6	2.8	0.8	4.0	0.9	14.9	29.1	0.4	1.0	21.5	0.8	6.9	0.1	4.2	2.2	7.8	3.9	1.5	123.2	1.3	1.9	17.9	18.3	16.4	2.3	0.7	1.1	3.9	1.4	0.7	23.7	48.1	0.6	21.5	5.1	0.7	3.1	8.9	2.4	5.3	2.8	8.7	0.5	3.0	3.4	2.4	1.5	0.7	6.4	22.1	1.9	25.7	26.0	0.8	1.4	11.0	3.4	0.0	65.5	18.1	0.0	1.0	0.2	2.9	3.6	0.7	1.2	0.0	3.3	4.9	14.8	0.1	13.7	0.0	3.4	0.0	21.0	2.5	6.8	0.0	0.0	1.5	0.0	6.9	0.0	6.9	1.7	14.5	0.2	2.2	0.5	0.0	1.4	2.0	4.5	1.2	5.5	0.2	21.9	0.0	8.1	36.8	3.2	0.1	7.6	4.6	17.8	0.0	6.5	4.7	0.0	4.5	0.0	5.8	12.8	77.9	6.0	68.6	34.3	0.0	16.6	1.9	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	1.3	1.9	0.7	1.1	0.6	0.5	1.5	0.8	17.3	0.0	3.2	0.7	0.2	7.4	0.7	0.9	0.6	18.0	0.5	0.6	37.3	0.0	0.9	12.9	25.0	138.0	0.2	0.2	0.0	0.0	0.6	2.1	2.2	4.5	0.0	0.0	1.6	0.0	63.1	225.8	0.5	3.7	1.3	29.0	0.4	11.8	15.3	6.7	2.2	0.2	0.0	0.6	12.4	1.0	0.6	6.7	3.6	1.9	0.0	13.8	0.0	29.7	1.6	0.5	0.4	0.0	0.0	2.1	0.0	0.0	0.0	12.6	0.0	6.1	16.9	25.8	47.7	1.0	7.4	241.6	1.1	19.1	0.0	0.4
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	31.4	24.4	15.2	30.0	16.0	45.3	21.0	16.6	15.8	16.7	17.8	25.7	60.3	19.1	13.9	31.0	15.6	20.7	46.4	15.5	21.1	18.3	20.7	22.5	22.9	18.8	18.0	15.8	16.8	22.7	12.9	20.1	18.5	16.6	22.9	14.4	19.3	18.6	73.8	43.0	49.1	23.0	17.5	25.9	24.2	22.4	18.1	18.1	17.2	42.1	26.8	21.0	19.8	17.1	92.6	36.6	25.8	37.2	52.2	53.9	37.0	68.2	47.1	59.2	51.8	92.3	32.8	23.9	215.2	78.1	60.2	71.4	40.5	52.1	50.4	42.1	28.6	68.6	40.6	39.5	45.2	34.3	56.7	47.4	40.0	55.9	39.6	35.4	63.0	21.0	38.3	53.3	58.1	79.6	19.9	17.3	21.4	55.7	53.0	34.5	31.0	37.5	35.7	53.6	25.4	18.3	44.5	79.5	44.2	32.8	114.1	37.2	88.5	45.5	25.2	61.8	92.7	45.8	101.1	44.1	69.6	43.8	56.9	9.6	9.2	10.4	8.8	9.3	7.5	7.2	6.5	9.7	9.1	6.3	4.2	6.3	21.0	9.4	11.0	5.9	14.9	5.2	15.2	16.0	16.6	15.8	15.5	21.1	18.8	18.0	18.5	17.5	18.1	17.1	24.7	16.0	25.7	15.3	19.9	14.5	9.4	19.7	14.2	15.9	14.1	9.4	70.1	20.0	17.5	14.7	25.0	11.9	27.3	36.4	13.7	24.8	76.3	17.8	22.9	23.2	22.1	12.2	20.4	22.9	17.7	17.0	23.4	15.6	20.8	16.1	26.7	35.6	37.4	8.4	22.7	24.2	6.1	34.6	27.1	67.6	19.9	33.9	19.6	20.6	39.4	13.1	39.1	16.1	17.6	24.6	21.1	28.2	27.2	12.0	67.2	23.2	33.9	12.8	26.3	15.0	19.0	46.0	13.2	30.0	21.5	18.6	25.6	25.5	23.8	12.2
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900958-81911432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.7;testis: 261.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 763.2;Late spermatids: 2829.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 218.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	29.7	16.8	40.0	9.5	40.1	12.1	25.2	44.4	45.8	14.9	30.4	25.5	63.9	18.0	13.5	26.3	23.9	9.9	47.7	41.2	37.7	44.0	165.7	21.3	12.0	47.0	43.0	20.9	25.3	20.2	14.4	12.0	47.3	24.2	16.7	8.6	22.3	12.1	33.5	16.3	43.0	9.6	41.3	12.8	35.4	261.7	41.0	13.5	16.2	29.3	11.9	21.2	15.1	44.0	42.6	23.9	18.8	53.1	91.8	48.0	27.9	29.9	63.2	40.7	48.0	94.0	43.0	14.8	16.0	31.1	75.3	34.5	28.6	55.1	23.5	4.5	24.3	32.1	33.3	218.2	97.8	32.5	26.0	39.8	31.4	36.8	28.4	14.5	38.6	44.0	60.6	29.6	30.8	35.7	39.3	40.1	15.1	147.2	25.9	25.4	20.2	52.4	49.2	78.8	23.9	21.9	22.4	121.7	29.0	36.5	33.9	75.3	26.1	30.0	19.7	22.9	25.0	19.3	9.1	15.3	31.2	42.8	29.9	1.5	2.4	0.9	4.6	2.6	3.0	4.2	5.5	4.7	4.5	5.6	4.5	4.6	0.7	3.3	2.1	4.4	3.6	3.1	40.0	40.1	44.4	45.8	41.2	37.7	47.0	43.0	47.3	41.3	41.0	44.0	11.5	0.0	17.3	15.0	11.1	5.4	8.1	11.7	6.8	12.5	25.1	11.0	17.0	62.9	9.6	25.8	0.0	73.1	21.0	41.6	119.3	19.5	763.2	29.0	7.5	8.7	13.9	47.8	5.3	18.3	39.7	7.7	36.2	15.8	9.5	39.6	21.8	166.0	24.1	16.8	4.6	29.1	20.3	11.8	3.3	2829.0	27.7	8.1	33.8	0.0	14.7	26.7	22.6	3.5	12.2	17.8	18.8	25.9	13.4	11.4	144.4	130.3	29.4	10.6	26.3	6.2	11.5	253.1	18.1	16.5	5.7	50.8	13.6	34.4	48.7	7.7
PDCD5	"MGC9294, TFAR19"	ENSG00000105185	"Programmed cell death 5"	O14737	19	32581190-32587453	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018471	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		47000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA018471: AB_1855108"	"unprognostic (1.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.02e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.54e-2)"	95.7	96.1	86.2	73.8	87.0	46.8	82.0	85.4	110.2	73.2	80.8	100.1	65.8	68.8	50.8	109.3	70.9	34.8	170.9	86.7	91.1	97.8	101.2	68.0	58.6	87.1	87.7	71.8	102.4	52.6	95.1	61.2	88.4	64.3	55.7	39.2	70.1	41.9	224.2	60.5	62.0	65.8	85.8	56.8	78.9	144.4	94.6	41.8	60.6	132.2	59.5	91.1	80.3	89.9	499.0	630.0	168.8	163.7	223.8	334.0	190.0	353.2	225.6	295.2	252.2	525.0	188.3	272.6	498.7	177.1	286.3	133.2	213.6	281.7	254.4	493.1	333.6	412.4	303.9	382.8	284.0	587.0	157.3	219.7	253.8	195.9	315.0	145.1	198.8	214.9	381.0	298.8	247.2	332.0	243.6	298.6	164.9	410.5	211.6	238.9	248.8	323.6	231.9	167.6	326.0	178.4	338.1	351.8	283.4	125.2	152.6	294.6	299.4	272.6	291.7	274.2	602.7	270.6	413.0	504.4	302.3	459.8	244.2	40.7	93.4	50.9	106.4	149.0	134.3	147.3	167.4	132.1	120.6	116.3	115.3	114.3	13.7	116.9	197.6	123.6	217.8	122.7	86.2	87.0	85.4	110.2	86.7	91.1	87.1	87.7	88.4	85.8	94.6	89.9	115.4	73.7	62.7	16.6	70.4	121.6	174.0	292.0	97.3	43.2	129.1	216.4	336.1	94.4	119.4	75.4	27.1	194.7	69.0	94.6	189.8	245.3	469.7	94.0	166.4	121.3	71.3	44.8	24.0	247.3	216.5	150.4	64.2	115.0	46.9	84.9	83.6	151.1	146.7	50.5	29.3	113.6	140.4	48.3	93.1	481.2	142.6	67.4	124.5	11.2	113.8	104.0	66.9	17.6	16.8	292.2	100.4	123.0	124.4	392.4	125.1	216.8	107.9	45.3	72.3	126.8	218.4	487.0	413.1	170.9	119.9	143.0	78.4	164.9	157.8	140.4
PDCL	"DKFZp564M1863, PhLP"	ENSG00000136940	"Phosducin like"	Q13371	9	122798389-122828588	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021571, HPA021647, CAB026473"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	Nucleoplasm	"CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115"	"unprognostic (3.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-1)"	11.0	8.7	6.8	10.4	9.5	19.4	13.0	8.5	8.7	12.1	7.3	10.2	9.3	13.4	7.7	9.8	10.3	9.5	8.8	6.5	9.2	8.8	6.4	13.1	13.1	8.8	8.4	9.9	6.8	11.0	5.0	14.1	9.2	11.1	10.5	12.4	12.8	9.2	5.9	10.6	9.1	11.3	7.4	12.7	10.7	6.7	8.5	13.1	11.6	6.9	12.3	9.2	7.5	10.6	16.9	23.2	38.4	14.4	34.1	22.5	21.4	23.1	23.8	20.9	21.2	15.2	21.9	28.1	18.7	27.5	23.0	32.3	24.1	22.6	22.7	28.0	12.1	29.2	30.1	25.3	17.4	24.6	55.3	19.7	15.8	20.7	10.3	19.3	43.3	17.6	29.7	16.1	23.1	25.8	27.1	22.2	28.4	28.8	17.6	27.8	36.5	20.9	25.6	0.0	30.8	27.4	31.3	17.3	13.8	25.1	26.5	16.8	48.4	19.4	23.0	28.4	22.8	12.0	26.7	30.5	16.6	19.6	19.0	30.4	13.8	23.9	15.2	12.5	16.2	12.7	18.2	14.1	14.5	16.0	18.5	16.4	11.4	19.8	21.8	17.0	31.3	13.4	6.8	9.5	8.5	8.7	6.5	9.2	8.8	8.4	9.2	7.4	8.5	10.6	43.0	9.6	9.2	5.2	16.7	24.2	14.7	25.4	25.6	42.6	19.9	16.0	5.7	14.3	13.4	20.2	22.9	27.6	29.1	12.9	9.8	20.7	5.5	29.9	22.3	37.5	12.6	50.5	5.8	18.0	27.3	26.7	9.7	36.3	57.1	14.4	31.8	7.6	24.9	40.4	8.2	19.0	24.4	22.6	15.7	4.1	23.0	19.3	19.6	10.3	30.4	36.1	20.6	6.6	15.4	16.5	13.2	17.0	18.2	15.8	9.1	15.3	21.9	38.2	19.7	15.8	21.6	14.5	21.9	25.8	23.2	31.9	25.9	19.9	13.5	16.5
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.5;brain: 109.1"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 1722.6;Oligodendrocytes: 4039.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 88.9"	"Group enriched"	"Detected in all"	5	"B-cells: 37.4;granulocytes: 88.9;T-cells: 34.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.8;HUVEC TERT2: 93.2;NTERA-2: 56.1;SK-MEL-30: 58.6;TIME: 52.6;U-266/84: 51.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	18.3	3.1	40.1	39.5	82.5	75.5	20.0	63.3	53.5	7.2	1.6	8.3	4.6	8.3	1.1	4.5	4.2	10.1	21.4	45.7	68.4	5.4	10.9	14.7	23.2	85.9	74.4	2.1	1.6	1.4	3.8	17.2	78.5	23.0	10.5	14.1	21.1	12.1	44.3	8.9	12.2	12.4	66.4	22.6	5.1	3.8	62.9	14.0	7.2	15.0	19.9	32.1	4.6	109.1	0.2	18.5	34.7	61.8	1.6	1.7	0.1	11.5	13.3	10.1	13.4	0.0	0.0	5.3	0.2	20.7	0.4	0.1	0.3	0.0	9.7	15.5	0.1	0.3	5.2	0.0	1.2	13.1	0.0	3.4	0.5	4.5	0.2	1.6	93.2	0.0	0.0	3.3	4.7	0.3	0.0	7.5	56.1	0.0	0.7	2.6	6.2	3.6	8.7	0.0	0.2	26.6	0.0	3.0	58.6	2.9	0.2	4.5	52.6	7.2	1.9	4.6	1.9	1.5	51.6	19.3	8.6	13.4	3.7	10.8	6.8	22.0	10.1	5.8	19.5	36.8	19.4	14.8	6.2	37.4	21.3	15.0	88.9	11.3	5.7	6.4	34.7	9.6	40.1	82.5	63.3	53.5	45.7	68.4	85.9	74.4	78.5	66.4	62.9	109.1	24.7	9.6	12.2	531.8	233.3	20.3	28.4	0.5	27.9	40.9	51.6	34.3	25.4	0.0	6.9	5.5	0.0	7.3	79.8	0.4	0.0	0.8	14.4	1.7	14.9	36.8	4.2	0.0	315.6	0.9	2.0	20.2	9.7	4.2	15.2	0.2	11.7	2.4	13.0	114.4	559.7	1.9	8.2	40.6	187.4	9.4	0.3	176.9	51.6	173.3	67.0	19.3	1.0	1722.6	4039.6	0.1	0.4	2.6	351.9	93.6	0.0	2.1	1.5	4.0	0.0	54.0	10.3	0.7	0.8	4.8	8.1	5.6	143.1	0.4	1.3	9.4
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 255.9;Gastric mucus-secreting cells: 141.2;Paneth cells: 251.4;Proximal enterocytes: 73.0;Skeletal myocytes: 106.5;Undifferentiated cells: 103.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.2;cerebral cortex: 1.1"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Hep G2: 2.0;U-87 MG: 4.4"									"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	1.4	0.6	0.2	0.1	1.2	0.5	0.7	0.0	1.1	3.2	0.0	4.3	0.7	3.4	3.4	0.7	3.0	1.1	4.4	0.2	0.0	4.8	1.3	3.4	0.2	0.0	0.0	1.8	0.7	0.2	2.8	3.7	0.0	2.3	0.6	0.2	0.5	2.7	8.3	0.3	2.4	1.8	0.0	2.1	3.8	2.5	0.0	0.0	1.1	21.3	0.1	1.0	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.2	0.3	0.0	1.2	0.0	0.2	0.0	0.1	0.4	0.9	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.7	0.2	0.2	0.0	0.1	0.0	0.3	0.0	0.6	0.3	0.1	4.4	0.1	0.0	1.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.0	0.2	1.2	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.2	10.6	2.0	0.8	5.5	5.8	8.6	5.2	3.9	0.2	0.4	35.3	4.3	22.4	0.0	6.2	2.1	0.0	255.9	0.0	0.0	32.9	0.1	0.1	4.6	7.2	0.0	8.2	0.0	4.3	6.3	141.2	0.1	4.5	0.0	1.1	0.3	0.5	0.0	2.1	55.2	4.1	1.4	4.5	38.4	0.6	2.1	1.8	0.0	0.4	1.9	1.0	0.5	0.9	0.0	251.4	4.1	1.6	1.8	73.0	0.0	9.4	3.0	46.0	106.5	17.2	1.9	2.2	28.6	3.8	1.1	1.2	0.0	103.3	17.3
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 74.9;skeletal muscle: 70.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 619.3;Excitatory neurons: 2969.7;Inhibitory neurons: 1116.9;Oligodendrocyte precursor cells: 848.0;Oligodendrocytes: 443.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 57.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 57.9"	"Cell line enhanced"	"Detected in many"		"A549: 62.2;AN3-CA: 70.4;HeLa: 104.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.9	1.3	3.3	9.8	9.9	74.9	4.6	0.0	11.3	5.3	0.0	21.0	5.5	7.4	18.4	13.7	7.3	9.1	15.7	4.4	4.2	17.2	2.8	13.3	5.3	7.0	2.0	3.0	3.7	5.5	6.7	16.6	1.2	19.9	15.0	21.4	7.4	21.2	70.4	4.5	7.0	15.3	0.8	4.0	10.3	3.4	3.8	8.6	7.4	34.4	5.6	22.0	8.2	5.7	0.1	62.2	12.8	70.4	2.3	4.4	10.1	1.6	1.8	3.4	4.9	24.5	2.0	4.8	0.2	0.5	10.3	10.6	0.0	2.8	5.9	2.9	7.0	9.2	104.6	5.3	9.1	4.4	0.7	9.3	2.3	9.6	1.7	1.1	7.3	0.3	0.0	1.6	5.9	4.5	3.6	10.3	2.4	1.8	3.2	1.2	16.0	10.5	15.9	23.5	2.3	8.0	16.4	27.1	14.2	11.4	1.9	9.3	8.5	0.9	0.2	12.0	3.3	3.5	0.1	0.5	10.3	17.3	2.7	4.2	2.0	57.9	1.5	0.1	1.5	11.0	1.4	0.7	1.4	11.3	0.9	0.7	3.1	0.4	0.2	0.0	0.8	1.1	3.3	9.9	0.0	11.3	4.4	4.2	7.0	2.0	1.2	0.8	3.8	5.7	22.5	32.1	110.0	619.3	32.3	10.6	30.1	6.6	35.3	20.2	5.1	2.7	35.7	8.6	30.2	42.3	73.0	11.3	118.6	28.1	11.7	0.6	21.4	19.0	8.6	16.9	33.4	2.1	2969.7	1.8	25.7	27.5	40.2	21.9	22.2	0.3	17.2	0.8	5.2	1.7	1116.9	18.2	6.1	4.8	11.1	36.6	1.5	29.5	10.6	407.5	6.0	12.0	29.9	848.0	443.3	8.2	11.9	4.9	44.4	43.3	8.9	27.5	19.4	52.8	0.0	64.0	6.3	1.1	7.7	40.6	8.8	3.1	94.3	1.1	11.7	26.5
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494397-119628804	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9"	"Group enriched"	"Detected in all"	4	"prostate cancer: 7.0;thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6"	"Region enhanced"	"Detected in all"		"cerebellum: 18.2"	"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		850000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	15.4	11.3	0.9	10.9	3.5	2.1	9.6	4.9	3.7	32.7	12.6	37.0	15.5	14.4	41.5	41.3	22.9	10.4	12.8	1.4	3.6	5.9	1.5	22.1	6.4	4.9	8.2	5.4	12.4	8.3	3.5	13.2	5.2	59.8	25.9	9.6	9.8	49.8	6.9	5.0	18.9	11.4	0.0	5.8	9.6	9.4	3.4	3.7	16.8	5.6	3.5	14.6	15.8	1.9	16.7	0.8	11.0	1.2	3.7	5.5	1.9	10.7	47.5	0.5	1.0	1.0	1.3	1.6	0.5	13.4	3.0	5.8	3.5	1.7	1.3	0.4	7.4	18.5	2.6	0.9	65.9	3.9	1.7	6.1	3.3	1.1	0.1	24.6	1.4	3.7	2.0	2.9	1.6	0.9	5.0	0.6	2.3	1.8	2.8	0.7	5.9	4.3	4.1	4.9	4.3	8.8	13.0	15.3	1.3	8.1	2.7	2.1	2.5	6.2	5.2	3.4	1.5	4.1	2.0	1.5	5.9	1.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.3	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.1	0.1	1.2	0.9	3.5	4.9	3.7	1.4	3.6	4.9	8.2	5.2	0.0	3.4	1.9	7.8	6.4	3.9	19.9	1.3	3.4	2.8	1.1	5.7	8.1	11.0	8.4	5.5	14.3	3.7	1.8	14.6	0.4	0.9	15.5	0.0	15.8	30.6	5.0	12.6	7.8	2.4	0.0	66.1	2.9	0.3	28.1	1.1	3.9	1.3	1.6	0.7	0.9	0.3	5.0	58.3	9.5	2.0	0.0	3.5	11.5	20.8	11.3	5.4	40.3	1.3	28.5	2.1	56.8	41.1	3.9	10.3	104.9	1.4	3.6	7.9	0.5	0.8	5.8	19.7	5.5	80.9	5.4	6.3	3.5	2.4	0.3	1.7	7.0	11.1	2.6
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625573-670782	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 385.0"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 460.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.5;JURKAT: 17.3;MOLT-4: 31.3;REH: 16.8;SCLC-21H: 20.2;SH-SY5Y: 11.9;U-266/84: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.9	2.2	13.5	5.5	25.7	8.4	4.1	8.2	22.3	2.5	1.9	1.7	1.2	2.7	4.0	1.7	10.2	3.7	5.9	11.2	22.6	4.9	1.0	4.6	14.3	22.8	19.9	2.8	1.8	8.2	4.1	3.1	25.5	2.8	1.3	385.0	3.8	3.0	1.1	2.1	3.0	2.5	9.3	10.1	2.9	4.4	24.1	12.2	12.0	0.1	9.3	3.8	1.4	39.3	0.1	0.0	1.2	0.5	0.3	0.4	0.4	0.0	0.1	0.8	2.0	0.0	0.1	0.3	11.5	0.3	0.9	0.1	2.5	0.6	0.0	0.1	0.0	1.0	0.3	0.1	5.8	0.2	0.4	0.7	0.0	3.5	0.0	0.8	1.1	17.3	0.1	1.0	0.1	0.3	31.3	0.1	9.4	0.7	0.0	16.8	0.2	0.2	2.1	1.3	20.2	11.9	0.0	0.3	0.1	4.2	0.6	0.0	0.4	0.2	1.2	0.2	0.4	7.7	24.0	0.3	0.3	0.3	0.2	16.8	5.4	0.9	14.0	7.7	12.6	12.8	9.3	9.8	8.5	21.4	14.6	15.8	1.4	14.4	8.1	18.2	15.5	9.4	13.5	25.7	8.2	22.3	11.2	22.6	22.8	19.9	25.5	9.3	24.1	39.3	0.5	3.2	5.0	4.2	6.4	0.4	2.1	1.2	2.8	20.7	3.9	2.4	4.4	0.0	3.5	0.0	83.4	0.1	8.4	0.2	1.9	6.9	0.4	7.0	2.2	2.9	1.8	7.4	40.3	0.6	0.3	1.3	1.5	2.5	3.8	5.4	2.2	0.0	11.3	11.8	27.3	0.5	4.1	5.1	1.4	0.3	1.5	3.3	3.6	4.7	6.2	31.1	7.2	10.1	33.9	0.8	0.2	1.5	7.5	1.9	0.0	8.4	11.2	460.1	0.0	1.6	1.1	4.3	11.0	1.9	0.3	0.3	5.9	3.5	0.4	1.3
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77428256	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.9;Excitatory neurons: 183.1;Horizontal cells: 69.0;Inhibitory neurons: 276.5;Muller glia cells: 86.5;Oligodendrocyte precursor cells: 190.5"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.6;HeLa: 34.8;SK-BR-3: 11.1"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	20.9	4.8	24.2	1.0	28.6	0.4	14.0	4.8	24.6	17.4	0.0	5.6	2.0	26.4	6.3	2.0	28.7	4.3	23.7	25.5	32.5	15.6	2.3	5.2	1.2	20.5	15.9	4.2	7.9	0.8	12.5	23.8	18.8	19.0	1.2	22.5	10.5	11.9	0.7	2.0	3.3	17.7	9.9	0.8	5.5	3.0	36.7	0.3	124.7	0.8	1.0	4.0	4.9	17.2	0.1	4.9	0.8	0.3	1.5	0.0	0.5	1.5	13.6	0.2	0.1	1.4	0.1	0.3	0.1	0.1	0.2	0.6	0.2	0.0	0.2	0.2	0.7	0.4	34.8	0.3	0.0	0.4	0.5	0.8	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.2	0.0	0.2	0.5	0.8	0.8	0.2	0.1	0.6	0.9	0.4	0.0	0.2	5.4	1.0	2.3	11.1	0.7	0.7	1.8	0.9	0.5	0.3	0.3	0.2	0.5	0.7	0.5	0.4	1.2	0.5	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	24.2	28.6	4.8	24.6	25.5	32.5	20.5	15.9	18.8	9.9	36.7	17.2	0.8	3.2	2.8	64.9	0.3	0.4	2.0	0.1	0.0	10.8	5.8	3.0	28.0	2.8	1.6	1.8	54.2	0.0	0.2	0.1	0.0	2.3	6.8	15.3	2.1	4.5	4.9	0.0	183.1	0.0	0.1	3.8	0.0	7.9	1.3	1.8	2.9	0.1	0.4	69.0	276.5	1.0	0.0	1.0	1.6	5.1	5.9	0.9	1.8	10.3	0.1	86.5	0.0	190.5	45.5	0.2	0.4	0.0	0.3	29.1	0.2	0.7	0.7	5.8	6.6	1.8	7.7	1.1	2.6	0.5	1.1	0.0	0.1	8.8	1.2	4.2
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1202.1;Plasma cells: 883.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		15000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.20e-4)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	118.3	112.3	54.5	155.8	64.6	140.8	124.9	57.1	66.7	178.8	71.2	156.0	122.4	131.6	418.5	98.2	133.5	96.7	113.4	55.9	60.8	130.3	260.5	103.8	118.1	61.1	55.4	99.8	252.1	149.7	74.0	171.3	60.7	127.4	171.6	48.0	184.1	135.5	59.3	64.3	121.5	155.5	60.9	107.4	155.4	55.1	62.6	86.6	363.3	59.4	153.7	130.9	75.7	66.4	287.0	304.6	425.7	672.6	535.6	459.4	753.4	677.8	625.9	348.3	465.1	435.1	548.5	460.9	464.7	668.9	674.1	228.0	324.1	568.3	371.1	363.2	253.4	374.2	228.4	713.2	577.5	387.9	268.9	334.2	428.4	338.1	603.3	642.1	798.0	171.8	328.0	963.6	348.7	338.8	150.5	400.8	356.6	923.4	236.4	355.7	433.0	846.4	498.3	339.9	272.0	543.2	267.6	387.0	396.2	547.8	136.8	648.5	395.0	324.4	409.8	296.3	399.1	900.0	596.6	297.1	438.5	479.6	464.8	276.1	200.0	95.5	198.4	210.9	219.0	197.6	154.2	187.6	215.0	161.0	74.3	125.1	35.0	241.6	161.4	268.9	174.4	319.2	54.5	64.6	57.1	66.7	55.9	60.8	61.1	55.4	60.7	60.9	62.6	66.4	217.1	57.7	124.2	17.6	193.9	103.0	294.2	552.8	61.5	69.1	121.1	91.7	35.9	148.7	264.6	196.8	29.2	456.3	164.6	125.8	43.0	338.6	8.2	146.5	382.9	176.2	157.7	89.2	47.4	240.6	1202.1	228.2	138.1	255.0	131.3	210.6	211.3	355.6	413.1	42.1	30.5	276.3	170.9	155.7	149.8	16.2	121.2	145.9	199.3	15.0	132.1	106.5	142.2	32.6	25.3	175.4	131.2	135.1	883.2	385.4	99.9	149.6	145.8	60.1	85.5	96.9	225.3	98.5	117.9	95.4	102.6	554.1	125.7	254.3	248.3	265.3
PDLIM4	RIL	ENSG00000131435	"PDZ and LIM domain 4"	P50479	5	132257696-132273454	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 315.5;Prostatic glandular cells: 473.0;Skeletal myocytes: 225.2;Urothelial cells: 381.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 91.8;HBEC3-KT: 109.2;HHSteC: 103.7;hTEC/SVTERT24-B: 117.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011912	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments, Cytosol"		"HPA011912: AB_1856277"	"unprognostic (1.36e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.40e-3)"	24.8	6.6	14.5	18.6	13.8	0.7	34.5	17.9	17.8	36.5	20.1	104.9	6.9	90.7	17.7	50.0	48.3	20.5	61.6	15.8	23.8	33.3	1.2	10.5	4.5	27.7	20.5	28.4	6.5	4.9	28.2	8.0	21.3	50.2	4.8	2.6	47.4	28.1	5.4	64.4	27.2	42.9	22.5	6.7	32.2	6.3	17.9	6.6	14.2	2.6	10.1	59.4	39.1	21.7	46.6	0.0	9.7	0.1	13.2	36.7	3.3	12.9	6.3	12.9	4.2	0.0	4.3	0.3	8.6	68.4	65.8	91.8	0.0	109.2	6.1	0.2	5.1	0.0	0.0	2.2	103.7	0.0	0.3	46.5	7.8	117.6	43.7	45.9	74.0	0.0	20.2	0.1	57.6	0.0	0.0	0.3	3.4	0.0	28.1	2.2	66.4	0.2	29.0	0.0	0.0	39.0	29.7	0.0	0.0	7.7	0.1	4.8	47.9	46.3	49.9	48.4	72.9	0.1	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.5	13.8	17.9	17.8	15.8	23.8	27.7	20.5	21.3	22.5	17.9	21.7	10.1	0.0	4.4	5.5	0.7	105.7	315.5	183.8	76.2	0.5	38.2	149.5	6.8	0.0	57.0	14.7	2.1	5.1	0.8	0.6	107.6	121.5	14.2	21.1	81.0	69.8	16.8	0.0	0.7	9.9	14.4	85.1	6.1	17.9	4.5	10.7	21.0	0.3	6.6	0.0	0.6	16.6	61.1	0.3	32.5	15.8	36.4	3.4	165.4	3.7	1.0	17.7	0.0	0.0	0.3	105.7	154.6	27.4	0.0	473.0	5.6	8.9	138.3	0.7	26.3	225.2	53.8	9.9	13.9	47.8	82.8	22.8	4.2	2.0	5.5	381.7
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 80.0;Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 14.2;basal ganglia: 20.1;cerebral cortex: 41.7;hippocampal formation: 23.4;white matter: 18.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 117.8;hTERT-RPE1: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	10.6	62.6	14.2	10.5	20.1	14.4	16.1	0.0	41.7	14.2	1.2	8.9	7.2	15.5	17.0	14.2	12.2	19.4	49.2	23.4	0.0	12.8	4.2	12.6	12.9	0.0	2.3	19.3	19.9	29.9	5.4	13.8	0.0	10.3	12.4	14.1	11.7	9.4	72.9	4.3	7.6	11.2	0.0	13.2	11.7	26.7	3.0	11.6	18.8	16.9	12.4	14.0	6.8	18.5	25.7	12.0	25.9	10.9	21.0	37.9	8.6	19.3	21.7	22.1	25.8	12.7	90.3	13.9	63.8	30.8	117.8	54.4	11.0	16.1	32.8	1.5	5.6	6.6	15.7	4.5	23.9	3.3	9.0	24.5	31.5	37.7	59.8	117.1	50.9	12.4	2.4	22.8	27.6	6.0	20.3	10.3	12.1	26.8	15.4	4.8	15.5	2.6	15.3	17.0	2.4	11.4	12.7	1.4	61.8	20.9	4.0	3.9	90.9	27.5	17.2	63.8	23.3	12.6	5.8	12.1	34.2	11.7	25.1	6.4	27.9	14.5	9.2	25.3	8.9	15.6	15.1	12.0	22.5	17.9	8.9	7.8	3.1	5.4	41.1	3.7	34.9	18.0	14.2	20.1	0.0	41.7	23.4	0.0	0.0	2.3	0.0	0.0	3.0	18.5	10.7	12.8	7.8	15.0	18.0	13.0	12.7	36.3	68.9	38.3	11.6	7.0	80.0	14.3	35.6	16.5	8.4	4.3	13.7	27.5	5.9	33.3	144.2	33.3	14.9	15.0	10.2	1.3	73.6	14.0	3.9	20.8	16.3	70.2	6.3	3.7	12.5	3.3	6.3	10.1	23.4	5.5	10.2	19.2	19.1	28.1	11.5	19.9	10.6	19.7	22.4	18.8	10.3	13.0	8.5	24.5	9.6	13.5	8.1	15.6	4.9	11.4	30.5	11.5	6.6	35.4	13.1	10.1	11.4	26.5	10.9	4.4	19.3	7.1	10.7	23.9
PDSS1	"COQ1, COQ1A, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697701-26746798	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.1;lymphoid tissue: 13.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 32.5;Proximal enterocytes: 29.8;Undifferentiated cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA038032: AB_10670650, HPA042741: AB_2678139"	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	2.1	1.4	0.8	5.3	0.9	5.8	2.3	2.6	1.4	1.8	0.6	14.1	19.1	1.9	1.3	4.3	1.5	1.6	2.8	0.8	0.8	6.2	3.6	2.2	4.0	0.8	0.9	1.7	1.3	2.2	0.8	2.4	0.9	1.5	15.1	1.9	1.8	1.3	5.7	1.4	15.3	2.9	0.8	1.8	2.8	2.8	0.9	13.8	1.2	9.5	4.7	3.1	2.2	1.1	15.6	11.8	8.9	16.3	2.9	5.4	12.2	14.0	3.6	20.0	13.7	18.3	8.4	35.0	7.2	7.0	7.6	19.2	28.6	21.8	16.7	14.7	23.6	30.4	9.9	13.6	4.3	20.3	11.6	6.8	9.2	19.0	5.0	3.5	10.7	22.8	28.4	9.3	14.4	24.9	64.6	14.7	17.9	24.9	11.3	29.6	25.1	25.5	12.0	7.3	25.7	15.8	13.5	27.6	15.9	9.2	9.9	23.7	6.8	11.1	17.9	22.9	22.5	3.6	14.1	25.6	10.9	51.3	8.7	0.0	2.8	0.5	0.4	2.3	1.0	0.2	0.8	0.6	2.6	2.4	1.6	0.7	0.1	0.4	1.2	0.7	0.0	0.7	0.8	0.9	2.6	1.4	0.8	0.8	0.8	0.9	0.9	0.8	0.9	1.1	3.6	0.0	0.0	18.9	4.8	6.9	3.6	5.7	8.0	2.9	4.4	5.1	2.2	5.7	3.9	3.7	4.2	7.7	4.9	11.7	7.9	6.1	12.0	2.1	3.8	2.7	10.8	8.4	16.9	3.9	12.4	3.4	10.2	3.3	0.0	3.7	1.8	4.5	8.8	1.7	32.5	13.0	6.1	5.3	2.7	4.1	2.1	7.7	1.8	5.6	6.2	1.2	1.0	6.6	6.5	5.6	9.8	2.6	9.1	3.7	29.8	26.3	2.1	4.9	0.0	4.1	6.5	12.5	9.4	13.6	3.1	6.3	4.8	4.6	29.8	3.3
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 595.8"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 280.0;Proximal tubular cells: 1113.8"	"Group enriched"	"Detected in many"	4	"liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 14.7"	"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.2"	"Group enriched"	"Detected in many"	4	"RPTEC TERT1: 250.0;T-47d: 653.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.6	3.5	0.7	0.5	0.9	0.6	19.6	14.7	2.0	2.4	1.9	4.7	74.8	0.7	15.8	0.2	1.0	22.0	0.4	1.0	0.5	595.8	128.1	0.3	0.7	1.4	0.8	0.3	16.6	0.0	0.6	0.5	1.8	0.3	8.2	3.0	0.4	0.8	0.3	2.6	124.9	0.8	0.4	0.7	2.8	0.6	0.8	0.3	0.3	0.1	0.2	0.2	0.3	1.5	7.6	1.2	0.8	0.8	0.3	0.4	3.0	1.2	0.3	0.2	1.0	106.6	1.0	0.7	1.3	5.9	0.5	3.4	0.2	0.6	0.6	10.3	2.0	0.9	2.8	45.7	0.0	1.1	0.9	0.3	0.7	0.4	0.2	0.8	0.0	0.4	0.8	1.6	0.8	6.0	0.7	1.4	1.2	1.5	3.6	0.4	7.3	1.6	250.0	0.3	0.6	6.7	1.7	1.8	0.2	6.4	653.8	0.9	0.5	1.3	1.3	0.9	1.1	8.8	1.2	0.6	1.0	0.6	0.5	0.1	0.1	0.0	0.7	0.1	0.2	0.6	0.2	0.8	0.0	0.4	0.2	0.3	0.1	4.2	0.0	0.5	0.0	0.3	0.7	0.9	14.7	2.0	1.0	0.5	1.4	0.8	1.8	0.4	0.8	1.5	0.2	0.0	0.0	2.0	4.1	0.1	0.0	0.1	0.0	0.4	20.2	3.3	0.5	72.9	0.0	57.0	0.0	0.0	0.9	27.4	138.9	1.2	8.6	1.1	0.5	0.4	6.6	0.0	2.8	2.0	0.1	0.5	0.5	4.9	0.0	0.2	1.1	47.9	0.2	0.0	1.9	7.8	0.0	0.9	0.3	9.0	0.0	4.9	0.0	1.9	0.0	0.3	2.1	3.0	0.7	1.5	7.4	0.0	0.0	0.1	280.0	1113.8	0.1	0.5	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.1	4.1	4.3	6.5	0.1
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183582-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 1047.0"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 5516.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 148.8;RPTEC TERT1: 501.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	20.9	8.2	0.6	24.6	0.8	43.2	36.4	0.4	1.2	29.9	0.7	44.4	21.6	10.7	2.9	205.9	25.7	197.6	1.4	0.5	0.7	1047.0	6.8	29.5	0.4	0.4	0.5	0.7	99.9	0.0	1.1	3.9	0.7	12.1	30.9	0.0	203.4	8.6	1.6	153.1	66.4	3.1	0.4	3.7	63.4	1.4	0.9	1.9	1.5	0.6	60.2	20.0	66.6	0.4	54.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	41.5	0.0	148.8	0.0	0.0	0.7	0.0	0.5	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.6	501.3	0.0	0.0	0.0	0.5	4.3	0.0	0.0	1.4	0.0	0.0	0.1	1.2	0.1	0.4	0.3	0.6	0.3	0.1	0.1	0.0	0.0	3.4	0.3	0.6	1.1	0.2	0.0	0.0	0.0	1.7	0.4	0.2	0.0	6.6	0.7	0.1	1.5	1.1	144.5	0.6	0.8	0.4	1.2	0.5	0.7	0.4	0.5	0.7	0.4	0.9	0.4	1.6	76.9	47.4	0.0	31.2	14.1	13.3	489.8	7.4	0.0	152.9	105.5	0.1	303.1	413.3	233.6	0.0	0.1	1.7	118.8	414.8	1175.8	0.0	6.1	3.3	4.5	39.6	148.4	0.0	760.0	0.0	6.6	36.7	38.1	10.8	0.2	5.0	1.7	0.3	0.0	0.0	143.3	52.9	0.3	2.1	0.0	3.4	59.3	8.8	0.0	13.6	0.6	2.1	0.0	0.0	1115.2	91.0	0.0	0.1	38.9	106.2	5516.6	147.6	0.0	0.0	0.1	28.7	0.0	0.1	30.7	54.0	0.8	22.0	0.0	150.5	68.5
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118136124-118145584	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2083.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 3705.6;Hepatocytes: 2242.4;Proximal enterocytes: 2177.7;Proximal tubular cells: 4542.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA008819, CAB009906, CAB013493, HPA063904"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		51000000	"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708"	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	217.9	1754.1	941.2	84.0	966.0	121.8	235.5	987.9	1049.0	258.0	958.4	208.9	601.4	186.6	383.7	219.5	218.4	154.8	463.8	932.6	951.5	1046.1	2083.1	176.4	122.7	959.0	965.9	335.9	357.5	1162.7	292.3	128.8	982.6	261.6	191.2	336.1	344.5	233.2	580.3	190.3	510.6	167.6	1006.6	121.2	201.7	152.2	1025.0	138.1	739.7	546.8	160.2	200.8	179.0	1081.7	289.2	241.6	340.0	348.8	493.5	250.2	500.0	214.5	262.3	347.7	177.1	151.6	96.4	439.6	221.3	336.2	139.9	194.4	495.0	202.8	257.7	115.1	454.2	220.0	274.7	1021.7	289.2	403.6	94.5	240.8	334.7	203.9	140.0	396.1	162.7	240.9	375.8	169.2	356.4	346.3	226.8	813.7	319.7	243.1	273.9	446.1	235.6	829.7	428.7	277.2	397.5	306.9	439.9	306.2	446.0	200.4	443.6	293.0	168.9	253.7	147.0	254.0	237.3	161.6	315.1	234.1	301.1	303.2	280.9	5.0	67.5	20.0	155.2	76.4	247.0	271.7	258.9	193.1	205.1	210.0	244.6	201.2	8.0	138.1	68.6	231.6	259.7	258.4	941.2	966.0	987.9	1049.0	932.6	951.5	959.0	965.9	982.6	1006.6	1025.0	1081.7	193.7	403.8	433.3	101.5	230.9	318.1	449.3	367.6	288.5	539.4	538.4	590.7	697.3	713.4	243.2	783.5	95.9	999.6	144.6	207.1	3705.6	507.9	44.3	499.3	319.0	186.5	320.6	218.1	93.7	244.6	862.3	347.9	169.2	369.8	371.8	419.7	213.8	2242.4	591.6	721.8	99.6	378.8	335.7	201.4	239.0	84.4	543.1	195.3	743.5	53.4	296.8	1792.2	101.0	39.2	199.8	184.2	313.3	731.6	279.3	517.4	2177.7	4542.6	291.6	411.6	368.1	337.5	347.8	330.6	145.7	367.7	325.2	615.5	216.7	921.6	631.3	399.5
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 172.1;brain: 348.9;placenta: 467.0"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 2015.8;Syncytiotrophoblasts: 2856.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 773.3;HAP1: 1015.3;Hep G2: 805.0;SCLC-21H: 488.6"	"Region enhanced"	"Detected in all"		"hypothalamus: 110.7"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	3.2	172.1	101.2	2.6	111.9	0.9	24.6	43.7	46.4	7.5	0.0	5.5	0.8	5.6	1.9	2.3	10.0	3.2	1.6	43.5	331.8	7.3	2.4	15.4	5.1	55.2	122.0	65.1	11.4	2.1	88.3	467.0	136.0	2.7	2.0	23.0	9.1	2.6	2.2	0.6	1.5	3.9	32.2	2.0	2.8	41.1	348.9	13.2	11.4	3.3	3.2	3.6	1.6	23.0	22.8	111.6	773.3	329.0	16.0	28.5	45.0	60.7	35.3	42.8	57.3	187.6	37.0	2.5	2.2	70.2	87.5	6.9	1015.3	43.1	58.9	2.9	107.0	0.1	121.8	805.0	12.0	129.6	0.2	63.9	13.9	105.7	73.0	37.1	25.8	0.0	0.5	243.7	84.5	5.8	0.5	0.1	355.4	19.1	70.5	48.5	247.6	67.4	194.3	83.2	488.6	28.2	0.4	16.9	59.9	192.8	105.8	0.3	0.0	33.7	2.0	4.2	46.9	65.2	46.4	97.1	76.3	0.1	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	101.2	111.9	43.7	46.4	43.5	331.8	55.2	122.0	136.0	32.2	348.9	23.0	4.0	153.8	82.4	11.4	37.1	0.8	9.1	2.5	0.6	87.5	49.4	74.3	42.8	5.7	69.8	16.5	8.4	2015.8	3.3	0.9	64.6	18.1	4.5	9.7	3.0	8.4	60.4	0.0	15.8	5.3	205.1	45.3	2.0	15.4	2.5	24.2	4.2	4.7	175.8	37.0	21.9	0.6	8.2	0.0	0.6	18.9	9.0	1.7	14.2	4.7	0.0	109.0	0.0	10.1	12.8	5.2	0.0	4.1	1.5	9.6	0.0	22.0	8.9	29.7	6.6	173.1	23.0	52.9	51.5	2.5	0.9	2856.1	2.6	68.9	0.7	0.6
PER2	KIAA0347	ENSG00000132326	"Period circadian regulator 2"	O15055	2	238244044-238290102	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053136, HPA060510"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA053136: , HPA060510: AB_2684298"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.22e-2)"	12.2	3.3	4.7	5.0	5.2	8.4	14.2	7.2	5.8	11.9	2.4	7.6	5.1	10.2	5.7	13.6	7.9	12.3	5.7	5.7	5.1	3.9	12.4	7.1	4.7	5.2	5.7	7.8	14.4	4.2	9.0	2.9	4.4	9.3	6.2	5.1	14.1	8.9	11.4	17.0	8.0	4.9	5.4	4.8	13.4	11.8	4.7	4.1	8.8	7.6	6.2	8.7	8.2	4.7	1.6	11.7	2.4	4.2	0.1	1.2	8.2	1.1	4.1	1.5	1.4	1.8	5.8	10.3	1.2	2.7	1.5	8.6	2.4	3.5	2.2	2.9	1.7	9.1	6.2	8.2	2.0	13.8	9.2	1.6	8.3	1.8	6.1	1.5	0.8	4.2	4.5	6.3	1.3	7.7	6.9	15.2	3.5	7.6	2.3	16.5	5.5	3.3	1.5	3.3	9.7	1.2	2.9	6.3	1.8	0.7	5.9	8.5	2.1	3.6	4.2	2.8	4.1	7.1	1.8	12.3	6.7	5.9	4.5	2.1	1.2	0.3	1.0	2.2	1.6	1.5	1.6	1.2	1.4	1.5	1.5	1.6	1.0	1.2	2.1	1.8	1.2	0.3	4.7	5.2	7.2	5.8	5.7	5.1	5.2	5.7	4.4	5.4	4.7	4.7	24.9	16.0	30.1	18.6	9.9	73.9	61.7	21.3	38.1	20.6	67.8	33.8	5.7	31.5	46.9	27.6	2.1	9.2	27.0	22.5	7.9	7.5	9.6	69.7	30.1	15.6	24.6	6.9	20.9	10.4	6.3	39.8	52.5	86.1	9.5	3.3	11.4	35.8	3.9	11.8	13.9	35.1	18.3	10.1	25.3	4.7	11.1	12.4	24.9	5.6	5.3	13.5	2.1	9.0	7.2	7.6	35.3	18.4	10.9	15.0	10.9	5.5	44.2	7.8	6.6	110.1	32.2	31.3	17.0	38.4	85.4	13.0	13.6	3.7	36.9	33.9
PFDN1	PFD1	ENSG00000113068	"Prefoldin subunit 1"	O60925	5	140245035-140303113	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006499	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006499: AB_1079596"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.66e-3)"	"prognostic unfavorable (8.81e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.00e-1)"	74.1	50.9	73.9	37.7	75.6	60.2	50.0	82.2	88.4	41.4	70.8	59.2	40.2	50.8	54.3	52.3	41.9	35.7	93.3	77.2	79.7	61.6	38.5	46.9	46.1	82.9	77.2	37.2	34.7	52.8	39.4	50.8	80.5	44.8	42.9	35.1	45.4	43.7	149.0	46.2	39.8	61.4	79.1	36.6	40.7	29.9	79.3	51.5	42.4	86.4	51.6	45.9	40.9	81.2	172.4	79.6	137.7	80.9	89.7	91.8	133.8	229.6	114.9	174.6	192.6	172.1	107.9	114.9	224.1	124.3	180.0	62.6	102.0	228.7	204.2	122.6	102.9	102.4	76.5	113.0	105.1	213.5	76.4	98.2	119.8	148.5	156.3	112.6	196.0	132.8	93.7	73.1	149.8	78.5	146.0	147.6	92.0	70.3	119.2	101.3	195.9	86.3	197.1	77.9	78.2	81.8	172.1	148.6	136.8	128.5	102.1	122.3	249.1	121.8	119.6	71.9	208.0	70.3	198.6	299.2	122.5	138.5	144.1	149.5	84.7	130.3	86.2	131.1	91.8	106.0	98.6	100.4	100.5	97.9	97.3	88.4	14.0	114.7	130.3	93.0	129.3	115.5	73.9	75.6	82.2	88.4	77.2	79.7	82.9	77.2	80.5	79.1	79.3	81.2	87.9	67.3	33.0	16.3	57.4	38.0	65.9	96.2	30.7	42.5	50.1	57.3	81.3	52.9	62.1	66.2	45.9	116.1	53.1	56.6	123.3	121.9	3.9	58.0	56.6	73.8	46.6	62.9	31.2	101.7	86.6	55.4	35.2	70.9	54.4	53.6	72.1	56.9	85.4	25.2	29.3	43.6	48.8	61.1	37.7	12.9	52.2	63.4	74.7	37.5	90.4	84.9	71.1	24.1	39.3	128.9	55.1	52.3	35.5	45.4	80.9	147.3	45.3	42.9	65.7	39.6	63.7	23.7	61.8	40.8	34.9	85.6	45.2	42.9	47.3	63.6
PFDN6	"H2-KE2, HKE2, KE-2, PFD6"	ENSG00000204220	"Prefoldin subunit 6"	O15212	6	33289302-33298401	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 220.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043032, HPA048123"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		89000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA043032: AB_2678278, HPA048123: AB_2680273"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.68e-3)"	45.3	78.2	23.7	13.7	24.4	12.9	45.4	24.2	27.3	49.2	22.6	55.9	9.3	54.8	14.2	70.2	46.2	6.7	85.1	24.4	24.4	78.8	98.1	41.7	15.9	24.6	24.6	45.3	51.7	14.4	62.7	13.6	24.7	51.0	11.6	8.6	47.6	8.0	129.3	49.6	45.3	9.9	23.7	49.9	58.4	91.4	24.0	17.1	45.6	14.7	17.0	55.6	46.7	25.2	49.4	36.0	34.9	56.7	22.7	17.3	43.4	37.2	20.6	48.0	48.7	42.6	24.0	102.8	43.1	20.5	83.5	42.2	69.5	47.6	58.3	49.3	52.9	89.8	39.4	78.3	33.2	56.3	49.3	20.7	50.9	64.8	41.6	28.5	40.2	61.2	107.2	29.6	36.7	36.0	73.9	58.7	47.7	33.0	37.6	71.9	38.0	65.2	58.9	23.4	61.3	83.9	32.1	83.3	61.3	35.0	44.4	65.0	22.5	24.7	36.0	26.0	68.7	71.2	220.3	89.4	20.5	71.9	38.1	1.8	2.6	1.8	1.9	3.2	2.1	3.3	2.3	3.1	2.4	3.2	1.8	2.5	1.1	2.1	3.5	3.5	3.5	1.9	23.7	24.4	24.2	27.3	24.4	24.4	24.6	24.6	24.7	23.7	24.0	25.2	17.4	25.6	8.7	5.2	49.1	55.7	45.2	92.6	43.9	24.5	30.2	17.1	20.7	60.1	51.6	55.2	10.4	127.5	37.6	90.0	121.3	87.6	94.2	106.5	64.7	30.6	50.4	48.4	4.3	103.8	126.1	32.6	44.4	66.9	61.6	32.9	19.2	74.0	79.2	18.5	4.1	75.7	87.5	35.4	45.2	42.7	61.8	37.2	71.2	2.8	66.3	51.0	50.4	1.5	7.1	88.0	71.3	49.2	55.3	53.9	76.4	210.0	53.0	29.0	39.5	43.6	96.3	208.2	60.4	64.3	63.9	110.8	36.9	47.4	82.7	46.7
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 5241.0;monocytes: 4824.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037134, CAB037140"	Enhanced		Approved	Cytosol		NA	NA		660000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	573.1	365.8	278.0	1133.4	302.0	1613.0	397.0	323.2	333.0	393.7	289.2	970.2	764.0	734.4	346.4	582.7	500.9	372.7	343.8	281.8	301.5	460.9	661.6	559.2	1357.9	347.3	325.4	247.7	246.4	311.3	198.9	581.1	348.6	419.4	808.4	71.8	346.9	601.4	337.9	449.8	772.9	1034.7	315.2	910.8	675.1	116.2	366.2	1197.6	269.2	238.7	1440.0	842.6	425.0	355.2	3019.5	4276.8	1461.5	1205.2	778.8	977.1	1972.7	2416.8	1970.4	2568.6	1923.7	1684.1	1181.1	2476.9	1892.0	2542.0	1453.6	1825.4	1383.6	3040.5	2049.6	3560.1	2355.1	2516.6	2034.3	2225.8	2144.0	1630.4	5006.0	1152.4	1331.9	1957.6	1939.8	1477.6	2361.3	1646.4	1488.6	1736.7	3150.5	1815.0	2469.9	3448.0	2095.2	1474.7	2297.3	2451.9	2035.1	1494.6	2491.7	1909.8	564.0	1586.2	1910.5	1180.9	1679.7	1226.8	1121.0	1359.7	2731.7	2136.6	1675.1	1512.3	3969.3	931.3	1070.7	1799.3	1834.4	1949.7	3316.4	8100.1	8206.3	13914.4	9850.0	10858.8	6780.3	5722.0	8185.7	9586.6	9920.0	4970.0	5238.0	7604.7	9387.0	9112.1	13547.4	7809.7	11245.6	23570.1	278.0	302.0	323.2	333.0	281.8	301.5	347.3	325.4	348.6	315.2	366.2	355.2	561.8	112.2	176.1	12.1	1070.6	1806.0	873.2	3658.3	1003.3	25.0	767.4	914.1	147.6	457.5	1020.0	741.2	0.0	1911.0	1725.6	1733.8	992.0	1866.6	19.7	313.4	546.1	806.6	603.7	713.5	7.1	1625.2	5241.0	599.9	733.4	422.7	486.5	291.2	637.5	754.3	4094.2	38.7	6.4	1399.7	1452.6	1434.3	2934.8	31.0	263.8	1854.7	873.4	21.5	4824.7	99.8	3216.3	9.0	37.2	2933.5	1585.7	375.0	927.8	1238.2	1472.2	1671.2	559.4	17.8	506.2	282.3	1838.4	97.4	355.4	1170.1	1513.5	1682.8	1804.7	410.7	1355.5	1177.9
PFN3		ENSG00000196570	"Profilin 3"	P60673	5	177400109-177400661	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 25.7"	"Group enriched"	"Detected in some"	176	"Early spermatids: 666.2;Late spermatids: 1589.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA038274			Approved	Vesicles,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA038274: "										"unprognostic (1.03e-2)"					"unprognostic (1.13e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	666.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1589.2	6.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 1132.9;skeletal muscle: 4350.5;tongue: 1754.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 539.1;Late spermatids: 1891.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		38000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		4.1	3.7	32.9	0.1	37.7	0.1	2.9	40.9	43.1	2.8	28.9	2.1	2.0	1.8	0.7	58.9	2.3	2.4	1132.9	29.3	45.0	10.6	1.8	2.0	0.3	33.8	39.8	2.0	2.1	4.0	13.5	0.1	46.0	16.5	0.3	4.3	33.6	0.6	4350.5	1.8	1.3	0.5	30.8	1.2	1.7	193.9	46.8	23.9	5.1	1754.5	0.5	0.7	1.9	39.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	65.8	7.0	0.0	0.3	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	32.9	37.7	40.9	43.1	29.3	45.0	33.8	39.8	46.0	30.8	46.8	39.8	0.7	0.0	0.0	6.8	1.2	1.1	0.3	0.1	0.6	15.6	0.2	0.6	0.0	0.0	0.3	0.0	10.4	0.0	0.0	0.2	80.3	0.1	539.1	4.0	0.4	1.5	22.9	0.0	0.1	0.5	0.0	0.6	1.5	5.6	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.4	4.1	0.3	1.4	1891.7	7.8	1.5	1.8	1.9	0.0	5.6	0.0	1.0	0.5	0.3	1.2	6.0	1.4	0.2	0.4	9.2	0.1	4.6	26.3	78.3	18.6	187.6	7.0	0.2	0.6	0.0	0.6	0.1	0.2	0.5
PGAP3	"CAB2, MGC9753, PER1, PERLD1, PP1498"	ENSG00000161395	"Post-GPI attachment to proteins phospholipase 3"	Q96FM1	17	39671122-39696797	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"OE19: 800.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016591	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA016591: AB_1855203"	"unprognostic (1.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.57e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.94e-2)"	10.5	11.9	17.0	5.6	17.2	5.0	12.9	14.0	19.6	14.6	16.2	18.6	14.9	11.3	18.3	25.8	15.9	13.4	14.8	17.5	16.7	20.6	35.6	12.1	7.4	14.9	15.4	13.5	27.1	22.7	14.9	11.8	14.6	18.5	13.7	7.1	25.1	11.7	8.3	21.0	17.1	6.1	14.7	12.3	16.6	9.1	16.5	4.8	27.1	4.5	7.5	12.2	13.7	15.5	3.7	9.6	7.7	7.0	7.9	8.1	7.9	4.3	10.1	6.7	6.1	5.4	23.8	4.2	19.7	8.3	2.2	12.6	2.4	2.9	3.1	8.6	7.7	5.2	6.0	9.3	10.6	12.9	12.8	14.9	15.0	3.1	6.8	7.6	2.2	1.9	4.9	9.6	6.1	8.7	2.9	11.7	7.6	800.4	2.1	3.2	4.7	12.1	10.7	12.0	7.1	4.7	11.9	134.0	6.9	0.8	11.4	12.4	3.4	7.2	7.6	3.5	3.3	8.5	2.0	1.4	8.1	4.9	8.1	2.6	7.2	4.6	15.2	11.6	8.3	8.1	10.6	12.5	5.7	7.7	10.1	10.1	2.0	10.4	4.3	3.9	5.4	7.3	17.0	17.2	14.0	19.6	17.5	16.7	14.9	15.4	14.6	14.7	16.5	15.5	6.5	3.2	14.9	7.8	3.7	3.8	3.3	5.6	3.4	12.6	9.1	7.0	7.7	14.3	10.1	14.7	8.4	8.1	5.3	20.3	1.9	7.6	0.1	3.5	4.5	5.0	8.4	3.0	9.0	11.1	6.5	5.1	9.2	5.7	8.9	6.8	4.6	9.0	4.4	13.5	6.3	15.3	8.2	5.1	2.8	0.1	3.1	3.7	1.8	2.8	1.9	7.5	4.1	9.0	6.1	6.3	13.9	1.5	2.8	3.7	22.9	3.4	4.9	22.1	0.0	5.0	3.3	0.7	2.4	8.1	2.8	10.4	4.9	5.8	13.3	3.1
PGBD1	"dJ874C20.4, HUCEP-4, SCAND4"	ENSG00000137338	"PiggyBac transposable element derived 1"	Q96JS3	6	28281572-28302549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 33.4;Inhibitory neurons: 26.7;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.7;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007267	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA007267: AB_1079601"	"unprognostic (2.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.28e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (6.79e-4)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.68e-1)"	2.9	2.9	5.8	1.9	6.2	1.6	2.9	5.9	7.3	3.8	2.9	5.9	1.4	4.4	2.6	2.1	3.4	1.9	3.2	6.8	4.5	3.2	2.6	2.5	1.6	4.1	4.2	3.1	2.1	2.4	3.1	2.0	4.5	3.5	2.1	6.2	2.1	3.2	2.1	1.4	2.7	5.4	4.0	3.2	3.2	3.1	4.4	2.3	2.5	1.6	1.6	3.3	2.8	6.7	6.4	3.5	10.9	15.5	8.6	6.1	3.6	8.2	5.6	10.2	11.5	3.9	2.6	4.2	5.1	5.7	11.6	2.8	11.9	6.7	13.2	4.7	6.8	7.8	6.9	4.9	4.0	9.7	0.9	5.0	3.1	10.1	3.5	5.8	12.7	8.1	10.2	0.5	11.5	2.0	8.2	12.1	4.1	0.1	6.9	14.0	13.9	0.1	5.1	3.4	7.5	14.3	5.6	1.0	6.5	10.8	3.1	5.9	9.1	15.2	10.2	1.0	13.2	4.0	4.3	5.5	3.4	5.5	7.3	1.7	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.3	0.0	0.1	0.0	0.5	0.0	1.5	0.1	0.1	5.8	6.2	5.9	7.3	6.8	4.5	4.1	4.2	4.5	4.0	4.4	6.7	6.1	6.4	1.1	12.7	1.4	0.3	3.0	0.7	1.8	6.2	2.3	2.9	7.5	0.0	0.2	0.0	2.1	0.8	3.6	0.5	0.0	1.1	1.4	1.1	4.4	4.6	1.2	5.2	33.4	2.5	3.7	4.1	0.5	1.0	3.8	4.7	3.6	0.2	1.7	5.0	26.7	0.7	2.0	4.0	1.4	1.0	1.8	1.2	3.6	7.5	2.1	4.4	0.0	20.6	22.3	1.1	0.3	3.4	1.5	0.8	0.6	3.9	4.2	4.4	0.0	6.2	4.3	5.0	9.7	1.8	0.3	0.4	1.3	3.1	1.1	0.5
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420511	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 400.2;esophagus: 572.4"	"Cell type enhanced"	"Detected in all"		"monocytes: 214.9;Squamous epithelial cells: 496.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1060.2;classical monocyte: 321.0;eosinophil: 1074.7;neutrophil: 332.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 1074.7;monocytes: 321.0"	"Cell line enhanced"	"Detected in all"		"A549: 1445.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		41000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	115.8	51.0	49.5	59.8	49.2	400.2	89.0	52.9	49.3	75.9	52.5	52.9	91.6	23.1	41.9	572.4	30.0	94.2	34.3	47.4	54.3	53.2	81.3	88.5	38.1	57.0	54.6	35.7	32.0	52.7	43.8	47.4	55.4	30.4	46.3	49.1	133.7	22.9	34.7	50.0	70.7	35.0	49.7	110.4	61.4	68.3	59.2	53.6	71.8	28.2	73.8	61.8	126.9	52.0	191.5	1445.2	319.3	340.6	445.4	274.0	71.8	124.8	185.9	144.4	195.3	219.2	190.4	163.5	151.0	109.2	202.4	148.0	225.6	192.1	96.4	127.5	199.9	227.8	264.3	452.1	136.3	390.9	249.7	196.5	92.2	229.4	55.5	186.9	344.0	223.0	305.3	145.7	183.5	202.5	321.4	179.4	194.7	221.0	109.1	252.7	298.1	312.2	199.6	105.5	178.0	154.1	99.1	153.5	137.5	196.7	173.3	308.5	369.3	81.1	149.6	98.3	134.5	111.6	256.0	323.5	175.1	393.9	73.6	1060.2	321.0	1074.7	23.2	137.7	26.5	33.1	21.4	20.8	144.6	23.3	21.1	22.3	332.6	19.7	105.6	98.7	23.1	225.0	49.5	49.2	52.9	49.3	47.4	54.3	57.0	54.6	55.4	49.7	59.2	52.0	7.4	19.2	35.0	11.8	24.9	13.0	30.8	78.0	70.6	7.8	30.4	18.5	11.0	50.1	73.2	20.2	18.8	134.6	29.8	24.3	52.8	52.1	10.9	17.8	18.6	22.6	23.4	55.7	8.6	40.3	40.7	37.5	41.8	24.5	25.9	53.9	16.1	66.2	134.6	1.7	12.6	30.2	59.0	163.8	30.9	13.4	17.1	150.9	17.8	4.7	214.9	16.5	10.3	13.6	9.0	38.7	26.7	10.5	41.9	43.5	66.6	55.1	46.2	20.2	19.7	23.4	21.5	41.5	38.4	496.0	16.6	81.3	19.4	27.3	51.7	76.1
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955626	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.5;thyroid gland: 52.5"	"Group enriched"	"Detected in many"	11	"Extravillous trophoblasts: 1604.4;Syncytiotrophoblasts: 2122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"BEWO: 422.4;HUVEC TERT2: 199.1"	"Low region specificity"	"Detected in all"							HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	No	No	20800		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	11.8	4.9	7.4	7.8	7.6	0.1	11.3	7.3	11.7	22.4	20.2	7.0	2.4	7.6	1.4	10.0	21.8	5.9	18.8	8.7	20.6	8.1	6.0	7.2	6.4	9.5	15.7	6.4	4.9	8.4	5.5	50.5	9.3	19.3	2.0	1.2	10.5	10.3	9.9	15.7	12.5	7.8	7.0	3.3	4.8	3.2	8.6	3.9	52.5	5.9	3.3	13.6	14.8	7.8	1.4	1.5	1.3	1.3	2.0	0.2	422.4	4.0	3.6	1.8	2.2	10.9	0.6	0.3	9.1	2.8	0.2	0.5	1.8	19.2	1.6	0.2	2.4	0.0	0.1	11.3	1.5	0.2	11.0	4.7	4.5	7.5	1.8	0.5	199.1	0.0	0.0	0.1	55.6	0.9	0.0	0.5	2.1	0.1	3.4	0.2	51.3	0.0	0.5	1.0	31.0	17.0	0.0	0.8	7.7	25.0	0.1	0.5	40.6	0.3	10.2	0.1	17.0	0.4	0.2	0.7	6.3	0.5	0.5	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	7.4	7.6	7.3	11.7	8.7	20.6	9.5	15.7	9.3	7.0	8.6	7.8	32.4	9.6	4.6	1.0	1.0	24.6	10.3	111.4	34.7	1.3	8.9	16.0	3.6	0.0	26.0	0.0	14.6	83.8	2.4	2.0	0.0	2.7	0.1	1.1	3.3	169.4	7.1	2.7	0.1	0.5	1604.4	30.8	1.1	0.8	6.3	0.2	5.3	0.3	37.4	0.0	0.2	2.1	18.3	0.6	8.9	0.8	13.1	2.1	21.4	0.0	0.0	1.9	0.0	0.0	0.2	0.5	1.2	19.5	0.2	3.2	0.6	1.1	12.1	7.8	105.2	7.1	86.4	0.2	6.8	8.1	19.6	2122.6	3.0	3.0	2.3	5.8
PGGT1B	"BGGI, GGTI"	ENSG00000164219	"Protein geranylgeranyltransferase type I subunit beta"	P53609	5	115204012-115262877	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030646	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Endoplasmic reticulum"	Cytosol	"HPA030646: AB_10602019"	"unprognostic (2.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (7.34e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.15e-2)"	9.4	8.1	4.6	11.1	6.1	12.8	9.6	6.1	4.2	7.6	5.6	14.6	13.0	8.0	3.6	9.6	7.5	7.4	6.7	4.2	5.9	8.1	12.8	7.4	9.8	5.3	5.9	7.3	9.6	12.6	3.2	8.3	6.4	8.4	15.1	12.0	6.6	5.9	7.8	4.9	11.1	9.8	5.8	10.3	11.7	5.6	5.6	9.4	8.6	9.1	11.0	11.3	5.4	6.8	14.7	15.6	17.5	22.7	10.0	8.3	8.6	17.7	10.4	14.5	14.8	17.1	15.3	29.6	23.4	12.4	14.9	11.2	23.3	23.3	21.5	32.9	12.9	17.1	21.0	13.9	13.3	23.7	24.2	12.5	14.0	14.3	14.8	9.2	14.7	17.2	14.1	12.3	16.7	22.8	20.9	7.9	13.0	16.4	12.0	22.6	23.3	30.3	15.2	27.3	17.0	13.0	21.0	15.8	17.6	10.4	21.2	17.4	17.0	14.8	14.0	10.3	20.9	20.4	24.5	15.5	10.7	24.1	20.9	13.7	19.0	34.1	7.0	25.3	8.0	9.7	7.8	8.9	17.2	11.3	7.4	6.8	19.5	10.5	27.0	15.5	7.6	10.3	4.6	6.1	6.1	4.2	4.2	5.9	5.3	5.9	6.4	5.8	5.6	6.8	21.8	12.8	20.8	24.8	26.2	9.9	11.8	12.2	9.1	23.3	18.3	10.4	17.1	5.7	18.3	16.5	47.9	15.3	27.2	29.0	27.4	19.3	49.2	15.8	21.3	20.3	30.1	9.5	30.5	21.6	14.9	15.5	19.9	13.5	23.5	17.2	20.7	25.7	22.6	23.5	27.6	22.4	10.2	21.9	13.2	10.2	13.4	24.8	10.6	33.7	26.8	27.8	24.7	38.2	38.0	24.0	27.2	15.4	12.0	15.6	20.7	22.8	20.3	111.2	13.1	20.5	16.7	14.7	13.9	10.7	12.4	13.5	16.1	19.6	23.9	20.3
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023053	"Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 629.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.2;Excitatory neurons: 1.7;Inhibitory neurons: 1.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.4"	"Group enriched"	"Detected in some"	202	"eosinophil: 443.7;neutrophil: 494.6"	"Lineage enriched"	"Detected in many"	213	"granulocytes: 494.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.1;HEK 293: 1.8;HeLa: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045702, HPA070227"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		35000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles	"Nucleoplasm, Cytosol"	"HPA045702: AB_10960204, HPA070227: "	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	1.5	0.3	0.3	1.8	1.1	629.4	0.3	3.4	1.5	0.1	0.0	0.3	0.6	0.2	0.0	0.5	0.6	0.2	1.7	0.6	0.0	0.8	2.5	8.7	0.5	0.0	0.1	0.1	0.5	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.5	0.0	0.3	1.0	0.7	0.1	0.0	42.5	0.4	1.0	0.0	3.3	0.5	2.3	0.0	0.4	0.2	0.0	0.3	3.1	0.5	0.3	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	0.2	0.8	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.8	1.8	0.3	1.7	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.3	0.0	0.2	0.2	0.9	0.2	0.0	1.2	0.7	0.1	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.7	0.6	0.3	0.4	0.7	0.0	0.2	0.4	443.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	494.6	0.0	2.3	0.0	0.1	3.9	0.3	1.1	3.4	1.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	23.6	21.0	12.0	18.1	12.9	9.3	18.0	20.2	15.2	24.4	19.6	18.0	15.8	17.1	34.5	12.3	13.4	24.6	14.3	9.7	10.5	13.6	38.3	16.8	11.2	10.9	10.2	22.7	46.1	13.3	28.2	47.5	13.1	51.0	23.4	26.8	35.8	20.3	6.7	10.9	18.2	18.5	6.6	11.5	24.9	32.3	11.1	8.2	25.6	8.6	15.2	19.0	12.3	15.9	35.1	23.4	41.8	51.0	68.9	72.9	48.9	118.1	82.9	55.2	83.3	60.1	16.1	18.3	24.7	112.3	53.0	20.1	38.4	49.5	104.6	14.6	37.8	22.7	41.9	105.0	77.6	22.6	11.2	46.2	40.1	96.6	120.0	55.5	64.6	12.1	74.9	19.6	61.0	39.1	3.7	14.7	18.8	31.8	31.6	16.2	92.5	11.3	42.0	36.0	16.9	26.3	34.8	28.5	20.9	61.8	27.0	25.5	94.2	38.3	21.2	74.9	60.5	36.5	16.1	13.0	29.7	17.7	58.4	10.8	4.1	2.7	2.6	3.5	3.9	4.6	2.8	3.4	3.6	2.5	4.5	4.7	1.8	3.5	4.5	4.2	2.1	2.3	12.0	12.9	20.2	15.2	9.7	10.5	10.9	10.2	13.1	6.6	11.1	15.9	14.3	28.9	27.7	14.4	13.0	15.8	29.2	28.5	5.7	16.4	19.9	15.0	6.8	15.7	36.1	11.0	10.4	32.4	12.7	15.9	7.9	31.7	67.7	17.0	35.1	13.8	16.1	6.9	25.1	49.6	71.1	46.1	23.9	36.4	5.1	25.4	14.3	32.6	17.6	8.4	29.4	35.5	18.3	6.0	8.7	20.9	33.5	8.6	10.6	15.9	10.1	25.9	2.1	41.2	36.8	37.9	19.7	18.4	44.1	56.5	16.1	23.2	22.2	21.1	6.6	22.1	26.6	75.5	34.2	11.6	15.6	64.4	10.1	12.2	17.6	25.6
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	107.3	51.9	23.8	38.1	25.6	41.7	76.6	25.8	29.8	58.4	34.1	68.1	127.3	52.3	51.3	57.5	44.2	53.4	50.7	25.0	30.2	96.0	173.8	42.7	30.6	25.6	29.6	57.9	74.2	80.5	49.0	85.3	27.7	53.0	65.2	55.1	55.3	73.2	54.4	98.2	121.9	67.4	26.6	32.5	95.8	39.5	28.5	28.0	65.6	44.0	40.8	56.3	51.0	29.8	123.3	44.4	80.3	64.9	339.8	177.6	80.5	164.6	182.7	119.4	158.3	46.4	123.6	86.3	187.8	213.4	138.8	70.1	74.3	81.6	149.3	49.7	42.7	58.0	111.3	88.3	429.1	84.7	41.7	140.9	161.3	100.3	123.3	277.0	109.1	55.0	98.2	105.6	173.7	38.2	78.9	39.2	63.1	148.5	39.7	62.5	64.2	59.8	176.8	42.9	63.3	59.7	92.4	103.1	97.3	131.2	79.7	38.0	203.5	100.0	81.4	103.8	77.3	121.0	106.0	91.3	109.9	74.4	70.1	2.2	1.0	2.0	1.5	0.9	0.7	1.2	1.8	1.5	0.6	0.9	1.6	1.5	0.9	1.1	0.7	2.4	2.0	0.6	23.8	25.6	25.8	29.8	25.0	30.2	25.6	29.6	27.7	26.6	28.5	29.8	95.9	54.5	41.0	16.6	27.0	100.1	49.7	27.8	54.1	22.4	49.2	32.8	60.7	58.6	35.9	44.1	10.4	85.4	41.2	68.2	29.4	57.3	80.9	42.2	59.1	50.0	35.5	104.2	20.4	74.2	146.6	69.9	53.0	64.2	12.0	31.0	47.2	125.1	35.3	11.8	19.1	67.8	40.7	15.7	39.5	49.5	46.3	22.1	67.6	13.1	19.0	98.6	21.6	13.6	25.0	69.7	50.6	37.6	48.9	58.0	177.3	111.0	27.4	41.1	13.1	63.3	53.1	33.3	27.3	51.9	111.8	274.9	32.4	39.4	58.8	34.4
PHACTR4	"FLJ13171, PPP1R124"	ENSG00000204138	"Phosphatase and actin regulator 4"	Q8IZ21	1	28369582-28500364	"Predicted intracellular proteins"	Neurogenesis	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 212.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028985	Approved		Approved	"Plasma membrane,Intermediate filaments,Cytosol"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA028985: AB_10602142"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (9.65e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.26e-2)"	7.2	6.5	6.3	8.6	8.1	11.8	10.1	8.2	6.8	13.6	10.2	12.9	9.1	13.7	7.1	33.0	13.2	8.9	8.9	5.8	8.5	14.1	16.3	12.4	7.8	9.1	6.8	13.1	11.7	15.1	4.0	10.4	7.2	11.8	14.1	5.1	11.3	8.2	11.9	16.2	10.3	13.8	5.5	12.0	10.7	8.6	8.0	11.9	12.4	18.3	12.2	9.4	14.8	9.3	26.0	17.2	37.8	27.5	9.6	10.2	5.8	18.1	18.3	38.5	40.0	16.4	28.1	24.5	15.9	21.6	24.3	17.7	26.3	17.4	33.9	18.1	14.9	51.6	28.2	26.5	14.3	31.2	56.7	9.9	16.4	24.7	42.7	14.0	52.0	19.5	26.0	16.9	24.5	8.0	22.3	7.8	28.3	14.0	11.8	23.2	35.7	18.5	20.2	22.8	20.1	26.0	41.0	16.9	20.9	14.9	22.5	11.1	33.3	18.8	34.6	13.4	35.8	12.4	19.7	20.1	18.4	26.2	20.3	1.9	2.0	2.0	3.3	2.0	2.9	1.4	2.6	3.3	2.2	2.2	1.8	2.6	1.4	2.4	3.3	2.6	1.2	1.5	6.3	8.1	8.2	6.8	5.8	8.5	9.1	6.8	7.2	5.5	8.0	9.3	65.9	70.5	49.8	60.7	38.9	38.6	23.6	24.1	46.7	34.6	37.0	35.8	38.5	40.0	53.7	23.9	20.9	17.6	36.7	59.9	17.6	32.4	6.1	125.6	58.6	56.2	49.3	32.2	65.8	36.5	17.3	29.1	35.2	212.6	48.0	38.8	42.5	63.3	22.8	23.5	82.6	57.0	24.4	33.6	32.3	8.5	19.3	40.3	17.8	92.8	33.7	19.8	51.5	117.1	148.1	48.2	33.5	29.7	30.8	24.4	40.0	45.5	63.3	39.8	39.5	45.6	31.0	47.1	39.4	62.1	54.1	15.2	35.7	15.3	50.6	30.9
PHF14	KIAA0783	ENSG00000106443	"PHD finger protein 14"	O94880	7	10973336-11169623	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000538, HPA017376"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Nucleoplasm, Cytosol"	"HPA000538: AB_1079604, HPA017376: AB_2732420"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.73e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.33e-1)"	9.9	8.0	17.2	8.6	15.6	5.5	13.7	17.5	26.9	9.1	12.7	9.8	8.2	13.1	7.8	8.4	8.8	9.3	5.3	17.0	16.1	10.0	11.4	8.6	9.9	16.5	16.7	14.5	7.1	9.5	7.9	8.4	17.3	10.0	10.4	6.7	7.9	8.1	6.0	8.5	8.2	11.0	14.2	10.3	10.3	9.3	16.0	17.8	9.2	7.8	10.2	9.2	7.6	16.9	16.4	32.8	46.4	49.2	16.2	15.6	23.1	12.6	10.0	14.5	15.9	29.5	28.9	62.4	22.7	11.7	32.7	22.8	42.4	14.6	16.0	23.1	17.3	31.1	28.1	38.0	14.8	70.2	28.8	14.2	15.0	17.3	30.9	20.4	21.2	24.2	42.4	21.6	17.6	21.6	28.0	30.4	39.3	68.1	24.4	45.9	30.3	19.8	15.0	30.6	42.2	58.3	19.5	64.6	21.1	33.6	34.6	50.1	20.6	20.3	27.1	13.6	25.0	27.7	51.1	43.2	14.4	57.8	48.6	1.0	0.9	0.6	1.3	0.8	1.0	1.8	1.4	1.6	0.5	1.4	1.9	1.7	0.0	1.4	0.8	2.7	1.9	0.4	17.2	15.6	17.5	26.9	17.0	16.1	16.5	16.7	17.3	14.2	16.0	16.9	80.6	41.7	41.6	141.0	66.9	57.5	68.6	27.5	68.9	92.7	80.3	91.3	22.7	37.1	44.2	33.1	58.4	68.8	58.4	54.6	27.4	92.0	23.9	40.9	82.7	77.4	92.2	46.9	223.8	84.3	80.9	65.9	55.5	48.1	56.5	103.7	64.2	43.6	42.1	79.1	260.6	72.3	42.7	39.6	24.7	16.2	102.9	39.1	37.4	116.2	58.0	36.5	87.6	263.4	200.8	90.4	45.9	116.9	34.3	82.0	46.0	35.9	28.0	63.3	52.6	71.0	67.6	142.3	133.7	56.5	52.4	39.8	58.6	73.7	72.0	54.2
PHF21B	"BHC80L, FLJ34161, PHF4"	ENSG00000056487	"PHD finger protein 21B"	Q96EK2	22	44881162-45010005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 96.6;Cone photoreceptor cells: 22.9;Horizontal cells: 28.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 29.1;Rod photoreceptor cells: 23.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;AN3-CA: 10.0;JURKAT: 8.8;SCLC-21H: 8.7;SH-SY5Y: 37.5;U-2 OS: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053834, HPA074665"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA053834: AB_2682276, HPA074665: "	"unprognostic (1.04e-1)"	"unprognostic (7.76e-2)"		"unprognostic (2.00e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.37e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.02e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.22e-1)"	0.2	1.2	6.7	0.1	7.9	0.0	0.4	4.8	6.1	9.0	1.5	0.2	0.1	3.2	0.4	0.4	2.5	0.1	0.9	5.1	5.1	2.6	0.0	0.1	0.0	8.5	8.3	4.0	0.5	0.9	18.9	0.0	5.2	5.2	0.0	6.1	0.3	0.5	0.2	0.1	0.2	0.7	4.4	0.1	0.6	5.4	6.8	0.2	2.0	0.3	0.0	0.2	3.2	4.7	0.0	0.0	11.2	10.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.0	0.1	2.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.6	0.0	0.0	8.8	0.0	0.0	0.1	0.9	1.3	0.0	6.7	0.0	0.4	0.0	2.6	0.2	0.0	0.1	8.7	37.5	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.5	8.5	0.0	0.2	0.4	0.0	5.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.9	4.8	6.1	5.1	5.1	8.5	8.3	5.2	4.4	6.8	4.7	0.0	0.0	0.0	96.6	0.0	0.1	0.6	0.0	0.0	14.1	0.0	0.3	2.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	1.9	0.0	16.2	0.1	3.2	0.4	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.3	0.0	0.6	0.0	0.0	0.1	28.6	9.1	0.0	0.0	0.0	0.0	41.9	0.6	0.1	0.0	5.6	0.0	5.0	0.0	29.1	9.3	0.1	0.0	1.9	0.0	1.7	0.0	0.0	0.7	23.3	0.0	1.1	0.5	1.2	2.9	0.0	0.0	0.0	0.3	1.9	0.0	0.1
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Muscle protein"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"parathyroid gland: 32.0;skeletal muscle: 102.6;tongue: 89.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001081, HPA075355"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA001081: AB_1079607, HPA075355: "	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	3.2	17.7	6.9	1.0	11.4	0.7	4.8	8.9	5.7	2.6	17.0	4.0	1.1	3.3	6.5	5.6	3.8	3.2	7.5	6.0	8.7	2.7	2.3	2.1	1.1	8.8	11.9	8.3	7.6	32.0	9.8	1.8	9.1	6.0	3.3	3.9	7.1	6.4	102.6	3.4	2.1	3.4	7.9	3.4	6.9	2.1	10.4	4.0	6.9	89.2	1.4	4.8	3.5	6.7	15.3	21.2	1.2	12.4	7.2	6.8	12.9	2.8	2.6	0.5	0.1	6.2	13.3	0.0	8.2	0.3	15.1	5.9	24.9	10.3	0.8	39.2	25.1	7.0	17.4	5.7	7.5	0.0	0.0	9.1	10.0	2.4	16.7	12.5	14.5	12.7	11.0	0.0	13.6	11.0	11.1	0.7	16.5	25.2	28.0	0.0	0.0	0.0	3.7	7.2	12.9	15.3	13.4	17.3	0.2	15.4	6.2	0.6	7.5	0.0	6.2	2.7	7.3	17.1	17.1	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	11.4	8.9	5.7	6.0	8.7	8.8	11.9	9.1	7.9	10.4	6.7	5.8	0.0	3.7	85.2	0.5	2.4	6.5	2.3	4.0	2.4	5.2	3.7	6.6	1.5	3.5	11.0	8.4	1.0	0.1	0.8	0.0	1.6	0.4	4.8	1.4	3.5	2.4	4.0	5.3	2.7	1.1	2.5	3.6	2.9	6.3	3.4	5.7	1.9	1.6	3.3	16.0	1.8	4.1	10.4	0.7	0.1	3.1	0.6	1.8	6.5	0.0	1.5	0.0	18.6	0.5	5.4	0.4	8.6	1.3	9.0	0.4	1.6	6.6	3.3	0.0	7.1	1.9	0.4	1.0	5.6	3.4	0.5	0.3	1.9	2.6	8.9
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.0;skin 1: 43.5"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 58.0;Urothelial cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (4.11e-5)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	3.7	9.2	6.3	5.6	5.5	3.5	6.4	3.9	6.4	14.4	8.9	6.1	5.0	5.3	1.1	42.0	8.0	6.1	5.7	5.1	7.8	8.1	13.9	5.6	7.7	4.5	3.8	12.7	8.0	4.2	10.5	3.1	5.8	14.8	1.7	0.8	15.6	3.7	3.7	43.5	6.6	1.9	2.8	6.6	6.3	30.1	4.5	6.2	5.0	1.0	6.8	8.2	22.4	11.3	6.9	7.2	3.0	7.4	2.6	5.3	19.1	4.9	4.3	4.8	3.3	7.3	7.2	4.1	15.2	3.0	3.8	8.0	2.1	8.6	0.9	9.9	6.8	4.6	7.4	8.8	6.5	1.8	8.5	4.5	10.7	5.1	3.1	3.7	4.3	10.2	8.3	6.1	2.4	11.0	7.2	0.4	1.8	16.6	5.8	8.3	3.9	2.8	2.3	23.3	0.1	6.4	6.3	13.5	6.2	1.8	9.7	5.8	5.4	3.1	8.2	3.8	4.7	15.8	18.8	4.7	2.9	3.4	5.3	0.2	2.3	0.3	2.4	1.4	1.8	2.2	2.2	1.8	4.4	2.4	3.2	3.0	0.5	1.8	0.1	5.1	2.3	1.7	6.3	5.5	3.9	6.4	5.1	7.8	4.5	3.8	5.8	2.8	4.5	11.3	2.7	0.0	1.7	2.6	17.1	29.1	27.2	11.6	31.9	1.0	10.0	8.0	1.9	8.6	7.6	9.2	0.0	18.5	7.6	7.1	1.9	5.5	11.3	12.9	9.6	4.6	3.0	1.7	5.1	2.4	4.5	7.3	4.6	9.8	5.7	3.2	4.6	12.6	3.6	0.0	7.0	4.3	8.2	2.8	34.7	8.9	3.7	11.2	5.4	11.2	6.7	4.1	7.2	4.0	2.0	2.1	4.7	3.4	11.6	22.0	10.5	8.5	12.7	1.9	6.6	8.6	10.9	28.2	4.8	37.7	38.4	58.0	14.3	4.6	3.7	45.1
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 953.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		590000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	71.5	109.2	196.7	54.5	200.5	64.6	62.4	206.2	245.6	76.0	192.2	74.0	54.0	44.7	103.0	70.6	99.3	62.0	267.2	192.3	203.3	82.6	47.9	57.3	57.4	199.3	191.9	65.0	153.4	160.9	85.2	49.8	200.3	89.2	50.5	26.3	144.0	86.6	432.6	45.8	62.9	78.1	198.8	41.6	61.5	56.9	199.1	68.5	86.7	441.5	40.0	71.8	41.4	216.2	53.6	452.5	225.6	199.1	153.4	266.0	412.8	147.6	170.8	158.8	138.6	165.7	138.0	145.1	142.8	168.6	180.0	155.0	51.2	293.9	50.2	116.9	132.5	45.4	276.8	380.3	177.5	82.6	176.4	322.8	248.7	91.8	109.5	145.8	218.8	93.1	102.9	129.7	257.2	328.2	156.9	176.7	216.0	372.5	206.6	106.5	106.6	196.7	255.6	113.3	137.6	132.8	146.7	155.8	75.1	107.0	127.2	226.4	177.0	390.6	130.8	91.5	166.5	60.5	93.4	94.0	174.3	59.7	235.8	38.2	290.0	31.0	197.6	318.4	170.7	241.3	173.9	184.6	321.8	178.9	126.0	175.8	13.7	196.7	231.7	425.4	223.6	324.1	196.7	200.5	206.2	245.6	192.3	203.3	199.3	191.9	200.3	198.8	199.1	216.2	125.7	96.1	159.8	24.8	111.8	150.3	187.7	659.2	204.9	43.9	223.1	317.7	384.8	178.7	326.5	217.0	22.9	322.1	111.8	337.1	747.4	196.1	271.3	122.2	168.1	111.9	265.1	80.2	8.1	252.4	489.5	213.1	140.6	170.3	123.5	367.4	83.6	201.9	286.5	67.3	12.5	370.9	309.3	97.2	197.1	953.5	205.0	133.6	334.4	5.6	273.2	194.7	146.2	10.6	25.0	185.3	359.8	223.4	187.8	257.5	540.1	817.4	250.6	77.7	85.5	137.1	249.6	141.8	143.8	140.3	161.8	264.1	106.4	352.5	336.0	199.5
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.7;tongue: 57.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.1;Inhibitory neurons: 94.6;Oligodendrocyte precursor cells: 91.5;Oligodendrocytes: 144.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 25.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA012312: AB_2668649"	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (5.53e-2)"	7.9	4.8	3.7	13.1	4.6	12.3	7.1	5.0	6.3	8.7	2.7	6.0	4.0	8.7	5.2	8.6	5.4	10.7	13.0	4.6	3.8	5.7	6.3	7.6	18.1	4.1	3.2	8.2	4.5	26.3	4.6	11.0	3.7	6.7	6.6	7.2	5.0	8.0	112.7	6.8	8.0	11.9	3.9	12.8	4.4	10.0	3.9	9.1	6.5	57.7	17.6	11.7	5.8	7.2	34.6	15.5	20.9	42.6	17.8	19.5	17.3	59.6	54.1	34.9	39.3	26.6	27.3	31.0	4.8	46.4	37.8	27.9	30.1	15.5	49.3	20.9	24.0	12.7	16.7	7.8	19.3	16.9	33.5	11.6	14.5	20.4	30.4	22.4	12.6	17.1	21.0	53.1	37.7	21.7	14.0	10.9	18.9	9.6	18.2	13.8	42.3	25.4	9.6	45.9	20.0	27.9	33.4	37.5	21.9	30.5	39.7	13.0	12.9	59.7	31.9	34.0	35.5	24.9	31.1	38.3	18.9	26.7	52.5	14.1	2.7	4.6	1.8	11.7	3.7	8.2	5.6	1.7	2.8	5.3	1.7	1.8	1.6	5.1	25.4	1.2	8.2	2.7	3.7	4.6	5.0	6.3	4.6	3.8	4.1	3.2	3.7	3.9	3.9	7.2	12.8	6.4	15.2	31.6	54.0	15.9	20.9	9.0	21.1	8.7	13.2	10.0	23.8	14.3	10.8	7.3	12.5	13.7	18.4	8.9	0.0	4.4	27.4	8.1	20.9	9.6	5.4	8.4	109.1	6.7	8.6	18.3	7.7	12.5	39.2	26.7	18.9	5.7	11.7	3.3	94.6	6.6	22.4	32.7	32.6	4.5	12.2	39.7	10.6	47.8	11.1	4.7	10.3	91.5	144.4	5.7	5.6	13.5	34.8	9.0	2.3	2.2	9.7	9.0	13.1	15.1	15.3	47.6	39.2	14.4	17.8	14.8	54.2	14.7	4.8	21.5
PHYHIPL	"Em:AC025038.1, KIAA1796"	ENSG00000165443	"Phytanoyl-CoA 2-hydroxylase interacting protein like"	Q96FC7	10	59176643-59247774	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 18.4;brain: 45.5;retina: 30.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 210.6;Early spermatids: 208.4;Horizontal cells: 144.7;Inhibitory neurons: 170.2;Late spermatids: 241.4;Muller glia cells: 246.1;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 357.1"	"Group enriched"	"Detected in many"	5	"glioma: 21.1;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.3;Hep G2: 34.3;SCLC-21H: 6.1;SH-SY5Y: 19.4;SK-BR-3: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038746	Uncertain		Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA038746: AB_10673293"	"unprognostic (6.34e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.60e-7)"	"unprognostic (1.29e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	0.3	18.4	22.5	0.4	30.1	0.0	0.4	31.6	36.9	1.6	0.3	2.1	8.5	0.7	1.8	0.3	1.1	0.1	0.3	21.2	36.1	11.0	1.1	0.2	0.0	41.3	32.1	0.8	5.4	0.0	6.7	1.8	32.8	2.8	0.3	30.5	0.7	2.6	0.6	0.3	8.9	0.1	42.4	0.1	0.6	6.5	26.2	0.0	0.2	0.0	0.0	0.1	1.2	45.5	0.0	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	19.4	0.0	8.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	30.1	31.6	36.9	21.2	36.1	41.3	32.1	32.8	42.4	26.2	45.5	3.1	0.0	0.0	210.6	0.0	0.0	14.0	0.0	0.0	135.2	0.2	1.0	0.5	2.8	0.0	3.7	12.5	1.0	0.0	0.1	13.7	0.6	208.4	24.1	8.0	1.6	0.0	2.7	97.3	6.5	0.3	1.2	0.0	71.9	0.0	0.8	0.7	1.8	0.5	144.7	170.2	3.0	0.0	0.0	0.0	241.4	13.1	1.3	1.8	11.2	0.0	246.1	0.0	264.9	357.1	1.7	6.3	0.4	0.0	4.0	24.0	80.3	0.0	53.9	0.0	3.0	2.4	137.1	27.2	0.1	0.0	49.0	0.6	0.3	9.6	2.8
PI15	P25TI	ENSG00000137558	"Peptidase inhibitor 15"	O43692	8	74824534-74855029	"Predicted secreted proteins"		"Developmental protein, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.4;prostate: 31.0;smooth muscle: 49.9"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 36.8;Breast glandular cells: 73.2;Breast myoepithelial cells: 13.6;Prostatic glandular cells: 19.3;Smooth muscle cells: 36.2;Urothelial cells: 15.7"	"Group enriched"	"Detected in many"	7	"breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 23.3;SH-SY5Y: 21.3;SK-MEL-30: 30.0;U-266/70: 7.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"spinal cord: 6.3"	"HPA006593, HPA030057"	Uncertain		Approved	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Cytosol	"HPA006593: AB_1078568, HPA030057: AB_10602143"	"unprognostic (2.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.63e-14)"	"unprognostic (2.54e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	5.8	1.1	0.6	54.4	0.8	0.0	22.1	0.1	1.6	11.0	0.0	7.8	0.2	19.8	2.1	2.5	20.9	1.5	1.8	0.9	0.9	0.9	0.2	2.2	0.6	0.7	0.8	6.3	0.3	0.0	0.5	0.3	0.4	31.0	4.6	0.6	2.0	6.8	0.4	0.4	4.6	49.9	1.1	1.3	0.7	0.5	2.4	0.4	0.6	0.2	0.2	8.3	6.5	0.6	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.1	21.3	0.0	0.1	30.0	0.4	0.5	0.5	0.0	0.0	0.5	0.0	0.1	7.9	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.1	1.6	0.9	0.9	0.7	0.8	0.4	1.1	2.4	0.6	0.2	0.0	0.0	2.3	0.1	0.1	36.8	0.0	0.6	0.2	73.2	13.6	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.6	0.2	9.1	2.5	0.0	0.0	4.3	0.0	0.4	3.9	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.6	1.9	0.9	0.2	3.6	1.0	0.0	0.0	0.0	0.5	2.0	0.0	0.0	0.0	0.1	19.3	0.0	0.1	0.0	0.5	0.0	1.7	36.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.0	15.7
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11149569	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 58.3"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BJ hTERT+ SV40 Large T+: 16.9;BJ hTERT+ SV40 Large T+ RasG12V: 23.1;HeLa: 38.1;U-266/70: 23.0;U-698: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015986, HPA031974, HPA040616"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	1.2	0.5	7.3	1.3	20.2	0.4	1.7	14.7	14.4	1.0	0.1	3.9	0.3	0.6	1.6	5.1	1.1	5.3	0.3	7.9	8.7	1.1	4.1	6.6	0.9	18.2	14.4	0.7	1.8	0.5	0.9	0.0	18.2	3.0	1.4	0.1	0.3	2.9	0.1	1.1	1.1	2.1	8.5	2.7	1.6	1.2	16.8	0.8	1.5	0.2	0.6	5.3	0.7	58.3	0.0	1.8	15.1	0.0	0.0	0.0	0.0	0.8	4.4	16.9	23.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	10.6	0.0	0.5	0.0	38.1	8.8	5.2	0.0	0.1	0.1	0.3	4.3	1.2	0.1	5.2	0.6	0.0	0.3	2.7	0.0	0.3	0.0	4.5	6.7	0.0	0.0	0.0	7.0	0.0	5.3	12.7	0.0	0.1	0.0	0.8	6.7	0.0	4.5	0.0	0.0	5.8	0.3	0.9	23.0	0.2	16.2	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	20.2	14.7	14.4	7.9	8.7	18.2	14.4	18.2	8.5	16.8	58.3	3.3	0.0	5.3	2.0	0.0	0.8	0.3	0.0	0.0	0.0	2.3	0.8	1.6	10.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	31.7	0.2	0.2	9.9	0.0	0.0	2.5	0.2	0.0	11.2	2.6	0.0	5.1	0.1	17.2	5.9	1.0	0.0	37.0	0.0	0.0	3.2	0.8	11.9	0.0	0.6	0.0	9.4	0.0	0.0	0.0	2.0	399.6	0.1	0.0	0.0	0.4	0.1	0.0	0.1	7.3	0.0	6.6	0.9	4.5	0.3	1.4	0.2	0.9	0.4	0.6	32.9	0.0	0.1
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.57e-4)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	9.6	8.6	8.0	6.3	8.4	5.6	10.1	9.7	10.4	8.6	8.5	8.8	10.6	8.3	11.8	8.1	8.9	6.1	5.6	7.8	8.5	9.0	14.3	7.7	7.8	7.8	7.8	10.4	10.2	6.1	10.4	6.3	8.2	9.8	8.4	6.3	8.2	6.1	5.3	11.4	10.1	5.9	7.6	7.8	10.5	8.7	8.2	6.4	10.1	3.3	8.3	7.8	8.1	9.4	12.5	16.3	11.4	9.3	16.0	15.2	4.6	6.3	8.0	10.8	19.5	17.2	15.4	6.6	13.7	6.7	6.9	17.4	14.7	8.2	15.0	13.1	38.3	12.3	13.6	21.9	17.3	5.0	7.4	12.5	20.3	19.1	22.0	10.9	13.0	20.1	14.6	7.3	8.6	11.1	9.3	11.6	4.5	25.2	8.3	9.0	9.7	15.6	12.3	6.6	6.0	8.5	6.7	4.9	14.6	29.9	5.4	4.5	7.6	9.1	6.0	6.6	19.8	5.5	0.2	10.3	12.2	12.5	6.2	0.0	2.7	4.7	4.6	2.6	4.1	3.7	6.3	3.7	2.0	2.8	6.4	5.5	0.0	4.8	1.8	5.3	5.4	2.5	8.0	8.4	9.7	10.4	7.8	8.5	7.8	7.8	8.2	7.6	8.2	9.4	8.5	9.6	21.0	19.2	10.0	4.5	9.2	9.1	11.4	11.5	9.8	9.8	2.4	7.2	13.0	12.9	10.4	15.6	9.3	7.3	5.9	6.3	3.0	7.7	11.4	6.6	7.8	11.6	46.7	7.5	8.0	8.8	11.7	6.9	5.1	14.0	5.0	10.5	5.2	6.7	45.3	11.2	10.2	3.5	4.3	2.9	7.8	5.9	3.6	26.2	3.6	5.2	9.2	24.6	34.9	9.4	9.7	11.3	12.2	8.3	9.8	5.9	10.6	12.2	0.0	9.1	7.3	16.1	8.3	7.5	6.0	9.6	11.8	9.4	12.6	10.4
PIGU	"bA346K17.2, CDC91L1, GAB1"	ENSG00000101464	"Phosphatidylinositol glycan anchor biosynthesis class U"	Q9H490	20	34560542-34698790	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041706, HPA046766"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA041706: AB_2677627, HPA046766: AB_2679794"	"unprognostic (1.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-3)"	"unprognostic (7.94e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.86e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.27e-2)"	"unprognostic (4.21e-3)"	11.0	14.8	20.8	9.7	25.3	10.6	13.5	23.4	25.3	13.6	18.0	20.0	12.2	16.3	19.8	18.6	25.1	11.4	16.2	21.2	22.0	16.0	13.8	10.3	11.8	24.5	22.5	20.9	11.5	28.9	14.3	15.9	24.7	12.3	22.3	16.5	12.3	13.5	16.2	12.9	13.3	17.6	23.3	9.6	10.9	19.1	22.7	14.7	13.2	20.5	15.8	14.2	13.8	31.7	30.2	37.2	47.0	34.4	30.0	36.1	46.8	30.0	35.8	50.3	43.9	69.3	61.9	38.4	48.0	30.0	65.1	54.5	43.1	57.0	50.6	16.5	23.2	87.3	22.6	78.9	27.9	53.4	20.0	32.1	36.2	28.9	32.8	23.2	36.7	37.9	44.4	33.4	43.0	33.5	45.6	54.0	23.7	68.8	55.9	32.7	58.5	61.8	44.5	27.4	30.0	28.2	56.6	101.0	38.0	26.0	55.8	37.1	21.7	82.0	29.1	44.8	30.8	22.2	33.3	25.4	49.9	54.8	36.0	14.0	5.6	2.4	16.2	8.4	14.4	10.7	14.5	17.8	13.6	12.6	14.4	14.5	1.0	16.7	6.8	13.2	14.1	8.8	20.8	25.3	23.4	25.3	21.2	22.0	24.5	22.5	24.7	23.3	22.7	31.7	5.2	9.6	4.8	26.8	6.4	4.5	11.8	32.7	7.4	8.9	4.9	4.7	6.6	8.6	21.6	11.0	16.7	40.1	5.7	15.4	1.9	19.2	17.8	14.4	7.2	9.1	10.2	9.1	30.4	17.6	29.3	10.1	4.6	11.5	8.2	19.5	7.1	8.5	15.8	1.7	39.0	15.3	22.4	6.5	2.2	16.7	5.6	4.7	1.8	16.9	5.7	8.5	5.2	46.3	78.5	10.4	19.0	7.9	7.6	10.6	9.0	9.2	28.5	9.5	19.7	8.3	13.7	34.6	12.8	9.5	5.8	21.2	6.8	9.8	24.3	8.7
PIGV	FLJ20477	ENSG00000060642	"Phosphatidylinositol glycan anchor biosynthesis class V"	Q9NUD9	1	26787054-26800659	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.8;Late spermatids: 96.0;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054181			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA054181: "	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (7.60e-7)"	"unprognostic (1.71e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (5.96e-3)"	6.6	13.9	4.6	3.4	5.3	3.0	7.6	5.1	4.8	9.5	4.1	8.1	6.5	8.1	13.8	9.0	10.2	6.2	4.4	4.2	4.7	10.9	24.1	6.2	4.2	6.1	5.2	7.9	10.3	13.9	10.0	6.2	5.5	8.4	8.4	3.7	10.0	8.0	4.4	11.3	7.3	6.7	5.2	6.9	8.9	30.0	5.1	6.7	10.6	4.8	6.4	8.5	8.3	5.4	10.6	4.4	4.1	4.7	7.3	10.8	5.8	6.7	14.0	7.6	7.9	2.3	25.9	6.7	7.3	7.7	8.2	20.3	4.2	8.6	8.6	11.5	2.5	5.6	5.1	5.1	10.3	7.7	10.0	11.8	43.8	9.8	12.2	12.0	5.1	9.4	10.0	12.2	14.0	3.9	3.7	3.0	9.9	20.9	3.0	3.8	6.2	15.0	11.0	1.0	7.6	3.9	9.2	4.3	8.7	9.8	14.1	6.5	8.1	10.8	6.5	6.0	1.8	3.8	2.2	2.9	10.7	10.0	8.2	33.1	14.1	11.0	14.0	13.0	21.1	8.8	9.9	14.4	12.5	8.8	10.2	12.4	14.2	21.5	18.5	4.5	9.7	10.8	4.6	5.3	5.1	4.8	4.2	4.7	6.1	5.2	5.5	5.2	5.1	5.4	5.2	3.2	6.0	7.5	6.0	4.2	11.0	27.5	6.2	3.3	10.0	7.6	1.9	4.3	12.7	7.3	8.4	27.4	10.6	5.0	7.9	7.2	50.8	6.7	4.7	4.6	3.5	13.5	2.8	4.6	14.8	8.8	6.1	6.4	0.0	6.8	6.4	16.6	9.2	8.4	3.2	6.5	12.2	5.2	3.2	96.0	7.2	4.2	7.2	2.8	8.2	11.1	7.2	0.0	5.5	4.9	4.8	9.8	6.5	7.6	12.1	10.2	16.3	2.7	0.0	5.7	4.9	80.8	15.1	7.3	4.1	14.1	8.2	12.1	9.2	8.4
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 87.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 87.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029409, HPA073301"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029409: AB_10610280, HPA073301: "	"unprognostic (8.83e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	10.5	10.3	14.4	10.4	15.6	9.0	9.9	14.7	16.7	7.5	19.5	10.8	9.1	8.3	12.4	10.3	7.9	8.3	9.6	15.2	16.7	12.2	8.2	7.2	7.1	15.1	15.8	6.8	9.0	19.6	12.7	8.3	14.8	12.8	10.1	17.4	9.9	10.5	17.1	10.4	9.1	11.2	16.0	6.8	7.6	6.0	16.2	11.6	9.2	14.1	10.9	8.7	7.6	16.7	39.4	18.7	21.4	18.1	22.7	15.3	12.6	18.1	20.7	19.3	20.5	13.7	25.6	20.3	63.6	15.4	25.1	22.2	19.5	16.6	23.1	18.6	19.6	21.0	12.8	12.6	19.2	20.6	34.6	15.1	25.7	17.1	15.7	16.3	12.7	36.5	11.7	38.6	21.0	30.1	59.2	32.1	12.8	30.7	18.3	31.1	27.6	29.5	24.6	11.5	24.4	29.2	31.8	23.9	29.7	16.9	71.8	20.3	8.2	18.1	9.2	25.6	29.5	57.0	70.4	41.1	20.7	26.9	21.5	39.6	7.5	87.5	3.3	10.8	3.0	4.6	3.1	4.6	7.7	5.5	3.7	3.2	18.8	8.7	11.6	3.3	4.4	4.1	14.4	15.6	14.7	16.7	15.2	16.7	15.1	15.8	14.8	16.0	16.2	16.7	14.2	19.2	16.3	13.7	16.4	17.1	30.1	5.5	31.9	34.9	28.3	19.2	12.6	21.5	8.4	29.5	47.9	21.4	31.6	20.8	35.2	7.9	30.5	17.2	23.5	16.9	15.7	15.8	17.7	5.6	20.9	22.0	9.2	17.9	12.0	19.3	17.5	16.6	20.1	33.7	23.7	17.0	8.2	21.4	25.4	22.7	28.0	18.1	21.4	15.9	25.0	50.0	32.0	12.1	14.5	5.2	12.5	35.0	20.1	33.8	27.1	32.5	10.2	39.1	26.3	23.6	28.1	27.1	36.0	29.3	15.9	11.6	21.2	22.7	25.7	23.0
PIH1D1	"FLJ20643, MOT48, NOP17, Pih1"	ENSG00000104872	"PIH1 domain containing 1"	Q9NWS0	19	49446298-49453497	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047258	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA047258: AB_10964561"	"unprognostic (2.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	38.0	37.1	31.4	26.8	32.0	34.5	37.1	31.5	39.5	38.0	33.8	40.4	43.5	32.4	13.2	45.0	39.7	27.0	31.5	33.0	31.8	41.4	47.7	30.5	43.6	31.7	30.9	29.9	39.7	50.4	34.5	33.1	32.0	39.6	29.5	11.8	49.5	33.8	67.5	45.3	37.2	26.3	31.9	39.4	41.3	17.8	33.1	46.1	37.1	57.6	36.1	33.0	39.4	31.8	133.6	67.0	84.6	130.3	40.1	37.2	54.0	52.9	68.8	79.8	122.3	72.4	89.6	89.1	48.6	56.7	20.0	79.9	44.8	96.6	46.2	85.5	85.1	79.9	89.6	93.0	63.1	86.7	115.3	43.5	40.4	59.0	55.8	74.8	74.8	79.2	119.5	76.8	50.5	59.9	98.4	173.3	101.1	118.4	63.2	83.1	93.6	90.4	65.1	107.2	109.2	158.0	54.3	91.2	53.2	41.1	44.0	104.3	44.9	66.9	52.0	26.9	84.2	205.5	172.8	49.8	36.6	93.6	47.5	166.8	104.5	121.0	88.3	104.0	75.6	116.1	98.8	94.9	105.1	110.1	79.5	73.4	11.8	103.7	108.7	100.2	158.3	107.0	31.4	32.0	31.5	39.5	33.0	31.8	31.7	30.9	32.0	31.9	33.1	31.8	45.5	38.5	36.6	10.7	54.8	55.8	61.9	80.2	59.7	20.9	46.8	50.0	11.2	41.5	46.4	20.2	18.8	101.7	48.8	48.6	62.6	74.1	18.1	47.4	24.1	39.2	57.5	33.4	10.5	46.3	116.5	59.9	43.8	30.6	52.6	30.8	35.3	44.3	71.2	23.5	8.5	63.9	38.7	40.8	55.7	9.9	62.4	40.7	64.0	11.2	59.0	55.0	40.2	10.1	10.9	47.3	75.4	47.0	60.3	65.6	90.2	115.9	59.4	22.6	26.3	44.5	46.8	40.6	29.9	49.0	67.1	94.0	50.4	48.2	59.4	66.2
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593315-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 83.2;lymphoid tissue: 62.3;salivary gland: 73.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;Hepatocytes: 70.7;Kupffer cells: 127.0;Macrophages: 89.8;Microglial cells: 60.9;monocytes: 57.4;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 44.7;memory B-cell: 48.3;naive B-cell: 44.5;non-classical monocyte: 123.0"	"Group enriched"	"Detected in all"	6	"B-cells: 48.3;monocytes: 123.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;NB-4: 62.1;REH: 183.5;THP-1: 92.9;U-698: 114.7;U-937: 95.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	8.1	4.5	2.1	51.1	2.0	47.5	4.7	2.4	3.2	2.8	2.7	7.3	6.8	2.1	1.7	2.4	2.2	24.8	2.5	1.9	2.9	11.8	83.2	16.7	61.2	6.5	4.6	6.0	22.8	2.0	1.4	14.1	5.3	2.8	8.6	3.1	73.6	2.4	0.7	1.0	7.7	8.3	4.7	62.3	6.9	3.0	5.7	8.7	4.1	3.1	57.8	15.2	0.6	7.6	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.2	2.8	1.5	85.3	8.5	0.0	1.3	0.1	17.7	0.0	0.6	48.0	3.0	13.0	0.0	1.7	0.1	36.1	6.7	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.9	0.1	0.1	0.4	1.1	62.1	0.8	24.3	1.0	183.5	4.3	20.0	0.2	0.1	3.6	2.0	0.2	0.2	1.1	0.3	0.2	92.9	0.0	0.0	2.8	0.1	0.7	0.7	0.2	114.7	0.0	95.2	0.0	6.1	16.0	10.5	13.3	44.7	4.7	48.3	0.3	4.1	12.9	44.5	0.1	3.3	13.5	14.0	123.0	11.3	0.5	14.4	2.1	2.0	2.4	3.2	1.9	2.9	6.5	4.6	5.3	4.7	5.7	7.6	0.5	3.2	3.9	1.3	53.7	1.5	0.1	0.1	0.6	0.6	2.2	2.3	2.6	32.9	2.2	1.8	2.1	0.5	41.5	8.1	1.9	40.0	4.3	0.3	0.1	1.8	1.8	10.3	0.8	29.1	0.9	0.7	0.0	0.2	14.0	0.2	5.7	70.7	47.7	0.0	0.8	2.8	4.1	127.0	32.5	1.0	1.2	89.8	5.4	60.9	57.4	0.2	58.7	1.0	0.3	16.4	21.2	2.2	9.4	0.4	1.6	18.3	1.1	3.4	0.0	0.6	0.8	0.8	0.2	0.3	1.1	2.3	18.3	0.4	3.8	0.3
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 70.3;RT4: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.0	3.6	10.4	15.2	23.6	5.0	9.7	8.5	23.3	7.4	0.0	15.8	14.4	8.4	4.8	12.9	6.5	8.0	10.6	11.2	18.8	10.2	4.9	17.2	23.4	19.2	20.4	3.0	5.2	3.2	3.3	12.8	17.1	6.2	12.9	2.9	7.2	5.4	20.9	21.2	14.9	9.9	7.3	13.6	18.9	1.9	28.0	22.3	8.1	10.8	22.1	10.9	10.7	44.2	7.5	14.8	12.9	11.9	7.4	0.6	70.3	0.9	2.9	2.8	2.1	8.8	19.2	12.7	2.7	1.7	2.5	18.3	7.7	5.2	1.1	7.7	2.1	0.3	30.1	3.3	0.4	4.5	9.3	0.9	5.4	0.7	0.4	1.1	19.1	12.6	4.7	8.3	0.2	16.7	15.4	12.8	11.8	29.3	9.3	16.6	3.3	2.4	3.5	75.6	14.1	7.8	26.0	35.9	8.4	4.7	16.1	2.4	0.7	0.4	4.5	1.3	0.2	8.9	2.6	16.4	0.5	6.7	1.9	0.0	0.1	0.0	0.5	0.0	0.5	1.5	0.6	0.4	0.1	3.2	0.3	0.3	0.2	0.8	0.0	0.0	1.2	0.2	10.4	23.6	8.5	23.3	11.2	18.8	19.2	20.4	17.1	7.3	28.0	44.2	26.7	0.0	12.2	16.0	15.3	3.8	2.1	7.9	1.2	16.6	5.3	4.4	6.9	5.7	6.9	3.7	0.0	4.4	3.3	29.2	0.0	1.8	0.6	2.0	2.5	26.1	9.6	0.0	14.3	3.4	4.4	4.5	28.5	2.4	32.4	8.5	31.1	5.5	4.2	15.2	22.8	23.8	2.0	1.6	5.1	0.7	1.2	2.9	3.6	27.2	2.3	2.7	4.1	23.6	111.5	4.7	14.5	7.5	4.9	2.4	14.6	2.1	9.1	1.0	0.0	7.7	3.3	0.1	1.5	8.1	8.0	2.2	5.0	9.4	15.5	13.8
PIK3R1	"GRB1, p85, p85-ALPHA"	ENSG00000145675	"Phosphoinositide-3-kinase regulatory subunit 1"	P27986	5	68215756-68301821	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Protein transport, Stress response, Transport"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 410.2;Endometrial stromal cells: 479.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 265.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001216, CAB004268"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB004268: AB_628126, HPA001216: AB_1079612"	"unprognostic (5.74e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (8.09e-4)"	"unprognostic (3.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.59e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.54e-1)"	60.6	27.3	13.6	27.8	33.3	126.4	92.1	12.5	40.8	51.2	0.6	38.2	17.2	65.8	45.0	43.2	69.0	35.0	72.3	29.9	13.0	35.9	100.8	26.7	28.5	11.2	22.1	53.3	13.4	40.2	7.3	32.4	12.0	26.7	22.2	59.9	64.5	31.9	63.5	28.7	24.5	74.8	9.9	38.1	18.3	8.6	20.3	46.5	20.6	33.9	23.7	27.0	31.7	36.0	4.3	8.2	23.8	71.4	265.5	76.9	10.4	23.2	10.6	8.8	9.4	20.4	7.4	21.8	38.5	32.0	4.3	10.2	6.7	46.9	11.0	90.6	8.9	26.1	6.5	17.0	89.2	27.0	20.1	81.9	104.2	16.1	83.6	4.1	11.7	25.0	4.1	16.1	8.1	11.3	65.7	10.5	6.9	14.7	4.3	61.1	11.3	17.0	11.5	47.9	4.7	21.3	4.0	6.3	15.0	13.7	34.3	19.0	14.0	10.3	10.4	17.3	14.8	18.0	29.2	25.2	11.1	32.9	7.8	22.0	1.7	8.8	11.5	2.4	16.6	1.7	14.9	11.1	3.0	3.9	18.6	14.1	2.2	11.7	6.5	1.2	12.3	5.5	13.6	33.3	12.5	40.8	29.9	13.0	11.2	22.1	12.0	9.9	20.3	36.0	47.7	51.3	24.8	112.3	47.7	14.4	23.5	30.8	175.2	46.0	61.4	168.4	263.0	38.6	19.3	5.5	25.0	13.4	410.2	28.4	72.4	15.8	12.6	38.7	479.9	39.0	9.6	43.5	232.8	9.5	18.5	151.0	43.8	93.2	68.9	110.4	31.1	198.3	30.7	48.8	82.7	32.6	28.5	69.2	24.7	11.9	172.1	68.8	33.8	117.1	37.6	194.1	137.0	281.5	199.9	12.3	19.8	122.2	173.2	8.4	24.3	39.1	8.7	89.4	19.7	127.2	76.5	1.7	4.5	37.2	10.2	10.0	309.9	45.4	36.5	8.1
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802722-8867677	"Metabolic proteins, Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 21.9;eosinophil: 75.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 75.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 148.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	0.4	0.0	1.1	1.8	1.6	2.2	0.4	0.9	1.1	0.6	0.8	0.8	1.5	0.9	0.1	0.5	0.2	1.2	1.3	1.0	1.1	0.0	0.3	1.2	2.1	1.4	1.5	0.0	0.4	0.1	0.0	0.6	1.6	0.3	0.6	0.0	0.2	0.3	0.5	0.8	2.2	0.7	1.1	2.9	1.0	0.4	1.9	2.1	0.0	0.3	1.5	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	19.4	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	2.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	21.9	7.2	75.8	0.5	9.6	0.4	2.7	0.1	0.3	10.8	0.3	0.1	0.2	1.1	1.5	7.8	0.0	0.0	3.3	1.1	1.6	0.9	1.1	1.0	1.1	1.4	1.5	1.6	1.1	1.9	1.6	0.2	0.0	1.3	0.3	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	11.5	0.0	0.1	2.6	0.0	0.4	0.6	0.0	0.1	0.2	0.5	0.0	47.4	0.0	0.4	0.0	7.6	0.0	0.5	0.0	0.0	4.4	1.6	20.6	0.0	3.9	1.8	7.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	1.6	0.1	0.0	0.0
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.3;intestine: 87.6;lymphoid tissue: 163.9"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 738.8"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"HDLM-2: 567.6;Karpas-707: 675.0;RPMI-8226: 703.9;U-266/70: 1218.7;U-266/84: 1160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favorable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	7.9	7.1	10.9	85.4	11.4	102.3	8.8	9.6	12.3	6.1	11.1	40.8	87.6	5.1	10.1	8.2	11.9	16.7	5.2	15.4	12.4	9.8	10.4	23.5	114.3	9.7	10.7	10.3	4.7	3.8	10.1	4.9	11.7	7.4	50.9	5.6	36.4	7.3	2.5	6.3	46.4	6.9	10.3	163.9	45.1	10.1	13.5	45.5	10.1	2.7	104.7	45.6	6.4	8.8	17.5	14.8	8.0	15.4	2.8	2.0	11.7	10.5	13.1	14.8	13.2	13.3	12.9	74.5	4.8	5.3	5.6	10.6	25.1	10.0	14.1	567.6	19.6	90.8	15.0	13.9	6.2	21.7	58.7	5.9	8.4	15.3	9.2	12.1	5.5	9.8	97.8	675.0	8.4	12.6	8.4	45.2	165.2	6.1	22.7	9.9	5.4	703.9	14.9	2.6	5.4	7.8	11.5	8.0	8.3	36.9	19.3	29.8	3.6	3.5	2.5	3.1	10.6	1218.7	1160.5	144.1	14.0	19.0	3.7	279.1	8.2	77.7	60.4	9.7	102.3	124.8	165.9	85.6	13.2	73.5	172.4	113.3	195.5	92.7	17.4	15.2	331.9	79.0	10.9	11.4	9.6	12.3	15.4	12.4	9.7	10.7	11.7	10.3	13.5	8.8	2.9	12.8	36.0	1.0	161.6	20.3	9.0	7.1	45.5	2.6	16.2	4.7	3.5	2.8	9.9	3.7	2.1	5.8	46.8	5.7	3.9	3.3	1.9	15.6	1.0	5.3	13.1	49.9	2.3	3.5	9.1	5.1	10.7	3.9	23.4	1.3	4.2	6.3	7.2	11.8	2.2	7.5	18.3	7.5	123.1	1.8	1.8	19.8	94.3	0.0	99.5	2.2	38.1	0.5	1.0	2.0	3.7	4.1	738.8	4.6	4.1	6.8	16.3	2.1	0.0	3.8	6.2	2.2	1.6	15.7	13.8	2.5	97.1	8.6	11.8	3.4
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700468	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"U-2197: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	22.1	15.6	30.7	11.5	36.6	3.4	19.2	19.4	66.4	24.0	0.0	62.2	8.6	44.9	7.6	20.3	29.8	8.2	32.2	40.2	5.0	15.8	8.7	22.6	6.5	13.3	7.7	22.2	18.0	10.7	20.6	11.2	12.9	33.9	4.5	13.2	18.1	25.1	17.7	16.0	24.1	16.0	0.0	22.4	29.7	61.4	19.5	5.3	21.1	4.8	4.2	39.4	24.7	33.2	18.9	18.0	13.4	18.0	25.5	21.0	20.3	36.1	22.4	15.2	12.3	16.1	5.2	7.8	13.6	39.0	16.5	16.4	6.5	11.7	6.2	28.7	11.9	9.0	15.0	13.1	22.0	9.4	26.7	23.7	9.9	12.4	4.1	9.9	25.6	11.5	14.1	13.5	14.4	15.7	11.2	6.6	14.4	6.8	24.6	21.4	7.2	11.2	11.5	15.9	13.7	12.0	18.7	10.1	11.1	16.6	7.9	14.1	57.3	21.3	11.8	75.1	17.0	16.0	14.3	3.5	27.6	19.2	15.0	1.0	0.7	0.0	0.7	0.5	0.2	0.6	0.5	0.4	0.8	0.3	0.2	0.4	0.5	0.5	0.8	0.5	0.4	0.6	30.7	36.6	19.4	66.4	40.2	5.0	13.3	7.7	12.9	0.0	19.5	33.2	20.3	6.4	5.0	8.8	6.2	5.4	3.0	6.1	7.4	56.8	9.6	6.6	7.5	7.2	3.0	16.5	37.5	7.8	10.6	12.2	1.9	7.9	11.6	6.4	29.0	22.1	8.4	2.1	30.6	7.1	7.4	10.7	7.1	11.6	1.3	10.7	16.1	4.0	15.7	30.3	17.9	9.7	6.1	19.6	13.2	24.0	14.9	15.5	5.4	22.5	15.0	14.3	11.3	9.0	6.8	12.1	13.2	24.0	5.7	4.4	7.2	6.4	4.1	26.8	13.1	8.4	10.4	18.6	11.8	7.8	6.8	16.4	8.0	11.9	7.2	5.3
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"	"Cataract, Deafness, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 223.5;Syncytiotrophoblasts: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 80.7"					"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.27e-5)"	34.1	13.7	6.7	12.2	6.3	18.7	16.0	14.3	9.8	7.4	7.5	8.9	8.8	10.1	4.8	7.3	10.8	7.1	7.3	6.1	7.5	18.9	6.3	14.7	8.4	7.0	6.0	7.6	9.2	5.0	12.6	19.9	6.8	9.0	2.0	3.5	7.5	5.3	5.3	7.8	7.8	3.2	3.8	18.0	8.2	20.3	7.2	3.8	11.5	3.2	4.3	7.3	7.1	5.1	21.7	19.7	5.8	5.8	17.3	6.6	13.2	17.4	13.6	11.9	12.9	28.6	6.6	12.9	18.0	8.8	15.8	24.0	7.9	15.5	1.9	14.4	16.9	13.5	12.8	23.7	35.9	28.7	34.2	12.4	8.5	21.2	9.1	4.9	10.6	9.0	40.3	7.6	6.9	80.7	12.5	12.4	5.7	14.2	8.1	17.4	6.5	13.0	7.6	18.9	14.2	8.4	10.1	31.8	11.0	4.7	26.5	15.5	21.0	14.9	17.7	9.6	16.3	8.9	13.3	16.2	14.2	19.0	12.1	24.1	21.7	16.1	10.6	15.8	10.3	11.9	7.7	9.0	18.3	11.9	10.3	8.6	47.0	10.4	8.7	8.9	8.2	13.8	6.7	6.3	14.3	9.8	6.1	7.5	7.0	6.0	6.8	3.8	7.2	5.1	11.1	16.0	15.6	17.3	12.4	25.6	34.7	31.5	38.7	26.0	18.6	12.6	55.5	12.8	31.1	42.3	20.9	223.5	12.9	12.0	11.7	33.2	60.0	36.2	17.9	19.6	20.9	32.4	40.3	16.8	25.9	13.6	17.3	87.3	18.3	13.2	8.9	7.5	36.4	18.5	35.5	12.9	22.4	36.4	12.7	81.9	9.6	19.8	3.6	9.4	27.1	11.8	24.7	16.1	19.9	15.9	8.4	7.2	11.4	52.1	12.3	13.9	10.9	25.8	19.7	4.9	11.1	25.0	17.9	27.7	21.3	245.0	11.8	8.3	14.2	43.5
PITPNA	"PITPN, VIB1A"	ENSG00000174238	"Phosphatidylinositol transfer protein alpha"	Q00169	17	1517718-1562792	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000528	Uncertain		Approved	Vesicles,Cytosol		NA	NA		190000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (1.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (7.88e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (1.80e-6)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.81e-3)"	42.5	36.8	41.7	61.0	45.4	93.6	41.7	46.6	56.2	50.7	51.0	47.2	56.7	55.3	58.8	76.6	65.9	45.4	39.1	43.8	50.5	40.0	39.0	46.9	40.4	62.4	45.4	32.1	33.9	60.8	33.1	50.2	58.4	54.2	55.6	47.6	84.1	61.7	24.7	93.2	88.9	54.3	41.9	42.4	40.5	44.8	52.2	33.2	64.7	22.7	57.1	51.9	41.8	43.0	64.9	70.5	70.5	61.0	72.1	78.8	110.7	68.9	75.8	70.6	50.9	78.7	25.7	81.8	62.4	94.0	45.4	79.5	64.2	68.4	97.0	68.3	69.2	44.7	61.4	37.0	70.6	31.1	51.6	58.9	90.6	70.5	73.1	74.4	118.4	67.1	63.3	44.9	74.8	36.5	80.1	28.5	49.3	103.4	34.1	63.8	27.2	46.9	70.5	73.5	25.2	55.2	83.2	59.1	51.4	70.5	52.2	24.7	113.8	44.8	39.5	126.4	95.5	27.2	49.8	28.8	77.4	47.9	58.4	3.7	2.4	3.2	2.1	2.7	4.0	4.3	3.1	2.8	3.5	3.1	2.9	2.6	8.0	3.7	1.9	2.7	5.2	1.7	41.7	45.4	46.6	56.2	43.8	50.5	62.4	45.4	58.4	41.9	52.2	43.0	29.3	35.3	35.0	28.7	14.1	31.0	17.5	12.0	12.0	36.4	30.0	30.2	23.9	17.2	17.1	25.8	8.4	43.4	26.9	41.2	13.7	16.0	12.0	50.5	48.4	31.4	22.1	15.6	42.4	18.5	47.3	19.1	13.3	36.5	19.0	16.8	34.6	30.2	40.5	40.4	46.3	27.7	10.2	29.9	49.7	16.8	12.5	36.4	19.6	36.5	36.6	40.2	13.4	12.1	16.0	26.0	22.9	21.8	15.7	33.0	78.0	16.3	21.7	18.4	6.6	18.8	45.1	35.8	34.7	37.8	41.8	120.0	14.9	24.7	25.3	27.0
PITPNB	VIB1B	ENSG00000180957	"Phosphatidylinositol transfer protein beta"	P48739	22	27851669-27920134	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000528	Uncertain		Approved	Vesicles,Cytosol		NA	NA		300000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (9.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.64e-1)"	42.2	27.1	27.9	33.3	30.4	21.6	33.0	30.9	34.1	31.7	22.6	53.1	21.9	31.5	28.6	52.5	29.3	35.4	35.8	32.2	31.6	25.2	56.9	32.1	34.6	29.5	31.8	30.0	28.3	24.0	22.5	49.2	30.5	27.5	30.1	18.1	24.7	37.0	21.3	30.3	28.1	44.2	29.1	27.7	35.3	19.4	31.9	33.4	24.8	21.7	41.1	54.2	36.6	30.5	94.1	39.8	71.5	53.8	62.3	74.7	54.5	88.8	77.4	95.5	91.7	63.4	43.1	64.7	46.0	86.0	70.5	96.6	103.0	88.7	133.2	111.1	97.4	66.1	62.0	58.5	66.9	152.5	102.6	67.2	85.0	115.7	119.6	62.9	94.4	44.8	95.3	130.5	88.5	50.0	64.9	74.7	54.4	97.8	52.1	81.6	112.9	95.6	79.1	87.6	83.6	104.7	60.8	72.7	75.7	75.9	39.4	53.7	93.2	94.9	138.9	72.9	94.2	53.0	66.7	125.2	81.6	74.1	82.2	36.0	18.6	18.6	30.9	21.7	34.0	35.2	29.7	32.3	24.9	30.9	28.4	28.0	16.7	27.4	21.2	22.2	40.8	26.0	27.9	30.4	30.9	34.1	32.2	31.6	29.5	31.8	30.5	29.1	31.9	30.5	97.0	28.9	32.4	57.8	44.3	96.0	128.9	40.8	65.4	24.1	37.4	33.4	57.8	35.8	48.4	31.3	14.6	39.7	45.9	26.1	37.2	49.0	21.4	55.4	72.5	62.4	25.2	15.8	51.8	50.2	52.3	65.9	32.6	79.8	21.5	37.0	30.7	45.8	27.3	32.0	45.7	26.7	24.4	23.6	42.2	6.9	32.0	35.1	26.6	68.4	55.6	17.4	48.4	60.8	67.0	66.7	21.1	48.2	54.2	97.5	17.2	29.6	22.8	16.1	26.3	57.9	76.7	44.0	35.4	60.9	82.1	48.6	42.3	46.9	24.0	112.9
PITPNC1	"RDGB-BETA, RDGBB, RDGBB1"	ENSG00000154217	"Phosphatidylinositol transfer protein cytoplasmic 1"	Q9UKF7	17	67377281-67697261	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1255.9;Inhibitory neurons: 330.9;Oligodendrocyte precursor cells: 281.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA026563, HPA031250"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	Nucleoplasm	"HPA026563: AB_1855409, HPA031250: AB_2673808"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.17e-2)"	"prognostic favorable (4.85e-5)"	"unprognostic (6.57e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-2)"	25.7	8.9	27.2	5.6	30.1	3.8	18.6	23.5	26.9	8.7	13.2	7.6	1.5	7.8	3.8	9.8	10.9	3.8	13.3	22.7	31.2	21.8	9.8	15.1	8.8	38.4	41.0	15.2	23.1	1.8	13.7	6.0	28.2	11.9	2.2	15.0	14.1	4.4	5.4	4.9	8.7	3.5	28.7	9.4	12.6	2.5	42.7	8.4	9.0	5.0	7.4	12.0	9.2	20.1	4.2	1.0	4.5	6.8	2.8	5.1	3.9	6.0	2.9	0.8	0.4	0.0	6.4	4.6	1.4	3.6	1.7	2.0	6.7	6.0	1.1	9.3	3.0	0.7	7.6	3.4	0.7	1.4	9.8	3.6	2.2	0.9	2.5	0.5	3.2	6.5	0.3	16.9	2.3	7.0	10.9	2.8	6.6	1.8	7.7	15.2	0.9	4.2	9.7	5.4	4.7	13.0	1.7	3.3	4.1	4.8	3.0	4.7	3.7	1.8	1.0	2.4	2.9	13.2	6.2	3.7	14.4	4.6	1.6	0.7	1.4	10.3	11.1	2.6	5.7	0.5	6.9	9.2	0.9	1.3	8.2	8.3	1.7	5.2	4.1	0.1	2.8	4.1	27.2	30.1	23.5	26.9	22.7	31.2	38.4	41.0	28.2	28.7	42.7	20.1	102.6	9.6	1.1	1255.9	9.6	5.4	55.6	4.6	8.0	15.2	7.7	4.1	6.9	21.5	4.6	0.0	2.1	7.9	84.0	5.8	21.5	43.3	0.2	13.7	5.7	59.8	6.0	4.0	88.4	49.1	13.6	18.9	8.2	30.9	5.1	7.7	21.4	10.1	13.8	74.0	330.9	1.3	4.1	21.4	22.3	1.4	5.0	17.7	10.6	103.0	20.2	34.6	84.5	281.5	9.7	38.7	4.4	14.7	28.0	32.9	0.1	21.2	3.4	21.8	26.3	66.5	25.7	0.4	3.8	9.0	4.3	3.4	75.7	2.7	3.8	54.3
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288149-100330264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;lymphoid tissue: 7.9;retina: 13.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Hofbauer cells: 13.6;Horizontal cells: 60.6;Kupffer cells: 14.4;Late spermatids: 20.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB022621, HPA070002"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB022621: , HPA070002: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.2	0.1	5.4	0.4	5.6	0.9	0.7	4.8	10.8	0.1	4.8	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	4.9	0.3	1.6	2.3	1.5	4.9	5.2	0.1	0.1	0.0	0.1	0.5	5.1	0.3	1.2	13.3	0.1	0.0	0.1	0.0	0.6	0.0	5.0	7.9	0.0	2.3	5.0	0.9	0.0	0.0	1.7	0.2	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	5.4	5.6	4.8	10.8	5.4	4.9	4.9	5.2	5.1	5.0	5.0	5.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	2.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	13.6	60.6	0.4	0.0	0.0	14.4	0.0	20.1	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 42.7;Spermatocytes: 52.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.2;Karpas-707: 2.6;U-266/70: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA041903: AB_2677734, HPA043634: AB_2678591"	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.4	0.9	1.5	0.5	1.7	1.5	0.2	3.2	1.1	0.2	0.3	0.1	0.3	0.3	0.7	0.4	0.3	0.4	1.1	0.8	1.2	0.2	0.1	0.2	0.9	0.7	0.5	0.3	0.8	0.1	0.3	0.2	0.8	0.4	0.2	1.1	0.5	0.0	2.3	0.5	0.2	0.1	0.1	0.7	0.4	8.2	1.1	0.1	0.7	0.8	0.2	0.1	0.2	3.1	0.7	0.5	0.1	0.0	0.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	1.4	1.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.6	2.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.2	1.4	0.7	2.6	0.0	0.2	0.5	1.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.4	0.4	0.6	0.1	0.4	0.3	0.2	0.2	0.2	0.4	0.7	0.2	0.5	2.0	1.6	0.1	1.0	0.2	0.8	5.3	0.9	1.8	1.0	0.6	0.5	1.5	0.8	0.7	0.5	1.9	1.0	0.9	4.1	1.0	0.6	2.0	0.6	0.6	1.5	1.7	3.2	1.1	0.8	1.2	0.7	0.5	0.8	0.1	1.1	3.1	0.6	3.2	2.2	4.6	4.7	2.2	1.8	0.6	7.4	2.4	0.5	0.4	1.7	0.0	0.9	0.0	0.0	0.4	1.6	0.6	0.0	0.1	42.7	1.5	1.3	1.3	0.0	0.8	5.0	0.0	0.2	1.5	0.5	1.8	1.3	0.5	1.4	0.4	0.3	3.3	5.6	0.0	2.0	0.6	1.9	8.2	0.6	1.3	3.6	1.9	0.1	0.9	1.0	3.5	6.1	0.1	0.0	0.4	1.7	1.5	0.1	0.3	0.0	4.1	0.0	3.2	1.1	52.3	3.1	2.6	1.1	0.1	3.1	0.8	0.2	0.8
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 233.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 370.6;naive B-cell: 377.4"	"Lineage enriched"	"Detected in all"	11	"B-cells: 377.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 540.5;HSkMC: 211.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: AB_2685091"	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	90.3	76.6	77.4	59.0	80.0	20.7	74.2	70.9	95.6	105.2	78.0	189.1	30.3	111.4	37.8	76.4	101.7	73.8	289.9	82.7	82.5	104.5	44.5	162.9	49.4	80.9	77.0	57.5	32.3	66.8	69.1	82.3	72.5	102.4	31.5	26.9	45.9	75.3	104.8	31.4	72.2	92.6	73.1	42.7	81.8	68.3	83.4	19.3	68.4	91.1	46.7	169.0	68.9	73.4	27.8	27.9	44.7	28.8	67.0	135.7	6.2	66.0	540.5	73.6	55.4	64.7	12.5	108.3	52.7	58.5	61.2	10.6	9.0	14.4	23.9	54.8	16.3	16.7	4.1	45.7	61.7	2.1	1.1	211.7	28.5	35.8	7.9	36.4	167.5	29.3	13.4	2.6	6.8	35.0	17.2	27.5	23.7	0.2	39.4	2.8	1.2	2.6	40.7	5.5	18.0	58.7	16.9	7.9	45.6	19.3	21.0	13.6	108.5	99.9	44.2	44.8	32.3	13.9	41.9	76.3	49.5	1.9	43.8	2.9	1.8	0.7	1.5	1.7	1.3	370.6	1.9	1.8	9.1	377.4	5.4	8.8	2.2	4.4	1.6	35.8	1.0	17.8	77.4	80.0	70.9	95.6	82.7	82.5	80.9	77.0	72.5	73.1	83.4	73.4	93.3	9.6	6.1	26.8	82.9	25.2	14.4	20.3	10.2	24.6	37.6	45.1	233.6	24.3	15.7	46.0	20.9	15.1	6.2	44.2	127.2	70.6	110.1	104.2	91.5	122.3	44.2	34.9	65.9	30.8	17.8	93.2	5.1	18.5	47.5	27.8	65.0	37.8	8.2	10.1	42.7	15.7	32.6	3.8	20.4	40.1	73.0	14.2	49.8	22.5	8.1	94.1	3.1	25.6	25.4	39.1	46.9	61.3	11.8	11.6	19.3	156.6	78.3	28.7	118.3	19.5	153.0	155.9	27.4	5.3	30.0	36.7	8.5	80.8	29.1	10.2
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 19.6;kidney: 25.1;liver: 92.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 22.1;Hepatocytes: 16.3;Late spermatids: 23.0;Proximal enterocytes: 14.8;Proximal tubular cells: 48.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"K-562: 107.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	Cytosol		No	NA		5200000		"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.0	0.0	0.0	0.0	0.1	19.6	0.0	0.7	0.1	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	25.1	92.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.2	7.2	0.0	0.0	0.1	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.5	0.2	0.2	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1.5	0.0	1.8	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.2	0.3	0.1	0.0	22.1	1.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.7	16.3	0.2	0.0	1.2	0.9	0.0	0.0	0.0	23.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	14.8	48.9	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 80.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 80.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	19.3	16.5	9.3	17.6	14.2	48.7	24.1	20.7	10.9	16.4	17.0	23.9	30.5	23.6	25.0	24.7	18.1	17.1	14.1	9.5	9.7	16.9	20.5	20.4	18.2	12.3	10.4	31.2	15.5	22.3	10.1	24.7	12.7	20.3	30.0	26.7	16.3	15.4	9.8	20.3	30.8	18.5	10.1	19.0	20.9	10.5	12.6	17.8	26.1	13.4	17.4	21.3	15.4	17.6	61.1	23.8	45.2	27.3	29.8	33.6	29.6	35.3	32.2	38.5	39.8	25.3	42.5	23.9	41.0	33.6	47.3	46.7	44.7	26.6	52.4	8.6	33.0	17.7	49.3	21.4	26.2	17.6	5.1	27.7	27.1	30.2	36.3	30.6	44.7	18.6	29.9	16.8	42.2	12.2	20.5	15.2	22.8	23.1	27.1	19.3	68.8	9.8	34.3	117.9	22.0	14.5	52.7	29.8	45.7	33.9	22.5	15.7	42.2	32.5	29.2	42.1	37.2	9.2	8.6	16.6	13.6	17.1	12.6	15.3	9.9	16.6	5.7	5.9	5.1	8.0	5.1	5.3	5.0	9.3	6.6	5.6	80.5	3.5	8.0	8.6	4.6	2.7	9.3	14.2	20.7	10.9	9.5	9.7	12.3	10.4	12.7	10.1	12.6	17.6	104.7	41.7	57.8	102.5	52.5	48.4	44.3	33.3	75.1	85.4	60.2	67.9	50.8	38.6	47.9	69.9	89.6	42.9	48.1	101.5	11.7	61.2	2.6	63.7	68.7	59.5	44.3	57.7	134.2	60.7	33.1	53.1	85.6	84.6	15.8	107.0	47.5	39.4	24.2	65.6	130.8	64.3	32.6	35.8	27.9	6.6	54.3	44.9	32.0	178.0	57.3	50.5	22.6	117.1	146.4	77.6	98.1	48.2	54.8	64.7	84.0	26.7	49.1	150.5	39.5	62.8	55.5	43.6	34.6	83.0	52.4	37.4	44.8	90.2	65.0	124.2
PLA2G4C	cPLA2-gamma	ENSG00000105499	"Phospholipase A2 group IVC"	Q9UP65	19	48047843-48110817	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 78.8;skeletal muscle: 66.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 77.1;Cone photoreceptor cells: 66.7;Muller glia cells: 57.1;Oligodendrocytes: 137.1;Rod photoreceptor cells: 153.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"B-cells: 4.0;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 13.1;TIME: 19.4"	"Not detected"	"Not detected"							HPA043083	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA043083: AB_10795714"	"unprognostic (1.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.01e-2)"	5.1	17.3	13.8	5.5	23.8	0.3	4.3	20.8	20.5	4.6	4.5	6.5	6.3	8.6	3.0	4.3	5.1	5.8	25.1	14.1	18.2	6.1	4.7	8.0	10.2	24.8	23.5	1.7	4.9	12.8	6.6	5.1	26.7	6.8	3.3	78.8	4.1	8.0	66.7	6.4	8.5	10.3	14.3	11.2	3.3	2.8	21.1	4.7	4.9	41.2	5.6	5.1	2.6	41.5	0.7	1.3	0.0	0.3	5.7	3.0	0.1	1.3	8.5	1.4	3.4	0.0	2.1	0.0	1.8	3.7	2.7	0.3	0.0	0.2	2.2	0.9	0.2	0.0	0.5	1.3	13.1	0.0	1.9	0.6	0.3	0.7	5.7	2.6	4.9	0.1	0.0	8.0	2.2	2.2	0.1	0.2	0.1	1.0	0.1	0.1	2.0	0.8	2.7	0.6	0.9	0.1	1.5	2.9	7.1	4.3	0.8	2.2	19.4	2.2	0.8	2.8	1.0	0.5	1.8	0.2	1.9	0.0	4.8	0.0	2.1	0.0	0.1	5.7	0.4	4.0	0.5	0.0	1.2	0.9	0.0	0.0	0.0	1.1	1.4	0.8	0.1	1.4	13.8	23.8	20.8	20.5	14.1	18.2	24.8	23.5	26.7	14.3	21.1	41.5	7.2	3.2	1.7	30.7	2.4	2.8	1.0	1.5	1.2	77.1	2.4	2.9	35.3	5.7	0.5	0.0	66.7	0.2	0.6	1.2	1.9	13.0	0.3	0.5	4.6	14.3	0.0	0.0	31.6	2.9	0.2	7.4	1.1	0.7	0.0	0.1	4.6	2.0	5.6	33.7	34.7	1.6	18.3	1.2	11.1	0.2	0.6	4.9	7.2	15.0	3.1	57.1	1.0	25.1	137.1	2.7	1.4	7.9	0.7	2.5	5.7	5.2	0.2	153.8	13.1	18.0	9.9	0.9	1.0	0.2	3.0	0.1	1.1	1.6	0.3	0.4
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094562	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 19.1;skin 1: 16.1;vagina: 22.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Glandular and luminal cells: 1.1;Ionocytes: 2.0;Prostatic glandular cells: 3.0;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 2.0;melanoma: 1.8;prostate cancer: 1.3;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RPMI-8226: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074206			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA074206: "	"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.3	5.2	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	19.1	0.0	0.2	0.8	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.4	22.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	15.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.4
PLA2G4E	FLJ45651	ENSG00000188089	"Phospholipase A2 group IVE"	Q3MJ16	15	41981582-42051190	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 17.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 12.9;Basal keratinocytes: 18.1;Suprabasal keratinocytes: 44.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041105, HPA072562"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Cytosol"		"HPA041105: AB_2677300, HPA072562: "	"unprognostic (2.98e-1)"	"unprognostic (5.52e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.99e-2)"		"unprognostic (5.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-7)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	18.1	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.1	0.5	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	5.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	44.9	0.0	0.1	0.0	0.2	0.7
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38214778	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease variant, Dystonia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.5;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;HMC-1: 25.6;U-266/70: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	20.0	22.2	14.1	4.6	16.6	12.2	19.5	15.2	20.3	24.9	12.3	11.4	9.2	17.8	10.6	10.3	26.2	13.2	9.5	14.3	13.7	24.0	13.3	10.4	8.5	17.2	15.0	24.3	16.1	6.7	17.7	4.1	19.5	24.9	2.8	8.3	15.9	9.2	10.7	17.2	12.5	3.4	15.3	17.1	13.2	42.1	15.4	11.7	51.8	4.4	4.6	13.2	14.4	25.5	0.8	1.3	2.6	6.3	8.0	5.5	9.8	0.9	1.0	0.5	1.2	3.2	2.4	5.9	6.7	1.3	0.9	3.5	2.2	2.5	0.3	9.2	11.1	39.1	3.4	3.5	3.1	2.6	25.6	13.3	3.7	2.3	4.6	6.6	0.8	11.7	8.0	13.3	0.7	3.1	8.5	3.0	3.4	2.7	1.3	6.5	1.2	6.1	2.8	5.9	7.1	1.9	1.9	3.1	6.7	3.9	4.1	2.4	0.6	2.1	4.5	0.9	0.6	20.6	2.7	4.0	4.0	3.2	2.0	1.4	0.1	0.0	1.0	0.0	0.7	0.5	1.0	1.5	0.4	0.3	0.4	1.2	0.6	3.7	0.2	1.3	1.6	0.7	14.1	16.6	15.2	20.3	14.3	13.7	17.2	15.0	19.5	15.3	15.4	25.5	5.6	3.2	2.7	19.9	4.6	3.1	3.5	4.0	4.6	9.9	7.4	6.5	2.0	4.3	5.0	12.9	4.2	3.3	11.1	11.3	0.0	2.1	28.5	9.5	4.4	3.1	11.4	7.4	6.4	1.0	2.7	3.3	11.2	8.7	0.0	10.6	3.6	3.5	1.7	15.2	5.9	8.6	2.0	1.0	0.8	18.3	5.9	2.1	1.8	4.7	2.3	4.9	8.2	4.5	25.2	1.1	12.6	3.8	4.7	2.9	21.9	1.9	7.6	7.5	6.6	2.6	3.4	44.5	7.7	4.1	3.4	4.9	6.6	6.8	8.4	2.1
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062615	"Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 39.1;thyroid gland: 41.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 33.1;Excitatory neurons: 34.6;Inhibitory neurons: 43.5;Muller glia cells: 33.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.5;ASC TERT1: 19.5;BJ hTERT+: 16.2;hTERT-RPE1: 26.3;TIME: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		960000		"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"CAB068217: AB_2665660, CAB068218: AB_2665661"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.7	2.9	0.7	1.4	0.8	0.0	14.9	9.7	2.2	6.9	1.7	3.1	3.9	8.8	2.9	4.7	5.4	9.3	2.5	0.5	1.5	20.8	1.4	2.6	1.9	2.0	2.7	10.8	0.6	19.7	2.2	3.8	2.1	3.1	3.2	5.6	39.1	2.9	0.5	10.9	6.1	6.9	1.4	5.1	1.6	1.0	2.5	0.6	41.9	1.3	2.7	3.9	6.0	1.0	0.2	1.6	0.6	0.0	14.5	19.5	0.1	6.8	16.2	1.3	1.8	0.0	3.4	0.0	0.4	7.2	1.4	3.3	0.1	5.0	1.4	0.0	0.0	0.0	11.8	0.0	1.2	0.0	0.0	7.9	5.4	1.9	2.1	26.3	9.3	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	1.4	0.7	0.0	0.0	11.8	2.2	0.0	1.7	2.6	0.2	47.3	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.7	0.8	9.7	2.2	0.5	1.5	2.0	2.7	2.1	1.4	2.5	1.0	11.1	6.4	2.8	20.9	0.1	9.4	2.7	18.1	21.6	2.7	22.1	14.5	4.1	5.7	11.3	33.1	0.0	7.3	0.5	1.7	0.0	0.6	0.1	5.6	22.0	4.0	1.2	0.0	34.6	2.0	1.3	14.8	0.0	9.4	1.3	9.6	8.6	0.0	0.6	16.8	43.5	7.2	4.1	0.0	2.1	1.4	16.1	0.5	7.2	25.3	0.0	33.5	0.0	5.5	1.8	5.1	11.3	16.6	0.1	2.6	15.6	2.3	8.1	1.4	6.6	3.4	4.8	0.1	1.0	9.3	5.4	1.5	0.6	6.3	7.5	3.0
PLAAT1	"A-C1, H-REV107, HRASLS, HRASLS1, PLA/AT1, PLAAT-1"	ENSG00000127252	"Phospholipase A and acyltransferase 1"	Q9HDD0	3	193241128-193277738	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 90.1;testis: 73.6;tongue: 44.5"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 12.5"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 12.9;NTERA-2: 11.0;PC-3: 23.8;RH-30: 10.7;SCLC-21H: 22.0;U-2 OS: 13.3;U-251 MG: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"	Cytosol	"HPA051179: AB_2681375"	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.9	2.5	4.6	0.2	4.9	0.1	1.8	3.5	6.0	0.4	0.8	0.6	0.0	0.9	5.9	6.5	0.5	0.2	9.3	5.1	6.0	0.7	0.1	0.2	0.0	4.5	4.3	0.2	1.4	2.1	2.2	0.1	4.2	0.1	0.1	9.0	2.0	0.7	90.1	3.3	0.3	1.3	2.3	0.2	0.8	73.6	3.9	2.2	7.0	44.5	0.3	0.3	0.4	4.5	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.4	0.0	0.1	0.0	0.2	0.0	5.3	0.0	12.9	0.4	0.6	0.0	5.6	6.9	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.4	23.8	0.0	10.7	0.0	3.7	0.0	22.0	4.1	1.5	3.3	0.0	2.1	6.5	0.1	0.1	0.0	13.3	0.0	18.6	0.1	0.0	0.0	7.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	4.6	4.9	3.5	6.0	5.1	6.0	4.5	4.3	4.2	2.3	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta associated 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 365.9;esophagus: 92.0;intestine: 236.0;lymphoid tissue: 155.1;stomach 1: 117.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1118.2;Distal enterocytes: 1514.4;Extravillous trophoblasts: 572.2;NK-cells: 1103.0;Paneth cells: 865.7;Respiratory ciliated cells: 549.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 2310.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 183.2;CAPAN-2: 510.7;HL-60: 329.1;NB-4: 160.1;RPMI-8226: 238.2;THP-1: 187.8;U-937: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	9.2	2.0	1.8	81.3	2.0	365.9	3.8	2.8	2.4	32.8	1.4	236.0	78.9	2.7	1.2	92.0	18.7	6.5	2.8	1.5	1.7	2.6	35.4	41.2	93.8	7.8	2.7	1.0	1.6	0.5	2.0	33.7	5.5	3.7	163.3	1.1	6.6	2.3	2.0	1.0	88.5	18.5	2.3	155.1	117.5	0.8	2.4	40.5	2.6	0.8	137.5	11.0	5.8	3.7	183.2	1.3	0.5	1.1	0.0	0.2	28.6	4.6	1.1	11.1	13.7	3.5	510.7	30.7	1.5	52.3	17.0	18.7	3.2	1.4	41.6	0.2	0.6	0.8	33.4	15.2	1.8	329.1	1.7	0.9	3.6	1.8	2.4	0.3	0.8	16.0	0.4	2.6	29.5	0.8	62.6	160.1	1.0	14.4	0.9	8.0	10.6	238.2	0.9	5.4	25.8	0.5	1.2	29.1	0.6	9.0	1.6	187.8	1.3	1.1	31.7	0.9	0.9	1.8	0.4	81.7	2.3	149.7	0.2	49.2	139.2	95.9	392.1	635.8	299.4	523.8	185.1	229.2	129.5	481.1	225.9	263.4	29.7	1053.3	358.9	2310.7	13.8	577.1	1.8	2.0	2.8	2.4	1.5	1.7	7.8	2.7	5.5	2.3	2.4	3.7	4.3	195.5	39.2	0.3	247.4	0.4	1.7	77.3	0.0	0.3	0.9	1.4	0.5	2.8	119.1	0.0	0.0	18.5	1118.2	1514.4	0.0	0.3	0.5	45.6	1.1	95.0	86.8	58.4	0.1	3.6	572.2	3.1	119.8	2.9	26.6	0.6	141.0	8.4	21.7	1.7	0.1	231.2	67.1	384.5	7.4	0.6	0.0	213.3	7.2	1.0	157.3	1.2	1103.0	0.0	0.2	99.0	865.7	0.0	35.7	1.1	374.4	1.4	549.6	0.3	6.6	0.7	8.0	0.2	0.8	10.1	0.1	14.2	150.6	0.1	104.2	9.0
PLAG1	ZNF912	ENSG00000181690	"PLAG1 zinc finger"	Q6DJT9	8	56160909-56211324	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 32.0;Microglial cells: 28.1;Rod photoreceptor cells: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;ASC TERT1: 20.9;hTERT-HME1: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA072290			Supported	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA072290: AB_2686508"	"unprognostic (1.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.14e-2)"	0.7	1.4	0.8	1.0	1.2	0.9	0.9	2.5	1.1	3.0	0.6	0.8	1.4	1.4	4.1	0.7	3.1	0.7	3.1	0.7	1.0	1.3	0.3	1.9	1.8	1.5	1.4	4.9	0.8	1.2	3.8	1.6	1.8	1.3	0.6	7.7	3.0	1.8	0.4	1.4	2.3	0.4	1.2	2.6	1.3	2.4	1.3	2.8	1.3	1.4	2.3	1.3	3.0	2.0	2.0	0.0	11.9	0.1	16.0	20.9	3.7	5.4	6.9	2.5	1.1	0.8	6.2	0.2	5.1	2.9	0.7	0.4	3.4	7.1	2.5	0.2	7.4	8.0	0.8	1.8	3.3	2.5	2.3	14.9	3.9	1.4	15.6	6.9	4.7	5.3	3.4	0.1	5.3	0.1	0.7	4.7	3.4	0.5	1.8	6.1	0.8	4.9	3.2	0.7	0.1	0.0	0.1	0.1	0.4	8.0	0.1	2.4	7.2	3.6	4.6	5.9	1.4	1.8	1.5	2.9	4.1	0.9	1.0	0.6	0.0	0.4	0.1	0.0	0.1	1.3	0.4	0.2	0.0	0.7	1.8	1.8	0.4	0.3	0.2	0.1	0.1	0.4	0.8	1.2	2.5	1.1	0.7	1.0	1.5	1.4	1.8	1.2	1.3	2.0	2.6	6.4	3.2	2.9	13.0	1.0	2.5	6.2	1.8	23.6	1.6	0.6	12.2	4.3	6.7	5.5	25.0	8.3	2.0	1.0	0.0	0.7	6.2	3.0	2.3	3.7	5.4	5.0	16.8	1.3	4.2	4.0	2.6	4.2	1.3	0.4	15.7	0.7	5.8	32.0	12.3	3.6	6.1	2.9	2.2	6.7	15.2	2.8	16.0	28.1	1.2	16.3	4.1	2.0	19.2	1.4	4.1	10.1	6.3	5.0	5.1	0.8	9.1	27.8	0.0	2.4	1.4	9.0	8.8	1.1	0.9	7.1	4.5	0.9	3.6	12.9
PLAGL2	ZNF900	ENSG00000126003	"PLAG1 like zinc finger 2"	Q9UPG8	20	32192504-32207743	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.7;Glandular and luminal cells: 47.7;Late spermatids: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"intermediate monocyte: 18.3;non-classical monocyte: 34.8"	"Lineage enriched"	"Detected in many"	15	"monocytes: 34.8"	"Cell line enhanced"	"Detected in all"		"CACO-2: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005900	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA005900: AB_1079629"	"unprognostic (9.40e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.09e-1)"	4.4	3.2	4.4	6.6	5.2	32.2	4.6	5.0	5.0	4.8	7.4	7.8	10.4	6.0	5.2	12.8	9.4	4.1	5.2	5.1	4.0	4.9	4.3	6.6	7.7	4.3	4.1	7.7	6.0	8.5	5.5	3.9	3.6	5.3	8.0	13.0	6.8	5.4	10.2	7.5	12.9	7.2	3.7	6.2	7.2	16.4	4.2	8.9	4.8	8.3	10.7	5.6	6.1	4.2	19.4	10.9	28.5	10.4	10.4	8.0	17.8	7.5	11.9	16.0	14.5	82.3	9.5	19.8	10.1	7.8	22.4	18.6	35.7	17.3	21.0	11.9	16.1	80.3	9.4	39.8	12.7	35.5	17.0	9.7	15.1	12.9	9.1	7.5	11.7	20.7	28.7	17.5	8.5	10.8	39.2	24.4	13.4	14.8	12.4	25.0	36.8	12.6	6.9	14.6	12.9	14.2	18.5	9.9	16.1	16.5	14.9	42.8	8.8	19.3	20.5	14.0	15.5	47.5	28.5	25.1	11.2	73.5	12.1	2.2	3.6	0.9	0.7	18.3	1.4	1.4	1.0	1.5	2.2	1.0	1.2	0.7	0.9	0.5	34.8	0.6	0.8	2.5	4.4	5.2	5.0	5.0	5.1	4.0	4.3	4.1	3.6	3.7	4.2	4.2	4.3	12.8	21.1	2.0	6.0	7.5	13.5	6.2	10.8	7.4	8.6	6.5	4.2	2.8	12.2	1.8	31.3	3.2	8.1	13.1	3.9	3.8	56.7	26.1	9.1	5.2	10.7	10.3	4.5	5.2	3.1	5.7	8.2	47.7	2.5	6.4	7.1	3.8	6.0	3.3	3.8	12.4	2.0	8.9	7.8	159.8	2.5	11.9	0.0	4.7	11.1	6.3	0.0	1.5	4.9	6.2	8.9	7.2	7.9	15.0	29.3	3.4	6.8	21.3	6.6	7.1	4.1	11.8	10.8	21.2	11.6	4.1	7.4	6.2	16.7	21.7
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.4;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 22.6;granulocytes: 26.6;Hofbauer cells: 30.3;Kupffer cells: 46.6;Macrophages: 41.7;Microglial cells: 39.4;monocytes: 20.9;NK-cells: 26.8;T-cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 78.6;HMC-1: 93.4;THP-1: 28.1;U-937: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	5.9	4.0	3.8	29.2	3.9	52.4	2.5	3.8	5.4	3.3	3.4	5.1	6.1	2.7	1.4	3.0	4.5	9.7	3.0	4.0	5.6	1.9	6.3	16.8	28.7	8.4	7.1	1.5	1.3	1.3	2.1	7.0	7.3	2.6	8.0	0.5	5.4	4.0	1.2	1.9	10.4	7.3	6.2	40.7	5.5	1.3	7.7	20.5	2.2	1.7	22.2	7.3	1.8	9.6	0.4	0.0	0.6	0.0	0.0	0.0	10.5	0.0	0.1	0.0	0.0	0.1	19.1	1.5	17.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	78.6	0.0	0.0	0.0	16.9	93.4	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.7	4.3	0.0	0.0	4.7	9.2	0.9	0.0	0.2	13.7	2.0	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.2	5.1	0.0	28.1	10.1	0.0	9.1	0.0	0.0	0.0	0.0	3.7	0.0	53.2	0.0	1.7	2.6	5.3	1.8	2.7	1.2	0.4	0.9	0.9	2.7	0.5	0.9	1.0	4.2	1.2	2.7	1.0	1.9	1.5	3.8	3.9	3.8	5.4	4.0	5.6	8.4	7.1	7.3	6.2	7.7	9.6	0.9	6.4	16.8	0.3	9.6	0.9	0.1	0.1	0.6	0.1	1.9	2.5	3.3	1.5	3.2	1.8	0.0	0.5	22.6	0.2	0.0	0.1	2.2	0.2	0.5	1.7	0.0	8.0	1.8	0.0	0.5	1.9	0.0	0.2	26.6	0.1	1.1	0.4	30.3	0.0	0.8	1.7	0.0	46.6	15.5	0.6	0.3	41.7	3.6	39.4	20.9	0.0	26.8	0.5	0.2	0.4	0.3	0.0	5.7	0.0	0.0	0.9	4.4	0.2	0.0	0.4	0.7	0.5	2.3	0.3	0.6	0.4	20.8	0.3	2.0	0.0
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	9.0	4.2	69.4	33.0	141.3	30.3	8.5	706.3	105.2	5.0	347.5	8.6	17.3	8.6	22.5	4.6	5.5	13.4	4.3	40.1	122.6	23.4	14.3	9.4	66.8	301.3	122.7	1.6	3.9	2.8	1.2	8.2	207.3	2.8	7.0	0.5	7.1	3.4	1.9	4.0	19.4	8.8	241.5	34.8	8.7	2.0	283.3	10.0	6.9	3.6	72.0	10.1	3.9	437.2	1.4	3.2	0.6	2.9	0.2	0.2	4.0	0.3	0.4	2.3	0.8	0.9	8.1	183.3	30.1	0.2	7.4	4.2	4.0	0.5	1.4	1.4	2.1	22.1	0.4	0.3	1.2	22.3	84.2	0.3	1.8	1.3	1.0	0.3	4.2	8.1	2.5	15.0	0.4	5.7	2.6	55.5	3.1	2.3	1.3	75.1	0.1	23.7	0.5	3.9	1.4	0.4	5.0	1.6	1.5	3.9	3.3	67.7	1.1	0.4	3.2	0.4	0.6	35.2	61.4	403.4	0.3	30.0	1.6	9.4	12.1	76.2	1.9	16.1	0.9	51.1	0.6	2.9	10.7	49.6	0.8	1.9	65.7	41.3	36.8	7.0	0.5	6.9	69.4	141.3	706.3	105.2	40.1	122.6	301.3	122.7	207.3	241.5	283.3	437.2	187.0	12.8	54.0	0.0	138.3	2.9	1.6	2.3	1.8	224.8	139.5	113.0	7.2	28.6	13.1	16.5	104.3	13.6	94.0	0.4	13.7	2.6	20.5	65.5	88.0	61.7	21.5	23.2	0.7	0.0	2.2	30.6	16.8	86.6	40.4	29.0	37.1	43.2	27.7	101.0	0.8	2.7	65.1	47.4	9.4	30.7	11.1	46.7	8.8	95.5	21.8	221.7	47.4	2.0	1.3	0.1	9.8	4.9	138.6	3.5	5.5	5.9	6.9	196.2	6.6	28.0	51.9	4.8	2.9	3.0	2.3	11.1	48.2	8.7	1.9	6.5
PLCXD1	FLJ11323	ENSG00000182378	"Phosphatidylinositol specific phospholipase C X domain containing 1"	Q9NUJ7	X	276322-303356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 34.7;Distal enterocytes: 34.2;Gastric mucus-secreting cells: 33.1;Paneth cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 110.4;HEL: 172.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007721	Approved		Approved	Cytosol		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA007721: AB_1079630"	"unprognostic (2.73e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.80e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.82e-14)"	"unprognostic (6.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	14.7	4.1	4.6	9.4	8.8	32.9	9.7	13.0	19.2	10.0	0.0	8.2	8.6	5.6	1.4	17.5	9.1	8.8	5.6	4.4	0.0	5.7	10.1	7.4	17.3	3.4	1.5	12.8	7.5	3.2	7.7	7.8	4.4	7.5	5.7	6.0	11.4	3.7	8.4	18.7	12.5	2.7	0.5	17.5	26.9	6.7	4.0	8.9	10.4	2.7	9.0	6.1	9.7	13.4	28.4	110.4	25.7	38.8	5.0	3.9	20.4	24.4	2.9	12.8	12.4	40.6	29.1	34.8	17.9	10.7	19.0	8.5	6.3	15.9	6.7	21.2	46.2	172.6	36.1	59.7	15.6	17.4	63.1	20.1	1.9	47.0	4.9	8.6	9.7	57.2	44.0	18.7	9.2	8.2	52.3	24.2	57.8	7.1	19.2	29.1	13.3	53.9	3.9	12.9	25.9	15.0	24.6	14.4	21.1	17.5	27.6	22.0	7.2	17.1	28.2	18.5	26.9	6.3	17.9	86.4	11.0	44.4	18.2	3.7	2.7	5.4	1.9	6.0	2.7	1.6	1.4	2.4	2.0	5.6	1.8	1.9	3.3	1.2	9.0	2.1	3.2	2.3	4.6	8.8	13.0	19.2	4.4	0.0	3.4	1.5	4.4	0.5	4.0	13.4	15.8	9.6	34.7	5.5	4.1	6.9	13.6	3.9	2.2	7.4	4.7	3.6	6.5	10.0	2.8	0.0	2.1	10.1	4.9	34.2	0.0	6.3	0.9	1.6	3.4	6.1	3.0	9.9	5.3	1.8	11.3	6.1	33.1	3.2	3.8	32.1	4.6	6.9	5.5	8.4	6.1	11.2	0.0	7.3	9.8	0.9	2.5	11.9	0.0	5.6	3.7	2.3	9.2	0.5	5.7	18.8	40.9	3.8	2.7	5.3	3.0	1.7	1.3	7.1	13.1	6.5	7.9	8.4	15.9	4.2	8.7	27.0	3.8	2.8	9.4	8.0
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524697	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 16.2;choroid plexus: 52.8"	"Group enriched"	"Detected in some"	6	"Inhibitory neurons: 319.5;Oligodendrocyte precursor cells: 127.6;Oligodendrocytes: 226.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	5	"cerebellum: 16.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.0;AF22: 10.3;HDLM-2: 5.3;SH-SY5Y: 2.9;U-2 OS: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol		No	No				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Vesicles, Cytosol"	"HPA028389: AB_10602145, HPA050367: AB_2681105"	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	0.4	1.7	1.7	0.0	2.9	0.0	0.4	16.2	2.5	0.6	52.8	0.2	0.0	1.1	0.2	0.4	1.1	0.1	0.1	3.4	2.5	0.4	0.0	0.2	1.1	2.9	2.6	2.1	1.0	0.2	2.4	0.4	2.8	0.8	0.1	0.3	0.7	3.0	0.2	0.1	0.1	0.9	2.0	0.7	0.3	1.5	2.2	0.4	0.2	0.0	0.4	0.1	0.3	2.7	0.0	3.0	10.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.9	16.2	2.5	3.4	2.5	2.9	2.6	2.8	2.0	2.2	2.7	0.1	0.0	0.0	7.8	0.2	0.1	0.0	0.0	1.2	0.5	0.0	1.7	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	9.1	2.9	0.6	0.3	0.0	0.0	35.5	0.0	0.0	3.1	0.0	8.2	0.0	0.7	0.0	0.0	0.0	3.3	319.5	0.2	0.0	0.0	0.0	21.0	5.0	0.1	0.0	5.6	0.0	0.4	0.0	127.6	226.8	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.2	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.1
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915153-143976734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 256.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"PC-3: 384.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Supported	"Intermediate filaments,Focal adhesion sites,Cytosol"		NA	NA		7400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	41.8	30.9	44.2	22.6	25.4	43.2	37.9	20.4	39.7	57.4	6.7	58.0	21.1	55.2	8.5	59.7	47.9	22.8	78.9	42.2	31.0	30.0	31.3	49.2	22.1	48.5	28.6	47.1	27.6	8.1	33.0	18.3	30.8	49.5	13.0	3.9	42.9	19.8	256.5	83.1	53.8	27.7	28.8	46.1	49.1	15.3	43.2	14.4	25.7	74.7	15.8	56.5	55.7	25.9	92.6	247.3	15.1	20.3	31.6	66.9	62.8	125.9	49.3	32.3	18.7	39.2	88.5	8.9	82.9	179.7	54.6	98.9	10.3	162.6	13.3	58.7	10.0	24.9	268.0	34.0	54.0	9.6	26.1	71.8	40.7	84.6	164.2	28.3	43.0	7.6	16.2	25.9	39.7	175.3	5.1	19.8	12.2	29.4	384.8	1.8	46.2	24.6	67.7	147.7	16.6	16.8	217.4	50.0	21.1	21.7	55.7	12.4	125.7	117.8	217.3	110.6	155.1	4.7	3.7	6.3	106.9	15.2	176.2	0.0	2.0	0.1	0.6	1.7	1.3	0.6	1.2	0.9	1.6	0.6	0.8	0.5	0.4	0.3	1.2	1.3	1.4	2.0	44.2	25.4	20.4	39.7	42.2	31.0	48.5	28.6	30.8	28.8	43.2	25.9	83.8	28.9	15.6	78.0	27.0	108.0	53.1	62.9	50.7	15.8	29.4	27.9	39.3	31.5	42.9	40.5	25.0	34.4	27.1	257.8	0.0	39.3	1.4	39.4	52.6	68.2	32.2	11.8	47.3	20.2	32.1	45.7	170.2	57.3	8.2	14.4	63.1	69.0	35.2	30.3	36.5	79.9	10.2	67.5	100.4	5.0	44.4	61.2	33.8	27.2	54.9	11.2	15.5	14.6	3.4	157.8	194.1	74.9	39.3	144.9	124.9	4.6	50.3	10.8	6.6	42.1	61.5	1.2	7.1	72.2	76.7	69.0	35.0	18.8	61.6	121.0
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 53.4;Smooth muscle cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 63.4;BJ hTERT+ SV40 Large T+ RasG12V: 49.5;SK-MEL-30: 77.0"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"spinal cord: 45.0"	"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: AB_2678249, HPA048473: AB_2680409"	"prognostic favorable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	34.0	24.6	8.8	12.1	8.8	0.7	31.7	8.0	9.5	28.7	10.9	43.0	5.6	34.6	5.0	14.3	30.5	11.1	41.4	8.7	10.6	32.4	32.8	25.7	5.8	16.9	14.7	47.5	13.2	9.5	29.9	5.6	10.4	28.3	3.9	2.5	15.1	8.4	19.3	17.2	16.0	10.7	10.8	16.2	21.1	11.0	12.4	5.5	31.0	13.1	3.3	34.4	21.7	10.3	9.0	0.5	9.9	63.4	14.2	41.7	8.0	7.0	24.7	26.8	49.5	5.9	2.5	0.4	11.8	9.8	10.4	2.7	3.5	3.6	4.2	0.0	3.4	2.3	1.7	6.6	11.0	0.0	14.2	21.5	2.2	15.6	1.0	11.1	8.0	11.2	9.5	5.3	7.4	5.4	3.2	0.5	1.5	6.0	0.8	0.3	31.5	0.6	8.3	0.1	0.0	11.0	3.0	2.6	77.0	2.5	3.9	3.0	1.3	8.5	6.8	11.2	1.8	28.3	25.4	5.3	10.2	0.7	23.0	0.0	0.3	0.9	1.8	0.3	1.3	1.7	1.7	1.1	0.1	3.9	2.8	2.6	0.1	0.8	0.3	1.2	0.6	0.9	8.8	8.8	8.0	9.5	8.7	10.6	16.9	14.7	10.4	10.8	12.4	10.3	6.4	0.0	18.7	2.3	1.4	9.6	31.3	17.6	12.0	0.7	11.4	18.3	37.1	17.2	27.2	7.3	0.0	3.3	2.9	3.2	1.9	23.3	0.8	11.6	34.1	7.0	1.2	3.2	0.4	5.1	6.8	41.7	7.7	11.6	0.0	18.8	6.4	13.3	2.9	0.0	0.5	2.5	4.1	0.8	9.2	2.0	41.3	1.9	12.4	1.9	1.3	9.9	2.1	0.5	0.2	6.9	0.5	53.4	0.7	29.8	0.7	14.6	20.5	1.0	6.6	33.0	48.4	4.0	3.7	5.7	9.8	2.9	2.4	16.0	3.3	21.4
PLEKHG2	"ARHGEF42, CLG, FLJ00018"	ENSG00000090924	"Pleckstrin homology and RhoGEF domain containing G2"	Q9H7P9	19	39412669-39428415	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Leukodystrophy, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 86.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017973, HPA048054"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA017973: AB_2669719, HPA048054: AB_2680241"	"unprognostic (3.55e-1)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (3.79e-8)"	"unprognostic (8.01e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	32.6	10.7	4.6	22.8	3.8	22.1	20.3	4.6	7.5	28.2	11.3	24.5	8.1	31.2	4.4	10.1	24.9	17.4	25.6	4.3	3.7	27.7	8.0	42.2	20.7	7.1	4.4	20.1	7.1	5.2	12.2	23.0	5.1	21.0	5.2	4.6	8.4	15.1	6.3	9.0	18.9	18.5	4.7	33.4	15.6	15.7	9.3	21.1	19.1	4.9	18.3	20.9	17.4	5.2	8.5	40.8	73.0	39.9	6.9	9.0	10.6	21.9	17.3	14.9	12.8	26.5	14.9	14.7	15.8	28.8	12.4	2.8	11.1	19.4	7.9	49.3	10.2	19.3	23.5	12.4	11.9	2.2	23.1	20.7	3.3	17.9	8.7	25.8	19.3	41.7	13.2	16.9	24.1	17.0	24.2	7.5	17.3	7.8	3.9	86.1	8.9	4.6	12.7	15.4	2.0	23.6	4.9	1.8	7.0	25.2	21.9	21.8	24.8	38.8	30.0	14.5	14.4	12.6	4.1	21.4	21.6	8.7	22.0	1.3	0.5	0.1	1.4	0.2	0.9	1.2	0.7	0.8	0.3	1.1	1.0	1.2	0.8	0.4	0.7	1.4	1.3	1.1	4.6	3.8	4.6	7.5	4.3	3.7	7.1	4.4	5.1	4.7	9.3	5.2	30.4	6.4	27.4	1.6	9.7	4.0	5.5	2.9	6.8	0.6	4.6	11.7	6.4	2.8	6.4	0.0	0.0	0.8	8.7	5.0	0.0	5.6	14.2	11.9	20.1	17.7	1.2	1.7	0.5	4.9	2.9	16.9	13.3	30.4	2.5	6.9	8.2	0.8	9.9	0.0	0.8	3.7	0.0	12.8	21.1	19.8	7.2	25.6	5.4	2.8	5.4	1.1	4.1	2.5	0.3	4.2	2.1	8.2	9.1	3.0	2.6	0.2	2.2	2.4	6.6	64.5	26.8	2.5	4.1	6.5	2.8	1.1	12.2	2.4	3.1	1.9
PLEKHH2	"KIAA2028, PLEKHH1L"	ENSG00000152527	"Pleckstrin homology, MyTH4 and FERM domain containing H2"	Q8IVE3	2	43637260-43767987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 66.2;Endometrial stromal cells: 150.5;Oligodendrocyte precursor cells: 191.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 7.4;RPTEC TERT1: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077225			Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA077225: AB_2686828"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.82e-2)"	13.1	3.0	2.8	1.7	2.7	0.1	8.9	3.6	2.8	20.9	8.8	11.8	3.7	19.8	4.4	4.6	15.9	7.3	4.8	2.3	2.8	15.9	1.7	27.6	2.9	3.0	3.4	23.0	2.9	5.4	2.0	3.8	3.1	5.1	4.3	1.7	4.8	5.0	1.8	8.4	6.5	9.8	2.7	5.4	5.0	3.9	2.7	0.4	5.5	2.5	1.8	6.2	8.5	2.5	0.5	4.0	1.6	0.0	3.1	7.4	0.3	0.5	2.0	0.8	2.0	0.0	1.3	1.0	0.2	0.6	3.3	2.6	0.5	0.6	1.5	0.0	1.1	0.1	0.6	0.1	0.5	0.0	0.5	2.2	0.6	1.9	0.1	1.1	1.7	1.6	3.9	0.1	0.7	1.1	0.8	0.1	0.9	0.6	3.9	0.0	4.6	0.0	6.3	0.2	1.2	0.6	0.4	0.0	3.9	1.1	0.5	0.1	0.2	4.5	1.3	0.2	1.4	0.9	0.2	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	2.7	3.6	2.8	2.3	2.8	3.0	3.4	3.1	2.7	2.7	2.5	4.6	38.5	8.7	19.2	0.9	8.7	17.5	5.8	6.8	1.0	5.3	8.3	2.9	11.5	12.9	66.2	6.2	0.3	1.3	0.1	5.9	6.2	1.6	5.9	150.5	3.8	0.0	0.0	15.6	1.4	0.3	57.4	3.1	8.8	1.3	42.6	2.2	0.0	0.8	0.0	4.3	0.3	2.0	0.3	8.6	3.3	35.8	1.2	12.4	15.9	0.2	5.8	0.0	191.0	52.7	7.2	0.0	50.4	0.4	9.2	0.3	4.1	7.3	4.1	46.0	40.7	24.6	10.8	5.9	2.6	8.4	0.5	3.6	13.1	0.6	8.7
PLEKHM3	"DAPR, PLEKHM1L"	ENSG00000178385	"Pleckstrin homology domain containing M3"	Q6ZWE6	2	207821288-208025527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 99.1;Inhibitory neurons: 70.5;Microglial cells: 36.5;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 86.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035046	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Vesicles	"HPA035046: AB_10603128"	"unprognostic (3.62e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.06e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.86e-4)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.33e-2)"	2.9	4.1	2.3	1.3	2.6	4.3	2.4	0.4	2.9	2.7	0.0	3.1	0.9	2.5	0.9	1.6	2.0	1.4	2.9	2.8	2.1	1.9	3.1	2.9	1.5	2.0	2.6	3.1	2.2	4.0	2.5	1.4	2.2	2.5	1.5	8.3	2.2	1.4	2.4	2.6	1.9	1.9	0.2	1.9	2.2	1.7	1.3	2.2	3.6	1.6	1.4	1.9	2.5	2.0	0.7	0.7	1.6	0.9	2.7	2.7	2.5	1.5	1.6	1.2	1.1	0.9	0.7	0.6	1.5	1.8	1.2	0.8	1.7	2.2	1.6	1.2	2.6	1.3	2.2	1.3	1.6	1.4	0.7	2.2	2.6	1.3	1.6	1.9	1.3	2.1	0.8	1.7	1.5	0.4	1.7	0.9	1.6	0.5	0.8	1.3	1.4	1.3	0.6	0.9	3.5	1.8	1.4	0.1	1.5	2.7	0.4	1.1	1.8	1.9	1.1	1.1	1.0	2.0	2.4	0.6	2.2	0.8	1.4	1.3	0.8	0.4	0.9	0.3	0.3	0.9	0.8	0.8	0.7	0.6	1.0	0.8	2.6	0.9	0.7	0.7	0.5	0.2	2.3	2.6	0.4	2.9	2.8	2.1	2.0	2.6	2.2	0.2	1.3	2.0	6.3	19.2	21.7	29.0	2.7	0.0	0.2	0.1	0.6	3.1	4.1	3.7	1.2	1.5	5.6	1.8	12.5	0.3	4.1	1.2	0.0	3.1	2.5	4.1	6.3	2.3	0.0	4.0	99.1	3.4	0.5	3.0	2.0	4.7	0.0	25.0	0.4	0.6	0.6	6.7	70.5	0.1	0.0	1.0	2.4	5.2	0.3	3.8	0.0	36.5	4.6	2.3	0.0	45.2	86.9	3.5	1.6	0.0	2.0	0.2	1.1	4.9	0.8	9.6	0.0	1.7	3.8	0.4	0.7	1.1	0.1	0.1	2.5	6.9	0.5	0.1
PLEKHO2	"DKFZp761K2312, PLEKHQ1, PP1628, pp9099"	ENSG00000241839	"Pleckstrin homology domain containing O2"	Q8TD55	15	64841883-64868002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 103.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 63.2;Kupffer cells: 52.3;Macrophages: 46.5;Muller glia cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 27.1;granulocytes: 77.3;monocytes: 73.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 68.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040055	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		200000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA040055: AB_10793954"	"unprognostic (4.32e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.85e-3)"	37.9	31.8	23.1	30.5	26.9	52.0	22.7	25.0	25.0	17.0	16.7	23.6	10.0	19.8	5.7	13.9	22.4	26.0	16.5	21.7	24.4	14.2	11.8	42.2	34.3	31.8	26.2	14.9	8.2	7.4	10.3	25.4	26.6	17.4	7.8	14.4	9.9	13.9	5.8	10.6	17.8	22.9	27.6	103.2	16.3	8.3	28.0	16.0	29.9	8.2	21.1	25.8	16.7	25.5	6.5	4.2	7.9	7.8	68.0	38.8	18.4	18.5	27.4	19.2	19.6	5.1	4.0	17.1	9.5	37.7	19.5	2.2	9.0	7.4	11.2	26.6	2.7	17.2	1.9	6.0	52.2	19.4	24.7	28.3	6.5	24.0	7.8	16.6	27.0	3.5	5.2	59.5	25.9	1.9	4.1	20.9	15.0	3.2	3.7	14.9	19.0	12.2	3.1	4.4	0.6	6.7	7.7	2.6	25.4	12.9	2.7	26.1	35.3	14.8	13.4	14.1	7.8	22.0	37.1	5.8	16.0	24.8	8.8	22.2	43.2	25.6	13.2	52.3	11.9	9.8	7.4	12.2	27.1	6.8	3.1	6.5	77.3	7.0	73.0	3.1	10.7	36.0	23.1	26.9	25.0	25.0	21.7	24.4	31.8	26.2	26.6	27.6	28.0	25.5	24.9	0.0	5.6	17.3	9.1	5.6	2.3	2.3	0.6	0.6	6.4	8.3	3.6	2.8	2.4	9.2	0.0	4.2	15.9	0.5	3.9	2.4	5.0	1.4	5.9	26.1	0.0	2.1	0.2	1.5	5.9	8.6	0.5	2.3	18.4	2.5	34.2	2.1	63.2	0.0	0.2	0.3	4.1	52.3	24.3	2.9	18.3	46.5	14.2	8.4	18.9	56.8	16.5	2.5	2.7	2.0	0.0	25.6	2.7	3.5	0.0	2.2	2.1	3.8	13.1	10.2	5.9	0.9	2.3	1.9	4.4	6.0	10.5	4.6	0.4	3.4
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460139	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 380.7;Extravillous trophoblasts: 257.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"NK-cell: 9.1"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1060.6;T-47d: 396.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	24.3	8.4	25.6	7.4	35.7	9.3	40.6	6.4	31.2	37.9	16.4	11.8	9.3	29.0	9.3	35.5	21.0	32.1	54.7	44.4	10.4	15.7	31.1	32.3	7.2	8.1	12.3	19.3	23.4	5.9	6.3	47.6	8.4	17.7	14.6	2.1	42.9	10.5	7.4	47.3	12.9	26.6	7.3	83.6	10.4	38.1	11.8	7.2	18.0	13.6	7.6	29.8	32.1	16.8	131.1	115.6	38.3	3.1	19.9	31.9	15.1	27.1	44.8	86.3	49.8	8.6	112.1	0.0	176.3	95.2	208.3	159.8	1.7	61.5	75.6	0.3	3.5	0.0	50.8	9.7	106.1	0.6	3.6	18.7	82.0	33.3	90.9	1060.6	175.4	0.0	0.1	4.4	169.8	47.5	0.3	0.2	7.6	12.4	18.5	6.3	106.5	0.0	221.6	25.4	2.3	5.1	82.4	16.0	76.0	66.1	396.9	2.0	231.9	24.3	63.8	11.0	217.8	0.1	0.3	0.3	18.8	0.3	110.7	2.2	0.5	1.9	0.1	1.2	0.0	0.8	0.5	0.0	2.2	0.6	0.9	0.4	1.5	9.1	0.5	1.5	0.4	0.4	25.6	35.7	6.4	31.2	44.4	10.4	8.1	12.3	8.4	7.3	11.8	16.8	144.6	19.2	15.8	5.9	23.4	141.7	194.1	116.1	380.7	3.8	108.5	203.7	128.9	30.0	134.9	18.4	4.2	66.5	22.7	66.3	9.8	109.8	10.9	132.7	67.8	178.7	84.3	2.7	44.3	77.9	257.3	107.8	136.6	165.4	9.5	4.1	89.3	7.7	14.9	0.0	22.8	39.9	124.1	8.1	19.3	5.0	12.8	39.5	24.9	15.9	3.2	3.3	0.0	3.5	4.9	103.2	44.6	10.9	8.2	76.1	38.5	5.5	31.6	2.9	0.0	74.0	106.6	65.1	10.4	184.9	103.4	129.8	21.2	7.4	45.6	63.1
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880893-127899224	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 22.6;lymphoid tissue: 14.4;testis: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.0	1.1	0.4	4.9	0.5	22.6	2.0	0.2	0.7	0.9	0.1	3.5	2.8	1.5	0.6	3.2	1.3	1.1	0.5	0.5	0.6	0.6	0.8	0.9	7.4	0.5	0.5	1.0	0.4	0.6	0.2	3.6	0.4	0.9	4.3	2.1	0.9	0.9	0.1	2.3	2.9	1.8	0.4	1.6	2.0	22.6	0.6	14.4	0.9	0.7	7.3	1.3	1.4	0.4	26.1	12.1	44.3	22.9	1.5	4.2	20.1	24.9	17.6	32.4	33.3	17.0	26.1	34.9	9.0	13.9	26.3	16.7	31.6	19.9	49.6	27.4	13.1	31.6	20.0	16.0	0.5	45.2	35.9	1.4	2.0	29.7	13.6	5.9	25.3	26.3	37.5	45.2	27.6	18.2	69.9	20.1	20.7	26.3	13.6	36.0	30.9	12.1	10.8	16.4	24.4	20.0	15.8	14.2	7.6	18.7	11.5	19.3	11.0	25.3	24.4	17.4	31.4	23.1	27.4	49.0	13.0	33.7	28.7	0.0	0.1	0.4	0.4	0.2	0.3	0.1	0.5	0.5	0.2	0.2	0.1	0.6	0.0	0.4	0.1	0.1	1.2	0.2	0.4	0.5	0.2	0.7	0.5	0.6	0.5	0.5	0.4	0.4	0.6	0.4	1.6	0.0	0.6	0.0	1.6	1.7	0.9	1.7	1.2	1.8	1.0	0.9	0.9	0.0	0.6	1.8	0.0	6.0	1.9	2.0	0.0	0.6	65.9	4.7	1.0	1.0	2.4	19.6	0.8	0.4	12.9	1.6	4.1	2.0	1.3	7.5	0.4	0.5	3.7	0.0	0.8	3.3	6.1	1.3	0.6	87.5	2.8	1.5	0.0	1.0	1.2	1.1	1.0	1.0	1.2	0.1	0.5	0.4	8.7	0.7	0.5	0.6	3.7	0.8	0.0	0.4	3.6	53.5	13.4	6.8	0.9	3.8	2.1	0.8	4.5	1.7
PLPP6	"FLJ46512, FLJ90191, PDP1, PPAPDC2"	ENSG00000205808	"Phospholipid phosphatase 6"	Q8IY26	9	4662294-4665258	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 82.2;Late spermatids: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HDLM-2: 99.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018096	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA018096: AB_1855609"	"unprognostic (2.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.88e-2)"	3.6	6.6	3.8	6.2	4.0	1.5	7.3	7.0	5.0	5.0	8.7	9.3	10.5	4.0	12.7	7.4	3.3	4.6	2.8	4.3	3.3	5.4	18.9	3.4	8.2	3.4	3.6	4.0	17.2	7.7	4.7	7.1	3.6	16.4	9.9	5.1	7.7	4.8	1.9	8.2	11.4	3.4	3.3	6.0	11.3	5.9	3.3	6.1	7.1	1.5	8.4	5.2	5.1	3.5	8.2	8.3	8.8	10.9	6.9	7.7	8.8	5.5	7.1	4.4	5.0	2.2	5.3	7.9	2.2	5.5	10.9	10.0	6.2	7.8	4.6	99.2	5.9	15.7	8.7	11.3	6.3	5.7	11.4	8.5	6.2	3.4	7.5	5.8	6.6	8.8	2.7	8.1	5.6	8.8	5.4	15.0	8.1	8.2	2.9	5.3	0.0	6.1	7.6	9.3	22.0	11.1	6.5	5.8	3.5	10.8	8.2	12.7	7.8	3.9	3.3	5.3	3.6	1.7	6.4	2.0	6.1	4.1	3.7	6.8	4.1	3.5	3.1	3.7	3.6	2.6	5.6	4.8	4.2	3.3	9.6	6.9	1.8	4.2	4.4	3.2	8.6	4.1	3.8	4.0	7.0	5.0	4.3	3.3	3.4	3.6	3.6	3.3	3.3	3.5	2.8	6.4	2.7	0.0	2.6	0.0	2.5	0.0	2.8	7.5	4.2	2.7	0.0	5.7	1.3	1.8	2.1	18.6	2.9	9.7	1.9	11.0	82.2	2.1	3.4	3.0	10.9	2.1	0.0	13.9	2.9	2.3	7.1	5.3	0.0	4.1	4.2	15.3	6.5	3.3	0.0	7.3	0.0	4.7	0.0	46.3	2.8	1.7	0.0	0.0	3.0	4.6	3.1	0.0	0.0	10.8	6.5	4.9	1.5	7.5	13.4	2.8	0.0	4.9	0.0	1.7	1.8	0.5	1.1	4.6	0.0	10.4	3.4	3.5	5.1	3.1
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821955	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 9.8;brain: 21.1;fallopian tube: 11.1"	"Cell type enriched"	"Detected in some"	7	"Endometrial ciliated cells: 37.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 61.8;THP-1: 128.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.0	0.0	16.8	0.2	14.1	9.8	2.2	0.0	21.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	11.1	0.1	0.1	14.2	11.5	0.0	0.0	2.3	0.1	4.1	8.2	0.3	0.0	0.2	0.4	0.0	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	2.3	0.2	0.1	3.2	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.5	12.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.7	0.1	0.1	8.4	0.1	0.1	0.3	2.3	0.0	0.0	0.0	5.2	0.0	1.6	0.0	0.5	4.4	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.3	0.0	1.1	0.0	61.8	9.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	15.5	0.3	0.0	0.0	6.3	5.4	128.9	0.1	0.2	0.2	0.3	0.1	0.2	0.5	0.2	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	14.1	0.0	21.1	14.2	11.5	4.1	8.2	1.5	2.3	13.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	37.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.1	5.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;retina: 1.6;testis: 2.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 8.5;Horizontal cells: 3.3;Spermatogonia: 6.9"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 11.9;SH-SY5Y: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: AB_2732631"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavorable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.0	0.4	5.2	0.0	5.8	0.0	0.0	0.1	6.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.5	0.0	0.0	0.0	0.0	1.3	3.9	0.0	0.4	0.0	0.2	0.0	2.8	0.0	0.1	1.6	0.0	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.0	7.1	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.9	0.0	0.0	0.0	0.5	0.1	0.4	21.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.8	0.1	6.6	6.1	4.5	1.3	3.9	2.8	2.0	7.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351450-17377342	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 436.2"	"Group enriched"	"Detected in many"	4	"Adipocytes: 439.2;Endothelial cells: 344.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 35.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 35.2"	"Cell line enriched"	"Detected in some"	27	"EFO-21: 549.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		53000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	283.0	51.1	2.7	54.6	3.1	1.7	210.5	2.9	4.2	102.7	18.2	95.7	86.7	90.0	5.1	48.9	83.3	139.2	92.5	3.3	3.1	153.0	6.9	31.0	50.5	3.7	3.5	16.7	96.1	98.6	64.3	48.8	3.6	68.4	22.3	0.0	77.9	38.0	32.7	58.9	103.3	50.5	3.6	166.7	116.6	4.4	3.5	18.9	436.2	12.9	16.2	104.4	80.8	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	549.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	9.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.1	20.0	0.0	2.3	0.1	0.3	0.5	2.2	2.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	35.2	0.0	0.6	2.7	3.1	2.9	4.2	3.3	3.1	3.7	3.5	3.6	3.6	3.5	4.1	439.2	6.4	0.0	0.3	0.7	22.9	1.0	0.0	8.0	0.0	2.7	3.3	3.7	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	3.6	0.4	0.3	344.9	0.0	0.4	0.4	2.5	0.1	48.9	0.0	0.3	0.0	0.4	79.6	0.2	1.8	0.0	0.3	0.0	0.0	3.5	28.8	0.8	0.0	5.5	23.2	6.5	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	7.6	1.5	0.0	0.0	0.0	0.1	0.0	1.4	6.1	0.5	0.7	2.9	16.8	0.1	1.4	0.7	0.0	2.3
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"basophil: 210.5"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 210.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		21000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	18.5	18.3	3.3	15.1	4.6	6.4	16.7	3.3	4.2	13.7	8.4	26.0	25.0	10.6	11.9	29.0	10.7	10.6	13.2	3.8	3.5	16.7	51.8	13.8	13.7	3.6	3.7	7.5	36.5	10.2	12.1	15.5	3.5	14.2	26.0	1.5	22.6	7.4	9.7	16.2	21.3	12.5	3.5	14.0	19.6	4.5	3.9	9.6	11.3	5.9	14.2	21.7	15.7	3.6	26.1	56.5	12.3	32.7	21.8	33.7	27.4	39.8	47.3	38.8	41.6	42.5	31.5	41.0	16.3	69.4	20.2	35.1	25.3	48.5	39.2	30.7	29.0	13.6	33.0	73.8	40.4	36.9	31.6	50.4	33.7	41.1	37.9	18.1	40.1	24.5	18.9	39.6	26.0	68.3	37.9	33.9	52.8	60.0	35.8	47.2	27.4	82.8	43.5	45.0	23.5	43.7	32.7	71.4	23.9	19.5	46.4	31.7	47.7	27.8	31.5	76.6	39.5	48.2	43.3	51.5	23.4	45.5	38.0	210.5	16.5	3.2	7.9	13.0	11.7	9.5	7.0	10.2	12.1	7.8	7.7	7.5	26.5	6.2	8.4	10.9	5.7	10.9	3.3	4.6	3.3	4.2	3.8	3.5	3.6	3.7	3.5	3.5	3.9	3.6	16.5	16.0	24.1	12.7	18.4	3.8	11.6	7.7	14.8	4.7	10.6	9.5	3.1	4.3	28.8	0.0	14.6	8.9	11.9	11.2	9.8	16.3	0.9	15.9	32.0	11.7	7.7	9.0	29.3	28.5	11.9	16.6	23.9	38.5	22.8	12.9	2.5	12.8	5.5	1.7	26.1	21.2	2.0	4.7	1.7	0.9	6.2	10.4	1.8	21.5	9.6	2.5	9.2	22.6	21.6	23.3	9.7	2.2	49.5	12.6	12.3	17.4	16.8	9.0	0.0	13.5	9.8	2.0	4.2	27.0	4.1	10.7	16.0	13.1	12.6	14.9
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669733-153689010	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.1;intestine: 81.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 40.9;Excitatory neurons: 29.0;Extravillous trophoblasts: 63.9;Granulosa cells: 46.9;Syncytiotrophoblasts: 49.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"AN3-CA: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.2	43.7	1.9	48.8	0.0	0.6	6.5	53.3	1.3	4.8	81.7	3.4	6.5	1.7	14.0	4.1	2.6	6.5	49.8	40.8	1.9	0.2	0.6	0.0	19.6	22.8	0.9	0.3	0.5	1.8	2.0	21.1	17.2	3.8	7.9	0.4	37.6	2.0	1.8	13.4	15.7	15.0	0.2	15.9	8.8	65.1	1.4	0.3	0.3	0.1	27.4	2.2	28.5	0.3	0.1	0.4	33.9	0.0	0.0	3.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.2	0.4	0.5	0.0	0.0	0.0	3.9	0.0	0.0	0.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.3	0.4	0.3	0.2	0.7	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.2	3.7	0.0	0.1	2.7	0.9	0.3	0.4	0.0	0.2	1.2	0.0	0.2	0.2	0.0	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	48.8	6.5	53.3	49.8	40.8	19.6	22.8	21.1	15.0	65.1	28.5	0.0	0.0	0.0	18.9	0.0	0.6	0.4	40.9	0.0	21.6	0.3	0.9	3.0	0.0	18.0	0.0	22.9	13.5	0.1	1.7	0.0	0.4	0.3	0.3	4.4	0.3	0.0	0.0	29.0	0.4	63.9	0.5	0.0	0.3	0.0	46.9	0.0	0.0	2.4	0.0	24.2	1.1	12.2	0.0	0.0	0.8	0.0	0.3	1.8	1.0	0.0	3.2	0.0	11.1	13.2	2.9	0.1	0.4	0.0	0.3	20.3	0.4	2.6	19.4	0.0	0.0	4.0	0.6	0.9	0.0	0.6	49.5	0.1	0.6	0.4	1.0
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99397629-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favorable (1.09e-4)"	68.2	68.8	56.9	52.0	55.4	106.8	75.3	78.4	89.8	103.1	67.5	114.5	51.4	79.7	93.6	51.8	93.2	38.2	84.6	54.3	56.4	67.1	62.2	74.4	78.7	56.7	54.7	123.0	66.0	38.4	112.0	36.4	52.9	91.2	49.4	102.1	76.6	48.1	89.4	64.1	94.1	49.4	49.3	90.6	77.1	39.4	56.9	51.4	114.5	31.2	54.9	81.6	80.3	60.1	26.7	19.5	98.8	72.0	35.3	46.8	45.8	44.1	22.8	25.6	29.9	33.3	49.2	85.8	26.6	25.3	28.7	41.9	49.3	33.3	45.2	75.0	48.8	52.6	105.0	30.6	22.2	73.0	67.9	51.8	50.0	27.4	37.5	95.7	34.2	44.8	59.3	52.5	31.3	25.2	31.8	71.2	55.2	24.5	15.3	62.1	29.6	32.4	47.1	47.1	43.4	51.9	21.7	23.6	35.3	75.4	32.8	58.6	45.0	25.2	28.9	25.7	37.2	35.9	24.3	70.5	37.5	68.3	27.0	12.3	10.8	11.9	12.5	6.4	13.0	19.3	12.0	10.4	5.0	25.8	17.9	16.6	30.0	23.5	7.7	19.6	12.4	3.7	56.9	55.4	78.4	89.8	54.3	56.4	56.7	54.7	52.9	49.3	56.9	60.1	175.8	185.9	237.6	356.2	375.8	195.3	357.3	250.5	165.6	546.2	143.9	192.5	121.2	137.2	215.7	178.4	446.2	158.3	336.4	152.4	74.3	130.8	17.0	132.2	185.7	210.7	247.8	194.4	241.5	104.5	102.1	240.1	100.9	140.5	190.5	344.5	135.7	109.4	99.7	498.0	257.4	129.6	199.4	128.0	236.8	47.9	593.3	152.1	167.2	193.9	261.6	223.6	375.9	270.4	252.6	133.1	176.2	441.2	209.8	293.6	205.8	58.6	179.6	419.9	249.8	288.7	236.3	342.6	181.3	115.5	173.6	180.9	283.8	363.3	151.3	352.4
PNMA8A	"FLJ10781, KIAA1183L, PNMAL1"	ENSG00000182013	"PNMA family member 8A"	Q86V59	19	46466491-46471563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Endometrial ciliated cells: 8.4;Granulosa cells: 13.5;Respiratory ciliated cells: 10.9;Theca cells: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 32.9;K-562: 36.3;LHCN-M2: 35.9;SH-SY5Y: 31.3"	"Low region specificity"	"Detected in all"							"HPA012956, HPA077702"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA012956: AB_1844328, HPA077702: "	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.76e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.48e-3)"	1.1	22.8	45.8	0.9	44.8	0.7	4.7	16.2	54.3	5.8	13.9	3.6	0.7	12.5	16.2	1.2	22.1	5.2	15.0	45.4	53.9	8.7	0.4	1.7	0.3	27.0	30.1	17.2	6.3	15.8	36.7	2.6	35.3	8.8	0.7	35.6	6.0	9.6	1.6	1.2	1.3	7.2	23.3	0.6	1.8	22.5	39.8	30.1	15.4	1.1	0.6	3.1	1.6	34.6	0.0	13.9	19.7	19.6	5.6	12.7	3.5	1.3	0.2	2.4	1.2	0.2	1.6	0.1	18.1	0.9	6.8	0.2	32.9	5.3	1.6	0.1	12.2	0.0	0.5	0.5	9.4	0.2	0.2	3.3	6.5	8.2	0.0	1.8	2.0	11.9	36.3	0.2	35.9	0.1	0.2	0.2	16.5	0.0	0.0	0.0	21.5	0.0	8.2	0.1	16.0	31.3	0.1	0.3	0.0	18.0	0.2	0.3	1.2	0.0	0.2	0.2	6.8	0.1	0.1	0.2	0.3	0.1	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	0.0	0.0	45.8	44.8	16.2	54.3	45.4	53.9	27.0	30.1	35.3	23.3	39.8	34.6	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.9	0.0	0.0	1.8	11.0	0.0	1.9	0.0	0.0	3.9	0.9	0.0	8.4	2.3	0.3	0.0	0.0	0.0	0.0	0.5	2.8	0.0	1.3	0.0	13.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	10.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.0
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923792-43964488	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 31.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 35.9;Cone photoreceptor cells: 18.8;Hepatocytes: 42.3;Rod photoreceptor cells: 37.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 16.7;LHCN-M2: 19.3"	"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.6	0.2	0.6	0.5	0.8	0.1	1.6	0.1	1.2	0.6	5.9	0.1	0.8	0.3	0.1	0.2	0.9	0.4	0.2	1.2	0.7	4.5	31.0	0.8	0.3	1.7	1.8	0.3	0.0	0.2	0.0	0.3	2.0	0.0	0.1	6.4	0.7	0.0	1.7	5.8	0.5	0.0	0.2	0.4	0.2	0.4	1.3	0.1	0.1	0.1	0.2	0.0	0.3	0.6	5.1	1.6	16.7	6.8	4.6	5.2	0.5	3.1	1.8	4.1	8.8	5.0	9.0	0.0	2.5	5.2	2.4	4.3	10.6	5.0	3.4	0.0	0.9	0.3	4.5	9.4	7.5	0.0	0.3	6.0	3.8	13.2	0.6	7.0	0.5	0.2	0.0	0.0	19.3	0.7	0.3	0.0	11.5	0.6	0.0	0.1	8.9	0.2	1.7	0.2	1.5	0.1	3.4	1.4	4.8	2.9	5.3	5.8	0.6	1.6	4.9	0.1	0.1	0.1	0.0	0.0	14.3	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.1	1.2	1.2	0.7	1.7	1.8	2.0	0.2	1.3	0.6	0.4	0.0	0.0	4.2	0.2	0.4	0.5	2.4	0.0	35.9	0.5	0.1	1.3	10.0	1.4	0.0	18.8	0.0	0.2	0.2	0.0	0.4	0.0	1.5	0.5	0.4	1.8	0.0	1.9	0.0	0.1	0.5	0.0	3.6	0.0	1.9	0.7	42.3	0.7	0.0	1.2	0.8	0.0	2.8	0.3	0.3	0.3	0.9	1.8	0.0	0.0	1.1	0.0	0.0	0.8	2.6	0.0	0.7	0.0	0.7	0.4	5.0	0.1	37.3	0.0	1.0	0.8	0.6	0.6	0.0	0.1	0.0	0.2	1.6	0.4	0.4
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.4;Late spermatids: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007522, HPA064773"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA007522: AB_1079649, HPA064773: "	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	17.9	27.3	18.3	26.2	23.2	26.1	16.4	14.7	31.5	20.2	12.6	25.7	26.9	20.8	5.3	20.4	16.8	13.7	20.7	21.9	16.3	25.6	21.9	40.4	19.5	23.4	20.3	18.8	16.4	15.6	32.7	13.6	25.6	21.4	8.4	10.6	15.8	12.8	33.5	17.5	29.6	14.5	10.1	41.9	19.2	36.4	23.7	10.9	22.7	19.5	8.9	24.6	17.4	23.6	32.4	80.1	14.7	36.1	25.5	37.0	34.3	42.2	41.9	31.4	28.8	18.6	43.7	27.3	69.1	55.3	19.7	40.8	13.1	39.4	16.3	68.5	29.2	17.7	41.8	13.9	29.2	20.2	53.0	31.6	22.2	41.8	23.8	49.2	62.7	31.4	14.9	36.5	28.6	15.7	22.2	26.0	16.2	15.5	71.7	17.3	9.0	31.9	27.9	31.2	19.0	32.5	34.9	15.7	45.6	20.4	14.1	27.6	67.0	38.5	22.1	53.3	44.2	42.6	30.1	12.2	64.2	23.2	36.7	15.7	11.3	37.6	5.4	20.0	5.5	6.5	3.8	5.7	12.1	4.3	3.3	4.5	3.2	7.9	35.0	3.8	6.9	8.8	18.3	23.2	14.7	31.5	21.9	16.3	23.4	20.3	25.6	10.1	23.7	23.6	12.6	6.4	12.0	16.6	11.9	4.8	4.1	9.3	8.6	12.1	10.9	8.3	10.0	15.7	10.1	33.1	27.1	18.2	14.4	48.5	1.9	15.8	73.4	8.2	7.2	13.5	17.4	25.4	14.0	7.1	15.5	7.3	14.8	10.7	12.0	19.5	13.6	20.2	27.4	21.9	16.1	14.6	10.2	68.3	16.0	106.1	9.6	42.4	8.8	15.0	23.6	9.2	21.6	9.0	16.4	9.5	17.9	7.5	8.8	4.9	67.0	12.1	14.4	16.5	0.0	7.1	7.7	60.8	10.5	8.5	5.5	12.4	15.9	10.0	20.9	3.6
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470417-108569666	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	27.8	47.3	23.6	17.9	25.1	82.9	20.2	21.6	29.6	19.4	22.1	14.1	11.8	17.9	17.7	21.1	11.6	21.4	25.3	24.0	26.5	30.0	34.6	17.5	18.0	23.5	23.3	14.7	13.9	28.4	16.5	26.6	23.4	18.0	15.1	24.4	11.9	17.7	35.9	15.0	10.7	20.9	24.9	17.7	15.6	15.5	22.9	18.6	24.3	34.7	22.1	29.1	12.7	26.5	28.6	12.8	22.1	19.7	47.7	32.7	32.4	26.6	47.2	21.6	35.8	12.4	16.0	15.9	33.1	26.4	43.4	10.6	37.9	17.1	32.6	24.2	10.1	11.0	19.3	9.1	34.8	7.6	21.7	29.8	31.7	29.2	26.9	23.4	29.5	17.7	13.0	44.5	27.2	18.9	18.0	18.3	9.8	17.9	17.8	6.5	23.3	34.3	25.9	35.9	18.3	25.3	25.8	27.4	32.7	27.7	11.6	12.6	24.2	35.1	15.7	52.8	15.0	37.4	41.5	23.9	33.4	11.4	23.2	21.9	29.8	26.2	14.6	32.8	17.8	28.6	14.2	14.6	29.2	27.3	15.4	14.7	24.5	22.9	43.4	11.6	19.1	22.9	23.6	25.1	21.6	29.6	24.0	26.5	23.5	23.3	23.4	24.9	22.9	26.5	64.5	41.7	49.3	66.3	91.3	92.9	124.0	42.2	55.2	64.0	45.7	35.9	49.7	8.6	51.2	23.9	18.8	58.0	72.7	44.3	93.9	32.0	52.3	124.9	67.3	57.1	57.1	50.7	42.4	37.8	37.5	76.6	45.3	236.1	71.7	19.0	23.2	44.3	32.2	32.0	42.9	27.8	67.1	45.5	90.0	47.4	32.0	113.8	55.2	23.4	43.5	42.9	18.6	38.2	41.3	29.6	38.6	39.5	76.8	80.1	16.7	41.0	62.0	32.5	19.7	88.9	63.9	18.6	23.1	60.5	135.7	130.2	69.1	43.7	22.9	122.7
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Hepatocytes: 53.4;Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	7.3	15.8	16.5	6.2	15.9	3.5	10.6	16.7	22.0	7.0	12.9	8.8	10.2	5.0	11.6	10.7	10.1	6.6	13.2	16.0	21.9	35.1	88.8	6.4	6.9	19.1	21.2	5.8	10.9	26.6	9.2	7.0	20.6	8.0	8.6	5.4	10.4	7.8	21.1	6.7	9.6	6.1	16.5	7.2	8.6	6.6	20.6	5.8	17.8	19.6	7.7	6.7	7.3	14.3	37.9	30.9	2.4	5.8	15.3	11.7	0.0	12.2	7.7	14.0	11.9	51.1	27.6	35.2	57.4	12.7	5.5	22.0	19.4	34.7	20.3	43.4	16.4	24.6	13.9	53.6	16.3	22.6	16.6	15.4	26.9	25.8	32.7	13.1	18.0	26.1	24.4	12.2	16.5	28.3	25.3	7.8	4.5	37.4	37.1	18.8	10.4	26.2	40.2	19.5	12.1	9.5	11.2	18.6	10.7	8.5	32.4	9.1	19.1	22.6	12.8	22.2	26.2	27.8	34.0	19.0	18.4	19.2	11.7	2.5	12.3	2.8	7.2	17.7	8.2	6.7	6.3	7.6	13.5	5.3	8.2	8.1	1.1	7.9	11.9	9.8	7.0	10.3	16.5	15.9	16.7	22.0	16.0	21.9	19.1	21.2	20.6	16.5	20.6	14.3	7.6	12.8	13.9	7.5	3.9	1.5	6.7	5.0	5.7	1.1	16.2	14.4	1.9	18.6	6.8	12.9	4.2	8.4	7.8	7.3	62.6	18.2	0.8	11.2	6.4	5.9	3.6	7.4	4.2	15.6	1.9	5.3	4.6	13.3	12.7	8.8	6.4	53.4	17.2	3.3	6.2	11.6	2.0	11.4	2.4	0.9	9.9	10.6	1.8	2.8	8.6	7.1	3.1	2.5	3.2	15.0	8.9	6.0	4.9	9.0	20.2	86.3	5.9	1.9	0.0	4.1	3.8	0.7	1.3	7.2	2.3	6.3	4.7	19.5	15.4	5.0
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693873-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Excitatory neurons: 42.3;Inhibitory neurons: 65.7;Microglial cells: 57.1;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.92e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.48e-2)"	"unprognostic (8.41e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.08e-1)"	3.7	2.0	1.9	4.8	2.5	7.3	5.1	2.2	1.8	4.3	0.8	4.1	2.4	4.2	1.4	3.9	3.7	2.1	3.5	1.3	1.9	2.9	2.0	3.1	6.8	2.3	2.3	5.8	2.8	3.4	1.8	5.6	2.4	3.1	5.2	3.7	3.0	3.5	4.9	4.0	3.5	4.8	2.2	3.5	3.7	2.6	2.1	11.9	3.1	3.1	7.7	3.7	3.8	2.6	32.7	24.6	30.3	24.1	5.2	6.5	6.9	23.6	12.7	25.0	28.3	20.4	17.0	41.1	7.7	9.6	23.4	26.0	59.7	18.7	33.6	21.1	24.8	31.0	42.8	13.5	2.4	41.6	15.5	4.1	3.6	31.2	8.4	5.8	13.0	20.8	28.7	20.0	16.8	22.4	45.2	7.2	30.7	20.3	19.1	39.0	81.5	30.7	7.1	21.1	27.9	16.7	28.1	11.2	11.6	33.0	25.7	11.5	10.1	21.3	14.9	42.4	22.6	11.6	18.1	32.7	12.4	18.3	24.9	0.0	0.2	0.2	0.6	1.4	0.8	1.0	0.8	1.0	0.7	0.4	0.4	0.5	0.0	0.8	0.2	0.2	0.9	0.5	1.9	2.5	2.2	1.8	1.3	1.9	2.3	2.3	2.4	2.2	2.1	2.6	5.8	9.6	6.5	38.5	5.2	2.8	4.6	1.8	5.7	3.9	4.7	4.3	11.8	0.0	7.2	1.8	2.1	6.1	3.2	2.5	3.9	3.2	0.2	3.2	4.7	6.3	4.2	24.2	42.3	3.0	4.9	4.6	4.6	3.8	9.5	8.3	3.3	3.4	4.4	1.7	65.7	4.2	4.1	4.4	1.5	1.7	6.2	4.5	0.0	57.1	3.7	4.8	5.2	59.3	97.7	1.4	1.2	3.4	8.6	2.0	2.3	1.6	6.1	7.4	6.6	9.2	6.0	6.4	4.5	5.5	2.3	2.3	4.9	5.0	4.2	2.4
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958643-74970128	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 110.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 47: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA054979: AB_2682661, HPA071815: AB_2686453"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	19.7	17.1	16.0	5.4	16.1	23.3	19.9	14.5	25.3	14.7	13.9	16.4	5.9	12.0	2.7	11.4	11.9	7.7	15.0	15.8	14.9	14.5	15.2	12.1	12.5	15.4	15.2	13.6	8.6	3.0	3.1	6.5	15.8	10.7	6.0	7.1	12.2	6.7	29.0	10.5	13.2	7.3	15.1	12.1	14.6	6.8	15.5	5.3	10.3	16.9	7.3	15.0	12.0	17.2	37.4	33.5	3.3	3.3	11.2	23.4	0.0	24.3	29.1	36.6	30.7	43.1	16.2	33.3	19.9	26.6	10.1	16.0	15.6	19.5	39.6	15.5	42.2	28.0	20.3	46.7	38.8	40.4	41.5	23.8	37.0	15.3	33.3	12.6	16.1	4.8	33.9	21.2	28.1	35.6	12.0	110.1	24.2	23.0	59.1	14.1	28.8	29.4	30.3	1.0	10.8	15.9	33.5	13.9	19.1	1.9	10.4	13.6	18.4	8.7	9.6	6.0	24.7	7.3	5.0	12.8	31.2	58.8	43.4	7.0	53.6	19.1	13.3	32.7	14.5	35.2	19.2	16.1	29.7	33.3	20.5	14.7	3.5	10.6	30.2	33.8	20.4	31.8	16.0	16.1	14.5	25.3	15.8	14.9	15.4	15.2	15.8	15.1	15.5	17.2	156.9	25.6	40.4	3.9	83.9	84.5	96.6	82.4	62.0	33.9	89.9	80.4	40.3	48.6	52.6	73.5	43.8	156.3	69.5	116.4	148.7	53.6	12.1	37.3	34.2	96.0	12.2	50.9	6.2	80.7	154.7	66.4	30.5	33.4	61.6	53.9	94.2	147.1	115.6	18.5	6.6	100.8	44.7	113.7	111.5	24.0	67.1	91.9	97.8	9.4	134.1	174.9	87.6	4.0	11.1	83.5	157.5	54.5	55.8	100.3	190.7	182.3	49.2	126.8	78.9	99.4	68.8	45.9	91.5	57.8	97.7	94.0	70.3	108.1	88.3	95.4
POLR1B	"FLJ10816, FLJ21921, RPA135, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112579818	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 181.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli fibrillar center"	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	5.7	4.6	2.9	5.6	3.0	4.1	8.2	3.5	3.1	5.3	3.8	5.5	4.4	4.7	4.4	8.1	6.7	3.7	4.1	2.8	3.5	8.1	10.7	4.1	9.3	2.6	2.7	6.3	8.1	11.9	4.4	5.6	2.5	5.0	6.2	5.2	3.8	4.7	7.5	5.2	3.8	5.3	2.6	6.7	4.3	8.4	3.1	7.2	10.7	6.4	10.8	7.9	3.6	3.4	21.1	21.6	11.2	28.2	13.9	13.2	24.0	15.1	11.9	24.0	21.5	48.8	12.5	46.1	22.9	9.8	18.8	29.5	56.1	30.6	28.4	22.3	30.9	26.5	21.4	37.1	14.2	43.6	18.1	12.7	21.6	25.4	39.6	9.8	19.9	10.2	55.0	16.8	13.2	17.5	20.5	29.7	66.3	29.5	42.8	30.9	21.3	54.1	17.2	19.2	34.3	29.1	12.1	34.7	19.7	13.8	16.3	15.6	15.9	14.6	23.2	13.7	21.8	24.3	44.4	40.9	11.0	28.8	13.1	0.4	8.0	3.3	10.0	8.3	21.5	11.4	9.9	10.7	14.2	11.6	12.4	12.5	0.8	15.3	6.5	3.5	15.2	9.6	2.9	3.0	3.5	3.1	2.8	3.5	2.6	2.7	2.5	2.6	3.1	3.4	4.8	16.0	5.9	4.6	8.5	15.0	4.7	4.1	9.6	3.6	4.2	3.7	6.4	7.2	5.8	9.2	2.1	3.4	6.5	2.0	5.9	3.9	181.9	3.5	7.6	5.8	3.6	5.9	8.8	4.6	2.8	3.5	8.6	4.2	5.1	6.5	1.4	9.4	3.8	1.7	9.2	3.8	0.0	4.3	3.7	40.9	3.1	3.8	1.8	3.7	4.5	4.3	8.2	7.5	8.1	3.8	5.8	3.0	6.4	6.2	1.2	5.1	3.2	2.9	0.0	5.1	3.5	10.3	7.9	12.7	17.2	0.5	6.2	6.8	5.5	3.9
POLR3K	"C11, RPC11"	ENSG00000161980	"RNA polymerase III subunit K"	Q9Y2Y1	16	46407-53608	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 183.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005891	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA005891: AB_1079653"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.03e-3)"	"unprognostic (9.06e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.63e-2)"	6.9	10.4	12.5	13.1	13.0	11.6	7.0	12.3	13.5	6.4	11.0	8.1	8.3	6.8	7.3	8.7	7.4	5.2	10.3	12.6	12.8	8.2	9.0	6.5	18.4	11.8	11.9	7.1	6.9	12.3	6.1	6.7	12.5	8.0	7.6	5.1	8.4	6.8	20.5	5.3	8.5	6.7	11.5	11.9	8.4	2.6	13.6	13.1	9.5	12.6	16.3	8.8	5.8	13.2	36.1	60.9	37.7	39.4	15.2	9.4	30.3	50.2	16.0	43.4	28.7	79.4	38.2	93.1	37.1	17.7	17.3	35.0	88.5	23.0	31.0	56.5	82.1	68.2	44.5	56.6	11.6	62.1	64.3	9.2	20.4	48.3	24.3	9.9	21.7	40.9	99.0	29.0	28.4	89.9	75.1	41.2	62.3	44.8	57.4	89.9	43.7	96.7	25.0	25.7	55.1	32.5	34.7	63.2	30.8	15.9	37.2	55.2	20.9	28.1	34.5	37.8	61.6	18.5	47.5	183.8	12.1	45.1	42.5	30.5	36.3	93.2	40.4	54.7	42.1	114.6	51.3	46.5	34.4	109.9	45.8	42.6	27.7	41.2	51.8	70.2	87.6	53.1	12.5	13.0	12.3	13.5	12.6	12.8	11.8	11.9	12.5	11.5	13.6	13.2	23.3	3.2	11.3	2.0	31.8	33.3	19.9	34.4	17.6	16.4	29.7	33.8	28.9	18.6	30.3	18.4	4.2	42.5	28.2	17.6	49.0	34.0	0.7	21.6	15.6	20.0	18.0	38.3	5.1	35.0	51.1	16.9	9.2	14.9	22.2	29.7	20.7	27.5	43.7	10.1	4.6	21.8	71.2	15.1	24.3	1.8	21.1	23.2	23.2	3.7	44.1	23.5	34.0	1.0	3.4	37.0	16.2	16.6	28.1	29.6	17.1	43.4	30.6	10.8	13.1	12.0	25.2	4.5	18.9	23.4	44.2	12.9	23.1	58.8	29.3	22.1
POMT2	LGMD2N	ENSG00000009830	"Protein O-mannosyltransferase 2"	Q9UKY4	14	77274956-77320883	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.1;Oligodendrocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003663	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003663: AB_1079655"	"unprognostic (2.15e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (7.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.94e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.46e-2)"	5.8	12.4	13.2	4.1	14.9	2.5	5.7	13.5	13.4	8.0	12.5	6.7	2.6	6.7	9.8	5.5	5.8	4.0	7.9	12.7	13.1	10.8	9.3	5.6	1.8	14.6	14.6	6.1	8.8	8.6	12.6	7.0	13.4	7.8	3.3	5.6	6.3	6.9	19.1	4.7	4.9	4.6	13.7	5.6	5.9	37.5	14.4	2.9	10.9	8.4	1.9	7.9	5.3	15.4	15.6	19.4	18.6	21.1	13.0	10.3	14.8	13.4	10.8	19.3	16.6	9.6	13.6	4.6	10.6	12.6	27.1	17.1	8.8	13.3	13.5	6.9	12.1	2.8	8.9	7.9	15.8	3.2	8.9	10.5	13.9	18.3	17.8	13.6	11.5	4.5	7.4	10.5	13.0	30.7	5.4	15.0	5.3	21.4	16.2	5.3	18.0	4.1	20.4	11.3	15.6	15.2	8.7	14.6	11.3	12.0	15.1	6.5	9.6	14.6	22.8	17.1	12.0	6.8	14.5	2.1	7.4	4.8	13.2	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.1	13.2	14.9	13.5	13.4	12.7	13.1	14.6	14.6	13.4	13.7	14.4	15.4	3.2	6.4	2.8	27.1	2.0	3.1	2.7	3.4	2.8	7.5	7.2	7.6	4.3	4.3	1.6	1.8	16.7	6.0	1.2	6.5	0.0	7.6	14.3	5.8	6.7	3.1	18.0	0.0	12.9	7.5	10.2	6.1	4.1	7.0	2.5	6.4	2.5	5.7	5.5	8.4	14.5	3.2	2.0	2.2	2.6	17.2	1.8	2.4	1.8	9.4	2.3	5.9	0.0	20.1	30.5	5.5	3.2	4.1	2.1	5.2	2.5	3.6	5.1	15.1	0.0	6.2	5.0	11.3	8.2	5.2	1.8	5.7	1.2	13.9	3.6	1.9
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105157900-105180014	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.0;skeletal muscle: 96.3;tongue: 29.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 42.8;Early spermatids: 88.0;Excitatory neurons: 16.6;Late spermatids: 18.2;Oligodendrocytes: 15.0;Skeletal myocytes: 32.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.9;RH-30: 15.8;SH-SY5Y: 15.4;U-87 MG: 14.2;WM-115: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012514			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.5	0.3	5.1	0.3	6.8	0.0	0.2	5.8	10.0	0.5	4.8	2.5	0.1	0.9	1.5	1.8	0.4	0.7	23.0	6.2	6.2	0.2	0.0	0.1	0.1	6.3	6.4	0.2	0.1	0.1	4.4	0.7	6.2	0.8	0.0	0.5	1.3	0.3	96.3	0.2	0.5	0.0	6.3	0.0	3.2	3.9	6.0	0.0	0.2	29.6	0.0	1.3	0.4	9.7	1.3	1.6	0.5	0.2	2.7	6.8	0.6	2.9	2.5	4.5	5.2	0.0	1.6	0.1	1.1	5.5	25.9	0.0	1.7	1.5	3.6	0.0	4.1	0.0	1.1	0.0	0.1	0.0	0.0	2.3	0.3	7.5	1.0	1.4	0.3	0.1	3.4	7.0	12.8	0.0	0.0	1.5	3.0	0.0	6.3	0.5	15.8	0.0	0.0	0.0	7.5	15.4	0.0	0.1	11.5	1.4	0.0	6.2	6.5	3.4	0.0	2.1	10.7	0.0	0.0	0.0	14.2	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.8	5.8	10.0	6.2	6.2	6.3	6.4	6.2	6.3	6.0	9.7	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	42.8	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	88.0	1.5	1.0	0.4	0.0	0.0	16.6	0.0	1.2	2.0	0.0	5.6	0.0	0.1	0.0	0.0	0.3	0.0	4.9	0.0	2.0	0.0	0.0	18.2	0.6	0.7	0.0	2.8	2.0	0.0	0.0	0.5	15.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	32.0	3.5	2.9	5.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 313.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 489.2;Proximal enterocytes: 274.2;Theca cells: 647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 328.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		12000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	53.4	197.4	19.9	32.1	20.7	17.9	44.7	14.1	18.6	42.0	15.5	35.9	105.2	32.1	29.4	53.6	50.2	37.0	43.3	20.7	30.2	38.1	313.3	55.0	19.9	22.2	24.5	52.2	44.5	77.6	71.4	46.3	20.9	31.8	21.9	12.7	29.9	113.1	56.2	43.8	92.4	28.2	16.9	43.8	41.5	25.5	34.7	38.0	131.3	68.1	23.2	36.6	42.3	15.3	59.6	133.0	57.0	106.3	212.9	79.8	98.0	24.4	79.3	44.7	62.3	100.7	257.0	56.1	21.9	53.1	151.8	28.3	76.0	38.4	19.6	48.1	57.9	26.0	36.9	189.4	146.5	26.2	45.5	163.9	47.4	59.2	43.2	36.3	42.3	27.1	79.1	24.0	40.8	90.9	29.0	49.4	71.7	92.9	74.8	41.0	37.6	61.1	50.0	72.8	59.3	57.4	65.4	328.4	91.0	32.6	94.0	44.2	38.6	41.7	45.8	63.6	48.7	23.8	38.3	39.0	59.3	39.8	54.9	65.9	42.6	60.4	20.6	39.6	17.1	11.0	17.5	19.4	45.6	11.2	17.1	14.7	53.8	25.9	30.2	12.5	19.3	36.6	19.9	20.7	14.1	18.6	20.7	30.2	22.2	24.5	20.9	16.9	34.7	15.3	34.3	38.5	39.7	23.2	17.1	17.1	29.4	172.3	13.1	31.4	20.5	14.0	10.9	54.3	201.4	73.5	12.5	99.9	26.0	97.7	1.9	65.0	27.6	62.1	28.0	27.1	19.8	11.8	10.1	29.4	95.0	40.1	67.8	46.6	24.7	121.4	32.2	489.2	67.8	15.2	17.1	41.7	124.1	35.2	16.1	9.5	75.8	47.3	12.4	11.2	20.5	25.9	12.3	11.6	8.8	27.9	102.0	112.5	17.0	20.7	274.2	31.7	178.6	23.0	65.7	32.7	46.9	21.3	30.8	18.2	14.6	193.2	25.4	647.6	44.5	45.9
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 48.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.1	0.1	0.2	0.1	0.1	0.2	2.0	0.3	0.4	0.8	0.0	0.6	0.9	0.0	1.7	1.3	0.5	0.7	0.1	0.1	0.1	0.3	0.1	1.0	0.2	0.1	0.1	0.1	0.2	6.3	0.4	0.3	0.1	0.6	0.2	0.1	1.1	2.0	0.2	48.0	0.7	0.3	0.0	0.2	0.7	0.1	0.1	0.2	0.7	0.0	0.5	0.4	2.1	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	3.6	0.1	1.3	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	2.5	0.0	0.3	3.9	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	8.2	0.3	0.0	20.9	10.6	5.0	1.8	0.0	3.0	1.5	0.8	0.0	3.9	11.0	0.0	1.5	0.1	0.9	0.0	5.3	2.2	1.3	0.7	0.3	3.0	0.0	0.4	1.3	0.4	0.6	10.2	4.8	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.2	8.2	0.0	2.2	5.5	0.0	0.1	5.4	0.0	0.0	0.4	0.0	0.0	0.5	20.8	1.1	0.0	0.0	5.0	0.4	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.1	7.0	37.6	7.9	0.5	0.2	0.6	14.2
PPCDC	"FLJ14585, MDS018"	ENSG00000138621	"Phosphopantothenoylcysteine decarboxylase"	Q96CD2	15	75023586-75117462	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 71.4;granulocytes: 153.5;monocytes: 71.6"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 133.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045667	Approved		Approved	Cytosol		NA	NA		25000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA045667: AB_2679412"	"unprognostic (8.66e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-3)"	11.1	19.1	7.4	10.8	8.8	19.7	10.9	8.3	8.4	9.7	8.7	11.5	9.7	8.3	9.8	19.0	10.8	8.4	8.5	6.9	8.0	17.2	13.1	10.8	16.4	9.2	8.8	9.0	16.5	21.3	9.3	9.2	8.5	13.0	9.4	7.6	13.9	7.6	11.9	9.0	9.9	5.4	8.0	18.8	11.3	9.7	8.6	12.1	11.2	5.9	12.3	11.2	10.0	10.3	15.6	28.8	11.8	9.2	7.0	6.4	10.1	15.5	7.0	20.3	15.9	16.9	41.2	17.7	26.8	7.8	12.5	15.9	19.2	25.6	10.4	62.6	23.4	31.1	18.8	18.3	19.9	18.3	38.7	8.6	16.7	21.0	32.3	8.2	16.6	25.8	21.3	133.2	14.8	30.0	10.9	28.1	18.9	32.9	13.4	18.2	23.0	38.3	15.3	22.2	28.3	8.3	22.9	31.3	34.6	13.4	38.7	23.4	9.4	20.6	14.4	10.5	27.6	40.5	29.3	30.1	12.7	45.9	23.7	47.2	23.1	153.5	11.6	65.6	19.4	15.7	10.6	13.0	17.6	8.6	11.7	14.5	139.7	18.5	71.6	71.4	12.7	15.8	7.4	8.8	8.3	8.4	6.9	8.0	9.2	8.8	8.5	8.0	8.6	10.3	10.2	16.0	5.2	2.9	10.5	3.8	6.1	8.5	8.6	2.8	9.6	8.8	4.2	4.3	9.7	9.2	0.0	17.5	16.0	19.7	25.4	17.3	1.0	8.2	4.3	10.7	4.2	11.6	1.4	15.3	13.6	7.4	14.8	8.3	12.0	9.9	10.4	5.3	20.0	8.4	1.7	10.9	12.2	15.7	6.7	2.5	4.4	15.5	14.2	2.8	20.0	4.7	8.2	2.5	4.6	18.0	38.1	5.3	33.9	6.5	10.5	19.0	12.2	10.7	6.6	6.3	8.7	6.9	15.7	10.8	4.0	10.9	9.7	11.3	11.7	13.6
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 35.6;testis: 18.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 374.4;Endometrial ciliated cells: 226.5;Late spermatids: 75.1;Respiratory ciliated cells: 228.6;Spermatocytes: 101.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;ASC diff: 9.2;ASC TERT1: 11.5;hTERT-RPE1: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.1	0.9	4.7	0.6	5.2	0.2	3.0	5.7	5.3	3.8	12.2	1.3	1.4	3.0	9.0	1.4	35.6	1.1	2.1	4.8	5.2	4.3	0.6	4.7	0.6	7.5	8.2	5.3	2.3	5.2	2.7	1.1	5.5	1.2	1.0	7.4	2.3	2.7	4.3	1.3	0.7	2.0	7.2	0.8	1.7	18.9	5.1	0.8	11.1	1.7	0.6	1.5	1.2	7.6	1.4	1.2	1.1	6.0	9.2	11.5	0.6	0.0	2.2	0.5	0.1	0.1	1.6	0.0	0.4	0.6	0.8	0.9	1.0	0.0	0.3	0.4	0.4	0.5	0.1	0.0	4.6	0.5	0.2	2.4	5.6	0.2	3.5	8.6	0.7	1.3	0.6	0.4	0.4	0.6	0.1	0.7	0.2	4.0	0.8	0.6	0.0	0.5	4.7	0.1	1.3	2.1	0.1	0.3	3.9	0.3	0.4	0.9	0.3	0.1	0.2	1.0	0.2	0.2	0.1	0.1	1.9	0.1	0.4	0.8	0.1	0.2	0.1	0.1	0.1	1.5	0.2	0.1	0.3	0.5	0.1	0.1	0.4	0.4	0.1	0.4	0.1	0.2	4.7	5.2	5.7	5.3	4.8	5.2	7.5	8.2	5.5	7.2	5.1	7.6	2.6	6.4	6.9	11.8	1.8	2.2	3.7	18.2	2.8	2.4	5.7	7.0	3.7	2.8	22.1	3.7	2.1	0.8	0.4	0.9	25.4	1.9	374.4	226.5	7.3	1.8	3.0	0.4	15.0	1.2	0.8	3.9	2.6	5.8	0.0	4.1	1.1	0.2	0.4	1.7	6.1	2.0	22.4	0.0	0.3	75.1	5.3	1.1	3.6	3.7	0.6	7.8	0.0	8.5	6.2	0.7	0.8	5.3	0.8	3.8	1.5	13.0	228.6	13.4	0.0	5.2	5.6	101.4	21.5	1.9	3.0	0.7	1.2	3.0	2.0	1.5
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 728.1;vagina: 288.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Squamous epithelial cells: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.5;HaCaT: 191.1;MCF7: 71.5;SiHa: 102.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		80000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	56.3	4.9	2.5	1.0	3.2	0.2	39.8	0.3	4.2	163.0	3.3	10.4	6.5	5.7	7.3	728.1	11.5	7.1	5.7	3.6	0.0	13.2	13.3	18.6	0.4	0.0	2.8	5.9	10.6	4.1	14.3	6.4	1.1	17.3	3.4	2.4	149.5	11.5	12.0	188.4	12.3	1.7	0.0	0.3	11.1	1.9	0.0	3.5	22.1	5.3	57.0	22.0	288.6	0.5	24.0	8.6	0.1	0.1	60.0	86.5	29.6	0.1	1.6	0.2	0.6	39.5	59.5	0.4	13.5	1.2	3.4	191.1	1.3	23.0	0.0	0.0	1.3	0.1	46.3	7.1	3.8	0.1	0.1	4.2	20.7	0.2	7.1	4.6	0.1	0.2	0.2	0.2	0.1	71.5	0.1	0.2	6.0	31.3	18.1	0.1	0.1	30.0	44.6	37.5	30.9	0.3	102.5	33.8	0.3	8.9	17.4	0.5	0.3	0.2	0.3	0.3	0.1	0.4	1.1	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.2	0.3	4.2	3.6	0.0	0.0	2.8	1.1	0.0	0.0	0.5	4.1	73.7	29.1	1.6	1.2	35.1	32.5	30.5	35.9	8.4	18.8	13.8	5.1	35.8	42.6	57.0	6.2	2.1	2.0	3.6	1.9	18.4	0.7	31.6	4.1	8.0	39.4	0.0	6.6	4.5	1.6	38.0	9.2	28.0	0.0	0.8	2.9	12.7	0.7	1.7	2.5	3.8	18.3	0.9	9.0	1.3	55.3	1.4	17.8	1.0	1.2	3.7	2.1	1.0	1.7	23.4	8.3	4.1	0.2	35.1	13.5	1.2	32.5	12.5	0.0	28.7	4.3	3.9	3.1	138.0	51.3	1.4	2.7	0.4	4.8	53.2
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078902	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.7;Excitatory neurons: 344.6;Inhibitory neurons: 175.7;Oligodendrocyte precursor cells: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 4.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 79.8;U-266/70: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	6.0	5.9	7.6	2.2	8.5	2.4	3.2	11.0	13.4	7.3	0.0	5.9	1.9	4.2	1.9	6.2	4.1	5.9	6.6	9.2	5.6	5.8	3.2	3.0	1.0	11.3	7.6	2.2	3.7	15.5	10.1	8.6	13.1	4.0	3.9	11.3	15.2	2.2	21.8	6.0	2.5	4.1	0.0	2.2	6.1	1.7	12.7	3.5	10.7	17.8	2.2	10.8	4.0	0.8	2.6	1.7	8.7	4.6	5.1	0.1	5.4	0.3	0.2	0.9	0.3	0.5	0.6	0.5	0.8	0.4	2.0	8.1	7.4	0.5	0.3	79.8	7.9	7.7	7.0	0.9	0.2	4.7	8.6	0.9	3.5	0.2	0.5	0.6	0.5	3.8	0.3	12.0	0.1	4.2	1.8	0.5	5.1	14.2	1.7	9.5	1.5	1.8	0.4	8.4	10.5	9.0	4.5	5.2	0.3	3.0	5.7	4.7	0.4	0.9	0.9	0.7	2.9	75.6	0.3	4.3	1.1	3.9	1.9	0.4	1.6	3.2	1.5	3.5	0.1	0.1	0.3	1.0	0.8	0.6	0.5	1.0	0.1	0.6	4.9	0.4	0.0	1.6	7.6	8.5	11.0	13.4	9.2	5.6	11.3	7.6	13.1	0.0	12.7	0.8	2.6	6.4	2.7	126.7	1.5	8.7	5.7	3.0	8.6	59.4	4.7	3.0	33.9	8.6	10.9	1.8	35.5	3.8	11.6	12.5	0.0	2.1	1.2	3.2	17.5	5.3	13.8	3.4	344.6	4.3	3.4	6.5	11.7	6.8	0.0	2.2	2.5	18.1	7.1	6.7	175.7	8.0	14.2	15.4	7.2	1.2	5.0	14.0	3.6	53.4	6.6	10.2	26.8	111.6	77.4	2.2	8.3	5.3	2.9	5.9	2.2	3.7	9.5	10.4	0.0	42.5	21.4	2.6	3.4	13.1	8.7	2.6	3.8	2.6	5.6	21.2
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166056-161178013	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 65.9;Respiratory ciliated cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030123	Uncertain		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Vesicles, Cytosol"	"HPA030123: AB_10603987"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	9.3	17.1	24.2	3.5	24.5	25.2	10.3	25.2	38.2	14.5	24.7	12.7	3.9	10.9	8.3	8.9	22.0	4.7	13.1	24.4	24.7	15.5	11.5	8.6	5.7	25.0	25.0	13.8	10.8	7.2	13.7	6.5	24.6	13.4	3.9	12.6	8.7	7.7	7.6	11.2	8.5	6.6	25.0	13.6	10.9	6.9	24.0	5.0	11.9	5.6	5.2	11.6	9.6	25.4	10.0	8.0	12.7	8.5	10.4	9.3	3.5	5.9	5.7	7.5	10.3	10.4	9.3	7.4	14.3	5.3	4.1	6.3	9.8	8.8	7.1	4.6	20.3	9.0	18.9	23.9	8.6	3.0	4.6	7.6	11.0	6.3	9.4	9.4	14.7	7.0	22.8	11.2	5.6	9.2	12.0	8.6	8.2	11.2	18.8	13.6	8.2	16.7	15.1	4.2	9.8	14.7	6.6	10.3	12.0	14.6	19.9	9.5	5.7	6.5	7.1	6.5	7.5	19.4	15.3	10.5	6.8	6.0	4.9	6.3	7.2	5.3	10.4	7.6	7.2	9.0	7.8	7.6	10.4	8.2	6.8	6.9	2.9	12.0	5.2	6.6	16.1	7.8	24.2	24.5	25.2	38.2	24.4	24.7	25.0	25.0	24.6	25.0	24.0	25.4	10.9	3.2	13.7	10.4	9.8	12.0	8.3	16.6	9.1	18.0	12.1	14.1	10.1	4.3	15.6	7.3	22.9	21.4	10.6	3.6	21.5	9.5	9.8	39.1	5.9	8.3	6.0	65.9	5.9	5.6	9.4	9.1	5.1	4.6	6.3	12.3	8.9	6.1	9.3	15.2	7.5	7.3	26.4	4.7	8.4	12.1	10.2	8.0	1.8	5.6	8.1	10.4	8.2	9.0	8.9	6.3	3.8	6.8	16.9	3.2	6.6	17.2	84.4	20.9	6.6	9.6	15.6	12.8	9.3	7.2	14.9	10.4	10.6	11.1	7.5	6.2
PPP1R2	"IPP2, PPP1R2A"	ENSG00000184203	"Protein phosphatase 1 regulatory inhibitor subunit 2"	P41236	3	195514428-195543386	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 431.9;Spermatocytes: 354.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 142.1;U-266/70: 224.2"	"Low region specificity"	"Detected in all"							"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.13e-1)"	18.3	15.0	15.4	21.3	16.2	68.1	22.6	12.9	16.9	18.0	16.5	22.8	25.8	21.2	25.2	22.4	18.3	19.7	24.7	16.6	21.0	21.0	15.0	17.4	29.1	15.1	15.4	13.9	13.5	16.8	15.6	17.5	17.2	20.9	19.8	16.0	16.9	19.1	85.8	17.2	22.3	21.6	14.3	21.5	17.7	29.2	15.2	28.2	23.1	56.2	25.2	21.1	18.2	15.0	43.8	9.8	14.7	17.0	24.1	25.8	29.1	25.8	36.6	26.4	22.6	142.1	18.0	17.3	99.2	31.1	27.8	18.1	15.1	25.6	32.1	33.0	30.3	18.6	14.0	47.5	37.2	20.5	18.8	31.4	19.4	19.7	39.6	20.8	23.0	17.1	14.7	33.4	23.4	32.3	34.4	22.9	15.6	49.2	42.1	16.6	25.6	50.4	31.8	32.1	34.9	20.0	31.6	33.1	46.5	27.0	52.5	19.9	27.9	16.9	19.3	28.8	36.7	224.2	105.7	79.5	23.9	37.0	33.3	120.6	64.7	257.5	71.8	68.2	98.2	100.3	149.3	99.1	68.8	95.8	178.6	122.8	152.3	94.2	69.0	103.5	168.4	129.2	15.4	16.2	12.9	16.9	16.6	21.0	15.1	15.4	17.2	14.3	15.2	15.0	106.9	22.4	47.8	13.1	165.7	94.2	138.6	70.1	89.4	51.5	80.6	61.5	53.5	38.6	56.3	22.0	58.4	67.7	148.2	48.6	125.2	69.5	431.9	119.5	65.0	99.6	57.4	33.6	30.8	66.3	43.0	62.5	45.3	67.9	111.0	26.7	51.0	27.1	61.0	52.2	41.7	48.5	69.2	73.3	170.6	243.8	51.6	103.4	97.8	25.3	120.9	50.5	74.2	23.1	19.1	74.5	65.1	63.6	188.4	123.0	77.3	106.0	80.3	91.1	26.3	48.7	71.1	354.3	92.4	88.2	77.6	103.2	230.1	58.0	54.7	186.2
PPP1R27	"DYSFIP1, toonin"	ENSG00000182676	"Protein phosphatase 1 regulatory subunit 27"	Q86WC6	17	81833492-81835050	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"skeletal muscle: 1205.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 56.5;Skeletal myocytes: 108.8"	"Cancer enriched"	"Detected in single"	10	"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"HL-60: 206.4;THP-1: 385.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042227, HPA048632"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA042227: , HPA048632: AB_2680469"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.98e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.30e-1)"	0.3	0.9	0.0	0.0	0.1	1.3	0.4	0.2	0.3	0.4	0.0	0.2	0.0	0.1	0.0	1.2	0.1	0.0	0.5	0.1	0.0	0.2	0.7	0.2	0.0	0.1	0.0	0.2	0.4	0.0	11.8	0.0	0.1	1.8	0.0	0.0	5.8	0.0	1205.9	2.1	0.2	0.0	0.0	0.2	0.1	0.5	0.1	0.1	0.4	47.6	0.0	0.1	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	206.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.2	0.0	0.0	385.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	1.2	2.9	1.3	2.4	0.6	0.0	0.2	0.0	0.0	3.0	0.3	1.6	0.0	0.0	56.5	0.9	0.7	0.9	1.2	0.0	0.0	0.5	2.7	0.6	0.0	1.5	0.0	0.7	1.1	1.2	0.6	0.0	0.0	1.1	0.0	0.0	0.4	5.7	0.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.3	4.7	0.2	0.2	0.2	0.0	108.8	0.5	1.7	0.6	1.2	0.1	1.4	0.2	0.2	1.6	0.5
PPP1R2B	"MGC87149, PPP1R2P3"	ENSG00000231989	"PPP1R2 family member B"	Q6NXS1	5	156850295-156852528	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	121	"testis: 21.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"U-266/84: 1.2"									"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PPP1R37	LRRC68	ENSG00000104866	"Protein phosphatase 1 regulatory subunit 37"	O75864	19	45091396-45148077	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"RT4: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041500	Approved		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA041500: AB_10795122"	"unprognostic (8.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.89e-3)"	"unprognostic (7.72e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.71e-2)"	"prognostic favorable (2.04e-4)"	10.4	26.9	11.3	5.8	12.8	4.8	13.0	7.9	16.7	17.9	1.2	14.3	12.1	15.7	3.2	19.8	13.1	5.3	14.8	12.3	4.7	18.2	14.0	11.7	5.2	6.6	4.9	13.5	16.4	7.2	39.3	5.3	6.6	20.0	3.6	8.0	18.4	8.8	20.9	21.3	14.6	4.1	1.8	14.0	28.3	16.5	6.7	5.7	20.4	5.4	3.1	21.7	16.9	10.8	26.2	25.4	9.2	13.4	11.6	7.8	18.4	18.8	10.6	12.8	14.6	11.5	14.2	7.1	13.4	10.0	11.8	20.1	6.3	14.4	3.6	9.3	15.7	6.1	13.6	14.3	14.4	6.4	10.1	10.0	11.1	12.1	7.7	13.7	10.4	9.6	10.8	5.5	7.1	34.2	13.5	8.9	8.7	18.7	15.1	16.3	10.9	5.3	8.4	69.5	28.2	13.0	16.0	33.2	29.3	4.7	21.3	9.4	16.4	15.2	18.2	9.1	17.0	9.3	6.3	5.3	19.7	6.4	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.8	7.9	16.7	12.3	4.7	6.6	4.9	6.6	1.8	6.7	10.8	9.4	6.4	3.4	8.5	8.1	7.6	11.1	6.8	13.1	48.6	16.9	11.7	6.2	15.7	5.6	3.7	39.6	21.1	9.7	21.9	7.9	17.9	8.8	9.8	12.1	10.3	30.6	4.8	18.9	9.8	19.0	9.8	30.5	10.9	0.0	12.1	11.0	7.4	17.9	77.4	15.2	27.7	10.2	6.4	6.3	7.0	12.2	6.2	12.4	5.6	4.4	22.7	9.2	11.6	14.3	12.0	23.4	12.4	13.1	10.6	25.6	18.2	5.9	44.1	19.7	10.3	10.1	21.6	23.9	14.3	9.5	18.3	10.4	16.0	22.3	11.4
PPP1R3B	"FLJ14005, GL, PPP1R4"	ENSG00000173281	"Protein phosphatase 1 regulatory subunit 3B"	Q86XI6	8	9136255-9151574	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 144.9;skeletal muscle: 95.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 69.9;Hepatocytes: 184.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 53.6;eosinophil: 15.8;neutrophil: 50.4"	"Lineage enriched"	"Detected in all"	19	"granulocytes: 53.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 47.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028731	Enhanced		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA028731: AB_10602120"	"unprognostic (4.97e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.08e-7)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (3.33e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	24.1	7.5	1.9	8.2	2.8	12.3	15.9	3.4	3.8	19.6	5.9	16.1	4.6	19.8	4.4	17.2	12.9	9.0	29.9	1.7	3.1	7.6	144.9	9.2	4.3	4.8	3.0	10.4	5.1	50.1	3.3	10.4	4.1	21.7	9.5	7.1	13.9	18.6	95.4	12.3	7.2	12.0	3.1	7.7	12.0	7.1	3.9	4.5	11.7	17.7	3.6	26.4	15.0	4.5	6.7	2.5	7.3	2.5	17.9	15.1	26.3	2.4	7.9	2.9	3.5	10.0	3.1	2.3	3.9	5.0	16.1	1.2	1.3	1.9	3.1	7.2	1.1	4.0	1.0	0.0	8.0	2.0	17.1	12.4	5.9	2.5	14.6	22.0	47.3	11.6	3.1	5.6	1.1	4.1	11.2	3.8	10.6	15.2	2.2	4.5	9.2	4.0	28.6	26.9	0.0	13.6	4.4	0.1	18.6	11.6	3.4	4.1	32.9	8.5	2.9	1.7	3.1	3.1	7.5	0.0	14.8	6.2	2.6	53.6	1.6	15.8	2.2	1.1	1.8	1.6	2.0	1.2	0.9	1.2	2.7	1.5	50.4	2.2	0.7	1.8	1.5	1.6	1.9	2.8	3.4	3.8	1.7	3.1	4.8	3.0	4.1	3.1	3.9	4.5	16.7	12.8	34.5	0.7	5.5	10.7	18.8	7.2	3.4	3.7	19.4	12.7	69.9	24.3	21.8	9.2	6.2	12.9	7.6	26.7	3.9	8.8	20.3	29.5	21.9	21.0	0.0	0.8	0.8	12.7	38.3	12.7	9.7	51.7	33.6	10.4	31.1	184.7	6.9	6.7	0.4	11.5	8.2	9.8	27.9	5.2	9.6	15.6	5.4	3.7	3.1	3.9	4.1	3.5	1.4	18.4	7.5	18.0	4.5	8.0	7.4	6.8	30.8	13.0	13.1	10.9	17.9	1.7	5.7	0.6	12.1	18.3	10.8	9.4	5.5	2.2
PPP2R1A	"PP2A-Aalpha, PP2AA, PR65A"	ENSG00000105568	"Protein phosphatase 2 scaffold subunit Aalpha"	P30153	19	52190048-52229518	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Chromosome partition"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018599			Approved	Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB018599: AB_628178"	"unprognostic (1.78e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.76e-4)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.19e-2)"	98.5	300.7	305.0	60.5	311.1	58.1	98.7	292.0	394.2	126.9	261.4	115.7	91.5	126.8	101.0	164.4	126.8	63.2	322.8	342.6	299.4	156.9	106.0	87.5	72.7	308.9	301.1	163.7	100.7	129.9	123.9	69.1	312.8	123.3	82.2	89.8	99.8	92.2	239.7	119.3	98.5	96.0	280.1	87.6	106.0	67.2	331.7	76.9	107.9	170.7	90.0	123.5	121.9	299.2	153.6	248.4	210.9	182.0	166.9	173.4	105.3	130.3	173.2	174.1	151.1	129.3	122.1	132.5	91.0	213.9	95.7	108.8	228.0	197.9	100.6	101.3	562.8	99.6	126.9	148.2	152.6	105.6	93.1	234.3	163.8	163.5	149.2	162.9	167.9	92.1	114.3	96.8	196.3	178.6	159.6	215.4	204.6	162.2	218.4	148.6	118.3	152.5	285.0	251.7	153.3	161.3	149.0	160.1	100.3	136.3	141.9	197.3	153.1	133.2	120.5	65.7	154.2	96.9	151.5	160.0	143.1	109.7	170.5	172.6	172.0	169.4	143.9	212.2	131.0	143.1	126.3	134.3	192.8	157.1	101.6	119.6	103.7	228.6	199.0	119.7	177.5	255.6	305.0	311.1	292.0	394.2	342.6	299.4	308.9	301.1	312.8	280.1	331.7	299.2	55.3	44.8	35.4	21.5	76.0	70.4	99.0	178.0	56.9	114.0	64.5	71.1	100.2	74.4	99.5	119.5	25.0	203.7	47.3	157.0	117.4	213.5	4.4	77.5	79.7	72.4	107.0	39.7	27.4	155.7	259.9	85.7	77.5	100.7	68.5	96.7	65.0	52.8	146.2	144.7	39.5	128.8	144.5	68.1	39.3	10.4	72.4	58.0	53.4	17.8	103.7	118.0	62.8	25.6	29.9	168.2	189.0	85.4	60.3	88.3	147.5	135.3	80.6	61.5	78.9	49.2	90.3	16.5	68.8	74.4	63.2	182.0	64.2	99.7	185.2	104.2
PPP2R1B	"PP2A-Abeta, PR65B"	ENSG00000137713	"Protein phosphatase 2 scaffold subunit Abeta"	P30154	11	111726908-111766389	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 170.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 306.1;Late spermatids: 160.7;Spermatocytes: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 173.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004034, HPA018908"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"CAB004034: AB_490763, HPA018908: AB_1855655"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.84e-3)"	"unprognostic (3.27e-3)"	"unprognostic (3.43e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (4.58e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.30e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.22e-1)"	58.5	10.5	11.3	14.1	18.0	16.2	21.5	20.0	13.9	13.0	17.3	14.7	13.9	8.7	8.1	12.6	8.0	13.4	6.3	11.7	13.8	14.6	170.7	8.8	12.1	14.7	13.7	13.3	33.2	12.9	10.7	9.2	14.2	7.7	14.7	8.5	9.6	6.1	9.6	10.7	15.2	7.8	10.6	6.3	22.3	54.0	13.8	15.9	10.6	8.9	14.1	12.2	7.4	20.7	38.4	25.1	35.6	24.2	34.9	18.7	35.8	37.2	25.9	27.0	24.6	86.0	39.3	48.3	27.1	24.1	25.6	35.4	53.4	30.5	34.3	33.7	16.6	47.2	14.5	37.8	17.3	55.7	36.1	21.5	18.1	30.6	22.2	19.1	33.8	49.7	58.3	62.3	30.1	12.4	60.8	22.6	43.8	41.4	27.3	45.9	23.6	58.6	40.2	41.9	11.6	31.4	33.1	30.2	6.1	38.3	35.0	20.6	36.7	31.3	37.8	15.6	23.9	6.6	17.4	173.8	11.1	63.9	40.7	6.1	10.1	10.4	13.0	11.7	12.7	10.0	12.9	12.1	14.9	12.5	11.2	12.0	2.6	15.3	11.4	6.4	15.0	12.2	11.3	18.0	20.0	13.9	11.7	13.8	14.7	13.7	14.2	10.6	13.8	20.7	21.2	19.2	10.5	63.3	11.0	14.3	11.0	12.0	18.2	5.4	14.1	8.5	3.2	15.7	13.4	12.9	8.4	13.5	11.0	23.8	13.7	18.7	306.1	29.6	13.4	20.2	15.6	32.4	23.8	22.9	20.3	12.3	15.3	46.1	8.2	34.3	9.3	89.4	9.5	1.7	14.5	11.5	22.4	5.8	9.2	160.7	6.5	7.5	8.8	17.8	8.9	9.9	7.2	26.2	49.1	23.6	9.0	7.5	9.0	10.9	16.2	17.6	16.8	11.0	13.1	14.5	14.4	135.9	20.8	12.0	14.6	17.6	11.0	9.7	13.9	15.0
PPP2R2A	"B55A, B55alpha, PR52A, PR55A, PR55alpha"	ENSG00000221914	"Protein phosphatase 2 regulatory subunit Balpha"	P63151	8	26291508-26372680	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, CAB079289"	Approved		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB079289: AB_659890, HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.16e-1)"	32.1	16.1	8.9	12.7	13.1	4.7	30.4	9.1	14.3	33.1	6.4	19.1	21.7	22.3	8.5	59.6	24.6	14.1	26.7	9.5	10.2	18.0	28.3	25.8	16.0	9.4	9.7	24.7	14.7	14.0	13.5	38.2	9.2	19.5	15.2	10.5	27.0	15.9	53.4	38.9	19.4	18.3	10.2	17.9	17.7	18.1	8.8	16.0	19.4	23.6	25.7	24.2	37.0	13.6	42.1	33.5	52.5	32.2	28.3	43.6	54.2	74.5	49.4	63.1	65.2	48.9	24.2	54.5	19.1	28.9	31.5	51.2	56.9	50.1	78.0	23.8	24.4	43.8	36.6	23.0	42.0	25.2	19.1	29.3	62.4	39.4	52.0	31.7	96.1	27.5	64.1	37.1	51.7	26.0	54.4	17.6	62.5	73.6	20.5	36.1	35.1	41.8	31.0	74.8	21.0	27.7	30.3	27.9	41.0	37.2	26.9	13.7	45.8	28.5	46.0	31.4	47.0	18.6	32.4	80.9	35.1	39.7	52.2	0.6	0.4	1.6	0.4	0.9	0.7	1.3	1.1	1.0	1.1	1.1	0.6	0.9	1.0	0.9	0.9	0.7	1.8	0.7	8.9	13.1	9.1	14.3	9.5	10.2	9.4	9.7	9.2	10.2	8.8	13.6	63.4	73.7	67.8	42.1	59.2	136.6	215.9	81.6	72.8	53.0	65.6	52.5	36.9	27.1	98.8	14.7	47.9	76.6	70.2	57.5	49.0	45.5	47.9	100.5	51.6	82.3	76.9	53.5	95.1	32.2	65.3	65.5	57.6	98.4	55.2	61.0	55.3	34.6	36.6	37.0	49.9	51.2	61.1	32.0	66.1	128.8	46.9	47.6	60.5	72.1	48.1	51.6	35.0	122.6	250.6	61.0	50.1	73.4	53.5	140.0	44.4	43.9	111.2	40.8	52.6	56.1	76.7	44.6	57.2	102.3	142.9	66.9	66.5	59.9	50.6	232.8
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 61.0;Early spermatids: 67.4;Excitatory neurons: 203.3;Inhibitory neurons: 82.8;Late spermatids: 182.5;Oligodendrocytes: 94.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 31.4;A549: 46.1;CAPAN-2: 28.2;GAMG: 68.4;MCF7: 36.2;PC-3: 38.9;SCLC-21H: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Approved	Cytosol		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291"	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	0.8	6.2	72.9	0.6	86.7	0.0	1.4	42.1	106.2	18.0	0.0	1.1	0.8	27.0	7.4	35.9	9.9	0.4	2.5	85.7	44.5	0.3	0.1	0.1	0.3	52.5	52.7	0.6	0.7	1.5	22.6	0.1	55.1	5.0	0.3	10.9	5.3	14.5	0.8	34.0	1.2	11.9	62.3	0.3	0.8	7.3	66.9	2.7	0.1	0.9	3.1	0.9	11.5	91.2	31.4	46.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	19.0	0.0	68.4	13.7	20.0	0.7	0.0	0.0	2.4	0.0	3.2	3.7	0.7	0.0	0.1	6.6	11.4	0.0	0.0	0.0	0.1	4.2	0.0	0.1	6.6	36.2	0.0	0.1	2.2	0.6	38.9	0.0	0.0	1.2	0.0	0.1	39.1	7.5	1.5	0.1	0.0	1.1	18.9	0.1	0.0	0.2	22.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.9	86.7	42.1	106.2	85.7	44.5	52.5	52.7	55.1	62.3	66.9	91.2	0.2	0.0	0.0	61.0	0.0	14.7	0.4	0.8	4.6	11.0	1.9	0.4	4.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	67.4	0.8	5.7	0.6	0.0	0.0	203.3	0.2	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	3.3	82.8	0.0	0.0	0.0	1.1	182.5	6.8	0.0	0.0	4.7	0.0	6.5	0.0	14.1	94.6	2.4	0.0	4.5	0.0	1.3	0.0	0.2	0.0	3.1	0.0	0.0	2.5	2.3	1.6	6.5	22.0	0.0	0.2	0.1	0.0	0.2
PPP2R2D	"B55D, B55delta, MDS026"	ENSG00000175470	"Protein phosphatase 2 regulatory subunit Bdelta"	Q66LE6	10	131901008-131959834	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042122, HPA042770"	Approved		Approved	Cytosol		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (7.75e-3)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.90e-2)"	1.5	3.0	4.5	1.2	5.4	0.0	1.4	7.0	5.8	2.1	3.8	2.8	2.1	1.6	2.0	1.6	1.6	1.6	3.3	4.9	4.1	1.8	1.6	2.3	2.4	4.1	4.1	3.6	15.9	3.2	2.3	1.9	4.1	1.8	1.9	2.8	3.3	1.9	2.8	2.7	2.4	1.3	3.6	1.8	2.1	1.3	4.6	1.7	2.2	2.9	1.5	2.3	1.9	4.9	4.4	3.8	2.4	1.8	3.3	2.6	3.4	1.5	3.1	2.9	3.1	3.1	3.6	1.8	1.0	1.8	1.8	7.9	3.2	0.7	3.1	4.5	4.2	3.0	3.7	1.8	1.1	3.2	3.4	0.9	6.7	3.2	4.5	4.6	2.0	2.6	3.9	0.8	3.2	2.1	1.5	7.3	1.5	1.5	3.4	2.0	1.6	0.5	2.3	0.6	1.9	2.6	1.9	1.6	1.8	2.5	1.4	2.4	2.8	1.6	0.7	2.3	8.1	2.8	1.6	2.3	1.4	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	5.4	7.0	5.8	4.9	4.1	4.1	4.1	4.1	3.6	4.6	4.9	26.8	19.2	14.3	22.2	20.0	37.3	37.4	6.4	20.5	55.0	25.8	23.6	36.3	14.3	10.2	9.2	10.4	10.6	36.1	27.6	19.6	9.8	12.7	21.5	24.8	19.0	10.7	18.7	43.0	17.7	13.6	21.8	19.9	32.3	6.3	33.1	13.2	23.2	14.1	52.2	37.5	18.2	8.2	12.0	17.6	6.4	17.4	23.3	12.4	26.2	10.5	28.3	18.6	29.7	38.1	16.8	18.0	20.7	20.3	39.1	20.0	29.6	5.7	32.6	26.3	29.2	23.2	14.3	20.1	18.8	34.0	11.8	24.4	39.5	19.1	39.6
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333933-386955	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 73.0;skeletal muscle: 103.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 18.5;U-698: 29.9"									HPA026606			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.90e-5)"	4.4	4.7	1.2	0.2	1.2	1.9	4.9	0.8	1.6	8.3	0.8	4.0	0.5	6.9	0.0	9.5	9.3	0.3	73.0	1.0	1.6	4.0	3.7	3.9	0.6	1.5	1.7	7.6	4.5	0.2	10.3	0.6	1.5	9.1	0.0	0.1	7.1	0.3	103.4	16.5	4.7	0.3	1.2	7.2	4.6	16.3	1.4	1.3	5.0	2.6	0.0	11.8	7.7	1.8	1.0	5.0	0.6	1.9	0.1	0.1	8.1	7.6	1.3	4.7	6.0	5.4	0.0	1.8	4.0	5.4	0.7	0.0	0.1	0.0	1.0	5.6	6.3	1.1	1.8	0.3	0.0	2.3	3.1	0.2	0.1	0.0	3.7	0.4	0.1	3.3	1.6	0.2	0.7	3.1	11.8	8.6	3.1	0.1	18.5	5.3	3.7	0.4	1.0	1.4	0.0	11.1	0.0	0.6	5.3	4.0	0.0	1.7	0.4	2.5	3.6	0.0	2.0	0.2	0.4	29.9	0.0	2.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.8	1.6	1.0	1.6	1.5	1.7	1.5	1.2	1.4	1.8	6.7	0.0	1.7	11.4	3.8	6.8	8.6	1.7	4.6	13.5	8.5	10.7	72.3	4.3	2.1	0.0	27.1	5.2	5.7	3.8	0.0	2.5	0.6	12.1	4.6	5.4	4.8	4.8	2.8	4.0	7.3	8.0	4.6	7.4	0.0	25.6	2.9	1.8	3.7	6.7	3.7	3.9	0.0	2.8	4.5	2.0	4.1	5.8	5.4	5.6	3.1	8.6	6.2	17.6	10.4	2.4	0.6	3.0	3.3	3.7	1.8	1.7	4.3	19.0	0.0	12.2	6.5	16.7	27.1	6.1	7.5	4.0	5.0	7.8	3.6	4.5
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984553-43012342	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	23.2	20.2	29.9	17.5	32.5	18.3	20.2	25.7	38.1	30.9	17.2	27.2	29.7	28.7	4.3	24.3	28.5	15.2	30.3	33.1	26.8	18.2	20.8	18.7	19.9	31.0	26.6	28.6	19.1	24.5	15.9	18.1	30.8	24.8	23.5	29.7	19.8	21.2	40.6	27.8	35.8	30.6	21.1	18.7	22.3	28.6	29.6	44.4	18.3	41.2	24.0	24.7	27.4	31.2	71.3	38.0	72.6	88.2	61.0	63.6	32.6	38.3	39.9	108.5	86.6	58.7	24.9	55.8	36.3	71.8	67.3	38.6	108.6	66.4	94.6	45.3	67.5	62.9	51.2	81.8	33.5	51.4	43.6	45.6	47.3	88.5	35.1	54.1	87.2	68.7	67.4	41.1	63.0	44.0	114.9	40.0	26.2	228.1	36.3	86.3	73.8	37.3	45.3	39.0	77.9	45.7	56.2	38.7	47.3	63.2	47.9	55.5	57.1	57.2	50.9	55.8	61.4	39.6	54.6	109.0	21.2	48.0	51.6	18.4	13.8	21.9	18.4	11.6	19.2	10.1	16.9	21.2	13.7	9.2	12.8	15.6	8.1	14.3	8.9	14.4	23.9	20.1	29.9	32.5	25.7	38.1	33.1	26.8	31.0	26.6	30.8	21.1	29.6	31.2	6.2	9.6	6.7	6.8	7.6	8.4	2.9	5.1	13.1	12.9	6.9	6.6	4.9	4.3	6.3	7.3	10.4	7.5	10.1	15.7	5.9	6.9	6.4	7.7	19.9	7.4	9.0	12.4	10.5	7.8	11.0	9.7	7.1	9.5	8.2	10.8	6.4	11.3	9.2	3.3	10.3	8.3	8.2	6.2	5.2	7.0	9.6	6.9	10.6	3.7	6.8	8.1	3.1	3.0	5.3	9.8	9.0	14.7	7.7	3.7	35.7	5.2	5.1	7.5	6.6	8.7	10.8	8.3	10.2	13.3	9.5	4.5	11.1	6.1	13.0	2.5
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 189.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		42000	"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	53.7	37.7	56.1	32.4	92.9	73.6	27.1	38.0	127.3	27.3	0.0	27.6	25.7	31.0	26.1	30.0	23.3	28.0	20.6	99.0	24.2	21.4	58.2	27.7	40.2	23.5	18.4	24.9	20.7	17.0	18.3	36.6	24.9	26.3	27.8	189.9	24.9	30.1	88.8	33.6	23.9	35.3	14.4	34.2	24.8	20.6	30.0	42.6	23.8	31.0	40.5	32.9	28.6	64.5	61.5	51.7	69.7	48.4	47.4	54.3	70.5	86.3	75.9	98.8	86.8	75.9	55.4	85.7	28.7	61.4	69.5	41.8	74.4	64.8	120.0	59.4	52.9	284.0	38.3	71.1	93.1	111.9	92.2	55.1	57.6	76.9	78.0	55.9	67.2	72.2	67.8	96.8	73.2	53.8	96.1	99.4	81.9	52.0	44.4	69.1	90.6	139.9	61.7	66.1	91.4	64.2	50.4	72.3	65.9	45.0	33.9	51.8	69.5	84.6	76.5	64.2	75.1	53.8	62.6	124.7	61.3	115.2	54.0	1.5	0.5	1.3	0.2	0.3	0.5	0.2	0.3	0.1	0.5	0.3	0.3	0.5	2.7	0.3	0.6	0.7	0.3	0.4	56.1	92.9	38.0	127.3	99.0	24.2	23.5	18.4	24.9	14.4	30.0	64.5	37.0	9.6	12.7	81.6	40.4	74.8	11.6	7.0	72.8	22.2	21.0	13.1	17.9	10.0	7.7	16.5	52.1	11.7	34.0	20.5	11.7	7.1	20.0	19.9	23.0	34.0	15.1	52.8	151.2	8.7	17.2	24.2	18.8	29.1	19.7	11.2	15.4	19.2	24.7	11.8	93.1	15.6	4.1	40.0	105.1	7.7	9.9	54.7	35.6	105.9	21.2	27.8	18.6	72.9	77.5	12.9	10.6	8.6	39.2	17.3	12.6	20.1	5.8	92.7	13.1	14.4	29.8	2.9	6.1	64.0	70.5	12.0	39.9	14.2	13.2	21.3
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591604-101595021	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	161	"testis: 80.8"	"Group enriched"	"Detected in some"	38	"Early spermatids: 399.2;Late spermatids: 198.3;Spermatocytes: 600.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"	Cytosol	"HPA047157: AB_2679960"												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	80.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.1	0.0	0.4	0.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	399.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.3	10.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.2	600.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPTC7	TA-PP2C	ENSG00000196850	"Protein phosphatase targeting COQ7"	Q8NI37	12	110533245-110583318	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 140.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	18.8	25.5	6.9	16.1	7.3	52.3	13.4	12.1	11.1	15.5	8.3	15.7	13.4	14.3	6.4	21.6	11.3	15.0	40.0	6.5	14.1	21.5	21.0	15.6	20.7	12.7	12.4	13.1	13.2	30.6	8.4	10.7	12.1	12.3	16.7	15.6	17.8	13.4	88.7	21.5	13.2	16.1	9.2	15.2	11.9	14.0	13.0	18.4	11.6	140.0	18.4	19.0	19.1	7.4	24.3	13.6	11.4	12.0	27.8	24.3	16.3	10.9	14.3	11.7	11.7	15.4	9.3	42.2	11.1	10.8	16.7	23.0	23.1	25.3	23.5	30.9	19.1	37.5	14.4	16.7	26.3	41.8	29.6	21.0	40.7	16.6	48.4	17.4	22.5	28.8	28.3	11.7	19.2	6.3	37.2	35.7	16.1	13.0	25.0	30.7	15.3	25.8	48.7	26.7	18.4	14.2	20.6	28.2	24.4	11.0	13.4	22.1	25.9	10.7	11.5	32.8	18.6	33.5	40.0	46.7	18.0	22.6	21.4	0.0	0.6	0.5	0.8	0.5	0.8	0.4	0.6	0.6	0.4	0.7	0.7	0.6	2.1	0.6	0.4	0.5	0.5	0.2	6.9	7.3	12.1	11.1	6.5	14.1	12.7	12.4	12.1	9.2	13.0	7.4	14.1	22.4	28.3	16.0	35.7	91.9	53.1	33.9	56.9	8.6	20.2	12.8	105.4	12.8	36.0	9.2	14.6	7.5	28.2	36.7	17.6	7.7	29.7	34.4	20.4	22.3	16.8	7.8	15.5	8.2	8.4	26.1	12.8	63.3	23.5	8.6	15.4	29.5	17.4	13.5	19.8	15.2	30.5	28.3	97.6	33.2	11.5	30.8	33.8	21.5	31.9	4.8	20.6	19.1	11.7	14.6	15.1	9.8	28.2	57.3	16.5	13.1	35.4	23.8	13.1	22.8	22.4	15.9	24.1	57.1	104.3	6.7	28.7	8.2	17.2	77.5
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	12	"intestine: 206.4;prostate: 109.0"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 326.1;Enteroendocrine cells: 908.1;Intestinal goblet cells: 717.3;Paneth cells: 328.7;Undifferentiated cells: 624.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	32	"PC-3: 379.0"									HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA047871: AB_2680195"			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.2	0.3	4.4	0.1	106.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	109.0	206.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	12.4	12.8	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	379.0	11.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	110.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	326.1	0.0	0.0	0.7	0.0	0.0	0.4	908.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	717.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	328.7	0.0	0.0	101.9	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.9	0.0	624.3	63.1
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 542.1;NK-cells: 1231.7;T-cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 656.8;T-cells: 900.4"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 240.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	5.0	2.0	0.7	7.6	0.7	28.6	2.7	0.7	1.3	1.3	1.3	2.2	2.3	3.5	1.1	1.9	1.9	4.2	2.2	0.6	0.6	1.7	6.3	16.5	20.3	1.4	0.7	1.0	1.0	0.5	0.9	2.7	1.0	1.5	1.4	0.0	2.3	1.2	2.6	0.9	5.2	2.0	1.3	49.4	4.7	0.6	1.0	5.8	2.6	1.5	4.9	3.8	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	240.1	0.0	1.4	0.0	7.4	0.0	0.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	5.2	1.9	0.9	900.4	1.7	628.8	4.0	125.8	499.1	2.0	3.5	52.1	313.0	15.4	656.8	2.6	2.9	108.8	587.5	0.7	0.7	0.7	1.3	0.6	0.6	1.4	0.7	1.0	1.3	1.0	1.0	3.1	3.2	13.6	0.0	4.4	0.4	0.1	0.0	0.6	0.0	0.5	0.5	0.8	1.5	2.5	0.0	0.0	0.2	542.1	0.1	0.0	0.3	0.0	0.2	0.3	1.9	0.0	19.0	0.0	0.0	0.1	2.1	7.7	0.4	8.8	0.0	10.8	2.7	0.1	0.0	0.0	0.0	0.0	7.8	2.3	0.0	0.0	5.7	0.0	1.9	7.4	0.0	1231.7	0.0	0.1	0.0	0.0	0.0	88.5	0.1	0.1	1.6	1.5	0.0	0.0	1.1	0.8	0.0	0.0	0.5	0.9	0.7	265.4	0.0	0.1	0.0
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788485	"Predicted membrane proteins"	"Neurotransmitter degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.7"	"Group enriched"	"Detected in some"	9	"Muller glia cells: 35.5;Oligodendrocytes: 54.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 5.2;Hep G2: 3.3;NTERA-2: 2.3;SCLC-21H: 8.3;SH-SY5Y: 8.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.1"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046671: AB_2679744, HPA060047: AB_2684194"	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	5.8	3.0	6.1	2.9	11.3	0.0	3.8	10.8	12.3	17.5	2.5	53.7	2.1	13.9	2.1	8.0	18.3	1.6	8.8	5.2	7.9	2.5	0.8	1.0	0.1	17.1	11.3	5.4	1.3	0.0	0.7	1.0	14.7	15.6	3.7	5.7	5.0	5.0	0.9	3.4	21.6	8.1	12.7	0.2	20.0	1.7	9.1	0.2	1.7	1.4	2.3	11.0	14.4	18.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.2	0.0	0.0	0.1	0.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.3	8.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	11.3	10.8	12.3	5.2	7.9	17.1	11.3	14.7	12.7	9.1	18.4	0.2	0.0	0.0	1.3	0.0	0.5	1.0	0.3	0.6	2.6	0.4	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.4	0.2	0.0	0.0	0.2	0.0	0.0	3.4	2.6	0.6	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	1.2	2.8	0.1	0.0	0.0	0.0	35.5	0.0	2.0	54.7	0.1	0.0	0.0	1.2	0.7	0.0	0.1	0.0	0.3	0.0	4.9	0.3	0.7	1.4	0.6	0.3	0.0	0.0	0.0	0.0	0.1
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649667-184694963	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 24.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoplasm	"HPA054372: AB_2682466"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	7.2	8.0	4.0	6.0	4.9	5.5	8.9	7.6	4.2	8.5	4.4	7.9	4.7	10.7	8.2	7.0	8.9	6.9	7.0	3.6	4.1	5.7	6.8	7.5	7.9	4.3	4.1	12.1	4.8	6.8	4.6	6.6	4.3	7.1	8.6	7.2	4.7	8.2	4.7	6.6	6.7	9.2	4.2	8.6	5.9	5.5	4.3	8.6	7.6	5.3	6.4	6.4	5.3	5.6	13.1	5.7	13.2	15.0	17.5	23.2	8.9	13.8	21.8	22.9	19.9	4.4	13.3	7.5	5.0	10.6	12.6	7.9	11.3	14.6	24.0	15.9	5.3	7.8	7.8	5.3	11.4	6.4	11.5	14.5	11.4	21.2	13.7	13.4	12.6	20.7	16.5	24.0	16.5	4.4	13.3	5.4	4.3	5.8	4.6	12.3	9.4	9.0	11.8	7.8	9.4	11.9	8.3	2.1	15.2	10.4	6.6	12.3	6.8	7.5	9.7	5.9	8.9	13.4	10.2	3.8	11.1	8.5	18.6	11.2	2.5	24.0	3.8	2.4	5.6	3.6	3.6	3.9	3.2	3.7	3.0	3.0	1.2	4.7	5.6	2.7	4.6	3.1	4.0	4.9	7.6	4.2	3.6	4.1	4.3	4.1	4.3	4.2	4.3	5.6	7.7	6.4	8.6	23.5	6.7	9.6	9.5	10.0	9.1	6.2	10.1	6.3	2.6	7.2	10.4	5.5	0.0	14.3	8.1	5.9	5.9	7.7	5.5	9.0	11.1	7.3	6.7	17.5	13.9	5.2	10.0	9.7	8.2	6.3	15.2	12.0	8.9	7.5	9.7	8.4	26.9	58.8	6.1	14.8	6.4	5.7	12.5	9.5	8.8	19.7	6.5	11.1	6.2	27.2	28.1	3.7	10.4	9.1	8.6	4.0	7.2	5.7	15.4	8.2	13.1	11.1	9.0	18.8	13.1	6.9	9.8	4.9	8.9	5.7	8.0	5.4
PRKAB1		ENSG00000111725	"Protein kinase AMP-activated non-catalytic subunit beta 1"	Q9Y478	12	119667864-119681624	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004247, CAB005058"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	Nucleoplasm	"CAB005058: AB_562038, HPA004247: AB_1078149"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.42e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (5.40e-9)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.32e-2)"	16.8	16.9	11.9	13.9	13.1	44.0	15.3	12.8	13.2	25.3	12.6	34.8	32.5	16.8	16.3	21.4	17.2	14.5	12.2	11.7	13.0	53.3	17.3	25.3	18.1	14.6	13.5	14.3	33.4	18.9	10.7	27.6	14.1	11.9	33.4	19.4	16.0	15.6	12.6	10.6	22.7	17.0	12.7	24.1	29.0	21.4	13.1	19.7	20.8	10.5	23.9	15.1	10.7	15.7	11.4	30.8	22.1	21.5	17.8	16.7	29.7	18.3	22.7	28.2	20.4	39.9	24.0	36.6	21.8	23.6	12.6	15.2	22.6	32.1	24.9	22.4	36.5	57.8	17.1	51.5	35.6	26.7	66.0	22.4	29.9	24.4	29.7	30.0	21.2	54.5	89.4	13.5	21.6	33.0	60.4	35.4	32.3	16.5	50.1	33.9	20.8	22.7	32.7	33.7	18.7	31.8	22.1	8.6	25.3	26.7	27.2	34.1	25.0	16.9	20.2	13.3	17.8	45.8	45.7	26.8	16.5	19.7	25.5	50.6	28.5	70.3	28.5	32.6	34.4	47.1	30.0	31.0	30.8	39.5	32.3	29.7	34.7	42.0	38.6	27.8	36.1	36.4	11.9	13.1	12.8	13.2	11.7	13.0	14.6	13.5	14.1	12.7	13.1	15.7	20.6	48.1	49.7	3.3	11.9	3.3	6.5	15.3	15.4	16.2	10.0	6.3	5.3	8.6	16.6	22.0	4.2	18.4	7.5	27.0	46.9	8.3	1.2	12.7	7.7	13.2	19.7	34.5	7.1	30.2	10.9	8.6	12.8	15.4	12.0	18.5	5.3	7.1	12.3	21.9	6.2	15.3	14.2	7.0	5.2	2.2	5.6	9.6	3.6	8.4	10.3	13.4	11.3	7.5	7.6	11.7	17.9	6.4	6.4	5.2	16.2	38.2	12.7	17.9	6.6	4.8	8.2	25.6	13.2	13.7	4.3	15.1	9.9	26.3	23.7	8.3
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.2;tongue: 103.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044342	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA044342: AB_10966508"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.59e-3)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (6.78e-7)"	"unprognostic (4.78e-2)"	12.4	10.8	9.4	7.8	10.1	9.0	11.8	12.5	13.1	14.8	6.0	23.4	32.0	18.7	8.5	10.3	12.9	7.1	25.8	10.1	9.5	9.5	56.3	10.0	6.5	10.8	10.1	11.7	34.8	64.7	6.7	12.3	11.0	12.7	10.7	14.7	8.2	19.4	97.2	15.4	20.8	19.8	10.8	8.5	18.1	6.7	10.6	5.9	6.3	103.8	5.6	18.6	14.0	11.2	7.8	4.2	11.1	8.6	25.7	22.1	39.7	14.3	7.9	9.5	10.3	17.1	15.1	13.9	7.1	11.6	5.5	20.2	13.1	16.1	9.2	5.5	9.0	6.2	15.2	27.8	17.7	7.4	2.6	17.4	31.7	9.9	46.0	14.1	9.4	10.6	8.9	5.6	8.2	7.8	5.5	4.1	23.3	13.4	18.4	8.5	14.8	6.9	6.8	6.1	7.1	13.2	10.8	12.1	52.8	39.6	11.4	9.1	10.8	10.6	23.3	9.9	23.6	8.9	10.1	7.1	11.0	6.4	14.1	0.9	0.3	0.6	0.4	0.4	0.7	0.3	0.4	0.3	0.5	0.3	0.5	0.3	0.1	1.5	0.5	0.2	0.2	0.2	9.4	10.1	12.5	13.1	10.1	9.5	10.8	10.1	11.0	10.8	10.6	11.2	10.4	3.2	2.0	14.0	10.6	16.6	11.8	11.4	18.2	14.5	6.7	8.1	66.2	20.0	5.3	18.4	14.6	21.9	10.3	22.7	1.9	6.1	0.8	5.4	15.1	8.2	11.4	3.4	23.2	7.0	42.1	13.6	13.7	10.4	1.3	11.8	6.8	44.9	5.7	11.8	18.8	12.6	10.2	8.9	12.5	1.8	9.6	7.3	16.0	10.3	12.2	6.4	11.3	25.1	21.3	9.9	12.0	16.1	9.0	7.2	55.1	5.4	7.0	19.5	19.7	11.3	20.4	13.9	11.2	13.1	14.1	20.5	9.7	43.4	10.1	4.8
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 310.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 116.8;Theca cells: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		170000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	62.7	126.5	46.6	27.6	47.6	18.9	53.9	39.9	64.2	53.2	29.5	59.0	20.9	56.9	28.5	41.8	53.7	14.2	204.8	49.2	53.3	35.4	78.4	46.1	15.9	56.8	54.5	94.1	34.0	21.6	71.2	17.3	55.3	41.2	13.0	25.2	42.3	20.8	310.9	42.3	36.3	21.8	40.7	71.6	40.2	57.2	50.3	18.2	39.6	122.1	13.4	50.6	44.2	46.6	37.5	16.3	40.3	74.4	36.2	30.8	9.9	30.5	23.6	32.7	27.5	21.6	15.0	13.8	26.2	49.2	22.9	25.4	26.7	26.6	32.3	23.1	17.7	27.7	20.6	24.4	36.8	21.9	33.5	33.8	18.1	30.0	11.1	26.6	29.7	19.0	29.1	47.3	36.7	48.1	46.3	31.9	21.5	38.7	45.0	38.0	47.8	36.7	41.7	13.5	36.5	24.2	34.2	31.3	23.8	18.1	37.2	26.5	37.7	71.7	20.3	100.7	39.6	31.9	24.9	23.6	49.6	28.0	32.7	0.1	1.5	0.2	0.8	2.7	0.3	0.8	0.3	0.5	1.1	0.5	0.5	0.7	3.2	0.4	2.5	0.6	0.3	0.6	46.6	47.6	39.9	64.2	49.2	53.3	56.8	54.5	55.3	40.7	50.3	46.6	39.5	6.4	3.4	9.4	7.0	8.8	6.8	6.4	2.2	42.2	19.2	19.0	116.8	22.8	4.7	14.7	27.1	6.9	9.0	24.6	7.9	12.4	32.4	11.7	22.9	26.7	17.5	2.5	16.9	19.1	5.7	22.6	8.6	12.9	0.0	15.9	26.4	39.7	34.5	3.3	21.6	11.8	2.0	49.4	50.8	15.7	49.0	37.1	14.2	9.4	37.8	26.1	9.2	10.1	10.7	15.6	11.6	51.9	3.3	6.4	20.7	11.8	7.0	23.9	19.7	23.3	23.5	26.4	6.9	10.1	11.2	8.1	10.0	100.6	14.4	6.6
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 334.4;Inhibitory neurons: 348.8;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		130000	"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	16.5	47.7	79.4	26.1	101.6	16.0	17.7	70.0	113.3	19.8	0.0	55.9	10.8	19.2	38.8	17.8	10.0	26.2	23.8	100.7	107.5	23.8	20.8	15.8	41.8	53.5	44.4	17.8	27.8	23.5	24.7	11.5	65.4	30.6	51.7	71.6	83.7	27.3	4.9	4.1	12.7	28.8	59.9	36.0	34.1	8.1	91.0	63.5	25.2	13.5	36.8	27.6	7.7	110.0	8.6	16.9	26.4	31.8	29.9	26.1	12.3	41.7	31.4	20.8	19.4	0.4	7.5	45.1	28.0	32.8	38.0	5.8	12.6	13.6	22.0	44.1	6.8	99.3	21.3	3.2	29.4	39.8	2.2	15.6	6.0	20.2	11.2	30.2	97.2	16.7	3.2	25.2	34.3	1.6	51.8	21.0	26.1	0.1	11.8	39.6	41.2	27.3	50.5	30.2	8.6	33.4	23.0	8.8	25.6	19.7	8.1	8.2	86.8	28.7	22.4	29.4	31.9	18.6	24.2	45.3	13.7	41.5	36.5	56.3	7.5	16.4	59.3	10.2	47.7	35.2	43.4	52.9	19.4	28.4	65.0	69.5	3.8	73.1	16.2	11.1	44.2	66.8	79.4	101.6	70.0	113.3	100.7	107.5	53.5	44.4	65.4	59.9	91.0	110.0	9.5	0.0	1.5	118.8	56.6	5.1	7.2	3.5	11.4	44.9	11.5	9.1	44.4	21.5	5.2	14.7	35.5	1.9	103.0	115.5	33.2	6.2	2.9	11.4	27.0	13.4	21.7	52.3	334.4	11.9	1.2	17.0	16.3	14.0	58.9	15.2	28.5	17.0	27.1	47.1	348.8	58.1	4.1	62.3	24.4	3.6	14.9	51.6	16.0	95.5	14.6	35.6	96.8	302.6	499.0	20.6	42.2	21.8	53.9	10.0	4.5	25.6	6.3	34.4	13.1	14.1	20.3	13.9	8.0	8.1	2.8	0.7	87.6	11.4	51.1	9.1
PRKAG1		ENSG00000181929	"Protein kinase AMP-activated non-catalytic subunit gamma 1"	P54619	12	49002274-49018807	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 339.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077805			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA077805: AB_2686855"	"unprognostic (3.24e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.45e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.49e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (3.40e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.57e-2)"	42.8	54.5	36.4	29.8	40.5	47.4	50.5	39.9	46.3	37.6	41.9	40.7	32.6	32.9	59.1	44.2	33.4	31.3	80.9	38.2	38.6	50.5	49.4	30.8	38.7	34.5	35.5	25.6	37.4	59.1	33.9	35.1	36.5	37.7	47.8	42.3	36.1	39.9	122.7	43.0	29.9	44.8	33.5	28.6	33.5	33.5	34.9	41.8	37.7	112.4	50.8	40.1	30.8	41.5	79.8	45.8	50.5	76.3	157.8	141.6	33.2	85.5	117.4	84.4	55.7	50.9	66.1	50.4	72.9	98.9	53.9	65.4	42.5	115.6	80.4	69.6	57.1	70.4	66.5	34.2	120.2	97.7	54.6	110.0	94.6	65.9	141.4	123.6	90.3	67.6	60.1	70.0	108.6	52.8	45.8	31.5	29.1	339.6	96.8	24.1	53.3	59.7	114.0	67.6	42.1	57.7	61.0	99.1	142.5	39.7	134.1	49.5	72.5	44.4	52.3	87.7	63.5	109.1	113.3	36.0	89.3	69.9	34.5	87.3	59.8	59.9	53.0	58.7	50.0	51.9	46.1	47.6	68.7	51.3	41.3	43.0	70.9	71.8	56.0	45.2	66.8	73.0	36.4	40.5	39.9	46.3	38.2	38.6	34.5	35.5	36.5	33.5	34.9	41.5	20.2	9.6	22.7	16.6	31.2	20.0	30.3	64.5	11.4	29.2	24.3	20.8	49.8	18.6	29.9	36.8	37.5	65.6	30.5	24.5	76.3	48.3	11.3	11.4	21.3	21.9	21.0	30.3	18.1	46.4	57.7	26.7	15.8	12.9	21.5	31.4	30.4	23.2	52.2	15.2	24.1	31.6	63.1	36.2	26.5	15.7	36.7	26.7	37.4	9.4	55.5	41.6	55.6	23.1	21.1	47.8	16.5	27.1	25.0	24.2	38.6	69.3	19.2	30.1	19.7	18.5	27.5	49.3	43.9	19.1	26.0	67.0	26.3	33.6	32.2	23.6
PRKAR1A	"CNC1, PRKAR1, TSE1"	ENSG00000108946	"Protein kinase cAMP-dependent type I regulatory subunit alpha"	P10644	17	68511780-68551319	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 606.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019378, HPA049979"	Approved		Approved	Cytosol		NA	NA		1800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"CAB019378: , HPA049979: AB_2680980"	"unprognostic (8.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	125.9	158.2	72.0	124.1	83.2	57.1	118.4	76.7	119.1	151.2	97.3	70.0	51.7	145.5	122.3	98.5	141.3	125.2	430.0	89.0	102.1	164.3	150.8	163.7	111.4	85.6	91.8	202.8	63.1	300.2	88.0	164.3	105.0	114.5	79.1	132.2	169.7	137.6	250.6	63.8	58.7	132.1	71.7	121.7	86.9	130.8	91.8	109.4	173.6	147.4	103.6	136.4	67.6	93.5	95.5	180.0	225.9	136.1	294.6	331.7	33.9	125.7	257.9	192.2	168.6	70.5	125.5	96.3	84.3	276.7	196.8	77.2	168.8	204.2	273.8	65.8	60.4	149.1	154.0	233.0	213.0	115.8	160.2	239.1	207.4	222.3	185.9	215.0	324.6	80.8	68.5	147.2	236.4	181.0	128.2	60.9	83.9	97.7	121.4	88.1	373.6	106.7	292.4	204.3	81.8	110.3	115.4	207.6	496.8	208.5	162.8	161.1	232.2	269.4	127.6	123.3	119.0	121.6	93.5	142.4	163.0	107.8	171.8	149.6	108.3	189.4	48.6	101.0	48.8	42.8	35.9	43.6	105.9	32.3	32.1	35.9	208.2	76.1	120.9	34.7	50.9	113.5	72.0	83.2	76.7	119.1	89.0	102.1	85.6	91.8	105.0	71.7	91.8	93.5	134.1	147.4	263.4	38.5	126.0	142.8	100.1	136.8	116.7	99.6	106.8	65.4	606.2	81.5	156.4	252.0	66.7	77.4	127.4	58.1	178.1	80.7	407.9	142.9	116.4	131.8	136.9	52.5	76.1	52.0	86.8	163.2	78.5	110.3	185.0	78.2	158.1	120.7	146.1	139.7	78.4	53.3	136.3	176.2	171.1	93.7	133.6	151.1	192.1	46.9	142.3	125.1	78.2	57.3	76.3	74.6	51.5	190.7	95.6	85.3	27.1	210.1	307.7	59.9	85.5	123.2	210.9	219.8	54.2	122.4	131.7	82.5	117.3	184.0	43.9	112.8
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 128.4;Microglial cells: 267.9;NK-cells: 229.6;T-cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdT-cell: 116.5;MAIT T-cell: 91.3;memory CD4 T-cell: 88.0;memory CD8 T-cell: 137.0;naive CD4 T-cell: 106.9;naive CD8 T-cell: 105.5;NK-cell: 117.1;T-reg: 79.8"	"Group enriched"	"Detected in all"	14	"NK-cells: 117.1;T-cells: 137.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 81.8;HUVEC TERT2: 108.7;MOLT-4: 75.8;RT4: 46.4;TIME: 72.0"	"Group enriched"	"Detected in all"	6	"basal ganglia: 28.0;thalamus: 17.9"	"Low region specificity"	"Detected in all"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	26.6	7.8	21.1	21.9	30.2	24.2	21.9	12.4	15.7	20.6	9.5	8.9	9.5	14.5	10.9	30.0	13.6	19.7	19.2	13.2	13.9	14.5	10.3	35.3	55.2	19.3	21.7	5.9	8.4	14.2	15.0	32.5	19.4	15.8	8.8	3.1	28.3	11.4	14.2	23.7	16.6	18.1	18.6	38.5	9.6	7.5	29.9	65.8	21.1	18.1	38.5	25.3	21.7	15.5	18.1	6.3	0.8	4.9	2.8	0.6	81.8	0.3	1.5	0.8	0.8	1.9	10.5	0.3	12.4	0.1	1.6	12.3	0.6	13.5	1.4	2.2	7.9	0.1	2.0	0.7	1.2	0.0	2.4	2.2	13.8	0.7	9.4	1.2	108.7	35.4	0.2	0.4	6.2	32.7	75.8	0.7	1.4	12.9	8.4	6.3	3.2	0.2	0.2	46.4	3.2	5.1	2.1	16.2	10.2	14.5	15.9	1.4	72.0	2.1	14.0	2.1	0.9	1.4	0.2	0.6	3.1	1.1	3.6	0.8	3.0	2.4	116.5	1.9	91.3	2.2	88.0	137.0	9.2	1.4	106.9	105.5	5.9	117.1	1.1	3.0	79.8	84.0	21.1	30.2	12.4	15.7	13.2	13.9	19.3	21.7	19.4	18.6	29.9	15.5	59.7	6.4	11.4	2.0	6.6	18.7	16.4	8.3	15.9	0.4	15.0	9.3	9.0	10.0	15.5	0.0	0.0	27.6	128.4	0.6	3.9	6.0	32.6	10.3	2.1	70.8	11.9	18.1	1.7	6.8	21.2	5.0	7.1	20.9	1.3	15.4	68.9	2.0	6.0	0.0	3.1	2.7	2.0	14.4	6.9	6.0	1.8	15.4	16.0	267.9	8.9	7.0	229.6	4.5	1.8	5.4	4.3	6.8	26.6	14.7	4.6	1.2	9.2	0.5	0.0	4.4	5.2	0.1	2.4	18.1	26.7	48.3	130.5	1.6	1.3	26.0
PRKG1	"PGK, PKG, PKG1, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase cGMP-dependent 1"	Q13976	10	50990888-52298423	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 778.3;Excitatory neurons: 244.9;Inhibitory neurons: 473.0;Microglial cells: 188.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.3"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.3;BJ hTERT+: 19.2;fHDF/TERT166: 16.1;U-138 MG: 11.2;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	7.0	8.3	6.4	2.7	7.2	0.6	3.1	1.4	6.9	10.3	12.4	5.5	2.4	10.3	3.5	5.2	5.2	7.0	14.1	6.6	10.7	3.8	1.7	6.8	1.2	5.1	4.6	4.2	1.7	9.6	1.3	10.1	3.2	6.4	5.3	3.6	4.0	8.1	25.8	1.0	3.4	14.6	5.3	2.5	3.3	1.8	12.2	1.5	7.0	36.1	0.9	5.4	4.2	2.7	0.1	0.2	1.7	14.3	6.5	6.0	0.1	5.4	19.2	2.1	2.6	0.1	0.9	0.3	0.0	16.1	2.0	0.1	0.0	0.1	1.7	0.0	5.0	1.0	0.3	0.0	5.5	0.0	0.1	8.1	0.1	4.8	0.1	0.6	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.0	4.1	0.0	2.5	0.0	3.9	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	2.0	0.1	0.0	0.0	11.2	1.9	5.9	3.7	1.5	0.8	0.0	10.0	0.0	2.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.4	7.2	1.4	6.9	6.6	10.7	5.1	4.6	3.2	5.3	12.2	2.7	10.5	16.0	10.8	778.3	0.3	0.9	1.7	0.0	7.4	5.9	2.8	9.4	31.4	0.0	0.0	3.7	0.0	1.0	0.3	2.9	0.0	2.4	56.0	0.4	14.7	7.1	0.0	3.4	244.9	3.6	1.2	24.2	0.5	0.5	4.5	0.1	5.0	0.0	0.4	0.0	473.0	4.2	0.0	0.0	2.2	53.0	32.6	5.3	3.6	188.3	0.0	23.6	0.0	24.6	8.0	4.8	14.1	39.5	0.1	0.5	3.2	0.2	0.9	1.3	39.5	3.9	69.9	0.9	0.9	1.6	0.6	2.2	0.2	7.9	3.6	1.0
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280841-11281330	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1099	"testis: 14115.0"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 776887.9"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.4;U-2197: 1.7"					"Not detected"	"Not detected"			"HPA055150, HPA059371"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			2.3	2.2	0.0	0.5	0.0	0.0	9.9	0.0	0.0	2.1	0.0	2.1	1.5	1.0	0.0	1.9	1.2	0.0	2.2	0.0	0.2	2.7	4.4	1.3	0.4	0.1	0.0	1.6	3.0	0.0	1.9	0.0	0.1	12.8	0.0	0.0	2.1	1.3	5.8	3.7	4.0	0.0	0.0	1.4	2.4	14115.0	0.0	0.0	4.3	0.0	0.1	1.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126844.3	0.0	0.0	80.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	776887.9	1855.9	161.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1689.6	0.0	0.0	0.0	0.0	0.0	0.0	1157.0	0.0	0.0	2054.0	1211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRMT9	"FLJ46629, PRMT10"	ENSG00000164169	"Protein arginine methyltransferase 9"	Q6P2P2	4	147637785-147684163	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Rod photoreceptor cells: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036844, HPA042537"	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Nucleoplasm, Cytosol"	"HPA036844: AB_10672341, HPA042537: AB_2678043"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.30e-2)"	3.2	9.9	1.4	2.8	1.8	8.5	4.1	3.1	2.4	2.8	1.8	2.3	1.4	4.6	3.1	2.9	3.3	3.0	2.8	2.0	1.8	4.3	3.4	3.2	3.5	1.4	1.6	11.3	3.3	6.1	3.6	3.0	1.5	3.4	2.6	5.2	2.7	3.3	3.3	2.8	1.8	2.7	1.6	2.8	3.1	7.1	1.7	4.5	5.7	2.5	3.0	2.5	2.3	1.6	2.8	1.8	4.3	3.3	3.3	5.6	3.8	3.1	4.9	4.6	4.8	1.4	3.1	9.8	1.3	2.7	2.3	1.9	5.1	2.6	6.3	3.5	3.0	5.4	3.6	2.3	2.5	8.0	2.8	3.9	2.7	2.8	2.5	3.7	3.9	4.8	5.4	5.5	3.9	1.6	6.8	3.1	2.2	2.7	3.2	4.5	3.7	3.6	3.7	2.2	2.7	4.1	4.9	3.8	2.5	2.8	1.6	1.7	3.3	2.9	2.4	3.3	3.4	6.2	5.3	6.1	3.3	4.8	2.2	6.1	4.2	8.6	4.7	4.7	4.6	7.4	5.7	5.8	3.0	7.2	7.1	6.2	2.8	4.3	3.5	4.4	5.5	2.1	1.4	1.8	3.1	2.4	2.0	1.8	1.4	1.6	1.5	1.6	1.7	1.6	8.7	0.0	5.3	9.8	40.4	0.0	4.2	0.0	26.7	56.5	11.7	21.8	5.9	7.2	0.6	35.0	112.6	14.5	51.6	6.2	5.9	7.0	73.1	9.2	9.5	8.4	17.4	10.3	29.8	6.5	14.8	12.9	11.2	13.0	33.7	15.6	12.8	6.9	17.2	50.5	29.8	7.2	0.0	36.5	0.0	13.4	18.0	63.7	0.0	17.8	10.9	48.1	16.5	20.6	16.3	7.4	6.2	17.0	18.4	4.1	7.4	5.5	1.5	81.1	13.1	6.2	18.5	36.5	19.6	4.3	0.0	15.2	61.2	18.5	6.3	2.0
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686350-4701590	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 412.6;Basal squamous epithelial cells: 369.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"basophil: 875.9"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 875.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 1039.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	Yes		5100000	"Cluster 38: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: AB_2678461"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.96e-4)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	87.0	92.4	283.8	52.4	308.4	83.7	106.7	255.1	385.9	135.4	415.8	184.2	37.1	125.5	59.1	79.2	79.9	110.1	197.5	315.6	244.8	132.8	79.7	79.2	59.8	262.8	260.8	163.7	41.5	62.8	83.8	66.9	270.1	146.1	70.5	178.6	60.3	148.2	64.0	95.4	47.4	140.8	265.0	75.2	61.6	68.1	302.5	47.9	89.1	74.0	60.0	124.9	83.4	292.8	226.4	141.6	41.7	64.2	329.6	199.9	36.6	363.4	527.6	175.5	177.7	50.0	171.5	40.9	79.2	727.9	391.8	508.8	45.9	498.3	326.2	31.8	39.0	0.2	19.6	193.8	402.0	72.8	16.5	177.5	711.9	701.8	583.9	257.0	152.8	28.6	22.8	142.9	205.1	45.7	28.8	46.2	33.1	99.8	266.4	33.9	110.0	38.3	88.7	40.3	49.2	7.0	98.9	144.3	554.1	56.4	30.2	38.8	224.5	282.9	127.1	158.6	296.1	63.1	129.5	132.9	226.8	51.9	1039.0	875.9	74.1	5.4	67.3	60.9	100.7	25.1	56.9	55.8	62.9	25.6	33.5	40.1	4.6	23.6	50.4	24.6	72.8	72.7	283.8	308.4	255.1	385.9	315.6	244.8	262.8	260.8	270.1	265.0	302.5	292.8	44.9	80.1	45.4	120.2	85.3	412.6	211.8	132.5	369.3	265.4	60.8	103.0	257.7	32.9	68.2	33.1	116.7	7.7	71.8	2.6	11.7	58.1	6.0	14.1	73.2	66.7	29.9	31.8	125.5	14.7	6.3	177.4	14.8	18.2	173.0	25.5	41.0	36.2	63.6	45.4	170.8	5.4	40.7	219.1	200.4	13.6	143.2	126.3	168.9	59.0	54.5	142.4	42.2	95.0	158.8	18.7	4.5	170.0	47.0	120.3	2.2	84.0	38.1	99.0	13.1	73.0	82.3	36.6	4.5	81.6	284.4	14.4	107.2	10.3	8.8	122.6
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"kidney: 140.1;liver: 173.6"	"Group enriched"	"Detected in some"	13	"Hepatocytes: 157.6;Proximal tubular cells: 559.9"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 28.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"Hep G2: 33.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.1	173.6	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.9	1.5	0.0	12.9	0.0	0.0	0.0	0.0	27.4	0.0	2.8	0.3	0.0	0.3	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	157.6	0.1	0.0	0.1	0.0	0.0	4.7	0.0	0.9	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	559.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0
PROSER1	"bA50D16.2, C13orf23, FLJ12661"	ENSG00000120685	"Proline and serine rich 1"	Q86XN7	13	39009865-39038089	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034225, HPA055687"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB034225: AB_1564157, HPA055687: AB_2682886"	"unprognostic (6.75e-3)"	"unprognostic (9.56e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.95e-1)"	9.0	7.7	4.7	11.1	5.1	25.5	9.1	7.0	6.2	7.6	4.4	12.8	10.6	9.0	9.0	11.6	7.2	6.0	8.9	4.8	4.3	9.0	9.5	12.2	13.4	6.7	5.2	6.9	15.5	5.7	7.7	21.0	5.9	10.6	13.7	9.9	13.6	6.2	10.1	15.8	12.4	7.8	5.1	12.8	10.9	12.7	5.0	14.0	10.0	7.2	14.6	8.5	9.4	6.9	16.0	12.2	37.3	25.9	12.5	10.0	59.1	14.8	13.0	14.6	15.5	39.0	24.3	37.1	11.7	14.5	19.7	26.9	40.5	26.6	23.8	56.6	33.1	54.7	13.4	27.1	28.5	57.7	32.4	13.3	31.4	23.2	52.3	9.0	24.2	41.9	27.6	21.8	15.7	27.8	35.2	30.6	55.8	31.4	13.0	36.6	39.6	23.3	14.6	24.6	21.0	24.2	10.4	26.8	21.7	28.9	28.8	32.9	22.2	8.4	13.5	16.7	18.9	20.2	22.6	39.7	13.6	31.5	16.8	4.6	1.9	0.4	2.8	1.6	3.1	2.0	2.8	3.0	2.2	1.4	2.4	2.6	0.5	4.2	2.5	2.5	1.7	2.7	4.7	5.1	7.0	6.2	4.8	4.3	6.7	5.2	5.9	5.1	5.0	6.9	9.5	3.2	15.3	13.7	11.7	7.0	5.2	4.6	8.0	11.7	8.4	7.6	6.2	5.7	5.6	0.0	8.4	19.3	19.4	12.7	1.9	7.3	16.8	9.0	9.4	10.0	11.4	6.3	16.8	13.5	18.5	6.4	11.2	12.1	12.0	12.5	8.6	6.0	10.4	16.8	12.7	16.3	0.0	16.3	8.0	5.6	6.5	9.9	5.4	12.2	9.9	4.5	13.4	14.1	27.3	15.0	19.2	4.9	16.9	11.2	6.5	3.6	6.0	9.5	0.0	7.8	7.2	14.0	11.6	10.5	7.2	26.8	11.5	5.2	14.8	8.1
PRPF18	hPrp18	ENSG00000165630	"Pre-mRNA processing factor 18"	Q99633	10	13586939-13630859	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037599, HPA047950"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA037599: AB_10795137, HPA047950: AB_2680221"	"unprognostic (5.82e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.63e-1)"	14.6	15.9	8.4	14.4	9.7	43.0	19.6	12.2	10.4	12.8	8.9	16.0	16.9	14.0	28.1	15.8	11.7	15.5	14.3	8.5	10.8	20.7	21.9	14.9	18.2	8.7	8.7	12.9	17.0	18.7	10.7	17.4	8.7	14.3	18.1	10.1	14.3	13.0	23.2	14.3	16.5	15.1	8.6	13.6	15.0	18.8	9.1	25.0	23.6	22.2	19.7	16.4	12.3	10.1	29.5	21.7	18.9	16.4	25.9	24.7	23.5	33.6	16.6	35.9	34.2	20.8	43.8	24.4	18.3	31.1	16.3	23.8	25.1	27.8	41.3	36.3	24.9	28.4	18.5	16.3	30.7	22.6	32.9	19.4	44.3	31.3	15.4	21.9	35.3	35.0	29.9	32.1	33.1	30.5	42.2	15.6	17.8	29.0	10.7	29.8	22.8	30.6	23.9	12.6	13.2	32.7	26.6	18.8	29.1	23.0	29.0	36.6	30.2	22.2	26.1	36.5	25.5	31.2	35.8	34.8	32.8	27.9	15.4	27.2	27.3	36.5	27.7	25.1	24.0	26.9	24.8	23.9	27.4	25.8	26.4	32.6	40.3	39.7	37.4	23.3	33.5	16.8	8.4	9.7	12.2	10.4	8.5	10.8	8.7	8.7	8.7	8.6	9.1	10.1	24.5	19.2	22.4	14.7	32.8	45.6	24.0	35.7	25.0	13.5	22.6	15.0	9.4	30.0	32.9	22.0	10.4	30.5	28.7	21.1	41.1	30.9	29.8	27.5	22.8	21.1	12.6	25.9	27.0	29.1	40.4	18.9	19.4	22.0	27.1	10.5	16.4	28.4	26.0	21.9	25.3	21.8	46.8	20.7	18.0	16.5	17.7	19.4	24.9	18.7	29.7	20.2	36.0	28.1	29.3	33.7	28.9	13.2	27.1	16.2	30.2	50.6	31.8	21.7	19.7	20.8	18.3	105.8	41.1	17.1	46.9	41.7	33.2	11.6	19.0	25.8
PRPF40B	HYPC	ENSG00000110844	"Pre-mRNA processing factor 40 homolog B"	Q6NWY9	12	49568218-49644666	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 61.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038426, HPA038599"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Aggresome,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Aggresome, Cytosol"	"HPA038426: AB_10674684, HPA038599: AB_10674689"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.50e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.80e-2)"	8.3	16.3	16.3	3.2	15.6	0.7	11.5	13.3	18.8	23.9	13.7	15.6	4.0	17.9	10.4	10.4	19.1	6.4	15.6	16.6	16.5	23.9	9.2	7.4	3.1	16.4	14.5	25.4	16.0	20.3	26.2	6.5	15.9	17.5	3.4	12.3	13.3	11.7	25.2	11.4	7.6	7.8	13.3	9.5	14.5	33.7	14.7	3.5	29.2	13.5	3.4	14.6	14.6	15.3	7.2	10.5	10.3	10.0	8.4	5.4	9.5	5.8	8.1	6.1	3.0	12.2	15.8	5.8	12.0	7.7	8.6	4.2	6.3	20.1	3.1	4.4	2.5	6.1	4.2	4.4	10.6	2.0	7.8	7.7	16.8	6.1	22.0	13.2	4.9	11.7	3.0	3.0	7.3	6.7	1.4	4.2	4.4	8.2	3.9	5.1	1.6	4.8	13.0	6.6	10.9	13.1	4.7	12.8	7.2	9.4	24.5	5.7	2.0	3.7	14.9	4.9	2.5	7.1	4.3	2.4	11.2	1.5	3.5	0.0	0.1	0.0	0.8	0.1	1.1	0.3	0.8	0.3	0.2	0.6	0.8	0.9	0.0	1.3	0.0	0.5	0.3	0.3	16.3	15.6	13.3	18.8	16.6	16.5	16.4	14.5	15.9	13.3	14.7	15.3	5.3	12.8	20.3	15.7	4.1	3.6	8.7	10.2	11.4	19.1	6.6	9.7	1.2	5.7	17.5	18.4	10.4	21.9	1.2	1.5	7.9	13.8	28.9	8.6	7.5	5.2	7.7	3.0	19.3	11.1	7.4	7.2	4.1	5.6	2.5	15.6	8.2	3.1	5.4	11.8	22.9	3.2	12.2	1.6	2.1	23.1	11.8	1.5	3.6	6.5	4.9	8.3	2.1	20.6	17.2	6.8	1.1	12.0	1.1	6.7	1.4	5.6	24.5	19.8	13.1	9.8	9.7	61.3	26.6	8.0	6.0	26.4	3.1	9.2	5.2	5.0
PRPSAP1	PAP39	ENSG00000161542	"Phosphoribosyl pyrophosphate synthetase associated protein 1"	Q14558	17	76309478-76384521	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062396			Approved	Cytosol		NA	NA		24000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA062396: AB_2684750"	"unprognostic (1.12e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (3.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.51e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.37e-2)"	26.4	26.2	24.2	13.7	24.3	22.2	27.6	25.1	29.3	29.1	24.0	22.7	16.6	22.6	28.0	34.9	21.8	18.9	21.5	22.4	26.6	26.4	69.9	27.5	18.5	29.2	26.2	21.1	25.1	43.9	21.9	20.9	29.9	20.7	25.5	29.4	65.8	19.0	16.6	24.7	19.4	23.1	23.5	15.9	23.2	35.6	27.3	18.1	49.3	13.9	26.0	19.0	27.2	26.3	38.6	46.4	54.7	26.9	36.3	32.2	21.5	33.9	46.9	55.7	45.9	33.8	32.4	44.2	18.2	50.9	44.4	22.3	49.8	40.5	55.3	17.4	44.7	32.6	36.0	149.2	45.0	28.0	24.8	35.3	32.4	40.1	34.9	54.1	110.4	44.2	40.1	40.3	37.2	41.2	50.9	25.8	13.8	65.7	41.2	41.0	70.9	32.8	42.7	43.8	31.1	51.0	37.4	37.4	77.8	60.9	61.3	32.5	42.3	63.9	46.8	38.2	42.4	27.0	18.2	31.2	28.4	25.5	27.7	18.3	16.4	22.1	16.4	14.5	17.3	17.2	16.4	15.7	14.2	13.6	13.8	13.4	5.3	19.1	14.1	14.1	24.6	13.4	24.2	24.3	25.1	29.3	22.4	26.6	29.2	26.2	29.9	23.5	27.3	26.3	37.7	0.0	14.2	25.5	18.2	13.0	33.3	42.6	16.5	33.9	34.7	40.6	17.3	38.6	25.0	14.7	35.5	49.4	23.5	21.2	49.0	60.6	32.3	26.2	25.8	43.6	15.7	13.2	29.5	29.6	65.0	21.3	23.9	40.9	20.3	70.3	20.7	38.5	29.9	60.6	52.9	26.0	44.7	18.9	21.3	27.5	29.2	21.9	32.0	15.9	64.2	129.4	18.6	24.6	27.7	38.8	18.7	46.3	16.8	25.1	26.3	27.9	32.5	40.4	59.2	25.7	30.8	118.0	97.7	24.8	14.6	30.6	24.2	19.2	34.3	22.3
PRPSAP2	PAP41	ENSG00000141127	"Phosphoribosyl pyrophosphate synthetase associated protein 2"	O60256	17	18840085-18931287	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 274.7"	"Low region specificity"	"Detected in all"							HPA021881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021881: AB_1855782"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (4.57e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.08e-2)"	10.4	17.8	21.5	21.4	25.7	23.6	16.1	39.6	25.3	16.0	18.9	20.6	26.3	21.2	17.8	16.7	21.0	21.4	19.0	25.3	25.2	29.9	21.5	18.4	51.3	27.3	23.5	25.8	16.0	21.0	22.0	13.9	27.7	16.5	24.5	46.3	14.5	14.5	10.3	20.7	20.7	17.4	26.5	19.5	23.1	31.7	25.2	30.5	26.6	10.8	57.3	14.8	14.4	38.7	40.6	44.2	63.1	46.1	26.8	16.2	64.4	30.4	23.7	38.8	35.7	56.2	19.3	104.3	30.7	26.4	38.4	49.2	75.0	38.4	42.2	47.4	60.1	32.8	37.0	46.8	37.5	21.0	29.1	19.5	24.7	49.2	36.6	39.2	36.5	57.0	49.4	17.0	34.5	45.5	45.4	23.9	45.8	80.3	29.0	63.0	103.4	46.4	24.4	25.7	37.7	47.7	45.4	18.5	48.5	274.7	49.7	31.0	24.8	15.8	31.5	53.8	38.7	26.9	34.8	43.5	33.3	30.0	33.1	23.2	23.2	28.5	25.9	23.5	29.4	43.7	32.9	27.2	31.9	40.4	46.0	34.5	9.5	36.9	26.1	21.4	36.3	30.0	21.5	25.7	39.6	25.3	25.3	25.2	27.3	23.5	27.7	26.5	25.2	38.7	16.6	16.0	31.7	21.5	31.7	15.8	19.7	26.9	16.5	38.5	14.2	18.2	10.2	25.8	18.6	11.0	29.2	12.4	22.6	12.3	27.4	23.4	54.3	14.6	13.0	18.3	26.5	23.5	17.6	22.1	37.9	14.8	16.3	13.1	46.3	18.4	18.9	17.6	24.5	16.8	21.5	17.6	16.2	14.0	11.0	67.9	14.0	19.5	12.4	14.0	24.6	26.3	19.6	27.2	37.8	21.1	14.8	13.5	48.0	20.3	21.5	32.2	25.3	34.4	19.7	13.7	14.3	69.8	54.0	19.5	20.9	14.0	23.8	24.7	21.3	15.6
PRR12	KIAA1205	ENSG00000126464	"Proline rich 12"	Q9ULL5	19	49591182-49626439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011959	Approved		Approved	Cytosol		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA011959: AB_10610286"	"unprognostic (8.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.20e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.40e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.52e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.32e-2)"	"unprognostic (9.65e-3)"	11.6	12.6	8.8	7.2	6.5	5.4	11.8	7.6	11.3	15.1	0.0	14.2	6.2	16.7	2.0	12.3	14.3	3.1	11.0	7.6	4.0	10.1	6.9	10.2	7.8	4.4	3.0	16.3	11.3	4.7	22.9	4.6	1.7	13.0	2.2	4.5	13.0	7.4	14.8	21.3	12.7	3.5	0.9	14.8	12.8	7.5	2.8	7.5	15.7	3.4	4.2	14.0	13.1	2.6	15.4	23.4	12.6	14.0	5.6	5.0	10.0	9.5	4.6	5.2	4.1	9.0	8.9	15.5	7.9	6.8	4.9	14.0	5.8	8.3	1.7	13.2	17.3	16.0	12.4	9.0	4.0	15.1	23.0	6.4	8.2	5.9	3.9	6.3	5.8	9.2	11.1	8.9	4.6	11.6	17.1	18.2	17.9	7.8	21.5	22.2	9.8	5.8	4.7	19.0	10.0	18.6	13.8	12.8	6.7	5.0	9.0	11.0	13.9	18.0	17.2	6.8	15.7	11.4	14.4	10.4	11.2	8.6	11.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.8	6.5	7.6	11.3	7.6	4.0	4.4	3.0	1.7	0.9	2.8	2.6	8.8	6.4	2.6	9.8	8.1	4.0	1.3	8.2	8.6	7.7	8.1	6.5	2.9	7.2	3.6	12.9	4.2	5.5	8.7	5.8	1.9	4.1	1.1	5.1	8.8	5.5	10.2	2.5	9.3	7.5	3.3	5.6	8.6	7.1	10.2	9.6	6.8	2.9	6.4	5.0	11.9	6.6	4.1	7.5	2.8	2.1	14.0	5.8	3.6	8.4	3.3	3.6	5.2	10.6	8.8	13.4	5.7	14.7	6.0	1.9	6.6	2.5	6.5	3.6	13.1	7.3	5.5	2.7	6.8	6.9	7.7	1.1	7.5	6.9	6.9	1.5
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 178.4;pancreas: 103.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 203.0;Distal tubular cells: 170.2;Intestinal goblet cells: 127.8;Paneth cells: 226.4;Proximal enterocytes: 263.7;Undifferentiated cells: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 205.6"	"Not detected"	"Not detected"							HPA022918	Approved		Approved	Cytosol		No	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.29e-13)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	2.2	0.1	0.0	7.9	0.1	0.1	38.8	0.2	0.2	13.4	9.5	111.2	178.4	1.4	18.3	12.9	26.5	22.0	0.4	0.8	0.0	28.0	1.9	21.7	0.2	0.1	0.0	0.3	103.9	0.8	8.5	0.0	0.0	17.7	124.3	0.0	51.8	15.8	0.1	10.0	128.5	3.3	0.0	0.0	84.4	2.5	0.0	0.4	67.8	0.0	2.0	2.7	6.7	0.1	3.8	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	8.6	5.8	0.2	0.3	0.0	0.0	20.5	0.0	0.1	0.0	0.4	0.7	0.2	0.0	2.6	0.0	0.4	0.4	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	19.7	0.4	0.4	0.0	205.6	0.7	0.3	0.0	1.4	1.1	2.6	11.7	0.5	0.0	35.7	0.0	0.0	24.1	0.0	0.1	0.3	0.0	0.7	0.1	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	22.4	19.8	0.3	0.1	0.0	2.6	2.4	0.0	0.0	16.7	8.9	0.1	80.1	19.8	16.5	0.0	0.0	0.1	203.0	170.2	35.6	5.5	9.8	0.3	0.2	31.6	0.0	0.1	36.1	0.0	0.4	55.5	3.9	0.0	0.0	0.0	0.8	0.1	0.0	0.1	127.8	24.4	0.0	0.0	9.0	1.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	226.4	0.4	0.2	15.6	263.7	30.0	19.2	0.0	0.0	0.0	1.0	11.1	0.1	7.3	0.0	0.0	0.6	0.0	100.9	9.9
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464300-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 30.4"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 171.6;Inhibitory neurons: 188.9"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.3;BJ hTERT+: 83.9;fHDF/TERT166: 102.1;HSkMC: 62.5;hTERT-RPE1: 103.0;LHCN-M2: 97.9;U-138 MG: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Midbody, Cytosol"	"HPA049254: AB_2680693"	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.0	2.8	2.0	5.2	2.1	0.2	7.9	6.1	3.5	14.9	0.0	5.1	1.7	11.8	1.5	1.8	7.0	5.7	12.7	2.2	5.1	3.0	0.9	9.8	1.1	3.4	1.8	5.6	2.0	1.1	1.7	9.7	3.2	9.3	4.5	7.0	2.6	2.4	26.4	4.0	5.0	8.2	0.7	2.5	4.0	2.4	2.3	0.7	4.4	30.4	0.9	9.5	10.0	1.4	3.7	0.0	8.0	0.0	22.2	77.3	0.0	37.0	83.9	51.5	39.1	0.0	0.2	0.0	0.0	102.1	9.3	0.0	8.1	0.9	53.8	0.0	1.9	0.0	1.2	0.0	21.5	0.2	0.1	62.5	8.9	15.4	48.0	103.0	1.7	0.0	0.1	0.1	97.9	0.0	0.0	0.0	0.9	0.0	1.4	0.0	6.2	0.0	4.3	0.0	0.3	16.1	0.1	0.0	1.1	6.1	0.1	0.1	0.5	117.9	13.3	3.8	19.4	0.3	0.0	0.0	6.7	0.2	4.1	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.3	2.0	2.1	6.1	3.5	2.2	5.1	3.4	1.8	3.2	0.7	2.3	1.4	1.4	0.0	0.0	14.0	0.4	1.3	6.2	0.0	0.0	7.5	1.5	1.9	3.2	0.0	0.0	0.0	14.6	0.1	0.1	0.0	0.0	0.1	16.8	0.9	18.9	0.8	0.0	0.0	171.6	0.0	0.0	13.5	0.0	0.8	0.0	0.2	0.4	0.0	0.5	15.2	188.9	0.0	0.0	1.8	2.7	11.6	2.8	1.0	1.8	9.4	0.1	2.6	0.0	7.5	3.9	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.7	0.0	1.4	9.6	0.9	1.4	0.5	0.6	0.5	0.4	3.1	0.0	0.7
PRR22	MGC24975	ENSG00000212123	"Proline rich 22"	Q8IZ63	19	5782960-5784746	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 50.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 194.8;Late spermatids: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 17.3"	"Not detected"	"Not detected"							HPA044157	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA044157: AB_10960694"	"unprognostic (8.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.19e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.42e-3)"	"unprognostic (9.37e-3)"	"unprognostic (4.18e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-3)"	1.9	2.7	1.6	1.5	1.9	1.9	3.0	1.6	2.8	3.4	0.9	3.9	2.5	2.2	0.6	4.9	5.5	0.6	2.5	1.6	1.4	7.1	11.8	2.3	1.4	2.0	1.5	3.3	6.3	0.5	3.8	0.9	1.6	7.1	0.3	0.8	5.0	0.4	1.4	5.9	5.9	0.3	1.3	6.4	4.0	50.1	2.0	0.9	6.1	0.1	0.5	2.4	3.0	2.2	2.1	3.5	1.5	7.3	0.0	0.2	7.2	1.5	0.6	1.1	1.7	3.6	2.0	3.3	4.0	0.3	0.8	2.6	1.1	1.5	0.2	5.1	11.3	1.5	1.8	1.3	0.6	3.4	17.3	0.8	1.2	1.6	0.5	0.1	0.3	3.9	8.4	0.0	0.9	7.9	4.1	4.3	8.9	0.3	3.6	4.0	1.4	5.2	0.3	2.4	1.9	3.6	0.3	2.6	4.4	0.3	3.0	2.8	1.1	2.6	7.2	9.5	1.8	10.0	8.6	6.4	0.2	7.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.6	2.8	1.6	1.4	2.0	1.5	1.6	1.3	2.0	2.2	0.7	3.2	0.5	1.6	0.8	0.3	0.5	1.3	0.0	5.9	1.8	2.2	0.3	1.5	2.5	3.7	0.0	2.2	1.8	2.3	0.0	1.0	194.8	1.5	1.1	0.9	2.4	0.0	1.6	0.7	1.0	0.9	1.5	2.0	0.0	2.9	1.1	2.6	1.1	5.0	2.1	2.5	0.0	1.3	0.2	87.6	2.1	0.6	0.0	2.8	0.0	2.4	1.0	1.5	2.0	0.8	1.8	0.4	0.1	1.2	4.3	1.5	1.2	6.3	6.6	0.8	0.5	20.4	7.4	1.2	1.1	1.8	0.5	1.6	3.3	0.5
PRR23A		ENSG00000206260	"Proline rich 23A"	A6NEV1	3	139003962-139006268	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.48e-1)"			0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR23C	FLJ46210	ENSG00000233701	"Proline rich 23C"	Q6ZRP0	3	139042102-139044892	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.5;Late spermatids: 2.0;Spermatocytes: 1.6;Spermatogonia: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"			"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.00e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PRR3	"CAT56, Em:AB014077.1, Em:AB023052.2"	ENSG00000204576	"Proline rich 3"	P79522	6	30557280-30563723	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.6;HAP1: 20.1;HEL: 15.1;JURKAT: 14.7;U-266/84: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064061			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA064061: AB_2685185"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.25e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (6.49e-6)"	"prognostic favorable (5.61e-5)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (7.84e-7)"	"unprognostic (2.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.21e-3)"	3.9	5.3	0.7	0.1	0.7	0.0	3.5	0.7	3.0	6.5	0.6	3.4	0.0	6.9	1.1	2.5	5.9	0.0	3.6	0.7	0.7	3.5	3.1	3.3	0.3	0.7	0.9	10.6	3.2	0.1	5.8	0.0	0.8	4.3	0.2	0.6	2.6	0.2	1.5	3.1	3.6	0.0	0.6	5.0	3.1	4.8	0.7	0.8	3.9	0.0	0.6	4.5	4.1	0.7	0.1	3.9	7.7	16.6	5.2	1.3	0.0	0.0	0.0	0.0	0.0	6.6	0.1	7.0	8.6	2.1	4.4	0.6	20.1	1.5	0.0	4.1	3.7	15.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.6	0.0	0.0	0.0	14.7	7.8	0.0	3.6	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	1.7	0.3	0.1	10.6	4.8	0.5	0.0	0.0	0.0	4.3	0.5	6.4	0.1	0.0	0.0	9.2	13.1	8.8	0.0	5.8	3.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.5	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.1	0.7	0.7	0.7	3.0	0.7	0.7	0.7	0.9	0.8	0.6	0.7	0.7	10.6	9.6	19.1	11.4	18.2	5.7	6.4	8.6	12.5	11.3	11.0	22.9	3.6	11.5	10.7	3.7	14.6	14.2	11.2	14.0	7.9	5.8	0.6	8.7	14.2	8.0	7.8	7.6	18.8	9.5	8.7	10.9	24.5	8.4	12.0	16.3	9.3	5.9	7.9	6.7	16.4	10.2	14.2	6.0	7.9	2.6	10.2	8.8	10.6	9.4	12.7	6.4	12.3	17.1	12.2	5.7	5.7	10.1	14.5	5.7	9.9	9.4	11.3	19.2	6.6	11.9	9.8	10.3	6.6	9.1	5.7	9.9	12.0	15.9	8.3	3.9
PRR35	C16orf11	ENSG00000161992	"Proline rich 35"	P0CG20	16	560394-565529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 46.5;kidney: 17.2"	"Cell type enriched"	"Detected in some"	9	"Collecting duct cells: 36.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	20	"cerebellum: 46.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.5"	"Not detected"	"Not detected"			HPA069297	Uncertain		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	"Cytokinetic bridge, Cytosol"	"HPA069297: AB_2686113"		"unprognostic (6.96e-2)"		"unprognostic (3.08e-2)"	"unprognostic (5.25e-1)"	"unprognostic (8.11e-2)"				"unprognostic (2.56e-1)"				"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"			0.0	0.1	0.1	0.0	0.2	0.0	0.0	46.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	17.2	0.0	0.0	0.0	0.2	1.5	0.0	1.1	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	46.5	1.8	0.3	0.1	0.2	1.5	2.3	0.3	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	1.3	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR5L	"FLJ14213, PROTOR-2"	ENSG00000135362	"Proline rich 5 like"	Q6MZQ0	11	36296288-36465204	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.9;intestine: 34.7;lymphoid tissue: 36.4"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 302.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 35.5;HMC-1: 55.7;hTERT-HME1: 57.9;SiHa: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070174			Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cytokinetic bridge, Cytosol"		"HPA070174: AB_2686231"	"unprognostic (6.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.71e-8)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.98e-2)"	3.6	1.5	10.1	8.9	27.8	4.7	2.7	21.7	16.7	11.4	2.2	34.7	3.3	2.8	2.0	1.4	6.3	7.1	2.0	9.6	21.1	7.7	2.9	13.6	9.3	36.6	23.8	12.8	1.2	0.9	2.7	3.6	33.9	2.4	27.8	0.7	7.8	2.0	0.9	1.7	12.2	5.9	24.1	36.4	3.4	1.5	23.9	3.4	3.2	0.7	3.3	4.3	3.8	46.9	0.0	5.5	10.3	0.2	1.4	0.0	0.1	13.2	8.9	25.7	27.2	0.0	0.2	0.1	4.4	15.7	5.9	0.5	2.1	5.9	12.9	5.0	3.7	1.5	35.5	0.0	3.5	0.0	55.7	3.8	9.0	2.3	57.9	25.2	9.4	0.0	0.0	0.1	13.6	3.3	0.7	0.1	0.8	0.1	2.3	4.1	1.1	1.1	27.0	6.9	0.0	0.4	40.1	0.0	2.2	6.5	0.0	0.6	7.8	22.3	6.8	0.0	16.4	0.2	0.0	0.0	9.7	1.5	6.7	36.1	2.0	24.9	34.6	21.4	8.2	0.0	12.2	29.7	2.5	1.6	2.6	18.0	11.8	9.6	24.6	7.7	0.0	15.4	10.1	27.8	21.7	16.7	9.6	21.1	36.6	23.8	33.9	24.1	23.9	46.9	2.1	19.2	4.2	17.6	0.7	0.4	0.2	5.0	0.0	0.1	1.9	0.9	0.9	1.5	6.8	7.3	0.0	0.2	25.9	44.3	1.9	1.3	17.6	1.5	0.8	7.7	1.8	7.0	1.8	2.2	0.1	2.1	1.1	2.5	5.1	0.5	22.5	0.4	8.8	0.0	1.1	22.7	10.2	11.7	0.7	54.9	0.6	5.4	0.0	16.9	4.7	1.2	58.7	31.7	302.0	3.9	37.0	0.4	4.2	0.7	13.2	0.5	9.0	0.2	6.6	1.8	2.6	0.3	0.6	0.4	0.6	0.3	14.5	0.9	17.5	0.5
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"skin 1: 59.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 4.1;Late spermatids: 10.2;Syncytiotrophoblasts: 8.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SuSa: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027714	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Nucleoplasm, Vesicles"	"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	1.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
PRRG2	PRGP2	ENSG00000126460	"Proline rich and Gla domain 2"	O14669	19	49580646-49591004	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 28.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 47.2;Proximal enterocytes: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.9;OE19: 18.0;RT4: 11.7;SK-BR-3: 13.3;T-47d: 14.4;U-266/84: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010702	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA010702: AB_1079693"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (3.82e-9)"	"unprognostic (4.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.68e-2)"	1.2	0.4	0.9	1.2	0.9	0.1	7.0	1.3	2.6	4.9	0.6	8.4	12.0	1.5	12.9	13.5	4.9	4.3	1.2	0.9	1.0	11.8	6.4	3.9	0.9	1.2	0.9	0.3	13.1	28.4	15.6	2.1	1.1	6.2	7.7	0.1	11.3	9.0	0.9	12.9	11.0	1.1	0.9	1.0	9.8	0.9	1.1	2.3	13.4	0.1	3.9	6.7	5.5	1.0	11.1	0.4	0.3	0.9	1.3	0.0	4.6	0.2	0.0	0.4	0.4	2.2	14.9	0.7	1.6	0.1	0.3	8.5	0.3	8.5	0.4	1.1	1.2	0.5	0.8	0.7	0.9	0.4	1.1	0.9	7.4	0.3	0.3	0.7	3.4	0.9	0.2	0.8	0.0	2.4	0.2	0.7	0.6	18.0	1.4	0.2	0.3	8.7	6.5	11.7	2.4	0.3	1.3	13.3	0.1	1.0	14.4	0.2	0.6	0.8	0.7	0.4	0.1	5.1	18.7	0.5	0.2	0.3	0.4	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.2	0.5	0.0	0.2	1.2	0.2	0.1	0.9	0.9	1.3	2.6	0.9	1.0	1.2	0.9	1.1	0.9	1.1	1.0	6.4	6.4	13.4	0.7	3.4	4.1	11.6	20.2	29.6	2.2	21.5	22.6	0.9	8.6	14.2	12.9	2.1	13.0	4.1	47.2	3.9	31.9	0.7	10.8	4.1	6.4	16.2	1.3	0.5	33.2	6.5	1.6	16.8	16.1	2.5	2.3	1.1	6.8	2.3	5.0	0.4	18.0	8.2	1.9	1.2	0.4	0.3	3.3	1.8	1.9	8.2	0.9	2.1	2.0	0.4	27.4	29.4	0.0	4.4	14.5	46.3	15.5	8.8	4.1	0.0	0.8	3.9	1.9	2.1	23.3	4.7	12.7	4.1	4.6	20.7	14.6
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 84.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 84.1;Early spermatids: 111.0;Late spermatids: 349.7;Spermatocytes: 453.2;Spermatogonia: 270.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 16.1;eosinophil: 33.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 33.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.0;HEL: 28.5;HeLa: 71.0;K-562: 34.3;U-698: 104.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	38	"basal ganglia: 8.9"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.1	0.0	0.1	0.5	0.1	7.8	1.3	0.0	0.1	1.6	0.0	0.7	0.5	0.2	0.0	1.5	2.7	1.8	0.0	0.0	0.1	0.1	0.1	2.5	1.2	0.1	0.0	0.1	2.0	1.5	0.1	0.0	0.1	3.8	0.5	0.0	20.5	0.3	0.0	0.9	0.8	0.1	0.0	1.7	0.8	84.6	0.1	1.1	0.0	0.0	1.2	0.4	1.4	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	25.0	0.0	0.1	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	28.5	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	13.8	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	104.8	0.0	0.0	0.0	16.1	3.5	33.0	3.1	2.6	4.8	1.2	1.5	2.6	0.9	0.8	2.2	3.2	0.3	1.8	0.5	2.2	1.0	2.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	4.6	1.1	37.9	9.4	13.1	0.0	6.1	8.4	84.1	0.0	2.7	0.0	0.0	0.3	2.1	1.4	0.0	1.1	111.0	0.3	2.6	1.6	0.0	9.7	0.0	0.4	9.0	0.7	0.0	0.4	0.0	0.4	0.0	0.0	11.1	0.0	0.0	1.5	4.1	0.6	0.7	349.7	6.5	5.7	0.0	0.0	1.1	0.0	4.1	0.0	0.1	0.7	0.6	3.8	20.4	32.7	0.1	0.1	0.5	0.0	46.0	0.0	1.0	453.2	270.2	2.8	0.6	0.1	3.4	0.0	2.4	14.5
PRTFDC1	HHGP	ENSG00000099256	"Phosphoribosyl transferase domain containing 1"	Q9NRG1	10	24848614-24952606	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 136.1;Oligodendrocyte precursor cells: 111.6;Oligodendrocytes: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 75.9;CAPAN-2: 94.3;HEL: 56.2"					"Low region specificity"	"Detected in all"			HPA021458	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA021458: AB_1855793"	"unprognostic (2.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (9.49e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.94e-2)"	5.4	22.2	21.7	4.5	28.7	0.9	7.6	24.9	27.2	12.9	16.1	9.9	17.7	15.8	7.4	5.5	9.8	14.8	10.9	22.4	24.6	4.8	2.8	4.3	4.2	26.7	24.0	20.2	4.6	13.4	11.4	2.9	28.0	7.8	11.3	16.5	9.7	8.2	1.3	1.8	17.1	9.8	25.8	3.2	17.5	2.2	23.7	6.8	5.3	2.8	3.2	7.4	6.3	37.1	19.5	41.3	30.2	12.4	4.9	24.4	0.0	20.2	15.1	14.2	19.3	75.9	94.3	0.0	3.1	23.7	1.2	10.7	34.7	0.0	22.0	0.0	1.4	56.2	7.6	0.1	14.6	0.0	0.0	7.1	0.2	7.7	0.0	13.3	22.6	2.2	18.6	10.5	6.8	0.5	8.8	0.1	20.9	3.3	0.7	9.7	0.1	0.2	12.7	0.5	21.5	0.9	19.3	0.1	0.0	0.6	1.1	4.3	12.2	6.3	15.5	23.1	12.2	0.9	0.0	0.0	16.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	4.4	0.0	0.1	0.0	0.9	21.7	28.7	24.9	27.2	22.4	24.6	26.7	24.0	28.0	25.8	23.7	37.1	3.5	0.0	0.5	136.1	0.7	2.7	4.6	5.4	2.8	10.2	1.1	5.8	8.6	7.2	3.9	3.7	2.1	1.0	0.8	3.8	5.9	5.8	1.4	1.5	27.3	2.8	5.4	3.0	38.2	0.5	4.9	20.6	12.2	2.2	0.0	25.1	7.5	0.1	7.2	6.7	43.0	7.3	0.0	0.9	3.1	1.0	12.2	7.8	3.6	24.4	1.5	45.8	0.0	111.6	148.2	2.3	2.1	9.8	1.3	1.1	12.2	0.1	1.1	15.9	0.0	16.4	10.4	3.4	6.3	0.4	2.8	0.8	1.0	22.7	11.6	1.5
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611544-55743152	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 10.4;thyroid gland: 10.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 191.8;Oligodendrocyte precursor cells: 51.8;Rod photoreceptor cells: 62.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"AF22: 148.6;SuSa: 172.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Vesicles, Plasma membrane"	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	0.5	1.0	1.7	0.4	2.2	0.1	1.1	2.2	1.1	1.2	1.4	0.5	0.1	3.6	0.5	0.1	1.1	0.3	0.6	1.3	2.8	1.5	0.1	1.7	0.1	3.2	2.4	1.9	0.1	1.9	0.9	2.7	3.7	0.4	0.2	10.4	0.2	0.5	0.6	0.1	0.3	1.3	2.9	0.1	0.5	3.6	2.9	0.0	10.7	0.4	0.1	0.4	0.5	5.0	1.2	3.4	148.6	3.2	0.0	0.1	13.2	1.2	4.5	3.9	5.4	25.8	0.8	0.0	5.4	0.2	5.8	0.0	0.6	0.3	5.2	0.0	6.4	1.0	1.1	9.8	1.1	1.0	0.0	0.5	0.2	1.7	2.7	3.0	2.8	0.3	2.7	0.0	2.3	2.2	0.0	0.0	5.9	0.0	3.0	0.0	22.3	0.0	3.1	0.4	1.8	7.6	1.2	1.9	8.3	172.9	0.7	0.5	0.2	2.1	1.6	0.0	4.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	2.2	2.2	1.1	1.3	2.8	3.2	2.4	3.7	2.9	2.9	5.0	3.2	9.6	20.2	17.6	0.0	0.3	0.0	0.0	0.0	12.4	5.0	4.4	6.0	0.0	2.5	16.5	191.8	19.9	0.1	0.1	0.0	0.0	21.8	2.8	25.5	9.7	0.0	0.0	0.7	0.2	4.1	4.0	3.6	3.1	0.0	2.9	3.6	0.0	1.7	0.0	11.1	0.0	0.0	0.0	0.0	25.3	5.3	0.2	0.0	28.1	0.0	4.4	0.0	51.8	13.6	0.4	0.0	2.6	0.1	0.1	0.0	1.4	0.0	62.3	0.0	5.8	2.4	8.9	12.1	0.0	0.0	6.0	0.1	9.5	0.5	0.1
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840999-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"bone marrow: 2098.1"	"Cell type enriched"	"Detected in some"	17	"Erythroid cells: 26.5"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	6	"THP-1: 2054.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		390000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.8	0.2	0.6	0.0	0.7	2098.1	0.4	0.2	1.3	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.6	0.6	0.4	0.3	2.8	11.7	0.4	0.3	0.4	0.1	0.1	0.2	1.3	0.6	0.4	0.3	0.0	0.0	1.6	0.0	0.3	1.3	0.0	0.0	0.2	38.2	0.1	0.2	0.6	7.1	0.4	0.0	0.0	0.0	0.1	0.4	1.2	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	343.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2054.4	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	9.9	0.6	0.7	0.2	1.3	0.6	0.4	0.3	0.4	0.4	0.2	0.6	0.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.8	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	26.5	0.4	0.0	0.9	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.5	0.0	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1
PRXL2B	"C1orf93, FAM213B, MGC26818"	ENSG00000157870	"Peroxiredoxin like 2B"	Q8TBF2	1	2586491-2591469	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 5.0;Endothelial cells: 2.1;Hofbauer cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 51.8;U-2197: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006403	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA006403: AB_1853870"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.76e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (5.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.20e-2)"	8.3	18.6	11.0	4.8	12.0	3.2	9.2	5.5	16.4	9.4	2.3	24.4	18.7	9.3	1.4	12.3	10.9	6.0	6.4	12.1	10.2	15.6	7.0	11.7	5.0	9.4	10.1	6.3	6.8	5.4	8.7	6.7	11.7	10.0	5.9	2.8	7.8	5.6	1.3	7.8	20.5	3.6	7.3	15.2	14.3	6.6	11.1	4.1	8.1	0.7	3.9	11.7	8.1	8.3	15.8	8.7	9.8	9.1	3.8	4.6	1.2	5.4	6.2	13.6	5.6	6.7	18.0	4.2	13.9	9.5	5.4	12.6	8.2	9.5	4.5	11.8	3.8	9.9	6.1	11.3	10.3	5.3	3.0	6.4	5.2	9.8	3.2	6.7	19.0	6.8	13.3	6.4	13.9	7.7	12.2	2.5	10.4	19.8	31.6	14.2	12.8	10.1	14.2	8.3	11.7	18.0	12.2	51.8	16.8	2.2	9.3	2.2	28.1	11.2	12.7	46.3	5.4	5.2	8.1	3.0	11.0	19.9	2.8	1.9	1.5	0.8	2.5	1.5	4.2	1.2	2.8	2.9	1.6	0.9	2.5	3.7	1.1	4.8	1.4	0.7	4.4	2.4	11.0	12.0	5.5	16.4	12.1	10.2	9.4	10.1	11.7	7.3	11.1	8.3	5.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
PRY	"PRY1, PTPN13LY"	ENSG00000169789	"PTPN13 like Y-linked"	O14603	Y	22490397-22514637	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059887			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"			"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA059887: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRY2	PTPN13LY2	ENSG00000169807	"PTPN13 like Y-linked 2"	O14603	Y	22071756-22096007	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059887			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"				"Nucleoplasm, Nucleoli"	Cytosol	"HPA059887: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRYP3		ENSG00000169763	"PTPN13 like Y-linked pseudogene 3"	O14603	Y	23681440-23694579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 1.7;epididymis: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"A549: 4.5;HDLM-2: 7.7"									HPA059887			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 44: HDLM-2 - Immune response"		"Nucleoplasm, Nucleoli"	Cytosol	"HPA059887: "																		0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.0		0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.7	1.5	0.9	1.2	1.7	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSD	"EFA6, EFA6A, KIAA2011, PSD1, TYL"	ENSG00000059915	"Pleckstrin and Sec7 domain containing"	A5PKW4	10	102402617-102421539	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 233.9;intestine: 261.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.7;Cone photoreceptor cells: 95.9;Endometrial stromal cells: 47.7;Excitatory neurons: 41.1;Inhibitory neurons: 29.9;Rod photoreceptor cells: 70.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 7.7;MOLT-4: 4.4;SCLC-21H: 7.4;SH-SY5Y: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059237	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA059237: AB_2683954"	"unprognostic (2.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	1.2	9.1	159.5	3.8	151.7	0.7	1.5	7.8	233.9	53.8	0.0	261.8	6.1	78.3	1.4	1.6	46.2	8.9	4.4	220.9	63.9	2.8	2.4	1.2	0.9	23.8	25.4	15.3	5.0	1.5	99.4	0.8	27.3	4.3	3.5	36.8	1.0	1.2	0.4	1.6	41.4	17.7	14.9	1.5	44.2	12.4	70.2	1.4	1.1	0.0	0.4	105.7	14.7	87.6	0.2	0.0	3.0	2.7	1.1	0.6	0.3	0.2	0.0	0.1	0.0	2.1	0.3	0.2	1.8	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.1	1.6	0.0	0.1	7.7	0.2	0.5	0.1	1.2	0.0	1.0	0.4	0.7	0.0	1.7	4.4	0.2	0.4	0.3	0.0	1.2	0.0	0.1	0.0	0.1	7.4	6.4	0.1	0.1	0.2	0.2	0.5	0.4	0.0	2.2	3.5	0.2	0.0	1.9	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	159.5	151.7	7.8	233.9	220.9	63.9	23.8	25.4	27.3	14.9	70.2	87.6	0.7	3.2	0.5	6.8	1.0	0.6	0.3	0.3	0.0	50.7	1.1	0.5	1.5	2.8	1.5	0.0	95.9	0.2	0.6	0.8	1.9	0.2	6.6	4.8	47.7	1.0	18.0	0.0	41.1	1.9	0.2	4.0	2.6	1.8	0.0	0.4	0.0	1.3	0.7	13.5	29.9	0.9	0.0	0.6	0.7	2.7	3.7	0.5	0.0	3.7	0.1	13.2	0.0	9.0	2.4	0.7	1.4	4.1	0.1	0.4	1.3	1.2	0.5	70.8	0.0	2.0	1.1	4.0	3.7	0.7	0.1	0.7	1.9	8.8	1.3	0.1
PSD3	"DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942"	ENSG00000156011	"Pleckstrin and Sec7 domain containing 3"	Q9NYI0	8	18527303-19084730	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.3;Early spermatids: 686.7;Excitatory neurons: 284.7;Oligodendrocyte precursor cells: 488.1;Oligodendrocytes: 584.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.8;hTERT-RPE1: 48.0;LHCN-M2: 47.3;U-87 MG: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002455	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"	Cytosol	"HPA002455: AB_2666597"	"unprognostic (3.87e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (7.55e-4)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.45e-1)"	2.4	17.8	24.8	3.1	46.2	1.2	5.9	62.4	46.1	11.9	0.0	6.7	4.8	8.8	3.8	5.3	2.5	7.4	27.5	51.9	4.0	1.9	18.9	4.6	2.5	3.3	10.0	18.0	9.9	18.4	7.3	6.6	1.8	3.9	7.3	19.9	4.1	5.8	1.3	4.4	5.0	5.8	0.0	10.4	9.8	16.4	7.8	2.2	6.1	2.3	3.4	5.8	4.3	17.2	11.0	5.7	25.0	0.1	8.8	53.8	1.3	5.7	8.9	5.1	10.5	3.3	4.3	6.5	3.6	23.8	22.3	0.9	7.3	10.1	9.7	0.0	6.6	0.6	4.6	0.5	15.9	0.2	0.4	14.2	6.2	28.2	4.9	48.0	6.8	1.6	0.8	4.9	47.3	3.7	0.0	1.2	4.9	9.6	14.7	5.2	21.4	3.0	12.7	14.0	10.7	11.8	2.5	1.1	3.8	5.4	0.3	2.6	28.0	15.7	10.8	37.5	5.1	0.4	0.7	14.8	49.5	2.7	5.4	0.7	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.5	0.1	0.1	0.3	0.3	0.2	0.1	0.4	0.1	24.8	46.2	62.4	46.1	51.9	4.0	3.3	10.0	1.8	0.0	7.8	17.2	8.1	3.2	2.7	558.3	3.3	21.9	13.7	26.4	13.6	191.9	14.4	10.7	119.2	7.2	23.9	9.2	118.9	3.2	0.1	48.5	1.9	13.5	686.7	12.5	69.9	8.2	6.1	0.0	284.7	8.7	1.7	44.3	43.8	6.6	0.0	87.2	4.2	42.9	13.1	18.5	121.6	20.0	44.7	16.0	25.9	217.9	33.2	9.0	1.8	148.9	59.7	78.0	0.0	488.1	584.6	27.0	13.5	53.8	0.1	11.2	20.3	0.3	41.0	52.0	13.1	29.3	17.7	16.5	17.7	32.4	9.9	1.1	1.1	114.9	17.2	23.7
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86047109-86088621	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 2.4"	"Cell type enhanced"	"Detected in single"		"Rod photoreceptor cells: 2.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 9.4"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome 20S subunit beta 10"	P40306	16	67934506-67936864	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 122.3"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 183.4;RPMI-8226: 169.4;THP-1: 171.3;U-266/70: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030224, HPA030225, CAB034384"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Vesicles	"CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (5.44e-4)"	26.3	26.9	5.7	81.8	6.0	71.3	24.9	6.9	8.8	18.9	6.6	51.6	110.5	18.4	5.7	22.8	30.4	31.2	16.2	5.6	8.0	35.1	37.1	42.2	122.3	12.6	7.4	14.6	15.0	6.3	13.2	23.1	8.6	28.9	22.9	0.4	65.1	22.4	6.8	18.1	95.8	14.0	9.5	102.7	62.5	5.3	7.8	61.9	23.6	3.5	37.5	36.4	18.6	11.7	31.8	26.9	0.7	2.2	6.7	17.2	99.6	10.8	42.3	38.5	50.6	13.9	148.5	111.9	23.4	13.2	12.9	47.9	0.0	13.4	2.9	50.3	1.9	39.2	7.6	16.4	65.7	78.5	115.2	26.9	8.4	15.2	1.5	12.1	20.6	32.1	3.6	48.2	9.0	42.6	140.7	84.9	1.0	1.1	10.2	183.4	8.3	169.4	31.6	52.5	0.9	2.3	31.1	67.5	17.2	0.4	14.5	171.3	32.0	21.2	6.6	9.7	15.3	189.8	43.9	88.4	57.1	97.9	47.0	539.5	714.6	571.1	511.7	787.1	376.4	402.6	397.9	437.3	594.8	390.2	326.2	364.6	786.2	588.6	607.4	604.4	495.9	1155.7	5.7	6.0	6.9	8.8	5.6	8.0	12.6	7.4	8.6	9.5	7.8	11.7	24.7	22.4	26.8	4.6	72.9	17.2	14.3	101.2	26.2	1.0	15.8	13.8	1.6	28.6	43.9	18.4	0.0	29.5	66.2	80.8	23.5	58.5	14.0	17.6	20.1	22.8	16.3	32.6	3.4	104.3	30.0	23.4	110.6	12.3	51.9	7.2	37.1	10.2	87.4	0.0	5.0	74.6	52.9	81.9	66.4	35.9	30.1	88.5	48.0	9.4	123.3	3.0	112.3	2.5	7.3	51.2	139.7	21.1	110.5	12.1	173.5	69.4	83.9	1.1	19.7	10.3	26.6	16.4	7.5	24.1	9.9	22.6	93.9	16.9	79.5	24.8
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	85.3	86.1	106.8	64.7	117.3	96.1	77.9	105.3	131.0	73.7	105.8	110.2	52.2	89.9	62.5	88.7	69.0	44.0	172.1	107.8	106.3	73.8	117.7	76.2	65.3	108.6	114.7	58.2	81.4	74.1	55.4	78.8	111.0	74.2	59.1	30.9	73.0	69.8	292.0	103.4	64.0	77.5	104.6	67.8	87.7	74.7	115.2	90.6	69.4	162.9	76.5	80.8	71.7	107.0	223.7	248.2	233.5	173.3	109.6	117.3	226.5	181.5	267.4	445.7	313.8	223.3	126.8	179.5	110.1	230.1	195.7	218.3	206.7	237.7	199.0	269.4	268.1	173.1	301.1	218.5	141.4	203.7	177.0	131.4	126.1	181.6	202.5	98.4	253.8	182.7	249.2	164.7	276.0	497.0	259.5	258.4	229.5	280.7	296.1	269.3	458.8	157.3	209.5	165.2	170.0	147.1	148.7	206.9	116.2	98.2	255.7	209.8	181.3	253.7	321.1	363.8	474.7	176.5	220.0	209.2	262.4	201.7	325.1	111.5	154.3	121.8	160.8	194.6	146.7	146.8	132.9	147.8	160.6	122.4	116.5	118.6	33.9	173.3	211.6	160.0	191.0	254.7	106.8	117.3	105.3	131.0	107.8	106.3	108.6	114.7	111.0	104.6	115.2	107.0	81.5	57.7	42.0	3.9	59.5	86.3	112.8	198.5	50.7	41.2	61.4	64.1	217.6	81.5	103.7	68.0	16.7	265.9	60.0	143.9	152.6	199.2	152.5	72.0	75.7	96.0	64.5	136.6	6.4	202.6	257.9	100.4	54.0	70.1	75.3	79.2	77.1	144.2	158.2	37.0	5.3	111.5	75.3	62.4	80.0	217.6	88.6	62.5	99.6	1.9	132.0	120.2	74.2	3.0	5.2	214.2	110.8	100.1	96.3	102.8	127.7	191.3	76.9	47.4	118.3	75.1	193.3	147.0	63.6	51.3	77.3	352.9	61.8	74.1	117.6	101.6
PSMC6	p42	ENSG00000100519	"Proteasome 26S subunit, ATPase 6"	P62333	14	52707178-52728590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042823	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042823: AB_2678188"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.14e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.67e-1)"	43.4	48.4	38.8	47.3	39.2	44.1	58.1	41.2	54.0	44.0	37.4	52.2	50.0	47.6	49.2	65.1	49.2	36.5	78.7	39.8	42.1	65.9	87.1	39.6	55.4	41.1	41.0	51.0	43.7	59.9	5.5	54.9	42.0	45.3	54.3	60.1	37.9	45.6	118.1	44.6	46.6	56.8	41.5	38.8	46.5	31.4	41.0	56.3	54.3	106.7	67.0	57.2	7.9	44.1	182.0	115.0	135.4	99.0	92.4	95.8	146.0	139.3	133.1	220.8	165.1	142.6	143.5	156.8	169.8	121.6	111.5	134.0	173.9	121.9	230.6	151.2	74.5	115.0	91.3	153.5	111.0	164.9	106.8	71.8	118.4	112.1	111.6	120.1	141.2	77.4	174.2	64.7	161.8	163.2	129.5	111.8	108.7	170.1	153.8	108.4	237.2	70.7	144.6	178.5	96.0	71.2	123.8	76.5	122.3	120.8	156.4	117.0	108.9	121.2	171.0	95.8	145.2	45.6	127.0	175.8	79.1	110.5	112.9	77.5	62.4	67.0	51.2	71.9	59.5	63.4	62.7	56.4	73.9	56.4	59.6	59.0	52.7	55.6	73.0	38.5	85.4	75.4	38.8	39.2	41.2	54.0	39.8	42.1	41.1	41.0	42.0	41.5	41.0	44.1	81.2	70.5	58.9	23.5	74.2	86.2	141.9	187.1	50.1	65.5	55.3	51.3	76.6	62.9	140.6	57.0	68.8	162.2	69.4	73.5	135.0	131.0	30.4	92.8	75.3	78.2	70.4	85.2	37.4	106.9	139.9	72.1	38.7	96.3	67.7	68.7	50.0	84.4	92.1	62.2	39.0	58.9	109.9	71.3	67.9	19.9	67.1	61.4	80.0	20.6	90.9	64.6	52.5	38.2	46.7	116.2	46.2	65.5	64.0	85.2	72.5	140.2	116.4	107.6	72.3	66.5	130.6	63.4	82.8	48.9	72.0	237.5	65.0	79.7	73.4	116.6
PSMD12	"p55, Rpn5"	ENSG00000197170	"Proteasome 26S subunit, non-ATPase 12"	O00232	17	67337916-67366605	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023119	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		73000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Nucleoplasm, Cytosol"	"HPA023119: AB_1855845"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.63e-1)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.73e-6)"	"unprognostic (1.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	14.8	13.9	11.2	11.4	12.2	12.5	11.9	15.0	19.4	9.4	9.7	10.4	8.2	10.5	10.9	12.5	7.6	9.7	13.7	12.6	17.2	14.9	28.0	9.4	10.8	17.8	17.8	9.1	15.6	14.8	7.6	11.0	18.9	10.7	11.6	8.9	10.0	7.7	35.8	10.3	8.7	11.3	12.9	9.4	11.2	14.4	16.0	12.1	10.3	29.1	15.1	14.7	8.0	12.5	63.8	38.5	29.2	32.2	21.9	26.3	40.6	44.2	27.9	47.8	42.0	40.4	27.4	36.6	28.0	35.9	37.4	37.0	51.1	45.1	70.7	17.8	38.5	43.2	29.9	41.1	28.6	44.7	25.0	29.6	29.4	45.3	35.2	21.2	47.6	27.8	57.4	21.0	45.0	43.5	41.0	42.6	35.7	30.0	50.1	20.9	75.6	32.5	36.1	52.0	28.0	40.6	32.9	62.6	45.2	34.1	45.0	36.9	49.5	50.5	34.4	38.6	81.4	21.4	35.2	30.5	59.8	46.5	29.9	14.0	9.9	8.9	8.7	16.7	12.3	8.0	11.5	9.9	10.3	8.9	10.1	10.7	7.3	10.9	19.6	7.0	12.1	8.7	11.2	12.2	15.0	19.4	12.6	17.2	17.8	17.8	18.9	12.9	16.0	12.5	59.6	48.1	58.8	9.8	37.9	112.3	119.5	109.0	43.3	40.8	37.9	33.0	108.1	25.8	97.7	46.0	25.0	88.3	47.9	29.7	70.5	80.7	158.1	99.1	62.3	73.8	32.9	67.3	21.0	78.7	88.8	64.0	33.1	125.3	50.6	39.9	41.0	84.1	56.0	92.5	22.0	28.6	65.1	44.7	90.6	197.0	46.3	50.6	48.0	10.3	59.8	58.6	37.0	14.6	15.0	84.9	22.7	44.0	58.2	93.4	26.0	77.2	68.1	44.6	26.3	78.6	146.8	126.2	108.0	52.9	94.8	123.0	53.8	53.8	34.1	123.2
PSMD13	"p40.5, Rpn9"	ENSG00000185627	"Proteasome 26S subunit, non-ATPase 13"	Q9UNM6	11	236966-252984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038691, HPA038692"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA		81000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"	Cytosol	"HPA038691: AB_2676153, HPA038692: AB_10671749"	"unprognostic (1.32e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (2.24e-2)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.76e-5)"	"unprognostic (7.54e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.52e-13)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	56.6	41.3	48.2	65.2	49.1	69.4	74.9	50.0	51.5	57.8	49.5	64.1	57.0	50.7	62.6	63.6	51.8	42.9	76.1	50.3	52.6	53.6	71.8	56.2	79.5	50.3	50.2	40.0	48.9	45.6	18.0	64.9	54.0	67.1	66.7	30.8	46.3	52.0	122.4	62.4	55.7	68.1	51.1	54.3	45.9	44.2	49.5	91.6	48.3	124.3	86.9	65.5	20.1	52.3	240.7	163.7	155.2	163.7	135.3	114.0	102.3	151.8	186.1	277.7	210.6	156.1	352.4	193.0	178.2	172.7	145.5	179.4	154.6	200.2	251.0	202.7	148.7	109.9	52.4	131.7	160.9	203.8	207.7	116.3	149.7	138.4	121.2	114.0	241.7	186.3	249.1	158.1	189.9	126.3	197.4	185.0	243.1	195.0	184.0	168.6	145.3	156.3	190.2	59.2	141.7	111.5	106.5	166.7	111.0	103.6	97.7	123.7	192.6	115.2	96.8	60.3	160.6	161.2	192.4	271.8	185.2	193.0	176.3	198.6	171.3	133.6	145.8	173.0	143.0	125.0	133.1	141.1	176.1	128.6	121.3	130.3	127.8	168.7	194.7	122.1	169.2	286.0	48.2	49.1	50.0	51.5	50.3	52.6	50.3	50.2	54.0	51.1	49.5	52.3	80.8	48.1	41.4	17.0	64.7	35.8	54.1	124.8	26.2	43.2	43.8	41.7	45.7	52.9	68.8	31.3	31.3	162.3	79.9	76.5	82.2	114.8	39.2	41.6	47.1	75.1	48.0	35.7	16.8	130.8	138.6	55.9	34.1	45.2	67.2	59.9	54.7	59.0	100.5	37.0	15.5	75.2	71.2	47.5	43.5	57.8	68.6	64.4	46.2	11.2	91.9	65.0	71.1	8.5	17.2	123.4	65.5	59.8	73.9	58.7	80.8	76.2	61.3	44.2	85.5	40.8	66.9	94.0	86.4	34.4	38.8	205.8	71.6	73.8	74.2	51.4
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842951	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol		No	No		250000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	15.0	16.5	8.8	13.4	8.4	20.4	23.4	12.0	9.8	15.9	8.5	14.5	12.6	16.4	13.9	16.6	14.1	12.5	9.4	8.4	10.2	13.5	20.5	14.6	15.9	9.3	9.4	15.2	14.3	10.7	9.8	12.7	9.5	18.1	14.3	11.7	17.9	14.3	9.1	19.7	12.5	18.6	8.9	12.0	14.3	13.8	9.7	14.5	14.3	11.2	19.0	17.1	12.1	12.8	35.0	44.3	20.7	38.6	44.9	44.1	24.4	49.4	38.1	45.3	41.5	38.7	21.7	35.4	22.1	50.2	36.1	50.5	0.0	48.9	52.5	33.1	5.3	29.7	59.2	21.6	33.9	10.2	10.6	37.3	30.6	44.2	47.4	22.7	26.9	37.7	110.2	22.6	42.8	42.9	31.5	21.0	30.6	82.6	31.4	28.0	45.0	28.0	42.1	30.0	28.8	18.3	61.8	50.2	24.7	15.2	60.5	24.5	41.5	0.1	25.0	19.3	45.3	13.0	14.8	38.0	28.6	33.4	41.1	19.3	18.1	15.6	19.8	20.9	21.6	22.2	22.7	23.9	17.7	17.8	21.9	16.9	9.7	18.7	23.7	12.7	32.7	18.1	8.8	8.4	12.0	9.8	8.4	10.2	9.3	9.4	9.5	8.9	9.7	12.8	14.3	9.6	17.0	20.2	16.7	12.4	11.8	11.7	21.1	11.6	18.9	13.5	8.1	11.5	17.5	9.2	12.5	12.1	15.3	13.6	11.7	12.9	7.7	8.1	20.6	13.7	7.8	17.2	28.4	13.4	11.7	18.4	14.8	11.9	14.5	11.8	17.2	24.9	11.8	5.0	24.5	14.1	8.2	16.1	13.9	4.7	13.1	12.7	14.2	15.0	12.3	9.9	10.3	34.2	29.0	17.1	10.1	16.1	16.0	14.1	10.5	16.8	8.1	10.3	6.6	11.7	16.3	22.4	21.3	27.0	13.5	10.9	17.3	17.7	11.0	9.7
PSMD8	"HIP6, HYPF, Nin1p, p31, Rpn12, S14"	ENSG00000099341	"Proteasome 26S subunit, non-ATPase 8"	P48556	19	38374550-38383824	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 708.9"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 1164.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006702, CAB021101"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nuclear speckles"	"CAB021101: AB_10061018, HPA006702: AB_1079710"	"unprognostic (9.50e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.58e-3)"	"unprognostic (4.84e-2)"	224.8	130.8	102.3	78.0	109.6	118.8	184.9	104.1	114.8	109.6	97.6	111.8	98.1	115.8	119.4	156.6	104.0	69.2	361.8	114.4	117.5	122.4	143.0	114.9	90.8	109.2	104.3	82.1	117.3	150.2	111.1	101.1	121.9	107.1	98.9	60.6	118.8	84.5	708.9	178.4	106.4	105.2	105.4	99.4	117.6	145.8	112.6	120.3	91.2	361.1	109.9	106.3	111.0	112.6	337.3	522.7	202.2	231.9	322.0	256.9	105.9	238.7	322.9	358.9	372.3	362.0	196.3	234.7	242.8	320.0	220.1	114.1	341.7	296.8	321.6	389.8	225.6	256.1	159.6	226.4	415.1	260.8	217.9	261.2	290.8	309.7	408.8	197.3	286.5	279.9	324.9	255.7	400.6	332.8	247.6	146.1	157.8	492.8	282.7	254.7	324.6	187.4	255.7	275.1	210.8	214.3	247.3	315.7	233.8	187.1	165.3	242.0	212.7	272.1	251.5	289.0	355.8	257.2	322.4	318.0	410.1	264.8	310.1	169.0	239.5	132.6	188.2	265.1	160.0	172.8	162.0	181.0	263.1	173.6	133.0	129.5	89.0	182.7	319.8	183.2	295.2	352.3	102.3	109.6	104.1	114.8	114.4	117.5	109.2	104.3	121.9	105.4	112.6	112.6	137.4	67.3	67.9	8.1	122.9	206.0	224.5	293.5	80.2	102.6	116.3	141.0	263.8	81.5	158.8	80.9	54.2	367.2	128.2	194.6	348.3	276.0	422.3	137.2	158.2	127.0	146.0	129.2	14.7	267.4	327.5	146.8	71.4	122.5	93.8	146.9	81.4	123.1	296.9	77.4	15.4	183.9	219.7	93.1	169.5	1164.7	118.4	126.9	199.3	10.3	224.0	179.8	143.2	8.0	19.8	296.8	181.2	117.8	178.9	255.0	305.7	332.4	128.5	120.4	151.2	106.6	221.1	305.1	135.4	120.3	212.3	570.3	133.0	201.0	182.5	218.7
PSME1	"IFI5111, PA28alpha"	ENSG00000092010	"Proteasome activator subunit 1"	Q06323	14	24136163-24138967	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006632	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA		7500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nuclear bodies"	"HPA006632: AB_1079686"	"prognostic favorable (8.87e-5)"	"unprognostic (1.02e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-1)"	"unprognostic (7.04e-2)"	"unprognostic (9.63e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.50e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (1.62e-3)"	163.2	231.2	36.4	102.1	37.3	120.3	157.1	37.1	47.1	159.0	36.4	182.2	133.9	128.6	85.0	177.6	139.6	68.3	145.2	35.7	38.9	224.5	219.7	184.1	156.8	40.5	37.6	154.3	131.0	84.6	115.0	72.4	39.0	146.3	119.9	24.5	151.6	85.9	140.7	142.9	211.6	79.8	39.6	272.6	160.4	30.7	38.2	129.1	150.6	67.3	150.7	135.2	157.1	40.3	98.6	79.0	59.8	115.9	127.6	146.0	91.6	61.5	199.0	193.2	274.8	51.9	233.5	252.1	44.8	102.7	101.7	139.1	86.8	127.3	128.7	211.2	52.5	112.9	34.9	289.6	280.0	144.8	137.6	128.2	80.4	87.4	76.3	182.6	147.4	158.1	17.5	218.5	76.3	249.3	376.0	175.1	5.8	162.3	135.9	293.2	123.4	182.9	246.8	259.8	37.7	67.3	78.0	200.7	124.6	35.5	131.9	139.5	85.1	52.8	61.0	60.6	92.7	201.8	224.5	120.9	71.9	128.0	86.6	394.8	441.9	552.3	484.5	570.1	484.8	399.4	448.4	463.2	425.0	370.1	318.6	395.7	653.9	515.6	575.2	408.3	537.9	978.6	36.4	37.3	37.1	47.1	35.7	38.9	40.5	37.6	39.0	39.6	38.2	40.3	305.5	208.3	172.7	7.5	353.8	156.4	241.6	570.7	199.2	28.2	159.6	169.2	59.6	248.8	296.5	283.3	10.4	393.3	406.7	347.8	318.9	500.0	3.5	171.4	250.5	228.0	189.7	244.9	1.4	549.8	293.2	184.8	138.6	223.9	240.1	124.7	242.4	266.6	313.7	6.7	1.9	397.6	280.8	295.3	294.2	16.5	189.2	275.4	188.5	4.7	930.4	98.3	620.0	3.0	6.6	373.6	461.2	124.8	422.0	280.6	754.3	700.5	236.3	23.5	105.2	121.4	283.6	3.5	24.9	200.0	156.0	304.4	424.6	243.6	406.6	301.3
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 107.6;Early spermatids: 149.8;Late spermatids: 211.5;Proximal tubular cells: 91.7"	"Cancer enhanced"	"Detected in all"		"glioma: 41.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	4.7	9.4	11.0	3.7	12.4	3.7	3.9	11.8	10.8	4.7	13.3	4.8	4.2	4.9	5.2	8.7	16.1	5.9	8.1	11.0	11.0	10.0	6.8	3.5	5.1	12.3	12.9	8.2	6.7	6.6	9.4	3.7	11.7	6.4	4.4	4.4	4.5	6.4	4.6	4.2	4.1	5.1	12.2	3.9	6.2	7.1	12.1	5.8	7.0	6.0	5.9	5.2	5.7	16.1	130.1	37.6	23.1	93.0	18.9	25.3	16.7	32.5	18.5	18.7	32.7	34.7	23.5	62.9	21.0	29.4	44.5	26.9	52.6	26.9	19.0	48.1	27.9	17.9	11.1	62.2	44.4	18.6	26.8	31.8	50.2	27.7	32.6	25.1	17.7	61.2	44.4	42.4	26.4	17.3	27.7	48.3	38.0	47.5	52.1	35.9	14.4	39.8	17.2	6.8	43.6	49.8	23.5	14.9	68.9	20.9	44.8	41.4	14.5	15.1	24.8	45.5	30.3	26.9	53.0	72.8	21.9	39.9	49.7	2.5	6.2	5.9	3.1	4.4	2.3	5.4	3.0	3.8	9.6	6.1	4.5	4.1	2.9	4.7	7.1	9.3	4.0	4.8	11.0	12.4	11.8	10.8	11.0	11.0	12.3	12.9	11.7	12.2	12.1	16.1	2.1	3.2	1.5	11.4	5.2	6.8	16.9	20.5	8.6	5.2	8.3	5.8	13.1	11.5	11.4	5.5	2.1	12.8	4.5	2.4	107.6	8.6	149.8	62.9	5.4	4.2	4.8	7.2	9.3	8.0	7.5	9.9	3.1	9.4	1.3	16.5	5.0	9.8	9.5	1.7	9.8	5.0	4.1	4.4	5.8	211.5	8.4	4.3	7.2	0.0	5.7	46.8	2.1	7.1	13.8	7.1	3.5	6.0	10.1	6.5	3.1	91.7	28.3	3.1	13.1	5.1	20.0	30.1	22.5	7.6	8.5	4.7	3.9	16.1	7.3	7.7
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47856673-48111197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 479.8"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BEWO: 12.4;Hep G2: 21.8;LHCN-M2: 9.6;SuSa: 20.1;TIME: 9.9;WM-115: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	0.5	0.1	0.6	0.0	0.6	0.0	0.3	0.0	1.5	0.6	0.1	0.3	0.1	0.3	0.6	0.3	0.5	0.2	0.5	0.8	0.5	0.4	0.3	0.5	0.0	0.2	1.0	0.2	0.2	0.0	0.9	0.3	0.0	0.5	0.1	0.8	0.5	1.0	0.1	0.0	0.1	0.3	0.5	0.0	0.1	0.2	0.3	0.0	0.8	0.1	0.0	0.3	0.3	0.4	0.0	0.0	9.4	0.0	1.3	3.9	12.4	1.2	2.8	0.0	0.4	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.2	21.8	0.5	0.0	0.0	6.2	5.4	0.0	0.1	4.4	1.8	2.5	0.0	0.0	9.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.5	0.1	0.0	0.0	20.1	0.0	0.0	9.9	2.3	1.9	0.0	0.2	0.0	0.0	0.0	3.3	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.5	0.8	0.5	0.2	1.0	0.0	0.5	0.3	0.4	0.5	0.0	1.1	6.5	0.0	0.1	0.0	1.0	0.0	1.0	0.4	0.3	0.2	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	90.6	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	479.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	89.9	0.0	0.6	0.0	2.5	2.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.9	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
PTER		ENSG00000165983	"Phosphotriesterase related"	Q96BW5	10	16436943-16513745	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.5"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 190.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 6.9;basal ganglia: 16.5;cerebral cortex: 8.7;hippocampal formation: 14.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038044, HPA038045"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8600	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA038044: AB_2675803, HPA038045: AB_10672616"	"unprognostic (5.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.52e-6)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.36e-3)"	6.8	5.5	6.9	5.6	16.5	2.3	10.3	1.0	8.7	5.9	0.0	8.3	12.7	4.9	4.4	4.5	5.1	5.3	7.1	14.1	1.3	31.5	14.0	6.0	7.9	0.0	0.0	2.0	7.5	9.2	1.3	5.6	0.0	7.1	8.0	11.8	8.3	4.6	9.2	5.4	10.0	3.3	0.0	6.9	14.1	1.1	0.8	7.3	10.6	10.0	7.9	9.0	3.7	0.0	26.9	11.7	0.1	4.8	7.0	13.0	14.7	6.9	0.7	2.6	3.5	10.7	20.9	25.0	5.9	4.5	1.2	11.4	8.3	4.3	4.3	30.2	9.9	24.9	6.1	5.6	7.2	8.2	8.0	8.2	17.0	8.0	1.3	0.1	1.5	22.9	17.5	8.4	4.1	7.8	17.8	9.5	5.7	15.9	2.5	13.7	2.4	13.1	43.2	6.4	22.7	1.4	12.5	3.7	23.3	5.2	8.6	30.4	3.4	0.2	6.3	5.5	0.1	6.3	7.6	25.2	3.3	14.7	8.7	3.4	7.2	4.7	7.5	11.6	8.1	9.2	8.8	8.1	7.6	5.8	6.8	7.1	2.2	5.6	10.3	6.7	14.2	5.9	6.9	16.5	1.0	8.7	14.1	1.3	0.0	0.0	0.0	0.0	0.8	0.0	12.1	28.9	26.3	2.9	13.5	11.0	14.7	7.7	9.6	0.9	13.6	9.4	29.5	15.7	20.6	29.5	0.0	19.6	10.2	19.5	52.8	22.5	0.3	10.7	5.5	8.3	11.5	9.4	0.5	34.4	18.7	10.2	41.8	17.8	24.1	5.1	11.4	24.3	15.6	0.0	0.2	13.1	18.3	17.1	6.5	0.3	0.9	12.3	8.8	10.3	14.6	13.9	33.0	0.0	0.2	26.8	26.7	0.0	8.1	11.4	19.8	190.5	14.4	9.9	6.6	7.7	16.0	1.1	6.5	7.6	12.4	12.0	13.2	3.0	19.2	22.2
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		660000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	141.7	128.0	198.0	137.2	210.0	150.2	171.2	217.0	454.6	168.2	185.5	169.9	151.7	172.9	159.0	161.3	217.6	114.9	122.8	195.5	215.6	180.5	218.6	133.9	157.2	214.9	213.0	250.0	121.9	133.7	111.7	164.9	218.5	141.6	172.8	118.0	124.0	147.6	208.6	123.5	155.4	138.8	213.0	125.0	117.1	135.0	204.3	167.2	162.3	158.5	185.0	158.7	145.8	278.0	616.6	528.8	416.5	249.8	300.2	270.3	634.3	392.8	298.5	494.5	366.9	452.5	629.6	676.0	588.5	338.3	331.7	385.4	790.0	514.2	621.8	509.8	529.8	529.7	309.5	524.4	219.4	637.9	367.2	197.0	367.3	375.1	450.3	468.5	518.1	425.7	866.0	628.2	490.4	385.3	636.5	602.1	714.7	538.3	609.3	549.2	392.3	914.4	436.8	473.2	538.4	313.8	401.7	570.1	355.8	546.5	658.3	526.9	314.0	294.7	341.8	358.3	552.8	262.8	777.5	540.4	321.1	516.7	543.8	141.1	166.1	107.1	130.9	261.6	172.3	172.3	170.6	156.7	160.2	127.0	167.3	147.7	64.7	132.2	346.2	135.3	191.6	316.1	198.0	210.0	217.0	454.6	195.5	215.6	214.9	213.0	218.5	213.0	204.3	278.0	265.8	179.5	137.1	39.5	251.0	386.6	826.7	248.5	272.6	128.3	208.5	197.1	166.0	178.7	161.4	189.4	77.2	457.2	245.6	246.5	373.7	310.4	42.5	493.7	221.5	242.1	261.3	452.0	43.4	214.8	676.3	268.7	143.2	291.3	234.2	224.5	188.8	187.0	349.9	112.7	41.3	295.9	201.4	209.5	363.6	107.9	238.9	261.7	282.8	47.8	283.3	244.1	178.2	38.7	71.4	220.8	207.1	213.3	299.8	657.6	218.9	343.8	345.5	128.0	144.7	185.1	337.7	558.4	348.4	350.4	377.6	566.0	359.3	219.0	358.9	556.3
PTGES3L-AARSD1		ENSG00000108825	"PTGES3L-AARSD1 readthrough"	Q9BTE6	17	42950526-42980528	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 17.3;tongue: 10.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.5;granulocytes: 3.8;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 4.9;THP-1: 10.8"									"HPA021408, HPA022869, HPA023714"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (6.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.34e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.13e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.91e-4)"	"unprognostic (1.83e-1)"	0.4	0.2	0.1	0.8	1.0	0.7	0.4	0.0	0.8	0.7	0.2	4.3	0.8	3.2	0.4	1.1	1.0	0.8	3.0	0.3	0.3	0.3	0.2	0.4	0.2	0.1	0.1	0.3	0.3	0.3	1.2	0.2	0.0	1.3	1.8	0.6	0.6	1.7	17.3	0.3	1.2	5.6	0.0	0.2	1.5	3.3	0.0	0.2	0.3	10.6	0.2	1.9	0.6	0.3	0.6	0.0	1.7	1.8	0.1	0.0	0.4	1.2	1.5	0.8	0.7	1.2	0.1	0.1	1.2	0.2	0.5	0.0	0.3	0.8	1.2	0.7	0.2	4.1	1.7	2.5	0.0	0.5	2.7	0.0	0.5	1.3	0.0	0.5	0.3	1.1	1.3	0.3	1.6	0.0	1.4	0.4	0.4	2.5	0.4	0.7	4.9	0.5	0.2	0.3	0.8	2.4	1.0	0.3	1.1	2.3	0.5	10.8	0.0	0.5	0.9	0.0	0.4	2.9	0.8	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.0	0.0	0.8	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase non-receptor type 12"	Q05209	7	77537295-77640069	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		770000	"Cluster 40: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	60.5	30.1	24.2	43.9	26.6	69.9	50.3	29.2	31.6	40.9	25.9	48.9	18.9	38.6	18.6	38.5	39.6	40.2	39.0	25.1	27.3	36.1	30.9	65.0	27.5	28.5	27.8	34.6	20.1	21.0	21.9	74.7	30.5	26.4	27.7	30.9	23.8	33.2	24.6	36.9	29.7	40.2	26.7	52.7	27.1	30.1	32.7	33.9	31.0	44.5	27.5	46.7	39.6	30.2	72.4	43.5	100.6	51.8	69.1	71.7	54.2	73.3	93.0	56.6	80.0	21.6	109.9	8.6	23.2	86.3	123.6	50.2	34.2	73.4	113.3	21.2	19.2	44.9	44.2	88.4	67.7	25.8	28.8	59.0	80.3	123.2	157.6	101.0	121.6	2.1	54.9	12.2	182.6	49.4	3.6	71.9	81.7	97.6	49.2	15.1	80.6	4.5	97.6	38.5	12.5	66.6	90.4	81.5	73.4	172.2	39.5	93.9	89.3	121.4	73.1	45.0	141.3	12.6	7.4	22.2	71.6	65.9	215.7	3.6	4.1	6.8	3.1	2.8	1.3	2.3	1.1	2.6	3.8	1.0	0.6	3.3	9.5	13.3	5.3	0.3	1.6	2.7	24.2	26.6	29.2	31.6	25.1	27.3	28.5	27.8	30.5	26.7	32.7	30.2	139.3	70.5	56.2	30.0	18.2	68.8	60.0	55.9	23.9	16.7	40.9	26.3	41.3	28.6	46.4	20.2	8.4	40.0	89.0	31.2	3.9	42.1	3.5	43.9	62.4	114.4	12.1	16.6	65.8	39.6	58.7	54.6	21.4	87.2	14.5	21.7	119.2	24.6	50.1	35.3	58.0	21.7	28.5	82.0	121.3	6.7	46.6	96.1	35.6	93.7	54.9	66.9	163.7	70.4	67.3	75.0	21.4	47.0	17.6	62.0	10.9	19.2	23.2	15.2	65.7	127.9	66.8	51.2	71.4	29.8	101.4	72.1	27.3	24.4	23.3	104.8
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 124.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 223.1;Astrocytes: 165.2;Oligodendrocytes: 200.2;Rod photoreceptor cells: 179.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 117.6;RT4: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	14.0	6.7	9.9	3.0	16.6	0.3	11.7	8.1	10.8	18.8	22.4	5.2	0.8	13.1	25.5	22.2	13.0	7.7	6.1	14.2	10.6	26.6	1.4	22.9	5.2	16.7	13.1	28.7	4.9	17.5	16.8	3.3	10.5	11.0	2.4	124.3	6.6	10.6	1.0	55.9	2.6	7.9	8.2	4.0	4.1	15.8	13.8	7.6	20.8	5.0	11.5	20.7	22.7	20.4	13.8	6.8	117.6	11.5	48.2	41.9	0.0	25.0	51.0	9.4	11.7	0.1	6.8	0.0	5.3	28.0	3.3	44.4	20.6	37.9	18.0	0.3	15.1	11.4	14.6	0.0	5.9	20.5	0.1	27.2	11.8	6.8	22.4	19.7	0.0	0.0	0.0	19.2	0.0	6.2	1.8	7.4	26.5	0.0	5.1	4.1	0.0	0.0	35.6	57.2	6.8	9.8	7.4	16.4	13.3	18.8	9.6	0.7	0.0	9.1	6.9	0.2	3.3	19.8	0.0	0.0	9.5	0.0	4.0	0.0	0.1	0.0	0.1	1.3	0.9	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	9.9	16.6	8.1	10.8	14.2	10.6	16.7	13.1	10.5	8.2	13.8	20.4	5.3	48.1	223.1	165.2	0.6	109.4	25.6	26.3	79.1	11.6	11.2	8.9	1.8	11.5	52.0	47.8	91.8	0.2	0.3	0.1	3.9	5.0	23.2	16.9	49.4	3.7	4.8	0.8	67.0	3.7	0.1	28.8	4.1	7.7	5.1	7.5	3.6	0.1	0.3	1.7	39.3	1.1	8.2	1.4	10.6	20.8	45.7	4.5	19.6	51.5	0.5	20.3	0.0	75.4	200.2	6.2	2.7	32.7	3.0	16.0	0.1	10.9	27.3	179.0	13.1	10.1	20.8	25.4	20.5	97.8	99.4	0.3	6.6	14.0	0.7	52.5
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase non-receptor type 21"	Q16825	14	88465778-88555007	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Syncytiotrophoblasts: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Golgi apparatus"	"CAB011468: AB_442979, HPA073999: AB_2732247"	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favorable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.0	5.4	6.7	4.1	7.2	0.0	9.2	6.4	6.6	11.5	10.1	11.9	6.0	12.0	5.9	10.3	10.1	8.7	21.3	6.2	8.0	7.8	7.7	17.9	2.1	9.7	7.8	17.5	9.4	8.3	4.5	10.3	7.2	9.3	7.6	9.1	7.4	9.5	11.8	29.0	8.2	10.4	7.9	4.0	9.0	20.2	7.4	1.1	18.7	9.8	1.9	10.1	9.8	7.4	5.8	4.6	11.8	4.6	12.3	10.6	12.1	15.2	11.6	8.8	12.2	8.1	10.2	0.0	3.6	19.6	7.9	5.4	1.7	5.4	12.9	0.3	2.7	0.0	5.6	3.4	13.6	0.1	0.2	7.1	10.4	7.4	8.8	11.4	7.2	0.0	1.8	0.2	22.9	4.7	0.0	0.3	3.5	6.2	8.7	0.1	35.3	0.1	7.7	4.1	0.8	13.6	8.7	21.6	5.2	10.0	10.7	2.3	14.5	16.3	12.8	6.7	10.6	0.5	1.9	0.0	6.0	0.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.2	6.4	6.6	6.2	8.0	9.7	7.8	7.2	7.9	7.4	7.4	7.2	57.7	6.0	14.4	0.0	10.5	6.3	4.0	4.0	7.2	7.1	5.8	34.9	5.7	7.1	7.3	35.5	10.3	0.1	18.1	0.0	5.0	19.1	10.2	11.4	6.0	4.8	8.0	12.8	8.4	5.4	12.0	7.1	7.1	2.5	9.2	6.1	9.7	1.9	1.7	14.4	15.0	8.2	1.3	3.9	5.3	17.1	0.4	0.0	13.1	0.0	4.7	1.0	28.1	20.3	10.7	6.1	27.1	0.0	8.8	6.7	3.5	10.3	9.4	0.0	12.7	10.5	20.2	6.6	3.5	11.9	101.9	0.6	7.4	6.2	4.7
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase non-receptor type 4"	P29074	2	119759922-119984899	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 224.3;Horizontal cells: 161.5;Inhibitory neurons: 187.5;NK-cells: 247.2;Oligodendrocyte precursor cells: 200.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 37.3"	"Group enriched"	"Detected in many"	4	"gdT-cell: 35.0;MAIT T-cell: 28.1;memory CD4 T-cell: 16.9;memory CD8 T-cell: 27.9;naive CD8 T-cell: 19.2;NK-cell: 24.4;T-reg: 11.0"	"Group enriched"	"Detected in many"	16	"NK-cells: 24.4;T-cells: 35.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	4.5	3.8	5.9	3.6	5.0	5.1	4.7	37.3	10.1	5.7	0.0	3.4	5.1	4.1	4.2	4.1	5.5	3.7	5.7	5.2	2.7	7.4	4.2	5.2	5.4	0.1	9.6	5.2	2.8	6.3	3.5	2.5	1.4	3.5	2.4	12.1	4.1	2.5	8.0	3.0	2.8	2.8	0.0	5.9	5.7	4.9	12.6	8.1	14.0	12.8	4.2	3.2	2.6	5.9	7.4	4.3	5.0	7.3	4.8	5.0	9.1	3.2	9.3	1.8	4.9	6.2	10.9	4.1	7.6	3.5	5.2	5.3	4.4	5.1	4.8	12.6	3.6	3.7	3.5	6.1	3.2	3.9	2.6	4.5	9.6	8.5	3.7	6.0	8.2	4.8	5.7	4.8	5.0	5.0	5.2	4.4	7.3	4.0	6.9	3.4	9.6	6.9	6.7	10.0	6.8	8.5	4.2	5.8	4.0	4.0	2.8	2.4	10.7	0.0	6.1	1.9	4.0	8.9	13.7	6.6	4.7	0.1	3.0	0.3	0.2	1.8	35.0	0.5	28.1	0.6	16.9	27.9	0.5	0.6	5.2	19.2	0.6	24.4	0.7	0.3	11.0	10.4	5.9	5.0	37.3	10.1	5.2	2.7	0.1	9.6	1.4	0.0	12.6	5.9	20.5	3.2	14.6	128.9	24.4	8.2	15.5	8.5	27.3	55.7	13.9	11.2	17.9	10.0	8.3	16.5	104.3	10.5	95.5	7.3	7.9	8.0	5.4	18.2	15.7	15.0	9.1	35.4	224.3	7.3	11.8	11.3	16.8	15.8	11.4	47.9	15.0	11.0	4.0	161.5	187.5	9.9	12.2	8.6	7.6	8.8	17.4	9.0	8.8	38.4	11.8	24.9	247.2	200.6	113.6	6.3	9.6	14.3	30.1	12.7	10.6	13.6	8.8	79.8	0.0	25.5	9.0	31.4	26.4	12.8	6.7	3.7	79.4	23.3	11.5	9.5
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase receptor type Q"		12	80402178-80680273	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 7.1;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Club cells: 4.4;Early spermatids: 10.9;Excitatory neurons: 11.2;Late spermatids: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;BJ: 3.9;HBF TERT88: 2.6;RH-30: 2.9;RT4: 3.4;SiHa: 1.9;U-2197: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	3.2	0.0	0.3	0.0	2.0	0.0	0.4	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.9	0.1	1.6	0.2	1.1	0.2	0.4	7.1	0.0	2.3	0.9	1.0	0.7	0.3	0.3	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.8	0.0	0.1	2.7	0.3	0.2	2.9	0.0	0.3	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	3.9	0.8	1.2	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.4	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.7	0.2	0.4	1.0	0.7	0.6	0.8	0.3	0.0	0.0	16.0	1.1	2.0	0.0	0.0	1.9	0.3	0.0	0.1	0.0	0.0	3.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.9	0.0	2.5	1.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;skin 1: 31.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2714.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	1.6	1.6	66.0	1.2	64.2	0.0	4.0	57.2	88.4	1.8	21.5	4.4	0.6	0.1	0.8	7.9	0.3	0.7	1.3	64.0	64.1	0.1	0.1	1.2	0.0	60.9	62.9	0.7	2.7	0.0	2.3	0.2	62.4	1.0	1.1	19.0	3.4	0.7	0.1	31.9	1.0	1.3	63.7	1.0	13.8	0.3	58.6	0.2	0.1	0.3	2.6	0.9	2.3	72.4	0.1	0.0	425.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	27.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	126.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	5.4	15.2	0.1	0.0	0.0	0.1	0.0	0.0	0.7	10.9	5.6	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.0	64.2	57.2	88.4	64.0	64.1	60.9	62.9	62.4	63.7	58.6	72.4	0.1	0.0	1.5	625.2	0.2	25.2	8.6	82.2	44.9	18.3	5.6	12.2	1.3	0.0	39.7	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	37.7	0.7	0.1	1.3	9.2	0.0	0.0	10.1	0.0	0.0	0.1	65.6	72.0	0.0	0.0	0.0	1.6	0.7	0.3	0.1	19.6	22.5	0.0	90.4	0.0	2714.3	3.6	0.9	0.3	0.0	1.2	1.8	0.0	0.1	16.9	6.6	0.0	1.2	1.7	0.1	1.6	14.8	21.5	0.3	0.2	0.5	0.0	7.8
PTS	PTPS	ENSG00000150787	"6-pyruvoyltetrahydropterin synthase"	Q03393	11	112226367-112269955	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase	"Disease variant, Phenylketonuria"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001481	Uncertain		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA001481: AB_1079716"	"unprognostic (2.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.66e-3)"	"unprognostic (8.38e-3)"	"unprognostic (4.58e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.65e-1)"	11.7	63.0	17.6	10.2	18.7	22.7	20.5	20.2	27.6	17.5	20.2	18.9	15.0	13.6	29.7	29.0	11.7	20.6	8.8	16.5	25.1	44.7	68.9	7.8	10.5	23.1	26.1	9.9	15.0	29.0	32.8	18.0	24.6	21.1	21.5	19.0	17.5	16.4	18.5	17.0	16.1	13.0	19.7	7.7	27.4	10.3	20.5	4.4	23.2	10.9	12.4	21.7	19.2	21.6	24.5	24.2	33.4	12.9	23.9	26.8	35.4	78.3	38.8	45.5	48.5	57.0	26.1	28.5	53.5	51.6	60.8	38.0	47.5	54.8	50.6	19.7	28.8	7.5	44.6	55.8	70.9	18.4	4.0	47.8	77.1	43.9	53.0	36.5	35.2	24.6	24.9	16.8	30.1	29.8	14.8	23.8	23.1	54.2	48.3	9.4	6.3	37.6	101.2	38.8	32.2	32.5	41.1	43.8	26.0	109.0	32.3	15.2	40.2	42.5	43.0	49.7	60.7	9.9	20.8	69.4	29.3	19.4	44.1	1.1	0.4	0.4	1.2	0.7	1.3	1.5	1.7	1.8	0.7	1.6	1.1	1.5	0.2	1.5	2.0	2.0	1.9	0.7	17.6	18.7	20.2	27.6	16.5	25.1	23.1	26.1	24.6	19.7	20.5	21.6	43.7	19.2	26.5	13.1	28.6	122.6	80.4	146.2	59.2	17.4	69.4	69.0	95.0	47.1	85.7	55.2	0.0	56.7	41.4	80.0	211.3	91.9	5.5	66.4	37.0	42.8	80.0	23.2	16.8	78.9	120.7	47.9	37.8	72.6	20.8	45.1	34.6	123.6	36.9	10.1	25.4	73.1	150.5	21.4	38.1	7.6	14.6	28.4	26.6	15.0	26.1	48.5	22.6	17.6	36.1	114.4	74.4	25.9	33.0	91.9	58.3	151.0	80.8	18.3	26.3	22.7	70.8	23.3	92.6	65.4	131.1	70.3	28.5	59.6	44.4	114.9
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960398-37961128	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.7;Early spermatids: 5.2;Langerhans cells: 12.9;Smooth muscle cells: 3.7;Spermatocytes: 4.3;Suprabasal keratinocytes: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"		"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoli	"HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	0.2	0.0	0.5	0.2	0.7	1.1	0.1	0.6	1.0	0.4	0.2	1.4	0.0	0.5	0.3	0.1	0.5	0.2	1.0	1.0	0.0	0.3	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.4	0.3	0.1	0.0	0.1	0.2	0.7	0.1	0.4	0.3	0.1	0.9	0.3	0.0	0.1	0.1	0.2	0.6	0.2	0.6	0.3	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.6	1.0	1.0	0.0	0.3	0.1	0.4	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.8	4.7	0.7	0.7	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.6	1.5	0.0	0.0	0.0	5.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.6	12.9	0.5	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.6	3.7	4.3	0.2	0.0	2.8	0.0	0.6	0.0	0.2	0.4
PUDP	"DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A"	ENSG00000130021	"Pseudouridine 5'-phosphatase"	Q08623	X	6667865-7148158	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000292, HPA072672"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000292: , HPA072672: AB_2732208"	"unprognostic (1.84e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.00e-3)"	"unprognostic (3.22e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (3.42e-2)"	8.3	9.1	8.3	12.4	8.8	3.5	8.8	9.2	8.6	9.3	10.6	17.4	18.0	6.4	4.8	8.4	19.9	8.2	20.4	8.0	10.3	15.1	9.8	11.9	16.8	9.0	8.7	10.4	6.7	8.4	3.7	20.1	9.7	6.9	12.3	7.4	11.1	7.7	33.0	5.1	12.3	10.9	8.8	8.9	19.3	4.4	10.1	13.3	10.3	20.2	14.1	9.2	7.2	9.6	48.0	42.1	68.4	28.3	34.7	34.0	11.8	14.8	15.7	18.6	18.7	64.2	28.7	21.9	31.5	16.5	61.5	14.4	31.7	37.9	28.1	20.1	60.4	23.4	15.7	35.7	16.3	20.7	24.4	16.5	14.6	50.7	23.0	12.1	56.2	27.2	45.3	17.8	29.3	23.3	22.5	30.6	29.1	19.9	21.1	16.2	26.0	60.8	26.7	18.0	15.4	16.1	12.7	24.4	25.5	59.6	27.2	18.9	17.4	10.4	6.6	43.7	13.0	55.6	0.2	33.8	15.9	11.5	21.5	2.6	17.8	2.2	7.4	18.9	7.6	8.1	7.8	7.1	13.6	5.9	5.8	6.5	1.9	6.8	19.3	4.3	12.2	10.1	8.3	8.8	9.2	8.6	8.0	10.3	9.0	8.7	9.7	8.8	10.1	9.6	6.6	12.8	4.6	0.0	7.8	0.0	4.1	0.0	5.7	3.9	5.2	3.9	0.0	15.7	3.7	18.4	4.2	48.0	2.4	20.8	9.8	21.1	0.4	10.7	5.3	7.0	0.0	3.4	0.0	16.9	27.6	4.6	10.2	6.1	1.3	10.7	6.8	11.1	22.1	5.0	0.0	10.7	0.0	19.8	0.0	1.6	6.2	8.3	0.0	0.0	13.2	11.9	1.0	0.0	0.0	19.7	20.8	4.9	14.6	8.0	23.5	24.6	5.1	3.9	6.6	6.1	4.0	11.1	15.9	6.0	0.0	28.2	4.8	9.4	14.6	6.1
PUS3	FKSG32	ENSG00000110060	"Pseudouridine synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: AB_2685126"	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.3	8.4	7.1	8.2	7.8	3.3	9.4	8.4	11.6	7.7	6.7	8.5	10.9	7.8	9.7	9.0	7.4	6.5	7.1	7.1	8.7	9.0	33.2	6.1	9.2	7.8	7.8	7.3	17.8	7.0	8.5	6.7	7.3	8.7	7.9	8.4	7.7	5.4	15.0	9.5	6.8	9.7	7.0	7.6	10.1	7.2	8.5	11.0	9.3	15.2	10.5	10.1	6.3	7.6	6.5	7.9	23.2	24.9	24.3	29.7	11.0	21.1	17.0	11.6	13.2	24.0	23.2	31.4	33.3	9.2	17.1	22.5	37.6	19.7	11.5	28.2	18.2	31.2	9.5	18.6	24.6	20.5	9.2	23.1	23.4	13.7	29.8	16.2	21.0	23.5	34.0	16.1	13.0	4.0	23.7	23.6	19.8	47.0	15.8	4.8	20.5	18.4	20.3	9.5	27.1	25.7	13.1	21.4	11.7	16.5	43.2	13.8	15.3	24.0	10.1	11.9	17.3	12.4	20.1	33.6	6.7	31.9	17.1	14.2	10.5	9.9	13.4	10.8	15.3	13.3	13.1	12.8	9.2	14.8	17.0	16.0	4.2	14.9	14.0	8.0	15.0	8.3	7.1	7.8	8.4	11.6	7.1	8.7	7.8	7.8	7.3	7.0	8.5	7.6	8.5	9.6	11.5	3.6	9.5	12.9	12.2	10.6	8.0	9.3	7.3	9.4	5.4	11.5	13.6	5.5	29.2	9.7	7.4	3.6	5.9	17.8	7.7	4.4	8.9	10.5	4.8	14.5	2.9	27.2	12.7	6.1	9.2	4.4	12.7	6.1	10.4	33.0	8.2	5.0	3.4	4.6	10.2	5.0	2.9	6.3	7.8	5.5	1.8	1.9	9.9	9.8	6.2	2.5	3.8	15.0	3.9	7.9	6.7	9.1	10.2	16.9	6.2	10.9	6.6	9.9	10.1	7.8	7.2	6.7	11.8	14.0	7.9	12.8	6.5	10.9
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2 small subunit processome component"	Q15269	21	44107373-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 10.7;Basal respiratory cells: 9.6;Suprabasal keratinocytes: 8.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 82.9;Daudi: 84.3;U-266/84: 66.6"									HPA024573	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	4.0	3.2	3.3	3.2	4.4	0.9	3.3	3.6	4.4	4.2	2.4	3.6	1.5	3.3	2.6	3.5	5.7	0.5	3.7	3.5	3.2	2.6	3.0	3.2	3.0	3.5	3.5	2.9	4.1	1.9	2.2	2.5	4.2	3.0	0.3	1.2	3.4	1.4	5.0	4.9	3.7	0.5	3.2	4.5	4.6	3.1	3.4	5.6	2.9	7.2	6.9	4.1	3.2	5.7	4.7	0.5	1.5	3.6	10.4	11.4	28.5	39.2	16.9	44.3	29.5	82.9	1.4	84.3	1.4	0.0	4.5	4.2	1.5	26.4	24.7	24.4	59.5	10.8	15.6	19.2	6.2	6.8	2.9	0.7	0.0	27.1	0.0	10.1	1.7	39.2	32.5	33.8	17.1	1.1	0.2	2.1	1.5	4.1	3.3	4.8	0.2	44.1	0.0	1.2	26.8	5.4	2.2	3.0	24.2	14.6	0.9	3.2	20.9	19.6	3.1	42.4	4.3	47.6	66.6	3.7	1.8	10.6	28.4	0.5	2.2	2.5	4.7	2.7	5.8	5.1	4.0	5.1	1.8	3.4	3.7	4.6	1.1	2.7	3.7	2.2	3.3	3.0	3.3	4.4	3.6	4.4	3.5	3.2	3.5	3.5	4.2	3.2	3.4	5.7	0.4	0.0	2.0	0.3	3.2	10.7	0.1	9.6	3.4	0.7	1.1	0.3	4.5	0.0	5.4	0.0	0.0	0.1	2.3	4.6	1.9	0.0	0.1	0.2	0.2	2.0	2.4	4.8	0.0	0.0	2.0	1.8	1.1	0.4	0.0	0.3	2.2	0.3	1.9	0.0	0.0	3.8	6.1	5.4	4.9	0.0	1.2	0.4	1.8	0.0	0.6	0.5	3.1	0.0	0.0	0.0	2.4	0.0	1.5	1.2	1.8	0.3	4.6	0.3	0.0	1.4	3.7	1.4	1.7	0.8	8.5	0.7	2.6	0.5	4.6	0.3
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248085-25298012	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 122.8;Distal enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 407.8;SK-MEL-30: 528.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		NA	NA		14000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.37e-4)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.43e-4)"	50.8	36.4	78.2	27.7	77.9	14.1	61.1	84.1	82.4	37.0	35.4	140.9	27.0	51.9	21.4	106.6	37.8	39.1	163.9	77.3	74.9	43.7	14.6	32.1	19.1	85.4	80.8	25.9	25.4	18.1	61.5	11.5	81.2	107.9	72.6	25.4	125.1	106.3	18.7	85.3	44.8	59.8	84.7	22.6	51.3	25.2	80.3	18.4	45.2	10.5	17.3	154.2	53.0	84.8	31.5	220.1	39.1	38.3	97.9	182.7	28.7	62.2	80.9	51.4	43.0	50.1	38.0	37.1	71.8	83.6	96.1	123.9	44.5	165.8	27.9	21.1	27.5	29.5	18.6	86.9	115.7	44.7	40.0	107.1	152.4	130.5	191.3	63.5	66.6	23.0	16.5	91.4	73.0	87.1	45.1	34.6	35.2	38.2	407.8	33.7	71.0	49.8	280.5	56.8	58.4	36.5	42.7	74.0	528.7	31.0	51.9	28.4	147.4	60.3	36.5	65.1	128.7	35.2	58.8	14.4	67.9	34.8	335.3	4.6	14.1	7.1	10.2	19.4	9.9	5.4	8.1	9.2	14.5	4.6	10.3	12.9	3.3	11.2	23.4	7.1	9.6	23.4	78.2	77.9	84.1	82.4	77.3	74.9	85.4	80.8	81.2	84.7	80.3	84.8	10.0	9.6	34.6	43.1	8.7	11.9	23.1	20.7	22.2	35.8	31.6	43.6	122.8	11.5	14.6	25.8	37.5	7.1	10.7	185.2	11.7	17.6	3.5	12.7	17.2	13.5	28.2	8.6	22.9	16.5	7.2	15.3	40.2	21.6	6.3	16.2	8.9	5.8	10.8	18.5	26.9	47.3	57.0	13.8	10.7	9.2	27.4	18.5	35.6	15.0	16.6	21.3	15.5	11.6	19.1	27.0	68.5	86.5	22.9	17.6	20.9	11.1	11.9	9.3	0.0	13.5	23.1	2.0	8.5	15.3	10.1	4.4	12.9	20.3	72.0	9.7
PYGO1		ENSG00000171016	"Pygopus family PHD finger 1"	Q9Y3Y4	15	55538884-55588947	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.5;Endometrial stromal cells: 18.2;Inhibitory neurons: 30.4;Oligodendrocyte precursor cells: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-698: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042248	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA042248: AB_10794272"	"unprognostic (5.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-6)"	"unprognostic (3.36e-4)"	"unprognostic (4.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.80e-2)"	1.8	2.3	2.6	0.9	3.0	0.2	1.7	7.3	2.3	3.7	2.9	3.2	0.4	5.6	2.0	1.8	2.5	2.3	1.3	2.6	4.6	0.9	0.1	1.9	0.5	3.3	4.5	6.1	1.4	13.2	3.0	2.0	3.1	4.5	1.0	4.5	0.9	4.8	11.7	0.7	0.9	4.7	3.3	0.3	1.4	3.2	4.9	0.4	6.8	9.1	0.4	2.2	1.7	2.4	3.7	6.3	12.2	6.2	4.4	10.0	4.6	7.8	8.9	6.2	7.1	4.5	0.0	0.0	2.4	5.3	8.9	0.0	12.4	0.1	8.3	0.0	3.9	1.8	1.8	0.4	5.9	6.6	0.0	5.5	6.2	5.5	0.9	6.9	3.2	1.0	0.1	0.0	10.3	0.1	0.3	0.0	3.3	0.9	3.4	0.0	14.8	0.0	2.1	2.7	6.5	7.3	7.6	0.0	5.6	1.7	2.3	2.1	0.0	15.8	6.9	0.3	9.5	0.2	0.2	33.6	4.9	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	7.3	2.3	2.6	4.6	3.3	4.5	3.1	3.3	4.9	2.4	0.6	9.6	6.3	23.5	0.0	1.7	5.9	0.1	4.6	5.6	2.4	3.6	6.1	0.0	1.9	9.2	0.0	1.5	0.1	0.0	0.0	0.5	2.9	1.6	18.2	1.1	0.0	0.0	1.8	0.0	0.2	9.3	0.0	1.9	0.0	7.1	1.1	0.0	0.5	0.0	30.4	0.0	0.0	0.6	1.4	2.6	9.9	0.3	7.2	4.7	0.0	7.0	0.0	59.8	1.9	0.5	0.0	12.0	0.0	5.7	0.0	0.2	1.8	4.5	0.0	12.7	6.1	11.6	2.8	1.4	0.9	0.3	0.6	2.0	0.0	0.7
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37342827-37373322	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 170.3;epididymis: 104.0"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 217.0;Ionocytes: 138.4;Langerhans cells: 163.4;Melanocytes: 528.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 1527.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 1527.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 117.1;SK-MEL-30: 426.8;U-266/84: 341.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		390000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	5.6	170.3	8.4	14.2	7.5	47.3	15.8	5.1	11.5	21.2	4.2	25.3	5.6	9.8	104.0	3.4	2.2	10.8	5.1	8.9	27.4	6.1	2.6	5.6	8.1	9.7	11.6	1.0	13.7	14.8	27.0	9.2	14.7	7.2	10.2	11.9	25.5	6.7	4.1	36.3	4.5	8.3	7.8	13.9	7.6	2.0	20.3	5.1	3.8	2.8	12.5	15.2	4.6	6.7	1.0	40.7	0.1	0.0	6.0	13.3	0.1	6.6	86.5	6.4	10.1	2.9	7.1	0.2	3.0	32.6	72.9	0.1	2.7	0.6	10.3	0.6	76.0	18.7	0.3	7.7	0.6	3.0	0.1	8.5	0.0	47.3	0.2	0.4	26.2	0.0	0.0	0.0	0.2	4.5	0.0	1.7	0.6	0.3	0.0	0.0	0.0	0.8	42.6	10.9	117.1	0.2	6.4	1.4	426.8	8.0	0.7	2.9	19.4	0.0	0.2	0.1	0.6	15.3	341.7	0.3	25.8	0.3	0.0	9.8	344.8	3.2	0.4	38.7	1.0	2.6	0.6	0.5	124.7	1.2	0.5	0.3	1527.7	0.2	3.3	2.4	0.1	169.8	8.4	7.5	5.1	11.5	8.9	27.4	9.7	11.6	14.7	7.8	20.3	6.7	1.8	3.2	2.3	0.3	12.5	39.0	13.6	40.0	2.2	21.8	7.9	8.5	1.1	1.5	17.7	22.0	2.1	0.7	0.8	6.1	1.9	45.4	0.6	2.6	24.7	17.5	217.0	1.7	8.5	2.4	6.1	26.7	3.1	4.0	55.3	1.6	22.5	0.3	20.5	43.7	7.3	6.6	138.4	21.2	163.4	2.9	3.1	26.8	528.3	6.5	64.3	0.8	3.1	3.0	1.3	31.8	1.8	23.7	26.0	9.1	0.2	11.7	4.3	3.2	13.1	0.6	6.6	1.7	0.7	0.6	14.5	4.7	5.6	5.0	7.3	5.8
QSER1	FLJ21924	ENSG00000060749	"Glutamine and serine rich 1"	Q2KHR3	11	32892811-32993316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005682	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA005682: AB_1855985"	"unprognostic (2.94e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (7.94e-5)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-2)"	5.4	4.5	5.3	5.5	6.5	4.1	8.9	15.1	5.3	7.5	10.0	5.1	3.5	8.3	6.7	7.6	6.1	5.9	5.9	5.1	5.8	5.5	5.8	4.4	5.5	5.6	5.7	12.7	6.9	6.5	3.9	5.7	5.6	4.6	5.5	7.1	10.0	5.1	4.6	11.8	4.1	6.4	5.7	6.1	5.5	9.0	5.4	8.6	8.8	7.0	6.5	6.3	6.1	6.6	23.4	28.7	32.4	30.5	12.2	23.2	15.7	20.0	17.9	14.0	17.3	24.5	10.8	24.2	12.5	23.9	23.5	29.4	30.9	17.6	30.3	10.7	19.5	22.9	26.7	21.0	9.8	27.7	11.9	11.6	18.9	17.7	29.5	16.8	19.9	14.2	35.2	10.6	22.2	20.5	14.3	10.8	34.1	14.4	17.9	22.5	64.6	10.1	14.5	24.6	16.7	23.9	37.8	19.4	12.3	23.7	20.2	14.3	20.3	34.0	34.2	62.9	44.0	6.8	10.3	22.5	21.9	12.7	22.6	0.0	0.2	0.0	0.2	0.4	0.1	0.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.4	0.1	0.4	0.0	0.1	5.3	6.5	15.1	5.3	5.1	5.8	5.6	5.7	5.6	5.7	5.4	6.6	22.0	19.2	13.4	35.6	10.6	27.9	12.0	14.2	35.9	17.7	21.6	18.7	31.0	14.3	15.9	7.3	14.6	12.9	7.7	5.9	3.9	10.6	14.0	9.9	37.0	19.5	0.0	17.7	51.6	12.1	12.2	27.2	15.8	17.1	3.8	39.3	15.7	10.5	14.5	10.1	50.6	11.7	14.2	16.0	16.1	11.0	24.5	19.1	16.0	54.4	15.9	12.9	5.2	50.3	48.6	10.7	9.3	21.1	23.1	15.0	5.3	8.9	12.2	15.0	6.6	37.9	17.8	21.3	20.5	43.1	27.6	4.2	8.4	21.5	13.6	14.3
R3HCC1	DKFZp564N123	ENSG00000104679	"R3H domain and coiled-coil containing 1"	Q9Y3T6	8	23270120-23296279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2;Rod photoreceptor cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023073, HPA023153"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Nucleoplasm	"HPA023073: AB_1855987, HPA023153: AB_2237834"	"unprognostic (5.80e-2)"	"unprognostic (4.70e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (7.46e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.02e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (7.65e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.43e-1)"	20.5	21.9	41.2	15.2	52.7	29.0	19.6	53.7	43.8	23.4	36.4	33.6	19.7	23.9	14.8	16.1	22.5	16.2	33.1	39.9	42.3	20.1	28.2	16.7	22.5	60.9	49.8	27.2	42.8	29.0	22.6	13.7	63.6	22.7	15.3	62.7	35.7	19.9	54.5	22.5	20.4	22.2	49.3	20.2	28.4	30.8	48.6	20.3	17.6	31.5	18.8	22.2	17.8	73.7	38.2	48.7	36.7	35.9	15.2	20.6	25.2	24.7	23.4	41.0	29.7	35.0	17.6	38.1	25.6	30.2	28.0	28.3	38.9	45.8	27.5	24.7	41.6	35.7	33.4	29.2	36.0	24.7	25.6	24.8	35.5	35.0	16.4	30.1	31.7	42.9	41.8	31.0	24.3	33.1	55.6	43.8	29.8	40.4	35.8	37.9	44.8	22.8	20.3	41.9	47.2	41.1	28.1	32.8	41.8	25.0	30.3	29.2	27.4	37.9	31.8	32.2	51.1	23.8	22.2	39.3	29.5	34.3	48.5	38.4	50.5	82.5	64.8	44.1	56.5	56.5	52.7	55.0	56.7	42.1	40.5	47.0	31.3	59.5	50.3	52.9	61.5	51.4	41.2	52.7	53.7	43.8	39.9	42.3	60.9	49.8	63.6	49.3	48.6	73.7	25.2	25.6	14.7	4.9	15.5	14.9	16.5	35.9	10.2	28.0	22.8	32.9	24.1	24.3	20.5	5.5	27.1	18.8	19.8	17.9	56.7	32.3	36.4	15.2	17.0	21.1	19.2	17.9	5.1	50.9	21.3	25.4	20.9	10.2	22.8	24.7	20.0	21.6	30.2	18.5	5.0	21.5	22.4	18.2	12.3	113.2	17.7	16.2	21.4	5.6	18.8	59.3	42.2	4.5	9.5	37.0	22.1	21.8	34.7	11.4	41.7	38.5	22.0	115.7	13.1	19.9	31.1	49.8	32.4	13.6	16.2	7.7	18.3	30.7	22.8	13.6
R3HDM1	"KIAA0029, R3HDM"	ENSG00000048991	"R3H domain containing 1"	Q15032	2	135531455-135725270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 1088.8;Inhibitory neurons: 296.7;Oligodendrocyte precursor cells: 198.0;Oligodendrocytes: 173.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	5	"cerebral cortex: 53.0"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030936			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA030936: AB_10670835"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-3)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (5.83e-7)"	"unprognostic (1.16e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.47e-1)"	10.3	10.5	0.0	13.6	7.7	23.2	8.2	0.0	53.0	9.5	0.0	11.8	7.2	10.1	9.6	9.5	8.2	9.6	7.9	10.5	0.0	9.0	9.7	7.9	18.1	0.0	0.0	7.7	13.0	22.8	20.1	6.7	0.0	8.0	15.1	17.7	7.0	8.8	22.7	8.4	9.1	13.1	0.0	10.8	8.6	22.8	0.0	43.6	13.2	15.6	20.9	12.0	7.2	0.0	50.7	30.5	42.1	49.0	22.2	30.0	24.8	31.1	32.2	30.5	33.2	54.7	34.2	79.8	24.0	44.3	22.2	22.3	55.6	57.5	53.3	50.4	27.9	64.3	37.0	55.1	26.5	55.4	39.9	28.5	25.2	53.7	68.5	27.7	49.8	85.2	67.9	66.4	35.4	52.0	96.5	38.0	32.6	37.6	35.4	56.8	29.1	47.6	30.3	43.9	42.9	33.3	49.9	20.2	22.0	36.5	27.1	29.4	37.0	28.1	27.8	35.7	39.3	52.7	78.8	74.1	31.6	44.7	36.7	3.5	6.9	2.8	5.1	7.3	4.9	5.5	5.3	7.6	9.9	3.6	5.1	5.9	1.0	9.1	6.7	11.2	8.5	4.4	0.0	7.7	0.0	53.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	6.4	3.1	125.7	20.1	7.9	7.2	9.9	10.8	39.3	11.0	9.7	16.0	14.3	14.1	7.3	20.9	8.1	31.2	5.4	19.6	8.8	46.7	6.8	27.0	15.6	22.9	30.7	1088.8	7.4	10.4	11.5	15.8	12.6	18.3	25.9	11.7	14.2	12.2	26.9	296.7	11.7	14.2	19.5	13.8	44.7	13.7	18.8	7.2	98.4	21.9	8.6	22.6	198.0	173.5	8.3	6.3	11.3	33.7	10.0	5.3	13.4	4.3	40.5	0.0	14.7	25.3	26.5	24.5	20.3	9.7	3.1	23.4	36.6	11.5	6.8
R3HDM4	"C19orf22, MGC16353"	ENSG00000198858	"R3H domain containing 4"	Q96D70	19	896503-913245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 586.7"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 586.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043025, HPA048638"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA043025: AB_2678275, HPA048638: AB_2680472"	"unprognostic (9.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (7.33e-6)"	"unprognostic (4.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.74e-2)"	37.7	26.3	34.5	50.1	31.2	98.0	37.0	33.7	38.5	42.0	29.3	39.4	23.9	34.1	13.4	81.8	36.9	28.4	32.4	32.1	28.0	58.8	47.8	55.7	54.3	31.3	29.4	23.7	50.8	19.2	33.1	25.1	28.9	42.2	17.5	22.0	48.1	15.8	55.8	58.8	45.5	18.7	25.6	93.9	39.1	9.1	29.7	39.6	32.4	23.8	36.5	43.2	49.4	37.0	44.2	25.4	26.1	36.5	16.6	28.9	43.7	29.3	23.2	28.8	25.4	27.6	36.7	31.5	23.9	33.4	6.1	39.6	15.4	34.7	12.9	49.2	33.0	43.7	19.7	48.3	49.3	24.6	73.0	38.7	65.9	18.7	39.1	26.3	33.4	35.7	82.2	62.8	27.1	79.0	34.7	46.5	34.5	53.3	41.2	33.9	12.5	60.8	48.2	45.7	46.6	45.4	25.8	56.2	48.9	20.0	49.1	57.8	34.3	52.3	29.1	62.0	30.0	69.1	39.1	47.6	33.5	34.9	45.9	117.4	13.1	111.0	14.9	10.1	23.1	38.5	30.3	20.5	14.3	21.5	28.1	20.1	586.7	8.6	14.0	6.0	49.3	26.5	34.5	31.2	33.7	38.5	32.1	28.0	31.3	29.4	28.9	25.6	29.7	37.0	23.2	19.2	21.5	0.7	59.6	35.1	49.0	24.9	25.0	17.5	30.7	20.6	6.8	20.0	26.3	18.4	8.4	38.1	29.0	34.7	7.9	57.7	1.3	20.1	20.1	22.8	32.8	106.5	4.0	55.4	46.7	20.0	30.5	33.5	23.5	10.3	12.1	13.3	26.2	28.6	3.0	31.3	34.6	27.5	37.0	2.6	11.1	59.0	24.9	1.9	51.4	8.0	29.9	1.5	3.1	68.4	31.9	11.7	37.3	48.9	13.1	16.0	19.9	12.4	26.3	13.6	20.6	0.8	4.0	34.3	31.7	69.0	48.1	15.2	22.6	70.9
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.2;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		6500000	"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	0.3	2.6	7.9	1.1	10.2	1.0	11.9	0.0	11.9	3.0	0.0	4.9	5.1	0.8	0.4	14.0	1.1	3.8	0.1	13.3	5.2	0.3	1.3	7.2	0.5	0.0	0.1	0.2	4.1	2.3	1.0	1.1	0.6	20.5	5.3	1.0	14.0	1.0	0.2	15.6	4.9	0.9	0.1	1.7	44.1	4.5	2.6	1.4	0.3	0.5	5.2	6.2	5.2	3.3	7.8	22.4	0.8	0.0	1.5	19.3	0.0	1.7	13.5	1.8	1.3	0.0	8.6	1.3	0.1	3.9	16.7	14.5	0.2	9.0	0.5	0.0	0.5	63.3	5.0	0.0	2.6	3.4	7.0	15.3	46.6	25.5	56.0	21.1	1.2	0.3	0.0	3.9	16.1	7.9	0.2	7.4	0.2	14.0	14.7	0.0	0.0	0.3	4.1	28.9	0.2	10.3	2.2	13.4	0.0	0.1	8.3	0.3	0.3	18.8	0.6	9.8	2.0	0.4	0.0	0.0	165.2	35.6	0.9	0.6	0.0	0.1	2.2	0.0	0.5	0.0	0.7	1.1	0.0	0.0	0.2	1.0	0.2	2.6	0.0	0.0	0.0	1.6	7.9	10.2	0.0	11.9	13.3	5.2	0.0	0.1	0.6	0.1	2.6	3.3	0.3	48.1	37.6	3.3	0.9	25.6	8.6	18.2	8.0	2.4	59.8	25.3	0.5	8.6	36.9	5.5	2.1	6.5	15.0	5.7	1.9	7.2	259.3	30.9	4.4	1.9	4.2	3.4	101.0	41.0	4.5	2.0	178.4	64.0	246.6	0.4	2.5	0.9	0.6	6.7	75.8	31.3	20.3	0.6	2.7	209.9	2.1	38.1	7.2	2.8	2.1	1.4	29.9	98.5	2.6	34.0	18.6	0.4	3.2	78.9	3.0	0.0	15.8	0.4	6.6	0.3	2.2	7.9	1.4	79.2	49.2	2.9	13.9	0.5	7.9	42.2
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543833-146554953	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 175.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 232.6;Kupffer cells: 254.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 86.5"	"Group enriched"	"Detected in many"	42	"dendritic cells: 42.5;granulocytes: 86.5;monocytes: 46.8"	"Low cell line specificity"	"Detected in many"											HPA025731	Approved		Approved	Cytosol		NA	NA		63000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favorable (1.56e-4)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	35.0	16.5	7.5	29.7	7.8	175.1	27.0	8.6	11.0	19.0	9.2	38.3	17.4	26.5	14.6	11.6	20.8	24.1	17.9	7.1	8.2	21.3	50.2	32.1	22.3	9.9	8.2	13.0	12.2	8.3	5.0	14.8	8.9	14.5	37.7	2.2	18.1	16.9	4.6	20.2	18.4	46.5	9.2	54.1	19.4	33.3	8.8	22.5	11.0	8.3	15.2	28.6	15.4	11.7	65.5	34.5	38.7	65.3	58.0	98.5	0.1	123.3	138.4	167.7	276.7	21.2	31.6	0.1	43.9	132.2	183.5	84.2	2.4	80.4	225.2	0.4	29.1	82.4	78.3	77.3	252.1	114.2	115.9	87.6	133.1	95.8	135.3	86.7	110.5	0.0	15.8	0.4	92.8	15.8	52.0	61.8	5.0	0.0	65.2	0.0	41.5	0.9	65.6	45.2	0.1	50.6	144.7	17.6	219.3	34.3	33.7	91.7	88.0	50.2	67.7	133.1	152.6	0.2	9.4	0.4	115.1	86.0	69.3	86.5	46.8	8.2	0.0	21.2	0.0	0.0	0.0	0.1	42.5	0.0	0.1	0.0	16.5	1.3	15.4	2.2	0.0	14.4	7.5	7.8	8.6	11.0	7.1	8.2	9.9	8.2	8.9	9.2	8.8	11.7	30.8	48.1	9.4	2.9	4.1	53.5	95.3	92.6	17.6	1.4	29.0	38.9	2.0	52.9	36.8	11.0	4.2	2.2	3.4	64.1	25.4	164.4	96.9	8.5	40.3	34.3	60.1	14.9	2.3	105.7	6.9	51.5	18.3	12.4	57.8	27.7	27.5	75.4	232.6	0.0	1.3	31.3	22.4	254.6	101.7	156.7	24.5	146.7	168.9	24.4	147.2	9.0	2.1	4.0	4.6	154.3	46.3	25.6	0.5	99.6	33.3	83.2	9.5	1.4	19.7	46.1	46.3	70.9	14.2	2.5	19.0	3.1	7.0	33.1	62.5	65.6
RAB3A		ENSG00000105649	"RAB3A, member RAS oncogene family"	P20336	19	18196784-18204042	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 290.7;retina: 77.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.4;Distal tubular cells: 39.2;Excitatory neurons: 34.0;Horizontal cells: 92.5;Inhibitory neurons: 41.0;Rod photoreceptor cells: 46.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 290.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.8;SCLC-21H: 37.5;SH-SY5Y: 18.0;U-2197: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, CAB009949, CAB078998"	Enhanced	Supported	Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731"	"unprognostic (1.82e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (6.14e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.14e-2)"	2.6	15.6	41.0	1.7	56.7	0.9	2.1	6.8	290.7	3.3	0.0	6.4	3.1	2.7	1.5	2.5	5.2	2.0	25.7	53.4	32.5	5.9	3.8	2.5	1.5	26.8	4.6	25.8	2.0	12.8	38.4	1.4	23.3	3.9	1.8	77.5	4.0	3.9	9.9	4.1	3.2	2.1	0.0	2.8	4.5	2.2	29.4	1.3	2.3	8.9	0.9	2.6	3.6	90.5	1.4	1.6	3.5	4.9	5.7	1.4	2.2	3.2	1.9	2.2	2.9	1.4	0.9	5.2	3.4	2.6	2.0	4.2	16.6	2.0	1.0	1.1	5.3	2.1	6.3	6.0	1.4	3.6	6.2	4.6	2.0	1.2	0.6	4.2	0.6	6.4	1.1	1.8	2.0	5.2	8.0	1.0	2.9	4.4	20.8	5.5	0.3	4.4	2.3	0.8	37.5	18.0	1.6	6.6	3.7	1.4	1.4	0.6	0.7	1.8	1.4	26.2	1.8	3.2	7.4	1.3	4.9	2.7	1.7	0.0	1.3	1.8	1.3	0.9	1.8	1.9	1.3	1.3	2.9	0.9	1.7	1.8	2.2	0.3	1.3	2.6	0.8	1.3	41.0	56.7	6.8	290.7	53.4	32.5	26.8	4.6	23.3	0.0	29.4	90.5	2.3	0.0	0.0	8.5	4.7	3.2	2.5	3.7	8.6	102.4	4.8	4.8	1.3	2.8	2.2	16.5	8.4	1.6	7.4	1.6	39.2	2.3	2.4	1.0	1.3	2.6	9.6	0.0	34.0	0.9	5.2	3.1	2.0	1.4	0.0	1.6	2.5	1.6	5.2	92.5	41.0	2.8	4.1	2.2	15.3	0.2	4.4	4.5	10.6	13.1	2.9	15.4	1.0	7.5	10.1	1.0	2.0	5.7	1.1	1.1	5.3	8.3	1.2	46.5	0.0	1.8	8.2	0.4	3.6	6.0	4.8	1.8	5.3	4.5	4.2	2.1
RAB3C		ENSG00000152932	"RAB3C, member RAS oncogene family"	Q96E17	5	58582221-58859394	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 62.5"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 140.6;Inhibitory neurons: 509.9;Oligodendrocyte precursor cells: 131.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0;pancreatic cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;HEL: 2.5;NB-4: 1.6;SCLC-21H: 10.2;SH-SY5Y: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, HPA048156"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA003160: AB_1079731, HPA048156: AB_2680291"	"unprognostic (1.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.52e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.70e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.61e-3)"	1.1	9.0	19.1	1.2	20.6	0.0	0.7	0.9	32.7	0.1	0.0	0.6	1.6	0.7	0.0	0.2	0.2	0.7	0.1	10.2	62.5	0.0	0.1	0.1	0.2	7.4	12.3	0.3	1.7	0.1	6.8	0.1	31.6	0.0	0.8	6.0	0.1	0.0	0.1	0.0	1.8	0.7	3.9	0.0	0.9	0.1	19.2	0.1	0.1	0.0	0.2	0.6	0.2	3.8	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	3.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	20.6	0.9	32.7	10.2	62.5	7.4	12.3	31.6	3.9	19.2	3.8	8.6	0.0	0.6	10.1	0.4	0.1	0.0	0.0	0.0	28.3	0.3	0.3	0.7	0.0	0.0	0.0	4.2	0.0	0.0	0.0	3.9	0.1	20.0	0.0	0.1	12.1	57.6	1.3	140.6	9.6	0.8	0.2	0.0	0.0	2.5	0.0	5.7	1.2	0.1	3.3	509.9	5.5	0.0	0.9	1.1	11.8	0.9	0.1	1.8	6.5	0.0	1.6	0.0	131.2	8.4	3.9	1.2	0.7	0.0	0.0	0.3	0.1	0.0	6.7	13.1	0.5	0.2	2.4	4.1	0.0	0.1	0.0	1.3	0.1	0.3	0.0
RAB3GAP1	"KIAA0066, RAB3GAP, RAB3GAP130, WARBM1"	ENSG00000115839	"RAB3 GTPase activating protein catalytic subunit 1"	Q15042	2	135052292-135176394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034494, HPA034495"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		6300	"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA034494: AB_2674188, HPA034495: AB_10670158"	"unprognostic (1.02e-2)"	"unprognostic (2.43e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.15e-1)"	23.4	21.1	22.5	24.3	24.1	37.5	25.6	18.7	23.1	27.5	22.0	23.7	19.1	29.2	30.6	26.2	22.9	21.6	35.2	24.5	24.1	23.2	20.5	20.4	25.9	23.3	23.2	35.2	35.4	34.0	18.9	23.6	24.3	29.5	27.9	34.1	35.6	28.3	36.9	26.2	21.4	30.9	19.7	21.3	26.1	18.7	23.1	30.3	30.8	36.0	30.4	26.0	22.4	22.0	51.2	20.4	34.8	29.0	67.3	57.0	32.4	76.6	62.6	59.5	58.4	45.3	40.7	75.5	46.2	78.5	22.8	42.2	37.4	70.6	72.1	36.2	37.9	34.3	24.8	39.9	46.9	46.8	39.3	50.2	91.2	54.8	98.2	53.6	43.6	33.7	49.5	42.5	54.7	30.1	24.1	18.2	27.1	30.7	33.8	40.9	45.0	31.9	35.0	44.9	28.3	22.4	52.0	30.7	36.8	30.5	27.2	33.6	53.0	60.0	45.7	26.0	32.5	30.1	18.2	55.8	39.2	27.8	34.3	10.3	4.3	6.7	1.5	5.3	1.3	5.5	3.8	2.1	4.5	6.8	7.9	4.2	1.7	3.1	6.0	2.3	5.4	2.1	22.5	24.1	18.7	23.1	24.5	24.1	23.3	23.2	24.3	19.7	23.1	22.0	34.3	25.6	26.7	86.8	50.4	30.2	46.8	28.8	27.9	28.9	30.2	27.8	58.0	32.9	32.6	31.3	50.1	23.6	15.3	39.4	11.7	20.0	34.8	31.8	33.0	28.5	34.6	24.4	137.8	26.9	17.1	35.5	46.9	31.5	46.3	27.2	32.9	25.7	22.4	30.3	106.8	31.2	28.5	26.7	28.1	23.2	30.7	32.4	23.2	112.4	24.2	18.0	6.2	107.1	123.3	34.6	24.3	35.7	40.0	42.5	29.9	21.1	36.0	33.8	46.0	31.8	34.4	41.8	25.8	37.5	29.7	39.1	28.3	35.0	24.7	51.0
RAB3IL1	GRAB	ENSG00000167994	"RAB3A interacting protein like 1"	Q8TBN0	11	61897301-61920269	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.9;Hofbauer cells: 65.3;Late spermatids: 133.8;Leydig cells: 56.2;Peritubular cells: 45.1;Theca cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 36.9;HHSteC: 36.9;K-562: 34.4;RPMI-8226: 44.3;U-2197: 56.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039723	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Centriolar satellite, Cytosol"		"HPA039723: AB_10795406"	"unprognostic (1.62e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (1.97e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (7.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.59e-3)"	29.8	9.5	10.9	7.9	11.2	13.8	22.8	10.3	13.4	38.6	12.7	13.6	4.7	30.0	4.6	6.2	24.0	11.3	20.5	10.5	10.8	16.0	6.9	11.8	6.5	12.8	11.0	37.1	5.1	7.8	9.5	15.9	11.8	10.6	2.6	3.1	12.2	5.1	7.6	15.2	9.9	9.3	11.6	28.2	9.4	41.2	14.8	9.0	15.1	10.0	2.4	19.0	20.7	12.7	6.9	13.3	0.4	7.3	26.9	19.9	1.5	5.5	13.7	8.0	5.4	1.9	1.5	0.1	10.1	8.4	36.9	3.7	9.6	0.5	1.2	0.0	2.1	12.8	5.1	7.2	36.9	0.5	0.3	10.7	6.9	3.9	9.1	1.3	0.7	7.1	34.4	0.3	4.7	12.3	0.0	0.1	4.3	1.2	14.1	0.7	1.9	44.3	0.7	0.5	0.6	4.9	3.4	2.9	25.0	2.2	2.2	1.6	0.6	29.3	13.2	56.5	2.3	0.4	2.1	0.0	5.7	15.8	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	11.2	10.3	13.4	10.5	10.8	12.8	11.0	11.8	11.6	14.8	12.7	5.5	0.0	0.0	1.6	0.8	5.1	0.9	0.0	0.6	0.5	1.3	1.9	1.9	2.8	0.6	1.8	0.0	1.3	0.1	0.1	1.9	2.2	110.9	1.9	27.8	9.6	0.0	34.5	0.4	1.0	2.0	24.3	1.1	1.8	0.0	1.1	16.1	1.4	65.3	1.7	1.3	0.0	0.0	19.9	10.2	133.8	56.2	6.8	8.8	8.4	0.0	6.5	0.0	1.0	0.7	1.1	0.0	45.1	0.0	1.6	0.0	15.9	0.0	8.2	0.0	3.4	8.2	1.7	9.1	0.2	4.0	1.4	0.6	47.6	0.2	0.2
RAB5IF	"C20orf24, PNAS-11, RCAF1, RIP5"	ENSG00000101084	"RAB5 interacting factor"	Q9BUV8	20	36605779-36612557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 216.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 215.9;Exocrine glandular cells: 348.7;Hofbauer cells: 242.6;Pancreatic endocrine cells: 442.2;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057387	Uncertain		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA057387: AB_2683425"	"unprognostic (2.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.56e-6)"	"unprognostic (4.47e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.37e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.98e-2)"	45.2	49.0	33.0	46.4	33.4	69.0	33.4	36.0	40.4	45.4	35.8	71.6	49.3	29.1	40.9	152.2	27.3	38.6	53.0	32.8	34.9	53.1	115.7	41.9	38.6	35.0	33.7	22.6	42.8	55.2	20.8	33.4	34.4	29.8	59.9	28.6	56.3	27.6	216.9	39.8	43.2	34.7	35.4	57.0	48.5	37.5	36.1	41.6	27.8	78.2	56.4	50.3	58.1	37.0	224.8	164.4	59.9	75.2	127.2	74.8	142.5	135.8	79.4	132.7	119.5	455.9	279.5	96.6	327.4	122.2	244.8	163.2	123.3	219.3	130.5	73.5	119.1	230.0	233.3	516.7	149.1	247.4	109.3	92.6	225.0	187.7	110.1	70.4	124.5	104.0	158.9	226.4	125.2	156.9	148.6	318.2	98.5	227.1	344.6	114.8	137.2	245.9	119.3	163.5	99.3	76.0	195.3	513.2	187.6	89.3	111.5	206.5	135.1	192.6	132.5	195.3	211.7	138.8	236.0	162.2	204.4	281.3	104.7	22.0	76.9	97.3	17.7	38.9	17.8	35.7	21.2	27.4	47.9	33.6	26.1	19.4	120.6	18.4	46.4	32.8	39.8	28.1	33.0	33.4	36.0	40.4	32.8	34.9	35.0	33.7	34.4	35.4	36.1	37.0	47.5	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	87.1	64.5	0.0	0.0	0.0	42.3	0.0	83.1	111.1	0.0	76.3	215.9	0.0	43.0	34.8	24.4	0.0	0.0	0.0	348.7	126.8	14.5	0.0	61.6	0.0	24.3	0.0	0.0	242.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	93.0	0.0	0.0	0.0	0.0	442.2	0.0	0.0	11.9	0.0	0.0	147.8	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	135.6	27.0	29.9	0.0	0.0
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.6	4.8	5.6	3.7	6.1	6.1	4.6	6.5	5.6	4.8	2.9	5.8	2.5	5.6	4.2	4.0	4.6	2.7	4.4	5.0	5.2	4.0	7.8	4.9	4.2	5.5	5.7	5.3	5.3	3.8	4.5	4.8	5.5	4.4	3.4	7.5	4.5	3.9	7.1	5.5	5.0	4.1	5.3	5.2	5.2	5.0	6.3	6.2	4.6	5.3	5.2	4.8	4.3	6.2	6.6	5.1	12.8	12.7	7.0	5.0	6.7	5.5	7.8	7.4	6.9	9.1	3.8	17.4	1.5	9.7	7.8	5.0	20.5	6.8	9.1	9.2	4.6	14.9	11.5	6.0	6.4	16.8	8.5	5.8	5.4	11.3	10.9	4.6	8.3	14.8	10.3	9.1	5.9	5.1	15.0	7.6	10.2	3.2	5.5	6.9	9.9	2.3	3.8	8.4	5.2	10.0	8.7	8.2	5.7	7.7	5.4	9.9	10.9	7.7	8.9	8.0	10.8	9.8	10.7	16.8	8.3	9.2	10.0	3.1	2.2	2.2	3.3	2.6	3.5	1.8	2.9	2.8	2.3	2.9	1.9	2.3	0.9	3.0	3.5	2.3	2.9	2.2	5.6	6.1	6.5	5.6	5.0	5.2	5.5	5.7	5.5	5.3	6.3	6.2	10.8	9.6	14.4	31.3	11.3	9.2	8.6	6.7	3.4	33.8	8.7	8.0	11.0	15.7	7.8	9.2	31.3	19.3	12.2	7.7	1.9	9.3	7.5	9.5	12.0	15.1	16.3	3.8	54.9	10.4	8.7	9.6	9.2	19.8	18.3	14.2	10.4	21.9	8.9	47.1	54.3	8.1	4.1	9.1	8.4	3.1	15.2	9.4	14.2	26.2	13.2	9.1	30.9	42.7	42.3	13.9	9.7	17.0	11.3	12.4	4.6	4.4	9.5	29.9	13.1	17.1	11.6	43.9	36.4	5.5	8.9	29.7	12.5	10.1	7.9	12.5
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538114	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 480.1;Extravillous trophoblasts: 518.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 195.6"	"Cell line enhanced"	"Detected in all"		"OE19: 239.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: AB_2679738"	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	29.7	20.4	42.7	23.4	44.1	30.7	27.8	45.8	82.2	26.8	38.6	34.1	18.7	22.1	23.5	50.3	24.8	20.3	28.5	40.7	45.1	42.7	19.9	22.6	24.0	44.1	48.0	26.3	15.4	47.9	16.8	31.4	44.4	32.6	25.4	13.5	25.0	48.2	38.5	75.9	20.4	21.1	43.6	26.5	25.7	13.0	45.3	29.3	22.9	32.5	25.4	33.8	33.3	45.1	58.9	37.6	34.2	39.0	38.3	60.7	43.3	67.7	38.1	35.6	38.0	42.6	57.5	70.5	47.0	64.8	50.2	32.8	48.1	52.7	44.2	71.4	38.5	38.5	34.6	32.7	31.2	114.8	43.0	42.0	52.2	49.6	48.7	47.7	60.6	64.6	53.7	67.7	56.2	46.3	70.7	50.9	25.4	239.5	31.9	93.6	59.4	54.2	48.4	80.7	44.7	34.8	58.2	52.8	30.9	52.3	32.9	53.8	67.4	105.0	76.9	72.3	81.9	38.7	42.9	77.9	45.6	53.4	40.5	13.0	9.6	15.7	10.3	10.6	8.7	9.9	8.7	8.8	8.7	7.5	7.3	9.4	195.6	14.8	17.8	19.8	6.4	4.5	42.7	44.1	45.8	82.2	40.7	45.1	44.1	48.0	44.4	43.6	45.3	45.1	101.8	57.7	35.7	15.3	48.0	156.4	80.9	59.9	112.7	42.6	96.0	102.2	64.8	88.6	64.6	480.1	29.2	104.2	70.9	122.6	123.3	119.4	16.1	99.1	82.6	86.9	74.2	175.7	25.4	90.7	518.6	71.6	56.1	179.4	40.5	85.8	78.9	88.3	70.1	52.2	26.7	87.7	109.9	92.8	69.7	9.5	72.7	78.4	58.7	20.6	99.6	47.6	83.4	17.1	25.3	166.3	78.2	87.3	63.2	174.4	61.0	115.0	38.6	37.3	65.7	76.8	105.6	66.7	80.0	149.6	242.5	44.6	62.6	128.4	90.1	216.4
RALGAPA1	"DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1"	ENSG00000174373	"Ral GTPase activating protein catalytic subunit alpha 1"	Q6GYQ0	14	35538352-35809304	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 394.0;Inhibitory neurons: 233.9;Oligodendrocyte precursor cells: 239.3;Oligodendrocytes: 412.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000851	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	Mitochondria	"HPA000851: AB_1078945"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.90e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.46e-1)"	13.5	18.5	24.0	9.0	28.1	7.1	16.0	36.0	29.0	21.6	18.3	17.6	7.7	16.5	13.8	15.8	17.9	9.4	12.8	24.2	26.3	14.4	13.0	14.1	9.6	26.6	25.5	23.9	16.3	25.5	23.4	7.4	26.2	17.5	14.5	39.4	13.0	10.5	18.4	20.1	14.7	12.6	25.9	12.0	15.8	10.6	26.4	9.7	16.3	10.9	9.0	15.9	18.3	33.6	7.4	8.7	11.0	9.6	16.4	11.4	7.0	5.2	5.4	6.7	6.0	5.2	6.4	7.2	7.2	7.1	8.8	12.0	13.4	10.2	6.2	16.1	5.1	6.7	11.0	26.3	8.4	11.4	10.4	8.6	18.3	5.8	14.1	11.0	9.5	14.2	6.7	17.9	5.9	11.8	8.5	5.4	5.0	18.2	12.9	6.9	6.7	4.6	13.8	11.9	10.2	16.7	11.0	18.9	9.6	10.6	18.0	5.3	8.7	6.5	5.0	7.6	6.5	14.6	14.4	9.3	3.0	7.3	7.2	0.0	0.2	0.0	0.7	0.3	0.9	0.5	0.7	0.9	0.3	0.3	0.4	0.7	0.0	0.7	0.3	0.4	0.8	0.1	24.0	28.1	36.0	29.0	24.2	26.3	26.6	25.5	26.2	25.9	26.4	33.6	40.2	16.0	30.9	162.6	63.9	38.1	28.3	13.9	62.0	86.1	27.7	21.5	19.4	15.7	25.2	23.9	394.0	10.9	105.8	31.0	0.0	12.8	19.5	47.0	38.5	31.4	31.1	14.9	215.3	15.8	5.5	34.6	54.0	50.8	53.4	41.6	18.5	14.8	9.2	52.2	233.9	23.3	16.2	10.0	39.9	8.7	34.2	35.4	19.6	173.3	16.8	30.5	16.5	239.3	412.8	15.9	25.9	29.0	86.3	36.0	26.6	10.4	25.2	119.1	39.5	59.0	37.8	47.0	38.0	55.9	46.2	15.2	80.7	24.0	28.7	27.1
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.7;Excitatory neurons: 100.6;Glandular and luminal cells: 59.5;Inhibitory neurons: 152.9;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 87.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 4.0;SK-BR-3: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	0.2	0.8	0.3	0.1	0.2	0.1	0.2	2.3	0.6	0.2	0.8	0.2	0.2	0.5	0.2	0.0	0.4	0.5	0.2	0.1	1.1	0.4	0.3	0.8	0.3	0.9	0.9	0.2	1.4	0.8	0.4	0.8	1.3	0.4	0.4	0.8	0.8	0.5	0.0	0.1	0.3	0.3	0.6	0.0	0.3	1.4	0.6	0.2	1.0	0.0	0.1	0.1	0.1	1.1	0.0	0.7	4.0	3.3	1.3	0.3	2.4	2.6	1.2	1.8	1.1	1.5	0.0	0.1	2.0	2.5	0.0	0.0	0.0	1.2	3.5	0.0	2.4	0.7	1.4	0.0	1.1	0.0	0.0	2.6	0.2	0.2	0.0	0.2	1.7	0.0	0.3	0.0	1.0	1.7	0.0	0.0	0.3	0.6	0.2	0.0	2.4	0.0	0.6	1.0	0.2	1.4	0.0	3.9	1.5	1.7	0.7	1.2	2.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.3	0.6	0.1	1.1	0.9	0.9	1.3	0.6	0.6	1.1	9.4	9.6	2.0	12.7	0.0	0.3	6.2	5.8	1.8	24.8	6.1	2.8	1.3	7.2	4.8	0.0	14.6	10.4	1.7	2.3	0.0	7.3	112.7	22.4	17.5	7.9	5.4	5.5	100.6	1.4	3.2	4.9	5.1	59.5	0.0	15.6	4.2	1.6	1.9	0.0	152.9	3.7	2.0	0.6	1.4	46.5	2.8	1.0	1.8	9.4	1.2	5.5	5.2	65.4	87.1	5.3	2.9	3.0	0.8	13.0	3.9	0.9	2.4	26.9	0.0	3.0	5.1	27.2	26.7	1.4	0.0	2.5	0.8	7.5	6.3	7.6
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 152.4;thyroid gland: 162.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.1;Distal tubular cells: 72.4;Excitatory neurons: 82.0;Horizontal cells: 92.5;Intestinal goblet cells: 112.6;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 46.3;OE19: 162.8;SCLC-21H: 52.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 231.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.6	80.8	74.0	2.6	118.6	0.8	4.4	24.6	91.9	7.5	0.0	19.7	12.4	1.9	1.9	7.5	4.2	24.9	9.5	76.2	34.5	152.4	36.1	14.2	1.0	35.8	22.0	1.6	106.2	57.1	37.9	2.1	32.8	12.8	17.3	27.3	88.7	0.8	0.2	3.5	21.7	0.7	15.8	1.2	110.8	3.6	32.4	0.5	162.8	0.3	0.9	4.0	3.4	67.3	6.2	46.3	0.5	3.6	0.0	0.0	0.8	0.0	0.1	0.1	0.0	4.3	6.4	0.1	4.6	0.2	30.2	7.9	4.4	0.3	0.1	1.0	2.3	2.2	4.3	22.1	0.7	0.0	6.6	0.3	3.1	0.0	0.0	0.0	0.0	22.1	29.6	1.1	0.0	15.6	7.7	0.7	2.8	162.8	7.0	4.3	1.2	1.1	10.2	3.4	52.1	9.3	7.7	27.4	8.9	1.8	2.7	5.2	0.1	0.0	3.1	0.0	0.1	0.6	0.1	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.0	118.6	24.6	91.9	76.2	34.5	35.8	22.0	32.8	15.8	32.4	67.3	0.0	9.6	29.3	10.4	0.5	1.3	1.1	1.1	0.6	64.1	8.5	5.6	5.1	25.8	4.5	14.7	0.0	0.2	0.1	4.3	72.4	25.1	0.8	3.1	0.6	0.4	6.7	4.0	82.0	28.8	1.4	1.0	17.3	8.0	0.0	6.2	0.4	8.5	0.3	92.5	45.8	112.6	6.1	0.6	0.3	0.3	0.0	0.6	16.0	3.7	0.6	11.5	0.0	51.8	18.6	15.3	17.2	0.0	0.2	5.0	6.0	13.5	1.2	7.3	0.0	0.0	0.7	1.0	3.6	0.5	1.1	1.5	0.3	2.5	7.7	2.6
RAPH1	"ALS2CR18, ALS2CR9, KIAA1681"	ENSG00000173166	"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1"	Q70E73	2	203394345-203535335	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 84.0;Hepatic stellate cells: 103.5;Microglial cells: 92.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016744, HPA020027"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		69000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nuclear bodies, Plasma membrane"	Cytosol	"HPA016744: AB_1844781, HPA020027: AB_1844782"	"unprognostic (9.78e-2)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.79e-1)"	11.1	6.5	1.5	5.2	4.6	3.1	13.3	1.3	7.9	9.4	0.3	7.0	7.8	5.6	4.6	8.8	5.1	8.9	5.9	5.0	8.5	7.2	61.6	14.3	3.7	2.4	7.0	2.0	6.4	5.6	3.6	13.0	4.1	6.6	7.3	7.3	8.6	4.3	6.6	8.9	7.9	7.8	0.1	16.9	8.8	9.4	2.7	2.6	30.0	6.2	4.9	7.7	6.6	2.2	11.1	7.5	15.6	9.0	12.0	15.4	14.7	15.1	11.0	15.3	19.1	35.0	11.4	0.0	3.7	23.1	11.2	5.8	8.2	12.9	31.7	2.2	4.6	0.0	17.9	6.2	30.0	0.1	0.2	21.5	10.7	28.1	29.4	16.8	24.2	1.7	0.8	8.2	31.0	6.2	0.1	0.0	9.2	5.7	10.0	0.2	22.0	6.9	11.2	34.9	5.5	7.5	10.3	9.8	12.5	20.4	5.5	0.5	29.0	37.5	12.5	18.2	16.1	3.8	7.7	0.1	30.9	0.2	8.4	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	1.5	4.6	1.3	7.9	5.0	8.5	2.4	7.0	4.1	0.1	2.7	2.2	36.3	16.0	8.4	12.7	1.2	49.1	20.7	10.3	16.5	11.3	21.6	9.4	1.1	15.7	9.7	14.7	14.6	8.9	0.8	32.9	7.9	6.3	14.4	24.4	17.7	29.0	2.4	3.2	84.0	9.3	7.6	23.4	47.9	65.7	1.3	6.2	103.5	79.6	18.1	10.1	56.7	8.6	4.1	17.8	51.1	4.9	4.7	28.8	12.4	92.8	3.3	18.6	0.0	41.2	9.1	20.5	21.3	4.9	0.1	19.0	22.4	2.8	5.2	4.4	19.7	26.8	33.4	29.3	19.6	26.9	40.9	10.9	2.8	0.9	13.3	28.4
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437764-47449143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 88.9;tongue: 33.1"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 63.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 238.7"	"Low region specificity"	"Detected in some"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	0.3	1.5	0.5	0.2	0.5	0.3	0.2	0.3	1.2	0.2	0.9	0.8	0.1	0.0	0.1	1.2	0.1	0.1	2.6	0.5	0.5	0.3	0.5	0.4	0.2	0.3	0.5	0.0	0.2	0.0	0.1	2.1	0.5	0.7	0.0	0.1	1.3	0.0	88.9	0.5	0.5	0.1	0.4	0.6	0.2	0.3	0.6	0.1	0.2	33.1	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.2	0.7	0.1	0.2	1.2	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	59.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	238.7	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.3	0.1	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	1.2	0.5	0.5	0.3	0.5	0.5	0.4	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.3	1.4	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	2.7	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.5	0.0	0.2	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.3	13.8	0.0	0.5	0.0	0.0	0.6	1.3	0.0	0.5	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	63.8	0.5	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.2	0.1
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 59.8;salivary gland: 28.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 36.8;Excitatory neurons: 14.0;Gastric mucus-secreting cells: 57.1;Oligodendrocytes: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.3;EFO-21: 19.3;REH: 22.3;RPMI-8226: 50.0;RPTEC TERT1: 19.0;U-698: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041650	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.0	15.4	10.9	1.2	13.8	0.5	1.0	0.5	19.1	3.5	1.1	1.7	0.4	0.1	0.1	22.6	1.6	0.3	0.0	23.6	4.0	17.2	0.1	0.2	1.1	1.7	4.3	0.0	1.1	59.8	5.0	0.2	1.8	0.2	1.1	0.5	28.5	3.9	0.0	11.4	0.5	0.0	0.6	0.2	10.6	0.7	7.7	0.2	10.1	0.0	2.7	0.2	5.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.9	15.3	19.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	4.3	0.0	0.0	0.6	5.5	0.0	22.3	0.0	50.0	19.0	0.0	0.5	0.0	0.0	7.2	0.0	0.1	2.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	13.8	0.5	19.1	23.6	4.0	1.7	4.3	1.8	0.6	7.7	12.1	0.0	0.0	0.0	1.3	0.8	0.5	0.0	0.4	0.0	0.5	2.4	2.0	4.3	2.8	1.0	36.8	0.0	1.1	0.0	1.9	0.0	1.4	0.1	1.8	0.6	0.3	1.2	0.0	14.0	0.0	0.2	0.3	57.1	4.6	2.5	0.0	0.0	0.0	0.4	0.0	1.0	4.8	0.0	0.0	5.5	0.2	0.0	1.2	1.8	0.0	1.0	2.7	0.0	0.0	46.5	5.2	3.3	0.0	0.6	0.0	0.1	5.2	0.5	0.0	0.0	0.0	0.2	0.1	0.7	4.6	1.1	1.2	0.4	0.1	3.3	0.6
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540831-35553999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 212.9"	"Group enriched"	"Detected in some"	4	"Intestinal goblet cells: 13.1;Sertoli cells: 46.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 212.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.1;hTERT-RPE1: 9.8;SK-BR-3: 5.6;U-2 OS: 3.1;U-87 MG: 4.0"	"Region enriched"	"Detected in all"	8	"basal ganglia: 589.6"	"Region enriched"	"Detected in all"	8	"basal ganglia: 429.3"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.8	7.3	30.8	2.5	212.9	3.8	2.3	0.0	30.7	3.1	0.0	28.2	2.3	4.7	15.0	1.9	5.6	2.2	8.6	12.5	9.9	1.5	0.4	3.2	0.4	4.6	12.5	1.2	1.6	1.2	2.1	0.2	6.4	15.2	4.0	0.5	4.0	22.7	15.0	1.6	6.2	7.3	1.8	0.2	3.8	0.7	48.4	0.7	1.2	4.5	1.2	4.3	2.5	9.0	0.1	2.2	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.8	0.6	0.1	0.4	0.0	0.1	1.9	3.1	0.1	0.1	0.0	0.7	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.1	2.5	1.6	0.2	9.8	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.2	1.0	0.0	0.7	0.0	0.0	1.5	0.2	1.6	5.6	0.0	0.1	0.4	0.1	0.0	1.3	3.1	0.1	0.7	1.4	0.5	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	212.9	0.0	30.7	12.5	9.9	4.6	12.5	6.4	1.8	48.4	9.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.6	1.7	2.9	3.3	1.9	0.0	0.2	0.0	0.0	0.0	0.7	3.0	0.0	0.2	0.1	0.1	0.2	2.9	0.0	0.0	3.2	0.2	0.0	3.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.6	13.1	2.0	0.0	0.8	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.0	0.7	0.0	2.3	0.7	0.0	0.5	0.1	0.0	0.1	0.2	46.0	0.4	6.9	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.5	0.3
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 77.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.0;monocytes: 258.7;Muller glia cells: 260.3;Proximal tubular cells: 128.0;Skeletal myocytes: 186.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 84.8;intermediate monocyte: 63.9;myeloid DC: 84.2;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 84.2;monocytes: 84.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;RH-30: 162.7;RPMI-8226: 54.9;U-937: 85.4;WM-115: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	35.3	7.1	57.4	21.7	67.9	8.3	22.7	64.3	58.6	6.5	43.8	18.5	13.6	3.0	8.6	4.7	6.0	10.8	44.8	53.9	58.9	77.3	17.1	11.9	19.7	63.4	64.0	3.6	39.5	5.0	13.0	12.7	65.9	7.9	6.0	26.9	16.7	10.9	14.8	4.8	13.8	8.7	55.8	20.1	9.4	9.0	65.3	10.4	40.7	17.6	9.1	11.4	7.0	69.7	1.4	0.3	6.0	11.4	17.9	1.0	4.1	0.7	1.1	2.0	3.5	5.0	0.6	0.1	2.3	0.8	3.9	0.0	2.6	2.8	2.8	37.8	0.0	0.1	0.2	39.7	19.0	2.6	0.0	13.1	0.0	1.9	0.2	10.9	3.0	1.6	0.0	64.3	2.9	0.0	3.0	43.1	1.2	0.2	1.2	8.1	162.7	54.9	0.4	1.2	1.0	0.8	0.0	0.5	2.0	10.7	1.1	32.4	0.0	0.4	3.6	3.0	6.5	0.7	0.7	0.1	18.9	85.4	54.8	0.0	84.8	0.1	8.7	63.9	0.2	0.0	0.6	3.7	84.2	0.0	0.6	2.6	3.0	6.9	37.9	2.2	0.3	48.9	57.4	67.9	64.3	58.6	53.9	58.9	63.4	64.0	65.9	55.8	65.3	69.7	8.9	19.2	17.2	77.4	3.7	3.7	1.4	3.2	1.2	22.5	9.7	7.0	47.9	37.1	13.1	16.5	4.2	1.2	20.3	10.1	17.6	45.3	1.4	6.4	13.7	9.2	11.5	0.0	17.0	3.8	1.2	28.6	1.5	14.8	1.3	4.2	6.1	20.1	157.0	37.0	33.6	7.4	12.2	84.7	94.3	4.4	10.5	91.0	8.8	35.6	258.7	260.3	54.6	37.7	38.2	4.0	11.3	2.2	4.1	1.0	45.0	128.0	5.9	13.3	26.3	186.4	25.9	0.6	1.9	0.8	1.7	2.6	8.0	4.9	15.0	0.7
RASSF8	"C12orf2, HoJ-1"	ENSG00000123094	"Ras association domain family member 8"	Q8NHQ8	12	25959029-26079892	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 606.9;Horizontal cells: 430.7;Late spermatids: 722.1;Microglial cells: 229.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2197: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038163, HPA038164"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Mitochondria, Cytosol"		"HPA038163: AB_2675874, HPA038164: AB_10672621"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.58e-2)"	11.3	16.3	17.7	7.5	20.1	1.1	7.7	21.6	12.3	17.1	17.0	14.0	2.5	28.3	10.9	7.5	10.9	17.2	13.9	12.2	21.1	22.8	5.8	14.9	2.4	23.7	22.8	30.1	5.9	3.6	6.9	9.0	25.3	16.5	4.9	16.9	4.1	14.0	14.4	3.3	4.3	19.8	21.8	5.9	6.0	59.6	21.1	4.5	11.3	15.6	2.1	10.4	7.5	24.6	9.8	7.7	32.8	4.0	49.9	56.0	45.5	51.6	75.3	21.4	23.5	16.7	2.9	0.7	39.8	56.1	23.7	3.7	7.2	6.1	27.3	3.5	9.6	1.7	19.0	0.8	24.9	6.0	0.4	33.5	5.9	47.7	31.6	33.1	25.9	12.1	1.9	6.7	25.1	13.0	7.1	1.2	32.8	0.2	70.9	9.1	31.7	0.5	12.9	14.4	1.5	23.4	27.3	0.5	25.3	28.3	5.0	5.0	30.9	42.0	21.7	107.9	39.3	2.9	2.0	1.0	38.9	0.5	60.3	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	1.1	0.0	0.0	17.7	20.1	21.6	12.3	12.2	21.1	23.7	22.8	25.3	21.8	21.1	24.6	22.6	38.5	16.0	139.7	0.7	7.8	50.5	5.6	5.2	17.0	5.2	11.8	34.3	24.3	7.8	22.0	10.4	9.6	10.0	0.1	13.7	10.4	606.9	7.8	50.0	22.1	0.0	0.0	15.1	4.3	21.3	41.3	1.1	12.0	1.3	9.0	16.4	6.7	5.7	430.7	89.7	0.0	2.0	2.2	10.2	722.1	18.0	5.9	14.2	229.5	0.2	31.0	0.0	78.4	92.9	5.2	0.0	15.1	1.9	29.1	0.0	24.5	1.6	11.1	13.1	30.6	20.7	27.9	10.7	1.1	5.4	4.5	3.5	13.2	0.2	13.4
RAX2	"ARMD6, CORD11, MGC15631, RAXL1"	ENSG00000173976	"Retina and anterior neural fold homeobox 2"	Q96IS3	19	3769089-3772228	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	DNA-binding	"Age-related macular degeneration, Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"retina: 64.5"	"Group enriched"	"Detected in some"	9	"Cone photoreceptor cells: 123.0;Rod photoreceptor cells: 217.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA052533	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA052533: AB_2681862"										"unprognostic (5.53e-2)"				"unprognostic (1.39e-2)"	"unprognostic (4.48e-1)"			0.0	0.0	0.2	0.1	0.4	0.4	0.0	0.6	0.6	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.3	1.6	0.0	0.4	0.0	0.0	64.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.6	0.4	0.3	0.3	0.3	0.4	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	14.3	0.0	0.1	0.6	0.0	0.0	0.0	123.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	217.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713340	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 73.9;heart muscle: 25.2;skeletal muscle: 95.3;tongue: 45.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 5800.8;Inhibitory neurons: 5921.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Group enriched"	"Detected in many"	10	"basal ganglia: 28.1;cerebral cortex: 73.9;hippocampal formation: 26.6;white matter: 22.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746, HPA075862"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: , HPA075862: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		0.3	1.5	3.7	0.4	28.1	0.5	0.1	2.5	73.9	0.6	0.0	0.8	0.2	0.2	3.1	1.1	1.1	0.1	25.2	26.6	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	1.1	0.1	0.0	1.7	0.5	5.7	2.2	4.1	95.3	0.3	0.2	0.0	2.7	0.0	0.2	1.1	2.2	0.2	0.1	45.3	0.0	0.4	0.4	22.6	0.1	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	25.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.0	0.7	0.1	0.4	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.3	0.2	0.7	0.2	0.1	0.1	0.2	0.0	3.7	28.1	2.5	73.9	26.6	0.0	0.0	0.0	0.0	2.7	2.2	22.6	0.0	0.0	0.5	97.9	0.0	0.0	0.0	0.0	0.0	10.9	0.4	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	6.6	0.3	1.8	0.9	0.0	0.0	5800.8	0.2	0.0	3.5	0.0	0.1	0.0	47.8	0.0	0.0	0.1	0.0	5921.8	0.5	0.0	0.0	0.3	4.9	1.2	0.5	1.8	132.1	0.6	6.6	0.0	597.6	689.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.7	2.8	0.0	17.0	1.2	0.6	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0
RBIS	C8orf59	ENSG00000176731	"Ribosomal biogenesis factor"	Q8N0T1	8	85214048-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 56.0;Cytotrophoblasts: 105.8;dendritic cells: 39.1;Extravillous trophoblasts: 123.8;Hofbauer cells: 102.1;Syncytiotrophoblasts: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044805, HPA071903"			Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: AB_2679095, HPA071903: AB_2686469"	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	74.4	69.3	55.7	51.0	56.1	83.2	95.2	57.4	72.4	85.3	57.0	81.0	60.6	67.0	91.1	90.2	72.2	42.8	101.1	54.6	58.2	88.5	86.2	52.3	70.8	56.9	55.6	82.7	103.1	60.6	68.9	45.6	57.5	71.6	56.8	45.8	75.2	41.4	78.0	63.9	66.3	48.8	58.5	75.4	99.0	41.5	56.1	75.1	61.3	68.6	71.3	73.9	73.5	59.8	166.6	83.1	122.6	79.4	73.4	140.2	94.8	107.6	102.7	123.1	120.5	97.2	140.0	42.1	86.8	71.8	116.2	112.9	84.8	118.2	138.1	116.6	92.5	242.1	74.2	145.8	87.0	92.5	105.7	120.0	137.0	79.4	99.7	133.3	106.4	145.3	111.9	97.8	103.7	131.0	205.8	173.1	36.1	372.8	143.3	86.9	100.6	188.2	121.2	104.7	40.7	87.1	81.7	132.8	161.0	145.5	154.4	135.9	81.8	78.1	164.9	87.5	104.2	114.1	144.8	197.4	155.8	116.8	88.9	76.6	55.2	39.2	63.5	71.7	76.7	89.3	83.7	78.9	96.9	77.7	95.8	95.0	14.1	104.7	64.4	118.7	90.8	71.0	55.7	56.1	57.4	72.4	54.6	58.2	56.9	55.6	57.5	58.5	56.1	59.8	56.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	105.8	39.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	123.8	27.8	0.0	0.0	0.0	0.0	0.0	0.0	102.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	76.9	7.6	0.0	0.0	0.0
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781379-27890681	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 79.0;Proximal tubular cells: 110.9;Respiratory ciliated cells: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 17.8;RPTEC TERT1: 40.8;U-266/84: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		11000	"Cluster 22: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	5.8	24.8	3.9	2.0	4.3	1.8	3.9	5.2	5.1	3.5	5.0	6.1	25.2	2.8	10.9	3.1	15.5	2.7	5.2	4.1	4.4	27.5	46.5	3.1	1.7	4.4	4.6	8.1	4.6	9.3	11.0	1.8	4.3	2.4	5.2	13.8	2.1	3.4	8.2	1.5	25.6	2.2	3.9	1.7	2.8	9.2	3.9	3.1	9.8	5.9	2.2	2.2	2.3	4.4	6.4	4.9	0.5	0.6	0.4	1.7	3.9	1.3	1.7	1.5	1.1	9.3	2.9	2.4	17.8	3.6	3.0	2.3	0.6	2.7	2.1	0.9	0.3	0.1	0.7	8.2	2.7	1.7	0.2	2.4	3.3	5.8	7.8	1.5	1.2	3.8	0.5	4.0	3.6	8.2	1.5	4.6	0.8	4.6	4.3	1.8	0.3	1.4	40.8	0.5	1.7	2.5	6.1	7.7	2.8	2.3	3.9	9.3	0.2	1.2	0.9	4.3	2.7	13.6	18.2	3.8	3.6	5.6	0.2	1.6	2.5	1.4	1.9	0.9	4.2	4.4	2.7	4.8	3.5	3.7	3.1	2.3	1.0	4.5	0.2	0.4	4.2	2.3	3.9	4.3	5.2	5.1	4.1	4.4	4.4	4.6	4.3	3.9	3.9	4.4	9.9	6.4	5.0	14.7	24.0	2.0	3.1	11.7	26.7	10.7	5.1	7.1	7.1	5.7	9.7	18.4	4.2	4.2	10.5	12.2	46.9	12.6	36.9	35.2	2.4	7.8	3.6	3.0	13.9	12.3	1.3	10.9	8.6	7.4	2.5	4.6	2.9	29.5	6.5	8.4	18.3	4.7	6.1	4.4	3.4	26.4	1.5	50.8	1.8	2.8	2.4	15.5	3.1	15.6	10.3	7.0	14.9	2.6	21.2	1.0	79.0	110.9	59.0	25.6	0.0	3.3	11.2	23.8	20.0	5.2	1.6	1.5	19.6	9.5	10.7	1.9
RBM14-RBM4		ENSG00000248643	"RBM14-RBM4 readthrough"		11	66616626-66646469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.5;Club cells: 5.0;Excitatory neurons: 8.7;Inhibitory neurons: 8.7;Microglial cells: 5.6;Oligodendrocytes: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 10.0"									HPA047849	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA047849: AB_2680180"	"unprognostic (2.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-4)"	"unprognostic (3.92e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.77e-4)"	"unprognostic (5.74e-7)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.10e-2)"	0.6	0.8	3.5	0.4	2.5	3.0	0.5	3.4	3.4	0.6	2.9	1.3	0.1	0.8	0.8	1.0	0.7	0.6	2.7	2.6	3.6	1.0	3.0	0.7	0.6	2.9	1.9	0.6	1.1	0.3	1.0	0.4	1.8	1.1	0.4	0.7	0.9	0.5	1.0	0.6	1.0	0.5	1.3	1.1	1.0	0.5	2.6	0.8	1.0	0.4	0.4	1.1	0.7	3.4	1.6	0.9	0.7	1.3	1.0	0.1	0.8	0.9	0.5	1.6	0.3	2.6	0.5	0.9	1.3	0.7	1.2	2.5	1.8	0.6	0.6	0.8	0.7	2.7	1.8	2.0	0.5	1.7	1.5	0.4	0.5	0.8	0.2	0.6	0.0	1.4	3.8	1.4	1.0	3.2	2.5	10.0	1.7	1.9	4.4	2.8	3.4	1.5	0.7	1.8	2.2	1.0	0.7	2.3	5.9	0.5	1.4	1.2	0.7	2.1	1.5	1.7	1.1	1.1	1.0	1.7	1.8	1.2	1.8	4.8	4.3	5.9	4.6	4.8	2.7	5.9	2.9	3.1	4.3	5.9	1.9	2.5	2.8	3.5	5.0	8.4	2.1	3.6	3.5	2.5	3.4	3.4	2.6	3.6	2.9	1.9	1.8	1.3	2.6	3.4	0.5	0.0	1.1	5.5	1.1	0.0	0.5	0.1	1.2	1.1	0.4	0.4	0.0	1.5	5.0	0.0	4.2	0.5	2.0	0.3	0.0	0.5	1.7	1.4	0.9	0.6	0.0	0.4	8.7	0.2	0.4	0.8	1.1	1.1	0.0	0.7	0.0	0.5	0.2	0.0	8.7	0.5	0.0	0.3	0.3	0.9	0.0	1.2	0.0	5.6	0.0	0.1	0.0	4.0	10.3	0.4	0.1	0.0	1.0	0.5	0.0	0.4	3.6	0.8	0.0	0.8	0.4	1.0	0.9	1.0	0.1	1.1	1.0	0.5	0.2	0.8
RBM4	"LARK, RBM4A, ZCCHC21, ZCRB3A"	ENSG00000173933	"RNA binding motif protein 4"	Q9BWF3	11	66638667-66668374	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042174, HPA047849"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (8.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.07e-3)"	82.6	111.5	60.8	71.0	63.3	131.5	75.8	81.1	66.7	90.8	69.4	96.1	67.8	87.1	90.3	100.3	79.4	59.0	75.6	61.5	67.1	119.8	82.3	77.4	97.5	59.0	58.5	103.6	115.5	77.2	86.1	72.8	58.9	95.9	62.6	74.4	89.1	60.0	96.6	80.9	83.6	69.1	61.1	104.8	98.4	74.3	69.5	109.8	85.7	72.4	99.1	84.2	84.1	65.4	127.2	163.6	246.5	136.4	90.1	95.6	153.9	128.6	106.1	134.1	97.3	281.5	160.9	161.1	174.4	132.3	120.5	136.4	263.5	159.1	142.9	162.1	138.4	220.7	163.5	170.3	173.1	152.8	91.9	138.8	134.3	158.6	213.9	136.4	184.3	155.0	180.1	115.0	147.3	263.3	252.9	157.9	309.7	246.8	176.0	234.2	224.6	181.7	180.7	199.5	204.5	149.5	227.1	168.6	379.9	163.8	315.3	154.4	180.9	140.4	124.0	86.5	107.3	143.9	162.5	258.8	109.9	118.3	205.8	210.0	119.4	131.3	135.5	123.2	122.3	119.3	139.8	149.9	116.2	130.4	147.5	149.8	137.5	155.4	144.0	103.6	194.3	159.1	60.8	63.3	81.1	66.7	61.5	67.1	59.0	58.5	58.9	61.1	69.5	65.4	19.7	28.9	42.2	8.1	64.0	17.8	61.4	36.3	112.7	58.2	24.2	12.7	4.6	15.7	36.5	20.2	93.8	36.2	48.7	16.6	15.6	25.1	39.8	26.6	28.0	28.5	34.7	42.5	23.9	23.1	30.1	33.6	53.0	30.7	36.8	38.1	25.7	11.1	14.5	62.2	21.4	15.5	32.6	18.8	29.2	9.3	27.4	27.5	19.6	7.5	28.8	15.9	69.0	15.1	18.8	19.6	23.6	20.3	60.2	62.6	32.9	10.6	41.1	90.0	19.7	29.7	28.3	41.1	40.1	68.6	22.3	43.8	66.3	42.4	24.8	65.5
RBM41	FLJ11016	ENSG00000089682	"RNA binding motif protein 41"	Q96IZ5	X	107064420-107118823	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042881	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles, Cytosol"		"HPA042881: AB_10794536"	"unprognostic (1.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.92e-1)"	4.6	5.8	2.6	5.0	3.0	3.5	5.7	5.7	3.7	4.2	5.1	5.5	7.7	6.1	6.5	5.6	5.0	4.5	5.5	3.0	2.8	6.8	8.3	4.7	5.8	3.9	3.4	5.5	4.2	9.3	3.4	5.4	3.4	5.5	6.5	5.8	4.5	5.0	6.4	7.1	6.9	5.6	3.2	5.3	5.0	7.3	3.2	6.6	6.9	8.0	6.2	5.0	4.1	3.8	16.9	13.3	8.4	6.8	5.5	9.5	9.7	9.8	9.6	7.1	9.5	8.9	13.8	9.3	18.0	7.2	12.4	13.7	12.3	9.2	10.8	11.5	18.1	11.3	25.2	11.0	6.2	11.6	8.5	6.7	17.7	8.6	8.6	9.9	10.8	8.5	19.8	12.5	8.7	8.2	9.9	6.6	12.4	9.3	15.1	7.9	7.0	8.0	10.5	10.5	6.9	10.9	12.2	8.7	7.9	11.4	8.0	5.4	10.6	9.8	5.7	11.7	7.8	5.8	11.6	9.9	5.5	5.2	7.6	10.5	5.2	8.3	4.5	2.7	2.7	5.1	3.9	4.6	3.5	4.3	2.9	1.9	0.7	6.6	2.9	3.6	3.9	2.3	2.6	3.0	5.7	3.7	3.0	2.8	3.9	3.4	3.4	3.2	3.2	3.8	9.6	12.8	17.0	29.0	11.6	5.2	6.6	8.5	12.0	20.3	7.6	6.7	23.2	11.5	8.3	7.3	27.1	8.7	17.4	10.9	1.9	14.8	8.0	27.1	10.1	9.8	7.8	21.0	38.3	7.8	5.3	10.1	8.2	11.6	13.3	19.5	5.3	10.2	6.6	11.8	46.5	8.6	4.1	10.7	4.6	2.3	14.3	12.5	5.4	45.9	11.7	7.4	14.4	50.8	53.4	13.6	11.9	11.7	12.6	5.6	22.0	9.0	13.1	20.2	0.0	14.7	12.4	11.7	8.0	9.0	7.4	4.5	9.7	13.1	11.4	6.2
RBM42	MGC10433	ENSG00000126254	"RNA binding motif protein 42"	Q9BTD8	19	35629030-35637686	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 384.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043671	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA043671: AB_10794890"	"unprognostic (4.77e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.26e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.33e-2)"	57.6	48.0	34.9	24.5	39.8	38.2	54.3	41.3	41.5	56.1	30.9	60.6	27.5	65.2	12.0	58.5	53.8	11.8	60.8	35.1	36.3	57.5	54.0	46.5	24.1	43.8	38.0	54.8	39.6	23.1	41.4	23.2	38.7	55.2	10.7	9.1	44.2	24.9	76.0	67.3	46.3	14.5	37.6	51.7	49.7	41.5	38.0	25.9	49.9	21.6	15.5	58.0	50.8	42.9	115.6	176.5	38.8	52.9	34.6	27.0	104.8	77.2	41.8	88.3	69.0	105.0	72.8	63.7	137.8	49.4	48.2	46.6	44.8	54.0	26.0	165.6	80.0	87.8	57.7	87.5	88.8	78.5	81.1	38.6	42.3	65.4	36.0	28.4	48.8	65.3	92.9	50.8	40.5	130.5	99.9	103.1	44.4	103.1	71.9	107.7	52.9	63.8	43.0	52.6	50.5	73.3	87.8	71.5	62.4	21.1	57.0	122.0	76.2	63.1	86.4	84.4	136.6	123.0	140.7	99.1	60.9	73.8	90.2	98.8	79.6	124.5	82.8	95.6	70.9	76.2	67.8	83.1	94.3	81.3	59.4	67.1	73.9	79.3	94.5	87.6	82.6	73.3	34.9	39.8	41.3	41.5	35.1	36.3	43.8	38.0	38.7	37.6	38.0	42.9	56.5	38.5	24.6	4.6	38.4	51.9	52.6	94.3	43.9	23.3	31.2	37.5	14.7	40.0	57.4	53.3	12.5	197.9	47.0	67.2	74.3	78.0	38.4	41.0	35.4	50.9	52.1	43.8	2.3	90.4	101.5	47.0	38.7	41.6	51.4	46.0	46.8	31.6	91.2	10.1	2.6	56.4	54.9	31.1	60.9	16.3	58.1	40.9	53.4	2.8	63.0	46.5	27.8	3.5	5.8	80.6	48.9	63.2	43.7	31.8	72.3	78.0	44.5	19.8	52.6	34.5	92.4	71.9	52.9	36.2	43.5	384.3	44.9	44.3	64.7	45.4
RBM46	"CT68, MGC27016"	ENSG00000151962	"RNA binding motif protein 46"	Q8TBY0	4	154781213-154828813	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 27.6"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 135.7;Spermatogonia: 82.1"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	8	"spinal cord: 12.9"	HPA037746			Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA037746: "	"unprognostic (4.79e-1)"				"unprognostic (1.14e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.99e-7)"	"unprognostic (4.86e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.27e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	27.6	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.6	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	4.3	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	9.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	135.7	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 442.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 136.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 34.4;granulocytes: 136.2;monocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 134.0;CAPAN-2: 63.5;OE19: 56.7;SK-BR-3: 58.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006347	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	9.3	49.7	2.2	20.3	1.9	9.6	24.7	1.8	3.0	15.3	44.9	61.0	68.4	3.5	23.1	42.2	17.7	17.9	1.3	2.8	2.3	67.6	34.5	21.0	8.2	6.0	3.2	2.2	25.9	27.8	3.2	20.1	4.9	33.2	50.5	0.4	59.4	13.4	0.5	9.0	64.1	4.7	4.1	14.7	64.6	6.7	5.7	4.4	49.5	1.1	11.4	22.6	15.5	6.8	31.9	47.8	0.0	1.8	0.2	0.0	134.0	0.8	1.6	0.1	0.6	28.3	63.5	0.2	23.0	1.2	3.8	14.2	0.9	11.8	0.3	0.2	7.6	0.0	3.1	7.9	0.6	0.3	0.3	0.8	6.0	0.1	0.1	1.8	0.0	0.0	1.8	7.0	0.1	18.1	0.2	1.1	13.5	56.7	2.4	0.2	0.0	34.7	46.8	41.6	1.6	0.3	17.3	58.4	0.3	14.8	23.9	9.0	0.0	0.5	1.9	0.3	1.0	23.5	37.7	4.1	5.0	3.9	0.2	0.5	45.5	0.5	0.2	33.1	0.3	5.9	0.2	0.1	34.4	5.4	0.4	0.1	136.2	0.5	26.2	14.1	0.2	16.9	2.2	1.9	1.8	3.0	2.8	2.3	6.0	3.2	4.9	4.1	5.7	6.8	1.1	80.1	116.6	0.7	21.2	58.9	75.2	42.9	95.0	0.1	145.7	63.5	1.9	75.8	92.2	112.2	0.0	99.6	16.3	442.8	64.6	90.6	1.3	132.6	9.5	6.0	121.9	2.5	2.5	115.4	84.3	7.7	174.8	143.7	7.0	8.7	23.6	140.4	92.6	1.7	1.9	234.2	59.0	138.8	92.8	2.6	2.5	119.9	37.4	82.4	80.6	0.3	1.0	2.5	0.8	108.0	228.1	1.2	40.1	164.7	218.1	143.6	118.3	0.1	0.0	1.4	5.1	2.6	10.4	178.1	75.4	262.6	4.8	16.9	203.8	295.4
RBM4B	"MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B"	ENSG00000173914	"RNA binding motif protein 4B"	Q9BQ04	11	66664998-66677887	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042174, HPA047849"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.71e-2)"	8.1	16.2	25.9	11.1	26.2	4.9	10.7	36.5	31.5	21.9	23.2	15.2	10.0	19.8	20.4	13.7	18.7	10.4	10.9	25.7	27.7	15.2	14.3	9.4	16.1	25.2	24.9	30.0	13.6	13.1	23.6	13.1	25.3	18.6	12.0	34.5	15.3	14.9	16.3	18.8	14.5	14.5	24.7	15.6	12.6	16.2	26.2	13.3	16.1	15.3	17.3	14.0	15.5	29.9	21.3	21.0	45.1	37.7	21.7	22.3	15.3	19.9	20.0	21.9	22.3	29.5	21.9	23.8	27.9	25.5	21.5	27.2	30.1	27.7	23.2	23.0	20.4	25.7	26.6	31.9	15.9	26.4	24.4	23.3	18.6	22.5	19.1	25.1	21.5	19.0	20.0	23.1	29.8	34.3	16.5	20.4	26.7	47.8	27.9	33.4	35.8	24.4	20.2	21.1	27.7	25.2	23.9	12.1	47.3	28.8	32.3	24.7	20.1	24.1	24.6	23.7	18.3	11.2	20.5	24.2	22.2	18.4	21.7	26.4	15.1	43.9	16.1	22.6	15.7	34.6	14.9	15.8	18.2	28.9	18.1	13.5	9.8	22.6	25.9	15.1	12.2	13.8	25.9	26.2	36.5	31.5	25.7	27.7	25.2	24.9	25.3	24.7	26.2	29.9	7.5	12.8	5.9	15.3	25.9	8.0	14.7	29.8	24.5	36.3	14.4	13.6	6.9	12.8	15.9	18.4	33.3	36.5	11.5	8.1	11.7	11.9	26.5	13.4	12.8	9.5	19.2	12.0	20.0	5.8	16.5	14.9	11.2	11.7	8.9	17.0	12.8	9.0	13.0	25.2	25.8	11.7	26.4	9.8	6.1	53.9	18.3	9.8	16.0	11.2	10.5	23.3	13.4	29.1	31.1	4.7	12.4	13.5	13.4	7.0	21.2	13.4	22.6	60.4	6.6	12.0	14.2	50.8	42.8	13.6	7.1	22.2	14.6	12.2	10.9	5.7
RBMS2	SCR3	ENSG00000076067	"RNA binding motif single stranded interacting protein 2"	Q15434	12	56521820-56596193	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039225, HPA058784"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA039225: AB_10963056, HPA058784: AB_2683819"	"unprognostic (1.35e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.63e-2)"	19.4	7.1	12.5	5.7	11.5	3.6	17.4	9.3	13.1	14.7	15.1	12.9	4.7	13.7	9.3	8.2	13.7	9.5	15.6	9.2	10.0	14.7	3.4	37.3	3.2	14.5	11.7	12.6	7.0	8.6	6.1	23.5	13.4	11.2	8.8	6.0	10.1	8.7	8.4	8.3	9.0	12.1	9.8	10.5	8.5	4.3	15.2	3.5	18.3	10.8	3.9	10.3	13.9	11.7	28.8	24.3	10.5	14.9	23.7	22.7	9.3	34.8	37.0	26.9	23.9	18.7	50.2	0.2	42.1	36.6	11.1	20.4	7.8	57.8	30.1	8.3	6.7	3.7	19.0	4.8	15.4	3.8	6.5	20.9	13.9	28.1	33.5	31.4	51.1	6.1	1.8	6.5	47.0	3.7	4.1	4.9	6.2	0.0	7.5	2.4	11.5	0.3	34.1	6.4	0.8	6.9	39.6	14.9	5.1	22.2	16.0	6.3	78.2	16.7	35.8	9.5	8.4	6.1	2.5	1.7	6.1	0.9	23.6	0.6	4.7	1.6	0.8	1.3	0.9	0.3	0.3	1.2	2.7	0.5	0.9	0.6	1.6	1.0	0.3	0.6	0.5	0.8	12.5	11.5	9.3	13.1	9.2	10.0	14.5	11.7	13.4	9.8	15.2	11.7	74.4	41.7	20.5	34.6	1.5	3.7	9.7	6.8	11.4	4.2	11.4	9.4	7.9	12.8	14.2	12.9	10.4	19.8	7.0	19.7	1.9	23.6	12.6	16.4	16.9	47.9	5.4	3.2	7.2	16.9	38.5	16.9	6.1	21.8	8.2	10.4	52.1	1.0	10.5	8.4	10.0	5.9	4.1	22.7	5.5	24.2	17.4	11.2	0.0	53.4	6.2	5.4	4.1	30.7	9.6	37.8	11.5	24.8	0.8	13.4	1.6	13.4	6.8	1.7	26.3	11.2	15.5	0.9	1.8	5.4	2.0	23.7	2.5	8.7	7.0	17.3
RCAN1	DSCR1	ENSG00000159200	"Regulator of calcineurin 1"	P53805	21	34513142-34615113	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 256.2;parathyroid gland: 453.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 245.5;Endometrial ciliated cells: 336.9;Glandular and luminal cells: 504.9"	"Cancer enhanced"	"Detected in all"		"glioma: 41.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"SK-MEL-30: 1323.8;WM-115: 815.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037218, HPA068436"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB037218: AB_2179743, HPA068436: "	"unprognostic (3.83e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.27e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.60e-3)"	58.5	22.0	59.0	50.3	68.2	6.3	65.0	64.6	79.8	86.4	69.9	39.0	31.6	28.7	8.9	24.5	12.4	57.4	61.6	57.5	65.7	89.8	256.2	38.6	12.9	68.1	65.3	8.7	64.1	453.5	30.7	95.6	68.3	24.1	39.5	13.1	20.4	15.1	34.4	29.1	27.6	48.7	67.4	14.6	34.9	10.5	72.7	82.2	61.0	31.8	9.7	101.3	20.9	75.0	47.7	9.5	47.9	29.6	25.7	15.9	29.1	175.8	181.3	71.1	70.5	54.1	44.7	0.8	8.1	103.4	139.5	4.1	34.4	35.6	94.5	26.8	21.2	9.5	16.5	25.8	98.1	15.3	28.9	41.4	31.9	84.4	58.7	17.9	23.8	32.5	18.1	45.7	47.7	23.1	145.4	12.2	27.4	48.0	23.5	53.9	37.5	22.2	22.8	81.1	23.0	10.1	128.4	82.2	1323.8	43.3	111.4	25.4	25.8	237.5	24.7	39.9	43.1	38.9	26.4	8.5	77.4	44.4	815.5	0.0	1.1	5.0	0.7	2.1	1.0	1.1	0.8	0.7	1.6	0.8	0.3	0.7	0.5	0.1	2.4	3.0	1.1	0.5	59.0	68.2	64.6	79.8	57.5	65.7	68.1	65.3	68.3	67.4	72.7	75.0	158.3	96.1	52.4	15.3	8.2	94.6	20.7	20.5	38.1	19.4	245.5	142.4	24.9	21.5	32.7	206.0	27.1	10.9	11.8	204.9	21.5	82.0	48.3	336.9	46.4	175.4	3.6	7.4	28.3	18.9	15.3	60.3	23.4	504.9	8.8	3.9	25.0	187.8	58.9	3.3	54.2	30.7	4.1	19.6	74.0	13.1	7.2	39.8	56.9	15.9	29.5	10.9	3.1	41.7	71.3	26.3	140.5	9.8	6.1	16.3	41.2	142.3	14.1	7.5	0.0	30.3	68.9	10.8	2.6	12.3	79.3	11.1	11.5	10.5	16.3	50.4
RCC1L	WBSCR16	ENSG00000274523	"RCC1 like"	Q96I51	7	75027122-75074228	"Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 56.0;Distal tubular cells: 49.0;Extravillous trophoblasts: 42.3;Granulosa cells: 46.2;Proximal tubular cells: 37.0;Syncytiotrophoblasts: 54.5;Theca cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052184, HPA060643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA052184: AB_2681752, HPA060643: AB_2684335"	"unprognostic (9.73e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (8.91e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-1)"	27.4	46.3	19.6	17.3	21.4	14.0	25.2	19.5	22.5	24.0	22.9	35.0	19.0	28.2	6.8	30.7	21.9	12.7	53.1	18.5	19.6	40.1	59.8	20.2	18.7	21.4	20.2	28.8	28.8	18.2	27.2	15.4	19.3	30.6	10.3	5.3	22.8	17.5	103.1	22.0	23.2	12.7	20.8	25.3	28.8	21.6	22.0	12.4	25.9	45.9	12.7	32.0	23.1	20.5	44.8	59.2	34.8	54.0	24.5	19.8	45.3	42.9	30.5	36.1	29.5	64.6	53.5	47.2	18.9	34.8	46.9	51.9	29.8	28.8	15.0	52.0	47.7	35.1	41.5	61.3	34.6	56.6	53.7	24.7	23.1	31.4	24.9	24.2	32.4	7.7	113.8	29.5	28.3	92.8	1.5	84.6	80.0	53.2	52.1	24.5	27.4	98.6	31.5	38.9	34.5	55.3	57.1	119.0	54.4	24.3	83.8	58.3	35.8	46.9	38.5	40.7	56.5	32.4	26.7	73.6	35.8	58.3	63.6	3.5	2.3	1.4	4.2	3.1	3.4	3.6	4.6	3.7	3.3	4.2	4.3	5.3	0.8	4.6	2.3	3.3	3.7	1.7	19.6	21.4	19.5	22.5	18.5	19.6	21.4	20.2	19.3	20.8	22.0	20.5	15.9	0.0	7.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	15.2	15.5	0.0	0.0	2.5	22.0	0.0	56.0	13.0	0.0	49.0	24.3	0.0	11.7	17.7	8.0	0.0	0.0	0.0	20.6	42.3	10.5	0.0	13.8	5.1	46.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	18.1	0.0	0.0	1.8	0.0	0.0	37.0	2.9	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	54.5	6.6	53.8	0.0	0.0
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 209.7;Urothelial cells: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 60.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favorable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.5	4.8	2.5	3.4	2.6	2.2	4.5	3.9	3.6	9.4	3.9	8.6	6.7	4.2	0.7	19.8	4.8	3.0	13.0	2.4	3.5	9.2	8.2	4.4	3.5	3.5	4.2	3.7	8.6	12.4	6.4	10.1	3.7	6.3	3.8	2.1	9.6	3.7	9.7	21.0	6.1	2.0	1.6	6.2	10.5	5.3	3.8	2.2	7.5	4.8	2.7	5.1	12.2	2.3	10.9	12.3	2.9	10.3	1.5	3.0	17.9	3.4	2.1	3.7	6.4	23.3	15.7	9.4	5.3	1.2	2.7	14.1	7.8	7.2	1.7	7.3	60.0	12.2	9.8	14.6	2.9	12.4	8.0	2.6	6.3	3.0	2.9	3.7	3.0	5.2	27.2	2.9	2.3	13.4	6.1	9.6	2.5	17.7	25.7	15.7	6.7	27.6	8.2	37.3	8.8	6.2	8.9	31.3	7.0	2.7	12.0	9.3	3.0	0.3	3.7	0.1	8.2	7.8	11.0	9.6	9.1	10.6	6.6	3.8	4.1	4.1	8.2	6.3	7.7	5.4	6.3	7.6	4.2	5.8	8.4	6.1	1.9	7.8	5.0	6.4	5.5	3.0	2.5	2.6	3.9	3.6	2.4	3.5	3.5	4.2	3.7	1.6	3.8	2.3	8.9	16.0	13.1	3.9	6.6	10.7	31.7	11.1	7.4	21.0	12.2	9.9	27.5	20.0	19.3	14.7	41.7	41.3	9.4	47.2	11.7	13.5	24.3	18.3	8.8	9.1	12.0	4.2	9.4	6.5	29.0	7.1	46.4	31.8	8.2	24.4	18.5	7.3	11.5	25.2	10.0	27.5	12.2	4.9	5.0	13.2	3.7	4.2	7.2	4.7	5.0	9.0	6.2	5.0	2.9	14.5	35.7	3.4	8.7	30.6	20.3	4.8	12.8	25.3	6.6	5.1	6.5	3.2	8.9	11.1	17.5	209.7	9.2	11.1	28.1	110.1
RDH8	"PRRDH, SDR28C2"	ENSG00000080511	"Retinol dehydrogenase 8"	Q9NYR8	19	10013249-10022279	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"retina: 114.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.3;Cone photoreceptor cells: 54.2;Early spermatids: 72.6;Muller glia cells: 22.1;Rod photoreceptor cells: 203.4"	"Cancer enriched"	"Detected in some"	4	"melanoma: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064473			Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA064473: "			"unprognostic (4.12e-1)"		"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.98e-3)"		"unprognostic (4.58e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-1)"			"unprognostic (1.02e-1)"	"unprognostic (3.86e-1)"		"unprognostic (2.63e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	114.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.2	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	0.0	72.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	203.4	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	61	"intestine: 6743.6;pancreas: 12212.2"	"Group enriched"	"Detected in some"	11	"Exocrine glandular cells: 1988.6;Pancreatic endocrine cells: 5382.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.6;EFO-21: 15.8;HDLM-2: 15.4;NB-4: 17.7;RPMI-8226: 24.6;SH-SY5Y: 14.6;U-2 OS: 28.5;U-251 MG: 11.0;U-266/84: 15.1"									"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA		23000000		"Cluster 25: Pancreas - Digestion"	"Cluster 24: NB-4 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				18.5	10.0	0.0	13.3	0.0	0.2	0.6	0.0	0.0	0.3	0.0	19.2	5180.0	2.9	0.0	1.4	0.2	24.9	1.0	0.0	0.0	2.6	2.0	0.5	4.9	0.0	0.0	0.9	12212.2	0.0	2.1	0.1	0.0	0.5	0.0	0.0	2.1	0.0	0.6	0.4	6743.6	0.2	0.0	1.3	156.5	0.9	0.0	0.0	0.6	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.1	0.4	0.0	0.0	0.0	24.6	0.0	0.0	1.8	14.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.5	5.4	11.0	0.0	15.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	152.8	7.7	0.0	0.0	3.0	0.0	0.0	0.0	1988.6	0.0	0.0	189.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	6.8	0.0	1.4	0.0	0.0	55.8	0.0	0.0	0.0	0.0	5382.1	32.5	0.0	0.2	0.0	215.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	315.9	0.0
REG3G	"LPPM429, PAP1B, UNQ429"	ENSG00000143954	"Regenerating family member 3 gamma"	Q6UW15	2	79025686-79028505	"Predicted secreted proteins"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pancreas: 3517.1"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 184.9;Pancreatic endocrine cells: 53.5;Proximal enterocytes: 39.4"	"Cancer enriched"	"Detected in many"	13	"pancreatic cancer: 71.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Uncertain		Approved	Cytosol	"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"									"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"		"unprognostic (8.82e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.64e-2)"			1.0	46.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	2.4	0.1	165.7	0.3	0.3	0.0	0.2	0.0	0.0	6.0	0.4	0.1	0.0	0.0	0.0	0.2	3517.1	0.0	0.3	1.1	0.0	0.1	0.0	0.0	0.3	1.3	0.2	0.1	37.0	1.5	0.0	0.2	0.4	57.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.0	0.0	0.1	0.0	0.0	0.0	184.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	6.2	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	53.5	0.0	0.7	0.0	0.4	39.4	2.2	0.0	0.0	0.0	0.0	0.2	1.3	1.2	0.0	0.0	0.0	0.0	0.9	5.4	0.0
RELCH	"FLJ33841, HsT3308, HsT885, KIAA1468"	ENSG00000134444	"RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing"	Q9P260	18	62187255-62310249	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Cardiomyocytes: 9.4;Cytotrophoblasts: 6.5;dendritic cells: 8.2;Extravillous trophoblasts: 4.4;Hofbauer cells: 7.2;Plasma cells: 5.2;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039708, HPA040038"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA039708: AB_10794753, HPA040038: AB_10793860"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.71e-2)"	8.3	8.8	8.7	9.6	10.8	14.2	11.9	11.1	10.0	11.8	7.2	11.5	9.5	8.5	11.8	25.4	7.7	7.9	7.5	9.7	9.3	9.6	7.9	8.0	11.8	7.9	7.6	8.2	8.3	10.3	11.0	8.1	8.2	12.1	14.4	16.3	12.5	8.8	6.8	20.6	10.8	6.2	7.6	11.2	12.7	5.3	8.8	10.8	9.5	5.9	13.2	10.0	16.2	9.4	9.7	8.7	10.4	10.0	10.8	12.7	11.1	17.0	14.1	15.0	16.5	4.5	8.8	6.6	8.6	15.1	9.8	19.7	14.9	10.2	18.3	6.0	9.3	5.6	9.7	10.4	9.6	10.8	7.4	9.4	12.3	12.8	7.8	12.3	10.3	6.2	4.2	6.5	15.9	5.7	6.7	9.3	6.0	6.5	7.3	8.2	13.0	7.9	17.1	19.1	14.7	7.8	10.2	14.9	8.9	13.4	7.7	11.6	12.9	15.9	5.0	6.9	8.6	19.0	3.7	6.4	11.2	11.4	13.0	1.4	1.0	1.2	1.1	0.8	0.8	0.8	1.0	1.0	1.0	0.9	1.1	1.3	1.7	1.1	0.7	0.7	1.3	0.6	8.7	10.8	11.1	10.0	9.7	9.3	7.9	7.6	8.2	7.6	8.8	9.4	7.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.6	1.1	0.0	0.0	0.0
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 207.3;Excitatory neurons: 114.3;Inhibitory neurons: 138.1;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: AB_2673269"	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	13.5	11.9	24.7	14.9	25.4	23.2	23.6	27.7	36.8	19.2	14.8	17.4	15.4	21.9	40.2	28.0	18.4	14.0	23.9	27.4	24.0	17.4	31.3	15.2	19.4	25.2	23.9	21.1	18.8	41.0	31.7	17.2	21.3	15.9	17.3	38.8	26.1	16.2	17.5	30.0	16.4	19.5	21.5	22.1	18.1	35.6	25.9	36.0	17.8	12.6	22.2	19.5	20.1	25.3	29.3	22.6	42.3	53.1	23.4	41.6	46.2	27.8	30.7	31.9	38.2	54.1	24.8	35.2	22.9	38.9	38.0	33.6	48.7	42.0	42.1	37.6	41.9	29.6	12.9	32.9	35.3	94.6	45.9	34.1	33.7	58.6	70.3	30.2	33.5	51.2	40.2	35.1	41.4	49.4	53.9	51.3	40.4	37.4	21.3	62.4	26.0	20.0	26.5	43.6	37.7	37.2	25.7	38.7	38.0	62.0	18.6	64.4	32.9	17.8	29.6	48.5	38.8	34.4	33.7	49.2	21.1	38.3	26.4	5.9	1.3	1.9	2.2	4.0	3.8	3.0	2.9	3.2	1.9	1.6	2.9	3.6	0.7	2.9	4.5	3.5	3.3	1.2	24.7	25.4	27.7	36.8	27.4	24.0	25.2	23.9	21.3	21.5	25.9	25.3	11.8	19.2	7.4	207.3	18.0	13.4	11.7	7.9	22.2	12.6	13.7	9.5	28.4	10.0	12.2	5.5	16.7	25.6	18.9	11.9	7.9	7.8	13.7	17.5	9.7	10.3	6.0	5.0	114.3	7.1	28.3	11.5	16.3	23.3	15.9	14.4	15.7	43.8	13.3	13.5	138.1	12.8	6.1	24.0	10.3	7.7	7.2	17.2	5.4	47.8	10.5	36.8	15.5	99.5	71.2	8.9	14.7	8.6	23.9	11.2	13.5	8.6	16.5	14.4	19.7	16.8	10.9	41.7	33.8	26.4	14.9	28.6	18.7	7.6	15.2	18.1
RESF1	"C12orf35, FLJ10652, FLJ20696, GET, KIAA1551, UTA2-1"	ENSG00000174718	"Retroelement silencing factor 1"	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 73.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 35.8;B-cells: 43.7;dendritic cells: 88.1;Hofbauer cells: 34.1;Plasma cells: 66.6;T-cells: 21.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 212.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 212.8"	"Cell line enhanced"	"Detected in all"		"SuSa: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Nucleoli rim"	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	14.3	7.1	2.5	50.7	3.1	21.8	13.9	7.5	10.9	28.9	2.2	14.0	23.8	23.2	9.1	10.6	38.1	19.3	8.1	1.8	3.3	9.1	24.9	17.1	70.2	4.1	2.8	73.9	6.7	9.8	4.0	37.9	5.0	9.2	13.8	7.0	8.2	11.2	4.1	9.1	27.3	16.0	2.0	45.3	20.5	13.2	3.6	60.7	12.6	11.9	62.5	17.7	8.6	5.1	7.6	13.3	22.5	8.6	10.1	12.0	33.6	9.1	9.0	6.0	6.9	50.6	48.9	36.4	21.9	7.6	21.5	9.6	31.3	6.0	8.4	27.1	4.4	51.1	6.7	6.7	19.7	37.0	79.2	6.5	9.0	7.1	11.6	25.4	50.3	24.0	29.5	56.1	6.8	3.7	52.6	15.6	48.3	28.4	5.5	24.1	21.4	16.0	6.3	14.0	9.0	8.1	11.7	6.0	6.0	112.9	20.8	40.5	32.0	6.7	10.4	11.5	9.6	33.9	38.1	44.8	3.6	20.6	7.4	55.5	14.7	15.4	42.2	16.1	40.3	33.6	38.0	40.7	12.3	26.8	44.1	43.8	212.8	30.6	18.1	7.7	38.9	20.4	2.5	3.1	7.5	10.9	1.8	3.3	4.1	2.8	5.0	2.0	3.6	5.1	35.8	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	15.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	2.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	5.1	21.5	0.0	0.0	0.0
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 53.3;spinal cord: 19.4"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	20.8	1.0	1.3	0.9	0.4	1.1	5.1	5.6	1.0	0.2	3.4	1.4	0.6	0.3	0.4	0.5	0.6	2.2	0.3	5.5	0.9	3.0	0.4	0.6	14.4	27.3	0.4	1.3	31.8	5.3	0.5	12.0	1.8	1.4	4.7	5.1	2.0	5.9	0.9	1.4	1.0	4.8	0.2	2.2	2.7	7.6	1.6	0.8	3.1	0.2	0.6	1.4	5.8	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	42.2	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	329.3	0.1	0.0	0.1	0.5	4.1	95.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	1.0	0.9	5.1	5.6	0.3	5.5	14.4	27.3	12.0	4.8	7.6	5.8	0.4	0.0	0.5	1.6	0.0	0.3	0.8	0.0	0.0	1.7	6.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	1.5	0.0	0.3	1.1	0.0	0.0	4.2	0.2	2.3	6.8	0.0	0.0	1.3	0.5	0.0	1.2	0.1	79.1	8.6	1.9	26.4	0.0	0.6	1.5	0.3	0.5	0.0	1.0	0.0	0.8	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8	1.7	0.0	23.1	1.2	1.1	4.7	0.0	0.6	0.0	0.2	0.3	0.2	0.1
RETREG2	"C2orf17, FAM134A, MAG-2, MGC3035"	ENSG00000144567	"Reticulophagy regulator family member 2"	Q8NC44	2	219176225-219185475	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 42.1;Collecting duct cells: 46.0;Ductal cells: 43.8;Exocrine glandular cells: 48.3;Pancreatic endocrine cells: 40.4;Proximal tubular cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011170, HPA011844, HPA075910"	Approved		Approved	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA011170: AB_1845713, HPA011844: AB_2668544, HPA075910: "	"unprognostic (2.63e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (7.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (8.74e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.45e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.70e-2)"	34.4	47.6	73.6	26.5	74.1	47.4	34.1	73.2	90.1	42.7	66.1	41.3	31.7	35.1	45.9	38.5	38.4	32.1	24.6	74.9	76.6	51.8	57.2	29.7	34.3	77.4	77.3	51.9	52.4	76.6	43.7	28.3	77.2	36.9	38.5	50.6	39.8	29.7	24.9	45.0	36.7	33.9	76.5	38.2	42.9	104.0	78.8	34.3	44.6	27.7	34.6	37.7	35.9	78.0	34.6	36.2	30.5	46.5	113.2	47.7	32.5	41.4	71.3	49.4	42.7	36.3	58.1	28.1	40.4	78.5	101.4	43.3	37.1	37.1	54.1	39.5	31.0	37.5	51.2	61.1	64.7	41.1	49.6	52.0	95.5	55.5	53.3	84.7	45.2	29.9	26.3	62.8	69.3	50.9	24.8	44.4	22.6	44.0	41.5	31.4	33.8	22.7	41.1	40.3	43.6	44.9	26.7	50.8	98.4	47.4	42.4	44.9	36.0	55.0	29.4	78.6	31.5	63.4	39.3	31.5	57.5	40.3	31.0	12.5	6.3	6.3	9.3	8.3	8.3	8.3	7.4	9.5	4.3	5.7	6.6	8.8	23.5	5.2	8.1	6.6	9.6	3.6	73.6	74.1	73.2	90.1	74.9	76.6	77.4	77.3	77.2	76.5	78.8	78.0	22.4	16.0	13.7	0.0	7.9	0.0	0.0	0.0	0.0	0.0	42.1	32.0	0.0	0.0	6.2	46.0	0.0	31.1	21.1	0.0	21.5	43.8	0.0	21.4	19.3	8.6	0.0	0.0	0.0	48.3	37.2	11.9	0.0	30.5	5.1	29.2	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	11.4	0.0	0.0	0.0	0.0	40.4	0.0	0.0	5.7	0.0	0.0	42.3	2.2	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	30.1	8.2	24.2	0.0	0.0
RETREG3	"DKFZp686B1036, FAM134C, FLJ33806"	ENSG00000141699	"Reticulophagy regulator family member 3"	Q86VR2	17	42579513-42610623	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 29.8;Collecting duct cells: 31.3;Pancreatic endocrine cells: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016492	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA016492: AB_1853027"	"unprognostic (6.79e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (5.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.43e-2)"	16.2	21.7	17.3	13.2	16.6	6.9	16.9	16.4	18.9	23.0	18.7	19.0	14.2	18.5	21.3	29.2	16.8	10.9	16.2	17.0	17.4	19.5	33.4	17.4	19.5	16.9	18.0	19.6	39.9	18.9	20.4	20.9	17.7	25.5	16.8	31.4	23.2	14.0	22.4	33.9	20.7	15.1	16.8	30.1	22.8	38.7	19.1	20.6	16.3	16.4	21.6	19.4	23.1	15.0	12.0	36.6	15.8	25.8	39.6	21.9	22.5	16.9	22.7	19.6	22.9	17.5	25.3	26.3	23.1	27.5	20.1	45.9	20.5	25.3	18.9	28.2	19.3	10.7	22.2	31.0	27.2	18.6	26.5	33.6	34.2	21.5	21.8	21.7	21.3	19.0	22.3	25.4	15.7	20.7	27.5	26.9	10.0	22.5	9.0	14.7	24.2	27.2	22.5	38.2	28.2	19.3	18.1	14.6	26.1	28.9	41.5	14.2	27.2	21.0	12.8	21.1	16.2	43.4	55.3	22.7	19.3	11.6	16.2	54.9	16.2	36.4	44.5	19.2	39.1	23.7	36.5	42.9	15.1	24.8	35.1	40.4	13.8	28.2	24.1	15.0	57.0	36.4	17.3	16.6	16.4	18.9	17.0	17.4	16.9	18.0	17.7	16.8	19.1	15.0	16.7	25.6	29.8	0.0	8.8	0.0	0.0	0.0	0.0	0.0	21.7	18.3	0.0	0.0	6.2	31.3	0.0	22.4	24.7	0.0	7.9	16.4	0.0	14.5	16.7	7.4	0.0	0.0	0.0	25.4	16.0	7.4	0.0	20.0	7.6	26.8	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.8	0.0	0.0	8.8	0.0	0.0	13.4	5.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	20.4	8.1	17.3	0.0	0.0
REV1	REV1L	ENSG00000135945	"REV1 DNA directed polymerase"	Q9UBZ9	2	99400475-99490035	"Predicted intracellular proteins"	"DNA damage, DNA repair, DNA synthesis"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044534, HPA051036"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA044534: AB_2678975, HPA051036: AB_2681319"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.56e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-3)"	9.8	11.6	7.0	6.1	7.6	7.0	11.2	13.1	9.6	11.9	9.4	9.3	6.1	14.2	17.3	10.5	11.4	7.9	12.4	7.2	8.7	9.0	10.0	11.2	10.0	7.0	7.4	12.1	6.9	8.8	10.4	7.3	6.8	11.2	9.2	12.2	9.4	12.0	15.7	10.3	9.0	10.1	6.9	9.4	8.2	9.6	8.5	9.7	10.3	23.7	10.0	10.5	11.5	8.5	7.9	2.0	12.4	4.7	9.5	9.3	13.0	8.6	10.8	9.9	11.3	4.6	7.5	15.9	6.7	9.2	10.4	10.9	9.3	11.5	15.3	7.0	5.8	8.1	7.7	10.5	10.6	10.6	16.5	9.1	13.7	8.9	13.0	11.1	12.9	8.1	9.4	5.3	11.1	5.2	11.2	19.0	8.9	5.1	5.2	17.4	8.8	7.0	12.3	13.4	8.0	8.5	7.6	6.4	11.2	13.3	6.6	15.2	9.1	11.7	9.7	4.9	5.7	7.2	7.8	12.8	4.8	13.4	9.2	0.0	0.2	0.0	0.3	0.2	0.2	0.1	0.5	0.4	0.3	0.4	0.9	0.7	0.1	0.3	0.1	0.1	0.3	0.1	7.0	7.6	13.1	9.6	7.2	8.7	7.0	7.4	6.8	6.9	8.5	8.5	45.3	70.5	61.9	59.4	27.7	48.3	57.5	37.8	58.6	84.2	21.7	20.4	52.5	20.0	38.6	22.0	39.6	32.9	17.5	24.1	5.9	18.4	29.2	41.6	32.8	31.6	17.5	35.7	71.3	18.1	20.0	33.8	31.6	30.0	25.3	32.4	23.6	18.0	19.1	82.4	78.2	16.3	26.4	17.6	28.3	21.6	27.1	20.6	19.6	53.4	27.3	36.7	14.4	60.3	77.0	16.4	25.6	46.3	23.3	51.0	30.0	12.5	33.7	57.2	26.3	51.2	28.8	52.1	53.8	36.3	35.5	35.2	26.8	39.7	19.3	63.5
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.3;Endothelial cells: 51.1;Hofbauer cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 201.5"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 201.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 95.5;HMC-1: 222.1;NB-4: 74.8;U-937: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	19.8	5.9	2.4	7.4	2.5	77.9	15.6	2.3	2.8	8.7	10.1	13.7	3.2	10.1	3.5	3.1	7.1	4.6	12.8	3.3	2.2	8.6	3.5	13.3	5.4	2.5	2.4	5.7	3.5	3.9	4.3	10.4	2.2	9.5	1.9	1.5	4.1	2.8	7.9	6.3	9.6	6.1	2.7	10.5	8.6	3.7	2.4	16.7	8.2	3.9	4.8	11.8	5.4	2.1	30.5	8.0	4.0	18.9	13.0	9.4	20.8	48.8	21.4	15.8	7.7	0.5	1.1	0.0	1.2	95.5	7.0	3.0	11.2	1.1	14.5	0.2	6.5	1.3	1.5	2.2	19.0	11.4	222.1	5.2	0.3	5.0	1.9	6.1	16.0	4.8	4.7	0.3	18.1	0.4	0.6	74.8	8.6	0.8	0.3	3.2	8.6	0.0	2.9	0.1	0.3	43.6	19.8	0.0	17.6	14.9	0.4	34.7	3.2	12.4	11.0	7.5	0.1	7.1	7.7	0.0	0.2	64.1	19.5	201.5	6.9	80.7	6.1	5.4	6.2	0.1	6.1	5.2	2.1	0.1	9.7	8.7	35.5	2.2	7.3	9.1	4.3	3.8	2.4	2.5	2.3	2.8	3.3	2.2	2.5	2.4	2.2	2.7	2.4	2.1	101.3	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.1	7.4	0.0	0.0	1.8	1.8	0.0	0.8	16.5	0.0	0.0	1.1	0.0	2.3	1.9	51.1	0.0	0.0	0.0	0.9	1.2	9.2	0.0	6.0	1.3	12.5	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.9	0.0	0.0	0.5	1.5	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.5	10.7	4.2	0.0	0.0
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.4;liver: 3.4;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.1;Langerhans cells: 1.4"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 9.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.1;monocytes: 9.7"	"Cell line enriched"	"Detected in some"	20	"U-2 OS: 68.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA046368: AB_2679640"							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	3.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	68.4	0.0	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.0	9.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	1.4	0.0	0.7	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769118-55773420	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.3;monocytes: 3.5"	"Cell line enriched"	"Detected in some"	19	"U-2 OS: 40.2"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"		"Cluster 9: U-2 OS - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Centrosome, Cytosol"		"HPA046368: AB_2679640"															"unprognostic (8.87e-2)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFX2	FLJ14226	ENSG00000087903	"Regulatory factor X2"	P48378	19	5993164-6199572	"Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 56.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.2;Early spermatids: 163.7;Late spermatids: 196.2;Respiratory ciliated cells: 103.8;Spermatocytes: 113.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"neutrophil: 23.6"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 19.4;SCLC-21H: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048969	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA048969: AB_2680577"	"unprognostic (1.31e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.07e-1)"	9.8	2.0	9.0	2.2	8.0	9.5	6.9	12.1	8.1	5.9	35.2	19.4	3.3	16.2	1.2	8.0	20.8	5.0	7.8	10.4	8.7	2.2	1.7	10.5	1.5	15.5	21.2	6.7	4.4	1.8	10.4	0.9	12.7	6.0	1.8	1.3	3.2	2.3	2.0	11.2	8.8	5.3	15.4	2.9	7.0	56.9	12.7	4.2	3.5	0.6	1.6	9.6	6.3	11.7	5.3	3.9	6.2	12.3	3.2	1.9	3.9	3.3	4.3	2.6	4.1	1.8	6.0	5.7	3.4	4.1	5.7	7.6	1.6	6.2	3.6	1.4	0.9	8.8	4.0	1.8	3.6	4.1	19.4	2.2	5.3	5.8	3.0	3.1	4.0	7.7	6.0	0.2	2.6	2.6	7.7	5.5	1.7	6.8	2.6	2.1	3.9	0.6	3.3	9.5	24.2	3.4	3.0	2.4	1.7	0.6	4.2	4.3	6.1	1.1	5.6	4.3	3.3	8.2	2.9	3.3	3.2	14.4	2.3	0.0	2.7	1.1	0.1	0.5	0.0	0.4	0.5	0.3	2.1	0.2	0.5	0.6	23.6	0.7	1.6	0.0	0.1	0.8	9.0	8.0	12.1	8.1	10.4	8.7	15.5	21.2	12.7	15.4	12.7	11.7	12.0	25.6	31.6	84.2	2.6	26.4	33.7	11.5	12.5	3.6	8.5	10.9	7.6	15.7	26.0	3.7	2.1	5.9	2.0	4.1	3.9	5.6	163.7	69.0	9.5	13.2	13.8	6.5	5.2	1.8	8.8	23.0	2.6	4.7	46.2	14.7	12.1	2.8	7.0	0.0	5.5	4.4	2.0	6.2	17.3	196.2	8.1	13.0	7.2	8.4	5.1	5.7	5.2	3.0	1.8	3.5	1.6	4.1	2.4	7.9	4.6	2.1	103.8	3.5	26.3	49.2	11.4	113.2	13.5	6.3	22.0	5.6	5.6	2.6	5.1	22.0
RGMA	RGM	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3;skeletal muscle: 199.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		2000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	30.2	3.2	62.1	22.5	73.8	0.4	30.3	72.5	59.1	55.9	7.7	79.4	9.9	50.9	2.9	57.4	39.9	7.7	29.4	60.4	68.0	3.6	0.6	4.6	2.4	126.3	113.9	38.5	11.4	0.8	6.9	1.3	70.4	12.8	6.2	1.0	24.2	6.4	199.1	17.1	42.9	60.6	91.5	1.3	73.6	33.5	120.6	2.6	10.0	45.0	3.4	10.0	29.2	62.8	2.1	0.3	50.0	0.8	10.3	5.7	14.6	0.3	0.0	0.0	0.0	0.6	0.6	0.1	0.2	0.4	0.0	3.4	8.4	0.2	0.0	0.0	9.2	0.1	0.3	0.0	0.0	0.1	0.2	6.1	0.2	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.0	1.0	15.5	0.2	22.2	0.1	0.0	13.1	11.4	0.1	0.0	0.5	5.1	3.0	0.5	0.2	0.0	2.6	4.0	2.7	0.0	0.1	10.4	0.3	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	62.1	73.8	72.5	59.1	60.4	68.0	126.3	113.9	70.4	91.5	120.6	62.8	4.2	0.0	1.5	143.3	0.5	5.5	20.4	10.2	40.5	1.9	7.5	4.4	4.4	0.0	3.9	0.0	2.1	4.4	0.5	0.3	0.0	6.5	1.2	0.6	10.9	2.7	0.0	0.4	16.8	0.7	1.2	40.5	1.5	2.3	0.0	0.6	1.8	0.3	2.1	0.0	2.8	0.0	12.2	2.5	2.3	6.4	119.0	1.6	3.6	9.4	0.6	4.5	0.0	11.1	1.6	0.4	0.0	116.9	0.1	61.3	0.0	0.1	1.3	1.2	13.1	69.3	20.3	0.9	43.8	58.3	2.8	2.5	1.4	0.1	0.1	29.2
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 184.7;liver: 383.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Granulosa cells: 67.8;Hepatocytes: 175.7;Muller glia cells: 54.5;Peritubular cells: 69.6;Proximal tubular cells: 174.4"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 21.7;fHDF/TERT166: 6.9;Hep G2: 32.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103, HPA029104"	Enhanced		Approved	Cytosol		NA	NA		280000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: "	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	7.8	184.7	19.2	0.7	20.8	0.0	3.4	23.0	19.9	12.2	25.9	8.4	13.2	7.2	4.5	3.2	5.4	5.0	13.9	19.0	20.2	56.7	383.7	18.9	1.0	21.6	19.8	21.4	34.0	5.8	8.8	12.1	20.7	13.4	2.1	8.0	14.4	17.3	11.8	1.5	13.6	4.4	21.3	3.7	11.9	3.5	19.3	0.5	18.9	11.3	0.5	7.6	6.0	21.2	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.4	0.8	0.0	0.0	21.7	0.0	0.0	1.1	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	32.8	1.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	20.8	23.0	19.9	19.0	20.2	21.6	19.8	20.7	21.3	19.3	21.2	0.6	6.4	3.6	16.3	0.6	0.5	4.9	0.2	1.8	9.6	2.4	7.0	27.5	8.6	0.7	14.7	0.0	0.1	0.0	0.2	58.7	13.9	0.4	3.4	7.4	2.4	4.8	2.7	10.8	8.9	0.3	11.2	3.1	0.5	0.0	67.8	11.4	175.7	0.1	5.0	4.9	0.2	0.0	5.3	1.2	2.1	24.8	1.2	1.8	4.7	0.0	54.5	0.0	27.2	13.7	5.0	1.2	69.6	0.7	1.1	0.2	174.4	1.7	3.1	13.1	22.3	11.3	0.2	0.2	0.5	0.3	0.3	0.7	14.5	0.7	1.3
RGR	RP44	ENSG00000148604	"Retinal G protein coupled receptor"	P47804	10	84230666-84259960	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 139.0"	"Cell type enriched"	"Detected in some"	29	"Muller glia cells: 1475.8"	"Cancer enriched"	"Detected in single"	4	"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"midbrain: 23.4;olfactory bulb: 49.7;thalamus: 27.3"	HPA059149			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Plasma membrane, Cytosol"	"HPA059149: "	"unprognostic (9.28e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.53e-2)"				"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"				"unprognostic (1.59e-1)"	"unprognostic (1.97e-1)"			0.2	0.0	11.9	0.0	11.9	0.0	0.1	4.4	14.6	0.0	14.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.5	7.4	8.5	0.0	0.0	0.2	0.0	5.2	8.2	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	139.0	0.1	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.9	4.4	14.6	7.4	8.5	5.2	8.2	5.4	3.1	10.1	6.2	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	20.6	0.1	0.1	0.4	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	10.6	0.3	0.0	0.0	0.0	0.0	1475.8	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	2.8	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 142.0;Inhibitory neurons: 170.1;Suprabasal keratinocytes: 110.0;Urothelial cells: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: AB_2682555, HPA067421: AB_2685836"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	8.4	6.5	13.6	2.9	46.6	2.3	8.7	10.2	20.5	16.1	10.5	8.3	4.8	8.6	4.7	30.4	9.9	3.9	6.7	12.9	8.5	11.1	17.3	10.6	3.5	9.5	8.5	12.5	4.9	3.3	13.8	3.7	8.2	16.6	1.9	3.8	9.4	4.7	12.3	20.7	6.2	2.6	7.8	6.0	6.7	10.3	8.7	3.6	8.0	4.6	3.3	10.4	20.2	10.5	4.8	6.0	11.9	8.6	3.9	3.1	4.9	5.1	4.1	5.2	3.8	4.9	2.8	1.1	3.1	4.5	7.6	4.6	2.3	16.3	1.7	0.1	1.9	0.5	3.6	12.0	3.5	0.3	6.5	2.6	10.9	2.7	3.6	4.6	11.5	4.2	5.6	0.2	4.8	4.1	0.8	13.1	5.6	2.7	5.7	12.3	4.6	4.0	2.7	14.1	13.3	13.8	3.2	2.2	11.4	2.9	5.4	8.2	8.7	10.0	6.5	2.0	5.5	5.9	4.9	2.7	5.9	7.2	7.3	0.4	0.3	0.0	0.2	1.1	0.0	0.0	0.2	0.1	0.4	0.2	0.3	0.1	0.4	0.0	1.1	0.2	0.2	0.2	13.6	46.6	10.2	20.5	12.9	8.5	9.5	8.5	8.2	7.8	8.7	10.5	16.1	6.4	6.4	66.9	2.6	84.4	142.0	69.3	71.2	17.3	11.0	14.9	8.6	8.6	28.6	5.5	29.2	6.2	1.3	6.4	3.9	10.4	5.0	22.8	13.3	26.6	14.9	4.8	44.3	10.4	1.3	14.6	7.7	11.8	14.0	57.7	27.8	28.8	20.8	10.1	170.1	10.8	8.2	12.4	11.3	5.5	14.9	21.7	17.8	47.8	7.8	29.3	2.1	71.4	25.5	14.7	2.7	7.9	0.8	53.9	6.0	23.9	34.6	18.9	0.0	12.5	12.7	24.0	15.3	84.4	110.0	6.7	4.3	11.8	9.0	153.8
RGS16	"A28-RGS14, RGS-r"	ENSG00000143333	"Regulator of G protein signaling 16"	O15492	1	182598623-182604389	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 132.2;thyroid gland: 103.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 535.4;Muller glia cells: 265.9;Smooth muscle cells: 581.5;Theca cells: 253.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 132.2"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 109.3;NB-4: 60.7;SCLC-21H: 109.6;U-266/70: 124.0;U-698: 162.8"	"Region enriched"	"Detected in all"	5	"thalamus: 79.9"	"Group enriched"	"Detected in many"	7	"midbrain: 76.5;pons: 68.5;thalamus: 124.2"	"HPA053250, HPA055824"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA053250: AB_2682090, HPA055824: AB_2682934"	"unprognostic (4.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.07e-3)"	"unprognostic (5.39e-2)"	39.6	10.4	22.7	11.7	10.0	4.8	7.8	9.6	9.9	2.7	16.5	13.1	2.8	3.3	4.8	6.2	12.1	16.5	9.2	7.5	47.0	15.4	13.1	26.7	17.9	17.5	71.3	4.0	7.8	5.7	50.4	12.1	13.2	4.8	5.3	60.4	6.4	6.3	6.0	5.6	6.8	12.0	12.1	14.3	8.8	1.0	132.2	8.6	103.6	8.9	6.6	38.3	2.9	17.8	0.8	0.1	6.4	0.0	1.0	0.2	48.6	0.2	1.7	0.0	0.1	0.1	0.3	109.3	0.5	0.0	0.0	0.5	11.9	1.0	0.1	12.5	8.8	11.5	1.2	0.0	1.8	18.4	9.5	2.5	17.8	0.0	0.7	0.0	0.0	3.9	0.5	18.6	0.0	12.3	0.6	60.7	34.2	1.0	3.5	0.2	35.1	26.2	0.1	5.1	109.6	11.5	0.2	9.1	0.2	6.4	3.6	14.6	0.1	0.3	2.4	3.1	5.5	124.0	6.1	162.8	0.6	11.8	5.8	2.6	0.3	0.6	0.3	0.4	0.6	4.7	4.3	0.5	0.5	2.2	1.9	0.6	1.2	2.6	0.9	9.7	2.9	1.1	22.7	10.0	9.6	9.9	7.5	47.0	17.5	71.3	13.2	12.1	132.2	17.8	80.8	134.6	185.5	6.2	48.3	82.3	10.0	3.8	37.5	535.4	25.8	94.5	25.7	0.0	18.7	9.2	18.8	8.5	28.7	11.2	0.0	1.6	0.4	21.4	41.5	181.8	50.5	20.4	0.1	2.4	201.9	103.7	17.3	30.5	71.8	0.5	18.9	2.6	19.1	32.0	8.3	12.1	16.2	2.8	116.7	0.0	0.3	18.4	81.8	0.0	11.9	265.9	0.0	0.0	0.7	2.9	4.7	0.4	64.3	12.4	1.1	0.8	2.6	46.9	65.7	47.3	581.5	0.2	2.1	37.0	63.1	34.5	33.5	253.5	6.4	9.7
RGS4	SCZD9	ENSG00000117152	"Regulator of G protein signaling 4"	P49798	1	163068775-163076802	"Disease related genes, Predicted intracellular proteins"		"Signal transduction inhibitor"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 34.6;brain: 120.6"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 51.6;Excitatory neurons: 115.4;Inhibitory neurons: 59.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 120.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"hTERT-RPE1: 527.4;LHCN-M2: 244.2;SH-SY5Y: 429.5;TIME: 959.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030802			Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA030802: AB_10602295"	"unprognostic (1.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.02e-2)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.97e-4)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.30e-2)"	8.2	34.6	35.6	3.0	46.7	0.0	1.7	0.0	120.6	5.9	0.0	4.3	4.2	7.8	1.2	9.7	7.3	18.3	8.7	49.3	42.2	1.9	4.0	3.0	3.7	0.0	5.2	2.2	4.7	2.3	14.3	1.6	2.0	4.7	2.5	6.7	0.8	6.5	0.4	0.3	2.8	4.7	0.0	1.7	8.4	3.0	0.0	1.8	3.1	1.4	0.4	5.9	1.4	39.7	0.3	0.0	1.2	7.2	25.1	115.9	0.2	77.8	92.1	12.6	31.9	0.0	0.3	0.3	35.6	50.2	0.5	0.2	0.0	0.1	42.2	0.4	0.1	0.3	0.0	0.0	11.0	0.2	0.2	19.0	0.0	123.0	14.3	527.4	127.5	0.0	0.1	0.6	244.2	0.0	0.0	0.5	6.5	0.0	9.6	0.1	0.0	0.4	0.0	0.0	2.9	429.5	0.0	0.1	0.2	4.0	0.1	0.1	959.6	91.5	5.2	19.1	129.5	0.1	0.1	0.3	11.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	46.7	0.0	120.6	49.3	42.2	0.0	5.2	2.0	0.0	0.0	39.7	0.8	0.0	0.0	15.7	0.0	0.3	1.7	0.1	0.0	4.3	0.7	0.0	0.7	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.3	12.6	0.5	16.9	2.6	51.6	0.0	115.4	0.2	0.1	20.2	0.0	0.4	0.0	1.1	1.1	0.0	0.4	0.0	59.9	0.0	0.0	0.0	0.5	3.8	0.0	0.1	0.0	13.1	0.0	15.7	0.0	13.0	13.0	2.7	0.1	0.0	0.0	0.5	0.0	0.0	0.7	1.6	0.0	0.2	17.0	0.1	0.6	0.5	0.3	0.1	0.6	0.1	0.1	0.3
RGS7BP	R7BP	ENSG00000186479	"Regulator of G protein signaling 7 binding protein"	Q6MZT1	5	64506015-64612319	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 122.5;Inhibitory neurons: 170.6;Oligodendrocyte precursor cells: 67.8"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 26.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HUVEC TERT2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039600	Approved		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039600: AB_2676591"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.81e-3)"	"unprognostic (1.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.50e-3)"	1.9	3.2	3.2	0.5	12.2	0.0	0.5	1.0	26.0	4.0	0.0	0.6	0.9	2.3	3.7	1.7	7.8	1.7	2.6	7.2	1.2	2.0	1.0	1.4	0.3	0.2	3.3	2.4	0.2	0.1	0.8	0.0	0.0	5.3	0.7	4.8	1.8	7.4	0.1	0.3	1.0	1.4	0.0	0.7	0.8	0.8	10.2	0.0	0.3	1.0	0.1	0.9	0.5	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	12.2	1.0	26.0	7.2	1.2	0.2	3.3	0.0	0.0	10.2	5.0	0.4	0.0	0.0	5.5	0.1	0.0	0.1	0.1	0.6	6.5	0.7	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.1	5.1	4.6	0.0	2.7	122.5	0.0	0.0	0.8	0.0	4.7	0.0	0.1	23.2	0.1	0.0	0.0	170.6	0.0	0.0	0.3	0.0	1.9	7.2	0.1	0.0	12.2	0.0	3.6	0.0	67.8	6.4	0.0	0.0	13.9	0.0	0.1	0.0	0.2	2.2	2.1	6.6	0.1	13.2	0.3	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.2
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Horizontal cells: 334.8;Oligodendrocytes: 155.5;Syncytiotrophoblasts: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.8	13.9	5.6	4.1	6.6	0.9	7.1	5.2	7.8	15.7	5.3	8.1	6.6	14.5	2.4	3.0	10.9	11.5	13.5	4.6	4.7	30.8	6.8	10.6	2.8	6.1	6.1	10.2	9.2	8.6	3.2	37.1	6.3	7.7	4.8	24.3	2.1	9.9	144.2	3.6	5.6	12.1	4.9	14.9	20.8	15.1	7.6	1.9	3.3	19.6	1.2	7.4	7.5	7.8	0.2	12.0	17.8	0.0	8.3	7.3	0.0	5.3	4.8	4.3	6.4	0.6	0.2	0.0	21.9	28.0	2.0	0.3	5.3	1.6	5.0	0.0	4.8	1.1	8.8	67.3	9.0	1.4	0.4	10.6	3.0	2.6	2.7	16.5	20.6	3.8	10.2	0.0	19.1	0.4	5.2	0.0	7.7	0.2	7.9	4.5	24.9	6.4	14.1	0.7	4.9	19.0	6.3	6.9	6.9	11.1	1.4	2.4	18.5	8.2	21.1	0.2	5.9	0.0	0.0	0.0	4.1	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	5.6	6.6	5.2	7.8	4.6	4.7	6.1	6.1	6.3	4.9	7.6	7.8	13.7	16.0	8.7	3.6	1.0	1.8	1.0	0.5	0.6	3.4	3.7	2.5	29.5	1.5	2.3	1.8	135.5	66.1	0.2	0.7	1.9	3.8	75.2	11.0	14.7	13.6	8.3	3.8	74.3	16.0	3.4	8.6	34.1	4.5	0.0	59.0	17.9	9.6	11.3	334.8	23.1	7.7	4.1	21.5	1.4	35.3	8.1	14.1	1.8	57.1	0.4	16.0	0.0	14.1	155.5	16.4	2.5	4.9	0.1	1.2	1.5	36.4	10.2	25.1	6.6	16.7	11.8	2.8	1.4	0.6	1.4	302.4	0.8	15.2	4.3	0.4
RHOQ	"ARHQ, RASL7A, TC10"	ENSG00000119729	"Ras homolog family member Q"	P17081	2	46541806-46584688	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 189.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 1.5;classical monocyte: 2.5;eosinophil: 4.2;intermediate monocyte: 2.7;memory B-cell: 1.7;myeloid DC: 1.6;naive B-cell: 2.4;neutrophil: 4.8;non-classical monocyte: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 164.0;ASC TERT1: 132.0;SK-MEL-30: 150.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044938			Approved	Vesicles,Cytosol		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"		"HPA044938: AB_2679149"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (2.01e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.52e-2)"	96.9	35.7	34.8	30.1	40.1	12.4	64.8	38.9	41.4	59.6	43.9	67.0	11.0	53.2	67.7	18.9	59.3	26.7	196.8	34.3	44.7	44.3	22.6	56.0	23.8	40.9	44.2	40.8	28.6	50.4	29.5	28.6	38.9	50.6	13.5	27.7	32.7	36.5	162.4	28.1	35.3	38.4	39.2	42.7	32.8	10.1	36.8	9.9	39.1	181.3	19.1	62.8	44.7	43.5	12.3	12.4	21.0	28.6	164.0	132.0	3.7	32.8	84.1	16.2	24.4	6.2	4.1	28.7	34.0	58.5	52.4	5.8	20.6	9.8	29.3	10.2	15.3	8.2	9.8	20.9	81.8	8.8	10.7	118.1	17.3	20.1	22.5	39.0	19.3	3.1	12.1	44.0	35.2	8.1	6.9	17.9	20.8	8.9	14.4	5.3	34.5	10.1	23.1	22.4	15.3	50.3	11.6	16.4	150.8	32.9	9.0	20.7	13.2	50.1	44.8	49.3	14.1	48.5	17.7	28.4	73.6	22.1	18.4	1.5	2.5	4.2	0.4	2.7	0.3	1.7	0.2	0.4	1.6	2.4	0.0	0.3	4.8	0.3	1.9	0.6	0.3	0.7	34.8	40.1	38.9	41.4	34.3	44.7	40.9	44.2	38.9	39.2	36.8	43.5	27.9	57.7	22.4	65.3	38.1	22.4	31.0	18.1	11.4	21.1	30.4	22.4	189.2	14.3	22.1	20.2	10.4	14.6	32.2	1.0	17.6	21.4	30.8	22.1	90.2	23.4	6.0	2.1	12.8	32.0	3.6	82.8	4.1	24.6	12.0	12.1	17.5	12.2	44.5	121.1	27.7	5.5	8.2	90.9	77.8	11.4	35.4	90.7	42.7	68.4	55.1	52.9	15.5	52.3	41.5	22.4	0.3	42.5	42.0	41.2	0.2	30.1	18.8	24.2	46.0	54.2	82.3	2.3	4.5	6.8	19.7	25.9	17.0	10.9	1.9	31.9
RIC8A	"synembryn, synembryn-A"	ENSG00000177963	"RIC8 guanine nucleotide exchange factor A"	Q9NPQ8	11	207511-215113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041491, CAB046012"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		10000	"Cluster 44: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"CAB046012: AB_11129402, HPA041491: AB_2677510"	"unprognostic (3.93e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.13e-3)"	"unprognostic (8.70e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.63e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.60e-1)"	39.2	39.6	43.0	34.8	43.6	40.6	37.4	42.1	48.5	41.2	46.6	46.3	29.5	44.2	41.8	43.1	41.1	30.6	42.9	45.4	43.7	36.5	37.8	37.6	37.6	43.5	44.4	39.7	39.3	34.2	38.1	34.1	44.2	39.0	30.8	24.8	34.4	40.3	32.8	39.5	38.1	49.4	43.4	41.6	38.1	44.0	44.0	41.6	33.7	28.3	41.8	45.9	36.6	45.0	176.3	83.9	66.8	66.7	89.7	73.4	46.3	124.1	99.2	166.0	114.2	72.6	121.1	69.6	50.5	189.0	125.7	93.4	76.4	131.4	92.0	84.5	76.7	39.4	59.5	67.8	72.3	66.5	125.8	80.6	114.3	103.2	92.6	85.2	82.8	72.8	68.7	66.0	129.3	71.1	79.6	52.6	61.1	74.0	103.0	74.0	66.0	47.5	96.9	45.6	69.2	62.2	96.3	107.1	67.1	63.9	76.1	52.8	93.4	109.2	96.5	40.4	117.3	72.6	117.6	67.8	107.7	59.5	83.5	72.9	41.1	88.3	79.0	49.7	78.2	64.4	70.1	69.0	43.7	55.1	59.9	60.6	59.9	73.0	61.0	35.8	65.0	86.6	43.0	43.6	42.1	48.5	45.4	43.7	43.5	44.4	44.2	43.4	44.0	45.0	30.9	16.0	21.1	10.7	28.7	17.7	20.5	38.6	17.1	28.1	22.5	27.2	23.5	28.6	25.5	25.8	10.4	41.4	46.5	26.3	27.4	53.1	20.2	15.9	24.3	27.2	20.3	27.4	9.4	44.2	60.0	30.4	23.0	19.7	17.7	28.8	27.8	17.1	46.8	32.0	8.4	19.2	30.5	27.4	11.5	17.3	30.7	27.5	28.4	11.2	38.9	43.4	30.9	5.0	7.8	71.6	25.5	39.9	35.2	26.5	29.9	23.0	20.8	33.1	19.7	20.7	35.4	93.2	62.5	20.9	19.5	32.4	34.8	30.2	25.0	17.0
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 24.9;pituitary gland: 34.7;testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.9;Endometrial ciliated cells: 133.2;Enteroendocrine cells: 46.2;Late spermatids: 57.1;Respiratory ciliated cells: 73.9;Spermatocytes: 30.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;SCLC-21H: 1.6;SH-SY5Y: 2.7"	"Low region specificity"	"Detected in all"							HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.0	1.6	1.9	0.0	2.5	0.0	0.0	3.5	2.5	1.4	0.4	1.0	0.0	0.8	0.1	0.1	24.9	0.0	0.4	2.2	2.5	0.8	0.0	2.4	0.0	1.2	0.9	0.1	0.8	0.1	34.7	0.0	0.5	0.4	0.3	4.8	0.0	0.4	0.1	0.0	0.3	0.3	0.3	0.0	0.9	16.9	2.3	0.0	0.0	0.0	0.0	0.3	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.7	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	3.5	2.5	2.2	2.5	1.2	0.9	0.5	0.3	2.3	1.1	0.0	19.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	8.5	1.1	0.4	15.7	0.0	9.3	5.5	16.7	0.0	0.0	0.1	3.9	3.8	88.9	133.2	0.8	0.4	46.2	0.0	1.8	0.9	0.0	1.2	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.1	3.2	0.0	0.0	0.0	57.1	0.6	0.2	3.6	0.0	0.0	0.8	0.0	1.0	0.2	0.4	0.1	1.5	0.0	0.1	0.1	3.0	73.9	3.0	0.0	0.5	1.8	30.1	8.9	0.0	0.0	0.0	0.2	0.1	0.8	0.0
RILPL1	FLJ39378	ENSG00000188026	"Rab interacting lysosomal protein like 1"	Q5EBL4	12	123470054-123533719	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 62.4;skeletal muscle: 88.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Oligodendrocytes: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041314	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041314: AB_10795587"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.81e-1)"	7.8	9.0	17.1	3.1	21.1	2.6	7.5	18.6	18.3	10.7	17.9	10.5	1.3	12.0	4.1	5.1	9.5	3.4	62.4	15.2	16.7	6.8	4.2	6.8	1.8	19.0	19.7	8.5	3.7	6.6	6.4	7.3	18.6	9.1	1.4	3.0	6.8	7.4	88.9	6.8	4.2	6.3	15.9	4.4	5.5	4.1	18.0	1.5	13.3	41.1	1.0	9.5	7.5	27.1	8.3	11.4	10.1	7.9	11.1	10.4	10.6	14.6	8.1	7.8	6.9	7.1	1.9	0.3	7.1	14.3	5.6	8.9	7.5	7.0	3.1	8.4	13.8	1.1	8.1	10.6	19.4	0.4	3.0	11.9	13.6	8.7	12.5	19.5	8.0	1.5	6.6	0.4	8.0	13.8	0.9	2.7	7.4	2.4	11.9	1.3	5.5	0.4	5.6	8.5	1.6	9.3	7.8	6.7	17.9	5.5	9.0	0.2	16.0	10.2	5.1	14.8	9.4	1.7	0.9	0.2	10.4	0.0	6.5	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.5	0.4	1.1	0.3	0.3	0.3	0.2	0.2	17.1	21.1	18.6	18.3	15.2	16.7	19.0	19.7	18.6	15.9	18.0	27.1	13.0	38.5	11.7	32.3	0.7	4.6	5.1	3.4	6.2	14.1	4.6	14.7	9.8	4.3	7.2	11.0	6.2	9.1	0.7	0.2	1.9	2.2	1.8	6.3	18.0	8.5	0.0	0.0	28.8	2.2	6.2	9.4	1.1	7.4	1.3	18.9	9.7	1.6	5.7	23.5	16.4	1.3	0.0	1.3	2.4	1.6	15.5	3.3	5.4	18.7	0.9	21.4	0.0	13.6	64.9	2.2	0.5	8.2	0.3	5.1	0.1	2.6	4.1	6.4	6.6	14.4	9.9	0.9	2.9	2.3	3.8	9.3	2.0	21.5	0.7	3.3
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;parathyroid gland: 24.6;pituitary gland: 32.2"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 75.5;Excitatory neurons: 128.2;Inhibitory neurons: 191.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 28.9;SH-SY5Y: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041494: , HPA044114: AB_2678815"	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.6	14.5	6.3	0.9	11.3	0.2	0.2	0.0	17.5	7.2	17.3	1.5	2.9	2.7	2.5	0.5	7.8	0.9	0.0	25.9	19.2	5.9	0.2	0.4	0.1	1.7	19.6	2.1	2.5	24.6	32.2	0.0	20.6	1.1	1.8	11.2	0.3	1.3	0.2	2.7	2.5	2.4	0.1	1.0	5.9	2.6	0.9	0.3	0.6	3.9	0.1	0.3	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.0	0.4	7.3	0.0	0.0	28.9	55.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	11.3	0.0	17.5	25.9	19.2	1.7	19.6	20.6	0.1	0.9	2.7	0.4	0.0	0.0	5.9	0.0	2.0	0.1	0.0	0.6	19.4	0.0	0.1	1.4	0.0	0.0	0.0	31.3	0.0	0.0	0.4	0.0	0.0	3.8	3.0	1.4	0.4	75.5	0.0	128.2	0.0	0.0	0.7	4.1	6.4	0.0	0.0	0.0	0.0	0.0	10.1	191.4	2.6	6.1	0.0	0.5	2.1	0.9	0.0	0.0	1.0	0.0	3.2	0.0	19.6	5.3	0.1	0.1	0.7	0.0	0.1	0.0	0.1	0.7	14.0	0.0	0.0	0.2	1.7	1.5	0.1	0.6	0.0	0.1	0.0	0.8	0.0
RIMS2	"KIAA0751, OBOE, RAB3IP3, RIM2"	ENSG00000176406	"Regulating synaptic membrane exocytosis 2"	Q9UQ26	8	103500696-104256094	"Human disease related genes, Predicted intracellular proteins"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 50.6;brain: 48.2;retina: 102.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 383.6;Cone photoreceptor cells: 706.8;Excitatory neurons: 1589.3;Inhibitory neurons: 1234.9;Oligodendrocyte precursor cells: 577.0;Rod photoreceptor cells: 1088.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 9.2;RT4: 7.3;SCLC-21H: 16.5;SuSa: 8.8;U-2 OS: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046538, HPA066498, CAB079049"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"CAB079049: , HPA046538: , HPA066498: AB_2685678"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (8.01e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.67e-5)"	"unprognostic (8.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	0.2	50.6	22.4	0.2	27.1	0.4	0.7	35.5	48.2	7.5	0.0	0.1	0.4	0.6	0.9	0.3	5.9	0.9	0.1	18.4	16.4	0.3	0.1	0.1	0.3	5.5	9.7	2.0	0.7	0.0	15.0	0.4	6.4	1.7	0.1	102.3	0.8	1.0	0.2	0.3	0.5	1.3	3.5	0.1	0.6	2.8	16.7	0.8	1.3	0.1	0.2	1.7	2.4	29.4	4.6	0.0	4.8	0.0	0.0	0.1	0.0	0.4	0.3	1.0	1.3	0.1	0.3	9.2	0.1	0.1	1.4	0.3	1.9	0.8	2.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.0	1.5	0.0	1.2	0.0	0.5	0.0	0.4	0.9	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	7.3	16.5	3.3	0.0	0.1	0.7	8.8	0.4	0.2	0.0	0.0	6.5	0.1	0.1	1.2	0.0	0.1	0.4	0.3	0.3	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	22.4	27.1	35.5	48.2	18.4	16.4	5.5	9.7	6.4	3.5	16.7	29.4	0.4	28.9	22.5	38.5	0.2	0.3	1.8	2.8	1.8	383.6	0.7	0.6	0.9	1.5	16.9	0.0	706.8	0.5	0.1	0.2	1.9	0.1	34.2	2.1	0.4	4.9	8.4	0.0	1589.3	0.0	0.3	3.7	0.0	3.7	16.4	18.0	0.7	0.3	0.3	67.3	1234.9	0.9	0.0	0.6	0.8	20.1	72.1	2.5	1.8	63.7	0.6	86.6	1.0	577.0	27.0	0.3	1.2	29.3	0.3	4.1	2.0	0.2	10.6	1088.7	0.0	0.8	1.0	34.8	15.7	0.8	0.4	0.1	2.1	0.1	1.5	1.1
RIN2	RASSF4	ENSG00000132669	"Ras and Rab interactor 2"	Q8WYP3	20	19757606-20002457	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 198.5;Microglial cells: 191.1;Oligodendrocyte precursor cells: 296.6;Oligodendrocytes: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034641	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Nucleoli, Golgi apparatus"	"HPA034641: AB_10671230"	"unprognostic (8.23e-3)"	"unprognostic (8.09e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.27e-2)"	"prognostic favorable (8.34e-6)"	"unprognostic (3.10e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.02e-3)"	"unprognostic (3.63e-2)"	14.2	6.4	8.7	8.6	13.5	6.1	9.5	9.4	7.1	14.4	14.4	12.5	13.3	14.1	3.9	13.6	11.7	17.8	18.7	9.5	10.8	12.1	5.3	18.3	4.7	14.6	13.2	15.0	6.5	4.6	1.4	19.8	12.8	9.4	12.7	5.5	15.6	13.5	9.4	8.2	14.7	16.2	9.5	16.8	8.8	1.8	12.7	3.0	13.7	13.2	5.3	8.1	3.8	14.0	6.7	22.4	4.1	13.7	23.3	14.2	13.1	5.9	22.8	5.7	3.0	10.0	5.8	0.0	24.0	14.6	10.6	24.7	0.1	33.5	6.3	2.7	0.1	0.0	3.5	0.8	5.4	0.0	0.1	21.7	6.1	10.7	11.9	13.4	30.6	0.0	0.1	0.4	17.0	5.3	0.1	0.4	0.7	3.2	47.1	0.1	13.8	3.4	7.2	9.2	3.5	0.9	5.3	23.7	0.1	4.1	2.0	1.4	33.7	11.4	2.9	8.1	9.2	0.1	0.1	0.0	8.0	0.0	2.0	0.2	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.0	0.4	8.7	13.5	9.4	7.1	9.5	10.8	14.6	13.2	12.8	9.5	12.7	14.0	52.3	64.1	17.5	198.5	1.4	41.9	18.5	30.9	24.5	6.1	25.6	18.4	34.3	14.3	23.7	31.3	8.4	6.8	0.2	30.4	43.0	17.5	1.0	50.0	47.3	52.7	14.4	0.4	5.9	34.5	7.4	33.2	10.7	87.3	0.0	32.4	105.3	4.2	100.2	6.7	82.8	17.2	26.4	60.3	40.3	0.8	19.3	37.7	21.4	191.1	21.4	33.2	1.0	296.6	202.4	26.2	10.5	15.4	0.8	22.3	23.0	50.1	27.1	1.9	0.0	25.4	22.6	0.5	0.8	33.6	54.0	7.1	2.9	43.1	21.9	32.2
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208500-33212722	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	38.6	42.4	39.2	21.6	42.7	18.1	36.8	39.7	45.6	60.2	42.2	45.4	21.3	51.5	20.8	37.4	51.8	19.3	37.0	38.7	41.4	50.7	51.2	39.3	20.9	39.4	42.7	59.4	44.7	34.2	80.8	19.4	40.6	55.8	7.2	15.7	37.0	23.2	37.3	34.7	37.0	29.6	39.9	41.2	37.5	46.9	43.4	34.4	67.1	25.4	17.3	41.3	42.2	47.5	38.8	24.9	38.2	33.3	35.0	13.2	15.5	36.5	55.1	32.7	40.5	35.2	22.9	30.1	19.0	41.2	45.8	21.0	31.6	29.7	24.5	69.5	16.5	60.2	50.4	40.2	75.9	37.7	57.0	0.0	26.7	34.4	53.6	38.1	16.5	30.4	49.2	37.2	37.2	0.0	6.3	22.1	13.6	24.5	17.0	18.1	27.1	59.6	42.9	41.5	43.6	32.4	26.3	34.8	62.9	11.6	40.2	56.7	26.1	37.6	29.7	5.6	43.8	56.4	37.1	32.6	25.5	36.0	28.7	0.0	0.4	1.6	0.0	0.2	0.6	0.8	0.5	0.6	0.4	0.2	0.6	1.3	0.6	0.5	0.5	1.1	0.8	0.4	39.2	42.7	39.7	45.6	38.7	41.4	39.4	42.7	40.6	39.9	43.4	47.5	27.5	0.0	20.2	22.5	23.6	27.5	40.6	28.6	51.2	32.1	26.8	25.3	23.9	21.5	22.1	22.0	16.7	41.9	30.8	23.7	15.6	32.8	34.7	28.4	29.0	26.8	30.6	16.8	23.2	34.7	35.2	32.2	31.6	29.5	19.7	19.7	35.0	36.9	29.1	25.2	23.0	24.1	8.2	26.5	23.5	21.5	40.0	22.3	17.8	12.2	21.0	44.8	21.6	12.5	20.3	31.2	25.1	29.7	32.2	29.4	36.6	34.8	25.9	21.6	26.3	38.3	30.9	33.4	18.9	32.7	30.5	63.1	27.6	32.6	21.8	30.2
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183247	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	15.0	14.6	12.5	13.5	13.7	21.5	14.7	16.6	21.3	12.9	14.1	13.3	13.0	11.6	12.2	13.5	12.3	7.8	16.3	12.5	14.7	14.2	18.1	10.3	14.3	13.5	13.5	14.8	16.7	11.3	15.1	12.1	13.5	12.0	12.7	19.4	11.8	9.3	21.4	11.3	11.2	9.3	13.9	14.6	13.3	12.6	13.7	13.7	11.9	14.2	13.6	13.2	12.1	15.9	19.0	22.0	20.3	38.5	25.9	28.6	32.1	48.1	29.0	33.0	43.2	30.4	32.5	41.7	53.1	21.3	51.6	21.7	34.2	27.4	44.9	29.3	18.5	20.3	44.0	42.9	23.6	38.5	27.2	18.5	20.8	40.1	39.8	25.0	27.0	30.8	31.7	25.4	38.0	31.9	46.4	47.8	22.5	10.6	23.9	51.9	38.3	61.9	25.7	16.9	23.7	17.9	27.5	28.3	35.6	29.6	29.6	36.4	28.5	41.2	28.9	33.0	51.8	25.3	36.4	95.2	24.0	39.7	38.4	17.9	26.2	15.8	24.6	30.7	34.4	24.0	31.5	27.8	29.4	18.6	33.9	36.5	5.0	30.7	23.8	29.2	31.7	22.7	12.5	13.7	16.6	21.3	12.5	14.7	13.5	13.5	13.5	13.9	13.7	15.9	14.9	9.6	12.8	7.8	16.9	26.4	17.9	25.2	12.5	16.2	11.1	11.4	20.5	10.0	17.4	7.3	12.5	19.6	26.9	6.4	17.6	17.3	1.3	10.7	18.0	14.0	9.6	8.4	10.9	14.9	24.8	21.1	14.8	10.5	27.9	12.7	8.2	8.1	18.3	13.5	11.0	12.7	18.3	9.4	9.2	3.0	13.4	11.0	5.4	3.7	16.5	13.4	14.4	9.0	15.0	11.4	10.1	16.1	19.1	10.4	11.8	17.3	13.3	17.7	6.6	17.4	22.9	23.5	20.7	10.1	18.9	17.4	19.6	19.4	12.6	12.0
RIOK3	SUDD	ENSG00000101782	"RIO kinase 3"	O14730	18	23453287-23486603	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 174.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 338.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	"unprognostic (7.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.71e-2)"	23.1	18.5	5.5	20.4	7.1	174.3	19.2	7.9	10.2	17.4	8.3	47.5	51.6	16.7	12.4	65.5	14.8	24.3	32.7	5.9	6.7	29.6	55.6	22.7	22.8	9.3	7.3	15.7	27.6	22.8	5.4	34.9	8.9	20.1	43.5	19.6	23.2	14.5	52.9	33.3	62.5	19.7	7.5	21.5	38.5	36.6	6.9	21.5	22.2	48.8	30.2	25.8	27.0	10.6	41.9	15.7	17.8	25.0	31.8	37.7	28.5	38.9	29.8	27.6	28.4	17.3	47.5	27.6	52.3	43.7	26.9	57.6	25.9	45.4	38.9	29.5	12.0	25.9	26.9	22.2	71.7	74.7	25.8	39.0	91.2	44.1	66.7	36.7	38.4	19.2	39.8	34.7	45.0	19.4	25.8	15.6	17.6	59.0	31.3	31.3	33.2	41.2	39.3	50.0	39.5	28.9	50.1	28.4	37.4	41.0	21.9	45.0	63.7	48.4	10.9	21.2	28.9	66.1	56.0	38.2	31.0	36.7	38.2	50.1	24.5	14.8	15.0	34.6	10.8	14.0	12.3	12.6	19.1	18.5	9.8	11.2	17.2	15.0	39.0	8.6	19.4	20.7	5.5	7.1	7.9	10.2	5.9	6.7	9.3	7.3	8.9	7.5	6.9	10.6	49.7	80.1	57.7	23.2	46.4	120.4	92.4	78.6	113.8	44.1	49.3	35.6	69.1	51.5	81.5	25.8	56.3	43.0	74.6	338.1	25.4	51.0	271.5	130.1	85.5	44.1	62.8	259.8	35.5	52.7	64.6	48.8	93.8	267.2	63.3	40.0	29.6	88.5	41.1	28.6	34.2	119.9	50.8	59.9	51.2	305.8	22.4	85.7	42.7	15.9	80.6	18.3	53.5	34.2	49.5	148.4	210.7	30.1	63.4	118.5	199.5	52.5	72.3	46.4	6.6	43.9	51.6	28.4	10.1	164.2	143.6	88.4	57.3	71.1	77.2	244.4
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063824-3115187	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	18.5	12.0	1.9	9.3	1.9	0.5	16.2	1.8	3.8	12.8	2.4	17.5	12.3	14.5	5.3	17.6	12.8	10.6	11.8	1.8	1.9	13.7	23.6	13.5	10.1	2.2	1.9	8.5	17.4	12.2	12.3	10.9	2.0	13.7	13.0	2.4	16.4	8.9	11.7	20.7	19.9	11.9	2.0	19.4	16.5	5.3	2.0	11.9	14.4	5.0	13.0	15.5	13.7	1.9	14.4	9.8	12.9	12.4	27.6	19.2	5.5	21.4	30.8	22.8	26.7	12.4	8.0	13.8	20.9	30.1	23.2	14.3	17.9	17.2	24.3	27.8	9.4	16.7	4.5	6.9	17.2	15.6	20.1	24.8	15.1	20.4	15.3	17.6	20.6	6.2	19.4	4.6	22.0	17.8	10.7	7.7	8.8	17.4	12.7	11.8	10.9	14.5	17.3	27.2	11.3	12.2	14.7	7.8	22.4	26.0	15.2	8.7	25.1	20.6	12.1	8.2	16.4	9.8	15.3	13.5	8.9	7.0	27.7	0.1	0.4	0.9	0.6	0.9	1.0	0.3	0.9	1.7	1.0	1.2	0.7	0.7	0.0	1.5	0.5	0.5	1.7	0.8	1.9	1.9	1.8	3.8	1.8	1.9	2.2	1.9	2.0	2.0	2.0	1.9	28.6	6.4	12.0	17.3	14.7	11.0	10.3	6.6	16.5	4.4	14.7	17.8	8.6	17.2	16.7	9.2	12.5	8.9	21.9	27.1	5.9	9.4	2.0	10.5	14.0	16.7	6.6	7.2	23.1	12.9	7.7	18.3	27.0	13.4	10.8	8.7	10.0	14.6	11.6	5.0	26.7	17.7	4.1	6.7	11.1	0.8	6.8	15.3	3.6	11.2	13.8	6.6	12.3	14.6	16.2	13.8	11.7	6.0	22.3	11.3	12.7	8.7	17.4	21.4	19.7	32.5	17.9	1.2	2.8	20.5	9.9	11.9	20.8	10.6	11.3	14.5
RIPOR1	"FAM65A, FLJ13725"	ENSG00000039523	"RHO family interacting cell polarization regulator 1"	Q6ZS17	16	67518418-67546788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 49.2;Endothelial cells: 23.6;Hofbauer cells: 30.0;Pancreatic endocrine cells: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 11.2;eosinophil: 9.3;intermediate monocyte: 15.6;memory B-cell: 15.8;myeloid DC: 10.2;naive B-cell: 9.4;neutrophil: 6.6;non-classical monocyte: 15.1;plasmacytoid DC: 14.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005923	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Cytosol"		"HPA005923: AB_1078809"	"unprognostic (7.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.82e-8)"	"unprognostic (8.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.46e-2)"	44.4	28.1	27.6	23.4	30.6	27.2	37.7	26.4	38.6	39.9	7.5	36.0	8.8	45.2	6.0	18.5	36.2	21.5	53.6	33.6	16.3	67.6	16.7	55.8	20.8	26.6	17.1	33.2	30.1	20.6	26.5	29.8	25.4	30.6	7.4	43.8	22.8	20.2	34.9	21.4	32.7	25.2	12.3	61.2	25.9	18.6	21.5	10.8	36.4	22.3	17.5	37.1	30.4	18.6	44.0	36.6	16.1	25.3	40.0	35.7	35.7	45.7	44.9	51.6	43.0	75.7	31.5	6.0	62.4	78.8	26.0	24.4	32.7	41.3	33.2	19.3	17.0	57.9	53.6	17.4	44.7	4.6	28.0	35.5	18.8	69.7	47.1	36.8	55.2	10.2	6.5	6.4	38.7	47.7	13.8	14.4	4.4	8.5	29.1	46.8	29.0	31.2	39.0	22.1	12.1	31.9	85.1	13.8	28.6	15.9	30.2	10.7	96.8	58.3	34.2	49.8	32.2	9.0	6.8	17.8	38.8	11.1	31.7	0.1	11.2	9.3	1.2	15.6	1.8	15.8	1.0	0.5	10.2	9.4	0.7	0.7	6.6	1.7	15.1	14.4	0.8	6.0	27.6	30.6	26.4	38.6	33.6	16.3	26.6	17.1	25.4	12.3	21.5	18.6	49.2	16.0	16.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	12.1	8.8	0.0	0.0	1.8	7.3	0.0	0.8	3.7	0.0	0.0	15.8	0.0	9.3	17.9	23.6	0.0	0.0	0.0	12.5	1.3	6.9	0.0	18.5	10.1	7.9	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	37.0	0.0	0.0	2.3	0.0	0.0	5.8	2.2	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	2.1	2.3	16.6	0.0	0.0
RIT2	"RIBA, RIN"	ENSG00000152214	"Ras like without CAAX 2"	Q99578	18	42743227-43115691	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 225.8;Oligodendrocyte precursor cells: 202.5"	"Cancer enriched"	"Detected in single"	49	"glioma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA072174, HPA072526"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA072174: AB_2732195, HPA072526: "					"unprognostic (1.37e-2)"							"unprognostic (4.15e-1)"			"unprognostic (2.14e-1)"			0.0	1.9	9.3	0.1	10.6	0.0	0.0	25.9	16.8	0.1	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	13.3	0.0	0.0	0.0	0.0	12.8	9.2	0.0	0.0	0.0	0.5	0.0	17.4	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	8.9	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.0	0.0	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	10.6	25.9	16.8	8.8	13.3	12.8	9.2	17.4	8.9	11.6	8.8	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	225.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	42.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	3.7	0.0	1.0	0.0	202.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	1.4	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3541430-3558333	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA034817, HPA043037"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA034817: , HPA043037: AB_2678280"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	10.6	8.7	9.7	9.5	10.6	11.4	9.7	8.2	12.3	8.5	6.8	7.8	7.2	11.7	11.3	9.6	7.8	7.5	13.0	11.1	11.2	7.1	8.1	7.9	10.2	10.1	9.1	8.2	8.7	9.1	3.3	7.9	10.1	9.3	9.5	8.7	7.7	11.8	15.3	9.9	7.8	13.3	9.2	9.0	6.9	7.0	11.7	10.3	9.5	15.0	10.9	8.5	4.7	10.5	11.9	21.4	22.1	22.5	24.9	23.2	17.2	29.0	30.6	24.8	16.5	19.4	13.0	33.6	13.7	31.5	18.8	14.7	32.6	23.2	30.9	12.4	17.5	33.1	18.9	27.5	35.5	42.0	23.3	23.5	24.9	24.2	29.3	18.5	21.5	54.8	33.0	19.4	31.1	9.3	32.7	27.3	34.7	20.6	17.0	26.9	32.0	34.3	21.0	19.7	33.3	48.9	17.8	15.9	27.5	16.7	10.3	22.9	24.8	24.1	11.5	24.7	40.7	36.1	37.5	43.9	43.2	35.1	37.5	0.1	0.6	1.3	1.3	1.2	2.2	1.1	1.0	1.7	0.7	0.6	1.0	2.1	0.5	0.4	1.2	1.5	0.4	0.7	9.7	10.6	8.2	12.3	11.1	11.2	10.1	9.1	10.1	9.2	11.7	10.5	15.6	22.4	6.9	9.1	30.7	7.5	26.1	21.0	13.6	25.7	14.9	12.6	25.9	11.5	14.7	3.7	20.9	32.7	25.4	14.4	37.2	44.3	5.1	9.6	20.8	20.1	15.0	13.5	11.8	48.7	44.3	20.2	17.9	11.0	27.3	17.9	16.8	18.0	30.8	35.3	10.7	16.4	14.2	18.8	8.9	3.4	13.7	16.2	10.6	10.3	32.3	17.5	30.9	7.5	9.8	48.3	9.9	26.4	41.7	50.2	16.6	28.6	14.1	18.8	19.7	23.6	23.4	21.0	27.5	17.8	12.1	36.5	18.9	27.7	15.9	37.9
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689538-49721529	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.1;tongue: 112.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Supported		Approved	Cytosol		NA	NA		140000	"Cluster 37: B-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA065983: AB_2685592, HPA071879: AB_2686468"	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	13.0	19.0	18.9	9.0	19.2	34.6	12.5	18.5	23.9	13.1	21.0	17.8	19.5	14.7	10.5	13.4	12.5	9.7	27.8	19.6	16.5	22.0	57.7	12.3	10.4	17.5	16.9	11.6	13.5	16.3	17.4	9.4	17.2	14.6	6.8	6.0	14.4	9.2	156.1	14.5	18.2	9.3	14.7	17.9	17.9	23.7	18.0	13.7	14.6	112.0	7.3	14.2	12.0	17.9	9.7	12.6	15.5	16.2	23.2	13.9	17.1	12.1	15.9	15.0	16.0	14.1	16.1	23.2	10.9	17.6	13.3	11.8	11.6	18.1	10.0	15.8	15.0	19.7	27.8	31.6	23.1	19.3	19.8	17.6	17.9	14.4	16.5	14.8	16.2	23.0	20.0	20.0	13.2	14.1	19.8	30.7	8.2	11.5	21.0	9.3	9.7	24.4	21.5	16.4	10.6	20.8	16.4	14.4	18.7	8.7	15.4	33.0	16.2	13.4	16.3	11.9	14.9	26.4	28.4	9.5	19.2	23.6	20.5	8.9	6.9	5.6	6.7	6.2	4.0	7.1	4.5	4.1	5.5	7.0	5.3	5.0	4.0	5.5	6.8	7.9	3.6	3.8	18.9	19.2	18.5	23.9	19.6	16.5	17.5	16.9	17.2	14.7	18.0	17.9	7.1	9.6	5.3	16.3	6.5	2.3	3.1	4.7	1.8	8.6	7.1	6.1	1.1	11.5	5.8	3.7	4.2	6.8	9.3	10.4	5.9	5.3	13.3	8.1	5.8	5.9	6.7	52.4	18.0	5.5	4.6	5.9	11.2	7.5	7.0	9.5	10.0	29.8	5.6	6.7	14.6	6.1	10.2	9.6	1.4	16.5	7.5	6.0	3.6	5.6	6.3	5.4	7.2	7.5	7.2	7.2	6.3	5.7	7.0	5.0	19.2	10.2	5.4	8.9	0.0	7.6	5.6	10.7	8.9	4.6	3.0	8.5	6.0	7.5	6.9	4.1
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663233	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	21.2	23.4	11.8	16.0	13.0	21.8	21.7	10.8	19.4	19.1	3.8	26.6	21.6	20.8	2.7	42.3	19.1	4.6	25.9	13.4	9.7	20.7	40.2	19.3	14.1	13.2	10.3	16.8	23.0	6.8	20.2	8.8	13.1	20.2	4.9	4.3	21.0	7.0	61.6	45.3	27.2	4.9	10.2	30.6	24.3	49.4	11.9	10.1	14.7	12.8	5.8	21.6	24.0	16.6	79.7	26.5	21.0	30.6	4.8	6.7	38.5	40.6	15.0	22.5	21.2	52.1	26.9	64.2	25.9	16.5	8.9	51.7	12.6	30.0	6.2	43.8	98.8	32.7	24.5	47.0	18.2	64.9	46.0	11.3	22.9	18.5	14.3	9.0	20.6	51.8	68.5	63.4	12.0	62.9	67.7	35.0	62.4	22.5	50.6	48.9	18.1	102.0	17.0	43.6	52.0	42.1	30.1	39.8	42.4	7.2	25.3	51.5	28.6	40.6	30.6	62.1	71.1	112.3	59.5	77.6	52.1	39.2	43.0	3.7	14.7	12.3	25.1	18.4	21.1	23.9	23.1	24.7	19.0	25.5	17.7	16.6	3.7	27.7	22.6	21.5	28.3	14.8	11.8	13.0	10.8	19.4	13.4	9.7	13.2	10.3	13.1	10.2	11.9	16.6	34.2	12.8	7.4	9.1	66.9	137.9	61.2	44.3	45.5	31.4	35.7	39.6	27.6	27.1	23.2	9.2	16.7	72.8	74.8	60.9	54.8	60.6	146.4	20.2	17.8	31.0	21.7	37.8	11.9	75.6	139.2	29.3	40.2	22.7	14.7	23.1	22.9	22.9	43.2	32.0	9.9	39.3	26.4	26.7	58.9	36.8	21.5	32.9	42.7	3.7	47.5	32.7	112.3	7.1	15.7	136.2	70.0	19.5	76.5	98.2	68.1	40.8	14.8	24.6	59.2	22.0	40.5	153.6	65.3	74.4	144.8	88.1	60.7	43.2	58.1	87.0
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812770-149962139	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 591.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 462.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	48.2	41.2	58.1	40.4	95.2	19.9	53.9	88.1	91.5	33.6	63.7	35.0	28.9	33.3	57.2	32.6	30.2	40.6	34.4	55.0	77.3	67.9	73.8	64.1	38.0	101.8	83.9	35.6	36.1	52.3	18.3	64.1	100.8	46.6	37.1	40.4	75.5	39.3	36.5	32.5	30.5	36.9	85.6	53.0	34.3	25.2	75.9	32.0	64.0	42.6	33.2	42.3	28.9	131.0	60.6	39.4	24.4	29.0	92.2	55.2	40.3	32.2	86.2	32.3	47.4	33.4	84.4	26.6	48.7	42.0	58.7	58.0	37.5	41.5	42.9	34.1	24.6	35.8	17.3	31.2	61.5	35.0	41.8	59.9	73.1	26.5	71.8	37.3	37.0	24.9	10.1	49.7	28.0	34.5	26.2	18.8	16.8	58.6	29.1	19.0	26.7	108.5	54.2	29.6	12.6	37.6	28.5	39.9	110.3	19.2	79.2	34.0	37.8	40.8	16.5	45.6	23.4	89.9	61.9	51.5	35.9	30.1	23.6	98.2	130.1	106.5	37.4	153.8	48.8	51.9	41.5	44.8	93.1	48.4	38.0	42.4	462.3	46.3	207.8	68.3	48.7	104.5	58.1	95.2	88.1	91.5	55.0	77.3	101.8	83.9	100.8	85.6	75.9	131.0	100.9	109.0	72.3	78.7	55.3	73.5	68.2	84.3	74.0	44.5	54.5	51.1	27.3	48.6	68.1	47.8	29.2	101.2	61.9	30.2	43.0	63.0	2.5	32.5	34.5	69.4	20.3	32.4	122.1	70.6	83.5	84.8	31.6	39.7	60.8	14.6	80.3	53.7	201.2	21.9	98.8	27.7	67.1	183.9	173.7	6.7	76.1	177.6	103.2	92.8	93.5	98.5	38.1	115.6	591.2	58.7	33.6	88.0	62.4	71.9	38.5	71.5	40.4	37.2	92.1	76.3	55.5	23.6	32.5	52.3	72.5	52.5	49.8	38.2	27.7	55.8
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 11.4;granulocytes: 16.0;T-cells: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	27.4	39.3	13.7	39.4	15.9	20.4	28.2	16.2	16.1	24.7	18.6	26.4	12.2	21.0	30.9	53.1	16.9	48.3	18.8	15.6	19.8	19.5	15.3	73.6	38.7	11.1	13.1	29.0	12.3	47.7	19.4	52.4	11.6	25.9	29.3	33.8	25.6	32.7	9.0	22.3	16.6	27.4	14.3	29.2	26.7	12.1	20.3	26.5	33.8	13.7	48.4	68.1	24.4	14.7	65.5	63.5	95.2	115.1	98.5	43.6	18.6	51.3	88.9	46.3	74.6	22.2	52.9	22.4	89.7	45.3	87.9	83.1	75.9	67.3	80.9	92.7	27.2	47.2	68.5	18.4	42.1	31.4	43.2	27.0	118.8	43.2	63.0	64.7	46.2	53.6	47.7	83.6	44.1	1.9	36.1	9.8	41.3	20.5	32.0	47.3	41.6	44.8	61.4	22.3	34.5	63.9	51.8	54.7	86.5	64.7	38.5	28.4	49.7	51.6	47.0	41.9	92.1	18.4	27.6	20.6	60.3	38.4	113.1	3.5	2.5	16.0	3.0	2.6	3.5	11.4	4.4	3.6	1.9	5.1	5.8	4.0	9.5	2.3	2.3	2.7	6.3	1.3	13.7	15.9	16.2	16.1	15.6	19.8	11.1	13.1	11.6	14.3	20.3	14.7	34.1	112.2	244.1	25.1	62.9	122.7	102.0	90.0	73.4	106.7	97.2	77.3	12.7	65.8	114.0	36.8	58.4	2.8	55.1	98.4	19.6	75.0	28.9	27.5	37.1	75.7	54.1	67.5	89.2	114.4	24.3	45.7	52.0	36.7	69.1	30.2	127.8	19.5	45.5	114.4	74.2	41.8	32.6	115.0	240.8	39.5	46.3	69.4	65.8	52.5	153.9	56.1	47.4	40.2	38.9	108.6	53.7	51.9	38.1	123.8	16.9	10.6	65.6	53.4	46.0	25.4	46.5	19.2	34.8	81.9	99.4	10.9	69.3	19.0	72.0	163.1
RNF148	MGC35222	ENSG00000235631	"Ring finger protein 148"	Q8N7C7	7	122701668-122702922	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 49.3"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 405.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"cerebellum: 9.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.8;MCF7: 1.1"	"Not detected"	"Not detected"							HPA045587			Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA045587: AB_10963695"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-1)"	0.2	0.2	0.0	0.0	0.2	0.0	0.2	9.9	1.7	0.2	0.2	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.4	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.6	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	49.3	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.8	0.0	1.1	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.9	1.7	0.2	0.1	0.0	0.2	0.6	0.0	0.1	0.7	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	405.2	0.5	0.5	0.5	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.8	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	62.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.9	0.0	0.1	0.0	0.2	0.0	0.0	6.6	0.2	0.1	3.9	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1
RNF151		ENSG00000179580	"Ring finger protein 151"	Q2KHN1	16	1966823-1968975	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	411	"testis: 190.2"	"Group enriched"	"Detected in some"	137	"Early spermatids: 2202.5;Late spermatids: 1521.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055054			Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nuclear speckles, Vesicles"	"HPA055054: "	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.39e-3)"	"unprognostic (4.63e-1)"	"unprognostic (1.98e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.43e-2)"	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	190.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2202.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1521.4	9.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.2	0.1	13.5	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696499-88706408	"Enzymes, Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 91.2;lymphoid tissue: 101.6"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 132.3;NK-cells: 111.2;T-cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 108.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	22.7	18.4	16.1	28.8	16.2	91.2	16.0	14.4	24.5	18.3	13.9	18.3	14.1	16.6	3.2	11.8	20.0	14.0	21.3	15.5	15.0	20.7	23.4	48.3	40.4	19.4	16.8	17.8	19.5	5.4	17.6	8.2	17.6	19.7	4.9	3.4	14.8	5.8	21.3	11.8	37.2	6.3	16.9	101.6	17.8	12.8	20.9	18.0	18.8	8.2	21.1	18.1	14.4	20.0	10.3	15.9	12.5	18.4	5.8	5.0	23.3	10.3	6.5	11.8	5.3	11.1	6.4	12.4	13.0	6.0	6.8	11.1	7.2	6.8	4.7	6.4	21.7	16.7	12.4	18.7	15.9	16.7	20.4	6.0	6.4	9.4	8.2	6.9	12.4	20.6	28.6	8.8	5.0	20.3	38.9	108.0	20.3	4.4	21.5	36.3	7.8	32.2	5.3	4.5	11.8	12.3	23.9	4.8	12.1	5.9	13.4	53.3	18.6	8.7	13.4	13.5	12.5	19.9	13.5	31.6	7.8	62.8	12.4	7.0	25.6	61.3	31.6	19.1	27.7	4.2	19.3	27.6	23.8	3.9	15.7	22.9	40.4	11.3	22.7	14.8	21.8	21.6	16.1	16.2	14.4	24.5	15.5	15.0	19.4	16.8	17.6	16.9	20.9	20.0	15.2	9.6	3.6	7.8	23.5	4.8	4.6	2.4	6.2	10.1	6.0	7.1	2.8	4.3	3.1	7.3	6.2	8.8	132.3	2.3	9.8	6.5	1.4	5.2	7.4	11.0	4.9	13.7	6.5	9.2	9.6	8.8	8.2	4.9	21.0	12.3	8.6	4.8	38.8	8.4	4.8	3.1	2.0	46.7	32.4	2.5	9.3	52.4	10.6	15.0	41.5	11.7	111.2	3.5	4.5	5.5	1.0	7.9	55.1	4.5	1.8	7.0	4.7	9.6	6.6	8.9	10.0	9.1	9.9	4.8	5.8	3.7	73.1	12.2	3.7	1.9
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	75.0	110.6	141.9	53.0	146.7	69.0	73.1	146.4	179.9	93.2	138.6	111.5	66.6	94.9	76.4	122.1	84.3	45.3	131.8	141.5	146.4	106.7	184.2	77.5	64.5	146.3	145.4	87.4	115.1	105.8	96.8	50.7	146.3	95.0	65.7	98.1	92.5	70.5	152.9	127.8	100.5	52.8	142.4	113.8	111.8	110.6	150.3	98.1	93.4	94.2	71.6	106.7	90.4	153.3	102.6	143.1	61.1	73.7	132.8	68.7	92.7	63.4	76.1	119.7	93.4	96.2	43.3	71.5	120.3	93.5	63.9	147.5	103.2	114.8	86.1	74.5	166.1	121.9	164.4	94.9	100.6	59.0	245.0	79.6	176.5	129.8	116.2	74.6	77.2	101.0	49.9	237.5	96.2	66.3	92.8	70.6	75.4	102.0	86.8	62.8	61.9	91.5	137.3	77.4	49.2	61.1	56.0	92.9	81.9	83.1	87.3	55.9	49.5	76.6	48.3	66.8	119.3	79.5	88.0	23.7	98.4	80.6	77.9	108.4	88.8	236.9	195.3	94.0	153.4	100.4	148.0	195.7	73.9	98.7	103.2	152.2	219.8	118.8	117.7	75.9	153.0	177.0	141.9	146.7	146.4	179.9	141.5	146.4	146.3	145.4	146.3	142.4	150.3	153.3	36.9	0.0	3.9	12.4	54.3	68.6	44.4	65.8	51.8	43.2	56.6	44.7	15.8	77.2	38.9	49.7	20.9	120.1	64.7	65.2	56.7	78.5	59.6	29.8	25.1	36.4	31.8	60.6	11.3	66.7	139.7	36.3	36.2	32.2	14.0	26.3	45.7	95.1	58.4	18.5	11.2	45.7	65.1	41.3	43.6	86.5	48.7	36.1	39.2	6.5	53.1	46.9	114.4	10.1	17.9	60.7	44.9	53.8	59.1	32.6	108.2	64.0	31.1	32.3	39.5	28.4	35.1	127.1	106.7	61.4	83.3	125.2	82.5	37.2	59.6	48.0
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165843-64372869	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 90.5;Inhibitory neurons: 151.6;Oligodendrocyte precursor cells: 162.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favorable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	5.4	5.1	3.2	1.5	3.9	0.3	3.6	2.6	5.1	4.1	2.9	3.3	1.7	7.7	7.7	4.2	4.9	4.2	7.0	2.8	8.2	8.1	4.5	3.7	1.3	3.9	5.8	7.6	4.2	25.3	3.5	0.6	4.7	7.3	1.3	6.0	4.6	10.6	2.7	4.1	1.4	5.7	4.4	3.0	2.6	3.4	6.6	0.7	14.0	4.1	0.9	3.3	2.3	4.5	0.0	0.1	1.4	0.0	0.0	0.0	0.3	1.2	0.5	1.2	0.7	0.0	0.1	0.0	0.1	0.9	0.7	0.2	0.0	0.5	0.2	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.3	0.1	3.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.6	0.0	1.4	0.1	3.7	29.4	2.1	0.3	0.3	0.1	0.0	0.3	0.0	1.8	1.5	0.1	0.1	0.0	3.5	0.1	3.3	0.0	0.0	0.0	0.6	0.0	3.9	1.2	0.6	1.7	0.6	0.2	0.9	0.5	1.0	1.1	0.2	0.8	1.4	1.3	1.0	0.8	0.3	0.4	0.7	0.0	3.2	3.9	2.6	5.1	2.8	8.2	3.9	5.8	4.7	4.4	6.6	4.5	9.5	16.0	12.3	51.6	0.5	4.6	8.9	1.3	7.4	16.6	8.1	4.2	10.9	10.0	4.9	16.5	14.6	0.0	0.0	0.0	7.9	5.8	12.5	14.2	6.1	6.3	1.2	0.0	90.5	2.6	0.1	7.9	6.1	32.9	0.0	5.7	14.3	5.9	0.1	11.8	151.6	1.9	0.0	0.6	1.1	8.8	34.5	0.5	5.4	32.8	0.0	30.1	0.0	162.3	50.1	3.1	2.7	25.2	0.0	6.4	1.2	15.9	1.9	16.9	39.5	24.2	20.4	18.9	12.0	2.9	7.4	0.0	0.3	4.1	1.6	4.5
RNF181	HSPC238	ENSG00000168894	"Ring finger protein 181"	Q9P0P0	2	85595725-85597708	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 851.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046112, HPA062121"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA046112: AB_2679542, HPA062121: AB_2684687"	"unprognostic (3.79e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (3.24e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.49e-2)"	110.4	135.0	87.6	60.2	92.4	76.7	109.8	93.3	101.9	105.5	85.7	101.3	75.1	85.2	85.0	118.0	87.4	50.2	141.1	88.9	93.2	174.3	169.5	114.0	69.1	92.8	91.5	90.7	168.5	80.1	61.9	82.9	91.8	111.0	69.0	36.0	110.0	73.0	172.1	102.6	91.4	65.2	93.7	101.2	121.8	107.6	94.5	59.5	93.8	105.1	89.6	107.5	98.7	97.7	125.7	120.4	96.3	103.8	94.3	113.4	152.2	104.7	195.4	207.7	199.7	185.2	132.2	118.8	196.8	150.6	206.2	117.5	83.5	164.8	223.8	133.9	104.0	91.6	58.5	224.7	168.0	104.8	122.1	122.0	208.5	144.5	237.1	166.2	175.4	110.8	109.1	119.7	282.7	193.0	97.8	235.6	68.6	164.9	180.2	105.1	202.5	171.7	200.8	109.3	57.2	74.5	88.4	126.2	171.7	114.8	125.4	136.2	160.1	104.9	77.2	218.4	149.6	170.3	143.5	143.1	166.4	144.9	95.5	213.9	418.5	339.7	176.1	326.0	164.6	251.9	181.4	169.2	321.4	214.8	156.4	153.0	356.6	195.5	254.9	360.4	262.0	439.0	87.6	92.4	93.3	101.9	88.9	93.2	92.8	91.5	91.8	93.7	94.5	97.7	89.3	147.4	104.8	7.8	89.3	116.9	102.5	343.7	75.7	27.1	92.8	95.4	122.8	124.4	200.2	150.8	2.1	237.1	104.2	148.1	416.7	236.5	365.7	70.5	63.6	102.8	70.2	85.2	2.2	290.4	260.2	113.7	55.0	93.2	102.7	59.0	99.6	214.4	263.4	18.5	2.2	138.4	185.1	154.0	182.3	250.6	88.3	147.6	170.7	3.7	188.7	80.4	94.7	2.0	6.9	304.0	201.5	78.2	113.8	123.8	271.9	851.7	141.7	29.1	59.2	66.3	108.8	121.3	33.1	97.9	118.6	221.2	86.7	62.6	102.0	115.6
RNF19B	"FLJ90005, IBRDC3"	ENSG00000116514	"Ring finger protein 19B"	Q6ZMZ0	1	32936445-32964809	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 79.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.9"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 16.9"	"Cell line enhanced"	"Detected in all"		"Daudi: 107.6;Karpas-707: 124.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049587, HPA063640"	Approved		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA049587: AB_2680826, HPA063640: "	"unprognostic (2.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.39e-4)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (8.78e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.23e-2)"	14.5	19.1	10.7	24.3	9.6	74.1	10.9	14.5	10.7	16.8	7.6	23.3	25.0	15.0	5.0	35.3	12.3	17.4	10.4	9.9	12.1	21.1	11.3	21.1	17.7	10.7	9.6	9.7	9.2	11.5	7.9	14.9	11.8	11.0	25.8	18.9	15.4	8.9	16.2	22.6	21.7	18.0	11.6	15.1	13.1	79.0	10.8	13.0	9.0	11.1	30.6	30.1	20.9	11.6	18.7	14.3	11.9	11.3	7.1	9.6	79.5	8.5	10.0	14.7	15.6	16.8	54.9	107.6	14.2	10.7	18.2	26.5	14.3	19.8	13.3	39.6	9.5	9.2	10.5	16.9	22.5	14.7	19.0	7.9	36.3	32.5	39.3	17.2	31.9	10.3	11.7	124.8	14.5	6.1	9.6	18.4	19.2	21.1	15.8	12.7	17.3	11.3	11.5	26.4	18.9	9.6	27.0	9.1	63.1	29.1	8.0	20.8	35.1	8.1	11.5	21.1	15.1	29.6	16.1	38.0	11.9	14.7	12.5	6.1	2.0	4.0	1.6	1.9	1.3	1.2	1.4	0.7	1.4	1.5	0.4	0.6	16.9	1.0	1.7	0.6	1.7	0.8	10.7	9.6	14.5	10.7	9.9	12.1	10.7	9.6	11.8	11.6	10.8	11.6	20.6	12.8	4.4	5.5	8.7	46.1	27.0	26.7	24.5	4.6	15.8	11.7	16.2	10.0	9.9	7.3	2.1	12.6	14.6	48.0	1.9	12.9	34.8	25.4	7.3	15.3	11.3	5.2	9.7	11.5	6.3	8.4	13.3	36.9	4.5	3.2	7.1	4.8	13.5	3.3	9.8	22.1	6.1	20.9	37.7	26.3	2.1	42.4	5.4	19.7	39.5	2.8	2.1	7.5	6.6	25.7	31.9	3.8	4.6	34.2	38.6	9.2	14.4	7.7	0.0	5.9	9.6	34.7	16.3	23.9	32.5	7.4	10.3	2.3	16.3	41.7
RNF207	"C1orf188, FLJ32096, FLJ46380"	ENSG00000158286	"Ring finger protein 207"	Q6ZRF8	1	6205475-6221299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 31.8;Basal respiratory cells: 31.7;Club cells: 28.3;Urothelial cells: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.2;HaCaT: 7.6;HeLa: 7.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA028378, HPA042535"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA028378: AB_10601157, HPA042535: AB_2678042"	"unprognostic (5.53e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	3.3	3.3	3.2	1.3	3.2	0.0	3.1	4.0	4.2	9.5	5.9	5.8	2.0	4.3	1.5	5.9	7.9	0.9	34.7	3.2	3.1	9.8	7.6	1.7	0.9	3.7	2.9	2.5	6.9	1.2	5.5	1.2	3.7	11.8	1.4	2.1	6.7	3.8	1.7	1.2	4.4	1.2	2.6	1.4	4.1	1.2	3.2	0.5	6.7	4.2	1.3	6.3	5.4	3.0	2.6	4.5	0.4	2.9	0.2	0.3	3.1	1.3	1.0	0.2	0.3	2.2	17.2	0.2	1.3	1.1	0.0	7.6	0.4	1.0	0.1	2.8	1.7	0.1	7.0	2.2	1.3	1.7	0.1	1.1	0.2	0.0	0.0	3.8	0.1	0.3	0.7	3.6	0.1	1.8	0.2	0.3	0.2	0.3	3.8	0.0	0.7	2.9	2.2	3.9	0.4	1.1	2.8	1.5	1.1	0.7	2.7	0.1	0.5	0.0	0.8	0.4	0.0	3.9	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.2	3.2	4.0	4.2	3.2	3.1	3.7	2.9	3.7	2.6	3.2	3.0	2.9	9.6	3.9	2.0	1.7	0.3	31.8	31.7	6.2	4.0	4.4	4.3	19.5	14.3	28.3	18.4	2.1	15.6	0.4	8.5	0.0	15.4	0.7	2.3	6.8	2.9	3.6	0.4	13.2	9.8	6.3	4.6	17.3	2.7	0.0	1.7	1.1	3.9	1.1	3.3	13.2	15.6	10.2	0.0	0.7	0.2	0.0	1.6	0.0	0.0	2.2	7.5	0.0	3.5	1.7	19.0	3.5	1.2	1.5	21.3	9.5	3.5	10.1	16.3	6.6	1.5	5.0	0.1	2.8	3.8	0.4	5.6	1.9	2.0	6.4	37.1
RNF214	DKFZp547C195	ENSG00000167257	"Ring finger protein 214"	Q8ND24	11	117232625-117286454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 20.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 6.4;T-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039332	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA039332: AB_10671874"	"unprognostic (7.36e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.06e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	10.9	11.7	8.9	8.8	10.2	12.4	10.8	10.5	9.9	11.4	6.0	10.8	9.4	11.0	8.5	9.2	9.9	8.9	10.5	7.8	10.1	10.3	13.2	9.1	10.8	9.9	9.4	13.2	21.8	11.5	12.5	11.0	9.6	9.6	9.4	12.2	11.3	10.0	17.9	10.1	10.1	11.2	7.3	11.4	12.7	18.6	10.4	14.4	13.5	13.4	10.6	11.0	9.6	11.9	12.0	14.1	31.7	19.1	15.6	15.6	17.9	19.3	17.5	20.5	21.7	21.6	28.1	16.8	32.7	22.6	19.6	15.7	34.8	16.9	21.1	31.3	10.2	53.3	11.7	16.6	30.5	25.2	19.8	14.4	18.2	25.4	37.6	23.1	25.7	29.0	30.7	17.9	21.1	9.0	20.8	21.0	17.2	20.7	14.0	22.5	21.1	22.4	19.3	17.8	20.5	22.2	22.1	14.8	10.4	24.7	25.1	16.9	24.4	20.7	16.6	11.4	16.3	10.3	7.7	20.2	7.6	20.3	24.3	6.4	2.5	2.7	2.3	2.4	1.4	1.9	7.8	4.0	2.2	1.9	2.2	2.1	1.1	1.2	2.5	2.5	20.5	1.6	8.9	10.2	10.5	9.9	7.8	10.1	9.9	9.4	9.6	7.3	10.4	11.9	19.1	25.6	15.1	23.5	14.8	5.0	9.6	10.6	21.6	23.8	11.1	14.5	12.8	15.7	14.8	5.5	10.4	14.9	10.0	9.0	9.8	13.3	46.8	15.7	26.2	11.9	9.0	14.7	20.9	12.7	13.6	12.9	14.8	15.5	5.1	21.6	7.9	7.1	12.8	13.5	24.7	8.5	10.2	10.6	6.3	20.0	10.2	13.5	8.8	12.2	12.7	14.0	14.4	33.7	24.5	10.6	9.8	12.8	14.9	7.1	10.6	12.1	10.0	37.1	13.1	20.9	19.5	64.6	57.5	15.5	5.1	19.4	17.8	28.2	8.8	7.6
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663892-218672002	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA036420: AB_2675114, HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	10.9	11.4	18.5	8.9	18.6	7.3	10.9	18.3	21.0	12.2	17.1	12.0	6.2	12.7	15.8	11.7	12.4	10.8	13.9	18.6	19.7	10.4	11.1	10.4	14.5	18.4	18.4	14.5	11.5	15.1	11.4	11.4	19.0	11.8	8.2	7.0	11.0	13.9	15.0	14.5	7.9	13.6	18.5	10.3	9.4	14.3	19.2	15.1	14.1	17.1	11.9	14.0	9.7	19.0	18.8	20.4	22.1	24.6	27.6	17.5	20.4	27.3	43.5	58.0	53.6	32.4	13.2	11.6	17.6	42.3	35.2	19.5	22.1	33.9	31.0	16.4	27.3	22.7	21.3	34.6	33.6	19.3	20.6	33.9	30.9	55.5	44.7	21.4	31.0	40.9	27.4	24.3	41.1	45.3	20.6	20.4	32.9	16.2	23.4	23.2	15.5	15.9	36.3	21.8	19.5	23.8	18.1	17.2	28.4	21.9	20.6	25.6	26.6	40.2	20.5	19.2	31.1	23.7	13.7	23.5	33.4	19.1	25.7	58.6	21.5	32.6	26.0	21.3	24.8	25.7	25.7	27.2	17.1	30.4	29.0	23.2	17.1	30.5	25.2	15.0	25.9	24.8	18.5	18.6	18.3	21.0	18.6	19.7	18.4	18.4	19.0	18.5	19.2	19.0	4.2	0.0	0.5	5.2	7.8	6.2	4.8	16.3	6.8	7.7	3.4	3.7	4.0	10.0	8.9	1.8	8.4	12.3	4.5	7.4	15.6	12.3	16.8	6.3	8.1	7.6	1.2	2.1	6.2	12.9	9.7	7.5	9.7	4.8	7.0	5.9	8.9	7.1	13.2	5.0	5.8	5.5	8.2	5.0	4.0	5.3	7.2	5.5	8.8	2.8	8.9	7.9	9.2	3.5	4.9	12.7	9.6	12.8	8.5	3.8	7.2	14.8	8.2	5.0	26.3	5.6	9.2	19.3	12.8	5.9	6.8	10.0	8.0	8.5	6.1	3.6
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337309	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.73e-4)"	14.3	15.8	12.7	11.5	12.6	22.0	13.3	13.7	15.1	15.4	10.6	19.2	14.5	23.5	10.3	20.9	16.6	10.5	13.2	12.7	12.5	13.6	23.6	12.4	11.8	15.2	13.1	17.1	13.8	18.5	10.4	14.2	15.5	14.8	12.6	8.4	14.9	18.6	8.5	15.7	17.0	19.0	12.7	14.6	19.1	15.1	14.7	13.3	13.2	7.1	12.8	18.9	14.2	13.1	43.8	47.4	43.4	51.4	41.8	32.8	46.0	46.3	49.7	52.8	41.5	80.6	88.9	38.3	62.5	55.5	80.1	77.2	61.9	69.8	33.0	46.0	34.2	101.0	21.8	67.3	31.9	42.8	40.4	34.3	35.2	66.1	59.0	34.7	40.8	58.1	50.0	58.4	36.9	94.9	39.5	44.3	43.5	50.2	59.8	40.5	44.5	30.4	32.7	31.1	30.8	29.9	37.4	46.8	12.5	41.4	106.1	35.4	27.0	63.5	41.8	33.7	43.0	14.0	24.6	0.4	21.3	71.0	50.6	9.5	21.6	5.6	20.8	19.2	13.4	11.1	15.7	18.4	19.0	16.7	17.5	15.5	1.5	14.0	20.2	11.0	8.7	24.9	12.7	12.6	13.7	15.1	12.7	12.5	15.2	13.1	15.5	12.7	14.7	13.1	5.1	3.2	9.4	1.0	9.1	6.9	13.3	15.4	12.5	9.2	10.9	9.8	0.8	22.8	11.1	11.0	2.1	44.0	6.2	9.3	5.9	20.8	6.6	5.9	7.9	8.6	13.8	18.5	3.2	17.0	66.0	11.5	9.2	5.9	7.6	16.9	11.4	23.4	21.5	5.0	2.9	13.0	8.2	14.8	5.9	8.6	14.0	6.6	1.8	1.0	11.6	11.6	15.5	4.5	2.7	14.1	7.5	17.7	4.3	14.2	15.6	12.5	4.8	9.4	6.6	6.5	10.6	19.9	10.5	14.3	8.5	24.4	8.3	8.8	18.6	9.8
RNF31	"FLJ10111, FLJ23501, HOIP, Paul, ZIBRA"	ENSG00000092098	"Ring finger protein 31"	Q96EP0	14	24146683-24160660	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.0;Excitatory neurons: 8.8;Gastric mucus-secreting cells: 7.7;Inhibitory neurons: 8.2;Microglial cells: 10.3;Oligodendrocyte precursor cells: 9.5;Plasma cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"CAB009063, HPA048745"	Approved		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Cytosol		"CAB009063: AB_2127706, HPA048745: AB_2680509"	"unprognostic (3.58e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	14.3	18.5	4.9	9.1	4.8	9.5	14.3	4.2	6.6	16.7	3.6	15.0	7.1	18.2	6.9	16.2	14.8	6.9	19.6	4.6	4.1	17.5	15.8	14.9	10.4	5.3	4.4	17.8	23.9	10.4	18.7	6.9	4.5	16.6	6.6	4.1	16.9	7.1	41.5	19.3	15.9	9.6	4.5	26.1	17.9	16.4	4.8	11.7	16.5	17.9	9.6	15.1	14.0	4.4	6.1	10.8	10.5	14.8	6.1	6.3	23.2	9.9	15.1	18.2	15.6	10.2	13.5	10.9	6.9	11.8	10.2	7.6	5.4	11.8	9.7	13.2	4.2	11.0	9.5	32.5	12.8	17.5	18.8	12.3	10.4	7.2	12.9	9.6	12.0	7.9	5.9	12.9	7.7	17.3	17.6	8.6	5.3	9.9	12.7	10.1	9.8	6.8	8.9	20.8	9.9	12.7	8.6	25.6	12.5	9.2	7.4	13.3	11.1	12.6	10.2	8.8	8.9	21.4	21.2	11.5	4.4	6.1	13.6	0.0	0.8	0.8	0.6	1.7	1.8	0.4	0.9	0.6	0.5	0.4	0.6	0.4	1.7	1.7	1.0	1.8	1.1	0.4	4.9	4.8	4.2	6.6	4.6	4.1	5.3	4.4	4.5	4.5	4.8	4.4	0.9	0.0	4.6	16.0	5.2	0.6	0.3	0.0	4.6	0.6	1.0	0.3	0.3	0.0	3.1	0.0	0.0	0.6	1.0	0.8	0.0	0.3	0.1	1.0	1.3	1.3	0.0	3.8	8.8	0.0	0.5	1.3	7.7	0.9	0.0	1.1	0.4	0.8	0.4	0.0	8.2	0.3	2.0	0.6	1.5	0.4	0.3	2.7	0.0	10.3	0.5	0.3	3.1	9.5	7.3	0.2	0.2	0.0	8.7	0.2	0.5	0.2	0.8	0.8	0.0	1.4	1.2	1.6	0.8	5.7	0.9	0.5	4.3	0.8	0.1	0.3
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353979-37394734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 76.0"	"Not detected"	"Not detected"							"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	5.0	7.8	10.0	3.5	10.1	4.6	5.2	11.8	14.3	7.7	9.3	6.3	3.1	7.0	2.1	10.6	6.0	4.0	8.6	10.1	10.5	8.8	4.8	5.9	4.2	10.2	10.6	7.6	4.5	7.4	6.6	4.8	10.3	6.0	3.6	9.0	6.2	5.2	8.1	7.6	5.0	4.9	9.4	4.7	5.2	11.2	11.2	5.8	4.5	10.6	6.6	6.5	7.8	9.9	12.5	7.3	17.3	20.7	13.7	19.6	4.9	12.6	15.5	23.4	25.6	11.0	6.8	15.3	7.5	12.4	20.1	11.4	24.4	16.0	24.4	16.2	23.7	26.5	12.0	16.6	7.8	14.3	18.7	9.8	15.2	14.0	16.2	14.3	22.9	17.9	18.1	5.2	13.6	8.3	17.4	17.5	12.1	6.3	9.4	13.5	16.0	10.6	12.1	8.7	34.0	11.4	9.5	10.6	18.0	11.3	9.5	13.6	10.4	15.4	13.5	14.7	18.8	15.2	21.8	76.0	7.5	20.1	18.0	1.0	4.3	2.5	9.5	5.8	8.8	8.1	7.0	9.2	7.8	4.9	6.1	8.1	0.5	7.9	8.8	3.3	9.1	5.2	10.0	10.1	11.8	14.3	10.1	10.5	10.2	10.6	10.3	9.4	11.2	9.9	21.0	19.2	25.9	13.4	15.0	18.2	22.2	26.0	26.2	26.7	16.5	20.4	31.1	12.8	18.5	25.8	39.6	24.8	18.2	10.3	15.6	24.7	41.1	68.5	32.2	19.2	22.2	18.7	17.0	18.9	25.8	28.0	16.3	52.3	28.5	37.0	27.8	16.5	17.5	50.5	15.9	16.5	14.2	13.9	17.7	30.2	26.8	24.0	10.6	11.2	19.6	25.4	37.0	12.5	20.5	28.8	18.1	30.9	13.7	31.8	11.8	20.6	23.8	32.3	13.1	23.2	20.8	46.5	34.5	34.2	22.0	5.9	19.3	22.0	18.0	21.9
RNFT2	"FLJ14627, TMEM118"	ENSG00000135119	"Ring finger protein, transmembrane 2"	Q96EX2	12	116738178-116853631	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.8;pituitary gland: 5.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.9;Early spermatids: 49.3;Excitatory neurons: 22.7;Inhibitory neurons: 28.7;Late spermatids: 56.4;Oligodendrocyte precursor cells: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/84: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064161	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064161: AB_2685202"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.14e-5)"	"unprognostic (8.62e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.36e-3)"	"unprognostic (4.01e-4)"	0.4	1.0	9.8	0.5	9.8	1.0	0.2	5.7	13.8	0.2	2.9	0.3	0.5	0.2	0.8	0.4	0.3	0.4	0.4	10.6	8.4	0.7	0.1	0.3	1.1	11.8	7.6	0.4	0.2	0.4	5.1	1.0	11.9	0.2	0.3	4.9	0.6	0.2	0.6	0.6	0.5	0.2	4.2	0.8	0.3	3.7	7.9	1.4	0.5	0.1	1.2	0.2	0.1	9.3	1.3	7.3	2.9	9.8	0.1	0.1	6.8	0.5	0.5	1.6	1.2	3.3	1.2	6.5	1.9	0.1	2.2	1.3	7.8	0.6	0.9	7.0	4.6	1.1	5.5	2.4	1.1	0.5	4.9	0.2	0.1	3.6	0.8	0.9	0.3	4.4	8.0	2.1	0.1	4.0	7.6	1.1	4.5	1.9	1.3	4.1	1.5	3.4	2.0	1.2	5.0	4.8	1.8	0.8	1.9	2.6	5.0	1.7	0.4	1.0	4.5	2.2	2.5	3.6	14.9	8.5	4.0	0.5	0.6	1.1	0.2	0.2	0.3	0.1	0.1	0.7	0.3	0.3	0.1	0.8	0.6	0.7	0.7	0.5	0.3	0.7	0.2	0.2	9.8	9.8	5.7	13.8	10.6	8.4	11.8	7.6	11.9	4.2	7.9	9.3	0.9	0.0	0.5	11.8	2.2	0.0	0.3	0.2	0.0	17.9	0.7	0.3	1.2	1.5	0.2	7.3	16.7	3.1	0.3	0.5	0.0	0.9	49.3	0.7	0.3	1.9	4.2	0.4	22.7	0.2	3.0	0.6	1.1	0.6	0.0	3.8	0.4	0.2	2.2	10.1	28.7	0.8	2.0	1.9	0.8	56.4	0.6	0.7	1.8	3.7	1.0	5.5	0.0	18.6	7.0	0.6	0.1	1.5	2.0	0.2	0.6	1.0	1.4	10.3	0.0	0.7	0.9	3.8	5.2	0.2	0.0	1.6	0.5	1.1	0.8	0.2
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615116	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	18	"retina: 1186.9"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3239.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 2.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"HSkMC: 25.2;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028910, HPA073279"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA028910: AB_2672824, HPA073279: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	12.8	7.9	57.9	2.2	60.5	1.2	9.3	56.8	67.4	9.1	48.1	9.8	1.8	7.7	4.7	7.6	10.7	4.6	8.1	54.5	59.0	7.0	7.1	6.0	2.5	67.4	61.0	13.5	3.6	5.2	7.0	1.4	62.1	8.2	2.6	1186.9	4.2	5.0	3.3	5.4	5.3	5.4	60.0	7.5	7.0	6.2	63.1	1.6	6.0	3.7	2.5	9.6	7.3	62.1	3.2	1.9	3.1	6.6	4.5	22.0	0.6	2.1	3.7	4.3	2.8	0.9	5.3	3.0	15.9	12.2	2.0	4.1	1.5	4.2	1.1	5.3	3.0	3.1	8.6	4.0	13.0	1.1	0.9	25.2	5.9	4.5	9.1	15.1	7.0	1.2	4.0	6.5	9.1	8.3	1.7	2.3	0.8	1.7	5.9	1.6	2.6	19.1	5.0	1.8	3.3	5.1	5.0	5.8	2.5	0.5	8.1	1.4	8.3	7.2	2.7	8.3	2.5	2.9	31.9	2.4	14.2	3.1	1.5	0.0	0.4	0.3	0.3	0.1	0.9	0.2	1.2	0.3	0.2	0.3	0.5	0.6	0.1	2.7	0.4	0.3	0.4	0.5	57.9	60.5	56.8	67.4	54.5	59.0	67.4	61.0	62.1	60.0	63.1	62.1	19.9	0.0	4.4	4.9	0.6	3.7	5.7	5.0	7.4	356.6	3.8	7.2	2.5	2.8	2.3	5.5	594.2	1.0	0.6	2.4	1.9	1.6	2.0	1.0	4.1	31.3	4.2	0.0	0.2	3.1	0.2	4.1	1.1	1.0	1.3	1.2	21.8	1.7	1.1	171.6	0.5	2.8	0.0	1.9	0.8	7.9	19.0	1.2	3.6	1.9	1.3	516.9	1.0	1.0	6.5	2.1	2.5	5.7	0.6	3.1	3.1	4.7	2.7	3239.7	0.0	2.5	4.3	1.6	5.1	5.3	1.0	0.7	1.5	4.0	2.9	3.1
RPAP1	"DKFZP727M111, FLJ12732, KIAA1403, MGC858"	ENSG00000103932	"RNA polymerase II associated protein 1"	Q9BWH6	15	41517176-41544269	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041739	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA041739: AB_2677647"	"unprognostic (8.83e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (4.30e-3)"	7.0	5.7	4.9	6.1	5.4	3.5	5.1	4.4	5.2	5.4	3.7	7.2	5.7	6.4	3.2	8.1	6.7	3.9	6.7	5.1	4.2	4.0	4.9	4.7	7.2	5.0	5.1	8.0	5.9	7.2	3.9	5.9	4.8	6.1	4.6	2.8	7.0	5.6	19.0	7.0	5.2	6.6	4.7	6.5	6.1	6.5	5.0	6.9	5.2	11.6	6.8	6.9	5.3	5.9	13.3	15.3	20.8	21.9	17.1	12.3	17.7	12.8	11.0	16.4	15.8	42.3	11.7	10.3	20.6	14.2	26.1	30.5	37.9	18.7	13.8	18.3	18.5	19.6	21.2	18.8	10.7	16.3	11.9	12.6	23.3	19.2	13.3	11.0	18.4	23.1	46.4	11.5	15.2	8.3	17.6	10.0	36.9	20.3	14.3	31.4	18.0	11.2	7.2	30.5	19.0	25.4	16.4	16.9	8.8	18.0	28.1	20.0	16.9	25.3	16.4	25.5	20.6	19.2	57.5	11.6	18.1	17.4	24.4	0.0	1.9	0.0	4.6	2.4	4.0	2.9	2.6	2.8	2.9	3.3	3.7	3.4	0.0	3.1	4.4	1.9	3.1	2.5	4.9	5.4	4.4	5.2	5.1	4.2	5.0	5.1	4.8	4.7	5.0	5.9	4.1	3.2	5.4	10.4	7.7	2.8	4.4	4.6	8.6	10.2	5.1	5.2	9.0	2.8	4.7	5.5	12.5	6.5	6.1	3.9	1.9	5.5	1.5	3.7	6.5	5.8	2.4	11.2	7.7	5.3	5.8	6.1	8.6	5.2	2.5	11.9	5.0	9.6	4.8	16.8	6.7	5.6	6.1	5.2	2.8	1.7	3.7	3.5	1.8	6.5	6.0	5.0	5.2	7.5	9.3	5.3	2.7	9.4	4.4	6.7	4.1	3.0	5.2	7.4	0.0	6.5	4.6	10.6	9.5	6.1	4.1	2.7	7.0	10.8	7.5	3.1
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022260	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	21.9	27.6	15.9	20.1	20.0	19.4	25.4	18.3	21.7	19.7	11.9	24.0	21.8	22.6	22.3	29.1	21.0	19.8	14.5	16.2	14.7	30.0	27.4	17.9	25.1	11.0	13.3	25.4	15.1	21.0	17.2	29.4	12.8	22.5	31.8	17.8	20.6	31.1	11.0	19.7	19.8	29.3	14.6	19.2	24.2	15.3	16.5	22.9	29.5	27.4	29.4	27.4	17.4	23.1	62.4	81.0	47.5	47.9	71.3	68.0	85.4	80.2	60.9	67.9	93.1	118.7	92.1	39.9	50.6	58.8	104.1	59.9	69.7	81.9	103.3	49.7	47.8	78.2	112.3	112.3	98.8	80.7	56.1	51.7	75.4	83.2	107.5	60.2	94.8	39.1	79.7	57.2	55.5	106.7	43.5	63.5	68.2	121.4	59.8	52.4	58.4	56.7	78.6	94.7	56.6	31.4	70.2	63.7	52.3	85.6	54.4	85.2	80.0	96.7	66.9	47.5	73.8	31.9	49.5	88.6	69.6	76.0	62.5	20.2	40.2	19.1	23.1	51.0	19.8	20.2	17.7	21.7	69.5	21.6	23.4	21.0	3.7	77.2	34.8	25.4	26.7	28.8	15.9	20.0	18.3	21.7	16.2	14.7	11.0	13.3	12.8	14.6	16.5	23.1	14.9	6.4	7.5	14.4	13.1	16.6	15.2	21.6	13.1	13.2	13.2	10.3	6.2	10.0	20.1	18.4	20.9	35.4	18.1	14.0	31.3	24.5	10.7	13.5	17.4	14.3	10.2	17.2	61.9	17.5	42.8	17.4	14.3	11.2	6.3	18.1	18.2	17.5	37.0	10.1	44.7	14.6	14.2	19.4	45.8	11.8	11.1	17.2	14.2	15.0	19.7	8.9	26.8	27.2	39.2	19.4	11.6	14.7	12.2	19.9	14.2	48.6	15.9	12.7	6.6	11.1	16.1	14.7	17.4	20.1	20.3	25.6	10.5	24.8	21.3	14.8
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.1;Cone photoreceptor cells: 8.4;Ionocytes: 2.0;Rod photoreceptor cells: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA						"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.0	3.1	0.0	0.0	1.9	0.0	0.7	0.0	8.4	0.3	1.3	0.5	0.0	0.5	0.1	0.1	0.0	0.3	1.8	0.0	0.6	0.2	0.5	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.5	2.0	0.0	1.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.5	0.1	0.2	4.4	0.0	0.0	0.4	0.1	0.3	0.0	0.3	0.4	0.1	0.0	0.7	0.0
RPL10L		ENSG00000165496	"Ribosomal protein L10 like"	Q96L21	14	46651010-46651781	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 92.0"	"Group enriched"	"Detected in some"	17	"Early spermatids: 581.2;Late spermatids: 224.4;Spermatocytes: 310.1"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"U-2 OS: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011311	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"HPA011311: AB_1856431"	"unprognostic (7.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.70e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	92.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	41.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	10.4	0.3	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.2	0.0	2.2	0.0	0.0	581.2	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.3	19.2	224.4	6.2	0.9	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	0.0	6.6	0.1	0.1	0.1	0.0	6.6	2.9	20.8	310.1	14.7	0.0	18.8	0.3	2.4	0.2	2.0	4.3
RPL13A	"L13A, TSTA1"	ENSG00000142541	"Ribosomal protein L13a"	P40429	19	49487510-49493057	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038751	Approved		Approved	Nucleoli,Cytosol		NA	NA		44000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA038751: AB_10962004"	"unprognostic (2.35e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.81e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.87e-1)"	2188.0	2248.7	1092.3	1522.1	1122.8	3160.3	2279.6	1064.6	1616.8	2808.8	1147.7	1987.3	1681.3	1743.7	742.1	2699.3	2138.4	1061.8	1522.6	1034.5	1074.4	1532.8	1642.1	1467.3	2995.9	1117.3	1065.6	4462.0	4145.5	956.8	1244.7	1070.5	1119.3	2042.8	957.8	585.8	2381.8	963.3	2940.7	3275.0	1966.3	780.3	1131.1	2267.8	2148.1	451.9	1123.9	2070.4	1594.9	1484.8	1783.2	2092.3	2369.7	1115.7	2693.9	3191.9	1553.5	4384.1	2927.6	4606.7	1812.7	2265.3	2944.1	1696.6	1823.7	2817.9	2001.2	6730.4	1792.9	1804.0	687.0	1724.4	1978.2	3463.6	974.1	1895.7	4496.8	3377.7	1945.3	3984.3	3562.3	5127.9	2581.9	5363.6	5688.6	1203.5	4051.7	3536.9	2763.2	2430.9	2982.0	2472.0	1975.0	2322.6	3629.2	5266.7	2905.4	2535.0	2987.2	3504.5	3396.6	2968.4	2319.3	4481.3	2545.5	3362.0	1184.7	5205.9	5408.7	1180.0	2303.0	5907.2	3249.6	2026.5	2165.3	1276.1	3061.9	2474.5	3628.5	3102.4	1267.1	3505.6	1898.9	1499.6	2615.2	669.3	3673.1	2167.5	5384.1	8504.2	6249.9	5035.0	3741.0	7985.6	7293.6	5930.8	400.5	4696.2	1914.5	4364.8	5054.0	13490.7	1092.3	1122.8	1064.6	1616.8	1034.5	1074.4	1117.3	1065.6	1119.3	1131.1	1123.9	1115.7	759.0	1618.6	1998.3	5.9	5793.5	11583.3	12255.7	8593.4	1801.8	534.6	8903.0	5580.5	544.1	4340.8	4712.7	1590.9	214.8	7997.8	3602.5	2445.5	5433.2	4560.9	304.1	1462.1	3740.3	3725.7	3984.3	2696.0	5.1	12776.9	10340.4	3277.8	916.9	2114.2	2546.8	1496.7	5087.0	4397.2	5887.8	220.4	6.0	7002.5	2705.8	7291.2	8449.9	709.7	9127.2	3169.3	5695.4	9.4	7891.8	1658.7	5864.1	8.0	12.4	7364.8	6114.5	4432.7	1348.9	11217.2	5888.9	7303.9	2192.4	723.4	2655.9	5724.7	2897.9	456.9	817.2	2602.1	14282.8	8401.6	4958.9	2454.2	8198.9	13221.0
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859910-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 682.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055259	Approved		Approved	Nucleoli,Cytosol		No	No		44000	"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA055259: AB_2682764"	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	1984.9	1325.9	783.3	1207.3	801.9	2675.9	2006.4	765.1	966.5	2276.5	976.5	1896.2	1072.6	1684.5	414.2	2432.1	1900.0	848.3	1178.2	738.0	778.4	1205.8	1161.2	1350.6	2511.2	806.4	757.5	3627.6	3907.4	541.6	923.3	757.2	789.9	1596.6	718.5	205.8	2590.5	635.5	2533.1	3581.5	1721.9	686.3	819.5	2048.4	1928.7	350.6	801.3	1573.9	1398.1	1213.3	1488.2	1737.1	2164.1	808.5	2623.4	2001.4	1299.0	1847.0	1923.3	3152.4	3291.2	1559.5	1979.9	2038.9	1930.5	2789.2	2550.3	3921.7	3523.0	1365.1	805.3	1913.5	1555.9	3350.6	708.6	2020.7	4206.5	1833.5	1792.6	3238.9	3314.5	2660.3	1916.4	3952.5	4349.3	1127.8	2410.2	2094.2	2265.6	3157.8	2386.5	2462.6	1313.5	4085.3	3633.0	3514.7	3067.9	2909.3	3049.2	3210.9	1376.3	4708.0	1887.0	2464.1	1879.4	2817.6	554.3	3813.0	5042.2	637.7	1814.7	5079.9	1738.1	1244.6	1438.8	2512.2	2674.5	3251.9	3283.4	2639.9	1632.9	4270.0	1580.0	1247.5	4513.0	690.0	4974.8	4521.9	8679.3	14996.3	8499.1	6207.0	6569.7	15438.5	9988.2	7821.6	433.2	5415.3	3633.6	7634.4	8027.2	21239.5	783.3	801.9	765.1	966.5	738.0	778.4	806.4	757.5	789.9	819.5	801.3	808.5	1797.3	519.2	1033.4	1.3	6570.0	8683.5	6503.8	6346.6	5314.4	252.0	7203.4	8120.9	437.2	2077.4	2572.8	923.2	127.2	4676.6	3414.9	1440.2	2387.0	3503.1	57.0	1112.5	3101.7	2919.9	1842.7	2735.0	1.8	8949.1	8763.1	2652.7	2316.6	1639.3	1447.9	3627.9	2837.8	2144.2	3317.2	131.2	2.2	3965.3	1881.8	4748.0	8399.9	194.1	4165.1	3240.6	4747.4	1.9	6119.2	908.2	3084.5	1.5	2.5	5684.1	3130.7	1627.9	3619.6	6541.4	3169.3	3629.8	1019.5	499.6	1255.6	3061.1	4561.4	199.9	834.7	6806.4	11135.4	4659.3	4511.8	4057.7	4606.2	8094.9
RPL23A	L23A	ENSG00000198242	"Ribosomal protein L23a"	P62750	17	28719985-28724359	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA051754, HPA077474"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		86000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA051754: AB_2681593, HPA077474: AB_2686841"	"unprognostic (1.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (3.91e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.68e-1)"	1584.8	1113.1	654.3	671.5	688.0	1394.2	1570.3	652.4	1022.2	2187.2	625.1	1445.1	612.6	1394.1	718.6	1571.9	1634.3	535.3	1187.3	618.4	650.0	1099.0	883.0	1093.0	1433.2	673.2	651.5	3435.1	1784.0	525.5	1098.5	674.5	679.4	1319.5	821.4	343.6	1355.9	639.7	2007.1	2167.8	1341.4	670.2	718.7	1621.7	1365.0	394.3	691.1	970.1	1098.0	887.1	1529.3	1516.5	1724.7	701.9	1011.7	2016.2	1187.9	1478.2	1541.3	2460.3	1167.5	919.9	1609.3	1530.9	1285.0	2069.6	945.7	2272.0	842.9	1288.6	794.8	1336.2	1604.1	2059.1	1570.9	1207.4	4393.8	1090.0	1875.4	2228.4	1393.9	2286.0	1078.5	2415.4	2592.8	1218.4	1907.0	2198.5	1679.1	1024.9	1440.9	1494.0	1555.3	1668.7	2566.5	3014.5	1145.8	2554.4	1212.9	1485.1	2158.1	2703.9	1672.0	2029.6	1233.6	1432.9	656.5	4676.5	2224.2	1655.3	2336.4	2637.5	1009.1	833.0	1177.1	985.4	1663.8	1819.6	1831.8	1323.2	1314.2	1241.1	939.6	1095.3	1931.7	552.4	4031.6	2107.3	5926.1	6793.2	5786.8	5255.4	2964.7	5683.7	6315.4	5951.4	244.7	4162.0	1738.1	3784.3	4293.0	7336.1	654.3	688.0	652.4	1022.2	618.4	650.0	673.2	651.5	679.4	718.7	691.1	701.9	987.8	862.2	1387.4	42.1	4276.8	5192.7	5364.3	4497.6	1889.4	237.4	3483.7	2581.2	292.2	2254.7	2254.3	864.4	70.9	4486.2	3010.4	1253.0	3083.4	2444.1	968.0	1089.8	2060.3	2031.0	1846.3	1943.9	13.5	4593.6	6595.0	1928.4	821.6	1503.9	1512.6	1814.9	2939.2	2626.6	2651.7	163.2	17.2	3659.6	1310.2	3406.8	5015.0	360.5	4557.4	1983.9	3066.4	14.0	3997.3	1072.1	4293.5	16.1	23.3	2801.3	3326.6	2366.6	1803.5	5056.3	2925.9	3669.2	886.9	363.6	1709.2	3461.4	2748.7	674.8	779.0	2554.1	6196.5	4927.6	3651.6	2266.4	3979.8	5957.0
RPL26	L26	ENSG00000161970	"Ribosomal protein L26"	P61254	17	8377516-8383213	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030449, CAB037301"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"CAB037301: AB_796168, HPA030449: AB_10602125"	"unprognostic (2.02e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.38e-1)"	2647.0	1834.7	1444.0	1225.0	1483.6	3862.9	4202.6	1437.9	2302.9	2923.7	1394.3	2148.4	1286.2	1911.1	2229.1	2565.8	2254.3	1396.5	1756.1	1402.1	1503.8	2006.1	1826.0	1615.6	3047.7	1494.3	1433.2	4732.1	3616.6	1250.6	1067.0	1536.3	1496.7	2026.5	2044.1	815.9	2073.2	1272.7	2625.9	3123.9	1921.8	1379.7	1515.1	2060.3	2137.9	548.8	1463.6	2241.2	1926.2	1911.5	2840.0	2178.2	2560.6	1538.3	2791.7	2553.3	2428.3	2899.9	4595.7	7595.7	2377.2	2357.4	3627.6	3234.3	2430.6	2732.4	1406.4	4875.0	2641.6	2899.3	1278.3	3012.9	3173.2	4954.7	3806.7	1824.4	5711.8	1893.9	2682.1	3218.0	5344.6	2835.2	2347.9	6463.5	9908.8	2638.4	7949.9	4443.9	4106.5	2739.0	2210.9	1423.8	3478.6	1967.6	3153.9	3903.4	2275.5	2924.4	1691.8	3097.3	2453.7	3094.4	4394.8	2116.9	1014.7	2144.2	1268.6	2353.7	5882.6	2142.4	2417.5	3740.1	2492.5	1270.3	1564.9	1765.2	4201.2	1119.0	1485.1	2188.6	2074.1	4071.7	1920.7	490.8	1528.6	300.6	1323.8	1277.1	1928.7	2409.5	1960.7	1734.1	1901.2	2152.5	2270.0	2008.9	167.6	1562.4	1173.0	1634.7	1803.3	3235.4	1444.0	1483.6	1437.9	2302.9	1402.1	1503.8	1494.3	1433.2	1496.7	1515.1	1463.6	1538.3	2207.3	897.4	1239.5	29.0	4966.6	5577.5	3390.4	3434.2	4618.4	256.5	5263.8	5691.4	292.0	3039.7	1994.1	1004.2	133.5	4514.0	3481.7	1395.1	3946.3	2664.5	884.0	1146.1	2485.1	2507.8	2284.5	2894.1	39.3	4897.5	7026.7	2100.3	1725.3	1470.3	1868.6	1738.7	3416.5	2960.2	3431.5	136.3	33.9	4440.7	1062.0	5356.7	6335.6	1657.9	4777.0	3085.5	3198.1	45.9	6036.5	747.5	3887.8	22.1	39.7	3561.4	3590.4	2157.9	2546.9	3577.0	3412.0	5475.1	856.5	477.7	1512.0	4011.2	2218.8	568.4	716.4	6164.5	7093.8	4568.3	3804.2	2012.8	4955.7	3367.7
RPL26L1	RPL26P1	ENSG00000037241	"Ribosomal protein L26 like 1"	Q9UNX3	5	172958729-172969771	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 408.0;Spermatocytes: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030449	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA030449: AB_10602125"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-3)"	27.4	45.8	28.0	28.9	29.2	39.1	27.3	29.7	39.1	23.5	26.4	24.5	25.2	28.5	37.7	37.5	26.6	22.1	37.8	31.0	29.8	43.7	47.9	22.1	34.4	29.3	28.9	25.7	24.9	34.5	30.3	23.8	30.6	25.5	26.2	17.9	24.6	28.9	37.8	21.3	21.9	26.0	28.1	26.8	26.2	91.2	29.3	34.0	29.5	28.1	29.0	30.4	25.4	29.1	129.8	114.7	101.9	140.8	68.9	72.3	131.7	120.6	70.6	170.5	151.1	141.1	135.3	96.6	301.5	166.6	181.6	82.1	170.1	239.8	156.4	124.1	220.9	71.6	122.8	174.5	135.1	105.7	60.8	91.0	99.2	176.1	122.3	69.1	99.2	93.6	100.3	79.0	123.1	286.6	129.5	165.6	65.2	59.7	180.5	93.3	157.5	128.4	101.0	80.1	102.0	62.7	110.6	100.2	167.6	64.7	122.8	111.5	105.4	193.2	109.0	114.3	92.5	70.3	119.0	182.3	152.6	130.2	117.6	25.4	86.6	39.9	33.1	80.5	42.7	50.4	40.4	46.1	99.5	38.1	32.9	42.0	42.9	39.5	72.2	68.1	55.8	55.7	28.0	29.2	29.7	39.1	31.0	29.8	29.3	28.9	30.6	28.1	29.3	29.1	41.5	41.7	32.8	4.6	29.8	48.8	56.9	191.3	32.5	18.8	50.2	61.8	45.5	41.5	82.7	58.8	18.8	111.6	28.7	36.2	181.9	119.0	408.0	98.4	70.0	47.7	40.2	49.2	4.5	113.0	124.5	45.3	29.6	70.6	26.6	60.2	41.4	132.1	115.0	15.2	5.2	48.6	93.6	48.6	51.9	79.9	37.9	45.6	51.6	2.8	93.5	61.7	49.4	2.0	5.0	138.0	38.6	41.0	59.2	67.9	48.2	216.2	92.4	20.2	19.7	35.6	56.1	316.7	178.6	70.5	52.8	78.9	28.9	81.1	59.1	57.7
RPL30	L30	ENSG00000156482	"Ribosomal protein L30"	P62888	8	98024851-98046469	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002651	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		310000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA002651: AB_1079842"	"unprognostic (3.28e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.97e-3)"	2169.1	1286.7	1542.9	1403.8	1616.7	3766.6	4078.2	1552.0	2178.4	2624.2	1490.6	1879.4	1171.1	1990.6	2424.1	1907.8	2592.8	1319.4	1503.2	1501.7	1591.6	1375.6	2352.0	1477.3	3296.1	1596.1	1538.2	5616.9	2583.9	1413.7	1079.4	1341.1	1621.2	1773.7	1967.2	634.7	2148.1	1530.1	2778.6	2895.1	1788.4	1618.1	1613.6	1983.8	1841.8	658.7	1566.5	3112.9	1744.0	2442.9	3898.8	2116.9	2144.4	1661.2	3358.5	2302.6	2395.7	2319.1	3463.7	6460.5	2290.5	1929.4	3501.7	3277.9	2880.0	2560.3	3121.6	4403.5	4934.1	2851.4	1408.4	2158.4	3072.1	3675.9	3436.7	1734.7	2547.3	3817.6	2173.7	3445.6	5063.9	2047.0	1830.0	5463.0	5859.2	2408.7	6912.4	3818.6	3479.7	3804.8	2814.6	2850.5	2866.9	4562.1	4848.6	3870.2	2142.9	8254.3	3304.7	2578.5	1815.0	4130.4	2718.3	3174.1	3464.7	2947.9	1117.1	2785.7	4699.0	2414.5	3667.8	4793.0	1873.6	1253.2	1328.9	1885.1	2357.7	2931.8	2681.4	3686.5	1758.0	4203.3	1869.4	1087.1	1542.9	674.9	2014.7	1325.2	2975.8	3533.8	3482.3	2704.0	1937.3	3224.2	4471.8	3686.3	520.5	2037.1	1212.6	1921.8	2476.6	4634.7	1542.9	1616.7	1552.0	2178.4	1501.7	1591.6	1596.1	1538.2	1621.2	1613.6	1566.5	1661.2	3373.1	852.5	1462.3	22.2	6269.8	3791.4	4320.2	2146.2	5538.1	251.5	4342.6	9218.9	66.3	1441.3	1424.1	555.4	139.7	2675.7	4184.6	1233.9	1792.1	1872.1	1333.5	1359.6	3432.8	2196.1	1647.4	2350.9	24.2	3733.5	3914.4	2206.6	1829.8	1820.2	1560.7	3526.6	2224.6	2204.3	2298.9	144.7	28.3	3237.2	642.9	2912.4	4020.1	2532.2	4373.5	3115.9	1988.6	33.7	3957.1	1623.5	3901.2	18.1	54.5	2580.0	2676.0	2403.1	3084.7	4207.4	2142.3	2511.0	640.5	392.2	1406.8	3481.1	2754.6	926.1	635.4	5831.2	4174.6	2901.7	5319.1	2561.6	3407.3	4410.9
RPL32	L32	ENSG00000144713	"Ribosomal protein L32"	P62910	3	12834485-12841582	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047501, HPA051994"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		45000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA047501: AB_2680070, HPA051994: AB_2681686"	"unprognostic (6.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.44e-2)"	1907.8	1194.0	1183.6	985.6	1234.6	2971.9	2518.6	1157.9	1625.9	2186.9	1121.8	1558.0	888.8	1458.5	2020.0	1799.9	1857.7	928.0	1266.4	1148.0	1212.7	1252.7	1295.7	1185.9	2346.7	1206.9	1168.5	3697.3	2765.5	775.2	986.3	974.3	1231.2	1537.4	1561.1	523.9	1561.0	780.3	2422.9	2644.1	1380.3	1321.4	1242.7	1511.9	1420.5	567.9	1204.2	1741.0	1134.2	1544.1	2984.9	1566.9	1867.1	1268.7	1494.9	1746.7	1497.4	1918.8	2298.7	4080.5	4927.7	1200.0	2217.5	2476.7	1684.5	2327.2	1482.5	2572.0	1066.1	1735.3	812.9	909.5	1718.2	2495.2	2023.2	1198.1	2874.3	1501.4	2099.3	2562.1	3427.6	2450.0	1456.5	3696.3	5338.3	1895.4	3629.5	2438.7	2198.5	1863.5	1879.0	2323.9	2054.2	4479.6	2773.8	4208.3	2534.9	2129.5	3285.7	2180.2	1344.1	3390.6	2540.9	2434.9	945.7	1887.9	807.8	2141.2	2740.7	1329.5	3137.0	4624.7	1280.6	1066.6	1359.4	1419.3	2254.0	1557.7	2671.2	4640.8	1357.9	3466.6	1629.6	1259.1	2347.0	621.3	2399.6	1800.7	4325.6	5980.2	4749.7	3485.2	3077.9	5413.0	6661.3	5216.7	320.4	2897.7	1489.1	3049.5	3940.9	9478.6	1183.6	1234.6	1157.9	1625.9	1148.0	1212.7	1206.9	1168.5	1231.2	1242.7	1204.2	1268.7	3508.6	1070.5	1834.7	48.6	7663.9	9224.7	7932.7	5817.1	6926.2	342.4	9401.1	14609.2	488.6	3061.2	2689.8	1460.3	166.8	4947.7	4337.7	1512.3	4560.6	3028.0	1986.6	1422.0	4295.9	4075.7	2307.8	4056.3	39.3	6515.0	7623.3	3321.2	2414.9	1972.5	2387.6	3801.4	4734.3	3694.7	4285.0	180.0	41.2	5268.2	1723.2	5797.3	8513.9	7985.2	6662.4	3978.7	4845.2	43.1	6310.8	1703.6	4092.7	18.1	47.3	4383.7	3899.5	2998.1	3398.6	7138.0	3381.8	6786.8	1088.2	684.5	1965.6	5442.0	4616.2	1064.1	1260.6	8612.8	10963.5	4878.3	6299.1	5026.8	5534.7	8006.9
RPL35	L35	ENSG00000136942	"Ribosomal protein L35"	P42766	9	124857880-124861981	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006047	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA006047: AB_1856443"	"unprognostic (1.16e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.58e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	1898.8	1508.6	1462.7	973.8	1489.9	2729.0	1959.9	1434.2	1780.8	2116.4	1400.9	1768.2	809.5	1343.7	793.9	2540.7	1694.2	839.0	1467.3	1421.2	1502.6	1380.8	1746.4	1271.3	1990.2	1480.9	1456.2	3011.1	3413.2	853.0	1225.5	743.7	1484.9	1709.2	708.6	273.8	1811.1	736.6	2552.7	3033.7	1383.2	717.4	1498.9	1708.9	1567.2	669.4	1507.0	1569.3	1349.1	1589.5	1380.7	1655.0	2080.7	1516.5	2104.6	3225.4	1780.5	2469.8	1923.1	4033.9	2443.2	1626.3	2589.3	3295.8	2235.0	5370.0	2030.1	3127.8	1631.9	1836.1	1970.9	3986.3	2097.6	3578.7	1209.0	1929.9	3742.5	1266.5	4071.9	3541.9	3433.2	2856.0	1626.0	3759.1	5481.9	1973.9	3480.3	1809.7	2473.6	2927.1	2775.1	3857.2	2523.6	6848.9	3384.5	6510.7	3362.5	6272.1	4016.6	2849.6	2744.6	7026.2	2896.8	2469.0	2412.8	1946.7	1466.3	3452.9	3423.3	876.8	3508.4	4592.6	1269.5	1472.5	1558.9	2578.9	3357.6	2151.5	5523.9	4935.8	2059.7	2982.8	2523.1	753.7	1769.0	695.2	2322.2	1602.3	3101.1	4455.5	3086.5	2676.2	2564.2	4099.1	3218.0	2834.7	221.1	2414.5	1352.2	3650.6	2715.7	7293.7	1462.7	1489.9	1434.2	1780.8	1421.2	1502.6	1480.9	1456.2	1484.9	1498.9	1507.0	1516.5	1202.7	637.8	1152.6	15.3	3024.6	5507.5	4326.2	3639.5	1752.9	221.3	4389.9	4459.0	750.7	1732.9	1653.3	1134.8	85.5	2799.3	2227.9	1319.7	2701.9	2347.8	1562.9	826.5	1969.5	1751.1	1298.1	2073.6	9.0	6137.7	4495.9	1544.5	976.6	1135.5	1308.1	2164.6	2362.3	3182.4	2826.7	109.4	9.7	3044.7	1249.2	3375.2	4877.3	6025.8	2777.4	1833.7	2821.1	11.2	3348.5	925.7	2482.0	9.5	16.2	3542.4	2346.8	1285.2	1756.4	4196.5	2319.0	3772.0	618.9	410.0	992.7	2309.7	3771.2	790.9	905.5	3017.8	7263.3	2464.8	2473.5	1760.1	3346.1	3998.4
RPL36A-HNRNPH2		ENSG00000257529	"RPL36A-HNRNPH2 readthrough"		X	101391011-101412297	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 39.9;Club cells: 29.1;Fibroblasts: 8.8;granulocytes: 27.8;Respiratory ciliated cells: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (3.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"		"unprognostic (4.65e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.04e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-1)"	155.5	114.7	141.9	147.6	149.9	473.9	371.3	140.5	211.3	169.5	142.0	178.1	120.3	131.9	91.3	82.4	124.0	56.9	68.9	139.2	147.0	103.1	136.9	84.1	206.9	145.8	140.6	430.7	198.7	116.1	0.3	117.0	146.1	111.6	133.6	38.7	163.1	96.2	194.2	115.9	142.0	89.7	152.1	149.1	138.2	32.9	147.3	348.5	82.7	188.2	223.7	208.3	0.5	153.8	479.9	63.6	351.8	196.0	556.6	603.8	207.1	411.5	307.5	363.4	528.3	37.6	249.6	1272.3	379.1	379.3	282.1	312.4	692.9	639.6	308.0	494.4	334.8	589.7	99.9	58.4	726.0	839.5	372.7	837.9	498.0	458.3	744.0	628.2	359.2	413.5	590.6	507.6	266.5	119.0	364.7	535.8	425.9	1038.7	262.3	388.8	984.7	647.3	412.1	29.5	230.9	445.6	512.1	373.3	416.7	288.6	171.7	707.0	594.4	115.8	314.9	330.7	357.0	374.5	651.9	710.4	186.8	1188.4	141.9	97.1	324.6	105.0	284.3	334.8	348.1	373.2	363.3	332.4	450.1	354.6	364.2	357.9	57.5	277.5	292.2	306.2	274.4	605.1	141.9	149.9	140.5	211.3	139.2	147.0	145.8	140.6	146.1	152.1	147.3	153.8	0.0	12.8	39.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.5	0.0	0.0	8.8	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0
RPL36AL	RPL36A	ENSG00000165502	"Ribosomal protein L36a like"	Q969Q0	14	49618530-49620626	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (1.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.00e-1)"	279.7	310.9	234.2	246.4	241.7	404.2	328.6	232.1	349.8	381.8	221.4	331.8	260.5	280.7	492.7	277.4	315.9	162.6	273.2	225.1	244.6	255.3	372.3	240.5	311.9	244.4	237.3	501.3	628.8	220.0	252.9	176.7	240.6	250.8	248.8	102.0	327.5	253.2	378.6	247.6	284.9	197.9	242.0	294.2	360.3	137.6	240.5	283.4	211.2	206.5	377.1	297.8	285.9	246.2	635.8	473.9	330.1	192.6	471.3	649.8	194.9	508.9	569.9	475.4	534.7	499.0	426.1	833.4	474.5	430.3	327.9	443.5	287.6	441.3	554.8	288.1	331.1	521.6	527.5	652.8	595.1	838.8	426.0	667.8	668.2	362.7	485.9	553.7	614.6	367.3	339.5	714.4	372.8	831.7	496.5	752.6	186.0	452.1	482.0	308.6	519.5	449.5	730.7	964.2	290.3	178.1	448.5	350.8	544.1	313.0	762.2	460.1	468.2	291.3	463.0	382.3	399.8	427.6	487.0	842.7	210.5	376.9	283.7	1308.9	603.0	935.1	823.8	582.2	1113.2	959.3	1070.1	1040.5	614.8	729.1	984.7	937.6	654.0	806.3	542.2	1008.3	1096.2	1506.1	234.2	241.7	232.1	349.8	225.1	244.6	244.4	237.3	240.6	242.0	240.5	246.2	453.2	307.7	395.4	11.4	666.4	945.7	1352.2	1151.7	422.3	110.9	674.6	1022.1	662.4	652.0	643.5	312.6	25.0	690.0	778.0	871.5	995.9	739.8	614.3	490.0	431.4	515.5	366.2	535.9	14.1	1371.2	720.9	523.6	381.3	543.7	716.4	369.2	591.8	920.1	778.5	80.8	16.0	793.7	520.8	814.1	1020.0	236.4	725.7	585.0	843.1	22.5	1045.3	368.1	930.0	11.6	22.9	1311.2	1063.8	534.1	853.2	1279.2	1151.2	1194.4	579.1	127.7	486.4	693.6	898.3	364.7	150.2	390.6	839.3	516.3	888.1	355.4	620.5	1412.3
RPL37A	L37A	ENSG00000197756	"Ribosomal protein L37a"	P61513	2	216498825-216579180	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA065327	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		87000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA065327: AB_2685469"	"unprognostic (9.94e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.84e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.67e-1)"	2894.2	2485.3	3571.1	1229.7	3641.9	2540.7	3450.6	3500.1	5561.8	3540.4	3427.6	2751.2	1111.0	2511.3	1607.3	3586.9	2970.5	473.7	2704.2	3470.4	3604.5	2072.8	2064.6	1905.6	1484.2	3596.9	3545.7	5492.1	4241.2	2106.3	2029.8	971.3	3587.7	2527.0	1539.4	1236.7	2385.3	1378.1	5240.2	4441.1	2070.2	1297.7	3658.7	2374.5	2568.6	1257.5	3665.2	3015.1	1910.2	4156.0	2246.3	2758.2	3080.7	3688.7	2117.5	1757.0	3750.8	2542.5	3820.2	6666.2	2783.2	2804.7	3711.8	2778.8	2362.0	4478.9	2000.9	2310.8	3821.8	3450.3	3000.1	2165.8	3570.4	4118.4	2861.6	2653.7	3779.3	3786.9	3130.5	6449.1	6532.0	4206.8	2285.8	7292.0	8500.4	2410.8	6755.9	7614.5	3897.7	4509.9	3008.0	3296.4	3653.4	4222.0	4025.0	8611.8	4350.4	4680.8	1985.4	2874.3	2818.9	2846.9	3975.2	3650.5	2425.5	2719.7	1032.7	3199.3	6926.2	5291.2	2027.5	7146.0	2649.0	2006.9	2201.6	1991.6	3119.4	3471.7	5348.9	4515.3	2242.4	2876.4	2081.6	1025.7	2303.5	546.8	2463.3	1720.1	3379.1	4446.9	3801.3	3078.0	3061.9	4258.4	4343.3	4006.9	281.8	2725.4	1469.9	4230.5	3011.4	6099.2	3571.1	3641.9	3500.1	5561.8	3470.4	3604.5	3596.9	3545.7	3587.7	3658.7	3665.2	3688.7	1310.3	1198.7	1865.0	20.2	3813.1	4936.9	3370.7	3086.2	2318.0	513.1	5676.7	3353.1	1482.9	2713.7	2139.1	1265.3	185.6	3021.4	2978.5	1879.2	3155.8	2994.2	3958.3	1634.1	3979.9	2334.0	2623.6	2835.7	16.8	8453.9	5257.7	1903.5	1194.2	2334.1	2170.9	3057.7	3945.8	4967.1	3060.4	200.2	18.2	4863.9	935.8	4892.5	4112.7	7778.0	5740.1	2453.8	2853.1	15.9	3968.7	2304.7	3980.5	11.1	24.2	6102.8	5240.6	2969.2	2205.6	3694.1	3198.7	3898.4	964.1	755.8	2005.0	4215.6	2775.8	2230.8	1623.5	4320.7	7355.8	3208.5	2814.6	1760.7	5273.7	3405.9
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034600	Uncertain		Approved	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"		Yes	No		1300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	831.6	565.7	367.7	738.6	404.0	1928.0	2030.6	377.1	545.7	1385.7	370.7	970.8	451.2	1276.0	1088.2	1289.4	1454.2	776.9	914.1	385.6	388.6	751.5	914.9	666.3	1630.2	376.4	380.9	3022.1	1740.5	954.0	504.0	746.1	386.6	709.1	1143.5	350.6	1234.8	1092.1	1314.7	1327.1	507.9	1353.5	383.2	776.9	643.8	296.4	373.4	1883.4	1289.5	1921.7	2451.3	1322.4	782.5	406.8	1192.9	2343.4	973.0	1646.3	4272.4	7697.6	1710.1	1416.1	2899.7	2143.0	1648.1	2611.3	2025.2	4676.6	1572.3	3396.6	1011.9	2105.0	7026.5	5476.3	2352.2	1301.4	4208.3	2872.9	1955.7	2201.2	6007.7	3042.0	1376.1	7627.4	6980.3	2334.4	9237.8	2620.8	3489.1	2180.2	2682.6	1785.2	3252.1	1956.0	2044.2	1348.1	2136.9	2634.2	1661.9	2256.2	2213.4	4588.3	2958.1	2321.4	1718.4	1794.6	872.3	2447.5	3515.4	2022.2	1812.5	4303.4	2059.2	1111.1	1662.1	1048.4	2297.9	1736.5	2937.8	3118.9	1368.2	4015.4	1281.7	46.4	455.3	62.2	359.4	370.9	668.1	711.1	698.6	506.5	586.8	644.5	888.5	721.6	26.9	478.1	361.3	372.8	589.8	1758.0	367.7	404.0	377.1	545.7	385.6	388.6	376.4	380.9	386.6	383.2	373.4	406.8	393.9	451.9	1004.9	28.1	1553.4	2423.4	2769.6	2082.8	1295.3	122.6	1594.0	1140.4	403.3	760.7	1165.2	342.1	81.3	2059.9	1055.8	364.9	1651.3	1162.8	672.5	337.9	821.0	840.2	761.1	1195.8	26.2	2141.0	3735.7	879.7	467.9	430.0	945.5	899.2	711.0	715.5	1211.2	40.4	23.9	1089.8	636.8	1281.3	2031.3	1392.4	1334.0	991.6	1088.5	27.2	1920.9	417.7	1196.8	15.1	30.0	1239.9	737.1	996.0	1019.5	2031.3	370.6	1572.3	603.9	169.9	460.2	1196.4	934.7	376.4	454.9	1632.1	2583.2	2398.3	1289.5	1184.6	1371.2	2628.6
RPL7	"humL7-1, L7"	ENSG00000147604	"Ribosomal protein L7"	P18124	8	73290242-73295789	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 17748.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058373	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		380000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA058373: AB_2683694"	"unprognostic (3.75e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.31e-1)"	2254.0	1352.4	835.1	1322.3	886.2	3071.3	3298.9	846.6	1224.8	2495.7	843.0	1841.6	1316.8	1844.3	1839.2	2058.4	2057.2	1033.9	1342.4	799.0	860.0	1634.0	1593.8	1327.3	2285.6	859.3	828.4	4528.2	3067.3	1217.6	1195.0	1202.5	870.8	1650.4	1681.7	889.4	1843.5	1261.6	2391.6	2826.4	1420.5	1381.5	914.8	1388.9	1853.0	527.0	848.2	2225.3	1616.5	1832.1	2665.8	1978.5	2103.5	900.4	2902.0	2050.6	2163.3	2615.7	4308.7	5473.7	2120.8	3100.6	2474.6	2069.9	1621.0	2487.3	2940.4	8517.8	2467.6	2517.8	1409.2	2703.0	2888.8	3960.2	3204.7	2313.1	2394.1	4682.9	2687.5	2594.4	2583.2	3343.2	2298.0	5174.5	4574.0	1921.5	5950.9	3797.5	3412.0	2840.5	4261.7	3140.1	2980.2	2448.1	5345.2	5080.8	2528.5	5238.5	2182.9	3552.8	2474.4	3353.9	3241.5	2848.0	2977.1	2160.3	1454.9	17748.7	4599.1	1766.2	4497.4	4312.2	3227.1	1575.4	2407.3	2031.7	2913.1	1799.2	2782.6	5514.9	1649.7	4062.8	2654.8	3331.3	7192.1	1787.5	6932.4	5967.0	12630.9	14333.5	12042.7	9069.1	9565.2	12188.2	17585.4	12433.8	894.5	9240.8	5307.0	7970.3	10207.4	26909.6	835.1	886.2	846.6	1224.8	799.0	860.0	859.3	828.4	870.8	914.8	848.2	900.4	622.3	817.3	1610.8	26.1	2654.7	8054.8	9929.5	10766.1	1684.6	268.0	5251.9	4462.2	623.2	2396.3	3812.0	1311.3	125.1	4882.8	1798.3	926.5	5576.1	2795.4	1720.0	1068.3	2371.5	2338.1	1617.8	1779.1	27.0	5044.8	7032.5	2096.9	721.7	1300.7	1491.1	1110.8	2680.0	1876.1	3252.9	94.2	27.6	3112.1	3057.8	3661.5	5169.4	806.4	4246.4	1893.5	3705.1	25.3	4752.6	1792.8	3105.1	19.6	33.6	3149.3	2514.2	2310.6	952.9	5766.4	2274.7	5797.7	1454.2	380.6	1459.4	4118.3	2651.4	953.5	374.0	2143.1	9487.1	4878.7	2546.9	2145.3	4018.0	7816.6
RPLP2	"D11S2243E, LP2, MGC71408, P2, RPP2"	ENSG00000177600	"Ribosomal protein lateral stalk subunit P2"	P05387	11	809965-812880	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053635, HPA075365"	Approved		Approved	"Nuclear speckles,Mitotic spindle,Cytosol"	"Intracellular and membrane"	Yes	NA		2900000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Nuclear speckles, Cytosol"	"Mitotic spindle"	"HPA053635: AB_2682212, HPA075365: "	"unprognostic (6.98e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-2)"	2013.7	831.3	1119.2	993.1	1162.5	2166.9	1656.6	1099.7	1368.9	1256.2	1084.1	1277.1	1016.8	930.2	701.6	1241.3	1240.4	564.0	869.3	1057.5	1116.3	885.0	657.0	851.0	1924.7	1138.0	1095.8	2092.8	2087.8	545.7	595.5	830.9	1154.3	925.8	887.8	180.9	1908.3	775.7	1802.7	1760.4	1191.7	624.4	1204.8	1543.8	1006.0	377.6	1167.5	1545.7	785.0	936.1	1715.4	1075.5	1137.9	1217.7	2773.5	2229.6	1070.4	1864.1	2343.2	2458.2	2389.5	1728.2	1285.0	2090.8	1638.4	3307.6	2218.5	3851.6	1225.0	1629.9	1107.9	2546.7	1786.2	2778.3	836.3	1713.6	8117.9	1901.7	1416.9	3996.4	2837.3	3540.8	1905.4	3393.9	4684.6	764.1	2182.7	1860.8	2111.9	2798.2	3432.2	2040.5	1317.9	2656.6	2969.5	6002.3	3188.8	3394.5	6045.3	3345.1	1465.6	4369.9	1759.0	1281.0	2222.2	3142.1	1118.5	2825.8	3582.4	885.1	1198.9	3577.2	1881.2	1142.3	1393.9	964.1	1981.6	3838.4	3778.8	3419.3	1790.5	2952.3	1340.6	1565.3	3908.1	1299.1	4402.2	3129.1	6208.3	10718.3	8296.0	6323.4	4273.6	9867.1	10158.6	8083.9	529.9	4310.4	2525.7	5882.9	5140.5	13330.7	1119.2	1162.5	1099.7	1368.9	1057.5	1116.3	1138.0	1095.8	1154.3	1204.8	1167.5	1217.7	1311.8	1067.3	1685.0	16.3	5889.9	6113.3	6658.4	2808.0	2619.1	206.2	5955.7	4736.9	638.4	2505.0	1972.2	1601.9	79.2	5046.4	3469.2	2296.4	2592.4	3688.3	1403.0	1105.9	2434.1	2724.8	2370.2	3482.2	18.6	7413.9	8045.8	2074.3	1401.2	1787.6	1721.9	1543.2	4028.6	3068.9	4514.0	146.4	17.8	5925.5	870.8	5458.4	6404.8	3133.4	6393.4	3169.4	2986.4	27.2	5854.8	1052.2	5787.9	6.0	19.0	5201.1	4547.7	2821.7	2403.4	6640.3	4473.8	4234.1	900.4	235.5	1991.9	3688.9	2346.3	1123.1	2093.1	4264.4	7887.4	5841.1	4889.3	1629.7	6189.1	7014.0
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306245-58324695	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.8;tongue: 39.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	5.1	5.7	3.1	4.6	3.2	4.8	5.0	5.9	4.1	4.6	2.0	6.8	6.8	5.5	3.7	5.9	4.9	4.2	10.9	3.2	2.9	9.1	11.5	4.1	4.0	3.0	2.2	5.5	6.1	7.7	5.9	4.0	3.1	4.7	6.4	5.1	4.9	4.4	40.8	5.3	6.9	7.1	1.7	5.8	5.4	5.1	3.1	6.5	5.5	39.0	6.0	5.2	5.0	3.4	12.3	10.4	11.5	8.2	6.6	9.0	12.3	9.9	11.7	14.5	17.1	15.9	8.0	13.8	2.4	14.4	13.7	7.2	17.6	15.8	14.8	10.6	8.5	12.0	11.9	8.4	7.8	24.4	10.7	8.4	12.1	18.6	16.3	5.2	12.1	18.2	12.0	7.8	14.3	6.5	16.2	7.9	11.9	10.5	17.9	6.8	8.4	14.0	9.6	18.9	6.9	11.8	10.2	9.8	11.9	7.3	11.0	8.6	11.1	10.4	11.7	10.5	20.4	13.0	28.3	22.3	11.2	17.1	6.7	2.1	3.4	2.6	2.1	2.8	3.0	2.1	2.7	3.2	3.9	3.0	3.2	3.5	4.0	5.5	6.0	3.9	1.8	2.1	3.1	3.2	5.9	4.1	3.2	2.9	3.0	2.2	3.1	1.7	3.1	3.4	9.0	9.6	11.9	6.2	8.2	31.2	8.1	21.1	17.1	26.3	8.2	7.6	28.4	7.2	11.8	3.7	25.0	8.4	9.4	14.9	11.7	5.7	0.8	8.2	12.4	10.6	9.6	7.6	18.4	6.2	5.9	11.5	13.3	8.2	3.8	11.5	11.4	21.3	6.2	18.5	18.2	11.8	16.2	11.0	20.0	1.7	12.5	9.7	23.2	13.1	9.2	13.2	7.2	10.6	11.2	7.8	7.6	9.8	14.2	8.1	16.2	11.4	9.7	28.3	0.0	14.1	13.7	11.9	15.3	20.4	43.0	10.3	9.2	15.0	13.7	6.5
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871952-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	19.2	13.9	7.8	12.9	8.8	25.9	17.3	8.2	10.6	14.1	7.3	15.3	9.3	15.8	14.1	18.0	14.9	12.7	22.6	8.8	8.4	16.3	15.1	13.1	21.0	7.1	7.3	18.1	11.0	23.0	8.0	18.5	7.6	12.1	15.1	13.2	14.5	12.2	31.1	17.9	12.4	16.4	8.3	15.0	14.3	28.6	7.7	21.7	12.2	22.2	22.4	17.0	14.2	10.6	82.2	53.2	55.0	66.5	34.4	37.6	19.4	57.0	51.1	93.3	98.3	90.6	64.1	48.1	42.6	36.4	60.9	56.0	73.9	50.5	95.3	77.2	51.3	32.7	31.1	73.0	33.0	66.7	39.1	30.9	32.4	70.5	79.1	39.6	54.1	43.5	65.7	42.6	62.6	50.8	77.4	89.8	33.9	46.4	59.8	42.9	46.7	50.4	35.6	38.2	29.9	29.9	33.1	23.8	68.2	50.0	64.8	41.3	31.2	46.3	46.3	26.5	119.6	28.7	79.4	104.4	57.9	35.4	36.4	9.2	30.0	27.1	25.2	30.7	27.5	31.7	28.7	28.0	35.1	28.1	24.6	27.0	3.5	25.4	26.2	32.8	33.0	27.6	7.8	8.8	8.2	10.6	8.8	8.4	7.1	7.3	7.6	8.3	7.7	10.6	31.4	32.1	16.9	14.0	28.7	34.4	27.5	51.8	23.9	19.2	16.7	28.2	45.7	27.1	31.4	14.7	18.8	60.6	33.7	9.4	31.3	41.9	95.9	18.9	26.1	25.2	19.8	38.5	18.0	35.0	68.1	28.0	13.3	17.9	23.5	33.3	21.4	14.3	58.1	16.8	19.4	21.0	30.5	23.9	29.3	49.9	28.9	24.7	23.2	11.2	32.2	23.3	15.5	17.6	19.6	31.3	12.5	29.3	20.6	18.8	12.5	36.5	21.6	24.3	39.5	30.1	36.9	77.9	54.2	20.2	34.0	33.8	23.7	28.6	17.6	27.6
RPS10	"MGC88819, S10"	ENSG00000124614	"Ribosomal protein S10"	P46783	6	34417454-34426069	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 4571.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047268, HPA048084"	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA047268: AB_2680007, HPA048084: AB_2680255"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (4.98e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.45e-1)"	1437.4	1373.5	1054.1	937.6	1054.4	2688.5	2003.3	1013.6	1284.2	1984.1	1022.8	1472.3	919.9	1332.0	1064.3	1995.2	1606.9	756.7	1024.5	1010.7	1034.1	1114.4	1161.4	1006.5	2137.6	1058.2	1024.2	2878.3	2424.5	633.4	929.2	829.4	1051.3	1432.9	916.2	273.2	1532.7	895.2	1419.3	2399.7	1342.9	909.8	1088.6	1538.6	1455.3	558.6	1091.1	1486.2	1090.6	774.4	1696.6	1470.6	1716.1	1069.7	2314.3	1481.2	1486.9	3397.3	2550.1	3757.4	2454.7	1847.4	2604.3	3061.1	2200.4	3633.8	1140.6	4393.3	1873.0	2105.8	1522.9	1688.8	2814.8	3224.9	1840.0	1869.0	5082.5	1974.1	1475.4	3504.8	3492.4	3158.5	2028.2	4156.0	5548.7	2111.2	3977.8	2642.2	2725.4	2459.5	3452.0	2175.2	2327.1	3633.7	2591.3	4761.0	2242.3	5664.1	2144.7	2409.8	1736.7	4221.2	2314.1	2558.9	2492.6	1515.7	1328.4	2213.1	5332.3	1391.5	2878.1	7936.5	1837.0	1338.8	1699.0	1543.5	3072.5	1764.4	4423.0	3815.8	732.4	4092.2	2465.9	746.2	1242.2	378.2	1406.3	996.8	2067.1	2824.8	2408.2	1994.5	1679.6	2732.8	3083.6	2462.3	251.9	1676.0	963.1	1983.5	1767.5	5386.9	1054.1	1054.4	1013.6	1284.2	1010.7	1034.1	1058.2	1024.2	1051.3	1088.6	1091.1	1069.7	597.4	359.0	714.8	0.0	2967.8	1351.9	563.2	354.6	3754.5	62.0	1279.7	1271.1	65.3	1096.6	494.1	263.0	29.2	1497.5	1221.5	911.7	598.7	1451.9	447.1	169.2	282.1	670.4	1232.9	1778.0	0.0	2404.1	1918.4	612.0	1241.6	181.4	589.1	215.5	1258.9	970.6	1034.5	52.2	0.0	2462.2	130.2	1695.5	1330.7	1537.7	849.0	1006.5	633.3	0.0	1923.1	488.6	1562.3	0.0	0.0	1813.3	1843.4	472.4	2267.5	640.3	2166.8	1066.8	284.9	103.5	263.0	652.5	649.4	268.8	270.0	4571.8	1657.0	1454.1	1851.6	284.8	2985.5	573.4
RPS10-NUDT3		ENSG00000270800	"RPS10-NUDT3 readthrough"		6	34284887-34426071	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 58.7;Club cells: 19.2;granulocytes: 10.1;Respiratory ciliated cells: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047027, HPA047268, HPA048084, HPA055953"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA047027: AB_2679907, HPA047268: AB_2680007, HPA048084: AB_2680255, HPA055953: AB_2682984"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.28e-2)"	"unprognostic (6.85e-2)"		"unprognostic (8.95e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.17e-8)"	"unprognostic (5.80e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.42e-1)"	7.7	6.6	5.9	6.3	5.2	9.5	5.5	3.3	9.0	7.2	0.0	5.0	1.4	4.1	0.1	9.6	4.3	1.5	17.0	6.0	6.3	8.6	10.2	6.3	3.2	7.1	6.7	6.3	7.7	2.0	6.1	4.5	7.3	5.7	1.3	1.4	5.6	0.6	18.6	4.9	4.4	2.9	6.8	6.8	5.1	8.9	7.3	3.8	5.8	8.6	2.3	5.8	7.2	4.8	17.6	6.0	16.0	27.3	11.6	8.0	16.2	13.0	7.0	10.3	10.3	6.7	9.2	22.9	22.2	8.7	23.4	11.5	23.7	7.1	12.5	15.1	9.9	35.1	11.3	19.4	4.2	33.2	38.4	3.2	14.9	15.2	31.6	14.2	10.1	20.7	35.9	22.7	13.2	17.8	33.9	16.4	7.9	38.5	5.8	18.7	13.5	15.0	10.5	19.1	24.6	8.7	9.6	10.0	34.1	10.1	15.1	59.6	7.9	15.3	22.9	7.0	18.2	11.3	18.3	28.8	2.1	20.2	23.7	11.2	5.9	27.3	3.2	6.8	3.3	6.0	3.7	3.6	7.5	5.9	3.6	3.4	4.3	5.0	6.9	5.3	3.7	5.4	5.9	5.2	3.3	9.0	6.0	6.3	7.1	6.7	7.3	6.8	7.3	4.8	0.0	35.3	58.7	2.6	0.0	0.8	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	2.1	0.0	0.0	8.3	0.4	0.1	3.8	0.0	0.3	10.1	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.5	0.0	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.5	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	11.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	2.3	0.0	0.0	0.2
RPS15	"MGC111130, RIG, S15"	ENSG00000115268	"Ribosomal protein S15"	P62841	19	1438358-1440495	"Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054510, HPA057793"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		460000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA054510: AB_2682510, HPA057793: AB_2683528"	"unprognostic (4.47e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.08e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.33e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-2)"	1492.7	1253.1	1112.3	594.4	1143.2	1201.0	1547.4	1088.6	1395.0	1699.5	1028.4	1466.7	565.2	1205.7	337.6	1872.1	1415.6	166.3	1222.6	1051.4	1084.5	1226.1	1106.2	1025.6	705.7	1119.1	1079.2	2717.3	2330.8	409.2	1315.7	346.3	1114.3	1664.9	298.2	234.6	1381.1	396.4	1841.8	2676.2	1250.1	283.0	1143.2	1523.9	1350.1	477.9	1143.5	649.3	1103.0	594.2	600.6	1316.7	1721.5	1162.3	1863.6	1949.4	837.1	1144.5	771.7	1118.2	1433.0	948.7	754.2	1116.7	871.3	3150.8	639.1	2285.2	829.1	618.8	394.6	1156.9	825.1	1177.6	426.5	1914.8	4301.3	748.4	1695.6	3041.6	811.7	1925.8	1374.1	1376.2	1406.1	757.0	737.2	1077.8	988.8	2049.0	1550.5	3197.1	703.7	3284.2	1608.3	2585.9	1887.0	1480.4	2481.0	1646.7	996.2	3053.8	1040.3	2026.5	1343.5	1589.3	801.9	1364.7	2927.8	442.0	1044.2	2555.0	1017.1	939.2	1077.7	1889.0	2131.4	2749.8	2994.2	2300.7	930.5	1737.0	1099.9	1348.7	2387.0	1017.0	2368.1	2005.8	3279.4	5335.9	3615.4	2988.4	3232.2	4867.3	4338.2	3612.2	457.2	2451.1	1592.7	2680.6	3662.4	7245.4	1112.3	1143.2	1088.6	1395.0	1051.4	1084.5	1119.1	1079.2	1114.3	1143.2	1143.5	1162.3	2203.3	910.2	1539.7	53.8	4976.8	9160.6	6537.1	4454.9	5021.3	436.1	7563.8	10700.9	365.8	2203.3	2335.6	1533.8	175.2	3985.2	3071.1	1757.4	3887.6	2275.1	984.8	1187.0	2584.3	2724.2	1811.8	2836.0	34.2	5298.7	6326.9	2621.6	1808.4	1631.3	1777.8	3650.4	3121.2	3161.6	3741.9	153.1	40.3	4148.0	1395.6	4863.0	7853.2	3297.3	3973.6	3101.3	4637.0	35.6	4562.7	1951.5	3042.3	20.1	73.6	3575.5	3343.2	2100.7	3087.8	6046.3	4380.3	5701.1	1076.4	622.3	1341.1	3160.4	2955.8	681.9	901.2	5781.9	12628.8	3849.3	4291.2	2492.1	4237.1	6173.2
RPS17	"MGC72007, RPS17L, RPS17L1, RPS17L2, S17"	ENSG00000182774	"Ribosomal protein S17"	P08708	15	82536750-82540459	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 5841.9;Extravillous trophoblasts: 6575.5;Prostatic glandular cells: 6309.4;Urothelial cells: 5768.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055060	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		340000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA055060: AB_2682686"	"unprognostic (3.37e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.83e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.31e-1)"	1722.3	1537.3	1226.9	1519.3	1244.9	3816.2	3065.8	1206.6	1768.4	1818.7	1277.0	1724.0	1318.8	1489.3	1967.3	2266.9	1763.0	881.9	1192.2	1197.9	1253.8	1298.7	1646.6	1132.3	2832.4	1261.6	1218.6	3571.4	3388.7	859.1	987.5	1099.1	1264.1	1418.3	1477.9	477.2	2051.9	967.4	1588.9	2566.0	1319.4	1188.3	1265.4	1560.6	1555.5	375.1	1245.4	2012.1	1216.9	1063.5	2563.2	1567.2	1790.5	1281.2	3535.7	4567.8	3027.7	2844.3	3850.6	6013.0	3418.3	3504.2	3142.7	2924.3	2235.3	5420.6	3683.5	5561.4	3680.3	3142.1	2276.7	4963.3	6162.5	4765.3	2251.9	4262.2	8647.1	3224.4	5009.5	4698.1	5817.4	4197.2	2100.2	5478.2	7877.0	1959.5	6027.1	4520.5	3281.1	3993.8	3909.8	4288.1	3200.3	6205.4	3467.9	7403.5	4567.2	4224.9	2885.2	3333.8	3746.8	4676.4	3425.9	6945.5	2678.6	3325.2	2101.9	4289.8	9110.0	3205.5	3707.5	10012.4	2932.1	2388.1	3534.7	2353.9	6119.2	3312.3	7992.5	5635.5	2580.9	8286.2	2335.3	519.6	1072.5	302.9	1155.2	949.1	1830.0	2371.9	1954.3	1477.4	1685.5	2173.6	2280.0	1986.3	148.5	1335.8	859.0	1700.9	1707.8	3337.5	1226.9	1244.9	1206.6	1768.4	1197.9	1253.8	1261.6	1218.6	1264.1	1265.4	1245.4	1281.2	118.0	814.1	1488.0	8.1	1824.1	43.2	5841.9	11.0	675.6	83.2	1696.6	859.5	428.3	2093.2	1039.5	176.6	50.1	3419.1	1523.2	487.4	545.9	1846.4	75.5	269.9	496.3	1390.0	963.5	1971.9	5.5	3041.8	6575.5	973.4	375.1	305.1	937.3	67.5	2470.1	3241.0	2716.5	42.1	6.3	2545.9	2.0	3330.0	46.3	229.6	4400.2	1201.6	30.2	7.5	3519.0	296.5	3137.0	6.0	10.1	2490.2	2021.5	1873.5	547.9	6309.4	1840.9	1036.8	504.2	121.4	1183.3	2746.2	689.9	611.9	701.6	1140.4	63.9	3414.9	1379.0	53.7	3448.3	5768.6
RPS2	"LLREP3, S2"	ENSG00000140988	"Ribosomal protein S2"	P15880	16	1962058-1964841	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055133	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		320000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA055133: AB_2682708"	"unprognostic (2.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (7.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (3.04e-7)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.47e-1)"	1690.3	1371.4	724.2	1077.5	741.5	2753.6	1803.0	715.7	944.0	1873.9	730.0	1509.2	957.5	1382.0	615.7	2558.8	1584.3	696.4	1237.7	712.7	742.4	1051.6	1423.2	1204.2	1914.1	797.8	741.9	3256.7	4556.8	388.1	972.5	832.6	777.7	1473.5	762.9	148.1	1477.9	636.9	2367.2	2781.5	1482.9	616.5	775.9	1849.7	1599.6	419.7	767.4	1570.4	1025.2	1558.8	1602.3	1750.8	1810.5	777.2	2258.0	3020.8	1716.3	5571.2	2433.0	5946.5	3093.8	1506.8	3381.7	3653.7	2581.3	5415.0	1451.8	4124.7	2329.8	2599.8	1226.5	2625.3	2553.6	4786.8	1372.0	2720.7	4959.5	1437.5	3382.8	4939.7	6019.8	3263.4	2174.4	8105.2	6715.4	3155.0	5057.6	3734.5	3606.2	3601.3	3014.4	2244.9	2591.9	9854.0	4110.2	5683.0	5591.7	2742.4	2706.1	4981.3	2846.5	4915.9	3411.9	1993.3	3154.5	2856.4	1465.0	4355.3	3538.6	1481.8	2933.7	5612.6	1757.9	1961.2	2605.3	499.3	3123.2	908.6	1554.7	5464.5	1056.9	2809.3	2532.6	74.1	438.2	239.9	562.4	545.5	932.7	1765.0	1096.6	864.3	805.8	1525.5	1366.1	1034.5	88.0	667.8	449.4	803.5	844.5	749.9	724.2	741.5	715.7	944.0	712.7	742.4	797.8	741.9	777.7	775.9	767.4	777.2	1261.2	519.2	1240.7	8.8	5674.4	11938.0	10835.5	3903.6	3510.9	362.3	12291.0	12660.6	252.4	2427.7	2182.1	910.4	187.7	8328.8	4158.8	1406.9	3212.6	4491.8	298.5	1154.3	4108.9	4082.2	2111.6	4032.5	13.2	11401.9	14898.5	2987.2	1703.4	1777.4	1021.9	4053.7	3477.4	2195.6	6029.4	277.6	15.7	4569.6	1627.6	5640.5	9869.6	489.7	4210.7	3709.4	5115.6	15.9	6772.9	965.3	3821.9	13.0	25.5	5585.7	2941.4	1575.6	3202.3	9790.4	2044.2	2439.2	906.1	477.8	1255.6	4193.6	3603.8	388.8	1997.9	5900.2	15069.3	8184.0	4718.2	6863.0	6345.9	11758.5
RPS27	"MPS-1, MPS1, S27"	ENSG00000177954	"Ribosomal protein S27"	P42677	1	153990762-153992155	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA066851			Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: AB_2685737"	"prognostic favorable (9.69e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.05e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.86e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.81e-2)"	5616.3	3455.2	3594.8	2840.3	3661.4	7200.5	8666.0	3567.1	5829.2	7430.2	3632.2	5066.8	1888.2	4501.2	4042.3	4706.9	5856.4	2273.3	3532.4	3573.6	3695.5	4491.5	3641.9	4076.2	7137.0	3672.3	3637.9	12404.9	7506.0	3141.5	3807.8	2215.5	3648.3	5395.9	3581.3	1411.8	4351.2	3444.9	4963.3	7568.0	5438.8	2777.4	3605.2	6878.7	5028.9	1668.1	3632.1	8478.3	4692.8	4124.9	9185.3	5497.1	5730.0	3661.3	3446.4	3986.5	5147.0	2805.0	11901.1	11649.6	3148.9	4096.1	9832.9	5421.0	4866.7	8059.8	3705.0	7817.4	3304.5	6009.8	1792.6	3390.5	4624.1	6847.5	4577.2	3804.0	5945.0	3090.0	5442.0	5323.3	7881.7	6945.8	3888.2	11426.5	13193.2	4334.0	7920.5	8011.4	4546.6	6426.6	3865.0	4112.2	5239.5	8711.2	7513.7	4328.1	6227.9	11540.0	5775.4	4735.7	3753.2	6114.5	5064.7	6938.6	2702.3	5977.7	2340.0	8120.1	7572.9	6970.2	4531.0	13542.1	2672.3	1841.0	3043.3	2963.9	4141.0	8191.3	9166.7	9585.2	3202.5	3805.3	2591.7	12942.7	11463.1	5536.5	28801.5	11225.6	34790.5	56947.7	43040.6	37135.0	13993.9	48738.8	53667.4	42304.0	2458.8	27662.5	10603.9	23115.6	32257.9	76381.9	3594.8	3661.4	3567.1	5829.2	3573.6	3695.5	3672.3	3637.9	3648.3	3605.2	3632.1	3661.3	3187.7	2201.9	3978.4	11.4	13562.6	12494.3	5398.2	7693.2	4868.2	411.9	6937.5	6570.1	939.8	5752.0	4175.1	2155.5	193.9	6037.3	9149.7	2192.5	4431.5	4142.9	2927.6	1809.2	4392.1	3779.0	3022.4	4789.2	5.4	10431.2	6808.0	4116.6	2102.4	2597.5	4306.7	4628.6	6451.6	8222.0	4303.1	191.8	6.0	6849.8	1953.1	9173.5	14035.0	10184.0	7097.1	4890.7	5914.2	5.6	9465.8	1961.9	9527.4	3.0	6.8	6134.0	5941.1	3543.1	3703.6	4365.2	6412.1	6526.1	1955.9	646.0	2734.7	5847.6	4188.0	1563.3	1638.3	4859.8	14322.5	6382.1	11013.6	1757.5	6839.1	4530.7
RPS27AP5		ENSG00000231767	"Ribosomal protein S27a pseudogene 5"		1	192716132-192716653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 16.3"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.6;SK-MEL-30: 4.2;THP-1: 4.7"									"HPA041344, HPA049132, HPA054087"	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.09e-2)"	"unprognostic (7.80e-3)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (3.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.62e-2)"	0.2	0.3	0.2	0.8	0.2	0.7	0.5	0.2	0.6	0.2	0.2	0.2	0.8	0.5	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.3	0.1	0.1	1.1	0.2	0.3	0.7	0.0	0.0		0.2	0.3	0.2	0.0	0.3	1.0	0.1	1.1	0.1	0.5	0.0	0.2	0.5	0.3	0.1	0.3	0.0	0.1	0.0	0.3	0.0		0.3	1.0	0.4	0.2	0.6	0.3	0.0	2.5	0.1	0.5	0.0	0.3	0.0	0.7	0.2	2.5	0.0	0.2	1.0	0.1	0.3	0.0	0.9	0.5	0.4	0.4	1.9	0.2	0.7	1.3	0.3	0.4	0.2	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.5	0.9	4.6	1.1	0.1	0.2	1.0	0.3	0.6	0.3	1.3	0.8	1.6	0.2	1.5	4.2	0.1	1.0	4.7	0.5	0.6	1.2	0.8	2.4	1.5	1.1	0.9	0.8	0.7	0.1	1.2	0.9	0.5	2.0	1.3	2.8	4.2	3.5	2.2	1.8	3.8	4.4	4.5	0.3	3.0	1.0	1.6	2.5	5.6	0.2	0.2	0.2	0.6	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RPS28	"eS28, S28"	ENSG00000233927	"Ribosomal protein S28"	P62857	19	8321158-8323340	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 19765.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047132	Approved		Approved	Cytosol		NA	NA		730000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA047132: AB_10962147"	"unprognostic (3.47e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (3.09e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.81e-2)"	227.9	202.9	129.8	113.7	134.6	286.7	226.8	128.6	189.9	226.5	130.2	188.9	127.8	147.3	52.5	328.4	172.3	94.9	213.0	124.0	129.7	184.6	247.5	171.0	220.2	132.2	129.3	313.0	432.4	72.1	162.7	88.2	129.5	211.1	47.8	20.3	227.8	60.6	252.9	353.8	197.1	42.6	134.1	273.4	219.4	55.7	138.6	117.3	177.4	80.8	98.0	176.7	240.0	131.6	245.9	97.7	86.6	197.5	122.3	183.2	136.6	156.9	141.7	177.6	144.5	133.2	104.7	364.4	189.3	91.7	75.9	183.0	114.9	269.0	25.6	223.2	772.6	176.4	110.4	134.5	219.6	204.6	188.5	294.9	303.7	129.7	116.4	110.9	165.2	279.0	251.6	402.9	80.2	152.5	314.8	725.0	260.8	141.4	587.2	222.7	92.9	390.9	118.6	115.5	165.7	162.3	112.7	206.7	289.3	27.6	157.0	340.9	210.4	147.0	125.1	288.1	266.5	468.3	265.8	248.1	155.7	389.3	101.2	21.3	61.7	13.2	54.5	39.3	76.6	105.0	88.5	64.5	55.9	90.7	98.9	70.0	8.8	44.6	36.3	98.0	61.0	166.2	129.8	134.6	128.6	189.9	124.0	129.7	132.2	129.3	129.5	134.1	138.6	131.6	4308.7	1458.3	2798.6	9.8	6575.7	7900.9	4267.0	4952.1	5103.9	484.0	11594.7	19765.7	382.7	3044.0	2801.5	1340.8	296.1	3851.9	4608.0	2028.0	3335.8	3189.3	262.2	1687.9	4074.7	3610.1	2654.0	3550.8	7.4	7271.1	4542.0	2535.5	2746.2	2586.9	1954.3	4062.9	5016.7	5562.8	4537.9	267.5	9.3	5334.5	1287.8	5745.6	5979.8	559.6	3915.0	3716.8	3523.6	21.5	5150.0	1694.4	3560.3	6.6	14.5	5090.4	4152.6	1644.9	4225.1	3830.4	4316.3	5555.1	1153.6	729.0	1084.7	3477.1	2508.7	367.9	953.1	7848.6	10873.6	4244.9	5017.4	2121.3	5894.5	4043.4
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 10.5;monocytes: 2.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	15.0	13.1	14.8	11.8	16.1	10.9	12.5	17.0	17.9	13.7	10.5	16.8	9.8	16.5	2.8	31.0	12.0	4.7	16.2	15.3	13.7	14.2	12.0	16.4	12.0	14.7	14.7	8.5	12.2	3.3	6.8	11.7	14.7	13.1	5.6	2.1	12.5	5.6	16.0	22.8	17.1	6.8	14.4	25.0	15.8	3.5	15.1	5.7	10.2	5.0	9.5	16.6	14.6	14.3	76.1	41.5	5.9	15.0	12.8	11.9	84.0	39.4	20.6	30.2	14.9	41.7	38.8	7.9	44.9	22.9	38.6	69.1	7.1	32.1	14.7	24.1	14.0	17.8	36.8	21.6	12.8	18.0	32.0	12.0	29.7	25.7	20.9	10.9	18.4	14.2	7.4	10.6	15.6	69.2	16.6	28.4	6.5	29.2	88.1	31.8	24.4	25.3	21.1	34.4	8.7	6.9	40.7	24.8	35.6	8.5	28.6	22.3	37.0	41.0	51.7	74.7	35.9	12.5	10.4	7.8	27.0	20.6	21.2	1.3	2.7	1.4	0.7	2.1	0.7	0.4	0.5	0.6	2.2	0.2	0.3	0.3	0.2	0.2	1.3	10.5	0.5	2.6	14.8	16.1	17.0	17.9	15.3	13.7	14.7	14.7	14.7	14.4	15.1	14.3	11.8	3.2	3.0	8.5	6.4	12.1	6.8	8.6	8.6	7.3	5.4	4.8	15.2	7.2	5.4	3.7	4.2	70.0	75.0	25.2	5.9	20.1	0.8	3.5	8.7	9.9	8.4	9.9	6.6	25.2	38.2	9.3	26.0	7.6	19.1	5.7	10.8	7.8	29.6	8.4	5.3	14.3	2.0	30.5	13.2	1.5	11.1	25.8	8.8	11.2	26.6	3.6	10.3	4.5	5.4	65.1	12.8	6.8	5.7	10.2	16.2	8.4	3.1	2.1	0.0	6.0	10.2	0.7	6.5	13.9	10.7	46.7	11.3	7.5	19.9	9.6
RPS7	"eS7, S7"	ENSG00000171863	"Ribosomal protein S7"	P62081	2	3575260-3580920	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056586	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	Yes		820000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA056586: AB_2683179"	"unprognostic (3.28e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (6.41e-2)"	"unprognostic (6.02e-3)"	"unprognostic (7.08e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (1.34e-8)"	"unprognostic (3.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	1083.4	764.7	778.0	774.7	787.2	2152.4	2194.5	772.7	1112.6	1124.8	800.2	1044.1	766.0	867.6	1309.0	1281.8	1152.1	642.5	744.5	755.7	779.1	925.4	1082.6	717.6	1622.5	785.1	770.8	2394.6	1624.1	725.0	686.2	939.7	784.8	887.8	1166.3	603.2	1213.7	697.3	906.5	1419.8	866.8	895.3	805.3	964.6	1011.3	396.3	795.7	1665.6	797.7	843.0	1841.7	1038.2	1063.0	798.4	1235.6	1178.5	1778.9	1923.5	1725.8	3754.0	2913.5	1458.3	2527.9	2370.8	1371.5	2053.4	1890.4	4081.0	2369.1	1697.7	1646.1	1321.0	2038.5	2370.0	2077.4	1289.4	2743.3	1496.8	758.2	2998.2	4156.0	2622.8	1489.1	3183.4	3497.5	1475.1	3176.3	2552.1	2816.8	3707.9	2356.3	2015.2	2433.4	1661.0	2930.2	5815.8	2638.6	3679.7	1810.5	2300.9	1812.6	3670.5	2725.7	1487.1	2016.6	3028.5	771.7	2931.1	4670.0	1487.2	1615.3	3727.3	1327.2	1415.1	931.1	987.9	2387.5	2240.1	4420.9	4079.3	1489.6	3113.0	1617.9	337.1	656.8	243.1	808.8	570.7	1192.3	1411.3	1159.2	1036.9	1063.6	1172.7	1254.6	1132.2	129.3	1032.8	553.2	1016.6	1083.5	2065.3	778.0	787.2	772.7	1112.6	755.7	779.1	785.1	770.8	784.8	805.3	795.7	798.4	2544.8	496.8	793.2	28.1	3845.5	3923.3	4252.7	2961.9	3989.5	401.5	4245.2	7977.4	154.5	1720.0	1620.6	647.4	325.2	3627.9	2815.0	730.8	2606.1	2129.9	1517.5	1255.0	3316.9	1997.7	1250.9	2352.4	33.5	3434.0	5702.2	1854.2	1378.2	1489.1	1171.5	2855.2	2067.5	1515.6	2338.1	141.3	37.2	2244.0	929.8	2534.9	3126.0	485.1	2927.6	2110.0	2001.1	50.6	3250.8	1257.2	2634.4	27.6	49.8	2878.9	1747.3	1748.6	2572.7	4420.1	1233.7	4372.3	847.1	741.6	1452.9	1699.5	3261.7	1248.6	775.4	4912.8	5050.7	3716.9	3078.6	3673.3	2604.1	4351.5
RPUSD1	"C16orf40, MGC19600, RLUCL"	ENSG00000007376	"RNA pseudouridine synthase domain containing 1"	Q9UJJ7	16	784974-788397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041144, HPA041938"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions, Cytosol"	"HPA041144: AB_10794265, HPA041938: AB_10795601"	"unprognostic (1.51e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.07e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.25e-2)"	"unprognostic (8.07e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-1)"	11.8	12.9	12.3	9.7	11.9	13.5	12.0	11.2	21.1	11.0	6.8	14.9	9.8	13.1	3.1	18.7	10.6	4.7	12.0	12.5	10.0	13.0	15.3	9.5	11.3	12.9	10.7	9.2	16.1	4.5	11.2	4.2	10.9	14.6	2.5	2.2	15.2	5.1	11.2	18.1	15.6	3.6	9.7	21.9	17.0	7.2	12.4	8.3	11.0	3.1	5.3	13.1	11.8	11.6	28.2	32.5	7.8	35.7	6.8	7.9	36.2	22.9	13.0	29.4	21.3	76.4	25.8	38.9	24.3	11.1	20.6	47.2	18.1	23.1	5.3	35.7	74.0	19.2	52.1	28.0	10.9	35.8	31.1	11.7	21.9	25.4	6.7	8.7	20.4	22.6	45.7	17.1	10.2	89.2	44.8	37.4	40.0	13.0	55.4	79.0	21.0	80.5	10.9	17.0	40.8	29.4	26.4	42.7	26.1	4.6	22.0	43.9	23.3	29.1	37.9	30.9	33.6	27.2	29.6	45.7	14.1	27.8	24.5	16.5	14.8	13.7	12.7	13.7	12.6	10.2	10.7	14.1	17.0	12.0	10.7	11.1	9.2	13.4	13.6	15.8	14.8	13.1	12.3	11.9	11.2	21.1	12.5	10.0	12.9	10.7	10.9	9.7	12.4	11.6	9.4	3.2	3.3	3.6	12.9	15.9	3.5	13.2	10.8	42.0	12.8	13.3	4.4	5.7	5.2	9.2	2.1	20.5	13.7	23.0	7.9	19.5	0.4	4.7	7.1	8.1	13.2	6.3	6.0	26.9	25.7	6.8	17.9	8.2	0.0	10.9	9.3	5.1	19.6	1.7	4.2	11.5	10.2	5.7	7.0	1.8	6.8	9.0	14.2	1.9	19.2	11.1	23.7	1.5	3.5	29.9	16.6	6.4	19.5	6.3	21.1	10.2	3.4	3.8	13.1	3.6	9.4	3.6	11.4	11.5	16.8	14.6	11.9	13.3	20.7	5.0
RRAS2	TC21	ENSG00000133818	"RAS related 2"	P62070	11	14277922-14364506	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010420, HPA050942"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB010420: AB_2253855, HPA050942: AB_2681285"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (7.80e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.50e-2)"	"unprognostic (4.15e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	30.8	14.1	8.0	16.1	8.0	5.2	21.2	9.7	10.7	21.7	14.9	22.3	20.8	19.7	9.2	15.4	14.2	11.9	44.4	12.0	10.5	39.3	39.1	22.9	28.3	7.0	8.1	18.3	18.2	17.2	8.5	29.4	8.0	20.1	18.7	12.1	18.0	19.3	40.8	12.1	39.5	18.0	6.3	16.3	17.7	25.1	10.4	14.4	29.0	34.0	37.7	23.4	14.0	6.3	89.3	38.2	35.7	30.8	122.0	121.1	52.8	309.1	160.7	260.5	328.1	78.0	108.7	102.2	46.8	209.0	84.3	97.1	61.0	110.8	260.5	88.7	49.6	6.8	21.5	62.4	133.6	0.3	0.7	129.5	205.0	104.2	331.2	106.5	131.7	24.8	45.9	0.2	229.3	43.5	21.5	5.6	98.3	18.2	31.4	19.0	118.5	1.9	133.7	48.8	9.7	18.4	74.7	46.0	42.5	119.9	30.6	6.2	303.1	139.6	74.0	272.1	85.1	0.2	0.2	48.4	56.0	0.1	29.0	2.1	0.0	0.0	5.5	0.0	2.4	11.8	1.0	2.8	0.0	6.6	0.5	2.1	0.4	3.8	0.0	0.2	0.0	0.9	8.0	8.0	9.7	10.7	12.0	10.5	7.0	8.1	8.0	6.3	10.4	6.3	6.6	19.2	18.9	14.4	57.8	69.3	76.2	17.7	23.9	5.5	22.6	13.7	31.5	40.0	20.6	18.4	0.0	36.5	31.2	30.5	23.5	46.5	55.2	25.8	16.0	15.2	19.1	3.2	32.8	18.4	58.0	29.7	12.8	34.7	8.9	15.6	13.6	33.4	8.2	13.5	35.4	16.0	14.2	2.4	12.0	45.2	16.4	2.3	26.6	9.4	2.0	21.7	56.7	28.6	4.9	57.1	30.1	11.3	22.0	120.3	89.9	112.9	15.0	10.1	19.7	20.7	21.4	39.5	42.1	20.3	49.9	29.0	29.5	13.3	20.8	96.5
RRNAD1	"C1orf66, CGI-41, METTL25B"	ENSG00000143303	"Ribosomal RNA adenine dimethylase domain containing 1"	Q96FB5	1	156728442-156736960	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047426	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Cytosol	"HPA047426: AB_2680041"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.03e-3)"	17.1	21.3	16.5	14.1	20.0	11.9	21.9	18.8	18.1	22.4	20.6	21.0	27.4	22.0	26.0	21.8	28.2	17.7	14.9	15.9	17.1	18.6	28.4	17.7	19.5	20.7	18.7	26.5	27.6	25.4	20.5	14.8	18.8	25.0	17.4	17.9	27.2	22.9	30.2	29.1	24.0	14.8	18.2	20.4	23.8	24.4	18.6	14.2	29.4	22.8	17.0	22.5	20.9	22.9	14.6	28.3	20.6	20.3	54.2	24.7	31.3	10.8	32.8	18.3	13.7	15.3	65.7	24.8	31.6	17.1	25.7	60.7	28.9	25.4	7.3	49.5	24.3	15.0	27.5	11.6	34.1	22.4	39.2	38.4	47.5	18.3	34.3	21.5	15.5	21.8	36.3	54.1	9.9	35.3	11.6	26.0	23.9	63.2	8.7	18.7	13.6	58.1	21.8	15.6	26.7	38.2	19.2	38.7	24.0	31.2	51.5	47.2	15.0	11.3	13.8	17.7	14.7	62.7	67.7	31.8	12.7	24.9	13.9	4.1	1.8	2.7	3.5	1.3	3.6	1.7	3.3	2.5	3.2	2.3	2.7	3.0	4.0	4.0	2.3	1.2	5.1	1.7	16.5	20.0	18.8	18.1	15.9	17.1	20.7	18.7	18.8	18.2	18.6	22.9	9.5	6.4	15.1	11.4	15.8	10.1	21.5	13.5	22.2	11.2	20.0	19.9	7.1	31.5	13.9	3.7	12.5	24.9	8.9	16.4	9.8	12.7	60.2	12.3	6.4	9.7	9.6	14.3	4.6	13.1	17.2	11.2	18.3	10.9	5.1	8.7	12.5	19.5	10.9	8.4	6.3	16.9	14.2	11.1	4.9	14.7	11.1	9.6	8.8	4.7	10.1	20.5	5.2	5.5	15.9	9.3	12.8	9.4	14.8	21.4	36.5	12.8	13.9	13.6	13.1	9.6	9.6	20.6	23.2	18.9	11.5	32.4	8.1	8.2	16.2	18.0
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 90.9;skeletal muscle: 38.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 26.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	8.1	10.2	2.6	9.2	3.4	90.9	5.6	1.1	7.6	5.6	2.4	4.9	6.0	7.4	3.6	8.5	7.3	7.2	11.4	3.2	2.7	6.8	5.7	6.7	6.7	4.3	4.4	6.1	16.0	9.3	10.2	4.3	4.1	6.3	3.8	3.4	8.3	4.0	38.5	10.3	4.7	6.0	0.2	7.6	6.3	10.9	3.7	4.7	5.5	9.7	6.1	9.3	5.7	4.6	38.9	50.8	13.2	28.6	10.0	11.6	28.9	24.2	14.4	24.2	18.7	55.6	35.0	42.3	30.4	15.1	21.6	48.7	36.3	28.0	16.3	23.1	44.2	32.8	19.5	43.6	16.5	51.7	41.5	12.2	38.6	59.9	54.6	27.0	13.7	23.5	47.7	27.4	14.0	50.8	35.0	33.0	57.0	20.4	34.0	38.1	18.0	42.1	16.8	21.4	17.7	37.9	19.2	18.1	24.1	10.4	43.7	26.5	18.2	16.1	27.9	36.5	76.4	55.7	52.7	48.6	23.2	64.9	17.9	0.4	11.2	6.9	2.7	13.6	3.3	3.9	1.6	2.2	6.2	4.2	2.5	2.8	26.7	1.9	16.9	5.0	1.2	6.0	2.6	3.4	1.1	7.6	3.2	2.7	4.3	4.4	4.1	0.2	3.7	4.6	8.8	35.3	31.1	5.9	18.5	23.5	14.2	5.1	25.0	5.8	12.7	9.9	11.6	7.2	21.5	14.7	41.7	5.2	7.7	10.6	0.0	8.7	7.2	17.1	10.6	10.6	21.5	7.2	15.1	8.7	7.5	13.5	27.0	20.1	41.7	12.9	3.9	8.9	11.5	5.0	9.5	13.8	4.1	12.5	7.1	4.8	3.7	30.3	7.2	2.8	12.3	1.9	3.1	5.0	4.4	8.5	6.4	2.6	31.8	17.1	3.7	6.8	24.6	12.7	0.0	19.4	6.7	10.6	20.6	22.7	19.6	9.2	11.0	13.5	11.5	13.6
RSPH3	"dJ111C20.1, RSHL2, RSP3"	ENSG00000130363	"Radial spoke head 3"		6	158972871-159000202	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 149.3;Respiratory ciliated cells: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039109	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"HPA039109: AB_10794423"	"unprognostic (6.18e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	2.9	4.7	0.8	2.2	1.0	1.6	3.7	0.2	4.7	3.9	14.5	4.2	5.9	3.4	4.6	5.7	6.1	3.3	3.8	2.0	1.0	6.3	2.7	4.6	1.4	1.9	2.6	3.4	4.3	13.2	3.5	3.1	1.5	5.2	3.7	6.7	4.4	4.1	1.5	3.8	5.6	3.7	1.6	2.3	4.1	9.9	1.1	1.8	7.6	2.2	2.0	2.9	3.0	1.6	8.5	3.7	2.1	4.9	4.8	6.3	2.2	6.2	7.0	1.9	2.8	1.2	4.6	1.7	4.8	7.2	6.3	6.1	1.4	5.6	2.8	4.4	2.9	2.2	3.9	2.6	4.6	2.4	1.6	7.1	9.5	3.8	6.9	10.0	2.5	2.5	2.8	2.6	4.5	4.3	1.5	2.7	1.2	3.8	2.7	2.2	0.3	1.6	8.6	2.6	2.8	4.0	11.6	3.8	2.2	2.4	4.7	5.3	5.4	2.0	5.5	4.8	3.0	2.9	6.1	1.2	10.1	2.9	3.9	0.9	4.0	0.6	0.6	3.0	1.2	0.9	0.9	1.2	4.0	2.4	0.7	1.1	10.5	1.7	7.0	4.6	1.3	1.5	0.8	1.0	0.2	4.7	2.0	1.0	1.9	2.6	1.5	1.6	1.1	1.6	2.3	25.6	17.9	15.0	4.0	7.4	17.2	19.1	6.2	14.2	12.2	7.6	17.5	17.2	25.1	22.0	35.5	10.3	5.7	25.6	13.7	15.8	149.3	67.0	6.9	6.0	13.1	2.1	32.8	10.2	11.4	7.6	10.2	12.7	2.5	9.2	7.9	8.4	10.1	3.3	18.5	17.6	16.2	9.5	16.5	62.9	14.0	12.6	7.2	4.7	8.3	14.4	4.1	6.0	3.5	13.1	21.1	17.7	5.7	18.4	33.1	19.7	120.4	32.5	6.6	5.9	10.2	57.3	10.9	18.6	8.8	5.9	6.1	12.2	13.1	23.1
RSRC2	FLJ11021	ENSG00000111011	"Arginine and serine rich coiled-coil 2"	Q7L4I2	12	122503454-122527000	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 65.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040070, HPA048183"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA040070: AB_10673430, HPA048183: AB_2680302"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-2)"	12.6	12.2	11.5	11.0	11.4	65.7	13.2	17.6	18.4	14.6	11.3	13.9	8.6	14.1	12.5	17.4	12.3	13.6	13.1	11.3	15.3	16.3	11.4	13.8	16.8	12.1	13.7	16.4	13.8	8.0	14.5	13.3	11.7	12.7	12.0	17.1	12.6	9.5	28.5	12.7	12.5	8.8	7.7	11.6	10.8	14.0	11.8	13.2	15.4	16.1	10.7	14.0	15.0	14.0	21.4	24.8	23.2	9.5	18.4	11.2	16.9	38.8	12.0	16.0	8.7	35.5	8.6	24.4	32.0	13.3	9.7	13.3	25.9	10.8	15.7	22.8	23.9	42.1	32.0	38.3	10.1	37.0	24.8	14.5	12.3	13.6	23.2	20.1	11.6	10.7	27.8	14.6	14.1	16.3	26.8	27.8	19.6	17.8	19.6	19.6	20.9	15.9	21.1	39.8	18.4	16.7	29.6	10.0	22.0	23.1	15.9	13.4	18.1	16.5	20.3	18.4	21.7	16.7	42.8	39.5	9.8	21.6	9.4	27.5	17.7	25.4	17.2	14.7	14.3	28.3	15.3	13.9	18.0	33.4	19.3	15.4	18.7	18.3	22.2	17.0	22.4	12.3	11.5	11.4	17.6	18.4	11.3	15.3	12.1	13.7	11.7	7.7	11.8	14.0	176.8	86.6	102.0	44.7	208.7	202.3	376.1	94.0	118.4	114.3	155.6	146.0	103.3	104.4	107.1	93.8	79.2	149.1	219.3	193.5	195.6	109.3	247.3	223.6	218.6	141.7	156.3	143.1	39.1	97.2	183.8	169.3	89.7	238.0	216.5	127.5	84.9	113.7	94.3	149.7	39.9	185.7	101.7	87.6	184.9	107.1	119.9	139.0	126.3	35.6	107.0	132.9	133.9	34.2	49.6	107.3	171.0	105.7	134.2	219.0	110.1	132.7	128.5	131.0	124.9	194.8	176.7	229.2	165.3	116.0	187.0	280.1	210.3	107.6	154.8	287.1
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006714, CAB079946, CAB079947"	Supported		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB079946: , CAB079947: , HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	17.8	23.2	24.7	18.8	26.3	45.1	22.4	26.8	42.7	24.3	19.2	21.6	19.2	25.1	19.5	21.4	17.1	20.3	24.6	27.1	24.0	19.0	19.9	19.4	28.2	21.0	21.3	29.4	16.6	36.9	11.4	24.5	20.9	23.4	22.4	26.4	16.7	22.8	49.4	25.9	19.8	26.3	20.0	23.8	20.8	29.8	23.9	28.8	29.5	34.8	25.0	23.1	17.5	24.6	32.0	20.6	66.5	54.2	37.0	43.4	31.2	41.8	46.8	56.0	46.5	40.4	19.8	30.2	33.0	43.9	24.9	55.3	38.9	34.8	47.6	46.2	36.1	63.5	45.2	30.4	25.8	57.2	35.5	31.4	34.3	30.0	30.1	41.6	45.8	54.0	49.2	34.0	46.5	24.2	55.1	35.1	35.9	39.6	28.0	59.0	51.8	28.9	36.5	67.5	34.0	44.9	37.6	47.4	19.0	35.9	38.9	54.5	37.9	54.6	34.4	54.8	46.5	38.9	65.0	49.6	39.4	53.5	34.1	5.4	3.1	6.9	3.4	2.1	3.1	6.9	3.3	2.9	2.2	5.3	4.0	3.2	8.5	6.2	2.7	5.5	4.3	1.1	24.7	26.3	26.8	42.7	27.1	24.0	21.0	21.3	20.9	20.0	23.9	24.6	118.0	128.2	80.1	23.8	109.0	145.0	98.7	120.4	102.4	213.5	152.6	129.7	94.3	111.5	89.7	123.2	93.8	168.3	117.1	129.6	164.4	103.0	333.7	103.9	162.6	116.4	87.8	85.0	40.3	110.5	119.1	103.5	71.9	126.2	91.2	127.9	129.5	193.2	95.5	148.0	43.6	145.4	109.9	86.7	94.4	348.5	145.1	83.0	108.5	15.9	116.1	106.2	128.8	16.6	23.5	127.0	105.1	159.9	104.1	141.9	112.6	186.4	70.7	188.2	85.5	115.4	146.9	198.3	59.9	83.4	163.0	219.3	113.0	126.1	133.2	99.2
RTL1	"HUR1, Mar1, MART1, PEG11, SIRH2"	ENSG00000254656	"Retrotransposon Gag like 1"	A6NKG5	14	100879753-100903722	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.6;brain: 7.7;placenta: 2.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"melanoma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 572.5"					"Low region specificity"	"Detected in many"			"HPA066979, HPA077601"	Enhanced		Approved	Cytosol		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"		Cytosol		"HPA066979: AB_2685759, HPA077601: "					"unprognostic (1.61e-1)"					"unprognostic (3.30e-1)"	"unprognostic (1.26e-1)"			"unprognostic (1.42e-3)"	"unprognostic (2.10e-1)"			0.1	1.6	1.6	0.0	0.7	0.0	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	7.7	0.0	0.0	0.0	0.0	3.4	4.2	0.6	0.1	0.0	0.2	2.9	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	18.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	572.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.9	1.3	1.2	7.7	3.4	4.2	7.7	0.2	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 15: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	1.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.3	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL6	"dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3"	ENSG00000188636	"Retrotransposon Gag like 6"	Q6ICC9	22	44492583-44498233	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 11.1;Collecting duct cells: 12.9;Ductal cells: 8.4;Endometrial stromal cells: 12.9;Granulosa cells: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005697	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA005697: AB_1079244"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	10.6	12.1	21.3	7.2	19.2	3.2	8.9	15.1	18.9	11.2	8.3	12.5	8.8	15.7	12.1	8.2	16.6	11.0	15.3	20.1	17.4	9.3	3.2	9.4	6.3	18.8	20.0	19.2	11.0	17.8	8.7	5.1	17.1	9.8	9.1	9.6	7.2	13.6	15.5	3.4	8.4	16.9	18.8	7.5	9.7	11.2	21.9	14.2	10.2	18.0	4.8	10.4	5.4	17.2	13.8	18.9	23.9	31.9	18.3	14.8	6.3	17.9	21.1	24.6	19.2	6.3	8.0	0.0	10.9	33.5	18.5	11.8	16.3	17.7	15.1	6.5	31.8	0.0	35.8	0.0	22.6	1.8	8.7	16.2	16.8	22.5	17.3	33.4	22.3	21.6	7.8	0.1	16.9	24.3	44.4	4.1	14.7	15.1	20.0	12.1	12.7	0.0	21.1	15.8	25.6	30.0	29.2	14.0	18.1	11.5	14.0	19.3	23.1	19.2	25.7	25.7	14.5	8.3	3.5	0.0	28.5	4.5	29.2	0.0	0.7	0.0	1.8	0.3	1.9	0.0	1.0	1.5	0.5	0.0	0.4	1.0	0.0	0.4	0.4	0.0	0.2	1.1	21.3	19.2	15.1	18.9	20.1	17.4	18.8	20.0	17.1	18.8	21.9	17.2	5.8	0.0	5.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.1	6.5	0.0	0.0	2.5	12.9	0.0	2.9	4.8	0.0	0.0	8.4	0.0	7.4	12.9	4.0	0.0	0.0	0.0	6.5	2.7	3.5	0.0	8.1	0.0	13.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.7	0.0	0.0	5.7	7.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.2	1.8	5.2	0.0	0.0
RTTN	DKFZP434G145	ENSG00000176225	Rotatin	Q86VV8	18	70003031-70205726	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 69.3;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041343, HPA041967, HPA075089"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Centrosome	"HPA041343: AB_10794409, HPA041967: AB_10796790, HPA075089: "	"unprognostic (1.76e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.25e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	1.4	1.2	3.5	1.6	5.0	3.1	2.1	3.6	3.4	1.5	2.1	1.3	1.1	1.8	1.5	1.1	1.6	1.2	2.8	2.6	3.0	2.3	2.7	1.6	2.2	4.5	4.0	2.7	1.8	1.7	0.8	1.6	5.1	1.1	1.5	4.1	1.3	0.6	1.8	1.3	1.3	1.0	4.2	2.0	1.3	3.3	6.0	3.6	0.9	1.1	1.9	0.9	1.1	7.1	4.4	6.6	9.4	2.7	1.8	2.0	3.9	7.5	3.4	6.8	7.0	2.5	2.5	3.8	1.0	4.7	6.0	5.4	6.9	11.0	11.1	13.1	3.0	4.1	5.9	3.1	1.3	7.7	4.0	1.6	10.9	7.2	21.2	3.1	4.2	5.8	4.3	8.4	6.1	2.0	7.4	2.1	1.8	1.0	5.8	6.0	8.6	3.9	1.1	3.2	4.0	4.3	4.6	2.6	2.8	6.2	2.8	4.4	3.4	8.8	2.3	3.1	5.7	4.1	3.8	7.8	5.1	4.9	6.0	0.2	0.2	0.1	0.2	0.0	0.4	0.6	0.4	0.3	0.0	0.2	0.6	0.3	0.1	0.3	0.0	0.2	0.3	0.1	3.5	5.0	3.6	3.4	2.6	3.0	4.5	4.0	5.1	4.2	6.0	7.1	6.1	0.0	8.6	19.6	7.1	1.5	1.7	10.1	1.8	8.2	3.9	3.9	5.0	1.5	5.7	0.0	0.0	4.0	4.9	2.9	0.0	1.1	10.6	6.0	5.2	3.4	0.0	4.2	25.4	1.6	1.9	4.0	6.1	6.0	5.1	10.9	1.8	3.7	2.3	16.8	25.8	1.5	2.0	1.3	1.4	3.2	2.1	3.3	0.0	69.3	1.3	1.9	3.1	48.7	110.8	2.0	2.4	1.9	14.7	1.1	2.2	4.1	1.7	9.7	13.1	5.1	4.0	10.6	6.7	3.5	1.7	3.0	5.8	2.5	2.6	2.3
RUBCN	"KIAA0226, rubicon, rundataxin"	ENSG00000145016	"Rubicon autophagy regulator"	Q92622	3	197668867-197749727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Endocytosis, Immunity, Phagocytosis"		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 67.5;Plasma cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050908, HPA054497"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Vesicles, Cytosol"		"HPA050908: , HPA054497: AB_2682507"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.91e-5)"	"unprognostic (1.99e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.23e-1)"	8.3	7.5	16.2	11.6	16.3	8.5	7.2	10.5	17.0	9.2	4.4	10.4	7.3	8.8	4.0	12.0	8.5	7.2	11.4	17.0	19.0	7.7	5.6	11.8	15.3	20.0	17.8	10.7	9.1	6.8	15.8	5.8	15.9	7.4	5.7	10.9	7.3	7.2	8.9	9.1	13.1	7.8	14.5	19.2	8.1	14.6	23.7	8.8	7.1	8.1	16.1	8.9	8.4	17.4	30.9	7.4	8.2	16.2	14.4	8.3	8.6	13.8	9.2	17.0	14.2	12.7	8.4	33.6	26.7	15.8	16.1	17.0	15.0	8.0	13.6	9.3	13.9	21.6	13.4	4.9	8.4	12.0	18.0	7.0	9.6	14.8	17.6	7.9	10.7	14.4	12.3	87.7	11.5	24.4	15.7	7.5	7.1	8.8	23.2	14.9	8.6	22.6	9.6	13.9	34.3	7.9	10.2	19.8	10.8	5.5	29.2	8.1	13.7	9.9	9.9	27.8	18.9	36.5	34.2	27.0	13.6	22.4	8.7	0.8	2.6	17.5	3.7	3.9	2.4	7.7	3.1	4.7	1.6	8.5	2.2	3.2	2.9	1.8	4.8	16.6	4.4	1.7	16.2	16.3	10.5	17.0	17.0	19.0	20.0	17.8	15.9	14.5	23.7	17.4	8.5	6.4	11.2	0.0	33.9	0.0	6.0	0.0	8.0	21.0	7.3	7.0	0.0	7.2	4.3	12.9	18.8	1.8	28.9	3.8	1.9	5.8	21.7	4.8	6.2	6.7	0.0	5.7	0.0	6.4	3.7	4.8	7.1	9.8	2.5	6.1	9.3	3.5	9.2	21.9	0.0	3.7	0.0	16.3	0.0	16.4	5.0	18.7	0.0	0.0	67.5	15.0	14.4	0.0	0.0	8.5	1.5	6.4	48.3	8.9	5.8	2.7	0.7	14.3	6.6	9.7	6.8	34.1	21.3	5.6	0.0	6.4	15.9	4.9	2.8	12.3
RUBCNL	"C13orf18, FLJ21562, KIAA0226L, PACER"	ENSG00000102445	"Rubicon like autophagy enhancer"	Q9H714	13	46334681-46438190	"Predicted intracellular proteins"	"Autophagy, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 6.1;B-cells: 20.7;Endometrial stromal cells: 6.7;Hofbauer cells: 16.7;Macrophages: 5.2"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"memory B-cell: 161.2;naive B-cell: 155.8;neutrophil: 124.0;plasmacytoid DC: 106.2"	"Group enriched"	"Detected in many"	15	"B-cells: 161.2;dendritic cells: 106.2;granulocytes: 124.0"	"Group enriched"	"Detected in some"	4	"Daudi: 179.1;U-698: 341.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favorable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"	4.2	1.3	3.7	18.0	3.8	14.8	4.0	3.5	4.1	6.6	2.5	11.9	3.0	3.7	1.2	1.0	3.7	4.0	1.0	3.4	6.8	1.1	2.2	5.2	41.2	6.2	4.8	0.6	0.7	0.3	2.0	4.2	6.1	1.5	16.2	3.9	3.0	2.6	10.1	2.0	13.2	3.6	4.9	20.3	2.2	15.7	6.3	22.9	1.9	1.4	40.6	7.5	1.3	5.9	0.5	0.1	3.6	0.2	0.1	0.2	0.3	0.0	0.2	0.2	0.1	7.5	0.2	179.1	1.8	0.0	0.9	0.2	0.1	0.0	0.1	0.7	0.3	0.2	0.2	0.1	0.0	0.2	0.2	4.7	0.0	0.6	0.9	0.0	0.0	8.2	0.3	0.4	0.0	0.1	1.9	1.4	1.5	0.0	1.4	62.6	0.1	6.1	0.0	0.1	3.4	0.1	0.2	0.3	4.4	10.8	0.2	53.0	0.1	0.2	1.6	0.3	0.4	0.9	37.3	341.2	1.1	0.3	0.2	0.5	4.5	0.1	0.1	8.9	0.1	161.2	0.3	0.1	5.1	155.8	0.1	0.1	124.0	3.5	7.1	106.2	0.2	7.5	3.7	3.8	3.5	4.1	3.4	6.8	6.2	4.8	6.1	4.9	6.3	5.9	0.2	3.2	6.1	0.0	20.7	0.0	0.0	0.0	0.0	0.0	2.9	3.9	0.0	0.0	2.5	0.0	0.0	0.3	0.3	0.0	0.0	1.4	0.0	1.3	6.7	0.4	0.0	0.0	0.0	1.2	0.4	1.1	0.0	2.5	2.5	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
RUNDC1	DKFZp761H0421	ENSG00000198863	"RUN domain containing 1"	Q96C34	17	42980565-42993690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023726	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"	Cytosol	"HPA023726: AB_2184078"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.39e-2)"	"prognostic favorable (6.93e-5)"	"unprognostic (9.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.77e-3)"	5.5	8.0	8.7	6.6	11.0	6.8	10.0	6.5	11.0	8.6	9.7	9.4	6.5	8.7	12.1	6.6	14.5	6.1	7.3	9.6	8.8	8.4	5.0	6.9	7.2	6.3	6.8	5.0	7.9	12.0	9.4	4.8	6.2	12.1	7.6	8.5	7.5	8.5	11.6	7.1	7.8	8.6	5.8	8.1	10.1	6.8	7.9	6.7	10.2	9.0	7.7	8.4	6.2	8.2	12.9	22.1	8.8	11.9	14.7	8.8	9.3	12.2	12.6	17.1	12.7	14.0	7.2	8.6	10.7	12.1	11.6	15.8	11.3	12.3	18.9	9.7	17.7	5.8	12.8	13.5	9.4	12.6	11.9	6.6	14.7	15.1	10.0	13.6	9.2	9.3	11.2	5.3	9.9	9.3	15.6	8.9	9.9	18.3	13.8	11.2	12.3	8.6	14.3	17.0	12.8	11.8	9.6	9.0	10.2	12.9	17.5	13.9	7.6	15.4	9.6	9.2	14.7	12.6	13.1	7.5	11.0	6.6	9.8	4.7	2.3	7.9	1.3	3.8	1.7	3.7	1.6	1.1	1.8	3.7	1.6	1.7	5.4	1.1	2.8	5.6	2.0	1.0	8.7	11.0	6.5	11.0	9.6	8.8	6.3	6.8	6.2	5.8	7.9	8.2	5.3	44.8	38.4	6.5	18.7	15.0	11.0	5.8	9.1	18.9	19.2	9.8	13.7	22.8	17.2	5.5	22.9	9.8	19.1	28.7	21.5	11.8	8.1	26.4	9.6	10.3	19.2	5.7	13.8	9.8	7.3	8.6	20.4	19.5	11.4	8.4	10.4	6.1	8.4	38.7	11.0	16.9	6.1	10.5	14.7	4.5	9.9	9.5	3.6	7.5	14.3	14.3	12.3	5.0	6.2	10.1	16.4	14.3	11.7	16.6	15.1	12.8	24.7	33.2	19.7	8.5	9.6	22.9	14.9	7.2	14.6	5.5	13.9	10.4	17.8	17.0
RUSF1	"C16orf58, FLJ13868"	ENSG00000140688	"RUS family member 1"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.8;Cytotrophoblasts: 22.3;Extravillous trophoblasts: 21.0;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	27.1	31.8	19.6	20.0	18.9	21.5	28.8	12.0	21.3	45.4	14.2	29.6	31.3	43.2	20.7	26.5	38.2	23.0	28.5	19.9	19.7	29.5	57.9	25.0	19.8	17.0	16.0	49.6	56.8	46.2	48.4	25.7	18.5	39.1	19.1	22.4	64.8	34.2	9.4	26.9	30.3	25.6	13.8	22.3	39.5	21.4	17.0	18.0	42.0	9.8	15.6	31.8	31.4	17.0	28.6	37.2	22.7	39.7	51.7	34.3	42.3	33.4	56.6	25.5	30.2	11.3	49.1	24.5	69.4	49.8	32.9	39.0	22.9	31.0	11.8	35.8	23.0	24.8	20.6	28.8	74.8	29.4	28.6	41.7	33.1	33.7	68.5	50.2	24.9	38.4	37.3	40.9	25.3	53.9	13.7	19.8	17.8	41.8	24.1	31.1	34.2	74.8	29.3	17.6	24.8	38.2	25.2	65.3	52.8	21.5	56.6	42.9	22.0	44.3	24.7	28.7	22.1	59.0	37.0	18.8	56.7	44.7	62.5	3.1	5.7	7.6	7.8	8.4	7.2	6.7	8.2	7.8	9.7	6.3	7.9	7.0	0.9	9.4	8.1	8.9	9.4	7.2	19.6	18.9	12.0	21.3	19.9	19.7	17.0	16.0	18.5	13.8	17.0	17.0	5.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	22.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	21.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	22.3	0.4	0.0	0.0	0.0
RYK	"D3S3195, JTK5, JTK5A, RYK1"	ENSG00000163785	"Receptor like tyrosine kinase"	P34925	3	134065303-134250859	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034117, HPA045503, HPA075430"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293"	"unprognostic (7.84e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.85e-2)"	31.8	25.2	15.7	15.7	16.2	17.1	42.8	15.4	19.8	40.2	19.9	34.5	20.1	46.1	40.0	29.6	33.4	24.3	30.3	14.5	15.3	25.4	22.3	25.3	18.9	15.9	15.6	82.1	24.5	29.7	17.0	36.6	15.5	36.3	26.2	15.9	26.9	43.9	25.3	34.7	21.4	40.6	16.3	22.9	23.2	47.0	16.5	21.2	40.9	32.2	20.5	34.7	32.6	16.4	78.8	20.6	63.3	48.7	79.8	84.4	48.8	51.0	117.7	66.4	74.2	65.6	58.8	15.3	82.4	63.1	63.7	71.6	45.5	64.3	94.5	25.9	20.5	40.6	22.4	42.4	62.2	20.0	34.4	56.1	74.0	41.2	82.2	72.5	56.5	26.4	14.5	7.5	66.0	37.6	28.0	25.9	53.4	65.2	24.3	13.7	48.4	32.4	54.5	57.3	31.0	45.6	61.7	44.5	79.1	40.5	55.7	35.8	42.1	54.8	49.6	57.8	41.8	3.1	4.2	8.3	34.8	33.1	39.6	4.6	0.8	1.6	1.1	0.8	1.3	0.6	2.0	1.3	0.3	1.2	1.9	1.5	0.3	1.6	0.8	0.0	0.5	0.5	15.7	16.2	15.4	19.8	14.5	15.3	15.9	15.6	15.5	16.3	16.5	16.4	62.5	12.8	27.9	31.6	20.6	41.3	36.6	26.3	39.3	23.1	45.4	37.2	34.9	18.6	23.7	44.1	29.2	19.4	23.1	15.9	0.0	15.9	16.2	27.6	41.7	31.0	13.9	13.2	69.5	21.1	14.7	41.3	15.8	32.7	17.7	121.2	40.7	24.1	11.3	13.5	59.7	20.9	12.2	18.6	21.6	7.4	33.2	16.1	14.2	65.6	12.8	26.8	13.4	65.9	57.9	21.7	19.7	32.7	12.9	42.8	15.4	10.5	13.9	39.8	46.0	33.8	38.1	24.6	40.9	33.7	38.1	10.8	18.4	50.8	22.2	38.9
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433691-38587564	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 1618.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.4;Basal squamous epithelial cells: 22.8;Microglial cells: 49.6;Muller glia cells: 50.6;Skeletal myocytes: 41.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 1.8;myeloid DC: 2.9;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;HaCaT: 18.9;hTCEpi: 7.6;RH-30: 15.3;SiHa: 30.7;U-2 OS: 12.4"	"Low region specificity"	"Detected in single"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		46000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: AB_2683121"	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	1.4	2.4	10.3	1.6	8.0	0.3	2.1	8.5	9.3	2.1	1.0	1.2	0.5	0.7	1.3	17.2	1.7	1.1	0.9	7.5	20.5	1.9	0.4	2.6	2.1	8.6	9.7	0.9	0.4	1.9	1.5	1.8	7.7	3.8	0.3	10.6	14.0	1.4	1618.9	13.3	1.3	0.8	2.6	1.7	1.0	8.9	22.6	1.5	1.2	286.6	2.6	1.0	3.3	6.1	0.0	7.7	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.4	0.5	6.3	0.0	0.0	18.9	0.2	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.6	1.7	7.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.5	1.0	0.0	0.0	15.3	1.5	0.8	0.0	0.0	1.5	30.7	0.0	0.0	0.6	0.7	5.9	0.0	0.0	12.4	0.3	0.0	0.4	1.4	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.2	1.8	0.2	0.2	0.1	0.3	2.9	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.4	0.3	10.3	8.0	8.5	9.3	7.5	20.5	8.6	9.7	7.7	2.6	22.6	6.1	0.3	0.0	1.1	29.4	1.4	11.3	3.8	6.6	22.8	8.9	0.5	7.9	3.6	0.0	1.1	0.0	2.1	0.2	1.2	0.0	5.9	0.1	6.7	0.2	0.9	1.0	0.0	0.4	10.2	0.0	0.4	0.9	0.0	0.5	0.0	0.3	0.7	0.0	8.8	1.7	17.2	0.0	2.0	2.9	15.2	5.9	3.1	6.2	0.0	49.6	1.3	50.6	0.0	13.6	2.0	0.0	0.0	1.9	0.9	0.8	0.0	0.2	0.4	1.8	0.0	41.7	1.2	6.3	7.4	7.5	4.7	0.3	2.6	0.4	0.0	0.7
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 3574.5;kidney: 1380.0;urinary bladder: 1097.4"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 11464.4;Basal prostatic cells: 4796.7;Basal respiratory cells: 10600.9;Basal squamous epithelial cells: 4741.9;Club cells: 3331.1;Prostatic glandular cells: 9446.4;Squamous epithelial cells: 9013.7;Suprabasal keratinocytes: 3626.5;Urothelial cells: 5382.7"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 848.8;head and neck cancer: 1229.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.1"	"Group enriched"	"Detected in many"	5	"HBEC3-KT: 21286.9;RT4: 8382.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	4.0	2.1	2.5	4.1	2.7	1.0	17.3	2.4	3.6	279.9	2.0	3.1	0.8	2.5	16.1	3574.5	5.6	1.8	3.9	2.3	3.2	1380.0	1.7	12.0	0.5	4.1	3.0	1.9	2.1	0.1	5.4	0.8	3.0	48.1	1.6	0.4	377.1	16.9	3.3	429.6	1.6	1.9	3.0	1.5	3.6	2.8	3.4	6.3	11.9	1.4	416.1	1097.4	747.3	3.5	827.0	9.3	1.1	0.9	10.8	4.2	1.2	10.4	11.5	9.0	7.8	2.1	26.8	1.2	418.3	17.8	18.3	2001.4	1.3	21286.9	9.9	5.4	3.7	3.8	56.2	5.0	4.5	0.7	1.9	8.8	2777.8	24.1	3135.5	21.7	13.2	0.0	0.8	1.5	47.7	3.4	0.2	0.2	2.2	22.3	155.4	1.3	497.9	2.1	502.4	8382.8	16.5	0.5	34.9	5.8	9.0	5.9	3.2	5.7	6.0	12.5	692.6	92.4	280.6	1.9	2.4	4.7	26.5	1.8	24.2	10.1	0.4	0.0	2.3	0.0	1.4	0.4	1.6	1.3	0.3	0.0	0.4	0.3	4.3	0.0	0.5	2.2	1.6	0.7	2.5	2.7	2.4	3.6	2.3	3.2	4.1	3.0	3.0	3.0	3.4	3.5	1.4	9.6	17.3	2.6	1.0	11464.4	4796.7	10600.9	4741.9	0.0	22.2	35.4	2.9	1.5	3331.1	218.8	0.0	0.7	0.8	3.2	1226.7	24.8	4.5	16.3	2.5	108.2	1.8	3.0	0.1	27.6	1.0	130.8	1.5	24.5	17.1	1.2	0.4	0.1	1.8	0.0	0.0	1.6	789.4	0.8	676.4	8.1	0.6	18.0	759.5	0.0	5.3	1.1	0.0	2.0	0.1	668.7	2.5	0.7	25.9	9446.4	0.8	11.8	560.8	0.1	0.0	5.5	207.0	0.6	3.0	9013.7	3626.5	0.3	37.8	8.9	2.0	5382.7
S100G	"CABP1, CABP9K, CALB3"	ENSG00000169906	"S100 calcium binding protein G"	P29377	X	16650158-16654670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	202	"intestine: 238.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"breast cancer: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"CAB017688, HPA028920, HPA055873"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB017688: AB_1119899, HPA028920: , HPA055873: AB_2682952"	"unprognostic (2.68e-2)"									"unprognostic (2.78e-1)"				"unprognostic (9.88e-3)"				0.0	0.0	0.1	0.1	0.3	0.1	1.1	0.7	0.1	0.0	0.1	0.3	238.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	0.1	0.1	0.6	0.5	0.1	0.4	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100Z	"Gm625, S100-zeta"	ENSG00000171643	"S100 calcium binding protein Z"	Q8WXG8	5	76850001-76921650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;lymphoid tissue: 3.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 7.4;Kupffer cells: 8.7;Macrophages: 11.8;Microglial cells: 32.8;monocytes: 26.1"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 35.0;eosinophil: 31.8;intermediate monocyte: 34.0;myeloid DC: 19.5;neutrophil: 11.8;non-classical monocyte: 39.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 19.5;granulocytes: 31.8;monocytes: 39.6"	"Cell line enriched"	"Detected in some"	6	"U-698: 81.9"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.3"	"Low region specificity"	"Detected in all"			HPA051929	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA051929: AB_2732571"	"unprognostic (4.17e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.47e-5)"	"unprognostic (3.39e-4)"	"unprognostic (8.94e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.62e-1)"	0.3	0.2	1.1	2.0	0.6	2.4	0.2	0.4	1.1	0.0	0.1	0.3	0.4	0.1	0.1	0.3	0.1	0.7	0.1	0.5	0.5	0.1	0.3	0.7	0.9	0.6	0.6	0.0	0.9	0.1	0.1	1.2	0.6	0.2	0.4	0.0	0.2	0.1	0.2	0.0	0.8	0.6	0.5	3.2	0.4	0.2	1.0	0.8	0.1	0.0	2.5	0.5	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	2.7	0.1	0.2	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.1	1.0	0.1	81.9	3.3	0.0	0.0	2.5	35.0	31.8	0.8	34.0	0.2	4.7	0.5	0.1	19.5	2.1	0.0	0.0	11.8	0.7	39.6	0.1	0.7	10.5	1.1	0.6	0.4	1.1	0.5	0.5	0.6	0.6	0.6	0.5	1.0	1.1	0.2	0.0	0.0	0.3	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	2.1	2.1	0.0	0.2	0.2	0.5	0.2	0.0	0.5	0.4	0.0	7.4	0.0	2.0	0.0	0.0	8.7	1.1	0.0	0.0	11.8	3.6	32.8	26.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.1	1.4	0.0	0.0	0.0
SAC3D1	"HSU79266, SHD1"	ENSG00000168061	"SAC3 domain containing 1"		11	65040901-65044828	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.1;Late spermatids: 121.5;Spermatocytes: 166.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042677	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA042677: AB_10797506"	"unprognostic (1.35e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.00e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (9.67e-6)"	"unprognostic (4.11e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (2.97e-3)"	"unprognostic (5.71e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.49e-1)"	3.8	3.4	9.9	2.7	9.5	4.1	2.0	9.6	10.6	3.1	7.5	3.6	3.1	3.1	0.6	3.6	2.8	0.7	2.6	9.8	9.1	2.1	3.7	2.1	2.8	11.7	9.9	2.5	2.8	1.3	2.7	1.4	10.7	2.8	1.2	0.6	2.7	2.0	9.3	3.7	2.6	2.0	9.4	3.1	2.9	13.5	10.4	7.1	1.4	2.1	2.1	2.6	2.5	10.2	48.3	27.4	13.3	15.1	6.8	5.0	18.9	28.2	6.3	15.9	13.8	13.4	11.3	20.8	22.2	7.7	17.6	32.1	14.4	15.6	2.7	33.0	44.9	15.5	24.5	42.3	5.1	14.5	11.6	3.9	13.4	12.2	5.4	4.4	5.5	20.3	25.7	16.3	6.1	32.6	39.7	75.9	12.1	13.5	61.2	38.0	19.4	31.7	6.8	10.6	29.9	19.6	21.9	22.2	19.4	3.8	20.8	15.3	6.7	13.6	36.9	37.8	20.0	35.6	30.8	22.7	8.0	15.2	4.5	0.0	1.4	0.2	0.6	1.1	0.5	0.9	0.9	0.7	0.7	1.1	1.0	0.6	0.1	0.2	1.5	1.6	0.9	0.4	9.9	9.5	9.6	10.6	9.8	9.1	11.7	9.9	10.7	9.4	10.4	10.2	7.6	3.2	0.5	3.6	7.1	8.7	5.4	2.5	15.9	6.9	19.0	22.7	5.8	11.5	1.5	9.2	0.0	21.9	11.2	26.3	7.9	3.1	94.1	6.4	13.6	6.4	7.2	16.2	4.0	1.6	42.9	10.7	8.2	7.1	5.7	28.0	5.3	17.9	30.4	5.0	4.2	18.5	0.0	15.1	5.5	121.5	17.7	10.4	10.6	1.0	10.5	13.6	13.4	2.5	5.5	2.4	15.2	13.9	11.3	11.2	14.5	14.7	1.3	9.3	0.0	8.1	10.6	166.7	42.2	20.1	7.7	6.7	11.1	22.2	27.6	3.9
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;kidney: 36.4;liver: 36.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Cone photoreceptor cells: 25.0;Endometrial stromal cells: 17.5;Glandular and luminal cells: 14.3;Hepatocytes: 30.1;Microglial cells: 26.2;Oligodendrocytes: 47.6;Proximal tubular cells: 20.3"	"Cancer enhanced"	"Detected in many"		"glioma: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 29.5;BJ hTERT+: 25.3;NTERA-2: 48.0;RPTEC TERT1: 40.4;U-87 MG: 46.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 52.6"	"Low region specificity"	"Detected in all"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.3	0.0	18.0	0.6	29.2	0.1	0.3	29.7	21.3	19.6	2.1	2.6	1.0	17.4	0.0	0.3	11.0	0.4	0.8	17.9	21.7	36.4	36.5	0.0	0.0	41.0	32.2	4.5	1.0	6.5	6.5	3.9	36.6	0.8	2.6	4.6	0.2	1.6	0.0	0.2	1.3	8.4	31.1	0.0	2.5	1.7	26.6	0.1	23.7	0.2	0.0	2.8	7.2	40.2	0.0	1.7	29.5	0.2	0.8	0.6	0.0	10.0	25.3	0.6	1.4	0.0	0.0	0.0	11.2	14.1	8.8	0.0	18.6	0.0	0.9	0.0	11.3	0.0	0.0	18.5	0.7	0.0	8.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.8	1.9	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	46.2	0.0	10.0	0.2	0.6	0.5	0.1	0.4	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.0	0.3	0.4	0.2	0.3	18.0	29.2	29.7	21.3	17.9	21.7	41.0	32.2	36.6	31.1	26.6	40.2	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	1.4	10.0	0.0	9.2	25.0	0.0	0.0	0.0	11.7	0.5	0.7	8.9	17.5	0.9	0.0	2.7	0.2	0.0	0.0	1.6	0.0	14.3	0.0	0.0	0.7	30.1	0.1	0.0	8.2	0.0	0.0	1.0	0.3	0.1	0.0	0.4	0.0	26.2	0.0	0.5	0.0	5.0	47.6	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	1.0	0.0	0.0	0.5	0.2	2.3	0.0	0.1	0.0	0.3	0.6	0.0	0.1
SAMD1		ENSG00000141858	"Sterile alpha motif domain containing 1"		19	14087851-14091036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041662, HPA049059"	Uncertain		Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Mitochondria	"HPA041662: AB_2677605, HPA049059: AB_2680616"	"unprognostic (2.93e-2)"	"prognostic favorable (7.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (7.98e-5)"	"prognostic favorable (8.31e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.45e-1)"	24.7	18.1	53.2	18.3	51.9	22.3	21.2	49.0	50.5	29.9	33.9	32.3	20.1	30.0	8.7	37.0	24.7	8.2	37.6	48.6	49.6	25.8	24.2	24.5	21.4	57.0	51.6	27.5	24.8	8.0	14.9	10.8	54.4	21.8	14.2	7.1	20.2	14.0	50.9	39.7	29.4	11.7	51.7	38.2	28.6	26.3	52.6	44.5	20.6	22.6	17.7	29.4	30.4	54.0	73.2	54.8	47.3	67.3	28.7	29.7	71.8	39.3	9.4	39.5	31.7	41.5	35.3	125.1	51.2	25.6	18.9	57.9	51.5	29.5	19.5	84.3	42.8	55.5	73.7	76.0	25.9	33.1	33.1	20.7	47.5	27.4	9.2	37.6	23.5	79.6	67.9	33.8	22.9	110.2	69.0	129.2	96.7	53.0	47.9	92.1	41.9	91.8	33.5	35.2	86.5	86.1	34.8	46.6	26.6	25.0	29.6	70.0	26.1	68.7	62.1	69.5	50.7	62.0	58.1	105.2	41.0	89.0	28.4	0.2	1.3	2.5	0.8	0.5	1.0	2.1	0.9	1.0	1.2	1.4	1.2	0.9	0.2	3.7	0.5	0.9	1.1	0.8	53.2	51.9	49.0	50.5	48.6	49.6	57.0	51.6	54.4	51.7	52.6	54.0	42.0	3.2	6.7	0.7	10.9	11.5	4.6	14.4	18.8	31.4	25.2	31.4	11.9	21.5	5.5	11.0	6.2	3.9	22.4	48.6	1.9	11.2	0.3	24.4	21.6	19.4	24.7	43.6	0.3	11.1	9.3	14.3	9.7	24.5	8.2	15.2	13.6	13.8	15.5	52.2	0.4	24.0	6.1	25.7	16.1	2.2	19.3	19.6	10.6	0.0	11.3	19.4	2.1	1.0	0.9	13.0	18.9	18.8	13.3	6.6	23.6	6.6	10.6	8.5	13.1	7.5	18.8	0.8	20.4	29.2	17.2	1.8	14.1	8.2	30.5	4.8
SAMD12	FLJ39458	ENSG00000177570	"Sterile alpha motif domain containing 12"	Q8N8I0	8	118189455-118622112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 537.6;Inhibitory neurons: 531.7;Oligodendrocytes: 1158.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 34.6;U-266/70: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024634	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"		"HPA024634: AB_1856549"	"unprognostic (6.96e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (3.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.35e-3)"	0.7	1.4	2.4	1.1	4.9	0.4	3.0	0.7	8.8	2.3	0.0	4.0	3.7	1.1	4.0	4.1	5.3	3.6	6.9	7.5	0.8	5.2	1.6	4.2	0.7	1.4	0.5	0.9	1.9	9.6	3.3	0.1	2.6	3.7	4.7	5.9	2.4	5.0	0.8	0.8	2.0	0.7	0.9	2.6	5.7	1.3	2.1	1.0	10.2	0.1	2.0	4.4	1.1	8.4	10.2	0.7	0.9	0.0	0.0	0.0	2.1	3.4	10.4	7.8	4.3	1.1	12.1	3.4	0.8	8.2	1.6	1.9	2.0	4.7	11.9	0.1	1.1	0.0	5.7	0.0	0.0	0.0	0.2	0.0	2.3	4.6	0.4	2.8	0.2	5.9	0.0	6.0	6.0	2.0	1.6	0.0	0.8	13.2	1.3	0.0	0.0	9.7	5.4	13.5	4.0	0.0	2.8	34.6	0.0	2.1	0.5	0.0	0.0	0.1	3.8	1.4	1.2	14.9	10.2	0.4	1.8	0.0	1.1	0.1	0.0	0.0	0.1	0.0	1.0	1.5	0.8	0.5	0.0	1.0	1.0	0.6	0.1	0.6	0.0	0.3	0.8	0.2	2.4	4.9	0.7	8.8	7.5	0.8	1.4	0.5	2.6	0.9	2.1	8.4	4.7	112.2	95.0	53.5	8.0	1.7	10.1	10.3	13.1	16.8	10.9	5.1	12.1	12.8	57.5	29.5	43.8	0.0	3.3	10.5	19.6	12.9	5.2	12.1	1.5	13.0	14.3	2.1	537.6	12.4	0.1	9.1	26.5	16.4	56.8	4.4	7.5	5.2	0.1	30.3	531.7	11.2	14.2	0.3	0.0	6.1	0.3	6.5	7.2	163.0	0.7	4.5	4.1	122.6	1158.0	13.0	3.5	0.4	16.9	5.0	8.6	17.4	68.0	26.9	0.0	0.5	0.9	0.5	2.4	15.9	1.7	0.0	8.9	4.5	11.9	13.6
SAMD9L	"C7orf6, FLJ39885, KIAA2005"	ENSG00000177409	"Sterile alpha motif domain containing 9 like"	Q8IVG5	7	93130056-93148385	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.3"	"Cell type enhanced"	"Detected in many"		"monocytes: 64.8;NK-cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 54.0;GAMG: 44.1;HDLM-2: 51.2;Karpas-707: 131.4"	"Low region specificity"	"Detected in all"							"HPA019461, HPA019465, HPA019488"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA019461: AB_1856555, HPA019465: AB_2183384, HPA019488: AB_1856557"	"unprognostic (6.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.03e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.22e-1)"	10.2	6.0	4.0	24.4	4.6	10.0	7.5	3.6	4.4	7.2	3.7	10.5	11.5	7.3	4.5	6.3	6.5	13.8	6.2	3.6	4.9	6.8	6.1	21.9	27.1	9.5	4.5	9.1	3.2	1.9	3.9	12.6	5.9	4.3	11.4	2.4	12.9	4.2	2.9	4.1	11.7	9.1	8.0	38.3	14.4	2.9	5.4	22.9	6.7	4.6	16.2	11.9	6.3	6.3	7.2	0.4	0.0	0.4	9.3	18.7	0.2	6.2	25.7	34.5	54.0	0.0	15.9	4.7	7.7	16.7	44.1	3.1	0.0	2.2	5.5	51.2	0.0	4.3	1.9	0.0	7.5	9.6	7.0	7.2	0.8	6.9	1.0	6.4	15.1	7.1	0.0	131.4	14.6	0.0	15.3	8.5	0.5	0.0	1.8	6.3	2.2	11.0	1.8	0.6	0.0	0.3	1.3	0.2	9.8	0.1	0.4	5.0	35.8	10.1	2.2	29.6	3.8	36.4	13.0	1.3	10.6	8.6	10.1	30.1	6.7	16.7	13.4	13.3	11.6	15.1	7.4	10.0	6.3	10.3	4.3	7.7	29.2	8.2	12.8	4.7	11.8	4.0	4.0	4.6	3.6	4.4	3.6	4.9	9.5	4.5	5.9	8.0	5.4	6.3	37.4	35.3	11.2	15.7	28.5	2.3	2.3	6.0	4.6	0.0	8.0	5.5	1.8	2.8	9.6	11.0	0.0	0.3	34.2	18.8	9.8	12.7	0.1	4.9	16.3	28.0	1.2	10.1	0.2	5.7	1.0	14.3	20.4	2.4	34.2	12.2	27.5	0.4	24.4	0.0	0.1	12.6	6.1	20.4	12.9	1.1	9.6	36.5	7.2	44.0	64.8	14.1	91.6	0.0	0.2	16.2	50.2	11.7	28.1	3.1	5.1	4.2	18.6	0.4	6.6	15.0	7.7	0.3	0.2	4.1	2.3	0.1	34.0	12.2	4.1	8.0
SASH1	"dJ323M4.1, KIAA0790, SH3D6A"	ENSG00000111961	"SAM and SH3 domain containing 1"	O94885	6	148272304-148552048	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 194.8;Astrocytes: 426.7;Microglial cells: 179.9;Oligodendrocyte precursor cells: 186.5;Oligodendrocytes: 328.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"classical monocyte: 1.2;intermediate monocyte: 2.6;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	26	"monocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 198.0;ASC TERT1: 74.7;fHDF/TERT166: 73.4;HUVEC TERT2: 75.0;WM-115: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029947, HPA029949"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA029947: AB_10598915, HPA029949: AB_10602280"	"unprognostic (9.71e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.79e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.53e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.54e-1)"	76.1	6.1	45.5	6.6	62.5	0.3	47.6	58.2	35.4	24.5	10.3	18.1	6.8	13.6	5.1	45.2	15.9	19.7	17.0	40.0	43.0	15.0	9.3	26.5	6.2	72.1	60.0	6.5	9.5	14.2	5.1	30.3	59.4	11.6	9.8	15.4	19.8	9.2	17.9	31.0	11.8	16.1	49.1	13.7	9.5	4.6	65.1	5.1	39.0	22.5	7.8	13.8	27.9	59.3	4.8	2.9	23.6	7.9	198.0	74.7	3.9	27.3	65.6	20.2	30.7	6.2	5.7	0.0	14.1	73.4	10.1	5.7	7.3	6.7	16.9	0.0	5.3	0.0	13.6	5.7	6.1	0.0	1.3	35.1	6.8	30.6	8.3	8.3	75.0	0.0	0.4	0.1	19.1	5.5	0.0	0.0	6.9	2.6	3.8	0.0	16.8	0.2	15.1	15.1	0.9	0.0	8.4	30.8	21.5	6.1	2.4	14.0	65.6	19.7	4.0	63.1	5.9	0.0	0.0	0.0	31.6	0.0	95.6	0.0	1.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	45.5	62.5	58.2	35.4	40.0	43.0	72.1	60.0	59.4	49.1	65.1	59.3	194.8	16.0	21.7	426.7	0.6	41.0	6.2	5.1	29.6	21.9	17.7	24.0	18.5	5.7	18.3	46.0	6.2	20.6	0.8	4.4	7.9	3.1	0.8	45.3	36.2	104.7	4.8	0.0	16.4	2.4	59.5	66.5	8.2	40.1	2.5	2.3	60.3	8.1	8.8	3.3	120.7	5.3	10.2	42.4	18.5	1.6	18.3	15.6	42.7	179.9	4.9	100.4	0.0	186.5	328.6	1.5	2.9	28.2	1.3	6.4	2.3	15.0	15.5	4.7	78.9	49.9	73.2	0.5	3.7	46.3	33.0	32.7	1.6	3.1	7.2	7.4
SATL1		ENSG00000184788	"Spermidine/spermine N1-acetyl transferase like 1"	Q86VE3	X	85092284-85243911	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 12.8;Alveolar cells type 2: 12.9;Club cells: 6.8;Distal tubular cells: 3.9;Early spermatids: 5.4;granulocytes: 6.3;Late spermatids: 14.0;Respiratory ciliated cells: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060369	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA060369: AB_2684265"					"unprognostic (1.77e-1)"	"unprognostic (2.06e-1)"				"unprognostic (4.69e-3)"			"unprognostic (7.88e-2)"					0.0	0.3	0.3	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.0	0.2	0.4	0.0	12.8	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	6.8	0.0	0.0	0.0	0.2	0.0	3.9	0.0	5.4	0.3	0.3	1.2	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.2	6.3	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	14.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.8	0.0	0.4	0.7	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.7	0.3	0.0	0.0
SBF2	"CMT4B2, DENND7B, KIAA1766, MTMR13"	ENSG00000133812	"SET binding factor 2"	Q86WG5	11	9778667-10294219	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 224.6;Excitatory neurons: 244.9;Inhibitory neurons: 367.4;Microglial cells: 273.6;Oligodendrocyte precursor cells: 290.5;Oligodendrocytes: 228.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 105.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050933	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA050933: AB_2681280"	"unprognostic (2.26e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.36e-2)"	"unprognostic (5.55e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (3.66e-5)"	"unprognostic (3.72e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.11e-2)"	13.3	7.6	8.6	6.2	9.2	4.0	9.2	6.4	7.7	15.2	5.1	9.3	6.8	11.3	9.1	11.6	10.2	10.4	8.9	6.7	7.7	13.8	9.5	7.4	3.9	6.9	8.1	18.0	5.1	17.1	4.6	14.2	7.2	10.6	10.5	14.9	9.3	11.4	4.7	7.4	6.6	10.9	7.1	7.8	9.5	10.8	7.1	6.1	16.7	8.9	4.2	11.2	8.2	8.2	15.1	12.1	20.8	15.0	27.1	35.4	105.4	11.6	20.9	13.1	18.2	9.1	18.1	5.8	6.2	20.6	19.1	9.8	12.5	9.8	22.9	6.2	8.6	2.5	9.1	11.9	10.6	5.6	8.0	17.5	12.3	6.6	25.8	20.2	21.8	12.1	5.1	5.2	15.8	4.3	8.1	1.5	9.1	13.5	13.3	7.5	14.5	7.6	11.9	13.4	6.9	15.4	15.7	22.4	10.0	10.6	6.7	4.0	24.4	23.1	11.5	24.3	9.5	1.7	4.6	8.0	17.4	2.7	17.0	0.0	0.7	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	1.1	0.3	1.6	0.1	0.1	0.2	8.6	9.2	6.4	7.7	6.7	7.7	6.9	8.1	7.2	7.1	7.1	8.2	50.2	44.8	83.9	224.6	16.4	25.5	43.4	24.1	27.3	35.1	16.4	14.5	31.4	22.8	30.8	16.5	75.0	13.8	14.6	20.3	3.9	13.9	18.3	17.8	31.1	40.9	43.8	11.4	244.9	8.8	12.9	40.0	40.8	30.1	21.5	41.7	49.6	16.6	18.6	37.0	367.4	16.2	24.4	55.0	34.1	9.2	51.0	44.8	30.2	273.6	37.6	12.0	29.9	290.5	228.4	13.5	21.2	27.1	9.5	56.5	14.5	13.1	38.3	71.6	26.3	44.0	34.8	24.5	17.4	30.6	30.7	13.8	20.6	25.9	20.1	47.4
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292681-121313410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.6"	"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 141.0;Hepatocytes: 307.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	28.6	35.3	18.4	12.6	20.4	5.7	56.6	37.1	29.3	20.7	17.6	23.2	48.2	15.1	73.2	39.6	16.5	18.2	22.0	19.9	29.9	49.1	393.6	24.6	13.5	42.9	28.0	16.9	21.5	48.6	15.6	14.7	39.1	101.4	19.9	29.5	22.4	56.6	7.7	13.8	24.7	16.2	32.2	8.8	21.7	24.3	24.6	13.5	23.9	13.0	19.5	21.5	27.1	36.5	26.5	14.3	184.8	39.5	72.1	59.9	27.8	27.8	53.5	18.2	32.4	83.1	95.9	25.4	89.0	32.3	156.6	100.8	59.2	70.9	18.1	12.5	80.0	34.6	73.4	64.4	57.9	24.8	12.5	51.0	57.4	60.4	60.2	15.6	29.8	22.8	25.0	34.6	89.0	27.4	9.4	29.2	59.8	74.4	39.7	13.2	51.0	21.6	133.6	116.5	51.1	28.8	73.4	14.6	38.0	125.4	62.2	38.6	58.3	19.0	29.7	32.5	14.0	6.4	11.2	33.3	7.0	49.5	33.5	7.8	3.7	1.0	3.5	4.9	5.9	4.4	4.7	4.2	6.5	4.1	6.8	6.7	0.3	5.3	3.6	7.7	5.5	2.6	18.4	20.4	37.1	29.3	19.9	29.9	42.9	28.0	39.1	32.2	24.6	36.5	10.4	19.2	31.9	23.8	62.6	9.7	49.9	48.9	14.8	26.8	33.7	12.4	20.8	18.6	40.8	20.2	31.3	15.9	47.5	26.4	5.9	24.1	3.0	11.5	8.8	15.7	14.4	18.1	29.6	28.9	16.7	16.3	18.3	19.6	17.7	11.1	141.0	307.1	21.0	23.5	29.4	15.3	59.0	22.1	17.0	1.3	19.3	17.6	19.6	20.6	15.6	38.7	13.4	27.6	34.0	19.3	18.8	17.0	20.9	50.1	24.1	15.8	18.7	28.3	13.1	12.9	14.7	6.7	12.7	36.2	15.5	18.6	56.5	42.8	13.3	54.4
SCAF1	"FLJ00034, SR-A1"	ENSG00000126461	"SR-related CTD associated factor 1"	Q9H7N4	19	49642209-49658642	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046828, HPA054593"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA046828: AB_10961907, HPA054593: AB_2682536"	"unprognostic (1.16e-1)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.78e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.18e-2)"	25.4	22.6	24.5	19.0	22.8	17.4	23.7	11.2	31.1	27.2	0.0	30.3	19.3	32.2	6.9	28.1	26.5	18.0	28.3	29.5	13.6	21.1	26.2	21.5	20.4	31.1	21.7	28.9	22.2	17.8	29.4	16.0	22.7	26.7	8.7	11.2	23.2	11.3	47.3	28.3	22.3	15.1	10.7	23.5	23.0	28.2	22.5	17.3	24.7	16.9	13.9	28.7	24.9	21.3	84.1	143.1	38.7	64.0	18.0	17.1	47.2	61.9	20.0	28.4	23.8	78.2	50.6	48.5	41.4	22.9	42.8	63.2	28.0	37.9	8.3	75.4	80.5	54.6	72.9	40.1	30.8	52.1	52.0	28.7	23.5	34.1	24.0	27.4	23.1	19.5	71.6	48.1	22.6	53.4	53.2	28.3	49.6	37.8	86.1	64.7	53.6	50.1	18.7	118.5	57.2	62.7	63.5	66.0	23.4	23.4	46.2	29.0	63.9	102.0	59.1	37.0	91.6	68.5	110.2	46.3	61.6	32.8	59.1	2.0	1.4	1.4	1.9	1.2	1.2	2.8	1.0	1.3	1.1	2.1	1.0	1.1	3.6	1.0	1.1	2.4	0.2	1.8	24.5	22.8	11.2	31.1	29.5	13.6	31.1	21.7	22.7	10.7	22.5	21.3	16.4	6.4	0.0	7.8	17.0	12.1	8.8	12.4	22.2	12.3	15.7	12.7	3.0	12.8	6.0	22.0	4.2	14.6	13.4	32.1	7.9	13.0	31.8	18.6	14.1	10.8	14.4	9.4	7.0	13.1	14.7	12.9	17.3	21.1	5.7	22.1	18.2	14.7	14.5	10.1	8.4	21.1	12.2	9.1	6.9	97.4	22.1	12.3	10.6	8.4	9.5	10.6	10.3	9.0	8.7	19.0	22.7	23.7	18.0	13.4	22.9	13.1	10.6	8.0	13.1	16.5	17.1	24.9	17.8	23.0	11.9	22.0	12.6	17.5	19.8	11.1
SCAPER	"Zfp291, ZNF291"	ENSG00000140386	"S-phase cyclin A associated protein in the ER"	Q9BY12	15	76347904-76905444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 55.4"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Oligodendrocytes: 251.5;Rod photoreceptor cells: 710.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046253, HPA048077"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	No			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA046253: AB_2679600, HPA048077: "	"unprognostic (3.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.69e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.89e-3)"	5.5	7.9	9.7	4.0	12.2	7.4	6.9	18.2	10.4	6.2	6.5	6.0	6.5	7.4	7.7	8.9	6.4	5.3	13.8	9.0	12.8	9.0	7.5	6.3	4.7	11.5	10.5	12.1	8.3	14.5	8.2	6.5	11.3	7.0	4.4	55.4	7.9	6.2	13.6	6.9	6.3	6.3	9.2	5.9	6.1	21.0	10.7	8.6	12.2	12.0	6.0	5.0	6.5	16.3	6.3	5.8	7.8	4.5	3.9	7.0	6.5	8.3	5.9	3.8	5.4	6.1	5.0	6.3	7.2	2.8	10.0	6.7	18.5	3.5	5.7	14.7	9.1	3.3	6.8	3.0	4.9	9.0	7.6	5.9	6.0	4.5	7.3	8.2	5.2	12.6	4.8	17.5	6.6	2.6	8.8	2.7	2.3	5.5	3.3	7.9	12.4	2.2	3.5	6.3	18.4	8.9	11.2	3.9	9.0	9.4	5.8	7.3	6.3	8.7	8.1	4.1	7.4	10.5	23.7	8.9	5.1	11.1	5.9	40.8	6.3	17.4	11.4	3.5	13.1	16.3	11.5	10.3	3.6	17.0	18.8	12.1	10.7	17.1	4.2	9.3	9.7	4.2	9.7	12.2	18.2	10.4	9.0	12.8	11.5	10.5	11.3	9.2	10.7	16.3	28.5	99.3	61.5	190.7	33.2	20.6	28.9	10.6	18.8	91.5	13.9	15.5	191.3	12.8	27.4	12.9	252.3	33.8	26.6	17.1	1.9	14.6	59.1	10.6	13.8	23.5	16.2	1.7	151.5	6.0	11.8	22.1	17.3	18.4	22.1	41.9	21.8	9.3	14.3	77.4	201.8	9.0	6.1	13.6	11.3	24.9	20.5	14.4	10.6	135.9	12.8	51.3	34.0	203.1	251.5	6.5	11.4	19.2	28.6	15.9	72.6	7.8	12.3	710.6	19.7	39.1	23.5	143.9	68.9	15.1	18.8	52.0	30.5	26.7	13.4	19.7
SCARB2	"CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII"	ENSG00000138760	"Scavenger receptor class B member 2"	Q14108	4	76158737-76234536	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 12.5;classical monocyte: 14.1;intermediate monocyte: 26.0;myeloid DC: 8.2;non-classical monocyte: 24.9;plasmacytoid DC: 28.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 28.9;granulocytes: 12.5;monocytes: 26.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 499.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015415, HPA018014"	Supported		Approved	Cytosol		NA	NA		9200	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"CAB015415: AB_831511, HPA018014: AB_1852881"	"prognostic unfavorable (2.82e-5)"	"unprognostic (2.73e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.89e-2)"	60.6	24.0	33.5	27.7	63.5	7.3	56.7	58.9	38.9	60.8	18.9	61.6	39.2	44.1	58.4	33.9	45.4	60.0	61.6	29.6	48.6	46.8	89.9	77.1	20.2	62.2	49.6	58.9	58.9	63.6	11.1	80.2	62.5	72.3	64.0	53.2	80.5	55.4	89.8	26.0	49.1	57.8	60.1	47.0	60.7	19.4	50.7	21.3	65.9	81.3	20.6	65.3	25.1	92.9	39.8	38.4	48.9	97.1	499.7	242.0	35.8	131.5	250.2	114.0	178.2	72.5	112.3	0.0	85.1	262.3	109.6	28.3	28.3	78.9	96.0	138.8	30.1	3.2	32.9	25.3	129.9	19.0	12.1	186.9	72.3	117.3	54.5	268.9	200.6	10.0	15.6	188.6	159.2	58.2	1.6	4.0	9.7	120.3	23.6	23.3	82.7	42.0	64.4	43.6	101.3	110.2	104.7	61.3	115.5	49.3	34.6	17.1	131.3	125.9	48.5	104.7	47.5	167.6	98.8	0.2	158.1	22.2	170.9	12.5	14.1	3.1	2.8	26.0	2.6	3.8	1.9	1.5	8.2	3.0	2.6	4.3	1.9	1.1	24.9	28.9	3.0	6.1	33.5	63.5	58.9	38.9	29.6	48.6	62.2	49.6	62.5	60.1	50.7	92.9	89.0	176.3	52.4	47.3	20.1	24.0	90.5	64.8	34.1	109.6	69.7	36.4	53.0	87.2	52.1	99.3	60.5	35.3	43.6	109.0	7.9	119.9	7.1	50.3	74.0	69.9	102.4	28.6	57.4	72.9	47.5	108.3	40.8	88.8	3.8	84.8	79.6	108.7	143.4	60.6	55.4	77.1	44.7	165.7	27.5	5.6	45.4	76.2	67.6	38.4	43.5	87.2	6.2	106.1	201.1	78.0	68.3	66.5	82.2	133.5	103.2	27.6	54.4	81.7	92.1	91.0	68.1	18.2	16.5	34.8	33.8	59.4	16.3	56.5	55.3	93.4
SCARF2	"HUMZD58C02, SREC-II, SREC2"	ENSG00000244486	"Scavenger receptor class F member 2"	Q96GP6	22	20424584-20437826	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 44.8;Fibroblasts: 21.2;Leydig cells: 13.4;Peritubular cells: 17.7;Sertoli cells: 13.1;Smooth muscle cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 25.5;SH-SY5Y: 28.5;SK-MEL-30: 31.7;U-138 MG: 38.7;U-2 OS: 40.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035079	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		580000	"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035079: AB_10670287"	"unprognostic (2.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.38e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (4.28e-4)"	15.1	5.4	2.4	1.9	2.6	0.4	10.7	0.5	3.3	19.1	4.1	10.0	1.3	22.4	0.5	3.6	15.5	3.6	10.3	2.1	3.9	10.6	3.6	23.2	1.3	5.1	3.2	20.2	4.0	0.4	5.4	3.7	2.2	15.5	0.3	0.1	4.6	4.5	3.1	10.1	6.0	2.2	2.0	9.4	7.8	2.7	4.7	0.2	11.8	0.4	0.2	13.3	13.2	1.3	0.7	0.4	5.8	10.1	3.4	4.8	2.3	25.5	10.8	6.2	3.3	0.1	0.1	0.4	14.6	12.7	0.4	0.2	3.4	0.1	0.7	0.9	21.6	2.1	0.5	4.9	21.3	0.0	1.1	8.2	0.1	3.0	1.5	3.0	3.0	0.1	0.2	0.2	2.2	1.1	0.0	0.5	7.8	0.0	3.3	0.6	16.1	0.0	0.1	0.1	2.5	28.5	0.1	0.0	31.7	1.1	0.9	0.1	3.7	38.7	40.7	1.0	5.9	1.2	0.5	0.4	0.1	0.5	19.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	2.6	0.5	3.3	2.1	3.9	5.1	3.2	2.2	2.0	4.7	1.3	3.6	0.0	0.0	1.6	0.1	2.8	1.6	0.7	0.0	2.9	0.3	0.9	44.8	0.0	0.3	0.0	2.1	0.4	0.3	0.1	0.0	0.0	0.3	2.6	8.9	10.5	0.0	0.0	1.9	0.0	1.6	21.2	1.5	1.0	0.0	0.6	3.9	0.7	0.7	0.0	5.2	0.2	0.0	0.8	2.4	0.5	13.4	0.4	3.6	6.5	0.0	0.3	1.0	3.0	1.1	0.0	0.1	17.7	0.2	7.1	0.0	0.2	4.2	0.8	13.1	1.4	19.5	1.1	0.7	0.3	2.7	0.4	1.2	2.1	0.2	0.6
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660182	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.4;kidney: 47.1;placenta: 77.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 334.8;Distal enterocytes: 100.7;Early spermatids: 124.6;Hofbauer cells: 99.9;Paneth cells: 138.6;Proximal enterocytes: 318.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 94.3;SK-BR-3: 102.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020518, HPA024264"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		2300000	"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Cytosol	"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	2.9	1.0	3.6	1.3	4.5	1.3	0.9	4.6	5.3	1.3	2.9	18.3	26.7	1.3	0.5	17.9	4.1	2.8	0.3	3.8	4.8	47.1	0.3	4.1	0.6	9.4	6.8	0.7	0.9	1.1	2.6	77.6	9.7	3.2	16.0	2.4	10.7	1.1	0.5	3.6	46.4	1.1	7.1	0.5	19.6	7.1	5.7	0.6	1.1	1.7	4.3	3.5	1.3	12.3	0.2	0.2	0.2	0.8	0.0	0.0	0.3	0.3	0.1	0.1	0.5	0.1	0.5	0.3	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	10.4	0.1	1.3	0.2	0.1	0.4	0.3	0.2	1.4	0.4	0.0	0.2	0.1	0.2	0.4	20.8	0.5	0.5	0.2	1.4	0.2	5.7	3.2	0.3	0.5	0.1	94.3	3.6	4.1	0.2	1.0	102.8	0.1	0.7	10.8	0.6	0.1	0.3	0.8	2.0	0.2	3.4	0.2	0.2	0.1	0.4	0.1	1.2	0.2	0.2	0.3	0.2	0.3	1.1	0.3	0.3	0.2	0.5	0.3	0.3	0.6	0.4	0.3	0.3	0.2	0.1	3.6	4.5	4.6	5.3	3.8	4.8	9.4	6.8	9.7	7.1	5.7	12.3	3.5	0.0	23.6	0.0	0.7	2.8	1.5	1.6	0.6	3.2	3.3	1.7	1.2	4.3	8.5	334.8	0.0	23.8	0.2	100.7	82.2	0.6	124.6	25.5	1.0	6.7	9.1	0.0	0.1	0.2	4.7	2.7	55.5	11.3	39.9	0.0	0.4	0.1	99.9	0.0	0.2	62.9	46.8	3.0	0.5	87.8	0.3	2.8	10.6	15.0	1.7	0.4	0.0	0.0	0.3	8.6	138.6	1.2	1.4	4.7	318.4	3.2	17.2	3.0	0.0	0.9	1.0	3.8	5.5	26.6	6.5	65.8	2.2	0.1	21.4	23.1
SCMH1	Scml3	ENSG00000010803	"Scm polycomb group protein homolog 1"	Q96GD3	1	41027200-41242154	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 125.4;Excitatory neurons: 161.3;Inhibitory neurons: 213.0;Microglial cells: 102.1;Oligodendrocyte precursor cells: 154.3;Oligodendrocytes: 77.9;Spermatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048898, HPA053292"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA048898: , HPA053292: AB_2797246"	"unprognostic (6.02e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (5.80e-4)"	22.0	24.0	15.2	11.3	15.9	17.8	23.2	16.5	18.1	32.0	18.6	54.6	12.7	35.4	20.5	14.0	33.1	15.8	39.3	16.1	16.9	29.8	19.7	20.6	10.4	13.6	14.7	36.3	40.1	34.7	27.6	11.0	13.1	40.4	17.0	21.0	27.5	30.7	44.9	13.3	23.4	24.6	12.2	15.5	32.5	32.8	16.7	16.6	24.1	34.2	10.5	38.9	21.3	14.1	19.5	12.8	29.9	27.5	13.4	25.4	0.1	15.4	26.7	25.2	26.0	12.3	24.6	35.4	11.4	28.1	21.1	4.8	23.3	20.6	21.6	24.7	17.8	16.6	17.7	31.2	58.2	35.7	26.2	27.7	20.5	16.7	40.2	30.5	25.7	43.3	15.7	26.8	25.0	10.6	36.0	30.8	27.7	16.4	13.5	39.3	31.3	21.0	20.4	24.1	21.0	22.5	26.7	21.1	22.1	20.2	18.8	90.7	19.0	26.3	20.4	16.4	28.5	27.1	16.2	38.6	16.5	31.5	24.4	0.6	0.6	1.2	1.6	1.1	2.0	2.4	1.9	1.5	1.9	1.1	1.3	1.1	0.0	1.6	0.2	3.9	1.4	0.9	15.2	15.9	16.5	18.1	16.1	16.9	13.6	14.7	13.1	12.2	16.7	14.1	7.1	9.6	10.8	125.4	9.4	6.6	25.8	11.5	26.7	17.0	16.4	17.0	14.9	18.6	7.4	12.9	16.7	7.3	10.8	7.2	1.9	11.4	9.4	7.2	13.8	9.6	8.4	16.0	161.3	21.3	3.3	11.4	15.3	13.1	5.1	11.9	8.9	7.3	6.2	8.4	213.0	7.4	8.2	3.3	6.5	12.4	16.4	3.2	8.8	102.1	2.7	6.9	2.1	154.3	77.9	12.4	6.2	18.0	20.2	23.3	10.4	18.1	5.8	14.2	19.7	11.9	10.3	54.3	26.1	6.1	3.7	4.8	7.4	3.5	12.4	14.5
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239313-18354688	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.6"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 15.3;Oligodendrocyte precursor cells: 17.1;Spermatocytes: 26.3;Spermatogonia: 27.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 39.7;REH: 37.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: AB_2685333"	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	1.4	4.0	0.9	1.2	1.0	6.3	2.0	1.3	1.5	2.3	1.0	1.8	1.1	2.6	1.1	1.0	1.5	0.7	0.8	1.0	1.2	0.7	1.4	0.5	1.1	0.9	0.8	6.0	1.3	1.7	1.5	1.9	1.1	1.1	1.3	3.5	8.8	1.1	1.3	2.0	0.9	2.5	0.8	1.2	0.6	11.6	0.9	3.4	2.4	1.4	1.2	1.4	1.7	1.3	1.9	6.8	24.7	5.9	1.9	2.5	7.2	4.0	2.9	7.3	8.3	9.2	1.3	0.0	0.9	1.9	5.7	0.1	32.7	0.6	9.4	0.0	26.0	0.0	5.7	4.0	0.9	21.1	5.0	1.5	1.1	5.7	6.9	1.9	0.4	20.2	16.0	0.0	5.1	3.2	33.3	10.0	39.7	0.7	9.0	37.8	11.9	4.5	0.2	0.4	14.0	16.3	7.7	6.5	0.1	26.0	8.2	8.8	1.0	6.8	4.9	15.2	3.6	0.0	20.4	32.0	2.6	13.8	5.4	0.0	0.1	0.0	0.4	0.1	0.4	0.1	0.1	0.1	0.5	0.6	0.1	0.0	0.0	0.5	0.0	3.8	0.0	0.2	0.9	1.0	1.3	1.5	1.0	1.2	0.9	0.8	1.1	0.8	0.9	1.3	0.5	0.0	0.5	3.6	1.7	3.6	1.0	0.0	2.8	2.3	0.8	1.3	1.8	0.0	0.6	0.0	0.0	1.8	1.7	0.4	0.0	0.3	1.3	0.9	2.5	1.2	1.2	4.2	7.7	0.2	0.4	2.4	0.0	0.2	0.0	6.1	0.0	0.9	1.9	6.7	15.3	0.7	0.0	0.0	0.5	1.6	1.8	0.6	0.0	0.0	0.2	1.7	0.0	17.1	10.2	0.2	0.0	1.2	0.3	1.2	0.1	0.8	0.0	3.8	0.0	2.6	0.6	26.3	27.5	1.8	4.1	0.4	0.5	9.8	1.2	0.3
SCN3B	HSA243396	ENSG00000166257	"Sodium voltage-gated channel beta subunit 3"	Q9NY72	11	123629187-123655244	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.2;pituitary gland: 28.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 31.6;Excitatory neurons: 58.8;Horizontal cells: 20.2;Inhibitory neurons: 35.7;Late spermatids: 31.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Group enriched"	"Detected in many"	8	"amygdala: 34.3;basal ganglia: 40.6;cerebral cortex: 49.7;hippocampal formation: 54.2;white matter: 15.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;GAMG: 1.8;hTCEpi: 5.8;RH-30: 2.0;SCLC-21H: 5.5;SH-SY5Y: 4.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"hippocampal formation: 166.1"	HPA041707			Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Intermediate filaments"	Cytosol	"HPA041707: AB_2732493"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.13e-4)"	"unprognostic (3.93e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.29e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.34e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.16e-4)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.43e-2)"	1.9	8.4	34.3	0.6	40.6	0.4	1.8	0.0	49.7	1.0	0.0	1.4	0.8	1.5	0.7	0.7	1.2	0.5	1.4	54.2	2.4	1.4	0.1	1.0	0.3	0.0	4.7	1.0	1.1	4.4	28.0	0.1	0.5	0.8	0.8	10.0	0.7	0.5	14.1	1.5	1.3	1.4	0.9	0.5	0.7	2.2	0.9	0.2	4.1	3.3	0.2	0.8	1.0	15.3	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.1	1.8	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	5.8	0.1	0.1	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.0	0.0	0.0	0.1	5.5	4.5	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	34.3	40.6	0.0	49.7	54.2	2.4	0.0	4.7	0.5	0.9	0.9	15.3	7.7	0.0	0.5	3.9	0.0	5.7	1.1	0.0	1.2	31.6	1.3	1.0	2.1	0.0	0.0	1.8	6.2	0.1	0.0	0.3	0.0	0.3	13.9	0.2	0.3	13.0	4.2	0.0	58.8	1.0	0.1	1.5	0.0	0.2	0.0	1.4	5.3	0.0	0.2	20.2	35.7	0.0	0.0	0.0	2.3	31.3	0.0	0.4	0.0	5.6	0.0	6.3	1.0	4.5	2.5	0.3	0.0	0.4	0.0	1.0	0.1	0.5	0.0	6.0	6.6	5.7	0.8	1.0	2.0	0.4	5.5	0.0	0.1	1.4	0.1	0.5
SCRN1	KIAA0193	ENSG00000136193	"Secernin 1"	Q12765	7	29920104-29990289	"Enzymes, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 159.0"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 326.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024517	Enhanced		Approved	Cytosol		No	No		160000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA024517: AB_2184811"	"prognostic unfavorable (8.32e-4)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (2.60e-4)"	13.9	27.9	112.4	13.1	118.9	8.1	14.3	128.2	117.9	22.2	52.2	27.5	6.5	27.4	16.2	19.0	26.0	16.5	19.8	112.5	129.0	23.7	2.6	16.4	14.3	112.5	159.0	32.4	36.7	54.5	34.0	15.8	115.5	27.9	10.4	102.5	18.0	37.2	2.4	11.1	15.8	34.3	116.1	10.8	19.3	23.0	122.5	28.9	13.5	11.0	21.6	22.0	17.8	127.1	106.3	75.0	119.9	48.6	83.1	126.9	0.5	97.0	128.8	102.5	110.0	87.1	81.8	13.0	83.7	124.7	227.3	46.7	137.7	41.2	148.9	0.6	29.0	43.8	49.7	56.6	105.9	0.3	0.5	106.5	58.1	93.5	49.6	139.4	95.9	28.0	0.5	33.3	146.6	59.5	15.5	0.1	109.4	0.2	79.6	0.3	127.7	1.1	71.7	51.5	43.7	103.1	99.9	64.1	112.5	149.7	86.3	6.9	106.7	132.2	113.3	1.7	123.7	10.8	177.0	1.1	62.4	0.5	326.5	3.7	3.4	10.3	0.9	14.1	10.7	14.0	0.2	1.0	10.9	7.6	0.7	1.4	0.5	7.1	25.4	10.8	0.0	3.5	112.4	118.9	128.2	117.9	112.5	129.0	112.5	159.0	115.5	116.1	122.5	127.1	5.9	28.9	14.1	42.7	15.4	3.1	12.6	14.0	14.2	66.9	7.6	5.2	15.8	20.0	22.3	33.1	45.9	0.4	16.2	1.1	15.6	24.1	61.1	7.3	11.9	10.9	12.1	2.5	52.0	25.1	1.9	17.2	5.6	6.7	8.2	22.9	1.8	0.3	5.4	69.0	51.4	0.7	14.2	8.8	13.9	68.1	13.7	11.1	7.2	16.9	11.5	80.8	12.3	31.2	35.6	21.2	17.3	21.1	12.5	17.4	0.1	2.8	29.2	41.1	6.6	9.6	11.9	3.1	11.0	5.1	1.7	1.0	2.8	8.5	1.2	22.3
SCRN3	FLJ23142	ENSG00000144306	"Secernin 3"	Q0VDG4	2	174395730-174429575	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034689, HPA034690"	Approved		Approved	Vesicles,Cytosol		NA	NA		27000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Cytosol"		"HPA034689: AB_2674282, HPA034690: AB_10670574"	"unprognostic (5.39e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.57e-1)"	16.4	16.4	11.8	9.9	14.4	5.2	13.5	14.7	16.0	9.5	7.0	12.9	18.5	11.9	11.4	16.2	10.4	11.2	26.0	10.8	13.6	20.2	22.0	12.2	11.4	14.6	13.4	13.2	14.7	27.7	14.0	13.1	13.6	15.2	13.2	22.8	11.0	12.5	40.5	13.8	14.3	14.0	12.9	11.8	12.4	10.6	14.1	12.4	20.3	35.8	12.1	10.4	8.3	18.5	15.9	9.7	25.8	22.8	18.8	21.1	13.7	24.1	19.0	18.2	22.0	9.6	11.4	3.0	15.6	24.2	14.0	15.5	19.3	21.1	23.9	34.8	17.8	29.7	21.1	7.5	27.8	22.8	15.0	23.5	25.4	34.4	24.5	20.4	21.8	16.7	20.2	11.1	25.0	18.0	18.9	22.2	12.0	35.4	41.0	9.3	25.7	17.5	21.2	16.5	16.0	44.5	16.6	16.2	30.7	26.4	21.8	21.7	15.7	20.9	10.9	25.6	21.0	29.4	32.8	0.5	22.9	11.2	21.8	7.2	5.2	2.2	4.8	3.3	3.4	8.6	5.1	4.6	5.1	11.0	7.8	6.3	20.0	6.9	4.3	8.0	5.6	2.6	11.8	14.4	14.7	16.0	10.8	13.6	14.6	13.4	13.6	12.9	14.1	18.5	7.8	9.6	15.6	18.6	7.0	3.6	12.1	23.7	12.5	12.8	7.9	6.3	22.8	4.3	12.5	9.2	10.4	10.7	3.8	8.4	13.7	9.1	5.1	9.4	8.3	6.0	6.0	11.6	21.0	9.8	6.3	6.9	11.2	5.4	8.8	9.5	8.6	8.7	9.3	18.5	26.3	7.3	20.3	5.8	2.2	4.0	4.7	6.2	3.6	6.5	6.1	22.6	7.2	27.6	25.7	12.2	4.0	6.8	10.3	5.4	9.9	12.5	13.6	15.0	0.0	8.2	7.1	18.9	7.1	20.4	4.8	6.8	5.8	13.0	6.4	9.7
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493813-96611790	"CD markers, Predicted membrane proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 460.8;thyroid gland: 424.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 229.7;Hepatocytes: 235.5;Smooth muscle cells: 183.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in many"		"AF22: 643.1;EFO-21: 297.8;fHDF/TERT166: 288.4;RPTEC TERT1: 341.3;U-138 MG: 305.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA044416"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB025123: , HPA044416: AB_2678934"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.23e-1)"	109.5	36.3	35.2	35.9	41.0	10.2	66.6	37.6	49.9	157.0	26.4	77.9	21.8	76.0	15.2	50.1	84.6	44.5	68.9	32.1	51.8	88.9	460.8	56.8	18.9	41.1	46.6	170.5	61.2	30.2	61.5	124.4	37.5	63.4	40.1	29.7	25.0	104.4	19.9	25.3	39.8	90.9	38.5	25.8	41.9	25.5	49.6	5.3	424.5	58.5	8.0	84.0	58.1	33.7	0.5	0.3	643.1	0.3	230.2	214.1	0.6	94.8	113.4	54.3	60.5	19.8	0.2	0.2	297.8	288.4	8.0	0.5	114.3	1.8	47.1	0.3	44.4	0.6	56.7	250.2	7.4	1.9	2.9	83.1	2.8	123.5	3.1	210.2	1.9	0.1	64.3	0.3	23.1	6.0	0.3	16.9	68.1	0.0	0.7	0.7	101.5	2.4	341.3	57.2	19.1	49.5	0.2	0.3	4.9	217.8	27.6	73.0	51.3	305.1	91.5	1.5	53.2	6.0	0.3	1.1	96.9	0.4	97.5	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	13.6	0.0	0.1	0.0	0.0	0.6	35.2	41.0	37.6	49.9	32.1	51.8	41.1	46.6	37.5	38.5	49.6	33.7	11.9	57.7	38.1	93.7	1.7	53.8	78.9	29.6	15.9	36.6	41.4	30.2	32.7	37.1	5.1	57.0	12.5	1.9	0.5	0.1	29.4	14.4	31.6	29.3	65.1	10.7	3.5	10.7	4.6	15.3	2.5	229.7	9.7	76.4	1.3	44.3	17.5	235.5	109.8	5.0	22.0	1.5	138.4	20.5	154.7	18.6	52.5	62.9	62.2	21.5	68.2	17.4	0.0	7.1	1.7	8.9	1.2	104.9	2.5	41.7	0.8	56.4	4.0	12.5	32.9	100.0	183.1	5.5	57.6	1.3	39.2	3.8	4.2	33.3	5.7	17.6
SDK1	FLJ31425	ENSG00000146555	"Sidekick cell adhesion molecule 1"	Q7Z5N4	7	3301252-4269000	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 12.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 96.1;Excitatory neurons: 222.4;Inhibitory neurons: 551.0;Late spermatids: 190.0;Microglial cells: 201.4;Oligodendrocyte precursor cells: 112.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 8.5;BEWO: 10.5;RPTEC TERT1: 8.7;RT4: 11.2;SuSa: 10.3;U-2 OS: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011392	Approved		Approved	Cytosol		NA	NA		9500000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 25: Pancreas - Digestion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA011392: AB_1856648"	"unprognostic (2.39e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.37e-1)"	3.6	0.4	0.4	4.0	1.0	0.8	2.1	0.0	1.6	9.4	4.8	4.0	1.0	3.2	2.6	1.6	2.6	1.4	1.1	3.4	1.0	1.7	0.1	4.0	1.5	1.6	2.1	2.2	12.6	0.8	2.2	1.7	2.5	1.6	1.3	1.5	0.8	4.1	0.9	1.4	2.4	2.7	0.8	5.3	2.0	3.5	1.6	2.5	0.5	1.6	1.9	5.2	2.2	0.5	2.2	1.8	8.5	0.0	0.0	0.0	10.5	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.4	0.0	3.4	0.2	0.9	0.0	0.2	0.0	5.0	0.0	0.4	0.3	4.1	0.0	0.0	1.7	0.0	0.4	0.5	0.0	0.7	0.1	0.0	0.0	4.2	2.2	0.0	0.0	2.9	0.1	0.0	6.3	5.9	0.0	8.7	11.2	5.3	7.7	0.0	0.0	0.0	10.3	0.0	2.8	0.2	0.0	13.2	0.0	3.8	0.0	0.0	0.0	0.0	1.8	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	1.6	3.4	1.0	1.6	2.1	2.5	0.8	1.6	0.5	1.2	0.0	3.0	31.3	0.1	1.3	0.5	2.3	0.6	22.3	0.6	1.8	20.2	1.5	5.5	5.5	0.0	3.6	1.3	0.0	0.0	1.5	96.1	16.9	57.1	1.9	4.9	0.0	222.4	5.4	0.7	11.6	0.5	9.9	0.0	23.4	1.1	0.0	0.5	1.7	551.0	0.5	0.0	0.3	2.1	190.0	1.8	0.7	5.4	201.4	0.0	0.2	0.0	112.1	14.3	2.2	0.0	5.7	0.0	0.7	0.0	1.5	6.7	1.2	6.6	1.7	7.8	9.8	5.5	0.3	0.4	1.9	0.7	1.4	0.1	0.4
SDR39U1	"C14orf124, HCDI"	ENSG00000100445	"Short chain dehydrogenase/reductase family 39U member 1"	Q9NRG7	14	24439766-24442905	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044294, HPA075356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA044294: AB_10961400, HPA075356: "	"unprognostic (2.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.87e-3)"	"prognostic favorable (2.34e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.32e-2)"	41.5	73.9	55.4	14.8	56.9	28.9	44.6	59.7	65.1	40.4	53.4	43.3	16.9	33.5	17.7	35.1	35.8	11.6	83.7	54.0	55.7	60.2	57.9	35.1	22.6	56.7	57.9	47.2	50.1	22.7	58.1	14.4	56.6	47.2	9.3	37.9	38.0	23.1	96.7	40.1	42.1	11.6	57.4	57.7	47.5	34.7	58.5	27.8	38.7	72.5	14.1	41.1	33.4	57.3	20.1	35.4	25.5	30.0	34.8	26.5	24.4	11.5	16.3	26.4	30.2	27.4	26.0	28.4	30.0	13.4	19.6	37.1	22.8	29.2	11.5	38.2	39.5	25.3	26.1	74.1	16.9	23.7	23.4	29.7	34.6	19.0	27.2	26.9	28.5	65.5	23.1	24.5	26.3	36.2	40.2	39.2	24.1	31.3	32.6	50.9	13.2	20.9	47.5	27.1	43.8	36.8	30.3	55.4	28.3	15.1	38.1	34.9	14.2	8.0	25.5	23.7	15.3	38.3	26.9	35.7	21.1	30.6	21.2	39.1	38.3	23.8	40.3	23.7	39.2	49.7	30.7	32.3	43.7	49.7	43.2	45.2	11.4	58.4	20.3	60.7	40.2	33.0	55.4	56.9	59.7	65.1	54.0	55.7	56.7	57.9	56.6	57.4	58.5	57.3	34.9	28.9	21.7	10.1	35.0	26.5	40.8	40.1	21.6	37.2	44.2	47.2	0.2	45.8	36.5	40.5	12.5	48.4	41.6	19.7	121.3	29.1	16.9	16.9	15.9	27.3	27.6	35.3	12.2	19.9	24.3	24.8	13.3	17.8	36.1	28.4	21.0	38.6	30.2	28.6	12.6	25.8	38.7	19.3	19.6	26.3	32.9	21.6	42.7	12.2	22.9	63.4	37.0	11.1	17.0	15.7	17.7	31.6	34.4	24.9	21.3	71.7	26.8	47.4	0.0	25.5	24.0	67.1	22.6	21.0	27.3	56.1	28.6	27.0	22.5	29.8
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"liver: 1024.6"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 364.6;Hofbauer cells: 199.4;Langerhans cells: 111.9;Macrophages: 93.7;monocytes: 97.6"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"myeloid DC: 11.6"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 11.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;SK-BR-3: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039230	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	3.2	10.0	13.5	4.3	18.8	1.5	1.9	13.2	13.0	1.1	8.7	3.3	1.9	0.9	0.3	0.3	0.6	4.1	1.2	13.4	15.2	0.5	1024.6	6.3	0.8	30.0	27.7	0.5	1.0	0.8	1.1	2.9	16.1	1.1	2.3	3.0	2.7	0.1	0.8	0.2	2.0	0.5	10.5	1.7	2.9	0.4	19.1	0.4	1.0	0.0	0.3	3.8	0.3	11.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.2	0.0	0.3	0.5	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.0	0.4	13.5	18.8	13.2	13.0	13.4	15.2	30.0	27.7	16.1	10.5	19.1	11.4	0.2	0.0	0.6	15.0	5.1	2.4	0.4	0.0	0.0	0.2	0.4	1.5	0.5	17.2	0.0	0.0	0.0	0.8	0.3	0.1	0.0	2.8	0.0	0.1	0.2	1.3	0.0	29.5	0.1	0.4	1.3	0.6	0.0	0.1	0.0	0.1	18.9	364.6	199.4	0.0	0.1	0.0	0.0	45.1	111.9	0.0	0.0	93.7	1.8	0.0	97.6	1.9	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.4	3.1	2.5	2.4	0.8	0.0	0.1
SDSL	"cSDH, SDS-RS1"	ENSG00000139410	"Serine dehydratase like"	Q96GA7	12	113422380-113438276	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 78.2;Hepatocytes: 116.7;Hofbauer cells: 95.7;monocytes: 103.1;Proximal tubular cells: 115.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 8.7;intermediate monocyte: 10.0;myeloid DC: 18.5;plasmacytoid DC: 17.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 18.5;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 51.4;MCF7: 90.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005740	Approved		Approved	Cytosol		NA	NA		48000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA005740: AB_10601486"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (8.58e-4)"	"unprognostic (2.93e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.33e-2)"	4.5	33.1	12.7	7.1	14.2	3.2	4.9	16.4	15.2	4.6	10.8	12.2	16.8	4.8	9.9	2.5	7.9	7.7	12.8	11.8	16.1	34.9	104.6	5.7	3.4	18.7	16.2	4.6	18.7	12.4	15.5	4.4	16.0	8.5	8.5	2.4	4.8	6.6	3.0	1.3	12.2	5.2	15.8	5.8	9.1	10.6	16.4	1.5	23.9	1.3	1.7	6.2	1.4	17.4	8.5	33.3	4.7	14.1	0.9	1.9	3.2	4.8	1.2	5.2	4.4	14.1	8.7	0.4	24.2	8.1	14.4	8.6	2.2	11.4	1.7	20.5	8.4	22.1	8.5	6.3	27.5	2.8	51.4	4.4	16.0	12.8	18.8	5.9	8.0	0.0	17.3	6.6	6.5	90.2	0.1	10.2	4.6	9.6	14.6	0.0	7.0	16.5	13.6	10.6	1.5	0.5	20.6	23.6	18.4	4.2	28.6	24.8	7.2	6.2	11.9	26.9	4.2	1.4	1.4	0.3	26.3	8.4	7.8	0.2	8.7	0.0	0.0	10.0	0.0	2.2	0.0	0.0	18.5	0.1	0.0	0.0	0.4	1.8	1.3	17.8	0.3	2.5	12.7	14.2	16.4	15.2	11.8	16.1	18.7	16.2	16.0	15.8	16.4	17.4	1.2	0.0	5.1	2.0	3.1	0.9	2.2	7.0	0.0	0.5	15.3	10.2	18.2	27.1	6.3	29.5	2.1	16.3	4.9	43.7	78.2	36.1	0.5	14.8	7.7	4.0	31.8	10.1	1.3	20.1	3.0	4.5	12.8	10.1	43.8	15.3	6.4	116.7	95.7	3.3	0.6	36.4	4.1	18.1	8.4	1.5	2.8	36.9	3.6	1.9	103.1	33.5	0.0	1.5	2.0	16.2	63.2	5.7	0.0	6.1	63.2	115.7	3.8	2.6	0.0	0.2	7.3	0.2	0.4	1.1	0.6	7.3	1.9	29.5	31.0	5.9
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818509-82901166	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	98.7	103.3	52.2	78.4	54.3	119.4	111.4	62.4	70.1	145.5	94.9	107.1	124.2	119.7	162.1	92.6	90.9	122.1	110.7	54.0	61.4	133.6	174.8	96.2	88.2	58.4	58.7	152.8	192.6	116.4	108.4	143.2	58.7	113.4	127.2	87.9	134.0	111.3	96.8	107.8	111.0	131.5	50.9	76.5	110.1	77.8	54.4	93.8	168.0	85.6	102.1	113.1	94.1	63.9	146.2	65.2	183.6	130.4	318.9	394.5	133.3	264.8	295.4	146.0	179.2	113.2	182.3	188.3	113.7	532.2	84.6	68.1	183.3	176.2	200.4	193.4	72.7	115.3	110.5	302.1	316.4	124.4	140.7	380.5	217.7	223.5	254.3	251.2	240.5	83.8	178.4	181.1	264.2	128.6	164.9	99.6	126.1	154.0	58.3	121.2	100.1	140.3	237.2	83.0	118.6	131.2	105.7	180.7	174.9	184.8	142.1	137.8	248.2	190.7	98.9	169.0	168.8	135.1	62.4	256.7	190.6	147.8	224.2	84.3	66.9	51.2	65.1	74.0	80.5	60.0	57.6	64.3	73.3	50.0	56.9	54.6	19.2	89.9	83.1	61.1	52.7	71.8	52.2	54.3	62.4	70.1	54.0	61.4	58.4	58.7	58.7	50.9	54.4	63.9	62.6	105.8	85.3	50.9	58.1	60.5	60.5	64.1	56.9	52.3	54.5	43.7	85.5	51.5	109.8	47.8	54.2	57.3	61.0	62.8	27.4	65.8	30.6	90.1	164.6	65.0	38.3	41.2	61.0	71.2	85.3	125.2	100.9	119.7	75.2	241.0	65.0	94.0	45.9	42.1	60.0	99.4	50.8	51.2	55.3	19.3	139.1	63.8	51.6	67.5	60.4	36.5	38.1	74.9	72.6	67.5	46.3	126.0	152.2	76.3	121.0	65.9	100.5	66.9	52.6	86.5	98.9	30.3	34.6	62.2	74.2	81.5	55.4	78.9	54.9	101.1
SELENOF	SEP15	ENSG00000183291	"Selenoprotein F"	O60613	1	86862445-86914424	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 248.6;Ductal cells: 235.9;Extravillous trophoblasts: 338.3;Hofbauer cells: 241.2;Syncytiotrophoblasts: 315.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054937			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No		420000	"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli	Cytosol	"HPA054937: AB_2682642"	"unprognostic (6.15e-2)"	"unprognostic (6.98e-3)"	"prognostic favorable (6.53e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.65e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.34e-2)"	118.1	137.9	77.6	118.8	80.0	107.9	147.4	80.9	106.1	156.6	97.9	127.8	113.5	117.4	211.4	83.6	130.1	123.3	84.6	75.2	84.3	160.3	173.9	114.9	140.6	82.6	79.8	124.6	93.4	115.7	88.4	155.8	84.0	121.1	134.2	90.7	104.1	116.4	45.6	66.3	111.3	107.1	86.4	107.2	116.8	66.7	79.0	135.5	234.0	64.7	126.9	146.6	72.6	92.5	203.1	133.3	118.0	129.1	383.0	396.4	178.3	249.1	317.3	251.4	254.8	176.8	261.8	245.2	309.7	248.9	195.7	131.8	135.2	150.7	296.0	222.1	180.2	252.4	108.5	178.2	245.2	336.8	166.1	272.3	233.0	152.8	253.0	180.2	220.2	207.8	241.4	262.3	253.3	90.2	254.4	227.3	170.7	211.2	197.9	207.7	205.1	251.9	355.5	198.5	149.5	122.6	241.6	235.6	349.2	104.7	104.0	298.5	205.3	180.0	122.9	347.6	277.0	155.1	158.7	251.9	107.7	268.4	216.7	170.9	111.3	113.4	89.7	115.9	116.1	161.4	98.7	97.2	107.1	194.2	98.8	102.3	109.3	82.3	132.4	166.3	115.2	171.3	77.6	80.0	80.9	106.1	75.2	84.3	82.6	79.8	84.0	86.4	79.0	92.5	131.6	118.6	155.2	0.0	52.4	0.0	0.0	0.0	0.0	0.0	142.1	107.7	0.0	0.0	74.9	108.5	0.0	248.6	89.3	0.0	74.3	235.9	0.0	102.2	119.1	73.2	0.0	0.0	0.0	193.5	338.3	85.2	0.0	98.1	64.3	68.8	0.0	0.0	241.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	64.1	0.0	0.0	0.0	0.0	197.8	0.0	0.0	19.1	0.0	0.0	151.5	70.0	0.0	0.0	0.0	61.5	0.0	0.0	0.0	0.0	315.2	53.9	122.2	0.0	0.0
SELENOK	SELK	ENSG00000113811	"Selenoprotein K"	Q9Y6D0	3	53884417-53891962	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 373.5;Proximal tubular cells: 415.0;Syncytiotrophoblasts: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 471.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 471.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA008196	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA008196: AB_1856665"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.85e-1)"	"prognostic favorable (7.18e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.56e-3)"	39.6	51.9	52.3	27.0	53.0	70.1	35.8	55.2	67.9	29.8	52.3	35.9	23.3	29.1	64.4	27.8	33.9	23.4	90.1	52.0	55.8	42.1	74.2	38.3	23.7	55.0	53.7	48.6	51.7	55.7	62.8	26.5	55.5	34.6	29.3	86.5	29.7	28.5	86.7	24.1	30.4	18.7	55.7	32.3	39.6	32.0	53.3	26.7	43.0	61.2	29.4	35.5	26.1	58.4	22.4	14.9	34.3	23.3	52.1	32.8	36.8	32.0	40.5	43.4	48.9	33.4	33.1	33.8	13.8	23.4	48.7	13.8	40.7	24.5	37.8	59.6	50.3	21.1	61.4	77.6	49.1	28.3	48.6	19.8	40.3	30.1	39.4	25.2	35.3	25.1	20.1	86.3	38.5	24.7	18.5	33.5	33.4	27.5	55.1	11.5	20.9	61.9	51.3	37.1	17.5	49.5	21.9	29.4	32.7	37.5	19.6	44.0	20.6	24.4	28.7	62.2	45.7	62.8	76.3	31.4	36.8	37.3	38.2	471.4	41.7	110.7	69.5	47.2	67.5	60.3	63.0	70.0	36.6	49.0	55.0	63.0	94.1	52.2	56.6	66.3	72.1	82.6	52.3	53.0	55.2	67.9	52.0	55.8	55.0	53.7	55.5	55.7	53.3	58.4	223.1	134.6	103.9	0.0	173.5	0.0	0.0	0.0	0.0	0.0	233.7	237.5	0.0	0.0	53.9	149.0	0.0	162.3	373.5	0.0	189.8	258.5	0.0	150.1	113.5	62.7	0.0	0.0	0.0	199.6	239.6	86.9	0.0	237.9	237.1	59.1	0.0	0.0	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.6	0.0	0.0	74.9	0.0	0.0	0.0	0.0	282.5	0.0	0.0	110.6	0.0	0.0	415.0	53.9	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.0	350.1	155.9	94.7	0.0	0.0
SELENOM	"SELM, SEPM"	ENSG00000198832	"Selenoprotein M"	Q8WWX9	22	31104772-31120069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 373.6;Breast myoepithelial cells: 436.2;Collecting duct cells: 309.0;Distal tubular cells: 309.1;Endometrial stromal cells: 349.5;Exocrine glandular cells: 586.6;Smooth muscle cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 154.8;T-cells: 233.0"	"Cell line enhanced"	"Detected in many"		"BJ: 152.2;BJ hTERT+: 143.8;HHSteC: 183.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008667, HPA019601"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		170000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB008667: AB_1622762, HPA019601: AB_1856666"	"unprognostic (5.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.51e-3)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.19e-2)"	241.8	95.4	126.7	55.7	126.7	2.9	239.8	127.3	170.7	458.8	189.9	575.4	37.2	600.2	14.8	86.1	437.8	28.6	227.2	130.0	149.3	162.5	36.7	157.5	25.9	137.1	138.6	262.4	154.3	94.7	241.1	32.2	131.0	339.6	16.4	8.1	198.8	140.1	109.9	114.8	193.9	85.3	139.6	97.6	285.6	42.1	142.1	10.2	225.8	18.6	15.3	462.3	290.7	132.3	12.8	25.7	7.4	42.7	68.8	80.5	82.2	152.2	143.8	69.2	50.0	0.8	2.0	1.6	30.9	89.9	31.2	1.2	6.9	9.2	4.7	7.0	25.6	2.7	7.8	13.3	183.7	0.0	13.1	78.5	27.1	33.1	12.6	33.1	9.0	2.2	2.4	14.7	17.9	6.6	0.5	1.4	9.6	11.8	27.3	0.1	0.1	18.1	11.1	0.1	16.2	35.7	47.3	41.6	0.7	2.5	57.5	0.9	30.9	20.8	59.0	77.8	0.1	13.2	6.5	1.0	83.1	0.2	13.8	18.3	10.5	5.1	105.3	19.9	137.9	154.8	174.5	127.0	6.4	129.5	233.0	137.8	8.2	39.1	40.1	2.5	179.0	102.6	126.7	126.7	127.3	170.7	130.0	149.3	137.1	138.6	131.0	139.6	142.1	132.3	168.6	54.5	126.5	0.0	38.8	0.0	0.0	0.0	0.0	0.0	373.6	436.2	0.0	0.0	32.2	309.0	0.0	11.7	23.2	0.0	309.1	101.2	0.0	22.8	349.5	61.8	0.0	0.0	0.0	586.6	149.5	161.3	0.0	18.1	30.3	30.8	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	42.9	0.0	0.0	0.0	0.0	166.2	0.0	0.0	22.3	0.0	0.0	152.5	20.4	0.0	0.0	0.0	225.6	0.0	0.0	0.0	0.0	23.4	24.8	30.5	0.0	0.0
SEM1	"C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1"	ENSG00000127922	"SEM1 26S proteasome complex subunit"	"P60896, Q6ZVN7"	7	96481626-96709891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 636.7;Endometrial ciliated cells: 571.3;Exocrine glandular cells: 537.4;Extravillous trophoblasts: 712.8;Pancreatic endocrine cells: 543.9;Proximal tubular cells: 533.4;Syncytiotrophoblasts: 872.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020429, HPA072648"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA020429: AB_1859527, HPA072648: AB_2686543"	"unprognostic (5.41e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.52e-4)"	"unprognostic (4.55e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (8.00e-5)"	137.1	178.9	100.5	118.2	101.2	77.8	124.2	101.7	161.4	135.9	100.3	146.0	121.8	132.5	118.5	193.9	114.9	34.8	193.2	98.4	108.9	130.0	262.8	102.7	87.9	102.6	107.5	167.3	103.7	105.5	122.2	106.7	103.0	118.2	77.8	85.0	131.4	69.0	360.5	144.8	116.1	64.2	98.6	96.9	126.7	183.7	101.2	136.8	106.6	150.2	84.7	113.4	144.8	104.0	570.7	327.0	448.1	468.1	187.4	162.3	241.7	453.4	220.0	186.9	232.5	298.3	459.4	373.6	1096.4	222.8	575.9	288.2	379.5	306.5	263.6	437.4	285.9	448.3	505.7	472.5	171.2	670.0	321.4	208.4	233.7	279.8	283.7	291.4	253.8	438.4	592.4	444.7	193.0	716.9	760.9	942.6	607.0	572.4	297.3	291.6	576.4	441.1	273.2	555.6	367.8	463.6	845.0	701.6	497.9	681.4	200.6	502.2	525.6	365.3	641.2	683.1	575.0	278.3	818.9	1080.9	399.4	574.3	515.8	292.6	385.3	109.0	279.9	443.1	268.4	336.4	363.1	332.7	570.6	312.5	282.4	284.0	27.0	300.4	392.8	622.8	546.6	375.7	100.5	101.2	101.7	161.4	98.4	108.9	102.6	107.5	103.0	98.6	101.2	104.0	288.2	173.1	224.5	0.0	47.2	0.0	0.0	0.0	0.0	0.0	212.6	325.2	0.0	0.0	103.4	244.6	0.0	636.7	93.1	0.0	412.8	382.5	0.0	571.3	314.1	127.6	0.0	0.0	0.0	537.4	712.8	129.5	0.0	450.0	102.2	258.9	0.0	0.0	393.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123.0	0.0	0.0	241.3	0.0	0.0	0.0	0.0	543.9	0.0	0.0	19.6	0.0	0.0	533.4	149.4	0.0	0.0	0.0	140.3	0.0	0.0	0.0	0.0	872.3	65.9	187.2	0.0	0.0
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 92.2;Breast myoepithelial cells: 93.5;Fibroblasts: 109.6;Ionocytes: 91.6;Oligodendrocytes: 223.7;Respiratory ciliated cells: 103.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 49.6"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 49.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 252.7;RT4: 238.3;T-47d: 267.0;U-2197: 349.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		13000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	53.8	9.5	4.9	12.7	8.1	0.8	57.3	9.1	5.5	53.0	2.6	38.4	10.6	42.7	23.1	20.5	15.4	30.0	22.1	11.0	12.7	10.0	1.3	18.4	1.0	15.0	8.0	48.5	2.6	0.8	3.7	6.0	17.5	66.6	31.3	1.0	27.3	42.3	19.3	17.9	14.1	44.4	10.0	22.2	20.6	12.9	8.4	1.4	1.8	34.3	1.1	69.8	14.4	12.8	6.6	77.0	156.4	0.6	35.2	82.5	0.3	51.8	59.7	25.9	32.5	12.4	144.7	0.0	2.1	17.7	252.7	31.2	0.7	47.0	42.4	0.1	15.8	9.9	63.6	0.7	41.3	0.7	0.2	36.1	32.3	63.6	62.0	220.2	0.5	0.0	0.5	0.1	46.4	113.7	0.2	0.3	1.4	22.2	12.2	0.1	75.5	1.2	142.9	238.3	0.8	82.4	145.7	38.9	9.5	66.3	267.0	0.2	125.2	140.1	64.2	349.2	93.9	1.2	0.0	0.1	52.8	0.0	142.3	49.6	5.7	0.9	0.0	2.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	2.6	0.0	1.9	3.3	0.0	1.7	4.9	8.1	9.1	5.5	11.0	12.7	15.0	8.0	17.5	10.0	8.4	12.8	7.4	9.6	8.9	3.3	0.3	26.4	41.8	92.2	10.8	0.3	15.8	93.5	38.2	1.5	39.8	7.3	6.2	0.5	1.7	56.1	1.9	3.8	0.5	20.3	11.9	7.7	6.0	4.6	41.7	6.6	1.3	109.6	17.9	34.4	5.1	13.2	1.1	0.0	8.8	0.0	16.7	15.7	91.6	3.1	14.9	2.3	7.8	9.0	55.2	20.6	8.3	1.5	1.0	3.0	223.7	68.2	12.4	52.3	0.0	53.7	12.5	0.4	103.0	0.6	0.0	38.8	17.3	0.7	2.7	3.0	18.9	0.3	1.5	9.9	30.4	70.0
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 322.9;tongue: 96.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.9;Cardiomyocytes: 19.1;Cone photoreceptor cells: 20.9;Inhibitory neurons: 13.7;Skeletal myocytes: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 14.1;HUVEC TERT2: 24.8;TIME: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1500000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	8.8	2.8	7.7	1.8	6.7	1.2	7.9	21.9	9.4	12.0	1.0	7.6	13.7	10.5	1.4	5.5	10.7	3.7	38.8	7.9	5.4	12.1	12.4	5.1	1.7	5.0	5.0	14.8	3.6	2.1	13.4	1.9	4.9	8.3	1.8	5.2	8.5	2.3	322.9	8.9	10.8	6.2	2.2	3.0	5.4	32.2	7.3	2.2	4.7	96.9	0.9	8.4	8.8	5.3	0.9	1.0	14.1	5.4	5.8	1.9	1.3	1.0	0.5	0.9	1.3	0.3	0.6	0.7	4.0	3.3	2.0	1.4	1.3	0.5	0.8	1.3	4.2	7.7	0.7	1.2	0.8	0.1	2.7	3.3	1.7	1.2	0.6	2.8	24.8	4.1	0.7	0.7	2.3	0.5	1.3	1.0	6.3	0.2	1.7	9.0	3.1	0.3	0.5	0.4	7.1	9.3	1.3	0.6	1.2	3.5	1.6	1.3	11.8	2.3	3.3	3.5	0.6	5.9	1.2	6.1	0.6	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	6.7	21.9	9.4	7.9	5.4	5.0	5.0	4.9	2.2	7.3	5.3	12.9	0.0	2.8	3.9	1.0	1.7	0.8	0.3	0.6	5.7	1.9	3.0	19.1	1.5	0.8	0.0	20.9	0.2	0.6	0.1	0.0	0.3	0.6	0.4	2.8	10.2	0.0	0.8	6.7	0.4	0.6	4.4	0.5	0.4	0.0	9.9	6.8	5.3	0.4	6.7	13.7	0.3	0.0	2.5	0.7	3.1	5.6	0.5	1.8	4.7	0.4	1.9	1.0	5.5	1.5	0.4	0.0	2.6	1.9	0.5	3.3	2.9	0.3	7.5	0.0	12.0	2.9	3.3	1.2	0.5	1.0	0.1	0.8	0.5	0.8	0.5
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO specific peptidase 6"	Q9GZR1	6	75601509-75718281	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.1	22.6	12.8	24.6	16.8	37.9	31.4	47.6	15.5	28.6	7.5	26.6	20.9	33.0	22.1	25.3	26.8	26.0	22.6	9.6	14.3	28.5	28.0	26.4	28.5	11.9	11.9	40.5	27.0	39.4	22.3	33.4	12.8	29.3	26.0	31.4	21.8	28.9	25.5	25.2	20.5	31.9	12.3	28.9	24.9	33.8	12.0	32.4	41.9	30.1	30.4	29.7	21.2	22.3	23.8	24.5	54.3	39.1	41.3	54.6	40.3	41.9	46.5	34.6	43.1	33.9	22.4	40.1	38.6	48.7	40.9	29.8	51.6	28.0	53.1	59.2	44.2	60.8	28.9	31.7	57.3	53.5	42.8	42.6	45.6	32.6	71.8	41.9	58.2	32.8	74.9	43.2	43.0	29.0	21.4	28.6	33.1	31.9	20.4	39.7	28.7	59.0	36.7	35.0	47.2	48.7	35.8	31.3	36.4	43.5	28.2	50.1	49.0	30.8	33.4	15.9	43.8	48.9	52.4	31.4	15.4	49.8	33.1	7.5	8.0	20.8	7.3	8.4	10.5	9.1	7.4	9.9	8.9	10.5	10.5	9.6	14.9	10.1	14.7	11.0	6.9	6.3	12.8	16.8	47.6	15.5	9.6	14.3	11.9	11.9	12.8	12.3	12.0	22.3	76.7	67.3	128.3	158.0	74.0	46.5	65.0	27.6	78.6	58.8	53.0	59.6	76.7	31.5	70.9	29.5	91.8	33.0	73.8	43.2	17.6	33.7	40.4	62.9	78.1	57.9	27.6	50.5	152.6	33.7	29.4	69.3	51.0	62.9	65.1	74.2	42.1	32.0	29.5	60.6	177.3	35.6	24.4	43.2	41.5	35.6	70.8	57.7	35.6	149.9	68.4	56.6	50.4	218.1	228.9	32.1	29.9	63.2	62.8	63.4	32.6	26.8	47.2	65.7	26.3	98.9	73.7	107.7	61.7	61.4	48.4	41.2	67.2	66.0	46.3	66.8
SENP7		ENSG00000138468	"SUMO specific peptidase 7"	Q9BQF6	3	101324205-101513241	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 109.6;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 44.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 44.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027259, HPA071998"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Centrosome,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Nuclear bodies, Centrosome, Cytosol"	"HPA027259: AB_1856679, HPA071998: "	"unprognostic (1.50e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.38e-3)"	"unprognostic (9.25e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.08e-3)"	"unprognostic (3.27e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.23e-2)"	15.1	9.7	9.7	13.7	12.7	24.7	16.9	21.8	11.8	15.8	9.7	12.5	7.3	26.8	14.7	7.8	16.1	14.2	9.5	9.3	12.3	11.4	8.7	12.8	23.1	13.9	11.7	26.3	12.8	16.9	10.2	19.4	14.0	12.7	10.8	26.0	8.9	11.5	11.2	20.8	12.4	14.7	10.1	16.9	14.1	9.1	11.5	20.5	17.5	11.2	17.7	11.8	11.4	20.3	9.2	6.1	29.4	16.4	5.6	8.2	5.3	5.2	3.8	8.5	10.4	4.0	8.3	7.0	7.9	5.1	7.8	9.1	9.4	4.8	17.0	13.0	2.7	12.7	5.1	5.5	4.5	7.4	12.2	6.4	8.5	4.3	9.6	7.6	12.2	13.4	10.5	17.6	8.1	6.1	13.7	8.6	6.0	4.8	6.3	15.2	8.0	6.4	10.1	5.2	11.3	8.8	4.8	4.8	6.5	15.0	8.0	9.8	10.2	11.8	7.1	3.9	5.2	12.2	7.8	16.4	4.1	9.7	9.8	44.1	5.9	5.9	5.8	5.4	7.3	6.4	7.8	5.8	4.8	9.0	10.3	7.1	17.3	9.3	6.3	4.1	6.9	6.1	9.7	12.7	21.8	11.8	9.3	12.3	13.9	11.7	14.0	10.1	11.5	20.3	44.5	16.0	24.9	78.4	33.0	9.1	8.4	7.4	21.1	48.3	14.4	12.2	21.6	2.8	18.4	16.5	20.9	5.8	30.8	5.4	5.9	8.1	4.1	33.1	48.5	28.4	13.1	18.7	62.4	5.2	2.7	23.4	21.4	34.1	37.2	28.6	32.9	10.3	8.2	52.2	109.6	6.5	12.2	20.5	9.5	4.0	18.3	19.1	10.6	80.6	13.6	16.7	35.0	157.3	134.4	6.9	4.1	19.5	23.5	4.8	7.0	8.5	27.5	33.8	46.0	29.7	23.3	22.8	19.9	13.4	9.9	2.5	41.0	21.1	5.9	6.1
SEPTIN11	"FLJ10849, SEPT11"	ENSG00000138758	"Septin 11"	Q9NVA2	4	76949751-77040384	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 90.1;Extravillous trophoblasts: 266.8;Fibroblasts: 40.1;Hofbauer cells: 52.0;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 495.8;fHDF/TERT166: 604.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Approved		Approved	Cytosol		NA	NA		2800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (1.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (5.70e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	84.8	13.0	34.6	27.5	46.5	7.9	39.3	24.3	51.4	40.4	0.0	50.1	21.8	33.8	18.0	22.5	17.4	45.4	30.8	40.5	13.7	52.4	33.9	40.5	24.1	5.2	8.5	20.0	22.3	17.3	11.3	84.1	4.5	21.0	40.4	22.3	11.6	26.1	26.0	13.3	35.3	40.6	0.0	25.6	25.2	7.8	16.6	12.7	21.1	18.3	22.8	39.3	21.5	50.6	87.6	34.9	328.1	293.8	192.8	152.9	94.6	495.8	382.7	110.6	154.5	64.3	62.9	2.0	100.9	604.4	51.9	36.6	109.8	73.8	171.2	114.0	36.7	171.2	44.6	47.1	168.0	93.0	69.7	195.5	34.4	160.2	59.8	87.7	169.0	34.3	72.0	46.6	331.2	50.4	122.8	3.3	111.1	71.4	18.1	142.6	372.8	10.1	62.6	94.0	112.1	83.6	96.2	54.4	77.9	209.9	49.5	37.3	184.4	368.7	109.4	182.8	93.1	28.5	24.3	1.1	140.5	10.0	76.4	12.2	2.4	32.5	8.1	2.2	5.0	3.6	9.2	11.2	7.8	6.7	3.5	9.4	0.6	38.4	7.4	20.8	5.8	6.6	34.6	46.5	24.3	51.4	40.5	13.7	5.2	8.5	4.5	0.0	16.6	50.6	33.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	90.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	266.8	40.1	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	60.5	5.6	0.0	0.0	0.0
SEPTIN5	"H5, HCDCREL-1, PNUTL1, SEPT5"	ENSG00000184702	"Septin 5"	Q99719	22	19714503-19724224	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 321.9"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 3.4;Smooth muscle cells: 2.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	32	"eosinophil: 15.4;neutrophil: 5.8"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"K-562: 281.6;THP-1: 75.9"									"CAB016120, HPA029095, HPA063885"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		860000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Actin filaments, Cytosol"		"CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.87e-6)"	"unprognostic (3.39e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.30e-2)"	17.7	17.7	152.8	5.7	215.6	41.0	16.4	49.2	321.9	54.1	61.9	19.8	5.2	28.1	46.2	62.1	38.8	14.7	165.4	233.6	49.3	12.7	5.2	17.4	8.4	40.9	45.2	29.3	17.0	127.3	82.7	12.0	39.4	20.1	6.3	30.3	15.9	9.9	10.8	126.5	8.8	17.3	24.7	14.3	16.3	29.1	73.1	15.9	33.4	16.2	8.1	13.5	42.8	168.6	0.4	10.6	42.0	64.0	3.9	13.1	0.3	15.8	20.1	17.9	10.5	0.7	5.6	1.5	6.1	35.8	26.0	6.0	30.2	6.0	8.8	9.6	3.4	0.7	2.4	0.2	16.2	0.8	47.2	17.4	7.4	6.0	2.5	5.1	7.5	23.1	281.6	0.6	28.2	4.2	4.6	31.2	5.4	1.0	10.4	41.4	1.3	7.2	1.3	1.4	62.3	49.2	2.4	3.5	2.8	10.2	17.3	75.9	3.0	46.4	55.6	2.0	3.2	4.5	0.0	0.4	5.8	2.2	15.2	0.0	0.1	15.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	5.8	0.0	0.0	0.3	0.0	6.0	152.8	215.6	49.2	321.9	233.6	49.3	40.9	45.2	39.4	24.7	73.1	168.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SEPTIN6	"KIAA0128, MGC16619, MGC20339, SEP2, SEPT2, SEPT6"	ENSG00000125354	"Septin 6"	Q14141	X	119615724-119693370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 231.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 20.3;Cytotrophoblasts: 43.9;dendritic cells: 66.5;Extravillous trophoblasts: 50.1;Hofbauer cells: 54.8;Plasma cells: 28.4;Syncytiotrophoblasts: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 273.0;MOLT-4: 300.5;REH: 271.8;SH-SY5Y: 394.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Supported		Approved	Cytosol		NA	NA		2900000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (6.35e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.24e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.60e-2)"	13.1	73.4	14.5	66.7	12.8	61.1	12.7	16.9	16.9	11.5	7.8	47.4	14.3	11.2	16.9	17.9	18.1	17.5	16.1	12.4	20.8	18.1	21.3	16.5	119.7	18.3	18.0	11.4	4.6	9.9	9.8	14.7	22.1	13.4	18.5	38.9	18.2	40.5	4.6	7.1	35.3	24.4	13.5	61.9	20.0	40.3	20.5	231.3	7.6	5.9	103.9	18.6	9.7	12.0	6.5	10.1	37.9	68.5	3.5	7.7	53.9	18.9	41.7	31.4	53.8	3.4	14.4	130.7	14.6	23.9	32.6	3.7	60.2	12.1	21.7	80.6	13.9	58.1	20.3	23.5	9.1	66.3	29.4	14.0	2.6	24.8	0.6	13.1	46.4	273.0	43.6	68.0	18.7	4.8	300.5	38.6	40.2	1.9	31.0	271.8	31.3	106.7	33.5	6.8	16.8	394.7	49.1	17.9	20.6	40.7	24.3	33.8	29.0	8.5	17.2	27.5	4.7	33.8	14.5	170.7	0.8	69.0	6.3	34.2	17.2	39.9	58.6	26.1	61.4	65.0	75.3	68.6	34.0	64.0	79.3	69.4	11.8	81.3	38.8	63.7	112.4	53.9	14.5	12.8	16.9	16.9	12.4	20.8	18.3	18.0	22.1	13.5	20.5	12.0	13.8	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	43.9	66.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	50.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	43.0	15.5	0.0	0.0	0.0
SEPTIN8	"KIAA0202, SEP2, SEPT8"	ENSG00000164402	"Septin 8"	Q92599	5	132750819-132807241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 393.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Cardiomyocytes: 14.1;Cytotrophoblasts: 31.0;Extravillous trophoblasts: 12.1;Fibroblasts: 9.5;Hofbauer cells: 12.1;Smooth muscle cells: 8.8;Syncytiotrophoblasts: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005665, HPA036534"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Actin filaments"	"HPA005665: AB_1079910, HPA036534: AB_2797226"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.86e-2)"	"unprognostic (4.30e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.70e-1)"	26.9	19.5	192.8	18.0	273.3	8.3	22.2	279.1	238.2	28.2	111.6	26.3	26.2	18.8	18.5	34.0	21.4	25.2	33.0	188.3	218.5	34.8	13.0	26.2	14.9	319.9	262.0	25.2	23.3	23.9	22.3	44.3	304.7	20.5	26.9	74.6	33.4	20.6	10.9	49.7	25.8	21.3	238.1	14.8	26.8	6.9	250.4	18.0	32.3	12.4	18.6	36.1	31.1	393.6	55.8	26.4	37.3	76.7	50.8	49.5	122.0	58.9	56.2	54.7	66.5	46.6	39.2	0.3	51.1	57.3	32.4	42.3	70.5	96.4	59.9	71.3	50.8	54.4	35.5	40.5	37.2	19.4	76.0	35.9	30.6	25.3	35.8	53.5	77.4	47.7	84.6	10.6	29.7	53.0	63.3	18.2	19.8	33.7	17.0	57.4	43.5	4.7	32.0	141.1	50.0	31.0	50.0	11.5	32.9	107.4	100.6	25.4	80.9	60.6	39.2	15.1	42.5	14.3	14.3	2.0	38.7	28.6	46.5	0.5	1.0	0.0	2.0	0.6	2.0	0.4	1.6	2.5	1.2	0.1	0.4	1.0	0.0	0.2	0.3	0.0	1.9	1.0	192.8	273.3	279.1	238.2	188.3	218.5	319.9	262.0	304.7	238.1	250.4	393.6	7.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	31.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	12.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	10.1	0.6	0.0	0.0	0.0
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443351-122471807	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	213.6	242.8	220.4	93.2	248.8	148.2	157.8	237.5	334.0	151.4	178.5	104.6	99.4	146.6	108.1	94.9	104.4	128.0	163.7	248.3	257.3	194.1	241.3	160.5	96.8	258.9	243.3	164.4	100.4	243.3	71.7	195.1	282.9	139.6	100.1	225.5	97.1	143.3	152.6	79.0	114.3	141.7	268.4	123.6	96.5	65.6	241.3	89.7	203.1	194.8	79.5	121.7	84.8	306.8	40.5	49.1	121.7	111.8	450.2	245.1	64.5	208.4	259.8	111.6	171.6	57.8	106.9	27.1	159.7	236.5	127.9	78.7	72.6	90.2	166.1	87.1	86.0	76.9	79.0	105.9	201.3	77.5	146.3	256.7	173.0	139.0	190.8	256.4	98.1	69.9	77.4	149.3	233.8	46.8	35.1	51.4	39.7	63.5	61.9	42.5	60.0	66.5	240.3	70.1	63.6	114.5	92.3	101.2	146.8	107.4	70.0	107.1	201.3	133.7	57.9	110.8	109.9	112.4	134.4	35.9	176.8	62.1	159.5	158.3	43.0	92.6	44.7	53.2	48.1	27.7	45.9	43.3	35.9	23.7	53.2	46.9	108.7	51.7	62.0	28.0	54.2	56.0	220.4	248.8	237.5	334.0	248.3	257.3	258.9	243.3	282.9	268.4	241.3	306.8	167.8	150.6	99.2	44.4	73.9	66.2	81.1	55.7	61.5	114.4	71.7	57.1	156.2	87.2	58.9	77.3	70.9	53.8	80.9	88.8	9.8	63.0	3.2	54.9	103.3	130.0	84.5	81.5	92.5	48.7	57.7	131.4	39.8	106.8	124.0	58.1	127.8	132.1	73.1	138.0	145.7	41.8	36.7	158.2	86.4	10.0	126.8	107.4	94.3	65.6	58.1	97.2	58.7	48.2	134.0	78.4	43.6	131.3	80.0	86.1	80.1	44.0	56.1	70.6	59.2	105.1	110.6	25.7	17.0	39.0	74.9	119.7	100.7	99.8	32.7	97.1
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280460-94293268	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	104	"liver: 346.9"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 259.1"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	4700000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.4	0.4	0.4	0.6	0.7	3.3	0.6	3.2	1.4	0.6	0.4	0.7	0.7	0.7	0.5	0.4	0.3	0.5	0.6	0.4	0.4	0.5	346.9	0.4	0.8	1.5	0.5	0.9	0.5	0.2	0.2	0.5	0.8	0.4	0.7	3.1	0.4	0.4	0.5	1.7	0.7	0.6	0.4	0.7	0.7	0.6	0.7	1.3	0.7	0.4	0.4	0.2	0.1	2.5	0.6	0.2	1.8	0.7	0.7	0.6	0.4	0.5	0.5	0.9	0.8	2.7	0.6	2.1	0.3	0.4	0.2	0.4	2.2	0.5	1.3	0.8	1.4	2.0	0.8	21.2	0.4	1.6	1.1	0.6	0.5	0.3	0.7	1.1	1.0	1.1	0.5	1.3	1.0	0.3	1.4	0.8	0.8	0.2	0.6	0.9	1.2	0.9	0.5	0.7	0.9	0.8	0.4	0.4	0.2	1.0	0.9	0.9	0.6	0.7	0.4	0.7	0.6	1.1	0.5	0.9	0.9	1.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	3.2	1.4	0.4	0.4	1.5	0.5	0.8	0.4	0.7	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	2.8	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	6.6	8.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	3.3	259.1	0.0	0.0	0.0	0.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127104-101139247	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 418.0"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 165.1;Fibroblasts: 162.1;Pancreatic endocrine cells: 231.8;Smooth muscle cells: 239.3;Syncytiotrophoblasts: 651.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"BJ: 3483.8;HUVEC TERT2: 4014.7;LHCN-M2: 3874.5;TIME: 10032.6;U-138 MG: 4609.6;U-251 MG: 4256.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"	No	No	142000000	13000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"CAB068501: AB_1642775, HPA050039: AB_2680997"	"unprognostic (5.02e-2)"	"prognostic unfavorable (5.01e-4)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.88e-8)"	"prognostic unfavorable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.51e-4)"	215.5	75.3	3.1	91.6	3.4	1.7	56.2	5.2	12.8	62.1	5.0	31.7	7.4	31.1	1.0	16.4	41.3	360.3	136.0	3.9	6.6	166.2	345.8	260.2	21.3	6.4	3.7	105.6	135.1	11.8	12.3	418.0	4.5	37.8	5.4	4.9	10.6	8.0	17.8	21.2	13.1	74.3	4.8	13.8	30.3	5.5	12.7	6.7	59.5	4.3	3.5	359.9	19.2	6.0	77.3	64.4	1.2	5.1	766.6	1511.0	89.3	3483.8	654.6	1717.6	1487.4	9.4	5.5	2.7	812.6	1117.9	2367.3	18.1	0.4	269.4	1756.2	4.3	0.7	1.1	5.2	61.4	1532.6	0.2	3.8	596.1	106.9	2641.4	1374.8	928.5	4014.7	0.2	6.4	2.5	3874.5	0.4	0.6	2.2	18.2	1.3	41.7	0.6	6.1	4.8	5.1	30.3	1.0	0.8	286.3	77.2	8.3	410.9	3.3	9.9	10032.6	4609.6	204.0	1593.8	4256.0	0.6	2.9	4.2	1150.5	2.4	45.9	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	9.5	0.0	0.3	0.0	0.8	3.1	3.4	5.2	12.8	3.9	6.6	6.4	3.7	4.5	4.8	12.7	6.0	35.8	0.0	7.7	0.0	1.1	40.0	43.7	97.4	14.2	0.3	0.3	2.3	2.5	4.3	11.0	5.5	0.0	56.0	1.0	0.4	0.0	65.1	0.0	4.7	53.8	165.1	5.3	0.0	0.5	4.5	75.1	162.1	0.5	3.2	10.2	12.4	40.4	112.3	15.9	0.0	0.3	0.2	8.2	4.6	9.6	1.1	17.7	11.1	7.2	5.6	1.1	0.7	0.0	0.0	0.0	231.8	0.0	12.0	3.6	9.7	0.1	0.0	8.2	0.3	39.5	55.4	239.3	0.0	0.1	9.0	24.7	651.7	2.3	2.1	0.5	8.1
SESN2	"DKFZp761M0212, HI95, SES2, SEST2"	ENSG00000130766	"Sestrin 2"	P58004	1	28259518-28282491	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 46.5;SK-MEL-30: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018191	Uncertain		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA018191: AB_1856750"	"unprognostic (7.05e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (8.97e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-1)"	10.9	9.0	6.4	2.9	6.3	19.4	8.5	5.8	7.5	7.4	5.2	10.1	7.6	8.2	1.6	20.0	7.9	3.3	6.3	5.9	7.1	15.9	24.7	9.6	2.0	7.5	7.5	27.9	10.6	4.4	6.6	4.8	6.9	6.2	4.0	1.4	8.5	1.9	7.6	5.3	8.8	2.9	6.8	6.9	11.1	10.7	9.5	2.4	5.3	2.4	2.0	7.6	8.8	7.1	5.6	3.0	7.1	11.8	11.3	8.9	38.6	10.5	9.6	6.3	7.4	4.3	4.0	6.3	4.3	4.8	7.0	5.5	8.3	7.4	4.3	5.7	7.7	2.6	4.3	7.3	37.0	9.5	13.7	28.1	46.5	16.9	40.0	2.9	7.0	14.6	15.2	29.3	5.9	3.2	3.5	2.6	5.7	2.6	6.0	5.3	1.9	14.6	4.2	9.3	2.4	2.8	3.0	2.4	58.5	7.8	6.5	13.4	4.1	3.2	9.9	7.3	6.4	37.9	10.4	10.0	7.5	9.5	7.2	0.0	1.5	1.3	5.7	1.2	2.7	1.1	2.0	2.8	1.5	0.7	1.2	2.5	3.9	2.5	1.9	1.7	2.4	1.8	6.4	6.3	5.8	7.5	5.9	7.1	7.5	7.5	6.9	6.8	9.5	7.1	26.4	0.0	5.0	3.6	9.9	17.0	21.1	14.2	26.7	11.6	21.4	15.1	7.3	12.8	9.0	7.3	8.4	31.2	30.6	35.9	3.9	24.3	6.5	11.8	8.9	7.8	13.1	2.7	3.9	16.9	27.0	11.8	13.7	12.1	4.5	10.9	9.3	19.8	13.8	0.0	6.1	11.2	16.2	5.7	22.2	3.7	2.5	20.0	7.2	4.7	5.9	6.6	9.2	3.5	1.4	31.9	15.2	3.4	13.0	13.6	27.7	23.4	8.3	7.8	0.0	7.9	14.3	5.6	12.5	19.8	12.5	66.9	20.7	7.3	12.8	29.9
SESN3	"MGC29667, SEST3"	ENSG00000149212	"Sestrin 3"	P58005	11	95165513-95232541	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 680.7;Late spermatids: 529.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.7;ASC TERT1: 50.7;SuSa: 110.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037935			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA037935: AB_10670534"	"unprognostic (2.72e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.09e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.34e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.42e-2)"	9.6	17.5	42.3	14.3	56.4	17.9	14.7	24.3	37.8	11.8	26.0	5.7	6.5	11.4	14.1	8.9	8.4	12.4	5.4	32.6	30.7	10.5	7.5	9.1	24.4	21.4	40.6	21.9	3.1	25.8	11.2	7.1	22.5	10.2	6.5	23.4	9.9	5.5	5.3	10.7	12.5	9.2	28.8	17.3	4.9	57.7	54.6	21.8	21.7	13.1	24.2	11.2	8.8	26.6	0.0	1.0	28.2	0.1	46.7	50.7	0.1	0.2	0.0	0.0	0.1	1.2	0.9	7.7	3.4	0.1	1.3	5.7	17.3	12.5	0.0	6.4	9.0	3.9	15.4	1.2	0.9	3.4	0.7	28.1	21.4	0.1	6.3	8.7	1.1	4.5	0.4	1.4	2.3	0.2	2.5	9.0	11.5	0.2	1.2	5.7	1.7	0.6	6.2	19.1	3.6	7.9	0.3	0.2	1.6	110.9	0.0	11.0	0.3	3.2	7.1	0.6	1.1	0.3	0.0	1.0	1.4	4.0	6.9	0.5	0.3	0.2	0.2	0.7	0.3	1.8	0.8	0.5	0.3	1.1	1.6	0.6	0.3	0.3	1.5	0.4	1.7	0.3	42.3	56.4	24.3	37.8	32.6	30.7	21.4	40.6	22.5	28.8	54.6	26.6	13.4	25.6	7.9	152.8	97.6	23.1	26.2	38.3	76.2	48.2	16.1	25.5	7.6	2.8	15.6	35.0	22.9	0.7	7.1	6.9	1.9	6.0	680.7	7.7	45.4	36.4	7.3	73.4	130.8	2.3	0.6	36.5	10.7	14.5	7.0	28.0	35.3	6.4	23.4	0.0	95.1	11.4	8.2	54.8	58.8	529.5	40.7	36.7	32.0	97.4	82.0	98.9	10.3	48.2	37.2	2.2	7.3	87.3	11.9	13.6	27.7	22.5	4.5	14.8	6.6	31.5	28.9	45.4	11.1	38.2	12.5	1.6	41.3	76.4	14.8	14.9
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2, histone lysine methyltransferase"	Q9BYW2	3	47016429-47164113	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	9.9	6.5	8.2	10.7	10.5	23.8	10.3	24.1	8.3	12.6	10.8	9.7	9.1	13.3	6.1	9.8	11.0	8.5	7.2	6.2	6.7	10.8	10.0	9.4	13.5	8.3	8.5	15.3	13.3	16.2	2.2	11.4	8.4	10.2	11.0	10.6	9.6	9.7	11.1	9.0	10.3	11.9	8.1	11.4	10.7	13.1	7.9	19.2	15.5	14.5	13.3	9.8	4.0	12.8	21.1	13.2	25.4	14.5	15.3	18.9	11.3	17.9	17.0	20.8	19.9	15.4	13.8	43.5	11.6	25.5	20.0	12.4	29.5	17.6	27.6	27.5	12.2	47.3	24.8	12.4	11.7	34.1	26.5	15.2	17.3	20.7	24.6	15.3	20.1	22.8	29.9	16.6	17.8	9.5	26.7	8.5	20.6	9.4	15.4	17.5	25.6	23.2	12.4	26.6	10.9	17.6	29.5	11.8	12.0	17.2	12.9	27.5	26.7	24.6	18.1	21.5	29.9	22.0	25.4	43.7	14.2	19.6	14.6	1.3	1.2	2.9	2.0	1.1	1.1	2.2	1.2	1.6	1.4	2.5	1.7	1.6	3.3	3.6	1.1	1.5	0.6	0.6	8.2	10.5	24.1	8.3	6.2	6.7	8.3	8.5	8.4	8.1	7.9	12.8	50.5	48.1	58.8	115.9	58.3	33.3	22.6	15.6	54.1	40.5	31.0	29.1	67.2	27.1	53.2	11.0	41.7	20.3	58.2	32.6	11.7	20.9	26.1	62.8	63.0	41.2	22.1	38.9	131.4	22.4	12.7	39.2	56.6	66.2	58.8	68.9	23.6	29.8	16.8	26.9	129.4	28.2	14.2	28.8	26.5	35.1	30.4	42.7	17.8	148.9	37.9	22.7	43.3	113.1	143.2	23.7	22.3	33.1	54.0	31.2	24.6	11.5	49.7	39.9	13.1	56.1	42.6	71.0	29.3	60.2	35.7	18.5	65.3	57.1	29.5	34.7
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261962-41309473	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 299.3;choroid plexus: 509.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 710.9;Breast myoepithelial cells: 1158.6;Cardiomyocytes: 266.3;Leydig cells: 578.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 3203.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"	Yes	No		1300000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: AB_2685376"	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (3.12e-4)"	88.4	12.9	9.2	10.5	12.7	1.4	299.3	18.2	15.0	203.7	509.2	24.5	12.2	132.5	1.8	26.1	98.5	61.3	124.8	29.4	8.5	115.3	6.1	4.7	4.0	29.9	10.5	46.8	6.2	1.4	1.2	19.5	29.7	42.6	30.1	2.2	236.9	102.3	2.6	55.4	18.9	82.9	7.7	21.4	24.4	28.4	10.8	3.1	12.7	32.8	3.2	44.9	95.6	24.7	0.1	29.0	75.9	1.9	67.5	3.9	14.5	132.9	694.5	197.9	187.2	0.0	17.8	0.0	0.6	0.7	15.8	0.9	10.8	53.7	277.6	0.0	2.3	0.0	0.0	0.0	6.4	0.0	0.7	11.8	255.9	19.9	19.3	3203.5	6.2	0.2	0.0	0.0	3.7	0.0	0.0	0.2	205.8	0.1	0.3	0.0	15.7	0.0	422.6	0.0	4.1	18.5	5.5	0.0	41.5	264.7	0.1	2.1	1.9	0.1	19.6	0.2	18.3	0.0	0.0	0.0	0.2	0.0	279.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	12.7	18.2	15.0	29.4	8.5	29.9	10.5	29.7	7.7	10.8	24.7	8.4	0.0	0.0	2.0	1.2	11.2	134.0	1.4	147.4	1.8	710.9	1158.6	266.3	0.0	0.7	62.5	2.1	2.2	9.1	0.0	80.3	4.4	5.0	3.0	131.6	21.0	0.0	0.0	0.2	0.0	82.0	229.5	16.8	3.4	0.0	19.3	53.6	0.3	2.0	1.7	12.1	0.0	0.0	0.3	4.0	25.7	578.4	4.0	99.6	0.0	0.0	76.2	0.0	7.5	20.6	0.1	0.0	130.1	2.1	29.7	0.0	3.2	0.0	1.8	0.0	34.9	18.0	2.3	16.8	53.7	5.5	0.8	7.3	72.6	0.0	9.3
SFSWAP	"SFRS8, SWAP"	ENSG00000061936	"Splicing factor SWAP"	Q12872	12	131711081-131799738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039362, HPA040063"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039362: AB_10794089, HPA040063: AB_10795413"	"unprognostic (1.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (7.50e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	26.9	18.3	18.5	10.1	20.8	28.1	26.3	18.5	24.8	27.1	13.7	25.9	10.1	24.6	4.0	23.2	24.5	4.8	20.2	18.2	19.0	24.9	19.4	20.3	11.3	20.4	19.3	29.0	21.9	7.4	21.7	8.1	19.8	21.8	4.3	9.3	20.2	6.8	29.5	32.6	24.6	5.6	16.9	28.4	20.8	16.3	21.2	12.6	24.5	6.7	7.6	22.3	24.3	25.1	26.1	23.0	16.0	17.0	12.6	10.3	35.8	19.7	13.6	22.9	15.6	22.6	12.3	31.9	18.0	14.8	11.9	23.9	22.7	18.1	13.2	9.9	36.0	29.0	12.9	27.0	13.4	37.8	27.4	11.7	20.4	20.8	24.9	18.2	14.3	24.3	40.9	12.3	10.4	32.7	31.9	57.1	41.9	14.0	38.0	36.7	16.2	25.2	13.3	18.8	25.1	28.3	18.7	15.6	25.1	12.5	22.5	29.1	18.6	19.0	24.8	14.8	22.3	35.0	41.2	31.7	18.7	25.5	25.9	2.0	4.1	1.9	3.0	2.7	3.0	2.1	2.8	2.6	2.9	3.7	3.0	3.4	5.6	5.4	3.4	7.2	2.4	1.8	18.5	20.8	18.5	24.8	18.2	19.0	20.4	19.3	19.8	16.9	21.2	25.1	46.4	73.7	44.5	48.6	37.9	38.9	41.5	19.0	42.1	49.7	25.4	25.9	19.3	21.5	38.6	14.7	66.7	30.4	52.6	22.1	0.0	23.1	21.4	27.0	48.8	39.3	21.6	38.7	55.1	26.6	31.8	39.2	37.8	39.7	38.0	47.1	21.4	16.7	22.1	42.1	43.2	24.9	14.2	27.4	21.4	12.9	30.1	30.3	23.2	36.5	35.4	33.7	50.4	58.3	85.1	28.6	24.1	29.7	43.6	44.7	20.8	11.8	30.7	62.4	46.0	52.1	38.1	39.5	42.8	39.7	46.9	43.6	45.9	48.4	22.9	48.2
SFT2D1	"C6orf83, MGC19825, pRGR1"	ENSG00000198818	"SFT2 domain containing 1"	Q8WV19	6	166319728-166342576	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014677	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA014677: AB_2238986"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.47e-4)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (4.20e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.75e-2)"	40.8	43.9	55.0	35.6	61.7	35.8	45.9	62.3	76.2	35.4	54.0	52.1	39.2	26.5	68.2	36.6	33.8	34.4	30.5	54.5	59.0	51.0	24.5	37.0	50.9	64.0	59.0	31.9	51.1	36.1	17.3	48.9	65.3	47.5	50.1	12.9	70.7	28.0	22.2	24.7	39.0	24.8	62.9	41.9	50.7	26.9	57.2	41.7	46.3	27.5	47.9	40.4	29.4	72.4	47.1	39.9	41.9	86.3	76.1	65.9	56.4	70.7	69.6	56.8	85.5	80.2	103.3	43.9	55.7	68.8	90.2	59.7	62.5	67.0	88.3	58.8	88.4	53.0	35.4	133.4	65.9	134.9	106.5	61.1	78.9	65.5	58.3	81.8	31.3	73.1	96.1	46.8	90.3	68.5	42.1	241.5	40.2	154.5	36.2	28.6	45.0	105.4	141.6	46.1	8.0	34.3	45.6	87.8	73.0	48.1	46.4	252.3	28.6	33.4	60.4	87.4	79.7	40.7	32.3	50.6	70.4	84.8	85.5	141.1	90.7	126.3	62.1	98.6	38.7	88.1	47.3	52.3	103.4	72.5	50.3	51.7	166.0	58.9	107.3	204.9	79.4	92.7	55.0	61.7	62.3	76.2	54.5	59.0	64.0	59.0	65.3	62.9	57.2	72.4	45.6	41.7	66.5	25.1	103.4	86.5	127.8	262.4	59.2	10.0	136.0	103.6	25.0	51.5	143.9	108.5	0.0	153.0	154.2	109.3	90.1	154.5	70.3	52.0	49.9	55.8	28.8	63.3	15.6	126.8	259.4	81.5	61.2	73.9	149.0	31.3	65.3	30.6	211.6	15.2	13.6	162.5	168.9	178.5	178.4	25.2	85.1	143.5	99.6	21.5	198.3	31.7	111.2	16.6	71.5	155.4	146.5	47.4	108.5	239.2	115.5	140.4	96.0	9.1	85.5	69.5	64.0	159.0	93.4	72.9	102.9	131.2	74.9	63.2	131.4	194.0
SGCB	"A3b, LGMD2E, SGC"	ENSG00000163069	"Sarcoglycan beta"	Q16585	4	52020706-52038299	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 105.7"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 203.7"	"Cancer enhanced"	"Detected in all"		"glioma: 56.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 104.7"	"Low region specificity"	"Detected in all"							"HPA011422, HPA058656"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA011422: AB_1856795, HPA058656: AB_2683790"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.53e-6)"	"unprognostic (3.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (7.61e-4)"	32.7	21.6	27.1	9.5	30.3	0.5	14.7	28.0	32.2	23.4	21.4	32.9	13.1	28.1	11.1	21.9	20.5	19.5	57.2	25.3	27.7	35.0	10.8	15.2	6.1	29.7	28.4	20.1	6.5	47.0	13.9	24.2	30.3	25.0	16.2	16.6	13.5	27.2	105.7	7.2	14.9	37.3	29.0	11.1	14.0	16.0	28.3	5.6	9.2	81.3	4.5	20.4	15.7	33.4	11.4	13.7	27.8	10.6	104.7	78.5	10.1	62.8	79.9	34.5	36.2	3.7	14.9	3.0	11.8	82.9	53.5	5.5	20.9	23.1	36.7	18.8	7.8	0.2	11.8	6.8	42.8	6.8	3.6	86.8	15.9	29.9	17.3	89.8	46.1	10.7	0.1	0.1	74.5	4.4	15.1	0.1	10.0	4.6	20.4	0.0	14.8	0.2	29.2	3.8	16.2	28.4	39.9	1.9	14.1	31.0	5.2	4.1	47.0	50.8	17.0	24.1	56.6	14.9	20.4	5.5	37.5	2.4	59.7	0.3	1.0	0.0	2.1	0.5	2.1	2.6	2.5	2.3	0.5	2.3	1.7	2.2	0.5	0.3	0.4	1.0	4.2	1.0	27.1	30.3	28.0	32.2	25.3	27.7	29.7	28.4	30.3	29.0	28.3	33.4	38.9	32.1	13.1	15.3	6.6	13.4	25.8	70.2	9.6	22.0	8.6	19.7	88.8	25.8	19.6	12.9	6.2	5.7	2.8	15.6	1.9	28.7	61.1	32.6	48.1	27.2	16.3	0.0	17.3	51.8	49.8	64.6	12.8	29.7	2.5	16.7	36.0	15.7	2.8	28.6	21.2	4.2	8.2	2.1	8.7	203.7	38.8	2.7	26.6	24.4	1.9	23.6	1.0	38.7	38.1	53.8	6.0	91.4	4.6	11.7	32.6	64.6	20.4	16.5	46.0	102.8	59.8	12.2	17.4	8.0	10.5	6.3	7.3	14.2	15.1	13.5
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"	Q86VZ5	10	50305586-50625163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	15.8	19.3	19.8	10.7	27.4	24.0	14.5	21.5	20.3	16.9	33.9	10.1	13.5	11.9	19.9	15.3	16.6	15.4	13.2	17.2	23.0	20.2	27.9	21.9	14.9	29.5	24.1	18.6	13.3	52.9	6.4	24.6	28.5	19.5	11.7	20.2	18.0	16.8	9.9	25.3	16.0	15.8	23.6	11.7	14.3	11.3	23.4	12.0	24.7	10.5	14.5	20.9	13.1	41.3	30.2	14.0	4.0	9.0	14.2	18.6	18.8	19.6	19.7	13.5	12.6	11.7	30.3	22.1	11.3	25.9	12.2	18.7	9.5	20.6	14.0	19.4	10.2	32.7	17.9	9.0	16.5	7.5	7.6	12.1	23.6	18.0	21.7	8.7	19.3	7.9	62.6	32.2	14.6	12.7	3.3	4.2	9.2	13.7	13.7	5.5	18.4	8.8	19.7	31.2	6.2	4.9	14.4	14.2	7.5	11.3	21.4	2.7	27.1	14.6	17.8	14.1	14.6	11.0	9.5	6.3	18.2	12.0	12.1	3.4	9.3	28.4	4.6	4.9	10.3	7.0	6.2	6.8	5.2	6.5	8.2	5.4	16.7	10.1	4.0	3.2	15.6	6.3	19.8	27.4	21.5	20.3	17.2	23.0	29.5	24.1	28.5	23.6	23.4	41.3	17.1	44.8	40.0	106.7	19.9	54.4	28.9	15.6	23.9	20.1	15.8	8.9	26.3	10.0	30.0	29.5	4.2	10.9	15.6	6.2	15.6	17.6	17.0	20.9	10.5	19.6	14.9	32.0	153.1	21.6	7.7	19.8	30.5	32.4	20.8	12.1	17.9	16.0	29.0	5.0	117.2	11.1	4.1	46.5	17.6	30.6	16.1	34.5	12.4	229.5	12.4	17.4	10.3	313.1	422.0	10.7	6.4	10.5	13.7	32.3	18.4	9.3	25.1	36.4	0.0	20.5	27.1	12.8	2.3	18.7	83.4	4.9	20.0	11.8	12.4	25.4
SGSM2	"KIAA0397, RUTBC1"	ENSG00000141258	"Small G protein signaling modulator 2"	O43147	17	2337498-2381058	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021641, HPA024553"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA021641: AB_2188702, HPA024553: AB_1856512"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.84e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (9.00e-6)"	"unprognostic (2.78e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-2)"	22.2	30.2	84.3	20.2	83.0	28.4	31.0	52.5	102.7	32.1	53.8	37.0	15.5	26.3	51.7	36.0	27.4	21.2	27.1	83.0	81.3	36.5	19.3	28.2	24.3	64.0	67.5	28.9	27.9	27.4	80.7	15.8	62.6	53.7	10.1	15.7	41.9	21.6	21.6	33.3	32.6	17.9	58.4	37.6	33.6	30.0	76.9	17.5	41.4	13.9	14.1	31.8	28.7	68.4	20.7	31.1	27.9	39.0	15.5	18.6	41.4	17.4	20.4	23.6	23.9	31.2	38.6	9.9	18.5	25.3	8.7	28.4	17.2	20.6	8.2	14.5	35.3	17.2	55.6	33.8	13.3	10.4	25.0	20.1	13.4	24.1	13.7	34.1	24.9	26.4	10.5	14.4	14.3	43.5	22.4	14.0	13.7	14.7	13.5	48.5	14.2	8.0	30.5	42.5	13.5	31.9	21.7	16.2	13.4	17.1	41.9	12.3	29.3	18.9	21.5	28.1	23.4	11.8	1.9	9.5	16.4	13.6	17.0	7.0	0.3	1.3	0.9	0.1	0.8	0.1	0.3	0.5	0.4	0.3	1.1	0.6	0.1	0.9	0.0	0.5	0.6	0.4	84.3	83.0	52.5	102.7	83.0	81.3	64.0	67.5	62.6	58.4	76.9	68.4	9.4	6.4	24.7	52.9	5.4	6.8	8.3	13.8	5.7	59.6	31.9	24.0	15.6	11.5	23.5	12.9	135.5	13.8	9.3	7.1	0.0	6.7	18.2	9.9	11.0	11.8	13.8	5.7	39.7	4.5	8.8	10.0	14.3	14.7	20.3	18.1	14.3	8.3	7.8	30.3	38.2	9.9	16.2	7.6	9.9	38.1	8.1	9.2	5.4	16.9	6.3	11.9	7.2	22.6	10.3	6.4	4.5	12.0	4.6	15.0	7.0	4.0	16.5	51.2	19.7	9.6	11.0	4.1	6.7	11.9	7.7	14.1	11.6	15.2	8.2	13.5
SH2B1	"FLJ30542, SH2B"	ENSG00000178188	"SH2B adaptor protein 1"	Q9NRF2	16	28846600-28874212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060663, HPA076175"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA060663: , HPA076175: AB_2686782"	"unprognostic (3.60e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.27e-3)"	"unprognostic (6.10e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.38e-4)"	"unprognostic (1.39e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.60e-4)"	36.7	57.4	53.8	32.8	54.8	38.6	39.5	58.6	75.2	58.5	42.8	59.7	46.4	54.9	20.9	39.4	54.3	30.0	52.9	53.6	47.0	62.1	44.6	35.6	39.2	49.0	47.8	69.4	53.4	55.2	70.1	20.9	48.8	57.7	28.5	29.1	49.2	36.8	58.2	40.6	57.1	24.8	38.1	63.4	51.9	48.8	51.4	36.5	71.6	50.6	25.2	47.1	44.9	58.4	29.9	43.2	32.3	41.7	33.3	28.2	26.9	30.4	17.1	23.4	25.3	29.0	49.2	27.4	41.7	24.5	20.2	46.4	21.3	33.9	13.2	35.9	27.6	24.4	111.3	45.0	25.2	24.8	22.4	39.4	27.2	32.9	13.3	40.0	27.4	27.8	39.8	39.1	31.3	40.3	37.2	36.4	41.9	15.6	17.3	62.3	19.4	46.1	27.2	22.2	36.9	49.7	14.7	42.4	22.3	19.1	33.4	26.5	38.8	26.9	22.5	23.8	23.6	74.0	40.2	30.9	41.8	43.0	27.5	3.3	1.4	0.6	2.0	1.1	1.9	1.6	1.6	1.4	1.1	1.7	1.2	1.1	2.1	0.6	1.1	1.9	1.8	0.9	53.8	54.8	58.6	75.2	53.6	47.0	49.0	47.8	48.8	38.1	51.4	58.4	14.1	6.4	13.7	37.5	13.9	10.8	15.9	15.4	22.8	26.7	17.4	13.8	18.4	17.2	15.7	22.0	33.3	16.6	12.8	31.1	15.6	9.5	2.2	11.0	11.0	12.7	27.6	7.8	25.6	12.9	8.2	15.0	19.4	11.4	6.3	20.1	13.9	8.9	12.2	28.6	26.8	24.7	14.2	8.7	7.2	5.4	22.1	10.8	3.6	13.1	10.7	18.1	22.6	21.6	19.0	12.8	24.9	23.7	10.5	10.4	26.3	10.2	12.5	28.9	26.3	12.9	15.7	9.9	12.8	17.4	11.1	13.7	15.3	20.4	28.4	12.3
SH2B2	APS	ENSG00000160999	"SH2B adaptor protein 2"		7	102285091-102321711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 37.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 31.4;Extravillous trophoblasts: 67.0;Plasma cells: 30.0;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.4;granulocytes: 1.8;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 64.2;Karpas-707: 60.7;RPMI-8226: 46.7;U-266/70: 56.1;U-266/84: 106.7;U-698: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051131	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051131: AB_2681354"	"unprognostic (2.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.99e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.02e-3)"	"unprognostic (3.42e-2)"	5.4	1.8	6.3	5.8	4.9	3.6	3.6	4.3	5.3	4.6	1.3	2.6	2.2	4.5	0.3	1.9	4.6	1.5	2.2	3.9	9.3	6.0	1.8	5.7	10.7	10.6	11.2	1.9	1.9	1.0	3.0	1.8	7.0	4.4	0.5	0.8	2.8	0.7	37.3	3.6	5.5	0.9	7.1	14.5	2.4	3.4	10.4	0.8	4.5	13.8	5.5	4.0	3.4	3.5	3.7	2.8	3.0	6.6	0.7	0.3	27.6	1.3	0.5	0.8	0.6	0.8	0.6	64.2	6.4	0.5	2.8	3.7	0.7	0.9	0.3	8.1	2.8	0.0	1.7	0.6	0.6	0.5	2.2	0.6	0.9	0.5	0.2	1.1	0.2	1.6	0.4	60.7	1.3	6.9	0.3	11.5	7.0	2.3	11.5	8.1	3.3	46.7	2.1	1.0	3.2	11.4	2.3	5.6	1.6	2.3	1.0	8.4	0.2	1.0	6.2	11.0	1.3	56.1	106.7	88.3	3.9	2.3	1.5	0.0	0.3	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.3	3.4	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	6.3	4.9	4.3	5.3	3.9	9.3	10.6	11.2	7.0	7.1	10.4	3.5	5.6	0.0	0.0	6.2	31.4	2.5	2.5	0.0	1.8	6.8	3.4	2.9	1.1	1.5	0.0	0.0	0.0	9.3	2.9	0.8	0.0	0.2	0.4	3.8	2.4	7.3	1.8	0.4	2.2	0.0	67.0	2.0	1.1	5.4	0.0	1.0	2.2	0.8	7.8	5.0	4.8	0.6	0.0	14.1	17.6	2.0	0.6	15.1	7.2	2.8	6.0	9.2	1.0	1.0	0.5	0.1	0.5	0.4	30.0	5.7	0.1	13.0	0.0	1.4	0.0	6.6	2.0	1.1	15.8	0.6	1.6	58.1	1.3	0.4	1.3	2.2
SH2D1A	"DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD"	ENSG00000183918	"SH2 domain containing 1A"	O60880	X	124227868-124373197	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"lymphoid tissue: 262.5"	"Group enriched"	"Detected in some"	7	"dendritic cells: 77.6;NK-cells: 138.0;T-cells: 108.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	54	"gdT-cell: 120.2;MAIT T-cell: 162.9;memory CD4 T-cell: 90.4;memory CD8 T-cell: 175.8;naive CD4 T-cell: 91.2;naive CD8 T-cell: 108.3;NK-cell: 162.2;T-reg: 125.3"	"Group enriched"	"Detected in many"	70	"NK-cells: 162.2;T-cells: 175.8"	"Group enriched"	"Detected in some"	6	"HDLM-2: 101.1;JURKAT: 193.0;Karpas-707: 201.3;MOLT-4: 257.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA072265			Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA072265: "	"prognostic favorable (2.03e-4)"	"unprognostic (1.18e-3)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.94e-6)"	"unprognostic (1.27e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.14e-3)"	1.4	1.1	0.0	10.8	0.1	5.4	1.2	0.1	0.2	0.9	0.1	1.6	1.5	0.6	0.6	1.1	0.5	4.1	0.3	0.1	0.1	0.4	2.8	3.2	38.4	0.2	0.1	0.4	0.2	0.2	0.2	0.3	0.1	1.1	1.5	0.0	1.3	0.3	0.3	0.4	2.5	0.6	0.2	14.7	2.7	0.2	0.1	262.5	0.7	1.2	16.6	5.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	101.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	193.0	0.0	201.3	0.0	0.0	257.2	4.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	32.7	33.3	0.0	0.2	0.0	0.0	1.4	0.6	0.1	120.2	0.5	162.9	1.1	90.4	175.8	0.5	0.2	91.2	108.3	2.4	162.2	1.2	0.8	125.3	91.3	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	1.1	3.2	4.7	0.0	3.0	1.5	0.1	0.0	0.0	0.0	0.7	0.8	0.2	1.5	0.0	0.0	0.0	0.1	77.6	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	7.4	0.1	0.0	0.0	2.0	1.1	0.2	3.8	0.0	3.6	0.9	0.1	0.0	0.0	0.0	0.0	5.6	4.4	0.0	0.0	4.3	5.4	0.0	2.3	0.0	138.0	0.5	0.2	0.0	0.0	0.0	14.1	0.2	0.0	0.5	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.2	1.0	0.1	108.9	0.0	0.0	0.0
SH2D5		ENSG00000189410	"SH2 domain containing 5"	Q6ZV89	1	20719731-20732837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.7;testis: 8.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.8;Excitatory neurons: 9.9;Inhibitory neurons: 5.3;Syncytiotrophoblasts: 5.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.6"	"Group enriched"	"Detected in many"	8	"amygdala: 6.4;basal ganglia: 21.7;cerebral cortex: 11.3;hippocampal formation: 6.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 47.0;hTERT-HME1: 59.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030182			Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA030182: AB_10670431"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.80e-6)"	"unprognostic (1.11e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-2)"	0.1	0.2	6.4	0.5	21.7	0.0	0.0	0.0	11.3	1.0	0.0	0.3	0.4	0.6	0.0	0.2	0.2	0.1	0.2	6.7	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.3	3.5	0.0	0.6	0.0	0.4	0.1	0.7	0.0	0.2	0.1	0.4	0.0	0.0	0.2	8.0	1.3	0.0	0.7	0.0	0.1	0.2	0.3	0.0	18.8	7.4	1.6	0.0	0.0	0.0	0.2	9.0	11.8	8.3	5.6	3.2	2.9	0.0	2.2	2.7	18.1	0.8	6.1	47.0	3.5	0.1	3.4	0.0	1.1	2.2	6.3	0.0	0.1	0.5	10.0	15.6	59.0	3.0	0.1	1.5	0.0	0.0	3.7	1.7	1.0	0.0	2.9	1.0	9.4	0.2	0.3	0.4	8.2	1.1	2.8	0.4	0.6	0.2	2.8	1.3	0.0	0.0	0.0	9.6	17.6	14.7	4.2	0.0	0.1	0.8	3.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	21.7	0.0	11.3	6.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.3	0.0	4.8	1.4	0.7	0.0	1.8	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.4	0.1	0.1	0.1	0.0	0.0	9.9	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.0	0.8	1.9	0.0	0.0	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	0.8	0.0	2.3	5.1	0.1	0.0	0.1	0.3
SH2D7	LOC646892	ENSG00000183476	"SH2 domain containing 7"	A6NKC9	15	78077808-78104909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	7	"intestine: 2.1;testis: 3.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 21.1;Late spermatids: 35.1"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA051320, HPA058382, HPA076728"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA051320: AB_2681439, HPA058382: , HPA076728: "	"unprognostic (1.22e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	1.6	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.1	1.7	0.1	0.2	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.7	1.3	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	21.1	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	3.0	0.0	0.0	0.4	0.0
SH3BGR	21-GARP	ENSG00000185437	"SH3 domain binding glutamate rich protein"	P55822	21	39445855-39515506	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 1268.3;tongue: 578.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 180.2;Distal tubular cells: 46.9;Early spermatids: 151.2"	"Cancer enhanced"	"Detected in all"		"glioma: 21.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 101.0"					"Low region specificity"	"Detected in all"			CAB003685	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"CAB003685: AB_425682"	"unprognostic (3.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.68e-3)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.75e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.16e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-2)"	8.9	24.0	41.8	3.6	44.9	2.0	11.2	42.0	72.4	10.8	37.3	39.4	6.6	12.3	28.5	20.3	8.1	9.5	154.1	43.7	43.0	13.2	11.8	5.4	2.0	43.8	40.8	6.0	11.0	10.7	25.6	2.1	44.4	25.1	7.0	14.7	14.2	21.2	1268.3	4.8	8.5	11.0	41.0	3.3	16.9	20.1	42.4	3.2	16.3	578.1	2.1	20.8	8.1	50.5	2.0	2.9	3.7	4.2	5.5	9.2	1.0	2.7	0.6	1.9	1.5	1.6	3.9	6.6	8.9	10.9	14.5	0.3	1.2	3.1	2.9	3.9	7.6	7.6	0.9	3.1	15.1	2.8	1.3	7.6	13.5	7.0	12.1	3.4	1.8	13.9	5.0	7.7	7.8	9.4	3.7	4.2	3.2	6.2	6.2	6.5	13.1	4.5	8.3	1.8	10.0	4.0	5.8	4.9	5.4	2.3	19.8	0.5	1.6	5.0	0.6	3.1	7.9	26.3	5.7	6.7	101.0	5.0	6.9	0.0	0.2	0.0	0.2	0.9	0.9	1.4	0.4	0.9	0.9	0.6	1.6	1.2	0.2	1.2	0.9	3.7	0.1	0.4	41.8	44.9	42.0	72.4	43.7	43.0	43.8	40.8	44.4	41.0	42.4	50.5	2.4	3.2	3.9	15.3	1.4	2.7	12.8	5.9	1.8	2.1	11.4	25.0	180.2	5.7	4.4	5.5	4.2	3.7	3.2	2.3	46.9	5.1	151.2	11.3	5.0	3.1	1.2	0.8	6.4	21.3	1.7	5.6	3.6	10.6	4.5	5.3	2.2	9.2	2.4	5.0	6.5	1.7	4.1	1.6	2.0	35.4	2.1	1.5	12.4	5.6	1.2	21.2	0.0	3.0	14.6	4.8	3.2	5.7	1.0	3.3	2.3	14.4	6.7	6.2	6.6	22.7	16.9	32.4	23.6	1.1	1.7	1.9	1.4	4.7	2.7	4.6
SH3BP1	ARHGAP43	ENSG00000100092	"SH3 domain binding protein 1"	Q9Y3L3	22	37634654-37656117	"Metabolic proteins, Predicted intracellular proteins"	Phagocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.5;HMC-1: 45.4;NB-4: 44.7"	"Low region specificity"	"Detected in all"							HPA000757	Supported		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA000757: AB_1079951"	"unprognostic (7.81e-3)"	"unprognostic (7.91e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.78e-1)"	"prognostic unfavorable (3.48e-7)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.37e-2)"	"unprognostic (8.48e-3)"	4.2	3.6	3.4	14.2	3.4	14.4	3.4	3.7	6.2	12.2	2.7	19.4	18.1	3.2	0.7	37.7	4.0	2.1	2.0	4.1	4.5	3.2	2.6	8.8	12.1	6.0	3.9	3.4	2.8	2.2	2.1	5.1	4.7	7.6	4.5	0.2	9.3	2.0	0.7	27.0	20.9	2.0	4.8	27.0	4.3	5.7	4.7	8.2	2.5	0.5	7.7	10.5	21.1	5.7	20.1	1.0	3.9	3.4	0.9	3.9	28.6	3.8	6.4	6.3	7.0	5.9	2.3	12.6	2.7	2.4	2.0	43.5	2.0	26.0	2.6	36.9	13.7	18.5	0.6	8.6	3.3	25.9	45.4	4.9	6.3	7.9	0.9	5.2	1.0	6.3	6.4	4.8	0.6	12.7	3.0	44.7	7.6	13.7	3.8	15.7	3.2	11.0	0.8	22.2	3.8	10.1	1.0	5.3	17.9	3.9	6.7	22.1	1.3	2.3	10.8	0.5	0.2	29.9	10.2	9.0	3.2	26.4	13.0	1.8	1.4	4.6	1.0	1.8	1.0	0.3	1.1	1.1	0.7	0.1	0.6	1.4	0.9	0.8	3.7	1.2	1.1	0.6	3.4	3.4	3.7	6.2	4.1	4.5	6.0	3.9	4.7	4.8	4.7	5.7	1.2	0.0	7.2	0.7	23.7	19.1	22.2	42.5	23.3	0.3	3.3	4.1	1.2	4.3	8.0	0.0	2.1	47.5	36.1	55.0	0.0	3.0	0.4	0.6	4.3	1.7	4.2	7.8	5.6	4.7	43.9	6.0	11.2	1.3	14.0	3.4	4.2	0.5	48.3	8.4	0.8	29.9	12.2	33.3	19.0	0.1	5.0	45.6	5.4	2.8	36.0	3.0	53.5	5.0	0.9	2.0	46.8	1.9	20.9	29.6	41.9	0.3	11.4	0.5	0.0	0.9	3.6	3.4	6.0	23.6	15.3	37.5	52.7	5.0	23.6	42.0
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 32.6;Kupffer cells: 33.7;Macrophages: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.7"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;dendritic cells: 17.7;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.8;MOLT-4: 41.8;SK-MEL-30: 26.8;U-2197: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038132, HPA056807"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: AB_2683239"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	8.4	3.5	4.0	8.7	4.3	4.6	5.6	4.1	5.6	2.9	5.2	2.8	0.9	2.1	0.7	8.4	3.0	5.4	3.6	3.6	7.3	19.2	9.6	9.0	9.1	10.5	6.0	1.2	6.3	0.7	2.5	3.0	8.5	4.7	1.0	1.3	4.6	2.7	1.5	2.7	4.9	2.0	9.2	14.1	6.0	0.6	8.4	28.0	4.6	0.7	4.5	4.4	5.8	11.8	3.9	6.1	0.1	0.0	0.0	0.5	4.1	0.4	0.2	0.5	0.8	3.2	2.2	5.2	5.2	0.0	0.8	2.0	0.0	12.4	0.0	14.2	0.2	0.0	6.1	5.7	4.3	0.1	0.8	0.2	15.3	0.3	9.9	0.5	25.8	3.2	0.8	7.3	0.4	4.1	41.8	3.4	0.0	2.3	5.1	3.1	0.7	1.6	0.4	1.0	0.1	3.1	1.7	0.4	26.8	1.0	0.0	1.0	14.2	0.0	3.0	19.0	0.2	0.0	1.0	4.7	0.2	1.9	4.1	0.0	9.9	1.3	0.7	8.8	0.9	4.9	1.7	1.1	7.7	6.8	0.9	0.7	0.3	0.3	12.3	17.7	2.5	4.3	4.0	4.3	4.1	5.6	3.6	7.3	10.5	6.0	8.5	9.2	8.4	11.8	12.6	0.0	5.8	1.3	18.1	0.8	10.5	6.9	0.6	1.0	0.8	1.4	3.3	4.3	4.1	25.8	0.0	2.1	18.2	2.5	7.9	3.6	0.5	0.9	0.3	12.6	1.2	3.2	0.2	5.6	3.4	1.6	32.6	2.2	17.2	0.3	27.5	8.6	22.7	23.5	0.1	2.5	14.2	33.7	16.7	1.5	0.6	35.7	0.0	17.8	15.6	13.3	7.2	0.5	0.1	9.3	4.5	0.7	17.1	8.3	0.1	17.2	2.0	0.9	0.0	0.6	1.2	0.0	0.3	2.5	0.6	3.0	11.7	2.5	1.8	15.3
SH3TC2	"CMT4C, KIAA1985"	ENSG00000169247	"SH3 domain and tetratricopeptide repeats 2"	Q8TF17	5	148923639-149063163	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.6;retina: 3.9"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 270.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;HBEC3-KT: 2.2;RT4: 3.6;SK-MEL-30: 5.2;WM-115: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037683, HPA037684"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No				"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA037683: AB_2675608, HPA037684: AB_10672603"	"unprognostic (6.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.18e-2)"	"unprognostic (4.53e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.40e-1)"	0.1	0.0	4.7	0.0	8.0	0.1	0.1	5.1	5.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	3.6	5.1	0.0	0.0	0.0	0.0	7.1	6.9	0.0	0.0	0.0	0.0	0.4	7.3	0.0	0.0	3.9	0.1	0.1	0.2	0.1	0.0	0.0	5.8	0.0	0.0	1.5	7.1	0.0	0.0	0.1	0.0	0.1	0.0	12.6	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.3	0.1	2.6	1.5	0.0	1.8	0.1	0.6	1.9	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	1.6	0.0	1.3	0.0	0.7	3.6	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	8.0	5.1	5.0	3.6	5.1	7.1	6.9	7.3	5.8	7.1	12.6	1.9	3.2	3.7	0.3	0.1	0.9	0.8	1.0	0.0	1.4	0.7	0.4	1.7	1.5	3.8	0.0	4.2	0.8	0.0	0.6	0.0	0.6	6.4	0.3	0.1	2.8	0.0	0.0	0.4	0.2	0.4	0.5	0.0	0.5	2.5	0.1	1.4	0.3	0.4	0.0	0.4	0.0	2.0	1.8	0.7	2.3	0.3	2.2	0.0	4.7	0.1	2.3	0.0	0.0	270.4	1.6	0.0	0.0	0.1	1.2	0.0	0.1	4.1	25.4	0.0	0.3	0.4	2.3	0.9	1.0	0.9	11.9	0.3	0.1	0.2	8.8
SHC2	"SCK, SHCB, SLI"	ENSG00000129946	"SHC adaptor protein 2"	P98077	19	416583-460996	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 109.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.8;Hepatic stellate cells: 45.3;Hepatocytes: 56.7;Horizontal cells: 48.8;Oligodendrocyte precursor cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.9;HHSteC: 5.6;SCLC-21H: 12.6;SH-SY5Y: 11.4"									HPA006136	Approved		Approved	Cytosol		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA006136: AB_1856827"	"unprognostic (2.54e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.53e-4)"	"unprognostic (4.45e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.86e-2)"	"unprognostic (4.43e-2)"	16.0	19.9	21.4	1.6	17.9	0.1	17.5	9.5	31.1	28.2	5.1	22.0	6.3	24.2	2.0	5.0	23.6	10.9	18.2	17.0	32.0	12.2	63.8	17.3	1.7	24.9	18.6	14.1	109.8	7.0	48.0	7.6	19.6	32.6	0.4	1.2	24.5	5.1	5.0	10.2	10.6	2.9	15.7	26.6	21.4	9.6	29.0	0.3	32.7	1.2	0.3	10.0	11.7	19.0	0.0	0.1	0.4	0.1	0.0	0.0	0.6	0.5	2.5	0.3	0.0	0.0	0.4	0.0	4.9	0.0	1.2	0.4	1.1	0.0	0.0	1.1	1.7	0.0	0.0	2.8	5.6	0.0	1.9	0.3	0.0	0.0	0.0	2.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	1.9	0.0	12.6	11.4	0.0	0.0	0.0	2.3	0.3	2.0	0.0	0.5	3.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	17.9	9.5	31.1	17.0	32.0	24.9	18.6	19.6	15.7	29.0	19.0	44.8	6.4	8.8	33.3	0.5	1.9	2.0	0.8	0.6	11.4	11.3	10.0	9.9	18.6	1.5	0.0	2.1	0.1	0.9	0.1	0.0	25.2	2.5	2.8	4.9	16.6	8.4	2.7	22.1	38.5	0.1	9.5	3.6	4.1	0.0	15.4	45.3	56.7	0.9	48.8	33.1	3.5	6.1	5.3	1.7	7.2	9.0	0.4	8.8	15.0	1.0	29.5	0.0	49.8	28.4	21.1	0.1	11.3	0.2	11.3	0.3	0.4	1.4	3.5	0.0	4.5	13.8	14.7	11.0	0.4	3.1	0.0	1.0	1.6	0.9	3.7
SHC4	"RaLP, SHCD"	ENSG00000185634	"SHC adaptor protein 4"	Q6S5L8	15	48823741-48963919	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6;testis: 10.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.6;Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 81.8"	"Cancer enhanced"	"Detected in some"		"melanoma: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AN3-CA: 10.0;SK-MEL-30: 19.1;WM-115: 16.5"	"Low region specificity"	"Detected in all"							HPA074146			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA074146: AB_2686667"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-5)"	"unprognostic (9.84e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.36e-2)"	0.5	0.9	12.7	1.0	21.0	0.1	1.6	15.8	18.9	1.0	6.7	2.8	0.3	0.4	0.9	0.5	1.0	1.4	3.3	14.0	14.3	0.3	0.1	0.3	0.3	18.3	16.9	0.5	0.2	0.1	1.0	0.4	19.0	0.7	0.5	0.9	2.1	1.3	0.9	0.6	0.8	0.7	13.6	0.2	0.7	10.5	17.8	0.3	0.3	1.2	0.1	0.4	0.9	36.6	0.0	0.4	1.0	10.0	0.4	1.3	0.0	1.5	2.9	0.6	1.2	0.0	0.3	0.1	2.6	0.6	0.1	0.0	0.2	0.4	0.8	2.2	0.1	0.6	0.0	0.0	1.1	0.0	0.2	1.9	0.0	1.3	0.1	1.3	0.1	1.0	0.0	0.2	1.4	1.9	0.4	0.2	0.1	0.0	3.7	0.2	2.7	0.3	2.1	0.4	0.5	0.8	0.2	0.1	19.1	0.9	0.0	0.1	0.0	0.9	0.5	0.6	1.0	0.9	0.1	0.1	0.8	0.5	16.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	21.0	15.8	18.9	14.0	14.3	18.3	16.9	19.0	13.6	17.8	36.6	0.2	0.0	0.0	16.6	0.0	0.3	0.0	2.3	0.0	0.6	1.6	6.7	2.5	0.0	2.8	0.0	0.0	0.7	0.0	0.0	0.0	6.4	2.5	0.4	0.4	0.2	0.0	0.0	9.3	0.0	0.2	1.8	0.0	0.3	0.0	0.0	0.7	0.0	0.1	1.7	6.1	0.0	0.0	0.0	0.4	4.5	1.2	0.1	7.2	1.0	0.0	2.7	0.0	30.7	81.8	0.2	0.0	3.4	0.0	0.0	0.0	0.1	2.6	1.0	0.0	0.5	0.3	6.0	6.3	0.1	0.3	0.8	0.3	0.5	0.0	0.0
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502412	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.9;Alveolar cells type 2: 23.4;Endothelial cells: 64.4;Hepatic stellate cells: 85.3;Kupffer cells: 26.7;Late spermatids: 23.0;Microglial cells: 26.2;Spermatocytes: 30.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 49.1;TIME: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037417	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	23.4	9.8	9.4	3.3	8.8	1.2	20.9	7.7	10.6	13.2	7.4	7.4	3.4	12.1	4.3	5.0	12.5	6.9	22.7	8.3	8.3	10.5	5.8	20.6	3.9	8.4	9.1	7.6	3.0	4.9	3.7	16.5	8.8	8.1	4.2	0.6	5.4	4.2	7.1	6.4	8.9	8.0	8.1	21.4	5.5	22.2	10.2	2.6	22.1	11.3	2.3	9.7	9.9	8.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.5	0.0	1.0	13.6	0.0	0.3	1.4	0.0	0.1	0.2	0.1	0.0	1.0	0.0	0.5	0.3	0.2	1.5	1.5	1.1	0.9	0.6	0.6	0.1	0.9	0.8	0.9	2.4	1.7	1.1	4.0	0.0	0.5	9.4	8.8	7.7	10.6	8.3	8.3	8.4	9.1	8.8	8.1	10.2	8.0	56.9	0.0	23.4	3.9	0.3	3.3	0.4	0.3	1.2	0.1	0.4	1.3	4.4	1.5	1.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	13.0	0.4	0.3	64.4	0.0	2.7	0.3	0.0	0.0	6.7	0.0	0.5	3.8	2.1	85.3	3.4	1.4	0.0	0.3	0.0	0.0	26.7	6.6	23.0	1.5	2.0	0.0	26.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.7	0.0	0.1	0.0	0.4	0.0	3.3	2.2	30.6	13.0	0.3	1.6	0.1	0.7	0.3	0.0	0.3
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397488-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.3;heart muscle: 15.5;kidney: 21.4"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 43.0;Fibroblasts: 19.4;Hepatic stellate cells: 55.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 7.6;renal cancer: 7.8"	"Group enriched"	"Detected in all"	4	"midbrain: 13.3;thalamus: 10.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AN3-CA: 219.6;PC-3: 130.4"	"Region enriched"	"Detected in many"	23	"olfactory bulb: 51.7"	"Region enriched"	"Detected in many"	8	"spinal cord: 21.4"	HPA054754			Approved	"Lipid droplets,Cytosol"		NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Lipid droplets"	"HPA054754: AB_2682593"	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.1	1.8	1.8	1.8	1.6	0.0	2.3	1.1	1.6	0.7	1.2	6.2	2.2	0.2	0.3	1.7	0.5	1.0	15.5	1.0	2.2	21.4	0.6	5.7	7.0	1.7	13.3	0.3	0.2	0.2	0.6	0.0	2.6	0.8	3.0	0.1	0.6	1.0	1.6	0.5	10.4	4.3	1.4	0.4	2.9	0.6	10.1	0.1	5.0	1.4	0.8	3.5	1.3	1.2	0.0	0.0	0.0	219.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.7	0.1	0.0	0.0	23.3	0.0	0.0	0.0	2.6	0.0	0.1	0.0	6.6	0.0	0.8	0.4	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	1.2	0.0	10.1	0.0	130.4	0.2	0.0	0.0	9.0	0.0	0.1	0.3	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.6	1.1	1.6	1.0	2.2	1.7	13.3	2.6	1.4	10.1	1.2	4.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	3.7	0.0	0.0	0.1	0.1	43.0	0.0	0.0	0.1	2.5	3.7	0.0	5.3	0.0	0.0	0.0	19.4	0.5	0.1	0.0	1.1	55.0	0.2	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.0	3.4	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	2.4	0.0	0.1	0.0	0.2	1.4	0.5	0.4	0.1	0.0	0.0	0.0	2.4	0.1	0.0
SHISA7		ENSG00000187902	"Shisa family member 7"	A6NL88	19	55428740-55443277	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 13.5;Excitatory neurons: 19.4;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 2.9;HMC-1: 2.8;THP-1: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058935	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058935: AB_2683857"	"unprognostic (3.98e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"		"unprognostic (3.08e-1)"	"unprognostic (4.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.87e-7)"	"unprognostic (7.53e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.04e-1)"	0.0	0.4	20.2	0.0	19.7	1.1	0.0	0.5	20.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	10.4	0.0	0.0	0.0	0.0	5.1	4.9	0.0	0.0	0.0	4.9	0.0	3.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.3	9.6	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	19.7	0.5	20.2	25.9	10.4	5.1	4.9	3.6	4.6	9.6	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	13.5	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	16.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.1	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHISA9		ENSG00000237515	"Shisa family member 9"	B4DS77	16	12901598-13240416	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8"	"Group enriched"	"Detected in many"	17	"Excitatory neurons: 265.0;Inhibitory neurons: 427.9;Oligodendrocyte precursor cells: 636.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 48.5;LHCN-M2: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072399			Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"HPA072399: AB_2686517"	"unprognostic (1.88e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.69e-5)"	"unprognostic (2.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.90e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	0.5	2.8	12.5	0.8	12.7	1.3	0.6	0.0	14.8	0.3	0.0	3.2	0.8	0.4	1.1	0.5	0.2	0.4	0.6	10.9	6.3	1.9	0.6	0.2	0.4	6.9	5.9	0.4	0.6	0.1	0.9	0.4	6.2	4.2	0.9	3.7	0.9	0.7	1.5	0.9	0.9	0.6	1.7	0.4	0.5	0.7	11.0	0.1	2.1	0.0	0.3	0.2	0.2	4.2	0.8	0.4	0.6	0.5	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.5	0.5	48.5	0.1	0.7	0.6	0.1	0.2	0.1	0.6	0.2	0.6	0.9	0.3	0.1	0.6	0.6	1.5	0.1	0.1	3.3	0.4	0.1	0.6	0.4	1.0	40.5	5.5	0.4	0.7	10.2	0.7	0.5	0.6	0.4	0.3	10.9	1.5	10.1	0.5	0.4	1.4	0.4	4.4	0.9	0.4	0.4	0.6	5.8	0.6	0.4	0.9	1.0	0.5	0.4	0.3	1.0	0.8	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	12.5	12.7	0.0	14.8	10.9	6.3	6.9	5.9	6.2	1.7	11.0	4.2	0.0	25.6	20.1	5.2	0.1	0.1	0.5	0.2	0.0	0.8	1.7	0.8	1.3	1.5	7.0	1.8	0.0	0.1	0.0	0.3	1.9	1.4	4.8	0.1	0.5	1.1	0.0	0.0	265.0	0.0	0.0	2.0	0.0	0.3	11.4	0.0	0.0	0.0	0.0	0.0	427.9	0.3	0.0	0.0	0.4	3.4	0.3	1.0	0.0	5.6	0.0	0.5	0.0	636.3	4.9	0.1	2.3	0.0	0.0	1.8	0.0	1.3	11.8	0.3	0.0	6.6	0.2	0.5	2.0	0.0	0.1	0.1	1.3	0.0	0.8	0.6
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243665-44312951	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.2;endometrium 1: 33.6;smooth muscle: 29.3"	"Cell type enriched"	"Detected in single"	6	"Endometrial stromal cells: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SiHa: 36.2;U-2197: 80.8;U-87 MG: 46.3;WM-115: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol		No	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Vesicles, Cytosol"		"HPA051178: AB_2681374"	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	1.0	1.8	18.6	1.2	17.2	0.0	0.2	0.0	21.4	16.6	0.0	18.7	1.9	33.6	0.4	1.6	4.5	3.1	0.9	18.0	15.3	0.5	0.1	0.3	0.4	10.8	17.8	1.0	0.8	0.1	2.6	0.5	2.4	3.7	2.0	5.6	0.3	11.0	0.0	0.7	2.4	29.3	0.3	0.1	1.6	1.1	43.2	2.6	0.4	0.1	0.7	11.9	5.2	2.8	0.0	0.3	3.5	1.2	0.0	0.0	0.0	1.0	2.3	2.4	1.4	0.0	0.0	0.0	0.0	2.3	14.5	0.0	5.0	0.3	0.3	0.0	2.3	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	1.8	11.2	0.5	0.0	0.0	0.1	0.1	0.0	0.4	0.0	3.3	0.0	0.8	0.0	0.0	0.1	0.0	0.0	12.9	0.0	36.2	0.1	0.2	0.4	0.0	0.3	0.1	13.1	2.0	80.8	0.5	0.0	0.0	0.0	46.3	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	17.2	0.0	21.4	18.0	15.3	10.8	17.8	2.4	0.3	43.2	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SHOC1	"C9orf84, FLJ32779, MZIP2, Zip2"	ENSG00000165181	"Shortage in chiasmata 1"	Q5VXU9	9	111686173-111795008	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 17.1"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Endothelial cells: 1.0"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA032108			Approved	Vesicles,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 43: Testis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Vesicles, Cytosol"		"HPA032108: AB_10669884"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.33e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.31e-2)"	0.0	2.4	0.4	0.0	0.4	0.1	0.0	1.8	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.7	2.2	0.0	0.1	0.0	0.9	0.5	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.1	1.1	17.1	1.0	0.0	0.0	0.0	0.3	0.1	0.2	1.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	5.0	1.1	0.4	0.0	0.0	0.3	0.1	0.0	21.7	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.8	0.7	0.7	0.7	0.9	0.5	1.1	0.4	1.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHPRH	"bA545I5.2, FLJ90837, KIAA2023"	ENSG00000146414	"SNF2 histone linker PHD RING helicase"	Q149N8	6	145864245-145964423	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Helicase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;Oligodendrocytes: 164.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034854, HPA044852"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA034854: AB_10964488, HPA044852: "	"unprognostic (3.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (5.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.01e-1)"	4.9	4.2	3.1	4.7	3.7	4.2	7.2	18.4	5.1	5.4	3.2	4.3	4.2	7.7	6.0	4.3	5.2	4.6	3.5	3.0	2.5	5.5	4.6	4.2	6.9	2.8	2.6	12.2	3.9	6.7	2.0	4.5	4.5	5.5	5.0	16.3	5.8	5.1	4.2	9.7	4.5	5.7	2.5	6.4	5.4	7.6	2.9	7.2	8.4	5.2	5.8	4.3	3.3	5.5	4.2	3.2	15.3	9.1	7.0	7.3	7.2	4.9	3.9	5.9	7.6	7.0	2.9	14.5	5.9	3.7	4.6	7.0	9.5	6.9	7.7	6.5	10.9	14.6	7.6	6.1	5.2	31.2	8.6	5.2	7.8	5.6	8.0	5.8	6.4	10.0	20.3	7.9	5.1	3.7	19.8	11.6	10.3	6.9	5.4	14.1	23.6	5.0	8.0	4.1	12.6	8.8	8.7	7.9	5.4	10.5	4.2	14.6	7.2	3.7	7.0	7.4	5.8	6.4	9.4	17.1	3.9	13.0	6.0	0.7	0.9	1.9	1.7	0.9	1.5	1.5	1.4	1.1	1.1	2.5	1.5	1.3	0.0	1.5	1.0	2.0	1.4	0.5	3.1	3.7	18.4	5.1	3.0	2.5	2.8	2.6	4.5	2.5	2.9	5.5	31.4	28.9	23.4	106.7	31.0	21.2	17.9	14.5	19.4	117.2	21.5	20.3	17.2	20.0	20.7	22.0	210.6	16.1	34.6	9.1	7.9	18.6	20.4	20.9	52.8	26.0	19.2	15.3	131.0	12.9	7.0	25.9	23.9	18.1	13.3	145.7	15.7	20.5	12.0	94.2	140.3	14.7	6.1	21.4	9.8	8.0	50.7	19.8	14.2	93.7	30.6	40.7	36.0	143.7	164.6	15.9	8.8	34.3	23.5	18.8	17.2	7.5	14.9	158.5	72.3	47.1	39.1	83.2	65.0	16.5	19.7	6.6	26.4	61.5	18.0	12.5
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786429-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Cone photoreceptor cells: 47.9;Microglial cells: 24.4;Peritubular cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 19.2;SK-MEL-30: 18.2;SuSa: 18.6;WM-115: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051646	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: AB_2681562"	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	0.7	1.8	4.3	0.4	6.0	0.0	1.0	3.6	10.1	2.4	5.4	1.5	0.7	1.5	2.7	5.0	1.6	3.1	0.7	5.9	4.0	3.7	4.0	4.1	0.3	4.8	5.0	6.9	3.7	2.4	4.4	7.6	4.3	5.3	1.3	20.8	3.2	2.6	0.1	4.1	0.5	0.8	4.3	0.7	1.5	3.4	4.7	3.6	1.4	0.1	1.3	2.4	3.1	5.2	6.2	0.7	11.0	1.5	0.6	1.7	6.2	0.6	2.0	2.4	3.8	7.5	0.1	0.0	2.0	1.6	0.4	4.8	5.7	15.9	2.8	0.0	4.3	0.0	0.0	1.2	3.5	0.0	7.4	0.3	10.9	18.0	0.7	3.9	13.7	0.0	0.0	0.0	3.9	6.5	0.0	0.1	9.7	0.0	0.0	0.0	12.1	0.0	10.2	19.2	1.6	0.9	0.5	0.1	18.2	18.6	6.5	0.4	6.4	17.3	2.2	0.1	0.6	0.0	0.0	0.0	11.4	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	6.0	3.6	10.1	5.9	4.0	4.8	5.0	4.3	4.3	4.7	5.2	1.1	0.0	1.5	26.4	0.0	1.9	3.3	2.8	10.8	9.5	3.4	1.7	4.1	4.3	3.1	3.7	47.9	8.9	0.0	2.0	3.9	3.0	0.5	4.8	2.5	7.2	1.2	2.7	9.5	0.0	1.3	1.5	3.1	5.9	0.0	5.4	10.0	5.7	0.7	1.7	9.5	0.3	4.1	0.8	0.0	1.0	3.7	0.2	0.0	24.4	0.0	2.4	0.0	9.5	4.6	1.6	0.1	83.1	0.0	5.4	0.1	1.0	2.8	18.0	0.0	0.6	1.8	0.1	1.1	10.8	2.0	2.1	0.5	5.5	0.9	5.3
SHTN1	"KIAA1598, shootin-1, shootin1"	ENSG00000187164	"Shootin 1"	A0MZ66	10	116881477-117126586	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 128.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 19.7;intermediate monocyte: 12.9;myeloid DC: 19.3;non-classical monocyte: 6.6;plasmacytoid DC: 12.9"	"Group enriched"	"Detected in many"	42	"dendritic cells: 19.3;monocytes: 19.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037942, HPA037943"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA037942: AB_2675748, HPA037943: AB_10671637"	"unprognostic (1.00e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.08e-6)"	1.9	4.0	63.2	4.5	94.5	0.7	4.9	42.7	54.1	2.9	10.0	4.3	4.1	2.4	4.6	3.1	2.9	3.8	1.6	46.9	73.9	4.7	7.6	6.2	2.9	77.5	70.1	3.9	12.2	8.0	6.2	3.1	69.5	4.2	5.2	10.6	6.7	1.4	0.3	5.6	4.8	2.0	48.6	4.5	5.7	6.4	79.5	2.7	7.5	0.8	2.3	2.1	2.1	128.1	24.2	13.4	1.3	2.8	0.0	0.0	12.8	2.0	5.3	4.0	7.6	15.1	15.5	0.0	4.0	7.4	11.8	12.2	10.6	8.9	4.1	0.0	11.0	0.0	14.5	8.9	1.7	4.3	3.7	0.5	7.5	4.0	7.5	10.3	9.7	6.4	6.7	0.1	2.8	9.6	0.0	0.1	5.0	4.8	8.9	0.0	17.5	5.4	10.3	3.3	14.5	5.7	16.0	23.3	13.8	15.7	18.4	3.8	17.0	1.4	9.4	0.1	11.7	2.4	0.1	0.0	7.1	0.0	7.2	0.0	19.7	0.2	0.0	12.9	0.0	0.0	0.1	0.0	19.3	0.0	0.1	0.0	0.4	0.0	6.6	12.9	0.4	5.6	63.2	94.5	42.7	54.1	46.9	73.9	77.5	70.1	69.5	48.6	79.5	128.1	1.4	76.9	35.7	0.0	2.0	0.0	18.9	0.0	15.4	92.3	31.8	15.9	4.9	35.8	23.5	23.9	62.6	42.1	24.7	10.6	21.5	46.4	7.5	43.4	10.6	5.1	17.0	1.7	0.0	53.2	30.9	11.2	36.7	81.1	2.5	23.6	1.8	50.5	37.3	48.8	0.0	15.5	0.0	83.6	0.0	11.7	11.1	77.2	0.0	0.0	90.3	13.8	1.0	0.0	0.0	46.2	42.5	5.3	0.8	25.2	21.2	58.4	18.2	59.4	13.1	18.2	5.0	22.0	39.6	20.5	0.0	20.0	3.1	28.4	15.7	15.4
SIGIRR	"IL-1R8, TIR8"	ENSG00000185187	"Single Ig and TIR domain containing"	Q6IA17	11	405716-417455	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 401.9;Proximal tubular cells: 627.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 136.0;MCF7: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023188	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center, Cytosol"		"HPA023188: AB_1856856"	"unprognostic (6.21e-3)"	"prognostic favorable (7.44e-5)"	"unprognostic (7.30e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (6.85e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (1.00e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (1.54e-5)"	21.3	6.8	47.5	32.4	46.6	33.2	22.3	47.3	58.7	21.5	42.5	45.0	28.9	20.5	19.1	19.1	29.9	19.9	36.0	46.1	47.4	68.4	87.7	33.9	45.8	52.4	47.6	12.9	47.6	16.3	15.8	9.5	51.8	32.8	13.7	5.6	33.4	17.4	6.7	9.7	46.4	10.3	48.0	68.3	42.0	7.8	48.9	18.5	31.0	10.0	18.0	23.1	17.9	49.9	22.2	59.6	3.7	20.7	3.2	16.9	42.7	3.3	5.1	10.0	8.8	27.7	136.0	6.2	16.2	19.1	1.1	31.4	9.7	11.2	1.6	19.0	35.9	12.7	11.8	0.7	10.6	11.0	20.4	9.2	2.3	1.6	1.3	5.6	29.0	24.0	12.7	0.4	2.8	74.4	31.4	35.6	21.3	44.9	32.6	38.3	0.0	21.6	7.1	14.8	35.9	17.6	0.4	20.1	26.4	9.0	25.4	8.6	34.4	3.0	3.9	5.0	0.0	7.4	13.5	16.2	13.3	24.0	11.6	77.8	42.3	39.0	123.6	48.4	98.7	37.6	101.8	108.3	43.0	28.7	91.7	90.1	22.0	102.4	61.8	16.3	106.1	82.6	47.5	46.6	47.3	58.7	46.1	47.4	52.4	47.6	51.8	48.0	48.9	49.9	83.1	28.9	34.4	16.6	46.5	16.3	34.1	33.2	43.9	8.6	44.3	40.0	21.3	72.9	35.0	55.2	12.5	17.7	105.6	163.9	62.6	54.1	1.0	47.9	15.0	62.7	78.9	14.7	2.6	73.3	11.4	37.0	80.0	40.7	40.6	15.4	79.6	401.9	51.2	26.9	2.5	106.1	63.1	52.7	31.9	5.1	31.4	61.7	85.4	4.7	46.9	109.2	218.3	1.5	10.4	79.6	153.7	29.7	37.9	24.6	105.3	627.4	75.8	19.2	26.3	21.2	34.7	6.0	69.8	21.1	12.8	10.1	117.3	10.2	93.6	43.6
SIGLEC6	"CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6"	ENSG00000105492	"Sialic acid binding Ig like lectin 6"	O43699	19	51517819-51531856	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"placenta: 106.7"	"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 76.0;granulocytes: 55.0;Syncytiotrophoblasts: 188.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.9;memory B-cell: 7.2;naive B-cell: 4.5;plasmacytoid DC: 11.0"	"Group enriched"	"Detected in many"	13	"B-cells: 7.2;dendritic cells: 11.0;granulocytes: 4.9"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 500.7"									"HPA008945, HPA009084, HPA018198"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"		"HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868"	"unprognostic (1.97e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (9.31e-3)"		"unprognostic (8.46e-4)"	"unprognostic (2.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.57e-3)"	0.6	0.1	0.2	3.0	0.3	0.5	0.7	0.4	0.3	1.6	0.1	2.2	2.2	1.5	1.0	2.5	0.3	2.5	0.4	0.2	0.0	0.1	0.1	4.3	3.8	0.1	0.1	0.1	0.3	0.1	0.0	106.7	0.2	1.0	3.1	0.4	0.5	0.7	0.5	0.5	3.3	1.3	0.0	1.7	2.6	0.3	0.2	0.7	0.0	0.6	4.2	1.8	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	15.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	1.2	500.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.3	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.9	0.2	4.9	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	1.6	4.5	0.0	0.0	0.2	0.6	0.0	11.0	0.0	0.4	0.2	0.3	0.4	0.3	0.2	0.0	0.1	0.1	0.2	0.0	0.2	0.5	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	5.2	0.7	0.0	0.0	55.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.7	0.5	0.0	0.0	0.0
SIK2	"DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2"	ENSG00000170145	"Salt inducible kinase 2"	Q9H0K1	11	111602449-111730855	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.3;Excitatory neurons: 217.6;Inhibitory neurons: 132.4;Oligodendrocytes: 191.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC diff: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016026, HPA071049"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"	"Nuclear speckles, Intermediate filaments, Cytosol"	"HPA016026: AB_1857321, HPA071049: "	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.17e-9)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.13e-2)"	29.7	9.3	9.2	5.3	12.4	3.1	20.7	7.9	11.1	7.6	11.0	7.9	5.9	7.3	5.0	5.9	8.1	10.0	12.3	9.5	14.7	11.4	22.7	11.7	4.4	11.9	11.9	14.9	31.8	21.3	16.6	5.8	10.6	6.7	6.2	30.7	13.8	6.2	33.1	8.9	7.5	5.9	5.5	4.6	17.6	3.0	9.3	5.4	8.7	23.2	4.3	7.7	6.1	11.6	9.2	6.0	10.3	11.1	50.3	14.8	6.1	7.9	11.2	5.9	6.7	20.5	9.6	7.2	10.7	9.2	6.9	12.7	8.2	5.9	7.6	5.4	3.4	7.9	5.2	10.1	10.9	7.7	4.9	14.5	8.6	8.7	11.1	11.7	7.1	7.1	7.4	10.3	9.4	4.3	8.0	7.0	3.5	7.6	5.9	10.6	11.0	8.7	13.1	8.2	4.8	11.3	11.6	4.7	4.5	9.4	11.5	6.2	9.9	12.9	7.7	8.3	10.9	2.9	2.4	14.8	4.2	10.6	8.8	0.3	0.7	0.6	0.7	0.7	0.3	0.4	0.5	0.5	0.6	0.4	0.2	0.4	0.3	0.5	0.6	0.3	0.5	0.5	9.2	12.4	7.9	11.1	9.5	14.7	11.9	11.9	10.6	5.5	9.3	11.6	22.1	19.2	24.8	113.3	14.1	14.7	6.2	5.2	18.2	15.7	10.5	9.9	21.3	27.1	10.0	16.5	66.7	4.4	11.4	15.6	5.9	10.4	16.5	27.7	14.9	18.8	18.0	12.4	217.6	7.9	4.6	20.1	27.5	45.3	9.5	24.3	9.3	38.7	5.4	32.0	132.4	11.3	4.1	12.4	16.9	14.1	11.5	13.3	19.6	73.1	6.0	14.5	4.1	86.0	191.9	8.4	10.3	14.7	8.9	6.9	8.3	23.1	13.4	60.9	0.0	19.1	19.0	3.9	6.4	10.3	11.9	5.2	12.6	5.0	11.5	7.1
SINHCAF	"C12orf14, FAM60A, TERA"	ENSG00000139146	"SIN3-HDAC complex associated factor"	Q9NP50	12	31280584-31327058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 150.5;Extravillous trophoblasts: 118.8;Glandular and luminal cells: 149.3;monocytes: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 600.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038167, HPA057585"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA038167: AB_10675629, HPA057585: AB_2732615"	"unprognostic (2.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.75e-2)"	16.2	11.6	1.1	22.8	2.0	25.6	26.7	2.8	2.0	24.0	10.1	24.3	21.5	51.9	18.0	25.1	36.2	15.2	8.7	1.0	1.1	36.3	7.7	16.6	34.4	2.0	1.5	28.1	22.6	22.6	24.8	26.3	1.5	26.9	25.9	4.0	25.8	30.3	3.2	24.0	19.6	33.3	1.5	17.4	19.5	17.0	1.3	50.9	14.0	3.6	33.6	34.1	23.7	1.4	27.8	29.9	128.7	26.6	8.0	12.0	238.3	10.7	10.3	25.9	36.7	91.6	74.8	95.9	94.9	3.9	26.7	48.1	105.4	48.4	51.0	92.6	42.6	61.7	21.2	66.6	28.4	105.2	54.7	13.0	82.0	21.6	102.2	45.3	61.6	98.9	88.0	39.1	11.4	17.5	173.7	71.7	600.6	81.7	19.0	159.6	62.4	80.0	57.3	67.8	180.0	113.5	26.5	54.1	71.8	280.2	24.6	64.5	58.5	6.0	36.1	2.8	46.4	40.3	50.5	156.9	17.9	42.9	34.0	29.5	12.9	19.8	21.8	15.8	24.8	59.1	30.4	25.9	27.5	48.5	35.8	29.0	3.9	50.4	24.2	71.9	15.3	29.6	1.1	2.0	2.8	2.0	1.0	1.1	2.0	1.5	1.5	1.5	1.3	1.4	31.0	76.9	35.8	0.0	26.5	0.0	0.0	0.0	0.0	0.0	52.3	48.8	0.0	0.0	56.3	46.0	0.0	75.1	37.7	0.0	82.2	70.1	0.0	150.5	37.8	21.8	0.0	0.0	0.0	43.2	118.8	14.9	0.0	149.3	11.4	48.8	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	154.5	0.0	0.0	0.0	0.0	56.0	0.0	0.0	11.1	0.0	0.0	41.1	59.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	60.5	18.6	18.3	0.0	0.0
SKAP1	"SCAP1, SKAP55"	ENSG00000141293	"Src kinase associated phosphoprotein 1"	Q86WV1	17	48133442-48430275	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.1;granulocytes: 120.1;Late spermatids: 156.1;NK-cells: 213.1;T-cells: 147.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 29.3;HDLM-2: 16.0;HMC-1: 13.0;JURKAT: 22.2;Karpas-707: 15.7;RPMI-8226: 19.8;RPTEC TERT1: 22.6;U-266/70: 14.8;U-266/84: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002969, CAB025882, CAB055513"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB025882: , CAB055513: , HPA002969: AB_1079870"	"prognostic favorable (5.07e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.14e-4)"	1.4	6.4	0.1	11.2	0.2	6.5	8.3	0.0	0.2	10.1	0.0	3.4	2.7	3.8	17.2	1.7	13.7	3.6	0.5	0.3	0.5	11.9	3.1	5.4	28.7	0.9	0.2	0.8	5.4	13.8	9.8	0.5	0.4	1.0	4.6	0.0	6.1	6.2	0.2	0.8	5.3	1.1	1.4	12.2	4.9	9.5	0.2	35.8	1.0	0.5	26.6	6.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	29.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.1	22.2	0.0	15.7	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	19.8	22.6	0.0	0.0	0.0	1.7	0.0	0.2	0.0	7.8	0.0	0.1	0.0	0.1	0.0	0.0	14.8	11.2	0.0	0.0	0.0	0.0	12.6	0.7	1.8	171.0	0.5	144.2	15.9	139.7	155.6	0.7	54.5	121.2	135.4	3.7	121.0	1.1	0.9	268.9	126.8	0.1	0.2	0.0	0.2	0.3	0.5	0.9	0.2	0.4	1.4	0.2	0.3	3.1	3.2	10.5	1.0	27.1	2.0	0.1	0.0	2.8	0.1	9.7	5.3	0.8	0.0	3.1	9.2	0.0	0.1	107.1	0.5	46.9	0.5	58.1	12.3	1.6	2.4	1.2	9.0	7.0	2.0	0.1	1.1	7.7	14.0	120.1	0.0	7.5	28.7	0.3	0.0	1.4	1.1	0.0	5.4	3.1	156.1	1.5	3.8	1.8	12.2	2.6	1.6	213.1	0.5	1.6	1.3	0.3	0.7	31.0	0.2	0.8	2.0	1.5	0.3	6.6	0.7	1.1	46.4	9.9	0.7	1.3	0.3	147.0	1.2	0.3	0.6
SKIL	"SNO, SnoA, SnoN"	ENSG00000136603	"SKI like proto-oncogene"	P12757	3	170357678-170396835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008472, HPA014233"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA008472: AB_1856933, HPA014233: "	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (2.94e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.34e-1)"	11.9	12.0	6.1	18.8	7.3	23.1	9.0	8.5	10.0	9.4	8.3	10.4	13.8	12.0	8.2	9.2	6.4	21.1	12.0	6.6	10.9	10.3	15.6	16.1	13.8	10.7	10.8	9.2	9.6	5.7	11.0	13.9	10.5	11.6	9.7	9.6	7.4	8.9	11.0	5.8	14.2	10.5	12.0	7.2	15.9	13.0	11.4	9.2	11.3	21.4	18.4	14.6	8.8	13.2	19.9	24.0	15.6	10.4	20.0	8.7	29.1	19.6	13.6	13.8	10.6	4.9	42.2	24.9	60.5	18.2	23.1	44.8	9.9	9.0	21.3	43.6	9.2	32.8	24.8	11.0	17.8	13.7	17.4	15.3	8.8	19.9	15.0	42.9	34.1	2.4	14.7	27.9	28.4	21.3	5.9	4.5	61.2	21.8	8.1	13.6	52.8	5.0	20.8	31.7	11.5	14.1	48.3	47.4	10.3	31.6	32.2	14.2	66.1	38.2	35.9	33.0	37.1	36.2	18.6	47.3	14.3	7.1	18.3	3.1	3.4	1.8	1.3	8.3	1.8	3.6	1.1	1.7	2.4	4.4	1.9	2.0	4.0	2.8	10.3	1.6	0.5	1.9	6.1	7.3	8.5	10.0	6.6	10.9	10.7	10.8	10.5	12.0	11.4	13.2	104.1	73.7	72.8	21.2	142.1	72.7	88.8	52.5	67.7	25.6	79.3	38.1	12.4	21.5	70.4	35.0	54.2	14.8	124.9	45.9	15.6	56.7	115.7	118.4	80.9	86.0	23.8	3.0	48.6	111.4	58.3	100.6	93.8	102.0	204.8	46.3	72.5	32.0	26.3	53.8	21.6	62.4	22.4	65.4	85.2	35.8	37.9	121.7	35.6	60.0	42.1	12.7	14.4	26.2	27.5	176.5	29.1	68.1	104.3	43.5	41.3	45.9	82.1	30.5	26.3	143.6	63.6	53.9	37.6	61.3	96.0	41.2	81.5	17.5	31.3	117.8
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959117-31969751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	21.9	33.1	0.0	5.2	0.3	4.1	21.6	0.0	0.4	26.5	0.0	25.1	10.5	22.6	9.4	23.0	25.0	0.0	22.0	0.0	0.1	24.0	54.7	22.2	3.4	0.0	0.5	24.6	25.7	2.4	39.7	2.6	0.0	31.9	2.4	2.1	22.4	3.2	20.4	20.2	31.2	5.7	0.0	40.6	27.6	16.6	0.1	4.3	27.7	5.3	2.7	23.6	20.9	0.0	0.2	12.7	13.3	0.0	16.5	11.8	27.1	10.9	11.7	13.6	13.2	0.4	0.0	0.0	26.0	25.5	13.2	11.9	0.0	30.8	9.9	14.8	15.7	0.0	0.0	0.2	0.0	0.1	0.2	28.3	17.9	0.1	0.0	12.7	0.0	19.3	0.0	13.6	0.0	0.0	0.0	0.3	20.6	0.0	0.0	0.3	0.0	0.0	11.2	0.0	0.0	0.0	23.6	0.0	17.6	11.5	0.0	15.7	12.8	16.0	7.2	18.7	0.2	42.2	35.7	12.0	20.4	0.1	0.0	0.3	0.5	0.2	1.5	1.4	1.1	0.2	0.7	0.3	1.1	0.9	0.8	0.8	0.1	0.0	2.2	0.5	0.2	0.4	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	6.4	16.0	11.3	10.1	13.3	2.8	5.0	7.9	11.4	5.0	9.3	5.1	8.5	10.0	8.8	7.3	8.4	12.6	12.7	19.7	1.9	9.5	3.1	7.7	7.9	7.9	12.6	6.5	7.2	8.6	7.9	7.4	28.1	6.3	8.2	10.8	8.6	19.4	9.2	0.0	5.0	13.2	8.2	6.3	4.1	1.5	9.3	7.8	7.2	2.8	10.2	4.9	18.6	3.0	4.8	9.4	16.0	6.0	20.2	5.9	25.5	6.9	16.5	8.3	0.0	4.1	10.2	4.7	7.5	6.6	3.7	12.4	14.4	12.3	11.0	5.2
SKP1	"EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L"	ENSG00000113558	"S-phase kinase associated protein 1"	P63208	5	134148935-134176964	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012982, HPA053745, HPA058134"	Approved		Supported	Nucleoplasm,Cytosol		No	No		880000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.40e-1)"	430.5	566.7	442.5	194.9	463.6	363.7	559.0	471.7	648.6	455.4	486.2	529.3	230.1	441.3	490.7	401.9	437.8	330.1	650.5	470.8	492.5	588.6	442.8	346.6	305.9	465.9	457.1	525.4	266.6	776.2	501.0	394.6	474.2	420.9	350.2	484.3	366.9	550.9	1056.8	419.5	354.9	422.6	494.4	304.8	385.9	380.4	470.5	456.1	551.5	814.1	332.0	452.9	391.6	515.0	657.0	500.1	730.3	986.5	1103.6	891.8	519.2	744.6	939.1	854.0	877.1	773.0	620.0	481.9	1084.9	1009.8	974.9	356.6	738.2	1124.1	988.3	442.6	519.5	380.7	724.0	555.8	518.7	296.3	452.0	771.1	886.2	750.1	588.7	1060.4	928.4	611.2	467.4	411.8	1295.2	515.6	642.0	314.8	423.9	619.6	530.7	349.2	780.7	591.7	952.3	724.6	594.6	463.8	1010.2	254.4	726.9	942.4	738.5	454.6	705.3	547.5	338.4	578.2	766.4	254.7	459.1	717.8	762.3	555.5	608.0	1745.5	851.4	1484.9	884.6	841.7	1011.4	1202.8	1264.6	1099.9	817.8	1094.4	1495.5	1174.8	811.4	1096.1	1027.0	728.1	1416.7	2538.6	442.5	463.6	471.7	648.6	470.8	492.5	465.9	457.1	474.2	494.4	470.5	515.0	430.1	285.2	306.3	64.0	403.6	674.3	1025.7	1354.7	380.1	230.0	539.8	558.4	700.9	497.6	767.4	594.1	73.0	881.0	417.7	441.8	1696.3	644.9	593.3	511.9	405.3	410.1	356.0	617.8	66.5	376.9	749.4	561.5	270.1	439.0	336.9	433.9	340.2	376.9	471.6	223.8	65.8	402.2	1192.2	296.1	505.1	1048.6	601.4	344.8	718.6	33.7	565.4	792.8	338.8	43.7	87.0	378.1	564.0	712.8	278.2	744.7	630.0	1577.8	965.7	217.5	506.2	480.4	668.1	753.5	652.7	349.0	645.6	1347.0	511.1	500.4	410.4	837.6
SLA	"hSLAP, SLA1, SLAP, SLAP-1"	ENSG00000155926	"Src like adaptor"	Q13239	8	133036728-133102912	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 97.4;lymphoid tissue: 156.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 224.2;Hofbauer cells: 67.4;Kupffer cells: 199.4;Macrophages: 154.2;NK-cells: 109.2;Plasma cells: 83.0;T-cells: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 47.9;JURKAT: 201.5;Karpas-707: 129.2;MOLT-4: 35.8;U-266/84: 76.1;U-937: 55.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012296, HPA074192"	Enhanced		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane, Cytosol"		"HPA012296: AB_1856946, HPA074192: AB_2686673"	"unprognostic (1.19e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.73e-3)"	"unprognostic (6.07e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.65e-1)"	25.2	13.1	9.5	82.9	6.4	97.4	9.5	6.1	11.5	11.1	8.2	10.8	7.9	5.2	2.9	9.4	7.0	20.9	5.2	8.2	9.1	6.4	16.9	25.9	78.6	12.0	8.4	3.0	5.8	3.1	3.1	15.2	10.3	5.2	8.4	1.3	4.6	3.6	1.5	4.0	20.7	12.5	9.7	70.3	12.5	1.4	16.9	156.6	27.6	4.4	71.0	22.0	4.2	14.6	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.9	0.1	2.3	0.0	0.0	0.0	6.3	47.9	0.8	0.0	0.6	0.0	0.2	0.0	201.5	0.1	129.2	0.0	0.0	35.8	9.3	0.0	0.0	0.0	0.2	0.3	7.8	0.0	0.0	0.0	1.0	0.0	0.1	0.1	3.1	0.0	15.3	0.0	0.1	0.3	0.2	0.1	6.9	76.1	0.0	0.6	55.6	0.0	0.7	110.2	203.6	87.6	123.1	110.1	41.0	79.7	88.2	79.8	48.3	75.3	77.4	262.3	132.6	148.4	6.3	124.4	158.9	9.5	6.4	6.1	11.5	8.2	9.1	12.0	8.4	10.3	9.7	16.9	14.6	2.4	9.6	19.1	0.7	36.6	2.2	0.3	0.0	0.0	9.7	0.9	1.3	3.3	1.5	10.5	0.0	0.0	0.4	224.2	0.2	0.0	0.2	0.2	0.7	0.7	5.9	0.0	13.2	1.0	0.0	1.2	4.5	3.6	0.5	37.2	1.7	8.9	2.9	67.4	0.0	1.3	0.5	0.0	199.4	15.0	1.0	0.3	154.2	5.4	14.0	36.7	0.1	109.2	0.0	0.1	0.0	0.0	0.0	83.0	0.1	0.0	0.3	5.1	0.3	6.6	1.4	1.9	0.0	0.1	0.3	2.7	0.1	160.0	0.1	0.1	0.2
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 61.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 23.6;dendritic cells: 19.7;Late spermatids: 22.1;NK-cells: 45.3;Plasma cells: 21.4;T-cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Daudi: 88.2;U-698: 127.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA051363: AB_2681454, HPA051903: AB_2681658"	"prognostic favorable (9.42e-4)"	"prognostic favorable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favorable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favorable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"	1.7	1.1	0.2	20.6	0.2	3.2	2.2	0.8	0.4	2.0	0.3	3.8	2.7	1.3	1.4	2.1	1.3	4.6	1.0	0.2	0.1	0.9	4.0	4.4	61.7	0.3	0.1	1.2	0.9	0.2	0.2	1.8	0.3	1.3	3.5	0.1	2.2	0.5	0.4	0.6	13.8	1.4	0.1	32.2	5.5	1.2	0.4	19.3	1.7	0.5	48.6	5.7	1.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	6.7	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.8	0.1	0.0	0.0	21.8	1.3	0.1	0.7	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	14.2	127.4	0.0	0.6	0.0	11.2	0.3	23.1	56.1	1.0	38.9	36.2	35.6	71.4	0.3	35.4	19.5	39.5	2.5	41.3	3.1	1.0	45.6	22.2	0.2	0.2	0.8	0.4	0.2	0.1	0.3	0.1	0.3	0.1	0.4	0.3	0.1	0.0	1.3	0.0	23.6	0.4	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	19.7	0.1	0.0	0.1	9.4	0.1	0.1	0.3	0.0	3.2	0.0	0.2	0.0	0.4	0.5	0.1	1.3	0.0	3.3	1.1	1.1	0.0	0.0	0.0	0.0	4.3	0.8	22.1	0.0	1.1	0.0	0.0	1.6	0.0	45.3	0.0	0.0	0.1	0.1	0.0	21.4	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.3	0.0	26.1	0.0	0.0	0.0
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229784-34338060	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 15.2;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	6.4	4.0	5.9	11.5	7.4	26.8	5.5	7.2	7.9	11.9	2.5	5.5	7.3	5.2	7.0	18.8	4.6	5.2	7.3	6.5	7.3	15.9	3.9	9.1	10.1	8.9	7.3	4.2	3.5	3.1	5.6	4.3	9.3	3.5	6.1	31.1	6.4	3.8	10.6	7.6	9.1	4.9	6.6	12.9	6.7	25.9	7.7	15.5	9.0	10.9	11.6	8.3	17.6	8.4	4.4	5.2	3.1	4.7	10.0	11.4	2.4	5.9	15.1	4.9	7.1	3.1	7.2	3.1	5.9	7.2	4.3	44.0	7.9	5.3	5.8	1.2	5.1	24.6	14.0	7.0	6.4	14.5	24.6	6.9	9.1	14.1	29.1	10.9	14.9	6.8	5.4	6.8	6.7	1.6	1.6	11.0	2.4	3.8	5.7	7.1	5.5	3.3	5.5	11.2	7.2	5.0	7.1	0.2	1.5	7.1	2.8	4.8	9.4	5.9	4.2	21.0	1.4	6.4	6.8	1.9	6.6	10.5	2.2	15.2	1.4	2.6	0.6	1.8	0.4	1.4	0.9	0.9	0.9	2.4	1.6	1.4	23.4	0.7	0.8	1.0	3.2	1.0	5.9	7.4	7.2	7.9	6.5	7.3	8.9	7.3	9.3	6.6	7.7	8.4	16.4	22.4	21.0	30.0	32.0	1.1	4.5	1.5	7.4	15.3	5.2	4.3	8.7	5.7	4.2	5.5	85.5	3.2	11.5	8.6	0.0	5.6	15.6	9.8	7.4	17.7	6.7	35.9	47.7	4.7	1.6	7.0	17.9	22.4	5.1	8.4	16.1	7.5	13.2	8.4	52.0	7.0	2.0	37.1	3.8	8.3	8.1	25.6	0.0	50.6	34.5	8.7	15.5	40.7	58.4	13.1	9.7	8.6	29.9	6.5	18.3	16.4	4.2	56.6	19.7	7.0	4.0	39.9	21.2	14.8	0.9	1.1	18.0	4.1	7.4	43.6
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 414.0"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.3	2.7	4.8	0.0	7.0	0.0	0.3	4.8	8.0	0.3	2.7	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.1	5.3	7.9	0.7	414.0	0.0	0.2	6.8	6.1	0.6	0.3	0.0	0.8	0.0	5.4	0.0	0.0	1.7	38.0	0.0	0.0	0.1	0.0	0.0	4.8	3.3	0.0	2.3	8.4	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	7.0	4.8	8.0	5.3	7.9	6.8	6.1	5.4	4.8	8.4	3.9	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752672	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 203.0"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 414.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 55.5;SK-BR-3: 54.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.0	0.3	0.4	0.3	0.5	1.1	0.6	0.4	2.4	1.4	4.5	151.6	5.5	5.9	2.1	0.1	43.1	0.0	0.2	0.6	6.1	18.2	0.1	0.3	0.3	0.6	0.1	8.3	20.6	0.3	0.1	0.4	1.4	2.7	0.0	0.5	0.5	0.7	23.2	203.0	0.4	0.1	0.1	1.2	0.2	1.4	0.2	0.3	0.0	0.6	2.5	3.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.2	55.5	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.5	12.8	0.0	0.1	0.1	3.3	3.2	1.2	0.1	0.6	0.1	54.7	0.0	2.6	0.2	0.0	0.0	0.4	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.6	0.4	0.2	0.6	0.3	0.6	0.4	0.1	1.4	0.7	0.6	3.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	50.1	2.4	1.8	0.0	0.0	0.0	33.0	1.9	10.7	0.0	8.2	9.9	0.4	3.6	0.0	0.3	0.9	0.0	0.2	0.0	77.6	0.0	7.2	0.4	32.4	0.1	0.0	0.2	12.0	0.0	0.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.5	0.3	2.2	13.8	0.0	0.0	0.6	414.1	10.4	1.7	0.0	0.0	1.3	0.8	0.0	0.3	0.0	0.9	0.1	0.4	0.0	5.8	0.5
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036015-7040117	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 22.8;GAMG: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	1.4	1.0	1.1	2.1	0.8	0.4	1.4	1.8	1.1	1.8	1.0	2.2	9.2	0.8	1.3	5.3	1.8	3.7	1.6	0.9	1.0	6.8	36.1	2.4	2.8	1.2	1.2	0.5	1.2	2.9	0.8	1.5	1.0	1.4	1.6	0.3	3.3	0.8	0.4	5.3	5.5	0.9	0.9	3.5	1.9	0.5	1.0	1.8	3.3	0.2	2.5	1.2	2.6	0.8	13.1	22.8	5.3	3.2	3.2	1.8	2.2	1.3	3.3	2.9	6.5	7.4	14.3	8.3	2.2	2.1	26.2	20.1	4.1	7.0	1.2	10.3	2.9	3.4	1.8	18.0	3.6	1.2	7.6	2.1	7.8	4.3	3.5	3.9	11.9	7.4	4.0	2.3	3.1	6.5	5.1	2.1	2.2	6.6	1.8	2.4	1.8	1.4	2.7	3.6	0.2	1.4	4.0	2.2	1.8	7.8	6.1	1.8	4.5	1.8	4.1	3.0	1.9	4.0	8.9	0.5	5.4	3.0	0.8	0.0	0.8	1.0	1.2	0.8	0.9	1.1	1.0	1.5	0.8	2.5	1.1	1.1	0.9	1.2	0.9	1.1	1.2	0.5	1.1	0.8	1.8	1.1	0.9	1.0	1.2	1.2	1.0	0.9	1.0	0.8	2.3	0.0	1.5	0.7	5.1	0.5	0.9	1.3	4.0	0.4	1.6	0.9	0.4	1.5	0.8	5.5	0.0	1.9	2.4	1.1	0.0	1.0	0.0	0.5	0.5	2.8	0.0	0.4	1.8	0.2	0.4	0.6	4.1	0.7	3.8	1.1	2.2	8.2	0.5	3.3	1.1	1.2	2.0	0.6	3.1	0.0	0.9	1.6	0.0	1.0	1.4	0.9	6.2	0.5	0.0	0.5	0.1	0.0	2.9	0.9	2.4	1.9	1.4	0.5	0.0	0.3	1.1	0.0	0.0	7.4	1.6	2.5	4.7	0.5	1.0	1.0
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73653992	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 310.5"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.9;ASC TERT1: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	10.4	10.5	5.9	6.4	6.0	6.8	13.8	6.2	7.0	10.7	5.9	20.4	16.4	9.4	44.6	8.4	5.3	10.4	8.5	6.5	8.5	31.9	17.6	13.2	5.3	6.5	7.0	4.0	11.6	310.5	9.9	21.7	7.8	16.8	22.1	18.3	30.3	14.7	5.4	7.1	21.1	10.6	5.7	7.0	14.4	6.1	7.1	4.5	43.5	6.2	5.6	12.6	6.3	7.6	7.4	9.9	9.7	15.6	99.9	74.2	12.8	23.8	59.4	6.3	22.0	6.6	17.6	6.8	11.2	32.9	14.8	12.6	13.7	5.9	11.2	4.8	15.5	2.8	5.1	15.4	19.4	5.6	10.8	34.2	8.8	14.2	9.7	26.4	16.2	9.0	7.1	7.2	22.3	4.9	2.3	3.3	7.1	30.9	5.7	5.0	12.1	28.5	16.0	20.2	3.8	6.7	4.8	14.0	14.4	14.0	6.3	34.1	23.5	3.0	2.8	12.1	5.7	20.4	30.6	1.9	10.5	11.6	9.0	13.3	7.9	3.3	6.0	7.4	5.8	3.9	6.6	5.8	7.6	2.4	5.4	6.0	5.7	8.9	4.8	5.5	6.6	4.9	5.9	6.0	6.2	7.0	6.5	8.5	6.5	7.0	7.8	5.7	7.1	7.6	8.8	22.4	20.7	16.3	8.2	9.6	13.2	13.7	5.7	8.2	22.6	5.5	6.8	18.6	17.4	51.5	29.2	19.4	11.0	46.4	3.9	14.2	36.6	16.6	7.8	13.8	12.1	3.8	47.7	13.7	13.5	25.8	14.8	19.6	14.5	3.2	23.9	32.9	64.6	0.0	46.8	47.7	20.3	24.8	22.7	48.3	7.5	25.4	10.6	14.0	11.2	8.3	13.4	17.6	16.3	19.2	17.5	11.3	20.6	29.1	23.9	36.3	21.5	28.9	0.0	10.5	9.1	8.4	3.6	10.2	11.2	22.8	11.0	2.9	19.2	30.7
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132813339	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Hofbauer cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029747	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Cytosol	"HPA029747: AB_10600797"	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favorable (3.55e-4)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.9	8.9	21.0	6.3	21.6	4.6	9.7	22.5	28.0	9.4	23.1	9.7	14.5	6.4	5.8	13.6	9.8	11.9	3.9	21.2	22.2	12.7	7.6	5.7	7.7	21.6	22.3	6.9	9.9	12.9	8.3	15.7	21.0	5.4	10.1	2.6	13.1	4.5	3.2	9.5	10.5	5.9	22.8	8.3	16.1	2.0	25.1	7.9	10.2	3.5	8.1	11.1	7.2	22.8	6.8	6.5	10.0	0.0	1.5	3.2	5.7	2.5	7.2	4.4	13.4	14.9	13.8	0.2	9.2	1.5	7.9	17.3	13.4	15.4	3.3	10.3	27.6	3.6	11.3	16.8	7.5	3.0	0.3	9.3	13.7	7.2	14.5	7.3	13.6	20.7	40.4	2.5	3.8	9.4	10.5	0.3	14.1	15.8	8.7	15.7	11.7	11.8	36.6	11.4	21.2	0.0	12.9	25.2	20.1	6.0	8.9	0.1	6.0	1.9	5.3	2.1	5.7	8.5	0.5	0.4	11.5	0.1	1.7	0.0	14.4	0.8	4.3	3.2	8.1	6.6	6.5	6.0	19.9	9.7	9.5	6.6	0.8	3.4	0.3	15.5	11.9	8.1	21.0	21.6	22.5	28.0	21.2	22.2	21.6	22.3	21.0	22.8	25.1	22.8	10.4	0.0	6.5	93.4	15.2	10.1	10.3	30.4	22.8	5.5	13.0	7.4	3.1	40.0	20.6	27.6	2.1	53.1	8.2	5.4	9.8	32.0	0.2	12.6	4.8	7.8	16.3	49.1	32.2	15.1	19.3	7.8	20.4	5.8	0.0	5.8	18.2	15.6	65.6	0.0	25.3	11.9	32.6	21.5	9.0	0.5	6.8	26.7	14.2	27.2	11.4	9.3	5.2	51.3	4.4	14.6	6.0	4.5	6.6	8.8	7.2	6.4	27.9	3.5	0.0	8.6	4.8	0.3	0.5	25.5	10.9	28.5	7.3	21.7	15.3	13.2
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169485944	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.1;tongue: 84.9"	"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 84.5;Syncytiotrophoblasts: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favorable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	42.2	17.8	3.0	8.3	3.1	8.7	20.9	5.1	4.2	10.5	9.3	11.8	3.5	8.6	6.1	11.3	21.3	25.8	31.2	4.0	3.6	13.0	37.1	19.5	2.6	4.9	3.7	20.5	22.2	24.8	19.0	18.1	4.0	10.5	4.3	7.5	12.5	3.8	124.1	16.5	11.4	6.1	3.7	2.8	19.2	7.8	4.2	4.1	15.7	84.9	2.8	18.1	12.9	3.5	7.4	5.1	11.4	9.0	34.4	12.7	25.0	5.8	4.3	4.6	6.5	20.9	7.6	6.5	6.4	3.9	8.5	7.7	13.9	8.5	5.1	18.8	13.0	6.2	16.7	19.3	18.7	15.8	5.9	15.0	12.2	7.4	18.8	6.4	7.0	11.3	25.3	4.1	7.9	5.0	8.2	7.1	25.8	14.1	7.7	0.0	24.6	7.5	12.2	15.5	9.9	13.3	8.0	13.6	29.2	12.8	8.5	10.1	5.8	5.5	7.7	6.9	11.4	5.6	5.6	2.1	8.1	6.0	7.4	0.0	0.6	1.1	0.3	0.2	1.1	0.4	0.4	0.7	0.7	0.4	1.0	1.0	0.4	0.9	2.0	0.2	0.3	0.2	3.0	3.1	5.1	4.2	4.0	3.6	4.9	3.7	4.0	3.7	4.2	3.5	13.6	9.6	19.3	11.8	7.3	29.6	16.5	4.4	43.9	5.3	34.1	13.6	27.7	7.2	11.4	5.5	2.1	26.9	11.3	10.6	0.0	7.4	4.3	22.6	9.7	3.7	9.0	5.2	15.6	5.3	4.5	52.7	49.5	42.7	10.2	4.1	1.1	29.8	7.0	6.7	22.8	6.4	12.2	2.9	8.8	2.7	6.8	18.3	21.4	7.5	1.0	2.5	2.1	16.1	3.3	9.6	5.4	4.9	14.0	16.5	5.6	2.0	12.7	5.1	0.0	84.5	14.2	6.7	4.1	35.2	50.4	156.4	7.5	3.1	6.7	28.9
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718028	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.7;breast: 28.4;placenta: 24.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 65.4;Syncytiotrophoblasts: 160.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.9;BEWO: 6.2;CACO-2: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	46.7	0.6	5.0	1.9	3.3	1.2	28.4	4.7	4.3	0.5	1.0	2.6	9.1	0.5	0.1	0.7	0.5	5.7	0.7	3.4	4.4	2.2	13.8	4.1	0.8	5.2	4.2	0.9	1.7	0.1	0.1	24.1	5.4	0.3	1.8	2.2	1.1	0.1	0.9	1.6	5.6	0.4	4.4	0.5	0.5	0.5	5.7	0.2	0.4	0.8	0.4	1.0	0.4	4.0	0.3	0.9	0.2	0.8	13.9	0.3	6.2	0.1	0.2	0.2	0.6	20.2	0.4	0.2	0.1	0.1	4.6	0.4	0.6	0.5	0.8	0.0	1.0	0.1	1.1	0.8	1.8	0.2	0.1	3.4	0.4	0.1	0.8	0.3	0.0	0.3	0.1	0.6	0.0	1.6	0.1	0.5	3.0	0.7	0.1	0.3	0.1	0.2	0.2	0.2	0.9	0.1	0.3	1.9	0.5	2.6	0.2	0.2	0.6	0.4	0.4	4.1	0.4	0.1	0.1	0.6	1.4	0.2	0.5	6.8	0.8	1.0	0.4	0.6	0.3	0.8	0.4	0.4	0.2	1.3	0.5	0.5	3.3	2.2	0.7	1.0	0.2	0.3	5.0	3.3	4.7	4.3	3.4	4.4	5.2	4.2	5.4	4.4	5.7	4.0	0.2	9.6	5.1	2.3	0.0	0.0	0.5	0.0	0.6	5.3	0.2	0.1	0.4	5.7	0.0	1.8	0.0	65.4	0.1	5.7	1.9	4.4	0.3	0.1	0.0	2.6	1.2	0.0	0.4	0.0	7.4	3.2	0.0	0.1	0.0	0.3	0.0	13.1	5.1	0.0	0.9	1.6	0.0	0.6	0.0	0.7	0.3	0.9	0.0	25.3	0.0	0.8	0.0	4.5	0.3	0.4	1.0	0.0	0.1	0.4	9.3	3.0	0.0	0.2	0.0	1.7	1.6	0.0	0.3	0.0	0.0	160.6	0.2	0.1	6.5	0.4
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 20.5;testis: 21.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 34.9;Erythroid cells: 60.4;Late spermatids: 31.8;Spermatocytes: 43.1"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7;classical monocyte: 6.9"	"Group enriched"	"Detected in many"	56	"dendritic cells: 4.0;granulocytes: 5.7;monocytes: 6.9"	"Group enriched"	"Detected in some"	18	"NB-4: 16.9;REH: 14.6;THP-1: 53.1;U-937: 30.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036902	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"		"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	0.3	0.0	0.1	0.6	0.2	20.5	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.0	3.8	0.0	0.5	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.2	0.5	0.0	21.4	0.1	1.2	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	30.9	0.0	5.7	6.9	1.3	0.0	1.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.4	0.1	0.0	0.0	60.4	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	1.8	0.5	31.8	1.5	1.1	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	43.1	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0
SLC22A23	"C6orf85, FLJ22174"	ENSG00000137266	"Solute carrier family 22 member 23"	A1A5C7	6	3268962-3457050	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.8;Late spermatids: 229.3;Oligodendrocytes: 285.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014697	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	Cytosol	"HPA014697: AB_1844371"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (5.16e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.53e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (8.91e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	7.3	3.4	17.7	4.5	28.9	9.6	8.4	25.4	25.0	9.1	1.8	18.4	20.7	4.1	12.2	23.7	11.0	4.9	3.6	16.2	18.6	7.7	18.1	8.3	4.4	29.9	29.7	4.1	15.5	27.1	8.8	8.5	30.4	18.6	14.8	4.8	14.6	2.4	8.9	17.1	22.4	2.8	22.1	6.3	26.5	11.5	30.2	7.2	5.6	7.8	5.9	4.3	15.5	50.9	4.3	10.1	20.1	22.6	7.2	7.8	26.6	0.7	0.3	1.2	0.5	22.5	0.7	1.0	2.5	4.8	18.2	6.1	4.2	10.8	0.4	3.5	13.1	10.4	3.9	18.9	1.0	0.7	0.6	2.0	21.3	19.4	1.0	4.3	0.7	5.4	9.6	5.3	0.7	5.3	1.0	2.4	7.1	23.2	3.9	2.2	1.3	18.1	0.1	26.9	2.4	0.3	5.7	7.8	7.0	20.9	31.8	0.2	5.6	12.0	4.0	15.9	2.6	12.7	0.2	0.4	21.2	0.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.2	17.7	28.9	25.4	25.0	16.2	18.6	29.9	29.7	30.4	22.1	30.2	50.9	22.6	6.4	17.5	46.7	1.0	11.6	5.0	18.7	4.6	8.0	9.5	8.1	2.8	10.0	18.0	5.5	8.4	16.1	0.5	43.3	0.0	2.9	86.8	11.6	2.5	8.2	4.2	11.0	59.9	8.0	1.3	1.9	39.8	4.1	0.0	13.1	6.4	12.7	12.9	0.0	67.4	49.7	12.2	13.0	3.0	229.3	1.8	4.8	3.6	77.8	6.4	8.6	0.0	45.8	285.5	6.1	20.5	0.7	0.4	13.9	34.3	4.2	42.0	3.5	0.0	4.5	2.6	2.5	1.2	10.3	12.6	9.2	1.3	0.1	25.3	4.5
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348378-160452577	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 67.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 78.9;Hepatocytes: 68.8;Leydig cells: 33.8;Pancreatic endocrine cells: 57.3;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;HeLa: 38.1;Hep G2: 23.7;OE19: 12.0;RPTEC TERT1: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	11.7	15.2	2.1	3.8	2.7	0.0	6.6	3.3	2.1	15.9	1.8	8.8	1.7	18.4	27.6	7.7	18.7	11.0	1.5	2.0	3.5	6.3	34.9	16.4	16.2	6.2	3.8	21.1	0.7	0.2	1.3	44.3	4.5	43.4	2.4	0.2	51.8	52.6	67.4	10.7	5.7	26.3	3.3	0.6	6.0	2.6	4.2	0.5	2.0	8.5	4.9	6.2	15.7	3.2	0.0	27.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.4	0.0	0.0	0.0	38.1	23.7	1.2	0.0	0.0	0.8	6.9	3.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	12.0	7.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.7	3.3	2.1	2.0	3.5	6.2	3.8	4.5	3.3	4.2	3.2	0.6	16.0	78.9	6.2	0.1	4.7	0.3	2.1	2.8	0.2	0.2	0.3	2.9	5.7	6.4	0.0	0.0	0.3	0.1	0.2	5.9	8.2	0.6	0.2	10.2	1.0	0.0	0.0	0.5	3.0	0.3	10.0	12.8	0.3	2.5	0.8	0.0	68.8	0.7	0.0	25.1	1.6	2.0	1.0	2.4	1.6	33.8	0.3	3.6	7.5	0.0	0.0	0.0	19.6	0.2	57.3	0.1	24.5	0.1	6.1	2.1	2.9	0.8	0.1	0.0	29.8	12.3	0.3	0.2	3.7	6.7	0.4	1.2	0.0	2.8	0.8
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212642-19722926	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.7"	"Group enriched"	"Detected in many"	9	"Astrocytes: 134.5;Inhibitory neurons: 327.0;Oligodendrocyte precursor cells: 375.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"basophil: 5.8;eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	10.4	3.1	16.2	4.0	11.7	1.4	4.9	13.3	56.1	17.8	2.7	10.8	3.8	28.3	24.3	20.6	20.0	13.0	1.1	81.7	18.6	1.1	0.7	5.5	1.0	13.6	19.2	14.6	0.7	7.5	1.2	3.0	9.1	10.9	5.4	7.3	4.7	17.5	40.9	7.0	5.0	29.1	10.3	2.4	3.8	1.5	34.8	1.9	3.0	16.9	2.7	8.6	8.9	5.4	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.8	13.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	18.2	0.0	0.0	0.7	0.0	75.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	9.0	0.0	0.6	17.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.2	11.7	13.3	56.1	81.7	18.6	13.6	19.2	9.1	10.3	34.8	5.4	0.2	3.2	1.1	134.5	0.1	1.1	1.1	0.4	0.0	19.1	5.0	2.3	0.4	0.0	1.3	1.8	0.0	8.5	0.1	0.3	0.0	0.1	17.0	1.2	29.8	0.4	7.7	3.4	11.8	0.0	0.3	1.9	0.0	1.6	26.6	0.1	0.4	0.0	0.6	1.7	327.0	4.1	0.0	0.0	0.7	18.3	3.7	1.1	0.0	12.2	0.0	3.1	0.0	375.5	2.4	0.2	2.8	4.1	0.4	0.8	0.4	0.0	0.0	2.2	0.0	2.7	3.0	0.5	0.8	2.9	4.1	3.4	0.4	0.1	0.7	3.8
SLC25A36	"FLJ10618, PNC2"	ENSG00000114120	"Solute carrier family 25 member 36"	Q96CQ1	3	140941830-140980995	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027036	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Mitochondria, Cytosol"	Nucleoplasm	"HPA027036: AB_1857048"	"unprognostic (4.12e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (1.55e-4)"	27.1	22.2	16.6	14.3	16.2	61.6	33.5	16.2	22.7	31.9	13.9	25.7	30.9	34.4	47.7	15.0	32.6	18.4	39.8	16.1	20.1	38.7	4.2	27.5	21.3	17.0	16.4	39.0	45.2	28.9	26.9	26.4	17.5	27.1	19.5	42.6	23.4	20.8	38.4	22.5	22.9	19.2	16.9	20.1	34.0	23.8	18.2	20.6	31.8	20.8	17.6	23.0	23.9	21.5	52.3	11.5	36.0	30.8	33.0	40.7	46.2	19.4	23.6	18.2	27.3	28.6	24.0	42.1	46.9	17.3	31.2	34.9	40.1	15.2	40.6	33.8	36.5	33.9	29.8	20.9	45.9	48.8	21.3	44.1	61.1	15.4	45.8	44.4	22.0	32.0	17.6	27.4	29.2	22.8	30.6	34.1	37.8	12.8	18.4	34.2	32.0	59.6	23.5	17.7	22.4	38.2	26.7	45.1	80.9	30.3	32.6	29.2	24.1	29.5	17.1	52.2	19.0	56.4	36.8	51.2	36.0	21.1	15.0	10.7	9.2	15.1	9.6	11.5	11.8	16.3	9.6	10.2	14.0	15.1	13.5	12.6	1.7	18.3	13.5	9.7	9.9	9.8	16.6	16.2	16.2	22.7	16.1	20.1	17.0	16.4	17.5	16.9	18.2	21.5	60.3	99.3	143.0	85.5	47.6	68.2	68.0	38.1	116.7	106.0	72.2	77.5	90.3	38.6	52.0	71.7	133.5	58.8	58.2	22.7	64.6	26.4	10.6	113.4	78.0	45.8	59.3	27.3	127.7	38.3	38.0	73.9	58.1	106.3	65.9	92.8	35.7	0.5	26.5	92.5	115.6	32.5	30.5	38.2	45.8	16.0	59.7	38.4	56.9	46.9	36.9	68.2	25.7	108.6	109.1	29.3	22.8	59.5	48.2	88.9	44.9	57.5	98.8	121.8	59.2	80.0	59.2	59.4	68.8	61.3	54.4	49.4	49.1	83.2	46.8	78.9
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528956-23575463	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 707.8;Erythroid cells: 4197.2;Late spermatids: 1087.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 57.7"	"Lineage enriched"	"Detected in all"	19	"granulocytes: 57.7"	"Cell line enhanced"	"Detected in all"		"HEL: 118.7;hTERT-RPE1: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045680	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	Cytosol	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	14.5	41.9	13.5	16.5	16.9	138.4	17.9	13.4	21.0	26.8	15.2	11.4	50.6	9.8	6.0	9.9	17.2	6.7	15.3	13.4	14.0	20.1	25.2	26.4	6.0	15.0	14.1	23.0	29.5	10.9	15.0	8.0	15.4	35.5	5.7	10.3	36.7	7.5	16.2	10.1	21.8	5.7	13.0	46.1	11.1	6.8	15.0	2.8	14.6	12.7	5.0	13.4	20.4	14.6	9.6	10.3	10.7	9.9	13.7	16.8	15.7	7.4	9.6	5.3	5.9	10.4	19.9	15.3	8.7	6.3	34.5	12.0	9.9	20.0	7.2	2.3	4.9	118.7	19.4	3.7	11.5	6.7	4.4	14.5	19.2	11.6	11.5	65.9	8.4	12.3	26.3	7.5	8.5	4.2	8.1	28.1	5.4	11.6	7.5	8.3	5.3	6.0	16.4	5.2	3.2	4.6	10.1	15.2	7.6	10.0	4.4	10.3	13.3	25.6	3.8	15.3	14.5	5.9	2.4	9.4	24.1	16.1	16.5	1.4	3.0	2.7	1.1	1.1	0.9	2.3	0.6	0.5	2.8	1.5	2.1	1.2	57.7	1.3	1.5	0.6	1.3	1.4	13.5	16.9	13.4	21.0	13.4	14.0	15.0	14.1	15.4	13.0	15.0	14.6	43.5	38.5	61.7	36.6	45.5	93.3	125.2	95.8	28.5	35.6	120.0	49.1	35.6	61.5	75.8	77.3	68.8	44.6	19.1	78.4	15.6	93.8	707.8	33.1	68.6	94.5	20.4	4197.2	44.0	226.4	76.4	95.4	43.8	50.0	36.8	49.7	151.3	38.8	41.7	6.7	37.3	44.7	36.7	59.0	141.2	1087.9	52.5	86.8	69.4	73.1	45.5	30.5	10.3	16.1	21.9	176.9	47.7	37.2	24.0	347.1	189.0	34.1	42.5	59.7	19.7	55.9	52.3	24.6	42.3	23.3	53.8	18.3	32.4	86.7	70.3	137.6
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399336-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.7;Oligodendrocyte precursor cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035188, HPA078530"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA035188: AB_10602400, HPA078530: "	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	10.6	2.6	3.1	7.3	3.4	1.8	9.3	3.3	4.1	8.2	5.4	14.0	14.2	5.0	3.4	21.4	5.3	4.3	5.0	3.2	3.6	7.7	10.6	10.2	5.5	4.3	3.5	6.0	5.9	6.9	1.9	8.3	3.9	4.6	15.5	0.5	10.8	4.6	1.6	16.3	12.8	8.8	3.5	4.9	8.9	2.1	3.6	3.6	4.2	4.5	11.3	7.9	11.3	3.8	32.4	23.3	1.9	9.2	30.0	44.5	12.2	17.9	21.7	13.8	13.2	12.4	16.0	4.0	10.2	47.4	41.1	23.2	18.2	16.0	12.4	28.5	5.4	11.3	7.4	16.4	19.3	10.6	11.7	18.8	28.3	22.5	19.8	18.9	16.6	6.1	2.3	17.1	15.7	58.9	0.1	15.9	10.3	16.6	35.1	3.2	0.0	4.6	22.3	10.9	1.5	0.0	23.0	47.8	29.1	7.3	8.5	11.0	24.2	22.2	7.1	25.0	28.0	0.4	14.2	8.3	22.3	17.8	19.7	0.0	3.5	0.2	0.9	4.9	1.7	4.4	1.8	2.9	6.0	3.7	0.9	1.8	0.1	6.4	11.2	1.6	1.5	1.6	3.1	3.4	3.3	4.1	3.2	3.6	4.3	3.5	3.9	3.5	3.6	3.8	8.3	6.4	9.7	30.7	8.0	7.8	7.3	8.9	9.6	0.2	6.1	6.6	1.6	2.8	5.6	3.7	0.0	11.9	9.1	21.8	9.8	4.5	0.0	0.9	7.6	6.9	7.3	3.4	10.3	8.9	7.1	11.8	9.7	1.8	8.2	2.1	6.4	5.8	10.3	0.0	6.2	9.6	4.1	7.1	13.6	0.4	8.1	7.5	10.6	1.0	11.9	0.2	9.2	36.7	1.4	13.9	11.4	5.7	2.8	5.4	19.8	9.6	2.0	0.4	0.0	7.8	9.2	0.5	2.3	19.8	13.9	6.8	6.8	1.0	12.2	5.8
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 46.7;NK-cells: 103.0;Proximal enterocytes: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.5;Karpas-707: 22.8;RPMI-8226: 17.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA042495, HPA050821"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA042495: , HPA050821: AB_2681249"	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	3.7	3.3	3.1	5.8	3.3	4.9	4.7	2.8	4.1	1.9	2.6	3.4	5.6	1.8	2.5	2.5	2.0	2.0	3.8	3.1	3.1	6.5	12.1	3.9	10.1	3.7	3.1	1.9	34.2	3.0	6.6	1.9	3.5	3.8	1.8	0.3	6.3	1.9	7.1	2.9	7.6	1.3	3.3	13.3	2.8	1.9	3.1	8.0	12.1	3.7	6.6	2.0	1.9	4.0	0.4	5.8	0.2	8.5	1.5	0.7	4.2	1.0	2.6	0.5	0.5	1.4	2.7	5.2	4.7	2.4	2.1	0.8	0.6	0.4	0.0	17.5	1.2	5.7	3.2	0.4	0.9	1.8	5.7	1.9	0.1	0.7	0.5	0.4	0.9	9.9	0.8	22.8	0.9	1.9	4.2	0.1	0.3	0.3	2.6	7.7	1.1	17.1	0.9	0.1	2.8	3.7	1.8	4.5	1.0	0.5	2.4	0.9	1.7	0.6	2.0	5.5	0.4	9.5	6.4	1.5	1.7	1.3	3.3	10.5	6.3	4.8	8.8	11.2	9.3	10.6	7.8	8.5	6.9	11.9	12.4	9.3	3.9	17.1	13.3	23.0	7.7	3.1	3.1	3.3	2.8	4.1	3.1	3.1	3.7	3.1	3.5	3.3	3.1	4.0	5.0	0.0	5.6	0.3	40.0	2.8	5.9	4.2	3.4	12.3	10.7	7.7	5.6	8.6	4.7	12.9	0.0	2.1	46.7	14.4	0.0	5.9	5.1	6.2	3.1	6.0	6.7	3.0	5.2	5.4	1.7	7.7	5.6	7.9	4.5	21.8	6.8	14.0	7.3	6.7	0.6	16.7	4.1	9.7	14.4	3.9	6.8	11.7	5.4	4.7	18.4	5.5	103.0	1.5	3.9	5.2	12.5	3.8	15.3	7.0	90.9	6.9	12.3	0.4	6.6	12.6	3.6	2.2	0.4	2.2	2.0	1.5	31.6	11.8	13.3	4.6
SLC27A1	"ACSVL5, FATP, FATP1, FLJ00336, MGC71751"	ENSG00000130304	"Solute carrier family 27 member 1"	Q6PCB7	19	17468769-17506168	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Oligodendrocytes: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.7;SK-MEL-30: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076520			Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Mitochondria, Cytosol"	"HPA076520: AB_2732311"	"unprognostic (1.48e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	18.5	24.2	32.9	4.5	41.5	1.5	19.3	37.3	39.0	22.0	45.9	15.2	3.6	13.1	2.9	8.5	17.0	8.2	29.0	32.0	32.8	10.9	7.9	10.4	4.7	41.1	40.3	33.0	14.4	17.7	19.3	6.2	38.6	23.2	1.8	4.0	24.1	10.3	24.9	14.4	7.6	3.9	34.4	10.5	13.7	17.5	35.9	2.2	16.8	12.4	1.6	13.9	14.0	46.7	6.2	3.0	4.1	9.8	27.7	15.2	3.5	4.4	11.2	4.8	7.2	0.5	18.2	2.1	8.1	7.2	4.3	7.3	0.4	6.8	1.3	2.4	1.4	1.2	0.5	2.3	5.4	0.5	6.4	14.1	4.6	4.8	1.9	19.7	3.3	3.9	0.8	1.3	3.2	2.5	3.3	4.9	1.2	6.0	5.2	4.7	3.2	1.4	3.2	1.8	1.4	2.9	3.0	1.5	47.8	2.5	5.2	1.6	2.1	9.4	6.1	7.5	3.0	4.0	3.1	0.7	9.6	5.3	6.7	0.0	9.2	0.2	1.4	4.0	2.6	0.4	1.0	1.7	6.3	0.3	1.3	1.7	0.0	1.6	1.8	6.5	0.7	4.6	32.9	41.5	37.3	39.0	32.0	32.8	41.1	40.3	38.6	34.4	35.9	46.7	19.7	3.2	11.9	84.5	1.8	6.6	14.1	12.7	10.2	8.4	15.5	26.9	19.5	11.5	11.1	9.2	27.1	4.3	8.3	1.2	1.9	11.1	1.1	8.4	6.9	7.8	5.4	0.8	16.1	4.8	15.6	10.4	9.2	4.9	2.5	8.4	10.4	8.1	26.1	6.7	23.9	3.0	6.1	22.4	4.0	2.5	21.5	13.4	8.8	15.0	14.7	11.6	4.1	37.2	67.5	5.2	0.6	11.7	1.7	12.0	0.1	3.6	16.1	17.7	6.6	10.9	7.3	9.1	5.8	5.0	4.5	2.3	4.9	13.8	2.2	8.7
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252234-45277846	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 92.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Paneth cells: 35.7;Proximal enterocytes: 43.4;Undifferentiated cells: 48.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046068, HPA055623"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.4	0.7	0.4	0.1	0.0	0.3	0.4	2.6	0.0	9.5	68.0	0.5	0.4	0.1	0.1	9.8	0.3	0.3	0.1	3.5	0.8	0.1	0.3	0.4	0.0	0.3	0.3	0.0	0.0	0.6	0.4	0.1	34.6	0.7	0.2	0.0	0.3	0.3	92.3	0.0	0.1	0.2	22.8	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.4	0.1	0.2	0.6	0.5	0.0	8.1	1.6	0.9	0.1	0.4	0.4	0.0	2.9	0.3	0.0	0.7	8.6	4.5	0.0	2.1	12.3	0.3	19.6	0.0	0.1	0.7	1.0	0.4	1.0	13.9	2.7	1.8	0.0	2.7	1.0	4.6	1.2	8.8	0.7	0.7	0.3	0.9	1.7	1.5	14.5	0.0	0.3	0.4	0.4	0.0	1.3	0.0	0.0	0.2	1.0	2.1	2.0	2.0	0.0	35.7	0.7	0.4	0.2	43.4	1.2	4.6	6.6	0.0	0.3	0.2	2.4	2.1	0.0	0.3	4.7	1.3	0.2	48.9	0.2
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.2;epididymis: 68.5;testis: 35.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.4;Early spermatids: 17.8;Excitatory neurons: 15.6;Late spermatids: 42.4;Peritubular cells: 15.1;Spermatocytes: 16.6;Spermatogonia: 10.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.3"	"Group enriched"	"Detected in many"	10	"amygdala: 14.5;basal ganglia: 10.3;cerebral cortex: 18.2;hippocampal formation: 22.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HAP1: 11.2;Hep G2: 12.0;REH: 22.8;RH-30: 11.0"	"Group enriched"	"Detected in all"	4	"amygdala: 130.7;basal ganglia: 48.2;cerebral cortex: 110.9;hippocampal formation: 69.1;white matter: 34.7"	"Group enriched"	"Detected in many"	6	"amygdala: 18.5;cerebral cortex: 55.5;hippocampal formation: 43.0"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.1	2.1	14.5	0.1	10.3	0.3	0.1	0.0	18.2	0.2	0.0	0.1	0.0	0.4	68.5	0.1	0.3	0.1	7.9	22.2	0.0	0.1	0.2	0.2	0.5	0.5	0.0	0.2	0.0	0.5	0.3	0.0	0.8	0.3	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	35.2	0.0	0.0	0.2	0.0	0.1	0.0	0.2	1.5	0.4	1.3	0.1	2.0	0.2	0.2	0.3	0.0	0.0	1.3	1.4	0.5	0.5	0.0	0.1	0.0	8.8	0.3	11.2	0.0	0.3	0.0	1.2	5.9	0.5	12.0	0.2	0.2	2.3	0.0	0.0	0.6	0.0	0.2	0.9	2.9	1.7	0.1	0.2	3.9	0.1	0.4	1.8	0.4	0.0	22.8	11.0	1.4	0.0	0.3	0.0	0.7	2.8	0.0	0.0	0.1	0.0	0.8	0.1	0.3	5.1	0.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	14.5	10.3	0.0	18.2	22.2	0.0	0.5	0.0	0.8	0.0	0.0	1.5	0.3	0.0	0.0	2.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	17.8	0.0	0.1	0.4	0.0	0.0	15.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.4	42.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	15.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	16.6	10.7	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SLC32A1	"bA122O1.1, VGAT, VIAAT"	ENSG00000101438	"Solute carrier family 32 member 1"	Q9H598	20	38724486-38729372	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.7;Horizontal cells: 58.9;Inhibitory neurons: 20.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037156, HPA058859, HPA059985"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187"					"unprognostic (1.13e-2)"					"unprognostic (2.09e-1)"				"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"			0.0	0.0	12.4	0.0	39.8	0.2	0.0	3.4	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	36.5	0.3	0.0	0.0	0.0	14.2	6.8	0.0	0.0	0.0	7.6	0.0	8.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.4	39.8	3.4	22.0	2.4	36.5	14.2	6.8	8.7	6.3	5.1	1.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	14.7	0.0	0.0	0.4	0.0	0.1	0.0	4.2	0.0	1.3	0.0	0.0	0.0	2.5	0.2	0.0	0.4	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.9	20.7	0.0	0.0	0.0	0.4	0.6	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.1	0.0	0.0	0.1	2.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042430	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Vesicles, Cytosol"		"HPA042430: AB_10806238"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	8.8	11.0	3.9	4.9	4.8	2.9	8.4	4.6	4.7	12.3	9.2	7.2	6.9	8.8	12.9	8.0	9.5	7.8	7.6	4.6	5.3	10.4	17.2	8.4	5.0	4.4	4.2	8.0	30.9	11.6	5.9	6.6	4.6	8.3	6.4	6.8	11.2	11.0	4.7	6.4	7.7	7.1	5.2	5.8	8.8	5.4	5.2	7.1	18.8	4.8	6.2	6.8	7.9	7.3	18.9	17.7	7.3	8.3	24.4	23.5	12.9	13.1	21.2	19.8	18.7	8.5	22.0	9.9	24.1	13.1	19.8	17.1	14.3	15.2	20.8	16.5	13.3	11.3	6.5	15.8	41.5	13.3	8.9	18.4	26.7	9.7	49.5	20.5	19.8	12.4	8.6	27.8	14.3	14.3	5.0	3.7	6.8	17.7	14.9	5.6	8.1	29.1	9.7	11.8	7.9	5.9	11.1	24.5	21.4	11.3	8.1	11.2	21.4	10.1	4.9	17.9	13.1	33.2	14.4	12.3	14.6	8.8	14.0	12.7	8.4	6.2	8.9	6.3	9.6	5.4	6.0	6.8	10.4	3.5	5.4	5.5	1.7	6.6	6.5	16.1	5.7	5.9	3.9	4.8	4.6	4.7	4.6	5.3	4.4	4.2	4.6	5.2	5.2	7.3	9.0	22.4	25.0	16.0	14.8	8.9	11.7	20.8	18.2	17.5	16.0	9.0	23.8	18.6	21.5	11.0	27.1	18.2	21.1	14.2	5.9	15.3	13.7	11.2	20.3	13.7	12.5	8.4	17.9	15.4	28.3	19.7	20.9	16.6	12.0	12.8	16.4	64.3	19.5	18.5	17.4	18.1	12.2	14.7	15.8	13.2	18.6	15.2	12.4	10.3	19.0	15.4	12.3	11.1	20.8	14.4	5.3	21.4	33.3	19.5	18.9	17.1	23.4	23.0	13.1	16.0	16.0	19.5	9.2	12.2	9.5	37.6	15.3	10.2	13.9	10.9
SLC35A4		ENSG00000176087	"Solute carrier family 35 member A4"	"L0R6Q1, Q96G79"	5	140564446-140569100	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062210			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA062210: AB_2684712"	"unprognostic (3.01e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.56e-5)"	"unprognostic (2.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.55e-1)"	45.6	62.1	34.0	39.8	37.3	23.2	42.2	38.9	35.6	36.7	29.9	51.6	45.6	38.0	31.3	69.1	39.4	33.9	72.2	31.5	36.7	58.6	53.8	46.3	42.0	39.6	38.7	32.7	44.3	59.4	24.1	33.1	38.2	41.1	47.5	19.5	66.0	33.6	138.5	64.3	44.0	36.1	36.9	47.5	46.4	45.1	38.0	44.3	44.6	94.1	44.4	42.2	41.6	34.9	43.9	134.2	57.5	124.6	77.5	43.0	92.4	60.8	45.5	84.3	91.3	186.2	57.0	115.7	80.0	65.7	105.2	55.2	0.0	107.7	59.3	155.0	96.7	91.3	109.1	1.3	74.7	91.7	83.7	65.5	92.6	83.3	71.0	38.2	74.2	73.0	83.6	136.4	80.5	98.3	110.5	62.7	43.5	74.2	92.1	82.5	93.5	129.2	69.1	79.5	66.6	91.1	79.8	157.1	84.0	50.4	131.4	52.7	69.3	78.2	52.9	70.0	78.7	57.8	127.8	53.9	54.0	127.6	91.9	16.6	65.0	37.0	56.5	83.1	54.4	29.9	45.5	52.1	75.5	32.7	53.5	49.3	24.5	63.4	79.4	28.3	33.7	83.4	34.0	37.3	38.9	35.6	31.5	36.7	39.6	38.7	38.2	36.9	38.0	34.9	13.0	12.8	22.4	4.9	17.0	10.5	23.2	20.3	15.4	13.7	21.1	15.4	30.0	32.9	21.8	16.5	4.2	32.1	13.2	56.4	45.0	33.3	71.3	9.4	11.8	18.1	25.2	19.0	3.3	35.1	50.2	16.2	24.5	15.5	21.0	14.3	25.4	25.0	32.9	13.5	3.5	27.9	20.3	24.2	13.3	127.2	12.5	18.9	17.8	5.6	27.6	28.6	44.3	3.5	5.7	39.5	26.4	12.4	15.7	22.1	33.5	39.9	10.5	10.3	32.9	11.8	15.0	9.7	17.5	20.4	11.6	30.5	17.6	18.1	38.5	28.8
SLC35E4		ENSG00000100036	"Solute carrier family 35 member E4"	Q6ICL7	22	30635781-30669016	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 122.2;Late spermatids: 108.6;Spermatocytes: 55.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.8;U-2197: 21.0;U-87 MG: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049558	Approved		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA049558: AB_2680817"	"unprognostic (2.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-4)"	"unprognostic (5.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-7)"	"unprognostic (2.77e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.05e-3)"	2.6	1.8	3.5	1.4	5.0	1.5	2.2	2.9	6.7	2.6	0.4	3.2	1.0	3.5	1.3	2.8	2.5	1.1	3.4	4.1	3.5	2.4	0.5	2.0	0.8	4.7	4.5	1.9	1.7	1.7	2.3	0.4	4.7	2.3	1.7	1.5	2.1	1.3	11.1	5.3	1.8	1.4	1.9	1.9	3.4	22.9	4.5	0.3	1.6	2.8	0.5	3.1	2.8	7.3	10.0	4.3	1.6	3.2	4.3	10.9	0.9	6.4	5.6	4.3	4.0	0.3	2.6	0.7	3.4	6.6	6.1	6.2	2.8	3.7	2.2	22.8	3.1	0.1	3.3	0.3	6.1	0.4	2.7	3.5	1.6	17.3	5.4	6.8	14.9	0.8	0.9	2.8	6.8	2.8	0.4	1.9	1.9	2.9	16.2	1.8	3.2	0.3	2.0	0.8	8.7	3.4	6.6	2.8	3.2	0.7	2.0	0.7	20.0	18.2	5.8	21.0	6.2	0.8	0.9	0.3	22.3	0.3	4.9	0.6	0.6	0.1	0.2	0.8	0.4	0.0	0.6	0.9	1.1	0.1	0.5	0.5	0.2	0.6	0.7	0.3	0.7	0.3	3.5	5.0	2.9	6.7	4.1	3.5	4.7	4.5	4.7	1.9	4.5	7.3	5.7	0.0	1.5	2.6	2.7	14.5	2.5	1.9	8.0	10.6	2.0	3.7	1.9	0.0	1.2	1.8	22.9	0.1	4.8	5.4	0.0	3.4	122.2	6.0	4.9	9.1	2.4	0.8	4.2	2.3	0.5	3.7	2.6	2.0	1.3	4.1	4.2	0.3	1.8	11.8	4.9	4.4	2.0	1.2	7.7	108.6	3.4	8.0	3.6	4.7	2.5	17.2	1.0	2.5	9.2	2.5	11.1	3.8	3.1	1.7	1.2	0.4	5.7	10.5	0.0	3.9	5.0	55.1	3.8	4.2	19.0	0.1	4.9	2.4	5.0	2.1
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907264-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3;retina: 13.2"	"Group enriched"	"Detected in some"	17	"Astrocytes: 380.0;Excitatory neurons: 394.8;Inhibitory neurons: 503.6;Oligodendrocyte precursor cells: 1344.6"	"Cancer enriched"	"Detected in some"	4	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 47.8;WM-115: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	1.4	1.2	17.1	0.9	19.0	0.0	0.6	6.3	21.3	1.2	0.6	4.9	0.4	1.2	3.0	0.6	1.8	0.6	3.4	16.2	11.0	0.6	0.0	0.1	0.0	8.5	12.4	0.3	0.4	0.1	0.5	0.0	8.3	1.2	0.9	13.2	0.5	1.3	0.3	0.4	1.4	1.1	9.0	0.7	1.1	0.6	12.3	0.0	0.6	0.3	0.0	0.7	0.9	16.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.0	0.9	0.0	0.0	0.4	0.0	6.1	6.9	0.0	0.0	0.3	0.0	81.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	19.0	6.3	21.3	16.2	11.0	8.5	12.4	8.3	9.0	12.3	16.4	0.9	0.0	0.0	380.0	0.1	0.4	0.1	0.0	0.0	15.8	0.1	0.0	6.9	0.0	1.3	0.0	2.1	0.0	0.3	0.0	0.0	0.0	17.9	0.0	0.2	0.2	0.0	0.0	394.8	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.8	503.6	0.0	0.0	0.0	0.0	38.3	0.6	0.3	14.2	27.2	0.0	27.6	0.0	1344.6	10.3	0.0	0.0	1.2	0.1	1.0	0.0	0.1	0.0	2.2	0.0	1.1	5.4	3.0	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1
SLC35F6	"ANT2BP, C2orf18, FLJ20555, TANGO9"	ENSG00000213699	"Solute carrier family 35 member F6"	Q8N357	2	26764284-26781231	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 129.9;Karpas-707: 117.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034655	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Cytosol"	"HPA034655: AB_10696359"	"unprognostic (2.26e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.11e-4)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-2)"	18.6	20.7	9.6	7.3	10.5	4.6	16.2	10.1	9.2	14.5	8.4	10.1	7.9	11.9	7.3	22.0	10.7	7.3	13.8	9.6	11.8	19.5	17.7	11.9	6.5	13.9	12.9	8.5	10.3	21.3	10.8	9.4	12.3	11.4	5.7	5.8	14.5	8.1	12.8	21.2	10.0	10.1	10.4	10.8	11.3	5.1	13.0	5.7	16.0	9.9	7.6	12.1	13.0	11.6	24.6	43.6	12.3	32.6	41.7	19.4	20.4	14.9	20.3	16.8	15.2	27.9	44.5	6.6	23.4	18.7	42.0	29.4	18.1	26.9	11.8	11.5	10.1	7.6	16.4	23.3	129.9	7.8	36.4	29.8	26.9	18.9	62.7	7.6	19.9	9.6	14.2	117.3	16.9	40.5	10.0	7.0	7.6	17.2	10.9	8.9	35.9	10.9	44.1	20.3	9.6	12.7	22.8	37.4	25.4	10.1	14.1	8.2	19.2	21.8	24.0	30.7	15.2	23.9	32.6	12.9	23.6	13.4	21.0	12.1	18.1	8.0	11.9	25.6	7.0	4.8	8.2	10.8	11.4	3.6	5.3	7.9	11.7	13.6	30.9	7.8	5.9	9.5	9.6	10.5	10.1	9.2	9.6	11.8	13.9	12.9	12.3	10.4	13.0	11.6	39.0	12.8	10.5	11.8	5.9	17.0	13.2	10.2	7.4	17.2	17.5	10.2	13.5	28.6	11.1	33.1	6.2	24.1	12.0	21.5	7.9	34.2	1.7	13.4	29.7	20.8	9.1	0.8	6.9	38.7	22.3	25.2	12.2	22.8	1.3	11.9	31.8	25.4	51.2	15.2	7.9	11.2	8.2	61.0	16.8	1.5	18.3	28.8	28.4	4.7	19.8	19.2	11.3	9.0	10.8	48.2	14.3	12.0	5.5	18.3	21.5	57.2	9.0	11.1	26.3	17.8	20.2	3.7	7.1	14.9	25.7	38.0	10.6	16.8	11.2	11.7
SLC36A4	"FLJ38932, PAT4"	ENSG00000180773	"Solute carrier family 36 member 4"	Q6YBV0	11	93144174-93197991	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017887	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017887: AB_2190238"	"unprognostic (1.23e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.04e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.45e-3)"	"unprognostic (4.20e-2)"	5.8	7.4	4.2	9.3	4.6	19.4	4.6	8.1	5.8	5.1	6.2	5.4	2.0	7.1	2.1	5.3	4.8	5.7	6.0	4.0	8.5	9.4	7.8	6.0	5.3	7.2	6.9	5.7	5.7	6.5	7.7	6.2	7.7	4.9	6.4	15.3	3.7	5.9	2.4	4.1	3.1	8.1	5.5	4.1	4.3	4.3	6.1	7.3	8.8	2.3	6.7	6.9	3.6	7.0	10.4	18.2	36.5	7.3	12.7	25.6	20.5	17.6	29.2	25.6	31.0	14.6	33.1	12.5	9.9	16.5	13.3	12.5	11.4	6.5	23.4	21.1	13.3	14.5	35.3	9.8	10.0	36.6	20.6	12.4	20.0	14.9	9.2	12.0	14.0	17.6	1.3	0.2	26.5	2.6	16.3	27.4	14.8	4.0	18.4	7.2	21.7	5.1	8.7	15.1	33.6	43.8	25.7	9.9	6.4	26.4	18.0	10.6	15.7	48.0	14.8	28.6	26.0	5.1	10.9	0.0	10.9	15.0	25.4	0.1	4.9	5.3	0.8	2.6	1.0	0.9	0.6	1.0	1.9	1.0	1.5	1.0	1.5	0.5	1.7	0.7	0.5	1.1	4.2	4.6	8.1	5.8	4.0	8.5	7.2	6.9	7.7	5.5	6.1	7.0	11.9	12.8	11.5	35.9	29.5	30.7	43.2	9.7	25.6	21.2	10.3	8.0	11.5	20.0	7.1	20.2	22.9	10.7	13.6	3.1	35.2	24.4	9.9	15.5	19.2	18.5	27.6	5.5	66.8	43.6	25.8	21.9	18.8	5.7	4.5	29.0	13.2	9.1	13.6	26.9	71.0	19.6	10.2	52.3	47.1	4.2	18.0	50.1	21.4	27.2	42.8	20.7	13.4	45.2	59.4	33.2	6.3	15.4	22.1	70.4	0.4	16.2	20.8	24.2	6.6	18.0	18.1	7.3	3.3	11.8	32.0	16.3	15.7	20.6	4.3	30.6
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 331.6;retina: 172.9"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 88.3;Cone photoreceptor cells: 187.7;Hepatocytes: 114.6;Muller glia cells: 80.1;Rod photoreceptor cells: 124.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 49.8;SCLC-21H: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	Microtubules	"HPA031871: AB_2674080"	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	1.4	0.1	30.8	0.1	33.8	1.0	1.4	38.7	42.1	0.5	27.4	0.2	1.3	0.3	0.4	1.1	0.6	0.4	5.6	29.8	30.8	5.1	331.6	0.2	0.5	35.8	40.5	6.3	37.2	7.9	4.6	1.2	34.9	0.5	0.1	172.9	1.8	0.1	35.8	0.8	0.6	0.2	32.4	0.2	1.9	1.9	36.4	0.0	1.3	35.8	0.3	0.1	0.4	35.0	0.0	0.0	1.2	7.0	0.1	0.0	1.7	0.0	0.0	1.3	0.6	4.1	0.0	0.1	1.1	0.0	0.3	0.0	1.9	0.0	0.9	0.1	0.6	0.0	1.0	49.8	0.1	0.5	0.0	0.1	0.0	0.1	0.0	5.6	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.5	0.5	0.0	0.2	0.2	15.4	1.3	0.7	0.2	0.0	2.1	2.0	0.3	0.0	0.2	1.2	0.0	1.0	0.3	0.0	0.1	0.2	0.3	0.1	2.9	0.2	0.3	0.2	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.4	0.0	0.2	0.1	0.1	30.8	33.8	38.7	42.1	29.8	30.8	35.8	40.5	34.9	32.4	36.4	35.0	0.3	0.0	0.0	17.6	0.4	0.0	0.1	0.0	0.6	88.3	3.2	1.7	3.3	17.2	0.0	0.0	187.7	0.2	0.0	0.0	0.0	1.8	0.3	0.4	0.0	3.9	3.5	2.7	0.2	2.2	0.1	0.2	0.0	0.5	0.0	0.1	2.2	114.6	0.1	8.4	0.6	0.2	0.0	2.6	0.0	0.0	2.1	0.1	0.0	7.5	0.6	80.1	0.0	4.5	3.7	0.6	0.0	0.4	0.0	0.0	0.0	4.2	0.0	124.0	0.0	0.6	0.3	2.9	3.3	0.9	0.0	1.4	0.2	0.0	0.2	0.0
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470260	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pancreas: 237.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 196.3;Erythroid cells: 74.3;Exocrine glandular cells: 80.8;Pancreatic endocrine cells: 129.4;Plasma cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 214.0;HBEC3-KT: 326.7;HeLa: 300.0;hTCEpi: 237.8;Karpas-707: 282.8;RPMI-8226: 539.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	4.2	1.9	29.9	13.0	21.8	55.7	2.5	22.6	26.3	9.4	10.6	13.2	13.3	4.2	2.7	10.2	4.9	3.7	6.1	21.6	22.5	1.8	0.9	25.3	8.8	30.4	23.1	6.7	237.2	0.4	0.9	1.1	28.0	5.6	16.2	3.4	9.3	8.6	0.6	21.3	9.2	7.0	22.0	13.8	15.9	0.7	30.4	8.5	20.3	1.3	9.1	9.4	8.7	21.1	143.0	0.3	0.1	1.6	2.8	11.6	0.3	9.4	0.0	0.3	0.1	0.4	0.3	147.8	0.2	61.7	0.3	214.0	164.4	326.7	0.0	47.4	0.2	80.7	300.0	102.4	23.2	166.7	0.2	22.0	237.8	2.9	0.6	0.2	2.8	35.5	150.7	282.8	32.2	0.2	36.3	57.9	74.2	0.0	0.7	131.5	0.7	539.6	0.0	0.1	13.1	0.7	0.1	0.9	0.2	1.1	0.5	6.9	4.7	0.6	0.4	0.4	0.4	0.4	1.0	53.0	1.6	0.8	0.7	0.1	0.4	0.4	17.3	0.6	24.2	11.4	18.6	16.4	2.3	8.9	8.7	11.3	0.5	9.6	0.1	13.1	21.7	9.1	29.9	21.8	22.6	26.3	21.6	22.5	30.4	23.1	28.0	22.0	30.4	21.1	2.3	0.0	0.6	0.3	15.4	26.6	2.7	196.3	17.1	3.2	0.2	0.3	0.4	0.0	33.6	5.5	18.8	0.2	6.7	9.9	0.0	5.5	0.4	1.1	9.1	11.8	0.0	74.3	0.3	80.8	0.6	8.9	3.6	2.7	4.5	1.0	0.4	0.4	2.4	0.0	0.5	17.5	4.1	0.3	3.9	1.3	2.5	2.1	8.8	32.8	1.8	0.3	8.2	0.5	0.2	129.4	5.5	1.2	62.3	4.5	1.2	0.0	4.2	0.3	0.0	0.7	4.6	0.1	0.4	6.4	8.5	0.0	9.5	4.6	21.4	1.9
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58684770	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Group enriched"	"Detected in all"	13	"Early spermatids: 271.8;Late spermatids: 753.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041777, HPA049428"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782, HPA049428: "	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	6.0	11.4	7.5	6.0	7.8	2.6	5.3	6.0	8.9	5.1	6.1	5.1	4.3	5.5	6.2	6.5	4.0	5.6	15.9	7.9	7.4	7.3	13.6	5.4	4.3	7.7	7.6	4.6	4.8	14.1	7.2	7.5	8.1	5.5	5.9	4.7	6.2	4.6	9.4	5.3	5.5	7.4	5.8	10.3	5.4	32.8	9.8	3.6	7.8	8.3	4.6	5.4	4.9	7.0	6.9	10.9	10.8	16.5	22.0	12.9	19.3	16.2	18.7	22.7	15.6	9.9	11.0	4.5	8.9	22.9	17.9	15.9	10.2	11.7	13.3	2.8	9.4	5.1	9.3	16.5	32.9	10.6	14.0	25.9	23.6	16.1	10.3	12.3	23.5	10.4	14.9	6.3	16.7	8.0	4.3	6.3	11.7	7.5	16.0	15.2	11.6	12.1	10.0	15.4	7.9	11.3	25.7	17.0	7.0	14.4	7.6	4.2	18.7	12.3	9.3	21.8	5.0	9.7	6.7	5.2	16.8	6.3	9.3	0.1	6.8	2.0	4.0	6.6	2.2	1.3	2.4	2.9	4.5	2.5	1.9	2.1	0.5	1.8	6.4	1.7	1.8	5.5	7.5	7.8	6.0	8.9	7.9	7.4	7.7	7.6	8.1	5.8	9.8	7.0	3.3	3.2	4.4	7.8	2.0	3.8	4.0	4.4	1.2	9.8	4.7	3.2	12.8	4.3	4.8	11.0	12.5	8.4	5.0	3.7	3.9	14.0	271.8	3.5	6.8	6.2	13.1	2.1	13.3	8.5	9.5	5.1	9.7	6.0	1.3	10.7	8.2	9.3	38.6	16.8	15.5	3.1	12.2	10.1	8.2	753.3	9.6	11.6	8.8	9.4	4.0	7.1	8.2	5.0	7.6	12.8	2.7	8.6	1.8	3.7	4.8	5.9	3.8	7.1	6.6	4.8	5.1	6.9	7.6	4.6	4.3	15.3	2.7	8.6	4.9	3.2
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 48.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.8;Microglial cells: 362.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	8.2	9.7	7.9	6.3	7.4	4.6	7.1	0.0	21.0	10.8	0.0	4.3	3.9	11.0	3.7	3.6	9.5	8.8	4.3	15.8	0.0	8.7	2.0	7.4	8.3	0.1	0.4	7.9	4.8	5.2	1.1	12.8	1.7	19.1	4.2	5.1	3.7	6.7	1.3	7.0	4.0	7.7	1.4	18.3	5.0	9.3	9.9	10.6	48.4	3.1	7.6	6.3	2.1	5.8	7.3	27.1	46.8	13.0	9.5	21.1	24.3	34.8	16.4	16.1	8.1	38.4	26.4	10.4	51.3	19.6	12.4	10.4	28.6	31.6	19.9	5.4	21.8	11.7	37.1	34.0	10.8	45.4	4.9	12.9	5.1	17.7	20.2	56.9	37.3	10.5	34.9	14.3	26.7	7.3	12.7	14.0	53.8	44.1	18.8	28.9	16.6	27.0	74.8	12.7	17.5	24.7	34.4	65.1	18.7	81.2	11.2	26.5	36.1	28.7	33.6	19.0	18.7	4.6	3.7	6.3	24.5	19.9	29.9	41.5	4.7	3.7	7.5	4.4	6.1	12.3	6.8	6.7	6.4	15.8	6.0	7.8	0.8	21.7	3.3	32.8	7.6	2.6	7.9	7.4	0.0	21.0	15.8	0.0	0.1	0.4	1.7	1.4	9.9	5.8	72.1	3.2	12.8	40.8	42.0	25.6	12.1	51.3	13.1	23.0	16.9	23.1	7.6	5.7	33.2	36.8	8.4	49.3	60.2	4.3	1.9	17.7	28.5	13.2	48.7	75.4	15.6	26.9	170.8	11.3	66.0	35.3	11.2	16.5	13.3	25.7	26.4	2.8	24.5	8.4	78.3	5.9	26.4	20.7	27.1	16.0	19.0	31.8	7.2	362.6	16.2	17.0	20.6	49.3	49.5	24.3	2.8	18.8	21.3	20.1	4.5	14.7	9.5	20.0	13.1	41.9	29.1	61.3	33.6	7.5	20.5	23.4	35.4	30.8	6.2	7.8
SLC44A5	"CTL5, MGC34032"	ENSG00000137968	"Solute carrier family 44 member 5"	Q8NCS7	1	75202131-75611116	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 10.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 274.5;Inhibitory neurons: 563.3;Oligodendrocyte precursor cells: 265.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 7.7;RPTEC TERT1: 7.4;SH-SY5Y: 11.5;SuSa: 11.7;TIME: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047455, HPA051011"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA047455: AB_2680054, HPA051011: AB_2681309"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (1.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.30e-1)"	0.3	0.7	1.5	0.5	1.9	0.3	5.5	0.0	3.4	1.1	0.0	2.1	1.2	0.7	0.4	6.6	3.6	1.0	2.5	2.3	1.7	2.0	1.0	0.6	0.5	2.6	1.6	1.1	1.7	3.7	3.1	3.8	2.8	0.8	2.7	2.5	1.4	0.2	1.6	10.7	1.4	0.2	2.0	0.8	1.5	4.5	2.3	2.5	0.7	1.5	2.1	1.6	2.0	1.2	0.2	0.2	4.6	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.7	0.0	0.0	2.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.7	0.6	1.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.4	2.7	2.7	0.0	0.0	1.9	0.0	4.7	3.2	0.6	0.0	0.0	2.3	7.4	5.2	1.1	11.5	0.0	4.8	0.0	11.7	0.2	0.0	14.7	0.4	1.3	0.0	1.5	2.1	2.1	3.2	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	1.9	0.0	3.4	2.3	1.7	2.6	1.6	2.8	2.0	2.3	1.2	0.1	0.0	1.1	12.4	0.4	1.9	1.0	0.4	0.0	4.0	2.9	1.7	0.8	0.0	1.0	0.0	0.0	9.1	0.0	2.0	0.0	0.1	86.9	1.0	0.1	0.6	2.4	0.0	274.5	0.9	3.9	0.4	0.0	0.3	0.0	20.1	7.5	0.0	1.1	0.0	563.3	1.0	0.0	0.0	0.2	35.2	0.9	0.1	0.0	6.5	0.0	0.0	0.0	265.4	10.1	0.2	0.2	0.0	0.1	1.1	0.0	0.1	2.5	0.8	0.0	0.6	0.2	0.4	0.4	0.9	6.7	3.8	0.1	0.5	1.2	3.6
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 76.0;liver: 96.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 53.2;Hepatocytes: 51.3;Proximal enterocytes: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.0;T-47d: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favorable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	13.8	11.7	5.1	10.2	5.7	2.9	10.0	7.7	5.2	14.7	10.0	19.8	46.7	5.6	11.1	4.0	7.5	23.8	12.3	4.7	5.7	18.2	96.0	11.5	16.3	5.9	6.0	3.9	6.7	23.9	10.2	9.5	6.1	6.5	18.8	15.9	9.0	9.9	8.5	4.2	76.0	8.2	6.6	18.2	7.8	11.0	6.6	11.6	12.5	8.6	11.1	7.0	2.2	5.6	0.0	2.8	0.0	7.6	6.0	2.3	0.2	2.7	15.7	3.0	4.4	0.1	6.6	5.2	4.7	4.0	11.5	0.6	3.5	1.4	4.5	3.9	6.2	3.6	0.0	0.0	11.4	0.0	4.3	9.8	2.9	4.5	7.3	3.0	5.6	15.7	3.9	0.0	14.5	3.0	8.6	0.6	0.3	8.0	2.2	3.5	13.3	0.2	27.0	0.9	1.2	0.4	0.0	14.1	5.7	3.1	20.6	4.6	2.0	1.4	2.7	0.4	16.0	4.0	2.0	0.8	0.9	0.0	2.8	33.1	8.9	3.8	10.3	13.1	8.6	7.4	8.0	10.1	11.7	9.7	11.4	10.8	9.8	7.0	19.4	11.0	10.6	8.7	5.1	5.7	7.7	5.2	4.7	5.7	5.9	6.0	6.1	6.6	6.6	5.6	6.2	0.0	5.4	16.0	14.5	1.9	0.1	7.4	1.8	33.7	15.1	3.3	9.6	17.2	15.6	9.2	8.4	0.6	16.4	49.0	1.9	15.5	4.6	2.1	1.7	12.2	3.6	4.6	11.6	5.6	0.3	6.2	0.0	2.1	25.9	53.2	17.5	51.3	10.8	21.9	13.0	6.8	2.0	32.1	36.6	1.8	1.5	22.5	7.2	16.9	9.3	14.2	12.3	14.6	15.6	3.5	5.3	2.2	6.5	0.6	125.0	10.1	15.4	9.8	0.0	2.8	7.2	2.6	0.9	4.9	1.7	0.7	11.4	16.8	13.9	0.2
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 57.6;retina: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 733.9;Rod photoreceptor cells: 704.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	8.6	5.1	3.2	9.0	5.2	4.0	18.7	3.4	16.9	10.5	1.6	16.2	57.6	6.4	8.2	8.6	6.0	13.7	7.8	19.3	2.5	12.7	3.9	8.3	11.2	0.5	3.2	6.8	3.4	1.7	3.4	5.8	0.6	7.9	7.4	72.9	5.8	8.7	5.0	4.6	17.4	6.6	1.8	7.0	6.0	7.1	4.4	5.8	4.9	27.2	10.3	12.1	8.8	2.6	13.0	23.8	21.0	9.8	9.6	17.2	15.0	43.3	20.0	16.3	12.6	6.5	6.6	29.4	3.6	16.8	15.7	5.5	20.2	21.1	25.7	25.1	6.6	13.5	15.4	7.1	16.5	30.9	11.3	13.7	9.0	24.8	78.9	34.2	27.1	19.0	9.1	10.1	33.8	4.7	31.1	7.2	13.8	1.6	23.4	21.0	16.7	5.9	38.1	9.2	5.3	13.1	19.7	14.4	6.9	17.9	32.9	11.8	19.0	38.2	10.6	26.7	33.7	3.8	4.3	16.6	33.3	21.4	17.8	0.0	0.2	0.0	1.0	0.2	0.7	0.4	1.3	1.4	0.5	0.5	0.5	0.9	0.0	1.0	0.3	0.7	1.2	0.3	3.2	5.2	3.4	16.9	19.3	2.5	0.5	3.2	0.6	1.8	4.4	2.6	30.0	0.0	11.2	10.7	37.5	29.3	39.5	23.4	11.4	130.2	72.4	30.4	23.1	21.5	22.8	62.5	733.9	5.8	51.8	5.5	9.8	15.5	10.2	73.6	40.7	53.6	38.2	7.2	46.2	7.1	29.3	52.2	15.8	124.1	23.5	24.6	17.5	6.2	17.0	6.7	88.7	58.5	36.7	48.4	61.6	7.6	9.0	46.5	35.6	185.5	26.7	45.7	20.6	60.8	20.9	19.1	23.4	9.8	27.8	93.1	142.5	10.2	9.6	704.2	39.5	56.4	43.7	40.0	21.7	21.7	30.7	8.1	56.1	19.0	26.7	35.2
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 43.9"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 677.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 8.3;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.1	0.1	8.5	0.0	24.2	0.0	0.6	22.0	22.6	0.0	5.0	0.3	3.3	0.0	0.0	0.0	0.1	0.2	0.1	8.6	17.0	3.0	0.8	0.1	0.0	27.2	21.5	0.1	0.3	0.0	0.3	0.0	27.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	8.1	0.0	14.5	0.2	0.1	0.4	20.7	0.0	0.1	0.2	0.0	0.1	0.1	43.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	24.2	22.0	22.6	8.6	17.0	27.2	21.5	27.3	14.5	20.7	43.9	0.0	0.0	0.0	2.9	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	2.0	1.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	677.9	0.0	2.4	0.0	0.1	0.0	35.2	7.2	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.2	0.6	0.0
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 43.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 22.4;Proximal enterocytes: 84.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.8	43.3	0.1	1.2	0.2	0.1	2.5	0.0	0.0	0.0	3.8	7.8	3.0	0.0	0.2	0.2	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.1	1.1	42.0	0.0	0.0	0.0	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.3	0.2	22.4	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	2.8	0.0	0.0	0.0	0.0	0.0	3.1	1.9	0.5	6.3	0.5	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.5	4.5	0.0	0.7	4.4	0.1	0.0	0.2	2.9	0.0	1.3	0.0	11.0	0.3	0.3	0.0	1.9	0.1	0.0	0.0	7.5	2.9	0.1	1.7	0.4	0.0	0.0	84.0	4.1	0.0	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	3.0	0.0
SLC66A3	"C2orf22, MGC33602, PQLC3"	ENSG00000162976	"Solute carrier family 66 member 3"	Q8N755	2	11155198-11178870	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 15.5;Cytotrophoblasts: 17.5;Extravillous trophoblasts: 82.4;Fibroblasts: 16.1;Hofbauer cells: 56.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 72.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 64.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061607			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA061607: AB_2797264"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.00e-2)"	30.6	26.3	9.7	17.3	9.8	9.9	29.2	10.2	14.0	38.4	17.0	17.6	10.8	23.8	47.3	14.3	19.8	27.8	15.1	9.6	10.2	25.8	17.5	27.0	22.5	12.0	10.1	29.9	29.0	13.2	5.8	14.4	12.0	22.6	19.3	2.5	17.1	19.8	8.5	14.7	15.5	21.4	11.3	39.8	20.0	11.6	10.2	14.3	17.3	17.1	16.8	22.5	17.2	14.2	7.1	23.3	4.3	13.4	64.6	43.9	15.5	14.8	19.3	6.8	8.0	4.3	27.3	2.5	10.5	28.5	29.3	9.1	6.9	7.3	6.8	43.8	3.2	6.5	2.7	3.0	26.1	3.3	19.5	31.7	24.5	4.3	9.7	14.5	15.5	15.3	6.2	14.8	18.8	31.6	4.8	6.6	9.1	25.2	7.6	6.2	7.2	7.7	25.8	11.6	1.6	7.2	12.4	37.9	27.9	19.1	33.9	12.2	22.0	9.6	3.8	10.2	4.1	25.2	19.6	1.2	24.9	15.5	19.4	79.4	153.7	150.3	68.8	194.9	60.7	42.4	65.6	66.7	153.6	31.9	35.9	49.5	9.5	59.9	207.4	28.7	73.2	166.2	9.7	9.8	10.2	14.0	9.6	10.2	12.0	10.1	12.0	11.3	10.2	14.2	15.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	17.5	11.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	82.4	16.1	0.0	0.0	0.0	0.0	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	11.2	2.2	0.0	0.0	0.0
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 149.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in some"	10	"pons: 149.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"SH-SY5Y: 489.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 13.8"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	0.9	21.7	0.1	0.0	0.1	0.0	0.8	0.0	0.2	2.4	0.0	0.2	0.1	5.4	0.2	0.2	0.5	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	3.8	14.6	0.1	0.0	0.5	0.0	12.6	149.4	0.2	0.3	0.0	1.9	0.6	0.0	13.3	0.2	0.8	0.1	0.0	0.1	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.7	489.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	3.8	14.6	149.4	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	10.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	11.5	0.3	0.0	0.4	5.6	0.0	0.0	0.0	0.1
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 68.5"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 571.3;Rod photoreceptor cells: 547.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 59.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 59.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 66.6;RPTEC TERT1: 111.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.9	25.6	1.7	8.4	6.9	54.7	8.5	5.0	7.7	11.3	0.0	3.9	0.9	10.4	0.0	6.7	6.7	9.4	24.4	3.5	3.8	12.2	1.5	20.5	7.5	9.6	6.6	28.9	2.3	2.5	7.4	7.9	6.7	4.3	2.4	68.5	17.1	7.2	30.9	18.3	17.1	6.9	1.7	15.6	9.4	3.7	11.0	4.5	9.3	8.7	9.1	8.1	6.1	6.8	4.1	18.4	4.6	10.1	11.6	5.7	15.9	4.3	26.4	8.4	6.2	8.8	5.6	12.6	4.5	10.9	11.7	4.3	4.5	10.1	16.5	3.7	9.7	8.8	66.6	24.2	0.0	3.7	22.3	1.9	2.6	7.8	1.6	7.7	14.5	6.2	10.1	3.5	18.6	8.1	9.4	20.3	6.1	7.1	10.8	6.1	7.3	24.9	111.8	28.5	7.2	4.6	3.1	3.2	0.6	36.8	11.5	4.5	15.3	9.7	3.9	5.2	6.2	3.9	6.0	7.1	19.3	6.6	23.2	5.6	9.2	8.6	2.5	7.3	1.3	4.0	2.7	3.0	2.8	2.1	0.5	0.6	59.2	1.8	9.4	1.4	8.7	4.6	1.7	6.9	5.0	7.7	3.5	3.8	9.6	6.6	6.7	1.7	11.0	6.8	42.7	6.4	21.5	1.3	16.4	49.3	17.1	51.5	43.9	126.1	9.5	6.9	4.2	7.2	52.8	20.2	571.3	3.0	14.5	0.5	0.0	12.0	19.6	82.1	23.0	29.4	14.4	9.4	17.4	8.2	15.8	13.5	29.0	126.9	13.3	2.5	11.7	0.6	27.2	10.1	18.5	3.5	46.8	60.1	59.5	16.6	17.4	58.8	17.8	32.8	110.9	30.8	10.3	3.0	23.9	31.1	12.6	17.3	13.3	17.6	51.3	23.3	69.5	547.8	0.0	11.4	8.3	0.4	1.3	15.7	23.9	5.1	25.5	46.8	3.6	16.8
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459548-170586075	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 15.9;pituitary gland: 7.3;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.2;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	0.0	2.3	8.9	0.4	8.1	0.1	0.0	5.5	8.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.9	15.9	0.1	0.0	0.0	0.0	15.6	6.4	0.1	0.7	0.0	7.3	0.0	14.9	0.1	0.4	6.1	0.0	0.0	0.1	0.1	0.3	0.1	4.0	0.0	0.2	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.1	0.0	0.5	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	8.1	5.5	8.8	7.9	15.9	15.6	6.4	14.9	4.0	8.9	7.7	0.8	3.2	2.2	4.6	0.1	0.4	0.3	0.1	0.0	28.4	0.1	0.0	1.0	0.0	2.5	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.5	1.8	0.0	61.9	0.0	0.1	0.4	0.0	0.1	2.5	0.1	0.4	0.9	0.0	28.6	90.2	0.1	0.0	0.0	1.2	0.6	2.1	0.4	3.6	6.5	0.0	1.8	0.0	9.5	67.4	0.1	1.2	2.6	0.1	0.3	0.1	0.2	3.0	4.3	0.0	0.7	0.5	0.0	0.2	0.0	0.6	0.0	0.4	0.1	0.0	0.2
SLC7A6OS	"FLJ13291, Iwr1"	ENSG00000103061	"Solute carrier family 7 member 6 opposite strand"	Q96CW6	16	68284503-68310946	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041533	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA041533: AB_10794298"	"unprognostic (1.43e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.44e-4)"	"unprognostic (2.05e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	13.9	8.8	9.6	10.1	11.2	13.9	12.0	11.7	10.8	10.1	9.1	9.8	8.2	9.0	10.1	8.3	9.6	6.1	13.4	9.1	9.6	9.1	6.1	8.5	16.0	11.1	10.7	9.5	8.9	8.1	6.7	9.4	11.2	9.0	7.7	8.8	9.2	6.9	17.0	9.0	11.3	6.8	10.2	13.2	9.5	6.7	10.4	13.0	10.2	8.7	12.3	9.3	8.9	12.5	11.3	11.4	16.4	12.3	9.4	12.8	18.2	14.4	8.1	16.7	14.4	29.3	15.9	19.4	12.6	9.3	10.4	20.0	15.6	12.1	14.5	7.4	10.0	13.1	20.1	24.2	12.1	18.7	13.8	9.9	13.5	13.9	21.7	14.6	12.5	16.6	20.7	8.6	15.2	16.9	24.3	19.1	11.8	13.0	9.7	28.4	10.1	24.3	10.4	14.8	17.3	12.6	27.4	6.1	15.7	12.7	16.5	17.2	18.5	13.0	11.2	12.7	11.3	21.0	18.6	29.2	13.4	22.4	13.8	28.5	12.8	26.3	14.3	15.1	16.6	14.2	14.4	13.3	10.3	15.1	15.5	12.1	11.6	14.8	14.2	12.7	16.2	12.7	9.6	11.2	11.7	10.8	9.1	9.6	11.1	10.7	11.2	10.2	10.4	12.5	15.8	9.6	6.3	2.9	20.6	9.2	13.0	12.4	9.6	22.9	8.3	11.0	1.4	12.8	9.3	12.9	35.5	24.1	24.7	7.0	17.6	13.0	3.0	10.8	16.2	13.6	13.8	8.0	4.8	11.2	12.4	12.7	11.2	10.5	14.0	20.5	13.9	6.2	21.5	16.8	5.2	7.8	12.2	14.1	7.4	2.5	15.8	11.9	12.4	1.0	20.2	25.5	30.9	5.0	4.8	17.0	7.3	16.1	15.7	16.9	10.0	9.8	13.9	23.5	0.0	11.4	11.0	16.7	18.5	10.2	6.7	22.0	21.6	19.7	9.5	14.2
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296284	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 41.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 49.7;Early spermatids: 21.6;NK-cells: 26.8;Proximal tubular cells: 32.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5;neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.5;RPTEC TERT1: 98.8;U-937: 25.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.8	0.2	0.6	0.3	8.6	0.5	0.0	0.4	0.3	0.0	1.0	2.2	0.1	0.2	0.1	0.2	2.3	0.3	0.2	0.0	41.6	7.6	7.8	0.5	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.0	0.8	0.1	2.0	3.6	0.1	0.3	1.5	0.1	0.0	1.3	0.6	0.8	0.3	1.0	1.6	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	1.1	0.0	1.0	0.2	1.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	17.5	0.0	1.3	0.1	0.3	0.8	0.0	0.0	0.0	0.0	1.2	98.8	0.1	0.7	0.5	0.0	0.3	0.0	2.3	0.0	2.4	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	25.8	0.1	9.5	1.0	7.3	3.8	0.0	0.3	0.0	0.6	2.1	0.4	0.1	0.2	1.3	9.8	2.6	0.0	0.2	0.0	1.0	0.2	0.3	0.0	0.4	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.1	6.4	49.7	0.3	0.6	0.0	0.1	1.2	0.0	0.0	1.8	0.3	0.3	1.5	6.4	5.5	0.0	0.0	9.6	1.4	1.9	0.2	21.6	0.0	0.1	0.3	0.0	5.7	9.1	0.8	0.0	0.3	0.0	1.6	5.7	0.0	0.4	11.0	0.2	0.0	6.6	0.1	2.0	0.6	0.3	2.6	0.3	2.4	0.0	1.0	3.2	0.0	26.8	1.5	0.3	0.3	0.1	0.0	1.4	0.0	1.8	32.8	3.1	0.0	0.0	0.1	0.1	2.5	2.4	0.0	0.0	0.0	3.4	0.1	1.1	0.4
SLFNL1	FLJ23878	ENSG00000171790	"Schlafen like 1"	Q499Z3	1	41015597-41023237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"testis: 76.0"	"Group enriched"	"Detected in some"	76	"Early spermatids: 217.4;Late spermatids: 668.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054956			Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA054956: AB_2682649"	"unprognostic (7.01e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.11e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.40e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-4)"	"unprognostic (2.70e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.43e-1)"	0.3	0.3	1.1	0.2	1.1	0.5	0.2	1.4	1.6	1.2	2.8	1.0	0.3	1.0	0.0	0.3	1.1	0.2	0.4	1.0	1.1	0.7	1.6	2.0	0.3	1.0	0.8	1.3	0.7	0.0	0.9	0.1	0.9	1.4	0.0	0.6	4.2	0.1	0.3	0.3	1.1	0.0	0.7	0.4	0.4	76.0	0.9	0.0	0.7	0.0	0.0	0.7	0.6	0.9	0.5	0.8	0.4	0.6	0.0	0.1	2.5	1.1	0.0	0.0	0.0	5.4	0.5	0.9	0.9	0.0	0.2	0.9	0.0	0.0	0.0	0.7	1.5	0.7	1.5	0.7	0.3	1.0	0.6	0.1	0.1	0.0	0.0	0.2	0.1	0.8	0.6	1.1	0.0	0.4	0.6	1.1	0.9	0.1	1.3	1.3	0.6	0.6	0.0	1.4	0.6	0.3	0.2	0.5	0.4	0.4	0.3	0.6	0.4	1.0	1.2	0.5	0.8	0.6	0.3	1.1	0.1	1.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.4	1.6	1.0	1.1	1.0	0.8	0.9	0.7	0.9	0.9	0.1	0.0	5.1	0.3	0.0	0.3	0.1	0.0	0.0	0.7	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	217.4	0.1	0.2	0.2	0.0	0.0	2.2	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.3	668.9	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.4	0.0	0.0	2.2	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.0	5.8	2.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967140-104029233	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 201.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	20.5	15.1	10.9	15.2	19.9	28.9	21.7	20.9	13.7	19.9	15.3	20.4	13.3	21.3	16.2	56.4	14.1	21.3	22.4	11.7	10.0	20.6	17.8	24.0	11.8	11.5	11.1	24.0	16.7	26.3	9.6	25.8	11.7	17.6	20.8	15.1	21.9	17.7	23.1	26.3	14.7	20.6	10.3	14.9	24.1	15.2	12.3	15.2	22.4	25.1	17.5	30.5	28.6	18.5	50.5	28.9	33.7	24.3	36.6	50.1	14.2	30.6	40.7	22.5	20.9	18.4	53.7	26.6	18.6	31.8	19.1	53.7	18.0	39.5	33.5	21.3	24.7	27.0	23.5	15.6	26.6	32.7	22.4	25.5	49.5	30.9	87.6	31.7	40.9	16.9	34.6	17.9	29.8	18.6	23.0	18.0	8.4	32.4	18.2	22.2	41.4	13.8	29.0	60.3	8.0	13.8	26.6	25.7	25.8	17.2	13.8	23.4	63.4	16.6	16.9	30.6	36.3	21.6	28.0	16.7	24.2	43.1	10.7	0.6	0.5	1.7	1.4	0.5	1.5	0.4	0.8	1.0	0.5	0.6	0.6	1.0	2.7	0.5	0.4	0.9	0.8	0.3	10.9	19.9	20.9	13.7	11.7	10.0	11.5	11.1	11.7	10.3	12.3	18.5	73.5	179.5	129.5	38.5	19.9	57.0	87.1	30.9	26.7	32.2	32.0	35.1	110.4	30.0	100.9	44.1	25.0	37.4	40.1	70.0	3.9	34.0	8.4	43.3	77.1	80.2	18.5	25.5	35.3	54.0	13.6	52.6	44.9	90.3	35.3	54.6	50.7	25.3	19.9	25.2	39.3	37.2	18.3	24.5	36.9	16.6	46.6	37.5	8.8	34.7	43.9	25.7	27.8	34.2	63.9	85.5	81.6	63.2	22.3	67.8	21.9	11.5	57.9	25.4	6.6	68.1	49.3	46.3	35.3	61.4	68.5	52.4	44.2	71.7	37.4	201.0
SLX4IP	"C20orf94, dJ1099D15.3"	ENSG00000149346	"SLX4 interacting protein"	Q5VYV7	20	10435305-10636829	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Microglial cells: 53.4;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA046372	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA046372: AB_2679641"	"unprognostic (4.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.56e-3)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (6.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.55e-2)"	1.5	2.0	3.0	1.7	3.7	1.7	2.1	3.3	3.3	1.8	3.1	2.1	1.8	1.2	4.8	2.7	2.2	1.9	1.4	2.8	3.8	2.7	3.2	1.4	2.2	3.7	3.6	1.6	2.9	3.3	4.7	1.6	3.7	2.3	2.3	5.3	1.9	1.3	4.1	3.7	2.1	1.0	3.4	2.5	2.3	2.4	3.9	2.6	2.7	0.8	2.4	1.7	2.3	4.3	3.3	6.1	3.0	8.2	1.7	2.3	2.5	1.6	1.8	2.5	2.7	4.6	4.1	5.2	2.6	1.9	3.5	6.4	4.6	4.8	4.0	0.0	1.7	4.7	2.1	6.2	2.9	5.1	2.7	3.2	4.1	3.2	6.2	3.3	2.5	4.5	3.9	4.3	3.1	2.8	7.7	7.5	5.5	4.0	2.0	5.5	8.0	4.7	3.7	3.2	5.4	4.1	4.7	7.3	4.9	4.2	8.0	2.6	3.7	2.0	4.2	2.5	1.9	4.5	11.1	6.3	1.5	4.8	3.6	0.3	1.0	0.4	0.7	1.3	1.2	1.1	1.1	0.9	1.2	1.2	1.0	0.9	0.8	1.3	1.7	2.0	1.5	0.5	3.0	3.7	3.3	3.3	2.8	3.8	3.7	3.6	3.7	3.4	3.9	4.3	3.2	6.4	6.4	57.1	6.9	0.6	5.6	5.1	3.4	11.8	6.9	5.0	3.6	8.6	7.6	1.8	16.7	11.3	2.9	7.2	11.7	9.8	2.1	10.5	7.3	5.9	10.2	7.4	33.6	3.9	8.3	4.8	8.2	7.4	8.2	12.3	18.9	6.4	8.1	10.1	40.7	8.1	4.1	6.5	2.3	4.2	5.0	4.7	5.4	53.4	11.0	10.0	11.3	55.3	111.8	3.9	8.4	4.5	5.9	3.7	6.8	10.8	3.3	19.6	0.0	6.3	6.6	8.0	10.6	8.4	1.6	6.6	5.1	8.6	8.1	4.8
SMAP1	"FLJ13159, SMAP-1"	ENSG00000112305	"Small ArfGAP 1"	Q8IYB5	6	70667776-70862011	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 325.7;Late spermatids: 281.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030574	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA030574: AB_10601589"	"unprognostic (1.55e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.22e-1)"	17.0	12.8	24.4	16.1	27.8	18.6	13.6	19.5	44.8	15.2	13.3	27.5	26.8	14.1	18.0	28.4	10.2	17.4	23.1	27.6	24.3	14.1	16.6	14.9	15.4	22.7	25.3	11.1	37.2	28.5	8.6	16.1	23.7	17.6	28.3	24.8	18.0	15.2	32.9	20.4	26.7	19.7	20.1	13.7	20.9	30.9	24.4	24.8	21.1	20.1	22.4	18.1	16.1	29.2	60.3	18.6	28.5	35.3	26.0	33.9	46.4	26.6	29.5	21.4	20.9	27.9	17.4	31.4	28.1	32.0	30.5	18.5	27.4	28.1	35.5	36.3	39.4	34.7	16.5	23.6	17.2	25.5	28.0	22.3	31.3	24.2	29.2	39.6	34.2	16.1	33.8	36.9	33.8	35.0	19.2	31.4	21.3	30.9	21.9	36.0	107.9	51.8	38.1	36.0	40.7	28.7	16.9	23.3	17.1	24.2	31.0	37.3	33.6	17.2	29.7	11.4	23.5	34.3	32.9	16.0	13.0	29.4	24.2	35.0	16.4	18.4	18.2	18.3	20.7	14.8	24.3	21.0	14.0	12.7	12.1	15.7	22.6	25.6	20.0	13.7	25.3	23.4	24.4	27.8	19.5	44.8	27.6	24.3	22.7	25.3	23.7	20.1	24.4	29.2	45.0	38.5	39.4	58.1	39.3	66.9	37.7	66.9	33.0	51.8	39.6	47.2	38.8	52.9	46.0	38.6	37.5	26.2	47.6	111.3	54.8	78.9	325.7	26.1	46.8	43.2	41.9	28.8	120.1	151.0	48.8	40.3	64.7	52.1	48.2	42.9	58.5	41.3	56.6	55.5	104.3	82.3	61.1	61.2	59.8	281.1	50.7	53.0	32.0	60.0	64.1	69.7	64.9	115.6	72.7	108.2	99.5	67.0	51.8	76.3	92.6	69.6	21.1	38.6	65.7	36.3	53.3	105.2	84.2	89.3	77.3	31.7	64.9	44.1	75.8	51.6
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	98	"testis: 31.1"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 897.6;Spermatogonia: 448.5"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.9;EFO-21: 4.0;SiHa: 18.0;U-266/70: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.2	0.1	0.0	18.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.4	0.0	3.9	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.6	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	75.6	0.5	0.2	0.8	0.0	0.0	1.4	0.0	0.9	0.3	0.0	0.2	0.0	0.7	0.4	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	36.9	5.6	0.5	0.0	1.0	0.0	0.3	0.0	1.0	1.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.2	1.0	98.6	0.4	0.2	897.6	448.5	0.0	0.0	0.8	0.1	0.0	0.0	0.2
SMCO3	"C12orf69, LOC440087"	ENSG00000179256	"Single-pass membrane protein with coiled-coil domains 3"	A2RU48	12	14804650-14814182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.4;kidney: 3.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 5.9;Erythroid cells: 2.7;Hepatic stellate cells: 4.6;Proximal tubular cells: 7.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"spinal cord: 3.6"	"HPA040574, HPA047804"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"HPA040574: AB_2677026, HPA047804: AB_2680160"	"unprognostic (1.16e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.40e-4)"	"unprognostic (5.10e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.45e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-8)"	"unprognostic (2.85e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-1)"	0.5	0.4	0.0	0.1	0.2	0.3	0.2	0.1	0.1	3.4	0.3	0.2	0.0	0.3	0.1	0.0	0.3	1.8	0.9	0.1	0.2	3.0	1.5	1.1	0.5	0.1	0.2	0.2	0.2	0.5	0.2	1.1	0.1	0.8	0.1	1.3	0.1	1.6	0.1	0.1	0.1	0.1	0.1	1.8	0.1	0.2	0.1	0.0	0.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	1.9	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.5	2.8	0.0	1.8	0.0	0.1	0.0	0.0	5.9	0.2	0.0	0.0	0.2	0.3	0.0	2.7	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.0	4.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
SMG9	"C19orf61, FLJ12886"	ENSG00000105771	"SMG9 nonsense mediated mRNA decay factor"	Q9H0W8	19	43727983-43754962	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 103.2;Late spermatids: 329.5;Syncytiotrophoblasts: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041763, HPA042096"	Uncertain		Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"HPA041763: AB_2677659, HPA042096: AB_2677845"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.71e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.24e-3)"	"unprognostic (3.88e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (8.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (8.09e-4)"	9.0	11.7	10.3	10.9	10.8	8.4	8.7	10.9	13.5	10.6	5.9	9.0	8.0	9.0	7.7	9.2	7.7	6.8	7.7	10.2	10.6	7.7	6.6	10.0	13.0	13.1	11.6	7.8	5.8	8.8	9.4	10.1	13.6	11.5	6.2	5.9	12.0	6.9	7.5	10.7	10.0	8.1	9.5	13.5	8.7	33.8	11.6	11.8	8.3	7.1	12.0	10.0	9.9	14.9	25.3	27.2	19.5	12.5	13.4	18.9	13.1	35.1	20.8	38.4	28.7	19.4	32.5	27.4	16.9	24.1	13.2	10.7	22.9	19.7	24.9	21.1	13.2	49.2	20.5	12.9	15.6	37.4	25.9	10.1	16.6	27.9	29.6	32.1	15.8	25.0	37.7	23.6	18.0	17.9	39.9	10.6	9.4	48.0	18.2	21.2	16.1	12.3	20.4	20.4	32.4	15.9	36.7	27.4	21.3	15.4	16.6	20.5	19.2	59.7	35.4	22.3	27.1	11.5	26.8	33.4	17.9	28.4	49.7	1.0	5.3	3.3	5.1	7.7	4.5	7.4	5.1	4.3	6.9	5.3	6.7	4.5	1.3	4.2	11.7	6.1	4.1	11.3	10.3	10.8	10.9	13.5	10.2	10.6	13.1	11.6	13.6	9.5	11.6	14.9	7.7	32.1	8.3	20.9	13.7	9.3	15.0	16.8	11.4	13.2	10.0	11.0	4.4	4.3	9.0	9.2	4.2	49.5	11.3	9.5	1.9	12.2	103.2	5.5	7.0	12.0	4.2	7.8	19.5	8.7	15.8	11.4	15.8	8.9	9.5	12.1	11.0	3.3	21.4	13.5	23.0	11.3	8.2	10.3	9.2	329.5	13.1	12.1	10.6	11.2	16.2	6.0	4.1	16.1	29.6	13.6	9.2	12.0	11.2	15.9	8.5	6.8	8.4	9.2	6.6	11.2	8.5	42.6	16.2	8.4	7.1	95.4	9.3	11.8	12.2	11.1
SMIM20	"C4orf52, MITRAC7, PNX"	ENSG00000250317	"Small integral membrane protein 20"	Q8N5G0	4	25861830-25929874	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016552	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted to blood"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA016552: AB_1859536"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.86e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (5.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.12e-3)"	27.9	36.7	36.7	16.6	37.7	13.1	27.2	38.1	50.2	22.2	39.8	30.9	39.9	23.9	72.2	15.7	23.8	23.9	46.8	36.5	38.4	46.0	38.2	19.7	30.4	36.9	36.1	33.9	43.4	28.2	17.6	14.1	36.9	23.9	25.5	29.9	35.1	17.5	95.9	13.9	35.1	17.8	37.9	23.6	38.6	20.5	36.8	17.4	31.4	61.4	24.8	28.8	19.1	39.2	29.9	24.5	32.3	31.3	34.9	75.4	43.0	28.4	34.3	24.0	30.4	21.9	51.6	48.8	48.1	31.7	49.6	8.5	37.9	36.3	33.4	27.9	30.1	28.3	16.4	42.0	59.1	34.0	18.0	53.9	71.6	30.6	46.1	46.7	18.7	32.5	45.9	15.5	29.6	19.1	37.0	57.5	61.0	39.6	36.1	30.1	42.0	31.7	53.5	21.6	41.3	38.4	18.3	12.7	66.0	35.2	26.3	47.5	31.4	25.8	30.5	29.3	36.8	30.2	26.9	52.6	39.2	35.6	33.4	30.6	31.5	15.9	26.2	37.7	34.5	47.3	37.5	33.2	36.9	47.9	50.4	41.1	16.3	35.6	29.4	38.3	42.9	31.7	36.7	37.7	38.1	50.2	36.5	38.4	36.9	36.1	36.9	37.9	36.8	39.2	21.5	9.6	41.6	9.4	48.0	21.9	30.4	89.4	26.7	7.7	49.8	63.1	61.8	61.5	59.0	36.8	8.4	63.7	22.5	50.9	131.0	70.0	11.5	34.7	30.6	23.1	19.3	9.2	3.8	62.5	59.7	40.0	31.6	34.6	10.8	37.1	21.8	66.5	69.7	1.7	4.6	64.0	59.0	62.9	32.1	23.1	37.6	44.5	44.4	4.7	42.9	95.3	38.1	9.5	7.9	46.2	44.6	48.2	38.4	38.9	130.1	166.5	47.0	22.2	72.3	26.8	35.8	44.5	36.4	27.3	19.5	43.8	29.8	71.2	65.4	30.8
SMIM22	CASIMO1	ENSG00000267795	"Small integral membrane protein 22"	K7EJ46	16	4788397-4796491	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 193.6;pancreas: 154.3;salivary gland: 147.2;stomach 1: 201.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2005.0;Intestinal goblet cells: 1223.5;Paneth cells: 1462.9;Proximal enterocytes: 1685.8;Respiratory ciliated cells: 686.7;Undifferentiated cells: 775.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CAPAN-2: 261.7;OE19: 247.3;RT4: 89.8;SCLC-21H: 70.7;SK-BR-3: 201.2"	"Low region specificity"	"Detected in many"							HPA077331			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA077331: AB_2686834"	"unprognostic (6.55e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.69e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.73e-3)"	1.2	0.3	0.1	14.6	1.2	3.5	48.2	4.6	2.0	45.4	0.0	193.6	129.6	8.9	50.4	10.3	77.3	33.3	0.5	0.5	0.4	42.0	1.4	24.1	0.6	2.6	0.9	0.5	154.3	0.1	48.9	2.0	2.1	42.6	122.7	1.5	147.2	36.3	0.2	10.4	128.4	6.3	0.8	0.2	201.7	33.8	2.6	0.2	1.1	0.0	2.7	46.1	6.5	3.1	0.2	0.0	0.1	0.6	0.0	0.0	1.9	0.3	0.1	0.1	0.1	0.6	261.7	0.3	7.3	0.0	0.3	1.3	0.1	0.0	0.1	0.4	1.9	0.1	5.8	0.9	0.1	0.7	0.3	0.2	1.4	0.0	0.0	0.2	0.1	0.4	0.0	0.6	0.0	1.9	0.1	0.6	0.8	247.3	0.0	0.8	0.3	23.6	1.5	89.8	70.7	0.8	0.5	201.2	0.0	0.5	15.2	0.0	0.0	0.6	0.8	1.1	0.1	0.2	0.6	0.9	0.0	0.7	0.6	1.2	0.3	0.4	0.3	0.1	0.1	0.1	0.3	0.1	0.0	0.4	0.3	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.1	1.2	4.6	2.0	0.5	0.4	2.6	0.9	2.1	0.8	2.6	3.1	1.4	48.1	117.7	0.0	5.8	2.2	22.7	92.7	0.0	4.2	363.3	267.5	0.5	183.0	154.9	250.1	0.0	3.9	3.0	2005.0	25.4	259.8	40.1	430.4	26.5	4.4	470.3	0.0	0.5	381.9	0.4	4.7	438.8	258.3	18.4	0.1	0.4	0.2	0.4	1.7	0.3	1223.5	152.5	0.0	0.8	107.3	0.6	4.2	23.2	0.0	5.3	0.6	0.0	0.0	1.3	539.9	1462.9	1.2	1.0	29.5	1685.8	99.4	686.7	4.2	0.0	0.0	15.9	38.6	0.6	2.3	2.3	3.7	6.6	0.2	775.6	148.6
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480525	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"epididymis: 1580.8;intestine: 753.9;kidney: 844.8"	"Group enriched"	"Detected in many"	12	"Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.0	4.2	2.7	5.0	91.3	0.8	4.1	6.8	0.6	5.5	30.4	753.9	0.7	1580.8	0.4	2.8	82.0	0.1	4.7	4.3	844.8	35.8	0.4	1.6	4.3	4.6	0.3	8.0	0.2	3.5	0.1	4.3	1.0	24.5	91.6	0.3	2.3	0.3	1.2	628.2	0.8	4.0	1.2	150.1	2.9	4.6	50.4	0.2	0.1	2.0	0.2	0.2	4.4	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	154.9	0.5	0.2	7.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.0	1.0	117.7	0.0	6.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	1.5	0.1	0.1	0.0	113.8	15.8	0.0	185.0	0.3	61.5	0.1	4.3	1.6	0.1	1.4	2.3	0.1	0.1	1.6	0.4	0.0	1.9	0.0	0.0	0.4	1.2	0.1	0.0	0.0	6.5	0.0	87.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.4	1.0	0.0	5.9	0.0	1.5	1.6	0.8	4.2	5.0	4.1	6.8	4.7	4.3	4.3	4.6	4.3	4.0	4.6	4.4	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	14.1	0.1	0.8	0.2	188.8	0.0	58.8	27.1	0.0	0.5	35.1	238.7	4.0	5.1	7.7	0.8	0.3	139.0	22.3	0.7	12.4	0.2	0.3	205.4	13.0	1.3	0.2	0.4	36.3	0.1	0.0	0.1	136.6	0.0	0.6	0.0	15.0	0.3	11.6	0.0	0.0	0.7	4.1	0.0	0.0	0.2	12.4	178.9	0.0	1.7	0.3	4096.4	1884.8	0.0	34.9	0.0	0.2	0.3	0.6	0.7	0.0	0.0	0.0	7.4	0.0	141.3	0.2
SMIM26	"LINC00493, LOC388789"	ENSG00000232388	"Small integral membrane protein 26"	A0A096LP01	20	18567347-18569563	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 252.6;Breast myoepithelial cells: 317.5;Distal tubular cells: 389.4;Proximal tubular cells: 588.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068733			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA068733: AB_2686024"	"unprognostic (1.20e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (7.84e-5)"	76.0	104.3	92.2	43.6	96.2	83.4	107.0	102.7	123.1	72.8	103.9	89.8	63.2	67.2	134.8	71.0	78.9	67.9	136.4	93.6	97.0	96.1	117.7	53.7	72.6	94.8	93.6	113.0	103.4	99.4	90.7	51.3	96.9	71.3	69.8	63.1	91.1	61.9	243.1	69.2	65.8	56.5	96.2	57.8	98.5	37.6	94.4	88.7	85.2	213.5	73.6	79.7	63.6	103.4	99.3	129.1	94.3	98.0	85.9	116.0	110.8	72.3	86.5	83.4	95.2	80.9	113.0	99.4	81.1	79.7	149.1	106.8	90.4	120.2	95.9	42.5	112.9	131.7	59.4	270.2	162.4	86.6	96.5	100.0	159.4	94.6	152.2	144.7	128.1	120.8	98.5	89.3	105.4	125.0	104.0	240.4	53.8	188.5	153.6	67.4	110.0	136.8	192.0	100.4	92.8	98.1	77.2	145.6	297.5	82.9	106.8	126.0	65.8	58.1	60.8	71.7	76.6	85.0	229.8	113.7	52.2	56.2	44.4	142.4	133.5	108.6	96.5	116.6	102.8	155.6	131.7	112.3	164.5	145.7	145.0	139.2	241.3	99.5	112.8	157.7	150.0	130.5	92.2	96.2	102.7	123.1	93.6	97.0	94.8	93.6	96.9	96.2	94.4	103.4	83.8	128.2	83.8	0.0	44.4	0.0	0.0	0.0	0.0	0.0	252.6	317.5	0.0	0.0	35.9	171.0	0.0	205.5	62.6	0.0	389.4	146.2	0.0	185.2	95.5	36.4	0.0	0.0	0.0	214.3	137.9	57.8	0.0	118.7	35.3	100.5	0.0	0.0	188.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	0.0	0.0	66.2	0.0	0.0	0.0	0.0	187.7	0.0	0.0	12.1	0.0	0.0	588.2	87.5	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	208.0	37.2	108.8	0.0	0.0
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27935000-27959157	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.1;pancreas: 49.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.1;Ductal cells: 31.5;Paneth cells: 47.5;Proximal enterocytes: 37.4;Undifferentiated cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"eosinophil: 3.3;myeloid DC: 1.3;neutrophil: 1.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.3;granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;CAPAN-2: 35.3;NTERA-2: 27.6;RPMI-8226: 30.1;SK-BR-3: 45.9;T-47d: 33.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA030561: AB_10604095"	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.5	0.3	0.5	2.2	0.6	2.0	5.7	2.5	0.6	2.8	2.0	22.2	24.1	1.9	15.8	1.1	7.0	2.2	0.3	1.1	0.7	5.2	0.4	6.6	1.2	0.4	0.4	0.2	49.4	7.9	1.0	0.3	0.5	3.6	23.6	0.1	12.5	0.5	0.0	0.9	14.2	1.0	0.6	1.7	16.5	0.7	0.8	0.5	13.9	0.0	3.1	2.2	0.4	0.6	5.4	2.5	0.0	0.3	0.0	0.0	46.0	0.0	1.1	0.6	3.4	12.1	35.3	1.7	8.3	0.0	0.7	5.9	3.8	3.2	0.5	0.0	23.6	7.9	0.5	3.0	0.0	2.6	0.0	0.2	2.9	7.0	0.4	1.0	1.0	0.3	1.0	0.4	0.0	19.5	0.1	0.8	27.6	4.1	4.3	0.5	0.2	30.1	24.6	9.5	23.4	0.5	0.0	45.9	1.3	4.7	33.3	1.4	0.0	0.0	7.6	0.1	0.0	0.3	12.9	0.6	0.8	0.0	0.1	0.1	0.1	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.2	0.1	0.0	1.8	0.3	0.0	0.0	0.0	0.1	0.5	0.6	2.5	0.6	1.1	0.7	0.4	0.4	0.5	0.6	0.8	0.6	0.1	9.6	17.9	0.0	2.3	0.1	2.7	4.0	0.0	0.0	15.0	6.5	0.4	1.5	13.8	9.2	0.0	2.5	0.5	38.1	0.0	31.5	0.4	2.2	0.3	1.1	20.4	1.3	0.8	23.3	0.2	0.2	18.3	5.6	0.0	2.0	0.4	0.0	0.3	0.0	0.1	21.6	10.2	0.0	0.4	0.2	0.0	0.9	0.0	1.0	0.0	0.0	0.0	1.0	0.0	21.7	47.5	0.0	16.6	3.7	37.4	8.7	2.7	0.0	0.0	0.0	0.8	0.0	0.2	0.6	0.1	7.7	0.8	0.1	31.2	3.0
SMS	"MRSR, SPMSY, SpS, SRS"	ENSG00000102172	"Spermine synthase"	P52788	X	21940709-21994837	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	Transferase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 644.3;Distal tubular cells: 608.4;Syncytiotrophoblasts: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029849, HPA029852"	Approved		Approved	"Nuclear bodies,Cytosol"		No	No		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	Cytosol	"HPA029849: AB_10602072, HPA029852: AB_10611521"	"unprognostic (2.51e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (7.49e-4)"	"prognostic unfavorable (7.79e-8)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (7.85e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"	29.7	94.3	52.0	34.7	53.5	50.8	49.6	56.0	61.9	42.7	43.7	52.0	54.9	44.7	63.6	30.6	28.6	40.5	53.0	53.9	50.2	119.9	44.3	36.2	47.8	48.6	46.7	91.2	24.1	28.0	31.5	114.2	49.1	136.0	50.4	49.5	39.7	42.2	34.6	21.4	50.9	39.6	47.0	41.3	39.3	30.2	53.9	50.7	55.3	32.5	47.3	55.1	32.0	49.6	664.3	161.2	265.3	107.1	71.9	121.4	86.3	174.6	102.6	261.7	249.1	204.0	213.0	239.5	59.8	180.0	722.9	142.2	265.5	318.2	508.2	111.0	128.6	124.4	201.0	145.5	129.4	242.2	103.8	76.8	93.7	266.4	497.2	189.2	254.5	93.6	270.6	32.7	366.7	139.2	181.3	244.1	474.9	149.0	244.3	176.0	188.5	182.9	354.3	90.1	131.4	105.7	143.1	181.8	489.1	687.6	163.9	101.3	232.3	194.4	193.6	405.0	294.5	23.8	52.6	142.2	378.4	107.5	275.6	9.1	57.5	102.5	18.9	59.9	23.7	34.6	29.6	33.3	51.1	22.0	19.1	22.8	55.7	31.4	73.9	10.7	55.4	37.3	52.0	53.5	56.0	61.9	53.9	50.2	48.6	46.7	49.1	47.0	53.9	49.6	43.4	25.6	21.9	33.6	61.5	65.9	203.0	206.1	42.1	35.7	116.2	66.3	36.1	81.5	115.0	110.3	12.5	644.3	46.7	61.2	608.4	246.3	1.9	126.4	70.4	61.9	58.8	95.2	45.6	152.3	313.1	86.6	57.6	215.9	40.5	249.5	59.6	49.8	364.7	21.9	40.2	103.6	146.5	157.3	200.3	7.1	95.4	153.1	92.5	21.5	250.7	46.8	48.4	22.1	8.1	165.6	63.9	103.4	45.6	276.2	137.0	466.7	78.9	43.2	65.7	76.6	114.2	6.0	181.3	54.1	50.6	869.6	63.7	271.2	119.1	153.1
SMUG1	"FDG, HMUDG, UNG3"	ENSG00000123415	"Single-strand-selective monofunctional uracil-DNA glycosylase 1"	Q53HV7	12	54121277-54189008	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 98.9;Syncytiotrophoblasts: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026804, HPA065892"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA026804: , HPA065892: "	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.58e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.73e-1)"	20.5	29.2	21.9	13.9	22.4	10.7	26.3	20.7	24.2	17.3	22.6	20.8	17.1	17.1	39.9	38.6	24.5	16.9	19.4	22.3	21.1	28.9	49.6	14.7	18.9	23.7	21.4	18.8	30.0	23.9	16.9	19.1	22.1	24.0	18.7	14.3	29.7	18.1	27.4	29.4	21.3	16.3	22.1	21.8	32.2	15.9	22.7	17.8	21.9	21.8	18.6	20.3	20.1	24.8	31.9	57.5	22.2	23.2	40.4	31.3	37.7	24.2	31.4	37.2	33.8	58.0	69.5	19.0	60.4	35.1	34.8	40.3	15.7	63.7	23.5	19.7	33.3	28.6	47.4	42.3	48.2	19.3	34.0	35.7	97.7	43.9	43.2	40.4	30.2	33.3	48.2	40.3	41.4	60.8	24.3	37.2	27.7	54.3	51.7	17.5	22.6	34.3	46.6	46.2	33.1	39.2	27.6	47.3	43.5	44.9	73.7	35.9	14.3	24.7	27.5	22.5	28.1	37.3	32.1	13.1	35.8	15.0	38.4	89.6	46.2	57.1	28.5	39.5	28.4	49.7	27.3	30.7	40.3	36.6	24.6	24.6	45.5	27.1	31.5	45.5	41.0	33.9	21.9	22.4	20.7	24.2	22.3	21.1	23.7	21.4	22.1	22.1	22.7	24.8	6.6	6.4	16.0	2.9	13.3	7.5	14.4	40.2	11.4	10.5	25.5	22.5	17.7	22.8	26.4	25.8	8.4	87.5	8.8	28.4	60.7	37.1	5.2	15.3	8.9	11.0	11.5	7.4	6.8	40.2	98.9	13.6	16.3	11.0	2.5	10.1	18.2	49.4	46.1	6.7	6.1	25.8	32.6	19.2	5.8	11.8	18.6	14.0	5.4	3.7	34.0	16.3	19.6	5.0	8.1	41.4	24.6	17.7	12.6	20.7	58.4	56.6	27.1	11.9	32.9	8.5	13.8	26.2	28.0	20.8	10.4	100.0	9.5	19.4	23.7	19.6
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 198.8;skeletal muscle: 92.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 148.0;Cytotrophoblasts: 168.7;Early spermatids: 134.5;Extravillous trophoblasts: 110.5;Late spermatids: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Mitochondria	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	15.5	15.0	12.4	9.0	13.0	8.9	18.7	13.5	32.1	12.2	17.8	12.9	13.8	9.5	7.5	18.1	27.6	9.3	198.8	14.6	16.1	20.4	26.2	18.1	13.5	14.7	16.7	12.0	19.1	6.9	17.1	27.3	14.2	12.1	14.3	14.3	13.7	8.1	92.4	11.4	12.6	10.1	14.5	15.1	19.2	24.3	14.4	22.6	20.3	4.2	14.2	11.8	10.1	14.4	64.4	14.5	22.7	16.8	21.7	37.7	102.4	36.6	28.8	41.8	46.6	68.3	52.0	34.6	36.7	39.8	19.7	28.9	21.3	63.5	36.8	28.3	29.8	10.1	30.0	46.7	19.9	47.6	7.4	42.9	31.2	30.5	21.6	27.2	32.1	29.5	35.0	7.5	36.4	33.5	32.6	26.1	21.3	32.4	26.3	20.6	59.9	27.8	33.9	45.2	23.7	55.3	28.9	95.0	73.3	47.8	75.5	30.1	38.6	32.9	49.6	18.0	55.2	33.2	13.0	39.2	43.1	35.1	37.8	15.8	10.0	14.4	15.0	5.7	17.8	15.4	22.5	19.9	9.5	7.5	19.3	18.0	0.9	29.2	1.9	6.4	26.7	13.0	12.4	13.0	13.5	32.1	14.6	16.1	14.7	16.7	14.2	14.5	14.4	14.4	10.5	19.2	9.7	7.5	13.7	20.6	16.5	40.0	25.0	8.7	16.8	19.9	148.0	24.3	17.7	3.7	0.0	168.7	12.2	10.0	31.3	34.3	134.5	48.7	9.9	15.6	4.2	8.6	60.7	20.0	110.5	11.1	11.7	17.4	3.8	27.9	17.2	20.3	38.4	15.2	26.9	13.4	14.2	21.5	10.6	120.4	11.8	11.4	16.0	22.5	11.7	28.1	9.2	7.1	10.3	26.1	11.7	3.8	16.4	16.1	21.9	34.6	69.6	8.0	13.1	6.8	16.7	13.9	39.6	28.9	18.0	85.9	16.8	30.0	19.3	10.9
SMYD3	"KMT3E, ZMYND1, ZNFN3A1"	ENSG00000185420	"SET and MYND domain containing 3"	Q9H7B4	1	245749342-246507312	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 406.1;Excitatory neurons: 725.6;Inhibitory neurons: 788.3;Microglial cells: 277.3;Oligodendrocyte precursor cells: 372.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.2;K-562: 162.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012229, HPA045821, HPA054352"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458"	"unprognostic (7.00e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.78e-5)"	"unprognostic (9.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.58e-1)"	7.9	12.1	9.5	5.0	9.6	9.7	11.1	16.4	9.6	9.1	5.8	7.5	5.0	7.1	22.1	6.4	10.3	8.2	6.7	10.4	10.2	9.4	6.0	9.8	7.7	7.0	10.3	8.2	7.8	9.5	9.2	5.3	9.8	6.8	8.8	7.0	6.6	5.4	11.6	8.0	6.0	6.7	4.4	5.7	7.3	8.7	11.6	10.8	16.0	9.8	7.7	10.1	5.9	6.8	20.8	12.6	17.8	15.4	19.9	27.1	17.3	28.7	21.4	33.4	74.4	16.2	23.7	33.5	22.6	27.0	20.8	13.2	16.3	32.1	111.3	17.7	16.4	20.0	17.9	19.5	37.3	20.1	402.2	73.5	7.6	44.3	28.5	25.3	23.1	23.5	162.0	11.5	33.0	7.0	38.8	38.8	15.9	29.1	19.5	35.5	21.3	48.9	24.5	29.3	41.9	19.8	13.5	2.0	26.4	19.3	16.5	33.8	17.6	15.9	11.0	11.4	34.8	57.0	16.7	17.3	30.5	27.3	18.8	13.1	4.6	11.5	12.9	4.1	13.7	14.2	13.7	16.4	8.0	15.8	15.1	16.1	3.2	27.5	4.6	5.0	16.2	12.1	9.5	9.6	16.4	9.6	10.4	10.2	7.0	10.3	9.8	4.4	11.6	6.8	14.2	6.4	30.7	406.1	16.2	12.2	14.7	26.5	13.1	7.7	8.7	9.3	9.1	4.3	18.9	12.9	22.9	8.1	15.8	5.1	15.6	22.3	54.8	24.9	14.3	12.7	25.1	6.3	725.6	31.1	42.6	15.9	9.2	13.6	110.9	25.7	12.5	4.9	12.3	10.1	788.3	7.9	26.4	4.1	10.2	110.9	11.1	6.0	12.4	277.3	3.7	7.6	16.5	372.4	136.5	24.0	3.7	17.3	19.9	4.8	4.0	19.3	36.9	13.2	0.0	12.1	20.7	19.6	27.5	12.0	11.5	7.3	18.3	46.3	8.8	10.0
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	7.4	6.6	4.1	6.0	3.6	3.4	7.3	8.0	4.5	7.9	3.7	7.5	7.0	6.5	5.0	3.9	7.3	3.6	7.0	3.5	3.5	3.7	4.9	5.6	6.8	3.7	3.2	9.5	6.7	3.6	6.6	4.7	4.0	6.5	4.8	7.6	7.3	5.6	13.7	6.6	7.4	5.9	2.2	6.3	4.9	5.8	4.3	6.2	5.7	10.2	6.5	7.2	6.2	5.6	7.4	13.7	13.5	9.6	9.0	6.1	15.7	11.9	6.7	12.3	12.5	22.0	6.2	19.7	7.8	4.8	8.3	14.2	12.9	7.7	15.3	5.7	13.1	7.2	15.9	6.0	4.5	7.4	6.8	4.4	6.8	12.7	11.1	6.3	6.2	16.6	7.6	7.5	9.7	4.6	13.6	5.3	6.2	8.7	6.6	16.7	6.9	5.0	4.9	8.8	5.5	7.6	11.0	4.5	11.1	10.9	6.7	4.5	5.9	12.0	6.1	10.0	10.4	5.2	7.5	7.1	6.8	6.4	11.9	12.0	2.4	2.3	5.1	3.0	4.3	4.0	3.0	3.3	1.5	2.7	3.4	5.0	1.3	3.1	2.4	4.5	3.5	2.1	4.1	3.6	8.0	4.5	3.5	3.5	3.7	3.2	4.0	2.2	4.3	5.6	22.9	6.4	27.8	6.5	12.9	5.0	9.3	11.9	14.8	19.3	6.9	8.4	6.3	14.3	14.0	7.3	33.3	9.7	16.5	6.9	1.9	5.7	20.2	3.7	8.9	10.9	3.6	9.7	11.7	3.3	10.9	14.2	4.1	3.5	7.6	14.7	17.2	6.7	12.9	26.9	12.1	5.2	12.2	23.3	9.2	5.9	27.1	17.4	5.4	13.1	16.4	7.9	43.3	4.5	7.1	4.2	2.0	24.8	10.1	7.2	23.3	2.9	17.8	19.9	46.0	43.6	23.9	12.6	14.8	5.1	6.7	8.1	12.1	6.1	6.4	3.5
SNAP47	"C1orf142, SNAP-47, SVAP1"	ENSG00000143740	"Synaptosome associated protein 47"	Q5SQN1	1	227728200-227781826	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028167	Supported		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA028167: AB_10603032"	"unprognostic (3.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-1)"	14.2	43.8	19.8	10.0	22.0	10.1	16.9	18.3	23.8	23.9	12.5	20.5	10.1	28.9	15.3	14.0	25.9	12.4	38.6	22.4	17.0	19.4	27.0	11.7	18.1	14.4	15.4	47.2	16.5	23.5	27.4	20.1	15.2	17.3	8.9	12.9	18.2	12.1	36.3	16.6	15.3	18.5	15.3	14.6	17.0	38.6	16.7	17.1	17.1	23.4	14.1	19.9	14.7	17.7	33.5	44.2	27.2	27.7	30.3	25.1	35.0	21.2	33.7	35.5	26.5	29.4	29.8	23.8	37.9	33.2	27.3	36.2	33.6	37.9	27.6	48.1	63.4	19.8	28.0	18.9	21.6	30.8	17.8	28.0	32.2	43.3	24.7	28.3	29.4	28.7	37.6	23.7	32.1	22.0	31.5	29.0	44.3	42.5	65.1	32.8	32.3	37.7	20.4	28.1	50.5	32.1	33.6	44.0	33.5	26.4	55.1	27.8	21.3	30.9	38.4	30.7	52.5	30.2	23.2	28.9	28.0	23.0	40.8	19.1	21.0	34.0	29.4	21.2	28.3	22.6	33.1	34.2	23.3	21.3	27.1	25.4	7.4	30.5	27.7	24.0	46.4	25.4	19.8	22.0	18.3	23.8	22.4	17.0	14.4	15.4	15.2	15.3	16.7	17.7	10.1	6.4	13.1	9.4	16.1	13.4	15.9	16.2	16.5	30.8	16.5	14.7	13.0	22.8	13.2	14.7	27.1	24.3	18.7	8.7	35.2	19.9	49.4	7.2	14.3	11.7	16.2	13.5	12.0	18.2	28.4	15.1	10.7	6.9	5.7	21.0	11.0	13.8	16.3	42.1	9.6	8.6	22.4	8.8	6.2	95.9	25.7	7.6	12.4	8.4	22.3	30.5	45.3	6.6	6.1	17.0	3.3	20.7	22.7	16.5	12.4	15.8	8.9	33.5	13.1	12.0	14.0	41.9	26.4	8.5	15.3	27.5	19.4	23.3	10.5	10.1
SNAPC2	"PTFdelta, SNAP45"	ENSG00000104976	"Small nuclear RNA activating complex polypeptide 2"	Q13487	19	7920338-7923250	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049843, HPA077597"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049843: AB_2680910, HPA077597: AB_2732354"	"unprognostic (4.56e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.78e-2)"	21.2	21.6	15.4	10.4	17.7	16.7	19.6	14.7	21.4	37.1	11.0	36.1	9.7	50.7	5.7	14.3	35.0	8.3	16.6	17.1	16.0	17.2	11.9	17.1	9.1	15.6	15.2	20.7	17.8	10.1	25.5	6.5	16.4	27.0	3.8	1.8	16.6	17.2	9.0	20.5	15.2	12.4	13.8	21.4	18.7	32.6	16.3	7.6	13.1	9.7	4.9	31.7	25.1	15.3	20.6	22.9	10.8	42.0	14.7	31.1	10.0	21.4	22.6	20.5	18.5	10.6	17.4	17.6	25.8	25.0	16.4	24.7	7.7	15.9	5.9	22.7	19.7	24.5	9.6	15.4	26.6	15.4	38.7	25.5	24.0	24.3	14.9	16.6	23.5	18.1	24.5	28.3	12.7	18.1	19.9	43.6	13.9	10.4	51.8	23.4	10.7	17.6	19.1	7.1	12.7	28.7	11.0	11.8	48.6	4.8	19.2	16.6	30.9	68.8	24.5	65.2	26.8	27.4	48.1	10.8	43.1	31.6	22.2	7.0	23.8	23.5	19.0	30.8	19.2	15.7	16.1	16.5	30.1	14.5	16.6	16.9	3.5	27.7	33.4	19.9	24.0	16.4	15.4	17.7	14.7	21.4	17.1	16.0	15.6	15.2	16.4	13.8	16.3	15.3	19.8	3.2	3.7	3.3	15.4	24.3	20.0	25.1	35.9	8.6	25.8	26.2	3.2	7.2	10.7	11.0	0.0	12.2	22.9	9.8	17.6	21.2	1.9	10.7	25.0	20.7	12.0	20.2	4.1	24.5	24.2	18.5	8.6	15.0	18.4	15.4	12.5	5.2	28.6	23.5	2.6	11.9	14.2	19.6	28.0	6.0	13.7	19.2	19.6	1.0	31.3	6.0	13.4	2.0	3.0	28.9	6.6	14.3	8.4	28.5	16.7	16.1	3.0	6.1	13.1	7.3	30.1	9.5	38.6	19.0	24.3	9.9	18.4	29.2	15.5	24.1
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028939, HPA046627, HPA073243"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028939: , HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.3	5.3	3.5	6.0	2.9	8.5	6.6	2.0	6.3	8.0	2.7	6.2	5.7	6.7	3.0	5.8	9.8	3.9	5.8	2.9	0.5	7.6	10.8	6.5	6.9	1.7	1.1	8.0	11.3	5.9	11.2	3.7	0.9	8.0	4.1	5.4	6.6	4.6	6.3	8.2	7.2	4.5	0.1	10.1	6.0	19.7	0.9	5.2	8.6	2.4	6.0	6.7	6.4	2.2	9.2	10.5	10.6	14.8	6.7	12.9	19.4	11.7	7.8	12.0	9.5	24.3	8.2	14.0	8.2	9.3	8.3	29.0	12.9	15.0	7.1	19.9	20.3	9.5	30.3	11.6	5.9	20.2	10.8	10.3	12.4	10.4	9.8	10.4	10.8	11.3	19.8	10.1	8.4	20.6	11.7	22.7	21.9	14.5	13.7	19.0	10.7	19.9	6.9	16.4	30.4	21.2	11.7	19.1	6.2	9.1	19.7	11.6	15.4	12.3	11.2	22.3	16.9	6.3	7.9	11.2	8.6	9.3	7.3	0.0	0.5	0.4	0.7	0.3	0.3	0.5	0.3	0.3	0.1	1.5	0.2	0.1	1.0	0.7	0.1	0.5	0.2	0.1	3.5	2.9	2.0	6.3	2.9	0.5	1.7	1.1	0.9	0.1	0.9	2.2	3.6	6.4	9.0	12.1	4.8	5.4	2.8	3.9	5.7	8.2	6.0	5.0	5.9	5.7	3.8	3.7	2.1	2.6	5.9	5.4	0.0	6.2	4.1	15.1	5.6	4.1	5.3	7.0	12.2	4.5	2.0	4.1	4.6	7.1	1.3	7.0	5.7	8.1	3.2	3.3	8.5	5.0	10.2	4.2	7.7	2.5	5.0	3.4	0.0	5.6	3.2	4.4	3.1	7.1	5.5	6.8	5.8	4.9	4.6	3.7	3.6	4.3	20.3	12.2	0.0	4.2	4.4	9.5	10.0	3.0	6.8	1.4	5.7	6.2	6.1	2.9
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53828-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 156.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 219.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: AB_2677353, HPA044248: AB_2678873"	"unprognostic (7.87e-2)"	"prognostic favorable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	15.2	29.3	80.7	20.6	81.4	32.7	16.1	95.2	98.3	14.0	74.4	27.2	12.9	15.9	16.3	20.1	16.0	10.4	85.3	81.7	81.0	25.0	39.2	10.8	32.6	86.3	82.7	19.8	19.7	24.6	30.7	8.7	87.0	19.8	17.5	12.4	22.9	13.8	131.6	10.9	16.5	15.1	81.8	19.0	27.6	11.0	88.0	22.5	17.7	84.5	31.2	17.2	11.9	80.1	50.1	111.2	60.7	70.8	21.2	24.9	29.5	41.4	26.5	90.7	76.1	150.4	47.5	157.3	48.3	34.2	48.6	50.4	111.8	76.2	69.2	57.3	87.8	91.6	155.3	152.9	22.4	168.9	103.9	32.1	27.0	80.8	22.4	19.6	49.6	93.5	139.2	36.5	52.2	236.5	89.5	70.0	72.8	88.4	54.5	141.9	64.6	186.9	48.6	34.7	66.2	42.9	93.4	119.8	20.7	59.0	77.5	80.8	39.3	40.0	49.6	51.8	67.2	37.6	96.9	248.2	21.3	89.5	62.3	15.1	25.5	93.3	14.9	40.3	17.9	74.3	15.1	17.9	49.6	75.1	15.9	16.3	17.2	22.5	35.9	219.7	26.1	23.2	80.7	81.4	95.2	98.3	81.7	81.0	86.3	82.7	87.0	81.8	88.0	80.1	16.5	12.8	14.3	6.8	53.4	18.6	27.2	39.5	14.8	17.9	48.1	51.9	113.0	18.6	29.3	33.1	4.2	54.6	62.3	30.9	156.5	41.6	3.0	27.3	23.8	18.9	44.0	58.5	9.9	51.4	63.3	29.3	30.1	36.9	4.5	62.3	16.4	67.5	114.5	11.8	9.8	34.5	69.2	26.4	59.8	6.5	21.5	36.2	62.2	5.6	94.3	89.0	32.0	4.5	6.5	31.0	44.8	29.7	65.9	31.5	24.0	87.6	53.2	14.5	6.6	29.4	35.7	33.7	44.8	35.8	21.9	26.1	22.4	105.0	53.5	27.7
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	47.1	33.3	27.6	33.6	29.5	91.2	42.7	30.6	35.9	39.2	29.1	38.4	32.6	39.0	28.4	38.4	38.3	26.7	39.5	27.0	29.0	38.7	33.6	37.1	46.2	29.5	28.6	41.4	38.6	31.3	30.3	33.0	29.8	32.2	32.1	43.3	34.0	21.9	64.8	50.7	38.5	30.9	28.6	44.6	36.6	48.5	28.4	49.0	33.9	35.9	41.9	38.8	38.0	32.9	91.0	66.6	67.0	70.8	54.5	60.6	76.5	61.3	54.6	66.8	61.2	66.0	81.0	88.3	54.5	46.1	50.8	88.2	81.8	58.9	90.3	71.1	63.5	71.8	59.1	66.7	77.7	50.5	81.0	46.8	76.1	60.0	82.8	71.5	65.8	83.7	103.9	64.7	51.9	93.1	90.7	85.4	74.2	103.1	87.8	97.3	85.5	61.7	61.4	82.6	71.2	76.5	84.7	73.6	87.3	68.1	106.6	95.5	69.9	71.6	81.7	64.9	73.9	62.9	95.5	98.7	65.5	79.8	80.9	94.5	71.0	95.6	57.5	76.9	65.5	59.2	64.5	65.9	72.6	67.0	67.6	63.9	67.8	94.5	92.1	43.2	94.5	76.1	27.6	29.5	30.6	35.9	27.0	29.0	29.5	28.6	29.8	28.6	28.4	32.9	86.5	93.0	49.3	13.1	64.2	56.5	80.4	89.1	33.6	56.0	40.1	50.0	49.9	47.1	77.9	53.3	35.5	79.4	75.4	38.0	76.3	79.0	43.5	97.2	81.3	69.9	43.6	85.0	17.9	70.1	100.1	64.9	26.5	80.5	92.3	61.5	55.6	33.7	76.4	38.7	18.6	50.8	54.9	53.6	52.0	24.0	77.9	70.7	39.2	30.0	95.6	66.7	65.9	15.6	31.9	71.3	43.8	74.1	46.3	48.9	48.8	57.3	88.1	72.2	65.7	60.9	89.5	300.5	140.7	39.7	54.3	109.0	76.8	54.4	47.9	70.9
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	27.3	39.9	39.0	23.0	40.5	31.4	41.7	44.4	61.0	30.8	49.7	39.7	29.8	23.5	57.3	24.3	28.2	28.3	24.8	40.7	47.0	54.4	69.6	39.6	32.6	40.1	40.7	26.8	43.6	47.1	36.3	36.2	43.1	33.2	35.1	47.2	27.8	30.8	16.4	28.6	31.7	22.4	40.9	37.4	45.3	87.0	42.5	18.9	40.5	12.9	28.8	35.1	24.7	44.2	46.1	27.3	44.5	64.9	98.3	71.6	46.0	58.0	78.5	44.2	67.5	49.0	75.4	60.3	69.8	74.4	85.9	60.7	30.5	58.8	69.4	53.3	18.0	66.1	36.4	75.1	80.9	62.4	65.0	63.0	43.7	52.0	51.6	81.1	79.4	23.2	67.7	50.4	96.9	52.1	4.4	117.0	18.3	72.1	31.1	26.2	90.6	29.1	107.1	82.7	19.8	44.5	35.0	76.6	56.3	57.9	47.9	108.9	71.6	35.4	21.8	44.1	60.3	50.4	87.0	22.8	71.3	72.2	71.8	36.7	21.5	33.0	19.9	33.6	14.7	13.3	13.4	18.1	26.2	14.7	12.0	15.0	9.9	22.9	40.9	7.9	16.7	15.7	39.0	40.5	44.4	61.0	40.7	47.0	40.1	40.7	43.1	40.9	42.5	44.2	28.5	93.0	47.2	76.4	25.3	14.7	18.7	32.8	15.9	36.4	23.3	15.1	16.9	15.7	39.1	22.0	56.3	50.4	32.6	30.7	5.9	31.7	87.1	37.3	22.2	26.9	31.8	13.2	115.2	41.6	31.9	23.1	37.8	32.5	31.6	36.0	26.0	28.7	35.4	15.2	124.4	26.1	65.1	37.7	22.3	21.6	19.6	33.4	28.4	63.7	43.1	26.1	41.2	85.5	91.0	34.4	22.0	29.3	23.8	15.7	31.9	25.1	58.9	40.7	19.7	26.2	33.0	173.0	14.9	15.9	14.8	56.5	26.4	26.5	28.6	17.7
SNX18	"SH3PX2, SH3PXD3B, SNAG1"	ENSG00000178996	"Sorting nexin 18"	Q96RF0	5	54517759-54546586	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 90.0;Kupffer cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037800	Approved		Approved	Cytosol		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA037800: AB_10672465"	"unprognostic (2.22e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.81e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (6.79e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	14.9	8.7	12.1	11.2	21.3	68.0	9.1	20.4	13.1	11.5	9.1	9.2	9.3	13.5	6.4	10.1	9.4	11.4	7.4	10.3	12.2	12.8	15.1	11.3	13.3	22.8	19.9	26.6	9.3	12.0	3.6	21.8	19.6	8.6	5.5	14.8	11.2	11.5	7.2	7.6	9.5	14.1	18.8	18.8	12.0	7.3	18.6	5.6	15.6	8.0	7.0	11.2	7.7	25.2	9.0	7.4	11.4	13.0	26.2	27.8	61.7	14.8	37.1	7.6	12.6	9.1	16.4	0.4	23.1	23.1	13.9	8.2	10.8	14.5	9.6	4.6	7.7	2.7	4.6	5.7	43.5	5.0	2.5	44.1	17.2	10.4	10.8	13.5	16.1	6.5	4.8	60.7	13.3	8.6	4.7	5.7	5.7	3.7	7.6	12.4	6.4	14.5	7.4	26.0	14.1	8.3	12.4	14.2	16.2	17.4	16.7	8.4	5.5	28.4	13.8	21.1	15.6	40.0	41.8	2.5	11.0	11.8	29.9	0.0	0.9	0.1	0.7	1.5	0.1	0.8	0.3	0.4	1.1	0.6	0.1	0.5	3.8	1.0	3.8	2.5	0.2	0.3	12.1	21.3	20.4	13.1	10.3	12.2	22.8	19.9	19.6	18.8	18.6	25.2	14.4	54.5	26.8	7.5	16.6	9.8	4.4	12.8	10.2	10.0	13.6	10.5	16.5	7.2	22.5	22.0	73.0	26.5	48.2	4.2	15.6	14.2	0.3	7.5	9.8	16.5	6.1	3.4	10.3	15.2	30.3	23.0	27.5	6.2	5.7	90.0	43.9	28.1	41.6	5.0	9.2	7.3	12.2	87.4	26.2	2.5	14.0	52.1	10.6	37.5	42.6	11.2	35.0	6.6	21.6	12.8	7.3	17.7	12.7	5.6	8.6	6.9	24.0	47.5	0.0	13.3	38.5	3.6	13.1	8.9	11.8	8.2	12.5	58.6	10.8	13.1
SNX29	"FLJ12363, RUNDC2A"	ENSG00000048471	"Sorting nexin 29"	Q8TEQ0	16	11976734-12574287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 354.5;Late spermatids: 430.7;Microglial cells: 169.6;Oligodendrocytes: 241.6;Rod photoreceptor cells: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 22.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008889, HPA062810"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Nucleoli, Cytosol"	"HPA008889: AB_1079856, HPA062810: "	"unprognostic (2.50e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.82e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.08e-2)"	"prognostic favorable (1.38e-7)"	"unprognostic (3.85e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (1.03e-4)"	8.6	3.5	7.4	8.2	18.8	9.5	6.2	13.6	11.8	6.6	7.4	5.3	2.3	5.8	2.6	8.2	8.4	4.8	4.5	7.5	9.9	19.0	2.3	6.8	13.0	17.0	15.6	10.2	3.5	22.5	7.1	8.0	18.3	3.5	3.4	23.8	5.6	4.8	6.0	6.9	4.6	5.7	11.4	9.0	4.3	8.5	17.9	21.0	6.5	5.7	16.0	6.3	5.0	26.7	5.0	2.9	4.4	3.5	25.4	20.8	5.7	10.7	29.1	4.3	4.7	0.6	5.7	18.7	13.9	16.6	2.8	4.2	2.9	6.8	6.2	7.2	3.0	2.5	2.5	6.4	4.9	2.7	6.6	19.1	4.4	6.3	2.8	6.5	7.6	6.1	3.9	5.2	4.4	6.7	5.0	3.1	2.4	3.2	2.6	11.3	5.6	15.2	19.3	4.6	5.2	4.4	12.2	7.2	2.5	3.8	4.1	3.2	11.7	7.6	3.0	5.8	2.1	29.5	24.4	11.5	14.1	2.8	4.9	3.8	6.9	1.6	2.0	4.5	2.5	10.6	4.3	2.7	2.5	22.3	5.2	3.6	2.5	1.3	2.3	7.4	4.0	1.9	7.4	18.8	13.6	11.8	7.5	9.9	17.0	15.6	18.3	11.4	17.9	26.7	14.4	12.8	22.9	71.2	61.0	15.3	6.5	5.3	19.9	63.9	8.5	7.4	9.7	4.3	10.8	16.5	354.5	18.6	26.9	4.4	21.5	4.6	124.0	35.3	27.8	13.8	13.1	6.1	59.0	2.9	5.0	20.8	14.8	62.6	42.5	15.2	17.9	4.8	28.7	92.5	54.6	4.6	8.2	29.3	39.6	430.7	21.5	36.7	12.4	169.6	24.3	23.1	16.5	51.8	241.6	7.7	4.3	15.4	23.9	3.6	3.3	42.6	27.2	256.1	6.6	20.8	14.2	20.0	10.8	21.9	15.5	17.1	15.4	14.1	4.0	5.5
SNX30	ATG24A	ENSG00000148158	"Sorting nexin family member 30"	Q5VWJ9	9	112750760-112881671	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.9;Oligodendrocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019346	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA019346: AB_2286395"	"unprognostic (1.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (4.48e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-2)"	3.5	3.6	8.0	7.3	16.5	8.4	6.8	9.7	12.3	9.1	0.0	10.2	7.1	5.5	3.4	3.8	3.1	4.7	3.0	7.9	13.5	21.2	4.6	21.3	8.6	14.5	12.9	5.7	4.6	5.2	3.0	4.5	12.2	3.4	10.3	4.0	5.0	3.5	2.0	4.8	8.2	6.5	8.6	7.0	4.2	11.9	16.1	3.8	2.6	2.1	8.1	4.0	3.2	25.8	8.2	5.0	8.5	6.8	10.5	9.6	7.2	6.9	14.2	5.7	5.4	18.1	1.9	13.6	5.7	17.9	10.2	9.6	10.4	4.1	8.8	4.4	4.9	4.2	4.6	7.3	7.5	4.2	7.2	7.8	5.6	8.8	6.5	14.4	4.9	3.4	6.7	7.5	7.8	5.7	2.8	4.9	9.4	13.2	5.2	5.9	19.9	3.5	11.1	14.2	12.6	4.0	9.0	12.3	17.6	8.7	9.2	7.4	5.6	8.4	9.0	25.0	5.9	19.6	19.5	6.3	10.8	3.9	16.9	0.0	2.0	0.6	0.2	0.7	0.6	0.0	0.3	0.4	1.6	0.2	0.2	0.2	0.2	0.3	0.8	0.2	0.6	0.7	8.0	16.5	9.7	12.3	7.9	13.5	14.5	12.9	12.2	8.6	16.1	25.8	4.4	6.4	77.9	11.4	3.5	8.2	2.0	3.1	7.4	5.9	10.5	5.5	4.3	2.8	7.6	5.5	10.4	0.6	3.6	26.2	5.9	2.6	9.1	16.2	7.5	4.8	4.8	6.6	39.0	3.2	2.1	5.3	5.6	20.1	7.0	15.6	8.9	7.7	13.4	8.4	24.1	10.8	2.0	22.4	17.0	8.1	5.6	19.8	21.4	36.5	22.3	2.4	2.1	22.6	91.2	4.4	20.3	7.9	5.8	2.5	11.9	34.2	2.3	3.1	0.0	4.7	2.8	6.6	10.0	7.3	11.1	0.4	5.7	3.7	9.6	6.3
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572889-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 6.5;urinary bladder: 16.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 81.8"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RT4: 80.7"	"Region enriched"	"Detected in single"	5	"thalamus: 2.6"	"Not detected"	"Not detected"			"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.6	0.1	1.0	0.0	1.2	0.2	0.4	0.8	3.1	0.4	0.6	0.3	0.0	0.3	0.2	6.5	0.3	1.1	1.7	1.0	1.1	0.2	0.5	0.1	0.4	0.0	0.0	0.4	0.3	0.3	0.2	0.0	0.0	1.4	0.1	0.2	1.2	0.2	0.6	0.6	0.1	0.5	0.4	0.1	0.7	4.0	0.7	0.3	0.5	0.5	3.6	16.4	1.7	1.5	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	80.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.0	1.2	0.8	3.1	1.0	1.1	0.0	0.0	0.0	0.4	0.7	1.5	0.5	0.0	0.0	6.2	0.1	0.4	3.3	0.2	9.6	0.0	0.2	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	81.8	0.2	0.1	0.4	0.0	0.0	12.8	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	19.7	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	1.2	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.3	3.7	0.3	0.5	9.7	0.4	0.0	0.1	0.0	0.0	6.0
SOCS3	"CIS3, Cish3, SOCS-3, SSI-3"	ENSG00000184557	"Suppressor of cytokine signaling 3"	O14543	17	78356778-78360077	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 501.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 989.2;Endothelial cells: 635.9;Fibroblasts: 394.4;Langerhans cells: 381.5;Skeletal myocytes: 485.9;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.5;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 154.2;HSkMC: 73.3;U-266/70: 76.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 9.8"	"CAB012220, HPA068569"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane"	"CAB012220: AB_443287, HPA068569: AB_2686008"	"prognostic favorable (4.80e-4)"	"unprognostic (2.67e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (9.34e-9)"	"unprognostic (1.08e-2)"	"unprognostic (8.80e-2)"	"unprognostic (7.59e-3)"	"unprognostic (8.40e-2)"	501.5	50.3	19.1	99.0	20.2	126.4	114.1	18.8	27.5	35.1	21.7	119.0	19.4	53.4	1.9	72.7	306.5	190.4	76.8	16.8	21.2	72.1	84.2	234.8	46.9	43.1	22.1	55.5	46.2	23.6	55.7	77.5	24.6	61.8	27.2	4.2	36.3	17.1	26.1	55.3	64.2	125.2	23.7	52.0	123.9	5.9	32.2	115.9	54.1	37.1	11.8	187.9	31.6	19.6	6.4	10.2	7.3	3.8	2.8	44.3	19.1	31.4	28.3	32.1	13.6	6.6	4.4	0.2	6.7	7.5	20.4	2.0	1.5	3.1	12.7	154.2	0.9	5.8	24.1	1.4	14.5	0.1	2.7	73.3	2.6	24.9	9.3	19.4	14.0	0.5	17.4	58.2	15.1	3.3	3.3	1.0	5.2	1.2	12.8	0.2	36.9	1.1	51.4	6.3	0.3	4.6	9.5	2.5	1.3	26.8	2.9	1.4	8.4	62.7	17.6	22.2	18.4	76.0	46.9	0.1	51.6	0.8	4.1	0.0	1.0	0.2	0.8	0.1	1.9	0.0	2.1	0.9	1.1	0.0	3.1	0.6	9.5	0.3	0.0	1.0	1.3	0.5	19.1	20.2	18.8	27.5	16.8	21.2	43.1	22.1	24.6	23.7	32.2	19.6	989.2	48.1	125.6	0.7	64.7	164.3	120.7	75.0	125.2	1.0	176.3	136.4	23.1	18.6	51.7	38.6	2.1	14.9	42.1	20.5	5.9	44.4	0.8	106.7	207.6	635.9	33.0	11.6	0.0	38.6	46.0	394.4	125.4	166.8	36.0	5.8	307.3	20.2	94.6	0.0	0.1	25.0	30.5	78.4	381.5	1.7	78.3	231.0	85.4	1.0	33.6	7.7	1.0	0.0	1.0	43.0	28.1	2.2	115.5	72.0	24.3	11.5	38.1	2.7	13.1	485.9	381.7	0.4	1.0	36.3	133.0	62.1	88.7	5.3	41.0	90.5
SOCS4	SOCS7	ENSG00000180008	"Suppressor of cytokine signaling 4"	Q8WXH5	14	55027230-55049489	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 17.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013478, HPA057961"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB013478: , HPA057961: AB_2683564"	"unprognostic (7.18e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.74e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.82e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.13e-1)"	6.6	4.9	6.1	7.9	6.7	6.8	5.7	6.7	6.7	4.7	5.6	5.2	5.3	5.8	4.2	5.1	5.2	6.6	5.6	5.9	8.7	6.3	4.9	6.7	8.9	8.1	7.1	3.8	4.1	5.5	4.5	5.7	8.2	4.8	5.6	10.8	4.5	4.5	4.9	5.1	5.3	6.0	8.1	7.6	7.0	4.3	7.0	8.0	6.9	5.1	7.6	6.5	4.2	8.8	14.2	11.0	16.2	18.9	11.0	12.2	12.0	16.4	12.1	9.9	16.0	9.6	15.2	20.8	11.3	12.4	9.7	19.1	21.4	13.5	23.1	20.8	8.8	12.8	16.3	6.1	11.1	14.3	20.9	9.9	14.4	17.6	13.0	11.5	18.5	22.0	7.4	19.2	19.3	14.6	21.9	11.6	12.7	11.7	12.0	20.3	24.5	8.5	15.2	15.0	21.1	18.5	16.6	9.8	16.8	14.8	14.0	11.2	19.3	25.5	23.9	13.1	14.0	7.4	8.3	19.6	17.2	11.8	20.2	0.9	1.2	1.2	0.8	1.3	1.3	0.8	1.0	0.8	0.9	1.1	0.6	0.6	0.7	1.8	1.8	1.2	1.0	0.5	6.1	6.7	6.7	6.7	5.9	8.7	8.1	7.1	8.2	8.1	7.0	8.8	30.7	6.4	12.4	9.8	22.3	24.0	10.8	10.7	14.8	13.6	14.7	12.3	20.2	11.5	15.8	14.7	20.9	5.2	27.5	14.7	13.7	9.4	7.4	36.8	22.5	20.9	20.4	16.8	14.3	8.7	6.2	14.8	29.0	20.6	32.9	11.8	15.0	9.4	7.4	37.0	13.6	8.3	8.2	13.3	21.8	2.6	7.2	15.6	3.6	11.2	17.3	21.0	13.4	4.5	20.4	15.6	9.6	10.1	19.4	8.1	6.7	14.6	19.7	17.4	0.0	15.8	21.5	20.7	10.9	14.7	23.2	4.9	21.7	13.7	8.1	11.5
SOCS5	"CIS6, Cish5, CISH6, KIAA0671, SOCS-5"	ENSG00000171150	"Suppressor of cytokine signaling 5"	O75159	2	46698952-46780245	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 121.0;fHDF/TERT166: 121.9;U-138 MG: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020884, CAB025510"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025510: , HPA020884: AB_1857356"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (4.52e-2)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	12.0	10.2	7.6	6.3	7.7	7.7	13.0	15.9	9.6	13.0	7.5	9.7	5.2	14.1	9.1	8.5	9.3	11.3	11.3	8.1	7.6	9.2	6.7	8.7	6.7	8.3	8.3	23.2	6.2	14.2	5.6	7.3	8.5	9.9	6.6	12.7	8.7	12.4	9.0	7.5	6.7	13.9	8.5	9.0	6.6	10.3	8.2	7.6	9.9	16.0	6.7	9.3	8.5	8.6	14.5	10.8	9.3	13.8	29.9	42.3	11.4	66.5	121.0	31.5	18.6	10.3	6.9	7.5	12.7	121.9	9.7	7.1	9.9	10.8	41.2	7.3	9.4	11.8	10.0	13.2	18.4	6.9	12.7	33.9	15.8	26.7	10.7	35.8	11.0	3.0	10.2	8.1	21.5	5.3	5.9	12.0	10.4	15.1	8.7	7.8	15.9	9.5	13.2	11.1	7.3	19.8	16.4	10.7	13.0	8.9	4.4	10.3	12.8	80.0	17.7	26.9	13.2	9.7	6.4	6.5	36.9	13.7	25.5	0.5	0.4	2.5	0.9	0.4	1.1	1.8	0.5	0.6	0.5	3.0	1.1	1.5	0.4	1.0	1.7	0.5	1.0	0.7	7.6	7.7	15.9	9.6	8.1	7.6	8.3	8.3	8.5	8.5	8.2	8.6	17.2	3.2	6.1	18.9	11.3	16.6	7.2	8.3	16.5	12.8	15.1	12.2	14.2	18.6	8.0	3.7	22.9	3.7	6.2	11.0	5.9	7.3	12.3	9.9	29.2	24.3	10.8	6.1	43.4	6.8	2.5	18.8	10.2	12.0	17.1	17.4	17.2	7.9	4.5	18.5	51.5	7.1	2.0	8.4	15.2	8.1	17.4	7.7	7.2	18.7	8.4	9.7	6.2	38.2	25.4	6.8	8.8	17.0	7.0	11.0	5.1	7.3	5.3	5.5	13.1	13.8	20.1	13.3	18.8	9.9	14.5	2.7	7.0	7.3	5.6	7.8
SOCS6	"CIS4, Cish4, HSPC060, SOCS4, SSI4, STAI4, STATI4"	ENSG00000170677	"Suppressor of cytokine signaling 6"	O14544	18	70289045-70330199	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.6;myeloid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010189	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"	Cytosol	"CAB010189: AB_661195"	"unprognostic (1.76e-3)"	"unprognostic (6.83e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.80e-2)"	7.9	8.0	8.3	6.0	10.2	13.1	14.0	11.7	8.1	15.2	5.8	16.2	15.6	11.8	6.9	15.0	12.3	13.5	11.0	7.8	7.6	9.3	28.3	9.7	3.4	14.8	10.2	10.9	13.0	14.1	4.1	13.9	14.4	8.4	14.4	5.6	11.3	7.9	12.8	7.1	22.8	10.9	13.2	4.1	14.0	5.7	17.5	3.2	11.6	13.4	5.6	8.3	8.0	19.3	19.2	41.6	17.4	12.0	16.1	18.9	19.4	40.3	24.5	24.0	18.0	15.6	31.7	2.1	3.6	37.7	29.0	22.2	12.8	13.2	23.3	0.0	7.8	14.4	14.3	24.1	19.1	7.9	15.6	15.3	15.4	20.9	17.4	23.9	12.2	1.7	8.7	9.6	16.5	9.3	6.8	5.8	11.2	12.2	17.7	8.0	16.8	3.5	14.9	15.6	8.0	20.0	20.9	22.8	18.9	12.4	6.8	13.6	15.1	26.3	13.3	5.5	16.5	0.0	0.0	5.2	29.3	0.6	18.1	0.0	3.6	2.9	0.2	0.7	0.1	0.3	0.4	0.0	3.9	0.0	0.6	0.3	0.0	1.0	0.0	0.3	0.0	1.2	8.3	10.2	11.7	8.1	7.8	7.6	14.8	10.2	14.4	13.2	17.5	19.3	15.0	25.6	17.0	8.1	1.2	11.7	13.7	13.3	12.0	12.9	26.6	14.7	22.4	21.5	30.1	11.0	6.2	28.0	2.1	61.0	11.7	18.4	1.3	23.5	23.5	13.9	29.4	3.8	17.0	18.5	15.6	13.7	21.4	34.6	31.0	9.1	13.6	32.4	25.7	37.0	17.5	31.0	10.2	7.7	11.1	2.8	11.5	19.2	26.6	86.2	10.1	7.8	5.2	28.6	32.1	30.5	30.5	12.8	0.9	17.4	36.8	25.6	21.8	4.7	0.0	14.9	12.5	1.3	11.0	20.5	11.9	68.4	2.1	4.4	26.7	34.6
SOCS7	"NAP4, NCKAP4"	ENSG00000274211	"Suppressor of cytokine signaling 7"	O14512	17	38351844-38405593	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 74.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 254.0;Late spermatids: 500.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004475	Approved		Approved	Cytosol		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA004475: AB_2667194"	"prognostic unfavorable (7.49e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.62e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.88e-1)"	4.2	7.1	8.7	4.3	9.5	4.1	4.8	24.8	9.3	5.7	0.3	6.0	3.9	7.3	6.2	6.1	5.4	2.8	5.2	10.9	5.0	3.9	3.7	4.8	3.5	4.0	6.0	7.2	14.4	11.5	6.6	3.7	3.8	5.2	4.3	12.7	6.2	4.2	14.2	7.9	4.8	5.4	4.3	3.4	7.0	74.1	6.8	6.7	7.7	5.0	4.7	4.9	4.6	6.8	12.3	13.6	14.9	11.1	8.2	6.9	12.2	5.2	4.5	6.2	5.1	10.7	3.6	8.8	7.7	8.4	8.9	7.7	12.8	3.6	7.9	15.6	11.0	8.9	16.4	11.2	2.6	19.7	14.6	4.3	14.2	6.6	8.7	7.8	5.4	4.4	7.2	5.6	7.8	6.7	16.5	12.8	4.8	13.3	2.4	16.7	24.9	7.6	4.1	14.8	26.1	14.1	13.0	8.3	8.7	12.5	15.5	10.3	5.3	6.2	5.2	11.3	16.3	19.0	14.5	12.1	8.4	9.8	12.9	0.0	0.1	0.0	0.3	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	8.7	9.5	24.8	9.3	10.9	5.0	4.0	6.0	3.8	4.3	6.8	6.8	4.0	16.0	10.1	21.2	3.5	0.8	7.0	0.0	8.6	47.5	11.1	9.8	26.8	5.7	8.1	1.8	29.2	9.5	6.1	5.3	1.9	6.0	254.0	5.9	7.9	5.1	4.9	4.2	39.0	6.5	4.8	6.4	4.1	6.5	0.0	9.8	7.9	7.8	3.2	35.3	30.6	7.0	0.0	6.8	0.7	500.2	10.5	5.0	1.8	13.1	7.4	11.7	6.2	23.1	20.6	6.6	6.2	9.1	2.1	8.3	4.4	2.9	5.3	15.8	0.0	9.1	6.8	62.1	23.9	8.1	0.9	8.1	5.0	6.0	6.8	7.6
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777447-36863538	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 54.8;Oligodendrocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"	NA	Yes				"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli, Cytosol"		"HPA043992: AB_2678762"	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.6	14.2	13.4	3.6	18.1	1.1	6.2	63.9	16.4	9.5	0.0	12.3	1.9	10.9	3.8	7.0	9.6	4.8	9.5	12.8	14.4	7.8	0.9	6.2	2.5	14.6	15.0	10.4	2.8	7.3	4.9	6.2	12.6	9.0	2.8	4.5	4.7	8.8	2.4	8.6	5.8	8.4	8.8	4.6	6.4	7.9	15.1	2.9	12.2	3.9	3.1	11.2	7.4	21.9	13.4	18.0	21.5	23.2	12.2	11.2	5.6	11.6	12.5	16.1	9.5	7.3	2.1	6.0	4.2	20.4	14.0	17.8	17.3	10.8	16.8	0.9	3.4	9.7	18.5	9.7	6.4	2.1	9.0	6.3	13.0	15.4	10.9	7.0	10.6	6.5	6.9	1.2	17.8	13.0	6.9	5.1	5.5	1.3	13.8	16.1	19.9	2.3	9.5	4.0	25.5	15.9	24.1	26.1	7.5	9.4	33.3	14.4	16.3	40.2	7.7	19.9	25.7	2.4	0.6	5.8	17.1	2.8	26.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	13.4	18.1	63.9	16.4	12.8	14.4	14.6	15.0	12.6	8.8	15.1	21.9	16.5	0.0	1.8	18.9	4.4	12.6	5.4	6.3	13.6	26.3	9.6	8.9	16.1	5.7	6.7	20.2	37.5	15.6	11.3	1.7	1.9	3.8	0.9	8.6	20.5	14.5	6.0	1.3	19.9	1.5	10.2	12.0	0.5	21.9	10.8	33.0	10.4	0.6	10.0	23.5	30.3	1.5	0.0	7.6	10.7	2.4	12.2	8.1	5.4	21.5	4.5	17.8	0.0	54.8	50.9	1.4	2.4	18.8	1.8	6.0	2.1	1.5	3.9	3.8	13.1	23.2	16.9	0.5	1.3	13.7	16.1	3.3	1.4	14.0	3.0	2.9
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 78.1;Inhibitory neurons: 57.4;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 32.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.3;SCLC-21H: 28.9;SH-SY5Y: 16.9"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.3	0.9	2.3	0.6	2.5	0.0	0.1	2.4	6.6	0.4	0.0	0.3	0.1	0.7	0.0	0.8	0.3	0.7	0.2	2.6	1.7	0.2	0.1	1.0	0.2	3.8	1.2	1.2	0.6	0.0	2.0	0.4	1.9	0.4	0.2	1.2	0.4	0.1	0.1	0.3	0.6	0.1	0.7	0.4	1.3	0.7	3.8	0.0	0.6	0.1	0.0	0.4	0.3	4.4	0.3	4.2	9.3	1.5	0.0	0.8	0.4	0.9	1.1	1.2	2.9	0.3	0.4	0.6	0.3	0.2	7.3	0.0	1.0	0.0	0.7	1.1	0.1	0.8	0.0	0.1	0.0	0.4	0.2	1.5	0.0	4.4	0.0	1.0	0.0	1.5	0.4	0.2	0.7	0.7	6.5	0.0	4.3	0.0	1.0	0.6	2.2	0.0	0.2	0.0	28.9	16.9	0.0	0.0	0.2	1.1	0.0	0.4	0.2	6.8	1.5	0.5	2.2	0.3	0.1	0.1	5.4	1.5	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	2.5	2.4	6.6	2.6	1.7	3.8	1.2	1.9	0.7	3.8	4.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	57.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	44.2	32.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
SORCS1		ENSG00000108018	"Sortilin related VPS10 domain containing receptor 1"	Q8WY21	10	106573663-107164534	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3;thyroid gland: 11.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 522.2;Inhibitory neurons: 179.7;Oligodendrocyte precursor cells: 381.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"RH-30: 80.8;SH-SY5Y: 104.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011948	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA011948: AB_1857366"	"unprognostic (5.86e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.82e-3)"	"unprognostic (5.81e-2)"	"unprognostic (6.48e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-4)"	0.6	3.1	3.0	1.9	6.2	0.0	1.3	0.0	10.3	2.5	0.0	9.4	0.7	1.1	0.3	0.9	1.6	1.1	3.1	5.4	5.8	4.7	0.1	0.1	1.0	0.6	4.5	0.7	1.6	0.0	0.9	0.0	2.7	2.2	1.9	9.6	1.1	2.5	0.3	1.5	3.6	1.4	0.5	0.8	2.5	1.2	5.8	1.0	11.0	1.7	1.5	3.6	2.8	6.6	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	80.8	0.1	0.0	0.0	0.0	104.9	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	6.2	0.0	10.3	5.4	5.8	0.6	4.5	2.7	0.5	5.8	6.6	0.0	0.0	0.5	7.2	0.0	0.6	0.0	0.0	1.2	2.0	0.1	0.5	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	16.6	0.1	4.9	0.2	0.0	0.0	522.2	0.0	0.0	3.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	1.7	179.7	0.0	0.0	0.3	0.3	5.2	0.0	0.2	1.8	26.2	0.0	49.1	0.0	381.5	10.0	0.1	0.0	0.4	0.0	0.0	0.0	2.2	0.0	2.1	0.0	1.0	0.3	0.2	1.9	0.2	0.1	0.0	0.3	0.0	0.0	0.0
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023147-45077185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 163.8;liver: 247.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2"	"Group enriched"	"Detected in all"	4	"liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"basophil: 86.3;eosinophil: 55.9"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 86.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		2800000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	2.0	15.7	4.9	3.1	3.8	2.8	53.8	7.4	8.4	163.8	1.9	5.3	7.5	4.3	6.9	10.2	6.7	8.2	5.6	5.0	4.5	50.3	247.0	3.2	2.6	4.3	3.7	2.4	5.7	4.4	3.1	2.5	4.0	87.9	7.8	4.8	5.3	27.0	2.2	16.6	7.2	3.5	4.2	2.3	9.2	12.2	3.9	3.7	89.4	2.8	3.4	9.1	6.9	6.3	12.3	12.2	4.7	20.8	4.4	5.3	5.9	1.8	3.5	12.2	7.0	12.2	5.8	2.7	8.0	5.4	4.1	17.6	19.9	19.1	9.2	29.9	12.3	13.5	12.1	50.3	0.2	18.0	25.5	6.7	18.0	6.6	9.5	5.4	12.5	15.1	11.7	10.6	14.9	8.1	18.4	38.3	39.0	29.4	13.8	0.9	16.6	6.4	16.8	12.1	25.1	12.2	2.1	57.3	5.9	5.2	16.4	22.5	4.7	3.5	38.0	1.6	5.8	8.7	4.5	4.4	14.2	18.6	10.6	86.3	1.7	55.9	1.6	1.5	1.7	5.4	1.3	1.6	1.7	6.9	1.6	1.4	3.8	1.1	2.1	2.4	2.5	2.0	4.9	3.8	7.4	8.4	5.0	4.5	4.3	3.7	4.0	4.2	3.9	6.3	3.9	0.0	3.1	5.5	11.9	7.8	26.5	14.8	17.6	10.8	24.7	17.5	3.2	25.8	28.1	33.1	0.0	1.3	2.3	15.0	29.4	68.2	31.7	40.2	17.4	4.9	84.8	37.5	4.8	138.7	5.1	7.5	31.1	43.7	8.8	11.5	15.7	649.4	16.0	3.3	5.4	32.5	22.4	24.2	6.4	24.1	3.7	12.2	16.0	1.0	13.3	9.0	2.1	7.1	8.9	89.0	18.1	6.0	7.9	218.8	8.0	270.2	42.5	4.7	0.0	8.9	8.9	7.4	2.8	35.1	20.3	1.0	6.5	15.3	39.4	131.2
SOS1	"GF1, GINGF, HGF"	ENSG00000115904	"SOS Ras/Rac guanine nucleotide exchange factor 1"	Q07889	2	38981549-39124345	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 226.6;Inhibitory neurons: 224.0;Microglial cells: 161.1;Oligodendrocyte precursor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 134.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005396	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB005396: AB_2270724"	"unprognostic (6.68e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-2)"	17.5	8.4	8.2	14.8	10.2	10.8	9.8	14.1	10.3	13.1	6.8	11.0	14.7	14.3	10.3	12.3	11.2	13.5	9.5	9.7	10.8	11.0	11.9	11.0	16.9	9.5	10.2	20.1	9.1	17.1	0.1	17.0	9.5	13.4	12.9	13.2	9.0	12.2	13.7	9.4	15.6	13.8	6.7	12.5	11.5	10.3	8.7	15.4	15.1	16.4	17.8	13.5	0.1	10.6	24.8	15.1	22.8	16.2	29.1	35.0	23.8	15.3	18.7	12.0	11.4	16.3	14.6	35.8	10.3	20.1	18.5	14.4	26.9	13.9	22.1	36.3	11.9	55.5	12.8	22.0	11.8	17.9	134.9	21.6	20.5	16.3	15.8	19.5	18.9	8.1	23.9	16.4	15.4	13.5	19.4	15.8	14.3	30.4	10.4	21.5	20.5	10.5	12.1	19.8	22.0	22.0	18.3	32.3	18.2	18.5	10.4	9.3	21.5	19.8	16.0	15.7	15.4	19.3	20.9	18.4	15.8	17.3	12.0	0.0	0.5	1.4	1.3	0.7	1.9	1.6	1.3	1.4	0.4	1.0	1.5	1.4	0.6	2.7	0.9	0.6	0.9	0.4	8.2	10.2	14.1	10.3	9.7	10.8	9.5	10.2	9.5	6.7	8.7	10.6	72.3	16.0	31.2	120.5	20.9	20.8	15.5	10.9	19.9	19.0	18.4	16.9	33.9	18.6	17.8	9.2	10.4	10.2	27.6	19.5	1.9	11.0	64.9	30.0	36.6	43.2	12.0	12.8	226.6	11.9	8.4	22.9	21.4	34.0	3.8	30.0	12.8	18.6	10.3	8.4	224.0	16.9	26.4	19.1	13.2	11.4	22.7	19.9	7.2	161.1	19.6	15.1	26.8	173.4	125.2	14.2	14.6	21.8	37.5	25.3	28.0	12.8	20.4	11.2	6.6	27.1	22.7	11.3	7.0	17.1	25.3	10.4	33.2	18.4	17.0	28.4
SOWAHC	"ANKRD57, C2orf26, FLJ21870"	ENSG00000198142	"Sosondowah ankyrin repeat domain family member C"	Q53LP3	2	109614364-109618990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 147.6;Granulosa cells: 151.0;Squamous epithelial cells: 137.1;Suprabasal keratinocytes: 199.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 160.4;hTCEpi: 50.8;RT4: 66.2"	"Low region specificity"	"Detected in all"							HPA056131	Enhanced		Approved	Cytosol		No	No				"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA056131: AB_2683047"	"unprognostic (6.76e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (5.11e-3)"	"prognostic favorable (3.56e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.54e-2)"	6.3	3.6	2.5	3.5	3.2	0.6	9.4	3.0	2.7	8.0	7.6	11.3	5.1	5.1	3.9	33.3	4.5	8.4	2.0	2.7	4.3	14.0	29.3	7.0	2.9	4.8	6.2	13.0	3.6	5.2	1.9	4.2	4.1	7.0	8.7	5.5	8.3	7.3	1.1	19.3	7.3	6.2	4.0	3.3	5.9	6.5	4.2	4.3	7.9	2.1	7.5	23.1	12.0	4.5	19.3	3.6	10.8	5.9	5.3	8.8	35.1	41.3	24.1	7.1	7.4	17.0	6.0	0.0	16.6	6.3	13.4	18.1	2.5	27.1	7.7	160.4	18.0	0.0	8.6	24.3	4.9	0.0	4.8	4.7	50.8	15.3	10.9	5.9	1.8	0.0	0.3	0.1	5.5	6.4	0.0	1.7	7.6	17.5	16.2	0.0	2.4	0.3	10.7	66.2	13.5	5.8	14.2	2.5	11.3	10.5	5.3	0.4	2.7	5.6	21.6	3.3	3.0	5.3	5.5	0.1	6.6	0.6	13.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	3.2	3.0	2.7	2.7	4.3	4.8	6.2	4.1	4.0	4.2	4.5	18.9	16.0	9.8	2.9	1.2	147.6	43.2	32.0	93.9	15.7	30.5	22.7	3.6	20.0	14.7	12.9	10.4	4.3	0.7	61.1	3.9	15.9	37.8	28.7	21.1	10.8	15.6	2.7	0.2	7.1	28.6	15.6	13.3	76.9	0.0	151.0	6.8	53.2	8.0	0.0	1.2	32.7	10.2	7.0	15.1	13.7	11.8	6.2	19.6	0.0	3.4	7.3	2.1	1.5	2.4	14.2	34.2	15.1	0.6	21.0	21.5	25.1	5.5	20.7	13.1	12.1	20.8	20.8	13.2	137.1	199.3	10.0	2.2	5.3	36.7	80.9
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428043-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: AB_2676959"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	1.9	2.5	2.1	4.5	3.2	6.8	3.6	10.0	2.5	3.7	1.4	2.0	1.7	5.5	3.0	2.2	4.3	2.5	3.8	1.7	2.8	2.9	2.1	3.5	6.5	2.4	1.8	11.3	2.3	7.2	2.5	2.0	1.9	4.0	2.4	8.9	2.2	2.7	3.6	1.9	2.4	2.9	2.1	5.9	2.9	3.8	2.7	13.5	7.8	7.6	6.8	2.9	1.7	4.4	3.6	2.2	6.7	10.6	2.1	1.4	2.0	3.4	2.2	3.6	4.7	5.5	3.5	14.1	2.3	2.0	9.6	4.2	10.0	2.9	6.9	4.6	4.5	6.5	4.6	2.1	1.5	5.4	7.7	1.4	2.4	3.8	4.3	1.8	7.1	9.6	9.5	9.2	2.9	1.3	13.8	3.7	17.5	6.4	2.7	33.1	11.6	4.6	1.2	2.2	8.8	11.0	7.1	3.0	2.5	6.6	3.6	4.0	3.2	5.7	8.3	3.5	6.5	14.0	15.0	21.0	3.4	8.7	8.1	5.7	0.8	8.9	6.9	1.0	8.2	3.7	6.4	6.6	1.0	5.9	8.2	6.9	2.1	3.9	2.1	1.8	8.4	3.8	2.1	3.2	10.0	2.5	1.7	2.8	2.4	1.8	1.9	2.1	2.7	4.4	11.0	3.2	9.0	19.6	21.8	12.6	11.6	2.5	14.2	17.5	10.0	7.5	9.7	8.6	5.7	0.0	8.4	0.9	13.1	1.6	0.0	2.2	7.0	5.4	7.0	7.8	10.7	21.9	31.0	2.2	1.3	6.3	5.6	7.9	5.1	10.8	10.8	4.6	1.8	18.5	31.3	2.2	2.0	6.0	6.4	4.8	5.6	6.0	7.2	27.2	4.5	10.3	18.6	50.3	60.2	1.7	12.3	6.8	7.1	7.7	1.2	2.0	1.6	21.0	0.0	17.3	6.9	7.3	8.4	4.8	11.1	1.5	22.2	2.8	3.1	5.3
SPAG16	"DKFZp666P1710, FLJ22724, PF20, WDR29"	ENSG00000144451	"Sperm associated antigen 16"	Q8N0X2	2	213284379-214410501	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.1;Inhibitory neurons: 273.7;Respiratory ciliated cells: 330.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037542	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA037542: AB_10672353"	"unprognostic (4.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.17e-1)"	16.3	16.8	36.6	6.4	37.4	2.4	20.8	35.1	45.9	21.0	39.0	16.5	18.8	18.2	31.6	26.1	46.5	22.0	22.2	34.2	37.8	30.4	18.8	10.8	11.5	38.8	39.6	25.8	15.5	24.4	29.7	9.8	37.8	22.1	17.2	21.5	15.7	20.5	10.3	24.9	10.9	12.1	40.9	8.0	26.1	46.3	38.4	13.0	26.4	10.8	13.8	18.9	19.4	40.6	26.8	9.9	29.4	0.0	19.3	35.0	0.2	14.3	17.1	18.3	19.3	20.8	28.8	11.1	16.7	16.0	29.3	18.5	13.4	17.4	38.6	0.0	10.5	5.8	28.0	24.6	21.9	6.3	0.1	30.1	23.5	16.3	9.5	25.0	7.6	11.6	18.8	12.3	18.4	0.0	21.4	0.1	16.3	0.0	8.7	22.6	30.9	0.5	29.4	25.8	21.4	25.1	16.3	15.1	21.3	24.2	70.3	2.7	7.8	17.2	9.2	9.3	15.1	20.0	9.7	0.4	28.6	0.0	8.0	2.0	0.3	0.9	8.1	1.3	11.7	9.3	9.1	10.4	3.1	8.5	12.0	10.4	0.5	15.4	0.9	5.1	9.4	3.4	36.6	37.4	35.1	45.9	34.2	37.8	38.8	39.6	37.8	40.9	38.4	40.6	17.7	16.0	19.5	89.5	10.7	42.3	46.6	82.8	22.8	47.6	38.0	45.6	67.5	74.4	73.6	40.5	95.9	50.6	7.5	17.1	76.3	44.0	243.1	207.0	31.3	18.5	38.2	9.0	205.9	24.9	20.8	30.8	32.1	30.3	10.1	34.0	12.8	16.9	11.7	40.4	273.7	37.8	101.7	4.6	9.6	86.2	41.3	5.9	23.2	42.2	29.2	82.7	8.2	92.0	74.9	27.3	18.8	44.8	9.4	25.4	9.4	94.9	330.0	69.0	13.1	30.8	36.1	167.9	31.0	64.6	56.4	23.5	12.9	55.3	39.8	53.8
SPATA12		ENSG00000186451	"Spermatogenesis associated 12"	Q7Z6I5	3	57060664-57075432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 20.5"	"Group enriched"	"Detected in some"	145	"Early spermatids: 464.2;Late spermatids: 1195.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;RH-30: 1.1"									"HPA043323, HPA075578"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 78: Testis - Spermatogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA043323: AB_10796792, HPA075578: "	"unprognostic (2.31e-1)"	"unprognostic (2.18e-4)"	"unprognostic (3.47e-4)"	"unprognostic (2.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.71e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-3)"	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.2	0.2	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.2	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	20.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	1.1	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.7	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.2	0.6	2.0	0.8	0.7	0.5	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	464.2	1.0	0.1	0.6	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	1.3	0.0	1195.5	5.0	0.5	0.0	1.0	0.0	0.0	0.0	1.0	0.7	1.4	0.1	5.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	2.8	0.3	0.0	0.0	0.3	0.0	0.2	0.5
SPATA21	"spergen-2, spergen2"	ENSG00000187144	"Spermatogenesis associated 21"	Q7Z572	1	16387117-16437424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"testis: 7.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 40.4;Late spermatids: 44.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.7"	"Cell line enriched"	"Detected in single"	7	"Hep G2: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA032080			Approved	Vesicles,Cytosol		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Vesicles, Cytosol"		"HPA032080: "	"unprognostic (3.09e-1)"	"unprognostic (8.26e-2)"	"unprognostic (5.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.74e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.71e-2)"	0.0	0.1	0.2	0.0	0.2	0.6	0.0	1.8	0.5	0.0	0.5	0.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.1	7.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	5.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.0	1.7	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.3	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.1	0.2	0.2	1.8	0.5	0.3	0.1	0.2	0.0	0.1	0.0	0.1	0.3	0.1	0.0	1.1	1.0	0.4	0.3	0.3	0.0	0.6	1.5	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.0	40.4	0.3	0.9	0.3	0.0	0.0	1.6	0.2	0.3	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.1	5.0	1.4	0.0	0.0	0.6	0.4	44.6	0.3	0.3	0.0	0.0	0.1	0.7	0.0	1.0	1.3	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	1.2	0.0	0.9	0.3	1.2	0.4	0.4	0.4	0.3	0.3	0.1	0.3	0.2
SPATA2L	"C16orf76, MGC26885, tamo"	ENSG00000158792	"Spermatogenesis associated 2 like"	Q8IUW3	16	89696357-89701705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041182, HPA042453"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA041182: AB_2677352, HPA042453: AB_2678005"	"unprognostic (1.22e-1)"	"unprognostic (9.04e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.86e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.86e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.55e-1)"	6.7	5.1	5.7	2.3	6.6	5.0	4.9	4.8	8.7	3.9	5.2	6.2	5.9	6.1	0.7	5.8	6.2	2.2	4.9	8.0	4.9	10.3	13.6	7.1	1.5	4.9	3.8	5.4	14.2	2.2	16.7	1.8	3.1	5.9	0.8	0.6	5.7	1.3	1.3	7.7	7.1	1.4	2.6	6.0	6.9	4.9	4.2	1.7	7.0	0.3	0.8	3.8	3.5	6.3	7.4	5.8	2.0	9.6	1.5	1.6	10.7	4.9	2.3	2.3	1.5	11.1	6.2	2.5	6.6	1.6	3.1	12.5	1.8	2.8	0.5	2.5	19.9	1.7	2.2	15.3	5.1	1.3	5.0	1.6	3.5	3.6	1.1	2.6	2.6	2.9	7.7	1.7	1.6	34.0	4.3	8.0	5.4	7.6	7.5	9.4	1.0	7.4	3.4	2.6	11.0	7.0	5.3	5.4	6.5	0.9	14.0	5.7	6.7	2.3	8.5	0.4	2.3	4.2	2.8	2.3	6.9	4.1	4.4	2.8	4.0	5.3	5.5	6.5	3.9	3.7	3.9	4.2	4.4	4.1	3.5	3.9	13.7	2.1	4.9	4.6	3.7	4.1	5.7	6.6	4.8	8.7	8.0	4.9	4.9	3.8	3.1	2.6	4.2	6.3	5.9	3.2	0.5	2.3	10.8	15.7	18.7	7.7	5.2	9.5	11.0	6.6	0.4	7.2	3.1	11.0	0.0	8.7	18.4	27.8	1.9	13.7	7.4	7.6	3.2	6.3	23.8	0.0	13.6	13.8	5.7	6.4	9.2	9.3	4.5	2.1	6.1	5.7	7.4	3.3	7.1	7.6	14.2	6.1	13.2	1.5	2.8	9.1	8.8	2.8	4.3	6.6	8.2	2.5	1.3	12.7	21.8	2.2	8.6	12.7	32.3	10.3	1.5	8.0	0.0	9.3	7.0	2.7	2.5	2.6	19.9	24.9	10.5	4.7	9.3	11.7
SPATA45	"C1orf227, LOC149643"	ENSG00000185523	"Spermatogenesis associated 45"	Q537H7	1	212830141-212847649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"pancreas: 2.9;testis: 11.8"	"Group enriched"	"Detected in some"	24	"Early spermatids: 151.6;Late spermatids: 139.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-698: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049921	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Nuclear speckles, Cytosol"		"HPA049921: AB_2680953"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-3)"	0.2	0.1	0.3	0.1	0.5	0.3	0.3	0.4	0.9	0.1	0.0	0.3	0.1	0.3	0.7	0.2	0.7	0.4	0.1	0.2	0.4	0.3	0.4	0.4	0.8	0.7	0.4	0.1	2.9	0.1	0.3	0.3	0.5	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.2	0.5	0.5	0.5	0.2	11.8	0.6	0.1	0.4	0.5	0.4	0.2	0.0	0.7	0.1	1.5	0.3	0.9	0.2	0.7	0.9	0.1	0.0	0.3	0.4	0.3	0.2	0.3	0.0	0.0	0.6	0.1	0.6	0.0	0.3	1.4	0.0	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.6	0.8	0.9	0.1	0.3	0.2	0.3	0.5	0.8	0.1	0.0	0.7	0.1	0.3	1.0	0.6	0.0	0.0	0.3	0.2	0.5	0.0	0.3	0.0	0.7	0.4	0.4	0.7	1.7	0.1	0.6	0.4	0.0	0.1	1.6	0.2	0.3	0.3	0.1	0.0	0.0	0.2	1.1	0.2	0.3	0.8	0.1	0.2	0.0	0.1	0.1	0.3	0.5	0.4	0.9	0.2	0.4	0.7	0.4	0.5	0.5	0.6	0.7	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	5.9	0.0	151.6	0.1	0.0	0.2	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	139.9	1.5	0.2	0.0	1.0	0.6	0.0	0.0	1.0	2.1	0.1	0.0	0.4	0.0	0.0	0.8	0.3	1.5	0.0	0.0	0.0	0.1	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SPATA5	"AFG2, SPAF"	ENSG00000145375	"Spermatogenesis associated 5"	Q8NB90	4	122923070-123319433	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Hydrolase"	"Deafness, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 207.9;Inhibitory neurons: 59.0;Microglial cells: 104.0;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036450, HPA036451"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA036450: AB_2675131, HPA036451: AB_10670107"	"unprognostic (4.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (1.95e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.79e-1)"	1.3	0.8	0.8	0.9	1.1	1.4	1.6	2.3	1.0	1.3	1.2	1.0	0.6	1.3	0.8	1.0	1.0	0.8	0.9	0.6	1.2	1.1	1.1	0.9	1.2	1.2	1.1	1.2	0.8	1.5	0.7	1.4	1.2	1.1	1.2	2.2	1.0	1.1	1.3	1.2	0.7	1.3	1.0	1.3	2.3	3.6	1.0	2.0	1.5	1.2	1.2	1.0	1.1	1.3	2.3	3.2	2.9	7.1	2.4	1.7	1.9	4.0	1.6	3.3	3.3	1.5	3.2	3.7	2.4	2.4	2.4	2.0	5.0	2.2	5.6	6.2	0.9	3.8	5.7	2.5	1.1	5.2	4.0	1.2	1.1	3.8	3.3	1.7	3.4	2.4	7.7	6.2	4.6	2.4	10.1	3.2	2.1	3.6	1.3	3.3	7.2	2.4	1.9	1.9	4.8	3.1	3.2	2.3	1.7	4.2	2.2	2.0	2.6	6.9	5.2	4.6	4.2	3.9	5.0	3.3	3.3	4.4	6.2	0.5	0.2	0.2	0.6	0.6	0.4	0.5	0.5	0.5	0.1	0.5	0.5	0.5	0.3	0.5	0.2	0.7	0.3	0.2	0.8	1.1	2.3	1.0	0.6	1.2	1.2	1.1	1.2	1.0	1.0	1.3	10.7	16.0	5.0	34.6	9.1	5.1	5.6	2.6	6.2	6.2	4.2	3.2	4.3	11.5	7.4	1.8	14.6	5.1	6.7	2.9	0.0	3.1	207.9	4.5	9.6	8.5	2.4	11.2	48.8	3.6	4.3	5.1	14.3	5.2	5.1	8.6	4.2	3.2	3.5	3.3	59.0	2.6	0.0	4.1	5.3	25.0	7.2	5.3	0.0	104.0	1.8	4.0	4.1	79.9	91.4	4.2	2.1	4.5	10.6	3.9	1.5	3.1	6.4	11.3	0.0	12.5	6.6	14.7	10.6	5.0	5.4	2.2	9.9	4.7	4.1	3.0
SPATA7	"HSD3, LCA3"	ENSG00000042317	"Spermatogenesis associated 7"	Q9P0W8	14	88384924-88470350	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Group enriched"	"Detected in many"	9	"Early spermatids: 946.9;Late spermatids: 1152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038082, HPA038083"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA038082: AB_10671738, HPA038083: AB_10671519"	"unprognostic (2.09e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.50e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-3)"	"prognostic favorable (4.16e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.81e-2)"	5.8	6.0	8.6	1.6	10.4	1.7	6.0	28.4	9.5	7.2	6.7	5.8	2.2	6.6	7.0	2.8	8.3	5.5	5.4	8.6	10.4	9.5	5.1	4.6	1.8	8.6	9.2	12.3	7.9	7.6	11.1	2.8	8.6	6.6	3.1	10.2	4.1	4.6	5.0	5.6	3.2	4.7	8.9	3.6	5.0	57.0	9.2	3.0	12.1	4.5	1.2	5.4	4.9	11.2	2.3	3.7	5.5	7.5	8.8	16.5	6.0	5.2	9.3	5.1	3.4	1.2	4.5	2.2	2.5	5.7	3.8	2.3	2.5	4.0	4.8	3.2	1.8	0.5	1.9	2.1	12.7	3.9	0.5	7.8	6.6	2.1	3.9	16.8	9.4	5.0	1.3	2.7	4.8	2.8	2.8	3.7	1.4	2.9	4.6	3.9	5.6	1.3	8.1	1.9	3.9	4.9	5.1	6.7	5.0	6.5	6.0	4.2	4.9	3.7	4.0	5.2	2.9	2.6	2.1	1.3	6.2	1.1	2.6	0.0	1.0	0.2	2.1	1.4	2.5	1.9	1.7	1.0	2.1	0.4	1.0	1.8	0.8	0.4	0.9	2.1	0.7	1.0	8.6	10.4	28.4	9.5	8.6	10.4	8.6	9.2	8.6	8.9	9.2	11.2	7.8	12.8	7.3	38.5	1.5	2.4	7.6	9.8	7.4	10.8	6.3	8.5	12.0	7.2	8.8	3.7	20.9	2.6	5.3	1.1	9.8	11.0	946.9	22.3	13.2	6.8	16.3	1.3	113.0	7.2	3.6	11.8	4.1	4.2	1.3	19.4	7.9	4.5	5.7	15.2	91.6	4.0	12.2	17.2	2.8	1152.6	20.5	6.7	8.8	25.3	4.0	12.5	2.1	49.8	54.7	5.6	4.3	17.0	0.9	3.0	1.4	26.0	32.7	20.5	6.6	15.0	7.9	37.5	14.7	3.0	2.0	1.1	3.3	20.5	4.5	3.3
SPATC1L	C21orf56	ENSG00000160284	"Spermatogenesis and centriole associated 1 like"	Q9H0A9	21	46161148-46184476	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 48.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 208.9;Late spermatids: 472.3"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 3.7;cerebral cortex: 4.8;hippocampal formation: 2.9"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 36.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 37.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018979, HPA019165, HPA029394"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane, Cytosol"		"HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148"	"unprognostic (1.46e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.58e-1)"	7.6	23.4	4.2	1.0	3.7	1.3	8.5	0.0	4.8	11.4	0.0	9.7	1.3	9.8	0.6	7.7	6.8	1.4	11.5	2.9	0.6	7.3	1.3	5.9	1.6	0.4	0.1	13.9	11.3	1.6	14.2	1.1	0.1	32.5	0.7	0.3	6.7	2.5	5.6	10.5	6.9	0.8	0.0	8.4	8.3	48.9	0.9	1.0	6.3	0.8	1.0	9.8	11.7	0.1	2.9	0.0	3.6	6.7	2.0	4.7	1.9	4.1	2.2	2.2	1.7	0.0	1.8	9.0	8.0	5.0	2.6	0.5	0.0	3.2	0.6	8.3	6.6	21.6	1.3	5.0	0.1	0.0	8.5	5.0	1.5	0.0	0.0	4.2	7.2	10.1	37.8	13.2	3.1	5.7	7.0	2.5	15.0	4.0	18.0	15.4	4.9	10.0	3.4	0.8	1.1	6.9	3.2	1.7	8.6	2.5	5.6	8.3	0.4	6.5	8.0	9.3	6.3	21.9	12.6	6.6	8.6	11.9	6.1	1.5	5.7	36.1	4.3	6.8	5.6	7.6	6.2	5.9	8.6	7.6	9.7	9.2	0.3	6.6	4.7	7.2	7.0	3.6	4.2	3.7	0.0	4.8	2.9	0.6	0.4	0.1	0.1	0.0	0.9	0.1	20.5	0.0	0.0	3.6	13.5	23.6	11.6	21.4	18.2	6.8	11.9	14.6	1.9	12.8	6.9	3.7	0.0	3.4	10.1	7.7	15.6	16.8	208.9	6.3	14.6	15.4	60.4	12.8	2.6	20.5	17.7	18.1	13.7	8.8	0.0	18.8	14.6	0.6	13.7	3.3	2.0	16.4	8.2	8.8	24.4	472.3	32.3	9.9	28.4	1.0	5.9	5.8	6.2	3.0	3.1	17.8	6.6	31.6	28.0	24.1	6.8	13.4	2.8	3.1	19.7	12.0	14.0	17.8	14.7	17.0	40.1	3.1	11.7	4.0	18.3	8.1
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 140.7;salivary gland: 114.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 94.2;Breast myoepithelial cells: 61.1;Intestinal goblet cells: 315.1;Prostatic glandular cells: 72.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 388.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 288.4;OE19: 118.0;SK-BR-3: 192.2;T-47d: 154.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"midbrain: 2.9"	HPA055707			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.4	0.1	0.5	1.4	0.5	0.1	36.6	0.8	1.1	28.0	0.0	18.4	11.6	9.0	0.5	2.2	6.3	2.4	0.4	0.5	0.2	0.1	0.1	1.1	0.0	0.3	0.4	0.1	0.6	0.0	0.2	0.0	0.2	140.7	10.2	0.0	114.8	0.1	0.3	9.3	14.3	0.6	0.1	0.1	35.4	0.3	0.5	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	30.9	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.4	0.3	0.4	0.0	118.0	38.6	0.1	0.0	0.3	0.3	0.3	2.1	0.2	0.0	192.2	0.0	0.0	154.0	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.8	1.1	0.5	0.2	0.3	0.4	0.2	0.1	0.5	0.5	0.8	0.0	2.2	0.7	0.3	0.1	13.3	20.7	0.0	0.0	94.2	61.1	0.3	5.7	31.7	0.0	0.0	0.0	1.4	27.1	0.0	2.6	1.1	6.2	0.7	0.6	5.4	0.0	0.8	1.2	0.0	0.4	28.1	18.7	0.0	0.2	0.4	0.0	0.0	0.0	0.6	315.1	12.2	0.0	0.2	5.5	0.0	0.9	3.6	0.0	0.0	0.0	0.0	0.0	0.2	20.2	12.3	0.0	0.1	72.7	5.7	0.0	2.9	0.0	0.0	0.0	1.2	0.1	0.2	0.0	0.0	0.3	0.8	0.0	30.0	11.5
SPDL1	"CCDC99, FLJ20364, hSpindly"	ENSG00000040275	"Spindle apparatus coiled-coil protein 1"	Q96EA4	5	169583636-169604778	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 38.4;Spermatocytes: 112.9;Spermatogonia: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA044700, HPA048146"	Enhanced		Approved	Cytosol		NA	Yes			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA044700: AB_2679052, HPA048146: AB_2680284"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.59e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.48e-6)"	"unprognostic (2.63e-3)"	"unprognostic (5.70e-3)"	"unprognostic (8.27e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.93e-1)"	3.9	3.6	5.5	9.4	6.0	10.9	5.5	6.1	7.2	3.4	3.4	5.4	5.7	6.2	3.8	5.8	4.4	4.5	3.4	4.7	5.6	4.8	3.2	4.0	14.9	6.0	5.5	6.7	2.5	5.0	2.4	8.4	6.1	3.3	5.7	3.4	3.2	3.1	5.3	5.5	5.3	7.4	7.1	6.6	5.3	35.5	5.4	21.5	4.3	5.9	14.0	4.8	3.8	7.2	57.0	69.2	67.4	47.6	17.6	18.5	59.1	181.1	22.9	128.1	119.0	89.6	38.8	54.3	116.9	147.0	90.3	39.3	56.8	76.0	139.6	58.1	65.2	59.6	117.0	36.2	8.3	66.9	51.3	9.2	6.2	62.2	34.0	29.0	59.9	60.5	41.3	39.3	142.4	58.5	54.1	28.2	50.1	28.9	63.2	64.8	67.6	38.5	89.7	19.8	43.7	31.4	84.9	23.6	34.5	46.9	27.0	44.9	46.3	146.6	46.8	43.4	140.0	30.1	69.2	69.1	35.4	61.9	50.2	4.0	2.7	3.8	8.4	3.6	8.9	11.2	7.9	8.9	2.8	12.7	10.8	9.1	0.5	8.4	6.2	19.7	8.6	4.1	5.5	6.0	6.1	7.2	4.7	5.6	6.0	5.5	6.1	7.1	5.4	7.2	6.1	3.2	6.3	3.9	8.7	4.0	1.7	4.8	4.6	6.9	6.2	7.5	7.1	2.8	7.0	1.8	0.0	14.1	9.8	3.6	5.9	6.6	9.6	5.3	8.0	6.5	1.8	22.3	6.2	4.8	26.1	7.7	12.2	4.9	8.8	38.4	13.2	3.2	12.2	3.3	6.5	3.2	2.0	4.7	3.6	11.1	4.4	4.7	3.6	2.8	5.0	7.4	13.4	5.0	6.8	6.6	1.9	6.4	10.2	1.6	0.5	8.2	4.1	4.4	6.6	6.4	9.9	112.9	59.2	5.8	4.4	4.9	5.2	9.6	7.4	2.5
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20008865-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 217.1;Inhibitory neurons: 220.8;Microglial cells: 187.4;Oligodendrocytes: 317.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA		9800	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	12.5	9.6	30.8	7.3	35.1	23.6	9.2	24.1	43.7	6.1	22.3	15.1	9.8	12.8	4.7	9.2	8.3	14.8	5.0	41.4	21.4	4.7	1.2	5.7	5.3	32.8	25.8	16.6	4.8	3.3	6.4	3.6	24.5	6.1	10.0	6.1	6.2	5.0	5.1	3.6	10.5	9.5	21.0	13.5	10.3	22.8	41.1	3.0	5.2	2.8	5.2	4.6	4.3	47.3	26.2	37.3	15.7	7.2	14.7	6.9	29.1	10.0	12.4	12.4	21.4	67.6	17.1	1.5	45.3	11.4	24.3	21.1	10.7	33.4	3.7	12.8	18.5	14.5	34.4	10.5	4.9	1.3	5.6	10.6	36.9	10.2	24.9	46.8	0.0	4.4	1.0	15.1	10.4	24.0	0.3	5.3	14.5	17.0	6.3	11.8	49.5	23.6	32.2	11.4	7.1	6.9	75.7	35.6	13.9	62.2	26.3	9.1	0.3	0.5	21.1	0.9	30.8	5.4	11.7	0.9	19.1	12.6	6.5	42.1	15.8	33.0	2.2	8.4	3.2	1.8	1.5	3.4	26.6	1.4	1.0	1.4	11.1	13.0	7.9	4.6	0.6	5.5	30.8	35.1	24.1	43.7	41.4	21.4	32.8	25.8	24.5	21.0	41.1	47.3	28.7	22.4	14.7	170.4	5.7	5.5	12.5	22.0	10.8	7.4	5.8	4.7	10.3	7.2	21.1	18.4	68.8	5.5	10.2	56.8	9.8	30.9	100.0	40.1	44.1	13.1	7.7	82.5	217.1	36.3	11.5	18.6	34.1	64.1	116.4	29.5	3.9	0.2	22.0	0.0	220.8	54.8	12.2	12.4	15.9	54.5	5.0	29.0	21.4	187.4	84.7	13.6	11.3	125.2	317.8	67.7	24.7	44.8	7.0	19.7	25.2	3.6	18.1	31.4	59.2	7.3	81.3	73.8	68.9	5.9	2.6	2.2	10.0	87.8	27.4	21.5
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoli	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	1.8	1.7	1.4	2.7	1.3	10.2	3.3	0.9	1.7	2.4	1.7	3.6	2.2	3.4	2.3	5.9	2.7	2.1	1.3	1.3	3.1	1.5	1.3	3.1	3.5	1.6	2.0	2.9	1.7	1.7	2.3	4.4	1.6	3.3	4.1	2.0	7.2	1.7	0.5	2.0	2.2	3.5	1.2	2.8	2.2	0.7	2.5	3.1	2.5	0.5	5.6	2.1	2.7	1.8	31.7	8.0	18.2	14.9	3.9	5.5	13.1	15.6	6.5	8.9	10.6	5.4	30.7	0.0	6.7	7.3	10.2	10.3	23.7	11.2	16.2	13.7	7.5	40.5	10.3	4.9	1.7	35.5	30.3	2.6	3.9	14.9	8.0	4.3	9.9	7.0	12.5	38.2	20.4	10.7	11.9	19.0	18.8	5.2	11.5	16.4	39.2	8.7	6.5	8.3	0.1	10.0	27.9	8.1	3.0	37.4	17.4	16.9	4.3	17.9	19.9	29.8	9.8	8.4	10.4	20.5	9.5	28.8	10.7	0.7	0.8	1.6	0.5	0.9	0.2	0.4	0.3	0.3	0.6	0.4	0.1	0.4	0.0	2.6	0.8	0.0	0.2	0.4	1.4	1.3	0.9	1.7	1.3	3.1	1.6	2.0	1.6	1.2	2.5	1.8	3.0	0.0	2.0	2.3	2.9	3.3	1.4	3.5	6.2	5.7	6.0	4.3	1.5	1.5	5.8	3.7	2.1	6.1	3.9	3.6	1.9	0.6	0.0	3.4	3.2	5.1	6.7	11.1	2.4	1.4	6.8	3.4	2.0	2.1	9.5	3.5	8.6	1.3	2.6	1.7	3.3	6.7	4.1	1.0	2.1	0.4	3.1	2.2	5.4	1.9	1.1	1.3	5.2	3.0	4.5	1.3	6.3	3.4	0.7	2.3	0.6	1.3	5.7	2.8	0.0	2.5	2.6	0.1	0.5	9.8	6.3	3.3	3.1	4.3	5.7	5.7
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;testis: 9.7;urinary bladder: 9.5"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 13.2;Pancreatic endocrine cells: 30.9;Smooth muscle cells: 10.4;Spermatogonia: 13.1;Urothelial cells: 48.6"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.9;hTEC/SVTERT24-B: 51.5;RT4: 89.2;TIME: 46.2;U-87 MG: 84.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008"	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.05e-5)"	3.0	0.4	1.1	3.1	1.8	0.1	1.6	1.1	4.0	3.0	2.5	0.4	0.9	2.2	0.3	0.3	1.1	0.9	0.2	1.2	1.8	0.5	0.1	7.3	0.1	7.6	2.9	0.3	0.0	0.0	1.5	0.3	4.2	1.6	0.5	0.0	0.3	0.1	0.1	0.3	0.9	1.4	1.6	1.9	0.9	9.7	11.8	0.2	0.3	0.0	0.0	9.5	0.9	3.1	29.8	0.8	0.1	0.1	0.5	4.0	1.4	37.7	49.9	35.8	23.7	0.5	1.7	0.5	5.0	42.7	14.7	3.9	0.0	0.7	11.2	0.1	0.1	0.0	5.8	0.2	1.7	0.0	0.6	17.7	0.6	51.5	1.7	28.9	24.4	2.0	0.7	0.6	21.5	0.1	0.2	0.0	0.7	0.4	0.8	0.0	3.8	0.0	0.1	89.2	0.0	0.0	0.9	0.2	2.6	1.2	21.6	0.0	46.2	37.4	3.9	24.6	14.3	0.2	0.3	0.1	84.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.1	1.1	1.8	1.1	4.0	1.2	1.8	7.6	2.9	4.2	1.6	11.8	3.1	0.2	0.0	3.7	0.3	0.0	0.1	6.5	4.5	0.0	0.0	0.3	0.1	0.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	8.3	0.3	1.7	0.6	2.3	1.8	0.0	0.4	9.8	0.6	1.0	0.0	5.9	1.3	0.2	0.4	0.0	13.2	0.0	0.1	0.0	0.0	0.6	0.2	0.5	0.0	5.7	0.0	0.0	0.1	0.0	0.0	0.0	1.6	30.9	0.0	0.4	0.1	2.5	0.0	0.1	0.3	0.0	0.0	5.1	10.4	0.0	13.1	0.0	0.0	0.3	0.4	0.1	0.0	48.6
SPRY1	hSPRY1	ENSG00000164056	"Sprouty RTK signaling antagonist 1"	O43609	4	123396795-123403760	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 238.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 771.3;Endothelial cells: 352.8;Fibroblasts: 222.3;Leydig cells: 448.0;Skeletal myocytes: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 61.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 95.4;AN3-CA: 194.1;ASC diff: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013538, HPA051369, HPA070554"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Cytosol"	Nucleoplasm	"CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.21e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	238.1	38.4	6.5	22.3	7.9	22.7	154.3	7.6	9.0	71.9	26.6	46.6	15.7	40.9	24.1	42.5	81.2	83.8	73.1	7.5	8.4	35.6	21.5	58.3	13.0	5.5	5.4	30.0	31.8	37.4	27.3	49.6	5.8	52.0	27.5	19.0	45.2	24.7	49.9	79.8	25.2	57.7	5.6	17.0	35.1	10.2	7.6	29.2	92.7	49.9	10.1	74.4	71.0	6.0	6.3	1.8	95.4	194.1	76.5	51.6	6.4	0.4	4.9	0.3	2.0	5.8	10.3	0.0	42.4	2.9	0.4	1.2	2.6	4.6	0.7	0.1	10.0	2.2	0.0	31.0	21.7	14.2	0.1	21.1	2.5	0.7	2.1	10.5	8.1	2.2	1.7	1.9	4.7	0.7	16.4	34.8	22.8	22.6	32.0	7.1	10.3	0.2	13.2	14.5	14.5	12.3	0.1	19.4	19.6	10.1	1.9	0.0	20.2	1.2	0.2	0.4	2.9	1.0	0.1	0.2	1.4	2.6	3.2	0.1	0.4	6.5	1.1	0.2	33.1	29.8	4.0	9.2	0.1	61.2	5.7	6.4	0.4	14.2	0.1	1.7	0.0	2.0	6.5	7.9	7.6	9.0	7.5	8.4	5.5	5.4	5.8	5.6	7.6	6.0	771.3	28.9	28.3	14.4	16.2	49.6	17.3	37.3	68.9	86.2	22.8	69.6	16.9	32.9	20.6	27.6	33.3	12.7	21.6	10.4	80.3	5.0	2.5	45.9	41.9	352.8	26.5	5.7	5.0	10.9	1.7	222.3	8.2	67.4	9.5	0.2	166.3	5.9	10.1	6.7	2.2	15.0	14.2	15.3	37.9	10.5	448.0	17.1	46.2	5.6	0.7	158.3	0.0	7.5	0.3	7.0	6.3	57.9	6.1	16.8	8.1	38.7	11.7	84.5	151.2	245.0	81.6	6.2	9.6	37.0	43.3	3.1	57.3	1.8	17.9	13.5
SPRY3	HSPRY3	ENSG00000168939	"Sprouty RTK signaling antagonist 3"	O43610	X	155612572-155782459	"Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3"	"Group enriched"	"Detected in some"	7	"Astrocytes: 42.7;Excitatory neurons: 40.9;Inhibitory neurons: 43.5;Microglial cells: 62.8;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 20.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.7"					"Low region specificity"	"Detected in many"			CAB013505	Uncertain		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoli	"CAB013505: "	"unprognostic (3.70e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.52e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.49e-2)"	0.9	1.2	1.5	0.4	1.5	1.7	0.8	5.3	1.8	0.8	0.1	0.8	0.8	1.0	2.7	0.7	0.8	0.7	0.8	1.4	1.0	0.6	0.6	0.7	0.4	2.0	1.3	1.7	0.4	0.8	0.8	1.3	2.0	0.6	0.8	1.4	0.8	0.7	0.9	0.4	0.8	0.8	0.7	0.9	0.6	0.4	1.5	0.4	0.7	1.0	0.5	0.6	0.5	1.0	0.4	0.2	1.5	5.7	1.1	0.6	0.0	1.6	0.9	0.5	0.8	0.4	0.9	0.0	2.8	0.9	1.2	0.3	0.8	0.3	0.5	0.1	0.2	0.8	1.8	0.1	0.5	0.3	0.3	1.3	1.0	0.6	0.3	0.4	0.9	0.4	0.1	0.5	1.0	0.2	0.2	0.2	0.6	0.2	0.0	0.3	0.2	1.4	0.5	0.7	0.5	0.4	0.8	0.0	0.2	0.8	0.5	0.4	1.2	0.5	0.8	0.3	0.4	0.5	0.1	1.2	1.4	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	1.5	5.3	1.8	1.4	1.0	2.0	1.3	2.0	0.7	1.5	1.0	4.0	0.0	0.0	42.7	0.3	0.1	0.1	0.2	0.0	3.4	0.5	0.4	1.7	0.0	0.3	0.0	4.2	0.1	0.2	1.9	0.0	0.2	0.0	5.2	1.2	2.2	0.0	0.4	40.9	0.6	0.2	0.6	0.5	5.0	0.0	1.1	2.2	1.1	0.3	0.0	43.5	1.4	0.0	0.8	0.3	0.0	0.9	0.5	1.8	62.8	0.7	0.6	0.0	32.2	20.3	0.6	0.1	0.0	0.2	0.1	0.9	0.4	0.3	1.3	0.0	0.9	2.0	0.0	0.0	0.5	0.1	0.0	0.3	2.5	1.0	0.2
SPRYD3	FLJ14800	ENSG00000167778	"SPRY domain containing 3"	Q8NCJ5	12	53064316-53079404	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039426, HPA039685"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	"Vesicles, Plasma membrane, Actin filaments"	"HPA039426: AB_10673358, HPA039685: AB_2676623"	"unprognostic (7.73e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.27e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.78e-15)"	"unprognostic (9.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.41e-1)"	32.2	29.2	70.6	18.4	77.9	6.4	30.2	35.6	84.2	33.6	38.1	32.8	18.9	38.1	36.2	31.7	45.1	20.4	42.4	79.9	60.4	29.5	22.1	23.6	17.4	61.7	55.1	43.5	50.0	43.3	60.7	14.0	61.5	34.5	17.0	39.3	43.9	40.6	21.2	27.0	23.4	31.6	43.8	24.3	35.8	11.5	58.0	13.7	34.6	23.1	20.6	36.5	30.7	67.9	28.4	43.0	5.6	11.5	45.4	22.4	7.3	42.6	22.2	16.1	10.1	7.4	23.8	18.6	34.2	53.5	19.2	26.0	7.6	32.9	10.5	19.4	11.3	11.5	25.5	16.9	34.0	22.3	20.1	20.2	51.6	23.1	34.9	31.6	33.5	9.3	10.4	45.3	28.5	62.3	16.3	11.7	3.2	23.1	30.8	7.1	9.5	38.4	20.6	22.3	9.4	8.9	37.3	34.6	18.1	3.0	31.8	16.7	46.4	18.1	17.9	40.9	29.0	24.7	24.1	5.4	53.8	19.5	22.4	29.9	16.7	47.5	32.7	28.9	30.9	14.6	22.4	26.9	15.5	11.3	18.8	22.7	25.8	17.0	32.8	7.4	13.5	28.9	70.6	77.9	35.6	84.2	79.9	60.4	61.7	55.1	61.5	43.8	58.0	67.9	13.4	3.2	10.1	4.9	13.3	5.7	19.5	12.0	13.1	46.4	11.3	8.8	20.4	17.2	10.4	18.4	8.4	6.2	8.8	9.1	11.7	30.4	0.9	21.2	10.9	17.1	11.5	2.1	14.4	36.5	14.6	22.9	15.8	16.1	10.1	5.1	18.9	9.1	11.8	43.7	13.5	13.8	10.2	11.7	5.7	2.7	16.1	10.3	10.6	3.7	15.0	38.5	16.5	4.5	5.6	28.6	9.3	33.1	19.1	20.8	10.7	15.6	18.2	23.8	19.7	11.1	20.0	4.5	3.9	12.0	9.5	4.2	14.9	5.1	7.9	16.4
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.5;skeletal muscle: 123.9;tongue: 69.8"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 81.0;Excitatory neurons: 16.0;Horizontal cells: 16.8;Inhibitory neurons: 32.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 39.2;K-562: 47.8;U-937: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		NA	NA		7800000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	2.2	1.5	5.3	0.2	11.2	62.5	0.3	28.3	11.4	0.3	27.7	0.2	0.1	0.2	5.2	2.0	0.5	0.4	22.7	10.8	4.0	1.0	0.1	0.4	0.0	28.5	5.3	0.2	2.6	11.1	5.3	6.7	28.2	1.5	0.1	1.6	2.2	1.1	123.9	0.2	0.2	0.8	8.5	0.8	0.2	0.7	9.3	0.4	0.1	69.8	0.0	0.2	0.2	4.4	0.3	1.5	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.3	2.3	6.3	0.2	0.0	0.4	3.7	39.2	0.3	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	1.4	47.8	0.0	0.0	0.3	0.0	0.3	0.0	0.5	2.1	0.0	0.0	0.2	0.0	0.2	6.1	2.6	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	6.7	0.0	0.6	1.5	7.7	0.0	0.1	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.3	11.2	28.3	11.4	10.8	4.0	28.5	5.3	28.2	8.5	9.3	4.4	0.1	0.0	0.0	0.7	0.0	0.8	0.7	0.6	0.0	10.3	0.5	0.1	6.3	1.5	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.4	0.9	0.4	3.0	81.0	16.0	0.2	0.3	0.8	0.0	0.9	2.5	0.2	0.0	0.0	0.2	16.8	32.1	0.3	0.0	0.0	0.4	0.4	0.3	0.3	1.8	1.9	0.0	5.0	1.0	11.1	2.1	0.3	0.0	1.2	0.1	0.7	0.0	0.2	0.0	2.6	6.6	11.6	3.8	0.1	1.1	0.5	0.4	0.1	0.6	0.4	0.1	0.6
SRBD1	FLJ10379	ENSG00000068784	"S1 RNA binding domain 1"	Q8N5C6	2	45388680-45612165	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030567, HPA030568"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Mitochondria, Cytosol"		"HPA030567: AB_10611244, HPA030568: AB_10601856"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.20e-3)"	"unprognostic (4.14e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.29e-1)"	6.8	5.6	1.9	7.2	2.5	6.5	7.6	2.1	1.9	9.8	3.5	7.1	5.7	7.2	11.8	4.7	5.4	5.6	5.8	1.7	2.5	7.6	8.7	6.5	7.5	2.5	2.3	5.4	7.3	12.2	3.7	6.8	2.8	7.4	8.0	3.7	5.2	5.7	3.1	3.8	5.4	6.8	2.4	8.6	8.1	9.0	2.5	11.5	10.2	4.9	7.5	5.3	3.9	2.8	18.7	9.5	19.1	12.9	6.9	15.0	15.1	14.1	12.2	13.2	12.1	8.0	7.8	16.1	10.2	10.1	9.8	8.7	19.0	17.9	24.3	22.1	10.6	21.4	7.4	17.3	8.1	17.9	12.1	9.3	7.2	15.7	18.2	5.8	16.2	5.8	15.6	11.9	19.8	17.0	24.3	13.8	21.9	12.0	10.3	16.5	27.5	14.7	15.0	12.1	16.8	13.7	12.3	13.1	14.0	9.9	8.2	6.4	14.9	18.4	14.7	9.0	12.3	12.5	4.9	9.6	10.4	17.6	13.5	3.9	6.2	13.1	5.4	7.0	4.8	5.3	4.0	6.3	6.1	4.6	5.4	5.0	2.3	8.3	12.3	5.7	4.5	4.3	1.9	2.5	2.1	1.9	1.7	2.5	2.5	2.3	2.8	2.4	2.5	2.8	10.9	19.2	7.7	28.7	13.0	3.6	3.5	6.2	8.6	7.9	8.7	8.0	8.8	8.6	10.6	3.7	4.2	8.4	15.7	5.9	9.8	8.3	3.5	11.5	20.7	9.3	7.2	15.8	22.0	9.1	7.1	10.9	20.9	9.9	8.2	11.0	7.9	13.8	9.6	13.5	32.7	9.7	0.0	22.5	3.9	2.5	7.5	13.8	7.2	46.9	13.7	12.9	13.4	48.2	51.8	4.6	6.3	6.4	19.8	2.9	5.9	10.8	7.8	14.7	13.1	12.9	10.2	37.5	28.4	9.5	3.8	5.6	12.8	16.6	5.1	2.2
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346213-55373100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 245.5;Club cells: 245.2;Pancreatic endocrine cells: 155.5;Respiratory ciliated cells: 195.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 79.6"					"Low region specificity"	"Detected in all"			HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	12.5	12.0	10.4	2.5	11.5	3.7	12.2	11.0	12.4	12.9	9.2	7.3	3.8	6.8	4.2	26.1	5.6	10.3	9.3	10.7	10.1	9.6	14.5	10.5	2.5	11.0	11.2	3.1	20.2	7.0	5.9	4.0	10.8	7.4	4.1	1.5	16.4	2.9	6.3	15.4	7.0	2.6	10.9	6.8	9.7	3.3	10.9	6.0	7.6	5.4	6.0	10.0	14.7	12.7	9.7	4.3	10.3	10.1	29.4	20.4	5.6	10.4	9.3	2.4	5.4	6.5	19.5	21.2	11.7	11.0	11.1	7.0	5.3	7.9	3.9	6.6	17.1	12.3	5.2	15.8	9.2	23.7	6.1	17.6	14.5	5.4	5.3	7.8	14.4	38.5	21.2	47.7	21.1	10.8	36.0	10.3	13.0	53.2	9.3	11.4	3.3	14.0	12.8	7.9	16.0	9.1	10.7	79.6	8.3	9.0	9.4	17.9	8.3	25.0	4.7	2.0	8.1	28.6	15.8	7.9	34.1	29.5	25.9	25.6	35.8	11.7	16.1	56.5	18.6	12.5	12.0	15.2	30.2	12.7	10.2	14.4	1.8	8.6	59.5	61.7	12.5	23.1	10.4	11.5	11.0	12.4	10.7	10.1	11.0	11.2	10.8	10.9	10.9	12.7	25.4	9.6	15.9	4.6	7.8	13.6	13.3	245.5	5.2	4.9	43.8	29.3	5.3	34.3	245.2	5.5	4.2	27.0	21.2	12.2	3.9	93.4	3.2	51.2	31.0	19.6	12.0	14.9	11.1	105.4	106.0	16.2	13.3	105.9	14.0	6.7	17.5	18.6	63.4	10.1	17.1	22.6	57.0	32.4	34.1	0.5	1.8	27.6	24.9	4.7	31.3	21.9	18.6	8.5	23.4	155.5	10.0	5.7	16.8	17.5	9.4	18.4	195.0	3.9	13.1	13.3	28.2	3.5	20.1	32.7	29.7	7.5	7.2	15.4	23.3	108.6
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837011	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 202.5;SK-BR-3: 178.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710"	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	42.2	219.2	26.8	7.9	41.5	20.1	46.5	20.4	37.2	51.5	9.4	37.7	28.7	23.4	8.9	68.7	42.7	14.0	27.4	20.0	25.9	24.7	128.5	26.4	9.1	30.1	29.7	41.4	17.0	8.4	37.0	7.8	24.2	37.2	6.7	3.9	89.5	16.7	34.5	47.8	34.0	5.6	23.4	17.2	25.2	35.4	35.8	14.4	27.0	2.9	6.3	32.5	48.8	41.7	54.1	122.5	12.0	85.2	24.9	55.8	23.5	18.5	60.0	16.4	39.2	23.3	104.2	33.5	17.2	14.8	14.5	144.0	16.7	47.2	4.0	21.1	7.2	16.8	86.4	19.1	36.1	2.5	29.6	42.0	19.6	21.8	12.5	12.2	17.6	64.9	36.8	105.8	2.5	118.7	46.9	26.1	17.8	38.3	23.1	32.6	10.8	202.5	9.0	23.1	16.3	70.5	24.4	178.7	48.0	8.9	62.0	32.6	21.5	8.2	40.5	19.5	12.5	32.2	3.1	15.5	48.9	24.6	45.2	0.0	0.3	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.6	1.3	0.1	0.1	0.1	0.0	0.2	26.8	41.5	20.4	37.2	20.0	25.9	30.1	29.7	24.2	23.4	35.8	41.7	6.1	6.4	26.0	66.9	11.9	9.3	12.0	29.2	14.8	24.5	58.0	30.6	9.4	18.6	29.7	20.2	29.2	4.5	11.4	44.5	1.9	16.5	2.7	30.9	37.2	10.5	29.9	24.8	12.8	23.5	15.7	24.7	31.1	31.9	14.7	13.2	12.8	72.2	12.1	58.9	11.3	30.8	24.4	14.0	13.3	4.9	29.8	15.1	8.8	15.0	11.0	51.7	1.0	10.6	56.7	16.7	20.8	10.9	8.4	19.0	33.2	6.6	32.1	31.6	13.1	15.6	12.9	11.4	4.9	40.2	18.3	19.8	13.4	27.5	41.1	25.2
SRGAP1	"ARHGAP13, KIAA1304"	ENSG00000196935	"SLIT-ROBO Rho GTPase activating protein 1"	Q7Z6B7	12	63844700-64162217	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 159.0;Early spermatids: 192.4;Microglial cells: 151.8;Muller glia cells: 136.2;Oligodendrocyte precursor cells: 159.8;Oligodendrocytes: 135.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 30.4;hTERT-HME1: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052416, HPA078079"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA052416: AB_2681824, HPA078079: "	"unprognostic (3.05e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.54e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.56e-2)"	4.0	3.7	5.5	1.8	8.9	0.4	3.9	7.9	4.3	4.9	0.8	3.0	1.4	4.3	1.4	2.9	3.6	2.4	2.1	4.0	8.3	3.0	0.8	6.2	1.0	11.6	12.0	4.7	4.8	6.5	1.4	1.9	9.2	2.3	2.6	6.1	4.6	0.9	1.6	1.9	2.5	2.5	7.7	2.4	1.9	3.9	10.4	0.7	4.4	1.0	0.9	2.8	3.3	7.2	5.3	11.2	17.6	1.7	13.3	23.2	3.7	16.4	14.7	6.0	5.2	5.9	4.3	0.1	6.6	30.4	14.9	3.3	1.5	9.4	6.1	4.2	1.7	0.2	7.9	6.0	16.4	0.1	0.2	21.6	8.8	16.8	46.8	8.2	5.5	0.3	0.1	0.2	8.0	3.2	0.1	0.1	1.5	2.8	6.5	0.1	3.3	0.1	7.4	2.8	2.8	5.3	6.5	6.7	4.4	2.8	1.8	0.1	11.8	12.4	2.3	13.2	7.6	0.1	0.1	0.1	10.4	1.3	5.0	0.4	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	5.5	8.9	7.9	4.3	4.0	8.3	11.6	12.0	9.2	7.7	10.4	7.2	19.1	0.0	3.3	159.0	3.5	7.8	53.3	20.4	0.0	7.8	19.7	15.1	6.4	37.1	21.7	9.2	6.2	31.7	0.9	42.5	11.7	37.3	192.4	8.3	33.3	24.8	16.7	0.0	19.6	26.0	8.6	43.5	26.0	26.0	1.3	26.8	25.0	2.0	12.2	3.3	38.4	26.6	44.7	34.3	22.2	58.4	22.1	43.5	17.8	151.8	25.1	136.2	0.0	159.8	135.8	41.7	39.8	15.8	0.8	50.5	5.2	14.7	22.1	8.1	0.0	55.1	19.7	5.5	29.1	11.6	3.8	7.3	3.6	2.0	19.6	50.7
SRGAP2	"ARHGAP34, FNBP2, KIAA0456, SRGAP2A"	ENSG00000266028	"SLIT-ROBO Rho GTPase activating protein 2"	O75044	1	206203345-206464443	"Disease related genes, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.0"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 497.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028191, HPA028196, HPA078079"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: "	"unprognostic (2.57e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (2.70e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.18e-3)"	23.6	19.8	29.8	15.8	32.9	22.3	18.0	114.0	41.8	16.5	21.7	12.4	5.8	13.8	13.4	12.9	14.6	11.7	12.3	36.5	34.5	15.4	8.0	20.9	15.2	48.4	41.0	18.2	7.9	25.3	10.4	20.0	55.9	9.0	6.0	9.9	10.0	9.0	6.8	46.9	10.6	15.3	43.4	24.7	8.7	10.7	42.8	13.8	9.9	18.0	13.7	11.9	16.5	57.4	45.6	30.0	99.7	25.6	46.4	41.6	39.0	38.5	28.7	32.9	35.9	20.7	34.0	17.6	21.6	42.9	43.8	36.1	30.0	25.4	32.7	22.2	24.4	36.5	56.4	31.2	19.3	25.4	39.4	37.6	21.6	42.2	29.3	35.7	57.9	22.6	30.6	55.4	21.2	31.6	20.3	22.4	32.2	8.1	34.1	45.3	40.8	42.6	14.1	8.2	33.2	15.2	32.7	23.9	47.5	37.4	29.7	44.4	57.9	32.1	38.4	39.9	35.8	36.8	35.7	16.5	38.4	34.6	80.0	1.0	12.2	0.7	3.2	11.8	1.3	2.6	2.6	3.3	8.3	5.3	1.0	2.2	17.7	2.1	14.0	16.2	4.0	3.7	29.8	32.9	114.0	41.8	36.5	34.5	48.4	41.0	55.9	43.4	42.8	57.4	45.5	9.6	12.1	9.4	18.0	23.8	6.1	7.5	8.6	39.5	3.6	4.4	4.6	11.5	7.9	11.0	4.2	4.1	17.1	0.3	0.0	7.2	57.7	16.4	18.4	37.2	1.2	13.2	72.2	2.1	18.3	18.6	10.2	9.7	8.2	12.0	28.9	2.9	19.0	1.7	105.0	3.3	0.0	46.2	62.5	51.0	7.8	54.1	16.0	497.5	25.4	6.6	5.2	54.3	58.5	4.8	1.3	2.6	16.0	4.2	1.4	0.8	14.5	5.8	0.0	18.5	17.9	19.0	11.6	12.1	36.4	4.2	11.9	9.7	1.8	5.8
SRGAP2B	SRGAP2P2	ENSG00000196369	"SLIT-ROBO Rho GTPase activating protein 2B"	P0DMP2	1	144887265-145095528	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.7"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 239.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;granulocytes: 3.9;monocytes: 7.9"	"Low cell line specificity"	"Detected in all"											HPA078079			Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA078079: "	"unprognostic (1.13e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.48e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-5)"	"unprognostic (3.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-1)"	9.3	10.5	9.9	6.8	9.2	7.7	6.1	48.7	10.3	6.3	3.7	4.7	2.8	6.2	4.2	5.7	6.7	5.7	5.1	10.3	10.5	8.0	4.2	8.6	5.6	15.4	14.4	8.6	3.6	13.1	3.0	10.8	19.4	3.7	2.8	3.7	3.3	4.6	8.9	18.9	3.5	7.1	14.9	12.4	2.9	3.5	12.4	6.4	4.3	5.8	3.7	5.0	6.4	17.1	13.4	28.5	60.3	12.5	28.3	24.3	19.0	14.6	12.8	12.2	14.0	8.7	24.1	6.7	19.1	8.7	21.7	22.8	15.6	8.5	15.0	6.3	15.8	9.8	20.6	12.1	19.8	8.8	12.5	17.3	12.6	30.1	26.4	18.4	24.8	5.7	5.3	23.1	6.7	15.1	3.8	10.3	11.2	6.7	10.2	10.3	12.9	11.6	10.5	5.8	7.5	9.5	19.3	6.9	31.6	14.9	14.4	22.1	45.3	26.1	26.7	23.3	17.1	9.6	12.7	4.1	9.5	11.6	37.7	1.2	3.8	0.5	0.6	5.4	0.5	0.9	1.0	1.2	2.7	0.9	0.6	0.7	3.9	0.4	7.9	3.6	1.1	0.9	9.9	9.2	48.7	10.3	10.3	10.5	15.4	14.4	19.4	14.9	12.4	17.1	37.3	25.6	7.7	5.5	14.0	0.0	3.5	0.0	6.8	17.6	3.1	3.4	3.3	5.7	2.5	9.2	2.1	4.7	20.3	0.5	0.0	6.8	1.1	13.8	14.0	35.1	2.4	29.3	37.5	3.0	21.5	15.3	3.1	6.0	1.3	3.3	54.3	4.3	12.9	0.0	55.6	2.0	0.0	58.7	0.0	2.7	15.2	40.1	0.0	239.8	38.4	8.1	16.5	24.6	9.5	6.0	0.2	9.8	8.4	4.8	0.8	1.2	8.0	2.9	6.6	16.9	12.3	4.5	6.9	19.9	0.0	2.9	6.9	8.6	1.8	4.2
SRGAP2C	SRGAP2P1	ENSG00000171943	"SLIT-ROBO Rho GTPase activating protein 2C"	P0DJJ0	1	121184811-121392874	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.2"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 180.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 80.0"									HPA078079			Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA078079: "	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.48e-6)"	"unprognostic (2.40e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.18e-4)"	"unprognostic (6.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.71e-7)"	"unprognostic (4.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.66e-2)"	8.3	6.5	11.1	3.7	13.2	7.2	5.7	31.2	12.5	5.8	3.9	6.5	2.1	5.4	2.2	4.3	5.0	4.6	5.8	11.7	11.8	7.1	4.7	7.3	4.6	16.1	12.3	6.8	2.2	13.7	3.3	8.0	17.6	3.6	2.8	3.5	3.0	4.6	2.8	15.5	3.6	6.0	16.6	10.7	3.2	1.5	12.4	4.2	3.9	10.7	3.4	4.6	5.5	21.9	11.1	14.1	30.7	6.8	23.1	20.1	16.8	12.3	9.8	10.2	13.2	0.2	11.0	7.0	10.8	16.8	7.3	5.9	11.0	8.9	13.4	9.2	11.2	10.0	24.5	11.1	13.3	6.8	11.4	15.2	8.9	13.1	16.6	11.6	24.5	4.3	9.3	12.8	7.6	6.6	4.3	8.6	9.7	3.5	6.7	6.2	35.9	6.2	9.7	6.5	5.9	3.8	21.2	7.5	38.6	15.8	9.5	19.8	21.9	19.1	18.7	28.9	18.1	7.3	5.6	4.2	16.7	13.7	80.0	0.3	3.4	0.6	1.1	2.8	0.7	0.9	1.3	1.2	2.5	0.9	0.6	0.8	3.2	0.6	5.3	2.4	1.3	0.9	11.1	13.2	31.2	12.5	11.7	11.8	16.1	12.3	17.6	16.6	12.4	21.9	39.9	54.5	11.5	5.2	14.4	0.0	5.6	0.0	6.2	14.2	5.8	6.7	4.3	15.7	5.0	11.0	2.1	5.5	15.5	1.2	1.9	10.9	1.0	11.7	15.4	34.6	2.4	29.7	42.0	5.0	24.8	15.9	5.1	6.4	6.3	7.8	55.3	8.7	19.9	0.0	62.6	2.7	0.0	64.2	0.0	2.1	19.6	41.6	0.0	180.8	39.6	8.4	18.6	35.2	27.4	7.2	1.4	25.6	10.7	5.0	0.5	1.0	8.7	4.3	32.9	20.2	14.5	10.1	10.8	12.5	0.0	2.5	12.6	7.0	2.0	4.5
SRGAP3	"ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP"	ENSG00000196220	"SLIT-ROBO Rho GTPase activating protein 3"	O43295	3	8980591-9363053	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1;retina: 14.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 201.8;Bipolar cells: 217.5;Cone photoreceptor cells: 273.1;Endometrial ciliated cells: 166.0;Excitatory neurons: 223.1;Horizontal cells: 228.8;Inhibitory neurons: 281.2;Oligodendrocyte precursor cells: 159.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.3;HBEC3-KT: 8.2;hTCEpi: 7.8;RT4: 10.9;T-47d: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036959, HPA044074, HPA078079"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: "	"unprognostic (3.63e-3)"	"unprognostic (1.12e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.39e-3)"	0.7	3.3	12.3	0.7	13.9	0.3	1.5	22.1	16.9	5.2	0.3	1.0	0.7	2.2	1.5	2.3	10.9	1.0	1.8	14.5	9.1	3.2	0.5	1.0	1.1	5.1	9.8	3.7	1.1	0.6	6.1	0.7	7.4	4.5	1.1	14.8	4.2	1.4	1.3	3.7	0.9	0.7	5.6	0.7	1.5	3.5	11.9	1.8	2.6	2.1	0.9	4.1	1.7	10.0	0.5	0.5	9.3	0.4	0.6	1.2	1.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.0	0.1	4.8	0.2	8.2	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	5.0	0.7	7.8	0.6	0.8	0.2	0.0	2.1	0.0	0.0	0.0	0.1	0.2	2.0	0.9	1.6	0.7	1.1	0.0	0.0	3.8	10.9	1.0	1.2	0.2	2.8	0.1	2.2	10.5	0.0	0.0	0.0	0.3	0.1	0.1	2.7	0.1	0.0	0.8	1.7	0.3	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	12.3	13.9	22.1	16.9	14.5	9.1	5.1	9.8	7.4	5.6	11.9	10.0	1.0	3.2	5.6	201.8	2.3	4.1	28.7	36.3	23.3	217.5	7.9	9.8	9.6	0.0	40.6	77.3	273.1	2.4	3.5	1.4	5.9	3.2	24.1	166.0	6.0	4.2	3.0	0.8	223.1	0.5	0.8	4.9	8.2	93.8	1.3	5.4	0.7	2.1	13.2	228.8	281.2	6.2	12.2	18.6	6.0	20.2	2.5	9.4	1.8	37.5	3.3	80.6	1.0	159.8	132.2	0.6	0.5	1.2	1.4	12.3	0.5	1.4	59.4	94.8	0.0	2.9	3.9	6.1	7.1	17.2	5.8	1.4	14.7	12.0	3.1	31.2
SRM	"SPS1, SRML1"	ENSG00000116649	"Spermidine synthase"	P19623	1	11054584-11060020	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 371.7;Prostatic glandular cells: 249.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015746	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA015746: AB_1857472"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.25e-5)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.74e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.98e-2)"	77.5	69.5	53.9	54.3	54.8	31.5	64.5	45.9	71.1	58.1	45.4	56.2	19.1	68.7	16.0	63.9	57.8	18.7	89.5	57.1	52.5	43.3	77.5	53.7	44.4	49.4	58.9	60.6	190.8	15.1	53.4	26.0	51.8	50.1	19.8	10.2	52.4	28.7	127.1	54.2	40.1	40.8	49.0	70.7	57.6	33.0	57.9	24.2	34.4	48.3	38.2	74.5	48.6	47.5	149.6	212.1	69.1	232.5	134.8	144.6	107.7	224.9	114.7	315.1	168.1	263.5	87.4	284.3	127.8	197.2	98.8	114.0	222.6	181.6	104.2	140.5	337.0	180.1	225.3	302.0	197.7	305.6	157.6	145.9	129.1	306.0	266.0	73.8	134.8	183.2	298.1	234.7	155.8	326.5	261.7	266.3	150.5	136.0	405.4	194.6	71.3	466.2	112.4	58.3	132.3	126.5	116.8	248.4	182.3	53.1	87.1	153.2	113.4	204.3	161.7	357.5	257.1	185.6	201.7	429.6	142.4	406.2	241.2	0.0	5.9	0.4	7.4	6.8	10.8	12.5	7.2	9.3	7.0	11.3	8.5	10.0	0.2	5.7	3.5	11.2	8.8	2.3	53.9	54.8	45.9	71.1	57.1	52.5	49.4	58.9	51.8	49.0	57.9	47.5	68.5	0.0	4.6	4.9	115.2	95.0	92.6	6.9	18.2	27.4	75.7	165.7	31.7	28.6	4.0	29.5	20.9	78.0	44.9	23.0	76.3	20.0	4.1	11.0	97.9	54.5	27.5	67.9	13.9	43.2	198.4	91.8	36.2	16.6	26.7	102.0	35.0	50.5	96.4	30.3	23.0	39.9	6.1	41.2	41.7	14.7	71.7	39.8	67.6	10.3	22.4	44.0	29.9	15.6	9.6	30.4	10.8	53.0	371.7	249.9	3.5	86.0	2.5	18.3	0.0	70.7	66.3	14.1	75.9	47.8	113.1	36.0	49.5	108.3	43.1	95.5
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 1.6"	"Cell type enriched"	"Detected in single"	4	"Gastric mucus-secreting cells: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.3;MCF7: 3.0;OE19: 4.4;RT4: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.0	0.0	0.1	0.2	0.1	0.1	0.4	0.6	0.2	0.0	0.0	0.7	0.2	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.8	0.0	0.0	0.4	0.2	0.0	0.1	0.9	1.6	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	1.3	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.1	0.0	4.4	0.4	0.0	0.1	0.0	0.0	6.0	0.4	0.5	0.1	1.2	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029686	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Hydrolase, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 327.3;Late spermatids: 901.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA048977: AB_2680583, HPA062044: AB_2684668"	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	22.8	33.1	17.1	30.2	18.1	17.4	28.7	19.3	22.5	32.5	20.9	28.1	25.8	23.3	35.8	28.5	22.0	23.2	32.1	17.6	21.3	35.3	61.9	25.0	34.6	19.8	19.2	22.7	55.0	39.7	36.2	29.5	20.5	31.2	29.5	24.2	60.3	28.7	39.8	26.1	26.8	23.5	20.0	28.4	30.4	44.0	18.1	35.5	30.9	33.7	42.6	34.8	23.1	21.4	59.3	66.9	56.7	54.9	62.8	61.3	67.8	83.2	78.3	87.3	107.0	71.3	62.8	75.8	77.5	81.4	75.8	56.1	79.0	66.7	125.6	87.5	37.8	70.9	54.6	184.6	92.7	70.5	65.4	51.5	64.8	63.5	102.3	66.1	88.8	64.9	61.7	82.7	93.1	98.8	81.9	42.4	45.0	96.1	61.3	58.5	72.2	67.4	104.9	89.3	48.9	59.4	59.3	76.7	74.6	71.4	99.4	49.7	66.6	48.7	51.0	62.8	57.1	73.2	108.3	101.1	36.8	45.9	63.5	23.8	27.4	39.2	31.0	35.0	39.6	25.6	31.4	34.0	32.8	25.8	28.7	28.3	27.1	42.1	47.0	21.9	48.2	30.5	17.1	18.1	19.3	22.5	17.6	21.3	19.8	19.2	20.5	20.0	18.1	21.4	40.8	12.8	49.3	25.5	63.2	40.0	56.0	74.6	37.5	37.5	40.7	29.0	41.0	34.3	81.2	40.5	58.4	67.3	59.6	39.4	64.6	73.2	327.3	53.1	43.9	40.7	44.9	36.2	25.4	79.8	75.6	45.8	38.7	64.3	47.5	37.3	36.4	110.0	49.7	26.9	26.8	48.7	87.5	39.0	43.6	901.8	38.5	47.4	28.4	24.4	56.1	44.3	41.2	27.6	54.6	55.1	34.0	37.6	133.1	60.7	39.0	79.2	93.0	50.1	26.3	38.3	46.1	95.4	76.0	36.0	50.3	94.0	64.7	43.0	31.6	64.5
SRRD	"HC/HCC, SRR1L"	ENSG00000100104	"SRR1 domain containing"	Q9UH36	22	26483877-26494658	"Predicted intracellular proteins"	"Biological rhythms, Heme biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 49.0;Late spermatids: 54.9;Pancreatic endocrine cells: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002945	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA002945: AB_1079265"	"unprognostic (3.25e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (9.00e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.96e-1)"	5.0	3.5	8.4	4.1	8.8	6.2	6.2	10.4	9.7	5.5	6.2	6.0	3.6	6.3	6.1	5.3	5.5	3.7	7.6	8.7	8.0	6.4	6.9	5.3	5.6	8.2	8.2	7.1	5.5	6.7	5.1	5.3	7.7	6.8	5.2	5.8	4.9	7.2	19.6	6.0	3.9	7.0	8.1	5.4	4.9	4.8	8.6	5.7	10.5	17.1	7.3	5.5	4.2	8.6	10.7	6.3	10.6	10.9	10.8	6.5	6.1	7.4	10.4	14.7	13.5	6.2	4.6	23.6	5.1	9.7	7.4	9.5	16.6	15.6	14.3	12.2	16.5	10.4	5.5	10.1	7.6	23.1	7.8	6.2	13.4	10.5	16.4	9.7	12.9	13.8	17.2	14.5	9.7	9.2	10.4	7.3	6.6	11.7	7.9	23.3	13.2	17.0	9.7	7.6	11.2	7.6	8.5	7.6	19.7	8.8	9.1	9.0	9.9	11.3	37.2	6.4	13.1	9.5	8.3	19.4	7.7	9.4	15.0	0.3	0.5	0.2	0.7	0.4	1.0	1.1	0.8	1.0	0.5	0.6	1.1	1.2	0.4	0.9	0.4	0.4	0.2	0.3	8.4	8.8	10.4	9.7	8.7	8.0	8.2	8.2	7.7	8.1	8.6	8.6	12.1	0.0	6.4	3.6	10.6	29.7	16.2	7.5	3.4	13.0	10.0	10.5	3.0	12.8	5.9	1.8	2.1	13.3	5.9	3.7	9.8	24.9	22.4	5.8	10.6	11.2	4.8	46.9	3.1	49.0	22.9	8.9	7.7	8.9	11.4	15.1	11.0	15.4	14.1	13.5	3.0	4.5	2.0	3.8	8.6	54.9	7.2	8.6	8.8	1.0	6.1	9.8	10.3	3.5	1.9	48.9	2.4	9.1	10.4	12.1	3.4	19.9	3.2	9.3	6.6	12.6	10.3	17.8	12.9	7.7	31.8	16.7	9.1	21.7	5.9	14.7
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737333	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	106.0	106.8	27.8	95.5	29.6	184.7	92.1	29.9	34.0	83.6	37.7	100.3	86.2	88.9	64.0	129.5	89.5	42.1	78.5	29.2	32.9	83.0	115.2	95.4	111.6	30.8	28.5	85.6	88.3	48.4	81.9	66.0	30.3	78.0	71.6	53.4	90.6	52.3	91.7	96.5	113.2	49.0	31.3	121.6	94.4	49.5	30.0	94.2	102.1	36.0	100.2	80.0	94.3	36.0	318.7	239.8	289.5	207.5	70.9	58.5	300.5	197.3	146.8	225.4	207.0	257.2	216.8	478.0	143.3	188.7	164.3	279.9	293.3	229.0	230.2	202.3	489.3	357.9	246.6	311.9	79.3	404.4	210.6	65.2	51.1	186.2	54.0	91.1	179.9	212.0	373.4	209.6	183.7	251.0	460.0	440.9	339.5	186.4	340.2	455.0	310.6	360.5	156.5	225.2	247.7	350.8	227.1	196.3	120.4	154.0	238.8	301.6	187.9	206.9	271.3	139.4	330.0	278.2	219.2	552.9	187.3	318.9	177.1	2.5	40.9	10.0	26.0	53.3	26.0	23.5	17.7	26.7	67.0	19.6	20.1	19.4	4.4	35.6	33.6	49.2	24.0	33.0	27.8	29.6	29.9	34.0	29.2	32.9	30.8	28.5	30.3	31.3	30.0	36.0	271.3	118.6	105.6	57.5	396.7	460.8	439.7	205.9	540.1	151.9	291.7	277.9	86.2	148.7	141.5	88.3	91.8	339.4	548.0	233.1	156.5	199.1	203.6	176.8	181.9	204.3	266.3	366.6	51.1	157.3	579.7	233.9	196.7	257.4	218.4	241.7	116.7	125.1	251.3	99.3	55.4	246.9	132.2	143.7	480.4	162.0	159.1	273.5	282.8	63.7	226.9	153.3	196.7	55.8	87.9	189.0	288.7	127.5	492.0	384.8	250.5	128.7	97.4	188.9	118.3	286.8	242.1	272.3	296.8	489.5	443.4	316.0	469.1	185.4	329.4	459.4
SRSF5	"HRS, SFRS5, SRP40"	ENSG00000100650	"Serine and arginine rich splicing factor 5"	Q13243	14	69726900-69772005	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043484, HPA056523"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		23000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043484: AB_10797143, HPA056523: AB_2683164"	"unprognostic (2.08e-3)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.07e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	210.9	188.4	68.1	149.5	72.5	456.9	229.8	60.3	108.2	174.2	125.9	231.8	129.2	222.5	218.0	217.9	240.9	130.1	154.4	75.9	69.7	119.6	183.8	214.8	210.1	75.5	71.1	220.0	136.6	188.1	215.5	105.1	74.1	172.7	164.8	233.8	235.8	126.7	217.6	282.0	256.6	180.3	66.0	211.8	212.8	104.1	69.5	214.7	224.8	68.3	155.0	189.3	177.4	97.1	456.4	133.5	313.8	141.4	192.7	179.6	177.4	214.6	239.7	177.6	183.7	164.7	283.6	473.1	110.4	301.8	174.7	210.2	242.5	309.2	209.7	407.4	142.3	354.3	386.7	183.6	224.3	334.7	255.7	350.9	201.2	199.7	216.3	260.4	247.0	401.8	255.4	268.3	114.3	382.1	385.1	232.4	182.0	356.6	128.2	324.0	148.5	183.3	237.2	563.1	165.9	236.3	364.3	214.1	296.0	188.5	235.9	292.3	299.7	98.4	264.2	110.9	205.6	261.6	184.5	754.8	232.3	286.1	140.1	137.1	65.8	103.6	93.1	117.9	94.9	109.5	83.1	85.0	70.1	108.7	81.1	79.6	161.9	86.2	129.6	99.8	74.8	77.2	68.1	72.5	60.3	108.2	75.9	69.7	75.5	71.1	74.1	66.0	69.5	97.1	380.7	253.2	309.1	218.1	392.8	138.0	768.6	610.1	204.9	387.4	248.6	259.1	195.0	240.2	386.6	183.9	239.8	444.3	542.9	471.8	320.8	201.7	190.3	224.2	169.8	293.6	302.9	195.4	199.5	171.8	261.5	288.0	188.6	225.3	480.2	251.3	249.9	225.4	217.7	378.6	177.7	376.6	380.5	236.2	154.3	105.0	345.5	314.7	133.4	104.9	323.4	277.4	428.5	128.2	268.7	226.6	538.5	267.1	212.3	376.7	484.7	228.2	373.4	317.3	276.1	583.7	354.2	201.8	149.8	196.4	145.6	749.2	456.6	201.6	275.5	542.1
SRSF8	"SFRS2B, SRP46"	ENSG00000263465	"Serine and arginine rich splicing factor 8"	Q9BRL6	11	95066919-95071225	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049905	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.99e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.75e-3)"	14.8	13.5	16.3	12.1	16.0	14.7	16.7	16.5	18.0	14.7	16.8	15.1	15.7	17.3	16.0	14.5	15.3	12.0	13.4	15.8	17.0	19.3	15.1	13.5	17.4	15.0	15.5	20.7	21.9	17.9	15.7	14.3	15.3	19.0	15.6	10.4	19.9	16.8	13.2	14.9	17.4	14.7	16.2	20.0	15.8	5.3	17.5	12.3	23.2	14.1	14.7	13.2	13.6	17.7	7.6	7.7	19.1	0.0	24.9	15.5	21.7	11.1	12.2	5.1	5.5	18.4	24.2	40.3	32.2	16.9	9.4	16.3	16.2	24.1	5.9	24.4	17.8	33.8	9.0	16.6	18.3	34.3	17.7	20.3	25.1	5.4	25.3	15.0	16.2	18.1	25.9	21.5	10.1	10.3	17.9	30.4	10.2	19.8	21.7	22.1	5.8	32.1	20.1	24.8	24.2	24.7	13.8	24.1	16.7	12.0	9.6	18.7	15.3	9.9	13.3	13.5	11.6	11.6	19.1	21.4	5.1	22.5	22.1	10.1	2.1	0.7	5.4	1.2	7.9	9.2	9.4	8.1	4.0	7.1	12.0	9.1	0.6	6.2	1.1	3.7	10.9	4.1	16.3	16.0	16.5	18.0	15.8	17.0	15.0	15.5	15.3	16.2	17.5	17.7	32.5	44.8	29.3	8.8	82.8	0.0	51.4	0.0	57.5	49.3	54.4	60.3	21.4	58.6	11.8	33.1	33.3	39.2	56.5	41.1	150.6	36.7	1.8	22.1	27.6	45.8	56.9	122.9	18.3	45.7	52.7	31.4	40.2	33.8	10.2	43.2	52.5	57.8	26.1	18.5	16.6	82.6	0.0	24.2	0.0	6.0	41.0	41.9	0.0	18.7	40.2	45.7	97.9	13.6	29.6	28.9	40.8	60.9	46.8	46.4	53.4	110.1	9.5	50.9	32.9	34.6	31.0	7.2	6.4	63.5	0.0	51.2	58.4	52.1	67.5	38.0
SS18	"SSXT, SYT"	ENSG00000141380	"SS18 subunit of BAF chromatin remodeling complex"	Q15532	18	26016253-26091217	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055741, HPA059539"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA055741: AB_2682901, HPA059539: AB_2684055"	"unprognostic (2.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.30e-1)"	29.5	46.2	21.2	27.7	24.9	23.0	33.2	23.6	22.6	32.1	26.3	28.4	18.0	32.2	39.4	34.5	33.2	29.8	29.4	21.8	23.6	36.8	41.9	26.8	35.9	25.5	24.7	47.7	23.8	52.0	30.5	36.9	24.5	35.0	23.4	24.7	29.7	31.2	11.6	41.2	27.7	31.8	23.8	28.5	26.8	25.9	22.4	33.6	45.4	17.5	38.6	38.3	31.2	29.1	52.4	37.2	90.8	43.9	69.0	65.1	45.8	62.9	57.6	55.1	53.6	24.5	43.1	90.6	49.1	75.0	49.0	67.1	50.1	62.0	67.5	58.4	23.3	45.4	56.2	39.8	55.6	69.8	66.5	81.4	71.3	68.6	74.3	53.7	43.7	26.6	34.2	45.0	76.3	53.1	28.5	39.9	17.3	51.6	35.7	33.0	70.2	44.2	57.6	60.7	38.1	57.7	96.0	43.8	27.0	64.6	45.5	40.9	51.4	114.1	22.6	26.8	63.9	80.9	58.3	64.0	53.9	47.8	62.2	27.1	13.5	19.4	16.4	19.7	19.2	17.7	15.6	17.1	15.2	15.0	16.2	18.6	5.7	24.6	20.2	8.5	18.2	16.3	21.2	24.9	23.6	22.6	21.8	23.6	25.5	24.7	24.5	23.8	22.4	29.1	28.8	28.9	23.7	43.8	45.9	8.9	27.8	13.9	40.9	28.8	29.4	26.4	16.0	22.8	18.1	23.9	16.7	70.0	34.0	25.2	21.5	30.3	52.7	44.8	31.5	27.9	24.7	26.1	50.7	26.0	48.8	30.4	22.4	32.3	36.8	60.2	22.1	34.5	27.6	87.5	42.7	25.7	6.1	25.5	10.9	51.4	33.2	22.6	5.4	65.6	19.7	51.1	22.6	90.5	118.0	34.8	15.7	41.0	42.0	24.8	19.1	24.9	30.5	29.8	39.5	23.4	31.3	29.3	20.3	37.2	13.2	85.1	34.0	30.7	16.9	24.7
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519099	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 39.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 19.3;Fibroblasts: 27.0;Leydig cells: 18.0;Peritubular cells: 15.8;Skeletal myocytes: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.9;BJ: 22.7;fHDF/TERT166: 27.5;hTERT-RPE1: 23.2;U-87 MG: 27.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		88000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	13.1	2.2	2.6	3.6	4.6	0.1	8.8	3.0	2.1	23.0	1.8	33.6	1.9	39.7	3.9	5.7	17.0	12.9	17.6	1.8	2.1	3.6	1.7	9.1	1.3	3.9	2.6	14.5	1.8	0.3	17.6	1.9	4.0	8.8	2.8	1.1	3.4	12.8	3.6	5.6	8.7	20.1	2.2	11.1	9.8	2.6	3.6	2.0	3.8	2.8	0.5	10.6	15.9	2.1	0.1	1.4	0.5	0.0	3.3	26.9	0.0	22.7	5.5	3.7	4.6	0.4	0.0	1.2	0.3	27.5	1.1	0.0	0.0	0.0	1.9	0.1	0.3	5.6	1.5	0.0	5.2	0.1	9.6	12.3	0.0	5.4	0.0	23.2	0.0	0.7	0.2	0.3	0.6	0.1	0.1	0.5	0.9	0.0	0.2	0.7	1.2	0.3	2.5	0.0	2.9	0.4	0.4	0.0	0.5	0.5	0.4	1.2	7.9	1.0	1.3	1.1	3.8	0.4	0.0	0.1	27.8	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.6	3.0	2.1	1.8	2.1	3.9	2.6	4.0	2.2	3.6	2.1	3.5	3.2	0.6	4.2	0.3	1.9	0.3	0.3	0.0	5.3	0.8	1.1	2.8	0.0	0.1	0.0	2.1	0.1	0.4	0.8	1.9	0.1	0.6	1.5	19.3	3.3	0.0	0.0	1.5	0.0	0.1	27.0	2.0	0.9	0.0	0.5	2.2	0.0	1.2	3.3	1.1	0.4	0.0	1.0	3.8	1.3	18.0	2.0	1.8	2.8	0.7	2.1	0.0	0.0	0.3	0.1	0.3	15.8	0.3	0.3	4.6	0.2	0.7	1.9	0.0	32.1	6.8	0.9	1.1	0.4	1.8	0.0	0.5	0.9	1.4	0.2
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303478-67312607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.6;eosinophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 64.9;MCF7: 64.1;RT4: 111.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	14.4	7.8	8.9	4.0	12.0	9.3	16.2	14.1	11.6	25.9	9.5	19.3	13.3	16.0	7.5	41.9	18.3	11.5	12.5	9.1	10.1	13.1	10.9	12.7	3.1	14.6	10.8	23.5	15.3	9.8	9.7	6.5	13.2	29.9	9.3	1.2	26.2	28.8	6.8	25.2	15.0	6.1	12.3	9.4	20.1	2.3	11.5	1.9	16.3	3.8	4.8	37.4	32.5	14.9	17.3	18.7	0.4	0.6	11.4	11.8	18.8	10.3	13.7	5.6	5.1	21.2	46.8	1.0	32.5	10.5	11.9	64.9	6.0	46.4	2.8	3.6	6.3	4.3	32.2	9.9	8.2	0.9	16.0	12.2	40.5	8.3	8.3	12.9	6.3	0.4	0.1	1.5	6.2	64.1	0.8	7.3	4.2	48.9	13.8	20.6	0.6	3.1	18.2	111.2	3.7	5.8	24.8	41.0	12.8	6.3	57.1	15.3	10.4	4.5	9.8	12.7	2.7	1.5	0.9	0.5	12.7	6.9	4.9	11.6	1.5	11.1	2.0	2.3	1.7	0.2	1.9	1.7	1.7	0.1	0.8	0.8	4.4	1.5	1.1	1.1	1.8	1.1	8.9	12.0	14.1	11.6	9.1	10.1	14.6	10.8	13.2	12.3	11.5	14.9	7.6	3.2	8.7	8.5	0.9	7.0	20.8	25.2	11.4	0.8	21.3	17.3	3.8	20.0	23.4	16.5	0.0	15.1	3.3	28.3	3.9	19.4	0.1	8.3	5.6	4.7	3.6	5.2	4.2	21.6	24.9	8.0	20.9	17.8	3.8	8.1	3.9	5.0	7.7	1.7	5.3	14.4	24.4	6.2	3.1	0.6	13.1	4.8	8.8	2.8	9.2	4.8	7.2	0.0	15.9	20.0	21.0	12.0	0.7	15.4	20.2	7.4	11.6	0.5	0.0	4.9	9.2	0.5	0.4	27.0	10.4	15.7	4.4	5.3	21.4	26.8
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325986-57335892	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		42000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	52.3	42.7	37.6	62.9	39.1	78.9	53.7	37.9	46.4	61.0	37.2	64.7	48.3	64.9	47.7	67.7	68.3	37.0	47.0	39.3	41.2	48.8	43.3	51.7	76.1	38.2	38.9	74.1	74.0	60.9	57.4	57.5	37.1	46.6	66.1	36.0	55.0	49.6	140.6	67.0	55.1	58.4	38.5	52.6	59.8	45.8	42.4	87.8	54.0	63.9	91.9	58.6	56.4	40.2	353.0	332.0	308.3	226.9	95.1	105.1	150.7	188.9	181.1	321.8	229.2	230.0	255.2	424.4	196.7	166.7	204.5	264.8	493.7	293.9	402.2	297.7	276.9	271.5	233.1	250.5	149.3	455.4	195.3	106.7	175.7	331.8	456.8	149.1	213.3	320.7	376.0	207.9	222.6	237.1	463.3	400.3	406.1	186.1	201.7	386.1	520.4	412.0	151.7	249.3	321.4	271.6	267.6	226.2	286.7	157.0	275.3	177.0	162.7	218.2	287.1	298.3	328.9	240.9	259.9	431.9	185.0	251.6	294.6	0.8	4.1	4.6	8.6	5.1	8.2	8.4	7.4	9.5	6.0	10.5	8.2	11.0	1.0	7.2	5.2	10.0	9.9	5.0	37.6	39.1	37.9	46.4	39.3	41.2	38.2	38.9	37.1	38.5	42.4	40.2	31.2	76.9	91.2	4.6	51.0	74.9	78.1	52.0	55.8	27.3	38.3	39.8	26.4	44.3	78.1	29.5	25.0	115.6	31.7	29.9	13.7	92.5	83.0	40.8	47.2	52.0	28.8	106.8	10.5	99.4	116.9	45.3	32.1	33.2	41.0	55.6	33.2	39.7	57.5	25.2	9.1	45.2	32.6	37.9	45.5	158.0	42.6	34.9	28.4	8.4	42.5	26.3	40.2	6.0	8.4	69.0	32.9	44.4	72.2	80.0	32.3	25.7	101.0	18.9	19.7	53.1	66.1	58.4	108.0	75.3	76.3	67.6	43.5	46.7	78.4	70.7
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	105.4	77.3	101.9	64.1	107.4	61.0	94.8	101.9	119.7	82.1	112.6	95.9	75.1	80.4	88.3	123.3	80.6	52.7	131.5	106.2	113.3	105.5	122.4	87.9	74.3	106.6	106.6	81.9	115.0	63.4	99.9	52.0	109.0	86.8	62.7	52.1	100.6	53.6	246.7	100.2	90.8	53.8	103.4	105.9	96.1	58.9	113.2	65.1	107.8	136.3	67.7	83.6	87.2	103.9	204.6	127.6	90.2	140.3	152.1	145.4	92.2	172.8	134.1	147.6	152.5	120.8	229.7	205.4	92.1	137.0	143.7	155.0	147.4	142.5	142.8	172.8	173.9	129.3	110.7	193.8	171.5	165.6	108.4	130.7	117.8	158.4	149.8	123.2	140.1	122.6	227.9	154.1	118.6	181.4	190.8	264.5	158.5	198.9	191.5	149.5	145.5	289.8	163.7	61.8	166.1	114.0	117.1	296.3	535.3	152.0	154.6	142.0	107.8	140.8	89.2	160.9	150.7	186.5	241.2	258.1	148.0	260.1	69.9	143.4	93.0	188.6	80.0	98.9	99.3	120.7	105.9	95.9	100.2	117.7	127.6	105.1	204.1	75.3	91.7	62.9	161.5	101.0	101.9	107.4	101.9	119.7	106.2	113.3	106.6	106.6	109.0	103.4	113.2	103.9	107.5	28.9	72.7	14.7	130.6	186.2	138.9	100.0	108.1	95.9	169.6	173.7	92.4	151.5	69.2	101.2	20.9	208.6	129.9	171.2	291.6	76.3	283.0	107.8	77.6	91.5	142.0	78.8	23.3	106.6	239.4	84.4	89.7	101.0	61.5	90.6	98.6	132.7	141.1	112.7	23.8	165.8	83.4	178.4	130.0	700.2	104.7	123.3	167.2	15.9	144.8	152.3	193.6	25.6	20.1	91.9	206.7	85.7	132.5	199.6	242.8	325.8	59.0	73.4	59.2	77.6	136.6	97.1	157.4	155.9	220.4	245.3	128.1	86.2	172.1	153.2
ST7	"ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7"	ENSG00000004866	"Suppression of tumorigenicity 7"	Q9NRC1	7	116953238-117230176	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 184.1;Early spermatids: 131.4;Excitatory neurons: 191.5;Inhibitory neurons: 176.0;Oligodendrocyte precursor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038325, HPA038326"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA038325: AB_10671740, HPA038326: AB_10672644"	"unprognostic (3.40e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.40e-2)"	13.5	21.7	22.6	6.7	22.0	17.8	15.2	50.6	24.7	19.9	11.1	13.6	12.1	14.5	35.8	9.7	18.6	12.3	22.4	21.8	22.6	29.4	41.3	26.1	7.6	15.0	17.4	17.4	32.9	19.0	24.5	20.9	15.9	13.8	12.4	12.6	21.7	21.2	12.5	11.5	11.0	12.6	14.6	10.4	17.3	8.7	22.5	8.6	28.4	11.2	8.6	12.6	11.1	19.7	29.4	17.2	28.2	24.4	31.0	20.5	12.3	23.0	30.2	24.4	35.2	24.0	32.8	7.7	25.5	21.4	34.7	24.6	24.2	24.5	31.3	11.1	33.9	23.4	26.5	20.2	21.8	27.4	39.4	16.1	24.3	30.7	21.8	21.6	24.9	5.2	36.0	54.6	22.3	18.1	0.2	21.0	26.9	40.1	19.3	6.7	18.8	33.6	25.5	16.2	42.2	33.8	27.8	115.5	32.0	20.6	10.1	23.3	19.1	27.6	11.0	30.5	23.3	34.7	28.2	29.6	22.9	24.0	28.6	1.5	3.1	0.4	7.3	1.2	5.1	2.2	4.4	6.2	5.7	1.0	2.9	3.0	0.0	7.0	1.1	5.6	10.3	3.0	22.6	22.0	50.6	24.7	21.8	22.6	15.0	17.4	15.9	14.6	22.5	19.7	6.3	22.4	38.1	184.1	5.0	7.5	8.6	8.8	10.8	12.2	9.0	7.4	13.5	12.8	12.9	5.5	0.0	21.1	6.4	3.1	5.9	6.0	131.4	7.1	5.9	9.5	3.6	15.8	191.5	13.4	22.8	10.6	12.8	14.2	19.6	3.5	8.6	24.5	8.7	3.3	176.0	6.8	8.2	14.4	6.0	53.5	11.1	7.9	7.2	44.0	7.5	12.8	4.1	111.1	46.9	8.8	3.6	6.0	10.3	6.7	3.6	17.3	6.3	1.3	0.0	9.9	12.1	12.8	5.8	7.4	5.5	21.2	4.6	4.6	5.3	8.8
ST8SIA2	"HsT19690, SIAT8B, ST8SIA-II, STX"	ENSG00000140557	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2"	Q92186	15	92393881-92468728	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.4;heart muscle: 3.9"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 2.9;Cardiomyocytes: 4.3;Inhibitory neurons: 3.5;Muller glia cells: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.8;LHCN-M2: 7.7;RH-30: 11.7;RPMI-8226: 8.9;SH-SY5Y: 5.0;WM-115: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA054518, HPA057819"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA054518: AB_2682514, HPA057819: "	"unprognostic (4.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.87e-2)"		"unprognostic (2.32e-1)"	"unprognostic (1.28e-5)"	"unprognostic (3.91e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.00e-1)"	0.0	0.3	0.6	0.0	0.6	0.0	0.4	0.6	2.2	0.8	0.0	0.1	0.0	0.4	0.8	0.0	0.0	0.2	3.9	1.5	1.2	0.1	0.0	0.0	0.0	8.4	1.9	0.0	0.0	0.0	0.2	0.0	8.2	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.4	1.8	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.2	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.0	4.1	0.0	0.0	0.0	11.7	8.9	0.0	0.0	0.6	5.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.2	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	2.2	1.5	1.2	8.4	1.9	8.2	0.1	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	1.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins, Transporters"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 439.5"	"Cell type enriched"	"Detected in many"	4	"Hepatic stellate cells: 745.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	59	"classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	60	"dendritic cells: 2.5;monocytes: 9.4"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		96000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	194.2	160.4	41.0	50.4	42.9	13.8	84.5	41.4	58.3	54.4	62.8	87.7	29.6	45.3	8.5	29.2	79.3	25.8	74.6	41.9	44.4	85.6	102.1	104.7	12.9	50.0	48.4	32.2	32.2	5.0	52.0	55.4	53.7	57.6	31.0	0.6	45.7	16.0	25.9	24.0	95.1	33.8	43.0	439.5	53.2	21.0	65.3	6.8	55.1	4.6	8.2	105.7	48.6	47.8	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.2	0.2	0.6	0.0	0.0	1.8	0.1	0.0	0.1	0.0	103.1	0.1	0.3	0.1	0.0	0.0	0.0	146.9	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.0	0.0	128.8	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	9.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	41.0	42.9	41.4	58.3	41.9	44.4	50.0	48.4	53.7	43.0	65.3	47.8	31.3	0.0	3.8	0.0	5.5	6.0	0.6	0.0	1.8	1.0	1.5	2.7	2.4	11.5	0.0	3.7	0.0	1.7	1.9	0.0	0.0	0.0	0.5	0.4	0.5	43.0	1.2	21.5	0.3	0.0	2.0	3.3	0.5	0.3	18.3	0.0	745.0	19.7	130.7	0.0	0.3	0.0	0.0	185.4	30.3	2.9	4.4	147.0	12.4	30.0	21.9	0.5	2.1	0.5	0.1	0.0	0.0	20.3	2.0	0.2	0.0	0.8	0.0	0.1	19.7	2.0	1.4	0.9	2.2	1.5	4.8	2.2	2.3	0.5	0.0	0.2
STAC2	24b2	ENSG00000141750	"SH3 and cysteine rich domain 2"	Q6ZMT1	17	39210541-39225945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.5;breast: 56.2;retina: 120.9;skin 1: 53.1"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 496.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 9.8;HeLa: 32.5;U-87 MG: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076925			Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA076925: "	"unprognostic (1.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (4.05e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.12e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.17e-1)"	2.2	0.5	11.2	0.2	24.6	0.0	56.2	10.3	59.5	8.5	2.2	0.9	0.1	5.2	10.7	0.5	4.8	0.0	2.5	14.5	22.4	14.2	0.0	0.8	0.0	30.9	18.3	2.4	0.2	0.1	1.6	0.2	30.7	5.1	0.1	120.9	15.1	23.5	0.3	53.1	0.6	0.8	5.4	0.1	0.4	0.2	5.4	0.0	0.1	0.6	0.0	0.5	2.6	34.2	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	9.8	0.0	3.9	0.0	0.0	0.0	0.5	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.3	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	24.6	10.3	59.5	14.5	22.4	30.9	18.3	30.7	5.4	5.4	34.2	0.6	3.2	5.8	2.0	0.7	0.4	1.0	0.2	0.0	13.3	52.7	45.3	2.7	0.0	2.5	3.7	10.4	0.1	1.8	0.1	5.9	0.0	0.2	0.3	3.9	1.7	0.0	0.0	19.0	0.0	0.2	1.9	0.0	0.3	0.0	0.2	0.0	0.0	0.1	18.5	16.6	0.0	16.2	0.6	1.5	0.0	2.8	0.8	42.7	3.7	0.0	496.8	2.1	1.0	1.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	1.5	17.5	0.0	0.2	1.4	0.2	1.0	0.0	1.7	0.3	1.2	0.1	0.1	0.2
STAM2	Hbp	ENSG00000115145	"Signal transducing adaptor molecule 2"	O75886	2	152116801-152175763	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035528, HPA035529"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	"Nucleoplasm, Cytosol"	"HPA035528: AB_10601606, HPA035529: AB_10672868"	"unprognostic (1.53e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	9.7	9.9	7.3	7.9	8.3	3.1	12.5	7.5	8.9	10.9	8.0	10.3	9.3	10.9	8.7	9.1	12.8	9.3	9.6	6.3	7.7	14.6	11.0	10.8	8.7	7.5	7.9	11.0	8.8	12.8	6.5	10.3	7.9	12.9	10.9	11.1	11.9	8.9	5.8	10.8	9.3	10.1	8.0	8.3	11.7	12.6	7.4	8.5	14.3	7.7	8.9	10.7	6.6	9.7	8.3	7.9	7.2	8.8	18.5	22.0	7.7	16.8	19.4	10.7	13.6	7.8	7.8	10.8	13.1	24.2	9.4	8.3	8.0	15.6	17.1	13.3	6.3	7.8	5.1	11.8	21.2	11.5	14.6	16.9	14.6	20.0	26.8	15.5	11.7	7.2	5.1	7.5	22.2	8.1	6.1	8.9	4.5	6.1	11.2	4.9	8.9	5.9	16.7	14.1	3.8	5.9	9.3	8.2	14.1	8.0	11.1	10.5	15.3	23.7	7.6	18.8	10.3	6.1	6.7	6.8	17.9	9.2	13.2	16.8	3.4	4.6	1.7	4.6	1.6	1.7	1.8	1.9	2.7	2.0	1.5	1.9	8.6	2.6	7.1	3.2	2.2	1.6	7.3	8.3	7.5	8.9	6.3	7.7	7.5	7.9	7.9	8.0	7.4	9.7	17.6	25.6	33.5	39.2	10.9	13.8	12.0	16.4	15.9	10.6	17.9	11.6	30.5	7.2	28.9	16.5	16.7	7.4	14.7	22.1	23.5	13.9	147.8	37.2	25.5	15.1	8.3	13.5	43.8	14.2	14.6	22.7	27.0	22.2	27.1	14.8	17.5	16.0	16.7	1.7	39.7	20.2	20.3	20.0	13.0	64.4	15.8	16.9	14.2	32.8	19.6	14.7	8.2	51.8	61.0	21.2	18.2	15.4	10.9	14.3	13.9	14.8	55.6	11.6	26.3	18.0	16.1	54.1	20.1	13.5	13.2	20.2	9.3	18.2	13.5	16.1
STARD5	MGC10327	ENSG00000172345	"StAR related lipid transfer domain containing 5"	Q9NSY2	15	81309053-81324183	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 28.0;Plasma cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 5.8;RPMI-8226: 6.2;U-266/70: 7.1;U-937: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040662	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Cytosol	"HPA040662: AB_10959593"	"unprognostic (5.35e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.84e-3)"	"unprognostic (7.55e-3)"	1.0	0.6	0.6	6.0	0.8	4.3	0.7	3.4	1.3	7.2	1.9	2.8	2.2	4.6	5.0	3.4	1.8	1.3	0.8	0.6	0.7	0.7	5.1	1.1	7.7	0.9	1.0	1.2	0.6	0.6	0.4	1.6	1.2	3.6	3.7	0.4	1.6	2.1	0.6	7.9	4.2	1.8	0.9	6.2	2.1	0.7	0.7	0.5	0.8	0.3	1.5	2.5	5.5	1.4	0.3	0.0	0.0	0.9	2.3	2.3	0.1	0.3	0.3	0.8	1.2	0.1	0.1	4.8	0.0	1.5	0.2	4.0	1.1	1.0	0.6	0.1	0.4	1.8	0.3	0.4	0.5	2.8	5.8	2.0	2.0	0.3	0.6	1.5	0.1	1.9	0.6	1.3	0.5	0.1	0.5	4.0	0.3	0.2	0.0	0.1	0.7	6.2	0.3	1.4	0.3	0.1	0.1	0.5	0.6	0.3	0.6	0.6	0.2	1.3	0.6	1.3	0.1	7.1	1.5	1.8	0.9	6.8	0.4	5.0	1.8	2.3	3.0	2.4	2.5	1.0	2.7	3.2	2.6	0.7	3.9	3.9	1.3	2.6	2.3	1.4	3.6	3.7	0.6	0.8	3.4	1.3	0.6	0.7	0.9	1.0	1.2	0.9	0.7	1.4	3.8	0.0	1.1	0.0	11.4	13.3	12.0	28.0	10.8	1.8	2.7	4.2	0.3	0.0	4.9	0.0	6.2	2.5	4.2	22.1	3.9	1.3	15.2	2.5	14.4	2.5	11.4	2.5	2.2	1.4	4.0	8.5	15.8	2.3	10.2	1.0	3.6	25.4	5.2	1.7	2.0	24.3	2.0	7.9	10.9	1.5	5.0	8.0	1.8	1.9	0.7	1.2	2.1	0.0	0.4	1.8	14.4	9.8	31.5	3.3	23.9	0.7	4.0	0.9	0.0	3.8	2.8	0.9	0.7	19.6	16.3	4.9	4.2	6.3	19.9	9.6
STAT5B		ENSG00000173757	"Signal transducer and activator of transcription 5B"	P51692	17	42199177-42276707	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 100.5;Late spermatids: 188.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 121.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004298, CAB005418, HPA042128, HPA049883, HPA051156"	Approved		Approved	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB004298: AB_2197067, CAB005418: AB_632445, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (4.06e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.68e-1)"	"unprognostic (4.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.98e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (9.19e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.13e-1)"	45.9	45.7	26.4	35.1	26.5	42.4	36.7	33.4	29.0	43.6	24.6	45.3	14.8	59.1	19.3	19.2	50.8	23.6	24.5	23.5	42.9	24.3	24.4	32.5	43.6	32.8	33.9	55.9	22.8	21.1	40.8	31.5	32.9	29.2	17.0	18.7	22.8	34.2	73.3	25.3	30.7	42.7	27.4	42.3	27.6	23.5	49.9	37.6	22.7	46.5	34.7	43.4	31.5	26.1	15.0	22.9	33.3	9.0	40.6	20.4	15.9	15.0	26.5	21.0	18.2	10.1	12.3	48.1	21.8	17.2	41.3	18.7	19.9	13.0	16.6	121.8	23.0	47.1	44.5	15.6	22.3	20.9	72.7	25.1	19.6	15.9	19.9	18.0	33.6	31.9	86.5	10.1	8.8	14.6	99.2	54.9	8.3	34.3	0.2	42.0	20.9	16.8	13.3	23.5	24.5	14.4	27.3	34.4	21.2	7.4	24.3	24.3	26.0	29.2	10.2	15.2	21.2	19.8	9.8	23.9	11.6	21.7	15.5	11.5	3.3	5.9	6.6	3.0	7.1	2.9	9.3	7.6	2.9	2.9	6.5	5.5	22.5	4.2	3.7	2.1	8.4	4.7	26.4	26.5	33.4	29.0	23.5	42.9	32.8	33.9	32.9	27.4	49.9	26.1	30.2	6.4	19.5	41.8	12.9	8.9	5.7	4.5	2.8	21.2	25.1	22.7	20.7	5.7	7.8	3.7	20.9	8.0	31.2	8.4	5.9	8.2	100.5	10.1	22.4	26.0	10.2	12.4	23.7	11.8	6.1	18.8	13.3	15.0	16.4	16.1	20.0	11.2	9.4	10.1	61.2	6.1	8.2	13.3	17.1	188.5	47.2	16.9	10.6	51.5	23.7	9.5	26.8	69.4	60.8	12.2	6.2	74.4	13.6	11.9	7.9	9.8	6.3	13.3	39.5	20.0	23.0	4.3	7.3	5.9	9.8	12.7	34.4	15.5	7.5	7.7
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 189.5;parathyroid gland: 78.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.3;Exocrine glandular cells: 36.2;Hepatocytes: 91.6;Respiratory ciliated cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.7;myeloid DC: 4.1;NK-cell: 1.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.1;monocytes: 2.7;NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Nucleoli	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	9.1	6.3	4.3	3.9	3.7	16.9	14.5	7.1	4.6	16.7	10.6	9.5	22.1	3.6	5.3	15.8	7.7	2.3	9.5	7.0	7.5	6.9	189.5	9.1	0.9	14.4	9.4	4.4	27.1	78.9	13.8	11.3	12.8	11.8	6.9	0.7	34.3	7.5	29.9	9.0	10.9	3.1	7.6	1.8	22.5	1.9	7.2	2.2	5.4	12.5	3.1	7.0	7.2	12.7	21.8	25.6	0.0	8.7	12.1	112.9	22.1	6.8	7.4	13.1	11.8	19.5	29.0	0.1	49.9	38.5	94.1	35.9	11.1	22.4	14.9	0.1	35.9	42.1	22.2	38.8	30.0	10.5	7.7	67.3	38.7	78.0	27.7	89.8	11.4	0.0	20.9	4.2	37.6	20.6	0.1	6.2	34.2	33.3	52.7	0.2	14.7	18.5	16.2	54.1	41.9	7.7	18.8	64.1	4.9	4.9	12.7	13.7	49.6	81.2	46.8	17.4	37.4	0.1	0.1	0.2	149.1	26.2	17.2	0.0	2.4	0.4	0.1	2.7	0.0	0.4	0.0	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.4	0.2	0.0	1.0	4.3	3.7	7.1	4.6	7.0	7.5	14.4	9.4	12.8	7.6	7.2	12.7	9.1	0.0	7.9	2.3	1.0	2.0	7.4	11.9	8.0	0.6	15.5	10.7	6.2	2.8	16.2	0.0	0.0	33.3	0.2	12.2	0.0	8.1	0.2	8.1	1.9	6.2	1.8	29.5	1.3	36.2	4.1	3.6	23.4	5.7	3.8	3.5	1.4	91.6	10.9	0.0	1.0	6.0	8.2	5.9	3.8	0.7	1.8	6.1	0.0	1.9	1.4	0.1	0.0	0.5	0.0	20.8	7.7	7.5	0.1	8.3	11.8	1.5	36.1	0.1	6.6	4.1	3.3	0.6	0.2	19.5	1.4	23.7	0.4	13.1	11.6	8.9
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Glandular and luminal cells: 12.4;Spermatocytes: 17.8;Spermatogonia: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046543			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA046543: AB_2679692"	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.0	0.5	0.8	3.0	0.8	10.8	2.9	0.7	1.2	1.1	0.2	4.1	2.9	1.4	1.4	2.5	0.9	1.4	0.6	0.8	0.6	0.7	1.0	0.9	4.9	0.7	0.6	0.8	0.7	0.9	0.4	1.9	0.8	1.3	5.6	1.2	1.7	0.5	0.6	3.1	2.7	1.4	0.4	1.4	1.8	6.6	0.8	9.9	0.9	0.7	5.7	1.1	1.0	1.0	33.7	17.4	24.7	22.1	1.8	3.8	15.7	29.3	14.0	32.0	33.2	18.5	16.1	39.4	13.3	14.4	32.7	21.4	29.4	15.3	33.7	29.6	12.9	44.5	20.9	16.6	0.8	35.7	21.5	1.6	2.1	27.2	17.5	3.8	21.5	29.5	31.7	35.9	24.1	14.3	35.6	10.9	30.0	18.6	14.2	23.0	40.3	19.0	9.0	20.0	22.0	13.2	31.4	22.2	14.6	29.6	14.5	20.6	12.2	29.6	29.9	21.2	40.0	11.9	26.4	38.1	13.8	27.0	28.0	0.3	0.1	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.7	0.0	0.3	0.3	0.1	0.8	0.8	0.7	1.2	0.8	0.6	0.7	0.6	0.8	0.4	0.8	1.0	1.6	3.2	0.5	2.0	2.4	0.9	0.6	2.0	1.2	1.1	2.8	3.0	0.5	0.0	2.3	0.0	4.2	2.5	1.6	5.4	0.0	1.6	1.6	7.8	3.2	2.2	1.8	12.8	5.1	0.4	4.4	1.6	3.1	12.4	2.5	8.2	1.4	0.5	2.9	0.0	3.9	6.1	0.0	2.4	1.2	1.1	0.3	2.7	0.0	0.0	3.0	0.8	1.0	2.0	4.8	1.9	1.8	0.7	10.2	1.1	1.4	0.4	7.6	0.6	0.0	1.7	2.0	17.8	14.4	5.3	2.4	0.8	3.3	2.6	5.5	1.4
STIMATE	"MGC52022, TMEM110"	ENSG00000213533	"STIM activating enhancer"	Q86TL2	3	52836219-52897548	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 7.3;Endometrial ciliated cells: 24.2;Extravillous trophoblasts: 6.9;Hofbauer cells: 9.7;Proximal tubular cells: 15.4;Respiratory ciliated cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA051855	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA051855: AB_2681639"	"unprognostic (1.45e-1)"	"unprognostic (7.93e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.55e-4)"	"unprognostic (3.34e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	9.0	9.7	8.1	8.1	7.9	23.2	7.9	7.0	8.0	10.1	4.2	9.1	5.9	10.6	5.6	6.6	12.8	6.9	6.3	6.9	5.9	7.1	30.6	12.1	9.5	8.6	8.0	8.7	11.7	6.0	6.1	5.3	7.5	7.6	4.8	4.6	10.7	7.9	17.5	8.3	8.0	9.4	6.9	11.1	8.6	6.9	7.8	10.3	8.8	5.1	8.2	10.9	7.7	7.8	9.6	8.2	12.6	22.1	27.9	17.7	24.8	13.3	15.5	18.5	17.0	10.2	10.0	9.2	2.6	16.1	17.8	8.7	15.1	13.7	12.8	20.3	10.6	15.3	10.3	15.9	18.4	23.0	11.3	13.8	18.6	20.7	9.3	11.7	15.4	15.2	5.2	9.3	15.8	7.9	12.7	12.9	11.3	8.0	15.8	6.7	8.5	6.4	8.8	12.5	2.7	9.1	14.1	9.5	12.9	6.9	8.2	20.3	15.5	14.8	8.4	19.7	16.5	16.8	11.9	9.0	13.0	23.2	11.5	0.0	1.6	0.9	1.0	3.1	0.9	0.9	1.6	1.2	2.0	0.7	0.8	0.6	0.1	0.4	2.9	1.1	2.4	0.8	8.1	7.9	7.0	8.0	6.9	5.9	8.6	8.0	7.5	6.9	7.8	7.8	2.4	0.0	2.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.6	7.3	0.0	1.8	1.8	0.0	1.9	2.4	0.0	24.2	1.7	0.5	0.0	0.0	0.0	2.9	6.9	0.8	0.0	1.6	0.0	1.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	15.4	9.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.9	1.2	4.6	0.0	0.0
STIMATE-MUSTN1	TMEM110-MUSTN1	ENSG00000248592	"STIMATE-MUSTN1 readthrough"		3	52833121-52897562	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"liver: 14.9;skeletal muscle: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.8;Karpas-707: 5.8;PC-3: 6.5"									HPA051855	Uncertain		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"		Cytosol		"HPA051855: AB_2681639"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.95e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.11e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.01e-6)"	"unprognostic (5.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.09e-5)"	3.6	1.7	0.9	0.5	1.4	1.4	2.6	1.4	2.0	2.9	1.6	1.3	0.0	2.1	0.3	2.1	1.2	0.1	4.4	0.9	0.4	3.1	14.9	2.3	0.1	1.5	1.2	1.6	3.2	0.0	1.4	0.0	1.6	1.4	0.1	0.1	1.6	0.0	9.9	2.0	1.7	0.1	1.9	2.4	2.0	1.4	2.0	0.2	2.1	0.6	0.1	2.5	2.7	2.3	1.8	0.5	0.0	4.0	0.3	0.0	1.1	4.1	0.6	0.1	0.1	0.0	0.5	1.8	0.8	0.0	1.3	1.7	1.0	0.7	0.0	8.8	4.4	2.1	0.0	0.0	0.1	2.8	2.7	0.0	0.2	0.1	0.7	0.0	0.1	2.4	1.6	5.8	0.0	0.6	1.9	0.9	1.4	0.1	6.5	0.8	0.0	1.3	0.0	0.0	0.4	0.7	0.9	0.5	1.9	0.2	0.3	0.9	1.1	0.4	2.2	0.8	2.3	5.0	4.2	0.8	0.9	2.9	1.3	0.0	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.9	1.4	1.4	2.0	0.9	0.4	1.5	1.2	1.6	1.9	2.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 340.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.23e-4)"	"prognostic unfavorable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	68.0	128.0	114.5	70.2	119.9	61.3	49.7	124.6	340.6	69.5	122.1	72.9	40.4	74.1	49.0	79.5	72.4	43.5	98.5	120.2	133.4	86.7	68.9	70.8	72.9	124.0	131.3	87.6	53.3	61.4	71.7	77.5	139.2	60.7	56.0	62.9	56.1	56.1	140.3	60.5	53.9	66.7	123.6	69.0	66.1	126.3	134.2	66.2	57.6	92.2	88.2	81.2	63.8	159.4	321.0	486.3	298.1	251.7	161.8	108.1	271.5	277.2	150.1	393.9	228.1	361.3	265.2	371.1	322.9	220.3	475.4	329.7	745.4	280.3	427.6	302.1	311.7	521.5	302.6	336.7	142.8	278.7	325.1	109.4	174.5	327.1	242.7	162.4	284.2	276.1	537.2	209.5	232.1	468.8	432.0	388.6	366.4	306.0	407.2	418.3	279.1	385.6	282.8	271.8	242.7	217.3	314.4	338.9	266.7	310.3	357.1	194.0	253.8	252.0	310.9	333.1	389.0	189.8	434.0	388.0	328.8	282.6	374.1	61.0	66.8	57.4	87.6	95.1	88.2	85.9	65.5	79.5	69.9	68.5	72.7	81.6	20.0	108.2	114.6	58.1	66.1	119.1	114.5	119.9	124.6	340.6	120.2	133.4	124.0	131.3	139.2	123.6	134.2	159.4	31.3	44.8	32.9	7.8	40.0	80.4	184.1	61.5	40.9	37.5	32.5	29.8	46.1	31.5	59.1	20.2	41.7	124.8	39.8	38.3	49.0	76.3	31.0	65.8	48.6	45.9	67.3	69.0	9.5	55.2	146.1	49.6	24.5	51.1	79.3	47.8	14.3	27.4	91.5	63.9	14.9	39.9	97.6	21.9	90.3	77.5	27.4	46.7	62.2	12.2	51.8	36.9	53.5	11.1	17.2	69.5	32.7	39.9	56.4	75.7	22.3	39.6	85.8	36.7	26.3	36.1	65.4	96.3	118.6	47.6	72.0	211.0	67.0	62.8	48.6	95.3
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051480-5500994	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0;lymphoid tissue: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 108.2;Late spermatids: 39.3;Microglial cells: 27.2;Oligodendrocyte precursor cells: 169.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.5;HUVEC TERT2: 27.5;REH: 25.2;U-2197: 43.8;WM-115: 112.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	3.5	0.3	2.3	1.2	7.8	1.5	4.3	1.9	2.3	3.3	1.5	1.1	0.5	3.5	0.3	1.2	1.3	1.4	0.4	2.1	4.5	15.0	0.1	0.9	1.8	3.7	3.9	0.6	1.8	0.3	0.4	3.2	3.7	0.6	1.1	0.8	1.0	0.9	1.3	2.4	1.1	2.5	3.6	0.2	6.0	4.5	3.5	19.5	1.7	1.7	1.0	3.1	1.5	3.6	0.0	14.0	0.8	0.0	0.6	1.0	0.0	9.7	1.1	6.3	0.2	0.1	0.0	0.0	2.1	19.7	27.5	0.1	1.5	0.0	2.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.2	27.5	1.4	0.0	0.1	3.4	0.0	0.0	2.0	4.1	0.0	0.0	25.2	0.1	0.0	6.2	0.0	0.4	0.0	0.0	0.1	8.5	0.6	0.0	0.0	7.1	0.2	2.8	43.8	0.0	0.9	0.1	0.0	0.1	0.0	112.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	7.8	1.9	2.3	2.1	4.5	3.7	3.9	3.7	3.6	3.5	3.6	3.6	0.0	1.1	1.6	0.0	2.3	0.2	0.0	0.0	0.0	4.2	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	17.6	1.1	108.2	0.2	0.1	3.2	0.0	0.0	3.7	0.0	0.1	5.5	4.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	14.4	0.0	0.0	0.0	1.2	39.3	1.5	1.1	5.4	27.2	0.5	0.0	0.0	169.4	1.3	0.4	0.0	1.2	0.0	0.1	0.0	18.9	0.0	0.0	0.0	0.6	0.4	1.2	5.5	0.0	1.0	0.0	0.2	0.4	0.0	0.1
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 49.3;testis: 51.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 213.8;Early spermatids: 98.8;Endometrial ciliated cells: 220.9;Late spermatids: 157.0;Oligodendrocyte precursor cells: 117.6;Respiratory ciliated cells: 155.3;Spermatocytes: 148.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.1;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.0;hTERT-RPE1: 22.0;Karpas-707: 21.2;SCLC-21H: 22.9;U-251 MG: 24.3;U-266/84: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: AB_2683257"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	1.3	8.1	6.7	2.0	6.6	1.3	0.5	8.5	4.9	5.6	49.3	8.3	3.3	12.0	11.3	2.7	42.3	5.1	16.2	6.1	10.1	10.2	0.4	7.1	2.0	14.7	15.6	13.4	6.5	23.1	24.1	0.1	13.3	6.4	1.5	15.6	2.1	11.5	3.9	0.2	3.4	9.3	12.0	1.5	6.0	51.8	12.8	3.8	20.0	6.0	2.2	3.4	1.7	8.3	0.0	3.4	15.4	0.0	0.0	0.0	0.0	3.0	3.1	7.0	6.2	2.2	0.0	23.0	11.5	0.6	8.7	0.0	6.9	2.5	6.0	0.0	18.9	0.0	4.2	5.6	2.5	13.4	0.0	1.1	0.0	0.2	0.0	22.0	0.5	11.2	0.0	21.2	0.3	0.0	0.4	0.0	11.2	0.0	0.0	8.8	2.2	14.3	6.1	0.0	22.9	6.2	0.0	0.0	0.1	4.3	0.0	1.3	0.0	0.0	10.6	0.2	24.3	5.1	21.2	0.3	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.7	0.0	2.2	0.0	0.6	0.0	0.1	0.0	0.4	0.1	0.2	6.7	6.6	8.5	4.9	6.1	10.1	14.7	15.6	13.3	12.0	12.8	8.3	0.1	19.2	14.5	213.8	6.2	0.0	1.3	1.9	0.0	20.7	0.1	0.3	37.8	8.6	27.5	20.2	70.9	0.1	1.4	0.2	3.9	9.5	98.8	220.9	5.5	1.8	9.1	1.7	12.0	4.9	3.3	5.0	6.1	17.8	1.3	29.3	0.4	0.0	0.3	1.7	15.4	1.6	6.1	0.0	0.0	157.0	4.4	0.6	0.0	23.4	0.0	31.0	0.0	117.6	19.7	4.4	0.4	17.0	5.2	0.5	3.6	13.5	155.3	77.4	0.0	0.2	2.7	148.3	26.8	0.2	0.0	0.0	1.3	6.3	3.5	0.0
STK38	"NDR, NDR1"	ENSG00000112079	"Serine/threonine kinase 38"	Q15208	6	36493892-36547479	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (3.58e-3)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.13e-3)"	27.6	11.5	13.2	28.9	13.6	30.6	23.2	15.8	18.1	23.5	15.2	40.4	24.0	21.3	12.5	39.6	21.4	20.7	24.2	14.2	13.4	23.1	24.7	24.9	34.5	14.4	13.4	16.0	12.5	8.3	14.4	21.7	13.6	23.8	36.5	11.3	33.6	16.0	16.1	30.6	41.6	27.4	13.0	34.6	23.2	13.8	14.8	28.0	14.0	16.2	33.8	30.0	28.4	14.2	43.0	31.1	32.1	34.8	63.4	47.9	27.9	46.7	37.6	47.6	47.4	24.0	28.7	57.3	35.3	70.0	39.5	44.7	26.9	19.6	55.7	23.6	23.0	41.1	40.8	21.9	31.2	15.8	21.7	31.9	50.0	36.9	23.6	54.5	30.1	28.7	34.0	32.4	68.5	25.7	25.5	40.8	13.4	50.5	27.3	97.7	38.9	15.3	45.0	52.9	37.4	17.7	57.0	25.9	34.0	35.7	27.8	40.8	29.4	38.4	33.6	30.9	30.7	27.1	51.4	39.9	8.7	60.1	37.8	91.2	45.2	34.6	57.0	49.5	44.1	22.4	46.9	50.4	29.1	16.2	41.1	45.8	59.4	59.3	73.3	14.4	48.7	58.3	13.2	13.6	15.8	18.1	14.2	13.4	14.4	13.4	13.6	13.0	14.8	14.2	29.7	19.2	16.0	27.4	25.7	13.5	9.6	21.5	21.1	3.0	16.0	14.5	15.5	18.6	47.9	7.3	0.0	13.8	59.5	47.1	1.9	18.9	9.0	15.3	16.0	18.4	14.4	16.6	46.5	12.7	17.8	22.2	34.7	20.4	13.3	13.5	12.1	15.0	13.2	5.0	34.2	25.4	22.4	38.2	20.3	5.3	27.1	40.1	17.8	57.1	48.7	7.6	101.0	38.2	36.8	27.8	30.8	30.1	39.6	12.8	32.8	16.6	40.4	7.7	13.1	8.3	14.0	26.5	10.3	31.5	21.2	15.3	45.5	10.1	28.4	27.9
STK38L	"KIAA0965, NDR2"	ENSG00000211455	"Serine/threonine kinase 38 like"	Q9Y2H1	12	27243968-27325959	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 49.9;granulocytes: 80.7;monocytes: 33.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038623, HPA051324"	Approved		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.05e-2)"	23.9	11.6	6.5	21.6	8.6	17.2	14.0	6.9	11.1	17.2	6.4	28.9	12.9	27.1	7.5	22.7	15.1	25.7	44.9	6.7	8.6	12.9	12.5	12.3	12.4	8.1	7.5	7.0	12.3	26.9	7.2	15.7	8.4	20.2	21.2	6.6	13.8	15.0	8.8	10.8	14.3	33.3	7.6	12.0	18.6	11.2	9.5	17.8	9.2	16.4	14.8	24.6	15.5	6.8	12.0	15.7	40.1	17.7	18.6	12.4	30.8	7.7	11.5	4.8	6.5	19.8	8.5	29.3	17.7	6.4	13.6	21.9	19.0	13.4	7.2	157.8	17.3	18.7	17.5	10.0	15.5	43.7	19.7	14.7	13.3	17.6	21.7	29.3	38.1	36.8	21.2	21.1	9.7	8.3	28.5	46.3	49.6	31.2	25.4	10.6	47.8	22.4	6.8	22.0	6.7	22.3	33.1	19.9	13.3	38.6	9.8	14.0	16.4	15.5	13.9	23.7	20.3	7.7	8.1	29.1	8.0	19.9	6.7	16.3	33.0	60.8	10.0	28.4	7.0	11.6	7.7	9.8	49.9	9.3	9.4	7.6	80.7	11.6	22.4	21.2	10.8	14.7	6.5	8.6	6.9	11.1	6.7	8.6	8.1	7.5	8.4	7.6	9.5	6.8	24.4	19.2	16.2	32.7	20.8	35.4	36.3	88.2	22.2	12.7	16.2	14.7	76.0	10.0	33.7	9.2	2.1	11.0	21.7	33.6	9.8	49.8	23.1	12.5	15.3	26.2	19.2	15.4	57.2	40.1	9.1	19.7	15.3	14.9	17.7	10.9	24.3	14.5	28.8	10.1	37.5	33.8	18.3	36.4	73.7	5.9	6.5	45.7	21.4	37.5	46.2	8.1	14.4	42.3	16.0	70.5	26.3	12.0	22.8	24.8	9.2	16.2	11.9	7.9	19.7	8.6	41.1	12.1	13.4	20.5	32.0	27.8	15.7	9.7	23.0	42.0
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 951.6;lymphoid tissue: 1343.2"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 2537.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 424.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 424.6;T-cells: 143.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 3270.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010107, HPA068438"	Enhanced		Approved	Cytosol		NA	NA		320000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB010107: AB_628297, HPA068438: "	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	56.4	69.1	526.8	103.8	568.0	260.5	60.6	514.2	951.6	57.7	333.6	93.2	70.5	129.8	40.7	115.9	45.2	51.1	56.0	573.2	568.2	77.7	35.8	60.7	253.2	560.1	516.8	172.4	23.2	43.8	103.5	120.1	552.4	31.7	110.6	304.7	43.4	32.7	29.5	56.3	89.1	100.0	537.1	72.8	54.5	387.0	531.7	1343.2	33.6	29.9	246.0	58.9	76.0	791.9	1026.8	226.1	2191.0	882.5	128.9	126.0	225.7	776.3	609.7	1081.9	1037.9	157.2	1018.3	1260.3	426.3	572.0	425.8	304.6	618.6	450.9	1616.1	390.4	310.9	786.0	363.3	547.6	51.9	994.6	529.3	77.0	65.6	439.6	496.8	405.5	833.6	1594.4	1074.4	1203.0	1429.6	268.0	3270.7	1441.5	1350.8	615.1	302.8	1907.9	1709.2	740.7	536.9	91.7	1479.2	1282.3	710.0	348.3	638.4	695.8	500.7	1240.1	406.2	721.8	853.6	634.3	664.8	702.5	1212.0	1535.8	357.7	1904.8	798.2	13.4	4.1	23.5	53.9	8.6	32.2	37.0	47.8	68.2	23.2	45.6	77.8	71.6	1.9	56.3	4.5	424.6	143.3	57.2	526.8	568.0	514.2	951.6	573.2	568.2	560.1	516.8	552.4	537.1	531.7	791.9	257.3	41.7	31.6	32.7	125.1	201.6	148.9	350.0	577.7	454.6	91.0	175.1	77.2	31.5	100.0	174.7	64.6	439.3	261.7	35.1	226.9	148.9	917.2	92.8	100.3	196.3	250.8	505.7	109.5	20.1	604.1	134.9	121.3	141.1	262.0	712.4	109.2	15.4	530.1	195.2	73.0	100.9	567.6	87.3	287.0	2537.2	44.7	130.0	268.6	32.8	32.1	252.4	84.5	38.2	217.4	59.0	69.3	47.0	261.7	63.5	21.0	221.4	59.1	183.6	39.5	68.0	267.6	873.0	260.8	423.9	90.4	130.4	224.9	66.5	177.1	95.7
STMN3	SCLIP	ENSG00000197457	"Stathmin 3"	Q9NZ72	20	63639705-63657682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 291.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.5;Granulosa cells: 254.2;Horizontal cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 125.1;MOLT-4: 142.0;REH: 143.8;SCLC-21H: 192.5;SH-SY5Y: 146.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012947	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA012947: AB_1857606"	"unprognostic (7.59e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-3)"	23.4	49.7	188.4	21.3	197.6	11.4	20.0	112.5	291.7	29.2	16.6	26.5	5.5	30.0	5.0	11.6	27.9	10.9	17.1	215.0	162.0	24.8	3.7	23.6	25.8	259.6	158.1	50.5	16.4	17.5	102.2	10.0	266.1	24.3	5.2	38.8	11.7	12.7	4.3	20.2	24.8	14.7	100.8	48.2	15.1	9.0	159.3	43.5	63.9	3.7	12.4	21.9	19.0	179.9	10.4	11.6	74.4	125.1	1.9	7.3	5.1	12.0	0.4	35.8	16.8	73.6	13.7	0.5	36.3	4.6	2.0	68.6	52.2	1.3	11.1	5.2	14.0	5.1	17.0	27.6	9.9	3.9	42.0	15.3	0.3	11.5	2.9	1.5	1.3	34.4	98.8	2.2	9.6	11.7	142.0	17.7	76.5	2.4	81.7	143.8	12.1	58.0	60.9	2.0	192.5	146.6	5.7	3.4	14.9	5.9	2.1	25.9	1.9	0.8	20.4	0.8	2.6	4.9	10.4	3.6	2.1	14.3	48.8	1.1	0.0	1.1	2.5	0.1	2.7	0.2	5.2	4.5	0.1	0.6	6.2	5.3	0.1	0.0	0.1	1.1	0.9	2.0	188.4	197.6	112.5	291.7	215.0	162.0	259.6	158.1	266.1	100.8	159.3	179.9	5.8	6.4	2.5	16.3	17.1	8.2	6.9	11.9	8.6	108.5	4.7	14.7	2.3	4.3	3.2	3.7	52.1	11.7	13.4	1.1	13.7	4.0	10.0	1.6	17.9	7.8	37.2	4.6	56.9	2.5	4.0	25.4	2.0	2.7	4.5	254.2	6.8	0.0	2.3	109.4	67.1	0.6	4.1	2.2	7.6	18.8	30.1	3.5	7.2	7.5	4.6	37.2	16.5	21.1	11.3	2.2	0.1	35.7	5.3	4.5	0.1	5.0	0.8	44.5	13.1	3.0	20.9	3.3	6.7	1.6	4.3	8.8	28.6	51.0	0.6	2.7
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338987-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 454.6;Erythroid cells: 535.1;Hepatocytes: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 591.3;hTCEpi: 497.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	339.0	117.3	100.4	101.0	108.1	358.2	243.8	94.7	103.9	129.3	74.8	226.0	46.1	139.9	72.2	87.8	141.7	153.3	219.7	90.5	113.1	123.9	355.4	290.7	67.7	120.7	115.1	81.3	38.9	45.3	49.8	272.7	108.9	111.6	58.4	15.0	95.5	93.4	102.6	118.3	114.1	155.9	105.2	121.6	139.3	24.7	111.0	33.8	112.9	106.2	46.4	182.4	129.6	108.7	8.4	55.0	4.8	26.0	591.3	170.3	0.4	138.6	149.3	40.7	64.5	7.6	10.8	66.5	34.3	186.6	23.9	14.7	31.7	133.0	79.3	41.7	12.0	144.7	108.8	23.1	299.0	61.4	32.4	272.2	497.3	60.9	88.0	11.7	152.5	21.0	33.3	88.2	96.8	45.2	2.2	47.0	64.4	3.5	16.6	8.7	0.2	147.7	34.7	1.7	5.9	0.5	114.5	107.8	62.1	44.9	36.6	47.4	172.8	92.0	28.1	91.3	13.6	36.5	44.9	4.4	35.1	58.1	51.0	21.4	35.5	4.1	168.9	55.8	165.7	5.9	84.2	153.3	35.8	4.2	15.0	81.1	20.8	147.1	41.0	6.1	8.7	128.8	100.4	108.1	94.7	103.9	90.5	113.1	120.7	115.1	108.9	105.2	111.0	108.7	454.6	160.3	96.6	30.0	13.2	105.5	251.8	107.0	62.0	5.0	135.8	72.3	36.7	121.5	159.0	35.0	6.2	121.9	72.1	26.3	3.9	56.6	3.6	97.0	75.4	313.6	0.0	535.1	3.2	22.0	54.7	140.3	17.9	11.7	36.1	76.0	282.7	371.2	92.1	3.3	4.8	1.1	54.9	226.3	92.3	9.0	66.5	105.9	88.9	70.3	37.9	8.6	127.7	6.6	4.5	39.1	18.3	103.0	16.9	90.2	33.8	92.8	216.0	5.0	138.1	73.2	188.1	40.8	13.7	48.4	119.1	172.8	98.8	81.8	2.2	200.0
STOML1	"FLJ36370, hUNC-24, SLP-1, STORP"	ENSG00000067221	"Stomatin like 1"	Q9UBI4	15	73978926-73994622	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042353	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 65: Brain - Ion transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA042353: AB_10797387"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.67e-2)"	11.4	17.3	33.0	6.5	33.7	4.5	10.4	22.0	38.5	9.8	17.1	11.0	5.9	9.1	5.6	9.4	7.3	6.3	23.6	36.8	32.4	8.6	13.2	10.2	5.6	34.6	30.5	8.5	10.1	7.8	16.6	7.5	36.8	9.9	3.6	3.1	8.3	8.8	18.6	9.4	7.9	7.7	26.5	7.9	9.5	13.1	32.6	8.1	13.6	8.9	3.8	11.8	9.2	28.4	5.8	10.8	6.4	8.8	12.7	8.0	5.4	18.3	7.1	9.8	8.3	3.2	31.4	5.8	28.3	14.9	7.3	18.9	6.1	12.9	3.1	19.4	6.6	6.1	10.0	3.6	12.5	4.0	4.6	14.3	9.9	15.4	14.5	8.1	9.3	13.1	14.6	10.9	14.3	8.8	7.6	2.9	3.1	8.9	8.6	4.5	6.5	8.9	20.7	6.3	12.1	7.9	8.4	10.9	11.9	4.0	9.1	4.4	14.3	22.4	7.2	25.8	24.9	10.6	5.8	3.0	20.6	12.1	11.6	1.0	4.1	2.5	5.3	7.7	4.4	4.5	4.3	7.0	6.5	5.6	8.7	9.2	2.1	8.0	18.2	11.5	8.1	5.5	33.0	33.7	22.0	38.5	36.8	32.4	34.6	30.5	36.8	26.5	32.6	28.4	15.2	0.0	4.1	7.2	5.3	3.2	3.7	7.2	1.8	13.1	7.0	4.8	10.8	2.8	5.8	7.3	6.2	13.0	3.5	8.9	1.9	25.1	1.0	2.8	6.2	7.7	10.2	4.2	6.9	19.0	8.6	11.4	12.8	5.4	4.5	8.5	5.0	5.1	10.8	16.8	8.1	7.3	4.1	3.3	2.2	2.6	9.0	3.3	3.6	2.8	2.5	11.9	2.1	7.5	4.1	20.8	4.9	11.7	3.4	6.8	12.6	4.8	2.7	14.0	6.6	7.5	9.7	20.8	7.8	4.7	2.0	5.6	4.1	13.7	5.6	3.3
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 181.7;Inhibitory neurons: 192.3;Microglial cells: 72.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;HeLa: 12.7;NTERA-2: 16.8;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: AB_2680875, HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	1.8	1.6	8.3	0.7	8.2	6.0	1.8	4.2	13.3	2.1	2.3	1.7	0.9	1.9	3.4	5.0	2.7	1.3	3.6	11.1	3.1	2.7	2.0	2.1	0.6	2.7	3.9	3.3	4.9	4.0	7.0	1.4	3.9	2.3	0.9	3.8	7.3	2.3	2.1	3.9	1.3	1.8	2.0	4.1	2.3	0.9	6.6	4.1	5.8	2.1	1.1	2.5	3.3	11.5	2.1	4.3	13.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.3	1.7	0.0	2.6	0.0	2.7	0.2	7.4	1.2	0.0	0.0	5.9	0.0	12.7	0.1	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.8	0.0	0.6	0.0	0.1	16.8	0.0	0.6	0.1	4.8	0.0	3.1	4.1	6.8	15.8	3.2	0.0	0.0	4.7	0.2	0.4	0.0	0.0	2.8	0.0	0.1	0.1	3.8	2.1	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	8.2	4.2	13.3	11.1	3.1	2.7	3.9	3.9	2.0	6.6	11.5	12.7	12.8	22.1	39.2	0.4	4.2	6.0	3.7	8.6	28.2	3.8	4.6	20.7	5.7	8.7	7.3	0.0	2.7	0.0	0.2	3.9	5.4	1.2	7.2	0.7	18.5	1.8	0.0	181.7	3.1	2.1	5.8	3.1	3.7	0.0	0.3	21.4	5.6	1.1	33.7	192.3	0.4	2.0	2.2	1.5	2.6	0.6	0.8	1.8	72.1	0.0	12.4	0.0	91.0	153.5	2.1	0.0	4.5	1.3	5.2	0.0	4.0	16.8	3.4	0.0	4.8	4.5	0.6	2.0	17.8	3.3	0.7	0.7	3.6	0.4	3.4
STPG4	"C2orf61, FLJ40172"	ENSG00000239605	"Sperm-tail PG-rich repeat containing 4"	Q8N801	2	47045538-47155308	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"testis: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047366, HPA052691"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"		Nucleoplasm	Cytosol	"HPA047366: , HPA052691: AB_2681918"	"unprognostic (6.74e-3)"	"unprognostic (5.81e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.36e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.64e-6)"	"unprognostic (5.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	14.7	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.3	0.4	0.6	0.2	0.4	0.2	0.4	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STRA8		ENSG00000146857	"Stimulated by retinoic acid 8"	Q7Z7C7	7	135231979-135258492	"Predicted intracellular proteins"	"Differentiation, DNA replication, Meiosis, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"choroid plexus: 6.6"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 10.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;THP-1: 2.4;U-266/84: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078044			Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA078044: "		"unprognostic (2.84e-1)"		"unprognostic (4.86e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.67e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.25e-1)"		"unprognostic (8.55e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.69e-1)"			0.1	0.0	0.6	0.0	0.5	0.0	0.0	0.3	0.5	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.3	0.0	0.1	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.2	1.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.3	0.5	1.0	0.3	0.6	0.5	0.6	0.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	10.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0
STRIP2	"FAM40B, FAR11B, KIAA1170"	ENSG00000128578	"Striatin interacting protein 2"	Q9ULQ0	7	129434432-129488399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;choroid plexus: 80.0;skeletal muscle: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.9;Cardiomyocytes: 49.5;Muller glia cells: 62.1;Oligodendrocyte precursor cells: 29.7;Spermatocytes: 79.1;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 41.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 44.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 102.5"	HPA019657	Approved		Approved	Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA019657: AB_1848399"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.87e-6)"	"prognostic favorable (5.41e-4)"	"unprognostic (4.06e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.50e-2)"	0.4	2.3	3.7	1.6	41.0	3.6	0.4	3.9	10.2	0.3	80.0	0.6	0.5	0.4	0.3	1.1	0.2	0.8	9.5	4.4	1.8	4.7	0.5	1.0	2.4	0.8	8.0	0.7	0.9	0.1	8.2	0.9	1.0	1.1	0.9	22.1	1.3	0.1	28.6	0.9	0.9	0.5	2.8	1.2	0.7	14.2	8.9	1.3	0.4	19.4	1.7	0.7	0.4	2.4	15.4	6.5	5.9	9.3	2.3	2.0	25.5	6.1	7.7	10.2	9.8	3.6	8.5	6.4	0.8	2.6	33.2	16.9	6.4	5.5	15.4	37.6	5.3	4.9	11.5	3.7	1.5	3.1	25.0	2.4	1.9	17.3	10.6	16.8	17.8	5.7	21.7	3.8	39.7	0.8	8.2	7.8	5.7	3.3	13.4	5.4	10.9	1.2	3.7	5.7	1.3	1.3	14.2	1.0	3.1	4.4	1.8	7.6	6.4	5.9	5.8	44.7	18.0	3.6	2.5	7.6	39.4	7.9	8.5	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	3.7	41.0	3.9	10.2	4.4	1.8	0.8	8.0	1.0	2.8	8.9	2.4	0.4	3.2	1.1	54.9	0.8	0.3	0.3	0.3	0.0	10.5	0.5	0.4	49.5	0.0	0.3	0.0	2.1	0.7	0.8	2.1	0.0	0.9	5.7	0.2	0.9	1.1	0.0	9.1	18.6	3.8	3.8	3.2	2.0	0.4	7.6	1.0	0.4	0.2	0.8	1.7	16.7	1.0	0.0	0.3	0.3	9.9	0.6	2.1	1.8	7.5	7.8	62.1	0.0	29.7	1.0	5.0	4.4	0.7	1.4	0.6	0.1	13.7	0.8	3.5	0.0	2.3	0.9	79.1	37.1	0.5	0.1	0.3	1.3	0.5	0.8	0.6
STRN	"PPP2R6A, STRN1"	ENSG00000115808	Striatin	O43815	2	36837698-36966536	"Cancer-related genes, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017286	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoplasm	"HPA017286: AB_1857618"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.43e-2)"	8.4	4.7	5.3	9.4	16.7	14.9	8.6	11.9	9.0	8.6	0.6	9.1	8.1	6.2	3.8	21.2	5.3	6.8	21.2	5.5	10.2	8.4	7.5	7.8	7.7	13.0	11.6	7.7	5.6	7.3	2.4	10.1	13.1	5.5	10.7	10.1	10.7	5.0	11.6	11.2	8.6	7.7	9.8	8.1	9.0	8.0	14.2	13.3	6.2	11.5	12.6	8.4	10.1	24.7	38.3	19.0	25.2	10.4	13.3	18.0	24.6	14.8	14.2	14.5	13.3	19.4	12.2	24.7	11.8	19.7	20.6	17.6	21.4	17.0	17.9	27.9	16.0	40.2	16.4	10.3	12.1	24.9	21.8	11.4	12.9	23.2	18.3	10.7	18.6	10.0	30.4	19.2	18.2	11.1	24.7	7.4	19.8	15.7	9.4	15.9	38.5	11.2	9.7	31.0	4.5	15.1	22.4	16.9	13.6	13.7	12.2	9.2	24.9	25.4	25.4	16.0	20.1	19.5	31.0	21.6	13.2	23.2	18.2	1.3	0.2	0.4	0.5	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.2	0.2	1.0	0.2	0.4	0.2	0.1	0.1	5.3	16.7	11.9	9.0	5.5	10.2	13.0	11.6	13.1	9.8	14.2	24.7	26.5	9.6	10.0	38.8	18.8	20.6	12.3	11.3	21.6	12.7	16.0	9.4	55.4	8.6	17.4	23.9	20.9	8.0	22.8	25.0	9.8	10.5	1.9	14.2	14.3	19.4	11.4	26.5	65.3	8.4	10.3	13.6	20.4	26.2	5.1	16.0	16.4	7.9	8.8	18.5	55.2	17.8	10.2	20.7	10.0	2.1	9.6	18.0	8.8	47.8	20.3	10.1	35.0	55.3	294.0	16.8	14.1	12.4	14.3	19.3	13.0	8.5	8.2	16.9	0.0	13.6	16.5	15.2	19.2	31.4	33.2	16.3	19.4	17.7	16.0	39.4
STRN4	"PPP2R6C, ZIN"	ENSG00000090372	"Striatin 4"	Q9NRL3	19	46719511-46746994	"Predicted intracellular proteins, Predicted membrane proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043051, HPA043527, HPA056706"	Supported		Approved	Cytosol		NA	NA		32000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA043051: AB_2678290, HPA043527: AB_10959664, HPA056706: AB_2683214"	"unprognostic (3.57e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (8.31e-3)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (1.56e-1)"	"unprognostic (9.41e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.74e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.84e-1)"	34.2	25.3	25.5	19.5	25.3	37.6	32.8	15.5	31.1	33.5	19.7	38.0	22.6	37.0	7.9	48.1	32.8	19.6	37.1	32.5	21.4	29.2	23.0	33.8	21.2	19.1	18.8	30.9	36.5	21.3	22.8	20.4	17.6	33.2	12.8	9.7	31.0	19.8	36.1	42.5	30.5	17.7	17.8	42.8	33.8	85.3	24.9	19.4	27.7	15.5	11.6	35.2	34.2	23.5	60.8	79.2	67.5	50.2	19.1	21.1	47.7	51.2	27.4	52.0	45.3	59.7	52.5	30.1	30.2	42.0	42.5	42.2	31.9	49.8	20.3	43.7	66.9	66.3	52.4	51.4	60.8	54.1	69.5	33.8	49.1	33.5	45.5	26.2	46.8	34.9	59.2	38.2	22.1	41.4	60.6	143.4	51.8	63.5	37.1	55.1	41.2	23.3	34.9	107.0	83.5	89.8	71.7	66.1	34.5	29.0	49.7	60.5	64.3	38.8	58.4	26.9	76.4	48.5	74.1	45.0	33.9	33.8	81.9	4.2	6.0	2.8	1.0	9.1	0.3	1.4	0.8	0.7	3.1	2.5	0.4	0.9	9.3	1.4	5.7	2.7	0.3	5.8	25.5	25.3	15.5	31.1	32.5	21.4	19.1	18.8	17.6	17.8	24.9	23.5	28.4	3.2	7.5	6.2	7.7	17.2	10.7	11.6	6.2	14.7	17.7	15.0	12.1	14.3	8.9	7.3	12.5	14.6	10.4	28.3	1.9	12.6	11.4	15.7	17.9	23.9	17.5	11.6	13.7	15.4	18.1	11.4	15.3	18.2	0.0	22.5	20.3	12.3	14.8	30.3	11.1	23.0	10.2	24.1	14.6	19.6	17.7	22.9	10.6	13.1	16.9	7.9	2.1	5.5	12.1	19.8	17.7	19.9	8.0	18.3	15.4	7.4	9.0	7.9	6.6	13.4	14.3	19.8	44.9	16.8	17.3	20.0	8.5	18.6	18.9	17.8
STUM	"C1orf95, DKFZp761P211"	ENSG00000203685	"Stum, mechanosensory transduction mediator homolog"	Q69YW2	1	226548764-226609230	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 234.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 9.8;Endometrial stromal cells: 3.8;Fibroblasts: 1.5;Glandular and luminal cells: 1.6;Smooth muscle cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"medulla oblongata: 234.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HEL: 29.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 70.3;basal ganglia: 76.6;cerebral cortex: 75.5;hippocampal formation: 74.0;thalamus: 21.3"	HPA074381			Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA074381: AB_2732253"	"unprognostic (3.23e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.14e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-3)"	3.7	1.0	45.5	1.2	40.0	0.0	2.8	0.0	43.7	3.1	0.0	15.7	1.6	3.2	1.3	5.7	3.1	0.8	2.2	38.8	17.6	5.5	0.1	0.5	0.2	234.8	30.0	2.5	0.9	0.9	7.4	0.4	101.9	4.0	2.1	1.4	1.0	1.2	3.6	4.2	2.7	5.8	9.4	1.0	2.3	1.4	49.5	0.5	0.7	1.3	0.3	6.8	3.5	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.9	0.4	29.9	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.4	0.3	0.0	4.4	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	40.0	0.0	43.7	38.8	17.6	234.8	30.0	101.9	9.4	49.5	5.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	1.0	3.8	0.2	0.0	0.0	0.0	0.2	0.5	1.5	0.0	1.6	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014365-94028597	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.3;intestine: 13.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 39.4;Glandular and luminal cells: 19.7;Intestinal goblet cells: 31.7;Paneth cells: 38.0;Proximal enterocytes: 19.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HaCaT: 1.3;hTCEpi: 4.0"	"Not detected"	"Not detected"							HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.1	0.0	0.3	1.7	0.5	0.0	5.4	0.4	0.6	2.8	3.7	13.0	7.6	0.8	16.3	6.0	1.4	1.8	0.1	0.3	0.2	0.4	0.1	4.0	0.0	0.3	0.6	0.1	6.7	4.6	0.1	0.1	0.2	3.9	13.4	1.2	8.8	0.1	0.1	9.1	8.1	0.3	0.1	0.4	7.3	0.2	0.2	0.2	0.1	0.0	1.2	0.2	2.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	4.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.6	0.3	0.2	0.3	0.6	0.2	0.1	0.2	0.3	0.4	16.0	15.9	1.0	0.2	1.7	2.2	6.4	2.8	3.0	5.6	3.7	0.1	0.0	9.9	0.0	12.5	0.2	0.1	39.4	1.9	4.4	1.9	15.9	2.1	0.2	0.0	0.0	3.9	8.2	0.0	0.1	10.2	19.7	0.0	0.1	0.0	0.0	0.2	0.0	2.4	31.7	10.2	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.5	0.0	1.0	1.6	7.1	38.0	0.7	0.0	1.5	19.2	0.1	16.1	14.8	0.0	1.0	0.5	0.2	0.1	2.7	1.8	0.3	0.3	0.0	15.7	1.6
STX8	CARB	ENSG00000170310	"Syntaxin 8"	Q9UNK0	17	9250471-9576591	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 261.6;Late spermatids: 964.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001540	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA001540: AB_1080168"	"unprognostic (8.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.14e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.51e-1)"	50.7	42.9	51.1	21.7	51.9	42.9	45.6	52.3	72.9	46.8	53.0	59.5	23.1	41.5	64.2	35.6	38.8	28.5	56.2	51.6	51.4	46.3	48.0	35.4	32.8	52.4	51.9	42.6	45.2	42.8	33.7	29.1	53.1	40.2	38.7	32.3	42.8	41.0	64.0	39.7	34.1	42.4	52.7	35.7	43.3	76.2	51.6	43.5	42.8	61.5	39.4	48.6	41.9	54.5	35.1	65.9	54.6	28.9	86.2	107.7	24.6	40.3	69.4	55.6	73.5	22.5	27.6	42.3	34.6	79.7	48.0	37.7	35.5	76.6	86.2	66.6	59.2	26.7	19.0	52.5	117.4	20.3	47.1	87.9	120.9	43.8	65.7	66.5	67.2	44.8	13.2	18.8	62.5	18.5	39.9	41.6	14.2	41.5	34.2	56.2	46.6	25.9	71.8	32.6	7.3	34.7	30.8	16.3	48.2	73.8	21.3	32.3	61.0	42.8	26.6	24.5	54.3	17.5	17.3	16.3	64.1	47.4	39.6	117.0	142.5	159.3	124.3	128.0	113.5	117.0	133.3	139.5	142.6	108.8	85.6	100.7	40.9	167.4	132.6	123.1	198.8	197.8	51.1	51.9	52.3	72.9	51.6	51.4	52.4	51.9	53.1	52.7	51.6	54.5	39.2	32.1	27.0	65.3	37.0	45.8	52.8	83.8	23.3	15.2	32.8	36.2	61.5	31.5	58.5	29.5	12.5	55.9	49.8	34.6	103.7	62.3	261.6	31.4	33.2	33.9	25.0	25.2	79.7	82.8	55.3	49.3	23.0	27.7	54.5	33.5	29.3	38.6	87.1	6.7	63.0	41.2	85.5	46.3	84.0	964.1	46.3	43.6	78.2	89.9	70.4	58.4	107.1	91.0	86.9	69.9	58.1	47.4	23.5	23.8	66.2	93.5	45.0	24.3	13.1	33.9	59.7	58.6	23.8	29.4	44.6	43.4	54.2	20.1	31.2	38.7
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 174.5;pituitary gland: 66.4;retina: 214.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 131.0;Cone photoreceptor cells: 156.4;Excitatory neurons: 243.2;Inhibitory neurons: 157.5;Rod photoreceptor cells: 155.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 174.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 144.1;SK-MEL-30: 131.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	27.5	28.8	22.8	7.8	33.2	1.1	21.0	38.6	174.5	21.8	0.0	15.9	5.5	24.1	7.1	10.4	32.3	11.4	24.0	48.3	12.2	14.1	3.1	32.1	6.0	48.7	0.0	25.2	24.8	15.0	66.4	14.1	33.1	10.5	8.4	214.2	15.6	10.4	9.0	11.4	9.3	21.0	0.0	10.4	13.3	9.1	6.8	5.8	20.1	9.2	7.0	15.4	16.4	27.2	13.2	27.1	25.5	28.8	56.6	48.3	23.2	45.0	22.9	26.6	23.3	1.5	15.4	13.1	24.2	29.7	74.2	4.7	22.6	28.1	32.7	29.8	15.4	17.1	69.7	4.9	28.5	1.8	14.6	36.6	15.4	70.0	33.7	42.6	32.2	43.4	17.8	19.6	45.5	24.5	12.5	5.2	21.5	21.4	35.9	7.5	12.1	31.3	22.0	0.6	144.1	69.9	72.9	37.2	131.9	22.5	5.8	5.6	47.5	30.0	15.1	59.9	17.4	40.2	73.2	17.4	59.2	18.9	28.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.9	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	22.8	33.2	38.6	174.5	48.3	12.2	48.7	0.0	33.1	0.0	6.8	27.2	24.3	25.6	70.7	34.0	1.2	11.6	10.1	8.4	12.5	131.0	10.5	8.0	15.2	1.5	9.2	3.7	156.4	2.7	1.1	0.5	7.9	13.1	2.2	8.3	14.7	28.9	45.6	4.0	243.2	8.4	5.9	18.7	3.1	7.0	5.1	5.0	26.7	1.4	4.4	84.1	157.5	10.2	8.2	2.5	5.6	2.2	20.5	3.0	10.6	45.0	0.6	27.0	0.0	61.3	39.0	5.3	0.0	44.4	1.6	10.8	0.1	8.9	15.9	155.6	13.1	9.5	11.2	40.6	16.9	2.9	7.5	24.5	2.3	17.7	0.9	7.1
STXBP4	"MGC50337, Synip"	ENSG00000166263	"Syntaxin binding protein 4"	Q6ZWJ1	17	54968727-55173632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 41.7;Oligodendrocyte precursor cells: 84.4;Oligodendrocytes: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007760, HPA022138, HPA022888, HPA024227"	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Cytosol	"CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630"	"unprognostic (5.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.00e-5)"	"unprognostic (4.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	1.4	2.0	2.3	1.7	2.3	1.4	1.8	2.2	1.7	2.2	7.8	1.7	2.5	2.8	1.7	1.9	2.8	2.6	1.8	1.5	3.1	4.3	0.9	2.1	1.2	3.2	3.9	2.9	1.5	6.0	2.0	1.8	2.8	3.0	1.7	4.5	1.4	3.5	1.1	1.0	1.4	2.7	3.0	1.1	1.6	2.1	3.2	1.8	3.1	1.0	1.2	1.9	1.3	3.7	5.0	7.3	6.6	5.9	5.5	5.4	2.7	3.8	3.6	4.8	4.7	4.3	2.6	3.4	7.9	3.8	4.2	2.9	8.6	3.8	8.9	5.1	4.9	4.4	4.8	8.9	2.3	2.8	1.3	6.1	1.1	7.0	1.6	2.2	4.9	2.9	7.2	2.6	5.8	2.2	9.3	1.8	4.8	4.2	5.2	3.9	7.7	2.0	8.6	3.0	6.3	4.8	5.8	0.9	3.2	3.5	8.4	1.9	3.8	6.8	5.2	4.2	4.0	2.3	2.3	5.8	4.4	3.6	4.1	1.7	0.4	0.0	0.9	0.3	1.0	0.7	0.8	0.6	0.5	1.1	0.7	0.9	0.1	2.2	0.5	1.1	0.8	0.3	2.3	2.3	2.2	1.7	1.5	3.1	3.2	3.9	2.8	3.0	3.2	3.7	6.6	0.0	9.1	39.5	3.9	0.9	2.4	3.3	4.6	5.6	4.4	3.3	9.6	2.8	5.4	9.2	41.7	1.6	2.1	2.0	9.8	6.0	6.7	16.6	14.4	4.3	6.0	5.2	29.0	2.7	1.9	7.5	6.1	5.8	7.6	6.1	6.1	5.1	2.3	8.4	25.5	1.4	0.0	2.4	1.4	5.3	17.7	2.4	7.2	20.6	2.1	5.9	1.0	84.4	39.3	3.3	2.1	11.7	1.6	2.2	4.9	7.2	17.4	21.6	32.9	8.8	11.4	11.1	7.3	2.8	3.0	0.3	4.8	5.1	3.1	1.2
SUCLG1		ENSG00000163541	"Succinate-CoA ligase GDP/ADP-forming subunit alpha"	P53597	2	84423528-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 554.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	118.7	73.3	70.6	43.1	73.2	48.2	80.0	76.2	92.5	49.9	91.1	156.9	231.1	42.4	78.8	86.9	54.6	41.9	258.1	71.1	74.5	554.0	193.0	41.6	47.8	71.7	70.2	45.7	93.6	244.2	46.8	48.8	72.9	54.3	165.9	38.4	120.6	66.6	274.1	55.4	195.4	63.5	73.8	39.6	81.1	36.9	73.3	61.7	97.6	368.1	63.1	66.4	58.5	76.9	90.2	94.9	73.8	91.1	137.8	91.2	127.7	98.4	85.2	126.0	91.2	224.5	72.0	122.4	67.0	119.8	100.2	126.8	156.7	118.4	149.8	119.3	141.4	105.9	75.4	129.2	116.0	110.6	82.7	109.1	95.6	106.3	143.7	76.7	115.1	97.9	110.1	98.1	117.5	137.4	158.2	101.1	39.4	334.1	170.0	98.3	172.6	134.5	172.2	106.4	89.8	49.3	78.9	163.7	162.3	69.0	99.8	85.4	93.1	96.6	94.6	119.9	124.9	84.2	131.0	107.8	113.9	150.4	88.0	101.6	91.0	80.8	79.0	110.2	88.5	70.2	72.0	88.4	115.4	55.4	79.1	84.3	49.7	102.3	114.3	63.2	107.7	142.7	70.6	73.2	76.2	92.5	71.1	74.5	71.7	70.2	72.9	73.8	73.3	76.9	52.7	64.1	96.5	32.7	61.0	35.4	108.9	129.6	44.3	33.3	105.0	109.1	408.6	131.5	115.2	141.6	22.9	232.3	49.9	218.1	935.2	131.8	49.2	67.1	56.9	57.0	106.3	68.4	45.8	113.2	129.3	69.8	79.5	80.8	91.3	46.0	57.5	210.0	131.7	45.4	43.5	202.1	105.8	71.3	46.0	35.9	54.7	82.2	119.2	16.9	89.8	68.2	58.7	28.1	46.2	67.1	215.4	74.1	57.1	64.2	647.5	2949.2	83.7	36.1	52.6	61.1	98.3	138.9	54.4	111.3	41.3	188.4	64.4	90.7	388.7	111.0
SUCO	"C1orf9, CH1, OPT, SLP1"	ENSG00000094975	"SUN domain containing ossification factor"	Q9UBS9	1	172532349-172611833	"Predicted membrane proteins"	Osteogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 83.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047251	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		45000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli fibrillar center, Cytosol"		"HPA047251: AB_2679999"	"unprognostic (1.28e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	"unprognostic (7.05e-2)"	9.8	11.9	8.4	9.4	10.3	83.3	14.4	7.9	10.3	13.3	8.6	9.1	10.0	12.1	61.9	8.8	15.7	11.6	9.2	7.5	9.9	12.0	6.9	9.5	9.7	8.2	10.2	17.9	26.1	27.1	13.1	16.9	8.3	13.5	9.4	35.5	14.7	24.5	3.0	12.1	15.2	9.4	9.2	8.9	13.2	24.6	8.9	14.0	17.6	4.6	9.9	12.8	8.0	11.4	30.2	13.1	37.9	34.0	19.1	18.2	42.8	35.9	20.9	22.3	27.0	23.9	31.5	15.0	21.1	20.6	22.9	46.4	16.3	14.0	38.1	8.4	11.8	11.8	8.2	14.7	22.2	19.1	15.9	16.5	14.1	27.6	22.4	69.0	19.7	17.0	7.7	20.8	33.9	7.2	12.8	12.9	34.5	34.6	30.4	12.5	22.0	9.8	34.6	41.6	20.2	26.1	16.6	28.3	31.9	64.8	27.5	20.5	25.9	20.2	21.2	19.5	36.9	30.9	26.5	26.7	19.2	9.9	32.4	6.5	3.5	6.3	4.3	3.2	4.2	4.5	3.9	3.7	2.9	5.2	4.3	4.4	3.2	5.9	3.9	4.2	3.2	2.4	8.4	10.3	7.9	10.3	7.5	9.9	8.2	10.2	8.3	9.2	8.9	11.4	20.9	48.1	30.9	40.5	30.4	26.3	32.4	22.6	59.2	43.0	40.5	31.2	30.1	14.3	39.0	27.6	50.1	38.8	35.6	14.2	3.9	15.0	40.7	30.4	29.4	22.2	26.4	48.6	32.3	32.0	27.3	29.1	29.6	56.9	13.9	25.7	15.0	15.2	13.3	47.1	43.8	30.7	18.3	13.1	17.2	55.8	45.7	22.7	26.6	34.7	18.7	63.5	18.6	82.4	66.3	25.0	7.1	28.2	61.9	38.8	34.0	13.2	37.0	53.8	26.3	29.6	23.0	73.6	36.7	28.9	27.0	49.4	37.4	30.0	11.2	34.7
SUDS3	"FLJ00052, SAP45, SDS3"	ENSG00000111707	"SDS3 homolog, SIN3A corepressor complex component"	Q9H7L9	12	118376555-118418033	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 271.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040402, HPA041972"	Approved		Supported	"Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA040402: , HPA041972: AB_2677776"	"unprognostic (1.49e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-1)"	10.8	12.3	13.3	12.0	14.2	16.9	18.7	9.6	15.2	16.6	12.1	16.5	14.3	14.9	16.0	19.9	18.1	11.7	12.8	15.8	12.9	16.1	14.0	11.9	14.7	12.7	14.6	15.0	17.3	25.3	11.6	11.5	14.1	16.2	18.3	16.3	19.2	15.7	11.3	20.1	14.1	13.7	10.6	13.7	16.2	16.4	12.2	17.9	21.7	11.9	19.5	14.4	15.2	13.2	29.4	21.9	29.4	29.4	16.1	21.1	31.5	22.5	23.2	25.8	20.4	24.1	18.6	39.8	23.5	21.8	16.0	34.3	35.3	23.8	30.3	35.3	20.9	27.7	18.4	21.6	18.4	30.9	20.5	14.6	25.0	12.8	22.7	33.5	22.2	36.9	30.8	14.1	23.9	20.2	36.7	40.2	30.5	38.8	17.0	32.9	26.4	28.3	23.7	42.7	22.9	22.7	31.9	18.7	19.9	36.7	61.1	24.9	18.7	17.5	16.6	19.7	15.5	26.2	31.4	29.2	19.4	19.4	21.4	1.8	4.3	5.9	5.0	2.8	6.1	8.8	5.4	5.7	4.7	8.4	6.4	4.4	12.6	4.3	2.8	6.8	5.5	3.9	13.3	14.2	9.6	15.2	15.8	12.9	12.7	14.6	14.1	10.6	12.2	13.2	25.5	28.9	15.9	19.6	37.8	64.7	44.7	55.0	46.1	75.4	85.6	63.0	37.5	41.5	37.1	47.8	77.2	34.6	26.9	75.1	80.3	41.5	271.9	87.6	54.4	24.6	37.3	30.3	22.4	19.3	54.5	31.5	36.7	73.2	8.2	37.5	21.0	34.1	25.0	107.7	29.1	60.2	59.0	18.2	36.1	59.4	38.5	20.8	28.4	13.1	30.5	30.0	29.9	30.2	21.6	26.4	52.6	41.0	49.1	60.5	38.3	45.7	61.9	57.3	26.3	42.8	48.5	62.6	53.4	74.1	78.7	49.1	32.9	41.6	56.8	61.9
SULT1C3		ENSG00000196228	"Sulfotransferase family 1C member 3"	Q6IMI6	2	108239971-108265351	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"breast: 368.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 36.7"	HPA060368			Approved	Cytosol		NA	NA				"Cluster 5: Breast - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA060368: "			"unprognostic (1.14e-3)"								"unprognostic (1.78e-1)"	"unprognostic (4.13e-1)"		"unprognostic (6.64e-2)"				0.1	0.0	0.1	0.0	0.1	0.0	368.4	0.0	0.1	0.1	1.6	0.4	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.5	4.4	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SULT1C4	"SULT1C, SULT1C2"	ENSG00000198075	"Sulfotransferase family 1C member 4"	O75897	2	108377911-108388989	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 13.3;Cholangiocytes: 37.1;Endothelial cells: 13.2;Granulosa cells: 15.3;Hepatic stellate cells: 17.9;Muller glia cells: 12.3;Oligodendrocyte precursor cells: 17.6"	"Group enriched"	"Detected in many"	6	"glioma: 7.1;renal cancer: 20.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.5;HUVEC TERT2: 10.7;SH-SY5Y: 42.0;SuSa: 11.6"					"Low region specificity"	"Detected in many"			HPA034530			Approved	Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA034530: AB_10670170"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-3)"	"prognostic favorable (9.99e-7)"	"unprognostic (1.79e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.38e-1)"	6.2	2.0	15.5	1.1	16.1	0.5	5.2	16.9	17.2	21.9	12.9	3.4	1.5	11.1	8.0	2.3	9.3	27.1	10.9	13.6	18.9	18.2	3.7	10.3	1.8	18.8	27.3	27.9	2.9	1.0	5.2	13.0	20.4	6.6	2.2	8.6	1.6	8.9	3.1	0.7	3.2	5.5	18.1	1.4	2.0	1.4	19.0	5.0	4.5	6.2	1.3	3.8	5.3	15.8	0.0	0.1	9.5	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	1.2	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.0	0.0	0.0	0.0	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	15.5	16.1	16.9	17.2	13.6	18.9	18.8	27.3	20.4	18.1	19.0	15.8	13.3	0.0	0.5	10.4	0.0	0.3	0.7	0.0	0.0	2.0	0.4	0.3	0.7	37.1	0.0	9.2	0.0	0.3	0.0	0.0	0.0	0.3	5.9	10.9	3.1	13.2	0.0	2.7	0.6	0.2	0.1	4.9	0.0	3.8	0.0	15.3	17.9	0.0	0.9	1.7	0.5	0.0	0.0	1.3	1.0	1.1	1.5	0.4	0.0	7.5	0.1	12.3	0.0	17.6	0.4	0.1	0.0	4.5	1.4	0.7	0.0	7.7	0.0	1.0	0.0	1.4	1.8	0.6	0.7	0.0	0.4	0.3	0.2	7.2	0.0	0.2
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone and transcription elongation factor"	Q7KZ85	17	28662198-28702679	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: AB_2675094"	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	31.2	33.5	24.6	25.4	25.8	65.3	28.3	25.0	26.8	27.0	26.8	36.6	20.0	30.6	26.8	26.5	26.6	24.7	28.8	24.0	29.0	25.6	35.8	28.9	28.4	24.0	25.2	31.2	31.4	30.8	34.3	27.8	24.3	28.7	20.9	29.2	29.1	25.6	54.5	39.2	32.2	27.3	21.6	34.4	31.3	21.4	28.7	34.0	28.9	32.6	30.3	32.1	25.6	25.6	49.4	101.3	49.8	57.1	59.1	39.3	38.2	66.2	70.3	76.3	67.8	94.7	21.5	52.1	33.6	66.5	58.7	57.5	73.6	48.1	78.4	97.6	65.4	72.9	83.2	59.4	49.4	77.2	77.9	54.6	28.4	81.2	53.6	50.3	50.8	50.3	72.9	59.7	55.1	59.1	76.9	33.4	38.7	43.2	32.4	38.7	91.2	42.7	37.6	95.9	37.8	49.9	77.6	120.5	41.6	67.9	74.2	54.2	80.6	59.8	49.4	57.5	85.3	75.4	62.2	74.4	67.5	34.4	50.5	14.7	4.5	4.4	3.7	2.9	3.9	4.5	3.1	4.1	3.7	4.5	3.1	2.8	6.8	4.3	5.0	6.2	3.1	3.1	24.6	25.8	25.0	26.8	24.0	29.0	24.0	25.2	24.3	21.6	28.7	25.6	33.9	38.5	51.0	24.2	36.5	22.4	19.2	16.8	43.3	29.5	27.4	26.0	51.6	22.8	28.4	20.2	56.3	24.4	38.4	29.5	5.9	22.1	5.4	31.0	45.3	32.6	31.0	33.0	21.6	21.3	21.3	32.7	46.4	49.1	50.5	36.6	22.9	33.9	23.7	30.3	19.7	23.1	8.2	23.0	22.4	17.8	25.7	41.8	8.8	16.9	29.9	22.0	30.9	17.6	19.4	31.9	18.7	26.7	55.7	20.0	23.4	10.5	25.7	44.4	32.9	32.4	32.0	19.8	19.1	40.1	24.3	49.8	38.3	42.0	22.9	25.7
SV2A	"KIAA0736, SV2"	ENSG00000159164	"Synaptic vesicle glycoprotein 2A"	Q7L0J3	1	149903318-149917844	"FDA approved drug targets, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 128.2;parathyroid gland: 48.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 111.9;Excitatory neurons: 63.4;Horizontal cells: 95.9;Inhibitory neurons: 107.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002226, HPA007863"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB002226: AB_564144, HPA007863: AB_1080135"	"unprognostic (8.05e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.24e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.81e-3)"	1.5	8.9	59.2	2.9	64.7	6.0	1.6	30.2	128.2	6.9	0.0	4.5	1.5	8.4	23.4	1.6	4.8	3.3	1.5	65.1	61.6	1.7	0.5	2.0	2.1	68.2	40.2	3.5	1.4	48.4	22.9	1.4	61.2	4.2	1.8	38.6	1.3	3.7	0.5	0.9	3.0	8.0	14.1	1.6	2.5	1.1	48.9	3.8	4.4	0.5	1.7	3.1	3.9	67.5	0.3	0.0	26.0	0.1	2.6	7.4	2.8	11.2	38.8	32.6	46.7	0.8	1.2	0.3	9.9	16.9	34.3	0.6	0.3	2.4	27.9	0.1	6.2	35.2	2.0	2.0	24.5	0.3	0.5	16.7	0.2	52.3	3.9	36.2	2.9	31.7	0.4	35.8	21.8	0.3	34.8	1.7	66.3	0.0	0.2	12.0	16.4	0.7	0.2	0.9	54.2	43.8	0.1	0.4	25.6	24.6	0.4	21.4	0.2	30.1	29.9	1.2	41.3	0.2	0.5	0.2	53.0	0.3	12.3	0.4	0.1	0.0	0.3	0.0	0.3	0.1	0.3	0.2	0.0	0.2	0.1	0.4	0.3	0.3	0.0	0.1	0.6	0.1	59.2	64.7	30.2	128.2	65.1	61.6	68.2	40.2	61.2	14.1	48.9	67.5	0.8	0.0	1.1	12.4	0.3	0.1	1.9	0.7	4.6	111.9	0.7	4.2	0.8	1.5	0.1	0.0	4.2	0.3	0.7	0.3	0.0	0.1	0.6	0.4	4.6	2.4	4.2	2.1	63.4	0.4	0.6	3.3	1.5	1.3	0.0	10.9	7.5	0.1	0.3	95.9	107.2	0.4	0.0	0.0	0.9	0.2	0.0	0.3	0.0	7.5	0.0	22.9	0.0	28.1	15.7	0.2	0.1	5.7	0.5	0.9	0.1	0.1	0.9	16.1	0.0	2.7	4.9	1.3	0.9	0.4	0.4	0.4	2.7	3.0	0.5	0.7
SVBP	"CCDC23, MGC45441"	ENSG00000177868	"Small vasohibin binding protein"	Q8N300	1	42807052-42817397	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.0;Erythroid cells: 135.4;Spermatocytes: 158.0;Spermatogonia: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008507	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"	"Secreted to blood"	Yes	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA008507: AB_2072066"	"prognostic favorable (6.33e-4)"	"unprognostic (2.68e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	34.7	15.1	36.4	13.7	37.7	43.1	29.9	39.1	49.9	30.9	33.6	29.3	11.6	24.9	26.2	17.7	27.2	15.2	24.7	37.1	38.4	25.6	19.1	17.4	23.0	38.2	37.3	36.3	12.1	22.1	30.6	20.6	37.5	20.3	15.7	22.6	15.9	15.4	28.0	17.7	19.9	19.2	38.2	22.1	19.0	52.9	37.1	48.3	19.0	23.5	23.5	23.9	24.8	40.3	25.9	12.9	75.2	26.9	30.9	48.3	37.2	21.5	18.1	28.8	29.7	22.8	20.2	29.1	23.5	28.6	22.6	18.3	14.3	23.7	35.2	53.6	23.7	54.5	12.1	43.9	25.6	41.3	35.2	31.2	37.4	16.2	15.4	29.7	29.1	56.0	46.2	14.3	35.3	12.0	41.5	50.8	40.8	23.7	14.5	30.9	55.8	19.2	29.9	25.3	45.5	40.4	26.8	14.9	31.7	76.9	11.3	120.1	22.7	25.4	28.1	19.6	35.6	14.9	19.1	20.7	16.1	27.5	24.4	60.5	40.2	76.5	26.8	40.8	23.5	56.4	46.5	32.3	39.2	59.8	42.8	37.2	70.3	37.3	43.8	33.0	115.7	24.7	36.4	37.7	39.1	49.9	37.1	38.4	38.2	37.3	37.5	38.2	37.1	40.3	46.2	9.6	6.3	0.0	25.0	0.0	33.0	0.0	23.9	6.2	33.1	53.1	0.0	28.6	9.3	20.2	2.1	53.8	20.0	19.5	54.8	51.7	149.0	32.2	34.6	32.3	18.2	135.4	0.0	24.5	66.0	36.6	14.3	18.2	11.4	22.8	42.8	45.6	70.4	6.7	0.0	19.6	0.0	51.8	0.0	61.6	42.9	48.4	0.0	0.0	70.2	33.1	29.9	0.0	0.0	43.1	21.7	53.8	16.9	21.9	20.5	43.2	7.3	15.5	59.2	28.1	28.4	158.0	153.8	21.4	0.0	61.6	21.4	24.1	23.6	31.1
SWI5	"bA395P17.9, C9orf119, SAE3"	ENSG00000175854	"SWI5 homologous recombination repair protein"		9	128275379-128316123	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 142.5"	"Group enriched"	"Detected in all"	9	"Early spermatids: 1180.8;Late spermatids: 1131.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052032	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA052032: AB_2681702"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.38e-2)"	27.5	26.5	29.0	11.2	31.3	11.0	28.2	31.3	40.8	39.2	32.7	23.5	15.9	27.5	68.8	33.3	31.7	17.8	34.9	28.7	31.9	36.4	42.3	20.6	12.5	30.4	30.8	40.8	21.2	71.4	54.5	17.6	30.4	32.8	12.7	21.1	25.6	37.1	25.2	26.0	18.6	20.3	29.7	18.0	23.0	142.5	30.4	17.1	44.0	25.6	17.7	26.4	31.5	31.6	29.2	51.4	29.7	34.8	79.2	71.8	33.7	50.6	66.7	64.2	42.6	66.6	33.5	27.7	65.7	82.6	39.5	47.8	48.1	67.5	42.6	41.4	35.7	21.0	97.5	52.9	101.9	13.6	18.6	60.8	31.7	107.4	57.8	55.9	62.5	96.8	50.5	42.8	66.5	119.9	29.6	19.6	20.3	67.8	105.3	27.1	41.0	44.4	43.6	15.2	34.0	18.9	63.0	39.8	63.0	32.9	66.2	14.5	39.0	46.4	38.0	90.9	43.3	45.6	75.0	37.0	61.8	20.9	50.7	54.3	14.2	25.8	14.5	8.7	17.0	17.6	14.1	14.4	14.7	20.2	16.7	21.6	9.0	22.2	9.1	21.4	15.6	15.3	29.0	31.3	31.3	40.8	28.7	31.9	30.4	30.8	30.4	29.7	30.4	31.6	33.8	6.4	17.4	5.2	18.0	24.5	35.1	54.0	31.3	13.7	33.6	38.9	36.2	31.5	33.5	36.8	12.5	65.7	13.7	15.7	66.5	25.5	1180.8	30.7	29.1	31.3	25.6	17.2	2.9	38.5	41.1	40.7	19.9	30.7	9.5	27.9	35.7	82.4	33.2	1.7	3.3	27.5	28.5	20.8	13.0	1131.1	43.2	31.5	37.4	2.8	23.8	50.7	20.6	4.5	7.8	29.8	27.1	31.6	17.9	34.9	68.4	84.1	29.5	21.1	32.9	25.7	31.3	93.7	44.3	33.5	21.9	117.0	18.6	32.8	23.4	36.6
SWSAP1	"C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1"	ENSG00000173928	"SWIM-type zinc finger 7 associated protein 1"	Q6NVH7	19	11374666-11376951	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052712	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 64: Macrophages - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA052712: AB_2681925"	"unprognostic (6.45e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-3)"	2.4	3.6	1.6	3.9	1.5	5.1	4.0	3.9	2.0	3.7	2.5	4.4	4.5	2.9	3.6	3.6	4.8	3.9	3.1	1.6	1.2	3.7	5.3	3.6	7.1	1.6	1.4	5.3	4.5	2.6	2.0	4.1	1.8	4.0	3.2	0.7	5.1	4.4	3.6	5.0	3.7	2.2	1.3	6.5	4.6	3.6	1.5	4.2	5.0	3.0	4.2	3.4	1.6	2.4	8.1	6.8	3.6	2.2	3.6	3.0	5.3	2.0	2.2	4.6	4.2	7.1	5.5	14.9	10.0	1.9	3.2	5.7	3.4	8.6	0.5	4.8	8.5	6.9	3.0	10.3	3.3	11.3	12.0	4.7	7.4	2.6	1.7	2.7	5.5	6.9	8.4	6.4	2.5	17.6	6.6	15.0	9.0	6.0	9.0	5.5	1.7	16.2	8.6	5.5	7.4	5.5	2.6	8.7	5.5	1.9	11.9	12.9	5.7	3.8	2.7	5.4	4.0	9.5	14.8	10.6	2.1	13.2	3.0	3.2	31.4	7.9	12.5	30.5	12.1	20.9	13.1	13.6	24.3	19.4	16.1	13.9	20.2	16.7	29.5	15.3	13.8	12.3	1.6	1.5	3.9	2.0	1.6	1.2	1.6	1.4	1.8	1.3	1.5	2.4	4.9	3.2	2.0	2.3	10.3	2.7	8.5	16.7	4.0	7.2	9.8	9.3	3.2	2.8	10.6	16.5	8.4	17.8	11.3	10.5	41.1	7.1	10.8	4.5	3.7	6.7	2.4	7.0	1.1	10.7	10.5	4.0	3.1	4.1	1.3	3.7	6.8	13.5	12.1	10.1	1.0	14.2	22.4	9.8	5.4	1.9	11.8	6.5	7.2	0.0	9.6	8.8	19.6	0.0	2.7	6.1	12.2	7.9	3.4	5.6	11.2	17.2	14.6	10.2	6.6	3.2	6.3	10.7	15.0	4.1	3.1	31.7	8.8	13.7	8.9	5.5
SWT1	"C1orf26, FLJ20121, HsSwt1"	ENSG00000116668	"SWT1 RNA endoribonuclease homolog"	Q5T5J6	1	185157080-185291781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 38.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.8;Late spermatids: 52.7;Oligodendrocytes: 55.2;Spermatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 18.4;U-266/84: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024214, HPA027334"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA024214: AB_1845642, HPA027334: AB_1845643"	"unprognostic (2.67e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.41e-3)"	"unprognostic (5.71e-3)"	"unprognostic (9.26e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.35e-2)"	3.3	3.2	4.0	2.9	5.8	9.0	4.1	4.5	3.9	3.8	3.7	3.4	4.9	4.3	4.4	2.7	2.9	3.7	3.6	3.2	5.3	4.8	3.3	3.4	2.8	5.2	5.1	6.3	9.2	4.3	2.4	5.6	5.3	4.6	3.3	5.4	6.5	3.1	2.9	3.0	3.8	3.2	4.6	3.0	4.9	38.3	4.7	4.9	5.2	4.5	3.0	3.3	2.8	7.2	2.1	1.8	5.0	2.7	8.1	6.2	4.2	2.1	3.6	2.6	3.9	1.5	1.7	2.1	4.1	1.6	2.6	1.8	3.1	2.8	3.3	5.6	2.1	2.2	1.2	2.0	4.0	0.7	1.8	4.6	2.8	2.8	2.5	4.4	6.3	4.2	4.8	10.2	2.7	0.7	2.5	1.9	5.4	5.5	1.0	1.9	4.5	5.2	2.5	1.3	1.0	7.7	1.7	2.6	7.2	11.7	2.9	1.4	3.0	3.4	2.2	3.2	1.3	18.4	15.2	0.8	3.8	1.3	1.3	14.2	1.9	2.8	1.5	1.8	2.8	2.3	3.1	2.3	1.2	3.3	2.9	2.2	5.6	0.8	4.3	1.1	6.1	1.1	4.0	5.8	4.5	3.9	3.2	5.3	5.2	5.1	5.3	4.6	4.7	7.2	7.1	3.2	1.1	37.2	4.0	1.0	2.0	1.4	2.8	4.3	5.0	3.4	7.3	2.8	3.2	5.5	4.2	3.2	2.2	5.1	0.0	2.9	150.8	5.3	4.4	4.9	0.0	8.2	25.5	2.7	6.8	5.5	4.6	4.9	2.5	4.5	7.9	3.8	3.7	8.4	32.3	3.6	0.0	5.7	1.9	52.7	4.7	3.1	1.8	21.5	3.8	2.6	4.1	31.7	55.2	2.1	7.8	5.7	5.7	2.4	4.4	5.3	2.4	5.4	0.0	4.3	5.7	54.3	11.5	3.0	0.6	6.7	3.6	2.3	2.9	2.3
SYCE1	"bA108K14.6, C10orf94, CT76"	ENSG00000171772	"Synaptonemal complex central element protein 1"	Q8N0S2	10	133553901-133569835	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 70.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 141.2;Late spermatids: 112.6;Spermatocytes: 362.8;Spermatogonia: 170.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 18.5;U-2 OS: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040208	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040208: AB_10796450"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"		"unprognostic (1.85e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.75e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	1.9	1.6	8.5	0.6	8.5	0.0	1.4	9.1	11.6	1.3	2.0	0.9	0.1	0.9	0.3	0.7	1.2	1.2	0.7	9.0	6.3	1.2	4.0	0.4	0.2	6.6	5.4	2.0	3.8	0.0	1.2	9.4	6.4	1.7	0.4	2.3	0.2	0.4	0.9	0.5	0.5	0.6	3.7	0.9	0.6	70.9	6.7	0.2	1.4	1.7	0.5	0.4	0.4	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.5	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.1	15.5	0.2	0.4	0.2	0.3	0.4	0.0	0.1	0.0	0.0	0.5	0.1	0.9	0.6	0.8	0.2	0.6	0.2	0.3	0.3	0.3	0.8	0.0	0.0	0.8	0.6	0.7	0.4	8.5	8.5	9.1	11.6	9.0	6.3	6.6	5.4	6.4	3.7	6.7	8.1	0.7	0.0	1.5	0.7	0.3	1.0	1.2	0.0	0.0	2.7	1.0	2.4	0.3	1.5	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	141.2	1.2	3.2	1.3	0.0	0.0	29.8	1.1	0.2	5.6	0.5	0.6	0.0	0.0	0.0	7.8	0.7	10.1	19.1	0.0	0.0	0.3	0.9	112.6	5.3	0.9	0.0	0.0	0.0	0.3	0.0	7.1	0.8	0.4	0.3	3.8	0.1	0.6	0.0	0.5	1.5	2.1	26.3	0.5	0.9	362.8	170.9	0.0	1.0	0.3	0.5	7.0	0.0	0.6
SYCP1	"CT8, HOM-TES-14, SCP1"	ENSG00000198765	"Synaptonemal complex protein 1"	Q15431	1	114854863-114995370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"testis: 40.2"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 1162.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	98	"THP-1: 17.2"	"Region enriched"	"Detected in single"	51	"cerebellum: 14.7"	"Not detected"	"Not detected"			HPA021083	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA021083: AB_1857685"	"unprognostic (2.91e-1)"									"unprognostic (6.89e-3)"				"unprognostic (4.87e-1)"	"unprognostic (8.74e-3)"			0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.5	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	56.7	5.3	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1162.6	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYDE1	"7h3, FLJ13511, SYD1"	ENSG00000105137	"Synapse defective Rho GTPase homolog 1"	Q6ZW31	19	15107401-15114985	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 140.3;Peritubular cells: 42.2;Sertoli cells: 85.5;Syncytiotrophoblasts: 134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013328	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA013328: AB_1848705"	"unprognostic (9.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.65e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (1.82e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.27e-4)"	23.3	12.6	7.8	5.7	8.0	0.0	17.6	7.4	7.8	27.6	15.7	28.6	3.8	32.9	4.6	6.6	23.2	5.7	20.8	6.9	7.2	16.3	4.9	18.1	3.5	9.7	8.0	23.5	6.0	2.5	6.7	15.4	7.9	18.2	2.5	1.4	6.1	11.5	5.4	8.6	11.7	10.8	7.8	12.9	13.5	4.7	8.5	0.9	12.4	3.8	1.4	23.9	18.8	7.3	11.2	17.4	9.0	23.9	19.9	18.2	7.1	46.9	33.7	44.4	37.5	4.1	7.0	0.0	30.3	46.5	15.2	7.0	7.0	8.1	24.6	0.3	8.0	1.6	34.2	7.6	37.7	0.1	0.1	32.1	5.9	26.6	12.0	26.8	8.2	0.0	0.0	0.1	33.6	5.9	0.0	0.0	14.7	0.3	17.3	0.0	22.4	0.2	11.1	1.8	0.3	17.8	25.9	15.9	31.6	8.7	1.9	1.2	17.5	107.3	32.8	49.6	50.4	0.1	0.3	0.2	29.3	0.1	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	8.0	7.4	7.8	6.9	7.2	9.7	8.0	7.9	7.8	8.5	7.3	18.6	3.2	1.1	3.6	0.2	2.4	0.8	1.2	1.8	0.3	0.9	3.2	4.1	1.5	0.8	1.8	0.0	7.6	0.0	0.0	0.0	4.7	10.0	0.7	13.6	15.2	0.0	0.0	0.0	0.4	140.3	16.2	0.0	0.5	0.0	12.8	20.0	0.3	3.4	1.7	0.0	0.0	0.0	1.0	2.7	19.3	29.5	0.6	14.2	6.5	0.0	20.0	0.0	1.0	0.2	1.7	0.0	42.2	0.0	0.5	0.0	6.1	0.1	0.8	85.5	10.7	30.8	3.1	0.6	0.3	2.6	134.5	0.4	7.5	0.0	0.2
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 73.8;parathyroid gland: 87.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 91.3;Hofbauer cells: 73.1;Kupffer cells: 96.7;Macrophages: 95.2;Microglial cells: 114.3;monocytes: 92.5;Plasma cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 77.3;eosinophil: 83.5;intermediate monocyte: 64.0;memory B-cell: 74.5;myeloid DC: 85.1;naive B-cell: 58.4;neutrophil: 112.1;NK-cell: 30.0;non-classical monocyte: 60.2;plasmacytoid DC: 63.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 125.8;HEL: 72.8;HL-60: 101.6;HMC-1: 64.1;REH: 84.4;THP-1: 76.8;U-698: 58.8;U-937: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		290000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.4	4.6	4.1	42.5	4.1	50.9	6.8	4.5	4.9	7.7	4.2	20.1	30.8	4.1	16.1	17.5	17.0	12.9	2.9	3.8	5.0	11.2	4.5	20.6	61.8	7.1	5.8	1.7	9.1	87.6	2.4	12.0	7.0	3.8	20.5	0.7	8.4	4.2	1.0	9.9	36.3	9.3	6.6	40.3	19.1	6.9	7.1	49.7	25.6	2.4	73.8	17.5	8.3	9.8	22.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.3	125.8	3.5	0.0	4.2	19.1	2.7	10.2	0.0	0.0	17.0	72.8	0.0	0.0	0.0	101.6	64.1	0.0	14.0	0.0	1.4	0.0	0.0	15.5	2.0	9.9	0.0	15.4	0.1	44.4	0.7	47.0	0.0	84.4	0.1	34.6	2.6	18.6	6.4	5.7	0.1	8.7	0.1	0.3	7.9	76.8	0.2	0.0	0.4	0.1	0.1	0.2	0.0	58.8	0.0	70.3	0.0	5.3	77.3	83.5	0.3	64.0	0.3	74.5	0.2	0.2	85.1	58.4	0.2	0.1	112.1	30.0	60.2	63.2	0.1	44.6	4.1	4.1	4.5	4.9	3.8	5.0	7.1	5.8	7.0	6.6	7.1	9.8	0.5	12.8	20.2	0.0	91.3	3.4	3.7	8.7	12.0	1.4	6.3	2.8	1.6	14.3	12.8	14.7	0.0	1.3	70.4	16.5	15.6	15.0	7.1	10.7	1.0	2.1	10.3	37.9	0.4	12.5	2.6	2.1	22.4	12.6	43.6	0.0	3.3	1.0	73.1	0.0	0.7	24.4	0.0	96.7	28.8	6.2	0.6	95.2	12.4	114.3	92.5	0.0	62.8	1.5	0.5	18.2	25.1	0.0	83.1	2.5	31.4	0.4	10.4	0.2	6.6	0.7	2.3	0.8	0.7	30.4	5.7	1.4	8.3	0.0	31.1	8.0
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863194	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.6;Late spermatids: 146.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: AB_2678003"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	18.0	17.3	15.5	29.3	17.0	27.4	18.0	12.5	19.8	24.1	11.9	22.5	22.2	25.3	20.1	19.7	23.5	18.0	17.5	14.9	14.1	19.1	21.4	20.6	34.8	18.9	15.6	23.6	19.1	20.7	32.6	25.0	17.1	23.8	14.1	15.7	24.7	16.4	38.5	25.3	22.8	16.1	11.4	28.5	22.9	41.0	16.6	30.0	24.0	18.9	22.8	20.7	19.9	22.7	57.7	101.0	40.4	29.9	39.0	46.8	67.7	44.5	32.0	45.8	51.0	45.8	51.1	101.6	30.2	51.0	25.7	46.2	55.1	49.9	40.0	79.4	62.2	58.7	68.9	47.5	43.7	64.9	65.6	36.1	29.2	49.3	55.4	31.2	47.6	52.6	79.3	64.4	39.4	54.8	61.0	70.3	34.0	50.0	23.9	64.6	46.4	62.6	31.8	102.7	46.0	57.7	55.1	35.5	36.7	40.3	48.4	89.4	53.5	37.1	58.5	28.8	66.9	84.1	173.1	81.5	42.4	42.8	61.8	1.7	3.0	1.5	2.0	2.5	1.9	2.9	1.8	3.2	2.8	4.8	1.5	1.4	3.4	2.7	5.0	5.8	1.4	2.1	15.5	17.0	12.5	19.8	14.9	14.1	18.9	15.6	17.1	11.4	16.6	22.7	14.7	0.0	7.7	34.9	30.2	20.9	18.7	15.6	18.2	21.6	17.4	15.4	7.0	22.8	12.0	25.8	35.5	35.5	20.9	32.7	54.8	21.6	141.6	24.9	29.9	23.4	36.3	26.5	24.6	17.5	34.5	17.5	41.8	27.7	12.7	35.1	26.0	31.8	18.2	21.9	27.1	38.7	10.2	27.0	25.6	146.4	19.3	24.4	14.2	19.7	47.3	11.3	32.0	29.1	28.4	20.4	25.5	21.1	19.8	21.5	30.8	14.9	15.6	27.4	19.7	17.4	20.4	35.3	34.1	14.4	21.3	57.3	21.2	21.9	38.6	20.6
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728040	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.9;retina: 48.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.9;Inhibitory neurons: 91.5;Oligodendrocytes: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	7.6	6.9	15.0	5.3	22.8	23.8	6.5	1.1	45.9	6.2	3.5	5.6	4.0	5.1	5.1	4.6	5.0	5.2	6.4	22.1	9.8	7.4	5.7	8.0	6.3	19.5	5.6	4.8	4.8	8.4	13.8	9.8	14.8	4.5	5.4	48.4	4.7	3.7	7.7	5.1	6.3	4.9	0.0	7.9	5.0	10.2	8.7	7.1	7.3	6.4	4.8	5.5	5.4	25.9	5.5	2.9	5.0	5.7	8.9	7.1	10.3	11.3	6.2	6.8	5.7	6.1	2.6	2.0	3.8	6.9	8.9	5.0	8.9	6.8	8.4	6.8	8.1	13.8	8.7	3.5	4.8	5.6	11.7	4.1	4.9	12.0	6.1	5.8	10.8	7.3	10.6	11.6	9.0	5.5	5.5	5.1	3.4	6.4	6.0	6.1	11.1	7.4	7.5	4.3	5.6	4.5	14.0	8.4	5.6	6.9	7.8	7.2	11.2	10.0	5.3	8.2	6.4	6.0	7.8	4.4	8.0	10.7	8.7	3.4	2.9	6.9	1.2	5.2	2.0	0.1	1.9	2.0	2.5	0.3	2.2	2.2	9.1	0.5	4.7	1.4	2.6	1.1	15.0	22.8	1.1	45.9	22.1	9.8	19.5	5.6	14.8	0.0	8.7	25.9	10.2	6.4	5.4	22.9	3.9	4.8	1.9	3.1	8.0	24.8	3.8	2.5	10.0	2.8	4.0	1.8	45.9	17.7	7.0	4.8	5.9	2.0	19.9	2.4	4.7	11.9	3.0	5.0	110.9	1.3	9.8	5.3	4.1	3.6	3.8	2.2	11.0	4.2	10.1	10.1	91.5	2.0	0.0	18.6	5.7	11.3	2.8	15.7	1.8	31.9	6.5	21.8	4.1	49.3	61.0	2.8	5.3	4.5	8.6	2.7	6.2	6.5	4.6	45.4	6.6	6.1	5.8	22.1	13.3	6.7	3.3	38.0	9.9	2.8	5.4	4.3
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981863-158099176	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 116.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.1;Glandular and luminal cells: 114.2;Oligodendrocytes: 502.1;Pancreatic endocrine cells: 140.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 133.4;TIME: 109.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavorable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	4.2	5.8	26.1	6.2	69.9	20.0	8.0	58.6	42.0	4.5	1.9	10.6	7.1	7.6	10.5	7.7	5.5	9.4	10.7	22.5	32.4	8.4	4.9	4.5	5.9	98.1	74.7	3.6	8.1	1.5	4.1	3.5	78.9	6.9	10.4	2.3	16.5	5.8	7.2	4.3	6.8	7.7	57.8	4.2	8.5	9.4	58.2	6.5	5.2	9.5	6.5	11.0	4.6	116.2	16.4	56.6	4.5	7.3	3.4	11.2	24.2	29.8	60.4	35.0	41.1	28.7	13.5	0.5	19.8	57.9	133.4	15.4	10.1	18.5	40.1	22.9	9.3	31.8	29.8	30.9	6.5	10.9	32.6	5.9	9.9	53.3	12.4	47.1	61.7	16.4	24.7	6.5	16.1	7.6	14.0	12.2	5.1	51.4	31.2	6.0	19.1	13.4	11.8	18.8	34.8	2.0	22.7	14.2	5.9	17.2	10.9	7.1	109.7	25.8	26.8	61.4	36.5	2.5	7.8	0.4	49.2	17.5	18.4	3.0	0.6	0.5	0.9	0.3	1.9	1.0	1.3	0.8	0.6	2.0	1.1	0.8	4.3	1.0	0.4	0.5	1.2	0.5	26.1	69.9	58.6	42.0	22.5	32.4	98.1	74.7	78.9	57.8	58.2	116.2	17.2	3.2	3.3	5.2	15.4	21.7	19.9	7.5	14.2	2.4	25.4	18.4	13.9	21.5	8.6	18.4	0.0	7.7	12.8	20.0	3.9	59.0	35.5	48.5	13.7	26.4	17.4	5.5	102.1	35.2	5.0	16.6	34.1	114.2	5.1	37.7	7.9	5.2	2.0	0.0	10.1	14.8	10.2	2.2	17.6	56.5	1.2	12.5	10.6	7.5	6.9	1.6	16.5	8.5	502.1	140.2	7.1	6.4	13.5	50.6	13.1	1.7	14.4	0.6	0.0	7.3	18.9	0.9	1.1	11.5	17.2	15.9	17.1	2.2	15.7	36.2
SYNRG	"AP1GBP1, MGC104959, SYNG"	ENSG00000275066	"Synergin gamma"	Q9UMZ2	17	37514807-37609472	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023554, HPA023555"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA023554: AB_1844892, HPA023555: AB_2058337"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.91e-2)"	"prognostic favorable (3.96e-4)"	8.3	9.1	4.5	12.9	6.6	6.7	7.7	5.6	7.0	8.4	7.1	8.7	6.8	7.6	10.8	9.6	7.5	8.1	5.7	4.1	7.4	9.9	8.5	8.8	21.4	6.7	7.5	8.3	8.8	11.9	11.7	7.7	7.4	8.0	9.5	9.2	9.1	6.7	7.1	8.5	12.1	6.9	6.2	16.6	10.4	13.0	6.8	24.2	9.8	6.0	19.3	8.5	8.4	7.5	7.9	13.1	18.0	12.0	12.0	11.5	7.6	12.3	12.4	13.2	15.1	12.5	11.8	15.5	11.4	11.3	13.5	8.0	15.8	6.5	19.7	14.0	9.1	8.9	8.2	6.0	14.0	14.0	19.2	13.1	14.9	15.5	8.8	12.4	18.3	26.3	18.0	13.3	14.3	6.4	29.4	7.3	7.9	7.3	4.8	19.1	15.3	10.5	12.3	15.4	14.2	13.4	11.5	3.7	10.8	20.5	10.5	11.0	17.4	9.6	12.3	8.0	11.5	14.9	18.5	24.4	10.9	7.1	10.7	12.4	4.0	8.8	12.5	2.9	16.4	10.9	10.9	12.5	3.4	10.9	10.7	10.6	8.3	17.5	3.2	13.2	11.8	4.4	4.5	6.6	5.6	7.0	4.1	7.4	6.7	7.5	7.4	6.2	6.8	7.5	26.9	54.5	38.7	37.5	64.8	8.5	14.6	17.2	19.9	49.8	22.6	21.2	26.3	20.0	25.1	33.1	54.2	18.5	77.0	24.1	17.6	24.7	43.7	26.4	29.7	28.1	42.6	17.9	36.5	21.8	10.6	20.4	26.0	31.8	25.9	23.5	22.9	23.2	21.8	37.0	42.5	22.4	18.3	40.9	24.7	50.1	22.7	27.2	16.0	40.3	30.4	31.2	108.1	55.3	71.3	26.4	19.6	24.0	67.6	17.5	23.5	29.7	23.4	49.5	13.1	29.3	20.2	65.8	23.9	19.0	9.2	26.5	81.8	21.7	17.1	20.8
SYPL2	Mg29	ENSG00000143028	"Synaptophysin like 2"	Q5VXT5	1	109466546-109482134	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 363.5;tongue: 175.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.5;Cardiomyocytes: 10.6;Collecting duct cells: 3.7;Hepatocytes: 4.8;Late spermatids: 11.1;Proximal tubular cells: 5.1;Skeletal myocytes: 4.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 31.6;ASC TERT1: 13.2;BJ: 14.1;BJ hTERT+: 44.1;fHDF/TERT166: 23.1;HAP1: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076657			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"HPA076657: "	"unprognostic (1.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.90e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.05e-4)"	"unprognostic (2.54e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.39e-4)"	2.8	11.7	1.5	0.6	1.5	0.0	1.5	1.3	2.4	4.0	4.0	6.2	0.5	6.6	4.5	4.6	1.4	0.9	19.9	1.6	1.3	9.6	9.5	1.3	0.5	1.4	1.3	3.0	5.1	5.8	1.1	3.2	1.2	3.1	1.0	0.4	4.2	6.0	363.5	0.7	1.6	6.0	1.0	1.1	3.2	9.3	1.6	0.1	8.0	175.3	0.3	4.1	2.4	1.3	0.0	0.1	0.1	1.8	31.6	13.2	0.0	14.1	44.1	4.3	1.6	0.0	0.1	0.0	0.0	23.1	0.5	0.0	11.8	0.0	0.9	0.0	5.1	0.0	0.4	0.2	0.6	0.0	1.1	1.2	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.1	0.1	0.0	1.4	3.3	2.3	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	1.3	2.4	1.6	1.3	1.4	1.3	1.2	1.0	1.6	1.3	0.2	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	10.6	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.2	2.8	0.0	0.1	0.4	0.0	0.0	0.3	1.3	0.0	1.0	0.0	0.0	0.0	0.9	0.0	4.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.0	0.1	0.0	1.0	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.1	0.0	5.1	0.0	0.0	0.0	4.8	2.6	0.4	1.4	0.0	0.0	0.1	0.2	0.4	0.0	0.0
SYT16	"CHR14SYT, Strep14, SYT14L, yt14r"	ENSG00000139973	"Synaptotagmin 16"	Q17RD7	14	61811974-62112550	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 16.5"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 281.4;Inhibitory neurons: 279.7;Oligodendrocyte precursor cells: 127.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.8;hTERT-HME1: 4.1;PC-3: 5.4;RPTEC TERT1: 6.2;RT4: 17.0;U-2 OS: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004199, HPA076871"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA004199: AB_1080156, HPA076871: AB_2732324"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (8.88e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.08e-2)"		"unprognostic (9.57e-2)"	"unprognostic (9.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.15e-1)"	0.0	0.4	7.5	0.0	11.0	0.1	0.1	0.0	16.5	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.1	12.7	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.1	1.1	0.4	0.0	2.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.8	3.8	0.0	0.0	0.0	0.0	0.3	0.2	0.4	10.8	0.2	0.3	0.0	0.0	0.0	0.1	0.7	1.0	1.0	0.6	0.0	0.0	0.1	0.2	0.0	0.6	0.6	0.0	1.0	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	0.0	6.2	17.0	0.3	2.8	0.5	0.7	0.0	1.0	0.0	0.0	0.0	2.7	6.6	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	11.0	0.0	16.5	12.7	8.0	0.0	0.0	0.0	0.1	3.8	0.4	0.0	0.0	0.0	8.8	0.1	0.0	0.1	0.0	0.0	2.0	0.0	0.0	1.3	0.0	0.0	3.7	2.1	0.7	0.0	0.0	0.0	0.3	45.0	0.1	0.4	0.1	0.0	0.0	281.4	0.0	0.6	0.1	3.1	0.3	0.0	3.4	0.0	0.0	0.1	0.0	279.7	0.0	0.0	0.0	0.0	17.1	0.3	0.0	0.0	8.4	0.0	0.7	0.0	127.2	13.9	0.1	0.0	0.0	0.3	1.7	0.0	0.2	0.1	0.1	0.0	0.0	0.4	3.8	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SYT17	Syt-17	ENSG00000103528	"Synaptotagmin 17"	Q9BSW7	16	19167971-19268332	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.8;Microglial cells: 51.5;Oligodendrocyte precursor cells: 114.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 6.2;memory B-cell: 7.8;naive B-cell: 19.0;non-classical monocyte: 20.1"	"Group enriched"	"Detected in many"	9	"B-cells: 19.0;monocytes: 20.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.2;CAPAN-2: 28.1;Daudi: 12.6;MCF7: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042059			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"		"HPA042059: AB_2677827"	"unprognostic (3.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.32e-2)"	"unprognostic (4.95e-3)"	4.8	4.8	20.8	1.4	25.7	0.3	4.3	13.4	24.4	3.1	20.2	2.6	4.2	1.0	2.7	4.4	2.2	1.0	1.7	25.8	23.3	5.9	17.4	7.8	3.3	17.8	28.6	0.6	3.0	25.3	18.8	3.8	17.7	9.2	2.8	1.7	1.6	3.3	0.3	10.0	1.9	0.8	15.8	1.3	5.9	0.4	28.2	0.6	6.8	0.6	4.7	3.4	2.6	16.0	0.1	10.4	0.1	0.1	0.3	0.7	14.2	0.0	0.0	0.1	0.0	0.4	28.1	12.6	3.4	0.0	3.8	5.0	0.7	0.4	0.0	0.0	2.1	0.0	10.9	0.2	0.0	0.0	0.1	0.9	2.5	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	21.8	0.0	0.1	1.2	8.3	5.7	0.0	1.2	1.0	3.5	6.2	2.1	1.2	4.0	11.0	0.5	6.7	10.9	2.8	0.0	0.0	7.1	0.1	0.0	2.0	0.0	11.4	0.0	0.1	0.0	0.4	0.7	0.0	0.0	6.2	0.0	7.8	0.0	0.0	2.2	19.0	0.0	0.0	0.1	0.0	20.1	0.2	0.0	0.9	20.8	25.7	13.4	24.4	25.8	23.3	17.8	28.6	17.7	15.8	28.2	16.0	0.7	6.4	9.3	90.8	8.6	3.8	12.0	3.8	7.4	1.8	7.6	4.1	1.6	2.8	7.5	22.0	0.0	6.4	0.0	4.3	27.4	4.9	0.2	2.3	0.6	2.9	21.6	5.3	18.6	0.6	15.3	2.3	2.0	2.5	0.0	0.1	3.9	23.2	4.0	1.7	20.9	10.0	34.6	4.0	4.0	0.1	1.5	3.6	12.4	51.5	6.2	12.0	0.0	114.1	1.7	3.6	9.0	0.7	0.0	6.0	0.4	0.6	5.8	0.5	0.0	6.7	1.6	0.3	3.9	3.6	9.7	4.0	0.2	0.1	4.3	8.2
SYTL5		ENSG00000147041	"Synaptotagmin like 5"	Q8TDW5	X	38006553-38128819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;stomach 1: 12.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 37.2;Inhibitory neurons: 92.0;Intestinal goblet cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.2;MCF7: 5.8;OE19: 8.4;SK-MEL-30: 14.8;SuSa: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026074	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Microtubules, Cytosol"	"HPA026074: AB_1857697"	"unprognostic (3.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	0.0	8.2	6.5	0.3	7.2	0.0	2.5	0.0	5.6	5.6	0.1	2.8	2.2	2.2	0.8	3.1	0.4	0.5	1.1	6.7	10.7	1.2	4.4	0.6	0.0	3.4	13.6	0.1	5.8	0.0	0.6	7.4	6.3	0.9	3.2	0.5	2.2	0.4	0.0	0.1	2.4	3.3	2.5	0.0	12.1	0.6	8.6	0.0	0.1	0.0	0.0	0.9	0.8	0.9	0.0	1.2	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	6.2	1.4	0.0	0.0	0.5	2.2	0.7	0.0	0.0	0.0	0.0	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.7	0.1	0.0	0.1	0.2	0.2	5.8	0.0	0.0	2.5	8.4	0.0	0.0	2.0	0.0	0.0	0.4	3.2	0.0	0.3	1.2	14.8	19.5	0.0	0.0	0.0	0.1	4.7	0.0	3.3	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	7.2	0.0	5.6	6.7	10.7	3.4	13.6	6.3	2.5	8.6	0.9	0.0	0.0	2.0	1.6	0.0	0.0	0.2	0.8	0.0	0.0	4.0	1.5	0.3	0.0	8.7	0.0	0.0	3.3	0.0	4.6	0.0	0.0	0.0	0.7	3.6	0.1	3.0	0.0	1.4	0.9	3.6	0.6	37.2	4.0	0.0	1.0	0.4	1.3	0.3	0.0	92.0	20.8	6.1	0.0	0.0	0.0	0.6	0.2	0.0	1.0	0.2	0.0	0.0	0.0	1.1	4.9	3.0	2.6	0.3	0.6	0.6	0.1	3.3	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	8.9	0.1	0.0	0.7	1.0
SZRD1	"C1orf144, DKFZp566C0424"	ENSG00000055070	"SUZ RNA binding domain containing 1"	Q7Z422	1	16352575-16398145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024221	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA024221: AB_10603450"	"unprognostic (3.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.98e-6)"	"unprognostic (2.53e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.60e-2)"	52.1	57.4	43.1	50.1	47.1	82.5	45.9	43.9	41.6	48.0	40.2	58.0	44.0	68.9	25.7	66.0	50.3	41.2	65.1	38.5	41.1	48.7	48.6	48.1	56.9	51.4	45.7	59.3	36.7	69.4	28.9	46.3	45.3	46.1	38.5	20.0	38.8	41.0	120.7	48.4	50.3	58.3	44.6	51.7	49.8	22.8	50.0	56.9	44.1	68.8	51.1	59.9	43.0	43.5	126.2	94.6	127.5	89.7	106.1	121.8	42.3	126.4	161.4	145.2	112.6	95.2	108.8	109.9	137.9	168.5	80.1	68.3	115.1	140.0	106.6	189.7	100.1	126.4	96.6	75.9	96.0	124.6	118.9	123.7	113.0	160.0	105.7	102.2	128.0	93.5	115.3	100.3	134.8	121.7	122.2	93.1	90.2	92.0	106.6	123.5	135.8	129.8	98.8	57.8	101.0	105.0	111.0	70.6	161.6	52.4	73.3	80.4	145.2	98.8	116.1	156.8	127.0	55.0	65.2	131.1	111.3	166.3	135.1	37.0	46.4	68.2	44.1	65.2	43.9	58.2	37.7	41.6	36.9	67.4	34.5	37.3	51.2	41.2	78.1	28.4	52.2	65.3	43.1	47.1	43.9	41.6	38.5	41.1	51.4	45.7	45.3	44.6	50.0	43.5	42.5	19.2	23.6	7.5	48.2	45.6	51.6	47.6	39.3	21.4	41.5	32.9	44.3	52.9	28.5	40.5	2.1	56.2	49.4	74.0	70.5	64.4	21.5	31.5	44.5	45.2	47.8	27.8	7.0	53.4	79.8	42.1	31.1	53.5	36.8	31.9	35.7	55.0	72.9	43.7	7.0	47.7	46.8	48.9	45.9	55.4	36.1	47.9	44.4	10.3	78.8	30.4	77.2	7.5	12.0	68.1	47.8	35.7	35.6	63.9	62.5	50.4	18.4	18.5	39.5	31.3	56.3	28.1	20.3	43.9	58.4	84.0	44.5	39.1	49.8	68.3
TAB3	MAP3K7IP3	ENSG00000157625	"TGF-beta activated kinase 1 (MAP3K7) binding protein 3"	Q8N5C8	X	30827442-30975084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034980, HPA034981"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Cytosol"		"HPA034980: AB_10602708, HPA034981: AB_2674394"	"unprognostic (4.39e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.51e-1)"	"prognostic favorable (8.45e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.75e-1)"	8.1	7.6	3.6	8.0	4.5	16.8	8.9	3.9	6.7	8.5	20.6	9.6	7.7	18.0	8.9	16.6	9.7	8.1	8.6	5.3	4.0	14.3	27.1	9.0	8.9	5.2	6.5	12.2	24.9	31.8	6.5	11.6	4.7	14.6	9.5	23.9	9.7	12.6	10.7	9.7	7.9	13.3	3.1	8.5	12.5	15.3	4.4	9.7	10.0	8.9	12.6	7.2	8.3	5.7	40.2	9.5	9.6	9.8	7.3	11.0	10.1	12.2	15.3	8.0	9.1	10.8	33.5	18.1	7.3	14.2	15.5	20.4	14.8	31.0	11.6	31.2	14.2	16.9	10.9	26.4	6.3	18.0	12.7	8.0	18.2	13.8	35.0	13.9	13.5	13.5	19.7	14.4	10.6	19.4	14.4	9.1	11.5	7.2	15.9	9.1	16.8	13.5	13.3	11.6	8.0	11.3	13.6	20.3	26.0	17.8	17.5	7.1	13.0	8.9	13.0	44.8	11.3	18.6	15.3	17.8	13.9	8.3	12.7	0.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.9	0.2	0.0	0.1	0.1	3.6	4.5	3.9	6.7	5.3	4.0	5.2	6.5	4.7	3.1	4.4	5.7	9.6	12.8	13.2	14.0	10.2	9.1	7.9	7.2	6.8	7.4	10.0	5.3	11.4	20.0	10.5	11.0	12.5	15.1	11.0	12.3	3.9	8.4	1.5	13.0	23.0	8.8	7.2	39.2	23.2	6.9	4.9	5.6	12.8	11.9	14.5	28.6	10.0	26.0	7.7	11.8	22.3	10.8	6.1	16.0	13.7	3.4	10.8	12.6	5.4	20.6	11.5	6.7	3.1	21.6	21.2	9.9	11.2	16.1	7.3	12.6	7.3	11.2	19.6	20.4	0.0	6.3	6.7	3.3	2.2	9.6	10.1	22.4	10.9	24.4	9.8	13.2
TACC1		ENSG00000147526	"Transforming acidic coiled-coil containing protein 1"	O75410	8	38728186-38853028	"Predicted intracellular proteins"	"Cell cycle, Cell division"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 554.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 34.8;granulocytes: 31.5;monocytes: 14.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017041, HPA024702, HPA056841"	Approved		Approved	Cytosol		NA	NA		47000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB017041: , HPA024702: AB_1857723, HPA056841: "	"unprognostic (1.83e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.31e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.94e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.18e-1)"	151.8	31.5	32.8	39.5	41.0	68.4	67.7	23.2	36.3	73.8	19.0	76.8	21.5	84.0	14.1	70.5	64.0	47.5	42.4	27.0	25.9	51.6	23.8	67.7	41.9	28.6	34.9	35.9	44.5	29.6	14.1	74.4	27.6	54.8	44.0	15.9	19.1	75.5	20.3	19.4	40.3	90.9	25.6	61.2	38.7	29.2	37.2	27.1	34.4	56.4	34.9	58.6	36.8	49.3	39.4	74.2	53.2	16.6	55.9	38.9	34.8	50.1	64.4	46.8	47.6	34.6	5.9	40.1	29.9	49.5	40.5	36.7	32.0	22.7	96.5	28.8	12.1	155.5	22.8	22.4	65.8	31.4	69.0	71.2	20.6	76.2	24.1	48.5	169.8	47.5	16.4	97.9	143.0	29.2	74.4	17.9	7.6	63.5	35.0	16.7	120.3	7.1	15.9	38.2	3.8	4.2	40.6	41.5	33.9	31.6	19.3	23.9	138.0	56.5	34.3	72.8	40.9	50.5	35.5	35.2	51.4	35.7	69.8	13.7	11.7	15.7	6.0	10.5	6.5	2.0	4.0	5.0	7.6	2.3	3.2	3.6	31.5	3.8	14.3	34.8	3.4	5.8	32.8	41.0	23.2	36.3	27.0	25.9	28.6	34.9	27.6	25.6	37.2	49.3	554.0	218.0	152.9	67.9	66.7	35.2	55.5	9.3	148.0	35.2	14.3	25.1	53.9	191.6	32.7	46.0	62.6	66.2	122.9	30.0	119.3	176.4	4.3	34.9	51.2	251.0	37.8	79.3	109.1	60.2	64.3	147.5	25.0	79.0	115.8	42.1	350.5	39.2	79.0	109.4	73.8	121.2	6.1	90.9	158.7	11.5	168.4	128.8	40.9	203.3	87.1	59.8	51.5	44.2	134.3	47.5	44.2	206.1	73.7	62.4	3.4	23.5	7.7	44.2	190.7	150.0	223.3	42.9	62.3	45.5	18.9	94.0	81.5	43.4	48.7	40.0
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876264	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	5.1	8.9	9.6	6.1	10.3	19.4	9.2	9.9	12.4	7.7	8.1	8.4	7.7	9.3	7.6	8.3	8.6	5.3	8.6	10.1	9.3	11.6	26.7	6.2	10.4	7.8	8.3	11.0	6.4	10.9	6.2	8.2	8.8	7.9	9.1	17.0	8.1	7.1	9.8	8.0	8.4	7.6	9.2	6.9	7.5	10.8	9.3	13.2	7.5	10.6	10.1	6.6	5.8	11.2	15.7	14.9	27.4	16.3	8.1	10.4	16.2	8.1	9.9	13.2	11.4	13.7	12.5	29.9	15.4	9.6	10.7	11.8	22.3	14.3	10.6	18.9	21.3	9.9	11.9	22.5	12.0	28.3	17.4	7.9	16.3	8.0	19.9	9.6	11.0	22.2	35.9	17.6	10.5	10.9	34.9	22.5	41.6	25.2	16.5	29.1	12.0	37.9	18.0	20.9	17.5	30.6	14.6	18.7	17.5	25.0	25.3	29.3	8.3	10.8	12.4	11.9	17.3	24.9	36.3	56.3	7.5	12.6	10.4	2.9	12.7	13.8	20.7	12.9	22.9	20.2	22.2	23.6	20.7	20.8	27.9	22.3	2.1	27.5	10.4	13.3	23.4	24.7	9.6	10.3	9.9	12.4	10.1	9.3	7.8	8.3	8.8	9.2	9.3	11.2	2.7	9.6	2.7	7.8	8.4	6.1	4.7	3.9	6.2	7.6	4.9	4.6	10.3	2.8	4.1	3.7	8.4	6.1	4.9	4.4	5.9	3.9	4.0	4.8	4.6	4.3	7.2	13.7	9.6	4.0	7.7	4.8	6.6	4.4	5.1	6.1	3.3	20.3	4.2	1.7	10.5	6.1	0.0	5.3	5.1	1.7	4.4	2.6	1.8	3.7	6.9	6.8	4.1	7.5	17.7	3.8	1.7	3.0	7.5	6.2	5.3	7.0	4.3	6.0	0.0	6.1	4.1	5.2	12.9	7.6	5.1	7.3	7.3	1.9	5.9	4.2
TAF6	"MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85"	ENSG00000106290	"TATA-box binding protein associated factor 6"	P49848	7	100107070-100119841	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006566			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA006566: AB_1080194"	"unprognostic (5.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.37e-1)"	24.2	37.0	28.9	23.4	29.2	23.4	24.4	24.1	42.7	39.5	23.8	38.9	17.2	42.9	21.9	27.3	34.9	20.5	32.2	31.3	25.2	30.9	20.6	24.8	22.6	25.2	23.2	41.2	23.0	30.5	41.1	24.9	24.4	30.7	19.5	19.2	25.5	31.1	45.0	26.5	28.0	33.9	19.0	28.3	28.0	38.5	25.4	29.3	32.9	35.8	25.7	37.3	29.9	25.6	55.1	101.8	64.4	105.7	84.1	44.5	89.3	60.0	66.4	77.2	70.6	76.1	65.6	50.4	65.5	92.7	130.4	45.7	90.6	73.2	81.3	82.0	57.0	49.4	99.3	50.8	86.6	46.2	43.5	46.4	44.5	111.0	121.7	61.0	63.0	87.7	84.6	89.0	69.2	194.4	101.1	76.9	94.7	50.1	82.4	73.2	78.7	75.0	54.5	44.8	57.9	84.4	73.7	115.3	49.3	93.2	42.1	47.2	60.4	113.2	114.6	146.2	77.6	55.0	104.0	85.1	74.9	65.7	99.2	17.2	13.5	17.5	18.0	14.4	21.5	11.9	17.3	18.3	17.6	17.9	17.0	16.3	7.1	18.8	35.3	10.3	18.3	17.5	28.9	29.2	24.1	42.7	31.3	25.2	25.2	23.2	24.4	19.0	25.4	25.6	13.0	9.6	11.8	10.1	15.4	11.3	21.0	25.1	12.5	12.7	13.2	15.9	0.9	18.6	15.7	25.8	0.0	72.1	13.0	12.9	17.6	25.7	28.3	20.7	18.5	14.8	15.6	12.8	12.6	16.6	34.5	16.3	18.3	14.6	0.0	25.6	13.6	6.1	20.9	13.5	10.7	11.9	26.4	8.8	6.9	50.7	21.8	12.3	12.4	3.7	18.7	18.7	18.6	6.0	7.3	14.9	18.7	31.2	12.8	13.0	14.2	25.8	21.8	14.0	26.3	14.6	23.8	25.5	52.3	15.4	11.8	34.5	18.3	16.2	17.4	14.4
TAF7L	"CT40, TAF2Q"	ENSG00000102387	"TATA-box binding protein associated factor 7 like"	Q5H9L4	X	101268253-101293057	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 31.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.1;Late spermatids: 15.8;Spermatocytes: 39.4;Spermatogonia: 25.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SiHa: 47.9"					"Low region specificity"	"Detected in many"			"HPA001879, HPA072008"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA001879: AB_1857751, HPA072008: "	"unprognostic (1.70e-2)"	"prognostic favorable (8.71e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.12e-2)"	0.1	0.0	1.2	0.1	0.8	0.3	0.1	0.0	1.3	1.6	1.7	0.5	0.1	0.5	2.4	0.1	0.1	0.0	0.1	1.4	0.2	0.5	1.1	0.0	0.0	0.0	0.4	0.1	0.1	3.9	0.3	0.3	0.0	0.7	0.1	0.1	0.1	1.7	0.1	0.9	0.1	0.1	0.0	0.0	0.1	31.6	0.5	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.2	1.0	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.2	0.9	0.0	0.2	0.3	0.2	2.2	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	47.9	0.3	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	1.3	1.4	0.2	0.0	0.4	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.3	26.1	1.2	5.5	0.2	0.0	0.0	2.9	0.0	0.2	0.2	0.0	0.4	0.0	0.5	0.4	2.1	0.1	0.0	2.4	0.1	0.0	0.3	0.2	15.8	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	39.4	25.2	0.0	0.1	1.6	0.1	0.6	0.1	0.1
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	5.0	2.8	1.0	28.9	1.1	146.6	3.9	1.3	2.1	3.4	3.0	5.9	4.4	9.5	2.3	4.1	2.0	6.9	1.6	1.2	3.4	1.3	4.1	8.4	39.6	2.7	2.0	2.2	0.9	0.7	0.8	3.4	2.1	2.8	8.2	1.5	3.0	1.8	0.7	1.2	10.2	26.0	2.2	22.8	7.2	1.6	2.2	24.3	1.6	2.3	47.6	10.0	1.2	4.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	30.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	6.2	0.0	0.0	0.0	15.6	42.5	0.3	0.0	0.0	0.0	0.0	0.0	9.0	0.1	43.8	0.0	0.0	4.0	8.2	12.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	1.2	0.0	6.9	0.2	0.0	0.0	0.0	0.0	4.7	20.6	39.6	0.0	33.4	0.0	163.6	27.8	88.4	54.8	20.4	62.6	45.9	73.9	64.6	27.9	46.6	56.9	40.8	169.7	45.6	27.6	9.3	57.5	60.9	1.0	1.1	1.3	2.1	1.2	3.4	2.7	2.0	2.1	2.2	2.2	4.2	5.2	3.2	6.6	0.0	249.5	2.8	0.3	0.2	3.4	0.3	4.4	6.0	0.6	0.0	1.4	0.0	0.0	0.7	152.3	0.2	0.0	0.1	0.3	0.5	0.4	5.2	0.0	8.8	1.2	0.0	0.6	4.3	16.8	0.5	19.0	1.8	1.4	0.8	24.9	0.0	1.0	0.0	0.0	21.9	60.2	1.1	1.2	91.1	28.4	20.6	21.5	0.4	86.5	1.5	0.0	0.0	0.0	22.6	272.1	0.3	0.0	0.3	1.2	0.2	0.0	0.8	2.0	0.1	0.1	2.0	2.7	0.8	223.6	4.6	0.4	0.3
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199370-117207464	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 9628.1;intestine: 11712.2"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 279.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 41.6;non-classical monocyte: 63.1"	"Lineage enriched"	"Detected in many"	12	"monocytes: 63.1"	"Cell line enhanced"	"Detected in all"		"BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		6300000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	2235.7	512.7	118.5	963.9	144.4	12.1	1680.5	126.1	215.9	3611.3	172.5	11712.2	451.2	9628.1	693.9	1954.6	4610.6	893.8	1583.5	119.6	120.4	774.5	302.8	1258.6	245.5	137.0	127.0	1643.4	218.6	65.3	254.6	348.0	129.2	4624.1	1154.6	22.9	461.8	6383.6	356.4	619.8	1948.4	7108.7	127.2	532.0	3148.4	202.5	138.2	52.2	723.2	152.4	59.9	5521.7	2331.2	130.0	17.5	5.5	293.3	8.2	140.0	123.8	226.7	1913.4	788.1	1641.8	609.0	1531.4	28.4	3.2	2145.6	2094.4	1.7	46.1	4.4	16.8	543.3	6.8	4.4	5.0	66.9	130.2	708.7	1.7	5.2	304.6	57.5	267.1	36.1	1499.7	3.3	4.5	3.3	6.7	1377.1	4.5	1.7	15.8	84.6	18.8	2.1	2.7	23.1	12.0	4.4	25.8	1.9	9.6	29.9	11.0	1.5	807.6	9.2	5.1	182.0	1598.8	276.9	14.4	86.6	8.9	8.8	21.7	9.1	7.7	6.2	1.8	2.7	0.1	0.3	41.6	0.5	3.6	0.1	0.0	3.2	5.1	0.2	0.1	0.3	0.0	63.1	1.6	0.5	2.1	118.5	144.4	126.1	215.9	119.6	120.4	137.0	127.0	129.2	127.2	138.2	130.0	264.8	38.5	6.1	4.6	10.3	63.9	453.4	248.6	10.8	9.9	74.0	2508.6	1.3	4.3	22.5	40.5	18.8	57.0	8.6	3.1	0.0	577.8	3.3	14.6	455.5	260.3	3.0	2.7	4.5	74.5	35.3	464.4	41.3	12.8	1.3	32.4	639.7	8.9	41.5	1.7	6.5	18.3	24.4	23.1	91.8	23.9	48.4	33.8	96.0	37.5	8.1	4.9	2.1	3.0	11.9	38.4	4.5	2306.4	3.2	414.0	12.1	2.2	23.0	9.9	2866.2	177.6	4563.9	6.0	13.7	8.6	60.9	32.2	15.1	8.3	3.1	62.0
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2404.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA		270000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavorable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	401.9	154.7	103.7	356.0	103.2	437.3	355.4	106.3	115.0	266.6	94.9	337.4	314.3	220.5	94.9	494.0	231.9	282.6	351.1	101.1	152.7	307.9	254.4	687.7	321.1	141.7	117.6	170.9	284.7	81.0	100.0	378.2	122.9	208.5	307.9	46.1	388.7	205.2	83.4	418.2	356.3	254.4	125.2	479.7	698.8	127.0	125.9	309.6	210.2	139.6	386.4	436.1	350.0	114.9	1382.3	723.7	22.3	8.3	266.8	646.6	835.4	760.0	872.6	1635.2	799.8	786.6	1049.3	862.0	628.0	954.9	495.0	1054.3	378.1	1039.9	978.8	974.3	355.5	1140.7	651.8	50.0	322.7	808.2	1221.4	667.4	776.9	1030.4	504.3	1134.7	1029.0	260.3	494.8	578.9	586.1	563.0	378.1	601.2	619.3	947.6	1457.7	2.9	391.7	1275.3	376.6	527.7	340.7	325.6	900.7	1435.1	410.3	1190.6	756.5	814.2	1147.3	955.1	1134.4	876.9	2078.0	230.8	110.6	525.0	1238.3	541.3	603.8	1458.4	742.0	3160.6	558.9	449.7	499.9	866.5	620.0	544.6	1177.7	680.2	321.6	360.3	3746.8	817.6	356.9	1966.4	756.1	2257.9	103.7	103.2	106.3	115.0	101.1	152.7	141.7	117.6	122.9	125.2	125.9	114.9	617.1	179.5	130.5	0.3	507.8	549.1	330.6	454.3	307.9	31.6	257.0	201.8	12.8	121.5	221.4	183.9	18.8	497.4	567.6	371.0	74.3	1273.4	54.3	289.4	145.9	509.6	317.8	197.6	0.1	1206.9	2404.5	405.2	545.3	242.7	418.8	32.0	265.2	64.1	443.7	3.3	0.6	445.5	284.8	285.9	952.4	85.9	118.7	651.5	334.4	16.9	911.4	66.3	186.4	0.5	1.6	877.4	263.2	63.9	393.4	337.5	324.2	208.2	275.9	25.6	184.1	358.3	324.3	14.3	20.7	494.1	572.5	230.4	393.6	136.7	271.7	405.9
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663124	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 13.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Distal tubular cells: 7.9;Enteroendocrine cells: 3.5;Muller glia cells: 2.7;Proximal tubular cells: 2.3"	"Group enriched"	"Detected in some"	4	"renal cancer: 1.6;testis cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 6.9;naive B-cell: 7.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;HAP1: 2.9;K-562: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"	0.1	0.2	0.4	0.1	0.5	0.0	0.1	0.3	0.9	0.2	1.3	0.1	0.0	0.1	0.6	0.1	0.2	0.0	0.2	0.5	0.5	3.0	0.2	0.1	0.2	0.5	0.6	0.3	0.1	0.0	0.4	0.1	0.6	0.1	0.1	0.5	0.1	0.1	13.7	0.1	0.1	0.0	0.4	0.2	0.1	0.3	0.4	0.1	0.1	2.4	0.3	0.1	0.1	0.7	0.0	0.4	1.5	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.2	2.1	0.1	0.0	0.1	0.0	0.4	0.0	2.9	0.0	0.1	0.4	0.3	0.7	0.0	0.0	0.1	0.3	1.1	0.1	0.3	0.1	0.1	0.1	0.0	0.5	8.2	0.2	0.2	0.2	0.5	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.7	0.1	0.1	0.1	0.0	0.2	1.3	0.3	0.2	0.4	0.4	0.6	0.6	1.2	0.0	0.1	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.4	0.5	0.3	0.9	0.5	0.5	0.5	0.6	0.6	0.4	0.4	0.7	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.4	0.1	0.2	0.0	0.0	0.0	4.2	0.0	0.1	0.0	7.9	0.1	0.1	0.0	0.2	0.0	3.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.2	0.0	0.4	0.1	0.0	0.0	2.3	0.0	1.0	0.0	0.8	0.1	0.6	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747415-765012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 820.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 2870.4;neutrophil: 3726.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		29000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	139.5	80.7	108.0	121.8	128.8	464.8	121.0	129.3	119.3	101.9	105.2	99.6	116.0	68.4	66.4	330.6	79.1	100.0	95.5	108.0	113.8	111.6	136.2	109.1	107.8	135.8	119.3	77.0	107.5	49.3	53.0	88.0	130.0	91.9	78.4	34.2	132.8	60.1	120.7	132.7	101.0	60.8	124.0	152.6	132.5	40.4	120.1	109.9	140.3	107.1	115.8	160.8	142.1	148.2	331.0	405.5	115.4	218.1	235.8	136.5	338.0	242.2	313.8	238.2	194.5	176.6	694.8	179.5	323.1	324.7	181.9	345.5	185.6	263.5	122.8	238.9	372.5	310.9	146.0	616.4	250.3	498.4	449.0	112.0	210.6	159.6	129.0	170.4	331.6	224.0	413.5	294.3	224.5	318.0	296.4	601.2	183.9	478.9	326.0	243.5	131.5	656.4	437.9	185.4	284.2	100.1	224.9	466.1	243.3	102.4	220.0	383.9	434.1	107.9	99.5	86.0	232.9	122.9	132.1	223.5	238.5	440.5	444.7	1456.7	1203.5	2870.4	94.1	432.7	102.3	145.5	125.7	115.5	654.2	127.2	100.9	94.9	3726.6	112.2	457.8	267.0	192.7	1066.0	108.0	128.8	129.3	119.3	108.0	113.8	135.8	119.3	130.0	124.0	120.1	148.2	90.2	141.1	117.2	10.7	91.1	73.5	199.8	354.0	61.5	50.3	113.0	122.2	46.4	100.1	253.4	150.8	14.6	419.8	83.8	151.0	250.5	230.4	82.1	156.5	85.4	85.6	101.5	507.0	13.1	272.1	427.6	97.3	144.3	216.7	161.4	86.0	93.5	149.7	418.3	50.5	11.6	186.0	268.5	271.8	169.4	21.2	117.8	352.8	140.5	7.5	820.0	142.1	84.5	10.6	54.8	257.6	200.3	104.2	129.4	361.9	197.7	309.1	232.6	61.7	72.3	59.6	115.0	143.2	140.6	257.6	83.1	526.6	86.8	77.5	215.1	342.6
TAMM41	"C3orf31, DKFZp434E0519, MGC16471"	ENSG00000144559	"TAM41 mitochondrial translocator assembly and maintenance homolog"	Q96BW9	3	11790442-11846919	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036834, HPA044861"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA036834: AB_10672270, HPA044861: AB_2679116"	"unprognostic (2.40e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.59e-3)"	8.3	7.4	5.8	5.6	6.2	4.3	8.0	6.4	8.5	8.0	2.6	6.5	4.9	7.2	9.7	9.0	6.9	4.1	8.0	5.3	6.9	6.7	5.5	5.0	7.1	3.9	4.1	11.0	5.6	5.8	5.6	4.1	4.0	5.2	4.9	6.3	6.8	4.5	9.2	10.1	6.2	6.2	2.8	6.5	6.0	5.7	5.4	6.5	6.0	5.2	7.8	8.4	8.2	6.2	6.2	11.3	13.5	9.4	14.3	18.0	24.9	9.3	6.6	13.9	13.8	13.6	9.9	23.4	13.3	9.8	6.2	7.4	22.9	13.9	17.9	8.8	21.6	14.0	10.6	15.9	16.7	25.8	7.1	10.3	20.3	13.1	14.6	9.1	21.8	18.3	20.8	7.0	18.0	17.8	14.6	19.2	10.9	9.6	23.8	14.4	7.7	20.7	21.6	14.8	6.2	5.4	8.1	10.3	16.6	15.1	13.5	11.6	5.7	7.2	8.3	21.8	13.5	5.4	14.2	12.1	8.8	21.8	6.7	1.9	4.5	7.1	5.7	3.2	7.6	7.5	9.1	5.8	7.8	7.1	8.4	8.8	0.2	6.9	6.7	5.8	7.7	4.8	5.8	6.2	6.4	8.5	5.3	6.9	3.9	4.1	4.0	2.8	5.4	6.2	9.4	6.4	7.0	24.5	11.4	4.2	8.1	15.7	5.7	11.5	5.5	8.3	8.9	0.0	8.7	3.7	12.5	12.2	8.6	3.3	9.8	10.1	2.2	5.4	9.2	7.6	3.0	9.4	34.5	9.3	11.0	7.2	6.6	4.4	2.5	10.5	5.7	5.8	9.2	10.1	34.7	8.1	12.2	6.4	6.4	1.5	7.8	6.8	3.6	14.0	5.9	11.0	10.3	34.7	32.0	7.9	3.4	6.4	7.1	6.7	4.2	10.3	11.8	14.7	0.0	8.6	8.7	7.4	12.4	6.6	4.1	7.0	9.5	10.8	7.3	5.9
TANC2	"DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA"	ENSG00000170921	"Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2"	Q9HCD6	17	63009556-63427699	"Disease related genes, Predicted intracellular proteins"			"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 597.7;Granulosa cells: 195.7;Inhibitory neurons: 394.9;Oligodendrocyte precursor cells: 641.4;Oligodendrocytes: 329.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 11.2;basal ganglia: 27.6;cerebral cortex: 22.3;hippocampal formation: 15.9;white matter: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023274	Uncertain		Approved	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA023274: AB_2199727"	"unprognostic (8.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.09e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.01e-1)"	5.8	6.4	11.2	2.9	27.6	12.0	5.6	0.0	22.3	6.8	0.0	4.2	2.0	5.1	8.3	6.1	4.2	5.4	5.1	15.9	2.8	6.3	2.2	12.5	1.5	1.6	0.0	4.4	4.2	30.5	10.4	4.1	4.3	6.1	2.0	6.4	7.3	5.3	2.2	11.1	2.5	7.0	1.3	2.5	3.8	18.4	1.1	3.4	3.7	2.5	1.7	8.3	7.0	17.5	28.2	25.9	15.8	2.7	7.9	19.0	30.5	17.6	17.3	17.0	21.0	1.5	8.0	0.0	5.3	30.3	21.6	3.8	25.6	51.6	38.2	10.9	11.8	41.0	38.9	1.5	6.9	11.2	0.0	29.3	29.5	19.9	56.9	18.8	5.5	10.4	5.2	0.0	24.6	21.4	7.4	1.8	1.8	4.9	16.8	5.7	31.7	2.1	15.1	38.4	26.5	29.2	9.8	18.3	7.2	27.3	8.4	2.9	28.0	41.3	21.4	2.7	21.7	0.0	0.0	0.0	15.2	2.9	15.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.3	0.4	0.0	0.3	0.1	0.2	0.3	0.9	0.0	0.4	0.0	0.0	11.2	27.6	0.0	22.3	15.9	2.8	1.6	0.0	4.3	1.3	1.1	17.5	13.2	16.0	59.4	79.0	2.3	25.1	13.0	25.3	6.8	63.1	11.6	8.5	3.9	10.0	19.2	27.6	16.7	8.0	9.4	3.4	1.9	10.9	17.5	15.4	12.6	12.3	4.2	3.8	597.7	14.0	35.0	8.5	7.7	19.7	0.0	195.7	24.3	1.3	7.3	8.4	394.9	3.3	20.3	9.7	10.9	10.4	5.6	16.7	10.6	151.8	11.2	3.9	14.4	641.4	329.8	29.4	2.8	3.4	2.9	10.6	0.3	1.7	10.2	7.1	19.7	62.9	6.9	23.0	20.4	10.8	15.9	16.4	9.9	8.8	2.2	11.8
TANGO6	"FLJ12688, KIAA1746, TMCO7"	ENSG00000103047	"Transport and golgi organization 6 homolog"	Q9C0B7	16	68843531-69085182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.2;Excitatory neurons: 45.4;Inhibitory neurons: 57.4;Late spermatids: 50.5;Oligodendrocyte precursor cells: 38.7;Oligodendrocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041312	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA041312: AB_10796342"	"unprognostic (8.55e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (6.02e-2)"	5.1	3.0	2.8	4.5	3.8	3.4	4.6	3.5	3.4	4.8	4.9	3.9	2.4	4.3	1.9	3.6	3.8	2.8	3.2	2.6	3.6	5.7	12.9	3.6	4.9	2.7	3.1	4.2	3.2	6.0	2.5	3.4	2.8	4.0	3.1	4.2	3.2	4.2	8.8	4.2	3.1	4.8	2.4	4.5	4.1	4.3	3.5	4.7	3.3	5.7	4.6	5.5	4.2	3.9	7.1	14.3	4.6	9.9	7.6	8.6	3.3	9.5	7.7	11.5	9.3	9.1	5.7	15.8	5.1	13.2	6.0	5.8	10.6	12.8	14.0	3.8	6.3	3.0	5.4	8.5	6.3	8.0	7.2	6.6	6.7	16.3	14.7	4.7	11.2	7.6	10.6	2.7	10.7	7.1	8.3	6.4	10.2	6.9	7.6	8.9	6.8	17.8	8.4	3.9	4.8	5.6	23.3	1.3	6.3	5.5	4.6	8.9	6.5	10.9	3.9	11.2	6.8	4.9	4.5	10.7	6.9	3.0	7.4	0.0	3.8	2.0	3.4	6.6	3.5	2.7	3.3	3.5	4.8	2.4	2.0	3.3	0.2	2.0	6.2	1.3	4.9	3.1	2.8	3.8	3.5	3.4	2.6	3.6	2.7	3.1	2.8	2.4	3.5	3.9	5.1	0.0	4.2	23.5	5.4	5.2	9.5	5.0	2.8	8.8	1.5	1.8	3.8	5.7	2.2	7.3	10.4	5.6	3.1	2.1	0.0	2.2	110.2	1.5	3.5	4.8	0.0	7.8	45.4	3.3	2.7	4.0	6.1	3.0	1.3	3.7	3.9	12.3	4.7	5.0	57.4	1.8	4.1	7.6	3.5	50.5	5.6	4.2	5.4	25.3	3.5	3.3	4.1	38.7	51.3	2.7	4.4	3.4	2.9	3.7	1.1	6.0	0.5	10.5	0.0	3.9	3.4	5.7	4.7	4.0	3.0	2.5	7.0	3.2	2.2	9.2
TARS1	TARS	ENSG00000113407	"Threonyl-tRNA synthetase 1"	P26639	5	33440696-33468091	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 63.4;Cytotrophoblasts: 36.6;dendritic cells: 15.9;Extravillous trophoblasts: 42.1;Hofbauer cells: 32.1;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		580000	"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavorable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavorable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	29.0	32.2	13.7	33.8	16.2	45.0	26.8	20.0	20.1	24.0	17.1	42.6	30.7	24.7	35.8	40.9	17.4	19.9	38.7	13.8	17.9	32.4	68.6	24.1	29.9	22.4	18.5	17.9	68.1	33.8	9.9	37.1	18.3	27.6	42.8	40.7	36.8	26.4	38.4	19.1	29.8	37.2	18.4	21.7	40.0	18.7	18.3	31.7	37.6	28.4	40.1	42.9	10.8	22.6	253.0	136.1	132.7	189.5	80.2	129.9	230.1	237.5	172.9	152.5	163.7	176.6	128.7	96.0	84.8	176.5	271.8	151.1	261.1	207.1	267.4	158.9	140.5	151.1	332.9	108.5	256.7	225.6	141.0	133.7	287.7	217.5	273.9	102.4	144.3	191.8	236.3	204.6	191.5	105.7	166.3	104.7	159.2	181.5	168.4	137.1	237.9	123.4	170.8	119.8	81.0	102.7	245.6	175.8	195.5	103.8	85.9	236.3	123.0	132.8	211.9	102.5	196.3	135.4	258.4	132.6	156.2	302.6	148.3	34.2	22.0	22.6	27.4	24.5	27.6	28.7	25.2	26.6	32.6	23.9	21.5	27.5	2.6	46.2	18.3	18.3	24.2	20.6	13.7	16.2	20.0	20.1	13.8	17.9	22.4	18.5	18.3	18.4	18.3	22.6	12.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	0.0	0.0	0.0	0.0	36.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	42.1	11.7	0.0	0.0	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	52.1	2.6	0.0	0.0	0.0
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	9.8	16.5	11.8	10.6	11.4	10.0	10.3	11.2	12.5	9.5	10.9	10.3	8.9	8.9	13.0	13.4	11.7	7.7	20.3	11.3	11.5	14.3	25.3	8.6	14.7	12.0	11.5	11.7	8.4	17.7	9.3	8.9	12.7	8.7	11.3	14.7	9.7	9.3	31.9	11.8	9.6	10.0	10.4	12.5	12.0	11.0	11.9	12.6	11.2	31.1	15.4	9.6	9.4	12.8	33.5	27.4	18.1	27.4	19.9	18.2	34.1	15.9	17.2	30.7	30.8	22.4	30.3	48.0	34.2	12.0	21.1	33.8	44.2	36.8	23.5	29.2	38.4	22.7	25.2	22.7	19.7	31.4	33.4	16.2	30.2	23.4	31.6	19.9	20.1	26.4	40.3	32.6	21.8	40.4	27.0	26.0	22.3	46.0	40.2	27.5	23.0	59.8	20.9	15.7	25.5	29.8	24.1	52.5	38.7	25.4	42.3	48.9	11.9	17.8	18.8	14.9	27.2	31.2	39.6	36.2	26.6	36.3	17.6	30.5	15.4	30.5	21.0	27.0	21.3	28.7	20.5	21.2	25.0	25.3	19.6	20.7	2.4	33.2	29.3	16.7	31.4	18.3	11.8	11.4	11.2	12.5	11.3	11.5	12.0	11.5	12.7	10.4	11.9	12.8	6.3	3.2	12.8	6.2	13.2	3.3	5.6	10.4	5.2	15.3	6.2	4.6	22.3	11.5	11.9	7.3	20.9	24.5	8.8	8.2	11.7	11.5	1.6	9.6	12.8	7.4	4.2	11.1	9.3	9.8	14.3	8.4	13.3	11.7	22.2	11.0	6.8	22.6	13.2	15.2	9.1	12.6	6.1	7.7	5.2	2.5	8.4	8.8	3.6	2.8	12.5	7.6	9.2	6.0	9.9	11.9	3.5	7.2	9.9	4.5	8.5	8.8	9.4	16.8	6.6	10.3	8.3	18.2	12.3	7.4	4.0	14.1	10.6	15.8	12.6	4.8
TARS3	"FLJ25005, TARSL2, ThrRS-L"	ENSG00000185418	"Threonyl-tRNA synthetase 3"	A2RTX5	15	101653596-101724473	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.8;skeletal muscle: 38.5;tongue: 36.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;B-cells: 9.5;Cardiomyocytes: 41.0;dendritic cells: 27.6;Plasma cells: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066697	Enhanced		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA066697: AB_2685705"	"unprognostic (9.33e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.76e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.79e-2)"	4.9	4.2	16.1	4.1	24.8	3.1	4.6	20.1	21.1	6.4	9.0	7.9	3.8	4.3	3.5	3.8	5.2	3.4	15.2	14.7	18.4	5.2	3.6	3.7	4.7	20.0	19.8	6.9	6.4	7.5	6.3	1.9	20.2	5.7	3.7	6.2	4.9	5.9	38.5	3.3	6.2	4.2	17.5	4.4	5.7	3.5	19.1	4.2	6.2	36.7	4.7	6.9	4.6	33.8	2.5	4.6	7.9	4.3	8.4	6.4	3.9	8.6	5.8	6.5	4.0	6.8	2.2	3.3	3.3	10.3	5.3	7.6	13.8	4.9	6.0	3.8	22.0	8.1	2.9	5.5	3.9	3.8	1.7	4.5	4.6	3.2	3.7	7.7	4.7	7.0	8.0	6.9	6.6	4.3	2.0	7.4	9.5	12.5	3.3	4.1	12.0	8.6	5.7	2.7	12.5	8.2	11.5	4.5	5.1	14.5	2.9	8.0	6.4	3.2	7.4	6.4	2.8	9.6	11.5	4.1	8.2	6.6	5.9	0.8	1.0	1.5	2.7	1.5	2.7	4.9	5.0	4.3	0.7	7.5	4.9	2.6	0.2	7.9	0.7	1.7	0.9	1.1	16.1	24.8	20.1	21.1	14.7	18.4	20.0	19.8	20.2	17.5	19.1	33.8	7.7	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	3.3	27.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.8	5.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	7.3	0.0	0.0	0.0
TAX1BP1	"CALCOCO3, TXBP151"	ENSG00000106052	"Tax1 binding protein 1"	Q86VP1	7	27739331-27844564	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024432	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA024432: AB_1857783"	"unprognostic (1.38e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.69e-1)"	"prognostic favorable (2.80e-6)"	"unprognostic (1.76e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.03e-1)"	57.0	107.0	58.0	54.9	61.1	106.6	78.7	62.5	67.6	64.7	71.5	72.3	63.4	63.5	88.2	113.6	78.4	73.1	128.1	56.4	65.7	102.2	80.4	69.5	57.5	61.2	59.9	55.3	69.9	125.2	44.7	104.2	61.3	83.3	79.6	124.3	91.6	79.7	94.4	57.1	67.9	66.0	59.6	66.2	76.3	77.2	63.6	76.7	98.6	89.2	67.8	101.5	52.4	64.5	180.9	98.2	98.1	93.4	151.9	109.9	66.5	131.5	160.9	96.6	120.1	79.8	142.8	38.3	120.9	193.5	166.1	125.0	92.8	86.1	149.8	72.3	48.2	103.6	98.5	160.2	143.0	152.7	117.9	93.7	175.2	112.4	127.9	115.7	105.5	65.3	117.3	113.9	197.5	66.5	67.4	150.1	110.7	234.6	91.0	55.6	105.3	79.1	136.7	200.8	64.9	105.4	184.5	237.8	280.6	187.1	111.1	226.5	114.6	90.5	140.1	113.8	87.8	207.6	154.1	71.2	106.1	283.6	212.3	155.3	81.3	211.8	68.6	100.4	84.4	70.8	81.7	81.2	59.6	62.3	74.5	75.2	163.7	63.4	114.8	55.0	117.1	85.8	58.0	61.1	62.5	67.6	56.4	65.7	61.2	59.9	61.3	59.6	63.6	64.5	111.3	214.7	199.3	58.1	122.8	183.3	269.4	220.7	100.7	375.3	161.6	98.2	595.7	134.4	268.4	128.8	95.9	154.7	178.2	209.3	412.8	211.5	124.3	342.9	128.2	142.9	140.0	160.4	107.4	262.9	105.6	156.7	118.3	245.9	148.8	101.3	78.9	106.3	123.1	159.9	107.0	162.1	242.1	144.7	107.3	94.2	116.8	191.4	113.8	86.2	260.0	189.8	141.1	82.0	105.7	301.4	166.1	148.6	157.4	291.0	146.0	323.4	546.6	147.6	105.2	126.6	202.7	221.8	137.5	121.7	191.9	621.4	166.1	197.0	140.3	393.3
TBC1D30	KIAA0984	ENSG00000111490	"TBC1 domain family member 30"	Q9Y2I9	12	64759484-64881033	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1;pancreas: 12.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.9;Inhibitory neurons: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 25.9;OE19: 11.9;RPMI-8226: 12.6;RT4: 12.8;SCLC-21H: 26.5;SK-BR-3: 16.7;T-47d: 14.5"									"HPA039772, HPA040043"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Cytosol	"HPA039772: AB_10795409, HPA040043: AB_10795411"	"unprognostic (1.85e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (3.61e-5)"	"unprognostic (9.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.65e-5)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.67e-3)"	"unprognostic (7.80e-3)"	1.5	1.1	2.0	1.0	2.7	0.3	2.3	4.9	10.1	3.0	1.4	1.4	1.8	1.4	1.8	0.6	1.5	1.8	0.6	5.3	1.7	2.2	1.2	2.3	0.4	6.8	1.8	0.9	12.0	2.4	6.4	0.6	6.9	3.0	1.5	2.2	6.8	2.7	0.3	0.8	1.6	0.9	2.0	1.9	3.9	1.9	2.0	0.3	1.5	0.3	0.3	3.3	1.3	3.8	5.1	1.0	0.5	0.3	0.1	0.6	0.7	0.0	0.0	0.1	0.0	4.3	1.8	0.1	0.9	0.1	0.3	0.1	5.3	0.2	0.0	0.0	3.8	0.3	1.4	0.1	0.0	4.0	0.8	0.3	0.1	0.0	0.0	0.6	3.8	1.2	0.0	2.0	0.3	25.9	0.0	0.6	1.1	11.9	5.2	0.2	0.1	12.6	0.9	12.8	26.5	1.8	1.4	16.7	0.3	0.3	14.5	1.4	4.2	0.0	0.9	0.9	2.5	0.0	0.0	0.1	0.1	0.4	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.0	2.7	4.9	10.1	5.3	1.7	6.8	1.8	6.9	2.0	2.0	3.8	5.1	0.0	6.3	4.9	0.6	0.9	4.6	0.9	0.0	9.3	7.2	3.8	0.6	5.7	4.5	3.7	8.4	0.7	1.5	2.5	9.8	3.9	14.2	2.2	0.8	6.5	0.0	0.0	30.9	4.9	0.3	0.7	3.6	4.2	8.9	0.8	1.8	0.3	1.6	0.0	42.8	6.4	6.1	4.0	6.2	1.9	0.3	3.0	5.4	12.2	1.2	2.6	0.0	1.5	2.0	2.7	4.9	0.0	0.6	9.1	3.9	2.3	1.8	0.6	0.0	0.6	1.0	3.7	3.0	0.3	1.4	0.1	0.8	0.4	4.4	8.7
TBC1D8B	"FLJ20298, GRAMD8B, RP11-321G1.1"	ENSG00000133138	"TBC1 domain family member 8B"	Q0IIM8	X	106802673-106876150	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 230.8;Alveolar cells type 2: 234.5;Club cells: 92.9;granulocytes: 113.0;Respiratory ciliated cells: 108.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023883, HPA027527"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA023883: AB_1857794, HPA027527: AB_2199395"	"unprognostic (6.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.69e-3)"	"unprognostic (8.15e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.16e-2)"	4.5	19.6	5.8	4.2	11.5	5.2	4.6	15.3	19.6	6.9	15.0	6.3	7.8	5.4	10.0	3.0	3.9	7.0	3.4	8.0	5.1	8.4	12.0	4.5	2.7	2.0	1.5	6.4	9.0	8.6	6.4	4.5	3.6	6.8	7.3	9.6	7.7	6.4	3.1	4.1	9.5	5.1	0.5	3.2	11.0	8.5	5.9	1.6	8.8	1.6	2.0	4.5	2.5	24.4	14.7	4.6	1.8	7.1	21.9	30.9	7.9	16.3	16.9	2.8	8.5	8.1	12.6	5.1	12.9	16.6	11.6	7.6	5.9	8.2	7.2	2.5	6.5	7.1	6.4	7.7	5.7	1.8	2.6	13.7	6.5	6.0	2.9	17.2	7.9	4.1	2.4	8.3	10.0	7.4	4.6	2.7	9.2	21.6	7.3	2.0	3.9	2.1	7.9	10.7	3.3	2.7	13.4	9.7	6.0	9.1	11.0	2.2	10.0	10.4	11.2	13.9	6.0	7.6	8.4	1.3	20.2	1.5	13.1	2.1	0.8	0.4	0.7	0.4	0.5	0.7	0.6	0.5	0.2	1.4	0.4	0.5	1.9	0.5	0.4	1.0	0.2	0.1	5.8	11.5	15.3	19.6	8.0	5.1	2.0	1.5	3.6	0.5	5.9	24.4	7.0	230.8	234.5	1.0	2.2	2.4	7.8	8.4	7.4	4.1	6.9	3.3	2.6	4.3	92.9	7.3	4.2	2.8	0.6	9.5	7.9	8.8	0.9	4.9	12.5	19.2	4.8	1.3	8.3	9.3	3.0	25.2	21.9	6.8	113.0	4.8	3.3	13.5	1.7	0.0	7.5	15.1	6.1	2.2	0.4	2.2	9.0	12.7	3.6	14.0	1.0	1.8	1.0	13.6	25.4	6.1	9.2	8.6	0.2	8.0	14.0	12.1	108.3	3.6	0.0	8.3	5.7	3.6	3.2	3.5	1.4	2.6	9.4	31.4	10.1	10.3
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620782-140756385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 91.6"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.9"	"Group enriched"	"Detected in many"	37	"B-cells: 5.9;dendritic cells: 3.2;monocytes: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	18.2	9.2	7.2	15.2	7.9	2.0	48.7	22.5	9.4	12.9	35.2	7.3	8.2	8.3	7.8	9.1	10.0	13.8	8.5	8.4	15.3	15.7	12.6	16.3	15.1	7.9	9.6	15.9	9.1	9.8	6.3	20.5	15.4	14.6	6.6	21.0	8.8	21.3	2.2	3.2	12.8	7.7	6.4	33.7	16.8	3.3	12.9	5.6	5.8	6.9	19.4	15.8	7.1	3.3	0.9	11.9	10.9	9.4	26.0	24.3	22.3	15.3	16.3	10.8	13.7	2.4	10.4	0.1	9.5	19.9	13.4	2.4	13.7	10.8	10.1	0.0	7.7	7.0	8.5	10.4	9.4	0.9	1.1	20.1	17.7	9.4	37.2	31.2	30.3	3.7	0.0	0.0	10.2	12.0	1.6	0.1	1.7	12.7	10.4	7.7	17.9	18.1	12.3	22.0	16.0	11.4	15.8	27.4	10.5	18.4	6.4	0.4	47.7	28.3	8.5	18.6	13.3	0.0	0.0	0.1	17.2	1.3	15.7	0.0	1.7	0.0	0.0	1.3	0.0	5.9	0.0	0.0	2.9	2.9	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.7	7.2	7.9	22.5	9.4	8.4	15.3	7.9	9.6	15.4	6.4	12.9	3.3	49.4	54.5	9.3	4.6	42.1	4.6	10.6	21.4	4.0	35.4	91.6	39.4	8.1	17.2	15.1	55.2	4.2	14.1	14.0	8.3	7.9	13.6	0.5	49.4	20.9	32.6	7.7	0.4	54.8	17.2	4.7	15.1	8.2	61.4	0.0	8.0	17.2	23.9	18.3	10.1	66.2	6.6	24.4	39.3	30.3	1.3	13.1	44.8	8.8	78.7	39.5	43.5	1.0	27.6	2.6	12.2	5.8	26.7	25.0	16.3	6.1	5.7	15.9	7.6	0.0	2.8	11.1	0.8	1.7	10.4	3.8	43.2	3.7	16.0	3.1	16.0
TBX10	"TBX13, TBX7"	ENSG00000167800	"T-box transcription factor 10"	O75333	11	67631303-67639560	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	14	"intestine: 9.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.8;Intestinal goblet cells: 103.8;Paneth cells: 20.4;Proximal enterocytes: 42.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;NTERA-2: 5.3;RPMI-8226: 3.6;SK-BR-3: 12.5;U-2 OS: 2.5"					"Low region specificity"	"Detected in single"			"HPA047881, HPA076197"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA047881: AB_2680199, HPA076197: "	"unprognostic (4.66e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.83e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.29e-2)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.17e-10)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.75e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.4	5.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.4	0.0	0.0	0.0	9.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	12.5	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.9	0.0	0.0	0.0	103.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	20.4	0.0	0.0	0.2	42.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.1
TBX2		ENSG00000121068	"T-box transcription factor 2"	Q13207	17	61399843-61409466	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 62.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 134.1;Collecting duct cells: 95.6;Muller glia cells: 139.8;Sertoli cells: 170.9;Smooth muscle cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 129.3;MCF7: 78.5;SH-SY5Y: 65.4;SK-MEL-30: 49.3;WM-115: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA008586, CAB013636"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB013636: , HPA008586: AB_1080222"	"unprognostic (6.18e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.34e-3)"	21.1	3.7	2.9	2.6	3.4	0.0	16.1	2.7	4.6	14.5	1.7	9.8	4.9	22.0	14.1	7.1	15.7	4.5	19.9	2.2	3.2	31.7	4.9	62.8	1.0	3.8	4.1	10.2	3.6	2.1	6.2	24.7	3.8	16.3	1.8	6.3	4.2	27.5	8.1	5.6	11.4	4.6	2.3	13.7	11.5	5.4	3.9	0.8	15.9	5.8	0.5	31.2	13.0	2.2	0.5	1.9	0.0	129.3	4.2	4.4	15.6	22.4	21.2	1.0	0.2	3.6	0.4	0.0	1.6	3.3	2.5	0.0	2.4	0.0	0.4	0.0	8.8	2.2	0.0	6.4	14.0	0.4	2.1	8.0	0.2	23.4	1.3	0.3	0.0	0.0	0.5	0.0	1.4	78.5	0.0	0.4	0.1	0.0	9.4	0.0	5.3	0.2	0.0	31.0	0.3	65.4	0.0	0.0	49.3	0.2	1.6	2.5	0.0	2.9	0.0	7.3	4.7	0.1	0.3	0.0	17.6	0.0	43.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.4	2.7	4.6	2.2	3.2	3.8	4.1	3.8	2.3	3.9	2.2	12.7	0.0	0.6	2.3	0.1	0.6	0.3	0.0	0.0	134.1	0.4	1.1	11.1	0.0	0.0	95.6	22.9	0.4	0.5	0.0	1.9	0.1	0.8	1.4	45.7	12.2	0.0	0.0	0.1	0.0	0.4	13.7	0.5	1.6	0.0	0.1	12.1	0.0	0.9	1.7	0.0	0.0	0.0	1.0	1.8	1.1	39.4	1.1	1.8	5.6	0.0	139.8	0.0	0.0	0.1	0.0	0.0	47.4	0.0	0.5	0.0	25.1	0.0	13.4	170.9	0.8	104.0	0.4	0.7	0.1	0.3	0.3	0.9	1.1	0.0	0.2
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box transcription factor 3"	O15119	12	114670255-114684175	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 178.4"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 613.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 103.0;BJ hTERT+: 97.3;RT4: 129.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.28e-4)"	13.3	178.4	5.1	2.5	4.7	0.0	34.1	3.9	5.7	37.5	2.9	7.4	37.6	32.8	44.6	2.8	24.0	4.5	13.2	3.8	14.9	12.9	31.3	32.8	1.4	4.6	4.4	44.2	2.9	1.0	12.9	41.3	4.8	80.4	3.7	1.8	18.9	53.2	10.4	14.9	30.3	10.0	3.8	7.0	6.0	1.3	6.6	1.3	50.0	16.5	1.7	53.9	34.2	3.7	2.4	18.2	0.0	0.0	26.1	35.6	40.1	103.0	97.3	39.0	38.3	16.3	4.4	0.0	1.6	18.0	2.4	4.7	8.4	3.6	47.7	0.0	12.3	0.0	4.8	48.1	8.4	0.0	0.0	16.0	2.4	13.1	26.8	0.0	0.5	0.0	3.8	0.0	3.4	1.6	0.0	0.5	0.2	53.0	5.4	0.0	0.0	2.6	0.0	129.3	6.6	19.4	14.6	6.6	3.6	44.6	5.1	0.2	0.0	11.9	7.7	6.8	33.9	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.7	3.9	5.7	3.8	14.9	4.6	4.4	4.8	3.8	6.6	3.7	48.9	0.0	1.9	0.3	1.8	9.8	85.2	5.8	7.4	14.3	110.3	80.5	12.5	0.0	1.1	35.0	4.2	60.7	0.7	12.0	0.0	0.6	1.5	3.3	144.7	38.6	4.9	0.0	0.0	0.0	7.0	41.3	5.1	3.8	0.0	3.9	1.1	40.2	6.1	1.7	0.0	23.9	4.1	0.9	4.6	2.8	5.3	2.9	3.6	14.0	0.0	1.9	0.0	0.0	0.0	0.3	22.4	6.0	0.0	72.4	37.9	0.1	0.4	2.0	39.5	27.2	58.2	0.1	3.8	3.2	9.8	613.9	2.0	112.0	12.1	69.1
TCEAL2	"my048, MY0876G05, WEX1"	ENSG00000184905	"Transcription elongation factor A like 2"	Q9H3H9	X	102125679-102140426	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 162.0;pituitary gland: 189.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 73.5;Bipolar cells: 141.8;Distal tubular cells: 70.5;Granulosa cells: 62.4;Horizontal cells: 97.6;Muller glia cells: 215.8"	"Cancer enhanced"	"Detected in many"		"glioma: 22.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 5.7;SCLC-21H: 6.2;U-2 OS: 11.0"									HPA076317			Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear speckles"	Cytosol	"HPA076317: AB_2686794"	"unprognostic (2.34e-3)"	"unprognostic (1.35e-2)"	"unprognostic (7.59e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.47e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.11e-3)"	8.1	25.9	115.4	2.3	114.2	0.0	5.9	114.3	162.0	25.5	85.6	48.6	3.0	34.7	10.3	5.9	30.0	7.6	28.0	113.2	123.5	19.2	0.6	10.2	0.7	116.4	119.0	86.9	5.4	25.0	189.9	0.0	112.1	33.6	3.7	62.3	23.7	27.6	0.7	3.4	11.5	17.8	103.5	4.7	24.7	42.2	111.0	1.4	45.9	2.1	1.5	12.5	16.5	121.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	1.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	11.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	115.4	114.2	114.3	162.0	113.2	123.5	116.4	119.0	112.1	103.5	111.0	121.9	0.6	6.4	16.3	12.7	0.1	1.9	73.5	0.0	6.8	141.8	0.7	9.7	8.7	4.3	12.4	31.3	6.2	0.1	0.0	0.0	70.5	0.2	3.8	0.2	0.4	5.7	0.0	0.0	30.1	0.4	0.1	11.1	0.0	0.1	2.5	62.4	7.1	0.3	0.0	97.6	30.9	0.0	0.0	0.0	1.1	9.6	6.5	0.9	7.2	4.7	0.6	215.8	0.0	16.6	8.7	1.0	0.0	5.7	0.1	47.3	0.0	0.7	0.0	45.4	6.6	46.3	9.6	4.6	3.6	0.2	1.3	0.0	0.7	0.4	0.0	7.6
TCEAL9	"DKFZp313K1940, WBP5, WEX6"	ENSG00000185222	"Transcription elongation factor A like 9"	Q9UHQ7	X	103356489-103358462	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1165.9;Distal tubular cells: 360.0;Extravillous trophoblasts: 456.2;Syncytiotrophoblasts: 780.1;Theca cells: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA011790	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA011790: AB_2214932"	"unprognostic (1.26e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.31e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.58e-2)"	93.9	178.7	62.9	49.8	65.5	13.8	71.7	69.0	116.6	82.8	86.4	67.6	24.8	101.5	185.0	51.1	71.6	82.0	78.7	65.6	68.0	96.7	34.7	81.2	23.4	67.8	68.7	272.5	46.5	107.0	82.9	219.3	69.4	86.0	55.9	45.4	45.5	105.4	14.4	36.4	38.3	97.5	66.6	55.4	76.2	72.4	67.6	36.0	120.0	31.5	25.6	115.9	60.8	74.4	130.5	64.1	195.0	100.8	412.6	397.8	146.6	267.7	355.5	185.7	300.7	122.0	135.2	0.5	387.2	219.4	342.5	77.2	33.8	169.8	247.8	0.6	73.6	133.2	156.0	79.6	282.8	0.2	0.3	275.6	162.1	248.5	245.0	323.5	312.7	55.2	119.9	9.7	445.4	0.2	66.2	0.8	121.8	0.1	120.4	0.3	389.7	0.7	227.4	239.7	88.3	106.2	168.8	5.4	188.5	209.0	27.0	7.3	258.1	165.0	71.9	502.2	75.9	0.1	7.8	1.1	400.9	0.2	134.4	1.2	1.6	0.0	0.3	1.0	0.0	2.4	1.9	0.7	1.3	1.6	4.0	3.5	0.0	1.6	0.1	23.6	1.2	1.4	62.9	65.5	69.0	116.6	65.6	68.0	67.8	68.7	69.4	66.6	67.6	74.4	121.4	173.1	70.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	81.5	125.3	0.0	0.0	47.0	233.6	0.0	1165.9	2.1	0.0	360.0	250.1	0.0	100.6	149.7	85.3	0.0	0.0	0.0	139.8	456.2	130.2	0.0	115.6	11.4	268.5	0.0	0.0	141.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	120.8	0.0	0.0	0.9	0.0	0.0	298.6	10.2	0.0	0.0	0.0	74.1	0.0	0.0	0.0	0.0	780.1	4.9	323.7	0.0	0.0
TCERG1L	FLJ38950	ENSG00000176769	"Transcription elongation regulator 1 like"	Q5VWI1	10	131092391-131311721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;retina: 6.1;thyroid gland: 14.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 69.9;Horizontal cells: 102.6"	"Cancer enriched"	"Detected in some"	14	"thyroid cancer: 20.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;RPMI-8226: 1.1;SuSa: 1.9;U-2 OS: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030816			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA030816: AB_10601721"	"unprognostic (6.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.69e-2)"		"unprognostic (1.62e-1)"	"unprognostic (4.96e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.03e-1)"	0.0	0.9	1.3	0.0	3.5	0.0	0.1	0.3	5.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	2.5	1.6	0.2	0.0	0.0	0.0	2.2	1.5	3.0	0.3	0.5	1.3	0.0	0.9	0.6	0.0	6.1	0.0	0.6	0.0	0.5	0.0	0.0	1.5	0.2	0.0	1.6	2.0	0.6	14.9	0.0	0.1	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.5	0.3	5.0	2.5	1.6	2.2	1.5	0.9	1.5	2.0	2.1	0.0	0.0	0.0	0.7	0.0	0.6	0.2	0.0	2.2	5.9	0.5	0.1	1.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	69.9	0.0	0.7	0.9	0.5	0.1	0.0	0.1	0.0	0.0	0.0	102.6	14.5	0.0	0.0	0.0	0.0	0.1	4.7	0.2	10.6	1.0	0.0	0.9	0.0	3.0	2.3	0.1	0.0	4.5	0.0	0.7	0.0	0.0	0.0	4.3	0.0	0.3	0.2	0.4	3.7	2.8	0.6	0.1	0.1	2.5	0.0	0.1
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222185-55664787	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease variant, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 820.0;Endothelial cells: 574.5;Inhibitory neurons: 1177.6;Oligodendrocyte precursor cells: 719.8;Oligodendrocytes: 573.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.1"	"Group enriched"	"Detected in many"	14	"memory B-cell: 173.6;naive B-cell: 146.8;plasmacytoid DC: 559.8"	"Group enriched"	"Detected in many"	33	"B-cells: 173.6;dendritic cells: 559.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 140.4;SH-SY5Y: 157.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavorable (9.95e-4)"	20.3	9.6	3.7	12.8	12.5	9.5	11.6	65.1	26.5	28.5	0.0	7.4	5.1	23.0	2.1	9.7	13.4	17.4	17.5	29.8	0.0	4.4	4.4	15.5	14.7	5.5	1.0	25.9	5.8	8.0	6.5	28.9	3.9	6.6	7.9	14.0	6.8	10.2	6.1	6.4	5.0	24.1	2.2	13.1	6.0	15.4	2.4	9.8	13.3	16.7	14.7	13.1	7.3	14.4	0.1	4.1	36.8	11.4	8.5	14.4	0.1	18.4	40.6	13.2	17.2	23.1	3.6	28.8	0.1	41.9	2.7	4.5	17.9	17.1	9.2	140.4	13.9	12.1	0.1	0.0	4.0	5.3	2.8	19.6	5.3	18.5	0.7	9.1	45.8	1.6	19.5	22.0	11.0	0.0	7.6	0.0	10.4	0.1	2.4	41.6	14.9	65.4	0.0	0.9	12.6	157.7	0.0	1.5	0.0	11.1	1.6	1.3	49.1	48.5	17.4	2.1	14.6	16.3	32.2	25.7	11.0	5.2	15.5	0.9	7.4	0.8	0.9	8.3	0.7	173.6	0.2	0.5	20.6	146.8	0.5	0.3	1.8	11.2	7.4	559.8	0.7	11.3	3.7	12.5	65.1	26.5	29.8	0.0	5.5	1.0	3.9	2.2	2.4	14.4	820.0	6.4	13.1	501.1	217.4	117.0	37.8	34.0	80.8	293.0	6.5	23.4	35.5	4.3	32.6	22.0	83.4	1.8	446.8	0.1	0.0	1.5	103.2	17.5	201.4	574.5	5.4	34.2	503.8	7.1	1.5	296.7	1.5	12.2	13.9	105.7	316.3	6.6	39.6	25.2	1177.6	0.3	26.4	112.4	129.2	116.3	205.3	80.4	64.0	474.1	32.7	372.8	13.4	719.8	573.6	2.1	0.1	182.1	131.7	20.8	0.0	2.3	25.9	54.7	236.7	304.5	221.0	8.7	14.5	47.5	84.4	2.6	15.1	164.8	0.2	17.8
TCF7L1	TCF3	ENSG00000152284	"Transcription factor 7 like 1"	Q9HCS4	2	85133392-85310387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 49.2;Astrocytes: 76.4;Leydig cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 43.3;NTERA-2: 99.0;RH-30: 44.7;T-47d: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071298			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA071298: AB_2686383"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (6.16e-5)"	"unprognostic (1.79e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.06e-4)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (5.38e-4)"	37.8	5.3	7.5	4.0	9.9	3.7	33.4	7.8	6.4	33.1	13.8	27.6	4.3	25.9	6.7	10.0	20.1	7.2	20.3	6.9	7.7	15.7	12.5	17.8	5.9	10.8	13.0	27.5	4.5	7.0	8.9	5.2	6.9	20.0	4.1	1.7	13.1	14.5	15.0	14.6	12.2	13.0	7.4	11.8	10.7	9.1	10.0	5.8	30.6	7.9	3.5	18.3	24.1	6.7	2.1	1.5	33.5	25.8	12.6	2.6	20.3	2.5	8.5	5.8	5.3	5.2	2.0	0.7	4.0	5.6	6.4	4.7	25.9	43.3	4.0	1.8	4.1	0.7	2.1	2.3	1.2	0.3	4.9	2.1	7.7	0.6	1.4	2.6	11.2	1.3	0.5	1.3	6.8	1.6	0.2	1.6	99.0	1.3	0.9	0.6	44.7	0.5	2.7	3.7	1.0	10.4	4.0	17.1	1.3	25.9	44.3	0.9	12.1	6.5	9.2	0.4	3.3	1.1	0.3	0.4	0.2	1.0	5.2	5.1	0.5	1.1	0.5	0.4	0.7	1.1	0.6	0.7	0.2	1.5	0.7	0.9	1.3	0.9	0.5	0.9	0.6	0.1	7.5	9.9	7.8	6.4	6.9	7.7	10.8	13.0	6.9	7.4	10.0	6.7	49.2	6.4	37.3	76.4	1.0	6.0	14.4	12.9	15.9	0.2	20.0	33.1	9.1	5.7	10.5	16.5	0.0	6.3	0.8	0.3	0.0	3.7	28.2	9.4	17.5	31.4	0.0	0.0	1.1	5.6	4.0	28.9	0.5	16.0	5.1	39.4	45.7	6.7	1.7	0.0	2.2	2.9	8.2	9.1	8.3	5.4	65.3	2.2	3.6	22.5	1.0	4.9	0.0	32.2	1.5	1.1	1.6	28.6	1.4	10.8	5.0	2.2	7.7	0.2	6.6	24.9	28.9	1.9	9.3	3.4	3.4	1.4	1.2	2.9	2.1	2.4
TCIM	"C8orf4, hTC-1, TC-1, TC1"	ENSG00000176907	"Transcriptional and immune response regulator"	Q9NR00	8	40153482-40155310	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.5;Alveolar cells type 2: 882.5;Collecting duct cells: 200.5;Distal tubular cells: 193.7;Ductal cells: 331.6;Glandular and luminal cells: 397.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 48.5;AF22: 134.4;BJ: 51.5;BJ hTERT+: 134.4;EFO-21: 87.5;HeLa: 94.8;RPTEC TERT1: 67.2;SuSa: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027188	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 12: NES - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027188: AB_10601150"	"unprognostic (8.88e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.15e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.48e-2)"	91.5	24.2	6.2	42.9	7.4	0.0	64.0	6.0	10.8	134.1	10.6	68.7	30.9	67.7	18.3	22.3	20.3	105.2	130.8	6.5	6.5	252.6	210.0	165.4	18.0	6.5	6.6	44.6	51.5	70.3	18.9	165.1	6.9	67.7	71.1	4.5	176.0	28.3	37.7	13.2	101.4	43.5	6.9	83.3	56.1	4.8	8.6	3.8	53.9	47.9	4.1	255.3	26.2	7.8	0.0	48.5	134.4	0.0	0.0	0.0	0.3	51.5	134.4	0.2	0.6	0.7	0.0	0.0	87.5	1.0	0.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	94.8	21.4	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.3	1.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.2	67.2	0.1	0.1	0.2	0.2	4.6	0.0	50.4	0.0	0.0	43.6	0.0	1.2	0.4	0.8	1.2	1.7	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.4	6.0	10.8	6.5	6.5	6.5	6.6	6.9	6.9	8.6	7.8	209.5	99.3	882.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	124.9	62.0	0.0	0.0	77.4	200.5	0.0	12.3	1.5	0.0	193.7	331.6	0.0	152.6	90.7	103.2	0.0	0.0	0.0	111.2	26.5	13.5	0.0	397.4	26.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	102.4	0.0	0.0	0.1	0.0	0.0	2.5	8.7	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	4.5	8.1	22.7	0.0	0.0
TCL1B	TML1	ENSG00000213231	"TCL1 family AKT coactivator B"	O95988	14	95686426-95692628	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;lymphoid tissue: 2.5;testis: 2.5"	"Cell type enriched"	"Detected in some"	8	"Syncytiotrophoblasts: 72.7"	"Cancer enriched"	"Detected in single"	72	"testis cancer: 8.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	24	"naive B-cell: 11.7;plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	24	"B-cells: 11.7;dendritic cells: 6.2"	"Cell line enriched"	"Detected in some"	7	"U-698: 511.8"					"Not detected"	"Not detected"			HPA053163	Uncertain		Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA053163: AB_2682064"															"unprognostic (1.55e-1)"			0.1	0.0	0.1	0.4	0.7	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	2.2	0.6	0.4	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	2.5	0.4	0.2	0.0	0.0	2.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	73.5	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	2.5	0.6	0.4	0.0	0.0	1.3	0.0	0.2	0.2	0.4	511.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.3	0.3	0.0	6.2	0.0	0.3	0.1	0.7	0.1	0.2	0.1	0.2	0.6	0.4	0.5	0.1	0.4	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.1	9.0	0.0	0.0	72.7	0.0	0.1	0.0	0.1
TCN2	"D22S676, D22S750, TC2"	ENSG00000185339	"Transcobalamin 2"	P20062	22	30607003-30627271	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 115.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.0;Hepatic stellate cells: 137.4;Kupffer cells: 144.1;Proximal enterocytes: 563.6;Proximal tubular cells: 125.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 43.8;intermediate monocyte: 66.5;non-classical monocyte: 24.4"	"Lineage enriched"	"Detected in many"	8	"monocytes: 66.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 117.6;HUVEC TERT2: 142.6;Karpas-707: 184.0;RPTEC TERT1: 70.7;TIME: 85.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000837			Approved	Cytosol	"Secreted to blood"	NA	NA		19000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA000837: AB_1080235"	"unprognostic (6.43e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.53e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.95e-3)"	"unprognostic (4.94e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	49.6	30.6	24.6	16.0	24.1	5.5	37.9	25.5	30.6	25.9	27.1	23.4	23.6	28.7	20.3	8.6	21.5	50.1	28.7	22.7	25.3	115.8	17.3	37.7	35.3	27.1	26.1	14.8	12.1	8.6	15.1	18.6	27.7	16.0	27.8	11.1	13.2	45.4	6.0	9.0	59.5	36.8	25.5	46.7	17.4	21.9	29.7	6.4	26.4	13.7	10.0	22.0	14.7	25.3	0.2	9.5	41.8	0.2	24.6	117.6	1.4	3.1	30.9	8.0	13.1	4.6	21.2	0.6	45.7	6.2	0.7	1.5	3.7	2.2	2.5	0.0	2.3	0.2	1.2	2.0	58.5	0.6	33.7	19.8	2.5	6.1	5.1	8.8	142.6	0.0	0.8	184.0	12.7	0.1	0.1	3.3	16.4	11.7	1.0	4.9	6.0	64.2	70.7	1.1	14.4	1.9	0.3	0.6	12.0	2.8	0.4	2.0	85.3	26.4	3.5	3.3	1.3	5.1	1.4	0.2	9.5	1.7	0.6	0.0	43.8	0.0	0.1	66.5	0.7	0.0	0.8	0.4	7.9	0.0	0.3	0.6	1.4	0.0	24.4	1.5	0.2	18.8	24.6	24.1	25.5	30.6	22.7	25.3	27.1	26.1	27.7	25.5	29.7	25.3	105.0	3.2	3.9	3.9	3.7	5.2	2.2	4.7	0.6	8.0	7.1	5.1	6.5	27.1	13.7	12.9	20.9	0.4	0.5	70.9	7.9	7.8	1.1	3.5	5.4	64.6	6.7	0.8	0.2	6.0	0.8	19.5	5.1	6.2	4.5	23.4	137.4	5.6	45.9	1.7	1.9	28.6	4.1	144.1	9.4	1.4	10.5	53.8	23.2	8.4	8.8	7.4	0.0	5.5	1.7	5.1	50.2	9.8	13.5	2.0	563.6	125.8	2.8	29.1	13.1	0.9	5.5	1.0	12.6	0.5	5.3	0.4	2.2	5.6	21.0	2.7
TCP11L1	FLJ11336	ENSG00000176148	"T-complex 11 like 1"	Q9NUJ3	11	33039417-33105943	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005769	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Golgi apparatus"	"HPA005769: AB_2202398"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.99e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.50e-3)"	6.3	5.0	5.6	5.5	7.9	7.4	4.5	0.7	7.3	4.8	0.0	6.9	6.1	5.0	3.3	4.9	4.0	8.1	4.7	9.6	7.4	5.9	4.0	4.6	4.9	4.9	8.9	5.3	5.7	4.0	5.0	7.0	8.3	5.0	7.2	6.0	4.9	7.0	3.0	5.4	8.9	8.7	1.0	5.4	4.2	5.6	3.1	7.6	3.2	4.1	5.7	5.8	4.5	7.5	11.9	21.3	10.7	10.2	18.3	20.3	7.2	16.9	14.4	12.8	17.3	11.0	5.6	12.3	4.6	33.1	19.0	18.7	14.5	13.2	18.2	16.1	13.0	8.3	23.1	8.1	12.0	8.2	10.8	16.4	16.2	13.2	25.0	14.6	12.8	17.4	5.2	14.3	32.4	17.6	8.1	3.2	8.0	8.8	8.2	9.4	22.4	2.2	11.6	4.6	9.1	18.3	43.3	27.5	7.9	13.5	7.0	3.4	20.0	22.7	32.5	25.7	18.1	17.5	19.7	13.9	16.5	4.0	18.1	18.6	6.1	8.8	3.4	3.9	3.4	2.1	1.8	3.8	5.9	2.8	1.8	2.4	3.6	4.8	1.1	11.1	5.9	3.5	5.6	7.9	0.7	7.3	9.6	7.4	4.9	8.9	8.3	1.0	3.1	7.5	4.9	9.6	1.1	12.7	5.0	2.3	10.7	4.2	12.0	5.6	1.7	2.0	3.1	2.8	1.8	0.0	4.2	3.8	4.6	3.5	1.9	4.6	11.6	1.8	4.4	4.5	1.8	2.1	22.5	4.0	19.2	6.3	3.1	2.3	4.5	2.4	4.2	1.6	6.8	8.4	23.7	1.2	2.0	5.7	5.2	6.3	1.8	6.9	0.0	18.7	20.2	1.6	8.2	23.1	29.6	5.7	1.6	2.6	11.6	8.9	13.3	5.0	0.7	5.7	0.0	7.0	6.4	10.4	5.4	6.1	2.6	4.7	6.7	2.8	1.4	3.9
TCTA		ENSG00000145022	"T cell leukemia translocation altered"	P57738	3	49412206-49416475	"Disease related genes, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007342	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA007342: AB_2202399"	"unprognostic (5.58e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.17e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (3.74e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.00e-15)"	"unprognostic (1.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.41e-3)"	21.7	48.0	49.1	13.1	52.3	12.3	21.5	50.1	52.9	23.2	47.0	24.7	18.9	23.1	60.6	15.6	26.1	16.6	22.6	48.4	50.6	51.0	41.9	23.5	15.8	51.6	51.6	27.1	24.1	39.8	48.8	14.5	52.3	34.5	28.8	14.0	21.8	25.1	19.6	14.2	23.1	21.8	48.8	25.9	23.3	15.7	52.1	20.1	45.3	13.8	16.0	25.4	15.9	51.5	12.8	15.5	9.8	14.8	42.5	18.5	12.9	26.0	19.2	25.8	21.6	9.1	13.6	15.2	18.6	61.5	29.6	14.4	19.3	26.2	21.0	22.9	13.4	25.4	19.6	11.9	25.8	10.9	31.9	40.2	26.8	28.7	22.9	24.7	27.0	12.0	9.4	33.8	63.8	11.7	13.4	9.8	8.0	24.1	35.5	8.1	10.6	36.0	44.5	16.7	26.3	8.7	30.9	33.8	28.6	19.7	28.8	10.2	24.5	19.3	11.9	40.4	9.8	18.4	26.1	10.4	45.4	19.3	27.2	20.4	17.8	23.2	19.1	34.2	11.1	12.0	12.0	14.7	10.1	13.7	14.9	15.5	20.1	23.0	47.5	15.6	17.8	22.4	49.1	52.3	50.1	52.9	48.4	50.6	51.6	51.6	52.3	48.8	52.1	51.5	15.5	25.6	15.6	8.8	19.3	2.7	10.0	10.3	14.2	10.2	19.9	18.0	14.1	20.0	12.9	27.6	12.5	25.9	20.5	34.0	46.9	15.3	8.0	15.5	15.0	14.7	17.5	9.0	12.3	11.6	11.5	17.6	53.5	17.0	5.7	7.1	11.4	31.8	24.8	10.1	11.0	19.1	20.3	18.6	6.0	14.3	15.5	19.2	14.2	11.2	15.5	26.3	26.8	11.1	16.8	15.1	28.6	16.1	13.2	13.4	34.9	50.3	22.8	11.3	6.6	13.7	16.6	8.2	6.1	10.4	4.5	20.0	21.6	22.1	16.6	7.9
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.1;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.9;Late spermatids: 60.4;Spermatocytes: 43.2;Spermatogonia: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.5	3.1	5.1	4.4	5.1	1.4	4.5	7.9	5.8	2.1	2.3	3.2	2.2	1.6	6.0	1.8	2.0	1.9	3.5	5.5	6.0	4.0	3.6	4.4	5.9	7.4	5.8	0.9	3.0	30.1	4.6	3.6	8.2	6.0	4.0	9.6	7.0	5.7	4.2	2.2	2.2	2.8	4.7	6.3	2.9	22.2	6.0	10.0	7.3	4.9	5.4	2.6	1.7	5.4	10.8	9.4	8.1	18.8	0.5	0.8	7.7	1.8	1.0	5.6	3.7	6.1	15.1	12.6	16.3	0.7	13.1	6.4	11.9	12.5	8.5	32.5	8.3	12.6	2.6	4.2	3.4	2.4	2.0	1.0	4.8	11.8	5.0	1.6	5.9	24.3	9.8	11.0	1.8	29.3	20.3	3.9	6.2	16.0	16.0	2.5	5.0	26.2	9.6	5.3	11.7	19.2	13.2	10.5	12.4	14.5	22.9	9.4	2.4	2.6	4.6	8.2	10.2	22.2	29.4	14.1	12.0	10.1	3.6	5.2	0.9	2.0	8.2	4.3	12.5	3.9	7.6	8.3	2.0	3.6	5.6	6.9	0.6	7.7	8.0	5.3	9.9	4.1	5.1	5.1	7.9	5.8	5.5	6.0	7.4	5.8	8.2	4.7	6.0	5.4	1.0	3.2	8.3	2.3	2.5	0.3	2.1	1.5	0.6	3.4	4.4	1.1	4.8	0.0	2.2	7.3	4.2	2.7	2.4	0.7	1.9	3.1	23.9	1.5	0.2	1.7	0.0	2.1	6.6	2.5	2.9	0.5	2.6	1.2	4.5	4.6	1.4	1.6	5.4	6.7	5.9	0.9	2.0	2.6	1.3	60.4	0.3	2.3	1.8	2.8	2.2	1.8	0.0	6.0	8.3	1.9	0.3	2.2	1.9	1.6	0.1	1.4	1.4	3.5	13.1	1.9	1.0	43.2	27.4	0.4	0.1	2.5	2.9	0.6	0.9	1.8
TEDC1	C14orf80	ENSG00000185347	"Tubulin epsilon and delta complex 1"	Q86SX3	14	105489855-105499575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 66.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039049, HPA039050"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039049: AB_2676320, HPA039050: AB_10670918"	"unprognostic (8.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.73e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-3)"	5.1	1.6	5.2	4.9	5.5	6.8	4.7	4.1	7.8	4.3	0.5	5.5	5.1	3.8	1.0	6.8	4.6	1.8	4.3	5.8	3.0	4.0	5.4	4.9	5.4	7.0	3.5	2.5	3.0	1.0	5.3	1.6	4.2	4.2	1.6	0.5	4.3	2.3	2.3	8.2	5.4	1.0	3.1	6.8	5.9	4.9	3.6	4.5	5.7	0.5	3.1	3.9	4.5	5.3	17.2	38.9	9.2	13.5	0.8	1.5	24.5	13.4	5.0	15.9	14.7	14.0	31.2	25.6	27.2	2.2	6.2	43.5	3.2	14.0	3.0	29.0	16.0	6.5	22.8	13.3	0.6	12.9	17.9	0.3	4.6	10.6	3.5	2.0	6.4	23.2	10.5	31.2	2.5	66.7	26.9	29.6	11.9	14.6	41.8	21.9	13.8	17.9	4.5	14.3	25.7	15.5	13.7	15.8	9.8	2.0	26.0	12.6	7.8	10.9	18.4	33.4	22.4	17.8	8.2	15.7	13.9	14.8	18.0	0.0	0.5	0.6	0.5	0.9	0.4	0.1	0.8	1.4	0.7	0.3	0.6	0.1	0.1	0.0	0.8	2.4	0.6	0.2	5.2	5.5	4.1	7.8	5.8	3.0	7.0	3.5	4.2	3.1	3.6	5.3	4.8	3.2	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	5.9	5.3	0.0	0.0	0.6	1.8	0.0	8.0	10.1	0.0	3.9	11.6	0.0	12.0	3.0	4.0	0.0	0.0	0.0	12.7	26.6	3.4	0.0	7.2	0.0	8.1	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	11.9	0.0	0.0	0.0	0.0	14.7	0.0	0.0	4.7	0.0	0.0	2.0	3.6	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.0	4.2	2.5	0.0	0.0
TENT2	"FLJ38499, GLD2, PAPD4, TUT2"	ENSG00000164329	"Terminal nucleotidyltransferase 2"	Q6PIY7	5	79612120-79686648	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 37.6;Glandular and luminal cells: 33.2;Granulosa cells: 31.9;Hofbauer cells: 33.9;Syncytiotrophoblasts: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054468			Approved	Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA054468: AB_2682497"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.37e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.67e-3)"	19.1	15.1	10.4	20.4	12.8	44.4	25.0	11.5	15.6	17.9	15.0	18.5	17.8	19.6	23.6	16.5	16.0	17.3	14.5	9.6	10.8	17.6	23.8	17.9	30.2	12.0	11.1	22.7	15.2	15.5	11.5	21.0	12.5	15.7	20.8	14.3	15.1	15.3	16.2	23.8	19.1	18.3	10.9	27.8	17.7	17.5	11.2	27.2	22.4	14.3	28.1	19.1	15.9	15.2	22.5	15.3	16.8	26.7	28.8	33.2	26.8	26.6	40.6	30.5	48.3	13.8	26.1	41.8	13.6	29.6	35.9	21.1	21.8	29.6	34.6	31.3	19.9	23.9	19.4	21.6	37.3	35.7	31.6	29.5	31.4	21.6	40.1	29.7	26.2	30.0	27.7	30.0	34.0	12.3	40.8	45.6	15.6	17.0	10.8	36.2	16.8	47.2	29.4	31.8	11.0	20.1	21.1	22.8	42.8	26.4	19.6	55.6	24.2	16.4	11.1	16.0	29.9	31.3	27.8	40.7	28.9	36.8	23.4	30.7	21.5	21.6	19.0	24.8	31.3	21.6	20.5	21.0	21.9	17.2	19.5	20.6	19.2	21.8	26.0	12.0	23.4	19.0	10.4	12.8	11.5	15.6	9.6	10.8	12.0	11.1	12.5	10.9	11.2	15.2	25.9	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	24.2	16.5	0.0	0.0	0.0	27.6	0.0	26.3	37.6	0.0	17.6	10.2	0.0	21.3	29.0	7.2	0.0	0.0	0.0	10.2	22.6	8.7	0.0	33.2	0.0	31.9	0.0	0.0	33.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	9.8	0.0	0.0	0.0	0.0	14.9	0.0	0.0	11.5	0.0	0.0	26.5	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	33.7	11.0	23.7	0.0	0.0
TENT5A	"C6orf37, FAM46A, FLJ20037"	ENSG00000112773	"Terminal nucleotidyltransferase 5A"	Q96IP4	6	81491439-81752774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 225.9;salivary gland: 104.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 73.1;Endometrial stromal cells: 70.6;Extravillous trophoblasts: 115.4;Glandular and luminal cells: 176.7;Syncytiotrophoblasts: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 81.9;HeLa: 86.1;HL-60: 95.6;THP-1: 162.0;U-937: 72.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051067: , HPA067140: AB_2685788"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	13.5	21.3	4.3	7.9	4.6	225.9	12.2	9.0	5.8	21.3	9.9	17.2	16.4	10.2	19.7	4.4	12.0	32.3	21.7	4.0	14.0	6.4	35.9	9.1	5.2	7.8	7.1	23.6	8.3	9.4	17.4	18.7	6.1	9.9	16.9	8.7	104.4	24.8	2.1	18.7	22.2	11.1	5.0	9.9	37.8	3.7	6.7	2.9	8.8	5.1	4.3	16.6	8.8	5.3	3.5	5.0	3.3	0.2	67.9	29.8	6.2	27.0	19.2	15.7	23.5	51.0	2.6	0.3	1.0	81.9	10.0	2.9	2.4	4.2	11.5	0.0	6.2	0.1	86.1	8.0	21.2	95.6	7.1	13.2	2.4	12.3	2.1	51.2	2.0	0.8	1.4	0.0	10.6	14.7	0.0	67.2	0.9	29.2	3.8	0.0	28.8	0.1	2.1	6.2	3.3	4.4	12.1	5.2	8.3	9.9	1.2	162.0	4.5	17.9	3.8	7.6	7.6	0.4	0.3	0.3	25.3	72.7	7.8	37.3	29.9	46.3	11.5	29.6	6.8	18.2	4.3	5.7	24.2	21.0	8.1	8.0	13.8	16.9	47.3	8.5	5.6	14.0	4.3	4.6	9.0	5.8	4.0	14.0	7.8	7.1	6.1	5.0	6.7	5.3	22.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	40.8	44.2	0.0	0.0	0.0	5.5	0.0	39.9	43.1	0.0	3.9	30.5	0.0	73.1	70.6	2.9	0.0	0.0	0.0	23.4	115.4	32.7	0.0	176.7	0.0	40.9	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	26.7	0.0	0.0	5.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	162.0	9.4	12.6	0.0	0.0
TESMIN	"CXCDC2, MTL5"	ENSG00000132749	"Testis expressed metallothionein like protein"	Q9Y4I5	11	68707440-68751520	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 52.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 9.6;Breast myoepithelial cells: 7.4;Endometrial ciliated cells: 31.5;Glandular and luminal cells: 27.0;Proximal tubular cells: 11.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 11.9;T-47d: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA018539			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA018539: "	"unprognostic (1.99e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (3.22e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-1)"	0.3	0.5	0.7	1.0	0.7	7.4	4.3	0.6	0.6	0.7	0.6	2.5	1.4	0.7	0.7	1.6	1.7	0.4	0.2	0.5	0.8	3.1	0.4	0.4	1.3	1.2	0.7	0.8	1.1	2.1	2.3	0.3	1.2	2.3	2.9	1.5	1.9	1.1	0.0	0.6	1.4	0.4	0.5	1.3	0.9	52.5	0.7	2.1	1.1	0.1	1.1	0.4	0.9	0.5	7.2	3.1	1.3	0.1	0.0	0.0	3.5	1.6	0.8	2.2	1.0	0.9	7.1	2.9	1.6	0.3	0.0	3.4	1.0	1.4	1.7	3.0	2.5	2.1	1.0	0.0	0.0	1.5	11.9	0.0	3.8	0.1	2.2	3.0	0.7	3.4	4.5	5.4	0.3	4.8	0.8	4.2	7.3	3.3	3.1	1.9	0.4	0.8	2.6	0.1	4.4	4.7	0.0	1.5	0.0	3.7	23.8	10.0	2.7	0.2	0.5	0.2	0.1	2.1	2.0	2.8	0.1	4.2	1.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.7	0.7	0.6	0.6	0.5	0.8	1.2	0.7	1.2	0.5	0.7	0.5	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.6	7.4	0.0	0.0	0.6	0.0	0.0	1.8	0.7	0.0	5.9	6.3	0.0	31.5	2.6	0.3	0.0	0.0	0.0	4.0	4.7	0.3	0.0	27.0	2.5	4.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.5	0.0	0.0	11.5	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	1.1	0.2	0.0	0.0
TET3	"hCG_40738, MGC22014"	ENSG00000187605	"Tet methylcytosine dioxygenase 3"	O43151	2	73984910-74108176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;skin 1: 16.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 88.5;Oligodendrocytes: 86.7;Suprabasal keratinocytes: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050845	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA050845: AB_2681256"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.05e-1)"	"unprognostic (5.30e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.10e-1)"	2.2	1.6	3.7	5.2	2.4	19.7	3.0	6.3	13.7	2.5	0.0	4.1	5.4	2.0	1.4	7.6	1.9	2.5	1.2	9.3	1.7	1.6	3.9	4.1	3.7	2.0	1.5	1.5	2.6	2.0	1.5	4.6	2.2	2.5	4.3	3.6	4.2	1.1	1.2	16.2	6.0	2.1	0.6	3.8	4.3	1.6	2.7	5.8	2.3	1.3	4.1	3.4	4.0	5.8	9.0	8.0	14.5	8.9	1.2	1.3	26.4	1.8	2.4	3.4	2.7	16.6	8.1	14.9	3.5	2.4	1.6	9.4	13.0	5.2	3.6	6.7	5.2	19.2	7.0	5.6	5.1	20.2	11.3	2.0	13.3	4.2	9.9	4.3	5.3	10.3	13.4	4.8	2.0	14.6	10.0	13.0	8.1	7.7	2.7	15.4	9.1	5.2	3.8	16.5	18.1	15.5	4.0	10.3	4.9	5.7	6.6	16.1	6.7	3.7	15.4	1.8	6.8	4.2	2.0	12.7	2.4	13.9	4.9	0.1	0.4	0.2	0.0	0.4	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.2	3.7	2.4	6.3	13.7	9.3	1.7	2.0	1.5	2.2	0.6	2.7	5.8	4.2	6.4	9.0	31.3	6.4	49.5	3.5	4.2	14.8	16.3	8.0	5.8	2.9	2.8	8.0	1.8	20.9	7.0	7.3	10.5	0.0	3.5	4.7	18.8	11.9	6.6	6.0	24.8	88.5	4.4	30.1	3.4	13.7	29.6	2.5	6.2	3.6	6.1	10.1	10.1	45.7	8.0	8.2	26.9	23.2	0.8	0.6	26.9	10.6	54.4	27.1	1.5	2.1	41.7	86.7	6.2	7.7	3.0	4.8	6.2	10.3	1.5	11.9	8.6	0.0	3.8	7.7	0.5	2.6	24.4	68.2	2.5	5.5	2.3	6.9	7.0
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Vesicles, Plasma membrane"	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.5	0.1	0.6	1.7	0.2	1.1	0.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.5	0.4	0.2	0.2	0.1	0.5	0.5	0.3	0.1	0.0	0.2	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	27.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	6.3	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	7.9	0.0	3.3	0.3	0.0	0.4	0.1	0.1	0.3	0.2	1.2	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.1	0.6	0.4	0.5	0.5	0.5	0.5	0.5	0.5	0.8	4.4	0.0	0.0	2.9	5.7	0.9	1.8	0.7	2.8	0.6	4.7	7.2	1.3	5.7	1.5	1.8	0.0	1.6	0.7	0.1	0.0	0.0	23.3	0.4	0.2	1.5	0.0	0.0	2.2	0.0	1.0	0.7	0.5	1.8	1.3	0.2	1.4	0.8	3.7	0.0	2.2	0.5	2.0	0.6	2.3	6.4	0.3	4.6	3.6	2.8	0.0	0.6	1.0	1.0	3.0	0.1	0.0	0.4	4.3	0.7	0.0	0.1	0.2	1.3	0.0	1.2	1.5	56.4	16.2	1.7	0.1	1.1	0.7	0.0	0.0	0.4
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913008	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 6.7;smooth muscle: 5.3;testis: 12.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Early spermatids: 114.3;Late spermatids: 49.7;Spermatocytes: 95.4;Spermatogonia: 98.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.4;HEL: 19.3;K-562: 5.5;OE19: 4.2;SCLC-21H: 4.1"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.2"	"Low region specificity"	"Detected in many"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.2	0.4	12.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.9	0.0	8.4	1.1	0.0	1.2	3.1	19.3	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.0	0.0	0.1	0.1	0.1	3.7	4.2	0.3	0.0	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	3.6	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.1	0.4	0.7	0.3	0.3	0.6	0.7	0.2	0.4	0.2	0.1	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.3	0.1	1.3	0.5	0.0	0.0	5.7	0.0	0.0	1.2	0.0	0.0	0.0	1.7	2.5	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	49.7	1.2	0.1	0.0	1.0	0.0	1.3	0.0	0.5	0.4	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.1	13.1	0.0	0.1	95.4	98.5	0.0	0.0	0.1	0.0	4.4	0.0	0.0
TEX261	"MGC32043, TEG-261"	ENSG00000144043	"Testis expressed 261"	Q6UWH6	2	70985942-70994873	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016631	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA016631: AB_2240434"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-1)"	39.5	38.8	30.8	21.5	34.8	20.0	29.7	33.1	31.2	32.2	39.1	28.3	25.0	25.4	45.5	27.5	35.3	22.7	36.0	29.3	32.7	41.1	38.8	30.4	22.0	38.5	34.5	39.6	47.5	66.1	29.2	25.0	33.5	31.6	32.7	43.9	36.0	34.3	56.4	20.9	25.6	34.0	32.9	23.5	30.0	36.9	33.4	25.7	46.1	54.3	27.0	26.2	21.6	33.4	61.9	57.1	39.4	50.3	116.4	58.9	44.7	69.8	65.6	79.1	49.6	67.5	49.8	50.2	25.9	122.5	74.7	45.6	75.3	82.7	113.8	38.4	62.8	60.1	28.7	71.8	68.3	70.7	48.7	53.7	54.3	76.2	51.6	43.4	81.5	51.3	75.7	32.4	93.6	48.2	61.2	39.3	26.2	98.7	66.4	43.1	120.7	43.1	57.7	53.1	64.0	33.8	72.3	70.9	46.0	26.2	46.3	41.3	66.1	96.8	83.6	52.4	93.8	25.3	23.9	58.4	84.4	91.7	83.2	8.7	3.8	7.7	3.4	3.9	2.9	1.8	3.7	4.6	2.9	2.7	4.1	3.3	2.8	2.6	3.9	3.1	3.3	2.1	30.8	34.8	33.1	31.2	29.3	32.7	38.5	34.5	33.5	32.9	33.4	33.4	14.7	3.2	14.7	9.4	11.3	8.3	10.7	8.2	5.7	14.7	20.6	14.9	22.9	20.0	8.4	23.9	37.5	16.4	9.0	21.8	7.9	24.9	15.7	10.8	11.9	15.5	8.4	17.4	8.0	23.8	17.4	16.3	12.2	13.3	2.5	17.1	16.4	35.2	19.5	8.4	7.5	18.2	8.2	18.3	6.4	28.5	15.8	11.9	19.6	6.5	13.0	28.1	14.4	15.1	12.6	21.1	14.9	18.4	7.4	12.9	24.4	18.3	5.5	72.9	0.0	16.7	15.0	45.3	11.2	12.8	7.5	17.9	8.7	14.4	18.9	7.7
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264, ER-phagy receptor"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 374.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	34.7	73.4	43.5	23.1	46.5	22.3	35.6	48.7	51.7	39.0	53.1	41.5	39.0	34.2	41.2	41.1	44.0	39.7	41.4	43.8	47.2	67.6	65.3	29.8	33.5	47.2	45.5	31.3	54.3	88.5	26.2	29.4	46.4	45.1	34.5	20.4	58.7	46.9	34.2	69.3	37.6	26.3	46.3	40.9	46.7	111.5	45.9	29.1	48.7	29.6	26.3	35.9	34.9	48.4	36.5	65.5	11.6	59.3	116.8	56.4	23.5	31.0	72.0	50.1	50.1	35.2	84.2	51.6	21.9	44.1	84.2	34.7	32.7	61.6	23.7	42.0	51.9	49.6	40.2	47.8	104.0	31.5	53.6	74.8	96.9	56.3	57.1	45.3	36.9	39.0	26.6	87.7	51.9	42.1	50.9	73.3	12.6	59.8	72.7	24.3	15.3	98.7	79.7	50.1	16.5	26.8	37.4	101.5	48.0	15.7	49.6	66.0	27.3	49.8	20.8	53.0	41.2	61.0	71.3	26.4	61.5	65.9	50.9	99.2	110.1	69.3	119.7	115.6	120.3	98.6	122.6	113.6	104.6	102.4	100.9	103.1	23.5	76.1	115.6	92.4	159.9	139.9	43.5	46.5	48.7	51.7	43.8	47.2	47.2	45.5	46.4	46.3	45.9	48.4	63.6	35.3	21.9	12.4	36.7	34.8	46.7	123.9	45.5	33.5	69.9	68.2	24.4	65.8	68.2	99.3	58.4	142.9	52.3	70.3	62.6	83.1	57.7	44.9	31.8	54.8	32.9	24.8	6.5	75.7	88.9	41.4	29.0	48.2	16.5	45.3	38.9	63.1	105.4	42.1	9.1	56.5	118.0	48.3	45.5	61.2	51.0	47.8	65.8	8.4	56.1	62.6	89.6	7.5	12.3	59.6	76.4	48.9	36.0	45.6	137.6	126.7	49.7	55.4	26.3	30.8	30.7	374.8	111.7	46.3	35.4	76.3	61.9	110.4	86.0	49.9
TEX52		ENSG00000283297	"Testis expressed 52"	A6NCN8	12	2849046-2857039	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.0"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.8;Karpas-707: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043581			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"		Nucleoplasm	Cytosol	"HPA043581: "																		0.5	0.4	0.1	1.0	0.3	0.8	0.5	0.0	0.4	0.4	2.3	0.5	1.2	0.3	0.0	0.5	0.4	0.3	0.3	0.0	0.0	0.4	0.5	0.3	1.0	0.5	0.1	0.5	1.1	0.0	0.5	0.1	0.3	0.6	0.0	2.9	1.5	0.0	2.5	3.4	1.0	0.0	0.1	0.9	0.5	8.0	0.3	0.0	1.0	0.0	0.0	0.4	0.5	1.2	0.2	0.8	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.6	0.7	0.1	2.8	0.9	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	2.9	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.1	0.4	0.3	0.0	0.3	0.1	0.7	0.4	0.2	0.5	0.1	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.5	0.1	0.3	0.1	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX9		ENSG00000151575	"Testis expressed 9"	Q8N6V9	15	56244009-56445997	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.1;Endometrial ciliated cells: 86.2;Respiratory ciliated cells: 125.6;Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"basophil: 4.3;memory B-cell: 14.4;naive B-cell: 11.4"	"Group enriched"	"Detected in many"	12	"B-cells: 14.4;granulocytes: 4.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039415	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA039415: AB_10672775"	"unprognostic (3.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	1.8	6.1	4.1	4.6	3.9	3.4	10.1	7.4	3.9	8.8	17.0	3.6	11.6	5.2	8.4	4.4	28.0	5.2	1.1	3.2	4.2	10.8	1.5	4.4	6.0	9.4	8.6	5.4	5.4	14.2	9.9	1.6	4.5	4.5	4.8	18.0	10.5	3.4	1.2	5.6	8.0	2.2	5.3	3.2	12.2	16.4	6.6	3.7	17.4	1.5	10.6	2.7	1.6	5.7	7.8	7.1	15.3	13.7	3.7	10.8	2.0	1.7	6.3	4.8	5.7	1.7	6.9	15.5	7.0	1.2	8.2	6.6	6.6	7.4	5.5	1.7	7.8	9.1	6.7	5.2	1.1	3.3	1.3	5.9	13.3	5.4	4.1	6.9	0.2	11.1	5.2	1.4	2.6	4.5	6.5	1.2	7.2	13.2	3.0	2.6	7.1	5.5	15.9	4.4	24.3	9.8	8.7	4.9	5.5	11.2	14.6	3.0	0.7	20.3	5.8	6.5	6.4	2.1	16.5	11.7	8.0	1.7	3.9	4.3	0.1	0.1	0.4	0.6	0.1	14.4	0.4	0.3	0.2	11.4	0.2	0.8	0.3	0.4	0.4	0.4	0.6	0.7	4.1	3.9	7.4	3.9	3.2	4.2	9.4	8.6	4.5	5.3	6.6	5.7	1.5	6.4	7.5	38.8	21.0	4.2	7.3	13.2	20.5	6.4	11.3	11.7	0.8	5.7	23.5	11.0	12.5	1.8	0.3	2.3	21.5	15.6	89.1	86.2	5.1	3.2	7.7	5.9	14.3	7.0	0.5	5.0	17.3	4.8	1.3	5.1	1.8	0.4	1.3	1.7	20.4	3.7	16.2	0.0	2.1	40.9	4.7	2.7	3.6	4.7	1.2	6.8	1.0	14.6	15.1	4.5	5.4	3.8	15.8	3.7	12.3	21.7	125.6	37.5	0.0	4.6	6.0	74.6	36.6	6.9	2.3	0.3	1.0	6.2	6.7	4.9
TFDP1	"DILC, Dp-1, DP1, DRTF1"	ENSG00000198176	"Transcription factor Dp-1"	Q14186	13	113584721-113641473	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 344.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 31.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033605, HPA044754, HPA068909, HPA077304"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056, HPA077304: "	"unprognostic (4.28e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (5.50e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.57e-4)"	"prognostic favorable (6.17e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	28.2	23.5	24.3	38.6	24.0	164.0	27.2	24.5	24.4	33.5	32.5	37.8	30.5	27.6	19.4	50.1	32.8	24.6	34.3	24.1	22.8	23.2	25.9	21.8	67.1	27.5	24.4	19.3	18.4	28.5	21.3	40.6	25.3	26.1	42.4	20.2	26.1	30.8	58.2	42.8	32.3	34.3	26.6	30.8	31.3	49.6	26.8	53.4	33.1	59.0	68.3	37.5	30.1	25.7	343.2	82.5	104.4	89.5	138.4	122.7	118.5	187.8	168.7	238.1	218.6	173.3	155.9	314.6	61.3	181.3	130.3	160.3	183.0	167.1	232.2	215.9	212.8	184.4	129.2	109.8	86.8	468.3	155.7	102.1	147.3	151.3	87.4	85.0	162.7	116.2	154.1	82.6	215.5	117.7	207.0	181.4	96.6	322.7	105.0	138.9	93.0	181.1	91.3	129.1	268.2	79.3	84.8	228.8	58.7	75.1	157.9	371.7	114.4	77.2	122.9	165.6	210.8	69.5	92.4	326.4	171.9	285.2	133.2	31.9	3.0	4.6	3.1	3.8	3.4	4.4	4.1	3.7	5.9	3.6	6.3	3.2	3.8	2.3	5.5	3.0	5.3	2.5	24.3	24.0	24.5	24.4	24.1	22.8	27.5	24.4	25.3	26.6	26.8	25.7	21.4	9.6	15.8	12.7	38.8	59.8	32.1	16.1	33.6	10.3	45.6	35.2	26.6	28.6	14.7	29.5	14.6	83.2	33.8	29.8	80.3	12.3	5.5	34.4	28.2	25.8	40.2	344.3	22.5	11.9	128.0	30.8	38.7	31.0	21.0	23.3	34.6	58.7	49.2	6.7	19.5	36.1	12.2	49.1	51.2	10.7	28.6	41.1	35.6	5.6	24.8	14.7	16.5	9.5	10.2	19.0	24.2	28.2	67.3	35.7	29.4	66.5	21.0	22.5	6.6	20.0	32.7	76.7	52.7	74.6	60.0	66.6	32.1	30.3	47.4	35.8
TFIP11	"DKFZP434B194, Spp382, TIP39"	ENSG00000100109	"Tuftelin interacting protein 11"	Q9UBB9	22	26491225-26512505	"Plasma proteins, Predicted intracellular proteins"	"Biomineralization, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027085			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA027085: AB_1857964"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	13.5	13.0	12.4	16.3	13.5	62.8	12.5	15.4	13.9	11.5	12.1	12.7	12.9	12.4	10.4	14.8	13.1	12.6	16.0	12.9	12.0	13.9	19.3	14.0	24.9	12.0	11.8	12.4	16.7	13.0	10.5	14.5	11.3	12.4	12.6	13.4	11.0	10.6	41.8	20.3	13.5	13.1	11.6	17.7	11.9	26.6	13.0	20.1	16.2	21.5	24.7	14.8	10.9	14.3	22.9	26.4	22.3	24.6	34.7	20.6	21.5	26.4	34.5	41.8	39.1	19.8	16.1	44.4	16.6	33.9	27.6	32.8	32.1	26.3	30.3	32.3	30.4	27.4	16.4	20.2	31.4	63.6	33.2	25.9	34.9	40.0	30.9	22.3	32.6	22.4	37.4	38.9	28.2	28.2	29.2	33.8	21.4	32.2	21.9	43.6	34.6	38.8	24.2	22.4	16.7	24.0	31.9	22.7	32.8	21.4	18.7	27.7	31.6	35.2	56.8	22.4	25.6	29.8	41.8	86.6	27.8	24.6	26.8	68.7	28.4	50.1	37.2	31.3	35.1	37.9	33.0	35.2	26.1	42.9	30.9	28.4	44.9	36.3	44.1	16.4	44.5	33.0	12.4	13.5	15.4	13.9	12.9	12.0	12.0	11.8	11.3	11.6	13.0	14.3	11.3	9.6	9.7	11.4	17.8	16.8	11.2	13.2	22.2	9.7	7.5	6.3	3.5	17.2	12.3	12.9	8.4	17.9	20.7	14.8	13.7	15.1	67.9	12.2	9.2	13.3	16.2	20.2	7.1	20.7	14.4	7.8	9.2	12.6	8.2	11.9	13.2	10.8	13.3	15.2	7.2	11.2	6.1	6.2	7.8	12.3	11.1	10.4	7.2	4.7	12.3	7.7	19.6	6.0	6.5	25.3	8.4	9.8	18.6	7.6	11.4	9.3	14.1	6.9	0.0	10.1	10.6	43.6	19.4	14.2	16.8	19.4	17.4	11.6	10.7	10.9
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574054-94596242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 75.2;U-698: 97.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	10.4	9.4	5.3	8.2	5.5	6.0	12.4	5.6	8.2	10.4	6.3	8.0	10.2	8.0	11.8	6.9	9.2	6.8	5.4	4.9	5.6	10.9	30.0	7.1	12.9	5.6	5.4	12.1	10.0	8.1	8.4	10.1	5.9	7.9	9.5	6.9	7.7	7.6	4.1	7.5	9.2	6.7	5.6	9.2	9.1	6.0	5.3	14.1	13.3	4.3	11.0	9.1	6.4	6.6	16.7	7.2	11.6	10.6	17.2	13.5	14.1	15.3	14.9	14.2	13.4	18.9	15.9	26.0	14.8	10.9	8.8	10.4	20.1	11.9	14.9	20.3	7.7	20.7	8.1	18.1	21.0	75.2	13.8	14.9	9.5	8.0	22.8	11.1	13.2	18.9	21.3	8.9	13.3	10.8	20.6	38.4	15.2	26.8	8.3	17.1	11.4	15.9	18.3	7.4	15.9	8.9	11.6	24.2	43.5	19.1	10.2	39.8	12.2	5.6	14.5	8.6	12.6	20.0	11.4	97.5	14.9	26.5	15.5	14.7	5.5	10.8	9.6	6.6	14.9	9.5	11.6	10.7	8.7	7.1	16.8	12.5	1.6	12.1	8.3	7.6	13.8	6.9	5.3	5.5	5.6	8.2	4.9	5.6	5.6	5.4	5.9	5.6	5.3	6.6	7.4	12.8	6.8	8.1	12.8	2.4	9.2	15.9	6.8	4.3	7.8	7.9	5.2	8.6	11.9	7.3	2.1	15.7	12.5	5.8	9.8	11.9	1.2	10.4	8.9	7.0	5.4	3.4	7.7	9.1	17.7	12.9	6.1	6.0	11.4	7.7	7.9	21.4	11.2	1.7	6.7	7.7	8.2	8.8	7.2	1.0	14.3	7.5	8.8	8.4	11.1	7.0	7.2	12.1	10.4	8.9	6.6	8.2	10.7	10.9	10.0	17.6	15.9	4.7	26.3	6.7	8.1	11.9	12.3	8.5	3.7	10.4	11.0	9.2	9.1	9.7
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 265.6;intestine: 264.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 92.2;Peritubular cells: 179.0;Sertoli cells: 223.5;Smooth muscle cells: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 100.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		800000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	65.5	17.0	4.8	22.7	5.1	1.0	52.8	4.6	6.9	119.0	4.4	264.4	14.5	265.6	12.4	38.2	143.2	14.4	48.5	4.6	4.7	26.6	9.7	54.7	4.8	5.6	4.6	78.6	8.2	8.6	8.2	19.7	5.0	87.6	23.9	0.7	21.0	80.8	13.1	28.5	61.7	106.1	4.7	33.0	78.5	10.2	5.1	1.4	26.8	10.5	4.9	171.1	73.6	4.4	13.3	16.6	25.9	0.0	25.4	46.1	0.3	70.8	64.8	43.6	30.1	6.6	4.5	0.0	65.1	62.3	29.1	20.6	6.0	13.3	56.4	0.1	0.3	17.5	29.1	3.7	67.4	0.0	19.8	31.1	18.7	27.5	16.3	100.0	29.2	0.0	1.5	0.0	51.9	0.1	0.0	1.6	1.4	1.4	16.2	0.0	30.9	0.1	12.5	6.6	0.0	19.0	27.5	0.2	14.1	20.9	0.1	1.7	82.4	79.8	19.2	21.4	31.8	0.1	0.1	0.2	34.9	0.8	49.6	9.5	0.0	0.1	0.2	0.0	0.3	0.9	0.9	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.3	1.6	1.3	4.8	5.1	4.6	6.9	4.6	4.7	5.6	4.6	5.0	4.7	5.1	4.4	76.9	6.4	4.8	0.0	0.4	12.6	23.9	34.8	14.8	0.4	4.1	71.5	13.4	5.7	3.4	7.3	0.0	1.2	1.5	1.8	7.9	33.3	1.2	3.6	76.2	48.8	0.0	11.0	0.1	22.5	1.2	64.4	4.6	2.9	6.3	35.3	29.6	0.3	14.6	0.0	0.1	4.7	0.0	0.3	15.4	3.3	92.2	9.3	40.9	2.8	4.2	7.0	0.0	3.5	0.1	28.4	2.2	179.0	1.4	20.1	13.3	19.7	1.1	1.4	223.5	17.4	176.0	1.5	3.6	1.9	11.2	1.8	2.6	20.3	5.3	4.6
TGFBR3	"betaglycan, BGCAN"	ENSG00000069702	"Transforming growth factor beta receptor 3"	Q03167	1	91680343-91906335	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.9;Hepatic stellate cells: 322.7;Leydig cells: 146.3;Skeletal myocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 35.2"	"Group enriched"	"Detected in many"	18	"NK-cells: 16.6;T-cells: 35.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 227.2;ASC TERT1: 108.4;RT4: 57.1;U-2197: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008257, CAB018971"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA		50000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB018971: , HPA008257: AB_1080258"	"unprognostic (7.57e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (9.39e-3)"	"prognostic favorable (4.84e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.08e-2)"	66.3	35.2	6.9	9.2	6.8	5.0	62.1	7.6	8.0	56.6	20.4	28.8	8.2	33.9	24.2	28.5	36.6	20.0	16.2	7.6	6.7	28.2	16.6	27.3	7.2	6.0	10.1	81.5	12.3	5.9	7.1	58.5	7.8	16.4	12.5	1.5	35.0	32.7	12.8	25.0	19.7	27.4	7.9	40.0	18.1	11.0	8.0	7.7	13.2	29.4	4.2	47.3	28.6	7.8	9.9	9.4	14.1	2.4	227.2	108.4	44.6	7.1	35.3	8.1	9.9	4.4	1.4	0.1	1.7	13.0	6.4	1.4	3.6	1.0	6.2	34.1	7.6	0.0	11.1	41.2	5.0	0.3	0.1	26.3	4.7	17.8	4.0	1.3	4.2	0.0	23.6	0.7	2.4	0.2	0.1	0.1	5.9	4.6	3.2	0.5	4.8	2.1	3.2	57.1	0.7	0.0	3.4	0.2	20.4	5.8	1.2	3.7	12.7	13.5	3.5	78.0	1.7	34.8	3.3	0.0	2.8	1.9	1.7	1.2	0.0	0.0	35.2	0.2	19.4	0.0	8.7	19.2	0.0	0.0	2.7	12.7	0.6	16.6	1.4	1.2	4.5	8.1	6.9	6.8	7.6	8.0	7.6	6.7	6.0	10.1	7.8	7.9	8.0	7.8	77.6	9.6	9.7	58.8	3.1	37.6	10.0	2.3	44.3	0.3	38.2	60.1	20.7	30.0	4.2	31.3	2.1	27.5	66.7	0.5	3.9	2.0	54.3	11.2	32.8	90.5	24.0	10.7	7.7	5.1	12.0	143.9	5.1	8.1	2.5	20.5	322.7	21.0	11.8	0.0	34.0	1.9	8.2	23.2	29.4	29.8	146.3	5.2	35.6	82.4	0.7	1.2	62.8	7.5	0.9	3.3	0.4	74.4	21.3	8.5	1.4	20.9	8.3	0.2	13.1	187.2	36.5	0.8	2.2	17.2	34.1	58.0	36.9	92.2	3.7	8.0
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127385-38166578	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 432.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 204.5;Cytotrophoblasts: 311.1;Ductal cells: 226.7;Endometrial stromal cells: 459.1;Hepatic stellate cells: 408.0;Hepatocytes: 205.7;Pancreatic endocrine cells: 326.5;Syncytiotrophoblasts: 374.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 1546.7;EFO-21: 505.5;hTERT-RPE1: 994.3;HUVEC TERT2: 695.3;TIME: 924.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	Yes	No		1700000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	105.9	45.1	23.0	68.4	22.3	3.2	30.3	22.9	29.5	432.0	53.0	30.6	29.8	266.3	28.3	37.3	217.7	127.7	394.9	21.4	23.0	76.7	244.1	288.5	18.0	25.4	22.5	40.6	25.6	19.3	95.9	234.3	26.0	88.7	20.8	2.1	9.8	56.6	63.9	4.0	63.7	159.0	24.4	32.7	62.3	3.9	30.6	15.4	36.3	33.4	10.3	154.2	87.8	24.8	65.0	47.5	0.2	1.8	47.3	5.1	24.0	95.5	45.2	0.7	1.8	78.4	1546.7	0.1	505.5	1.0	105.4	1.7	0.1	221.7	3.4	0.7	0.2	10.3	2.6	35.0	191.9	0.0	0.5	5.2	0.4	40.2	0.3	994.3	695.3	0.0	21.4	0.1	16.0	0.3	0.0	0.6	0.8	0.9	4.6	0.0	0.1	0.3	69.0	0.0	0.0	1.3	224.4	0.2	7.6	31.6	2.2	0.6	924.2	1.6	57.6	7.8	46.3	0.0	0.6	0.8	60.7	0.1	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	22.3	22.9	29.5	21.4	23.0	25.4	22.5	26.0	24.4	30.6	24.8	58.0	9.6	18.3	0.0	7.4	0.5	10.4	41.0	0.6	0.0	8.5	8.8	204.5	31.5	55.3	14.7	2.1	311.1	0.1	11.7	3.9	226.7	3.2	16.7	459.1	183.8	0.0	74.5	0.1	145.7	38.6	37.7	0.5	13.1	2.5	2.8	408.0	205.7	54.4	0.0	0.1	1.8	6.1	23.7	2.1	5.0	1.2	35.5	0.0	28.1	6.5	0.4	0.0	0.0	0.3	326.5	1.1	6.0	0.0	68.6	63.0	27.6	23.6	0.5	0.0	5.2	49.1	0.4	4.0	0.9	0.0	374.2	3.9	2.1	3.3	26.4
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171815	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"adrenal gland: 196.6;brain: 270.9"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 9.0;Extravillous trophoblasts: 12.4;Leydig cells: 3.4;Syncytiotrophoblasts: 2.2"	"Cancer enriched"	"Detected in some"	5	"urothelial cancer: 4.0"	"Group enriched"	"Detected in many"	5	"midbrain: 192.4;pons: 270.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"PC-3: 60.8;SK-BR-3: 21.0"	"Region enhanced"	"Detected in many"		"olfactory bulb: 178.8"	"Region enriched"	"Detected in many"	20	"midbrain: 594.4"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374"	"unprognostic (1.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.75e-4)"	"unprognostic (8.82e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.18e-2)"	3.3	196.6	1.9	0.1	3.0	0.0	0.0	0.2	1.3	0.6	0.2	0.1	0.0	0.5	0.1	0.7	0.2	0.4	0.1	1.3	46.5	0.4	0.4	0.0	0.0	13.9	192.4	0.7	0.2	0.0	1.7	0.1	270.9	0.3	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.8	0.2	0.3	0.5	14.6	0.0	0.0	0.0	0.0	1.4	1.5	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	60.8	0.0	0.0	0.0	0.1	0.1	1.1	0.2	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.0	0.2	1.3	1.3	46.5	13.9	192.4	270.9	0.8	14.6	1.6	0.3	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.2	1.8	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.4	9.0	0.4	0.0	0.0	0.1	0.0	12.4	0.4	0.0	0.3	0.0	0.0	1.1	0.2	0.5	0.0	0.3	0.1	0.0	0.0	0.3	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	2.2	0.1	0.3	0.2	0.2
THADA	"ARMC13, FLJ21877, GITA, KIAA1767"	ENSG00000115970	"THADA armadillo repeat containing"	Q6YHU6	2	43230851-43596038	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.7;Excitatory neurons: 77.5;Inhibitory neurons: 77.2;Microglial cells: 89.9;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 111.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 17.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA035191, HPA035192"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA035191: AB_10670290, HPA035192: AB_2674512"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (8.27e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.14e-1)"	11.0	9.3	7.0	7.5	8.3	8.9	11.1	7.1	7.3	12.1	14.8	9.1	4.2	11.0	10.2	9.9	11.1	6.1	9.0	6.9	7.3	9.6	17.3	9.8	14.3	8.3	8.2	11.5	11.5	12.4	11.1	6.1	7.9	13.0	6.1	8.3	10.2	6.9	10.1	13.8	9.4	7.3	7.3	11.7	9.1	10.2	8.1	10.2	13.5	6.1	9.8	10.5	11.0	9.3	19.2	22.6	10.0	0.3	26.6	22.8	14.4	12.6	10.3	11.6	9.8	13.3	11.3	17.5	21.0	15.0	15.8	17.4	15.7	21.6	19.9	14.6	15.5	12.5	8.6	17.7	9.3	19.5	9.7	15.0	19.1	24.5	31.8	12.2	16.1	6.5	22.6	9.1	14.2	24.2	19.4	21.7	20.2	27.4	12.7	8.9	18.1	13.3	18.4	16.9	13.2	20.5	11.9	11.5	11.3	11.6	11.8	10.1	13.6	19.0	14.0	14.7	22.9	23.0	15.2	19.6	15.4	19.1	15.7	17.2	2.6	1.2	3.4	4.0	3.7	3.6	3.7	4.2	4.2	3.6	3.4	4.0	1.8	5.4	2.9	3.2	4.5	2.2	7.0	8.3	7.1	7.3	6.9	7.3	8.3	8.2	7.9	7.3	8.1	9.3	11.7	19.2	14.4	74.7	15.4	8.5	16.5	8.9	23.3	11.9	11.8	11.0	8.5	18.6	12.0	14.7	16.7	7.9	9.6	5.1	1.9	8.8	20.9	19.5	17.0	10.3	7.3	12.4	77.5	9.6	5.4	12.5	15.3	11.2	6.3	19.7	11.4	17.8	9.7	3.3	77.2	5.4	4.1	9.7	7.4	11.1	9.9	12.9	3.6	89.9	7.9	5.3	10.3	73.9	111.0	6.4	7.2	8.6	11.5	11.3	2.5	7.4	22.6	24.9	0.0	16.2	9.1	20.7	14.1	11.0	4.4	4.8	16.5	20.3	6.3	7.4
THAP10		ENSG00000129028	"THAP domain containing 10"	Q9P2Z0	15	70881342-70892433	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.5;Early spermatids: 12.6;Spermatocytes: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"U-2197: 40.4"									"HPA041416, HPA073220"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041416: AB_10795592, HPA073220: "	"unprognostic (1.00e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.15e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.25e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.44e-3)"	1.7	2.2	4.6	1.3	5.2	0.1	1.9	6.1	7.3	2.4	2.4	2.2	2.3	2.1	1.8	1.9	3.2	1.5	4.7	3.9	5.2	3.0	2.1	1.8	1.0	5.1	5.4	3.7	1.9	5.1	1.7	1.8	5.2	3.0	1.9	10.8	1.8	3.1	2.3	1.3	1.2	2.0	5.0	0.9	2.9	3.4	6.3	0.9	3.6	2.3	0.9	2.6	1.4	5.9	7.3	12.6	7.7	9.8	4.1	5.0	0.1	13.5	6.1	11.4	13.5	2.0	9.5	0.0	8.2	3.8	14.3	11.3	16.2	3.7	10.2	0.0	8.3	2.6	6.2	0.9	2.0	0.7	5.2	1.6	5.1	6.5	6.2	7.9	5.8	0.0	0.9	0.0	8.3	5.7	0.0	2.9	11.2	5.2	5.3	0.0	9.9	0.3	5.1	5.9	8.6	8.9	9.3	3.9	6.5	7.5	4.6	6.3	4.3	7.9	5.6	40.4	9.6	3.4	4.3	0.0	5.0	0.9	11.6	0.0	0.3	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.4	4.2	0.0	0.2	0.1	4.6	5.2	6.1	7.3	3.9	5.2	5.1	5.4	5.2	5.0	6.3	5.9	3.5	0.0	0.5	0.0	0.5	1.8	4.1	2.4	1.2	17.5	2.0	2.0	6.1	1.5	2.0	11.0	0.0	0.2	0.0	2.5	9.8	3.0	12.6	5.5	1.9	2.7	3.0	0.4	3.0	1.1	0.3	2.4	1.1	1.1	0.0	2.1	1.4	1.8	1.3	1.7	4.0	1.5	8.2	0.6	1.0	7.8	2.5	0.7	0.0	0.0	0.1	5.2	0.0	1.0	4.7	0.8	5.3	4.9	1.2	2.2	0.6	6.8	5.4	4.6	0.0	1.5	2.9	19.3	2.7	2.6	1.4	0.1	0.2	1.8	2.9	4.2
THAP11	"CTG-B43a, CTG-B45d, HRIHFB2206, RONIN"	ENSG00000168286	"THAP domain containing 11"	Q96EK4	16	67842320-67844195	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041434, HPA042189, HPA072537"	Supported		Supported	Nucleoplasm,Cytosol		NA	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: "	"unprognostic (1.43e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.87e-2)"	16.6	14.4	20.5	14.9	21.1	10.2	16.3	21.4	21.3	21.9	19.2	26.7	12.3	24.5	13.0	19.5	22.4	10.1	25.1	20.7	21.7	16.1	14.9	15.4	20.8	22.1	20.8	20.9	19.3	16.9	16.4	12.3	20.6	16.1	11.1	10.9	15.7	19.6	48.1	26.1	22.1	17.2	22.5	24.8	20.8	12.6	21.1	23.5	14.9	26.4	19.0	23.9	18.4	23.1	31.3	40.2	27.4	25.9	37.5	25.7	28.7	15.5	27.0	37.1	31.9	51.9	23.6	68.0	31.7	15.9	22.3	35.6	48.6	29.0	21.1	25.4	55.3	27.1	22.5	64.1	34.2	34.9	29.4	23.6	28.4	25.6	22.4	26.8	27.7	45.9	39.5	15.4	22.9	49.1	37.7	62.6	55.1	36.9	34.7	73.6	32.7	61.4	19.0	20.2	38.2	43.1	45.4	16.4	33.2	19.6	40.1	35.2	22.3	23.4	28.4	21.3	19.2	60.9	65.9	67.5	18.3	38.2	25.8	7.6	13.6	14.7	26.3	18.4	20.7	13.8	23.6	24.2	14.3	18.8	29.9	24.0	4.1	21.3	17.5	11.3	31.5	17.9	20.5	21.1	21.4	21.3	20.7	21.7	22.1	20.8	20.6	22.5	21.1	23.1	20.4	22.4	13.1	3.3	24.4	29.2	25.0	6.6	22.8	25.6	27.4	23.6	15.1	12.8	5.3	11.0	4.2	19.6	32.8	12.5	52.8	7.6	1.2	18.6	18.0	21.3	13.2	23.8	4.6	9.5	25.9	17.4	7.1	14.3	7.6	20.3	24.3	14.0	22.4	8.4	4.6	16.2	6.1	19.6	20.0	2.2	23.6	19.1	10.6	4.7	24.5	29.8	43.3	7.1	6.1	6.5	5.9	31.2	18.9	25.0	13.5	19.8	6.1	16.9	19.7	24.2	22.2	16.1	27.4	20.9	39.1	13.5	32.5	28.6	16.5	20.2
THAP12	"DAP4, P52rIPK, PRKRIR, THAP0"	ENSG00000137492	"THAP domain containing 12"	O43422	11	76349956-76381132	"Plasma proteins, Predicted membrane proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 42.4;dendritic cells: 31.6;Endometrial stromal cells: 34.7;Theca cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 241.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008758, HPA077077"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA008758: AB_1855714, HPA077077: "	"unprognostic (2.79e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-2)"	25.7	21.9	13.8	20.1	14.2	33.4	29.7	13.6	16.3	21.4	13.2	24.1	19.9	24.2	21.1	11.2	19.0	16.7	17.2	14.4	13.8	19.6	19.5	21.8	33.0	13.1	14.2	20.3	41.6	14.2	9.5	26.2	13.1	17.1	25.7	37.2	15.6	19.0	31.7	14.5	20.0	22.0	13.9	26.0	21.5	18.1	14.2	30.6	22.1	32.9	28.7	20.4	15.0	13.6	37.7	29.3	54.6	31.1	36.4	51.5	33.4	38.0	38.9	46.4	40.8	58.9	38.9	100.8	57.1	36.2	40.7	36.5	67.4	44.6	73.9	78.3	21.5	72.2	20.2	27.4	40.2	92.3	34.9	37.1	57.8	41.3	76.9	28.1	40.7	70.5	85.3	55.3	42.0	40.4	81.4	51.9	22.7	98.5	31.8	60.3	124.7	105.0	27.1	38.8	53.1	35.6	36.7	40.1	20.5	36.5	40.6	35.8	36.7	55.4	91.7	114.2	33.9	49.9	56.6	241.7	13.3	50.8	30.6	0.7	1.5	1.7	4.5	1.6	5.2	3.3	4.7	5.0	2.1	3.6	3.4	4.4	0.5	5.6	1.5	0.9	4.7	1.7	13.8	14.2	13.6	16.3	14.4	13.8	13.1	14.2	13.1	13.9	14.2	13.6	42.4	25.6	25.3	0.0	13.6	0.0	0.0	0.0	0.0	0.0	29.6	24.0	0.0	0.0	6.2	11.0	0.0	14.2	31.6	0.0	13.7	10.9	0.0	13.6	34.7	9.8	0.0	0.0	0.0	26.4	21.5	11.3	0.0	19.3	7.6	24.5	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	8.3	0.0	0.0	0.0	0.0	14.1	0.0	0.0	7.6	0.0	0.0	16.3	5.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	16.3	13.4	34.4	0.0	0.0
THBD	CD141	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049672	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 254.3;Endothelial cells: 200.6;Langerhans cells: 138.1;Leydig cells: 130.8;Macrophages: 130.9;Peritubular cells: 259.2;Squamous epithelial cells: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 24.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.8;granulocytes: 24.6;monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;CAPAN-2: 39.2;EFO-21: 33.5;HaCaT: 33.1;hTCEpi: 42.6;OE19: 29.8;THP-1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA	5550000	1300000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.96e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.81e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.58e-3)"	"unprognostic (9.71e-2)"	65.4	11.4	2.0	19.6	1.8	15.5	25.5	1.6	3.2	16.7	3.4	16.5	5.5	12.6	3.1	36.8	27.5	26.5	31.0	2.4	3.0	19.7	9.7	56.7	14.5	4.1	2.7	6.9	13.2	9.9	20.4	28.5	2.8	8.0	5.9	0.2	10.8	4.6	40.7	71.4	20.0	15.6	3.0	43.6	30.8	7.6	8.5	5.1	35.5	17.5	8.0	20.8	21.0	2.4	11.5	9.9	0.3	0.0	24.3	1.4	0.2	0.2	0.0	0.0	0.0	0.0	39.2	0.0	33.5	3.4	1.7	33.1	0.0	1.8	0.0	0.0	0.1	0.1	1.0	0.0	4.7	0.0	0.2	1.1	42.6	0.7	2.8	23.0	11.0	0.0	4.2	0.0	0.9	0.8	0.0	4.2	0.1	29.8	1.6	0.0	0.0	4.9	0.2	16.2	0.7	0.0	9.4	1.2	17.4	2.9	0.0	24.8	21.7	0.1	0.6	3.2	0.0	0.0	0.0	0.0	2.0	5.8	0.8	0.0	4.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	24.6	2.0	8.7	10.8	0.0	2.0	2.0	1.8	1.6	3.2	2.4	3.0	4.1	2.7	2.8	3.0	8.5	2.4	254.3	22.4	21.4	0.0	2.0	34.3	10.4	9.5	23.3	0.1	3.9	5.3	16.8	1.5	21.3	0.0	0.0	3.2	16.9	0.0	0.0	1.8	0.9	1.9	1.8	200.6	0.0	2.7	0.3	0.2	37.1	46.1	2.6	7.2	7.6	0.2	65.3	0.8	14.9	0.0	0.7	0.4	4.1	32.4	138.1	4.9	130.8	130.9	16.0	1.0	8.1	0.0	0.0	0.0	0.0	9.0	0.0	259.2	2.3	4.5	0.0	0.3	2.5	0.0	6.6	51.4	39.0	0.2	1.0	237.3	98.6	42.4	3.2	2.8	0.1	58.2
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 86.8;Endometrial stromal cells: 71.1;Fibroblasts: 127.7;Langerhans cells: 69.8;Melanocytes: 56.9;Oligodendrocyte precursor cells: 40.7;Oligodendrocytes: 55.8;Smooth muscle cells: 33.7;Suprabasal keratinocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 250.2;ASC TERT1: 200.3;BJ hTERT+: 88.6;BJ hTERT+ SV40 Large T+: 96.3;BJ hTERT+ SV40 Large T+ RasG12V: 117.8;HSkMC: 113.2;hTEC/SVTERT24-B: 127.2;U-2197: 107.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		21000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	52.9	7.9	5.5	14.8	15.4	0.0	36.2	10.9	7.7	63.1	0.2	20.4	2.5	50.0	0.7	12.0	34.7	50.4	44.2	6.5	13.1	8.3	8.2	19.8	3.3	17.1	18.2	33.2	5.6	1.7	9.5	2.2	21.4	9.7	2.4	0.1	8.2	2.5	3.4	41.1	9.2	21.3	11.3	3.3	5.4	2.3	15.0	0.6	17.0	1.8	1.2	29.1	30.8	19.3	0.2	0.0	2.5	1.1	250.2	200.3	0.0	76.8	88.6	96.3	117.8	0.4	0.0	0.1	0.1	76.1	0.2	0.1	2.4	3.2	22.5	0.0	0.0	0.0	0.0	0.0	73.1	0.3	0.0	113.2	0.0	127.2	0.0	0.2	0.0	0.0	0.0	0.1	3.7	0.0	0.1	1.7	16.3	0.0	0.6	0.0	0.1	1.1	0.0	0.4	0.3	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.0	46.1	0.4	107.6	9.3	0.1	0.7	0.0	30.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	15.4	10.9	7.7	6.5	13.1	17.1	18.2	21.4	11.3	15.0	19.3	3.5	6.4	0.0	6.8	0.0	86.8	1.6	0.1	1.8	0.4	2.2	1.8	5.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.2	3.1	71.1	4.6	0.0	0.0	1.2	0.0	0.0	127.7	1.1	1.4	0.0	0.0	15.4	0.0	0.3	0.0	1.7	0.0	0.0	0.0	69.8	0.3	8.1	1.2	56.9	6.5	0.0	0.2	0.0	40.7	55.8	0.5	0.0	16.1	0.0	1.9	0.0	4.4	0.0	0.2	0.0	1.0	33.7	0.0	0.4	1.2	42.3	0.1	2.1	5.5	0.0	0.9
THEM6	"C8orf55, DSCD75"	ENSG00000130193	"Thioesterase superfamily member 6"	Q8WUY1	8	142727223-142736927	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 82.4;RT4: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023255	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"		"HPA023255: AB_1845782"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.76e-2)"	"prognostic favorable (6.66e-7)"	"unprognostic (7.02e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (4.49e-4)"	14.3	17.2	15.8	4.4	13.9	5.3	15.6	14.4	18.3	9.6	12.0	13.3	11.5	6.9	3.5	21.0	9.4	7.3	16.6	16.1	15.4	21.6	47.0	10.6	6.5	20.7	17.2	4.4	23.1	15.7	12.5	8.3	16.7	12.5	5.1	1.4	16.3	10.3	12.4	16.6	11.6	3.5	15.0	11.0	15.6	3.7	15.9	6.8	14.2	7.2	4.1	17.2	11.5	14.2	28.5	23.1	3.5	23.9	10.9	3.8	16.6	14.3	11.8	21.5	14.9	14.2	41.5	11.9	31.8	5.4	8.0	64.4	10.2	31.0	3.5	9.9	28.2	9.1	12.3	28.9	11.9	5.3	9.2	5.5	10.9	4.2	6.0	4.3	18.4	16.6	4.3	5.9	3.7	82.4	21.7	1.3	5.4	53.0	74.5	24.9	2.4	27.4	25.9	114.0	53.1	20.8	21.9	64.7	18.6	3.2	31.9	4.3	10.7	9.2	6.7	26.8	2.5	3.8	5.6	5.2	9.5	25.7	11.6	7.2	4.9	2.6	10.9	9.2	16.6	5.1	11.6	14.1	4.7	6.7	13.6	12.9	0.7	11.1	9.0	3.6	11.6	9.1	15.8	13.9	14.4	18.3	16.1	15.4	20.7	17.2	16.7	15.0	15.9	14.2	35.4	9.6	5.8	6.2	6.7	3.6	7.5	5.7	2.8	10.4	24.7	25.3	7.4	11.5	7.8	18.4	6.2	18.3	11.5	16.6	5.9	13.7	3.3	5.5	3.0	14.6	31.8	11.6	11.3	11.6	10.1	4.8	7.7	9.0	0.0	6.6	19.2	20.8	11.4	16.8	7.8	13.5	6.1	3.1	1.4	15.7	2.8	3.9	5.4	2.8	2.3	13.5	16.5	11.6	7.3	9.4	9.0	4.1	3.7	10.7	29.0	16.2	2.4	11.3	0.0	6.1	4.3	2.7	5.7	18.4	7.7	3.4	10.3	8.2	22.4	25.1
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 32.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 47.1;Microglial cells: 15.0;T-cells: 59.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	22	"gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3"	"Lineage enriched"	"Detected in single"	88	"T-cells: 58.3"	"Group enriched"	"Detected in some"	4	"HDLM-2: 32.6;JURKAT: 54.1;MOLT-4: 51.6;RPMI-8226: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	0.4	0.5	0.5	3.3	3.2	1.7	0.6	0.1	2.3	0.4	0.3	0.7	1.6	0.2	0.4	0.6	0.2	1.4	0.1	0.9	0.1	0.2	0.7	1.4	7.5	0.6	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.4	0.9	0.0	0.9	0.1	0.1	0.2	2.3	0.3	0.3	3.2	1.5	0.1	0.3	32.9	0.4	0.1	4.0	1.1	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	26.7	0.1	34.0	0.1	33.5	48.9	0.2	0.2	30.0	58.3	0.6	0.1	0.2	0.2	1.7	20.3	0.5	3.2	0.1	2.3	0.9	0.1	0.6	0.3	0.4	0.3	0.3	1.9	0.5	0.0	3.0	2.9	2.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.9	0.1	0.2	0.4	0.0	1.7	47.1	0.0	0.0	0.7	5.1	0.1	1.3	0.0	1.1	0.1	0.1	0.0	0.9	0.0	0.0	0.8	0.8	0.2	0.0	1.5	7.2	15.0	1.4	0.0	0.0	0.0	9.7	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.1	1.4	0.0	59.9	0.0	0.0	0.1
THNSL1	"FLJ22002, TSH1"	ENSG00000185875	"Threonine synthase like 1"	Q8IYQ7	10	25016612-25026664	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6;Early spermatids: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037585	Uncertain		Approved	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"	Mitochondria	"HPA037585: AB_10696940"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.11e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.06e-2)"	1.7	6.0	4.0	1.8	4.2	0.6	3.6	3.2	4.5	4.1	2.9	2.7	2.6	3.6	4.9	1.9	5.6	2.0	3.7	4.1	4.2	9.7	21.4	1.5	2.8	3.9	3.5	7.3	3.0	5.3	3.7	1.7	4.2	2.9	3.0	4.1	3.4	2.6	4.6	2.2	2.4	2.2	3.9	2.2	2.7	5.9	4.1	3.3	8.3	5.9	2.7	1.8	1.5	4.3	7.1	8.1	5.0	10.0	5.0	6.2	1.3	3.4	1.3	3.7	2.4	5.3	8.8	32.7	10.6	1.6	4.0	3.8	7.2	6.4	3.8	4.5	3.9	12.0	2.2	3.4	5.6	0.0	2.0	3.9	11.6	2.7	5.7	6.4	2.5	13.3	10.4	3.8	8.0	11.1	6.6	2.3	9.2	12.3	3.9	3.5	1.3	14.2	10.6	1.6	8.3	4.7	6.8	6.0	12.3	2.6	6.0	0.6	2.5	4.4	3.9	5.9	3.2	2.7	3.8	0.0	7.3	6.6	3.5	0.1	0.4	0.0	2.9	0.5	5.1	5.0	4.1	3.8	2.2	3.8	9.5	6.3	0.6	10.8	0.7	3.7	2.0	3.1	4.0	4.2	3.2	4.5	4.1	4.2	3.9	3.5	4.2	3.9	4.1	4.3	1.3	3.2	3.2	2.6	3.4	0.6	3.1	5.6	2.8	4.2	2.1	2.9	8.5	1.5	6.1	3.7	0.0	6.1	0.8	0.6	15.6	3.3	29.9	5.1	3.9	1.8	1.2	2.5	4.0	1.3	3.9	2.7	1.5	2.5	0.0	7.8	2.2	9.8	2.1	3.3	5.1	1.8	2.0	0.9	0.8	5.5	2.1	0.6	0.0	4.7	1.5	6.8	0.0	2.0	5.4	1.1	1.0	1.5	0.9	1.8	2.3	11.0	8.7	4.5	0.0	4.3	1.9	8.2	13.6	2.6	1.0	1.0	2.8	11.8	3.5	1.1
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677718	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.9;retina: 19.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 25.0;Horizontal cells: 90.9;Inhibitory neurons: 153.4;Rod photoreceptor cells: 32.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Daudi: 11.0;SCLC-21H: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051416: AB_2681477, HPA056745: AB_2683224"	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	1.9	0.0	0.8	0.0	1.2	0.0	0.7	0.6	1.2	0.2	0.1	0.1	0.0	0.2	4.1	0.3	0.9	0.2	0.5	1.2	2.3	0.9	0.1	0.1	0.0	8.2	3.3	0.0	0.0	0.3	0.6	0.2	8.9	0.7	0.0	19.7	0.4	0.2	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	1.6	0.8	0.7	0.1	0.0	0.2	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.2	1.2	2.3	8.2	3.3	8.9	0.6	1.6	1.6	1.1	0.0	0.0	2.6	0.0	0.1	0.7	0.0	13.6	1.6	0.1	0.9	0.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	1.9	0.0	3.7	0.5	0.2	0.8	0.0	0.0	9.5	0.0	0.0	0.2	0.0	1.4	0.0	1.7	1.8	0.0	0.0	90.9	153.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	8.4	0.0	1.8	0.0	1.5	7.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	32.2	6.6	0.3	3.3	0.5	0.5	1.4	0.0	0.0	0.0	0.4	0.0	0.1
THUMPD1	"FLJ20274, Tan1"	ENSG00000066654	"THUMP domain containing 1"	Q9NXG2	16	20702816-20742084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027851	Approved		Approved	Cytosol		NA	NA		9300000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA027851: AB_10670036"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.48e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.45e-1)"	"prognostic favorable (8.52e-8)"	"unprognostic (1.98e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-2)"	16.0	16.4	10.9	14.4	11.4	21.2	38.3	12.4	14.2	23.0	12.3	23.0	13.3	25.3	28.3	15.2	21.8	15.6	11.4	11.3	12.8	22.8	17.0	16.6	21.0	10.6	10.9	23.5	18.9	30.5	13.8	17.6	10.4	33.4	18.5	20.6	19.6	22.8	17.1	15.7	17.6	24.4	11.2	18.3	23.3	16.4	12.9	20.7	20.2	20.3	20.7	20.0	19.2	12.0	22.4	22.8	41.9	23.7	35.7	31.3	25.2	22.0	22.8	20.7	20.4	17.6	23.2	53.9	42.0	25.0	19.5	21.3	27.7	29.6	32.5	32.0	16.0	49.0	20.5	43.3	23.6	79.2	100.2	25.5	40.0	22.5	25.3	23.8	24.1	24.0	95.7	41.5	23.9	25.3	38.7	32.3	35.3	20.5	14.2	51.6	38.0	43.8	24.4	17.9	31.8	21.7	18.2	32.1	23.4	25.5	22.4	28.4	23.1	28.9	17.1	19.8	21.9	42.6	43.2	38.5	21.9	22.7	24.6	13.3	6.4	19.3	15.3	7.4	19.5	10.7	15.6	15.0	6.4	9.7	19.7	17.7	2.9	14.3	8.3	5.5	12.4	9.4	10.9	11.4	12.4	14.2	11.3	12.8	10.6	10.9	10.4	11.2	12.9	12.0	55.6	41.7	48.5	16.3	66.6	48.4	37.5	27.1	57.5	37.0	62.7	48.8	30.3	42.9	38.2	31.3	20.9	61.0	81.6	35.6	39.2	29.8	5.9	66.2	64.3	47.9	36.5	23.5	25.6	34.4	35.3	45.5	26.5	97.0	72.1	42.7	42.1	45.2	30.0	35.3	24.7	38.3	26.4	34.8	35.2	8.9	41.0	34.3	33.8	20.6	45.5	45.1	55.6	21.1	32.6	27.5	33.8	67.7	41.3	52.0	32.2	49.7	39.8	37.0	46.0	50.9	50.7	44.1	66.3	46.6	55.4	73.1	72.5	25.5	44.9	35.6
THYN1	THY28	ENSG00000151500	"Thymocyte nuclear protein 1"	Q9P016	11	134248279-134253370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038732, HPA038733"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA038732: AB_10697397, HPA038733: AB_2676183"	"unprognostic (5.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.48e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.01e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.61e-2)"	42.3	40.5	74.2	22.0	75.4	43.3	45.1	74.4	104.9	39.8	68.5	53.9	30.2	43.1	75.8	28.1	47.6	31.1	51.7	75.9	76.2	40.1	57.5	28.3	40.5	72.2	71.3	62.9	32.8	27.9	50.8	22.2	73.2	50.1	44.9	41.3	29.6	54.2	32.3	28.1	36.3	42.3	72.5	36.6	39.4	42.6	74.9	77.1	52.1	38.0	44.5	44.3	33.1	76.6	32.0	19.5	69.8	56.0	65.9	74.7	41.0	26.9	59.2	62.0	58.1	106.8	76.3	60.0	88.6	37.8	66.6	48.9	106.8	82.0	60.5	61.5	30.3	165.5	25.7	97.6	94.3	133.0	52.4	56.9	43.2	73.9	48.2	80.6	98.9	199.0	78.1	28.0	56.5	17.7	155.1	242.8	81.0	127.0	71.0	72.3	51.8	50.6	86.4	55.4	66.4	53.7	55.8	13.6	33.1	50.3	78.2	66.5	52.7	26.6	41.3	24.4	41.7	31.4	35.0	126.9	39.5	170.6	31.5	185.4	89.8	330.3	145.2	108.4	175.6	122.1	152.3	146.8	99.1	96.4	175.4	200.0	47.2	139.1	104.4	131.3	199.8	160.0	74.2	75.4	74.4	104.9	75.9	76.2	72.2	71.3	73.2	72.5	74.9	76.6	41.9	32.1	28.8	8.1	31.1	23.8	42.2	107.4	28.5	28.6	37.5	65.4	52.1	47.1	57.7	36.8	14.6	52.7	33.5	25.5	86.1	48.2	28.2	44.7	33.8	36.9	57.6	40.8	15.3	55.6	52.9	42.3	20.4	23.4	40.5	65.5	37.1	47.9	53.0	28.6	12.0	47.9	75.3	22.2	23.7	16.0	50.4	32.7	40.9	8.4	43.1	65.7	44.3	11.1	11.1	53.2	33.0	48.5	29.8	13.4	49.3	93.3	73.1	23.9	46.0	34.0	51.3	79.1	94.9	31.4	20.6	13.8	44.1	72.7	52.7	31.6
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 207.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 207.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	7.2	12.7	40.3	6.6	35.2	2.8	5.4	207.9	49.2	17.8	12.5	5.1	1.7	9.9	3.2	39.7	11.0	4.6	5.5	51.8	26.5	5.5	7.9	5.8	11.1	26.7	33.4	3.3	2.2	0.3	12.9	4.3	36.1	9.0	3.1	8.6	5.6	3.3	0.9	27.2	5.0	11.1	27.5	5.2	2.4	10.5	37.3	18.7	1.9	0.8	11.1	12.1	18.5	28.6	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.3	35.2	207.9	49.2	51.8	26.5	26.7	33.4	36.1	27.5	37.3	28.6	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TIFA	"MGC20791, T2BP, T6BP, TIFAA"	ENSG00000145365	"TRAF interacting protein with forkhead associated domain"	Q96CG3	4	112274537-112285904	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 86.6;Syncytiotrophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 137.4;U-698: 123.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045889	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA045889: AB_10963785"	"unprognostic (2.41e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.49e-3)"	6.4	6.3	2.0	19.9	1.8	40.6	13.7	4.3	2.1	7.7	4.3	7.0	6.7	5.6	2.1	15.6	6.8	7.5	10.7	2.3	2.4	5.2	11.3	10.2	32.2	2.3	2.1	9.3	41.3	11.5	2.1	14.2	2.5	6.7	6.9	2.8	34.8	3.7	3.8	9.3	8.8	5.3	2.1	11.7	10.3	2.1	2.3	15.4	21.1	6.4	34.6	11.6	7.7	2.3	21.9	5.5	7.9	13.4	9.5	7.7	15.9	17.0	32.0	10.6	18.1	2.8	19.1	66.3	13.5	6.8	15.5	6.3	10.9	13.0	22.1	54.1	6.4	6.6	12.4	6.2	6.4	21.2	8.8	10.4	7.0	11.4	12.3	18.0	17.0	18.1	6.8	137.4	14.3	11.0	37.3	11.5	1.6	13.4	7.0	63.7	19.9	44.7	23.6	14.7	18.1	18.6	13.7	28.2	6.6	3.4	12.2	29.9	12.7	16.7	19.8	14.2	13.6	85.3	84.8	123.8	15.7	13.8	12.6	6.8	7.2	4.0	11.1	5.2	18.1	38.2	20.4	19.4	13.2	40.4	9.0	11.6	21.4	17.4	6.8	12.3	33.9	11.3	2.0	1.8	4.3	2.1	2.3	2.4	2.3	2.1	2.5	2.1	2.3	2.3	35.7	19.2	27.4	0.0	44.8	21.3	15.7	27.8	43.9	1.4	31.6	30.9	15.4	12.8	15.7	12.9	0.0	47.9	23.4	4.4	19.6	16.5	0.1	10.0	9.6	31.8	9.0	7.6	1.4	24.4	20.9	22.3	14.8	21.0	3.8	5.4	6.4	10.7	17.8	0.0	0.6	8.4	28.5	13.0	29.7	1.4	9.0	13.1	33.8	2.8	7.1	12.5	11.3	0.5	0.1	11.4	8.0	10.9	86.6	29.2	11.0	9.5	8.8	0.6	6.6	27.2	10.5	2.5	3.8	39.2	26.0	79.4	35.9	5.7	7.0	15.1
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779730	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 22.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 107.6;Rod photoreceptor cells: 30.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.1;U-266/70: 4.5;U-266/84: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035649, HPA073768"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"HPA035649: AB_10670956, HPA073768: "	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.2	0.3	0.6	0.2	0.7	0.0	0.4	0.6	0.7	0.8	1.3	0.2	0.3	0.7	1.2	0.1	2.0	0.2	0.3	0.5	0.9	0.7	0.1	0.4	0.1	1.1	1.2	0.5	0.2	1.5	1.2	0.1	0.8	0.4	0.2	22.1	0.7	0.3	0.4	0.4	0.2	0.2	1.0	0.2	0.3	4.9	0.8	0.3	0.7	0.8	0.1	0.2	0.1	0.8	0.4	0.4	2.0	0.8	0.1	0.2	0.2	0.0	0.4	0.2	0.4	0.3	0.9	0.7	0.1	0.1	0.9	0.4	0.8	0.3	0.3	0.7	0.1	1.0	0.6	0.2	0.1	0.4	0.2	0.0	0.3	0.3	0.2	0.4	0.1	1.5	0.3	3.1	0.2	0.2	2.0	0.2	0.9	0.3	0.3	0.3	0.4	0.0	1.3	0.1	0.9	1.0	0.1	0.2	1.9	0.9	0.5	0.1	0.0	0.2	0.4	0.3	0.4	4.5	9.4	0.4	0.6	1.1	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.6	0.7	0.5	0.9	1.1	1.2	0.8	1.0	0.8	0.8	0.4	0.0	1.5	8.5	0.6	0.0	0.4	0.6	0.6	7.9	0.8	0.8	0.1	0.0	0.3	1.8	12.5	0.2	0.8	0.2	0.0	0.7	107.6	6.9	0.6	0.7	1.2	0.4	6.5	1.1	0.2	0.4	1.1	1.4	0.0	0.2	0.0	0.1	0.5	1.7	6.3	0.4	0.0	0.3	0.0	14.0	0.3	0.5	0.0	5.6	0.0	14.1	0.0	5.5	2.1	0.4	1.1	0.4	0.0	0.4	0.4	2.0	9.3	30.3	0.0	1.0	0.5	8.3	3.2	0.0	0.0	0.3	0.6	0.1	0.4	0.3
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	4.3	4.3	1.5	4.9	1.4	2.9	4.5	3.1	2.4	5.4	3.6	5.3	7.6	4.5	2.5	4.4	5.3	4.5	5.3	1.3	2.1	3.9	6.3	4.2	4.1	1.9	1.8	8.0	4.7	7.2	3.6	4.9	2.1	5.7	5.5	3.1	8.0	6.4	5.3	4.3	6.9	4.7	1.0	5.0	4.3	1.5	1.6	3.1	4.8	4.9	5.1	4.5	3.3	1.1	2.2	7.0	3.7	6.2	6.2	8.5	4.4	5.7	9.3	3.9	3.7	11.0	8.3	5.7	9.6	5.9	6.9	6.2	3.9	4.4	1.5	15.3	3.7	15.4	4.2	7.1	4.9	9.6	7.9	6.4	6.0	7.4	5.1	4.7	6.5	4.6	4.2	12.9	4.6	4.0	0.3	1.5	1.7	15.9	6.3	2.0	1.0	5.4	3.1	7.8	4.6	5.8	6.8	6.7	4.6	4.8	18.2	4.9	6.5	2.2	2.1	4.5	4.3	3.6	5.6	4.2	3.4	7.5	7.0	5.3	5.8	2.9	4.0	4.5	3.7	2.1	3.1	4.2	4.6	3.8	2.5	2.4	4.9	2.6	3.2	3.2	3.5	3.7	1.5	1.4	3.1	2.4	1.3	2.1	1.9	1.8	2.1	1.0	1.6	1.1	1.7	6.4	2.6	2.3	3.7	0.4	1.8	2.0	4.0	3.5	2.7	2.0	1.3	2.8	2.8	3.7	0.0	3.4	2.2	4.2	0.0	3.3	0.0	1.1	2.3	3.2	1.2	0.8	3.7	4.0	4.9	2.7	2.0	1.7	1.3	2.0	2.5	4.8	5.2	3.3	5.0	3.9	2.0	4.4	0.8	0.3	4.7	3.7	1.8	3.7	2.1	3.6	4.1	3.0	1.8	3.6	8.1	4.5	9.2	2.0	6.5	2.2	1.6	2.5	0.0	2.0	2.5	0.1	0.6	3.5	0.1	2.6	4.2	2.3	2.4	1.5
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333220-61353295	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Lyase, Multifunctional enzyme, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 192.8;liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 115.9;Proximal enterocytes: 415.8;Proximal tubular cells: 91.2;Theca cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 133.2;RPMI-8226: 140.7;T-47d: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Nucleoplasm	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	9.5	82.8	5.9	9.4	6.0	16.6	12.1	5.8	6.6	9.5	5.7	12.5	192.8	11.0	7.6	16.3	15.4	9.2	7.6	6.4	5.1	45.5	115.8	9.0	13.6	6.8	6.3	10.3	24.0	6.7	14.0	6.1	6.2	12.2	5.7	5.6	16.2	8.9	10.9	17.8	138.0	5.2	6.5	13.0	16.6	28.2	6.0	7.5	14.7	5.6	8.0	10.9	11.0	7.2	19.9	51.3	8.5	30.0	10.7	11.4	24.2	11.7	12.4	10.4	6.9	23.1	47.1	25.0	39.3	8.5	11.0	27.7	16.3	21.8	3.5	42.5	21.7	15.7	26.2	133.2	17.9	13.4	25.0	18.2	14.5	9.9	35.4	9.4	10.7	17.1	27.2	46.7	7.9	91.8	11.9	11.9	23.8	19.2	33.8	20.0	13.8	140.7	17.1	35.0	33.0	29.6	21.0	36.4	19.3	6.0	135.4	9.2	13.0	21.0	21.6	16.6	7.0	85.8	76.5	22.9	21.3	12.3	19.7	2.6	13.4	6.5	7.1	7.8	9.6	10.3	8.3	7.1	21.2	9.7	5.8	6.2	1.2	6.5	6.5	10.1	12.9	9.7	5.9	6.0	5.8	6.6	6.4	5.1	6.8	6.3	6.2	6.5	6.0	7.2	8.0	0.0	14.5	0.0	9.5	0.0	13.8	0.0	11.4	12.8	19.1	16.0	3.8	11.5	6.8	14.7	14.6	31.2	8.3	4.8	29.4	19.6	16.2	16.4	6.6	8.0	13.3	7.8	0.0	14.6	6.2	11.2	20.4	12.1	7.6	10.8	7.5	115.9	17.1	8.4	0.0	31.6	0.0	17.2	0.0	12.0	15.2	8.2	0.0	0.0	21.2	10.0	9.2	0.0	0.0	11.2	32.9	22.6	11.0	11.1	415.8	91.2	10.9	17.8	6.6	4.7	3.6	37.5	14.1	12.6	0.0	15.2	6.5	93.6	47.6	13.4
TLCD5	"MGC17839, TMEM136"	ENSG00000181264	"TLC domain containing 5"	Q6ZRR5	11	120325296-120333686	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 51.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 28.3;Cytotrophoblasts: 10.0;Extravillous trophoblasts: 4.2;Fibroblasts: 6.1;Syncytiotrophoblasts: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074432			Approved	Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA074432: AB_2686689"	"unprognostic (1.02e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.65e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.28e-2)"	4.4	13.1	11.3	1.0	15.2	0.2	3.3	13.4	10.9	5.0	8.8	2.8	0.6	5.1	7.6	1.5	5.7	3.2	11.0	10.9	12.1	3.6	0.8	4.8	1.4	12.3	15.3	7.7	3.9	4.5	7.0	7.2	12.0	4.9	1.1	51.9	2.0	3.3	1.2	1.3	1.9	3.8	11.3	2.6	2.5	3.1	12.6	0.8	5.4	1.9	1.4	3.5	3.5	14.0	2.4	6.0	15.8	10.9	10.9	16.8	3.0	5.0	12.3	8.4	12.7	3.2	10.2	0.0	15.3	3.2	16.2	1.6	10.1	3.8	9.8	0.0	6.3	8.1	6.1	5.4	12.4	0.0	0.0	14.7	2.8	11.4	17.0	19.7	9.2	9.5	2.2	14.8	10.9	2.9	0.0	0.1	5.1	0.6	3.8	6.3	4.9	0.8	10.4	2.2	8.3	7.2	7.3	0.9	1.5	13.4	9.3	0.2	6.9	8.7	9.0	2.0	3.1	0.2	0.0	0.0	2.6	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	11.3	15.2	13.4	10.9	10.9	12.1	12.3	15.3	12.0	11.3	12.6	14.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772238-38782990	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 47.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 57.2;dendritic cells: 9.4;Microglial cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 39.0;naive B-cell: 24.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 39.0"	"Group enriched"	"Detected in some"	53	"Daudi: 68.6;REH: 22.9;U-698: 24.7"					"Low region specificity"	"Detected in many"			HPA066755			Approved	Centrosome,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.9	0.3	1.0	15.8	0.9	1.4	0.8	1.0	1.2	0.2	0.5	1.4	1.2	0.4	0.4	0.5	0.5	1.3	0.1	0.9	1.2	0.2	0.4	0.8	42.3	1.9	1.5	0.0	0.1	0.1	0.2	0.2	2.0	1.0	1.9	0.1	1.4	0.4	0.2	0.5	10.0	0.3	2.0	24.3	2.9	0.1	1.4	5.1	0.4	0.1	47.9	2.7	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	22.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.4	0.0	0.1	0.0	24.7	0.0	0.1	0.0	0.3	0.4	0.9	0.0	2.8	0.0	39.0	0.0	0.0	6.4	24.0	0.1	0.1	1.3	0.1	3.6	7.2	0.0	1.8	1.0	0.9	1.0	1.2	0.9	1.2	1.9	1.5	2.0	2.0	1.4	2.2	0.2	0.0	1.1	0.0	57.2	0.4	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.2	2.7	0.3	0.0	0.0	0.9	0.0	0.2	1.3	0.0	0.4	0.3	0.8	0.0	0.3	0.2	0.0	1.9	0.8	0.0	0.0	4.5	0.0	16.9	1.0	0.2	0.0	4.5	0.1	0.0	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2
TLR5	"FLJ10052, MGC126430, MGC126431, SLEB1, TIL3"	ENSG00000187554	"Toll like receptor 5"	O60602	1	223109404-223143248	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 20.2"	"Cell type enhanced"	"Detected in many"		"Club cells: 23.3;Glandular and luminal cells: 25.6;Kupffer cells: 29.5;Microglial cells: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 30.8;intermediate monocyte: 28.1;myeloid DC: 23.4;neutrophil: 25.3;non-classical monocyte: 12.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 23.4;granulocytes: 25.3;monocytes: 30.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HaCaT: 3.2;OE19: 1.8;SK-BR-3: 2.0;T-47d: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB009013			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB009013: AB_2240732"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	3.5	1.9	2.6	4.7	2.2	0.5	8.6	2.5	2.4	6.0	2.3	2.0	1.6	2.1	2.6	4.9	5.1	4.5	1.7	2.3	2.7	4.1	1.6	6.2	4.3	3.7	3.5	20.2	4.0	4.4	0.7	3.4	3.6	3.3	2.1	0.7	10.3	2.4	1.4	2.0	2.1	2.6	3.1	2.9	4.1	1.8	3.4	2.5	1.9	1.6	5.0	4.0	2.4	5.0	2.1	0.2	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.0	3.2	0.0	0.2	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.2	0.1	0.8	0.4	0.0	0.0	0.3	0.5	0.1	1.1	1.8	0.0	0.0	0.0	0.1	0.9	0.4	0.8	0.3	0.6	2.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.3	0.2	0.0	30.8	0.4	0.2	28.1	0.4	0.2	1.5	0.4	23.4	0.1	2.3	0.7	25.3	0.4	12.4	0.3	1.2	10.9	2.6	2.2	2.5	2.4	2.3	2.7	3.7	3.5	3.6	3.1	3.4	5.0	1.0	3.2	17.0	0.0	0.2	0.5	5.8	18.9	4.6	0.1	10.6	5.3	1.7	14.3	23.3	22.0	2.1	1.5	0.3	0.4	3.9	5.9	4.6	13.6	2.0	2.1	1.2	0.0	0.5	3.8	0.3	7.7	3.1	25.6	2.5	4.6	0.7	0.7	18.1	0.0	1.0	0.6	6.1	29.5	3.1	5.7	9.3	22.4	3.6	23.4	14.4	1.4	0.0	1.5	0.1	2.4	0.1	8.6	0.1	3.0	0.5	0.1	11.0	0.2	0.0	4.2	4.1	5.4	5.5	15.9	1.6	0.8	1.7	4.1	1.5	6.3
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA054064: AB_2682366"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	32.2	38.3	58.9	23.5	62.8	28.2	33.9	57.0	74.7	36.7	51.4	31.1	24.6	40.8	43.5	23.9	34.2	29.6	47.8	62.0	70.1	32.2	58.1	28.1	30.5	54.9	58.7	55.7	30.3	40.6	35.7	31.7	58.5	32.7	24.2	32.3	34.4	35.3	44.5	27.0	26.2	32.1	55.9	29.2	29.1	28.0	61.1	29.5	45.2	55.7	31.7	32.8	28.5	58.0	20.1	48.9	25.6	46.6	71.9	53.1	31.3	25.9	42.6	30.0	33.4	26.4	55.5	32.5	34.9	35.5	50.7	45.9	40.3	33.3	23.7	31.2	88.4	48.7	39.9	45.4	47.2	38.4	55.8	44.2	66.3	18.1	37.4	42.1	42.1	41.5	40.6	47.8	47.9	40.8	28.3	40.2	39.5	90.4	16.2	33.9	32.3	51.0	61.5	52.0	34.3	31.3	35.8	37.4	54.3	43.7	35.5	49.8	33.7	31.6	32.5	21.2	28.9	45.0	71.2	35.3	26.9	47.5	26.7	36.4	40.6	81.9	41.2	41.9	46.4	30.6	33.6	31.6	29.1	44.8	44.1	41.4	69.6	52.4	32.4	24.6	38.4	41.3	58.9	62.8	57.0	74.7	62.0	70.1	54.9	58.7	58.5	55.9	61.1	58.0	52.4	25.6	28.7	22.2	55.8	66.3	58.5	142.3	32.5	47.1	42.6	45.8	35.7	35.8	67.9	42.3	33.3	73.7	51.9	23.0	19.6	61.0	8.0	28.1	38.2	48.8	27.0	30.3	41.5	42.3	64.7	53.7	23.0	44.8	25.3	37.6	60.3	56.6	32.3	69.0	55.3	23.2	91.6	42.1	36.4	10.8	73.7	39.2	26.6	37.5	44.4	60.6	56.7	29.1	45.8	27.8	20.7	62.8	41.3	66.6	32.6	39.5	47.2	46.8	72.3	40.1	67.0	89.3	84.2	25.0	55.4	91.0	55.1	21.5	27.8	40.0
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.9"	"Group enriched"	"Detected in many"	4	"Adipocytes: 226.1;Endothelial cells: 188.9;Hepatic stellate cells: 151.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 94.8;EFO-21: 194.9;GAMG: 38.7;HUVEC TERT2: 65.9;NTERA-2: 47.2"					"Low region specificity"	"Detected in many"			"HPA053639, HPA069378"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Cytosol	"HPA053639: , HPA069378: AB_2686133"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	21.3	5.2	9.4	4.9	9.6	0.1	16.3	9.2	11.5	8.3	10.4	3.4	3.9	7.6	4.7	3.4	6.4	10.6	8.4	9.1	10.3	19.1	7.9	9.2	6.6	12.2	9.6	3.2	9.8	6.8	3.1	17.4	11.5	4.0	3.3	1.1	4.0	6.5	5.9	2.4	3.6	14.9	10.0	33.9	3.4	1.9	12.1	2.1	12.7	5.7	5.0	6.7	2.5	10.4	0.1	94.8	3.5	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.2	1.2	0.0	194.9	0.0	38.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.3	0.1	0.7	0.0	0.0	0.0	24.7	65.9	0.0	0.0	0.0	6.2	0.7	0.0	0.2	47.2	0.0	0.0	0.1	2.6	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.5	1.5	0.1	0.1	8.4	0.1	1.2	0.0	0.5	0.1	0.1	0.5	0.0	0.1	15.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	9.4	9.6	9.2	11.5	9.1	10.3	12.2	9.6	11.5	10.0	12.1	10.4	226.1	0.0	4.4	0.3	1.6	3.2	0.2	0.0	0.6	0.2	41.4	23.9	2.8	4.3	0.0	1.8	0.0	0.0	1.0	0.0	9.8	35.2	0.4	0.7	1.1	188.9	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.9	1.3	0.3	151.0	1.1	0.1	0.0	0.1	0.0	0.0	9.1	3.0	1.8	2.1	1.2	1.8	33.7	0.6	0.4	0.0	0.5	0.6	0.9	0.0	6.8	2.5	1.3	0.0	35.8	0.7	0.0	0.0	1.5	2.5	0.2	0.5	0.2	2.8	0.0	1.1	5.2	0.0	0.6
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149474697-149503394	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 945.8;intestine: 650.8;liver: 703.8"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 2070.3;Hepatocytes: 578.1"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	1.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.0	650.8	0.6	2.3	0.7	0.5	945.8	0.3	0.0	0.0	0.8	703.8	0.3	0.8	0.0	0.0	0.0	72.5	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	514.8	0.9	0.0	0.1	21.3	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.6	0.3	0.2	4.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.8	0.1	20.3	0.0	0.0	0.5	1.4	36.5	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.1	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	4.1	2070.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	25.9	1.1	3.1	0.3	0.6	3.0	13.5	0.1	2.0	0.2	0.1	10.7	3.3	0.0	0.0	7.1	578.1	0.1	0.0	0.1	41.6	0.0	11.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	8.2	17.5	0.0	0.3	0.0	76.6	4.8	0.1	0.0	0.0	0.0	0.7	4.1	0.3	0.0	0.0	0.1	0.5	5.6	2.0	0.2
TMCO3	"C13orf11, FLJ20623"	ENSG00000150403	"Transmembrane and coiled-coil domains 3"	Q6UWJ1	13	113491021-113554590	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 20.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039561, HPA048126"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA039561: AB_2676573, HPA048126: AB_2680276"	"unprognostic (7.89e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (6.78e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (2.93e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.47e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (4.10e-4)"	24.2	26.9	20.5	18.6	18.3	76.7	22.7	29.8	21.5	31.1	49.2	23.1	21.0	33.1	20.0	14.4	25.2	27.7	28.2	17.3	16.3	24.2	14.3	24.3	16.3	19.4	18.8	25.2	40.7	35.1	23.1	30.1	19.4	22.1	22.0	18.1	38.7	21.6	19.1	13.4	22.7	29.6	19.6	19.8	44.3	16.1	19.6	12.4	10.7	15.2	13.1	19.6	18.9	21.2	97.8	32.6	46.3	32.0	93.1	136.4	25.0	105.0	99.6	45.1	45.3	35.7	41.9	23.1	25.9	115.7	61.7	38.5	24.8	38.0	70.0	48.0	25.1	20.9	52.2	36.0	87.9	34.3	41.7	112.0	88.5	33.9	68.9	116.7	74.5	14.3	30.3	31.6	79.6	17.5	18.0	20.6	23.2	46.5	50.9	22.4	28.0	16.7	74.3	12.6	40.4	33.5	32.3	70.3	33.6	65.3	41.5	64.6	117.4	50.3	53.5	36.9	44.8	39.2	23.9	14.8	167.2	17.8	24.6	3.1	8.3	8.5	1.3	5.6	1.5	3.1	1.5	2.0	6.0	1.8	1.7	1.7	20.2	5.0	11.3	1.3	1.5	2.7	20.5	18.3	29.8	21.5	17.3	16.3	19.4	18.8	19.4	19.6	19.6	21.2	34.3	12.8	15.1	21.5	12.5	9.8	37.2	25.8	21.6	16.4	39.2	17.5	20.3	24.3	27.8	25.8	14.6	21.6	13.5	37.1	5.9	46.8	14.6	28.2	39.2	31.3	34.2	23.5	42.9	37.4	53.8	35.0	39.3	28.6	26.6	18.4	35.0	12.4	19.1	21.9	41.0	69.2	12.2	31.3	18.8	37.1	36.7	24.5	17.8	12.2	31.4	25.9	17.5	24.6	31.9	52.6	28.2	47.8	19.2	64.0	20.0	11.2	45.2	19.0	6.6	26.2	31.9	17.6	12.2	15.9	7.1	13.0	11.8	34.4	17.7	31.3
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397775	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.2;skeletal muscle: 23.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 209.9;Excitatory neurons: 357.3;Inhibitory neurons: 475.3;Oligodendrocyte precursor cells: 480.0"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 24.2;LHCN-M2: 13.8;SCLC-21H: 21.0;SH-SY5Y: 92.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		55000		"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: AB_2684993"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	1.4	11.3	6.3	1.5	9.6	0.2	1.5	3.4	10.0	2.0	3.2	1.5	0.4	2.4	0.6	9.6	1.7	0.8	6.8	9.6	2.9	0.4	0.1	11.0	1.7	0.0	4.1	0.3	0.3	3.0	2.2	2.4	4.0	1.0	1.3	35.2	1.3	2.0	23.1	1.4	1.6	5.5	0.0	1.3	1.3	13.9	7.9	1.3	3.1	7.0	2.3	8.3	0.8	0.8	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.7	1.0	1.8	8.5	0.0	0.0	0.0	0.0	24.2	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	13.8	0.7	0.1	0.3	3.8	0.0	0.0	0.0	4.8	0.1	1.1	0.0	21.0	92.6	0.0	0.1	0.3	5.5	0.2	0.0	0.0	0.1	0.1	0.0	3.4	1.3	0.0	0.7	1.8	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.6	3.4	10.0	9.6	2.9	0.0	4.1	4.0	0.0	7.9	0.8	0.6	3.2	4.6	209.9	0.0	2.4	0.5	0.2	0.0	10.4	1.3	2.8	1.7	1.5	5.0	0.0	102.2	1.8	0.0	0.0	0.0	0.0	80.6	1.0	0.6	1.3	0.0	0.0	357.3	0.4	8.6	4.6	4.1	0.2	1.3	5.5	0.4	0.0	0.3	1.7	475.3	0.0	0.0	0.0	0.8	38.2	0.9	0.1	0.0	33.7	0.0	5.7	0.0	480.0	22.2	0.3	0.0	0.7	1.2	0.2	0.0	0.0	0.0	57.6	0.0	6.8	3.3	17.2	11.2	0.0	1.6	1.1	1.0	4.9	0.0	0.4
TMEM109	MGC5508	ENSG00000110108	"Transmembrane protein 109"	Q9BVC6	11	60914158-60923443	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011785	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Cytosol"		"HPA011785: AB_1858075"	"unprognostic (5.23e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (2.68e-4)"	83.0	46.4	22.2	44.4	23.2	27.0	71.9	23.3	25.5	85.4	42.1	75.1	26.2	97.7	26.7	93.8	73.7	35.7	84.0	19.8	23.2	47.3	32.1	71.8	48.0	26.7	24.5	81.5	46.1	67.3	41.1	46.8	25.4	52.4	27.0	14.3	81.8	60.8	99.4	69.7	47.8	70.0	25.9	58.1	58.2	14.4	25.5	41.4	57.3	77.0	50.3	70.4	79.9	24.7	111.5	103.5	63.3	102.1	169.4	77.7	51.5	107.3	100.4	118.5	99.8	94.5	115.7	131.5	190.4	130.1	69.9	143.5	73.2	48.8	72.5	102.5	97.0	96.2	44.3	21.1	50.2	188.4	77.0	54.1	61.6	92.9	46.8	41.9	148.1	104.8	48.4	330.4	85.4	217.2	139.9	80.8	104.6	62.8	111.4	132.3	123.9	183.0	56.6	63.6	25.3	44.4	86.2	196.8	102.7	44.8	110.4	35.8	143.7	136.9	65.9	174.4	95.8	108.7	89.5	69.9	121.2	82.0	159.7	39.0	76.0	56.4	188.7	69.5	193.3	116.5	108.4	161.4	227.4	140.4	97.4	124.8	8.2	121.1	52.4	470.0	91.1	139.4	22.2	23.2	23.3	25.5	19.8	23.2	26.7	24.5	25.4	25.9	25.5	24.7	118.2	70.5	23.2	5.5	60.2	50.7	43.8	30.9	63.7	13.4	39.5	45.3	34.6	25.8	23.9	25.8	0.0	120.7	83.4	6.8	25.4	76.6	20.7	18.7	25.9	91.2	7.2	33.0	5.3	80.2	116.4	75.9	10.7	27.9	50.7	22.2	71.0	18.9	66.8	30.3	3.8	10.1	22.4	21.3	69.1	11.1	89.5	43.4	51.6	11.2	45.4	30.2	68.0	3.5	5.1	53.1	14.7	97.4	38.4	36.5	10.6	17.1	18.7	34.8	39.5	45.0	67.6	5.9	7.2	55.1	50.6	53.2	52.7	25.8	16.8	33.9
TMEM120B		ENSG00000188735	"Transmembrane protein 120B"	A0PK00	12	121712752-121783001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 93.1;NK-cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014066	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"	Cytosol	"HPA014066: AB_1845296"	"unprognostic (8.80e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.29e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.86e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.72e-2)"	7.6	10.9	6.7	2.6	17.1	7.7	6.9	18.2	8.9	27.1	4.3	6.9	3.5	13.7	2.3	4.4	18.6	2.1	7.7	9.8	3.3	11.4	7.9	6.5	3.0	5.2	1.5	8.6	16.7	4.4	19.9	1.7	5.5	9.0	2.0	4.2	11.0	2.7	13.9	5.5	5.3	5.5	1.0	6.7	8.8	5.6	5.1	1.3	13.8	4.9	1.7	6.7	11.7	3.0	5.4	17.3	4.1	11.7	5.0	6.6	8.5	7.0	7.8	6.4	5.2	11.0	5.6	5.6	4.3	7.0	6.3	8.9	9.6	8.1	3.4	3.4	9.7	7.9	6.1	7.1	6.8	5.5	5.9	6.1	7.2	7.3	5.2	11.0	4.0	12.2	7.2	3.8	3.9	8.1	9.6	7.6	7.7	3.4	10.9	11.4	16.9	7.4	3.4	5.7	15.6	11.1	7.2	5.4	6.1	7.4	12.8	4.4	5.3	8.7	10.0	5.5	6.1	9.5	3.8	3.9	10.9	7.0	8.8	1.0	0.3	0.3	0.7	0.3	0.5	0.6	0.7	0.5	0.4	1.1	0.5	0.5	0.7	0.6	0.3	0.9	0.6	0.3	6.7	17.1	18.2	8.9	9.8	3.3	5.2	1.5	5.5	1.0	5.1	3.0	3.3	25.6	12.2	12.1	14.0	6.5	5.3	6.5	4.6	35.4	9.2	5.5	5.9	8.6	9.9	11.0	22.9	6.4	45.9	36.7	7.9	7.8	19.7	30.6	12.6	4.8	6.6	16.6	29.8	12.3	6.9	9.1	8.2	42.9	4.5	29.8	1.8	4.6	5.7	13.5	40.7	4.9	4.1	4.7	93.1	39.9	6.5	17.6	1.8	10.3	32.1	3.6	76.2	7.1	6.6	30.3	33.6	6.4	19.8	7.2	29.4	7.0	15.7	20.6	6.6	10.3	8.6	8.4	7.5	2.9	7.0	11.4	28.0	16.8	5.4	10.0
TMEM121	"hole, MGC4659, TMEM121A"	ENSG00000184986	"Transmembrane protein 121"	Q9BTD3	14	105526583-105530202	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 31.2;Muller glia cells: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.1;MCF7: 8.1;PC-3: 10.2;REH: 6.7;SCLC-21H: 5.3;WM-115: 5.4"	"Low region specificity"	"Detected in all"							HPA049857	Uncertain		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA049857: AB_2680917"	"unprognostic (4.25e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.48e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.90e-2)"	2.0	1.0	4.8	0.5	5.0	0.2	2.4	2.9	6.4	4.6	0.4	2.4	0.2	4.3	0.1	1.0	4.6	0.1	2.3	5.7	3.1	2.6	2.6	1.7	0.3	5.8	4.8	2.4	2.4	0.6	5.1	0.2	3.8	3.7	0.0	0.0	1.4	0.4	0.3	1.5	1.8	0.2	2.6	3.4	1.8	1.2	3.3	0.1	2.6	0.0	0.0	2.1	2.1	3.9	0.0	4.0	0.4	3.6	0.0	0.2	0.7	2.4	0.5	0.4	0.0	0.0	1.3	1.2	8.1	0.0	0.7	0.4	0.4	0.1	0.0	0.5	1.9	0.0	0.4	1.4	0.6	0.0	1.4	0.2	0.0	0.1	0.0	0.2	0.4	0.5	0.1	0.0	0.2	8.1	0.2	0.0	1.2	0.1	10.2	6.7	0.0	0.1	0.1	0.0	5.3	2.0	0.4	0.0	2.0	0.0	2.4	0.3	1.4	1.1	2.1	0.2	0.4	0.6	0.0	0.0	0.1	0.5	5.4	0.0	0.0	0.0	0.6	0.0	1.0	2.1	1.2	0.6	0.2	0.6	0.7	0.4	0.0	0.8	0.0	0.0	0.0	0.2	4.8	5.0	2.9	6.4	5.7	3.1	5.8	4.8	3.8	2.6	3.3	3.9	10.6	0.0	0.5	2.3	2.8	4.6	2.6	0.1	2.2	5.1	8.9	10.8	1.5	1.5	0.7	5.5	0.0	0.2	0.7	0.0	0.0	1.0	1.7	5.4	5.5	9.5	0.0	3.4	5.7	0.2	2.2	4.6	1.1	1.4	0.0	31.2	10.8	2.3	0.4	10.1	4.8	0.0	0.0	0.6	4.8	2.2	4.4	0.4	7.2	2.8	0.0	14.4	1.0	12.1	11.5	0.0	0.0	6.4	0.5	1.8	0.0	0.1	1.6	1.6	0.0	4.0	3.2	0.7	3.1	0.4	2.6	0.3	3.2	1.8	0.2	0.6
TMEM123	"KCT3, PORIMIN"	ENSG00000152558	"Transmembrane protein 123"	Q8N131	11	102396332-102470384	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 988.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026001, HPA062862"			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026001: , HPA062862: AB_2732691"	"unprognostic (2.64e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.65e-2)"	56.0	80.2	53.0	120.2	60.3	225.1	153.3	56.7	68.2	114.9	67.0	120.0	63.5	174.7	47.8	100.1	91.7	99.6	71.2	48.0	61.0	93.2	393.7	119.2	196.4	71.2	68.6	86.8	82.5	70.7	15.8	98.5	65.1	105.2	97.1	9.2	224.0	104.1	20.4	95.6	78.8	130.6	61.3	111.2	125.5	73.3	61.5	238.6	312.3	49.7	142.9	146.8	70.7	89.8	220.5	195.8	186.9	174.8	233.5	185.6	135.8	169.7	352.0	324.4	358.1	247.9	988.1	370.2	423.9	387.9	234.5	228.3	212.3	272.9	339.4	228.4	82.5	192.0	67.8	352.3	207.5	404.1	137.4	219.1	280.7	240.1	352.3	433.9	361.8	187.8	134.3	0.9	257.7	71.8	353.0	135.4	115.8	340.3	181.1	214.7	532.0	359.3	291.3	207.9	90.7	110.5	201.8	267.6	109.9	197.2	161.3	154.0	451.9	211.3	249.4	190.5	126.6	139.4	84.3	366.6	62.0	432.7	143.2	159.7	113.3	207.0	102.6	121.8	155.3	70.1	158.8	123.8	126.1	95.3	208.6	181.7	72.4	223.9	111.0	33.7	183.8	248.7	53.0	60.3	56.7	68.2	48.0	61.0	71.2	68.6	65.1	61.3	61.5	89.8	93.3	125.0	78.1	33.0	179.3	160.3	257.1	307.3	157.6	0.7	144.9	118.4	53.9	143.0	202.8	163.7	0.0	45.8	91.8	48.2	80.3	153.7	41.3	141.1	47.6	140.0	90.5	68.3	1.0	118.8	41.1	82.2	88.2	161.4	58.9	126.6	271.3	317.6	107.1	1.7	2.2	163.1	160.7	249.6	419.9	23.6	94.1	189.8	161.9	63.7	229.4	4.7	83.4	25.6	114.0	127.8	55.1	93.3	117.8	324.2	31.0	52.9	257.0	1.1	65.7	181.9	80.2	23.1	74.9	146.3	177.2	30.4	164.8	109.4	146.3	270.2
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269983-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 75.7;pancreas: 89.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 121.8;Alveolar cells type 2: 136.9;Distal enterocytes: 72.7;Proximal enterocytes: 164.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.8;BEWO: 21.8;CACO-2: 20.6;CAPAN-2: 48.3;OE19: 31.3;SK-BR-3: 41.2;T-47d: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015796			Approved	Midbody,Cytosol		Yes	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favorable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.3	0.7	17.4	3.2	32.2	0.2	11.5	27.6	29.9	16.4	12.8	21.2	35.4	1.6	18.3	10.9	15.5	11.3	0.9	17.0	20.7	16.4	1.1	75.7	0.3	31.5	28.5	1.4	89.6	22.2	31.0	4.4	29.0	22.0	21.0	0.1	31.8	7.1	0.0	12.9	27.5	0.8	22.6	0.3	27.4	1.5	26.8	0.4	44.9	0.0	2.5	2.9	3.4	42.8	26.8	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	20.6	48.3	0.1	1.2	0.0	0.0	11.7	0.0	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	12.1	0.1	0.1	1.1	31.3	0.0	0.0	0.0	0.7	0.4	8.5	12.4	0.1	0.0	41.2	0.0	3.6	33.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	17.4	32.2	27.6	29.9	17.0	20.7	31.5	28.5	29.0	22.6	26.8	42.8	0.2	121.8	136.9	0.0	0.9	0.0	2.3	18.0	0.6	0.0	30.4	15.2	0.5	42.9	56.0	16.5	0.0	33.5	0.1	72.7	17.6	39.1	3.7	20.1	1.4	0.6	21.7	0.0	0.2	38.5	2.2	0.6	45.3	13.1	1.3	4.9	0.0	0.0	2.4	0.0	0.2	63.0	34.6	0.0	0.2	7.9	0.3	0.6	0.0	0.0	0.6	1.7	1.0	0.0	55.3	22.7	40.1	1.2	0.6	12.2	164.2	33.9	43.8	0.0	0.0	0.0	2.3	1.4	0.3	2.1	0.4	7.3	1.0	0.1	38.6	9.1
TMEM126A	"DKFZp586C1924, OPA7"	ENSG00000171202	"Transmembrane protein 126A"	Q9H061	11	85647967-85656547	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046648	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA046648: AB_2679737"	"unprognostic (3.79e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.60e-5)"	"unprognostic (8.25e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.17e-1)"	31.9	28.0	40.3	23.1	41.5	43.8	33.5	41.4	52.3	21.8	39.5	28.0	32.6	20.0	31.2	27.2	19.8	19.9	82.1	41.4	42.3	33.1	49.0	20.5	27.3	40.7	40.6	21.0	33.9	26.3	22.2	22.8	41.5	23.5	29.3	23.9	31.3	19.5	81.6	19.4	26.0	27.6	41.1	21.0	32.8	38.5	41.4	24.2	26.6	98.7	27.8	30.5	20.1	42.4	46.7	53.2	50.9	33.0	67.2	66.7	38.0	55.9	60.1	82.3	77.6	65.9	67.5	25.4	61.3	69.2	32.0	48.9	53.8	59.5	70.7	72.5	31.0	72.5	56.9	73.7	82.4	89.0	54.8	58.0	65.8	73.1	78.0	43.5	71.6	72.2	51.1	39.0	86.2	57.5	48.6	112.3	48.1	175.1	68.4	48.3	49.5	79.2	54.5	57.0	34.3	34.7	49.4	72.9	44.7	44.5	88.1	64.4	42.8	70.4	52.7	134.6	65.3	27.5	54.4	70.4	37.0	63.6	85.2	6.6	23.9	11.6	21.2	28.1	26.0	29.8	26.4	23.8	32.9	27.3	24.4	24.1	1.9	15.1	23.4	24.7	26.4	18.7	40.3	41.5	41.4	52.3	41.4	42.3	40.7	40.6	41.5	41.1	41.4	42.4	40.5	28.9	24.3	12.7	39.6	31.7	55.3	87.9	29.6	14.8	45.8	62.1	110.8	28.6	57.5	38.6	6.2	67.8	38.5	23.6	146.8	51.0	147.8	26.8	32.8	36.7	21.7	46.1	8.6	93.2	73.3	40.8	23.4	24.2	37.4	33.6	26.7	68.5	94.6	8.4	9.0	46.6	40.7	54.4	43.3	80.6	29.5	48.4	33.8	5.6	66.3	35.1	38.1	8.5	11.8	64.5	34.8	26.7	45.4	73.4	61.8	109.4	39.7	21.9	19.7	40.0	40.9	119.0	57.9	49.4	42.1	52.9	42.1	42.2	57.1	71.2
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.6"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 217.3;Microglial cells: 160.2;Oligodendrocyte precursor cells: 580.6"	"Group enriched"	"Detected in some"	4	"glioma: 1.6;ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"gdT-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Group enriched"	"Detected in some"	7	"AF22: 3.7;ASC diff: 5.2;Daudi: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Approved	Centrosome,Cytosol		NA	NA		78000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	31.6	2.7	8.3	0.3	7.6	0.0	14.0	6.8	7.3	16.8	15.5	1.4	0.3	5.4	3.8	3.1	11.8	1.1	4.3	6.7	7.4	0.4	0.1	1.5	1.1	9.3	14.4	8.6	2.7	0.1	0.7	2.5	8.7	2.4	0.4	3.6	1.7	4.1	0.5	2.0	1.8	1.0	6.7	0.3	1.2	1.3	9.6	1.0	0.9	3.4	0.4	4.7	9.2	6.0	0.0	0.0	3.7	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.6	6.8	7.3	6.7	7.4	9.3	14.4	8.7	6.7	9.6	6.0	1.9	0.0	0.0	70.2	0.0	0.4	0.0	0.0	0.0	18.6	0.0	0.0	1.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.1	0.2	7.6	26.1	1.0	0.0	0.0	32.2	0.0	0.0	6.3	0.0	9.8	0.0	3.7	0.0	0.0	0.1	0.0	217.3	0.1	0.0	0.0	1.1	0.2	9.0	0.1	1.8	160.2	0.0	0.4	0.0	580.6	42.3	0.1	0.0	15.1	0.0	0.0	0.1	0.1	0.0	2.3	0.0	0.8	2.5	0.1	0.4	0.1	0.0	0.0	0.3	0.0	0.1	0.0
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		170000	"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.3	0.1	4.6	0.0	3.0	0.0	0.1	6.1	6.4	0.4	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.5	2.6	6.2	3.6	0.4	0.1	0.1	17.9	5.1	0.2	0.0	0.0	0.1	0.1	10.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.7	0.1	8.7	0.3	0.1	1.9	6.5	0.0	0.2	0.0	0.1	0.1	0.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	4.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	3.0	6.1	6.4	2.6	6.2	17.9	5.1	10.2	8.7	6.5	11.1	0.1	0.0	0.0	2.6	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	6.4	0.0	0.0	1.9	0.7	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.2	0.5	1.2	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291894-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 112.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 70.1"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	3.1	1.4	41.3	0.0	68.0	0.0	0.0	73.5	60.8	0.0	3.8	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.8	45.2	44.0	0.1	0.2	0.1	0.0	86.0	68.1	0.2	1.1	0.3	9.7	0.0	69.6	0.1	0.0	1.5	0.2	0.0	0.0	0.0	0.1	0.0	61.8	0.0	5.4	0.3	70.6	0.0	0.0	0.0	0.0	0.0	0.1	112.9	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.0	1.1	0.0	3.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	15.3	3.5	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	68.0	73.5	60.8	45.2	44.0	86.0	68.1	69.6	61.8	70.6	112.9	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.7	4.3	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	7.7	0.0	11.6	0.4	0.0	1.0	9.2	0.1	0.0	0.0	0.0	0.0	0.1	15.2	11.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	2.5	0.0	2.0	70.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMEM161A	"FLJ20422, FLJ39645"	ENSG00000064545	"Transmembrane protein 161A"	Q9NX61	19	19119169-19138513	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043365	Approved		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA043365: AB_10796793"	"unprognostic (4.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.15e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.18e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.89e-3)"	13.0	22.5	4.5	4.4	4.6	5.4	13.6	4.8	6.9	19.8	7.1	15.8	3.5	21.7	1.5	14.8	17.6	5.4	17.7	4.3	4.3	15.3	25.9	12.3	4.8	6.9	4.6	17.7	15.7	13.7	8.2	3.3	5.4	14.3	3.7	2.5	14.9	7.1	50.7	16.9	11.2	6.3	4.4	10.4	14.7	6.3	5.4	5.8	19.5	13.2	4.8	14.3	15.9	5.9	28.9	19.3	12.6	20.1	24.8	17.1	12.8	13.4	12.8	16.4	20.1	17.5	30.8	26.4	57.9	9.4	11.3	23.9	20.6	29.3	11.4	9.9	47.6	10.0	10.6	24.0	30.9	9.1	14.7	26.9	23.9	15.6	25.9	14.9	17.9	30.5	31.6	27.2	12.5	33.8	19.5	24.7	9.9	37.1	19.6	33.4	9.4	44.8	13.0	13.0	13.0	13.6	20.2	20.1	15.7	9.1	17.1	24.0	7.6	13.3	5.3	34.4	21.1	27.8	14.9	16.1	13.9	22.5	20.7	1.3	6.1	1.4	8.2	5.3	6.7	4.3	7.5	6.2	8.4	5.6	8.8	6.3	1.1	5.4	7.1	19.4	11.4	4.1	4.5	4.6	4.8	6.9	4.3	4.3	6.9	4.6	5.4	4.4	5.4	5.9	15.7	6.4	18.3	5.5	9.5	6.1	15.1	27.1	14.8	15.7	13.4	15.4	8.7	20.0	18.3	11.0	10.4	19.8	14.8	6.5	7.9	20.5	1.2	8.8	14.1	11.3	5.4	6.7	10.9	12.9	15.1	14.6	14.8	9.5	15.9	15.1	9.7	25.3	16.3	16.8	11.4	10.0	10.2	9.5	4.1	1.5	11.8	7.5	12.4	5.6	6.8	15.8	8.2	4.5	8.4	11.9	7.5	17.7	13.6	14.9	12.5	29.1	11.8	14.5	13.1	13.5	14.3	8.7	8.4	12.4	8.7	12.3	11.4	33.8	19.3	10.0
TMEM168	DKFZp564C012,FLJ13576	ENSG00000146802	"Transmembrane protein 168"	Q9H0V1	7	112762377-112790423	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020389, HPA077143"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA020389: AB_1858101, HPA077143: "	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.30e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (1.60e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.30e-2)"	12.9	10.6	6.0	12.5	7.6	6.7	15.6	7.5	7.1	11.6	9.5	22.4	13.7	13.2	17.9	14.1	10.7	12.2	13.9	5.8	6.8	12.8	8.4	12.1	11.3	8.1	6.6	12.1	6.7	28.6	8.3	14.4	8.2	16.3	24.6	20.2	20.6	13.4	9.4	26.7	14.8	15.3	7.8	12.3	12.6	10.2	6.7	13.5	17.7	9.4	11.2	10.9	12.9	10.1	16.0	13.2	12.2	10.9	20.4	41.5	17.2	17.3	16.2	6.4	5.6	17.0	16.4	16.9	11.4	17.2	14.6	16.8	12.5	15.1	16.5	26.8	12.9	14.7	16.8	9.7	13.7	16.4	17.9	20.3	38.6	7.3	10.9	6.0	18.9	13.6	19.9	15.0	23.3	25.2	14.2	10.3	9.9	16.7	10.2	9.5	6.1	24.9	16.0	29.9	9.2	18.2	23.3	30.6	14.0	14.9	17.5	14.4	27.0	30.5	15.5	14.5	22.6	25.4	23.1	18.9	19.7	14.7	40.0	21.2	14.9	11.6	12.1	12.6	14.4	10.9	12.9	11.8	16.0	13.2	18.6	13.0	8.4	13.5	13.2	11.1	13.0	9.5	6.0	7.6	7.5	7.1	5.8	6.8	8.1	6.6	8.2	7.8	6.7	10.1	17.4	12.8	22.3	43.1	18.6	31.1	19.1	12.0	27.3	31.5	16.4	14.4	18.1	10.0	18.9	33.1	27.1	35.5	14.3	16.9	0.0	5.9	2.9	9.2	22.1	17.3	20.5	14.1	29.9	9.1	8.9	17.6	18.3	11.8	12.0	19.2	18.5	12.6	8.9	16.8	32.6	34.8	16.2	13.5	9.3	1.9	18.3	10.9	24.9	41.2	10.8	16.3	15.5	70.9	71.5	6.1	17.0	14.7	10.2	21.6	15.5	6.0	7.1	29.6	6.6	19.4	16.7	18.1	13.3	24.8	26.0	14.2	13.8	21.1	30.5	14.5
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;retina: 3.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.4;Cone photoreceptor cells: 22.9;Excitatory neurons: 13.1;Inhibitory neurons: 13.9;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 9.3;Rod photoreceptor cells: 11.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 7.3;RPTEC TERT1: 12.3;SCLC-21H: 9.9;SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"							"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	0.5	1.0	1.4	1.0	3.0	0.3	0.2	1.5	2.6	0.7	0.0	0.4	0.7	0.3	0.7	0.2	1.0	0.8	0.4	2.3	2.1	1.8	1.7	0.6	1.0	2.6	2.1	0.3	0.3	0.1	0.8	0.1	2.8	0.4	0.3	3.4	0.2	0.3	0.3	0.5	0.6	0.4	1.0	1.0	0.2	0.3	1.7	1.0	2.6	0.3	0.7	0.2	0.1	2.8	0.0	0.3	7.3	0.1	1.0	0.0	0.0	0.3	0.2	0.2	0.8	0.3	2.4	0.0	5.8	0.3	0.4	0.1	0.9	0.0	0.2	1.4	0.3	2.9	0.1	1.4	1.9	0.1	0.5	0.6	0.6	0.5	0.7	1.8	0.0	0.9	0.0	0.3	6.3	0.8	0.2	0.1	4.1	0.0	0.0	1.4	2.0	0.0	12.3	0.0	9.9	14.5	0.3	0.1	5.7	4.0	0.5	1.0	0.0	0.2	0.4	0.0	0.4	1.7	2.2	0.4	1.9	0.2	1.4	0.8	1.0	0.1	1.2	1.0	0.9	1.5	2.0	1.4	0.0	1.4	2.1	0.9	2.3	0.3	3.2	0.1	3.7	0.7	1.4	3.0	1.5	2.6	2.3	2.1	2.6	2.1	2.8	1.0	1.7	2.8	0.3	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	14.4	0.1	0.5	0.8	4.3	0.0	5.5	22.9	0.1	0.3	0.0	0.0	0.6	0.0	0.4	0.4	0.2	4.9	0.0	13.1	0.0	0.0	0.2	0.5	0.5	0.0	0.0	1.4	0.8	0.4	0.0	13.9	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.0	3.7	0.2	2.2	3.1	11.1	9.3	0.1	0.6	0.4	0.3	0.1	0.3	2.8	0.1	11.6	0.0	3.6	0.4	0.0	0.7	0.0	0.0	0.0	0.8	0.1	0.2	0.1
TMEM184B	"C22orf5, DKFZP586A1024, FM08, HS5O6A"	ENSG00000198792	"Transmembrane protein 184B"	Q9Y519	22	38219291-38273010	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 86.8;Oligodendrocytes: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024076	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA024076: AB_1858106"	"unprognostic (1.52e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.94e-6)"	"unprognostic (1.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.96e-1)"	28.6	21.9	49.5	14.0	52.3	5.8	24.9	54.5	59.6	18.6	22.1	21.0	16.9	19.4	7.2	17.3	17.1	14.5	35.7	49.6	48.2	25.9	11.4	35.9	8.4	56.8	56.0	16.2	18.4	18.9	34.3	38.4	54.8	18.8	10.8	15.2	22.6	14.4	28.7	16.0	17.6	14.0	52.9	22.0	22.4	7.5	56.7	6.2	26.1	17.4	8.2	18.4	16.5	66.9	55.8	47.5	27.5	21.9	53.6	42.6	63.4	58.8	82.9	46.9	41.5	35.1	25.2	10.6	44.9	87.6	42.4	67.2	24.9	57.8	31.6	37.9	45.0	20.9	34.0	29.5	56.3	16.6	28.0	36.1	50.2	55.4	61.5	48.5	59.5	15.9	13.5	36.2	41.5	31.6	10.6	14.1	22.4	41.2	43.4	18.1	24.8	10.6	34.8	60.6	59.3	10.5	44.2	63.6	32.0	31.7	35.2	12.0	89.2	47.7	48.4	42.5	36.2	74.5	197.9	8.5	69.2	12.1	42.0	14.2	3.3	4.7	5.3	2.3	4.6	1.4	2.9	4.0	4.5	1.1	2.1	2.5	10.9	6.2	1.6	7.0	1.0	3.2	49.5	52.3	54.5	59.6	49.6	48.2	56.8	56.0	54.8	52.9	56.7	66.9	43.4	6.4	14.8	86.8	7.5	12.4	19.8	22.3	17.6	16.4	15.9	10.5	17.1	8.6	18.7	14.7	2.1	35.0	17.8	12.5	3.9	17.3	5.6	17.4	15.5	34.6	25.9	4.6	42.6	22.2	48.3	17.4	13.3	33.8	2.5	15.3	18.2	4.4	14.7	15.2	40.7	19.7	12.2	8.5	19.7	2.4	11.8	8.4	14.2	22.5	12.2	44.4	23.7	42.3	93.1	28.3	9.8	13.5	35.6	32.9	11.1	4.3	15.9	9.0	19.7	15.3	27.0	3.3	6.1	5.3	9.7	78.4	9.3	10.2	10.1	37.0
TMEM187	"CXorf12, DXS9878E, ITBA1"	ENSG00000177854	"Transmembrane protein 187"	Q14656	X	153972754-153983194	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in single"			HPA038134	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"		"HPA038134: AB_10669517"	"unprognostic (1.51e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.14e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.04e-2)"	6.9	9.1	5.5	4.8	6.5	2.7	6.5	6.3	6.5	6.7	8.9	6.2	5.0	5.8	7.0	5.1	7.4	4.2	6.2	5.5	6.0	5.6	8.3	4.8	7.7	6.8	6.3	7.1	12.4	5.6	6.8	3.6	6.3	6.7	3.2	2.7	10.7	6.2	6.4	8.5	6.8	4.4	6.7	7.0	6.4	3.9	6.1	5.4	5.0	3.2	4.6	5.9	5.6	8.0	11.9	13.1	2.9	11.6	12.1	10.0	1.8	4.7	2.9	1.4	4.7	2.8	20.7	1.8	27.5	5.2	7.7	11.3	3.9	7.4	1.1	15.8	6.4	3.2	8.3	4.8	10.4	1.9	3.5	12.8	12.1	4.0	7.6	7.4	4.2	7.4	2.9	15.0	6.7	14.7	6.8	2.6	2.1	14.2	18.4	6.5	2.0	20.1	9.2	3.9	4.4	4.1	8.2	6.9	5.8	3.2	11.9	4.0	7.3	2.4	2.6	10.1	2.9	10.9	7.7	2.5	6.9	7.7	1.7	31.5	15.2	19.6	21.5	11.7	21.8	14.6	25.9	23.1	11.4	18.8	31.6	19.5	14.1	17.0	11.4	30.6	29.3	17.7	5.5	6.5	6.3	6.5	5.5	6.0	6.8	6.3	6.3	6.7	6.1	8.0	6.7	0.0	6.3	3.9	4.7	2.8	6.1	11.7	5.2	4.8	9.4	9.8	5.2	12.8	5.1	7.3	6.2	13.3	8.5	5.9	1.9	10.1	0.3	9.4	5.4	7.0	2.4	4.0	1.5	8.7	10.8	6.8	3.6	7.9	3.8	9.0	7.9	16.1	12.4	1.7	1.8	8.2	12.2	7.0	3.3	0.6	14.6	7.1	10.6	0.0	7.0	14.6	5.2	0.5	3.7	9.9	3.8	14.3	3.6	5.9	12.0	8.7	6.5	6.0	6.6	7.8	5.5	1.7	9.4	4.3	4.7	9.9	6.9	14.7	8.1	3.8
TMEM214	FLJ20254	ENSG00000119777	"Transmembrane protein 214"	Q6NUQ4	2	27032910-27041694	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034551			Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Golgi apparatus, Cytosol"		"HPA034551: AB_10602481"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.39e-10)"	"unprognostic (1.54e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.92e-2)"	45.8	39.0	14.7	30.8	15.8	23.1	43.2	15.3	17.3	45.0	28.7	38.3	30.5	43.7	66.2	31.5	37.5	30.7	36.7	14.8	17.0	30.0	46.5	37.7	25.1	19.1	18.7	41.4	79.9	56.0	60.4	45.8	18.3	37.9	41.7	8.8	83.6	44.4	35.7	37.8	33.6	45.1	15.6	37.4	40.8	19.5	17.8	21.7	42.3	21.3	34.4	36.7	33.9	14.9	82.4	53.5	32.2	68.2	102.8	103.7	69.4	105.9	142.4	76.0	85.2	53.0	67.3	37.6	52.4	156.6	59.7	57.6	39.3	74.9	61.0	36.3	44.1	49.9	41.4	109.8	128.1	45.7	82.5	90.4	52.7	66.8	112.0	58.6	83.5	24.3	46.0	75.3	85.9	59.6	23.3	34.1	23.1	110.0	42.8	31.3	58.5	91.0	57.1	57.0	27.8	32.3	49.4	83.3	38.2	31.0	45.9	27.0	72.4	55.2	52.8	57.0	60.4	100.9	73.3	59.2	71.1	56.8	77.9	5.7	3.5	2.8	3.9	3.8	5.0	2.5	3.0	2.8	2.8	2.8	1.5	2.1	0.6	5.6	2.2	5.0	2.6	2.5	14.7	15.8	15.3	17.3	14.8	17.0	19.1	18.7	18.3	15.6	17.8	14.9	15.8	3.2	20.1	3.9	18.5	7.6	9.6	10.4	3.4	9.3	19.8	11.0	8.2	21.5	15.0	14.7	10.4	43.6	15.0	37.5	1.9	24.7	6.4	11.3	25.4	17.5	17.9	18.5	4.8	34.6	62.9	26.9	33.1	23.8	14.5	17.0	32.5	28.9	27.3	6.7	4.4	37.6	10.2	18.9	12.8	7.8	32.6	11.7	5.4	6.5	14.6	6.9	14.4	4.0	3.8	21.7	22.3	20.3	63.0	20.8	25.4	10.4	11.0	8.4	26.3	11.6	19.6	24.4	12.7	8.4	9.2	71.7	12.0	17.6	27.6	15.8
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212178-37258155	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.5;Exocrine glandular cells: 16.0;Pancreatic endocrine cells: 15.9;Spermatocytes: 55.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 7.7;HUVEC TERT2: 6.4;TIME: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045432, HPA071187"			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Cytosol	"HPA045432: AB_2732519, HPA071187: AB_2732174"	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.7	3.1	0.9	0.7	1.0	2.8	0.5	1.0	1.6	0.3	0.9	0.3	1.1	0.3	1.5	1.6	0.7	1.2	0.3	0.9	0.9	0.6	0.9	0.7	0.4	0.9	0.9	0.3	2.7	1.3	0.1	0.3	1.0	0.3	0.3	0.7	1.2	0.1	0.1	1.0	0.4	0.4	0.8	0.2	0.2	9.1	1.0	0.7	0.7	0.0	0.3	2.2	0.1	1.1	0.7	0.0	0.5	0.4	0.3	2.1	0.3	2.2	3.9	1.9	5.5	1.7	1.3	0.1	0.8	0.5	2.4	1.2	0.7	0.6	2.0	0.7	1.1	7.7	1.7	0.9	0.9	0.2	3.7	1.4	1.7	5.0	0.5	1.0	6.4	0.8	2.5	0.0	0.9	0.9	0.5	3.2	0.6	0.0	0.3	1.0	0.2	0.2	2.1	0.8	0.6	0.3	0.4	0.4	1.0	0.9	0.1	0.4	17.6	1.8	0.5	0.2	0.4	0.5	0.7	1.9	0.3	1.7	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.9	1.0	1.0	1.6	0.9	0.9	0.9	0.9	1.0	0.8	1.0	1.1	2.6	0.0	0.6	2.9	0.7	2.5	8.9	2.6	0.6	0.8	3.9	1.8	0.2	1.5	3.9	1.8	0.0	0.8	1.3	3.4	3.9	15.0	20.5	8.3	1.3	3.3	1.8	0.0	2.9	16.0	0.6	3.8	2.0	5.6	5.7	1.4	0.4	0.1	0.9	3.3	2.1	0.4	2.0	0.6	6.3	14.9	0.6	2.8	1.8	0.0	0.0	6.4	0.0	1.5	3.0	15.9	1.1	0.0	0.5	6.9	0.8	1.1	5.0	0.5	0.0	4.1	1.8	55.0	0.8	3.4	3.0	1.1	1.1	1.5	1.0	13.9
TMEM218		ENSG00000150433	"Transmembrane protein 218"	A2RU14	11	125096545-125111763	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038489	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"HPA038489: AB_10672748"	"unprognostic (3.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.63e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.95e-2)"	"prognostic favorable (5.50e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.72e-2)"	17.7	18.1	4.8	9.5	5.5	5.3	14.0	5.3	6.5	15.5	5.3	13.5	8.4	16.6	6.9	11.6	14.8	7.4	10.2	4.6	5.4	12.7	12.9	12.0	10.5	6.0	5.5	15.0	14.5	10.3	15.2	5.9	5.8	13.0	6.0	6.5	10.9	6.8	9.2	8.9	11.8	8.3	5.7	16.6	13.2	5.6	5.1	8.4	10.9	5.7	7.0	13.8	13.2	6.3	12.5	24.0	14.9	18.2	13.5	18.6	9.0	12.2	9.2	9.3	12.0	2.5	35.9	15.6	29.9	7.5	14.2	14.2	9.4	11.6	12.2	22.0	13.5	35.1	6.1	10.0	13.3	11.1	12.6	14.7	15.2	16.5	19.6	14.9	13.7	19.1	14.4	19.4	16.2	6.4	2.9	23.3	12.2	34.0	22.6	16.3	18.0	12.0	8.3	12.3	12.9	19.4	16.6	6.6	9.1	8.7	31.3	15.7	17.6	11.4	10.3	13.4	13.5	11.1	10.1	12.9	9.1	22.9	20.3	43.7	40.1	17.4	21.6	31.6	18.7	29.6	20.5	20.5	47.4	23.9	17.2	20.4	15.7	32.5	30.9	41.1	20.5	27.0	4.8	5.5	5.3	6.5	4.6	5.4	6.0	5.5	5.8	5.7	5.1	6.3	21.0	19.2	13.4	7.8	17.8	12.1	19.6	34.6	19.4	7.0	22.1	24.6	8.1	15.7	16.6	14.7	0.0	28.0	18.1	5.7	27.4	20.5	3.4	23.1	22.4	15.8	10.8	14.5	4.4	16.2	18.4	21.1	8.6	10.6	3.8	22.2	18.5	15.1	42.2	23.5	7.4	11.7	20.3	21.0	17.5	1.9	10.2	21.9	17.8	14.0	26.0	26.0	18.6	9.5	11.2	13.1	3.9	16.6	15.8	9.4	8.5	19.7	29.4	12.4	26.3	16.7	18.3	16.6	13.8	18.0	14.2	9.7	14.5	27.0	13.7	16.6
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA016579: AB_2669392, HPA059374: AB_2683995"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	26.6	38.2	61.9	13.0	60.1	23.8	27.1	58.7	76.8	25.1	57.4	26.9	15.0	28.1	24.4	36.1	29.6	19.2	34.5	61.2	65.4	32.8	49.4	22.4	16.1	61.7	64.4	26.6	28.6	30.6	38.4	13.0	62.3	39.0	14.4	10.6	26.7	23.9	36.8	28.9	23.8	18.8	60.7	25.0	30.1	28.8	63.8	21.1	29.4	20.7	14.1	27.6	24.2	59.5	26.2	31.2	25.7	42.3	39.2	28.2	20.7	39.6	45.1	52.9	44.8	13.0	53.5	16.5	30.2	42.4	24.6	35.3	28.3	38.5	21.9	22.0	54.4	27.6	24.7	30.1	58.0	27.8	26.5	49.4	21.5	50.8	28.7	24.3	35.7	32.4	21.2	37.1	33.6	23.4	40.1	29.2	48.3	27.0	38.6	32.8	17.7	33.5	51.6	15.2	54.8	48.4	30.6	42.6	39.7	9.2	42.3	44.2	33.1	31.1	26.1	50.6	38.1	39.8	38.5	17.6	47.1	53.3	45.8	38.2	20.6	27.7	32.5	32.5	24.8	37.4	29.7	24.6	18.5	30.0	29.1	30.2	56.3	31.9	35.3	30.4	37.4	25.6	61.9	60.1	58.7	76.8	61.2	65.4	61.7	64.4	62.3	60.7	63.8	59.5	22.9	9.6	13.5	8.5	25.4	11.7	13.3	26.2	15.9	42.1	24.0	29.2	8.9	18.6	13.3	12.9	14.6	30.9	20.9	24.5	39.2	39.1	25.5	13.2	17.2	20.6	29.9	43.8	12.4	40.5	33.9	22.6	18.8	12.4	17.1	22.0	11.0	15.1	28.3	43.7	15.0	21.0	40.7	8.5	12.9	76.9	20.2	12.2	26.6	6.5	20.6	51.9	22.6	17.1	14.4	48.6	22.7	19.9	18.6	19.9	28.8	19.2	7.9	18.7	13.1	19.6	20.3	27.2	18.0	19.3	13.5	30.8	20.5	22.4	23.1	12.4
TMEM245	"C9orf5, CG-2"	ENSG00000106771	"Transmembrane protein 245"	Q9H330	9	109015135-109119947	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023892	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA023892: AB_1845828"	"unprognostic (1.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.46e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-2)"	29.2	47.6	18.1	12.4	19.4	7.3	20.2	16.8	19.4	21.0	32.6	22.9	12.6	27.3	26.1	23.1	29.2	19.2	43.1	19.6	21.4	45.9	25.2	28.7	15.1	17.3	19.6	45.3	24.6	65.1	11.3	29.1	17.8	25.5	16.9	27.7	26.2	33.9	35.4	14.2	15.9	34.2	20.6	17.9	17.8	16.8	22.0	17.0	74.2	39.2	11.6	18.9	11.9	18.4	32.3	42.2	30.5	10.3	69.9	39.9	67.0	45.4	35.0	47.9	37.6	56.9	62.9	28.9	45.3	34.7	46.4	49.5	39.1	29.2	56.2	37.8	16.8	36.0	32.2	33.7	30.5	27.5	27.2	42.9	29.2	46.7	42.8	51.5	40.7	31.5	24.4	31.2	55.1	21.2	36.8	12.6	33.9	43.2	37.5	20.8	60.3	18.0	50.8	31.0	16.8	16.4	30.0	29.6	30.2	44.9	39.6	15.4	44.9	37.0	27.7	34.9	52.4	20.6	56.9	9.2	51.5	14.5	54.9	4.4	1.6	1.5	2.4	1.1	2.9	1.5	4.0	3.4	1.6	2.1	5.2	3.6	0.6	3.3	2.4	2.2	4.3	1.8	18.1	19.4	16.8	19.4	19.6	21.4	17.3	19.6	17.8	20.6	22.0	18.4	55.0	115.4	93.1	36.6	22.4	25.2	18.8	27.4	27.3	43.8	34.4	23.0	135.6	74.4	33.8	86.5	106.3	50.7	20.1	27.0	3.9	22.7	6.7	31.6	24.8	51.8	31.2	70.5	71.4	31.1	17.7	31.3	25.5	56.4	31.6	62.8	74.3	98.3	18.0	63.9	62.0	31.1	10.2	28.4	14.3	7.8	41.0	18.9	23.2	46.9	18.3	52.6	16.5	60.8	75.8	30.0	35.6	51.1	19.7	23.1	55.3	33.7	45.6	32.4	46.0	40.7	37.9	27.4	43.8	21.0	28.4	15.1	28.2	81.4	35.6	21.7
TMEM258	"C11orf10, Kud, Kuduk"	ENSG00000134825	"Transmembrane protein 258"	P61165	11	61768501-61792802	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044602	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"HPA044602: AB_10961423"	"unprognostic (6.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (1.34e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.58e-1)"	116.4	158.4	125.5	66.1	128.7	128.4	120.8	130.8	162.2	142.2	123.0	112.4	80.9	116.0	350.1	122.8	123.1	59.3	170.8	122.6	128.7	123.5	160.6	110.0	83.0	130.0	125.6	154.9	300.3	80.5	128.9	80.4	130.3	105.5	107.6	44.0	183.9	88.7	146.7	95.3	99.8	81.5	131.1	124.4	142.8	79.1	126.8	111.7	109.1	120.6	108.9	107.5	111.7	140.1	144.3	254.9	194.9	173.3	329.0	308.4	117.1	113.9	177.1	104.5	124.8	223.5	265.5	103.9	205.9	272.1	196.1	154.8	186.7	222.7	149.1	141.7	168.6	86.8	258.3	347.6	310.7	186.9	96.3	272.5	339.6	137.1	364.8	267.9	210.9	207.4	221.7	394.5	185.4	501.1	131.2	318.8	267.1	315.6	172.9	142.1	144.6	673.0	241.5	243.7	169.3	173.1	103.8	221.7	211.5	179.6	244.5	347.3	108.0	129.2	111.7	166.1	78.3	248.6	201.7	173.6	183.8	112.6	135.7	507.9	225.6	287.6	169.5	200.4	216.5	233.2	198.8	190.1	177.8	187.1	167.1	166.7	182.4	151.7	204.4	496.4	236.8	244.9	125.5	128.7	130.8	162.2	122.6	128.7	130.0	125.6	130.3	131.1	126.8	140.1	211.3	102.5	224.1	6.8	323.6	228.9	220.5	794.5	170.8	41.3	525.1	608.3	491.3	403.2	445.9	318.2	18.8	409.5	279.8	306.2	295.4	534.8	234.4	369.2	304.7	254.8	311.1	197.7	7.4	654.4	667.7	314.8	210.5	305.6	226.7	261.8	335.2	572.9	461.4	37.0	8.2	631.5	441.5	401.7	396.9	142.8	335.5	265.7	569.2	3.7	430.0	418.6	270.8	6.0	25.8	469.4	432.6	214.4	821.3	296.6	392.2	553.8	470.9	73.9	170.9	192.3	248.5	399.4	433.8	297.4	279.0	508.0	245.2	135.3	442.1	274.9
TMEM260	"C14orf101, FLJ20392"	ENSG00000070269	"Transmembrane protein 260"	Q9NX78	14	56488354-56650606	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 39.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Excitatory neurons: 66.7;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003502	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA003502: AB_1078314"	"unprognostic (4.63e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (7.11e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.81e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-2)"	4.6	4.3	4.5	4.0	5.4	2.1	5.5	4.7	4.9	39.8	12.4	5.8	5.2	6.2	7.8	3.4	7.4	5.9	2.5	4.4	4.5	6.8	5.6	4.4	4.7	4.6	4.4	9.3	4.5	7.3	3.7	5.7	4.5	5.2	5.8	6.9	3.8	4.5	2.2	5.6	5.7	3.9	4.4	4.0	5.5	5.2	4.5	5.8	8.4	2.2	3.8	4.7	3.6	7.3	8.0	5.5	4.2	8.9	14.5	11.9	8.2	8.4	9.2	5.4	6.4	2.6	5.8	6.5	8.0	6.2	6.1	9.1	9.7	6.1	8.4	8.1	4.9	4.2	2.7	3.6	10.2	5.9	9.6	14.6	10.7	3.0	10.3	9.8	7.1	4.9	5.2	6.8	7.1	5.3	3.1	2.2	3.9	13.0	8.6	4.3	6.7	2.2	9.0	11.7	8.8	4.3	9.4	6.7	5.5	7.8	8.6	9.0	10.0	10.9	4.1	8.2	4.2	4.1	3.5	3.8	6.8	4.3	5.5	0.0	1.1	1.2	1.3	0.8	0.9	0.7	0.8	0.7	0.9	0.7	1.2	0.8	0.5	2.5	0.7	1.9	1.3	0.8	4.5	5.4	4.7	4.9	4.4	4.5	4.6	4.4	4.5	4.4	4.5	7.3	12.2	19.2	17.2	39.8	13.0	5.4	7.1	5.9	5.7	14.6	8.0	7.7	3.7	2.8	8.5	22.0	4.2	10.2	9.8	9.4	1.9	8.1	88.5	22.8	17.6	8.3	18.0	7.6	66.7	3.8	7.7	10.4	9.2	29.1	12.0	20.0	8.9	13.3	6.5	6.7	62.8	10.0	6.1	12.8	5.0	31.5	15.2	8.7	1.8	39.4	11.1	5.2	14.4	69.9	106.0	5.6	7.6	10.9	9.3	9.3	9.5	4.8	14.2	16.4	0.0	7.0	8.0	9.3	11.0	10.0	5.5	11.1	8.9	14.5	12.1	8.0
TMEM268	"C9orf91, DKFZp547P234, FLJ38045"	ENSG00000157693	"Transmembrane protein 268"	Q5VZI3	9	114611206-114646422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 10.3;Breast glandular cells: 8.8;Endometrial stromal cells: 8.9;Glandular and luminal cells: 8.8;Granulosa cells: 9.6;Hofbauer cells: 8.9;monocytes: 19.1;Syncytiotrophoblasts: 8.8;Theca cells: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017199	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA017199: AB_1845845"	"unprognostic (8.57e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (3.61e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	7.3	7.7	11.0	6.9	12.7	3.6	7.5	2.9	16.6	6.5	6.4	6.9	3.4	6.8	6.3	4.3	4.7	3.7	3.3	14.4	6.1	3.3	5.3	5.2	9.5	4.4	5.3	8.5	4.7	14.1	4.1	4.8	5.3	12.2	5.4	4.5	8.9	6.5	4.6	4.2	6.3	6.8	5.3	13.3	7.2	3.9	6.5	8.6	6.2	4.3	9.4	6.3	5.1	11.3	4.7	7.1	3.8	8.2	10.1	7.6	2.9	4.3	7.9	6.0	6.1	5.1	2.0	19.5	3.5	4.8	17.0	8.1	7.4	3.7	5.2	9.9	4.6	6.5	5.8	4.0	17.9	13.6	3.0	6.7	6.5	7.8	8.4	7.7	4.1	24.9	12.3	51.5	4.4	13.6	15.4	4.5	9.8	6.0	7.8	17.4	4.5	17.7	3.5	3.4	12.5	8.4	14.4	18.8	41.3	2.4	25.2	12.2	2.5	6.0	6.8	2.3	8.3	27.8	27.5	20.7	3.1	11.4	11.0	0.3	1.3	0.2	0.6	1.0	0.2	1.3	0.7	0.4	0.7	2.2	0.9	0.8	1.0	0.8	1.0	4.7	0.1	0.5	11.0	12.7	2.9	16.6	14.4	6.1	4.4	5.3	5.3	5.3	6.5	11.3	1.7	0.0	10.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	8.8	5.2	0.0	0.0	1.3	0.0	0.0	4.7	3.0	0.0	0.0	1.4	0.0	5.0	8.9	0.5	0.0	0.0	0.0	4.6	1.2	1.3	0.0	8.8	0.0	9.6	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	19.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.6	0.0	0.0	1.9	4.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.8	1.1	9.7	0.0	0.0
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438504	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 101.1;liver: 100.0;parathyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.9;Hepatocytes: 184.5;Muller glia cells: 146.8;Proximal enterocytes: 575.7;Proximal tubular cells: 188.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 57.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"EFO-21: 26.9;Hep G2: 74.7;RPTEC TERT1: 60.0"	"Low region specificity"	"Detected in all"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA053794: AB_2682265"	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	53.1	11.1	2.1	6.6	2.0	0.7	25.6	1.8	3.6	21.9	2.5	37.3	53.5	6.4	4.8	6.8	3.4	23.2	4.8	1.5	1.8	101.1	100.0	15.4	10.2	2.5	2.1	12.7	13.3	124.7	1.0	14.9	2.3	3.9	19.0	23.6	7.0	7.6	2.4	10.5	76.1	4.8	2.5	25.7	18.1	5.1	3.7	3.0	31.1	4.2	4.9	7.0	5.6	3.2	0.0	7.3	0.7	0.3	4.3	0.4	1.0	0.2	0.1	0.0	0.1	11.4	6.4	0.0	26.9	3.4	0.6	1.7	3.0	0.0	0.0	0.0	2.9	1.0	4.0	74.7	5.9	0.0	0.1	9.7	0.0	0.0	0.0	0.2	5.9	0.0	0.2	10.9	0.0	0.7	0.0	0.8	5.4	0.1	0.2	0.0	0.1	9.9	60.0	4.9	0.9	0.4	0.3	2.9	0.0	5.0	1.2	1.7	3.8	0.0	10.4	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.1	2.0	1.8	3.6	1.5	1.8	2.5	2.1	2.3	2.5	3.7	3.2	12.2	25.6	9.6	0.0	3.2	2.0	0.3	11.1	0.0	2.4	1.8	1.5	2.1	82.9	13.6	18.4	0.0	64.9	0.1	179.9	50.9	36.1	0.3	7.7	98.8	15.1	9.1	5.3	0.0	52.3	3.8	17.9	11.7	10.3	1.3	16.4	61.8	184.5	64.6	6.7	0.0	22.0	14.2	65.5	5.0	1.9	49.7	19.5	1.8	0.0	0.6	146.8	0.0	0.0	0.6	15.3	68.1	3.8	0.0	0.1	575.7	188.1	7.6	17.4	0.0	0.9	14.8	0.0	0.8	1.0	2.8	104.1	2.4	45.3	23.3	2.3
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733528-12769457	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 219.8;skin 1: 64.7;vagina: 80.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 104.7;Cytotrophoblasts: 128.3;Macrophages: 121.3;Squamous epithelial cells: 116.5;Suprabasal keratinocytes: 201.9;Syncytiotrophoblasts: 656.6;Urothelial cells: 157.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3;urothelial cancer: 12.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 244.9;hTCEpi: 56.1;hTERT-HME1: 68.0;RT4: 36.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044165, HPA073122"	Enhanced		Approved	Cytosol		NA	NA		2500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA044165: AB_10961279, HPA073122: "	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.1	0.1	0.4	0.0	0.4	3.3	3.2	0.5	0.6	42.1	0.3	0.0	0.1	0.1	1.3	219.8	3.1	0.1	4.2	0.5	0.3	0.2	0.3	2.1	0.1	0.4	0.3	0.1	0.1	3.2	0.2	15.9	0.3	3.7	0.0	0.1	27.3	2.5	1.3	64.7	0.0	0.1	0.1	1.8	0.2	0.8	0.4	1.5	0.1	0.6	25.9	15.2	80.1	0.3	26.6	0.1	0.0	0.1	0.0	0.0	22.4	0.2	1.1	1.3	1.4	1.0	4.1	0.1	0.2	0.0	0.6	7.6	0.0	244.9	5.1	0.2	0.0	1.9	0.2	0.8	0.0	0.0	0.0	0.0	56.1	0.0	68.0	0.4	0.0	0.0	0.1	0.0	0.0	7.7	0.0	0.0	0.0	0.2	4.3	0.0	1.6	0.0	1.6	36.0	0.2	0.2	0.1	31.3	0.0	4.6	2.8	0.7	0.0	0.0	1.6	0.0	2.1	0.3	0.1	0.4	0.1	0.0	0.0	1.6	0.9	1.1	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	6.0	0.0	0.0	0.8	0.0	32.9	0.4	0.4	0.5	0.6	0.5	0.3	0.4	0.3	0.3	0.1	0.4	0.3	0.1	0.0	0.0	0.3	0.3	64.2	104.7	71.7	17.6	0.0	1.5	5.6	4.7	0.0	39.4	1.8	0.0	128.3	0.0	0.1	0.0	0.5	0.8	2.9	0.0	1.8	0.0	0.0	0.3	0.0	14.7	1.8	0.0	0.1	0.0	0.0	2.2	0.7	10.8	0.0	0.3	0.0	12.2	4.8	7.3	2.0	0.3	121.3	10.6	0.0	2.6	0.0	2.1	0.0	0.2	2.2	0.0	0.0	0.0	53.5	0.0	0.0	55.0	0.0	0.0	0.1	3.6	0.7	6.8	116.5	201.9	656.6	1.0	0.2	0.0	157.9
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059101: AB_2683905, HPA059790: AB_2684125"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	9.0	27.2	9.6	5.4	9.3	11.0	10.2	9.7	11.0	10.0	8.9	7.9	26.4	8.7	11.2	23.6	9.2	7.6	9.9	9.0	9.4	14.7	20.5	10.6	7.4	9.4	11.6	14.1	9.7	8.7	5.7	8.4	9.2	10.2	8.9	7.5	12.0	8.3	9.8	19.9	24.1	7.4	9.8	12.5	10.3	9.3	12.1	7.8	7.0	16.4	12.6	10.8	14.6	10.9	43.6	15.4	10.1	12.5	15.6	16.8	29.6	16.3	14.3	20.2	14.6	40.5	16.7	13.4	30.5	15.3	28.5	29.4	28.1	17.5	20.4	22.6	25.8	23.3	8.6	41.2	17.5	25.3	12.5	15.7	25.6	18.3	20.9	12.7	15.6	16.8	42.1	32.4	13.0	16.8	15.6	14.5	16.8	34.1	24.1	15.5	15.6	24.6	17.4	31.4	10.1	13.1	14.1	35.8	25.7	14.4	42.8	19.6	11.4	11.9	15.0	25.2	34.5	47.2	78.0	26.5	18.2	15.1	14.6	14.0	8.2	7.2	16.3	9.4	21.0	17.5	16.7	18.1	9.3	15.6	18.2	19.8	2.8	12.2	12.2	21.7	15.3	9.2	9.6	9.3	9.7	11.0	9.0	9.4	9.4	11.6	9.2	9.8	12.1	10.9	12.1	9.6	30.5	7.2	16.7	53.0	42.8	29.5	50.7	22.4	38.2	20.6	12.6	24.3	24.9	20.2	18.8	27.5	18.3	23.3	7.9	33.4	0.7	17.7	14.5	19.8	18.6	16.4	8.1	56.0	23.5	18.0	36.2	38.0	8.8	50.2	17.2	40.9	19.6	16.8	9.8	28.3	16.2	14.2	17.3	2.8	14.3	12.5	8.8	2.8	65.9	11.4	11.3	20.1	7.6	50.3	17.0	13.5	20.9	64.2	200.8	23.2	9.6	28.6	19.7	16.8	16.5	22.1	14.3	113.0	84.7	46.0	18.5	82.6	45.6	93.4
TMEM44	DKFZp686O18124	ENSG00000145014	"Transmembrane protein 44"	Q2T9K0	3	194587673-194633689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.2;Hepatic stellate cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 3.7;NK-cell: 8.1"	"Group enriched"	"Detected in many"	10	"granulocytes: 3.7;NK-cells: 8.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043718	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA043718: AB_10794662"	"unprognostic (8.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.31e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.78e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (6.55e-13)"	"unprognostic (1.23e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.66e-2)"	10.3	2.9	9.8	2.3	11.7	5.2	8.9	7.8	12.4	6.9	7.1	11.0	2.7	5.6	13.7	5.6	5.4	4.5	9.6	10.3	10.1	6.0	3.4	11.3	3.0	9.9	9.7	4.9	3.5	0.9	2.6	7.4	10.0	5.2	7.2	0.6	7.7	2.2	3.2	3.6	6.8	3.2	8.8	9.3	4.9	2.2	10.5	2.0	5.6	2.3	1.6	5.3	5.9	9.2	11.1	9.1	13.4	14.2	4.8	16.2	11.8	8.2	15.3	6.8	10.8	5.0	21.8	2.0	38.9	10.0	20.3	12.6	4.5	6.4	4.6	18.1	6.3	12.4	10.6	3.8	8.7	3.9	18.9	10.0	6.8	15.4	6.8	32.8	28.2	12.1	3.4	0.5	22.9	10.1	5.9	9.9	6.9	11.1	14.8	11.5	8.4	0.3	7.2	6.3	3.7	7.7	6.1	1.9	12.6	5.6	9.0	8.5	33.7	20.8	7.6	6.4	11.2	1.5	1.2	4.0	31.4	15.0	10.4	3.7	0.2	0.2	0.4	0.1	0.0	0.1	0.1	0.6	0.0	0.2	0.0	0.2	0.4	8.1	0.3	0.4	0.0	0.0	9.8	11.7	7.8	12.4	10.3	10.1	9.9	9.7	10.0	8.8	10.5	9.2	22.0	0.0	2.3	3.3	2.1	0.5	3.3	4.9	1.8	0.9	2.8	2.3	1.7	1.5	6.0	5.5	2.1	9.5	1.7	31.2	0.0	5.7	0.6	2.3	3.7	23.8	6.0	4.0	12.7	4.9	4.0	6.0	22.4	2.0	17.7	10.6	53.2	0.6	3.5	0.0	5.4	25.2	6.1	1.3	3.4	0.3	3.1	1.5	1.8	12.2	0.1	0.5	2.1	2.5	1.5	14.9	21.0	1.9	1.3	6.0	3.9	0.4	7.5	0.6	6.6	1.8	3.6	0.5	6.5	2.4	0.6	8.8	1.9	6.0	21.0	6.3
TMEM50A	SMP1	ENSG00000183726	"Transmembrane protein 50A"	O95807	1	25338317-25362361	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065192			Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA065192: AB_2685429"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-3)"	"prognostic favorable (8.64e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (7.39e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.39e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-3)"	"unprognostic (3.44e-2)"	47.2	63.0	43.9	44.5	47.8	41.8	55.5	45.3	55.8	47.0	43.7	58.5	49.6	35.7	53.0	36.5	38.4	45.7	44.2	45.0	44.4	55.0	33.4	58.1	52.2	46.5	44.4	26.2	32.6	49.5	14.6	57.7	46.4	54.4	65.7	45.4	81.5	52.7	16.9	41.1	55.4	46.0	47.2	46.9	49.5	16.1	45.5	47.1	47.0	26.5	47.3	55.1	29.8	50.4	43.3	44.6	74.3	42.3	132.9	119.8	28.1	89.0	123.6	143.4	159.5	36.5	110.9	50.2	47.9	274.6	55.7	62.6	56.3	61.9	161.2	126.1	81.4	104.7	47.5	55.2	96.5	82.4	80.3	128.0	91.4	106.1	60.5	69.7	107.0	50.8	73.1	79.5	140.9	30.6	53.2	90.2	90.6	73.7	37.1	45.7	85.3	88.9	148.8	30.9	64.5	42.3	89.0	64.2	72.2	69.3	32.7	52.0	171.0	86.5	36.6	144.9	36.8	52.3	61.5	45.0	117.1	117.2	50.3	275.5	76.9	109.8	87.9	94.7	91.9	49.6	77.2	91.1	55.9	40.9	55.1	76.6	159.2	80.5	117.3	51.9	95.4	106.3	43.9	47.8	45.3	55.8	45.0	44.4	46.5	44.4	46.4	47.2	45.5	50.4	244.8	144.2	84.2	21.2	107.9	253.4	184.5	392.3	146.8	43.9	162.0	164.8	105.6	102.9	212.7	169.2	27.1	108.9	191.0	175.6	50.9	300.3	25.4	136.4	119.3	203.3	83.0	93.6	31.6	215.6	312.5	198.1	91.3	180.8	126.6	58.2	152.0	68.3	227.1	25.2	27.3	170.7	309.3	162.4	245.1	12.7	151.9	223.8	199.3	16.9	253.8	102.0	154.5	28.1	48.8	315.3	164.8	98.9	168.2	340.6	120.0	113.1	205.1	41.7	210.4	71.6	200.6	94.7	47.0	166.8	317.7	181.6	180.9	116.9	106.9	274.3
TMEM51	"C1orf72, FLJ10199"	ENSG00000171729	"Transmembrane protein 51"	Q9NW97	1	15152532-15220478	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 87.0;Exocrine glandular cells: 74.1;Pancreatic endocrine cells: 71.0;Urothelial cells: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014547, HPA019441"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA014547: AB_1858121, HPA019441: AB_2670142"	"unprognostic (1.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (7.81e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.91e-2)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.67e-3)"	5.0	20.5	8.1	8.8	8.1	0.8	5.5	18.1	10.6	16.0	7.4	19.8	22.8	5.3	7.3	17.6	11.3	21.2	5.8	8.0	7.4	36.0	4.0	14.2	4.8	9.4	8.6	21.3	45.1	12.9	7.0	10.8	8.5	15.7	10.7	0.4	10.4	15.3	1.7	8.4	20.1	7.9	8.2	7.0	30.2	2.6	8.8	2.2	4.8	3.0	5.0	30.3	18.1	9.1	42.7	22.4	12.5	3.0	2.1	4.5	0.0	4.8	20.1	14.5	19.6	29.6	46.8	0.0	15.4	3.2	20.7	40.2	4.3	15.7	8.2	0.1	11.1	1.0	1.2	29.8	17.8	0.0	39.7	1.4	13.7	18.9	20.6	9.3	13.6	1.7	6.5	0.1	7.5	14.7	0.0	0.1	2.3	33.7	8.4	5.9	8.0	7.4	37.0	43.3	1.9	37.0	4.0	16.2	40.6	7.5	2.3	4.5	9.5	15.0	13.2	6.6	15.2	0.4	0.6	0.1	14.8	0.6	18.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	8.1	8.1	18.1	10.6	8.0	7.4	9.4	8.6	8.5	8.2	8.8	9.1	2.7	0.0	2.6	19.9	1.5	18.2	53.8	9.4	15.4	0.1	9.7	6.7	3.0	34.3	10.7	49.7	0.0	6.3	0.1	20.3	5.9	87.0	0.5	10.0	1.9	10.5	19.2	0.0	0.7	74.1	0.9	10.3	26.0	15.7	0.0	0.3	8.6	0.4	48.1	0.0	8.1	18.7	57.0	31.4	19.2	0.4	2.8	22.1	14.2	23.4	13.1	0.0	0.0	11.6	0.4	71.0	27.2	13.9	0.3	53.7	14.3	12.1	11.7	0.1	32.9	1.6	30.3	0.5	3.6	20.7	21.2	1.4	1.1	1.0	15.4	117.9
TMEM74	"FLJ30668, NET36"	ENSG00000164841	"Transmembrane protein 74"	Q96NL1	8	108606850-108787594	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 4.6;Bipolar cells: 4.7;Cone photoreceptor cells: 6.2;Excitatory neurons: 5.1;Muller glia cells: 3.3;Rod photoreceptor cells: 8.3;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.7;JURKAT: 1.5;NTERA-2: 2.1;RH-30: 1.5;SCLC-21H: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015672, HPA076461"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA015672: AB_1858132, HPA076461: "	"unprognostic (8.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.75e-4)"	"unprognostic (8.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.46e-3)"	0.3	0.2	1.8	0.1	2.2	0.0	0.2	4.7	2.4	0.2	1.4	1.3	0.0	0.1	0.0	0.5	0.1	0.1	1.3	3.7	3.0	0.1	0.8	0.1	0.0	3.8	1.7	0.1	0.5	0.0	0.4	0.0	3.5	0.1	0.1	2.5	0.2	0.1	0.8	0.3	0.2	0.4	6.1	0.1	0.3	0.3	1.6	0.3	0.1	0.2	0.1	0.2	0.4	8.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	1.7	0.7	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	1.5	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.7	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.2	4.7	2.4	3.7	3.0	3.8	1.7	3.5	6.1	1.6	8.2	0.4	0.0	0.0	2.0	0.0	0.9	0.7	0.0	4.6	4.7	0.2	0.6	0.8	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	1.8	0.0	5.1	0.2	0.8	0.7	0.0	0.1	0.0	0.5	0.0	0.7	0.1	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	8.3	0.0	0.8	0.9	0.2	4.1	2.0	0.6	0.1	0.1	0.1	0.0	0.0
TMOD3	UTMOD	ENSG00000138594	"Tropomodulin 3"	Q9NYL9	15	51829628-51947295	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 397.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001849	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		1200000	"Cluster 42: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Actin filaments"	"HPA001849: AB_1080313"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (7.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.58e-3)"	12.2	7.4	4.8	13.6	4.9	9.7	9.4	4.2	5.3	11.4	6.7	15.4	15.5	9.9	10.3	43.4	13.2	11.8	6.9	4.2	3.7	13.5	13.7	21.7	12.8	5.0	5.2	6.9	8.0	7.3	3.4	21.9	4.9	7.5	15.4	3.6	12.8	9.8	3.4	15.0	16.0	9.6	4.9	13.7	16.9	3.4	5.8	12.6	9.6	6.4	19.5	16.4	18.7	5.0	59.4	56.0	22.3	5.8	21.6	35.9	25.8	26.1	35.5	26.7	23.8	21.8	42.4	13.9	21.7	28.0	18.9	82.3	20.7	58.5	33.9	23.8	9.1	20.6	62.6	17.9	24.0	26.6	22.1	24.2	55.7	21.5	66.2	32.9	47.7	20.0	22.3	20.6	32.6	43.9	17.8	17.7	12.4	36.3	10.3	21.0	26.7	37.8	43.5	41.5	5.4	14.6	43.5	28.9	15.6	29.7	19.7	21.0	53.8	33.9	22.6	27.8	31.3	12.5	39.5	15.6	21.7	48.0	20.4	47.6	27.9	41.4	22.7	34.7	20.2	20.4	19.8	20.3	20.6	23.8	16.7	15.7	45.5	18.8	39.3	29.0	26.0	16.7	4.8	4.9	4.2	5.3	4.2	3.7	5.0	5.2	4.9	4.9	5.8	5.0	147.9	397.4	68.2	23.8	43.5	106.9	91.4	66.3	70.6	8.3	38.8	27.3	45.8	30.0	112.7	42.3	14.6	56.1	63.3	117.4	41.1	85.8	38.9	67.5	87.6	131.6	18.6	50.9	29.4	71.6	66.3	84.1	71.9	91.3	143.0	28.8	101.4	52.9	53.9	15.2	25.5	52.0	36.7	51.7	74.1	99.3	45.1	88.4	32.0	33.7	67.5	19.2	60.8	17.1	17.1	152.6	79.0	44.4	44.1	160.3	65.5	56.5	82.2	12.6	13.1	35.2	58.0	14.5	13.9	137.0	132.1	51.3	74.3	57.4	59.9	215.9
TMSB4X	"TB4X, TMSB4"	ENSG00000205542	"Thymosin beta 4 X-linked"	P62328	X	12975110-12977227	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 30742.3;Langerhans cells: 57681.0;monocytes: 48133.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033806	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Vesicles, Cytosol"		"CAB033806: AB_2256019"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	6173.6	4217.0	3255.7	5088.7	3773.0	8722.4	4452.0	3539.2	4521.9	3685.7	2999.1	4327.1	1776.8	3731.3	2877.9	2069.6	2709.3	4129.3	2652.4	3319.4	3573.5	3300.1	2360.4	6225.5	10448.1	4064.7	3620.0	2592.1	1852.6	483.2	1053.7	2450.2	4203.0	2335.6	3793.9	273.3	1886.8	2441.9	816.5	1962.4	3671.2	3340.7	4219.2	7935.5	4690.0	486.8	3591.8	6377.6	1648.7	1475.0	7233.8	5168.6	2907.2	4467.6	5980.6	4886.3	9387.7	14881.1	11264.5	12247.2	23.0	3083.9	8032.6	2344.3	4005.4	1016.1	4865.3	1417.1	2900.6	9443.7	4198.0	2564.2	1411.5	2072.7	3135.4	8343.4	80.9	1771.0	2621.8	12.9	2619.8	6994.8	14038.1	5755.3	2911.9	2781.9	2412.7	5704.5	14335.9	3714.1	230.0	22.0	8424.8	2121.5	8390.5	15083.5	3384.1	2853.1	3337.3	6352.0	3321.0	5858.5	14234.5	1720.4	994.2	422.9	4461.8	207.4	583.3	6898.2	5536.5	6961.4	11607.2	3383.5	1647.5	19441.4	3123.6	4432.5	3490.6	2774.8	5183.2	2860.5	2499.5	42940.3	34738.5	50992.6	21474.2	33907.1	18326.4	18757.1	23777.1	23343.2	31253.2	16919.4	19802.1	20330.2	35862.9	18444.5	37523.3	12797.6	34088.1	86809.5	3255.7	3773.0	3539.2	4521.9	3319.4	3573.5	4064.7	3620.0	4203.0	4219.2	3591.8	4467.6	6885.8	5253.2	4939.6	35.9	6293.8	8836.3	2708.7	10515.3	296.5	332.9	2318.3	1124.2	106.9	3484.4	8003.6	6882.2	22.9	283.0	9136.2	9016.2	2181.5	17304.6	142.1	2613.2	4698.0	9239.4	1765.0	1339.1	54.3	23029.4	511.7	4800.1	2728.9	5047.4	4380.4	4646.7	6638.0	1088.5	30742.3	62.2	81.0	4883.9	14806.8	20982.2	57681.0	343.6	3932.0	17648.1	6349.9	212.7	48133.8	86.7	20882.8	19.6	102.1	25113.5	5826.4	6035.9	2541.8	3272.5	6888.7	835.1	2596.4	99.4	5732.4	1018.2	5450.7	58.2	126.3	933.7	9528.5	454.8	12719.6	3874.8	3140.6	9064.0
TMTC1	"ARG99, FLJ31400, FLJ41625, OLF"	ENSG00000133687	"Transmembrane O-mannosyltransferase targeting cadherins 1"	Q8IUR5	12	29500840-29784759	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.0;Astrocytes: 64.6;Excitatory neurons: 186.0;Inhibitory neurons: 200.5;Skeletal myocytes: 60.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 83.0;HSkMC: 56.9;hTERT-HME1: 103.8;LHCN-M2: 58.8;RH-30: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016720	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA016720: AB_1858155"	"unprognostic (1.67e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.63e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.49e-4)"	"unprognostic (5.89e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.51e-3)"	36.7	14.1	14.5	5.2	21.0	0.2	16.8	6.7	13.5	11.9	13.3	11.9	3.1	9.0	3.0	6.8	14.3	7.1	16.5	20.0	25.0	14.7	2.4	8.7	2.7	11.4	24.0	9.3	2.6	28.0	10.7	2.8	15.8	6.9	5.9	2.6	4.5	8.8	18.5	4.0	6.4	13.2	7.9	42.4	8.3	2.4	25.1	6.9	4.7	31.2	2.1	12.1	8.2	6.3	0.0	0.0	15.3	0.0	47.7	31.6	0.1	14.7	33.1	4.3	3.4	0.0	0.2	0.1	7.4	10.0	17.6	0.0	0.5	0.2	0.2	0.3	4.6	0.0	41.5	0.7	83.0	2.1	0.0	56.9	5.6	40.3	103.8	12.2	2.2	0.0	0.0	2.2	58.8	0.0	0.0	0.0	11.1	0.2	20.8	0.0	122.4	2.1	0.0	0.3	1.2	1.2	1.7	0.0	4.1	5.4	0.0	0.8	6.2	3.7	2.4	2.3	12.5	19.6	0.0	0.0	27.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.5	21.0	6.7	13.5	20.0	25.0	11.4	24.0	15.8	7.9	25.1	6.3	105.0	3.2	0.6	64.6	0.9	3.3	1.0	6.1	11.4	12.1	1.3	10.4	32.3	0.0	2.4	3.7	0.0	0.1	0.0	0.0	0.0	0.1	29.6	7.7	16.2	57.9	0.0	0.0	186.0	0.0	0.0	17.5	2.0	7.0	0.0	4.3	54.7	5.4	0.5	0.0	200.5	0.2	0.0	17.7	4.2	7.5	8.1	4.9	10.6	30.9	0.5	0.5	0.0	9.5	5.7	0.0	0.0	18.4	0.3	4.0	0.1	0.7	6.0	1.3	46.0	60.3	24.9	2.4	1.7	1.3	2.0	1.9	1.0	21.9	0.0	0.4
TMUB1	"C7orf21, HOPS, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081085-151083493	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	33.1	53.3	26.8	25.6	24.7	23.0	34.3	25.6	38.6	34.0	19.4	52.7	47.2	33.6	8.6	54.2	32.8	14.9	50.4	24.9	24.6	56.3	131.3	41.6	26.3	29.6	25.9	37.0	93.5	20.3	68.8	20.4	27.0	51.2	8.3	5.2	44.1	14.9	84.5	47.0	56.7	9.0	24.2	53.6	66.8	25.9	29.4	17.9	51.3	20.0	12.1	40.8	38.9	23.7	88.3	77.5	18.0	93.2	11.6	14.2	67.2	35.3	29.3	30.8	34.3	67.5	104.6	58.6	73.9	17.4	39.9	58.6	20.0	31.2	6.8	108.0	74.4	24.8	74.8	104.7	29.5	31.3	84.8	22.0	25.4	25.8	6.9	23.4	22.9	59.3	159.4	77.4	14.0	141.2	104.5	134.5	77.2	51.7	48.3	64.8	22.7	108.5	32.2	67.4	65.6	73.2	28.6	43.6	47.9	10.6	34.0	42.9	28.3	39.0	28.5	49.3	59.1	121.2	72.5	41.4	89.8	58.2	50.4	4.2	3.1	23.8	5.7	4.3	5.0	5.3	8.7	6.4	3.2	11.2	8.7	4.8	5.3	3.7	2.6	4.8	12.1	2.4	26.8	24.7	25.6	38.6	24.9	24.6	29.6	25.9	27.0	24.2	29.4	23.7	24.0	6.4	3.2	7.5	51.2	26.4	25.9	26.0	31.9	15.2	45.7	34.8	9.9	28.6	15.9	22.0	14.6	93.1	50.2	136.7	35.2	73.1	11.9	15.8	11.7	21.5	41.3	23.2	4.5	109.6	60.2	18.3	52.0	29.3	15.9	23.3	25.4	51.4	44.2	20.2	5.3	85.9	46.8	30.4	61.2	5.1	12.5	32.4	32.0	6.5	44.8	28.9	70.0	2.5	7.2	96.3	109.7	16.6	67.8	39.3	191.0	37.9	6.4	16.0	39.5	9.3	21.8	22.3	15.6	39.5	36.9	94.5	52.8	25.4	84.0	37.9
TMUB2	MGC3123	ENSG00000168591	"Transmembrane and ubiquitin like domain containing 2"	Q71RG4	17	44186970-44191929	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043137	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Vesicles, Cytosol"		"HPA043137: AB_10794388"	"unprognostic (4.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.78e-3)"	32.2	35.7	34.1	22.9	34.4	43.9	32.5	34.9	38.1	37.3	32.5	39.1	24.5	32.5	21.9	37.3	33.9	25.2	33.1	34.2	32.8	36.9	35.8	31.5	26.3	33.6	33.8	35.2	36.9	27.5	32.9	25.9	32.9	42.0	21.9	16.8	36.1	26.3	32.7	32.4	36.5	21.7	32.2	52.8	36.7	46.8	34.2	23.2	42.7	20.0	20.5	35.3	34.3	34.3	22.8	43.0	27.6	25.1	41.6	32.8	21.6	29.5	31.6	53.7	54.4	22.7	41.5	15.8	31.1	36.1	40.5	42.3	19.3	28.0	33.4	38.7	39.7	16.5	40.9	35.1	43.8	18.7	35.5	40.1	39.8	36.9	22.9	45.1	37.8	25.8	19.2	45.4	35.7	15.9	26.0	23.8	9.1	19.0	35.7	23.2	33.3	25.5	33.8	25.2	21.8	22.2	15.5	14.4	29.4	27.6	42.2	23.0	31.8	44.4	27.0	31.1	26.7	33.5	26.1	15.4	34.0	15.7	30.4	84.1	30.0	57.3	17.1	26.7	14.5	16.6	14.3	16.5	19.1	23.8	13.4	15.3	65.4	13.9	29.0	23.1	18.1	20.4	34.1	34.4	34.9	38.1	34.2	32.8	33.6	33.8	32.9	32.2	34.2	34.3	24.8	35.3	25.9	21.2	40.8	13.0	21.2	27.0	25.6	30.8	29.8	25.3	16.7	22.8	27.2	22.0	31.3	46.3	24.9	42.5	3.9	21.0	51.0	13.9	16.8	20.4	33.5	25.7	15.8	18.8	29.6	22.0	23.0	25.1	22.1	25.6	18.9	13.9	42.6	21.9	16.4	27.1	12.2	37.9	25.9	28.4	21.8	30.9	14.2	16.9	31.5	29.1	25.7	14.6	12.2	25.8	33.2	24.0	18.8	20.5	39.6	10.7	18.9	27.9	26.3	14.6	19.6	81.5	37.1	17.2	14.9	96.7	27.6	30.0	27.0	23.4
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712593-57740973	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	52.9	75.1	77.7	37.3	83.0	27.0	50.5	87.4	101.9	43.6	103.3	70.0	56.4	39.4	58.2	62.8	42.7	33.2	71.5	75.0	84.1	78.7	83.4	45.0	31.5	81.7	81.5	40.9	57.7	84.9	43.1	44.0	83.5	50.1	80.8	64.7	49.6	53.8	44.7	45.1	58.3	43.1	84.3	44.9	60.9	30.6	85.5	34.9	57.1	41.3	47.6	48.2	43.8	90.6	122.7	141.4	78.5	143.4	144.8	77.2	86.6	144.2	111.8	140.0	117.9	135.3	205.6	115.1	156.6	116.3	207.1	220.0	203.5	115.4	146.3	83.3	88.9	110.2	105.7	136.8	119.3	156.6	145.5	94.8	166.5	154.8	243.2	76.3	80.6	95.3	194.4	130.9	157.7	62.7	93.0	177.1	153.8	227.7	191.5	124.7	97.9	242.5	174.4	136.4	90.3	129.3	110.2	255.7	168.3	76.7	228.5	102.2	66.7	130.5	84.8	176.1	152.1	127.9	269.5	115.3	146.6	109.3	198.3	37.8	41.5	40.0	34.6	72.4	44.0	36.8	34.4	40.9	40.6	34.9	43.1	43.8	11.2	37.8	86.0	49.7	32.0	45.0	77.7	83.0	87.4	101.9	75.0	84.1	81.7	81.5	83.5	84.3	85.5	90.6	37.9	38.5	34.0	0.0	32.0	32.1	44.9	108.2	19.9	43.4	35.8	28.1	42.6	30.0	60.8	49.7	31.3	108.0	29.9	39.5	43.0	72.4	2.0	19.6	27.4	36.8	28.8	37.6	0.0	43.5	85.6	38.6	23.0	20.7	43.1	29.9	31.8	48.7	62.0	30.3	0.0	49.6	81.4	30.8	21.4	3.6	48.7	31.9	48.0	0.0	37.8	91.1	19.6	0.0	0.0	54.5	32.0	43.6	32.5	49.0	51.4	41.1	37.4	66.7	39.5	36.3	34.5	60.7	62.2	33.6	32.7	99.6	26.6	46.6	75.2	43.6
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103121476-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 277.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 48.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 785.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: AB_2673552"	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (7.17e-5)"	119.9	76.8	9.0	103.6	11.5	106.8	78.4	6.7	12.2	53.8	12.1	39.8	38.0	50.9	6.6	88.3	57.1	102.2	48.3	8.0	9.7	67.7	61.6	142.4	87.4	17.1	10.4	16.9	33.6	66.8	16.6	48.4	16.2	73.6	26.8	1.6	84.0	14.9	35.0	53.3	52.5	24.8	13.6	147.9	37.4	37.1	21.4	39.5	36.8	32.5	80.3	277.5	74.6	16.1	34.7	156.3	1.1	0.6	10.1	45.9	54.5	9.7	43.2	26.4	8.9	1.6	148.7	0.3	120.3	48.5	142.5	104.2	11.6	0.0	11.9	6.1	0.6	15.4	120.0	0.7	19.2	7.7	20.0	17.8	1.6	8.4	0.1	10.5	14.2	7.7	15.5	35.3	3.6	3.4	0.4	11.6	9.7	19.6	13.4	6.8	18.9	24.9	80.8	785.1	1.3	2.3	150.2	52.4	1.9	5.6	83.8	50.4	28.4	5.1	13.5	30.3	31.5	31.4	2.4	0.9	38.1	34.0	16.1	5.9	16.8	9.0	0.1	18.6	0.1	0.1	0.1	0.0	9.4	0.2	0.1	0.1	48.4	0.2	15.0	0.5	0.0	4.5	9.0	11.5	6.7	12.2	8.0	9.7	17.1	10.4	16.2	13.6	21.4	16.1	45.8	0.0	25.1	2.3	8.2	28.3	41.8	295.5	6.8	1.1	24.2	11.4	14.1	51.5	126.1	27.6	0.0	1.2	1.3	1.0	0.0	160.9	36.8	92.4	122.2	47.1	17.3	1.7	2.5	44.7	61.2	123.3	5.6	172.8	33.7	4.5	18.9	8.0	54.1	0.0	5.7	0.3	85.5	151.2	198.7	48.8	8.4	163.3	30.2	25.3	351.9	5.9	5.2	1.0	0.9	122.1	18.3	2.2	11.7	186.0	0.7	14.4	121.5	0.7	19.7	104.9	39.7	2.1	4.6	20.7	33.4	4.8	8.3	1.1	1.9	138.6
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867214-137883312	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 519.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	57.0	15.6	4.4	114.6	3.8	519.5	23.3	2.9	23.9	27.5	12.0	22.6	21.4	31.3	5.2	26.6	23.4	47.8	23.0	3.2	2.8	13.8	27.4	56.2	76.8	6.1	3.9	73.2	25.8	25.8	7.5	28.9	6.7	17.3	24.7	19.1	16.1	10.3	8.6	50.5	30.7	33.5	6.6	46.1	22.8	8.3	9.5	71.1	11.7	3.8	55.7	171.1	14.6	6.2	32.6	4.8	1.8	2.8	10.1	16.9	7.8	18.8	67.6	4.8	5.7	34.9	8.8	7.3	43.1	20.0	106.5	22.6	1.1	50.4	8.9	46.8	2.2	7.5	19.8	21.1	11.2	10.3	12.8	15.6	7.3	56.4	53.6	5.6	2.9	21.2	17.4	161.3	8.4	1.8	56.2	41.4	1.5	2.1	1.4	151.5	39.4	6.1	14.8	15.1	0.7	0.3	3.6	5.3	16.9	7.0	3.4	11.7	14.8	46.9	6.8	46.0	9.6	48.7	131.4	14.0	16.9	13.1	6.1	7.3	12.6	9.6	19.6	9.3	27.9	7.4	19.4	18.0	14.3	7.8	13.1	10.1	13.6	11.1	5.1	26.2	19.2	14.8	4.4	3.8	2.9	23.9	3.2	2.8	6.1	3.9	6.7	6.6	9.5	6.2	71.8	38.5	76.3	2.0	94.5	774.9	150.2	102.1	384.7	1.1	29.0	42.3	4.6	25.8	53.7	0.0	29.2	8.1	395.5	53.9	1.9	60.0	2.6	605.2	365.9	114.8	11.9	5.2	0.1	26.9	104.8	110.1	111.1	1498.3	255.9	2.3	48.5	13.5	45.7	0.0	0.3	38.6	67.1	125.2	461.8	3.2	6.8	596.6	129.9	8.4	59.1	1.7	14.4	2.0	0.3	30.5	29.5	6.0	331.4	170.2	37.3	3.1	84.3	13.3	6.6	29.0	94.9	2.7	2.2	367.9	745.7	23.1	624.2	14.9	20.9	78.1
TNFRSF12A	"CD266, FN14, TweakR"	ENSG00000006327	"TNF receptor superfamily member 12A"	Q9NP84	16	3018445-3022383	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 612.4;Basal prostatic cells: 1315.6;Basal respiratory cells: 622.2;Ductal cells: 938.2;Exocrine glandular cells: 698.4;Pancreatic endocrine cells: 1232.3;Prostatic glandular cells: 757.9;Urothelial cells: 695.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"eosinophil: 139.6;neutrophil: 102.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 139.6"	"Cell line enhanced"	"Detected in many"		"U-251 MG: 699.6"									HPA007853	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		370000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA007853: AB_1858463"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.06e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.04e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.98e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.17e-2)"	42.0	45.9	5.3	27.0	5.2	8.3	24.4	6.1	9.9	12.5	9.4	26.5	37.5	34.8	1.2	17.6	19.0	55.2	108.3	5.6	8.8	133.5	61.0	72.6	2.4	8.2	7.9	8.2	116.3	56.1	59.3	33.0	7.0	33.4	4.5	4.8	48.4	17.1	58.5	18.1	21.6	32.5	7.4	6.7	42.6	5.4	10.4	5.2	37.0	9.3	3.1	73.8	13.9	7.0	217.6	155.6	17.7	31.9	31.0	71.3	109.1	444.3	277.5	316.2	205.5	70.1	336.0	1.5	566.2	270.4	401.3	224.2	4.2	283.4	132.2	8.3	11.2	1.5	52.4	58.4	205.1	3.7	15.2	65.2	196.7	345.1	433.5	298.1	100.9	0.6	24.5	2.4	362.7	394.0	0.6	28.3	85.5	88.7	369.6	1.9	207.1	7.8	355.8	37.6	19.9	7.3	314.7	127.9	255.8	57.7	69.4	5.8	192.2	601.9	303.2	423.8	699.6	6.6	2.9	3.1	190.0	18.9	488.8	12.2	11.4	139.6	6.1	7.3	7.9	0.2	2.8	4.9	14.6	0.2	1.4	2.7	102.9	8.0	4.7	0.6	3.4	4.0	5.3	5.2	6.1	9.9	5.6	8.8	8.2	7.9	7.0	7.4	10.4	7.0	16.9	102.5	37.7	0.3	6.9	612.4	1315.6	622.2	113.3	1.5	139.0	46.7	63.9	195.9	238.7	182.1	2.1	134.6	10.0	74.2	64.6	938.2	1.3	170.5	29.4	47.5	27.3	1.3	0.2	698.4	169.5	155.1	33.1	173.1	59.1	3.0	24.3	20.7	39.7	0.0	0.5	19.9	152.5	5.6	121.4	0.8	6.2	23.0	112.1	1.9	10.8	23.3	4.1	0.0	0.1	1232.3	155.3	6.8	5.3	757.9	52.9	118.0	118.4	5.9	6.6	190.5	228.6	10.9	9.4	35.5	359.7	189.1	25.3	1.3	50.0	695.6
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Host-virus interaction, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 148.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 179.9;Prostatic glandular cells: 180.8;Syncytiotrophoblasts: 178.7;Urothelial cells: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	35	"plasmacytoid DC: 69.2"	"Lineage enriched"	"Detected in single"	303	"dendritic cells: 69.2"	"Cell line enhanced"	"Detected in many"		"OE19: 208.0;RT4: 523.8;SuSa: 213.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	55.7	6.6	17.6	17.7	31.0	13.4	13.4	48.9	31.4	17.5	1.1	38.1	12.3	17.1	2.5	41.3	16.4	35.7	9.8	21.8	27.4	49.6	8.9	16.9	17.2	76.8	43.8	6.5	20.0	58.8	6.5	33.2	56.9	13.7	34.8	4.1	25.6	4.0	6.0	4.0	19.2	15.7	43.7	14.9	60.8	8.1	49.0	26.8	4.0	14.1	32.9	148.1	17.1	100.1	156.6	50.0	47.7	15.3	127.4	37.5	53.9	17.9	34.9	5.5	2.1	86.7	107.7	11.6	70.3	13.1	101.8	92.2	7.2	66.1	3.1	0.2	15.1	0.1	6.4	88.2	74.6	2.5	0.6	67.1	77.2	3.3	58.1	4.2	25.8	10.1	3.8	0.1	1.9	30.8	13.9	1.4	37.5	208.0	50.8	29.1	14.7	17.1	90.8	523.8	34.1	7.5	15.6	14.4	12.9	213.0	11.1	11.0	5.2	14.1	12.9	0.5	16.5	0.1	0.2	16.1	23.1	11.1	40.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.1	0.1	0.1	69.2	0.0	0.6	17.6	31.0	48.9	31.4	21.8	27.4	76.8	43.8	56.9	43.7	49.0	100.1	5.5	0.0	9.8	1.6	3.1	23.7	179.9	140.5	64.9	1.1	8.0	10.8	10.2	35.8	59.9	1.8	0.0	31.0	77.3	100.7	15.6	86.8	55.0	12.0	17.3	8.6	12.0	3.0	46.6	29.6	21.4	32.9	80.5	13.8	19.7	2.1	1.1	0.3	22.4	0.0	29.6	42.9	107.8	53.6	12.5	40.3	2.8	22.6	12.4	13.1	0.6	5.4	0.0	53.3	44.7	89.1	54.5	1.2	2.0	180.8	14.7	51.3	54.7	1.4	78.9	21.5	24.2	1.0	3.7	40.4	9.9	178.7	2.8	13.1	19.9	387.3
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784652-114806039	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 9.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.6;Basal squamous epithelial cells: 14.8;Endometrial ciliated cells: 15.7;Glandular and luminal cells: 28.9;Squamous epithelial cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.2;hTEC/SVTERT24-B: 8.6;HUVEC TERT2: 16.7;OE19: 16.0;RT4: 16.5;TIME: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	NA	NA	1110000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	0.8	0.7	0.1	2.5	0.2	0.1	0.9	0.1	0.5	1.5	0.1	2.3	9.5	1.0	0.9	1.2	0.9	1.9	0.0	0.1	0.2	4.5	0.2	4.1	0.8	0.3	0.1	0.1	0.1	0.8	0.1	4.4	0.2	4.1	2.0	0.0	4.8	1.9	0.1	0.6	3.5	2.0	0.0	0.5	2.9	0.1	0.2	0.6	0.9	0.0	1.0	4.7	0.7	0.4	0.5	4.4	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.2	3.0	1.6	0.0	0.0	0.5	13.2	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	16.7	0.0	0.0	0.9	0.4	0.6	0.0	0.0	0.3	16.0	0.0	0.0	0.1	0.0	0.1	16.5	0.1	0.0	0.0	0.7	0.0	5.6	1.2	0.0	7.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.1	0.2	0.0	0.2	0.4	0.2	12.8	12.1	0.0	0.1	0.5	7.7	25.6	14.8	0.3	3.7	3.7	0.6	1.5	4.9	7.3	0.0	0.7	0.4	8.0	0.0	4.9	0.7	15.7	2.9	0.3	0.0	0.0	0.1	2.0	0.2	1.2	8.2	28.9	0.0	0.0	0.0	0.0	2.3	0.0	0.7	2.4	2.0	0.3	5.1	0.1	0.0	5.0	0.0	0.0	5.3	0.1	0.0	0.0	0.1	1.3	0.5	0.4	1.2	4.9	8.9	9.3	1.0	0.3	0.0	0.4	3.0	0.0	0.0	13.7	0.6	0.3	1.0	0.1	7.4	6.5
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	622	"heart muscle: 10813.5"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 12618.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.9"	"Low region specificity"	"Detected in many"			"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		2400000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"CAB009349: AB_793465, HPA046428: AB_2679661"	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	1.1	3.0	0.3	0.0	0.5	0.0	17.3	0.2	0.4	0.7	0.7	0.7	0.0	0.3	0.1	0.8	6.2	0.9	10813.5	0.6	0.2	1.0	1.1	7.3	1.6	0.5	2.8	1.4	2.3	0.2	0.6	1.0	1.3	2.4	0.0	0.2	1.3	0.0	6.5	1.2	0.6	0.0	0.6	0.4	0.7	3.7	0.3	0.1	1.5	2.4	0.0	0.4	0.6	0.3	1.2	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	0.0	0.3	1.8	6.3	0.0	1.1	1.1	1.2	0.3	0.0	0.0	13.0	3.0	0.0	1.9	0.5	0.0	20.3	0.0	0.6	0.1	0.3	0.1	0.1	0.8	39.1	0.8	0.0	0.6	0.2	0.0	0.7	54.6	0.5	1.9	0.4	0.1	1.8	0.0	0.1	2.2	0.0	0.0	0.2	0.0	2.8	9.5	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.4	0.6	0.2	0.5	2.8	1.3	0.6	0.3	0.3	0.1	0.0	0.0	0.0	0.2	6.9	0.0	0.8	13.6	0.0	1.0	0.9	12618.4	8.6	1.8	5.5	0.0	1.4	0.1	0.4	0.0	0.7	56.2	3.5	0.1	131.3	1.8	0.0	0.0	0.2	0.5	202.7	0.0	1.3	0.0	996.2	0.0	0.0	2.2	1.7	0.2	0.4	2.0	0.3	0.7	222.9	0.3	4.6	1.8	1.9	0.0	4.2	0.0	0.0	0.1	1.0	0.0	1.9	0.0	0.0	0.0	0.1	11.2	0.5	0.0	0.4	123.6	6.4	16.1	0.7	2.8	2.5	0.6	1.2	1.0	0.1
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132698-55149206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	29	"skeletal muscle: 21567.3;tongue: 13372.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 61.2;Basal squamous epithelial cells: 47.8;Cardiomyocytes: 51.5;Skeletal myocytes: 192.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 211.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 211.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 829.4;RH-30: 638.8"	"Region enriched"	"Detected in many"	5	"thalamus: 125.0"	"Region enhanced"	"Detected in all"		"thalamus: 23.1"	"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		79000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavorable (4.66e-4)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	5.7	1.2	42.1	0.4	45.7	3.3	5.0	44.3	55.4	1.9	36.4	2.7	1.0	1.1	1.0	593.5	8.4	1.0	256.7	43.9	38.9	1.3	2.5	8.3	0.4	36.7	41.4	1.5	2.5	2.3	8.5	6.0	38.5	200.4	0.6	0.6	171.2	0.4	21567.3	48.5	2.0	0.4	35.6	1.9	1.9	10.6	40.8	3.4	3.8	13372.6	2.0	1.7	5.8	40.8	178.4	102.3	1.0	22.4	0.0	1.7	33.3	8.0	30.1	11.1	32.7	37.9	115.8	2.6	66.5	3.2	88.8	88.5	24.0	76.0	9.4	11.8	192.2	33.6	11.8	6.7	3.7	2.7	829.4	36.6	121.3	3.4	127.0	125.7	0.5	35.1	171.7	158.6	10.3	168.0	3.4	0.3	21.4	45.0	202.1	113.9	638.8	21.2	26.5	5.8	6.6	49.3	10.7	1.3	57.9	8.5	106.3	102.7	2.9	163.6	238.9	6.5	12.4	1.2	7.0	8.8	171.8	26.4	50.9	2.4	39.4	211.5	0.3	21.7	0.3	0.2	0.3	0.3	37.4	0.4	0.3	0.4	1.9	0.6	10.2	0.9	0.1	12.2	42.1	45.7	44.3	55.4	43.9	38.9	36.7	41.4	38.5	35.6	40.8	40.8	0.0	0.0	0.0	0.7	0.3	61.2	0.6	25.1	47.8	4.5	0.5	5.3	51.5	0.0	2.8	0.0	0.0	2.2	0.0	0.5	0.0	2.1	2.1	9.7	0.3	2.6	2.4	2.7	0.4	0.0	18.0	18.8	0.0	3.4	0.0	22.1	1.4	0.0	12.9	0.0	0.7	0.3	0.0	13.2	3.8	10.7	0.3	8.9	3.6	0.0	25.8	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.7	0.0	192.0	3.5	4.3	34.1	2.5	30.4	3.6	1.6	1.2	0.8	0.2
TOB2	"APRO5, bK223H9, TOB4, TOBL, TROB2"	ENSG00000183864	"Transducer of ERBB2, 2"	Q14106	22	41433494-41446801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016603, HPA054112"	Approved		Approved	Cytosol		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA016603: AB_2669400, HPA054112: AB_2682385"	"unprognostic (1.21e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (3.08e-5)"	"unprognostic (3.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.18e-6)"	"unprognostic (1.50e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.13e-2)"	46.1	31.3	39.3	15.6	56.3	9.7	25.5	78.1	40.1	26.5	18.5	30.1	22.4	25.0	11.8	26.6	38.4	28.8	41.2	39.3	43.8	24.6	27.1	20.7	18.5	61.7	42.9	38.0	29.0	35.6	22.8	22.0	44.0	26.6	15.5	55.0	17.2	19.4	86.5	27.1	23.9	20.1	39.5	20.6	30.5	13.6	52.0	19.6	36.1	68.1	19.7	23.3	21.0	71.9	36.8	16.6	28.5	19.4	65.4	45.5	27.5	23.9	36.7	29.8	26.2	21.9	17.0	22.4	23.5	34.8	11.6	31.4	26.7	13.4	27.1	23.0	34.2	12.3	23.9	33.4	44.8	33.5	15.9	42.1	22.5	35.6	15.4	30.1	30.2	7.6	18.9	24.5	24.6	40.8	13.9	19.2	24.4	48.1	17.6	29.7	19.2	19.4	21.3	25.3	13.1	8.8	60.0	32.2	44.6	17.7	17.9	16.5	37.9	29.3	27.1	23.0	22.7	22.9	10.7	12.2	17.8	14.2	19.7	3.9	5.9	4.1	7.5	8.0	7.1	10.0	6.2	6.3	5.3	7.5	3.2	4.7	3.8	3.8	8.4	8.0	5.5	6.1	39.3	56.3	78.1	40.1	39.3	43.8	61.7	42.9	44.0	39.5	52.0	71.9	48.5	48.1	59.6	48.6	61.4	126.8	66.6	24.3	105.3	56.0	83.1	56.9	59.8	58.6	31.7	47.8	64.6	34.7	56.9	76.9	23.5	29.7	41.1	88.6	59.3	45.3	54.3	16.8	12.2	19.1	37.3	54.1	42.3	116.9	34.1	13.7	52.5	29.7	19.6	25.2	15.1	67.7	10.2	22.0	117.9	61.6	66.8	51.4	53.4	14.0	34.6	58.3	18.6	10.1	43.6	32.3	60.0	82.0	26.2	73.6	103.6	29.2	45.9	105.2	52.6	97.4	60.9	23.8	28.9	88.7	136.7	63.3	57.4	19.6	61.9	92.2
TOLLIP	IL-1RAcPIP	ENSG00000078902	"Toll interacting protein"	Q9H0E2	11	1274371-1309654	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 498.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038621, HPA038622"	Enhanced		Approved	Cytosol		NA	NA		140000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA038621: AB_10673177, HPA038622: AB_10675946"	"unprognostic (8.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (8.89e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-2)"	26.8	35.4	58.2	12.4	73.5	13.6	25.8	27.5	80.9	35.9	17.6	26.3	25.5	23.5	11.5	93.4	22.4	18.4	31.3	85.0	39.4	43.1	113.3	26.6	14.2	39.9	39.1	24.6	58.2	18.9	54.2	12.1	39.8	31.4	8.2	11.4	31.6	20.5	76.2	75.9	23.4	11.1	32.9	28.8	31.9	73.4	42.7	13.2	24.7	22.7	14.2	33.5	48.8	56.5	31.4	32.6	16.3	18.6	34.0	21.2	14.2	27.2	24.5	31.3	27.7	35.4	19.5	14.6	25.6	25.3	47.9	27.7	14.7	33.4	8.5	30.1	30.1	11.9	6.9	54.2	48.4	22.8	29.0	32.1	38.5	18.6	17.9	17.1	19.7	21.7	19.9	38.5	26.1	26.3	29.1	27.9	20.0	33.9	42.1	21.8	16.6	14.6	20.9	41.3	43.5	25.5	24.4	29.4	30.7	8.3	23.3	25.7	36.0	33.8	14.4	14.4	16.0	38.8	37.8	18.3	53.2	14.9	27.0	45.4	126.6	139.6	33.4	114.0	27.8	38.8	35.3	31.5	99.9	50.0	27.4	26.1	179.1	44.5	108.8	52.4	48.8	77.3	58.2	73.5	27.5	80.9	85.0	39.4	39.9	39.1	39.8	32.9	42.7	56.5	19.5	9.6	19.3	15.0	27.8	66.9	43.9	71.7	23.3	42.6	30.3	24.6	22.8	58.6	30.9	23.9	8.4	49.2	28.0	50.8	70.5	66.3	173.6	11.7	14.8	24.9	51.6	45.0	35.1	69.2	41.1	27.6	19.4	15.8	38.1	20.7	37.9	112.2	92.1	74.0	17.0	30.8	48.8	38.4	33.1	498.2	21.8	48.3	71.2	16.9	50.6	38.1	19.6	10.6	15.0	76.3	53.7	30.9	33.4	55.7	66.6	110.1	15.4	20.6	6.6	18.5	24.5	100.7	39.6	76.3	98.9	104.4	22.0	27.4	29.3	74.0
TOM1		ENSG00000100284	"Target of myb1 membrane trafficking protein"	O60784	22	35299275-35347992	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 213.8"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 170.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000818, HPA001749"	Approved		Approved	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		44000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA000818: AB_2666101, HPA001749: AB_1080323"	"unprognostic (3.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.20e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.16e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.31e-2)"	34.7	47.8	20.8	17.0	19.4	60.8	32.1	19.9	25.8	43.6	23.6	22.7	29.1	26.6	12.7	76.5	26.8	24.9	43.2	19.8	26.6	32.7	49.0	37.1	15.3	30.2	24.5	21.5	20.2	48.5	37.4	27.7	32.9	23.2	9.8	5.9	60.6	11.7	213.8	74.9	28.4	10.8	19.6	23.9	20.8	25.9	24.8	13.1	26.5	68.6	12.7	19.5	45.0	22.1	15.8	15.3	8.8	14.3	58.3	34.9	42.3	15.5	43.8	28.4	31.1	21.5	14.3	6.2	28.0	45.4	18.3	7.3	8.6	15.6	9.9	18.7	21.3	5.3	17.1	43.8	58.6	10.8	23.6	49.8	19.2	39.6	13.3	18.5	19.8	11.6	10.3	15.3	14.1	13.8	8.2	27.5	7.0	18.9	8.6	14.9	12.3	13.2	10.9	11.3	14.9	12.1	34.1	34.8	34.5	7.3	18.0	16.7	22.0	34.0	29.4	27.3	7.7	18.0	12.4	16.7	45.7	10.5	11.4	18.6	100.9	44.5	19.3	60.7	15.6	13.6	29.5	18.4	48.0	11.0	22.6	15.7	129.1	15.1	66.2	25.9	48.2	63.3	20.8	19.4	19.9	25.8	19.8	26.6	30.2	24.5	32.9	19.6	24.8	22.1	10.1	22.4	36.9	8.8	12.7	12.7	10.3	29.5	7.4	11.1	19.1	11.0	23.2	15.7	33.0	12.9	12.5	64.6	13.8	41.6	27.4	40.9	29.9	32.0	17.8	14.2	16.2	9.7	9.3	38.9	57.1	22.6	15.3	48.0	22.8	10.4	16.1	34.0	60.8	11.8	15.2	18.1	50.8	33.5	35.2	21.4	11.5	45.2	19.6	7.5	34.0	19.5	9.2	6.6	13.2	34.2	21.5	12.8	5.7	11.9	55.3	34.9	24.2	8.2	6.6	16.6	15.4	23.5	5.6	17.3	21.9	170.2	18.2	13.4	15.2	10.7
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA		45000	"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	34.6	59.7	31.3	25.1	30.1	32.9	29.0	33.6	37.2	25.2	28.0	34.7	28.4	25.0	14.1	51.8	25.3	10.8	46.1	30.7	33.5	33.5	50.8	28.4	23.6	32.6	33.5	24.9	26.6	31.4	25.3	20.0	33.6	24.7	23.0	18.0	24.1	17.4	64.0	34.4	26.1	16.4	30.2	26.4	29.3	22.0	35.0	25.2	22.3	34.4	22.6	29.9	29.5	32.2	147.6	244.6	87.6	121.3	32.2	28.4	110.3	103.3	57.1	192.1	136.6	268.8	99.5	215.3	107.7	68.8	108.7	155.2	228.9	149.1	87.0	84.0	206.1	145.3	93.5	214.7	68.0	187.6	125.1	45.2	83.4	149.3	94.1	36.0	67.3	102.4	232.6	73.3	76.4	184.2	205.4	137.1	153.6	209.6	149.1	206.1	99.2	125.3	89.6	201.8	135.2	86.4	109.9	229.4	75.2	48.4	77.1	188.2	55.9	132.0	133.6	93.1	273.7	78.3	176.0	212.9	98.2	197.0	142.1	0.7	3.6	3.7	2.8	4.6	3.2	5.8	2.8	4.1	4.6	2.4	4.9	5.4	0.7	3.2	4.3	4.6	3.5	1.4	31.3	30.1	33.6	37.2	30.7	33.5	32.6	33.5	33.6	30.2	35.0	32.2	26.2	16.0	7.3	8.8	34.9	87.4	73.7	17.1	35.9	68.2	32.7	30.9	15.7	25.8	14.3	31.3	29.2	104.5	28.9	78.8	39.2	48.1	11.3	22.7	41.0	31.0	29.3	52.4	11.3	38.6	169.9	38.6	40.2	29.5	19.1	57.8	12.5	24.2	100.1	70.7	16.9	59.4	28.5	21.0	44.9	7.2	26.8	35.0	39.2	4.7	31.9	46.6	27.8	5.5	12.8	53.6	32.4	24.5	47.9	139.0	34.5	39.5	4.9	60.2	19.7	49.1	47.8	46.2	64.5	60.5	89.4	72.9	26.7	105.9	132.1	75.5
TPD52	"D52, hD52, N8L"	ENSG00000076554	"Tumor protein D52"	P55327	8	80034745-80231232	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 187.6"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 50.5"	"Group enriched"	"Detected in many"	5	"B-cells: 50.5;NK-cells: 15.1;T-cells: 22.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 252.6;SK-BR-3: 572.5"									"HPA028427, HPA062167"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		310000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	"Golgi apparatus"	"HPA028427: AB_10610561, HPA062167: AB_2684704"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.77e-3)"	"unprognostic (8.24e-2)"	"unprognostic (3.75e-1)"	"unprognostic (7.99e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-2)"	5.4	9.2	34.9	28.4	40.2	8.9	75.9	34.2	69.4	19.6	36.6	117.7	98.9	9.9	56.2	34.9	15.3	31.1	11.7	42.9	35.4	46.5	30.7	19.8	44.0	33.2	37.1	2.4	41.8	27.4	34.3	22.9	36.3	104.8	129.7	187.6	80.7	18.3	8.6	46.9	100.3	10.4	32.8	16.0	84.1	5.2	53.3	15.5	64.5	9.8	56.2	20.9	20.2	48.1	131.8	34.9	1.6	23.0	0.0	0.0	51.7	8.6	12.9	34.7	17.1	18.0	37.4	189.9	45.2	0.8	25.5	52.5	52.7	36.3	24.6	23.8	44.2	26.8	46.9	29.4	0.2	8.6	0.7	0.0	25.2	0.1	12.2	21.6	2.0	128.9	0.4	252.6	0.1	43.6	42.6	39.4	11.7	148.8	86.0	0.3	0.7	122.0	60.7	31.6	64.9	44.1	40.1	572.5	110.7	51.0	55.9	34.2	2.1	0.0	35.2	0.6	30.8	94.1	87.1	155.2	22.5	0.2	2.6	0.6	0.1	5.5	12.7	0.1	22.0	50.5	12.4	11.1	2.5	44.7	8.1	9.3	0.5	15.1	0.1	5.2	9.1	8.3	34.9	40.2	34.2	69.4	42.9	35.4	33.2	37.1	36.3	32.8	53.3	48.1	17.3	44.8	67.8	10.4	133.6	80.7	89.6	83.4	51.2	171.1	105.6	54.2	22.2	82.9	78.1	66.2	118.9	98.9	28.6	230.9	170.2	112.8	20.6	25.2	8.4	26.2	169.9	11.6	85.4	79.6	116.9	6.7	97.3	72.8	1.3	15.3	25.7	40.6	13.1	32.0	53.9	331.9	476.0	14.6	24.2	13.0	1.2	10.8	104.9	37.5	91.2	50.3	60.8	69.9	181.0	79.7	317.5	1.5	270.5	214.4	132.3	135.3	21.4	232.2	0.0	49.6	8.3	1.6	18.2	91.4	124.6	231.2	51.3	0.3	247.1	135.4
TPD52L1	"D53, hD53, TPD53"	ENSG00000111907	"TPD52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.3;salivary gland: 298.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 390.1;Squamous epithelial cells: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	44.7	258.3	83.9	10.1	96.2	0.8	67.0	72.6	97.4	35.8	103.4	36.2	9.7	15.2	68.8	152.4	34.6	27.3	71.4	78.4	81.3	40.6	58.4	10.9	6.6	81.4	76.8	20.7	47.1	67.3	24.8	8.9	78.8	41.0	13.0	1.9	298.3	79.1	111.9	47.9	10.6	12.3	68.5	2.0	43.1	5.1	81.5	3.4	60.7	126.2	12.3	59.6	60.8	76.6	37.7	42.0	0.5	269.1	2.4	0.6	63.3	6.2	5.9	0.0	0.7	67.3	46.9	0.1	136.2	31.2	9.1	83.8	8.4	58.2	0.2	0.8	58.0	0.8	58.0	0.5	5.7	0.2	0.1	7.4	234.3	0.1	30.7	82.5	0.0	0.0	30.5	0.6	4.7	365.5	0.0	0.7	4.4	36.8	22.7	0.4	0.1	0.0	271.4	9.8	9.1	0.2	70.5	189.4	4.6	9.6	162.3	0.8	0.2	1.8	5.9	0.5	2.0	0.1	0.1	0.2	1.0	0.3	0.7	1.8	0.5	0.3	0.3	0.2	0.3	0.3	0.6	0.2	0.2	0.4	0.7	0.5	2.7	2.6	0.1	0.4	0.2	0.4	83.9	96.2	72.6	97.4	78.4	81.3	81.4	76.8	78.8	68.5	81.5	76.6	141.6	0.0	28.3	390.1	2.2	19.6	44.6	70.2	128.1	3.8	164.4	154.9	45.8	25.8	51.7	125.0	4.2	32.7	3.2	3.9	176.1	30.7	6.9	71.7	21.1	87.2	16.2	0.0	16.4	110.8	140.2	18.8	13.7	184.5	2.5	29.5	15.4	59.9	10.9	0.0	48.2	11.3	83.4	2.1	5.2	4.9	17.4	3.4	131.6	28.1	0.6	3.9	1.0	11.6	2.9	35.3	2.3	36.5	2.6	37.1	10.9	45.4	15.7	1.3	0.0	177.1	10.1	5.7	9.2	272.2	37.2	14.4	3.5	53.8	17.8	19.2
TPD52L2	"D54, hD54, TPD54"	ENSG00000101150	"TPD52 like 2"	O43399	20	63865228-63891545	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 187.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047489	Approved		Approved	Vesicles,Cytosol		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Vesicles	Cytosol	"HPA047489: AB_2680067"	"unprognostic (1.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (3.63e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.74e-8)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.15e-3)"	85.1	84.6	75.8	52.8	76.8	98.9	68.9	76.0	88.1	74.1	74.0	79.7	38.3	72.6	31.4	109.6	68.0	42.6	85.7	76.8	81.6	66.2	51.4	60.8	43.2	80.8	77.4	60.7	45.5	38.3	58.9	65.9	79.5	66.3	35.2	24.6	50.3	60.9	70.2	70.8	52.6	72.1	78.0	71.4	54.5	40.2	83.5	35.7	49.8	53.4	41.7	83.6	71.5	81.4	175.2	87.9	54.5	66.9	122.4	193.8	80.4	196.7	173.0	343.1	145.0	326.9	194.9	70.0	211.3	200.0	204.2	168.4	111.5	269.0	198.7	39.5	46.4	66.9	112.6	199.6	129.9	85.0	66.3	140.3	296.6	138.5	221.3	121.6	160.1	74.0	140.4	101.0	137.0	96.3	83.5	109.4	78.7	172.6	308.1	114.0	59.5	113.3	135.8	76.0	82.3	92.2	230.9	177.5	165.3	80.3	120.6	171.5	170.1	273.4	79.1	160.9	145.4	63.2	108.6	85.0	256.8	79.0	86.6	66.9	73.0	47.1	29.4	55.1	36.8	33.5	32.3	34.2	47.6	31.4	32.4	29.8	137.3	47.5	48.1	24.0	38.8	74.6	75.8	76.8	76.0	88.1	76.8	81.6	80.8	77.4	79.5	78.0	83.5	81.4	37.5	16.0	23.4	36.2	26.6	44.1	28.3	58.8	33.0	18.9	28.0	31.1	45.4	20.0	31.3	22.0	6.2	77.2	28.6	27.8	39.2	50.5	7.8	21.7	38.4	36.7	18.6	26.9	19.6	32.1	104.0	37.7	23.9	31.9	38.7	25.8	28.9	14.5	187.3	8.4	21.7	27.2	20.3	47.4	33.0	12.1	42.0	52.3	28.4	7.5	50.6	32.5	27.8	13.6	32.3	74.8	25.1	65.1	29.4	51.7	37.5	36.6	26.5	19.7	46.0	18.9	65.6	13.9	25.6	37.2	42.3	108.8	25.0	42.3	27.9	44.4
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 10621.0;skeletal muscle: 12678.0;tongue: 5183.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 13012.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 3141.3;SuSa: 3810.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		120000000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	372.0	103.6	49.8	232.9	53.2	21.6	348.8	52.4	53.9	577.4	59.3	2947.3	289.6	1566.9	250.5	639.0	823.8	288.0	10621.0	53.3	42.2	215.5	94.8	247.1	48.1	42.5	44.3	320.3	383.4	37.5	70.6	206.4	43.7	809.6	523.1	83.9	258.2	1545.5	12678.0	150.7	680.8	1754.9	44.8	134.3	976.5	52.3	50.0	21.1	156.8	5183.6	29.4	1511.0	425.8	42.2	554.5	357.3	418.1	20.9	143.1	89.9	1335.5	1509.1	552.8	905.9	669.2	253.9	107.6	1.7	677.7	1517.1	602.7	295.9	361.8	243.4	597.0	14.5	50.9	81.2	376.3	124.5	403.3	3.8	17.9	125.7	138.0	742.1	198.2	3141.3	243.2	14.7	8.7	20.4	695.3	286.4	25.6	7.1	496.0	129.0	61.1	9.0	146.5	15.8	1308.7	298.8	101.1	71.7	180.9	284.4	65.1	3810.3	204.8	15.3	1095.8	1178.8	572.0	181.6	1094.8	5.9	4.3	7.8	335.9	22.4	842.1	48.7	9.9	4.8	4.0	19.2	3.1	5.5	3.6	4.3	14.1	5.6	4.0	3.6	10.7	1.9	14.3	2.4	6.3	15.6	49.8	53.2	52.4	53.9	53.3	42.2	42.5	44.3	43.7	44.8	50.0	42.2	542.3	57.7	86.3	19.9	12.1	71.9	202.0	344.1	18.2	49.0	450.1	953.1	13012.4	346.0	147.0	318.2	383.7	212.1	20.6	561.3	187.9	2502.6	6.5	147.2	614.4	294.3	267.7	137.0	44.2	1671.1	3094.8	557.1	279.3	211.2	52.0	85.3	175.6	138.1	201.5	52.2	53.2	964.7	183.1	42.5	72.1	27.3	205.0	114.3	81.8	111.5	47.5	47.4	28.8	36.2	6.0	2372.3	623.4	1130.3	8.8	244.3	724.7	361.1	104.2	447.5	1038.7	484.0	1685.9	27.4	82.2	29.4	50.4	103.0	29.0	130.7	385.3	198.2
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease variant, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	13	"skeletal muscle: 8905.8;tongue: 6106.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		170000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (6.73e-6)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.39e-5)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	140.7	103.2	95.0	233.2	104.1	590.1	97.1	83.3	116.2	94.9	73.3	199.0	163.5	69.6	73.4	287.4	100.6	136.1	318.5	104.8	101.5	81.5	114.4	178.7	287.3	96.6	101.4	45.4	265.9	91.7	19.6	141.1	101.6	122.3	201.5	60.3	101.5	56.0	8905.8	103.0	167.8	111.6	94.6	208.9	152.8	64.8	93.8	203.0	88.8	6106.5	287.2	183.2	29.7	98.2	529.4	332.8	306.1	225.4	262.1	341.1	317.9	439.0	419.1	597.9	437.7	596.1	513.9	414.6	366.9	500.2	206.4	472.1	320.0	468.7	485.8	315.7	171.9	537.6	234.1	311.7	200.9	728.2	627.5	260.0	246.2	515.8	355.1	224.9	929.4	269.0	411.8	429.7	710.0	342.2	582.0	683.1	714.2	775.9	515.9	510.0	233.2	574.9	405.6	387.4	234.4	409.4	360.0	443.7	419.2	303.9	645.0	788.9	758.8	558.8	353.9	497.3	711.1	332.4	623.0	516.2	490.7	514.7	860.0	932.1	743.2	1729.3	547.2	945.6	480.1	395.2	464.0	504.4	792.6	324.5	347.2	442.6	824.3	386.4	1104.4	392.9	551.5	2029.4	95.0	104.1	83.3	116.2	104.8	101.5	96.6	101.4	101.6	94.6	93.8	98.2	346.0	621.8	343.2	17.6	318.6	149.5	227.6	169.5	127.5	84.2	135.4	88.4	85.0	125.8	275.6	97.5	31.3	127.3	475.7	494.5	105.7	292.1	72.3	353.7	191.1	395.7	141.0	189.8	65.7	347.0	331.0	170.4	245.6	474.2	531.3	119.5	200.3	110.6	559.1	304.5	50.5	291.2	93.6	355.6	504.7	182.3	46.6	648.3	152.9	31.9	704.0	54.5	466.5	12.5	30.6	530.4	363.9	29.7	218.2	204.8	220.1	179.8	230.8	62.8	19.7	155.1	128.5	38.6	67.6	223.6	143.3	101.9	422.6	119.2	302.1	324.6
TPM4		ENSG00000167460	"Tropomyosin 4"	P67936	19	16067021-16103002	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1297.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 2111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004685, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		370000000	"Cluster 44: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Actin filaments"	Cytosol	"CAB004685: AB_425723, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.27e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-3)"	"unprognostic (7.38e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	324.1	109.9	24.7	186.3	26.3	33.8	269.0	42.1	40.4	342.4	23.4	255.0	64.6	455.0	10.6	401.8	310.0	144.8	189.6	23.2	27.0	168.1	54.1	374.1	78.2	30.7	28.7	293.8	77.9	23.6	93.4	170.7	31.9	212.1	39.2	3.6	267.2	140.4	50.3	241.4	153.8	190.4	29.1	244.1	201.4	66.2	36.6	32.4	119.4	19.3	68.5	287.5	333.8	27.8	614.5	275.2	194.7	190.9	701.3	728.2	725.6	1082.9	470.3	356.4	357.7	325.5	473.5	31.1	724.2	492.9	383.9	331.6	72.9	386.7	141.6	503.8	138.8	305.4	270.2	232.3	357.0	52.3	728.3	715.2	94.0	327.6	331.1	353.2	427.2	115.7	46.2	217.9	360.8	290.2	152.4	233.0	227.1	461.2	380.4	201.4	413.2	143.4	87.3	387.9	75.3	315.3	670.4	155.5	298.8	90.6	5.3	60.8	1237.2	954.1	166.8	2111.0	875.3	82.4	167.3	142.5	651.4	144.5	337.0	130.8	81.4	5.9	96.0	93.9	71.4	59.6	69.0	84.3	96.6	53.0	18.6	47.2	82.1	75.2	50.4	76.8	151.0	158.4	24.7	26.3	42.1	40.4	23.2	27.0	30.7	28.7	31.9	29.1	36.6	27.8	389.4	400.6	156.6	9.4	148.6	431.1	1297.2	175.2	273.8	45.9	194.3	189.4	49.1	120.1	297.0	242.8	10.4	263.5	205.6	298.4	13.7	717.1	67.3	159.0	506.6	425.5	94.0	33.4	23.8	571.6	852.9	345.1	303.7	305.0	249.6	170.8	288.8	4.2	336.8	5.0	19.0	215.8	101.7	112.0	368.8	54.8	173.1	433.2	142.3	26.2	249.5	7.5	132.8	13.6	48.5	1017.2	258.8	547.2	310.9	900.2	61.2	29.0	133.1	11.7	335.2	170.0	516.6	29.5	10.1	328.2	343.8	568.9	192.0	222.3	162.7	1025.0
TPRG1L	"FAM79A, FLJ21811, RP11-46F15.3"	ENSG00000158109	"Tumor protein p63 regulated 1 like"	Q5T0D9	1	3625015-3630127	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063163, CAB079051"		Supported	Approved	Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Cytosol"		"CAB079051: , HPA063163: AB_2684953"	"unprognostic (1.92e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.46e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-3)"	"prognostic favorable (1.76e-9)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-1)"	45.7	37.3	80.3	21.4	84.6	35.4	36.5	58.7	92.7	39.5	56.9	49.4	50.1	36.5	40.7	56.8	48.1	37.7	52.5	87.7	81.1	65.6	85.5	34.4	27.4	80.3	74.7	49.0	38.1	38.4	47.0	24.0	83.9	33.3	46.4	49.8	39.9	47.0	67.6	54.7	54.4	35.7	62.9	30.2	40.5	18.7	80.3	25.0	43.5	70.0	38.5	41.7	39.8	76.9	31.3	22.0	13.3	23.9	98.1	67.8	12.2	45.4	62.4	41.3	27.2	41.5	27.9	11.5	39.6	62.5	22.2	48.1	16.1	42.0	34.7	36.7	25.7	16.0	24.4	48.4	59.4	23.6	18.3	51.3	60.7	34.2	34.7	50.2	59.0	19.7	11.6	39.8	58.3	14.3	17.1	24.2	17.9	71.5	50.9	14.2	19.8	27.8	42.5	32.3	37.1	36.6	24.3	49.8	50.6	30.2	31.2	20.3	67.7	34.5	10.2	79.3	13.1	35.9	49.8	13.0	20.4	51.2	4.6	20.7	3.6	5.6	5.9	2.9	7.6	4.9	6.7	6.0	3.2	6.2	6.2	7.2	18.9	3.2	3.1	8.9	4.1	3.8	80.3	84.6	58.7	92.7	87.7	81.1	80.3	74.7	83.9	62.9	80.3	76.9	21.1	16.0	17.8	9.4	9.3	12.0	10.1	9.2	6.8	50.4	15.6	16.9	39.7	12.8	8.8	11.0	8.4	10.6	23.0	69.8	11.7	18.0	3.0	30.1	13.3	16.8	19.2	11.0	12.8	35.4	12.3	20.3	11.7	19.5	8.2	8.2	28.2	61.4	15.7	126.2	10.1	29.2	20.3	18.6	9.7	4.1	18.6	12.8	7.2	2.8	14.0	71.3	20.6	4.5	6.6	33.8	27.4	21.4	9.7	10.8	62.3	37.6	22.9	38.0	6.6	16.3	19.9	7.0	12.8	21.0	18.9	9.2	12.9	21.8	28.4	9.4
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	201	"testis: 107.2"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 464.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.7;K-562: 8.2;Karpas-707: 6.4;MCF7: 4.9;PC-3: 4.8;RPMI-8226: 9.0;SuSa: 7.6;U-266/70: 7.7"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.4	0.0	4.9	0.0	0.0	1.0	0.0	4.8	0.0	0.0	9.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	7.6	0.0	0.0	0.0	1.8	4.1	2.1	0.0	7.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	13.9	5.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	13.1	0.0	0.0	464.7	69.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 7.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.9;Early spermatids: 9.8;Excitatory neurons: 4.6;Inhibitory neurons: 6.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 7.5;Oligodendrocytes: 3.6;Spermatocytes: 14.8;Spermatogonia: 3.9"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 4.8;Karpas-707: 1.3"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.1	0.1	0.3	0.1	0.4	0.0	0.1	0.6	0.9	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.1	7.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.9	0.4	0.5	0.5	0.4	0.6	0.5	0.4	0.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	6.3	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	3.7	0.1	0.5	0.0	7.5	3.6	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	14.8	3.9	0.0	0.1	0.1	0.1	0.1	0.0	0.2
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185914558-185938103	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 444.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		62000	"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	38.2	41.3	18.1	35.2	19.1	46.3	30.2	23.0	31.1	25.2	25.7	41.7	21.5	31.3	26.3	38.7	27.1	16.0	31.7	19.6	22.3	41.6	37.5	21.5	38.7	19.8	17.2	25.5	28.3	28.9	20.3	26.3	20.4	25.8	24.9	18.5	27.0	18.4	34.1	25.5	27.0	25.2	17.4	36.2	31.1	22.4	19.5	47.6	23.2	23.2	43.9	28.7	26.8	26.3	145.0	44.2	135.0	67.8	30.3	27.3	78.2	101.5	71.1	117.5	90.2	75.3	67.6	124.5	134.4	53.2	79.5	94.1	140.9	104.5	120.9	117.5	89.6	122.0	40.1	92.7	42.4	133.3	101.1	26.5	44.3	75.1	51.0	36.5	90.4	63.5	120.4	81.6	79.6	66.4	344.9	164.1	191.3	113.0	85.5	201.1	109.4	147.5	94.3	58.9	98.0	104.0	73.3	90.1	117.8	66.5	101.1	138.0	52.7	81.3	110.8	68.2	170.1	159.6	444.0	272.0	78.0	151.0	130.6	84.1	39.2	33.0	36.3	33.1	32.8	71.2	36.1	34.0	35.3	64.0	45.0	40.9	44.0	41.3	39.6	73.2	36.4	21.5	18.1	19.1	23.0	31.1	19.6	22.3	19.8	17.2	20.4	17.4	19.5	26.3	236.3	64.1	122.0	46.4	201.7	258.4	196.9	136.6	157.1	107.8	206.0	148.2	67.2	140.2	104.0	69.9	196.0	188.9	196.6	156.2	72.4	126.8	156.9	152.7	284.5	181.6	227.6	233.4	49.7	109.5	230.7	147.2	92.2	274.6	197.6	155.9	189.9	93.0	174.6	72.3	53.7	259.8	85.5	280.7	283.1	46.6	127.7	228.1	135.2	74.0	196.9	115.5	167.9	78.4	67.0	97.5	129.1	117.4	152.1	218.3	121.2	59.1	66.7	219.5	105.2	177.0	214.7	168.2	151.5	141.3	260.7	214.9	212.6	89.4	232.4	163.7
TRADD	Hs.89862	ENSG00000102871	"TNFRSF1A associated via death domain"	Q15628	16	67154185-67159909	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 163.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004602, HPA071341"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB004602: AB_2209061, HPA071341: AB_2732178"	"unprognostic (2.66e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (1.40e-4)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.83e-1)"	15.4	19.4	9.5	12.8	10.5	4.9	15.6	10.9	10.2	17.8	10.8	17.4	8.4	14.2	3.7	26.9	16.6	4.1	11.2	9.9	8.8	22.2	18.4	17.6	12.4	13.2	10.0	10.5	17.8	7.0	12.1	6.7	12.4	21.2	5.6	1.1	23.8	6.2	6.3	22.5	19.2	4.9	11.3	29.9	19.1	5.0	10.1	7.4	18.1	2.1	10.6	18.2	17.9	12.0	17.3	14.0	0.2	4.8	12.6	10.0	16.8	12.6	9.5	6.0	9.3	8.2	13.0	9.0	21.8	11.0	12.6	29.0	2.0	11.4	4.9	26.1	12.8	5.7	6.4	9.0	15.7	7.3	13.7	10.5	16.0	8.0	3.1	15.3	11.8	8.7	8.4	13.1	9.1	15.5	8.8	14.5	0.2	16.0	42.2	17.1	6.6	36.4	10.4	10.9	2.2	8.1	28.6	6.4	9.0	4.7	11.0	10.3	13.2	7.5	8.2	13.3	9.5	26.3	9.4	10.6	19.9	6.5	9.4	51.9	42.4	95.1	54.4	56.2	84.2	72.0	166.0	96.2	54.2	71.8	46.7	38.5	75.7	40.7	78.6	76.4	82.1	49.5	9.5	10.5	10.9	10.2	9.9	8.8	13.2	10.0	12.4	11.3	10.1	12.0	24.0	3.2	8.6	3.9	37.7	17.3	22.9	60.2	12.5	0.9	29.8	25.0	3.5	30.0	32.8	5.5	0.0	32.0	47.9	24.9	31.3	70.0	1.4	31.0	18.1	20.5	19.2	9.9	1.8	38.1	41.5	22.3	44.9	27.6	8.9	25.9	17.2	19.2	47.0	0.0	2.4	28.2	38.7	37.7	35.0	2.9	30.1	28.6	56.9	0.0	163.4	5.0	48.4	1.0	8.3	62.0	35.7	30.5	52.5	57.7	28.1	80.3	40.7	2.1	26.3	16.0	21.9	2.2	7.6	29.7	25.7	30.5	46.7	23.3	23.8	42.1
TRAFD1	FLN29	ENSG00000135148	"TRAF-type zinc finger domain containing 1"	O14545	12	112125538-112153604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 117.6;Spermatocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039254, HPA039266"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA039254: AB_10805358, HPA039266: AB_10795142"	"unprognostic (7.80e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (1.07e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (3.92e-5)"	17.1	14.6	15.9	30.4	21.5	30.1	20.3	21.2	18.9	21.2	24.7	40.6	16.7	16.8	15.6	32.0	15.4	17.7	22.3	15.1	17.3	15.7	13.5	26.3	37.1	22.4	20.0	18.7	11.8	15.7	11.7	19.0	23.0	22.0	20.6	18.7	19.0	19.8	12.9	35.9	20.3	25.9	20.5	31.3	17.2	29.1	20.1	32.6	13.8	11.4	40.4	29.9	21.7	30.2	23.8	26.2	41.8	40.8	28.8	27.3	22.1	27.2	38.8	36.5	29.4	29.5	21.9	27.4	22.6	28.9	15.7	49.0	42.0	26.3	24.2	47.3	40.1	44.4	37.7	16.3	50.0	27.1	67.7	34.4	43.5	27.1	35.7	37.2	32.6	16.6	50.1	16.9	23.6	41.2	31.5	39.0	35.4	27.8	31.8	43.8	25.6	46.8	24.3	89.5	36.4	27.3	57.4	55.7	15.1	30.8	35.8	38.7	22.1	17.2	12.2	17.1	14.3	40.3	36.2	29.3	18.5	21.6	19.1	323.7	96.1	226.1	45.1	86.8	30.1	56.7	43.1	40.3	50.1	60.2	39.4	36.6	188.2	70.8	93.1	33.5	63.7	101.2	15.9	21.5	21.2	18.9	15.1	17.3	22.4	20.0	23.0	20.5	20.1	30.2	10.7	19.2	13.1	6.8	12.4	12.2	7.4	18.5	30.7	7.0	14.7	11.8	10.9	5.7	18.9	12.9	25.0	20.1	8.5	15.4	5.9	21.3	1.7	9.0	14.3	11.3	15.6	9.0	8.4	20.8	15.6	15.1	15.3	7.5	12.0	10.0	7.9	5.7	14.8	15.2	12.2	10.3	30.5	11.9	9.9	3.7	11.8	14.0	7.2	7.5	117.6	9.9	19.6	10.6	28.6	25.8	15.5	12.8	8.7	22.7	13.0	6.3	10.2	10.9	0.0	5.6	8.8	75.6	36.0	22.0	15.2	26.4	14.0	10.0	9.4	14.4
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828601-49856574	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 8.2;Spermatocytes: 15.6;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 10.8"	"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavorable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	1.5	1.0	1.6	1.8	2.5	6.8	1.9	0.7	1.8	2.0	0.4	2.3	1.5	1.7	1.4	2.9	1.8	1.0	0.9	1.6	0.9	0.8	0.8	0.9	4.6	0.6	0.6	2.1	1.0	0.8	1.2	1.6	0.7	1.4	2.9	2.3	1.2	0.9	2.0	4.2	2.0	2.1	0.6	1.9	1.2	7.9	1.3	5.3	1.4	1.2	4.4	1.3	1.9	0.9	10.4	12.4	17.4	17.6	1.6	2.4	14.4	12.4	5.8	25.3	24.0	15.2	11.6	25.5	8.5	7.1	17.7	13.4	18.5	14.0	18.8	14.7	12.2	19.2	16.3	13.6	0.7	15.8	15.4	1.6	2.0	20.4	10.7	3.0	6.7	22.3	14.0	17.8	11.4	15.1	26.5	20.1	14.0	12.3	20.3	14.4	11.7	14.8	4.6	14.2	8.4	14.4	13.6	11.3	8.8	12.4	10.2	22.4	5.2	16.1	19.0	22.5	24.4	13.0	33.7	27.3	8.1	21.2	14.6	0.0	0.6	0.3	0.9	0.3	0.9	2.9	0.5	2.1	0.6	1.5	0.7	1.1	0.1	1.2	1.3	0.7	0.3	0.6	1.6	2.5	0.7	1.8	1.6	0.9	0.6	0.6	0.7	0.6	1.3	0.9	0.6	3.2	0.6	1.0	1.8	1.1	0.6	1.5	2.2	2.8	1.2	1.4	2.6	0.0	0.3	3.7	0.0	4.2	1.2	1.8	0.0	2.0	4.3	0.6	0.9	0.8	0.0	3.8	1.4	1.0	8.2	2.0	1.5	0.9	0.0	5.7	1.1	0.7	3.5	0.0	0.9	2.0	0.0	0.8	0.4	4.8	2.5	0.7	1.8	1.0	1.8	1.7	0.0	0.5	0.6	1.1	0.3	1.2	4.3	0.8	0.9	0.3	0.5	3.3	0.0	1.4	1.7	15.6	9.1	2.3	0.3	1.0	1.2	1.2	4.6	0.2
TRAM2	KIAA0057	ENSG00000065308	"Translocation associated membrane protein 2"	Q15035	6	52497408-52577060	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 122.0;Plasma cells: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 250.1;ASC TERT1: 265.8;fHDF/TERT166: 253.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035092, HPA057925"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA035092: AB_10610562, HPA057925: AB_2683557"	"unprognostic (2.32e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.12e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-1)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.19e-2)"	19.5	4.9	3.4	14.8	4.7	5.3	13.8	3.0	4.3	14.9	7.8	12.5	14.0	13.1	11.5	5.6	13.5	17.3	10.4	3.0	3.3	7.4	16.2	14.1	7.5	4.3	3.5	12.4	7.0	2.8	3.9	35.8	3.6	6.0	14.7	3.9	6.4	5.8	3.6	11.5	12.6	17.5	3.3	19.2	9.5	13.3	4.4	4.5	12.4	5.9	13.3	13.3	9.6	3.3	45.4	19.8	22.7	22.6	250.1	265.8	39.8	130.0	130.8	106.7	98.2	43.2	9.2	11.0	21.4	253.4	76.0	10.0	14.9	81.3	133.6	24.8	8.0	24.1	20.5	54.9	71.3	6.2	13.1	97.4	8.0	93.5	41.2	155.1	124.1	9.1	15.1	78.4	154.5	16.2	8.9	17.7	10.4	17.9	8.8	10.9	59.8	91.0	25.3	7.5	5.5	8.7	29.9	13.2	31.6	47.7	20.6	12.9	198.8	177.6	38.4	65.0	72.1	53.4	97.7	31.1	64.7	16.1	110.8	0.1	1.0	1.0	0.9	1.1	0.5	1.2	0.7	0.5	1.1	0.8	0.3	0.6	0.2	0.7	2.1	0.5	0.2	0.7	3.4	4.7	3.0	4.3	3.0	3.3	4.3	3.5	3.6	3.3	4.4	3.3	12.8	6.4	3.2	6.8	15.9	8.2	2.8	8.5	3.4	3.1	4.0	5.1	9.9	4.3	4.1	7.3	25.0	36.2	6.6	7.8	3.9	3.6	38.3	4.0	28.9	17.9	9.0	8.6	12.0	3.2	30.8	26.2	6.1	5.0	2.5	34.0	19.6	36.1	15.7	5.0	9.2	19.6	6.1	12.0	6.9	122.0	20.8	5.7	26.6	13.1	4.3	1.8	8.2	3.5	3.1	6.2	1.7	23.3	69.5	2.8	7.0	3.1	4.9	12.7	13.1	16.2	15.7	23.4	8.6	1.2	4.1	20.7	6.0	14.3	5.7	1.5
TRAPPC11	"C4orf41, FLJ12716, foigr, gry"	ENSG00000168538	"Trafficking protein particle complex 11"	Q7Z392	4	183659267-183713594	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038173			Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Vesicles	"HPA038173: "	"unprognostic (2.24e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.14e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.66e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.92e-2)"	12.1	15.9	4.3	13.4	5.5	11.4	15.5	8.3	6.4	12.4	15.4	13.2	11.0	14.1	11.8	13.8	12.4	11.0	12.4	5.5	4.8	14.8	16.9	13.6	14.9	3.4	4.1	20.8	14.2	19.1	6.8	13.8	3.7	14.1	15.0	13.8	14.8	12.1	15.1	12.1	11.7	15.7	4.4	14.2	13.5	16.0	4.9	17.8	14.8	18.7	17.6	13.6	8.0	6.0	15.1	14.4	23.2	23.1	28.5	31.3	17.6	21.6	21.7	17.8	16.2	9.0	19.1	20.7	6.0	21.8	13.9	10.8	21.2	20.5	20.4	23.1	9.3	26.0	12.0	12.8	26.2	28.3	24.8	24.2	21.5	17.8	20.6	23.2	26.5	23.9	21.1	41.8	22.5	10.8	34.1	13.8	8.7	10.2	10.7	23.4	13.8	15.8	22.8	15.3	15.6	20.7	21.1	21.6	21.4	20.5	16.6	31.0	26.7	10.1	11.9	9.7	12.4	21.8	12.7	12.4	20.6	18.7	18.0	3.8	12.9	8.2	5.7	14.9	7.6	4.7	6.2	6.1	12.8	3.4	5.7	5.9	3.7	10.0	25.6	3.3	5.4	7.6	4.3	5.5	8.3	6.4	5.5	4.8	3.4	4.1	3.7	4.4	4.9	6.0	9.5	3.2	14.5	33.0	12.3	4.5	3.1	7.4	9.1	11.0	5.7	6.2	14.8	8.6	9.1	7.3	8.4	7.9	10.0	9.8	3.9	7.4	57.7	8.2	13.3	9.1	13.1	12.0	47.5	9.3	8.4	12.0	12.2	8.0	7.6	18.7	9.3	8.5	11.6	8.4	47.4	7.2	0.0	16.0	6.8	7.3	13.4	16.1	3.6	30.0	19.5	6.4	11.3	37.2	35.2	9.0	7.1	11.3	10.6	5.5	11.7	4.6	12.9	13.6	0.0	9.9	8.6	7.7	14.9	10.4	6.1	7.0	9.4	12.4	7.9	5.9
TRAPPC3	BET3	ENSG00000054116	"Trafficking protein particle complex 3"	O43617	1	36136570-36156053	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028408	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Golgi apparatus"	"HPA028408: AB_10601826"	"unprognostic (3.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (7.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.10e-3)"	"unprognostic (6.53e-2)"	43.7	74.7	42.5	31.2	43.0	28.8	46.6	47.0	50.7	38.5	53.7	57.0	33.6	41.1	60.7	61.6	37.0	32.6	51.1	43.1	44.9	55.3	51.2	36.4	38.3	48.0	45.1	28.2	46.0	54.4	47.0	37.8	47.2	39.2	42.5	39.9	46.4	45.4	48.9	51.5	38.5	49.9	48.3	41.6	48.2	53.1	46.3	51.3	59.9	44.6	54.4	46.2	41.2	48.9	95.7	65.6	44.9	70.2	114.2	91.4	87.9	85.2	109.0	100.0	97.0	55.9	90.0	40.4	79.0	95.0	79.6	68.8	69.9	114.1	113.8	79.8	103.7	75.8	77.2	81.7	132.6	80.0	76.7	78.3	98.5	93.8	91.5	103.6	126.7	101.2	93.2	67.0	122.0	71.4	95.6	74.6	60.5	79.5	93.7	65.8	63.8	90.9	128.4	76.1	67.8	49.7	69.2	78.5	140.1	115.2	50.2	59.6	95.6	59.1	66.7	116.0	116.3	80.1	87.0	67.3	100.7	88.7	60.5	161.9	130.2	148.7	85.0	142.5	89.4	93.6	100.4	90.4	132.6	89.0	96.0	86.9	134.3	95.8	116.3	109.4	135.4	155.3	42.5	43.0	47.0	50.7	43.1	44.9	48.0	45.1	47.2	48.3	46.3	48.9	41.9	25.6	27.6	12.1	45.6	101.1	111.5	152.1	52.3	41.8	97.8	78.5	57.8	55.8	75.7	38.6	16.7	145.7	43.0	55.1	170.2	157.0	286.1	51.8	38.3	59.1	48.3	63.3	15.4	188.5	146.0	52.1	29.0	55.6	45.7	40.5	33.2	49.8	145.0	53.8	16.9	51.2	132.2	56.1	74.7	131.0	42.9	60.6	96.0	10.3	104.4	68.0	61.8	8.5	17.9	178.4	72.1	51.9	80.7	196.9	73.3	115.9	49.2	30.7	32.9	37.4	69.2	172.5	89.4	63.4	123.6	191.4	50.4	50.3	54.3	134.1
TRAPPC4	"PTD009, SBDN, TRS23"	ENSG00000196655	"Trafficking protein particle complex 4"	Q9Y296	11	119018763-119025454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 335.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039752, HPA041371"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA039752: AB_2676664, HPA041371: AB_2677439"	"unprognostic (5.26e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.18e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	20.8	37.8	14.6	4.3	14.8	8.2	20.2	15.3	18.6	17.9	15.5	22.9	8.4	17.9	11.8	21.3	18.0	5.2	27.2	14.4	16.7	36.8	26.1	19.5	8.1	15.6	15.0	15.5	25.5	13.5	29.2	5.6	15.0	20.8	6.1	9.2	18.9	12.3	38.3	19.6	23.6	4.0	15.3	22.1	22.6	31.5	14.7	16.9	17.6	18.2	6.1	19.3	16.0	16.2	15.5	14.1	16.9	20.2	25.2	19.3	8.7	59.6	44.3	45.6	40.0	35.1	6.4	18.6	40.3	27.2	23.6	14.5	32.0	25.9	32.9	31.5	15.3	28.5	14.2	40.0	33.4	25.3	14.8	25.1	29.2	40.1	30.1	23.5	42.3	20.7	34.7	7.3	28.8	38.6	30.0	24.9	13.7	30.0	44.4	26.3	13.1	25.9	34.7	20.2	7.4	16.2	10.5	13.1	15.4	19.8	58.5	21.5	24.9	10.5	18.8	13.1	19.7	9.2	18.9	45.9	11.8	20.1	18.5	68.3	37.0	77.0	50.8	45.8	53.5	59.1	59.6	59.8	37.2	55.5	54.7	59.6	32.6	54.6	58.3	52.4	96.4	61.2	14.6	14.8	15.3	18.6	14.4	16.7	15.6	15.0	15.0	15.3	14.7	16.2	50.3	38.5	34.4	7.5	38.8	51.4	59.1	166.1	37.5	60.1	38.4	38.7	30.8	41.5	83.4	71.7	14.6	90.7	61.1	30.4	140.8	107.6	41.9	46.0	39.1	47.7	67.6	45.3	9.0	76.2	56.5	45.1	15.3	33.2	62.1	335.0	46.1	21.8	80.4	38.7	11.7	33.5	152.5	27.3	30.7	16.4	44.4	33.1	30.2	10.3	76.3	88.5	41.2	10.1	15.0	103.4	44.3	60.9	26.9	51.1	83.0	206.1	89.0	61.2	46.0	21.6	82.2	78.2	67.0	28.7	59.0	87.3	52.7	49.1	36.8	52.4
TRAPPC8	"GSG1, HsT2706, KIAA1012, TRS85"	ENSG00000153339	"Trafficking protein particle complex 8"	Q9Y2L5	18	31829197-31953136	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041107	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Microtubules	"HPA041107: AB_10793869"	"unprognostic (4.04e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (1.85e-9)"	"unprognostic (3.55e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.92e-1)"	10.5	9.9	5.4	10.1	6.1	10.2	9.8	8.5	6.7	9.3	11.3	9.9	10.2	8.5	5.9	11.5	9.6	7.6	10.5	5.8	5.6	12.7	18.1	8.9	13.0	6.3	5.2	9.0	9.8	14.6	7.1	9.7	5.8	8.3	10.9	20.9	10.4	8.7	16.9	13.6	11.9	9.4	5.0	10.7	10.0	30.2	5.5	16.3	12.4	12.4	13.4	9.2	9.7	8.7	12.3	10.2	11.9	9.0	17.3	16.3	13.0	16.0	16.9	14.7	14.4	7.0	9.1	17.6	12.6	15.5	13.4	18.4	17.2	9.1	20.2	19.8	8.0	14.4	9.5	8.7	13.5	42.4	16.1	14.9	12.1	13.8	19.6	16.4	17.0	14.6	21.2	15.7	15.0	8.4	18.2	14.5	11.9	36.1	8.7	19.0	14.1	18.5	14.4	19.1	9.0	10.6	20.5	12.2	14.3	18.7	13.5	18.3	20.8	15.5	7.8	5.7	9.9	19.6	23.5	25.9	15.0	18.2	16.3	8.7	1.6	1.7	1.0	1.5	2.2	1.3	1.4	1.2	1.6	1.4	1.2	1.3	2.3	1.9	1.5	1.2	1.7	0.7	5.4	6.1	8.5	6.7	5.8	5.6	6.3	5.2	5.8	5.0	5.5	8.7	16.9	28.9	15.1	44.1	26.3	18.0	8.7	10.0	31.9	12.2	14.3	9.7	21.6	21.5	14.6	11.0	29.2	11.2	19.9	27.3	1.9	11.0	35.3	23.4	14.9	16.1	12.6	20.0	68.1	9.4	9.6	14.8	32.6	17.4	3.8	11.1	19.6	34.2	16.6	11.8	71.6	14.7	8.2	24.0	13.3	42.4	15.5	22.3	10.6	43.1	23.4	11.0	23.7	55.3	82.8	14.2	10.1	9.4	18.7	16.1	26.2	15.5	25.8	24.7	13.1	14.8	14.3	88.8	47.4	21.8	27.1	20.5	16.6	11.6	13.7	15.5
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 66.3"	"Group enriched"	"Detected in some"	5	"Late spermatids: 315.7;Proximal enterocytes: 186.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039913, HPA042045"	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		12000000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.7	0.2	1.6	0.3	3.7	0.0	0.4	0.6	3.8	0.3	0.0	1.6	60.0	0.4	0.6	1.6	0.3	2.6	1.0	1.1	2.7	13.4	6.1	0.2	0.1	2.1	2.0	0.2	1.8	0.0	0.3	0.1	1.9	0.5	1.3	0.0	0.2	0.0	0.0	0.1	66.3	0.1	0.6	0.1	1.7	1.8	2.5	0.0	0.4	0.0	0.0	0.4	0.3	6.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	0.6	3.8	1.1	2.7	2.1	2.0	1.9	0.6	2.5	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.3	1.5	0.0	1.8	0.0	0.1	0.0	2.3	7.9	0.2	45.6	0.8	1.6	0.1	3.0	0.0	0.1	2.5	0.0	0.3	4.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	7.0	0.0	0.0	0.4	315.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	5.3	0.9	6.3	1.9	0.1	0.3	186.3	32.8	0.0	0.0	0.0	0.3	0.2	1.7	0.8	2.1	0.0	0.0	0.1	0.0	3.7	0.0
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.9;Inhibitory neurons: 111.4;Microglial cells: 52.5;Oligodendrocyte precursor cells: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	3.4	5.7	1.3	5.8	2.2	13.9	2.6	1.1	3.8	7.7	0.0	3.7	3.2	6.0	2.9	8.8	5.1	3.9	1.8	0.8	0.6	2.9	1.0	2.9	7.7	0.3	0.7	7.1	1.6	3.9	3.5	2.6	0.0	5.4	3.4	2.0	2.3	3.6	1.1	6.4	4.7	3.9	0.2	7.2	4.2	6.0	1.6	10.3	2.0	1.2	5.0	7.0	8.0	0.8	13.7	9.4	10.3	13.2	4.7	10.4	14.5	10.2	16.2	11.4	9.4	0.1	7.1	12.7	2.2	15.5	15.6	16.2	13.2	12.6	9.1	144.3	1.0	13.7	8.0	0.0	3.2	25.4	42.1	4.3	17.3	10.2	4.1	10.3	0.0	8.5	0.1	4.1	5.0	3.0	6.6	42.9	11.3	10.1	9.6	11.8	0.8	4.7	6.7	16.7	8.3	4.4	6.1	0.2	1.0	5.6	5.9	34.1	4.5	6.5	7.5	10.7	2.9	1.7	9.5	13.7	4.4	22.7	0.1	1.1	0.6	4.6	1.5	0.2	1.4	0.2	1.1	1.3	0.7	0.0	0.9	1.0	2.0	1.5	0.1	0.6	1.2	0.7	1.3	2.2	1.1	3.8	0.8	0.6	0.3	0.7	0.0	0.2	1.6	0.8	2.7	3.2	1.3	37.9	3.6	8.3	2.9	3.2	6.2	9.9	4.1	2.5	1.9	1.5	5.9	5.5	0.0	3.4	20.9	8.4	0.0	1.8	2.7	3.3	16.2	5.4	3.0	0.4	96.9	1.0	0.9	11.8	11.2	1.7	12.0	14.7	6.4	0.3	2.6	8.4	111.4	2.1	4.1	4.7	10.4	3.2	14.0	8.0	3.6	52.5	7.9	4.2	12.3	80.4	3.8	1.2	2.5	22.2	7.2	1.6	1.0	0.2	8.5	0.5	26.3	4.4	7.9	10.0	7.4	23.5	7.4	1.2	18.0	4.2	3.8	4.3
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430358-125438403	"Enzymes, Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 365.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 242.7;Distal enterocytes: 281.6;Endometrial stromal cells: 240.1;Plasma cells: 283.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 9.9;neutrophil: 4.7;non-classical monocyte: 3.5;T-reg: 2.8"	"Group enriched"	"Detected in many"	12	"granulocytes: 9.9;monocytes: 3.5;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"HEL: 193.9;U-266/70: 114.2;U-266/84: 123.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA063982: AB_2685165"	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	82.5	25.5	7.5	40.9	9.0	365.5	28.0	12.1	16.2	35.9	7.0	45.1	20.4	25.5	13.6	33.5	15.7	80.2	18.3	8.2	10.1	23.9	139.6	53.7	17.2	9.0	8.4	4.1	43.0	78.9	12.0	28.9	8.7	45.4	51.9	16.3	19.2	7.1	44.0	20.4	32.0	43.2	7.5	22.3	38.0	6.9	11.9	36.0	107.5	19.2	18.0	99.1	5.4	7.6	14.7	16.4	2.2	4.6	4.6	8.8	25.4	9.4	13.2	6.8	2.3	22.1	18.9	26.5	8.5	6.9	40.6	11.0	7.0	9.1	5.8	11.8	34.3	193.9	7.3	43.6	11.6	98.3	17.0	8.5	13.5	27.8	62.8	33.0	20.0	0.3	17.5	81.6	0.9	15.8	9.2	15.3	15.8	35.1	31.6	18.5	3.3	29.2	54.6	55.1	13.7	5.0	22.9	24.6	93.1	14.0	6.4	4.6	10.4	7.3	9.5	7.3	11.7	114.2	123.2	36.6	13.1	0.7	17.7	0.0	0.7	9.9	0.0	1.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	4.7	0.0	3.5	0.3	2.8	0.1	7.5	9.0	12.1	16.2	8.2	10.1	9.0	8.4	8.7	7.5	11.9	7.6	69.6	134.6	168.5	13.7	19.8	100.1	242.7	68.6	77.4	25.5	100.8	71.9	16.6	31.5	67.9	16.5	0.0	12.3	2.8	281.6	11.7	45.3	0.4	96.6	240.1	62.0	112.0	5.3	2.1	24.7	19.1	54.6	58.6	222.5	29.9	0.5	8.2	131.7	35.3	21.9	0.7	129.6	32.6	72.0	59.7	1.7	0.3	85.9	56.9	4.7	27.5	20.1	0.0	4.5	0.2	45.5	130.9	0.4	283.6	139.0	117.4	24.9	39.7	3.8	0.0	36.6	45.1	0.3	2.2	88.2	64.2	30.6	14.8	1.5	106.9	128.7
TRIB2	"GS3955, TRB2"	ENSG00000071575	"Tribbles pseudokinase 2"	Q92519	2	12716889-12742734	"Enzymes, Predicted membrane proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 104.3;Muller glia cells: 100.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 48.8"	"Group enriched"	"Detected in many"	8	"B-cells: 12.2;NK-cells: 19.3;T-cells: 48.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 183.5;HEL: 185.7;K-562: 258.0;SK-MEL-30: 189.3;WM-115: 246.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001305	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"HPA001305: AB_1080371"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.31e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.13e-2)"	43.3	63.1	29.1	38.9	29.9	16.8	38.3	36.1	35.2	21.7	30.5	27.0	17.8	44.4	43.4	15.5	23.4	28.8	51.0	31.6	37.7	92.3	21.0	39.8	72.7	31.4	30.8	97.8	26.2	18.0	20.0	46.6	29.7	33.0	13.4	137.8	20.4	25.6	14.3	16.9	25.2	34.2	29.7	79.7	41.8	28.5	32.4	39.3	23.9	19.5	69.6	48.4	19.5	28.0	0.2	0.4	138.8	183.5	48.9	44.7	0.2	7.9	7.5	4.9	7.9	0.9	15.3	16.3	5.5	16.9	0.8	2.3	10.3	16.1	4.2	18.3	28.9	185.7	0.4	2.7	60.7	10.7	68.0	41.7	16.0	20.3	5.6	48.9	22.1	23.8	258.0	0.3	7.9	1.7	24.4	44.8	66.1	7.0	18.0	0.0	46.2	6.7	31.9	23.4	118.9	56.6	1.1	7.4	189.3	41.4	0.2	1.1	13.9	65.3	32.0	0.6	17.8	0.1	0.2	22.9	35.2	36.3	246.7	1.7	0.2	3.2	12.7	0.0	15.8	9.6	26.1	13.8	1.2	12.2	15.0	9.2	0.5	19.3	0.2	0.1	48.8	8.9	29.1	29.9	36.1	35.2	31.6	37.7	31.4	30.8	29.7	29.7	32.4	28.0	52.2	3.2	8.3	25.5	12.5	6.1	9.1	26.9	19.4	55.0	7.9	8.6	17.1	12.8	15.6	16.5	31.3	2.6	17.5	0.7	7.9	17.2	4.3	9.7	11.6	43.9	0.0	22.1	13.5	104.3	0.2	11.3	20.9	15.9	34.2	77.3	59.6	6.7	5.8	20.2	6.9	0.4	28.5	5.1	8.2	14.3	77.3	3.8	30.2	13.1	3.0	100.3	26.8	59.8	2.7	45.3	0.2	74.4	21.0	11.6	0.3	1.0	17.9	66.7	52.6	9.9	41.2	1.0	6.0	5.7	5.4	0.8	27.1	30.5	0.8	32.5
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 17.1;kidney: 6.0;liver: 14.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 139.1;Intestinal goblet cells: 41.5;Paneth cells: 332.0;Proximal enterocytes: 80.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 14.4;liver cancer: 5.6;pancreatic cancer: 7.7;renal cancer: 4.4;stomach cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 16.5;Hep G2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047527			Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.8	17.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	6.0	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.7	12.2	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.5	0.0	0.0	0.0	0.0	0.0	139.1	1.9	1.8	0.0	0.0	0.1	0.0	0.0	2.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	332.0	0.0	0.0	0.0	80.0	21.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.5	0.0	29.1	0.0
TRIM36	"HAPRIN, RBCC728, RNF98"	ENSG00000152503	"Tripartite motif containing 36"	Q9NQ86	5	115124762-115180546	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 44.2;testis: 174.3"	"Group enriched"	"Detected in many"	26	"Early spermatids: 2120.7;Late spermatids: 4980.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 5.8;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	48	"dendritic cells: 5.8;granulocytes: 3.2;monocytes: 6.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 24.5;SCLC-21H: 28.3;SH-SY5Y: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061321			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA061321: AB_2684479"	"unprognostic (6.36e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.33e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.82e-13)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.80e-3)"	0.5	1.3	13.2	1.6	16.7	0.5	4.4	3.9	14.2	2.4	8.7	7.5	14.1	0.9	0.6	0.3	2.2	0.5	0.2	16.1	15.7	0.3	0.4	1.8	0.3	17.0	10.5	4.7	1.6	0.2	13.4	1.1	16.1	10.0	7.5	44.2	0.5	0.6	0.2	0.6	13.8	0.8	10.2	0.5	4.6	174.3	12.7	0.7	0.2	0.4	0.4	0.4	1.3	20.0	3.6	0.9	1.6	8.4	0.2	0.1	2.0	0.7	2.8	1.5	1.7	1.2	1.7	0.0	1.4	0.1	11.9	1.1	7.9	1.5	1.1	0.6	2.7	6.0	3.3	1.7	0.3	6.0	4.8	0.1	1.4	0.7	2.0	1.9	0.1	11.2	0.2	7.9	2.3	4.6	1.6	5.4	6.7	0.6	3.8	1.3	24.5	1.9	0.9	0.1	28.3	19.6	5.3	0.5	3.2	0.8	5.8	7.4	0.7	2.3	1.8	1.7	2.7	1.2	0.8	0.0	2.5	3.4	1.1	0.0	1.2	3.2	0.0	1.3	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	0.3	0.0	6.5	1.2	0.0	0.6	13.2	16.7	3.9	14.2	16.1	15.7	17.0	10.5	16.1	10.2	12.7	20.0	0.4	0.0	3.4	1.0	0.1	2.3	0.6	0.2	0.6	5.0	14.8	9.3	2.3	0.0	0.5	1.8	56.3	0.0	1.8	27.6	0.0	0.4	2120.7	3.3	0.3	2.0	3.5	0.0	39.7	1.8	0.5	1.4	6.6	1.1	1.3	0.1	0.4	0.0	2.8	5.0	14.0	15.8	2.0	1.9	18.1	4980.3	14.9	6.0	8.8	29.0	3.4	6.9	0.0	2.5	53.4	1.5	20.4	12.8	0.1	12.1	28.2	0.2	5.0	76.8	6.6	2.0	2.3	136.2	26.9	1.2	1.3	0.3	0.7	0.1	8.8	0.2
TRIM39-RPP21		ENSG00000248167	"TRIM39-RPP21 readthrough"		6	30328907-30346854	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;Club cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051120	Uncertain		Approved	Cytosol		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA051120: AB_2681348"	"unprognostic (1.20e-1)"	"unprognostic (7.35e-2)"			"unprognostic (2.56e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.60e-1)"	"unprognostic (1.33e-1)"			"unprognostic (1.56e-1)"	"unprognostic (5.84e-4)"		"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136124-30148735	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 3.0;liver: 1.6;testis: 1.4"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 20.1;Paneth cells: 24.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 1.1"	"Region enriched"	"Detected in single"	18	"thalamus: 3.1"	"Low region specificity"	"Detected in many"			HPA043818	Uncertain		Approved	Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.7	0.0	0.0	0.0	3.8	0.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0
TRIM49D1	"TRIM49D, TRIM49D1P, TRIM49DP"	ENSG00000223417	"Tripartite motif containing 49D1"	C9J1S8	11	89911111-89921767	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	285	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	285	"granulocytes: 28.5"	"Not detected"	"Not detected"											HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"				Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM49D2	"TRIM49D2P, TRIM49L, TRIM49L1"	ENSG00000233802	"Tripartite motif containing 49D2"	C9J1S8	11	89924064-89933063	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	186	"basophil: 18.6"	"Lineage enriched"	"Detected in single"	186	"granulocytes: 18.6"	"Not detected"	"Not detected"											HPA072153			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"				Nucleoplasm	Cytosol	"HPA072153: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312536-73328082	"Enzymes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"pancreas: 29.1;parathyroid gland: 33.3;stomach 1: 48.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Gastric mucus-secreting cells: 17.9;Spermatocytes: 5.2;Spermatogonia: 4.2"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"Hep G2: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA019862, HPA047843"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA019862: AB_1858305, HPA047843: AB_2680176"	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	6.8	0.3	0.1	0.0	0.1	0.1	0.2	29.1	33.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.9	0.0	0.1	0.4	48.7	8.7	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	17.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.2	4.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282429-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 213.2;skeletal muscle: 580.7;tongue: 177.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 81.7;Ductal cells: 35.5;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 46.5;Skeletal myocytes: 17.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.1"	"Immune cell enriched"	"Detected in single"	17	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 3.6"	"Group enriched"	"Detected in some"	8	"HAP1: 7.3;NTERA-2: 15.6"	"Region enhanced"	"Detected in some"		"amygdala: 3.1"					HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	0.4	9.3	1.5	0.0	0.9	0.0	0.3	0.9	5.1	0.9	0.1	0.3	4.3	0.8	24.5	5.0	0.8	0.2	213.2	2.3	0.0	1.7	0.1	0.2	0.2	0.6	0.3	0.5	0.5	0.0	0.1	0.0	0.3	3.4	0.0	0.0	9.5	0.1	580.7	0.9	2.1	0.0	0.3	0.9	0.1	22.3	0.1	0.1	0.5	177.3	0.0	0.1	0.5	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	15.6	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	1.5	0.9	0.9	5.1	2.3	0.0	0.6	0.3	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.4	81.7	10.0	0.1	3.7	0.0	0.0	0.3	2.3	0.0	35.5	1.5	0.1	0.0	0.8	0.0	2.7	11.3	42.5	0.0	2.2	0.0	0.2	4.5	0.0	0.4	0.0	0.1	0.0	0.8	1.8	0.0	0.0	0.0	4.7	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.3	46.5	1.9	0.7	0.0	0.2	2.4	3.1	0.2	0.0	0.0	17.9	16.8	6.8	2.4	0.0	0.0	0.0	0.3	0.2	6.4	0.3
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175485	"Predicted intracellular proteins, Predicted membrane proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 61.8;liver: 37.9;skeletal muscle: 29.6;tongue: 33.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 108.9;Endometrial ciliated cells: 64.7;Hepatocytes: 30.4;Skeletal myocytes: 31.0;Spermatocytes: 23.8"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 426.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	Cytosol	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	1.4	0.0	0.1	0.1	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.1	0.1	3.5	0.8	5.3	0.1	61.8	0.0	0.0	4.8	37.9	0.2	0.0	0.1	0.6	0.0	0.2	0.2	0.4	0.0	0.3	0.7	0.1	0.0	1.3	0.2	29.6	0.4	0.1	0.1	0.0	0.1	0.0	7.3	0.0	0.2	0.3	33.7	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	7.2	0.1	0.3	0.1	0.0	0.4	0.5	0.6	0.0	60.5	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.2	426.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.7	1.5	27.6	0.0	2.4	0.0	0.0	0.1	0.0	91.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.6	0.0	0.1	2.8	0.0	0.0	0.1	0.0	108.9	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.8	64.7	0.2	1.2	0.0	0.0	0.2	0.0	0.1	3.8	0.0	3.5	0.0	0.0	0.7	30.4	0.1	0.0	1.5	0.0	0.0	1.3	0.0	6.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	7.4	15.4	0.0	6.6	31.0	2.9	23.8	1.2	0.0	0.0	3.8	0.3	0.0	0.0	0.3
TRIM56	RNF109	ENSG00000169871	"Tripartite motif containing 56"	Q9BRZ2	7	101085481-101097967	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024358	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA024358: AB_1858308"	"unprognostic (6.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.44e-3)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (2.63e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.13e-4)"	13.6	11.3	12.9	14.4	13.9	6.7	12.9	11.7	12.2	14.8	12.6	11.8	11.7	13.5	13.4	12.4	14.8	7.5	9.9	10.4	11.5	12.9	10.8	17.7	15.4	17.0	13.8	19.0	10.1	9.6	8.6	8.9	14.0	14.8	9.7	2.0	14.0	13.0	11.9	15.7	14.7	8.5	12.7	21.4	12.4	3.8	14.2	12.9	12.7	6.7	12.4	12.6	13.4	16.8	16.4	20.1	8.5	10.9	19.1	19.7	10.2	13.4	11.7	21.2	19.6	9.6	23.0	19.2	14.0	11.1	29.3	18.4	3.5	12.3	14.2	19.2	5.5	12.2	28.9	7.1	17.1	21.6	26.4	12.6	17.3	13.8	22.4	20.7	11.2	12.2	21.6	23.7	14.8	22.4	18.3	24.0	8.5	8.8	16.7	16.8	13.9	12.7	11.1	16.9	0.4	0.3	14.8	40.8	11.6	10.8	9.3	14.0	21.6	29.4	26.1	22.4	14.4	11.7	12.4	14.7	14.6	17.2	23.6	1.7	1.2	1.2	1.8	0.8	1.4	1.1	1.4	1.2	0.4	1.6	1.3	1.7	3.9	4.1	1.2	1.1	0.7	0.6	12.9	13.9	11.7	12.2	10.4	11.5	17.0	13.8	14.0	12.7	14.2	16.8	62.5	73.7	82.7	3.3	45.7	5.2	82.2	6.7	28.5	3.1	30.4	27.2	21.7	108.7	32.8	51.5	2.1	41.6	45.4	51.9	3.9	61.4	2.1	60.8	53.7	80.6	29.1	43.5	0.1	48.1	25.7	40.0	33.1	42.5	15.2	129.9	114.5	48.1	19.3	10.1	0.1	40.9	4.1	48.7	4.5	5.2	132.3	33.3	1.8	8.4	60.0	20.4	141.1	2.5	3.6	56.9	45.4	94.4	24.9	79.9	76.5	11.4	51.0	4.0	65.7	76.7	38.9	5.4	7.2	15.9	3.3	29.8	44.3	64.5	41.1	60.5
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 193.3;tongue: 51.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 17.8;Cardiomyocytes: 40.1;Squamous epithelial cells: 39.6;Suprabasal keratinocytes: 28.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 16.4;HDLM-2: 35.0;PC-3: 18.8;TIME: 16.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	"Nucleoplasm, Cytosol"	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	2.1	1.5	1.2	0.4	1.0	0.4	2.1	10.5	3.0	5.5	0.4	1.9	0.3	1.3	3.1	27.0	2.2	0.2	8.5	0.9	1.7	3.9	0.6	2.6	0.4	3.1	2.9	1.5	4.8	2.7	5.5	0.3	2.8	2.8	0.5	1.6	7.3	0.6	193.3	28.7	1.3	0.6	1.3	1.4	2.2	1.3	2.0	0.4	6.3	51.0	2.1	2.2	9.5	1.3	9.0	4.4	0.1	0.5	0.7	0.8	0.2	1.9	0.0	0.7	1.8	0.4	12.0	0.6	6.1	2.6	3.7	16.4	4.8	13.8	0.2	35.0	1.8	0.9	12.2	0.2	2.2	0.0	2.0	0.1	10.5	0.4	6.7	2.7	3.9	1.6	0.5	2.0	0.4	1.3	0.5	0.3	0.0	14.5	18.8	0.4	6.0	1.4	4.9	0.0	0.4	1.1	4.2	0.2	6.5	0.2	1.0	0.4	16.0	0.2	3.4	0.6	6.3	2.8	0.4	1.0	0.5	0.7	1.5	0.0	1.7	0.0	0.4	0.7	0.7	0.1	0.4	0.4	0.3	0.2	0.7	0.5	0.0	0.1	0.5	0.2	0.9	0.3	1.2	1.0	10.5	3.0	0.9	1.7	3.1	2.9	2.8	1.3	2.0	1.3	7.3	0.0	1.1	0.0	1.0	17.8	4.3	11.1	12.0	6.2	0.8	1.5	40.1	0.0	6.3	3.7	0.0	0.1	0.8	5.9	5.9	0.7	0.9	0.2	0.3	4.6	0.0	0.0	1.3	2.4	0.7	4.8	11.2	0.7	0.0	0.1	5.7	0.4	1.1	0.0	3.9	3.3	2.0	6.0	2.8	0.0	0.9	2.9	1.8	0.0	5.7	0.6	1.0	2.0	0.1	5.0	6.5	1.5	0.1	2.5	0.0	1.5	2.9	2.9	13.1	17.3	5.8	1.5	0.4	39.6	28.4	0.0	1.4	0.1	3.4	5.3
TRIM74	"MGC45440, TRIM50C"	ENSG00000155428	"Tripartite motif containing 74"	Q86UV6	7	72959485-72969466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 10.2;testis: 6.6"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.9;Respiratory ciliated cells: 2.1;Spermatocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.8;Hep G2: 2.8"									HPA047843			Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA047843: AB_2680176"	"unprognostic (8.78e-3)"	"unprognostic (3.78e-4)"	"unprognostic (5.84e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.78e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-3)"	0.9	1.6	1.2	0.6	1.4	1.0	1.2	2.5	1.6	1.8	0.8	0.8	1.3	1.2	1.2	0.5	2.5	0.5	0.7	1.3	1.4	1.7	2.6	0.7	1.2	1.5	1.3	1.8	2.5	0.5	1.7	0.1	1.3	1.9	0.3	0.6	0.7	0.5	0.5	0.9	1.3	0.4	1.2	1.2	10.2	6.6	1.2	0.6	1.5	0.2	0.3	0.8	1.2	1.8	0.0	0.1	0.7	0.7	0.2	0.0	0.0	0.4	0.0	0.1	0.2	1.0	0.7	0.5	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.4	3.8	0.6	0.0	2.8	0.1	1.3	1.6	0.3	0.2	0.0	0.2	0.5	0.0	0.9	0.5	2.2	0.0	1.1	0.4	1.9	0.0	0.0	0.8	0.9	0.3	0.4	1.1	0.4	0.3	0.3	0.4	0.0	0.8	0.1	0.0	0.6	1.4	0.1	0.5	0.2	0.0	1.7	1.4	0.3	0.5	0.7	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	1.4	2.5	1.6	1.3	1.4	1.5	1.3	1.3	1.2	1.2	1.8	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.1;testis: 2.6"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 16.5;Early spermatids: 17.3;Extravillous trophoblasts: 6.7;Late spermatids: 5.2;Spermatocytes: 6.4;Spermatogonia: 6.4;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	33.8	0.0	0.0	0.0	0.1	18.3	0.2	1.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	7.5	0.9	6.4	0.1	0.0	2.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	145.3	0.0	0.0	0.2	0.1	7.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.5	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	6.4	0.0	0.0	8.9	0.1	0.0	0.0	0.3
TRIO	ARHGEF23	ENSG00000038382	"Trio Rho guanine nucleotide exchange factor"	O75962	5	14143342-14532128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 205.7;Excitatory neurons: 400.9;Inhibitory neurons: 443.4;Microglial cells: 308.2;Oligodendrocyte precursor cells: 476.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 215.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008157, HPA064664"	Supported		Approved	Vesicles,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: AB_2685315"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.23e-1)"	35.3	20.5	31.7	11.6	33.3	5.5	31.8	32.2	38.6	23.4	34.5	36.6	6.8	38.9	15.5	14.5	21.2	18.8	31.9	37.2	33.6	24.9	22.1	25.7	10.2	28.1	28.1	52.8	20.6	9.1	28.9	11.6	26.6	28.2	13.6	10.2	17.4	11.1	20.9	18.7	27.8	19.2	26.4	38.9	22.9	17.2	31.4	13.3	17.0	17.4	10.6	27.1	20.5	27.2	43.7	15.9	37.2	18.0	78.6	101.0	41.3	40.4	49.2	32.6	36.9	10.3	17.4	10.4	28.0	56.6	79.6	13.0	6.5	19.4	66.6	25.8	8.0	5.5	46.1	13.2	40.0	13.9	14.8	47.6	19.9	114.4	36.4	30.3	28.8	6.8	1.4	6.8	78.7	8.3	0.1	9.5	9.3	4.8	13.7	9.9	22.9	34.2	31.6	20.5	17.1	67.5	34.3	9.0	18.9	47.1	5.3	2.0	66.4	61.4	38.3	44.7	48.4	0.3	2.2	12.9	215.1	8.8	14.8	0.1	0.5	0.0	0.0	0.7	0.1	0.7	0.0	0.0	0.5	1.8	0.0	0.0	0.0	1.6	0.6	1.1	0.3	0.1	31.7	33.3	32.2	38.6	37.2	33.6	28.1	28.1	26.6	26.4	31.4	27.2	33.0	19.2	25.9	205.7	16.6	16.4	13.0	15.6	17.1	30.5	21.9	15.0	19.3	10.0	21.0	11.0	14.6	9.7	5.6	24.8	0.0	21.2	2.9	11.7	24.8	28.7	18.0	6.5	400.9	14.2	22.0	38.9	7.7	34.2	17.7	17.2	14.6	17.1	14.2	28.6	443.4	20.6	14.2	15.4	22.1	6.6	78.6	20.2	5.4	308.2	12.1	7.3	2.1	476.5	80.4	38.5	14.9	42.9	29.2	52.8	9.2	5.4	18.3	2.7	6.6	27.5	20.0	3.5	6.2	7.2	13.8	8.2	3.8	11.7	19.4	20.3
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	22.0	19.8	16.5	16.2	15.3	21.1	21.0	14.7	22.1	24.3	14.8	20.0	11.8	22.9	6.3	22.3	23.6	8.9	17.3	15.5	14.7	18.0	22.1	17.3	23.2	16.0	14.8	28.7	25.4	10.0	17.2	11.3	16.8	23.0	10.9	6.5	17.0	11.4	28.8	23.4	21.7	12.5	14.2	30.6	18.9	16.8	16.2	11.6	19.2	10.5	15.9	22.3	22.2	17.6	38.6	25.3	26.9	46.0	26.7	34.1	38.7	42.1	20.9	45.3	39.1	27.4	30.8	47.7	53.6	22.9	23.7	34.8	45.2	37.3	20.9	31.3	62.8	38.0	68.7	46.5	48.7	77.2	43.1	48.4	48.4	47.3	44.1	28.9	33.8	35.2	83.7	14.9	28.6	42.6	31.7	83.3	64.0	24.2	57.5	52.5	34.6	65.8	28.3	38.2	63.5	28.9	26.2	53.7	44.8	19.4	21.0	42.8	38.2	65.1	25.5	39.8	75.1	25.6	53.4	44.1	30.3	80.7	34.7	1.8	18.9	0.6	8.9	15.0	8.6	12.4	9.6	8.6	18.2	12.9	11.1	8.5	3.7	5.6	9.9	10.6	6.9	10.7	16.5	15.3	14.7	22.1	15.5	14.7	16.0	14.8	16.8	14.2	16.2	17.6	15.5	12.8	13.1	8.5	47.5	24.0	27.0	16.8	22.8	8.9	16.6	20.2	8.3	11.5	9.6	12.9	2.1	21.7	19.6	16.6	5.9	17.3	22.4	7.9	11.7	17.6	7.2	13.0	12.0	14.9	22.6	14.3	17.9	9.8	29.8	19.7	6.1	10.8	47.7	8.4	9.1	14.1	4.1	80.0	51.0	47.9	14.0	57.4	17.8	10.3	64.8	6.1	12.3	2.5	7.5	12.8	6.8	12.8	24.2	29.0	7.8	14.2	9.2	12.6	13.1	17.5	16.1	21.1	20.0	20.7	20.6	15.5	24.4	14.6	22.5	20.3
TRMT13	"CCDC76, FLJ10287, FLJ11219"	ENSG00000122435	"TRNA methyltransferase 13 homolog"	Q9NUP7	1	100133150-100150498	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028494	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA028494: AB_10601254"	"unprognostic (1.12e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.16e-3)"	"unprognostic (3.28e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (6.89e-6)"	"unprognostic (3.12e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-3)"	8.8	8.7	6.9	12.2	9.8	5.2	14.5	9.6	9.6	11.2	6.7	9.3	11.2	13.9	11.8	8.5	9.2	7.2	8.0	6.5	9.7	8.8	8.7	7.8	18.2	8.5	9.0	13.5	11.5	12.9	6.8	10.7	8.7	10.4	11.3	21.7	9.1	8.1	13.1	14.7	10.7	10.1	7.0	14.1	10.0	9.4	8.5	11.3	12.0	6.2	14.6	9.5	10.3	14.9	17.5	10.0	16.5	11.5	8.7	16.9	18.0	18.0	7.1	13.4	11.1	11.9	7.0	28.7	21.8	14.4	8.9	15.4	30.6	14.0	23.1	29.0	24.2	17.2	23.1	11.6	15.7	30.0	15.4	11.9	15.5	25.5	33.3	8.4	12.4	21.0	36.6	17.9	13.6	6.7	24.6	15.6	23.0	16.7	19.9	26.0	25.0	15.7	11.1	13.6	10.7	17.9	16.6	15.8	21.6	16.1	9.3	26.1	13.0	17.8	11.9	15.1	24.3	22.8	20.0	34.0	20.1	23.5	7.0	0.2	5.8	3.1	10.5	6.1	13.0	19.9	11.3	10.6	7.0	18.7	16.8	14.0	2.5	7.9	5.1	12.8	8.6	5.6	6.9	9.8	9.6	9.6	6.5	9.7	8.5	9.0	8.7	7.0	8.5	14.9	13.1	25.6	17.0	34.0	29.0	9.7	14.2	14.2	19.9	38.9	10.7	7.9	11.1	12.8	22.2	14.7	29.2	14.2	18.9	8.0	13.7	10.5	20.9	14.3	21.0	15.7	20.4	11.3	23.1	6.1	10.2	13.7	11.7	8.0	21.5	18.7	17.9	11.4	7.6	28.6	32.1	9.9	18.3	10.1	7.0	6.0	24.8	10.3	10.6	25.3	14.7	16.6	41.2	33.7	97.4	8.5	9.6	18.4	9.0	12.6	13.0	10.7	20.4	44.7	19.7	16.0	13.4	47.6	21.9	12.2	11.9	7.3	21.5	15.8	13.6	10.0
TRMT2A	HTF9C	ENSG00000099899	"TRNA methyltransferase 2 homolog A"	Q8IZ69	22	20111875-20117392	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 131.7;Late spermatids: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 84.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001077	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA001077: AB_1079092"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.19e-3)"	"unprognostic (5.93e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.99e-8)"	"unprognostic (4.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.14e-3)"	15.7	24.0	11.2	7.6	11.4	8.2	16.8	11.4	16.8	17.7	12.0	15.3	8.7	14.7	4.4	16.3	16.0	6.4	13.8	11.3	10.6	18.0	31.4	12.9	13.1	12.2	10.9	15.5	24.2	5.8	21.8	5.5	11.9	20.7	2.7	2.4	19.1	5.6	15.6	17.1	16.3	3.6	11.1	28.1	17.2	22.8	11.7	10.2	18.7	4.8	5.2	15.3	13.8	12.9	13.8	15.4	6.1	9.9	6.0	4.4	20.9	12.3	6.4	9.7	8.8	18.5	11.7	18.7	10.2	5.9	7.4	21.0	4.5	7.2	1.4	20.3	52.2	22.7	23.3	17.0	15.8	34.9	21.2	8.2	9.0	10.3	3.8	6.7	9.9	15.4	84.5	13.1	6.8	21.7	19.5	21.6	11.2	16.2	19.9	22.8	10.6	7.4	5.7	15.1	16.0	12.2	7.9	18.9	21.5	2.6	13.6	28.7	9.3	11.5	15.4	9.3	10.6	44.3	21.6	14.6	15.2	14.7	11.9	10.2	12.2	7.4	9.8	15.3	14.4	9.7	10.3	11.7	14.3	6.3	11.1	11.1	1.5	10.6	13.5	12.7	8.4	12.3	11.2	11.4	11.4	16.8	11.3	10.6	12.2	10.9	11.9	11.1	11.7	12.9	10.8	12.8	13.8	13.4	13.4	9.8	10.2	13.9	9.6	12.5	15.9	18.0	7.4	14.3	14.1	11.0	8.4	25.0	18.3	17.0	13.7	12.3	131.7	8.9	9.5	10.9	18.6	14.5	6.9	13.0	18.9	10.8	15.8	6.6	25.4	15.8	8.9	18.6	25.0	15.2	7.4	13.4	14.2	18.9	8.9	206.4	17.7	13.7	7.2	4.7	16.9	22.7	12.3	3.5	9.0	13.0	13.4	14.3	18.1	12.1	14.4	10.5	11.9	12.8	6.6	11.8	11.2	16.4	13.7	10.4	11.2	28.5	16.6	19.2	20.0	9.7
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 118.6;choroid plexus: 375.5"	"Cell type enhanced"	"Detected in some"		"Club cells: 9.9;Collecting duct cells: 14.7;Distal tubular cells: 11.7;Endometrial ciliated cells: 35.1;Glandular and luminal cells: 18.7;Respiratory ciliated cells: 14.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 118.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.0;BJ: 8.7;fHDF/TERT166: 11.9;RPTEC TERT1: 4.0;SCLC-21H: 4.3;U-266/84: 4.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 31.1"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	1.3	0.4	6.1	0.6	6.8	0.3	2.3	118.6	7.9	1.7	375.5	1.6	0.7	1.0	0.9	0.9	2.0	1.6	6.3	25.2	6.3	3.5	2.2	1.7	0.4	5.4	7.2	0.3	2.2	1.6	1.4	0.4	11.5	1.2	1.2	24.5	2.6	1.0	3.2	3.2	1.2	0.4	4.8	1.5	1.1	1.2	17.5	0.2	33.7	1.6	0.3	0.9	0.8	5.0	0.1	0.0	6.0	0.0	0.0	0.0	1.4	8.7	2.0	1.2	0.6	0.0	0.1	0.1	0.4	11.9	1.1	0.2	0.1	0.2	1.2	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.6	0.2	3.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.1	0.7	0.1	0.0	1.0	0.0	0.1	4.0	0.1	4.3	0.1	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.1	0.8	0.8	0.1	0.2	4.4	0.0	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	6.1	6.8	118.6	7.9	25.2	6.3	5.4	7.2	11.5	4.8	17.5	5.0	6.2	6.4	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	6.7	0.0	0.0	9.9	14.7	0.0	1.0	0.2	0.0	11.7	2.3	0.0	35.1	6.4	2.1	0.0	0.0	0.0	1.1	0.2	1.8	0.0	18.7	1.3	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.3	14.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0
TRNAU1AP	"FLJ20503, SECP43, TRSPAP1"	ENSG00000180098	"TRNA selenocysteine 1 associated protein 1"	Q9NX07	1	28553085-28578545	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032068, HPA032069"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA032068: AB_2674135, HPA032069: AB_10603998"	"unprognostic (4.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.93e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (5.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.76e-1)"	5.8	4.7	8.2	3.9	8.5	4.1	5.2	10.1	10.5	5.2	7.7	5.8	2.7	4.2	5.5	5.2	5.0	2.5	5.4	7.9	8.5	5.3	3.3	5.2	5.9	8.4	8.2	5.8	5.6	5.7	4.0	4.1	8.5	4.3	4.4	7.2	4.8	5.1	4.0	6.9	4.7	3.7	8.1	5.3	5.1	2.9	8.2	8.5	3.8	3.4	7.0	5.0	4.6	9.2	5.1	3.0	8.6	6.0	7.7	14.6	4.1	6.7	13.5	12.1	10.9	4.7	7.8	7.7	2.6	7.4	5.7	3.8	9.4	10.7	12.1	6.8	10.6	5.8	10.1	3.2	7.1	4.5	4.8	15.7	9.2	9.5	7.4	8.5	17.4	7.8	6.8	6.1	12.0	3.5	7.7	5.2	6.1	5.5	6.5	5.5	6.0	5.4	13.3	5.1	5.0	6.5	8.0	6.9	7.7	9.1	7.7	5.4	5.0	3.1	3.0	5.0	6.1	7.9	10.6	4.8	7.6	9.7	9.1	5.4	2.7	7.3	4.2	4.5	4.2	3.6	4.5	5.3	3.3	4.1	5.3	3.4	1.6	9.7	2.8	2.2	3.3	2.2	8.2	8.5	10.1	10.5	7.9	8.5	8.4	8.2	8.5	8.1	8.2	9.2	30.3	35.3	36.6	15.0	29.2	17.6	20.0	33.8	17.6	35.1	22.3	23.0	19.9	21.5	39.9	18.4	35.5	30.6	37.1	13.4	17.6	37.4	11.1	41.0	20.4	23.8	10.3	32.2	29.7	32.8	52.8	23.0	14.8	28.0	35.4	28.1	25.4	10.8	33.1	23.5	28.2	13.9	36.7	30.1	23.2	5.0	28.9	27.6	14.2	6.5	35.1	25.5	39.1	17.6	29.9	40.8	12.2	22.6	37.5	22.2	23.4	19.5	84.7	35.4	32.9	22.0	55.0	21.9	25.3	36.3	20.5	68.4	31.8	23.1	14.8	28.9
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 9.4;Excitatory neurons: 14.6;Granulosa cells: 12.3;Inhibitory neurons: 20.0;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 37.1;SH-SY5Y: 33.8;SuSa: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071449			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles	"Plasma membrane, Cytosol"	"HPA071449: "	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	3.9	3.0	13.9	1.3	10.6	1.0	3.7	0.8	23.7	9.5	0.9	3.2	0.9	13.4	6.6	1.6	5.3	4.2	2.4	9.3	17.2	3.9	16.8	2.1	1.6	6.2	5.1	17.5	7.1	5.3	24.4	4.3	6.9	5.5	2.1	6.2	1.5	5.2	31.1	1.2	1.6	8.6	3.4	1.0	2.0	2.6	12.6	4.7	10.1	1.0	1.6	2.5	5.5	13.3	0.0	0.3	37.1	0.1	7.1	9.8	0.0	2.1	13.1	2.0	0.7	0.0	0.0	0.0	5.3	13.8	3.1	0.2	0.3	0.6	1.0	0.1	23.3	18.0	0.0	1.5	2.7	0.0	0.1	22.8	0.0	12.0	0.0	11.8	0.9	9.1	0.0	0.2	14.0	0.0	0.3	0.1	19.6	0.1	0.0	11.3	16.4	0.1	3.5	0.3	25.3	33.8	0.0	0.5	3.1	74.2	0.0	2.2	0.0	15.7	15.9	0.2	2.2	5.8	0.9	0.0	2.3	0.0	13.8	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	2.2	0.1	0.9	0.0	0.1	13.9	10.6	0.8	23.7	9.3	17.2	6.2	5.1	6.9	3.4	12.6	13.3	0.4	0.0	0.0	9.4	0.3	0.4	1.4	0.8	5.2	4.2	0.5	1.9	1.8	0.0	1.9	3.7	0.0	0.8	0.2	0.0	0.0	1.7	0.4	0.3	7.9	1.9	0.0	0.0	14.6	0.2	0.6	7.0	0.5	0.5	1.3	12.3	0.4	0.0	0.5	8.4	20.0	0.0	0.0	0.0	0.4	0.6	5.9	0.2	0.0	1.0	0.1	2.2	0.0	17.1	9.4	0.2	0.0	3.8	0.1	0.4	0.0	0.4	0.0	0.9	0.0	1.5	3.3	1.2	1.9	0.1	0.1	0.7	0.7	2.9	0.0	0.3
TRPC4AP	"C20orf188, dJ756N5.2, DKFZp586C1223, DKFZP727M231, PPP1R158, TRRP4AP"	ENSG00000100991	"Transient receptor potential cation channel subfamily C member 4 associated protein"	Q8TEL6	20	35002404-35092807	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051197, HPA065061"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA051197: AB_2681384, HPA065061: AB_2685416"	"unprognostic (3.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.25e-8)"	"unprognostic (1.33e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	54.2	60.9	40.6	37.4	49.5	69.3	50.5	43.6	47.4	45.6	41.3	42.6	36.4	41.7	32.1	45.8	41.3	34.1	46.4	40.7	44.2	43.0	61.9	55.9	42.2	50.0	46.4	40.4	64.2	42.4	62.1	47.8	50.7	46.6	36.1	29.7	48.2	36.1	80.5	46.1	46.9	37.6	43.3	60.4	51.9	35.7	50.0	41.6	47.3	39.7	38.9	41.9	41.4	63.0	53.7	64.4	56.3	58.2	85.2	81.6	86.0	85.2	99.8	95.7	109.6	141.6	78.3	50.0	79.5	99.1	97.4	70.0	51.6	121.5	73.7	26.7	40.2	127.5	54.8	131.0	85.0	74.9	83.8	91.4	75.4	71.7	61.0	100.0	107.9	101.1	61.2	58.3	77.0	40.6	91.1	84.0	44.3	49.2	86.9	56.4	80.9	51.2	82.3	68.9	49.6	50.1	91.9	153.2	59.3	66.6	55.6	59.9	106.7	117.9	53.2	64.8	51.6	52.9	30.6	41.5	128.2	36.6	61.7	30.6	30.5	50.6	24.0	32.4	25.5	17.4	19.9	25.7	40.2	15.3	17.2	18.7	48.5	25.9	38.2	17.4	24.7	27.0	40.6	49.5	43.6	47.4	40.7	44.2	50.0	46.4	50.7	43.3	50.0	63.0	24.2	19.2	14.1	49.0	29.9	15.2	15.2	20.6	21.6	25.7	24.1	19.9	13.1	12.8	19.1	20.2	79.2	52.6	37.0	34.9	3.9	30.1	14.8	16.0	21.9	25.1	20.4	21.5	44.6	27.3	43.8	23.9	48.4	24.9	19.7	43.4	21.0	23.4	37.2	67.3	56.3	24.6	28.5	25.6	22.2	8.5	25.4	23.7	12.4	40.3	27.9	28.5	23.7	59.3	138.0	36.2	24.1	23.0	45.8	23.6	30.4	11.4	18.0	29.2	39.5	18.3	24.0	23.2	27.3	19.1	15.8	68.4	32.2	30.3	24.0	24.0
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 108.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.2;Oligodendrocytes: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	11.5	9.6	4.3	13.3	6.5	21.4	13.6	15.4	6.7	10.3	29.3	13.8	14.4	12.7	14.6	8.6	9.4	11.1	15.5	4.8	3.5	22.9	25.3	11.6	16.6	4.9	3.9	16.4	12.2	108.9	5.3	13.3	5.9	10.9	14.4	10.5	10.9	10.6	7.8	16.6	13.1	11.4	3.2	12.2	13.6	9.9	6.4	15.5	17.3	9.1	14.4	11.4	8.1	10.4	21.4	21.0	17.2	19.1	48.5	36.2	20.9	26.4	36.7	16.5	21.6	29.1	11.6	46.4	12.7	30.8	42.5	35.1	23.3	19.5	23.4	26.0	13.7	37.1	31.5	15.4	44.0	38.8	27.6	33.9	22.4	18.8	35.0	24.0	13.5	28.8	42.6	34.5	30.4	33.7	25.1	18.8	13.0	29.4	12.8	27.2	23.7	22.7	23.0	49.9	14.2	18.1	18.2	28.7	35.8	30.1	18.0	41.6	20.7	26.1	12.4	122.4	30.8	23.3	54.9	44.0	28.4	77.5	24.8	1.8	1.3	1.6	2.5	1.3	2.9	2.2	1.8	1.7	1.5	2.3	1.6	1.9	1.7	2.4	1.4	1.9	2.0	0.8	4.3	6.5	15.4	6.7	4.8	3.5	4.9	3.9	5.9	3.2	6.4	10.4	23.9	19.2	31.3	73.1	36.4	31.6	17.2	11.0	44.9	21.9	18.8	11.9	25.9	21.5	8.2	12.9	12.5	23.0	38.4	17.0	3.9	11.7	33.3	21.6	27.1	19.7	18.5	29.6	122.2	12.7	9.4	26.1	37.8	23.1	17.7	26.0	14.6	43.9	14.6	21.9	92.7	19.5	6.1	22.4	19.8	26.0	26.4	26.5	19.6	66.5	24.2	8.5	29.9	80.9	109.1	15.5	13.9	20.3	33.2	24.9	23.4	11.0	19.3	22.6	13.1	30.0	22.0	23.1	23.6	25.7	24.2	16.3	34.5	22.2	20.4	11.1
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557812	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.2;skin 1: 4.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.7;Plasma cells: 15.9;Proximal enterocytes: 26.1;Suprabasal keratinocytes: 24.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.3;BEWO: 5.0;CACO-2: 3.1;RH-30: 11.9;T-47d: 5.2;U-266/70: 3.1;U-266/84: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: AB_2686149"	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.1	0.0	1.1	0.5	1.1	0.5	0.2	0.1	1.1	0.3	0.0	0.9	2.0	0.0	0.1	0.2	0.0	0.1	0.0	0.6	0.3	0.0	0.6	0.1	0.3	0.4	0.3	0.2	0.0	0.1	0.3	0.2	0.4	0.1	1.7	0.2	0.1	0.0	1.5	4.8	5.2	0.1	0.1	0.2	0.9	0.4	0.9	0.0	0.0	0.5	0.5	0.2	0.3	1.8	3.3	0.0	0.3	0.0	0.2	0.3	5.0	0.1	0.0	0.0	0.0	3.1	0.8	0.1	1.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.1	0.5	0.2	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.2	0.4	0.1	11.9	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	5.2	0.1	0.0	0.0	0.1	0.1	0.0	3.1	2.7	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	1.1	0.1	1.1	0.6	0.3	0.4	0.3	0.4	0.1	0.9	1.8	0.2	0.0	2.5	2.9	5.8	18.7	3.9	0.2	10.2	1.2	0.9	0.5	3.5	1.5	0.2	0.0	0.0	0.3	2.6	8.9	1.9	0.0	0.3	0.7	0.9	1.6	0.0	0.0	1.6	0.0	0.9	3.7	6.1	0.9	0.0	1.1	0.0	0.3	0.3	5.0	0.6	2.7	0.0	0.0	3.8	0.4	3.1	0.8	7.2	0.0	0.1	2.2	3.1	0.5	2.3	1.2	2.5	3.4	15.9	5.9	26.1	2.3	0.2	1.0	0.0	6.9	1.8	0.0	1.5	2.9	24.6	0.5	1.8	2.8	0.9	3.7
TSBP1	"C6orf10, TSBP"	ENSG00000204296	"Testis expressed basic protein 1"	Q5SRN2	6	32288526-32371912	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	61	"testis: 35.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA047479, HPA057426"	Approved		Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"			Cytosol		"HPA047479: , HPA057426: "	"unprognostic (1.00e-1)"	"unprognostic (2.24e-1)"				"unprognostic (1.05e-1)"		"unprognostic (5.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"		"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.56e-2)"		0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSC22D2	"KIAA0669, TILZ4a, TILZ4b, TILZ4c"	ENSG00000196428	"TSC22 domain family member 2"	O75157	3	150408335-150466431	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004926	Approved		Approved	Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA004926: AB_1080401"	"unprognostic (4.65e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.28e-3)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (1.10e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.49e-1)"	20.9	11.8	8.1	10.7	8.9	34.9	13.2	9.9	15.2	18.9	3.3	14.9	6.0	23.4	14.4	23.8	15.4	22.6	21.5	9.1	9.0	15.9	29.6	15.0	10.3	8.5	8.8	15.2	11.4	10.8	9.8	16.9	9.0	11.4	12.4	16.7	10.6	7.3	17.0	11.1	11.9	26.3	6.1	13.8	16.3	17.8	6.6	11.8	12.9	14.4	9.9	20.6	23.3	11.1	45.7	6.2	19.6	18.8	25.1	12.2	56.4	44.6	16.9	32.1	39.5	25.0	22.4	14.9	25.1	33.7	65.7	18.9	19.8	16.2	63.7	11.8	11.1	16.0	11.6	12.7	28.5	9.8	10.6	22.6	12.4	20.9	31.4	19.4	20.4	7.1	27.7	23.9	22.6	16.1	10.5	12.1	25.1	13.6	12.3	11.0	35.8	17.7	20.7	26.6	11.3	10.1	20.5	10.8	45.8	23.5	10.3	13.0	33.0	21.1	21.9	25.3	41.6	31.9	6.6	20.6	14.3	29.2	12.7	0.5	1.7	2.0	1.1	1.6	1.8	1.1	1.4	1.2	1.1	1.4	1.1	1.1	2.2	2.0	2.9	1.2	0.6	1.5	8.1	8.9	9.9	15.2	9.1	9.0	8.5	8.8	9.0	6.1	6.6	11.1	97.4	64.1	30.8	160.3	52.5	148.9	81.5	12.6	111.0	18.6	65.1	28.4	46.9	20.0	18.2	12.9	29.2	28.6	53.7	77.6	17.6	13.8	23.2	85.5	107.6	48.3	31.6	10.3	78.7	13.8	33.0	59.6	50.0	166.6	65.4	10.9	29.3	40.1	18.4	16.8	70.9	45.4	22.4	24.1	94.9	29.6	18.6	58.9	42.7	86.2	20.2	31.8	16.5	59.3	86.5	26.0	82.2	15.1	37.3	42.6	16.0	10.6	10.8	21.3	13.1	79.0	48.9	51.6	29.3	77.0	108.3	54.9	48.7	17.9	34.8	83.5
TSC22D3	"DIP, DSIPI, GILZ, hDIP, TSC-22R"	ENSG00000157514	"TSC22 domain family member 3"	Q99576	X	107713221-107777342	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 1234.8;dendritic cells: 1146.4;Plasma cells: 2348.5;T-cells: 1479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 380.5;ASC TERT1: 259.7;HHSteC: 628.0;hTCEpi: 572.7;Karpas-707: 364.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001916, CAB034364"	Approved		Approved	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nuclear speckles, Golgi apparatus"	"CAB034364: AB_2272198, HPA001916: AB_2666504"	"unprognostic (3.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.49e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.73e-3)"	"unprognostic (4.40e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-1)"	"unprognostic (9.64e-2)"	536.4	240.5	90.3	394.8	93.5	433.3	447.3	101.0	105.0	396.4	104.1	290.2	87.2	269.3	72.0	300.4	369.8	167.1	331.9	81.3	102.9	194.9	177.4	522.6	281.0	99.6	97.2	371.1	113.8	55.7	136.2	163.8	98.9	404.4	183.6	22.5	333.4	160.5	729.3	493.6	426.3	178.7	92.8	408.2	390.4	43.8	99.3	203.2	313.0	187.8	338.2	508.2	486.9	91.3	10.9	18.2	9.3	25.7	380.5	259.7	3.7	16.9	14.1	7.8	8.6	0.1	35.8	23.4	40.1	13.7	5.5	53.5	19.1	54.2	3.3	7.0	9.0	11.5	76.9	1.0	628.0	2.5	37.7	238.8	572.7	6.1	158.7	78.8	29.3	2.5	3.6	364.1	67.2	37.8	0.7	40.5	16.3	11.5	11.7	1.2	23.5	51.3	26.1	7.3	2.4	20.3	16.6	89.2	128.8	16.9	17.0	52.4	44.1	23.6	7.1	4.8	3.4	79.6	37.8	11.2	12.0	46.7	6.7	668.9	417.2	1653.1	649.7	524.1	484.2	584.0	740.6	641.5	399.5	559.6	686.3	643.0	2396.6	968.4	851.8	81.4	1080.9	1624.1	90.3	93.5	101.0	105.0	81.3	102.9	99.6	97.2	98.9	92.8	99.3	91.3	423.5	64.1	164.7	10.4	1234.8	110.0	82.8	129.7	435.4	52.0	97.0	47.5	31.8	70.1	106.9	47.8	0.0	3.2	1146.4	26.2	232.8	28.3	28.8	24.2	40.9	171.7	64.2	481.5	13.1	22.2	140.5	454.2	200.3	29.7	353.2	15.3	247.0	95.6	121.3	62.2	12.9	32.9	83.4	396.3	191.8	41.2	230.5	539.1	437.6	16.9	126.0	8.9	234.8	37.7	23.7	22.7	19.6	319.7	2348.5	106.5	58.6	48.6	61.0	19.1	433.9	245.4	248.3	24.1	15.3	182.6	79.1	9.9	1479.6	89.6	33.0	42.2
TSC22D4	"THG-1, TILZ2"	ENSG00000166925	"TSC22 domain family member 4"	Q9Y3Q8	7	100463359-100479232	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 601.0;choroid plexus: 224.0"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 778.8"	"Cancer enhanced"	"Detected in all"		"glioma: 118.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 198.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006757	Uncertain		Approved	Cytosol		NA	NA		160000	"Cluster 52: Eosinophils - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 24: NB-4 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA006757: AB_1080403"	"unprognostic (2.34e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.81e-3)"	37.1	52.7	437.1	33.6	601.0	72.0	36.1	524.6	456.9	43.4	224.0	47.5	23.5	40.5	10.1	73.0	36.8	14.4	59.7	384.9	457.3	64.1	30.0	42.6	40.6	527.5	563.9	44.1	37.3	18.5	52.1	22.7	484.3	55.7	10.7	21.9	97.6	22.2	26.2	58.8	44.4	14.0	485.2	95.2	38.6	36.7	538.9	31.2	34.5	28.7	23.2	37.8	46.8	565.4	42.0	30.8	10.3	33.7	34.2	40.5	19.9	30.5	49.6	28.3	25.8	16.9	25.0	36.8	36.1	24.4	66.0	31.2	12.2	26.7	9.9	65.6	25.2	34.2	34.5	14.6	54.4	44.1	86.3	45.7	24.0	32.4	32.2	33.0	58.3	29.0	75.2	64.2	22.9	74.3	55.6	198.4	14.0	35.7	42.6	89.7	8.1	51.6	23.2	22.3	8.8	25.1	41.4	78.8	65.5	16.7	22.5	63.1	50.2	38.4	39.1	95.0	22.8	40.9	42.6	27.1	35.7	66.4	47.8	9.7	18.7	30.0	19.0	20.2	14.9	11.9	16.3	17.9	12.7	11.8	15.2	16.2	56.1	18.8	20.5	13.3	25.0	18.2	437.1	601.0	524.6	456.9	384.9	457.3	527.5	563.9	484.3	485.2	538.9	565.4	16.7	12.8	8.9	123.4	50.8	32.8	35.9	50.7	37.5	15.4	47.3	61.3	17.7	44.3	32.5	40.5	6.2	30.7	69.3	60.3	137.0	63.5	1.7	14.0	25.5	26.1	33.6	60.6	3.8	33.9	35.3	29.8	21.4	19.9	15.9	36.1	42.1	11.1	79.9	18.5	4.6	32.1	38.7	57.7	67.1	5.2	45.7	56.7	55.2	14.0	77.2	778.8	116.4	50.8	162.6	60.6	52.7	39.9	31.8	59.2	62.8	21.0	13.7	18.2	46.0	16.1	34.5	1.7	5.4	32.8	33.8	79.1	78.2	28.9	31.7	80.3
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484421-12541549	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.9	9.4	3.4	1.1	3.9	0.3	8.9	4.4	4.8	11.5	3.7	11.5	1.4	10.9	2.6	8.6	12.0	1.8	15.5	3.5	3.7	10.2	8.5	6.0	2.2	3.6	3.5	14.2	12.1	3.2	10.9	0.9	3.6	10.0	2.3	3.4	6.7	3.2	15.9	8.3	6.9	3.2	3.3	6.6	9.7	6.7	3.9	2.6	9.0	3.8	2.2	11.5	9.7	3.8	6.2	11.8	5.5	7.4	6.3	7.7	7.6	5.8	4.3	6.6	5.1	4.2	5.2	5.5	3.3	4.0	5.8	5.8	7.8	9.4	5.4	5.5	9.8	5.1	9.1	5.7	5.4	9.3	2.1	4.9	11.2	10.1	9.7	3.3	4.7	8.8	10.7	3.4	6.5	11.9	9.6	6.1	6.5	10.5	13.5	4.6	2.3	13.5	9.9	4.8	1.5	4.5	6.7	5.0	4.8	3.1	10.1	5.1	4.5	4.2	3.9	4.7	9.7	3.1	8.6	6.2	5.6	11.8	5.4	0.6	1.9	0.0	2.7	1.6	4.4	3.7	4.6	3.8	2.3	3.2	6.2	5.1	0.4	2.5	1.7	3.4	1.6	2.6	3.4	3.9	4.4	4.8	3.5	3.7	3.6	3.5	3.6	3.3	3.9	3.8	5.5	3.2	3.3	26.1	8.9	2.9	11.2	5.6	13.1	28.1	3.7	4.3	7.0	10.0	3.8	11.0	43.8	8.8	2.6	9.2	1.9	6.2	1.6	7.1	7.4	6.2	4.2	8.4	42.8	4.2	4.3	5.7	13.7	3.7	5.1	17.7	3.6	5.0	4.6	10.1	46.4	5.2	4.1	3.5	1.7	2.8	9.0	3.6	3.6	16.9	2.4	8.0	6.2	19.1	31.8	4.5	5.0	10.1	3.8	6.2	2.3	6.9	11.1	34.1	6.6	7.9	6.3	14.0	23.0	7.1	4.8	1.9	4.6	15.3	8.4	8.0
TSGA10	"CEP4L, CT79"	ENSG00000135951	"Testis specific 10"	Q9BZW7	2	98997261-99154964	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 51.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 458.9;Late spermatids: 294.2;Oligodendrocytes: 144.9;Spermatocytes: 206.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036879			Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA036879: AB_10671715"	"unprognostic (1.71e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-6)"	"unprognostic (1.06e-2)"	"unprognostic (9.91e-3)"	"unprognostic (9.79e-2)"	"unprognostic (8.37e-4)"	1.1	1.0	1.8	0.6	1.6	0.7	1.4	1.6	1.9	1.3	3.7	0.9	1.0	1.1	1.6	0.6	12.6	1.1	0.2	1.8	1.6	3.0	0.5	1.6	1.0	3.4	3.5	0.5	1.7	1.6	2.5	0.4	2.5	1.0	1.3	2.6	1.1	0.6	0.1	1.9	0.6	0.3	2.7	0.8	1.4	51.5	1.5	1.1	3.1	0.2	0.8	0.6	0.4	3.7	0.8	0.2	1.2	0.5	0.6	0.7	0.9	0.0	0.1	0.3	0.2	0.2	0.8	0.7	0.2	0.0	0.5	0.2	0.2	0.2	0.3	1.0	0.8	0.1	0.0	0.3	0.0	0.5	1.7	0.9	1.0	0.1	0.1	0.7	0.0	0.9	0.0	0.0	0.6	0.2	0.2	0.4	0.1	0.3	0.2	0.3	0.1	0.2	4.2	0.7	1.7	0.2	0.9	0.7	0.2	1.3	0.2	0.3	0.4	0.2	0.4	0.0	0.1	0.6	0.3	0.3	0.3	1.0	0.4	0.1	0.2	0.2	0.6	0.0	0.7	0.7	0.7	0.8	0.0	0.8	1.1	0.7	0.0	1.0	0.0	0.4	0.7	0.3	1.8	1.6	1.6	1.9	1.8	1.6	3.4	3.5	2.5	2.7	1.5	3.7	3.1	3.2	9.2	35.3	13.3	3.6	10.3	8.6	6.2	19.3	13.9	15.4	7.1	17.2	14.5	23.9	29.2	9.7	5.6	4.7	25.4	8.4	458.9	80.6	4.5	4.0	15.5	8.6	73.4	10.5	4.3	5.8	8.6	10.9	5.1	5.3	4.2	7.1	4.6	20.2	57.9	6.7	12.2	3.1	1.4	294.2	11.1	5.1	1.8	23.4	4.5	21.1	15.5	27.6	144.9	4.7	12.2	9.8	8.1	7.8	8.0	12.9	107.9	36.6	6.6	5.7	6.2	206.8	36.6	5.6	4.4	9.3	8.9	5.9	8.4	7.9
TSGA13		ENSG00000213265	"Testis specific 13"	Q96PP4	7	130668643-130687432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	103	"testis: 14.0"	"Group enriched"	"Detected in some"	18	"Early spermatids: 86.4;Late spermatids: 224.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022968	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA022968: AB_2671013"					"unprognostic (1.49e-1)"					"unprognostic (1.13e-2)"		"unprognostic (1.86e-1)"		"unprognostic (1.34e-1)"				0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.2	3.9	0.0	0.3	1.7	0.1	0.0	0.0	1.2	0.3	0.1	0.1	0.0	1.9	0.0	8.4	0.1	0.3	0.0	0.0	0.0	86.4	0.3	0.3	1.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.4	0.0	0.4	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.9	2.2	224.1	0.6	0.8	0.0	0.0	0.1	0.6	1.0	0.5	0.1	0.0	0.0	0.7	0.3	0.0	0.0	0.0	6.0	1.5	0.0	0.0	0.3	1.6	0.6	0.0	0.4	0.7	0.6	0.1	0.0	0.0
TSNARE1	FLJ31164	ENSG00000171045	"T-SNARE domain containing 1"	Q96NA8	8	142212080-142403182	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 26.7;Inhibitory neurons: 23.0;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 24.5"					"Low region specificity"	"Detected in all"			HPA074249	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA074249: "	"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.33e-4)"	10.1	9.5	10.8	6.6	10.6	4.2	12.0	5.0	19.0	16.3	4.8	11.3	11.6	13.8	2.9	10.4	15.0	5.9	9.1	9.9	7.3	13.6	10.0	9.9	6.7	12.0	8.4	20.4	28.5	7.0	12.9	3.3	9.2	13.7	2.8	4.0	13.4	6.4	11.0	27.3	12.9	3.8	5.9	12.6	13.3	13.4	8.9	6.2	16.3	4.6	4.4	11.8	12.1	14.1	6.6	6.4	4.2	5.3	3.2	2.9	13.2	1.9	3.1	1.9	1.9	2.1	7.0	3.5	10.7	1.5	3.2	5.9	1.9	6.6	0.8	4.0	6.4	4.2	1.7	7.2	8.5	9.5	9.6	5.6	6.2	0.0	4.3	3.9	2.1	18.4	8.4	0.3	1.3	8.7	8.1	8.8	4.2	6.4	15.8	0.0	2.2	6.2	3.6	8.0	17.5	10.6	8.9	7.1	12.8	2.0	4.7	8.2	5.1	3.1	8.5	5.6	4.3	0.5	2.8	5.6	5.7	24.5	3.2	1.6	0.5	0.1	0.9	2.3	0.6	0.3	0.5	0.2	0.6	0.4	0.2	0.3	0.0	0.5	2.0	0.0	0.6	0.6	10.8	10.6	5.0	19.0	9.9	7.3	12.0	8.4	9.2	5.9	8.9	14.1	1.9	0.0	1.1	12.1	2.3	4.5	2.2	0.8	6.8	2.6	1.8	1.8	4.6	2.8	0.5	1.8	2.1	0.3	1.6	1.6	3.9	1.6	2.4	1.9	1.0	1.5	1.8	2.5	26.7	1.8	1.8	1.5	4.1	1.4	0.0	1.2	1.1	1.3	1.9	0.0	23.0	2.1	0.0	2.6	2.9	5.3	0.9	1.7	3.6	12.2	1.5	3.1	2.1	21.1	24.6	1.6	0.2	1.5	1.6	1.3	1.6	1.4	2.3	1.3	0.0	2.3	1.7	5.0	3.7	3.5	7.5	0.3	3.1	0.7	0.9	1.5
TSNAX	"C3PO, TRAX"	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528541-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 194.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		36000	"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	22.7	31.9	12.2	20.2	12.8	15.1	25.4	11.5	15.1	19.5	17.8	18.4	17.7	21.5	22.8	19.4	18.0	18.7	26.2	13.2	15.2	31.7	26.0	20.8	26.4	11.9	12.7	18.3	16.3	40.0	17.0	20.4	12.3	22.8	19.6	19.9	18.1	20.5	50.5	21.8	17.3	20.7	13.4	28.5	17.7	20.9	13.2	26.6	29.8	40.7	25.7	19.9	14.9	13.7	30.3	24.1	36.7	29.7	27.1	32.6	41.4	33.1	50.9	42.2	36.0	21.4	40.8	42.3	55.0	38.0	15.7	31.9	29.3	31.4	53.9	38.4	51.7	40.7	23.9	28.6	35.8	67.8	82.1	40.4	32.4	40.9	32.3	26.4	30.7	31.6	66.6	28.8	58.0	12.9	44.0	32.9	53.4	26.5	28.3	42.8	39.8	56.8	46.9	33.9	34.1	65.7	35.3	43.3	116.8	14.5	63.2	113.0	28.9	28.3	26.3	57.6	61.0	48.2	68.9	46.4	46.8	52.0	79.7	194.4	34.8	85.6	30.6	40.2	30.3	28.5	33.5	30.6	33.2	28.3	34.6	34.0	37.7	51.9	55.7	22.3	39.4	33.6	12.2	12.8	11.5	15.1	13.2	15.2	11.9	12.7	12.3	13.4	13.2	13.7	48.3	28.9	41.3	0.0	25.5	43.8	21.4	42.4	8.6	59.2	27.2	20.1	24.1	40.0	25.3	42.3	29.2	44.4	36.9	21.8	54.8	30.6	12.6	23.6	20.5	46.1	28.9	59.5	0.0	31.1	51.5	28.1	11.7	19.3	77.3	26.2	31.8	32.8	49.5	65.6	0.0	28.2	38.7	62.2	35.0	9.4	33.5	40.5	26.6	0.0	51.7	72.0	37.0	0.0	0.0	26.5	21.8	36.1	13.4	17.3	22.4	45.8	31.9	47.1	39.5	34.4	30.2	40.8	65.4	13.0	51.4	36.3	30.5	46.8	25.6	14.9
TSNAXIP1	TXI1	ENSG00000102904	"Translin associated factor X interacting protein 1"	Q2TAA8	16	67806765-67832148	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 8.6;testis: 21.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 99.9;Endometrial ciliated cells: 41.1;Late spermatids: 178.6;Respiratory ciliated cells: 51.9;Spermatocytes: 53.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.0;SiHa: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA053516			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053516: AB_2682175"	"unprognostic (9.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.59e-3)"	0.5	1.0	1.1	0.4	1.3	0.1	0.5	0.8	1.8	1.4	2.8	1.0	0.0	0.9	0.9	0.2	8.6	0.4	0.3	1.3	1.2	1.2	0.8	1.3	0.1	1.8	2.2	1.5	1.2	1.3	6.4	0.1	1.7	0.9	0.1	3.5	0.3	0.4	0.2	0.3	0.3	0.4	1.2	0.3	0.5	21.5	1.3	0.2	0.7	0.0	0.1	0.6	0.5	1.0	0.5	0.1	1.1	3.0	1.4	0.4	0.4	0.1	0.7	0.2	1.0	0.3	0.3	0.4	0.4	0.1	0.3	0.6	0.3	0.4	0.6	0.1	0.4	0.0	0.4	0.0	0.4	0.7	0.0	0.3	0.4	1.4	0.2	0.2	0.0	0.6	0.2	0.1	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.8	0.3	0.0	1.3	0.3	0.8	1.0	2.0	0.0	0.2	0.3	0.8	0.0	0.3	0.1	0.0	0.3	0.1	0.5	1.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.8	1.8	1.3	1.2	1.8	2.2	1.7	1.2	1.3	1.0	0.6	0.0	2.7	9.1	0.2	0.1	0.4	2.5	0.6	2.9	1.0	1.1	12.0	0.0	4.8	5.5	4.2	0.4	0.2	0.2	0.0	0.7	99.9	41.1	2.0	1.1	0.0	0.4	7.9	0.0	0.2	1.6	0.0	1.3	0.0	1.3	0.7	0.7	0.3	3.3	4.9	0.0	10.2	0.0	0.2	178.6	2.8	0.3	0.0	3.7	0.0	3.7	0.0	3.0	1.3	0.1	0.0	1.9	0.0	0.3	0.0	2.5	51.9	10.2	6.6	0.6	1.7	53.3	8.9	0.1	0.3	0.5	0.2	1.4	0.0	0.2
TSPAN31	SAS	ENSG00000135452	"Tetraspanin 31"	Q12999	12	57738013-57750219	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	4	"glioma: 54.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030758, HPA057489"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA030758: , HPA057489: AB_2683447"	"unprognostic (2.66e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (4.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (9.91e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.58e-1)"	24.5	29.7	9.0	11.2	10.8	5.5	23.1	10.8	15.6	26.2	11.8	20.5	16.4	26.2	13.2	20.4	25.8	20.9	26.7	9.5	10.3	26.7	20.9	22.8	11.8	11.2	10.2	25.6	25.2	32.7	24.4	12.5	11.0	22.1	10.7	29.7	25.6	13.5	21.0	18.6	18.5	8.4	11.1	20.8	23.0	8.0	9.9	9.8	30.2	21.2	8.7	21.0	20.1	13.0	9.5	23.4	21.1	5.4	44.3	24.0	13.5	15.8	11.7	4.6	5.1	16.7	46.4	7.6	32.7	29.0	9.4	17.5	5.7	26.7	10.7	23.1	15.4	10.7	18.7	6.6	45.2	10.6	17.9	29.6	30.2	13.7	30.3	22.1	14.6	4.6	7.5	19.9	19.6	19.4	9.2	5.9	4.3	18.3	7.0	10.5	139.8	20.0	15.7	19.0	6.6	16.7	15.6	21.3	10.5	4.5	41.1	15.8	27.6	11.3	9.5	5.6	7.4	28.9	8.1	4.1	32.7	6.3	19.2	25.4	26.3	16.4	35.8	28.6	34.8	31.1	28.5	30.7	27.6	31.0	28.3	26.2	5.8	35.4	42.0	58.3	22.1	33.0	9.0	10.8	10.8	15.6	9.5	10.3	11.2	10.2	11.0	11.1	9.9	13.0	37.1	48.1	32.4	8.1	23.8	11.2	46.4	37.4	22.2	43.2	32.0	27.4	5.1	20.0	31.4	31.3	41.7	20.9	29.8	19.9	9.8	37.6	1.2	18.5	32.5	26.7	26.5	8.2	9.1	39.0	15.2	31.7	11.7	20.4	45.0	28.9	22.1	21.6	22.4	21.9	9.1	21.6	32.6	18.0	16.4	1.8	25.7	24.2	32.0	8.4	21.6	62.7	35.0	11.1	13.3	37.6	20.3	17.3	18.4	30.5	30.6	18.1	27.9	60.4	19.7	22.3	31.9	9.2	7.7	16.1	12.6	24.5	20.4	35.3	19.4	31.8
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627108-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 422.5;Granulosa cells: 684.8;Late spermatids: 1708.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 121.7;RT4: 153.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	29.6	18.2	7.2	4.9	7.5	0.6	34.2	7.2	8.9	26.9	26.8	40.0	19.7	20.5	14.8	46.8	39.5	16.7	8.6	7.4	9.0	36.5	70.2	11.3	3.0	8.7	9.3	53.4	20.2	34.7	36.9	20.0	8.2	18.9	33.1	6.2	52.6	10.3	4.6	9.7	18.5	7.2	8.9	8.7	14.8	74.9	9.6	4.2	19.3	5.3	6.8	32.2	24.1	12.0	24.8	23.0	80.6	42.2	28.7	16.6	30.4	12.9	17.3	20.3	47.6	54.9	37.7	0.0	53.3	12.2	16.9	19.9	0.3	19.7	25.8	0.1	33.3	3.8	14.9	62.0	17.1	0.1	2.5	30.2	9.3	19.5	6.6	34.4	49.3	0.0	0.0	0.1	21.7	19.8	0.1	0.3	121.7	35.4	18.4	0.0	35.5	0.0	33.0	153.5	4.7	20.3	11.6	10.0	18.5	61.9	16.6	3.3	12.7	16.0	24.4	24.3	8.6	0.1	0.2	0.3	13.4	0.0	11.5	0.3	0.0	0.1	0.3	0.0	1.1	0.1	0.8	0.3	0.0	0.1	2.1	1.2	0.3	0.1	0.1	0.1	0.0	0.3	7.2	7.5	7.2	8.9	7.4	9.0	8.7	9.3	8.2	8.9	9.6	12.0	147.0	3.2	10.1	14.4	2.3	7.1	41.0	75.7	29.0	0.6	72.5	46.1	8.2	50.1	89.4	93.8	0.0	28.7	1.1	94.9	23.5	80.3	422.5	54.0	21.4	37.4	33.6	4.8	0.9	12.6	40.7	25.6	21.9	19.2	0.0	684.8	47.5	104.0	4.5	0.0	0.8	47.9	193.3	10.2	3.1	1708.3	32.9	3.1	10.6	1.0	1.0	48.2	0.0	9.5	0.4	18.7	55.5	35.7	0.3	33.0	43.5	43.8	193.9	1.9	19.7	17.1	43.1	20.9	32.4	23.3	5.4	13.5	2.5	49.4	94.3	89.7
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 68.7;Extravillous trophoblasts: 105.1;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 96.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 213.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.1"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	25.4	12.9	11.0	7.1	12.1	0.6	25.0	96.6	13.5	29.6	9.7	18.0	7.9	32.3	11.5	15.4	23.2	35.2	128.8	6.9	12.6	45.8	54.8	35.8	5.4	12.3	13.0	35.3	13.1	28.1	8.6	58.7	14.5	27.6	6.2	14.8	18.0	24.4	16.8	27.9	12.3	23.6	8.6	20.6	13.4	5.1	17.1	19.1	18.4	12.4	7.1	18.4	22.3	7.6	1.5	12.7	20.1	16.1	19.2	15.5	48.3	26.7	82.3	20.1	26.1	30.6	11.6	0.8	23.9	14.6	19.7	3.1	9.5	9.6	11.8	5.0	9.3	36.3	8.5	20.6	42.2	0.2	3.0	17.7	7.4	40.4	16.9	50.4	55.7	1.1	1.0	1.1	17.6	16.7	0.0	0.8	25.5	7.8	7.4	9.9	213.0	3.1	61.7	7.4	36.8	22.6	18.8	36.6	16.4	45.9	13.7	0.2	27.2	8.5	28.8	14.8	25.7	0.2	0.6	0.3	20.3	0.5	10.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.2	11.0	12.1	96.6	13.5	6.9	12.6	12.3	13.0	14.5	8.6	17.1	7.6	60.1	0.0	4.1	10.4	0.8	19.2	13.3	22.4	13.1	68.7	19.8	9.0	50.1	11.5	6.5	12.9	2.1	53.1	0.2	1.7	5.9	21.1	3.0	2.3	24.9	43.1	6.0	5.3	16.8	9.1	105.1	22.2	2.0	5.7	0.0	13.0	41.0	36.7	6.2	33.7	45.5	2.3	2.0	3.2	3.5	4.1	17.4	7.1	12.4	30.9	0.8	4.0	0.0	9.0	2.0	9.9	0.6	17.3	1.4	13.8	2.4	22.4	2.5	4.7	19.7	1.4	20.9	1.3	3.4	9.7	11.9	80.7	1.5	6.4	2.5	10.5
TSPY1	"CT78, TSPY"	ENSG00000258992	"Testis specific protein Y-linked 1"	Q01534	Y	9466955-9469749	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	74	"testis: 7.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	9	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	366	"U-266/70: 248.7;U-266/84: 249.2"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (2.91e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	248.7	249.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY10		ENSG00000236424	"Testis specific protein Y-linked 10"	P0CW01	Y	9527880-9530682	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.6"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 10.3"	"Cancer enriched"	"Detected in single"	13	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 63.8"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (5.36e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.8	63.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY2	TSPYQ1	ENSG00000168757	"Testis specific protein Y-linked 2"	A6NKD2	Y	6246223-6249019	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 7.5"	"Group enriched"	"Detected in some"	34	"Spermatocytes: 7.7;Spermatogonia: 27.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	656	"U-266/70: 107.3;U-266/84: 119.3"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (3.69e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.3	119.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY3	CT78	ENSG00000228927	"Testis specific protein Y-linked 3"	P0CV98	Y	9398421-9401223	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 3.0"	"Cell type enriched"	"Detected in some"	5	"Spermatogonia: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	75	"U-266/70: 148.5;U-266/84: 145.3"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (4.19e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	148.5	145.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY4		ENSG00000233803	"Testis specific protein Y-linked 4"	P0CV99	Y	9337464-9340284	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	138	"testis: 32.7"	"Cell type enriched"	"Detected in single"	11	"Spermatogonia: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	591	"U-266/70: 1954.4;U-266/84: 2232.7"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "																		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	2.4	1954.4	2232.7	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY8		ENSG00000229549	"Testis specific protein Y-linked 8"	P0CW00	Y	9357797-9360599	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 1.3"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 2.0;Spermatogonia: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	266	"U-266/84: 291.5"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA049384: AB_2680738, HPA067289: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	1.0	291.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY9P	TSPY9	ENSG00000238074	"Testis specific protein Y-linked 9, pseudogene"		Y	9487313-9489893	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	50	"testis: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	625	"U-266/70: 678.1;U-266/84: 699.0"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA					"Cluster 29: U-266 - Adaptive immune response"		Cytosol		"HPA049384: AB_2680738, HPA067289: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.3	0.0	0.0	0.0	0.0	0.0	0.0		0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	678.1	699.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPYL5	KIAA1750	ENSG00000180543	"TSPY like 5"	Q86VY4	8	97273488-97277928	"Predicted intracellular proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.7"	"Group enriched"	"Detected in many"	8	"Early spermatids: 172.9;Late spermatids: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 34.9;K-562: 30.5;SCLC-21H: 60.8;SH-SY5Y: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031347	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Golgi apparatus"	"HPA031347: AB_10601454"	"prognostic favorable (1.21e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.31e-2)"	"unprognostic (3.13e-1)"	6.0	8.6	11.1	4.3	12.6	1.2	12.1	6.7	11.4	11.4	0.8	9.7	1.8	15.2	15.5	4.5	12.4	6.6	12.4	10.0	17.6	10.0	1.7	7.2	6.2	10.3	8.6	25.2	8.7	8.1	11.8	4.3	12.5	15.3	3.2	11.3	9.7	18.3	12.9	4.1	4.1	14.3	7.6	7.3	8.4	44.7	14.4	7.4	8.3	10.5	7.3	9.7	4.6	8.7	0.0	15.9	0.0	0.0	0.4	0.4	0.1	12.4	0.0	12.2	7.9	0.0	0.5	0.0	16.8	14.8	0.0	4.4	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	19.4	0.0	17.2	0.0	0.0	0.2	34.9	30.5	0.0	0.5	23.4	0.0	0.0	0.0	0.0	0.2	23.1	0.0	0.1	10.2	0.1	60.8	47.1	0.0	4.1	0.0	8.2	0.0	1.9	0.0	0.0	26.2	0.1	0.0	14.4	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.3	0.2	0.1	0.0	0.2	0.0	0.5	0.2	0.0	11.1	12.6	6.7	11.4	10.0	17.6	10.3	8.6	12.5	7.6	14.4	8.7	7.5	6.4	4.1	0.0	5.5	2.3	4.5	0.7	6.8	12.5	9.9	8.8	16.3	2.8	2.1	9.2	20.9	0.2	2.6	0.0	5.9	5.8	172.9	6.4	13.7	9.8	2.4	3.4	0.0	3.5	0.1	12.1	10.2	2.6	0.0	19.2	6.4	0.8	6.3	8.4	0.0	0.3	2.0	5.0	5.9	419.0	24.5	4.6	7.2	0.0	2.2	13.1	0.0	0.0	0.0	3.7	0.0	21.1	0.8	7.8	0.0	1.4	4.1	12.2	6.6	12.4	9.3	35.5	31.0	5.6	1.6	0.1	1.3	9.9	0.3	4.1
TSPYL6		ENSG00000178021	"TSPY like 6"	Q8N831	2	54253178-54256229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 21.5"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 33.9;Spermatogonia: 22.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	69	"K-562: 8.3"									"HPA034699, HPA034700"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA034699: AB_2674288, HPA034700: AB_10670159"	"unprognostic (8.21e-2)"				"unprognostic (4.25e-1)"			"unprognostic (1.06e-2)"		"unprognostic (1.00e-1)"			"unprognostic (5.54e-6)"	"unprognostic (4.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-1)"		0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.7	0.1	0.3	0.3	0.0	0.4	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	33.9	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2 ribosome maturation factor"	Q969E8	X	54440404-54448032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	35.2	45.1	50.9	11.2	49.9	11.9	35.6	43.4	59.4	36.8	39.3	42.2	10.2	34.9	23.0	34.6	32.2	7.7	45.5	46.2	52.9	43.8	36.7	30.4	12.6	48.9	48.0	34.6	30.2	25.0	47.1	14.6	47.3	33.3	13.3	27.4	32.6	16.9	51.7	40.7	31.3	13.2	50.3	32.4	38.8	16.5	50.6	14.9	41.1	18.6	15.8	36.3	35.0	47.8	24.1	26.6	23.9	20.6	19.9	13.0	18.7	22.4	17.5	19.6	17.3	26.2	24.1	23.5	15.8	18.2	35.7	24.9	47.9	28.3	24.8	29.8	26.8	19.3	20.8	19.6	12.5	32.7	19.4	12.9	18.0	26.4	27.1	19.7	13.8	22.9	20.5	16.9	19.3	37.9	27.4	29.9	34.6	23.6	33.0	26.5	38.2	19.6	20.6	18.3	25.9	20.5	42.1	19.9	28.0	38.0	45.4	14.7	21.0	16.2	27.1	38.0	19.9	19.8	32.3	29.7	24.4	27.5	23.2	29.7	16.6	32.0	36.3	23.1	30.0	44.8	34.0	33.6	15.1	46.3	42.6	32.3	10.4	29.7	26.0	16.7	40.8	24.9	50.9	49.9	43.4	59.4	46.2	52.9	48.9	48.0	47.3	50.3	50.6	47.8	39.1	25.6	30.2	1.6	39.8	32.8	43.0	42.7	26.7	61.6	27.4	28.6	49.0	28.6	38.6	35.0	27.1	98.5	36.0	26.3	125.2	43.9	1.2	17.7	23.7	35.6	18.1	18.1	5.7	32.9	71.5	33.8	16.8	22.9	45.0	20.3	31.8	25.2	46.6	57.2	5.6	35.5	61.1	18.2	31.4	2.8	34.8	24.6	40.9	6.5	48.6	85.6	44.3	2.5	6.5	38.1	29.5	45.1	22.3	36.7	32.6	64.6	33.8	67.0	46.0	29.8	38.0	20.5	43.3	25.4	31.7	75.9	37.8	36.2	30.9	33.9
TSR3	"C16orf42, MGC24381"	ENSG00000007520	"TSR3 ribosome maturation factor"	Q9UJK0	16	1349240-1351878	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040760, HPA046265"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA040760: AB_2677122, HPA046265: AB_10963942"	"unprognostic (4.04e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.14e-1)"	44.0	47.6	47.7	18.9	50.4	17.4	40.4	47.9	54.6	35.5	43.3	60.7	25.6	38.6	11.1	51.2	33.5	12.6	72.8	46.1	44.5	51.8	58.3	34.4	20.4	52.7	50.0	32.2	57.2	18.5	35.0	15.2	46.8	42.6	9.0	8.3	42.6	19.8	86.8	46.5	38.3	11.6	48.7	43.0	49.1	30.5	49.6	15.9	35.0	27.9	11.7	48.9	38.1	47.7	60.0	65.2	26.6	35.7	30.8	37.3	44.7	54.3	23.8	38.1	35.3	72.7	59.6	37.8	70.8	36.7	40.5	61.6	24.2	45.2	13.1	73.8	110.8	16.7	56.3	58.2	56.0	36.2	31.8	39.5	63.8	34.3	33.0	29.5	41.7	60.2	54.1	32.6	31.8	107.4	53.6	61.1	44.6	34.4	78.0	93.5	32.3	103.0	33.5	23.7	41.9	53.9	41.9	52.3	73.0	20.8	50.3	44.8	45.9	63.0	67.3	54.2	67.4	67.8	49.2	51.3	31.9	43.5	43.6	13.8	4.0	12.0	4.7	3.6	5.9	7.4	5.9	4.4	3.4	10.0	6.2	5.7	10.4	2.6	3.9	5.2	4.8	1.7	47.7	50.4	47.9	54.6	46.1	44.5	52.7	50.0	46.8	48.7	49.6	47.7	45.2	19.2	16.2	3.3	33.7	28.2	44.9	7.4	18.8	27.1	54.3	48.9	9.4	44.3	12.1	25.8	12.5	48.6	37.8	43.1	103.7	36.5	3.5	30.7	30.9	30.7	24.0	32.4	4.3	46.6	48.7	28.5	18.3	26.9	8.2	45.0	33.9	54.1	48.8	18.5	5.2	35.3	10.2	42.4	26.7	4.9	28.0	38.0	48.0	1.9	34.6	53.9	49.4	3.5	9.2	38.5	32.6	32.0	47.3	53.8	41.5	125.6	11.1	33.6	6.6	27.7	40.4	15.7	39.7	50.3	41.5	29.8	34.7	38.4	35.7	49.2
TSSC4		ENSG00000184281	"Tumor suppressing subtransferable candidate 4"	Q9Y5U2	11	2400488-2403878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041801, HPA058763"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041801: AB_10793934, HPA058763: AB_2683811"	"unprognostic (1.98e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.38e-2)"	34.9	26.0	25.2	16.5	27.1	42.5	30.9	26.5	32.5	33.5	22.4	44.4	17.6	43.1	6.4	33.5	36.7	16.0	38.7	24.8	25.1	35.0	46.8	31.8	21.2	26.8	26.5	31.1	28.4	9.6	31.3	11.9	25.6	39.6	6.0	5.9	25.1	19.3	62.3	39.3	29.2	13.1	25.7	39.1	31.5	72.7	27.6	17.1	29.7	16.6	10.5	39.6	29.4	28.0	48.1	62.4	18.9	29.8	15.4	11.1	35.8	31.9	21.8	38.0	26.1	46.8	60.2	34.9	27.6	24.8	42.6	46.6	21.5	37.5	7.1	40.7	66.7	20.3	34.7	47.3	43.0	35.9	40.5	27.3	51.9	24.2	22.7	16.2	27.2	33.7	47.0	37.5	18.0	64.7	41.9	61.9	54.4	35.7	74.3	46.6	17.2	30.6	19.0	42.0	48.7	49.2	28.3	59.8	38.5	9.7	31.4	40.8	36.1	49.4	26.0	47.3	37.2	73.8	70.3	29.1	42.9	35.4	53.1	105.4	64.9	69.6	64.2	58.7	68.9	64.1	63.6	66.6	67.3	87.2	56.6	53.3	64.0	70.5	65.5	65.0	74.9	57.6	25.2	27.1	26.5	32.5	24.8	25.1	26.8	26.5	25.6	25.7	27.6	28.0	56.4	19.2	17.8	8.1	33.8	67.3	56.3	59.0	18.2	35.3	36.0	36.2	20.5	31.5	34.0	12.9	12.5	50.9	44.3	72.7	50.9	55.0	88.1	31.6	31.9	42.4	57.3	52.8	4.0	50.5	45.9	32.4	29.6	31.6	17.2	33.4	37.5	32.0	39.0	28.6	4.1	44.9	63.1	29.8	34.9	178.8	44.4	32.3	32.0	6.5	53.4	43.7	57.7	5.5	6.8	62.3	53.9	33.8	27.9	71.9	58.2	46.7	20.9	40.6	39.5	43.3	45.6	129.3	73.1	27.9	82.3	82.1	38.2	38.9	46.9	55.8
TSTD1	KAT	ENSG00000215845	"Thiosulfate sulfurtransferase like domain containing 1"	Q8NFU3	1	161037631-161038977	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 684.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 205.3;OE19: 215.1;SK-BR-3: 284.0;T-47d: 274.9;U-266/70: 315.4;U-266/84: 243.2"	"Region enriched"	"Detected in some"	4	"olfactory bulb: 6.6"	"Low region specificity"	"Detected in all"			"HPA006518, HPA006655"	Approved		Approved	"Cytosol,Cytoplasmic bodies"		NA	NA		57000	"Cluster 37: B-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cytosol, Cytoplasmic bodies"		"HPA006518: AB_2667608, HPA006655: AB_10600919"	"unprognostic (6.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.88e-3)"	33.8	72.1	28.3	25.8	31.4	48.3	73.6	19.8	40.3	31.4	34.6	60.3	40.4	10.4	101.5	91.3	69.2	18.9	55.4	28.2	28.0	125.3	74.7	47.4	52.8	21.2	23.4	55.1	93.5	167.2	119.2	13.2	23.2	98.6	40.8	11.4	175.7	43.5	38.7	79.6	50.5	8.5	20.8	39.7	61.3	35.6	27.3	59.5	140.0	18.6	51.2	29.9	46.4	24.9	119.8	1.6	0.3	0.6	0.0	0.0	2.1	0.2	0.0	0.2	0.0	11.1	112.5	25.0	67.9	0.0	0.0	107.2	0.1	46.4	0.0	98.4	84.9	13.3	43.2	0.0	12.2	43.7	0.9	0.6	28.2	0.0	4.8	0.1	15.6	100.8	0.4	130.8	12.8	205.3	118.6	0.6	0.7	215.1	0.3	38.7	0.0	184.8	98.0	32.8	67.5	37.2	0.0	284.0	0.9	54.0	274.9	0.6	0.5	0.0	41.5	0.6	4.8	315.4	243.2	26.3	0.3	0.2	0.4	438.2	24.2	357.7	226.5	72.0	218.8	530.9	296.2	252.0	72.6	506.1	333.3	282.1	337.5	306.5	104.8	203.9	410.8	220.6	28.3	31.4	19.8	40.3	28.2	28.0	21.2	23.4	23.2	20.8	27.3	24.9	6.5	253.2	228.8	1.0	170.3	86.3	307.5	331.1	160.5	16.2	443.9	457.1	68.4	223.1	259.0	367.8	27.1	271.5	101.2	478.1	684.8	169.7	16.3	336.9	29.2	14.0	218.5	29.0	5.8	151.5	112.7	35.8	59.1	201.2	124.7	88.7	10.8	149.3	72.3	3.3	1.9	418.1	402.8	18.7	116.2	25.1	8.4	40.7	151.2	1.9	178.3	73.0	206.0	1.0	0.7	131.5	383.6	9.8	110.5	386.2	426.6	665.8	615.1	31.8	19.7	99.5	37.7	73.3	44.4	199.6	135.8	151.0	149.3	31.7	267.0	384.9
TTC21B	"FAP60, FLA17, FLJ11457, IFT139B, JBTS11, NPHP12, THM1"	ENSG00000123607	"Tetratricopeptide repeat domain 21B"	Q7Z4L5	2	165857475-165953851	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 67.8;Excitatory neurons: 81.2;Inhibitory neurons: 85.5;Oligodendrocyte precursor cells: 77.9;Oligodendrocytes: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035495, HPA073293"	Supported		Approved	Cytosol		NA	No			"Cluster 38: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA035495: AB_10672866, HPA073293: "	"unprognostic (1.63e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.84e-2)"	5.5	4.1	3.1	3.1	3.4	2.1	5.3	6.5	4.3	6.8	2.6	5.1	2.6	6.3	2.8	3.0	7.3	2.8	5.2	3.2	3.2	5.2	4.0	4.7	4.1	3.3	3.5	8.0	5.0	4.3	4.6	4.7	3.5	6.1	4.0	7.5	4.6	4.2	9.1	4.7	4.2	4.1	3.2	4.0	4.3	4.4	3.1	5.0	4.3	9.2	3.3	4.7	6.0	3.9	4.1	2.1	11.8	6.2	11.0	7.0	3.6	8.2	5.9	4.9	5.8	4.4	2.5	8.9	3.8	3.2	4.7	5.0	8.2	4.8	6.9	6.4	4.9	6.5	4.4	13.6	6.2	6.7	0.0	4.0	2.9	5.9	5.2	8.4	7.0	5.6	9.6	6.1	9.0	2.4	7.0	7.8	6.9	4.6	6.9	9.5	9.1	3.9	6.2	8.2	9.6	6.9	4.7	1.7	8.6	6.3	2.5	7.2	3.9	12.0	5.1	6.5	5.4	3.5	4.5	5.8	5.2	5.4	7.2	3.2	0.5	0.6	0.8	0.6	1.1	1.2	1.0	0.8	0.9	1.0	1.0	1.3	0.2	1.4	1.0	0.4	1.1	0.5	3.1	3.4	6.5	4.3	3.2	3.2	3.3	3.5	3.5	3.2	3.1	3.9	11.1	3.2	9.8	32.7	12.9	9.2	8.3	5.3	22.8	21.6	7.2	6.9	12.5	4.3	9.4	5.5	33.3	3.8	20.2	4.6	0.0	3.3	2.4	67.8	15.3	8.2	7.2	13.7	81.2	1.8	4.6	11.3	11.2	21.6	6.3	12.8	10.8	8.4	13.1	15.2	85.5	7.7	6.1	8.1	4.9	3.2	10.5	7.2	10.6	44.0	5.7	9.9	9.2	77.9	58.9	1.1	6.5	12.8	14.5	6.3	4.0	7.2	34.7	22.7	6.6	15.9	10.7	7.1	12.1	8.5	3.8	2.9	12.5	8.5	5.8	4.7
TTC23	"FLJ12572, HCC-8"	ENSG00000103852	"Tetratricopeptide repeat domain 23"	Q5W5X9	15	99136323-99251223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039806, HPA040369"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA039806: AB_10793921, HPA040369: AB_10795381"	"prognostic favorable (3.17e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.40e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.56e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.23e-1)"	8.3	10.1	5.3	4.3	6.6	1.1	8.0	5.1	6.3	11.6	6.6	17.1	3.5	11.2	6.9	9.8	10.0	8.8	10.6	4.5	6.2	8.9	8.1	6.6	3.1	6.7	5.8	14.9	8.0	8.9	5.3	9.4	6.5	10.7	7.8	7.2	6.7	9.2	8.1	8.4	6.8	10.0	5.7	5.2	9.1	13.0	6.0	3.7	12.7	7.6	3.3	13.2	10.1	8.1	9.9	9.8	15.3	17.8	18.0	20.2	6.4	12.0	14.8	12.6	14.2	8.8	17.0	2.4	23.7	13.7	11.4	19.0	5.0	12.0	13.7	3.3	16.3	10.7	17.1	7.0	10.4	2.4	0.7	14.5	10.5	9.9	9.5	13.7	21.6	4.8	8.3	1.4	11.8	6.0	8.6	2.7	8.4	2.7	7.0	2.7	19.9	3.8	10.0	13.2	6.7	3.0	15.8	6.4	14.7	15.4	10.7	10.9	14.3	16.0	9.4	10.7	15.5	8.1	12.4	3.3	14.3	0.8	9.6	1.8	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.7	0.1	0.0	0.0	0.5	0.5	0.1	0.5	0.1	0.0	5.3	6.6	5.1	6.3	4.5	6.2	6.7	5.8	6.5	5.7	6.0	8.1	5.9	3.2	7.0	27.1	0.6	2.4	4.6	4.4	4.6	1.7	4.6	4.3	9.5	4.3	5.2	5.5	0.0	4.6	0.1	4.3	5.9	6.0	12.5	3.3	10.6	7.0	0.0	0.8	3.3	6.2	4.6	7.4	10.2	4.5	1.3	13.5	9.3	5.3	4.0	8.4	3.5	5.7	6.1	3.8	1.7	8.5	9.0	2.5	1.8	15.9	0.6	11.5	0.0	6.6	13.2	3.9	2.6	10.1	0.1	3.1	3.8	5.5	4.0	5.4	6.6	6.5	5.5	18.0	9.2	7.9	4.0	1.9	0.4	10.9	6.7	2.6
TTC28	KIAA1043	ENSG00000100154	"Tetratricopeptide repeat domain 28"	Q96AY4	22	27978014-28679865	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 291.5;Excitatory neurons: 169.6;Inhibitory neurons: 289.8;Microglial cells: 332.6;Oligodendrocyte precursor cells: 318.7;Oligodendrocytes: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001080			Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Cytosol	"HPA001080: "	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (4.30e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (4.36e-1)"	7.2	4.6	4.3	2.9	3.0	0.8	6.3	0.4	3.4	8.8	2.6	6.9	3.1	10.2	9.8	5.2	8.7	6.4	4.9	3.9	1.8	4.9	3.5	7.2	2.0	2.4	2.0	16.8	5.0	3.8	3.8	8.8	1.4	5.1	2.9	3.4	6.8	6.9	5.4	3.0	3.8	8.5	1.8	3.5	4.8	8.1	2.1	2.7	6.8	5.1	1.4	6.3	5.0	2.1	0.0	6.8	17.1	7.4	10.0	14.8	0.3	5.1	9.4	7.1	6.1	0.5	0.0	0.1	6.9	14.9	2.3	1.0	11.1	0.3	3.8	0.7	7.5	1.1	8.6	6.5	4.5	0.2	6.8	14.9	0.3	4.6	3.2	4.8	13.0	4.5	4.5	0.6	1.6	2.5	0.1	0.6	3.1	0.0	4.3	7.0	4.3	0.1	3.3	0.2	4.8	10.6	7.1	0.2	4.5	4.7	3.5	0.6	12.2	8.4	4.0	5.5	3.8	2.2	0.2	0.1	3.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.3	3.0	0.4	3.4	3.9	1.8	2.4	2.0	1.4	1.8	2.1	2.1	29.4	3.2	12.5	291.5	3.2	6.0	5.8	1.7	11.4	34.1	8.7	8.0	9.7	8.6	1.6	12.9	18.8	6.0	2.3	2.1	0.0	6.2	10.8	7.9	28.9	30.9	9.0	7.0	169.6	6.0	1.5	27.3	4.1	12.4	1.3	32.3	36.8	15.3	3.7	28.6	289.8	5.8	0.0	9.4	7.2	9.1	31.4	4.3	10.6	332.6	0.7	11.5	5.2	318.7	116.3	3.9	4.4	45.5	3.1	5.0	4.8	18.6	1.9	24.9	13.1	27.2	19.7	23.8	11.6	6.7	3.8	2.5	3.2	27.4	6.9	4.0
TTC31	FLJ12788	ENSG00000115282	"Tetratricopeptide repeat domain 31"	Q49AM3	2	74483073-74494559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041783	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA041783: AB_10794306"	"unprognostic (2.38e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (2.64e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.56e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (2.49e-4)"	6.4	4.8	3.5	8.4	3.9	9.0	4.8	3.4	4.3	5.4	3.8	7.9	11.1	5.9	4.5	6.1	5.9	5.9	5.7	3.3	3.6	6.0	18.7	6.8	9.8	4.3	3.8	6.3	7.9	9.2	3.2	9.2	3.9	5.2	8.2	4.8	4.7	4.5	3.7	8.8	9.9	7.4	3.8	8.2	7.5	3.2	3.8	9.7	4.8	3.9	10.6	5.7	4.6	4.5	16.0	13.1	11.7	6.3	7.3	17.0	12.9	11.2	11.4	16.2	11.9	11.3	13.0	20.6	6.4	9.5	14.2	11.8	9.5	10.5	11.0	23.0	8.3	22.4	12.9	24.9	11.0	10.1	21.5	11.5	13.7	14.0	9.8	14.3	11.0	12.0	15.0	11.5	12.0	13.7	17.4	9.2	7.6	12.2	7.9	13.7	24.0	11.5	11.5	11.8	5.6	16.5	7.9	12.4	10.2	7.4	9.7	6.2	17.6	12.5	18.7	9.5	12.6	13.6	10.8	14.1	13.5	12.5	11.4	4.9	8.3	6.1	6.5	8.1	7.2	7.0	4.9	6.2	8.1	4.7	4.6	5.4	0.8	6.6	8.7	4.4	7.3	7.4	3.5	3.9	3.4	4.3	3.3	3.6	4.3	3.8	3.9	3.8	3.8	4.5	5.4	16.0	9.2	7.2	10.8	2.8	4.1	5.2	4.6	11.1	5.2	5.0	3.5	14.3	7.8	9.2	39.6	8.3	9.8	7.8	1.9	5.8	4.6	3.8	8.0	6.7	6.1	13.3	3.0	5.5	5.3	6.0	7.1	5.9	19.0	8.8	4.6	20.8	8.3	5.0	3.4	5.9	6.1	7.9	3.5	5.0	6.2	7.5	3.6	10.3	13.2	9.2	19.6	2.5	4.4	5.9	9.4	5.7	9.6	3.1	13.9	6.0	4.3	23.6	6.6	7.3	5.3	8.3	10.0	4.2	3.3	8.1	9.8	8.2	6.5	3.8
TTC38	FLJ20699	ENSG00000075234	"Tetratricopeptide repeat domain 38"	Q5R3I4	22	46267961-46294008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 233.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 134.2;NK-cells: 182.3;Proximal enterocytes: 144.5;Proximal tubular cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 90.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 29.9;NK-cells: 38.0;T-cells: 90.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029302, HPA075893"	Approved		Approved	Cytosol		NA	NA		170000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA029302: AB_10601704, HPA075893: "	"unprognostic (7.78e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.92e-3)"	"prognostic favorable (3.21e-6)"	"unprognostic (8.34e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.72e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.02e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.97e-1)"	"unprognostic (8.33e-2)"	24.7	23.6	9.5	10.2	11.6	46.9	25.7	10.3	10.7	16.8	12.8	42.1	79.4	13.8	6.4	12.5	17.2	15.5	23.2	9.7	11.0	64.4	233.6	15.6	10.7	13.3	12.3	26.0	35.5	7.6	13.2	7.8	11.9	23.6	31.9	4.7	27.0	7.3	20.6	12.2	80.9	10.3	10.3	22.8	29.1	6.8	12.2	2.5	15.2	12.3	5.9	16.9	13.5	11.3	12.0	13.2	16.4	34.5	15.2	13.1	15.7	17.2	11.5	18.7	14.6	21.8	8.5	0.1	10.8	17.9	7.4	10.8	16.8	13.9	6.8	27.0	36.9	15.6	28.4	76.0	21.0	9.0	59.8	22.6	7.3	8.5	9.7	12.9	15.9	0.2	11.9	19.4	12.2	12.1	0.3	28.2	12.5	22.6	13.1	0.0	8.0	8.0	12.6	13.8	2.9	22.8	23.7	16.3	13.3	7.5	26.1	18.0	18.5	13.0	14.1	10.3	11.0	14.7	9.2	1.7	8.8	13.7	13.8	29.9	11.9	22.5	90.5	11.4	9.7	2.3	8.5	41.0	10.8	1.7	3.5	36.9	7.6	38.0	8.7	4.3	4.5	42.5	9.5	11.6	10.3	10.7	9.7	11.0	13.3	12.3	11.9	10.3	12.2	11.3	9.2	0.0	7.5	13.7	6.5	3.3	5.9	4.3	3.4	2.6	10.2	6.7	9.2	38.6	4.3	9.2	6.2	10.4	69.1	69.0	23.5	10.4	0.3	7.4	9.6	8.9	20.9	10.5	0.3	10.2	9.3	7.5	11.7	6.9	17.2	13.3	9.7	134.2	13.4	5.0	1.8	37.8	4.1	14.9	4.3	0.9	7.5	9.6	5.4	9.4	12.8	9.3	182.3	5.5	5.6	9.7	51.6	13.9	16.2	8.6	144.5	149.6	5.3	5.4	6.6	7.4	5.9	1.8	3.7	5.3	8.2	6.4	29.2	22.7	51.7	4.6
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 25.3;lymphoid tissue: 46.6;testis: 34.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	0.7	0.8	0.0	4.2	0.1	25.3	2.2	0.1	0.3	0.7	0.0	4.8	4.0	1.0	0.1	4.8	0.6	0.5	0.1	0.1	0.1	0.2	0.5	0.8	8.1	0.2	0.1	0.2	0.2	0.3	0.0	3.9	0.2	0.8	5.9	1.8	0.7	0.1	0.0	3.6	4.1	1.7	0.1	1.4	3.3	34.3	0.2	46.6	0.4	0.1	9.0	1.2	1.4	0.2	39.9	23.4	68.2	56.4	3.1	9.5	38.5	44.9	27.4	64.2	77.8	32.1	29.6	58.5	34.1	19.5	66.9	50.0	60.7	27.6	88.6	53.4	49.3	54.1	29.4	26.5	0.2	64.4	33.9	1.2	2.8	45.0	28.6	9.6	36.9	80.6	60.2	58.5	55.2	29.5	37.0	46.4	40.4	35.4	27.9	32.7	124.4	24.4	16.3	25.2	46.8	27.4	26.6	28.3	16.3	36.6	26.6	48.3	15.4	28.8	28.5	18.8	72.9	13.1	47.1	32.4	10.3	58.9	25.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.4	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.3	3.2	1.1	0.0	1.4	1.3	0.6	2.6	0.0	0.2	0.9	0.5	0.6	0.0	2.3	0.0	2.1	9.8	0.8	2.2	3.9	0.4	43.3	3.1	1.6	1.1	1.8	23.1	0.2	0.2	15.0	2.1	2.6	2.3	1.3	13.9	0.7	0.2	6.5	0.0	0.2	3.0	4.1	2.6	1.2	21.4	0.9	1.9	0.0	0.0	5.2	0.2	1.0	0.0	0.1	0.6	0.2	0.7	5.1	0.4	0.3	0.1	3.0	1.6	6.6	0.1	1.7	130.5	33.0	8.5	0.3	3.7	1.1	0.5	5.6	1.6
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187134	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 104.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 56.3;Paneth cells: 56.9;Squamous epithelial cells: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: AB_2666770"	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	13.9	28.1	8.7	16.6	8.5	26.2	13.0	10.0	15.1	25.8	1.8	35.6	24.4	13.9	3.6	104.5	13.9	18.5	10.2	9.5	9.7	9.0	21.0	9.3	11.2	16.2	8.7	23.7	19.2	9.4	14.7	7.2	15.8	15.2	19.5	4.7	21.9	6.8	12.6	36.8	22.9	7.1	6.5	10.7	33.4	25.7	8.1	8.0	9.1	7.9	12.9	15.5	37.0	9.1	113.2	46.7	18.5	45.9	27.8	19.0	59.7	36.3	12.8	34.1	17.8	76.2	62.7	107.9	43.0	30.3	16.7	78.8	77.3	66.5	8.7	13.6	123.3	26.5	73.6	66.4	43.5	120.2	26.4	30.2	79.3	40.8	43.4	18.3	36.5	52.1	166.1	24.8	16.1	104.4	84.1	65.2	67.4	78.9	46.1	84.4	63.5	155.6	28.7	36.6	56.2	23.2	77.1	111.2	41.6	8.4	44.0	52.9	35.2	22.7	31.7	44.1	51.4	41.6	55.4	81.0	25.7	60.8	31.4	0.0	2.3	0.3	2.6	1.2	2.5	1.8	2.5	1.9	1.8	1.1	2.4	1.7	0.6	2.3	1.7	1.6	1.8	1.9	8.7	8.5	10.0	15.1	9.5	9.7	16.2	8.7	15.8	6.5	8.1	9.1	3.7	6.4	6.7	3.6	6.4	11.2	11.4	11.0	17.1	8.5	13.5	9.9	4.5	17.2	7.6	7.3	4.2	8.8	3.2	56.3	5.9	14.2	1.0	5.0	9.5	5.8	9.1	39.1	8.0	8.6	19.0	6.0	34.1	14.7	0.0	14.3	8.2	35.0	9.8	0.0	8.5	30.6	10.2	14.2	2.9	2.6	8.7	7.5	10.6	1.9	7.7	4.2	4.1	3.0	2.2	25.8	56.9	17.0	9.4	28.7	32.1	8.3	5.0	5.6	0.0	5.2	7.2	2.0	12.2	60.2	18.2	4.1	5.9	13.4	39.9	13.7
TTPAL	"C20orf121, dJ179M20.3"	ENSG00000124120	"Alpha tocopherol transfer protein like"	Q9BTX7	20	44475874-44494603	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 28.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 91.0;HSkMC: 78.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046957, HPA066532"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus, Cytosol"		"HPA046957: AB_10959741, HPA066532: AB_2685686"	"unprognostic (8.71e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.09e-5)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.93e-2)"	8.2	4.4	5.4	5.7	5.5	9.0	5.2	4.7	5.4	6.1	7.1	3.6	3.5	5.0	4.7	5.5	4.9	4.0	2.8	6.3	7.3	4.1	28.7	3.3	8.4	5.2	6.3	4.1	6.4	7.2	7.0	2.8	8.1	4.6	4.0	2.9	5.0	4.3	2.7	12.5	4.0	5.4	3.2	4.6	4.0	3.0	5.2	6.2	7.6	1.7	7.9	5.0	5.3	4.3	21.1	10.8	8.2	14.6	91.0	35.3	8.2	22.4	31.1	21.3	18.1	40.1	12.5	13.1	18.8	20.9	38.8	20.4	10.5	35.2	22.9	13.6	4.8	6.2	11.6	11.8	25.2	9.3	14.1	78.5	22.6	20.9	35.0	10.1	7.3	11.0	8.0	13.4	17.2	24.2	9.1	5.9	9.8	11.4	18.0	2.8	8.8	7.1	8.3	15.0	18.2	8.6	31.1	13.5	14.0	10.1	14.8	6.0	7.5	47.2	18.8	14.2	19.5	19.8	14.5	14.0	22.8	6.6	14.1	0.6	1.1	1.8	4.0	2.2	4.4	3.6	3.6	4.2	1.1	3.8	3.0	4.7	2.6	5.7	2.3	2.0	3.8	2.3	5.4	5.5	4.7	5.4	6.3	7.3	5.2	6.3	8.1	3.2	5.2	4.3	3.9	9.6	11.4	6.2	15.7	6.4	17.2	9.5	1.8	24.4	8.0	5.8	5.3	18.6	10.3	22.0	25.0	7.4	19.8	8.7	1.9	10.2	4.9	8.4	30.5	7.5	9.5	38.9	8.3	9.4	8.6	13.8	2.6	9.3	9.5	8.3	8.2	60.7	4.9	18.5	9.1	5.3	2.0	17.6	6.5	10.3	18.6	6.9	3.6	2.8	8.4	11.5	30.9	8.5	7.1	13.3	9.3	11.3	8.6	14.3	11.0	4.7	8.4	20.3	6.6	16.3	10.1	9.6	11.4	6.1	20.0	10.9	17.9	12.3	9.5	10.9
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859479-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 83.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 13: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (1.92e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (2.86e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (4.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.83e-2)"	4.4	4.4	5.8	4.9	6.9	3.9	7.0	9.2	7.4	7.5	5.0	7.5	3.8	5.5	9.1	10.6	6.5	4.6	6.0	5.9	6.3	6.2	5.9	5.1	6.7	6.7	6.9	9.0	7.8	5.9	6.9	4.2	7.0	7.8	4.7	5.6	7.0	6.2	6.5	6.8	4.8	4.3	6.3	5.8	6.4	5.5	6.2	8.2	7.3	7.7	8.3	6.4	8.3	8.9	11.7	15.8	12.2	12.8	6.8	4.9	9.7	9.1	5.3	11.7	9.5	17.0	7.5	10.5	15.0	2.1	7.9	9.7	17.4	5.4	11.1	6.1	21.2	12.6	12.4	20.4	3.6	7.6	6.4	2.7	8.3	10.1	3.5	4.0	9.4	10.3	27.5	7.1	4.0	83.1	15.6	8.5	10.8	13.0	6.9	16.1	17.9	16.2	5.0	4.8	11.3	6.8	6.4	4.9	6.5	14.5	11.8	7.2	3.0	8.4	18.3	5.9	9.8	8.3	13.7	16.2	4.0	8.3	7.5	6.5	8.4	16.3	11.4	5.8	13.2	11.7	14.0	12.1	5.9	8.9	18.1	14.8	8.8	10.1	6.5	9.9	16.7	7.1	5.8	6.9	9.2	7.4	5.9	6.3	6.7	6.9	7.0	6.3	6.2	8.9	8.3	12.8	36.1	10.7	16.9	15.7	14.4	9.1	10.8	7.6	10.9	11.3	5.3	5.7	17.6	3.7	6.2	6.3	9.4	3.2	11.7	5.7	1.7	9.2	8.5	9.4	10.3	13.9	9.2	4.8	7.4	9.6	4.1	16.3	11.4	9.9	8.9	3.8	4.0	3.3	9.5	5.5	8.2	4.7	7.1	0.8	5.6	6.9	7.2	9.4	6.0	10.3	13.4	8.5	18.4	3.7	7.5	8.2	10.9	12.5	3.6	3.6	9.4	8.6	6.6	13.3	9.6	14.7	24.2	10.6	16.9	4.0	16.2	2.6	4.9	6.8
TULP2	"CT65, TUBL2"	ENSG00000104804	"TUB like protein 2"	O00295	19	48880967-48898744	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 37.6"	"Group enriched"	"Detected in some"	16	"Early spermatids: 281.1;Late spermatids: 233.0"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;U-266/70: 3.0;U-266/84: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075828			Approved	Cytosol	"Secreted in male reproductive system"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA075828: "	"unprognostic (9.97e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.69e-4)"	"unprognostic (6.79e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.94e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.59e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.97e-1)"	0.2	0.5	1.9	0.1	2.3	5.2	0.5	3.5	8.4	0.3	1.0	0.3	0.0	1.0	0.1	0.8	0.8	0.8	0.5	2.3	1.9	0.2	0.1	0.5	0.2	1.6	1.4	1.4	0.1	0.1	0.1	0.1	2.0	0.7	0.2	0.5	0.1	0.2	0.5	0.1	0.5	0.4	1.4	1.4	0.4	37.6	2.1	0.1	0.3	0.1	0.3	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.9	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.0	0.0	0.0	1.9	2.3	3.5	8.4	2.3	1.9	1.6	1.4	2.0	1.4	2.1	1.7	0.2	0.0	0.5	0.3	0.8	0.3	0.1	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	281.1	0.8	2.7	1.0	0.0	0.0	0.9	0.0	0.1	0.6	0.0	2.2	2.5	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.0	0.3	0.7	233.0	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	6.4	1.4	15.4	1.4	0.4	0.4	0.0	0.6	0.1	0.0	0.0
TUSC2	"C3orf11, FUS1, PAP, PDAP2"	ENSG00000114383	"Tumor suppressor 2, mitochondrial calcium regulator"	O75896	3	50320027-50328251	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 351.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030116			Approved	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA030116: AB_10602253"	"unprognostic (1.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (8.70e-7)"	"unprognostic (9.22e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-3)"	17.7	25.4	53.4	14.9	54.1	12.4	17.0	51.0	56.2	16.3	43.9	25.2	12.8	17.7	28.2	18.9	20.6	11.5	35.4	54.8	55.5	29.2	25.9	18.4	17.1	54.6	56.2	15.8	27.4	34.8	21.5	17.3	55.6	22.1	16.6	36.0	18.4	17.8	50.9	13.8	20.3	13.7	50.5	23.7	26.9	22.6	56.1	20.4	23.1	36.4	20.5	20.5	14.2	50.8	24.7	20.2	27.5	30.1	29.8	15.4	30.1	19.3	26.5	36.3	30.7	35.6	22.0	41.8	21.0	18.3	37.4	15.5	33.9	25.7	31.7	24.8	31.2	20.6	18.6	38.7	26.1	36.7	34.8	16.8	40.7	36.5	18.1	25.5	38.0	32.8	25.4	19.6	21.1	18.8	38.7	46.5	37.6	30.4	28.9	13.3	13.4	34.4	36.9	26.4	14.7	30.3	14.4	25.4	29.9	27.2	24.2	44.3	30.3	10.8	26.6	24.8	40.2	47.6	79.7	29.4	24.2	24.1	17.4	16.7	21.2	34.6	24.0	19.6	24.3	23.0	20.8	25.2	14.2	24.6	23.5	25.2	30.2	22.4	18.1	26.3	25.2	32.3	53.4	54.1	51.0	56.2	54.8	55.5	54.6	56.2	55.6	50.5	56.1	50.8	39.8	12.8	17.0	3.9	41.7	57.5	36.8	60.7	37.0	55.5	61.0	44.2	39.6	55.8	37.9	57.0	22.9	62.9	54.4	46.5	115.4	73.9	123.1	55.6	15.8	39.2	50.4	40.4	12.9	74.1	55.5	24.9	25.0	28.4	29.9	16.4	40.4	72.7	76.6	74.0	11.4	46.1	73.2	46.1	51.1	351.8	27.1	37.7	55.2	5.6	57.6	69.0	59.8	4.0	7.8	74.0	61.0	24.8	45.8	67.8	72.0	178.6	71.5	45.5	13.1	18.0	38.5	54.1	49.2	47.4	91.2	69.6	38.7	28.9	46.1	63.7
TUT1	"FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TENT1, TUTase"	ENSG00000149016	"Terminal uridylyl transferase 1, U6 snRNA-specific"	Q9H6E5	11	62575045-62591637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.5;Early spermatids: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA069055, HPA071838"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA069055: AB_2686075, HPA071838: AB_2686456"	"unprognostic (3.81e-2)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-3)"	10.5	10.7	9.1	7.4	10.1	6.0	11.8	9.1	9.9	10.4	8.1	8.9	8.8	9.9	5.8	9.3	11.2	6.1	9.5	8.8	8.6	10.7	22.2	8.3	11.8	10.5	9.3	11.2	19.4	7.6	10.6	6.2	10.1	12.7	4.0	5.4	11.7	7.3	20.4	12.8	10.2	4.6	9.4	12.7	12.6	13.6	9.8	10.2	12.3	7.6	7.9	10.4	9.2	12.0	12.5	16.0	10.7	15.4	12.6	7.3	14.0	12.7	8.3	11.2	9.7	14.0	24.9	19.5	30.1	6.6	14.3	23.7	19.8	15.9	5.7	15.1	10.5	20.3	15.8	14.1	14.3	14.8	9.3	10.3	16.6	13.7	21.1	10.5	10.8	26.2	32.1	20.7	9.6	28.8	21.1	33.3	12.4	8.4	19.1	23.7	16.6	50.9	10.6	6.9	18.2	24.6	10.4	19.6	17.5	8.9	27.2	14.2	10.1	12.9	11.3	15.2	10.1	36.1	32.9	24.6	14.8	11.5	10.7	6.0	5.9	7.0	9.9	7.2	13.7	9.2	9.5	8.1	7.9	11.6	14.3	11.7	3.5	11.0	5.6	9.3	9.2	7.7	9.1	10.1	9.1	9.9	8.8	8.6	10.5	9.3	10.1	9.4	9.8	12.0	32.5	0.0	6.7	7.5	7.5	2.7	5.2	7.2	4.0	8.4	5.9	5.2	4.2	18.6	7.1	11.0	6.2	12.8	6.0	4.4	5.9	8.5	34.3	5.7	3.1	15.0	7.2	3.2	3.9	7.4	7.8	5.1	7.7	4.1	2.5	5.5	18.2	17.8	5.9	1.7	4.6	9.1	6.1	5.0	2.2	16.4	7.2	4.3	10.6	1.0	4.0	9.8	14.4	4.0	5.4	5.6	3.6	3.4	4.9	7.1	8.4	7.1	13.1	8.4	0.0	4.1	4.1	10.0	16.3	3.1	2.3	14.0	5.6	5.6	7.0	3.1
TXLNA	DKFZp451J0118	ENSG00000084652	"Taxilin alpha"	P40222	1	32179675-32198285	"Cancer-related genes, Predicted intracellular proteins"	Exocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045383, HPA072477"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Nucleoplasm, Centrosome"	"HPA045383: AB_10967649, HPA072477: AB_2686525"	"prognostic favorable (6.24e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (5.53e-4)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (3.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.69e-5)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (7.21e-7)"	"unprognostic (3.94e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	26.1	35.8	20.6	20.7	22.0	16.5	20.3	20.6	21.3	30.7	27.5	32.2	16.9	35.4	22.7	30.7	30.5	18.7	22.2	20.4	22.8	30.0	45.6	23.1	22.0	25.3	23.6	29.0	29.2	32.5	31.7	16.7	22.1	30.1	17.9	12.6	23.2	21.7	21.8	31.3	24.4	27.8	21.5	28.5	26.5	29.4	23.9	19.3	27.0	14.5	27.0	28.6	24.3	22.7	45.1	37.7	38.5	43.5	48.8	63.8	31.1	62.7	49.6	59.3	56.6	42.4	47.4	51.1	24.9	61.2	19.5	49.5	53.0	41.2	53.7	58.8	41.0	80.8	57.6	55.8	51.7	59.4	61.4	64.3	54.2	62.8	29.6	43.6	47.6	60.8	33.5	51.3	49.2	25.0	43.8	38.1	56.1	32.0	34.3	50.8	58.3	45.1	40.6	56.4	40.1	41.3	65.1	40.8	68.5	46.9	37.8	35.6	49.9	62.3	53.5	83.3	81.1	75.8	63.0	45.7	64.5	79.5	58.9	11.0	8.8	4.6	12.9	9.8	11.0	6.8	8.8	9.7	6.9	7.4	7.6	8.3	1.4	14.2	13.3	14.3	7.0	10.6	20.6	22.0	20.6	21.3	20.4	22.8	25.3	23.6	22.1	21.5	23.9	22.7	26.2	22.4	21.4	13.4	13.4	8.8	11.3	14.1	17.1	16.0	26.4	24.6	9.5	11.5	16.8	14.7	39.6	10.8	18.9	15.0	1.9	17.4	14.4	26.9	44.7	23.6	26.3	12.4	9.7	16.4	14.3	27.7	23.9	27.4	13.3	20.2	16.1	32.2	18.2	26.9	9.6	18.1	12.2	11.0	10.0	16.8	23.9	15.9	5.4	7.5	20.9	13.3	10.3	9.5	12.9	22.4	7.2	20.7	19.8	12.4	8.3	12.7	24.1	26.1	13.1	33.6	25.8	34.3	23.8	21.2	12.1	6.8	15.5	23.2	14.7	7.7
TXLNG	"CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX"	ENSG00000086712	"Taxilin gamma"	Q9NUQ3	X	16786432-16844519	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000297, HPA000841"	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA000297: AB_1078590, HPA000841: AB_1078589"	"unprognostic (2.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.00e-3)"	14.4	15.9	4.6	8.0	5.3	14.0	10.1	7.8	6.3	6.9	6.7	6.3	8.3	9.8	6.6	6.1	9.1	6.3	5.7	4.1	5.6	7.5	8.0	7.7	12.6	3.9	4.6	16.5	8.5	11.6	6.9	5.8	4.1	6.5	6.0	14.6	7.0	8.7	5.9	6.1	6.5	7.5	4.0	7.7	6.8	6.0	4.6	9.2	10.4	6.0	11.5	7.9	4.6	6.4	27.7	16.9	15.9	28.3	28.4	15.5	8.4	10.8	10.4	12.1	11.8	23.7	16.1	57.6	26.7	6.1	34.8	17.5	54.9	35.4	21.6	17.7	66.7	20.7	23.5	15.3	12.1	31.1	14.2	9.2	17.1	28.2	50.6	16.4	15.5	23.4	40.3	16.6	9.5	16.5	28.6	17.9	47.6	18.3	19.4	19.5	21.7	47.7	9.7	13.6	25.8	18.7	25.0	23.6	19.8	27.1	28.7	12.7	7.6	7.6	10.0	26.9	18.9	17.4	28.4	57.6	9.6	20.1	7.8	0.6	1.9	1.0	3.1	1.5	4.0	3.7	3.4	3.7	2.1	4.0	4.0	4.4	0.7	2.9	1.7	2.1	3.8	2.1	4.6	5.3	7.8	6.3	4.1	5.6	3.9	4.6	4.1	4.0	4.6	6.4	26.3	16.0	24.8	17.6	32.0	41.0	60.2	13.6	23.3	35.9	27.0	29.1	13.3	17.2	23.3	9.2	6.2	14.2	37.7	9.0	21.5	19.3	4.4	33.5	27.3	15.6	14.4	19.8	32.5	16.7	13.2	35.8	9.7	27.2	13.3	13.1	13.2	16.1	9.0	28.6	39.7	15.0	8.2	7.7	11.1	2.2	27.1	12.2	17.8	11.2	9.0	17.7	12.3	16.1	28.3	15.6	7.7	21.1	17.0	43.6	12.3	20.5	16.3	23.0	6.6	42.3	25.8	17.1	37.7	19.1	34.8	21.9	32.9	16.3	16.2	33.0
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996579	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2550.5;NK-cells: 2028.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 951.8;HSkMC: 1276.5;hTCEpi: 664.0;hTERT-RPE1: 781.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	1542.7	466.8	130.3	566.5	159.9	404.7	1396.7	137.1	158.5	846.0	133.8	965.4	223.3	811.8	381.2	428.7	730.3	395.0	745.2	120.3	136.6	532.6	204.0	841.9	800.8	182.0	144.9	382.9	580.5	634.0	192.3	594.0	185.4	352.4	487.5	14.5	567.0	554.5	1446.1	1060.4	810.7	658.7	157.1	946.4	713.4	106.4	159.2	373.7	556.6	2306.2	1068.8	740.9	638.7	217.3	56.5	0.2	13.0	0.9	291.6	951.8	29.7	66.0	131.3	58.5	79.7	35.3	74.6	15.8	379.6	18.1	9.7	15.0	13.0	124.8	154.8	74.2	7.1	45.7	20.2	32.6	13.8	189.7	91.7	1276.5	664.0	119.0	206.7	781.9	23.2	61.8	184.8	121.2	30.2	76.5	31.9	180.2	36.3	112.5	48.5	28.5	107.8	498.3	151.6	122.8	61.7	99.9	283.1	80.5	239.0	26.2	29.1	266.6	56.5	160.1	10.0	304.2	108.7	169.3	170.7	13.8	39.3	86.6	86.3	1059.6	571.2	1219.2	792.2	551.3	729.8	519.3	668.8	710.4	334.4	542.4	650.2	708.5	1246.6	637.1	496.3	154.8	674.5	1684.4	130.3	159.9	137.1	158.5	120.3	136.6	182.0	144.9	185.4	157.1	159.2	217.3	2550.5	227.6	328.5	26.4	1360.4	70.7	236.9	129.8	413.8	6.5	167.4	111.2	526.0	185.8	184.4	272.2	29.2	5.0	1004.6	578.0	450.0	79.7	8.3	179.8	594.5	740.2	164.2	270.8	0.2	53.8	4.1	666.5	160.5	464.2	377.4	53.6	349.8	114.8	231.9	6.7	0.5	320.9	136.3	845.1	184.9	35.5	654.5	730.8	108.5	36.5	892.0	3.6	2028.9	45.2	55.8	225.7	459.4	447.2	639.6	370.7	79.0	169.3	155.8	3.7	1196.5	452.4	398.7	7.6	63.7	160.1	72.2	10.9	1142.8	303.9	186.9	516.2
TXNL4A	"DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD"	ENSG00000141759	"Thioredoxin like 4A"	P83876	18	79970813-80033949	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"		Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 360.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041324			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA041324: AB_2677410"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	61.1	79.1	88.1	39.9	92.5	59.6	52.1	96.0	98.7	37.2	94.9	53.5	32.8	35.7	50.3	69.4	38.1	24.1	88.6	95.0	98.4	87.7	97.1	48.2	53.4	89.4	95.8	32.6	86.0	42.2	95.5	31.6	94.1	53.9	33.2	36.5	55.0	25.3	88.5	59.3	48.0	25.6	93.1	67.8	60.5	88.0	91.6	52.4	51.1	61.3	45.6	46.1	45.5	99.3	98.5	129.3	113.0	108.1	90.3	94.7	99.8	104.3	83.5	138.7	124.9	121.2	68.0	118.8	37.8	100.3	94.1	81.4	137.1	121.5	91.2	139.7	173.7	85.6	196.1	288.7	115.4	247.6	134.1	88.6	105.5	98.7	125.6	87.9	132.4	145.0	76.2	168.0	97.8	177.1	177.0	166.3	88.6	74.3	276.9	106.2	75.7	245.4	137.7	152.7	172.1	125.0	51.6	151.8	200.5	96.9	74.6	145.0	62.9	121.3	149.5	55.7	129.4	74.0	302.3	198.6	113.4	185.7	113.9	10.6	10.3	9.0	14.7	12.7	9.9	15.8	11.8	11.6	14.5	17.6	11.7	14.0	8.2	15.6	13.1	31.3	17.3	6.1	88.1	92.5	96.0	98.7	95.0	98.4	89.4	95.8	94.1	93.1	91.6	99.3	81.0	19.2	42.6	14.0	89.2	87.2	76.9	73.6	64.3	35.7	131.9	139.7	80.3	65.8	62.3	66.2	35.5	107.8	104.8	53.6	360.0	123.4	259.3	98.5	66.0	65.2	56.3	94.1	25.3	125.2	156.9	69.8	71.4	88.1	11.4	84.1	47.2	97.4	126.0	45.4	22.5	88.4	59.0	66.4	76.9	245.5	42.0	89.5	94.3	14.0	87.2	81.5	60.8	21.1	34.8	144.5	54.9	45.1	177.9	177.2	48.6	271.8	41.9	51.3	46.0	61.2	100.8	84.6	74.2	147.6	109.8	96.7	78.7	112.6	71.1	119.4
TXNL4B	"Dim2, DLP, FLJ20511"	ENSG00000140830	"Thioredoxin like 4B"	Q9NX01	16	72044289-72094431	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065865			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA065865: AB_2685571"	"unprognostic (1.45e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-1)"	9.5	7.2	8.8	9.5	11.1	14.3	9.6	10.7	12.2	8.1	9.9	7.4	10.1	7.7	7.6	9.1	10.1	8.7	8.6	9.5	10.1	8.3	16.2	6.7	11.3	10.7	10.1	20.9	9.1	7.6	8.4	7.5	10.8	7.3	8.2	6.7	8.7	7.4	9.0	8.0	8.5	6.4	10.4	7.4	7.9	15.6	10.5	11.7	8.1	8.3	9.7	7.3	6.9	15.5	14.3	20.8	11.2	15.9	8.2	9.7	25.0	18.1	14.7	31.0	23.3	21.4	12.7	20.6	12.8	9.4	14.5	19.3	20.1	10.9	24.0	10.3	18.9	19.0	16.8	32.7	17.4	22.8	15.9	10.1	7.3	27.5	26.1	12.0	13.5	22.6	46.5	12.2	14.8	26.7	27.6	20.5	20.9	9.0	19.1	28.3	14.2	28.3	11.5	10.6	25.9	22.2	17.0	8.0	24.6	8.6	18.7	14.5	12.9	14.9	21.6	12.5	17.2	23.9	41.8	86.0	16.7	15.4	15.2	25.4	8.8	12.3	7.6	9.8	11.9	9.7	7.9	6.7	7.8	7.1	10.8	10.8	12.6	4.9	14.0	8.5	9.9	9.1	8.8	11.1	10.7	12.2	9.5	10.1	10.7	10.1	10.8	10.4	10.5	15.5	7.1	3.2	8.3	7.5	13.1	8.5	7.7	5.4	9.6	3.7	9.8	10.4	2.0	7.2	5.5	5.5	2.1	13.5	8.9	7.4	5.9	10.7	1.6	10.5	9.7	10.1	9.0	10.8	3.3	10.1	17.5	7.9	7.7	12.5	9.5	16.0	10.8	13.3	12.0	10.1	3.3	9.5	0.0	9.2	4.6	4.5	11.8	9.3	7.2	2.8	10.8	4.5	8.2	7.5	5.8	7.6	3.3	9.1	7.9	7.7	11.6	16.2	7.2	5.1	0.0	8.2	6.7	8.2	8.8	9.6	8.2	19.4	9.7	10.2	9.1	7.2
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380572	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 206.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favorable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favorable (4.16e-4)"	53.0	60.5	69.9	37.0	71.9	82.6	52.5	70.7	82.3	55.8	72.2	51.5	29.4	44.8	22.6	46.2	49.0	26.2	65.0	69.6	68.8	77.3	111.2	72.6	51.5	75.1	71.4	56.4	65.1	28.6	66.2	20.1	71.5	64.5	25.7	25.2	50.8	20.6	41.3	51.1	73.9	23.5	70.2	140.8	54.6	16.6	71.8	54.4	60.2	33.7	51.8	49.3	46.0	76.4	29.1	41.1	24.1	38.0	31.9	44.2	23.5	38.9	39.1	48.1	52.2	31.5	18.7	44.5	44.5	43.4	32.8	28.4	29.4	45.5	24.2	78.0	45.5	81.4	90.5	80.2	49.4	34.4	89.4	43.2	31.3	54.5	32.2	29.9	46.5	56.6	35.0	116.1	42.3	90.1	50.7	206.9	7.7	28.4	71.8	49.9	21.1	45.1	40.0	90.1	22.4	28.0	37.6	38.6	28.1	18.4	21.5	57.2	41.1	61.7	22.7	74.1	45.9	97.2	81.4	40.2	32.4	70.8	36.6	9.8	20.8	27.2	12.8	15.2	7.9	7.5	7.6	11.6	23.5	8.0	5.0	7.1	33.0	8.6	15.7	13.0	10.1	13.0	69.9	71.9	70.7	82.3	69.6	68.8	75.1	71.4	71.5	70.2	71.8	76.4	18.6	12.8	17.9	13.1	17.5	6.6	5.4	7.6	13.1	9.2	10.3	11.0	25.7	11.5	11.1	9.2	4.2	7.0	23.2	14.6	52.8	7.6	2.1	10.2	12.6	12.8	4.8	8.6	10.4	11.1	9.7	11.1	27.0	12.0	19.6	17.1	15.4	27.1	14.6	0.0	9.2	8.7	8.2	28.2	14.6	8.8	7.5	30.8	16.0	12.2	25.3	8.7	17.5	11.1	11.1	11.8	12.9	9.8	19.5	5.9	12.1	29.0	11.2	11.0	0.0	10.5	12.6	1.5	4.5	8.8	7.2	6.7	19.4	13.6	11.1	6.3
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530032	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6"	"Not detected"	"Not detected"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		11000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nuclear bodies, Golgi apparatus"	Cytosol	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	46.8	19.5	6.1	77.7	6.0	22.0	37.9	7.1	7.9	32.2	12.7	20.4	26.1	7.8	0.5	58.5	30.0	7.2	26.7	6.4	8.6	38.2	82.0	63.4	31.5	22.1	18.3	4.0	13.8	4.5	8.8	15.4	15.9	21.0	3.6	0.0	40.0	5.6	10.7	24.5	32.5	9.1	10.9	86.1	31.2	3.0	18.0	15.6	25.4	1.6	15.3	22.9	27.0	12.2	27.0	2.5	0.4	0.8	1.8	2.2	5.1	3.7	0.5	6.1	17.4	0.1	40.0	1.8	4.1	5.8	1.3	21.0	0.2	1.0	0.0	9.0	16.5	1.8	3.9	3.5	95.2	1.3	26.9	4.7	4.6	5.4	0.0	0.1	0.1	0.5	2.8	68.6	0.9	1.9	1.5	9.9	0.6	1.9	9.1	5.7	0.4	35.1	0.3	1.2	0.7	5.6	22.9	17.3	6.5	0.2	4.2	13.8	6.7	0.8	4.7	1.5	1.5	68.6	15.9	5.7	1.9	1.5	1.6	19.5	135.8	74.9	2.0	98.4	1.2	6.7	2.9	1.2	39.5	6.9	1.6	1.3	114.1	9.5	77.1	9.3	3.1	10.1	6.1	6.0	7.1	7.9	6.4	8.6	22.1	18.3	15.9	10.9	18.0	12.2	122.6	12.8	29.0	0.3	122.9	58.5	57.4	169.9	53.5	3.4	101.5	90.8	3.2	50.1	88.6	33.1	4.2	17.2	65.8	154.8	29.4	340.2	2.2	55.7	56.0	55.7	16.8	19.6	0.3	643.9	300.8	81.9	38.7	59.2	53.4	3.0	38.2	93.0	477.4	0.0	0.4	50.2	24.4	371.8	409.4	8.7	5.0	561.7	113.8	4.7	2174.6	2.9	71.1	0.5	0.2	364.0	86.4	1.9	102.1	109.8	214.5	105.1	78.0	6.6	26.3	93.3	62.4	1.5	8.0	71.7	56.7	33.5	62.5	3.7	51.1	76.0
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	12.9	15.4	10.8	11.7	11.8	13.1	17.0	11.3	12.7	13.4	10.2	15.2	8.9	16.0	12.2	11.6	14.7	9.2	20.3	10.5	12.5	17.4	13.8	10.6	14.6	11.2	12.1	26.6	11.7	21.5	11.7	12.7	11.8	15.1	11.1	14.6	14.0	13.6	10.6	9.9	8.9	17.9	11.5	11.0	11.5	11.9	11.6	12.7	19.2	14.4	16.4	15.2	11.1	13.2	19.6	16.1	27.3	19.5	30.3	32.9	41.4	32.9	30.0	30.7	26.9	34.3	16.2	51.0	29.4	28.6	45.1	15.6	31.5	37.9	38.3	31.9	27.1	40.2	49.4	67.0	19.9	81.2	24.9	25.1	37.7	39.2	37.6	24.7	27.7	34.8	70.8	38.0	39.9	16.6	39.8	27.1	72.8	29.2	37.2	37.2	56.8	23.0	26.6	25.2	21.1	18.0	15.7	42.4	53.7	29.5	23.2	29.3	18.2	13.6	37.0	37.0	40.2	21.9	42.7	35.4	30.3	29.0	39.9	9.1	6.4	1.8	10.6	8.8	10.0	10.7	9.2	9.7	9.9	9.8	13.2	14.2	0.5	15.4	6.9	9.6	9.4	5.8	10.8	11.8	11.3	12.7	10.5	12.5	11.2	12.1	11.8	11.5	11.6	13.2	30.6	16.0	23.9	17.6	34.1	25.6	40.5	32.7	58.1	34.5	32.4	42.3	29.9	20.0	28.6	16.5	4.2	44.5	21.2	7.4	78.2	36.2	19.8	28.9	38.8	31.7	13.8	18.5	28.0	59.4	51.1	34.7	15.8	29.0	21.0	32.8	21.8	29.2	33.1	50.5	22.7	19.5	22.4	30.9	22.6	19.6	43.5	26.2	21.4	14.0	39.5	27.6	37.0	30.2	24.5	32.5	8.4	61.3	35.6	45.7	12.2	64.4	18.4	22.5	13.1	44.2	36.0	34.3	45.3	44.1	22.7	22.3	29.2	55.7	25.9	31.2
UAP1L1		ENSG00000197355	"UDP-N-acetylglucosamine pyrophosphorylase 1 like 1"	Q3KQV9	9	137077517-137084539	"Metabolic proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 21.7;Horizontal cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044356	Approved		Approved	"Intermediate filaments,Cytosol"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	Cytosol	"HPA044356: AB_10959902"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.64e-3)"	11.6	14.1	13.5	5.5	18.7	3.1	9.5	14.3	16.4	15.0	15.8	8.1	5.7	6.7	5.1	6.0	7.6	5.3	11.0	14.4	14.0	14.0	2.8	12.5	7.9	16.6	15.8	3.8	9.6	7.9	15.4	6.3	15.8	13.0	3.6	2.9	11.0	5.6	2.7	10.1	10.8	3.5	12.6	22.0	10.2	3.2	19.0	2.4	14.1	2.7	5.9	10.0	9.1	24.1	0.8	5.8	0.0	15.7	26.4	12.1	4.5	8.1	21.1	22.4	15.4	11.7	2.6	3.7	4.7	8.3	40.6	12.1	29.6	2.0	4.6	10.0	2.7	7.9	9.5	11.3	58.5	0.1	31.5	8.9	2.1	12.7	10.4	10.4	17.7	7.3	2.4	18.0	15.2	13.5	0.8	8.1	2.6	28.3	8.3	12.8	0.2	11.3	8.9	1.1	9.3	5.8	2.0	44.3	18.7	3.7	23.9	21.8	14.1	40.2	8.6	28.3	3.9	19.6	30.1	7.9	34.9	8.6	11.7	0.1	1.0	0.0	0.2	0.5	0.8	0.5	0.1	0.3	0.5	0.2	0.2	0.3	0.1	0.0	0.0	0.3	0.5	0.4	13.5	18.7	14.3	16.4	14.4	14.0	16.6	15.8	15.8	12.6	19.0	24.1	2.4	0.0	8.4	16.0	6.9	6.1	0.6	2.0	4.0	6.8	4.8	3.9	4.0	5.7	1.5	0.0	2.1	0.4	7.1	2.1	11.7	1.4	0.2	2.2	4.9	3.1	1.8	0.4	3.3	0.9	5.0	4.0	1.1	3.4	4.5	0.8	7.1	0.7	21.7	20.2	5.1	1.8	6.1	10.9	9.9	0.2	2.5	11.2	8.8	6.5	9.1	4.7	3.1	6.6	18.4	0.8	1.9	3.8	5.6	2.0	0.5	3.4	1.1	5.1	0.0	3.0	16.5	0.6	1.5	3.5	4.4	1.4	4.5	1.0	3.1	0.2
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 383.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473"	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	34.3	32.3	83.7	39.4	225.9	39.1	43.4	138.0	136.2	32.1	32.1	34.5	28.8	35.8	41.0	33.9	27.5	29.7	66.6	109.7	198.7	33.9	31.2	32.2	49.6	240.4	162.7	30.0	19.3	45.6	22.9	41.7	245.4	36.6	35.8	62.0	44.9	32.2	41.5	45.0	30.3	39.8	131.0	38.9	26.4	23.7	197.1	44.8	27.1	34.7	49.8	39.4	26.6	383.0	76.6	31.4	75.8	47.1	69.0	90.9	56.1	65.9	74.4	70.4	70.2	39.2	52.2	55.2	18.6	72.5	71.3	42.1	59.1	76.5	80.2	105.0	38.5	77.0	57.7	39.6	53.8	77.1	62.4	72.0	49.8	67.9	54.9	86.7	92.3	45.2	31.9	45.6	94.0	26.8	49.5	49.7	67.5	95.4	26.9	39.6	55.9	53.0	113.2	94.6	32.8	46.2	70.3	51.0	58.4	80.9	34.3	73.3	71.4	53.0	46.9	70.6	93.3	53.2	91.8	67.3	54.5	84.3	69.7	87.9	45.7	71.0	24.3	54.0	28.1	33.6	32.2	30.3	40.1	29.7	29.6	30.5	40.9	39.8	57.1	20.1	40.8	53.0	83.7	225.9	138.0	136.2	109.7	198.7	240.4	162.7	245.4	131.0	197.1	383.0	21.9	35.3	31.4	35.9	35.5	33.8	29.2	66.2	31.9	22.9	21.6	17.9	68.5	14.3	44.5	35.0	39.6	74.5	19.8	15.8	19.6	37.1	15.2	25.1	21.2	26.9	18.6	30.7	44.6	23.6	57.2	28.3	22.4	25.6	42.4	26.0	22.9	17.2	34.1	33.7	62.8	16.3	97.6	37.1	49.6	10.3	40.4	39.6	30.2	44.0	60.6	29.1	24.7	53.3	76.7	31.5	11.7	38.0	28.3	23.7	16.7	36.9	47.3	48.9	26.3	22.2	31.0	34.2	32.1	34.9	42.8	56.8	34.0	24.3	17.5	32.5
UBA52	"CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40"	ENSG00000221983	"Ubiquitin A-52 residue ribosomal protein fusion product 1"	P62987	19	18571730-18577550	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 11928.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041344, HPA049132, HPA056624"	Supported		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196"	"unprognostic (1.98e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	1161.5	955.0	823.8	793.2	845.7	2181.5	1115.4	815.0	1021.1	1262.7	808.6	984.4	531.1	938.2	966.2	1196.8	984.5	610.9	989.3	803.8	848.5	931.1	927.4	888.7	1469.5	861.9	825.6	1622.0	1664.8	844.0	758.0	720.8	858.2	917.0	789.6	235.6	1061.1	615.4	1629.9	1444.0	916.6	712.9	883.0	1239.2	989.5	755.3	853.4	1487.1	748.6	1196.7	1674.0	995.3	1107.5	875.5	1680.6	1304.1	961.2	1612.8	2437.7	2298.9	2376.3	1260.7	1738.5	2044.2	1618.9	2381.2	1521.6	2403.4	1268.0	2092.8	803.0	1103.3	1881.9	2242.7	1918.7	650.0	2938.0	1320.1	1942.1	2733.4	1770.8	2898.3	1616.2	2684.2	3008.4	1406.4	2024.7	1778.7	2083.2	1508.8	2131.5	3231.7	1769.8	2786.9	2336.4	2584.2	2162.6	3166.1	2800.9	1899.3	958.6	2769.6	2001.7	2497.0	1246.1	1505.9	914.3	2187.0	2300.9	1424.6	970.6	3681.4	1562.7	1017.6	850.0	2172.8	2271.9	1973.0	2863.7	2412.2	1386.0	3245.8	1412.8	962.6	2155.2	1163.1	1761.2	1764.2	2401.7	3126.7	2616.4	2119.8	2320.3	3025.4	2946.4	2445.0	1168.8	1864.5	1629.2	2469.2	2250.9	4829.5	823.8	845.7	815.0	1021.1	803.8	848.5	861.9	825.6	858.2	883.0	853.4	875.5	831.5	464.8	673.1	15.0	2198.0	1898.4	2027.9	1544.8	1365.8	117.9	1444.5	1279.9	332.3	1109.5	886.1	654.7	68.8	2020.5	1806.7	1264.6	1571.0	1437.7	3146.5	772.1	1337.9	1108.6	1106.6	2241.7	10.8	2271.5	2803.3	1060.1	672.2	1194.9	805.8	1061.9	1385.3	1919.9	2574.7	104.3	12.4	1812.7	710.1	3200.4	2894.6	11928.8	1875.2	2003.3	1250.4	8.4	3379.8	599.1	2276.1	11.1	23.1	1799.4	1853.6	1034.7	1202.4	2110.3	1645.1	2688.2	510.4	219.1	696.8	1483.1	2041.1	629.9	674.5	1939.2	2239.4	2282.9	1892.0	1285.6	1783.6	2426.6
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805209-49813953	"Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 52.5;granulocytes: 83.0;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 56.7;HEL: 55.7;HMC-1: 103.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		370000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: AB_2683631"	"prognostic favorable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.48e-4)"	21.6	21.4	10.1	32.7	10.6	40.2	20.7	10.4	12.1	25.6	10.4	29.0	43.4	22.5	15.6	18.7	23.8	27.7	17.9	9.8	10.5	25.6	23.0	35.4	51.2	13.7	11.1	32.8	17.2	2.9	14.1	19.4	12.1	34.8	26.1	1.2	42.3	22.4	9.1	20.5	48.6	20.6	12.3	65.6	27.5	5.8	12.2	39.8	31.8	10.3	33.6	23.1	23.3	13.8	11.6	0.1	0.9	0.3	30.2	31.7	3.5	6.1	27.0	42.7	56.7	0.0	23.9	0.4	4.8	22.4	18.3	6.2	0.1	10.9	3.7	29.9	0.1	55.7	0.6	3.5	22.3	5.3	103.7	49.0	0.7	16.9	1.0	29.6	21.7	2.0	0.1	3.4	10.0	0.3	11.6	13.7	0.1	0.0	1.2	14.6	1.0	1.9	8.8	22.3	0.0	0.9	7.4	10.7	3.8	0.6	1.1	36.8	9.7	8.3	1.1	3.7	2.4	0.1	0.2	0.3	23.2	19.8	2.0	20.7	22.5	38.5	16.4	32.9	14.3	17.1	15.0	14.5	21.3	18.1	13.4	12.4	6.8	17.1	27.6	7.6	15.9	22.0	10.1	10.6	10.4	12.1	9.8	10.5	13.7	11.1	12.1	12.3	12.2	13.8	17.3	32.1	20.3	11.4	28.0	3.8	6.3	10.5	6.8	0.2	9.2	9.1	6.9	17.2	16.6	12.9	0.0	5.2	15.5	28.7	0.0	9.5	6.9	5.8	3.0	13.5	9.5	8.0	0.2	7.8	3.5	11.8	52.5	6.5	83.0	13.2	16.1	7.6	21.6	0.0	0.1	21.7	8.2	20.1	6.4	34.1	11.1	32.5	0.0	15.0	16.8	2.4	19.6	1.0	0.1	5.2	21.7	11.3	14.1	4.4	51.8	5.6	12.8	1.2	6.6	5.8	8.1	0.9	0.3	7.3	4.7	2.9	17.7	6.9	20.2	6.6
UBAC2	"FLJ30548, PHGDHL1, RP11-178C10.1"	ENSG00000134882	"UBA domain containing 2"	Q8NBM4	13	99200774-99386504	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013448	Approved		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA013448: AB_1855301"	"unprognostic (7.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.26e-2)"	15.3	13.3	9.0	18.2	9.3	19.6	20.0	7.3	9.2	21.3	9.9	21.5	30.7	19.9	17.9	28.6	27.6	22.6	27.3	10.1	8.4	21.9	27.7	16.9	25.4	10.9	9.6	19.1	17.4	30.0	2.7	29.4	8.8	18.4	22.9	7.6	25.8	17.3	39.0	30.6	23.3	19.7	11.6	20.8	17.7	26.2	12.6	29.3	30.0	38.9	27.3	23.9	8.6	8.8	51.8	26.8	22.4	33.9	52.2	62.8	56.3	25.9	73.3	40.3	36.4	29.2	108.7	19.9	43.8	34.8	27.0	49.2	28.8	41.1	22.0	33.8	33.7	37.2	16.9	22.5	48.7	48.2	28.1	45.9	54.9	24.6	71.0	54.6	38.8	39.6	31.1	13.3	31.6	14.3	32.1	15.3	32.6	104.0	27.0	27.6	24.9	15.2	32.7	29.6	25.2	40.3	21.0	67.8	41.4	39.4	41.5	148.7	30.3	21.9	19.0	20.1	29.5	16.3	12.0	6.6	42.9	71.9	38.3	64.6	53.7	41.9	61.3	57.3	87.3	48.1	53.8	62.6	46.2	55.2	73.6	74.5	48.8	84.6	57.5	57.3	40.2	88.1	9.0	9.3	7.3	9.2	10.1	8.4	10.9	9.6	8.8	11.6	12.6	8.8	28.7	6.4	19.1	58.8	45.3	27.1	26.0	41.7	40.5	27.3	31.2	24.3	23.8	21.5	29.4	23.9	27.1	111.6	48.5	37.3	23.5	44.1	26.0	24.5	21.7	26.4	8.4	31.3	110.9	34.9	84.6	31.6	19.4	21.9	22.2	34.3	17.9	29.1	48.5	32.0	103.0	30.1	40.7	39.1	121.4	22.0	35.1	88.4	30.2	81.5	35.7	48.8	69.0	82.0	73.3	29.0	32.6	50.8	11.7	48.7	48.0	22.6	31.6	21.2	32.9	24.7	32.1	66.2	35.1	31.7	33.1	132.4	66.0	54.4	39.1	34.4
UBALD1	FAM100A	ENSG00000153443	"UBA like domain containing 1"	Q8TB05	16	4608883-4615027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 110.3;Late spermatids: 129.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066771	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA066771: AB_2685717"	"unprognostic (7.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.63e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-2)"	25.5	28.4	21.7	11.1	20.0	26.2	24.6	23.9	39.5	29.9	7.4	44.3	14.2	38.6	2.6	32.8	32.0	6.2	39.8	23.3	16.4	39.2	70.6	29.9	8.7	16.2	14.2	29.2	30.1	5.1	25.0	10.6	14.5	39.6	2.3	4.8	23.7	9.5	51.1	31.4	25.5	6.8	10.6	29.3	34.9	29.1	16.8	5.5	35.4	8.6	4.4	33.5	27.5	24.2	13.5	38.2	8.9	14.2	6.0	7.6	39.4	19.7	8.2	7.6	11.0	18.6	15.5	19.8	21.6	6.3	5.7	36.5	5.7	20.4	2.1	42.4	57.4	18.7	42.8	29.6	12.1	11.8	30.8	10.8	14.9	11.6	5.7	8.7	8.3	15.0	28.7	20.4	3.0	66.0	19.5	63.6	33.3	12.0	33.4	27.9	11.1	65.6	6.7	19.0	25.7	23.7	23.5	35.9	33.1	5.1	23.2	18.9	24.4	15.2	17.2	61.5	13.0	38.8	34.2	22.9	6.2	15.8	8.1	0.9	1.6	8.7	1.6	2.5	1.0	1.3	1.3	1.7	1.9	1.2	1.3	1.4	2.7	1.1	3.3	1.2	1.7	1.3	21.7	20.0	23.9	39.5	23.3	16.4	16.2	14.2	14.5	10.6	16.8	24.2	12.0	9.6	8.2	3.3	14.3	110.3	55.8	32.7	29.6	9.7	23.7	20.6	4.2	15.7	17.9	18.4	4.2	65.8	15.1	26.4	31.3	21.1	37.6	29.1	16.2	16.8	84.6	26.1	6.2	23.6	60.1	16.2	43.3	28.7	10.8	13.6	16.1	32.4	23.6	10.1	6.1	34.4	28.5	14.7	25.9	129.1	16.1	14.5	21.4	1.9	19.4	13.0	23.7	3.5	8.1	22.4	19.0	19.9	22.2	37.6	24.4	57.0	7.3	11.5	46.0	15.2	25.1	18.6	14.6	20.2	102.9	107.8	15.9	14.0	22.0	33.1
UBAP2	"bA176F3.5, FLJ22435, KIAA1491"	ENSG00000137073	"Ubiquitin associated protein 2"	Q5T6F2	9	33921693-34048949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021684	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA021684: AB_2211887"	"unprognostic (2.71e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-3)"	"prognostic favorable (1.95e-4)"	"unprognostic (8.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.77e-2)"	12.2	25.7	12.5	8.2	12.9	17.2	12.8	17.3	13.4	15.5	5.3	13.8	8.7	13.0	8.8	19.1	11.4	6.6	15.3	9.5	13.7	14.9	11.1	13.2	10.4	9.4	9.5	15.2	15.4	9.3	11.0	11.8	9.7	14.3	12.1	9.9	13.1	6.7	37.8	22.2	10.8	10.3	6.8	10.9	14.0	32.5	13.6	13.9	15.8	20.5	12.1	12.5	15.2	12.9	40.5	36.5	25.9	32.9	25.2	22.0	31.2	31.8	19.6	32.1	31.0	49.9	21.0	46.8	9.8	26.7	24.7	23.1	43.9	34.9	35.5	34.8	21.5	26.2	47.2	55.0	20.5	59.6	40.3	20.4	28.8	40.8	28.2	16.7	26.3	28.3	36.5	37.6	29.4	26.9	44.6	100.4	27.7	22.6	28.5	34.1	16.0	29.9	31.2	30.1	26.5	18.4	37.6	30.3	9.4	25.8	26.9	26.3	30.9	19.0	25.5	22.8	35.7	14.5	32.3	49.3	20.9	22.5	48.3	1.6	2.7	3.0	2.2	3.1	4.7	2.7	2.7	3.2	3.1	1.4	2.4	3.3	1.6	4.5	7.2	4.1	3.3	2.3	12.5	12.9	17.3	13.4	9.5	13.7	9.4	9.5	9.7	6.8	13.6	12.9	23.8	54.5	23.1	56.8	15.0	28.2	23.8	21.0	27.3	28.7	25.3	26.2	59.9	8.6	32.4	12.9	60.5	44.4	24.7	28.1	3.9	20.0	102.8	52.5	30.3	28.6	25.1	20.8	46.8	19.8	36.3	23.7	32.6	68.8	14.5	36.2	11.7	14.0	16.6	16.8	48.3	30.4	14.2	17.0	21.4	85.0	30.4	17.1	26.6	33.7	19.0	12.5	16.5	50.8	46.3	27.0	26.8	24.5	28.4	24.9	12.3	15.9	24.1	27.0	26.3	27.4	22.6	81.0	70.4	25.9	31.1	72.9	22.3	68.4	29.6	23.7
UBAP2L	"KIAA0144, NICE-4"	ENSG00000143569	"Ubiquitin associated protein 2 like"	Q14157	1	154220179-154271510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 147.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035068	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA		67000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cytosol"		"HPA035068: AB_10696366"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (5.10e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.96e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (7.40e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-1)"	54.1	49.3	30.7	60.9	31.3	62.8	50.0	29.2	40.4	52.2	32.5	53.2	34.2	59.8	48.6	55.0	54.6	44.8	62.7	32.0	31.2	39.8	36.6	54.5	60.7	26.3	27.6	60.5	37.9	60.4	49.4	70.6	26.3	45.7	40.8	46.0	48.0	47.1	83.1	60.2	40.6	55.2	20.4	53.6	45.9	64.5	27.2	59.5	53.6	49.1	65.9	54.0	50.9	35.0	189.3	184.8	167.4	136.5	121.0	138.0	148.1	212.1	154.9	187.6	131.6	197.9	143.6	235.3	213.2	178.9	94.6	160.8	224.3	158.4	167.7	208.1	199.7	255.7	184.6	162.7	113.7	269.6	144.0	130.5	68.3	173.8	114.8	117.9	153.1	92.0	235.0	111.5	152.6	212.6	207.8	101.1	320.4	140.1	170.9	148.9	135.5	207.8	120.7	220.5	173.1	209.3	245.1	227.2	91.4	186.8	226.6	180.6	245.9	117.0	123.8	145.1	205.7	239.1	278.4	313.2	125.7	144.8	179.0	15.1	28.2	20.4	23.1	35.9	25.4	20.9	21.8	21.2	34.9	26.4	24.6	27.7	24.5	36.4	41.3	16.3	21.5	29.6	30.7	31.3	29.2	40.4	32.0	31.2	26.3	27.6	26.3	20.4	27.2	35.0	29.2	25.6	38.5	22.9	31.7	18.4	18.7	21.5	22.2	18.4	21.5	21.5	39.0	17.2	32.3	18.4	8.4	51.3	32.7	16.7	17.6	28.4	80.6	34.3	43.8	26.8	23.4	34.9	26.7	27.1	39.5	29.0	21.9	35.7	24.7	32.3	23.2	19.1	36.1	15.2	25.3	21.7	26.4	22.6	30.2	147.1	21.5	32.4	19.6	26.2	24.5	13.7	24.7	29.1	29.1	30.9	10.4	22.6	20.6	25.1	12.5	15.9	29.7	20.4	13.1	31.1	51.6	42.2	48.8	31.7	20.5	77.8	23.5	35.6	22.0	21.9
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655722-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0;lymphoid tissue: 15.6;placenta: 13.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038606, HPA038607"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		23000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	3.4	0.7	1.1	4.8	1.5	6.7	1.1	15.0	1.9	3.0	0.1	1.2	1.3	1.0	0.2	1.1	0.5	1.9	0.9	1.2	5.5	1.7	1.3	4.6	5.7	10.3	7.1	0.2	0.6	0.4	0.3	13.8	10.2	0.7	1.4	1.9	0.7	0.7	1.1	3.4	1.7	1.9	1.2	15.6	1.4	1.2	2.8	15.1	2.3	0.3	3.2	4.4	0.5	1.4	13.1	31.5	5.6	7.5	2.4	4.4	29.1	45.6	25.1	18.1	13.9	12.5	6.8	5.3	3.5	24.3	17.2	6.4	0.1	16.3	28.7	0.2	0.9	122.2	1.0	10.8	6.7	15.0	88.9	3.9	1.0	72.9	26.9	19.7	12.4	5.3	0.1	0.1	17.8	0.5	18.5	9.6	2.5	13.3	7.4	73.3	3.3	0.7	28.6	10.9	12.7	0.2	12.1	0.9	10.1	11.7	0.2	4.0	32.3	23.4	12.6	13.9	19.1	1.0	0.0	15.1	12.4	20.6	43.4	0.0	1.3	9.9	1.8	6.3	1.9	0.3	2.3	1.7	1.7	1.1	2.6	1.4	2.7	6.4	11.1	0.2	4.7	1.8	1.1	1.5	15.0	1.9	1.2	5.5	10.3	7.1	10.2	1.2	2.8	1.4	2.2	0.0	4.7	9.1	4.6	7.1	4.2	3.4	2.8	1.8	1.2	1.3	1.1	0.0	2.0	3.7	0.0	32.5	10.0	0.6	0.0	8.4	2.4	0.6	4.0	4.5	0.0	1.7	24.8	9.7	54.9	4.9	2.0	1.5	12.7	11.5	5.0	0.6	35.7	11.8	166.3	0.5	4.1	26.0	51.2	3.9	0.0	26.5	1.8	30.0	9.1	0.2	17.5	26.2	2.7	26.3	0.3	0.4	11.4	4.7	0.2	0.6	2.5	1.1	0.0	3.8	3.4	0.1	0.8	2.4	6.0	47.6	16.8	0.1	0.4	3.1
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.5;lymphoid tissue: 113.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Erythroid cells: 182.1;Extravillous trophoblasts: 449.1;Granulosa cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.1;T-cells: 8.2"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.3;white matter: 11.4"	"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Approved	"Plasma membrane,Cytosol"		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	2.6	2.9	0.3	21.5	0.3	78.5	4.3	0.9	0.6	6.1	0.7	26.7	21.4	5.7	0.6	37.2	1.9	2.7	1.4	0.2	0.3	1.9	2.9	5.4	45.3	0.3	0.7	1.3	1.0	0.4	0.4	20.4	0.7	1.5	30.9	0.2	5.0	0.9	0.9	18.5	20.6	10.5	0.2	15.8	13.0	16.4	1.6	113.5	1.1	0.2	69.5	6.9	12.3	0.4	312.8	223.9	390.9	188.3	10.4	24.0	225.2	238.5	121.6	390.7	278.4	743.8	345.4	327.6	233.2	115.5	475.6	294.9	2.2	260.5	395.8	141.7	213.7	101.5	168.5	196.0	3.0	145.4	241.6	7.6	27.8	265.7	257.3	57.4	193.4	206.4	1.8	261.6	325.4	516.2	243.5	41.1	237.1	350.8	529.4	256.0	354.8	1.4	134.9	105.9	226.1	188.7	378.3	271.7	154.4	196.2	276.6	209.4	70.1	341.2	298.4	236.2	473.4	84.3	2.9	369.4	208.0	103.4	328.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	1.7	0.6	0.1	0.1	0.1	2.1	2.1	0.5	0.3	8.2	3.2	0.3	0.3	0.9	0.6	0.2	0.3	0.3	0.7	0.7	0.2	1.6	0.4	0.9	0.0	3.7	0.0	17.9	17.3	7.8	39.0	5.7	0.0	8.6	14.6	0.0	1.5	9.3	0.0	0.0	129.6	3.6	27.4	0.0	1.3	12.0	5.8	5.9	9.5	1.2	182.1	0.0	0.5	449.1	28.5	25.5	9.6	5.7	119.0	18.2	3.6	92.6	0.0	0.1	41.1	50.8	20.8	18.1	6.4	0.9	24.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	7.2	0.0	37.0	12.6	6.2	0.6	1.8	0.0	0.0	0.5	19.2	52.2	50.7	83.2	11.6	31.2	13.7	2.5	68.4	18.4
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628434	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favorable (5.09e-5)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	78.4	59.9	75.8	66.9	82.0	106.9	72.6	79.3	84.2	84.2	63.0	106.8	46.5	72.8	102.6	89.0	95.0	49.8	93.7	77.9	85.8	80.1	82.6	77.0	83.5	78.7	80.4	64.3	66.5	72.8	62.3	65.5	80.0	57.0	92.8	77.2	61.0	72.3	190.3	77.9	70.4	74.3	81.9	79.3	70.2	135.6	80.1	128.0	61.3	127.3	140.2	79.7	72.8	86.4	175.9	113.9	194.3	137.0	127.9	161.7	125.4	179.6	165.5	204.7	238.6	292.0	160.6	247.8	229.1	185.7	254.0	108.8	192.6	300.2	272.5	162.4	113.7	140.1	115.0	172.1	249.9	136.9	119.7	129.9	152.0	204.9	301.8	177.4	221.8	159.5	125.0	203.1	192.9	175.5	215.3	197.2	108.1	60.4	124.0	162.7	198.1	179.6	220.4	202.0	177.5	117.0	157.1	198.7	309.4	413.4	125.2	121.6	148.9	156.4	87.6	132.5	223.5	146.0	260.0	343.8	112.3	223.2	128.0	44.1	57.0	115.9	57.7	53.7	62.1	89.2	82.1	80.9	63.3	90.7	102.5	90.3	90.7	65.1	66.2	106.1	110.8	58.0	75.8	82.0	79.3	84.2	77.9	85.8	78.7	80.4	80.0	81.9	80.1	86.4	137.1	32.1	69.8	35.9	215.4	171.8	182.3	204.8	112.7	76.3	124.8	146.9	96.4	124.4	96.5	68.0	81.3	181.4	205.8	158.0	215.2	208.4	637.0	457.2	94.2	131.0	123.4	148.8	62.0	178.4	228.0	104.8	77.5	230.9	138.8	119.4	109.9	80.6	178.0	94.2	54.4	120.8	142.4	136.4	203.4	550.0	104.4	150.8	152.9	49.6	189.5	170.7	234.8	38.2	65.7	228.7	127.1	93.6	237.3	234.8	123.8	200.9	63.9	105.1	118.3	102.2	171.2	459.7	152.5	149.4	203.7	249.6	217.1	111.7	160.4	247.1
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926436-43956136	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 32.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 30.2"					"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.86e-4)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	5.8	8.3	11.7	2.4	12.2	2.2	5.0	14.2	17.6	4.6	9.8	6.5	2.4	4.5	5.7	5.2	4.5	3.4	10.9	12.3	11.2	6.9	10.7	4.4	2.7	12.0	11.7	5.1	10.0	4.6	5.1	2.8	11.9	5.7	2.9	6.9	5.6	4.4	32.5	4.9	3.9	4.4	11.8	4.7	4.6	3.0	11.5	2.7	4.9	27.8	2.7	5.3	5.2	12.7	4.9	4.0	2.4	11.0	11.0	4.5	1.8	2.3	5.8	2.9	3.7	2.1	5.6	4.6	6.3	6.3	8.1	5.3	3.1	2.5	4.4	10.5	5.4	5.0	5.8	5.4	4.1	10.9	9.8	3.4	5.2	3.3	5.0	4.2	3.6	5.5	5.6	9.2	4.0	3.0	6.5	6.1	5.4	5.9	5.1	4.0	3.3	7.1	6.2	5.9	8.8	30.2	5.0	9.7	3.8	4.4	4.9	3.3	3.2	1.9	6.0	4.1	6.9	13.5	10.8	2.2	5.7	14.2	10.9	10.2	14.5	17.5	11.1	23.8	11.4	12.8	13.5	12.5	15.1	12.7	16.2	13.4	1.4	9.9	28.7	13.0	12.6	8.8	11.7	12.2	14.2	17.6	12.3	11.2	12.0	11.7	11.9	11.8	11.5	12.7	14.9	0.0	6.5	8.8	10.4	6.2	9.1	9.4	4.0	9.6	24.3	24.3	24.6	14.3	10.0	16.5	2.1	11.9	11.9	8.4	54.8	18.7	6.2	8.9	7.2	12.9	18.7	9.9	14.2	28.4	20.3	14.9	8.2	8.7	4.5	11.1	12.5	25.4	27.4	11.8	13.5	8.0	8.2	11.6	14.1	10.7	12.2	12.5	16.0	8.4	18.4	18.8	5.2	20.1	12.1	14.1	7.6	21.8	11.2	12.1	15.5	52.0	5.5	11.6	6.6	23.0	10.5	15.6	9.6	10.8	11.2	7.7	8.8	16.5	8.4	12.3
UBE2F	NCE2	ENSG00000184182	"Ubiquitin conjugating enzyme E2 F (putative)"	Q969M7	2	237966827-238042782	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 282.2;monocytes: 215.5;NK-cells: 193.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA037444	Approved		Approved	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA037444: AB_10672491"	"unprognostic (1.73e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.04e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.51e-1)"	26.7	29.7	33.0	25.5	33.7	41.8	22.8	35.9	40.6	27.7	32.5	29.6	24.7	23.1	53.0	43.1	18.8	28.7	56.7	33.4	38.0	28.2	44.2	22.6	32.1	37.5	37.7	12.6	70.5	41.8	21.0	39.9	38.7	25.4	33.7	16.0	25.2	30.3	60.7	18.8	26.9	35.6	35.5	23.7	26.5	26.0	36.1	34.5	35.4	69.1	33.1	40.7	23.5	38.3	42.9	23.9	53.6	55.1	69.2	83.0	74.8	38.9	55.5	43.3	44.4	26.0	26.4	22.0	13.7	88.7	93.7	35.1	62.3	84.9	67.9	33.7	22.7	31.6	28.5	86.6	86.2	13.1	70.1	48.1	137.7	57.9	87.1	40.1	78.1	100.8	94.2	13.7	80.1	64.0	35.1	55.9	59.8	60.9	33.8	41.8	35.0	39.1	66.3	17.8	36.0	53.0	45.2	36.2	77.0	89.4	31.0	52.8	49.7	47.6	41.7	54.9	43.1	17.1	14.3	43.6	57.1	38.4	35.8	112.4	50.0	63.8	66.3	68.2	26.2	26.2	44.8	40.4	45.0	25.4	40.7	41.4	37.3	102.3	78.5	56.4	51.6	63.6	33.0	33.7	35.9	40.6	33.4	38.0	37.5	37.7	38.7	35.5	36.1	38.3	17.6	6.4	18.4	0.0	26.4	32.5	24.1	33.0	11.4	24.2	37.7	24.9	48.1	30.0	21.6	27.6	8.4	84.9	87.3	38.6	56.7	49.7	23.6	15.0	23.9	27.1	41.8	102.5	0.0	79.4	282.2	24.9	15.8	13.8	21.5	13.1	22.1	41.7	152.7	26.9	0.0	58.1	32.6	72.2	105.7	61.3	25.7	67.6	35.6	0.0	215.5	28.3	193.6	0.0	0.0	71.8	31.9	30.9	25.7	46.0	49.7	62.2	23.4	21.7	39.5	14.8	31.4	123.5	79.4	19.0	40.3	65.7	36.2	16.0	35.5	34.6
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 210.2"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 286.0;Late spermatids: 248.3;Suprabasal keratinocytes: 239.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"		"HPA045681: AB_2679417, HPA050551: AB_2681171"	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	21.0	19.1	15.8	25.4	21.4	31.5	20.1	21.0	24.3	25.2	11.6	39.7	22.5	22.7	14.7	52.2	16.3	16.0	37.9	16.1	18.7	27.0	30.3	15.6	38.8	21.5	19.2	15.6	18.4	21.5	9.7	18.9	21.7	22.6	24.2	17.5	21.0	20.8	210.2	28.0	23.6	27.2	20.3	20.7	21.8	23.2	21.0	24.9	16.1	84.1	46.4	24.5	32.1	26.5	54.5	57.8	52.7	38.9	42.2	44.3	74.9	51.7	41.4	48.2	42.1	40.0	27.0	84.5	52.8	51.2	39.4	57.2	66.3	48.1	77.2	44.8	53.9	31.7	28.6	45.9	41.3	46.5	57.4	38.0	70.3	45.8	66.1	33.8	65.6	55.8	56.5	88.9	40.1	24.3	59.4	42.5	58.2	40.1	29.6	76.1	27.9	78.1	56.4	35.1	22.7	42.3	48.9	41.8	41.6	77.4	41.1	29.9	49.6	48.1	36.8	57.0	58.7	34.3	43.8	118.9	36.9	42.8	37.7	13.3	15.8	39.0	22.2	16.8	29.9	34.1	28.3	29.1	20.2	24.4	28.3	28.9	28.1	32.5	18.6	14.8	28.9	21.8	15.8	21.4	21.0	24.3	16.1	18.7	21.5	19.2	21.7	20.3	21.0	26.5	28.3	22.4	14.4	31.3	70.6	286.0	36.5	47.8	111.5	18.8	47.0	31.0	67.6	27.1	32.2	25.8	6.2	47.0	47.8	41.4	82.2	30.9	139.5	36.7	25.7	35.5	38.4	26.5	47.9	26.7	59.6	31.1	32.6	39.9	21.0	13.9	31.1	62.3	48.1	15.2	46.3	38.3	44.7	36.5	81.1	248.3	19.6	35.7	67.6	30.9	43.1	28.7	36.0	36.2	84.4	43.0	30.4	21.1	154.3	65.7	40.4	75.6	35.4	17.1	6.6	25.9	43.5	70.8	50.8	85.3	239.7	66.8	58.2	13.8	30.1	54.0
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698109-39782792	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		390000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	29.9	19.4	13.5	23.4	17.5	21.4	21.7	20.9	24.5	16.0	9.2	35.8	31.2	17.8	17.7	26.2	12.7	12.9	18.4	18.3	14.9	26.7	45.4	16.4	20.1	12.9	14.0	13.6	13.2	20.4	15.8	24.4	13.1	19.8	24.2	21.0	16.9	14.9	37.3	22.6	24.8	17.2	7.8	18.0	31.8	16.5	14.2	22.4	23.8	25.6	18.0	20.2	17.2	16.0	91.3	90.7	49.3	45.6	29.8	28.7	82.8	122.8	26.4	32.8	34.0	138.0	91.1	114.3	105.2	35.0	79.8	39.0	95.4	54.7	51.9	76.1	70.0	145.7	88.9	121.6	38.4	159.0	79.6	27.1	60.2	46.0	49.0	35.2	43.3	49.3	152.9	39.6	33.9	86.6	111.5	89.9	67.7	54.4	69.8	66.3	144.0	44.2	46.0	123.9	103.9	47.4	91.7	34.5	58.9	54.1	44.4	58.2	116.9	49.9	105.7	60.0	114.5	55.3	174.0	121.4	26.9	101.4	59.5	19.6	18.1	24.8	14.4	16.9	13.4	20.7	15.0	13.8	19.7	14.7	11.2	12.6	15.1	14.0	25.4	27.6	16.0	10.5	13.5	17.5	20.9	24.5	18.3	14.9	12.9	14.0	13.1	7.8	14.2	16.0	63.2	57.7	63.1	69.2	53.0	122.9	65.5	74.3	59.7	62.2	65.3	52.5	72.3	52.9	66.7	49.7	29.2	84.5	76.5	143.7	66.5	83.5	144.9	72.0	82.3	65.6	59.7	85.8	115.9	89.4	168.7	59.2	68.3	90.9	34.8	40.1	63.5	113.6	80.2	104.3	113.8	74.5	65.1	77.1	91.8	202.4	65.3	76.5	56.9	89.0	104.0	87.1	56.7	87.0	118.2	139.6	94.3	56.4	55.5	111.4	75.3	98.0	60.7	42.9	39.5	61.8	121.1	145.2	55.1	74.3	137.9	147.5	61.3	54.8	74.1	107.0
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 544.4"									"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		5800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	41.5	46.0	63.7	37.1	64.8	54.4	33.9	65.0	72.0	35.5	54.4	45.5	39.6	35.0	41.0	49.1	38.5	34.0	51.5	65.4	65.3	40.1	40.9	33.9	48.8	67.8	64.7	33.9	30.3	43.2	31.2	42.7	66.8	39.1	45.6	28.1	33.9	36.8	63.5	36.2	40.7	48.6	62.3	37.6	37.5	28.5	66.7	51.9	36.4	53.1	52.5	46.8	32.3	65.5	121.9	68.9	98.3	77.4	105.1	93.1	56.6	100.0	113.6	125.8	118.7	79.0	57.0	114.2	49.0	133.5	94.7	101.4	132.1	108.6	124.3	114.4	142.9	132.1	63.3	94.8	70.0	190.9	91.0	82.7	93.1	91.2	65.7	90.6	143.4	69.4	544.4	59.3	137.9	89.6	100.0	137.6	72.8	134.8	71.6	80.5	147.6	31.2	118.8	96.2	88.0	65.4	79.9	99.1	95.6	89.4	61.7	104.0	103.8	88.6	113.5	75.5	103.6	57.3	99.7	103.7	120.0	87.5	86.0	84.4	87.8	105.7	84.9	102.2	79.7	77.3	79.9	91.6	109.2	73.6	69.0	82.9	73.2	81.2	89.0	106.3	106.1	141.1	63.7	64.8	65.0	72.0	65.4	65.3	67.8	64.7	66.8	62.3	66.7	65.5	102.6	109.0	83.9	26.1	110.7	125.5	171.6	318.5	51.2	54.5	76.9	72.8	64.9	101.5	180.3	71.7	16.7	312.1	159.0	215.1	197.6	288.2	79.9	133.1	104.6	125.9	126.0	173.0	25.6	385.0	406.5	102.6	60.1	124.9	129.3	79.3	109.6	159.8	298.5	69.0	24.3	153.1	193.3	126.9	159.7	61.1	87.3	140.9	126.3	19.7	257.9	98.4	200.8	22.6	30.4	432.1	222.1	103.8	98.4	186.7	213.5	257.2	173.9	45.5	105.2	81.0	205.4	202.8	121.2	87.6	129.7	372.1	130.1	133.7	154.0	208.4
UBE2L6	UBCH8	ENSG00000156587	"Ubiquitin conjugating enzyme E2 L6"	O14933	11	57551656-57568284	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 165.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003328, CAB073407"	Enhanced		Approved	Cytosol		NA	NA		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB073407: , HPA003328: AB_1858539"	"prognostic favorable (6.75e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.42e-2)"	70.7	60.4	84.4	92.3	84.8	85.5	51.1	80.0	95.2	54.2	70.7	46.3	47.6	44.1	68.5	42.7	66.1	66.6	35.2	80.2	88.0	51.5	121.1	91.1	119.9	93.6	88.1	61.5	24.3	39.9	36.8	53.1	86.2	47.0	43.6	23.6	103.3	49.2	14.3	36.1	57.6	67.3	96.2	126.4	55.6	17.1	94.6	113.4	37.4	29.3	86.7	76.0	44.4	86.1	55.6	26.2	85.8	29.0	179.2	222.3	9.7	30.2	178.8	261.3	337.0	9.8	140.9	169.3	110.3	92.5	223.3	43.7	38.0	99.4	55.4	163.9	1.5	169.2	0.0	38.0	330.7	38.8	54.3	238.9	22.9	122.8	33.6	96.2	83.9	173.2	7.9	118.5	47.8	67.6	280.1	92.2	23.3	0.5	33.3	243.1	52.9	118.4	71.0	58.5	2.1	45.2	60.3	5.4	139.9	15.3	68.3	20.3	30.9	56.3	19.6	43.6	10.2	162.1	176.6	3.4	161.0	98.8	12.3	508.1	534.8	487.8	359.2	638.4	394.1	379.2	368.2	377.9	401.3	310.9	315.1	331.1	838.8	486.9	556.7	256.3	513.7	1060.5	84.4	84.8	80.0	95.2	80.2	88.0	93.6	88.1	86.2	96.2	94.6	86.1	94.6	28.9	22.2	2.9	53.5	23.3	26.2	75.7	26.2	12.4	31.9	38.7	6.0	24.3	38.2	12.9	4.2	4.2	59.3	16.4	64.6	95.4	4.9	16.6	83.4	65.5	23.9	53.0	2.0	65.2	38.1	43.8	23.0	16.4	53.9	41.3	53.2	35.3	165.3	13.5	4.8	38.6	48.8	77.4	36.9	10.9	48.1	73.1	8.8	9.4	79.0	54.0	97.9	3.5	2.0	37.3	48.1	33.4	51.4	52.8	47.7	32.3	33.3	4.4	26.3	15.4	33.8	2.4	9.8	25.6	27.7	3.4	68.8	26.9	22.7	33.3
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558954	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 1197.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No		49000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	46.3	66.1	133.2	39.2	138.8	82.2	42.8	116.7	199.7	48.9	104.0	72.5	41.7	48.1	36.3	61.8	51.3	30.9	111.0	141.2	129.3	63.2	45.6	46.3	43.4	123.5	124.4	46.0	47.5	84.5	69.7	45.0	127.7	48.3	32.5	49.7	48.5	46.1	174.0	56.6	41.6	39.5	111.9	49.3	55.8	81.0	124.4	51.7	44.3	104.5	43.7	58.3	45.8	139.1	161.8	272.1	119.3	124.8	61.7	71.9	112.2	166.0	117.4	97.8	82.8	162.7	109.7	161.9	135.5	93.4	198.1	105.9	130.1	138.6	69.2	207.3	1197.4	235.5	163.7	113.7	154.4	197.3	192.9	82.1	107.1	145.9	167.3	102.6	117.8	146.3	119.6	179.4	127.3	158.2	177.2	223.7	87.1	155.1	306.5	171.7	106.7	204.5	111.6	166.8	239.5	205.5	133.1	149.7	163.3	41.6	94.4	188.4	105.2	333.4	80.5	110.6	281.3	262.3	411.9	169.6	206.0	177.6	220.5	6.7	3.6	4.2	3.0	2.6	2.2	2.8	3.2	3.2	2.8	3.8	3.3	2.2	10.1	1.7	2.7	6.7	2.9	1.9	133.2	138.8	116.7	199.7	141.2	129.3	123.5	124.4	127.7	111.9	124.4	139.1	75.1	6.4	13.0	14.7	32.7	40.4	36.3	15.9	6.2	100.0	74.5	81.3	38.5	20.0	11.6	18.4	20.9	21.0	72.9	63.9	7.9	17.3	25.7	89.6	68.0	40.1	41.2	39.8	22.9	30.6	22.4	38.9	21.9	63.3	19.7	103.3	28.5	38.0	35.4	109.4	20.8	43.8	20.3	27.0	33.5	34.0	17.4	42.5	35.6	15.9	21.1	142.3	14.4	8.5	17.9	41.8	21.4	13.9	35.4	59.1	37.9	33.9	18.6	81.1	26.3	41.5	55.4	27.1	7.9	17.0	56.8	52.5	41.0	156.1	41.6	56.2
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	25.4	23.1	36.1	19.0	37.0	32.2	22.4	34.5	43.3	21.2	35.2	24.3	18.7	21.8	27.2	27.4	23.7	19.9	25.9	37.3	38.0	28.8	31.6	25.0	29.5	36.0	36.0	23.1	31.8	28.3	31.3	23.9	37.5	21.2	28.2	25.9	22.5	20.9	26.3	26.7	25.5	24.4	35.5	32.3	26.8	34.6	38.2	29.8	23.0	25.8	35.2	25.7	22.2	36.2	39.0	33.0	45.6	35.0	45.8	46.9	39.4	38.0	57.0	47.3	38.0	37.3	40.4	47.5	53.3	52.8	39.5	33.0	54.3	43.6	40.5	48.7	34.3	37.8	29.6	36.4	57.5	62.1	58.3	45.5	56.7	38.5	44.1	51.3	61.8	43.3	32.4	57.1	61.3	60.4	38.1	45.6	62.5	92.3	55.5	43.4	31.8	50.3	52.4	40.6	46.2	64.6	38.1	70.6	64.5	77.5	43.3	93.2	43.3	30.5	34.1	36.5	41.2	69.3	55.2	62.1	34.2	43.2	47.1	3.9	1.3	2.9	2.1	1.6	2.0	1.4	2.0	2.7	1.2	1.5	2.2	2.5	2.0	2.3	1.3	2.4	3.1	0.8	36.1	37.0	34.5	43.3	37.3	38.0	36.0	36.0	37.5	35.5	38.2	36.2	40.8	32.1	26.5	9.8	24.7	16.2	18.0	15.9	15.4	41.2	27.3	32.5	29.4	27.1	18.4	16.5	4.2	19.8	45.2	33.4	11.7	14.5	4.5	24.8	20.9	32.8	33.6	12.0	12.2	21.0	18.2	23.3	14.3	24.9	10.8	31.9	35.3	38.3	27.5	60.6	11.7	29.2	22.4	48.0	19.7	7.3	17.7	27.9	14.2	10.3	30.9	42.8	39.1	7.1	11.7	26.2	18.5	19.2	22.1	29.5	29.6	19.7	29.0	23.1	13.1	20.1	21.2	34.1	29.2	18.1	19.0	19.6	26.5	36.3	25.7	31.4
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	29.1	29.0	28.0	27.6	30.3	32.4	32.6	42.8	41.7	33.5	14.0	33.5	22.9	32.9	29.5	32.9	29.9	24.5	40.6	31.0	28.2	32.6	42.2	24.9	33.3	22.3	23.6	37.1	27.2	38.4	15.3	28.4	24.0	31.8	28.9	32.8	23.3	28.4	109.2	26.8	29.5	30.9	19.9	26.9	26.1	45.6	28.1	41.7	41.5	92.0	34.2	32.8	20.0	29.2	55.9	33.6	77.7	46.1	45.0	56.4	38.4	84.8	54.8	59.9	55.6	76.0	27.6	103.4	61.2	68.2	57.8	51.2	106.8	62.2	75.2	54.1	32.7	85.8	49.0	43.1	65.5	107.0	60.2	60.6	56.2	58.3	71.6	60.0	47.6	87.0	89.0	71.1	95.1	32.3	84.0	29.1	50.3	62.1	46.6	88.6	117.8	45.6	51.7	91.1	80.0	59.6	72.1	72.1	102.1	51.3	57.9	56.7	59.2	102.1	84.7	52.1	64.5	77.5	103.4	139.5	60.4	56.6	55.3	14.4	12.7	17.2	17.0	11.2	19.9	17.3	18.5	20.8	16.7	22.8	20.8	18.7	2.2	29.6	22.3	15.2	15.8	9.7	28.0	30.3	42.8	41.7	31.0	28.2	22.3	23.6	24.0	19.9	28.1	29.2	56.6	96.1	80.5	112.6	74.7	71.1	83.8	40.6	84.2	82.7	59.5	42.3	175.3	42.9	58.7	38.6	56.3	52.3	74.3	43.3	19.6	51.6	139.4	53.6	75.2	58.7	68.7	64.3	187.7	49.6	49.6	64.1	52.5	63.8	62.8	84.1	44.3	58.6	46.0	80.8	196.3	55.0	12.2	60.9	41.1	61.6	56.8	64.4	53.4	87.1	53.3	54.5	54.6	126.2	124.4	59.8	41.5	64.7	95.7	102.8	51.4	50.3	59.4	59.2	78.9	119.0	80.5	146.1	88.3	78.3	90.6	74.0	63.3	65.7	52.6	98.6
UBL7	"BMSC-UbP, MGC14421"	ENSG00000138629	"Ubiquitin like 7"	Q96S82	15	74445977-74461182	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 175.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040423, HPA041897"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA040423: AB_10673442, HPA041897: AB_2677732"	"unprognostic (4.21e-2)"	"prognostic favorable (6.37e-5)"	"unprognostic (2.93e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.43e-2)"	33.8	38.4	27.0	13.5	28.9	15.9	32.9	26.7	35.0	34.0	23.9	48.1	15.0	36.8	15.4	37.8	30.3	10.6	67.9	29.4	26.9	38.1	32.0	29.7	21.4	28.2	27.3	31.1	44.7	25.0	30.3	15.6	29.2	36.4	16.5	13.1	34.2	16.3	114.6	54.3	36.9	18.4	25.5	48.2	43.5	55.8	25.9	27.3	37.0	37.8	29.6	38.7	33.1	29.0	18.7	20.3	31.6	42.3	32.4	42.1	21.8	29.8	36.0	37.6	46.6	24.7	26.4	27.2	31.1	35.9	48.6	29.4	88.4	40.4	36.5	36.0	55.6	35.8	32.2	45.3	31.7	22.4	29.1	32.9	35.5	32.1	43.0	32.3	32.0	60.8	30.9	39.3	39.3	26.2	28.1	35.3	75.7	31.2	24.6	29.4	25.0	60.5	32.6	21.2	31.1	61.8	28.8	26.8	40.1	44.1	28.6	36.7	18.8	34.6	20.4	17.4	37.5	39.8	82.1	30.5	22.7	40.3	30.6	32.9	51.6	59.7	35.1	58.5	33.7	50.5	35.3	37.1	70.6	55.3	33.9	40.6	65.3	55.5	55.5	151.5	65.6	52.1	27.0	28.9	26.7	35.0	29.4	26.9	28.2	27.3	29.2	25.5	25.9	29.0	17.3	32.1	18.2	3.9	35.4	15.8	24.1	35.6	26.7	5.8	24.9	23.9	29.9	18.6	20.0	14.7	8.4	71.1	36.8	25.5	58.7	37.3	75.3	12.7	13.0	20.7	23.4	45.8	5.7	34.7	66.9	20.7	22.4	13.5	19.0	21.5	22.5	16.3	41.9	5.0	3.8	26.9	20.3	38.3	31.4	175.8	24.5	31.4	21.4	5.6	82.6	18.2	23.7	4.0	4.5	29.5	27.6	21.1	51.6	19.5	48.9	44.6	16.1	9.0	19.7	13.5	50.5	59.2	31.1	29.8	25.1	68.4	23.0	19.6	28.0	25.2
UBTD1	FLJ11807	ENSG00000165886	"Ubiquitin domain containing 1"	Q9HAC8	10	97498924-97571206	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 6.4;neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034825	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane, Cytosol"	"HPA034825: AB_10602254"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.66e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.78e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.50e-3)"	18.8	11.1	14.9	5.7	15.2	8.8	14.7	16.8	17.0	16.5	12.6	10.3	1.8	13.5	4.0	9.5	13.6	7.0	35.1	13.5	15.8	29.2	18.6	29.8	3.1	17.7	17.1	8.7	9.6	3.6	15.9	3.8	16.2	13.4	0.6	6.0	11.2	7.5	34.2	49.5	5.5	3.6	16.1	11.0	9.4	60.3	18.9	1.6	14.6	11.2	1.1	12.4	16.3	14.6	18.1	17.7	4.6	23.0	18.9	17.8	5.4	20.3	29.4	21.3	16.3	12.0	15.4	2.2	24.1	13.8	13.4	21.4	4.6	27.2	3.0	5.6	9.1	2.2	5.5	15.2	27.2	2.0	5.9	24.6	9.0	23.3	5.7	32.8	34.3	4.7	1.2	3.3	13.9	8.6	0.9	18.5	7.5	3.4	32.1	1.8	8.1	2.1	16.7	6.7	1.5	4.8	9.2	5.6	27.1	4.0	20.8	13.6	37.5	26.9	16.4	28.4	26.8	4.2	5.1	0.9	22.7	12.3	14.3	1.0	2.6	6.4	0.1	0.7	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	6.6	0.0	0.7	0.9	0.3	0.5	14.9	15.2	16.8	17.0	13.5	15.8	17.7	17.1	16.2	16.1	18.9	14.6	5.0	41.7	28.6	13.1	1.1	26.0	8.8	32.2	19.4	3.8	10.0	4.8	15.5	8.6	21.2	7.3	4.2	3.5	0.6	1.5	11.7	18.9	53.5	8.2	8.7	23.8	0.0	0.4	5.6	12.8	12.8	11.6	2.6	4.0	0.0	0.8	7.9	7.0	25.8	6.7	5.9	0.2	10.2	10.1	18.9	33.8	12.8	10.3	10.6	12.2	8.4	16.5	2.1	2.0	14.5	22.1	0.1	9.4	3.0	14.0	0.0	10.4	19.1	18.6	13.1	8.5	10.3	7.5	7.9	8.2	29.7	2.9	1.9	1.5	0.4	7.6
UBXN11	"SOC, SOCI, UBXD5"	ENSG00000158062	"UBX domain protein 11"	Q5T124	1	26281328-26318363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.1;Late spermatids: 327.4;Respiratory ciliated cells: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 93.2;intermediate monocyte: 82.6;myeloid DC: 48.4;non-classical monocyte: 72.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 48.4;monocytes: 93.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028600, HPA031357"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA028600: AB_10604001, HPA031357: AB_2673840"	"unprognostic (1.78e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (8.18e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.53e-1)"	"prognostic favorable (4.90e-4)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (8.41e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.59e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-2)"	10.5	10.8	23.2	9.5	25.2	19.3	10.6	17.8	35.1	11.6	45.1	8.4	3.4	9.5	14.7	6.2	31.2	5.1	11.0	26.8	23.9	19.1	7.8	17.7	8.0	25.3	27.9	13.4	11.1	8.0	31.3	4.3	22.0	11.5	2.7	15.0	9.4	6.5	5.6	7.6	8.0	4.1	24.3	21.8	8.8	48.4	25.0	6.8	25.1	3.4	3.9	8.5	7.5	20.1	26.4	11.7	5.7	11.6	4.1	3.1	19.7	5.7	8.8	15.6	11.3	4.6	22.8	15.3	8.5	3.6	10.3	14.0	3.5	9.3	3.9	7.7	13.6	2.6	18.1	11.5	7.2	11.2	5.0	4.7	9.9	26.3	6.7	4.9	4.3	11.1	10.2	10.3	5.4	11.8	6.4	5.4	11.5	7.4	8.8	13.1	4.2	13.8	8.7	3.8	26.9	6.3	14.1	13.1	10.2	2.9	10.3	10.7	4.2	8.9	13.4	13.4	8.7	9.7	29.8	17.7	11.0	15.4	7.5	2.2	93.2	4.6	9.0	82.6	11.4	12.7	13.6	10.8	48.4	16.2	15.2	9.7	6.8	6.1	72.2	7.5	12.5	41.7	23.2	25.2	17.8	35.1	26.8	23.9	25.3	27.9	22.0	24.3	25.0	20.1	4.3	0.0	1.1	5.5	18.8	21.4	15.7	23.4	5.2	11.9	13.2	15.5	1.3	5.7	16.2	23.9	22.9	9.9	10.0	5.5	13.7	14.7	131.1	78.6	9.2	5.1	9.0	6.7	7.0	8.7	20.8	10.0	17.9	8.3	10.2	11.9	6.1	3.0	20.9	23.5	5.1	5.9	18.3	62.4	35.3	327.4	12.8	59.9	10.6	2.8	41.9	24.2	12.3	2.0	1.6	7.6	2.5	10.1	9.5	9.8	1.2	26.7	121.2	54.9	19.7	6.6	11.5	26.1	24.0	5.1	13.4	7.3	23.7	8.7	8.3	12.1
UBXN6	"UBXD1, UBXDC2"	ENSG00000167671	"UBX domain protein 6"	Q9BZV1	19	4444999-4457794	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1342.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040906, HPA041313, HPA061872"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (5.68e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.78e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.79e-1)"	99.7	188.7	60.5	35.0	60.9	85.8	89.4	53.3	91.6	94.9	64.0	93.6	49.2	94.5	21.1	89.7	89.1	33.7	116.1	72.3	53.1	118.4	122.2	72.0	35.2	64.0	64.8	115.2	100.3	64.7	146.1	34.8	64.1	93.8	14.1	23.8	86.1	50.7	216.6	113.8	67.7	23.2	52.9	77.8	88.5	174.8	55.1	26.9	111.8	84.3	18.1	91.8	85.3	57.5	71.7	49.4	23.3	50.6	57.7	70.6	35.1	71.3	84.3	50.9	54.1	30.8	58.8	31.8	63.5	70.8	26.3	40.8	18.2	54.8	18.6	56.3	39.4	26.4	53.5	41.4	94.5	33.6	51.1	65.2	70.4	40.1	38.7	62.3	62.9	42.7	55.6	83.6	38.3	45.4	67.2	56.8	37.6	27.4	42.9	30.4	33.3	76.0	48.3	43.9	67.1	97.3	40.1	40.9	116.7	10.8	48.5	54.4	76.8	67.4	51.4	145.0	47.7	186.6	80.7	33.2	128.7	62.5	61.4	6.4	6.6	10.4	3.8	8.0	6.2	5.3	4.5	5.2	6.7	6.0	5.3	4.2	6.7	2.7	4.9	10.2	5.5	4.9	60.5	60.9	53.3	91.6	72.3	53.1	64.0	64.8	64.1	52.9	55.1	57.5	26.7	41.7	30.1	13.7	25.1	37.2	44.9	26.7	15.9	37.2	36.3	25.1	47.2	64.3	21.2	44.1	27.1	54.5	31.9	105.0	80.3	58.1	297.0	29.1	35.6	30.5	46.8	172.0	14.4	65.0	43.1	39.0	28.5	32.2	34.3	50.0	47.5	61.6	54.8	13.5	11.9	66.2	20.3	52.8	35.9	1342.0	100.0	37.5	53.4	1.9	49.0	60.1	25.7	5.5	10.3	65.6	90.1	73.0	16.4	50.9	136.9	112.2	21.4	35.2	72.3	38.8	29.5	139.9	68.9	20.4	41.1	79.6	18.5	41.4	58.4	48.5
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000277-74009085	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	80	"skeletal muscle: 393.2;tongue: 263.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Late spermatids: 14.0;NK-cells: 6.2;Skeletal myocytes: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	1.2	1.7	2.5	1.3	2.6	2.2	1.3	3.9	3.0	1.4	2.3	1.7	0.7	1.4	2.0	2.9	1.5	0.8	2.4	2.7	2.1	1.7	1.3	1.4	1.3	2.4	2.1	1.1	1.1	0.9	2.7	0.5	2.3	1.8	0.7	4.0	3.7	0.7	393.2	1.4	1.7	0.8	1.8	3.1	1.2	3.9	2.4	1.6	2.6	263.1	0.7	1.4	0.9	2.8	0.2	1.8	1.7	1.5	0.7	0.3	0.3	0.5	0.4	0.4	0.2	0.4	0.4	0.9	0.2	0.3	0.2	1.9	0.7	0.3	0.7	15.8	0.5	0.3	2.4	0.2	0.5	1.1	1.4	0.4	1.1	1.1	0.1	0.3	0.5	0.9	0.4	1.2	0.6	1.0	0.7	1.4	0.9	1.4	1.1	1.4	3.6	0.5	0.9	0.5	0.9	1.0	0.4	0.7	0.6	0.3	0.2	1.0	0.3	0.2	1.1	0.6	1.1	1.4	1.5	0.7	0.2	1.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.5	2.6	3.9	3.0	2.7	2.1	2.4	2.1	2.3	1.8	2.4	2.8	0.8	0.0	0.0	1.6	0.8	0.1	0.1	0.5	0.6	2.3	1.0	1.1	0.7	0.0	1.1	0.0	0.0	0.3	2.0	0.3	0.0	0.3	15.4	1.2	1.1	0.6	0.0	0.4	1.6	0.5	0.2	0.4	0.0	0.8	0.0	0.7	1.1	0.3	0.7	0.0	1.6	0.5	2.0	0.8	0.0	14.0	0.0	0.6	0.0	1.0	0.7	0.8	6.2	0.5	0.6	0.4	0.1	0.7	0.5	0.2	0.3	0.1	3.0	2.1	0.0	6.5	0.5	1.5	0.8	0.4	0.3	0.3	1.5	0.3	0.6	0.1
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	10.1	8.4	5.3	8.8	7.9	4.5	11.8	6.5	6.7	11.5	6.3	13.4	11.1	8.8	8.7	10.7	8.8	9.4	9.2	5.7	6.4	12.3	9.0	9.0	7.0	8.1	7.1	8.0	7.2	9.9	4.2	9.4	8.5	10.4	14.1	9.7	7.5	9.5	11.0	14.8	10.0	11.0	6.6	6.9	9.8	5.3	7.0	7.6	10.9	10.5	8.6	10.2	6.9	11.1	16.2	19.6	8.9	8.6	28.2	25.1	8.3	17.5	24.3	22.7	21.6	8.1	4.6	5.0	9.4	20.7	19.8	24.8	8.2	18.1	25.8	14.6	10.7	7.5	8.8	9.1	12.7	11.5	10.4	17.4	18.3	11.2	15.5	15.9	21.2	0.4	5.7	4.7	29.3	12.3	0.3	3.7	2.4	24.9	19.8	1.8	20.7	6.2	26.9	25.4	3.7	7.9	19.1	23.8	15.1	11.0	19.1	6.8	16.2	20.7	11.1	34.0	17.2	0.9	11.3	1.1	17.7	8.7	21.3	4.6	4.9	3.1	4.2	5.1	4.0	2.6	3.1	3.5	3.4	2.7	1.8	2.6	6.5	5.2	4.2	4.2	2.3	2.4	5.3	7.9	6.5	6.7	5.7	6.4	8.1	7.1	8.5	6.6	7.0	11.1	10.3	16.0	19.3	18.9	4.5	6.2	6.3	9.9	8.6	9.3	11.2	6.3	10.1	5.7	12.4	23.9	10.4	8.4	9.4	27.3	3.9	10.8	3.3	13.6	12.4	11.6	9.1	4.8	14.7	13.3	7.4	8.7	10.7	12.9	6.3	11.6	13.6	13.5	12.5	15.2	14.4	15.4	18.3	18.6	10.3	2.0	8.1	11.0	7.2	20.6	11.9	13.3	11.3	25.1	34.3	14.5	10.3	18.4	3.4	8.3	12.8	12.8	23.9	11.1	13.1	10.2	8.7	7.1	7.2	10.1	9.2	7.7	6.6	11.7	15.7	7.6
UFC1	HSPC155	ENSG00000143222	"Ubiquitin-fold modifier conjugating enzyme 1"	Q9Y3C8	1	161152776-161158856	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 703.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027481, HPA028722"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA		62000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	Cytosol	"HPA027481: AB_10599850, HPA028722: AB_10601674"	"unprognostic (2.16e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.62e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.22e-2)"	85.3	112.1	135.3	76.1	139.3	134.5	134.0	137.6	167.5	100.4	138.9	114.5	112.6	91.7	170.6	100.2	209.3	103.2	111.9	135.4	149.2	129.5	115.4	87.8	107.6	136.4	139.0	140.7	164.7	148.0	102.4	92.9	143.0	106.5	141.9	85.1	126.0	112.2	101.0	110.5	103.1	108.4	139.6	79.1	116.3	56.3	137.6	110.4	108.9	108.3	128.6	125.9	76.8	142.3	140.7	119.8	107.8	129.9	137.5	226.7	223.5	124.7	154.0	122.7	111.8	165.0	268.6	183.2	232.8	180.7	77.3	65.7	89.1	127.2	96.1	154.4	238.6	109.4	163.0	200.9	139.8	233.4	271.9	190.4	202.6	152.5	104.6	207.4	227.9	189.4	183.0	123.8	159.8	161.3	126.1	234.9	198.9	387.9	128.5	152.6	80.8	258.6	248.4	158.2	112.9	196.2	108.1	324.2	163.8	176.8	148.2	482.1	165.6	90.5	92.2	90.7	196.1	233.3	322.2	177.5	140.7	164.8	119.7	137.3	156.7	104.5	174.7	164.1	212.8	209.3	185.0	188.2	192.4	164.1	161.9	175.4	28.4	208.3	121.6	206.4	274.4	268.1	135.3	139.3	137.6	167.5	135.4	149.2	136.4	139.0	143.0	139.6	137.6	142.3	107.0	70.5	85.3	18.3	151.9	99.8	173.3	244.6	106.4	57.4	174.2	177.5	117.6	147.3	171.6	104.8	41.7	253.8	170.8	150.8	440.3	224.2	131.0	421.2	96.6	123.3	204.5	124.7	8.7	380.8	386.9	99.2	111.6	113.2	119.7	143.1	116.7	106.2	244.7	47.1	7.7	240.0	205.4	150.7	138.5	392.3	105.0	132.0	131.6	9.4	229.3	161.8	195.7	11.1	13.3	265.5	189.1	91.0	182.6	148.0	243.5	380.9	703.0	72.0	65.7	86.3	106.7	96.6	42.4	125.2	120.9	431.9	155.1	124.4	193.7	218.6
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449911-19479202	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 121.1;Ductal cells: 115.7;Exocrine glandular cells: 142.2;Extravillous trophoblasts: 107.3;Pancreatic endocrine cells: 149.9;Syncytiotrophoblasts: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 782.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	43.8	39.8	23.6	36.8	26.3	64.8	37.8	27.6	29.8	33.9	25.7	42.5	32.1	46.8	54.4	48.4	31.4	29.3	44.8	24.6	28.6	36.7	51.9	37.2	43.4	28.9	26.7	31.8	39.3	44.7	31.7	35.3	29.5	32.1	38.4	21.7	38.1	30.1	98.3	42.5	35.7	39.5	27.2	38.6	40.8	53.3	27.1	61.6	34.9	42.5	47.5	40.2	37.0	29.7	187.5	132.4	110.6	168.5	89.0	62.0	86.0	150.2	148.8	202.9	187.1	147.8	78.8	129.2	114.1	126.7	93.3	157.5	131.5	132.1	175.1	239.8	138.0	136.5	88.3	119.4	84.4	218.6	177.7	57.4	133.0	173.2	84.4	59.1	164.7	67.9	782.0	240.5	125.1	268.5	142.0	133.4	79.8	232.2	111.9	170.1	262.0	50.1	126.6	172.5	90.5	102.2	118.2	126.0	123.3	114.2	75.9	103.5	180.9	169.6	230.8	143.2	164.1	102.9	221.7	168.8	142.5	110.3	158.6	150.9	90.6	158.1	107.0	140.3	103.7	87.7	122.5	112.4	81.0	82.6	104.6	102.9	167.1	105.7	140.7	113.1	224.5	129.5	23.6	26.3	27.6	29.8	24.6	28.6	28.9	26.7	29.5	27.2	27.1	29.7	68.3	25.6	34.5	0.0	16.4	0.0	0.0	0.0	0.0	0.0	39.7	55.2	0.0	0.0	16.7	27.6	0.0	121.1	44.9	0.0	84.1	115.7	0.0	43.1	36.9	32.6	0.0	0.0	0.0	142.2	107.3	25.4	0.0	44.9	27.8	36.0	0.0	0.0	88.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	149.9	0.0	0.0	7.5	0.0	0.0	81.0	27.7	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	170.3	26.3	61.5	0.0	0.0
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399537-185425979	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	21.2	24.9	19.9	9.5	21.7	5.7	24.3	25.2	24.1	21.6	29.6	19.5	13.0	19.9	28.1	25.8	17.7	15.6	32.1	20.4	21.9	37.3	24.1	17.1	11.9	20.4	20.2	31.4	19.7	23.8	10.0	14.0	20.9	19.8	15.3	56.4	20.3	19.2	48.5	21.6	12.0	20.2	20.7	14.5	17.5	21.0	21.3	14.3	25.9	40.6	16.1	16.2	10.1	25.3	17.5	11.9	28.8	24.3	25.8	25.6	15.3	20.3	20.5	19.3	19.3	18.4	23.2	17.9	9.0	19.7	14.7	16.1	20.4	32.2	17.4	21.8	12.4	11.8	13.0	23.3	30.2	15.3	12.3	14.7	26.8	16.5	16.7	26.7	35.7	21.9	24.8	34.3	28.2	16.3	22.0	16.4	8.7	11.8	16.7	20.2	11.5	20.4	31.9	11.4	18.6	14.8	11.3	25.6	23.1	17.6	15.4	13.6	27.3	9.5	16.8	7.5	17.2	34.6	14.8	9.5	30.5	11.0	25.3	10.8	12.3	7.6	21.2	10.4	25.7	22.0	21.7	24.1	14.1	15.4	23.2	22.9	0.7	21.5	11.1	19.9	20.6	12.5	19.9	21.7	25.2	24.1	20.4	21.9	20.4	20.2	20.9	20.7	21.3	25.3	33.8	6.4	23.9	14.7	30.1	22.0	28.7	35.1	33.0	47.6	20.9	25.5	27.0	15.7	31.1	20.2	66.7	26.0	23.4	8.3	111.6	28.3	190.5	16.4	28.9	24.1	19.3	24.0	12.2	33.1	29.7	34.2	20.4	19.2	29.7	21.9	21.8	17.3	27.2	18.5	17.8	18.6	28.5	22.1	18.8	52.9	35.4	18.5	35.6	12.2	17.3	71.8	21.6	23.6	33.2	19.7	14.6	42.2	53.0	15.4	22.2	100.9	23.7	87.9	65.7	31.8	38.9	89.3	56.7	22.6	18.9	41.9	27.1	35.6	14.8	19.6
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951006-36001028	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 51.1;liver: 58.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 49.7;Early spermatids: 125.9;Hepatocytes: 72.1;Late spermatids: 24.5;Proximal tubular cells: 87.0"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	42	"RH-30: 28.2"									"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.1	58.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.2	0.0	0.1	0.3	0.0	0.7	0.1	0.2	3.0	0.0	6.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	49.7	0.0	0.0	0.0	0.0	3.9	0.0	125.9	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	72.1	0.1	0.0	0.3	0.7	0.0	2.6	0.0	24.5	0.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.5	0.4	0.0	0.0	3.8	87.0	0.0	0.2	6.6	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.5	0.0	1.8	0.1
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035021-36071358	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 14.7;skin 1: 10.3"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0"	"Low region specificity"	"Detected in many"							HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.0	0.8	0.0	0.0	0.0	6.5	1.1	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	2.6	0.6	0.0	0.0	1.0	1.1	0.0	0.0	0.1	0.9	0.2	1.2	0.4	0.0	0.1	0.1	0.0	0.1	10.3	0.0	0.0	0.1	1.2	0.1	2.9	0.6	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.3	0.4	0.0	1.3	0.0	0.5	6.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.4	0.0	5.3	0.0	0.0	29.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.2	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.0	1.1	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	1.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0
UHRF1BP1	"C6orf107, dJ349A12.1, FLJ20302, ICBP90"	ENSG00000065060	"UHRF1 binding protein 1"	Q6BDS2	6	34792015-34883138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032099, HPA032100"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA032099: AB_10696057, HPA032100: AB_10671087"	"unprognostic (2.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.58e-2)"	"unprognostic (4.39e-3)"	"unprognostic (9.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.24e-2)"	4.3	4.4	2.8	4.3	2.8	14.2	3.6	7.1	3.2	2.7	4.6	3.1	3.2	3.3	2.4	3.2	2.8	2.5	6.8	2.4	3.4	3.7	3.9	4.2	4.9	3.5	3.7	3.3	8.0	8.5	3.0	5.3	3.9	3.6	3.9	7.5	5.9	2.9	14.3	3.1	3.6	3.9	3.5	4.4	4.0	12.0	3.5	5.8	6.0	7.5	4.2	3.5	2.4	3.8	12.9	9.1	7.9	25.9	4.1	3.0	14.3	7.4	5.0	7.1	10.0	18.2	3.4	19.4	7.9	7.7	12.3	9.6	29.2	4.2	9.6	10.0	9.4	17.2	8.7	15.2	16.7	15.7	10.3	6.8	12.0	5.7	12.0	6.6	9.1	16.6	29.3	7.5	3.1	12.3	12.2	10.2	3.6	9.3	6.3	7.3	12.7	11.8	9.6	11.8	9.5	9.7	18.7	9.7	24.7	8.1	18.5	20.3	5.6	3.5	12.7	5.5	8.2	11.1	18.6	12.0	1.9	21.5	8.8	0.1	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1	0.4	1.3	0.1	0.1	0.2	2.8	2.8	7.1	3.2	2.4	3.4	3.5	3.7	3.9	3.5	3.5	3.8	5.1	16.0	6.3	16.0	5.0	1.0	3.0	3.9	5.7	10.1	5.2	2.9	16.8	4.3	9.1	0.0	20.9	6.9	3.7	3.0	1.9	5.4	10.0	5.8	4.9	6.3	9.5	6.7	20.8	5.8	3.8	4.9	10.2	11.5	1.3	14.3	15.0	6.0	15.6	5.0	39.3	4.9	10.2	19.0	6.0	18.2	5.6	11.9	0.0	22.5	9.4	4.6	4.1	25.6	14.1	7.2	3.3	2.6	11.4	9.9	4.1	3.9	5.1	10.8	13.1	7.5	5.4	16.4	10.8	8.3	2.8	4.9	3.9	4.0	3.8	8.5
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149963943-149973715	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.4;lung: 1.7;testis: 3.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.2;Breast myoepithelial cells: 3.0;Respiratory ciliated cells: 2.2;Squamous epithelial cells: 2.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 4.4;cerebral cortex: 1.9;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.5;HAP1: 29.3;HDLM-2: 17.1;HHSteC: 18.0;JURKAT: 26.1"									"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: AB_2686332"	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.2	0.1	0.1	0.2	0.1	0.3	0.0	4.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.6	0.2	0.4	0.1	1.7	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	3.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.2	2.1	1.0	1.6	0.0	3.3	6.8	3.2	3.0	0.9	0.6	2.0	0.2	3.1	3.5	0.7	16.5	6.9	0.7	29.3	1.4	2.7	17.1	3.8	0.3	0.6	0.0	18.0	0.1	1.2	9.1	6.8	13.6	2.5	0.0	1.1	26.1	3.3	0.0	3.5	2.7	4.3	0.0	0.5	1.4	2.3	0.0	1.3	0.5	0.0	0.4	1.0	0.4	4.4	2.0	0.0	1.3	2.9	6.4	0.3	1.6	0.0	1.4	0.0	0.5	0.7	2.3	8.7	5.0	3.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.1	4.4	1.9	1.6	0.2	0.1	0.2	0.5	0.1	0.1	0.2	1.6	6.4	2.2	0.0	0.5	0.1	0.5	0.0	0.6	0.0	1.0	3.0	0.9	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.6	0.0	1.6	0.0	0.7	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.3	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.0	0.0	1.6	1.3	0.2	0.2	2.5	0.6	0.0	0.7	0.2	0.3	0.1
ULK1	"ATG1, ATG1A"	ENSG00000177169	"Unc-51 like autophagy activating kinase 1"	O75385	12	131894622-131923150	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.0;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;granulocytes: 4.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063990			Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA063990: AB_2685167"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.21e-3)"	"unprognostic (8.01e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.04e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.03e-2)"	"unprognostic (9.09e-3)"	"unprognostic (8.19e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.16e-1)"	19.9	30.1	21.2	7.2	46.0	31.4	20.9	8.3	28.4	31.5	6.2	31.2	9.0	27.2	6.5	21.5	27.2	9.3	35.0	24.4	4.7	21.7	36.4	20.9	6.7	10.9	8.7	39.9	55.6	12.1	47.2	7.1	9.6	27.8	2.3	14.4	21.4	9.4	81.6	43.1	19.5	4.9	1.5	29.3	27.8	17.8	9.9	7.9	24.5	13.8	2.9	23.1	26.8	12.4	9.1	28.8	13.1	16.4	5.8	4.7	17.8	14.1	10.1	5.9	4.8	6.3	9.2	2.4	14.5	10.0	12.0	8.9	3.0	5.6	1.7	9.8	17.2	6.1	25.2	8.6	10.8	4.4	12.9	8.6	15.1	6.6	2.7	16.4	7.3	18.2	8.1	7.0	4.0	20.6	27.5	25.6	14.4	4.3	27.2	20.5	4.7	12.2	3.5	11.1	33.1	18.2	15.1	15.3	7.9	13.1	23.4	29.5	14.2	14.1	8.3	24.8	6.6	30.9	12.0	3.3	23.8	7.6	16.6	0.2	0.9	1.4	0.4	0.4	0.1	0.1	0.3	0.4	0.2	0.3	0.2	0.3	4.0	0.1	0.4	3.8	0.3	0.4	21.2	46.0	8.3	28.4	24.4	4.7	10.9	8.7	9.6	1.5	9.9	12.4	15.6	16.0	17.4	17.9	7.8	14.4	6.1	11.6	9.6	25.0	19.6	14.4	22.0	15.7	15.6	7.3	39.6	5.7	23.7	10.5	1.9	8.5	0.8	19.1	35.7	14.9	19.2	12.0	27.0	12.7	4.2	13.1	13.3	28.0	3.8	24.4	8.6	33.8	5.4	53.8	21.9	14.6	18.3	12.0	6.7	3.0	12.5	13.1	5.4	11.2	12.3	14.7	5.2	20.1	13.9	24.5	7.7	15.8	11.9	15.0	9.9	3.2	13.9	84.3	13.1	19.5	16.9	6.8	7.5	9.7	19.5	17.2	9.1	8.8	7.7	9.5
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962130	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 352.3;Excitatory neurons: 108.6;Inhibitory neurons: 99.2;Late spermatids: 405.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	2.7	3.1	1.6	2.9	2.1	8.5	2.5	0.4	1.7	8.5	16.9	1.6	1.2	6.6	4.5	1.5	9.0	1.9	8.6	2.3	2.5	3.9	2.1	3.5	3.0	6.9	7.6	2.1	2.0	8.0	2.9	2.7	3.9	2.2	1.7	6.0	1.7	2.4	0.4	2.1	2.0	3.5	5.6	2.0	2.4	23.4	2.5	3.0	4.9	0.4	2.7	1.9	3.7	2.1	8.3	2.9	2.8	3.8	1.1	1.7	4.8	2.7	2.7	3.2	3.0	1.0	2.3	9.5	1.6	6.3	3.5	4.1	3.7	2.1	2.9	1.5	1.0	2.1	5.7	3.3	4.1	6.5	1.8	1.6	2.3	16.1	3.2	4.4	2.2	6.4	2.1	7.5	2.3	6.4	8.1	4.9	3.4	2.1	3.4	1.7	9.1	4.5	7.2	7.6	1.6	10.3	3.1	1.3	2.8	1.8	3.1	2.0	6.6	2.0	2.4	14.2	2.5	4.5	9.0	3.9	11.5	6.3	2.5	3.7	3.7	4.0	5.0	4.3	4.1	3.7	5.3	4.5	3.3	4.7	4.0	5.7	6.6	1.8	2.3	3.3	7.7	3.0	1.6	2.1	0.4	1.7	2.3	2.5	6.9	7.6	3.9	5.6	2.5	2.1	6.4	9.6	6.9	84.9	11.2	2.0	3.0	4.0	5.2	5.6	5.7	4.6	14.8	4.3	5.1	3.7	54.2	3.1	9.9	2.0	0.0	3.4	352.3	45.3	27.4	6.0	1.8	2.1	108.6	2.4	4.1	8.7	10.2	7.5	1.3	49.6	1.8	6.6	7.3	11.8	99.2	1.2	2.0	3.1	4.0	405.2	6.5	6.9	0.0	80.6	5.9	10.4	3.1	49.8	62.0	3.0	0.7	4.1	5.1	0.9	1.1	5.9	47.3	26.7	6.6	4.4	10.5	38.9	9.6	3.3	3.7	4.2	10.8	3.6	1.9	1.2
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730433-124749273	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Approved	Cytosol		NA	NA		9200	"Cluster 26: Non-specific - Mitochondria"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	1.3	1.4	2.5	1.2	2.5	1.3	1.8	2.8	2.9	1.0	1.1	2.3	2.0	1.3	1.0	2.0	1.8	0.7	0.8	2.6	1.8	1.8	2.6	0.9	1.4	2.8	2.1	1.9	2.1	1.5	0.8	0.7	2.3	1.4	1.6	1.8	1.3	0.7	3.1	2.3	2.1	1.1	2.0	2.6	1.8	0.9	2.3	1.8	1.1	0.7	1.7	0.8	1.0	3.5	1.4	4.4	5.1	2.1	2.9	3.4	5.4	7.9	2.4	3.1	2.6	3.8	2.1	4.0	8.2	3.0	7.9	9.0	7.1	2.4	5.0	4.4	4.2	8.2	3.0	2.7	2.6	8.7	6.0	3.8	2.3	1.8	3.9	1.9	1.2	8.2	3.7	1.9	2.3	3.5	10.8	1.7	12.1	3.9	2.7	7.4	6.0	3.3	2.4	2.5	4.0	2.6	11.3	4.2	4.3	3.7	4.1	3.1	15.4	2.5	5.2	7.4	3.2	8.0	12.5	12.1	2.8	3.4	2.6	5.9	10.3	5.5	14.0	11.3	12.4	17.0	9.2	12.1	14.6	24.3	13.9	10.8	0.7	12.8	9.3	11.0	12.4	11.9	2.5	2.5	2.8	2.9	2.6	1.8	2.8	2.1	2.3	2.0	2.3	3.5	9.6	6.4	11.5	6.5	11.2	15.8	24.5	41.3	18.8	8.3	8.9	12.3	6.2	20.0	22.8	9.2	4.2	66.8	13.2	9.0	29.4	29.8	3.2	10.9	18.2	15.2	9.6	16.2	11.0	30.5	35.0	12.7	14.3	12.1	12.0	22.8	7.9	31.4	22.0	5.0	12.0	10.3	20.3	7.0	5.9	4.4	13.7	8.3	3.6	10.3	18.0	11.0	13.4	15.6	12.2	23.4	8.6	13.9	10.4	14.6	14.0	25.9	22.1	9.1	13.1	13.3	17.1	23.2	32.1	20.6	19.0	109.2	11.0	29.5	17.8	21.1
UNC45B	"CMYA4, UNC45"	ENSG00000141161	"Unc-45 myosin chaperone B"	Q8IWX7	17	35147817-35189345	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	59	"heart muscle: 100.3;skeletal muscle: 196.6;tongue: 151.9"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 201.8;Late spermatids: 59.4"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.9;testis cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.1"	"Group enriched"	"Detected in some"	11	"BEWO: 1.7;HSkMC: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA017861			Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA017861: AB_1847012"	"unprognostic (7.17e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.49e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.13e-6)"	"unprognostic (6.77e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	100.3	0.2	0.1	0.1	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	2.5	0.0	196.6	0.1	0.0	0.1	0.1	1.4	0.4	1.3	0.1	0.4	0.0	151.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.2	0.5	0.0	0.0	0.1	0.6	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	201.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	24.6	0.0	0.0	2.3	0.0	2.7	0.4	0.0	0.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	59.4	0.6	0.1	0.0	1.9	0.0	0.0	1.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.5	0.2	0.7	0.0	0.1	0.0	1.1	0.5	0.0	0.1
UNC5A	"KIAA1976, UNC5H1"	ENSG00000113763	"Unc-5 netrin receptor A"	Q6ZN44	5	176810519-176880898	"Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 30.4;pituitary gland: 14.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 54.4;Inhibitory neurons: 19.4;Muller glia cells: 13.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.5"	"Group enriched"	"Detected in many"	6	"amygdala: 10.5;basal ganglia: 15.1;cerebral cortex: 30.4;hippocampal formation: 16.3;white matter: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 86.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071450			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA071450: AB_2686397"	"unprognostic (5.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.66e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.07e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.77e-5)"	"unprognostic (6.39e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.17e-2)"	0.4	7.5	10.5	0.3	15.1	0.4	0.7	2.6	30.4	0.3	0.0	0.1	0.4	0.4	0.2	0.1	0.6	0.2	0.3	16.3	0.0	0.1	0.1	0.3	0.9	0.0	0.0	0.1	1.8	0.0	14.7	0.0	0.0	0.2	0.0	3.1	2.5	0.0	0.0	0.5	0.1	0.1	0.0	0.1	1.0	0.7	0.0	0.1	0.5	0.0	0.0	0.2	0.1	11.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.4	3.5	0.0	0.0	0.0	2.5	10.1	0.0	86.4	3.9	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.5	15.1	2.6	30.4	16.3	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	4.7	0.6	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.1	0.9	0.0	0.0	54.4	0.0	0.0	0.0	0.0	1.6	0.0	2.0	0.0	0.0	0.0	5.0	19.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	4.7	0.0	13.9	0.0	7.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097597-109110992	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 64.9;Spermatogonia: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	19.8	56.7	32.4	14.7	32.4	16.0	23.1	30.1	34.8	16.6	27.7	28.0	17.1	14.5	12.7	29.7	15.6	10.4	21.1	29.2	34.9	27.5	32.2	9.6	18.0	32.2	31.4	15.7	12.4	33.2	10.9	17.8	34.1	13.6	29.3	6.8	17.7	17.6	43.0	32.7	18.8	14.5	31.6	16.1	17.7	24.3	33.5	22.8	22.2	33.5	27.0	13.5	20.1	30.8	77.1	77.5	72.8	66.6	118.6	33.8	69.5	44.4	30.1	68.6	52.3	61.7	51.6	100.3	65.1	40.2	35.9	47.6	81.4	46.0	66.4	85.6	150.9	98.1	41.1	105.5	17.7	147.6	58.2	30.7	41.6	33.0	18.3	54.6	50.4	117.8	80.9	32.5	47.0	96.2	136.8	173.6	130.0	124.2	117.7	123.9	109.8	85.9	43.4	95.6	103.3	57.4	79.6	67.8	39.5	94.2	126.2	68.2	26.0	59.1	52.7	39.3	62.5	62.6	145.0	190.5	44.8	97.7	73.8	12.9	2.7	5.0	22.4	5.3	31.6	16.0	25.5	25.6	6.8	17.2	16.4	18.4	0.0	16.5	5.5	4.9	25.5	14.4	32.4	32.4	30.1	34.8	29.2	34.9	32.2	31.4	34.1	31.6	33.5	30.8	26.6	0.0	4.8	16.0	9.2	18.0	11.0	13.2	25.0	2.6	21.7	14.1	12.4	7.2	5.0	42.3	4.2	64.9	12.5	14.7	19.6	14.4	3.4	7.6	15.0	17.7	8.4	32.4	7.0	6.2	38.1	12.6	14.3	9.9	7.6	24.8	20.3	20.8	18.3	5.0	6.2	21.4	10.2	3.8	5.4	4.2	14.0	5.5	14.2	6.5	3.8	15.8	7.2	6.6	4.0	5.0	10.3	14.7	16.7	6.8	9.3	20.2	3.2	3.5	6.6	10.2	11.5	21.9	74.6	37.8	20.9	20.4	15.3	25.7	40.4	9.7
UPF3A	"HUPF3A, RENT3A, UPF3"	ENSG00000169062	"UPF3A regulator of nonsense mediated mRNA decay"	Q9H1J1	13	114281601-114305817	"Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 480.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018325, HPA061316"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA018325: AB_1858638, HPA061316: AB_2684477"	"unprognostic (9.08e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.44e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.71e-4)"	17.5	20.0	13.7	15.1	14.6	18.0	16.4	19.6	19.7	17.6	10.2	17.4	18.1	18.7	8.3	13.3	18.4	11.7	12.9	12.9	16.9	14.5	10.3	12.1	17.0	16.4	14.6	15.5	19.7	13.7	17.1	11.2	17.3	16.4	11.1	11.6	16.5	14.5	23.8	15.6	15.9	11.3	13.2	16.3	16.7	46.3	14.3	17.9	30.2	7.5	10.8	15.4	14.3	17.5	55.9	15.9	35.3	31.7	16.4	28.1	22.3	42.0	30.0	26.4	29.1	24.4	19.4	54.0	11.9	19.6	17.8	29.3	17.2	14.1	32.6	39.8	33.7	47.0	50.9	27.1	28.3	81.7	20.3	19.1	28.1	17.8	20.5	27.7	21.2	14.0	29.0	24.7	26.6	16.7	33.8	22.1	46.7	36.8	15.9	43.2	19.8	31.7	23.4	17.5	39.1	43.3	33.6	51.3	31.3	23.6	37.6	72.7	27.5	27.8	46.0	15.5	26.6	53.4	39.3	74.5	51.7	46.7	23.3	3.0	5.6	4.8	6.8	4.7	5.2	13.2	7.0	7.2	6.5	9.7	7.1	6.7	0.9	11.9	6.1	16.9	10.8	4.3	13.7	14.6	19.6	19.7	12.9	16.9	16.4	14.6	17.3	13.2	14.3	17.5	104.8	67.3	61.5	88.5	64.2	68.7	57.8	57.2	76.8	85.3	80.6	84.3	22.8	52.9	60.8	58.8	83.4	65.0	75.3	32.1	103.7	54.3	205.8	148.7	101.2	78.1	57.5	51.9	84.7	71.2	45.2	69.7	42.8	65.4	55.6	57.7	63.9	72.6	45.7	79.1	114.7	50.5	79.3	44.9	46.1	96.8	100.6	53.8	55.2	59.0	51.1	74.2	83.4	188.5	130.9	52.6	34.0	87.6	81.1	59.1	36.0	69.8	96.0	72.3	85.5	77.5	56.4	480.3	172.4	82.4	71.9	40.5	64.3	111.8	62.2	46.7
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823258	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		69000	"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	27.9	41.3	54.1	13.4	55.3	67.5	26.9	40.6	64.5	15.9	33.0	29.9	20.9	21.4	56.9	24.9	19.3	15.6	73.2	56.3	45.8	40.7	59.7	20.5	18.8	41.6	48.1	22.5	32.9	30.0	29.9	11.3	43.5	27.4	16.5	26.2	29.6	19.1	83.8	23.0	24.2	18.1	40.2	28.0	29.6	31.2	51.8	18.6	32.5	80.0	19.1	27.3	17.0	47.8	45.5	56.3	29.8	74.9	38.5	42.2	51.9	51.4	94.5	39.0	34.6	22.9	54.0	58.4	24.7	72.9	24.3	23.5	18.5	43.1	31.3	78.1	39.9	125.3	27.9	40.1	67.3	50.7	29.7	59.3	20.7	25.8	66.0	47.5	34.4	48.5	24.4	54.1	63.5	65.2	51.2	72.8	37.7	31.8	54.0	33.1	34.1	37.3	53.9	28.2	26.2	46.8	51.6	41.8	80.7	30.8	40.4	59.1	33.8	52.3	19.6	38.1	48.2	50.7	36.8	40.6	75.6	23.1	26.3	4.9	31.9	4.6	30.1	33.1	33.9	30.1	29.3	38.6	53.5	37.5	38.1	29.6	2.1	53.6	31.9	25.3	29.8	38.1	54.1	55.3	40.6	64.5	56.3	45.8	41.6	48.1	43.5	40.2	51.8	47.8	19.0	19.2	23.1	20.5	34.3	9.3	12.0	31.8	9.6	49.3	36.2	39.5	70.5	40.0	28.6	36.8	45.9	60.8	36.3	19.1	101.8	59.7	57.0	11.2	25.5	22.2	14.5	231.5	23.9	59.6	47.4	33.3	23.9	16.9	11.4	112.3	28.2	53.4	79.3	47.1	25.2	25.6	40.7	47.8	20.8	123.7	35.8	31.6	62.2	9.4	58.7	77.0	69.0	13.6	29.6	42.7	15.8	40.6	46.9	27.3	52.9	142.6	20.4	42.3	6.6	22.8	36.7	55.7	100.9	28.5	12.8	20.0	37.8	55.0	38.8	21.3
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179653032-179804366	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 149.2;tongue: 108.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 93.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.2	11.9	3.9	2.8	13.6	1.5	5.3	8.6	12.0	3.3	0.0	2.9	1.2	5.7	3.4	4.0	3.4	4.5	42.5	3.7	4.7	3.0	4.6	5.4	3.6	11.3	10.5	12.5	4.1	4.0	5.8	2.6	12.7	4.3	2.2	7.1	6.2	2.7	149.2	2.2	1.9	6.3	6.4	2.1	1.7	6.0	8.1	2.4	9.7	108.9	3.5	3.5	2.2	34.4	27.6	11.3	20.0	14.8	8.9	14.1	11.6	18.6	17.4	23.7	18.8	17.1	9.6	35.6	18.0	17.2	27.6	2.6	21.4	9.1	26.4	93.3	14.8	9.0	23.6	14.4	6.3	26.5	1.1	10.5	3.0	18.8	18.5	9.1	16.6	11.9	4.7	43.0	15.7	15.0	22.5	3.0	17.9	1.3	13.1	29.3	20.2	27.4	11.7	7.9	13.0	14.5	14.1	16.9	7.2	5.4	37.0	12.7	24.1	28.6	27.6	23.7	64.1	29.5	21.2	78.3	13.0	15.0	27.2	0.1	0.3	0.0	2.6	0.5	15.6	3.2	1.8	3.8	1.5	0.9	1.2	1.3	0.0	0.0	0.7	4.5	0.7	1.3	3.9	13.6	8.6	12.0	3.7	4.7	11.3	10.5	12.7	6.4	8.1	34.4	45.0	9.6	35.9	14.0	5.3	2.5	1.9	1.4	0.6	13.7	7.1	5.2	208.5	5.7	5.4	1.8	6.2	10.7	5.6	1.4	15.6	1.1	2.6	13.9	11.4	10.1	9.6	5.5	23.2	4.4	2.4	12.0	4.1	2.5	2.5	35.5	22.1	7.6	4.3	16.8	52.2	2.9	0.0	4.8	3.5	3.6	9.3	5.0	14.2	16.9	1.7	7.0	3.1	36.2	42.5	1.0	12.2	9.4	4.5	4.4	0.1	2.7	3.7	10.2	13.1	17.8	12.0	6.1	2.8	4.8	1.6	5.1	4.1	58.8	4.5	1.4
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 514.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	27.0	23.0	18.8	23.4	23.2	29.3	27.4	21.3	20.4	22.7	19.1	24.6	25.1	25.2	25.2	25.2	19.9	20.4	29.3	17.5	20.5	22.1	30.7	20.9	27.9	20.5	20.8	22.3	26.0	34.3	16.7	24.2	21.7	25.7	26.4	42.3	24.7	23.6	34.7	19.9	22.8	22.6	20.2	21.9	23.4	25.7	20.3	30.0	33.8	37.5	32.3	27.1	14.1	27.5	59.9	23.4	36.5	33.0	25.4	41.5	34.2	56.9	37.9	38.5	36.4	29.5	38.3	60.5	16.8	54.8	58.7	26.5	45.6	41.5	50.1	58.6	48.4	80.9	27.3	33.1	37.6	80.3	43.0	35.9	42.9	50.3	46.4	28.7	37.5	33.9	67.7	103.8	45.3	27.3	49.7	29.3	39.2	48.4	29.9	33.0	89.7	69.6	31.7	42.5	39.4	41.9	36.8	58.1	51.1	24.9	40.2	54.2	38.0	44.8	55.7	41.8	59.3	87.8	129.3	62.5	46.8	57.3	45.6	37.4	24.1	33.6	36.3	24.9	28.6	40.7	34.1	33.6	23.1	46.0	36.9	35.8	23.5	31.5	34.0	36.2	38.9	17.2	18.8	23.2	21.3	20.4	17.5	20.5	20.5	20.8	21.7	20.2	20.3	27.5	60.3	86.6	91.9	27.4	114.4	57.2	132.5	68.9	55.2	161.0	65.8	58.7	84.2	64.3	83.1	53.3	89.6	81.7	108.2	90.2	133.1	77.9	514.9	85.9	82.6	55.0	82.6	40.8	18.2	119.9	79.7	68.3	55.0	107.7	141.8	61.5	45.7	86.2	59.9	72.3	27.6	100.4	44.7	62.0	53.1	117.0	87.7	69.4	62.2	25.3	117.3	94.1	96.8	28.1	47.3	94.0	99.2	86.9	106.8	100.1	74.8	91.8	94.1	183.5	59.2	133.4	83.2	100.4	82.4	68.4	64.4	162.0	105.3	72.8	90.6	141.9
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881828	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 95.9;K-562: 60.2;MOLT-4: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	8.1	12.0	8.7	13.5	8.0	22.6	8.3	4.8	8.7	12.5	2.5	13.6	8.2	12.5	4.2	7.9	12.1	7.7	7.5	7.8	10.6	7.6	7.4	8.4	18.3	10.2	9.1	13.5	10.9	8.4	18.4	6.7	10.0	14.8	4.9	6.7	11.4	13.2	10.9	12.1	12.5	8.2	5.4	13.9	9.9	10.0	8.9	32.3	18.7	7.5	11.8	14.9	10.1	6.5	6.0	5.8	10.0	13.4	12.8	10.8	14.1	9.5	7.9	7.1	4.9	4.7	6.5	8.1	8.0	9.3	8.0	14.7	6.0	6.7	2.9	43.4	7.9	14.9	17.0	3.3	8.8	14.2	10.6	9.6	9.8	9.3	7.0	12.4	7.7	95.9	60.2	9.9	4.4	15.9	56.4	33.6	7.9	12.7	13.6	9.4	11.2	14.0	5.5	6.5	2.2	11.0	11.0	13.9	9.1	5.9	14.4	19.9	11.5	7.8	3.5	10.5	6.3	9.7	15.3	5.7	15.5	18.6	7.4	1.0	1.9	5.4	8.6	1.5	9.1	3.7	8.7	8.3	2.6	3.4	9.8	8.9	2.8	10.0	1.5	2.1	11.5	6.3	8.7	8.0	4.8	8.7	7.8	10.6	10.2	9.1	10.0	5.4	8.9	6.5	3.0	9.6	6.9	16.3	9.2	2.8	2.2	2.5	4.0	7.8	6.4	8.0	7.7	4.3	3.0	1.8	4.2	5.9	9.4	6.2	3.9	2.4	2.1	4.1	6.3	4.3	8.4	12.8	17.0	4.0	2.5	4.6	8.2	5.7	1.3	6.8	6.4	6.1	3.3	10.1	21.1	4.6	4.1	1.6	3.8	3.3	6.2	6.0	3.6	11.2	3.1	5.3	11.3	9.5	14.3	2.7	5.0	4.9	6.7	3.0	4.1	2.9	5.0	6.3	0.0	4.3	5.7	12.1	6.0	4.8	2.0	6.2	19.3	2.9	5.2	1.6
USP31	KIAA1203	ENSG00000103404	"Ubiquitin specific peptidase 31"	Q70CQ4	16	23061406-23149270	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006937	Uncertain		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA006937: AB_1080523"	"unprognostic (6.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (5.59e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-3)"	5.5	2.9	7.5	2.0	23.4	4.3	6.7	18.9	13.0	12.9	0.7	4.2	1.7	11.0	3.8	6.0	5.3	1.9	9.2	10.0	10.5	3.6	5.6	6.1	1.8	22.3	20.3	2.2	4.3	5.5	5.7	3.9	21.3	7.5	2.3	3.2	4.6	4.1	8.9	11.2	2.6	7.5	11.3	1.6	2.6	11.8	20.6	2.6	3.0	8.4	2.5	7.5	7.9	31.2	12.0	12.4	3.5	4.9	6.2	4.8	3.3	4.1	3.7	5.1	6.1	7.9	7.1	4.0	4.2	5.1	8.3	15.2	8.7	15.9	8.4	2.9	3.5	1.6	7.4	16.7	7.8	4.2	4.3	4.1	13.5	9.5	21.8	1.9	9.3	3.9	4.9	12.0	7.1	8.0	2.0	3.5	6.9	3.9	3.8	9.9	9.8	7.9	7.7	17.5	9.3	6.0	6.3	12.4	3.6	3.9	5.0	9.2	5.5	10.3	7.6	5.3	11.2	3.9	7.0	4.2	7.4	5.5	4.2	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	7.5	23.4	18.9	13.0	10.0	10.5	22.3	20.3	21.3	11.3	20.6	31.2	25.9	6.4	3.7	11.1	2.2	66.8	62.7	35.5	44.9	13.7	7.6	19.8	13.6	7.2	10.9	5.5	2.1	13.8	3.6	2.7	0.0	7.0	4.8	20.6	12.8	17.6	4.8	8.2	59.2	8.6	7.5	6.9	2.0	13.2	1.3	23.7	7.5	27.7	4.7	0.0	49.6	3.5	12.2	3.5	10.8	10.4	7.8	5.0	7.2	32.8	3.1	4.0	3.1	31.7	198.7	7.9	2.0	4.5	2.8	32.0	1.5	11.6	17.6	8.1	19.7	8.8	11.2	24.2	57.1	17.4	26.6	7.5	2.9	4.4	6.4	23.9
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60177327-60422470	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 241.8;Inhibitory neurons: 113.1;Oligodendrocytes: 268.9;Rod photoreceptor cells: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 59.2"	"Group enriched"	"Detected in all"	10	"dendritic cells: 59.2;granulocytes: 29.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 171.4"					"Low region specificity"	"Detected in all"			HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	Cytosol	"HPA044365: AB_2678914"	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	16.1	21.8	13.6	15.0	27.8	32.1	14.1	23.2	23.6	12.4	25.2	13.0	9.5	10.3	6.8	21.7	10.7	11.8	17.4	14.3	22.8	20.2	26.6	20.7	10.5	22.2	25.0	10.0	12.5	19.2	11.9	13.2	24.8	10.8	11.4	58.8	12.9	11.2	40.8	21.0	10.5	13.7	18.1	18.5	12.2	102.1	22.3	14.4	20.6	29.2	11.6	13.1	14.7	44.4	32.6	38.2	19.0	30.8	44.8	45.3	17.2	26.4	41.9	34.5	45.8	18.6	20.0	19.4	21.5	50.0	56.1	16.3	33.1	36.9	61.5	16.8	13.9	39.7	31.8	19.5	44.1	31.7	33.6	39.6	24.6	49.9	45.2	33.5	38.6	24.4	42.9	17.1	41.1	171.4	32.3	21.3	21.7	29.6	18.8	15.8	51.6	11.5	33.1	24.5	13.1	19.1	22.9	6.0	33.8	32.1	27.4	41.3	32.6	49.7	54.9	33.1	23.5	16.2	37.4	19.6	24.6	23.6	33.4	14.5	4.3	16.5	2.0	3.7	1.4	3.0	1.4	1.7	8.5	2.2	1.0	1.9	29.4	1.3	4.6	59.2	2.6	2.1	13.6	27.8	23.2	23.6	14.3	22.8	22.2	25.0	24.8	18.1	22.3	44.4	8.0	6.4	16.4	58.8	12.5	26.9	13.3	5.8	11.4	17.3	9.2	7.6	8.2	10.0	10.1	5.5	241.8	5.1	12.6	8.5	3.9	11.3	95.0	9.0	9.9	9.8	8.3	44.2	92.3	7.5	8.4	12.6	15.8	11.6	11.4	18.5	12.5	12.0	18.5	13.5	113.1	5.6	6.1	29.7	41.3	33.3	13.1	25.1	5.4	101.2	28.0	10.4	24.7	70.4	268.9	9.6	11.4	5.7	8.3	10.3	7.4	4.6	7.0	136.4	26.3	11.9	9.1	92.7	14.9	11.2	21.9	4.9	10.9	8.5	5.5	8.2
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223874	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 65.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	6.5	4.4	2.5	6.2	4.3	21.6	4.6	4.3	2.9	6.2	4.3	8.0	7.9	5.5	2.3	7.0	4.3	5.2	6.8	2.2	2.4	7.0	13.2	6.3	6.4	5.9	3.8	3.7	8.2	7.7	3.3	8.1	4.9	5.5	5.7	4.5	5.8	5.6	36.6	5.9	7.2	5.7	4.9	7.4	6.3	6.8	3.2	9.3	7.4	21.3	5.8	6.8	3.9	6.8	8.5	7.9	6.6	11.3	8.4	8.2	5.1	13.0	12.5	11.8	10.1	23.1	11.7	10.5	9.2	11.5	7.8	6.5	15.9	13.5	10.2	26.0	10.5	9.7	8.5	4.7	11.3	19.4	9.4	10.2	11.1	12.0	9.5	8.3	12.2	11.9	21.5	31.5	7.9	13.3	25.6	3.7	6.1	17.7	15.3	16.7	10.2	10.1	7.2	9.2	13.8	12.3	10.5	17.3	10.9	4.9	10.8	7.6	14.6	10.8	9.1	9.6	14.1	35.7	65.3	18.6	10.9	14.4	9.3	13.4	4.5	9.7	5.7	4.6	7.0	4.6	4.9	4.9	6.6	4.5	4.8	4.2	4.3	10.1	4.9	2.7	7.9	4.3	2.5	4.3	4.3	2.9	2.2	2.4	5.9	3.8	4.9	4.9	3.2	6.8	21.5	22.4	19.8	13.7	19.5	53.5	21.0	6.2	25.6	7.4	20.8	13.7	18.4	10.0	12.2	0.0	12.5	12.8	22.2	35.5	1.9	8.3	36.4	20.7	26.1	15.3	30.6	31.5	19.6	7.7	7.1	13.4	26.0	52.1	3.8	9.9	17.9	38.4	10.6	8.4	15.9	20.2	4.1	17.0	16.6	20.3	6.8	21.9	12.4	9.4	10.1	15.1	12.3	18.6	22.8	10.2	13.4	9.4	38.6	16.8	17.0	18.5	10.9	8.9	13.1	15.0	14.1	11.3	4.7	31.5	59.1	26.7	23.2	11.0	17.6	45.4
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432325-99521728	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 53.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.1;Inhibitory neurons: 44.4;Oligodendrocytes: 39.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 53.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	6.1	4.4	5.2	4.9	5.8	4.4	4.6	53.5	9.4	4.3	3.8	5.3	7.3	5.1	4.8	5.3	4.0	6.2	6.2	5.8	6.3	6.3	4.2	3.7	7.4	6.0	7.7	4.5	4.0	4.5	3.6	5.2	8.2	5.1	6.7	6.7	4.0	4.2	6.0	6.3	5.8	4.5	5.3	4.6	4.4	3.3	6.2	3.1	5.3	5.5	5.2	4.3	3.8	9.0	5.9	4.0	8.1	11.2	14.3	13.5	8.7	10.3	11.1	10.1	14.7	8.2	6.4	15.2	7.3	10.3	11.9	7.7	12.1	9.8	13.9	12.2	12.0	15.2	8.4	6.7	11.4	14.2	8.3	15.3	7.6	9.2	15.5	10.7	15.4	13.8	37.2	14.8	9.6	5.5	4.5	13.3	12.8	9.1	8.9	6.8	5.9	8.9	13.8	6.8	11.3	9.2	7.0	9.1	7.8	10.0	4.9	6.8	15.5	5.5	7.1	8.1	15.5	6.3	6.2	29.1	9.8	13.1	10.1	2.9	1.4	0.4	3.2	0.8	4.2	5.3	2.7	4.0	2.4	6.7	1.9	1.9	0.3	1.9	2.0	3.6	2.6	1.0	5.2	5.8	53.5	9.4	5.8	6.3	6.0	7.7	8.2	5.3	6.2	9.0	13.3	3.2	5.8	22.5	13.3	2.3	9.6	6.8	4.6	10.3	4.4	4.6	9.4	4.3	4.7	3.7	18.8	6.4	7.3	5.9	5.9	4.3	15.7	10.1	10.3	7.6	2.4	4.2	47.1	2.5	6.6	7.1	9.7	4.3	2.5	5.8	6.8	4.5	4.0	10.1	44.4	2.9	10.2	4.8	2.6	10.2	13.1	4.6	3.6	22.5	10.0	5.4	2.1	32.6	39.4	5.0	3.1	8.6	6.5	8.6	8.3	15.8	10.4	7.4	0.0	6.3	6.7	1.9	7.5	5.2	2.8	7.4	7.1	5.8	7.3	6.9
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852148-6866632	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	27.1	37.9	23.7	26.7	26.1	22.8	19.5	15.5	38.0	24.1	2.4	31.3	25.3	31.5	17.4	38.2	25.9	18.5	33.0	25.3	33.6	20.1	23.1	20.5	29.2	31.0	31.3	19.4	17.8	41.4	27.8	25.4	38.8	26.5	22.2	15.7	20.0	29.6	66.7	48.1	26.1	35.5	15.0	21.2	22.9	40.9	28.9	36.5	26.7	42.5	29.4	29.8	24.2	29.0	88.1	135.7	88.4	100.4	59.0	53.9	113.4	93.0	70.9	109.2	78.8	129.4	84.9	105.7	47.6	98.5	86.5	75.2	98.6	92.7	69.5	198.6	84.0	97.1	105.5	71.0	45.8	88.5	97.2	55.6	52.9	94.8	64.9	72.9	94.8	41.7	85.4	40.9	91.1	97.4	132.9	44.4	172.8	89.3	56.5	103.4	115.5	73.5	62.9	84.5	48.5	97.4	63.5	96.3	41.1	110.6	38.3	72.4	92.4	91.5	109.1	70.4	117.6	49.0	124.5	163.8	102.1	55.3	91.3	5.4	19.3	8.3	24.3	25.1	23.1	15.0	21.7	20.8	28.4	13.9	20.1	20.9	1.3	17.6	24.4	20.5	19.9	27.7	23.7	26.1	15.5	38.0	25.3	33.6	31.0	31.3	38.8	15.0	28.9	29.0	11.3	9.6	13.1	7.5	14.0	11.6	11.4	18.0	8.6	18.7	13.1	10.8	9.5	17.2	11.5	22.0	60.5	45.9	14.8	21.5	11.7	28.1	14.7	10.6	14.7	15.3	16.7	19.4	11.5	20.5	30.7	16.6	10.2	13.7	14.7	29.6	11.4	22.2	28.4	40.4	11.9	19.3	14.2	13.0	7.4	19.2	23.0	10.9	16.0	9.4	32.4	16.0	13.4	6.0	11.9	20.2	17.4	33.8	14.1	10.3	22.5	18.5	7.9	16.2	32.9	13.3	17.2	51.7	25.6	17.6	15.5	52.8	15.4	27.6	27.5	7.9
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 51.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.7;Muller glia cells: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Nucleoli fibrillar center"	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	1.4	3.1	2.5	0.9	2.7	0.5	1.7	2.8	2.8	1.9	4.2	0.8	0.4	3.1	51.7	0.6	5.5	0.8	2.1	2.2	4.2	3.7	1.2	1.5	1.1	2.2	3.1	6.5	1.1	5.6	1.4	2.4	2.4	2.4	0.8	3.1	0.8	2.5	0.4	1.1	0.7	1.9	2.5	1.8	0.8	2.3	3.8	2.4	5.3	1.1	1.2	0.9	0.7	2.5	0.0	0.6	3.9	1.1	1.9	1.0	0.0	0.6	0.3	0.7	0.9	1.2	0.5	0.0	4.6	0.8	0.8	0.2	1.0	0.4	1.2	1.3	0.0	1.0	0.2	0.0	0.8	2.5	0.2	3.9	0.0	0.4	0.0	0.3	0.2	3.0	3.1	3.0	0.6	2.6	2.4	1.3	4.8	0.0	0.2	3.4	0.7	1.5	0.9	0.1	0.0	0.7	1.1	0.1	3.7	7.0	0.9	1.3	0.2	1.5	2.1	0.4	0.1	4.7	2.0	0.9	1.0	1.4	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	2.7	2.8	2.8	2.2	4.2	2.2	3.1	2.4	2.5	3.8	2.5	5.1	3.2	5.5	3.3	2.6	0.9	2.2	0.9	2.2	23.7	3.8	7.4	6.9	1.5	2.0	3.7	6.2	4.3	1.2	0.2	9.8	1.5	0.3	9.0	9.2	6.0	3.6	5.0	2.7	0.0	2.2	8.1	0.0	2.1	1.3	7.9	6.4	0.7	7.6	6.7	5.0	0.5	0.0	5.6	2.5	1.0	4.1	4.7	5.4	1.9	0.3	32.9	3.1	3.5	3.7	0.2	0.3	8.2	1.0	1.0	0.0	13.1	11.2	16.4	0.0	7.1	5.0	11.4	12.5	1.0	0.4	2.7	3.1	13.0	0.4	0.5
USP53	KIAA1350	ENSG00000145390	"Ubiquitin specific peptidase 53"	Q70EK8	4	119212587-119295517	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 586.8;Microglial cells: 269.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 327.9;SK-MEL-30: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035844, HPA035845"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA035844: AB_10669532, HPA035845: AB_2674817"	"unprognostic (9.33e-2)"	"unprognostic (1.49e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (4.37e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.54e-6)"	"prognostic favorable (3.58e-8)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	37.8	14.4	5.6	5.7	5.8	0.9	25.3	6.1	6.2	18.5	11.8	16.3	5.7	13.1	13.1	17.0	30.6	10.2	24.0	4.9	7.3	19.9	7.3	29.4	12.4	9.4	8.1	9.4	24.6	8.1	10.3	10.5	7.3	9.2	16.1	3.4	12.7	11.5	33.5	11.7	9.7	10.2	6.5	7.2	15.1	7.8	8.6	5.4	10.5	51.7	8.0	12.7	12.0	5.5	11.4	6.8	2.4	0.0	60.5	60.4	13.6	70.6	327.9	6.2	8.1	7.4	10.4	46.1	2.5	21.1	12.1	5.5	5.5	5.3	16.1	6.1	4.5	3.1	5.2	2.6	47.2	3.9	0.7	20.3	15.0	21.9	31.0	11.7	29.8	3.0	7.3	1.7	8.4	2.5	2.9	5.2	6.7	7.0	3.8	0.9	11.4	9.2	16.4	7.2	3.8	3.0	3.9	27.5	102.4	13.3	7.0	2.7	32.3	2.0	7.0	26.3	6.4	3.3	5.2	7.8	31.4	1.7	7.9	1.3	0.0	0.0	0.4	0.0	0.5	0.7	1.0	0.8	0.1	0.7	1.9	1.0	0.2	0.9	0.0	0.3	0.9	0.3	5.6	5.8	6.1	6.2	4.9	7.3	9.4	8.1	7.3	6.5	8.6	5.5	27.6	35.3	44.5	80.6	18.5	61.8	73.6	21.2	48.3	17.8	74.1	46.6	99.0	32.9	33.9	119.5	29.2	48.4	15.1	207.8	45.0	33.4	5.6	167.2	45.9	35.7	34.6	4.8	32.4	62.7	17.3	86.0	41.8	586.8	70.8	19.8	23.9	30.5	9.3	25.2	32.5	80.4	52.9	21.3	76.4	7.3	19.0	36.5	14.2	269.8	45.6	25.0	12.3	11.6	11.9	110.6	214.5	10.9	18.6	138.6	46.0	20.1	27.3	31.5	6.6	91.8	32.9	18.0	4.0	62.6	42.3	49.8	26.8	14.8	62.6	124.8
VAC14	"ArPIKfyve, FLJ10305, TAX1BP2"	ENSG00000103043	"VAC14 component of PIKFYVE complex"	Q08AM6	16	70687439-70801160	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027766, HPA075382"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA027766: AB_1848651, HPA075382: "	"unprognostic (9.25e-2)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-1)"	17.3	25.0	20.6	14.5	19.3	11.3	17.1	19.5	24.7	16.2	18.0	16.7	12.1	16.9	8.6	19.0	15.1	10.2	20.3	20.8	20.5	26.3	27.1	16.9	24.7	21.5	20.0	14.3	23.7	17.5	16.6	10.9	21.4	17.5	8.3	6.8	17.4	10.7	24.3	23.0	17.9	11.5	19.2	22.5	20.7	16.2	21.6	15.5	21.4	12.0	13.9	18.1	14.9	21.6	25.9	25.3	21.0	23.6	29.9	20.3	32.0	18.5	29.0	34.6	15.5	31.6	41.0	33.3	23.3	22.5	39.9	32.3	27.8	30.1	16.3	10.0	28.2	16.9	18.6	39.5	76.8	29.1	33.7	36.0	30.9	50.7	45.1	20.7	33.0	29.2	30.1	14.6	30.1	37.3	27.1	48.5	36.9	20.4	22.7	32.3	14.9	48.6	16.7	17.4	24.9	26.7	60.9	18.5	43.0	15.2	27.4	27.0	26.7	45.7	25.9	29.2	20.4	20.4	27.5	62.9	76.1	25.1	21.3	0.8	2.7	4.4	1.5	3.6	1.4	2.5	2.2	3.1	5.6	3.9	2.0	1.8	1.0	2.4	3.6	3.1	1.3	1.1	20.6	19.3	19.5	24.7	20.8	20.5	21.5	20.0	21.4	19.2	21.6	21.6	5.1	3.2	4.2	15.0	10.1	4.2	7.8	7.0	9.6	8.4	8.4	7.4	12.6	12.8	8.0	3.7	2.1	16.7	4.0	11.5	5.9	19.2	20.4	14.2	5.4	8.2	9.1	5.7	11.7	22.5	29.2	5.9	11.7	6.7	5.7	11.6	16.4	15.9	42.9	10.1	13.8	10.0	14.2	18.3	13.5	74.4	6.2	15.6	10.6	10.3	19.2	6.8	8.2	8.5	16.3	20.8	10.8	3.4	15.8	8.9	13.7	15.0	14.6	7.7	6.6	5.9	7.9	4.8	13.5	10.3	9.1	19.6	6.5	8.7	12.6	7.1
VASH2	FLJ12505	ENSG00000143494	"Vasohibin 2"	Q86V25	1	212950520-212992037	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 92.8;Late spermatids: 80.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 24.2;AN3-CA: 29.6;NTERA-2: 46.2;RH-30: 135.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045820			Approved	Cytosol	"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA045820: "	"unprognostic (2.22e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-5)"	"unprognostic (1.95e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.81e-4)"	1.7	0.1	0.9	3.3	0.8	0.9	2.0	0.2	1.1	1.7	0.0	0.5	0.7	1.9	0.4	4.0	0.7	2.6	1.1	0.6	0.4	0.4	0.2	1.1	2.3	1.6	0.9	0.6	0.2	0.8	2.6	0.8	1.6	2.7	0.6	0.5	0.9	0.8	0.5	0.5	0.9	1.8	0.2	1.2	0.8	7.9	2.1	4.3	0.3	0.8	2.1	1.4	0.5	0.7	0.3	1.7	24.2	29.6	0.2	0.1	4.0	0.1	0.0	1.0	1.3	0.1	0.6	0.1	0.4	0.1	0.6	0.1	9.9	0.0	1.2	20.3	3.7	2.0	1.4	1.5	0.1	0.2	0.4	3.8	0.0	1.3	0.0	0.6	0.3	11.4	0.1	5.9	2.0	0.5	13.1	1.5	46.2	0.0	3.6	7.6	135.5	1.3	0.2	1.9	5.6	8.6	3.1	0.2	0.3	12.4	4.5	0.9	0.0	1.0	2.7	0.6	1.3	3.4	6.2	0.9	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.8	0.2	1.1	0.6	0.4	1.6	0.9	1.6	0.2	2.1	0.7	0.9	0.0	1.1	0.0	0.6	1.5	0.8	0.2	5.7	3.0	4.1	6.0	1.2	0.0	0.0	0.0	2.1	0.1	12.6	0.2	0.0	0.7	92.8	0.9	1.4	1.1	1.2	0.8	5.4	0.2	0.3	10.9	2.0	1.0	0.0	11.2	0.0	0.1	0.2	1.7	4.3	0.2	2.0	0.3	3.2	80.8	0.3	1.5	0.0	0.0	0.7	0.4	0.0	0.5	0.6	0.1	0.0	0.7	1.0	1.5	0.0	0.4	0.9	2.0	0.0	8.4	4.0	3.2	1.1	0.4	1.6	0.0	0.5	0.1	0.3	0.4
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788564-77980107	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adrenal gland: 70.1;brain: 186.9;choroid plexus: 232.4;retina: 188.7"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 297.8;Muller glia cells: 106.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.1;BJ hTERT+: 68.7;fHDF/TERT166: 38.1;NTERA-2: 79.9;U-87 MG: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.8	70.1	30.0	3.3	38.1	0.8	0.5	45.7	24.1	0.7	232.4	3.6	2.3	5.4	6.8	1.7	0.9	4.0	15.2	19.6	186.9	5.3	1.0	0.3	0.4	60.2	53.2	0.3	1.8	0.7	4.5	1.9	84.0	0.3	5.6	188.7	1.4	0.4	0.2	0.1	3.2	2.5	49.9	0.0	1.9	1.9	67.4	0.1	2.4	0.3	2.3	1.4	1.2	37.4	0.0	0.0	23.1	0.0	7.8	0.0	0.0	2.8	68.7	0.9	0.7	0.0	0.0	0.0	0.0	38.1	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.5	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.4	79.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.0	3.7	0.0	1.1	0.0	14.1	0.1	18.6	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	82.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	38.1	45.7	24.1	19.6	186.9	60.2	53.2	84.0	49.9	67.4	37.4	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.5	9.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.2	4.4	0.0	0.2	0.9	3.0	0.0	20.7	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.0	0.2	297.8	31.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.0	0.6	106.9	0.0	44.7	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0
VAV1	VAV	ENSG00000141968	"Vav guanine nucleotide exchange factor 1"	P15498	19	6772708-6857366	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 54.1;lymphoid tissue: 46.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 30.7;dendritic cells: 31.3;granulocytes: 34.9;Hofbauer cells: 50.6;Kupffer cells: 29.4;Macrophages: 33.9;Microglial cells: 30.9;T-cells: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 100.7;Karpas-707: 114.7;MOLT-4: 115.8;REH: 76.1;THP-1: 88.9;U-266/84: 89.5;U-937: 95.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001864, HPA005925"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA001864: AB_1858722, HPA005925: "	"unprognostic (2.93e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.28e-1)"	6.6	3.8	3.3	36.3	3.3	54.1	2.7	3.6	4.6	2.6	4.5	6.5	5.8	1.8	1.4	3.7	2.4	6.3	1.9	3.3	4.4	2.1	5.0	11.5	46.4	6.2	4.9	1.1	1.3	4.2	1.6	8.7	5.6	2.8	7.1	0.2	6.1	2.3	1.0	1.7	14.1	5.3	5.0	44.9	5.5	1.8	5.7	45.7	2.0	2.1	39.1	13.0	1.7	7.6	1.6	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	12.7	51.0	16.5	0.0	0.0	0.2	0.0	0.0	0.0	22.0	1.8	61.8	0.0	0.0	0.0	60.7	100.7	0.0	0.0	0.0	0.0	0.0	0.0	63.9	2.3	114.7	0.0	9.6	115.8	36.6	0.0	0.0	0.0	76.1	0.0	41.0	2.2	0.0	0.0	0.0	0.0	18.3	0.1	0.0	8.0	88.9	0.2	0.0	1.6	0.1	0.1	69.9	89.5	57.9	0.1	95.3	0.0	1.6	18.3	20.0	22.0	30.3	15.7	14.3	16.1	19.3	16.6	13.6	17.2	15.6	40.6	19.2	39.8	14.4	14.5	18.2	3.3	3.3	3.6	4.6	3.3	4.4	6.2	4.9	5.6	5.0	5.7	7.6	0.5	3.2	3.0	0.0	30.7	1.3	0.8	3.7	0.0	0.5	0.4	0.4	1.1	0.0	6.9	0.0	0.0	0.8	31.3	1.5	0.0	4.2	5.4	5.3	0.3	1.5	1.2	9.9	1.9	0.4	0.7	1.2	1.1	1.1	34.9	0.0	1.8	0.3	50.6	0.0	1.5	1.0	8.2	29.4	19.6	2.2	0.0	33.9	1.8	30.9	18.8	0.0	22.6	0.5	1.2	9.9	6.1	0.0	21.6	0.3	0.0	0.2	11.9	0.0	0.0	0.3	1.2	1.7	1.4	0.3	0.9	1.4	26.5	0.3	2.4	0.6
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 235.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 141.7;Proximal enterocytes: 88.7;Undifferentiated cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"classical monocyte: 3.5;eosinophil: 1.9;intermediate monocyte: 6.5;myeloid DC: 5.1;neutrophil: 6.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.5;monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 55.5;HDLM-2: 80.0;U-937: 85.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.1"	"Region enhanced"	"Detected in some"		"spinal cord: 4.3"	"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.6	13.7	0.2	13.3	0.2	8.2	11.3	0.2	0.4	5.0	0.9	40.4	56.0	1.6	0.4	13.6	1.8	8.5	1.2	0.2	0.7	21.0	1.1	7.7	5.3	0.7	0.4	0.5	2.1	235.9	11.1	2.9	0.6	1.9	35.3	0.2	6.1	1.8	2.8	22.1	55.0	3.8	0.1	2.6	7.4	1.0	1.4	1.5	2.2	0.6	7.2	10.4	7.6	0.3	15.0	2.6	0.1	0.1	12.0	16.4	0.2	17.7	8.6	15.0	12.9	10.6	12.1	3.5	17.4	13.6	10.7	27.1	0.5	55.5	6.4	80.0	4.0	6.3	3.1	0.9	8.1	12.2	20.3	23.6	30.5	16.4	26.0	22.3	1.2	1.3	1.8	3.9	7.0	9.2	0.3	6.0	0.2	34.8	19.1	0.3	0.0	9.9	13.3	13.5	6.2	0.2	14.7	42.6	5.9	0.1	47.6	6.7	1.0	28.8	7.3	8.2	10.2	2.2	0.1	3.0	8.6	85.3	7.7	0.1	3.5	1.9	0.0	6.5	0.1	0.5	0.3	0.0	5.1	0.0	0.1	0.0	6.5	0.2	6.7	0.4	0.7	1.5	0.2	0.2	0.2	0.4	0.2	0.7	0.7	0.4	0.6	0.1	1.4	0.3	0.4	12.8	20.1	0.3	1.4	36.1	9.0	8.5	24.5	0.5	21.2	13.7	1.7	0.0	9.2	7.3	0.0	0.2	0.9	141.7	7.9	3.5	0.2	11.9	0.5	1.3	21.7	0.0	0.4	10.9	0.1	5.3	14.3	4.7	7.0	0.2	0.0	0.3	3.4	0.0	0.3	32.8	2.0	7.3	43.4	0.0	0.0	21.2	8.8	1.0	10.4	0.2	0.0	0.5	0.1	22.4	43.3	0.4	10.9	8.3	88.7	32.0	9.0	0.2	0.0	1.1	2.2	0.7	0.3	23.4	40.6	0.3	2.8	0.0	72.4	11.6
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.2;kidney: 27.0;lung: 29.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 266.0;Alveolar cells type 2: 175.9;Distal tubular cells: 46.9;Early spermatids: 64.5;Late spermatids: 84.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.3;renal cancer: 4.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 92.0;hTERT-RPE1: 96.7;HUVEC TERT2: 245.1;TIME: 147.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.4	20.2	0.2	0.1	0.3	2.2	1.9	0.8	0.1	3.1	11.1	0.8	0.7	0.3	17.6	0.0	5.4	0.9	0.2	0.7	0.4	27.0	0.5	29.4	0.0	2.7	1.1	0.2	13.1	2.1	17.1	1.3	2.9	1.4	0.8	0.4	2.5	2.8	0.1	1.5	0.1	0.2	0.4	4.0	0.9	2.9	0.4	0.1	2.0	0.1	0.0	0.4	0.3	0.2	7.3	0.8	16.0	0.0	9.2	33.8	0.0	41.9	92.0	12.2	17.7	1.1	6.4	0.0	16.0	45.3	1.9	0.3	0.5	1.0	67.2	0.2	0.0	7.3	0.8	0.0	2.9	0.0	0.1	9.9	0.7	51.9	10.3	96.7	245.1	0.0	2.5	0.0	33.4	0.9	0.0	0.0	6.6	1.9	6.2	0.0	1.2	0.0	6.1	3.6	0.6	0.0	1.3	1.9	17.0	0.2	70.7	0.1	147.2	48.0	1.6	16.8	58.0	0.0	0.0	0.0	38.6	0.0	11.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	0.2	0.3	0.8	0.1	0.7	0.4	2.7	1.1	2.9	0.4	0.4	0.2	0.1	266.0	175.9	1.6	0.5	1.8	0.2	0.0	0.0	0.2	4.5	3.7	0.5	22.8	14.3	31.3	2.1	1.8	0.2	1.2	46.9	6.9	64.5	11.1	0.5	0.9	0.0	0.0	2.8	10.1	0.1	0.9	0.0	4.4	0.0	0.8	0.0	0.0	0.2	0.0	3.3	0.4	0.0	0.0	0.3	84.7	1.5	2.3	28.4	0.0	0.7	1.5	0.0	0.0	0.9	1.8	3.2	0.4	0.0	0.3	0.0	28.7	8.1	0.5	0.0	0.1	1.3	0.3	0.9	0.0	0.4	0.0	0.6	0.9	0.8	0.2
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.93e-5)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	7.3	9.9	7.7	5.8	8.0	3.3	8.9	11.3	9.9	9.2	3.1	7.6	5.8	8.2	9.6	6.6	7.7	7.4	9.5	8.5	8.6	6.9	6.2	7.8	6.4	4.4	5.7	11.2	9.0	8.6	13.4	9.4	5.7	9.6	6.3	20.3	5.4	7.6	23.8	10.3	5.9	7.1	4.0	4.1	5.6	4.5	6.9	6.6	18.9	21.2	6.4	7.5	8.5	7.1	14.4	12.9	18.0	9.5	14.7	9.2	6.8	10.3	13.3	8.7	12.9	4.8	6.6	18.6	6.5	8.8	4.3	7.4	13.3	9.2	15.2	12.6	7.3	7.2	3.3	5.2	7.5	14.2	4.1	12.7	15.6	7.6	21.9	19.0	17.1	8.9	4.2	7.0	7.6	4.0	12.4	6.7	9.2	4.5	13.1	11.1	8.4	6.0	23.8	10.3	12.1	10.6	10.1	14.9	4.9	15.8	18.4	2.4	13.9	7.2	2.8	3.5	5.8	6.8	11.4	16.3	2.8	5.1	3.8	0.2	1.5	0.5	1.5	1.6	2.1	2.5	2.2	0.9	2.0	1.8	1.0	0.9	0.1	1.1	0.4	0.8	1.8	0.5	7.7	8.0	11.3	9.9	8.5	8.6	4.4	5.7	5.7	4.0	6.9	7.1	36.5	70.5	49.3	88.8	31.1	77.8	58.1	37.5	63.2	67.9	46.3	28.6	49.0	37.1	44.5	33.1	85.5	39.6	26.3	40.0	9.8	50.1	16.5	30.1	48.4	44.6	38.4	22.1	151.8	45.2	22.3	31.0	27.5	53.8	29.2	59.9	47.8	36.7	21.6	62.2	149.1	36.1	30.5	27.1	37.5	11.4	32.6	23.2	37.4	74.9	25.2	24.1	14.4	101.0	98.4	76.4	39.4	33.1	40.5	54.6	33.0	21.5	33.1	146.6	6.6	39.0	37.3	39.4	21.3	57.8	72.5	110.7	29.1	32.7	24.9	71.7
VGLL3	VGL-3	ENSG00000206538	"Vestigial like family member 3"	A8MV65	3	86876388-86991149	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 40.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.1;Extravillous trophoblasts: 178.1;Late spermatids: 71.8;Leydig cells: 132.3;Peritubular cells: 149.3;Skeletal myocytes: 65.9;Syncytiotrophoblasts: 80.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.9;urothelial cancer: 6.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"U-2197: 518.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054983	Approved		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli, Cytosol"		"HPA054983: AB_2682663"	"unprognostic (9.08e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.73e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.05e-1)"	21.0	1.5	5.7	3.3	1.8	0.4	7.4	0.5	2.1	5.4	6.8	6.7	1.1	8.0	1.4	3.0	5.4	9.6	4.3	1.9	6.9	1.5	0.6	15.9	2.3	0.9	2.3	14.2	4.0	1.2	0.3	40.1	1.0	11.0	2.2	1.1	1.6	4.1	1.7	4.1	2.2	9.0	0.6	2.0	2.6	3.4	2.7	0.5	3.0	1.5	0.8	9.3	4.0	0.5	8.1	13.1	69.5	0.2	90.5	112.2	1.1	48.6	34.0	40.8	50.8	15.2	3.1	0.0	0.1	76.9	4.6	6.9	4.8	4.6	55.9	28.4	0.1	3.6	4.8	0.3	41.3	0.5	0.2	86.6	7.6	60.1	26.9	21.8	6.1	0.1	0.0	0.1	51.5	0.1	0.5	0.4	1.4	0.1	0.3	0.1	91.7	0.4	0.0	8.3	0.2	0.1	20.8	0.7	0.1	2.4	0.2	0.3	2.8	90.3	13.4	518.3	1.6	0.2	0.2	0.0	16.8	0.0	3.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	5.7	1.8	0.5	2.1	1.9	6.9	0.9	2.3	1.0	0.6	2.7	0.5	2.5	3.2	2.2	0.0	0.0	8.0	11.1	2.1	4.0	0.0	0.9	4.6	1.2	1.5	3.3	11.0	0.0	35.6	0.1	0.0	0.0	13.4	138.1	1.3	31.0	1.7	0.0	0.0	0.4	2.6	178.1	33.4	1.1	1.2	0.0	0.1	2.5	0.0	7.5	0.0	2.0	0.0	2.0	0.0	10.3	71.8	132.3	0.7	3.6	6.5	0.0	17.1	0.0	0.0	1.4	13.2	0.0	149.3	0.0	17.7	0.0	0.1	3.2	0.3	13.1	65.9	21.8	1.1	1.4	1.8	5.3	80.7	0.5	23.1	0.0	4.5
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 61.9;stomach 1: 97.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 221.7;Gastric mucus-secreting cells: 192.7;Paneth cells: 139.0;Proximal enterocytes: 165.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.0;OE19: 78.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA035675, HPA035676"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA035675: AB_10671223, HPA035676: "	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (1.35e-4)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	5.4	3.7	8.7	11.0	9.0	12.6	6.4	6.6	10.6	9.5	6.4	46.8	61.9	5.7	1.5	7.2	6.7	15.7	6.4	8.6	7.8	5.3	1.4	7.7	9.8	8.3	8.4	6.8	3.4	1.2	5.1	4.1	8.0	16.0	26.6	1.2	5.7	4.0	1.2	9.1	61.7	4.1	8.0	11.8	97.5	5.4	8.2	10.2	7.4	1.4	6.3	17.5	7.4	7.2	8.2	0.1	0.2	0.4	2.8	2.2	0.8	2.3	1.9	2.3	2.2	6.1	25.0	3.9	3.5	1.6	0.0	1.9	1.8	0.2	0.5	0.8	0.0	7.3	0.1	0.6	3.4	7.7	9.5	3.3	2.2	2.2	0.0	0.0	4.5	16.1	7.3	2.3	2.6	0.1	12.4	8.7	0.2	78.4	0.0	4.8	0.0	2.0	0.8	9.8	0.1	0.3	0.0	0.5	1.8	0.0	0.7	12.4	2.8	1.0	0.3	3.0	0.0	1.4	3.1	1.2	0.6	10.9	5.0	0.0	3.2	0.0	6.8	2.0	7.4	3.5	4.4	3.9	2.1	4.6	5.6	4.2	0.1	3.4	1.4	3.8	5.8	4.1	8.7	9.0	6.6	10.6	8.6	7.8	8.3	8.4	8.0	8.0	8.2	7.2	4.9	9.6	7.4	10.4	7.2	2.3	5.7	25.5	6.8	0.9	3.3	2.9	1.9	8.6	46.1	0.0	0.0	3.0	13.3	221.7	0.0	3.4	6.2	1.5	2.7	4.5	9.6	6.1	5.5	16.9	3.4	6.7	192.7	1.5	8.2	6.1	5.3	0.3	2.4	1.7	3.0	64.4	14.2	1.9	2.4	19.9	3.7	4.0	1.8	3.7	4.2	28.1	7.2	2.5	1.2	38.7	139.0	2.6	4.4	6.2	165.6	1.6	40.5	0.8	0.0	4.3	7.1	5.4	3.4	3.1	1.4	1.0	8.1	5.6	50.5	33.4
VPS11	"PEP5, RNF108"	ENSG00000160695	"VPS11 core subunit of CORVET and HOPS complexes"	Q9H270	11	119067818-119081972	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039020	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA039020: AB_10674847"	"unprognostic (6.97e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.44e-4)"	"unprognostic (4.07e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-1)"	21.6	25.1	16.7	14.7	16.8	17.6	19.4	16.7	18.6	20.8	15.3	19.6	13.4	23.5	19.0	14.6	20.1	12.8	16.6	17.6	17.8	16.9	11.5	16.8	18.1	17.0	17.6	22.5	18.0	22.4	22.8	17.3	17.3	18.4	13.4	17.6	18.2	16.5	21.7	21.4	17.9	19.5	16.0	21.7	18.5	13.3	17.5	20.1	21.1	21.1	17.2	21.0	17.4	18.4	11.6	11.8	12.8	9.8	27.5	24.2	14.0	15.4	18.4	15.3	16.5	19.9	24.2	16.6	21.5	30.2	27.1	21.0	16.1	20.7	15.1	17.1	8.0	36.6	12.0	19.5	30.8	22.9	21.5	29.6	21.3	23.2	15.9	27.2	24.4	13.9	29.5	28.8	20.2	30.5	19.3	21.6	6.4	21.2	22.5	21.7	21.1	12.6	18.2	24.1	10.2	17.5	19.2	25.3	16.8	13.7	38.3	20.1	24.5	19.1	7.1	6.9	11.5	11.3	11.0	15.6	14.0	27.2	17.0	24.8	16.8	12.8	16.4	13.9	16.8	11.3	13.7	15.2	20.7	11.9	12.9	16.6	3.8	16.5	19.0	8.7	16.5	13.9	16.7	16.8	16.7	18.6	17.6	17.8	17.0	17.6	17.3	16.0	17.5	18.4	9.9	6.4	10.5	8.1	10.2	2.9	4.4	7.0	8.6	10.2	8.1	9.8	7.6	8.6	12.1	9.2	12.5	11.2	16.2	9.7	9.8	8.2	7.8	9.9	10.0	10.7	9.6	6.3	9.6	10.1	7.0	9.7	11.2	9.9	15.2	10.2	13.2	6.0	17.0	5.0	9.9	10.1	6.1	14.8	8.9	3.0	17.1	12.6	7.2	7.5	11.6	9.2	5.2	6.6	14.4	7.2	6.8	15.4	11.5	3.6	9.2	11.0	10.5	15.5	13.1	6.2	10.2	11.3	7.3	6.5	4.8	14.1	12.2	9.4	9.5	3.8
VPS13D	"FLJ10619, KIAA0453"	ENSG00000048707	"Vacuolar protein sorting 13 homolog D"	Q5THJ4	1	12230030-12512047	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 181.4;Inhibitory neurons: 149.2;Late spermatids: 208.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027332, HPA051621"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"	Cytosol	"HPA027332: AB_2672223, HPA051621: AB_2681555"	"unprognostic (2.97e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"prognostic favorable (7.42e-12)"	"unprognostic (5.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.31e-2)"	10.9	6.9	14.3	4.4	17.2	5.0	10.3	14.5	17.9	13.7	18.1	12.2	3.8	8.1	8.7	12.6	8.9	5.3	21.9	15.8	14.5	10.5	10.4	8.8	6.4	14.6	16.5	8.9	10.9	13.4	7.7	5.3	14.3	17.4	6.4	14.1	10.8	9.3	18.1	24.7	8.7	6.0	13.4	9.3	11.1	6.1	17.8	6.6	15.5	15.3	6.2	9.6	10.6	16.6	9.3	5.2	5.8	4.4	15.1	11.9	2.7	4.4	7.7	7.4	7.0	3.5	6.4	8.7	5.4	12.6	6.2	8.3	10.1	8.7	10.3	4.7	3.4	7.4	8.1	2.8	6.3	10.8	3.7	10.1	11.9	9.5	9.3	9.2	12.0	8.2	15.5	4.3	6.9	4.3	6.4	4.2	2.3	5.0	6.5	5.5	6.9	2.6	5.3	5.4	2.8	3.8	12.9	9.4	9.0	5.4	8.1	3.6	13.1	4.6	4.7	12.0	3.7	3.8	3.3	13.4	5.2	7.5	7.1	3.2	0.7	0.5	1.1	0.7	1.2	0.9	1.2	0.8	0.6	1.6	1.1	0.9	0.9	0.7	0.5	1.5	0.6	0.3	14.3	17.2	14.5	17.9	15.8	14.5	14.6	16.5	14.3	13.4	17.8	16.6	28.9	19.2	23.4	111.0	19.8	21.7	45.1	23.2	19.9	38.1	18.8	12.8	68.0	14.3	35.7	18.4	73.0	8.4	20.3	24.7	3.9	9.1	83.1	20.6	23.5	23.0	14.4	9.4	181.4	14.4	7.2	19.4	28.1	48.1	12.6	26.3	17.9	21.2	11.5	47.1	149.2	15.1	18.3	17.3	15.5	208.7	23.0	17.5	12.4	79.6	16.7	23.0	17.5	78.4	107.4	17.0	11.2	21.8	11.8	32.0	18.2	9.8	32.0	34.1	46.0	23.4	46.5	18.8	12.3	38.2	31.4	14.8	21.4	20.3	15.5	37.3
VPS37A	"FLJ32642, HCRP1, PQBP2, SPG53"	ENSG00000155975	"VPS37A subunit of ESCRT-I"	Q8NEZ2	8	17246931-17302427	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024705, HPA024781"	Supported		Approved	Vesicles,Centrosome,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Centrosome, Cytosol"	"HPA024705: AB_10601776, HPA024781: AB_10602100"	"unprognostic (8.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.18e-1)"	18.9	19.4	11.9	14.8	15.1	15.4	18.5	28.7	17.5	21.1	5.0	16.8	20.9	19.4	14.3	20.2	13.7	16.8	36.2	10.1	13.6	25.0	27.8	16.2	14.2	11.2	12.5	18.4	17.5	33.8	12.4	29.7	12.1	20.2	17.2	55.0	12.5	23.2	39.4	14.7	17.5	24.4	10.0	12.3	14.5	32.3	12.2	17.5	18.9	31.2	15.2	25.1	15.0	18.4	17.2	27.3	24.0	21.7	51.8	41.5	25.8	60.8	50.2	53.9	45.9	17.6	16.2	14.6	31.6	48.7	50.1	16.7	27.2	26.4	63.8	15.1	7.8	26.5	13.7	20.2	59.7	11.3	25.1	39.7	50.2	50.4	51.5	38.0	38.7	22.7	20.2	36.8	57.7	11.7	32.0	26.9	23.4	38.2	14.2	15.4	26.5	17.6	45.8	23.4	27.1	14.4	23.8	23.9	37.9	47.1	15.6	22.2	33.4	33.1	16.7	47.6	32.0	12.0	25.0	17.2	37.5	19.9	33.8	34.0	17.2	16.5	13.9	13.1	17.1	10.5	13.4	13.6	13.4	10.8	12.0	14.8	17.6	24.5	12.4	11.8	13.3	14.1	11.9	15.1	28.7	17.5	10.1	13.6	11.2	12.5	12.1	10.0	12.2	18.4	31.8	16.0	15.6	19.6	21.2	39.5	32.7	33.1	18.8	26.4	19.3	13.5	40.7	14.3	25.8	7.3	58.4	36.1	20.5	15.8	37.2	29.3	93.2	20.9	29.0	24.6	18.0	26.1	32.4	15.5	59.2	27.0	15.8	28.4	9.5	16.8	24.3	23.1	44.6	21.9	30.7	16.6	30.5	17.5	22.7	39.6	25.7	25.3	21.4	20.6	22.4	25.8	15.5	24.1	34.0	31.2	13.1	25.9	21.5	50.6	27.8	48.8	18.8	60.2	26.3	21.5	36.6	111.6	43.4	22.5	37.8	113.0	22.7	17.1	14.6	52.6
VPS53	"FLJ10979, HCCS1"	ENSG00000141252	"VPS53 subunit of GARP complex"	Q5VIR6	17	508503-721717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 270.0;Late spermatids: 203.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022988, HPA024446"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Cytosol	"HPA022988: AB_1848679, HPA024446: AB_1848680"	"unprognostic (8.62e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.39e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.31e-1)"	4.3	4.7	7.0	3.0	5.9	20.5	4.6	21.4	10.3	5.2	2.8	4.5	3.7	4.4	3.4	9.0	4.0	3.6	4.3	8.2	3.3	4.0	4.5	5.1	4.9	3.0	3.9	5.3	4.5	6.4	6.0	4.6	4.2	4.6	5.9	8.1	4.7	5.0	7.0	7.1	4.0	6.1	0.9	4.5	5.0	14.6	4.0	4.9	7.6	5.1	5.2	4.1	4.8	9.4	12.9	26.5	7.6	8.3	12.4	9.5	5.5	6.4	9.4	15.8	15.4	12.6	5.8	7.8	5.9	19.9	10.0	10.9	16.5	13.9	23.1	6.7	11.4	5.0	17.2	8.1	6.1	6.6	9.2	11.1	7.8	14.7	9.8	6.4	11.7	9.7	9.1	9.1	14.9	8.9	4.3	5.1	6.2	5.6	6.9	10.5	3.9	5.2	8.0	10.4	7.6	6.1	12.4	4.3	5.4	7.5	6.5	3.5	7.9	6.8	5.4	12.5	7.0	4.3	3.3	4.8	11.5	5.2	8.6	8.1	1.9	4.4	2.4	2.3	1.8	2.1	2.2	1.7	1.1	3.0	2.3	1.9	6.1	1.9	5.6	3.0	1.9	0.9	7.0	5.9	21.4	10.3	8.2	3.3	3.0	3.9	4.2	0.9	4.0	9.4	16.0	12.8	25.9	54.5	19.3	25.5	16.5	11.6	19.9	53.3	19.6	9.3	17.4	14.3	21.5	40.5	70.9	10.5	19.9	24.9	1.9	16.7	270.0	23.9	22.2	18.7	24.6	5.0	109.3	18.3	7.9	18.5	26.5	28.1	24.1	18.2	15.7	17.7	21.4	63.9	103.6	27.4	4.1	20.6	19.4	203.9	18.6	21.0	10.6	39.4	27.5	18.3	37.0	48.2	62.5	25.3	15.5	23.0	20.6	18.7	21.0	10.6	24.3	52.2	6.6	31.1	20.7	46.0	35.3	24.6	38.8	8.9	26.8	17.2	22.0	19.6
VPS8	"FLJ32099, KIAA0804"	ENSG00000156931	"VPS8 subunit of CORVET complex"	Q8N3P4	3	184812143-185052614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 154.1;Granulosa cells: 124.3;Inhibitory neurons: 132.2;Oligodendrocytes: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036871	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA036871: AB_10672103"	"unprognostic (4.36e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.97e-2)"	10.9	9.6	18.7	10.0	22.1	23.2	10.6	24.2	24.0	12.7	29.1	11.4	8.3	12.3	16.3	10.1	9.0	11.1	19.6	20.4	23.6	10.6	8.5	10.7	10.5	25.1	21.4	14.3	8.9	15.8	16.3	12.1	26.3	10.9	14.7	16.4	7.9	10.1	28.6	12.9	9.3	12.9	17.1	13.3	13.0	16.9	26.1	11.6	14.9	15.3	10.7	10.4	10.3	36.4	18.0	10.7	15.9	15.9	32.5	28.8	10.6	17.7	18.8	12.3	17.0	13.6	9.0	19.1	29.3	26.9	50.4	20.8	17.3	21.0	23.6	34.8	15.4	20.4	13.0	8.1	20.0	14.3	27.0	20.6	19.4	17.6	17.5	22.6	31.4	17.7	10.9	13.5	22.7	12.8	11.6	8.5	10.5	18.4	10.1	14.1	30.6	15.0	12.2	30.8	16.2	10.6	19.9	20.8	15.6	23.6	33.2	7.5	27.9	18.8	10.5	19.6	15.3	16.5	21.5	25.9	21.6	17.7	15.5	19.0	6.6	22.9	5.0	5.2	4.9	4.4	5.4	5.2	8.1	5.5	8.0	5.4	23.9	5.7	6.6	2.3	4.8	4.3	18.7	22.1	24.2	24.0	20.4	23.6	25.1	21.4	26.3	17.1	26.1	36.4	11.8	12.8	11.5	66.3	17.9	10.5	9.2	8.3	11.4	24.5	8.7	8.3	24.6	11.5	9.7	9.2	18.8	12.8	10.8	17.3	7.9	7.7	22.2	11.0	17.5	12.8	18.0	11.6	154.1	4.6	6.7	14.7	21.9	14.3	2.5	124.3	12.5	7.7	20.2	11.8	132.2	16.6	12.2	19.1	16.7	16.5	10.5	21.2	10.6	89.9	32.0	10.1	32.0	86.5	149.2	6.4	12.7	12.8	14.4	9.4	9.2	8.8	14.4	17.3	6.6	13.0	10.0	94.3	27.8	15.8	16.1	7.7	17.8	11.8	13.2	13.0
VPS9D1	"ATP-BL, C16orf7"	ENSG00000075399	"VPS9 domain containing 1"	Q9Y2B5	16	89707134-89720898	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.2;Inhibitory neurons: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"neutrophil: 18.0"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 18.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007847, HPA023620"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA007847: AB_1845582, HPA023620: AB_1845583"	"unprognostic (7.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.63e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.91e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-3)"	12.9	26.9	23.8	16.2	26.3	13.2	10.5	15.8	39.2	13.2	16.5	14.6	13.5	11.0	4.4	33.3	12.0	7.4	15.8	25.4	19.3	23.1	30.4	16.1	9.3	25.4	19.5	10.8	12.6	12.5	31.6	5.4	25.7	15.3	3.8	5.7	15.3	6.1	11.6	12.7	17.2	4.9	15.4	29.1	12.8	18.8	21.3	3.5	17.3	5.5	5.1	11.2	15.9	23.6	6.2	9.3	10.2	10.8	10.2	9.9	8.5	11.3	11.7	9.6	4.7	8.0	13.6	6.3	7.1	12.6	5.4	14.1	0.9	6.4	2.7	5.7	15.0	4.5	8.7	10.0	7.7	2.6	10.5	10.9	5.8	11.6	2.7	15.5	6.7	5.8	11.5	3.8	6.5	28.1	4.8	10.0	3.8	4.9	10.4	11.8	8.5	3.8	7.7	9.8	8.4	8.8	14.5	5.3	11.6	3.1	24.0	11.0	10.5	12.4	15.5	10.2	6.9	17.4	5.9	5.4	18.0	6.8	10.6	2.2	0.6	0.3	0.3	0.5	0.1	0.2	0.1	0.1	0.3	0.4	0.4	0.2	18.0	0.2	0.3	0.0	0.2	0.2	23.8	26.3	15.8	39.2	25.4	19.3	25.4	19.5	25.7	15.4	21.3	23.6	3.5	6.4	5.1	30.0	3.6	2.0	2.0	5.4	5.7	13.3	6.5	5.5	8.8	2.8	6.4	9.2	10.4	3.0	6.1	11.6	7.9	4.9	13.5	5.8	6.8	3.1	10.8	1.7	43.2	7.8	2.3	5.3	8.2	9.3	4.5	8.7	9.7	9.6	4.8	8.4	41.9	3.9	2.0	8.5	8.3	21.7	6.2	12.6	3.6	4.7	3.7	6.6	3.1	16.1	17.5	6.2	5.1	6.0	3.9	1.8	13.5	6.1	4.6	12.8	0.0	5.2	5.8	12.3	4.7	7.5	3.8	3.0	4.5	8.6	7.2	2.8
VSIG1	"GPA34, MGC44287"	ENSG00000101842	"V-set and immunoglobulin domain containing 1"	Q86XK7	X	108044970-108079184	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"stomach 1: 193.6"	"Cell type enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 333.8"	"Group enriched"	"Detected in many"	17	"lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 12.0;T-reg: 12.9"	"Lineage enriched"	"Detected in many"	4	"T-cells: 12.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.5;HUVEC TERT2: 7.4;PC-3: 2.3;TIME: 1.7"	"Not detected"	"Not detected"							"HPA001445, HPA036310, HPA036311"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 4: Stomach - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Vesicles, Cytosol"		"HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350"	"unprognostic (4.33e-3)"	"unprognostic (4.60e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-3)"	0.0	0.1	0.1	1.3	0.3	0.5	0.1	0.2	0.3	0.0	0.2	0.2	1.2	0.1	0.3	0.2	0.0	8.4	0.0	0.2	0.2	0.1	0.1	1.0	1.9	0.1	0.1	0.0	0.2	0.0	2.6	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.5	0.0	0.0	0.8	193.6	47.7	0.1	0.8	0.1	0.0	1.6	8.9	0.1	0.1	0.1	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.0	1.1	0.0	7.4	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.2	0.6	2.3	0.2	0.0	0.0	0.3	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.7	0.1	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	1.0	0.0	3.8	2.8	8.1	3.6	0.0	1.3	12.0	5.8	0.3	0.1	0.1	0.1	12.9	2.6	0.1	0.3	0.2	0.3	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	25.6	11.0	1.0	2.4	0.6	0.9	0.7	0.0	0.9	0.2	0.1	0.5	1.5	0.7	0.0	0.0	0.0	0.1	0.4	0.0	2.9	6.1	1.1	0.1	1.0	0.0	0.0	4.1	4.6	0.0	0.6	333.8	0.2	2.5	0.0	0.0	0.0	0.1	0.0	1.4	0.3	0.0	0.0	0.4	10.8	0.6	0.7	0.0	0.0	0.3	0.1	1.0	0.0	0.1	32.9	0.0	0.0	1.0	0.6	0.0	0.0	0.9	0.8	0.0	1.1	0.2	1.0	0.6	0.0	0.0	0.1	4.5	0.2	0.1	3.8
VSIG10		ENSG00000176834	"V-set and immunoglobulin domain containing 10"	Q8N0Z9	12	118063593-118136026	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 69.3;Proximal enterocytes: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062022	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Centriolar satellite"	"HPA062022: AB_2732675"	"unprognostic (1.32e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-2)"	6.1	11.3	4.5	2.3	5.5	0.8	6.0	5.4	4.6	6.8	4.8	13.3	13.9	4.3	3.1	8.7	4.7	3.8	3.8	3.9	4.5	6.2	5.7	8.4	1.5	6.0	4.9	6.4	7.1	8.1	4.4	8.6	4.9	5.9	15.8	1.9	7.0	5.2	17.0	5.6	24.5	3.2	5.4	3.9	6.5	2.6	5.3	0.9	12.1	10.8	2.1	5.9	6.9	4.8	7.9	11.4	4.8	16.1	19.4	8.8	12.4	13.3	8.5	6.4	5.3	3.3	18.2	1.1	5.3	9.8	12.0	18.9	33.8	3.4	7.6	4.0	5.1	1.8	11.0	5.0	3.9	1.1	2.7	4.0	9.8	4.9	3.1	18.6	14.2	3.8	2.3	0.1	6.1	8.3	0.0	1.1	14.9	22.8	7.5	2.8	13.2	0.0	9.4	25.1	4.1	5.3	13.0	5.4	3.4	10.2	11.9	5.3	16.8	7.4	4.7	9.2	6.8	0.1	0.1	0.1	10.7	5.5	15.0	0.2	0.5	0.6	0.1	0.1	0.1	0.0	0.1	0.0	0.6	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.1	4.5	5.5	5.4	4.6	3.9	4.5	6.0	4.9	4.9	5.4	5.3	4.8	23.6	19.2	28.6	14.0	3.3	2.4	13.0	1.8	6.8	9.9	15.1	11.7	11.4	31.5	5.0	29.5	12.5	38.0	2.2	69.3	19.6	26.2	6.1	10.3	13.0	19.1	50.4	9.9	4.7	20.3	41.0	11.9	16.8	13.6	2.5	33.3	21.0	27.5	11.2	5.0	5.1	40.4	2.0	6.7	9.4	9.9	18.0	5.6	3.6	3.7	7.4	18.9	2.1	9.0	3.1	26.7	45.3	14.7	3.1	10.4	106.6	13.7	2.7	7.9	0.0	12.9	8.6	4.0	6.1	12.4	3.1	14.0	4.0	24.7	48.2	15.3
VSNL1	"HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1"	ENSG00000163032	"Visinin like 1"	P62760	2	17539126-17657018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 663.3"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 442.7;Inhibitory neurons: 243.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 663.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 125.9;Hep G2: 124.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053808			Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA053808: AB_2682270"	"unprognostic (1.04e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (4.90e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.14e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.51e-2)"	0.8	27.5	100.4	1.4	143.0	0.1	6.2	12.9	663.3	13.5	0.0	4.6	0.2	1.1	0.0	47.9	2.0	0.2	39.7	105.8	12.3	1.9	20.8	2.9	0.1	21.6	0.0	3.6	1.2	0.2	2.7	5.4	19.7	3.9	5.4	18.6	9.7	0.8	1.3	13.8	0.3	1.1	0.0	0.3	1.4	0.8	4.3	1.1	0.8	2.9	7.3	1.5	26.3	188.8	0.7	0.1	1.4	21.2	2.4	3.0	0.1	0.0	0.0	0.0	0.6	0.3	13.6	0.0	0.0	0.0	0.0	125.9	0.8	4.0	0.0	0.0	0.5	0.0	0.1	124.4	0.0	0.0	0.3	0.9	6.0	0.0	2.9	0.1	0.0	0.0	0.1	0.6	1.6	0.0	0.0	0.1	21.0	6.7	0.0	0.1	0.1	0.0	0.0	0.4	9.3	8.5	0.0	0.0	0.0	4.9	0.0	0.1	0.0	4.2	0.0	0.0	2.4	0.1	0.0	0.0	3.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.4	143.0	12.9	663.3	105.8	12.3	21.6	0.0	19.7	0.0	4.3	188.8	0.1	0.0	0.5	41.1	0.0	18.2	29.8	54.3	59.2	8.8	4.9	19.7	30.8	4.3	18.0	0.0	0.0	0.3	0.1	2.2	1.9	0.1	5.1	0.0	0.1	1.1	1.2	0.0	442.7	0.2	0.2	5.9	0.0	0.1	0.0	0.1	0.0	17.8	0.6	3.3	243.2	7.1	18.3	0.3	0.8	6.5	0.6	0.5	3.6	54.4	0.6	3.7	0.0	36.7	42.9	0.2	1.0	0.0	0.0	15.0	0.0	4.0	0.8	14.7	0.0	0.2	1.3	1.7	0.9	85.5	20.2	0.4	0.8	1.8	5.6	14.2
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;choroid plexus: 19.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 10.9;Inhibitory neurons: 1.8;Late spermatids: 9.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"SCLC-21H: 1.2"	"Low region specificity"	"Detected in many"							"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	0.4	0.8	0.1	0.9	0.0	0.0	0.1	0.1	0.0	19.1	0.0	0.0	0.0	1.3	0.0	0.3	0.2	0.0	1.1	2.9	1.3	0.0	0.1	0.1	3.7	6.3	0.0	0.0	1.1	2.9	0.1	5.1	0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.2	3.0	0.0	0.2	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.1	0.1	1.1	2.9	3.7	6.3	5.1	1.5	3.0	0.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777328	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 21.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 4.2;Gastric mucus-secreting cells: 8.2;Proximal enterocytes: 5.0;Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 2.9;hypothalamus: 8.2;medulla oblongata: 5.9;pons: 5.5;thalamus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;HMC-1: 1.3;Karpas-707: 1.1;U-266/84: 1.6"	"Group enriched"	"Detected in some"	5	"cerebellum: 7.0;pons and medulla: 3.9"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		9200	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	0.4	0.3	0.5	0.1	0.3	0.0	0.7	0.1	2.9	0.8	0.0	1.3	1.0	4.6	0.0	0.4	7.2	0.7	5.2	0.8	8.2	5.7	1.4	1.4	0.1	5.9	1.0	0.5	2.6	1.7	21.3	0.0	5.5	0.8	0.4	0.2	1.4	1.3	6.6	0.8	2.3	0.0	0.0	0.5	3.0	0.7	7.5	0.0	1.8	0.0	0.1	0.6	0.7	1.0	0.8	1.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.1	0.0	0.9	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.1	2.9	0.8	8.2	5.9	1.0	5.5	0.0	7.5	1.0	0.0	0.0	1.1	0.0	0.6	0.1	0.4	0.5	1.2	0.5	0.1	0.3	0.8	0.0	0.3	1.8	0.0	0.0	0.2	1.4	1.9	0.6	0.0	1.5	0.1	0.1	4.2	0.0	1.5	0.5	0.0	0.1	8.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	0.4	0.3	5.0	2.4	1.6	0.8	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.5	0.4
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.3;salivary gland: 3.3;thyroid gland: 3.1"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.8;Excitatory neurons: 11.8;Granulosa cells: 5.4;Inhibitory neurons: 11.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 5.0;K-562: 13.0;NTERA-2: 4.8;SCLC-21H: 7.0"					"Low region specificity"	"Detected in many"			"HPA026619, HPA036044, HPA036045"	Uncertain		Approved	Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA026619: AB_2671920, HPA036044: AB_2674916, HPA036045: "	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.0	0.3	0.5	0.1	0.8	2.3	1.6	0.0	0.5	0.1	0.0	0.3	0.1	0.4	4.3	0.1	1.1	0.4	2.0	0.4	0.3	0.2	0.1	0.2	0.1	0.4	0.4	0.0	0.0	0.3	0.4	0.1	0.3	1.1	0.1	0.0	3.3	1.6	0.0	0.4	0.1	0.1	0.5	0.1	0.7	0.2	0.3	0.1	3.1	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.0	1.2	0.0	0.2	2.4	0.0	1.5	0.5	0.7	0.3	2.4	0.1	0.0	0.0	0.9	0.7	1.7	1.6	1.1	2.7	2.4	3.4	5.0	0.0	0.0	1.9	1.5	0.1	0.2	0.0	1.1	2.4	1.0	1.3	13.0	0.0	0.0	1.6	0.0	0.0	4.8	0.0	0.8	0.0	0.0	1.1	0.4	1.2	7.0	1.5	0.0	1.4	0.0	1.7	0.0	0.8	0.1	0.0	0.9	0.0	1.5	2.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.8	0.0	0.5	0.4	0.3	0.4	0.4	0.3	0.5	0.3	0.1	0.1	0.0	1.5	0.3	0.0	0.3	2.1	0.9	2.8	0.0	1.6	1.0	8.8	0.0	1.2	0.0	0.0	0.3	0.0	0.2	0.0	0.1	1.2	0.7	0.2	0.2	0.0	3.0	11.8	0.0	0.5	1.1	0.0	1.8	0.0	5.4	0.0	0.0	0.1	0.0	11.6	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	1.2	0.0	0.0	2.9	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.4	0.4	0.7	0.1	0.1	0.7	0.4	0.5	1.8
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"WASP actin nucleation promoting factor"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.4;lymphoid tissue: 83.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 83.2;dendritic cells: 91.7;Hofbauer cells: 111.5;Kupffer cells: 110.7;Macrophages: 118.1;monocytes: 88.2;NK-cells: 84.5;Plasma cells: 57.8;T-cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 37.4"	"Group enriched"	"Detected in all"	4	"granulocytes: 37.4;monocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.5;HEL: 67.6;HMC-1: 157.0;MOLT-4: 70.8;NB-4: 75.7;RPMI-8226: 94.0;THP-1: 68.8;U-266/70: 83.1;U-937: 87.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	10.2	5.2	6.3	52.2	5.8	58.4	4.4	5.9	8.1	3.3	6.3	6.4	8.0	2.8	3.0	3.5	5.6	6.9	3.5	6.0	8.0	4.4	7.2	19.1	54.2	11.1	8.2	1.8	2.4	1.4	2.9	9.0	8.6	4.2	5.0	0.4	4.9	2.8	1.4	2.8	23.0	6.1	8.0	83.0	7.0	1.9	8.6	42.0	3.5	3.4	36.2	10.3	3.0	10.8	0.8	0.2	0.4	1.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.6	0.9	76.5	0.3	0.0	0.3	2.0	0.3	0.2	0.0	44.2	0.4	67.6	0.9	0.0	0.8	34.9	157.0	0.3	0.1	0.1	0.0	0.0	0.0	40.3	0.7	45.7	0.0	7.6	70.8	75.7	0.4	1.1	0.4	61.1	0.3	94.0	0.1	0.0	0.5	0.9	1.0	0.7	0.5	0.2	0.4	68.8	0.5	0.1	0.4	1.2	0.1	83.1	43.6	53.7	0.5	87.4	0.2	3.3	7.6	37.4	4.6	8.4	3.4	3.0	3.5	3.9	5.7	3.3	3.1	3.5	29.2	3.6	9.5	3.1	5.4	4.0	6.3	5.8	5.9	8.1	6.0	8.0	11.1	8.2	8.6	8.0	8.6	10.8	1.5	3.2	14.3	0.7	83.2	2.4	0.2	0.2	2.2	0.2	1.1	1.8	1.1	0.0	0.1	0.0	0.0	0.9	91.7	0.3	1.9	0.4	0.6	0.4	0.4	2.6	1.2	14.1	0.3	0.4	1.1	1.5	5.6	0.3	48.1	0.2	3.9	1.6	111.5	0.0	0.3	0.2	0.0	110.7	54.5	1.1	0.0	118.1	3.6	4.7	88.2	0.2	84.5	0.5	0.0	0.1	0.1	0.0	57.8	0.2	0.1	1.8	1.6	0.2	0.0	1.0	1.3	1.3	1.1	0.8	1.4	1.4	99.3	0.4	0.1	0.2
WASF2	"SCAR2, WAVE2"	ENSG00000158195	"WASP family member 2"	Q9Y6W5	1	27404230-27490167	"Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022632, HPA045288"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		84000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"	Cytosol	"CAB022632: , HPA045288: AB_2679287"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (5.29e-8)"	"unprognostic (3.94e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.26e-2)"	55.2	34.1	37.9	44.1	48.1	59.8	45.8	42.3	36.3	41.3	29.5	49.4	27.5	53.8	21.6	89.8	46.3	31.1	32.9	33.4	39.5	28.4	14.9	45.7	48.1	58.9	49.0	63.5	35.2	31.0	17.0	52.3	53.6	33.1	39.3	9.1	38.3	41.9	18.4	56.7	42.3	51.9	48.2	47.6	40.3	36.8	48.4	54.6	35.5	27.8	52.3	47.8	39.9	50.6	75.4	35.3	80.3	73.4	57.1	74.3	46.5	59.9	55.5	64.7	57.9	30.8	79.2	52.1	56.6	94.4	44.1	58.8	65.5	98.4	77.1	73.3	41.1	113.5	60.5	36.7	76.9	91.9	62.8	68.5	105.1	70.7	130.8	70.0	82.3	56.8	92.3	26.3	89.0	27.1	68.7	42.1	64.9	38.3	53.7	141.8	98.5	53.3	46.3	42.0	39.9	43.8	104.6	46.3	78.3	48.6	38.7	55.1	109.1	53.4	54.8	112.1	47.8	53.6	76.0	67.7	63.0	111.2	61.3	50.0	65.4	54.7	33.3	79.8	27.2	37.8	26.3	23.5	41.7	46.6	26.9	21.2	100.7	24.4	112.7	60.5	28.8	58.6	37.9	48.1	42.3	36.3	33.4	39.5	58.9	49.0	53.6	48.2	48.4	50.6	243.0	67.3	57.5	58.1	112.7	148.1	221.8	245.9	104.2	24.4	143.0	201.9	39.6	75.8	144.1	90.1	14.6	219.2	145.1	147.0	62.6	111.0	51.4	86.6	167.7	194.8	108.5	195.1	19.1	101.7	118.9	157.9	85.1	174.2	58.9	77.7	163.5	48.4	151.2	20.2	12.8	101.9	93.6	250.4	129.2	75.9	165.0	162.7	76.5	93.7	207.6	61.2	142.2	29.1	67.1	164.9	131.8	182.4	74.2	281.7	139.1	50.7	104.4	19.2	138.1	206.1	180.6	120.7	118.1	216.3	194.5	143.5	104.5	79.3	120.3	372.5
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"WASP like actin nucleation promoting factor"	O00401	7	123681943-123749003	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 282.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 138.3;U-2197: 128.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favorable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	20.4	24.7	19.2	12.8	22.2	5.6	21.7	13.5	42.4	29.1	13.6	42.4	37.2	27.1	18.3	29.5	18.7	28.4	18.2	43.0	20.4	44.1	46.8	19.9	7.8	18.0	19.1	35.1	29.5	40.0	13.0	34.6	17.4	25.3	37.9	24.9	22.3	24.0	24.7	18.0	41.5	23.6	13.5	17.0	30.1	22.5	20.9	10.3	35.2	28.7	11.0	38.7	22.5	18.4	34.4	24.8	26.7	23.0	41.2	42.4	34.7	23.3	38.7	16.9	21.7	20.5	42.2	3.5	18.1	35.3	36.0	25.1	50.1	25.7	25.9	6.0	19.9	3.0	19.6	22.2	44.7	4.6	2.9	34.2	47.0	25.0	42.2	37.9	29.5	3.6	15.5	6.6	40.6	20.7	6.0	6.1	50.1	36.5	22.4	3.6	21.6	7.7	35.6	138.3	32.9	48.1	32.1	95.0	63.0	41.4	18.6	4.5	33.8	44.9	12.6	128.1	23.2	7.2	2.7	7.5	38.8	3.8	36.7	2.4	1.7	0.8	1.7	1.7	1.4	2.0	1.1	1.0	1.5	1.3	1.4	1.5	0.7	2.5	3.0	1.9	0.6	0.6	19.2	22.2	13.5	42.4	43.0	20.4	18.0	19.1	17.4	13.5	20.9	18.4	71.2	86.6	61.1	36.9	11.5	60.4	48.9	44.4	46.1	32.9	67.6	57.1	69.8	52.9	53.7	53.3	20.9	41.6	12.6	200.2	52.8	52.6	26.2	58.0	53.1	43.9	67.9	5.9	55.9	54.1	52.4	62.6	50.0	68.8	3.8	35.0	56.4	61.9	12.7	26.9	51.2	105.1	40.7	13.8	25.1	9.3	48.1	15.6	30.2	34.7	14.0	60.9	6.2	42.7	48.7	70.6	113.4	64.7	14.0	104.4	108.0	96.0	49.5	32.4	19.7	54.1	75.3	17.2	21.3	54.9	68.3	81.3	13.1	76.0	74.8	282.3
WBP1	WBP-1	ENSG00000239779	"WW domain binding protein 1"	Q96G27	2	74458400-74460891	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 29.0;Gastric mucus-secreting cells: 33.1;Plasma cells: 57.2;Squamous epithelial cells: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057067	Approved		Approved	Cytosol		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA057067: AB_2683326"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (6.05e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (6.83e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (6.36e-4)"	36.9	70.7	141.7	19.6	145.8	31.9	37.7	139.4	171.9	48.2	133.1	46.6	29.1	39.1	44.8	35.7	56.1	36.5	49.9	137.7	136.6	71.2	80.3	33.7	32.2	144.2	141.3	55.6	62.3	73.7	60.8	24.9	138.2	69.9	17.7	24.4	56.4	37.3	31.4	34.9	33.2	19.8	138.1	42.5	58.0	31.8	145.0	44.7	66.9	53.9	20.6	45.7	37.5	139.0	20.6	91.3	56.2	66.7	69.9	54.0	45.7	20.6	40.3	22.4	17.5	47.3	41.9	19.4	39.3	48.9	33.2	28.3	24.8	55.8	19.0	74.3	49.1	27.4	41.4	68.9	47.6	10.3	27.4	76.2	58.9	30.4	42.2	93.8	44.7	51.6	11.5	72.0	54.8	133.8	40.1	25.5	43.3	53.6	46.3	36.4	63.5	33.6	55.9	83.1	35.0	81.3	28.2	49.9	62.5	49.4	65.5	26.9	26.5	53.0	41.9	20.0	23.5	106.7	38.8	22.2	56.2	27.0	48.5	24.1	28.5	19.2	26.5	23.5	22.5	28.4	23.0	25.5	30.2	27.8	31.3	28.0	18.6	34.6	20.1	47.0	39.2	27.1	141.7	145.8	139.4	171.9	137.7	136.6	144.2	141.3	138.2	138.1	145.0	139.0	1.5	3.2	4.2	0.0	14.3	0.9	0.6	2.0	29.0	1.6	3.2	2.2	0.5	0.0	4.2	1.8	2.1	1.4	1.7	3.3	1.9	5.5	2.4	3.1	2.4	3.6	1.8	9.7	0.0	3.9	1.4	7.2	33.1	1.8	1.3	1.1	0.4	0.8	1.7	0.0	0.0	4.7	2.0	2.4	1.0	1.8	2.1	7.1	0.0	0.0	6.0	1.7	2.1	0.0	0.0	5.2	3.1	1.2	57.2	1.2	5.6	3.3	13.1	1.7	0.0	0.5	5.8	0.6	0.2	28.1	1.3	1.8	10.4	0.9	3.7	0.3
WBP2NL	"FLJ26145, GRAMD7, MGC26816, PAWP"	ENSG00000183066	"WBP2 N-terminal like"	Q6ICG8	22	41998725-42058456	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 17.8"	"Group enriched"	"Detected in many"	10	"Early spermatids: 254.5;Late spermatids: 807.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA048557	Enhanced		Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA048557: AB_2680440"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-4)"	"unprognostic (2.77e-3)"	"unprognostic (6.12e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (9.84e-4)"	"unprognostic (3.31e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.36e-5)"	0.2	0.1	0.6	0.0	0.6	0.0	0.7	0.6	0.9	0.2	0.0	0.2	0.1	0.2	1.2	0.1	0.5	0.2	0.0	0.6	0.6	0.3	0.1	0.3	0.2	1.0	0.7	0.6	0.7	0.4	0.3	0.1	1.0	0.3	0.1	0.7	0.5	0.3	0.1	0.4	0.2	0.1	0.8	0.2	0.3	17.8	0.5	0.1	0.6	0.1	0.1	0.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.6	0.9	0.6	0.6	1.0	0.7	1.0	0.8	0.5	1.4	0.3	0.0	2.8	50.6	4.3	0.4	2.1	1.0	2.8	16.4	1.8	2.4	0.7	2.8	3.7	0.0	20.9	2.2	0.6	1.7	3.9	0.9	254.5	0.9	1.5	1.3	4.8	0.4	16.0	1.3	1.0	0.9	1.5	1.3	0.0	4.7	2.2	1.5	1.4	10.1	18.6	2.2	4.1	2.8	1.9	807.7	6.5	2.3	1.8	9.4	1.8	2.9	3.1	9.5	16.6	0.9	3.9	5.7	1.5	1.2	3.4	2.0	0.8	23.0	0.0	0.6	0.7	30.6	20.2	1.2	0.9	1.9	1.9	1.6	2.7	1.4
WDCP	"C2orf44, FLJ21945, MMAP"	ENSG00000163026	"WD repeat and coiled coil containing"	Q9H6R7	2	24029347-24049575	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 9.2;Distal tubular cells: 7.9;Granulosa cells: 4.3;Theca cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041054	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli	Cytosol	"HPA041054: AB_10796566"	"unprognostic (1.07e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (5.14e-8)"	"unprognostic (7.69e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.00e-1)"	2.6	3.7	3.9	3.8	4.1	1.4	4.4	4.7	4.0	3.5	4.6	4.2	2.5	4.2	3.7	3.2	3.2	2.7	3.4	3.8	4.0	3.5	4.1	2.6	6.6	3.9	4.1	5.4	2.6	5.0	2.3	4.2	4.0	3.6	2.9	6.3	2.9	4.5	6.1	2.9	3.3	3.5	3.9	4.2	3.0	4.9	4.3	7.7	3.1	8.7	7.0	3.6	2.7	4.6	12.3	18.8	20.1	14.0	13.6	10.7	7.2	14.6	7.8	15.1	14.1	17.2	5.6	32.0	6.2	7.5	12.6	8.8	28.7	10.0	15.6	19.4	16.4	19.7	8.5	17.8	9.3	18.0	13.0	6.5	7.6	15.6	7.7	7.8	14.3	18.4	27.5	8.7	15.9	5.6	23.8	10.8	24.3	12.2	14.3	25.7	33.8	12.9	7.1	6.1	15.4	21.3	7.2	7.0	9.1	14.0	5.4	7.9	13.9	12.0	13.1	7.2	13.6	14.4	19.2	45.2	7.7	19.0	9.5	0.0	1.8	1.1	5.2	2.7	5.3	3.3	3.3	3.8	3.1	2.9	4.6	5.0	0.4	3.9	2.0	1.1	5.4	3.3	3.9	4.1	4.7	4.0	3.8	4.0	3.9	4.1	4.0	3.9	4.3	4.6	3.1	3.2	3.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.7	2.7	0.0	0.0	0.6	9.2	0.0	2.9	1.8	0.0	7.9	2.3	0.0	1.5	3.2	1.6	0.0	0.0	0.0	2.0	2.5	1.4	0.0	1.0	0.0	4.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	1.4	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.1	1.0	4.5	0.0	0.0
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 28.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 44.7;dendritic cells: 29.9;Early spermatids: 47.2;Langerhans cells: 30.6;Macrophages: 24.6;Microglial cells: 81.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 14.3;myeloid DC: 11.3;naive B-cell: 21.2;neutrophil: 10.2;plasmacytoid DC: 32.5"	"Group enriched"	"Detected in many"	7	"B-cells: 21.2;dendritic cells: 32.5;granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 61.0;HDLM-2: 56.3;HL-60: 21.5;THP-1: 18.9;U-698: 25.6;U-937: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	1.9	0.7	3.2	12.1	3.4	11.7	1.4	4.2	4.8	1.1	3.2	1.9	1.5	0.8	1.9	1.4	0.7	3.2	0.6	3.2	4.2	0.8	1.3	5.2	28.5	6.0	4.9	0.6	1.0	0.4	0.3	1.2	6.2	0.8	1.9	0.1	1.3	0.6	0.7	2.6	7.4	1.7	5.9	17.3	2.3	3.7	6.3	12.3	0.6	0.4	23.9	3.1	0.3	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	56.3	0.0	6.5	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	25.0	0.0	0.0	3.0	0.0	0.0	2.8	0.0	14.3	0.0	0.1	11.3	21.2	0.0	0.0	10.2	0.0	1.3	32.5	0.0	1.1	3.2	3.4	4.2	4.8	3.2	4.2	6.0	4.9	6.2	5.9	6.3	9.3	0.2	0.0	1.1	2.0	44.7	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.3	0.0	0.6	1.8	0.0	0.1	29.9	0.0	1.9	0.0	47.2	0.0	0.1	0.3	0.0	0.4	0.7	0.0	0.2	1.1	0.0	0.0	5.7	0.0	0.0	0.0	13.0	0.0	0.4	0.1	0.0	12.9	30.6	17.7	0.3	24.6	1.8	81.5	16.4	0.0	0.0	1.0	0.5	0.0	0.0	0.4	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	2.9	0.5	0.2	0.3	0.3	1.5	0.0	0.3	0.1
WDR11	"BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15"	ENSG00000120008	"WD repeat domain 11"	Q9BZH6	10	120851305-120909524	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038980	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Microtubules, Cytosol"		"HPA038980: AB_10675955"	"unprognostic (8.98e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.84e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.80e-3)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.38e-2)"	15.2	12.3	5.9	16.9	5.7	6.6	15.3	6.7	5.1	15.4	10.8	15.2	14.2	15.3	10.8	14.8	17.7	15.0	7.8	6.0	7.1	24.4	20.2	15.2	18.6	10.1	6.5	16.0	13.6	38.6	5.3	16.8	10.9	15.6	16.6	15.1	14.4	14.2	3.5	9.7	14.9	16.9	10.3	18.5	16.1	11.5	6.6	17.9	22.5	6.5	20.2	15.7	8.6	14.7	28.5	25.1	24.8	43.4	35.4	42.2	18.0	26.0	52.4	28.3	34.9	14.7	29.1	19.9	13.1	37.5	22.5	26.5	29.1	35.8	35.4	26.5	24.2	20.8	19.9	15.3	33.6	29.6	23.6	36.7	28.5	26.2	42.2	51.7	53.1	14.0	16.9	23.3	30.1	12.1	18.7	12.9	12.8	24.8	16.1	7.7	43.3	17.4	33.7	21.8	12.2	21.8	22.6	24.9	68.8	43.3	18.4	18.7	40.0	18.6	11.6	2.8	25.1	12.9	8.6	24.3	26.4	24.8	9.9	27.4	8.5	3.8	4.5	11.2	3.6	8.5	3.0	4.1	9.7	4.6	3.1	3.3	0.6	5.9	25.3	2.3	4.3	5.2	5.9	5.7	6.7	5.1	6.0	7.1	10.1	6.5	10.9	10.3	6.6	14.7	23.7	6.4	16.4	77.7	42.3	12.0	13.5	15.5	10.8	42.8	16.6	13.6	8.3	27.1	20.1	25.8	98.0	19.3	30.5	24.3	11.7	18.3	3.8	31.7	33.1	24.4	27.1	16.6	57.0	10.5	12.1	21.8	29.6	32.7	9.5	34.2	33.9	33.9	32.2	25.2	54.2	24.5	12.2	43.2	16.5	4.4	43.5	34.9	3.6	30.9	42.4	21.0	20.6	112.1	84.7	25.3	23.4	38.7	25.6	17.9	34.8	19.9	30.1	85.3	19.7	28.9	17.9	25.8	16.3	15.6	14.2	15.2	18.9	41.7	20.6	19.3
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874261-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	2.6	3.6	2.1	2.7	2.3	3.6	3.6	2.3	3.2	2.5	1.4	3.0	4.1	3.2	3.2	3.2	3.1	2.3	4.0	2.2	2.9	5.2	4.2	1.7	3.3	2.5	2.1	3.2	2.2	3.5	1.9	2.7	2.7	2.2	4.0	2.6	1.9	2.3	4.8	3.6	2.9	3.4	1.5	2.1	2.3	3.5	2.8	3.2	3.2	6.0	3.7	4.1	2.3	2.5	5.3	5.8	6.4	12.5	12.3	10.4	11.4	7.6	6.6	10.1	9.8	14.8	7.5	10.2	7.2	6.6	8.5	6.6	18.2	13.3	16.0	4.6	11.1	17.0	9.0	17.7	8.0	22.1	9.9	9.5	9.4	12.0	23.6	6.4	10.8	10.2	26.7	5.9	11.3	6.5	14.8	13.3	14.9	7.3	14.3	11.1	9.7	16.1	11.2	6.5	11.4	9.8	6.5	8.2	9.8	11.0	4.7	14.1	8.3	8.3	6.9	7.4	8.4	8.0	12.8	16.3	8.7	15.3	8.8	1.3	1.6	0.6	1.4	1.7	2.0	1.9	1.3	1.4	2.1	1.9	1.7	1.7	0.6	1.3	1.7	2.4	1.6	1.1	2.1	2.3	2.3	3.2	2.2	2.9	2.5	2.1	2.7	1.5	2.8	2.5	10.1	9.6	16.9	12.1	13.6	20.5	21.4	24.4	13.1	10.2	8.4	9.1	27.9	7.2	19.1	5.5	2.1	25.3	7.9	7.8	15.6	18.0	14.3	14.7	25.3	12.6	5.4	22.1	19.2	10.6	34.9	16.5	9.7	13.3	15.2	15.8	8.2	15.0	18.0	15.2	20.3	10.6	24.4	7.2	6.0	8.9	17.1	9.2	1.8	12.2	13.7	6.4	5.2	10.6	9.9	14.2	6.6	15.4	9.3	17.3	13.9	38.1	15.7	8.3	13.1	20.1	41.9	43.0	32.3	18.2	17.3	21.5	10.7	21.0	19.2	17.0
WDR19	"DYF-2, FAP66, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182504-39285810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 61.8;Inhibitory neurons: 82.5;Respiratory ciliated cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.3;ASC TERT1: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	7.5	8.0	3.1	5.3	2.5	3.7	9.2	5.3	3.8	10.5	10.8	6.8	1.9	16.0	13.3	3.9	20.3	8.4	4.2	2.3	2.5	8.8	6.3	8.8	4.7	5.3	3.6	17.9	5.4	8.1	9.1	6.2	2.9	7.7	4.2	13.0	5.7	8.4	2.3	5.5	4.7	9.1	3.5	4.6	6.2	14.0	2.7	6.9	16.7	2.4	4.9	6.2	6.8	3.6	6.1	5.2	10.3	12.1	45.3	47.0	4.7	7.5	17.2	8.1	10.6	2.8	6.5	10.4	4.1	7.8	17.2	4.0	10.9	5.4	8.6	0.5	8.5	2.2	10.3	6.1	16.1	9.6	2.6	30.5	11.1	11.9	7.2	24.6	10.7	11.0	8.7	9.1	9.9	2.1	7.7	8.1	3.5	3.7	5.6	8.2	10.4	4.2	7.0	2.9	11.5	10.4	10.2	2.4	6.1	13.1	5.5	3.6	7.9	7.9	5.3	17.5	7.8	7.2	7.6	7.6	11.9	3.3	3.7	0.1	0.3	0.2	0.3	0.5	0.3	0.8	0.5	0.6	0.3	1.2	0.5	0.6	0.3	0.8	0.5	0.1	0.3	0.2	3.1	2.5	5.3	3.8	2.3	2.5	5.3	3.6	2.9	3.5	2.7	3.6	5.5	12.8	9.3	26.1	5.4	4.8	4.9	4.6	2.2	10.1	7.3	7.4	4.5	2.8	9.4	18.4	10.4	1.2	1.8	0.7	0.0	5.5	5.1	32.3	14.6	6.7	2.4	4.0	61.8	3.6	3.2	10.8	2.0	12.0	2.5	13.4	4.2	10.0	3.2	25.2	82.5	2.0	12.2	3.2	3.6	3.4	16.4	3.0	1.8	19.7	1.8	6.7	1.0	18.1	19.7	2.9	0.2	18.8	3.9	3.0	0.3	4.0	46.6	21.7	0.0	10.9	7.9	33.8	10.2	3.9	4.7	1.4	2.9	13.1	1.1	1.9
WDR24	"C16orf21, DKFZp434F054, JFP7"	ENSG00000127580	"WD repeat domain 24"	Q96S15	16	684622-690444	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039506	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA039506: AB_10795148"	"unprognostic (9.07e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.15e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.05e-1)"	"prognostic favorable (3.75e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	6.1	9.1	3.9	4.0	3.6	3.9	6.2	5.0	6.9	7.5	4.1	7.1	4.8	7.9	1.0	7.1	7.5	2.8	7.9	3.8	3.0	7.5	11.2	6.0	4.8	4.2	4.0	9.2	7.2	5.8	9.4	3.2	3.5	8.5	1.1	1.8	6.9	3.0	11.7	8.5	7.1	2.0	3.2	9.2	7.8	14.2	3.9	4.3	8.7	4.1	2.4	7.5	6.6	3.7	6.1	14.0	6.2	8.6	5.9	4.2	10.9	7.5	6.7	9.2	8.0	15.3	8.8	9.4	12.8	3.4	2.3	9.4	6.1	7.4	2.0	15.9	19.0	6.4	19.8	5.8	9.4	7.9	9.6	7.4	4.9	6.6	5.5	4.8	5.0	9.0	12.7	10.3	3.4	22.2	14.0	5.8	9.7	3.1	10.6	20.4	5.1	17.6	3.0	4.2	15.1	6.9	8.5	14.3	8.7	2.8	13.2	7.8	7.3	6.6	6.8	7.4	7.3	21.9	21.5	15.3	4.3	7.8	9.4	4.3	5.1	2.8	6.6	3.0	5.4	4.3	4.2	4.9	5.1	3.7	4.9	4.8	1.2	3.0	7.8	4.1	6.1	5.0	3.9	3.6	5.0	6.9	3.8	3.0	4.2	4.0	3.5	3.2	3.9	3.7	2.9	6.4	6.2	2.3	4.2	1.1	2.6	4.7	4.0	5.1	5.2	4.4	5.0	1.5	5.0	7.3	2.1	7.4	2.9	6.0	7.9	4.9	17.1	12.2	2.9	3.1	10.1	5.2	2.0	5.6	4.4	3.1	6.6	2.9	4.5	6.9	2.5	9.6	5.1	21.9	2.0	7.3	4.1	6.3	1.6	48.0	5.6	3.9	0.0	1.9	4.4	7.3	1.0	2.0	2.4	4.5	2.1	3.0	6.8	3.8	8.0	6.4	19.4	2.6	19.7	2.6	4.2	18.8	8.7	2.1	1.6	7.4	3.4	7.6	5.5	2.0
WDR31	FLJ35921	ENSG00000148225	"WD repeat domain 31"	Q8NA23	9	113313222-113340298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 18.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 69.6;Cone photoreceptor cells: 29.2;Early spermatids: 29.5;Late spermatids: 27.2;Rod photoreceptor cells: 42.0;Spermatocytes: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019340, HPA019347"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nuclear bodies"	"HPA019340: AB_1858800, HPA019347: AB_2215267"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-3)"	"prognostic favorable (1.85e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.90e-9)"	"unprognostic (9.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-3)"	"unprognostic (8.50e-2)"	1.2	3.4	2.6	0.5	2.9	1.0	2.8	1.9	2.4	1.9	4.8	1.5	1.1	1.5	1.9	1.4	3.9	1.4	5.7	2.3	2.8	3.4	1.6	1.4	0.4	2.5	3.0	2.2	1.8	11.1	2.9	0.6	2.3	2.0	1.3	18.0	3.8	2.0	0.9	1.5	0.6	1.1	2.2	0.4	1.3	4.9	3.1	0.9	3.7	1.0	0.4	1.3	1.1	1.9	3.6	2.6	0.9	1.8	3.1	3.6	0.8	0.8	1.7	0.9	1.1	0.4	2.3	1.3	0.6	1.3	2.5	2.2	0.8	1.7	1.7	2.2	0.2	1.1	1.4	0.4	3.5	0.6	0.1	1.9	2.2	3.6	3.2	2.4	0.7	1.9	3.0	1.2	0.9	2.4	1.1	0.9	0.5	3.4	3.3	1.3	0.7	1.6	2.3	0.7	2.2	1.6	4.2	0.7	2.0	0.7	5.5	0.5	0.4	1.1	1.3	3.1	0.9	2.4	2.5	0.2	1.7	0.8	1.2	1.7	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.9	0.4	0.2	0.2	0.2	0.2	2.6	2.9	1.9	2.4	2.3	2.8	2.5	3.0	2.3	2.2	3.1	1.9	0.9	6.4	8.2	11.1	0.2	5.4	5.3	2.2	3.4	5.5	3.5	2.4	69.6	4.3	8.1	1.8	29.2	0.4	1.5	1.1	5.9	2.0	29.5	12.3	2.9	3.8	0.0	4.4	7.9	0.2	0.3	7.6	0.0	2.3	5.1	3.4	1.4	3.0	0.8	6.7	8.8	1.4	0.0	1.2	2.2	27.2	1.8	1.3	0.0	1.9	0.2	8.2	1.0	2.0	3.2	1.0	0.6	1.5	0.1	2.8	0.2	5.5	24.6	42.0	0.0	6.0	4.1	25.1	8.6	1.7	4.3	0.3	1.1	2.8	2.1	3.3
WDR4	"TRM82, TRMT82"	ENSG00000160193	"WD repeat domain 4"	P57081	21	42843094-42879568	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, tRNA processing"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 25.8;Prostatic glandular cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017381	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA017381: AB_1858807"	"unprognostic (3.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.48e-7)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.46e-2)"	5.1	4.7	4.0	7.2	3.9	6.7	3.9	3.8	4.8	4.3	3.4	3.8	5.0	5.1	1.9	9.1	4.1	1.8	3.5	3.8	3.4	4.8	6.0	3.8	9.3	4.3	3.9	4.3	5.6	2.9	2.3	4.1	4.4	3.4	3.1	1.6	3.6	2.6	6.7	5.0	4.0	3.3	3.9	5.4	3.6	4.7	4.0	5.3	4.1	3.2	7.3	5.7	5.0	4.5	35.7	48.5	12.9	18.5	6.9	8.2	30.7	20.2	7.3	16.9	10.7	48.9	18.1	58.8	11.5	14.5	24.5	19.3	44.7	25.5	11.8	19.2	42.0	59.7	52.0	41.9	13.3	36.8	14.5	4.7	11.2	22.9	16.4	6.3	22.1	20.9	72.6	22.0	14.8	29.4	38.5	20.9	32.3	26.4	47.0	41.6	7.8	58.4	12.8	21.2	30.4	19.5	21.2	31.1	10.2	4.1	20.4	28.2	16.4	25.9	17.3	12.1	41.0	28.9	21.6	48.1	12.5	57.2	31.1	0.0	3.9	0.2	2.4	6.8	3.6	5.4	3.4	3.1	7.1	4.9	3.4	3.5	0.0	3.6	4.2	3.5	4.4	3.5	4.0	3.9	3.8	4.8	3.8	3.4	4.3	3.9	4.4	3.9	4.0	4.5	3.6	0.0	4.8	5.5	10.3	8.5	12.7	7.3	4.0	4.1	5.3	4.6	2.5	0.0	3.2	0.0	2.1	16.3	5.5	5.9	0.0	7.4	4.8	2.8	5.8	5.2	5.4	8.4	4.8	6.7	25.8	4.7	6.1	3.4	10.2	5.4	3.6	7.0	12.5	3.3	4.5	6.0	4.1	3.5	4.0	3.8	2.8	4.7	7.2	2.8	1.9	3.8	2.1	1.5	5.1	6.9	1.0	3.0	15.3	24.6	3.5	6.8	2.1	4.6	6.6	2.7	6.1	10.4	8.4	7.5	10.9	11.5	3.6	8.2	7.7	10.7
WDR41	FLJ10904	ENSG00000164253	"WD repeat domain 41"	Q9HAD4	5	77425970-77620611	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043124	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA043124: AB_10793990"	"unprognostic (1.81e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.15e-3)"	"unprognostic (6.11e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.90e-3)"	16.3	9.4	13.5	13.7	15.1	19.3	15.7	13.3	18.3	13.4	8.5	12.8	8.9	10.9	12.3	19.6	16.6	11.7	17.1	13.8	13.7	12.9	14.8	14.0	15.2	15.0	13.6	7.6	21.0	13.8	6.9	11.4	14.8	11.3	13.1	20.6	12.1	10.9	21.4	12.1	8.8	19.1	12.4	11.8	11.3	27.6	14.0	11.7	22.4	21.0	17.2	14.8	10.8	17.0	17.7	29.8	42.6	62.1	41.9	60.1	32.2	55.5	59.6	26.3	47.5	28.1	28.7	54.1	24.6	53.1	44.4	22.3	31.6	77.8	27.6	65.5	37.1	21.6	32.0	24.7	63.7	46.1	50.0	38.5	96.1	30.1	63.1	28.3	42.0	29.6	21.7	56.8	42.2	39.1	24.7	29.7	15.4	17.8	11.7	58.1	56.1	38.7	27.9	14.8	23.5	29.7	48.2	31.0	47.9	49.9	29.4	57.8	38.2	34.3	28.0	19.1	41.3	51.3	44.8	96.7	48.1	20.7	59.4	25.4	28.5	50.1	11.3	33.8	10.9	19.0	6.5	10.2	51.0	13.3	4.4	8.0	13.7	31.8	38.5	23.2	5.8	16.5	13.5	15.1	13.3	18.3	13.8	13.7	15.0	13.6	14.8	12.4	14.0	17.0	10.2	38.5	12.3	63.3	12.6	12.0	25.2	31.0	14.2	34.8	11.6	12.3	17.3	12.8	16.5	18.4	20.9	8.8	16.4	4.4	37.2	22.7	178.8	17.7	25.6	11.3	6.0	13.5	41.3	20.9	25.5	23.7	9.2	8.3	15.8	11.7	8.9	11.5	26.3	23.5	46.7	8.5	14.2	20.2	29.5	87.5	9.6	23.9	17.8	36.5	16.4	14.9	15.5	56.8	78.9	15.2	7.4	8.2	25.6	26.8	5.0	18.7	17.0	19.2	6.6	12.7	22.3	56.4	44.5	23.9	14.2	6.3	11.4	35.5	10.9	28.0
WDR45B	"WDR45L, WIPI3"	ENSG00000141580	"WD repeat domain 45B"	Q5MNZ6	17	82614562-82648553	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 462.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017886			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA017886: AB_1858810"	"unprognostic (1.91e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.23e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.93e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.02e-1)"	39.4	44.5	50.7	22.4	56.1	58.7	37.6	52.4	50.4	35.6	41.4	33.6	30.8	37.9	30.1	59.3	43.6	36.8	37.0	48.9	50.9	37.3	32.4	32.9	23.3	53.0	51.7	50.1	46.1	46.2	36.8	25.5	50.7	37.5	25.9	30.9	46.6	28.5	24.4	46.9	34.4	27.5	54.3	28.6	39.9	50.0	54.6	23.8	32.1	26.8	25.8	39.8	40.1	60.3	100.5	65.1	56.0	54.6	53.8	44.4	63.0	71.1	77.7	106.4	93.5	78.7	53.8	27.9	44.8	64.2	76.9	52.4	52.8	58.5	101.4	18.6	93.7	55.4	40.5	67.8	64.1	42.8	42.8	50.9	61.7	62.1	57.3	52.1	88.2	38.0	41.6	27.8	63.0	66.8	31.3	37.6	72.3	86.8	78.2	36.6	92.0	28.1	65.0	99.3	68.3	100.9	66.9	74.7	90.7	67.6	86.9	39.2	63.6	120.0	94.4	81.5	135.8	66.5	29.7	40.5	76.8	42.9	87.0	34.2	27.5	33.9	16.4	27.6	16.6	13.4	12.5	13.7	22.2	12.8	10.9	10.5	21.9	13.9	22.8	10.9	11.3	19.3	50.7	56.1	52.4	50.4	48.9	50.9	53.0	51.7	50.7	54.3	54.6	60.3	62.1	32.1	47.3	17.0	51.5	59.9	48.6	71.5	48.3	39.7	76.3	54.0	21.2	60.1	84.4	42.3	12.5	54.4	49.6	85.6	88.0	128.8	152.7	145.2	72.5	56.1	47.4	14.5	16.9	137.7	77.3	44.9	43.3	177.1	73.5	32.7	47.2	71.5	45.8	45.4	20.0	68.0	67.1	62.0	42.5	462.7	57.2	72.8	56.9	15.9	57.8	66.2	44.3	13.0	24.6	157.6	55.4	48.2	24.8	72.8	58.3	71.5	91.1	34.9	32.9	44.6	53.2	94.5	171.6	53.8	72.5	108.1	46.7	37.0	68.3	101.0
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 31.3;choroid plexus: 29.3;fallopian tube: 10.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 79.0;Endometrial ciliated cells: 43.4;Respiratory ciliated cells: 47.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.7;myeloid DC: 2.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 2.9;monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;NTERA-2: 3.0;THP-1: 14.5;U-937: 7.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 9.5"	"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA036225: AB_10696652, HPA036226: AB_2675007"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.1	0.1	10.2	0.4	8.2	2.0	0.1	16.6	3.4	0.3	29.3	0.1	2.0	0.4	0.0	0.9	10.0	0.2	2.1	7.0	15.6	0.3	0.0	1.9	0.3	30.1	27.0	0.1	0.3	0.0	0.5	0.0	23.8	0.2	0.1	0.0	0.2	0.0	0.0	0.1	4.6	0.1	31.3	0.4	0.2	0.6	15.5	0.4	0.0	0.2	0.3	0.2	0.2	23.4	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	2.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.5	10.2	8.2	16.6	3.4	7.0	15.6	30.1	27.0	23.8	31.3	15.5	23.4	0.2	0.0	0.6	79.0	0.1	0.0	0.9	1.7	9.1	0.0	0.1	0.1	1.1	0.0	10.9	0.0	0.0	0.0	1.6	0.1	0.0	0.1	2.4	43.4	0.3	0.2	0.0	1.7	4.5	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	4.1	1.6	2.5	0.8	0.0	1.8	0.0	0.0	4.0	0.0	0.0	2.5	3.0	0.0	0.0	0.0	0.1	0.4	3.3	0.0	47.7	0.0	6.6	0.3	0.6	0.1	0.2	1.0	0.1	0.0	0.1	0.0	0.2	0.8
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 74.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 313.9;Late spermatids: 118.8;Spermatocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	7.8	7.4	9.4	6.9	10.3	14.7	9.0	10.3	12.1	7.7	9.7	8.1	4.3	8.1	11.0	9.0	7.1	6.3	8.1	9.5	10.0	8.8	10.0	6.9	10.6	9.6	9.7	7.0	5.9	10.0	6.7	6.3	11.2	7.2	7.1	8.9	7.0	6.1	13.0	11.9	7.9	7.4	9.4	10.8	7.2	74.2	9.8	12.1	7.1	12.6	11.9	7.2	7.6	11.3	39.4	8.5	14.6	13.6	15.0	13.2	23.8	20.1	16.2	23.0	21.7	22.8	20.2	18.9	66.4	13.0	21.2	22.3	18.9	18.4	28.8	30.0	16.3	19.4	21.2	14.6	18.5	26.9	14.3	10.7	25.9	20.6	22.2	11.4	18.7	23.6	18.8	34.5	17.7	36.4	22.5	27.5	19.5	25.7	24.4	26.5	25.3	40.5	12.8	13.4	15.0	15.2	15.0	20.8	32.2	19.8	53.0	24.2	17.2	18.9	18.0	21.5	40.6	29.5	63.8	56.6	12.7	34.2	19.4	13.1	5.5	15.7	8.8	4.7	14.1	7.8	12.2	8.5	4.7	7.5	10.2	6.1	4.7	7.4	7.8	6.2	16.5	5.0	9.4	10.3	10.3	12.1	9.5	10.0	9.6	9.7	11.2	9.4	9.8	11.3	3.9	0.0	2.8	6.8	3.8	4.2	3.2	8.1	2.8	3.7	3.4	3.4	5.6	2.8	5.8	3.7	0.0	5.7	3.5	1.7	5.9	5.0	313.9	3.3	3.5	4.7	0.0	7.4	5.5	4.2	6.1	3.9	0.5	2.7	9.5	3.2	3.9	2.5	4.3	3.3	4.8	1.6	10.2	3.8	3.0	118.8	5.0	3.9	5.4	10.3	7.3	4.0	4.1	6.0	7.1	3.7	1.9	3.4	3.7	2.9	1.5	5.0	3.1	2.8	19.7	4.0	5.5	135.6	13.9	3.5	4.7	4.7	6.3	4.1	2.7	2.6
WDR54	FLJ12953	ENSG00000005448	"WD repeat domain 54"	Q9H977	2	74421678-74425755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 70.2"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 207.0;Late spermatids: 124.6;Respiratory ciliated cells: 395.9;Spermatocytes: 147.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043257, HPA053558"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Cytosol"		"HPA043257: AB_10795981, HPA053558: AB_2682189"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.85e-2)"	8.2	8.5	11.0	6.5	11.7	6.7	7.7	8.5	11.2	11.8	17.6	6.7	3.2	10.4	5.6	3.4	70.2	8.4	4.3	11.8	14.2	12.1	1.9	10.7	11.6	10.3	12.5	10.8	6.3	30.0	24.4	6.3	11.2	7.4	4.0	28.0	5.2	9.9	1.3	4.9	7.0	7.7	10.8	12.2	7.0	38.0	11.7	18.5	7.8	1.7	11.2	8.6	6.3	9.9	44.9	78.3	37.9	32.5	14.0	25.7	11.8	22.5	45.8	56.8	52.8	6.9	34.4	39.3	22.5	25.1	34.5	37.6	27.8	100.6	49.8	30.3	16.8	19.4	42.4	4.7	14.3	30.6	15.3	11.6	27.6	58.1	30.3	67.5	30.6	61.6	7.7	45.8	32.4	69.8	48.6	32.3	30.3	10.9	29.8	41.2	44.1	84.4	51.3	22.4	66.4	52.1	17.6	15.9	27.0	11.2	25.6	14.7	15.3	29.2	50.9	32.1	50.7	49.2	26.7	10.1	86.5	18.8	21.6	6.6	8.5	0.6	31.1	11.5	31.4	24.2	35.5	33.7	28.6	22.0	25.1	23.8	0.7	29.1	10.1	46.7	36.8	21.6	11.0	11.7	8.5	11.2	11.8	14.2	10.3	12.5	11.2	10.8	11.7	9.9	20.0	3.2	12.8	1.3	23.1	7.0	20.1	64.1	10.2	48.3	9.4	10.9	1.7	20.0	39.4	23.9	83.4	9.8	30.1	1.5	19.6	28.5	77.8	207.0	18.5	25.1	28.9	5.5	5.6	6.0	14.6	14.3	7.1	9.2	12.7	23.8	30.0	1.9	8.6	32.0	4.1	6.0	38.7	6.9	17.4	124.6	17.1	7.4	12.4	0.0	29.8	51.9	26.8	3.0	2.4	13.6	4.4	22.2	17.5	9.4	0.8	28.4	395.9	112.5	0.0	8.4	30.6	147.9	19.3	1.7	4.8	2.9	30.5	37.2	3.8	13.3
WDR59	FLJ12270	ENSG00000103091	"WD repeat domain 59"	Q6PJI9	16	74871362-75000173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041084, HPA048218"	Approved		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA041084: AB_10793867, HPA048218: AB_2680318"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.16e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (8.83e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.21e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.61e-2)"	11.6	19.0	18.2	13.8	22.1	16.1	14.2	18.2	21.3	19.2	15.5	15.3	13.1	16.1	21.1	17.3	14.9	9.7	17.0	17.9	20.0	17.3	35.7	11.1	12.7	19.0	19.3	22.4	16.9	22.6	22.9	14.1	19.8	15.8	14.0	37.9	14.1	11.6	24.8	21.1	16.4	13.2	17.2	15.3	14.2	13.9	20.6	22.3	22.9	17.4	16.0	14.5	17.3	28.5	15.6	23.8	27.1	25.8	20.8	18.7	22.9	9.8	17.0	20.7	23.5	32.3	27.1	21.8	10.6	18.3	19.3	24.6	21.7	23.4	29.3	13.2	23.1	27.9	16.3	52.5	12.6	20.4	32.7	21.8	18.7	25.1	23.7	26.7	21.7	52.5	42.0	10.6	9.9	46.1	31.4	36.4	21.6	34.0	9.7	31.3	11.9	18.3	22.2	13.9	16.5	18.2	28.0	16.2	12.6	28.5	24.5	17.8	19.0	12.9	19.6	14.8	8.5	20.1	29.3	47.2	22.8	14.1	14.3	0.7	0.7	0.7	1.0	0.4	3.4	1.9	1.9	1.5	0.4	1.1	1.2	1.4	0.7	1.0	0.8	0.7	1.0	0.4	18.2	22.1	18.2	21.3	17.9	20.0	19.0	19.3	19.8	17.2	20.6	28.5	9.8	16.0	16.5	77.1	15.0	22.4	20.0	12.7	21.6	38.8	15.0	16.3	17.6	21.5	15.0	22.0	62.6	34.4	9.6	13.1	9.8	13.0	37.4	13.1	14.6	11.8	22.1	21.0	41.5	9.6	16.5	13.6	17.3	20.1	13.3	22.4	17.9	24.6	10.8	20.2	53.8	11.9	12.2	13.2	17.1	79.2	13.4	12.7	8.8	29.0	15.3	11.9	14.4	65.9	88.8	11.9	14.0	11.7	5.9	24.1	17.0	19.6	16.7	55.5	19.7	17.1	9.7	17.7	19.1	16.5	24.2	47.3	15.3	13.8	16.8	23.4
WDR7	"KIAA0541, TRAG"	ENSG00000091157	"WD repeat domain 7"	Q9Y4E6	18	56651343-57029811	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 99.6;Excitatory neurons: 268.8;Inhibitory neurons: 223.0;Microglial cells: 111.5;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 244.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042074, HPA051057"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA042074: AB_2677833, HPA051057: AB_2732563"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (4.80e-2)"	"unprognostic (4.52e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	5.9	7.6	13.2	5.9	14.2	7.2	4.9	7.0	19.8	4.8	3.1	5.4	4.1	4.8	5.3	4.4	4.2	5.3	5.9	16.2	11.1	5.3	7.4	5.0	7.4	14.6	8.8	4.2	4.2	9.2	8.4	4.7	14.7	7.5	4.9	18.8	4.2	5.7	8.2	4.3	4.3	5.6	7.8	6.2	4.9	4.6	9.6	10.3	9.1	9.6	5.8	5.0	4.5	16.0	4.7	7.7	8.7	4.9	13.5	7.8	2.2	9.2	7.8	7.4	8.8	3.1	2.9	13.0	3.6	8.3	6.3	4.9	8.8	7.2	9.2	15.1	5.4	12.3	5.8	2.8	8.1	18.7	15.0	6.7	5.9	9.9	6.6	6.1	9.3	6.1	6.0	17.5	9.3	4.6	13.0	5.5	3.7	2.4	5.1	5.8	6.7	6.3	5.7	8.4	11.3	5.6	6.5	3.1	4.3	7.4	4.9	5.2	8.3	10.5	5.3	3.2	5.0	17.4	14.2	13.9	8.6	9.3	7.2	4.0	3.0	5.5	3.6	4.4	4.5	2.4	4.0	3.7	3.6	2.2	4.2	3.8	2.6	4.6	5.5	1.7	5.2	2.0	13.2	14.2	7.0	19.8	16.2	11.1	14.6	8.8	14.7	7.8	9.6	16.0	8.7	3.2	4.8	99.6	7.5	2.9	1.9	2.3	2.8	24.5	3.4	2.4	12.5	5.7	6.8	0.0	31.3	2.0	7.7	5.8	3.9	3.2	21.0	4.4	6.0	6.6	8.4	8.2	268.8	3.6	1.2	6.3	7.7	3.9	10.8	9.0	9.3	8.9	5.8	26.9	223.0	2.7	0.0	16.2	2.8	7.0	5.6	11.3	0.0	111.5	8.8	7.1	10.3	146.3	244.7	2.6	2.6	8.2	10.1	2.6	4.5	3.2	5.7	26.3	6.6	10.7	5.8	2.0	1.7	5.8	2.4	0.7	9.9	9.3	4.1	1.6
WDR70	FLJ10233	ENSG00000082068	"WD repeat domain 70"	Q9NW82	5	37379285-37753435	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 177.2;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 153.3;Oligodendrocytes: 168.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043064, HPA048149"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Mitochondria, Cytosol"		"HPA043064: , HPA048149: AB_2680287"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.11e-2)"	9.2	6.2	3.6	7.4	4.4	12.6	10.5	8.2	5.0	9.3	4.7	9.1	7.1	11.5	8.6	8.1	8.9	6.8	7.8	3.4	4.8	7.3	8.0	8.2	10.4	5.1	4.3	10.8	8.4	9.4	4.0	9.5	5.2	8.4	9.3	5.2	7.5	8.8	15.4	8.8	8.2	10.6	3.5	9.5	7.8	8.8	5.0	11.8	8.9	11.1	10.8	8.6	7.9	6.7	17.8	11.5	22.7	28.9	22.8	22.4	31.2	21.6	21.9	26.3	21.6	19.5	17.9	28.7	12.7	21.6	19.8	16.4	19.4	21.7	27.9	27.5	24.5	21.5	34.3	13.9	17.6	37.4	18.5	21.8	15.8	19.9	26.9	19.8	21.5	21.7	27.2	11.5	16.7	12.2	23.8	18.6	15.4	14.7	21.4	27.2	56.1	29.9	13.3	21.0	19.5	18.3	73.6	16.3	16.6	17.0	21.0	23.3	23.8	22.7	21.6	22.2	17.8	15.3	24.1	32.9	15.1	33.3	19.2	8.1	16.5	15.0	9.7	20.7	10.5	13.4	11.2	10.6	17.9	14.8	11.0	10.5	3.7	14.0	19.5	18.4	12.0	8.3	3.6	4.4	8.2	5.0	3.4	4.8	5.1	4.3	5.2	3.5	5.0	6.7	23.7	32.1	29.1	103.2	25.1	9.2	13.7	15.4	12.5	37.2	23.3	17.5	18.6	17.2	14.4	9.2	37.5	27.1	33.6	18.3	19.6	18.3	20.1	16.9	36.4	17.7	13.8	17.7	177.2	20.7	26.7	17.9	15.8	20.1	19.7	22.8	22.5	25.7	18.9	25.2	166.2	21.5	14.2	25.8	6.4	7.0	29.5	21.2	12.4	113.4	31.3	16.4	30.9	153.3	168.6	16.1	17.0	22.6	21.5	6.9	16.1	21.2	20.8	52.2	13.1	20.0	21.7	42.7	25.2	11.9	7.7	22.2	20.2	17.3	22.1	8.7
WDR89	"C14orf150, MGC9907"	ENSG00000140006	"WD repeat domain 89"	Q96FK6	14	63597039-63641871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000813	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 58: T-cells - T-cell receptor"	"Intermediate filaments, Cytosol"		"HPA000813: AB_1078324"	"prognostic favorable (3.37e-4)"	"unprognostic (6.46e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.29e-1)"	4.9	5.8	4.4	7.6	4.9	3.0	8.1	7.0	5.9	6.8	3.3	6.1	5.1	6.9	6.8	5.3	6.4	4.8	4.4	4.5	4.6	8.8	8.8	5.4	11.2	4.5	4.4	8.2	5.9	7.4	3.0	6.6	4.2	5.8	6.8	11.4	4.1	4.5	5.8	6.1	4.0	5.3	3.9	8.6	5.4	5.3	5.1	10.1	9.2	7.3	10.3	6.6	4.4	5.7	35.4	16.2	18.2	10.2	10.7	11.2	27.2	14.0	7.6	14.4	16.2	11.6	17.0	33.7	11.4	4.2	9.7	16.7	22.8	13.2	24.3	21.8	13.1	22.7	10.5	14.4	13.8	29.9	15.5	10.1	17.1	16.0	22.7	8.1	12.8	24.0	19.7	17.8	10.5	19.5	24.0	17.3	17.5	23.9	29.2	18.2	18.3	19.2	15.5	14.6	16.5	12.4	15.0	16.8	11.1	18.1	19.2	16.0	9.2	16.8	16.4	11.0	16.6	10.4	8.8	20.9	7.2	20.9	11.9	0.1	2.8	0.5	8.4	2.7	10.5	8.0	8.8	7.8	4.8	7.3	14.3	12.4	0.6	9.4	4.6	3.1	10.1	5.3	4.4	4.9	7.0	5.9	4.5	4.6	4.5	4.4	4.2	3.9	5.1	5.7	5.6	9.6	6.7	4.9	14.5	9.7	13.9	4.6	8.0	6.7	6.3	5.3	4.8	8.6	7.0	5.5	4.2	9.9	7.0	3.8	13.7	6.8	2.8	3.4	7.7	7.0	3.6	11.6	11.3	5.5	13.6	6.5	2.6	4.1	1.3	7.5	5.3	8.0	6.3	1.7	13.2	5.1	4.1	6.3	4.2	4.6	4.4	5.1	3.6	6.5	5.6	7.0	8.2	8.5	14.5	3.6	2.4	6.4	6.1	11.2	2.7	7.9	3.1	9.3	13.1	6.9	4.9	6.1	11.6	6.3	10.9	7.0	11.2	8.7	5.5	7.3
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235798-159286703	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: AB_2683628"	"unprognostic (1.37e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	6.7	10.9	9.1	4.6	10.2	10.6	12.0	10.7	12.0	7.8	11.7	6.7	4.9	8.2	17.5	7.5	9.8	5.9	10.1	8.9	9.3	23.5	6.9	9.0	7.9	9.7	9.3	13.5	10.6	13.9	9.1	9.7	9.8	9.1	7.6	11.1	10.4	6.8	6.7	6.9	5.8	6.6	8.9	8.6	7.4	6.7	9.4	7.0	17.3	6.5	5.8	6.2	6.3	11.7	8.4	6.3	5.4	9.0	10.1	11.4	19.1	6.7	13.0	11.4	20.4	13.7	13.6	11.7	6.9	9.9	20.3	5.2	15.9	5.9	16.1	4.5	13.4	12.1	6.8	14.0	12.2	10.2	15.6	6.7	21.5	14.4	12.0	22.2	9.8	14.9	16.0	8.5	11.1	8.8	7.3	18.5	7.5	14.3	13.6	11.3	8.3	6.2	13.6	12.2	10.3	6.8	7.0	8.6	15.9	26.0	6.7	17.3	4.1	8.2	6.2	11.8	6.5	4.2	7.7	10.7	14.4	12.6	5.3	3.9	11.1	3.5	14.3	8.6	10.9	11.8	5.6	9.1	12.2	9.9	6.7	8.0	0.8	20.8	7.9	11.6	3.3	7.8	9.1	10.2	10.7	12.0	8.9	9.3	9.7	9.3	9.8	8.9	9.4	11.7	8.2	12.8	6.8	28.4	10.7	5.4	8.7	13.0	11.4	6.9	9.3	8.0	11.3	10.0	11.3	20.2	2.1	25.4	11.2	5.1	35.2	9.5	4.5	13.7	6.9	7.0	5.4	6.7	42.4	3.6	9.2	9.9	10.2	16.1	12.0	13.2	6.4	2.0	17.3	5.0	52.0	4.5	12.2	14.8	4.8	2.9	12.8	10.2	5.4	29.0	9.2	6.6	14.4	31.7	34.6	4.0	7.0	11.3	3.8	6.8	6.9	23.7	15.0	9.7	0.0	12.0	7.8	10.1	22.5	11.1	6.3	23.0	9.1	12.7	7.1	7.3
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 126.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 172.7;monocytes: 187.2;NK-cells: 245.1;Oligodendrocytes: 217.2;Plasma cells: 162.8;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.1;Karpas-707: 296.8;U-266/70: 233.0"	"Low region specificity"	"Detected in all"							"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		520000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300"	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	31.0	14.7	14.2	93.0	37.2	56.8	21.0	36.1	20.5	30.6	11.1	26.0	18.2	22.4	11.5	14.2	14.4	34.8	16.0	14.9	28.8	13.0	16.4	31.8	126.9	46.2	38.6	12.3	7.3	12.9	4.8	33.5	42.3	14.9	20.8	3.4	17.7	23.0	5.9	9.9	32.5	29.1	27.9	89.7	21.8	4.7	35.1	66.4	15.4	11.5	110.5	31.5	17.0	53.8	0.7	7.0	16.3	0.2	40.4	70.9	16.9	31.1	26.4	12.1	18.7	1.9	1.4	209.1	9.2	47.0	15.6	0.5	2.8	0.0	15.1	144.8	4.1	106.5	26.9	0.0	15.1	94.9	167.2	29.6	5.1	27.7	2.6	16.0	25.0	18.7	3.3	296.8	34.4	0.1	106.6	87.1	19.1	0.0	1.4	90.0	6.6	37.9	11.3	0.7	2.6	33.8	0.3	8.8	18.7	30.4	0.4	46.8	21.2	41.0	11.5	30.1	29.9	233.0	165.2	113.7	60.4	64.7	111.7	41.5	35.4	87.2	71.6	37.3	59.4	35.1	47.6	71.1	26.1	28.6	38.0	51.4	166.1	57.4	43.7	11.2	57.7	54.7	14.2	37.2	36.1	20.5	14.9	28.8	46.2	38.6	42.3	27.9	35.1	53.8	32.1	19.2	21.7	27.7	134.5	12.5	6.3	0.9	2.8	2.1	3.3	4.3	10.5	1.5	4.6	3.7	25.0	2.0	172.7	0.3	5.9	1.7	40.2	3.3	21.9	30.8	4.9	30.1	5.3	11.6	82.5	40.5	9.7	2.1	67.2	2.1	36.8	3.7	86.2	0.0	7.2	1.6	0.0	142.2	128.0	96.9	25.1	139.8	26.6	98.4	187.2	1.2	245.1	120.6	217.2	16.8	0.8	18.0	162.8	5.0	0.2	35.9	0.1	3.4	13.1	15.7	21.4	4.4	4.1	1.2	11.1	4.1	208.1	8.8	2.1	3.1
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 127.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 165.7;Syncytiotrophoblasts: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 114.1;eosinophil: 223.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 224.3;HHSteC: 216.7;HSkMC: 180.8;SK-MEL-30: 183.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	31.3	18.8	11.2	14.1	11.2	26.6	30.5	12.5	15.1	33.1	19.1	36.4	12.8	15.3	14.4	14.8	12.6	23.3	78.4	10.6	12.9	33.3	18.7	26.2	8.7	12.5	12.0	11.2	29.8	25.2	17.8	62.4	12.5	17.4	38.5	8.2	55.0	18.3	127.2	21.9	14.8	18.8	11.4	12.5	29.3	9.6	15.5	5.9	21.1	97.5	16.7	22.0	14.4	11.9	4.9	9.8	8.6	12.5	224.3	167.2	49.0	36.3	163.5	13.7	43.6	7.2	7.3	3.0	16.0	74.2	47.9	3.7	3.3	22.1	23.9	4.4	4.6	34.7	3.2	42.6	216.7	2.4	48.5	180.8	39.5	54.2	72.0	44.2	61.3	5.3	2.5	82.0	41.1	29.9	0.5	7.1	1.8	12.7	15.0	0.4	30.3	35.7	20.2	16.7	2.4	11.4	7.7	103.8	183.4	44.4	54.8	9.5	61.2	65.4	10.1	31.0	8.6	78.2	92.0	10.5	98.9	16.5	29.7	114.1	18.4	223.6	11.9	22.7	5.3	4.4	3.1	11.7	9.0	1.4	0.2	5.6	39.0	10.7	24.7	6.3	2.7	15.0	11.2	11.2	12.5	15.1	10.6	12.9	12.5	12.0	12.5	11.4	15.5	11.9	26.2	9.6	11.5	12.7	13.3	7.8	11.9	45.6	0.6	15.0	24.1	8.9	7.3	28.6	48.5	16.5	2.1	44.0	18.3	30.2	31.3	31.2	6.3	26.3	19.9	17.2	12.0	56.6	9.4	57.2	165.7	41.2	25.5	40.0	7.0	12.3	33.9	11.7	35.6	10.1	8.2	67.6	44.7	18.2	14.5	5.2	46.3	37.1	42.7	20.6	34.2	10.6	20.6	6.0	12.2	28.8	20.1	42.2	83.3	55.3	8.5	71.8	49.6	15.7	26.3	10.1	24.1	5.0	5.1	3.3	6.8	125.1	13.6	27.8	28.2	36.7
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190196-5233840	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 255.9;Spermatocytes: 233.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	31.1	30.9	38.8	22.9	40.7	47.0	30.8	35.2	41.8	27.3	37.1	33.9	24.7	32.1	26.3	35.8	29.0	23.2	38.0	42.8	38.6	32.2	35.7	26.4	30.2	36.3	39.1	28.2	37.1	38.2	30.6	32.8	38.7	28.7	20.2	19.1	43.5	28.2	41.3	47.1	26.7	26.8	37.0	29.6	33.6	53.8	38.7	36.8	27.4	45.0	29.2	27.1	30.0	39.8	67.5	42.1	40.4	69.4	60.7	63.3	62.0	58.7	66.9	61.2	64.2	41.2	60.9	47.7	43.9	73.8	76.0	48.2	41.2	47.8	47.4	24.9	64.1	32.7	39.7	45.8	59.9	51.8	34.4	66.9	56.4	69.7	38.3	60.9	86.3	64.3	94.2	41.9	56.2	69.9	39.6	90.0	84.3	35.9	61.1	64.3	57.7	79.5	40.4	32.3	50.3	75.4	43.0	72.8	52.4	67.3	44.8	97.2	69.2	38.9	80.9	65.6	44.4	75.0	75.2	54.7	63.4	59.3	58.8	0.4	4.7	13.6	4.4	6.0	2.8	5.7	5.8	8.0	4.2	6.2	7.5	4.7	9.1	2.6	4.2	6.4	9.0	2.2	38.8	40.7	35.2	41.8	42.8	38.6	36.3	39.1	38.7	37.0	38.7	39.8	40.2	38.5	31.5	16.3	51.6	54.9	39.5	13.9	39.3	71.5	49.4	50.5	37.0	42.9	17.6	18.4	62.6	89.4	62.7	42.6	72.4	43.0	195.8	50.0	38.1	37.9	39.5	125.0	19.7	41.8	96.6	43.1	34.7	48.0	31.1	54.8	54.7	60.4	69.1	47.1	19.6	42.6	18.3	61.4	44.8	255.9	42.6	55.9	44.4	20.6	64.5	89.5	44.3	13.6	23.5	55.6	37.0	56.1	67.7	97.7	48.7	80.6	26.4	52.8	52.6	39.7	39.4	233.0	117.3	49.8	71.0	150.8	46.8	44.1	43.0	69.8
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP"	ENSG00000116729	"Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 22.1;neutrophil: 61.7"	"Group enriched"	"Detected in many"	46	"granulocytes: 61.7;monocytes: 22.1"	"Cell line enhanced"	"Detected in many"		"AF22: 392.1;ASC TERT1: 294.1;SuSa: 357.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	36.8	42.9	77.4	21.5	70.8	4.6	36.4	63.6	73.5	46.9	124.7	73.9	23.8	49.1	135.8	62.3	48.7	68.2	63.7	62.0	89.1	92.6	23.4	53.0	13.0	109.4	127.8	76.7	83.6	38.5	16.9	77.3	91.6	71.7	57.4	137.2	32.6	102.0	14.2	45.9	34.0	61.9	101.6	29.7	56.6	23.9	132.2	13.5	22.6	25.2	19.2	64.4	37.8	98.8	11.5	17.3	392.1	0.3	214.0	294.1	228.4	55.6	135.1	75.7	104.0	24.3	26.2	0.2	54.9	16.0	70.7	116.0	89.3	91.7	63.6	0.6	67.8	0.4	45.4	0.2	187.2	0.1	0.9	214.0	60.3	185.3	60.6	77.2	181.0	21.4	0.0	1.0	113.0	1.7	0.3	1.3	17.7	24.7	27.3	0.1	82.2	0.5	13.5	60.3	21.8	46.0	51.0	2.3	67.3	357.0	10.6	1.6	209.7	71.7	56.9	116.9	76.1	26.6	0.8	0.2	165.0	1.8	134.1	0.0	22.1	0.0	0.0	5.4	0.1	0.1	0.0	0.0	0.9	0.1	0.0	0.0	61.7	0.0	0.7	0.3	0.0	4.8	77.4	70.8	63.6	73.5	62.0	89.1	109.4	127.8	91.6	101.6	132.2	98.8	20.9	48.1	34.6	145.3	1.2	42.4	60.1	28.5	95.0	8.9	25.4	61.2	32.6	42.9	41.3	27.6	139.7	134.7	0.9	65.7	9.8	74.3	15.3	110.8	60.1	31.5	9.6	0.0	27.0	60.3	6.7	44.9	28.5	235.3	5.7	4.6	43.5	10.9	24.9	13.5	132.3	24.5	61.1	10.6	11.2	9.4	32.6	14.7	19.6	61.8	18.0	11.8	0.0	59.3	3.7	69.1	27.2	55.3	0.2	31.3	8.9	36.2	81.1	166.4	39.5	15.7	46.4	0.8	1.0	39.7	30.0	55.1	3.2	39.2	38.4	46.8
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 83.1;skeletal muscle: 62.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.4;Cone photoreceptor cells: 160.6;Excitatory neurons: 128.5;Inhibitory neurons: 98.8;Intestinal goblet cells: 77.3;Rod photoreceptor cells: 106.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.8;Hep G2: 31.0;SCLC-21H: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	2.0	3.0	14.9	3.3	14.8	0.0	4.9	4.6	39.1	4.7	0.3	36.0	17.9	5.8	4.2	5.7	15.4	1.3	83.1	18.3	7.7	0.8	1.3	0.9	0.5	13.8	6.0	1.1	42.8	2.3	29.6	3.0	8.8	16.7	11.9	28.8	47.3	12.3	62.3	15.8	21.5	4.5	1.9	2.7	14.7	6.6	14.2	7.1	1.8	31.0	1.0	5.5	3.4	10.5	7.4	6.6	4.6	13.2	0.0	0.0	8.8	0.0	0.0	0.1	0.0	2.7	0.2	18.8	2.4	0.0	1.3	0.3	10.4	0.0	0.0	0.0	12.1	0.0	5.8	31.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	12.2	0.0	0.0	9.8	0.2	0.2	11.5	7.2	0.4	0.0	0.0	15.3	0.0	1.1	37.6	14.8	2.4	10.2	0.9	1.3	1.3	2.2	0.1	0.0	4.8	0.2	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	14.8	4.6	39.1	18.3	7.7	13.8	6.0	8.8	1.9	14.2	10.5	0.3	0.0	0.0	76.4	0.3	1.3	8.5	3.1	0.0	62.0	19.4	18.7	58.1	31.5	14.1	0.0	160.6	15.5	0.2	34.3	0.0	17.1	1.2	7.7	9.2	1.3	32.4	0.0	128.5	9.1	6.7	2.7	3.6	15.8	0.0	8.6	0.4	0.2	3.4	1.7	98.8	77.3	6.1	1.3	2.2	2.6	0.9	0.1	1.8	29.0	0.6	60.3	0.0	9.0	3.2	3.2	57.0	6.0	0.2	11.1	47.7	1.1	6.6	106.8	13.1	3.5	5.0	0.7	7.7	1.1	5.5	15.6	0.4	0.1	59.0	8.9
WWC3	"BM042, KIAA1280"	ENSG00000047644	"WWC family member 3"	Q9ULE0	X	10015254-10144474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 131.5"					"Low region specificity"	"Detected in all"			HPA039814	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Actin filaments"	"HPA039814: AB_10674987"	"unprognostic (2.53e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (9.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.50e-2)"	11.2	13.8	13.7	9.6	16.9	5.5	10.9	13.0	11.8	11.2	12.2	15.2	4.0	11.3	19.3	11.3	9.7	9.7	18.6	10.3	11.4	7.3	3.4	21.7	12.6	14.1	15.1	18.1	8.5	7.8	6.5	15.7	13.4	11.3	4.8	1.9	9.3	26.7	8.5	13.5	11.6	8.3	12.4	11.6	10.8	5.4	15.1	7.1	12.2	6.4	9.6	11.0	11.3	16.6	17.2	19.1	22.7	7.5	9.4	13.2	21.6	9.6	16.5	5.7	6.2	2.5	17.5	1.8	0.2	12.8	22.0	8.8	5.3	9.9	4.7	13.0	1.9	3.9	13.1	1.7	20.1	0.0	5.8	8.5	20.4	14.1	14.8	30.0	26.7	3.2	0.3	22.4	13.7	35.2	4.2	1.1	21.4	9.0	6.7	12.5	1.1	7.5	5.5	8.7	2.4	6.4	11.7	14.9	10.2	42.0	131.5	1.4	36.0	16.4	0.5	24.4	10.8	18.2	13.3	6.3	10.0	6.3	24.7	4.0	0.8	0.2	5.8	0.7	4.9	2.0	2.8	4.3	0.4	5.0	2.5	3.0	10.7	2.6	0.7	0.6	1.4	1.8	13.7	16.9	13.0	11.8	10.3	11.4	14.1	15.1	13.4	12.4	15.1	16.6	41.0	22.4	68.4	20.2	15.4	5.6	12.9	8.2	7.4	6.1	22.9	15.9	20.5	5.7	13.0	5.5	6.2	14.3	7.1	7.9	0.0	6.2	0.7	6.3	15.4	26.9	16.1	24.8	29.0	9.5	6.3	15.3	2.6	7.5	3.8	12.7	31.8	5.6	11.6	3.3	21.1	4.2	8.2	19.4	11.8	1.4	12.8	12.2	16.0	12.2	6.8	4.1	10.3	13.0	35.7	9.5	7.4	24.8	10.2	14.8	8.1	2.5	11.5	2.0	19.7	11.9	20.2	0.7	2.5	8.8	13.1	7.9	12.0	15.8	3.6	9.4
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342547-86478420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 171.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	33.6	22.1	16.3	25.8	21.5	18.2	40.6	19.6	16.3	23.6	24.3	26.9	26.3	23.0	24.6	33.1	18.5	45.3	50.8	14.3	20.7	40.9	111.7	27.2	39.0	18.3	19.0	24.7	28.0	116.3	9.8	36.9	19.7	33.4	33.1	43.2	25.9	25.6	171.4	40.8	28.1	24.6	18.1	45.7	34.3	29.5	19.5	22.7	32.6	122.2	30.6	33.7	15.8	23.1	59.8	27.1	18.3	13.1	23.0	22.4	16.3	21.0	22.5	16.5	19.5	18.9	35.3	24.9	14.0	36.5	22.9	49.3	26.4	34.1	28.5	31.6	21.0	28.7	24.4	44.7	16.8	11.7	14.0	20.5	42.5	18.2	33.3	25.3	74.1	29.0	14.3	28.7	28.4	29.6	27.7	8.1	11.2	82.6	30.0	18.0	21.4	22.5	37.3	44.5	5.5	12.9	21.2	104.7	23.0	39.8	31.3	10.8	84.4	23.9	28.7	26.3	10.7	33.9	22.0	25.7	29.9	1.6	19.0	6.2	2.1	3.9	5.2	1.9	4.6	2.7	6.4	5.3	1.5	2.4	7.5	4.7	1.3	2.4	2.2	1.9	6.5	2.0	16.3	21.5	19.6	16.3	14.3	20.7	18.3	19.0	19.7	18.1	19.5	23.1	51.2	25.6	22.6	29.0	13.0	35.8	26.9	15.4	26.7	28.8	41.7	23.5	82.7	44.3	19.2	29.5	58.4	28.3	19.5	23.7	43.0	20.5	42.1	22.6	20.1	32.3	23.6	3.0	55.3	37.6	3.3	27.6	35.2	35.5	3.8	18.0	62.4	88.8	55.9	40.4	134.6	25.3	14.2	95.2	28.1	12.7	32.3	43.0	30.2	61.8	18.6	23.3	18.6	60.3	103.8	45.1	16.0	36.5	18.5	45.1	15.8	45.7	17.2	52.6	6.6	18.8	16.6	12.4	21.2	28.8	39.5	23.0	32.0	25.1	19.7	38.3
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738949-129769536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 166.6;kidney: 156.0"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 475.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4"	"Group enriched"	"Detected in many"	7	"monocytes: 2.8;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	7.5	0.9	0.1	3.7	0.1	0.2	3.0	0.1	0.1	3.7	0.1	5.5	99.0	2.4	0.1	2.2	6.3	4.3	5.3	0.1	0.1	156.0	23.1	2.1	0.5	0.2	0.1	1.8	0.3	0.3	0.1	1.2	0.1	1.8	6.3	0.0	1.5	0.4	0.5	4.4	166.6	6.0	0.1	0.3	3.4	0.1	0.1	1.0	1.4	2.4	0.4	7.8	4.0	0.1	0.0	0.0	0.5	0.0	8.2	40.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.4	1.2	0.0	1.3	2.8	0.2	0.2	0.4	2.0	0.1	0.0	2.8	0.4	1.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.2	0.5	11.4	5.9	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.0	0.0	10.0	1.1	0.0	0.0	0.0	0.4	18.5	0.8	0.0	0.3	12.8	0.0	1.0	3.6	0.0	0.0	1.0	1.8	1.0	0.0	0.0	3.1	0.0	0.1	0.0	21.0	0.0	0.1	0.0	475.9	75.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.0	1.2	0.9	0.0	8.4	0.0
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097976-28211965	"Metabolic proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 202.1"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 202.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (8.80e-4)"	48.0	48.3	70.0	55.9	73.7	92.0	39.9	61.7	87.0	43.7	63.9	47.0	21.8	42.3	18.8	57.0	44.8	24.5	36.2	72.2	72.0	47.2	62.1	70.9	62.9	76.1	69.2	36.6	43.2	26.9	56.6	25.7	73.6	48.6	27.4	35.2	44.9	20.1	29.9	52.9	63.0	26.8	67.8	160.6	42.8	100.3	72.9	51.1	50.5	13.7	44.9	44.9	46.0	77.8	82.9	63.3	54.8	58.8	37.2	58.8	57.9	97.0	98.0	124.8	124.8	89.1	61.7	59.8	78.6	99.8	63.3	53.8	131.6	83.9	151.5	115.3	72.1	67.6	90.0	101.6	87.9	95.4	70.8	46.3	61.2	111.1	108.9	53.5	73.1	63.4	118.0	31.0	86.0	101.1	116.2	116.1	88.1	43.6	55.4	101.0	64.3	101.2	46.8	45.2	103.3	55.0	52.9	88.3	47.8	60.8	62.7	63.3	75.4	104.1	64.4	87.2	84.8	63.0	83.8	89.8	78.7	98.4	89.1	21.1	9.9	32.9	14.2	11.4	15.4	20.7	16.5	15.8	7.3	15.7	18.1	22.6	202.1	10.7	17.6	9.5	14.7	8.4	70.0	73.7	61.7	87.0	72.2	72.0	76.1	69.2	73.6	67.8	72.9	77.8	9.6	9.6	14.2	27.4	20.2	18.6	11.4	12.6	5.2	20.8	15.0	14.6	8.0	5.7	12.6	23.9	31.3	11.5	30.2	28.5	7.9	14.1	39.2	12.7	21.5	11.6	23.5	10.3	51.2	19.2	17.3	13.3	12.2	32.8	2.5	34.6	9.3	16.7	23.4	21.9	55.4	20.6	10.2	27.9	15.8	44.8	10.8	22.6	7.2	43.1	28.6	8.3	23.7	59.3	90.3	23.4	13.5	8.6	16.5	22.4	13.3	7.1	10.3	28.1	6.6	13.5	12.2	31.6	26.5	18.0	21.3	8.3	27.0	9.5	21.2	15.4
YAE1	"C7orf36, CIAB2, GK003, YAE1D1"	ENSG00000241127	"YAE1 maturation factor of ABCE1"	Q9NRH1	7	39566385-39610320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 17.2;Cytotrophoblasts: 15.1;Extravillous trophoblasts: 12.0;Fibroblasts: 6.2;Hofbauer cells: 10.0;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019226, HPA031249"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA019226: AB_1845759, HPA031249: AB_2673807"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-3)"	11.2	13.9	14.6	9.7	15.6	2.3	17.4	17.4	20.3	14.7	15.4	18.9	14.4	17.0	21.9	15.2	15.4	11.0	16.4	14.8	15.0	15.3	12.0	11.1	10.0	14.5	14.8	21.0	11.1	21.1	14.4	10.9	14.8	13.5	20.0	18.3	13.4	12.3	13.9	11.0	19.3	15.9	14.9	9.4	14.1	19.8	14.4	11.0	14.9	16.6	9.1	12.4	11.6	16.4	29.3	18.5	35.5	40.2	28.5	28.5	21.3	43.8	33.6	35.4	39.7	14.9	17.1	15.1	19.9	33.4	62.4	27.9	35.2	26.3	33.1	15.4	28.7	13.7	20.9	28.7	26.6	14.6	10.5	26.9	21.0	39.3	42.4	21.1	29.6	13.7	46.8	6.9	29.7	18.5	11.8	29.2	81.0	34.6	21.8	16.5	24.9	17.4	33.0	24.4	48.1	52.3	32.7	46.6	44.1	38.9	41.3	27.6	21.3	17.7	34.3	23.8	35.5	22.1	50.3	34.9	22.1	34.6	56.2	21.6	6.4	8.6	9.9	6.8	11.0	16.1	12.8	15.2	7.1	16.2	22.7	16.6	0.7	10.7	5.1	10.6	15.5	7.9	14.6	15.6	17.4	20.3	14.8	15.0	14.5	14.8	14.8	14.9	14.4	16.4	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	15.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	12.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.0
YKT6		ENSG00000106636	"YKT6 v-SNARE homolog"	O15498	7	44200959-44214294	"Metabolic proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030817, HPA030818"	Approved		Approved	Mitochondria,Cytosol		No	No		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	Mitochondria	"HPA030817: AB_10599828, HPA030818: AB_10602102"	"unprognostic (1.25e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.30e-3)"	"unprognostic (7.80e-3)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.66e-3)"	31.6	33.4	52.4	31.7	51.8	36.9	26.4	50.8	52.2	23.5	46.3	34.9	30.5	30.3	38.7	50.1	22.8	19.9	37.8	53.9	57.8	33.7	20.2	27.7	27.6	56.1	62.8	19.5	52.6	34.3	31.7	27.7	60.2	27.2	34.5	16.0	37.6	27.1	49.6	34.3	29.7	35.0	57.2	30.2	40.4	28.4	58.7	38.4	28.8	36.5	34.9	31.2	24.7	56.5	81.9	86.1	71.3	94.8	85.3	72.6	63.1	161.5	130.3	104.5	103.6	93.7	75.9	88.0	71.4	157.7	184.5	94.5	83.1	111.0	140.8	89.4	65.3	53.7	63.1	58.7	105.1	103.4	80.8	66.7	97.6	114.7	123.4	77.5	111.5	75.9	126.2	64.8	125.2	79.4	87.3	106.8	178.8	111.5	120.2	81.9	76.0	68.4	72.2	69.2	94.2	151.6	83.0	126.4	97.8	115.8	100.0	100.4	138.0	112.5	123.9	104.2	199.1	134.5	187.8	130.3	146.2	87.5	219.4	5.6	10.8	18.2	5.3	11.5	7.9	7.1	7.0	9.0	10.0	10.1	5.4	5.4	8.9	5.1	10.6	7.9	7.5	5.5	52.4	51.8	50.8	52.2	53.9	57.8	56.1	62.8	60.2	57.2	58.7	56.5	12.4	12.8	9.4	9.1	16.2	26.0	18.1	14.1	10.2	8.4	21.6	15.4	19.7	7.2	13.7	20.2	10.4	25.3	13.9	45.4	25.4	47.1	25.4	9.4	15.8	19.3	13.8	9.5	7.0	83.0	63.5	18.7	18.8	17.7	1.3	15.1	14.6	15.7	41.2	13.5	6.5	26.6	16.2	19.4	19.3	8.3	9.9	19.5	26.6	1.0	40.2	11.0	23.7	8.0	8.3	79.0	23.3	13.5	38.8	35.8	33.1	23.1	8.7	7.9	0.0	13.1	23.8	18.9	23.0	22.9	25.9	49.3	15.2	11.8	24.0	44.4
YPEL5	CGI-127	ENSG00000119801	"Yippee like 5"	P62699	2	30146941-30160533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 438.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 548.0;Plasma cells: 545.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042809	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA042809: AB_2678179"	"unprognostic (7.22e-3)"	"unprognostic (6.50e-3)"	"unprognostic (9.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.67e-3)"	65.2	67.0	61.5	44.9	65.6	438.1	55.2	58.0	81.2	61.3	68.2	70.3	40.5	51.4	84.3	55.6	51.3	64.0	56.7	66.0	64.7	87.4	64.4	61.1	62.7	64.0	57.2	60.3	44.8	101.5	45.6	64.6	63.0	68.8	45.5	77.2	63.3	95.5	54.1	51.9	44.4	65.1	61.8	58.9	49.4	71.4	60.8	77.2	61.8	48.7	62.8	78.1	47.0	61.6	35.9	18.1	42.5	20.9	113.3	109.4	35.0	50.7	152.6	28.5	43.3	16.3	36.7	21.4	32.7	100.7	65.0	19.1	9.9	50.5	40.2	94.1	19.1	11.0	8.0	26.0	98.3	3.7	24.9	114.1	100.7	53.0	67.6	122.5	53.8	13.5	15.5	36.8	77.2	18.5	11.3	26.3	23.9	41.2	22.7	7.0	56.8	20.9	96.4	69.6	16.7	51.1	24.6	24.4	65.2	77.1	27.3	20.5	70.6	77.4	29.5	21.2	14.2	86.5	34.9	28.7	55.1	9.9	31.7	229.3	82.4	190.7	53.3	95.4	54.7	89.9	65.8	64.2	78.0	74.0	62.2	55.8	306.9	56.5	149.5	152.9	95.8	146.6	61.5	65.6	58.0	81.2	66.0	64.7	64.0	57.2	63.0	61.8	60.8	61.6	83.8	83.3	90.5	13.4	398.6	134.0	162.9	184.8	122.3	70.7	142.5	105.5	73.2	47.1	119.3	101.2	47.9	172.8	300.4	104.1	138.9	90.9	253.9	178.0	71.0	74.3	208.9	93.7	30.9	78.8	140.4	84.2	126.9	213.7	81.3	46.4	56.0	43.3	103.3	63.9	25.9	94.5	114.0	132.1	168.7	548.0	57.8	214.9	170.7	15.9	321.0	103.4	50.4	19.6	28.3	110.2	108.6	82.8	545.7	143.3	84.8	137.0	101.4	63.5	52.6	87.4	114.9	133.8	78.0	97.4	142.6	408.0	358.5	53.5	46.8	281.2
YWHAG	"14-3-3γ, 14-3-3GAMMA, PPP1R170"	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326799-76358991	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 337.4;skeletal muscle: 349.8"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 408.8;Suprabasal keratinocytes: 425.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013274, CAB018389, HPA026918"	Approved	Approved	Approved	Cytosol		NA	NA		66000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	188.1	99.2	165.6	60.6	185.3	27.3	61.0	80.2	337.4	41.1	8.5	48.4	47.8	50.9	20.8	64.5	37.9	54.5	111.4	206.5	206.1	50.8	72.4	47.1	43.2	204.5	120.7	40.7	59.7	50.1	32.6	55.4	192.9	46.1	44.0	87.2	39.9	40.0	349.8	43.7	41.6	66.4	81.5	44.2	38.2	28.9	135.1	40.2	29.7	238.4	48.6	78.8	46.3	199.1	189.0	231.9	200.5	256.7	200.5	114.9	90.5	213.3	105.0	129.6	139.5	147.0	196.7	263.5	71.7	190.8	215.2	171.6	254.3	235.8	180.5	179.9	110.9	250.2	150.0	164.5	182.6	309.0	234.0	127.1	221.0	151.5	310.8	137.3	208.9	140.2	349.9	289.0	195.8	177.6	222.3	227.1	223.0	150.7	160.4	256.3	203.0	291.7	204.5	126.3	107.0	297.1	236.7	299.2	156.0	256.9	208.5	184.2	222.6	250.7	145.7	225.4	290.1	95.1	191.6	399.5	225.5	285.3	273.8	1.5	2.3	0.5	0.8	2.0	1.4	1.3	1.0	1.1	2.4	0.7	0.7	0.9	0.5	0.5	1.8	2.6	0.9	0.9	165.6	185.3	80.2	337.4	206.5	206.1	204.5	120.7	192.9	81.5	135.1	199.1	73.7	32.1	26.4	23.2	51.8	408.8	128.3	87.9	126.9	102.9	107.0	70.1	234.0	40.0	55.1	38.6	12.5	36.5	39.3	49.9	37.2	52.4	91.2	96.0	82.9	92.0	85.4	72.8	99.9	38.2	84.1	97.4	61.2	127.9	67.3	38.7	50.0	93.1	83.5	124.5	78.5	35.7	44.7	90.3	229.0	25.2	46.3	87.8	94.3	40.3	64.2	27.1	20.6	23.1	57.1	71.1	29.9	43.2	56.6	129.8	34.1	61.3	47.2	35.3	32.9	92.5	91.5	13.4	19.0	160.1	425.4	67.2	41.5	46.4	45.1	177.1
Z83844.2		ENSG00000285304	"Novel protein"		22	37639693-37666932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 8.8"	"Not detected"	"Not detected"							"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA000757	Approved		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"		Cytosol		"HPA000757: AB_1079951"																		1.0	0.2	0.1	7.3	0.0	8.8	1.0	0.1	1.4	3.1	0.0	5.9	5.6	1.3	0.0	4.0	1.6	1.3	0.5	0.2	0.1	0.0	0.9	3.4	7.4	0.0	0.0	1.0	0.7	2.6		3.7	0.2	0.9	5.0	0.1	2.1	2.3	0.2	1.7	8.1	2.3	0.1	3.9	1.4	0.7	0.2	6.5	0.5	0.0	6.6	4.2		0.4	14.7	2.1	7.7	5.0	2.3	6.5	8.3	4.1	12.9	15.3	15.8	9.8	3.5	8.4	1.4	4.5	5.1	12.2	9.2	22.3	4.7	10.2	7.0	21.3	0.0	10.7	4.2	33.2	25.5	7.8	9.4	17.7	1.6	6.5	0.9	6.1	5.9	7.5	0.7	13.4	1.2	1.9	7.9	23.9	1.6	12.6	4.9	7.7	1.6	4.5	4.4	7.2	1.1	4.9	8.0	5.4	6.4	14.5	1.5	2.0	7.5	1.2	0.0	12.3	4.7	8.8	5.2	21.5	14.8	0.0	0.6	0.0	0.4	0.3	0.3	0.3	0.2	0.5	0.9	0.2	0.6	0.4	0.0	0.5	0.6	0.4	0.6	0.3	0.1	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 47.6;thyroid gland: 71.0"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 44.8"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 54.8;EFO-21: 37.4;HaCaT: 53.1;HBEC3-KT: 119.3;RPTEC TERT1: 77.6"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.2	0.0	0.0	1.7	0.4	0.3	0.2	0.0	0.1	5.4	0.0	0.1	0.1	0.1	0.2	12.8	20.0	0.3	0.1	0.0	0.0	0.2	0.0	10.4	6.9	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.1	0.0	2.8	0.4	0.0	2.2	0.5	0.0	0.0	0.3	0.5	0.0	0.0	47.6	71.0	0.0	12.9	0.4	9.9	0.0	15.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	54.8	0.5	37.4	0.0	0.0	53.1	0.0	119.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	10.8	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	1.2	0.2	0.1	0.0	2.1	0.6	0.8	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	1.1	0.0	0.6	4.5	0.3	3.1	4.6	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	3.8	0.0	4.5	0.0	0.1	0.2
ZBTB14	"ZFP161, ZNF478"	ENSG00000198081	"Zinc finger and BTB domain containing 14"	O43829	18	5289019-5297053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050758, HPA070819"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA050758: AB_2681226, HPA070819: AB_2686316"	"unprognostic (5.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.72e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.90e-2)"	10.3	8.6	9.3	14.7	10.5	9.6	12.5	11.4	12.2	9.6	7.4	10.4	8.7	9.9	16.4	12.4	10.6	12.0	8.6	8.7	9.6	11.2	13.4	11.1	24.7	9.5	10.3	15.6	14.4	12.0	4.8	9.1	9.6	9.8	10.0	7.3	12.2	12.1	8.5	14.0	9.3	8.7	10.2	16.2	11.9	5.9	9.5	21.8	15.5	8.4	21.8	9.6	5.2	11.4	9.0	11.8	15.1	11.2	11.0	14.5	10.0	8.8	13.0	12.0	10.5	11.3	11.5	31.2	7.6	10.7	13.9	8.2	11.2	13.2	12.2	6.0	6.0	12.4	11.1	10.5	7.8	15.8	14.4	11.6	10.9	8.5	7.9	13.0	19.2	22.3	8.1	10.1	12.4	9.9	23.8	10.5	13.4	11.1	6.0	14.0	9.7	9.2	10.0	10.8	13.3	13.0	13.4	8.8	14.3	15.0	10.5	17.9	10.7	15.6	12.8	12.2	13.3	6.4	6.9	19.9	16.4	13.3	14.0	9.8	5.5	14.1	8.7	7.8	8.6	7.5	11.0	10.0	8.2	10.4	11.6	11.1	1.2	7.6	7.5	6.1	7.6	7.3	9.3	10.5	11.4	12.2	8.7	9.6	9.5	10.3	9.6	10.2	9.5	11.4	8.8	6.4	6.7	5.9	8.5	2.4	1.6	2.9	5.2	7.4	5.6	4.3	3.6	1.5	2.2	5.5	0.0	5.3	6.3	5.5	5.9	4.9	0.8	4.3	5.5	7.4	1.2	9.1	2.9	3.3	5.5	4.6	0.5	3.7	15.9	6.0	11.7	6.9	7.1	5.0	3.1	5.1	8.2	7.5	4.5	2.8	5.9	6.3	1.8	1.0	7.8	10.8	6.2	2.5	6.6	3.5	4.0	5.7	2.2	2.4	5.7	5.5	2.5	5.9	0.0	6.0	5.7	1.0	9.3	4.2	3.0	2.2	8.8	5.1	5.2	1.5
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364115-151391559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	8.4	4.8	4.8	8.5	5.1	16.1	8.5	6.0	6.3	6.9	4.5	8.0	7.5	8.5	6.9	5.9	7.7	7.9	6.0	5.2	5.1	6.9	9.4	9.7	14.4	5.4	5.3	13.3	8.3	7.1	3.0	8.7	5.4	6.1	9.0	3.2	7.1	5.9	9.1	6.9	8.2	9.4	5.0	9.3	7.4	6.7	5.2	20.8	29.7	9.7	12.6	11.0	5.4	6.6	15.3	10.9	16.3	12.4	17.1	17.9	17.4	23.6	33.9	29.2	27.7	21.1	12.2	38.9	12.8	23.9	29.5	17.8	26.5	28.7	36.1	17.7	19.7	17.5	12.6	32.2	25.3	47.9	20.8	19.0	16.9	26.8	32.6	16.6	17.4	18.1	32.5	22.2	20.8	34.2	26.1	22.3	19.8	18.8	16.4	24.6	15.4	15.6	22.2	22.7	18.1	12.6	18.6	24.2	18.8	16.3	16.3	28.4	14.4	24.5	26.8	11.3	31.8	29.4	32.9	43.2	10.1	25.7	17.8	18.7	6.5	16.8	11.3	7.1	14.2	6.3	10.2	13.5	7.1	4.5	8.4	10.4	7.3	8.9	12.9	2.9	9.2	7.1	4.8	5.1	6.0	6.3	5.2	5.1	5.4	5.3	5.4	5.0	5.2	6.6	13.3	9.6	4.6	4.6	13.2	15.7	11.4	5.8	42.7	3.0	14.4	7.4	8.8	5.7	9.1	0.0	0.0	5.9	18.0	4.6	13.7	4.8	9.4	18.7	14.2	12.7	9.0	8.2	5.6	2.9	19.6	9.9	6.6	29.5	9.5	4.9	5.7	3.3	7.5	1.7	4.4	6.3	18.3	8.8	17.4	10.5	8.7	10.8	10.6	1.0	4.4	3.1	12.3	5.5	11.1	5.0	2.0	4.1	11.1	14.8	5.8	5.3	7.1	2.3	6.6	6.2	10.8	4.1	6.7	23.8	18.3	12.4	16.3	3.7	7.3	9.6
ZBTB37	"MGC2629, ZNF908"	ENSG00000185278	"Zinc finger and BTB domain containing 37"	Q5TC79	1	173868082-173903549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 12.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.2;Late spermatids: 67.0;Rod photoreceptor cells: 60.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023438	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA023438: AB_1858954"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.96e-2)"	3.0	1.6	4.6	2.6	7.5	5.7	2.6	6.3	4.6	2.8	2.1	1.9	1.8	2.1	2.3	1.4	2.1	1.6	2.0	4.4	4.6	2.2	2.1	2.7	3.8	8.6	6.3	3.3	2.0	1.8	2.6	2.1	9.2	2.3	1.6	10.8	2.0	1.4	1.8	3.2	2.3	1.8	4.4	3.8	2.3	9.3	6.4	3.2	2.7	2.2	3.0	2.0	2.3	12.7	1.7	2.5	3.8	1.6	2.3	1.8	4.2	1.5	1.1	2.7	1.9	3.2	2.1	4.6	3.1	2.4	1.4	2.1	3.2	1.7	2.2	2.6	2.0	6.4	3.0	1.6	1.3	3.8	3.9	1.7	1.1	4.0	2.6	1.6	1.4	3.2	5.7	3.0	2.8	1.2	2.6	0.9	3.6	1.3	0.6	1.7	3.3	1.5	1.5	4.2	2.8	3.5	2.1	2.9	2.8	4.0	4.2	3.9	2.5	3.5	3.7	1.7	2.4	5.3	4.2	7.3	2.3	2.1	2.1	0.1	0.4	1.4	1.1	0.4	0.4	0.2	0.5	0.7	0.2	0.6	0.2	0.6	2.3	0.9	0.4	0.9	0.4	0.3	4.6	7.5	6.3	4.6	4.4	4.6	8.6	6.3	9.2	4.4	6.4	12.7	8.5	6.4	6.3	2.0	9.7	2.9	3.7	3.6	4.0	27.2	5.7	2.8	9.2	12.8	4.2	11.0	33.3	8.3	11.9	4.6	7.9	3.6	60.2	9.1	8.8	6.8	3.5	5.7	1.6	3.8	3.9	7.4	5.1	7.6	2.5	16.9	11.0	4.7	5.0	18.5	2.1	3.9	0.0	15.4	5.5	67.0	8.7	10.0	10.6	2.8	10.6	10.3	18.6	3.5	5.3	2.8	2.7	13.2	5.7	4.3	4.7	5.4	10.6	60.1	6.6	9.5	10.8	23.2	13.2	3.2	5.8	9.2	9.3	11.6	3.6	3.4
ZBTB41	"DKFZp686C06120, FLJ36199, FRBZ1, ZNF924"	ENSG00000177888	"Zinc finger and BTB domain containing 41"	Q5SVQ8	1	197153682-197201293	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034841, HPA034842"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA034841: AB_2674355, HPA034842: AB_10669995"	"unprognostic (2.36e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.01e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.58e-1)"	3.5	4.7	5.0	3.0	4.7	1.3	7.0	6.6	5.8	5.2	2.2	3.2	3.2	4.2	4.7	3.4	3.7	4.3	3.2	4.6	5.8	5.3	4.4	3.4	3.9	5.5	6.1	6.8	4.0	4.8	3.9	3.3	5.6	4.2	3.5	7.0	3.9	3.4	3.6	3.5	2.9	3.2	6.0	4.4	4.3	3.8	5.8	5.2	7.5	4.7	3.3	3.9	2.4	6.9	8.1	4.6	5.8	4.7	9.0	13.6	4.6	4.8	7.8	4.9	4.6	2.9	6.7	3.0	6.8	10.9	3.0	6.5	4.1	4.1	7.7	2.7	2.4	2.4	6.0	2.6	8.0	4.8	2.3	5.6	10.6	5.0	8.6	10.0	3.4	3.4	5.7	3.5	12.8	3.9	3.6	2.7	2.3	5.6	1.6	2.5	8.1	5.4	6.0	4.5	8.3	7.4	8.6	14.9	9.3	4.2	11.4	3.6	5.6	9.7	5.6	7.8	6.3	4.0	2.2	3.2	4.6	1.7	13.8	0.3	0.1	0.1	0.2	0.1	0.4	0.4	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.4	0.1	0.1	0.2	0.1	5.0	4.7	6.6	5.8	4.6	5.8	5.5	6.1	5.6	6.0	5.8	6.9	11.6	19.2	8.9	21.2	9.4	7.5	6.9	5.8	11.4	13.6	17.5	10.7	14.7	10.0	10.0	16.5	2.1	4.3	10.6	4.2	1.9	6.3	3.2	14.5	18.0	8.2	13.1	1.7	32.1	5.7	4.0	13.3	7.7	11.3	1.3	18.5	6.8	9.2	4.4	25.2	27.9	7.3	2.0	7.3	5.2	4.6	15.5	8.1	12.4	13.1	9.3	28.5	11.3	19.6	41.0	6.8	2.9	12.0	6.3	9.4	4.3	10.4	12.8	9.1	6.6	13.3	12.7	7.0	4.9	10.8	10.1	3.4	7.7	16.0	7.0	6.0
ZBTB45	"FLJ14486, ZNF499"	ENSG00000119574	"Zinc finger and BTB domain containing 45"	Q96K62	19	58513530-58538911	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035754, HPA075485"	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Nuclear bodies"	"HPA035754: AB_10603461, HPA075485: "	"unprognostic (1.38e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.40e-1)"	7.9	8.5	6.5	5.1	6.7	4.9	8.6	5.2	11.4	9.9	1.9	10.3	6.1	12.0	1.1	10.1	9.5	3.1	9.1	7.1	4.9	7.7	6.9	6.1	4.2	8.9	6.4	9.3	8.2	4.2	7.1	3.1	8.3	9.5	1.6	2.1	9.0	4.1	10.3	12.7	7.6	2.4	4.5	8.0	8.3	4.9	6.7	3.3	8.3	3.0	2.3	10.5	9.0	7.4	21.3	29.7	7.6	11.7	7.7	6.6	9.6	11.8	4.8	3.0	2.9	5.8	13.4	31.9	15.6	6.6	8.4	13.2	4.2	10.7	1.1	21.4	55.3	17.3	15.1	7.1	4.9	11.1	11.1	6.3	7.4	4.7	3.9	5.6	6.2	32.1	16.0	1.8	4.6	14.2	17.4	11.6	10.6	12.5	26.1	13.8	4.7	19.4	6.2	19.4	23.4	16.7	8.7	22.5	6.1	4.6	33.4	7.6	13.1	12.9	5.6	4.3	11.7	34.8	27.2	15.9	14.7	4.6	8.4	5.8	5.0	10.2	5.7	7.6	6.8	4.4	3.9	5.3	5.3	5.0	4.6	3.4	4.4	5.5	9.1	6.4	3.7	4.7	6.5	6.7	5.2	11.4	7.1	4.9	8.9	6.4	8.3	4.5	6.7	7.4	3.3	9.6	0.5	2.9	5.6	1.7	3.7	5.5	2.2	4.2	4.5	4.6	3.3	1.5	4.0	12.9	0.0	8.9	5.1	6.3	5.9	10.6	0.6	3.4	4.6	5.0	10.3	7.4	1.9	8.9	8.0	3.9	8.6	3.8	0.0	5.6	8.6	4.5	6.6	6.7	2.0	4.6	8.2	6.8	2.4	1.3	5.9	3.7	7.2	0.0	12.3	3.7	7.2	1.5	1.6	8.8	2.6	9.8	3.6	3.8	5.9	5.6	3.8	3.0	13.1	2.5	5.1	5.2	5.9	3.5	2.7	5.6	3.1	4.8	6.0	2.6
ZBTB49	"FLJ38559, ZNF509"	ENSG00000168826	"Zinc finger and BTB domain containing 49"	Q6ZSB9	4	4290251-4321786	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024450	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Microtubules, Cytosol"	"HPA024450: AB_1859311"	"unprognostic (4.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.54e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.88e-5)"	2.3	1.8	0.8	2.2	0.7	5.1	2.4	1.0	1.6	2.4	1.1	2.1	1.6	2.2	2.4	1.8	1.9	1.9	2.3	0.8	0.8	1.8	1.9	2.4	3.0	0.9	0.7	3.7	2.9	2.1	3.1	2.0	1.2	2.8	1.6	3.4	2.2	2.2	2.9	2.2	1.9	2.3	0.4	3.5	1.7	4.0	1.0	2.0	2.9	2.1	3.0	2.4	2.1	2.3	1.4	2.2	2.7	4.6	3.6	3.7	3.2	1.6	3.2	3.6	2.8	1.9	2.6	4.9	1.7	1.9	4.4	2.3	4.8	2.8	3.7	1.6	1.9	5.7	1.5	2.8	2.8	3.5	2.0	2.4	2.3	3.3	2.1	2.0	3.6	5.2	3.0	2.6	3.4	2.2	6.9	6.7	4.7	2.0	3.0	4.1	3.6	3.1	1.4	2.4	3.3	3.2	3.7	1.4	3.7	3.6	2.0	3.3	3.6	3.2	1.4	2.0	3.7	3.1	3.3	4.3	2.3	2.9	3.2	2.9	2.0	9.8	4.6	2.1	3.8	1.6	2.6	4.5	1.5	2.4	2.9	3.4	4.6	2.8	1.8	0.3	2.6	1.5	0.8	0.7	1.0	1.6	0.8	0.8	0.9	0.7	1.2	0.4	1.0	2.3	3.1	0.0	1.1	3.9	5.3	2.5	1.9	1.8	2.2	2.9	2.2	3.4	1.9	1.5	2.1	1.8	4.2	2.0	5.8	0.8	0.0	1.9	2.7	1.2	2.7	3.1	1.2	3.6	11.5	2.6	1.5	3.1	2.0	1.3	1.3	5.4	3.9	2.2	1.8	1.7	12.5	1.8	2.0	3.1	2.4	0.7	1.5	2.7	3.6	4.7	4.5	1.7	9.2	11.6	10.0	1.1	2.9	2.2	6.6	2.1	1.8	0.9	1.3	8.2	0.0	2.2	2.1	9.7	5.5	1.7	2.6	1.5	6.3	4.6	1.6	1.2
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465072-32496686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Langerhans cells: 4.7;Oligodendrocyte precursor cells: 9.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RT4: 1.0"									"HPA055553, HPA071427"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA055553: AB_2682848, HPA071427: "	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.0	0.1	1.6	0.1	1.1	0.4	0.1	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.0	1.9	0.0	0.0	0.0	0.1	1.2	1.9	0.1	0.1	0.1	0.6	0.1	1.1	0.1	0.0	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.2	1.8	0.0	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.9	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.2	0.1	0.0	1.6	1.1	0.8	1.2	1.0	1.9	1.2	1.9	1.1	0.4	1.8	0.8	0.4	0.0	1.8	0.3	0.2	1.7	1.1	0.1	0.0	2.6	0.3	0.5	0.8	0.0	0.7	0.0	6.2	1.9	1.4	0.3	0.0	0.0	2.1	0.5	1.6	0.7	0.0	0.0	0.8	0.0	1.3	0.8	0.0	0.5	3.8	2.8	0.7	0.2	0.4	3.3	2.2	0.0	0.0	0.3	4.7	2.1	0.6	0.7	1.8	1.9	0.0	1.4	1.0	9.0	0.4	0.0	0.0	0.0	0.3	0.9	0.0	0.1	1.5	2.4	0.0	1.6	0.7	2.2	1.5	0.0	0.6	0.3	0.7	0.9	0.0	0.9
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.5;Ionocytes: 6.1;Respiratory ciliated cells: 4.3;Suprabasal keratinocytes: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.6;BEWO: 11.3;GAMG: 16.5;HMC-1: 14.2;U-698: 12.0"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	2.8	3.9	0.9	1.5	1.0	1.7	2.3	0.8	1.6	2.5	8.6	2.4	2.3	2.6	1.7	3.8	2.5	0.6	3.0	1.9	0.7	4.4	3.2	2.4	1.9	1.2	0.9	3.0	2.9	0.6	10.0	0.5	0.6	2.4	1.4	1.9	2.9	0.1	1.8	3.8	2.7	0.8	0.2	3.5	2.7	7.4	0.4	0.2	2.2	1.0	3.3	2.5	2.2	0.9	1.0	0.3	11.6	2.9	2.1	0.1	11.3	0.6	0.2	0.2	0.1	3.0	0.8	2.7	1.8	0.3	16.5	1.2	4.8	2.4	1.3	3.1	2.0	9.0	2.3	0.0	0.0	2.3	14.2	0.5	0.9	3.3	2.6	0.6	0.1	1.5	3.2	1.8	2.6	1.6	0.6	0.9	4.3	0.5	0.7	5.6	3.0	2.7	2.2	2.3	1.8	1.1	3.3	0.3	1.1	1.1	1.6	0.4	1.9	0.9	1.3	1.3	1.2	0.7	3.5	12.0	0.9	2.9	0.3	5.2	1.1	0.4	2.8	0.8	1.2	0.4	1.2	2.6	1.5	0.8	2.5	1.9	0.8	1.3	1.7	0.3	2.2	0.6	0.9	1.0	0.8	1.6	1.9	0.7	1.2	0.9	0.6	0.2	0.4	0.9	0.1	0.0	0.0	1.3	2.1	4.5	0.0	1.9	1.8	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.3	0.4	0.1	0.6	1.8	1.3	1.2	1.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.7	6.1	0.0	1.2	1.1	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.6	0.0	0.2	0.1	4.3	0.0	0.0	0.0	0.7	0.1	0.1	0.8	3.7	0.0	0.7	0.1	1.0	0.0
ZC2HC1A	"C8orf70, CGI-62, FAM164A"	ENSG00000104427	"Zinc finger C2HC-type containing 1A"	Q96GY0	8	78666089-78719765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 44.6"	"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 45.1;T-reg: 33.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 42.1;SK-BR-3: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024726	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Actin filaments"	"HPA024726: AB_1846597"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.19e-7)"	"unprognostic (2.96e-1)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.05e-3)"	6.5	5.5	8.4	5.7	9.5	1.6	13.8	11.0	9.9	10.7	1.7	6.2	2.7	19.5	8.4	11.1	19.0	9.7	8.2	9.4	8.4	7.7	2.3	12.6	5.3	9.3	6.9	22.7	3.7	24.0	8.5	6.6	10.1	12.2	7.3	10.9	7.3	9.9	2.4	44.6	4.2	12.1	6.3	5.8	5.5	8.8	7.6	5.1	19.7	6.3	8.4	9.0	8.8	10.9	5.2	6.3	11.6	9.5	24.1	25.2	5.0	14.1	9.4	6.9	8.8	1.7	9.0	8.6	5.8	14.2	14.5	4.2	7.0	7.8	10.1	28.6	4.5	1.0	5.5	5.2	14.3	1.5	2.8	18.2	13.0	5.6	16.8	21.1	9.6	2.9	1.6	42.1	14.6	5.1	1.7	2.5	2.9	0.4	9.9	0.0	14.8	1.8	10.4	11.0	4.5	18.0	11.0	79.2	15.8	10.7	2.0	0.3	7.9	21.4	8.9	9.9	7.1	10.5	11.4	5.8	10.1	0.1	8.3	45.1	6.7	0.2	0.1	7.5	0.0	8.8	6.7	0.4	6.0	6.3	2.0	0.7	0.3	1.2	15.9	0.5	33.3	2.7	8.4	9.5	11.0	9.9	9.4	8.4	9.3	6.9	10.1	6.3	7.6	10.9	21.7	67.3	23.7	71.8	17.0	29.2	38.7	39.9	52.3	26.3	12.3	47.5	15.9	5.7	27.4	18.4	4.2	29.0	1.0	1.8	27.4	18.1	16.3	55.5	38.0	17.5	9.0	1.7	96.4	8.2	29.9	34.5	13.3	25.8	6.3	18.8	21.8	0.8	15.9	47.1	68.3	4.2	16.2	6.0	11.3	5.9	19.3	11.1	16.0	14.0	18.5	39.2	0.0	65.9	52.4	9.4	2.4	36.9	12.5	13.1	0.1	11.8	105.5	25.5	6.6	32.0	33.9	48.6	32.2	26.0	42.3	17.4	6.5	9.4	4.4	14.6
ZCCHC2	"C18orf49, FLJ20222, FLJ20281, KIAA1744"	ENSG00000141664	"Zinc finger CCHC-type containing 2"	Q9C0B9	18	62523025-62587709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 143.8;Late spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040943	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA040943: AB_10795496"	"unprognostic (9.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	10.7	5.5	6.2	5.8	6.6	26.5	9.1	9.3	8.2	6.7	6.0	7.1	6.7	6.3	5.9	5.5	7.8	8.6	8.5	5.5	6.9	5.5	23.3	10.2	7.0	7.2	6.8	8.0	6.2	5.8	8.0	8.1	6.7	7.3	5.4	10.0	37.2	5.3	12.2	11.6	7.5	5.8	5.3	9.0	6.4	12.0	6.6	7.6	7.3	7.3	6.3	7.9	6.5	11.5	8.0	6.8	5.8	11.5	17.1	7.3	10.9	4.5	6.7	10.5	10.4	3.7	4.8	22.4	5.8	7.4	8.6	13.2	18.6	9.9	4.3	15.5	8.8	5.9	15.6	25.2	5.9	11.4	8.3	7.2	12.6	6.7	12.3	7.6	19.9	9.9	6.4	7.3	3.5	6.5	7.5	4.8	3.7	5.8	6.7	9.7	6.1	0.1	7.3	8.0	7.2	4.5	7.5	16.8	6.6	10.2	5.9	8.9	8.6	10.3	7.0	4.1	6.5	2.8	5.8	9.4	7.6	4.7	3.9	0.0	0.3	0.8	0.5	0.5	0.4	0.1	0.3	0.4	0.1	0.4	0.6	0.4	1.5	0.2	0.1	0.3	0.4	0.1	6.2	6.6	9.3	8.2	5.5	6.9	7.2	6.8	6.7	5.3	6.6	11.5	23.1	25.6	18.8	28.1	10.8	26.6	16.9	7.5	10.8	33.1	15.2	13.2	18.8	20.0	12.4	16.5	54.2	7.4	33.6	10.2	3.9	6.8	143.8	24.1	12.3	28.8	12.6	8.2	48.5	6.2	10.9	9.7	10.2	27.5	2.5	4.4	17.5	35.4	14.1	43.7	33.9	15.5	2.0	44.4	22.0	158.6	8.1	30.6	7.2	29.0	11.9	7.7	9.2	37.2	51.7	5.1	9.1	7.9	10.7	16.5	8.4	5.3	10.8	19.5	6.6	15.6	15.0	16.3	15.2	15.3	18.5	6.8	22.6	5.6	11.5	12.2
ZDBF2	"FLJ45338, KIAA1571"	ENSG00000204186	"Zinc finger DBF-type containing 2"	Q9HCK1	2	206274663-206314427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.0;Granulosa cells: 44.4;Inhibitory neurons: 56.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039121, HPA050311"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"HPA039121: AB_2676357, HPA050311: AB_2681081"	"unprognostic (8.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.73e-3)"	"unprognostic (7.59e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.40e-1)"	2.3	4.1	1.8	0.9	3.5	0.6	1.6	3.4	1.8	3.0	7.8	2.4	0.4	2.6	1.7	1.1	3.2	1.2	2.3	2.3	3.8	1.4	1.5	1.3	1.1	1.2	1.4	9.5	5.0	1.5	8.0	2.3	1.1	1.8	0.6	5.5	1.7	1.4	2.7	1.1	1.7	1.3	0.4	1.4	2.0	1.7	3.5	0.9	2.0	1.5	0.9	1.7	2.0	0.4	1.4	0.2	4.4	0.8	1.7	1.4	6.9	1.4	1.5	0.7	0.9	0.4	1.2	0.0	0.6	1.5	2.6	0.3	3.0	1.1	1.3	1.4	2.9	0.0	3.4	0.1	2.2	1.3	2.9	1.4	1.9	1.4	2.7	5.1	2.1	1.1	0.2	1.9	2.1	0.2	0.4	0.0	6.2	0.1	1.6	0.0	4.6	0.0	0.8	0.6	2.4	5.6	2.6	0.0	2.5	10.0	0.1	0.0	2.6	0.7	2.3	0.5	1.1	4.1	1.1	0.2	3.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	3.5	3.4	1.8	2.3	3.8	1.2	1.4	1.1	0.4	3.5	0.4	6.9	3.2	3.9	15.7	19.3	4.0	1.9	3.1	7.4	26.9	4.4	3.3	9.2	1.5	4.4	11.0	14.6	5.2	9.7	0.6	0.0	2.8	4.1	1.9	7.5	5.1	7.8	0.8	75.0	2.2	6.9	11.7	4.6	0.6	12.7	44.4	3.3	3.4	0.5	8.4	56.5	1.3	4.1	0.3	4.2	5.1	4.4	2.3	1.8	18.7	0.1	8.7	0.0	26.2	3.1	1.2	0.5	5.3	23.4	3.5	1.0	2.3	10.6	18.1	0.0	19.2	9.2	4.4	9.0	6.0	3.3	9.0	13.5	24.5	0.5	0.8
ZDHHC1	"C16orf1, HSU90653, ZNF377"	ENSG00000159714	"Zinc finger DHHC-type containing 1"	Q8WTX9	16	67394152-67416833	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 84.6;Late spermatids: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.4;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 11.4;ASC TERT1: 11.3;U-138 MG: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042531, HPA048659"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA042531: AB_2678041, HPA048659: AB_2680483"	"unprognostic (8.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.05e-3)"	"prognostic favorable (1.25e-6)"	"unprognostic (1.68e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.55e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.63e-3)"	17.7	10.9	3.7	1.8	3.5	0.2	17.9	3.2	5.6	27.1	7.4	14.5	2.3	21.7	3.9	6.8	22.4	6.3	10.8	3.4	4.2	19.3	4.4	12.4	1.4	4.9	6.7	23.6	17.7	7.8	20.4	3.1	4.1	19.5	1.7	0.8	17.0	6.7	10.7	19.1	7.4	3.9	4.7	14.9	10.6	20.3	4.4	0.6	29.4	3.0	0.8	12.8	16.3	2.8	5.2	6.0	1.4	7.3	11.4	11.3	0.0	3.2	9.0	2.6	2.8	0.0	2.6	0.0	1.3	4.2	2.5	3.3	0.4	0.6	0.5	1.6	4.6	0.5	0.1	0.4	5.2	0.2	4.0	6.0	5.3	2.7	0.6	6.0	3.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	2.9	1.8	0.1	0.0	0.0	0.0	3.5	2.9	2.1	7.4	0.5	0.1	6.5	0.4	1.9	1.1	5.8	11.7	2.0	5.6	3.3	1.4	0.3	0.0	7.2	0.1	4.7	0.0	1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.3	3.7	3.5	3.2	5.6	3.4	4.2	4.9	6.7	4.1	4.7	4.4	2.8	7.0	0.0	0.0	10.4	0.9	7.1	6.7	1.3	10.8	2.2	7.5	7.0	1.1	10.0	1.4	7.3	4.2	2.0	0.3	5.2	9.8	3.4	29.3	84.6	10.9	5.2	9.0	0.4	5.7	4.0	0.2	13.6	8.6	7.3	0.0	8.5	6.1	2.0	2.0	3.3	5.0	12.9	2.0	16.4	6.8	53.0	14.6	9.3	5.4	2.8	8.2	7.9	1.0	4.0	2.5	2.2	4.9	10.9	0.7	7.2	2.0	6.6	5.5	0.5	0.0	5.1	9.4	12.4	8.6	6.2	7.1	5.7	0.7	10.4	6.8	4.8
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type palmitoyltransferase 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.2;Inhibitory neurons: 17.7;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 3.2;K-562: 2.1;LHCN-M2: 2.2;MOLT-4: 2.4;NTERA-2: 2.0;RH-30: 3.1;RPTEC TERT1: 1.7;SH-SY5Y: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003618, HPA064901"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686, HPA064901: "	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	0.8	1.5	1.7	0.3	1.7	0.1	1.6	1.8	1.5	1.6	1.3	1.0	0.2	1.9	1.0	0.8	1.2	0.8	1.7	1.5	2.5	1.5	0.2	1.2	0.3	2.2	2.2	2.5	1.1	1.1	1.1	0.0	2.0	1.1	0.5	1.9	4.5	1.1	0.3	0.7	0.3	1.5	1.8	0.8	0.4	0.6	3.0	0.8	2.0	0.5	0.2	0.7	0.8	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.1	0.0	2.2	0.0	2.4	0.0	2.0	0.0	0.0	0.0	3.1	0.0	1.7	0.0	0.8	2.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.5	0.0	0.4	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.7	1.8	1.5	1.5	2.5	2.2	2.2	2.0	1.8	3.0	2.0	2.9	6.4	3.1	8.5	0.1	4.0	1.6	0.0	3.4	4.2	2.0	1.5	9.5	1.5	1.3	5.5	4.2	0.0	0.3	0.0	0.0	0.7	0.0	0.2	2.9	3.5	1.8	0.4	18.2	0.7	0.0	3.5	0.0	0.3	1.3	2.5	2.2	0.1	0.1	0.0	17.7	0.0	0.0	0.0	4.4	0.2	0.9	0.1	0.0	5.6	0.0	2.2	1.0	17.1	9.1	0.2	0.0	3.8	0.0	0.7	0.0	1.0	0.0	2.3	6.6	5.4	2.5	0.2	0.7	2.2	3.7	0.0	0.5	2.3	0.0	0.6
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type palmitoyltransferase 16"	Q969W1	10	97446170-97457370	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	15.6	14.9	17.8	10.2	18.5	6.8	16.3	20.3	21.9	15.0	16.4	17.1	14.3	16.4	18.5	19.9	12.2	9.9	22.1	18.1	16.5	25.1	30.3	20.8	11.3	17.2	17.8	15.9	22.8	25.5	16.7	21.6	16.4	18.3	17.3	17.4	24.2	12.1	25.8	13.1	14.7	16.6	16.1	14.5	24.1	17.3	18.8	12.6	16.0	27.9	15.1	17.1	15.3	16.7	50.7	57.4	37.9	47.1	58.7	40.4	38.7	54.6	72.1	61.2	58.4	45.7	43.6	44.4	60.1	79.8	53.4	58.0	48.2	76.7	54.2	43.7	56.0	28.5	39.8	44.3	47.4	34.0	39.7	45.7	49.8	71.6	51.3	66.3	63.9	40.4	23.1	32.8	79.0	48.4	51.8	46.0	29.9	45.8	49.5	34.0	38.6	40.9	51.9	23.2	18.4	25.9	33.2	33.7	30.6	37.7	44.6	32.9	39.6	38.2	35.0	25.0	64.7	29.2	53.0	26.9	44.1	51.7	20.7	0.3	11.1	11.1	7.2	11.9	8.1	9.0	12.5	11.5	15.7	10.6	10.0	10.1	0.5	14.5	11.8	12.0	11.1	6.8	17.8	18.5	20.3	21.9	18.1	16.5	17.2	17.8	16.4	16.1	18.8	16.7	6.2	19.2	23.1	3.9	9.0	5.2	18.9	31.8	14.8	15.8	13.6	9.3	10.1	14.3	27.6	12.9	4.2	39.8	10.3	11.5	25.4	35.5	24.8	7.0	13.3	11.3	7.2	11.6	8.2	32.3	67.2	13.7	10.2	10.9	7.0	13.3	7.5	19.5	24.6	13.5	9.2	18.9	28.5	7.3	5.9	7.6	8.7	9.3	3.6	9.4	18.4	14.9	15.5	11.1	8.4	31.5	12.1	3.8	17.1	20.0	18.9	22.2	8.3	13.0	6.6	5.2	12.2	20.1	12.9	13.8	4.3	37.9	7.2	10.9	20.9	19.3
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type palmitoyltransferase 21"	Q8IVQ6	9	14611071-14693432	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 219.4;Inhibitory neurons: 201.6;Oligodendrocyte precursor cells: 268.9;Oligodendrocytes: 158.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"		"HPA065254: AB_2685446"	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.28e-6)"	3.7	5.7	4.7	4.6	5.8	2.5	6.2	12.7	6.7	6.2	2.2	4.7	6.8	4.9	6.1	8.5	4.5	3.5	5.1	6.0	4.5	4.9	2.6	5.2	6.6	3.4	3.3	5.2	4.7	4.8	6.5	4.2	3.7	5.2	5.2	10.6	4.6	3.7	4.5	8.7	7.2	4.1	3.4	5.5	4.3	4.1	3.5	2.6	6.1	3.4	6.1	4.2	6.7	4.7	7.1	3.6	6.9	4.6	1.1	1.2	5.3	8.9	2.7	3.1	3.5	1.8	3.3	7.0	2.1	6.2	3.9	4.5	4.8	2.9	4.4	14.1	3.7	29.9	8.3	3.5	3.6	5.3	9.5	2.3	6.6	3.6	2.3	5.7	18.4	2.8	2.5	0.8	5.5	3.9	1.2	5.1	4.8	3.0	6.7	0.0	3.3	3.5	9.6	7.8	4.2	11.3	4.1	5.0	2.8	5.3	6.3	8.6	13.2	2.2	3.3	2.2	8.3	2.8	5.6	0.0	4.6	0.3	2.3	0.2	0.1	0.0	0.4	0.3	0.4	2.0	0.4	0.4	0.0	1.4	0.3	0.4	0.0	1.1	0.2	0.5	0.6	0.2	4.7	5.8	12.7	6.7	6.0	4.5	3.4	3.3	3.7	3.4	3.5	4.7	18.0	22.4	24.1	132.9	46.6	9.6	9.3	8.1	13.1	45.1	23.0	14.1	23.2	24.3	18.2	44.1	43.8	8.8	27.7	31.9	5.9	16.0	5.3	18.1	23.5	18.4	15.6	7.2	219.4	17.9	7.1	14.0	26.5	24.6	10.8	36.7	32.9	10.1	11.1	37.0	201.6	14.6	10.2	15.5	8.2	7.7	19.3	11.8	1.8	107.7	17.7	65.7	41.2	268.9	158.2	35.9	14.1	31.2	20.8	12.4	46.7	11.3	12.7	49.4	6.6	19.7	15.3	22.3	26.6	24.4	20.0	7.7	14.4	10.5	13.9	16.1
ZDHHC24		ENSG00000174165	"Zinc finger DHHC-type containing 24"	Q6UX98	11	66520637-66546235	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA016619	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"		"HPA016619: AB_2288672"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.55e-3)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (8.76e-2)"	"unprognostic (7.74e-3)"	"unprognostic (7.11e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.35e-1)"	5.2	6.9	5.8	3.3	4.5	5.0	4.7	4.2	5.4	3.6	5.8	3.5	2.8	4.3	5.1	4.3	3.9	2.2	3.6	4.9	5.2	6.2	4.6	4.5	4.3	5.5	5.2	2.7	7.1	6.0	4.7	2.5	4.8	4.5	2.1	2.6	5.0	2.7	2.9	5.1	4.7	1.9	4.4	7.2	4.8	3.7	6.4	3.1	5.9	1.1	3.0	4.0	3.4	4.5	5.2	7.4	2.4	6.5	5.8	4.7	6.2	3.9	3.4	3.1	2.1	6.5	7.7	1.6	11.5	3.3	8.3	11.9	1.9	3.4	2.1	7.6	4.9	2.9	3.7	4.1	5.5	3.4	6.9	5.6	6.2	2.5	3.6	3.7	5.1	13.0	4.2	4.3	4.0	10.4	7.4	8.6	5.3	12.2	7.6	8.8	5.3	9.3	3.9	3.6	3.5	5.6	6.7	6.5	11.6	2.7	9.5	2.4	8.0	7.1	2.4	8.3	3.1	6.9	2.2	2.1	6.2	1.5	8.2	3.0	5.9	1.0	7.3	5.7	6.6	6.4	6.0	8.4	7.2	7.5	3.8	5.9	2.2	8.0	5.0	23.1	6.6	6.1	5.8	4.5	4.2	5.4	4.9	5.2	5.5	5.2	4.8	4.4	6.4	4.5	21.7	12.8	8.3	7.8	21.9	8.0	15.2	26.8	10.8	9.6	21.5	15.2	4.5	22.8	17.3	23.9	10.4	33.0	49.9	29.0	9.8	50.3	13.5	15.1	14.4	23.3	14.4	6.3	7.6	49.4	37.2	15.0	17.9	19.8	8.9	18.5	23.2	14.9	63.9	23.5	7.0	17.8	20.3	42.8	14.8	12.1	7.5	27.9	17.8	5.6	36.4	16.9	46.4	4.0	8.5	42.8	40.6	9.8	15.8	24.9	54.8	35.2	14.7	10.3	19.7	11.2	15.1	29.6	4.1	21.6	8.1	24.1	23.3	18.5	21.8	23.1
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type palmitoyltransferase 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	31.6	31.2	13.8	18.6	15.1	10.7	30.4	11.3	26.4	32.6	0.0	22.8	12.1	31.2	7.5	29.3	27.7	13.0	31.6	13.9	7.0	30.4	36.1	31.0	17.1	12.2	10.0	34.6	35.6	14.4	41.3	16.9	9.9	28.1	7.0	7.4	27.6	15.4	23.6	32.2	24.7	13.1	6.6	35.7	26.4	14.9	12.3	13.7	37.3	10.3	11.7	25.3	30.9	12.8	30.0	18.7	29.3	38.7	42.0	25.0	26.3	55.1	37.3	36.6	32.6	9.8	15.2	0.1	22.3	46.0	19.8	40.2	15.5	42.2	18.0	43.2	59.4	14.5	57.2	23.0	34.5	0.0	19.5	43.7	27.9	28.2	23.6	22.5	41.4	21.0	101.4	22.8	33.0	14.7	17.8	39.1	14.9	13.2	29.4	37.8	25.6	10.9	15.6	35.9	46.9	23.7	22.4	10.7	26.6	13.1	0.7	20.4	48.0	82.5	59.8	46.8	25.0	32.6	11.5	11.7	24.2	18.7	24.8	1.3	0.4	0.1	0.8	0.5	0.4	0.2	0.2	0.4	0.1	0.5	0.4	0.5	0.0	0.4	0.2	1.3	0.7	0.2	13.8	15.1	11.3	26.4	13.9	7.0	12.2	10.0	9.9	6.6	12.3	12.8	17.4	3.2	3.1	17.6	3.7	9.1	3.8	3.6	5.7	11.9	8.2	8.1	7.1	4.3	3.5	11.0	14.6	3.6	9.2	4.3	1.9	5.2	0.5	4.3	15.7	11.5	4.2	0.8	16.6	4.5	8.5	9.3	10.2	8.7	5.7	8.7	10.4	9.8	4.9	13.5	9.9	5.9	10.2	5.0	5.0	2.1	10.8	5.7	5.4	9.4	3.7	7.4	1.0	13.0	13.3	7.7	5.4	14.7	2.7	7.6	2.7	2.1	1.5	10.8	6.6	10.5	6.8	1.4	3.8	5.5	9.8	3.4	4.2	8.0	5.0	3.4
ZDHHC9	"CGI-89, CXorf11, DHHC9, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type palmitoyltransferase 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 66.0;Oligodendrocytes: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	28.2	12.0	39.2	10.2	66.6	5.4	24.3	46.5	52.5	19.1	23.3	22.0	31.6	11.8	11.7	15.6	12.1	15.3	15.5	39.2	49.0	37.1	40.1	26.7	3.3	60.5	58.2	11.2	25.9	25.2	11.4	17.2	52.5	18.8	24.9	6.0	21.1	11.3	13.4	35.3	34.0	15.3	44.8	3.9	19.5	4.1	57.8	3.6	13.8	11.3	6.6	23.8	14.5	78.6	45.9	23.8	33.2	67.5	112.4	87.7	27.0	44.3	50.6	20.9	26.0	37.6	58.4	1.6	73.7	47.6	54.0	30.4	38.0	44.6	30.0	2.6	23.7	9.2	24.0	50.1	44.4	6.1	15.7	96.0	71.1	34.0	50.1	36.5	39.9	15.0	10.1	17.6	34.0	40.0	8.8	11.4	18.0	102.3	40.4	8.2	21.4	27.1	30.1	25.2	26.3	22.0	12.7	64.7	20.5	38.9	27.6	10.1	32.8	21.1	7.3	50.0	36.3	16.5	12.7	5.5	37.9	25.1	10.8	0.0	2.2	1.8	3.0	2.0	3.7	2.7	3.6	2.9	2.4	1.5	4.5	2.6	0.0	2.5	5.2	5.1	1.8	2.1	39.2	66.6	46.5	52.5	39.2	49.0	60.5	58.2	52.5	44.8	57.8	78.6	66.0	22.4	28.6	4.6	2.8	18.6	12.4	12.8	13.1	9.1	16.8	15.1	4.6	17.2	15.9	46.0	2.1	5.6	2.7	20.1	3.9	18.6	1.8	23.8	16.9	16.6	18.0	4.2	10.5	19.8	19.1	32.7	18.3	59.7	2.5	11.5	7.9	43.7	4.9	1.7	11.8	23.2	10.2	3.5	12.2	2.0	12.2	3.9	10.6	7.5	0.3	1.5	1.0	9.5	118.2	33.5	14.6	7.5	7.7	39.1	51.0	25.8	7.2	2.8	0.0	9.5	11.1	8.4	8.7	16.9	19.2	10.3	5.1	7.5	27.2	22.1
ZER1	"C9orf60, Hzyg, ZYG, ZYG11BL"	ENSG00000160445	"Zyg-11 related cell cycle regulator"	Q7Z7L7	9	128729786-128772414	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 67.7;Inhibitory neurons: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048464			Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA048464: AB_2756306"	"unprognostic (1.37e-1)"	"prognostic favorable (1.18e-6)"	"unprognostic (9.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.65e-1)"	"unprognostic (4.90e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (5.15e-11)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.14e-1)"	24.3	31.0	57.4	12.4	56.4	17.1	23.8	28.3	72.8	26.7	23.2	38.9	33.3	29.8	13.1	28.6	25.9	17.4	44.1	59.7	48.2	26.5	22.9	19.9	13.9	44.6	40.1	28.1	26.6	31.9	33.5	15.9	44.8	31.7	13.0	17.3	27.4	24.7	72.0	33.8	31.5	16.4	28.5	19.6	26.9	36.6	43.8	19.2	26.5	43.6	11.3	31.0	24.7	46.1	17.3	19.1	12.4	17.0	36.4	24.9	34.3	16.7	28.4	22.6	18.1	17.3	19.6	10.6	18.1	29.3	16.9	37.1	13.8	24.8	9.5	21.2	17.7	7.0	34.2	12.4	28.3	11.1	20.1	31.1	36.6	22.9	16.1	30.6	19.5	21.2	13.7	22.9	15.5	65.9	20.9	12.5	12.3	24.6	24.4	18.6	15.6	41.4	16.8	23.4	23.7	17.9	26.7	35.4	18.9	14.4	52.0	12.7	22.2	18.4	7.8	23.5	10.2	28.7	29.3	8.6	27.2	6.6	13.5	11.5	3.2	8.8	4.4	4.7	6.0	3.0	4.7	5.7	3.3	3.8	4.9	4.7	13.6	5.1	5.2	4.9	4.7	5.0	57.4	56.4	28.3	72.8	59.7	48.2	44.6	40.1	44.8	28.5	43.8	46.1	10.7	12.8	16.8	33.0	8.0	2.8	2.9	5.2	6.2	20.2	13.0	12.6	22.6	4.3	4.7	5.5	14.6	4.8	4.8	41.7	1.9	5.8	7.1	15.2	8.6	9.0	7.2	17.9	67.7	9.6	2.5	8.6	13.7	11.8	10.2	12.0	7.1	13.0	6.2	21.9	61.2	15.0	2.0	4.4	1.0	2.4	11.1	5.7	8.8	16.9	9.5	9.8	6.2	23.1	48.9	7.1	23.2	10.5	8.7	6.4	25.4	13.8	13.5	13.4	13.1	9.2	9.1	10.6	3.5	8.0	5.8	8.5	7.1	16.0	9.6	3.4
ZFAND1	FLJ14007	ENSG00000104231	"Zinc finger AN1-type containing 1"	Q8TCF1	8	81701334-81732903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023383	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Centrosome, Cytosol"		"HPA023383: AB_1859008"	"unprognostic (6.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.74e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.04e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.36e-2)"	30.3	26.8	15.2	14.8	15.9	28.6	41.8	19.1	21.4	30.8	11.8	27.6	25.8	35.3	26.9	28.3	32.0	24.2	22.2	15.6	17.4	30.7	35.5	24.5	26.8	15.4	15.7	55.7	53.8	32.3	21.7	18.9	16.7	28.1	29.9	21.0	39.9	26.5	21.6	20.7	23.6	32.5	14.0	25.2	30.0	9.2	16.0	31.8	58.1	27.9	29.6	32.1	23.5	16.4	74.1	23.5	31.3	29.4	40.5	86.0	31.0	42.5	57.8	38.3	48.0	26.4	56.8	72.5	49.1	32.5	41.4	47.2	35.9	61.7	57.4	60.1	36.8	41.1	35.1	29.5	78.7	53.9	26.6	70.8	138.4	26.0	239.0	64.6	46.9	70.6	61.1	96.7	38.6	46.0	65.4	35.6	9.6	147.5	70.1	43.8	26.2	32.5	48.1	67.1	30.8	21.6	30.1	19.3	71.6	35.2	62.6	38.7	29.7	27.2	39.4	38.5	60.5	38.2	26.2	45.3	30.9	4.6	21.9	16.8	29.5	8.4	21.8	21.3	36.7	36.4	35.2	28.8	40.8	27.2	46.6	36.1	2.9	37.0	25.8	24.3	44.1	36.0	15.2	15.9	19.1	21.4	15.6	17.4	15.4	15.7	16.7	14.0	16.0	16.4	44.1	25.6	38.3	14.4	47.9	95.8	73.0	73.0	88.2	27.3	49.7	63.6	18.8	41.5	41.4	25.8	4.2	33.8	32.8	10.0	103.7	27.4	3.4	20.1	25.3	42.8	23.4	31.5	49.2	49.4	45.6	36.3	32.1	21.4	34.9	28.9	41.7	22.5	29.1	23.5	45.3	33.6	36.7	47.7	75.0	3.7	39.7	29.1	49.8	20.6	35.2	15.3	23.7	26.7	29.0	33.6	24.4	29.7	44.4	72.2	28.4	80.1	20.9	15.2	32.9	42.6	48.1	18.5	17.3	53.0	78.4	32.7	42.6	49.1	33.3	61.5
ZFAND2B	AIRAPL	ENSG00000158552	"Zinc finger AN1-type containing 2B"	Q8WV99	2	219195237-219209651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 144.0;Proximal enterocytes: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035159, HPA035160"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA035159: AB_2674499, HPA035160: AB_10670697"	"unprognostic (3.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.77e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.38e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.02e-2)"	28.5	26.6	33.2	20.7	34.3	38.2	28.3	34.4	43.7	38.2	27.4	41.6	41.5	29.7	18.1	48.8	28.5	20.0	28.1	33.3	34.0	44.1	64.5	32.3	28.4	37.2	33.3	29.0	40.7	26.8	36.2	17.4	34.3	31.3	25.0	10.8	27.7	17.6	34.3	42.5	45.4	15.9	33.1	45.9	37.4	15.6	34.3	37.9	49.8	15.5	23.3	33.0	35.5	37.5	23.0	14.4	17.2	23.7	17.6	18.5	23.5	22.8	26.3	32.1	31.7	34.8	18.9	16.5	23.0	39.2	26.0	15.5	15.4	28.9	25.5	27.8	25.2	41.8	25.6	30.3	36.3	22.9	45.3	15.3	62.2	31.9	75.0	17.7	21.2	40.0	25.0	38.9	31.9	40.0	37.9	47.9	8.9	31.7	17.5	22.4	8.3	31.6	29.6	17.7	33.7	16.3	10.9	17.3	24.8	19.3	15.4	47.3	22.5	32.2	29.5	37.2	33.3	20.2	6.6	34.1	31.5	44.2	25.6	30.8	34.8	48.6	49.1	46.0	42.5	43.6	44.2	48.0	26.7	53.0	39.9	48.9	58.3	53.5	38.3	33.5	51.6	44.3	33.2	34.3	34.4	43.7	33.3	34.0	37.2	33.3	34.3	33.1	34.3	37.5	30.4	22.4	21.2	17.6	43.5	27.1	26.3	34.0	19.9	14.9	37.1	33.7	12.7	44.3	24.5	20.2	14.6	26.9	52.4	144.0	56.7	44.1	4.9	14.6	17.7	26.4	40.2	15.2	17.8	66.0	24.3	19.6	42.3	20.7	32.4	11.6	23.6	39.4	34.9	8.4	16.1	67.5	36.7	32.4	31.3	7.8	32.0	35.6	35.6	5.6	24.4	21.5	44.3	6.0	15.3	60.3	101.1	29.7	39.5	25.1	170.6	79.5	13.8	17.2	26.3	15.9	28.7	6.2	22.9	27.6	36.1	51.3	46.7	27.8	54.4	28.8
ZFAND5	"ZA20D2, ZFAND5A, ZNF216"	ENSG00000107372	"Zinc finger AN1-type containing 5"	O76080	9	72351413-72365235	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 591.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 450.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018129, HPA077824"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA018129: AB_1859012, HPA077824: "	"unprognostic (1.97e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.03e-2)"	312.2	187.7	99.9	55.3	112.7	145.7	150.0	105.5	136.0	97.6	70.9	88.1	39.4	91.0	115.7	99.8	120.6	87.3	117.7	103.9	107.8	114.9	204.7	108.5	46.9	93.9	113.3	250.4	73.6	69.1	138.8	79.2	105.6	76.8	49.2	50.7	69.8	121.4	591.1	75.4	69.0	94.9	100.5	60.4	95.5	88.5	105.9	52.3	79.2	273.9	59.1	108.9	87.1	110.8	115.9	113.0	138.8	59.4	156.5	77.3	104.3	131.9	178.9	71.1	55.1	14.5	112.6	60.4	81.3	194.5	105.2	122.4	305.1	50.4	103.4	450.1	43.1	53.5	57.7	70.1	120.4	74.7	71.1	99.0	87.6	72.7	79.2	156.3	122.1	60.4	49.8	82.1	82.6	31.3	96.3	38.8	178.9	107.2	74.3	74.1	72.4	70.5	218.4	109.3	101.2	86.4	85.2	91.2	117.2	142.1	42.1	64.3	97.1	57.4	71.7	104.7	90.9	113.9	110.3	38.1	77.2	49.1	146.3	39.0	35.9	37.3	11.2	52.1	12.0	17.0	14.6	14.1	33.6	15.1	13.2	12.2	27.7	19.2	81.6	6.2	11.2	23.9	99.9	112.7	105.5	136.0	103.9	107.8	93.9	113.3	105.6	100.5	105.9	110.8	370.7	176.3	192.1	102.8	125.8	339.2	573.2	130.6	376.7	93.9	267.0	207.1	322.6	92.9	132.6	132.4	75.0	145.1	118.6	213.3	148.7	145.8	91.8	257.1	291.9	195.3	136.7	155.6	45.7	142.6	164.8	270.8	145.2	527.6	109.2	116.1	97.5	308.3	198.0	40.4	38.6	119.8	126.1	290.6	320.1	44.5	118.4	470.1	208.1	31.9	268.8	84.2	53.5	38.7	67.2	185.9	221.3	93.3	149.3	329.9	87.2	127.1	109.2	70.6	85.5	674.9	285.2	148.7	116.4	298.1	291.2	226.3	165.5	102.9	109.4	528.2
ZFP28	"KIAA1431, mkr5"	ENSG00000196867	"ZFP28 zinc finger protein"	Q8NHY6	19	56538948-56556808	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028879	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA028879: AB_10603841"	"unprognostic (5.02e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.32e-4)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-1)"	4.2	4.2	6.7	2.3	7.0	1.3	4.4	8.0	7.8	5.4	5.0	4.8	1.9	6.4	4.8	2.9	4.6	3.9	4.6	7.7	7.4	4.2	0.9	4.3	2.6	6.9	6.9	10.7	3.5	6.2	6.1	3.8	7.8	4.9	2.2	11.0	3.2	4.6	2.9	3.5	2.7	5.1	6.0	3.8	3.2	7.5	6.8	3.4	5.3	3.9	2.7	4.6	4.3	8.4	0.0	1.7	7.9	2.4	2.6	2.5	4.1	5.2	5.0	4.1	6.7	0.0	1.1	0.0	2.6	6.2	7.9	0.2	3.9	1.7	6.2	0.0	6.7	5.4	0.3	0.0	7.4	0.2	6.0	6.9	2.2	6.2	0.1	8.1	0.8	2.8	1.1	0.1	5.3	0.0	2.7	1.0	3.6	0.0	1.7	4.2	10.3	0.0	5.5	3.4	0.0	7.2	0.0	0.3	1.2	7.2	3.0	5.4	2.0	3.8	4.1	0.4	6.4	0.1	0.2	0.5	0.1	0.1	0.4	0.0	0.1	1.4	0.1	0.1	0.8	0.6	0.8	0.6	0.4	1.1	0.6	0.5	0.1	0.8	0.1	0.5	1.3	0.3	6.7	7.0	8.0	7.8	7.7	7.4	6.9	6.9	7.8	6.0	6.8	8.4	5.1	9.6	3.6	6.2	1.0	5.7	2.8	2.0	4.0	7.6	3.3	2.5	5.6	1.5	2.1	5.5	4.2	0.8	1.2	0.6	7.9	2.7	4.2	2.7	3.5	4.3	2.4	1.7	6.7	0.8	0.8	3.5	1.1	3.6	3.8	3.8	2.2	0.5	0.7	10.1	6.7	0.4	4.1	0.3	3.1	2.0	4.1	1.6	5.4	3.7	1.7	6.0	0.0	6.0	8.1	1.1	1.8	4.9	0.2	3.1	0.1	2.7	2.5	5.9	0.0	6.7	4.6	9.7	5.7	2.1	3.8	0.7	3.0	3.9	0.8	1.8
ZFP3	"FLJ30726, ZNF752"	ENSG00000180787	"ZFP3 zinc finger protein"	Q96NJ6	17	5078467-5096374	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 5.8;SH-SY5Y: 6.0;SiHa: 5.5"	"Low region specificity"	"Detected in all"							"HPA053085, HPA057290"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA053085: AB_2682039, HPA057290: AB_2683400"	"unprognostic (3.71e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.69e-7)"	"unprognostic (8.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.29e-3)"	2.6	2.6	2.9	3.9	3.7	0.9	4.7	6.4	4.4	3.3	6.7	4.8	7.1	3.4	3.3	2.7	5.8	2.5	6.8	3.2	3.4	5.2	1.2	3.8	5.3	3.9	3.9	4.9	4.6	9.4	2.1	2.7	3.4	3.9	5.7	8.0	6.0	3.7	6.8	3.5	6.1	3.2	3.2	5.1	4.4	3.1	3.9	5.0	5.8	9.7	6.2	2.8	2.3	3.7	0.0	1.0	0.2	0.0	0.9	0.4	0.0	2.2	0.0	1.7	1.9	4.5	2.0	0.0	3.1	2.2	0.8	4.5	0.0	0.0	0.9	0.0	0.1	0.1	1.9	0.0	3.0	0.0	5.8	1.5	0.0	1.2	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	3.2	0.4	0.0	0.6	1.5	2.7	2.7	2.7	6.0	5.5	4.5	2.9	1.0	2.7	4.4	0.0	0.0	0.8	1.5	3.2	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.8	0.6	1.0	0.9	0.6	0.8	0.6	0.9	0.5	2.1	1.5	1.1	0.0	0.7	0.8	0.3	0.6	0.7	2.9	3.7	6.4	4.4	3.2	3.4	3.9	3.9	3.4	3.2	3.9	3.7	1.8	0.0	4.2	1.6	2.1	0.3	0.4	0.9	1.2	4.1	1.6	1.4	7.8	1.5	2.1	1.8	8.4	1.2	2.4	3.1	0.0	1.7	1.8	3.1	2.7	1.8	0.0	0.8	3.0	1.1	0.4	1.8	4.6	0.8	1.3	2.9	4.2	0.1	1.7	3.3	4.5	2.2	0.0	2.5	0.2	0.5	1.5	1.2	0.0	0.0	0.9	2.8	2.1	4.5	3.1	0.6	1.0	1.2	1.8	0.6	2.6	1.4	11.0	6.0	0.0	3.0	1.5	7.1	3.8	2.3	0.1	0.8	1.6	2.9	2.5	0.5
ZFP30	"KIAA0961, ZNF745"	ENSG00000120784	"ZFP30 zinc finger protein"	Q9Y2G7	19	37613749-37692337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030606	Uncertain		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA030606: AB_10602684"	"unprognostic (1.86e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.64e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (5.96e-2)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.01e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-3)"	2.7	3.7	2.2	2.1	3.4	1.1	4.8	8.5	3.4	3.2	0.8	3.0	2.3	4.5	3.8	3.4	4.1	2.6	2.7	2.3	2.9	3.4	2.3	3.1	4.0	1.7	2.1	5.1	3.6	5.8	1.1	4.4	2.0	4.4	2.9	8.7	2.6	4.3	3.0	5.4	2.0	3.5	2.0	4.1	3.2	7.3	2.4	4.6	6.1	3.9	3.8	2.4	1.1	4.7	9.4	8.1	12.9	18.2	6.8	6.6	3.9	9.5	8.7	7.0	7.6	6.5	1.7	0.0	9.5	8.7	5.7	3.4	12.9	5.0	7.5	14.2	5.0	9.4	10.0	5.0	5.1	1.3	7.0	6.0	7.6	6.1	9.1	5.6	4.1	6.4	7.2	0.0	9.1	4.3	10.3	4.8	2.8	1.2	5.5	4.0	16.8	0.1	4.3	15.3	14.4	15.6	11.1	4.3	3.4	5.1	5.9	2.5	9.0	9.5	32.5	4.6	9.6	4.9	5.5	5.9	0.0	0.1	7.3	2.2	0.5	1.3	1.1	0.6	1.5	0.5	1.4	1.1	0.4	2.1	1.7	1.8	0.3	2.8	0.2	0.9	1.1	1.0	2.2	3.4	8.5	3.4	2.3	2.9	1.7	2.1	2.0	2.0	2.4	4.7	4.6	6.4	1.8	9.8	6.7	0.8	1.2	1.5	2.8	11.4	2.6	2.5	7.3	4.3	2.7	3.7	4.2	2.6	3.0	1.4	1.9	3.4	60.5	3.5	5.5	6.3	4.2	1.7	17.6	2.3	1.6	5.1	4.6	3.6	9.5	7.3	3.6	0.9	2.5	8.4	19.1	3.1	0.0	2.1	1.1	14.3	7.5	2.4	0.0	11.2	1.6	4.8	5.2	20.1	17.5	1.8	0.8	6.4	1.4	1.8	0.6	2.8	3.2	9.2	6.6	5.4	4.6	9.4	5.2	2.9	0.4	0.8	4.0	4.1	2.2	0.7
ZFP69B	"FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B"	ENSG00000187801	"ZFP69 zinc finger protein B"	Q9UJL9	1	40450102-40463718	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.2;Inhibitory neurons: 7.9;Oligodendrocyte precursor cells: 11.1;Spermatogonia: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA044289	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA044289: AB_10962717"	"unprognostic (2.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.05e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-5)"	"unprognostic (1.64e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.89e-1)"	0.4	0.5	1.7	1.7	1.4	0.4	0.9	0.0	2.9	0.9	0.0	0.9	0.9	1.4	0.7	0.7	0.5	1.1	0.6	1.3	0.5	0.4	0.8	0.5	1.4	0.2	0.5	0.6	1.0	0.7	0.5	0.4	1.0	0.6	1.0	1.5	0.4	0.6	0.4	0.5	0.6	1.0	0.0	0.8	0.9	1.4	1.0	1.9	0.9	0.3	1.9	1.2	0.3	1.2	3.6	1.5	6.1	14.8	2.2	5.8	1.7	3.5	3.2	1.5	2.9	1.6	2.3	6.9	3.3	3.0	3.0	1.3	3.1	3.0	3.4	6.0	1.3	2.8	3.5	5.2	1.5	0.4	4.4	1.3	4.9	5.4	7.1	1.5	2.1	9.0	7.5	6.9	4.6	2.5	9.4	0.6	8.1	1.3	1.5	5.3	5.9	3.3	3.0	3.5	8.0	8.4	5.6	4.6	2.4	3.4	2.4	8.0	4.6	4.9	10.4	4.6	5.0	10.4	10.6	14.8	6.5	0.9	5.2	0.0	0.1	0.3	0.9	0.7	1.2	0.6	0.6	0.5	0.4	0.6	1.2	1.0	0.0	0.6	0.2	0.1	1.4	0.3	1.7	1.4	0.0	2.9	1.3	0.5	0.2	0.5	1.0	0.0	1.0	1.2	1.1	0.0	0.0	1.3	2.4	0.3	0.6	0.3	0.0	3.4	0.8	0.6	0.7	0.0	0.2	1.8	0.0	0.6	1.0	0.1	0.0	1.2	0.0	0.8	1.6	1.3	0.0	0.4	10.2	0.2	1.4	0.7	1.1	0.5	0.0	3.2	1.1	0.1	1.1	0.0	7.9	0.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	1.0	1.1	0.9	3.1	11.1	1.8	1.1	0.3	0.4	2.4	0.3	0.2	0.2	0.1	2.2	0.0	0.9	1.3	1.8	5.7	0.3	0.1	0.0	1.5	0.9	0.4	0.2
ZFP82	"KIAA1948, MGC45380, ZNF545"	ENSG00000181007	"ZFP82 zinc finger protein"	Q8N141	19	36383120-36418644	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051669, HPA060470"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA051669: AB_2732568, HPA060470: AB_2684290"	"unprognostic (1.52e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.14e-4)"	"unprognostic (9.63e-2)"	"unprognostic (9.17e-4)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.91e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.05e-1)"	2.1	2.1	4.5	1.3	4.8	0.7	2.7	6.4	6.8	3.6	3.4	2.7	0.7	3.1	4.2	0.9	3.0	1.9	2.6	4.5	4.7	2.3	0.6	1.5	2.6	3.9	4.3	4.4	1.2	2.7	3.1	2.4	3.9	2.7	1.1	5.1	1.4	1.8	0.8	0.9	1.7	2.2	3.9	2.7	1.3	2.5	4.3	2.9	4.1	1.1	2.6	3.0	2.3	4.8	0.1	2.8	8.6	7.3	2.0	2.8	2.7	2.9	3.2	5.0	6.3	1.3	1.0	7.0	5.5	3.2	4.8	0.3	0.0	0.8	6.1	4.6	4.0	7.2	1.5	1.6	4.9	0.0	5.7	3.8	1.1	3.4	0.9	0.0	2.2	9.8	0.1	0.1	5.3	0.0	12.2	0.1	4.8	0.0	1.2	8.8	5.2	1.5	2.8	3.9	0.4	8.6	0.0	0.6	4.0	6.4	1.7	4.1	0.5	2.1	2.8	4.3	5.6	5.6	3.7	10.0	0.1	0.1	4.6	0.2	0.5	0.7	2.7	0.5	2.6	4.8	2.6	3.0	1.3	4.3	4.0	3.6	0.4	2.5	0.6	1.6	1.7	1.5	4.5	4.8	6.4	6.8	4.5	4.7	3.9	4.3	3.9	3.9	4.3	4.8	3.6	0.0	6.4	7.5	9.0	1.0	2.3	2.4	1.8	20.3	3.7	3.6	4.6	1.5	3.4	5.5	22.9	7.8	3.5	0.1	9.8	6.0	11.2	2.2	4.6	5.9	3.0	1.7	16.4	1.4	5.9	5.5	0.5	1.7	6.3	11.4	3.3	0.6	4.4	33.7	19.0	0.3	6.1	2.6	3.4	2.5	5.9	3.5	5.4	6.5	1.4	7.9	3.1	21.1	22.1	1.1	0.2	7.5	3.2	1.9	0.4	4.8	6.1	11.8	19.7	4.7	5.0	17.5	9.1	0.6	0.6	1.4	5.7	7.6	0.9	1.2
ZFPM1	"FOG, FOG1, ZC2HC11A, ZNF89A"	ENSG00000179588	"Zinc finger protein, FOG family member 1"	Q8IX07	16	88453280-88537031	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 35.3;Muller glia cells: 58.0;Theca cells: 37.4"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 12.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 19.3;K-562: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046603	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA046603: AB_2679718"	"unprognostic (1.29e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (4.24e-4)"	2.1	2.5	4.8	1.9	2.4	9.2	1.9	5.7	5.8	2.3	4.2	1.7	12.4	2.2	1.0	1.8	4.0	1.5	4.8	5.8	2.1	3.7	8.6	2.1	2.7	3.5	3.2	2.2	10.4	1.4	5.6	0.8	2.6	3.2	0.8	0.7	2.8	1.3	1.6	3.7	6.8	0.2	1.6	4.9	13.7	5.7	3.3	1.5	4.0	0.3	1.2	2.3	2.0	1.6	1.4	3.8	2.8	5.9	0.5	0.1	11.9	4.0	0.5	1.3	0.4	12.1	1.5	5.9	3.0	0.6	1.4	9.5	0.1	3.3	0.3	4.6	2.5	19.3	8.1	10.7	2.1	1.1	6.2	1.3	2.1	1.4	0.5	1.4	1.3	1.6	29.2	0.4	1.0	7.3	6.9	7.0	1.9	9.3	3.2	2.0	1.3	2.9	1.3	4.8	7.7	12.8	4.9	0.3	3.9	1.4	3.1	3.1	4.8	4.9	3.1	2.2	0.8	1.4	1.0	0.5	1.4	2.3	4.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	2.4	5.7	5.8	5.8	2.1	3.5	3.2	2.6	1.6	3.3	1.6	16.7	3.2	2.2	12.4	4.8	0.9	6.1	0.7	0.0	20.7	13.5	25.8	17.2	5.7	0.4	1.8	29.2	0.4	27.5	10.8	1.9	1.3	0.7	24.1	23.7	6.3	6.0	4.8	6.8	5.1	0.2	10.9	14.3	20.1	0.0	16.0	5.0	8.8	0.9	35.3	8.0	6.7	0.0	5.3	1.2	1.1	0.9	7.5	1.8	8.4	1.6	58.0	2.1	5.5	13.4	2.9	6.2	1.5	9.5	1.4	1.3	1.3	0.4	23.9	0.0	16.1	12.4	0.7	1.0	1.9	1.4	0.3	9.6	37.4	5.2	2.1
ZFYVE27	"FLJ32919, SPG33"	ENSG00000155256	"Zinc finger FYVE-type containing 27"	Q5T4F4	10	97737121-97760907	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037523, HPA069876"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA037523: AB_10672351, HPA069876: AB_2686218"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (7.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (7.80e-4)"	14.4	27.9	33.1	12.9	32.1	23.2	15.8	29.2	35.9	20.6	34.8	25.6	24.8	16.5	22.9	16.5	20.3	12.1	17.8	35.5	33.6	28.3	32.6	17.7	16.1	32.6	31.4	25.9	23.7	19.2	38.3	9.5	33.2	22.0	16.3	28.4	18.9	10.3	12.8	18.2	30.6	8.5	29.1	29.1	19.8	23.0	33.5	12.7	20.4	5.9	13.1	16.8	17.0	32.4	17.7	21.4	12.6	28.1	14.1	9.8	17.2	17.7	18.5	20.3	19.7	19.1	35.9	27.2	19.8	12.8	25.9	38.8	18.4	17.2	10.6	28.3	18.6	12.9	23.1	18.1	18.1	20.9	24.9	16.0	20.4	19.9	15.2	32.4	11.5	22.5	19.6	17.9	15.3	13.8	16.9	39.4	10.3	15.3	16.4	19.2	12.7	13.0	19.5	10.8	10.1	19.7	11.9	9.9	47.2	11.5	21.8	20.5	12.4	10.2	11.9	15.6	34.2	20.6	18.6	14.3	25.3	26.5	11.9	4.8	5.8	9.3	9.6	6.2	8.2	7.1	6.6	7.9	5.4	6.7	7.5	8.3	8.2	6.8	9.2	5.6	9.5	8.3	33.1	32.1	29.2	35.9	35.5	33.6	32.6	31.4	33.2	29.1	33.5	32.4	10.0	3.2	11.4	14.0	22.1	8.2	12.8	11.3	18.8	29.9	11.1	8.9	7.2	14.3	9.7	14.7	58.4	7.4	21.2	33.9	7.9	14.9	5.2	14.3	7.8	11.0	20.3	14.3	33.6	16.0	5.7	10.1	19.4	11.4	14.0	17.3	10.8	10.9	8.2	37.0	35.2	15.6	14.2	8.8	5.7	1.5	9.6	11.0	10.6	16.9	11.2	14.8	15.5	12.5	20.2	13.9	26.1	9.1	13.4	13.8	35.5	8.6	16.6	43.7	19.7	6.7	9.9	8.9	7.6	10.4	5.5	13.5	17.9	10.9	14.7	17.7
ZFYVE28	"KIAA1643, lst-2"	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418651	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.9;Inhibitory neurons: 93.2;NK-cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.6;NB-4: 14.2;U-266/70: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: AB_2683477"	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	5.5	8.7	4.6	3.1	7.5	2.1	5.4	49.9	18.0	5.5	0.5	8.0	6.1	4.8	1.6	4.7	5.4	3.4	3.9	7.3	0.3	8.7	6.5	6.2	4.0	9.4	6.9	4.5	5.0	4.3	10.8	1.0	7.4	4.0	2.8	4.0	5.5	2.8	2.9	5.4	8.8	1.5	1.0	6.7	7.2	8.1	5.0	2.6	7.7	1.8	2.0	4.8	4.6	6.2	0.9	1.2	0.2	4.2	2.4	0.8	0.2	2.1	3.5	1.1	0.3	0.1	7.6	0.0	2.2	3.7	2.9	4.4	1.4	0.3	0.7	11.7	1.5	0.3	5.3	0.3	4.8	0.8	12.6	3.3	0.7	1.3	0.1	7.7	3.5	1.1	2.2	9.2	1.0	2.6	0.1	14.2	0.2	2.4	9.3	0.0	0.0	4.7	1.7	0.6	6.6	0.5	2.1	0.1	1.2	0.1	2.8	0.3	0.6	2.0	0.1	6.2	0.2	14.8	11.7	0.2	6.0	2.8	2.0	0.4	0.2	0.0	1.9	0.0	0.8	0.4	1.0	1.3	0.3	1.8	1.3	1.4	0.0	0.2	0.1	0.1	1.9	0.5	4.6	7.5	49.9	18.0	7.3	0.3	9.4	6.9	7.4	1.0	5.0	6.2	12.2	0.0	1.7	41.4	3.7	5.9	3.4	2.1	5.7	12.2	7.6	6.2	3.4	7.2	2.9	11.0	18.8	0.3	25.4	32.3	7.9	3.4	29.1	5.1	4.8	8.0	2.4	1.3	133.9	2.3	0.3	3.6	11.7	6.3	8.9	2.6	5.3	3.7	1.9	8.4	93.2	7.8	2.0	2.2	33.0	8.9	1.5	5.1	7.2	32.8	4.0	1.6	48.4	23.6	36.4	2.6	16.8	2.2	9.8	1.7	18.1	4.2	3.0	17.8	0.0	2.3	3.0	3.1	8.0	6.2	4.8	0.3	31.6	8.2	6.6	5.4
ZGRF1	"C4orf21, FLJ11331"	ENSG00000138658	"Zinc finger GRF-type containing 1"	Q86YA3	4	112539333-112636995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.0;Microglial cells: 17.8;Oligodendrocytes: 27.5;Spermatocytes: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA030704, HPA030706"	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA030704: AB_2673577, HPA030706: AB_10601784"	"unprognostic (8.48e-2)"	"unprognostic (6.17e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.83e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.72e-3)"	"unprognostic (7.60e-10)"	"unprognostic (3.45e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.02e-4)"	1.0	0.7	0.9	2.0	1.4	7.8	1.3	2.2	1.5	0.9	0.1	1.1	1.2	1.2	0.3	1.0	0.8	0.5	0.7	0.8	0.7	0.5	0.6	0.9	2.5	1.3	0.9	1.1	0.7	0.3	1.3	1.7	1.3	0.9	1.4	4.3	0.9	0.4	1.2	1.4	1.5	0.9	1.0	1.8	0.9	3.6	1.0	5.2	0.8	0.6	2.9	0.7	0.8	2.1	5.0	3.6	12.1	8.6	0.9	1.6	4.7	8.8	3.7	8.7	7.8	6.9	7.3	13.2	2.5	2.7	3.6	4.0	12.7	4.7	10.0	7.3	3.1	8.3	5.8	2.1	0.4	18.5	5.3	0.8	0.6	11.0	3.0	1.2	3.5	13.6	12.0	14.3	6.0	8.2	25.0	6.7	6.3	5.2	4.2	13.8	18.1	4.5	1.5	4.4	5.6	9.5	3.9	5.3	1.7	8.8	2.5	5.4	4.2	10.9	10.6	5.9	7.1	5.5	10.1	17.0	4.9	6.3	6.3	0.0	0.1	0.3	0.2	0.7	0.1	0.3	0.1	0.0	0.0	0.5	0.4	0.4	0.2	0.2	0.1	0.7	0.2	0.1	0.9	1.4	2.2	1.5	0.8	0.7	1.3	0.9	1.3	1.0	1.0	2.1	3.3	0.0	1.3	10.4	5.4	0.0	1.3	0.0	0.6	10.4	2.1	1.7	2.4	0.0	3.7	1.8	8.4	3.5	10.4	2.1	0.0	1.0	2.9	1.8	3.5	1.9	1.2	11.1	18.0	0.5	2.7	2.3	4.6	2.8	2.5	12.2	1.1	0.6	1.8	5.0	14.5	1.8	0.0	1.6	0.0	2.8	0.6	4.1	0.0	17.8	1.3	1.6	6.2	17.6	27.5	0.6	1.4	2.2	10.5	0.8	0.7	0.3	0.7	17.6	0.0	3.1	2.7	22.1	15.6	3.6	0.0	0.8	5.0	2.2	2.5	0.9
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406809	"Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 68.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.0;Late spermatids: 13.5;Microglial cells: 6.5;Muller glia cells: 5.5;Oligodendrocytes: 6.9;Skeletal myocytes: 6.2"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Region enriched"	"Detected in all"	4	"cerebellum: 68.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.5;ASC diff: 4.7;BEWO: 3.5;MCF7: 4.7;SH-SY5Y: 4.9;U-2197: 3.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"cerebellum: 67.3"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030194: AB_2673367"	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.6	0.0	1.9	0.0	6.6	0.0	0.0	68.5	4.7	0.0	5.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.7	5.5	0.0	0.3	0.0	0.0	10.6	5.8	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	4.8	0.0	0.0	1.3	1.2	0.1	0.0	2.7	0.0	0.0	0.5	10.5	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	16.5	0.0	4.7	1.9	3.5	1.8	0.4	0.2	0.5	0.0	0.0	0.0	2.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.1	0.0	3.9	1.8	0.0	0.0	0.0	1.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.6	68.5	4.7	1.7	5.5	10.6	5.8	9.0	2.7	10.5	15.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	6.5	0.0	5.5	0.0	0.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.2	0.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZIM2	ZNF656	ENSG00000269699	"Zinc finger imprinted 2"	Q9NZV7	19	56774547-56840729	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;ovary: 7.2;testis: 3.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.0;Inhibitory neurons: 19.2;Late spermatids: 33.7;Spermatocytes: 11.7;Spermatogonia: 19.3;Theca cells: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;Hep G2: 2.5"									HPA071856			Approved	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA071856: AB_2686460"	"unprognostic (9.01e-4)"				"unprognostic (8.77e-2)"		"unprognostic (5.09e-2)"			"unprognostic (4.60e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"		0.1	2.3	1.8	0.0	1.2	0.0	0.4	0.9	3.5	0.3	3.2	0.3	0.0	0.4	0.0	0.1	0.6	0.0	0.3	1.1	3.6	0.1	0.1	0.0	0.0	0.8	0.7	7.2	0.1	0.1	0.9	2.0	0.2	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.7	1.7	0.0	0.2	0.0	0.1	0.2	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.2	0.9	3.5	1.1	3.6	0.8	0.7	0.2	0.8	1.7	1.8	0.1	0.0	0.0	5.5	0.0	0.1	0.1	0.0	0.6	7.0	0.4	0.9	0.9	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.9	0.1	25.0	0.0	1.2	0.3	0.0	0.0	8.8	0.0	1.2	1.8	0.0	0.1	0.0	7.6	0.0	0.0	0.7	10.1	19.2	0.0	0.0	0.0	0.3	33.7	1.8	0.0	0.0	1.0	0.0	3.8	0.0	6.6	5.7	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.0	2.4	0.0	1.5	1.0	11.7	19.3	0.3	0.1	9.9	0.0	15.5	0.0	0.0
ZKSCAN8	"LD5-1, ZNF192, ZSCAN40"	ENSG00000198315	"Zinc finger with KRAB and SCAN domains 8"	Q15776	6	28141883-28159460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA003483: AB_1080686"	"unprognostic (2.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.80e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.33e-3)"	11.0	7.7	4.5	8.1	6.2	14.8	11.5	8.9	7.2	11.2	7.4	11.8	6.6	15.9	13.3	5.6	11.1	7.6	7.6	4.5	5.6	7.7	7.3	9.2	10.5	5.5	5.1	17.6	9.9	12.9	8.4	9.4	6.1	10.3	8.4	17.6	9.0	11.6	8.1	7.9	10.7	10.7	5.0	10.8	9.2	9.1	5.2	13.1	10.6	8.9	10.9	10.2	7.9	9.2	9.0	5.6	26.1	25.4	15.8	14.9	8.2	9.7	18.3	12.6	15.7	6.3	5.3	19.4	15.7	9.4	10.5	7.4	16.7	6.2	17.9	11.2	14.1	17.7	11.7	13.6	14.4	21.8	12.7	15.4	10.4	12.9	19.2	21.5	12.5	16.9	27.9	7.1	12.9	4.4	15.5	18.2	9.5	2.1	6.4	17.0	16.5	15.2	8.6	10.9	19.5	24.7	11.6	5.3	11.9	14.3	5.9	11.7	10.9	18.1	10.5	6.1	13.2	17.3	13.2	15.6	5.1	14.8	9.9	2.2	0.5	0.6	1.0	1.2	1.1	0.5	0.6	0.4	0.4	1.7	1.0	0.8	0.1	1.1	2.1	0.7	0.6	0.6	4.5	6.2	8.9	7.2	4.5	5.6	5.5	5.1	6.1	5.0	5.2	9.2	6.9	3.2	9.3	11.8	9.8	4.8	2.6	3.8	14.8	9.5	8.5	5.1	8.0	7.2	5.0	7.3	6.2	4.2	11.0	2.0	0.0	3.1	3.7	5.9	10.0	8.8	7.2	9.4	11.1	2.9	2.0	9.5	4.6	7.4	5.1	12.7	8.6	10.2	4.1	6.7	12.5	4.6	4.1	11.1	6.8	5.2	9.0	6.0	1.8	15.9	5.9	6.5	4.1	26.7	17.1	3.0	2.4	9.1	9.0	4.3	2.3	3.5	6.1	9.2	0.0	9.9	7.3	11.9	8.6	8.5	2.8	2.3	7.1	7.4	3.7	1.9
ZMYM4	"KIAA0425, MYM, ZNF198L3, ZNF262"	ENSG00000146463	"Zinc finger MYM-type containing 4"	Q5VZL5	1	35268709-35422058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 127.9;Inhibitory neurons: 136.5;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051301, HPA054802"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA051301: AB_2681431, HPA054802: AB_2682605"	"unprognostic (8.95e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (9.75e-9)"	"unprognostic (9.76e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.21e-1)"	12.1	11.4	13.3	12.5	14.3	13.6	17.2	23.9	15.2	17.2	12.0	11.8	8.9	16.3	15.5	12.7	14.8	13.5	11.2	11.8	14.9	13.3	12.8	12.1	14.4	12.8	13.3	21.7	13.9	18.1	9.3	17.2	14.0	15.0	11.5	24.6	12.2	13.6	14.9	10.9	9.2	13.7	13.8	14.8	13.7	34.2	14.0	20.9	18.4	15.3	17.0	14.6	9.9	16.0	28.1	22.6	67.7	35.0	19.2	41.4	24.9	32.7	49.1	39.1	50.7	24.6	27.6	52.0	19.6	41.3	19.1	17.8	47.3	24.4	56.2	29.5	27.8	63.5	25.0	21.4	35.5	54.7	28.1	31.3	21.1	38.3	35.9	32.4	44.0	28.5	70.0	14.1	47.9	17.4	47.4	32.0	56.3	15.0	19.9	52.4	43.4	26.1	28.7	37.2	39.1	37.5	39.1	29.4	45.7	42.3	23.2	41.4	53.7	36.4	37.8	16.3	35.9	15.3	29.9	40.0	26.2	41.4	35.7	1.8	3.6	2.7	3.1	5.1	2.9	3.2	2.8	2.7	3.5	2.4	2.7	2.6	0.7	6.6	7.1	7.0	2.4	1.9	13.3	14.3	23.9	15.2	11.8	14.9	12.8	13.3	14.0	13.8	14.0	16.0	33.6	12.8	21.9	94.3	17.4	11.5	16.6	14.4	17.1	30.7	31.8	29.1	32.0	25.8	20.8	27.6	31.3	14.7	20.6	6.6	5.9	22.7	59.8	25.0	45.1	22.8	22.3	22.5	127.9	23.7	12.5	27.0	21.9	33.7	14.5	49.1	18.5	16.1	13.1	23.5	136.5	14.7	14.2	23.1	12.5	91.9	26.4	21.4	5.4	109.6	27.5	22.5	26.8	174.4	132.6	19.9	8.1	23.0	13.9	22.7	5.5	11.8	21.6	33.0	19.7	33.4	29.0	34.4	13.3	13.8	11.4	14.1	13.9	45.5	14.0	22.7
ZMYND10	"BLU, CILD22, DNAAF7"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50345732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 120.2;testis: 258.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 309.4;Endometrial ciliated cells: 221.8;Late spermatids: 415.3;Respiratory ciliated cells: 390.8;Spermatocytes: 529.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"T-47d: 5.6;U-87 MG: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035255			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.3	0.1	5.0	0.2	5.0	0.7	1.1	3.5	2.8	4.3	29.2	0.2	0.2	1.7	1.6	0.2	120.2	0.5	0.2	4.3	6.7	2.1	0.9	11.1	0.2	12.5	15.6	0.6	1.1	3.7	5.9	0.1	9.4	0.7	0.1	3.2	0.3	0.4	0.4	0.5	0.4	0.5	10.4	0.6	0.3	258.5	7.3	0.5	1.9	0.2	0.1	0.2	0.3	9.2	1.6	0.6	0.2	0.5	0.6	0.9	0.3	0.2	0.9	1.6	0.5	0.0	1.0	0.7	0.6	1.0	0.2	0.2	1.5	0.0	0.1	0.4	0.6	1.5	1.2	0.0	0.0	0.5	0.8	0.0	0.1	2.0	0.1	1.5	0.1	1.3	0.5	0.1	0.2	1.0	0.3	2.7	0.0	0.2	0.7	0.7	0.0	0.5	2.0	0.0	1.8	0.5	0.1	0.5	0.0	0.0	5.6	0.6	0.0	0.3	0.4	0.9	0.1	1.0	0.4	0.1	3.9	2.2	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.1	5.0	5.0	3.5	2.8	4.3	6.7	12.5	15.6	9.4	10.4	7.3	9.2	0.5	3.2	5.1	1.3	0.7	0.5	0.4	24.2	1.2	1.2	2.3	1.7	0.8	0.0	33.1	1.8	4.2	0.1	1.7	0.2	0.0	1.1	309.4	221.8	2.4	1.2	0.0	3.2	0.5	0.0	0.2	1.1	0.0	3.6	0.0	0.3	0.7	0.4	0.6	0.0	0.3	0.7	22.4	0.0	0.4	415.3	9.0	1.3	1.8	1.0	0.9	1.2	2.1	0.5	1.3	0.1	0.0	5.7	0.9	0.6	0.0	1.0	390.8	7.6	0.0	0.9	9.8	529.7	9.1	1.1	0.4	0.1	1.7	0.2	0.3	0.1
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491141	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 392.5;tongue: 465.5"	"Cell type enriched"	"Detected in all"	9	"Cardiomyocytes: 1836.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 29.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 161.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: AB_2682431"	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	32.4	11.2	20.8	14.3	29.8	24.4	17.9	19.0	28.1	18.0	109.2	19.7	10.0	15.9	17.3	18.5	12.7	17.2	175.6	23.3	22.6	16.5	8.7	20.9	17.5	23.6	29.1	15.9	10.3	17.8	10.3	12.9	22.5	20.9	13.9	22.0	12.9	14.7	392.5	11.7	13.3	23.0	20.8	17.1	12.8	14.3	27.4	15.6	13.2	465.5	18.6	14.6	9.1	27.7	27.2	15.1	29.0	33.5	86.8	68.5	16.1	21.7	22.2	19.6	20.5	33.9	7.8	17.8	19.0	27.7	22.8	31.8	28.3	23.4	29.5	29.0	13.1	34.7	37.9	13.6	23.2	43.1	20.2	55.4	17.8	28.0	32.6	19.5	32.3	23.2	43.0	2.7	36.9	11.9	16.2	13.3	11.0	26.1	15.1	15.2	54.3	10.8	12.1	31.5	16.5	10.2	45.0	22.8	28.7	23.4	20.0	30.0	42.2	20.8	32.5	26.1	32.3	14.8	32.2	76.5	18.4	33.6	37.6	86.8	63.8	27.1	15.6	52.3	13.5	21.8	13.0	13.3	35.6	26.8	11.3	10.6	161.0	12.5	66.8	36.0	13.0	18.0	20.8	29.8	19.0	28.1	23.3	22.6	23.6	29.1	22.5	20.8	27.4	27.7	58.0	134.6	107.7	46.0	49.6	38.5	57.9	41.9	44.3	58.5	50.9	46.0	1836.4	62.9	57.0	29.5	95.9	37.9	67.2	31.7	41.1	43.2	197.2	75.2	67.1	69.9	40.2	50.5	73.3	42.4	39.3	141.7	31.1	37.5	44.9	49.5	62.8	40.1	53.5	35.3	62.9	32.6	32.6	132.7	43.4	105.2	37.6	89.8	65.8	47.8	124.3	53.6	66.9	31.2	34.2	65.7	26.9	92.6	50.7	74.8	39.7	41.5	161.1	79.9	46.0	151.2	70.0	62.3	38.1	49.8	29.8	30.6	46.0	85.9	36.6	68.2
ZNF114	MGC17986	ENSG00000178150	"Zinc finger protein 114"	Q8NC26	19	48270081-48287608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 5.9"	"Cell type enhanced"	"Detected in some"		"Spermatogonia: 4.4;Syncytiotrophoblasts: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.2;Hep G2: 27.8;NTERA-2: 13.8;REH: 14.6"									"HPA025019, HPA029553"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA025019: AB_1859080, HPA029553: AB_10603005"	"unprognostic (1.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.63e-1)"	0.8	0.4	1.8	0.7	1.6	0.8	0.6	2.1	2.1	1.1	0.8	0.3	0.3	1.1	0.7	0.5	0.9	0.5	0.7	1.7	1.8	0.5	0.2	0.7	0.6	1.4	1.8	0.4	0.8	1.6	0.4	1.4	1.2	0.4	0.2	0.6	0.4	0.5	0.5	1.0	0.1	0.2	0.6	0.6	0.1	0.9	1.8	0.2	5.9	0.4	0.6	0.2	0.3	2.3	3.8	5.9	6.9	0.2	0.0	0.0	22.2	0.4	0.0	2.1	2.8	2.2	5.6	0.0	6.4	0.3	2.4	7.4	9.5	0.1	2.5	0.1	0.6	0.3	1.4	27.8	1.5	3.7	0.5	0.4	0.7	1.1	0.0	0.5	0.1	0.4	0.7	0.0	0.2	10.9	0.3	11.6	13.8	10.3	0.9	14.6	0.0	0.0	0.2	2.7	2.7	3.1	3.7	0.1	3.7	4.2	1.4	7.0	0.9	0.5	2.2	1.7	0.6	0.2	0.2	0.0	0.2	1.8	0.5	1.8	0.3	0.3	0.2	0.2	0.1	0.4	0.2	0.1	0.7	1.2	0.1	0.1	2.0	0.7	0.2	1.0	0.1	0.1	1.8	1.6	2.1	2.1	1.7	1.8	1.4	1.8	1.2	0.6	1.8	2.3	2.3	3.2	1.8	0.7	0.2	0.4	1.3	0.5	0.0	1.2	0.3	0.4	0.5	0.0	2.6	0.0	0.0	2.1	0.2	0.0	1.9	0.5	2.6	3.3	1.6	1.4	0.0	1.3	0.2	0.6	2.5	0.6	0.0	3.9	0.0	0.9	2.2	0.8	1.8	0.0	0.9	0.0	0.0	0.3	2.0	0.8	1.2	0.6	0.0	0.0	0.2	1.3	0.0	2.0	0.2	0.3	0.0	0.7	0.1	0.9	0.0	0.4	0.8	0.7	0.0	0.9	0.6	0.8	4.4	0.0	0.1	15.3	0.5	0.7	0.1	1.1
ZNF117	"H-plk, HPF9"	ENSG00000152926	"Zinc finger protein 117"	Q03924	7	64971772-65006684	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.0;SuSa: 21.9;THP-1: 21.9"									HPA031148			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nucleoli fibrillar center, Cytosol"		"HPA031148: AB_2673759"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (2.17e-11)"	"unprognostic (1.08e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	20.6	28.1	3.8	7.1	3.0	5.4	17.0	3.2	4.5	13.1	4.3	6.8	2.2	8.3	11.2	12.0	8.2	10.2	7.6	3.2	3.7	6.8	3.5	10.8	6.0	4.4	4.3	10.6	5.2	3.7	9.3	10.1	3.1	7.6	4.7	11.8	7.8	4.9	2.8	8.2	4.9	5.7	3.2	8.9	4.6	12.3	3.7	4.7	8.5	1.4	5.6	6.7	11.6	4.1	1.7	0.1	20.0	21.0	7.4	3.4	11.2	4.4	1.0	1.1	2.1	0.9	8.6	7.6	3.6	2.2	3.2	1.3	2.3	0.5	2.4	2.3	2.0	3.5	0.5	4.2	0.6	0.0	2.0	4.3	0.8	0.8	0.8	8.0	3.4	8.8	14.4	5.1	5.0	3.8	8.0	7.9	8.4	2.5	0.3	10.4	1.3	1.5	2.7	3.3	3.1	16.9	2.2	0.9	0.9	21.9	3.8	21.9	10.2	6.0	0.7	3.6	2.8	3.4	6.7	3.9	2.2	9.7	3.7	0.2	0.2	0.3	0.2	0.7	0.2	0.3	0.1	0.1	0.2	0.3	0.1	0.1	2.4	0.3	0.2	0.2	0.1	0.1	3.8	3.0	3.2	4.5	3.2	3.7	4.4	4.3	3.1	3.2	3.7	4.1	10.3	3.2	43.0	35.6	4.2	3.3	5.8	6.2	0.6	14.3	15.5	10.7	7.3	12.8	23.2	5.5	0.0	5.4	5.4	3.3	11.7	10.9	3.1	7.5	10.4	10.9	5.3	2.1	11.4	28.5	2.5	9.6	3.1	8.9	10.8	21.1	17.5	4.2	6.6	28.6	11.6	4.1	10.2	7.9	7.5	3.1	8.7	11.8	5.4	9.4	4.1	7.1	7.2	19.6	7.2	17.7	1.7	5.3	2.3	4.6	1.6	3.3	20.2	7.7	6.6	7.1	7.9	7.2	8.4	3.2	4.7	11.1	3.8	10.3	2.4	12.3
ZNF135	"pHZ-17, ZNF61, ZNF78L1"	ENSG00000176293	"Zinc finger protein 135"	P52742	19	58059239-58086310	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 5.5;HSkMC: 5.5;MOLT-4: 6.3;NTERA-2: 5.5;T-47d: 7.0"					"Low region specificity"	"Detected in all"			HPA006961	Approved		Approved	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA006961: AB_1080670"	"unprognostic (4.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-2)"	"unprognostic (9.18e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.34e-1)"	"prognostic favorable (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.25e-1)"	3.6	2.5	5.2	2.1	5.1	1.3	6.2	3.8	5.0	6.5	4.3	4.6	1.3	8.7	7.9	2.7	6.2	4.2	3.5	4.4	5.2	6.2	0.8	2.7	2.2	4.7	4.3	11.4	2.3	10.6	8.3	3.9	4.5	6.0	2.0	10.0	2.3	5.2	2.0	4.6	2.1	6.8	3.0	3.9	2.6	6.5	4.9	7.1	8.0	1.8	2.3	4.8	3.8	7.8	0.0	0.0	1.4	0.0	0.1	0.0	0.0	3.3	0.0	4.3	0.2	0.0	0.2	0.0	3.6	4.7	2.6	0.2	0.0	0.0	4.7	0.0	5.1	0.0	0.0	0.0	1.9	0.0	5.5	5.5	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	6.3	0.0	5.5	0.0	0.0	0.0	0.0	0.0	2.2	3.8	5.2	0.1	0.0	0.0	0.0	4.8	7.0	0.0	0.0	0.0	2.9	0.0	0.0	0.2	2.3	0.0	0.0	0.0	2.6	0.0	0.0	1.9	0.0	0.1	0.0	0.4	0.1	0.1	0.8	1.7	1.7	1.0	0.0	2.6	0.0	2.0	0.1	0.4	5.2	5.1	3.8	5.0	4.4	5.2	4.7	4.3	4.5	3.0	4.9	7.8	2.7	0.0	1.1	5.5	3.2	2.3	2.5	0.8	2.8	11.9	7.9	7.6	5.3	11.5	1.2	9.2	16.7	0.9	0.8	0.1	21.5	6.4	13.3	7.8	5.6	3.3	2.4	1.7	8.1	0.7	0.2	4.1	0.0	3.6	5.1	12.3	4.2	0.3	0.6	15.2	9.3	1.2	2.0	0.3	0.3	11.5	7.8	0.5	1.8	1.9	0.3	8.0	1.0	6.0	13.7	0.6	0.3	6.8	0.0	2.1	0.2	2.5	4.2	14.0	0.0	3.3	5.3	12.7	11.5	1.0	3.1	0.7	1.0	4.6	0.9	1.6
ZNF14	"GIOT-4, KOX6"	ENSG00000105708	"Zinc finger protein 14"	P17017	19	19710472-19733112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049863	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA049863: AB_2680921"	"unprognostic (1.04e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (8.09e-6)"	"unprognostic (1.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.05e-3)"	3.0	2.6	3.4	3.3	3.7	8.3	7.3	7.1	4.4	5.6	1.4	3.1	2.2	5.2	5.2	2.7	5.1	2.8	3.8	2.8	3.6	4.7	0.8	2.7	6.8	2.3	3.2	8.7	3.2	7.6	3.3	4.2	2.8	5.4	2.8	4.8	3.8	5.1	2.0	3.6	3.1	3.4	2.3	5.3	4.1	3.5	3.8	4.9	7.8	4.4	6.5	3.6	3.2	5.0	2.8	2.7	4.7	6.1	3.1	3.4	5.6	2.9	4.0	4.2	4.5	2.7	2.1	7.6	4.7	3.0	2.4	2.8	4.9	2.9	5.2	1.9	5.6	3.5	2.0	3.5	3.7	0.1	5.2	3.3	3.0	2.9	2.5	5.5	2.6	3.7	4.2	3.5	4.2	4.7	6.6	4.1	6.1	5.3	8.1	3.4	7.6	3.6	3.0	5.6	4.6	3.3	0.0	3.3	4.7	4.0	4.6	7.3	1.7	3.6	1.0	4.3	3.8	2.7	3.5	6.5	0.2	3.9	2.2	22.4	2.7	9.4	13.3	4.7	21.0	14.9	18.1	16.6	3.8	12.0	24.8	19.9	6.1	10.1	5.8	4.4	12.7	9.1	3.4	3.7	7.1	4.4	2.8	3.6	2.3	3.2	2.8	2.3	3.8	5.0	3.6	0.0	3.7	11.4	8.5	2.4	4.4	1.5	3.4	4.6	3.2	3.4	2.8	0.0	1.4	3.7	0.0	3.4	5.3	0.4	3.9	1.7	0.6	1.5	2.1	3.4	3.0	4.8	9.7	1.3	1.5	3.5	2.6	2.5	1.3	4.7	3.3	0.2	1.8	6.7	12.5	1.4	4.1	0.8	1.4	0.9	1.8	1.8	3.6	11.2	0.3	3.8	4.1	12.5	13.7	0.8	2.5	3.8	2.8	2.2	1.0	3.0	2.9	5.7	6.6	3.2	2.9	3.4	3.0	1.5	1.4	2.2	9.5	2.2	1.3	2.5
ZNF155	pHZ-96	ENSG00000204920	"Zinc finger protein 155"	Q12901	19	43967862-43998326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.5;Excitatory neurons: 22.0;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003220	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA003220: AB_1080675"	"unprognostic (2.71e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.98e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.57e-2)"	4.1	5.6	4.1	3.3	4.8	2.9	5.5	7.2	5.1	4.6	4.3	4.0	3.3	4.7	6.1	3.6	3.7	3.6	6.0	4.0	4.7	5.2	6.5	4.4	4.4	4.1	3.9	6.1	3.0	8.2	4.5	4.4	4.3	5.1	4.6	8.6	3.8	4.6	3.2	5.4	4.0	5.8	3.8	6.0	5.2	3.3	4.4	6.6	7.8	3.5	4.3	4.0	2.9	5.5	5.1	4.2	10.4	9.5	5.6	6.5	3.0	4.1	3.9	2.8	4.1	2.8	2.5	0.0	5.1	6.4	4.0	3.9	3.5	8.7	4.7	5.7	8.7	10.8	9.8	3.1	5.8	3.9	6.0	9.2	7.0	5.8	8.5	8.2	6.6	0.2	0.2	0.1	7.8	4.5	4.9	3.9	6.4	2.1	3.7	0.0	11.1	3.8	7.5	16.3	7.0	9.3	10.1	0.6	4.0	9.1	6.7	9.3	5.0	6.3	9.2	4.1	6.0	11.5	9.1	0.0	5.3	0.7	5.9	8.1	2.7	9.8	6.5	2.9	6.3	4.0	4.5	7.0	4.1	5.2	5.5	5.0	2.4	5.5	2.2	2.4	4.2	4.2	4.1	4.8	7.2	5.1	4.0	4.7	4.1	3.9	4.3	3.8	4.4	5.5	2.4	0.0	1.3	23.5	2.7	1.5	1.1	2.2	1.2	3.6	2.4	2.2	0.4	1.5	1.9	0.0	0.0	1.8	1.8	2.3	1.9	1.8	0.5	0.8	1.3	2.6	0.0	0.8	22.0	1.5	0.6	2.0	2.0	1.2	1.3	3.2	2.5	1.5	1.6	6.7	16.1	1.3	2.0	0.8	1.3	0.9	2.8	1.3	1.8	9.4	0.9	4.2	1.0	24.6	24.1	0.9	0.8	5.7	1.0	1.2	1.9	1.9	0.8	3.2	0.0	2.2	2.4	1.3	1.4	1.4	1.3	1.1	2.2	3.0	1.5	1.0
ZNF160	"F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18"	ENSG00000170949	"Zinc finger protein 160"	Q9HCG1	19	53066606-53103436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 67.7;Theca cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 48.6"									HPA023599	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA023599: AB_2218442"	"unprognostic (1.18e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.90e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.65e-5)"	"unprognostic (5.20e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.67e-5)"	19.3	29.0	7.3	7.8	10.2	7.4	17.6	12.2	11.6	19.6	4.9	17.4	8.0	18.9	13.7	11.0	17.9	13.9	15.9	6.9	11.9	22.5	13.8	15.0	11.6	9.0	9.5	20.8	12.7	18.1	10.2	13.7	10.3	15.3	10.7	14.2	14.2	13.5	8.4	12.4	12.5	14.1	6.7	33.3	13.7	14.9	9.6	13.5	29.3	9.0	10.4	17.2	15.5	17.1	9.8	8.6	11.6	17.8	19.1	13.4	19.7	10.4	13.9	8.3	13.2	7.4	6.0	11.1	8.8	9.7	11.0	7.0	11.1	10.7	16.4	8.3	13.4	17.2	6.6	4.2	10.5	0.0	11.3	16.7	10.8	8.9	12.5	20.9	9.0	12.9	8.8	0.0	15.8	6.7	14.5	10.6	10.9	2.6	13.7	9.1	12.2	8.6	13.0	48.6	9.8	12.8	0.0	8.2	1.6	37.0	8.8	10.0	17.3	23.0	8.2	6.9	7.7	6.1	27.4	15.9	4.0	4.2	11.1	10.9	3.1	11.4	6.7	4.2	10.0	8.6	6.9	9.2	4.4	9.9	10.4	8.3	6.6	17.6	6.6	4.2	7.9	5.5	7.3	10.2	12.2	11.6	6.9	11.9	9.0	9.5	10.3	6.7	9.6	17.1	46.5	22.4	30.5	23.8	18.5	4.0	10.0	14.7	9.6	23.2	9.4	9.5	20.6	15.7	14.1	9.2	29.2	8.3	16.8	8.0	5.9	8.2	31.0	12.4	21.6	29.8	8.4	9.9	17.1	6.8	9.5	15.4	20.4	16.0	18.3	67.7	34.2	5.0	6.4	47.1	18.8	8.3	8.2	11.3	6.4	10.2	10.8	13.0	1.8	15.9	7.1	13.8	19.6	21.6	29.4	8.1	6.3	14.3	12.7	12.6	11.1	5.9	12.7	19.1	13.1	13.9	18.4	8.3	8.3	8.1	4.0	10.4	18.5	66.0	5.7	13.0
ZNF169	MGC51961	ENSG00000175787	"Zinc finger protein 169"	Q14929	9	94259298-94301829	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.4;Inhibitory neurons: 16.7;NK-cells: 15.5;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041769, HPA061185"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Vesicles, Cytosol"	"HPA041769: AB_2677662, HPA061185: "	"unprognostic (1.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.27e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.45e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-4)"	3.0	2.7	3.8	4.4	4.4	3.2	3.9	4.3	4.8	5.4	3.4	4.3	2.9	3.9	4.2	2.6	4.8	1.7	2.6	3.8	2.4	3.7	2.1	3.2	6.0	3.7	2.6	5.4	3.3	2.3	2.7	2.1	3.8	4.2	5.5	4.2	3.9	2.6	4.6	5.2	5.7	2.8	1.8	6.1	4.1	2.6	3.5	3.8	4.8	1.8	5.1	4.0	4.1	5.7	3.0	2.6	2.8	4.9	1.5	3.4	3.1	1.1	2.0	2.2	2.3	1.8	4.3	7.3	1.4	1.7	2.2	5.8	5.7	2.7	2.9	4.0	6.3	5.1	6.5	3.3	1.8	7.8	5.0	3.0	2.9	1.8	2.8	2.8	2.7	6.8	4.6	2.1	2.8	2.9	3.7	4.4	4.6	6.2	3.2	3.1	2.0	2.3	1.9	2.5	2.9	3.5	1.9	3.5	1.4	2.7	2.2	3.2	3.1	2.0	2.6	2.6	2.2	3.9	1.5	1.4	1.9	5.2	1.9	2.2	3.0	3.2	2.4	3.4	3.1	3.0	2.9	1.7	2.1	4.0	3.0	4.1	2.5	3.3	2.6	2.0	3.1	1.7	3.8	4.4	4.3	4.8	3.8	2.4	3.7	2.6	3.8	1.8	3.5	5.7	2.0	3.2	0.5	10.4	8.0	0.3	2.2	1.3	1.2	4.8	1.0	1.3	1.2	1.5	2.6	1.8	4.2	0.5	3.9	2.5	0.0	1.1	1.0	0.6	1.4	2.3	1.2	3.8	18.4	0.9	0.8	1.8	2.6	0.5	0.0	6.3	2.5	0.8	0.7	5.0	16.7	4.1	0.0	4.4	1.6	1.0	5.9	4.1	0.0	7.5	7.8	2.3	15.5	14.1	19.9	1.2	3.1	3.4	2.6	2.6	4.3	1.0	2.4	4.5	0.0	2.9	1.7	5.2	3.6	0.7	0.4	0.4	4.7	3.7	2.1	2.4
ZNF18	"HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38"	ENSG00000154957	"Zinc finger protein 18"	P17022	17	11977439-11997475	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.0;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006144	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA006144: AB_1080683"	"unprognostic (2.99e-3)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (5.12e-6)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (1.52e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.53e-3)"	7.2	5.7	7.9	5.8	8.6	13.7	6.1	7.7	11.2	6.7	7.4	6.0	5.0	5.3	6.3	7.5	5.7	5.5	5.9	7.9	8.3	5.8	12.4	5.1	8.8	8.4	8.0	5.7	6.0	4.3	7.7	4.0	8.8	8.4	6.7	4.9	5.2	5.1	7.3	9.7	6.6	5.8	7.6	10.2	5.3	14.1	8.1	8.5	6.2	4.6	8.0	6.3	6.6	9.8	3.0	6.1	6.4	9.7	11.9	10.5	3.4	4.3	7.5	5.5	5.9	2.9	5.0	10.3	6.3	4.7	4.8	6.1	5.4	6.8	5.9	7.8	4.5	6.1	6.9	4.0	8.4	3.4	7.8	8.7	10.8	4.2	7.6	6.3	8.4	12.0	3.6	4.7	7.6	3.1	11.5	6.9	4.8	10.9	2.8	9.4	6.5	4.6	8.0	3.6	2.5	5.4	7.3	3.6	5.9	37.2	5.1	3.2	6.7	6.5	3.2	2.9	3.3	5.2	4.1	5.1	7.5	7.9	7.8	10.5	5.9	6.9	10.3	5.9	9.6	9.0	9.3	9.7	5.8	7.2	10.0	10.3	19.1	7.7	8.2	8.6	11.1	6.1	7.9	8.6	7.7	11.2	7.9	8.3	8.4	8.0	8.8	7.6	8.1	9.8	2.5	0.0	2.0	10.1	3.8	2.0	1.7	4.2	4.6	2.0	2.0	1.4	1.6	2.8	2.1	1.8	2.1	2.4	3.5	2.5	1.9	3.1	23.0	1.8	2.8	1.9	1.2	5.2	7.4	0.9	2.2	2.7	2.0	1.8	2.5	5.1	2.5	3.7	4.3	1.7	8.4	4.2	6.1	3.8	1.8	27.3	3.4	3.2	1.8	8.4	3.4	2.0	5.2	7.5	9.3	2.1	5.0	3.4	2.3	1.6	3.9	3.1	2.5	1.2	0.0	2.5	2.3	9.6	4.9	5.0	2.3	1.5	4.7	2.8	3.1	1.1
ZNF195		ENSG00000005801	"Zinc finger protein 195"	O14628	11	3339261-3379222	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030605	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA030605: AB_10602686"	"unprognostic (2.30e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.24e-4)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.79e-7)"	9.3	10.1	12.1	6.6	12.0	10.8	13.7	13.1	16.0	12.3	11.8	11.1	9.4	8.5	15.6	9.1	8.5	7.1	7.7	12.1	13.7	13.0	13.1	8.7	11.3	13.9	12.5	6.8	13.1	6.2	10.2	6.4	13.7	13.7	12.1	14.1	10.3	6.2	11.8	8.3	12.4	7.5	11.9	16.5	10.3	4.9	12.8	17.1	10.2	9.5	11.0	10.3	9.2	13.4	15.8	18.6	32.0	38.2	9.9	11.8	37.7	16.7	14.1	16.4	22.6	19.4	24.3	26.7	11.1	10.8	24.2	21.1	34.5	20.0	24.6	14.2	28.4	18.3	15.6	19.1	12.5	32.3	28.7	14.7	17.9	13.4	21.7	12.1	21.7	35.0	32.8	17.3	17.9	12.7	37.6	25.1	66.4	18.4	19.1	35.8	20.4	14.2	27.4	38.3	47.8	49.5	18.5	21.2	15.9	27.8	10.7	29.0	17.2	9.1	14.2	11.6	14.0	14.9	25.5	43.8	7.7	23.6	13.8	2.4	11.6	14.7	15.4	13.0	20.0	18.8	19.0	19.5	17.3	17.8	17.9	20.3	1.8	18.7	11.6	14.5	28.4	11.3	12.1	12.0	13.1	16.0	12.1	13.7	13.9	12.5	13.7	11.9	12.8	13.4	13.8	16.0	21.9	15.0	16.6	12.1	16.9	18.6	14.2	15.3	9.7	12.8	18.3	11.5	20.8	7.3	10.4	9.7	17.3	9.0	9.8	25.1	3.3	10.3	18.7	12.7	20.4	12.0	19.8	18.9	10.5	12.0	23.4	13.3	6.3	33.9	8.2	7.5	10.9	18.5	24.3	14.0	14.2	12.3	8.4	0.8	5.9	8.8	7.2	6.5	9.8	17.9	15.5	20.1	27.9	25.3	13.5	5.7	16.9	13.6	10.0	12.5	15.6	13.7	0.0	12.6	12.3	12.3	9.6	12.4	6.8	4.0	15.9	15.2	15.8	17.5
ZNF2	"A1-5, Zfp661, ZNF661"	ENSG00000275111	"Zinc finger protein 2"	Q9BSG1	2	95165432-95184317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041358	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041358: AB_10795539"	"unprognostic (1.18e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	2.1	2.6	2.3	2.3	2.5	0.7	2.5	2.7	2.9	3.2	2.0	2.4	2.1	2.4	3.2	2.3	2.9	1.5	3.1	2.2	2.2	2.7	1.9	2.4	3.1	2.3	2.3	3.9	2.1	3.8	1.9	2.2	2.4	2.6	1.7	3.0	2.3	3.2	3.4	2.9	1.8	2.6	2.1	2.9	2.5	3.0	2.3	3.2	3.1	3.6	3.2	2.3	1.8	3.0	4.1	3.7	4.5	7.6	6.2	5.1	2.8	4.0	5.7	6.1	7.7	3.9	2.5	2.2	3.0	4.1	4.3	3.0	5.1	3.2	6.1	5.8	4.0	5.8	2.9	4.9	5.1	2.8	3.4	4.4	4.3	5.5	7.8	6.3	5.1	4.6	3.9	1.9	5.9	3.1	4.2	4.1	1.8	3.3	4.9	4.1	7.4	3.3	3.4	2.3	4.0	5.2	4.1	5.7	4.9	3.8	3.6	4.4	4.0	7.0	4.2	5.4	3.6	3.4	3.3	3.0	4.4	3.7	5.2	5.6	3.4	12.9	6.3	4.8	4.4	5.4	4.9	5.5	4.0	5.1	6.3	6.2	2.6	3.5	4.0	3.1	6.2	4.0	2.3	2.5	2.7	2.9	2.2	2.2	2.3	2.3	2.4	2.1	2.3	3.0	2.1	0.0	1.7	3.3	2.0	1.0	0.7	1.1	1.8	3.3	2.3	1.5	2.6	5.7	2.1	1.8	0.0	1.8	2.9	0.8	5.9	1.8	2.7	1.3	2.0	1.9	0.0	1.3	7.7	2.0	1.4	2.1	1.5	1.2	1.3	4.7	2.5	1.6	2.5	1.7	6.2	0.7	0.0	2.5	1.2	0.8	2.1	2.2	0.0	3.7	0.5	4.2	4.1	7.1	5.7	0.9	0.5	3.0	1.4	0.9	1.5	2.8	2.5	2.7	6.6	1.6	2.0	5.5	7.5	0.9	1.1	1.6	1.6	2.8	1.1	0.7
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142804	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.7;Late spermatids: 58.3;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: AB_2683225"	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	4.3	6.7	5.0	3.6	4.9	3.9	4.6	5.7	6.2	5.1	0.9	5.7	5.5	6.5	1.7	6.9	5.1	3.2	5.6	4.9	3.3	4.6	2.5	3.5	5.7	7.1	4.6	6.5	7.2	4.9	6.7	2.1	4.7	5.7	1.2	4.3	10.4	3.0	11.5	10.0	6.8	2.3	3.4	4.9	5.7	17.9	5.1	2.5	5.2	1.2	0.9	5.7	5.2	5.4	3.6	11.1	4.9	11.3	4.7	3.8	6.0	6.4	2.6	3.3	3.9	3.6	7.2	4.3	6.2	4.2	4.9	8.4	2.2	7.1	1.3	9.2	8.3	2.4	13.4	7.0	8.8	7.5	7.8	3.7	8.7	4.4	1.8	2.5	2.5	8.2	8.0	9.4	2.2	15.1	7.0	9.1	8.3	3.8	8.4	9.4	5.7	8.1	2.6	2.4	10.0	8.5	9.7	5.7	4.7	3.1	7.5	12.8	6.3	6.8	6.2	7.7	4.5	5.2	5.4	6.4	2.7	9.9	5.3	0.0	0.5	1.3	1.2	0.9	1.1	0.9	1.2	0.8	0.5	1.5	1.5	1.1	1.3	1.6	0.7	1.2	0.7	0.8	5.0	4.9	5.7	6.2	4.9	3.3	7.1	4.6	4.7	3.4	5.1	5.4	4.1	0.0	1.1	3.6	1.9	1.9	1.5	2.1	2.8	5.3	4.8	4.2	4.4	1.5	1.7	0.0	2.1	1.8	3.4	10.2	1.9	4.0	22.7	3.0	3.1	3.4	2.4	2.1	3.2	4.9	2.0	3.9	4.6	4.4	4.5	4.8	4.6	1.4	3.2	8.4	3.5	6.0	0.0	5.1	1.7	58.3	6.5	3.6	0.0	1.0	4.4	5.6	5.2	0.5	4.6	5.2	4.2	7.2	1.3	2.1	14.6	2.5	1.5	5.2	19.7	3.9	4.1	9.5	4.5	4.8	2.0	1.4	2.3	3.5	6.6	1.8
ZNF23	"KOX16, Zfp612, ZNF359, ZNF612"	ENSG00000167377	"Zinc finger protein 23"	P17027	16	71447597-71463095	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.2;Oligodendrocyte precursor cells: 13.0;Oligodendrocytes: 16.0;Respiratory ciliated cells: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023534	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA023534: AB_1859140"	"unprognostic (8.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.04e-2)"	5.5	4.3	8.6	5.3	8.4	4.4	6.2	8.8	9.9	5.8	8.9	5.6	2.8	6.9	8.0	4.2	7.1	3.6	5.1	8.6	8.5	5.6	5.4	5.4	6.2	8.4	8.3	8.2	4.6	5.4	14.3	4.7	8.1	5.3	5.7	16.9	4.3	5.8	6.5	5.8	5.0	6.9	8.2	5.7	4.1	6.9	8.6	4.9	7.5	7.1	6.0	4.2	3.5	9.8	7.8	4.7	12.0	8.8	7.6	6.6	7.8	17.1	15.9	11.7	8.6	6.1	7.6	15.1	4.2	13.1	11.4	4.7	7.9	10.2	13.7	4.0	5.2	6.7	5.0	6.5	9.2	12.3	5.7	10.7	9.0	12.1	18.6	10.9	4.1	7.9	11.1	2.9	12.5	13.0	6.4	6.0	13.4	4.0	3.9	3.3	5.3	4.6	7.7	6.4	9.9	12.8	5.5	3.9	5.3	7.5	5.1	6.4	11.5	21.2	7.2	5.9	10.7	6.5	10.6	19.8	16.0	6.2	13.2	0.8	0.8	0.5	1.9	1.8	1.8	1.3	1.0	2.1	1.1	2.7	2.1	1.5	0.0	2.6	1.0	1.9	1.9	0.9	8.6	8.4	8.8	9.9	8.6	8.5	8.4	8.3	8.1	8.2	8.6	9.8	0.6	6.4	2.3	15.0	2.6	0.3	0.3	0.2	2.8	2.6	0.7	0.6	0.4	0.0	3.2	0.0	6.2	0.2	0.4	0.5	1.9	2.0	0.2	1.0	1.0	1.1	0.0	7.8	10.0	1.0	0.3	0.9	1.5	0.5	2.5	1.3	1.1	0.5	0.4	3.3	11.2	1.0	0.0	0.3	0.3	0.0	0.6	0.5	0.0	6.5	0.4	1.4	2.1	13.0	16.0	1.5	1.4	0.0	1.5	0.3	0.7	0.3	9.2	3.3	0.0	0.7	0.9	1.5	1.4	2.3	0.0	0.0	1.4	0.5	1.5	0.1
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822557-76972901	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	2.5	2.2	3.2	2.2	5.3	4.9	2.4	9.2	4.4	3.0	0.0	2.8	1.9	3.2	2.8	2.5	2.9	2.0	2.3	3.4	4.3	2.0	2.1	2.1	2.6	2.3	3.5	4.3	2.8	3.1	3.6	2.2	2.6	2.6	1.5	2.4	2.7	2.3	2.5	4.1	2.5	2.1	1.4	2.3	2.8	6.8	3.5	4.1	2.6	3.1	2.4	2.6	2.9	5.7	2.5	2.4	4.7	3.4	3.7	3.4	1.9	1.8	2.6	2.9	2.4	2.3	2.3	3.6	0.9	2.5	3.2	4.6	3.0	2.8	2.5	3.8	3.1	3.4	3.9	2.8	2.1	5.7	3.7	3.4	3.1	2.8	4.4	3.4	3.0	5.5	3.3	2.9	3.1	2.2	6.9	3.2	2.5	0.6	2.6	4.3	4.9	2.4	2.4	3.8	2.6	2.8	3.6	2.2	2.5	2.2	2.5	3.9	3.2	5.3	2.0	1.3	2.9	2.0	3.0	4.4	3.6	3.0	3.9	0.7	2.0	3.9	3.1	1.9	3.0	5.9	2.3	2.1	1.4	4.4	2.6	2.7	2.1	1.9	1.8	2.8	2.7	0.9	3.2	5.3	9.2	4.4	3.4	4.3	2.3	3.5	2.6	1.4	3.5	5.7	9.3	9.6	7.9	39.5	11.9	7.1	8.5	5.4	10.8	15.3	8.0	7.6	9.5	12.8	6.7	7.3	10.4	8.4	12.9	5.6	1.9	5.4	6.9	10.8	12.6	9.3	6.0	12.8	37.7	3.9	7.2	8.8	9.2	10.5	1.3	15.8	10.0	6.8	6.0	25.2	25.3	5.0	6.1	7.2	7.2	6.0	10.5	8.7	7.2	16.9	8.4	9.7	9.2	41.7	39.7	4.7	3.1	7.2	9.1	6.8	5.9	3.0	10.9	15.9	6.6	14.2	10.4	26.7	26.2	8.8	8.4	6.0	12.4	7.8	5.7	6.3
ZNF250	"MGC9718, ZFP647, ZNF647"	ENSG00000196150	"Zinc finger protein 250"	P15622	8	144876497-144902168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020853	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA020853: AB_1859152"	"unprognostic (1.16e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.43e-7)"	"unprognostic (2.23e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-2)"	"prognostic favorable (8.26e-4)"	4.7	3.9	3.2	3.3	3.2	2.9	5.6	10.5	4.7	9.7	2.3	6.9	4.8	7.4	2.8	6.4	7.6	3.3	4.9	2.4	4.5	7.6	4.0	5.1	3.0	3.0	3.2	9.7	4.9	6.0	7.3	5.5	3.3	7.5	3.6	7.9	6.0	5.2	4.8	10.9	5.2	4.2	1.5	5.5	4.9	4.5	3.3	4.5	10.0	5.8	3.3	6.3	8.6	3.4	5.1	2.9	13.4	11.1	6.8	5.9	4.3	5.6	6.4	9.4	7.7	2.4	3.9	12.0	9.8	6.5	3.8	6.6	5.3	4.8	6.0	3.8	7.8	10.8	14.9	3.5	2.0	1.8	3.6	3.9	6.5	5.6	4.5	7.2	3.9	7.1	8.6	11.5	7.9	6.8	12.6	4.1	4.0	6.0	12.5	14.4	5.9	5.0	7.8	3.7	13.2	10.1	11.8	4.4	5.3	5.3	6.3	6.1	5.1	9.2	8.8	7.3	5.3	5.6	5.1	8.0	4.7	6.2	4.1	3.2	5.1	5.8	10.5	2.7	8.1	10.3	7.7	5.8	6.6	9.7	8.9	7.3	2.9	6.0	3.7	2.6	11.7	4.5	3.2	3.2	10.5	4.7	2.4	4.5	3.0	3.2	3.3	1.5	3.3	3.4	5.8	12.8	3.0	10.7	10.7	5.5	3.2	7.5	10.2	8.4	4.3	6.6	4.3	1.5	3.9	5.5	0.0	2.3	18.6	2.4	3.9	7.5	7.4	5.1	6.0	5.5	4.2	1.7	11.9	1.9	1.3	5.2	2.6	4.9	2.5	6.3	5.0	2.1	1.7	8.4	17.5	1.9	12.2	2.2	8.0	3.0	4.1	3.0	5.4	4.7	2.0	3.3	5.2	11.1	7.8	2.6	1.0	5.3	8.2	3.3	3.7	3.4	5.0	9.9	13.1	4.1	6.1	14.3	8.7	4.4	5.5	1.9	10.9	4.9	3.4	2.3
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 63.5;NK-cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.9	12.5	13.3	11.0	14.2	21.0	10.4	13.5	15.9	12.5	9.3	13.0	10.7	10.0	3.5	19.1	14.5	5.3	10.0	12.4	11.8	13.5	14.3	12.0	16.9	15.2	13.2	16.0	13.6	4.4	14.6	4.8	14.0	13.4	5.7	3.8	11.7	4.2	10.6	17.6	19.6	4.5	11.0	26.8	12.0	9.3	14.4	8.1	12.8	4.6	10.6	10.8	14.4	19.7	6.6	5.5	4.8	11.8	3.7	5.4	7.9	5.2	3.0	4.6	1.7	7.4	7.4	8.4	4.6	5.2	2.1	12.1	6.0	5.6	3.1	5.4	25.8	7.9	12.0	3.1	6.8	7.7	9.7	7.3	7.2	6.2	4.7	4.5	5.9	7.7	13.9	7.8	1.9	9.9	9.1	19.3	3.2	7.1	10.6	14.4	5.5	6.0	5.5	3.9	11.5	10.0	9.4	8.8	6.0	2.8	11.8	11.0	7.6	6.3	9.1	5.2	4.3	24.4	8.5	4.7	6.2	14.5	7.2	3.8	1.2	1.5	6.6	1.1	3.3	1.2	3.7	5.4	0.7	1.7	3.7	4.9	3.1	3.8	1.0	1.2	2.7	2.0	13.3	14.2	13.5	15.9	12.4	11.8	15.2	13.2	14.0	11.0	14.4	19.7	17.1	9.6	13.3	15.7	20.8	11.5	8.3	11.2	14.8	15.8	13.9	11.7	2.6	12.8	10.7	11.0	20.9	4.6	63.5	16.8	1.9	7.6	1.9	11.5	14.7	13.6	7.2	13.5	17.6	6.6	3.9	9.5	15.8	14.4	12.6	14.3	20.0	11.5	9.0	6.7	14.6	14.5	2.0	9.8	9.8	2.3	11.5	19.7	8.8	18.7	13.5	9.7	89.6	25.1	30.6	9.2	13.2	10.5	25.4	12.9	19.8	3.4	10.1	21.6	13.1	12.3	8.7	17.0	9.7	15.5	16.1	4.0	39.0	24.0	15.7	11.0
ZNF280D	"FLJ20086, SUHW4, ZNF634"	ENSG00000137871	"Zinc finger protein 280D"	Q6N043	15	56630176-56734086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 176.6;Oligodendrocyte precursor cells: 200.1;Oligodendrocytes: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA030233	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"	"Golgi apparatus, Centrosome"	"HPA030233: AB_10602590"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.72e-2)"	11.3	11.4	3.4	8.7	3.9	23.1	15.4	9.0	4.6	18.0	4.8	10.2	7.5	20.1	8.1	8.4	12.4	9.6	9.2	3.6	3.8	10.3	13.2	10.1	10.0	3.1	3.0	23.7	13.7	11.1	4.5	11.5	3.6	10.6	11.5	12.4	10.5	9.9	12.6	6.6	9.5	15.1	4.0	10.3	10.3	7.8	3.5	35.9	11.5	11.6	9.9	10.9	8.5	9.8	13.4	7.4	13.6	20.9	13.3	18.7	9.9	20.2	14.3	8.2	9.3	5.4	13.6	22.7	8.4	14.5	7.9	10.0	6.7	5.3	9.9	11.6	4.1	2.4	12.5	8.2	13.3	20.4	6.6	12.8	7.6	5.6	8.0	20.6	18.3	23.0	11.9	25.7	13.0	9.6	14.4	2.3	0.0	15.6	5.8	4.3	22.2	16.1	10.1	15.4	11.2	20.0	16.9	10.5	6.7	0.7	11.4	19.9	16.2	12.1	18.2	11.3	16.1	13.2	21.6	0.0	13.7	31.0	13.2	7.8	2.6	3.5	2.1	2.2	2.0	3.4	1.9	1.7	3.6	3.2	2.0	2.4	0.4	1.8	2.0	3.6	1.9	1.0	3.4	3.9	9.0	4.6	3.6	3.8	3.1	3.0	3.6	4.0	3.5	9.8	32.4	9.6	18.9	176.6	31.1	11.1	18.3	12.9	42.7	79.8	20.5	20.7	37.9	22.8	14.6	3.7	83.4	23.0	25.5	12.2	7.9	12.0	18.3	14.3	33.0	36.5	32.3	27.5	107.2	14.0	21.5	37.5	26.0	14.2	17.7	37.8	34.2	31.1	36.6	69.0	151.3	25.7	16.2	35.6	18.1	49.5	33.2	22.9	16.0	91.8	27.0	24.9	28.8	200.1	293.3	10.5	10.4	21.1	41.4	21.1	26.8	14.2	12.8	84.5	6.6	47.4	30.8	49.4	33.8	26.8	13.9	13.3	21.4	27.7	22.2	16.3
ZNF282	HUB1	ENSG00000170265	"Zinc finger protein 282"	Q9UDV7	7	149195546-149226238	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.6;Late spermatids: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024374	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA024374: AB_1851322"	"unprognostic (1.79e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.23e-3)"	"unprognostic (3.11e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	10.4	10.1	8.8	6.6	8.2	11.0	11.0	10.3	9.0	15.1	5.7	13.6	9.9	14.3	2.5	15.6	12.4	6.0	12.3	7.9	7.2	10.4	13.1	8.8	6.8	8.3	8.0	14.0	17.0	6.8	9.9	8.0	7.4	18.3	4.0	3.7	12.7	7.0	16.9	17.0	10.8	5.7	6.9	12.6	12.5	5.3	8.0	7.2	11.4	9.1	4.7	14.0	12.1	8.8	20.6	20.3	11.5	27.7	10.0	11.6	17.0	18.4	13.4	15.8	15.7	18.8	21.9	20.7	27.1	11.6	14.0	22.2	13.6	17.6	6.0	31.3	49.1	17.2	13.1	16.0	15.0	22.0	18.8	13.6	23.4	15.2	16.5	11.9	16.7	13.6	33.8	15.6	8.6	24.6	46.4	33.0	37.3	12.0	25.3	29.9	11.2	28.8	8.7	19.6	26.1	25.1	20.3	24.2	16.9	6.1	15.6	21.3	20.9	22.5	5.1	27.2	27.0	22.4	14.4	15.5	18.8	19.0	19.7	0.0	0.5	1.1	0.5	0.5	0.6	0.2	0.7	0.6	0.3	1.7	0.3	0.4	0.5	0.6	0.6	0.7	1.0	0.3	8.8	8.2	10.3	9.0	7.9	7.2	8.3	8.0	7.4	6.9	8.0	8.8	8.2	3.2	4.5	5.2	3.9	7.1	2.7	4.7	5.2	11.4	9.0	8.3	4.8	7.2	3.6	1.8	4.2	11.7	3.8	10.2	0.0	4.9	31.6	7.0	6.2	6.8	13.1	3.0	6.1	4.4	5.4	5.4	4.6	9.3	5.7	13.3	7.5	8.7	6.0	15.2	6.7	11.5	2.0	6.8	2.7	32.6	6.2	4.5	1.8	9.4	4.2	6.9	3.1	6.0	9.3	6.3	11.9	5.7	4.4	4.9	9.9	3.2	2.9	7.7	13.1	7.5	6.3	11.8	1.3	6.0	6.5	5.1	5.3	9.6	10.1	4.4
ZNF30	"DKFZp686N19164, FLJ20562, KOX28"	ENSG00000168661	"Zinc finger protein 30"	P17039	19	34926903-34945170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 15.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 15.4;Horizontal cells: 13.5;Inhibitory neurons: 13.2;Oligodendrocytes: 15.6;Rod photoreceptor cells: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA030400	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA030400: AB_10603245"	"unprognostic (3.04e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.10e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-2)"	2.1	2.9	5.1	1.4	5.4	0.5	2.6	8.0	6.0	2.5	2.7	2.5	2.0	2.1	1.5	1.8	3.0	1.2	2.6	4.5	4.2	2.9	3.6	2.7	2.6	4.4	4.2	2.4	3.7	3.0	3.3	1.5	4.8	3.3	2.0	15.6	2.3	2.2	2.7	2.6	2.4	2.3	4.2	3.7	2.3	2.5	4.5	1.8	2.1	2.8	2.4	2.2	2.2	5.7	3.4	7.3	3.1	7.8	5.3	3.3	0.1	3.2	2.2	2.9	3.2	5.3	1.1	0.0	4.2	2.2	1.1	2.0	9.0	4.6	3.6	0.0	4.3	2.4	4.2	4.1	2.5	3.3	2.2	2.9	4.0	2.7	3.9	1.1	4.6	6.5	8.0	0.0	4.6	2.5	2.4	1.4	4.3	8.2	3.8	3.1	2.4	0.7	2.2	2.9	4.0	5.8	0.0	0.1	2.9	3.2	3.0	0.8	3.4	6.1	3.2	2.2	4.4	2.1	11.1	0.9	1.2	0.0	3.6	1.8	0.1	0.1	3.1	0.3	3.1	2.2	2.5	1.4	0.9	1.3	4.7	4.9	0.0	4.7	0.0	0.8	2.7	1.3	5.1	5.4	8.0	6.0	4.5	4.2	4.4	4.2	4.8	4.2	4.5	5.7	3.6	0.0	1.1	8.8	1.3	0.4	0.4	0.5	1.8	6.4	1.2	0.9	3.6	0.0	0.4	1.8	6.2	0.1	2.6	0.1	3.9	1.1	0.6	1.0	2.5	3.6	1.2	6.1	15.4	1.3	0.5	1.4	2.0	0.9	5.7	2.4	5.0	1.0	0.8	13.5	13.2	1.2	0.0	1.9	0.3	0.8	2.1	0.5	1.8	3.7	0.3	4.4	6.2	9.0	15.6	1.0	0.7	2.2	1.0	0.5	0.5	1.4	2.5	11.5	0.0	1.4	1.5	2.7	2.6	1.2	0.1	0.0	2.3	2.1	1.5	0.4
ZNF304		ENSG00000131845	"Zinc finger protein 304"	Q9HCX3	19	57351271-57359898	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA050531	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear speckles"	Cytosol	"HPA050531: AB_2681160"	"unprognostic (4.44e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (1.52e-7)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.31e-1)"	"unprognostic (9.00e-3)"	4.4	6.3	4.2	3.5	4.4	4.3	6.5	6.7	6.0	4.3	3.5	4.9	2.6	5.0	7.4	5.2	5.2	4.3	6.2	4.8	4.4	4.5	3.5	5.3	5.2	3.0	3.6	6.7	2.5	10.0	5.0	5.5	3.2	5.5	3.1	5.3	4.7	6.2	5.0	6.1	3.8	5.1	3.4	6.8	3.9	4.4	4.3	7.5	7.0	5.3	7.3	4.2	3.0	4.1	6.4	3.1	7.6	9.6	6.2	5.9	4.8	6.4	9.7	7.1	16.0	0.0	3.0	5.3	3.9	7.4	3.7	2.3	4.4	8.4	10.6	1.7	20.5	8.4	8.9	4.5	4.4	4.7	5.1	7.1	11.0	7.0	9.7	7.6	4.5	11.8	2.6	0.0	7.6	1.7	10.0	2.7	5.1	0.0	9.9	6.3	12.3	6.7	5.0	13.7	6.0	6.4	6.7	5.1	4.4	6.9	6.2	6.6	5.2	9.9	5.9	3.1	6.8	8.1	7.7	7.8	6.3	0.1	5.3	2.5	1.3	1.1	1.4	1.0	2.6	2.3	2.4	2.0	1.8	1.8	1.9	2.1	0.1	2.8	2.8	0.9	2.0	1.7	4.2	4.4	6.7	6.0	4.8	4.4	3.0	3.6	3.2	3.4	4.3	4.1	5.0	0.0	0.5	4.2	3.2	6.4	0.8	1.3	4.6	4.9	6.9	5.1	4.4	7.2	4.6	0.0	0.0	1.7	2.9	1.0	1.9	1.7	1.2	3.2	1.8	4.1	0.0	0.0	8.2	1.0	0.8	1.9	1.5	4.0	0.0	5.2	10.4	2.7	1.6	3.3	6.4	1.4	4.1	2.1	2.8	1.1	1.8	1.6	3.6	2.8	0.6	1.4	1.0	3.0	2.8	0.9	0.5	2.2	1.6	1.4	0.8	1.6	6.2	2.2	0.0	2.2	2.8	2.2	4.2	5.4	5.5	1.1	2.1	5.0	1.9	1.2
ZNF324	"ZF5128, ZNF324A"	ENSG00000083812	"Zinc finger protein 324"	O75467	19	58467045-58475436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 37.0;Horizontal cells: 33.7;Rod photoreceptor cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 54.2"									HPA039774	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA039774: AB_10673149"	"unprognostic (8.60e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.74e-5)"	"unprognostic (6.39e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (3.56e-1)"	3.4	3.9	4.8	3.4	4.9	6.7	3.7	6.3	6.0	4.6	2.8	4.1	4.3	5.0	3.2	5.9	5.2	2.9	3.4	5.1	4.2	3.1	5.7	3.2	3.1	4.7	3.9	5.8	7.0	4.4	6.6	2.9	3.8	4.6	2.2	3.0	4.7	4.2	3.0	6.6	3.9	3.3	2.9	3.9	4.4	4.4	3.4	6.8	4.8	2.6	2.9	4.4	3.8	4.8	7.8	8.9	5.0	10.1	5.3	5.0	7.2	6.3	6.4	5.6	5.0	8.5	4.2	11.2	5.9	4.3	7.6	9.3	6.4	6.6	2.1	10.5	54.2	6.9	6.7	3.6	4.5	12.3	9.2	3.9	8.5	7.1	3.3	5.1	3.7	7.9	11.4	7.1	6.0	6.0	12.5	6.6	5.4	6.4	12.9	13.9	6.5	7.3	3.8	15.5	11.8	9.5	6.5	10.8	3.8	3.6	4.9	10.1	6.4	17.6	3.9	6.4	11.2	10.4	12.0	5.8	9.5	6.7	6.5	2.3	5.3	8.9	10.5	5.9	11.5	5.8	8.0	11.6	3.8	6.2	12.1	9.7	15.6	7.3	4.5	7.0	8.8	4.2	4.8	4.9	6.3	6.0	5.1	4.2	4.7	3.9	3.8	2.9	3.4	4.8	4.8	0.0	1.7	5.2	8.4	9.1	5.5	3.1	2.2	37.0	10.3	7.5	7.5	2.8	3.8	0.0	25.0	4.8	6.9	9.9	0.0	4.9	1.2	6.3	6.3	5.5	7.8	6.5	5.6	4.1	3.8	6.0	6.6	3.6	1.3	11.3	7.5	3.6	2.9	33.7	6.3	7.9	6.1	2.4	3.7	1.6	12.8	3.2	3.6	7.5	4.1	15.8	7.2	4.5	6.7	4.2	12.4	14.7	5.6	8.0	9.0	2.3	5.8	57.2	6.6	11.7	8.5	19.4	15.8	4.8	13.4	6.7	7.6	11.2	6.3	3.8
ZNF324B	FLJ45850	ENSG00000249471	"Zinc finger protein 324B"	Q6AW86	19	58451611-58457833	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Inhibitory neurons: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.0"	"Cell line enhanced"	"Detected in all"		"HEK 293: 38.7"									HPA023400	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli	Cytosol	"HPA023400: AB_1859195"	"unprognostic (2.75e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (5.58e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.94e-2)"	2.4	2.2	1.0	2.8	1.1	1.7	2.7	2.3	2.3	3.4	0.4	2.3	1.8	2.9	1.4	3.0	3.0	2.1	1.8	1.3	0.4	2.3	2.4	2.2	2.3	0.8	0.2	3.0	3.6	2.6	3.0	1.4	0.4	2.7	1.8	1.9	2.7	2.4	3.1	3.8	2.3	2.2	0.0	3.4	2.6	3.0	0.3	2.5	2.8	1.7	2.0	3.0	2.6	0.8	5.9	9.6	5.2	8.6	3.6	3.1	3.8	5.2	3.8	4.2	3.0	3.4	2.5	8.0	3.2	3.1	4.3	4.8	6.9	4.8	3.2	8.1	38.7	6.9	8.5	1.3	3.7	11.3	9.8	3.1	4.8	4.7	4.0	2.7	3.0	7.0	10.1	4.7	4.3	3.9	8.4	2.7	2.8	6.9	5.4	7.9	6.8	4.8	2.7	11.4	12.2	7.0	4.9	7.9	1.3	3.5	2.9	3.2	3.5	9.9	2.5	5.3	8.5	10.2	9.9	5.7	3.9	4.8	3.9	0.0	0.6	0.0	0.6	0.3	0.4	0.2	0.3	0.4	0.3	0.5	0.6	0.4	0.7	4.0	0.2	0.3	0.2	0.5	1.0	1.1	2.3	2.3	1.3	0.4	0.8	0.2	0.4	0.0	0.3	0.8	1.8	0.0	0.5	9.1	2.9	0.8	1.0	0.6	1.8	3.1	1.6	1.3	0.9	1.5	2.2	1.8	22.9	0.9	2.4	2.2	0.0	1.8	1.0	1.9	3.1	1.5	0.0	2.1	9.5	1.6	0.9	1.5	1.5	1.2	0.0	1.8	1.4	1.3	0.9	5.0	10.6	1.0	0.0	2.2	0.4	1.8	3.1	1.2	0.0	0.0	2.0	2.0	3.1	7.5	9.5	1.4	0.6	2.6	1.5	1.0	1.2	1.2	2.7	6.6	6.6	2.3	1.6	6.6	4.8	1.2	1.0	0.7	2.0	4.2	1.3	1.0
ZNF334	bA179N14.1	ENSG00000198185	"Zinc finger protein 334"	Q9HCZ1	20	46499630-46513559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 43.1;Inhibitory neurons: 29.1;Oligodendrocyte precursor cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;BEWO: 19.4;NTERA-2: 10.4;SCLC-21H: 12.9;SuSa: 22.0"	"Low region specificity"	"Detected in all"							HPA050022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA050022: AB_2680994"	"unprognostic (3.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.71e-3)"	3.5	7.9	9.3	0.9	9.8	1.4	6.9	15.1	10.3	7.9	10.2	3.7	2.0	6.7	9.3	2.1	9.5	4.1	2.5	8.2	10.5	6.9	5.5	3.4	1.4	11.6	10.6	15.8	8.9	1.7	16.1	5.1	9.7	12.6	2.3	15.7	6.4	5.8	0.9	2.0	3.6	3.3	9.3	3.2	5.2	7.7	10.7	2.9	12.3	1.7	1.1	5.1	5.5	10.2	0.1	0.0	15.5	0.1	1.0	0.1	19.4	1.4	0.1	1.2	0.1	0.0	4.0	0.0	0.0	0.4	4.8	0.0	0.0	0.3	0.6	0.0	3.3	5.1	0.1	5.7	4.1	0.1	0.0	4.9	0.0	1.3	0.0	0.7	0.1	0.1	3.5	0.0	0.1	0.0	0.0	9.1	10.4	2.6	1.3	0.0	0.0	0.1	4.2	3.9	12.9	7.3	0.0	0.4	0.2	22.0	0.1	4.5	0.0	0.2	6.9	0.1	0.0	1.2	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	9.3	9.8	15.1	10.3	8.2	10.5	11.6	10.6	9.7	9.3	10.7	10.2	1.2	9.6	4.5	43.1	0.2	0.1	3.5	1.1	2.8	11.0	5.6	4.3	1.9	1.5	5.5	3.7	2.1	4.1	0.0	0.4	5.9	4.5	0.6	2.5	6.2	1.7	0.0	2.1	15.7	1.3	3.7	3.9	7.7	1.3	2.5	11.1	2.2	0.9	1.7	10.1	29.1	1.2	0.0	0.0	0.3	1.4	2.8	1.2	0.0	3.7	0.0	7.8	0.0	33.2	7.5	1.7	0.3	1.9	0.2	2.2	0.6	3.4	7.9	12.3	0.0	5.1	2.4	5.7	7.5	1.4	0.0	1.0	0.2	6.5	1.8	1.6
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99473877-99504857	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 97.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Approved		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	13.3	9.6	8.6	10.3	9.5	97.0	12.5	16.4	8.3	11.9	8.8	12.5	10.3	10.4	6.9	12.6	12.5	7.3	12.2	7.7	9.0	10.4	10.1	13.3	13.6	9.8	9.1	13.9	9.7	7.7	9.4	8.1	9.0	13.5	8.6	5.4	10.2	7.7	12.2	15.4	14.3	7.8	8.5	19.2	11.5	10.6	9.4	12.8	10.2	9.6	11.3	11.9	12.2	10.6	10.3	10.2	6.6	14.0	10.4	7.1	13.1	8.5	11.6	9.9	9.7	11.0	11.0	12.4	12.2	9.2	13.5	9.6	9.2	11.2	9.8	9.1	12.0	12.2	12.0	12.1	8.3	17.4	20.0	9.4	9.6	9.6	10.2	7.3	11.6	10.5	17.6	24.0	9.3	19.6	18.3	28.8	15.0	12.9	12.0	10.2	7.3	22.1	11.0	14.7	7.8	16.5	10.2	24.6	16.9	16.5	6.4	21.8	11.9	11.7	12.0	17.4	10.9	19.7	22.1	20.0	8.5	17.4	12.9	56.8	20.6	36.6	31.7	25.5	33.2	24.5	31.8	34.3	22.6	23.6	38.5	30.8	37.8	36.8	26.8	32.8	37.7	24.6	8.6	9.5	16.4	8.3	7.7	9.0	9.8	9.1	9.0	8.5	9.4	10.6	29.3	16.0	19.7	5.2	37.1	35.6	36.1	16.4	16.5	9.7	20.6	14.6	11.4	8.6	16.6	11.0	12.5	15.8	56.7	26.3	17.6	15.7	10.4	17.3	12.9	22.2	20.8	31.5	4.6	14.1	18.2	17.5	25.0	24.4	58.9	17.1	17.5	12.3	18.9	15.2	5.0	16.9	8.2	25.5	29.6	2.9	15.5	29.3	28.4	1.9	19.3	13.6	45.3	7.1	5.6	16.4	20.8	13.5	31.8	29.2	29.7	11.7	19.4	11.7	13.1	22.6	19.7	41.9	30.6	21.5	35.5	29.7	54.3	24.6	18.6	65.6
ZNF397	"MGC13250, ZNF47, ZSCAN15"	ENSG00000186812	"Zinc finger protein 397"	Q8NF99	18	35241030-35267133	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026087	Uncertain		Approved	"Nucleoli,Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Plasma membrane, Cytosol"	Microtubules	"HPA026087: AB_1859243"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.09e-3)"	12.9	13.4	17.6	14.4	23.4	5.0	16.1	19.1	20.0	13.5	14.9	12.8	10.6	15.7	12.4	9.8	11.7	10.1	10.5	16.4	20.7	11.3	10.6	10.4	16.2	20.5	20.9	17.8	12.4	14.8	12.0	11.9	20.1	13.9	13.9	25.0	12.4	12.1	11.7	13.6	12.6	11.5	15.4	16.1	13.3	9.9	20.3	13.1	15.7	11.0	15.8	11.9	11.8	34.4	4.2	7.9	18.7	17.1	20.3	17.0	8.9	8.4	8.3	4.1	5.4	3.0	5.7	21.2	7.4	6.7	5.6	11.1	12.2	9.2	5.7	13.5	7.5	0.9	11.7	8.6	6.7	10.3	7.4	7.7	12.1	4.9	14.1	14.6	2.6	16.1	12.7	14.4	10.7	9.1	17.4	7.8	16.1	3.2	3.2	18.2	5.4	15.1	8.4	11.0	20.2	17.4	13.7	7.2	8.2	16.2	12.5	7.6	4.2	13.6	7.6	4.6	3.8	23.2	9.3	11.9	12.0	7.1	13.1	10.1	4.6	8.3	5.7	7.5	4.1	10.6	5.3	4.7	3.3	11.3	7.8	5.4	11.0	4.7	9.4	7.5	3.0	2.2	17.6	23.4	19.1	20.0	16.4	20.7	20.5	20.9	20.1	15.4	20.3	34.4	15.5	35.3	21.0	24.5	35.3	4.1	19.4	8.0	10.2	51.0	11.8	10.4	16.4	15.7	17.3	14.7	35.5	22.6	15.8	14.1	13.7	18.7	66.0	10.8	20.4	17.6	31.0	20.4	17.4	10.9	13.4	18.4	12.8	8.9	11.4	31.7	31.1	12.6	10.8	33.7	19.5	11.5	12.2	20.5	5.4	49.6	18.6	11.8	8.8	23.4	20.3	24.6	15.5	30.2	94.1	10.7	18.3	22.6	6.1	15.8	24.3	11.4	16.4	46.1	32.9	25.3	16.6	29.7	23.4	7.8	4.5	14.6	13.9	22.1	16.1	11.1
ZNF408	FLJ12827	ENSG00000175213	"Zinc finger protein 408"	Q9H9D4	11	46701030-46705912	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017892	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA017892: AB_1859248"	"unprognostic (7.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (3.01e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.99e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-2)"	5.9	5.1	6.2	4.0	6.6	14.5	5.6	6.8	7.8	6.4	4.7	6.6	5.1	7.8	1.6	8.6	5.7	4.0	6.6	5.9	5.8	5.9	12.7	3.9	5.3	6.7	6.4	5.7	6.5	3.2	5.3	3.7	6.1	7.2	2.8	1.2	5.7	4.3	10.3	10.1	6.6	3.4	6.1	7.5	7.4	5.9	6.5	5.4	5.3	6.2	3.3	7.2	5.9	6.8	4.8	11.4	5.2	9.4	6.5	5.7	13.5	6.3	8.8	12.5	9.1	10.3	5.3	7.4	5.7	7.6	9.0	12.2	6.7	12.4	4.4	5.9	13.5	7.1	8.0	12.7	12.2	7.4	9.7	11.2	12.0	6.3	9.0	6.7	6.2	11.1	11.4	6.5	5.2	15.5	9.0	15.1	21.8	15.9	13.8	9.8	7.8	11.7	6.7	12.5	7.3	9.8	12.1	15.0	10.0	4.8	13.1	12.9	7.1	12.2	8.1	10.2	12.4	9.4	8.8	10.9	7.9	8.5	9.9	3.9	7.6	7.8	8.5	8.3	6.6	6.3	8.3	10.2	7.2	7.6	9.2	7.0	7.1	5.8	6.3	5.7	8.1	7.3	6.2	6.6	6.8	7.8	5.9	5.8	6.7	6.4	6.1	6.1	6.5	6.8	4.6	6.4	2.2	1.6	7.5	6.6	5.5	12.0	7.4	5.1	6.4	5.5	5.3	4.3	5.7	1.8	0.0	10.1	8.5	9.6	11.7	7.8	5.6	7.0	7.2	4.8	8.4	11.4	1.4	4.8	7.7	4.5	6.6	14.9	0.0	8.2	5.3	9.2	5.5	3.3	1.6	9.4	2.0	7.1	2.8	3.2	6.2	3.2	10.6	1.9	6.6	7.9	8.2	1.5	2.1	5.9	3.2	6.4	5.2	4.5	9.0	5.8	4.3	3.5	13.1	3.7	7.2	11.2	9.0	7.5	4.1	10.5	4.8	5.7	7.1	6.0
ZNF414	"MGC15716, Zfp414"	ENSG00000133250	"Zinc finger protein 414"	Q96IQ9	19	8509678-8514167	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 93.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 40.5"	"Low region specificity"	"Detected in all"							HPA053769	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053769: AB_2682255"	"unprognostic (7.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.26e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.67e-6)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.71e-4)"	14.3	19.6	5.6	5.2	6.3	9.1	15.9	5.0	12.3	22.3	0.5	16.8	7.9	23.2	1.3	18.3	17.2	1.8	16.7	5.7	4.8	17.2	20.9	11.4	6.3	7.1	5.6	22.4	14.9	3.4	21.3	3.7	6.3	23.9	1.1	2.1	15.0	4.4	18.1	21.9	15.6	1.8	3.5	19.3	14.5	20.6	6.6	4.3	22.5	2.7	1.9	17.2	18.0	11.1	9.2	7.8	4.2	6.8	1.1	2.6	9.2	6.9	2.6	4.4	3.9	6.9	4.4	12.5	19.3	2.1	3.2	12.5	1.4	5.6	0.6	11.4	31.0	7.9	7.2	8.3	5.9	7.0	10.3	4.8	4.0	3.6	1.3	2.4	1.9	7.8	10.7	18.0	2.7	11.3	15.7	40.5	12.5	2.4	22.0	18.1	2.2	12.8	3.1	7.5	14.4	22.3	7.5	5.7	6.6	0.8	10.8	8.1	7.1	12.8	6.5	18.7	8.9	26.0	11.8	10.0	10.2	5.8	7.1	1.4	0.5	0.3	0.6	0.4	0.3	0.8	0.9	0.9	0.5	0.8	0.8	0.8	1.6	0.8	0.7	1.2	0.4	0.4	5.6	6.3	5.0	12.3	5.7	4.8	7.1	5.6	6.3	3.5	6.6	11.1	9.7	0.0	1.1	4.2	11.8	11.9	13.5	6.9	26.2	18.3	12.1	14.7	2.1	11.5	2.5	3.7	10.4	28.8	15.8	14.3	15.6	3.9	27.1	5.7	9.2	8.2	22.2	9.2	3.6	5.3	22.8	11.8	17.3	8.0	4.5	15.0	13.2	10.9	13.1	11.8	3.6	14.6	2.0	12.7	7.6	93.4	20.5	11.6	8.8	3.7	8.8	20.4	11.3	4.0	6.5	4.6	16.0	16.1	9.3	9.1	16.2	17.6	1.4	21.9	13.1	11.5	10.0	21.3	38.3	18.0	12.1	31.5	12.8	19.0	13.2	9.8
ZNF416	FLJ20557	ENSG00000083817	"Zinc finger protein 416"	Q9BWM5	19	57571566-57578911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA063318			Approved	"Nuclear bodies,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear bodies"	"HPA063318: AB_2684983"	"unprognostic (1.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.57e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.20e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-1)"	2.2	2.2	2.6	1.6	3.0	2.6	3.7	4.3	3.7	2.7	2.2	2.3	1.4	2.3	3.9	3.2	3.4	1.8	2.7	2.7	2.5	2.6	2.0	2.5	2.8	2.0	2.2	4.4	1.4	4.4	2.0	2.9	2.0	2.7	2.1	3.7	2.2	3.1	2.6	5.1	1.7	2.8	2.2	2.8	2.1	4.2	2.6	4.0	3.6	3.0	4.1	2.4	2.4	2.9	3.2	3.1	6.5	5.2	3.9	5.6	4.3	3.2	5.8	6.2	4.0	2.2	1.7	2.2	2.3	4.1	4.5	1.2	3.8	5.5	7.6	3.5	15.5	5.3	3.5	1.8	7.0	4.7	3.3	5.6	5.6	3.9	8.2	4.9	4.3	5.3	0.7	1.7	8.4	1.3	9.9	2.2	7.7	3.8	5.7	4.9	9.7	4.8	4.3	6.8	4.7	5.3	5.8	3.0	2.9	7.3	2.7	5.6	3.2	6.7	3.2	2.2	4.8	5.4	9.5	5.9	1.5	3.1	4.1	1.1	2.6	1.9	4.3	1.9	7.7	6.6	5.9	6.3	4.1	10.4	8.0	5.8	0.8	9.0	1.7	3.7	2.9	3.7	2.6	3.0	4.3	3.7	2.7	2.5	2.0	2.2	2.0	2.2	2.6	2.9	1.1	0.0	0.5	1.3	2.9	1.7	1.6	1.6	1.2	3.5	1.6	1.8	1.8	1.5	1.6	0.0	0.0	2.1	1.0	0.6	3.9	2.8	5.0	0.9	0.9	1.8	0.0	3.6	1.5	0.9	0.8	1.1	1.5	1.1	2.5	2.6	0.7	1.2	1.7	8.4	1.4	1.1	0.0	1.0	0.6	2.0	0.9	0.6	0.0	1.0	0.5	3.2	3.1	3.0	0.2	1.4	1.2	0.7	0.8	1.3	1.1	1.3	0.6	2.8	6.6	1.5	1.2	3.1	4.1	1.3	2.4	1.9	1.3	2.4	0.9	2.2
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369836	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.8;HSkMC: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	10.0	14.8	4.8	2.3	5.2	1.4	9.8	5.5	5.4	9.8	4.5	8.5	3.1	9.9	8.0	16.5	6.9	5.5	8.3	5.5	5.3	4.0	3.7	4.2	2.7	6.3	5.2	15.4	6.9	5.3	4.4	4.2	5.6	9.5	3.1	4.6	14.6	5.1	6.5	12.6	5.6	6.2	5.6	7.0	6.1	7.9	5.4	3.5	9.0	6.2	3.6	10.4	10.2	5.9	3.8	2.4	8.6	4.5	9.1	18.8	4.1	3.4	4.6	4.3	5.0	1.4	3.3	2.6	3.8	4.9	2.8	4.8	15.0	5.7	4.6	3.2	3.3	2.8	5.3	2.2	3.6	1.2	1.9	34.9	8.0	3.6	4.1	7.8	6.2	3.1	3.4	1.8	4.5	1.8	2.9	2.1	0.3	1.7	3.8	3.8	3.6	2.5	3.4	9.5	3.9	4.9	9.6	4.7	3.7	2.9	2.6	1.4	5.0	3.7	2.7	2.9	1.9	2.8	3.6	2.1	2.9	2.3	2.9	0.0	0.7	0.7	0.7	0.8	0.7	0.4	0.5	0.8	1.1	0.5	0.8	0.7	0.5	2.6	0.8	0.1	0.9	0.6	4.8	5.2	5.5	5.4	5.5	5.3	6.3	5.2	5.6	5.6	5.4	5.9	7.8	0.0	0.5	2.6	2.0	5.2	1.6	1.9	22.2	4.1	6.9	5.0	6.4	1.5	1.6	5.5	6.2	3.8	2.6	3.5	0.0	2.9	2.3	5.0	8.5	14.0	3.6	1.7	4.2	4.9	1.8	9.6	2.0	7.8	0.0	9.4	3.3	3.1	2.1	10.1	3.3	4.6	2.0	1.9	3.8	1.5	9.9	2.1	5.4	0.0	4.5	9.3	2.1	2.5	3.1	3.6	5.9	11.7	2.1	3.3	4.0	2.8	2.4	2.4	0.0	4.5	4.5	5.5	6.9	22.1	9.7	2.9	2.4	7.9	3.1	2.0
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Excitatory neurons: 55.3;Inhibitory neurons: 74.7;Microglial cells: 76.8;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;U-937: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	11.9	3.6	5.5	6.4	5.7	5.5	7.4	5.1	7.3	8.5	5.7	11.3	3.8	9.2	6.6	4.6	8.2	5.6	11.0	5.6	5.8	4.4	5.4	8.4	4.0	5.3	5.2	5.9	3.1	3.7	4.9	4.0	5.5	5.4	4.1	4.5	6.2	5.6	24.6	6.8	5.3	8.7	5.3	10.3	6.0	8.4	6.3	7.8	9.7	17.4	3.1	9.3	6.8	6.5	3.7	3.7	3.1	2.7	18.0	12.5	1.7	2.9	4.2	4.5	5.6	0.2	4.4	5.0	3.3	5.2	4.2	1.0	1.6	2.2	6.3	11.6	1.2	2.2	2.0	0.2	10.1	1.7	2.3	6.0	3.7	6.4	3.6	4.1	19.0	5.8	4.3	3.5	6.2	2.7	5.9	9.7	0.3	2.7	1.5	2.6	4.5	2.9	6.4	0.9	2.3	2.5	1.4	0.6	2.1	2.0	1.4	16.2	7.9	2.0	3.5	6.1	3.6	0.8	1.5	0.1	4.0	25.3	1.5	1.3	7.2	3.3	2.0	6.9	1.5	1.0	1.5	2.7	2.2	3.7	3.1	1.7	13.1	3.9	4.3	2.8	3.6	3.5	5.5	5.7	5.1	7.3	5.6	5.8	5.3	5.2	5.5	5.3	6.3	6.5	7.8	3.2	4.8	111.3	3.2	1.0	2.0	1.7	5.2	5.5	2.1	2.2	13.0	5.7	4.2	3.7	6.2	3.5	2.0	1.8	7.9	3.6	25.2	2.7	5.6	6.1	0.0	2.5	55.3	4.2	4.6	9.1	7.1	2.4	12.6	4.1	6.4	1.8	6.9	3.3	74.7	2.6	0.0	12.9	3.5	9.6	4.1	36.3	0.0	76.8	7.3	2.4	7.2	137.2	86.9	3.7	0.8	8.2	3.6	1.3	2.5	3.9	3.9	5.3	6.6	17.0	6.7	12.8	8.0	6.0	2.4	1.6	4.2	2.4	2.3	1.8
ZNF44	"KOX7, ZNF504, ZNF55, ZNF58"	ENSG00000197857	"Zinc finger protein 44"	P15621	19	12224686-12294883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 95.9;Early spermatids: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003146	Supported		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Microtubules, Cytosol"	"HPA003146: AB_1080723"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.65e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.56e-3)"	"unprognostic (7.30e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.69e-2)"	"prognostic favorable (9.21e-6)"	6.9	5.7	2.5	2.7	2.7	9.6	6.8	3.8	3.1	7.5	3.8	6.9	3.3	5.4	5.2	6.8	6.3	2.1	5.2	2.5	2.7	12.1	11.0	6.1	4.4	2.8	2.7	9.4	6.8	4.0	7.1	2.7	2.8	7.4	4.9	5.0	5.7	3.1	3.5	7.9	7.4	2.6	2.3	9.4	5.0	9.7	2.8	3.2	6.7	2.4	4.2	7.0	6.9	3.4	3.0	0.9	1.8	4.3	2.1	1.9	9.6	4.2	1.7	6.5	5.9	4.2	1.7	3.0	5.0	3.4	1.9	3.2	3.0	2.6	5.6	0.0	2.7	2.9	4.4	11.3	2.9	0.0	7.4	2.5	3.9	4.1	4.9	2.6	2.6	3.8	1.9	0.6	4.2	3.2	4.6	5.7	1.8	3.0	5.2	3.2	4.7	3.8	3.7	7.1	2.6	2.9	5.4	2.2	1.4	6.2	4.5	4.6	2.8	8.3	2.3	8.3	3.7	6.5	7.5	2.8	0.2	2.7	2.4	11.9	1.7	15.8	7.3	3.2	8.5	4.2	7.9	7.9	1.3	3.4	8.4	8.4	5.6	11.5	3.2	3.2	6.1	3.4	2.5	2.7	3.8	3.1	2.5	2.7	2.8	2.7	2.8	2.3	2.8	3.4	14.6	28.9	19.9	16.6	16.1	9.1	6.6	8.2	8.0	16.1	10.6	8.3	16.9	17.2	13.9	64.4	37.5	17.2	21.5	17.9	95.9	9.9	113.1	21.1	11.6	11.8	15.6	6.5	13.8	9.3	6.8	8.3	6.1	25.1	24.1	14.4	11.0	12.4	8.5	16.8	16.1	12.9	10.2	11.1	8.7	34.1	14.0	10.9	10.6	25.3	8.8	9.8	27.8	17.6	21.7	9.6	13.0	6.0	13.7	6.2	17.1	13.6	24.8	36.7	19.7	11.6	9.8	36.5	24.8	16.4	11.6	8.6	19.2	8.4	12.9	9.6
ZNF445	"ZKSCAN15, ZNF168, ZSCAN47"	ENSG00000185219	"Zinc finger protein 445"	P59923	3	44431705-44477670	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006678	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA006678: AB_10603329"	"unprognostic (7.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.05e-1)"	4.2	3.0	2.3	1.8	2.5	1.3	3.9	4.3	2.4	6.0	1.1	4.7	1.4	5.1	2.0	2.7	5.0	1.6	3.6	2.4	2.4	3.3	4.9	4.1	1.9	2.1	2.1	7.0	4.4	2.8	5.0	2.0	2.2	4.4	1.7	4.2	3.6	2.1	4.4	3.7	3.5	2.2	1.7	3.9	3.9	3.1	2.2	3.3	3.8	2.7	2.1	4.1	4.4	2.9	1.9	2.1	6.4	5.1	3.5	3.6	2.9	2.5	2.1	3.7	3.7	3.2	1.6	3.3	1.5	2.6	2.3	1.5	4.4	1.7	4.5	3.6	1.6	6.1	4.7	3.2	2.2	7.8	4.9	2.5	2.1	4.2	2.6	3.1	2.6	4.6	4.8	2.4	3.0	1.2	7.5	5.2	4.4	1.2	1.9	3.3	4.0	1.6	2.0	3.8	3.2	3.9	3.9	2.0	1.0	4.7	3.7	3.4	3.2	5.2	4.6	3.2	3.2	1.9	1.5	2.7	1.9	3.8	3.2	1.0	0.3	0.6	0.3	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.3	0.2	1.0	0.5	0.8	0.3	0.1	0.1	2.3	2.5	4.3	2.4	2.4	2.4	2.1	2.1	2.2	1.7	2.2	2.9	11.7	12.8	17.4	19.2	8.4	4.1	4.4	2.9	9.6	36.0	4.8	4.4	11.1	5.7	7.6	11.0	37.5	4.1	15.7	3.8	1.9	5.8	2.5	6.3	14.1	9.7	7.2	10.3	21.7	8.4	1.7	9.0	7.1	6.8	11.4	26.6	13.2	10.1	5.7	28.6	24.3	6.3	2.0	16.4	4.7	2.2	9.3	10.5	0.0	9.4	11.6	10.1	22.6	11.6	19.5	4.9	6.0	9.8	9.5	5.6	4.3	2.8	9.6	28.4	13.1	14.5	10.6	6.7	6.9	5.6	2.6	1.4	9.8	9.3	7.2	3.8
ZNF449	"FLJ23614, ZSCAN19"	ENSG00000173275	"Zinc finger protein 449"	Q6P9G9	X	135344796-135363413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 15.8;Inhibitory neurons: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018079	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA018079: AB_1859277"	"unprognostic (5.51e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.61e-2)"	"unprognostic (4.22e-2)"	7.3	10.3	2.9	4.4	3.2	1.4	6.1	2.6	4.0	5.6	2.7	5.5	3.2	6.4	5.3	3.6	4.4	5.3	5.3	3.2	3.4	3.8	3.5	5.0	3.9	3.2	2.9	4.5	8.3	5.8	4.2	6.8	3.1	5.6	3.4	4.9	4.8	4.3	5.2	3.6	3.7	4.8	2.8	6.1	4.9	2.8	3.8	2.8	7.0	5.5	3.4	4.5	4.7	3.1	2.7	3.8	7.7	6.3	6.8	13.5	3.7	5.1	3.9	3.2	7.8	1.3	3.6	1.7	6.4	4.0	4.3	3.1	5.4	2.3	5.1	2.3	4.6	2.2	4.3	2.0	5.2	1.8	3.2	5.3	6.6	2.7	7.9	4.5	6.2	4.2	2.2	1.8	9.2	1.5	2.3	2.0	2.7	2.6	4.2	1.9	5.1	2.5	4.7	1.6	1.8	4.5	1.2	3.7	3.8	4.9	2.7	2.0	6.1	7.4	2.7	5.0	4.6	1.4	1.8	1.3	2.9	3.0	4.8	0.7	1.2	1.7	1.2	1.5	2.4	0.7	1.1	1.7	1.1	0.4	1.1	1.1	0.3	2.6	3.3	0.7	1.1	1.0	2.9	3.2	2.6	4.0	3.2	3.4	3.2	2.9	3.1	2.8	3.8	3.1	6.7	0.0	2.2	7.8	2.4	0.9	0.9	1.1	1.2	6.0	2.5	2.5	10.2	1.5	1.3	1.8	0.0	2.5	1.3	0.8	0.0	1.7	0.3	1.2	3.4	6.4	3.0	0.8	15.8	0.6	2.1	3.7	3.1	1.1	1.3	6.4	6.8	0.6	4.2	10.1	12.5	0.8	0.0	3.2	1.9	0.5	5.3	2.4	3.6	8.4	5.0	3.9	0.0	9.5	7.2	1.2	1.4	4.1	1.1	1.1	0.6	0.6	2.2	2.8	0.0	2.4	4.0	2.8	2.3	1.0	2.3	1.2	1.9	11.5	0.6	0.6
ZNF484	"BA526D8.4, FLJ33884"	ENSG00000127081	"Zinc finger protein 484"	Q5JVG2	9	92844182-92878038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.7;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA028973	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028973: AB_10610703"	"unprognostic (5.52e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.84e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.77e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.51e-1)"	2.0	2.2	1.9	2.0	2.7	4.1	2.2	9.7	3.3	2.5	0.0	1.6	1.2	2.4	1.7	1.3	2.1	1.6	1.6	1.8	3.4	2.4	1.9	2.0	2.4	2.8	2.8	3.1	1.3	3.6	2.1	2.8	3.1	2.3	1.8	5.3	1.5	2.0	1.1	1.3	1.5	2.1	2.7	2.9	2.1	1.7	3.5	2.6	3.1	2.3	2.8	2.1	1.8	4.0	3.1	3.6	4.7	3.0	2.4	3.0	0.0	2.4	3.8	4.2	4.4	1.2	2.2	2.5	2.1	1.9	2.9	5.0	3.5	3.7	4.4	4.2	1.5	2.2	3.1	2.4	3.7	1.9	3.7	3.3	2.7	4.7	4.9	3.2	3.9	2.8	2.4	10.6	4.5	2.9	2.7	0.8	4.0	3.4	1.7	2.2	5.8	1.9	2.3	3.4	3.2	3.0	4.3	1.2	2.4	3.5	0.2	1.5	3.7	3.7	3.7	2.0	1.8	3.9	2.1	1.5	2.4	1.5	3.1	0.6	1.2	2.8	2.4	1.8	3.1	1.8	2.6	2.1	1.1	2.6	3.4	3.2	0.7	2.4	1.6	1.3	2.2	1.5	1.9	2.7	9.7	3.3	1.8	3.4	2.8	2.8	3.1	2.7	3.5	4.0	6.2	0.0	1.5	9.8	13.2	0.1	0.7	1.1	6.8	5.0	1.6	0.9	2.2	0.0	4.7	1.8	0.0	1.2	6.3	0.9	1.9	1.3	0.7	1.3	4.4	4.9	0.0	3.4	17.7	0.4	1.2	4.3	5.6	1.3	2.5	3.6	0.7	0.6	0.8	5.0	22.6	1.4	4.1	0.6	0.4	0.9	0.6	2.7	0.0	12.2	1.2	3.1	5.2	27.2	19.1	0.7	1.6	1.5	5.8	0.6	0.9	1.5	4.1	3.8	0.0	3.7	4.8	0.8	0.7	3.9	0.1	0.7	9.3	3.3	0.7	0.6
ZNF487	"KRBO1, ZNF487P"	ENSG00000243660	"Zinc finger protein 487"		10	43436841-43483181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 191.2;Endometrial ciliated cells: 65.7;Late spermatids: 289.9;Respiratory ciliated cells: 73.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037820			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA037820: AB_10697083"	"unprognostic (1.97e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.42e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.97e-4)"	"unprognostic (5.85e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.92e-2)"	2.9	2.1	2.1	2.0	2.1	4.3	2.8	2.0	6.3	3.2	4.5	2.6	2.4	3.8	2.1	2.1	6.0	3.7	2.1	2.3	1.9	2.3	2.2	3.0	2.4	7.5	6.0	4.2	1.6	3.6	2.4	1.9	5.0	2.3	1.9	8.9	1.5	2.7	1.2	2.1	2.5	3.0	4.7	2.4	2.3	28.2	2.2	3.6	3.3	1.6	2.2	3.3	2.1	3.8	1.7	1.6	2.0	2.1	2.4	4.8	0.6	2.7	4.7	2.5	2.7	2.6	4.7	4.3	0.4	3.4	2.4	2.7	0.6	1.0	2.4	0.5	0.9	1.4	0.4	1.5	3.1	1.4	1.7	5.0	2.3	4.2	3.0	5.2	0.9	0.9	0.7	0.6	1.9	3.0	2.9	1.1	0.4	0.8	0.9	1.5	0.7	1.8	5.7	1.9	1.7	1.3	2.4	1.3	1.1	1.2	2.2	1.6	1.5	2.4	1.5	1.4	0.7	0.3	1.1	4.7	5.6	2.0	0.9	1.8	3.0	4.5	3.3	2.2	2.6	1.9	2.4	2.9	3.9	2.5	1.9	2.3	10.4	2.9	1.2	2.9	1.6	2.1	2.1	2.1	2.0	6.3	2.3	1.9	7.5	6.0	5.0	4.7	2.2	3.8	4.0	22.4	4.8	11.8	6.2	1.8	6.3	6.6	3.4	5.4	6.6	7.7	3.3	7.2	8.3	5.5	8.4	1.4	9.8	6.1	11.7	4.5	191.2	65.7	6.5	5.3	7.8	1.3	19.4	2.1	4.0	5.4	5.6	6.3	0.0	3.4	3.3	2.7	3.3	6.7	21.1	4.4	10.2	5.6	3.1	289.9	4.7	6.3	1.8	0.0	7.3	12.6	2.1	6.0	7.1	2.1	3.9	6.8	3.6	3.2	13.0	12.7	73.5	18.7	0.0	6.3	5.1	16.7	7.5	1.9	2.8	1.6	5.6	3.8	3.5	6.1
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384293	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.4;intestine: 22.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 7.0;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 20.1;Proximal enterocytes: 21.5;Syncytiotrophoblasts: 36.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.9;HDLM-2: 70.1;RT4: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"HPA035957: AB_10672234, HPA035958: AB_2674887"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.2	0.1	10.2	0.1	22.2	0.0	0.8	23.6	18.1	0.3	3.1	0.6	22.4	0.1	1.6	0.9	0.1	0.2	0.1	18.0	14.8	1.1	0.0	0.2	0.0	29.4	26.4	0.3	0.0	0.0	0.8	3.4	26.8	0.3	0.6	2.6	0.4	0.1	0.0	1.7	11.2	0.1	20.4	0.0	0.3	0.8	23.2	0.3	0.1	0.1	0.6	0.5	0.5	34.4	4.9	13.7	2.3	0.7	0.0	0.0	0.2	0.5	0.6	0.8	0.8	5.3	12.7	0.3	0.8	0.0	5.3	46.9	1.2	5.2	0.7	70.1	1.4	0.2	1.5	0.4	0.0	0.1	0.7	0.0	12.2	0.5	1.3	0.2	0.0	2.7	0.0	0.0	0.0	0.2	0.5	0.2	3.5	10.3	1.3	0.0	5.8	0.0	0.3	38.2	11.1	2.0	3.3	0.5	0.0	5.1	1.1	0.1	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	22.2	23.6	18.1	18.0	14.8	29.4	26.4	26.8	20.4	23.2	34.4	0.2	0.0	0.0	1.0	0.0	0.6	0.9	0.4	0.0	1.8	0.2	0.4	0.6	0.0	0.2	0.0	0.0	7.0	0.0	0.8	5.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	1.9	0.2	0.5	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	10.1	20.1	0.6	0.0	0.0	0.0	1.1	21.5	0.2	0.0	0.5	0.0	0.2	0.6	0.1	1.5	0.0	0.1	36.1	0.0	0.1	1.5	0.4
ZNF496	"MGC15548, ZKSCAN17, ZSCAN49"	ENSG00000162714	"Zinc finger protein 496"	Q96IT1	1	247297412-247331846	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025824			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA025824: "	"unprognostic (1.88e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.55e-1)"	8.6	6.0	7.8	5.4	8.1	6.8	8.1	6.8	8.2	13.6	6.3	11.6	3.8	14.3	5.5	5.6	14.7	7.8	9.0	7.0	7.4	8.7	3.6	8.5	6.9	7.4	7.5	18.7	15.4	11.3	6.4	9.9	7.0	9.4	5.6	5.7	7.8	8.4	15.6	5.8	6.8	11.5	6.9	9.2	9.0	10.8	8.2	23.8	12.3	13.7	5.4	9.2	8.0	8.4	20.8	18.7	19.4	23.7	7.5	19.1	24.2	9.5	23.5	20.9	18.8	10.3	18.9	5.9	16.1	15.6	7.8	17.4	20.1	18.3	20.8	16.0	4.8	19.2	13.1	11.8	20.3	23.5	9.5	20.4	19.0	16.2	38.9	23.2	25.1	27.3	34.6	14.5	13.1	13.3	23.4	16.2	39.0	9.2	27.5	22.0	21.2	8.1	12.8	24.8	16.5	36.4	12.7	14.3	19.0	17.6	14.9	28.7	17.4	15.1	21.4	6.9	30.2	16.1	13.8	16.8	6.3	1.6	16.8	0.0	0.4	0.1	0.8	0.3	1.2	0.3	0.3	0.9	1.1	0.4	0.7	2.1	0.1	1.1	0.4	0.7	0.1	0.8	7.8	8.1	6.8	8.2	7.0	7.4	7.4	7.5	7.0	6.9	8.2	8.4	9.2	0.0	3.2	16.3	3.3	3.7	4.4	5.0	8.0	7.4	7.0	7.5	8.3	5.7	4.7	1.8	2.1	4.8	2.4	1.2	1.9	4.4	11.2	4.9	7.5	7.5	4.9	3.0	13.0	6.0	5.8	6.8	7.1	6.5	3.8	13.7	7.1	2.3	6.0	3.3	16.9	2.5	2.0	5.1	3.6	40.0	5.6	4.0	3.6	9.4	3.4	1.7	5.2	18.6	10.8	4.9	2.6	7.2	7.5	7.5	0.8	3.0	3.9	7.3	6.6	9.7	6.2	15.9	10.8	2.4	3.4	4.2	4.7	7.5	4.3	4.3
ZNF503	"FLJ45745, MGC2555, Nlz2"	ENSG00000165655	"Zinc finger protein 503"	Q96F45	10	75397830-75401764	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 255.0;Squamous epithelial cells: 189.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 115.1;PC-3: 149.2;U-87 MG: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026848	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA026848: AB_10610704"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.63e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.63e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.97e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	14.5	39.9	6.1	3.1	10.1	2.0	9.2	3.8	5.2	34.5	1.0	17.7	8.1	44.1	10.3	20.1	23.8	2.4	9.0	7.4	5.5	25.6	7.1	14.2	1.5	12.0	9.2	46.3	25.4	4.6	4.8	3.3	7.6	17.5	1.8	1.4	9.5	17.6	3.6	5.3	8.5	7.7	10.0	8.0	16.3	2.4	8.1	1.1	7.8	2.1	1.0	13.8	18.2	6.5	5.2	4.9	1.1	6.3	10.6	7.1	1.6	4.6	2.8	1.9	1.7	7.5	20.4	0.0	13.4	4.6	1.1	9.4	0.7	4.9	1.4	0.0	115.1	0.0	12.4	24.8	8.5	6.1	12.9	19.1	4.8	3.5	2.0	16.6	0.5	0.5	0.1	0.2	2.6	2.7	0.2	18.8	0.1	3.8	149.2	0.0	5.6	0.1	2.8	4.1	4.1	5.2	8.5	0.6	27.1	1.0	1.0	4.2	3.9	14.6	16.3	30.7	13.0	0.0	0.0	0.0	44.9	27.2	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	10.1	3.8	5.2	7.4	5.5	12.0	9.2	7.6	10.0	8.1	6.5	27.2	38.5	11.6	2.3	1.7	27.1	35.6	15.0	255.0	23.7	7.7	42.3	20.4	10.0	10.1	40.5	20.9	0.5	2.1	0.8	58.7	45.9	0.1	53.2	72.2	41.0	3.6	5.3	12.6	34.7	0.3	60.1	18.3	48.1	6.3	2.7	44.6	10.3	13.5	6.7	3.2	6.7	10.2	27.4	30.5	2.0	59.7	30.7	24.9	13.1	8.2	7.7	0.0	4.0	0.7	33.2	1.5	49.2	3.9	19.7	13.4	32.5	1.7	26.3	39.5	10.2	78.1	0.2	6.0	189.3	13.9	0.3	4.0	24.5	9.7	14.3
ZNF516	"HsT287, KIAA0222"	ENSG00000101493	"Zinc finger protein 516"	Q92618	18	76357682-76495242	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.1;Early spermatids: 77.4;Endometrial stromal cells: 78.9;Langerhans cells: 69.7;Oligodendrocyte precursor cells: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"THP-1: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015792	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA015792: AB_1859314"	"prognostic favorable (7.09e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.63e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	5.8	7.6	19.6	4.5	18.5	24.5	6.4	9.4	11.2	32.2	2.3	8.4	6.2	32.2	8.5	9.0	23.6	5.1	5.3	18.1	21.9	4.6	6.2	7.6	3.0	16.8	18.2	22.8	6.8	9.5	11.3	3.0	10.8	9.7	2.6	16.2	6.4	17.3	14.2	10.1	6.2	11.8	10.7	6.8	6.3	34.4	18.8	4.4	6.4	5.9	2.8	10.3	15.3	6.8	2.4	2.7	18.8	25.0	5.3	8.0	2.4	14.6	12.1	3.1	5.7	5.5	8.9	12.7	3.0	15.5	7.7	5.2	10.4	14.0	2.0	0.0	8.0	1.2	0.0	11.7	13.2	8.5	8.3	15.4	5.9	6.3	6.7	4.2	3.5	5.2	0.0	0.0	3.0	5.2	0.2	14.4	9.5	1.5	0.7	5.7	1.9	6.6	4.7	11.1	18.9	11.3	0.2	0.0	15.3	7.3	3.1	33.2	2.3	7.1	12.4	0.2	1.5	0.1	0.4	9.9	4.2	5.8	18.6	2.5	1.8	2.9	0.0	1.2	0.4	0.0	0.1	0.0	1.2	0.3	0.4	0.2	10.2	0.7	1.4	0.8	0.0	0.4	19.6	18.5	9.4	11.2	18.1	21.9	16.8	18.2	10.8	10.7	18.8	6.8	9.6	9.6	10.1	75.1	5.0	19.5	17.9	12.7	9.1	15.0	8.6	8.1	8.5	5.7	8.8	1.8	31.3	0.3	6.1	4.2	3.9	5.8	77.4	33.1	78.9	9.8	12.6	3.0	19.8	2.9	0.4	15.6	4.6	47.7	1.3	10.4	7.9	11.4	8.4	3.3	37.3	5.2	6.1	20.0	69.7	43.5	30.4	14.2	12.4	30.0	20.9	8.4	9.2	73.9	0.7	5.5	4.5	35.0	0.6	11.8	7.4	5.4	15.3	30.3	13.1	16.1	15.5	3.7	33.1	7.0	20.2	0.5	2.8	21.5	4.5	20.8
ZNF528	KIAA1827	ENSG00000167555	"Zinc finger protein 528"	Q3MIS6	19	52397849-52418412	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 51.2;U-266/84: 69.0"									HPA065435			Approved	"Nuclear speckles,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA065435: "	"unprognostic (1.90e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.26e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-3)"	8.9	9.2	7.9	5.4	10.1	5.7	10.9	16.8	8.6	9.9	9.6	8.6	4.9	13.5	18.8	8.9	13.6	10.1	10.1	6.6	10.3	9.6	4.7	8.0	9.1	9.2	7.6	18.2	5.2	12.7	9.2	9.9	11.2	11.6	8.8	19.7	10.7	9.3	6.4	11.4	6.7	8.3	4.0	11.3	9.3	13.1	9.8	9.8	17.7	5.7	10.7	9.8	8.5	13.6	0.2	0.0	6.1	36.5	13.6	16.9	15.0	13.6	22.3	8.2	18.1	0.2	6.9	0.3	3.3	16.9	20.4	4.1	0.0	8.6	10.5	0.1	9.8	5.7	2.0	3.5	20.4	0.1	15.2	17.2	15.5	9.0	0.0	2.5	19.7	0.3	3.8	0.6	11.9	0.2	21.5	2.9	15.9	0.3	9.4	0.2	24.5	6.5	10.1	51.2	25.1	20.8	0.0	1.1	9.1	21.2	24.2	3.3	23.3	14.2	16.3	5.6	18.8	0.6	69.0	12.9	7.1	0.2	22.5	7.6	5.1	11.8	6.6	5.4	12.7	7.8	8.2	10.2	5.4	11.1	7.7	6.9	1.4	17.6	5.5	8.8	9.6	3.9	7.9	10.1	16.8	8.6	6.6	10.3	9.2	7.6	11.2	4.0	9.8	13.6	9.8	6.4	3.2	8.8	5.8	3.7	4.1	5.2	1.2	19.6	8.6	7.1	12.2	2.8	7.4	1.8	14.6	4.1	6.0	4.1	3.9	5.6	2.9	13.1	7.7	8.8	1.2	0.8	13.2	1.9	4.5	6.0	2.0	13.2	8.8	16.7	6.1	1.3	3.5	21.9	12.7	4.0	4.1	3.8	4.7	3.1	5.0	4.7	1.8	7.5	0.7	12.3	11.3	20.6	10.3	7.1	6.3	4.1	1.5	4.7	4.0	3.9	10.4	21.8	0.0	6.1	6.9	17.6	10.2	2.3	3.1	3.1	7.6	7.3	3.0	4.1
ZNF541	DKFZp434I1930	ENSG00000118156	"Zinc finger protein 541"	Q9H0D2	19	47520685-47555856	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 21.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 25.5;Late spermatids: 12.2;Proximal tubular cells: 19.1;Spermatocytes: 37.3;Spermatogonia: 11.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 1.5;SiHa: 5.0;U-87 MG: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058541, HPA076453"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA058541: AB_2683748, HPA076453: AB_2732310"	"unprognostic (4.49e-2)"	"prognostic favorable (2.94e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.92e-5)"	"unprognostic (7.98e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-2)"	1.0	3.1	0.3	0.1	0.3	0.1	0.6	0.2	0.8	0.1	0.0	0.8	0.1	0.3	0.0	0.0	0.2	0.2	0.9	0.5	0.0	0.7	0.1	0.1	0.2	0.4	0.1	2.3	0.1	0.1	0.6	0.3	0.4	0.1	0.1	0.5	0.1	0.1	0.5	0.4	0.3	0.2	0.0	0.5	0.1	21.9	0.2	0.1	0.5	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.5	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.8	0.5	0.0	0.4	0.1	0.4	0.0	0.2	0.2	4.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.5	0.3	1.8	0.0	0.0	1.8	2.1	0.0	0.3	0.0	0.0	0.0	25.5	0.0	0.1	1.6	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.3	0.0	2.0	6.1	0.4	0.0	0.0	1.5	0.1	0.0	0.0	0.0	12.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.5	19.1	0.0	0.8	0.0	0.0	0.1	37.3	11.7	0.0	0.1	0.0	0.4	0.5	0.0	0.0
ZNF546	"MGC43537, ZNF49"	ENSG00000187187	"Zinc finger protein 546"	Q86UE3	19	39984134-40021038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 13.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Oligodendrocytes: 20.1;Spermatocytes: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA030838			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030838: AB_10603332"	"unprognostic (4.38e-6)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.58e-5)"	1.9	2.8	1.1	0.7	1.8	0.5	1.9	1.8	1.5	2.2	1.6	2.1	0.4	1.7	0.9	1.0	2.2	0.5	2.4	1.3	1.0	2.3	3.7	1.3	0.9	1.6	1.3	2.9	1.9	1.2	2.8	0.8	1.8	2.1	0.5	2.4	1.4	1.1	2.5	1.0	1.8	1.4	0.9	3.2	1.5	13.5	1.4	1.0	2.4	1.4	1.1	2.0	1.7	2.8	0.1	2.2	0.8	1.2	1.9	1.1	0.1	0.8	1.2	0.8	1.3	0.1	0.3	1.1	0.9	0.6	0.3	0.0	0.4	0.1	1.3	1.0	1.5	1.4	1.7	0.7	1.0	1.5	0.9	1.1	0.4	0.5	1.3	1.1	1.2	2.0	1.7	2.9	1.0	0.3	0.5	0.3	0.2	0.1	0.2	0.7	0.8	0.5	0.5	0.2	0.5	0.7	0.5	0.0	0.5	0.8	0.3	0.7	0.5	0.3	0.6	0.1	0.5	1.9	2.2	0.2	0.6	0.5	0.4	0.7	0.4	0.8	1.0	0.7	0.7	0.8	0.7	0.6	0.8	0.6	1.3	1.2	0.3	0.8	0.3	0.2	0.9	0.3	1.1	1.8	1.8	1.5	1.3	1.0	1.6	1.3	1.8	0.9	1.4	2.8	3.1	0.0	4.6	7.8	3.9	0.5	1.0	0.8	2.8	8.4	2.4	1.9	6.8	2.8	1.1	3.7	12.5	1.4	4.1	0.6	1.9	1.4	36.0	2.5	4.5	4.0	0.0	1.7	9.9	0.4	0.2	4.9	0.5	1.5	0.0	6.3	4.6	3.0	1.8	1.7	11.7	0.5	2.0	1.9	0.5	7.4	4.4	2.0	0.0	8.4	1.5	4.8	3.1	8.5	20.1	0.3	0.4	4.1	1.9	0.8	2.4	3.5	4.1	7.9	0.0	6.2	2.6	57.8	5.4	1.0	0.0	0.3	2.3	4.8	0.6	0.7
ZNF548	FLJ32932	ENSG00000188785	"Zinc finger protein 548"	Q8NEK5	19	57389850-57402992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 55.6"									HPA066042	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 2: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA066042: AB_2685602"	"prognostic favorable (7.85e-4)"	"unprognostic (4.61e-2)"	"unprognostic (5.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (5.85e-2)"	13.8	6.8	5.2	16.9	5.4	26.3	12.3	11.6	11.2	8.2	6.6	10.0	6.8	10.8	6.9	8.1	10.2	11.3	11.1	7.2	5.5	6.5	6.8	12.0	23.8	4.8	5.0	11.8	6.9	8.6	7.1	8.4	4.5	7.8	8.2	12.6	7.1	7.1	7.6	10.3	14.6	11.6	3.6	18.9	7.2	6.5	5.3	13.4	11.8	5.5	17.9	8.4	7.7	7.2	7.5	6.8	12.1	8.7	5.7	6.2	2.5	5.4	8.0	8.4	14.0	1.7	20.5	7.4	3.4	4.3	5.6	3.3	5.1	5.9	7.6	3.5	17.4	7.7	55.6	8.8	4.1	8.1	16.3	7.2	8.5	8.0	11.7	8.1	4.2	15.1	0.5	0.1	7.6	2.0	12.8	3.1	3.4	0.2	7.6	15.6	13.3	10.1	4.4	12.7	7.5	9.1	6.6	3.5	4.0	10.2	7.6	6.1	6.9	10.0	9.7	3.3	9.8	18.7	13.1	10.3	6.9	4.5	10.1	1.3	1.5	2.6	4.0	1.7	5.6	3.9	3.7	5.2	3.1	8.4	5.5	5.8	1.4	5.1	2.2	2.6	7.0	2.6	5.2	5.4	11.6	11.2	7.2	5.5	4.8	5.0	4.5	3.6	5.3	7.2	10.2	3.2	6.7	4.6	9.5	6.6	4.9	4.3	4.6	5.0	9.1	7.1	5.7	7.2	4.0	7.3	6.2	4.4	8.9	1.9	3.9	4.4	12.7	5.3	4.4	9.1	6.0	1.7	3.0	2.4	2.9	5.9	2.0	4.5	9.5	7.6	11.0	8.4	4.2	1.7	3.9	3.8	4.1	4.8	2.9	5.1	5.6	4.3	0.0	1.9	3.2	6.3	8.2	4.0	4.6	2.5	1.1	4.1	8.8	3.5	3.3	2.7	5.8	9.4	0.0	7.7	7.8	11.7	7.1	4.5	5.7	4.4	9.4	4.2	2.3	2.2
ZNF549	FLJ34917	ENSG00000121406	"Zinc finger protein 549"	Q6P9A3	19	57527325-57557542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Rod photoreceptor cells: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.2"	"Group enriched"	"Detected in all"	4	"B-cells: 4.5;NK-cells: 11.2;T-cells: 4.6"	"Low cell line specificity"	"Detected in many"											HPA039511	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA039511: AB_10671998"	"unprognostic (6.27e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.01e-4)"	"unprognostic (4.03e-3)"	"unprognostic (2.51e-8)"	"unprognostic (2.88e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.89e-3)"	"unprognostic (9.11e-3)"	2.5	3.3	4.3	3.4	4.3	3.6	4.3	9.9	4.1	2.9	3.3	3.3	1.9	3.3	3.9	2.0	4.1	2.7	3.5	4.6	3.6	3.9	1.3	3.3	5.0	2.9	2.8	5.6	2.4	5.5	4.9	3.7	2.7	4.2	2.3	11.8	3.0	3.3	3.0	3.9	3.3	3.2	2.0	5.6	2.9	4.0	3.6	5.9	4.7	2.4	5.3	3.3	2.4	4.5	1.5	2.0	7.9	6.6	2.4	1.9	1.9	3.8	4.5	3.6	17.5	2.1	1.4	2.2	2.6	3.5	4.5	0.9	2.5	5.5	5.9	0.2	14.7	10.2	1.9	3.1	3.3	8.6	7.0	3.4	4.2	3.7	5.1	5.2	2.3	5.7	0.1	0.3	6.6	0.9	9.8	3.6	6.8	0.2	5.3	6.8	6.6	4.7	1.4	3.9	3.3	5.7	0.1	0.5	4.4	6.6	4.5	6.7	1.9	6.9	4.7	0.3	5.5	3.7	11.6	7.0	1.1	2.9	6.4	0.6	0.8	1.5	2.4	0.7	3.2	2.2	3.3	3.8	1.5	4.5	4.6	3.0	0.5	11.2	1.2	1.4	2.2	1.9	4.3	4.3	9.9	4.1	4.6	3.6	2.9	2.8	2.7	2.0	3.6	4.5	2.2	0.0	2.8	5.9	7.0	1.7	1.7	1.3	0.6	7.5	2.2	1.7	3.2	4.3	0.8	1.8	14.6	1.6	5.6	0.4	3.9	1.4	0.6	2.2	2.3	3.6	3.6	5.7	9.8	0.7	0.8	2.2	1.1	1.9	6.3	6.1	3.9	0.6	1.5	8.4	7.9	0.5	0.0	3.2	0.4	0.4	3.1	2.3	5.4	6.5	1.5	3.9	7.2	8.0	4.1	0.7	1.8	2.2	1.3	1.8	0.7	0.8	5.8	14.8	6.6	2.6	2.3	1.2	4.7	0.6	1.6	1.1	4.0	2.3	0.9	1.2
ZNF559	MGC13105	ENSG00000188321	"Zinc finger protein 559"	Q9BR84	19	9323772-9351162	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA059632, HPA065485"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA059632: AB_2684089, HPA065485: AB_2685497"	"unprognostic (1.35e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (6.99e-4)"	"unprognostic (7.28e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	14.8	14.2	12.5	9.2	13.7	4.0	16.8	19.7	14.0	23.5	17.8	16.7	6.4	22.4	21.5	7.4	23.1	9.9	19.7	12.4	12.9	19.1	11.1	12.4	16.0	12.7	12.3	32.7	10.6	22.2	25.9	12.1	12.4	20.5	11.0	20.4	12.3	12.9	4.7	10.7	14.8	19.1	11.8	22.1	12.9	16.3	13.7	22.7	19.7	10.6	13.1	17.0	15.6	19.4	15.4	8.3	15.6	19.3	9.2	8.3	4.2	9.3	18.6	13.3	11.4	3.8	1.8	12.4	10.8	13.7	18.4	5.4	9.5	8.8	16.9	19.9	13.5	16.2	14.0	5.7	16.0	15.0	18.3	17.3	15.6	14.7	18.7	11.4	11.3	18.8	12.7	42.8	8.7	0.0	20.4	46.8	25.4	2.6	13.4	10.0	18.8	16.7	8.1	21.5	17.8	14.7	17.9	2.9	22.6	22.9	12.7	11.5	9.6	24.6	5.6	20.1	14.2	3.5	0.1	12.6	4.6	9.4	16.0	40.7	4.8	11.4	12.1	4.7	16.4	17.4	13.0	13.3	7.7	17.0	21.0	17.2	2.7	20.9	6.5	6.4	12.6	9.0	12.5	13.7	19.7	14.0	12.4	12.9	12.7	12.3	12.4	11.8	13.7	19.4	9.8	3.2	3.3	0.0	12.9	3.8	6.7	6.2	5.7	30.2	7.0	7.1	8.8	10.0	5.1	3.7	27.1	7.0	12.4	2.2	1.9	7.3	9.1	6.1	8.3	11.0	3.0	3.0	0.0	3.2	5.3	9.8	1.5	3.8	2.5	17.8	12.8	2.7	4.9	26.9	0.0	4.0	2.0	7.0	3.7	2.9	12.8	4.7	3.6	0.0	7.7	17.3	29.9	0.0	0.0	3.2	3.0	13.5	1.8	4.6	2.2	3.4	5.7	27.2	6.6	14.1	10.1	27.0	40.4	2.9	3.0	2.9	10.0	8.5	4.1	2.8
ZNF567	MGC45586	ENSG00000189042	"Zinc finger protein 567"	Q8N184	19	36687612-36727701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 86.7;Late spermatids: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA023937	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA023937: AB_1859351"	"unprognostic (4.39e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.03e-2)"	3.3	3.7	2.7	2.9	2.7	3.4	5.8	5.1	4.1	4.1	3.3	3.4	2.3	5.1	4.2	3.1	3.9	3.2	3.1	2.8	3.0	3.3	4.8	3.4	4.7	2.1	2.6	4.6	2.6	5.5	4.8	5.6	2.3	5.2	2.8	4.9	3.6	5.0	2.3	3.3	3.0	4.5	2.5	4.5	3.3	9.5	3.2	6.6	4.8	3.1	4.9	4.2	3.5	3.0	7.1	5.5	9.8	8.7	5.5	5.4	9.3	5.1	7.8	5.7	9.1	3.1	2.5	4.4	6.0	4.6	4.2	1.8	9.1	5.3	7.7	8.8	4.7	8.4	6.0	3.0	5.0	10.8	6.2	8.4	6.2	5.4	10.5	7.4	6.7	8.9	3.3	2.3	6.9	4.5	13.9	4.1	9.4	4.8	4.3	6.8	13.5	6.4	3.8	10.7	7.3	7.8	9.5	4.7	4.9	10.9	5.9	7.2	4.2	7.5	7.6	3.8	5.8	8.8	7.8	14.9	0.0	4.3	6.7	5.0	1.8	5.8	5.7	1.5	4.8	5.7	6.2	5.4	3.2	7.0	6.0	6.1	0.9	6.8	1.6	2.2	5.5	2.5	2.7	2.7	5.1	4.1	2.8	3.0	2.1	2.6	2.3	2.5	3.2	3.0	15.5	6.4	6.9	4.6	15.3	11.7	12.5	7.4	7.4	9.0	13.4	14.7	5.8	5.7	8.8	9.2	10.4	15.3	13.3	3.8	3.9	8.6	86.7	13.4	7.8	9.9	4.2	11.6	12.8	5.1	13.5	7.7	8.2	11.1	17.2	11.7	12.8	6.5	7.5	11.8	11.2	4.6	4.1	5.1	3.7	153.0	9.9	4.7	7.2	11.2	6.7	8.1	14.4	8.5	11.9	4.4	6.2	15.1	5.9	13.1	3.7	6.7	4.8	6.1	6.6	11.5	10.1	42.2	13.4	6.1	17.6	27.5	13.2	12.2	4.4	13.3
ZNF573	FLJ30921	ENSG00000189144	"Zinc finger protein 573"	Q86YE8	19	37735833-37817300	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.9;Inhibitory neurons: 28.1;Oligodendrocytes: 22.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042776	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Intermediate filaments"	Cytosol	"HPA042776: AB_10961399"	"unprognostic (3.79e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.60e-2)"	1.6	1.7	0.5	1.1	1.2	2.1	2.0	4.0	1.4	1.0	0.2	0.9	1.3	1.9	2.7	0.7	1.2	1.7	0.9	0.6	2.6	1.3	0.7	1.4	1.2	0.7	0.6	2.1	1.3	1.4	0.8	1.5	0.9	1.3	1.2	2.7	0.8	0.9	0.9	2.1	1.0	0.9	0.2	1.7	2.0	1.3	0.6	1.1	2.5	0.7	1.6	0.7	0.8	2.4	0.5	1.8	1.4	1.3	0.7	1.5	0.6	1.2	1.3	0.4	1.0	1.8	1.2	1.8	1.1	1.0	0.5	1.1	1.4	1.9	1.7	0.4	1.2	2.0	2.8	0.9	0.6	1.7	1.6	1.4	0.6	2.5	1.0	0.9	1.3	1.0	0.8	0.8	0.3	0.7	1.4	1.0	2.0	0.5	0.2	1.4	2.8	0.6	0.0	1.3	1.8	1.6	2.2	0.6	0.2	0.9	1.7	1.5	0.5	1.6	1.5	1.4	1.9	2.1	2.8	2.6	0.3	0.2	1.3	2.1	0.4	1.6	1.9	0.6	1.5	1.5	1.6	2.1	0.9	2.8	2.6	2.0	0.2	1.7	1.3	1.5	1.0	0.5	0.5	1.2	4.0	1.4	0.6	2.6	0.7	0.6	0.9	0.2	0.6	2.4	3.1	0.0	3.9	7.2	7.4	1.8	2.6	2.1	1.8	15.7	2.1	2.4	11.8	2.8	1.9	3.7	12.5	4.0	7.1	0.8	1.9	2.5	37.9	1.4	3.8	4.7	1.2	3.4	22.2	0.7	3.2	4.0	1.1	1.3	0.0	7.6	5.0	1.4	4.0	16.8	28.1	1.3	0.0	1.3	2.5	16.8	8.7	2.2	3.6	12.2	3.2	7.3	7.2	21.1	22.9	1.3	1.6	6.4	1.8	1.9	2.6	2.9	2.4	12.0	0.0	5.2	3.8	7.7	7.6	2.8	2.6	1.6	5.7	3.6	2.1	1.2
ZNF575	FLJ32567	ENSG00000176472	"Zinc finger protein 575"	Q86XF7	19	43525497-43536130	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 18.9;Paneth cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051865	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA051865: AB_2681643"	"unprognostic (1.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.53e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.87e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.75e-1)"	2.8	1.6	1.5	1.1	2.2	0.6	2.1	2.5	4.4	3.0	0.0	4.5	1.6	2.9	1.0	1.6	2.3	0.7	2.3	2.1	0.0	2.1	2.1	1.6	1.1	0.9	0.2	3.1	1.5	0.5	3.2	0.4	0.9	2.1	2.0	0.6	1.7	1.0	4.6	2.0	2.2	0.8	0.0	2.1	1.5	0.8	1.1	1.1	2.1	0.5	0.6	2.2	2.3	1.5	1.9	1.7	0.4	0.5	2.4	2.0	0.1	1.2	0.8	0.4	0.6	0.4	0.7	0.4	0.8	0.9	0.2	1.0	0.0	0.2	0.2	2.7	0.3	1.4	0.7	0.3	0.5	0.6	1.7	1.2	0.7	0.6	0.1	1.3	0.3	2.6	0.5	2.6	0.7	1.3	7.7	0.2	0.1	1.3	0.8	4.1	0.0	1.0	0.4	1.1	0.3	0.6	0.9	1.2	1.3	0.3	0.3	0.7	1.3	2.3	1.5	0.5	0.9	1.3	2.2	1.2	1.4	1.7	2.4	0.0	0.4	0.3	1.4	0.2	0.5	0.7	1.3	1.4	0.6	1.8	2.1	1.5	0.4	3.3	0.2	0.9	1.4	0.7	1.5	2.2	2.5	4.4	2.1	0.0	0.9	0.2	0.9	0.0	1.1	1.5	1.5	6.4	1.1	1.6	1.3	0.1	0.6	1.2	1.8	1.2	1.1	1.9	2.0	0.0	0.9	0.0	4.2	1.3	1.9	18.9	3.9	0.4	0.1	0.5	1.6	1.8	1.2	1.3	0.9	0.6	0.9	3.5	1.1	1.1	0.0	1.5	2.5	2.3	1.6	0.0	1.1	2.3	0.0	2.7	1.0	0.4	2.5	1.8	1.8	0.0	0.8	0.8	4.1	0.0	1.3	0.2	8.7	3.4	2.6	0.3	2.0	2.5	0.2	0.1	0.0	2.0	2.6	0.1	1.1	2.6	1.7	0.3	3.1	0.7	2.7	0.5
ZNF582	FLJ30927	ENSG00000018869	"Zinc finger protein 582"	Q96NG8	19	56375846-56393545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 13.7;Muller glia cells: 13.2;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028858	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA028858: AB_10603247"	"unprognostic (1.19e-3)"	"unprognostic (9.86e-4)"	"unprognostic (3.88e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.02e-7)"	"unprognostic (3.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.00e-3)"	2.3	4.5	5.8	2.2	6.8	1.6	3.3	7.5	8.6	3.2	6.2	3.1	1.1	4.1	6.9	2.5	3.1	3.3	4.4	5.8	7.0	4.0	2.5	2.7	4.8	6.5	6.2	5.1	2.1	3.8	5.0	2.9	6.3	4.3	1.3	10.5	2.1	2.7	1.8	3.0	2.0	2.3	6.2	4.1	1.9	5.1	6.2	2.6	7.4	1.6	1.9	3.0	2.1	7.3	0.0	1.3	6.9	1.4	1.6	1.7	0.0	2.9	3.0	1.8	1.4	0.0	0.4	0.0	1.8	1.6	4.0	0.0	0.9	0.4	1.3	0.0	28.3	7.0	0.0	0.5	2.9	1.8	5.4	6.1	1.5	1.1	0.0	1.8	1.1	0.7	1.6	0.0	1.1	0.0	4.1	4.5	3.9	0.1	0.0	1.9	2.3	2.5	1.5	3.9	0.0	4.5	0.0	0.9	0.0	5.1	3.1	3.8	1.2	3.6	7.4	0.9	3.9	6.0	7.0	4.4	0.2	0.4	2.1	2.9	1.4	4.2	2.8	2.3	4.2	4.3	3.4	2.8	2.3	3.2	2.4	3.1	0.4	7.6	1.7	2.3	1.1	1.9	5.8	6.8	7.5	8.6	5.8	7.0	6.5	6.2	6.3	6.2	6.2	7.3	4.9	0.0	0.0	4.2	4.0	1.3	2.4	2.3	1.2	4.4	2.5	2.8	3.5	1.5	2.1	7.3	2.1	2.7	2.9	0.2	13.7	2.5	1.0	2.8	1.7	4.6	0.0	0.4	4.5	0.6	0.7	2.6	1.1	1.9	8.2	3.2	4.6	2.4	2.8	1.7	4.9	0.5	6.1	1.0	2.0	0.9	2.1	2.3	3.6	0.0	1.6	13.2	5.2	7.1	9.2	1.4	0.3	4.1	0.1	4.2	0.7	4.9	2.2	5.5	13.1	3.5	2.8	2.8	7.9	0.9	1.0	3.6	2.7	4.5	0.6	2.3
ZNF583	FLJ31030	ENSG00000198440	"Zinc finger protein 583"	Q96ND8	19	56397966-56436035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.5;Late spermatids: 43.0;Spermatocytes: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023805, HPA023957"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli	Cytosol	"HPA023805: AB_2671318, HPA023957: AB_2671383"	"unprognostic (9.89e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	3.2	2.4	3.9	1.7	4.0	1.0	1.9	5.6	4.2	2.2	1.3	2.1	1.3	2.6	2.2	1.5	2.4	2.3	2.1	3.7	4.9	2.8	2.6	2.8	1.8	4.0	3.9	4.6	2.6	4.0	2.7	2.0	3.8	2.4	1.4	4.0	0.9	1.9	2.1	0.8	1.3	2.6	4.2	2.4	1.6	7.4	3.9	2.7	3.4	3.3	1.8	2.1	1.3	4.3	0.0	2.1	4.9	0.0	3.4	2.7	0.0	6.2	6.2	2.8	2.3	0.3	0.7	4.7	3.0	5.7	5.1	0.3	2.0	1.9	3.0	2.2	10.8	6.2	0.0	1.1	3.9	5.2	5.4	3.8	3.0	4.0	2.0	4.1	2.8	4.8	2.3	1.7	9.3	0.0	6.5	1.7	1.2	0.0	2.0	3.2	9.3	3.5	2.2	4.5	2.8	4.2	0.0	0.6	1.6	2.5	3.1	6.6	1.9	14.5	4.0	2.8	12.4	6.2	12.3	7.4	0.3	1.4	5.2	9.7	1.5	3.3	3.1	2.2	4.6	4.5	2.5	2.9	1.7	3.5	4.6	2.8	0.6	6.1	3.7	2.4	3.6	1.9	3.9	4.0	5.6	4.2	3.7	4.9	4.0	3.9	3.8	4.2	3.9	4.3	7.7	3.2	1.5	4.6	7.9	1.8	3.2	2.8	0.6	17.5	3.5	1.8	5.3	0.0	1.9	1.8	6.2	1.8	4.9	0.6	9.8	5.7	60.5	2.1	6.2	6.6	0.0	9.1	14.6	2.7	0.5	6.5	1.1	2.9	10.8	10.5	7.5	2.4	3.9	10.1	12.1	1.6	0.0	3.3	4.3	43.0	6.8	3.3	3.6	4.7	3.8	12.2	16.5	15.1	12.0	2.5	1.8	13.5	1.6	3.0	1.2	5.2	1.7	15.1	6.6	13.8	7.1	30.6	17.2	0.6	1.7	1.1	6.8	6.9	1.4	2.4
ZNF598	"FLJ00086, HEL2"	ENSG00000167962	"Zinc finger protein 598, E3 ubiquitin ligase"		16	1997654-2009821	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041760, HPA041896"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA041760: AB_10792490, HPA041896: AB_10796464"	"unprognostic (9.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.81e-2)"	15.0	10.1	2.3	6.8	2.2	11.8	13.9	2.3	5.3	15.4	0.9	14.7	7.0	15.4	0.0	19.4	13.1	2.6	11.6	2.5	2.1	13.1	21.0	15.3	5.5	2.9	2.4	12.4	32.3	2.2	16.3	5.0	2.3	16.2	1.4	0.4	18.7	4.4	26.7	30.0	14.8	2.1	1.7	18.6	14.9	17.6	2.6	5.1	10.8	3.8	2.9	15.8	15.3	2.0	22.8	30.1	7.0	17.5	4.9	6.6	22.0	17.3	7.4	10.5	8.3	31.9	12.4	23.4	20.0	6.7	7.7	27.0	9.3	17.3	1.7	31.2	69.9	18.6	33.5	18.3	22.3	29.3	20.0	7.9	23.2	16.6	18.9	1.1	11.6	27.2	41.3	31.5	4.0	40.5	25.2	45.0	21.6	8.9	35.4	62.4	14.2	52.9	4.0	8.7	33.5	28.9	17.4	20.4	28.3	1.3	14.5	46.6	20.6	23.0	27.6	21.0	32.4	39.2	36.3	29.6	9.7	27.6	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	2.3	2.2	2.3	5.3	2.5	2.1	2.9	2.4	2.3	1.7	2.6	2.0	11.7	6.4	11.5	6.2	7.5	29.7	12.9	9.0	10.2	12.8	13.9	12.4	1.0	10.0	8.8	1.8	16.7	9.1	11.1	21.2	0.0	8.1	5.6	10.1	11.6	12.7	11.4	10.8	5.4	26.5	12.8	10.5	36.2	13.7	12.7	11.9	6.8	20.1	9.5	16.8	5.3	36.2	12.2	8.4	10.3	9.7	13.4	8.8	1.8	5.6	8.2	7.8	9.2	1.0	6.7	19.6	9.5	8.2	9.3	23.9	13.5	3.3	12.7	10.7	0.0	11.2	9.1	9.0	11.9	14.0	34.8	9.3	9.8	13.1	20.8	19.7
ZNF599	FLJ30663	ENSG00000153896	"Zinc finger protein 599"	Q96NL3	19	34758073-34773229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 33.2;Early spermatids: 81.4;Late spermatids: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA014701	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA014701: AB_1859371"	"unprognostic (3.52e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.35e-3)"	"unprognostic (9.20e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.12e-3)"	4.4	5.9	5.8	2.3	6.7	1.2	5.6	6.8	6.0	8.1	8.1	6.3	2.5	7.6	11.9	3.9	8.6	2.4	4.7	5.5	6.4	9.5	4.7	4.7	3.3	6.4	6.6	7.4	4.8	9.8	11.0	3.1	6.3	9.5	2.8	4.7	5.9	4.8	3.6	4.4	4.3	3.6	6.2	5.0	4.8	14.0	6.6	4.2	11.1	5.0	2.7	6.0	6.1	7.3	4.8	2.4	4.6	3.4	5.2	6.9	2.6	1.7	4.5	4.1	4.7	2.0	3.1	0.5	4.3	3.1	3.8	2.3	3.4	2.3	4.9	0.5	4.2	3.6	4.9	5.7	4.1	0.8	3.5	6.5	3.1	1.9	2.0	6.7	4.7	8.3	6.2	0.4	6.0	1.9	9.1	3.8	2.0	6.5	0.1	4.6	4.5	3.0	5.1	1.1	5.8	8.4	5.6	1.0	3.2	3.0	2.8	0.4	2.6	3.2	4.4	3.0	1.9	5.1	5.6	0.4	2.5	0.1	3.8	1.9	0.6	3.5	3.4	1.4	2.3	1.0	3.5	1.9	1.0	2.2	3.5	3.2	0.3	3.5	3.2	2.2	2.8	1.6	5.8	6.7	6.8	6.0	5.5	6.4	6.4	6.6	6.3	6.2	6.6	7.3	5.8	0.0	3.7	5.2	2.5	3.1	7.6	5.5	6.8	4.2	10.2	11.2	4.4	1.5	8.3	18.4	2.1	7.9	5.2	1.1	33.2	4.6	81.4	25.4	6.4	5.3	1.2	3.8	0.7	2.3	4.5	8.3	1.5	4.1	0.0	6.6	5.0	4.0	3.8	0.0	3.5	3.3	4.1	1.0	1.9	30.8	10.2	1.2	5.4	0.0	0.9	14.4	4.1	9.5	8.1	3.1	0.9	4.9	4.8	5.5	2.9	15.3	22.7	2.7	6.6	5.7	5.7	26.2	7.5	4.8	1.6	1.9	3.9	7.2	3.2	6.0
ZNF609	KIAA0295	ENSG00000180357	"Zinc finger protein 609"	O15014	15	64460742-64686068	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 123.4;Cone photoreceptor cells: 141.8;Excitatory neurons: 142.1;Microglial cells: 139.6;Oligodendrocytes: 208.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040742, HPA040832"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA040742: AB_10963581, HPA040832: AB_10960400"	"unprognostic (2.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	9.5	8.3	11.3	8.3	10.1	5.5	8.5	13.0	9.6	11.3	8.8	12.0	8.7	12.0	4.5	7.8	11.9	7.2	8.1	11.2	12.6	6.7	7.1	10.9	8.7	10.6	10.4	20.5	7.2	14.1	8.4	11.9	7.4	10.3	7.8	20.5	9.7	9.5	7.2	9.6	8.7	11.1	8.3	9.8	8.2	22.0	10.1	18.0	9.0	9.9	8.3	11.3	10.8	12.1	11.1	27.6	29.1	11.2	11.0	13.8	9.9	14.2	18.8	17.5	17.5	17.1	17.2	19.0	11.7	16.9	23.9	23.2	43.1	19.6	18.2	22.2	9.2	34.7	16.0	8.4	20.2	20.2	22.3	14.1	17.6	18.3	35.8	25.3	32.8	15.9	55.6	12.0	14.5	10.1	15.7	8.5	22.1	14.8	7.7	14.3	26.5	10.0	12.7	19.7	23.6	18.0	19.5	21.9	13.1	27.7	10.9	14.0	33.0	16.2	25.8	8.4	17.9	13.3	16.1	16.6	10.1	21.6	13.4	1.3	0.4	0.6	0.5	0.1	0.3	0.2	0.3	0.4	0.1	0.2	0.8	0.8	0.5	1.1	0.2	0.5	0.2	0.2	11.3	10.1	13.0	9.6	11.2	12.6	10.6	10.4	7.4	8.3	10.1	12.1	14.6	12.8	25.4	123.4	8.8	18.0	16.2	10.5	8.0	35.8	12.6	11.8	20.1	24.3	20.3	18.4	141.8	19.1	13.9	12.2	3.9	13.8	22.6	42.2	21.9	18.4	18.6	11.1	142.1	14.6	14.7	13.6	13.7	16.1	10.1	19.4	18.9	14.6	10.0	45.4	116.5	11.9	4.1	30.5	18.3	12.7	18.0	16.4	14.2	139.6	19.1	17.3	19.6	108.6	208.0	13.2	13.5	13.9	10.5	22.9	9.9	3.9	33.8	54.9	19.7	14.4	16.9	48.3	17.0	9.3	17.3	31.2	17.0	20.8	11.2	20.1
ZNF614	FLJ21941	ENSG00000142556	"Zinc finger protein 614"	Q8N883	19	52012765-52030240	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Late spermatids: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA021197	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021197: AB_1859380"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.15e-3)"	4.1	3.6	4.0	3.3	4.6	6.3	5.6	8.2	5.3	4.2	2.4	3.0	2.5	5.3	3.9	3.4	4.2	3.3	4.0	3.7	4.8	3.8	2.3	3.5	4.3	4.5	4.6	7.5	1.8	5.0	3.3	6.9	4.3	8.9	3.0	8.7	3.0	4.7	4.0	4.3	2.9	4.9	4.1	4.5	3.2	6.9	5.2	5.9	8.0	5.0	4.4	3.9	2.1	6.4	4.8	3.5	8.8	11.5	6.2	6.9	1.1	6.4	4.5	5.8	7.0	4.4	2.7	12.1	3.4	5.5	5.4	2.0	13.3	8.5	8.6	3.2	18.8	18.2	6.6	9.0	5.1	3.8	8.8	5.4	4.6	5.9	8.2	5.8	6.9	10.5	9.9	2.6	7.9	1.9	16.0	7.6	10.2	0.7	6.3	10.5	17.0	10.0	6.0	12.0	11.6	7.1	3.8	4.7	3.9	10.8	6.3	9.6	7.1	5.7	7.9	3.2	7.6	5.2	8.7	18.3	5.5	5.2	7.6	2.3	2.4	1.6	3.2	3.2	3.9	3.0	2.9	3.1	3.0	2.8	4.1	2.6	1.7	5.7	2.8	1.7	3.2	1.8	4.0	4.6	8.2	5.3	3.7	4.8	4.5	4.6	4.3	4.1	5.2	6.4	5.2	0.0	2.2	3.6	4.8	3.2	5.3	2.4	4.6	6.8	4.2	4.2	5.8	4.3	4.9	5.5	4.2	6.1	6.5	1.7	0.0	2.9	47.9	2.8	6.1	5.8	5.4	7.4	6.6	0.9	7.1	3.7	5.6	3.7	7.0	5.0	8.2	1.6	2.3	16.8	6.7	2.4	2.0	4.1	2.3	34.9	4.1	3.2	1.8	4.7	2.2	5.1	10.3	6.0	9.2	1.4	0.7	7.2	5.4	4.6	1.8	2.0	0.9	5.6	0.0	7.1	5.7	2.2	5.0	4.4	2.7	14.4	4.1	2.7	2.2	5.1
ZNF630	"BC037316, dJ54B20.2, FLJ20573, MGC138344"	ENSG00000221994	"Zinc finger protein 630"	Q2M218	X	47983356-48071658	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 5.0;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 5.3"					"Low region specificity"	"Detected in all"			"HPA001053, HPA068130"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA001053: AB_2666183, HPA068130: AB_2685961"	"unprognostic (1.03e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.83e-2)"	"unprognostic (9.06e-3)"	"unprognostic (8.68e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.51e-5)"	1.9	2.2	3.8	1.5	4.0	0.9	2.8	5.0	4.8	3.6	4.1	2.5	1.8	2.6	2.8	2.1	2.6	2.5	2.7	3.6	3.8	2.4	1.4	2.1	1.8	4.0	4.1	4.7	3.2	4.2	2.6	1.6	4.2	3.8	2.5	3.7	2.3	2.8	1.0	1.9	1.8	2.4	3.8	2.3	2.9	0.7	4.2	0.9	3.7	1.2	1.5	3.0	2.7	4.6	1.0	0.7	0.2	0.0	0.1	0.0	0.0	1.4	0.5	1.1	0.6	2.3	4.0	0.1	0.8	1.4	1.6	1.8	0.0	0.8	0.9	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.0	4.0	2.3	0.0	2.6	0.7	0.0	0.0	4.2	2.5	4.3	0.0	0.0	1.5	3.5	1.2	0.5	1.0	0.0	1.7	2.2	2.3	1.8	5.3	3.7	1.4	3.2	4.3	0.9	1.3	0.0	1.8	1.8	0.0	0.0	3.7	0.0	0.0	0.1	3.3	2.3	0.8	2.0	0.8	0.3	0.9	1.0	0.7	0.7	1.5	0.6	0.9	1.0	0.9	0.7	0.3	0.4	0.5	0.9	3.8	4.0	5.0	4.8	3.6	3.8	4.0	4.1	4.2	3.8	4.2	4.6	0.8	0.0	0.0	2.6	1.4	0.1	1.0	0.8	3.4	2.5	1.6	1.3	1.6	0.0	0.8	1.8	0.0	0.1	0.4	0.9	1.9	1.4	0.0	1.2	1.9	1.2	4.2	0.8	2.2	1.1	0.9	1.4	1.1	1.3	0.0	4.0	1.8	0.3	0.9	0.0	2.6	1.6	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.0	1.3	0.7	0.0	5.0	3.2	1.0	0.6	0.4	1.0	0.9	1.1	0.7	0.5	1.0	6.6	1.4	1.4	0.2	0.4	1.7	0.3	0.3	1.1	4.0	1.0	0.8
ZNF646	KIAA0296	ENSG00000167395	"Zinc finger protein 646"	O15015	16	31074422-31084196	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.8;Spermatocytes: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 25.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042364, HPA066468"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA042364: AB_10794796, HPA066468: AB_2732746"	"unprognostic (1.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.66e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.23e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	5.6	4.1	4.4	6.7	4.9	9.2	5.0	6.9	5.9	5.8	1.6	5.0	6.4	6.5	2.5	5.2	5.5	3.5	4.8	3.7	2.9	4.9	4.3	4.7	7.1	6.2	4.7	6.2	5.6	4.4	5.0	4.0	4.9	5.4	2.8	1.6	6.2	4.0	7.9	8.0	6.4	3.2	3.5	8.0	5.5	25.7	5.8	8.6	5.1	3.7	5.1	5.4	4.9	6.3	7.8	15.8	10.2	8.0	7.1	5.5	13.7	8.3	8.8	9.8	9.0	11.6	7.1	15.0	13.0	7.1	6.5	10.2	8.5	9.2	3.7	17.2	8.1	11.1	15.6	9.7	7.4	14.4	16.7	7.1	8.1	10.6	6.0	7.6	5.9	12.5	18.2	8.5	7.5	12.2	16.0	9.9	13.8	3.5	8.1	25.5	20.2	15.3	3.1	7.3	14.7	14.9	9.5	10.0	4.9	4.4	8.4	12.5	12.1	12.3	7.0	8.2	7.8	14.2	14.1	14.9	11.2	15.5	9.8	9.8	4.5	13.2	5.1	4.2	2.6	3.9	2.4	2.1	4.6	4.4	2.7	3.0	25.1	4.8	2.8	6.6	2.6	2.1	4.4	4.9	6.9	5.9	3.7	2.9	6.2	4.7	4.9	3.5	5.8	6.3	4.7	3.2	1.3	3.6	4.2	3.3	1.0	2.6	2.8	3.6	3.4	3.4	1.7	1.5	2.2	1.8	4.2	1.9	6.6	6.6	1.9	4.1	24.8	3.0	3.7	3.4	6.0	2.1	2.2	3.5	2.1	2.5	5.6	4.9	1.3	5.1	1.8	1.9	4.9	1.7	2.1	3.4	4.1	4.7	2.8	6.6	2.8	6.4	0.0	7.5	3.7	3.6	4.1	2.0	3.1	4.4	7.6	4.5	2.3	2.4	5.8	2.2	2.7	1.1	0.0	3.5	2.3	16.2	7.0	2.9	4.0	2.5	4.9	2.8	3.7	1.9
ZNF670	MGC12466	ENSG00000277462	"Zinc finger protein 670"	Q9BS34	1	247034637-247078811	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA003142	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA003142: AB_1859404"	"unprognostic (2.11e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.05e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-2)"	2.2	1.5	0.8	1.1	0.9	0.5	2.3	2.8	1.2	1.5	0.3	1.5	1.0	2.3	0.6	1.2	1.6	1.3	1.1	0.9	0.8	1.7	1.7	1.5	1.5	0.5	0.8	2.1	1.8	1.6	1.0	0.7	0.5	1.3	1.3	2.1	1.5	1.1	1.0	1.5	1.5	1.7	0.5	1.4	2.0	2.3	0.9	1.9	1.4	1.4	1.7	1.7	1.5	0.8	2.7	1.7	5.7	6.9	1.3	1.9	12.0	3.1	2.0	3.7	3.6	2.4	2.5	4.5	6.2	1.9	2.2	2.1	6.3	2.4	6.8	3.1	0.7	4.1	1.4	3.4	1.1	4.6	2.6	1.2	2.5	2.3	4.9	0.6	2.4	3.8	5.4	1.9	3.9	1.1	5.7	2.4	9.8	5.5	3.6	5.7	7.5	3.9	2.2	5.7	6.7	5.4	4.5	1.8	2.6	3.0	1.9	9.3	1.7	2.5	2.4	1.8	3.6	3.8	6.8	8.0	0.9	3.4	3.0	0.0	0.6	0.5	1.2	0.7	0.6	2.1	1.1	1.3	1.3	1.5	1.8	1.3	0.3	1.0	0.4	0.7	0.9	0.6	0.8	0.9	2.8	1.2	0.9	0.8	0.5	0.8	0.5	0.5	0.9	0.8	4.2	3.2	1.7	0.0	2.5	24.2	9.3	6.1	3.4	4.1	5.0	4.8	0.9	4.3	5.1	5.5	0.0	2.3	2.7	0.4	5.9	5.2	8.9	11.9	2.6	5.2	0.0	3.8	0.0	2.9	8.3	6.3	1.5	13.4	0.0	2.0	5.7	2.9	2.5	6.7	0.0	1.8	8.2	1.6	10.2	2.0	1.8	1.5	7.2	0.0	2.0	3.0	1.0	0.0	0.0	3.5	1.8	1.5	0.9	5.2	1.0	3.6	4.7	1.5	0.0	9.3	4.0	3.2	4.0	2.3	11.2	0.8	1.4	2.2	1.8	3.6
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli, Mitochondria, Cytosol"		"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	2.5	3.1	2.2	3.0	3.3	3.4	3.7	3.6	2.8	3.6	1.1	2.9	2.3	3.8	2.4	2.1	3.1	3.1	1.9	2.3	4.3	2.6	2.2	3.2	4.4	3.1	2.8	4.0	3.3	2.3	1.5	4.2	2.8	4.0	4.1	5.7	2.7	2.4	1.5	1.4	2.1	2.4	2.3	3.6	3.3	3.9	3.4	4.4	5.4	2.7	4.0	2.1	2.3	5.6	2.5	4.0	13.6	15.5	1.6	3.7	8.3	3.3	3.2	4.8	4.9	3.3	2.9	9.7	8.3	1.5	2.5	4.6	8.3	2.2	7.6	4.2	15.8	4.5	2.9	2.0	3.0	8.0	12.0	3.3	3.8	2.8	6.0	3.5	4.5	10.9	12.4	15.1	5.2	2.0	11.3	2.8	12.1	3.6	6.3	8.4	8.9	3.9	3.4	7.7	5.8	11.2	4.8	5.6	2.3	6.6	7.9	9.2	3.3	5.9	5.5	5.2	6.6	4.8	11.8	10.5	2.3	1.4	6.2	5.4	0.6	0.8	1.3	0.1	1.6	3.7	1.3	0.8	1.2	2.6	1.2	1.7	0.1	1.4	0.4	1.8	1.7	0.8	2.2	3.3	3.6	2.8	2.3	4.3	3.1	2.8	2.8	2.3	3.4	5.6	10.9	3.2	7.3	21.2	7.8	2.3	4.0	2.9	2.2	12.2	5.5	2.9	4.2	4.3	4.5	3.7	4.2	2.1	8.2	6.8	1.9	4.0	0.9	4.6	6.0	6.5	9.6	10.3	11.7	5.2	2.4	6.5	7.1	4.8	3.8	9.4	5.3	3.0	1.8	1.7	17.2	4.8	4.1	3.1	3.7	0.6	7.5	3.3	0.0	17.8	3.3	4.7	5.2	38.2	44.7	3.3	7.3	2.6	5.8	5.4	1.3	1.4	5.5	7.3	0.0	12.3	4.9	7.6	10.5	3.1	0.6	1.4	5.8	4.2	3.8	3.8
ZNF684	MGC27466	ENSG00000117010	"Zinc finger protein 684"	Q5T5D7	1	40531573-40548167	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 36.0"					"Low region specificity"	"Detected in all"			HPA059153	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA059153: AB_2683932"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.67e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.10e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.96e-2)"	"prognostic favorable (4.89e-10)"	"unprognostic (4.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.52e-2)"	2.4	3.7	1.7	2.2	2.6	6.4	3.0	2.0	3.3	1.7	2.2	2.8	2.3	2.4	2.8	1.7	1.7	2.4	7.7	1.5	1.8	6.9	12.4	2.5	3.3	2.3	2.2	2.6	2.6	3.3	1.2	1.5	2.6	1.8	3.4	2.1	2.5	1.4	3.3	2.9	1.9	2.3	1.4	3.1	3.2	3.2	2.3	3.4	3.8	2.8	2.7	1.7	1.4	3.9	2.9	0.9	3.6	4.8	3.2	4.8	2.1	2.6	2.5	3.2	5.4	1.7	3.7	5.0	2.1	1.7	2.1	3.5	3.6	2.7	4.9	4.4	6.3	5.4	3.2	4.9	1.7	5.7	5.7	3.0	1.0	3.8	1.5	1.8	4.6	4.0	2.9	6.9	4.5	0.9	8.6	6.6	8.8	1.3	2.8	4.1	10.3	3.6	4.7	2.5	2.5	4.4	4.7	4.5	5.2	4.7	2.0	36.0	2.8	2.9	6.3	3.1	5.1	5.8	4.8	5.9	2.6	5.9	4.8	4.1	1.9	1.0	3.0	4.1	1.6	3.5	2.0	1.7	1.2	1.5	1.3	2.6	1.0	1.9	2.2	1.9	2.6	1.3	1.7	2.6	2.0	3.3	1.5	1.8	2.3	2.2	2.6	1.4	2.3	3.9	4.9	6.4	3.2	10.4	6.8	2.3	1.6	2.2	4.6	3.4	2.0	2.8	13.0	5.7	2.9	7.3	0.0	1.2	7.2	3.2	17.6	5.7	6.5	1.6	3.2	5.0	1.2	4.2	7.8	14.7	2.5	4.2	1.5	1.8	2.5	4.6	4.2	15.8	4.8	3.3	7.9	2.2	4.1	4.2	2.3	3.7	2.5	4.2	8.8	5.6	6.3	4.3	4.1	12.5	16.1	6.4	2.0	3.0	3.2	1.0	1.1	17.3	4.3	2.6	0.0	5.8	4.8	8.7	4.6	1.7	1.3	0.0	5.9	5.3	3.2	1.5
ZNF70	"Cos17, MGC48959"	ENSG00000187792	"Zinc finger protein 70"	Q9UC06	22	23738682-23751112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA018821	Uncertain		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA018821: AB_1859423"	"unprognostic (3.17e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.69e-2)"	1.4	1.2	1.0	1.3	1.4	1.6	1.3	2.8	1.1	1.9	2.2	1.4	0.8	1.9	2.3	0.8	1.9	1.1	1.6	0.9	1.0	1.0	0.7	1.2	1.4	2.0	1.4	3.9	1.8	2.1	1.6	1.2	1.1	1.5	1.2	3.0	2.0	1.5	2.6	1.1	1.2	1.6	0.8	1.4	1.3	1.2	1.6	1.2	1.8	2.1	1.6	1.4	1.3	2.5	1.2	1.5	2.9	3.0	4.2	2.0	0.9	1.1	2.2	2.5	3.5	1.5	0.8	1.7	0.7	2.4	1.6	1.3	2.0	1.5	3.1	1.1	1.8	3.3	3.0	1.3	2.5	3.0	2.7	2.0	0.9	3.3	2.7	3.2	2.0	1.3	1.2	2.4	1.8	1.6	1.7	1.4	0.7	1.1	0.6	7.2	2.8	0.4	0.9	1.6	1.6	2.0	1.6	2.0	1.2	2.0	1.0	1.4	2.6	2.7	3.4	1.8	1.2	2.4	0.4	1.5	2.4	1.3	2.4	1.5	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.3	0.8	0.5	0.2	0.4	0.1	0.1	1.0	1.4	2.8	1.1	0.9	1.0	2.0	1.4	1.1	0.8	1.6	2.5	1.2	0.0	2.8	0.7	1.0	0.4	1.1	0.0	1.2	3.8	1.1	1.4	2.6	2.8	1.8	3.7	10.4	0.4	2.1	0.3	0.0	1.1	1.4	1.6	3.9	1.7	1.2	0.8	0.8	1.1	0.6	3.2	0.5	1.0	1.3	3.8	4.2	0.5	0.8	6.7	1.2	0.6	0.0	1.6	0.6	3.3	6.2	1.0	0.0	0.0	0.8	2.1	0.0	0.0	1.6	0.4	0.0	4.1	1.5	0.7	0.8	0.9	3.6	4.0	6.6	5.4	2.7	2.7	2.5	1.0	0.0	0.3	1.2	2.8	0.7	0.9
ZNF720		ENSG00000197302	"Zinc finger protein 720"	Q7Z2F6	16	31713229-31794869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA041570	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041570: AB_10795126"	"unprognostic (5.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-3)"	"unprognostic (8.72e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.47e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-2)"	6.0	6.9	5.9	6.8	5.7	6.5	7.2	10.8	6.4	5.1	5.9	7.3	4.1	6.2	9.4	7.8	7.0	5.9	4.6	5.7	6.3	8.7	6.7	6.1	11.0	6.8	7.3	4.4	7.2	7.2	7.3	9.2	7.7	7.9	7.9	6.1	5.8	7.0	6.3	10.0	5.3	6.1	6.6	8.2	8.3	8.2	6.5	7.4	7.7	4.4	10.8	6.2	5.7	6.3	15.1	10.5	12.6	10.7	10.9	16.5	12.4	15.9	10.1	7.6	10.1	7.9	15.8	7.3	27.2	5.3	11.2	10.2	12.7	6.2	11.3	32.7	6.6	4.1	5.7	21.8	16.4	8.8	21.6	11.1	16.7	5.3	7.3	15.1	14.3	17.4	13.8	9.4	8.3	24.5	8.9	11.6	12.5	10.4	8.2	17.0	5.7	11.5	8.5	9.4	5.6	8.6	15.9	6.8	15.4	19.9	13.5	17.3	9.5	5.5	4.3	11.1	4.9	15.5	18.3	21.0	4.9	13.3	8.8	21.2	6.7	33.7	18.6	7.6	14.3	19.9	13.0	17.2	7.4	20.3	12.2	15.1	8.8	20.2	8.5	12.9	18.1	6.8	5.9	5.7	10.8	6.4	5.7	6.3	6.8	7.3	7.7	6.6	6.5	6.3	19.4	16.0	21.0	25.8	19.8	9.1	16.9	23.4	6.8	25.6	15.0	18.4	12.2	5.7	19.4	5.5	6.2	35.4	24.5	10.3	23.5	16.9	7.3	20.6	19.2	21.5	17.4	9.9	32.0	13.5	12.3	16.4	15.3	20.1	21.5	25.8	15.7	10.6	16.8	23.5	28.7	13.5	22.4	9.5	14.5	4.1	13.4	13.0	10.6	24.4	14.5	18.1	40.2	40.2	31.0	19.0	10.8	18.4	13.9	28.4	7.2	15.7	19.5	9.8	32.9	21.3	15.3	28.2	19.3	9.4	11.5	71.0	20.9	25.7	10.6	24.3
ZNF721	KIAA1982	ENSG00000182903	"Zinc finger protein 721"	Q8TF20	4	425815-499156	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA065313			Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Centriolar satellite"	"HPA065313: AB_2685464"	"unprognostic (2.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (2.76e-4)"	12.5	10.9	8.3	14.4	9.2	18.0	18.8	18.9	12.7	12.1	4.4	10.9	10.5	12.9	14.2	10.4	14.7	10.0	8.2	9.2	8.7	11.8	12.8	12.6	22.6	5.0	5.2	15.3	15.1	15.5	11.2	10.0	6.1	11.5	12.0	19.9	11.1	10.0	10.5	18.5	11.4	10.3	4.6	14.9	12.9	14.2	7.1	19.1	16.8	16.1	22.0	10.9	11.9	12.5	17.2	10.4	20.2	25.0	14.5	19.9	12.7	15.2	13.1	16.4	14.5	15.4	17.1	28.8	16.3	14.9	23.6	11.3	20.9	19.0	22.0	10.4	24.4	51.0	10.7	10.4	14.2	21.5	2.4	17.5	16.3	18.0	27.3	25.6	17.1	40.4	29.9	19.7	23.0	16.4	35.3	32.4	32.1	11.3	22.1	28.6	30.1	16.4	17.9	22.8	29.6	18.9	20.2	11.6	19.3	17.3	21.2	22.4	22.0	14.5	5.3	11.5	27.3	22.7	22.2	68.7	11.1	5.2	13.9	8.0	8.3	12.9	12.1	8.7	12.2	16.6	13.3	12.0	8.4	15.9	20.8	16.5	11.4	13.5	8.2	10.3	16.7	7.3	8.3	9.2	18.9	12.7	9.2	8.7	5.0	5.2	6.1	4.6	7.1	12.5	44.4	25.6	31.9	29.7	44.9	21.0	26.4	18.6	25.6	38.0	25.0	27.3	16.7	25.8	24.8	18.4	31.3	16.9	33.0	10.9	15.6	12.9	34.5	29.6	31.9	30.7	12.7	33.2	37.6	14.9	10.6	26.0	29.0	29.0	26.0	32.0	28.5	17.6	10.9	23.5	30.1	16.4	4.1	18.8	19.1	12.3	19.6	18.8	12.4	11.2	14.8	24.7	46.4	24.6	32.7	13.8	11.3	12.0	23.4	27.8	12.4	14.5	24.9	35.1	19.7	30.5	20.1	35.2	34.3	23.1	23.2	17.4	40.9	29.5	15.8	31.0
ZNF747	MGC2474	ENSG00000169955	"Zinc finger protein 747"	Q9BV97	16	30530367-30535347	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003203, HPA069173"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Centrosome, Cytosol"		"HPA003203: AB_1080753, HPA069173: AB_2686097"	"unprognostic (3.82e-2)"	"prognostic favorable (6.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.46e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.01e-1)"	6.7	7.4	7.1	4.0	7.4	2.7	6.8	7.7	7.3	7.6	5.8	8.8	4.1	8.4	3.3	5.4	7.8	3.0	8.8	6.8	6.4	7.1	10.8	5.2	4.4	7.5	7.3	7.3	6.2	7.6	6.9	2.5	7.4	7.6	3.8	4.6	5.6	6.1	9.7	6.2	7.1	4.1	6.4	7.4	7.2	6.2	7.3	5.3	7.0	6.2	3.9	8.2	5.8	7.9	4.6	4.4	1.3	7.1	5.5	4.8	7.1	3.7	5.6	5.3	5.1	2.6	5.8	9.9	2.5	4.4	0.7	6.7	3.3	4.7	2.3	11.9	7.3	8.6	4.7	4.1	6.0	4.0	11.8	5.5	5.9	4.3	6.6	3.5	3.5	12.3	2.4	8.2	3.7	5.0	18.1	5.5	8.4	2.4	2.9	21.3	0.5	9.2	4.7	2.3	9.8	8.6	5.6	3.7	4.2	3.3	7.2	7.9	2.8	6.7	3.0	5.3	0.1	15.7	11.8	5.5	1.4	6.1	8.1	7.7	3.1	4.4	2.7	1.7	3.1	4.6	3.1	3.1	3.9	5.3	5.2	4.0	1.7	4.4	1.5	5.1	2.4	3.0	7.1	7.4	7.7	7.3	6.8	6.4	7.5	7.3	7.4	6.4	7.3	7.9	5.7	3.2	6.3	1.3	5.8	1.5	3.4	4.8	4.6	8.7	6.1	5.7	6.0	5.7	3.1	0.0	4.2	2.6	8.3	4.4	7.9	6.2	2.6	4.9	5.4	6.2	7.3	8.6	1.9	5.8	2.3	5.8	2.6	3.9	3.8	8.6	6.8	8.7	7.0	6.7	2.0	4.4	0.0	8.8	1.6	1.2	5.9	4.3	0.0	0.0	10.4	7.1	7.2	3.5	2.8	5.2	12.6	9.8	3.6	3.9	9.7	7.6	5.8	7.5	13.1	6.9	5.4	13.1	4.2	4.2	1.1	1.2	4.0	5.7	5.0	2.1
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	15.7	33.0	17.9	11.7	18.3	10.0	18.2	17.5	18.6	22.4	20.7	21.2	12.6	17.4	18.5	15.5	20.9	9.9	30.3	17.4	17.7	27.5	25.6	17.7	17.5	18.8	18.2	30.9	23.4	21.5	45.2	11.0	18.2	27.8	10.4	22.9	21.3	14.5	54.7	13.1	23.1	10.7	17.2	33.7	20.3	24.7	18.6	15.3	39.1	31.7	14.6	20.2	18.0	18.3	10.7	9.6	20.7	23.0	8.6	13.2	14.8	9.0	15.1	14.9	11.9	7.3	14.0	23.1	13.1	13.5	14.2	5.9	17.5	13.6	8.6	34.5	26.7	22.2	15.7	11.6	17.1	11.2	12.6	16.2	8.5	17.2	16.0	9.1	13.7	23.1	16.6	23.7	13.7	23.5	19.1	13.1	10.2	8.5	9.2	18.1	10.7	21.4	13.5	14.7	32.5	11.9	11.0	13.9	27.3	6.8	20.8	36.1	10.6	10.4	8.9	7.2	13.2	23.8	17.8	21.6	9.0	17.4	28.0	5.2	7.2	6.3	16.8	9.5	13.2	10.9	12.1	12.0	8.2	10.4	12.6	13.2	2.2	10.8	10.9	4.1	10.3	10.3	17.9	18.3	17.5	18.6	17.4	17.7	18.8	18.2	18.2	17.2	18.6	18.3	9.6	16.0	9.6	16.3	19.3	5.7	8.3	10.2	15.9	28.5	14.0	10.2	20.3	8.6	9.7	9.2	50.1	23.7	11.6	13.4	21.5	12.5	20.6	9.2	7.7	10.5	12.1	6.9	19.7	15.5	12.4	10.0	7.7	10.1	12.7	19.5	10.0	8.7	11.3	30.3	22.0	13.9	8.2	7.2	6.9	13.4	11.1	7.6	5.4	21.5	6.1	15.3	16.5	24.1	23.9	7.6	13.1	6.0	16.1	6.8	12.1	12.5	9.2	31.2	19.7	8.8	10.2	21.9	10.4	8.7	6.3	22.7	12.6	14.8	10.1	7.9
ZNF764	MGC13138	ENSG00000169951	"Zinc finger protein 764"	Q96H86	16	30553764-30558374	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003203	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003203: AB_1080753"	"unprognostic (9.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.47e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.62e-2)"	"unprognostic (9.75e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.64e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.05e-1)"	3.5	4.4	2.4	3.1	2.3	4.1	3.6	4.4	2.6	5.0	1.2	4.9	4.8	4.9	1.1	3.5	4.7	2.2	6.6	2.4	2.4	4.2	5.9	3.1	4.5	2.3	2.0	5.6	4.4	3.3	5.0	2.1	2.3	4.8	2.9	2.9	3.5	2.3	3.9	3.5	4.8	1.8	1.5	5.2	6.8	5.8	2.3	3.5	3.5	2.3	2.8	3.7	3.7	2.7	2.9	3.6	6.8	6.6	2.9	2.8	4.1	3.7	2.9	3.5	2.6	2.7	2.8	5.3	4.3	2.1	2.1	4.1	3.6	2.4	2.7	6.0	9.7	3.6	4.5	5.1	3.4	3.4	5.5	2.2	2.9	2.9	3.8	4.6	3.2	12.8	6.8	6.0	3.1	6.6	9.6	5.5	4.0	1.8	4.7	13.0	2.8	7.2	2.8	1.5	13.0	10.1	2.5	5.8	3.6	4.1	5.0	6.2	2.9	4.8	2.6	2.7	3.7	8.1	6.0	4.5	3.4	4.8	6.7	2.3	1.4	4.4	2.9	1.7	3.9	1.8	3.0	3.7	1.8	2.4	3.1	3.0	1.4	7.2	1.8	2.0	2.1	1.8	2.4	2.3	4.4	2.6	2.4	2.4	2.3	2.0	2.3	1.5	2.3	2.7	3.9	0.0	3.2	2.9	5.0	1.7	2.7	1.9	2.8	5.4	3.9	2.8	5.2	7.2	3.1	1.8	0.0	2.6	5.0	4.4	0.0	3.4	0.6	5.3	4.6	3.8	2.4	3.0	1.7	3.0	2.1	2.8	5.6	3.6	1.3	4.6	4.2	2.5	3.7	1.7	1.9	4.2	0.0	3.5	1.2	0.8	3.4	3.2	0.0	0.0	4.2	3.3	6.2	2.5	2.0	3.8	10.4	2.6	3.3	2.6	4.7	2.9	6.3	5.7	6.6	2.6	3.8	10.5	4.3	3.5	0.4	1.0	6.0	2.7	4.4	1.9
ZNF772	DKFZp686I1569	ENSG00000197128	"Zinc finger protein 772"	Q68DY9	19	57466663-57477570	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 26.4"					"Low region specificity"	"Detected in all"			HPA031312	Uncertain		Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA031312: AB_10603941"	"unprognostic (2.30e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (1.02e-6)"	"unprognostic (7.99e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-2)"	1.8	3.8	2.8	1.7	3.2	1.5	4.8	12.9	3.6	2.9	5.6	1.6	1.7	2.3	5.5	2.4	5.3	2.6	6.9	2.5	3.8	4.1	2.6	2.9	3.4	2.0	2.9	6.2	2.9	11.0	4.5	4.4	1.1	4.5	1.6	14.0	4.1	4.1	5.6	4.3	1.9	2.0	1.4	4.8	2.5	3.7	2.5	6.1	9.1	7.9	4.1	1.9	1.4	3.5	2.9	1.9	11.7	4.9	3.0	6.3	4.8	5.1	6.0	7.8	26.4	0.8	2.6	0.3	3.7	4.4	3.4	0.4	2.5	6.4	9.5	0.0	18.5	9.6	1.1	3.1	4.0	1.2	9.7	4.8	3.0	5.5	10.2	7.1	5.7	3.8	2.9	1.8	7.4	2.1	1.4	2.5	7.4	0.7	5.2	2.6	14.4	9.6	3.7	7.5	12.1	7.5	0.2	2.6	3.7	7.9	7.6	6.2	2.7	7.1	4.6	1.6	5.1	11.5	22.2	3.4	1.5	0.2	7.3	0.2	1.2	1.1	0.3	0.8	1.3	2.1	1.0	0.4	1.5	3.7	1.9	1.0	0.6	1.6	0.9	0.8	0.2	1.0	2.8	3.2	12.9	3.6	2.5	3.8	2.0	2.9	1.1	1.4	2.5	3.5	1.5	6.4	2.6	6.5	2.7	0.6	0.5	0.9	0.6	7.0	2.2	1.5	5.3	2.8	1.6	16.5	6.2	2.3	0.4	1.0	0.0	2.0	0.0	1.0	0.8	2.6	2.4	1.7	4.3	0.4	0.9	1.3	1.1	1.2	2.5	3.8	4.2	3.3	2.6	6.7	4.2	1.4	4.1	4.1	0.5	1.2	0.6	1.6	0.0	1.0	1.2	5.4	1.0	7.5	4.5	0.7	0.5	2.2	0.8	1.2	1.0	2.1	1.7	8.8	0.0	1.1	1.9	0.6	1.3	2.3	1.1	1.8	0.7	1.9	1.5	0.8
ZNF774	MGC75360	ENSG00000196391	"Zinc finger protein 774"	Q6NX45	15	90352284-90369146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Granulosa cells: 45.3;Spermatocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.0"									"HPA030839, HPA030840"	Uncertain		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Intermediate filaments"	Cytosol	"HPA030839: AB_2673630, HPA030840: AB_10602691"	"unprognostic (1.11e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.89e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.82e-2)"	0.7	2.7	2.3	1.2	4.2	1.0	3.4	4.3	3.6	2.6	0.0	4.6	2.2	2.8	4.1	1.4	3.0	2.9	2.8	1.9	2.6	1.4	1.1	1.1	0.7	0.7	1.0	1.1	3.9	3.1	3.0	0.7	0.8	2.4	7.1	4.0	3.9	5.7	6.2	3.1	2.0	1.8	0.0	0.6	2.6	2.2	2.7	1.5	2.7	7.2	0.9	1.9	1.6	3.3	1.7	0.7	2.1	2.4	0.9	0.5	5.0	1.0	1.7	1.3	1.6	2.7	2.0	0.6	2.0	1.3	3.7	2.5	2.2	3.7	1.3	1.2	4.2	1.8	9.0	1.3	1.6	1.0	1.3	0.5	4.4	1.9	1.8	3.6	2.3	3.4	2.0	0.8	2.1	1.6	1.4	0.9	0.6	4.5	2.5	1.3	1.8	0.5	2.6	4.6	4.8	2.0	2.0	3.1	0.8	2.4	2.1	0.2	1.1	1.4	1.3	1.1	2.2	5.2	3.8	0.4	2.3	2.8	0.7	1.4	0.3	0.7	0.2	0.1	0.1	0.2	0.2	0.3	0.6	0.4	0.2	0.2	1.2	0.7	0.2	0.3	0.1	0.1	2.3	4.2	4.3	3.6	1.9	2.6	0.7	1.0	0.8	0.0	2.7	3.3	0.6	6.4	3.2	0.3	0.7	0.8	2.5	1.0	2.2	6.4	2.4	2.4	4.9	0.0	1.1	0.0	0.0	1.7	0.2	6.8	1.9	2.8	15.4	1.7	2.3	1.0	2.4	0.0	2.5	2.0	1.1	0.9	4.1	3.2	0.0	45.3	0.0	1.5	0.8	8.4	2.3	3.3	0.0	0.3	0.7	11.0	0.3	0.8	0.0	0.0	0.2	2.0	0.0	1.5	1.1	1.7	5.5	2.2	0.7	1.4	1.9	1.1	0.7	5.3	0.0	1.7	1.9	11.8	4.5	1.3	0.3	1.4	0.5	0.3	5.5	2.0
ZNF776	FLJ38288	ENSG00000152443	"Zinc finger protein 776"	Q68DI1	19	57746815-57758148	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA046653, HPA068553"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA046653: AB_10961126, HPA068553: AB_2686002"	"unprognostic (6.73e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (3.99e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.86e-2)"	4.4	6.5	4.5	5.2	5.5	17.2	9.1	10.6	6.3	6.6	5.4	6.4	6.4	5.0	21.6	5.0	7.0	4.0	7.2	5.4	4.9	7.7	6.8	6.3	8.3	4.4	3.8	8.3	4.7	10.8	8.3	7.7	4.7	8.5	6.7	20.7	7.8	7.7	9.1	6.4	5.9	4.2	3.7	8.2	7.6	6.6	4.4	12.6	9.3	10.3	8.2	5.5	5.3	8.2	6.2	5.3	16.7	11.2	2.6	8.2	7.2	5.0	8.3	8.7	5.6	3.2	6.8	7.2	4.4	4.6	4.6	4.1	8.8	8.7	13.8	6.5	32.1	9.8	12.6	3.7	6.2	5.5	7.5	9.5	7.1	5.8	6.2	9.2	6.7	11.6	6.6	5.0	11.2	2.9	18.2	4.9	9.7	2.8	11.0	11.6	12.7	8.3	6.4	20.0	18.7	13.7	9.3	7.7	5.5	9.0	7.9	7.7	6.2	9.2	4.9	0.8	7.6	13.8	16.8	12.1	5.5	5.1	7.7	6.6	1.8	8.9	1.1	1.3	2.7	2.4	1.9	2.4	1.7	3.7	2.8	2.2	4.6	5.6	1.7	1.9	1.8	1.6	4.5	5.5	10.6	6.3	5.4	4.9	4.4	3.8	4.7	3.7	4.4	8.2	3.3	3.2	4.1	7.2	7.1	2.7	4.1	3.9	1.8	8.7	7.7	5.3	12.3	11.5	3.2	9.2	2.1	3.1	2.5	3.9	5.9	3.3	1.4	8.3	3.7	6.5	8.4	8.6	7.1	1.3	2.3	2.8	4.1	6.9	3.8	6.9	10.4	8.1	3.5	11.8	7.7	4.1	6.1	6.0	1.8	0.6	1.2	3.6	0.0	6.5	3.1	12.0	5.2	8.0	9.1	2.5	2.1	4.9	3.9	4.1	3.9	2.8	6.0	7.5	0.0	2.6	3.9	2.9	4.8	3.1	1.7	2.9	3.3	2.9	3.2	5.5
ZNF783	DKFZp667J212	ENSG00000204946	"Zinc finger family member 783"	Q6ZMS7	7	149262171-149297302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA020375	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA020375: AB_1859453"	"unprognostic (3.17e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (2.24e-7)"	"unprognostic (2.49e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.11e-4)"	7.1	5.4	6.6	5.3	6.5	3.0	7.4	6.6	7.4	10.8	5.0	7.7	4.0	8.9	3.6	6.0	10.1	3.0	5.4	6.2	6.6	9.9	3.4	6.2	7.3	7.1	6.6	11.7	7.1	2.9	7.1	2.9	6.7	9.4	3.8	2.9	5.8	4.0	6.4	7.0	9.2	4.5	6.1	12.8	6.6	6.6	6.8	4.0	8.3	3.3	6.4	8.1	7.8	8.0	3.5	3.5	5.7	4.1	3.7	6.9	5.3	2.1	1.1	5.0	2.2	5.6	6.5	11.9	5.5	3.5	1.1	2.3	4.0	4.3	2.2	3.3	3.5	7.6	8.7	1.1	8.5	5.1	9.2	7.4	8.7	4.5	5.5	3.1	3.4	4.2	6.2	6.0	4.2	7.6	7.6	7.8	12.8	8.1	4.7	1.6	0.5	10.6	5.6	5.8	4.5	9.5	8.5	4.0	6.0	3.0	4.4	10.1	5.0	4.0	0.9	2.1	4.9	9.1	6.2	0.1	5.6	1.8	8.7	0.1	0.4	0.1	1.0	0.7	0.8	0.7	0.6	0.6	0.4	1.3	0.8	0.7	0.1	0.5	1.7	0.9	0.4	0.4	6.6	6.5	6.6	7.4	6.2	6.6	7.1	6.6	6.7	6.1	6.8	8.0	6.7	3.2	2.7	5.5	6.1	2.5	2.5	4.6	1.8	13.3	7.5	7.6	2.2	7.2	3.2	0.0	10.4	3.0	6.1	3.4	3.9	2.1	5.3	3.2	7.9	4.3	3.6	1.7	5.7	2.7	2.0	7.0	7.1	6.2	0.0	6.4	5.0	6.6	4.2	6.7	6.3	4.7	4.1	7.9	4.6	5.0	8.7	3.9	5.4	11.2	5.2	3.8	8.2	4.0	8.5	3.0	1.6	5.7	3.9	4.0	3.0	1.1	5.5	8.8	13.1	7.4	5.0	16.3	6.9	3.6	3.0	1.1	5.0	6.9	4.3	2.4
ZNF785	FLJ32130	ENSG00000197162	"Zinc finger protein 785"	A8K8V0	16	30573740-30585769	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA004010			Approved	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA004010: "	"unprognostic (2.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.54e-4)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (3.37e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-2)"	5.2	5.7	5.7	4.9	6.4	3.1	6.1	9.1	8.3	10.9	2.9	8.1	8.4	9.6	5.4	6.2	8.8	4.4	5.6	5.6	6.2	8.2	5.8	5.8	5.5	6.1	4.7	11.0	8.3	5.7	9.5	3.6	4.8	10.2	4.7	6.5	8.2	5.1	6.0	7.4	8.2	4.2	2.6	7.6	7.5	3.3	6.3	4.4	8.0	3.6	3.9	9.0	8.5	9.8	5.7	0.5	5.4	7.1	6.5	7.2	1.7	4.9	4.3	5.0	3.7	7.5	8.9	5.9	5.6	4.7	0.3	8.0	0.1	3.2	2.9	4.0	1.4	7.2	17.4	1.8	4.8	0.6	11.8	4.8	6.7	3.3	3.1	4.2	5.3	1.0	6.9	7.1	4.6	9.8	7.3	6.7	3.0	2.2	3.2	18.8	6.1	2.9	4.6	5.8	14.7	10.4	4.0	5.0	3.0	3.2	6.3	6.1	8.1	1.9	5.2	4.4	0.4	0.9	3.3	2.4	6.3	4.3	8.1	2.8	1.1	0.4	0.9	0.6	0.9	2.7	1.1	0.7	0.8	1.1	1.3	1.0	1.9	1.3	2.4	2.3	1.5	0.5	5.7	6.4	9.1	8.3	5.6	6.2	6.1	4.7	4.8	2.6	6.3	9.8	5.3	0.0	3.4	11.1	5.3	1.0	7.6	3.4	6.8	10.7	4.1	2.4	1.8	4.3	2.5	7.3	20.9	1.3	14.3	4.7	5.9	3.9	0.1	3.5	11.1	7.1	12.0	3.4	14.1	3.7	1.1	5.2	3.6	4.5	0.0	14.8	3.6	3.5	2.6	13.5	13.6	5.2	0.0	5.0	3.1	0.8	13.4	3.3	5.4	6.5	6.0	5.8	15.5	6.6	11.4	4.2	8.1	13.2	1.4	7.0	6.6	2.4	4.0	12.0	0.0	6.2	4.6	5.3	3.1	3.1	2.6	0.8	4.7	6.8	7.4	5.1
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favorable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	2.6	3.6	2.1	3.3	2.7	3.4	3.6	5.6	2.5	3.1	2.6	3.6	2.6	3.5	4.4	2.9	4.0	2.0	3.2	2.0	2.7	2.9	3.3	2.9	4.1	2.8	2.3	3.8	2.9	4.9	2.6	3.0	2.2	3.5	3.5	3.1	3.4	3.4	4.7	3.6	2.8	3.7	1.6	3.7	3.0	6.2	2.4	5.5	3.8	5.2	4.7	4.3	2.2	2.9	2.5	5.0	6.5	3.9	7.1	4.2	18.2	6.1	7.4	7.2	8.2	5.3	2.3	5.4	2.4	4.6	9.5	7.7	4.9	7.5	5.7	5.4	3.2	3.7	8.4	6.0	8.4	8.9	5.7	4.2	8.3	8.9	7.2	4.6	7.5	6.1	6.4	7.9	6.9	5.5	7.0	3.3	5.2	6.2	6.4	5.7	9.0	7.7	3.1	3.6	7.4	5.0	11.7	5.9	3.5	5.6	7.9	5.0	5.3	4.6	4.2	4.6	4.8	10.5	24.1	6.8	5.9	2.7	7.8	2.2	3.3	5.1	6.0	4.1	6.7	5.1	3.9	7.6	4.7	5.8	5.2	5.7	4.5	7.2	2.8	4.9	5.5	3.6	2.1	2.7	5.6	2.5	2.0	2.7	2.8	2.3	2.2	1.6	2.4	2.9	0.8	0.0	0.5	2.6	2.4	1.5	1.2	0.8	1.8	0.8	1.0	0.9	2.5	2.8	1.7	0.0	0.0	2.0	0.9	0.9	1.9	2.0	4.5	0.4	1.9	1.1	0.0	4.8	3.1	0.6	0.6	1.2	2.6	0.5	0.0	1.1	1.1	1.2	2.1	1.7	3.2	0.5	0.0	0.8	1.2	4.7	0.6	0.6	0.0	1.0	0.1	0.9	2.1	4.0	2.9	0.5	0.3	1.9	3.0	0.7	0.9	1.0	0.7	1.2	0.0	0.4	1.3	5.8	1.6	2.3	1.0	2.6	1.5	1.3	1.1	0.9
ZNF793		ENSG00000188227	"Zinc finger protein 793"	Q6ZN11	19	37506939-37548762	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 31.3;Early spermatids: 39.6;Horizontal cells: 48.8;Rod photoreceptor cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.6;RT4: 10.0;U-266/70: 18.4;U-266/84: 12.7"					"Low region specificity"	"Detected in all"			HPA034781	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA034781: AB_10602784"	"unprognostic (4.80e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.12e-3)"	1.8	4.4	6.1	2.4	5.7	1.2	3.6	10.0	5.9	4.9	4.3	3.7	1.8	5.3	3.8	3.3	4.6	2.5	4.2	5.5	5.5	5.3	0.8	2.1	3.7	4.4	4.4	8.1	2.5	6.0	9.2	2.7	4.2	4.6	3.3	14.7	2.8	3.2	2.4	6.4	2.5	3.3	3.2	3.6	3.0	9.0	5.3	2.8	6.5	2.3	2.8	3.7	4.5	6.0	0.1	0.2	4.5	11.6	0.9	0.9	0.3	3.7	0.2	0.7	0.4	0.2	1.5	3.4	5.6	1.9	1.0	0.5	0.3	2.9	0.3	0.8	4.2	0.4	0.4	0.3	2.4	0.2	2.9	3.5	2.2	0.7	0.1	0.3	0.1	0.4	0.1	0.5	0.5	3.2	0.4	0.4	7.3	0.0	0.2	0.1	0.1	0.8	3.3	10.0	3.4	6.8	0.1	0.1	0.0	8.2	6.7	0.3	0.4	0.1	1.8	0.2	3.5	18.4	12.7	0.2	0.0	0.2	0.6	4.0	0.6	0.5	0.6	0.2	0.9	0.9	1.1	1.0	0.4	1.4	0.7	0.9	1.6	1.6	0.2	0.9	1.0	0.7	6.1	5.7	10.0	5.9	5.5	5.5	4.4	4.4	4.2	3.2	5.3	6.0	6.5	3.2	5.8	24.2	4.0	3.3	3.8	2.6	6.2	29.1	5.0	5.8	9.7	7.2	5.0	12.9	31.3	5.5	2.9	1.7	3.9	3.6	39.6	5.0	8.7	7.0	9.0	2.1	14.9	1.5	4.1	4.6	1.1	3.9	2.5	21.5	6.4	0.5	0.9	48.8	16.3	2.9	0.0	0.3	3.4	11.2	5.0	0.9	0.0	2.8	1.5	13.6	8.2	19.6	16.7	2.0	1.0	10.1	1.1	2.8	1.0	2.7	5.7	33.6	0.0	8.7	5.3	6.0	6.9	4.0	3.3	1.9	4.0	12.7	3.7	1.9
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 74.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA023090: AB_1859457, HPA052194: AB_2681757"	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	10.7	7.2	5.7	11.6	7.3	74.6	12.0	20.2	5.0	8.4	1.4	10.8	10.4	9.6	7.9	12.5	7.8	11.3	6.0	2.9	4.4	8.2	14.7	10.2	16.6	5.4	6.3	10.3	12.5	11.3	3.5	9.2	5.9	9.3	10.1	9.9	8.2	7.7	5.7	10.6	10.7	9.5	5.9	13.2	11.4	20.6	6.3	13.2	11.0	7.2	14.3	10.5	5.5	7.9	16.0	8.4	9.5	16.5	13.5	17.3	9.2	14.9	17.5	15.1	14.6	7.8	15.0	27.1	9.0	14.6	16.3	11.1	15.7	15.6	20.9	23.9	9.5	17.7	8.5	7.1	16.9	24.2	32.3	15.4	14.9	16.2	22.0	12.5	16.5	16.3	22.3	27.0	16.9	12.4	26.5	17.2	7.9	14.5	10.8	16.7	13.3	18.0	11.0	19.8	13.6	13.9	14.8	58.7	19.8	12.9	7.0	16.3	18.0	25.0	8.0	17.2	18.1	31.7	15.2	39.0	18.8	21.5	21.8	22.1	8.7	13.6	16.1	8.0	16.3	15.4	11.8	16.5	9.0	17.3	19.2	21.0	7.5	25.0	9.0	15.3	18.6	8.0	5.7	7.3	20.2	5.0	2.9	4.4	5.4	6.3	5.9	5.9	6.3	7.9	49.0	38.5	23.5	27.7	65.1	44.7	51.7	14.7	52.3	29.0	28.3	20.6	16.8	11.5	20.1	12.9	22.9	12.0	70.5	30.2	11.7	24.1	44.8	22.2	30.8	37.2	16.2	52.0	46.4	19.2	14.0	32.0	40.2	26.3	29.2	26.3	26.7	17.5	14.4	77.4	35.5	29.3	8.2	25.3	34.1	11.3	27.1	41.7	28.4	45.9	37.9	17.5	79.3	41.7	71.8	24.5	22.0	31.6	57.8	48.3	26.8	13.3	18.3	27.9	26.3	54.9	30.1	111.9	39.9	44.4	47.9	22.0	65.5	30.1	25.5	68.5
ZNF852		ENSG00000178917	"Zinc finger protein 852"	Q6ZMS4	3	44494847-44510636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA048312, HPA071850"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA048312: AB_2680352, HPA071850: AB_2686458"	"unprognostic (2.64e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.62e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.11e-2)"	1.3	1.4	0.7	2.5	0.6	1.6	2.1	3.4	0.9	2.0	3.6	1.9	1.7	2.2	1.7	0.9	1.6	1.3	0.5	0.8	1.1	1.7	1.7	1.8	2.5	0.9	0.7	2.5	2.1	2.9	0.8	2.3	1.1	2.6	3.1	0.9	3.7	2.1	0.5	2.5	2.0	1.9	0.3	2.7	3.0	1.3	1.2	2.9	1.7	0.9	3.2	1.1	0.8	0.7	1.0	1.4	3.9	6.6	0.8	2.3	2.4	1.0	1.3	2.1	3.1	2.1	1.1	3.2	0.7	0.8	0.9	0.8	4.3	1.1	2.8	2.8	1.5	3.1	6.5	1.9	1.2	3.3	5.7	0.8	1.9	2.7	1.1	2.2	1.7	3.3	3.7	1.4	2.5	0.2	3.0	3.8	2.4	1.2	0.8	1.5	4.3	1.9	1.6	3.2	3.0	2.5	2.2	0.9	0.7	6.6	2.2	3.5	2.8	2.6	2.5	1.4	1.0	2.4	1.9	1.9	1.1	2.6	1.7	0.0	0.4	0.7	0.2	0.5	0.3	1.1	0.5	0.3	0.2	0.9	0.5	0.7	0.6	0.4	0.2	1.4	0.2	0.1	0.7	0.6	3.4	0.9	0.8	1.1	0.9	0.7	1.1	0.3	1.2	0.7	2.0	0.0	5.4	5.9	2.3	3.3	0.8	0.9	1.2	2.1	1.5	1.5	1.8	2.8	1.4	0.0	2.1	0.8	5.1	0.8	3.9	1.9	0.3	2.6	1.6	2.0	0.0	3.2	5.7	1.4	0.9	1.4	1.1	1.5	1.3	1.8	2.2	1.4	0.7	1.7	6.8	0.9	2.0	0.3	1.0	0.4	0.6	1.4	1.8	1.9	1.4	2.8	3.1	9.0	9.2	1.5	0.1	1.2	6.8	1.1	1.0	1.0	4.2	1.6	0.0	2.4	1.6	2.0	1.6	0.5	1.8	0.3	2.3	1.6	0.8	0.9
ZNRD2	"p27, SSSCA1"	ENSG00000173465	"Zinc ribbon domain containing 2"	O60232	11	65570460-65573942	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 44.9;Cytotrophoblasts: 81.1;Extravillous trophoblasts: 84.5;Hofbauer cells: 57.9;Syncytiotrophoblasts: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039789, HPA064670"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA039789: AB_2676680, HPA064670: AB_2732718"	"unprognostic (9.32e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.03e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.34e-2)"	39.1	46.0	16.3	32.8	20.2	48.2	38.9	14.0	28.5	38.4	9.1	50.7	22.5	45.9	8.8	41.5	42.5	20.2	50.5	21.7	14.4	45.4	47.6	38.7	32.8	16.1	16.5	38.8	61.8	19.9	31.2	23.3	14.8	41.9	9.1	7.2	45.2	20.7	104.0	42.4	30.9	16.1	9.9	41.4	41.2	50.6	14.7	25.7	35.9	37.0	16.4	43.1	35.7	18.7	79.4	61.5	39.2	72.0	23.5	20.1	61.0	55.0	31.2	50.8	35.5	59.1	79.9	75.3	93.4	30.8	37.0	68.9	29.5	59.2	18.1	54.7	45.8	67.7	61.0	48.0	32.8	81.6	53.8	31.5	40.2	39.4	40.2	39.2	40.6	68.0	79.8	97.0	28.8	110.0	100.1	72.1	63.9	28.2	104.7	77.4	29.0	142.1	30.3	40.2	78.2	81.3	33.4	82.3	79.8	15.9	111.4	41.3	47.3	92.1	50.5	111.1	69.0	69.0	102.8	66.1	74.3	57.1	83.5	15.4	62.8	27.1	56.5	55.5	59.1	103.5	57.2	57.4	51.5	89.5	66.1	57.7	20.1	85.4	37.5	85.9	69.8	50.7	16.3	20.2	14.0	28.5	21.7	14.4	16.1	16.5	14.8	9.9	14.7	18.7	16.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	81.1	16.2	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	84.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	57.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	79.9	2.3	0.0	0.0	0.0
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006637, HPA007018"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA006637: AB_1080646, HPA007018: "	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	2.4	2.3	1.8	2.6	2.0	2.2	5.6	3.6	2.5	3.6	1.6	2.9	2.5	4.3	3.6	1.8	3.0	2.3	2.4	1.8	2.2	2.9	1.6	2.9	4.7	1.7	2.1	5.5	3.2	4.0	2.0	3.6	1.6	4.3	2.9	6.8	3.1	3.7	0.9	1.8	2.7	3.6	1.6	3.9	2.9	4.1	2.2	5.1	5.1	1.7	4.1	3.1	2.9	2.0	5.5	1.8	8.1	0.1	4.1	3.2	5.7	3.7	5.1	5.5	7.6	1.2	2.0	5.3	6.8	2.6	2.8	2.4	0.0	4.6	5.6	0.0	6.6	7.6	5.6	3.8	3.8	2.7	1.8	4.2	4.3	5.5	9.9	6.0	1.5	0.0	11.4	1.1	3.5	0.6	0.0	6.1	5.1	0.5	0.9	9.2	7.3	1.4	4.1	3.5	9.8	10.0	1.9	4.3	6.4	8.0	1.7	6.7	1.5	2.2	4.6	1.7	3.0	3.1	3.4	1.0	1.9	0.7	3.4	2.4	0.7	1.5	1.5	0.4	1.4	1.8	1.1	1.8	1.0	2.7	1.8	1.6	0.2	1.8	0.8	0.9	0.9	0.8	1.8	2.0	3.6	2.5	1.8	2.2	1.7	2.1	1.6	1.6	2.2	2.0	2.1	6.4	5.1	4.6	4.0	0.4	1.1	0.9	0.6	6.1	2.6	2.5	3.2	1.5	6.5	0.0	4.2	1.5	3.6	0.3	1.9	1.7	31.8	0.6	2.4	1.9	1.2	2.1	6.9	2.6	1.0	2.7	1.5	0.9	1.3	5.5	3.3	1.0	1.0	6.7	7.0	1.2	0.0	1.3	1.1	9.7	1.8	1.1	1.8	1.0	1.8	4.9	2.1	10.1	6.2	1.3	0.3	3.4	2.4	1.5	1.5	1.2	0.6	6.0	6.6	1.7	2.4	12.6	3.9	1.2	0.3	0.5	1.5	4.2	2.1	0.7
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.0;Proximal tubular cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favorable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.16e-5)"	7.6	5.8	3.0	4.2	3.9	8.7	7.2	4.8	3.6	6.7	2.3	4.5	3.1	6.4	2.3	2.3	4.0	3.5	6.0	3.2	4.1	7.5	8.8	3.0	4.1	3.2	3.3	6.0	16.6	4.1	4.1	2.1	3.8	5.2	2.9	6.2	6.8	3.0	8.2	2.6	4.4	3.3	2.8	5.9	8.1	11.8	3.7	10.1	4.1	3.1	3.1	4.6	3.5	4.8	2.2	13.4	9.0	14.6	5.7	3.5	8.5	2.5	6.2	5.3	6.4	10.4	5.2	4.9	6.9	3.5	9.8	5.6	6.9	5.0	4.6	10.4	13.0	6.2	8.4	22.0	4.9	3.9	4.4	5.6	4.9	7.0	6.6	7.0	15.5	24.0	8.4	3.9	5.6	6.7	16.8	9.6	16.9	4.5	7.9	16.8	5.6	9.2	5.3	16.7	13.5	23.1	7.6	4.1	11.7	14.5	9.1	9.8	10.8	6.3	12.4	3.2	3.3	6.3	9.5	16.8	4.3	8.7	3.7	6.4	5.8	5.0	5.7	6.4	2.8	3.9	5.2	4.3	6.6	3.5	3.8	4.3	3.1	5.6	8.4	5.9	7.8	3.9	3.0	3.9	4.8	3.6	3.2	4.1	3.2	3.3	3.8	2.8	3.7	4.8	9.1	0.0	2.0	1.6	3.9	0.9	1.2	2.6	2.2	3.1	3.5	3.2	2.5	4.3	1.7	7.3	2.1	1.6	2.5	1.3	5.9	6.9	18.0	5.7	3.3	3.0	3.0	3.0	1.6	8.6	5.1	2.3	4.6	6.9	1.3	8.0	1.1	7.5	3.6	0.0	1.6	3.2	4.1	2.8	2.3	12.3	0.9	2.9	1.8	1.0	5.5	2.3	2.1	4.0	2.5	9.9	4.2	1.5	11.1	2.6	1.9	22.6	1.8	3.1	6.6	2.3	3.9	7.1	8.2	0.9	0.4	1.4	3.7	3.6	2.6	1.5
ZSCAN30	"ZNF397OS, ZNF917"	ENSG00000186814	"Zinc finger and SCAN domain containing 30"	Q86W11	18	35251058-35290245	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA007289	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA007289: AB_1079726"	"unprognostic (6.02e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-3)"	"unprognostic (7.02e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.44e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.36e-1)"	9.2	14.1	12.1	7.9	14.4	7.5	10.1	26.1	16.2	12.3	9.3	11.2	8.6	10.7	10.9	7.1	11.7	7.3	17.5	11.0	15.8	12.1	8.4	9.2	11.0	12.9	9.6	11.1	10.7	13.1	16.7	8.1	12.6	11.3	6.8	28.0	9.3	7.0	16.9	9.9	11.2	7.6	7.7	12.9	9.3	10.0	14.5	11.1	14.6	8.7	7.9	9.7	9.1	26.9	6.2	1.7	13.4	18.2	9.1	17.8	9.3	11.9	15.9	6.7	13.1	5.1	7.6	11.3	7.7	12.5	11.5	4.1	6.5	12.4	18.0	11.5	3.7	7.1	8.9	3.6	9.3	5.9	6.8	11.6	9.6	17.9	15.5	17.5	13.2	15.7	12.1	12.8	18.0	2.8	9.1	10.5	8.9	1.8	5.7	13.6	4.6	8.4	10.4	4.2	19.4	9.9	11.7	3.7	4.8	14.1	5.8	8.3	15.5	24.6	5.2	3.8	4.6	23.4	10.7	10.0	18.4	6.8	13.9	1.4	0.6	2.3	2.1	0.8	1.3	2.5	2.0	1.2	1.1	3.3	2.3	2.6	2.3	2.0	1.0	2.6	2.0	1.2	12.1	14.4	26.1	16.2	11.0	15.8	12.9	9.6	12.6	7.7	14.5	26.9	8.4	9.6	8.7	22.2	7.5	1.8	2.0	3.2	13.6	30.5	4.8	5.5	15.5	10.0	9.1	1.8	20.9	3.3	6.4	3.4	5.9	5.2	9.3	7.0	11.9	10.7	7.2	7.8	21.8	3.4	1.5	6.0	7.7	6.5	8.8	18.8	10.0	5.2	2.6	20.2	18.4	4.0	2.0	4.7	1.7	9.0	5.9	3.3	0.0	23.4	2.3	12.2	7.2	26.2	52.1	3.1	4.0	7.9	3.3	2.0	5.9	4.5	6.2	19.3	0.0	10.3	6.3	13.5	5.3	4.2	1.0	1.8	5.3	15.4	3.1	1.6
ZSCAN31	"ZNF310P, ZNF323"	ENSG00000235109	"Zinc finger and SCAN domain containing 31"	Q96LW9	6	28324693-28356271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.5;Late spermatids: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.5;EFO-21: 40.1;TIME: 31.0;U-2 OS: 47.6"					"Low region specificity"	"Detected in all"			HPA007124	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA007124: AB_1080703"	"unprognostic (1.11e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (2.19e-5)"	"unprognostic (8.43e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	5.3	3.4	10.5	2.5	12.9	4.7	13.0	24.1	18.3	8.1	4.4	9.9	4.1	19.2	9.5	11.3	7.9	18.7	7.9	15.5	8.7	6.2	5.6	10.7	2.5	14.0	10.8	19.7	7.2	4.4	6.2	3.0	14.6	8.3	6.1	8.2	6.4	9.3	9.6	13.4	4.4	12.6	11.7	2.7	16.9	20.9	12.7	4.6	13.5	8.0	4.1	5.7	6.3	21.2	2.0	2.7	4.1	19.1	0.7	0.9	6.0	0.9	1.2	0.9	0.8	2.5	29.5	0.5	40.1	1.4	5.9	6.2	2.1	1.8	0.6	3.6	1.7	6.5	16.0	4.5	1.7	14.0	8.3	0.7	16.2	1.1	1.7	1.9	28.0	5.4	7.7	4.9	4.3	2.9	2.4	3.4	1.3	1.4	12.1	6.2	3.7	3.7	2.8	2.5	13.6	3.7	26.3	16.6	3.9	3.0	8.4	4.7	31.0	6.1	47.6	1.2	2.2	2.1	3.3	0.5	0.7	6.7	1.4	17.6	0.3	0.6	1.3	0.2	1.2	1.2	1.1	1.0	0.3	1.0	0.8	1.2	0.2	1.3	0.3	1.8	0.2	0.3	10.5	12.9	24.1	18.3	15.5	8.7	14.0	10.8	14.6	11.7	12.7	21.2	7.0	28.9	3.3	15.7	0.5	0.8	2.4	7.5	14.8	8.9	3.3	2.8	7.6	2.8	11.6	3.7	0.0	1.9	1.8	4.9	7.9	2.9	138.5	6.6	1.5	7.4	6.0	0.8	27.9	8.1	0.9	4.1	10.2	5.8	2.5	2.2	1.8	4.8	0.7	1.7	11.7	2.5	16.2	0.8	1.2	65.0	3.7	0.7	1.8	4.7	0.7	7.2	1.0	4.0	18.5	4.8	2.6	5.3	2.0	1.4	1.2	8.1	3.9	5.9	6.6	2.7	3.4	11.2	4.5	6.8	2.3	0.8	1.1	2.3	3.3	1.5
ZSCAN32	"FLJ20417, ZNF434"	ENSG00000140987	"Zinc finger and SCAN domain containing 32"	Q9NX65	16	3382081-3401065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA005758	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA005758: AB_1080720"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.71e-2)"	4.8	5.9	8.9	5.6	9.4	3.6	5.9	8.6	10.9	6.2	10.0	6.6	7.8	6.0	4.4	4.9	6.9	5.0	5.3	8.6	10.1	5.9	5.5	6.0	8.6	9.6	9.6	8.2	7.4	7.6	8.4	5.4	9.5	6.5	5.7	11.6	4.9	7.0	4.6	6.1	5.4	5.5	8.8	6.9	5.9	7.4	9.6	10.1	7.2	3.3	9.1	6.1	5.2	11.4	6.0	10.1	12.7	15.3	10.1	10.0	9.5	7.1	12.6	10.3	9.9	5.2	8.8	19.4	7.5	10.6	6.8	6.4	10.6	10.6	12.0	13.0	7.6	16.7	9.1	7.1	12.7	11.9	12.1	10.0	17.1	10.2	17.3	11.2	10.6	21.3	16.5	7.5	13.5	7.5	16.4	8.1	13.8	10.6	5.1	16.0	13.1	18.6	8.9	6.4	11.2	8.6	14.4	8.8	7.8	8.1	10.1	14.7	12.8	8.9	8.4	7.3	8.6	12.4	14.8	25.1	2.5	9.4	13.6	4.1	5.4	7.3	9.7	4.2	8.3	8.3	6.7	6.2	4.9	6.7	9.3	9.0	6.0	15.0	13.1	5.0	9.5	6.2	8.9	9.4	8.6	10.9	8.6	10.1	9.6	9.6	9.5	8.8	9.6	11.4	3.9	19.2	5.3	3.3	5.1	2.3	2.2	1.7	1.8	4.6	3.0	3.4	0.9	5.7	6.2	1.8	8.4	4.9	3.6	2.7	11.7	5.6	1.6	3.5	3.8	3.9	0.0	6.1	4.8	6.2	2.7	2.8	1.5	2.2	5.1	4.6	2.5	3.4	3.0	8.4	4.4	3.3	2.0	5.1	1.8	1.4	4.4	5.1	1.8	9.4	6.2	6.0	9.2	8.0	7.7	5.8	3.2	5.3	3.6	3.9	3.1	3.7	1.7	4.2	0.0	4.1	2.9	15.9	15.9	2.9	2.8	2.6	5.6	6.5	3.1	1.5
ZSCAN9	"PRD51, ZNF193"	ENSG00000137185	"Zinc finger and SCAN domain containing 9"	O15535	6	28224886-28233487	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA054512, HPA059951"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA054512: AB_2682511, HPA059951: AB_2684176"	"unprognostic (1.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.14e-3)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.74e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.16e-5)"	9.7	11.2	11.3	8.9	12.6	10.7	13.9	15.0	13.8	14.5	14.4	13.4	9.2	14.2	13.4	7.9	11.4	9.4	11.8	11.1	12.6	15.2	9.3	10.1	8.6	12.4	12.5	14.3	12.1	11.5	14.2	11.2	12.9	14.6	14.8	17.4	11.6	11.8	9.1	6.4	12.9	11.7	12.2	16.3	11.8	20.9	12.6	4.4	13.2	7.9	10.3	12.0	10.3	13.4	11.2	7.7	25.7	30.9	9.8	10.6	8.9	13.5	11.3	12.9	14.4	7.1	5.5	0.1	19.9	8.5	12.5	7.7	12.3	12.5	14.6	7.5	10.6	17.1	16.8	13.1	12.4	20.4	13.1	9.1	19.1	10.9	16.6	19.5	16.9	0.0	25.8	9.3	19.2	6.5	0.1	33.4	9.5	5.0	8.6	10.5	17.9	11.7	16.3	15.4	22.3	30.0	11.8	8.8	16.3	19.1	10.9	13.8	13.9	26.2	18.0	6.3	23.2	20.8	22.5	4.5	5.4	24.6	15.4	4.3	3.5	5.1	3.5	1.8	2.9	4.7	1.2	2.7	5.0	4.0	0.4	0.7	1.3	11.7	0.9	2.6	0.9	2.2	11.3	12.6	15.0	13.8	11.1	12.6	12.4	12.5	12.9	12.2	12.6	13.4	6.1	9.6	3.6	5.9	4.4	0.9	5.3	8.0	0.6	7.3	5.5	4.3	5.1	12.8	10.2	3.7	0.0	5.1	5.3	3.8	1.9	8.5	21.5	2.5	4.9	6.5	5.4	4.0	4.5	6.4	3.1	5.3	2.0	3.6	5.7	7.3	5.7	2.4	5.4	6.7	4.7	6.9	4.1	5.3	4.6	5.1	3.7	5.0	3.6	10.3	3.1	4.8	4.1	8.0	10.0	6.1	6.1	4.9	3.6	3.5	4.9	3.8	4.8	6.6	6.6	5.0	5.3	23.7	15.8	3.1	1.1	12.0	2.3	5.8	6.7	2.5
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA041147: AB_2677329, HPA046751: AB_2679785"	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	3.0	4.1	2.7	3.7	2.6	6.0	3.5	4.6	2.9	3.1	2.7	4.1	4.6	3.4	3.5	3.5	4.2	3.2	4.9	2.7	2.5	3.6	1.9	3.3	5.0	2.6	2.7	5.8	4.2	4.9	1.1	4.0	2.5	4.1	3.5	8.2	4.9	3.4	15.9	6.5	4.4	3.5	1.9	4.6	4.3	3.8	2.9	3.9	4.5	5.1	4.9	3.4	1.4	3.1	7.2	8.6	6.4	7.8	11.2	6.3	6.5	4.8	5.9	10.2	9.3	19.5	8.4	8.4	13.9	6.7	11.2	17.0	10.1	12.9	7.7	3.4	6.1	10.7	11.5	14.0	6.8	9.2	10.9	9.2	10.6	8.6	8.2	7.8	7.9	7.3	9.8	6.7	6.0	20.8	10.0	7.9	3.6	8.1	9.7	7.8	9.1	6.0	6.7	10.1	8.6	5.5	16.2	24.0	5.8	5.7	14.6	7.2	7.0	11.5	7.3	6.4	7.0	6.6	5.0	8.2	9.2	6.8	6.0	2.4	1.4	3.6	0.5	1.8	0.3	2.4	1.7	0.7	0.7	2.2	2.3	2.1	1.6	0.6	1.8	2.2	1.4	0.8	2.7	2.6	4.6	2.9	2.7	2.5	2.6	2.7	2.5	1.9	2.9	3.1	0.8	3.2	2.7	0.7	1.4	1.1	2.4	2.4	2.2	3.0	0.8	0.5	5.7	4.3	1.2	0.0	0.0	2.9	0.3	4.2	3.9	2.4	0.6	1.1	1.7	1.7	2.4	4.4	0.8	3.8	2.8	1.9	4.1	1.5	3.8	2.5	2.5	2.1	1.7	6.7	0.9	2.8	2.0	1.4	1.9	0.7	3.4	0.7	0.0	0.0	1.8	1.6	1.0	0.0	0.8	3.3	3.7	1.5	0.5	1.6	2.4	1.2	0.4	3.8	0.0	2.0	1.8	1.0	2.0	1.4	1.6	2.3	1.8	3.6	3.0	2.0
ZSWIM3	"C20orf164, dJ337O18.7, PPP1R174"	ENSG00000132801	"Zinc finger SWIM-type containing 3"	Q96MP5	20	45857614-45879122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 7.6;Inhibitory neurons: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055692, HPA060508"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA055692: AB_2682887, HPA060508: AB_2684297"	"prognostic unfavorable (9.32e-5)"	"unprognostic (8.53e-2)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.77e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.72e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.13e-2)"	1.3	2.9	2.3	2.0	2.2	0.7	1.8	2.8	2.5	1.8	1.4	2.3	2.4	1.9	2.8	1.8	2.1	1.5	2.0	2.1	2.3	1.8	2.3	1.9	3.4	2.0	2.1	2.7	1.5	2.2	1.9	1.7	2.1	1.9	2.3	3.3	1.8	1.6	1.4	2.2	2.4	1.7	2.0	3.2	1.8	3.2	2.2	3.5	1.9	2.4	3.9	1.6	1.4	2.1	1.7	1.4	4.1	2.4	4.9	3.5	2.4	2.6	3.1	4.7	4.6	5.9	2.6	5.3	8.8	2.2	2.3	2.8	5.9	2.8	3.5	3.3	2.5	5.1	2.6	3.8	5.9	2.9	6.7	3.2	3.1	3.6	2.2	5.0	4.1	4.6	4.8	2.5	3.6	8.5	4.0	5.8	1.6	3.9	5.6	3.9	3.8	4.0	1.3	1.0	5.4	2.7	4.2	4.8	3.3	3.1	2.3	7.6	4.1	4.7	1.5	1.8	1.6	5.4	3.0	3.4	4.0	3.4	1.5	1.0	1.1	1.6	1.3	1.5	2.8	2.1	1.5	2.0	1.9	1.8	1.4	1.9	0.8	1.7	4.8	1.1	2.4	1.1	2.3	2.2	2.8	2.5	2.1	2.3	2.0	2.1	2.1	2.0	2.2	2.1	1.6	3.2	1.1	4.6	4.1	0.4	0.3	0.7	0.6	4.4	1.1	1.0	1.3	0.0	0.5	1.8	0.0	1.3	1.4	2.8	0.0	1.2	0.5	0.6	1.2	1.8	2.4	0.8	7.6	1.4	0.6	1.4	1.5	1.0	0.0	5.2	2.2	0.8	1.0	0.0	9.2	1.1	0.0	1.3	1.4	0.7	0.3	1.1	0.0	6.5	0.6	2.8	0.0	7.1	7.0	0.6	0.3	1.2	2.6	0.2	2.0	1.2	0.5	4.3	0.0	1.3	1.2	2.4	4.3	1.3	0.3	0.8	3.1	4.7	0.9	0.4
ZSWIM6	KIAA1577	ENSG00000130449	"Zinc finger SWIM-type containing 6"	Q9HCJ5	5	61332258-61546172	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 500.1;Microglial cells: 365.4;Oligodendrocyte precursor cells: 765.6;Oligodendrocytes: 740.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035938	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA035938: AB_10672077"	"unprognostic (2.22e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.99e-1)"	8.1	5.4	11.0	8.9	17.0	3.8	5.8	13.0	14.3	6.6	4.1	9.6	6.0	5.0	5.5	8.8	6.3	9.5	4.8	11.0	12.0	5.1	7.8	13.4	5.7	15.7	13.6	7.2	7.7	5.8	6.4	7.8	14.9	8.3	10.7	8.3	6.9	6.4	3.4	5.3	7.5	6.2	12.4	7.0	10.0	7.4	14.2	6.9	6.5	2.5	5.0	7.6	8.4	26.5	6.0	7.8	35.4	2.5	7.5	13.6	3.0	7.9	7.1	8.6	13.2	3.1	9.4	1.5	6.7	9.9	13.7	5.1	7.9	9.6	12.0	25.0	7.4	2.9	16.3	1.7	9.9	1.9	4.1	9.9	7.0	20.2	17.2	11.8	21.3	3.3	0.9	29.3	35.4	4.3	1.6	3.8	5.4	1.8	5.8	11.8	10.3	44.4	14.1	7.7	7.2	11.3	18.7	1.1	7.3	13.7	3.1	7.7	29.8	7.1	9.2	9.9	11.4	5.1	0.8	3.2	11.0	2.3	15.4	0.9	1.1	0.5	0.0	0.9	0.3	0.2	0.1	0.1	0.5	0.3	0.1	0.1	1.6	0.4	1.3	1.3	0.1	0.2	11.0	17.0	13.0	14.3	11.0	12.0	15.7	13.6	14.9	12.4	14.2	26.5	24.5	25.6	12.6	500.1	13.3	47.4	80.2	12.0	42.1	6.9	25.8	20.4	12.2	25.8	27.1	11.0	10.4	0.4	29.5	38.4	1.9	12.0	12.7	47.4	37.4	23.6	14.2	1.7	223.4	12.9	0.5	22.7	28.1	86.1	14.5	9.6	27.8	8.0	25.9	8.4	167.7	25.8	14.2	59.3	49.0	8.5	5.6	53.3	16.0	365.4	34.0	15.6	2.1	765.6	740.4	19.2	30.2	6.4	14.3	40.6	9.4	4.9	28.8	5.1	6.6	19.5	22.7	18.9	18.8	32.2	39.9	1.4	15.7	27.1	19.8	58.3
ZSWIM8	"4832404P21Rik, KIAA0913"	ENSG00000214655	"Zinc finger SWIM-type containing 8"	A7E2V4	10	73785606-73801797	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041244	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA041244: AB_10794269"	"unprognostic (8.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-2)"	"prognostic favorable (5.61e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.52e-1)"	60.4	97.0	86.7	19.7	88.1	42.8	59.3	85.1	110.5	77.1	88.3	77.7	27.2	63.8	43.4	105.6	62.5	24.9	65.1	87.5	85.5	97.3	143.6	68.9	25.1	87.9	86.4	69.8	64.4	35.4	145.0	24.8	87.1	91.1	17.8	27.5	70.9	28.4	62.2	88.9	70.1	28.1	83.7	109.8	68.1	96.4	87.8	25.1	87.6	22.4	21.6	74.5	77.1	90.4	14.0	23.3	28.4	46.9	65.6	31.2	16.3	17.5	48.1	24.3	29.1	20.7	11.3	7.9	12.3	28.6	23.6	20.6	10.1	19.9	12.2	12.6	21.3	11.2	26.1	27.7	49.2	7.7	41.4	51.4	36.2	30.2	35.0	66.0	28.5	16.4	16.0	14.9	28.3	21.2	11.7	22.8	8.4	11.2	72.8	13.9	13.5	4.7	34.9	29.6	6.8	30.9	14.5	42.1	25.9	24.5	28.5	15.8	29.6	26.7	16.0	12.2	18.1	37.6	21.6	5.1	29.5	11.3	14.1	2.4	2.2	1.9	3.0	1.5	1.7	1.8	1.3	1.3	1.8	1.2	0.6	1.9	4.9	1.1	2.5	3.8	1.8	1.0	86.7	88.1	85.1	110.5	87.5	85.5	87.9	86.4	87.1	83.7	87.8	90.4	17.2	3.2	11.5	49.6	7.2	12.4	7.4	15.1	11.4	32.8	20.2	17.7	1.4	20.0	12.8	20.2	68.8	13.4	27.2	21.7	1.9	13.7	5.5	14.0	19.0	17.1	20.4	11.4	34.0	14.8	8.4	13.2	24.5	22.2	0.0	18.8	29.6	35.0	19.0	35.3	30.2	18.3	14.2	24.2	15.7	2.2	22.1	17.1	16.0	21.5	19.2	19.6	15.5	26.7	36.5	17.5	19.5	24.0	8.2	17.7	41.3	11.7	15.4	45.3	13.1	21.1	18.3	35.8	15.9	14.9	14.2	28.7	13.9	19.3	12.1	17.9